Citrus Sinensis ID: 012887

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450----
Protein Sequence
MKEVFLHIKLIEQASGDDRPAIMIQEVSDDEAQGSVYKLTFACNSSISWPAMSGALDTASICCKKIQIFEKKGFTLGVVILAVQAGQEKSFKSQIENALKSAIKKPKPTSVKLPFGLCGCQEENTKGRDFGEIEEEEACDESFRNGVENSNLKIQLQMPLPSSSFVVSVDEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNSSNR
Secondary Structure (PSIPRED)
cHHHHHHHHHHHHHccccccEEEEEEEEcccccccEEEEEccccccccccccccccccccEEEccEEEEEcccccHHEEEHHHHccccHHHHHHHHHHHHHHHccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEcccccccccEEEccccccEEEccEEEEEEEEcccccHHHHHHHHHHHHHHHHcccccEEEEEEEEEcccccEEEEEEccccccHHHHHHccccccHHHHHHHHHHHHHHHHHHHcccccccccccccEEEcccccEEEEccccEEEccccccccccccccccccHHHHHccccccccccccccEEEHHHHHHHHHccccccccccHHHHHHHHHHccccccccccccHHHHHHHHHHccccccccccHHHHHHHHHHHHHccccccc
Secondary Structure Prediction (SSPRO)
ccHHHHHHHHHHHHHcccccEEEEEEEcccccccEEEEEEEEcccccccccccccccccHHHHHHHHHHHccccEEEEEEEEEcccHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccccccccccccHHHHcccccccccccccccccccEEEccccccccccccccccccEEEccccEEEEEEEcccccccEEEcEEEEEEEccccccccHHHHHHHHHHHHHHHcccccEEEEEEEEEcccccEEEEEEccccccHHHHHHHcccccHHHHHHHHHHHHHHHHHHHHccccHHHHHHHHHEEccccEEEEEcccHHEEccccccHHcccccccEcccHHHHHcccccEEEEcHHHHHHHHHHHHHHHccccccccccHHHHHHHHHHccccccccccccHHHHHHHHHHHHccccccccHHHHHHHHHHHHcccccccc
Coil and Loop (DISEMBL)
MKEVFLHIKLIEqasgddrpaimiqevsddeaqgsVYKLTFAcnssiswpamsgalDTASICCKKIQIFEKKGFTLGVVILAVQAGQEKSFKSQIENALKSAikkpkptsvklpfglcgcqeentkgrdfgeieeeeacdesfrngvensnlkiqlqmplpsssfvvsvdewqtvqsGGEEIGRwllnsdnlefidqigpnsfkgvykgkrvgieklkgcdkgnaYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKlmeggsvndLILKSRKLQTKEIIRIAIDVAEGIKFLndhgvayrdlnsQRILldrhgnvclgdMGIVTACKSvgeateyetdgyrwlapeiiagdpesvseTWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAacglrpeipkdcPQILKSLMIkcwnnspskrpqFSEIISLLLRtnnisnssnr
Flexible Loop (DISEMBL)
MKEVFLHIKLieqasgddrpaIMIQEVSDDEAQGSVYKLTFACNSSISWPAMSGALDTASICCKKIQIFEKKGFTLGVVILAVQAGQEKSFKSQIENALKsaikkpkptsvklpfglcgcqeentkgrdfgeIEEEEACDESFRNGVENSNLKIQLQMPLPSSSFVVSVDEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGieklkgcdkgnAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISlllrtnnisnssnr
Low Complexity Region (SEG)
MKEVFLHIKLIEQASGDDRPAIMIQEVSDDEAQGSVYKLTFACNSSISWPAMSGALDTASICCKKIQIFEKKGFTLGVVILAVQAGQEKSFKSQIENALKSAIKKPKPTSVKLPFGLCGCQEENTKGRDFGEIEEEEACDESFRNGVENSNLKIQLQMPLPSSSFVVSVDEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNSSNR
Disordered region (IsUnstruct)
***VFLHIKLIE*********IMI********QGSVYKLTFACNSSISWPAMSGALDTASICCKKIQIFEKKGFTLGVVILAVQAG*************************KLPFGLCGC******************************************SSFVVSVDEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAAC*********************CPQILKSLMIKCWNN********SEIISLLL***********
Disordered Region (DISOPRED)
*KEVFLHIKLIEQASGDDRPAIMI***************TFACNSSISW*****ALDTASICCKKIQIFEKKGFTLGVVIL*******************************************************************************************************WLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE*TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLL***********
Disordered Region (DISEMBL)
MKEVFLHIKLIEQASGDDRPAIMIQEVSDDEAQGSVYKLTFACNSSISWPAMSGALDTASICCKKIQIFEKKGFTLGVVILAVQAGQEKSFKSQIENALKSAIKKPKPTSVKLPFGLCGCQEENTKGRDFGEIEEEEACDESFRNGVENSNLKIQLQMPLPSSSFVVSVDEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNSSNR
Disordered Region (DISPRO)
*KEVFLHIKLIEQASGDDRPAIMIQEVSDDEAQGSVYKLTFACNSSISWPAMSGALDTASICCKKIQIFEKKGFTLGVVILAVQAGQEKSFKSQIENALKSAIKKPKPTSVKLPFGLCGCQ***********************************QMPLPSSSFVVSVDEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNI******
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MKEVFLHIKLIEQASGDDRPAIMIQEVSDDEAQGSVYKLTFACNSSISWPAMSGALDTASICCKKIQIFEKKGFTLGVVILAVQAGQEKSFKSQIENALKSAIKKPKPTSVKLPFGLCGCQEENTKGRDFGEIEEEEACDESFRNGVENSNLKIQLQMPLPSSSFVVSVDEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNSSNR
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	454	2.2.26 [Sep-21-2011]
Q55GU0	916	Probable serine/threonine	yes	no	0.515	0.255	0.347	1e-34
Q55A09	1331	Probable serine/threonine	no	no	0.550	0.187	0.313	6e-34
Q2MHE4	390	Serine/threonine-protein	no	no	0.583	0.679	0.293	7e-33
Q7TQP6	835	Serine/threonine-protein	yes	no	0.669	0.364	0.306	5e-32
Q54I36	1338	Dual specificity protein	no	no	0.548	0.186	0.301	2e-31
Q5GIG6	834	Serine/threonine-protein	yes	no	0.555	0.302	0.323	7e-31
P18161	1155	Dual specificity protein	no	no	0.544	0.213	0.301	1e-30
Q59H18	835	Serine/threonine-protein	no	no	0.548	0.298	0.319	4e-30
Q7T6Y2	1624	Putative serine/threonine	N/A	no	0.671	0.187	0.285	3e-29
Q9ESL4	802	Mitogen-activated protein	no	no	0.546	0.309	0.320	4e-28

>sp|Q55GU0|Y9955_DICDI Probable serine/threonine-protein kinase DDB_G0267514 OS=Dictyostelium discoideum GN=DDB_G0267514 PE=3 SV=1

 Score =  148 bits (373), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 84/242 (34%), Positives = 132/242 (54%), Gaps = 8/242 (3%)

Query: 203 FKGVYKGKRVGIEKLK-GCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCV 261
           +KG+++G  V I+++K   D  N    E RK+L  L    H NI+     C    + LC 
Sbjct: 677 YKGLWRGSSVAIKQIKINEDVNNQVLEEFRKELTILSRLRHPNIVLLMAACTAPPN-LCF 735

Query: 262 VTKLMEGGSVND-LILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH 320
           +T+ + GGS+ D L  K  K+  +   ++AI +A+G+ +L+  GV +RD+ S  +LLD H
Sbjct: 736 ITEYLPGGSLYDALHSKKIKMNMQLYKKLAIQIAQGMNYLHLSGVIHRDIKSLNLLLDEH 795

Query: 321 GNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWE 380
            NV + D G+ +  KS             W++PE++ G+      T   +VY+FG+++WE
Sbjct: 796 MNVKICDFGL-SKLKSKSTEMTKSIGSPIWMSPELLMGE----DYTEKVDVYAFGIILWE 850

Query: 381 MVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIIS 440
           + TGE  Y+    VQ A+ +    LRP IP   P  L  L+  CW+  P KRP F+EI++
Sbjct: 851 LGTGELPYSGLDSVQLALAVTTKSLRPPIPNAWPYQLSHLIQACWHQDPLKRPSFTEILN 910

Query: 441 LL 442
           LL
Sbjct: 911 LL 912

Dictyostelium discoideum (taxid: 44689)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q55A09|Y9963_DICDI Probable serine/threonine-protein kinase DDB_G0272254 OS=Dictyostelium discoideum GN=DDB_G0272254 PE=3 SV=1

 Score =  145 bits (366), Expect = 6e-34,   Method: Compositional matrix adjust.
 Identities = 86/274 (31%), Positives = 148/274 (54%), Gaps = 24/274 (8%)

Query: 186  LLNSDNLEFIDQIGPNSF----KGVYKGKRVGIEKLKGCDKGNAYE---FELRKDLLELM 238
            ++N  +++   +IG   F    KG +KGK V ++KL   +K  A E    E + ++  L 
Sbjct: 1067 MINYSDIKIDKEIGKGHFSKVLKGNWKGKDVAVKKL-NSNKDKAREEMIQEFKAEVELLG 1125

Query: 239  TCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL-------KSRKLQTKEIIRIAI 291
            +  H N++  Y   ++    +C+V + +  G++ +LI        +S KL +  I+ IA 
Sbjct: 1126 SLQHPNLVTCYGYSLNP---MCIVMEFLPSGNLFELIHSKPSEQQQSIKLDSTLILAIAF 1182

Query: 292  DVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWL 351
            D+A G++ L+   + +RDL S  +L+D+H N+ + D+GI          T   T    W 
Sbjct: 1183 DIARGMQHLHTRNIIHRDLKSSNLLMDKHFNIKIADLGIARETSFTQTMTTIGTVA--WT 1240

Query: 352  APEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPK 411
            APEI+  +    S    ++VYS+ +V++E++TGE  Y    P+ A + +A+ GLRPE+P 
Sbjct: 1241 APEILRHE----SYNQKADVYSYAIVLYELLTGEEPYQGIPPMNAGILVASKGLRPELPD 1296

Query: 412  DCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRT 445
            +C    K L++ CW+  P+KRP F EI + L +T
Sbjct: 1297 NCDPNWKKLVVWCWSEDPNKRPSFEEITNYLTKT 1330

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q2MHE4|HT1_ARATH Serine/threonine-protein kinase HT1 OS=Arabidopsis thaliana GN=HT1 PE=1 SV=1

 Score =  142 bits (357), Expect = 7e-33,   Method: Compositional matrix adjust.
 Identities = 84/286 (29%), Positives = 147/286 (51%), Gaps = 21/286 (7%)

Query: 168 SVDEWQTVQSGGEEIGRWLLNSDNL----EFIDQIGPNSFKGVYKGKRVGIEKLK----G 219
           +V+ W+  +   EE   W  +   L    +F        ++G+YK + V ++ ++     
Sbjct: 65  NVETWEASKGEREE---WTADLSQLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPTHK 121

Query: 220 CDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR 279
            +     E + + ++  L    H NI+QF   C  +    C++T+ M  G++   + K  
Sbjct: 122 EETRAKLEQQFKSEVALLSRLFHPNIVQFIAAC-KKPPVYCIITEYMSQGNLRMYLNKKE 180

Query: 280 --KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC-KS 336
              L  + ++R+A+D++ G+++L+  GV +RDL S  +LL+    V + D G  T+C ++
Sbjct: 181 PYSLSIETVLRLALDISRGMEYLHSQGVIHRDLKSNNLLLNDEMRVKVADFG--TSCLET 238

Query: 337 VGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQA 396
                +     YRW+APE+I   P     T   +VYSFG+V+WE+ T    +   +PVQA
Sbjct: 239 QCREAKGNMGTYRWMAPEMIKEKPY----TRKVDVYSFGIVLWELTTALLPFQGMTPVQA 294

Query: 397 AVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
           A  +A    RP +P  C   L  L+ +CW+ +PSKRP FS I+++L
Sbjct: 295 AFAVAEKNERPPLPASCQPALAHLIKRCWSENPSKRPDFSNIVAVL 340

Serine/threonine kinase involved in the control of stomatal movement in response to CO(2). Shows a reduced response to ABA or light compared to CO(2).

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q7TQP6|TNI3K_RAT Serine/threonine-protein kinase TNNI3K OS=Rattus norvegicus GN=Tnni3k PE=2 SV=3

 Score =  139 bits (349), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 101/329 (30%), Positives = 167/329 (50%), Gaps = 25/329 (7%)

Query: 128 RDFGEIEEEEACDESFRNGVENSNLKIQLQMPLPSSSFVVSVDEWQTVQSGGEEI-GRWL 186
           + +   +EE  C+E  + G + S + +    P P         E   V     E+  R+ 
Sbjct: 402 KHYKRPQEELPCNEYSQPGGDGSYVSV----PSPLGKIKSMTKEKADVLLLRAELPSRFH 457

Query: 187 LNSDNLEFIDQIGPNSFKGVYKG----KRVGIEKLKG---CDKGNAYEFELRKDLLELMT 239
           L    +EF + IG  SF  VYKG    K V I++ +    C K +   F   +++  L  
Sbjct: 458 LQLSEIEFHEIIGSGSFGKVYKGRCRNKIVAIKRYRANTYCSKSDVDMF--CREVSILCQ 515

Query: 240 CGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK---LQTKEIIRIAIDVAEG 296
             H  ++QF   C+D+     +VT+ + GGS+  L+ + ++   LQ+K II  A+DVA+G
Sbjct: 516 LNHPCVVQFVGACLDDPSQFAIVTQYISGGSLFSLLHEQKRILDLQSKLII--AVDVAKG 573

Query: 297 IKFLND--HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG-YRWLAP 353
           +++L+     + +RDLNS  ILL   G+  + D G     +S+ E    +  G  RW+AP
Sbjct: 574 MEYLHSLTQPIIHRDLNSHNILLYEDGHAVVADFGESRFLQSLDEDNMTKQPGNLRWMAP 633

Query: 354 EIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDC 413
           E+     +    T  ++V+S+ + +WE++TGE  +A   P  AA  +A   +RP I    
Sbjct: 634 EVFT---QCTRYTIKADVFSYSLCLWELLTGEIPFAHLKPAAAAADMAYHHIRPPIGYSI 690

Query: 414 PQILKSLMIKCWNNSPSKRPQFSEIISLL 442
           P+ + SL+I+ WN  P  RP+FSE++S L
Sbjct: 691 PKPISSLLIRGWNACPEGRPEFSEVVSKL 719

May play a role in cardiac physiology.

Rattus norvegicus (taxid: 10116)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q54I36|PYK3_DICDI Dual specificity protein kinase pyk3 OS=Dictyostelium discoideum GN=pyk3 PE=1 SV=1

 Score =  137 bits (345), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 80/265 (30%), Positives = 140/265 (52%), Gaps = 16/265 (6%)

Query: 183  GRWLLNSDNLEFIDQIGPNSFK----GVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELM 238
            G+  +  D +  ++++G  SF     G++ G +V I+ LK     N  +F   K++  L+
Sbjct: 1048 GKKEIKFDEVAIVEKVGAGSFANVFLGIWNGYKVAIKILKNESISNDEKF--IKEVSSLI 1105

Query: 239  TCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLI-LKSRKLQTKEIIRIAIDVAEGI 297
               H N++ F   C+D     C+ T+ ++GGS+ D++ ++  KL    + ++  D++ G+
Sbjct: 1106 KSHHPNVVTFMGACID---PPCIFTEYLQGGSLYDVLHIQKIKLNPLMMYKMIHDLSLGM 1162

Query: 298  KFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIA 357
            + L+   + +RDL S+ ILLD   N+ + D G+ T      + T       RW +PE+  
Sbjct: 1163 EHLHSIQMLHRDLTSKNILLDEFKNIKIADFGLATTLS--DDMTLSGITNPRWRSPELTK 1220

Query: 358  GDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQIL 417
            G    +      +VYSFG+V++E+ TG+  +       +A   A    RP IP DCP  L
Sbjct: 1221 G----LVYNEKVDVYSFGLVVYEIYTGKIPFEGLDGTASAAKAAFENYRPAIPPDCPVSL 1276

Query: 418  KSLMIKCWNNSPSKRPQFSEIISLL 442
            + L+ KCW + PS+RP F+EI++ L
Sbjct: 1277 RKLITKCWASDPSQRPSFTEILTEL 1301

Involved in the development. Negatively regulates tyrosine phosphorylation and activation state of dstC/STATc, probably by activating a dstC/STATc phosphatase.

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 2

EC: .

EC: 1

>sp|Q5GIG6|TNI3K_MOUSE Serine/threonine-protein kinase TNNI3K OS=Mus musculus GN=Tnni3k PE=2 SV=4

 Score =  135 bits (340), Expect = 7e-31,   Method: Compositional matrix adjust.
 Identities = 88/272 (32%), Positives = 146/272 (53%), Gaps = 20/272 (7%)

Query: 184 RWLLNSDNLEFIDQIGPNSFKGVYKG----KRVGIEKLKG---CDKGNAYEFELRKDLLE 236
           R+ L    +EF + IG  SF  VYKG    K V I++ +    C K +   F   +++  
Sbjct: 454 RFHLQLSEIEFHEIIGSGSFGKVYKGRCRNKIVAIKRYRANTYCSKSDVDMF--CREVSI 511

Query: 237 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK---LQTKEIIRIAIDV 293
           L    H  ++QF   C+D+     +VT+ + GGS+  L+ + ++   LQ+K II  A+DV
Sbjct: 512 LCQLNHPCVVQFVGACLDDPSQFAIVTQYISGGSLFSLLHEQKRILDLQSKLII--AVDV 569

Query: 294 AEGIKFLND--HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG-YRW 350
           A+G+++L+     + +RDLNS  ILL   G+  + D G     +S+ E    +  G  RW
Sbjct: 570 AKGMEYLHSLTQPIIHRDLNSHNILLYEDGHAVVADFGESRFLQSLDEDNMTKQPGNLRW 629

Query: 351 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIP 410
           +APE+     +    T  ++V+S+ + +WE++TGE  +A   P  AA  +A   +RP I 
Sbjct: 630 MAPEVFT---QCTRYTIKADVFSYALCLWELLTGEIPFAHLKPAAAAADMAYHHIRPPIG 686

Query: 411 KDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
              P+ + SL+++ WN  P  RP+FSE++  L
Sbjct: 687 YSIPKPISSLLMRGWNACPEGRPEFSEVVRKL 718

May play a role in cardiac physiology.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P18161|SPLB_DICDI Dual specificity protein kinase splB OS=Dictyostelium discoideum GN=splB PE=2 SV=2

 Score =  134 bits (338), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 83/275 (30%), Positives = 142/275 (51%), Gaps = 28/275 (10%)

Query: 185  WLLNSDNLEFIDQIGPNSF----KGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTC 240
            ++++ ++++FI ++G  +F    +G +KG  V I+KLK       ++    +++  L   
Sbjct: 846  YIIDINDIQFIQKVGEGAFSEVWEGWWKGIHVAIKKLKIIGDEEQFKERFIREVQNLKKG 905

Query: 241  GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR------KLQTKEIIRIAIDVA 294
             H+NI+ F   C       C++T+ M GGS+ +++          K     ++++A D+A
Sbjct: 906  NHQNIVMFIGACYKP---ACIITEYMAGGSLYNILHNPNSSTPKVKYSFPLVLKMATDMA 962

Query: 295  EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRW 350
             G+  L+   + +RDL SQ ILLD  GN+ + D G+       G  T   T+G     RW
Sbjct: 963  LGLLHLHSITIVHRDLTSQNILLDELGNIKISDFGLSREKSREGSMTM--TNGGICNPRW 1020

Query: 351  LAPEI---IAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP 407
              PE+   +    E V      +VY F +V+WE++TGE  ++     QA+  +A  GLRP
Sbjct: 1021 RPPELTKNLGHYSEKV------DVYCFSLVVWEILTGEIPFSDLDGSQASAQVAYAGLRP 1074

Query: 408  EIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
             IP+ C   LK L+ +CW   P+ RP F+ I++ L
Sbjct: 1075 PIPEYCDPELKLLLTQCWEADPNDRPPFTYIVNKL 1109

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 0

EC: .

EC: 2

>sp|Q59H18|TNI3K_HUMAN Serine/threonine-protein kinase TNNI3K OS=Homo sapiens GN=TNNI3K PE=1 SV=3

 Score =  132 bits (333), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 86/269 (31%), Positives = 145/269 (53%), Gaps = 20/269 (7%)

Query: 184 RWLLNSDNLEFIDQIGPNSFKGVYKG----KRVGIEKLKG---CDKGNAYEFELRKDLLE 236
            + L    +EF + IG  SF  VYKG    K V I++ +    C K +   F   +++  
Sbjct: 455 HFHLQLSEIEFHEIIGSGSFGKVYKGRCRNKIVAIKRYRANTYCSKSDVDMF--CREVSI 512

Query: 237 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK---LQTKEIIRIAIDV 293
           L    H  ++QF   C+++     +VT+ + GGS+  L+ + ++   LQ+K II  A+DV
Sbjct: 513 LCQLNHPCVIQFVGACLNDPSQFAIVTQYISGGSLFSLLHEQKRILDLQSKLII--AVDV 570

Query: 294 AEGIKFLND--HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG-YRW 350
           A+G+++L++    + +RDLNS  ILL   G+  + D G     +S+ E    +  G  RW
Sbjct: 571 AKGMEYLHNLTQPIIHRDLNSHNILLYEDGHAVVADFGESRFLQSLDEDNMTKQPGNLRW 630

Query: 351 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIP 410
           +APE+     +    T  ++V+S+ + +WE++TGE  +A   P  AA  +A   +RP I 
Sbjct: 631 MAPEVFT---QCTRYTIKADVFSYALCLWEILTGEIPFAHLKPAAAAADMAYHHIRPPIG 687

Query: 411 KDCPQILKSLMIKCWNNSPSKRPQFSEII 439
              P+ + SL+I+ WN  P  RP+FSE++
Sbjct: 688 YSIPKPISSLLIRGWNACPEGRPEFSEVV 716

May play a role in cardiac physiology.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q7T6Y2|YR831_MIMIV Putative serine/threonine-protein kinase/receptor R831 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R831 PE=4 SV=2

 Score =  130 bits (326), Expect = 3e-29,   Method: Compositional matrix adjust.
 Identities = 93/326 (28%), Positives = 156/326 (47%), Gaps = 21/326 (6%)

Query: 126  KGRDFGEIEEEEACDESFRNGVENSNLKIQLQMPLPSSSFVVSVDEWQTVQSGGEEIGRW 185
            K R FG I      D++     ++SN        +    ++  +D+  +  +    + RW
Sbjct: 1302 KNRFFGGITYVNYNDDTDSGTADDSNYD---SGKIIDIDYMADIDKEDSFLTSAN-MCRW 1357

Query: 186  LLNSDNLEFIDQIGPNS----FKGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCG 241
            ++N D +    QIG  S    F G +KG  V ++K            E R ++  L    
Sbjct: 1358 IINYDEISIGKQIGLGSYGIVFNGKWKGVDVAVKKFVKQKLSETQLLEFRAEMAFLSELK 1417

Query: 242  HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR--KLQTKEIIRIAIDVAEGIKF 299
            H NI+ F   C+ +   +C+VT+ M  G++ D +LK+   K+     +++    A GI +
Sbjct: 1418 HSNIVTFIGACI-KKPNICIVTEYMRMGNLRD-VLKNPDIKITFANKLKLLYGAAMGIDY 1475

Query: 300  LNDHG--VAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIA 357
            L+     + +RD+    IL+D H NV + D G     +     T   T    W APE+I 
Sbjct: 1476 LHSSNPMIVHRDIKPANILVDEHFNVKIADFGFARIKEDNTTMTRCGTPC--WTAPEVIR 1533

Query: 358  GDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQIL 417
            G  E   E   ++V+SFG+V+WE++TG+  +A C+ ++ ++ I   G RP IP DCP   
Sbjct: 1534 G--EKYCEK--ADVFSFGVVMWEVLTGKEPFAECNFMKVSLDILEGG-RPIIPSDCPHEF 1588

Query: 418  KSLMIKCWNNSPSKRPQFSEIISLLL 443
              L+ KCW+    KRP  +E++  L+
Sbjct: 1589 AKLIKKCWHAKAHKRPTMTEVVQQLM 1614

Acanthamoeba polyphaga (taxid: 5757)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ESL4|MLTK_MOUSE Mitogen-activated protein kinase kinase kinase MLT OS=Mus musculus GN=Mltk PE=1 SV=1

 Score =  126 bits (316), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 86/268 (32%), Positives = 138/268 (51%), Gaps = 20/268 (7%)

Query: 190 DNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFY 249
           D+L+F +  G  SF  VY+ K +  +K     K      ++ K+   L    H+NI+QFY
Sbjct: 14  DDLQFFENCGGGSFGSVYRAKWISQDKEVAVKKL----LKIEKEAEILSVLSHRNIIQFY 69

Query: 250 CVCVDE-NHGLCVVTKLMEGGSVNDLILKSR--KLQTKEIIRIAIDVAEGIKFLNDHG-- 304
            V ++  N+G  +VT+    GS+ D I  +R  ++  + I+  A DVA+G+ +L+     
Sbjct: 70  GVILEPPNYG--IVTEYASLGSLYDYINSNRSEEMDMEHIMTWATDVAKGMHYLHMEAPV 127

Query: 305 -VAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG-YRWLAPEIIAGDPES 362
            V +RDL S+ +++   G + + D G   A +     T     G + W+APE+I   P  
Sbjct: 128 KVIHRDLKSRNVVIAADGVLKICDFG---ASRFHNHTTHMSLVGTFPWMAPEVIQSLP-- 182

Query: 363 VSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMI 422
           VSET   + YS+G+V+WEM+T E  +     +Q A  +     R  IP  CP+    L+ 
Sbjct: 183 VSET--CDTYSYGVVLWEMLTREVPFKGLEGLQVAWLVVEKNERLTIPSSCPRSFAELLH 240

Query: 423 KCWNNSPSKRPQFSEIISLLLRTNNISN 450
           +CW     KRP F +IIS+L   +N +N
Sbjct: 241 QCWEADAKKRPSFKQIISILESMSNDTN 268

Stress-activated component of a protein kinase signal transduction cascade. Regulates the JNK and p38 pathways. Pro-apoptotic. Role in regulation of S and G2 cell cycle checkpoint by direct phosphorylation of CHEK2. Isoform 1, but not isoform 2, phosphorylates histone H3 at 'Ser-28'.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 5

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	454
255571340	609	protein kinase, putative [Ricinus commun	0.982	0.732	0.870	0.0
225434500	592	PREDICTED: cell surface receptor daf-1 [	0.975	0.748	0.867	0.0
224103877	448	predicted protein [Populus trichocarpa]	0.980	0.993	0.829	0.0
356553098	590	PREDICTED: mitogen-activated protein kin	0.980	0.754	0.767	0.0
356500890	588	PREDICTED: focal adhesion kinase 1-like	0.980	0.756	0.763	0.0
449450836	585	PREDICTED: probable LIM domain-containin	0.982	0.762	0.746	0.0
356537583	582	PREDICTED: uncharacterized protein LOC10	0.982	0.766	0.751	0.0
297793387	604	kinase family protein [Arabidopsis lyrat	0.975	0.733	0.772	0.0
449505184	461	PREDICTED: probable serine/threonine-pro	0.982	0.967	0.746	0.0
15237684	604	protein kinase family protein [Arabidops	0.975	0.733	0.761	0.0

>gi|255571340|ref|XP_002526619.1| protein kinase, putative [Ricinus communis] gi|223534059|gb|EEF35778.1| protein kinase, putative [Ricinus communis]

 Score =  830 bits (2144), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 389/447 (87%), Positives = 427/447 (95%), Gaps = 1/447 (0%)

Query: 1   MKEVFLHIKLIEQASGDDRPAIMIQEVSDDEAQGSVYKLTFACNSSISWPAMSGALDTAS 60
           MK+VFLHIKLIEQAS D++PAIMIQEVSDDE QGSV+KLTFACNS ISWPAMSGALD AS
Sbjct: 161 MKDVFLHIKLIEQASVDEQPAIMIQEVSDDEVQGSVFKLTFACNSLISWPAMSGALDNAS 220

Query: 61  ICCKKIQIFEKKGFTLGVVILAVQAGQEKSFKSQIENALKSAIKKPKPTSVKLPFGLCGC 120
           ICCKKIQIFEKKGFTL V++L VQAG EKSFK++IENALK+AIKKPK T+VKLPFGLCGC
Sbjct: 221 ICCKKIQIFEKKGFTLAVILLLVQAGHEKSFKNRIENALKNAIKKPKQTTVKLPFGLCGC 280

Query: 121 QEENTKGRDFGEIEEEEACDESFRNGVENSNLKIQLQMPLPSSSFVVSVDEWQTVQSGGE 180
           QEENT+GRDFGEIEE+   + S+RNG EN N+KIQL+MPLP+SSFVVS+DEWQT+QSGG+
Sbjct: 281 QEENTRGRDFGEIEEDPN-ELSYRNGTENLNVKIQLEMPLPTSSFVVSIDEWQTMQSGGD 339

Query: 181 EIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTC 240
           EIG+WLLNSDNLEF+DQIGPNSFKGVYKGKRVGIEKLKGCDKGNAY+FELRKDLLELMTC
Sbjct: 340 EIGKWLLNSDNLEFVDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYDFELRKDLLELMTC 399

Query: 241 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL 300
           GHKN+LQFY VCVDENHGLCVVTKLMEGGSV+DL+LK++KLQTKEIIRIA+D+AEGIKF+
Sbjct: 400 GHKNVLQFYGVCVDENHGLCVVTKLMEGGSVSDLMLKNKKLQTKEIIRIAVDIAEGIKFM 459

Query: 301 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDP 360
           NDHGVAYRDLN+QRILLDRHGN CLGDMGIVTACKS+GEA EYETDGYRWLAPEIIAGDP
Sbjct: 460 NDHGVAYRDLNTQRILLDRHGNACLGDMGIVTACKSMGEAMEYETDGYRWLAPEIIAGDP 519

Query: 361 ESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSL 420
           ESV+ETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP+IPKDCPQILKSL
Sbjct: 520 ESVTETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPDIPKDCPQILKSL 579

Query: 421 MIKCWNNSPSKRPQFSEIISLLLRTNN 447
           M KCWNN PSKRPQFSEI+S+LLR +N
Sbjct: 580 MTKCWNNCPSKRPQFSEILSILLRFSN 606

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225434500|ref|XP_002275567.1| PREDICTED: cell surface receptor daf-1 [Vitis vinifera] gi|297745851|emb|CBI15907.3| unnamed protein product [Vitis vinifera]

 Score =  795 bits (2054), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 385/444 (86%), Positives = 420/444 (94%), Gaps = 1/444 (0%)

Query: 1   MKEVFLHIKLIEQASGDDRPAIMIQEVSDDEAQGSVYKLTFACNSSISWPAMSGALDTAS 60
           MK+VFLHI++IEQAS DD PAI+IQEVSDDE QGSV+KLTFACNSSISWPAMSGALD+AS
Sbjct: 133 MKDVFLHIRMIEQASVDDHPAILIQEVSDDEIQGSVFKLTFACNSSISWPAMSGALDSAS 192

Query: 61  ICCKKIQIFEKKGFTLGVVILAVQAGQEKSFKSQIENALKSAIKKPKPTSVKLPFGLCGC 120
           ICCKKIQIFEKKGFTLG+++L VQAGQEKSF+++IENALK AIKK KPT+VKLPFGLCGC
Sbjct: 193 ICCKKIQIFEKKGFTLGIILLLVQAGQEKSFQNRIENALKFAIKKSKPTTVKLPFGLCGC 252

Query: 121 QEENTKGRDFGEIEEEEACDESFRNGVENSNLKIQLQMPLPSSSFVVSVDEWQTVQSGGE 180
           QEENTKGR+ GEIEEE       RNG++NSN K+QLQMPLP+SSFVVSVDEWQTVQSGGE
Sbjct: 253 QEENTKGREVGEIEEEGGEPH-HRNGIDNSNTKVQLQMPLPTSSFVVSVDEWQTVQSGGE 311

Query: 181 EIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTC 240
           EIG+WLLNSDNLEF+DQIGPNSFKGVYKGKRVGIEKLKGCDKGN+YEFELRKDLLELMTC
Sbjct: 312 EIGKWLLNSDNLEFVDQIGPNSFKGVYKGKRVGIEKLKGCDKGNSYEFELRKDLLELMTC 371

Query: 241 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL 300
           GHKNILQF+ VCVDENHGLCVVTKLMEGGSV+D+ILK++K Q KEIIRIAIDVAEGIKF+
Sbjct: 372 GHKNILQFFGVCVDENHGLCVVTKLMEGGSVHDVILKNKKFQNKEIIRIAIDVAEGIKFM 431

Query: 301 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDP 360
           NDHGVAYRDLN+QR+LLDRHGN CLGDMGIVTACKSVGEA EYETDGYRWLAPEIIAGDP
Sbjct: 432 NDHGVAYRDLNTQRVLLDRHGNACLGDMGIVTACKSVGEAMEYETDGYRWLAPEIIAGDP 491

Query: 361 ESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSL 420
           ESV+ET MSNVYSFGMV+WEMVTGEAAY+A SPVQAAVGIAACGLRPEIPKDCPQIL+SL
Sbjct: 492 ESVTETLMSNVYSFGMVLWEMVTGEAAYSAYSPVQAAVGIAACGLRPEIPKDCPQILRSL 551

Query: 421 MIKCWNNSPSKRPQFSEIISLLLR 444
           M KCWNN PSKRPQFSEI+S+LLR
Sbjct: 552 MTKCWNNCPSKRPQFSEILSILLR 575

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224103877|ref|XP_002313229.1| predicted protein [Populus trichocarpa] gi|222849637|gb|EEE87184.1| predicted protein [Populus trichocarpa]

 Score =  768 bits (1983), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 371/447 (82%), Positives = 419/447 (93%), Gaps = 2/447 (0%)

Query: 1   MKEVFLHIKLIEQASGDDRPAIMIQEVSDDEAQGSVYKLTFACNSSISWPAMSGALDTAS 60
           MKEVF+H+KLIEQA  D++PAIMIQEVSDDE QG+VYKLTFACNSSISWP MSGALD+AS
Sbjct: 1   MKEVFMHMKLIEQALVDEQPAIMIQEVSDDEIQGAVYKLTFACNSSISWPVMSGALDSAS 60

Query: 61  ICCKKIQIFEKKGFTLGVVILAVQAGQEKSFKSQIENALKSAIKKPKPTSVKLPFGLCGC 120
           ICCKKIQIFEKKGFTLGVV+L VQAGQ KSFK++IENALKS++KK K T+VKLPFGLCGC
Sbjct: 61  ICCKKIQIFEKKGFTLGVVLLLVQAGQAKSFKARIENALKSSVKKSKSTTVKLPFGLCGC 120

Query: 121 QEENTKGRDFGEIEEEEACDESFRNGVENSNLKIQLQMPLPSSSFVVSVDEWQTVQSGGE 180
           QEEN +G +FGEIEE+  C+++FRNG+EN N+KIQL+MPLP+SS VV+VDEWQT+ SGG+
Sbjct: 121 QEENIRG-NFGEIEED-PCEQNFRNGIENPNVKIQLEMPLPTSSIVVAVDEWQTINSGGD 178

Query: 181 EIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTC 240
           E+G+WLLNSDNLEFIDQIGP+SFKGVYKGKRVGIEKLKGCDKGN+YEFELRKDLLELMTC
Sbjct: 179 ELGKWLLNSDNLEFIDQIGPSSFKGVYKGKRVGIEKLKGCDKGNSYEFELRKDLLELMTC 238

Query: 241 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL 300
           GHKNI QFY +CVDENHGLCVVTKLMEGGSVN+L+LK++KLQ KEI+RIA DVAEG++F+
Sbjct: 239 GHKNIHQFYGICVDENHGLCVVTKLMEGGSVNELMLKNKKLQPKEIMRIATDVAEGMRFM 298

Query: 301 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDP 360
           NDHGVAYRDLN+QRILLDRHGN CLGDMGIVT CKS+GEA EYETDGYRWLAPEIIAGDP
Sbjct: 299 NDHGVAYRDLNTQRILLDRHGNACLGDMGIVTVCKSMGEAMEYETDGYRWLAPEIIAGDP 358

Query: 361 ESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSL 420
           E+++ETWMSN YSFGMV+WEMVTGEAAYAA SPVQAAVGIAACGLRPEIPKDC  IL+SL
Sbjct: 359 ENITETWMSNAYSFGMVVWEMVTGEAAYAAYSPVQAAVGIAACGLRPEIPKDCLLILRSL 418

Query: 421 MIKCWNNSPSKRPQFSEIISLLLRTNN 447
           M KCWNNSPSKRPQFSEI+S+LLR +N
Sbjct: 419 MTKCWNNSPSKRPQFSEILSILLRPSN 445

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356553098|ref|XP_003544895.1| PREDICTED: mitogen-activated protein kinase kinase kinase 10-like [Glycine max]

 Score =  733 bits (1892), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 344/448 (76%), Positives = 400/448 (89%), Gaps = 3/448 (0%)

Query: 1   MKEVFLHIKLIEQASGDDRPAIMIQEVSDDEAQGSVYKLTFACNSSISWPAMSGALDTAS 60
           MK+VFLHIKL+EQAS  D+PAI+IQE  D E QGS  +LTFACNS ISWPAMSGALD++S
Sbjct: 142 MKDVFLHIKLMEQASESDQPAILIQEECDYEVQGSALRLTFACNSPISWPAMSGALDSSS 201

Query: 61  ICCKKIQIFEKKGFTLGVVILAVQAGQEKSFKSQIENALKSAIKKPKPTSVKLPFGLCGC 120
           ICCK++QIFEKKGFTLGVV+L VQ+G +K  ++++E+ALK A+K+PK  +VKLPFGLCGC
Sbjct: 202 ICCKRMQIFEKKGFTLGVVLLVVQSGHDKLVRTRVESALKFAMKRPKTGAVKLPFGLCGC 261

Query: 121 QEENTKGRDFGEIEEEEACDESFRNG-VENSNLKIQLQMPLPSSSFVVSVDEWQTVQSGG 179
           QEEN+KG D  EIEEE    + +R    ENS  +IQLQ+PLPSSSFVVSVDEWQT++SGG
Sbjct: 262 QEENSKGGDLVEIEEE--ISDGYRGKEFENSGQRIQLQVPLPSSSFVVSVDEWQTIKSGG 319

Query: 180 EEIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMT 239
           +EI +WLLNSD++EF++QIGPNSFKGVY GKRV IEKLKGCDKGN+YEFEL KDLLELMT
Sbjct: 320 DEIEKWLLNSDSVEFVEQIGPNSFKGVYLGKRVKIEKLKGCDKGNSYEFELHKDLLELMT 379

Query: 240 CGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKF 299
           CGH+NILQF  +CVD+NHGLCVVTK MEGGSV+DL++K++KLQTK+I+RIA+DVAEGIKF
Sbjct: 380 CGHRNILQFCGICVDDNHGLCVVTKFMEGGSVHDLMMKNKKLQTKDIVRIAVDVAEGIKF 439

Query: 300 LNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGD 359
           +NDHGVAYRDLN+ RILLDRHGN CLGDMGIVTACKSVGEA EYETDGYRWLAPEIIAGD
Sbjct: 440 MNDHGVAYRDLNTPRILLDRHGNACLGDMGIVTACKSVGEAMEYETDGYRWLAPEIIAGD 499

Query: 360 PESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKS 419
           PE+V+ETWMSNVYSFGMVIWEMVTGE AY++ SPVQAAVGIAACGLRPEIPKDC Q LK 
Sbjct: 500 PENVTETWMSNVYSFGMVIWEMVTGETAYSSFSPVQAAVGIAACGLRPEIPKDCQQTLKY 559

Query: 420 LMIKCWNNSPSKRPQFSEIISLLLRTNN 447
           +M KCWNN+PSKRP FSEI+++LLR NN
Sbjct: 560 IMTKCWNNNPSKRPHFSEILAILLRPNN 587

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356500890|ref|XP_003519263.1| PREDICTED: focal adhesion kinase 1-like [Glycine max]

 Score =  720 bits (1858), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 342/448 (76%), Positives = 400/448 (89%), Gaps = 3/448 (0%)

Query: 1   MKEVFLHIKLIEQASGDDRPAIMIQEVSDDEAQGSVYKLTFACNSSISWPAMSGALDTAS 60
           MK VFLHIKL+EQAS  D+PAI+IQE  D E QGS  +LTFACNS ISWPAMSGALD++S
Sbjct: 140 MKNVFLHIKLMEQASESDQPAILIQEECDGEIQGSALRLTFACNSPISWPAMSGALDSSS 199

Query: 61  ICCKKIQIFEKKGFTLGVVILAVQAGQEKSFKSQIENALKSAIKKPKPTSVKLPFGLCGC 120
           ICCK++QIFEKKGFTLGVV+L V  G +K  ++++ENALK A+KKPK  +VKLPFGLCGC
Sbjct: 200 ICCKRMQIFEKKGFTLGVVLLVVLPGHDKLVRTRVENALKFAMKKPKTGAVKLPFGLCGC 259

Query: 121 QEENTKGRDFGEIEEEEACDESFRNG-VENSNLKIQLQMPLPSSSFVVSVDEWQTVQSGG 179
           QEEN+KGR+  EIEEE    + +R    ENS+ +IQLQ+PLPSSSFVVSVDEWQT++SGG
Sbjct: 260 QEENSKGRELVEIEEETG--DGYRGKEFENSSQRIQLQVPLPSSSFVVSVDEWQTIKSGG 317

Query: 180 EEIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMT 239
            EI +WLLNSD++EF++QIGPNS++GVY GKRVGIEKLKGCDKGN+YEFEL KDLLELMT
Sbjct: 318 NEIEKWLLNSDSVEFVEQIGPNSYRGVYMGKRVGIEKLKGCDKGNSYEFELHKDLLELMT 377

Query: 240 CGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKF 299
           CGH+NILQF  +CVD+NHGLCVVTK MEGGSV+DL++K++KLQTK+++RIA+DVAEGIKF
Sbjct: 378 CGHRNILQFCGICVDDNHGLCVVTKFMEGGSVHDLMMKNKKLQTKDVVRIAVDVAEGIKF 437

Query: 300 LNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGD 359
           +NDHGVAYRDLN++ ILLD+HGN CLGDMGIVTACKSVGEA EYETDGYRWLAPEIIAGD
Sbjct: 438 MNDHGVAYRDLNTRGILLDKHGNACLGDMGIVTACKSVGEAMEYETDGYRWLAPEIIAGD 497

Query: 360 PESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKS 419
           PE+V+ETWMSNVYSFGMVIWEMVTGEAAY++ SPVQAAVGIAACGLRPEIPKDC Q LK 
Sbjct: 498 PENVTETWMSNVYSFGMVIWEMVTGEAAYSSFSPVQAAVGIAACGLRPEIPKDCQQTLKH 557

Query: 420 LMIKCWNNSPSKRPQFSEIISLLLRTNN 447
           +M KCWNN+PSKRP FSEI+++LLR NN
Sbjct: 558 IMTKCWNNTPSKRPHFSEILAILLRPNN 585

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449450836|ref|XP_004143168.1| PREDICTED: probable LIM domain-containing serine/threonine-protein kinase DDB_G0287001-like [Cucumis sativus]

 Score =  711 bits (1835), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 335/449 (74%), Positives = 393/449 (87%), Gaps = 3/449 (0%)

Query: 1   MKEVFLHIKLIEQASGDDRPAIMIQEVSDDEAQGSVYKLTFACNSSISWPAMSGALDTAS 60
           MK+VFLHIKL+EQAS  D PAI+ QEV++ + Q  + K TFACNSS+SW AMSGAL+TA+
Sbjct: 134 MKDVFLHIKLMEQASVYDHPAILFQEVTNRDVQKPIIKFTFACNSSVSWSAMSGALETAA 193

Query: 61  ICCKKIQIFEKKGFTLGVVILAVQAGQEKSFKSQIENALKSAIKKPKPTSVKLPFGLCGC 120
           I C+KIQIFEKK FTLGV++      QEK FKS++ENALK AIKKPK T+VKLPFG CGC
Sbjct: 194 IRCEKIQIFEKKKFTLGVILFVNLDLQEKLFKSKVENALKLAIKKPKTTAVKLPFGFCGC 253

Query: 121 QEENTKGRDFGEIEEEEACDESFRNGVENSNL--KIQLQMPLPSSSFVVSVDEWQTVQSG 178
           QE NT G+D  E EE+   + + R+G ENSNL   +Q++MPL +SSF V+VDEWQT+QSG
Sbjct: 254 QEGNTGGKDLRETEED-GVEPNCRSGFENSNLSENLQIEMPLCTSSFAVTVDEWQTIQSG 312

Query: 179 GEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELM 238
           G E+G+WLL+S+NLEF+DQ+GPNSFKGVYKG+RV IEK+KGC+KG +Y+FELRKDLLELM
Sbjct: 313 GNELGKWLLSSENLEFVDQMGPNSFKGVYKGRRVAIEKIKGCEKGVSYKFELRKDLLELM 372

Query: 239 TCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIK 298
           TCGHKNIL FY VC+DENHGLCVVTKLMEGGSV++L+LK++KLQTKEI RIAID+ EGIK
Sbjct: 373 TCGHKNILMFYGVCIDENHGLCVVTKLMEGGSVHELMLKNKKLQTKEITRIAIDIVEGIK 432

Query: 299 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAG 358
           F+NDHGVAYRDLN+QRILLD++GN CLGDMGI+TACK++GEA EYETDGYRWLAPEIIAG
Sbjct: 433 FMNDHGVAYRDLNTQRILLDKNGNACLGDMGILTACKNLGEAMEYETDGYRWLAPEIIAG 492

Query: 359 DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILK 418
           DPESV+ETWMSNVYS GMVIWEMVTGEAAY A SPVQAAVGIAACGLRP++PKDC   LK
Sbjct: 493 DPESVNETWMSNVYSLGMVIWEMVTGEAAYGAYSPVQAAVGIAACGLRPDVPKDCSSTLK 552

Query: 419 SLMIKCWNNSPSKRPQFSEIISLLLRTNN 447
           SLMI+CWNN PSKRPQFSEI+SLLL +NN
Sbjct: 553 SLMIRCWNNCPSKRPQFSEILSLLLDSNN 581

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356537583|ref|XP_003537306.1| PREDICTED: uncharacterized protein LOC100819097 [Glycine max]

 Score =  711 bits (1835), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 339/451 (75%), Positives = 398/451 (88%), Gaps = 5/451 (1%)

Query: 1   MKEVFLHIKLIEQASGDDRPAIMIQEVSDDE--AQGSVYKLTFACNSSISWPAMSGALDT 58
           +K+VFLH+KL+EQA  D++ AI+IQE  DDE   QGSV+KLTFACNS ISWPAMSGALD 
Sbjct: 130 VKDVFLHMKLMEQALEDEQAAILIQEECDDEIQLQGSVFKLTFACNSPISWPAMSGALDA 189

Query: 59  ASICCKKIQIFEKKGFTLGVVILAVQAG--QEKSFKSQIENALKSAIKKPKPTSVKLPFG 116
            SICCKKIQIFEKK FTLG+V+L V +G  Q+K  ++++E+ALK A+K+PK   VKLPFG
Sbjct: 190 YSICCKKIQIFEKKCFTLGIVLLLVLSGGGQDKLVRTRVESALKIAMKRPKAGGVKLPFG 249

Query: 117 LCGCQEENTKGRDFGEIEEEEACDESFRNGVENSNLKIQLQMPLPSSSFVVSVDEWQTVQ 176
           LCGCQEEN+KGR  GEIEE+   D    NG EN + KI+LQ+PLPSSSF+V VDEWQT+Q
Sbjct: 250 LCGCQEENSKGRRLGEIEED-GWDAYCGNGFENLSQKIELQVPLPSSSFLVVVDEWQTIQ 308

Query: 177 SGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLE 236
           SGG EI +WLLNSD+LEF++QI PNS+KG Y GK+VGIEKL+GC+KGN+YEFELRKDLL 
Sbjct: 309 SGGAEIEKWLLNSDSLEFVEQIAPNSYKGTYMGKKVGIEKLRGCEKGNSYEFELRKDLLA 368

Query: 237 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEG 296
           LMTCGH+NI+QF  VCVD+NHGLCVVTK +EGGSV+DL+LK++KL +K+I+RIA DVAEG
Sbjct: 369 LMTCGHRNIMQFCGVCVDDNHGLCVVTKFVEGGSVHDLMLKNKKLPSKDIVRIAADVAEG 428

Query: 297 IKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEII 356
           IKF NDHGVAYRDLN+QRILLD+HGN CLGDMGIVTACK+VGEA +YETDGYRWLAPEII
Sbjct: 429 IKFKNDHGVAYRDLNTQRILLDKHGNACLGDMGIVTACKNVGEAMDYETDGYRWLAPEII 488

Query: 357 AGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQI 416
           AGDPESV+ETWMSNVYSFGMVIWEMVTGEAAY+A SPVQAAVGIAACGLRPEIPKDCPQ 
Sbjct: 489 AGDPESVTETWMSNVYSFGMVIWEMVTGEAAYSAFSPVQAAVGIAACGLRPEIPKDCPQT 548

Query: 417 LKSLMIKCWNNSPSKRPQFSEIISLLLRTNN 447
           LKSLM +CWNN+PSKRP FSEI+++LLR++N
Sbjct: 549 LKSLMTRCWNNTPSKRPNFSEILAILLRSSN 579

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297793387|ref|XP_002864578.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] gi|297310413|gb|EFH40837.1| kinase family protein [Arabidopsis lyrata subsp. lyrata]

 Score =  710 bits (1833), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 343/444 (77%), Positives = 389/444 (87%), Gaps = 1/444 (0%)

Query: 1   MKEVFLHIKLIEQASGDDRPAIMIQEVSDDEAQGSVYKLTFACNSSISWPAMSGALDTAS 60
           MKEVFLH+KLIEQASGDD P  MIQEVS +E +GSV +LTFACNSS+SW  MSGALD+AS
Sbjct: 158 MKEVFLHVKLIEQASGDDNPVFMIQEVSAEEPRGSVLRLTFACNSSLSWSTMSGALDSAS 217

Query: 61  ICCKKIQIFEKKGFTLGVVILAVQAGQEKSFKSQIENALKSAIKKPKPTSVKLPFGLCGC 120
           ICCKKIQIFEKKG TLGVV+L  Q+GQ   FK+++ENALK A KKPKPTSVKLPFGLCGC
Sbjct: 218 ICCKKIQIFEKKGLTLGVVLLLDQSGQHNFFKTRVENALKVATKKPKPTSVKLPFGLCGC 277

Query: 121 QEENTKGRDFGEIEEEEACDESFRNGVENSNLKIQLQMPLPSSSFVVSVDEWQTVQSGGE 180
           QE+N    +     EEE+   S R G+EN N  IQL +PL SSSF VSVDEWQT+QSGG 
Sbjct: 278 QEQNGGVGE-LGGVEEESIQHSNRLGIENLNSTIQLHIPLLSSSFAVSVDEWQTIQSGGS 336

Query: 181 EIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTC 240
           EIG+WLLNSD+ EF DQIGP SFKG+++GKRVGIEKLKGCDKGN+YEFELRKD LELM C
Sbjct: 337 EIGKWLLNSDSFEFGDQIGPTSFKGIFRGKRVGIEKLKGCDKGNSYEFELRKDYLELMAC 396

Query: 241 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL 300
           GHK+ILQFY VC+DENHGLCVVTKLMEGGS+++L+LKS+KLQTK+I+RIAID+AEG+KF+
Sbjct: 397 GHKSILQFYGVCIDENHGLCVVTKLMEGGSLHELMLKSKKLQTKQILRIAIDIAEGLKFV 456

Query: 301 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDP 360
           NDHGVAYRDLN+QRILLD+HGN CLGD+GIVTACKS GEA EYETDGYRWLAPEIIAGDP
Sbjct: 457 NDHGVAYRDLNTQRILLDKHGNACLGDIGIVTACKSFGEAVEYETDGYRWLAPEIIAGDP 516

Query: 361 ESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSL 420
           E+ +ETWMSN YSFGMV+WEMVTGEAAYA+CSPVQAAVGIAACGLRP+IPK+CPQ L +L
Sbjct: 517 ENTTETWMSNAYSFGMVLWEMVTGEAAYASCSPVQAAVGIAACGLRPDIPKECPQALGTL 576

Query: 421 MIKCWNNSPSKRPQFSEIISLLLR 444
           MI CWNNSPSKRP FS I + LLR
Sbjct: 577 MINCWNNSPSKRPNFSHIHNTLLR 600

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449505184|ref|XP_004162400.1| PREDICTED: probable serine/threonine-protein kinase DDB_G0267514-like [Cucumis sativus]

 Score =  708 bits (1827), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 335/449 (74%), Positives = 393/449 (87%), Gaps = 3/449 (0%)

Query: 1   MKEVFLHIKLIEQASGDDRPAIMIQEVSDDEAQGSVYKLTFACNSSISWPAMSGALDTAS 60
           MK+VFLHIKL+EQAS  D PAI+ QEV++ + Q  + K TFACNSS+SW AMSGAL+TA+
Sbjct: 10  MKDVFLHIKLMEQASVYDHPAILFQEVTNRDVQKPIIKFTFACNSSVSWSAMSGALETAA 69

Query: 61  ICCKKIQIFEKKGFTLGVVILAVQAGQEKSFKSQIENALKSAIKKPKPTSVKLPFGLCGC 120
           I C+KIQIFEKK FTLGV++      QEK FKS++ENALK AIKKPK T+VKLPFG CGC
Sbjct: 70  IRCEKIQIFEKKKFTLGVILFVNLDLQEKLFKSKVENALKLAIKKPKTTAVKLPFGFCGC 129

Query: 121 QEENTKGRDFGEIEEEEACDESFRNGVENSNL--KIQLQMPLPSSSFVVSVDEWQTVQSG 178
           QE NT G+D  E EE+   + + R+G ENSNL   +Q++MPL +SSF V+VDEWQT+QSG
Sbjct: 130 QEGNTGGKDLRETEED-GVEPNCRSGFENSNLSENLQIEMPLCTSSFAVTVDEWQTIQSG 188

Query: 179 GEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELM 238
           G E+G+WLL+S+NLEF+DQ+GPNSFKGVYKG+RV IEK+KGC+KG +Y+FELRKDLLELM
Sbjct: 189 GNELGKWLLSSENLEFVDQMGPNSFKGVYKGRRVAIEKIKGCEKGVSYKFELRKDLLELM 248

Query: 239 TCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIK 298
           TCGHKNIL FY VC+DENHGLCVVTKLMEGGSV++L+LK++KLQTKEI RIAID+ EGIK
Sbjct: 249 TCGHKNILMFYGVCIDENHGLCVVTKLMEGGSVHELMLKNKKLQTKEITRIAIDIVEGIK 308

Query: 299 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAG 358
           F+NDHGVAYRDLN+QRILLD++GN CLGDMGI+TACK++GEA EYETDGYRWLAPEIIAG
Sbjct: 309 FMNDHGVAYRDLNTQRILLDKNGNACLGDMGILTACKNLGEAMEYETDGYRWLAPEIIAG 368

Query: 359 DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILK 418
           DPESV+ETWMSNVYS GMVIWEMVTGEAAY A SPVQAAVGIAACGLRP++PKDC   LK
Sbjct: 369 DPESVNETWMSNVYSLGMVIWEMVTGEAAYGAYSPVQAAVGIAACGLRPDVPKDCSSTLK 428

Query: 419 SLMIKCWNNSPSKRPQFSEIISLLLRTNN 447
           SLMI+CWNN PSKRPQFSEI+SLLL +NN
Sbjct: 429 SLMIRCWNNCPSKRPQFSEILSLLLDSNN 457

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|15237684|ref|NP_200660.1| protein kinase family protein [Arabidopsis thaliana] gi|110738981|dbj|BAF01411.1| protein kinase like protein [Arabidopsis thaliana] gi|332009679|gb|AED97062.1| protein kinase family protein [Arabidopsis thaliana]

 Score =  707 bits (1824), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 338/444 (76%), Positives = 389/444 (87%), Gaps = 1/444 (0%)

Query: 1   MKEVFLHIKLIEQASGDDRPAIMIQEVSDDEAQGSVYKLTFACNSSISWPAMSGALDTAS 60
           MKEVFLH+KLIEQA+GDD P  MIQEVS +E +GSV +LTFACNS +SW  MSG LD+AS
Sbjct: 158 MKEVFLHVKLIEQAAGDDNPVFMIQEVSTEEPRGSVLRLTFACNSFLSWSTMSGVLDSAS 217

Query: 61  ICCKKIQIFEKKGFTLGVVILAVQAGQEKSFKSQIENALKSAIKKPKPTSVKLPFGLCGC 120
           ICCKKIQIFEKKG TLGVV+L  Q+GQ   FK+++EN LK A KKPKPTSVKLPFGLCGC
Sbjct: 218 ICCKKIQIFEKKGLTLGVVLLLDQSGQHSLFKTRVENTLKVATKKPKPTSVKLPFGLCGC 277

Query: 121 QEENTKGRDFGEIEEEEACDESFRNGVENSNLKIQLQMPLPSSSFVVSVDEWQTVQSGGE 180
           QE+N    +     EEE+   S R G+EN N  IQ+Q+PLPSSSF VSVDEWQT+QSGG 
Sbjct: 278 QEQNGGVGEL-GGVEEESIQHSSRLGIENLNSTIQIQVPLPSSSFAVSVDEWQTIQSGGN 336

Query: 181 EIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTC 240
           EIG+WLLNSD+ EF DQIGP S KG+++GKRVGIEKLKGCDKGN+YEFELRKD LELM C
Sbjct: 337 EIGKWLLNSDSFEFGDQIGPTSLKGIFRGKRVGIEKLKGCDKGNSYEFELRKDYLELMAC 396

Query: 241 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL 300
           GHK+ILQFY VC+DENHGLCVVTKLMEGGS+++L+LK++KLQTK+I+RIAID+AEG+KF+
Sbjct: 397 GHKSILQFYGVCIDENHGLCVVTKLMEGGSLHELMLKNKKLQTKQILRIAIDIAEGLKFV 456

Query: 301 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDP 360
           NDHGVAYRDLN+QRILLD+HGN CLG++GIVTACKS GEA EYETDGYRWLAPEIIAGDP
Sbjct: 457 NDHGVAYRDLNTQRILLDKHGNACLGNIGIVTACKSFGEAVEYETDGYRWLAPEIIAGDP 516

Query: 361 ESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSL 420
           E+ +ETWMSN YSFGMV+WEMVTGEAAYA+CSPVQAAVGIAACGLRPEIPK+CPQ+L++L
Sbjct: 517 ENTTETWMSNAYSFGMVLWEMVTGEAAYASCSPVQAAVGIAACGLRPEIPKECPQVLRTL 576

Query: 421 MIKCWNNSPSKRPQFSEIISLLLR 444
           MI CWNNSPSKRP FS I + LLR
Sbjct: 577 MINCWNNSPSKRPNFSHIHNTLLR 600

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	454
TAIR|locus:2171213	604	AT5G58520 [Arabidopsis thalian	0.975	0.733	0.763	5.3e-191
TAIR|locus:2182905	583	AT5G07140 [Arabidopsis thalian	0.975	0.759	0.710	3e-179
TAIR|locus:2128043	570	STY17 "serine/threonine/tyrosi	0.513	0.408	0.355	2.5e-41
TAIR|locus:2827943	546	STY8 "serine/threonine/tyrosin	0.550	0.457	0.347	2.6e-40
TAIR|locus:2121154	575	STY46 "serine/threonine/tyrosi	0.640	0.506	0.335	2.6e-40
TAIR|locus:2126311	412	AT4G31170 [Arabidopsis thalian	0.515	0.567	0.337	1.7e-34
TAIR|locus:2154573	525	AT5G58950 [Arabidopsis thalian	0.530	0.459	0.323	7.4e-34
DICTYBASE|DDB_G0267514	916	DDB_G0267514 "protein kinase,	0.550	0.272	0.332	4.4e-33
DICTYBASE|DDB_G0272254	1331	DDB_G0272254 "protein kinase,	0.552	0.188	0.318	1.8e-32
RGD|727908	835	Tnni3k "TNNI3 interacting kina	0.656	0.356	0.312	4.2e-32

TAIR|locus:2171213 AT5G58520 [Arabidopsis thaliana (taxid:3702)]

 Score = 1851 (656.6 bits), Expect = 5.3e-191, P = 5.3e-191
 Identities = 339/444 (76%), Positives = 391/444 (88%)

Query:     1 MKEVFLHIKLIEQASGDDRPAIMIQEVSDDEAQGSVYKLTFACNSSISWPAMSGALDTAS 60
             MKEVFLH+KLIEQA+GDD P  MIQEVS +E +GSV +LTFACNS +SW  MSG LD+AS
Sbjct:   158 MKEVFLHVKLIEQAAGDDNPVFMIQEVSTEEPRGSVLRLTFACNSFLSWSTMSGVLDSAS 217

Query:    61 ICCKKIQIFEKKGFTLGVVILAVQAGQEKSFKSQIENALKSAIKKPKPTSVKLPFGLCGC 120
             ICCKKIQIFEKKG TLGVV+L  Q+GQ   FK+++EN LK A KKPKPTSVKLPFGLCGC
Sbjct:   218 ICCKKIQIFEKKGLTLGVVLLLDQSGQHSLFKTRVENTLKVATKKPKPTSVKLPFGLCGC 277

Query:   121 QEENTKGRDFGEIEEEEACDESFRNGVENSNLKIQLQMPLPSSSFVVSVDEWQTVQSGGE 180
             QE+N    + G +EEE +   S R G+EN N  IQ+Q+PLPSSSF VSVDEWQT+QSGG 
Sbjct:   278 QEQNGGVGELGGVEEE-SIQHSSRLGIENLNSTIQIQVPLPSSSFAVSVDEWQTIQSGGN 336

Query:   181 EIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTC 240
             EIG+WLLNSD+ EF DQIGP S KG+++GKRVGIEKLKGCDKGN+YEFELRKD LELM C
Sbjct:   337 EIGKWLLNSDSFEFGDQIGPTSLKGIFRGKRVGIEKLKGCDKGNSYEFELRKDYLELMAC 396

Query:   241 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL 300
             GHK+ILQFY VC+DENHGLCVVTKLMEGGS+++L+LK++KLQTK+I+RIAID+AEG+KF+
Sbjct:   397 GHKSILQFYGVCIDENHGLCVVTKLMEGGSLHELMLKNKKLQTKQILRIAIDIAEGLKFV 456

Query:   301 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDP 360
             NDHGVAYRDLN+QRILLD+HGN CLG++GIVTACKS GEA EYETDGYRWLAPEIIAGDP
Sbjct:   457 NDHGVAYRDLNTQRILLDKHGNACLGNIGIVTACKSFGEAVEYETDGYRWLAPEIIAGDP 516

Query:   361 ESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSL 420
             E+ +ETWMSN YSFGMV+WEMVTGEAAYA+CSPVQAAVGIAACGLRPEIPK+CPQ+L++L
Sbjct:   517 ENTTETWMSNAYSFGMVLWEMVTGEAAYASCSPVQAAVGIAACGLRPEIPKECPQVLRTL 576

Query:   421 MIKCWNNSPSKRPQFSEIISLLLR 444
             MI CWNNSPSKRP FS I + LLR
Sbjct:   577 MINCWNNSPSKRPNFSHIHNTLLR 600

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0009832 "plant-type cell wall biogenesis" evidence=RCA

GO:0010413 "glucuronoxylan metabolic process" evidence=RCA

GO:0045492 "xylan biosynthetic process" evidence=RCA

TAIR|locus:2182905 AT5G07140 [Arabidopsis thaliana (taxid:3702)]

 Score = 1740 (617.6 bits), Expect = 3.0e-179, P = 3.0e-179
 Identities = 317/446 (71%), Positives = 382/446 (85%)

Query:     1 MKEVFLHIKLIEQASGDDRPAIMIQEVSDDEA--QGSVYKLTFACNSSISWPAMSGALDT 58
             MK+VF+HIKLIEQA GDD P  +IQEV D+EA  QGSV+KLTFAC  S+ W  +SG+LD 
Sbjct:   135 MKDVFVHIKLIEQAFGDDNPVFVIQEVCDEEADDQGSVFKLTFACTCSLPWSTISGSLDG 194

Query:    59 ASICCKKIQIFEKKGFTLGVVILAVQAGQEKSFKSQIENALKSAIKKPKPTSVKLPFGLC 118
             A ICCKK+QIFEKKG TLGVV+L V++GQEK FK ++ NAL+SA++KPK TSVKLPFGLC
Sbjct:   195 ALICCKKVQIFEKKGLTLGVVLLLVESGQEKMFKVKVVNALRSAVRKPKSTSVKLPFGLC 254

Query:   119 GCQEENTKGRDFGEIEEEEACDESFRNGVENSNLKIQLQMPLPSSSFVVSVDEWQTVQSG 178
             GC+E+N    +FG+++ E + D+ +R+ +++ N +IQLQMP PSSSF VSVDEWQT+QSG
Sbjct:   255 GCEEQNAGVGEFGDVDVE-SIDQCYRHELDDLNTRIQLQMPPPSSSFSVSVDEWQTIQSG 313

Query:   179 GEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELM 238
             G++I +WLLNSD+LEF  Q+GPNSFKGVY+G +V IEKLKGC+KGN+YEF +RKD LELM
Sbjct:   314 GDDIRKWLLNSDDLEFSGQLGPNSFKGVYRGTKVAIEKLKGCEKGNSYEFAIRKDFLELM 373

Query:   239 TCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIK 298
             TCGHK+ILQFY VC+DENHGLCVVTKLM+GGS+ +L+LK +KLQTK I +IA+D+AEG+K
Sbjct:   374 TCGHKSILQFYGVCIDENHGLCVVTKLMQGGSLRELVLKKKKLQTKLIFQIAVDIAEGMK 433

Query:   299 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAG 358
             F+NDHGVAYRDLN+QRILLD+  N CLGD+GIVTACKSV EA EYETDGYRWLAPEIIAG
Sbjct:   434 FINDHGVAYRDLNTQRILLDKQCNACLGDLGIVTACKSVNEAMEYETDGYRWLAPEIIAG 493

Query:   359 DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILK 418
             DPE   E+WMSN YSFGMV+WEMVTGE AY +CSPVQAAVGIAACGLRP+IPK+CPQ+LK
Sbjct:   494 DPEKTRESWMSNAYSFGMVLWEMVTGEEAYGSCSPVQAAVGIAACGLRPDIPKECPQVLK 553

Query:   419 SLMIKCWNNSPSKRPQFSEIISLLLR 444
              LMIKCWN  PS R  FS+I  +LLR
Sbjct:   554 YLMIKCWNTCPSTRLNFSQIHCILLR 579

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2128043 STY17 "serine/threonine/tyrosine kinase 17" [Arabidopsis thaliana (taxid:3702)]

 Score = 418 (152.2 bits), Expect = 2.5e-41, Sum P(2) = 2.5e-41
 Identities = 86/242 (35%), Positives = 144/242 (59%)

Query:   203 FKGVYKGKRVGIEKLKGCDKGNAYEF-ELRKDLLELMTCGHKNILQFYCVCVDENHGLCV 261
             F+G Y  + V I+ LK  ++ NA    E  +++  +    HKN++QF   C   +  LC+
Sbjct:   307 FRGTYCSQEVAIKILKP-ERVNAEMLREFSQEVYIMRKVRHKNVVQFIGACT-RSPNLCI 364

Query:   262 VTKLMEGGSVNDLILKSRKL-QTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH 320
             VT+ M  GS+ D + K + + + + ++++A+DV++G+ +L+ + + +RDL +  +L+D H
Sbjct:   365 VTEFMTRGSIYDFLHKHKGVFKIQSLLKVALDVSKGMNYLHQNNIIHRDLKTANLLMDEH 424

Query:   321 GNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWE 380
               V + D G+       G  T  ET  YRW+APE+I   P        ++V+S+ +V+WE
Sbjct:   425 EVVKVADFGVARVQTESGVMTA-ETGTYRWMAPEVIEHKPYD----HRADVFSYAIVLWE 479

Query:   381 MVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIIS 440
             ++TGE  Y+  +P+QAAVG+   GLRP+IPK+    L  L+ KCW   P+ RP F+EII 
Sbjct:   480 LLTGELPYSYLTPLQAAVGVVQKGLRPKIPKETHPKLTELLEKCWQQDPALRPNFAEIIE 539

Query:   441 LL 442
             +L
Sbjct:   540 ML 541

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0008152 "metabolic process" evidence=IEA

GO:0016597 "amino acid binding" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0005829 "cytosol" evidence=IDA

GO:0009658 "chloroplast organization" evidence=IGI

GO:0007015 "actin filament organization" evidence=RCA

TAIR|locus:2827943 STY8 "serine/threonine/tyrosine kinase 8" [Arabidopsis thaliana (taxid:3702)]

 Score = 429 (156.1 bits), Expect = 2.6e-40, P = 2.6e-40
 Identities = 92/265 (34%), Positives = 152/265 (57%)

Query:   185 WLLNSDNLEFIDQIGPNSF----KGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTC 240
             W ++   L+   ++   S+    +G Y  + V I+ LK     N    E  +++  +   
Sbjct:   279 WEIDVTQLKIEKKVASGSYGDLHRGTYCSQEVAIKFLKPDRVNNEMLREFSQEVFIMRKV 338

Query:   241 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR---KLQTKEIIRIAIDVAEGI 297
              HKN++QF   C   +  LC+VT+ M  GS+ D + K +   KLQT  ++++A+DVA+G+
Sbjct:   339 RHKNVVQFLGACT-RSPTLCIVTEFMARGSIYDFLHKQKCAFKLQT--LLKVALDVAKGM 395

Query:   298 KFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIA 357
              +L+ + + +RDL +  +L+D HG V + D G+       G  T  ET  YRW+APE+I 
Sbjct:   396 SYLHQNNIIHRDLKTANLLMDEHGLVKVADFGVARVQIESGVMTA-ETGTYRWMAPEVIE 454

Query:   358 GDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQIL 417
               P +      ++V+S+ +V+WE++TG+  YA  +P+QAAVG+   GLRP+IPK     +
Sbjct:   455 HKPYNHK----ADVFSYAIVLWELLTGDIPYAFLTPLQAAVGVVQKGLRPKIPKKTHPKV 510

Query:   418 KSLMIKCWNNSPSKRPQFSEIISLL 442
             K L+ +CW+  P +RP F EII +L
Sbjct:   511 KGLLERCWHQDPEQRPLFEEIIEML 535

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0008152 "metabolic process" evidence=IEA

GO:0016597 "amino acid binding" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0005829 "cytosol" evidence=IDA

GO:0009658 "chloroplast organization" evidence=IGI

GO:0007015 "actin filament organization" evidence=RCA

TAIR|locus:2121154 STY46 "serine/threonine/tyrosine kinase 46" [Arabidopsis thaliana (taxid:3702)]

 Score = 429 (156.1 bits), Expect = 2.6e-40, P = 2.6e-40
 Identities = 107/319 (33%), Positives = 171/319 (53%)

Query:   141 ESFRNGVENSNLKIQLQM---PLPSSSFVVSVDEWQT-------VQSGGEEIGRWLLNSD 190
             E  R  +E    KI+LQ    P+   SF    +  QT       + + G ++  W +N  
Sbjct:   232 ERLRISLEKEAAKIELQSQSWPM-QQSFSPEKENGQTGARTHVPIPNDGTDV--WEINLK 288

Query:   191 NLEFIDQIGPNSFKGVYKG----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNIL 246
             +L+F  +I   S+  +YKG    + V I+ LK     +  E E  +++  +    HKN++
Sbjct:   289 HLKFGHKIASGSYGDLYKGTYCSQEVAIKVLKPERLDSDLEKEFAQEVFIMRKVRHKNVV 348

Query:   247 QFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR---KLQTKEIIRIAIDVAEGIKFLNDH 303
             QF   C    H LC+VT+ M GGSV D + K +   KL T  + ++AID+ +G+ +L+ +
Sbjct:   349 QFIGACTKPPH-LCIVTEFMPGGSVYDYLHKQKGVFKLPT--LFKVAIDICKGMSYLHQN 405

Query:   304 GVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESV 363
              + +RDL +  +L+D +  V + D G+       G  T  ET  YRW+APE+I   P   
Sbjct:   406 NIIHRDLKAANLLMDENEVVKVADFGVARVKAQTGVMTA-ETGTYRWMAPEVIEHKPYDH 464

Query:   364 SETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIK 423
                  ++V+S+G+V+WE++TG+  Y   +P+QAAVG+   GLRP IPK+    L  L+ +
Sbjct:   465 K----ADVFSYGIVLWELLTGKLPYEYMTPLQAAVGVVQKGLRPTIPKNTHPKLAELLER 520

Query:   424 CWNNSPSKRPQFSEIISLL 442
              W +  ++RP FSEII  L
Sbjct:   521 LWEHDSTQRPDFSEIIEQL 539

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0008152 "metabolic process" evidence=IEA

GO:0016597 "amino acid binding" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0005829 "cytosol" evidence=IDA

GO:0009658 "chloroplast organization" evidence=IGI

GO:0007015 "actin filament organization" evidence=RCA

TAIR|locus:2126311 AT4G31170 [Arabidopsis thaliana (taxid:3702)]

 Score = 374 (136.7 bits), Expect = 1.7e-34, P = 1.7e-34
 Identities = 83/246 (33%), Positives = 136/246 (55%)

Query:   203 FKGVYKGKRVGIEKLKGCD----KGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHG 258
             ++G Y G+ V I+ L+  D    K  A E + ++++  L    H NI++F   C+ +   
Sbjct:   146 YRGTYNGEDVAIKLLERSDSNPEKAQALEQQFQQEVSMLAFLKHPNIVRFIGACI-KPMV 204

Query:   259 LCVVTKLMEGGSVNDLILK--SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRIL 316
              C+VT+  +GGSV   + K  +R +  K  +  A+DVA G+ ++++    +RDL S  +L
Sbjct:   205 WCIVTEYAKGGSVRQFLTKRQNRAVPLKLAVMQALDVARGMAYVHERNFIHRDLKSDNLL 264

Query:   317 LDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGM 376
             +    ++ + D G V   +   E    ET  YRW+APE+I   P     T   +VYSFG+
Sbjct:   265 ISADRSIKIADFG-VARIEVQTEGMTPETGTYRWMAPEMIQHRPY----TQKVDVYSFGI 319

Query:   377 VIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFS 436
             V+WE++TG   +   + VQAA  +   G+RP +P DC  +L  +M +CW+  P  RP F+
Sbjct:   320 VLWELITGLLPFQNMTAVQAAFAVVNRGVRPTVPADCLPVLGEIMTRCWDADPEVRPCFA 379

Query:   437 EIISLL 442
             EI++LL
Sbjct:   380 EIVNLL 385

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0005886 "plasma membrane" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0006499 "N-terminal protein myristoylation" evidence=RCA

GO:0006914 "autophagy" evidence=RCA

GO:0010053 "root epidermal cell differentiation" evidence=IMP

TAIR|locus:2154573 AT5G58950 [Arabidopsis thaliana (taxid:3702)]

 Score = 368 (134.6 bits), Expect = 7.4e-34, P = 7.4e-34
 Identities = 85/263 (32%), Positives = 142/263 (53%)

Query:   192 LEFIDQIGPNSFKGVYKGKRVGIEKL-------KGCDKGNAYEFELRKDLLELMTCGHKN 244
             L+F   +    + G Y+ K V ++ +        GC  G   E +  K++  L    H N
Sbjct:   211 LKFAHGLYSRLYHGKYEDKAVAVKLITVPDDDDNGC-LGARLEKQFTKEVTLLSRLTHPN 269

Query:   245 ILQFYCVCVDENHGLCVVTKLMEGGSVNDLILK--SRKLQTKEIIRIAIDVAEGIKFLND 302
             +++F     D     CV+T+ +  GS+   + K  +R L  K++I  AID+A G+++++ 
Sbjct:   270 VIKFVGAYKDPPV-YCVLTQYLPEGSLRSFLHKPENRSLPLKKLIEFAIDIARGMEYIHS 328

Query:   303 HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG---YRWLAPEIIAGD 359
               + +RDL  + +L+D   ++ + D GI  AC+   E  +   D    YRW+APE+I   
Sbjct:   329 RRIIHRDLKPENVLIDEEFHLKIADFGI--ACEE--EYCDMLADDPGTYRWMAPEMIKRK 384

Query:   360 PESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKS 419
             P        ++VYSFG+V+WEMV G   Y   +P+QAA  +    +RP IP DCP  +K+
Sbjct:   385 PHGRK----ADVYSFGLVLWEMVAGAIPYEDMNPIQAAFAVVHKNIRPAIPGDCPVAMKA 440

Query:   420 LMIKCWNNSPSKRPQFSEIISLL 442
             L+ +CW+ +P KRP+F +I+ +L
Sbjct:   441 LIEQCWSVAPDKRPEFWQIVKVL 463

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0005886 "plasma membrane" evidence=IDA

GO:0005829 "cytosol" evidence=IDA

DICTYBASE|DDB_G0267514 DDB_G0267514 "protein kinase, TKL group" [Dictyostelium discoideum (taxid:44689)]

 Score = 371 (135.7 bits), Expect = 4.4e-33, P = 4.4e-33
 Identities = 87/262 (33%), Positives = 141/262 (53%)

Query:   187 LNSDNLEFIDQIGPNSF----KGVYKGKRVGIEKLK-GCDKGNAYEFELRKDLLELMTCG 241
             ++   L+   ++G  +F    KG+++G  V I+++K   D  N    E RK+L  L    
Sbjct:   657 ISFSELKISSKLGEGTFGVVYKGLWRGSSVAIKQIKINEDVNNQVLEEFRKELTILSRLR 716

Query:   242 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLI-LKSRKLQTKEIIRIAIDVAEGIKFL 300
             H NI+     C    + LC +T+ + GGS+ D +  K  K+  +   ++AI +A+G+ +L
Sbjct:   717 HPNIVLLMAACTAPPN-LCFITEYLPGGSLYDALHSKKIKMNMQLYKKLAIQIAQGMNYL 775

Query:   301 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDP 360
             +  GV +RD+ S  +LLD H NV + D G+ +  KS             W++PE++ G  
Sbjct:   776 HLSGVIHRDIKSLNLLLDEHMNVKICDFGL-SKLKSKSTEMTKSIGSPIWMSPELLMG-- 832

Query:   361 ESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSL 420
             E  +E    +VY+FG+++WE+ TGE  Y+    VQ A+ +    LRP IP   P  L  L
Sbjct:   833 EDYTEK--VDVYAFGIILWELGTGELPYSGLDSVQLALAVTTKSLRPPIPNAWPYQLSHL 890

Query:   421 MIKCWNNSPSKRPQFSEIISLL 442
             +  CW+  P KRP F+EI++LL
Sbjct:   891 IQACWHQDPLKRPSFTEILNLL 912

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005575 "cellular_component" evidence=ND

GO:0016740 "transferase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

DICTYBASE|DDB_G0272254 DDB_G0272254 "protein kinase, TKL group" [Dictyostelium discoideum (taxid:44689)]

 Score = 360 (131.8 bits), Expect = 1.8e-32, Sum P(2) = 1.8e-32
 Identities = 87/273 (31%), Positives = 149/273 (54%)

Query:   186 LLNSDNLEFIDQIGPNSF----KGVYKGKRVGIEKLKGC-DKGNAYEFELRKDLLELM-T 239
             ++N  +++   +IG   F    KG +KGK V ++KL    DK      +  K  +EL+ +
Sbjct:  1067 MINYSDIKIDKEIGKGHFSKVLKGNWKGKDVAVKKLNSNKDKAREEMIQEFKAEVELLGS 1126

Query:   240 CGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLI-------LKSRKLQTKEIIRIAID 292
               H N++  Y   ++    +C+V + +  G++ +LI        +S KL +  I+ IA D
Sbjct:  1127 LQHPNLVTCYGYSLNP---MCIVMEFLPSGNLFELIHSKPSEQQQSIKLDSTLILAIAFD 1183

Query:   293 VAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLA 352
             +A G++ L+   + +RDL S  +L+D+H N+ + D+GI          T   T    W A
Sbjct:  1184 IARGMQHLHTRNIIHRDLKSSNLLMDKHFNIKIADLGIARETSFTQTMTTIGT--VAWTA 1241

Query:   353 PEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKD 412
             PEI+    ES ++   ++VYS+ +V++E++TGE  Y    P+ A + +A+ GLRPE+P +
Sbjct:  1242 PEILRH--ESYNQK--ADVYSYAIVLYELLTGEEPYQGIPPMNAGILVASKGLRPELPDN 1297

Query:   413 CPQILKSLMIKCWNNSPSKRPQFSEIISLLLRT 445
             C    K L++ CW+  P+KRP F EI + L +T
Sbjct:  1298 CDPNWKKLVVWCWSEDPNKRPSFEEITNYLTKT 1330

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005575 "cellular_component" evidence=ND

GO:0016740 "transferase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

GO:0016021 "integral to membrane" evidence=IEA

GO:0016020 "membrane" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

RGD|727908 Tnni3k "TNNI3 interacting kinase" [Rattus norvegicus (taxid:10116)]

 Score = 361 (132.1 bits), Expect = 4.2e-32, P = 4.2e-32
 Identities = 101/323 (31%), Positives = 165/323 (51%)

Query:   134 EEEEACDESFRNGVENSNLKIQLQMPLPSSSFVVSVDEWQTVQSGGEEI-GRWLLNSDNL 192
             +EE  C+E  + G + S + +    P P         E   V     E+  R+ L    +
Sbjct:   408 QEELPCNEYSQPGGDGSYVSV----PSPLGKIKSMTKEKADVLLLRAELPSRFHLQLSEI 463

Query:   193 EFIDQIGPNSFKGVYKG----KRVGIEKLKG---CDKGNAYEFELRKDLLELMTCGHKNI 245
             EF + IG  SF  VYKG    K V I++ +    C K +   F   +++  L    H  +
Sbjct:   464 EFHEIIGSGSFGKVYKGRCRNKIVAIKRYRANTYCSKSDVDMF--CREVSILCQLNHPCV 521

Query:   246 LQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK---LQTKEIIRIAIDVAEGIKFLND 302
             +QF   C+D+     +VT+ + GGS+  L+ + ++   LQ+K II  A+DVA+G+++L+ 
Sbjct:   522 VQFVGACLDDPSQFAIVTQYISGGSLFSLLHEQKRILDLQSKLII--AVDVAKGMEYLHS 579

Query:   303 --HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG-YRWLAPEIIAGD 359
                 + +RDLNS  ILL   G+  + D G     +S+ E    +  G  RW+APE+    
Sbjct:   580 LTQPIIHRDLNSHNILLYEDGHAVVADFGESRFLQSLDEDNMTKQPGNLRWMAPEVFT-- 637

Query:   360 PESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKS 419
              +    T  ++V+S+ + +WE++TGE  +A   P  AA  +A   +RP I    P+ + S
Sbjct:   638 -QCTRYTIKADVFSYSLCLWELLTGEIPFAHLKPAAAAADMAYHHIRPPIGYSIPKPISS 696

Query:   420 LMIKCWNNSPSKRPQFSEIISLL 442
             L+I+ WN  P  RP+FSE++S L
Sbjct:   697 LLIRGWNACPEGRPEFSEVVSKL 719

GO:0004672 "protein kinase activity" evidence=IEA;ISO

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=IEA;ISO

GO:0005737 "cytoplasm" evidence=IEA;ISO

GO:0006468 "protein phosphorylation" evidence=ISO

GO:0008022 "protein C-terminus binding" evidence=ISO

GO:0031013 "troponin I binding" evidence=ISO

GO:0046872 "metal ion binding" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
3rd Layer	2.7.11	LOW CONFIDENCE prediction!

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: GSVIVG00024046001 SubName- Full=Chromosome chr6 scaffold_3, whole genome shotgun sequence; (592 aa) (Vitis vinifera)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	454
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	2e-46
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	7e-45
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	2e-44
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	4e-42
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	2e-40
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	3e-34
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	4e-34
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	5e-32
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	9e-30
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	3e-29
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	7e-29
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	2e-28
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	2e-27
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	7e-27
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	1e-26
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	4e-26
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	6e-26
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	1e-25
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	6e-25
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	6e-25
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	9e-25
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	2e-24
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	5e-24
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	1e-23
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	3e-23
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	4e-23
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	2e-22
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-22
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	3e-22
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	6e-22
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	9e-22
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	2e-21
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	3e-21
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	3e-21
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	3e-21
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	8e-21
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	8e-21
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	2e-20
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	2e-20
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	2e-20
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	5e-20
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	7e-20
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	7e-20
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	9e-20
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	9e-20
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	1e-19
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	2e-19
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	2e-19
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	4e-19
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	4e-19
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	5e-19
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	5e-19
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	7e-19
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	1e-18
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	1e-18
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	1e-18
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	2e-18
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	3e-18
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	4e-18
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	5e-18
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	7e-18
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	7e-18
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	7e-18
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	8e-18
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	8e-18
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	9e-18
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	1e-17
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	1e-17
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	1e-17
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	1e-17
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	3e-17
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	3e-17
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	3e-17
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	6e-17
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	7e-17
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	8e-17
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	9e-17
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	1e-16
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	1e-16
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	2e-16
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	2e-16
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	3e-16
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	6e-16
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	7e-16
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	9e-16
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	1e-15
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	1e-15
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	1e-15
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	2e-15
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	2e-15
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	2e-15
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	2e-15
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	3e-15
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	3e-15
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	4e-15
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	5e-15
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	7e-15
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	7e-15
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	7e-15
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	1e-14
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	1e-14
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	1e-14
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	1e-14
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	2e-14
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	2e-14
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	2e-14
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	2e-14
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	2e-14
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	3e-14
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	6e-14
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	7e-14
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	9e-14
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	1e-13
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	1e-13
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	1e-13
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	1e-13
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	2e-13
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	4e-13
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	4e-13
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	5e-13
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	6e-13
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	7e-13
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	1e-12
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	1e-12
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	2e-12
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	3e-12
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	3e-12
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	3e-12
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	3e-12
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	3e-12
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	4e-12
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	5e-12
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	9e-12
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	9e-12
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	1e-11
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	1e-11
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	2e-11
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	2e-11
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	2e-11
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	3e-11
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	3e-11
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	4e-11
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	4e-11
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	5e-11
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	6e-11
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	7e-11
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	1e-10
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	1e-10
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	1e-10
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-10
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	1e-10
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-10
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	2e-10
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	2e-10
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	2e-10
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	3e-10
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	4e-10
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	4e-10
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	5e-10
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	5e-10
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	5e-10
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	5e-10
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	5e-10
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	7e-10
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	7e-10
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	1e-09
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	1e-09
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	1e-09
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	1e-09
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	2e-09
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	2e-09
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	2e-09
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	2e-09
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-09
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	3e-09
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	3e-09
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	4e-09
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	5e-09
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	6e-09
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	6e-09
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	6e-09
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	1e-08
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	1e-08
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	1e-08
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	1e-08
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-08
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	2e-08
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	2e-08
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	2e-08
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	2e-08
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	3e-08
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	3e-08
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	4e-08
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	4e-08
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	5e-08
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	5e-08
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	8e-08
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	9e-08
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	1e-07
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	1e-07
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	1e-07
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	2e-07
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	2e-07
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	3e-07
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	3e-07
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	3e-07
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	3e-07
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	3e-07
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	3e-07
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	5e-07
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	5e-07
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	5e-07
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	6e-07
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	7e-07
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	7e-07
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	1e-06
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	1e-06
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	2e-06
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	2e-06
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	3e-06
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	4e-06
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	4e-06
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	4e-06
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	4e-06
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	5e-06
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	5e-06
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	5e-06
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	6e-06
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	7e-06
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	8e-06
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	9e-06
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	1e-05
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	1e-05
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	2e-05
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	2e-05
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	2e-05
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	4e-05
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	6e-05
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	7e-05
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	7e-05
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	8e-05
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	9e-05
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-04
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	1e-04
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	1e-04
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	1e-04
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	2e-04
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-04
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	2e-04
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	2e-04
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	3e-04
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	3e-04
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	3e-04
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	4e-04
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	4e-04
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	4e-04
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	5e-04
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	6e-04
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	7e-04
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	0.001
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	0.001
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	0.001
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	0.002
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	0.002
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	0.002
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	0.002
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	0.004

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  161 bits (409), Expect = 2e-46
 Identities = 79/268 (29%), Positives = 129/268 (48%), Gaps = 27/268 (10%)

Query: 192 LEFIDQIGPNSFKGVYKGKRVGIEKLKGCD------KGNAYEFELRKDLLE----LMTCG 241
           LE   ++G  +F  VYKG   G  +           K  A E E R++ LE    +    
Sbjct: 1   LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASE-EEREEFLEEASIMKKLS 59

Query: 242 HKNILQFYCVCVDENHGLCVVTKLMEGGSVND-LILKSRKLQTKEIIRIAIDVAEGIKFL 300
           H NI++   VC      L +VT+ M GG + D L     KL  K+++++A+ +A+G+++L
Sbjct: 60  HPNIVRLLGVCTQGEP-LYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYL 118

Query: 301 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG-----YRWLAPEI 355
                 +RDL ++  L+  +  V + D G+    + + E   Y   G      +W+APE 
Sbjct: 119 ESKNFVHRDLAARNCLVTENLVVKISDFGL---SRDIYEDDYYRKRGGGKLPIKWMAPES 175

Query: 356 IAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCP 414
           +     +      S+V+SFG+++WE+ T GE  Y   S  +    +   G R   P++CP
Sbjct: 176 LKDGKFTSK----SDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLED-GYRLPRPENCP 230

Query: 415 QILKSLMIKCWNNSPSKRPQFSEIISLL 442
             L  LM++CW   P  RP FSE++  L
Sbjct: 231 DELYELMLQCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  156 bits (398), Expect = 7e-45
 Identities = 76/271 (28%), Positives = 128/271 (47%), Gaps = 34/271 (12%)

Query: 192 LEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLLE----L 237
           L    ++G  +F  VYKGK           V ++ LK          +  ++ L     +
Sbjct: 1   LTLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKED-----ASEQQIEEFLREARIM 55

Query: 238 MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEG 296
               H N+++   VC +E   L +V + MEGG +   + K+R KL   +++  A+ +A G
Sbjct: 56  RKLDHPNVVKLLGVCTEE-EPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARG 114

Query: 297 IKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRWLA 352
           +++L      +RDL ++  L+  +  V + D G+    + + +   Y   G     RW+A
Sbjct: 115 MEYLESKNFIHRDLAARNCLVGENLVVKISDFGL---SRDLYDDDYYRKRGGKLPIRWMA 171

Query: 353 PEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPK 411
           PE +    E    T  S+V+SFG+++WE+ T GE  Y   S  +    +   G R   P 
Sbjct: 172 PESLK---EGKF-TSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKN-GYRLPQPP 226

Query: 412 DCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
           +CP  L  LM++CW   P  RP FSE++ +L
Sbjct: 227 NCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  155 bits (395), Expect = 2e-44
 Identities = 75/272 (27%), Positives = 127/272 (46%), Gaps = 35/272 (12%)

Query: 192 LEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLLE----L 237
           L    ++G  +F  VYKG            V ++ LK          +  ++ L     +
Sbjct: 1   LTLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLK-----EDASEQQIEEFLREARIM 55

Query: 238 MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK--LQTKEIIRIAIDVAE 295
               H NI++   VC +E   L +V + M GG + D + K+R   L   +++  A+ +A 
Sbjct: 56  RKLDHPNIVKLLGVCTEE-EPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIAR 114

Query: 296 GIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRWL 351
           G+++L      +RDL ++  L+  +  V + D G+    + + +   Y+  G     RW+
Sbjct: 115 GMEYLESKNFIHRDLAARNCLVGENLVVKISDFGL---SRDLYDDDYYKVKGGKLPIRWM 171

Query: 352 APEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIP 410
           APE +    E    T  S+V+SFG+++WE+ T GE  Y   S  +    +   G R   P
Sbjct: 172 APESLK---EGKF-TSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKK-GYRLPKP 226

Query: 411 KDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
            +CP  L  LM++CW   P  RP FSE++ +L
Sbjct: 227 PNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  149 bits (379), Expect = 4e-42
 Identities = 78/264 (29%), Positives = 122/264 (46%), Gaps = 38/264 (14%)

Query: 203 FKGVYKGK-----RVGIEKLKGCDKGNAYEFELRKDLLE----LMTCGHKNILQFYCVCV 253
           +KG  KGK      V ++ LK          E RKD L+    +   GH N+++   VC 
Sbjct: 12  YKGKLKGKDGKTTEVAVKTLKEDA-----SEEERKDFLKEARVMKKLGHPNVVRLLGVCT 66

Query: 254 DENHGLCVVTKLMEGGSVNDLILKSRK---------LQTKEIIRIAIDVAEGIKFLNDHG 304
           +E   L +V + MEGG + D + KSR          L  K+++  AI +A+G+++L    
Sbjct: 67  EEEP-LYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK 125

Query: 305 VAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG-----YRWLAPEIIAGD 359
             +RDL ++  L+     V + D G+    + V +   Y          RW+APE +   
Sbjct: 126 FVHRDLAARNCLVGEDLVVKISDFGL---SRDVYDDDYYRKKTGGKLPIRWMAPESLKDG 182

Query: 360 PESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILK 418
             +      S+V+SFG+++WE+ T G   Y   S  +    +   G R   P+ CP  L 
Sbjct: 183 IFTS----KSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK-GYRLPKPEYCPDELY 237

Query: 419 SLMIKCWNNSPSKRPQFSEIISLL 442
            LM+ CW   P  RP FSE++  L
Sbjct: 238 ELMLSCWQLDPEDRPTFSELVERL 261

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  144 bits (366), Expect = 2e-40
 Identities = 73/260 (28%), Positives = 127/260 (48%), Gaps = 19/260 (7%)

Query: 192 LEFIDQIGPNSFKGVYKGKRVGIEKL---KGCDKGNAYEFELRKDLLELM---TCGHKNI 245
            E + ++G  SF  VYK K  G  K+   K   K +    + +    E+       H NI
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60

Query: 246 LQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGV 305
           ++      D++H L +V +  EGG + D + +   L   E  +IA+ +  G+++L+ +G+
Sbjct: 61  VRLIDAFEDKDH-LYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGI 119

Query: 306 AYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYET-DG-YRWLAPEIIAGDPESV 363
            +RDL  + ILLD +G V + D G+  A K +  ++   T  G   ++APE++ G     
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGL--AKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYG 177

Query: 364 SETWMSNVYSFGMVIWEMVTGEAAYAACSPV---QAAVGIAACGLRPEIPKDCPQI--LK 418
            +    +V+S G++++E++TG+  ++  + +   Q    I    L  + PK        K
Sbjct: 178 PK---VDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAK 234

Query: 419 SLMIKCWNNSPSKRPQFSEI 438
            L+ KC N  PSKRP   EI
Sbjct: 235 DLIKKCLNKDPSKRPTAEEI 254

Length = 260

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  128 bits (324), Expect = 3e-34
 Identities = 63/263 (23%), Positives = 110/263 (41%), Gaps = 33/263 (12%)

Query: 193 EFIDQIGPNSFKGVYKGKRVGIEK---LKGCDKGNAYEFELRKDLLE----LMTCGHKNI 245
           E ++++G  SF  VY  +     K   +K   K    +   R+ +L     L    H NI
Sbjct: 2   EILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKD--RERILREIKILKKLKHPNI 59

Query: 246 LQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGV 305
           ++ Y V  DE+  L +V +  EGG + DL+ K  +L   E       +   +++L+  G+
Sbjct: 60  VRLYDVFEDEDK-LYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGI 118

Query: 306 AYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR--------WLAPEIIA 357
            +RDL  + ILLD  G+V L D G+         A + +             ++APE++ 
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGL---------ARQLDPGEKLTTFVGTPEYMAPEVLL 169

Query: 358 GDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPK--DCPQ 415
           G     +     +++S G++++E++TG+  +     +            P  P   D   
Sbjct: 170 GKGYGKA----VDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISP 225

Query: 416 ILKSLMIKCWNNSPSKRPQFSEI 438
             K L+ K     P KR    E 
Sbjct: 226 EAKDLIRKLLVKDPEKRLTAEEA 248

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  126 bits (320), Expect = 4e-34
 Identities = 73/256 (28%), Positives = 117/256 (45%), Gaps = 52/256 (20%)

Query: 198 IGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV 251
           +G   F  VY       GK+V I+ +K  D  +  E EL +++  L    H NI++ Y V
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLE-ELLREIEILKKLNHPNIVKLYGV 59

Query: 252 CVDENHGLCVVTKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDL 310
             DENH L +V +  EGGS+ DL+ +   KL   EI+RI + + EG+++L+ +G+ +RDL
Sbjct: 60  FEDENH-LYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDL 118

Query: 311 NSQRILLD-RHGNVCLGDMGIVTACKSVGEATEYETDG---YRWLAPEIIAGDPESVSET 366
             + ILLD  +G V L D G+    K +               ++APE++ G       +
Sbjct: 119 KPENILLDSDNGKVKLADFGL---SKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYY---S 172

Query: 367 WMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWN 426
             S+++S G++++E+                                   LK L+ K   
Sbjct: 173 EKSDIWSLGVILYEL---------------------------------PELKDLIRKMLQ 199

Query: 427 NSPSKRPQFSEIISLL 442
             P KRP   EI+  L
Sbjct: 200 KDPEKRPSAKEILEHL 215

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  122 bits (308), Expect = 5e-32
 Identities = 79/273 (28%), Positives = 127/273 (46%), Gaps = 35/273 (12%)

Query: 185 WLLNSDNLEFIDQIGPNSF----KGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLE---L 237
           W +NS  L+    IG   F     G Y+G++V ++ LK  D   A  F     L E   +
Sbjct: 1   WAINSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLK-DDSTAAQAF-----LAEASVM 54

Query: 238 MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK---LQTKEIIRIAIDVA 294
            T  H N++Q   V +  N  L +VT+ M  GS+ D  L+SR    +   + +  A+DV 
Sbjct: 55  TTLRHPNLVQLLGVVLQGNP-LYIVTEYMAKGSLVDY-LRSRGRAVITLAQQLGFALDVC 112

Query: 295 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR----W 350
           EG+++L +    +RDL ++ +L+       + D G+        +      D  +    W
Sbjct: 113 EGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGL-------AKEASQGQDSGKLPVKW 165

Query: 351 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEI 409
            APE +    E    T  S+V+SFG+++WE+ + G   Y    P++  V     G R E 
Sbjct: 166 TAPEALR---EKKFST-KSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPHVEKGYRMEA 220

Query: 410 PKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
           P+ CP  +  +M  CW   P+KRP F ++   L
Sbjct: 221 PEGCPPEVYKVMKDCWELDPAKRPTFKQLREQL 253

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score =  116 bits (293), Expect = 9e-30
 Identities = 80/297 (26%), Positives = 129/297 (43%), Gaps = 57/297 (19%)

Query: 185 WLLNSDNLEFIDQIGPNSFKGVYKG-----------KRVGIEKLKGCDK-GNAYEFELRK 232
           W L  + +  I ++G  SF  VY+G            RV I+ +          EF    
Sbjct: 1   WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEA 60

Query: 233 DLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQ---------- 282
            +++   C H  +++   V       L VV +LM  G +    L+SR+ +          
Sbjct: 61  SVMKEFNCHH--VVRLLGVVSTGQPTL-VVMELMAKGDLKSY-LRSRRPEAENNPGLGPP 116

Query: 283 -TKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT 341
             ++ I++A ++A+G+ +L      +RDL ++  ++     V +GD G+           
Sbjct: 117 TLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDI------- 169

Query: 342 EYETDGY----------RWLAPEIIAGDPESVSE---TWMSNVYSFGMVIWEMVT-GEAA 387
            YETD Y          RW+APE       S+ +   T  S+V+SFG+V+WEM T  E  
Sbjct: 170 -YETDYYRKGGKGLLPVRWMAPE-------SLKDGVFTTKSDVWSFGVVLWEMATLAEQP 221

Query: 388 YAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR 444
           Y   S  +    +   G   ++P++CP  L  LM  CW  +P  RP F EI+S L  
Sbjct: 222 YQGLSNEEVLKFVIDGGHL-DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  114 bits (288), Expect = 3e-29
 Identities = 71/260 (27%), Positives = 119/260 (45%), Gaps = 18/260 (6%)

Query: 185 WLLNSDNLEFIDQIGPNSFKGVYKGK-----RVGIEKLKGCDKGNAYEFELRKDLLELMT 239
           W    +      ++G   F  V++G      RV I+ LK  D     +F+  K++  L  
Sbjct: 1   WERPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQ--KEVQALKR 58

Query: 240 CGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGI 297
             HK+++  + VC      + ++T+LME GS+   +     + L    +I +A  VAEG+
Sbjct: 59  LRHKHLISLFAVC-SVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGM 117

Query: 298 KFLNDHGVAYRDLNSQRILLDRHGNVC-LGDMGIVTACKSVGEATEYETDGYRWLAPEII 356
            +L +    +RDL ++ IL+     VC + D G+    K     +  +   Y+W APE  
Sbjct: 118 AYLEEQNSIHRDLAARNILVG-EDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAA 176

Query: 357 AGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ 415
           +    S      S+V+SFG++++EM T G+  Y   +           G R   P  CPQ
Sbjct: 177 SHGTFSTK----SDVWSFGILLYEMFTYGQVPYPGMN-NHEVYDQITAGYRMPCPAKCPQ 231

Query: 416 ILKSLMIKCWNNSPSKRPQF 435
            +  +M++CW   P  RP F
Sbjct: 232 EIYKIMLECWAAEPEDRPSF 251

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  113 bits (286), Expect = 7e-29
 Identities = 59/199 (29%), Positives = 99/199 (49%), Gaps = 14/199 (7%)

Query: 242 HKNILQFY-CVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL 300
           H NI+++Y     +E + L +  + + GGS++ L+ K  KL    I +    + EG+ +L
Sbjct: 58  HPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYL 117

Query: 301 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY-----RWLAPEI 355
           + +G+ +RD+    IL+D  G V L D G     K +G+    E  G       W+APE+
Sbjct: 118 HSNGIVHRDIKGANILVDSDGVVKLADFG---CAKRLGDIETGEGTGSVRGTPYWMAPEV 174

Query: 356 IAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVG-IAACGLRPEIPKDCP 414
           I G+    +    ++++S G  + EM TG+  ++      AA+  I + G  PEIP+   
Sbjct: 175 IRGEEYGRA----ADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLS 230

Query: 415 QILKSLMIKCWNNSPSKRP 433
           +  K  + KC    P KRP
Sbjct: 231 EEAKDFLRKCLRRDPKKRP 249

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score =  112 bits (283), Expect = 2e-28
 Identities = 70/253 (27%), Positives = 117/253 (46%), Gaps = 23/253 (9%)

Query: 204 KGVY---KGKR--VGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHG 258
           KGVY    GK   V ++ LK  +   A + E  ++   +    H  I++   VC  E   
Sbjct: 13  KGVYLMKSGKEVEVAVKTLKQ-EHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKGE--P 69

Query: 259 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLD 318
           L +V +L   G +   + K R++   ++  +A  VA G+ +L      +RDL ++ +LL 
Sbjct: 70  LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLV 129

Query: 319 RHGNVCLGDMGIVTACKSVGEATEY---ETDG---YRWLAPEIIAGDPESVSETWMSNVY 372
                 + D G+    +++G  ++Y    T G    +W APE I     S      S+V+
Sbjct: 130 NRHQAKISDFGM---SRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSK----SDVW 182

Query: 373 SFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSK 431
           S+G+ +WE  + G   Y      +  + +   G R   P++CPQ + S+M+ CW   P  
Sbjct: 183 SYGVTLWEAFSYGAKPYGEMKGAEV-IAMLESGERLPRPEECPQEIYSIMLSCWKYRPED 241

Query: 432 RPQFSEIISLLLR 444
           RP FSE+ S   R
Sbjct: 242 RPTFSELESTFRR 254

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  109 bits (275), Expect = 2e-27
 Identities = 86/272 (31%), Positives = 133/272 (48%), Gaps = 39/272 (14%)

Query: 194 FIDQ-IGPNSFKGVYKG---------KRVGIEKLK-GCDKGNAYEFELRKDLLELMTCG- 241
            I++ IG   F  V +G           V I+ LK G       +F     L E    G 
Sbjct: 7   TIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDF-----LTEASIMGQ 61

Query: 242 --HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIK 298
             H NI++   V V ++  + ++T+ ME GS++  + ++  K    +++ +   +A G+K
Sbjct: 62  FDHPNIIRLEGV-VTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMK 120

Query: 299 FLNDHGVAYRDLNSQRILLDRHGNVC-LGDMGIVTACKSVGEATEYETDG----YRWLAP 353
           +L++    +RDL ++ IL++ +  VC + D G+    +   EAT Y T G     RW AP
Sbjct: 121 YLSEMNYVHRDLAARNILVNSN-LVCKVSDFGLSRRLEDS-EAT-YTTKGGKIPIRWTAP 177

Query: 354 EIIAGDPESVSETWMSNVYSFGMVIWE-MVTGEAAYAACS--PVQAAVGIAACGLRPEIP 410
           E IA    + +    S+V+SFG+V+WE M  GE  Y   S   V  AV     G R   P
Sbjct: 178 EAIAYRKFTSA----SDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVED---GYRLPPP 230

Query: 411 KDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
            DCP  L  LM+ CW    ++RP FS+I+S L
Sbjct: 231 MDCPSALYQLMLDCWQKDRNERPTFSQIVSTL 262

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  108 bits (271), Expect = 7e-27
 Identities = 73/260 (28%), Positives = 123/260 (47%), Gaps = 38/260 (14%)

Query: 193 EFIDQIGPNSFKGVYK------GKRVGIEKLK--GCDKGNAYEFELRKDLLELMTCGHKN 244
           E +++IG   F  VYK      GK V I+ +K    +K      E++  +L+   C H N
Sbjct: 3   EILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQ--ILK--KCKHPN 58

Query: 245 ILQFYCVCVDENHGLCVVTKLMEGGSVNDLI-LKSRKLQTKEIIRIAIDVAEGIKFLNDH 303
           I+++Y     +   L +V +   GGS+ DL+   ++ L   +I  +  ++ +G+++L+ +
Sbjct: 59  IVKYYG-SYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN 117

Query: 304 GVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS-------VGEATEYETDGYRWLAPEII 356
           G+ +RD+ +  ILL   G V L D G+             VG  T Y      W+APE+I
Sbjct: 118 GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVG--TPY------WMAPEVI 169

Query: 357 AGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIA---ACGLRPEIPKDC 413
            G P        ++++S G+   E+  G+  Y+   P++A   IA     GLR   P+  
Sbjct: 170 NGKPYDYK----ADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLR--NPEKW 223

Query: 414 PQILKSLMIKCWNNSPSKRP 433
               K  + KC   +P KRP
Sbjct: 224 SDEFKDFLKKCLQKNPEKRP 243

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  108 bits (272), Expect = 1e-26
 Identities = 67/286 (23%), Positives = 126/286 (44%), Gaps = 48/286 (16%)

Query: 190 DNLEFIDQIGPNSFKGVYK----------GKRVGIEKLKGCDKGNAYEFELRKDLLELMT 239
            +L+FI Q+G   F  V            G++V ++ L        +  +  +++  L T
Sbjct: 4   RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLN-HSGEEQHRSDFEREIEILRT 62

Query: 240 CGHKNILQFYCVCVDENHG--LCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEG 296
             H+NI+++  VC ++  G  L ++ + +  GS+ D + + R ++  K ++  +  + +G
Sbjct: 63  LDHENIVKYKGVC-EKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKG 121

Query: 297 IKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYET---DG---YRW 350
           + +L      +RDL ++ IL++    V + D G+    K + E  +Y      G     W
Sbjct: 122 MDYLGSQRYIHRDLAARNILVESEDLVKISDFGLA---KVLPEDKDYYYVKEPGESPIFW 178

Query: 351 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAAC------ 403
            APE +     S +    S+V+SFG+ ++E+ T G+ +    SP    + +         
Sbjct: 179 YAPECLRTSKFSSA----SDVWSFGVTLYELFTYGDPS---QSPPAEFLRMIGIAQGQMI 231

Query: 404 ----------GLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEII 439
                     G R   P  CP  +  LM  CW   P  RP F+++I
Sbjct: 232 VTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLI 277

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  106 bits (266), Expect = 4e-26
 Identities = 67/260 (25%), Positives = 121/260 (46%), Gaps = 18/260 (6%)

Query: 185 WLLNSDNLEFIDQIGPNSFKGVYKG-----KRVGIEKLKGCDKGNAYEFELRKDLLELMT 239
           W ++  +++ + ++G   F  V++G       V ++ LK    G     +   +   +  
Sbjct: 1   WEIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLK---PGTMDPKDFLAEAQIMKK 57

Query: 240 CGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGI 297
             H  ++Q Y VC  E   + +VT+LM+ GS+ + +     R L+  ++I +A  VA G+
Sbjct: 58  LRHPKLIQLYAVCTLEE-PIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGM 116

Query: 298 KFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK-SVGEATEYETDGYRWLAPEII 356
            +L      +RDL ++ +L+  +    + D G+    K  + EA E      +W APE  
Sbjct: 117 AYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAA 176

Query: 357 AGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ 415
             +  S+     S+V+SFG+++ E+VT G   Y   +  +    +   G R   P  CP+
Sbjct: 177 LYNRFSIK----SDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQ-GYRMPCPPGCPK 231

Query: 416 ILKSLMIKCWNNSPSKRPQF 435
            L  +M+ CW   P  RP F
Sbjct: 232 ELYDIMLDCWKEDPDDRPTF 251

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score =  105 bits (264), Expect = 6e-26
 Identities = 77/267 (28%), Positives = 133/267 (49%), Gaps = 21/267 (7%)

Query: 185 WLLNSDNLEFIDQIGPNSF----KGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTC 240
           WLLN   L   + IG   F    +G Y G++V ++ +K CD   A  F     ++  +  
Sbjct: 1   WLLNLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIK-CDV-TAQAFLEETAVMTKLH- 57

Query: 241 GHKNILQFYCVCVDENHGLCVVTKLMEGGS-VNDLILKSRKL-QTKEIIRIAIDVAEGIK 298
            HKN+++   V +  ++GL +V +LM  G+ VN L  + R L    ++++ ++DVAEG++
Sbjct: 58  -HKNLVRLLGVIL--HNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGME 114

Query: 299 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAG 358
           +L    + +RDL ++ IL+   G   + D G+        + ++      +W APE +  
Sbjct: 115 YLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPV---KWTAPEALKH 171

Query: 359 DPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQIL 417
              S      S+V+S+G+++WE+ + G A Y   S  +    +   G R E P+ CP  +
Sbjct: 172 KKFSSK----SDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEK-GYRMEPPEGCPADV 226

Query: 418 KSLMIKCWNNSPSKRPQFSEIISLLLR 444
             LM  CW   P KRP F ++   L +
Sbjct: 227 YVLMTSCWETEPKKRPSFHKLREKLEK 253

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score =  104 bits (261), Expect = 1e-25
 Identities = 69/262 (26%), Positives = 124/262 (47%), Gaps = 21/262 (8%)

Query: 185 WLLNSDNLEFIDQIGPNSFKGV----YKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTC 240
           W LN   L+ +  IG   F  V    Y+G +V ++    C K +A       +   +   
Sbjct: 1   WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVK----CIKNDATAQAFLAEASVMTQL 56

Query: 241 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK---LQTKEIIRIAIDVAEGI 297
            H N++Q   V V+E  GL +VT+ M  GS+ D  L+SR    L    +++ ++DV E +
Sbjct: 57  RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDY-LRSRGRSVLGGDCLLKFSLDVCEAM 115

Query: 298 KFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIA 357
           ++L  +   +RDL ++ +L+       + D G+     S  +  +      +W APE + 
Sbjct: 116 EYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV---KWTAPEALR 172

Query: 358 GDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQI 416
               S      S+V+SFG+++WE+ + G   Y    P++  V     G + + P  CP +
Sbjct: 173 EKKFSTK----SDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPRVEKGYKMDAPDGCPPV 227

Query: 417 LKSLMIKCWNNSPSKRPQFSEI 438
           +  +M +CW+   + RP F ++
Sbjct: 228 VYDVMKQCWHLDAATRPSFLQL 249

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  103 bits (259), Expect = 6e-25
 Identities = 79/291 (27%), Positives = 127/291 (43%), Gaps = 54/291 (18%)

Query: 189 SDNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELM---- 238
            +  + +++IG  +   VYK      GK V I+K++           LRK   EL+    
Sbjct: 18  RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMR-----------LRKQNKELIINEI 66

Query: 239 ----TCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLI-LKSRKLQTKEIIRIAIDV 293
                C H NI+ +Y   +  +  L VV + M+GGS+ D+I     ++   +I  +  +V
Sbjct: 67  LIMKDCKHPNIVDYYDSYLVGDE-LWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREV 125

Query: 294 AEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGI---VTACKS-----VGEATEYET 345
            +G+++L+   V +RD+ S  ILL + G+V L D G    +T  KS     VG  T Y  
Sbjct: 126 LQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVG--TPY-- 181

Query: 346 DGYRWLAPEIIAGDP--ESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAAC 403
               W+APE+I        V      +++S G++  EM  GE  Y    P++A   I   
Sbjct: 182 ----WMAPEVIKRKDYGPKV------DIWSLGIMCIEMAEGEPPYLREPPLRALFLITTK 231

Query: 404 GLRPEI--PKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNSS 452
           G+ P +  P+      K  + KC    P KRP   E++             
Sbjct: 232 GI-PPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKACPKEE 281

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  102 bits (257), Expect = 6e-25
 Identities = 68/261 (26%), Positives = 127/261 (48%), Gaps = 19/261 (7%)

Query: 192 LEFIDQIGPNSFKGVYKGKRVGIEK--LKGCDKGNAYEFELRKDLLELMTCGHKNILQFY 249
           L F+ ++G   F  V+ GK  G     +K   +G   E +  ++   +M   H N++Q Y
Sbjct: 6   LTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLY 65

Query: 250 CVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGVAYR 308
            VC  +   + +VT+ M  G + + + + + KL T+ ++ +  DV E +++L  +G  +R
Sbjct: 66  GVCT-KQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHR 124

Query: 309 DLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG-----YRWLAPEIIAGDPESV 363
           DL ++  L+     V + D G+    + V +  +Y +        +W  PE+      S 
Sbjct: 125 DLAARNCLVGEDNVVKVSDFGLA---RYVLD-DQYTSSQGTKFPVKWAPPEVFDYSRFSS 180

Query: 364 SETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMI 422
                S+V+SFG+++WE+ + G+  Y   S  +    ++A G R   PK  P  + ++M 
Sbjct: 181 K----SDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSA-GYRLYRPKLAPTEVYTIMY 235

Query: 423 KCWNNSPSKRPQFSEIISLLL 443
            CW+  P  RP F +++S L 
Sbjct: 236 SCWHEKPEDRPAFKKLLSQLT 256

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score =  102 bits (256), Expect = 9e-25
 Identities = 82/279 (29%), Positives = 137/279 (49%), Gaps = 48/279 (17%)

Query: 198 IGPNSFKGVYKGK------------RVGIEKLKGCDKGNAYEFELRKDLLE--LMT-CGH 242
           +G  +F  VY+G             RV ++ L+   KG A + E ++ L E  LM+   H
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLR---KG-ATDQEKKEFLKEAHLMSNFNH 58

Query: 243 KNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK-------LQTKEIIRIAIDVAE 295
            NI++   VC+  N    ++ +LMEGG +   +  +R        L  KE++ I +DVA+
Sbjct: 59  PNIVKLLGVCLL-NEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAK 117

Query: 296 GIKFLNDHGVAYRDLNSQRILLDRHGNVC-----LGDMGIVTACKSVGEATEYETDG--- 347
           G  +L      +RDL ++  L+   G        +GD G+    + + ++  Y  +G   
Sbjct: 118 GCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA---RDIYKSDYYRKEGEGL 174

Query: 348 --YRWLAPE-IIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAAC 403
              RW+APE ++ G       T  S+V+SFG+++WE++T G+  Y A +  +    + A 
Sbjct: 175 LPVRWMAPESLLDG-----KFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAG 229

Query: 404 GLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
           G R + P++CP  +  LM  CW   PS+RP F  I  +L
Sbjct: 230 G-RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEIL 267

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score =  101 bits (253), Expect = 2e-24
 Identities = 79/265 (29%), Positives = 129/265 (48%), Gaps = 33/265 (12%)

Query: 198 IGPNSFKGVYKG---------KRVGIEKLKGCDKGNAYEFELRKDLL-ELMTCG---HKN 244
           IG   F  V++G           V I+ LK       Y  + R+D L E    G   H N
Sbjct: 13  IGAGEFGEVFRGILKMPGRKEVAVAIKTLKP-----GYTEKQRQDFLSEASIMGQFSHHN 67

Query: 245 ILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR--KLQTKEIIRIAIDVAEGIKFLND 302
           I++   V       + ++T+ ME G++ D  L+    +  + +++ +   +A G+K+L+D
Sbjct: 68  IIRLEGVVTKFKPAM-IITEYMENGAL-DKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSD 125

Query: 303 HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRWLAPEIIAG 358
               +RDL ++ IL++ +    + D G+    +   E T Y T G     RW APE IA 
Sbjct: 126 MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGT-YTTSGGKIPIRWTAPEAIA- 183

Query: 359 DPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQIL 417
                  T  S+V+SFG+V+WE+++ GE  Y   S  +    I   G R   P DCP  +
Sbjct: 184 ---YRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAIND-GFRLPAPMDCPSAV 239

Query: 418 KSLMIKCWNNSPSKRPQFSEIISLL 442
             LM++CW    ++RP+F +I++LL
Sbjct: 240 YQLMLQCWQQDRARRPRFVDIVNLL 264

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score =  100 bits (250), Expect = 5e-24
 Identities = 75/266 (28%), Positives = 130/266 (48%), Gaps = 28/266 (10%)

Query: 196 DQIGPNSFKGVYKGK---------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNIL 246
            ++G  SF  V +G+          V ++ LK  DK +    +  K+   + +  H+N++
Sbjct: 1   KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKS-DKLSDIMDDFLKEAAIMHSLDHENLI 59

Query: 247 QFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRI---AIDVAEGIKFLNDH 303
           + Y V +   H L +VT+L   GS+ D  L+   L    I  +   A+ +A G+++L   
Sbjct: 60  RLYGVVLT--HPLMMVTELAPLGSLLDR-LRKDALGHFLISTLCDYAVQIANGMRYLESK 116

Query: 304 GVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR-----WLAPEIIAG 358
              +RDL ++ ILL     V +GD G++ A     +   Y  + +      W APE +  
Sbjct: 117 RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNED--HYVMEEHLKVPFAWCAPESL-- 172

Query: 359 DPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQIL 417
              + + +  S+V+ FG+ +WEM T GE  +A  S  Q    I   G R E P+ CPQ +
Sbjct: 173 --RTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDI 230

Query: 418 KSLMIKCWNNSPSKRPQFSEIISLLL 443
            ++M++CW ++P+ RP F+ +   L 
Sbjct: 231 YNVMLQCWAHNPADRPTFAALREFLP 256

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 99.8 bits (249), Expect = 1e-23
 Identities = 78/293 (26%), Positives = 134/293 (45%), Gaps = 54/293 (18%)

Query: 191 NLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD-------KGNAYEFELRKDL---LELMT- 239
            + F++++G  +F  VYKG+  G  +            K NA E +++++     ELM+ 
Sbjct: 6   AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMSD 64

Query: 240 CGHKNILQFYCVCVDENHGLCVVTKLMEGGSVND-LILKS---------------RKLQT 283
             H NI+    VC  E    C++ + +  G +++ L+  S                 L  
Sbjct: 65  LQHPNIVCLLGVCTKE-QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDC 123

Query: 284 KEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY 343
            + + IAI +A G+++L+ H   +RDL ++  L+     V + D G+            Y
Sbjct: 124 SDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDI--------Y 175

Query: 344 ETDGY----------RWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACS 392
             D Y          RW+ PE I     +      S+++SFG+V+WE+ + G   Y   S
Sbjct: 176 SADYYRVQSKSLLPVRWMPPEAILYGKFTTE----SDIWSFGVVLWEIFSYGLQPYYGFS 231

Query: 393 PVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRT 445
             +    I +  L P  P+DCP  + +LMI+CWN  P++RP+F + I   LR+
Sbjct: 232 NQEVIEMIRSRQLLP-CPEDCPARVYALMIECWNEIPARRPRFKD-IHTRLRS 282

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 98.0 bits (244), Expect = 3e-23
 Identities = 80/247 (32%), Positives = 125/247 (50%), Gaps = 25/247 (10%)

Query: 209 GKR---VGIEKLKGCDKGNAYEFELRKDLL-ELMTCG---HKNILQFYCVCVDENHGLCV 261
           GKR   V I+ LK       Y  + R+D L E    G   H NI+    V V ++  + +
Sbjct: 29  GKREIPVAIKTLKA-----GYTEKQRRDFLSEASIMGQFDHPNIIHLEGV-VTKSKPVMI 82

Query: 262 VTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH 320
           VT+ ME GS++  + K   +    +++ +   +A G+K+L+D G  +RDL ++ IL++ +
Sbjct: 83  VTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSN 142

Query: 321 GNVCLGDMGIVTACKSVGEATEYETDG----YRWLAPEIIAGDPESVSETWMSNVYSFGM 376
               + D G+    +   EA  Y T G     RW APE IA    + +    S+V+S+G+
Sbjct: 143 LVCKVSDFGLSRVLEDDPEAA-YTTRGGKIPIRWTAPEAIAYRKFTSA----SDVWSYGI 197

Query: 377 VIWE-MVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQF 435
           V+WE M  GE  Y   S  Q  +     G R   P DCP  L  LM+ CW    ++RP+F
Sbjct: 198 VMWEVMSYGERPYWEMSN-QDVIKAIEEGYRLPAPMDCPAALHQLMLDCWQKDRNERPKF 256

Query: 436 SEIISLL 442
            +I+S+L
Sbjct: 257 EQIVSIL 263

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 97.7 bits (243), Expect = 4e-23
 Identities = 72/266 (27%), Positives = 124/266 (46%), Gaps = 21/266 (7%)

Query: 187 LNSDNLEFIDQIGPNSFKGVYKGKRVGIEK--LKGCDKGNAYEFELRKDLLELMTCGHKN 244
           ++   L  + +IG   F  V+ G  +   K  +K   +G   E +  ++   +M   H  
Sbjct: 1   IHPSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPK 60

Query: 245 ILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDH 303
           ++Q Y VC  E   +C+V + ME G ++D +   R K   + ++ + +DV EG+ +L   
Sbjct: 61  LVQLYGVCT-ERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESS 119

Query: 304 GVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRWLAPEIIAGD 359
            V +RDL ++  L+  +  V + D G+    + V +     + G     +W +PE+ +  
Sbjct: 120 NVIHRDLAARNCLVGENQVVKVSDFGMT---RFVLDDQYTSSTGTKFPVKWSSPEVFSFS 176

Query: 360 PESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILK 418
             S      S+V+SFG+++WE+ + G+  Y   S  +    I A G R   P+   Q + 
Sbjct: 177 KYSSK----SDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINA-GFRLYKPRLASQSVY 231

Query: 419 SLMIKCWNNSPSKRPQFSEIISLLLR 444
            LM  CW   P  RP F    SLLL 
Sbjct: 232 ELMQHCWKERPEDRPSF----SLLLH 253

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 96.6 bits (240), Expect = 2e-22
 Identities = 78/288 (27%), Positives = 134/288 (46%), Gaps = 41/288 (14%)

Query: 187 LNSDNLEFIDQIGPNSFKGVYKG-----------KRVGIEKLKGCDKGNAYEFELRKDLL 235
           +N   + F++++G + F  VYKG           + V I+ LK   +G   E E + + +
Sbjct: 2   INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLRE-EFKHEAM 60

Query: 236 ELMTCGHKNILQF---------------YCVCVDENHGLCVVTKLMEGGSVNDLILKSRK 280
                 H NI+                 YC   D +  L + +   + GS +D       
Sbjct: 61  MRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKST 120

Query: 281 LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA 340
           L+  + + I   +A G++FL+ H V ++DL ++ +L+    NV + D+G+    + V  A
Sbjct: 121 LEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLF---REVYAA 177

Query: 341 TEYETDG-----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPV 394
             Y+  G      RW++PE I     S+     S+++S+G+V+WE+ + G   Y   S  
Sbjct: 178 DYYKLMGNSLLPIRWMSPEAIMYGKFSID----SDIWSYGVVLWEVFSYGLQPYCGYSNQ 233

Query: 395 QAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
                I    + P  P DCP  + +LM++CWN  PS+RP+F +I S L
Sbjct: 234 DVIEMIRNRQVLP-CPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRL 280

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 95.9 bits (239), Expect = 2e-22
 Identities = 78/275 (28%), Positives = 133/275 (48%), Gaps = 34/275 (12%)

Query: 185 WLLNSDNLEFIDQIGPNSFKGVYKGK-----RVGIEKLK-GCDKGNAYEFELRKDLLELM 238
           W +  ++L+   ++G   F  V+ G      +V ++ LK G     A+  E +     +M
Sbjct: 1   WEIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQ-----IM 55

Query: 239 -TCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKS---RKLQTKEIIRIAIDVA 294
               H  ++Q Y VC +E   + +VT+ M  GS+ D  LKS   +KL+  +++ +A  +A
Sbjct: 56  KKLRHDKLVQLYAVCSEEE-PIYIVTEYMSKGSLLDF-LKSGEGKKLRLPQLVDMAAQIA 113

Query: 295 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYET-DGYR---- 349
           EG+ +L      +RDL ++ IL+  +    + D G+      + E  EY   +G +    
Sbjct: 114 EGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLA----RLIEDDEYTAREGAKFPIK 169

Query: 350 WLAPE-IIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRP 407
           W APE    G       T  S+V+SFG+++ E+VT G   Y   +  +    +   G R 
Sbjct: 170 WTAPEAANYG-----RFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVER-GYRM 223

Query: 408 EIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
             P +CP+ L  LM++CW+  P +RP F  + S L
Sbjct: 224 PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFL 258

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 95.6 bits (238), Expect = 3e-22
 Identities = 74/286 (25%), Positives = 125/286 (43%), Gaps = 44/286 (15%)

Query: 187 LNSDNLEFIDQIGPNSFKGVYKGKRVGIE----------KLKGCDKGNAYEFELRKDLLE 236
               NL+ I  +G   F  V+  K  GIE          K     K    + E R++L  
Sbjct: 2   FPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDM 61

Query: 237 LMTCGHKNILQFYCVCVD-ENHGLCVVTKLMEGGSVNDLILKSRK---------LQTKEI 286
                HKN+++   +C + E H   ++ +  + G +   +  ++          L TK+ 
Sbjct: 62  FRKLSHKNVVRLLGLCREAEPH--YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQK 119

Query: 287 IRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETD 346
           + +   +A G+  L++    +RDL ++  L+     V +  + +    K V     Y ++
Sbjct: 120 VALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSL---SKDV-----YNSE 171

Query: 347 GY---------RWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQA 396
            Y         RWLAPE +  D  S      S+V+SFG+++WE+ T GE  +   S  + 
Sbjct: 172 YYKLRNALIPLRWLAPEAVQEDDFSTK----SDVWSFGVLMWEVFTQGELPFYGLSDEEV 227

Query: 397 AVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
              + A  L   +P+ CP  L  LM +CW  +P  RP FSE++S L
Sbjct: 228 LNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSAL 273

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 94.8 bits (236), Expect = 6e-22
 Identities = 62/265 (23%), Positives = 120/265 (45%), Gaps = 26/265 (9%)

Query: 192 LEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCG 241
           LE I  +G  +F  VYKG            V I+ L+  +       E+  +   + +  
Sbjct: 9   LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLRE-ETSPKANKEILDEAYVMASVD 67

Query: 242 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFL 300
           H ++++   +C+       ++T+LM  G + D +   +  + ++ ++   + +A+G+ +L
Sbjct: 68  HPHVVRLLGICLSSQV--QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYL 125

Query: 301 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRWLAPEII 356
            +  + +RDL ++ +L+    +V + D G +     V E  EY  +G     +W+A E I
Sbjct: 126 EEKRLVHRDLAARNVLVKTPQHVKITDFG-LAKLLDVDE-KEYHAEGGKVPIKWMALESI 183

Query: 357 AGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ 415
                    T  S+V+S+G+ +WE++T G   Y    P      +   G R   P  C  
Sbjct: 184 ----LHRIYTHKSDVWSYGVTVWELMTFGAKPYEGI-PAVEIPDLLEKGERLPQPPICTI 238

Query: 416 ILKSLMIKCWNNSPSKRPQFSEIIS 440
            +  +++KCW      RP F E+I+
Sbjct: 239 DVYMVLVKCWMIDAESRPTFKELIN 263

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 94.8 bits (236), Expect = 9e-22
 Identities = 84/295 (28%), Positives = 131/295 (44%), Gaps = 44/295 (14%)

Query: 184 RWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD-------KGNAYEFELRKDL-- 234
            W L  D L     +G  +F  V K + VG++             K +A E +L  DL  
Sbjct: 6   EWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDL-SDLVS 64

Query: 235 -LELM-TCG-HKNILQFYCVCVDENHGLCVVTKL----------------MEGGSVNDLI 275
            +E+M   G HKNI+    VC  E   L VV +                  E  S +D  
Sbjct: 65  EMEMMKMIGKHKNIINLLGVCTQEGP-LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPR 123

Query: 276 LKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK 335
                L  K+++  A  VA G++FL      +RDL ++ +L+     + + D G+    +
Sbjct: 124 PPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLA---R 180

Query: 336 SVGEATEYE--TDG---YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYA 389
            +     Y   T+G    +W+APE +         T  S+V+SFG+++WE+ T G + Y 
Sbjct: 181 DIHHIDYYRKTTNGRLPVKWMAPEALF----DRVYTHQSDVWSFGVLLWEIFTLGGSPYP 236

Query: 390 ACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR 444
              PV+    +   G R E P++C Q L  LM  CW+  PS+RP F +++  L R
Sbjct: 237 GI-PVEELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDR 290

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 93.2 bits (232), Expect = 2e-21
 Identities = 69/277 (24%), Positives = 124/277 (44%), Gaps = 42/277 (15%)

Query: 190 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHK 243
           D+ E I+ IG  +   VY        ++V I+++   +K      ELRK++  +  C H 
Sbjct: 1   DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRID-LEKCQTSVDELRKEVQAMSQCNHP 59

Query: 244 NILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK---LQTKEIIRIAIDVAEGIKFL 300
           N++++Y   V     L +V   + GGS+ D++  S     L    I  +  +V +G+++L
Sbjct: 60  NVVKYYTSFV-VGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYL 118

Query: 301 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR----------- 349
           + +G  +RD+ +  ILL   G+V + D G V+A             G R           
Sbjct: 119 HSNGQIHRDIKAGNILLGEDGSVKIADFG-VSAS--------LADGGDRTRKVRKTFVGT 169

Query: 350 --WLAPEIIAGDPESVSE-TWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGI---AAC 403
             W+APE++    E V    + ++++SFG+   E+ TG A Y+   P++  +        
Sbjct: 170 PCWMAPEVM----EQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPP 225

Query: 404 GLRPEI-PKDCPQILKSLMIKCWNNSPSKRPQFSEII 439
            L      K   +  + ++  C    PSKRP   E++
Sbjct: 226 SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELL 262

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 92.6 bits (230), Expect = 3e-21
 Identities = 67/267 (25%), Positives = 129/267 (48%), Gaps = 27/267 (10%)

Query: 187 LNSDNLEFIDQIGPNSFKGVYKGK-----RVGIEKLKGCDKGNAYEFELRKDLLELMTCG 241
           ++  +L F+ ++G   F  V  GK      V I+ +K   +G+  E E  ++   +M   
Sbjct: 1   IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK---EGSMSEDEFIEEAKVMMKLS 57

Query: 242 HKNILQFYCVCVDENHGLCVVTKLMEGGS-VNDLILKSRKLQTKEIIRIAIDVAEGIKFL 300
           H+ ++Q Y VC  +   + +VT+ M  G  +N L    ++ Q  +++ +  DV EG+ +L
Sbjct: 58  HEKLVQLYGVCTKQ-RPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYL 116

Query: 301 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIV------TACKSVGEATEYETDGYRWLAPE 354
                 +RDL ++  L+D  G V + D G+           SVG  +++     RW  PE
Sbjct: 117 ESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVG--SKFPV---RWSPPE 171

Query: 355 IIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDC 413
           ++     S      S+V++FG+++WE+ + G+  Y   +  +    ++  GLR   P   
Sbjct: 172 VLLYSKFSSK----SDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQ-GLRLYRPHLA 226

Query: 414 PQILKSLMIKCWNNSPSKRPQFSEIIS 440
            + + ++M  CW+    +RP F +++S
Sbjct: 227 SEKVYAIMYSCWHEKAEERPTFQQLLS 253

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 92.3 bits (230), Expect = 3e-21
 Identities = 69/257 (26%), Positives = 117/257 (45%), Gaps = 28/257 (10%)

Query: 191 NLEFIDQIGPNSFKGVYKG-----------KRVGIEKLKGCD-KGNAYEFELRKDLLELM 238
           N +  D IG  +F  VYKG           K++ +EK+K    K    E +L K+L    
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNL---- 56

Query: 239 TCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIK 298
              H NI+++       +  L ++ +  E GS+  +I K        +      V +G+ 
Sbjct: 57  --KHPNIVKYIGSIETSDS-LYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLA 113

Query: 299 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG--YRWLAPEII 356
           +L++ GV +RD+ +  IL  + G V L D G+ T    V +  +    G  Y W+APE+I
Sbjct: 114 YLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK-DDASVVGTPY-WMAPEVI 171

Query: 357 AGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQI 416
                S +    S+++S G  + E++TG   Y   +P+ A   I      P +P+     
Sbjct: 172 EMSGASTA----SDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQ-DDHPPLPEGISPE 226

Query: 417 LKSLMIKCWNNSPSKRP 433
           LK  +++C+   P+ RP
Sbjct: 227 LKDFLMQCFQKDPNLRP 243

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 92.1 bits (229), Expect = 3e-21
 Identities = 65/253 (25%), Positives = 109/253 (43%), Gaps = 18/253 (7%)

Query: 198 IGPNSFKGVYKG-----------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNIL 246
           +G  SF  VY+G           K V +       +    + E    LL  +   H NI+
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ--HPNIV 65

Query: 247 QFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVA 306
           Q+     +E++ L +  +L+ GGS+  L+ K        I      +  G+++L+D    
Sbjct: 66  QYLGTEREEDN-LYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTV 124

Query: 307 YRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSET 366
           +RD+    IL+D +G V L D G+         A  ++   Y W+APE+IA   +     
Sbjct: 125 HRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPY-WMAPEVIA---QQGGYG 180

Query: 367 WMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWN 426
             ++++S G  + EM TG+  ++    V A   I      P IP       K  ++KC  
Sbjct: 181 LAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCLQ 240

Query: 427 NSPSKRPQFSEII 439
             PS RP  +E++
Sbjct: 241 RDPSLRPTAAELL 253

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 91.1 bits (226), Expect = 8e-21
 Identities = 71/264 (26%), Positives = 126/264 (47%), Gaps = 17/264 (6%)

Query: 187 LNSDNLEFIDQIGPNSFKGVYKGK-RVGIE-KLKGCDKGNAYEFELRKDLLELMTCGHKN 244
           +N   L F+ ++G   F  V+ GK R  I+  +K  ++G   E +  ++   +M   H  
Sbjct: 1   INPSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPK 60

Query: 245 ILQFYCVCVDENHGLCVVTKLMEGGS-VNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDH 303
           ++Q Y VC  +   L +VT+ ME G  +N L  +  KL    ++ +  DV EG+++L  +
Sbjct: 61  LVQLYGVCT-QQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERN 119

Query: 304 GVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRWLAPEIIAGD 359
              +RDL ++  L+   G V + D G+    + V +     + G     +W  PE+    
Sbjct: 120 SFIHRDLAARNCLVSSTGVVKVSDFGMT---RYVLDDEYTSSSGAKFPVKWSPPEVFNFS 176

Query: 360 PESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILK 418
             S      S+V+SFG+++WE+ T G+  +   S  +    I+  G R   PK     + 
Sbjct: 177 KYSSK----SDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISR-GFRLYRPKLASMTVY 231

Query: 419 SLMIKCWNNSPSKRPQFSEIISLL 442
            +M  CW+  P  RP F+E++  +
Sbjct: 232 EVMYSCWHEKPEGRPTFAELLRAI 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 91.6 bits (227), Expect = 8e-21
 Identities = 74/282 (26%), Positives = 134/282 (47%), Gaps = 47/282 (16%)

Query: 192 LEFIDQIGPNSFKGVYKG----------KRVGIEKLKGCDKGNAYEF-ELRKDLLELMTC 240
           + F++++G  +F  +YKG          + V I+ LK  D  N  ++ E +++   +   
Sbjct: 7   VRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLK--DINNPQQWGEFQQEASLMAEL 64

Query: 241 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVND-LILKS----------------RKLQT 283
            H NI+    V V +   +C++ + +  G +++ LI++S                  L  
Sbjct: 65  HHPNIVCLLGV-VTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDH 123

Query: 284 KEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY 343
            + + IAI +A G+++L+ H   ++DL ++ IL+    +V + D+G+    + +  A  Y
Sbjct: 124 GDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGL---SREIYSADYY 180

Query: 344 ETDG-----YRWLAPE-IIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQA 396
                     RW+ PE I+ G   S S+ W     SFG+V+WE+ + G   Y   S  + 
Sbjct: 181 RVQPKSLLPIRWMPPEAIMYGKFSSDSDIW-----SFGVVLWEIFSFGLQPYYGFSNQEV 235

Query: 397 AVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEI 438
              +    L P   +DCP  + SLM +CW   PS+RP+F +I
Sbjct: 236 IEMVRKRQLLP-CSEDCPPRMYSLMTECWQEGPSRRPRFKDI 276

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 89.8 bits (223), Expect = 2e-20
 Identities = 73/263 (27%), Positives = 123/263 (46%), Gaps = 26/263 (9%)

Query: 191 NLEFIDQIGPNSFKGVYKGKRVGIEK---LKGCDKGNAYEFELRKDLLE---LMTCGHKN 244
           + + + ++G  S+  VYK KR+   +   LK  D G+  + E    + E   L +  H N
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60

Query: 245 ILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK----LQTKEIIRIAIDVAEGIKFL 300
           I+ +    +D N  LC+V +    G ++  I K +K    +  +EI RI I +  G++ L
Sbjct: 61  IISYKEAFLDGNK-LCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQAL 119

Query: 301 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDP 360
           ++  + +RDL S  ILL  +  V +GD+GI    K     T+  T  Y  +APE+  G P
Sbjct: 120 HEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQIGTPHY--MAPEVWKGRP 177

Query: 361 ESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIP----KDCPQI 416
            S      S+++S G +++EM T    + A S       +   G  P IP    +D    
Sbjct: 178 YSYK----SDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQR-GKYPPIPPIYSQDLQNF 232

Query: 417 LKSLMIKCWNNSPSKRPQFSEII 439
           ++S++       P  RP   +I+
Sbjct: 233 IRSMLQV----KPKLRPNCDKIL 251

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 90.4 bits (224), Expect = 2e-20
 Identities = 64/257 (24%), Positives = 129/257 (50%), Gaps = 28/257 (10%)

Query: 204 KGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDE-NHGLCVV 262
           +G   G++V ++ LK    GN +  +L+K++  L    H+NI+++  +C ++  +G+ ++
Sbjct: 28  EGDNTGEQVAVKSLKPESGGN-HIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLI 86

Query: 263 TKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG 321
            + +  GS+ + + +++ K+  K+ ++ A+ + +G+ +L      +RDL ++ +L++   
Sbjct: 87  MEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEH 146

Query: 322 NVCLGDMGIVTACKSVGEATEYETD---GYRWLAPEIIAGDPESVSETWMSNVYSFGMVI 378
            V +GD G+  A ++  E    + D      W APE +      ++    S+V+SFG+ +
Sbjct: 147 QVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIA----SDVWSFGVTL 202

Query: 379 WEMVTGEAAYAACSP----------------VQAAVGIAACGLRPEIPKDCPQILKSLMI 422
           +E++T     +  SP                V   V +   G R   P +CP+ +  LM 
Sbjct: 203 YELLT--YCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMR 260

Query: 423 KCWNNSPSKRPQFSEII 439
           KCW   PSKR  F  +I
Sbjct: 261 KCWEFQPSKRTTFQNLI 277

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 90.2 bits (224), Expect = 2e-20
 Identities = 76/291 (26%), Positives = 127/291 (43%), Gaps = 55/291 (18%)

Query: 190 DNLEFIDQIGPNSFKGVYKGK-----------RVGIEKLKGCDKGNAYE-FELRKDLLEL 237
           D +    ++G  +F  V+ G+            V ++ LK     +A + FE   +LL  
Sbjct: 5   DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTN 64

Query: 238 MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDL---------ILKSRK-----LQT 283
               H+NI++FY VC + +    +V + ME G +N            LKS       L  
Sbjct: 65  F--QHENIVKFYGVCTEGD-PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTL 121

Query: 284 KEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY 343
            ++++IA+ +A G+ +L      +RDL ++  L+     V +GD G+    + V     Y
Sbjct: 122 SQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGM---SRDV-----Y 173

Query: 344 ETDGY----------RWLAPE-IIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAAC 391
            TD Y          RW+ PE I+         T  S+V+SFG+V+WE+ T G+  +   
Sbjct: 174 TTDYYRVGGHTMLPIRWMPPESIMYR-----KFTTESDVWSFGVVLWEIFTYGKQPWYGL 228

Query: 392 SPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
           S  +    I   G   + P+ CP  +  +M+ CW   P +R    +I   L
Sbjct: 229 SNEEVIECITQ-GRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERL 278

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 89.0 bits (221), Expect = 5e-20
 Identities = 67/286 (23%), Positives = 120/286 (41%), Gaps = 49/286 (17%)

Query: 190 DNLEFIDQIGPNSFKGVYKGKRVGIE----------KLKGCDKGNAYEFELRKDLLELMT 239
           D++  +  +G  +F  VY+G   G +          K          E +   + L +  
Sbjct: 6   DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSK 65

Query: 240 CGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-------KLQTKEIIRIAID 292
             H+NI++   V  +      ++ +LM GG +   + ++R        L  K+++  A D
Sbjct: 66  FNHQNIVRLIGVSFERLPRF-ILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARD 124

Query: 293 VAEGIKFLNDHGVAYRDLNSQRILLDRHGN---VCLGDMGIVTACKSVGEATE-YETDGY 348
           VA+G K+L ++   +RD+ ++  LL   G      + D G+         A + Y    Y
Sbjct: 125 VAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGM---------ARDIYRASYY 175

Query: 349 R----------WLAPE-IIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQA 396
           R          W+ PE  + G   S ++ W     SFG+++WE+ + G   Y      Q 
Sbjct: 176 RKGGRAMLPIKWMPPEAFLDGIFTSKTDVW-----SFGVLLWEIFSLGYMPYP-GRTNQE 229

Query: 397 AVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
            +     G R + PK CP  +  +M  CW ++P  RP F+ I+  +
Sbjct: 230 VMEFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERI 275

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 88.5 bits (219), Expect = 7e-20
 Identities = 58/210 (27%), Positives = 99/210 (47%), Gaps = 18/210 (8%)

Query: 242 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL-KSRKLQTKEIIRIAIDVAEGIKFL 300
           H NI++   VC  +   + +V +L++GG     +  +  +L+ KE+I++  + A G+++L
Sbjct: 52  HPNIVRLIGVCT-QKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYL 110

Query: 301 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR-----WLAPEI 355
                 +RDL ++  L+     + + D G+    +   +     T G +     W APE 
Sbjct: 111 ESKHCIHRDLAARNCLVTEKNVLKISDFGM---SREEEDGVYASTGGMKQIPVKWTAPEA 167

Query: 356 IA-GDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDC 413
           +  G   S S+ W     SFG+++WE  + G   YA  S  Q    I   G+R   P+ C
Sbjct: 168 LNYGRYSSESDVW-----SFGILLWEAFSLGAVPYANLSNQQTREAIEQ-GVRLPCPELC 221

Query: 414 PQILKSLMIKCWNNSPSKRPQFSEIISLLL 443
           P  +  LM +CW   P +RP FS +   L 
Sbjct: 222 PDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 88.3 bits (219), Expect = 7e-20
 Identities = 77/257 (29%), Positives = 126/257 (49%), Gaps = 26/257 (10%)

Query: 196 DQIGPNSFKGVYKGK-RVGIE-KLKGCDKGNAYEFELRKDLLE---LMTCGHKNILQFYC 250
           ++IG  +F  VYKG  +   E  +K C +        RK L E   L    H NI++   
Sbjct: 1   EKIGKGNFGDVYKGVLKGNTEVAVKTC-RSTLPPDLKRKFLQEAEILKQYDHPNIVKLIG 59

Query: 251 VCVDENHGLCVVTKLMEGGS-VNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRD 309
           VCV +   + +V +L+ GGS +  L  K  +L  K+++++++D A G+++L      +RD
Sbjct: 60  VCVQK-QPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRD 118

Query: 310 LNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE-TDGYR-----WLAPEII-AGDPES 362
           L ++  L+  +  + + D G+        E   Y  +DG +     W APE +  G   S
Sbjct: 119 LAARNCLVGENNVLKISDFGM----SREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTS 174

Query: 363 VSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLM 421
            S+ W     S+G+++WE  + G+  Y   S  Q    I + G R   P+ CP+ +  LM
Sbjct: 175 ESDVW-----SYGILLWETFSLGDTPYPGMSNQQTRERIES-GYRMPAPQLCPEEIYRLM 228

Query: 422 IKCWNNSPSKRPQFSEI 438
           ++CW   P  RP FSEI
Sbjct: 229 LQCWAYDPENRPSFSEI 245

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 88.1 bits (218), Expect = 9e-20
 Identities = 67/249 (26%), Positives = 119/249 (47%), Gaps = 16/249 (6%)

Query: 204 KGVYKGKR----VGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGL 259
           KG+YK K+    V ++ LK  +   A + EL ++   +    +  I++   +C  E+   
Sbjct: 13  KGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEAES--W 70

Query: 260 CVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDR 319
            +V +L E G +N  + K++ +  K I  +   V+ G+K+L +    +RDL ++ +LL  
Sbjct: 71  MLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVT 130

Query: 320 HGNVCLGDMGIVTACKSVGEATEYETDG---YRWLAPEIIAGDPESVSETWMSNVYSFGM 376
                + D G+  A  +     + +T G    +W APE +     S      S+V+SFG+
Sbjct: 131 QHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSK----SDVWSFGV 186

Query: 377 VIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQF 435
           ++WE  + G+  Y      +    I + G R E P+ CP  +  LM  CW     +RP F
Sbjct: 187 LMWEAFSYGQKPYKGMKGNEVTQMIES-GERMECPQRCPPEMYDLMKLCWTYGVDERPGF 245

Query: 436 SEIISLLLR 444
           + ++ L LR
Sbjct: 246 A-VVELRLR 253

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 88.9 bits (220), Expect = 9e-20
 Identities = 76/291 (26%), Positives = 133/291 (45%), Gaps = 49/291 (16%)

Query: 185 WLLNSDNLEFIDQIGPNSFKGVYKG-----------KRVGIEKL-KGCDKGNAYEFELRK 232
           W ++ + +  + ++G  SF  VY+G            RV ++ + +        EF    
Sbjct: 1   WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEA 60

Query: 233 DLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLI--LKS-------RKLQT 283
            +++  TC H  +++   V V +     VV +LM  G +   +  L+        R   T
Sbjct: 61  SVMKGFTCHH--VVRLLGV-VSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPT 117

Query: 284 -KEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE 342
            +E+I++A ++A+G+ +LN     +RDL ++  ++     V +GD G+            
Sbjct: 118 LQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDI-------- 169

Query: 343 YETDGYR----------WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAAC 391
           YETD YR          W+APE +    +    T  S+++SFG+V+WE+ +  E  Y   
Sbjct: 170 YETDYYRKGGKGLLPVRWMAPESL----KDGVFTTSSDMWSFGVVLWEITSLAEQPYQGL 225

Query: 392 SPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
           S  Q    +   G   + P +CP+ +  LM  CW  +P  RP F EI++LL
Sbjct: 226 SNEQVLKFVMDGGYLDQ-PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLL 275

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 87.9 bits (219), Expect = 1e-19
 Identities = 74/265 (27%), Positives = 122/265 (46%), Gaps = 32/265 (12%)

Query: 195 IDQIGPNSFKGVYKGKRVGIEKL---KGCDKGNAYEFELRKDLLE---LMTCGHKNILQF 248
           I QIG  SF  VY  +R    KL   K  D  N  E E    L E   L    H NI+++
Sbjct: 5   IKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKY 64

Query: 249 YCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQT----KEIIRIAIDVAEGIKFLNDHG 304
           Y    ++   LC+V +  +GG ++  I K +K       ++I+   + +   +K+L+   
Sbjct: 65  YESFEEKGK-LCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK 123

Query: 305 VAYRDLNSQRILLDRHGNVCLGDMGI-------VTACKS-VGEATEYETDGYRWLAPEII 356
           + +RD+  Q I L  +G V LGD GI       V   K+ VG  T Y      +L+PE+ 
Sbjct: 124 ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVG--TPY------YLSPELC 175

Query: 357 AGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQI 416
              P +      S+++S G V++E+ T +  +   + ++ A+ I   G  P IP      
Sbjct: 176 QNKPYNYK----SDIWSLGCVLYELCTLKHPFEGENLLELALKILK-GQYPPIPSQYSSE 230

Query: 417 LKSLMIKCWNNSPSKRPQFSEIISL 441
           L++L+       P +RP  ++I+  
Sbjct: 231 LRNLVSSLLQKDPEERPSIAQILQS 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 87.6 bits (217), Expect = 2e-19
 Identities = 78/272 (28%), Positives = 126/272 (46%), Gaps = 29/272 (10%)

Query: 185 WLLNSDNLEFIDQIGPNSF----KGVYKG-KRVGIEKLK-GCDKGNAY--EFELRKDLLE 236
           W +  + L+ + ++G   F     G Y G  +V I+ LK G     A+  E  L K L  
Sbjct: 1   WEVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQL-- 58

Query: 237 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKS---RKLQTKEIIRIAIDV 293
                H  +++ Y V   E   + ++T+ ME GS+ D  LK+    KL   ++I +A  +
Sbjct: 59  ----QHPRLVRLYAVVTQEP--IYIITEYMENGSLVDF-LKTPEGIKLTINKLIDMAAQI 111

Query: 294 AEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY--RWL 351
           AEG+ F+      +RDL +  IL+       + D G+    +   E T  E   +  +W 
Sbjct: 112 AEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIED-NEYTAREGAKFPIKWT 170

Query: 352 APEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIP 410
           APE I     ++     S+V+SFG+++ E+VT G   Y   +  +    +   G R   P
Sbjct: 171 APEAINYGTFTIK----SDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLER-GYRMPRP 225

Query: 411 KDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
            +CP+ L  LM  CW   P +RP F  + S+L
Sbjct: 226 DNCPEELYELMRLCWKEKPEERPTFEYLRSVL 257

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 87.2 bits (216), Expect = 2e-19
 Identities = 74/265 (27%), Positives = 122/265 (46%), Gaps = 31/265 (11%)

Query: 198 IGPNSFKGVYKGK---------RVGIEKLKGCDKGNAYEFELRKDLL-ELMTCG---HKN 244
           IG   F  V +G+          V I+ LK       Y  + R+D L E    G   H N
Sbjct: 12  IGAGEFGEVCRGRLKLPGKREIFVAIKTLKS-----GYTEKQRRDFLSEASIMGQFDHPN 66

Query: 245 ILQFYCVCVDENHGLCVVTKLMEGGSVNDLI-LKSRKLQTKEIIRIAIDVAEGIKFLNDH 303
           I+    V V ++  + ++T+ ME G+++  +     +    +++ +   +A G+K+L++ 
Sbjct: 67  IIHLEGV-VTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEM 125

Query: 304 GVAYRDLNSQRILLDRHGNVCLGDMGIVTACK-SVGEATEYETDG----YRWLAPEIIAG 358
              +RDL ++ IL++ +    + D G+    +    + T   + G     RW APE IA 
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIA- 184

Query: 359 DPESVSETWMSNVYSFGMVIWE-MVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQIL 417
                  T  S+V+S+G+V+WE M  GE  Y   S  Q  +       R   P DCP  L
Sbjct: 185 ---YRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-QDVINAIEQDYRLPPPMDCPTAL 240

Query: 418 KSLMIKCWNNSPSKRPQFSEIISLL 442
             LM+ CW    + RP+F +I+S L
Sbjct: 241 HQLMLDCWQKDRNARPKFGQIVSTL 265

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 86.9 bits (215), Expect = 4e-19
 Identities = 70/265 (26%), Positives = 121/265 (45%), Gaps = 50/265 (18%)

Query: 209 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDE-NHGLCVVTKLME 267
           G+ V ++ LK  + G       +K++  L T  H+NI+++   C ++   GL ++ + + 
Sbjct: 33  GEMVAVKTLKR-ECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVP 91

Query: 268 GGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGD 327
            GS+ D + K  KL   +++  A  + EG+ +L+     +RDL ++ +LLD    V +GD
Sbjct: 92  LGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGD 150

Query: 328 MGIVTACKSVGEATEYETDGYR----------WLAPEIIAGDPESVSETWMSNVYSFGMV 377
            G+    K+V E  EY    YR          W A E +    +    ++ S+V+SFG+ 
Sbjct: 151 FGLA---KAVPEGHEY----YRVREDGDSPVFWYAVECL----KENKFSYASDVWSFGVT 199

Query: 378 IWEMVTGEAAYAACSPVQAA-------VGIAAC-------------GLRPEIPKDCPQIL 417
           ++E++T       C   Q+        +G                 G+R   PK+CPQ +
Sbjct: 200 LYELLT------HCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEV 253

Query: 418 KSLMIKCWNNSPSKRPQFSEIISLL 442
             LM  CW      RP F  +I +L
Sbjct: 254 YILMKNCWETEAKFRPTFRSLIPIL 278

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 86.6 bits (214), Expect = 4e-19
 Identities = 76/285 (26%), Positives = 134/285 (47%), Gaps = 41/285 (14%)

Query: 185 WLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEK--------LKGCDKGNAY----EFELRK 232
           W +  + +    ++G  SF  VY+G   G+ K        +K  ++  +     EF    
Sbjct: 1   WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEA 60

Query: 233 DLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQT--------- 283
            +++   C H  +++   V V +     V+ +LM  G +    L+S + +          
Sbjct: 61  SVMKEFNCHH--VVRLLGV-VSQGQPTLVIMELMTRGDLKSY-LRSLRPEMENNPVQAPP 116

Query: 284 --KEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT 341
             K++I++A ++A+G+ +LN +   +RDL ++  ++     V +GD G+    + + E  
Sbjct: 117 SLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMT---RDIYETD 173

Query: 342 EYETDG-----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQ 395
            Y   G      RW++PE +    + V  T+ S+V+SFG+V+WE+ T  E  Y   S  Q
Sbjct: 174 YYRKGGKGLLPVRWMSPESLK---DGVFTTY-SDVWSFGVVLWEIATLAEQPYQGMSNEQ 229

Query: 396 AAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIIS 440
               +   GL  + P +CP +L  LM  CW  +P  RP F EIIS
Sbjct: 230 VLRFVMEGGLL-DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 273

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 86.7 bits (215), Expect = 5e-19
 Identities = 70/271 (25%), Positives = 122/271 (45%), Gaps = 36/271 (13%)

Query: 190 DNLEFIDQIGPNSFKGVYKGKRVGIEKL---KGCDKGNAYEFELRKDLLE---LMTCGHK 243
           D  E I ++G  +F  VYK +          K     +  E EL   ++E   L  C H 
Sbjct: 5   DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES--EEELEDFMVEIDILSECKHP 62

Query: 244 NILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIR-IAIDVAEGIKFLND 302
           NI+  Y     EN  L ++ +  +GG+++ ++L+  +  T+  IR +   + E + FL+ 
Sbjct: 63  NIVGLYEAYFYENK-LWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHS 121

Query: 303 HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE------ATEYETDGYRWLAPEII 356
           H V +RDL +  ILL   G+V L D G+    KS  +       T Y      W+APE++
Sbjct: 122 HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPY------WMAPEVV 175

Query: 357 AGDPESVSET---WMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPK-D 412
           A   E+  +    + ++++S G+ + E+   E  +   +P++  + I    L+ E P  D
Sbjct: 176 AC--ETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKI----LKSEPPTLD 229

Query: 413 CPQI----LKSLMIKCWNNSPSKRPQFSEII 439
            P          +  C    P  RP  +E++
Sbjct: 230 QPSKWSSSFNDFLKSCLVKDPDDRPTAAELL 260

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 85.8 bits (212), Expect = 5e-19
 Identities = 67/259 (25%), Positives = 120/259 (46%), Gaps = 35/259 (13%)

Query: 198 IGPNSFKGVYKG--KRVGIEKLKGCDKGNAYEFELR--KDLLELMTCGHKNILQFYCVCV 253
           +G  +F  V+KG  K      +K C +    E +++   +   L    H NI++   VC 
Sbjct: 3   LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62

Query: 254 DENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNS 312
            +   + +V +L+ GG     + K + +L+TK++++ A+D A G+ +L      +RDL +
Sbjct: 63  -QRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAA 121

Query: 313 QRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY-----------RWLAPEIIA-GDP 360
           +  L+  +  + + D G+          +  E DG            +W APE +  G  
Sbjct: 122 RNCLVGENNVLKISDFGM----------SRQEDDGIYSSSGLKQIPIKWTAPEALNYGRY 171

Query: 361 ESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKS 419
            S S+ W     S+G+++WE  + G   Y   +  QA   +   G R   P+ CP  +  
Sbjct: 172 SSESDVW-----SYGILLWETFSLGVCPYPGMTNQQAREQVEK-GYRMSCPQKCPDDVYK 225

Query: 420 LMIKCWNNSPSKRPQFSEI 438
           +M +CW+  P  RP+FSE+
Sbjct: 226 VMQRCWDYKPENRPKFSEL 244

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 86.1 bits (213), Expect = 7e-19
 Identities = 55/199 (27%), Positives = 96/199 (48%), Gaps = 30/199 (15%)

Query: 261 VVTKLMEGGSVNDLILKSR------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQR 314
           V+   M+ G ++  +L SR       L  + ++R  ID+A G+++L+     +RDL ++ 
Sbjct: 84  VILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARN 143

Query: 315 ILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR----------WLAPEIIAGDPESVS 364
            +L+ +  VC+ D G+    K +     Y  D YR          WLA E +A +  +  
Sbjct: 144 CMLNENMTVCVADFGL---SKKI-----YSGDYYRQGCASKLPVKWLALESLADNVYTTH 195

Query: 365 ETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIK 423
               S+V++FG+ +WE++T G+  YA     +    +   G R + P DC + +  LM +
Sbjct: 196 ----SDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIK-GNRLKQPPDCLEDVYELMCQ 250

Query: 424 CWNNSPSKRPQFSEIISLL 442
           CW+  P  RP F  +   L
Sbjct: 251 CWSPEPKCRPSFQHLRDQL 269

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 85.6 bits (212), Expect = 1e-18
 Identities = 78/289 (26%), Positives = 137/289 (47%), Gaps = 58/289 (20%)

Query: 192 LEFIDQIGPNSFKGVYK----------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCG 241
           L+FI Q+G  +F  V            G+ V ++KL+     +  +FE  +++  L +  
Sbjct: 6   LKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFE--REIEILKSLQ 63

Query: 242 HKNILQFYCVCVDENH-GLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKF 299
           H NI+++  VC       L +V + +  GS+ D + K R +L  ++++  A  + +G+++
Sbjct: 64  HDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEY 123

Query: 300 LNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR---------- 349
           L      +RDL ++ IL++    V +GD G+    K + +  EY    Y+          
Sbjct: 124 LGSKRYVHRDLATRNILVESENRVKIGDFGLT---KVLPQDKEY----YKVREPGESPIF 176

Query: 350 WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYA--ACSP-----------VQA 396
           W APE +     SV+    S+V+SFG+V++E+ T    Y+  +CSP            Q 
Sbjct: 177 WYAPESLTESKFSVA----SDVWSFGVVLYELFT----YSDKSCSPPAEFMRMMGNDKQG 228

Query: 397 A------VGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEII 439
                  + +     R   P  CP  + ++M +CWNN PS+RP FSE+ 
Sbjct: 229 QMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELA 277

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 85.8 bits (212), Expect = 1e-18
 Identities = 72/295 (24%), Positives = 126/295 (42%), Gaps = 59/295 (20%)

Query: 191 NLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD-------KGNAYEFELRKDLLE---LMTC 240
           NL     +G   F  V K     ++   G         K NA   ELR  L E   L   
Sbjct: 1   NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV 60

Query: 241 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK-------------------- 280
            H ++++ Y  C  ++  L ++ +  + GS+   + +SRK                    
Sbjct: 61  NHPHVIKLYGAC-SQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNP 119

Query: 281 ----LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS 336
               L   ++I  A  ++ G+++L +  + +RDL ++ +L+     + + D G+    + 
Sbjct: 120 DERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGL---SRD 176

Query: 337 VGEATEYETDGY----------RWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GE 385
           V     YE D Y          +W+A E +         T  S+V+SFG+++WE+VT G 
Sbjct: 177 V-----YEEDSYVKRSKGRIPVKWMAIESLFDH----IYTTQSDVWSFGVLLWEIVTLGG 227

Query: 386 AAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIIS 440
             Y   +P +    +   G R E P++C + + +LM+ CW   P KRP F++I  
Sbjct: 228 NPYPGIAP-ERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 84.9 bits (210), Expect = 1e-18
 Identities = 58/219 (26%), Positives = 103/219 (47%), Gaps = 20/219 (9%)

Query: 227 EFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEI 286
           E +L K+L       H+ I+Q+Y  C+ ++  L +  + M GGSV D +     L     
Sbjct: 54  EIQLLKNLQ------HERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVT 106

Query: 287 IRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMG----IVTACKSVGEATE 342
            +    + EG+++L+ + + +RD+    IL D  GNV LGD G    + T C S      
Sbjct: 107 RKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKS 166

Query: 343 YETDGYRWLAPEIIAGDPESVSETW--MSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGI 400
                Y W++PE+I+G      E +   ++V+S G  + EM+T +  +A    + A   I
Sbjct: 167 VTGTPY-WMSPEVISG------EGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKI 219

Query: 401 AACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEII 439
           A     P++P       ++ + + +  +  KRP   E++
Sbjct: 220 ATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELL 258

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 84.7 bits (209), Expect = 2e-18
 Identities = 75/272 (27%), Positives = 129/272 (47%), Gaps = 29/272 (10%)

Query: 185 WLLNSDNLEFIDQIGPNSFKGVYKG-----KRVGIEKLK-GCDKGNAY--EFELRKDLLE 236
           W +  ++L+ I ++G   F  V+ G      +V ++ LK G     ++  E ++ K L  
Sbjct: 1   WEIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKL-- 58

Query: 237 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL--KSRKLQTKEIIRIAIDVA 294
                H  ++Q Y V  +E   + +VT+ M  GS+ D +   + R L+   ++ +A  VA
Sbjct: 59  ----RHDKLVQLYAVVSEEP--IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVA 112

Query: 295 EGIKFLNDHGVAYRDLNSQRILLDRHGNVC-LGDMGIVTACKSVGEATEYETDGY--RWL 351
            G+ ++      +RDL S  IL+   G VC + D G+    +   E T  +   +  +W 
Sbjct: 113 AGMAYIERMNYIHRDLRSANILVG-DGLVCKIADFGLARLIED-NEYTARQGAKFPIKWT 170

Query: 352 APEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIP 410
           APE       ++     S+V+SFG+++ E+VT G   Y   +  +    +   G R   P
Sbjct: 171 APEAALYGRFTIK----SDVWSFGILLTELVTKGRVPYPGMNNREVLEQVER-GYRMPCP 225

Query: 411 KDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
           +DCP  L  LM++CW   P +RP F  + S L
Sbjct: 226 QDCPISLHELMLQCWKKDPEERPTFEYLQSFL 257

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 83.7 bits (207), Expect = 3e-18
 Identities = 55/208 (26%), Positives = 97/208 (46%), Gaps = 17/208 (8%)

Query: 242 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFL 300
           H N+L    +C+       VV   M+ G + + I   +     K++I   + VA+G+++L
Sbjct: 55  HPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYL 114

Query: 301 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR-------WLAP 353
                 +RDL ++  +LD    V + D G+    + + +   Y    +        W+A 
Sbjct: 115 ASKKFVHRDLAARNCMLDESFTVKVADFGLA---RDIYDKEYYSVHNHTGAKLPVKWMAL 171

Query: 354 EIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKD 412
           E +    ++   T  S+V+SFG+++WE++T G   Y         V +   G R   P+ 
Sbjct: 172 ESL----QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQ-GRRLLQPEY 226

Query: 413 CPQILKSLMIKCWNNSPSKRPQFSEIIS 440
           CP  L  +M+ CW+  P  RP FSE++S
Sbjct: 227 CPDPLYEVMLSCWHPKPEMRPTFSELVS 254

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 83.7 bits (207), Expect = 4e-18
 Identities = 53/204 (25%), Positives = 99/204 (48%), Gaps = 16/204 (7%)

Query: 242 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEII--RIAIDVAEGIKF 299
           H N++Q   VC  E     ++T+ M  G++ D + +  + +   ++   +A  ++  +++
Sbjct: 61  HPNLVQLLGVCTREP-PFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEY 119

Query: 300 LNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRWLAPEI 355
           L      +RDL ++  L+  +  V + D G+    + +   T     G     +W APE 
Sbjct: 120 LEKKNFIHRDLAARNCLVGENHLVKVADFGL---SRLMTGDTYTAHAGAKFPIKWTAPES 176

Query: 356 IAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCP 414
           +A +  S+     S+V++FG+++WE+ T G + Y     +     +   G R E P+ CP
Sbjct: 177 LAYNKFSIK----SDVWAFGVLLWEIATYGMSPYPGID-LSQVYELLEKGYRMERPEGCP 231

Query: 415 QILKSLMIKCWNNSPSKRPQFSEI 438
             +  LM  CW  +PS RP F+EI
Sbjct: 232 PKVYELMRACWQWNPSDRPSFAEI 255

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 83.0 bits (206), Expect = 5e-18
 Identities = 46/201 (22%), Positives = 83/201 (41%), Gaps = 17/201 (8%)

Query: 237 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEG 296
           L    H  I++ +     E   L +V +   GG +   + K  +   +     A ++   
Sbjct: 47  LSRINHPFIVKLHYAFQTEEK-LYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLA 105

Query: 297 IKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE-----TDGYRWL 351
           +++L+  G+ YRDL  + ILLD  G++ L D G+    K +            T  Y  L
Sbjct: 106 LEYLHSLGIIYRDLKPENILLDADGHIKLTDFGL---AKELSSEGSRTNTFCGTPEY--L 160

Query: 352 APEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPK 411
           APE++ G     +  W    +S G++++EM+TG+  + A    +    I         P+
Sbjct: 161 APEVLLGKGYGKAVDW----WSLGVLLYEMLTGKPPFYAEDRKEIYEKILK--DPLRFPE 214

Query: 412 DCPQILKSLMIKCWNNSPSKR 432
                 + L+       P+KR
Sbjct: 215 FLSPEARDLISGLLQKDPTKR 235

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 82.8 bits (204), Expect = 7e-18
 Identities = 71/272 (26%), Positives = 125/272 (45%), Gaps = 28/272 (10%)

Query: 185 WLLNSDNLEFIDQIGPNSFKGVYKG-----KRVGIEKLK-GCDKGNAY--EFELRKDLLE 236
           W +  ++++ + ++G   F  V+ G      +V ++ LK G     A+  E  L K    
Sbjct: 1   WEIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMK---- 56

Query: 237 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR---KLQTKEIIRIAIDV 293
             T  H  +++ Y V V +   + ++T+ M  GS+ D  LKS    K+   ++I  +  +
Sbjct: 57  --TLQHDKLVRLYAV-VTKEEPIYIITEYMAKGSLLDF-LKSDEGGKVLLPKLIDFSAQI 112

Query: 294 AEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY--RWL 351
           AEG+ ++      +RDL +  +L+       + D G+    +   E T  E   +  +W 
Sbjct: 113 AEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIED-NEYTAREGAKFPIKWT 171

Query: 352 APEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIP 410
           APE I       S T  S+V+SFG++++E+VT G+  Y   S       +   G R    
Sbjct: 172 APEAI----NFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQR-GYRMPRM 226

Query: 411 KDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
           ++CP  L  +M  CW     +RP F  + S+L
Sbjct: 227 ENCPDELYDIMKTCWKEKAEERPTFDYLQSVL 258

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 83.5 bits (206), Expect = 7e-18
 Identities = 71/286 (24%), Positives = 123/286 (43%), Gaps = 55/286 (19%)

Query: 192 LEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLE----LMTCGHKNILQ 247
            EF+   G   F G  +   V ++ L+      A     R D L+    +    + NI++
Sbjct: 30  AEFL-GEGAPEFDG--QPVLVAVKMLRADVTKTA-----RNDFLKEIKIMSRLKNPNIIR 81

Query: 248 FYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTK-------------EIIRIAIDVA 294
              VCV ++  LC++T+ ME G +N   L  R++++               ++ +A+ +A
Sbjct: 82  LLGVCVSDD-PLCMITEYMENGDLN-QFLSQREIESTFTHANNIPSVSIANLLYMAVQIA 139

Query: 295 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG-----YR 349
            G+K+L      +RDL ++  L+  H  + + D G+    +++     Y   G      R
Sbjct: 140 SGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGM---SRNLYSGDYYRIQGRAVLPIR 196

Query: 350 WLAPE-IIAGDPESVSETWMSNVYSFGMVIWEMVT--GEAAYAACSPVQAAVGIAACG-- 404
           W+A E I+ G   + S+ W     +FG+ +WEM T   E  Y+  S  Q    I   G  
Sbjct: 197 WMAWESILLGKFTTASDVW-----AFGVTLWEMFTLCKEQPYSLLSDEQV---IENTGEF 248

Query: 405 LRPE-------IPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLL 443
            R +           CP  +  LM++CW+     RP F++I   L 
Sbjct: 249 FRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score = 84.8 bits (208), Expect = 7e-18
 Identities = 64/278 (23%), Positives = 117/278 (42%), Gaps = 32/278 (11%)

Query: 191 NLEFIDQIGPNSFKGVYKGKR---VGIEKLKGCDKGNAYEFELRKDLLELMT--CGHKNI 245
           +   + ++G  SF  VY  +    V ++ L    +  + E E     ++++       NI
Sbjct: 1   SYRILRKLGEGSFGEVYLARDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNI 60

Query: 246 LQFYCVCVDENHGLCVVTKLMEGGSVNDLI---LKSRKLQTKEIIRIAIDVAEGIKFLND 302
           ++ Y    DE   L +V + ++GGS+ DL+    +   L   E + I   +   +++L+ 
Sbjct: 61  VKLYDFFQDEGS-LYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS 119

Query: 303 HGVAYRDLNSQRILLDRHGN-VCLGDMGIVTACKSVGEATEYE--------TDGYRWLAP 353
            G+ +RD+  + ILLDR G  V L D G+       G  +           T GY   AP
Sbjct: 120 KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM--AP 177

Query: 354 EIIAGDPESVSETWMSNVYSFGMVIWEMVTG----EAAYAACSPVQAAVGIAACG----- 404
           E++ G   + + +  S+++S G+ ++E++TG    E    + +  Q    I         
Sbjct: 178 EVLLGLSLAYA-SSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLA 236

Query: 405 --LRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIIS 440
             L P  P+   +    L+ K     P  R   S  +S
Sbjct: 237 SPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLS 274

Length = 384

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 82.6 bits (204), Expect = 8e-18
 Identities = 65/264 (24%), Positives = 122/264 (46%), Gaps = 29/264 (10%)

Query: 198 IGPNSFKGVYKG-----------KRVGIEKL--KGCDKGNAYEFELRKDLLELMTCGHKN 244
           IG  SF  VY G           K+V +  +     D+  +    L +++  L    H+N
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67

Query: 245 ILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHG 304
           I+Q+    +D +H L +  + + GGSV  L+      +   +      + +G+ +L++ G
Sbjct: 68  IVQYLGSSLDADH-LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRG 126

Query: 305 VAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR--------WLAPEII 356
           + +RD+    IL+D  G + + D GI  + K    +   +T+G R        W+APE++
Sbjct: 127 IIHRDIKGANILVDNKGGIKISDFGI--SKKLEANSLSTKTNGARPSLQGSVFWMAPEVV 184

Query: 357 AGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQI 416
               +  S T  ++++S G ++ EM+TG+  +  C+ +QA   I      PEIP +    
Sbjct: 185 ----KQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGE-NASPEIPSNISSE 239

Query: 417 LKSLMIKCWNNSPSKRPQFSEIIS 440
               + K +    +KRP  +E++ 
Sbjct: 240 AIDFLEKTFEIDHNKRPTAAELLK 263

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 82.9 bits (205), Expect = 8e-18
 Identities = 52/165 (31%), Positives = 84/165 (50%), Gaps = 26/165 (15%)

Query: 242 HKNILQFY-CVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL 300
           H NI++ Y    V +   L VV + +EGG++ D++  +R +  ++I  + + V + + FL
Sbjct: 75  HPNIVEMYSSYLVGDE--LWVVMEFLEGGALTDIVTHTR-MNEEQIATVCLAVLKALSFL 131

Query: 301 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE---------ATEYETDGYRWL 351
           +  GV +RD+ S  ILL   G V L D G    C  V +          T Y      W+
Sbjct: 132 HAQGVIHRDIKSDSILLTSDGRVKLSDFGF---CAQVSKEVPRRKSLVGTPY------WM 182

Query: 352 APEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQA 396
           APE+I+  P   +E    +++S G+++ EMV GE  Y    P+QA
Sbjct: 183 APEVISRLPYG-TEV---DIWSLGIMVIEMVDGEPPYFNEPPLQA 223

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 82.8 bits (205), Expect = 9e-18
 Identities = 58/227 (25%), Positives = 104/227 (45%), Gaps = 46/227 (20%)

Query: 242 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR--------KLQTKEIIRIAIDV 293
           H+NIL    VC+++     V+   M  G++   + + R         L T++++ +AI +
Sbjct: 67  HQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQI 126

Query: 294 AEGIKFLNDHGVAYRDLNSQRILLDRHGNV-----------------CLGDMGIVTACKS 336
           A G+ +L+  GV ++D+ ++  ++D    V                 CLGD         
Sbjct: 127 ACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGD--------- 177

Query: 337 VGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQ 395
                  E    +W+A E +     S +    S+V+SFG+++WE++T G+  Y    P +
Sbjct: 178 ------NENRPVKWMALESLVNKEYSSA----SDVWSFGVLLWELMTLGQTPYVEIDPFE 227

Query: 396 AAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
            A  +   G R   P +CP  L ++M  CW   P +RP FS+++  L
Sbjct: 228 MAAYLKD-GYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCL 273

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 82.7 bits (204), Expect = 1e-17
 Identities = 65/253 (25%), Positives = 117/253 (46%), Gaps = 33/253 (13%)

Query: 212 VGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSV 271
           V ++ LK        +F+   +LL  +   H++I++FY VC D +  L +V + M+ G +
Sbjct: 38  VAVKALKDPTLAARKDFQREAELLTNLQ--HEHIVKFYGVCGDGD-PLIMVFEYMKHGDL 94

Query: 272 ND----------LILKSRKLQTK------EIIRIAIDVAEGIKFLNDHGVAYRDLNSQRI 315
           N           +++  +  Q K      +++ IA  +A G+ +L      +RDL ++  
Sbjct: 95  NKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNC 154

Query: 316 LLDRHGNVCLGDMGIVTACKSVGEATEYETDGY-----RWLAPEIIAGDPESVSETWMSN 370
           L+  +  V +GD G+    + V     Y   G+     RW+ PE I     +      S+
Sbjct: 155 LVGANLLVKIGDFGM---SRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTE----SD 207

Query: 371 VYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSP 429
           V+SFG+++WE+ T G+  +   S  +    I   G   E P+ CP+ +  +M+ CW   P
Sbjct: 208 VWSFGVILWEIFTYGKQPWFQLSNTEVIECITQ-GRVLERPRVCPKEVYDIMLGCWQREP 266

Query: 430 SKRPQFSEIISLL 442
            +R    EI  +L
Sbjct: 267 QQRLNIKEIYKIL 279

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 82.4 bits (203), Expect = 1e-17
 Identities = 63/219 (28%), Positives = 105/219 (47%), Gaps = 35/219 (15%)

Query: 242 HKNILQFYCVCVD--ENHGL---CVVTKLMEGGSVNDLILKSR------KLQTKEIIRIA 290
           H N+++   VC+   E+ G     V+   M+ G ++  +L SR       L T+ +++  
Sbjct: 59  HPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFM 118

Query: 291 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR- 349
            D+A G+++L+     +RDL ++  +L+ + NVC+ D G+    K +     Y  D YR 
Sbjct: 119 TDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGL---SKKI-----YNGDYYRQ 170

Query: 350 ---------WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVG 399
                    W+A E +A   + V  T  S+V+SFG+ +WE+ T G+  Y      +    
Sbjct: 171 GRIAKMPVKWIAIESLA---DRVYTT-KSDVWSFGVTMWEIATRGQTPYPGVENSEIYDY 226

Query: 400 IAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEI 438
           +   G R + P DC   L SLM  CW  +P  RP F  +
Sbjct: 227 LRQ-GNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETL 264

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 82.3 bits (203), Expect = 1e-17
 Identities = 69/252 (27%), Positives = 116/252 (46%), Gaps = 28/252 (11%)

Query: 212 VGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSV 271
           V ++ LK   +    +F+   +LL ++   H++I++FY VC  E   L +V + M  G +
Sbjct: 38  VAVKALKEASESARQDFQREAELLTVLQ--HQHIVRFYGVCT-EGRPLLMVFEYMRHGDL 94

Query: 272 NDL---------ILKSRKLQT------KEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRIL 316
           N           IL   +          +++ IA  +A G+ +L      +RDL ++  L
Sbjct: 95  NRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCL 154

Query: 317 LDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESV---SETWMSNVYS 373
           + +   V +GD G+     S    T+Y   G R + P I    PES+     T  S+++S
Sbjct: 155 VGQGLVVKIGDFGMSRDIYS----TDYYRVGGRTMLP-IRWMPPESILYRKFTTESDIWS 209

Query: 374 FGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKR 432
           FG+V+WE+ T G+  +   S  +A   I   G   E P+ CP  + ++M  CW   P +R
Sbjct: 210 FGVVLWEIFTYGKQPWYQLSNTEAIECITQ-GRELERPRTCPPEVYAIMQGCWQREPQQR 268

Query: 433 PQFSEIISLLLR 444
               +I S L  
Sbjct: 269 MVIKDIHSRLQA 280

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 82.8 bits (204), Expect = 1e-17
 Identities = 74/304 (24%), Positives = 136/304 (44%), Gaps = 42/304 (13%)

Query: 184 RWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD---------KGNAYEFELRKDL 234
           RW +  D L     +G   F  V   + +G++K K            K +A E +L   +
Sbjct: 12  RWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLI 71

Query: 235 LEL----MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR----------- 279
            E+    M   HKNI+     C  ++  L V+ +    G++ + +   R           
Sbjct: 72  SEMEMMKMIGKHKNIINLLGACT-QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPT 130

Query: 280 -----KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC 334
                +L  K+++  A  VA G+++L      +RDL ++ +L+     + + D G+    
Sbjct: 131 QVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI 190

Query: 335 KSVGEATEYETDG---YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAA 390
             + +  +  T+G    +W+APE +         T  S+V+SFG+++WE+ T G + Y  
Sbjct: 191 HHI-DYYKKTTNGRLPVKWMAPEALF----DRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 245

Query: 391 CSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISN 450
             PV+    +   G R + P +C   L  +M  CW+  PS+RP F +++  L R   ++ 
Sbjct: 246 V-PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI--LAL 302

Query: 451 SSNR 454
           +SN+
Sbjct: 303 TSNQ 306

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 81.6 bits (201), Expect = 3e-17
 Identities = 78/287 (27%), Positives = 136/287 (47%), Gaps = 46/287 (16%)

Query: 190 DNLEFIDQIGPNSFKGVYKG--KRVG------IEKLKGCDKGNAYEFELRKDLLELMTCG 241
           ++++F D IG  +F  V +   K+ G      I+ LK     N +  +   +L  L   G
Sbjct: 2   EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHR-DFAGELEVLCKLG 60

Query: 242 -HKNILQFYCVCVDENHG-LCVVTKLMEGGSVNDLILKSRKLQT---------------- 283
            H NI+     C  EN G L +  +    G++ D + KSR L+T                
Sbjct: 61  HHPNIINLLGAC--ENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTS 118

Query: 284 KEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGI-----VTACKSVG 338
           +++++ A DVA G+++L++    +RDL ++ +L+  +    + D G+     V   K++G
Sbjct: 119 QQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMG 178

Query: 339 EATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAA 397
                     RW+A E +     SV  T  S+V+SFG+++WE+V+ G   Y   +  +  
Sbjct: 179 RLP------VRWMAIESLN---YSVYTT-KSDVWSFGVLLWEIVSLGGTPYCGMTCAELY 228

Query: 398 VGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR 444
             +   G R E P++C   +  LM +CW + P +RP F++I   L R
Sbjct: 229 EKLPQ-GYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSR 274

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 80.7 bits (199), Expect = 3e-17
 Identities = 63/227 (27%), Positives = 105/227 (46%), Gaps = 36/227 (15%)

Query: 234 LLELMTCG---HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRI 289
           L E +T G   H NI++   V +   + + +VT+ M  G+++  + K   +L   +++ +
Sbjct: 54  LAEALTLGQFDHSNIVRLEGV-ITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGM 112

Query: 290 AIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG--------EAT 341
              +A G+K+L++ G  ++ L + ++L++               CK  G           
Sbjct: 113 LPGLASGMKYLSEMGYVHKGLAAHKVLVNSD-----------LVCKISGFRRLQEDKSEA 161

Query: 342 EYETDGYR----WLAPEIIA-GDPESVSETWMSNVYSFGMVIWE-MVTGEAAYAACSPVQ 395
            Y T   +    W APE I      S S+ W     SFG+V+WE M  GE  Y   S  Q
Sbjct: 162 IYTTMSGKSPVLWAAPEAIQYHHFSSASDVW-----SFGIVMWEVMSYGERPYWDMSG-Q 215

Query: 396 AAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
             +     G R   P++CP +L  LM+ CW     +RP+FS+I S+L
Sbjct: 216 DVIKAVEDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSIL 262

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 81.9 bits (202), Expect = 3e-17
 Identities = 75/296 (25%), Positives = 135/296 (45%), Gaps = 48/296 (16%)

Query: 184 RWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFELRKD---------- 233
           +W    D L     +G   F  V + +  GI+K +  D+      ++ KD          
Sbjct: 6   KWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRP-DQTVTVAVKMLKDNATDKDLADL 64

Query: 234 --LLELMTC--GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK--------- 280
              +ELM     HKNI+    VC  E   L V+ +    G++ +  L++R+         
Sbjct: 65  ISEMELMKLIGKHKNIINLLGVCTQEG-PLYVIVEYAAKGNLREF-LRARRPPGPDYTFD 122

Query: 281 --------LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVT 332
                   L  K+++  A  VA G+++L      +RDL ++ +L+     + + D G+  
Sbjct: 123 ITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLA- 181

Query: 333 ACKSVGEATEYE--TDG---YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEA 386
             + V +   Y+  ++G    +W+APE +    + V  T  S+V+SFG+++WE+ T G +
Sbjct: 182 --RGVHDIDYYKKTSNGRLPVKWMAPEALF---DRVY-THQSDVWSFGILMWEIFTLGGS 235

Query: 387 AYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
            Y    PV+    +   G R + P +C   L  LM +CW+  P++RP F +++  L
Sbjct: 236 PYPGI-PVEELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEAL 290

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 80.3 bits (198), Expect = 6e-17
 Identities = 57/206 (27%), Positives = 102/206 (49%), Gaps = 14/206 (6%)

Query: 242 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR--KLQTKE--IIRIAIDVAEGI 297
           H+NI+Q Y     EN    +  + + GGS++ L L+S+   L+  E  II     + EG+
Sbjct: 64  HRNIVQ-YLGSDSENGFFKIFMEQVPGGSLSAL-LRSKWGPLKDNEQTIIFYTKQILEGL 121

Query: 298 KFLNDHGVAYRDLNSQRILLDRHGNVC-LGDMGIVTACKSVGEATEYETDGYRWLAPEII 356
           K+L+D+ + +RD+    +L++ +  V  + D G       +   TE  T   +++APE+I
Sbjct: 122 KYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVI 181

Query: 357 AGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAA---VGIAACGLRPEIPKDC 413
              P        ++++S G  I EM TG+  +      QAA   VG+    + PEIP+  
Sbjct: 182 DKGPRGYGAP--ADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFK--IHPEIPESL 237

Query: 414 PQILKSLMIKCWNNSPSKRPQFSEII 439
               K+ +++C+   P KR    +++
Sbjct: 238 SAEAKNFILRCFEPDPDKRASAHDLL 263

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 79.7 bits (196), Expect = 7e-17
 Identities = 75/272 (27%), Positives = 128/272 (47%), Gaps = 29/272 (10%)

Query: 185 WLLNSDNLEFIDQIGPNSFKGVY-----KGKRVGIEKLK-GCDKGNAY--EFELRKDLLE 236
           W +  ++L+   ++G   F  V+     K  +V ++ +K G     A+  E  + K L  
Sbjct: 1   WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTL-- 58

Query: 237 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKS---RKLQTKEIIRIAIDV 293
                H  +++ + V   E   + ++T+ M  GS+ D  LKS    K    ++I  +  +
Sbjct: 59  ----QHDKLVKLHAVVTKEP--IYIITEFMAKGSLLDF-LKSDEGSKQPLPKLIDFSAQI 111

Query: 294 AEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY--RWL 351
           AEG+ F+      +RDL +  IL+       + D G+    +   E T  E   +  +W 
Sbjct: 112 AEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIED-NEYTAREGAKFPIKWT 170

Query: 352 APEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIP 410
           APE I       S T  S+V+SFG+++ E+VT G   Y   S  +    +   G R   P
Sbjct: 171 APEAI----NFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER-GYRMPRP 225

Query: 411 KDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
           ++CP+ L ++M++CW N P +RP F  I S+L
Sbjct: 226 ENCPEELYNIMMRCWKNRPEERPTFEYIQSVL 257

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 80.5 bits (198), Expect = 8e-17
 Identities = 72/260 (27%), Positives = 120/260 (46%), Gaps = 33/260 (12%)

Query: 212 VGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSV 271
           V ++ LK        +F    +LL  +   H++I++FY VCV E   L +V + M+ G +
Sbjct: 38  VAVKTLKDASDNARKDFHREAELLTNLQ--HEHIVKFYGVCV-EGDPLIMVFEYMKHGDL 94

Query: 272 N--------DLILKSR-----KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLD 318
           N        D +L +      +L   +++ IA  +A G+ +L      +RDL ++  L+ 
Sbjct: 95  NKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVG 154

Query: 319 RHGNVCLGDMGIVTACKSVGEATEYETDGY-----RWLAPEIIAGDPESVSETWMSNVYS 373
            +  V +GD G+    + V     Y   G+     RW+ PE I         T  S+V+S
Sbjct: 155 ENLLVKIGDFGM---SRDVYSTDYYRVGGHTMLPIRWMPPESIM----YRKFTTESDVWS 207

Query: 374 FGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKR 432
            G+V+WE+ T G+  +   S  +    I   G   + P+ CP+ +  LM+ CW   P  R
Sbjct: 208 LGVVLWEIFTYGKQPWYQLSNNEVIECITQ-GRVLQRPRTCPKEVYDLMLGCWQREPHMR 266

Query: 433 PQFSEIISLLLRTNNISNSS 452
               EI SLL    N++ +S
Sbjct: 267 LNIKEIHSLL---QNLAKAS 283

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 80.5 bits (198), Expect = 9e-17
 Identities = 71/294 (24%), Positives = 131/294 (44%), Gaps = 40/294 (13%)

Query: 184 RWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD---------KGNAYEFELRKDL 234
           RW  + D L     +G   F  V   + +GI+K K  +         K +A E +L   +
Sbjct: 9   RWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLV 68

Query: 235 LEL----MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR----------- 279
            E+    M   HKNI+     C  ++  L V+ +    G++ + +   R           
Sbjct: 69  SEMEMMKMIGKHKNIINLLGACT-QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIA 127

Query: 280 -----KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC 334
                ++  K+++     VA G+++L      +RDL ++ +L+  +  + + D G+    
Sbjct: 128 RVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDV 187

Query: 335 KSVGEATEYETDG---YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAA 390
            ++ +  +  T+G    +W+APE +         T  S+V+SFG+++WE+ T G + Y  
Sbjct: 188 NNI-DYYKKTTNGRLPVKWMAPEALF----DRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 242

Query: 391 CSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR 444
             PV+    +   G R + P +C   L  +M  CW+  PS RP F +++  L R
Sbjct: 243 I-PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDR 295

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 79.4 bits (196), Expect = 1e-16
 Identities = 65/257 (25%), Positives = 117/257 (45%), Gaps = 29/257 (11%)

Query: 198 IGPNSFKGVYKGK-----RVGIEKLKGCDKGNAYEFELRKD---LLELMTCGHKNILQFY 249
           IG  ++  VY+GK     RV   K+   D  +    +++++   L +L      NI ++Y
Sbjct: 9   IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68

Query: 250 -CVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYR 308
                     L ++ +  EGGSV  L +K+  +  K I  I  +V   +K+++  GV +R
Sbjct: 69  GSYLKGPR--LWIIMEYAEGGSVRTL-MKAGPIAEKYISVIIREVLVALKYIHKVGVIHR 125

Query: 309 DLNSQRILLDRHGNVCLGDMGI------VTACKSVGEATEYETDGYRWLAPEIIAGDPES 362
           D+ +  IL+   GNV L D G+       ++ +S    T Y      W+APE+I    E 
Sbjct: 126 DIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPY------WMAPEVIT---EG 176

Query: 363 VSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDC-PQILKSLM 421
                 ++++S G+ I+EM TG   Y+     +A + I      P +  +   ++L+  +
Sbjct: 177 KYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSK-PPRLEDNGYSKLLREFV 235

Query: 422 IKCWNNSPSKRPQFSEI 438
             C +  P +R    E+
Sbjct: 236 AACLDEEPKERLSAEEL 252

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 80.1 bits (197), Expect = 1e-16
 Identities = 72/301 (23%), Positives = 134/301 (44%), Gaps = 40/301 (13%)

Query: 184 RWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFELR-----KDLLEL- 237
           +W L+   L     +G   F  V   + +GI+K K           L+     KDL +L 
Sbjct: 6   KWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLV 65

Query: 238 -------MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLI--------------- 275
                  M   HKNI+     C  ++  L V+ +    G++ + +               
Sbjct: 66  SEMEMMKMIGKHKNIINLLGACT-QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTC 124

Query: 276 -LKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC 334
            L   +L  K+++  A  VA G+++L      +RDL ++ +L+     + + D G+    
Sbjct: 125 KLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDV 184

Query: 335 KSVGEATEYETDG---YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAA 390
            ++ +  +  T+G    +W+APE +         T  S+V+SFG+++WE+ T G + Y  
Sbjct: 185 HNI-DYYKKTTNGRLPVKWMAPEALF----DRVYTHQSDVWSFGVLLWEIFTLGGSPYPG 239

Query: 391 CSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISN 450
             PV+    +   G R + P +C   L  +M +CW+  PS+RP F +++  L R   +++
Sbjct: 240 I-PVEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTS 298

Query: 451 S 451
           +
Sbjct: 299 T 299

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 79.1 bits (195), Expect = 2e-16
 Identities = 58/225 (25%), Positives = 101/225 (44%), Gaps = 39/225 (17%)

Query: 242 HKNILQFYCVCVD--ENHGL---CVVTKLMEGGSVNDLILKSR------KLQTKEIIRIA 290
           H N+++   VC +      +    V+   M+ G ++  +L SR      KL  + +++  
Sbjct: 60  HPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFM 119

Query: 291 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR- 349
           +D+A G+++L++    +RDL ++  +L     VC+ D G+            Y  D YR 
Sbjct: 120 VDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGL--------SKKIYSGDYYRQ 171

Query: 350 ---------WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAA-- 397
                    W+A E +A        T  S+V++FG+ +WE+ T G+  Y     V+    
Sbjct: 172 GRIAKMPVKWIAIESLADR----VYTSKSDVWAFGVTMWEIATRGQTPYPG---VENHEI 224

Query: 398 VGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
                 G R + P+DC   L  LM  CW   P  RP F+++  +L
Sbjct: 225 YDYLRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVL 269

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 79.2 bits (195), Expect = 2e-16
 Identities = 65/234 (27%), Positives = 108/234 (46%), Gaps = 46/234 (19%)

Query: 244 NILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKE------------------ 285
           NI++   VCVDE+  LC++T+ ME G +N   L S  L  KE                  
Sbjct: 80  NIIRLLGVCVDED-PLCMITEYMENGDLNQF-LSSHHLDDKEENGNDAVPPAHCLPAISY 137

Query: 286 --IIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY 343
             ++ +A+ +A G+K+L+     +RDL ++  L+  +  + + D G+    +++     Y
Sbjct: 138 SSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGM---SRNLYAGDYY 194

Query: 344 ETDG-----YRWLAPE-IIAGDPESVSETWMSNVYSFGMVIWE--MVTGEAAYAACSPVQ 395
              G      RW+A E I+ G   + S+ W     +FG+ +WE  M+  E  Y   +  Q
Sbjct: 195 RIQGRAVLPIRWMAWECILMGKFTTASDVW-----AFGVTLWEILMLCKEQPYGELTDEQ 249

Query: 396 AAVGIAACGLRPE-------IPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
             +  A    R +        P  CPQ L  LM++CW+    +RP FS+I + L
Sbjct: 250 V-IENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFL 302

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 78.6 bits (193), Expect = 3e-16
 Identities = 69/262 (26%), Positives = 121/262 (46%), Gaps = 16/262 (6%)

Query: 192 LEFIDQIGPNSFKGVYKGKRVGIEKL---KGCDKGNAYEFELRKDLLELMTCGH-KNILQ 247
            E ++ +G  ++  VYKG+ V   +L   K  D     E E+++++  L    H +NI  
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67

Query: 248 FYCVCVDEN-----HGLCVVTKLMEGGSVNDLI--LKSRKLQTKEIIRIAIDVAEGIKFL 300
           +Y   + +N       L +V +    GSV DLI   K   L+ + I  I  ++  G+  L
Sbjct: 68  YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHL 127

Query: 301 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC-KSVGEATEYETDGYRWLAPEIIAGD 359
           + H V +RD+  Q +LL  +  V L D G+     ++VG    +    Y W+APE+IA D
Sbjct: 128 HQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPY-WMAPEVIACD 186

Query: 360 --PESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQIL 417
             P++  + + S+++S G+   EM  G        P++A   I          K   +  
Sbjct: 187 ENPDATYD-FKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWSKKF 245

Query: 418 KSLMIKCWNNSPSKRPQFSEII 439
           +S +  C   + S+RP   +++
Sbjct: 246 QSFIESCLVKNHSQRPTTEQLM 267

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 77.0 bits (190), Expect = 6e-16
 Identities = 54/208 (25%), Positives = 90/208 (43%), Gaps = 18/208 (8%)

Query: 242 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 301
           H N++++Y V V     + +  +   GG++ +L+   R L    I    + + EG+ +L+
Sbjct: 58  HPNLVKYYGVEVHREK-VYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLH 116

Query: 302 DHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRW------LAPEI 355
            HG+ +RD+    I LD +G + LGD G   A K     T    +          +APE+
Sbjct: 117 SHGIVHRDIKPANIFLDHNGVIKLGDFG--CAVKLKNNTTTMGEEVQSLAGTPAYMAPEV 174

Query: 356 IAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ 415
           I G           +++S G V+ EM TG+  ++        +     G +P IP     
Sbjct: 175 ITGGKGKGHGRAA-DIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDS--- 230

Query: 416 ILKSLMIK-----CWNNSPSKRPQFSEI 438
           +  S   K     C  + P KRP  SE+
Sbjct: 231 LQLSPEGKDFLDRCLESDPKKRPTASEL 258

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 77.0 bits (189), Expect = 7e-16
 Identities = 60/220 (27%), Positives = 103/220 (46%), Gaps = 36/220 (16%)

Query: 242 HKNILQFYCVCVDENHG-LCVVTKLMEGGSVNDLILKSRKLQT----------------K 284
           H NI+     C  E+ G L +  +    G++ D + KSR L+T                +
Sbjct: 55  HPNIINLLGAC--EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 112

Query: 285 EIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGI-----VTACKSVGE 339
           +++  A DVA G+ +L+     +RDL ++ IL+  +    + D G+     V   K++G 
Sbjct: 113 QLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGR 172

Query: 340 ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAV 398
                    RW+A E +     SV  T  S+V+S+G+++WE+V+ G   Y   +  +   
Sbjct: 173 LP------VRWMAIESLN---YSVYTT-NSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE 222

Query: 399 GIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEI 438
            +   G R E P +C   +  LM +CW   P +RP F++I
Sbjct: 223 KLPQ-GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQI 261

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 76.8 bits (189), Expect = 9e-16
 Identities = 65/253 (25%), Positives = 112/253 (44%), Gaps = 14/253 (5%)

Query: 195 IDQIGPNSF------KGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQF 248
           + +IG  SF      K    GK+  I+++           E RK++  L    H NI+Q 
Sbjct: 5   VKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQ- 63

Query: 249 YCVCVDENHGLCVVTKLMEGGSVNDLILKSRKL--QTKEIIRIAIDVAEGIKFLNDHGVA 306
           Y    +EN  L +V    EGG +   I   R +     +I+   + +   +K ++D  + 
Sbjct: 64  YQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKIL 123

Query: 307 YRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSET 366
           +RD+ SQ I L + G + LGD GI     S  E          +L+PEI    P +    
Sbjct: 124 HRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNNK-- 181

Query: 367 WMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWN 426
             S++++ G V++EM T + A+ A +     + I   G  P +       L++L+ + + 
Sbjct: 182 --SDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIR-GSYPPVSSHYSYDLRNLVSQLFK 238

Query: 427 NSPSKRPQFSEII 439
            +P  RP  + I+
Sbjct: 239 RNPRDRPSVNSIL 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 77.1 bits (190), Expect = 1e-15
 Identities = 72/281 (25%), Positives = 124/281 (44%), Gaps = 33/281 (11%)

Query: 184 RWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEK-----------LKGCDKGNAYEFELRK 232
           +W    +NL F   +G  +F  V +    G+ K           LK     ++ E E   
Sbjct: 29  KWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLK--PTAHSSEREALM 86

Query: 233 DLLELMT--CGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK-LQTKEIIRI 289
             L++M+    H+NI+     C      L +      G  +N L  K    L  ++++  
Sbjct: 87  SELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSF 146

Query: 290 AIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVC-LGDMGIVTACKSVGEATEYETDG- 347
           +  VA+G+ FL      +RDL ++ +LL  HG +  + D G+    + +   + Y   G 
Sbjct: 147 SYQVAKGMAFLASKNCIHRDLAARNVLLT-HGKIVKICDFGLA---RDIMNDSNYVVKGN 202

Query: 348 ----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAV-GIA 401
                +W+APE I      V  T+ S+V+S+G+++WE+ + G   Y    PV +    + 
Sbjct: 203 ARLPVKWMAPESIF---NCVY-TFESDVWSYGILLWEIFSLGSNPYPGM-PVDSKFYKLI 257

Query: 402 ACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
             G R   P+  P  +  +M  CW+  P KRP F +I+ L+
Sbjct: 258 KEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLI 298

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 76.0 bits (187), Expect = 1e-15
 Identities = 61/254 (24%), Positives = 113/254 (44%), Gaps = 24/254 (9%)

Query: 193 EFIDQIGPNSFKGVYKGKRVG---IEKLKGCDKGNAYEFELRKDLLE---LMTCGHKNIL 246
           E +++IG  SF  V+K  R     +  +K  D       E  + + E   L       I+
Sbjct: 3   EILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYII 62

Query: 247 QFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK--LQTKEIIRIAIDVAEGIKFLNDHG 304
           ++Y     +   L +V +  E G ++ L+   R   L   ++ R  I +  G+  L+   
Sbjct: 63  RYY-ESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK 121

Query: 305 VAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE-----TDGYRWLAPEIIAGD 359
           + +RD+ S  + LD + NV +GD+G+    K + + T +      T  Y  L+PE+    
Sbjct: 122 ILHRDIKSLNLFLDAYDNVKIGDLGVA---KLLSDNTNFANTIVGTPYY--LSPELCEDK 176

Query: 360 PESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKS 419
           P +      S+V++ G+V++E  TG+  + A +     + I   G+ P + +   Q L  
Sbjct: 177 PYNEK----SDVWALGVVLYECCTGKHPFDANNQGALILKIIR-GVFPPVSQMYSQQLAQ 231

Query: 420 LMIKCWNNSPSKRP 433
           L+ +C      +RP
Sbjct: 232 LIDQCLTKDYRQRP 245

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 76.6 bits (188), Expect = 1e-15
 Identities = 67/274 (24%), Positives = 127/274 (46%), Gaps = 24/274 (8%)

Query: 186 LLNSDNLEFIDQIGPNSFKGVYKG------KRVGIE---KLKGCDKGNAYEFELRKDLLE 236
           +L    L+ +  +G  +F  VYKG      + V I    K+     G     E   + L 
Sbjct: 3   ILKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALI 62

Query: 237 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAE 295
           + +  H ++++   VC+     + +VT+LM  G + D + + +  + ++ ++   + +A+
Sbjct: 63  MASMDHPHLVRLLGVCLSPT--IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAK 120

Query: 296 GIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRWL 351
           G+ +L +  + +RDL ++ +L+    +V + D G+    +  G+  EY  DG     +W+
Sbjct: 121 GMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLE--GDEKEYNADGGKMPIKWM 178

Query: 352 APEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIP 410
           A E I         T  S+V+S+G+ IWE++T G   Y    P +    +   G R   P
Sbjct: 179 ALECI----HYRKFTHQSDVWSYGVTIWELMTFGGKPYDGI-PTREIPDLLEKGERLPQP 233

Query: 411 KDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR 444
             C   +  +M+KCW      RP+F E+ +   R
Sbjct: 234 PICTIDVYMVMVKCWMIDADSRPKFKELAAEFSR 267

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 76.2 bits (187), Expect = 2e-15
 Identities = 65/242 (26%), Positives = 111/242 (45%), Gaps = 25/242 (10%)

Query: 192 LEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCG----HKNILQ 247
            E ++ +G  ++  VYKG+ V   +L      +  E E  +  LE+        H+NI  
Sbjct: 18  FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIAT 77

Query: 248 FYCVCVDE-----NHGLCVVTKLMEGGSVNDLILKSRKLQTKE--IIRIAIDVAEGIKFL 300
           +Y   + +     +  L +V +    GSV DL+  ++    KE  I  I  ++  G+  L
Sbjct: 78  YYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHL 137

Query: 301 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC-KSVGEATEYETDGYRWLAPEIIAGD 359
           + H V +RD+  Q +LL  +  V L D G+     ++VG    +    Y W+APE+IA D
Sbjct: 138 HAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPY-WMAPEVIACD 196

Query: 360 --PESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQIL 417
             P++  + + S+++S G+   EM  G        P++A            IP++ P  L
Sbjct: 197 ENPDATYD-YRSDIWSLGITAIEMAEGAPPLCDMHPMRALF---------LIPRNPPPKL 246

Query: 418 KS 419
           KS
Sbjct: 247 KS 248

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 76.2 bits (187), Expect = 2e-15
 Identities = 50/198 (25%), Positives = 98/198 (49%), Gaps = 17/198 (8%)

Query: 258 GLCV------VTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDL 310
           G+C+      VT+LM  G + D + +++ ++ +++++   + +A+G+ +L +  + +RDL
Sbjct: 76  GICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDL 135

Query: 311 NSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRWLAPEIIAGDPESVSET 366
            ++ +L+    +V + D G+        + TEY  DG     +W+A E I         T
Sbjct: 136 AARNVLVKSPNHVKITDFGLARLLDI--DETEYHADGGKVPIKWMALESIL----HRRFT 189

Query: 367 WMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWN 426
             S+V+S+G+ +WE++T  A      P +    +   G R   P  C   +  +M+KCW 
Sbjct: 190 HQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTIDVYMIMVKCWM 249

Query: 427 NSPSKRPQFSEIISLLLR 444
                RP+F E++    R
Sbjct: 250 IDSECRPRFRELVDEFSR 267

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 76.2 bits (188), Expect = 2e-15
 Identities = 59/258 (22%), Positives = 110/258 (42%), Gaps = 35/258 (13%)

Query: 212 VGIEKLK-GCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGS 270
           V ++ L+         +F   K++  L      NI +   VC  +   LC++ + ME G 
Sbjct: 49  VAVKVLRPDASDNAREDFL--KEVKILSRLSDPNIARLLGVCTVDPP-LCMIMEYMENGD 105

Query: 271 VN-----------DLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDR 319
           +N            L   S+ L    ++ +A  +A G+++L      +RDL ++  L+ +
Sbjct: 106 LNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGK 165

Query: 320 HGNVCLGDMGIVTACKSVGEATEYETDG-----YRWLAPEIIAGDPESVSETWMSNVYSF 374
           +  + + D G+    +++  +  Y   G      RW+A E +     +      S+V++F
Sbjct: 166 NYTIKIADFGM---SRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTK----SDVWAF 218

Query: 375 GMVIWEMVT--GEAAYAACSP---VQAAVGIAACGLRPEI---PKDCPQILKSLMIKCWN 426
           G+ +WE++T   E  Y   +    ++ A        R      P +CP+ +  LM++CW 
Sbjct: 219 GVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWR 278

Query: 427 NSPSKRPQFSEIISLLLR 444
                RP F EI   L R
Sbjct: 279 RDEEDRPTFREIHLFLQR 296

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 77.4 bits (190), Expect = 2e-15
 Identities = 50/175 (28%), Positives = 84/175 (48%), Gaps = 16/175 (9%)

Query: 278 SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV 337
           S  L T +++     VA G++FL      +RDL ++ +LL +   V + D G+    + +
Sbjct: 231 SEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLA---RDI 287

Query: 338 GEATEYETDG-----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAAC 391
              + Y + G      +W+APE I  +      T +S+V+S+G+++WE+ + G   Y   
Sbjct: 288 MHDSNYVSKGSTFLPVKWMAPESIFDN----LYTTLSDVWSYGILLWEIFSLGGTPYPGM 343

Query: 392 SPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQF---SEIISLLL 443
                       G R   P    Q +  +M+KCWN+ P KRP F   S+I+  LL
Sbjct: 344 IVDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 75.4 bits (185), Expect = 3e-15
 Identities = 59/208 (28%), Positives = 97/208 (46%), Gaps = 18/208 (8%)

Query: 224 NAYEFELRKDLLELMTCGHKNILQFY-CVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQ 282
           NA E E++  LL+ +   H  I+Q+Y C+   E   L +  + M GGS+ D +     L 
Sbjct: 49  NALECEIQ--LLKNLR--HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALT 104

Query: 283 TKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMG----IVTACKSVG 338
                R    + +G+ +L+ + + +RD+    IL D  GNV LGD G    I T C S G
Sbjct: 105 ENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMS-G 163

Query: 339 EATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAV 398
              +  T    W++PE+I+G+         ++V+S    + EM+T +  +A    + A  
Sbjct: 164 TGIKSVTGTPYWMSPEVISGEGYGRK----ADVWSVACTVVEMLTEKPPWAEYEAMAAIF 219

Query: 399 GIAACGLRPEIPKD----CPQILKSLMI 422
            IA    +P +P      C   LK + +
Sbjct: 220 KIATQPTKPMLPDGVSDACRDFLKQIFV 247

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 75.6 bits (186), Expect = 3e-15
 Identities = 73/297 (24%), Positives = 129/297 (43%), Gaps = 55/297 (18%)

Query: 190 DNLEFIDQIGPNSFKGVYKGKR-----------VGIEKLK-GCDKGNAYEFELRKDLLEL 237
           +N+E++  IG  +F  V++ +            V ++ LK         +F+    L+  
Sbjct: 5   NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 64

Query: 238 MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLI---------------LKSRK-- 280
               H NI++   VC      +C++ + M  G +N+ +                 +RK  
Sbjct: 65  FD--HPNIVKLLGVCA-VGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCG 121

Query: 281 -----LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK 335
                L   E + IA  VA G+ +L++    +RDL ++  L+  +  V + D G+     
Sbjct: 122 LNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 181

Query: 336 SVG--EATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACS 392
           S    +A+E +    RW+ PE I  +      T  S+V+++G+V+WE+ + G   Y   +
Sbjct: 182 SADYYKASENDAIPIRWMPPESIFYN----RYTTESDVWAYGVVLWEIFSYGMQPYYGMA 237

Query: 393 --PVQAAV---GIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR 444
              V   V    + +C      P +CP  L +LM  CW+  PS RP F+ I  +L R
Sbjct: 238 HEEVIYYVRDGNVLSC------PDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 75.3 bits (185), Expect = 4e-15
 Identities = 59/225 (26%), Positives = 105/225 (46%), Gaps = 34/225 (15%)

Query: 244 NILQFYCVCVDENHGLCVVTKLMEGGSVNDLILK-----------SRKLQTKEIIRIAID 292
           NI++   VC+  +  LC++T+ ME G +N  + +              +    +I +A  
Sbjct: 80  NIIRLLAVCITSD-PLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQ 138

Query: 293 VAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----- 347
           +A G+K+L+     +RDL ++  L+ ++  + + D G+    +++     Y   G     
Sbjct: 139 IASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGM---SRNLYSGDYYRIQGRAVLP 195

Query: 348 YRWLAPE-IIAGDPESVSETWMSNVYSFGMVIWEMVT--GEAAYAACSPVQAAVGIAAC- 403
            RW++ E I+ G       T  S+V++FG+ +WE++T   E  Y+  S  Q         
Sbjct: 196 IRWMSWESILLG-----KFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFF 250

Query: 404 ---GLRPEIPKD--CPQILKSLMIKCWNNSPSKRPQFSEIISLLL 443
              G +  +PK   CP  L  LM+ CW  +  +RP F EI + LL
Sbjct: 251 RDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 75.0 bits (184), Expect = 5e-15
 Identities = 76/292 (26%), Positives = 133/292 (45%), Gaps = 50/292 (17%)

Query: 187 LNSDNLEFIDQIGPNSFKGVYKGK--------RVGIEKLKGCDKGNAYEFELRKDLLELM 238
           L  ++++F D IG  +F  V K +           I+++K     + +  +   +L  L 
Sbjct: 4   LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHR-DFAGELEVLC 62

Query: 239 TCG-HKNILQFYCVCVDENHG-LCVVTKLMEGGSVNDLILKSRKLQT------------- 283
             G H NI+     C  E+ G L +  +    G++ D + KSR L+T             
Sbjct: 63  KLGHHPNIINLLGAC--EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 120

Query: 284 ---KEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGI-----VTACK 335
              ++++  A DVA G+ +L+     +RDL ++ IL+  +    + D G+     V   K
Sbjct: 121 LSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK 180

Query: 336 SVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAA--CS 392
           ++G          RW+A E +     SV  T  S+V+S+G+++WE+V+ G   Y    C+
Sbjct: 181 TMGRLP------VRWMAIESLN---YSVYTT-NSDVWSYGVLLWEIVSLGGTPYCGMTCA 230

Query: 393 PVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR 444
            +   +     G R E P +C   +  LM +CW   P +RP F++I+  L R
Sbjct: 231 ELYEKLPQ---GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 279

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 74.3 bits (182), Expect = 7e-15
 Identities = 63/223 (28%), Positives = 104/223 (46%), Gaps = 27/223 (12%)

Query: 227 EFELRKDLLELMTCGHKNILQFY-CVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKE 285
           E +L K+LL      H+ I+Q+Y C+       L +  + M GGS+ D  LKS    T+ 
Sbjct: 54  EIQLLKNLL------HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQ-LKSYGALTEN 106

Query: 286 IIR-IAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMG----IVTACKSVGEA 340
           + R     + EG+ +L+ + + +RD+    IL D  GNV LGD G    + T C S G  
Sbjct: 107 VTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLS-GTG 165

Query: 341 TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGI 400
            +  T    W++PE+I+G+         ++++S G  + EM+T +  +A    + A   I
Sbjct: 166 MKSVTGTPYWMSPEVISGEGYGRK----ADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKI 221

Query: 401 AACGLRPEIPKD----CPQILKSLMIKCWNNSPSKRPQFSEII 439
           A     P +P      C   LK + ++        RP   E++
Sbjct: 222 ATQPTNPVLPPHVSDHCRDFLKRIFVEA-----KLRPSADELL 259

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 74.4 bits (183), Expect = 7e-15
 Identities = 56/240 (23%), Positives = 104/240 (43%), Gaps = 21/240 (8%)

Query: 209 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHG-LCVVTKLME 267
              +   K    D     + ++ ++L    +C    I+++Y   +DE+   + +  +  E
Sbjct: 25  TGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCE 84

Query: 268 GGSVNDLI--LKSRKLQTKE--IIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 323
           GGS++ +   +K R  +  E  + +IA  V +G+ +L+   + +RD+    ILL R G V
Sbjct: 85  GGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQV 144

Query: 324 CLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT 383
            L D G+     +    T   T  Y  +APE I G P S++    S+V+S G+ + E+  
Sbjct: 145 KLCDFGVSGELVNSLAGTFTGTSFY--MAPERIQGKPYSIT----SDVWSLGLTLLEVAQ 198

Query: 384 GEAAY-AACSPVQAAVGIAACGLRPEIP--KDCPQI-------LKSLMIKCWNNSPSKRP 433
               +     P    + + +  +    P  KD P          K  + +C    P++RP
Sbjct: 199 NRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRP 258

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 74.3 bits (182), Expect = 7e-15
 Identities = 54/193 (27%), Positives = 98/193 (50%), Gaps = 14/193 (7%)

Query: 207 YKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYC--VCVDENHGLCVVTK 264
           + GK+V ++K+    K    E  L  +++ +    H+N++  Y   +  DE   L VV +
Sbjct: 45  HTGKQVAVKKMD-LRKQQRREL-LFNEVVIMRDYHHENVVDMYNSYLVGDE---LWVVME 99

Query: 265 LMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVC 324
            +EGG++ D++  +R +  ++I  + + V   + +L++ GV +RD+ S  ILL   G + 
Sbjct: 100 FLEGGALTDIVTHTR-MNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIK 158

Query: 325 LGDMGIVT-ACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT 383
           L D G      K V +        Y W+APE+I+  P         +++S G+++ EM+ 
Sbjct: 159 LSDFGFCAQVSKEVPKRKSLVGTPY-WMAPEVISRLPYGTE----VDIWSLGIMVIEMID 213

Query: 384 GEAAYAACSPVQA 396
           GE  Y    P+QA
Sbjct: 214 GEPPYFNEPPLQA 226

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 74.3 bits (182), Expect = 1e-14
 Identities = 62/270 (22%), Positives = 123/270 (45%), Gaps = 26/270 (9%)

Query: 186 LLNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLL 235
           +L     + I  +G  +F  VYKG            V I++L+      A + E+  +  
Sbjct: 3   ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EILDEAY 61

Query: 236 ELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVA 294
            + +  + ++ +   +C+     L  +T+LM  G + D + + +  + ++ ++   + +A
Sbjct: 62  VMASVDNPHVCRLLGICLTSTVQL--ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 119

Query: 295 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRW 350
           +G+ +L +  + +RDL ++ +L+    +V + D G+     +  +  EY  +G     +W
Sbjct: 120 KGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA--DEKEYHAEGGKVPIKW 177

Query: 351 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEI 409
           +A E I         T  S+V+S+G+ +WE++T G   Y    P      I   G R   
Sbjct: 178 MALESI----LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQ 232

Query: 410 PKDCPQILKSLMIKCWNNSPSKRPQFSEII 439
           P  C   +  +M+KCW      RP+F E+I
Sbjct: 233 PPICTIDVYMIMVKCWMIDADSRPKFRELI 262

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 73.2 bits (179), Expect = 1e-14
 Identities = 69/271 (25%), Positives = 123/271 (45%), Gaps = 27/271 (9%)

Query: 185 WLLNSDNLEFIDQIGPNSFKGVYKGK-----RVGIEKLK-GCDKGNAY--EFELRKDLLE 236
           W +  ++L    ++G   F  V+ G      +V I+ LK G     A+  E ++ K L  
Sbjct: 1   WEIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLR- 59

Query: 237 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVA 294
                H  ++  Y V  +E   + +VT+ M  GS+ D + +   + L+  +++ +A  +A
Sbjct: 60  -----HDKLVPLYAVVSEEP--IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIA 112

Query: 295 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY--RWLA 352
           +G+ ++      +RDL +  IL+  +    + D G+    +   E T  +   +  +W A
Sbjct: 113 DGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIED-NEYTARQGAKFPIKWTA 171

Query: 353 PEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPK 411
           PE       ++     S+V+SFG+++ E+VT G   Y      +    +   G R   P+
Sbjct: 172 PEAALYGRFTIK----SDVWSFGILLTELVTKGRVPYPGMVNREVLEQVER-GYRMPCPQ 226

Query: 412 DCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
            CP+ L  LM  CW   P +RP F  I S L
Sbjct: 227 GCPESLHELMKLCWKKDPDERPTFEYIQSFL 257

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 73.9 bits (181), Expect = 1e-14
 Identities = 50/157 (31%), Positives = 84/157 (53%), Gaps = 10/157 (6%)

Query: 242 HKNILQFY-CVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL 300
           H+N+++ Y    V E   L V+ + ++GG++ D++ ++R L  ++I  +   V + + +L
Sbjct: 77  HQNVVEMYKSYLVGEE--LWVLMEFLQGGALTDIVSQTR-LNEEQIATVCESVLQALCYL 133

Query: 301 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTA-CKSVGEATEYETDGYRWLAPEIIAGD 359
           +  GV +RD+ S  ILL   G V L D G      K V +        Y W+APE+I+  
Sbjct: 134 HSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPY-WMAPEVISRT 192

Query: 360 PESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQA 396
           P         +++S G+++ EMV GE  Y + SPVQA
Sbjct: 193 PYGTE----VDIWSLGIMVIEMVDGEPPYFSDSPVQA 225

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 73.2 bits (179), Expect = 1e-14
 Identities = 68/271 (25%), Positives = 123/271 (45%), Gaps = 27/271 (9%)

Query: 185 WLLNSDNLEFIDQIGPNSFKGVYKGK-----RVGIEKLK-GCDKGNAY--EFELRKDLLE 236
           W +  ++L    ++G   F  V+ G      RV I+ LK G     A+  E ++ K L  
Sbjct: 1   WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLR- 59

Query: 237 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL--KSRKLQTKEIIRIAIDVA 294
                H+ ++Q Y V  +E   + +VT+ M  GS+ D +     + L+  +++ +A  +A
Sbjct: 60  -----HEKLVQLYAVVSEEP--IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIA 112

Query: 295 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY--RWLA 352
            G+ ++      +RDL +  IL+  +    + D G+    +   E T  +   +  +W A
Sbjct: 113 SGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKWTA 171

Query: 353 PEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPK 411
           PE       ++     S+V+SFG+++ E+ T G   Y      +    +   G R   P 
Sbjct: 172 PEAALYGRFTIK----SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER-GYRMPCPP 226

Query: 412 DCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
           +CP+ L  LM +CW   P +RP F  + + L
Sbjct: 227 ECPESLHDLMCQCWRKEPEERPTFEYLQAFL 257

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 72.8 bits (178), Expect = 2e-14
 Identities = 61/220 (27%), Positives = 101/220 (45%), Gaps = 19/220 (8%)

Query: 227 EFELRKDLLELMTCGHKNILQFY-CVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKE 285
           E +L K+L       H+ I+Q+Y C+       L +  + M GGSV D  LK+    T+ 
Sbjct: 54  EIQLLKNL------QHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQ-LKAYGALTES 106

Query: 286 IIR-IAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMG----IVTACKSVGEA 340
           + R     + EG+ +L+ + + +RD+    IL D  GNV LGD G    + T C S G  
Sbjct: 107 VTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMS-GTG 165

Query: 341 TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGI 400
               T    W++PE+I+G+         ++V+S G  + EM+T +  +A    + A   I
Sbjct: 166 IRSVTGTPYWMSPEVISGEGYGRK----ADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKI 221

Query: 401 AACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIIS 440
           A     P++P    +  +   + C       RP   E++ 
Sbjct: 222 ATQPTNPQLPSHISEHARDF-LGCIFVEARHRPSAEELLR 260

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 72.6 bits (179), Expect = 2e-14
 Identities = 69/272 (25%), Positives = 110/272 (40%), Gaps = 61/272 (22%)

Query: 198 IGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV 251
           IG  SF  VYK       + V I K+   ++      ++++++  L  C    I ++Y  
Sbjct: 9   IGKGSFGEVYKAIDKRTNQVVAI-KVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYG- 66

Query: 252 CVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLN 311
              +   L ++ +   GGS  DL LK  KL    I  I  +V  G+++L++ G  +RD+ 
Sbjct: 67  SFLKGSKLWIIMEYCGGGSCLDL-LKPGKLDETYIAFILREVLLGLEYLHEEGKIHRDIK 125

Query: 312 SQRILLDRHGNVCLGDMGIV-----TACKS---VGEATEYETDGYRWLAPEIIAGDPESV 363
           +  ILL   G+V L D G+      T  K    VG  T +      W+APE+I       
Sbjct: 126 AANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVG--TPF------WMAPEVI------- 170

Query: 364 SETWMSNVYSFGMVIW-------EMVTGEAAYAACSPVQAAVGIAACGLRPEIPK-DCPQ 415
                 + Y     IW       E+  GE   +   P++         L   IPK + P 
Sbjct: 171 ----KQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRV--------LF-LIPKNNPPS 217

Query: 416 I--------LKSLMIKCWNNSPSKRPQFSEII 439
           +         K  +  C N  P +RP   E++
Sbjct: 218 LEGNKFSKPFKDFVSLCLNKDPKERPSAKELL 249

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 72.7 bits (179), Expect = 2e-14
 Identities = 55/216 (25%), Positives = 99/216 (45%), Gaps = 28/216 (12%)

Query: 190 DNLEFIDQIGPNSFKGVYKGKRVGIE-----KLKGCDKGNAYEFELRKDLLELMTCGHKN 244
           D+LE++ ++G  +   V K            K    +   A + ++ ++L  L  C    
Sbjct: 1   DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPY 60

Query: 245 ILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEII--RIAIDVAEGIKFL-N 301
           I+ FY    +    + +  + M+GGS+ D ILK  + +  E I  +IA+ V +G+ +L  
Sbjct: 61  IVGFYGAFYNNGD-ISICMEYMDGGSL-DKILKEVQGRIPERILGKIAVAVLKGLTYLHE 118

Query: 302 DHGVAYRDLNSQRILLDRHGNVCLGDMGIVT------ACKSVGEATEYETDGYRWLAPEI 355
            H + +RD+    IL++  G + L D G+        A   VG ++        ++APE 
Sbjct: 119 KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFVGTSS--------YMAPER 170

Query: 356 IAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAAC 391
           I G+  SV     S+++S G+ + E+ TG   Y   
Sbjct: 171 IQGNDYSVK----SDIWSLGLSLIELATGRFPYPPE 202

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 72.7 bits (178), Expect = 2e-14
 Identities = 57/221 (25%), Positives = 106/221 (47%), Gaps = 13/221 (5%)

Query: 229 ELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEII 287
           E+   +L + +  H  I++   +C      L +VT+L   GS+ D + + R  L  + ++
Sbjct: 55  EITDHMLAMGSLDHAYIVRLLGIC--PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLL 112

Query: 288 RIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA---TEYE 344
              + +A+G+ +L +H + +R+L ++ ILL     V + D G+        +    +E++
Sbjct: 113 NWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHK 172

Query: 345 TDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAAC 403
           T   +W+A E I         T  S+V+S+G+ +WEM++ G   YA   P      +   
Sbjct: 173 TP-IKWMALESILFG----RYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP-HEVPDLLEK 226

Query: 404 GLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR 444
           G R   P+ C   +  +M+KCW    + RP F E+ +   R
Sbjct: 227 GERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTR 267

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 72.2 bits (177), Expect = 2e-14
 Identities = 55/203 (27%), Positives = 102/203 (50%), Gaps = 12/203 (5%)

Query: 242 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK--LQTKEIIRIAIDVAEGIKF 299
           H NI+++Y   +++   L +V +   GG++ + I K     L    I+   + +   +  
Sbjct: 58  HPNIIEYYENFLEDK-ALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHH 116

Query: 300 LNDHGVAYRDLNSQRILLDRHGNVC-LGDMGIVTACKSVGEA-TEYETDGYRWLAPEIIA 357
           ++   + +RDL +Q ILLD+H  V  +GD GI     S  +A T   T  Y  ++PE+  
Sbjct: 117 VHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCY--ISPELCE 174

Query: 358 GDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQIL 417
           G P +      S++++ G V++E+ + + A+ A +     + I +    P   +  P  L
Sbjct: 175 GKPYNQK----SDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPD-L 229

Query: 418 KSLMIKCWNNSPSKRPQFSEIIS 440
           + L++   N  PSKRPQ S+I++
Sbjct: 230 RQLILSMLNLDPSKRPQLSQIMA 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 72.7 bits (178), Expect = 3e-14
 Identities = 56/203 (27%), Positives = 98/203 (48%), Gaps = 15/203 (7%)

Query: 242 HKNILQFY--CVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKF 299
           H+N+++ Y   +  DE   L VV + +EGG++ D++  +R +  ++I  + + V + +  
Sbjct: 76  HENVVEMYNSYLVGDE---LWVVMEFLEGGALTDIVTHTR-MNEEQIAAVCLAVLKALSV 131

Query: 300 LNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVT-ACKSVGEATEYETDGYRWLAPEIIAG 358
           L+  GV +RD+ S  ILL   G V L D G      K V          Y W+APE+I+ 
Sbjct: 132 LHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPY-WMAPELISR 190

Query: 359 DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIP--KDCPQI 416
            P         +++S G+++ EMV GE  Y    P++A   I    L P++         
Sbjct: 191 LPYGPE----VDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD-NLPPKLKNLHKVSPS 245

Query: 417 LKSLMIKCWNNSPSKRPQFSEII 439
           LK  + +     P++R   +E++
Sbjct: 246 LKGFLDRLLVRDPAQRATAAELL 268

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 71.5 bits (176), Expect = 6e-14
 Identities = 60/256 (23%), Positives = 111/256 (43%), Gaps = 20/256 (7%)

Query: 190 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHK 243
            +LE +  +G  S   VYK      GK   ++K+        +  +L ++L  L +C   
Sbjct: 1   SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEE-FRKQLLRELKTLRSCESP 59

Query: 244 NILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL-ND 302
            +++ Y     +   + +V + M+GGS+ DL+ K  K+    +  IA  + +G+ +L   
Sbjct: 60  YVVKCYGA-FYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTK 118

Query: 303 HGVAYRDLNSQRILLDRHGNVCLGDMGI--VTACKSVGEATEYETDGYRWLAPEIIAGDP 360
             + +RD+    +L++  G V + D GI  V         T   T  Y  ++PE I G+ 
Sbjct: 119 RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTY--MSPERIQGES 176

Query: 361 ESVSETWMSNVYSFGMVIWEMVTGEAAY-AACSPVQAAVGIAAC-GLRPEIPKD-CPQIL 417
            S +    ++++S G+ + E   G+  +     P    +  A C G  P +P +      
Sbjct: 177 YSYA----ADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEF 232

Query: 418 KSLMIKCWNNSPSKRP 433
           +  +  C    P KRP
Sbjct: 233 RDFISACLQKDPKKRP 248

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 71.1 bits (175), Expect = 7e-14
 Identities = 59/267 (22%), Positives = 116/267 (43%), Gaps = 39/267 (14%)

Query: 193 EFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNIL 246
           + ++++G  S+  VYK      G+ V I+ +           E+ K++  L  C    I+
Sbjct: 6   DILEKLGEGSYGSVYKAIHKETGQVVAIKVVPV----EEDLQEIIKEISILKQCDSPYIV 61

Query: 247 QFY-CVCVDENHGLCVVTKLMEGGSVNDLI-LKSRKLQTKEIIRIAIDVAEGIKFLNDHG 304
           ++Y     + +  L +V +    GSV+D++ + ++ L  +EI  I     +G+++L+ + 
Sbjct: 62  KYYGSYFKNTD--LWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK 119

Query: 305 VAYRDLNSQRILLDRHGNVCLGDMGIVT------ACKSVGEATEYETDGYRWLAPEIIAG 358
             +RD+ +  ILL+  G   L D G+        A ++    T +      W+APE+I  
Sbjct: 120 KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPF------WMAPEVIQE 173

Query: 359 DP-ESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP----EIPKDC 413
               + ++ W     S G+   EM  G+  Y+   P++A   I     +P      P+  
Sbjct: 174 IGYNNKADIW-----SLGITAIEMAEGKPPYSDIHPMRA---IFMIPNKPPPTLSDPEKW 225

Query: 414 PQILKSLMIKCWNNSPSKRPQFSEIIS 440
                  + KC    P +RP   +++ 
Sbjct: 226 SPEFNDFVKKCLVKDPEERPSAIQLLQ 252

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 71.5 bits (175), Expect = 9e-14
 Identities = 54/203 (26%), Positives = 86/203 (42%), Gaps = 23/203 (11%)

Query: 238 MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGI 297
           +   H  + Q YC C      L  V + + GG +   I KSR+         A ++   +
Sbjct: 51  LARNHPFLTQLYC-CFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSAL 109

Query: 298 KFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTA--CKSVGEATEYETDGYRWLAPEI 355
            FL+D G+ YRDL    +LLD  G+  L D G+           +T   T  Y  +APEI
Sbjct: 110 MFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDY--IAPEI 167

Query: 356 IAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEI------ 409
           +       S  W    ++ G++++EM+ G A + A    +    +    L  E+      
Sbjct: 168 LQEMLYGPSVDW----WAMGVLLYEMLCGHAPFEA----ENEDDLFEAILNDEVVYPTWL 219

Query: 410 PKDCPQILKSLMIKCWNNSPSKR 432
            +D   ILK+ M K    +P+ R
Sbjct: 220 SQDAVDILKAFMTK----NPTMR 238

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 71.6 bits (176), Expect = 1e-13
 Identities = 40/152 (26%), Positives = 74/152 (48%), Gaps = 15/152 (9%)

Query: 242 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 301
           H  + Q +  C      L  V + + GG +   I +S +         A ++  G++FL+
Sbjct: 55  HPFLTQLHS-CFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLH 113

Query: 302 DHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS-----VGEATEYETDGYRWLAPEII 356
           + G+ YRDL    +LLD  G++ + D G+   CK      V  +T   T  Y  +APEI+
Sbjct: 114 ERGIIYRDLKLDNVLLDSEGHIKIADFGM---CKEGILGGVTTSTFCGTPDY--IAPEIL 168

Query: 357 AGDPESVSETWMSNVYSFGMVIWEMVTGEAAY 388
           +  P   +  W    ++ G++++EM+ G++ +
Sbjct: 169 SYQPYGPAVDW----WALGVLLYEMLAGQSPF 196

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 70.9 bits (173), Expect = 1e-13
 Identities = 57/250 (22%), Positives = 115/250 (46%), Gaps = 12/250 (4%)

Query: 195 IDQIGPNSFKGVYKG-----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFY 249
           +++IG  SF  V+KG     ++V   K+   ++      ++++++  L  C    + ++Y
Sbjct: 9   LEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 68

Query: 250 CVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRD 309
              + +   L ++ + + GGS  DL L+   L   +I  I  ++ +G+ +L+     +RD
Sbjct: 69  GSYLKDTK-LWIIMEYLGGGSALDL-LEPGPLDETQIATILREILKGLDYLHSEKKIHRD 126

Query: 310 LNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMS 369
           + +  +LL  HG V L D G+                   W+APE+I    +S  ++  +
Sbjct: 127 IKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIK---QSAYDS-KA 182

Query: 370 NVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSP 429
           +++S G+   E+  GE  ++   P++    I      P +  +  + LK  +  C N  P
Sbjct: 183 DIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNN-PPTLEGNYSKPLKEFVEACLNKEP 241

Query: 430 SKRPQFSEII 439
           S RP   E++
Sbjct: 242 SFRPTAKELL 251

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 71.0 bits (174), Expect = 1e-13
 Identities = 51/194 (26%), Positives = 89/194 (45%), Gaps = 13/194 (6%)

Query: 242 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 301
           H  +   +C    + H L  V + + GG +   I  S +         A ++  G++FL+
Sbjct: 55  HPFLTHLFCTFQTKEH-LFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLH 113

Query: 302 DHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS--VGEATEYETDGY-RWLAPEIIAG 358
             G+ YRDL    +LLD+ G++ + D G+   CK    GE       G   ++APEI+ G
Sbjct: 114 KKGIIYRDLKLDNVLLDKDGHIKIADFGM---CKENMNGEGKASTFCGTPDYIAPEILKG 170

Query: 359 DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILK 418
              + S  W    +SFG++++EM+ G++ +      +    I     RP  P+   +  K
Sbjct: 171 QKYNESVDW----WSFGVLLYEMLIGQSPFHGEDEDELFDSI--LNDRPHFPRWISKEAK 224

Query: 419 SLMIKCWNNSPSKR 432
             + K +   P+KR
Sbjct: 225 DCLSKLFERDPTKR 238

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 70.0 bits (171), Expect = 1e-13
 Identities = 61/244 (25%), Positives = 112/244 (45%), Gaps = 17/244 (6%)

Query: 204 KGVYKGKR----VGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGL 259
           KGVYK ++    V I+ LK  ++ +  + E+ ++   +    +  I++   VC  E   L
Sbjct: 13  KGVYKMRKKQIDVAIKVLKNENEKSVRD-EMMREAEIMHQLDNPYIVRMIGVCEAEA--L 69

Query: 260 CVVTKLMEGGSVND-LILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLD 318
            +V ++  GG +N  L  K  ++    ++ +   V+ G+K+L      +RDL ++ +LL 
Sbjct: 70  MLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLV 129

Query: 319 RHGNVCLGDMGIVTACKSVGEATEYETDG---YRWLAPEIIAGDPESVSETWMSNVYSFG 375
                 + D G+  A  +     +  + G    +W APE I     S      S+V+S+G
Sbjct: 130 NQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSR----SDVWSYG 185

Query: 376 MVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQ 434
           + +WE  + G+  Y      +    I   G R + P +CP  + +LM  CW      RP 
Sbjct: 186 ITMWEAFSYGQKPYKKMKGPEVMSFIEQ-GKRLDCPAECPPEMYALMKDCWIYKWEDRPN 244

Query: 435 FSEI 438
           F+++
Sbjct: 245 FAKV 248

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 69.9 bits (171), Expect = 2e-13
 Identities = 57/262 (21%), Positives = 114/262 (43%), Gaps = 25/262 (9%)

Query: 197 QIGPNSFKGVYKGKRVG------IEKLKGC-----DKGNAYEFELRKDLLELMTCGHKNI 245
           Q+G  +F   Y+ + V       ++++        ++    E  LRK++  +    H +I
Sbjct: 7   QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVE-ALRKEIRLMARLNHPHI 65

Query: 246 LQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGV 305
           ++      +++H   +  + M GGSV+ L+ K    +   II     +  G+ +L+++ +
Sbjct: 66  IRMLGATCEDSH-FNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQI 124

Query: 306 AYRDLNSQRILLDRHGN-VCLGDMG----IVTACKSVGEATEYETDGYRWLAPEIIAGDP 360
            +RD+    +L+D  G  + + D G    +       GE          ++APE++ G+ 
Sbjct: 125 IHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQ 184

Query: 361 ESVSETWMSNVYSFGMVIWEMVTGEAAYAA---CSPVQAAVGIAACGLRPEIPKDCPQIL 417
              S     +V+S G VI EM T +  + A    + +     IA+    P IP+     L
Sbjct: 185 YGRS----CDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGL 240

Query: 418 KSLMIKCWNNSPSKRPQFSEII 439
           + + ++C    P  RP   E++
Sbjct: 241 RDVTLRCLELQPEDRPPSRELL 262

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 69.3 bits (169), Expect = 4e-13
 Identities = 60/258 (23%), Positives = 111/258 (43%), Gaps = 28/258 (10%)

Query: 195 IDQIGPNSFKGVYKG-----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFY 249
           +++IG  SF  VYKG     K V   K+   ++      ++++++  L  C    I ++Y
Sbjct: 9   LERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYY 68

Query: 250 CVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRD 309
              + +   L ++ + + GGS  DL LK   L+   I  I  ++ +G+ +L+     +RD
Sbjct: 69  GSYL-KGTKLWIIMEYLGGGSALDL-LKPGPLEETYIATILREILKGLDYLHSERKIHRD 126

Query: 310 LNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMS 369
           + +  +LL   G+V L D G+                   W+APE+I    +  +  + +
Sbjct: 127 IKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI----KQSAYDFKA 182

Query: 370 NVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQIL--------KSLM 421
           +++S G+   E+  GE   +   P++             IPK+ P  L        K  +
Sbjct: 183 DIWSLGITAIELAKGEPPNSDLHPMRVLF---------LIPKNSPPTLEGQYSKPFKEFV 233

Query: 422 IKCWNNSPSKRPQFSEII 439
             C N  P  RP   E++
Sbjct: 234 EACLNKDPRFRPTAKELL 251

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 69.1 bits (169), Expect = 4e-13
 Identities = 53/225 (23%), Positives = 90/225 (40%), Gaps = 25/225 (11%)

Query: 227 EFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEI 286
           E E  KDL       H NI+Q Y         L +  + + GGS+   +    + + + +
Sbjct: 58  EIETLKDL------DHLNIVQ-YLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLV 110

Query: 287 IRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETD 346
                 V EG+ +L+  G+ +RDL +  +L+D  G   + D GI      +     Y+ D
Sbjct: 111 RFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDI-----YDND 165

Query: 347 GYR-------WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVG 399
                     W+APE+I    +  S     +++S G V+ EM  G   ++    + A   
Sbjct: 166 QNMSMQGSVFWMAPEVIHSYSQGYSAK--VDIWSLGCVVLEMFAGRRPWSDEEAIAAMFK 223

Query: 400 IAACGLRPEIPKDCPQILKS----LMIKCWNNSPSKRPQFSEIIS 440
           +      P IP D    L       +  C+  +P  RP   E++ 
Sbjct: 224 LGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 69.9 bits (171), Expect = 5e-13
 Identities = 50/170 (29%), Positives = 87/170 (51%), Gaps = 17/170 (10%)

Query: 281 LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVC-LGDMGIVTACKSVGE 339
           L T++++  +  VA+G+ FL      +RDL ++ ILL  HG +  + D G+    + +  
Sbjct: 211 LDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLT-HGRITKICDFGLA---RDIRN 266

Query: 340 ATEYETDG-----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSP 393
            + Y   G      +W+APE I      V  T+ S+V+S+G+++WE+ + G + Y    P
Sbjct: 267 DSNYVVKGNARLPVKWMAPESIF---NCVY-TFESDVWSYGILLWEIFSLGSSPYPGM-P 321

Query: 394 VQAAV-GIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
           V +    +   G R   P+  P  +  +M  CW+  P KRP F +I+ L+
Sbjct: 322 VDSKFYKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLI 371

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 68.7 bits (168), Expect = 6e-13
 Identities = 58/228 (25%), Positives = 105/228 (46%), Gaps = 37/228 (16%)

Query: 229 ELRKDLLE----LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTK 284
            +RK +L     +  C    I+ FY   ++EN+ +C+  + M+ GS++ +  K   +  +
Sbjct: 45  SVRKQILRELQIMHECRSPYIVSFYGAFLNENN-ICMCMEFMDCGSLDRIYKKGGPIPVE 103

Query: 285 EIIRIAIDVAEGIKFL-NDHGVAYRDLNSQRILLDRHGNVCLGDMGI------VTACKSV 337
            + +IA+ V EG+ +L N H + +RD+    IL++  G + L D G+        A   V
Sbjct: 104 ILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFV 163

Query: 338 GEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAA 397
           G +T        +++PE I G   +V     S+V+S G+ I E+  G+  +A  S +   
Sbjct: 164 GTST--------YMSPERIQGGKYTVK----SDVWSLGISIIELALGKFPFAF-SNIDDD 210

Query: 398 VGIAACGL-----------RPEIPK-DCPQILKSLMIKCWNNSPSKRP 433
                 G+            P +P  D P+ L+  +  C    P++RP
Sbjct: 211 GQDDPMGILDLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERP 258

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 68.4 bits (167), Expect = 7e-13
 Identities = 43/133 (32%), Positives = 67/133 (50%), Gaps = 9/133 (6%)

Query: 259 LCVVTKLMEGGSVNDLI--LKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRIL 316
           LC+V  LM GG +   I  +  R L+ + +I  +  +  GI  L+   + YRD+  + +L
Sbjct: 68  LCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVL 127

Query: 317 LDRHGNVCLGDMGIVTACKSVGEATEYE-TDGYRWLAPEIIAGDPESVSETWMSNVYSFG 375
           LD  GN  L D+G+    K     T+   T+GY  +APEI+  +P S    W    ++ G
Sbjct: 128 LDDQGNCRLSDLGLAVELKDGKTITQRAGTNGY--MAPEILKEEPYSYPVDW----FAMG 181

Query: 376 MVIWEMVTGEAAY 388
             I+EMV G   +
Sbjct: 182 CSIYEMVAGRTPF 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 68.1 bits (167), Expect = 1e-12
 Identities = 70/286 (24%), Positives = 122/286 (42%), Gaps = 53/286 (18%)

Query: 189 SDNLEFIDQIGPNSFKGVYKGKR--------VGIEKLKGCDKGN-AYEFELRKDLLELMT 239
           +   E ++ IG  ++  VYK +         + I  +   ++     E+ + +       
Sbjct: 5   TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKY----- 59

Query: 240 CGHKNILQFYCVCVDENHG-----LCVVTKLMEGGSVNDLILKSRKL--QTKE--IIRIA 290
             H NI  FY   + +N       L +V +L  GGSV DL+   RK   + KE  I  I 
Sbjct: 60  SNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYIL 119

Query: 291 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY-- 348
            +   G+ +L+++ V +RD+  Q ILL ++  V L D G+     S    T    + +  
Sbjct: 120 RETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDS----TLGRRNTFIG 175

Query: 349 --RWLAPEIIAGDPESVSETW--MSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG 404
              W+APE+IA D E    ++   S+V+S G+   E+  G+       P++A        
Sbjct: 176 TPYWMAPEVIACD-EQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALF------ 228

Query: 405 LRPEIPKDCPQILKS----------LMIKCWNNSPSKRPQFSEIIS 440
              +IP++ P  LKS           + +C   +  +RP   E++ 
Sbjct: 229 ---KIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 67.5 bits (165), Expect = 1e-12
 Identities = 49/206 (23%), Positives = 95/206 (46%), Gaps = 12/206 (5%)

Query: 242 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKE--IIRIAIDVAEGIKF 299
           H NI+ +Y   +D+N  L +  +   GG++ D I++ +    +E  ++     +   + +
Sbjct: 58  HPNIIAYYNHFMDDN-TLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSY 116

Query: 300 LNDHGVAYRDLNSQRILLDRHGNVCLGDMGI--VTACKSVGEATEYETDGYRWLAPEIIA 357
           ++  G+ +RD+ +  I L + G + LGD GI  +   +     T   T  Y  ++PE+  
Sbjct: 117 IHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYY--MSPELCQ 174

Query: 358 GDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQIL 417
           G    V   + S++++ G V++E++T +  + A +P+   V I      P         L
Sbjct: 175 G----VKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPV-VSVYSSEL 229

Query: 418 KSLMIKCWNNSPSKRPQFSEIISLLL 443
            SL+       P KRP   E++   L
Sbjct: 230 ISLVHSLLQQDPEKRPTADEVLDQPL 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 66.8 bits (163), Expect = 2e-12
 Identities = 53/204 (25%), Positives = 87/204 (42%), Gaps = 19/204 (9%)

Query: 198 IGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQF----YCVCV 253
           +G   F  V   +     K+  C K +    + RK   E M    K IL+     + V +
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKG--EQMALNEKKILEKVSSRFIVSL 58

Query: 254 ----DENHGLCVVTKLMEGGSVNDLI--LKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAY 307
               +    LC+V  LM GG +   I  +          I  A  +  G++ L+   + Y
Sbjct: 59  AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVY 118

Query: 308 RDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE-TDGYRWLAPEIIAGDPESVSET 366
           RDL  + +LLD HGNV + D+G+    K   +      T GY  +APE++ G+    S  
Sbjct: 119 RDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGY--MAPEVLQGEVYDFSVD 176

Query: 367 WMSNVYSFGMVIWEMVTGEAAYAA 390
           W    ++ G  ++EM+ G + +  
Sbjct: 177 W----FALGCTLYEMIAGRSPFRQ 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 66.7 bits (163), Expect = 3e-12
 Identities = 64/257 (24%), Positives = 115/257 (44%), Gaps = 30/257 (11%)

Query: 201 NSFKGVYKGKR-----VGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDE 255
           + ++GVY         V ++  K C   +  E  L++  + +    H +I++   V  + 
Sbjct: 21  DVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYI-MRQFDHPHIVKLIGVITEN 79

Query: 256 NHGLCVVTKLMEGGSVNDL--ILKSRK--LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLN 311
                 V  +ME   + +L   L+  K  L    +I  +  ++  + +L      +RD+ 
Sbjct: 80  P-----VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIA 134

Query: 312 SQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR----WLAPEIIAGDP-ESVSET 366
           ++ +L+     V LGD G+    + + + + Y+    +    W+APE I      S S+ 
Sbjct: 135 ARNVLVSSPDCVKLGDFGL---SRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDV 191

Query: 367 WMSNVYSFGMVIWE-MVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCW 425
           WM     FG+ +WE ++ G   +         +G    G R  +P +CP  L SLM KCW
Sbjct: 192 WM-----FGVCMWEILMLGVKPFQGV-KNNDVIGRIENGERLPMPPNCPPTLYSLMTKCW 245

Query: 426 NNSPSKRPQFSEIISLL 442
              PSKRP+F+E+ + L
Sbjct: 246 AYDPSKRPRFTELKAQL 262

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 66.1 bits (162), Expect = 3e-12
 Identities = 78/280 (27%), Positives = 116/280 (41%), Gaps = 47/280 (16%)

Query: 193 EFIDQIGPNSFKGVYKGKRVGIEKL---KGCDKGNAYEFELRKDLL--------ELMTCG 241
           E ++ IG  SF  V K +R    K+   K  D GN  E E  K  L        EL    
Sbjct: 3   EVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKE--KQQLVSEVNILRELK--- 57

Query: 242 HKNILQFYCVCVD-ENHGLCVVTKLMEGGSVNDLILKSRK----LQTKEIIRIAIDVAEG 296
           H NI+++Y   +D  N  L +V +  EGG +  LI K +K    ++ + I RI   +   
Sbjct: 58  HPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLA 117

Query: 297 IK-----FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGI--------VTACKSVGEATEY 343
           +          + V +RDL    I LD + NV LGD G+          A   VG  T Y
Sbjct: 118 LYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVG--TPY 175

Query: 344 ETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAAC 403
                 +++PE +            S+++S G +I+E+      + A + +Q A  I   
Sbjct: 176 ------YMSPEQLNHMSYDEK----SDIWSLGCLIYELCALSPPFTARNQLQLASKIKE- 224

Query: 404 GLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLL 443
           G    IP      L  ++    N  P KRP   E++ L L
Sbjct: 225 GKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPL 264

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 66.1 bits (161), Expect = 3e-12
 Identities = 66/263 (25%), Positives = 119/263 (45%), Gaps = 25/263 (9%)

Query: 191 NLEFIDQIGPNSFKGVY--KGK---------RVGIEKLKGCDKGNAYEFELRKDLLELMT 239
             E I +IG  SF  +Y  K K          + + K+   +K  +     +K+++ L  
Sbjct: 1   RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEAS-----KKEVILLAK 55

Query: 240 CGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKE--IIRIAIDVAEGI 297
             H NI+ F+     EN  L +V +  +GG +   I + R +   E  I+   + ++ G+
Sbjct: 56  MKHPNIVTFFA-SFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGL 114

Query: 298 KFLNDHGVAYRDLNSQRILLDRHGNVC-LGDMGIVTACKSVGEATEYETDGYRWLAPEII 356
           K ++D  + +RD+ SQ I L ++G V  LGD GI        E          +L+PEI 
Sbjct: 115 KHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEIC 174

Query: 357 AGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQI 416
              P +      ++++S G V++E+ T +  +   +  Q  + I      P I  +  + 
Sbjct: 175 QNRPYNNK----TDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAP-ISPNFSRD 229

Query: 417 LKSLMIKCWNNSPSKRPQFSEII 439
           L+SL+ + +  SP  RP  + I+
Sbjct: 230 LRSLISQLFKVSPRDRPSITSIL 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 66.9 bits (163), Expect = 3e-12
 Identities = 46/168 (27%), Positives = 83/168 (49%), Gaps = 13/168 (7%)

Query: 281 LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA 340
           L  +++I  +  VA G++FL      +RDL ++ ILL  +  V + D G+    + + + 
Sbjct: 171 LTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLA---RDIYKD 227

Query: 341 TEYETDG-----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPV 394
            +Y   G      +W+APE I    + V  T  S+V+SFG+++WE+ + G + Y      
Sbjct: 228 PDYVRKGSARLPLKWMAPESIF---DKVYTT-QSDVWSFGVLLWEIFSLGASPYPGVQIN 283

Query: 395 QAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
           +        G R   P++    +  +M+ CW   P +RP FS ++ +L
Sbjct: 284 EEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALVEIL 331

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 66.6 bits (162), Expect = 3e-12
 Identities = 57/230 (24%), Positives = 101/230 (43%), Gaps = 23/230 (10%)

Query: 189 SDNLEFIDQIGPNSFKGVYK--GKRVG-------IEKLKGCDKGNAYEFELRKDLLELMT 239
           +D  E I+ IG  ++  VYK   K+ G       ++ +   D+    E E   ++L+ + 
Sbjct: 21  TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDE----EIEAEYNILQSLP 76

Query: 240 CGHKNILQFYCVCVDENH----GLCVVTKLMEGGSVNDLI----LKSRKLQTKEIIRIAI 291
             H N+++FY +    +      L +V +L  GGSV +L+    +  ++L    I  I  
Sbjct: 77  -NHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILY 135

Query: 292 DVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWL 351
               G++ L+++ + +RD+    ILL   G V L D G+     S             W+
Sbjct: 136 GALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWM 195

Query: 352 APEIIAGDPE-SVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGI 400
           APE+IA + +   S     +V+S G+   E+  G+       PV+    I
Sbjct: 196 APEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKI 245

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 66.1 bits (161), Expect = 4e-12
 Identities = 49/222 (22%), Positives = 99/222 (44%), Gaps = 20/222 (9%)

Query: 229 ELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLME---GGSVNDLILKSRKLQTKE 285
           +L++++  L +  H NI+Q+   C+D+      ++  ME   GGS++ ++ +   L    
Sbjct: 48  KLQEEVDLLKSLKHVNIVQYLGTCLDD----NTISIFMEFVPGGSISSILNRFGPLPEPV 103

Query: 286 IIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYET 345
             +    + +G+ +L+++ V +RD+    ++L  +G + L D G       VG      +
Sbjct: 104 FCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG-LHGTHS 162

Query: 346 DGYR-------WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAV 398
           +  +       W+APE+I            S+++S G  ++EM TG+   A+   + A  
Sbjct: 163 NMLKSMHGTPYWMAPEVI----NESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMF 218

Query: 399 GIAA-CGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEII 439
            I A  GL P +P          +  C      +RP   +++
Sbjct: 219 YIGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLL 260

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 66.6 bits (162), Expect = 5e-12
 Identities = 46/168 (27%), Positives = 82/168 (48%), Gaps = 13/168 (7%)

Query: 281 LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA 340
           L  +++I  +  VA+G++FL      +RDL ++ ILL  +  V + D G+    + + + 
Sbjct: 176 LTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLA---RDIYKD 232

Query: 341 TEYETDG-----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPV 394
            +Y   G      +W+APE I     ++     S+V+SFG+++WE+ + G + Y      
Sbjct: 233 PDYVRKGDARLPLKWMAPETIFDRVYTIQ----SDVWSFGVLLWEIFSLGASPYPGVKID 288

Query: 395 QAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
           +        G R   P      +   M+ CW+  PS+RP FSE++  L
Sbjct: 289 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 336

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 65.3 bits (159), Expect = 9e-12
 Identities = 59/212 (27%), Positives = 100/212 (47%), Gaps = 33/212 (15%)

Query: 242 HKNILQF---YCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIK 298
           H NI+ +   Y V  DE   L VV + + GGS+ D++ ++  +   +I  +  +  + ++
Sbjct: 75  HPNIVNYLDSYLVG-DE---LWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALE 129

Query: 299 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC------KSVGEATEYETDGYRWLA 352
           FL+ + V +RD+ S  ILL   G+V L D G           +S    T Y      W+A
Sbjct: 130 FLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPY------WMA 183

Query: 353 PEII---AGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEI 409
           PE++   A  P+        +++S G++  EMV GE  Y   +P++A   IA  G  PE+
Sbjct: 184 PEVVTRKAYGPK-------VDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG-TPEL 235

Query: 410 --PKDCPQILKSLMIKCWNNSPSKRPQFSEII 439
             P+    I +  + +C      KR    E++
Sbjct: 236 QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELL 267

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 65.1 bits (158), Expect = 9e-12
 Identities = 54/250 (21%), Positives = 113/250 (45%), Gaps = 12/250 (4%)

Query: 195 IDQIGPNSFKGVYKG---KRVGIEKLKGCDKGNAYEF--ELRKDLLELMTCGHKNILQFY 249
           +++IG  SF  V+KG   +   +  +K  D   A +   ++++++  L  C    + ++Y
Sbjct: 9   LERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 68

Query: 250 CVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRD 309
              + +   L ++ + + GGS  DL L++      +I  +  ++ +G+ +L+     +RD
Sbjct: 69  GSYL-KGTKLWIIMEYLGGGSALDL-LRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRD 126

Query: 310 LNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMS 369
           + +  +LL   G+V L D G+                   W+APE+I    +S  ++  +
Sbjct: 127 IKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQ---QSAYDS-KA 182

Query: 370 NVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSP 429
           +++S G+   E+  GE   +   P++    I      P +  +  +  K  +  C N  P
Sbjct: 183 DIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNN-PPTLTGEFSKPFKEFIDACLNKDP 241

Query: 430 SKRPQFSEII 439
           S RP   E++
Sbjct: 242 SFRPTAKELL 251

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 64.6 bits (157), Expect = 1e-11
 Identities = 71/277 (25%), Positives = 122/277 (44%), Gaps = 38/277 (13%)

Query: 189 SDNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGH 242
           SD  E I+ IG  ++  V+K      G +  ++ L      +  E E   ++L+ ++  H
Sbjct: 17  SDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDE-EIEAEYNILKALS-DH 74

Query: 243 KNILQFYCVCV--DENHG--LCVVTKLMEGGSVNDLI---LKSRKLQTKEIIRIAIDVA- 294
            N+++FY +    D  +G  L +V +L  GGSV DL+   LK  +   + II   +  A 
Sbjct: 75  PNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEAL 134

Query: 295 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPE 354
            G++ L+ +   +RD+    ILL   G V L D G+     S             W+APE
Sbjct: 135 MGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPE 194

Query: 355 IIAGDPESVSETW--MSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKD 412
           +IA + + +  T+    +V+S G+   E+  G+   A   P++A           +IP++
Sbjct: 195 VIACE-QQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALF---------KIPRN 244

Query: 413 CPQILKS----------LMIKCWNNSPSKRPQFSEII 439
            P  L             + KC      KRP  S+++
Sbjct: 245 PPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLL 281

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 65.4 bits (159), Expect = 1e-11
 Identities = 47/182 (25%), Positives = 83/182 (45%), Gaps = 13/182 (7%)

Query: 267 EGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLG 326
           E    + LI +S  L   +++  +  VA G++FL      +RDL ++ +L+     V + 
Sbjct: 222 ERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKIC 281

Query: 327 DMGIVTACKSVGEATEYETDG-----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEM 381
           D G+    + +   + Y + G      +W+APE I  +      T +S+V+SFG+++WE+
Sbjct: 282 DFGLA---RDIMRDSNYISKGSTFLPLKWMAPESIFNN----LYTTLSDVWSFGILLWEI 334

Query: 382 VT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIIS 440
            T G   Y      +        G R   P      +  +M KCW      RP FS+++ 
Sbjct: 335 FTLGGTPYPELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVH 394

Query: 441 LL 442
           L+
Sbjct: 395 LV 396

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 63.9 bits (156), Expect = 2e-11
 Identities = 50/180 (27%), Positives = 90/180 (50%), Gaps = 26/180 (14%)

Query: 193 EFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNIL 246
           E I +IG  ++  VYK      G+ V I+ +K  + G+ +E  +++++  L  C H NI+
Sbjct: 6   ELIQRIGSGTYGDVYKARDIATGELVAIKVIK-LEPGDDFE-IIQQEISMLKECRHPNIV 63

Query: 247 QFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK-LQTKEIIRIAIDVAEGIKFLNDHGV 305
            ++   +     L +V +   GGS+ D+   +R  L   +I  +  +  +G+ +L++ G 
Sbjct: 64  AYFGSYL-RRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGK 122

Query: 306 AYRDLNSQRILLDRHGNVCLGDMGI---VTACKS-----VGEATEYETDGYRWLAPEIIA 357
            +RD+    ILL   G+V L D G+   +TA  +     +G  T Y      W+APE+ A
Sbjct: 123 IHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIG--TPY------WMAPEVAA 174

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 64.6 bits (157), Expect = 2e-11
 Identities = 43/150 (28%), Positives = 74/150 (49%), Gaps = 11/150 (7%)

Query: 242 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 301
           H  +   YC    + + L  V + + GG +   I    K         A ++  G++FL+
Sbjct: 55  HPFLTHLYCTFQTKEN-LFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLH 113

Query: 302 DHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS--VGEATEYETDGY-RWLAPEIIAG 358
             G+ YRDL    ILLD  G++ + D G+   CK   +G+A      G   ++APEI+ G
Sbjct: 114 SKGIVYRDLKLDNILLDTDGHIKIADFGM---CKENMLGDAKTCTFCGTPDYIAPEILLG 170

Query: 359 DPESVSETWMSNVYSFGMVIWEMVTGEAAY 388
              + S  W    +SFG++++EM+ G++ +
Sbjct: 171 QKYNTSVDW----WSFGVLLYEMLIGQSPF 196

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 64.9 bits (158), Expect = 2e-11
 Identities = 52/175 (29%), Positives = 88/175 (50%), Gaps = 16/175 (9%)

Query: 281 LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA 340
           L  +++I  +  VA G++FL      +RDL ++ ILL  +  V + D G+    + + + 
Sbjct: 170 LTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLA---RDIYKD 226

Query: 341 TEYETDG-----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPV 394
            +Y   G      +W+APE I    + V  T  S+V+SFG+++WE+ + G + Y      
Sbjct: 227 PDYVRKGDARLPLKWMAPESIF---DKVYTT-QSDVWSFGVLLWEIFSLGASPYPGVQID 282

Query: 395 QAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFS---EIISLLLRTN 446
           +        G R   P+     + S+M+ CW+N+P  RP FS   EI+  LL+ N
Sbjct: 283 EEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQEN 337

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 63.9 bits (155), Expect = 3e-11
 Identities = 67/291 (23%), Positives = 132/291 (45%), Gaps = 26/291 (8%)

Query: 180 EEIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKL---KGCDKGNAYEFELRKDLLE 236
           E + R L  ++  E I ++G  +F  VYK K      L   K  +  +  E EL   ++E
Sbjct: 2   EHVRRDLDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYMVE 59

Query: 237 ---LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILK-SRKLQTKEIIRIAID 292
              L TC H  I++       +   L ++ +   GG+V+ ++L+  R L   +I  I   
Sbjct: 60  IEILATCNHPYIVKLLGAFYWDGK-LWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQ 118

Query: 293 VAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGI-VTACKSVGEATEYETDGYRWL 351
           + E +++L+   + +RDL +  +LL   G++ L D G+     K++     +    Y W+
Sbjct: 119 MLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPY-WM 177

Query: 352 APEIIAGDPESVSET---WMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPE 408
           APE++    E++ +T   + ++++S G+ + EM   E  +   +P++  + IA    + E
Sbjct: 178 APEVVMC--ETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIA----KSE 231

Query: 409 IPK-DCPQI----LKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNSSNR 454
            P    P       +  +    +  P  RP  ++++     ++  SN   R
Sbjct: 232 PPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSNRPLR 282

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 63.6 bits (155), Expect = 3e-11
 Identities = 53/243 (21%), Positives = 112/243 (46%), Gaps = 12/243 (4%)

Query: 203 FKGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVDENHGLCV 261
           +KG++  K V I   K   KG+    ++ ++ ++ +      NIL+ Y   +D    L  
Sbjct: 37  YKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPR 96

Query: 262 VTKLME---GGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDH-GVAYRDLNSQRILL 317
           ++ ++E    G + +++ K + L  K  + +AID  +G+  L  +    Y++L S   L+
Sbjct: 97  LSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLV 156

Query: 318 DRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSE-TWMSNVYSFGM 376
             +  + +   G+    K +        +   + + +++    +  SE T   ++YS G+
Sbjct: 157 TENYKLKIICHGLE---KILSSPPFKNVNFMVYFSYKMLN---DIFSEYTIKDDIYSLGV 210

Query: 377 VIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFS 436
           V+WE+ TG+  +   +  +    I       ++P DCP  +K ++  C ++   KRP   
Sbjct: 211 VLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIK 270

Query: 437 EII 439
           EI+
Sbjct: 271 EIL 273

Length = 283

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 64.1 bits (156), Expect = 4e-11
 Identities = 48/174 (27%), Positives = 84/174 (48%), Gaps = 15/174 (8%)

Query: 278 SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVC-LGDMGIVTACKS 336
           S  L   +++R +  VA+G+ FL      +RD+ ++ +LL   G V  + D G+    + 
Sbjct: 206 SWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLT-DGRVAKICDFGLA---RD 261

Query: 337 VGEATEYETDG-----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAA 390
           +   + Y   G      +W+APE I         T  S+V+S+G+++WE+ + G++ Y  
Sbjct: 262 IMNDSNYVVKGNARLPVKWMAPESIF----DCVYTVQSDVWSYGILLWEIFSLGKSPYPG 317

Query: 391 CSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR 444
                    +   G +   P   P  + S+M  CWN  P++RP FS+I  L+ R
Sbjct: 318 ILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQR 371

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 62.8 bits (152), Expect = 4e-11
 Identities = 55/261 (21%), Positives = 121/261 (46%), Gaps = 17/261 (6%)

Query: 190 DNLEFIDQIGPNSFKGVYKGKRVGIEKLKGC-----DKGNAYEFELRKDLLELMTCGHKN 244
           ++ E I +IG  ++  VYK + V   +L        + G  +   ++++++ +  C H N
Sbjct: 9   EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAV-VQQEIIMMKDCKHSN 67

Query: 245 ILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHG 304
           I+ ++   +  +  L +  +   GGS+ D+   +  L   +I  ++ +  +G+ +L+  G
Sbjct: 68  IVAYFGSYLRRDK-LWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKG 126

Query: 305 VAYRDLNSQRILLDRHGNVCLGDMGI---VTACKSVGEATEYETDGYRWLAPEIIAGDPE 361
             +RD+    ILL  +G+V L D G+   +TA  ++ +   +    Y W+APE+ A + +
Sbjct: 127 KMHRDIKGANILLTDNGHVKLADFGVSAQITA--TIAKRKSFIGTPY-WMAPEVAAVERK 183

Query: 362 SVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSL- 420
                 + ++++ G+   E+   +       P++A   +     +P   KD  +   S  
Sbjct: 184 G-GYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFH 242

Query: 421 -MIK-CWNNSPSKRPQFSEII 439
             +K     +P KRP   +++
Sbjct: 243 HFVKMALTKNPKKRPTAEKLL 263

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 62.5 bits (152), Expect = 5e-11
 Identities = 65/289 (22%), Positives = 128/289 (44%), Gaps = 54/289 (18%)

Query: 190 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLE----LMT 239
            N +   +IG   F  VYK      G+ V ++K++  +  +A   + R+D L+    L  
Sbjct: 2   GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDA---KARQDCLKEIDLLKQ 58

Query: 240 CGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK----LQTKEIIRIAIDVAE 295
             H N++++    ++ N  L +V +L + G ++ +I   +K    +  + I +  + +  
Sbjct: 59  LDHPNVIKYLASFIENNE-LNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCS 117

Query: 296 GIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGI-------VTACKS-VGEATEYETDG 347
            ++ ++   + +RD+    + +   G V LGD+G+        TA  S VG  T Y    
Sbjct: 118 ALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVG--TPY---- 171

Query: 348 YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT------GEAA--YAACSPVQAAVG 399
             +++PE I  +       + S+++S G +++EM        G+    Y+ C        
Sbjct: 172 --YMSPERIHEN----GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKK------ 219

Query: 400 IAACGLRPEIPKD-CPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNN 447
           I  C   P +P D   + L+ L+ +C N  P KRP  S ++ +    + 
Sbjct: 220 IEKCDYPP-LPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMHA 267

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 62.3 bits (151), Expect = 6e-11
 Identities = 51/203 (25%), Positives = 96/203 (47%), Gaps = 13/203 (6%)

Query: 242 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLI--LKSRK---LQTKEIIRIAIDVAEG 296
           H NI+ +      E+  L +V    EGG   DL   LK +K   L   +++   + +A  
Sbjct: 58  HPNIVAYRESWEGEDGLLYIVMGFCEGG---DLYHKLKEQKGKLLPENQVVEWFVQIAMA 114

Query: 297 IKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEII 356
           +++L++  + +RDL +Q + L R   + +GD+GI    ++  +          +++PE+ 
Sbjct: 115 LQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELF 174

Query: 357 AGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQI 416
           +  P +    + S+V++ G  ++EM T + A+ A   + + V     G  P +PKD    
Sbjct: 175 SNKPYN----YKSDVWALGCCVYEMATLKHAFNA-KDMNSLVYRIIEGKLPPMPKDYSPE 229

Query: 417 LKSLMIKCWNNSPSKRPQFSEII 439
           L  L+    +  P KRP    I+
Sbjct: 230 LGELIATMLSKRPEKRPSVKSIL 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 62.6 bits (152), Expect = 7e-11
 Identities = 60/256 (23%), Positives = 114/256 (44%), Gaps = 25/256 (9%)

Query: 191 NLEFIDQIGPNSFKGVYK-----GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNI 245
           ++++ + +G  +   VYK      +R+   K+   D     + ++  +L  L  C    I
Sbjct: 2   DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYI 61

Query: 246 LQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGV 305
           + FY     EN  + + T+ M+GGS++      RK+    + RIA+ V +G+ +L    +
Sbjct: 62  IGFYGAFFVENR-ISICTEFMDGGSLD----VYRKIPEHVLGRIAVAVVKGLTYLWSLKI 116

Query: 306 AYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSE 365
            +RD+    +L++  G V L D G+ T   +    T   T+ Y  +APE I+G+   +  
Sbjct: 117 LHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYVGTNAY--MAPERISGEQYGI-- 172

Query: 366 TWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCP--------QIL 417
              S+V+S G+   E+  G   Y      Q ++ +    L+  + +D P        +  
Sbjct: 173 --HSDVWSLGISFMELALGRFPYPQIQKNQGSL-MPLQLLQCIVDEDPPVLPVGQFSEKF 229

Query: 418 KSLMIKCWNNSPSKRP 433
              + +C    P +RP
Sbjct: 230 VHFITQCMRKQPKERP 245

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 62.0 bits (150), Expect = 1e-10
 Identities = 48/186 (25%), Positives = 88/186 (47%), Gaps = 14/186 (7%)

Query: 259 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLD 318
           L VV + + GGS+ D++ ++  +   +I  +  +  + ++FL+ + V +RD+ S  ILL 
Sbjct: 92  LWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG 150

Query: 319 RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEII---AGDPESVSETWMSNVYSFG 375
             G+V L D G                    W+APE++   A  P+        +++S G
Sbjct: 151 MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK-------VDIWSLG 203

Query: 376 MVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEI--PKDCPQILKSLMIKCWNNSPSKRP 433
           ++  EM+ GE  Y   +P++A   IA  G  PE+  P+    I +  + +C +    KR 
Sbjct: 204 IMAIEMIEGEPPYLNENPLRALYLIATNG-TPELQNPEKLSAIFRDFLNRCLDMDVEKRG 262

Query: 434 QFSEII 439
              E++
Sbjct: 263 SAKELL 268

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 62.2 bits (151), Expect = 1e-10
 Identities = 43/153 (28%), Positives = 67/153 (43%), Gaps = 5/153 (3%)

Query: 238 MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGI 297
           +   H  +   +C C      L  V + + GG +   I +SRK         A +V   +
Sbjct: 51  LAAKHPFLTALHC-CFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLAL 109

Query: 298 KFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIA 357
            FL+ HGV YRDL    ILLD  G+  L D G+       G  T        ++APEI+ 
Sbjct: 110 MFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQ 169

Query: 358 GDPESVSETWMSNVYSFGMVIWEMVTGEAAYAA 390
                 S  W    ++ G++++EM+ G+  + A
Sbjct: 170 ELEYGPSVDW----WALGVLMYEMMAGQPPFEA 198

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 62.0 bits (150), Expect = 1e-10
 Identities = 48/186 (25%), Positives = 87/186 (46%), Gaps = 14/186 (7%)

Query: 259 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLD 318
           L VV + + GGS+ D++ ++  +   +I  +  +  + ++FL+ + V +RD+ S  +LL 
Sbjct: 91  LFVVMEYLAGGSLTDVVTET-CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLG 149

Query: 319 RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEII---AGDPESVSETWMSNVYSFG 375
             G+V L D G                    W+APE++   A  P+        +++S G
Sbjct: 150 MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK-------VDIWSLG 202

Query: 376 MVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEI--PKDCPQILKSLMIKCWNNSPSKRP 433
           ++  EMV GE  Y   +P++A   IA  G  PE+  P+    I +  + +C      KR 
Sbjct: 203 IMAIEMVEGEPPYLNENPLRALYLIATNG-TPELQNPEKLSPIFRDFLNRCLEMDVEKRG 261

Query: 434 QFSEII 439
              E++
Sbjct: 262 SAKELL 267

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 61.4 bits (150), Expect = 1e-10
 Identities = 61/275 (22%), Positives = 109/275 (39%), Gaps = 41/275 (14%)

Query: 190 DNLEFIDQIGPNSFKGVYKGKRVGIEK---LKGCDK------GNAYEFELRKDLLELMTC 240
           D+ +F   IG  SF  V   K     K   +K  DK            ++ K++L  +  
Sbjct: 1   DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLN- 59

Query: 241 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL 300
           GH  I++ Y    DE + L  V +    G +   I K   L  K     A ++   +++L
Sbjct: 60  GHPGIIKLYYTFQDEEN-LYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYL 118

Query: 301 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC-------------KSVGEATEYETDG 347
           +  G+ +RDL  + ILLD+  ++ + D G  TA               +    ++ E + 
Sbjct: 119 HSKGIIHRDLKPENILLDKDMHIKITDFG--TAKVLDPNSSPESNKGDATNIDSQIEKNR 176

Query: 348 YR---------WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAV 398
            R         +++PE++   P   S    S++++ G +I++M+TG+  +   +      
Sbjct: 177 RRFASFVGTAEYVSPELLNEKPAGKS----SDLWALGCIIYQMLTGKPPFRGSNEYLTFQ 232

Query: 399 GIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRP 433
            I         P + P   K L+ K     P  R 
Sbjct: 233 KILKLEY--SFPPNFPPDAKDLIEKLLVLDPQDRL 265

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 61.7 bits (151), Expect = 1e-10
 Identities = 44/154 (28%), Positives = 67/154 (43%), Gaps = 22/154 (14%)

Query: 242 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDL--ILKSR--KLQTKEIIRIAIDVAEGI 297
           H NI++   V   E   L +V +  +     DL   L  R   L    I  I   +  G+
Sbjct: 57  HPNIVKLLDVIHTERK-LYLVFEYCD----MDLKKYLDKRPGPLSPNLIKSIMYQLLRGL 111

Query: 298 KFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA--TEYETDGYRWLAPEI 355
            + + H + +RDL  Q IL++R G + L D G+  A          E  T  YR  APEI
Sbjct: 112 AYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYR--APEI 169

Query: 356 IAGDPE---SVSETWMSNVYSFGMVIWEMVTGEA 386
           + G      +V      +++S G +  EM+TG+ 
Sbjct: 170 LLGSKHYSTAV------DIWSVGCIFAEMITGKP 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 61.6 bits (150), Expect = 2e-10
 Identities = 54/214 (25%), Positives = 94/214 (43%), Gaps = 46/214 (21%)

Query: 195 IDQIGPNSFKGVYK------GKRVGIEKLK------GCDKGNAYEFELRKDLLELMTCGH 242
           + +IG  ++  VYK      G+ V I+K+K      G  K    E +L K+L       H
Sbjct: 4   LGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKEL------NH 57

Query: 243 KNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIR-IAIDVAEGIKFLN 301
            NI++   V   +   L +V + M+   +  LI   ++   + +I+     + +G+ F +
Sbjct: 58  PNIIKLLDVFRHKGD-LYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH 115

Query: 302 DHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIA 357
            HG+ +RDL  + +L++  G + L D G+    +S G      T  Y   RW  APE++ 
Sbjct: 116 SHGILHRDLKPENLLINTEGVLKLADFGL---ARSFGSPVRPYTH-YVVTRWYRAPELLL 171

Query: 358 GDPESVSETWMSNVYSFGMVIW-------EMVTG 384
           GD            YS  + IW       E+++ 
Sbjct: 172 GD----------KGYSTPVDIWSVGCIFAELLSR 195

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 61.6 bits (149), Expect = 2e-10
 Identities = 38/137 (27%), Positives = 68/137 (49%), Gaps = 4/137 (2%)

Query: 252 CVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLN 311
           C      L  V + + GG +   I +  + +    +  A ++A G+ FL+  G+ YRDL 
Sbjct: 69  CFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLK 128

Query: 312 SQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNV 371
              ++LD  G++ + D G+       G  T+       ++APEIIA  P   S  W    
Sbjct: 129 LDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDW---- 184

Query: 372 YSFGMVIWEMVTGEAAY 388
           ++FG++++EM+ G+A +
Sbjct: 185 WAFGVLLYEMLAGQAPF 201

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 61.6 bits (149), Expect = 2e-10
 Identities = 36/137 (26%), Positives = 67/137 (48%), Gaps = 4/137 (2%)

Query: 252 CVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLN 311
           C      L +V + + GG +   + + RKL  +     A ++   + FL++ G+ YRDL 
Sbjct: 64  CFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLK 123

Query: 312 SQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNV 371
              +LLD  G++ L D G+       G+ T        ++APEI+ G+    S  W    
Sbjct: 124 LDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDW---- 179

Query: 372 YSFGMVIWEMVTGEAAY 388
           ++ G++++EM+ G + +
Sbjct: 180 WALGVLMFEMMAGRSPF 196

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 61.0 bits (148), Expect = 2e-10
 Identities = 60/264 (22%), Positives = 118/264 (44%), Gaps = 18/264 (6%)

Query: 190 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHK 243
           D +E +D++G  ++  VYK      G  + +++++  +   +   ++  +L  L      
Sbjct: 1   DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIR-LELDESKFNQIIMELDILHKAVSP 59

Query: 244 NILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKE---IIRIAIDVAEGIKFL 300
            I+ FY     E   + +  + M+ GS++ L       +      + RI   V +G+KFL
Sbjct: 60  YIVDFYGAFFIEG-AVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFL 118

Query: 301 -NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGD 359
             +H + +RD+    +L++ +G V L D G+     +    T      Y  +APE I   
Sbjct: 119 KEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNIGCQSY--MAPERIKSG 176

Query: 360 PESVSETW--MSNVYSFGMVIWEMVTGEAAYA--ACSPVQAAVGIAACGLRPEIPKDCPQ 415
             + + T+   S+V+S G+ I EM  G   Y     + + A +     G  P +P     
Sbjct: 177 GPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSD 236

Query: 416 ILKSLMIKCWNNSPSKRPQFSEII 439
             +  + KC N  P++RP +++++
Sbjct: 237 DAQDFVAKCLNKIPNRRPTYAQLL 260

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 60.8 bits (147), Expect = 3e-10
 Identities = 51/215 (23%), Positives = 100/215 (46%), Gaps = 7/215 (3%)

Query: 193 EFIDQIGPNSFKGVYKGKRVGIEKLKGCDK-GNAYEFELRKDLLE---LMTCGHKNILQF 248
           E I ++G  +F  VYK +      L          E EL   ++E   L +C H NI++ 
Sbjct: 8   EIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKL 67

Query: 249 YCVCVDENHGLCVVTKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAY 307
                 EN+ L ++ +   GG+V+ ++L+  R L   +I  +     E + +L+++ + +
Sbjct: 68  LDAFYYENN-LWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIH 126

Query: 308 RDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGD-PESVSET 366
           RDL +  IL    G++ L D G+        +  +       W+APE++  +  +     
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYD 186

Query: 367 WMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIA 401
           + ++V+S G+ + EM   E  +   +P++  + IA
Sbjct: 187 YKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIA 221

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 60.7 bits (147), Expect = 4e-10
 Identities = 45/150 (30%), Positives = 76/150 (50%), Gaps = 21/150 (14%)

Query: 247 QFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAE---GIKFLNDH 303
             YC    + H L  V + + GG   DL+   +     ++ R     AE   G++FL+  
Sbjct: 60  HLYCTFQTKEH-LFFVMEFLNGG---DLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSK 115

Query: 304 GVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS--VGE---ATEYETDGYRWLAPEIIAG 358
           G+ YRDL    ++LDR G++ + D G+   CK    G+   +T   T  Y  +APEI+ G
Sbjct: 116 GIIYRDLKLDNVMLDRDGHIKIADFGM---CKENVFGDNRASTFCGTPDY--IAPEILQG 170

Query: 359 DPESVSETWMSNVYSFGMVIWEMVTGEAAY 388
              + S  W    +SFG++++EM+ G++ +
Sbjct: 171 LKYTFSVDW----WSFGVLLYEMLIGQSPF 196

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 60.8 bits (147), Expect = 4e-10
 Identities = 46/176 (26%), Positives = 81/176 (46%), Gaps = 10/176 (5%)

Query: 259 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLD 318
           L  V + + GG +   I +  K +  + +  A +++ G+ FL+  G+ YRDL    ++LD
Sbjct: 76  LYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLD 135

Query: 319 RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVI 378
             G++ + D G+       G  T        ++APEIIA  P   S  W    +++G+++
Sbjct: 136 SEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDW----WAYGVLL 191

Query: 379 WEMVTGEAAYAACSPVQAAVGIAACGLR--PEIPKDCPQILKSLMIKCWNNSPSKR 432
           +EM+ G+  +      +    I    +     + K+   I K LM K     PSKR
Sbjct: 192 YEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMTK----HPSKR 243

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 59.9 bits (146), Expect = 5e-10
 Identities = 50/231 (21%), Positives = 88/231 (38%), Gaps = 69/231 (29%)

Query: 193 EFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCG----------- 241
           E I QIG  ++  VYK +     +L            L+K  +E    G           
Sbjct: 2   EKIAQIGEGTYGQVYKARNKKTGEL----------VALKKIRMENEKEGFPITAIREIKL 51

Query: 242 -----HKNILQFYCVCVDENHGLC-VVTKLMEGGSVNDL--ILKSR--KLQTKEIIRIAI 291
                H NI++   +   +  G   +V + M+    +DL  +L S   K    +I     
Sbjct: 52  LQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMD----HDLTGLLDSPEVKFTESQIKCYMK 107

Query: 292 DVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG---- 347
            + EG+++L+ +G+ +RD+    IL++  G + L D G+         A  Y        
Sbjct: 108 QLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGL---------ARPYTKRNSADY 158

Query: 348 --------YRWLAPEIIAG----DPESVSETWMSNVYSFGMVIWEMVTGEA 386
                   YR   PE++ G     PE        +++S G ++ E+  G+ 
Sbjct: 159 TNRVITLWYR--PPELLLGATRYGPE-------VDMWSVGCILAELFLGKP 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 59.6 bits (144), Expect = 5e-10
 Identities = 47/206 (22%), Positives = 97/206 (47%), Gaps = 19/206 (9%)

Query: 242 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILK----SRKLQTKEIIRIAIDVAEGI 297
           H  I++F+   + E    C++T+  EG  ++  + +     + L   ++    I +  G+
Sbjct: 61  HPAIVKFHASFL-ERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGV 119

Query: 298 KFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE---ATEYETDGYRWLAPE 354
            +++   + +RDL ++ I L ++  + +GD G+  +   +G    AT +    Y +++PE
Sbjct: 120 HYMHQRRILHRDLKAKNIFL-KNNLLKIGDFGV--SRLLMGSCDLATTFTGTPY-YMSPE 175

Query: 355 IIAGDP-ESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDC 413
            +     +S S+ W     S G +++EM     A+   + +   + I   G  P +P+  
Sbjct: 176 ALKHQGYDSKSDIW-----SLGCILYEMCCLAHAFEGQNFLSVVLRIVE-GPTPSLPETY 229

Query: 414 PQILKSLMIKCWNNSPSKRPQFSEII 439
            + L S+M    N  PS RP  +EI+
Sbjct: 230 SRQLNSIMQSMLNKDPSLRPSAAEIL 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 60.1 bits (145), Expect = 5e-10
 Identities = 47/186 (25%), Positives = 86/186 (46%), Gaps = 14/186 (7%)

Query: 259 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLD 318
           L VV + + GGS+ D++ ++  +   +I  +  +  + + FL+ + V +RD+ S  ILL 
Sbjct: 91  LWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLG 149

Query: 319 RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEII---AGDPESVSETWMSNVYSFG 375
             G+V L D G                    W+APE++   A  P+        +++S G
Sbjct: 150 MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK-------VDIWSLG 202

Query: 376 MVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEI--PKDCPQILKSLMIKCWNNSPSKRP 433
           ++  EMV GE  Y   +P++A   IA  G  PE+  P+    + +  + +C      +R 
Sbjct: 203 IMAIEMVEGEPPYLNENPLRALYLIATNG-TPELQNPERLSAVFRDFLNRCLEMDVDRRG 261

Query: 434 QFSEII 439
              E++
Sbjct: 262 SAKELL 267

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 60.1 bits (145), Expect = 5e-10
 Identities = 34/137 (24%), Positives = 67/137 (48%), Gaps = 4/137 (2%)

Query: 252 CVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLN 311
           C      L  V + + GG +   + + RKL  +     + +++  + +L++ G+ YRDL 
Sbjct: 64  CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLK 123

Query: 312 SQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNV 371
              +LLD  G++ L D G+       G+ T        ++APEI+ G+    S  W    
Sbjct: 124 LDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDW---- 179

Query: 372 YSFGMVIWEMVTGEAAY 388
           ++ G++++EM+ G + +
Sbjct: 180 WALGVLMFEMMAGRSPF 196

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 59.7 bits (144), Expect = 5e-10
 Identities = 58/274 (21%), Positives = 120/274 (43%), Gaps = 38/274 (13%)

Query: 191 NLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLE----LMTC 240
           N     +IG   F  VY+      G  V ++K++  D  +A   + R D ++    L   
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDA---KARADCIKEIDLLKQL 59

Query: 241 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL----KSRKLQTKEIIRIAIDVAEG 296
            H N++++Y   +++N  L +V +L + G ++ +I     + R +  K + +  + +   
Sbjct: 60  NHPNVIKYYASFIEDNE-LNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSA 118

Query: 297 IKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEII 356
           ++ ++   V +RD+    + +   G V LGD+G+     S   A         +++PE I
Sbjct: 119 LEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI 178

Query: 357 AGDPESVSETWMSNVYSFGMVIWEMVTGEAA--------YAACSPVQAAVGIAACGLRPE 408
             +       + S+++S G +++EM   ++         Y+ C  ++       C   P 
Sbjct: 179 HEN----GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE------QCDY-PP 227

Query: 409 IPKD-CPQILKSLMIKCWNNSPSKRPQFSEIISL 441
           +P D   + L+ L+  C N  P KRP  + +  +
Sbjct: 228 LPSDHYSEELRQLVNMCINPDPEKRPDITYVYDV 261

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 59.5 bits (145), Expect = 7e-10
 Identities = 45/178 (25%), Positives = 71/178 (39%), Gaps = 26/178 (14%)

Query: 265 LME---GGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG 321
           +ME   GG +   + KS +         A  V   +++L+   + YRDL  + +LLD  G
Sbjct: 79  VMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDG 138

Query: 322 NVCLGDMGIVTACKSVGEAT-------EYETDGYRWLAPEIIAGDPESVSETWMSNVYSF 374
            + + D G     K V   T       EY       LAPEII       +  W    ++ 
Sbjct: 139 YIKITDFGF---AKRVKGRTYTLCGTPEY-------LAPEIILSKGYGKAVDW----WAL 184

Query: 375 GMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKR 432
           G++I+EM+ G   +   +P+Q    I    +R   P       K L+        +KR
Sbjct: 185 GILIYEMLAGYPPFFDDNPIQIYEKILEGKVR--FPSFFSPDAKDLIRNLLQVDLTKR 240

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 59.8 bits (145), Expect = 7e-10
 Identities = 57/215 (26%), Positives = 98/215 (45%), Gaps = 52/215 (24%)

Query: 198 IGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFE-LRKDLLE----LMTCGHKNILQFYCVC 252
           +G  SF     GK   + K+ G D G  Y  + L+K  L+    + T   ++IL      
Sbjct: 4   LGQGSF-----GKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDIL------ 52

Query: 253 VDENHGLCV--------------VTKLMEGGSVNDLILKSRK--LQTKEIIRIAI-DVAE 295
            + NH   V              +   + GG   DL  +  K  + T+E ++  + ++A 
Sbjct: 53  AEVNHPFIVKLHYAFQTEGKLYLILDFLRGG---DLFTRLSKEVMFTEEDVKFYLAELAL 109

Query: 296 GIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY------R 349
            +  L+  G+ YRDL  + ILLD  G++ L D G+    K   E+ ++E   Y       
Sbjct: 110 ALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGL---SK---ESIDHEKKAYSFCGTVE 163

Query: 350 WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTG 384
           ++APE++     + S  W    +SFG++++EM+TG
Sbjct: 164 YMAPEVVNRRGHTQSADW----WSFGVLMFEMLTG 194

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 58.9 bits (142), Expect = 1e-09
 Identities = 53/265 (20%), Positives = 119/265 (44%), Gaps = 25/265 (9%)

Query: 191 NLEFIDQIGPNSFKGVYKGKRVGIEKLKGC-----DKGNAYEFELRKDLLELMTCGHKNI 245
           + E I ++G  ++  VYK + +   +L        + G+ +   +++++  +  C H NI
Sbjct: 10  DYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSL-IQQEIFMVKECKHCNI 68

Query: 246 LQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGV 305
           + ++   +     L +  +   GGS+ D+   +  L   +I  +  +  +G+ +L+  G 
Sbjct: 69  VAYFGSYLSREK-LWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGK 127

Query: 306 AYRDLNSQRILLDRHGNVCLGDMGI---VTACKSVGEATEYETDGYRWLAPEIIAGDPES 362
            +RD+    ILL  +G+V L D G+   +TA  ++ +   +    Y W+APE+ A +   
Sbjct: 128 MHRDIKGANILLTDNGDVKLADFGVAAKITA--TIAKRKSFIGTPY-WMAPEVAAVEKNG 184

Query: 363 VSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ------- 415
                + ++++ G+   E+   +       P++A   ++    +P   KD  +       
Sbjct: 185 -GYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHN 243

Query: 416 ILKSLMIKCWNNSPSKRPQFSEIIS 440
            +K  + K    +P KRP    +++
Sbjct: 244 FVKISLTK----NPKKRPTAERLLT 264

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 58.4 bits (141), Expect = 1e-09
 Identities = 57/220 (25%), Positives = 105/220 (47%), Gaps = 24/220 (10%)

Query: 231 RKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKE-IIR 288
           RK+ + L    H NI+ F      + H L +V +  +GG +   I   R KL  ++ I++
Sbjct: 46  RKEAVLLAKMKHPNIVAFKESFEADGH-LYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQ 104

Query: 289 IAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMG--------IVTACKSVGEA 340
             + +  G++ +++  V +RD+ S+ I L ++G V LGD G           AC  VG  
Sbjct: 105 WFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVG-- 162

Query: 341 TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGI 400
           T Y      ++ PEI     E++     S+++S G +++E+ T +  + A S     + +
Sbjct: 163 TPY------YVPPEIW----ENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKV 212

Query: 401 AACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIIS 440
                +P +P      L+SL+ + +  +P  RP  + I+S
Sbjct: 213 CQGSYKP-LPSHYSYELRSLIKQMFKRNPRSRPSATTILS 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 59.1 bits (143), Expect = 1e-09
 Identities = 53/174 (30%), Positives = 82/174 (47%), Gaps = 26/174 (14%)

Query: 197 QIGPNSFKGVY------KGKRVGIEKLKGCDKGNAYEFE-LRKDLLELMTCGHKNILQFY 249
           +IG  SF  VY        + V I+K+    K +  +++ + K++  L    H N ++ Y
Sbjct: 22  EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIE-Y 80

Query: 250 CVCVDENHGLCVVTKLMEG--GSVNDLILKSRK-LQTKEIIRIAIDVAEGIKFLNDHGVA 306
             C    H   +V   ME   GS +D++   +K LQ  EI  I     +G+ +L+ H   
Sbjct: 81  KGCYLREHTAWLV---MEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERI 137

Query: 307 YRDLNSQRILLDRHGNVCLGDMG---IVTACKS-VGEATEYETDGYRWLAPEII 356
           +RD+ +  ILL   G V L D G   +V+   S VG  T Y      W+APE+I
Sbjct: 138 HRDIKAGNILLTEPGTVKLADFGSASLVSPANSFVG--TPY------WMAPEVI 183

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 59.0 bits (143), Expect = 1e-09
 Identities = 34/102 (33%), Positives = 56/102 (54%), Gaps = 10/102 (9%)

Query: 290 AIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS--VGEATEYETDG 347
           A ++A G+ FL+  G+ YRDL    ++LD  G++ + D G+   CK    G  T     G
Sbjct: 107 AAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGM---CKENIFGGKTTRTFCG 163

Query: 348 Y-RWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAY 388
              ++APEIIA  P   S  W    ++FG++++EM+ G+  +
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDW----WAFGVLLYEMLAGQPPF 201

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 58.1 bits (141), Expect = 2e-09
 Identities = 38/143 (26%), Positives = 70/143 (48%), Gaps = 11/143 (7%)

Query: 248 FYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAI-DVAEGIKFLNDHGVA 306
           +Y    +EN  + +V  L+ GG +   + +  K  ++E ++  I ++   +++L+  G+ 
Sbjct: 66  WYSFQDEEN--MYLVVDLLLGGDLRYHLSQKVKF-SEEQVKFWICEIVLALEYLHSKGII 122

Query: 307 YRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE-TDGYRWLAPEIIAGDPESVSE 365
           +RD+    ILLD  G+V + D  I T        T    T GY  +APE++     SV+ 
Sbjct: 123 HRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTPGY--MAPEVLCRQGYSVAV 180

Query: 366 TWMSNVYSFGMVIWEMVTGEAAY 388
            W    +S G+  +E + G+  Y
Sbjct: 181 DW----WSLGVTAYECLRGKRPY 199

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 58.0 bits (140), Expect = 2e-09
 Identities = 39/139 (28%), Positives = 68/139 (48%), Gaps = 23/139 (16%)

Query: 259 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLD 318
           L  +  LM GG ++  + +       E+   A ++  G++ +++  V YRDL    ILLD
Sbjct: 72  LSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLD 131

Query: 319 RHGNVCLGDMGIVTACK--------SVGEATEYETDGYRWLAPEIIA-GDPESVSETWMS 369
            HG+V + D+G+  AC         SVG      T GY  +APE++  G     S  W  
Sbjct: 132 EHGHVRISDLGL--ACDFSKKKPHASVG------THGY--MAPEVLQKGVAYDSSADW-- 179

Query: 370 NVYSFGMVIWEMVTGEAAY 388
             +S G ++++++ G + +
Sbjct: 180 --FSLGCMLFKLLRGHSPF 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 58.1 bits (140), Expect = 2e-09
 Identities = 32/135 (23%), Positives = 67/135 (49%), Gaps = 7/135 (5%)

Query: 258 GLCVVTKLMEGGSVNDLI--LKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRI 315
            LC+V  +M GG +   I  + +   + +  +  A ++  G++ L+     YRDL  + I
Sbjct: 74  ALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENI 133

Query: 316 LLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFG 375
           LLD +G++ + D+G+       GE+         ++APE++     ++S  +    +  G
Sbjct: 134 LLDDYGHIRISDLGLAVKIPE-GESIRGRVGTVGYMAPEVLNNQRYTLSPDY----WGLG 188

Query: 376 MVIWEMVTGEAAYAA 390
            +I+EM+ G++ +  
Sbjct: 189 CLIYEMIEGQSPFRG 203

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 58.1 bits (140), Expect = 2e-09
 Identities = 35/131 (26%), Positives = 67/131 (51%), Gaps = 7/131 (5%)

Query: 259 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLD 318
           LC +  LM GG ++  + +      KE+   A ++  G++ +++  V YRDL    ILLD
Sbjct: 72  LCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLD 131

Query: 319 RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEII-AGDPESVSETWMSNVYSFGMV 377
            HG+V + D+G+  AC    +        + ++APE++  G     S  W    +S G +
Sbjct: 132 EHGHVRISDLGL--ACDFSKKKPHASVGTHGYMAPEVLQKGTAYDSSADW----FSLGCM 185

Query: 378 IWEMVTGEAAY 388
           +++++ G + +
Sbjct: 186 LFKLLRGHSPF 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 57.7 bits (139), Expect = 2e-09
 Identities = 43/183 (23%), Positives = 81/183 (44%), Gaps = 17/183 (9%)

Query: 216 KLKGCDKGNAYEFELRKDLLELMTCGHKNILQ--------FYCVCVDENHGLCVVTKLME 267
           K+  C K      + RK   E M    K IL+              +    LC+V  LM 
Sbjct: 26  KMYACKKLEKKRIKKRKG--ESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMN 83

Query: 268 GGSVNDLI--LKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCL 325
           GG +   I  +     +    +  A ++  G++ L+   + YRDL  + ILLD HG++ +
Sbjct: 84  GGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRI 143

Query: 326 GDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGE 385
            D+G+       G+  +       ++APE++  +  + S  W    ++ G +++EM+ G+
Sbjct: 144 SDLGLAVHVPE-GQTIKGRVGTVGYMAPEVVKNERYTFSPDW----WALGCLLYEMIAGQ 198

Query: 386 AAY 388
           + +
Sbjct: 199 SPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 57.6 bits (140), Expect = 3e-09
 Identities = 46/153 (30%), Positives = 76/153 (49%), Gaps = 16/153 (10%)

Query: 237 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAID-VAE 295
           L  C H  I++ Y    D+ + + ++ +   GG +   IL+ R L  +   R  I  V  
Sbjct: 47  LEECNHPFIVKLYRTFKDKKY-IYMLMEYCLGGELWT-ILRDRGLFDEYTARFYIACVVL 104

Query: 296 GIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK-SVGEATEYE---TDGYRWL 351
             ++L++ G+ YRDL  + +LLD +G V L D G   A K   G+ T +    T  Y  +
Sbjct: 105 AFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFG--FAKKLKSGQKT-WTFCGTPEY--V 159

Query: 352 APEIIAGDPESVSETWMSNVYSFGMVIWEMVTG 384
           APEII       S  +    +S G++++E++TG
Sbjct: 160 APEIILNKGYDFSVDY----WSLGILLYELLTG 188

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 58.5 bits (141), Expect = 3e-09
 Identities = 51/184 (27%), Positives = 84/184 (45%), Gaps = 29/184 (15%)

Query: 279 RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG 338
           R +   +I+ I   V   I++L+++ + +RD+ ++ I ++  G+VCLGD G   AC  V 
Sbjct: 177 RNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFG--AACFPVD 234

Query: 339 -EATEYETDGYRWL------APEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAY--- 388
             A +Y    Y W       APE++A DP   +     +++S G+V++EM T   +    
Sbjct: 235 INANKY----YGWAGTIATNAPELLARDPYGPA----VDIWSAGIVLFEMATCHDSLFEK 286

Query: 389 ----AAC-SPVQAAVGIAACGLRP-EIPKDCPQILKSLMIKCWNNS---PSKRPQFSEII 439
                 C S  Q  + I   G  P E P D    L  + I     S   P  RP ++ + 
Sbjct: 287 DGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLY 346

Query: 440 SLLL 443
            L +
Sbjct: 347 ELPI 350

Length = 391

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 57.2 bits (138), Expect = 4e-09
 Identities = 55/222 (24%), Positives = 90/222 (40%), Gaps = 29/222 (13%)

Query: 242 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKL-----QTKEIIRIAIDVAEG 296
           H N+LQ    C+ E+    +V +    G + + +  +R +     Q   + R+A +VA G
Sbjct: 54  HPNVLQCLGQCI-ESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASG 112

Query: 297 IKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG-----YRWL 351
           + +L+     + DL  +   L    +V +GD G+    +       Y T        RWL
Sbjct: 113 LLWLHQADFIHSDLALRNCQLTADLSVKIGDYGL-ALEQY--PEDYYITKDCHAVPLRWL 169

Query: 352 APEII---AGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRP 407
           APE++     D     +T  SN++S G+ +WE+ T  +  Y   S  Q    +       
Sbjct: 170 APELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQV---LKQVVREQ 226

Query: 408 EIPKDCPQILKSL-------MIKCWNNSPSKRPQFSEIISLL 442
           +I    PQ+           M  CW   P  RP   E+  LL
Sbjct: 227 DIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 56.3 bits (136), Expect = 5e-09
 Identities = 54/217 (24%), Positives = 97/217 (44%), Gaps = 23/217 (10%)

Query: 237 LMTC-GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK--LQTKEIIRIAIDV 293
           LM+   HK++++ Y VCV + + +  V + ++ G + D+ L   K  +     + +A  +
Sbjct: 54  LMSQLSHKHLVKLYGVCVRDENIM--VEEYVKFGPL-DVFLHREKNNVSLHWKLDVAKQL 110

Query: 294 AEGIKFLNDHGVAYRDLNSQRILLDRHGN-------VCLGDMGIVTACKSVGEATEYETD 346
           A  + +L D  + + ++  + IL+ R+G        + L D GI     S     E   +
Sbjct: 111 ASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSR----EERVE 166

Query: 347 GYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGL 405
              W+APE I       S T  ++ +SFG  + E+ + GE   +  S  +          
Sbjct: 167 RIPWIAPECIRNG--QASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHR 224

Query: 406 RPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
            P    DC ++   L+ +CW   P+KRP F  I+  L
Sbjct: 225 LPMP--DCAELAN-LINQCWTYDPTKRPSFRAILRDL 258

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 57.0 bits (138), Expect = 6e-09
 Identities = 39/153 (25%), Positives = 72/153 (47%), Gaps = 16/153 (10%)

Query: 241 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL--KSRKLQTKEIIRIAIDVAEGIK 298
            H  ++  +     E+H +C V +   GG   DL++   +        +  A  V  G++
Sbjct: 60  RHPFLVNLFACFQTEDH-VCFVMEYAAGG---DLMMHIHTDVFSEPRAVFYAACVVLGLQ 115

Query: 299 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS---VGEATEYETDGYRWLAPEI 355
           +L+++ + YRDL    +LLD  G V + D G+   CK     G+ T        +LAPE+
Sbjct: 116 YLHENKIVYRDLKLDNLLLDTEGFVKIADFGL---CKEGMGFGDRTSTFCGTPEFLAPEV 172

Query: 356 IAGDPESVSETWMSNVYSFGMVIWEMVTGEAAY 388
           +     + +  W    +  G++I+EM+ GE+ +
Sbjct: 173 LTETSYTRAVDW----WGLGVLIYEMLVGESPF 201

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 56.5 bits (136), Expect = 6e-09
 Identities = 57/208 (27%), Positives = 93/208 (44%), Gaps = 22/208 (10%)

Query: 242 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL--KSRKLQTKEIIRIAIDVAEGIKF 299
           HK+I+  Y VCV +   + +V + +E G + DL +  KS  L T    ++A  +A  + +
Sbjct: 63  HKHIVLLYGVCVRDVENI-MVEEFVEFGPL-DLFMHRKSDVLTTPWKFKVAKQLASALSY 120

Query: 300 LNDHGVAYRDLNSQRILLDRHG--NVC-----LGDMGIVTACKSVGEATEYETDGYRWLA 352
           L D  + + ++ ++ ILL R G    C     L D GI     S  E  E       W+A
Sbjct: 121 LEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVER----IPWIA 176

Query: 353 PEIIAGDPESVSETWMSNVYSFGMVIWEMV-TGEAAYAACSPVQAAVGIAACGLRPEIPK 411
           PE +    +S + +  ++ +SFG  +WE+   GE      +  +              P 
Sbjct: 177 PECVE---DSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYEGQ-CMLVTP- 231

Query: 412 DCPQILKSLMIKCWNNSPSKRPQFSEII 439
            C + L  LM  C N  P++RP F  I+
Sbjct: 232 SCKE-LADLMTHCMNYDPNQRPFFRAIM 258

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 56.8 bits (137), Expect = 6e-09
 Identities = 34/132 (25%), Positives = 66/132 (50%), Gaps = 7/132 (5%)

Query: 259 LCVVTKLMEGGSVNDLI--LKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRIL 316
           LC+V  LM GG +   I  + +     +  +  A ++  G++ L+   + YRDL  + IL
Sbjct: 75  LCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENIL 134

Query: 317 LDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGM 376
           LD +G++ + D+G+       GE          ++APE++  +  + S  W    +  G 
Sbjct: 135 LDDYGHIRISDLGLAVEIPE-GETIRGRVGTVGYMAPEVVKNERYTFSPDW----WGLGC 189

Query: 377 VIWEMVTGEAAY 388
           +I+EM+ G++ +
Sbjct: 190 LIYEMIEGKSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 55.9 bits (135), Expect = 1e-08
 Identities = 35/148 (23%), Positives = 70/148 (47%), Gaps = 8/148 (5%)

Query: 237 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEG 296
           L    H  I++ +    D+   L ++ + + GG +   +  S +      +  A ++   
Sbjct: 55  LKEVSHPFIIRLFWTEHDQRF-LYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCA 113

Query: 297 IKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEII 356
           +++L+   + YRDL  + ILLD+ G++ L D G     K + + T        +LAPE+I
Sbjct: 114 LEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFA---KKLRDRTWTLCGTPEYLAPEVI 170

Query: 357 AGDPESVSETWMSNVYSFGMVIWEMVTG 384
                + +  W    ++ G++I+EM+ G
Sbjct: 171 QSKGHNKAVDW----WALGILIYEMLVG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 55.4 bits (134), Expect = 1e-08
 Identities = 53/199 (26%), Positives = 83/199 (41%), Gaps = 31/199 (15%)

Query: 194 FIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQ 247
            + +IG  +F  V K      GK   I+ +K   K       LR+         H NIL+
Sbjct: 3   ILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILR 62

Query: 248 FYCVCVDENHG-LCVVTKLMEGGSVNDLILKSRK--LQTKEIIRIAIDVAEGIKFLNDHG 304
              V  D   G L +V +LM+  ++ +LI K RK  L  K +      + + +  ++ +G
Sbjct: 63  LIEVLFDRKTGRLALVFELMDM-NLYELI-KGRKRPLPEKRVKSYMYQLLKSLDHMHRNG 120

Query: 305 VAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV---GEATEY-ETDGYRWLAPEIIAGDP 360
           + +RD+  + IL+     + L D G   +C+ +      TEY  T  YR  APE +  D 
Sbjct: 121 IFHRDIKPENILIKD-DILKLADFG---SCRGIYSKPPYTEYISTRWYR--APECLLTD- 173

Query: 361 ESVSETWMSNVYSFGMVIW 379
                      Y   M IW
Sbjct: 174 ---------GYYGPKMDIW 183

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 55.8 bits (134), Expect = 1e-08
 Identities = 45/182 (24%), Positives = 72/182 (39%), Gaps = 6/182 (3%)

Query: 259 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLD 318
           L  V   + GG +   + + R          A ++A  + +L+   + YRDL  + ILLD
Sbjct: 71  LYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLD 130

Query: 319 RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVI 378
             G+V L D G+     +  + T        +LAPE+I   P   +  W    +  G V+
Sbjct: 131 SQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDW----WCLGAVL 186

Query: 379 WEMVTGEAAYAACSPVQAAVGI--AACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFS 436
           +EM+ G   +      +    I      LRP        IL+ L+ K        +  F 
Sbjct: 187 YEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEKDRQRRLGAKEDFL 246

Query: 437 EI 438
           EI
Sbjct: 247 EI 248

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 55.2 bits (133), Expect = 1e-08
 Identities = 64/278 (23%), Positives = 119/278 (42%), Gaps = 58/278 (20%)

Query: 196 DQIGPNSFKGVYKGKR--VGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFY---- 249
           + +G  +F  ++KG R  VG       D G  ++ E+   LL+++   H+N  + +    
Sbjct: 1   ESLGQGTFTKIFKGIRREVG-------DYGELHKTEV---LLKVLDKSHRNYSESFFEAA 50

Query: 250 -----------------CVCVDENHGLCVVTKLMEGGSVNDLILKSRK--LQTKEIIRIA 290
                            CVC DE+    +V + ++ GS+ D  LK  K  +     + +A
Sbjct: 51  SMMSQLSHKHLVLNYGVCVCGDES---IMVQEYVKFGSL-DTYLKKNKNLINISWKLEVA 106

Query: 291 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGN--------VCLGDMGIVTACKSVGEATE 342
             +A  + FL D G+ + ++ ++ +LL R  +        + L D GI           E
Sbjct: 107 KQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLP----KE 162

Query: 343 YETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTG-EAAYAACSPVQAAVGIA 401
              +   W+ PE I  +P+++S    ++ +SFG  +WE+ +G +   +A    +      
Sbjct: 163 ILLERIPWVPPECIE-NPQNLS--LAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYE 219

Query: 402 ACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEII 439
               R ++P      L +L+ +C +  P  RP F  II
Sbjct: 220 D---RHQLPAPKWTELANLINQCMDYEPDFRPSFRAII 254

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 55.2 bits (133), Expect = 2e-08
 Identities = 37/135 (27%), Positives = 64/135 (47%), Gaps = 8/135 (5%)

Query: 259 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLD 318
           L +V + + GG    LI     L      +   +V  G++ L+  G+ +RD+  + +L+D
Sbjct: 72  LYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLID 131

Query: 319 RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVI 378
           + G++ L D G+       G   +       +LAPE I G    V +  MS+ +S G VI
Sbjct: 132 QTGHLKLTDFGL----SRNGLENKKFVGTPDYLAPETILG----VGDDKMSDWWSLGCVI 183

Query: 379 WEMVTGEAAYAACSP 393
           +E + G   + A +P
Sbjct: 184 FEFLFGYPPFHAETP 198

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 55.4 bits (133), Expect = 2e-08
 Identities = 51/192 (26%), Positives = 89/192 (46%), Gaps = 13/192 (6%)

Query: 197 QIGPNSFKGVY------KGKRVGIEKLKGCDKGNAYEFE-LRKDLLELMTCGHKNILQFY 249
           +IG  SF  VY        + V I+K+    K +  +++ + K++  L    H N +Q Y
Sbjct: 22  EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ-Y 80

Query: 250 CVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRD 309
             C    H   +V +   G + + L +  + LQ  EI  +     +G+ +L+ H + +RD
Sbjct: 81  RGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRD 140

Query: 310 LNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMS 369
           + +  ILL   G V LGD G   +   +  A  +    Y W+APE+I    E   +  + 
Sbjct: 141 VKAGNILLSEPGLVKLGDFG---SASIMAPANXFVGTPY-WMAPEVILAMDEGQYDGKV- 195

Query: 370 NVYSFGMVIWEM 381
           +V+S G+   E+
Sbjct: 196 DVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 55.2 bits (133), Expect = 2e-08
 Identities = 50/229 (21%), Positives = 95/229 (41%), Gaps = 29/229 (12%)

Query: 180 EEIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLE--- 236
            +   W L+  + E  + +G  SF       RV I K KG  +  A +   ++++L+   
Sbjct: 10  PDTSSWKLS--DFEMGETLGTGSFG------RVRIAKHKGTGEYYAIKCLKKREILKMKQ 61

Query: 237 ----------LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEI 286
                     LM   H  I+   C   DEN  +  + + + GG +   + K+ +      
Sbjct: 62  VQHVAQEKSILMELSHPFIVNMMCSFQDENR-VYFLLEFVVGGELFTHLRKAGRFPNDVA 120

Query: 287 IRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETD 346
                ++    ++L+   + YRDL  + +LLD  G+V + D G     K V + T     
Sbjct: 121 KFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFA---KKVPDRTFTLCG 177

Query: 347 GYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQ 395
              +LAPE+I       +  W    ++ G++++E + G   +   +P +
Sbjct: 178 TPEYLAPEVIQSKGHGKAVDW----WTMGVLLYEFIAGYPPFFDDTPFR 222

Length = 329

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 55.0 bits (132), Expect = 2e-08
 Identities = 35/132 (26%), Positives = 64/132 (48%), Gaps = 7/132 (5%)

Query: 259 LCVVTKLMEGGSVNDLI--LKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRIL 316
           LC+V  +M GG +   I  + +     +  I  A ++  G++ L    + YRDL  + IL
Sbjct: 75  LCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENIL 134

Query: 317 LDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGM 376
           LD  G++ + D+G+       GE          ++APE+I  +  + S  W    +  G 
Sbjct: 135 LDDRGHIRISDLGLAVQIPE-GETVRGRVGTVGYMAPEVINNEKYTFSPDW----WGLGC 189

Query: 377 VIWEMVTGEAAY 388
           +I+EM+ G++ +
Sbjct: 190 LIYEMIQGQSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 54.8 bits (133), Expect = 2e-08
 Identities = 53/178 (29%), Positives = 88/178 (49%), Gaps = 23/178 (12%)

Query: 193 EFIDQIGPNSFKGVYKGKR------VGIEKLKGCDKGNAYE--FELR--KDLLELMTCGH 242
           + I Q+G  +F  VY  +       V I+K+K   K  ++E    LR  K L +L    H
Sbjct: 2   KVIKQLGDGTFGSVYLARNKETGELVAIKKMKK--KFYSWEECMNLREVKSLRKLN--EH 57

Query: 243 KNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQ--TKEIIR-IAIDVAEGIKF 299
            NI++   V  + +  L  V + MEG ++  L+ K RK +  ++ +IR I   + +G+  
Sbjct: 58  PNIVKLKEVFRENDE-LYFVFEYMEG-NLYQLM-KDRKGKPFSESVIRSIIYQILQGLAH 114

Query: 300 LNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY-ETDGYRWLAPEII 356
           ++ HG  +RDL  + +L+     V + D G+    +S    T+Y  T  YR  APEI+
Sbjct: 115 IHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTRWYR--APEIL 170

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 54.7 bits (131), Expect = 3e-08
 Identities = 58/250 (23%), Positives = 104/250 (41%), Gaps = 13/250 (5%)

Query: 197 QIGPNSFKGVY------KGKRVGIEKLKGCDKGNAYEFE-LRKDLLELMTCGHKNILQFY 249
           +IG  SF  VY        + V I+K+    K +  +++ + K++  L    H N ++ Y
Sbjct: 32  EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIE-Y 90

Query: 250 CVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRD 309
             C    H   +V +   G + + L +  + LQ  EI  I     +G+ +L+ H + +RD
Sbjct: 91  KGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRD 150

Query: 310 LNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMS 369
           + +  ILL   G V L D G   +      A  +    Y W+APE+I    E   +  + 
Sbjct: 151 IKAGNILLTEPGQVKLADFG---SASIASPANSFVGTPY-WMAPEVILAMDEGQYDGKV- 205

Query: 370 NVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSP 429
           +V+S G+   E+   +      + + A   IA          +     ++ +  C    P
Sbjct: 206 DVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIP 265

Query: 430 SKRPQFSEII 439
             RP   E++
Sbjct: 266 QDRPTSEELL 275

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 54.6 bits (131), Expect = 3e-08
 Identities = 34/99 (34%), Positives = 51/99 (51%), Gaps = 12/99 (12%)

Query: 290 AIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY- 348
           A +VA  I +L+   + YRDL  + ILLD  G+V L D G+   CK  G   E  T  + 
Sbjct: 102 AAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGL---CKE-GVEPEETTSTFC 157

Query: 349 ---RWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTG 384
               +LAPE++  +P   +  W    +  G V++EM+ G
Sbjct: 158 GTPEYLAPEVLRKEPYDRTVDW----WCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 54.6 bits (131), Expect = 4e-08
 Identities = 62/256 (24%), Positives = 108/256 (42%), Gaps = 37/256 (14%)

Query: 198 IGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN- 256
           IG  +F  VY+ ++    ++      +  E   +K++    T G +NIL      +DE+ 
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAH--TIGERNILV--RTLLDESP 56

Query: 257 ------------HGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAE---GIKFLN 301
                         L +VT  M GG +   + K  +       R    +AE    ++ L+
Sbjct: 57  FIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSED---RAKFYIAELVLALEHLH 113

Query: 302 DHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPE 361
            + + YRDL  + ILLD  G++ L D G+  A  +  + T        +LAPE++    +
Sbjct: 114 KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLL---D 170

Query: 362 SVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDC-----PQI 416
               T   + +S G++++EM  G + + A    Q    IA   +R   PK+       Q 
Sbjct: 171 EKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVR--FPKNVLSDEGRQF 228

Query: 417 LKSLMIKCWNNSPSKR 432
           +K L+    N +P  R
Sbjct: 229 VKGLL----NRNPQHR 240

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 54.3 bits (130), Expect = 4e-08
 Identities = 58/255 (22%), Positives = 107/255 (41%), Gaps = 15/255 (5%)

Query: 194 FID--QIGPNSFKGVY------KGKRVGIEKLKGCDKGNAYEFE-LRKDLLELMTCGHKN 244
           F+   +IG  SF  VY        + V ++K+    K    +++ + K++  L    H N
Sbjct: 23  FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82

Query: 245 ILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHG 304
            ++ Y  C  + H   +V +   G + + L +  + LQ  EI  I     +G+ +L+ H 
Sbjct: 83  TIE-YKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN 141

Query: 305 VAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVS 364
           + +RD+ +  ILL   G V L D G   +      A  +    Y W+APE+I    E   
Sbjct: 142 MIHRDIKAGNILLTEPGQVKLADFG---SASKSSPANSFVGTPY-WMAPEVILAMDEGQY 197

Query: 365 ETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKC 424
           +  + +V+S G+   E+   +      + + A   IA          +     +  +  C
Sbjct: 198 DGKV-DVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDYC 256

Query: 425 WNNSPSKRPQFSEII 439
               P +RP  +E++
Sbjct: 257 LQKIPQERPASAELL 271

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 53.7 bits (129), Expect = 5e-08
 Identities = 34/140 (24%), Positives = 63/140 (45%), Gaps = 16/140 (11%)

Query: 259 LCVVTKLMEGGSVNDLILKSRK----LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQR 314
           LC+V  +M GG +   I    +                +  G++ L+   + YRDL  + 
Sbjct: 68  LCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPEN 127

Query: 315 ILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR----WLAPEIIAGDPESVSETWMSN 370
           +LLD  GNV + D+G+    K      + +T GY     ++APE++ G+    S  +   
Sbjct: 128 VLLDNDGNVRISDLGLAVELK----DGQSKTKGYAGTPGFMAPELLQGEEYDFSVDY--- 180

Query: 371 VYSFGMVIWEMVTGEAAYAA 390
            ++ G+ ++EM+     + A
Sbjct: 181 -FALGVTLYEMIAARGPFRA 199

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 54.5 bits (131), Expect = 5e-08
 Identities = 32/107 (29%), Positives = 54/107 (50%), Gaps = 14/107 (13%)

Query: 281 LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA 340
           L  ++ I I   + E + +L+  G+ +RD+ ++ I LD   N  LGD G   ACK   +A
Sbjct: 182 LPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFG--AACKL--DA 237

Query: 341 TEYETDGYRWL------APEIIAGDPESVSETWMSNVYSFGMVIWEM 381
                  Y W       +PE++A DP        ++++S G+V++EM
Sbjct: 238 HPDTPQCYGWSGTLETNSPELLALDPYCAK----TDIWSAGLVLFEM 280

Length = 392

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 53.0 bits (128), Expect = 8e-08
 Identities = 51/221 (23%), Positives = 98/221 (44%), Gaps = 38/221 (17%)

Query: 243 KNILQ----------FYCVCVDENHGLCVVTKLMEGGSVNDL--ILKSRKLQTKEIIRIA 290
           ++IL           +Y     +N  L +V + + GG   DL  +L++     +++ RI 
Sbjct: 44  RDILSQAQSPYVVKLYYSFQGKKN--LYLVMEYLPGG---DLASLLENVGSLDEDVARIY 98

Query: 291 I-DVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGD-----MGIVTACKSVGEATEYE 344
           I ++   +++L+ +G+ +RDL    IL+D +G++ L D     +G+V    ++ +  + +
Sbjct: 99  IAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKED 158

Query: 345 -----TDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVG 399
                T  Y  +APE+I G   S +  W    +S G +++E + G   +   +P +    
Sbjct: 159 KRIVGTPDY--IAPEVILGQGHSKTVDW----WSLGCILYEFLVGIPPFHGETPEEIFQN 212

Query: 400 IAACGLRPEIPKDC--PQILKSLMIKCWNNSPSKRPQFSEI 438
           I     + E P+D         L+ K     P KR     I
Sbjct: 213 I--LNGKIEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSI 251

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 53.3 bits (128), Expect = 9e-08
 Identities = 35/137 (25%), Positives = 67/137 (48%), Gaps = 4/137 (2%)

Query: 252 CVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLN 311
           C      L  V + + GG +   + + RKL  +     + +++  + FL++ G+ YRDL 
Sbjct: 64  CFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLK 123

Query: 312 SQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNV 371
              +LLD  G++ L D G+       G+ T        ++APEI+ G+    S  W    
Sbjct: 124 LDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDW---- 179

Query: 372 YSFGMVIWEMVTGEAAY 388
           ++ G++++EM+ G + +
Sbjct: 180 WALGVLMFEMMAGRSPF 196

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 52.7 bits (126), Expect = 1e-07
 Identities = 38/179 (21%), Positives = 83/179 (46%), Gaps = 9/179 (5%)

Query: 259 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLD 318
           L ++   + GG +   + +  + + +E+   + ++   ++ L+  G+ YRD+  + ILLD
Sbjct: 80  LHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLD 139

Query: 319 RHGNVCLGDMGIVTACKSVGEATEYETDG-YRWLAPEIIAGDPESVSET--WMSNVYSFG 375
            +G+V L D G+            Y   G   ++AP+I+ G      +   W    +S G
Sbjct: 140 SNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDW----WSMG 195

Query: 376 MVIWEMVTGEAAYAACSPVQAAVGIAACGLR--PEIPKDCPQILKSLMIKCWNNSPSKR 432
           ++++E++TG + +       +   I+   L+  P  P++   + K ++ +     P KR
Sbjct: 196 VLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDIIQRLLMKDPKKR 254

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 53.4 bits (128), Expect = 1e-07
 Identities = 30/111 (27%), Positives = 58/111 (52%), Gaps = 16/111 (14%)

Query: 277 KSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMG---IVTA 333
           + R L   ++  +A  +   I +++  G+ +RD+ ++ +L++   ++CLGD G       
Sbjct: 253 RLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARG 312

Query: 334 CKSV----GEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWE 380
             S     G A   +T+     APE++AGDP + S     +++S G+VI+E
Sbjct: 313 SWSTPFHYGIAGTVDTN-----APEVLAGDPYTPS----VDIWSAGLVIFE 354

Length = 461

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 52.7 bits (126), Expect = 1e-07
 Identities = 47/204 (23%), Positives = 96/204 (47%), Gaps = 13/204 (6%)

Query: 187 LNSDNLEFIDQIGPNSFKGVYK-----GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCG 241
           L  D+ E I ++G  +   V+K        +   KL   +   A   ++ ++L  L  C 
Sbjct: 2   LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECN 61

Query: 242 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 301
              I+ FY     +   + +  + M+GGS++ ++ K+ ++  + + +++I V +G+ +L 
Sbjct: 62  SPYIVGFYGAFYSDGE-ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 120

Query: 302 D-HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDP 360
           + H + +RD+    IL++  G + L D G+          +   T  Y  ++PE + G  
Sbjct: 121 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSY--MSPERLQGTH 178

Query: 361 ESVSETWMSNVYSFGMVIWEMVTG 384
            SV     S+++S G+ + EM  G
Sbjct: 179 YSVQ----SDIWSMGLSLVEMAIG 198

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 52.4 bits (126), Expect = 2e-07
 Identities = 50/201 (24%), Positives = 84/201 (41%), Gaps = 38/201 (18%)

Query: 271 VNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGI 330
           ++DL      L    + +    +  GI+F + H + +RD+  + IL+ + G V L D G 
Sbjct: 87  LDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGF 146

Query: 331 VTACKSVGEA-TEY-ETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAY 388
                + GE  T+Y  T  YR  APE++ GD +        ++++ G ++ EM+TGE  +
Sbjct: 147 ARTLAAPGEVYTDYVATRWYR--APELLVGDTKYGRAV---DIWAVGCLVTEMLTGEPLF 201

Query: 389 AACSPVQAAVGIAAC-------------------GLR-PEI----------PKDCPQILK 418
              S +     I  C                   G+R PE+          PK    +L 
Sbjct: 202 PGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVL- 260

Query: 419 SLMIKCWNNSPSKRPQFSEII 439
            L  +C    P  RP  S+++
Sbjct: 261 DLAKQCLRIDPDDRPSSSQLL 281

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 51.8 bits (124), Expect = 2e-07
 Identities = 44/151 (29%), Positives = 69/151 (45%), Gaps = 14/151 (9%)

Query: 242 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL----KSRKLQTKEIIRIAIDVAEGI 297
           H NILQ    CV E     +V +  E G +   +       R  Q   + R+A ++A G+
Sbjct: 54  HPNILQCLGQCV-EAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGV 112

Query: 298 KFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGI-VTACKSVGEATEYETDGY---RWLAP 353
             ++ H   + DL  +   L     V +GD GI  +  K   +  E E D     RWLAP
Sbjct: 113 THMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKE--DYIETEDDKCVPLRWLAP 170

Query: 354 EIIA---GDPESVSETWMSNVYSFGMVIWEM 381
           E++    G   +  +T  SNV++ G+ +WE+
Sbjct: 171 ELVGEFHGGLITAEQTKPSNVWALGVTLWEL 201

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 51.7 bits (124), Expect = 3e-07
 Identities = 47/192 (24%), Positives = 82/192 (42%), Gaps = 30/192 (15%)

Query: 232 KDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKS-RKLQTKEIIRIA 290
           ++L  L  C    I+ FY     +   + +  + M+GGS+ D +LK   ++    + +I+
Sbjct: 48  RELKVLHECNSPYIVGFYGAFYSDGE-ISICMEHMDGGSL-DQVLKKAGRIPENILGKIS 105

Query: 291 IDVAEGIKFLND-HGVAYRDLNSQRILLDRHGNVCLGDMGI------VTACKSVGEATEY 343
           I V  G+ +L + H + +RD+    IL++  G + L D G+        A   VG     
Sbjct: 106 IAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVG----- 160

Query: 344 ETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTG--------EAAYAACSPVQ 395
            T  Y  ++PE + G   +V     S+++S G+ + EM  G             A     
Sbjct: 161 -TRSY--MSPERLQGTHYTVQ----SDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRP 213

Query: 396 AAVGIAACGLRP 407
            + G A    RP
Sbjct: 214 VSEGEAKESHRP 225

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 51.6 bits (123), Expect = 3e-07
 Identities = 44/208 (21%), Positives = 98/208 (47%), Gaps = 21/208 (10%)

Query: 187 LNSDNLEFIDQIGPNSFKGVYK-----GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCG 241
           L  D+ E I ++G  +   V K        +   KL   +   A   ++ ++L  L  C 
Sbjct: 2   LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECN 61

Query: 242 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 301
              I+ FY     +   + +  + M+GGS++ ++ +++++  + + +++I V  G+ +L 
Sbjct: 62  SPYIVGFYGAFYSDGE-ISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLR 120

Query: 302 D-HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY----RWLAPEII 356
           + H + +RD+    IL++  G + L D G+       G+  +   + +     +++PE +
Sbjct: 121 EKHQIMHRDVKPSNILVNSRGEIKLCDFGV------SGQLIDSMANSFVGTRSYMSPERL 174

Query: 357 AGDPESVSETWMSNVYSFGMVIWEMVTG 384
            G   SV     S+++S G+ + E+  G
Sbjct: 175 QGTHYSVQ----SDIWSMGLSLVELAIG 198

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 51.5 bits (123), Expect = 3e-07
 Identities = 68/252 (26%), Positives = 105/252 (41%), Gaps = 46/252 (18%)

Query: 222 KGNAYEFELRKDLLELM---TCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKS 278
           + +A   E  K L E     +  H N+LQ    C +    L V    ME   + DL    
Sbjct: 31  RVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLV----MEFCPLGDLKGYL 86

Query: 279 RKLQTKEII--------RIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGI 330
           R  +  E++        R+A ++A G+  L+ +   + DL  +  LL     V +GD G+
Sbjct: 87  RSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGL 146

Query: 331 VTACKSVGEATEYETDGY----------RWLAPEI---IAGDPESVSETWMSNVYSFGMV 377
            +  K       Y+ D Y          RW+APE+   + G+   V +T  SNV+S G+ 
Sbjct: 147 -SHNK-------YKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVT 198

Query: 378 IWEMVT-GEAAYAACSPVQA-AVGIAACGLRPEIPKDCPQILKS-----LMIKCWNNSPS 430
           IWE+   G   Y   S  Q     +    L+  +PK   ++  S     +M  CW   P 
Sbjct: 199 IWELFELGSQPYRHLSDEQVLTYTVREQQLK--LPKPRLKLPLSDRWYEVMQFCW-LQPE 255

Query: 431 KRPQFSEIISLL 442
           +RP   E+  LL
Sbjct: 256 QRPSAEEVHLLL 267

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 51.6 bits (123), Expect = 3e-07
 Identities = 37/151 (24%), Positives = 64/151 (42%), Gaps = 6/151 (3%)

Query: 290 AIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR 349
           A ++A  + +L+   + YRDL  + ILLD  G++ L D G+          T        
Sbjct: 102 AAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPE 161

Query: 350 WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGI--AACGLRP 407
           +LAPE++   P   +  W    +  G V++EM+ G   + + +  +    I      L+P
Sbjct: 162 YLAPEVLHKQPYDRTVDW----WCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKP 217

Query: 408 EIPKDCPQILKSLMIKCWNNSPSKRPQFSEI 438
            I      +L+ L+ K        +  F EI
Sbjct: 218 NITNSARHLLEGLLQKDRTKRLGAKDDFMEI 248

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 51.3 bits (123), Expect = 3e-07
 Identities = 42/172 (24%), Positives = 71/172 (41%), Gaps = 28/172 (16%)

Query: 276 LKSRKLQTKEIIRIAI-DVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC 334
           L  R+  T+  +R+ I ++   +  L+  G+ YRD+  + ILLD  G+V L D G+    
Sbjct: 96  LYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGL---S 152

Query: 335 KSVGEATEYETDGY----RWLAPEIIAGDPESVSET--WMSNVYSFGMVIWEMVTGEAAY 388
           K      E     +     ++APE+I G      +   W    +S G++ +E++TG    
Sbjct: 153 KEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDW----WSLGVLTFELLTG---- 204

Query: 389 AACSPV--------QAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKR 432
              SP         Q+ +       +P  PK      +  + K     P KR
Sbjct: 205 --ASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEARDFIQKLLEKDPKKR 254

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 51.7 bits (124), Expect = 3e-07
 Identities = 31/99 (31%), Positives = 49/99 (49%), Gaps = 12/99 (12%)

Query: 290 AIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY- 348
           A ++A  + +L+   + YRDL  + ILLD  G+V L D G+   CK  G      T  + 
Sbjct: 102 AAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGL---CKE-GIEHSKTTSTFC 157

Query: 349 ---RWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTG 384
               +LAPE++   P   +  W    +  G V++EM+ G
Sbjct: 158 GTPEYLAPEVLRKQPYDRTVDW----WCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 50.9 bits (122), Expect = 5e-07
 Identities = 56/227 (24%), Positives = 104/227 (45%), Gaps = 53/227 (23%)

Query: 191 NLEFIDQIGPNSFKGVYKG-----------KRVGIEKLKGCDKGNAYEFELRKDLLELMT 239
           N + ++++G  ++  VYKG           K + ++  +G       E  L K+L     
Sbjct: 1   NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKEL----- 55

Query: 240 CGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVA----- 294
             H+NI++ + V   EN  L +V + M+     DL    +K      +R A+D       
Sbjct: 56  -KHENIVRLHDVIHTENK-LMLVFEYMD----KDL----KKYMDTHGVRGALDPNTVKSF 105

Query: 295 -----EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE-----ATEYE 344
                +GI F +++ V +RDL  Q +L+++ G + L D G+    ++ G      + E  
Sbjct: 106 TYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLA---RAFGIPVNTFSNEVV 162

Query: 345 TDGYRWLAPEIIAGDPESVSETWMS--NVYSFGMVIWEMVTGEAAYA 389
           T  YR  AP+++ G     S T+ +  +++S G ++ EM+TG   + 
Sbjct: 163 TLWYR--APDVLLG-----SRTYSTSIDIWSVGCIMAEMITGRPLFP 202

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 50.6 bits (121), Expect = 5e-07
 Identities = 55/219 (25%), Positives = 94/219 (42%), Gaps = 39/219 (17%)

Query: 191 NLEFIDQIGPNSFKGVYK------GKRVGIEKLK------GCDKGNAYEFELRKDLLELM 238
           N + +++IG  ++  VYK      G+ V ++K++      G       E  L K+L    
Sbjct: 1   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL---- 56

Query: 239 TCGHKNILQFYCVCVDENHGLCV-------VTKLMEGGSVNDLILKSRKLQTKEIIRIAI 291
              H NI++   V   EN    V       + K M+   ++ + L   K    +++    
Sbjct: 57  --NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLL---- 110

Query: 292 DVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE--TDGYR 349
              +G+ F + H V +RDL  Q +L++  G + L D G+  A         +E  T  YR
Sbjct: 111 ---QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYR 167

Query: 350 WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAY 388
             APEI+ G       +   +++S G +  EMVT  A +
Sbjct: 168 --APEILLG---CKYYSTAVDIWSLGCIFAEMVTRRALF 201

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 50.5 bits (121), Expect = 5e-07
 Identities = 42/169 (24%), Positives = 79/169 (46%), Gaps = 11/169 (6%)

Query: 277 KSRKLQTKEII--RIAIDVAEGIKFLNDH-GVAYRDLNSQRILLDRHGNVCLGDMGIV-T 332
             + L   E I  +IA+ + + +++L+    V +RD+    +L++R+G V L D GI   
Sbjct: 94  YDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGY 153

Query: 333 ACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAAC- 391
              SV +  +     Y  +APE I  +         S+V+S G+ + E+ TG   Y +  
Sbjct: 154 LVDSVAKTIDAGCKPY--MAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWK 211

Query: 392 SPVQAAVGIAACGLRPEIPKD--CPQILKSLMIKCWNNSPSKRPQFSEI 438
           +P Q    +      P++P +   P+  +  + KC   +  +RP + E+
Sbjct: 212 TPFQQLKQVVE-EPSPQLPAEKFSPEF-QDFVNKCLKKNYKERPNYPEL 258

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 50.7 bits (122), Expect = 6e-07
 Identities = 35/202 (17%), Positives = 84/202 (41%), Gaps = 17/202 (8%)

Query: 193 EFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNIL 246
           + + +IG  +   V+K      G+ V ++K+           +  +++  L  C H  ++
Sbjct: 3   KILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVV 62

Query: 247 QFYCVCVDENHGLCVVTKLME--GGSVNDLILKSRK-LQTKEIIRIAIDVAEGIKFLNDH 303
           +   V     HG   V  +ME     +++++    + L   ++      + +G+ +++ +
Sbjct: 63  KLLDV---FPHGSGFVL-VMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN 118

Query: 304 GVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWL-APEIIAGDPES 362
           G+ +RDL    +L+   G + + D G+                  RW  APE++ G  + 
Sbjct: 119 GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKY 178

Query: 363 VSETWMSNVYSFGMVIWEMVTG 384
                  ++++ G +  E++ G
Sbjct: 179 DPGV---DLWAVGCIFAELLNG 197

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 50.4 bits (121), Expect = 7e-07
 Identities = 38/159 (23%), Positives = 65/159 (40%), Gaps = 16/159 (10%)

Query: 242 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKE--IIRIAIDVAEGIKF 299
           H NIL +    +  +  L VV+ LM  GS  DL+         E  I  I  DV   + +
Sbjct: 58  HPNILPYVTSFIV-DSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDY 116

Query: 300 LNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA---------TEYETDGYRW 350
           ++  G  +R + +  ILL   G V L   G+  +   +             +       W
Sbjct: 117 IHSKGFIHRSVKASHILLSGDGKVVLS--GLRYSVSMIKHGKRQRVVHDFPKSSVKNLPW 174

Query: 351 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYA 389
           L+PE++  + +  +E   S++YS G+   E+  G   + 
Sbjct: 175 LSPEVLQQNLQGYNEK--SDIYSVGITACELANGHVPFK 211

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 50.2 bits (120), Expect = 7e-07
 Identities = 59/231 (25%), Positives = 100/231 (43%), Gaps = 27/231 (11%)

Query: 190 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLK-GCDKGNAYEFELRKDLLELMTCGH 242
           D  E +++IG  ++  VYK      GK V ++K +   D+       LR+  L  M    
Sbjct: 1   DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60

Query: 243 KNILQFYCV-CVDENHG---LCVVTKLMEGGSVNDLIL----KSRKLQTKEIIRIAIDVA 294
             I++   V  V+E +G   L +V + ++      +        R L  K I      + 
Sbjct: 61  IYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLL 120

Query: 295 EGIKFLNDHGVAYRDLNSQRILLDRHGNVC-LGDMGIVTACK-SVGEAT-EYETDGYRWL 351
           +G+   + HGV +RDL  Q +L+D+   +  + D+G+  A    V   T E  T  YR  
Sbjct: 121 KGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYR-- 178

Query: 352 APEIIAGDPESVSETWMSNV--YSFGMVIWEMVTGEAAYAACSPVQAAVGI 400
           APE++ G     S  + + V  +S G +  EM   +  +   S +Q  + I
Sbjct: 179 APEVLLG-----STHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHI 224

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 50.3 bits (120), Expect = 1e-06
 Identities = 38/155 (24%), Positives = 72/155 (46%), Gaps = 25/155 (16%)

Query: 274 LILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGI--- 330
           L  +SR L   + + I   + EG+++L+   + +RD+ ++ I ++    VC+GD+G    
Sbjct: 147 LTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQF 206

Query: 331 -VTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMV------- 382
            V A   +G A   ET+     APE++A D  +      ++++S G+V++EM+       
Sbjct: 207 PVVAPAFLGLAGTVETN-----APEVLARDKYNSK----ADIWSAGIVLFEMLAYPSTIF 257

Query: 383 ----TGEAAYAACSPVQAAVGIAACGLRP-EIPKD 412
               +    Y           I+   + P E P+D
Sbjct: 258 EDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRD 292

Length = 357

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 49.3 bits (117), Expect = 1e-06
 Identities = 51/265 (19%), Positives = 112/265 (42%), Gaps = 30/265 (11%)

Query: 191 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLE----LMTC 240
           N +   +IG   F  VY+       K V ++K++  +  +A   + R+D ++    L   
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDA---KARQDCVKEIDLLKQL 59

Query: 241 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL----KSRKLQTKEIIRIAIDVAEG 296
            H N++++    +++N  L +V +L + G ++ +I     + R +  + + +  + +   
Sbjct: 60  NHPNVIKYLDSFIEDNE-LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSA 118

Query: 297 IKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEII 356
           ++ ++   V +RD+    + +   G V LGD+G+       G     +T     L     
Sbjct: 119 VEHMHSRRVMHRDIKPANVFITATGVVKLGDLGL-------GRFFSSKTTAAHSLVGTPY 171

Query: 357 AGDPESVSE---TWMSNVYSFGMVIWEMVTGEAAYAA--CSPVQAAVGIAACGLRPEIPK 411
              PE + E    + S+++S G +++EM   ++ +     +       I  C   P   +
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTE 231

Query: 412 DCPQILKSLMIKCWNNSPSKRPQFS 436
              + L+ L+  C    P +RP   
Sbjct: 232 HYSEKLRELVSMCIYPDPDQRPDIG 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 49.3 bits (118), Expect = 2e-06
 Identities = 41/148 (27%), Positives = 63/148 (42%), Gaps = 21/148 (14%)

Query: 303 HGVAYRDLNSQRILLDRHGNVCLGDMGI-------VTACKSVGEATEYETDGYRWLAPEI 355
           HGV +RD+    ILLD  GNV L D GI           +S G A         ++APE 
Sbjct: 134 HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAGCAA--------YMAPER 185

Query: 356 IAGDPESVSETW--MSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIP--K 411
           I  DP   +  +   ++V+S G+ + E+ TG+  Y  C      +        P +P  +
Sbjct: 186 I--DPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNE 243

Query: 412 DCPQILKSLMIKCWNNSPSKRPQFSEII 439
                  S +  C      KRP++ E++
Sbjct: 244 GFSPDFCSFVDLCLTKDHRKRPKYRELL 271

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 48.8 bits (116), Expect = 2e-06
 Identities = 35/133 (26%), Positives = 61/133 (45%), Gaps = 6/133 (4%)

Query: 300 LNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGD 359
           L+   V YRDL  + ILLD  G++ L D G+        + T        +LAPE++ G 
Sbjct: 109 LHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGH 168

Query: 360 PESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKS 419
             + +  W    ++ G++++EM+TG   +   +  +    I    LR   P    +  K 
Sbjct: 169 GYTKAVDW----WTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLR--FPDGFDRDAKD 222

Query: 420 LMIKCWNNSPSKR 432
           L+I   +  P++R
Sbjct: 223 LLIGLLSRDPTRR 235

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 48.3 bits (115), Expect = 3e-06
 Identities = 52/273 (19%), Positives = 108/273 (39%), Gaps = 27/273 (9%)

Query: 191 NLEFIDQIGPNSFKGVYK-GKRVGIEKLKGCDKGNAYEFELRKDLLE--------LMTCG 241
               ++ +G  +F  VYK  K+   + L    + N +     KD  E        +    
Sbjct: 1   EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVT 60

Query: 242 -------HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLI--LKSRK--LQTKEIIRIA 290
                  H NI+++Y   + EN  L +V  L+EG  + +    LK +K     + I  I 
Sbjct: 61  IIKEQLRHPNIVRYYKTFL-ENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIF 119

Query: 291 IDVAEGIKFLN-DHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR 349
           + +   +++L+ +  + +RDL    I+L     V + D G+    K              
Sbjct: 120 VQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQ-KQPESKLTSVVGTIL 178

Query: 350 WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEI 409
           +  PEI+  +P        ++V++FG ++++M T +  + + + +  A  I      P  
Sbjct: 179 YSCPEIVKNEP----YGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLP 234

Query: 410 PKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
                + +  ++  C       RP   ++ +++
Sbjct: 235 EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMI 267

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 48.9 bits (116), Expect = 4e-06
 Identities = 43/197 (21%), Positives = 89/197 (45%), Gaps = 33/197 (16%)

Query: 204 KGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT 263
           +G  K +R+  +++K   +       L  ++L L    H+NIL+   +   E +   +  
Sbjct: 187 QGKPKCERLIAKRVKAGSRAAIQ---LENEILALGRLNHENILKIEEILRSEANTYMITQ 243

Query: 264 K-------LMEGGSVNDLILKSRKL--QTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQR 314
           K        M          K R L  QT+ I++    +   +++++D  + +RD+  + 
Sbjct: 244 KYDFDLYSFMYDE---AFDWKDRPLLKQTRAIMK---QLLCAVEYIHDKKLIHRDIKLEN 297

Query: 315 ILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWL------APEIIAGDPESVSETWM 368
           I L+  G + LGD G     +   EA +Y      W+      +PEI+AGD        +
Sbjct: 298 IFLNCDGKIVLGDFGTAMPFEKEREAFDYG-----WVGTVATNSPEILAGD----GYCEI 348

Query: 369 SNVYSFGMVIWEMVTGE 385
           ++++S G+++ +M++ +
Sbjct: 349 TDIWSCGLILLDMLSHD 365

Length = 501

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 48.4 bits (115), Expect = 4e-06
 Identities = 36/156 (23%), Positives = 65/156 (41%), Gaps = 12/156 (7%)

Query: 242 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILK--SRKLQTKEIIRIAIDVAEGIKF 299
           H NI+ +    + +N  L VVT  M  GS  DLI       +    I  I   V + + +
Sbjct: 58  HPNIVPYRATFIADNE-LWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDY 116

Query: 300 LNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTA-------CKSVGEATEYETDGYRWLA 352
           ++  G  +R + +  IL+   G V L  +    +        + V +  +Y      WL+
Sbjct: 117 IHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLS 176

Query: 353 PEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAY 388
           PE++  + +       S++YS G+   E+  G   +
Sbjct: 177 PEVLQQNLQGYDAK--SDIYSVGITACELANGHVPF 210

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 48.1 bits (115), Expect = 4e-06
 Identities = 33/119 (27%), Positives = 57/119 (47%), Gaps = 11/119 (9%)

Query: 272 NDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMG-- 329
           N+L    R +    I +I     + + F + H   +RD+  + IL+ + G + L D G  
Sbjct: 88  NELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFA 147

Query: 330 -IVTACKSVGEATEY-ETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEA 386
            I+T      + T+Y  T  YR  APE++ GD +        +V++ G V  E++TG+ 
Sbjct: 148 RILTG--PGDDYTDYVATRWYR--APELLVGDTQYGPPV---DVWAIGCVFAELLTGQP 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 48.3 bits (115), Expect = 4e-06
 Identities = 28/94 (29%), Positives = 46/94 (48%), Gaps = 4/94 (4%)

Query: 297 IKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEII 356
           ++ L+  G+ YRDL  + ILLD  G+V L D G+       G  T        ++APEI+
Sbjct: 113 LEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEIL 172

Query: 357 AGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAA 390
                  +  W    +S G ++++M+TG   + A
Sbjct: 173 MRSGHGKAVDW----WSLGALMYDMLTGAPPFTA 202

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 48.0 bits (115), Expect = 5e-06
 Identities = 50/211 (23%), Positives = 91/211 (43%), Gaps = 46/211 (21%)

Query: 193 EFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYE----FELR--KDLLELMTC 240
           E   ++G  ++  VYK      G+ V I+K+K  ++  A +      LR  K L EL   
Sbjct: 3   EKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK-- 60

Query: 241 GHKNILQFYCV-CVDENHGLCVVTKLMEGGSVNDL--ILKSRKL-----QTKEIIRIAID 292
            H NI+    V     N  + +V + ME     DL  ++K + +       K  + + + 
Sbjct: 61  -HPNIIGLLDVFGHKSN--INLVFEFMET----DLEKVIKDKSIVLTPADIKSYMLMTL- 112

Query: 293 VAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE--TDGYRW 350
              G+++L+ + + +RDL    +L+   G + L D G+  +  S      ++  T  YR 
Sbjct: 113 --RGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYR- 169

Query: 351 LAPEIIAGDPESVSETWMSNVYSFGMVIWEM 381
            APE++ G          +  Y  G+ +W +
Sbjct: 170 -APELLFG----------ARHYGVGVDMWSV 189

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 48.1 bits (114), Expect = 5e-06
 Identities = 44/163 (26%), Positives = 78/163 (47%), Gaps = 27/163 (16%)

Query: 245 ILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL------KSRKLQTKEIIRIAIDVAEGIK 298
           ++Q +C   D+ + L +V + M GG + +L+       K  K  T E++ +A+D      
Sbjct: 105 VVQLFCAFQDDKY-LYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVV-LALDA----- 157

Query: 299 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA---TEYETDGYRWLAPEI 355
            ++  G+ +RD+    +LLD+HG++ L D G        G     T   T  Y  ++PE+
Sbjct: 158 -IHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDY--ISPEV 214

Query: 356 I---AGDPESVSET-WMSNVYSFGMVIWEMVTGEAAYAACSPV 394
           +    GD     E  W    +S G+ ++EM+ G+  + A S V
Sbjct: 215 LKSQGGDGYYGRECDW----WSVGVFLFEMLVGDTPFYADSLV 253

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 48.0 bits (114), Expect = 5e-06
 Identities = 39/145 (26%), Positives = 64/145 (44%), Gaps = 8/145 (5%)

Query: 292 DVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG-YRW 350
           ++   ++ L+  G+ YRD+  + ILLD  G+V L D G+     S  +   Y   G   +
Sbjct: 113 EIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEY 172

Query: 351 LAPEIIAGDP-ESVSETWMSNVYSFGMVIWEMVTGEAAYA--ACSPVQAAVGIAACGLRP 407
           +APEII G      +  W    +S G++I+E++TG + +        Q+ V        P
Sbjct: 173 MAPEIIRGKGGHGKAVDW----WSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDP 228

Query: 408 EIPKDCPQILKSLMIKCWNNSPSKR 432
             P       + L+ K     P KR
Sbjct: 229 PFPSFIGPEAQDLLHKLLRKDPKKR 253

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 48.7 bits (116), Expect = 6e-06
 Identities = 49/202 (24%), Positives = 84/202 (41%), Gaps = 34/202 (16%)

Query: 242 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 301
           H NI+            L  V + + G ++ +++     L   E  R+ + V + +   +
Sbjct: 37  HPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVLAADGALPAGETGRLMLQVLDALACAH 96

Query: 302 DHGVAYRDLNSQRILLDRHG---NVCLGDMGIVTACKSVGEA--------TEY-ETDGYR 349
           + G+ +RDL  Q I++ + G   +  + D GI T    V +A        TE   T  Y 
Sbjct: 97  NQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTY- 155

Query: 350 WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAA----------YAACSPVQAAVG 399
             APE + G+P     T  S++Y++G++  E +TG+            Y   SPV  ++ 
Sbjct: 156 -CAPEQLRGEP----VTPNSDLYAWGLIFLECLTGQRVVQGASVAEILYQQLSPVDVSLP 210

Query: 400 IAACG------LRPEIPKDCPQ 415
               G      LR  + KD  Q
Sbjct: 211 PWIAGHPLGQVLRKALNKDPRQ 232

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 47.3 bits (113), Expect = 7e-06
 Identities = 44/209 (21%), Positives = 85/209 (40%), Gaps = 21/209 (10%)

Query: 190 DNLEFIDQIGPNSFKGVYKGKR------VGIEKLKGCDKGNAYEFELRKDLLELMTCGHK 243
           +  E +  +G  ++  V K +       V I+K K  +     +    +++  L    H+
Sbjct: 1   NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE 60

Query: 244 NILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDH 303
           NI+        +   L +V + +E   +  L      L    +      + + I + + H
Sbjct: 61  NIVNLKEAFRRKGR-LYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSH 119

Query: 304 GVAYRDLNSQRILLDRHGNVCLGDMGIVTA--CKSVGEATEY-ETDGYRWLAPEIIAGDP 360
            + +RD+  + IL+   G + L D G   A   +     T+Y  T  YR  APE++ GD 
Sbjct: 120 NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYR--APELLVGDT 177

Query: 361 E---SVSETWMSNVYSFGMVIWEMVTGEA 386
                V      +V++ G ++ E++ GE 
Sbjct: 178 NYGKPV------DVWAIGCIMAELLDGEP 200

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 47.4 bits (112), Expect = 8e-06
 Identities = 30/133 (22%), Positives = 63/133 (47%), Gaps = 10/133 (7%)

Query: 259 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLD 318
           LC V + + GG +   + + R            ++   + +L+   + YRDL  + ++LD
Sbjct: 70  LCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLD 129

Query: 319 RHGNVCLGDMGIVTACKS-VGEATEYET--DGYRWLAPEIIAGDPESVSETWMSNVYSFG 375
           + G++ + D G+   CK  + +A   +T      +LAPE++  +    +  W    +  G
Sbjct: 130 KDGHIKITDFGL---CKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDW----WGLG 182

Query: 376 MVIWEMVTGEAAY 388
           +V++EM+ G   +
Sbjct: 183 VVMYEMMCGRLPF 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 47.1 bits (112), Expect = 9e-06
 Identities = 41/161 (25%), Positives = 73/161 (45%), Gaps = 24/161 (14%)

Query: 242 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDL--ILKSRKLQTKEIIRIAIDVAEGIKF 299
           H+NI+    + +     +  VT+L+      DL  +L SR L+ + I      +  G+K+
Sbjct: 68  HENIISLSDIFISPLEDIYFVTELLG----TDLHRLLTSRPLEKQFIQYFLYQILRGLKY 123

Query: 300 LNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY-ETDGYRWLAPEIIAG 358
           ++  GV +RDL    IL++ + ++ + D G+        + T Y  T  YR  APEI+  
Sbjct: 124 VHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP--QMTGYVSTRYYR--APEIML- 178

Query: 359 DPESVSETWMS-----NVYSFGMVIWEMVTGEAAYAACSPV 394
                  TW       +++S G +  EM+ G+  +     V
Sbjct: 179 -------TWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHV 212

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 46.5 bits (111), Expect = 1e-05
 Identities = 37/159 (23%), Positives = 67/159 (42%), Gaps = 37/159 (23%)

Query: 259 LCVVTKLMEGGSVNDLILKSR--KLQTKEIIRI-AIDVAEGIKFLNDHGVAYRDLNSQRI 315
           LC+V     GG +  L L+ +  K  ++E+ R  A +V   +++L+  G+ YRDL  + I
Sbjct: 76  LCLVMDYCPGGELFRL-LQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENI 134

Query: 316 LLDRHGNVCLGDMGIVTACKSVGEATEY--------------------ETDGYR------ 349
           LL   G++ L D  +                                 E   +R      
Sbjct: 135 LLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVG 194

Query: 350 ---WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGE 385
              ++APE+I+GD    +  W    ++ G++++EM+ G 
Sbjct: 195 TEEYIAPEVISGDGHGSAVDW----WTLGILLYEMLYGT 229

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 46.5 bits (110), Expect = 1e-05
 Identities = 52/218 (23%), Positives = 95/218 (43%), Gaps = 47/218 (21%)

Query: 195 IDQIGPNSFKGVYKG-----------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHK 243
           +D++G  ++  VYKG           K + +E  +G       E  L KDL       H 
Sbjct: 11  LDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDL------KHA 64

Query: 244 NILQFYCVCVDENHGLCVVTKLME----------GGSVNDLILKSRKLQTKEIIRIAIDV 293
           NI+  + + +     L +V + ++          G S+N   + + KL   +++R     
Sbjct: 65  NIVTLHDI-IHTEKSLTLVFEYLDKDLKQYLDDCGNSIN---MHNVKLFLFQLLR----- 115

Query: 294 AEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT---EYETDGYRW 350
             G+ + +   V +RDL  Q +L++  G + L D G+  A KS+   T   E  T  YR 
Sbjct: 116 --GLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARA-KSIPTKTYSNEVVTLWYR- 171

Query: 351 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAY 388
             P+I+ G  +  ++    +++  G + +EM TG   +
Sbjct: 172 -PPDILLGSTDYSTQI---DMWGVGCIFYEMSTGRPLF 205

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 46.2 bits (109), Expect = 2e-05
 Identities = 31/129 (24%), Positives = 61/129 (47%), Gaps = 10/129 (7%)

Query: 259 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLD 318
           LC V +   GG +   + + R    +       ++   +++L+   V YRD+  + ++LD
Sbjct: 70  LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLD 129

Query: 319 RHGNVCLGDMGIVTACKS--VGEATEYETDGY-RWLAPEIIAGDPESVSETWMSNVYSFG 375
           + G++ + D G+   CK      AT     G   +LAPE++  +    +  W    +  G
Sbjct: 130 KDGHIKITDFGL---CKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDW----WGLG 182

Query: 376 MVIWEMVTG 384
           +V++EM+ G
Sbjct: 183 VVMYEMMCG 191

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 46.3 bits (110), Expect = 2e-05
 Identities = 63/243 (25%), Positives = 110/243 (45%), Gaps = 50/243 (20%)

Query: 180 EEIGRWLLNSDNLEFIDQIGPNSF-----------KGVYKGKRVG-IEKLKGCDKGNAYE 227
           E+I +  + +++ + I  IG  +F           K VY  K +   E +K  D  +A+ 
Sbjct: 33  EKITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSD--SAFF 90

Query: 228 FELRKDLLELMTCGHKN---ILQFYCVCVDENHGLCVVTKLMEGGS-VN-----DLILKS 278
           +E R    ++M   H N   I+Q +    D+ + L +V + M GG  VN     D+  K 
Sbjct: 91  WEER----DIM--AHANSEWIVQLHYAFQDDKY-LYMVMEYMPGGDLVNLMSNYDIPEKW 143

Query: 279 RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG 338
            +  T E++ +A+D       ++  G  +RD+    +LLD+ G++ L D G      + G
Sbjct: 144 ARFYTAEVV-LALDA------IHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANG 196

Query: 339 EA---TEYETDGYRWLAPEII---AGDPESVSET-WMSNVYSFGMVIWEMVTGEAAYAAC 391
                T   T  Y  ++PE++    GD     E  W    +S G+ ++EM+ G+  + A 
Sbjct: 197 MVRCDTAVGTPDY--ISPEVLKSQGGDGYYGRECDW----WSVGVFLYEMLVGDTPFYAD 250

Query: 392 SPV 394
           S V
Sbjct: 251 SLV 253

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 45.5 bits (108), Expect = 2e-05
 Identities = 52/204 (25%), Positives = 88/204 (43%), Gaps = 26/204 (12%)

Query: 195 IDQIGPNSFKGVYKGKR------VGIEKLK------GCDKGNAYEFELRKDLLELMTCGH 242
           I++IG  ++  VYKG+       V ++K++      G       E  L K+L       H
Sbjct: 5   IEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKEL------QH 58

Query: 243 KNILQFYCVCVDENHGLCVVTKL-MEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 301
            NI+    V + E+    +   L M+     D + K + +  + +      + +GI F +
Sbjct: 59  PNIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH 118

Query: 302 DHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE--TDGYRWLAPEIIAGD 359
              V +RDL  Q +L+D  G + L D G+  A         +E  T  YR  APE++ G 
Sbjct: 119 SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYR--APEVLLGS 176

Query: 360 PESVSETWMSNVYSFGMVIWEMVT 383
           P   +     +++S G +  EM T
Sbjct: 177 PRYSTPV---DIWSIGTIFAEMAT 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 44.8 bits (106), Expect = 4e-05
 Identities = 29/130 (22%), Positives = 58/130 (44%), Gaps = 4/130 (3%)

Query: 255 ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQR 314
            +  LC V +   GG +   + + R            ++   + +L+   V YRDL  + 
Sbjct: 66  THDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLEN 125

Query: 315 ILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSF 374
           ++LD+ G++ + D G+     S G   +       +LAPE++  +    +  W    +  
Sbjct: 126 LMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDW----WGL 181

Query: 375 GMVIWEMVTG 384
           G+V++EM+ G
Sbjct: 182 GVVMYEMMCG 191

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 44.3 bits (105), Expect = 6e-05
 Identities = 66/275 (24%), Positives = 121/275 (44%), Gaps = 34/275 (12%)

Query: 189 SDNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELM---T 239
           +++L+ + +IG  +F  V K      G  + +++++        +  L  DL  +M    
Sbjct: 3   AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIR-STVDEKEQKRLLMDLDVVMRSSD 61

Query: 240 CGHKNILQFYCVCVDENHGLC-VVTKLMEGGSVNDLILKSRKLQTKEII------RIAID 292
           C    I++FY     E  G C +  +LM+     D   K      K +I      +IA+ 
Sbjct: 62  C--PYIVKFYGALFRE--GDCWICMELMD--ISLDKFYKYVYEVLKSVIPEEILGKIAVA 115

Query: 293 VAEGIKFL-NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR-W 350
             + + +L  +  + +RD+    ILLDR+GN+ L D GI  + + V    +    G R +
Sbjct: 116 TVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGI--SGQLVDSIAKTRDAGCRPY 173

Query: 351 LAPEIIAGDPESVSETWM-SNVYSFGMVIWEMVTGEAAYAACSPV----QAAVGIAACGL 405
           +APE I  DP +     + S+V+S G+ ++E+ TG+  Y   + V       V      L
Sbjct: 174 MAPERI--DPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPIL 231

Query: 406 RPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIIS 440
                ++      + +  C     SKRP++ E++ 
Sbjct: 232 SNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE 266

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 44.5 bits (106), Expect = 7e-05
 Identities = 44/170 (25%), Positives = 73/170 (42%), Gaps = 35/170 (20%)

Query: 241 GHKNILQFYCVCVDENH-GLCVVTKLMEGGSVNDL--ILKSRKLQTKEIIRIAIDVAEGI 297
            H NI++   V   EN   + +V + ME     DL  ++++  L+      I   + + +
Sbjct: 65  DHPNIVKLLNVIKAENDKDIYLVFEYME----TDLHAVIRANILEDVHKRYIMYQLLKAL 120

Query: 298 KFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----Y---RW 350
           K+++   V +RDL    ILL+    V L D G+    +S+ E  E   +     Y   RW
Sbjct: 121 KYIHSGNVIHRDLKPSNILLNSDCRVKLADFGL---ARSLSELEENPENPVLTDYVATRW 177

Query: 351 L-APEIIAGDPESVSETWMSNVYSFGMVIW-------EMVTGEAAYAACS 392
             APEI+ G          S  Y+ G+ +W       EM+ G+  +   S
Sbjct: 178 YRAPEILLG----------STRYTKGVDMWSVGCILGEMLLGKPLFPGTS 217

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 44.0 bits (104), Expect = 7e-05
 Identities = 59/218 (27%), Positives = 92/218 (42%), Gaps = 44/218 (20%)

Query: 190 DNLEFIDQIGPNSFKGVYKGK-RVGIE-------KLKGCDKG----NAYEFELRKDLLEL 237
           D  E +++IG  ++  VYK + RV  E       +L+  D+G       E  L K++   
Sbjct: 2   DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEM--- 58

Query: 238 MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKE------IIRIAI 291
               H NI++   V   E     V   L       DL LK     + +      +I+  +
Sbjct: 59  ---QHGNIVRLQDVVHSEKRLYLVFEYL-------DLDLKKHMDSSPDFAKNPRLIKTYL 108

Query: 292 -DVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVC-LGDMGIVTACKSVGEATEYE--TDG 347
             +  GI + + H V +RDL  Q +L+DR  N   L D G+  A         +E  T  
Sbjct: 109 YQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLW 168

Query: 348 YRWLAPEIIAGDPESVSETWMS--NVYSFGMVIWEMVT 383
           YR  APEI+ G     S  + +  +++S G +  EMV 
Sbjct: 169 YR--APEILLG-----SRHYSTPVDIWSVGCIFAEMVN 199

Length = 294

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 43.7 bits (103), Expect = 8e-05
 Identities = 39/149 (26%), Positives = 68/149 (45%), Gaps = 15/149 (10%)

Query: 238 MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGI 297
           M C HK I       V E+  + +V +  EGG +   I K   +  + + R A ++   +
Sbjct: 47  MVCLHKYI-------VSED-SVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVAL 98

Query: 298 KFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIA 357
             L+  G+  RDLN   ILLD  G++ L           V ++ + E     + APE+  
Sbjct: 99  DALHREGIVCRDLNPNNILLDDRGHIQLTYFS---RWSEVEDSCDGEAVENMYCAPEVGG 155

Query: 358 GDPESVSETWMSNVYSFGMVIWEMVTGEA 386
              E+ +  W    +S G +++E++TG+ 
Sbjct: 156 ISEETEACDW----WSLGAILFELLTGKT 180

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 44.3 bits (104), Expect = 9e-05
 Identities = 54/240 (22%), Positives = 95/240 (39%), Gaps = 51/240 (21%)

Query: 202 SFKGVYKGKRVGIEKLKGCDKGNAYEFE-LRK-DLLELMTCGH----KNIL--------- 246
           S K + +G    +  ++  D G+ Y  + LRK D+LE    GH    ++IL         
Sbjct: 5   SLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVV 64

Query: 247 -QFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGV 305
             FY     +   L ++ + + GG +  L++K   L  +E      +    I  ++  G 
Sbjct: 65  KMFYSF--QDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGF 122

Query: 306 AYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY----------------- 348
            +RD+    +LLD  G+V L D G+ T  K       Y    +                 
Sbjct: 123 IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKA 182

Query: 349 -------RWLAPEIIAGDPESVS-ETWMSNVY-------SFGMVIWEMVTGEAAYAACSP 393
                  R LA   + G P+ ++ E +M   Y       S G++++EM+ G   + + +P
Sbjct: 183 ETWKRNRRQLAFSTV-GTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETP 241

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 43.8 bits (104), Expect = 1e-04
 Identities = 33/98 (33%), Positives = 44/98 (44%), Gaps = 21/98 (21%)

Query: 295 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE--TDGYRWLA 352
           +GI + + H V +RDL  Q +L+DR G + L D G+  A         +E  T  YR  A
Sbjct: 110 QGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVTLWYR--A 167

Query: 353 PEIIAGDPESVSETWMSNVYSFGMVIW-------EMVT 383
           PEI+ G          S  YS  + IW       EMV 
Sbjct: 168 PEILLG----------SRQYSTPVDIWSIGCIFAEMVN 195

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 43.8 bits (103), Expect = 1e-04
 Identities = 49/217 (22%), Positives = 91/217 (41%), Gaps = 24/217 (11%)

Query: 190 DNLEFIDQIGPNSFKGV----YKGKR---VGIEKLKGC----DKGNAYEFELRKDLLELM 238
           ++  FI  +G  SF  V    YK +    V I++ +       K   + F  RK L  + 
Sbjct: 30  EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYI- 88

Query: 239 TCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIK 298
              H   +  Y    DE++ L +V + + GG     + ++++         A  +    +
Sbjct: 89  --NHPFCVNLYGSFKDESY-LYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFE 145

Query: 299 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY-RWLAPEIIA 357
           +L    + YRDL  + +LLD+ G + + D G       V +   Y   G   ++APEI+ 
Sbjct: 146 YLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFA----KVVDTRTYTLCGTPEYIAPEILL 201

Query: 358 GDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPV 394
                 +  W    ++ G+ I+E++ G   + A  P+
Sbjct: 202 NVGHGKAADW----WTLGIFIYEILVGCPPFYANEPL 234

Length = 340

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 43.4 bits (102), Expect = 1e-04
 Identities = 50/201 (24%), Positives = 88/201 (43%), Gaps = 30/201 (14%)

Query: 257 HGLCV-------VTKLMEGGSVNDLILKSRKLQTKEI--IRIAIDVAEGIKFLNDHGVAY 307
           HG+CV       V + +E G + D+ L+  K +      I +A  +A  + +L D  + +
Sbjct: 82  HGVCVRGSENIMVEEFVEHGPL-DVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVH 140

Query: 308 RDLNSQRILLDRHG-------NVCLGDMGI-VTACKSVGEATEYETDGYRWLAPEIIAGD 359
            ++ ++ ILL R G        + L D G+  TA      + E   +   W+APE +   
Sbjct: 141 GNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTAL-----SREERVERIPWIAPECV--- 192

Query: 360 PESVSETWMSNVYSFGMVIWEMV-TGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILK 418
           P   S +  ++ +SFG  + E+   GE      +P +           PE    C + L 
Sbjct: 193 PGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFYEKKHRLPE--PSCKE-LA 249

Query: 419 SLMIKCWNNSPSKRPQFSEII 439
           +L+ +C    P++RP F  I+
Sbjct: 250 TLISQCLTYEPTQRPSFRTIL 270

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 43.5 bits (102), Expect = 1e-04
 Identities = 45/194 (23%), Positives = 88/194 (45%), Gaps = 31/194 (15%)

Query: 209 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 263
           G RV ++KL    +   +     ++L  L    H+N++    V      ++E + + +VT
Sbjct: 42  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 101

Query: 264 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 323
            LM G  +N+ I+K +KL    +  +   +  G+K+++   + +RDL    + ++    +
Sbjct: 102 HLM-GADLNN-IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL 159

Query: 324 CLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIAGDPESVSETWMS-----NVYSF 374
            + D G+          T+ E  GY   RW  APEI+          WM      +++S 
Sbjct: 160 KILDFGL-------ARHTDDEMTGYVATRWYRAPEIML--------NWMHYNQTVDIWSV 204

Query: 375 GMVIWEMVTGEAAY 388
           G ++ E++TG   +
Sbjct: 205 GCIMAELLTGRTLF 218

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 43.1 bits (101), Expect = 2e-04
 Identities = 49/217 (22%), Positives = 93/217 (42%), Gaps = 19/217 (8%)

Query: 189 SDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGC-------DKGNAYEFELRKDLLELMTCG 241
           +D+ E ++++G  S+  VYKGK     KL          ++G  +       LL+ +   
Sbjct: 4   ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLK-- 61

Query: 242 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 301
           H NI+  + + +     L +V + +       +      L  + +      +  G+ +++
Sbjct: 62  HANIVLLHDI-IHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIH 120

Query: 302 DHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT---EYETDGYRWLAPEIIAG 358
              + +RDL  Q +L+   G + L D G+  A KSV   T   E  T  YR   P+++ G
Sbjct: 121 QRYILHRDLKPQNLLISDTGELKLADFGLARA-KSVPSHTYSNEVVTLWYR--PPDVLLG 177

Query: 359 DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQ 395
             E  +     +++  G +  EM+ G AA+     +Q
Sbjct: 178 STEYST---CLDMWGVGCIFVEMIQGVAAFPGMKDIQ 211

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 43.1 bits (102), Expect = 2e-04
 Identities = 55/249 (22%), Positives = 97/249 (38%), Gaps = 55/249 (22%)

Query: 190 DNLEFIDQIGPNSFKGVY------KGKRVGIEKLKGCD---KGNAYEFELRKDLLELMTC 240
           D+ E I  IG  +F  V+       G+   ++ L+  D   +         +D+L     
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDIL--ADA 58

Query: 241 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLI-LKSRKLQ-TKEIIRIAIDVAE--- 295
               I++ Y    DE H L +V + M GG   DL+ L  RK    +E  R  I  AE   
Sbjct: 59  DSPWIVKLYYSFQDEEH-LYLVMEYMPGG---DLMNLLIRKDVFPEETARFYI--AELVL 112

Query: 296 GIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR------ 349
            +  ++  G  +RD+    IL+D  G++ L D G+        +   Y  D +       
Sbjct: 113 ALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDN 172

Query: 350 -----------------------WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEA 386
                                  ++APE++ G P  +   W    +S G++++EM+ G  
Sbjct: 173 VLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDW----WSLGVILYEMLYGFP 228

Query: 387 AYAACSPVQ 395
            + + +  +
Sbjct: 229 PFYSDTLQE 237

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 43.1 bits (101), Expect = 2e-04
 Identities = 28/131 (21%), Positives = 58/131 (44%), Gaps = 5/131 (3%)

Query: 259 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN-DHGVAYRDLNSQRILL 317
           LC V +   GG +   + + R            ++   + +L+ +  V YRDL  + ++L
Sbjct: 70  LCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLML 129

Query: 318 DRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMV 377
           D+ G++ + D G+       G   +       +LAPE++  +    +  W    +  G+V
Sbjct: 130 DKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDW----WGLGVV 185

Query: 378 IWEMVTGEAAY 388
           ++EM+ G   +
Sbjct: 186 MYEMMCGRLPF 196

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 42.7 bits (100), Expect = 2e-04
 Identities = 49/217 (22%), Positives = 96/217 (44%), Gaps = 45/217 (20%)

Query: 195 IDQIGPNSFKGVYKG-----------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHK 243
           ++++G  ++  V+KG           K + +E  +G       E  L KDL       H 
Sbjct: 11  LEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDL------KHA 64

Query: 244 NILQFYCVCVDENHGLCVVTKLMEG---------GSVNDLILKSRKLQTKEIIRIAIDVA 294
           NI+  + + V  +  L +V + ++          G++  + + + K+   +I+R      
Sbjct: 65  NIVTLHDI-VHTDKSLTLVFEYLDKDLKQYMDDCGNI--MSMHNVKIFLYQILR------ 115

Query: 295 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT---EYETDGYRWL 351
            G+ + +   V +RDL  Q +L++  G + L D G+  A KSV   T   E  T  YR  
Sbjct: 116 -GLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARA-KSVPTKTYSNEVVTLWYR-- 171

Query: 352 APEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAY 388
            P+++ G  E  ++    +++  G + +EM +G   +
Sbjct: 172 PPDVLLGSSEYSTQI---DMWGVGCIFFEMASGRPLF 205

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 42.5 bits (100), Expect = 3e-04
 Identities = 34/146 (23%), Positives = 68/146 (46%), Gaps = 16/146 (10%)

Query: 255 ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAI-DVAEGIKFLNDHGVAYRDLNSQ 313
           +   L +V +   GG +  L+ +      +++ +  + ++   I  ++  G  +RD+  +
Sbjct: 72  DKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPE 131

Query: 314 RILLDRHGNVCLGDMG---IVTACKSVGEATEYETDGYRWLAPEI---IAGDPES---VS 364
            +L+DR G++ L D G    +TA K V       T  Y  +APE+   + GD +    V 
Sbjct: 132 NVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDY--IAPEVLTTMNGDGKGTYGVE 189

Query: 365 ETWMSNVYSFGMVIWEMVTGEAAYAA 390
             W    +S G++ +EM+ G + +  
Sbjct: 190 CDW----WSLGVIAYEMIYGRSPFHE 211

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 42.5 bits (101), Expect = 3e-04
 Identities = 41/162 (25%), Positives = 73/162 (45%), Gaps = 35/162 (21%)

Query: 242 HKNILQ----FYCVCVDENHGLCVVTKLMEGGSVNDL--ILKSRKLQTKEIIR-IAIDVA 294
           H+NI+           ++ + + +VT+LME     DL  ++KS +  T + I+     + 
Sbjct: 58  HENIIGLLDILRPPSPEDFNDVYIVTELME----TDLHKVIKSPQPLTDDHIQYFLYQIL 113

Query: 295 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMG----IVTACKSVGEATEY-ETDGYR 349
            G+K+L+   V +RDL    IL++ + ++ + D G    +       G  TEY  T  YR
Sbjct: 114 RGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYR 173

Query: 350 WLAPEIIAGDPESVSETWMSNVYSFGMVIW-------EMVTG 384
             APE++            S+ Y+  + IW       E++T 
Sbjct: 174 --APELLL----------SSSRYTKAIDIWSVGCIFAELLTR 203

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 42.2 bits (100), Expect = 3e-04
 Identities = 43/155 (27%), Positives = 76/155 (49%), Gaps = 21/155 (13%)

Query: 237 LMTCGHKNILQ-FYCVCVDENHGLCVVTKLM---EGGSVNDLILKSRKLQTKEIIRIAID 292
           LM   + N ++ +Y V   + H L     +M   + G + DL+ K  KL   E+ +I   
Sbjct: 64  LMKD-NPNFIKLYYSVTTLKGHVL-----IMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQ 117

Query: 293 VAEGIKFLNDHGVAYRDLNSQRILLDRH-GNVCLGDMGIVTACKSVGEATEYETDG-YRW 350
           + E +  L+ H + + D+  + +L DR    + L D G+   CK +G  + Y  DG   +
Sbjct: 118 LVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGL---CKIIGTPSCY--DGTLDY 172

Query: 351 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGE 385
            +PE I G    VS  W    ++ G++ +E++TG+
Sbjct: 173 FSPEKIKGHNYDVSFDW----WAVGVLTYELLTGK 203

Length = 267

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 42.4 bits (100), Expect = 4e-04
 Identities = 50/220 (22%), Positives = 97/220 (44%), Gaps = 27/220 (12%)

Query: 193 EFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNIL 246
           E    IG  +F  V+       GKRV ++K+    +       + ++L  L    H N+L
Sbjct: 3   EPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVL 62

Query: 247 QFYCVC----VDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLND 302
               +     +D    + VVT+LM+   ++ +I+  + L +  +      +  G+K+L+ 
Sbjct: 63  SALDILQPPHIDPFEEIYVVTELMQS-DLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHS 121

Query: 303 HGVAYRDLNSQRILLDRHGNVCLGDMGIV------TACKSVGEA-TEYETDGYRWLAPEI 355
            G+ +RD+    +L++ +  + + D G+        +     E  T+Y    YR  APEI
Sbjct: 122 AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY----YR--APEI 175

Query: 356 IAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQ 395
           + G     S     +++S G +  E++     + A SP+Q
Sbjct: 176 LMGSRHYTSAV---DIWSVGCIFAELLGRRILFQAQSPIQ 212

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 42.1 bits (99), Expect = 4e-04
 Identities = 66/302 (21%), Positives = 125/302 (41%), Gaps = 42/302 (13%)

Query: 152 LKIQLQMPLPSSSFVVSVDEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYK--- 208
           L + L +P PSSS   S     +  SG        L+   LE +++IG  +   VYK   
Sbjct: 41  LAVPLPLPPPSSS---SSSSSSSSASGSAPSAAKSLS--ELERVNRIGSGAGGTVYKVIH 95

Query: 209 ---GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQ---FYCVCVDENHGLCVV 262
              G+   ++ + G +  +    ++ +++  L    H N+++    +    D N  + V+
Sbjct: 96  RPTGRLYALKVIYG-NHEDTVRRQICREIEILRDVNHPNVVKCHDMF----DHNGEIQVL 150

Query: 263 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGN 322
            + M+GGS+      +     + +  +A  +  GI +L+   + +RD+    +L++   N
Sbjct: 151 LEFMDGGSLEG----THIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKN 206

Query: 323 VCLGDMGI-------VTACK-SVGEATEYETDGYRWLAPEIIAGD-PESVSETWMSNVYS 373
           V + D G+       +  C  SVG      T  Y  ++PE I  D      + +  +++S
Sbjct: 207 VKIADFGVSRILAQTMDPCNSSVG------TIAY--MSPERINTDLNHGAYDGYAGDIWS 258

Query: 374 FGMVIWEMVTGEAAYAACSPVQ-AAVGIAAC-GLRPEIPKDCPQILKSLMIKCWNNSPSK 431
            G+ I E   G   +        A++  A C    PE P    +  +  +  C    P+K
Sbjct: 259 LGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASREFRHFISCCLQREPAK 318

Query: 432 RP 433
           R 
Sbjct: 319 RW 320

Length = 353

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 41.9 bits (98), Expect = 4e-04
 Identities = 61/285 (21%), Positives = 111/285 (38%), Gaps = 53/285 (18%)

Query: 193 EFIDQIGPNSFKGVYK-------GKRVGIEKLKGCDKGNAYEFELRKD---LLELMTCGH 242
           E + +IG  ++  V+K       G+ V +++++             ++   L  L T  H
Sbjct: 4   ECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEH 63

Query: 243 KNILQFYCVCV----DENHGLCVVTKLMEGGSVNDLILKSRK-----LQTKEIIRIAIDV 293
            N+++ + VC     D    L +V + ++     DL     K     + T+ I  +   +
Sbjct: 64  PNVVRLFDVCTVSRTDRETKLTLVFEHVD----QDLTTYLDKVPEPGVPTETIKDMMFQL 119

Query: 294 AEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAP 353
             G+ FL+ H V +RDL  Q IL+   G + L D G+     S   A         + AP
Sbjct: 120 LRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR-IYSFQMALTSVVVTLWYRAP 178

Query: 354 EIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACS--------------------P 393
           E++    +S   T + +++S G +  EM   +  +   S                    P
Sbjct: 179 EVLL---QSSYATPV-DLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 234

Query: 394 VQAAVGIAACGLRPEIP-----KDCPQILKSLMIKCWNNSPSKRP 433
              A+   A   +   P      D  ++ K L++KC   +P+KR 
Sbjct: 235 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRI 279

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 41.9 bits (99), Expect = 5e-04
 Identities = 37/134 (27%), Positives = 65/134 (48%), Gaps = 26/134 (19%)

Query: 261 VVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH 320
           +VT LM G  +N+ I+K +KL    I  +   +  G+K+++  G+ +RDL    I ++  
Sbjct: 97  LVTHLM-GADLNN-IVKCQKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNED 154

Query: 321 GNVCLGDMGIVTACKSVGEATEYETDGY---RW-LAPEIIAGDPESVSETWMS-----NV 371
             + + D G+          T+ E  GY   RW  APEI+          WM      ++
Sbjct: 155 CELKILDFGL-------ARHTDDEMTGYVATRWYRAPEIML--------NWMHYNQTVDI 199

Query: 372 YSFGMVIWEMVTGE 385
           +S G ++ E++TG+
Sbjct: 200 WSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 41.6 bits (97), Expect = 6e-04
 Identities = 43/174 (24%), Positives = 83/174 (47%), Gaps = 35/174 (20%)

Query: 229 ELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVTKLMEGGSVNDLILKSRKLQT 283
           ELR  LL+ M   H+N++    V      ++  + + +VT LM G  +N+ I+K +KL  
Sbjct: 64  ELR--LLKHMK--HENVIGLLDVFTPATSIENFNEVYLVTNLM-GADLNN-IVKCQKLSD 117

Query: 284 KEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY 343
           + +  +   +  G+K+++  G+ +RDL    + ++    + + D G+           + 
Sbjct: 118 EHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGL-------ARQADD 170

Query: 344 ETDGY---RWL-APEIIAGDPESVSETWMS-----NVYSFGMVIWEMVTGEAAY 388
           E  GY   RW  APEI+          WM      +++S G ++ E++ G+A +
Sbjct: 171 EMTGYVATRWYRAPEIML--------NWMHYNQTVDIWSVGCIMAELLKGKALF 216

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 41.1 bits (96), Expect = 7e-04
 Identities = 45/194 (23%), Positives = 84/194 (43%), Gaps = 31/194 (15%)

Query: 209 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 263
           G +V I+KL    +   +     ++L  L    H+N++    V      +D  H   +V 
Sbjct: 40  GAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVM 99

Query: 264 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 323
             M  G+    ++K  KL    I  +   + +G+K+++  G+ +RDL    + ++    +
Sbjct: 100 PFM--GTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCEL 157

Query: 324 CLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIAGDPESVSETWMS-----NVYSF 374
            + D G+          T+ E  GY   RW  APE+I          WM      +++S 
Sbjct: 158 KILDFGL-------ARQTDSEMTGYVVTRWYRAPEVIL--------NWMHYTQTVDIWSV 202

Query: 375 GMVIWEMVTGEAAY 388
           G ++ EM+TG+  +
Sbjct: 203 GCIMAEMLTGKPLF 216

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 40.4 bits (94), Expect = 0.001
 Identities = 48/209 (22%), Positives = 91/209 (43%), Gaps = 29/209 (13%)

Query: 195 IDQIGPNSFKGVYKG-----------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHK 243
           +D++G  ++  V+KG           K + +E  +G       E  L K+L       H 
Sbjct: 10  LDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNL------KHA 63

Query: 244 NILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAI-DVAEGIKFLND 302
           NI+  + + +     L +V + ++   +   +     L +   ++I +  +  G+ + + 
Sbjct: 64  NIVTLHDI-IHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHK 121

Query: 303 HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT---EYETDGYRWLAPEIIAGD 359
             + +RDL  Q +L++  G + L D G+  A KSV   T   E  T  YR   P+++ G 
Sbjct: 122 RKILHRDLKPQNLLINEKGELKLADFGLARA-KSVPTKTYSNEVVTLWYR--PPDVLLGS 178

Query: 360 PESVSETWMSNVYSFGMVIWEMVTGEAAY 388
            E  +   M  V   G +++EM TG   +
Sbjct: 179 TEYSTPIDMWGV---GCILYEMATGRPMF 204

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 40.3 bits (94), Expect = 0.001
 Identities = 28/102 (27%), Positives = 50/102 (49%), Gaps = 9/102 (8%)

Query: 296 GIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT---EYETDGYRWLA 352
           G+ +++   + +RDL  Q +L+   G + L D G+  A KS+   T   E  T  YR   
Sbjct: 115 GLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARA-KSIPSQTYSSEVVTLWYR--P 171

Query: 353 PEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPV 394
           P+++ G  +  S     +++  G +  EM+ G+ A+   S V
Sbjct: 172 PDVLLGATDYSSAL---DIWGAGCIFIEMLQGQPAFPGVSDV 210

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 40.5 bits (95), Expect = 0.001
 Identities = 33/135 (24%), Positives = 59/135 (43%), Gaps = 18/135 (13%)

Query: 266 ME---GGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGN 322
           ME   GG    L+     L          ++ E +  L++ G  +RDL  +  L+D  G+
Sbjct: 80  MEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGH 139

Query: 323 VCLGDMG----IVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVI 378
           + L D G    IVT   SV  + +Y       +APE++ G     +  +    +S G ++
Sbjct: 140 IKLTDFGLSKGIVTYANSVVGSPDY-------MAPEVLRGKGYDFTVDY----WSLGCML 188

Query: 379 WEMVTGEAAYAACSP 393
           +E + G   ++  +P
Sbjct: 189 YEFLCGFPPFSGSTP 203

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 40.1 bits (94), Expect = 0.002
 Identities = 40/164 (24%), Positives = 71/164 (43%), Gaps = 37/164 (22%)

Query: 191 NLEFIDQIGPNSFKGVYKG-----------KRVGIEKLKGCDKGNAYEFELRKDLLELMT 239
             E +++IG  ++  V+K            KRV ++     D        LR+  L L  
Sbjct: 1   KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD----DDEGVPSSALREICL-LKE 55

Query: 240 CGHKNILQFYCVCVDENHGLCVVTKLME----------GGSVNDLILKSRKLQTKEIIRI 289
             HKNI++ Y V +  +  L +V +  +           G ++  I+KS   Q       
Sbjct: 56  LKHKNIVRLYDV-LHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQ------- 107

Query: 290 AIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTA 333
              + +G+ F + H V +RDL  Q +L++++G + L D G+  A
Sbjct: 108 ---LLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARA 148

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 40.0 bits (93), Expect = 0.002
 Identities = 59/252 (23%), Positives = 99/252 (39%), Gaps = 59/252 (23%)

Query: 190 DNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFE-LRK-DLLELMTCGH----K 243
           D+ E +  IG  +F  V    R+  +K    D G+ Y  + LRK D+LE     H    +
Sbjct: 1   DDFESLKVIGRGAFGEV----RLVQKK----DTGHIYAMKILRKADMLEKEQVAHIRAER 52

Query: 244 NIL----------QFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDV 293
           +IL           FY     +   L ++ + + GG +  L++K   L  +       + 
Sbjct: 53  DILVEADGAWVVKMFYSF--QDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAET 110

Query: 294 AEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY---------- 343
              I  ++  G  +RD+    +LLD  G+V L D G+ T  K       Y          
Sbjct: 111 VLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSD 170

Query: 344 ------------ET--DGYRWLAPEIIAGDPESVS-ETWMSNVY-------SFGMVIWEM 381
                       ET     R LA   + G P+ ++ E +M   Y       S G++++EM
Sbjct: 171 FSFQNMNSKRKAETWKKNRRQLAYSTV-GTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEM 229

Query: 382 VTGEAAYAACSP 393
           + G   + + +P
Sbjct: 230 LIGYPPFCSETP 241

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 40.0 bits (93), Expect = 0.002
 Identities = 46/188 (24%), Positives = 84/188 (44%), Gaps = 19/188 (10%)

Query: 209 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 263
           G  V ++KL    +   +     ++L+ L    HKNI+    V      ++E   + +V 
Sbjct: 46  GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVM 105

Query: 264 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 323
           +LM+    N   +   +L  + +  +   +  GIK L+  G+ +RDL    I++     +
Sbjct: 106 ELMDA---NLCQVIHMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL 162

Query: 324 CLGDMGIV-TACKSVGEATEYETDGYRWLAPEIIAG--DPESVSETWMSNVYSFGMVIWE 380
            + D G+  TAC +        T  YR  APE+I G    E+V      +++S G ++ E
Sbjct: 163 KILDFGLARTACTNFMMTPYVVTRYYR--APEVILGMGYKENV------DIWSVGCIMGE 214

Query: 381 MVTGEAAY 388
           +V G   +
Sbjct: 215 LVKGSVIF 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 39.6 bits (92), Expect = 0.002
 Identities = 45/187 (24%), Positives = 83/187 (44%), Gaps = 19/187 (10%)

Query: 210 KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVTK 264
           + V I+KL    +   +     ++L+ +    HKNI+    V      ++E   + +V +
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME 109

Query: 265 LMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVC 324
           LM+    N   +   +L  + +  +   +  GIK L+  G+ +RDL    I++     + 
Sbjct: 110 LMDA---NLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLK 166

Query: 325 LGDMGIV-TACKSVGEATEYETDGYRWLAPEII--AGDPESVSETWMSNVYSFGMVIWEM 381
           + D G+  TA  S        T  YR  APE+I   G  E+V      +++S G ++ EM
Sbjct: 167 ILDFGLARTAGTSFMMTPYVVTRYYR--APEVILGMGYKENV------DIWSVGCIMGEM 218

Query: 382 VTGEAAY 388
           + G   +
Sbjct: 219 IKGGVLF 225

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 38.9 bits (90), Expect = 0.004
 Identities = 49/234 (20%), Positives = 98/234 (41%), Gaps = 23/234 (9%)

Query: 210 KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVTK 264
           + V I+KL    +   +     ++L+ +    HKNI+    V      ++E   + +V +
Sbjct: 43  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVME 102

Query: 265 LMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVC 324
           LM+    N   +   +L  + +  +   +  GIK L+  G+ +RDL    I++     + 
Sbjct: 103 LMDA---NLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLK 159

Query: 325 LGDMGIVTACKSVGEATEYETDGYRWLAPEII--AGDPESVSETWMSNVYSFGMVIWEMV 382
           + D G+     +    T Y    Y + APE+I   G  E+V      +++S G ++ EMV
Sbjct: 160 ILDFGLARTAGTSFMMTPYVVTRY-YRAPEVILGMGYKENV------DIWSVGCIMGEMV 212

Query: 383 TGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFS 436
             +  +     +     +       ++   CP+ +K L      N    RP+++
Sbjct: 213 RHKILFPGRDYIDQWNKVIE-----QLGTPCPEFMKKLQPTV-RNYVENRPKYA 260

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	454
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.97
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.97
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.97
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.97
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.97
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.97
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.96
KOG1152	772	consensus Signal transduction serine/threonine kin	99.96
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.96
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.95
PLN00181	793	protein SPA1-RELATED; Provisional	99.95
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.94
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.93
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.93
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.93
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.92
PRK09188	365	serine/threonine protein kinase; Provisional	99.91
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.9
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.9
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.89
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.88
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.88
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.86
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.85
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.84
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.83
PRK12274	218	serine/threonine protein kinase; Provisional	99.83
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.82
PRK10345	210	hypothetical protein; Provisional	99.81
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.8
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.79
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.76
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.75
PRK14879	211	serine/threonine protein kinase; Provisional	99.75
smart00090	237	RIO RIO-like kinase.	99.74
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.73
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.71
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.7
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.67
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.62
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.62
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.57
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.51
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.4
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.35
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.34
KOG1243	690	consensus Protein kinase [General function predict	99.34
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.33
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.25
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.23
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.19
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	98.96
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	98.9
KOG3087	229	consensus Serine/threonine protein kinase [General	98.84
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.8
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.74
COG4248	637	Uncharacterized protein with protein kinase and he	98.72
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.62
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.62
PRK09902	216	hypothetical protein; Provisional	98.54
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.46
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.44
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.25
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.18
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.11
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.09
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.08
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.06
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.03
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.95
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.78
PF01636	239	APH: Phosphotransferase enzyme family This family	97.77
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	97.63
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.5
KOG1235	538	consensus Predicted unusual protein kinase [Genera	97.5
PLN02876	822	acyl-CoA dehydrogenase	97.39
KOG1093	725	consensus Predicted protein kinase (contains TBC a	97.34
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.24
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.09
KOG2270	520	consensus Serine/threonine protein kinase involved	96.16
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	95.97
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	95.92
KOG2268	465	consensus Serine/threonine protein kinase [Signal	95.71
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	95.69
PRK09550	401	mtnK methylthioribose kinase; Reviewed	95.47
PRK05231	319	homoserine kinase; Provisional	95.42
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	95.3
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	94.13
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	93.73
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	93.71
PLN02756	418	S-methyl-5-thioribose kinase	93.53
PRK10593	297	hypothetical protein; Provisional	92.71
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	92.7
KOG1236	565	consensus Predicted unusual protein kinase [Genera	92.38
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	92.27
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	91.8
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	90.91
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	90.64
PRK10271	188	thiK thiamine kinase; Provisional	89.41
PRK12396	409	5-methylribose kinase; Reviewed	89.23
PF05445	434	Pox_ser-thr_kin: Poxvirus serine/threonine protein	88.56
PHA03111	444	Ser/Thr kinase; Provisional	88.49
smart00587	196	CHK ZnF_C4 abd HLH domain containing kinases domai	86.7
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	86.66
PTZ00384	383	choline kinase; Provisional	86.58
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	86.43
PLN02236	344	choline kinase	85.77
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	85.64

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=8.8e-53  Score=424.28  Aligned_cols=264  Identities=38%  Similarity=0.671  Sum_probs=238.4

Q ss_pred             cceeecCCCEEEeceeeccCCceEEEe----EE-EEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCC
Q 012887          183 GRWLLNSDNLEFIDQIGPNSFKGVYKG----KR-VGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH  257 (454)
Q Consensus       183 ~~~~~~~~~~~~~~~LG~G~fG~Vy~g----~~-vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~  257 (454)
                      ..|.++.+++.+.+.||+|+||+||+|    .. ||||++............+.+|+.+|.+++|||||+++|+|.++..
T Consensus        34 ~~~~i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~  113 (362)
T KOG0192|consen   34 PEEEIDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPG  113 (362)
T ss_pred             cceecChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            567788888899999999999999985    45 9999998766665557789999999999999999999999998874


Q ss_pred             eEEEEEeccCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhcC-cccCCccCCcEEEccCC-cEEEEccCCccc
Q 012887          258 GLCVVTKLMEGGSVNDLILK--SRKLQTKEIIRIAIDVAEGIKFLNDHG-VAYRDLNSQRILLDRHG-NVCLGDMGIVTA  333 (454)
Q Consensus       258 ~l~lV~E~~~~gsL~~~l~~--~~~l~~~~~~~i~~qI~~gL~yLH~~~-iiHrDIKp~NILl~~~~-~vKL~DFGla~~  333 (454)
                      .+++||||+++|+|.+++.+  .+.++...++.++.||++||+|||+++ ||||||||+|||++.++ ++||+|||+++.
T Consensus       114 ~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~  193 (362)
T KOG0192|consen  114 SLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSRE  193 (362)
T ss_pred             ceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCcccee
Confidence            49999999999999999976  569999999999999999999999999 99999999999999998 999999999987


Q ss_pred             cccCCCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCc
Q 012887          334 CKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDC  413 (454)
Q Consensus       334 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~  413 (454)
                      ............||+.|||||++.+.  ...++.|+||||||++||||+||+.||.+..+.+....+...+.++.+|..+
T Consensus       194 ~~~~~~~~~~~~GT~~wMAPEv~~~~--~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~  271 (362)
T KOG0192|consen  194 KVISKTSMTSVAGTYRWMAPEVLRGE--KSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKEC  271 (362)
T ss_pred             eccccccccCCCCCccccChhhhcCC--CCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccC
Confidence            66543444557899999999999965  3457778999999999999999999999999988888899999999999999


Q ss_pred             cHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCC
Q 012887          414 PQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNI  448 (454)
Q Consensus       414 ~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~  448 (454)
                      ++.+..+|..||..||..||+|.+|+..|..+...
T Consensus       272 ~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~  306 (362)
T KOG0192|consen  272 PPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSH  306 (362)
T ss_pred             CHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHh
Confidence            99999999999999999999999999999977653

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-52  Score=405.37  Aligned_cols=253  Identities=21%  Similarity=0.395  Sum_probs=224.5

Q ss_pred             eecCCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeE
Q 012887          186 LLNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGL  259 (454)
Q Consensus       186 ~~~~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l  259 (454)
                      .+..++++.++.||+|+.|+||++      +.+|.|.+. .........++.+|+.++..++|||||.+||+|++++..+
T Consensus        75 ~i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~-~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~i  153 (364)
T KOG0581|consen   75 GISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVIL-LNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEI  153 (364)
T ss_pred             ccCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeec-ccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceE
Confidence            356678999999999999999984      678999995 5566677889999999999999999999999999887349


Q ss_pred             EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-cCcccCCccCCcEEEccCCcEEEEccCCccccccCC
Q 012887          260 CVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLND-HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG  338 (454)
Q Consensus       260 ~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~-~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~  338 (454)
                      +|+||||++|||++++...+++++..+..++.+|++||.|||+ ++||||||||+|||++..|.|||||||.++.+.+. 
T Consensus       154 sI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-  232 (364)
T KOG0581|consen  154 SICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-  232 (364)
T ss_pred             EeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh-
Confidence            9999999999999999888899999999999999999999995 99999999999999999999999999999887665 


Q ss_pred             CcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC-----CHHHHHHHHHHcCCCCCCCCC-
Q 012887          339 EATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAAC-----SPVQAAVGIAACGLRPEIPKD-  412 (454)
Q Consensus       339 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~-----~~~~~~~~i~~~~~~~~~p~~-  412 (454)
                       ......||..|||||++.++.|+.+    +||||||++++|+++|++||...     ...+.+..|. .+.+|.+|.. 
T Consensus       233 -~a~tfvGT~~YMsPERi~g~~Ys~~----sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv-~~ppP~lP~~~  306 (364)
T KOG0581|consen  233 -IANTFVGTSAYMSPERISGESYSVK----SDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIV-DEPPPRLPEGE  306 (364)
T ss_pred             -hcccccccccccChhhhcCCcCCcc----cceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHh-cCCCCCCCccc
Confidence             4566789999999999999876655    99999999999999999999874     3344444444 5678889997 


Q ss_pred             ccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 012887          413 CPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTN  446 (454)
Q Consensus       413 ~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~  446 (454)
                      +|+++.+++..||++||.+||++.|+++|-+-..
T Consensus       307 fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~  340 (364)
T KOG0581|consen  307 FSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKK  340 (364)
T ss_pred             CCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhh
Confidence            9999999999999999999999999999876543

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-52  Score=421.12  Aligned_cols=260  Identities=25%  Similarity=0.479  Sum_probs=227.3

Q ss_pred             ccceeecCCCEEEeceeeccCCceEEEeE-----EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCC
Q 012887          182 IGRWLLNSDNLEFIDQIGPNSFKGVYKGK-----RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN  256 (454)
Q Consensus       182 ~~~~~~~~~~~~~~~~LG~G~fG~Vy~g~-----~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~  256 (454)
                      .++|.++.+.+.+++.||+|.||.|+.|.     .||+|.++..   ......+.+|+.+|++|+|+|||+++|+|..++
T Consensus       198 ~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~---~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~  274 (468)
T KOG0197|consen  198 RDPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG---SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQE  274 (468)
T ss_pred             cCCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEecc---ccChhHHHHHHHHHHhCcccCeEEEEEEEecCC
Confidence            47899999999999999999999999984     7999999854   333456779999999999999999999999877


Q ss_pred             CeEEEEEeccCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCcccc
Q 012887          257 HGLCVVTKLMEGGSVNDLILK--SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC  334 (454)
Q Consensus       257 ~~l~lV~E~~~~gsL~~~l~~--~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~  334 (454)
                      . +|||||||+.|+|.++|+.  ++.+...+++.++.|||+||+||+++++|||||.++|||++++..+||+|||||+..
T Consensus       275 p-iyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~  353 (468)
T KOG0197|consen  275 P-IYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLI  353 (468)
T ss_pred             c-eEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEccccccccc
Confidence            4 9999999999999999976  458999999999999999999999999999999999999999999999999999954


Q ss_pred             ccCCC-cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHcCCCCCCCCC
Q 012887          335 KSVGE-ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKD  412 (454)
Q Consensus       335 ~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~  412 (454)
                      .++.. ......-++.|+|||.+....    ++.|||||||||+||||+| |+.||++.+..+.+.. +..|+|++-|..
T Consensus       354 ~d~~Y~~~~~~kfPIkWtAPEa~~~~~----FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~-le~GyRlp~P~~  428 (468)
T KOG0197|consen  354 GDDEYTASEGGKFPIKWTAPEALNYGK----FSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLEL-LERGYRLPRPEG  428 (468)
T ss_pred             CCCceeecCCCCCCceecCHHHHhhCC----cccccceeehhhhHHHHhccCCCCCCCCCHHHHHHH-HhccCcCCCCCC
Confidence            43222 122223467899999999775    4556999999999999999 9999999888776654 456899999999


Q ss_pred             ccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCCCC
Q 012887          413 CPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISN  450 (454)
Q Consensus       413 ~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~  450 (454)
                      ||++++++|..||..+|++||||..+...|.......+
T Consensus       429 CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~~  466 (468)
T KOG0197|consen  429 CPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTSTE  466 (468)
T ss_pred             CCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhccc
Confidence            99999999999999999999999999999988766443

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.3e-50  Score=412.08  Aligned_cols=248  Identities=22%  Similarity=0.365  Sum_probs=227.8

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCC-CCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCD-KGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  262 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~-~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV  262 (454)
                      ..|+..+.||+|+|..||.+      ..+|+|++.... ........+.+||.+.++|+|||||+++++|.+.++ +|||
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~n-VYiv   96 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNN-VYIV   96 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCc-eEEE
Confidence            56999999999999999984      579999986533 233456678999999999999999999999999987 9999


Q ss_pred             EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCccc
Q 012887          263 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE  342 (454)
Q Consensus       263 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~  342 (454)
                      +|+|..++|..++++++.++|.+++.++.||+.||.|||+++|||||||..|+|++++.+|||+|||||+.+..+.+...
T Consensus        97 LELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Erk~  176 (592)
T KOG0575|consen   97 LELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGERKK  176 (592)
T ss_pred             EEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcccccc
Confidence            99999999999999888999999999999999999999999999999999999999999999999999999998888888


Q ss_pred             ccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHHHHHH
Q 012887          343 YETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMI  422 (454)
Q Consensus       343 ~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~li~  422 (454)
                      ..+|||.|.|||++....++..    +||||+||+||.|+.|++||+..+-.+....|....+.  +|..++.++++||.
T Consensus       177 TlCGTPNYIAPEVl~k~gHsfE----vDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~--~P~~ls~~A~dLI~  250 (592)
T KOG0575|consen  177 TLCGTPNYIAPEVLNKSGHSFE----VDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYS--MPSHLSAEAKDLIR  250 (592)
T ss_pred             eecCCCcccChhHhccCCCCCc----hhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcc--cccccCHHHHHHHH
Confidence            8999999999999997776665    99999999999999999999998888888888887666  77899999999999


Q ss_pred             HhcccCCCCCCCHHHHHHHHHh
Q 012887          423 KCWNNSPSKRPQFSEIISLLLR  444 (454)
Q Consensus       423 ~cl~~dP~~RPs~~ell~~L~~  444 (454)
                      ++|+.||.+|||+++|+.+=.-
T Consensus       251 ~lL~~~P~~Rpsl~~vL~h~Ff  272 (592)
T KOG0575|consen  251 KLLRPNPSERPSLDEVLDHPFF  272 (592)
T ss_pred             HHhcCCcccCCCHHHHhcCHhh
Confidence            9999999999999999987554

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.9e-50  Score=392.00  Aligned_cols=255  Identities=17%  Similarity=0.214  Sum_probs=218.0

Q ss_pred             cCCCEEEeceeeccCCceEEE------eEEEEEEEeecCCCCc-----hHHHHHHHHHHHHHhCCCCceeEEEEEEEeCC
Q 012887          188 NSDNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGN-----AYEFELRKDLLELMTCGHKNILQFYCVCVDEN  256 (454)
Q Consensus       188 ~~~~~~~~~~LG~G~fG~Vy~------g~~vavK~l~~~~~~~-----~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~  256 (454)
                      ..+.|.+.+.||+|+||.|-+      |+.||||.+.......     .....+++|+.+|++++|||||+++++|..++
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD  249 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence            347889999999999999987      5799999986543222     23345789999999999999999999999888


Q ss_pred             CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccC---CcEEEEccCCccc
Q 012887          257 HGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH---GNVCLGDMGIVTA  333 (454)
Q Consensus       257 ~~l~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~---~~vKL~DFGla~~  333 (454)
                      . .||||||++||+|.+.+-.++.+.+..-..++.|++.|+.|||++||+||||||+|||++.+   ..+||+|||+|+.
T Consensus       250 s-~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~  328 (475)
T KOG0615|consen  250 S-SYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKV  328 (475)
T ss_pred             c-eEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhc
Confidence            6 89999999999999999889999999999999999999999999999999999999999877   7899999999998


Q ss_pred             cccCCCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHHHcCCCC--CCC
Q 012887          334 CKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQ-AAVGIAACGLRP--EIP  410 (454)
Q Consensus       334 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~-~~~~i~~~~~~~--~~p  410 (454)
                      ... .......+|||.|.|||++.+..... +..+.|+||+||+||-+++|.+||.+..... ....|....+..  +..
T Consensus       329 ~g~-~sfm~TlCGTpsYvAPEVl~~kg~~~-~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w  406 (475)
T KOG0615|consen  329 SGE-GSFMKTLCGTPSYVAPEVLASKGVEY-YPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQW  406 (475)
T ss_pred             ccc-ceehhhhcCCccccChhheecCCeec-ccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhh
Confidence            763 34566779999999999998775543 3357999999999999999999999765555 555565554432  334


Q ss_pred             CCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 012887          411 KDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRT  445 (454)
Q Consensus       411 ~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~  445 (454)
                      ..++++..+||.+||..||++|||+.|++.|-|--
T Consensus       407 ~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~  441 (475)
T KOG0615|consen  407 DRISEEALDLINWMLVVDPENRPSADEALNHPWFK  441 (475)
T ss_pred             hhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhh
Confidence            56899999999999999999999999999987743

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-49  Score=382.01  Aligned_cols=248  Identities=23%  Similarity=0.332  Sum_probs=219.2

Q ss_pred             ecCCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCch-HHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeE
Q 012887          187 LNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNA-YEFELRKDLLELMTCGHKNILQFYCVCVDENHGL  259 (454)
Q Consensus       187 ~~~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~-~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l  259 (454)
                      ...++|++++.||+|+||+||..      +.+|.|+++....... ....+..|..+|.+++||+||+++..|++.++ +
T Consensus        22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~k-L  100 (357)
T KOG0598|consen   22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEK-L  100 (357)
T ss_pred             CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCe-E
Confidence            44689999999999999999974      5788888875544333 45668899999999999999999999999887 9


Q ss_pred             EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCC
Q 012887          260 CVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE  339 (454)
Q Consensus       260 ~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~  339 (454)
                      |+|+||+.||.|...|.+.+.+++..+..|+.+|+.||.|||++|||||||||+|||+|.+|+++|+||||++.....+.
T Consensus       101 ylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~  180 (357)
T KOG0598|consen  101 YLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGD  180 (357)
T ss_pred             EEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCCC
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999998777777


Q ss_pred             cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHHH
Q 012887          340 ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKS  419 (454)
Q Consensus       340 ~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~  419 (454)
                      .+...+||+.|||||++.+..++.    ++|.||||+++|||++|.+||.+.+.......+.... .+..|...+.+.++
T Consensus       181 ~t~tfcGT~eYmAPEil~~~gy~~----~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k-~~~~p~~ls~~ard  255 (357)
T KOG0598|consen  181 ATRTFCGTPEYMAPEILLGKGYDK----AVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGK-LPLPPGYLSEEARD  255 (357)
T ss_pred             ccccccCCccccChHHHhcCCCCc----ccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCc-CCCCCccCCHHHHH
Confidence            788889999999999999886554    4999999999999999999999988888877777653 34456668999999


Q ss_pred             HHHHhcccCCCCCC----CHHHHHH
Q 012887          420 LMIKCWNNSPSKRP----QFSEIIS  440 (454)
Q Consensus       420 li~~cl~~dP~~RP----s~~ell~  440 (454)
                      +++++|..||++|.    ++.+|.+
T Consensus       256 ll~~LL~rdp~~RLg~~~d~~~ik~  280 (357)
T KOG0598|consen  256 LLKKLLKRDPRQRLGGPGDAEEIKR  280 (357)
T ss_pred             HHHHHhccCHHHhcCCCCChHHhhc
Confidence            99999999999995    4555443

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.4e-50  Score=377.94  Aligned_cols=250  Identities=22%  Similarity=0.361  Sum_probs=219.4

Q ss_pred             CCEEEeceeeccCCceEEE------eEEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEE-EEEeCCCeEEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYC-VCVDENHGLCVV  262 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~------g~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g-~~~~~~~~l~lV  262 (454)
                      .+|++.++||+|+||+||+      |..+|.|+++-.........++..|+.+|++|+|||||++|+ .+.+++..++||
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            6789999999999999999      467899999866666667788999999999999999999998 455445458999


Q ss_pred             EeccCCCCHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHh--cC--cccCCccCCcEEEccCCcEEEEccCCcccc
Q 012887          263 TKLMEGGSVNDLIL----KSRKLQTKEIIRIAIDVAEGIKFLND--HG--VAYRDLNSQRILLDRHGNVCLGDMGIVTAC  334 (454)
Q Consensus       263 ~E~~~~gsL~~~l~----~~~~l~~~~~~~i~~qI~~gL~yLH~--~~--iiHrDIKp~NILl~~~~~vKL~DFGla~~~  334 (454)
                      ||||.+|+|.++++    +.+.+++..++.++.|++.||+++|+  .+  |+||||||.||+|+.+|.|||+||||++.+
T Consensus        99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l  178 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL  178 (375)
T ss_pred             HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence            99999999999984    34589999999999999999999999  45  999999999999999999999999999999


Q ss_pred             ccCCCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCC-CCc
Q 012887          335 KSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIP-KDC  413 (454)
Q Consensus       335 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p-~~~  413 (454)
                      .+.........|||-||+||.+.+.+|+.+    |||||+||++|||+.-++||.+.+-.+...+|.++..+ ++| ..+
T Consensus       179 ~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~k----SDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~-~~p~~~Y  253 (375)
T KOG0591|consen  179 SSKTTFAHSLVGTPYYMSPERIHESGYNFK----SDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYP-PLPDEHY  253 (375)
T ss_pred             cchhHHHHhhcCCCcccCHHHHhcCCCCcc----hhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCC-CCcHHHh
Confidence            887777778899999999999998876655    99999999999999999999999888877788776554 456 678


Q ss_pred             cHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 012887          414 PQILKSLMIKCWNNSPSKRPQFSEIISLLLR  444 (454)
Q Consensus       414 ~~~l~~li~~cl~~dP~~RPs~~ell~~L~~  444 (454)
                      |.++..||..|++.||+.||+...++..++.
T Consensus       254 S~~l~~li~~ci~vd~~~RP~t~~~v~di~~  284 (375)
T KOG0591|consen  254 STDLRELINMCIAVDPEQRPDTVPYVQDIQS  284 (375)
T ss_pred             hhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence            9999999999999999999996555555544

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-48  Score=379.90  Aligned_cols=246  Identities=22%  Similarity=0.382  Sum_probs=215.9

Q ss_pred             CCEEEeceeeccCCceEEEeE------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  263 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g~------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~  263 (454)
                      .+|.+.++||+|+||.||+|+      .||||.+....-......-+..|+.+|+.++|||||++++++.+.+. +|+||
T Consensus        10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~-i~lVM   88 (429)
T KOG0595|consen   10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDF-IYLVM   88 (429)
T ss_pred             ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCe-EEEEE
Confidence            678999999999999999974      79999997554455566778999999999999999999999998886 99999


Q ss_pred             eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccC------CcEEEEccCCccccccC
Q 012887          264 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH------GNVCLGDMGIVTACKSV  337 (454)
Q Consensus       264 E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~------~~vKL~DFGla~~~~~~  337 (454)
                      |||+||+|.+++++.+.+++..+..++.||+.||++||+++||||||||+||||+..      -.+||+|||+|+.+...
T Consensus        89 EyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~  168 (429)
T KOG0595|consen   89 EYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPG  168 (429)
T ss_pred             EeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCch
Confidence            999999999999998999999999999999999999999999999999999999875      35899999999988643


Q ss_pred             CCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCC-CCCCCCccHH
Q 012887          338 GEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR-PEIPKDCPQI  416 (454)
Q Consensus       338 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~-~~~p~~~~~~  416 (454)
                       ......+|++.|||||++....    |+-|+|+||+|++||+|++|+.||...+..+....+...... +.++..++..
T Consensus       169 -~~a~tlcGSplYMAPEV~~~~~----YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s~~  243 (429)
T KOG0595|consen  169 -SMAETLCGSPLYMAPEVIMSQQ----YDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAELSNP  243 (429)
T ss_pred             -hHHHHhhCCccccCHHHHHhcc----ccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhccCc
Confidence             4456678999999999998665    555699999999999999999999999999988877765544 4456667888


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHHH
Q 012887          417 LKSLMIKCWNNSPSKRPQFSEIISL  441 (454)
Q Consensus       417 l~~li~~cl~~dP~~RPs~~ell~~  441 (454)
                      +.+++...+..+|.+|-++.+...+
T Consensus       244 ~~~Ll~~ll~~~~~~~~~~~~~~~~  268 (429)
T KOG0595|consen  244 LRELLISLLQRNPKDRISFEDFFDH  268 (429)
T ss_pred             hhhhhhHHHhcCccccCchHHhhhh
Confidence            8899999999999999888876654

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.5e-48  Score=412.09  Aligned_cols=264  Identities=28%  Similarity=0.500  Sum_probs=229.5

Q ss_pred             ccccceeecCCCEEEeceeeccCCceEEEe-----------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEE
Q 012887          180 EEIGRWLLNSDNLEFIDQIGPNSFKGVYKG-----------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQF  248 (454)
Q Consensus       180 ~~~~~~~~~~~~~~~~~~LG~G~fG~Vy~g-----------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~  248 (454)
                      .......+...++++.+.||+|+||+||+|           ..||||.++. ......+.+|++|+..+..++|||||++
T Consensus       476 ~~~~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd-~a~~~~~~dF~REaeLla~l~H~nIVrL  554 (774)
T KOG1026|consen  476 PDLKVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKD-KAENQARQDFRREAELLAELQHPNIVRL  554 (774)
T ss_pred             CccceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcc-cccHHHHHHHHHHHHHHHhccCCCeEEE
Confidence            344567788899999999999999999996           3799999984 3445577889999999999999999999


Q ss_pred             EEEEEeCCCeEEEEEeccCCCCHHHHHHhCC----------C----CCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCc
Q 012887          249 YCVCVDENHGLCVVTKLMEGGSVNDLILKSR----------K----LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQR  314 (454)
Q Consensus       249 ~g~~~~~~~~l~lV~E~~~~gsL~~~l~~~~----------~----l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~N  314 (454)
                      +|+|.+++. +|+|+|||..|+|.++|+.+.          .    ++..+.+.++.||+.||+||-++++|||||..+|
T Consensus       555 lGVC~~~~P-~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRN  633 (774)
T KOG1026|consen  555 LGVCREGDP-LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRN  633 (774)
T ss_pred             EEEEccCCe-eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhh
Confidence            999998876 999999999999999996321          2    7889999999999999999999999999999999


Q ss_pred             EEEccCCcEEEEccCCccccccCCCccc--ccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 012887          315 ILLDRHGNVCLGDMGIVTACKSVGEATE--YETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAAC  391 (454)
Q Consensus       315 ILl~~~~~vKL~DFGla~~~~~~~~~~~--~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~  391 (454)
                      +||.++..|||+||||++..-+......  ...-+++|||||.|..++    |+.+||||||||+|||+++ |..||.+.
T Consensus       634 CLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~k----FTteSDVWs~GVvLWEIFsyG~QPy~gl  709 (774)
T KOG1026|consen  634 CLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGK----FTTESDVWSFGVVLWEIFSYGKQPYYGL  709 (774)
T ss_pred             ceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCc----ccchhhhhhhhhhhhhhhccccCccccc
Confidence            9999999999999999876543221111  112357999999999775    5556999999999999999 99999999


Q ss_pred             CHHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCCCC
Q 012887          392 SPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISN  450 (454)
Q Consensus       392 ~~~~~~~~i~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~  450 (454)
                      +..+++..+..... .+-|++||.+++.||..||+.+|.+||+|+||-..|+.+.+.++
T Consensus       710 Sn~EVIe~i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s~  767 (774)
T KOG1026|consen  710 SNQEVIECIRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQASP  767 (774)
T ss_pred             chHHHHHHHHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcCc
Confidence            99998888877666 88999999999999999999999999999999999999887654

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=8.8e-47  Score=380.43  Aligned_cols=250  Identities=22%  Similarity=0.353  Sum_probs=215.5

Q ss_pred             eecCCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCc-hHHHHHHHHHHHHHhC-CCCceeEEEEEEEeCCC
Q 012887          186 LLNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGN-AYEFELRKDLLELMTC-GHKNILQFYCVCVDENH  257 (454)
Q Consensus       186 ~~~~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~-~~~~~~~~Ei~~l~~l-~HpnIv~~~g~~~~~~~  257 (454)
                      .....||.+++.||.|+|++|+++      +.+|||++....... .....+.+|-..|.+| +||.||++|..|+|+..
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s  148 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES  148 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence            345689999999999999999996      578888875432211 1223355666677777 89999999999998887


Q ss_pred             eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccC
Q 012887          258 GLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV  337 (454)
Q Consensus       258 ~l~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~  337 (454)
                       +|+|+||+++|+|.++|.+-+.|++...+.|+.||+.||+|||++|||||||||+|||+|.+|++||+|||-|+.+...
T Consensus       149 -LYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~  227 (604)
T KOG0592|consen  149 -LYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPS  227 (604)
T ss_pred             -eEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChh
Confidence             9999999999999999999999999999999999999999999999999999999999999999999999999877542


Q ss_pred             CCc---------c----cccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcC
Q 012887          338 GEA---------T----EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG  404 (454)
Q Consensus       338 ~~~---------~----~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~  404 (454)
                      ...         .    ...+||-.|.+||.+.....+..    +|+|+||||||.|+.|.+||.+.++.-.+.+|+...
T Consensus       228 ~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~----sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~  303 (604)
T KOG0592|consen  228 QKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPS----SDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALD  303 (604)
T ss_pred             hccccCccCcccccCcccceeeeecccCHHHhcCCCCCcc----cchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhc
Confidence            211         1    33578999999999998765544    999999999999999999999999998888888754


Q ss_pred             CCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 012887          405 LRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL  442 (454)
Q Consensus       405 ~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L  442 (454)
                      +  .+|.++|+.+.+|++++|..||.+|++..+|.+|.
T Consensus       304 y--~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp  339 (604)
T KOG0592|consen  304 Y--EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHP  339 (604)
T ss_pred             c--cCCCCCCHHHHHHHHHHHccCccccccHHHHhhCc
Confidence            4  48999999999999999999999999999998764

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.7e-47  Score=386.56  Aligned_cols=263  Identities=29%  Similarity=0.528  Sum_probs=232.8

Q ss_pred             cceeecCCCEEEeceeeccCCceEEEeE---------E-EEEEEeecC-CCCchHHHHHHHHHHHHHhCCCCceeEEEEE
Q 012887          183 GRWLLNSDNLEFIDQIGPNSFKGVYKGK---------R-VGIEKLKGC-DKGNAYEFELRKDLLELMTCGHKNILQFYCV  251 (454)
Q Consensus       183 ~~~~~~~~~~~~~~~LG~G~fG~Vy~g~---------~-vavK~l~~~-~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~  251 (454)
                      ..|++..++..+.++||+|+||.||+|+         . ||||..+.. ........++.+|.++++.++|||||++||+
T Consensus       150 ~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGV  229 (474)
T KOG0194|consen  150 QKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGV  229 (474)
T ss_pred             cccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence            5799999999999999999999999973         2 789988853 3445567789999999999999999999999


Q ss_pred             EEeCCCeEEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCC
Q 012887          252 CVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGI  330 (454)
Q Consensus       252 ~~~~~~~l~lV~E~~~~gsL~~~l~~~~-~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGl  330 (454)
                      +..... +++|||+|+||+|.++|++.+ .++..+...++.+.+.||+|||++++|||||.++|+|++.++.+||+|||+
T Consensus       230 a~~~~P-l~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGL  308 (474)
T KOG0194|consen  230 AVLEEP-LMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGL  308 (474)
T ss_pred             EcCCCc-cEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCcccc
Confidence            998775 999999999999999998877 599999999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHcCCCCCC
Q 012887          331 VTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEI  409 (454)
Q Consensus       331 a~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~  409 (454)
                      ++.............-+.+|+|||.+....    ++.+||||||||++||+++ |..||.+....+....+...+++.+.
T Consensus       309 s~~~~~~~~~~~~~klPirWLAPEtl~~~~----~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~  384 (474)
T KOG0194|consen  309 SRAGSQYVMKKFLKKLPIRWLAPETLNTGI----FSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPI  384 (474)
T ss_pred             ccCCcceeeccccccCcceecChhhhccCc----cccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCC
Confidence            876542111121223568999999998775    4455999999999999999 89999999999999999899999999


Q ss_pred             CCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCCCC
Q 012887          410 PKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISN  450 (454)
Q Consensus       410 p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~  450 (454)
                      |...|.++..++.+||..||++||+|.++.+.|..+....+
T Consensus       385 ~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~  425 (474)
T KOG0194|consen  385 PSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE  425 (474)
T ss_pred             CCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence            99999999999999999999999999999999998877654

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=3.7e-46  Score=374.66  Aligned_cols=258  Identities=24%  Similarity=0.446  Sum_probs=214.8

Q ss_pred             eeecCCCEEEeceeeccCCceEEEeE-----------EEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEEEEEE
Q 012887          185 WLLNSDNLEFIDQIGPNSFKGVYKGK-----------RVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVC  252 (454)
Q Consensus       185 ~~~~~~~~~~~~~LG~G~fG~Vy~g~-----------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~~~g~~  252 (454)
                      |.++.++|++.+.||+|+||.||+|.           .||+|.++.. ........+.+|+.++..+ +||||++++++|
T Consensus         2 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~   80 (338)
T cd05102           2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEG-ATASEHKALMSELKILIHIGNHLNVVNLLGAC   80 (338)
T ss_pred             cccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccc-cchHHHHHHHHHHHHHHHhccCcceeeEEeEe
Confidence            67888999999999999999999873           5899988732 2333445688999999998 899999999999


Q ss_pred             EeCCCeEEEEEeccCCCCHHHHHHhC------------------------------------------------------
Q 012887          253 VDENHGLCVVTKLMEGGSVNDLILKS------------------------------------------------------  278 (454)
Q Consensus       253 ~~~~~~l~lV~E~~~~gsL~~~l~~~------------------------------------------------------  278 (454)
                      ...+..+++||||+++|+|.+++...                                                      
T Consensus        81 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (338)
T cd05102          81 TKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP  160 (338)
T ss_pred             cCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence            87765689999999999999998642                                                      


Q ss_pred             --------CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCC--cccccCCCC
Q 012887          279 --------RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE--ATEYETDGY  348 (454)
Q Consensus       279 --------~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~--~~~~~~gt~  348 (454)
                              ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.......  ......+++
T Consensus       161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~  240 (338)
T cd05102         161 QETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL  240 (338)
T ss_pred             hhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCc
Confidence                    2377788899999999999999999999999999999999999999999999875433221  112223467


Q ss_pred             cccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhccc
Q 012887          349 RWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNN  427 (454)
Q Consensus       349 ~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~li~~cl~~  427 (454)
                      .|+|||++.+..+    +.++|||||||++|||++ |..||.+.............+.++..|..+++.+.+++.+||+.
T Consensus       241 ~y~aPE~~~~~~~----~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~  316 (338)
T cd05102         241 KWMAPESIFDKVY----TTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQG  316 (338)
T ss_pred             cccCcHHhhcCCC----CcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccC
Confidence            8999999976644    456999999999999997 99999876655555555555666667888999999999999999


Q ss_pred             CCCCCCCHHHHHHHHHhhcC
Q 012887          428 SPSKRPQFSEIISLLLRTNN  447 (454)
Q Consensus       428 dP~~RPs~~ell~~L~~~~~  447 (454)
                      ||.+|||+.|+++.|+++..
T Consensus       317 dp~~RPs~~el~~~l~~~~~  336 (338)
T cd05102         317 DPKERPTFSALVEILGDLLQ  336 (338)
T ss_pred             ChhhCcCHHHHHHHHHHHHh
Confidence            99999999999999998765

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6e-47  Score=372.18  Aligned_cols=254  Identities=25%  Similarity=0.417  Sum_probs=215.7

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCC-eEEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH-GLCVV  262 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~-~l~lV  262 (454)
                      .++...+.||+|+||.||++      ...|||.+......  ....+.+|+.+|.+++|||||+++|....... .+++.
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~--~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~   94 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSP--TSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIF   94 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccch--hHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEee
Confidence            45677899999999999984      57899988754222  14568999999999999999999997444432 48999


Q ss_pred             EeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEcc-CCcEEEEccCCcccccc---C
Q 012887          263 TKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDR-HGNVCLGDMGIVTACKS---V  337 (454)
Q Consensus       263 ~E~~~~gsL~~~l~~~~-~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~-~~~vKL~DFGla~~~~~---~  337 (454)
                      |||+++|||.+++.+.+ .+++..+..+..||++||+|||++|||||||||+|||++. ++.+||+|||+++....   .
T Consensus        95 mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~  174 (313)
T KOG0198|consen   95 MEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTK  174 (313)
T ss_pred             eeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccccc
Confidence            99999999999998766 8999999999999999999999999999999999999999 79999999999887653   1


Q ss_pred             CCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHHHcCCCCCCCCCccHH
Q 012887          338 GEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAA-CSPVQAAVGIAACGLRPEIPKDCPQI  416 (454)
Q Consensus       338 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~-~~~~~~~~~i~~~~~~~~~p~~~~~~  416 (454)
                      ........||+.|||||++.++...   ..++|||||||++.||+||..||.. .........+......|.+|..+|.+
T Consensus       175 ~~~~~~~~Gtp~~maPEvi~~g~~~---~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~  251 (313)
T KOG0198|consen  175 SDSELSVQGTPNYMAPEVIRNGEVA---RRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDE  251 (313)
T ss_pred             ccccccccCCccccCchhhcCCCcC---CccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHH
Confidence            1224456789999999999853211   1359999999999999999999998 56667777777777777999999999


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHHHHHhhcCC
Q 012887          417 LKSLMIKCWNNSPSKRPQFSEIISLLLRTNNI  448 (454)
Q Consensus       417 l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~  448 (454)
                      .++++.+|+..||.+|||++++++|..-..+.
T Consensus       252 a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~  283 (313)
T KOG0198|consen  252 AKDFLRKCFKRDPEKRPTAEELLEHPFLKQNS  283 (313)
T ss_pred             HHHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence            99999999999999999999999998776544

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.7e-46  Score=376.36  Aligned_cols=253  Identities=21%  Similarity=0.319  Sum_probs=221.3

Q ss_pred             cCCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCC---chHHHHHHHHHHHHHhCC-CCceeEEEEEEEeCCC
Q 012887          188 NSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG---NAYEFELRKDLLELMTCG-HKNILQFYCVCVDENH  257 (454)
Q Consensus       188 ~~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~---~~~~~~~~~Ei~~l~~l~-HpnIv~~~g~~~~~~~  257 (454)
                      ....|++.+.||+|+||.|+.|      ..||+|.+......   ......+.+|+.+++.++ ||||++++.++....+
T Consensus        15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~   94 (370)
T KOG0583|consen   15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK   94 (370)
T ss_pred             ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence            3478999999999999999986      57999966543111   134556779999999998 9999999999998887


Q ss_pred             eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccC-CcEEEEccCCcccccc
Q 012887          258 GLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH-GNVCLGDMGIVTACKS  336 (454)
Q Consensus       258 ~l~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~-~~vKL~DFGla~~~~~  336 (454)
                       +++||||+.||+|.+++.+.+++.+..+..++.||+.|++|||++||+||||||+|||++.+ +++||+|||++.....
T Consensus        95 -~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~  173 (370)
T KOG0583|consen   95 -IYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISPG  173 (370)
T ss_pred             -EEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccCC
Confidence             99999999999999999888899999999999999999999999999999999999999999 9999999999987743


Q ss_pred             CCCcccccCCCCcccccccccCCC-CCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCc-c
Q 012887          337 VGEATEYETDGYRWLAPEIIAGDP-ESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDC-P  414 (454)
Q Consensus       337 ~~~~~~~~~gt~~y~APE~l~~~~-~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~-~  414 (454)
                      ........+|++.|+|||++.+.. |..   .++||||+||+||.|++|..||...+.......+...  +..+|..+ +
T Consensus       174 ~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g---~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~--~~~~p~~~~S  248 (370)
T KOG0583|consen  174 EDGLLKTFCGSPAYAAPEVLSGKGTYSG---KAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKG--EFKIPSYLLS  248 (370)
T ss_pred             CCCcccCCCCCcccCCHHHhCCCCCcCC---chhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcC--CccCCCCcCC
Confidence            344566778999999999999876 653   3699999999999999999999998877777776554  45588888 9


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 012887          415 QILKSLMIKCWNNSPSKRPQFSEIISLLLRTN  446 (454)
Q Consensus       415 ~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~  446 (454)
                      +++..|+.+||..||.+|+++.+|+.+-|-..
T Consensus       249 ~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  249 PEARSLIEKMLVPDPSTRITLLEILEHPWFQK  280 (370)
T ss_pred             HHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence            99999999999999999999999998877654

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-47  Score=386.44  Aligned_cols=250  Identities=26%  Similarity=0.531  Sum_probs=225.1

Q ss_pred             ccceeecCCCEEEeceeeccCCceEEEe----EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCC
Q 012887          182 IGRWLLNSDNLEFIDQIGPNSFKGVYKG----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH  257 (454)
Q Consensus       182 ~~~~~~~~~~~~~~~~LG~G~fG~Vy~g----~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~  257 (454)
                      -+-|.++.+.+.-++.||+|+.|.||+|    +.||||+++..         -+.+|.-|+.|+||||+.|.|+|....-
T Consensus       116 ~e~WeiPFe~IsELeWlGSGaQGAVF~Grl~netVAVKKV~el---------kETdIKHLRkLkH~NII~FkGVCtqsPc  186 (904)
T KOG4721|consen  116 EELWEIPFEEISELEWLGSGAQGAVFLGRLHNETVAVKKVREL---------KETDIKHLRKLKHPNIITFKGVCTQSPC  186 (904)
T ss_pred             hhhccCCHHHhhhhhhhccCcccceeeeeccCceehhHHHhhh---------hhhhHHHHHhccCcceeeEeeeecCCce
Confidence            3678899999999999999999999997    47999998632         2367788999999999999999987664


Q ss_pred             eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccC
Q 012887          258 GLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV  337 (454)
Q Consensus       258 ~l~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~  337 (454)
                       +|||||||..|.|...|+..+.+....+..|..+|+.||.|||.+.|||||||.-||||+.+..|||+|||-++...+.
T Consensus       187 -yCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~  265 (904)
T KOG4721|consen  187 -YCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK  265 (904)
T ss_pred             -eEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhh
Confidence             9999999999999999998899999999999999999999999999999999999999999999999999998877665


Q ss_pred             CCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHH
Q 012887          338 GEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQIL  417 (454)
Q Consensus       338 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l  417 (454)
                       .......||..|||||++..++.+.    |+|||||||+||||+||..||.+.....+++.+-.+-+.++.|..||+.+
T Consensus       266 -STkMSFaGTVaWMAPEvIrnePcsE----KVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~Gf  340 (904)
T KOG4721|consen  266 -STKMSFAGTVAWMAPEVIRNEPCSE----KVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGF  340 (904)
T ss_pred             -hhhhhhhhhHhhhCHHHhhcCCccc----ccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHH
Confidence             3345568999999999999887554    49999999999999999999999888877777777777889999999999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 012887          418 KSLMIKCWNNSPSKRPQFSEIISLLLRTN  446 (454)
Q Consensus       418 ~~li~~cl~~dP~~RPs~~ell~~L~~~~  446 (454)
                      +-||++||...|..||+|.+|+.||.-..
T Consensus       341 klL~Kqcw~sKpRNRPSFrqil~HldIa~  369 (904)
T KOG4721|consen  341 KLLLKQCWNSKPRNRPSFRQILLHLDIAS  369 (904)
T ss_pred             HHHHHHHHhcCCCCCccHHHHHHHHhhcC
Confidence            99999999999999999999999997544

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=2e-46  Score=353.88  Aligned_cols=235  Identities=21%  Similarity=0.335  Sum_probs=212.5

Q ss_pred             cCCCEEEeceeeccCCceEEE------eEEEEEEEeecCCCCch-HHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEE
Q 012887          188 NSDNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNA-YEFELRKDLLELMTCGHKNILQFYCVCVDENHGLC  260 (454)
Q Consensus       188 ~~~~~~~~~~LG~G~fG~Vy~------g~~vavK~l~~~~~~~~-~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~  260 (454)
                      ..++|++++.||.|+||+|.+      |..+|.|.+.....-.. .......|..+|+.+.||+++++++.|.+.++ +|
T Consensus        42 ~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~-ly  120 (355)
T KOG0616|consen   42 SLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSN-LY  120 (355)
T ss_pred             chhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCe-EE
Confidence            347899999999999999998      45789999875443333 33457889999999999999999999998887 99


Q ss_pred             EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCc
Q 012887          261 VVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA  340 (454)
Q Consensus       261 lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~  340 (454)
                      |||||.+||-|..++++.+++++..++.++.||+.||+|||+++|++|||||+|||+|.+|++||+|||+|+....   .
T Consensus       121 mvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~---r  197 (355)
T KOG0616|consen  121 MVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG---R  197 (355)
T ss_pred             EEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecC---c
Confidence            9999999999999999999999999999999999999999999999999999999999999999999999987654   3


Q ss_pred             ccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHHHH
Q 012887          341 TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSL  420 (454)
Q Consensus       341 ~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~l  420 (454)
                      +...+|||.|+|||++...+++..    +|.|||||++|||+.|.+||.+.++.....+|.....+  +|..++.++++|
T Consensus       198 T~TlCGTPeYLAPEii~sk~ynka----vDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~--fP~~fs~~~kdL  271 (355)
T KOG0616|consen  198 TWTLCGTPEYLAPEIIQSKGYNKA----VDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVK--FPSYFSSDAKDL  271 (355)
T ss_pred             EEEecCCccccChHHhhcCCCCcc----hhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCccc--CCcccCHHHHHH
Confidence            667799999999999998776554    99999999999999999999999999999999887555  899999999999


Q ss_pred             HHHhcccCCCCC
Q 012887          421 MIKCWNNSPSKR  432 (454)
Q Consensus       421 i~~cl~~dP~~R  432 (454)
                      ++++|+.|-++|
T Consensus       272 l~~LL~vD~t~R  283 (355)
T KOG0616|consen  272 LKKLLQVDLTKR  283 (355)
T ss_pred             HHHHHhhhhHhh
Confidence            999999999999

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=3e-46  Score=380.52  Aligned_cols=264  Identities=28%  Similarity=0.508  Sum_probs=225.2

Q ss_pred             ccceeecCCCEEEeceeeccCCceEEEeE---EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCe
Q 012887          182 IGRWLLNSDNLEFIDQIGPNSFKGVYKGK---RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHG  258 (454)
Q Consensus       182 ~~~~~~~~~~~~~~~~LG~G~fG~Vy~g~---~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~  258 (454)
                      ...|.|..+++.+...||+|+||+||+|+   .||||.+............+..|+..+++.+|.||+-|.|+|..+.  
T Consensus       384 ~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whGdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~--  461 (678)
T KOG0193|consen  384 LEEWEIPPEEVLLGERIGSGSFGTVYRGRWHGDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP--  461 (678)
T ss_pred             ccccccCHHHhhccceeccccccceeecccccceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc--
Confidence            37899999999999999999999999997   6999999988877777788999999999999999999999998765  


Q ss_pred             EEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccc--
Q 012887          259 LCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK--  335 (454)
Q Consensus       259 l~lV~E~~~~gsL~~~l~~~~-~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~--  335 (454)
                      +.||+.+|+|-+|+.++.-.+ +|....++.|++||+.||.|||.++|||||||..|||+.+++.|||+||||+....  
T Consensus       462 ~AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w  541 (678)
T KOG0193|consen  462 LAIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRW  541 (678)
T ss_pred             eeeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeee
Confidence            589999999999999996544 89999999999999999999999999999999999999999999999999976432  


Q ss_pred             cCCCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCC---CCCCC
Q 012887          336 SVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP---EIPKD  412 (454)
Q Consensus       336 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~---~~p~~  412 (454)
                      ..........|...|||||++..+. ...|+..|||||||+++|||++|..||......++++.+-.+-..+   ....+
T Consensus       542 ~g~~q~~qp~gsilwmAPEvIRmqd-~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s~  620 (678)
T KOG0193|consen  542 SGEQQLEQPHGSLLWMAPEVIRMQD-DNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRSN  620 (678)
T ss_pred             ccccccCCCccchhhhcHHHHhhcc-cCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhcc
Confidence            2223344557788999999998554 4568888999999999999999999999655555444333321222   23457


Q ss_pred             ccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCC
Q 012887          413 CPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNI  448 (454)
Q Consensus       413 ~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~  448 (454)
                      ++.++++|+..||.+++++||.|.+|+..|..+...
T Consensus       621 ~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~  656 (678)
T KOG0193|consen  621 CPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS  656 (678)
T ss_pred             CHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence            899999999999999999999999999988777663

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=1e-45  Score=372.87  Aligned_cols=251  Identities=19%  Similarity=0.312  Sum_probs=215.6

Q ss_pred             eecCCCEEEeceeeccCCceEEE------eEEEEEEEeecCCCCch-HHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCe
Q 012887          186 LLNSDNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNA-YEFELRKDLLELMTCGHKNILQFYCVCVDENHG  258 (454)
Q Consensus       186 ~~~~~~~~~~~~LG~G~fG~Vy~------g~~vavK~l~~~~~~~~-~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~  258 (454)
                      .+..++|+++..||+|+||.||+      |..+|+|+++....... ....++.|-.+|...++|+||++|..|++.++ 
T Consensus       137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~-  215 (550)
T KOG0605|consen  137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEY-  215 (550)
T ss_pred             cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCe-
Confidence            35668999999999999999998      45799999986544333 23457788888888899999999999999887 


Q ss_pred             EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccC-
Q 012887          259 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV-  337 (454)
Q Consensus       259 l~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~-  337 (454)
                      +||||||++||++..+|.+.+.|++.++..|+.+++.|++.||++|+|||||||+|+|||..||+||+||||++..... 
T Consensus       216 LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~  295 (550)
T KOG0605|consen  216 LYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKH  295 (550)
T ss_pred             eEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhh
Confidence            9999999999999999998899999999999999999999999999999999999999999999999999998543220 


Q ss_pred             --------------------CCc--------------------------ccccCCCCcccccccccCCCCCCCCCchhhH
Q 012887          338 --------------------GEA--------------------------TEYETDGYRWLAPEIIAGDPESVSETWMSNV  371 (454)
Q Consensus       338 --------------------~~~--------------------------~~~~~gt~~y~APE~l~~~~~~~~~~~ksDV  371 (454)
                                          .+.                          .....|||.|+|||++.+..|...    +|.
T Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~----cDw  371 (550)
T KOG0605|consen  296 RIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKE----CDW  371 (550)
T ss_pred             hhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCcc----ccH
Confidence                                000                          012258999999999998876554    999


Q ss_pred             HHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCC--ccHHHHHHHHHhcccCCCCCCC---HHHHHHHH
Q 012887          372 YSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKD--CPQILKSLMIKCWNNSPSKRPQ---FSEIISLL  442 (454)
Q Consensus       372 wSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~--~~~~l~~li~~cl~~dP~~RPs---~~ell~~L  442 (454)
                      ||||||+|||+.|-+||.+.++.+....|........+|..  +++++++||.+|+. ||++|..   +.||.+|-
T Consensus       372 WSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HP  446 (550)
T KOG0605|consen  372 WSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHP  446 (550)
T ss_pred             HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCC
Confidence            99999999999999999999999999999887656666654  78999999999999 9999965   77777654

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=3.2e-46  Score=376.64  Aligned_cols=245  Identities=22%  Similarity=0.378  Sum_probs=223.3

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  263 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~  263 (454)
                      ++|.+.+.||+|+||.||||      +.||+|.+....+..+....+++|+++++.++|||||.++++|....+ +|+|+
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~-~~vVt   80 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAH-LWVVT   80 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccce-EEEEe
Confidence            57888999999999999997      469999998888888788889999999999999999999999998887 99999


Q ss_pred             eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCcccc
Q 012887          264 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY  343 (454)
Q Consensus       264 E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~  343 (454)
                      |||.| +|..++...+.++++.+..++.+++.||.|||+++|+|||+||+|||++.+|++|+||||+|+.........+.
T Consensus        81 e~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vlts  159 (808)
T KOG0597|consen   81 EYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVLTS  159 (808)
T ss_pred             hhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCceeeee
Confidence            99987 99999999999999999999999999999999999999999999999999999999999999988776666777


Q ss_pred             cCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHHHHHHH
Q 012887          344 ETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIK  423 (454)
Q Consensus       344 ~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~li~~  423 (454)
                      ..|||.|||||...+.+|+..    +|.||+||++|||++|++||...+-.+....|...  +...|...+..+..++..
T Consensus       160 ikGtPlYmAPElv~e~pyd~~----sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d--~v~~p~~~S~~f~nfl~g  233 (808)
T KOG0597|consen  160 IKGTPLYMAPELVEEQPYDHT----SDLWSLGCILYELYVGQPPFYARSITQLVKSILKD--PVKPPSTASSSFVNFLQG  233 (808)
T ss_pred             ccCcccccCHHHHcCCCccch----hhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcC--CCCCcccccHHHHHHHHH
Confidence            789999999999998876654    99999999999999999999987777776666654  445677899999999999


Q ss_pred             hcccCCCCCCCHHHHHHHH
Q 012887          424 CWNNSPSKRPQFSEIISLL  442 (454)
Q Consensus       424 cl~~dP~~RPs~~ell~~L  442 (454)
                      .|.+||.+|.+..+++.|-
T Consensus       234 LL~kdP~~RltW~~Ll~Hp  252 (808)
T KOG0597|consen  234 LLIKDPAQRLTWTDLLGHP  252 (808)
T ss_pred             HhhcChhhcccHHHHhcCh
Confidence            9999999999999998763

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=3.9e-46  Score=352.66  Aligned_cols=248  Identities=20%  Similarity=0.334  Sum_probs=209.5

Q ss_pred             CCEEEeceeeccCCceEEE------eEEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  263 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~------g~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~  263 (454)
                      +.|+.+.++|+|+||.||+      |+.||||++...........-..+|++.|++++|+|+|.++++|..... +++|+
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrk-lhLVF   80 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRK-LHLVF   80 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcce-eEEEe
Confidence            5688899999999999998      5789999998665555555667899999999999999999999987776 99999


Q ss_pred             eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCcccc
Q 012887          264 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY  343 (454)
Q Consensus       264 E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~  343 (454)
                      |||+..-|+++-+-...++...+..++.|++.|+.|+|++++|||||||+||||+.+|.+||||||+|+.+..+++..+.
T Consensus        81 E~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~YTD  160 (396)
T KOG0593|consen   81 EYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNYTD  160 (396)
T ss_pred             eecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcchhhh
Confidence            99988444444334458999999999999999999999999999999999999999999999999999998877776666


Q ss_pred             cCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHc-------------------C
Q 012887          344 ETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAAC-------------------G  404 (454)
Q Consensus       344 ~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~-------------------~  404 (454)
                      ...|-+|.|||.+.|..   .|....||||+||++.||++|.+.|++.++...+..|...                   |
T Consensus       161 YVATRWYRaPELLvGDt---qYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~G  237 (396)
T KOG0593|consen  161 YVATRWYRAPELLVGDT---QYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHG  237 (396)
T ss_pred             hhhhhhccChhhhcccC---cCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceee
Confidence            78899999999999853   3444599999999999999999999999998877655432                   1


Q ss_pred             CCCCCCC----------CccHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012887          405 LRPEIPK----------DCPQILKSLMIKCWNNSPSKRPQFSEIISL  441 (454)
Q Consensus       405 ~~~~~p~----------~~~~~l~~li~~cl~~dP~~RPs~~ell~~  441 (454)
                      .+.+.|.          ..+.-+.+++++||..||++|++.++++.|
T Consensus       238 v~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H  284 (396)
T KOG0593|consen  238 VRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH  284 (396)
T ss_pred             eecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence            1222221          345678999999999999999999999865

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-45  Score=360.54  Aligned_cols=257  Identities=25%  Similarity=0.417  Sum_probs=218.3

Q ss_pred             cceeecCCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCC
Q 012887          183 GRWLLNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN  256 (454)
Q Consensus       183 ~~~~~~~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~  256 (454)
                      .+|.++.++|++...||.|.-+.||+|      ..||||++.-.+... .-..+++|+..++.++||||++++..|..++
T Consensus        19 ~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~-~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~   97 (516)
T KOG0582|consen   19 KEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNN-DLDALRKEVQTMSLIDHPNIVTYHCSFVVDS   97 (516)
T ss_pred             ccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhh-hHHHHHHHHHHhhhcCCCCcceEEEEEEecc
Confidence            567888999999999999999999986      589999997544433 3677999999999999999999999999887


Q ss_pred             CeEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCcccc
Q 012887          257 HGLCVVTKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC  334 (454)
Q Consensus       257 ~~l~lV~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~  334 (454)
                      . +|+||.||.+||+.+++...  ..+++..+..+.+++++||.|||.+|.||||||+.||||+.+|.|||+|||.+..+
T Consensus        98 ~-LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l  176 (516)
T KOG0582|consen   98 E-LWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASL  176 (516)
T ss_pred             e-eEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeee
Confidence            6 99999999999999999653  36999999999999999999999999999999999999999999999999997666


Q ss_pred             ccCCCcc----cccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCC--
Q 012887          335 KSVGEAT----EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPE--  408 (454)
Q Consensus       335 ~~~~~~~----~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~--  408 (454)
                      .+.+...    ....||++|||||++.....  .|+.|+||||||++..||.+|..||....+.+.+..-.++..+-.  
T Consensus       177 ~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~--GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t  254 (516)
T KOG0582|consen  177 FDSGDRQVTRFNTFVGTPCWMAPEVLMQQLH--GYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLT  254 (516)
T ss_pred             cccCceeeEeeccccCcccccChHHhhhccc--CccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCccc
Confidence            5544322    34479999999999754432  477789999999999999999999999999887766555432211  


Q ss_pred             --CC----CCccHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 012887          409 --IP----KDCPQILKSLMIKCWNNSPSKRPQFSEIISLLL  443 (454)
Q Consensus       409 --~p----~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~  443 (454)
                        ++    ..++..++.++..||.+||.+|||+++++++-.
T Consensus       255 ~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~F  295 (516)
T KOG0582|consen  255 SGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAF  295 (516)
T ss_pred             ccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHH
Confidence              11    236778999999999999999999999998754

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.5e-45  Score=367.31  Aligned_cols=268  Identities=22%  Similarity=0.380  Sum_probs=222.4

Q ss_pred             ccchhhhcCCCccccce-eecCCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCC
Q 012887          169 VDEWQTVQSGGEEIGRW-LLNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCG  241 (454)
Q Consensus       169 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~  241 (454)
                      ...|..... ++.+..| ....+.|+.+++||+|+||.||++      +.||+|+++..........-..+||.+|++|+
T Consensus        96 ~p~~l~~~~-ge~~~~w~~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~  174 (560)
T KOG0600|consen   96 WPAWLSSVA-GEALHGWGPRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLD  174 (560)
T ss_pred             Ccccccccc-ccccccccccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcC
Confidence            334443333 3334444 356678999999999999999995      57999999876656666677899999999999


Q ss_pred             CCceeEEEEEEEeC-CCeEEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEcc
Q 012887          242 HKNILQFYCVCVDE-NHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDR  319 (454)
Q Consensus       242 HpnIv~~~g~~~~~-~~~l~lV~E~~~~gsL~~~l~~~~-~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~  319 (454)
                      ||||+++.+...+. ...+|||+|||++ +|..++...+ .|++.++..|+.||+.||+|||++||+|||||.+|||||.
T Consensus       175 HpNIikL~eivt~~~~~siYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn  253 (560)
T KOG0600|consen  175 HPNIIKLEEIVTSKLSGSIYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDN  253 (560)
T ss_pred             CCcccceeeEEEecCCceEEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcC
Confidence            99999999999988 3469999999988 9999986654 8999999999999999999999999999999999999999


Q ss_pred             CCcEEEEccCCccccccCCCc-ccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHH
Q 012887          320 HGNVCLGDMGIVTACKSVGEA-TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAV  398 (454)
Q Consensus       320 ~~~vKL~DFGla~~~~~~~~~-~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~  398 (454)
                      +|.+||+|||||+.+...... .+..+-|.+|.|||.+.|..   .|+.+.|+||.||||.||+.|++.|.+.+..+.+.
T Consensus       254 ~G~LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t---~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~  330 (560)
T KOG0600|consen  254 NGVLKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGAT---SYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLH  330 (560)
T ss_pred             CCCEEeccccceeeccCCCCcccccceEEeeccChHHhcCCc---ccccceeehhhhHHHHHHHcCCCCcCCccHHHHHH
Confidence            999999999999976554432 44446689999999999874   47778999999999999999999999999998887


Q ss_pred             HHHHc-CCCC-------CCC-------------------CCccHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012887          399 GIAAC-GLRP-------EIP-------------------KDCPQILKSLMIKCWNNSPSKRPQFSEIISL  441 (454)
Q Consensus       399 ~i~~~-~~~~-------~~p-------------------~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  441 (454)
                      .|... +-+.       .+|                   ..+|....+|+..+|..||++|.|+.+.+..
T Consensus       331 kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s  400 (560)
T KOG0600|consen  331 KIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS  400 (560)
T ss_pred             HHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence            76542 1110       111                   2467889999999999999999999998864

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.3e-45  Score=395.55  Aligned_cols=255  Identities=27%  Similarity=0.531  Sum_probs=221.4

Q ss_pred             ecCCCEEEeceeeccCCceEEEeE-----------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeC
Q 012887          187 LNSDNLEFIDQIGPNSFKGVYKGK-----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDE  255 (454)
Q Consensus       187 ~~~~~~~~~~~LG~G~fG~Vy~g~-----------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~  255 (454)
                      ++.+..++...||+|+||.||.|.           .||+|.++.. .......++.+|..+|..++|||||+++|+|.+.
T Consensus       689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~-~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~  767 (1025)
T KOG1095|consen  689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL-SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDS  767 (1025)
T ss_pred             CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc-CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCC
Confidence            457889999999999999999973           4899999743 3445667799999999999999999999999996


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEcc
Q 012887          256 NHGLCVVTKLMEGGSVNDLILKS-------RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDM  328 (454)
Q Consensus       256 ~~~l~lV~E~~~~gsL~~~l~~~-------~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DF  328 (454)
                      .. .+|++|||.||+|..+|++.       ..+...+++.++.|||+|+.||+++++|||||..+|+|++....|||+||
T Consensus       768 ~~-~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDF  846 (1025)
T KOG1095|consen  768 GP-PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADF  846 (1025)
T ss_pred             CC-cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEccc
Confidence            65 88999999999999999765       26889999999999999999999999999999999999999999999999


Q ss_pred             CCccccccCCCc-cccc-CCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHcCC
Q 012887          329 GIVTACKSVGEA-TEYE-TDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGL  405 (454)
Q Consensus       329 Gla~~~~~~~~~-~~~~-~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~i~~~~~  405 (454)
                      |+|+........ .... .-+.+|||||.+..+.    ++.|||||||||+|||++| |..||.+.++.+...-....+ 
T Consensus       847 GlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~i----FtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg-  921 (1025)
T KOG1095|consen  847 GLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGI----FTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG-  921 (1025)
T ss_pred             chhHhhhhchheeccCccccceecCCHHHHhhcc----cccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC-
Confidence            999844332211 1111 2357899999998653    5667999999999999999 999999999988887777766 


Q ss_pred             CCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCC
Q 012887          406 RPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNI  448 (454)
Q Consensus       406 ~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~  448 (454)
                      |++.|..||+.++++|.+||+.+|++||+|..|++.+..+.+.
T Consensus       922 RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~  964 (1025)
T KOG1095|consen  922 RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNA  964 (1025)
T ss_pred             ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhh
Confidence            9999999999999999999999999999999999988877664

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-46  Score=368.74  Aligned_cols=248  Identities=21%  Similarity=0.322  Sum_probs=211.1

Q ss_pred             CCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCC-CCceeEEEEEEEeCCCeEEE
Q 012887          189 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCG-HKNILQFYCVCVDENHGLCV  261 (454)
Q Consensus       189 ~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~~~g~~~~~~~~l~l  261 (454)
                      .++|.++++||.|+||.||+|      ..||||+++..... ..+.--.+|+..|++++ |||||++.+++.+.+..+|+
T Consensus         9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f   87 (538)
T KOG0661|consen    9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF   87 (538)
T ss_pred             HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence            478899999999999999985      57999999864433 34445679999999998 99999999999998856999


Q ss_pred             EEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCc
Q 012887          262 VTKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA  340 (454)
Q Consensus       262 V~E~~~~gsL~~~l~~-~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~  340 (454)
                      |||||+. +|+++++. ++.|++..+..|+.||+.||+|+|.+|+.|||+||+|||+..+..+||+|||+|+...+....
T Consensus        88 VfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpPY  166 (538)
T KOG0661|consen   88 VFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSKPPY  166 (538)
T ss_pred             eHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccCCCc
Confidence            9999977 99999965 458999999999999999999999999999999999999999999999999999988776655


Q ss_pred             ccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHc-----------------
Q 012887          341 TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAAC-----------------  403 (454)
Q Consensus       341 ~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~-----------------  403 (454)
                      ++| .+|-+|.|||++....   .|+.+.|+||+|||++|+++-++.|++.+..+.+.+|...                 
T Consensus       167 TeY-VSTRWYRAPEvLLrs~---~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~  242 (538)
T KOG0661|consen  167 TEY-VSTRWYRAPEVLLRSG---YYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLAS  242 (538)
T ss_pred             chh-hhcccccchHHhhhcc---ccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHH
Confidence            554 6788899999998543   3555699999999999999999999999888877665321                 


Q ss_pred             --CCCCC---------CCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 012887          404 --GLRPE---------IPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL  442 (454)
Q Consensus       404 --~~~~~---------~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L  442 (454)
                        +.+.+         +-.+++.++.++|.+|++.||.+|||+.+++++-
T Consensus       243 ~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p  292 (538)
T KOG0661|consen  243 AMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHP  292 (538)
T ss_pred             HhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence              11111         1124789999999999999999999999999874

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.6e-45  Score=372.70  Aligned_cols=245  Identities=20%  Similarity=0.365  Sum_probs=220.8

Q ss_pred             EEeceeeccCCceEEE------eEEEEEEEeecC-CCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEEec
Q 012887          193 EFIDQIGPNSFKGVYK------GKRVGIEKLKGC-DKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKL  265 (454)
Q Consensus       193 ~~~~~LG~G~fG~Vy~------g~~vavK~l~~~-~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~E~  265 (454)
                      ++++.||.|+-|.|-+      |+..|||.+... .........+++||.+|+.+.||||+++|++|.+..+ +|+|.||
T Consensus        15 kLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~-lylvlEy   93 (786)
T KOG0588|consen   15 KLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQH-LYLVLEY   93 (786)
T ss_pred             eccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCce-EEEEEEe
Confidence            7789999999999997      678999998755 3334455679999999999999999999999998877 9999999


Q ss_pred             cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCcccccC
Q 012887          266 MEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYET  345 (454)
Q Consensus       266 ~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~  345 (454)
                      ++||-|++++.+.+++++.++++++.||+.|+.|+|..+|+||||||+|+|+|..+++||+|||+|.... .+......+
T Consensus        94 v~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~-~gklLeTSC  172 (786)
T KOG0588|consen   94 VPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEV-PGKLLETSC  172 (786)
T ss_pred             cCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeeccc-CCccccccC
Confidence            9999999999999999999999999999999999999999999999999999999999999999987543 334566678


Q ss_pred             CCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhc
Q 012887          346 DGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCW  425 (454)
Q Consensus       346 gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~li~~cl  425 (454)
                      |.|-|+|||++.|.+|...   ++||||.|||||.|++|+.||.+.+....+.++..+.+.  +|.++|.++++||++|+
T Consensus       173 GSPHYA~PEIV~G~pYdG~---~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~--MPs~Is~eaQdLLr~ml  247 (786)
T KOG0588|consen  173 GSPHYAAPEIVSGRPYDGR---PSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFE--MPSNISSEAQDLLRRML  247 (786)
T ss_pred             CCcccCCchhhcCCCCCCC---ccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCccc--CCCcCCHHHHHHHHHHh
Confidence            9999999999999988654   699999999999999999999998888888888776555  77999999999999999


Q ss_pred             ccCCCCCCCHHHHHHHHHh
Q 012887          426 NNSPSKRPQFSEIISLLLR  444 (454)
Q Consensus       426 ~~dP~~RPs~~ell~~L~~  444 (454)
                      ..||++|.|..||++|.+-
T Consensus       248 ~VDp~~RiT~~eI~kHP~l  266 (786)
T KOG0588|consen  248 DVDPSTRITTEEILKHPFL  266 (786)
T ss_pred             ccCccccccHHHHhhCchh
Confidence            9999999999999999764

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-45  Score=362.13  Aligned_cols=256  Identities=19%  Similarity=0.283  Sum_probs=214.0

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCC------------chHHHHHHHHHHHHHhCCCCceeEEEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG------------NAYEFELRKDLLELMTCGHKNILQFYCV  251 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~------------~~~~~~~~~Ei~~l~~l~HpnIv~~~g~  251 (454)
                      ++|++++.||+|.||.|-++      +.+|+|++......            ......+.+||.+|++++|||||+++++
T Consensus        97 Nqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEv  176 (576)
T KOG0585|consen   97 NQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEV  176 (576)
T ss_pred             hheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEe
Confidence            78999999999999999985      68999998543211            1122468899999999999999999999


Q ss_pred             EEeCC-CeEEEEEeccCCCCHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccC
Q 012887          252 CVDEN-HGLCVVTKLMEGGSVNDLILKSRK-LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMG  329 (454)
Q Consensus       252 ~~~~~-~~l~lV~E~~~~gsL~~~l~~~~~-l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFG  329 (454)
                      ..+.. ..+|||+|||..|.+...- ..+. +.+.+++.|+.+++.||+|||.+|||||||||+|+||+++|+|||+|||
T Consensus       177 LDDP~s~~~YlVley~s~G~v~w~p-~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIsDFG  255 (576)
T KOG0585|consen  177 LDDPESDKLYLVLEYCSKGEVKWCP-PDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKISDFG  255 (576)
T ss_pred             ecCcccCceEEEEEeccCCccccCC-CCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEeeccc
Confidence            87764 4599999999988876542 2234 8999999999999999999999999999999999999999999999999


Q ss_pred             CccccccC-----CCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcC
Q 012887          330 IVTACKSV-----GEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG  404 (454)
Q Consensus       330 la~~~~~~-----~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~  404 (454)
                      .+......     ........|||.|+|||.+.++.....-+.+.||||+||+||.|+.|+.||.+....+...+|+.. 
T Consensus       256 Vs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIvn~-  334 (576)
T KOG0585|consen  256 VSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIVND-  334 (576)
T ss_pred             eeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHhcC-
Confidence            98766322     222334689999999999987543223445789999999999999999999998888888888865 


Q ss_pred             CCCCCCCC--ccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCC
Q 012887          405 LRPEIPKD--CPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNI  448 (454)
Q Consensus       405 ~~~~~p~~--~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~  448 (454)
                       +..+|..  ...++++||.++|.+||+.|.+..+|..|.|.....
T Consensus       335 -pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g  379 (576)
T KOG0585|consen  335 -PLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDG  379 (576)
T ss_pred             -cccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccCC
Confidence             4445554  789999999999999999999999999999877653

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1.5e-43  Score=347.96  Aligned_cols=255  Identities=22%  Similarity=0.341  Sum_probs=214.8

Q ss_pred             ecCCCEEEe--ceeeccCCceEEEe----EEEEEEEeecCCCCch-HHHHHHHHHHHHHhCCCCceeEEEEEEEe--CC-
Q 012887          187 LNSDNLEFI--DQIGPNSFKGVYKG----KRVGIEKLKGCDKGNA-YEFELRKDLLELMTCGHKNILQFYCVCVD--EN-  256 (454)
Q Consensus       187 ~~~~~~~~~--~~LG~G~fG~Vy~g----~~vavK~l~~~~~~~~-~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~--~~-  256 (454)
                      ++.++++..  ..||+|++|.||+|    +.||+|.++....... ....+.+|+.+|.+++||||++++|++.+  ++ 
T Consensus        15 i~~~~i~~~~~~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~   94 (283)
T PHA02988         15 IESDDIDKYTSVLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL   94 (283)
T ss_pred             cCHHHcCCCCCeEEeeCCceEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCC
Confidence            334444444  57999999999996    5899999875443332 23557799999999999999999999977  32 


Q ss_pred             CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhc-CcccCCccCCcEEEccCCcEEEEccCCccccc
Q 012887          257 HGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDH-GVAYRDLNSQRILLDRHGNVCLGDMGIVTACK  335 (454)
Q Consensus       257 ~~l~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~-~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~  335 (454)
                      ..+++||||+++|+|.+++.+.+.+++.....++.|++.||.|||+. +++||||||+|||++.++.+||+|||++....
T Consensus        95 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~  174 (283)
T PHA02988         95 PRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILS  174 (283)
T ss_pred             CceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhc
Confidence            34899999999999999998878899999999999999999999984 99999999999999999999999999987654


Q ss_pred             cCCCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccH
Q 012887          336 SVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ  415 (454)
Q Consensus       336 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~  415 (454)
                      ..   .....++..|+|||++.+..  ..++.++|||||||++|||++|..||.+.+..+....+...+.++.+|..+|+
T Consensus       175 ~~---~~~~~~~~~y~aPE~~~~~~--~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  249 (283)
T PHA02988        175 SP---PFKNVNFMVYFSYKMLNDIF--SEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPL  249 (283)
T ss_pred             cc---cccccCcccccCHHHhhhcc--ccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcH
Confidence            32   22345788999999987521  13566799999999999999999999988877777777667777788888999


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 012887          416 ILKSLMIKCWNNSPSKRPQFSEIISLLLRTN  446 (454)
Q Consensus       416 ~l~~li~~cl~~dP~~RPs~~ell~~L~~~~  446 (454)
                      ++.++|.+||+.||.+|||+.|+++.|.+..
T Consensus       250 ~l~~li~~cl~~dp~~Rps~~ell~~l~~~~  280 (283)
T PHA02988        250 EIKCIVEACTSHDSIKRPNIKEILYNLSLYK  280 (283)
T ss_pred             HHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence            9999999999999999999999999998764

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=1.2e-43  Score=362.65  Aligned_cols=257  Identities=25%  Similarity=0.445  Sum_probs=214.8

Q ss_pred             cceeecCCCEEEeceeeccCCceEEEeE-----------EEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEEEE
Q 012887          183 GRWLLNSDNLEFIDQIGPNSFKGVYKGK-----------RVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYC  250 (454)
Q Consensus       183 ~~~~~~~~~~~~~~~LG~G~fG~Vy~g~-----------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~~~g  250 (454)
                      .+|.++.++|++.+.||+|+||.||+++           .||+|.++... .......+.+|+.++..+ +||||+++++
T Consensus        28 ~~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~il~~l~~HpnIv~l~~  106 (375)
T cd05104          28 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHINIVNLLG  106 (375)
T ss_pred             cccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc-CcHHHHHHHHHHHHHHHhcCCcceeeeee
Confidence            4677888899999999999999999864           68999887432 233445678899999999 8999999999


Q ss_pred             EEEeCCCeEEEEEeccCCCCHHHHHHhCC---------------------------------------------------
Q 012887          251 VCVDENHGLCVVTKLMEGGSVNDLILKSR---------------------------------------------------  279 (454)
Q Consensus       251 ~~~~~~~~l~lV~E~~~~gsL~~~l~~~~---------------------------------------------------  279 (454)
                      +|.+.+. .++||||+++|+|.+++.+..                                                   
T Consensus       107 ~~~~~~~-~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  185 (375)
T cd05104         107 ACTVGGP-TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADK  185 (375)
T ss_pred             eeccCCc-ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccc
Confidence            9988876 899999999999999985421                                                   


Q ss_pred             ------------------------CCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccc
Q 012887          280 ------------------------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK  335 (454)
Q Consensus       280 ------------------------~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~  335 (454)
                                              .+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||++....
T Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~  265 (375)
T cd05104         186 RRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIR  265 (375)
T ss_pred             ccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceecc
Confidence                                    46788899999999999999999999999999999999999999999999987654


Q ss_pred             cCCCc--ccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHcCCCCCCCCC
Q 012887          336 SVGEA--TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKD  412 (454)
Q Consensus       336 ~~~~~--~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~  412 (454)
                      .....  .....+++.|+|||.+.+..+    +.++|||||||++|||++ |..||...............+.++..|..
T Consensus       266 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~----~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  341 (375)
T cd05104         266 NDSNYVVKGNARLPVKWMAPESIFNCVY----TFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPEC  341 (375)
T ss_pred             CcccccccCCCCCCcceeChhHhcCCCC----CCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCC
Confidence            33221  111234567999999987654    445999999999999998 99999877666666666666667777777


Q ss_pred             ccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 012887          413 CPQILKSLMIKCWNNSPSKRPQFSEIISLLLRT  445 (454)
Q Consensus       413 ~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~  445 (454)
                      .+.++.+++.+||+.||++||++.|+++.|++.
T Consensus       342 ~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         342 APSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence            899999999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-44  Score=370.22  Aligned_cols=242  Identities=21%  Similarity=0.336  Sum_probs=213.3

Q ss_pred             eecCCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCch-HHHHHHHHHHHHHhC-CCCceeEEEEEEEeCCC
Q 012887          186 LLNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNA-YEFELRKDLLELMTC-GHKNILQFYCVCVDENH  257 (454)
Q Consensus       186 ~~~~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~-~~~~~~~Ei~~l~~l-~HpnIv~~~g~~~~~~~  257 (454)
                      .++.++|.+++.||+|+||+|+++      +.+|||.++....... .-.....|.+++... +||+++.+++.|++.++
T Consensus       364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~  443 (694)
T KOG0694|consen  364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH  443 (694)
T ss_pred             cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence            577799999999999999999985      5799999987654433 333456666665554 69999999999999988


Q ss_pred             eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccC
Q 012887          258 GLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV  337 (454)
Q Consensus       258 ~l~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~  337 (454)
                       +|+||||+.||++.. +...+.+++..+..|+..|+.||.|||++||||||||.+|||+|.+|++||+|||+++.....
T Consensus       444 -l~fvmey~~Ggdm~~-~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~  521 (694)
T KOG0694|consen  444 -LFFVMEYVAGGDLMH-HIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQ  521 (694)
T ss_pred             -EEEEEEecCCCcEEE-EEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCC
Confidence             999999999999443 345679999999999999999999999999999999999999999999999999999987766


Q ss_pred             CCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHH
Q 012887          338 GEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQIL  417 (454)
Q Consensus       338 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l  417 (454)
                      +..+...+|||.|||||++.+..|+.    ++|.|||||+||||+.|..||++.+..+....|+..  .+.+|..+|.+.
T Consensus       522 g~~TsTfCGTpey~aPEil~e~~Yt~----aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d--~~~yP~~ls~ea  595 (694)
T KOG0694|consen  522 GDRTSTFCGTPEFLAPEVLTEQSYTR----AVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVND--EVRYPRFLSKEA  595 (694)
T ss_pred             CCccccccCChhhcChhhhccCcccc----hhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC--CCCCCCcccHHH
Confidence            67788889999999999999887655    499999999999999999999999999999888875  555899999999


Q ss_pred             HHHHHHhcccCCCCCCCH
Q 012887          418 KSLMIKCWNNSPSKRPQF  435 (454)
Q Consensus       418 ~~li~~cl~~dP~~RPs~  435 (454)
                      ..||+++|.++|++|...
T Consensus       596 ~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  596 IAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             HHHHHHHhccCcccccCC
Confidence            999999999999999765

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1.1e-43  Score=362.80  Aligned_cols=259  Identities=26%  Similarity=0.446  Sum_probs=216.2

Q ss_pred             ccceeecCCCEEEeceeeccCCceEEEeE-----------EEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEEE
Q 012887          182 IGRWLLNSDNLEFIDQIGPNSFKGVYKGK-----------RVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFY  249 (454)
Q Consensus       182 ~~~~~~~~~~~~~~~~LG~G~fG~Vy~g~-----------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~~~  249 (454)
                      .+.|.+..++|++.+.||+|+||.||++.           .||+|.++... .......+.+|+.++..+ +|+|||+++
T Consensus        30 ~~~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~~h~nIv~~~  108 (374)
T cd05106          30 NEKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA-HTDEREALMSELKILSHLGQHKNIVNLL  108 (374)
T ss_pred             cccccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC-CHHHHHHHHHHHHHHHhhccCCceeeEe
Confidence            35677888999999999999999999864           69999987433 233345678899999998 899999999


Q ss_pred             EEEEeCCCeEEEEEeccCCCCHHHHHHhC---------------------------------------------------
Q 012887          250 CVCVDENHGLCVVTKLMEGGSVNDLILKS---------------------------------------------------  278 (454)
Q Consensus       250 g~~~~~~~~l~lV~E~~~~gsL~~~l~~~---------------------------------------------------  278 (454)
                      ++|.+.+. +++||||+++|+|.+++.+.                                                   
T Consensus       109 ~~~~~~~~-~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  187 (374)
T cd05106         109 GACTHGGP-VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPV  187 (374)
T ss_pred             eEecCCCC-eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCc
Confidence            99988776 99999999999999998532                                                   


Q ss_pred             -------------------CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCC
Q 012887          279 -------------------RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE  339 (454)
Q Consensus       279 -------------------~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~  339 (454)
                                         .++++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~  267 (374)
T cd05106         188 SSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSN  267 (374)
T ss_pred             cccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcc
Confidence                               1467888999999999999999999999999999999999999999999999876543221


Q ss_pred             c--ccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHH
Q 012887          340 A--TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQI  416 (454)
Q Consensus       340 ~--~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~  416 (454)
                      .  .....+++.|+|||++.+..    ++.++|||||||++|||++ |..||...............+.++..|...|++
T Consensus       268 ~~~~~~~~~~~~y~aPE~~~~~~----~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (374)
T cd05106         268 YVVKGNARLPVKWMAPESIFDCV----YTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPE  343 (374)
T ss_pred             eeeccCCCCccceeCHHHhcCCC----CCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHH
Confidence            1  11223456799999997654    4456999999999999997 999998876655566666666677777788999


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 012887          417 LKSLMIKCWNNSPSKRPQFSEIISLLLRTN  446 (454)
Q Consensus       417 l~~li~~cl~~dP~~RPs~~ell~~L~~~~  446 (454)
                      +.+++.+||+.||.+||++.++++.|+++.
T Consensus       344 l~~li~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         344 IYSIMKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence            999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-44  Score=367.67  Aligned_cols=244  Identities=27%  Similarity=0.444  Sum_probs=217.6

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  263 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~  263 (454)
                      ..|.-..+||+|+-|.||.+      +.||||++......  ...-+..|+.+|+..+|+|||.+++.|...+. +|+||
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~--~keLilnEi~Vm~~~~H~NiVnfl~Sylv~de-LWVVM  349 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQP--KKELLLNEILVMRDLHHPNIVNFLDSYLVGDE-LWVVM  349 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCC--chhhhHHHHHHHHhccchHHHHHHHHhcccce-eEEEE
Confidence            46888899999999999974      57999998743332  34457899999999999999999999887776 99999


Q ss_pred             eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCcccc
Q 012887          264 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY  343 (454)
Q Consensus       264 E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~  343 (454)
                      |||+||+|.|.+.. -.+++.+++.++.+++.||+|||.+||+|||||.+|||++.+|.+||+|||++............
T Consensus       350 Eym~ggsLTDvVt~-~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR~T  428 (550)
T KOG0578|consen  350 EYMEGGSLTDVVTK-TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKRST  428 (550)
T ss_pred             eecCCCchhhhhhc-ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccCcccc
Confidence            99999999999844 45999999999999999999999999999999999999999999999999999888777666777


Q ss_pred             cCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCC-CCCCCccHHHHHHHH
Q 012887          344 ETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP-EIPKDCPQILKSLMI  422 (454)
Q Consensus       344 ~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~-~~p~~~~~~l~~li~  422 (454)
                      ..|||-|||||++....|..    |.||||||++++||+-|++||-..++..++..|...+.+. ..|+.+|+.+++++.
T Consensus       429 mVGTPYWMAPEVvtrk~YG~----KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~  504 (550)
T KOG0578|consen  429 MVGTPYWMAPEVVTRKPYGP----KVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFLD  504 (550)
T ss_pred             ccCCCCccchhhhhhcccCc----cccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHHH
Confidence            89999999999999876655    4999999999999999999999999999998888766543 457789999999999


Q ss_pred             HhcccCCCCCCCHHHHHHH
Q 012887          423 KCWNNSPSKRPQFSEIISL  441 (454)
Q Consensus       423 ~cl~~dP~~RPs~~ell~~  441 (454)
                      +||+.|+.+|+++.|||+|
T Consensus       505 ~cL~~dv~~RasA~eLL~H  523 (550)
T KOG0578|consen  505 RCLVVDVEQRASAKELLEH  523 (550)
T ss_pred             HHhhcchhcCCCHHHHhcC
Confidence            9999999999999999987

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-45  Score=364.62  Aligned_cols=246  Identities=24%  Similarity=0.407  Sum_probs=218.2

Q ss_pred             CCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEE
Q 012887          189 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  262 (454)
Q Consensus       189 ~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV  262 (454)
                      ...|..++.||+|+||.||+|      +.||+|.+. .+.......++++|+..|.+++++||.++||.+..... ++++
T Consensus        12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~-Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~-Lwii   89 (467)
T KOG0201|consen   12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIID-LEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTK-LWII   89 (467)
T ss_pred             ccccccchhccccccceeeeeeeccccceEEEEEec-hhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeeccc-HHHH
Confidence            356777899999999999996      579999987 34445556778999999999999999999999998776 9999


Q ss_pred             EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCccc
Q 012887          263 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE  342 (454)
Q Consensus       263 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~  342 (454)
                      ||||.||++.+++.....+++..+.-++.++..||.|||.++.+|||||+.|||+..+|.|||+|||++...........
T Consensus        90 Mey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~  169 (467)
T KOG0201|consen   90 MEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRK  169 (467)
T ss_pred             HHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhccc
Confidence            99999999999997777779999999999999999999999999999999999999999999999999988877766667


Q ss_pred             ccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHHHHHH
Q 012887          343 YETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMI  422 (454)
Q Consensus       343 ~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~li~  422 (454)
                      ...|||.|||||++.+..|    +.|+||||||++.+||.+|.+||....|+..+..|.. ..+|.+...+++.+++++.
T Consensus       170 tfvGTPfwMAPEVI~~~~Y----~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk-~~PP~L~~~~S~~~kEFV~  244 (467)
T KOG0201|consen  170 TFVGTPFWMAPEVIKQSGY----DTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPK-SAPPRLDGDFSPPFKEFVE  244 (467)
T ss_pred             cccccccccchhhhccccc----cchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccC-CCCCccccccCHHHHHHHH
Confidence            8899999999999996654    4559999999999999999999999988766555543 4556666789999999999


Q ss_pred             HhcccCCCCCCCHHHHHHH
Q 012887          423 KCWNNSPSKRPQFSEIISL  441 (454)
Q Consensus       423 ~cl~~dP~~RPs~~ell~~  441 (454)
                      .||++||+.||++.++++|
T Consensus       245 ~CL~k~P~~RpsA~~LLKh  263 (467)
T KOG0201|consen  245 ACLDKNPEFRPSAKELLKH  263 (467)
T ss_pred             HHhhcCcccCcCHHHHhhh
Confidence            9999999999999999986

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-43  Score=349.76  Aligned_cols=245  Identities=20%  Similarity=0.305  Sum_probs=210.2

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCC-chHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  262 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV  262 (454)
                      ++|++.+.||+|+||.||++      +.+|+|.+...... ......+.+|+.++..++||||+++++++.+.+. +++|
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~-~~lv   79 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRF-LYML   79 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCe-EEEE
Confidence            47899999999999999985      57999998643222 1234457889999999999999999999887765 9999


Q ss_pred             EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCccc
Q 012887          263 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE  342 (454)
Q Consensus       263 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~  342 (454)
                      |||+++|+|.+++.+.+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......   ..
T Consensus        80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~---~~  156 (291)
T cd05612          80 MEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR---TW  156 (291)
T ss_pred             EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC---cc
Confidence            999999999999988888999999999999999999999999999999999999999999999999998765432   22


Q ss_pred             ccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHHHHHH
Q 012887          343 YETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMI  422 (454)
Q Consensus       343 ~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~li~  422 (454)
                      ...|++.|+|||++.+..+    +.++|||||||++|+|++|..||.+.+.......+...  ...+|..++..+.++|+
T Consensus       157 ~~~gt~~y~aPE~~~~~~~----~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~li~  230 (291)
T cd05612         157 TLCGTPEYLAPEVIQSKGH----NKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAG--KLEFPRHLDLYAKDLIK  230 (291)
T ss_pred             cccCChhhcCHHHHcCCCC----CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CcCCCccCCHHHHHHHH
Confidence            3468899999999987654    44699999999999999999999988877666666554  45577888999999999


Q ss_pred             HhcccCCCCCCC-----HHHHHHHHHh
Q 012887          423 KCWNNSPSKRPQ-----FSEIISLLLR  444 (454)
Q Consensus       423 ~cl~~dP~~RPs-----~~ell~~L~~  444 (454)
                      +||+.||.+||+     +.++++|-|-
T Consensus       231 ~~l~~dp~~R~~~~~~~~~~~l~h~~~  257 (291)
T cd05612         231 KLLVVDRTRRLGNMKNGADDVKNHRWF  257 (291)
T ss_pred             HHcCCCHHHccCCccCCHHHHhcCccc
Confidence            999999999995     9999988654

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=9.7e-43  Score=338.07  Aligned_cols=252  Identities=25%  Similarity=0.470  Sum_probs=209.6

Q ss_pred             ecCCCEEEeceeeccCCceEEEeE---------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCC
Q 012887          187 LNSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH  257 (454)
Q Consensus       187 ~~~~~~~~~~~LG~G~fG~Vy~g~---------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~  257 (454)
                      ++.++|++.+.||+|+||.||+|.         .+|+|.++.. ........+.+|+..+..++||||+++++++...+.
T Consensus         2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   80 (266)
T cd05064           2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAG-CSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNT   80 (266)
T ss_pred             CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCC-CCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCC
Confidence            345789999999999999999863         6888988743 223344568899999999999999999999987776


Q ss_pred             eEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCcccccc
Q 012887          258 GLCVVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS  336 (454)
Q Consensus       258 ~l~lV~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~  336 (454)
                       .++||||+++|+|.+++.+. ..+++..+..++.||+.||+|||++|++||||||+|||++.++.+|++|||.+.....
T Consensus        81 -~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~  159 (266)
T cd05064          81 -MMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS  159 (266)
T ss_pred             -cEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence             99999999999999998764 4789999999999999999999999999999999999999999999999998654322


Q ss_pred             CCCc-ccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHcCCCCCCCCCcc
Q 012887          337 VGEA-TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCP  414 (454)
Q Consensus       337 ~~~~-~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~  414 (454)
                      .... .....++..|+|||.+.+..+    +.++|||||||++||+++ |..||...+.......+ ..+.+++.|..++
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~----~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~  234 (266)
T cd05064         160 EAIYTTMSGKSPVLWAAPEAIQYHHF----SSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAV-EDGFRLPAPRNCP  234 (266)
T ss_pred             cchhcccCCCCceeecCHHHHhhCCc----cchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHH-HCCCCCCCCCCCC
Confidence            1111 112234568999999977654    446999999999999875 99999987776655544 3455666788899


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 012887          415 QILKSLMIKCWNNSPSKRPQFSEIISLLLRT  445 (454)
Q Consensus       415 ~~l~~li~~cl~~dP~~RPs~~ell~~L~~~  445 (454)
                      ..+.+++.+||+.+|.+||++.+|.+.|.++
T Consensus       235 ~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         235 NLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             HHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence            9999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=1.2e-42  Score=358.18  Aligned_cols=259  Identities=25%  Similarity=0.456  Sum_probs=217.5

Q ss_pred             cceeecCCCEEEeceeeccCCceEEEeE-----------EEEEEEeecCCCCchHHHHHHHHHHHHHhCC-CCceeEEEE
Q 012887          183 GRWLLNSDNLEFIDQIGPNSFKGVYKGK-----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCG-HKNILQFYC  250 (454)
Q Consensus       183 ~~~~~~~~~~~~~~~LG~G~fG~Vy~g~-----------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~~~g  250 (454)
                      ++|.++.++|++++.||+|+||.||+|.           .||+|+++.. ........+.+|+.++..+. ||||+++++
T Consensus        30 ~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~-~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~  108 (400)
T cd05105          30 SRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPT-ARSSEKQALMSELKIMTHLGPHLNIVNLLG  108 (400)
T ss_pred             CceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCC-CChHHHHHHHHHHHHHHhcCCCCCeeeEEE
Confidence            6899999999999999999999999874           4899998643 22334456889999999996 999999999


Q ss_pred             EEEeCCCeEEEEEeccCCCCHHHHHHhC----------------------------------------------------
Q 012887          251 VCVDENHGLCVVTKLMEGGSVNDLILKS----------------------------------------------------  278 (454)
Q Consensus       251 ~~~~~~~~l~lV~E~~~~gsL~~~l~~~----------------------------------------------------  278 (454)
                      +|.+.+. +|+|||||++|+|.+++.++                                                    
T Consensus       109 ~~~~~~~-~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  187 (400)
T cd05105         109 ACTKSGP-IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQ  187 (400)
T ss_pred             EEccCCc-eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccc
Confidence            9987776 99999999999999988532                                                    


Q ss_pred             --------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCc
Q 012887          279 --------------------------------------------RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQR  314 (454)
Q Consensus       279 --------------------------------------------~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~N  314 (454)
                                                                  ..+++..+..++.||+.||.|||+++|+||||||+|
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~N  267 (400)
T cd05105         188 YVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARN  267 (400)
T ss_pred             cchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHh
Confidence                                                        136778889999999999999999999999999999


Q ss_pred             EEEccCCcEEEEccCCccccccCCC--cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 012887          315 ILLDRHGNVCLGDMGIVTACKSVGE--ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAAC  391 (454)
Q Consensus       315 ILl~~~~~vKL~DFGla~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~  391 (454)
                      ||++.++.+||+|||++........  ......+++.|+|||.+.+..+    +.++|||||||++|||++ |..||...
T Consensus       268 ill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~----~~~~DiwSlGvil~ellt~g~~P~~~~  343 (400)
T cd05105         268 VLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLY----TTLSDVWSYGILLWEIFSLGGTPYPGM  343 (400)
T ss_pred             EEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCC----CchhhHHHHHHHHHHHHHCCCCCCccc
Confidence            9999999999999999876543222  1222345678999999976643    456999999999999997 99999876


Q ss_pred             CHHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 012887          392 SPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNN  447 (454)
Q Consensus       392 ~~~~~~~~i~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~  447 (454)
                      ............+.++..+..++.++.+++.+||+.||++||++.+|.+.|.++.+
T Consensus       344 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~  399 (400)
T cd05105         344 IVDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP  399 (400)
T ss_pred             chhHHHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence            65555555566666777788899999999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=1.6e-43  Score=354.06  Aligned_cols=241  Identities=19%  Similarity=0.271  Sum_probs=204.4

Q ss_pred             ceeeccCCceEEEe------EEEEEEEeecCCC-CchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEEeccCC
Q 012887          196 DQIGPNSFKGVYKG------KRVGIEKLKGCDK-GNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEG  268 (454)
Q Consensus       196 ~~LG~G~fG~Vy~g------~~vavK~l~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~E~~~~  268 (454)
                      +.||+|+||.||++      +.+|+|.++.... .......+.+|+.++..++||||+++++++...+. +|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~-~~lv~e~~~~   79 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDR-LCFVMEYANG   79 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCE-EEEEEeCCCC
Confidence            46999999999985      5799999874322 12233456789999999999999999999988776 9999999999


Q ss_pred             CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCcccccCCCC
Q 012887          269 GSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY  348 (454)
Q Consensus       269 gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~gt~  348 (454)
                      |+|.+++.+.+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.............||+
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~  159 (323)
T cd05571          80 GELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTP  159 (323)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceecCc
Confidence            99999998888999999999999999999999999999999999999999999999999999876443333344556899


Q ss_pred             cccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhcccC
Q 012887          349 RWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNS  428 (454)
Q Consensus       349 ~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~li~~cl~~d  428 (454)
                      .|+|||++.+..+    +.++|||||||++|||++|..||.+.+.......+...  ...+|..+++++.++|.+||+.|
T Consensus       160 ~y~aPE~~~~~~~----~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~--~~~~p~~~~~~~~~li~~~L~~d  233 (323)
T cd05571         160 EYLAPEVLEDNDY----GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME--EIRFPRTLSPEAKSLLAGLLKKD  233 (323)
T ss_pred             cccChhhhcCCCC----CccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHHHHHHHHHHccCC
Confidence            9999999987654    44599999999999999999999887766655555443  44578889999999999999999


Q ss_pred             CCCCC-----CHHHHHHHHH
Q 012887          429 PSKRP-----QFSEIISLLL  443 (454)
Q Consensus       429 P~~RP-----s~~ell~~L~  443 (454)
                      |.+||     ++.++++|-+
T Consensus       234 P~~R~~~~~~~~~~ll~h~~  253 (323)
T cd05571         234 PKQRLGGGPEDAKEIMEHRF  253 (323)
T ss_pred             HHHcCCCCCCCHHHHHcCCC
Confidence            99999     8999987643

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=2.1e-43  Score=354.31  Aligned_cols=245  Identities=20%  Similarity=0.295  Sum_probs=210.5

Q ss_pred             CCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCC-chHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEE
Q 012887          189 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCV  261 (454)
Q Consensus       189 ~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~l  261 (454)
                      .++|++.+.||+|+||.||++      +.+|+|.++..... ......+.+|+.++.+++||||+++++++.+++. +|+
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~-~~l   95 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENR-VYF   95 (329)
T ss_pred             chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCE-EEE
Confidence            378999999999999999986      46999998743221 1233457889999999999999999999988776 999


Q ss_pred             EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCcc
Q 012887          262 VTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT  341 (454)
Q Consensus       262 V~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~  341 (454)
                      ||||+++|+|.+++.+.+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......   .
T Consensus        96 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~---~  172 (329)
T PTZ00263         96 LLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR---T  172 (329)
T ss_pred             EEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC---c
Confidence            9999999999999988888999999999999999999999999999999999999999999999999998765432   2


Q ss_pred             cccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHHHHH
Q 012887          342 EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLM  421 (454)
Q Consensus       342 ~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~li  421 (454)
                      ....|++.|+|||++.+..+    +.++|||||||++|+|++|..||.+.++......+...  +..+|..++..+.+||
T Consensus       173 ~~~~gt~~y~aPE~~~~~~~----~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~--~~~~p~~~~~~~~~li  246 (329)
T PTZ00263        173 FTLCGTPEYLAPEVIQSKGH----GKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAG--RLKFPNWFDGRARDLV  246 (329)
T ss_pred             ceecCChhhcCHHHHcCCCC----CCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcC--CcCCCCCCCHHHHHHH
Confidence            33468999999999987654    44599999999999999999999988777666655543  4557888999999999


Q ss_pred             HHhcccCCCCCCC-----HHHHHHHHH
Q 012887          422 IKCWNNSPSKRPQ-----FSEIISLLL  443 (454)
Q Consensus       422 ~~cl~~dP~~RPs-----~~ell~~L~  443 (454)
                      .+||+.||.+||+     +.+++.|-+
T Consensus       247 ~~~L~~dP~~R~~~~~~~~~~ll~hp~  273 (329)
T PTZ00263        247 KGLLQTDHTKRLGTLKGGVADVKNHPY  273 (329)
T ss_pred             HHHhhcCHHHcCCCCCCCHHHHhcCCc
Confidence            9999999999987     789887754

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=6.3e-43  Score=352.29  Aligned_cols=259  Identities=25%  Similarity=0.444  Sum_probs=215.6

Q ss_pred             ceeecCCCEEEeceeeccCCceEEEe-----------EEEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEEEEE
Q 012887          184 RWLLNSDNLEFIDQIGPNSFKGVYKG-----------KRVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCV  251 (454)
Q Consensus       184 ~~~~~~~~~~~~~~LG~G~fG~Vy~g-----------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~~~g~  251 (454)
                      +|.++.++|++.+.||+|+||.||+|           +.||+|+++.. ........+.+|+.++.++ +|+||++++++
T Consensus         1 ~~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~   79 (337)
T cd05054           1 KWEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEG-ATASEYKALMTELKILIHIGHHLNVVNLLGA   79 (337)
T ss_pred             CcccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCC-CCHHHHHHHHHHHHHHHhhccCcchhheeee
Confidence            47788899999999999999999986           46999988632 2333345577899999998 79999999999


Q ss_pred             EEeCCCeEEEEEeccCCCCHHHHHHhC-----------------------------------------------------
Q 012887          252 CVDENHGLCVVTKLMEGGSVNDLILKS-----------------------------------------------------  278 (454)
Q Consensus       252 ~~~~~~~l~lV~E~~~~gsL~~~l~~~-----------------------------------------------------  278 (454)
                      |...+..++++|||+++++|.+++...                                                     
T Consensus        80 ~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (337)
T cd05054          80 CTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEED  159 (337)
T ss_pred             EecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccc
Confidence            987766699999999999999998532                                                     


Q ss_pred             --------CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCc--ccccCCCC
Q 012887          279 --------RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA--TEYETDGY  348 (454)
Q Consensus       279 --------~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~--~~~~~gt~  348 (454)
                              ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.........  .....++.
T Consensus       160 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~  239 (337)
T cd05054         160 EEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL  239 (337)
T ss_pred             hhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCc
Confidence                    25788999999999999999999999999999999999999999999999998765332211  12234466


Q ss_pred             cccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhccc
Q 012887          349 RWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNN  427 (454)
Q Consensus       349 ~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~li~~cl~~  427 (454)
                      .|+|||++.+..+    +.++|||||||++|||++ |..||.+....+........+.++..|..+++++.+++.+||+.
T Consensus       240 ~y~aPE~~~~~~~----~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~  315 (337)
T cd05054         240 KWMAPESIFDKVY----TTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHN  315 (337)
T ss_pred             cccCcHHhcCCCC----CccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccC
Confidence            7999999987654    445999999999999998 99999876555555555556666677788899999999999999


Q ss_pred             CCCCCCCHHHHHHHHHhhcC
Q 012887          428 SPSKRPQFSEIISLLLRTNN  447 (454)
Q Consensus       428 dP~~RPs~~ell~~L~~~~~  447 (454)
                      +|++||++.|++++|.++.+
T Consensus       316 ~p~~RPs~~ell~~l~~~~~  335 (337)
T cd05054         316 NPEDRPTFSELVEILGDLLQ  335 (337)
T ss_pred             ChhhCcCHHHHHHHHHHHHh
Confidence            99999999999999998765

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-43  Score=360.87  Aligned_cols=257  Identities=25%  Similarity=0.437  Sum_probs=222.5

Q ss_pred             cceeecCCCEEEeceeeccCCceEEEeE----------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEE
Q 012887          183 GRWLLNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVC  252 (454)
Q Consensus       183 ~~~~~~~~~~~~~~~LG~G~fG~Vy~g~----------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~  252 (454)
                      ..+.+..+.+...++||.|-||.||+|.          .||||.-+.....+ ....+..|..+++.++|||||+++|+|
T Consensus       382 rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d-~tekflqEa~iMrnfdHphIikLIGv~  460 (974)
T KOG4257|consen  382 RNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPD-DTEKFLQEASIMRNFDHPHIIKLIGVC  460 (974)
T ss_pred             CcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChh-hHHHHHHHHHHHHhCCCcchhheeeee
Confidence            4566777888889999999999999873          58999888644433 356688999999999999999999999


Q ss_pred             EeCCCeEEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCc
Q 012887          253 VDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIV  331 (454)
Q Consensus       253 ~~~~~~l~lV~E~~~~gsL~~~l~~~~-~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla  331 (454)
                      .+..  +|||||+++.|.|..+++.++ .++...+..|+.||+.||.|||+.++|||||..+|||+...-.|||+|||++
T Consensus       461 ~e~P--~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLS  538 (974)
T KOG4257|consen  461 VEQP--MWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLS  538 (974)
T ss_pred             eccc--eeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchh
Confidence            8764  899999999999999997665 8999999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCccc-ccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHcCCCCCC
Q 012887          332 TACKSVGEATE-YETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEI  409 (454)
Q Consensus       332 ~~~~~~~~~~~-~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~  409 (454)
                      +...+...... ...-++.|||||.++-.    +++.+||||.|||.+||++. |..||.+..+...+-.+ .+|.|++.
T Consensus       539 R~~ed~~yYkaS~~kLPIKWmaPESINfR----rFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~i-EnGeRlP~  613 (974)
T KOG4257|consen  539 RYLEDDAYYKASRGKLPIKWMAPESINFR----RFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHI-ENGERLPC  613 (974)
T ss_pred             hhccccchhhccccccceeecCccccchh----cccchhhHHHHHHHHHHHHHhcCCccccccccceEEEe-cCCCCCCC
Confidence            98776443222 22346789999999855    46677999999999999988 99999987766555444 45889999


Q ss_pred             CCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 012887          410 PKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNN  447 (454)
Q Consensus       410 p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~  447 (454)
                      |++||+.++.||.+||++||.+||+|+||...|..+.+
T Consensus       614 P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q  651 (974)
T KOG4257|consen  614 PPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ  651 (974)
T ss_pred             CCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence            99999999999999999999999999999999988765

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.3e-44  Score=348.08  Aligned_cols=246  Identities=19%  Similarity=0.348  Sum_probs=218.7

Q ss_pred             CCEEEeceeeccCCceEEE------eEEEEEEEeecCCCCch-HHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNA-YEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  262 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~------g~~vavK~l~~~~~~~~-~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV  262 (454)
                      .+|++.+.||+|.||.|-+      |+.||||.++.....+. ....+++|+.+|..|+||||+.+|.+|...+. +.||
T Consensus        53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdK-Iviv  131 (668)
T KOG0611|consen   53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDK-IVIV  131 (668)
T ss_pred             hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCce-EEEE
Confidence            5789999999999999987      68899999986544433 44569999999999999999999999998876 9999


Q ss_pred             EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCccc
Q 012887          263 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE  342 (454)
Q Consensus       263 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~  342 (454)
                      |||..+|.|+|++.+++.+++..+..++.||++|+.|+|.++++|||||.+|||+|.++++||+||||+..+.+.. ...
T Consensus       132 MEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~k-fLq  210 (668)
T KOG0611|consen  132 MEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKK-FLQ  210 (668)
T ss_pred             EEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhcccc-HHH
Confidence            9999999999999999999999999999999999999999999999999999999999999999999987765443 355


Q ss_pred             ccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHHHHHH
Q 012887          343 YETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMI  422 (454)
Q Consensus       343 ~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~li~  422 (454)
                      ..+|+|.|.+||+++|.+|...   ..|.|||||+||.|+.|..||++.+-......|....++.+   ..|.+..-||+
T Consensus       211 TFCGSPLYASPEIvNG~PY~GP---EVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP---~~PSdA~gLIR  284 (668)
T KOG0611|consen  211 TFCGSPLYASPEIVNGTPYKGP---EVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREP---ETPSDASGLIR  284 (668)
T ss_pred             HhcCCcccCCccccCCCCCCCC---ccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCC---CCCchHHHHHH
Confidence            6689999999999999988654   48999999999999999999999888888888877766643   23456889999


Q ss_pred             HhcccCCCCCCCHHHHHHHHH
Q 012887          423 KCWNNSPSKRPQFSEIISLLL  443 (454)
Q Consensus       423 ~cl~~dP~~RPs~~ell~~L~  443 (454)
                      .||..+|++|.|+.+|..|-|
T Consensus       285 wmLmVNP~RRATieDiAsHWW  305 (668)
T KOG0611|consen  285 WMLMVNPERRATIEDIASHWW  305 (668)
T ss_pred             HHHhcCcccchhHHHHhhhhe
Confidence            999999999999999999876

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=2.3e-43  Score=328.81  Aligned_cols=249  Identities=19%  Similarity=0.270  Sum_probs=214.8

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  263 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~  263 (454)
                      ++|...+.||+|.||.||+|      +.||||+++.....+.......+|+..|+.++|+||+.++++|.+.+. +.+|+
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~-l~lVf   80 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSN-LSLVF   80 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCc-eEEEE
Confidence            56788899999999999995      689999998766555556778899999999999999999999998876 99999


Q ss_pred             eccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCccc
Q 012887          264 KLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE  342 (454)
Q Consensus       264 E~~~~gsL~~~l~~~~-~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~  342 (454)
                      |||+. +|+..++... .+...++..|+.++++|++|||++.|+||||||.|+||+.+|.+||+|||+|+...+......
T Consensus        81 Efm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~  159 (318)
T KOG0659|consen   81 EFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQT  159 (318)
T ss_pred             Eeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcccc
Confidence            99987 9999996544 899999999999999999999999999999999999999999999999999999888777666


Q ss_pred             ccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCC---C-----------
Q 012887          343 YETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP---E-----------  408 (454)
Q Consensus       343 ~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~---~-----------  408 (454)
                      ....|-+|.|||.+.|.+   .|+...|+||.|||+.||+-|.+-|++.++-+.+..+...--.|   .           
T Consensus       160 ~~V~TRWYRAPELLfGsr---~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~  236 (318)
T KOG0659|consen  160 HQVVTRWYRAPELLFGSR---QYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYV  236 (318)
T ss_pred             cceeeeeccChHHhccch---hcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHH
Confidence            668888999999998764   45566999999999999999999999988887776654421111   0           


Q ss_pred             ------------CCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 012887          409 ------------IPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLL  443 (454)
Q Consensus       409 ------------~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~  443 (454)
                                  +-...+.++.+|+.++|..||.+|+++.|++++=.
T Consensus       237 ~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~y  283 (318)
T KOG0659|consen  237 KIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPY  283 (318)
T ss_pred             HHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchh
Confidence                        11235677899999999999999999999998743

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=2.3e-42  Score=341.91  Aligned_cols=251  Identities=25%  Similarity=0.451  Sum_probs=202.1

Q ss_pred             ecCCCEEEeceeeccCCceEEEeE----------------------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCc
Q 012887          187 LNSDNLEFIDQIGPNSFKGVYKGK----------------------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKN  244 (454)
Q Consensus       187 ~~~~~~~~~~~LG~G~fG~Vy~g~----------------------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~Hpn  244 (454)
                      +..++|++.+.||+|+||.||++.                      .||+|.+... .......++.+|+.++..++|||
T Consensus         2 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~n   80 (304)
T cd05096           2 FPRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPD-ANKNARNDFLKEVKILSRLKDPN   80 (304)
T ss_pred             CchhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCC-CCHHHHHHHHHHHHHHhhcCCCC
Confidence            345788999999999999999874                      5899988743 23334566889999999999999


Q ss_pred             eeEEEEEEEeCCCeEEEEEeccCCCCHHHHHHhCC-------------------CCCHHHHHHHHHHHHHHHHHHHhcCc
Q 012887          245 ILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-------------------KLQTKEIIRIAIDVAEGIKFLNDHGV  305 (454)
Q Consensus       245 Iv~~~g~~~~~~~~l~lV~E~~~~gsL~~~l~~~~-------------------~l~~~~~~~i~~qI~~gL~yLH~~~i  305 (454)
                      |+++++++.+.+. .++||||+++|+|.+++....                   .+++..+..++.||+.||.|||++||
T Consensus        81 iv~~~~~~~~~~~-~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i  159 (304)
T cd05096          81 IIRLLGVCVDEDP-LCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNF  159 (304)
T ss_pred             eeEEEEEEecCCc-eEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCc
Confidence            9999999988776 999999999999999985421                   36778899999999999999999999


Q ss_pred             ccCCccCCcEEEccCCcEEEEccCCccccccCCC--cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc
Q 012887          306 AYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE--ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT  383 (454)
Q Consensus       306 iHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt  383 (454)
                      +||||||+|||++.++.+||+|||+++.......  ......++..|+|||++.+..    ++.++||||||+++|||++
T Consensus       160 vH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~Dv~slG~~l~el~~  235 (304)
T cd05096         160 VHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGK----FTTASDVWAFGVTLWEILM  235 (304)
T ss_pred             cccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCC----CCchhhhHHHHHHHHHHHH
Confidence            9999999999999999999999999875533221  112223467899999987664    4456999999999999986


Q ss_pred             --CCCCCCCCCHHHHHHHHHH---c---CCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 012887          384 --GEAAYAACSPVQAAVGIAA---C---GLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLL  443 (454)
Q Consensus       384 --G~~Pf~~~~~~~~~~~i~~---~---~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~  443 (454)
                        +..||...+..........   .   ......|..+|..+.++|.+||+.||.+|||+.+|.+.|.
T Consensus       236 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~  303 (304)
T cd05096         236 LCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT  303 (304)
T ss_pred             ccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence              6788887666554432211   1   1122345678999999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=3.9e-43  Score=354.33  Aligned_cols=249  Identities=20%  Similarity=0.269  Sum_probs=212.0

Q ss_pred             eeecCCCEEEeceeeccCCceEEEeE-------EEEEEEeecCCC-CchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCC
Q 012887          185 WLLNSDNLEFIDQIGPNSFKGVYKGK-------RVGIEKLKGCDK-GNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN  256 (454)
Q Consensus       185 ~~~~~~~~~~~~~LG~G~fG~Vy~g~-------~vavK~l~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~  256 (454)
                      ..+..++|++.+.||+|+||.||+|.       .+|+|.+..... .......+.+|+.++..++||||+++++++.+.+
T Consensus        25 ~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~  104 (340)
T PTZ00426         25 NKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDES  104 (340)
T ss_pred             CCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCC
Confidence            34566889999999999999999863       689998864322 1223345778999999999999999999998887


Q ss_pred             CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCcccccc
Q 012887          257 HGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS  336 (454)
Q Consensus       257 ~~l~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~  336 (454)
                      . +|+||||+++|+|.+++.+.+.+++..+..++.||+.||.|||++||+||||||+|||++.++++||+|||++.....
T Consensus       105 ~-~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~  183 (340)
T PTZ00426        105 Y-LYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT  183 (340)
T ss_pred             E-EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence            6 999999999999999998888999999999999999999999999999999999999999999999999999876543


Q ss_pred             CCCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHH
Q 012887          337 VGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQI  416 (454)
Q Consensus       337 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~  416 (454)
                      .   .....||+.|+|||++.+..+    +.++|||||||++|||++|..||.+.++......+...  ...+|..+++.
T Consensus       184 ~---~~~~~gt~~y~aPE~~~~~~~----~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~~~~  254 (340)
T PTZ00426        184 R---TYTLCGTPEYIAPEILLNVGH----GKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEG--IIYFPKFLDNN  254 (340)
T ss_pred             C---cceecCChhhcCHHHHhCCCC----CccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcC--CCCCCCCCCHH
Confidence            2   234568999999999987654    44599999999999999999999988776665555543  34467888999


Q ss_pred             HHHHHHHhcccCCCCCC-----CHHHHHHHHH
Q 012887          417 LKSLMIKCWNNSPSKRP-----QFSEIISLLL  443 (454)
Q Consensus       417 l~~li~~cl~~dP~~RP-----s~~ell~~L~  443 (454)
                      +.++|++||+.||.+|+     +++++++|-+
T Consensus       255 ~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~  286 (340)
T PTZ00426        255 CKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPW  286 (340)
T ss_pred             HHHHHHHHcccCHHHcCCCCCCCHHHHHcCCC
Confidence            99999999999999995     8999998754

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-43  Score=358.48  Aligned_cols=259  Identities=24%  Similarity=0.463  Sum_probs=226.2

Q ss_pred             cccceeecCCCEEEeceeeccCCceEEEeE------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEe
Q 012887          181 EIGRWLLNSDNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVD  254 (454)
Q Consensus       181 ~~~~~~~~~~~~~~~~~LG~G~fG~Vy~g~------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~  254 (454)
                      ..++|.+...++...++||-|.||.||.|.      .||||.++   .......++.+|..+|+.++|||+|+++|+|..
T Consensus       258 n~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLK---EDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~  334 (1157)
T KOG4278|consen  258 NADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK---EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTH  334 (1157)
T ss_pred             CcchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhh---hcchhHHHHHHHHHHHHhhcCccHHHHhhhhcc
Confidence            347899999999999999999999999984      58999997   334455678899999999999999999999998


Q ss_pred             CCCeEEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCcc
Q 012887          255 ENHGLCVVTKLMEGGSVNDLILKSR--KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVT  332 (454)
Q Consensus       255 ~~~~l~lV~E~~~~gsL~~~l~~~~--~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~  332 (454)
                      +.. +|||+|||.+|+|.++|+++.  -++...+++++.||..||+||..+++|||||..+|+|+.++..||++||||++
T Consensus       335 EpP-FYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsR  413 (1157)
T KOG4278|consen  335 EPP-FYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSR  413 (1157)
T ss_pred             CCC-eEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhh
Confidence            876 999999999999999998754  58888999999999999999999999999999999999999999999999998


Q ss_pred             ccccCCCccc-ccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHcCCCCCCC
Q 012887          333 ACKSVGEATE-YETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIP  410 (454)
Q Consensus       333 ~~~~~~~~~~-~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p  410 (454)
                      .+..+..... ...-++.|.|||.+....++    .|||||+|||+|||+.| |..||++..-. ....++..++|+.-|
T Consensus       414 lMtgDTYTAHAGAKFPIKWTAPEsLAyNtFS----iKSDVWAFGVLLWEIATYGMsPYPGidlS-qVY~LLEkgyRM~~P  488 (1157)
T KOG4278|consen  414 LMTGDTYTAHAGAKFPIKWTAPESLAYNTFS----IKSDVWAFGVLLWEIATYGMSPYPGIDLS-QVYGLLEKGYRMDGP  488 (1157)
T ss_pred             hhcCCceecccCccCcccccCcccccccccc----cchhhHHHHHHHHHHHhcCCCCCCCccHH-HHHHHHhccccccCC
Confidence            8765322111 11235789999999876544    45999999999999999 99999986654 456777889999999


Q ss_pred             CCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCC
Q 012887          411 KDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNI  448 (454)
Q Consensus       411 ~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~  448 (454)
                      ..||+.+++||+.||+..|.+||+|.||...++.+...
T Consensus       489 eGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~  526 (1157)
T KOG4278|consen  489 EGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSS  526 (1157)
T ss_pred             CCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcc
Confidence            99999999999999999999999999999999887764

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=2.6e-42  Score=336.95  Aligned_cols=250  Identities=28%  Similarity=0.532  Sum_probs=208.8

Q ss_pred             cCCCEEEeceeeccCCceEEEeE-----------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCC
Q 012887          188 NSDNLEFIDQIGPNSFKGVYKGK-----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN  256 (454)
Q Consensus       188 ~~~~~~~~~~LG~G~fG~Vy~g~-----------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~  256 (454)
                      ..++|++.+.||+|+||.||+|.           .+|+|.++.. ........+.+|+..+..++||||+++++++.+.+
T Consensus         3 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~-~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~   81 (283)
T cd05048           3 PLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKEN-AEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQ   81 (283)
T ss_pred             ChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccC-CCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCC
Confidence            34688999999999999999863           5888888643 23334456889999999999999999999998776


Q ss_pred             CeEEEEEeccCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccC
Q 012887          257 HGLCVVTKLMEGGSVNDLILKS----------------RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH  320 (454)
Q Consensus       257 ~~l~lV~E~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~  320 (454)
                      . .+++|||+++++|.+++.+.                ..+++..+..++.|++.||.|||+++++||||||+||+++++
T Consensus        82 ~-~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~  160 (283)
T cd05048          82 P-TCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEG  160 (283)
T ss_pred             c-eEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCC
Confidence            5 89999999999999998653                457889999999999999999999999999999999999999


Q ss_pred             CcEEEEccCCccccccCCC--cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHH
Q 012887          321 GNVCLGDMGIVTACKSVGE--ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAA  397 (454)
Q Consensus       321 ~~vKL~DFGla~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~  397 (454)
                      +.+||+|||++........  ......+++.|+|||.+.+..+    +.++|||||||++|||++ |..||.+.+..+..
T Consensus       161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~----~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~  236 (283)
T cd05048         161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKF----TTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVI  236 (283)
T ss_pred             CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcC----chhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence            9999999999875533221  1222345678999999876543    456999999999999998 99999987776654


Q ss_pred             HHHHHcCCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 012887          398 VGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR  444 (454)
Q Consensus       398 ~~i~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~  444 (454)
                      ..+. .+..+..|..+|.++.+|+.+||+.||.+||++.||+++|..
T Consensus       237 ~~i~-~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         237 EMIR-SRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             HHHH-cCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence            4443 455566788899999999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.2e-43  Score=355.88  Aligned_cols=247  Identities=22%  Similarity=0.346  Sum_probs=225.6

Q ss_pred             CCEEEeceeeccCCceEEE------eEEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  263 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~------g~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~  263 (454)
                      ++|+.++.+|+|+||.++.      .+.+++|++.........+....+|+.+++++.|||||.+++.|.+++..++|||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            7889999999999999997      3579999998777777777788999999999999999999999998887799999


Q ss_pred             eccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCcc
Q 012887          264 KLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT  341 (454)
Q Consensus       264 E~~~~gsL~~~l~~~--~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~  341 (454)
                      +||+||+|.+.+.+.  ..+++..+..|+.||+.|+.|||+++|+|||||+.|||++.++.|||+|||+|+.........
T Consensus        84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~~a  163 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDSLA  163 (426)
T ss_pred             eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCchhhh
Confidence            999999999999643  379999999999999999999999999999999999999999999999999999988776567


Q ss_pred             cccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHHHHH
Q 012887          342 EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLM  421 (454)
Q Consensus       342 ~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~li  421 (454)
                      ....||+-||+||.+.+.+|+.+    +|||||||++|||++-+++|.+.+......++.... -.++|..++.+++.+|
T Consensus       164 ~tvvGTp~YmcPEil~d~pYn~K----SDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~-~~Plp~~ys~el~~lv  238 (426)
T KOG0589|consen  164 STVVGTPYYMCPEILSDIPYNEK----SDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGL-YSPLPSMYSSELRSLV  238 (426)
T ss_pred             heecCCCcccCHHHhCCCCCCcc----CcchhhcchHHHHHhcccccCccchHHHHHHHhhcc-CCCCCccccHHHHHHH
Confidence            77789999999999998876654    999999999999999999999999888888887754 4568999999999999


Q ss_pred             HHhcccCCCCCCCHHHHHHH
Q 012887          422 IKCWNNSPSKRPQFSEIISL  441 (454)
Q Consensus       422 ~~cl~~dP~~RPs~~ell~~  441 (454)
                      +.||..+|..||++.+++.+
T Consensus       239 ~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  239 KSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             HHHhhcCCccCCCHHHHhhC
Confidence            99999999999999999976

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=9.5e-43  Score=348.64  Aligned_cols=240  Identities=17%  Similarity=0.266  Sum_probs=202.6

Q ss_pred             ceeeccCCceEEEe------EEEEEEEeecCCCC-chHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEEeccCC
Q 012887          196 DQIGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEG  268 (454)
Q Consensus       196 ~~LG~G~fG~Vy~g------~~vavK~l~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~E~~~~  268 (454)
                      +.||+|+||.||++      +.+|+|.++..... ......+.+|+.++..++||||+++++++...+. +|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~-~~lv~E~~~~   79 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDR-LCFVMEYANG   79 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCE-EEEEEeCCCC
Confidence            46999999999985      57999998743221 2233456789999999999999999999988776 9999999999


Q ss_pred             CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCcccccCCCC
Q 012887          269 GSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY  348 (454)
Q Consensus       269 gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~gt~  348 (454)
                      |+|.+++.+.+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..............|++
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~  159 (323)
T cd05595          80 GELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTP  159 (323)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccCCc
Confidence            99999998778899999999999999999999999999999999999999999999999999875433333333456899


Q ss_pred             cccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhcccC
Q 012887          349 RWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNS  428 (454)
Q Consensus       349 ~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~li~~cl~~d  428 (454)
                      .|+|||++.+..+    +.++|||||||++|||++|..||...+.......+...  ...+|..+++++.++|.+||+.|
T Consensus       160 ~y~aPE~~~~~~~----~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~--~~~~p~~~~~~~~~li~~~L~~d  233 (323)
T cd05595         160 EYLAPEVLEDNDY----GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME--EIRFPRTLSPEAKSLLAGLLKKD  233 (323)
T ss_pred             CcCCcccccCCCC----CchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--CCCCCCCCCHHHHHHHHHHccCC
Confidence            9999999987654    44599999999999999999999887776666555543  34477889999999999999999


Q ss_pred             CCCCC-----CHHHHHHHH
Q 012887          429 PSKRP-----QFSEIISLL  442 (454)
Q Consensus       429 P~~RP-----s~~ell~~L  442 (454)
                      |.+||     ++.+++++-
T Consensus       234 P~~R~~~~~~~~~~~l~h~  252 (323)
T cd05595         234 PKQRLGGGPSDAKEVMEHR  252 (323)
T ss_pred             HHHhCCCCCCCHHHHHcCC
Confidence            99998     899988764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-42  Score=349.18  Aligned_cols=246  Identities=16%  Similarity=0.266  Sum_probs=206.7

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCC-chHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  262 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV  262 (454)
                      ++|++++.||+|+||.||+|      +.||+|.++..... ......+.+|+.++..++||||+++++++.+.+. .|+|
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~-~~lv   79 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEY-LYLA   79 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCE-EEEE
Confidence            46899999999999999986      47999998743221 1233457789999999999999999999988776 9999


Q ss_pred             EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCccc
Q 012887          263 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE  342 (454)
Q Consensus       263 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~  342 (454)
                      |||+++|+|.+++.+.+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....   ...
T Consensus        80 ~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~---~~~  156 (333)
T cd05600          80 MEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---YAN  156 (333)
T ss_pred             EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc---ccC
Confidence            99999999999998778899999999999999999999999999999999999999999999999999876543   234


Q ss_pred             ccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCC------CccHH
Q 012887          343 YETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPK------DCPQI  416 (454)
Q Consensus       343 ~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~------~~~~~  416 (454)
                      ...|++.|+|||++.+..+    +.++|||||||++|||++|..||...+..+....+.........|.      .++++
T Consensus       157 ~~~gt~~y~aPE~~~~~~~----~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~  232 (333)
T cd05600         157 SVVGSPDYMAPEVLRGKGY----DFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDE  232 (333)
T ss_pred             CcccCccccChhHhcCCCC----CCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHH
Confidence            4568899999999987644    4459999999999999999999998877766555543322222221      46899


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHHHHH
Q 012887          417 LKSLMIKCWNNSPSKRPQFSEIISLLL  443 (454)
Q Consensus       417 l~~li~~cl~~dP~~RPs~~ell~~L~  443 (454)
                      +.++|.+||..+|.+||++.+++.+.+
T Consensus       233 ~~~li~~~l~~~~~rr~s~~~ll~h~~  259 (333)
T cd05600         233 AWDLITKLINDPSRRFGSLEDIKNHPF  259 (333)
T ss_pred             HHHHHHHHhhChhhhcCCHHHHHhCcc
Confidence            999999999999999999999998754

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=1e-43  Score=369.50  Aligned_cols=260  Identities=27%  Similarity=0.471  Sum_probs=230.1

Q ss_pred             eecCCCEEEeceeeccCCceEEEeE---------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCC
Q 012887          186 LLNSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN  256 (454)
Q Consensus       186 ~~~~~~~~~~~~LG~G~fG~Vy~g~---------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~  256 (454)
                      +|+.+.+.+.+.||.|.||.|++|+         .||||.++. ......+.++..|..+|-+.+||||+++-|+.....
T Consensus       625 EId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~-GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~  703 (996)
T KOG0196|consen  625 EIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKA-GYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSK  703 (996)
T ss_pred             hcChhheEEEEEEecccccceecccccCCCCcceeEEEeeecc-CccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCc
Confidence            4777889999999999999999973         699999995 344556678999999999999999999999998766


Q ss_pred             CeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccc
Q 012887          257 HGLCVVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK  335 (454)
Q Consensus       257 ~~l~lV~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~  335 (454)
                      . ++||+|||++|+|+.+|+++ +.|...++..+++.|+.||.||-++++|||||.++|||++.+-..|++|||+++.+.
T Consensus       704 P-vMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvle  782 (996)
T KOG0196|consen  704 P-VMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE  782 (996)
T ss_pred             e-eEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecc
Confidence            5 99999999999999999765 489999999999999999999999999999999999999999999999999999887


Q ss_pred             cCCCcccccCC---CCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHcCCCCCCCC
Q 012887          336 SVGEATEYETD---GYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPK  411 (454)
Q Consensus       336 ~~~~~~~~~~g---t~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~  411 (454)
                      ++.+......|   +.+|.|||.+...+    ++.+|||||||++|||.++ |..||.+.++.+.+..+. .++|++.|.
T Consensus       783 dd~~~~ytt~GGKIPiRWTAPEAIa~RK----FTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe-~gyRLPpPm  857 (996)
T KOG0196|consen  783 DDPEAAYTTLGGKIPIRWTAPEAIAYRK----FTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIE-QGYRLPPPM  857 (996)
T ss_pred             cCCCccccccCCccceeecChhHhhhcc----cCchhhccccceEEEEecccCCCcccccchHHHHHHHH-hccCCCCCC
Confidence            76644333333   47899999998664    5667999999999999888 999999999888777665 489999999


Q ss_pred             CccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCCCCCC
Q 012887          412 DCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNSS  452 (454)
Q Consensus       412 ~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~~~  452 (454)
                      +||..+.+||..||++|-.+||.|.+|+.+|.++-...++.
T Consensus       858 DCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~SL  898 (996)
T KOG0196|consen  858 DCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNSL  898 (996)
T ss_pred             CCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchhh
Confidence            99999999999999999999999999999999988776654

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.4e-43  Score=325.98  Aligned_cols=253  Identities=17%  Similarity=0.325  Sum_probs=221.4

Q ss_pred             cceeecCCCEEEeceeeccCCceEEEeE------EEEEEEeecCCC-CchHHHHHHHHHHHHHhCCCCceeEEEEEEEeC
Q 012887          183 GRWLLNSDNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDK-GNAYEFELRKDLLELMTCGHKNILQFYCVCVDE  255 (454)
Q Consensus       183 ~~~~~~~~~~~~~~~LG~G~fG~Vy~g~------~vavK~l~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~  255 (454)
                      ..|.+  ++|++++.||+|.||.||.|+      .||+|++..... ....+.++.+|+.+-..|+||||+++|++|.+.
T Consensus        17 ~~~~l--~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~   94 (281)
T KOG0580|consen   17 KTWTL--DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDS   94 (281)
T ss_pred             cccch--hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheecc
Confidence            44444  899999999999999999974      699999864322 223456788999999999999999999999988


Q ss_pred             CCeEEEEEeccCCCCHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccc
Q 012887          256 NHGLCVVTKLMEGGSVNDLIL--KSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTA  333 (454)
Q Consensus       256 ~~~l~lV~E~~~~gsL~~~l~--~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~  333 (454)
                      .. +|+++||.+.|+|...|.  +..++++.....|+.|++.||.|+|.++||||||||+|+|++..+.+||+|||-+..
T Consensus        95 ~r-iyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~  173 (281)
T KOG0580|consen   95 KR-IYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVH  173 (281)
T ss_pred             ce-eEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceee
Confidence            87 999999999999999997  556899999999999999999999999999999999999999999999999998765


Q ss_pred             cccCCCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCc
Q 012887          334 CKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDC  413 (454)
Q Consensus       334 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~  413 (454)
                      ..  .......+||..|.|||+..+..++.    ..|+|++|++.||++.|.+||.+.+..+...+|...  +..+|+.+
T Consensus       174 ~p--~~kR~tlcgt~dyl~pEmv~~~~hd~----~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~--~~~~p~~i  245 (281)
T KOG0580|consen  174 AP--SNKRKTLCGTLDYLPPEMVEGRGHDK----FVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKV--DLKFPSTI  245 (281)
T ss_pred             cC--CCCceeeecccccCCHhhcCCCCccc----hhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHc--cccCCccc
Confidence            43  33456678999999999999876554    499999999999999999999998877777777765  45578999


Q ss_pred             cHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 012887          414 PQILKSLMIKCWNNSPSKRPQFSEIISLLLRTN  446 (454)
Q Consensus       414 ~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~  446 (454)
                      +.++.++|.+|+.++|.+|.+..|+++|-|-..
T Consensus       246 s~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a  278 (281)
T KOG0580|consen  246 SGGAADLISRLLVKNPIERLALTEVMDHPWIVA  278 (281)
T ss_pred             ChhHHHHHHHHhccCccccccHHHHhhhHHHHh
Confidence            999999999999999999999999999987543

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=6.3e-42  Score=343.71  Aligned_cols=250  Identities=18%  Similarity=0.334  Sum_probs=205.3

Q ss_pred             ecCCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEE
Q 012887          187 LNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLC  260 (454)
Q Consensus       187 ~~~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~  260 (454)
                      +..++|++++.||+|+||.||++      ..+|+|.+... ........+.+|+.++..++||||+++++++.+.+. ++
T Consensus         2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~   79 (331)
T cd06649           2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLE-IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE-IS   79 (331)
T ss_pred             CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecc-cCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCE-EE
Confidence            45689999999999999999985      46888888643 233345668899999999999999999999988776 99


Q ss_pred             EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhc-CcccCCccCCcEEEccCCcEEEEccCCccccccCCC
Q 012887          261 VVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDH-GVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE  339 (454)
Q Consensus       261 lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~-~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~  339 (454)
                      +||||+++|+|.+++.+...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++......  
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--  157 (331)
T cd06649          80 ICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  157 (331)
T ss_pred             EEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc--
Confidence            9999999999999998878899999999999999999999986 6999999999999999999999999998765332  


Q ss_pred             cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH-------------------
Q 012887          340 ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGI-------------------  400 (454)
Q Consensus       340 ~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i-------------------  400 (454)
                      ......+++.|+|||++.+..+    +.++|||||||++|||++|+.||......+....+                   
T Consensus       158 ~~~~~~g~~~y~aPE~~~~~~~----~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (331)
T cd06649         158 MANSFVGTRSYMSPERLQGTHY----SVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRP  233 (331)
T ss_pred             ccccCCCCcCcCCHhHhcCCCC----CchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccc
Confidence            2233468899999999987644    45699999999999999999999765443321110                   


Q ss_pred             --------------------------HHcCCCCCCC-CCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 012887          401 --------------------------AACGLRPEIP-KDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR  444 (454)
Q Consensus       401 --------------------------~~~~~~~~~p-~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~  444 (454)
                                                .....++..+ ..+++++.+||.+||+.||++|||+++++++.+-
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~  304 (331)
T cd06649         234 RPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFI  304 (331)
T ss_pred             ccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHH
Confidence                                      1111122222 2468899999999999999999999999999764

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-42  Score=345.98  Aligned_cols=238  Identities=19%  Similarity=0.274  Sum_probs=201.6

Q ss_pred             eeccCCceEEEe------EEEEEEEeecCCC-CchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEEeccCCCC
Q 012887          198 IGPNSFKGVYKG------KRVGIEKLKGCDK-GNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGS  270 (454)
Q Consensus       198 LG~G~fG~Vy~g------~~vavK~l~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~E~~~~gs  270 (454)
                      ||+|+||.||++      +.+|+|.++.... .......+.+|+.++..++||||+++++++.+.+. +++||||+++|+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~lv~e~~~~g~   79 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEK-LYLVLAFINGGE   79 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCe-EEEEEcCCCCCc
Confidence            799999999985      4689999874322 22234557789999999999999999999987765 999999999999


Q ss_pred             HHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCcccccCCCCcc
Q 012887          271 VNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRW  350 (454)
Q Consensus       271 L~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~gt~~y  350 (454)
                      |.+++.+.+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.............||+.|
T Consensus        80 L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y  159 (312)
T cd05585          80 LFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEY  159 (312)
T ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCccc
Confidence            99999887889999999999999999999999999999999999999999999999999987544333334445689999


Q ss_pred             cccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhcccCCC
Q 012887          351 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPS  430 (454)
Q Consensus       351 ~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~li~~cl~~dP~  430 (454)
                      +|||++.+..+    +.++|||||||++|+|++|..||.+.+.......+...  +..+|..+++++.++|.+||+.||.
T Consensus       160 ~aPE~~~~~~~----~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dp~  233 (312)
T cd05585         160 LAPELLLGHGY----TKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQE--PLRFPDGFDRDAKDLLIGLLSRDPT  233 (312)
T ss_pred             CCHHHHcCCCC----CCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcC--CCCCCCcCCHHHHHHHHHHcCCCHH
Confidence            99999987654    44599999999999999999999988777666655543  4567888999999999999999999


Q ss_pred             CCCC---HHHHHHHH
Q 012887          431 KRPQ---FSEIISLL  442 (454)
Q Consensus       431 ~RPs---~~ell~~L  442 (454)
                      +||+   +.|++.|-
T Consensus       234 ~R~~~~~~~e~l~hp  248 (312)
T cd05585         234 RRLGYNGAQEIKNHP  248 (312)
T ss_pred             HcCCCCCHHHHHcCC
Confidence            9975   67777663

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=7.4e-42  Score=340.50  Aligned_cols=254  Identities=22%  Similarity=0.444  Sum_probs=211.8

Q ss_pred             ecCCCEEEeceeeccCCceEEEeE----------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCC
Q 012887          187 LNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN  256 (454)
Q Consensus       187 ~~~~~~~~~~~LG~G~fG~Vy~g~----------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~  256 (454)
                      +...+|++.+.||+|+||.||+|.          .||+|.++.. .......++.+|+.++..++||||++++|+|....
T Consensus         4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~~   82 (316)
T cd05108           4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTST   82 (316)
T ss_pred             cchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCCC
Confidence            456789999999999999999975          2889988632 23334556788999999999999999999998653


Q ss_pred             CeEEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccc
Q 012887          257 HGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK  335 (454)
Q Consensus       257 ~~l~lV~E~~~~gsL~~~l~~~~-~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~  335 (454)
                        .++|+||+++|+|.+++.+.. .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus        83 --~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~  160 (316)
T cd05108          83 --VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  160 (316)
T ss_pred             --ceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEcccccccccc
Confidence              679999999999999997644 78999999999999999999999999999999999999999999999999988664


Q ss_pred             cCCCcc--cccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHcCCCCCCCCC
Q 012887          336 SVGEAT--EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKD  412 (454)
Q Consensus       336 ~~~~~~--~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~  412 (454)
                      ......  .....+..|+|||.+.+..    ++.++|||||||++|||++ |..||.+....+. ..+...+.+.+.|..
T Consensus       161 ~~~~~~~~~~~~~~~~y~apE~~~~~~----~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~  235 (316)
T cd05108         161 ADEKEYHAEGGKVPIKWMALESILHRI----YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-SSILEKGERLPQPPI  235 (316)
T ss_pred             CCCcceeccCCccceeecChHHhccCC----CCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH-HHHHhCCCCCCCCCC
Confidence            432211  1122356799999997664    4456999999999999998 9999987665543 445555666677788


Q ss_pred             ccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCC
Q 012887          413 CPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNI  448 (454)
Q Consensus       413 ~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~  448 (454)
                      ++.++.+++.+||..+|++||++.+++..|..+...
T Consensus       236 ~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~  271 (316)
T cd05108         236 CTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  271 (316)
T ss_pred             CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence            899999999999999999999999999999887654

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=3e-42  Score=337.55  Aligned_cols=247  Identities=16%  Similarity=0.224  Sum_probs=200.3

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  263 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~  263 (454)
                      ++|++.+.||+|+||.||++      +.+|+|+++...........+.+|+.++..++||||+++++++...+. +++||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~lv~   79 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGK-LYLVF   79 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCE-EEEEE
Confidence            46899999999999999985      468999987654444445567889999999999999999999987775 99999


Q ss_pred             eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCC-ccc
Q 012887          264 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE-ATE  342 (454)
Q Consensus       264 E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~-~~~  342 (454)
                      ||++++.+..+......+++..+..++.||+.||.|||+++|+||||||+||+++.++.+||+|||++........ ...
T Consensus        80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  159 (287)
T cd07848          80 EYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYT  159 (287)
T ss_pred             ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccccccc
Confidence            9999977776655556899999999999999999999999999999999999999999999999999876543222 122


Q ss_pred             ccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCC----------------
Q 012887          343 YETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR----------------  406 (454)
Q Consensus       343 ~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~----------------  406 (454)
                      ...+++.|+|||++.+..+    +.++|||||||++|||++|+.||.+.+.......+......                
T Consensus       160 ~~~~~~~y~aPE~~~~~~~----~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (287)
T cd07848         160 EYVATRWYRSPELLLGAPY----GKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFH  235 (287)
T ss_pred             ccccccccCCcHHHcCCCC----CCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhc
Confidence            3467889999999987654    44699999999999999999999987665443332211000                


Q ss_pred             -CC-------------CCCCccHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012887          407 -PE-------------IPKDCPQILKSLMIKCWNNSPSKRPQFSEIISL  441 (454)
Q Consensus       407 -~~-------------~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  441 (454)
                       ..             ....+|.++.++|++||+.||++|||++++++|
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h  284 (287)
T cd07848         236 GLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH  284 (287)
T ss_pred             ccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence             00             112367889999999999999999999999976

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=4.3e-42  Score=346.68  Aligned_cols=259  Identities=24%  Similarity=0.438  Sum_probs=213.6

Q ss_pred             ceeecCCCEEEeceeeccCCceEEEe-----------EEEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEEEEE
Q 012887          184 RWLLNSDNLEFIDQIGPNSFKGVYKG-----------KRVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCV  251 (454)
Q Consensus       184 ~~~~~~~~~~~~~~LG~G~fG~Vy~g-----------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~~~g~  251 (454)
                      +|.++.++|++.+.||+|+||.||+|           +.||+|.++.. ........+.+|+.++.++ +||||++++++
T Consensus         1 ~~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~   79 (343)
T cd05103           1 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVNLLGA   79 (343)
T ss_pred             CcccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccC-CChHHHHHHHHHHHHHHhccCCccHhhhcce
Confidence            47788899999999999999999986           46899998743 2333445678899999999 68999999999


Q ss_pred             EEeCCCeEEEEEeccCCCCHHHHHHhC-----------------------------------------------------
Q 012887          252 CVDENHGLCVVTKLMEGGSVNDLILKS-----------------------------------------------------  278 (454)
Q Consensus       252 ~~~~~~~l~lV~E~~~~gsL~~~l~~~-----------------------------------------------------  278 (454)
                      +...+..+++||||+++|+|.+++...                                                     
T Consensus        80 ~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (343)
T cd05103          80 CTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLS  159 (343)
T ss_pred             eecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccc
Confidence            987766689999999999999998542                                                     


Q ss_pred             --------------CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCc--cc
Q 012887          279 --------------RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA--TE  342 (454)
Q Consensus       279 --------------~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~--~~  342 (454)
                                    ..+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||++.........  ..
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  239 (343)
T cd05103         160 DVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKG  239 (343)
T ss_pred             cchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcC
Confidence                          13677888999999999999999999999999999999999999999999998765332211  11


Q ss_pred             ccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHHHHH
Q 012887          343 YETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLM  421 (454)
Q Consensus       343 ~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~li  421 (454)
                      ...+++.|+|||.+.+..    ++.++||||||+++|+|++ |..||...............+.++..|..+++++.+++
T Consensus       240 ~~~~~~~y~aPE~~~~~~----~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (343)
T cd05103         240 DARLPLKWMAPETIFDRV----YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTM  315 (343)
T ss_pred             CCCCCcceECcHHhcCCC----CCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHH
Confidence            223456799999987654    3456999999999999997 99999876554445555555666677777889999999


Q ss_pred             HHhcccCCCCCCCHHHHHHHHHhhcC
Q 012887          422 IKCWNNSPSKRPQFSEIISLLLRTNN  447 (454)
Q Consensus       422 ~~cl~~dP~~RPs~~ell~~L~~~~~  447 (454)
                      .+||+.||.+||++.||+++|.++.+
T Consensus       316 ~~cl~~~p~~Rps~~eil~~l~~~~~  341 (343)
T cd05103         316 LDCWHGEPSQRPTFSELVEHLGNLLQ  341 (343)
T ss_pred             HHHccCChhhCcCHHHHHHHHHHHHh
Confidence            99999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.2e-42  Score=354.59  Aligned_cols=259  Identities=18%  Similarity=0.255  Sum_probs=215.4

Q ss_pred             cceeecCCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCc-hHHHHHHHHHHHHHhCCCCceeEEEEEEEeC
Q 012887          183 GRWLLNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGN-AYEFELRKDLLELMTCGHKNILQFYCVCVDE  255 (454)
Q Consensus       183 ~~~~~~~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~  255 (454)
                      ..+.+..++|++.+.||+|+||.||++      +.+|+|.+....... .....+.+|+.++..++||||+++++++.+.
T Consensus        36 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~  115 (370)
T cd05596          36 TKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDD  115 (370)
T ss_pred             ccCCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence            445567789999999999999999985      479999986432221 2233467889999999999999999999877


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccc
Q 012887          256 NHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK  335 (454)
Q Consensus       256 ~~~l~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~  335 (454)
                      +. +|+||||+++|+|.+++.+ ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus       116 ~~-~~lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~  193 (370)
T cd05596         116 KY-LYMVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMD  193 (370)
T ss_pred             CE-EEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence            76 9999999999999998854 468999999999999999999999999999999999999999999999999987654


Q ss_pred             cCCC-cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCC--C
Q 012887          336 SVGE-ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPK--D  412 (454)
Q Consensus       336 ~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~--~  412 (454)
                      .... ......||+.|+|||++.+......++.++|||||||++|||++|..||.+.+.......+........+|.  .
T Consensus       194 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  273 (370)
T cd05596         194 ANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIE  273 (370)
T ss_pred             CCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCC
Confidence            3322 223446899999999997654444466779999999999999999999999888777777765544455555  4


Q ss_pred             ccHHHHHHHHHhcccCCCC--CCCHHHHHHHHH
Q 012887          413 CPQILKSLMIKCWNNSPSK--RPQFSEIISLLL  443 (454)
Q Consensus       413 ~~~~l~~li~~cl~~dP~~--RPs~~ell~~L~  443 (454)
                      +|.++.++|.+||..+|.+  ||++.+++.|-+
T Consensus       274 ~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~  306 (370)
T cd05596         274 ISKQAKDLICAFLTDREVRLGRNGVDEIKSHPF  306 (370)
T ss_pred             CCHHHHHHHHHHccChhhccCCCCHHHHhcCcc
Confidence            7999999999999999988  999999998854

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.3e-42  Score=345.67  Aligned_cols=242  Identities=19%  Similarity=0.309  Sum_probs=204.8

Q ss_pred             eceeeccCCceEEEe---------EEEEEEEeecCCC--CchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEE
Q 012887          195 IDQIGPNSFKGVYKG---------KRVGIEKLKGCDK--GNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  263 (454)
Q Consensus       195 ~~~LG~G~fG~Vy~g---------~~vavK~l~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~  263 (454)
                      ++.||+|+||.||++         +.+|+|.++....  .......+..|+.++..++||||+++++++.+++. +|+||
T Consensus         1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~-~~lv~   79 (323)
T cd05584           1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGK-LYLIL   79 (323)
T ss_pred             CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCe-EEEEE
Confidence            367999999999975         3599999874321  12233456789999999999999999999988776 99999


Q ss_pred             eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCcccc
Q 012887          264 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY  343 (454)
Q Consensus       264 E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~  343 (454)
                      ||+++++|.+++.+.+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...........
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  159 (323)
T cd05584          80 EYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT  159 (323)
T ss_pred             eCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCcccc
Confidence            99999999999988888999999999999999999999999999999999999999999999999998754433333444


Q ss_pred             cCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHHHHHHH
Q 012887          344 ETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIK  423 (454)
Q Consensus       344 ~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~li~~  423 (454)
                      ..|++.|+|||++.+..+    +.++|||||||++|||++|..||...+.......+...  ...+|..+++.+.++|.+
T Consensus       160 ~~gt~~y~aPE~~~~~~~----~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~  233 (323)
T cd05584         160 FCGTIEYMAPEILMRSGH----GKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKG--KLNLPPYLTPEARDLLKK  233 (323)
T ss_pred             cCCCccccChhhccCCCC----CCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHHHHHHHHH
Confidence            568999999999987644    44699999999999999999999987776666555543  456788899999999999


Q ss_pred             hcccCCCCCC-----CHHHHHHHHH
Q 012887          424 CWNNSPSKRP-----QFSEIISLLL  443 (454)
Q Consensus       424 cl~~dP~~RP-----s~~ell~~L~  443 (454)
                      ||+.||.+||     ++.+++++-+
T Consensus       234 ~l~~~p~~R~~~~~~~~~~l~~h~~  258 (323)
T cd05584         234 LLKRNPSSRLGAGPGDAAEVQSHPF  258 (323)
T ss_pred             HcccCHhHcCCCCCCCHHHHhcCCC
Confidence            9999999999     8999888654

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1.4e-42  Score=348.21  Aligned_cols=241  Identities=18%  Similarity=0.255  Sum_probs=203.3

Q ss_pred             ceeeccCCceEEEe------EEEEEEEeecCCCC-chHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEEeccCC
Q 012887          196 DQIGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEG  268 (454)
Q Consensus       196 ~~LG~G~fG~Vy~g------~~vavK~l~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~E~~~~  268 (454)
                      +.||+|+||.||++      +.+|+|.+...... ......+.+|+.++..++||||+++++++.+.+. +++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~-~~lv~Ey~~~   79 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDR-LCFVMEYVNG   79 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCE-EEEEEeCCCC
Confidence            36899999999984      57999998743222 2234457789999999999999999999987776 9999999999


Q ss_pred             CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCcccccCCCC
Q 012887          269 GSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY  348 (454)
Q Consensus       269 gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~gt~  348 (454)
                      |+|.+.+...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.............|++
T Consensus        80 g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~  159 (328)
T cd05593          80 GELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTP  159 (328)
T ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccCCc
Confidence            99999988778899999999999999999999999999999999999999999999999999875433333334456899


Q ss_pred             cccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhcccC
Q 012887          349 RWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNS  428 (454)
Q Consensus       349 ~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~li~~cl~~d  428 (454)
                      .|+|||++.+..+    +.++|||||||++|+|++|..||...+.......+..  ....+|..+++++.++|.+||+.|
T Consensus       160 ~y~aPE~~~~~~~----~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~--~~~~~p~~~~~~~~~li~~~L~~d  233 (328)
T cd05593         160 EYLAPEVLEDNDY----GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM--EDIKFPRTLSADAKSLLSGLLIKD  233 (328)
T ss_pred             CccChhhhcCCCC----CccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhcc--CCccCCCCCCHHHHHHHHHHcCCC
Confidence            9999999987654    4459999999999999999999988776665544443  344578889999999999999999


Q ss_pred             CCCCC-----CHHHHHHHHH
Q 012887          429 PSKRP-----QFSEIISLLL  443 (454)
Q Consensus       429 P~~RP-----s~~ell~~L~  443 (454)
                      |.+||     ++.+++++-+
T Consensus       234 P~~R~~~~~~~~~~il~h~~  253 (328)
T cd05593         234 PNKRLGGGPDDAKEIMRHSF  253 (328)
T ss_pred             HHHcCCCCCCCHHHHhcCCC
Confidence            99997     8999998743

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=2.6e-42  Score=334.36  Aligned_cols=243  Identities=31%  Similarity=0.587  Sum_probs=200.2

Q ss_pred             EEeceeeccCCceEEEe----------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEE
Q 012887          193 EFIDQIGPNSFKGVYKG----------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  262 (454)
Q Consensus       193 ~~~~~LG~G~fG~Vy~g----------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV  262 (454)
                      ++.+.||.|+||.||+|          ..|+||.++. .........+.+|+..+.+++||||++++|++...+. .++|
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~-~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~-~~lv   79 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKP-SSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEP-LFLV   79 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEEST-TSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSS-EEEE
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecc-ccccccceeeeeccccccccccccccccccccccccc-cccc
Confidence            57789999999999995          4579999864 3334446778999999999999999999999996665 9999


Q ss_pred             EeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCC-
Q 012887          263 TKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE-  339 (454)
Q Consensus       263 ~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~-  339 (454)
                      |||+++|+|.+++...  ..+++..+..++.||+.||.|||+++++|+||+++|||++.++.+||+|||++........ 
T Consensus        80 ~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~  159 (259)
T PF07714_consen   80 MEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY  159 (259)
T ss_dssp             EE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            9999999999999776  5899999999999999999999999999999999999999999999999999876532211 


Q ss_pred             -cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHH
Q 012887          340 -ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQIL  417 (454)
Q Consensus       340 -~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l  417 (454)
                       ..........|+|||.+.+..    ++.++||||||+++|||++ |..||...+.......+ ..+.+++.|..++..+
T Consensus       160 ~~~~~~~~~~~~~aPE~~~~~~----~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  234 (259)
T PF07714_consen  160 KNDSSQQLPLRYLAPEVLKDGE----YTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKL-KQGQRLPIPDNCPKDI  234 (259)
T ss_dssp             EESTTSESGGGGS-HHHHHHSE----ESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHH-HTTEETTSBTTSBHHH
T ss_pred             cccccccccccccccccccccc----ccccccccccccccccccccccccccccccccccccc-cccccceeccchhHHH
Confidence             122233567899999998664    4567999999999999999 78999988777666666 6667777888999999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHHHH
Q 012887          418 KSLMIKCWNNSPSKRPQFSEIISLL  442 (454)
Q Consensus       418 ~~li~~cl~~dP~~RPs~~ell~~L  442 (454)
                      .++|.+||+.||.+||++.+|++.|
T Consensus       235 ~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  235 YSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             HHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             HHHHHHHcCCChhhCcCHHHHHhcC
Confidence            9999999999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=6.1e-42  Score=336.72  Aligned_cols=248  Identities=15%  Similarity=0.238  Sum_probs=200.3

Q ss_pred             CCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEE
Q 012887          189 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  262 (454)
Q Consensus       189 ~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV  262 (454)
                      .++|++.+.||+|+||.||+|      +.||+|.++.... ......+.+|+.++..++||||+++++++.+.+. .++|
T Consensus         4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~lv   81 (288)
T cd07871           4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKNLKHANIVTLHDIIHTERC-LTLV   81 (288)
T ss_pred             cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc-CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCe-EEEE
Confidence            367999999999999999986      5799999864322 2233456789999999999999999999987765 9999


Q ss_pred             EeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCcc
Q 012887          263 TKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT  341 (454)
Q Consensus       263 ~E~~~~gsL~~~l~~~~-~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~  341 (454)
                      |||+++ +|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..........
T Consensus        82 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~  160 (288)
T cd07871          82 FEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTY  160 (288)
T ss_pred             EeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCccc
Confidence            999976 9999886544 68999999999999999999999999999999999999999999999999987654333333


Q ss_pred             cccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCC--------------
Q 012887          342 EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP--------------  407 (454)
Q Consensus       342 ~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~--------------  407 (454)
                      ....+++.|+|||.+.+..   .++.++|||||||++|+|++|..||.+.+..+....+......+              
T Consensus       161 ~~~~~~~~y~aPE~~~~~~---~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (288)
T cd07871         161 SNEVVTLWYRPPDVLLGST---EYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEF  237 (288)
T ss_pred             cCceecccccChHHhcCCc---ccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhh
Confidence            3446788999999987532   24557999999999999999999999877665544332210000              


Q ss_pred             ---CC-----------CCCccHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 012887          408 ---EI-----------PKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL  442 (454)
Q Consensus       408 ---~~-----------p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L  442 (454)
                         .+           ....+.+..++|.+||..||.+|||++|+++|-
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp  286 (288)
T cd07871         238 RSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHS  286 (288)
T ss_pred             hccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCC
Confidence               01           124578899999999999999999999999763

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=4e-42  Score=349.55  Aligned_cols=247  Identities=19%  Similarity=0.294  Sum_probs=203.5

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCC-chHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  262 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV  262 (454)
                      ++|++++.||+|+||.||++      +.+|+|.+...... ......+.+|+.++..++||||+++++.+.+.+. +|+|
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~-~~lv   79 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLN-LYLI   79 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCe-EEEE
Confidence            47899999999999999985      57999998743222 2233457789999999999999999999988776 9999


Q ss_pred             EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCC---
Q 012887          263 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE---  339 (454)
Q Consensus       263 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~---  339 (454)
                      |||+++|+|.+++.+.+.+++..+..++.||+.||+|||++||+||||||+|||++.++++||+|||+++.......   
T Consensus        80 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~  159 (363)
T cd05628          80 MEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEF  159 (363)
T ss_pred             EcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccccccccccc
Confidence            99999999999998888999999999999999999999999999999999999999999999999999875432110   


Q ss_pred             --------------------------------cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCC
Q 012887          340 --------------------------------ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAA  387 (454)
Q Consensus       340 --------------------------------~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~P  387 (454)
                                                      ......||+.|+|||++.+..+    +.++|||||||++|||++|..|
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~----~~~~DvwSlGvil~ell~G~~P  235 (363)
T cd05628         160 YRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGY----NKLCDWWSLGVIMYEMLIGYPP  235 (363)
T ss_pred             cccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCC----CCchhhhhhHHHHHHHHhCCCC
Confidence                                            0122468999999999987654    4459999999999999999999


Q ss_pred             CCCCCHHHHHHHHHHcCCCCCCCC--CccHHHHHHHHHhcc--cCCCCCCCHHHHHHH
Q 012887          388 YAACSPVQAAVGIAACGLRPEIPK--DCPQILKSLMIKCWN--NSPSKRPQFSEIISL  441 (454)
Q Consensus       388 f~~~~~~~~~~~i~~~~~~~~~p~--~~~~~l~~li~~cl~--~dP~~RPs~~ell~~  441 (454)
                      |.+.++......+........+|.  .+++++.++|.+++.  .++..||++.||++|
T Consensus       236 f~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h  293 (363)
T cd05628         236 FCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN  293 (363)
T ss_pred             CCCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence            998888777766665444444554  368899999998654  233456899999987

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=5.9e-42  Score=336.33  Aligned_cols=247  Identities=18%  Similarity=0.286  Sum_probs=200.9

Q ss_pred             CEEEeceeeccCCceEEEe------EEEEEEEeecCCCC-chHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEE
Q 012887          191 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  263 (454)
Q Consensus       191 ~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~  263 (454)
                      .|+..+.||+|+||.||++      +.+|+|.+...... ......+.+|+.++..++|+||+++++++.+.+. +++||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~-~~lv~   79 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDA-LCLVL   79 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCe-EEEEE
Confidence            3678899999999999985      57999988643322 2233456789999999999999999999987776 99999


Q ss_pred             eccCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCcc
Q 012887          264 KLMEGGSVNDLILK--SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT  341 (454)
Q Consensus       264 E~~~~gsL~~~l~~--~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~  341 (454)
                      ||+++|+|.+++..  ...+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||++....... ..
T Consensus        80 e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~  158 (285)
T cd05631          80 TIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE-TV  158 (285)
T ss_pred             EecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC-ee
Confidence            99999999988754  2368999999999999999999999999999999999999999999999999987653322 22


Q ss_pred             cccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH--HHcCCCCCCCCCccHHHHH
Q 012887          342 EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGI--AACGLRPEIPKDCPQILKS  419 (454)
Q Consensus       342 ~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i--~~~~~~~~~p~~~~~~l~~  419 (454)
                      ....|++.|+|||++.+..+    +.++|||||||++|+|++|..||...........+  ........++..++.++.+
T Consensus       159 ~~~~g~~~y~aPE~~~~~~~----~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  234 (285)
T cd05631         159 RGRVGTVGYMAPEVINNEKY----TFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKS  234 (285)
T ss_pred             cCCCCCCCccCHhhhcCCCC----CcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHH
Confidence            33468899999999987654    44599999999999999999999875443221111  1123344567789999999


Q ss_pred             HHHHhcccCCCCCCC-----HHHHHHHHH
Q 012887          420 LMIKCWNNSPSKRPQ-----FSEIISLLL  443 (454)
Q Consensus       420 li~~cl~~dP~~RPs-----~~ell~~L~  443 (454)
                      |+++||+.||.+||+     +.+++++-+
T Consensus       235 li~~~l~~~P~~R~~~~~~~~~~~~~h~~  263 (285)
T cd05631         235 ICRMLLTKNPKERLGCRGNGAAGVKQHPI  263 (285)
T ss_pred             HHHHHhhcCHHHhcCCCCCCHHHHhcCHh
Confidence            999999999999997     899988744

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=1.6e-41  Score=336.63  Aligned_cols=262  Identities=24%  Similarity=0.475  Sum_probs=215.7

Q ss_pred             cceeecCCCEEEeceeeccCCceEEEeE-------------EEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEE
Q 012887          183 GRWLLNSDNLEFIDQIGPNSFKGVYKGK-------------RVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQF  248 (454)
Q Consensus       183 ~~~~~~~~~~~~~~~LG~G~fG~Vy~g~-------------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~~  248 (454)
                      .+|.+..++|.+.+.||+|+||.||+++             .+|+|.++.. ........+..|+.++..+ +||||+++
T Consensus        11 ~~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~e~~~l~~l~~h~~i~~~   89 (307)
T cd05098          11 PRWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINL   89 (307)
T ss_pred             CcceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCC-CChHHHHHHHHHHHHHHHhcCCCCEeeE
Confidence            5677888999999999999999999874             4888888743 2233345677899999988 79999999


Q ss_pred             EEEEEeCCCeEEEEEeccCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhcCcccCCccC
Q 012887          249 YCVCVDENHGLCVVTKLMEGGSVNDLILKSR----------------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNS  312 (454)
Q Consensus       249 ~g~~~~~~~~l~lV~E~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp  312 (454)
                      ++++...+. .++||||+++|+|.+++.+.+                .+++..++.++.||+.||+|||++|++||||||
T Consensus        90 ~~~~~~~~~-~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp  168 (307)
T cd05098          90 LGACTQDGP-LYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAA  168 (307)
T ss_pred             EEEEecCCc-eEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccH
Confidence            999988776 999999999999999996532                478899999999999999999999999999999


Q ss_pred             CcEEEccCCcEEEEccCCccccccCCCc--ccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCC
Q 012887          313 QRILLDRHGNVCLGDMGIVTACKSVGEA--TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYA  389 (454)
Q Consensus       313 ~NILl~~~~~vKL~DFGla~~~~~~~~~--~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~  389 (454)
                      +|||++.++.+||+|||++.........  .....+++.|+|||++.+..    ++.++|||||||++|+|++ |..||.
T Consensus       169 ~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~DvwslG~~l~el~~~g~~p~~  244 (307)
T cd05098         169 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI----YTHQSDVWSFGVLLWEIFTLGGSPYP  244 (307)
T ss_pred             HheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCC----CCcHHHHHHHHHHHHHHHcCCCCCCC
Confidence            9999999999999999998765432111  11122346799999997654    3456999999999999998 899998


Q ss_pred             CCCHHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCCCCC
Q 012887          390 ACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNS  451 (454)
Q Consensus       390 ~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~~  451 (454)
                      ...... .........+...|..++.++.+++.+||..+|.+||++.++++.|.++....++
T Consensus       245 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~~~  305 (307)
T cd05098         245 GVPVEE-LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALTSN  305 (307)
T ss_pred             cCCHHH-HHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHhhc
Confidence            765544 3344445556677888999999999999999999999999999999998775443

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.6e-43  Score=351.08  Aligned_cols=248  Identities=21%  Similarity=0.328  Sum_probs=208.8

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCc-hHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGN-AYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  262 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV  262 (454)
                      ++|++.+.||+|+||.||++      +.+|+|.++...... .....+.+|+.++..++||||+++++++.+.+. +++|
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~-~~lv   79 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEH-LYLV   79 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCe-EEEE
Confidence            46899999999999999985      579999987533222 334557889999999999999999999988776 9999


Q ss_pred             EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCC----
Q 012887          263 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG----  338 (454)
Q Consensus       263 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~----  338 (454)
                      |||+++++|.+++.+.+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......    
T Consensus        80 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~  159 (350)
T cd05573          80 MEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREY  159 (350)
T ss_pred             EcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcccc
Confidence            9999999999999877889999999999999999999999999999999999999999999999999987654433    


Q ss_pred             -------------------------CcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCH
Q 012887          339 -------------------------EATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSP  393 (454)
Q Consensus       339 -------------------------~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~  393 (454)
                                               .......||+.|+|||++.+..    ++.++|||||||++|||++|..||...+.
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwSlG~il~ell~g~~Pf~~~~~  235 (350)
T cd05573         160 YLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTP----YGLECDWWSLGVILYEMLYGFPPFYSDTL  235 (350)
T ss_pred             cccccccccccccccccccccccccccccccccCccccCHHHHcCCC----CCCceeeEecchhhhhhccCCCCCCCCCH
Confidence                                     1223346889999999998774    44569999999999999999999998887


Q ss_pred             HHHHHHHHHcCCCCCCCC--CccHHHHHHHHHhcccCCCCCCC-HHHHHHHHH
Q 012887          394 VQAAVGIAACGLRPEIPK--DCPQILKSLMIKCWNNSPSKRPQ-FSEIISLLL  443 (454)
Q Consensus       394 ~~~~~~i~~~~~~~~~p~--~~~~~l~~li~~cl~~dP~~RPs-~~ell~~L~  443 (454)
                      ......+........+|.  .+++++.++|.+||. ||.+||+ +.+++.+.+
T Consensus       236 ~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~  287 (350)
T cd05573         236 QETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPF  287 (350)
T ss_pred             HHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCC
Confidence            776666665222333333  369999999999997 9999999 999998754

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=6.5e-42  Score=346.60  Aligned_cols=254  Identities=17%  Similarity=0.317  Sum_probs=204.1

Q ss_pred             ecCCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEE
Q 012887          187 LNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLC  260 (454)
Q Consensus       187 ~~~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~  260 (454)
                      ...++|++++.||+|+||.||++      +.||+|.+... ........+.+|+.++..++|+||+++++++.+.+. ++
T Consensus        71 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~  148 (353)
T PLN00034         71 KSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGN-HEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGE-IQ  148 (353)
T ss_pred             CCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecC-CcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCe-EE
Confidence            34478899999999999999986      47999998643 233345668899999999999999999999987776 99


Q ss_pred             EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCc
Q 012887          261 VVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA  340 (454)
Q Consensus       261 lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~  340 (454)
                      +||||+++|+|.+.    ...++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus       149 lv~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~  224 (353)
T PLN00034        149 VLLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP  224 (353)
T ss_pred             EEEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccccccc
Confidence            99999999998653    34677888999999999999999999999999999999999999999999998766543333


Q ss_pred             ccccCCCCcccccccccCCCCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCHH--HHHHHHHHcCCCCCCCCCccHHH
Q 012887          341 TEYETDGYRWLAPEIIAGDPES-VSETWMSNVYSFGMVIWEMVTGEAAYAACSPV--QAAVGIAACGLRPEIPKDCPQIL  417 (454)
Q Consensus       341 ~~~~~gt~~y~APE~l~~~~~~-~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~--~~~~~i~~~~~~~~~p~~~~~~l  417 (454)
                      .....|+..|+|||++...... ...+.++|||||||++|||++|+.||......  ............+..+..++.++
T Consensus       225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  304 (353)
T PLN00034        225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASREF  304 (353)
T ss_pred             ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCHHH
Confidence            3445789999999998643221 12334699999999999999999999743221  22222223344556677899999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 012887          418 KSLMIKCWNNSPSKRPQFSEIISLLLRTN  446 (454)
Q Consensus       418 ~~li~~cl~~dP~~RPs~~ell~~L~~~~  446 (454)
                      .+||.+||+.||++||++.|+++|-+-..
T Consensus       305 ~~li~~~l~~~P~~Rpt~~ell~hp~~~~  333 (353)
T PLN00034        305 RHFISCCLQREPAKRWSAMQLLQHPFILR  333 (353)
T ss_pred             HHHHHHHccCChhhCcCHHHHhcCccccc
Confidence            99999999999999999999999865433

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-42  Score=351.04  Aligned_cols=248  Identities=21%  Similarity=0.301  Sum_probs=207.0

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCC-chHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  262 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV  262 (454)
                      ++|++++.||+|+||.||++      +.||+|.+...... ......+.+|+.++..++||||+++++++.+.+. +|+|
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~-~~lv   79 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENY-LYLI   79 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCe-EEEE
Confidence            47899999999999999985      57999999743221 2233457789999999999999999999998776 9999


Q ss_pred             EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCC---
Q 012887          263 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE---  339 (454)
Q Consensus       263 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~---  339 (454)
                      |||+++|+|.+++.+.+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++........   
T Consensus        80 ~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~  159 (364)
T cd05599          80 MEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEF  159 (364)
T ss_pred             ECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceeccccccccc
Confidence            99999999999998878899999999999999999999999999999999999999999999999999865432110   


Q ss_pred             -----------------------------------cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcC
Q 012887          340 -----------------------------------ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTG  384 (454)
Q Consensus       340 -----------------------------------~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG  384 (454)
                                                         ......||+.|+|||++.+..+    +.++|||||||++|||++|
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~----~~~~DiwSlG~il~el~~G  235 (364)
T cd05599         160 YRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY----NKECDWWSLGVIMYEMLVG  235 (364)
T ss_pred             cccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCC----CCeeeeecchhHHHHhhcC
Confidence                                               0012358999999999987654    4459999999999999999


Q ss_pred             CCCCCCCCHHHHHHHHHHcCCCCCCCC--CccHHHHHHHHHhcccCCCCCCC---HHHHHHHHH
Q 012887          385 EAAYAACSPVQAAVGIAACGLRPEIPK--DCPQILKSLMIKCWNNSPSKRPQ---FSEIISLLL  443 (454)
Q Consensus       385 ~~Pf~~~~~~~~~~~i~~~~~~~~~p~--~~~~~l~~li~~cl~~dP~~RPs---~~ell~~L~  443 (454)
                      ..||.+.++.+....+........+|.  .+++++.++|.+|+. +|.+|++   +.+++.+-+
T Consensus       236 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~  298 (364)
T cd05599         236 YPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPF  298 (364)
T ss_pred             CCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCC
Confidence            999998888777666665444444444  468999999999996 9999998   999988754

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=4.5e-42  Score=351.52  Aligned_cols=248  Identities=18%  Similarity=0.285  Sum_probs=204.4

Q ss_pred             CEEEeceeeccCCceEEEe------EEEEEEEeecCCCC-chHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEE
Q 012887          191 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  263 (454)
Q Consensus       191 ~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~  263 (454)
                      .|++++.||+|+||.||++      +.+|+|.+...... ......+.+|+.++..++||||+++++++.+.+. +|+||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~-~~lv~   80 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDN-LYFVM   80 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCE-EEEEE
Confidence            5889999999999999986      47999999753322 2234567889999999999999999999998776 99999


Q ss_pred             eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCC----
Q 012887          264 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE----  339 (454)
Q Consensus       264 E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~----  339 (454)
                      ||+++|+|.+++.+.+.+++..+..++.||+.||+|||++||+||||||+|||++.++++||+|||++........    
T Consensus        81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~  160 (381)
T cd05626          81 DYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYY  160 (381)
T ss_pred             ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccc
Confidence            9999999999998878899999999999999999999999999999999999999999999999999753311000    


Q ss_pred             -------------------------------------------cccccCCCCcccccccccCCCCCCCCCchhhHHHHHH
Q 012887          340 -------------------------------------------ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGM  376 (454)
Q Consensus       340 -------------------------------------------~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGv  376 (454)
                                                                 ......||+.|+|||++.+..+    +.++|||||||
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~----~~~~DiwSlG~  236 (381)
T cd05626         161 QKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGY----TQLCDWWSVGV  236 (381)
T ss_pred             cccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCC----CCccceeehhh
Confidence                                                       0112368899999999987654    44599999999


Q ss_pred             HHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCC--CccHHHHHHHHH--hcccCCCCCCCHHHHHHHHH
Q 012887          377 VIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPK--DCPQILKSLMIK--CWNNSPSKRPQFSEIISLLL  443 (454)
Q Consensus       377 iL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~--~~~~~l~~li~~--cl~~dP~~RPs~~ell~~L~  443 (454)
                      ++|||++|..||...++......+........+|.  .+++++.++|.+  |+..+|..||++.+++.|-+
T Consensus       237 il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~  307 (381)
T cd05626         237 ILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPF  307 (381)
T ss_pred             HHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcc
Confidence            99999999999998877766666654433444444  578999999999  45566667999999998854

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=3.2e-41  Score=326.67  Aligned_cols=251  Identities=27%  Similarity=0.495  Sum_probs=209.8

Q ss_pred             cCCCEEEeceeeccCCceEEEeE---------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCe
Q 012887          188 NSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHG  258 (454)
Q Consensus       188 ~~~~~~~~~~LG~G~fG~Vy~g~---------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~  258 (454)
                      ..++|++.+.||+|+||.||+|.         .+|+|.++.. ........+.+|+..+..++||||+++++++.+.+. 
T Consensus         2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-   79 (266)
T cd05033           2 DPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAG-SSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRP-   79 (266)
T ss_pred             ChHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCC-CChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCc-
Confidence            45789999999999999999874         5788887643 233345567889999999999999999999987766 


Q ss_pred             EEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccC
Q 012887          259 LCVVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV  337 (454)
Q Consensus       259 l~lV~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~  337 (454)
                      .++||||+++++|.+++... ..+++..+..++.|++.||.|||+++|+|+||||+|||++.++.++|+|||++......
T Consensus        80 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~  159 (266)
T cd05033          80 VMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS  159 (266)
T ss_pred             eEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence            89999999999999998654 47899999999999999999999999999999999999999999999999998876421


Q ss_pred             CC--cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHcCCCCCCCCCcc
Q 012887          338 GE--ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCP  414 (454)
Q Consensus       338 ~~--~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~  414 (454)
                      ..  ......+++.|+|||.+.+..+    +.++||||||+++|+|++ |..||...........+. ...+.+.+..++
T Consensus       160 ~~~~~~~~~~~~~~y~~Pe~~~~~~~----~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~  234 (266)
T cd05033         160 EATYTTKGGKIPIRWTAPEAIAYRKF----TSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVE-DGYRLPPPMDCP  234 (266)
T ss_pred             ccceeccCCCCCccccChhhhccCCC----ccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCC
Confidence            11  1112234578999999986643    445999999999999998 999998877665554443 445556677899


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 012887          415 QILKSLMIKCWNNSPSKRPQFSEIISLLLRT  445 (454)
Q Consensus       415 ~~l~~li~~cl~~dP~~RPs~~ell~~L~~~  445 (454)
                      ..+.+++.+||+.+|++||++.+++++|.++
T Consensus       235 ~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         235 SALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             HHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            9999999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=6.6e-42  Score=342.38  Aligned_cols=244  Identities=22%  Similarity=0.299  Sum_probs=203.4

Q ss_pred             CEEEeceeeccCCceEEEe------EEEEEEEeecCCC-CchHHHHHHHHHHHHHhCCC-CceeEEEEEEEeCCCeEEEE
Q 012887          191 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDK-GNAYEFELRKDLLELMTCGH-KNILQFYCVCVDENHGLCVV  262 (454)
Q Consensus       191 ~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~-~~~~~~~~~~Ei~~l~~l~H-pnIv~~~g~~~~~~~~l~lV  262 (454)
                      +|++++.||+|+||.||+|      +.+|+|.+..... .......+..|..++..+.| ++|+++++++.+.+. +|+|
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~-~~lv   79 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR-LYFV   79 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCE-EEEE
Confidence            5789999999999999986      3699999874321 12233456778888888866 568888888887765 9999


Q ss_pred             EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCccc
Q 012887          263 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE  342 (454)
Q Consensus       263 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~  342 (454)
                      |||+++|+|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...........
T Consensus        80 ~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~  159 (324)
T cd05587          80 MEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTR  159 (324)
T ss_pred             EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCcee
Confidence            99999999999998878899999999999999999999999999999999999999999999999999865433223334


Q ss_pred             ccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHHHHHH
Q 012887          343 YETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMI  422 (454)
Q Consensus       343 ~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~li~  422 (454)
                      ...|++.|+|||++.+..+    +.++|||||||++|+|++|..||.+.+.......+..  ....+|..++.++.+++.
T Consensus       160 ~~~gt~~y~aPE~~~~~~~----~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~~~li~  233 (324)
T cd05587         160 TFCGTPDYIAPEIIAYQPY----GKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIME--HNVSYPKSLSKEAVSICK  233 (324)
T ss_pred             eecCCccccChhhhcCCCC----CcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHc--CCCCCCCCCCHHHHHHHH
Confidence            4568999999999987654    4459999999999999999999998877766666554  345678889999999999


Q ss_pred             HhcccCCCCCCCH-----HHHHHH
Q 012887          423 KCWNNSPSKRPQF-----SEIISL  441 (454)
Q Consensus       423 ~cl~~dP~~RPs~-----~ell~~  441 (454)
                      +||..||.+|++.     .+++++
T Consensus       234 ~~l~~~P~~R~~~~~~~~~~~~~h  257 (324)
T cd05587         234 GLLTKHPAKRLGCGPTGERDIREH  257 (324)
T ss_pred             HHhhcCHHHcCCCCCCCHHHHhcC
Confidence            9999999999986     677665

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=7.7e-42  Score=338.21  Aligned_cols=249  Identities=20%  Similarity=0.309  Sum_probs=196.7

Q ss_pred             CCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEE
Q 012887          189 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  262 (454)
Q Consensus       189 ~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV  262 (454)
                      .++|++.+.||+|+||.||+|      +.+|+|.++.... ........+|+.+++.++||||+++++++.+.+. .++|
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~lv   81 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE-EGTPFTAIREASLLKGLKHANIVLLHDIIHTKET-LTLV   81 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc-cccchhHHHHHHHHhhCCCCCcCeEEEEEecCCe-EEEE
Confidence            478999999999999999986      4689999874332 2233456789999999999999999999988775 9999


Q ss_pred             EeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCcc
Q 012887          263 TKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT  341 (454)
Q Consensus       263 ~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~  341 (454)
                      |||++ ++|.+++.+. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..........
T Consensus        82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  160 (303)
T cd07869          82 FEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTY  160 (303)
T ss_pred             EECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCccC
Confidence            99996 5888877554 478999999999999999999999999999999999999999999999999987544333333


Q ss_pred             cccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHH-HHHHHHc-CCC-------------
Q 012887          342 EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQA-AVGIAAC-GLR-------------  406 (454)
Q Consensus       342 ~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~-~~~i~~~-~~~-------------  406 (454)
                      ....+++.|+|||++.+..   .++.++|||||||++|+|++|..||.+..+... ...+... +.+             
T Consensus       161 ~~~~~~~~y~aPE~~~~~~---~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (303)
T cd07869         161 SNEVVTLWYRPPDVLLGST---EYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPH  237 (303)
T ss_pred             CCCcccCCCCChHHHcCCC---CCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccc
Confidence            3456788999999987542   245579999999999999999999987544322 2222110 000             


Q ss_pred             --C-----CCC---------CCccHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 012887          407 --P-----EIP---------KDCPQILKSLMIKCWNNSPSKRPQFSEIISLLL  443 (454)
Q Consensus       407 --~-----~~p---------~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~  443 (454)
                        +     ..|         ...++++.+++.+||+.||.+|||+.|+++|-+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~  290 (303)
T cd07869         238 FKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEY  290 (303)
T ss_pred             cccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcc
Confidence              0     001         123567899999999999999999999998754

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1.8e-41  Score=327.22  Aligned_cols=251  Identities=24%  Similarity=0.465  Sum_probs=209.8

Q ss_pred             eeecCCCEEEeceeeccCCceEEEeE-----EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeE
Q 012887          185 WLLNSDNLEFIDQIGPNSFKGVYKGK-----RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGL  259 (454)
Q Consensus       185 ~~~~~~~~~~~~~LG~G~fG~Vy~g~-----~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l  259 (454)
                      |.+..++|+++++||+|+||.||+|.     .+|+|.+...   ......+.+|+.++..++|+||+++++.+.+.+. .
T Consensus         1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~   76 (261)
T cd05072           1 WEIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG---TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEP-I   76 (261)
T ss_pred             CcCchHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCC---chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC-c
Confidence            55778999999999999999999963     5888887632   2234567889999999999999999999887776 8


Q ss_pred             EEEEeccCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccC
Q 012887          260 CVVTKLMEGGSVNDLILK--SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV  337 (454)
Q Consensus       260 ~lV~E~~~~gsL~~~l~~--~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~  337 (454)
                      +++|||+++++|.+++.+  ...+++..+..++.|++.||+|||+++++||||||+||+++.++.+||+|||++......
T Consensus        77 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~  156 (261)
T cd05072          77 YIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDN  156 (261)
T ss_pred             EEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCC
Confidence            999999999999999864  347889999999999999999999999999999999999999999999999998765432


Q ss_pred             CCc-ccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHcCCCCCCCCCccH
Q 012887          338 GEA-TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ  415 (454)
Q Consensus       338 ~~~-~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~  415 (454)
                      ... .....++..|+|||.+.+..+    +.++|||||||++|+|++ |..||...........+. ...+.+.+..++.
T Consensus       157 ~~~~~~~~~~~~~y~aPE~~~~~~~----~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~  231 (261)
T cd05072         157 EYTAREGAKFPIKWTAPEAINFGSF----TIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQ-RGYRMPRMENCPD  231 (261)
T ss_pred             ceeccCCCccceecCCHHHhccCCC----ChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCH
Confidence            211 122234567999999876644    445999999999999998 999998877666555444 3455556667899


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 012887          416 ILKSLMIKCWNNSPSKRPQFSEIISLLLR  444 (454)
Q Consensus       416 ~l~~li~~cl~~dP~~RPs~~ell~~L~~  444 (454)
                      ++.+++.+||..+|++||+++++.+.|++
T Consensus       232 ~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  260 (261)
T cd05072         232 ELYDIMKTCWKEKAEERPTFDYLQSVLDD  260 (261)
T ss_pred             HHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            99999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=2.2e-41  Score=330.00  Aligned_cols=253  Identities=26%  Similarity=0.464  Sum_probs=206.2

Q ss_pred             eeecCCCEEEeceeeccCCceEEEe-----------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEE
Q 012887          185 WLLNSDNLEFIDQIGPNSFKGVYKG-----------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCV  253 (454)
Q Consensus       185 ~~~~~~~~~~~~~LG~G~fG~Vy~g-----------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~  253 (454)
                      |.+..++|++.+.||+|+||.||+|           ..+|+|++.... ......++.+|+.++..++||||+++++++.
T Consensus         1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~   79 (277)
T cd05062           1 WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVS   79 (277)
T ss_pred             CcccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence            4566788999999999999999975           358999875322 2234456788999999999999999999998


Q ss_pred             eCCCeEEEEEeccCCCCHHHHHHhCC----------CCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcE
Q 012887          254 DENHGLCVVTKLMEGGSVNDLILKSR----------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV  323 (454)
Q Consensus       254 ~~~~~l~lV~E~~~~gsL~~~l~~~~----------~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~v  323 (454)
                      +... .++||||+++++|.+++.+.+          .+++..+..++.|++.||.|||+.+++||||||+|||++.++.+
T Consensus        80 ~~~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~  158 (277)
T cd05062          80 QGQP-TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTV  158 (277)
T ss_pred             CCCC-eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCE
Confidence            7766 899999999999999986422          35678889999999999999999999999999999999999999


Q ss_pred             EEEccCCccccccCCCcc--cccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHH
Q 012887          324 CLGDMGIVTACKSVGEAT--EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGI  400 (454)
Q Consensus       324 KL~DFGla~~~~~~~~~~--~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~i  400 (454)
                      +|+|||++..........  ....+++.|+|||.+.+..+    +.++|||||||++|||++ |..||.+.+.......+
T Consensus       159 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~----~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~  234 (277)
T cd05062         159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVF----TTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFV  234 (277)
T ss_pred             EECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCc----CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            999999987543322111  11234678999999986544    446999999999999999 78999887665544433


Q ss_pred             HHcCCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 012887          401 AACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR  444 (454)
Q Consensus       401 ~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~  444 (454)
                      . ....+..+..++..+.+++.+||+.||++||++.|++++|++
T Consensus       235 ~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         235 M-EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             H-cCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence            3 344456678889999999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=1.8e-41  Score=349.42  Aligned_cols=257  Identities=24%  Similarity=0.444  Sum_probs=216.2

Q ss_pred             cceeecCCCEEEeceeeccCCceEEEeE-----------EEEEEEeecCCCCchHHHHHHHHHHHHHhCC-CCceeEEEE
Q 012887          183 GRWLLNSDNLEFIDQIGPNSFKGVYKGK-----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCG-HKNILQFYC  250 (454)
Q Consensus       183 ~~~~~~~~~~~~~~~LG~G~fG~Vy~g~-----------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~~~g  250 (454)
                      ..|.++.++|.+.+.||+|+||.||+|+           .||+|+++... .......+.+|+.+|.++. |||||++++
T Consensus        30 ~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~~H~niv~~~~  108 (401)
T cd05107          30 SAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA-RSSEKQALMSELKIMSHLGPHLNIVNLLG  108 (401)
T ss_pred             CcceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC-ChhHHHHHHHHHHHHHhcCCCCCeEEEEE
Confidence            4588889999999999999999999874           69999997432 2223345788999999997 999999999


Q ss_pred             EEEeCCCeEEEEEeccCCCCHHHHHHhCC---------------------------------------------------
Q 012887          251 VCVDENHGLCVVTKLMEGGSVNDLILKSR---------------------------------------------------  279 (454)
Q Consensus       251 ~~~~~~~~l~lV~E~~~~gsL~~~l~~~~---------------------------------------------------  279 (454)
                      +|...+. +++||||+++|+|.+++.+.+                                                   
T Consensus       109 ~~~~~~~-~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  187 (401)
T cd05107         109 ACTKGGP-IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESA  187 (401)
T ss_pred             EEccCCC-cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCcccc
Confidence            9988776 999999999999999985431                                                   


Q ss_pred             -----------------------------------------------CCCHHHHHHHHHHHHHHHHHHHhcCcccCCccC
Q 012887          280 -----------------------------------------------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNS  312 (454)
Q Consensus       280 -----------------------------------------------~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp  312 (454)
                                                                     .+++..+..++.||+.||+|||+.+++||||||
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp  267 (401)
T cd05107         188 DYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAA  267 (401)
T ss_pred             CccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCc
Confidence                                                           356677889999999999999999999999999


Q ss_pred             CcEEEccCCcEEEEccCCccccccCCC--cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCC
Q 012887          313 QRILLDRHGNVCLGDMGIVTACKSVGE--ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYA  389 (454)
Q Consensus       313 ~NILl~~~~~vKL~DFGla~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~  389 (454)
                      +|||++.++.+||+|||+++.......  ......+++.|+|||.+.+..+    +.++|||||||++|||++ |..||.
T Consensus       268 ~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~----~~~~DvwslGvil~e~l~~g~~P~~  343 (401)
T cd05107         268 RNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLY----TTLSDVWSFGILLWEIFTLGGTPYP  343 (401)
T ss_pred             ceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCC----CcHhHHHHHHHHHHHHHHcCCCCCC
Confidence            999999999999999999876433221  1122345778999999976543    446999999999999998 899998


Q ss_pred             CCCHHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 012887          390 ACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRT  445 (454)
Q Consensus       390 ~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~  445 (454)
                      .....+........+.++..|..++.++.+++.+||..+|.+||++.+|+..|.++
T Consensus       344 ~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~  399 (401)
T cd05107         344 ELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL  399 (401)
T ss_pred             CCCchHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            77666666666666777778888999999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=3.3e-41  Score=329.74  Aligned_cols=249  Identities=26%  Similarity=0.495  Sum_probs=205.9

Q ss_pred             CCCEEEeceeeccCCceEEEeE----------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCe
Q 012887          189 SDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHG  258 (454)
Q Consensus       189 ~~~~~~~~~LG~G~fG~Vy~g~----------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~  258 (454)
                      .++|++.+.||+|+||.||+|.          .+++|.++... .......+.+|+.++..++||||+++++++...+. 
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-   81 (283)
T cd05090           4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQP-   81 (283)
T ss_pred             hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCc-
Confidence            4788999999999999999974          58888887432 23334567889999999999999999999987776 


Q ss_pred             EEEEEeccCCCCHHHHHHhC-----------------CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCC
Q 012887          259 LCVVTKLMEGGSVNDLILKS-----------------RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG  321 (454)
Q Consensus       259 l~lV~E~~~~gsL~~~l~~~-----------------~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~  321 (454)
                      .|+||||+++++|.+++...                 ..+++..+..++.|++.||.|||++|++||||||+|||++.++
T Consensus        82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~  161 (283)
T cd05090          82 VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQL  161 (283)
T ss_pred             eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCC
Confidence            89999999999999998422                 2478889999999999999999999999999999999999999


Q ss_pred             cEEEEccCCccccccCCC--cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHH
Q 012887          322 NVCLGDMGIVTACKSVGE--ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAV  398 (454)
Q Consensus       322 ~vKL~DFGla~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~  398 (454)
                      .+||+|||+++.......  ......++..|+|||++.+..+    +.++|||||||++|||++ |..||.+.++.....
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~----~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~  237 (283)
T cd05090         162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKF----SSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIE  237 (283)
T ss_pred             cEEeccccccccccCCcceecccCCCccceecChHHhccCCC----CchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence            999999999876533221  1222334667999999976543    446999999999999998 999998876654443


Q ss_pred             HHHHcCCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 012887          399 GIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR  444 (454)
Q Consensus       399 ~i~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~  444 (454)
                       .......++.+..++..+.+++.+||+.||.+||++.+|+++|..
T Consensus       238 -~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         238 -MVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             -HHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence             334445556778899999999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=6.7e-42  Score=342.37  Aligned_cols=243  Identities=21%  Similarity=0.318  Sum_probs=201.4

Q ss_pred             EEEeceeeccCCceEEEe------EEEEEEEeecCCCC-chHHHHHHHHHHHH---HhCCCCceeEEEEEEEeCCCeEEE
Q 012887          192 LEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLEL---MTCGHKNILQFYCVCVDENHGLCV  261 (454)
Q Consensus       192 ~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~-~~~~~~~~~Ei~~l---~~l~HpnIv~~~g~~~~~~~~l~l  261 (454)
                      |++++.||+|+||.||++      +.+|+|.++..... ......+.+|+.++   ..++||||+++++++.+.+. +|+
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~-~~l   79 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDH-VCF   79 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCE-EEE
Confidence            578899999999999985      57999999743221 12233455665544   45689999999999987776 999


Q ss_pred             EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCcc
Q 012887          262 VTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT  341 (454)
Q Consensus       262 V~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~  341 (454)
                      ||||+++++|...+. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..........
T Consensus        80 v~E~~~~~~L~~~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~  158 (324)
T cd05589          80 VMEYAAGGDLMMHIH-TDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRT  158 (324)
T ss_pred             EEcCCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCCcc
Confidence            999999999998874 4579999999999999999999999999999999999999999999999999987544333334


Q ss_pred             cccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHHHHH
Q 012887          342 EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLM  421 (454)
Q Consensus       342 ~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~li  421 (454)
                      ....|++.|+|||.+.+..+    +.++|||||||++|+|++|..||.+.+.......+...  ...+|..+++.+.++|
T Consensus       159 ~~~~g~~~y~aPE~~~~~~~----~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~--~~~~p~~~~~~~~~li  232 (324)
T cd05589         159 STFCGTPEFLAPEVLTETSY----TRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVND--EVRYPRFLSREAISIM  232 (324)
T ss_pred             cccccCccccCHhHhcCCCC----CcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCCCCCCHHHHHHH
Confidence            45578999999999987654    44599999999999999999999988777766666554  3447788999999999


Q ss_pred             HHhcccCCCCCC-----CHHHHHHHH
Q 012887          422 IKCWNNSPSKRP-----QFSEIISLL  442 (454)
Q Consensus       422 ~~cl~~dP~~RP-----s~~ell~~L  442 (454)
                      .+||+.||.+||     ++.+++++-
T Consensus       233 ~~~L~~dP~~R~~~~~~~~~~l~~~~  258 (324)
T cd05589         233 RRLLRRNPERRLGSGEKDAEDVKKQP  258 (324)
T ss_pred             HHHhhcCHhHcCCCCCCCHHHHhhCC
Confidence            999999999999     688887764

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=2.9e-41  Score=325.56  Aligned_cols=242  Identities=26%  Similarity=0.442  Sum_probs=203.1

Q ss_pred             eeeccCCceEEEe--------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEEeccCC
Q 012887          197 QIGPNSFKGVYKG--------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEG  268 (454)
Q Consensus       197 ~LG~G~fG~Vy~g--------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~E~~~~  268 (454)
                      +||+|+||.||+|        ..+|+|.++...........+.+|+.++..++||||+++++++..+ . .++||||+++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~-~~lv~e~~~~   79 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEAE-S-WMLVMELAEL   79 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-C-cEEEEecCCC
Confidence            5899999999985        5689998875544444566788999999999999999999988543 3 7899999999


Q ss_pred             CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCc---ccccC
Q 012887          269 GSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA---TEYET  345 (454)
Q Consensus       269 gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~---~~~~~  345 (454)
                      |+|.+++.+...+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++.........   .....
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~  159 (257)
T cd05116          80 GPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGK  159 (257)
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCC
Confidence            999999987778999999999999999999999999999999999999999999999999998765433221   11223


Q ss_pred             CCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHHHHHHHh
Q 012887          346 DGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKC  424 (454)
Q Consensus       346 gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~li~~c  424 (454)
                      +++.|+|||.+.+..    .+.++|+|||||++|||++ |..||...........+ ..+..++.|..+++++.++|.+|
T Consensus       160 ~~~~y~aPE~~~~~~----~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i-~~~~~~~~~~~~~~~l~~li~~~  234 (257)
T cd05116         160 WPVKWYAPECMNYYK----FSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMI-ESGERMECPQRCPPEMYDLMKLC  234 (257)
T ss_pred             CCccccCHhHhccCC----cCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-HCCCCCCCCCCCCHHHHHHHHHH
Confidence            357899999987654    3446999999999999998 99999887766554444 44556778888999999999999


Q ss_pred             cccCCCCCCCHHHHHHHHHhh
Q 012887          425 WNNSPSKRPQFSEIISLLLRT  445 (454)
Q Consensus       425 l~~dP~~RPs~~ell~~L~~~  445 (454)
                      |+.||.+||++.+|...|++.
T Consensus       235 ~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         235 WTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             hccCchhCcCHHHHHHHHhcc
Confidence            999999999999999998753

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=2.8e-41  Score=325.27  Aligned_cols=246  Identities=26%  Similarity=0.489  Sum_probs=204.8

Q ss_pred             cCCCEEEeceeeccCCceEEEe-----EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEE
Q 012887          188 NSDNLEFIDQIGPNSFKGVYKG-----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  262 (454)
Q Consensus       188 ~~~~~~~~~~LG~G~fG~Vy~g-----~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV  262 (454)
                      +.++|++.+.||+|+||.||++     ..+|+|.+....   .....+.+|+..++.++||||+++++++.+.+. .++|
T Consensus         2 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~iv   77 (256)
T cd05114           2 NPSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA---MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKP-LYIV   77 (256)
T ss_pred             CHHHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC---ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCC-EEEE
Confidence            3467899999999999999986     367888775322   224567889999999999999999999987776 9999


Q ss_pred             EeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCc-
Q 012887          263 TKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA-  340 (454)
Q Consensus       263 ~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~-  340 (454)
                      |||+++|+|.+++... ..+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||+++........ 
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~  157 (256)
T cd05114          78 TEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS  157 (256)
T ss_pred             EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence            9999999999998653 46899999999999999999999999999999999999999999999999998754332211 


Q ss_pred             ccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHHH
Q 012887          341 TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKS  419 (454)
Q Consensus       341 ~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~  419 (454)
                      .....++..|+|||.+.+..    ++.++||||||+++|+|++ |+.||...+..+....+.. +.++..|...+..+.+
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~----~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~-~~~~~~~~~~~~~~~~  232 (256)
T cd05114         158 SSGAKFPVKWSPPEVFNFSK----YSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISR-GFRLYRPKLASMTVYE  232 (256)
T ss_pred             cCCCCCchhhCChhhcccCc----cchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC-CCCCCCCCCCCHHHHH
Confidence            11223456799999997654    3456999999999999999 9999988777666655544 4455567778899999


Q ss_pred             HHHHhcccCCCCCCCHHHHHHHH
Q 012887          420 LMIKCWNNSPSKRPQFSEIISLL  442 (454)
Q Consensus       420 li~~cl~~dP~~RPs~~ell~~L  442 (454)
                      ++.+||+.+|.+||++.++++.|
T Consensus       233 li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         233 VMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             HHHHHccCCcccCcCHHHHHHhh
Confidence            99999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=7.9e-42  Score=341.68  Aligned_cols=244  Identities=21%  Similarity=0.287  Sum_probs=203.1

Q ss_pred             CEEEeceeeccCCceEEEe------EEEEEEEeecCCCC-chHHHHHHHHHHHHHhC-CCCceeEEEEEEEeCCCeEEEE
Q 012887          191 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLELMTC-GHKNILQFYCVCVDENHGLCVV  262 (454)
Q Consensus       191 ~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~-~~~~~~~~~Ei~~l~~l-~HpnIv~~~g~~~~~~~~l~lV  262 (454)
                      +|++++.||+|+||.||+|      +.+|+|.+...... .........|..++..+ +|++|+++++++.+.+. +++|
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~-~~lv   79 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDR-LYFV   79 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCE-EEEE
Confidence            5789999999999999986      47999998743221 12223455666666666 58999999999887775 9999


Q ss_pred             EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCccc
Q 012887          263 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE  342 (454)
Q Consensus       263 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~  342 (454)
                      |||+++|+|.+++.+.+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++...........
T Consensus        80 ~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~~~  159 (323)
T cd05616          80 MEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTK  159 (323)
T ss_pred             EcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCccc
Confidence            99999999999998778899999999999999999999999999999999999999999999999999875443333344


Q ss_pred             ccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHHHHHH
Q 012887          343 YETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMI  422 (454)
Q Consensus       343 ~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~li~  422 (454)
                      ...||+.|+|||++.+..+    +.++|||||||++|||++|..||.+.+.......+...  ...+|..++.++.+++.
T Consensus       160 ~~~gt~~y~aPE~~~~~~~----~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~  233 (323)
T cd05616         160 TFCGTPDYIAPEIIAYQPY----GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH--NVAYPKSMSKEAVAICK  233 (323)
T ss_pred             cCCCChhhcCHHHhcCCCC----CCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCCCcCCHHHHHHHH
Confidence            4568999999999987654    44599999999999999999999988877766666543  44577889999999999


Q ss_pred             HhcccCCCCCCCH-----HHHHHH
Q 012887          423 KCWNNSPSKRPQF-----SEIISL  441 (454)
Q Consensus       423 ~cl~~dP~~RPs~-----~ell~~  441 (454)
                      +||+.||.+|++.     .+++++
T Consensus       234 ~~l~~~p~~R~~~~~~~~~~i~~h  257 (323)
T cd05616         234 GLMTKHPGKRLGCGPEGERDIKEH  257 (323)
T ss_pred             HHcccCHHhcCCCCCCCHHHHhcC
Confidence            9999999999984     666654

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=3.3e-41  Score=326.31  Aligned_cols=252  Identities=24%  Similarity=0.462  Sum_probs=210.2

Q ss_pred             eeecCCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCe
Q 012887          185 WLLNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHG  258 (454)
Q Consensus       185 ~~~~~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~  258 (454)
                      |.+...+|.+.+.||+|+||.||+|      +.+++|.+...   ......+.+|+..+..++||||+++++++...+. 
T Consensus         1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-   76 (263)
T cd05052           1 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP-   76 (263)
T ss_pred             CCCchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC---chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCC-
Confidence            4466678999999999999999985      57899987632   2234567889999999999999999999987776 


Q ss_pred             EEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCcccccc
Q 012887          259 LCVVTKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS  336 (454)
Q Consensus       259 l~lV~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~  336 (454)
                      +++||||+++++|.+++...  ..+++..+..++.|++.||.|||++|++||||||+|||+++++.+||+|||++.....
T Consensus        77 ~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~  156 (263)
T cd05052          77 FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG  156 (263)
T ss_pred             cEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCcccccccc
Confidence            89999999999999998653  3689999999999999999999999999999999999999999999999999876543


Q ss_pred             CCCcc-cccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHcCCCCCCCCCcc
Q 012887          337 VGEAT-EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCP  414 (454)
Q Consensus       337 ~~~~~-~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~  414 (454)
                      ..... .....++.|+|||.+.+..+    +.++|||||||++|||++ |..||.+........ ......++..|..+|
T Consensus       157 ~~~~~~~~~~~~~~y~aPE~~~~~~~----~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~  231 (263)
T cd05052         157 DTYTAHAGAKFPIKWTAPESLAYNKF----SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE-LLEKGYRMERPEGCP  231 (263)
T ss_pred             ceeeccCCCCCccccCCHHHhccCCC----CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH-HHHCCCCCCCCCCCC
Confidence            22111 11123567999999876654    445999999999999998 999998866654443 344456777888899


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 012887          415 QILKSLMIKCWNNSPSKRPQFSEIISLLLRT  445 (454)
Q Consensus       415 ~~l~~li~~cl~~dP~~RPs~~ell~~L~~~  445 (454)
                      .++.+++.+||+.||++||++.++++.|+++
T Consensus       232 ~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         232 PKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             HHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence            9999999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.1e-41  Score=328.08  Aligned_cols=252  Identities=27%  Similarity=0.471  Sum_probs=209.6

Q ss_pred             eeecCCCEEEeceeeccCCceEEEe-----------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEE
Q 012887          185 WLLNSDNLEFIDQIGPNSFKGVYKG-----------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCV  253 (454)
Q Consensus       185 ~~~~~~~~~~~~~LG~G~fG~Vy~g-----------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~  253 (454)
                      |.+..++|++.+.||+|+||.||+|           ..+|+|.+.... .......+.+|+.++..++||||+++++++.
T Consensus         1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~   79 (277)
T cd05032           1 WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVS   79 (277)
T ss_pred             CccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEc
Confidence            4567789999999999999999985           358888875332 2233456778999999999999999999998


Q ss_pred             eCCCeEEEEEeccCCCCHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcE
Q 012887          254 DENHGLCVVTKLMEGGSVNDLILKS----------RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV  323 (454)
Q Consensus       254 ~~~~~l~lV~E~~~~gsL~~~l~~~----------~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~v  323 (454)
                      ..+. .++||||+++|+|.+++...          ..+++..+..++.||+.||.|||+++++||||||+|||++.++.+
T Consensus        80 ~~~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~  158 (277)
T cd05032          80 TGQP-TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTV  158 (277)
T ss_pred             CCCC-cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCE
Confidence            8776 89999999999999998542          236788999999999999999999999999999999999999999


Q ss_pred             EEEccCCccccccCCC--cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHH
Q 012887          324 CLGDMGIVTACKSVGE--ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGI  400 (454)
Q Consensus       324 KL~DFGla~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~i  400 (454)
                      ||+|||+++.......  ......++..|+|||.+.+...    +.++|||||||++||+++ |..||...+.......+
T Consensus       159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~----~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~  234 (277)
T cd05032         159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVF----TTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFV  234 (277)
T ss_pred             EECCcccchhhccCcccccCCCCCccccccCHHHHhcCCC----CcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHH
Confidence            9999999876543221  1222345678999999876543    445999999999999998 99999887776655544


Q ss_pred             HHcCCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 012887          401 AACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLL  443 (454)
Q Consensus       401 ~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~  443 (454)
                      . .+..+..|..++.++.+++.+||+.+|++|||+.++++.|+
T Consensus       235 ~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         235 I-DGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             h-cCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence            4 55566788889999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.3e-42  Score=346.33  Aligned_cols=239  Identities=20%  Similarity=0.317  Sum_probs=202.3

Q ss_pred             ceeeccCCceEEEe---------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEEecc
Q 012887          196 DQIGPNSFKGVYKG---------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLM  266 (454)
Q Consensus       196 ~~LG~G~fG~Vy~g---------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~E~~  266 (454)
                      +.||+|+||.||++         +.+|+|.++...........+..|+.++.+++||||+++++++.+++. +|+||||+
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~lv~e~~   80 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGK-LYLILDFL   80 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCE-EEEEEcCC
Confidence            57999999999964         568999987533333334456789999999999999999999988776 99999999


Q ss_pred             CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCcccccCC
Q 012887          267 EGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETD  346 (454)
Q Consensus       267 ~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~g  346 (454)
                      ++|+|.+++.+...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..............|
T Consensus        81 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g  160 (318)
T cd05582          81 RGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCG  160 (318)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceecccC
Confidence            99999999987778999999999999999999999999999999999999999999999999998765443333444568


Q ss_pred             CCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhcc
Q 012887          347 GYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWN  426 (454)
Q Consensus       347 t~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~li~~cl~  426 (454)
                      ++.|+|||.+.+..+    +.++|||||||++|||++|..||...+.......+...  ...+|..+++++.++|++||+
T Consensus       161 ~~~y~aPE~~~~~~~----~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~--~~~~p~~~~~~~~~li~~~l~  234 (318)
T cd05582         161 TVEYMAPEVVNRRGH----TQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKA--KLGMPQFLSPEAQSLLRALFK  234 (318)
T ss_pred             ChhhcCHHHHcCCCC----CCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHHHHHHHHHHhh
Confidence            999999999987644    44699999999999999999999988777666665543  345778899999999999999


Q ss_pred             cCCCCCCC-----HHHHHHH
Q 012887          427 NSPSKRPQ-----FSEIISL  441 (454)
Q Consensus       427 ~dP~~RPs-----~~ell~~  441 (454)
                      .||.+||+     ..+++.+
T Consensus       235 ~~P~~R~~a~~~~~~~~~~~  254 (318)
T cd05582         235 RNPANRLGAGPDGVEEIKRH  254 (318)
T ss_pred             cCHhHcCCCCCCCHHHHhCC
Confidence            99999999     5556654

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=2.6e-42  Score=345.49  Aligned_cols=241  Identities=18%  Similarity=0.268  Sum_probs=202.3

Q ss_pred             ceeeccCCceEEEe------EEEEEEEeecCCCC-chHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEEeccCC
Q 012887          196 DQIGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEG  268 (454)
Q Consensus       196 ~~LG~G~fG~Vy~g------~~vavK~l~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~E~~~~  268 (454)
                      +.||+|+||.||++      +.+|+|.++..... ......+..|+.++..++||||+++++++.+.+. +|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~-~~lv~E~~~~   79 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDR-LCFVMEYANG   79 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCE-EEEEEeCCCC
Confidence            46999999999975      57999998743221 2233456788888999999999999999987776 9999999999


Q ss_pred             CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-cCcccCCccCCcEEEccCCcEEEEccCCccccccCCCcccccCCC
Q 012887          269 GSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLND-HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG  347 (454)
Q Consensus       269 gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~-~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~gt  347 (454)
                      |+|.+++.+.+.+++..+..++.||+.||.|||+ +||+||||||+|||++.++.+||+|||++..............|+
T Consensus        80 ~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt  159 (325)
T cd05594          80 GELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGT  159 (325)
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccccCC
Confidence            9999999877889999999999999999999997 799999999999999999999999999987543333333445689


Q ss_pred             CcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhccc
Q 012887          348 YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNN  427 (454)
Q Consensus       348 ~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~li~~cl~~  427 (454)
                      +.|+|||++.+..++    .++|||||||++|+|++|..||.+.+.......+...  ...+|..+++++.+++.+||+.
T Consensus       160 ~~y~aPE~~~~~~~~----~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~~~~~~~li~~~L~~  233 (325)
T cd05594         160 PEYLAPEVLEDNDYG----RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME--EIRFPRTLSPEAKSLLSGLLKK  233 (325)
T ss_pred             cccCCHHHHccCCCC----CccccccccceeeeeccCCCCCCCCCHHHHHHHHhcC--CCCCCCCCCHHHHHHHHHHhhc
Confidence            999999999876544    4599999999999999999999887776655554433  4457888999999999999999


Q ss_pred             CCCCCC-----CHHHHHHHHH
Q 012887          428 SPSKRP-----QFSEIISLLL  443 (454)
Q Consensus       428 dP~~RP-----s~~ell~~L~  443 (454)
                      ||.+|+     ++.++++|-+
T Consensus       234 dP~~R~~~~~~~~~~il~h~~  254 (325)
T cd05594         234 DPKQRLGGGPDDAKEIMQHKF  254 (325)
T ss_pred             CHHHhCCCCCCCHHHHhcCCC
Confidence            999996     8999998743

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=5.7e-41  Score=327.39  Aligned_cols=255  Identities=22%  Similarity=0.441  Sum_probs=211.6

Q ss_pred             ecCCCEEEeceeeccCCceEEEeE----------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCC
Q 012887          187 LNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN  256 (454)
Q Consensus       187 ~~~~~~~~~~~LG~G~fG~Vy~g~----------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~  256 (454)
                      +..++|++++.||+|+||.||+|+          .||+|.++.. ........+.+|+.++..++||||+++++++....
T Consensus         4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   82 (279)
T cd05109           4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLREN-TSPKANKEILDEAYVMAGVGSPYVCRLLGICLTST   82 (279)
T ss_pred             cchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCC-CCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCCC
Confidence            556889999999999999999974          3789988743 23334566888999999999999999999997543


Q ss_pred             CeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccc
Q 012887          257 HGLCVVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK  335 (454)
Q Consensus       257 ~~l~lV~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~  335 (454)
                        .+++|||+++|+|.+++... ..+++..+..++.||+.||.|||+++++||||||+|||++.++.+||+|||+++...
T Consensus        83 --~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~  160 (279)
T cd05109          83 --VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLD  160 (279)
T ss_pred             --cEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecc
Confidence              67999999999999999664 479999999999999999999999999999999999999999999999999987664


Q ss_pred             cCCCc--ccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHcCCCCCCCCC
Q 012887          336 SVGEA--TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKD  412 (454)
Q Consensus       336 ~~~~~--~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~  412 (454)
                      .....  .....+++.|+|||.+.+..    ++.++|||||||++|||++ |..||......... .....+..++.+..
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~----~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~  235 (279)
T cd05109         161 IDETEYHADGGKVPIKWMALESILHRR----FTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIP-DLLEKGERLPQPPI  235 (279)
T ss_pred             cccceeecCCCccchhhCCHHHhccCC----CCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH-HHHHCCCcCCCCcc
Confidence            32221  11223456799999997664    4556999999999999998 99999876655443 34445556666778


Q ss_pred             ccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCCC
Q 012887          413 CPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNIS  449 (454)
Q Consensus       413 ~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~  449 (454)
                      ++.++.+++.+||+.||++||++.++++.|.++....
T Consensus       236 ~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~  272 (279)
T cd05109         236 CTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP  272 (279)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence            9999999999999999999999999999998887654

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4e-42  Score=351.20  Aligned_cols=248  Identities=17%  Similarity=0.237  Sum_probs=203.9

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCC-CchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDK-GNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  262 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV  262 (454)
                      ++|++++.||+|+||.||++      +.+|+|.+..... .......+.+|+.++..++||||+++++++.+.+. +|+|
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~-~~lv   79 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQY-LYLI   79 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCe-eEEE
Confidence            47899999999999999985      5799999864322 12233457789999999999999999999998776 9999


Q ss_pred             EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCC---
Q 012887          263 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE---  339 (454)
Q Consensus       263 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~---  339 (454)
                      |||+++|+|.+++.+.+.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.......   
T Consensus        80 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  159 (377)
T cd05629          80 MEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAY  159 (377)
T ss_pred             EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccccccccccccc
Confidence            99999999999998878899999999999999999999999999999999999999999999999999863221000   


Q ss_pred             --------------------------------------------cccccCCCCcccccccccCCCCCCCCCchhhHHHHH
Q 012887          340 --------------------------------------------ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFG  375 (454)
Q Consensus       340 --------------------------------------------~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlG  375 (454)
                                                                  ......||+.|+|||++.+..+    +.++||||||
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~----~~~~DiwSlG  235 (377)
T cd05629         160 YQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGY----GQECDWWSLG  235 (377)
T ss_pred             ccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCC----CCceeeEecc
Confidence                                                        0001358899999999987654    4459999999


Q ss_pred             HHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCC--CccHHHHHHHHHhcccCCCCC---CCHHHHHHHHH
Q 012887          376 MVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPK--DCPQILKSLMIKCWNNSPSKR---PQFSEIISLLL  443 (454)
Q Consensus       376 viL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~--~~~~~l~~li~~cl~~dP~~R---Ps~~ell~~L~  443 (454)
                      |++|||++|..||.+.++......+........+|.  .++.++.++|.+|+. +|.+|   +++.+++.+-+
T Consensus       236 vil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~  307 (377)
T cd05629         236 AIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPF  307 (377)
T ss_pred             hhhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCC
Confidence            999999999999998877766666655444445554  478999999999997 66665   59999998854

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=6.8e-42  Score=342.03  Aligned_cols=241  Identities=22%  Similarity=0.289  Sum_probs=200.5

Q ss_pred             ceeeccCCceEEEe------EEEEEEEeecCCC-CchHHHHHHHHHHHHHhC-CCCceeEEEEEEEeCCCeEEEEEeccC
Q 012887          196 DQIGPNSFKGVYKG------KRVGIEKLKGCDK-GNAYEFELRKDLLELMTC-GHKNILQFYCVCVDENHGLCVVTKLME  267 (454)
Q Consensus       196 ~~LG~G~fG~Vy~g------~~vavK~l~~~~~-~~~~~~~~~~Ei~~l~~l-~HpnIv~~~g~~~~~~~~l~lV~E~~~  267 (454)
                      +.||+|+||.||++      +.+|+|.++.... .......+..|+.++..+ +||||+++++++.+.+. +|+||||++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~-~~iv~Ey~~   79 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDR-LFFVMEFVN   79 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCE-EEEEEcCCC
Confidence            36899999999985      4699999874321 122233456777777765 69999999999987776 999999999


Q ss_pred             CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCcccccCCC
Q 012887          268 GGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG  347 (454)
Q Consensus       268 ~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~gt  347 (454)
                      +|+|.+++.+.+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..............|+
T Consensus        80 ~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt  159 (320)
T cd05590          80 GGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGT  159 (320)
T ss_pred             CchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccccccC
Confidence            99999999888899999999999999999999999999999999999999999999999999987543333334455789


Q ss_pred             CcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhccc
Q 012887          348 YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNN  427 (454)
Q Consensus       348 ~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~li~~cl~~  427 (454)
                      +.|+|||++.+..++    .++|||||||++|+|++|..||...+.......+...  ...+|..++.++.+++++||+.
T Consensus       160 ~~y~aPE~~~~~~~~----~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~li~~~L~~  233 (320)
T cd05590         160 PDYIAPEILQEMLYG----PSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND--EVVYPTWLSQDAVDILKAFMTK  233 (320)
T ss_pred             ccccCHHHHcCCCCC----CccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcC--CCCCCCCCCHHHHHHHHHHccc
Confidence            999999999876544    4599999999999999999999988877766665543  4456778899999999999999


Q ss_pred             CCCCCCCH------HHHHHHHH
Q 012887          428 SPSKRPQF------SEIISLLL  443 (454)
Q Consensus       428 dP~~RPs~------~ell~~L~  443 (454)
                      ||.+||++      ++++.|-+
T Consensus       234 dP~~R~~~~~~~~~~~~~~h~~  255 (320)
T cd05590         234 NPTMRLGSLTLGGEEAILRHPF  255 (320)
T ss_pred             CHHHCCCCCCCCCHHHHHcCCC
Confidence            99999998      77776643

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-41  Score=324.68  Aligned_cols=249  Identities=23%  Similarity=0.389  Sum_probs=212.1

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCc---hHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGN---AYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLC  260 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~---~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~  260 (454)
                      ++|++.+.||+|+||.||++      +.+|+|.+.......   .....+.+|+.++.+++||||+++++++.+.+. ++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-~~   80 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDET-LS   80 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCe-EE
Confidence            56888999999999999985      578999886433221   123457889999999999999999999988775 99


Q ss_pred             EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCc
Q 012887          261 VVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA  340 (454)
Q Consensus       261 lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~  340 (454)
                      +||||+++++|.+++.+.+.+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++.........
T Consensus        81 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~  160 (263)
T cd06625          81 IFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSS  160 (263)
T ss_pred             EEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccccccc
Confidence            99999999999999987788999999999999999999999999999999999999999999999999998755432211


Q ss_pred             c---cccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHH
Q 012887          341 T---EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQIL  417 (454)
Q Consensus       341 ~---~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l  417 (454)
                      .   ....++..|+|||.+.+..    .+.++||||||+++|+|++|+.||....................+|..++..+
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~----~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (263)
T cd06625         161 GTGMKSVTGTPYWMSPEVISGEG----YGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDA  236 (263)
T ss_pred             cccccCCCcCccccCcceeccCC----CCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHH
Confidence            1   2335677899999998764    44569999999999999999999988777766666666666777888899999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHHHHH
Q 012887          418 KSLMIKCWNNSPSKRPQFSEIISLLL  443 (454)
Q Consensus       418 ~~li~~cl~~dP~~RPs~~ell~~L~  443 (454)
                      .++|.+||..+|.+||++.+++.+.+
T Consensus       237 ~~li~~~l~~~p~~Rpt~~~ll~~~~  262 (263)
T cd06625         237 RNFLRRTFVENAKKRPSAEELLRHFF  262 (263)
T ss_pred             HHHHHHHhhcCcccCCCHHHHhhCCC
Confidence            99999999999999999999998753

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=6.8e-42  Score=349.20  Aligned_cols=260  Identities=18%  Similarity=0.277  Sum_probs=213.9

Q ss_pred             cceeecCCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCC-chHHHHHHHHHHHHHhCCCCceeEEEEEEEeC
Q 012887          183 GRWLLNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLELMTCGHKNILQFYCVCVDE  255 (454)
Q Consensus       183 ~~~~~~~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~  255 (454)
                      .+..+..++|++.+.||+|+||.||++      +.+|+|.+...... ......+.+|+.++..++||||+++++++.++
T Consensus        36 ~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~  115 (370)
T cd05621          36 RKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDD  115 (370)
T ss_pred             HhcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC
Confidence            344566789999999999999999985      47899998643222 22334467888999999999999999999877


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccc
Q 012887          256 NHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK  335 (454)
Q Consensus       256 ~~~l~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~  335 (454)
                      +. +|+||||+++|+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus       116 ~~-~~lv~Ey~~gg~L~~~l~~-~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~  193 (370)
T cd05621         116 KY-LYMVMEYMPGGDLVNLMSN-YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMD  193 (370)
T ss_pred             CE-EEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecc
Confidence            76 9999999999999999854 468999999999999999999999999999999999999999999999999987654


Q ss_pred             cCCC-cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCC--C
Q 012887          336 SVGE-ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPK--D  412 (454)
Q Consensus       336 ~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~--~  412 (454)
                      .... ......||+.|+|||++.+......++.++|||||||++|+|++|..||.+.+.......+........+|.  .
T Consensus       194 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~  273 (370)
T cd05621         194 ETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVE  273 (370)
T ss_pred             cCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCccc
Confidence            3322 123446899999999998654433456679999999999999999999998888777777776555555665  4


Q ss_pred             ccHHHHHHHHHhcccCCCC--CCCHHHHHHHHHh
Q 012887          413 CPQILKSLMIKCWNNSPSK--RPQFSEIISLLLR  444 (454)
Q Consensus       413 ~~~~l~~li~~cl~~dP~~--RPs~~ell~~L~~  444 (454)
                      ++..+.+++.+||..++.+  |+++.|+++|-+-
T Consensus       274 ~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~  307 (370)
T cd05621         274 ISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFF  307 (370)
T ss_pred             CCHHHHHHHHHHccCchhccCCCCHHHHhcCccc
Confidence            6899999999999865544  8999999998654

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=2.5e-41  Score=329.26  Aligned_cols=249  Identities=26%  Similarity=0.483  Sum_probs=207.2

Q ss_pred             cCCCEEEeceeeccCCceEEEeE-----------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCC
Q 012887          188 NSDNLEFIDQIGPNSFKGVYKGK-----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN  256 (454)
Q Consensus       188 ~~~~~~~~~~LG~G~fG~Vy~g~-----------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~  256 (454)
                      ..++|.+.+.||+|+||.||+|.           .+|+|.++... .......+.+|+.++..++||||+++++++...+
T Consensus         3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   81 (280)
T cd05049           3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA-SNDARKDFEREAELLTNFQHENIVKFYGVCTEGD   81 (280)
T ss_pred             ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC-CHHHHHHHHHHHHHHHhcCCCCchheeeEEecCC
Confidence            34678999999999999999863           58899886432 2224567889999999999999999999998887


Q ss_pred             CeEEEEEeccCCCCHHHHHHhC--------------CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCc
Q 012887          257 HGLCVVTKLMEGGSVNDLILKS--------------RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGN  322 (454)
Q Consensus       257 ~~l~lV~E~~~~gsL~~~l~~~--------------~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~  322 (454)
                      . .++||||+++++|.+++...              ..+++..+..++.||+.||.|||++|++||||||+||+++.++.
T Consensus        82 ~-~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~  160 (280)
T cd05049          82 P-PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLV  160 (280)
T ss_pred             C-eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCe
Confidence            6 99999999999999998643              24788999999999999999999999999999999999999999


Q ss_pred             EEEEccCCccccccCCC--cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHH
Q 012887          323 VCLGDMGIVTACKSVGE--ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVG  399 (454)
Q Consensus       323 vKL~DFGla~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~  399 (454)
                      +||+|||++........  ......+++.|+|||++.+..+    +.++|||||||++|||++ |..||...........
T Consensus       161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~----~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~  236 (280)
T cd05049         161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKF----TTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIEC  236 (280)
T ss_pred             EEECCcccceecccCcceecCCCCcccceecChhhhccCCc----chhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence            99999999865432211  1222344678999999987654    445999999999999998 9999988776665554


Q ss_pred             HHHcCCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 012887          400 IAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLL  443 (454)
Q Consensus       400 i~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~  443 (454)
                      +. .+.....+..++..+.+++.+||+.||++||++.|+++.|.
T Consensus       237 ~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         237 IT-QGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             HH-cCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence            44 44455567789999999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.2e-41  Score=323.72  Aligned_cols=251  Identities=25%  Similarity=0.483  Sum_probs=209.8

Q ss_pred             eeecCCCEEEeceeeccCCceEEEe-----EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeE
Q 012887          185 WLLNSDNLEFIDQIGPNSFKGVYKG-----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGL  259 (454)
Q Consensus       185 ~~~~~~~~~~~~~LG~G~fG~Vy~g-----~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l  259 (454)
                      |.+..++|++.+.||+|+||.||+|     +.+|+|.++...   .....+.+|+..+.+++||||+++++++...+. .
T Consensus         1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~   76 (261)
T cd05068           1 WEIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT---MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEP-I   76 (261)
T ss_pred             CccchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc---ccHHHHHHHHHHHHHCCCCCccceeEEEecCCC-e
Confidence            4566788999999999999999986     468999886432   224557889999999999999999999887776 8


Q ss_pred             EEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccC
Q 012887          260 CVVTKLMEGGSVNDLILKSR--KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV  337 (454)
Q Consensus       260 ~lV~E~~~~gsL~~~l~~~~--~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~  337 (454)
                      ++||||+++++|.+++....  .+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus        77 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~  156 (261)
T cd05068          77 YIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKED  156 (261)
T ss_pred             eeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCC
Confidence            99999999999999996543  7899999999999999999999999999999999999999999999999998766532


Q ss_pred             CCcc-cccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHcCCCCCCCCCccH
Q 012887          338 GEAT-EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ  415 (454)
Q Consensus       338 ~~~~-~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~  415 (454)
                      .... .....+..|+|||.+.+..    ++.++||||||+++|||++ |+.||.+.+.......+. ...+.+.+..++.
T Consensus       157 ~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~  231 (261)
T cd05068         157 IYEAREGAKFPIKWTAPEAALYNR----FSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVD-QGYRMPCPPGCPK  231 (261)
T ss_pred             cccccCCCcCceeccCccccccCC----CCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-cCCCCCCCCcCCH
Confidence            2111 1112235799999987654    4456999999999999999 999998877766555443 3455566778899


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 012887          416 ILKSLMIKCWNNSPSKRPQFSEIISLLLR  444 (454)
Q Consensus       416 ~l~~li~~cl~~dP~~RPs~~ell~~L~~  444 (454)
                      .+.+++.+||+.+|.+||++.++...|+.
T Consensus       232 ~~~~li~~~l~~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         232 ELYDIMLDCWKEDPDDRPTFETLQWKLED  260 (261)
T ss_pred             HHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence            99999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=1.5e-41  Score=328.90  Aligned_cols=250  Identities=18%  Similarity=0.370  Sum_probs=204.4

Q ss_pred             CCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEE
Q 012887          189 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  262 (454)
Q Consensus       189 ~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV  262 (454)
                      .++|++++.||+|+||.||+|      +.+|+|++.....  .....+.+|+..+..++||||+++++++...+. +++|
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~--~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~-~~iv   84 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG--DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREK-LWIC   84 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc--chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCE-EEEE
Confidence            368999999999999999986      4589998864322  223457789999999999999999999987775 8999


Q ss_pred             EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCccc
Q 012887          263 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE  342 (454)
Q Consensus       263 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~  342 (454)
                      |||+++++|.+++.+...+++..+..++.|++.||.|||+++|+||||+|+||+++.++.+||+|||++...........
T Consensus        85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~  164 (267)
T cd06646          85 MEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRK  164 (267)
T ss_pred             EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccccccC
Confidence            99999999999997777899999999999999999999999999999999999999999999999999876543322233


Q ss_pred             ccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCC---CCCccHHHHH
Q 012887          343 YETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEI---PKDCPQILKS  419 (454)
Q Consensus       343 ~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~---p~~~~~~l~~  419 (454)
                      ...+++.|+|||.+.+... ..++.++|||||||++|||++|..||....+......+......++.   +..++..+.+
T Consensus       165 ~~~~~~~y~~PE~~~~~~~-~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (267)
T cd06646         165 SFIGTPYWMAPEVAAVEKN-GGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHN  243 (267)
T ss_pred             ccccCccccCHhHcccccC-CCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHHHH
Confidence            4467888999999864321 23556799999999999999999999766554443333333222222   2356889999


Q ss_pred             HHHHhcccCCCCCCCHHHHHHHH
Q 012887          420 LMIKCWNNSPSKRPQFSEIISLL  442 (454)
Q Consensus       420 li~~cl~~dP~~RPs~~ell~~L  442 (454)
                      +|++||..+|++||++++++++|
T Consensus       244 li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         244 FVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             HHHHHhhCChhhCcCHHHHhcCC
Confidence            99999999999999999999876

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=4.5e-41  Score=325.21  Aligned_cols=252  Identities=19%  Similarity=0.373  Sum_probs=206.4

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCC-CchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDK-GNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  262 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV  262 (454)
                      ++|++.+.||+|+||.||+|      +.+|+|.+..... .......+.+|+.+++.++||||+++++++.+.+. .++|
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~~v   80 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNE-LNIV   80 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCe-EEEE
Confidence            57899999999999999986      5789998864332 23344567889999999999999999999988776 8999


Q ss_pred             EeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCC
Q 012887          263 TKLMEGGSVNDLILK----SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG  338 (454)
Q Consensus       263 ~E~~~~gsL~~~l~~----~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~  338 (454)
                      |||+++++|.+++..    ...+++..+..++.||+.||.|||+++++|+||||+|||++.++.++|+|||++.......
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~  160 (267)
T cd08228          81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT  160 (267)
T ss_pred             EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchh
Confidence            999999999988742    3458999999999999999999999999999999999999999999999999987665433


Q ss_pred             CcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCH--HHHHHHHHHcCCCCCCCCCccHH
Q 012887          339 EATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSP--VQAAVGIAACGLRPEIPKDCPQI  416 (454)
Q Consensus       339 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~--~~~~~~i~~~~~~~~~p~~~~~~  416 (454)
                      .......+++.|+|||.+.+..    .+.++|+||||+++|+|++|..||.....  ......+.....++..+..++..
T Consensus       161 ~~~~~~~~~~~~~aPE~~~~~~----~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (267)
T cd08228         161 TAAHSLVGTPYYMSPERIHENG----YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEK  236 (267)
T ss_pred             HHHhcCCCCccccChhhhccCC----CCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHH
Confidence            3333446788899999997654    34469999999999999999999975432  23333333333333334567899


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 012887          417 LKSLMIKCWNNSPSKRPQFSEIISLLLRTN  446 (454)
Q Consensus       417 l~~li~~cl~~dP~~RPs~~ell~~L~~~~  446 (454)
                      +.++|.+||..+|++||++.++++.++++.
T Consensus       237 ~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~  266 (267)
T cd08228         237 LRELVSMCIYPDPDQRPDIGYVHQIAKQMH  266 (267)
T ss_pred             HHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence            999999999999999999999999998753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=4.7e-41  Score=332.48  Aligned_cols=262  Identities=23%  Similarity=0.457  Sum_probs=216.0

Q ss_pred             cceeecCCCEEEeceeeccCCceEEEeE-------------EEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEE
Q 012887          183 GRWLLNSDNLEFIDQIGPNSFKGVYKGK-------------RVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQF  248 (454)
Q Consensus       183 ~~~~~~~~~~~~~~~LG~G~fG~Vy~g~-------------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~~  248 (454)
                      .+|.+..++|.+.+.||+|+||.||+++             .+|+|.+... ........+.+|+..+..+ +||||+++
T Consensus         8 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~i~~~   86 (304)
T cd05101           8 PRWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINL   86 (304)
T ss_pred             CcccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccc-cchHHHHHHHHHHHHHHhhccCCCchhe
Confidence            4567788999999999999999999874             4788877632 2233445688999999998 79999999


Q ss_pred             EEEEEeCCCeEEEEEeccCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccC
Q 012887          249 YCVCVDENHGLCVVTKLMEGGSVNDLILKS----------------RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNS  312 (454)
Q Consensus       249 ~g~~~~~~~~l~lV~E~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp  312 (454)
                      ++++...+. .++||||+++|+|.+++.+.                ..++...+..++.||+.||.|||++|++||||||
T Consensus        87 ~~~~~~~~~-~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp  165 (304)
T cd05101          87 LGACTQDGP-LYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAA  165 (304)
T ss_pred             eEEEecCCc-eEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeeccccc
Confidence            999987775 89999999999999998653                2467788999999999999999999999999999


Q ss_pred             CcEEEccCCcEEEEccCCccccccCCCc--ccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCC
Q 012887          313 QRILLDRHGNVCLGDMGIVTACKSVGEA--TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYA  389 (454)
Q Consensus       313 ~NILl~~~~~vKL~DFGla~~~~~~~~~--~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~  389 (454)
                      +|||++.++.+||+|||+++........  .....+++.|+|||++.+..    ++.++||||||+++|+|++ |..||.
T Consensus       166 ~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~Di~slG~~l~el~~~g~~p~~  241 (304)
T cd05101         166 RNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRV----YTHQSDVWSFGVLMWEIFTLGGSPYP  241 (304)
T ss_pred             ceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCC----CCchhhHHHHHHHHHHHHcCCCCCcc
Confidence            9999999999999999998766443221  22223457899999997654    4456999999999999998 889998


Q ss_pred             CCCHHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCCCCC
Q 012887          390 ACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNS  451 (454)
Q Consensus       390 ~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~~  451 (454)
                      +.+..+.... ...+.+...+..++.++.+++.+||..+|.+||++.|+++.|.++.....+
T Consensus       242 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~~~  302 (304)
T cd05101         242 GIPVEELFKL-LKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTTN  302 (304)
T ss_pred             cCCHHHHHHH-HHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhhhc
Confidence            7766554444 444556667788999999999999999999999999999999998776443

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=5.8e-41  Score=328.04  Aligned_cols=254  Identities=25%  Similarity=0.444  Sum_probs=207.8

Q ss_pred             ecCCCEEEeceeeccCCceEEEeEE----------EEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCC
Q 012887          187 LNSDNLEFIDQIGPNSFKGVYKGKR----------VGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN  256 (454)
Q Consensus       187 ~~~~~~~~~~~LG~G~fG~Vy~g~~----------vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~  256 (454)
                      +..++|++++.||+|+||.||+|..          +++|.+... .......++..|+..+..++||||+++++++... 
T Consensus         4 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~~-   81 (279)
T cd05111           4 LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR-SGRQTFQEITDHMLAMGSLDHAYIVRLLGICPGA-   81 (279)
T ss_pred             CCHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc-cchHHHHHHHHHHHHHhcCCCCCcceEEEEECCC-
Confidence            4557899999999999999999753          677776532 2223335577888888999999999999987533 


Q ss_pred             CeEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccc
Q 012887          257 HGLCVVTKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK  335 (454)
Q Consensus       257 ~~l~lV~E~~~~gsL~~~l~~-~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~  335 (454)
                      . .++++||+++|+|.+++.. .+.+++..+..++.||+.||.|||+++++||||||+|||++.++.+||+|||+++...
T Consensus        82 ~-~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~  160 (279)
T cd05111          82 S-LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLY  160 (279)
T ss_pred             c-cEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceecc
Confidence            3 7899999999999999965 4579999999999999999999999999999999999999999999999999987654


Q ss_pred             cCCC--cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHcCCCCCCCCC
Q 012887          336 SVGE--ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKD  412 (454)
Q Consensus       336 ~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~  412 (454)
                      ....  ......++..|+|||.+.+..+    +.++|||||||++|||++ |..||.+..+... ..+...+.++..+..
T Consensus       161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~----~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~  235 (279)
T cd05111         161 PDDKKYFYSEHKTPIKWMALESILFGRY----THQSDVWSYGVTVWEMMSYGAEPYAGMRPHEV-PDLLEKGERLAQPQI  235 (279)
T ss_pred             CCCcccccCCCCCcccccCHHHhccCCc----CchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH-HHHHHCCCcCCCCCC
Confidence            3221  1222345678999999986654    456999999999999998 9999988765543 444555666667778


Q ss_pred             ccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCC
Q 012887          413 CPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNI  448 (454)
Q Consensus       413 ~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~  448 (454)
                      ++.++..++.+||..||++||++.|+++.|..+.+.
T Consensus       236 ~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~  271 (279)
T cd05111         236 CTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD  271 (279)
T ss_pred             CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence            899999999999999999999999999999886553

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=5.2e-41  Score=329.69  Aligned_cols=255  Identities=27%  Similarity=0.476  Sum_probs=211.3

Q ss_pred             ecCCCEEEeceeeccCCceEEEeE-----------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeC
Q 012887          187 LNSDNLEFIDQIGPNSFKGVYKGK-----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDE  255 (454)
Q Consensus       187 ~~~~~~~~~~~LG~G~fG~Vy~g~-----------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~  255 (454)
                      |+.++|.+.+.||+|+||.||++.           .+|+|.+...  .......+.+|+.++.+++||||+++++++...
T Consensus         2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   79 (288)
T cd05093           2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEG   79 (288)
T ss_pred             CchHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence            345789999999999999999864           3778877532  233445688999999999999999999999887


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhCC-------------CCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCc
Q 012887          256 NHGLCVVTKLMEGGSVNDLILKSR-------------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGN  322 (454)
Q Consensus       256 ~~~l~lV~E~~~~gsL~~~l~~~~-------------~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~  322 (454)
                      +. +++||||+++++|.+++...+             .+++..+..++.|++.||+|||++|++||||||+|||++.++.
T Consensus        80 ~~-~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~  158 (288)
T cd05093          80 DP-LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL  158 (288)
T ss_pred             Cc-cEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCc
Confidence            76 999999999999999986432             4899999999999999999999999999999999999999999


Q ss_pred             EEEEccCCccccccCCC--cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHH
Q 012887          323 VCLGDMGIVTACKSVGE--ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVG  399 (454)
Q Consensus       323 vKL~DFGla~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~  399 (454)
                      +||+|||++........  ......+++.|+|||.+.+..    ++.++|||||||++|+|++ |..||...........
T Consensus       159 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~  234 (288)
T cd05093         159 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK----FTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIEC  234 (288)
T ss_pred             EEeccCCccccccCCceeecCCCCCccccccCHHHhccCC----CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            99999999875533211  112223467899999997654    4446999999999999998 9999988777665555


Q ss_pred             HHHcCCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCCC
Q 012887          400 IAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNIS  449 (454)
Q Consensus       400 i~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~  449 (454)
                      +.. +.....+..++.++.+++.+||+.||.+|||+.++.+.|+.+...+
T Consensus       235 i~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~~  283 (288)
T cd05093         235 ITQ-GRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKAS  283 (288)
T ss_pred             HHc-CCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHhc
Confidence            543 4445567778999999999999999999999999999999887654

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=1e-41  Score=340.24  Aligned_cols=239  Identities=22%  Similarity=0.338  Sum_probs=197.1

Q ss_pred             ceeeccCCceEEEe------EEEEEEEeecCCCC-chHHHHHHHHHHHHHh-CCCCceeEEEEEEEeCCCeEEEEEeccC
Q 012887          196 DQIGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLELMT-CGHKNILQFYCVCVDENHGLCVVTKLME  267 (454)
Q Consensus       196 ~~LG~G~fG~Vy~g------~~vavK~l~~~~~~-~~~~~~~~~Ei~~l~~-l~HpnIv~~~g~~~~~~~~l~lV~E~~~  267 (454)
                      +.||+|+||.||+|      +.||+|.++..... .........|..++.. .+||||+++++++...+. +++||||++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~-~~lv~e~~~   79 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEH-LFFVMEYLN   79 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCE-EEEEEcCCC
Confidence            36999999999986      36999998743211 1122334455555554 489999999999987775 999999999


Q ss_pred             CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCcccccCCC
Q 012887          268 GGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG  347 (454)
Q Consensus       268 ~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~gt  347 (454)
                      +|+|.+++.....+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||++..............||
T Consensus        80 gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt  159 (316)
T cd05592          80 GGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGT  159 (316)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccccccCC
Confidence            99999999877889999999999999999999999999999999999999999999999999987654333334455789


Q ss_pred             CcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhccc
Q 012887          348 YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNN  427 (454)
Q Consensus       348 ~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~li~~cl~~  427 (454)
                      +.|+|||++.+..+    +.++|||||||++|||++|..||.+.+..+....+..  ..+.+|..++.++.+++.+||+.
T Consensus       160 ~~y~aPE~~~~~~~----~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~~~ll~~~l~~  233 (316)
T cd05592         160 PDYIAPEILKGQKY----NESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILN--DRPHFPRWISKEAKDCLSKLFER  233 (316)
T ss_pred             ccccCHHHHcCCCC----CCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHc--CCCCCCCCCCHHHHHHHHHHccC
Confidence            99999999987654    4459999999999999999999998877666555543  45667888999999999999999


Q ss_pred             CCCCCCCHH-HHHHH
Q 012887          428 SPSKRPQFS-EIISL  441 (454)
Q Consensus       428 dP~~RPs~~-ell~~  441 (454)
                      ||.+||++. +++++
T Consensus       234 ~P~~R~~~~~~l~~h  248 (316)
T cd05592         234 DPTKRLGVDGDIRQH  248 (316)
T ss_pred             CHHHcCCChHHHHcC
Confidence            999999865 66554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.1e-41  Score=339.17  Aligned_cols=250  Identities=17%  Similarity=0.209  Sum_probs=197.9

Q ss_pred             CEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCC----CeEE
Q 012887          191 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN----HGLC  260 (454)
Q Consensus       191 ~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~----~~l~  260 (454)
                      +|++.+.||+|+||.||+|      +.||+|++............+.+|+.++..++||||+++++++...+    ..+|
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            4789999999999999986      57999998754333334456789999999999999999999986543    2389


Q ss_pred             EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCC-
Q 012887          261 VVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE-  339 (454)
Q Consensus       261 lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~-  339 (454)
                      +||||+. ++|.+++.+...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... 
T Consensus        81 lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~  159 (338)
T cd07859          81 VVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT  159 (338)
T ss_pred             EEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccCc
Confidence            9999995 59999998777899999999999999999999999999999999999999999999999999875432221 


Q ss_pred             --cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH---------------
Q 012887          340 --ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAA---------------  402 (454)
Q Consensus       340 --~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~---------------  402 (454)
                        ......+++.|+|||++.+..  ..++.++|||||||++|+|++|..||.+.+.......+..               
T Consensus       160 ~~~~~~~~~t~~y~aPE~~~~~~--~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  237 (338)
T cd07859         160 AIFWTDYVATRWYRAPELCGSFF--SKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRN  237 (338)
T ss_pred             cccccCCCCCCCcCCHHHHhccc--cccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhh
Confidence              112346889999999986521  1345679999999999999999999987654332211100               


Q ss_pred             -----------cCCCCCC---CCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 012887          403 -----------CGLRPEI---PKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLL  443 (454)
Q Consensus       403 -----------~~~~~~~---p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~  443 (454)
                                 ...+..+   -..+++.+.+++.+||+.||++||+++|++++-+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~  292 (338)
T cd07859         238 EKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPY  292 (338)
T ss_pred             hhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCch
Confidence                       0001111   1246788999999999999999999999998854

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=2.4e-41  Score=331.58  Aligned_cols=246  Identities=21%  Similarity=0.337  Sum_probs=194.9

Q ss_pred             CCEEEeceeeccCCceEEEe-------EEEEEEEeecCCCCchHHHHHHHHHHHHHhC---CCCceeEEEEEEEe----C
Q 012887          190 DNLEFIDQIGPNSFKGVYKG-------KRVGIEKLKGCDKGNAYEFELRKDLLELMTC---GHKNILQFYCVCVD----E  255 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g-------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l---~HpnIv~~~g~~~~----~  255 (454)
                      ++|++.+.||+|+||.||++       +.+|+|.++.............+|+.++..+   +||||++++++|..    .
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            36889999999999999985       4589998875443333334455666666554   79999999999863    2


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccc
Q 012887          256 NHGLCVVTKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTA  333 (454)
Q Consensus       256 ~~~l~lV~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~  333 (454)
                      +..+++||||++ ++|.+++...  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~  159 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI  159 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEe
Confidence            334899999997 4999998653  3689999999999999999999999999999999999999999999999999876


Q ss_pred             cccCCCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCC------
Q 012887          334 CKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP------  407 (454)
Q Consensus       334 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~------  407 (454)
                      .... .......+++.|+|||.+.+..+    +.++|||||||++|||++|.+||.+.+.......+......+      
T Consensus       160 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~----~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~  234 (290)
T cd07862         160 YSFQ-MALTSVVVTLWYRAPEVLLQSSY----ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP  234 (290)
T ss_pred             ccCC-cccccccccccccChHHHhCCCC----CCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhch
Confidence            5432 22334567899999999976644    445999999999999999999999877766555544311000      


Q ss_pred             -------------------CCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012887          408 -------------------EIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISL  441 (454)
Q Consensus       408 -------------------~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  441 (454)
                                         .+...+++.+.+++.+||+.||++|||+.|+++|
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h  287 (290)
T cd07862         235 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  287 (290)
T ss_pred             hhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence                               0113467889999999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=6.2e-41  Score=332.13  Aligned_cols=257  Identities=24%  Similarity=0.455  Sum_probs=214.8

Q ss_pred             cceeecCCCEEEeceeeccCCceEEEeE-----------EEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEEEE
Q 012887          183 GRWLLNSDNLEFIDQIGPNSFKGVYKGK-----------RVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYC  250 (454)
Q Consensus       183 ~~~~~~~~~~~~~~~LG~G~fG~Vy~g~-----------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~~~g  250 (454)
                      ..|.+..++|++.+.||+|+||.||++.           .+|+|.++... .......+.+|+.++.++ +||||+++++
T Consensus        28 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~  106 (302)
T cd05055          28 LKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA-HSSEREALMSELKIMSHLGNHENIVNLLG  106 (302)
T ss_pred             ccccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC-ChHHHHHHHHHHHHHHhccCCCCcceEEE
Confidence            3466777899999999999999999863           58888876432 223345678999999999 7999999999


Q ss_pred             EEEeCCCeEEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEcc
Q 012887          251 VCVDENHGLCVVTKLMEGGSVNDLILKSR--KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDM  328 (454)
Q Consensus       251 ~~~~~~~~l~lV~E~~~~gsL~~~l~~~~--~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DF  328 (454)
                      ++...+. .++||||+++|+|.+++.+..  .+++..+..++.||+.||.|||+++++|+||||+|||++.++.++|+||
T Consensus       107 ~~~~~~~-~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~df  185 (302)
T cd05055         107 ACTIGGP-ILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDF  185 (302)
T ss_pred             EEecCCc-eEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCC
Confidence            9987776 999999999999999986543  4899999999999999999999999999999999999999999999999


Q ss_pred             CCccccccCCCc--ccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHcCC
Q 012887          329 GIVTACKSVGEA--TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGL  405 (454)
Q Consensus       329 Gla~~~~~~~~~--~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~i~~~~~  405 (454)
                      |++.........  .....+++.|+|||.+.+..    ++.++|||||||++|+|++ |..||...............+.
T Consensus       186 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~  261 (302)
T cd05055         186 GLARDIMNDSNYVVKGNARLPVKWMAPESIFNCV----YTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGY  261 (302)
T ss_pred             cccccccCCCceeecCCCCcccccCCHhhhccCC----CCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCC
Confidence            998765433211  11224567899999997664    3456999999999999998 9999988776666666666666


Q ss_pred             CCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 012887          406 RPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRT  445 (454)
Q Consensus       406 ~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~  445 (454)
                      ++..+...+..+.+++.+||+.+|++||++.+++..|.+.
T Consensus       262 ~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         262 RMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence            6667777899999999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=3.7e-41  Score=338.65  Aligned_cols=252  Identities=18%  Similarity=0.353  Sum_probs=204.5

Q ss_pred             ecCCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEE
Q 012887          187 LNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLC  260 (454)
Q Consensus       187 ~~~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~  260 (454)
                      +..++|++.+.||+|+||.||++      ..+|+|.+... ........+.+|+.+++.++||||++++++|.+.+. ++
T Consensus         2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~   79 (333)
T cd06650           2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLE-IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE-IS   79 (333)
T ss_pred             cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecc-cCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCE-EE
Confidence            45689999999999999999985      46788887643 233345668899999999999999999999998776 99


Q ss_pred             EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhc-CcccCCccCCcEEEccCCcEEEEccCCccccccCCC
Q 012887          261 VVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDH-GVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE  339 (454)
Q Consensus       261 lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~-~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~  339 (454)
                      +||||+++|+|.+++.+.+.+++..+..++.|++.||.|||+. +++||||||+|||++.++.+||+|||++......  
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--  157 (333)
T cd06650          80 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  157 (333)
T ss_pred             EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh--
Confidence            9999999999999998878899999999999999999999985 7999999999999999999999999998755332  


Q ss_pred             cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHH---------------------
Q 012887          340 ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAV---------------------  398 (454)
Q Consensus       340 ~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~---------------------  398 (454)
                      ......++..|+|||.+.+..    ++.++|||||||++|+|++|..||..........                     
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~----~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (333)
T cd06650         158 MANSFVGTRSYMSPERLQGTH----YSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRP  233 (333)
T ss_pred             ccccCCCCccccCHHHhcCCC----CCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCC
Confidence            123346788999999998764    3456999999999999999999997644332211                     


Q ss_pred             ----------------------HHHHcCCCCCCCC-CccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 012887          399 ----------------------GIAACGLRPEIPK-DCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTN  446 (454)
Q Consensus       399 ----------------------~i~~~~~~~~~p~-~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~  446 (454)
                                            .......++.++. .++.++.+||.+||+.||++||++.|++.+-+--.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~  304 (333)
T cd06650         234 PGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKR  304 (333)
T ss_pred             ccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhc
Confidence                                  0111112222322 36788999999999999999999999998876543

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=1.3e-41  Score=347.23  Aligned_cols=260  Identities=18%  Similarity=0.253  Sum_probs=212.0

Q ss_pred             cceeecCCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCC-chHHHHHHHHHHHHHhCCCCceeEEEEEEEeC
Q 012887          183 GRWLLNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLELMTCGHKNILQFYCVCVDE  255 (454)
Q Consensus       183 ~~~~~~~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~  255 (454)
                      ....+..++|++.+.||+|+||.||++      +.+|+|.+...... ......+.+|+.++..++||||+++++++.+.
T Consensus        36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~  115 (371)
T cd05622          36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD  115 (371)
T ss_pred             hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence            445566789999999999999999985      46899988642221 12233467888889999999999999999877


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccc
Q 012887          256 NHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK  335 (454)
Q Consensus       256 ~~~l~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~  335 (454)
                      +. +++||||+++|+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++++||+|||++....
T Consensus       116 ~~-~~lv~Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~  193 (371)
T cd05622         116 RY-LYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN  193 (371)
T ss_pred             CE-EEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcC
Confidence            65 9999999999999999854 468999999999999999999999999999999999999999999999999987654


Q ss_pred             cCCC-cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCC--C
Q 012887          336 SVGE-ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPK--D  412 (454)
Q Consensus       336 ~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~--~  412 (454)
                      .... ......||+.|+|||++.+......++.++|||||||++|||++|..||.+.+.......+........+|.  .
T Consensus       194 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  273 (371)
T cd05622         194 KEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDND  273 (371)
T ss_pred             cCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCC
Confidence            3322 223456899999999998654333456779999999999999999999998887777766665444444444  5


Q ss_pred             ccHHHHHHHHHhcccCCCC--CCCHHHHHHHHHh
Q 012887          413 CPQILKSLMIKCWNNSPSK--RPQFSEIISLLLR  444 (454)
Q Consensus       413 ~~~~l~~li~~cl~~dP~~--RPs~~ell~~L~~  444 (454)
                      ++..+.++|.+||..++.+  |+++.++++|.+-
T Consensus       274 ~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~  307 (371)
T cd05622         274 ISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFF  307 (371)
T ss_pred             CCHHHHHHHHHHcCChhhhcCCCCHHHHhcCccc
Confidence            8999999999999844433  7899999998754

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1.6e-41  Score=340.46  Aligned_cols=247  Identities=21%  Similarity=0.311  Sum_probs=201.4

Q ss_pred             CEEEeceeeccCCceEEEe---------EEEEEEEeecCCC--CchHHHHHHHHHHHHHhC-CCCceeEEEEEEEeCCCe
Q 012887          191 NLEFIDQIGPNSFKGVYKG---------KRVGIEKLKGCDK--GNAYEFELRKDLLELMTC-GHKNILQFYCVCVDENHG  258 (454)
Q Consensus       191 ~~~~~~~LG~G~fG~Vy~g---------~~vavK~l~~~~~--~~~~~~~~~~Ei~~l~~l-~HpnIv~~~g~~~~~~~~  258 (454)
                      +|++++.||+|+||.||++         +.+|+|.+.....  .......+..|+.++..+ +||||+++++++.+++. 
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~-   79 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAK-   79 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCE-
Confidence            5789999999999999974         4589999864321  122334567888899988 58999999999887765 


Q ss_pred             EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCC
Q 012887          259 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG  338 (454)
Q Consensus       259 l~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~  338 (454)
                      +++||||+++|+|.+++.+...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus        80 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~  159 (332)
T cd05614          80 LHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE  159 (332)
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccC
Confidence            99999999999999999887889999999999999999999999999999999999999999999999999987643322


Q ss_pred             C-cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCH----HHHHHHHHHcCCCCCCCCCc
Q 012887          339 E-ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSP----VQAAVGIAACGLRPEIPKDC  413 (454)
Q Consensus       339 ~-~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~----~~~~~~i~~~~~~~~~p~~~  413 (454)
                      . ......||+.|+|||++.+..   .++.++|||||||++|||++|..||.....    ......+.  ...+.+|..+
T Consensus       160 ~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~  234 (332)
T cd05614         160 KERTYSFCGTIEYMAPEIIRGKG---GHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRIL--KCDPPFPSFI  234 (332)
T ss_pred             CCccccccCCccccCHHHhcCCC---CCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHh--cCCCCCCCCC
Confidence            2 223346899999999997643   234569999999999999999999964321    22222222  3456678889


Q ss_pred             cHHHHHHHHHhcccCCCCCC-----CHHHHHHHHH
Q 012887          414 PQILKSLMIKCWNNSPSKRP-----QFSEIISLLL  443 (454)
Q Consensus       414 ~~~l~~li~~cl~~dP~~RP-----s~~ell~~L~  443 (454)
                      ++.+.+++.+||+.||.+||     ++.+++++-+
T Consensus       235 ~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~  269 (332)
T cd05614         235 GPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPF  269 (332)
T ss_pred             CHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCC
Confidence            99999999999999999999     7889988754

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1e-41  Score=340.57  Aligned_cols=241  Identities=23%  Similarity=0.255  Sum_probs=201.2

Q ss_pred             ceeeccCCceEEEe------EEEEEEEeecCCC-CchHHHHHHHHHHHHHhC-CCCceeEEEEEEEeCCCeEEEEEeccC
Q 012887          196 DQIGPNSFKGVYKG------KRVGIEKLKGCDK-GNAYEFELRKDLLELMTC-GHKNILQFYCVCVDENHGLCVVTKLME  267 (454)
Q Consensus       196 ~~LG~G~fG~Vy~g------~~vavK~l~~~~~-~~~~~~~~~~Ei~~l~~l-~HpnIv~~~g~~~~~~~~l~lV~E~~~  267 (454)
                      +.||+|+||.||+|      +.+|+|.++.... .......+..|..++..+ +||||+++++++.+.+. +|+||||++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~-~~lv~E~~~   79 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDR-LFFVMEYVN   79 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCe-EEEEEeCCC
Confidence            36899999999986      4689999874321 122233456677777655 79999999999988776 999999999


Q ss_pred             CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCcccccCCC
Q 012887          268 GGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG  347 (454)
Q Consensus       268 ~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~gt  347 (454)
                      +|+|.+.+.+.+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..............|+
T Consensus        80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt  159 (321)
T cd05591          80 GGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGT  159 (321)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCccccccccC
Confidence            99999999888889999999999999999999999999999999999999999999999999987544333334445689


Q ss_pred             CcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhccc
Q 012887          348 YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNN  427 (454)
Q Consensus       348 ~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~li~~cl~~  427 (454)
                      +.|+|||++.+..+    +.++|||||||++|+|++|..||...+.......+...  ...+|..++.++.+++.+||+.
T Consensus       160 ~~y~aPE~~~~~~~----~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~--~~~~p~~~~~~~~~ll~~~L~~  233 (321)
T cd05591         160 PDYIAPEILQELEY----GPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHD--DVLYPVWLSKEAVSILKAFMTK  233 (321)
T ss_pred             ccccCHHHHcCCCC----CCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHHHHHHHHHHhcc
Confidence            99999999987654    44599999999999999999999988877766666543  3446777899999999999999


Q ss_pred             CCCCCC-------CHHHHHHHHH
Q 012887          428 SPSKRP-------QFSEIISLLL  443 (454)
Q Consensus       428 dP~~RP-------s~~ell~~L~  443 (454)
                      ||.+||       ++.+++++-+
T Consensus       234 dp~~R~~~~~~~~~~~~~~~hp~  256 (321)
T cd05591         234 NPNKRLGCVASQGGEDAIKQHPF  256 (321)
T ss_pred             CHHHcCCCCCCCCCHHHHhcCCc
Confidence            999999       8888887753

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=5e-42  Score=343.75  Aligned_cols=252  Identities=14%  Similarity=0.208  Sum_probs=207.5

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCC-CchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDK-GNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  262 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV  262 (454)
                      ++|++.+.||+|+||.||++      +.+|+|.++.... .......+.+|+.++..++||||+++++++.+.+. +++|
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~-~~lv   79 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDN-LYLV   79 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCe-EEEE
Confidence            46899999999999999985      5799999975332 12234457788888999999999999999987765 9999


Q ss_pred             EeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCc-
Q 012887          263 TKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA-  340 (454)
Q Consensus       263 ~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~-  340 (454)
                      |||+++|+|.+++.+. ..+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||++......... 
T Consensus        80 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~  159 (330)
T cd05601          80 MEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVN  159 (330)
T ss_pred             ECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCcee
Confidence            9999999999999765 58999999999999999999999999999999999999999999999999998765433221 


Q ss_pred             ccccCCCCcccccccccCCCC--CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCC--CccHH
Q 012887          341 TEYETDGYRWLAPEIIAGDPE--SVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPK--DCPQI  416 (454)
Q Consensus       341 ~~~~~gt~~y~APE~l~~~~~--~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~--~~~~~  416 (454)
                      .....+|+.|+|||++.....  ...++.++|||||||++|+|++|..||...+.......+........+|.  .++.+
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  239 (330)
T cd05601         160 SKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSD  239 (330)
T ss_pred             eecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHH
Confidence            223468899999999874321  12355679999999999999999999998877776666655433333443  47899


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHHHHH
Q 012887          417 LKSLMIKCWNNSPSKRPQFSEIISLLL  443 (454)
Q Consensus       417 l~~li~~cl~~dP~~RPs~~ell~~L~  443 (454)
                      +.+|+.+||. +|.+||++.+++.|-+
T Consensus       240 ~~~li~~ll~-~p~~R~t~~~l~~h~~  265 (330)
T cd05601         240 FLDLIQSLLC-GQKERLGYEGLCCHPF  265 (330)
T ss_pred             HHHHHHHHcc-ChhhCCCHHHHhCCCC
Confidence            9999999998 9999999999997743

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1.2e-41  Score=348.33  Aligned_cols=246  Identities=18%  Similarity=0.302  Sum_probs=203.0

Q ss_pred             CEEEeceeeccCCceEEEe------EEEEEEEeecCCCC-chHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEE
Q 012887          191 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  263 (454)
Q Consensus       191 ~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~  263 (454)
                      .|++++.||+|+||.||++      +.+|+|.+...... ......+.+|+.++..++||||+++++++.+.+. +|+||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~-~~lv~   80 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDN-LYFVM   80 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCE-EEEEE
Confidence            5889999999999999996      46899998743221 2234467889999999999999999999998776 99999


Q ss_pred             eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCC-----
Q 012887          264 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG-----  338 (454)
Q Consensus       264 E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~-----  338 (454)
                      ||+++|+|.+++.+.+.+++..+..++.||+.||+|||++||+||||||+|||++.+|++||+|||++.......     
T Consensus        81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~  160 (382)
T cd05625          81 DYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY  160 (382)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccccc
Confidence            999999999999877789999999999999999999999999999999999999999999999999975321100     


Q ss_pred             ------------------------------------------CcccccCCCCcccccccccCCCCCCCCCchhhHHHHHH
Q 012887          339 ------------------------------------------EATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGM  376 (454)
Q Consensus       339 ------------------------------------------~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGv  376 (454)
                                                                .......||+.|+|||++.+..++    .++|||||||
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~----~~~DiwSlGv  236 (382)
T cd05625         161 QSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT----QLCDWWSVGV  236 (382)
T ss_pred             ccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCC----CeeeEEechH
Confidence                                                      001123588999999999876544    4599999999


Q ss_pred             HHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCC--CCccHHHHHHHHHhcccCCCCCCC---HHHHHHHH
Q 012887          377 VIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIP--KDCPQILKSLMIKCWNNSPSKRPQ---FSEIISLL  442 (454)
Q Consensus       377 iL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p--~~~~~~l~~li~~cl~~dP~~RPs---~~ell~~L  442 (454)
                      ++|||++|..||.+.++......+.........|  ..+++++.++|.+|+ .+|.+|++   +.+++.|-
T Consensus       237 il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp  306 (382)
T cd05625         237 ILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHP  306 (382)
T ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCC
Confidence            9999999999999888777666666544444444  357899999999976 59999997   89888763

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=6e-42  Score=349.60  Aligned_cols=248  Identities=18%  Similarity=0.294  Sum_probs=203.2

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCC-chHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  262 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV  262 (454)
                      ++|++++.||+|+||.||++      +.+|+|.+...... ......+.+|+.+++.++||||+++++.+.+++. +|+|
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~-~~lv   79 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDN-LYFV   79 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCE-EEEE
Confidence            47899999999999999985      57999998643211 1233457789999999999999999999988776 9999


Q ss_pred             EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCC----
Q 012887          263 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG----  338 (454)
Q Consensus       263 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~----  338 (454)
                      |||+++|+|.+++.+.+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......    
T Consensus        80 ~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~  159 (376)
T cd05598          80 MDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY  159 (376)
T ss_pred             EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccccc
Confidence            9999999999999887889999999999999999999999999999999999999999999999999975321000    


Q ss_pred             ---------------------------------------CcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHH
Q 012887          339 ---------------------------------------EATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIW  379 (454)
Q Consensus       339 ---------------------------------------~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~  379 (454)
                                                             .......||+.|+|||++.+..++    .++|||||||++|
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~----~~~DiwSlGvily  235 (376)
T cd05598         160 YQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYT----QLCDWWSVGVILY  235 (376)
T ss_pred             cccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCC----cceeeeeccceee
Confidence                                                   001123588999999999876544    4599999999999


Q ss_pred             HHHcCCCCCCCCCHHHHHHHHHHcCCCCCCC--CCccHHHHHHHHHhcccCCCCCC---CHHHHHHHHH
Q 012887          380 EMVTGEAAYAACSPVQAAVGIAACGLRPEIP--KDCPQILKSLMIKCWNNSPSKRP---QFSEIISLLL  443 (454)
Q Consensus       380 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p--~~~~~~l~~li~~cl~~dP~~RP---s~~ell~~L~  443 (454)
                      ||++|..||.+.++......+........+|  ..+++++.++|.+|+ .+|.+|+   ++.+++.|-+
T Consensus       236 ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~  303 (376)
T cd05598         236 EMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPF  303 (376)
T ss_pred             ehhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCC
Confidence            9999999999888776655554433333333  367899999999976 5999999   9999998844

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=2.4e-41  Score=330.50  Aligned_cols=250  Identities=26%  Similarity=0.497  Sum_probs=206.3

Q ss_pred             cCCCEEEeceeeccCCceEEEe-----------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCC
Q 012887          188 NSDNLEFIDQIGPNSFKGVYKG-----------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN  256 (454)
Q Consensus       188 ~~~~~~~~~~LG~G~fG~Vy~g-----------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~  256 (454)
                      +..+|++.+.||+|+||.||+|           +.+|+|.++... .......+.+|+.++..++||||+++++++.+.+
T Consensus         3 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~   81 (283)
T cd05091           3 NLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQ   81 (283)
T ss_pred             CHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCC
Confidence            3467888999999999999996           458999987432 2334456788999999999999999999998877


Q ss_pred             CeEEEEEeccCCCCHHHHHHh----------------CCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccC
Q 012887          257 HGLCVVTKLMEGGSVNDLILK----------------SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH  320 (454)
Q Consensus       257 ~~l~lV~E~~~~gsL~~~l~~----------------~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~  320 (454)
                      . .++++||+++++|.+++..                ...+++..+..++.|++.||.|||++|++||||||+|||++.+
T Consensus        82 ~-~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~  160 (283)
T cd05091          82 P-LSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDK  160 (283)
T ss_pred             c-eEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCC
Confidence            6 8999999999999999842                1247888999999999999999999999999999999999999


Q ss_pred             CcEEEEccCCccccccCCC--cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHH
Q 012887          321 GNVCLGDMGIVTACKSVGE--ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAA  397 (454)
Q Consensus       321 ~~vKL~DFGla~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~  397 (454)
                      +.+||+|||+++.......  ......+++.|+|||.+.+..+    +.++|||||||++|||++ |..||.+.......
T Consensus       161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~----~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~  236 (283)
T cd05091         161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKF----SIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVI  236 (283)
T ss_pred             CceEecccccccccccchheeeccCccCCccccCHHHHhcCCC----CcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence            9999999999876533221  1222345678999999876654    445999999999999998 89999887776555


Q ss_pred             HHHHHcCCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 012887          398 VGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR  444 (454)
Q Consensus       398 ~~i~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~  444 (454)
                      ..+. .+.....|..++..+.+++.+||+.+|.+||++.+|+..|.+
T Consensus       237 ~~i~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         237 EMIR-NRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             HHHH-cCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence            4444 344556788899999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-43  Score=325.57  Aligned_cols=252  Identities=19%  Similarity=0.263  Sum_probs=217.8

Q ss_pred             CCCEEEeceeeccCCceEEE------eEEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEE
Q 012887          189 SDNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  262 (454)
Q Consensus       189 ~~~~~~~~~LG~G~fG~Vy~------g~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV  262 (454)
                      .+.|++.+.||+|.|+.||+      |+.+|+|.+....-....-.++.+|+++-..|+|||||++.+...+... .|+|
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~-~ylv   88 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESF-HYLV   88 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccce-eEEE
Confidence            47889999999999999997      5666766664333333344568899999999999999999999887776 8999


Q ss_pred             EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccC---CcEEEEccCCccccccCCC
Q 012887          263 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH---GNVCLGDMGIVTACKSVGE  339 (454)
Q Consensus       263 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~---~~vKL~DFGla~~~~~~~~  339 (454)
                      +|+|.|++|..-+-++..+++..+-.+++||+++|.|+|.+||||||+||.|+|+.+.   .-+||+|||+|.... .+.
T Consensus        89 Fe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~-~g~  167 (355)
T KOG0033|consen   89 FDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN-DGE  167 (355)
T ss_pred             EecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC-Ccc
Confidence            9999999998777565778999999999999999999999999999999999999654   359999999998877 555


Q ss_pred             cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCC--CCCCccHHH
Q 012887          340 ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPE--IPKDCPQIL  417 (454)
Q Consensus       340 ~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~--~p~~~~~~l  417 (454)
                      ......|||.|||||++...+++.+    +|||+.||+||-|+.|.+||.+.+......+|....+..+  ..+.++++.
T Consensus       168 ~~~G~~GtP~fmaPEvvrkdpy~kp----vDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~A  243 (355)
T KOG0033|consen  168 AWHGFAGTPGYLSPEVLKKDPYSKP----VDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEA  243 (355)
T ss_pred             ccccccCCCcccCHHHhhcCCCCCc----chhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHH
Confidence            5666789999999999999987766    9999999999999999999999999999999988766544  345789999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 012887          418 KSLMIKCWNNSPSKRPQFSEIISLLLRTN  446 (454)
Q Consensus       418 ~~li~~cl~~dP~~RPs~~ell~~L~~~~  446 (454)
                      ++|+++||..||.+|.|+.|.++|-|-..
T Consensus       244 k~LvrrML~~dP~kRIta~EAL~HpWi~~  272 (355)
T KOG0033|consen  244 KSLIRRMLTVNPKKRITADEALKHPWICN  272 (355)
T ss_pred             HHHHHHHhccChhhhccHHHHhCCchhcc
Confidence            99999999999999999999999887543

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=1.7e-41  Score=338.53  Aligned_cols=239  Identities=21%  Similarity=0.334  Sum_probs=196.9

Q ss_pred             ceeeccCCceEEEe------EEEEEEEeecCCCC-chHHHHHHHHHHHHHh-CCCCceeEEEEEEEeCCCeEEEEEeccC
Q 012887          196 DQIGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLELMT-CGHKNILQFYCVCVDENHGLCVVTKLME  267 (454)
Q Consensus       196 ~~LG~G~fG~Vy~g------~~vavK~l~~~~~~-~~~~~~~~~Ei~~l~~-l~HpnIv~~~g~~~~~~~~l~lV~E~~~  267 (454)
                      +.||+|+||.||++      +.+|+|.++..... .........|..++.. .+||||+++++++.+.+. +|+||||++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~-~~lv~E~~~   79 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEH-LFFVMEFLN   79 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCE-EEEEECCCC
Confidence            46999999999985      47999998743211 1222345566666664 489999999999988776 999999999


Q ss_pred             CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCcccccCCC
Q 012887          268 GGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG  347 (454)
Q Consensus       268 ~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~gt  347 (454)
                      +|+|.+++.+...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..............|+
T Consensus        80 ~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt  159 (316)
T cd05620          80 GGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGT  159 (316)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccCCC
Confidence            99999999877889999999999999999999999999999999999999999999999999986543323334445689


Q ss_pred             CcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhccc
Q 012887          348 YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNN  427 (454)
Q Consensus       348 ~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~li~~cl~~  427 (454)
                      +.|+|||++.+..++    .++|||||||++|||++|..||.+.+.......+..  ..+.+|..++.++.++|.+||+.
T Consensus       160 ~~y~aPE~~~~~~~~----~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~  233 (316)
T cd05620         160 PDYIAPEILQGLKYT----FSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRV--DTPHYPRWITKESKDILEKLFER  233 (316)
T ss_pred             cCccCHHHHcCCCCC----cccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh--CCCCCCCCCCHHHHHHHHHHccC
Confidence            999999999876544    459999999999999999999998777665555543  34557778999999999999999


Q ss_pred             CCCCCCCH-HHHHHH
Q 012887          428 SPSKRPQF-SEIISL  441 (454)
Q Consensus       428 dP~~RPs~-~ell~~  441 (454)
                      ||.+||++ .++++|
T Consensus       234 dP~~R~~~~~~~~~h  248 (316)
T cd05620         234 DPTRRLGVVGNIRGH  248 (316)
T ss_pred             CHHHcCCChHHHHcC
Confidence            99999997 467654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=1.2e-40  Score=327.70  Aligned_cols=254  Identities=26%  Similarity=0.458  Sum_probs=209.6

Q ss_pred             cCCCEEEeceeeccCCceEEEeE-----------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCC
Q 012887          188 NSDNLEFIDQIGPNSFKGVYKGK-----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN  256 (454)
Q Consensus       188 ~~~~~~~~~~LG~G~fG~Vy~g~-----------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~  256 (454)
                      ...+|.+.+.||+|+||.||+|+           .+++|.+..  ........+.+|+..+.+++||||+++++++...+
T Consensus         3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   80 (291)
T cd05094           3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKD--PTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGD   80 (291)
T ss_pred             chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCC--ccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence            34678999999999999999874           377777653  22233456789999999999999999999998777


Q ss_pred             CeEEEEEeccCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccC
Q 012887          257 HGLCVVTKLMEGGSVNDLILKSR----------------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH  320 (454)
Q Consensus       257 ~~l~lV~E~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~  320 (454)
                      . .++||||+++++|.+++....                .+++..++.++.||+.||.|||++|++||||||+|||++.+
T Consensus        81 ~-~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~  159 (291)
T cd05094          81 P-LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN  159 (291)
T ss_pred             c-eEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccC
Confidence            6 899999999999999996432                37899999999999999999999999999999999999999


Q ss_pred             CcEEEEccCCccccccCCC--cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHH
Q 012887          321 GNVCLGDMGIVTACKSVGE--ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAA  397 (454)
Q Consensus       321 ~~vKL~DFGla~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~  397 (454)
                      +.++|+|||++........  ......++..|+|||.+.+..+    +.++|||||||++|||++ |..||...+.....
T Consensus       160 ~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~----~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~  235 (291)
T cd05094         160 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKF----TTESDVWSFGVILWEIFTYGKQPWFQLSNTEVI  235 (291)
T ss_pred             CcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCC----CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            9999999999875543221  1222345678999999887643    446999999999999999 99999887766554


Q ss_pred             HHHHHcCCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCCC
Q 012887          398 VGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNIS  449 (454)
Q Consensus       398 ~~i~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~  449 (454)
                      ..+ ..+..+..+..+|..+.+++.+||+.||++||++.++++.|.++.+..
T Consensus       236 ~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~~  286 (291)
T cd05094         236 ECI-TQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKAT  286 (291)
T ss_pred             HHH-hCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhhc
Confidence            443 444555567778999999999999999999999999999999986643

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=3.3e-41  Score=325.03  Aligned_cols=250  Identities=27%  Similarity=0.503  Sum_probs=210.6

Q ss_pred             ecCCCEEEeceeeccCCceEEEe-----EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEE
Q 012887          187 LNSDNLEFIDQIGPNSFKGVYKG-----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCV  261 (454)
Q Consensus       187 ~~~~~~~~~~~LG~G~fG~Vy~g-----~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~l  261 (454)
                      ....+|++.+.||.|+||.||+|     +.+++|.+.....  .....+..|+.++..++||||+++++++.+.+. .++
T Consensus         3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-~~l   79 (261)
T cd05148           3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDL--LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEP-VYI   79 (261)
T ss_pred             CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccch--hhHHHHHHHHHHHhcCCCcchhheeeeEecCCC-eEE
Confidence            34567899999999999999986     4588988864322  234457889999999999999999999988776 899


Q ss_pred             EEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCC
Q 012887          262 VTKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE  339 (454)
Q Consensus       262 V~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~  339 (454)
                      ||||+++++|.+++.+.  ..+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++........
T Consensus        80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~  159 (261)
T cd05148          80 ITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY  159 (261)
T ss_pred             EEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence            99999999999999653  4689999999999999999999999999999999999999999999999999876644332


Q ss_pred             cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHH
Q 012887          340 ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILK  418 (454)
Q Consensus       340 ~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~  418 (454)
                      ......+++.|+|||.+.+..+    +.++||||||+++|+|++ |..||...+..+....+. .+.+++.+..+++.+.
T Consensus       160 ~~~~~~~~~~~~~PE~~~~~~~----~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  234 (261)
T cd05148         160 LSSDKKIPYKWTAPEAASHGTF----STKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT-AGYRMPCPAKCPQEIY  234 (261)
T ss_pred             cccCCCCceEecCHHHHccCCC----CchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHH-hCCcCCCCCCCCHHHH
Confidence            2333345678999999876544    445999999999999998 899998877666555444 4566777888999999


Q ss_pred             HHHHHhcccCCCCCCCHHHHHHHHHh
Q 012887          419 SLMIKCWNNSPSKRPQFSEIISLLLR  444 (454)
Q Consensus       419 ~li~~cl~~dP~~RPs~~ell~~L~~  444 (454)
                      ++|.+||..||.+|||+.+|++.|+.
T Consensus       235 ~~i~~~l~~~p~~Rpt~~~l~~~L~~  260 (261)
T cd05148         235 KIMLECWAAEPEDRPSFKALREELDN  260 (261)
T ss_pred             HHHHHHcCCCchhCcCHHHHHHHHhc
Confidence            99999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=7.5e-41  Score=323.00  Aligned_cols=247  Identities=24%  Similarity=0.491  Sum_probs=205.5

Q ss_pred             cCCCEEEeceeeccCCceEEEeE-----EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEE
Q 012887          188 NSDNLEFIDQIGPNSFKGVYKGK-----RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  262 (454)
Q Consensus       188 ~~~~~~~~~~LG~G~fG~Vy~g~-----~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV  262 (454)
                      +.++|++++.||+|+||.||+|+     .+|+|.++....   ....+.+|+..+..++||||+++++++.+.+. +++|
T Consensus         2 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~lv   77 (256)
T cd05113           2 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM---SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRP-IYIV   77 (256)
T ss_pred             ChHHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc---cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCC-cEEE
Confidence            34788999999999999999975     489998763322   23557889999999999999999999987765 8999


Q ss_pred             EeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCcc
Q 012887          263 TKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT  341 (454)
Q Consensus       263 ~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~  341 (454)
                      |||+.+|+|.+++... ..+++..+..++.||+.||.|||++|++|+||||+|||++.++.+||+|||+++.........
T Consensus        78 ~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~  157 (256)
T cd05113          78 TEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS  157 (256)
T ss_pred             EEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence            9999999999999664 378999999999999999999999999999999999999999999999999987554322111


Q ss_pred             -cccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHHH
Q 012887          342 -EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKS  419 (454)
Q Consensus       342 -~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~  419 (454)
                       ....++..|+|||.+.+..    ++.++|||||||++|+|++ |..||...+.......+. .+.+...+...+..+.+
T Consensus       158 ~~~~~~~~~y~~pe~~~~~~----~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  232 (256)
T cd05113         158 SVGSKFPVRWSPPEVLLYSK----FSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVS-QGLRLYRPHLASEKVYA  232 (256)
T ss_pred             cCCCccChhhCCHHHHhcCc----ccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHh-cCCCCCCCCCCCHHHHH
Confidence             1223456799999997654    3446999999999999999 999998877665555444 34555567778999999


Q ss_pred             HHHHhcccCCCCCCCHHHHHHHHH
Q 012887          420 LMIKCWNNSPSKRPQFSEIISLLL  443 (454)
Q Consensus       420 li~~cl~~dP~~RPs~~ell~~L~  443 (454)
                      ++.+||+.+|.+||++.+|++.|+
T Consensus       233 li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         233 IMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             HHHHHcCCCcccCCCHHHHHHhhC
Confidence            999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=9.8e-41  Score=320.22  Aligned_cols=245  Identities=22%  Similarity=0.376  Sum_probs=209.6

Q ss_pred             CEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEEe
Q 012887          191 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTK  264 (454)
Q Consensus       191 ~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~E  264 (454)
                      +|++.+.||+|+||.||++      +.+++|.+............+.+|+.+++.++||||+++++++.+.+. .++|||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~lv~e   79 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGK-LNIVME   79 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCE-EEEEEE
Confidence            5788999999999999986      568999887554455566678899999999999999999999987765 999999


Q ss_pred             ccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCccc
Q 012887          265 LMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE  342 (454)
Q Consensus       265 ~~~~gsL~~~l~~~--~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~  342 (454)
                      |+++++|.+++...  ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++...........
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~~  159 (256)
T cd08529          80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFAN  159 (256)
T ss_pred             eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccchhh
Confidence            99999999999654  5789999999999999999999999999999999999999999999999999876655433334


Q ss_pred             ccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHHHHHH
Q 012887          343 YETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMI  422 (454)
Q Consensus       343 ~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~li~  422 (454)
                      ...+++.|+|||++.+..+    +.++|+|||||++|+|++|..||...+.......+. .+..+.++..++.++.+++.
T Consensus       160 ~~~~~~~y~aPE~~~~~~~----~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~  234 (256)
T cd08529         160 TIVGTPYYLSPELCEDKPY----NEKSDVWALGVVLYECCTGKHPFDANNQGALILKII-RGVFPPVSQMYSQQLAQLID  234 (256)
T ss_pred             ccccCccccCHHHhcCCCC----CCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-cCCCCCCccccCHHHHHHHH
Confidence            4467888999999987643    445999999999999999999998877655544444 34555677788999999999


Q ss_pred             HhcccCCCCCCCHHHHHHH
Q 012887          423 KCWNNSPSKRPQFSEIISL  441 (454)
Q Consensus       423 ~cl~~dP~~RPs~~ell~~  441 (454)
                      +||+.+|++||++.+++.+
T Consensus       235 ~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         235 QCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             HHccCCcccCcCHHHHhhC
Confidence            9999999999999999875

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-40  Score=320.65  Aligned_cols=249  Identities=26%  Similarity=0.482  Sum_probs=210.5

Q ss_pred             eeecCCCEEEeceeeccCCceEEEe----EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEE
Q 012887          185 WLLNSDNLEFIDQIGPNSFKGVYKG----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLC  260 (454)
Q Consensus       185 ~~~~~~~~~~~~~LG~G~fG~Vy~g----~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~  260 (454)
                      |.+..++|++.+.||+|+||.||++    +.+|+|.+.....   ...++.+|+.++..++|+||+++++++.+.+. .+
T Consensus         1 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-~~   76 (256)
T cd05039           1 WAINSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNP-LY   76 (256)
T ss_pred             CccChhhccceeeeecCCCceEEEEEecCcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCC-eE
Confidence            3456688999999999999999974    6899999874332   45668889999999999999999999987665 99


Q ss_pred             EEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCC
Q 012887          261 VVTKLMEGGSVNDLILKSR--KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG  338 (454)
Q Consensus       261 lV~E~~~~gsL~~~l~~~~--~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~  338 (454)
                      +||||+++++|.+++.+..  .+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++...... 
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~-  155 (256)
T cd05039          77 IVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG-  155 (256)
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccccc-
Confidence            9999999999999996654  7999999999999999999999999999999999999999999999999998765322 


Q ss_pred             CcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHH
Q 012887          339 EATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQIL  417 (454)
Q Consensus       339 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l  417 (454)
                        ......+..|+|||.+.+..+    +.++||||||+++|+|++ |..||...+...... ....+.+...|..+|+.+
T Consensus       156 --~~~~~~~~~~~ape~~~~~~~----~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  228 (256)
T cd05039         156 --QDSGKLPVKWTAPEALREKKF----STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP-HVEKGYRMEAPEGCPPEV  228 (256)
T ss_pred             --cccCCCcccccCchhhcCCcC----CcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH-HHhcCCCCCCccCCCHHH
Confidence              112334567999999876543    446999999999999997 999998876655443 333455667788899999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 012887          418 KSLMIKCWNNSPSKRPQFSEIISLLLRT  445 (454)
Q Consensus       418 ~~li~~cl~~dP~~RPs~~ell~~L~~~  445 (454)
                      .+++.+||..+|.+||+++++++.|+++
T Consensus       229 ~~li~~~l~~~p~~Rp~~~~l~~~l~~~  256 (256)
T cd05039         229 YKVMKDCWELDPAKRPTFKQLREQLALI  256 (256)
T ss_pred             HHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence            9999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=2e-41  Score=338.15  Aligned_cols=240  Identities=20%  Similarity=0.289  Sum_probs=200.6

Q ss_pred             ceeeccCCceEEEe------EEEEEEEeecCCC-CchHHHHHHHHHHHHHhC-CCCceeEEEEEEEeCCCeEEEEEeccC
Q 012887          196 DQIGPNSFKGVYKG------KRVGIEKLKGCDK-GNAYEFELRKDLLELMTC-GHKNILQFYCVCVDENHGLCVVTKLME  267 (454)
Q Consensus       196 ~~LG~G~fG~Vy~g------~~vavK~l~~~~~-~~~~~~~~~~Ei~~l~~l-~HpnIv~~~g~~~~~~~~l~lV~E~~~  267 (454)
                      +.||+|+||.||++      +.+|+|.++.... .......+..|+.++..+ +||||+++++++.+.+. +|+||||++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~-~~lv~e~~~   79 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDR-LFFVMEYVN   79 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCE-EEEEEcCCC
Confidence            46999999999985      4789999874321 122334456777777776 69999999999988776 999999999


Q ss_pred             CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCcccccCCC
Q 012887          268 GGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG  347 (454)
Q Consensus       268 ~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~gt  347 (454)
                      +|+|.+++.+.+.+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||++..............++
T Consensus        80 ~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~  159 (318)
T cd05570          80 GGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGT  159 (318)
T ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccceecC
Confidence            99999999887789999999999999999999999999999999999999999999999999986543333333444688


Q ss_pred             CcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhccc
Q 012887          348 YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNN  427 (454)
Q Consensus       348 ~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~li~~cl~~  427 (454)
                      +.|+|||++.+..++    .++|||||||++|+|++|..||.+.+.......+...  ...+|..++..+.++|.+||+.
T Consensus       160 ~~y~aPE~~~~~~~~----~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~li~~~l~~  233 (318)
T cd05570         160 PDYIAPEILSYQPYG----PAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILED--EVRYPRWLSKEAKSILKSFLTK  233 (318)
T ss_pred             ccccCHHHhcCCCCC----cchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC--CCCCCCcCCHHHHHHHHHHccC
Confidence            999999999876544    4599999999999999999999987776665555443  4456788999999999999999


Q ss_pred             CCCCCCCH-----HHHHHHH
Q 012887          428 SPSKRPQF-----SEIISLL  442 (454)
Q Consensus       428 dP~~RPs~-----~ell~~L  442 (454)
                      ||.+||++     .+++++-
T Consensus       234 dP~~R~s~~~~~~~~ll~~~  253 (318)
T cd05570         234 NPEKRLGCLPTGEQDIKGHP  253 (318)
T ss_pred             CHHHcCCCCCCCHHHHhcCC
Confidence            99999999     8888763

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=5.9e-42  Score=332.64  Aligned_cols=240  Identities=25%  Similarity=0.353  Sum_probs=201.4

Q ss_pred             CEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCC----eEE
Q 012887          191 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH----GLC  260 (454)
Q Consensus       191 ~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~----~l~  260 (454)
                      .|+-.+.+|+|+||.||+|      +.||||+........      .+|+.+|+.++|||||++..+|.....    .+.
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k------nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln   98 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK------NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN   98 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC------cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence            4677899999999999997      589999997544432      367888889999999999888765432    356


Q ss_pred             EEEeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccC-CcEEEEccCCccccc
Q 012887          261 VVTKLMEGGSVNDLILK----SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH-GNVCLGDMGIVTACK  335 (454)
Q Consensus       261 lV~E~~~~gsL~~~l~~----~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~-~~vKL~DFGla~~~~  335 (454)
                      +|||||+. +|.++++.    +.+++...+.-+..||.+||.|||++||+||||||.|+|+|.+ |.+||||||.|+...
T Consensus        99 lVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~  177 (364)
T KOG0658|consen   99 LVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLV  177 (364)
T ss_pred             HHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeec
Confidence            89999988 99999863    5689999999999999999999999999999999999999976 899999999999988


Q ss_pred             cCCCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCC--------
Q 012887          336 SVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP--------  407 (454)
Q Consensus       336 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~--------  407 (454)
                      .......+.++-+ |.|||.+.|..   .|+.+.||||.||++.||+-|++.|++.+....+..|...--.|        
T Consensus       178 ~~epniSYicSRy-YRaPELifga~---~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~m  253 (364)
T KOG0658|consen  178 KGEPNISYICSRY-YRAPELIFGAT---EYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSM  253 (364)
T ss_pred             cCCCceeEEEecc-ccCHHHHcCcc---ccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence            7766666666555 99999999864   47778999999999999999999999998888776654321111        


Q ss_pred             -------------------CCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012887          408 -------------------EIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISL  441 (454)
Q Consensus       408 -------------------~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  441 (454)
                                         -+....+++..+|+.++|.++|.+|.++.|++.|
T Consensus       254 n~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h  306 (364)
T KOG0658|consen  254 NPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH  306 (364)
T ss_pred             CcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence                               0234578999999999999999999999999875

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=7.3e-42  Score=327.41  Aligned_cols=250  Identities=19%  Similarity=0.280  Sum_probs=214.1

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCC-CeEEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN-HGLCVV  262 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~-~~l~lV  262 (454)
                      ++|+.+..|++|+||.||+|      +.||+|+++-.....-....-.+||.+|.+++|||||.+..+....+ +.+|||
T Consensus        76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V  155 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV  155 (419)
T ss_pred             HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence            67899999999999999997      47999999866554445566789999999999999999999887554 459999


Q ss_pred             EeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCcc
Q 012887          263 TKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT  341 (454)
Q Consensus       263 ~E~~~~gsL~~~l~~~~-~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~  341 (454)
                      ||||+. +|..++..-+ +|...+...++.|+++|++|||.+.|+||||||+|+|++..|.+||+|||+|+...++....
T Consensus       156 Me~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k~~  234 (419)
T KOG0663|consen  156 MEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLKPY  234 (419)
T ss_pred             HHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCcccC
Confidence            999988 9999996655 89999999999999999999999999999999999999999999999999999988876666


Q ss_pred             cccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCC--------------
Q 012887          342 EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP--------------  407 (454)
Q Consensus       342 ~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~--------------  407 (454)
                      +...-|.+|.|||.+.|.+   .|+.+.|+||+|||+.||+++.+.|++.+....+..|...--.|              
T Consensus       235 T~lVVTLWYRaPELLLG~~---tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~  311 (419)
T KOG0663|consen  235 TPLVVTLWYRAPELLLGAK---TYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAV  311 (419)
T ss_pred             cceEEEeeecCHHHhcCCc---ccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchh
Confidence            6677899999999999864   36677999999999999999999999988887777664421111              


Q ss_pred             ---------------CCCCC-ccHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 012887          408 ---------------EIPKD-CPQILKSLMIKCWNNSPSKRPQFSEIISLLL  443 (454)
Q Consensus       408 ---------------~~p~~-~~~~l~~li~~cl~~dP~~RPs~~ell~~L~  443 (454)
                                     .++.. .++.-.+|+..+|.+||.+|.|++|.++|=+
T Consensus       312 k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~  363 (419)
T KOG0663|consen  312 KKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEY  363 (419)
T ss_pred             hccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccc
Confidence                           12222 4577889999999999999999999998744

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=7.1e-41  Score=354.00  Aligned_cols=249  Identities=16%  Similarity=0.266  Sum_probs=209.2

Q ss_pred             cCCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCC----
Q 012887          188 NSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH----  257 (454)
Q Consensus       188 ~~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~----  257 (454)
                      ..++|++.+.||+|+||.||++      +.||+|.+............+.+|+..+..++|+||+++++.+...+.    
T Consensus        30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~  109 (496)
T PTZ00283         30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE  109 (496)
T ss_pred             cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence            3478999999999999999985      479999997655444555667899999999999999999887754321    


Q ss_pred             ---eEEEEEeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCC
Q 012887          258 ---GLCVVTKLMEGGSVNDLILK----SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGI  330 (454)
Q Consensus       258 ---~l~lV~E~~~~gsL~~~l~~----~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGl  330 (454)
                         .+++||||+++|+|.+++..    ...+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||+
T Consensus       110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFGl  189 (496)
T PTZ00283        110 NVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGF  189 (496)
T ss_pred             cceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEeccc
Confidence               26899999999999999854    24689999999999999999999999999999999999999999999999999


Q ss_pred             ccccccC--CCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCC
Q 012887          331 VTACKSV--GEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPE  408 (454)
Q Consensus       331 a~~~~~~--~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~  408 (454)
                      ++.....  ........||+.|+|||++.+..    ++.++|||||||++|||++|..||.+.+.......+.. +...+
T Consensus       190 s~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~----~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~-~~~~~  264 (496)
T PTZ00283        190 SKMYAATVSDDVGRTFCGTPYYVAPEIWRRKP----YSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLA-GRYDP  264 (496)
T ss_pred             CeeccccccccccccccCCcceeCHHHhCCCC----CCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc-CCCCC
Confidence            8765432  11233456899999999998765    44569999999999999999999998777666555544 34456


Q ss_pred             CCCCccHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012887          409 IPKDCPQILKSLMIKCWNNSPSKRPQFSEIISL  441 (454)
Q Consensus       409 ~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  441 (454)
                      +|..+++++.+++.+||+.||.+||++.+++.+
T Consensus       265 ~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        265 LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence            788899999999999999999999999999876

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=2.1e-41  Score=339.76  Aligned_cols=241  Identities=20%  Similarity=0.328  Sum_probs=196.8

Q ss_pred             ceeeccCCceEEEe------EEEEEEEeecCCCCc-hHHHHHHHHHHHHHhC-CCCceeEEEEEEEeCCCeEEEEEeccC
Q 012887          196 DQIGPNSFKGVYKG------KRVGIEKLKGCDKGN-AYEFELRKDLLELMTC-GHKNILQFYCVCVDENHGLCVVTKLME  267 (454)
Q Consensus       196 ~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~-~~~~~~~~Ei~~l~~l-~HpnIv~~~g~~~~~~~~l~lV~E~~~  267 (454)
                      +.||+|+||.||++      +.+|+|.++...... .....+.+|..++..+ +||||+++++++.+.+. +|+||||++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~-~~lv~e~~~   79 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESR-LFFVIEFVS   79 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCE-EEEEEeCCC
Confidence            36899999999985      479999997543222 2334577888888887 79999999999987776 999999999


Q ss_pred             CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCcccccCCC
Q 012887          268 GGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG  347 (454)
Q Consensus       268 ~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~gt  347 (454)
                      +|+|.+++.+.+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.............||
T Consensus        80 ~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt  159 (329)
T cd05588          80 GGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGT  159 (329)
T ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCccccccCC
Confidence            99999998877899999999999999999999999999999999999999999999999999987543333334445789


Q ss_pred             CcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC--------HHHHHHHHHHcCCCCCCCCCccHHHHH
Q 012887          348 YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACS--------PVQAAVGIAACGLRPEIPKDCPQILKS  419 (454)
Q Consensus       348 ~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~--------~~~~~~~i~~~~~~~~~p~~~~~~l~~  419 (454)
                      +.|+|||++.+..+    +.++|+|||||++|+|++|..||....        .......... .....+|..++.++.+
T Consensus       160 ~~y~aPE~~~~~~~----~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~p~~~~~~~~~  234 (329)
T cd05588         160 PNYIAPEILRGEDY----GFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVIL-EKQIRIPRSLSVKASS  234 (329)
T ss_pred             ccccCHHHHcCCCC----CCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHH-cCCCCCCCCCCHHHHH
Confidence            99999999987654    445999999999999999999996321        1112222222 2345578889999999


Q ss_pred             HHHHhcccCCCCCCC------HHHHHHHH
Q 012887          420 LMIKCWNNSPSKRPQ------FSEIISLL  442 (454)
Q Consensus       420 li~~cl~~dP~~RPs------~~ell~~L  442 (454)
                      +|.+||+.||.+||+      +.++++|-
T Consensus       235 li~~~L~~dP~~R~~~~~~~~~~~i~~hp  263 (329)
T cd05588         235 VLKGFLNKDPKERLGCHPQTGFRDIKSHP  263 (329)
T ss_pred             HHHHHhccCHHHcCCCCCCCCHHHHhcCC
Confidence            999999999999997      67887763

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=1.5e-40  Score=326.53  Aligned_cols=251  Identities=25%  Similarity=0.477  Sum_probs=206.8

Q ss_pred             CEEEeceeeccCCceEEEeE-----------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeE
Q 012887          191 NLEFIDQIGPNSFKGVYKGK-----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGL  259 (454)
Q Consensus       191 ~~~~~~~LG~G~fG~Vy~g~-----------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l  259 (454)
                      +|++.+.||+|+||.||+|.           .+++|.+... ........+.+|+..+..++||||+++++.+...+. .
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~   78 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKEN-ASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGP-L   78 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCC-CCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCC-c
Confidence            46788999999999999974           4777777532 222334568889999999999999999999987776 8


Q ss_pred             EEEEeccCCCCHHHHHHhC------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcE
Q 012887          260 CVVTKLMEGGSVNDLILKS------------------------RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRI  315 (454)
Q Consensus       260 ~lV~E~~~~gsL~~~l~~~------------------------~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NI  315 (454)
                      ++||||+.+++|.+++...                        ..+++..+..++.|++.||+|||+++++||||||+||
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ni  158 (290)
T cd05045          79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNV  158 (290)
T ss_pred             EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheE
Confidence            9999999999999998542                        2478889999999999999999999999999999999


Q ss_pred             EEccCCcEEEEccCCccccccCCC--cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCC
Q 012887          316 LLDRHGNVCLGDMGIVTACKSVGE--ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACS  392 (454)
Q Consensus       316 Ll~~~~~vKL~DFGla~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~  392 (454)
                      |+++++.+||+|||++........  ......++..|+|||.+.+..    ++.++||||||+++|||++ |..||.+..
T Consensus       159 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~----~~~~~Di~slG~~l~el~t~g~~p~~~~~  234 (290)
T cd05045         159 LVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHI----YTTQSDVWSFGVLLWEIVTLGGNPYPGIA  234 (290)
T ss_pred             EEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCC----cchHhHHHHHHHHHHHHHhcCCCCCCCCC
Confidence            999999999999999875433221  112224467899999987654    4456999999999999998 999998876


Q ss_pred             HHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCC
Q 012887          393 PVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNI  448 (454)
Q Consensus       393 ~~~~~~~i~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~  448 (454)
                      +.... .......+...|..++.++.+++.+||+.+|.+||++.++++.|+++...
T Consensus       235 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~  289 (290)
T cd05045         235 PERLF-NLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK  289 (290)
T ss_pred             HHHHH-HHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence            65544 34445566667888999999999999999999999999999999988654

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=3.2e-41  Score=336.67  Aligned_cols=239  Identities=22%  Similarity=0.337  Sum_probs=196.7

Q ss_pred             ceeeccCCceEEEe------EEEEEEEeecCCC-CchHHHHHHHHHHHHHh-CCCCceeEEEEEEEeCCCeEEEEEeccC
Q 012887          196 DQIGPNSFKGVYKG------KRVGIEKLKGCDK-GNAYEFELRKDLLELMT-CGHKNILQFYCVCVDENHGLCVVTKLME  267 (454)
Q Consensus       196 ~~LG~G~fG~Vy~g------~~vavK~l~~~~~-~~~~~~~~~~Ei~~l~~-l~HpnIv~~~g~~~~~~~~l~lV~E~~~  267 (454)
                      +.||+|+||.||+|      +.+|+|.++.... ..........|..++.. ++||||+++++++.+.+. +++||||++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~-~~lv~ey~~   79 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKEN-LFFVMEYLN   79 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCE-EEEEEeCCC
Confidence            46999999999986      4699999874321 11222334556666665 589999999999988776 999999999


Q ss_pred             CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCcccccCCC
Q 012887          268 GGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG  347 (454)
Q Consensus       268 ~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~gt  347 (454)
                      +|+|.+++.+...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..............||
T Consensus        80 ~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt  159 (316)
T cd05619          80 GGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGT  159 (316)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeecCC
Confidence            99999999877789999999999999999999999999999999999999999999999999987543322233445689


Q ss_pred             CcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhccc
Q 012887          348 YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNN  427 (454)
Q Consensus       348 ~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~li~~cl~~  427 (454)
                      +.|+|||++.+..+    +.++|||||||++|||++|..||.+.+.......+...  .+.+|..++.++.+++.+||+.
T Consensus       160 ~~y~aPE~~~~~~~----~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~li~~~l~~  233 (316)
T cd05619         160 PDYIAPEILLGQKY----NTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMD--NPCYPRWLTREAKDILVKLFVR  233 (316)
T ss_pred             ccccCHHHHcCCCC----CchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCCccCCHHHHHHHHHHhcc
Confidence            99999999987654    44699999999999999999999988776665555443  3456777899999999999999


Q ss_pred             CCCCCCCHH-HHHHH
Q 012887          428 SPSKRPQFS-EIISL  441 (454)
Q Consensus       428 dP~~RPs~~-ell~~  441 (454)
                      ||.+||++. +++.+
T Consensus       234 ~P~~R~~~~~~l~~h  248 (316)
T cd05619         234 EPERRLGVKGDIRQH  248 (316)
T ss_pred             CHhhcCCChHHHHcC
Confidence            999999996 67654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=2.1e-40  Score=325.30  Aligned_cols=255  Identities=25%  Similarity=0.453  Sum_probs=207.8

Q ss_pred             eeecCCCEEEeceeeccCCceEEEeE-----------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEE
Q 012887          185 WLLNSDNLEFIDQIGPNSFKGVYKGK-----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCV  253 (454)
Q Consensus       185 ~~~~~~~~~~~~~LG~G~fG~Vy~g~-----------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~  253 (454)
                      |.+..++|++.+.||+|+||.||+|.           .+|+|.+.... .......+.+|+..+..++||||+++++++.
T Consensus         1 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   79 (288)
T cd05061           1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-SLRERIEFLNEASVMKGFTCHHVVRLLGVVS   79 (288)
T ss_pred             CcccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence            56777899999999999999999863           58888876332 2233455778999999999999999999988


Q ss_pred             eCCCeEEEEEeccCCCCHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcE
Q 012887          254 DENHGLCVVTKLMEGGSVNDLILKS----------RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV  323 (454)
Q Consensus       254 ~~~~~l~lV~E~~~~gsL~~~l~~~----------~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~v  323 (454)
                      +.+. .++||||+++|+|.+++.+.          ..++...+..++.|++.||.|||+++|+||||||+|||++.++.+
T Consensus        80 ~~~~-~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~  158 (288)
T cd05061          80 KGQP-TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTV  158 (288)
T ss_pred             CCCC-cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcE
Confidence            7775 89999999999999999642          234667889999999999999999999999999999999999999


Q ss_pred             EEEccCCccccccCCCcc--cccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHH
Q 012887          324 CLGDMGIVTACKSVGEAT--EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGI  400 (454)
Q Consensus       324 KL~DFGla~~~~~~~~~~--~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~i  400 (454)
                      ||+|||+++.........  ....++..|+|||.+.+..    .+.++|||||||++|||++ |..||.+....+....+
T Consensus       159 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~----~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~  234 (288)
T cd05061         159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGV----FTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV  234 (288)
T ss_pred             EECcCCccccccccccccccCCCcccccccCHHHhccCC----CChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            999999987543322111  1123456799999987654    3456999999999999998 89999887666544444


Q ss_pred             HHcCCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 012887          401 AACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTN  446 (454)
Q Consensus       401 ~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~  446 (454)
                      . .+.....+..+++.+.+++.+||+.||.+||++.++++.|....
T Consensus       235 ~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~  279 (288)
T cd05061         235 M-DGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL  279 (288)
T ss_pred             H-cCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence            3 34445567788999999999999999999999999999998743

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=1.5e-40  Score=330.85  Aligned_cols=258  Identities=24%  Similarity=0.480  Sum_probs=212.8

Q ss_pred             cceeecCCCEEEeceeeccCCceEEEeE-------------EEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEE
Q 012887          183 GRWLLNSDNLEFIDQIGPNSFKGVYKGK-------------RVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQF  248 (454)
Q Consensus       183 ~~~~~~~~~~~~~~~LG~G~fG~Vy~g~-------------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~~  248 (454)
                      ..|.+..++|.+.+.||+|+||.||+++             .+|+|.++.. ........+..|+.++..+ +||||+++
T Consensus         5 ~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~   83 (314)
T cd05099           5 PKWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDN-ATDKDLADLISEMELMKLIGKHKNIINL   83 (314)
T ss_pred             ccccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCC-CChHHHHHHHHHHHHHHhccCCCCeeeE
Confidence            4577788999999999999999999874             4888887643 2233445678899999988 69999999


Q ss_pred             EEEEEeCCCeEEEEEeccCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccC
Q 012887          249 YCVCVDENHGLCVVTKLMEGGSVNDLILKS----------------RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNS  312 (454)
Q Consensus       249 ~g~~~~~~~~l~lV~E~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp  312 (454)
                      ++++.+.+. +++||||+++|+|.+++...                ..+++..+..++.||+.||.|||++|++||||||
T Consensus        84 ~~~~~~~~~-~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp  162 (314)
T cd05099          84 LGVCTQEGP-LYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAA  162 (314)
T ss_pred             EEEEccCCc-eEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccc
Confidence            999987765 89999999999999999643                2478889999999999999999999999999999


Q ss_pred             CcEEEccCCcEEEEccCCccccccCCCc--ccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCC
Q 012887          313 QRILLDRHGNVCLGDMGIVTACKSVGEA--TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYA  389 (454)
Q Consensus       313 ~NILl~~~~~vKL~DFGla~~~~~~~~~--~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~  389 (454)
                      +|||++.++.+||+|||+++........  .....+++.|+|||.+.+..    ++.++|||||||++|+|++ |..||.
T Consensus       163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~DiwslG~~l~el~~~g~~p~~  238 (314)
T cd05099         163 RNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRV----YTHQSDVWSFGILMWEIFTLGGSPYP  238 (314)
T ss_pred             eeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCC----cCccchhhHHHHHHHHHHhCCCCCCC
Confidence            9999999999999999998765432211  11223346799999987654    3456999999999999999 899998


Q ss_pred             CCCHHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 012887          390 ACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNN  447 (454)
Q Consensus       390 ~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~  447 (454)
                      +.........+ ..+.....|..++.++.+++.+||..+|.+||++.++++.|+++..
T Consensus       239 ~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~  295 (314)
T cd05099         239 GIPVEELFKLL-REGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA  295 (314)
T ss_pred             CCCHHHHHHHH-HcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence            77665544443 4455566778899999999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.2e-40  Score=350.98  Aligned_cols=244  Identities=17%  Similarity=0.243  Sum_probs=204.5

Q ss_pred             CCEEEeceeeccCCceEEEe-------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG-------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  262 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g-------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV  262 (454)
                      ..|.+.+.||+|+||.||++       ..|++|.+...  .......+.+|+..|..++|||||++++++...+. +|+|
T Consensus        67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~-~~lv  143 (478)
T PTZ00267         67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN--DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDK-LLLI  143 (478)
T ss_pred             eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCE-EEEE
Confidence            44899999999999999985       35777766422  22333457789999999999999999999998876 9999


Q ss_pred             EeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCC
Q 012887          263 TKLMEGGSVNDLILK----SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG  338 (454)
Q Consensus       263 ~E~~~~gsL~~~l~~----~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~  338 (454)
                      |||+++|+|.+++.+    ..++++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||++.......
T Consensus       144 ~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~  223 (478)
T PTZ00267        144 MEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV  223 (478)
T ss_pred             EECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence            999999999988743    3468999999999999999999999999999999999999999999999999988654322


Q ss_pred             C--cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHH
Q 012887          339 E--ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQI  416 (454)
Q Consensus       339 ~--~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~  416 (454)
                      .  ......||+.|+|||++.+..    ++.++|||||||++|+|++|..||.+.+.......+... ...++|..++.+
T Consensus       224 ~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~-~~~~~~~~~s~~  298 (478)
T PTZ00267        224 SLDVASSFCGTPYYLAPELWERKR----YSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYG-KYDPFPCPVSSG  298 (478)
T ss_pred             ccccccccCCCccccCHhHhCCCC----CCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-CCCCCCccCCHH
Confidence            1  123346899999999998764    445699999999999999999999987777666666553 334567788999


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHHH
Q 012887          417 LKSLMIKCWNNSPSKRPQFSEIISL  441 (454)
Q Consensus       417 l~~li~~cl~~dP~~RPs~~ell~~  441 (454)
                      +.++|.+||..||++||++.+++.+
T Consensus       299 ~~~li~~~L~~dP~~Rps~~~~l~~  323 (478)
T PTZ00267        299 MKALLDPLLSKNPALRPTTQQLLHT  323 (478)
T ss_pred             HHHHHHHHhccChhhCcCHHHHHhC
Confidence            9999999999999999999999764

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-42  Score=353.29  Aligned_cols=252  Identities=26%  Similarity=0.472  Sum_probs=219.7

Q ss_pred             cceeecCCCEEEeceeeccCCceEEEeE---------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEE
Q 012887          183 GRWLLNSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCV  253 (454)
Q Consensus       183 ~~~~~~~~~~~~~~~LG~G~fG~Vy~g~---------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~  253 (454)
                      .+-+|..+++.+.++||+|+||.|++|.         .||||.++... ....-.+|.+|+.+|.+|+|+|++++||+..
T Consensus       103 lkclIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~-l~~~mddflrEas~M~~L~H~hliRLyGvVl  181 (1039)
T KOG0199|consen  103 LKCLIPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDS-LNAIMDDFLREASHMLKLQHPHLIRLYGVVL  181 (1039)
T ss_pred             cceeccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCc-cchhHHHHHHHHHHHHhccCcceeEEeeeec
Confidence            3567888899999999999999999973         69999998543 3335677999999999999999999999998


Q ss_pred             eCCCeEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCc
Q 012887          254 DENHGLCVVTKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIV  331 (454)
Q Consensus       254 ~~~~~l~lV~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla  331 (454)
                      +.  .+.||||+++.|||.+.|++.  ..|....+..|+.||+.||.||.++++|||||..+|+|+...-.|||+||||.
T Consensus       182 ~q--p~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLm  259 (1039)
T KOG0199|consen  182 DQ--PAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLM  259 (1039)
T ss_pred             cc--hhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccce
Confidence            74  388999999999999999762  37888999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCccccc---CCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHcCCCC
Q 012887          332 TACKSVGEATEYE---TDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRP  407 (454)
Q Consensus       332 ~~~~~~~~~~~~~---~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~  407 (454)
                      +.+..........   .-.+.|.|||.+....    ++.+||||+|||+||||+| |+.||.+.....++..+- .+.++
T Consensus       260 RaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~k----FShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD-~~erL  334 (1039)
T KOG0199|consen  260 RALGENEDMYVMAPQRKVPFAWCAPESLRHRK----FSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNID-AGERL  334 (1039)
T ss_pred             eccCCCCcceEecCCCcCcccccCHhHhcccc----ccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcc-ccccC
Confidence            8876654322111   2357899999998765    5566999999999999999 999999999998887777 78899


Q ss_pred             CCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 012887          408 EIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL  442 (454)
Q Consensus       408 ~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L  442 (454)
                      +-|..||++++++|..||..+|.+||+|..|.+.+
T Consensus       335 pRPk~csedIY~imk~cWah~paDRptFsair~~~  369 (1039)
T KOG0199|consen  335 PRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL  369 (1039)
T ss_pred             CCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence            99999999999999999999999999999997443

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=1.3e-40  Score=326.89  Aligned_cols=257  Identities=28%  Similarity=0.498  Sum_probs=212.4

Q ss_pred             cceeecCCCEEEeceeeccCCceEEEeE-----------EEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEEEE
Q 012887          183 GRWLLNSDNLEFIDQIGPNSFKGVYKGK-----------RVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYC  250 (454)
Q Consensus       183 ~~~~~~~~~~~~~~~LG~G~fG~Vy~g~-----------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~~~g  250 (454)
                      ..|.+..++|++.+.||+|+||.||++.           .+|+|.+... ........+.+|+.++..+ +|+||+++++
T Consensus         5 ~~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~   83 (293)
T cd05053           5 PEWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINLLG   83 (293)
T ss_pred             cccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCC-CCHHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence            4577888999999999999999999874           5788887643 2233445678899999998 7999999999


Q ss_pred             EEEeCCCeEEEEEeccCCCCHHHHHHh----------------CCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCc
Q 012887          251 VCVDENHGLCVVTKLMEGGSVNDLILK----------------SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQR  314 (454)
Q Consensus       251 ~~~~~~~~l~lV~E~~~~gsL~~~l~~----------------~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~N  314 (454)
                      ++...+. ++++|||+++|+|.+++..                ...+++..+..++.||+.||.|||+++|+||||||+|
T Consensus        84 ~~~~~~~-~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~N  162 (293)
T cd05053          84 VCTQEGP-LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARN  162 (293)
T ss_pred             EEcCCCC-eEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceee
Confidence            9987776 9999999999999999853                2368899999999999999999999999999999999


Q ss_pred             EEEccCCcEEEEccCCccccccCCCc--ccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 012887          315 ILLDRHGNVCLGDMGIVTACKSVGEA--TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAAC  391 (454)
Q Consensus       315 ILl~~~~~vKL~DFGla~~~~~~~~~--~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~  391 (454)
                      ||++.++.+||+|||+++........  .....+++.|+|||.+.+..    ++.++|||||||++|||++ |..||.+.
T Consensus       163 il~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~Di~slG~il~el~~~g~~p~~~~  238 (293)
T cd05053         163 VLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRV----YTHQSDVWSFGVLLWEIFTLGGSPYPGI  238 (293)
T ss_pred             EEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCC----cCcccceeehhhHHHHHhcCCCCCCCCC
Confidence            99999999999999998765432211  12223456799999987654    3456999999999999998 99999887


Q ss_pred             CHHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 012887          392 SPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTN  446 (454)
Q Consensus       392 ~~~~~~~~i~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~  446 (454)
                      ...+... ....+..+..|..++.++.+++.+||..||.+|||+.|+++.|..+.
T Consensus       239 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         239 PVEELFK-LLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             CHHHHHH-HHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence            6655443 34445566677888999999999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=1.1e-40  Score=327.64  Aligned_cols=260  Identities=19%  Similarity=0.352  Sum_probs=213.1

Q ss_pred             cccceeecCCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEe
Q 012887          181 EIGRWLLNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVD  254 (454)
Q Consensus       181 ~~~~~~~~~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~  254 (454)
                      .++++....+.|++++.||.|+||.||+|      +.+++|.+...  .......+.+|+..+..++||||+++++.+..
T Consensus         3 ~~~~~~~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   80 (292)
T cd06644           3 HVRRDLDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEILATCNHPYIVKLLGAFYW   80 (292)
T ss_pred             hhhcccCcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEe
Confidence            45677788899999999999999999985      46888887632  23344567789999999999999999999987


Q ss_pred             CCCeEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccc
Q 012887          255 ENHGLCVVTKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTA  333 (454)
Q Consensus       255 ~~~~l~lV~E~~~~gsL~~~l~~-~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~  333 (454)
                      ++. .++||||+++++|..++.+ ...+++..+..++.|++.||.|||+++++||||||+||+++.++.+||+|||++..
T Consensus        81 ~~~-~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~  159 (292)
T cd06644          81 DGK-LWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAK  159 (292)
T ss_pred             CCe-EEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCcccee
Confidence            775 9999999999999988754 45799999999999999999999999999999999999999999999999999765


Q ss_pred             cccCCCcccccCCCCcccccccccCCCC-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCC-CCCCCC
Q 012887          334 CKSVGEATEYETDGYRWLAPEIIAGDPE-SVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGL-RPEIPK  411 (454)
Q Consensus       334 ~~~~~~~~~~~~gt~~y~APE~l~~~~~-~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~-~~~~p~  411 (454)
                      ............+++.|+|||.+.+... ...++.++|||||||++|+|++|..||...++......+..... ....+.
T Consensus       160 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  239 (292)
T cd06644         160 NVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPS  239 (292)
T ss_pred             ccccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCc
Confidence            4433333344567888999999864332 22356679999999999999999999988776655544443222 223456


Q ss_pred             CccHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 012887          412 DCPQILKSLMIKCWNNSPSKRPQFSEIISLLL  443 (454)
Q Consensus       412 ~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~  443 (454)
                      .++.++.++|.+||..+|++||++.+++++-+
T Consensus       240 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~  271 (292)
T cd06644         240 KWSMEFRDFLKTALDKHPETRPSAAQLLEHPF  271 (292)
T ss_pred             ccCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence            78899999999999999999999999988644

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-41  Score=330.38  Aligned_cols=248  Identities=20%  Similarity=0.274  Sum_probs=206.5

Q ss_pred             CCEEEeceeeccCCceEEE------eEEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeC----CCeE
Q 012887          190 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDE----NHGL  259 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~------g~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~----~~~l  259 (454)
                      ..|..++.||+|+||.|..      |+.||||++...........+..+|+..|+.++|+||+.+++++..+    -+.+
T Consensus        22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~Dv  101 (359)
T KOG0660|consen   22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDV  101 (359)
T ss_pred             ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccccee
Confidence            5566689999999999997      57899999987666666778889999999999999999999998762    2449


Q ss_pred             EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccC--
Q 012887          260 CVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV--  337 (454)
Q Consensus       260 ~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~--  337 (454)
                      |+|+|+|+. +|.+.++.+..+++..+..++.||++||.|+|+.+|+||||||.|+|++.+..+||+|||+|+.....  
T Consensus       102 YiV~elMet-DL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~  180 (359)
T KOG0660|consen  102 YLVFELMET-DLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFE  180 (359)
T ss_pred             EEehhHHhh-HHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccccCc
Confidence            999999955 99999988778999999999999999999999999999999999999999999999999999987643  


Q ss_pred             CCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH---------------
Q 012887          338 GEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAA---------------  402 (454)
Q Consensus       338 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~---------------  402 (454)
                      ....+....|-+|.|||.+...   ..|+.+.||||.|||+.||++|++.|++.+....+..+..               
T Consensus       181 ~~~mTeYVaTRWYRAPElll~~---~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s  257 (359)
T KOG0660|consen  181 DGFMTEYVATRWYRAPELLLNS---SEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRS  257 (359)
T ss_pred             ccchhcceeeeeecCHHHHhcc---ccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhcc
Confidence            1222334568889999998643   3467779999999999999999999998776654443321               


Q ss_pred             ---------cCCCCCCC-----CCccHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012887          403 ---------CGLRPEIP-----KDCPQILKSLMIKCWNNSPSKRPQFSEIISL  441 (454)
Q Consensus       403 ---------~~~~~~~p-----~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  441 (454)
                               ....+..|     .+.++...+|+.+||..||.+|+|++|.++|
T Consensus       258 ~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h  310 (359)
T KOG0660|consen  258 EKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH  310 (359)
T ss_pred             HHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence                     11111111     2568899999999999999999999999986

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=1.8e-41  Score=344.19  Aligned_cols=248  Identities=19%  Similarity=0.308  Sum_probs=204.7

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCC-chHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  262 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV  262 (454)
                      ++|++++.||+|+||.||++      +.+|+|.+...... ......+.+|+.++..++||||+++++.+.+.+. +|+|
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~-~~lv   79 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRN-LYLI   79 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE-EEEE
Confidence            47899999999999999985      57999998743221 2234557789999999999999999999988776 9999


Q ss_pred             EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCC---
Q 012887          263 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE---  339 (454)
Q Consensus       263 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~---  339 (454)
                      |||+++|+|.+++.+.+.+++..+..++.||+.||+|||++||+||||||+|||++.++++||+|||++........   
T Consensus        80 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~  159 (360)
T cd05627          80 MEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEF  159 (360)
T ss_pred             EeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCccccccccccc
Confidence            99999999999998888899999999999999999999999999999999999999999999999999765422100   


Q ss_pred             --------------------------------cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCC
Q 012887          340 --------------------------------ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAA  387 (454)
Q Consensus       340 --------------------------------~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~P  387 (454)
                                                      ......||+.|+|||++.+..++    .++|||||||++|||++|..|
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~----~~~DiwSlGvilyel~tG~~P  235 (360)
T cd05627         160 YRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYN----KLCDWWSLGVIMYEMLIGYPP  235 (360)
T ss_pred             ccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCC----CcceeccccceeeecccCCCC
Confidence                                            01123688999999999876544    459999999999999999999


Q ss_pred             CCCCCHHHHHHHHHHcCCCCCCCC--CccHHHHHHHHHhcccCCCCCCC---HHHHHHHHH
Q 012887          388 YAACSPVQAAVGIAACGLRPEIPK--DCPQILKSLMIKCWNNSPSKRPQ---FSEIISLLL  443 (454)
Q Consensus       388 f~~~~~~~~~~~i~~~~~~~~~p~--~~~~~l~~li~~cl~~dP~~RPs---~~ell~~L~  443 (454)
                      |.+.++......+........+|.  .+++++.++|.+++ .||.+|++   +.+++.|-+
T Consensus       236 f~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~  295 (360)
T cd05627         236 FCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPF  295 (360)
T ss_pred             CCCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcCCC
Confidence            998888777666665444444454  36899999999977 49999984   788887743

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-42  Score=321.33  Aligned_cols=253  Identities=20%  Similarity=0.383  Sum_probs=212.4

Q ss_pred             ceeecCCCEEEeceeeccCCceEEE------eEEEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEEEEEEEeCC
Q 012887          184 RWLLNSDNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVDEN  256 (454)
Q Consensus       184 ~~~~~~~~~~~~~~LG~G~fG~Vy~------g~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~~~g~~~~~~  256 (454)
                      ++..+.++++++..||+|+.|.|++      |..+|||.++..... ....++.+.+.++... +.|+||+++|+|..+.
T Consensus        86 r~~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nk-ee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~  164 (391)
T KOG0983|consen   86 RYQADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNK-EENKRILMDLDVVLKSHDCPYIVQCFGYFITNT  164 (391)
T ss_pred             ccccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCH-HHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCc
Confidence            4556667889999999999999998      468999999854332 3445677888776654 4899999999999877


Q ss_pred             CeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHh-cCcccCCccCCcEEEccCCcEEEEccCCcccc
Q 012887          257 HGLCVVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLND-HGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC  334 (454)
Q Consensus       257 ~~l~lV~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qI~~gL~yLH~-~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~  334 (454)
                      . +++.||.|.- .++.++++. +++++..+..+...++.||.||.+ ++|||||+||+|||+|+.|++||||||++.++
T Consensus       165 d-V~IcMelMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrl  242 (391)
T KOG0983|consen  165 D-VFICMELMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRL  242 (391)
T ss_pred             h-HHHHHHHHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeeccccccee
Confidence            6 8899999954 888887654 489999999999999999999975 68999999999999999999999999999887


Q ss_pred             ccCCCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCC--
Q 012887          335 KSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKD--  412 (454)
Q Consensus       335 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~--  412 (454)
                      .+.. ..+...|.+.|||||.+.... ..+|+.++||||||++++||.||++||.+..........+.+..+|.+|..  
T Consensus       243 vdSk-AhtrsAGC~~YMaPERidp~~-~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~g  320 (391)
T KOG0983|consen  243 VDSK-AHTRSAGCAAYMAPERIDPPD-KPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMG  320 (391)
T ss_pred             eccc-ccccccCCccccCccccCCCC-CCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccC
Confidence            6543 455668899999999998664 457888999999999999999999999997665554444445666777653  


Q ss_pred             ccHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012887          413 CPQILKSLMIKCWNNSPSKRPQFSEIISL  441 (454)
Q Consensus       413 ~~~~l~~li~~cl~~dP~~RPs~~ell~~  441 (454)
                      +|+.+.+++..||.+|+.+||.+.++++|
T Consensus       321 FSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h  349 (391)
T KOG0983|consen  321 FSPDFQSFVKDCLTKDHRKRPKYNKLLEH  349 (391)
T ss_pred             cCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence            79999999999999999999999999986

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=1.1e-40  Score=321.02  Aligned_cols=249  Identities=25%  Similarity=0.503  Sum_probs=207.8

Q ss_pred             eeecCCCEEEeceeeccCCceEEEe----EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEE
Q 012887          185 WLLNSDNLEFIDQIGPNSFKGVYKG----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLC  260 (454)
Q Consensus       185 ~~~~~~~~~~~~~LG~G~fG~Vy~g----~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~  260 (454)
                      |.++.++|++.+.||+|+||.||++    ..+++|.++..    .....+.+|+.+++.++|+|++++++++...+...+
T Consensus         1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   76 (256)
T cd05082           1 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY   76 (256)
T ss_pred             CCccHHhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCC----chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceE
Confidence            4566789999999999999999985    56888887532    223467889999999999999999998776655589


Q ss_pred             EEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCC
Q 012887          261 VVTKLMEGGSVNDLILKSR--KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG  338 (454)
Q Consensus       261 lV~E~~~~gsL~~~l~~~~--~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~  338 (454)
                      +||||+++++|.+++.+..  .+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus        77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  156 (256)
T cd05082          77 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ  156 (256)
T ss_pred             EEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccccC
Confidence            9999999999999986543  58999999999999999999999999999999999999999999999999977543321


Q ss_pred             CcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHH
Q 012887          339 EATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQIL  417 (454)
Q Consensus       339 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l  417 (454)
                         .....+..|+|||++.+..    ++.++|||||||++|+|++ |..||...........+ ..+..+..+..+++.+
T Consensus       157 ---~~~~~~~~y~aPE~~~~~~----~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  228 (256)
T cd05082         157 ---DTGKLPVKWTAPEALREKK----FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV-EKGYKMDAPDGCPPVV  228 (256)
T ss_pred             ---CCCccceeecCHHHHccCC----CCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-hcCCCCCCCCCCCHHH
Confidence               2223456799999987654    4456999999999999998 99999876665544443 3455667778899999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 012887          418 KSLMIKCWNNSPSKRPQFSEIISLLLRT  445 (454)
Q Consensus       418 ~~li~~cl~~dP~~RPs~~ell~~L~~~  445 (454)
                      .+++.+||+.+|++|||+.++++.|.++
T Consensus       229 ~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         229 YDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             HHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence            9999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1.7e-40  Score=322.06  Aligned_cols=248  Identities=24%  Similarity=0.449  Sum_probs=201.7

Q ss_pred             EEeceeeccCCceEEEeE--------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCC-----CeE
Q 012887          193 EFIDQIGPNSFKGVYKGK--------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN-----HGL  259 (454)
Q Consensus       193 ~~~~~LG~G~fG~Vy~g~--------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~-----~~l  259 (454)
                      .+.+.||+|+||.||+|.        .+|+|.++...........+.+|+..+..++||||+++++++....     ...
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   81 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP   81 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence            467889999999999974        5888888754444444566788999999999999999999875431     136


Q ss_pred             EEEEeccCCCCHHHHHHh------CCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccc
Q 012887          260 CVVTKLMEGGSVNDLILK------SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTA  333 (454)
Q Consensus       260 ~lV~E~~~~gsL~~~l~~------~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~  333 (454)
                      +++|||+++|+|.+++..      ...+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++.
T Consensus        82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  161 (272)
T cd05075          82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKK  161 (272)
T ss_pred             EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcccc
Confidence            899999999999988732      23588999999999999999999999999999999999999999999999999876


Q ss_pred             cccCCCc--ccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHcCCCCCCC
Q 012887          334 CKSVGEA--TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIP  410 (454)
Q Consensus       334 ~~~~~~~--~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p  410 (454)
                      .......  .....+++.|+|||.+.+..    ++.++||||||+++|||++ |..||.+.........+ ..+..+..+
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~----~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~-~~~~~~~~~  236 (272)
T cd05075         162 IYNGDYYRQGRIAKMPVKWIAIESLADRV----YTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYL-RQGNRLKQP  236 (272)
T ss_pred             cCcccceecCCcccCCcccCCHHHccCCC----cChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-HcCCCCCCC
Confidence            5432211  12224567899999998664    3456999999999999999 89999887665544443 344555667


Q ss_pred             CCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 012887          411 KDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRT  445 (454)
Q Consensus       411 ~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~  445 (454)
                      ..++..+.++|.+||+.||.+|||+.+|++.|.++
T Consensus       237 ~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         237 PDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            78899999999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=5.3e-41  Score=336.03  Aligned_cols=244  Identities=21%  Similarity=0.290  Sum_probs=201.7

Q ss_pred             CEEEeceeeccCCceEEEe------EEEEEEEeecCCC-CchHHHHHHHHHHHHHhCC-CCceeEEEEEEEeCCCeEEEE
Q 012887          191 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDK-GNAYEFELRKDLLELMTCG-HKNILQFYCVCVDENHGLCVV  262 (454)
Q Consensus       191 ~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~-~~~~~~~~~~Ei~~l~~l~-HpnIv~~~g~~~~~~~~l~lV  262 (454)
                      +|++.+.||+|+||.||++      +.||+|.+..... .......+..|+.++..+. |++|+++++++.+.+. +|+|
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~-~~lv   79 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDR-LYFV   79 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCE-EEEE
Confidence            4678899999999999985      4799999874321 1222334567777777775 5778889888887765 9999


Q ss_pred             EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCccc
Q 012887          263 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE  342 (454)
Q Consensus       263 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~  342 (454)
                      |||+++|+|.+++.+...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...........
T Consensus        80 ~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~~  159 (323)
T cd05615          80 MEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTR  159 (323)
T ss_pred             EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCcccc
Confidence            99999999999998878899999999999999999999999999999999999999999999999999875433333334


Q ss_pred             ccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHHHHHH
Q 012887          343 YETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMI  422 (454)
Q Consensus       343 ~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~li~  422 (454)
                      ...|++.|+|||++.+..+    +.++|||||||++|+|++|..||.+.+.......+...  ...+|..++.++.+++.
T Consensus       160 ~~~gt~~y~aPE~~~~~~~----~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~--~~~~p~~~~~~~~~li~  233 (323)
T cd05615         160 TFCGTPDYIAPEIIAYQPY----GKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEH--NVSYPKSLSKEAVSICK  233 (323)
T ss_pred             CccCCccccCHHHHcCCCC----CCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCCccCCHHHHHHHH
Confidence            4568999999999987654    44599999999999999999999988877766666553  34577889999999999


Q ss_pred             HhcccCCCCCCCH-----HHHHHH
Q 012887          423 KCWNNSPSKRPQF-----SEIISL  441 (454)
Q Consensus       423 ~cl~~dP~~RPs~-----~ell~~  441 (454)
                      +||+.+|.+|++.     .++++|
T Consensus       234 ~~l~~~p~~R~~~~~~~~~~i~~h  257 (323)
T cd05615         234 GLMTKHPSKRLGCGPEGERDIREH  257 (323)
T ss_pred             HHcccCHhhCCCCCCCCHHHHhcC
Confidence            9999999999984     555554

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=2.5e-41  Score=338.04  Aligned_cols=239  Identities=20%  Similarity=0.258  Sum_probs=196.3

Q ss_pred             ceeeccCCceEEEe------EEEEEEEeecCCCC-chHHHHHHHHHH-HHHhCCCCceeEEEEEEEeCCCeEEEEEeccC
Q 012887          196 DQIGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLL-ELMTCGHKNILQFYCVCVDENHGLCVVTKLME  267 (454)
Q Consensus       196 ~~LG~G~fG~Vy~g------~~vavK~l~~~~~~-~~~~~~~~~Ei~-~l~~l~HpnIv~~~g~~~~~~~~l~lV~E~~~  267 (454)
                      +.||+|+||.||++      +.+|+|.+...... ......+..|.. .+..++||||+++++++.+.+. +++||||++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~-~~lv~e~~~   79 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADK-LYFVLDYVN   79 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCE-EEEEEcCCC
Confidence            36999999999985      46999998643221 112233445544 4567899999999999987775 999999999


Q ss_pred             CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCcccccCCC
Q 012887          268 GGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG  347 (454)
Q Consensus       268 ~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~gt  347 (454)
                      +|+|.+++.+.+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..............|+
T Consensus        80 ~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt  159 (323)
T cd05575          80 GGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGT  159 (323)
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccccccCC
Confidence            99999999887889999999999999999999999999999999999999999999999999987543333334445689


Q ss_pred             CcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhccc
Q 012887          348 YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNN  427 (454)
Q Consensus       348 ~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~li~~cl~~  427 (454)
                      +.|+|||++.+..+    +.++|||||||++|+|++|..||...+..+....+...  ...++..++..+.++|.+||+.
T Consensus       160 ~~y~aPE~~~~~~~----~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~li~~~l~~  233 (323)
T cd05575         160 PEYLAPEVLRKQPY----DRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNK--PLRLKPNISVSARHLLEGLLQK  233 (323)
T ss_pred             hhhcChhhhcCCCC----CccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHHHHHHHHHHhhc
Confidence            99999999987654    44599999999999999999999987776666555543  3446677899999999999999


Q ss_pred             CCCCCCCH----HHHHHH
Q 012887          428 SPSKRPQF----SEIISL  441 (454)
Q Consensus       428 dP~~RPs~----~ell~~  441 (454)
                      ||.+||++    .+++++
T Consensus       234 ~p~~R~~~~~~~~~il~~  251 (323)
T cd05575         234 DRTKRLGAKDDFLEIKNH  251 (323)
T ss_pred             CHHhCCCCCCCHHHHHcC
Confidence            99999987    466654

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=1.5e-40  Score=320.79  Aligned_cols=250  Identities=27%  Similarity=0.491  Sum_probs=207.9

Q ss_pred             eeecCCCEEEeceeeccCCceEEEe-----EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeE
Q 012887          185 WLLNSDNLEFIDQIGPNSFKGVYKG-----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGL  259 (454)
Q Consensus       185 ~~~~~~~~~~~~~LG~G~fG~Vy~g-----~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l  259 (454)
                      |.+..++|++++.||+|+||.||++     +.+|+|.+.....   ....+.+|+.++++++|+||+++++++.. +. .
T Consensus         1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~-~   75 (260)
T cd05067           1 WEVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM---SPEAFLAEANLMKQLQHPRLVRLYAVVTQ-EP-I   75 (260)
T ss_pred             CccchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC---cHHHHHHHHHHHHhcCCcCeeeEEEEEcc-CC-c
Confidence            4567789999999999999999985     5799998874332   23467889999999999999999998743 33 8


Q ss_pred             EEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccC
Q 012887          260 CVVTKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV  337 (454)
Q Consensus       260 ~lV~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~  337 (454)
                      +++|||+++++|.+++.+.  ..+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++......
T Consensus        76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  155 (260)
T cd05067          76 YIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDN  155 (260)
T ss_pred             EEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCC
Confidence            9999999999999998543  37899999999999999999999999999999999999999999999999998765422


Q ss_pred             CC-cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHcCCCCCCCCCccH
Q 012887          338 GE-ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ  415 (454)
Q Consensus       338 ~~-~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~  415 (454)
                      .. ......++..|+|||++.+..+    +.++||||||+++|||++ |..||.+.+.......+ ..+.+.+.+..++.
T Consensus       156 ~~~~~~~~~~~~~y~~pe~~~~~~~----~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~  230 (260)
T cd05067         156 EYTAREGAKFPIKWTAPEAINYGTF----TIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNL-ERGYRMPRPDNCPE  230 (260)
T ss_pred             CcccccCCcccccccCHHHhccCCc----CcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHH-HcCCCCCCCCCCCH
Confidence            21 1222345678999999986654    345999999999999999 99999887665554443 34556677788899


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 012887          416 ILKSLMIKCWNNSPSKRPQFSEIISLLLR  444 (454)
Q Consensus       416 ~l~~li~~cl~~dP~~RPs~~ell~~L~~  444 (454)
                      ++.+++.+||+.+|++||+++++...|..
T Consensus       231 ~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         231 ELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             HHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence            99999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=2e-40  Score=327.19  Aligned_cols=252  Identities=26%  Similarity=0.466  Sum_probs=206.4

Q ss_pred             CCEEEeceeeccCCceEEEeE--------EEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEEEEEEEeCCCeEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKGK--------RVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVDENHGLC  260 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g~--------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~~~g~~~~~~~~l~  260 (454)
                      ++|++.+.||+|+||.||+|.        .+++|.++.. ........+.+|+.++.++ +||||+++++++.+.+. ++
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~-~~   79 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF-ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGY-LY   79 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc-CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCc-ce
Confidence            688999999999999999873        3677777632 2233345678899999998 79999999999987776 89


Q ss_pred             EEEeccCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEE
Q 012887          261 VVTKLMEGGSVNDLILKSR----------------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVC  324 (454)
Q Consensus       261 lV~E~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vK  324 (454)
                      +||||+++++|.+++.+..                .+++..+..++.||+.||+|||++|++||||||+|||++.++.+|
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~k  159 (297)
T cd05089          80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASK  159 (297)
T ss_pred             EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEE
Confidence            9999999999999986432                488899999999999999999999999999999999999999999


Q ss_pred             EEccCCccccccCCCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHc
Q 012887          325 LGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAAC  403 (454)
Q Consensus       325 L~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~i~~~  403 (454)
                      |+|||++....... .......+..|+|||++.+..+    +.++|||||||++|||++ |..||...........+. .
T Consensus       160 l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~----~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~-~  233 (297)
T cd05089         160 IADFGLSRGEEVYV-KKTMGRLPVRWMAIESLNYSVY----TTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLP-Q  233 (297)
T ss_pred             ECCcCCCcccccee-ccCCCCcCccccCchhhccCCC----CchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh-c
Confidence            99999975432111 1112223457999999876643    456999999999999997 999998877766554443 3


Q ss_pred             CCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCCC
Q 012887          404 GLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNIS  449 (454)
Q Consensus       404 ~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~  449 (454)
                      +..+..|..++.++.+++.+||+.+|.+||++.+++..|..+.+..
T Consensus       234 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~  279 (297)
T cd05089         234 GYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR  279 (297)
T ss_pred             CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence            4566677889999999999999999999999999999998877643

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=3.9e-41  Score=337.92  Aligned_cols=240  Identities=19%  Similarity=0.326  Sum_probs=195.6

Q ss_pred             ceeeccCCceEEEe------EEEEEEEeecCCCCc-hHHHHHHHHHHHHHhC-CCCceeEEEEEEEeCCCeEEEEEeccC
Q 012887          196 DQIGPNSFKGVYKG------KRVGIEKLKGCDKGN-AYEFELRKDLLELMTC-GHKNILQFYCVCVDENHGLCVVTKLME  267 (454)
Q Consensus       196 ~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~-~~~~~~~~Ei~~l~~l-~HpnIv~~~g~~~~~~~~l~lV~E~~~  267 (454)
                      +.||+|+||.||++      +.+|+|.++...... .....+..|+.++..+ +||||+++++++.+.+. +++||||++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~-~~lv~E~~~   79 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR-LFFVIEYVN   79 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCE-EEEEEeCCC
Confidence            46999999999985      479999987543222 2334567788887766 79999999999988776 999999999


Q ss_pred             CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCcccccCCC
Q 012887          268 GGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG  347 (454)
Q Consensus       268 ~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~gt  347 (454)
                      +|+|.+++.+.+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.............||
T Consensus        80 ~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt  159 (329)
T cd05618          80 GGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGT  159 (329)
T ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccccccCC
Confidence            99999998877899999999999999999999999999999999999999999999999999987543333334445789


Q ss_pred             CcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC--------CHHHHHHHHHHcCCCCCCCCCccHHHHH
Q 012887          348 YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAAC--------SPVQAAVGIAACGLRPEIPKDCPQILKS  419 (454)
Q Consensus       348 ~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~--------~~~~~~~~i~~~~~~~~~p~~~~~~l~~  419 (454)
                      +.|+|||++.+..++    .++|||||||++|+|++|..||...        .......... ......+|..++..+.+
T Consensus       160 ~~y~aPE~~~~~~~~----~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i-~~~~~~~p~~~~~~~~~  234 (329)
T cd05618         160 PNYIAPEILRGEDYG----FSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI-LEKQIRIPRSLSVKAAS  234 (329)
T ss_pred             ccccCHHHHcCCCCC----CccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHH-hcCCCCCCCCCCHHHHH
Confidence            999999999876544    4599999999999999999999521        1111222222 23345678889999999


Q ss_pred             HHHHhcccCCCCCCC------HHHHHHH
Q 012887          420 LMIKCWNNSPSKRPQ------FSEIISL  441 (454)
Q Consensus       420 li~~cl~~dP~~RPs------~~ell~~  441 (454)
                      +|.+||+.||.+||+      +.++++|
T Consensus       235 ll~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05618         235 VLKSFLNKDPKERLGCHPQTGFADIQGH  262 (329)
T ss_pred             HHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence            999999999999998      5677766

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=2.1e-40  Score=321.30  Aligned_cols=251  Identities=29%  Similarity=0.496  Sum_probs=207.8

Q ss_pred             cCCCEEEeceeeccCCceEEEeE---------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCe
Q 012887          188 NSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHG  258 (454)
Q Consensus       188 ~~~~~~~~~~LG~G~fG~Vy~g~---------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~  258 (454)
                      ...+|++.+.||+|+||.||+|.         .+|+|.++.. ........+.+|+..+.+++||||+++++++.+.+. 
T Consensus         2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-   79 (267)
T cd05066           2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAG-YTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKP-   79 (267)
T ss_pred             CHHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCC-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc-
Confidence            34678999999999999999874         4788887642 223345578899999999999999999999987765 


Q ss_pred             EEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccC
Q 012887          259 LCVVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV  337 (454)
Q Consensus       259 l~lV~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~  337 (454)
                      .++||||+++++|.+++.+. ..+++..+..++.|++.||.|||+++++||||||+|||++.++.++|+|||++......
T Consensus        80 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd05066          80 VMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  159 (267)
T ss_pred             cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence            99999999999999999654 47899999999999999999999999999999999999999999999999998765443


Q ss_pred             CCccc---ccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHcCCCCCCCCCc
Q 012887          338 GEATE---YETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDC  413 (454)
Q Consensus       338 ~~~~~---~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~  413 (454)
                      .....   ....+..|+|||.+.+..    ++.++|+||||+++|++++ |..||......+....+. .+.+.+.+..+
T Consensus       160 ~~~~~~~~~~~~~~~y~~pe~~~~~~----~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~  234 (267)
T cd05066         160 PEAAYTTRGGKIPIRWTAPEAIAYRK----FTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIE-EGYRLPAPMDC  234 (267)
T ss_pred             cceeeecCCCccceeecCHhHhccCc----cCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHh-CCCcCCCCCCC
Confidence            22111   112346799999998654    3446999999999999887 999998877665554444 34556667788


Q ss_pred             cHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 012887          414 PQILKSLMIKCWNNSPSKRPQFSEIISLLLRT  445 (454)
Q Consensus       414 ~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~  445 (454)
                      |+.+.+++.+||+.+|.+||++.++++.|.++
T Consensus       235 ~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         235 PAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             CHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence            99999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=1.9e-40  Score=324.39  Aligned_cols=249  Identities=26%  Similarity=0.453  Sum_probs=206.2

Q ss_pred             ecCCCEEEeceeeccCCceEEEeE-----------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeC
Q 012887          187 LNSDNLEFIDQIGPNSFKGVYKGK-----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDE  255 (454)
Q Consensus       187 ~~~~~~~~~~~LG~G~fG~Vy~g~-----------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~  255 (454)
                      ++.++|.+.++||+|+||.||+++           .+|+|.+..  ........+.+|+..+..++|+||+++++++.+.
T Consensus         2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   79 (280)
T cd05092           2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE--ASESARQDFQREAELLTVLQHQHIVRFYGVCTEG   79 (280)
T ss_pred             CChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCc--CCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecC
Confidence            345788999999999999999863           577887753  2334455688999999999999999999999877


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhCC---------------CCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccC
Q 012887          256 NHGLCVVTKLMEGGSVNDLILKSR---------------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH  320 (454)
Q Consensus       256 ~~~l~lV~E~~~~gsL~~~l~~~~---------------~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~  320 (454)
                      +. .+++|||+++++|.+++...+               .+++..+..++.||+.||.|||++|++||||||+|||++++
T Consensus        80 ~~-~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~  158 (280)
T cd05092          80 RP-LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQG  158 (280)
T ss_pred             Cc-eEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCC
Confidence            66 899999999999999986532               47899999999999999999999999999999999999999


Q ss_pred             CcEEEEccCCccccccCCC--cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHH
Q 012887          321 GNVCLGDMGIVTACKSVGE--ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAA  397 (454)
Q Consensus       321 ~~vKL~DFGla~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~  397 (454)
                      +.+||+|||++........  ......+++.|+|||.+.+..    ++.++|||||||++|||++ |.+||.........
T Consensus       159 ~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~  234 (280)
T cd05092         159 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRK----FTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAI  234 (280)
T ss_pred             CCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCC----cCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHH
Confidence            9999999999865432211  111223467899999998765    3456999999999999998 99999877766555


Q ss_pred             HHHHHcCCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 012887          398 VGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLL  443 (454)
Q Consensus       398 ~~i~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~  443 (454)
                      ..+. .+.....|..+|+.+.+++.+||+.||.+||++.+|++.|+
T Consensus       235 ~~~~-~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         235 ECIT-QGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             HHHH-cCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence            4443 34455667789999999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4e-41  Score=340.97  Aligned_cols=255  Identities=27%  Similarity=0.451  Sum_probs=199.7

Q ss_pred             cCCCEEEeceeeccCCceEEEe-----EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEE
Q 012887          188 NSDNLEFIDQIGPNSFKGVYKG-----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  262 (454)
Q Consensus       188 ~~~~~~~~~~LG~G~fG~Vy~g-----~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV  262 (454)
                      .+++|.--..||+|+||.||+|     ..||||++.......  ..++..|+.++.+++|||+|+++|+|.+.+...+||
T Consensus        73 AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LV  150 (361)
T KOG1187|consen   73 ATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLV  150 (361)
T ss_pred             HHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEE
Confidence            3467777789999999999996     479999887544332  455999999999999999999999999887338899


Q ss_pred             EeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhcC---cccCCccCCcEEEccCCcEEEEccCCccccccC
Q 012887          263 TKLMEGGSVNDLILKSR--KLQTKEIIRIAIDVAEGIKFLNDHG---VAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV  337 (454)
Q Consensus       263 ~E~~~~gsL~~~l~~~~--~l~~~~~~~i~~qI~~gL~yLH~~~---iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~  337 (454)
                      +|||++|+|.+++....  .++|....+|+.++|+||+|||+..   ||||||||+|||+|+++++||+|||+|+.....
T Consensus       151 YEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~  230 (361)
T KOG1187|consen  151 YEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEG  230 (361)
T ss_pred             EEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCcc
Confidence            99999999999996543  8999999999999999999999853   999999999999999999999999999655431


Q ss_pred             CCccccc-CCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCH------HHHHHHHHHcC-----C
Q 012887          338 GEATEYE-TDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSP------VQAAVGIAACG-----L  405 (454)
Q Consensus       338 ~~~~~~~-~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~------~~~~~~i~~~~-----~  405 (454)
                      ....... .||..|+|||++..+.    .+.|+|||||||+|.|+++|+.|.....+      ..........+     .
T Consensus       231 ~~~~~~~~~gt~gY~~PEy~~~g~----lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eii  306 (361)
T KOG1187|consen  231 DTSVSTTVMGTFGYLAPEYASTGK----LTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIV  306 (361)
T ss_pred             ccceeeecCCCCccCChhhhccCC----cCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhhee
Confidence            1112222 7899999999997643    45569999999999999999988775321      11111122211     1


Q ss_pred             CCCCC-CCcc-----HHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCC
Q 012887          406 RPEIP-KDCP-----QILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNI  448 (454)
Q Consensus       406 ~~~~p-~~~~-----~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~  448 (454)
                      .+.+. ..++     ..+..+...|++.+|.+||++.++++.|..+...
T Consensus       307 D~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~  355 (361)
T KOG1187|consen  307 DPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL  355 (361)
T ss_pred             CCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence            22222 2333     2356788899999999999999999999665543

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.3e-40  Score=319.59  Aligned_cols=249  Identities=24%  Similarity=0.464  Sum_probs=205.0

Q ss_pred             EEEeceeeccCCceEEEeE---------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCC-----
Q 012887          192 LEFIDQIGPNSFKGVYKGK---------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH-----  257 (454)
Q Consensus       192 ~~~~~~LG~G~fG~Vy~g~---------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~-----  257 (454)
                      |++.+.||+|+||.||+|.         .+|+|.++...........+.+|+..+..++||||+++++++.....     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            4678899999999999863         58999987544444445568899999999999999999998865432     


Q ss_pred             eEEEEEeccCCCCHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCc
Q 012887          258 GLCVVTKLMEGGSVNDLILKS------RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIV  331 (454)
Q Consensus       258 ~l~lV~E~~~~gsL~~~l~~~------~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla  331 (454)
                      ..+++|||+++|+|..++...      ..+++..+..++.|++.||.|||+++++||||||+||++++++.+||+|||++
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~  160 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS  160 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccce
Confidence            268999999999999988432      26899999999999999999999999999999999999999999999999998


Q ss_pred             cccccCCCc--ccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHcCCCCC
Q 012887          332 TACKSVGEA--TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPE  408 (454)
Q Consensus       332 ~~~~~~~~~--~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~  408 (454)
                      +........  ......+..|+|||.+.+..+    +.++|||||||++|||++ |..||.+....+....+ ..+....
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~----~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~-~~~~~~~  235 (273)
T cd05035         161 KKIYSGDYYRQGRIAKMPVKWIAIESLADRVY----TSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYL-RHGNRLK  235 (273)
T ss_pred             eeccccccccccccccCCccccCHhhcccCCC----CcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-HcCCCCC
Confidence            765433221  112234568999999876644    445999999999999999 99999887766555444 3455666


Q ss_pred             CCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 012887          409 IPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRT  445 (454)
Q Consensus       409 ~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~  445 (454)
                      .|..++..+.+++.+||+.||.+||++.|+++.|.++
T Consensus       236 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         236 QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            7888999999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=1.7e-40  Score=329.02  Aligned_cols=253  Identities=26%  Similarity=0.464  Sum_probs=205.9

Q ss_pred             cCCCEEEeceeeccCCceEEEeE--------EEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEEEEEEEeCCCe
Q 012887          188 NSDNLEFIDQIGPNSFKGVYKGK--------RVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVDENHG  258 (454)
Q Consensus       188 ~~~~~~~~~~LG~G~fG~Vy~g~--------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~~~g~~~~~~~~  258 (454)
                      ..++|++.+.||+|+||.||+|.        .+++|.++.. ........+.+|+.++.++ +||||+++++++.+.+. 
T Consensus         5 ~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~-   82 (303)
T cd05088           5 EWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY-   82 (303)
T ss_pred             chhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc-CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCC-
Confidence            44789999999999999999974        3577766532 2233445678899999998 89999999999988776 


Q ss_pred             EEEEEeccCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCc
Q 012887          259 LCVVTKLMEGGSVNDLILKSR----------------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGN  322 (454)
Q Consensus       259 l~lV~E~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~  322 (454)
                      .++||||+++++|.+++.+.+                .+++..+..++.||+.||+|||++|++||||||+|||++.++.
T Consensus        83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~  162 (303)
T cd05088          83 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV  162 (303)
T ss_pred             ceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCc
Confidence            999999999999999986432                5789999999999999999999999999999999999999999


Q ss_pred             EEEEccCCccccccCCCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHH
Q 012887          323 VCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIA  401 (454)
Q Consensus       323 vKL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~i~  401 (454)
                      +||+|||++...... ........+..|+|||.+.+..    ++.++|||||||++|||++ |..||...+..+....+ 
T Consensus       163 ~kl~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~----~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~-  236 (303)
T cd05088         163 AKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSV----YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL-  236 (303)
T ss_pred             EEeCccccCcccchh-hhcccCCCcccccCHHHHhccC----CcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHH-
Confidence            999999997643211 1122223456799999987654    3456999999999999998 99999876665544333 


Q ss_pred             HcCCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCC
Q 012887          402 ACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNI  448 (454)
Q Consensus       402 ~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~  448 (454)
                      ....+...+..++.++.+++.+||+.+|++||++.+++..|.++...
T Consensus       237 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~  283 (303)
T cd05088         237 PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE  283 (303)
T ss_pred             hcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence            33445566777899999999999999999999999999999887654

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=2.2e-40  Score=318.55  Aligned_cols=244  Identities=22%  Similarity=0.353  Sum_probs=206.1

Q ss_pred             CEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEEe
Q 012887          191 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTK  264 (454)
Q Consensus       191 ~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~E  264 (454)
                      +|++.+.||.|+||.||++      +.+++|.++... .......+.+|+.++..++||||+++++.+.+.+. +++|||
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~lv~e   78 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK-SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGH-LYIVME   78 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc-chHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCE-EEEEEe
Confidence            5789999999999999985      578999886432 23344567789999999999999999999988776 999999


Q ss_pred             ccCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCccc
Q 012887          265 LMEGGSVNDLILK--SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE  342 (454)
Q Consensus       265 ~~~~gsL~~~l~~--~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~  342 (454)
                      |+++++|.+++..  ...+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++...........
T Consensus        79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~  158 (255)
T cd08219          79 YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYAC  158 (255)
T ss_pred             eCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccccccc
Confidence            9999999998854  34689999999999999999999999999999999999999999999999999876654433344


Q ss_pred             ccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHHHHHH
Q 012887          343 YETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMI  422 (454)
Q Consensus       343 ~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~li~  422 (454)
                      ...+++.|+|||++.+..    .+.++|+||||+++|+|++|..||...+.......+. .+...+.|..++..+.+++.
T Consensus       159 ~~~~~~~~~aPE~~~~~~----~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~  233 (255)
T cd08219         159 TYVGTPYYVPPEIWENMP----YNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVC-QGSYKPLPSHYSYELRSLIK  233 (255)
T ss_pred             cccCCccccCHHHHccCC----cCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHh-cCCCCCCCcccCHHHHHHHH
Confidence            456788899999987654    4456999999999999999999999877665555444 34455577788999999999


Q ss_pred             HhcccCCCCCCCHHHHHHH
Q 012887          423 KCWNNSPSKRPQFSEIISL  441 (454)
Q Consensus       423 ~cl~~dP~~RPs~~ell~~  441 (454)
                      +||+.||.+||++.+++..
T Consensus       234 ~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         234 QMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             HHHhCCcccCCCHHHHhhc
Confidence            9999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=4e-40  Score=316.49  Aligned_cols=246  Identities=22%  Similarity=0.363  Sum_probs=206.9

Q ss_pred             CEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEEe
Q 012887          191 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTK  264 (454)
Q Consensus       191 ~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~E  264 (454)
                      +|++++.||+|+||.||++      +.+++|++............+.+|+..++.++|+|++++++.+...+..+++|||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            4789999999999999975      4699999875444444455678899999999999999999988755555899999


Q ss_pred             ccCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCccc
Q 012887          265 LMEGGSVNDLILK--SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE  342 (454)
Q Consensus       265 ~~~~gsL~~~l~~--~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~  342 (454)
                      |+++++|.+++..  ...+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++...........
T Consensus        81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~  160 (257)
T cd08223          81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAS  160 (257)
T ss_pred             ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCCccc
Confidence            9999999999865  34689999999999999999999999999999999999999999999999999876654433344


Q ss_pred             ccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHHHHHH
Q 012887          343 YETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMI  422 (454)
Q Consensus       343 ~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~li~  422 (454)
                      ...+++.|+|||.+.+..+    +.++||||||+++|+|++|..||...+.......+.. +..+..+..+++.+.+++.
T Consensus       161 ~~~~~~~y~aPE~~~~~~~----~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~  235 (257)
T cd08223         161 TLIGTPYYMSPELFSNKPY----NYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIE-GKLPPMPKDYSPELGELIA  235 (257)
T ss_pred             cccCCcCccChhHhcCCCC----CchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHh-cCCCCCccccCHHHHHHHH
Confidence            4567889999999987644    3459999999999999999999987766555444443 4444567788999999999


Q ss_pred             HhcccCCCCCCCHHHHHHH
Q 012887          423 KCWNNSPSKRPQFSEIISL  441 (454)
Q Consensus       423 ~cl~~dP~~RPs~~ell~~  441 (454)
                      +||+.+|.+||++.+++.+
T Consensus       236 ~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         236 TMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             HHhccCcccCCCHHHHhcC
Confidence            9999999999999999876

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=4.1e-41  Score=336.83  Aligned_cols=235  Identities=19%  Similarity=0.266  Sum_probs=193.8

Q ss_pred             ceeeccCCceEEEe------EEEEEEEeecCCCC-chHHHHHHHHHH-HHHhCCCCceeEEEEEEEeCCCeEEEEEeccC
Q 012887          196 DQIGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLL-ELMTCGHKNILQFYCVCVDENHGLCVVTKLME  267 (454)
Q Consensus       196 ~~LG~G~fG~Vy~g------~~vavK~l~~~~~~-~~~~~~~~~Ei~-~l~~l~HpnIv~~~g~~~~~~~~l~lV~E~~~  267 (454)
                      +.||+|+||.||++      +.+|+|.+...... ......+..|.. .+..++||||+++++++.+.+. +|+||||++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~-~~lv~e~~~   79 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADK-LYFVLDYIN   79 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCe-EEEEEeCCC
Confidence            36999999999986      46899998743211 122233444444 4567899999999999988776 999999999


Q ss_pred             CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCcccccCCC
Q 012887          268 GGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG  347 (454)
Q Consensus       268 ~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~gt  347 (454)
                      +|+|.+++.+.+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.............|+
T Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt  159 (325)
T cd05602          80 GGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGT  159 (325)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcccccCC
Confidence            99999999877889999999999999999999999999999999999999999999999999987544333334455689


Q ss_pred             CcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhccc
Q 012887          348 YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNN  427 (454)
Q Consensus       348 ~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~li~~cl~~  427 (454)
                      +.|+|||++.+..+    +.++|||||||++|+|++|..||.+.+..+....+...  ...++..++..+.+++.+||+.
T Consensus       160 ~~y~aPE~~~~~~~----~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~li~~~l~~  233 (325)
T cd05602         160 PEYLAPEVLHKQPY----DRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK--PLQLKPNITNSARHLLEGLLQK  233 (325)
T ss_pred             ccccCHHHHcCCCC----CCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhC--CcCCCCCCCHHHHHHHHHHccc
Confidence            99999999987654    44599999999999999999999988777666655543  3445667899999999999999


Q ss_pred             CCCCCCCHHH
Q 012887          428 SPSKRPQFSE  437 (454)
Q Consensus       428 dP~~RPs~~e  437 (454)
                      ||.+||++.+
T Consensus       234 ~p~~R~~~~~  243 (325)
T cd05602         234 DRTKRLGAKD  243 (325)
T ss_pred             CHHHCCCCCC
Confidence            9999998763

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=2.9e-40  Score=324.61  Aligned_cols=251  Identities=24%  Similarity=0.445  Sum_probs=204.1

Q ss_pred             cCCCEEEeceeeccCCceEEEeE----------------------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCce
Q 012887          188 NSDNLEFIDQIGPNSFKGVYKGK----------------------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNI  245 (454)
Q Consensus       188 ~~~~~~~~~~LG~G~fG~Vy~g~----------------------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnI  245 (454)
                      +.++|++.+.||+|+||.||++.                      .+|+|.+... ........+.+|+.++..++||||
T Consensus         3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i   81 (296)
T cd05051           3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPD-ASDNAREDFLKEVKILSRLSDPNI   81 (296)
T ss_pred             chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCc-cCHHHHHHHHHHHHHHHhcCCCCE
Confidence            34688999999999999999853                      3788887633 223445668899999999999999


Q ss_pred             eEEEEEEEeCCCeEEEEEeccCCCCHHHHHHhCC-----------CCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCc
Q 012887          246 LQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-----------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQR  314 (454)
Q Consensus       246 v~~~g~~~~~~~~l~lV~E~~~~gsL~~~l~~~~-----------~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~N  314 (454)
                      +++++++..++. .++||||+++++|.+++.+..           .+++..+..++.|++.||.|||+++++||||||+|
T Consensus        82 ~~~~~~~~~~~~-~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~N  160 (296)
T cd05051          82 ARLLGVCTVDPP-LCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRN  160 (296)
T ss_pred             eEEEEEEecCCC-cEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhc
Confidence            999999988766 899999999999999996654           68999999999999999999999999999999999


Q ss_pred             EEEccCCcEEEEccCCccccccCCC--cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc--CCCCCCC
Q 012887          315 ILLDRHGNVCLGDMGIVTACKSVGE--ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT--GEAAYAA  390 (454)
Q Consensus       315 ILl~~~~~vKL~DFGla~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt--G~~Pf~~  390 (454)
                      |+++.++.++|+|||++........  ......+++.|+|||.+.+..    ++.++|||||||++|||++  |..||..
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~Dv~slG~~l~el~~~~~~~p~~~  236 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGK----FTTKSDVWAFGVTLWEILTLCREQPYEH  236 (296)
T ss_pred             eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCC----CCccchhhhhHHHHHHHHhcCCCCCCCC
Confidence            9999999999999999875433221  122234567899999987654    4456999999999999998  7888887


Q ss_pred             CCHHHHHHHHHHc------CCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 012887          391 CSPVQAAVGIAAC------GLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR  444 (454)
Q Consensus       391 ~~~~~~~~~i~~~------~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~  444 (454)
                      .+...........      ......+..+|.++.+++.+||+.||.+||++.||++.|.+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~  296 (296)
T cd05051         237 LTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR  296 (296)
T ss_pred             cChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence            6665544433322      11123455678999999999999999999999999998853

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=4e-40  Score=330.70  Aligned_cols=259  Identities=25%  Similarity=0.480  Sum_probs=213.7

Q ss_pred             cceeecCCCEEEeceeeccCCceEEEeE-------------EEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEE
Q 012887          183 GRWLLNSDNLEFIDQIGPNSFKGVYKGK-------------RVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQF  248 (454)
Q Consensus       183 ~~~~~~~~~~~~~~~LG~G~fG~Vy~g~-------------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~~  248 (454)
                      .+|.+...+|++++.||+|+||.||+++             .+|+|.++. .........+.+|+.++.++ +||||+++
T Consensus         5 ~~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~~~E~~~l~~l~~h~~iv~~   83 (334)
T cd05100           5 PKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKD-DATDKDLSDLVSEMEMMKMIGKHKNIINL   83 (334)
T ss_pred             cccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccc-ccCHHHHHHHHHHHHHHHhhcCCCCeeee
Confidence            5688888899999999999999999874             478887763 22333445688899999998 79999999


Q ss_pred             EEEEEeCCCeEEEEEeccCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhcCcccCCccC
Q 012887          249 YCVCVDENHGLCVVTKLMEGGSVNDLILKSR----------------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNS  312 (454)
Q Consensus       249 ~g~~~~~~~~l~lV~E~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp  312 (454)
                      +++|.+.+. ++++|||+++|+|.+++.+..                .++...+..++.||+.||.|||++|++||||||
T Consensus        84 ~~~~~~~~~-~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp  162 (334)
T cd05100          84 LGACTQDGP-LYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAA  162 (334)
T ss_pred             eEEEccCCc-eEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeecccccc
Confidence            999988775 999999999999999986422                477888999999999999999999999999999


Q ss_pred             CcEEEccCCcEEEEccCCccccccCCCc--ccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCC
Q 012887          313 QRILLDRHGNVCLGDMGIVTACKSVGEA--TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYA  389 (454)
Q Consensus       313 ~NILl~~~~~vKL~DFGla~~~~~~~~~--~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~  389 (454)
                      +|||++.++.+||+|||+++........  .....++..|+|||++.+..+    +.++||||||+++|||++ |..||.
T Consensus       163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~----~~~~Di~slG~il~el~~~g~~p~~  238 (334)
T cd05100         163 RNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVY----THQSDVWSFGVLLWEIFTLGGSPYP  238 (334)
T ss_pred             ceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCc----CchhhhHHHHHHHHHHHhcCCCCCC
Confidence            9999999999999999998765432211  112233467999999976643    446999999999999998 899998


Q ss_pred             CCCHHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCC
Q 012887          390 ACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNI  448 (454)
Q Consensus       390 ~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~  448 (454)
                      +.+.......+ ........+..++.++.+++.+||+.+|.+||++.|+++.|.++...
T Consensus       239 ~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~  296 (334)
T cd05100         239 GIPVEELFKLL-KEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTV  296 (334)
T ss_pred             CCCHHHHHHHH-HcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhh
Confidence            87665544443 44556667788899999999999999999999999999999988743

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=5.7e-40  Score=316.88  Aligned_cols=252  Identities=20%  Similarity=0.375  Sum_probs=207.3

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCc-hHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGN-AYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  262 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV  262 (454)
                      ++|++.+.||+|+||.||+|      +.+|+|.++...... .....+.+|+.++++++|+||+++++++.+.+. .++|
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~-~~lv   80 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNE-LNIV   80 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCe-EEEE
Confidence            57899999999999999985      568999886433332 235668899999999999999999999988765 8999


Q ss_pred             EeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCC
Q 012887          263 TKLMEGGSVNDLILK----SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG  338 (454)
Q Consensus       263 ~E~~~~gsL~~~l~~----~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~  338 (454)
                      |||+++++|.+++..    ...+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++.......
T Consensus        81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~  160 (267)
T cd08224          81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT  160 (267)
T ss_pred             EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCC
Confidence            999999999999853    2368999999999999999999999999999999999999999999999999987654433


Q ss_pred             CcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHHHcCCCCCCCC-CccHH
Q 012887          339 EATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSP-VQAAVGIAACGLRPEIPK-DCPQI  416 (454)
Q Consensus       339 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~-~~~~~~i~~~~~~~~~p~-~~~~~  416 (454)
                      .......+++.|+|||.+.+..    ++.++|+|||||++|+|++|..||..... ..........+..++.|. .++..
T Consensus       161 ~~~~~~~~~~~y~apE~~~~~~----~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (267)
T cd08224         161 TAAHSLVGTPYYMSPERIHENG----YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEE  236 (267)
T ss_pred             cccceecCCccccCHHHhccCC----CCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHH
Confidence            3333446788899999987654    34469999999999999999999965432 122222222334445555 78899


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 012887          417 LKSLMIKCWNNSPSKRPQFSEIISLLLRTN  446 (454)
Q Consensus       417 l~~li~~cl~~dP~~RPs~~ell~~L~~~~  446 (454)
                      +.++|.+||..+|++||++.+|++.|++++
T Consensus       237 ~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         237 LRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             HHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence            999999999999999999999999998875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.8e-40  Score=318.53  Aligned_cols=245  Identities=26%  Similarity=0.499  Sum_probs=203.4

Q ss_pred             CCCEEEeceeeccCCceEEEeE-----EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEE
Q 012887          189 SDNLEFIDQIGPNSFKGVYKGK-----RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  263 (454)
Q Consensus       189 ~~~~~~~~~LG~G~fG~Vy~g~-----~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~  263 (454)
                      ..+|++.+.||+|+||.||+|+     .+|+|.+.....   ....+.+|+.+++.++||||+++++++.+.+. .++||
T Consensus         3 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-~~lv~   78 (256)
T cd05059           3 PSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM---SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRP-IFIVT   78 (256)
T ss_pred             hHHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC---CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc-eEEEE
Confidence            4678899999999999999864     588888753222   23456789999999999999999999887765 89999


Q ss_pred             eccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCcc-
Q 012887          264 KLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT-  341 (454)
Q Consensus       264 E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~-  341 (454)
                      ||+++++|.+++... ..+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||+++...+..... 
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~  158 (256)
T cd05059          79 EYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSS  158 (256)
T ss_pred             ecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceeccccccccc
Confidence            999999999998654 478999999999999999999999999999999999999999999999999987554321111 


Q ss_pred             cccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHHHH
Q 012887          342 EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSL  420 (454)
Q Consensus       342 ~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~l  420 (454)
                      ....++..|+|||.+.+..+    +.++||||||+++|+|++ |..||...++.+....+ ....+...|..+|.++.++
T Consensus       159 ~~~~~~~~y~~Pe~~~~~~~----~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l  233 (256)
T cd05059         159 QGTKFPVKWAPPEVFDYSRF----SSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESV-SAGYRLYRPKLAPTEVYTI  233 (256)
T ss_pred             CCCCCCccccCHHHhccCCC----CchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH-HcCCcCCCCCCCCHHHHHH
Confidence            11123457999999987654    446999999999999999 89999877766555444 3455667777899999999


Q ss_pred             HHHhcccCCCCCCCHHHHHHHH
Q 012887          421 MIKCWNNSPSKRPQFSEIISLL  442 (454)
Q Consensus       421 i~~cl~~dP~~RPs~~ell~~L  442 (454)
                      +.+||..+|.+||++.|+++.|
T Consensus       234 i~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         234 MYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             HHHHhcCChhhCcCHHHHHHHh
Confidence            9999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=5e-40  Score=317.67  Aligned_cols=241  Identities=23%  Similarity=0.426  Sum_probs=199.5

Q ss_pred             eeeccCCceEEEeE--------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEEeccCC
Q 012887          197 QIGPNSFKGVYKGK--------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEG  268 (454)
Q Consensus       197 ~LG~G~fG~Vy~g~--------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~E~~~~  268 (454)
                      .||+|+||.||+|.        .+|+|.+... ........+.+|+.++.+++||||+++++++.. +. .++||||+++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~-~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~-~~lv~e~~~~   78 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNE-NEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EA-LMLVMEMASG   78 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccc-cChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CC-eEEEEEeCCC
Confidence            48999999999863        4888888643 233344568899999999999999999998854 33 8999999999


Q ss_pred             CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCc---cccc
Q 012887          269 GSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA---TEYE  344 (454)
Q Consensus       269 gsL~~~l~~-~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~---~~~~  344 (454)
                      ++|.+++.. ...+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++.........   ....
T Consensus        79 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  158 (257)
T cd05115          79 GPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAG  158 (257)
T ss_pred             CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCC
Confidence            999999864 457999999999999999999999999999999999999999999999999998754432211   1112


Q ss_pred             CCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHHHHHHH
Q 012887          345 TDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIK  423 (454)
Q Consensus       345 ~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~li~~  423 (454)
                      .+++.|+|||.+.+..+    +.++|||||||++|++++ |..||.......... ....+.++..|..+++++.++|.+
T Consensus       159 ~~~~~y~aPE~~~~~~~----~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~  233 (257)
T cd05115         159 KWPLKWYAPECINFRKF----SSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMS-FIEQGKRLDCPAECPPEMYALMKD  233 (257)
T ss_pred             CCCcccCCHHHHccCCC----CchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHH-HHHCCCCCCCCCCCCHHHHHHHHH
Confidence            23568999999876543    446999999999999996 999998877665543 444556677888899999999999


Q ss_pred             hcccCCCCCCCHHHHHHHHHhh
Q 012887          424 CWNNSPSKRPQFSEIISLLLRT  445 (454)
Q Consensus       424 cl~~dP~~RPs~~ell~~L~~~  445 (454)
                      ||..+|++||++.++.+.|...
T Consensus       234 c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         234 CWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             HcCCChhhCcCHHHHHHHHhhh
Confidence            9999999999999999998764

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=4.5e-40  Score=321.71  Aligned_cols=251  Identities=27%  Similarity=0.448  Sum_probs=201.1

Q ss_pred             CCEEEeceeeccCCceEEEe----------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCC-Ce
Q 012887          190 DNLEFIDQIGPNSFKGVYKG----------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN-HG  258 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g----------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~-~~  258 (454)
                      +.|++++.||+|+||.||++          ..+|+|.++.. ........+.+|+..+..++||||+++++++...+ ..
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (283)
T cd05080           4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRE-CGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG   82 (283)
T ss_pred             hhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccc-cChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence            34589999999999999763          46899988743 22234456778999999999999999999887643 45


Q ss_pred             EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCC
Q 012887          259 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG  338 (454)
Q Consensus       259 l~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~  338 (454)
                      +++||||+++++|.+++.+ ..+++..+..++.|++.||.|||+++++||||||+|||++.++.+||+|||++.......
T Consensus        83 ~~lv~e~~~~~~l~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~  161 (283)
T cd05080          83 LQLIMEYVPLGSLRDYLPK-HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH  161 (283)
T ss_pred             EEEEecCCCCCCHHHHHHH-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCcc
Confidence            8999999999999999855 469999999999999999999999999999999999999999999999999987654322


Q ss_pred             Cc---ccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHH--------------HHHHHHH
Q 012887          339 EA---TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPV--------------QAAVGIA  401 (454)
Q Consensus       339 ~~---~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~--------------~~~~~i~  401 (454)
                      ..   .....++..|+|||.+.+...    +.++||||||+++|+|++|..||......              .......
T Consensus       162 ~~~~~~~~~~~~~~~~~PE~~~~~~~----~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (283)
T cd05080         162 EYYRVREDGDSPVFWYAVECLKENKF----SYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELL  237 (283)
T ss_pred             hhhccCCCCCCCceeeCHhHhcccCC----CcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhh
Confidence            11   112234566999999876543    44699999999999999999998643221              0111222


Q ss_pred             HcCCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 012887          402 ACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTN  446 (454)
Q Consensus       402 ~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~  446 (454)
                      ......+.|..++.++.+++.+||+.+|++||+++++++.|..+.
T Consensus       238 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         238 ERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             hcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            233444567788999999999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=4.2e-40  Score=316.01  Aligned_cols=241  Identities=26%  Similarity=0.496  Sum_probs=198.4

Q ss_pred             ceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEEeccCCC
Q 012887          196 DQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGG  269 (454)
Q Consensus       196 ~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~E~~~~g  269 (454)
                      +.||+|+||.||+|      +.+|+|..... ........+.+|+.++..++||||+++++++...+. .++||||++++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~lv~e~~~~~   78 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQP-IYIVMELVQGG   78 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCcc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCC-eEEEEeeccCC
Confidence            36899999999986      45899987632 233345668899999999999999999999988776 99999999999


Q ss_pred             CHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCcc--cccCC
Q 012887          270 SVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT--EYETD  346 (454)
Q Consensus       270 sL~~~l~~~~-~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~--~~~~g  346 (454)
                      +|.+++.+.+ .+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++..........  .....
T Consensus        79 ~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~  158 (252)
T cd05084          79 DFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQI  158 (252)
T ss_pred             cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCC
Confidence            9999986544 68999999999999999999999999999999999999999999999999987543221111  11122


Q ss_pred             CCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhc
Q 012887          347 GYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCW  425 (454)
Q Consensus       347 t~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~li~~cl  425 (454)
                      +..|+|||.+.+..    ++.++|||||||++|+|++ |..||...++......+ ....+...+..++..+.+++.+||
T Consensus       159 ~~~y~aPE~~~~~~----~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l  233 (252)
T cd05084         159 PVKWTAPEALNYGR----YSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAI-EQGVRLPCPELCPDAVYRLMERCW  233 (252)
T ss_pred             ceeecCchhhcCCC----CChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHH-HcCCCCCCcccCCHHHHHHHHHHc
Confidence            45699999997664    3456999999999999998 99999876665443333 345566778888999999999999


Q ss_pred             ccCCCCCCCHHHHHHHHH
Q 012887          426 NNSPSKRPQFSEIISLLL  443 (454)
Q Consensus       426 ~~dP~~RPs~~ell~~L~  443 (454)
                      +.+|++||++.++++.|.
T Consensus       234 ~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         234 EYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             CCChhhCcCHHHHHHHHh
Confidence            999999999999999885

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=1.3e-40  Score=326.07  Aligned_cols=241  Identities=19%  Similarity=0.291  Sum_probs=194.1

Q ss_pred             eeccCCceEEEe------EEEEEEEeecCCCCc-hHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEEeccCCCC
Q 012887          198 IGPNSFKGVYKG------KRVGIEKLKGCDKGN-AYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGS  270 (454)
Q Consensus       198 LG~G~fG~Vy~g------~~vavK~l~~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~E~~~~gs  270 (454)
                      ||+|+||.||++      +.+|+|.+....... .....+..|+.+++.++||||+++++++...+. +++||||+++|+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~-~~lv~e~~~~g~   79 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTD-LCLVMTIMNGGD   79 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCe-EEEEEeCCCCCC
Confidence            799999999985      579999986432221 122456789999999999999999999887766 999999999999


Q ss_pred             HHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCcccccCC
Q 012887          271 VNDLILK----SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETD  346 (454)
Q Consensus       271 L~~~l~~----~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~g  346 (454)
                      |.+++..    ...+++..+..++.||+.||.|||+++|+||||||+||+++.++.+||+|||++..............+
T Consensus        80 L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~g  159 (280)
T cd05608          80 LRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAG  159 (280)
T ss_pred             HHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccCC
Confidence            9988742    346999999999999999999999999999999999999999999999999998765543333344568


Q ss_pred             CCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH--HcCCCCCCCCCccHHHHHHHHHh
Q 012887          347 GYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIA--ACGLRPEIPKDCPQILKSLMIKC  424 (454)
Q Consensus       347 t~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~--~~~~~~~~p~~~~~~l~~li~~c  424 (454)
                      ++.|+|||++.+..+    +.++|||||||++|+|++|..||...........+.  .......+|..++..+.+++.+|
T Consensus       160 ~~~y~aPE~~~~~~~----~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  235 (280)
T cd05608         160 TPGFMAPELLQGEEY----DFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEAL  235 (280)
T ss_pred             CcCccCHHHhcCCCC----CccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHH
Confidence            899999999987654    446999999999999999999998643321111111  11223456778899999999999


Q ss_pred             cccCCCCCC-----CHHHHHHHHH
Q 012887          425 WNNSPSKRP-----QFSEIISLLL  443 (454)
Q Consensus       425 l~~dP~~RP-----s~~ell~~L~  443 (454)
                      |+.||.+||     +++++++|-+
T Consensus       236 l~~~P~~R~~~~~~~~~~~l~h~~  259 (280)
T cd05608         236 LAKDPEKRLGFRDGNCDGLRTHPL  259 (280)
T ss_pred             hcCCHHHhcCCCCCCHHHHhcChh
Confidence            999999999     7788887743

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.2e-41  Score=330.26  Aligned_cols=254  Identities=19%  Similarity=0.308  Sum_probs=211.1

Q ss_pred             cceeecCCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCC-chHHHHHHHHHHHHHhCCCCceeEEEEEEEeC
Q 012887          183 GRWLLNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLELMTCGHKNILQFYCVCVDE  255 (454)
Q Consensus       183 ~~~~~~~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~  255 (454)
                      ..-.+..++|++++.||.|.-|+||++      ..+|+|++...... .....+.+.|-.+|..++||.++.+|+.|..+
T Consensus        70 ~~~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~  149 (459)
T KOG0610|consen   70 KDGSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETD  149 (459)
T ss_pred             CCCccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeecc
Confidence            344567789999999999999999985      47899998654332 22344567777889999999999999999988


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccc
Q 012887          256 NHGLCVVTKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTA  333 (454)
Q Consensus       256 ~~~l~lV~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~  333 (454)
                      +. .|+|||||+||+|+.+++++  +.+++..+..|+.+++.||+|||-.|||+|||||+||||-++|||.|+||.|+..
T Consensus       150 ~~-~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~  228 (459)
T KOG0610|consen  150 KY-SCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLR  228 (459)
T ss_pred             ce-eEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeecccccc
Confidence            76 99999999999999998654  4899999999999999999999999999999999999999999999999998654


Q ss_pred             cccCC---------------------------------C-----------------------cccccCCCCccccccccc
Q 012887          334 CKSVG---------------------------------E-----------------------ATEYETDGYRWLAPEIIA  357 (454)
Q Consensus       334 ~~~~~---------------------------------~-----------------------~~~~~~gt~~y~APE~l~  357 (454)
                      +....                                 .                       .....+||-.|+|||++.
T Consensus       229 ~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~  308 (459)
T KOG0610|consen  229 CPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIR  308 (459)
T ss_pred             CCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeee
Confidence            42100                                 0                       001124677899999999


Q ss_pred             CCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhcccCCCCCCC---
Q 012887          358 GDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQ---  434 (454)
Q Consensus       358 ~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs---  434 (454)
                      |......    +|.|+|||+||||+.|..||.+.+..+.+..++......+-....+..+++||+++|.+||.+|..   
T Consensus       309 G~GHgsA----VDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~r  384 (459)
T KOG0610|consen  309 GEGHGSA----VDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKR  384 (459)
T ss_pred             cCCCCch----hhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhcccc
Confidence            9876554    999999999999999999999999999999998765543333357899999999999999999998   


Q ss_pred             -HHHHHHH
Q 012887          435 -FSEIISL  441 (454)
Q Consensus       435 -~~ell~~  441 (454)
                       +.||.+|
T Consensus       385 GA~eIK~H  392 (459)
T KOG0610|consen  385 GAAEIKRH  392 (459)
T ss_pred             chHHhhcC
Confidence             7776654

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.2e-40  Score=339.75  Aligned_cols=249  Identities=20%  Similarity=0.293  Sum_probs=201.5

Q ss_pred             CEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCC----CeEE
Q 012887          191 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN----HGLC  260 (454)
Q Consensus       191 ~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~----~~l~  260 (454)
                      +|++++.||+|+||.||++      +.||+|++............+.+|+.++..++||||+++++++...+    ..+|
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            4688999999999999985      57999998654333334456789999999999999999999998765    1389


Q ss_pred             EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCC-
Q 012887          261 VVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE-  339 (454)
Q Consensus       261 lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~-  339 (454)
                      +||||+. ++|.+.+.....+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++........ 
T Consensus        81 lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~  159 (372)
T cd07853          81 VVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESK  159 (372)
T ss_pred             EEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCccc
Confidence            9999996 48998887777899999999999999999999999999999999999999999999999999876433221 


Q ss_pred             cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH-----------------
Q 012887          340 ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAA-----------------  402 (454)
Q Consensus       340 ~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~-----------------  402 (454)
                      ......+++.|+|||.+.+..   .++.++|||||||++|||++|+.||.+.++......+..                 
T Consensus       160 ~~~~~~~~~~y~aPE~~~~~~---~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~  236 (372)
T cd07853         160 HMTQEVVTQYYRAPEILMGSR---HYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGA  236 (372)
T ss_pred             cCCCCCcCCCcCCHHHHcCCC---CCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHH
Confidence            122335678899999987643   245579999999999999999999988776554433321                 


Q ss_pred             ------cCCCC-------CCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 012887          403 ------CGLRP-------EIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLL  443 (454)
Q Consensus       403 ------~~~~~-------~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~  443 (454)
                            ....+       ......++++.++|.+||+.||.+|||+.|++.+-+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~  290 (372)
T cd07853         237 RAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPY  290 (372)
T ss_pred             HHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHh
Confidence                  11111       123456889999999999999999999999998865

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=5.3e-40  Score=318.13  Aligned_cols=252  Identities=24%  Similarity=0.448  Sum_probs=207.2

Q ss_pred             eeecCCCEEEeceeeccCCceEEEeE-----EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeE
Q 012887          185 WLLNSDNLEFIDQIGPNSFKGVYKGK-----RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGL  259 (454)
Q Consensus       185 ~~~~~~~~~~~~~LG~G~fG~Vy~g~-----~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l  259 (454)
                      |.+...+|++.+.||+|+||.||+|+     .+|+|.++....   ....+.+|+.++..++||||+++++.+.. +. .
T Consensus         1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~---~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~-~   75 (262)
T cd05071           1 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EP-I   75 (262)
T ss_pred             CCCChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc---CHHHHHHHHHHHHhCCCCCcceEEEEECC-CC-c
Confidence            34566789999999999999999973     589998874322   23457889999999999999999988743 33 7


Q ss_pred             EEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccC
Q 012887          260 CVVTKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV  337 (454)
Q Consensus       260 ~lV~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~  337 (454)
                      ++||||+++|+|.+++.+.  ..+++..+..++.|++.||.|||+.+++||||||+||+++.++.+||+|||++......
T Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~  155 (262)
T cd05071          76 YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN  155 (262)
T ss_pred             EEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeecccc
Confidence            8999999999999999653  36889999999999999999999999999999999999999999999999998765433


Q ss_pred             CCc-ccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHcCCCCCCCCCccH
Q 012887          338 GEA-TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ  415 (454)
Q Consensus       338 ~~~-~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~  415 (454)
                      ... .....++..|+|||.+.+..    ++.++||||||+++|+|++ |..||.+..+......+. .+.+.+.+..++.
T Consensus       156 ~~~~~~~~~~~~~y~~PE~~~~~~----~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~  230 (262)
T cd05071         156 EYTARQGAKFPIKWTAPEAALYGR----FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECPE  230 (262)
T ss_pred             ccccccCCcccceecCHhHhccCC----CCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHh-cCCCCCCccccCH
Confidence            221 11223456799999887654    3456999999999999999 899998877666554443 3444556677899


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 012887          416 ILKSLMIKCWNNSPSKRPQFSEIISLLLRTN  446 (454)
Q Consensus       416 ~l~~li~~cl~~dP~~RPs~~ell~~L~~~~  446 (454)
                      .+.+++.+||+.||++||++.++++.|+...
T Consensus       231 ~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~  261 (262)
T cd05071         231 SLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  261 (262)
T ss_pred             HHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence            9999999999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=4.5e-40  Score=320.98  Aligned_cols=250  Identities=24%  Similarity=0.483  Sum_probs=203.5

Q ss_pred             cCCCEEEeceeeccCCceEEEeE-----------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCC
Q 012887          188 NSDNLEFIDQIGPNSFKGVYKGK-----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN  256 (454)
Q Consensus       188 ~~~~~~~~~~LG~G~fG~Vy~g~-----------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~  256 (454)
                      ..++|.+.+.||+|+||.||+|.           .+++|.... ......+..+.+|+.++..++|+||+++++++.+.+
T Consensus         4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~-~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   82 (277)
T cd05036           4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPE-SCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERL   82 (277)
T ss_pred             CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCC-CCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence            34778999999999999999863           367776653 233334456788999999999999999999998877


Q ss_pred             CeEEEEEeccCCCCHHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCC---cEEEE
Q 012887          257 HGLCVVTKLMEGGSVNDLILKSR-------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG---NVCLG  326 (454)
Q Consensus       257 ~~l~lV~E~~~~gsL~~~l~~~~-------~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~---~vKL~  326 (454)
                      . .++||||+++++|.+++.+.+       .+++..+..++.||+.||+|||+++++||||||+|||++.++   .+||+
T Consensus        83 ~-~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~  161 (277)
T cd05036          83 P-RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIA  161 (277)
T ss_pred             C-cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEec
Confidence            6 889999999999999986543       588999999999999999999999999999999999998765   59999


Q ss_pred             ccCCccccccCCCc--ccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHc
Q 012887          327 DMGIVTACKSVGEA--TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAAC  403 (454)
Q Consensus       327 DFGla~~~~~~~~~--~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~i~~~  403 (454)
                      |||+++........  ......+..|+|||++.+..    ++.++|||||||++|||++ |..||...+...... ....
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~-~~~~  236 (277)
T cd05036         162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGI----FTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVME-FVTG  236 (277)
T ss_pred             cCccccccCCccceecCCCCCccHhhCCHHHHhcCC----cCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH-HHHc
Confidence            99998765322111  11112346799999997654    4456999999999999997 999999877665443 3444


Q ss_pred             CCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 012887          404 GLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR  444 (454)
Q Consensus       404 ~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~  444 (454)
                      ..+...|..+|..+.+++.+||+.+|++||++.+++++|.+
T Consensus       237 ~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~  277 (277)
T cd05036         237 GGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY  277 (277)
T ss_pred             CCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence            55666788899999999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.3e-40  Score=315.97  Aligned_cols=242  Identities=26%  Similarity=0.460  Sum_probs=201.9

Q ss_pred             ceeeccCCceEEEe---------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEEecc
Q 012887          196 DQIGPNSFKGVYKG---------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLM  266 (454)
Q Consensus       196 ~~LG~G~fG~Vy~g---------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~E~~  266 (454)
                      ++||+|+||.||+|         ..+|+|.+...... .....+.+|+..+..++||||+++++++.. +. .++||||+
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~-~~~v~e~~   77 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCKG-EP-LMLVMELA   77 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-Cc-eEEEEEeC
Confidence            46999999999986         36888988744332 455678899999999999999999998763 33 78999999


Q ss_pred             CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCccc---c
Q 012887          267 EGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE---Y  343 (454)
Q Consensus       267 ~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~---~  343 (454)
                      ++|+|.+++.+...+++..+..++.|++.||.|||+.+++|+||||+|||++.++.+||+|||++...........   .
T Consensus        78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~  157 (257)
T cd05060          78 PLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTA  157 (257)
T ss_pred             CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccC
Confidence            9999999998777899999999999999999999999999999999999999999999999999876644322111   1


Q ss_pred             cCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHHHHHH
Q 012887          344 ETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMI  422 (454)
Q Consensus       344 ~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~li~  422 (454)
                      ..++..|+|||.+.+..+    +.++||||||+++|+|++ |..||...+..+.... .....+.+.|..++..+.++|.
T Consensus       158 ~~~~~~y~aPE~~~~~~~----~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~  232 (257)
T cd05060         158 GRWPLKWYAPECINYGKF----SSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAM-LESGERLPRPEECPQEIYSIML  232 (257)
T ss_pred             ccccccccCHHHhcCCCC----CccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHH-HHcCCcCCCCCCCCHHHHHHHH
Confidence            122457999999976644    446999999999999998 9999988776554433 3445566778889999999999


Q ss_pred             HhcccCCCCCCCHHHHHHHHHhh
Q 012887          423 KCWNNSPSKRPQFSEIISLLLRT  445 (454)
Q Consensus       423 ~cl~~dP~~RPs~~ell~~L~~~  445 (454)
                      +||..+|.+||++.++++.|...
T Consensus       233 ~cl~~~p~~Rp~~~~l~~~l~~~  255 (257)
T cd05060         233 SCWKYRPEDRPTFSELESTFRRD  255 (257)
T ss_pred             HHhcCChhhCcCHHHHHHHHHhc
Confidence            99999999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-40  Score=326.46  Aligned_cols=247  Identities=18%  Similarity=0.287  Sum_probs=201.2

Q ss_pred             CEEEeceeeccCCceEEEe------EEEEEEEeecCCCC-chHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEE
Q 012887          191 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  263 (454)
Q Consensus       191 ~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~  263 (454)
                      .|++.+.||+|+||.||++      +.||+|++...... ......+.+|+.+++.++||||+++++.+.+.+. +++||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~lv~   79 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDA-LCLVL   79 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCe-EEEEE
Confidence            4788999999999999985      57999998743322 2223446789999999999999999999987776 99999


Q ss_pred             eccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCcc
Q 012887          264 KLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT  341 (454)
Q Consensus       264 E~~~~gsL~~~l~~~--~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~  341 (454)
                      ||+++|+|.+++...  ..+++..+..++.|++.||.|||+++++||||||+||++++++.++|+|||++....... ..
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~  158 (285)
T cd05605          80 TLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE-TI  158 (285)
T ss_pred             eccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC-cc
Confidence            999999999888543  369999999999999999999999999999999999999999999999999987653322 22


Q ss_pred             cccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH--HcCCCCCCCCCccHHHHH
Q 012887          342 EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIA--ACGLRPEIPKDCPQILKS  419 (454)
Q Consensus       342 ~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~--~~~~~~~~p~~~~~~l~~  419 (454)
                      ....++..|+|||.+.+..+    +.++|||||||++|+|++|..||.+.........+.  .......++..++..+.+
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~----~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (285)
T cd05605         159 RGRVGTVGYMAPEVVKNERY----TFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARS  234 (285)
T ss_pred             ccccCCCCccCcHHhcCCCC----CccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHH
Confidence            33467889999999976544    445999999999999999999998765433222211  123344567778999999


Q ss_pred             HHHHhcccCCCCCC-----CHHHHHHHHH
Q 012887          420 LMIKCWNNSPSKRP-----QFSEIISLLL  443 (454)
Q Consensus       420 li~~cl~~dP~~RP-----s~~ell~~L~  443 (454)
                      ++.+||..||.+||     ++.+++.+-+
T Consensus       235 li~~~l~~~P~~R~~~~~~~~~~l~~~~~  263 (285)
T cd05605         235 ICRQLLTKDPGFRLGCRGEGAEEVKAHPF  263 (285)
T ss_pred             HHHHHccCCHHHhcCCCCCCHHHHhcCcC
Confidence            99999999999999     8999988744

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=3.1e-40  Score=327.57  Aligned_cols=251  Identities=14%  Similarity=0.240  Sum_probs=201.1

Q ss_pred             CCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEE
Q 012887          189 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  262 (454)
Q Consensus       189 ~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV  262 (454)
                      .++|.+++.||+|+||.||+|      +.+|+|.++.... ......+.+|+.++.+++||||+++++++..++. .++|
T Consensus         5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~lv   82 (309)
T cd07872           5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKS-LTLV   82 (309)
T ss_pred             CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc-CCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCe-EEEE
Confidence            377999999999999999986      4689999874432 2223446789999999999999999999988776 9999


Q ss_pred             EeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCcc
Q 012887          263 TKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT  341 (454)
Q Consensus       263 ~E~~~~gsL~~~l~~~~-~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~  341 (454)
                      |||+++ +|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..........
T Consensus        83 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  161 (309)
T cd07872          83 FEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTY  161 (309)
T ss_pred             EeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCcccc
Confidence            999976 8888876544 68999999999999999999999999999999999999999999999999987654333333


Q ss_pred             cccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcC-----------------
Q 012887          342 EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG-----------------  404 (454)
Q Consensus       342 ~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~-----------------  404 (454)
                      ....+++.|+|||.+.+..   .++.++|||||||++|+|++|..||.+.+..+....+...-                 
T Consensus       162 ~~~~~~~~y~aPE~~~~~~---~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (309)
T cd07872         162 SNEVVTLWYRPPDVLLGSS---EYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEF  238 (309)
T ss_pred             ccccccccccCCHHHhCCC---CCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhh
Confidence            3445788999999987542   24567999999999999999999998876654433332110                 


Q ss_pred             ----CCC-------CCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 012887          405 ----LRP-------EIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRT  445 (454)
Q Consensus       405 ----~~~-------~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~  445 (454)
                          .+.       .....+++++.++|.+||..||.+|||+.|++.+-+-.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~  290 (309)
T cd07872         239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFR  290 (309)
T ss_pred             hhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhh
Confidence                000       01124678999999999999999999999999876543

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=3.1e-40  Score=318.63  Aligned_cols=250  Identities=26%  Similarity=0.488  Sum_probs=207.2

Q ss_pred             eeecCCCEEEeceeeccCCceEEEeE-----EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeE
Q 012887          185 WLLNSDNLEFIDQIGPNSFKGVYKGK-----RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGL  259 (454)
Q Consensus       185 ~~~~~~~~~~~~~LG~G~fG~Vy~g~-----~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l  259 (454)
                      |.+..++|++.+.||+|+||.||++.     .+|+|.+.....   ....+.+|+.++++++|+|++++++++.. +. .
T Consensus         1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~---~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~-~   75 (260)
T cd05070           1 WEIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM---SPESFLEEAQIMKKLRHDKLVQLYAVVSE-EP-I   75 (260)
T ss_pred             CCCchHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC---CHHHHHHHHHHHHhcCCCceEEEEeEECC-CC-c
Confidence            45667889999999999999999864     588888874332   23457899999999999999999998753 33 7


Q ss_pred             EEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccC
Q 012887          260 CVVTKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV  337 (454)
Q Consensus       260 ~lV~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~  337 (454)
                      +++|||+++++|.+++.+.  ..+++..+..++.|++.||.|||+++++||||||+||++++++.++|+|||++......
T Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~  155 (260)
T cd05070          76 YIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDN  155 (260)
T ss_pred             EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCc
Confidence            8999999999999998653  36899999999999999999999999999999999999999999999999998765432


Q ss_pred             CCc-ccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHcCCCCCCCCCccH
Q 012887          338 GEA-TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ  415 (454)
Q Consensus       338 ~~~-~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~  415 (454)
                      ... .....++..|+|||.+.+..    .+.++|+||||+++|+|++ |..||.+.+..+....+. .+.+++.+...+.
T Consensus       156 ~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~  230 (260)
T cd05070         156 EYTARQGAKFPIKWTAPEAALYGR----FTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVE-RGYRMPCPQDCPI  230 (260)
T ss_pred             ccccccCCCCCccccChHHHhcCC----CcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-cCCCCCCCCcCCH
Confidence            211 11223456799999987654    3446999999999999999 999998877666555444 3556667888999


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 012887          416 ILKSLMIKCWNNSPSKRPQFSEIISLLLR  444 (454)
Q Consensus       416 ~l~~li~~cl~~dP~~RPs~~ell~~L~~  444 (454)
                      .+.+++.+||..+|.+|||+.++.+.|..
T Consensus       231 ~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         231 SLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             HHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            99999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=8.1e-40  Score=316.90  Aligned_cols=252  Identities=27%  Similarity=0.482  Sum_probs=208.4

Q ss_pred             ecCCCEEEeceeeccCCceEEEeE---------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCC
Q 012887          187 LNSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH  257 (454)
Q Consensus       187 ~~~~~~~~~~~LG~G~fG~Vy~g~---------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~  257 (454)
                      +..++|+..+.||+|+||.||+|.         .+++|.++.. ........+..|+..+..++||||+++++++.+.+.
T Consensus         2 i~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (268)
T cd05063           2 IHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPG-YTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKP   80 (268)
T ss_pred             CChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEecccc-CCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCC
Confidence            345688999999999999999874         5788887643 223344567889999999999999999999987776


Q ss_pred             eEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCcccccc
Q 012887          258 GLCVVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS  336 (454)
Q Consensus       258 ~l~lV~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~  336 (454)
                       .++||||+++++|.+++.+. ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++.....
T Consensus        81 -~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~  159 (268)
T cd05063          81 -AMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLED  159 (268)
T ss_pred             -cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceeccc
Confidence             89999999999999998653 5789999999999999999999999999999999999999999999999999876543


Q ss_pred             CCCccc---ccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHcCCCCCCCCC
Q 012887          337 VGEATE---YETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKD  412 (454)
Q Consensus       337 ~~~~~~---~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~  412 (454)
                      ......   ....++.|+|||.+.+..    ++.++|||||||++|||++ |..||...+.......+. ...+.+.+..
T Consensus       160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~----~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~-~~~~~~~~~~  234 (268)
T cd05063         160 DPEGTYTTSGGKIPIRWTAPEAIAYRK----FTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAIN-DGFRLPAPMD  234 (268)
T ss_pred             ccccceeccCCCcCceecCHHHhhcCC----cChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHh-cCCCCCCCCC
Confidence            222111   112245799999987654    4456999999999999997 999998877666555554 3455566677


Q ss_pred             ccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 012887          413 CPQILKSLMIKCWNNSPSKRPQFSEIISLLLRT  445 (454)
Q Consensus       413 ~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~  445 (454)
                      ++.++.+++.+||..+|++||++.++++.|.++
T Consensus       235 ~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         235 CPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            899999999999999999999999999999765

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-40  Score=336.59  Aligned_cols=249  Identities=23%  Similarity=0.358  Sum_probs=219.0

Q ss_pred             CCEEEeceeeccCCceEEE------eEEEEEEEeecCCCCch-HHHHHHHHHHHHHhCC-CCceeEEEEEEEeCCCeEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNA-YEFELRKDLLELMTCG-HKNILQFYCVCVDENHGLCV  261 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~------g~~vavK~l~~~~~~~~-~~~~~~~Ei~~l~~l~-HpnIv~~~g~~~~~~~~l~l  261 (454)
                      +.|++.+.||.|.||.||+      |+.+|+|.+........ ....+.+|+.+|.++. |||||.++++|.+.+. +++
T Consensus        35 ~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~-~~l  113 (382)
T KOG0032|consen   35 EKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDS-VYL  113 (382)
T ss_pred             ccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCe-EEE
Confidence            6789999999999999998      46899999975543332 4467899999999998 9999999999998886 999


Q ss_pred             EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccC----CcEEEEccCCccccccC
Q 012887          262 VTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH----GNVCLGDMGIVTACKSV  337 (454)
Q Consensus       262 V~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~----~~vKL~DFGla~~~~~~  337 (454)
                      |||+|.||.|.+.+.+. .+++..+..++.||+.++.|||+.||+||||||+|+|+...    +.+|++|||++..... 
T Consensus       114 vmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~-  191 (382)
T KOG0032|consen  114 VMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP-  191 (382)
T ss_pred             EEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC-
Confidence            99999999999999665 49999999999999999999999999999999999999644    4799999999988776 


Q ss_pred             CCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCC--CCCCccH
Q 012887          338 GEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPE--IPKDCPQ  415 (454)
Q Consensus       338 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~--~p~~~~~  415 (454)
                      .......+||+.|+|||++.+.+++..    +||||+||++|.|++|.+||.+.+.......+....+...  ....++.
T Consensus       192 ~~~~~~~~Gtp~y~APEvl~~~~y~~~----~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~  267 (382)
T KOG0032|consen  192 GERLHTIVGTPEYVAPEVLGGRPYGDE----VDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISE  267 (382)
T ss_pred             CceEeeecCCccccCchhhcCCCCCcc----cchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCH
Confidence            556777899999999999997766554    9999999999999999999999998888888887766433  3345799


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 012887          416 ILKSLMIKCWNNSPSKRPQFSEIISLLLRT  445 (454)
Q Consensus       416 ~l~~li~~cl~~dP~~RPs~~ell~~L~~~  445 (454)
                      .++++++.++..||.+|+++.++++|.|-.
T Consensus       268 ~akd~i~~ll~~dp~~R~ta~~~L~HpWi~  297 (382)
T KOG0032|consen  268 SAKDFIRKLLEFDPRKRLTAAQALQHPWIK  297 (382)
T ss_pred             HHHHHHHHhcccCcccCCCHHHHhcCcccc
Confidence            999999999999999999999999997743

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=3.4e-40  Score=319.95  Aligned_cols=249  Identities=24%  Similarity=0.411  Sum_probs=203.4

Q ss_pred             CCEEEeceeeccCCceEEEeE------EEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEEEEEEEeCC-----C
Q 012887          190 DNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVDEN-----H  257 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g~------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~~~g~~~~~~-----~  257 (454)
                      +.|++.+.||+|+||.||+|.      .+|+|.+....   .....+..|+..+..+ +||||+++++++...+     .
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (272)
T cd06637           6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD   82 (272)
T ss_pred             hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC---ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence            567888999999999999864      68999886432   2335677888888887 6999999999987642     2


Q ss_pred             eEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccc
Q 012887          258 GLCVVTKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK  335 (454)
Q Consensus       258 ~l~lV~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~  335 (454)
                      .+++||||+++++|.+++...  ..+++..+..++.|++.||.|||+++|+||||||+||+++.++.+||+|||++....
T Consensus        83 ~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~  162 (272)
T cd06637          83 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD  162 (272)
T ss_pred             EEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceecc
Confidence            488999999999999998653  368999999999999999999999999999999999999999999999999987654


Q ss_pred             cCCCcccccCCCCcccccccccCCCC-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCcc
Q 012887          336 SVGEATEYETDGYRWLAPEIIAGDPE-SVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCP  414 (454)
Q Consensus       336 ~~~~~~~~~~gt~~y~APE~l~~~~~-~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~  414 (454)
                      ..........+++.|+|||++.+... ...++.++|||||||++|||++|..||....+......+.....+...+..++
T Consensus       163 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (272)
T cd06637         163 RTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWS  242 (272)
T ss_pred             cccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCCCCCcC
Confidence            33333444567889999999864321 22356679999999999999999999987666655544444444444455788


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012887          415 QILKSLMIKCWNNSPSKRPQFSEIISL  441 (454)
Q Consensus       415 ~~l~~li~~cl~~dP~~RPs~~ell~~  441 (454)
                      .++.++|.+||..||.+||++.+++++
T Consensus       243 ~~~~~li~~~l~~~p~~Rpt~~~il~~  269 (272)
T cd06637         243 KKFQSFIESCLVKNHSQRPTTEQLMKH  269 (272)
T ss_pred             HHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence            999999999999999999999999876

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=5.8e-41  Score=334.96  Aligned_cols=240  Identities=21%  Similarity=0.263  Sum_probs=195.4

Q ss_pred             ceeeccCCceEEEe------EEEEEEEeecCCC-CchHHHHHHHHHH-HHHhCCCCceeEEEEEEEeCCCeEEEEEeccC
Q 012887          196 DQIGPNSFKGVYKG------KRVGIEKLKGCDK-GNAYEFELRKDLL-ELMTCGHKNILQFYCVCVDENHGLCVVTKLME  267 (454)
Q Consensus       196 ~~LG~G~fG~Vy~g------~~vavK~l~~~~~-~~~~~~~~~~Ei~-~l~~l~HpnIv~~~g~~~~~~~~l~lV~E~~~  267 (454)
                      +.||+|+||.||++      +.+|+|.+..... .......+..|.. ++..++||||+++++++.+.+. +|+||||++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~-~~lv~e~~~   79 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEK-LYFVLDYVN   79 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCE-EEEEEcCCC
Confidence            36999999999986      4689999864321 1122334455544 4677899999999999987775 999999999


Q ss_pred             CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCcccccCCC
Q 012887          268 GGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG  347 (454)
Q Consensus       268 ~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~gt  347 (454)
                      +|+|.+.+.+...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..............|+
T Consensus        80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt  159 (321)
T cd05603          80 GGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGT  159 (321)
T ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccccccCC
Confidence            99999998777789999999999999999999999999999999999999999999999999987543333333445688


Q ss_pred             CcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhccc
Q 012887          348 YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNN  427 (454)
Q Consensus       348 ~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~li~~cl~~  427 (454)
                      +.|+|||++.+..+    +.++|||||||++|||++|..||.+.+.......+..  .+..+|...+..+.+++.+||+.
T Consensus       160 ~~y~aPE~~~~~~~----~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~~~li~~~l~~  233 (321)
T cd05603         160 PEYLAPEVLRKEPY----DRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILH--KPLQLPGGKTVAACDLLVGLLHK  233 (321)
T ss_pred             cccCCHHHhcCCCC----CCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhc--CCCCCCCCCCHHHHHHHHHHccC
Confidence            99999999987654    4459999999999999999999998776665555543  34567778899999999999999


Q ss_pred             CCCCCCCH----HHHHHHH
Q 012887          428 SPSKRPQF----SEIISLL  442 (454)
Q Consensus       428 dP~~RPs~----~ell~~L  442 (454)
                      ||.+||+.    .+++++.
T Consensus       234 ~p~~R~~~~~~~~~~~~~~  252 (321)
T cd05603         234 DQRRRLGAKADFLEIKNHV  252 (321)
T ss_pred             CHhhcCCCCCCHHHHhCCC
Confidence            99999875    4665543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=1.3e-40  Score=333.86  Aligned_cols=241  Identities=20%  Similarity=0.300  Sum_probs=196.6

Q ss_pred             ceeeccCCceEEEe------EEEEEEEeecCCCCc-hHHHHHHHHHHHHHhC-CCCceeEEEEEEEeCCCeEEEEEeccC
Q 012887          196 DQIGPNSFKGVYKG------KRVGIEKLKGCDKGN-AYEFELRKDLLELMTC-GHKNILQFYCVCVDENHGLCVVTKLME  267 (454)
Q Consensus       196 ~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~-~~~~~~~~Ei~~l~~l-~HpnIv~~~g~~~~~~~~l~lV~E~~~  267 (454)
                      +.||+|+||.||++      +.+|+|.++...... .....+.+|+.++..+ +||||+++++++.+.+. +|+||||++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~-~~lv~e~~~   79 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSR-LFLVIEYVN   79 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCE-EEEEEeCCC
Confidence            36999999999986      479999997543222 2334567888888777 69999999999987776 999999999


Q ss_pred             CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCcccccCCC
Q 012887          268 GGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG  347 (454)
Q Consensus       268 ~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~gt  347 (454)
                      +|+|.+++.+.+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.............||
T Consensus        80 ~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt  159 (327)
T cd05617          80 GGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGT  159 (327)
T ss_pred             CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceecccCC
Confidence            99999998877889999999999999999999999999999999999999999999999999987543333334455789


Q ss_pred             CcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC------CHHHHHHHHHHcCCCCCCCCCccHHHHHHH
Q 012887          348 YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAAC------SPVQAAVGIAACGLRPEIPKDCPQILKSLM  421 (454)
Q Consensus       348 ~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~------~~~~~~~~i~~~~~~~~~p~~~~~~l~~li  421 (454)
                      +.|+|||++.+..+    +.++|||||||++|+|++|..||...      ........... ..+..+|..++..+.+++
T Consensus       160 ~~y~aPE~~~~~~~----~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~p~~~~~~~~~li  234 (327)
T cd05617         160 PNYIAPEILRGEEY----GFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVIL-EKPIRIPRFLSVKASHVL  234 (327)
T ss_pred             cccCCHHHHCCCCC----CchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHH-hCCCCCCCCCCHHHHHHH
Confidence            99999999987654    44599999999999999999999632      12222333322 234557888999999999


Q ss_pred             HHhcccCCCCCCC------HHHHHHHH
Q 012887          422 IKCWNNSPSKRPQ------FSEIISLL  442 (454)
Q Consensus       422 ~~cl~~dP~~RPs------~~ell~~L  442 (454)
                      .+||+.||.+|++      +.++++|-
T Consensus       235 ~~~L~~dP~~R~~~~~~~~~~~i~~h~  261 (327)
T cd05617         235 KGFLNKDPKERLGCQPQTGFSDIKSHT  261 (327)
T ss_pred             HHHhccCHHHcCCCCCCCCHHHHHcCC
Confidence            9999999999997      56777663

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1e-39  Score=318.54  Aligned_cols=255  Identities=23%  Similarity=0.434  Sum_probs=211.2

Q ss_pred             ecCCCEEEeceeeccCCceEEEeE----------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCC
Q 012887          187 LNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN  256 (454)
Q Consensus       187 ~~~~~~~~~~~LG~G~fG~Vy~g~----------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~  256 (454)
                      +..++|++.+.||+|+||.||+|.          .+|+|.+... ........+.+|+..+.+++||||+++++++.. .
T Consensus         4 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~   81 (279)
T cd05057           4 LKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREE-TSPKANKEILDEAYVMASVDHPHVVRLLGICLS-S   81 (279)
T ss_pred             cCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCC-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-C
Confidence            445789999999999999999974          4788877643 223345668899999999999999999999987 4


Q ss_pred             CeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccc
Q 012887          257 HGLCVVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK  335 (454)
Q Consensus       257 ~~l~lV~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~  335 (454)
                      . .++||||+++|+|.+++.+. ..+++..+..++.||+.||+|||+.+++||||||+|||++.++.+||+|||++....
T Consensus        82 ~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~  160 (279)
T cd05057          82 Q-VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD  160 (279)
T ss_pred             c-eEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCccccccc
Confidence            3 89999999999999999664 479999999999999999999999999999999999999999999999999987654


Q ss_pred             cCCCccc--ccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHcCCCCCCCCC
Q 012887          336 SVGEATE--YETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKD  412 (454)
Q Consensus       336 ~~~~~~~--~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~  412 (454)
                      .......  ...++..|+|||.+.+..    ++.++|+||||+++||+++ |..||.+....+.... ...+...+.|..
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~----~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~  235 (279)
T cd05057         161 VDEKEYHAEGGKVPIKWMALESILHRI----YTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDL-LEKGERLPQPPI  235 (279)
T ss_pred             CcccceecCCCcccccccCHHHhhcCC----cCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH-HhCCCCCCCCCC
Confidence            3222111  122356799999987554    3456999999999999998 9999998776655443 344556667778


Q ss_pred             ccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCCC
Q 012887          413 CPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNIS  449 (454)
Q Consensus       413 ~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~  449 (454)
                      ++..+.+++.+||..||.+||++.++++.|.++.+..
T Consensus       236 ~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~  272 (279)
T cd05057         236 CTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARDP  272 (279)
T ss_pred             CCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhCC
Confidence            8999999999999999999999999999999886543

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.3e-40  Score=324.26  Aligned_cols=251  Identities=24%  Similarity=0.432  Sum_probs=201.9

Q ss_pred             cCCCEEEeceeeccCCceEEEeE--------------------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeE
Q 012887          188 NSDNLEFIDQIGPNSFKGVYKGK--------------------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQ  247 (454)
Q Consensus       188 ~~~~~~~~~~LG~G~fG~Vy~g~--------------------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~  247 (454)
                      +.++|++.+.||+|+||.||++.                    .+|+|.++.. ........+.+|+..+.+++|||+++
T Consensus         3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~ei~~l~~l~h~~i~~   81 (295)
T cd05097           3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRAD-VTKTARNDFLKEIKIMSRLKNPNIIR   81 (295)
T ss_pred             chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCC-CCHHHHHHHHHHHHHHHhCCCCCcCe
Confidence            45789999999999999999853                    4889888642 33334556889999999999999999


Q ss_pred             EEEEEEeCCCeEEEEEeccCCCCHHHHHHhCC------------CCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcE
Q 012887          248 FYCVCVDENHGLCVVTKLMEGGSVNDLILKSR------------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRI  315 (454)
Q Consensus       248 ~~g~~~~~~~~l~lV~E~~~~gsL~~~l~~~~------------~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NI  315 (454)
                      +++++...+. .++||||+++++|.+++....            .+++..+..++.|++.||.|||+++++||||||+||
T Consensus        82 ~~~~~~~~~~-~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Ni  160 (295)
T cd05097          82 LLGVCVSDDP-LCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNC  160 (295)
T ss_pred             EEEEEcCCCc-cEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhE
Confidence            9999987776 899999999999999985421            368889999999999999999999999999999999


Q ss_pred             EEccCCcEEEEccCCccccccCCCc--ccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc--CCCCCCCC
Q 012887          316 LLDRHGNVCLGDMGIVTACKSVGEA--TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT--GEAAYAAC  391 (454)
Q Consensus       316 Ll~~~~~vKL~DFGla~~~~~~~~~--~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt--G~~Pf~~~  391 (454)
                      +++.++.+||+|||++.........  .....++..|+|||++.+..    ++.++|||||||++|+|++  |..||...
T Consensus       161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~DvwSlG~~l~el~~~~~~~p~~~~  236 (295)
T cd05097         161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGK----FTTASDVWAFGVTLWEMFTLCKEQPYSLL  236 (295)
T ss_pred             EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCC----cCchhhHHHHHHHHHHHHHcCCCCCCccc
Confidence            9999999999999998754332111  11223466899999987664    3456999999999999988  77888877


Q ss_pred             CHHHHHHHHHH------cCCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 012887          392 SPVQAAVGIAA------CGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR  444 (454)
Q Consensus       392 ~~~~~~~~i~~------~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~  444 (454)
                      +.......+..      .......+..+|+.+.+|+.+||+.||++||++.+|++.|.+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~  295 (295)
T cd05097         237 SDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE  295 (295)
T ss_pred             ChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence            66554433321      111223455688999999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=7.5e-40  Score=317.56  Aligned_cols=250  Identities=26%  Similarity=0.470  Sum_probs=206.5

Q ss_pred             CCCEEEeceeeccCCceEEEeE---------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeE
Q 012887          189 SDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGL  259 (454)
Q Consensus       189 ~~~~~~~~~LG~G~fG~Vy~g~---------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l  259 (454)
                      ..+|++.+.||+|+||.||+|.         .+|+|.++.. ........+..|+..+..++||||+++++++.+.+. .
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~-~   80 (269)
T cd05065           3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRP-V   80 (269)
T ss_pred             hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCc-e
Confidence            3578999999999999999864         4899988643 233345568899999999999999999999887765 8


Q ss_pred             EEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCC
Q 012887          260 CVVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG  338 (454)
Q Consensus       260 ~lV~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~  338 (454)
                      ++||||+++++|.+++... +.+++..+..++.|++.||.|||++|++|+||||+||+++.++.+||+|||++.......
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~  160 (269)
T cd05065          81 MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT  160 (269)
T ss_pred             EEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence            9999999999999998653 478999999999999999999999999999999999999999999999999976554322


Q ss_pred             Ccccc---cC--CCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHcCCCCCCCCC
Q 012887          339 EATEY---ET--DGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKD  412 (454)
Q Consensus       339 ~~~~~---~~--gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~  412 (454)
                      .....   ..  .+..|+|||.+.+..    ++.++|||||||++|||++ |..||...........+ ....+.+.+..
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~----~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i-~~~~~~~~~~~  235 (269)
T cd05065         161 SDPTYTSSLGGKIPIRWTAPEAIAYRK----FTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAI-EQDYRLPPPMD  235 (269)
T ss_pred             cccccccccCCCcceeecCHhHhccCc----ccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHH-HcCCcCCCccc
Confidence            11111   11  135799999997654    3446999999999999887 99999887766555544 34455666778


Q ss_pred             ccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 012887          413 CPQILKSLMIKCWNNSPSKRPQFSEIISLLLRT  445 (454)
Q Consensus       413 ~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~  445 (454)
                      +|..+.+++.+||..+|++||++.+++..|.+.
T Consensus       236 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         236 CPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            899999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.3e-40  Score=316.23  Aligned_cols=249  Identities=21%  Similarity=0.404  Sum_probs=207.4

Q ss_pred             CCCEEEeceeeccCCceEEEeE------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEE
Q 012887          189 SDNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  262 (454)
Q Consensus       189 ~~~~~~~~~LG~G~fG~Vy~g~------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV  262 (454)
                      .++|++.+.||.|+||.||++.      .+++|.+......  ....+.+|+.+++.++||||+++++++.+.+. ++++
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~-~~l~   78 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD--DFEIIQQEISMLKECRHPNIVAYFGSYLRRDK-LWIV   78 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh--hHHHHHHHHHHHHhCCCCChhceEEEEEeCCE-EEEE
Confidence            4789999999999999999864      5889988743322  44568899999999999999999999988776 9999


Q ss_pred             EeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCcc
Q 012887          263 TKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT  341 (454)
Q Consensus       263 ~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~  341 (454)
                      |||+++++|.+++... ..+++..+..++.|++.||.|||+++++|+||+|+||+++.++.+||+|||++..........
T Consensus        79 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~  158 (262)
T cd06613          79 MEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKR  158 (262)
T ss_pred             EeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhhcc
Confidence            9999999999998765 689999999999999999999999999999999999999999999999999987655433333


Q ss_pred             cccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCC---CCCCccHHHH
Q 012887          342 EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPE---IPKDCPQILK  418 (454)
Q Consensus       342 ~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~---~p~~~~~~l~  418 (454)
                      ....++..|+|||.+.+... ..++.++|+||||+++|+|++|..||...++......+.....++.   .+..++.++.
T Consensus       159 ~~~~~~~~y~~Pe~~~~~~~-~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (262)
T cd06613         159 KSFIGTPYWMAPEVAAVERK-GGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFH  237 (262)
T ss_pred             ccccCCccccCchhhccccc-CCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHH
Confidence            44567788999999876521 2345679999999999999999999998777666555544433322   2344678899


Q ss_pred             HHHHHhcccCCCCCCCHHHHHHH
Q 012887          419 SLMIKCWNNSPSKRPQFSEIISL  441 (454)
Q Consensus       419 ~li~~cl~~dP~~RPs~~ell~~  441 (454)
                      +++.+||..+|.+||++.+++.+
T Consensus       238 ~li~~~l~~~p~~Rpt~~~il~~  260 (262)
T cd06613         238 DFIKKCLTKDPKKRPTATKLLQH  260 (262)
T ss_pred             HHHHHHcCCChhhCCCHHHHhcC
Confidence            99999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=5.1e-40  Score=333.33  Aligned_cols=247  Identities=19%  Similarity=0.249  Sum_probs=195.8

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCC-----Ce
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN-----HG  258 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~-----~~  258 (454)
                      ++|++.+.||+|+||.||++      +.+|+|++............+.+|+.+++.++||||+++++++...+     ..
T Consensus        21 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  100 (359)
T cd07876          21 KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQD  100 (359)
T ss_pred             hceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccce
Confidence            78999999999999999985      57999998754444445566789999999999999999999987543     23


Q ss_pred             EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCC
Q 012887          259 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG  338 (454)
Q Consensus       259 l~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~  338 (454)
                      +|+||||+++ +|.+.+.  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... 
T Consensus       101 ~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~-  176 (359)
T cd07876         101 VYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTN-  176 (359)
T ss_pred             eEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccccccC-
Confidence            7999999976 6776653  35889999999999999999999999999999999999999999999999998754332 


Q ss_pred             CcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHc---------------
Q 012887          339 EATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAAC---------------  403 (454)
Q Consensus       339 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~---------------  403 (454)
                      .......+|+.|+|||.+.+..++    .++|||||||++|+|++|..||.+.+.......+...               
T Consensus       177 ~~~~~~~~t~~y~aPE~~~~~~~~----~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (359)
T cd07876         177 FMMTPYVVTRYYRAPEVILGMGYK----ENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPT  252 (359)
T ss_pred             ccCCCCcccCCCCCchhccCCCCC----cchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHH
Confidence            122334678899999999876544    4599999999999999999999876543322111100               


Q ss_pred             -----CCCCC--------------------CCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 012887          404 -----GLRPE--------------------IPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR  444 (454)
Q Consensus       404 -----~~~~~--------------------~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~  444 (454)
                           ..++.                    .+...++++.+||.+||+.||.+|||+.|++.|-+-
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~  318 (359)
T cd07876         253 VRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYI  318 (359)
T ss_pred             HHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchh
Confidence                 00000                    111246789999999999999999999999998764

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=9.2e-40  Score=314.09  Aligned_cols=246  Identities=20%  Similarity=0.343  Sum_probs=209.1

Q ss_pred             CEEEeceeeccCCceEEE------eEEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEEe
Q 012887          191 NLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTK  264 (454)
Q Consensus       191 ~~~~~~~LG~G~fG~Vy~------g~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~E  264 (454)
                      +|++++.||.|+||.||.      ++.+++|.+............+.+|+.++++++|+||+++++++.+.+. ++++||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~-~~~~~e   79 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNT-LLIEME   79 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCe-EEEEEE
Confidence            488999999999998886      4578999887554444555667899999999999999999999988765 999999


Q ss_pred             ccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCccc
Q 012887          265 LMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE  342 (454)
Q Consensus       265 ~~~~gsL~~~l~~~--~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~  342 (454)
                      |+++++|.+++.+.  ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++...........
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~  159 (256)
T cd08221          80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAE  159 (256)
T ss_pred             ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccccccc
Confidence            99999999999654  4689999999999999999999999999999999999999999999999999876644433333


Q ss_pred             ccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHHHHHH
Q 012887          343 YETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMI  422 (454)
Q Consensus       343 ~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~li~  422 (454)
                      ...+++.|+|||.+.+...    +.++||||||+++|+|++|..||......+....+.... ..+.+..++.++.+++.
T Consensus       160 ~~~~~~~y~ape~~~~~~~----~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~  234 (256)
T cd08221         160 TVVGTPYYMSPELCQGVKY----NFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGN-YTPVVSVYSSELISLVH  234 (256)
T ss_pred             ccCCCccccCHhhcCCCCC----CCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC-CCCCccccCHHHHHHHH
Confidence            4567889999999876543    445999999999999999999999877777666665443 33455778999999999


Q ss_pred             HhcccCCCCCCCHHHHHHHH
Q 012887          423 KCWNNSPSKRPQFSEIISLL  442 (454)
Q Consensus       423 ~cl~~dP~~RPs~~ell~~L  442 (454)
                      +||..+|.+||+++++++++
T Consensus       235 ~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         235 SLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             HHcccCcccCCCHHHHhhCc
Confidence            99999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=8.8e-40  Score=318.93  Aligned_cols=255  Identities=24%  Similarity=0.476  Sum_probs=209.9

Q ss_pred             ecCCCEEEeceeeccCCceEEEe----------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCC
Q 012887          187 LNSDNLEFIDQIGPNSFKGVYKG----------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN  256 (454)
Q Consensus       187 ~~~~~~~~~~~LG~G~fG~Vy~g----------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~  256 (454)
                      +..++|++.+.||+|+||.||+|          ..+++|.++.. ........+.+|+.++..++||||+++++++...+
T Consensus         3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~   81 (280)
T cd05043           3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH-ASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDG   81 (280)
T ss_pred             cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence            45688999999999999999986          34677777632 23334566788999999999999999999988765


Q ss_pred             CeEEEEEeccCCCCHHHHHHhC--------CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEcc
Q 012887          257 HGLCVVTKLMEGGSVNDLILKS--------RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDM  328 (454)
Q Consensus       257 ~~l~lV~E~~~~gsL~~~l~~~--------~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DF  328 (454)
                      ...++++||+++++|.+++...        ..+++..+..++.||+.||+|||+++++||||||+||+++.++.+||+||
T Consensus        82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~  161 (280)
T cd05043          82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDN  161 (280)
T ss_pred             CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCC
Confidence            5588999999999999998543        35889999999999999999999999999999999999999999999999


Q ss_pred             CCccccccCCCc--ccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHcCC
Q 012887          329 GIVTACKSVGEA--TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGL  405 (454)
Q Consensus       329 Gla~~~~~~~~~--~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~i~~~~~  405 (454)
                      |+++........  .....++..|+|||.+.+..    ++.++|||||||++||+++ |..||...++..... ....+.
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~----~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~-~~~~~~  236 (280)
T cd05043         162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKE----YSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAA-YLKDGY  236 (280)
T ss_pred             CCcccccCCceEEeCCCCCcchhccCHHHHhcCC----CCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHH-HHHcCC
Confidence            998755332111  11223456799999997654    4456999999999999999 999998877655443 333455


Q ss_pred             CCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 012887          406 RPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNN  447 (454)
Q Consensus       406 ~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~  447 (454)
                      +...+..+|+++.+++.+||..||++|||+.++++.|...+.
T Consensus       237 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~  278 (280)
T cd05043         237 RLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA  278 (280)
T ss_pred             CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            656677789999999999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=3e-40  Score=319.48  Aligned_cols=252  Identities=21%  Similarity=0.392  Sum_probs=205.6

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCc-hHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGN-AYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  262 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV  262 (454)
                      ++|++.+.||+|+||.||++      +.+++|.+....... ....++.+|+.+++.++||||+++++++.+.+. .+++
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~-~~~v   80 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNE-LNIV   80 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCe-EEEE
Confidence            56888999999999999985      478999886433322 234567889999999999999999999988776 8999


Q ss_pred             EeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCC
Q 012887          263 TKLMEGGSVNDLILK----SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG  338 (454)
Q Consensus       263 ~E~~~~gsL~~~l~~----~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~  338 (454)
                      |||+++++|.+++..    ...+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd08229          81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT  160 (267)
T ss_pred             EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCC
Confidence            999999999998853    3468999999999999999999999999999999999999999999999999987654433


Q ss_pred             CcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHH--HHHHHHHHcCCCCCCCCCccHH
Q 012887          339 EATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPV--QAAVGIAACGLRPEIPKDCPQI  416 (454)
Q Consensus       339 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~--~~~~~i~~~~~~~~~p~~~~~~  416 (454)
                      .......++..|+|||.+.+..    .+.++|+||||+++|+|++|..||.+....  .....+.....++..+..++..
T Consensus       161 ~~~~~~~~~~~~~ape~~~~~~----~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (267)
T cd08229         161 TAAHSLVGTPYYMSPERIHENG----YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEE  236 (267)
T ss_pred             cccccccCCcCccCHHHhcCCC----ccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHH
Confidence            3333446788899999997654    345699999999999999999999754332  2222333323333334568899


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 012887          417 LKSLMIKCWNNSPSKRPQFSEIISLLLRTN  446 (454)
Q Consensus       417 l~~li~~cl~~dP~~RPs~~ell~~L~~~~  446 (454)
                      +.+++.+||+.||.+|||+.+|++.+.+..
T Consensus       237 ~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  266 (267)
T cd08229         237 LRQLVNMCINPDPEKRPDITYVYDVAKRMH  266 (267)
T ss_pred             HHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence            999999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-40  Score=332.50  Aligned_cols=253  Identities=20%  Similarity=0.274  Sum_probs=203.8

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCC-chHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  262 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV  262 (454)
                      ++|++++.||+|+||.||++      +.+|+|.+...... ......+.+|+.++..++|+||+++++++.++++ +|+|
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~-~~lv   79 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENN-LYLV   79 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCe-EEEE
Confidence            47899999999999999985      47999998642211 2233446788888999999999999999988776 9999


Q ss_pred             EeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCC-c
Q 012887          263 TKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE-A  340 (454)
Q Consensus       263 ~E~~~~gsL~~~l~~-~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~-~  340 (454)
                      |||+++|+|.+++.+ ...+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||++........ .
T Consensus        80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  159 (331)
T cd05597          80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQ  159 (331)
T ss_pred             EecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCcc
Confidence            999999999999965 45799999999999999999999999999999999999999999999999999876543322 2


Q ss_pred             ccccCCCCcccccccccCCCC-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCC---CCccHH
Q 012887          341 TEYETDGYRWLAPEIIAGDPE-SVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIP---KDCPQI  416 (454)
Q Consensus       341 ~~~~~gt~~y~APE~l~~~~~-~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p---~~~~~~  416 (454)
                      .....||+.|+|||++.+... ...++.++|||||||++|+|++|..||.+.+..+....+........+|   ..++..
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  239 (331)
T cd05597         160 SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEE  239 (331)
T ss_pred             ccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCHH
Confidence            223468999999999874321 1234567999999999999999999999887776666665543333333   347899


Q ss_pred             HHHHHHHhcccCCCC--CCCHHHHHHHHH
Q 012887          417 LKSLMIKCWNNSPSK--RPQFSEIISLLL  443 (454)
Q Consensus       417 l~~li~~cl~~dP~~--RPs~~ell~~L~  443 (454)
                      +.++|++|+..++.+  ||++.++++|-+
T Consensus       240 ~~~li~~ll~~~~~r~~r~~~~~~l~hp~  268 (331)
T cd05597         240 AKDLIRRLICSPETRLGRNGLQDFKDHPF  268 (331)
T ss_pred             HHHHHHHHccCcccccCCCCHHHHhcCCC
Confidence            999999988654443  789999999854

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=2e-40  Score=345.92  Aligned_cols=245  Identities=21%  Similarity=0.258  Sum_probs=195.7

Q ss_pred             cCCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeC------
Q 012887          188 NSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDE------  255 (454)
Q Consensus       188 ~~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~------  255 (454)
                      ..++|++++.||+|+||.||+|      +.||+|++....      ....+|+.++..++|||||++++++...      
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~  137 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNE  137 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeecccccCC
Confidence            3468999999999999999985      579999885321      1234789999999999999999887542      


Q ss_pred             -CCeEEEEEeccCCCCHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCC-cEEEEccC
Q 012887          256 -NHGLCVVTKLMEGGSVNDLIL----KSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG-NVCLGDMG  329 (454)
Q Consensus       256 -~~~l~lV~E~~~~gsL~~~l~----~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~-~vKL~DFG  329 (454)
                       ...+++||||+++ +|.+++.    ....+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||
T Consensus       138 ~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFG  216 (440)
T PTZ00036        138 KNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFG  216 (440)
T ss_pred             CceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccc
Confidence             1236799999986 7877664    345799999999999999999999999999999999999999665 69999999


Q ss_pred             CccccccCCCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCC----
Q 012887          330 IVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGL----  405 (454)
Q Consensus       330 la~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~----  405 (454)
                      +++....... .....+++.|+|||++.+..   .++.++|||||||++|||++|.+||.+.+.......+.....    
T Consensus       217 la~~~~~~~~-~~~~~~t~~y~aPE~~~~~~---~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~  292 (440)
T PTZ00036        217 SAKNLLAGQR-SVSYICSRFYRAPELMLGAT---NYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTE  292 (440)
T ss_pred             cchhccCCCC-cccCCCCcCccCHHHhcCCC---CCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence            9986543322 22346788999999987542   355679999999999999999999998777655544432110    


Q ss_pred             -----------------------CCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 012887          406 -----------------------RPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLL  443 (454)
Q Consensus       406 -----------------------~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~  443 (454)
                                             +..+|...|+++.+||.+||.+||.+|||+.|++.|-+
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~  353 (440)
T PTZ00036        293 DQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPF  353 (440)
T ss_pred             HHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChh
Confidence                                   11234567889999999999999999999999998866

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=8.1e-40  Score=322.46  Aligned_cols=251  Identities=25%  Similarity=0.453  Sum_probs=201.3

Q ss_pred             cCCCEEEeceeeccCCceEEEeE----------------------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCce
Q 012887          188 NSDNLEFIDQIGPNSFKGVYKGK----------------------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNI  245 (454)
Q Consensus       188 ~~~~~~~~~~LG~G~fG~Vy~g~----------------------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnI  245 (454)
                      +.++|++.+.||+|+||.||+++                      .+|+|.++.. .......++.+|+..++.++|+||
T Consensus         3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~-~~~~~~~~~~~E~~~l~~l~~~~i   81 (296)
T cd05095           3 PRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLRED-ANKNARNDFLKEIKIMSRLKDPNI   81 (296)
T ss_pred             ChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCc
Confidence            45679999999999999999752                      5788888643 233344568899999999999999


Q ss_pred             eEEEEEEEeCCCeEEEEEeccCCCCHHHHHHhCC-----------CCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCc
Q 012887          246 LQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-----------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQR  314 (454)
Q Consensus       246 v~~~g~~~~~~~~l~lV~E~~~~gsL~~~l~~~~-----------~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~N  314 (454)
                      +++++++.+.+. .++||||+++++|.+++.+..           .+++..+..++.||+.||.|||++|++||||||+|
T Consensus        82 ~~~~~~~~~~~~-~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~N  160 (296)
T cd05095          82 IRLLAVCITSDP-LCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRN  160 (296)
T ss_pred             ceEEEEEecCCc-cEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChhe
Confidence            999999988776 899999999999999986532           36678899999999999999999999999999999


Q ss_pred             EEEccCCcEEEEccCCccccccCCCc--ccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc--CCCCCCC
Q 012887          315 ILLDRHGNVCLGDMGIVTACKSVGEA--TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT--GEAAYAA  390 (454)
Q Consensus       315 ILl~~~~~vKL~DFGla~~~~~~~~~--~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt--G~~Pf~~  390 (454)
                      ||++.++.++|+|||++.........  ......++.|+|||...+..+    +.++|||||||++|||++  |..||..
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~----~~~~DiwSlG~~l~el~~~~~~~p~~~  236 (296)
T cd05095         161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKF----TTASDVWAFGVTLWEILTLCKEQPYSQ  236 (296)
T ss_pred             EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCc----cchhhhhHHHHHHHHHHHhCCCCCccc
Confidence            99999999999999998765332211  112233567999998876644    446999999999999998  7899987


Q ss_pred             CCHHHHHHHHHH------cCCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 012887          391 CSPVQAAVGIAA------CGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR  444 (454)
Q Consensus       391 ~~~~~~~~~i~~------~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~  444 (454)
                      .+..+.......      .....+.+..+++.+.+++.+||+.||.+||++.+|.+.|++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         237 LSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             cChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            666554332211      111223456788999999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=1e-39  Score=314.77  Aligned_cols=246  Identities=25%  Similarity=0.450  Sum_probs=197.2

Q ss_pred             ceeeccCCceEEEeE---------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEEecc
Q 012887          196 DQIGPNSFKGVYKGK---------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLM  266 (454)
Q Consensus       196 ~~LG~G~fG~Vy~g~---------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~E~~  266 (454)
                      +.||+|+||.||+|.         .+|+|.+... ........+.+|+..++.++||||+++++++...+...++||||+
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~   79 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI-TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYM   79 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCcc-CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecC
Confidence            368999999999864         5788887532 222334567788899999999999999998876555588999999


Q ss_pred             CCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCC----cc
Q 012887          267 EGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE----AT  341 (454)
Q Consensus       267 ~~gsL~~~l~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~----~~  341 (454)
                      .+|+|.+++.+. ..+++..+..++.||+.||.|||+.+++||||||+|||++.++.+||+|||++........    ..
T Consensus        80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~  159 (262)
T cd05058          80 KHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNH  159 (262)
T ss_pred             CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeeccc
Confidence            999999999654 3567888899999999999999999999999999999999999999999999875433211    11


Q ss_pred             cccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHHHH
Q 012887          342 EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSL  420 (454)
Q Consensus       342 ~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~l  420 (454)
                      ....+++.|+|||.+.+..    ++.++|||||||++|||++ |.+||...+....... ...+.++..+..+|+.+.++
T Consensus       160 ~~~~~~~~y~aPE~~~~~~----~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l  234 (262)
T cd05058         160 TGAKLPVKWMALESLQTQK----FTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVY-LLQGRRLLQPEYCPDPLYEV  234 (262)
T ss_pred             ccCcCCccccChhHhccCc----cchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-HhcCCCCCCCCcCCHHHHHH
Confidence            1223466899999987654    4456999999999999999 5677776665554433 33445556677789999999


Q ss_pred             HHHhcccCCCCCCCHHHHHHHHHhhcC
Q 012887          421 MIKCWNNSPSKRPQFSEIISLLLRTNN  447 (454)
Q Consensus       421 i~~cl~~dP~~RPs~~ell~~L~~~~~  447 (454)
                      +.+||..+|++||++.++++.|+++..
T Consensus       235 i~~cl~~~p~~Rp~~~~il~~l~~~~~  261 (262)
T cd05058         235 MLSCWHPKPEMRPTFSELVSRIEQIFS  261 (262)
T ss_pred             HHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence            999999999999999999999988653

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.5e-40  Score=314.90  Aligned_cols=251  Identities=27%  Similarity=0.514  Sum_probs=209.4

Q ss_pred             eeecCCCEEEeceeeccCCceEEEe-----EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeE
Q 012887          185 WLLNSDNLEFIDQIGPNSFKGVYKG-----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGL  259 (454)
Q Consensus       185 ~~~~~~~~~~~~~LG~G~fG~Vy~g-----~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l  259 (454)
                      |.+..++|++.+.||+|+||.||++     +.+++|.+.....   ...++.+|+..++.++|+||+++++++.+... .
T Consensus         1 ~~~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~   76 (261)
T cd05034           1 WEIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM---SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEP-I   76 (261)
T ss_pred             CccchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc---CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCc-e
Confidence            4567789999999999999999986     3589998874322   33567889999999999999999999887665 8


Q ss_pred             EEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccC
Q 012887          260 CVVTKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV  337 (454)
Q Consensus       260 ~lV~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~  337 (454)
                      ++||||+++++|.+++.+.  ..+++..+..++.|++.||.|||+++++|+||||+||+++.++.+||+|||++......
T Consensus        77 ~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~  156 (261)
T cd05034          77 YIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDD  156 (261)
T ss_pred             EEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccch
Confidence            9999999999999999654  37899999999999999999999999999999999999999999999999998765432


Q ss_pred             CC-cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHcCCCCCCCCCccH
Q 012887          338 GE-ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ  415 (454)
Q Consensus       338 ~~-~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~  415 (454)
                      .. .......+..|+|||.+.+...    +.++|+||||+++|+|++ |+.||.+.+.......+. .+.+.+.+..++.
T Consensus       157 ~~~~~~~~~~~~~y~~PE~~~~~~~----~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~  231 (261)
T cd05034         157 EYTAREGAKFPIKWTAPEAANYGRF----TIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVE-RGYRMPRPPNCPE  231 (261)
T ss_pred             hhhhhhccCCCccccCHHHhccCCc----CchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCH
Confidence            11 1112233567999999986644    445999999999999998 999998877665555444 4556667778899


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 012887          416 ILKSLMIKCWNNSPSKRPQFSEIISLLLR  444 (454)
Q Consensus       416 ~l~~li~~cl~~dP~~RPs~~ell~~L~~  444 (454)
                      ++.+++.+||..+|.+||+++++.+.|+.
T Consensus       232 ~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         232 ELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             HHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence            99999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=8e-41  Score=334.70  Aligned_cols=234  Identities=19%  Similarity=0.256  Sum_probs=193.1

Q ss_pred             ceeeccCCceEEEe------EEEEEEEeecCCC-CchHHHHHHHHHHH-HHhCCCCceeEEEEEEEeCCCeEEEEEeccC
Q 012887          196 DQIGPNSFKGVYKG------KRVGIEKLKGCDK-GNAYEFELRKDLLE-LMTCGHKNILQFYCVCVDENHGLCVVTKLME  267 (454)
Q Consensus       196 ~~LG~G~fG~Vy~g------~~vavK~l~~~~~-~~~~~~~~~~Ei~~-l~~l~HpnIv~~~g~~~~~~~~l~lV~E~~~  267 (454)
                      +.||+|+||.||++      +.+|+|.+..... .......+..|... +..++||||+++++++...+. +|+||||++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~-~~lv~e~~~   79 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEK-LYFVLDFVN   79 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCE-EEEEEcCCC
Confidence            46899999999985      4799999864322 12223344555544 566899999999999988776 999999999


Q ss_pred             CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCcccccCCC
Q 012887          268 GGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG  347 (454)
Q Consensus       268 ~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~gt  347 (454)
                      +|+|..++.+.+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..............|+
T Consensus        80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt  159 (325)
T cd05604          80 GGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGT  159 (325)
T ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcccccCC
Confidence            99999998888899999999999999999999999999999999999999999999999999987543333334445689


Q ss_pred             CcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhccc
Q 012887          348 YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNN  427 (454)
Q Consensus       348 ~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~li~~cl~~  427 (454)
                      +.|+|||++.+..++    .++|||||||++|+|++|..||...+..+....+...  ...++...+..+.+++++||+.
T Consensus       160 ~~y~aPE~~~~~~~~----~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~ll~~ll~~  233 (325)
T cd05604         160 PEYLAPEVIRKQPYD----NTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHK--PLVLRPGASLTAWSILEELLEK  233 (325)
T ss_pred             hhhCCHHHHcCCCCC----CcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcC--CccCCCCCCHHHHHHHHHHhcc
Confidence            999999999876544    4599999999999999999999987777666555543  3345567899999999999999


Q ss_pred             CCCCCCCHH
Q 012887          428 SPSKRPQFS  436 (454)
Q Consensus       428 dP~~RPs~~  436 (454)
                      +|.+||++.
T Consensus       234 ~p~~R~~~~  242 (325)
T cd05604         234 DRQRRLGAK  242 (325)
T ss_pred             CHHhcCCCC
Confidence            999999875

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-41  Score=340.20  Aligned_cols=254  Identities=26%  Similarity=0.429  Sum_probs=212.3

Q ss_pred             eecCCCEEEeceeeccCCceEEEe-----EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEE
Q 012887          186 LLNSDNLEFIDQIGPNSFKGVYKG-----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLC  260 (454)
Q Consensus       186 ~~~~~~~~~~~~LG~G~fG~Vy~g-----~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~  260 (454)
                      .++.+.+.+.++||+|.||.|.++     ..||||.++.. .....+.++.+|+++|.+|+|||||+++|+|..++. +|
T Consensus       534 EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~-a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DeP-ic  611 (807)
T KOG1094|consen  534 EFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPD-ATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDP-LC  611 (807)
T ss_pred             hcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcc-cchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCc-hH
Confidence            467788999999999999999984     68999999853 344456889999999999999999999999998876 99


Q ss_pred             EEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCC
Q 012887          261 VVTKLMEGGSVNDLILKSR--KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG  338 (454)
Q Consensus       261 lV~E~~~~gsL~~~l~~~~--~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~  338 (454)
                      +|||||++|+|.+++.++.  .+.......++.||+.||+||.+.++|||||.++|+|++.++++||+|||+++.+-...
T Consensus       612 mI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~  691 (807)
T KOG1094|consen  612 MITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGD  691 (807)
T ss_pred             HHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCC
Confidence            9999999999999997763  34566778899999999999999999999999999999999999999999988654322


Q ss_pred             Cc--ccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc--CCCCCCCCCHHHHHHHHH---HcCCC---CC
Q 012887          339 EA--TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT--GEAAYAACSPVQAAVGIA---ACGLR---PE  408 (454)
Q Consensus       339 ~~--~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt--G~~Pf~~~~~~~~~~~i~---~~~~~---~~  408 (454)
                      ..  .....-+++|||||.+..++    ++.+||||+||+++||+++  ...||...+..+.....-   ..+.+   +.
T Consensus       692 yy~vqgr~vlpiRwmawEsillgk----FttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~  767 (807)
T KOG1094|consen  692 YYRVQGRAVLPIRWMAWESILLGK----FTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLS  767 (807)
T ss_pred             ceeeecceeeeeeehhHHHHHhcc----ccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceecc
Confidence            11  11123468999999998664    6667999999999999876  899999887776554322   11111   34


Q ss_pred             CCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 012887          409 IPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRT  445 (454)
Q Consensus       409 ~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~  445 (454)
                      .|.-||..++++|..||..|-.+||+|+++..+|++.
T Consensus       768 ~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  768 RPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             CCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence            5778999999999999999999999999999999875

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=2.5e-40  Score=320.30  Aligned_cols=248  Identities=19%  Similarity=0.382  Sum_probs=203.1

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  263 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~  263 (454)
                      ++|++.+.||+|+||.||++      +.+|+|.++....  .....+.+|+.++..++||||+++++++...+. +++||
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~-~~lv~   85 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG--EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDK-LWICM   85 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch--hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCE-EEEEE
Confidence            57888999999999999985      5789998874322  222346788999999999999999999988776 99999


Q ss_pred             eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCcccc
Q 012887          264 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY  343 (454)
Q Consensus       264 E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~  343 (454)
                      ||+++++|.+++...+.+++..+..++.|++.||.|||++|++|+||||+||+++.++.+||+|||++............
T Consensus        86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~  165 (267)
T cd06645          86 EFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKS  165 (267)
T ss_pred             eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCccccccc
Confidence            99999999999987789999999999999999999999999999999999999999999999999998765443333344


Q ss_pred             cCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCC---CCCccHHHHHH
Q 012887          344 ETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEI---PKDCPQILKSL  420 (454)
Q Consensus       344 ~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~---p~~~~~~l~~l  420 (454)
                      ..+++.|+|||++..... ..++.++|+|||||++|+|++|..||....+.............++.   ...++..+.++
T Consensus       166 ~~~~~~y~aPE~~~~~~~-~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  244 (267)
T cd06645         166 FIGTPYWMAPEVAAVERK-GGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHF  244 (267)
T ss_pred             ccCcccccChhhhccccC-CCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHHHH
Confidence            568899999999753211 12456799999999999999999999876655544444333333222   12467899999


Q ss_pred             HHHhcccCCCCCCCHHHHHHH
Q 012887          421 MIKCWNNSPSKRPQFSEIISL  441 (454)
Q Consensus       421 i~~cl~~dP~~RPs~~ell~~  441 (454)
                      +.+||..+|++||++.+++++
T Consensus       245 i~~~l~~~P~~R~~~~~ll~~  265 (267)
T cd06645         245 VKMALTKNPKKRPTAEKLLQH  265 (267)
T ss_pred             HHHHccCCchhCcCHHHHhcC
Confidence            999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1.1e-39  Score=315.05  Aligned_cols=250  Identities=25%  Similarity=0.466  Sum_probs=205.7

Q ss_pred             eeecCCCEEEeceeeccCCceEEEeE-----EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeE
Q 012887          185 WLLNSDNLEFIDQIGPNSFKGVYKGK-----RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGL  259 (454)
Q Consensus       185 ~~~~~~~~~~~~~LG~G~fG~Vy~g~-----~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l  259 (454)
                      |.+..++|++.+.||+|+||.||++.     .+++|.+....   .....+.+|+.++..++|||++++++++.. +. .
T Consensus         1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~-~   75 (260)
T cd05069           1 WEIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT---MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EP-I   75 (260)
T ss_pred             CcCChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC---ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CC-c
Confidence            34556789999999999999999864     68888876322   233457789999999999999999988753 33 7


Q ss_pred             EEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccC
Q 012887          260 CVVTKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV  337 (454)
Q Consensus       260 ~lV~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~  337 (454)
                      ++||||+++++|.+++.+.  ..+++..+..++.|++.||.|||+.|++|+||||+||++++++.++|+|||++......
T Consensus        76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~  155 (260)
T cd05069          76 YIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDN  155 (260)
T ss_pred             EEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCC
Confidence            8999999999999999653  35889999999999999999999999999999999999999999999999998765432


Q ss_pred             CC-cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHcCCCCCCCCCccH
Q 012887          338 GE-ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ  415 (454)
Q Consensus       338 ~~-~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~  415 (454)
                      .. ......++..|+|||.+.+..    .+.++||||||+++|+|++ |..||.+..+......+ ..+.+++.+...+.
T Consensus       156 ~~~~~~~~~~~~~y~~Pe~~~~~~----~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~  230 (260)
T cd05069         156 EYTARQGAKFPIKWTAPEAALYGR----FTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQV-ERGYRMPCPQGCPE  230 (260)
T ss_pred             cccccCCCccchhhCCHHHhccCC----cChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-HcCCCCCCCcccCH
Confidence            21 112223567799999887654    4456999999999999999 99999887766555444 34555667778899


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 012887          416 ILKSLMIKCWNNSPSKRPQFSEIISLLLR  444 (454)
Q Consensus       416 ~l~~li~~cl~~dP~~RPs~~ell~~L~~  444 (454)
                      .+.+++.+||+.||.+||++.++++.|++
T Consensus       231 ~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         231 SLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             HHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            99999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=7e-40  Score=319.86  Aligned_cols=246  Identities=20%  Similarity=0.276  Sum_probs=197.8

Q ss_pred             CEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEEe
Q 012887          191 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTK  264 (454)
Q Consensus       191 ~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~E  264 (454)
                      +|++.+.||+|+||.||+|      ..+|+|+++...........+.+|+.++..++||||+++++++.+++. +++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~~v~e   79 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESR-LYLIFE   79 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCe-EEEEEe
Confidence            5789999999999999996      469999987543333344567889999999999999999999998776 999999


Q ss_pred             ccCCCCHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCcc
Q 012887          265 LMEGGSVNDLILKS---RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT  341 (454)
Q Consensus       265 ~~~~gsL~~~l~~~---~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~  341 (454)
                      |++ ++|.+++...   ..+++..+..++.||+.||.|||+++++||||||+|||++.++.+||+|||++..........
T Consensus        80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~  158 (285)
T cd07861          80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVY  158 (285)
T ss_pred             cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcccc
Confidence            997 5898887532   468999999999999999999999999999999999999999999999999987654332223


Q ss_pred             cccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCC----------------
Q 012887          342 EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGL----------------  405 (454)
Q Consensus       342 ~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~----------------  405 (454)
                      ....+++.|+|||++.+..   .++.++|||||||++|+|++|..||.+.+.......+.....                
T Consensus       159 ~~~~~~~~y~aPE~~~~~~---~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (285)
T cd07861         159 THEVVTLWYRAPEVLLGSP---RYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDY  235 (285)
T ss_pred             cCCcccccccChHHhcCCC---CcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHH
Confidence            3345678899999886542   245679999999999999999999987665443332211100                


Q ss_pred             C-----------CCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012887          406 R-----------PEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISL  441 (454)
Q Consensus       406 ~-----------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  441 (454)
                      .           ......+++++.++|++||+.||.+|||+.+++.+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~  282 (285)
T cd07861         236 KNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH  282 (285)
T ss_pred             HhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence            0           01123478899999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=1e-39  Score=312.85  Aligned_cols=241  Identities=31%  Similarity=0.551  Sum_probs=204.4

Q ss_pred             ceeeccCCceEEEeE---------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEEecc
Q 012887          196 DQIGPNSFKGVYKGK---------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLM  266 (454)
Q Consensus       196 ~~LG~G~fG~Vy~g~---------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~E~~  266 (454)
                      +.||+|+||.||++.         .+++|.+....... ....+.+|+..+..++|+||+++++++.+... +++||||+
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~-~~lv~e~~   78 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEP-LYLVLEYM   78 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecCCCc-eEEEEEec
Confidence            468999999999863         46888887543332 45678899999999999999999999988655 99999999


Q ss_pred             CCCCHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccC
Q 012887          267 EGGSVNDLILKS---------RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV  337 (454)
Q Consensus       267 ~~gsL~~~l~~~---------~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~  337 (454)
                      ++++|.+++...         ..+++..+..++.|++.||.|||+++++||||+|+||+++.++.+||+|||.+......
T Consensus        79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~  158 (262)
T cd00192          79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD  158 (262)
T ss_pred             cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccc
Confidence            999999999765         68999999999999999999999999999999999999999999999999998776543


Q ss_pred             C--CcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHcCCCCCCCCCcc
Q 012887          338 G--EATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCP  414 (454)
Q Consensus       338 ~--~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~  414 (454)
                      .  .......+++.|+|||.+.+..    ++.++||||||+++|+|++ |..||...........+.. +.+...|..+|
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~  233 (262)
T cd00192         159 DYYRKKTGGKLPIRWMAPESLKDGI----FTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK-GYRLPKPEYCP  233 (262)
T ss_pred             cccccccCCCcCccccCHHHhccCC----cchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-CCCCCCCccCC
Confidence            2  1233345678899999988663    4556999999999999999 6999998876655554443 66777888899


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 012887          415 QILKSLMIKCWNNSPSKRPQFSEIISLLL  443 (454)
Q Consensus       415 ~~l~~li~~cl~~dP~~RPs~~ell~~L~  443 (454)
                      .++.+++.+||..+|.+||++.+++++|.
T Consensus       234 ~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         234 DELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             hHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence            99999999999999999999999999873

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.6e-39  Score=317.82  Aligned_cols=251  Identities=26%  Similarity=0.463  Sum_probs=200.4

Q ss_pred             CCCEEEeceeeccCCceEEEeE----------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCC-C
Q 012887          189 SDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN-H  257 (454)
Q Consensus       189 ~~~~~~~~~LG~G~fG~Vy~g~----------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~-~  257 (454)
                      ..+|++++.||+|+||.||++.          .+|+|.+...  .......+.+|+.++..++||||+++++++...+ .
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   80 (284)
T cd05081           3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS--TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR   80 (284)
T ss_pred             cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence            4688999999999999999853          6899988643  2233456789999999999999999999876543 3


Q ss_pred             eEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCcccccc
Q 012887          258 GLCVVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS  336 (454)
Q Consensus       258 ~l~lV~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~  336 (454)
                      .+++||||+++++|.+++.+. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.....
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~  160 (284)
T cd05081          81 NLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ  160 (284)
T ss_pred             ceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence            489999999999999999654 4689999999999999999999999999999999999999999999999999876543


Q ss_pred             CCCc---ccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHH---------------HHHH
Q 012887          337 VGEA---TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPV---------------QAAV  398 (454)
Q Consensus       337 ~~~~---~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~---------------~~~~  398 (454)
                      ....   .....++..|+|||++.+..    ++.++|||||||++|||++|..|+......               ....
T Consensus       161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T cd05081         161 DKEYYKVREPGESPIFWYAPESLTESK----FSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLI  236 (284)
T ss_pred             CCcceeecCCCCCceEeeCHHHhccCC----cChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHH
Confidence            2221   11122344699999997654    345699999999999999987765432211               0111


Q ss_pred             HHHHcCCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 012887          399 GIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRT  445 (454)
Q Consensus       399 ~i~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~  445 (454)
                      .......+.+.+..++.++.+++.+||..+|++|||+.|+++.|..+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         237 ELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             HHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            23333445556677899999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=1.2e-39  Score=315.19  Aligned_cols=246  Identities=21%  Similarity=0.392  Sum_probs=203.9

Q ss_pred             CEEEeceeeccCCceEEEeE-----EEEEEEeecCCCCc----hHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEE
Q 012887          191 NLEFIDQIGPNSFKGVYKGK-----RVGIEKLKGCDKGN----AYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCV  261 (454)
Q Consensus       191 ~~~~~~~LG~G~fG~Vy~g~-----~vavK~l~~~~~~~----~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~l  261 (454)
                      +|++.+.||+|+||.||+|.     .+|+|.+.......    .....+.+|+..+..++|+||+++++++.+.+. .++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-~~l   79 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNT-ISI   79 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCe-EEE
Confidence            46778999999999999864     58999887432221    123457889999999999999999999988765 999


Q ss_pred             EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCC---
Q 012887          262 VTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG---  338 (454)
Q Consensus       262 V~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~---  338 (454)
                      ||||+++++|.+++.+...+++..+..++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||++.......   
T Consensus        80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~  159 (265)
T cd06631          80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHG  159 (265)
T ss_pred             EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccc
Confidence            99999999999999877789999999999999999999999999999999999999999999999999987543211   


Q ss_pred             ---CcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHc-CCCCCCCCCcc
Q 012887          339 ---EATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAAC-GLRPEIPKDCP  414 (454)
Q Consensus       339 ---~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~-~~~~~~p~~~~  414 (454)
                         .......++..|+|||.+.+..+    +.++|||||||++|+|++|..||...+.......+... ...+.++..++
T Consensus       160 ~~~~~~~~~~~~~~~~~pe~~~~~~~----~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (265)
T cd06631         160 THSNMLKSMHGTPYWMAPEVINESGY----GRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFS  235 (265)
T ss_pred             cccccccccCCCccccChhhhcCCCC----cchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCC
Confidence               11223357888999999986644    34599999999999999999999876655544444332 34456778899


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012887          415 QILKSLMIKCWNNSPSKRPQFSEIISL  441 (454)
Q Consensus       415 ~~l~~li~~cl~~dP~~RPs~~ell~~  441 (454)
                      .++.++|++||..+|.+||++.+++.+
T Consensus       236 ~~~~~~i~~~l~~~p~~Rp~~~~~l~~  262 (265)
T cd06631         236 AAAIDFVTSCLTRDQHERPSALQLLRH  262 (265)
T ss_pred             HHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            999999999999999999999999865

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-40  Score=321.14  Aligned_cols=255  Identities=23%  Similarity=0.401  Sum_probs=210.9

Q ss_pred             CCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEE
Q 012887          189 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  262 (454)
Q Consensus       189 ~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV  262 (454)
                      .++|++++.||.|+||.||++      ..+|+|.+...  .......+..|+.++..++||||+++++++.+.+. +++|
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~lv   80 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENK-LWIL   80 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCe-EEEE
Confidence            467899999999999999986      46889988642  22334567789999999999999999999987765 9999


Q ss_pred             EeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCcc
Q 012887          263 TKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT  341 (454)
Q Consensus       263 ~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~  341 (454)
                      |||+++++|.+++.+. ..+++..+..++.|++.||.|||+++|+|+||||+||+++.++.++|+|||++..........
T Consensus        81 ~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~  160 (280)
T cd06611          81 IEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKR  160 (280)
T ss_pred             eeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccccccc
Confidence            9999999999998664 479999999999999999999999999999999999999999999999999976654433334


Q ss_pred             cccCCCCcccccccccCCCC-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCC-CCCCCCCccHHHHH
Q 012887          342 EYETDGYRWLAPEIIAGDPE-SVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGL-RPEIPKDCPQILKS  419 (454)
Q Consensus       342 ~~~~gt~~y~APE~l~~~~~-~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~-~~~~p~~~~~~l~~  419 (454)
                      ....+++.|+|||.+..+.. ...++.++|+||||+++|+|++|..||...........+..... ....|..++.++.+
T Consensus       161 ~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (280)
T cd06611         161 DTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFND  240 (280)
T ss_pred             ceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHHHHH
Confidence            45567889999999864322 22355679999999999999999999988777666555544322 22345678999999


Q ss_pred             HHHHhcccCCCCCCCHHHHHHHHHhhc
Q 012887          420 LMIKCWNNSPSKRPQFSEIISLLLRTN  446 (454)
Q Consensus       420 li~~cl~~dP~~RPs~~ell~~L~~~~  446 (454)
                      +|.+||+.+|.+||++.+++++-+-..
T Consensus       241 li~~~l~~~p~~Rps~~~il~~~~~~~  267 (280)
T cd06611         241 FLKSCLVKDPDDRPTAAELLKHPFVSD  267 (280)
T ss_pred             HHHHHhccChhhCcCHHHHhcChhhcc
Confidence            999999999999999999999866443

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=2e-39  Score=314.74  Aligned_cols=254  Identities=24%  Similarity=0.443  Sum_probs=209.3

Q ss_pred             ecCCCEEEeceeeccCCceEEEeE---------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCC
Q 012887          187 LNSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH  257 (454)
Q Consensus       187 ~~~~~~~~~~~LG~G~fG~Vy~g~---------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~  257 (454)
                      +..++|.+.+.||.|+||.||+|.         .+++|..... ........+.+|+..+..++||||+++++++.+. .
T Consensus         3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~-~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-~   80 (270)
T cd05056           3 IQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNC-TSPSVREKFLQEAYIMRQFDHPHIVKLIGVITEN-P   80 (270)
T ss_pred             echhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCc-CCHHHHHHHHHHHHHHHhCCCCchhceeEEEcCC-C
Confidence            456788999999999999999974         3677777532 2233445688999999999999999999998754 3


Q ss_pred             eEEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCcccccc
Q 012887          258 GLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS  336 (454)
Q Consensus       258 ~l~lV~E~~~~gsL~~~l~~~~-~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~  336 (454)
                       .++||||+++|+|.+++.+.. .+++..+..++.|++.||.|||+++++|+||||+||+++.++.+||+|||++.....
T Consensus        81 -~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  159 (270)
T cd05056          81 -VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED  159 (270)
T ss_pred             -cEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeeccc
Confidence             789999999999999996644 689999999999999999999999999999999999999999999999999876544


Q ss_pred             CCCc-ccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHcCCCCCCCCCcc
Q 012887          337 VGEA-TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCP  414 (454)
Q Consensus       337 ~~~~-~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~  414 (454)
                      .... .....++..|+|||.+.+..    ++.++||||||+++||+++ |..||...+.......+. .+.+...|..+|
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~-~~~~~~~~~~~~  234 (270)
T cd05056         160 ESYYKASKGKLPIKWMAPESINFRR----FTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIE-NGERLPMPPNCP  234 (270)
T ss_pred             ccceecCCCCccccccChhhhccCC----CCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH-cCCcCCCCCCCC
Confidence            3221 11223346799999987654    3456999999999999986 999998877665554443 455666788899


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCC
Q 012887          415 QILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNI  448 (454)
Q Consensus       415 ~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~  448 (454)
                      ..+.++|.+||..+|++||++.++++.|..+.+.
T Consensus       235 ~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~  268 (270)
T cd05056         235 PTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE  268 (270)
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence            9999999999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=1.1e-39  Score=317.24  Aligned_cols=251  Identities=26%  Similarity=0.469  Sum_probs=205.9

Q ss_pred             cCCCEEEeceeeccCCceEEEeE-----------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCC
Q 012887          188 NSDNLEFIDQIGPNSFKGVYKGK-----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN  256 (454)
Q Consensus       188 ~~~~~~~~~~LG~G~fG~Vy~g~-----------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~  256 (454)
                      +.++|++++.||.|+||.||+|+           .+++|.+... ........+.+|+.++.+++|+||+++++++.+.+
T Consensus         3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   81 (275)
T cd05046           3 PRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKT-KDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAE   81 (275)
T ss_pred             ChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCc-cchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCC
Confidence            44788999999999999999875           4777776532 22224456889999999999999999999988766


Q ss_pred             CeEEEEEeccCCCCHHHHHHhCC---------CCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEc
Q 012887          257 HGLCVVTKLMEGGSVNDLILKSR---------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGD  327 (454)
Q Consensus       257 ~~l~lV~E~~~~gsL~~~l~~~~---------~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~D  327 (454)
                      . .++||||+++|+|.+++....         .+++..+..++.||+.||.|||+++|+||||||+|||++.++.++|+|
T Consensus        82 ~-~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~  160 (275)
T cd05046          82 P-HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSL  160 (275)
T ss_pred             c-ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcc
Confidence            5 899999999999999996544         689999999999999999999999999999999999999999999999


Q ss_pred             cCCccccccCCC-cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHcCC
Q 012887          328 MGIVTACKSVGE-ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGL  405 (454)
Q Consensus       328 FGla~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~i~~~~~  405 (454)
                      ||++........ ......++..|+|||.+.+...    +.++||||||+++|+|++ |..||...........+.....
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~----~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~  236 (275)
T cd05046         161 LSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDF----STKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKL  236 (275)
T ss_pred             cccccccCcccccccCCceeEEeecChhhhccCCC----CchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCc
Confidence            999764422111 1122234567999999876543    345999999999999999 8999987766665555554444


Q ss_pred             CCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 012887          406 RPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR  444 (454)
Q Consensus       406 ~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~  444 (454)
                      ....+..+|..+.+++.+||..+|.+||++.++++.|++
T Consensus       237 ~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~  275 (275)
T cd05046         237 ELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE  275 (275)
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence            455667789999999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.4e-39  Score=314.67  Aligned_cols=244  Identities=24%  Similarity=0.432  Sum_probs=203.7

Q ss_pred             EEEeceeeccCCceEEEe------EEEEEEEeecCCCCch-------HHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCe
Q 012887          192 LEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNA-------YEFELRKDLLELMTCGHKNILQFYCVCVDENHG  258 (454)
Q Consensus       192 ~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~-------~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~  258 (454)
                      |.+.+.||.|+||.||+|      +.+|+|.+........       ....+.+|+.++..++||||+++++++.+.+. 
T Consensus         2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-   80 (267)
T cd06628           2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH-   80 (267)
T ss_pred             ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc-
Confidence            466788999999999986      4689998864432221       22457889999999999999999999988776 


Q ss_pred             EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCC
Q 012887          259 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG  338 (454)
Q Consensus       259 l~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~  338 (454)
                      .++||||+++++|.+++.+.+.+++..+..++.|++.||+|||++|++||||+|+||+++.++.++|+|||+++......
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANS  160 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccccc
Confidence            89999999999999999877889999999999999999999999999999999999999999999999999987664321


Q ss_pred             C------cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCC
Q 012887          339 E------ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKD  412 (454)
Q Consensus       339 ~------~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~  412 (454)
                      .      ......++..|+|||.+.+..+    +.++|+|||||++|+|++|..||...+.......+.. ...+.+|..
T Consensus       161 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~----~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~  235 (267)
T cd06628         161 LSTKTNGARPSLQGSVFWMAPEVVKQTSY----TRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGE-NASPEIPSN  235 (267)
T ss_pred             ccCCccccccccCCCcCccChhHhccCCC----CchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhc-cCCCcCCcc
Confidence            1      1112346788999999976643    4459999999999999999999988766554444333 456677888


Q ss_pred             ccHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012887          413 CPQILKSLMIKCWNNSPSKRPQFSEIISL  441 (454)
Q Consensus       413 ~~~~l~~li~~cl~~dP~~RPs~~ell~~  441 (454)
                      ++..+.++|++||+.||.+||++.+++++
T Consensus       236 ~~~~~~~li~~~l~~~p~~Rp~~~~il~~  264 (267)
T cd06628         236 ISSEAIDFLEKTFEIDHNKRPTAAELLKH  264 (267)
T ss_pred             cCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence            99999999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=1.6e-39  Score=315.52  Aligned_cols=245  Identities=24%  Similarity=0.360  Sum_probs=191.7

Q ss_pred             ceeeccCCceEEEeE--------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEEeccC
Q 012887          196 DQIGPNSFKGVYKGK--------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLME  267 (454)
Q Consensus       196 ~~LG~G~fG~Vy~g~--------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~E~~~  267 (454)
                      +.||+|+||.||+|.        .+++|+++... .......+.+|+..+..++||||+++++++.+... +++||||++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~lv~e~~~   78 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSA-SVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTP-YLLVMEFCP   78 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCC-cEEEEECCC
Confidence            368999999999974        57888876433 23344568889999999999999999999987766 899999999


Q ss_pred             CCCHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCc--
Q 012887          268 GGSVNDLILKSR-----KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA--  340 (454)
Q Consensus       268 ~gsL~~~l~~~~-----~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~--  340 (454)
                      +|+|.+++.+..     ..++..+..++.|++.||+|||+.+++||||||+||+++.++++||+|||++.........  
T Consensus        79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~  158 (269)
T cd05087          79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT  158 (269)
T ss_pred             CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence            999999986422     4567788899999999999999999999999999999999999999999998653322111  


Q ss_pred             ccccCCCCcccccccccCCCCC---CCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHcC-CC---CCCCCC
Q 012887          341 TEYETDGYRWLAPEIIAGDPES---VSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACG-LR---PEIPKD  412 (454)
Q Consensus       341 ~~~~~gt~~y~APE~l~~~~~~---~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~---~~~p~~  412 (454)
                      .....++..|+|||++.+....   ..++.++|+||||+++|||++ |..||....+.+......... .+   +.+...
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (269)
T cd05087         159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLP  238 (269)
T ss_pred             CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCC
Confidence            1223456789999998653221   234667999999999999996 999998776665443332211 11   222335


Q ss_pred             ccHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 012887          413 CPQILKSLMIKCWNNSPSKRPQFSEIISLLL  443 (454)
Q Consensus       413 ~~~~l~~li~~cl~~dP~~RPs~~ell~~L~  443 (454)
                      .+..+.++|.+|| .+|++|||+.||...|.
T Consensus       239 ~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         239 LSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            6889999999999 68999999999998764

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=1.2e-39  Score=316.02  Aligned_cols=245  Identities=24%  Similarity=0.388  Sum_probs=191.8

Q ss_pred             ceeeccCCceEEEeE--------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEEeccC
Q 012887          196 DQIGPNSFKGVYKGK--------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLME  267 (454)
Q Consensus       196 ~~LG~G~fG~Vy~g~--------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~E~~~  267 (454)
                      +.||+|+||.||+|.        .+++|.+... ........+.+|+..+..++||||+++++.+.+.+. +++||||++
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~-~~lv~e~~~   78 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRAS-ATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIP-YLLVLEFCP   78 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCcc-CChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCc-eEEEEEeCC
Confidence            368999999999873        4566665432 223334557789999999999999999999987776 999999999


Q ss_pred             CCCHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCC--c
Q 012887          268 GGSVNDLILKSR-----KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE--A  340 (454)
Q Consensus       268 ~gsL~~~l~~~~-----~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~--~  340 (454)
                      +|+|.+++.+..     ..++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||++........  .
T Consensus        79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~  158 (269)
T cd05042          79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT  158 (269)
T ss_pred             CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence            999999996533     346788899999999999999999999999999999999999999999999764322211  1


Q ss_pred             ccccCCCCcccccccccCCC---CCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHcCC----CCCCCCC
Q 012887          341 TEYETDGYRWLAPEIIAGDP---ESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGL----RPEIPKD  412 (454)
Q Consensus       341 ~~~~~gt~~y~APE~l~~~~---~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~i~~~~~----~~~~p~~  412 (454)
                      .....+++.|+|||++....   .....+.++|||||||++|||++ |..||....+............    .+..+..
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (269)
T cd05042         159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLK  238 (269)
T ss_pred             cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCccccc
Confidence            12233467799999986422   12245668999999999999999 8899988777665555444322    2234456


Q ss_pred             ccHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 012887          413 CPQILKSLMIKCWNNSPSKRPQFSEIISLLL  443 (454)
Q Consensus       413 ~~~~l~~li~~cl~~dP~~RPs~~ell~~L~  443 (454)
                      ++..+.+++..|| .||++||+++++++.|.
T Consensus       239 ~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         239 YSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             CCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            8899999999999 59999999999998873

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.8e-40  Score=322.29  Aligned_cols=248  Identities=21%  Similarity=0.290  Sum_probs=205.5

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCc-eeEEEEEEEeCCC-----
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKN-ILQFYCVCVDENH-----  257 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~Hpn-Iv~~~g~~~~~~~-----  257 (454)
                      ..|+.+++||+|+||.||+|      +.||+|+++.....+-......+|+.+|..++|+| ||.+++++...+.     
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~   90 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG   90 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence            56778889999999999996      57999999865443223345679999999999999 9999999988773     


Q ss_pred             eEEEEEeccCCCCHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccc
Q 012887          258 GLCVVTKLMEGGSVNDLILKSR----KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTA  333 (454)
Q Consensus       258 ~l~lV~E~~~~gsL~~~l~~~~----~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~  333 (454)
                      .+++|+||++. +|..++....    .++...+..++.||+.||.|||+++|+||||||+||||+++|.+||+|||+|+.
T Consensus        91 ~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra  169 (323)
T KOG0594|consen   91 KLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLARA  169 (323)
T ss_pred             eEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHHH
Confidence            59999999977 9999996544    588889999999999999999999999999999999999999999999999987


Q ss_pred             cccCCCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCC------
Q 012887          334 CKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP------  407 (454)
Q Consensus       334 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~------  407 (454)
                      ..-+........+|..|.|||++.|...   |+...||||+|||++||+++++-|++.+....+..|...--.|      
T Consensus       170 ~~ip~~~yt~evvTlWYRaPEvLlGs~~---Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp  246 (323)
T KOG0594|consen  170 FSIPMRTYTPEVVTLWYRAPEVLLGSTS---YSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWP  246 (323)
T ss_pred             hcCCcccccccEEEeeccCHHHhcCCCc---CCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCC
Confidence            6644444555567888999999998743   4445999999999999999999999998887776664421111      


Q ss_pred             ----------CCC-----C-------CccHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012887          408 ----------EIP-----K-------DCPQILKSLMIKCWNNSPSKRPQFSEIISL  441 (454)
Q Consensus       408 ----------~~p-----~-------~~~~~l~~li~~cl~~dP~~RPs~~ell~~  441 (454)
                                .++     .       ..+++..+++.+||+.+|.+|.|++.++.|
T Consensus       247 ~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  247 GVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             CccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence                      111     1       122478899999999999999999999987

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=3.3e-40  Score=331.38  Aligned_cols=252  Identities=20%  Similarity=0.249  Sum_probs=204.5

Q ss_pred             CCEEEeceeeccCCceEEEeE------EEEEEEeecCCCC-chHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKG-NAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  262 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g~------~vavK~l~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV  262 (454)
                      ++|++.+.||+|+||.||+++      .+|+|.+...... ......+.+|+.++..++|+||+++++++.+.+. +++|
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~-~~lv   79 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENN-LYLV   79 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCE-EEEE
Confidence            478999999999999999864      6899988632211 1223346778888888999999999999987776 9999


Q ss_pred             EeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCC-c
Q 012887          263 TKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE-A  340 (454)
Q Consensus       263 ~E~~~~gsL~~~l~~-~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~-~  340 (454)
                      |||+++|+|.+++.+ ...+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||++........ .
T Consensus        80 ~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~  159 (332)
T cd05623          80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ  159 (332)
T ss_pred             EeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCcce
Confidence            999999999999976 45899999999999999999999999999999999999999999999999999865433222 2


Q ss_pred             ccccCCCCcccccccccCCCC-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCC---CccHH
Q 012887          341 TEYETDGYRWLAPEIIAGDPE-SVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPK---DCPQI  416 (454)
Q Consensus       341 ~~~~~gt~~y~APE~l~~~~~-~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~---~~~~~  416 (454)
                      .....||+.|+|||++.+... ...++.++|||||||++|||++|..||...+..+....+.....+..+|.   .++++
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~  239 (332)
T cd05623         160 SSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSED  239 (332)
T ss_pred             ecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCHH
Confidence            233468999999999864211 12355679999999999999999999998888777777765544444443   57999


Q ss_pred             HHHHHHHhcccCCCC--CCCHHHHHHHH
Q 012887          417 LKSLMIKCWNNSPSK--RPQFSEIISLL  442 (454)
Q Consensus       417 l~~li~~cl~~dP~~--RPs~~ell~~L  442 (454)
                      +.+++++|+..++.+  |+++.++++|-
T Consensus       240 ~~~li~~ll~~~~~r~~r~~~~~~~~h~  267 (332)
T cd05623         240 AKDLIRRLICSREHRLGQNGIEDFKQHP  267 (332)
T ss_pred             HHHHHHHHccChhhhcCCCCHHHHhCCC
Confidence            999999998765544  68999999884

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1.3e-39  Score=318.47  Aligned_cols=254  Identities=24%  Similarity=0.381  Sum_probs=202.6

Q ss_pred             ecCCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEEEEEEEe----C
Q 012887          187 LNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVD----E  255 (454)
Q Consensus       187 ~~~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~~~g~~~~----~  255 (454)
                      ...++|++.+.||+|+||.||++      +.+|+|.+...   ......+..|+.++..+ +||||+++++++..    .
T Consensus        15 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~---~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~   91 (286)
T cd06638          15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI---HDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKN   91 (286)
T ss_pred             CcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc---cchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCC
Confidence            34588999999999999999985      56889987532   22234567888888888 69999999998853    2


Q ss_pred             CCeEEEEEeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCc
Q 012887          256 NHGLCVVTKLMEGGSVNDLILK----SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIV  331 (454)
Q Consensus       256 ~~~l~lV~E~~~~gsL~~~l~~----~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla  331 (454)
                      +..+++||||+++++|.+++..    ...+++..+..++.|++.||.|||+++++||||||+||+++.++.+||+|||++
T Consensus        92 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~  171 (286)
T cd06638          92 GDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVS  171 (286)
T ss_pred             CCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCce
Confidence            2348999999999999998742    346899999999999999999999999999999999999999999999999998


Q ss_pred             cccccCCCcccccCCCCcccccccccCCC-CCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcC-CCCCC
Q 012887          332 TACKSVGEATEYETDGYRWLAPEIIAGDP-ESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG-LRPEI  409 (454)
Q Consensus       332 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~-~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~-~~~~~  409 (454)
                      ..............+++.|+|||++.... ....++.++|||||||++|+|++|..||....+........... .....
T Consensus       172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  251 (286)
T cd06638         172 AQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLHQ  251 (286)
T ss_pred             eecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCCCcccC
Confidence            76544333333446888999999986432 12335667999999999999999999998776655443332221 12224


Q ss_pred             CCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 012887          410 PKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLL  443 (454)
Q Consensus       410 p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~  443 (454)
                      |..++..+.++|.+||+.||++||++.|++++++
T Consensus       252 ~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~  285 (286)
T cd06638         252 PELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVF  285 (286)
T ss_pred             CCCcCHHHHHHHHHHccCCcccCCCHHHHhhccc
Confidence            5567889999999999999999999999998864

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=1.3e-39  Score=319.29  Aligned_cols=251  Identities=27%  Similarity=0.499  Sum_probs=205.3

Q ss_pred             ecCCCEEEeceeeccCCceEEEe-----------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeC
Q 012887          187 LNSDNLEFIDQIGPNSFKGVYKG-----------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDE  255 (454)
Q Consensus       187 ~~~~~~~~~~~LG~G~fG~Vy~g-----------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~  255 (454)
                      ++.++|++.+.||+|+||.||++           ..+|+|.+... ........+.+|+..+..++||||+++++++.+.
T Consensus         2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~   80 (288)
T cd05050           2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE-ASADMQADFQREAALMAEFDHPNIVKLLGVCAVG   80 (288)
T ss_pred             CChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCC-cCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC
Confidence            34578999999999999999985           35788887632 2233445688899999999999999999999877


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhCC----------------------CCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCC
Q 012887          256 NHGLCVVTKLMEGGSVNDLILKSR----------------------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQ  313 (454)
Q Consensus       256 ~~~l~lV~E~~~~gsL~~~l~~~~----------------------~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~  313 (454)
                      +. .++||||+++|+|.+++....                      .+++..++.++.||+.||.|||+++++||||||+
T Consensus        81 ~~-~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~  159 (288)
T cd05050          81 KP-MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATR  159 (288)
T ss_pred             Cc-cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHh
Confidence            76 899999999999999986421                      4678889999999999999999999999999999


Q ss_pred             cEEEccCCcEEEEccCCccccccCCC--cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCC
Q 012887          314 RILLDRHGNVCLGDMGIVTACKSVGE--ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAA  390 (454)
Q Consensus       314 NILl~~~~~vKL~DFGla~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~  390 (454)
                      |||++.++.++|+|||++........  .......+..|+|||.+.+..    ++.++|||||||++|||++ |..||.+
T Consensus       160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~Dv~slG~il~el~~~~~~p~~~  235 (288)
T cd05050         160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNR----YTTESDVWAYGVVLWEIFSYGMQPYYG  235 (288)
T ss_pred             heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCC----CCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence            99999999999999999765433211  111223456799999987664    4456999999999999998 8889987


Q ss_pred             CCHHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 012887          391 CSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR  444 (454)
Q Consensus       391 ~~~~~~~~~i~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~  444 (454)
                      ....+....+. .+.....|..++.++.+++.+||+.||.+||++.|+++.|++
T Consensus       236 ~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         236 MAHEEVIYYVR-DGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             CCHHHHHHHHh-cCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence            77666554444 344445677889999999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=3.3e-40  Score=331.41  Aligned_cols=253  Identities=20%  Similarity=0.257  Sum_probs=204.8

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCC-chHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  262 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV  262 (454)
                      ++|++.+.||+|+||.||++      +.+|+|.+...... ......+.+|+.++..++|+||+++++++.+.+. +|+|
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~-~~lv   79 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENY-LYLV   79 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE-EEEE
Confidence            57899999999999999986      46899988642211 2233446778888888999999999999988776 9999


Q ss_pred             EeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCc-
Q 012887          263 TKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA-  340 (454)
Q Consensus       263 ~E~~~~gsL~~~l~~-~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~-  340 (454)
                      |||+++|+|.+++.+ ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++......... 
T Consensus        80 ~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  159 (331)
T cd05624          80 MDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQ  159 (331)
T ss_pred             EeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCcee
Confidence            999999999999976 458999999999999999999999999999999999999999999999999998765433221 


Q ss_pred             ccccCCCCcccccccccCCCCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCC---CccHH
Q 012887          341 TEYETDGYRWLAPEIIAGDPES-VSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPK---DCPQI  416 (454)
Q Consensus       341 ~~~~~gt~~y~APE~l~~~~~~-~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~---~~~~~  416 (454)
                      .....|++.|+|||++.+.... ..++.++|||||||++|+|++|..||...+..+....+.....+..+|.   .++.+
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~  239 (331)
T cd05624         160 SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEE  239 (331)
T ss_pred             eccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCHH
Confidence            2234689999999998753211 1245579999999999999999999998887777666665554555554   46899


Q ss_pred             HHHHHHHhcccCCCC--CCCHHHHHHHHH
Q 012887          417 LKSLMIKCWNNSPSK--RPQFSEIISLLL  443 (454)
Q Consensus       417 l~~li~~cl~~dP~~--RPs~~ell~~L~  443 (454)
                      +.+++.+|+..++.+  |+++.++++|-+
T Consensus       240 ~~~li~~ll~~~~~~~~~~~~~~~~~h~~  268 (331)
T cd05624         240 AKDLIQRLICSRERRLGQNGIEDFKKHAF  268 (331)
T ss_pred             HHHHHHHHccCchhhcCCCCHHHHhcCCC
Confidence            999999999876654  468999987743

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1.2e-40  Score=320.05  Aligned_cols=246  Identities=25%  Similarity=0.446  Sum_probs=201.2

Q ss_pred             EEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEEec
Q 012887          192 LEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKL  265 (454)
Q Consensus       192 ~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~E~  265 (454)
                      |++++.||+|+||.||++      +.+|+|.+..............+|+..+.+++||||+++++++.+.+. .++|||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~-~~~v~~~   79 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNY-LYIVMEY   79 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSE-EEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccc-ccccccc
Confidence            789999999999999995      579999998655444444445669999999999999999999998776 8999999


Q ss_pred             cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCcccccC
Q 012887          266 MEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYET  345 (454)
Q Consensus       266 ~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~  345 (454)
                      +++++|.+++.+...+++..+..++.||+.||.|||+++++|+||||+||+++.++.++|+|||.+..............
T Consensus        80 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~  159 (260)
T PF00069_consen   80 CPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNPFV  159 (260)
T ss_dssp             ETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSSSS
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            99999999998778899999999999999999999999999999999999999999999999999875433333455567


Q ss_pred             CCCccccccccc-CCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHH---HHHHcCCCCC--CCCCccHHHHH
Q 012887          346 DGYRWLAPEIIA-GDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAV---GIAACGLRPE--IPKDCPQILKS  419 (454)
Q Consensus       346 gt~~y~APE~l~-~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~---~i~~~~~~~~--~p~~~~~~l~~  419 (454)
                      ++..|+|||++. +.    ..+.++||||||+++|+|++|..||..........   ..........  .....+.++.+
T Consensus       160 ~~~~y~aPE~~~~~~----~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  235 (260)
T PF00069_consen  160 GTPEYMAPEVLQQGK----KYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRD  235 (260)
T ss_dssp             SSGGGSCHHHHTTTS----SBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHH
T ss_pred             ccccccccccccccc----cccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHH
Confidence            788999999987 44    34557999999999999999999999873332222   2221111111  11223489999


Q ss_pred             HHHHhcccCCCCCCCHHHHHHHH
Q 012887          420 LMIKCWNNSPSKRPQFSEIISLL  442 (454)
Q Consensus       420 li~~cl~~dP~~RPs~~ell~~L  442 (454)
                      +|.+||+.||++||++.+++++-
T Consensus       236 li~~~l~~~p~~R~~~~~l~~~~  258 (260)
T PF00069_consen  236 LIKKMLSKDPEQRPSAEELLKHP  258 (260)
T ss_dssp             HHHHHSSSSGGGSTTHHHHHTSG
T ss_pred             HHHHHccCChhHCcCHHHHhcCC
Confidence            99999999999999999998764

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=1.5e-39  Score=312.64  Aligned_cols=245  Identities=24%  Similarity=0.370  Sum_probs=208.3

Q ss_pred             CEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEEe
Q 012887          191 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTK  264 (454)
Q Consensus       191 ~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~E  264 (454)
                      +|++.+.||+|+||.||++      +.+++|.+...........++.+|+.+++.++||||+++++++.+.+. .++|||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-~~lv~e   79 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGN-LYIVMD   79 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCe-EEEEEe
Confidence            4789999999999999984      579999987544444455678899999999999999999999987776 999999


Q ss_pred             ccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCccc
Q 012887          265 LMEGGSVNDLILKSR--KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE  342 (454)
Q Consensus       265 ~~~~gsL~~~l~~~~--~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~  342 (454)
                      |+++++|.+++....  .+++..+..++.|++.||.|||+++++|+||+|+||+++.++.++|+|||++...........
T Consensus        80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~  159 (256)
T cd08218          80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELAR  159 (256)
T ss_pred             cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhhh
Confidence            999999999986533  689999999999999999999999999999999999999999999999999876544333233


Q ss_pred             ccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHHHHHH
Q 012887          343 YETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMI  422 (454)
Q Consensus       343 ~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~li~  422 (454)
                      ...+++.|+|||++.+..    .+.++|+|||||++|+|++|..||...........+.. +..++.+..++.++.++|.
T Consensus       160 ~~~~~~~~~~pe~~~~~~----~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~  234 (256)
T cd08218         160 TCIGTPYYLSPEICENRP----YNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIR-GSYPPVSSHYSYDLRNLVS  234 (256)
T ss_pred             hccCCccccCHHHhCCCC----CCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhc-CCCCCCcccCCHHHHHHHH
Confidence            345778899999987664    34469999999999999999999988777666655543 4455677889999999999


Q ss_pred             HhcccCCCCCCCHHHHHHH
Q 012887          423 KCWNNSPSKRPQFSEIISL  441 (454)
Q Consensus       423 ~cl~~dP~~RPs~~ell~~  441 (454)
                      +||+.+|++||++.+++++
T Consensus       235 ~~l~~~p~~Rp~~~~vl~~  253 (256)
T cd08218         235 QLFKRNPRDRPSVNSILEK  253 (256)
T ss_pred             HHhhCChhhCcCHHHHhhC
Confidence            9999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=7.4e-40  Score=336.60  Aligned_cols=244  Identities=18%  Similarity=0.265  Sum_probs=193.3

Q ss_pred             ecCCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEE
Q 012887          187 LNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLC  260 (454)
Q Consensus       187 ~~~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~  260 (454)
                      +...+|++++.||+|+||.||++      +.||+|....        ..+.+|+.++..++||||+++++++...+. .+
T Consensus        89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~--------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~-~~  159 (391)
T PHA03212         89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR--------GGTATEAHILRAINHPSIIQLKGTFTYNKF-TC  159 (391)
T ss_pred             cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh--------hhhHHHHHHHHhCCCCCCCCEeEEEEECCe-eE
Confidence            45578999999999999999985      5789986531        235689999999999999999999988776 89


Q ss_pred             EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCC-C
Q 012887          261 VVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG-E  339 (454)
Q Consensus       261 lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~-~  339 (454)
                      +|||++. ++|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .
T Consensus       160 lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~  238 (391)
T PHA03212        160 LILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN  238 (391)
T ss_pred             EEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccccccc
Confidence            9999995 5999998777789999999999999999999999999999999999999999999999999986533221 1


Q ss_pred             cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC-------HHHHHHHHHH----------
Q 012887          340 ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACS-------PVQAAVGIAA----------  402 (454)
Q Consensus       340 ~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~-------~~~~~~~i~~----------  402 (454)
                      ......||+.|+|||++.+..+    +.++|||||||++|||++|..||....       ....+..+..          
T Consensus       239 ~~~~~~gt~~y~aPE~~~~~~~----~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~  314 (391)
T PHA03212        239 KYYGWAGTIATNAPELLARDPY----GPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFP  314 (391)
T ss_pred             ccccccCccCCCChhhhcCCCC----CcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcC
Confidence            2234468999999999987654    456999999999999999998875321       1111111110          


Q ss_pred             ----------------cCCCCC--CC-----CCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 012887          403 ----------------CGLRPE--IP-----KDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR  444 (454)
Q Consensus       403 ----------------~~~~~~--~p-----~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~  444 (454)
                                      .....+  .|     ...+.++.+||.+||+.||.+|||++|++++-+-
T Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f  379 (391)
T PHA03212        315 IDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAF  379 (391)
T ss_pred             cchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhh
Confidence                            000000  00     1246789999999999999999999999987654

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.4e-39  Score=317.95  Aligned_cols=233  Identities=22%  Similarity=0.395  Sum_probs=186.9

Q ss_pred             eeeccCCceEEEeE------------------------------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCcee
Q 012887          197 QIGPNSFKGVYKGK------------------------------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNIL  246 (454)
Q Consensus       197 ~LG~G~fG~Vy~g~------------------------------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv  246 (454)
                      .||+|+||.||+|.                              .|++|.+...  .......+.+|+.++..++||||+
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~~~~~~~l~h~niv   79 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS--HRDIALAFFETASLMSQVSHIHLA   79 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH--HHHHHHHHHHHHHHHhcCCCCCee
Confidence            59999999999874                              3677777532  222334567788888899999999


Q ss_pred             EEEEEEEeCCCeEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCC----
Q 012887          247 QFYCVCVDENHGLCVVTKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG----  321 (454)
Q Consensus       247 ~~~g~~~~~~~~l~lV~E~~~~gsL~~~l~~-~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~----  321 (454)
                      ++++++.+.+. .++||||+++|+|..++.+ .+.+++..+..++.||+.||+|||+++|+||||||+|||++..+    
T Consensus        80 ~~~~~~~~~~~-~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~  158 (274)
T cd05076          80 FVHGVCVRGSE-NIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEG  158 (274)
T ss_pred             eEEEEEEeCCc-eEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccC
Confidence            99999988776 8999999999999999865 45789999999999999999999999999999999999998654    


Q ss_pred             ---cEEEEccCCccccccCCCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHH-cCCCCCCCCCHHHHH
Q 012887          322 ---NVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMV-TGEAAYAACSPVQAA  397 (454)
Q Consensus       322 ---~vKL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ell-tG~~Pf~~~~~~~~~  397 (454)
                         .+|++|||++.....    .....++..|+|||.+.+..   .++.++|||||||++|||+ +|..||....+....
T Consensus       159 ~~~~~kl~d~g~~~~~~~----~~~~~~~~~~~aPe~~~~~~---~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~  231 (274)
T cd05076         159 TSPFIKLSDPGVSFTALS----REERVERIPWIAPECVPGGN---SLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKE  231 (274)
T ss_pred             ccceeeecCCcccccccc----ccccccCCcccCchhhcCCC---CCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHH
Confidence               389999998754322    12234677899999886532   2456799999999999985 699999876655433


Q ss_pred             HHHHHcCCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 012887          398 VGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL  442 (454)
Q Consensus       398 ~~i~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L  442 (454)
                      .. ...  ....|...++.+.++|.+||+.+|++||++.++++.|
T Consensus       232 ~~-~~~--~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L  273 (274)
T cd05076         232 RF-YEK--KHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL  273 (274)
T ss_pred             HH-HHh--ccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence            22 221  2334555678899999999999999999999999887

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=3.3e-39  Score=311.72  Aligned_cols=250  Identities=26%  Similarity=0.471  Sum_probs=206.7

Q ss_pred             eeecCCCEEEeceeeccCCceEEEeE-----EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeE
Q 012887          185 WLLNSDNLEFIDQIGPNSFKGVYKGK-----RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGL  259 (454)
Q Consensus       185 ~~~~~~~~~~~~~LG~G~fG~Vy~g~-----~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l  259 (454)
                      |.+..++|++.+.||+|+||.||++.     .+++|.+...   ......+.+|+.+++.++|+||+++++.+.+ .. .
T Consensus         1 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~-~   75 (260)
T cd05073           1 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG---SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EP-I   75 (260)
T ss_pred             CcccccceeEEeEecCccceEEEEEEecCCccEEEEecCCC---hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CC-e
Confidence            56778999999999999999999874     4888877632   2234567889999999999999999999877 44 8


Q ss_pred             EEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccC
Q 012887          260 CVVTKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV  337 (454)
Q Consensus       260 ~lV~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~  337 (454)
                      +++|||+++++|.+++.+.  ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++......
T Consensus        76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  155 (260)
T cd05073          76 YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN  155 (260)
T ss_pred             EEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCC
Confidence            8999999999999999653  36788899999999999999999999999999999999999999999999998765432


Q ss_pred             CC-cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHcCCCCCCCCCccH
Q 012887          338 GE-ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ  415 (454)
Q Consensus       338 ~~-~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~  415 (454)
                      .. ......++..|+|||++.+...    +.++|+|||||++|++++ |..||.+.+.......+ ..+...+.+...+.
T Consensus       156 ~~~~~~~~~~~~~y~~PE~~~~~~~----~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~  230 (260)
T cd05073         156 EYTAREGAKFPIKWTAPEAINFGSF----TIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL-ERGYRMPRPENCPE  230 (260)
T ss_pred             CcccccCCcccccccCHhHhccCCc----CccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHH-hCCCCCCCcccCCH
Confidence            21 1122234567999999976543    445999999999999999 99999887665554433 34455566777899


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 012887          416 ILKSLMIKCWNNSPSKRPQFSEIISLLLR  444 (454)
Q Consensus       416 ~l~~li~~cl~~dP~~RPs~~ell~~L~~  444 (454)
                      ++.+++.+||+.+|++||++.++++.|..
T Consensus       231 ~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         231 ELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             HHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            99999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=2.1e-39  Score=311.82  Aligned_cols=241  Identities=29%  Similarity=0.513  Sum_probs=203.7

Q ss_pred             ceeeccCCceEEEeE---------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEEecc
Q 012887          196 DQIGPNSFKGVYKGK---------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLM  266 (454)
Q Consensus       196 ~~LG~G~fG~Vy~g~---------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~E~~  266 (454)
                      +.||+|+||.||+|.         .+|+|.+...... .....+.+|+..+++++||||+++++++.+ . ..++||||+
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~-~~~~v~e~~   77 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-H-PLMMVTELA   77 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC-C-eEEEEEEec
Confidence            468999999999863         4788888754332 455678899999999999999999999987 4 489999999


Q ss_pred             CCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCC---cc
Q 012887          267 EGGSVNDLILKSR--KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE---AT  341 (454)
Q Consensus       267 ~~gsL~~~l~~~~--~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~---~~  341 (454)
                      ++++|.+.+.+..  .+++..+..++.|++.||.|||+++++|+||||+||+++.++.+||+|||++........   ..
T Consensus        78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  157 (257)
T cd05040          78 PLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVME  157 (257)
T ss_pred             CCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceecc
Confidence            9999999996653  689999999999999999999999999999999999999999999999999876644221   11


Q ss_pred             cccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHHHH
Q 012887          342 EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSL  420 (454)
Q Consensus       342 ~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~l  420 (454)
                      ....++..|+|||++.+..    ++.++|||||||++|+|++ |..||...+..+....+.........+..+|..+.++
T Consensus       158 ~~~~~~~~y~~pE~~~~~~----~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  233 (257)
T cd05040         158 EHLKVPFAWCAPESLRTRT----FSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNV  233 (257)
T ss_pred             cCCCCCceecCHHHhcccC----cCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHH
Confidence            2234567899999987654    3445999999999999998 9999988777776666665556666777889999999


Q ss_pred             HHHhcccCCCCCCCHHHHHHHHH
Q 012887          421 MIKCWNNSPSKRPQFSEIISLLL  443 (454)
Q Consensus       421 i~~cl~~dP~~RPs~~ell~~L~  443 (454)
                      +.+||+.+|.+||++.++++.|.
T Consensus       234 i~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         234 MLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             HHHHCCCCcccCCCHHHHHHHhc
Confidence            99999999999999999999874

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=1.7e-39  Score=321.69  Aligned_cols=254  Identities=24%  Similarity=0.466  Sum_probs=208.4

Q ss_pred             ecCCCEEEeceeeccCCceEEEeE----------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCC
Q 012887          187 LNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN  256 (454)
Q Consensus       187 ~~~~~~~~~~~LG~G~fG~Vy~g~----------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~  256 (454)
                      +..++|+..+.||+|+||.||+|.          .+|+|.+... ........+.+|+.++..++||||+++++++....
T Consensus         4 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~   82 (303)
T cd05110           4 LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNET-TGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPT   82 (303)
T ss_pred             cchhhceeccccccCCCccEEEEEEecCCCcceeeEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCCC
Confidence            456788999999999999999974          3688877632 22333446788999999999999999999987543


Q ss_pred             CeEEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccc
Q 012887          257 HGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK  335 (454)
Q Consensus       257 ~~l~lV~E~~~~gsL~~~l~~~~-~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~  335 (454)
                        .++++||+++|+|.+++.... .+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++...
T Consensus        83 --~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~  160 (303)
T cd05110          83 --IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLE  160 (303)
T ss_pred             --ceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEcccccccccc
Confidence              679999999999999986644 68999999999999999999999999999999999999999999999999987654


Q ss_pred             cCCCc--ccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHcCCCCCCCCC
Q 012887          336 SVGEA--TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKD  412 (454)
Q Consensus       336 ~~~~~--~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~  412 (454)
                      .....  .....++..|+|||.+.+..    .+.++|||||||++|||++ |..||.+..... ...+...+.+++.+..
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~----~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~  235 (303)
T cd05110         161 GDEKEYNADGGKMPIKWMALECIHYRK----FTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE-IPDLLEKGERLPQPPI  235 (303)
T ss_pred             CcccccccCCCccccccCCHHHhccCC----CChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHHCCCCCCCCCC
Confidence            32221  11223466899999987654    4456999999999999997 999998765443 3445555666666777


Q ss_pred             ccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCC
Q 012887          413 CPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNI  448 (454)
Q Consensus       413 ~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~  448 (454)
                      ++..+.+++.+||..+|++||++.++++.|.++...
T Consensus       236 ~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~  271 (303)
T cd05110         236 CTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD  271 (303)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence            899999999999999999999999999999987544

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-41  Score=347.58  Aligned_cols=240  Identities=22%  Similarity=0.457  Sum_probs=210.4

Q ss_pred             eeeccCCceEEEeE------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEEeccCCCC
Q 012887          197 QIGPNSFKGVYKGK------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGS  270 (454)
Q Consensus       197 ~LG~G~fG~Vy~g~------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~E~~~~gs  270 (454)
                      .||+|.||+||-|+      ++|||.+..  +....-.-+.+||...++++|.|||+++|.+..++. +-|.||-++|||
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpe--kdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf-~kIFMEqVPGGS  658 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPE--KDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGF-FKIFMEQVPGGS  658 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeeccc--ccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCe-EEEEeecCCCCc
Confidence            68999999999984      678888853  233333457899999999999999999999887775 889999999999


Q ss_pred             HHHHHHhC-CCC--CHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEcc-CCcEEEEccCCccccccCCCcccccCC
Q 012887          271 VNDLILKS-RKL--QTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDR-HGNVCLGDMGIVTACKSVGEATEYETD  346 (454)
Q Consensus       271 L~~~l~~~-~~l--~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~-~~~vKL~DFGla~~~~~~~~~~~~~~g  346 (454)
                      |.++++.. +++  ++..+..|.+||++||.|||++.|||||||.+|+||+. .|.+||+|||-++++...+..++..+|
T Consensus       659 LSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFTG  738 (1226)
T KOG4279|consen  659 LSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFTG  738 (1226)
T ss_pred             HHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCcccccccc
Confidence            99999643 567  89999999999999999999999999999999999975 689999999999998888888889999


Q ss_pred             CCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC-CHHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhc
Q 012887          347 GYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAAC-SPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCW  425 (454)
Q Consensus       347 t~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~-~~~~~~~~i~~~~~~~~~p~~~~~~l~~li~~cl  425 (454)
                      |..|||||++..++-  .|..++|||||||++.||.||++||... ++..+..+.-.-...|++|..++.+.+.+|.+|+
T Consensus       739 TLQYMAPEvIDqG~R--GYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~FilrcF  816 (1226)
T KOG4279|consen  739 TLQYMAPEVIDQGPR--GYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCF  816 (1226)
T ss_pred             chhhhChHhhccCCc--CCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHc
Confidence            999999999997753  4677899999999999999999999764 5555666666666789999999999999999999


Q ss_pred             ccCCCCCCCHHHHHHH
Q 012887          426 NNSPSKRPQFSEIISL  441 (454)
Q Consensus       426 ~~dP~~RPs~~ell~~  441 (454)
                      .+||.+||++++++..
T Consensus       817 epd~~~R~sA~~LL~D  832 (1226)
T KOG4279|consen  817 EPDPCDRPSAKDLLQD  832 (1226)
T ss_pred             CCCcccCccHHHhccC
Confidence            9999999999999864

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-42  Score=328.39  Aligned_cols=242  Identities=21%  Similarity=0.405  Sum_probs=211.9

Q ss_pred             CEEEeceeeccCCceEEE------eEEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEEe
Q 012887          191 NLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTK  264 (454)
Q Consensus       191 ~~~~~~~LG~G~fG~Vy~------g~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~E  264 (454)
                      -|.++++||+|+||.||+      |..+|||++..    .....++.+|+.++.+++.|+||++||.+..... +|+|||
T Consensus        34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV----~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sD-LWIVME  108 (502)
T KOG0574|consen   34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV----DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSD-LWIVME  108 (502)
T ss_pred             HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc----cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCc-eEeehh
Confidence            357789999999999997      78999999853    2234568899999999999999999999887666 999999


Q ss_pred             ccCCCCHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCcccc
Q 012887          265 LMEGGSVNDLIL-KSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY  343 (454)
Q Consensus       265 ~~~~gsL~~~l~-~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~  343 (454)
                      ||..|++.|.++ +++++.+..+..++...++||+|||...-||||||+.|||++.+|++||+|||+|..+.+.......
T Consensus       109 YCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRNT  188 (502)
T KOG0574|consen  109 YCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRNT  188 (502)
T ss_pred             hcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHHhhCc
Confidence            999999999995 5669999999999999999999999999999999999999999999999999999888776666777


Q ss_pred             cCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCC--CCCccHHHHHHH
Q 012887          344 ETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEI--PKDCPQILKSLM  421 (454)
Q Consensus       344 ~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~--p~~~~~~l~~li  421 (454)
                      ..|||.|||||++..-.    |+.++||||||++..||..|++||.+..|...++-+.. +.+|.+  |+.++.++.+++
T Consensus       189 VIGTPFWMAPEVI~EIG----Y~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT-~PPPTF~KPE~WS~~F~DFi  263 (502)
T KOG0574|consen  189 VIGTPFWMAPEVIEEIG----YDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPT-KPPPTFKKPEEWSSEFNDFI  263 (502)
T ss_pred             cccCcccccHHHHHHhc----cchhhhHhhhcchhhhhhcCCCCcccccccceeEeccC-CCCCCCCChHhhhhHHHHHH
Confidence            88999999999998665    44559999999999999999999999888876654443 333433  567899999999


Q ss_pred             HHhcccCCCCCCCHHHHHHHH
Q 012887          422 IKCWNNSPSKRPQFSEIISLL  442 (454)
Q Consensus       422 ~~cl~~dP~~RPs~~ell~~L  442 (454)
                      ++||.+.|++|-|+.++++|-
T Consensus       264 ~~CLiK~PE~R~TA~~L~~H~  284 (502)
T KOG0574|consen  264 RSCLIKKPEERKTALRLCEHT  284 (502)
T ss_pred             HHHhcCCHHHHHHHHHHhhhh
Confidence            999999999999999999874

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-40  Score=332.14  Aligned_cols=247  Identities=20%  Similarity=0.353  Sum_probs=219.7

Q ss_pred             CCEEEeceeeccCCceEE------EeEEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEE
Q 012887          190 DNLEFIDQIGPNSFKGVY------KGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  263 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy------~g~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~  263 (454)
                      .-|.+.+.||+|.|..|-      .|..||||++...+........+.+|++.|+.++|||||++|++...... +|+|+
T Consensus        18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTK-lyLiL   96 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTK-LYLIL   96 (864)
T ss_pred             eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccce-EEEEE
Confidence            447778899999998664      58899999998777777777889999999999999999999999876665 99999


Q ss_pred             eccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEcc-CCcEEEEccCCccccccCCCcc
Q 012887          264 KLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDR-HGNVCLGDMGIVTACKSVGEAT  341 (454)
Q Consensus       264 E~~~~gsL~~~l~~~~-~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~-~~~vKL~DFGla~~~~~~~~~~  341 (454)
                      |+=++|+|+|+|.+.. .+.+..+.+|+.||+.|+.|+|+.++|||||||+|+.+.+ -|-|||.|||++..+.+. ...
T Consensus        97 ELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG-~kL  175 (864)
T KOG4717|consen   97 ELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG-KKL  175 (864)
T ss_pred             EecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCc-chh
Confidence            9999999999997654 8999999999999999999999999999999999988764 688999999998766543 445


Q ss_pred             cccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHHHHH
Q 012887          342 EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLM  421 (454)
Q Consensus       342 ~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~li  421 (454)
                      +..+|...|-|||++.|..|..+   +.||||||||||.|++|++||...++.+.+.-|+.+.+.  +|...+.+.++||
T Consensus       176 ~TsCGSLAYSAPEILLGDsYDAP---AVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYt--vPshvS~eCrdLI  250 (864)
T KOG4717|consen  176 TTSCGSLAYSAPEILLGDSYDAP---AVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYT--VPSHVSKECRDLI  250 (864)
T ss_pred             hcccchhhccCchhhhcCccCCc---chhhhHHHHHHHHHHhCCCccccccchhhhhhhhccccc--CchhhhHHHHHHH
Confidence            66789999999999999987654   699999999999999999999999998888888888666  8899999999999


Q ss_pred             HHhcccCCCCCCCHHHHHHHHH
Q 012887          422 IKCWNNSPSKRPQFSEIISLLL  443 (454)
Q Consensus       422 ~~cl~~dP~~RPs~~ell~~L~  443 (454)
                      ..||..||.+|.+.+||..+-|
T Consensus       251 ~sMLvRdPkkRAslEeI~s~~W  272 (864)
T KOG4717|consen  251 QSMLVRDPKKRASLEEIVSTSW  272 (864)
T ss_pred             HHHHhcCchhhccHHHHhcccc
Confidence            9999999999999999987755

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1.6e-39  Score=312.55  Aligned_cols=246  Identities=26%  Similarity=0.523  Sum_probs=205.1

Q ss_pred             eeecCCCEEEeceeeccCCceEEEe----EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEE
Q 012887          185 WLLNSDNLEFIDQIGPNSFKGVYKG----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLC  260 (454)
Q Consensus       185 ~~~~~~~~~~~~~LG~G~fG~Vy~g----~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~  260 (454)
                      |.+..++|++.+.||+|+||.||+|    +.+|+|.++..    .....+.+|+..+..++|||++++++++..+.  .+
T Consensus         1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~----~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~--~~   74 (254)
T cd05083           1 WLLNLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCD----VTAQAFLEETAVMTKLHHKNLVRLLGVILHNG--LY   74 (254)
T ss_pred             CcccHHHceeeeeeccCCCCceEecccCCCceEEEeecCc----chHHHHHHHHHHHHhCCCCCcCeEEEEEcCCC--cE
Confidence            4556688999999999999999985    57899988632    22346788999999999999999999987543  78


Q ss_pred             EEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCC
Q 012887          261 VVTKLMEGGSVNDLILKSR--KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG  338 (454)
Q Consensus       261 lV~E~~~~gsL~~~l~~~~--~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~  338 (454)
                      +||||+++++|.+++....  .+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++...... 
T Consensus        75 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-  153 (254)
T cd05083          75 IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-  153 (254)
T ss_pred             EEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc-
Confidence            9999999999999996543  6899999999999999999999999999999999999999999999999998654321 


Q ss_pred             CcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHH
Q 012887          339 EATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQIL  417 (454)
Q Consensus       339 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l  417 (454)
                        ......+..|+|||.+.+..    ++.++|+|||||++|+|++ |..||...+....... ...+.++..+..+|..+
T Consensus       154 --~~~~~~~~~y~~pe~~~~~~----~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  226 (254)
T cd05083         154 --VDNSKLPVKWTAPEALKHKK----FSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKEC-VEKGYRMEPPEGCPADV  226 (254)
T ss_pred             --CCCCCCCceecCHHHhccCC----cCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHH-HhCCCCCCCCCcCCHHH
Confidence              12223456799999987654    3446999999999999998 9999988776654443 34456666677889999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHHHHHh
Q 012887          418 KSLMIKCWNNSPSKRPQFSEIISLLLR  444 (454)
Q Consensus       418 ~~li~~cl~~dP~~RPs~~ell~~L~~  444 (454)
                      .+++.+||+.+|.+||++.+++..|++
T Consensus       227 ~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         227 YVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             HHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence            999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=1.8e-39  Score=316.85  Aligned_cols=249  Identities=20%  Similarity=0.292  Sum_probs=201.7

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  263 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~  263 (454)
                      ++|++.+.||+|+||.||+|      +.+|+|.+............+.+|+.+++.++||||+++++++...+. +++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~-~~~v~   79 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRK-LHLVF   79 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCE-EEEEE
Confidence            46899999999999999985      579999887543333334457789999999999999999999988776 89999


Q ss_pred             eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCcccc
Q 012887          264 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY  343 (454)
Q Consensus       264 E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~  343 (454)
                      ||+++++|..++.....+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++............
T Consensus        80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~  159 (286)
T cd07847          80 EYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTD  159 (286)
T ss_pred             eccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcccccC
Confidence            99999888888766668999999999999999999999999999999999999999999999999998766544323333


Q ss_pred             cCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcC-------------------
Q 012887          344 ETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG-------------------  404 (454)
Q Consensus       344 ~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~-------------------  404 (454)
                      ..++..|+|||.+.+..   .++.++||||||+++|+|++|..||.+..+.+....+....                   
T Consensus       160 ~~~~~~~~aPE~~~~~~---~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (286)
T cd07847         160 YVATRWYRAPELLVGDT---QYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKG  236 (286)
T ss_pred             cccccccCCHHHHhCCC---CcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccccc
Confidence            45678899999987532   24556999999999999999999998776655443332110                   


Q ss_pred             CCCCC----------CCCccHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 012887          405 LRPEI----------PKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL  442 (454)
Q Consensus       405 ~~~~~----------p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L  442 (454)
                      ...+.          -...+..+.+++.+||+.+|++||++.|++.+-
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~  284 (286)
T cd07847         237 LSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHP  284 (286)
T ss_pred             ccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCC
Confidence            00000          124578899999999999999999999998763

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=2.8e-39  Score=310.66  Aligned_cols=246  Identities=25%  Similarity=0.341  Sum_probs=207.6

Q ss_pred             CEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeC-CCeEEEEE
Q 012887          191 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDE-NHGLCVVT  263 (454)
Q Consensus       191 ~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~-~~~l~lV~  263 (454)
                      +|++++.||.|+||.||++      +.+++|.+............+..|+..++.++||||+++++.+... +..++++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            5788999999999999985      5689998875555555566788999999999999999999988754 34589999


Q ss_pred             eccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHH-----hcCcccCCccCCcEEEccCCcEEEEccCCcccc
Q 012887          264 KLMEGGSVNDLILK----SRKLQTKEIIRIAIDVAEGIKFLN-----DHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC  334 (454)
Q Consensus       264 E~~~~gsL~~~l~~----~~~l~~~~~~~i~~qI~~gL~yLH-----~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~  334 (454)
                      ||+++++|.+++.+    ...+++..++.++.||+.||.|||     +.+++|+||+|+||+++.++.+||+|||++...
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~  160 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL  160 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence            99999999999854    357999999999999999999999     999999999999999999999999999998876


Q ss_pred             ccCCCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCcc
Q 012887          335 KSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCP  414 (454)
Q Consensus       335 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~  414 (454)
                      ...........+++.|+|||.+.+..    .+.++|+||||+++|+|++|..||......... .....+..+.+|..++
T Consensus       161 ~~~~~~~~~~~~~~~~~~pE~~~~~~----~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~  235 (265)
T cd08217         161 GHDSSFAKTYVGTPYYMSPEQLNHMS----YDEKSDIWSLGCLIYELCALSPPFTARNQLQLA-SKIKEGKFRRIPYRYS  235 (265)
T ss_pred             cCCcccccccccCCCccChhhhcCCC----CCchhHHHHHHHHHHHHHHCCCcccCcCHHHHH-HHHhcCCCCCCccccC
Confidence            55443233446788999999998764    345699999999999999999999887654443 3334445556788899


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012887          415 QILKSLMIKCWNNSPSKRPQFSEIISL  441 (454)
Q Consensus       415 ~~l~~li~~cl~~dP~~RPs~~ell~~  441 (454)
                      ..+.+++.+||+.+|++||++.+|+++
T Consensus       236 ~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         236 SELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             HHHHHHHHHHccCCcccCCCHHHHhhC
Confidence            999999999999999999999999976

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1.1e-39  Score=330.32  Aligned_cols=247  Identities=19%  Similarity=0.235  Sum_probs=195.9

Q ss_pred             CCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCC-----C
Q 012887          189 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN-----H  257 (454)
Q Consensus       189 ~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~-----~  257 (454)
                      .++|++.+.||+|+||.||++      +.+|+|++............+.+|+.+++.++||||+++++++....     .
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   95 (355)
T cd07874          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ   95 (355)
T ss_pred             hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence            378999999999999999985      57999998755444445566778999999999999999999986543     2


Q ss_pred             eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccC
Q 012887          258 GLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV  337 (454)
Q Consensus       258 ~l~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~  337 (454)
                      ..++||||+++ +|.+.+..  .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus        96 ~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~  172 (355)
T cd07874          96 DVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS  172 (355)
T ss_pred             eeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCCCc
Confidence            37999999976 77776643  5889999999999999999999999999999999999999999999999998764332


Q ss_pred             CCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcC-------------
Q 012887          338 GEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG-------------  404 (454)
Q Consensus       338 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~-------------  404 (454)
                       .......+|..|+|||++.+..+    +.++|||||||++|+|++|..||.+.........+...-             
T Consensus       173 -~~~~~~~~t~~y~aPE~~~~~~~----~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (355)
T cd07874         173 -FMMTPYVVTRYYRAPEVILGMGY----KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP  247 (355)
T ss_pred             -cccCCccccCCccCHHHHcCCCC----CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcH
Confidence             12233467889999999987654    445999999999999999999998766543322211100             


Q ss_pred             -------CC--------------------CCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 012887          405 -------LR--------------------PEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLL  443 (454)
Q Consensus       405 -------~~--------------------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~  443 (454)
                             ..                    ...+...+.++.++|.+||+.||.+|||+.|++++-+
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~  313 (355)
T cd07874         248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPY  313 (355)
T ss_pred             HHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcc
Confidence                   00                    0011223567899999999999999999999999854

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=2.1e-39  Score=314.25  Aligned_cols=247  Identities=23%  Similarity=0.375  Sum_probs=205.2

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCc---hHHHHHHHHHHHHHhCCCCceeEEEEEEEeC-CCeE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGN---AYEFELRKDLLELMTCGHKNILQFYCVCVDE-NHGL  259 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~---~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~-~~~l  259 (454)
                      .+|+..+.||+|+||.||++      +.+++|.+.......   .....+.+|+.++..++||||+++++++.+. +..+
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            46788999999999999985      478999886443222   2334578899999999999999999988764 3458


Q ss_pred             EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCC-
Q 012887          260 CVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG-  338 (454)
Q Consensus       260 ~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~-  338 (454)
                      +++|||+++++|.+++.+...+++.....++.|++.||.|||+.+++||||+|+||+++.++.+||+|||++....... 
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~  161 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICM  161 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccccc
Confidence            8999999999999999877789999999999999999999999999999999999999999999999999987543211 


Q ss_pred             --CcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHH
Q 012887          339 --EATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQI  416 (454)
Q Consensus       339 --~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~  416 (454)
                        .......++..|+|||.+.+..    ++.++|||||||++|||++|..||..................+.+|..+++.
T Consensus       162 ~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (266)
T cd06651         162 SGTGIRSVTGTPYWMSPEVISGEG----YGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEH  237 (266)
T ss_pred             cCCccccCCccccccCHHHhCCCC----CCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHH
Confidence              1112235778899999997654    4456999999999999999999998877666666665555567778888999


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHHH
Q 012887          417 LKSLMIKCWNNSPSKRPQFSEIISL  441 (454)
Q Consensus       417 l~~li~~cl~~dP~~RPs~~ell~~  441 (454)
                      +.+++ +||..+|++||+++|++.|
T Consensus       238 ~~~li-~~~~~~p~~Rp~~~eil~h  261 (266)
T cd06651         238 ARDFL-GCIFVEARHRPSAEELLRH  261 (266)
T ss_pred             HHHHH-HHhcCChhhCcCHHHHhcC
Confidence            99999 6888999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=3.2e-39  Score=318.75  Aligned_cols=248  Identities=21%  Similarity=0.374  Sum_probs=205.3

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  263 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~  263 (454)
                      .+|++++.||+|+||.||+|      +.+++|.+......  ....+.+|+.++..++||||+++++.+...+. .|+||
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~-~~lv~   96 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDE-LWVVM   96 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc--hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCE-EEEee
Confidence            68899999999999999986      47899988743322  23557789999999999999999999987775 99999


Q ss_pred             eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCcccc
Q 012887          264 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY  343 (454)
Q Consensus       264 E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~  343 (454)
                      ||+++++|.+++.+ ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++............
T Consensus        97 e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~  175 (296)
T cd06654          97 EYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST  175 (296)
T ss_pred             cccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccccccCc
Confidence            99999999999854 46899999999999999999999999999999999999999999999999997765433222334


Q ss_pred             cCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCC-CCCCCCCccHHHHHHHH
Q 012887          344 ETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGL-RPEIPKDCPQILKSLMI  422 (454)
Q Consensus       344 ~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~-~~~~p~~~~~~l~~li~  422 (454)
                      ..+++.|+|||.+.+...    +.++|||||||++|+|++|..||....+......+..... ....+..++..+.+++.
T Consensus       176 ~~~~~~y~aPE~~~~~~~----~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  251 (296)
T cd06654         176 MVGTPYWMAPEVVTRKAY----GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN  251 (296)
T ss_pred             ccCCccccCHHHHcCCCC----CccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHHH
Confidence            467889999999886543    3469999999999999999999988776554444333222 22345678899999999


Q ss_pred             HhcccCCCCCCCHHHHHHHHHhh
Q 012887          423 KCWNNSPSKRPQFSEIISLLLRT  445 (454)
Q Consensus       423 ~cl~~dP~~RPs~~ell~~L~~~  445 (454)
                      +||..||.+||++.+++.+-+-.
T Consensus       252 ~~l~~~p~~Rpt~~eil~~~~~~  274 (296)
T cd06654         252 RCLDMDVEKRGSAKELLQHQFLK  274 (296)
T ss_pred             HHCcCCcccCcCHHHHhhChhhh
Confidence            99999999999999999875443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9e-40  Score=352.64  Aligned_cols=258  Identities=26%  Similarity=0.506  Sum_probs=222.9

Q ss_pred             cceeecCCCEEEeceeeccCCceEEEeE-------------EEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEE
Q 012887          183 GRWLLNSDNLEFIDQIGPNSFKGVYKGK-------------RVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQF  248 (454)
Q Consensus       183 ~~~~~~~~~~~~~~~LG~G~fG~Vy~g~-------------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~~  248 (454)
                      ..|++..+++++.+.||+|.||.|++|.             .||||.++..... .....+..|+.++..+ .|+||+.+
T Consensus       289 ~~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~l  367 (609)
T KOG0200|consen  289 PKWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNL  367 (609)
T ss_pred             CceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhh
Confidence            3799999999999999999999999863             5899999855444 6667789999999987 59999999


Q ss_pred             EEEEEeCCCeEEEEEeccCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhcCcccCCccC
Q 012887          249 YCVCVDENHGLCVVTKLMEGGSVNDLILKSR----------------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNS  312 (454)
Q Consensus       249 ~g~~~~~~~~l~lV~E~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp  312 (454)
                      +|+|...+. +++|+||+..|+|.++++.++                .++..++..++.||+.||+||++.++|||||.+
T Consensus       368 lG~~t~~~~-~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAa  446 (609)
T KOG0200|consen  368 LGACTQDGP-LYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAA  446 (609)
T ss_pred             eeeeccCCc-eEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhh
Confidence            999998554 999999999999999996544                388999999999999999999999999999999


Q ss_pred             CcEEEccCCcEEEEccCCccccccCCCcc-cccC--CCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCC
Q 012887          313 QRILLDRHGNVCLGDMGIVTACKSVGEAT-EYET--DGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAY  388 (454)
Q Consensus       313 ~NILl~~~~~vKL~DFGla~~~~~~~~~~-~~~~--gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf  388 (454)
                      +|||+..+..+||+|||+++......... ....  -+..|||||.+....    ++.+||||||||+|||++| |..||
T Consensus       447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~----ft~kSDVWSfGI~L~EifsLG~~PY  522 (609)
T KOG0200|consen  447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRV----FTSKSDVWSFGILLWEIFTLGGTPY  522 (609)
T ss_pred             hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCc----ccccchhhHHHHHHHHHhhCCCCCC
Confidence            99999999999999999998654433322 2222  246799999998654    5666999999999999999 99999


Q ss_pred             CCCCHHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 012887          389 AACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTN  446 (454)
Q Consensus       389 ~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~  446 (454)
                      ++......+......|.++..|..|+++++++|+.||+.+|.+||+|.++.+.+....
T Consensus       523 p~~~~~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l  580 (609)
T KOG0200|consen  523 PGIPPTEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL  580 (609)
T ss_pred             CCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence            9876444456688889999999999999999999999999999999999999998853

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=8.6e-40  Score=319.66  Aligned_cols=239  Identities=21%  Similarity=0.282  Sum_probs=188.6

Q ss_pred             eeccCCceEEEe------EEEEEEEeecCCCCc-hHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEEeccCCCC
Q 012887          198 IGPNSFKGVYKG------KRVGIEKLKGCDKGN-AYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGS  270 (454)
Q Consensus       198 LG~G~fG~Vy~g------~~vavK~l~~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~E~~~~gs  270 (454)
                      ||+|+||.||++      +.+|+|.+....... ........|+.++..++||||+++++++.+... +++||||+++++
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~-~~lv~e~~~g~~   79 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTH-LCLVMSLMNGGD   79 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCe-EEEEEecCCCCC
Confidence            799999999984      579999886432221 223345678899999999999999999987766 999999999999


Q ss_pred             HHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCcccccCCCC
Q 012887          271 VNDLILKSR--KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY  348 (454)
Q Consensus       271 L~~~l~~~~--~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~gt~  348 (454)
                      |.+++....  .+++..+..++.||+.||+|||+.|++||||||+|||++.++.++|+|||++....... ......++.
T Consensus        80 L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~  158 (277)
T cd05607          80 LKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK-TITQRAGTN  158 (277)
T ss_pred             HHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc-eeeccCCCC
Confidence            998885433  68999999999999999999999999999999999999999999999999987654322 223346788


Q ss_pred             cccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHH----HHHHHHHcCCCCCCCCCccHHHHHHHHHh
Q 012887          349 RWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQ----AAVGIAACGLRPEIPKDCPQILKSLMIKC  424 (454)
Q Consensus       349 ~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~----~~~~i~~~~~~~~~p~~~~~~l~~li~~c  424 (454)
                      .|+|||++.+..    ++.++|||||||++|||++|..||.......    ......... .......+++++.+++.+|
T Consensus       159 ~y~aPE~~~~~~----~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~  233 (277)
T cd05607         159 GYMAPEILKEEP----YSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDE-VKFEHQNFTEESKDICRLF  233 (277)
T ss_pred             CccCHHHHccCC----CCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccc-cccccccCCHHHHHHHHHH
Confidence            999999998765    4445999999999999999999998643321    222222111 1112246899999999999


Q ss_pred             cccCCCCCCCHHHHHHHHH
Q 012887          425 WNNSPSKRPQFSEIISLLL  443 (454)
Q Consensus       425 l~~dP~~RPs~~ell~~L~  443 (454)
                      |+.||.+||++.|+++.+.
T Consensus       234 L~~~P~~R~~~~~~~~~~~  252 (277)
T cd05607         234 LAKKPEDRLGSREKNDDPR  252 (277)
T ss_pred             hccCHhhCCCCccchhhhh
Confidence            9999999999966554443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=1.1e-39  Score=318.79  Aligned_cols=253  Identities=21%  Similarity=0.361  Sum_probs=205.8

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  263 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~  263 (454)
                      +.|++.+.||.|+||.||+|      ..+++|.+...  .......+.+|+.+++.++||||+++++++...+. .++||
T Consensus         5 ~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~-~~~v~   81 (282)
T cd06643           5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENN-LWILI   81 (282)
T ss_pred             HHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC--CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCE-EEEEE
Confidence            34678899999999999986      45677777532  22334557789999999999999999999988775 89999


Q ss_pred             eccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCccc
Q 012887          264 KLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE  342 (454)
Q Consensus       264 E~~~~gsL~~~l~~-~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~  342 (454)
                      ||+++++|..++.+ ...+++..+..++.||+.||.|||+.|++||||||+|||++.++.+||+|||++...........
T Consensus        82 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~  161 (282)
T cd06643          82 EFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRD  161 (282)
T ss_pred             EecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccccccccc
Confidence            99999999998754 45799999999999999999999999999999999999999999999999999876543333334


Q ss_pred             ccCCCCcccccccccCCC-CCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCC-CCCCCCCccHHHHHH
Q 012887          343 YETDGYRWLAPEIIAGDP-ESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGL-RPEIPKDCPQILKSL  420 (454)
Q Consensus       343 ~~~gt~~y~APE~l~~~~-~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~-~~~~p~~~~~~l~~l  420 (454)
                      ...+++.|+|||++.... ....++.++|||||||++|+|++|..||...++......+..... ....|..++.++.++
T Consensus       162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  241 (282)
T cd06643         162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDF  241 (282)
T ss_pred             cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHHH
Confidence            456788999999985321 122355679999999999999999999998777666555544322 234566789999999


Q ss_pred             HHHhcccCCCCCCCHHHHHHHHHhh
Q 012887          421 MIKCWNNSPSKRPQFSEIISLLLRT  445 (454)
Q Consensus       421 i~~cl~~dP~~RPs~~ell~~L~~~  445 (454)
                      |.+||+.||.+||++.+++.+-+-.
T Consensus       242 i~~~l~~~p~~Rp~~~~il~~~~~~  266 (282)
T cd06643         242 LKKCLEKNVDARWTTTQLLQHPFVT  266 (282)
T ss_pred             HHHHccCChhhCcCHHHHhcCCCEe
Confidence            9999999999999999999876533

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=2.4e-39  Score=321.50  Aligned_cols=249  Identities=19%  Similarity=0.350  Sum_probs=201.6

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  263 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~  263 (454)
                      ++|++.+.||+|+||.||++      ..+|+|.+... .......++.+|+.++.+++||||+++++++.+++. +++||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~lv~   78 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLE-IKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGE-ISICM   78 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCE-EEEEe
Confidence            46899999999999999985      45788877632 223344567889999999999999999999988776 99999


Q ss_pred             eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-cCcccCCccCCcEEEccCCcEEEEccCCccccccCCCccc
Q 012887          264 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLND-HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE  342 (454)
Q Consensus       264 E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~-~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~  342 (454)
                      ||+++++|.+++.+.+.+++..+..++.||+.||.|||+ .+++||||||+|||++.++.+||+|||++......  ...
T Consensus        79 ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--~~~  156 (308)
T cd06615          79 EHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MAN  156 (308)
T ss_pred             eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc--ccc
Confidence            999999999999877889999999999999999999998 59999999999999999999999999997654322  123


Q ss_pred             ccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH---------------------
Q 012887          343 YETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIA---------------------  401 (454)
Q Consensus       343 ~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~---------------------  401 (454)
                      ...++..|+|||.+.+..+    +.++|+|||||++|+|++|..||...+.......+.                     
T Consensus       157 ~~~~~~~~~aPE~~~~~~~----~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (308)
T cd06615         157 SFVGTRSYMSPERLQGTHY----TVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPD  232 (308)
T ss_pred             cCCCCcCccChhHhcCCCC----CccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCC
Confidence            3467889999999876543    446999999999999999999997544332211110                     


Q ss_pred             --------------HcCCCCCCCC-CccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 012887          402 --------------ACGLRPEIPK-DCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTN  446 (454)
Q Consensus       402 --------------~~~~~~~~p~-~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~  446 (454)
                                    ....++..|. .++.++.+++.+||..+|++||++.+++.+.+-..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~  292 (308)
T cd06615         233 SPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKR  292 (308)
T ss_pred             ccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhh
Confidence                          1111222232 36788999999999999999999999999977544

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=3.4e-39  Score=313.62  Aligned_cols=243  Identities=26%  Similarity=0.470  Sum_probs=196.7

Q ss_pred             ceeeccCCceEEEeE--------EEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEEEEEEEeCCCeEEEEEecc
Q 012887          196 DQIGPNSFKGVYKGK--------RVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVDENHGLCVVTKLM  266 (454)
Q Consensus       196 ~~LG~G~fG~Vy~g~--------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~~~g~~~~~~~~l~lV~E~~  266 (454)
                      +.||+|+||.||+|.        .+++|.++.. ........+.+|+.++.++ +||||+++++++...+. .++||||+
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~-~~lv~e~~   78 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY-LYLAIEYA   78 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc-CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCC-ceEEEEeC
Confidence            358999999999974        3577777632 2233445678899999998 79999999999988776 89999999


Q ss_pred             CCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCC
Q 012887          267 EGGSVNDLILKSR----------------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGI  330 (454)
Q Consensus       267 ~~gsL~~~l~~~~----------------~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGl  330 (454)
                      ++|+|.+++.+.+                .+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+|||+
T Consensus        79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl  158 (270)
T cd05047          79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL  158 (270)
T ss_pred             CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCC
Confidence            9999999986432                478899999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHcCCCCCC
Q 012887          331 VTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEI  409 (454)
Q Consensus       331 a~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~  409 (454)
                      +...... ........+..|+|||++.+..    ++.++|||||||++|||++ |..||.+.+.......+ ..+.+...
T Consensus       159 ~~~~~~~-~~~~~~~~~~~y~apE~~~~~~----~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~-~~~~~~~~  232 (270)
T cd05047         159 SRGQEVY-VKKTMGRLPVRWMAIESLNYSV----YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL-PQGYRLEK  232 (270)
T ss_pred             ccccchh-hhccCCCCccccCChHHHccCC----CCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHH-hCCCCCCC
Confidence            7532211 1111122356799999987654    4456999999999999997 99999876655544333 34455567


Q ss_pred             CCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 012887          410 PKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTN  446 (454)
Q Consensus       410 p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~  446 (454)
                      +..++.++.+++.+||..+|.+||++.+++..|.++.
T Consensus       233 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         233 PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             CCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence            7778999999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.6e-39  Score=316.71  Aligned_cols=252  Identities=25%  Similarity=0.465  Sum_probs=202.3

Q ss_pred             CCCEEEeceeeccCCceEEEe----------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeC-CC
Q 012887          189 SDNLEFIDQIGPNSFKGVYKG----------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDE-NH  257 (454)
Q Consensus       189 ~~~~~~~~~LG~G~fG~Vy~g----------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~-~~  257 (454)
                      ...|++++.||+|+||.||++          ..+|+|.++... .......+.+|+.+++.++||||+++++++.+. ..
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (284)
T cd05079           3 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN   81 (284)
T ss_pred             hhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCC
Confidence            356789999999999999974          468999886432 233445688999999999999999999999876 24


Q ss_pred             eEEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCcccccc
Q 012887          258 GLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS  336 (454)
Q Consensus       258 ~l~lV~E~~~~gsL~~~l~~~~-~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~  336 (454)
                      ..++||||+++++|.+++.+.. .+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++.....
T Consensus        82 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~  161 (284)
T cd05079          82 GIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET  161 (284)
T ss_pred             ceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCcccccccc
Confidence            4899999999999999986543 689999999999999999999999999999999999999999999999999876543


Q ss_pred             CCCc---ccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC--------------CHHHHHHH
Q 012887          337 VGEA---TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAAC--------------SPVQAAVG  399 (454)
Q Consensus       337 ~~~~---~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~--------------~~~~~~~~  399 (454)
                      ....   .....++..|+|||++.+..    ++.++|||||||++|+|+++..|+...              ........
T Consensus       162 ~~~~~~~~~~~~~~~~y~apE~~~~~~----~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd05079         162 DKEYYTVKDDLDSPVFWYAPECLIQSK----FYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR  237 (284)
T ss_pred             CccceeecCCCCCCccccCHHHhccCC----CCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHH
Confidence            2221   12234566799999987654    344699999999999999987664321              11112223


Q ss_pred             HHHcCCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 012887          400 IAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRT  445 (454)
Q Consensus       400 i~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~  445 (454)
                      ....+.+.+.+..++..+.+|+.+||+.+|.+||++.++++.|+.+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         238 VLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             HHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            3334455566778999999999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=3.5e-39  Score=312.17  Aligned_cols=248  Identities=22%  Similarity=0.363  Sum_probs=205.3

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCc---hHHHHHHHHHHHHHhCCCCceeEEEEEEEeCC-CeE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGN---AYEFELRKDLLELMTCGHKNILQFYCVCVDEN-HGL  259 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~---~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~-~~l  259 (454)
                      ++|++.+.||+|+||.||+|      +.+|+|.+.......   .....+.+|+.++..++||||+++++++.+.. ..+
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            57899999999999999985      579999886432221   23346788999999999999999999887653 448


Q ss_pred             EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCC-
Q 012887          260 CVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG-  338 (454)
Q Consensus       260 ~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~-  338 (454)
                      ++||||+++++|.+++.+...+++..+..++.|++.||+|||+++++|+||||+||+++.++.++|+|||++....... 
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~  161 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICL  161 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccc
Confidence            8999999999999999777788999999999999999999999999999999999999999999999999987543211 


Q ss_pred             --CcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHH
Q 012887          339 --EATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQI  416 (454)
Q Consensus       339 --~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~  416 (454)
                        .......++..|+|||.+.+...    +.++|||||||++|+|++|..||...........+......+..|...+..
T Consensus       162 ~~~~~~~~~~~~~y~aPE~~~~~~~----~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (265)
T cd06652         162 SGTGMKSVTGTPYWMSPEVISGEGY----GRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDH  237 (265)
T ss_pred             cccccccCCCCccccChhhhcCCCC----CcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHH
Confidence              11223457788999999876543    456999999999999999999998876666655555555556677788899


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHHHH
Q 012887          417 LKSLMIKCWNNSPSKRPQFSEIISLL  442 (454)
Q Consensus       417 l~~li~~cl~~dP~~RPs~~ell~~L  442 (454)
                      +.+++.+||. +|.+||++++++.+-
T Consensus       238 ~~~~i~~~l~-~p~~Rp~~~~il~~~  262 (265)
T cd06652         238 CRDFLKRIFV-EAKLRPSADELLRHT  262 (265)
T ss_pred             HHHHHHHHhc-ChhhCCCHHHHhcCc
Confidence            9999999995 999999999998764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=1.5e-39  Score=319.33  Aligned_cols=246  Identities=19%  Similarity=0.306  Sum_probs=199.7

Q ss_pred             CEEEeceeeccCCceEEEe------EEEEEEEeecCCCCc-hHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEE
Q 012887          191 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGN-AYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  263 (454)
Q Consensus       191 ~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~  263 (454)
                      .|++.+.||+|+||.||++      +.+|+|.+....... .....+.+|+.++..++|+||+.+++.+.+.+. +++||
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~-~~lv~   79 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDA-LCLVL   79 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCE-EEEEE
Confidence            3678889999999999984      579999886443222 223456789999999999999999999988776 99999


Q ss_pred             eccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCcc
Q 012887          264 KLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT  341 (454)
Q Consensus       264 E~~~~gsL~~~l~~~--~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~  341 (454)
                      ||+++++|.+++...  ..+++..+..++.|++.||.|||+++|+||||||+||+++.++.++|+|||++....... ..
T Consensus        80 e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~~  158 (285)
T cd05630          80 TLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-TI  158 (285)
T ss_pred             EecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc-cc
Confidence            999999999988543  369999999999999999999999999999999999999999999999999986543222 12


Q ss_pred             cccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHHHHcCCCCCCCCCccHHHH
Q 012887          342 EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPV---QAAVGIAACGLRPEIPKDCPQILK  418 (454)
Q Consensus       342 ~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~---~~~~~i~~~~~~~~~p~~~~~~l~  418 (454)
                      ....++..|+|||.+.+..+    +.++|||||||++|+|++|..||......   ....... ...+..++..+++++.
T Consensus       159 ~~~~g~~~y~aPE~~~~~~~----~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  233 (285)
T cd05630         159 KGRVGTVGYMAPEVVKNERY----TFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLV-KEVQEEYSEKFSPDAR  233 (285)
T ss_pred             cCCCCCccccChHHHcCCCC----CCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhh-hhhhhhcCccCCHHHH
Confidence            23468899999999987654    44599999999999999999999864332   1111111 2233456777899999


Q ss_pred             HHHHHhcccCCCCCCC-----HHHHHHHHH
Q 012887          419 SLMIKCWNNSPSKRPQ-----FSEIISLLL  443 (454)
Q Consensus       419 ~li~~cl~~dP~~RPs-----~~ell~~L~  443 (454)
                      +++.+||+.||.+|||     +.|+++|-+
T Consensus       234 ~li~~~l~~~p~~R~s~~~~~~~~~~~h~~  263 (285)
T cd05630         234 SLCKMLLCKDPKERLGCQGGGAREVKEHPL  263 (285)
T ss_pred             HHHHHHhhcCHHHccCCCCCchHHHHcChh
Confidence            9999999999999999     899998755

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=2.3e-39  Score=319.93  Aligned_cols=249  Identities=16%  Similarity=0.240  Sum_probs=200.1

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  263 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~  263 (454)
                      ++|++.+.||+|+||.||+|      +.||+|.++.... ......+.+|+..+..++||||+++++++.+.+. .++||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~-~~lv~   83 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKS-LTLVF   83 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc-cCchhHHHHHHHHHHhcCCCCcceEEEEEecCCe-EEEEE
Confidence            78999999999999999986      4689998864332 2223456789999999999999999999987775 99999


Q ss_pred             eccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCccc
Q 012887          264 KLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE  342 (454)
Q Consensus       264 E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~  342 (454)
                      ||+++ +|.+++.+. ..+++..+..++.||+.||.|||++|++|+||||+|||++.++.+||+|||++...........
T Consensus        84 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~  162 (301)
T cd07873          84 EYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYS  162 (301)
T ss_pred             ecccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCccc
Confidence            99975 999888654 4789999999999999999999999999999999999999999999999999876443332233


Q ss_pred             ccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCC-----------------
Q 012887          343 YETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGL-----------------  405 (454)
Q Consensus       343 ~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~-----------------  405 (454)
                      ...+++.|+|||.+.+..   .++.++|||||||++|+|++|.+||...+..+....+...-.                 
T Consensus       163 ~~~~~~~y~~PE~~~~~~---~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (301)
T cd07873         163 NEVVTLWYRPPDILLGST---DYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK  239 (301)
T ss_pred             ccceeecccCcHHHhCCC---CCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccccc
Confidence            345678899999987542   245579999999999999999999988766544333221100                 


Q ss_pred             CCC-----------CCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 012887          406 RPE-----------IPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR  444 (454)
Q Consensus       406 ~~~-----------~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~  444 (454)
                      ...           ....+++++.+||.+||..||.+|||+.|++.+-|-
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f  289 (301)
T cd07873         240 SYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYF  289 (301)
T ss_pred             ccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccc
Confidence            000           113468889999999999999999999999987654

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-40  Score=332.23  Aligned_cols=240  Identities=21%  Similarity=0.276  Sum_probs=193.7

Q ss_pred             eeccCCceEEEe------EEEEEEEeecCCCCc-hHHHHHHHHHHHHHhC---CCCceeEEEEEEEeCCCeEEEEEeccC
Q 012887          198 IGPNSFKGVYKG------KRVGIEKLKGCDKGN-AYEFELRKDLLELMTC---GHKNILQFYCVCVDENHGLCVVTKLME  267 (454)
Q Consensus       198 LG~G~fG~Vy~g------~~vavK~l~~~~~~~-~~~~~~~~Ei~~l~~l---~HpnIv~~~g~~~~~~~~l~lV~E~~~  267 (454)
                      ||+|+||.||++      +.+|+|.+....... ........|..++...   +||||+++++++.+.+. +|+||||++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~-~~lv~e~~~   79 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSD-LYLVTDYMS   79 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCe-EEEEEcCCC
Confidence            799999999985      579999986422111 1222334455555543   69999999999988776 999999999


Q ss_pred             CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCcccccCCC
Q 012887          268 GGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG  347 (454)
Q Consensus       268 ~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~gt  347 (454)
                      +|+|.+++.+.+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..............||
T Consensus        80 ~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt  159 (330)
T cd05586          80 GGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGT  159 (330)
T ss_pred             CChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCccCC
Confidence            99999999888889999999999999999999999999999999999999999999999999987644333334455789


Q ss_pred             CcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCC-CccHHHHHHHHHhcc
Q 012887          348 YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPK-DCPQILKSLMIKCWN  426 (454)
Q Consensus       348 ~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~-~~~~~l~~li~~cl~  426 (454)
                      +.|+|||++.+..   .++.++|||||||++|+|++|..||.+.+..+....+.....+  +|. .+++++.+++++||+
T Consensus       160 ~~y~aPE~~~~~~---~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~~~~li~~~L~  234 (330)
T cd05586         160 TEYLAPEVLLDEK---GYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVR--FPKNVLSDEGRQFVKGLLN  234 (330)
T ss_pred             ccccCHHHHcCCC---CCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCC--CCCccCCHHHHHHHHHHcC
Confidence            9999999987543   2345699999999999999999999987776665555544332  343 478999999999999


Q ss_pred             cCCCCCC----CHHHHHHHHH
Q 012887          427 NSPSKRP----QFSEIISLLL  443 (454)
Q Consensus       427 ~dP~~RP----s~~ell~~L~  443 (454)
                      .||.+||    ++.++++|-+
T Consensus       235 ~~P~~R~~~~~~~~~ll~h~~  255 (330)
T cd05586         235 RNPQHRLGAHRDAVELKEHPF  255 (330)
T ss_pred             CCHHHCCCCCCCHHHHhcCcc
Confidence            9999998    6788877644

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=2.2e-39  Score=329.34  Aligned_cols=248  Identities=19%  Similarity=0.241  Sum_probs=197.5

Q ss_pred             CCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCC-----C
Q 012887          189 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN-----H  257 (454)
Q Consensus       189 ~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~-----~  257 (454)
                      .++|++.+.||+|+||.||++      +.+|+|++............+.+|+.++..++||||+++++++...+     .
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~  102 (364)
T cd07875          23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  102 (364)
T ss_pred             hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence            378999999999999999985      57999998754444445566788999999999999999999886443     2


Q ss_pred             eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccC
Q 012887          258 GLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV  337 (454)
Q Consensus       258 ~l~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~  337 (454)
                      .+|+||||+++ +|.+.+..  .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus       103 ~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~  179 (364)
T cd07875         103 DVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS  179 (364)
T ss_pred             eEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCCC
Confidence            37999999976 78777643  5889999999999999999999999999999999999999999999999998765332


Q ss_pred             CCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCC------------
Q 012887          338 GEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGL------------  405 (454)
Q Consensus       338 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~------------  405 (454)
                       .......+++.|+|||++.+..+    +.++|||||||++|+|++|..||.+.+.......+...-.            
T Consensus       180 -~~~~~~~~t~~y~aPE~~~~~~~----~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (364)
T cd07875         180 -FMMTPYVVTRYYRAPEVILGMGY----KENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP  254 (364)
T ss_pred             -CcccCCcccCCcCCHHHHhCCCC----CchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhH
Confidence             12233467889999999987654    4569999999999999999999988766554433322100            


Q ss_pred             --------CCC--------------------CCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 012887          406 --------RPE--------------------IPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR  444 (454)
Q Consensus       406 --------~~~--------------------~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~  444 (454)
                              ++.                    .+...+..+.++|.+||+.||.+|||+.++++|-+-
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~  321 (364)
T cd07875         255 TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI  321 (364)
T ss_pred             HHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccc
Confidence                    000                    011134678999999999999999999999998543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-39  Score=313.46  Aligned_cols=250  Identities=23%  Similarity=0.403  Sum_probs=209.3

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  263 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~  263 (454)
                      ++|++.+.||.|+||.||+|      +.+++|.+.... .......+.+|+.+++.++|+||+++++++.+... +++|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~~v~   78 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSK-LWIIM   78 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc-cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCe-EEEEE
Confidence            46788999999999999985      578999886432 23334567889999999999999999999987765 99999


Q ss_pred             eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCcccc
Q 012887          264 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY  343 (454)
Q Consensus       264 E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~  343 (454)
                      ||+++++|.+++... ++++..+..++.|++.||.|||+++++|+||+|+||++++++.++|+|||+++...........
T Consensus        79 e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~  157 (274)
T cd06609          79 EYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT  157 (274)
T ss_pred             EeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeeccccccccc
Confidence            999999999998654 8999999999999999999999999999999999999999999999999998776654333444


Q ss_pred             cCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCC-ccHHHHHHHH
Q 012887          344 ETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKD-CPQILKSLMI  422 (454)
Q Consensus       344 ~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~-~~~~l~~li~  422 (454)
                      ..+++.|+|||.+.+..    ++.++||||||+++|+|++|..||...++......+.. ...+.++.. ++.++.+++.
T Consensus       158 ~~~~~~y~~PE~~~~~~----~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~  232 (274)
T cd06609         158 FVGTPFWMAPEVIKQSG----YDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPK-NNPPSLEGNKFSKPFKDFVS  232 (274)
T ss_pred             ccCCccccChhhhccCC----CCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhh-cCCCCCcccccCHHHHHHHH
Confidence            56788899999998765    44569999999999999999999987766555444333 345555555 8999999999


Q ss_pred             HhcccCCCCCCCHHHHHHHHHhhcC
Q 012887          423 KCWNNSPSKRPQFSEIISLLLRTNN  447 (454)
Q Consensus       423 ~cl~~dP~~RPs~~ell~~L~~~~~  447 (454)
                      +||..+|++||++.+++.+-+-...
T Consensus       233 ~~l~~~p~~Rpt~~~il~~~~~~~~  257 (274)
T cd06609         233 LCLNKDPKERPSAKELLKHKFIKKA  257 (274)
T ss_pred             HHhhCChhhCcCHHHHhhChhhcCC
Confidence            9999999999999999987655443

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=6.3e-39  Score=316.87  Aligned_cols=247  Identities=21%  Similarity=0.372  Sum_probs=207.0

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  263 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~  263 (454)
                      .+|++.+.||.|+||.||+|      +.+++|.+.....  .....+.+|+..+..++||||+++++++...+. +++|+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~lv~   95 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ--PKKELIINEILVMKELKNPNIVNFLDSFLVGDE-LFVVM   95 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC--chHHHHHHHHHHHHhcCCCceeeeeeeEecCce-EEEEE
Confidence            57999999999999999985      5799998864322  234557889999999999999999999987775 99999


Q ss_pred             eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCcccc
Q 012887          264 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY  343 (454)
Q Consensus       264 E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~  343 (454)
                      ||+++++|.+++.+ ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.+||+|||++............
T Consensus        96 e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~  174 (296)
T cd06655          96 EYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST  174 (296)
T ss_pred             EecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccccCCC
Confidence            99999999998854 46899999999999999999999999999999999999999999999999998765443333334


Q ss_pred             cCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCC-CCCCCCCccHHHHHHHH
Q 012887          344 ETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGL-RPEIPKDCPQILKSLMI  422 (454)
Q Consensus       344 ~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~-~~~~p~~~~~~l~~li~  422 (454)
                      ..+++.|+|||.+.+..+    +.++|||||||++|+|++|..||...++......+..... ....+..+++.+.++|.
T Consensus       175 ~~~~~~y~aPE~~~~~~~----~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  250 (296)
T cd06655         175 MVGTPYWMAPEVVTRKAY----GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLN  250 (296)
T ss_pred             cCCCccccCcchhcCCCC----CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHHH
Confidence            467889999999876543    4469999999999999999999998877665555443322 23356678999999999


Q ss_pred             HhcccCCCCCCCHHHHHHHHHh
Q 012887          423 KCWNNSPSKRPQFSEIISLLLR  444 (454)
Q Consensus       423 ~cl~~dP~~RPs~~ell~~L~~  444 (454)
                      +||..||.+||++.+++.+=+-
T Consensus       251 ~~l~~dp~~Rpt~~~il~~~~~  272 (296)
T cd06655         251 RCLEMDVEKRGSAKELLQHPFL  272 (296)
T ss_pred             HHhhcChhhCCCHHHHhhChHh
Confidence            9999999999999999987554

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=2.5e-39  Score=316.70  Aligned_cols=246  Identities=18%  Similarity=0.267  Sum_probs=191.5

Q ss_pred             CEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHh---CCCCceeEEEEEEEeC----CC
Q 012887          191 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMT---CGHKNILQFYCVCVDE----NH  257 (454)
Q Consensus       191 ~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~---l~HpnIv~~~g~~~~~----~~  257 (454)
                      +|++.+.||+|+||.||++      +.+|+|.++.............+|+.++..   ++||||+++++++.+.    ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            4788999999999999996      468999887543332222334556665554   4799999999998653    23


Q ss_pred             eEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccc
Q 012887          258 GLCVVTKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK  335 (454)
Q Consensus       258 ~l~lV~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~  335 (454)
                      .+++||||+++ +|.+++.+.  ..+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++....
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~  159 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYS  159 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCcccccc
Confidence            48899999975 898888653  358999999999999999999999999999999999999999999999999987654


Q ss_pred             cCCCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcC-------CC--
Q 012887          336 SVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG-------LR--  406 (454)
Q Consensus       336 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~-------~~--  406 (454)
                      ... ......++..|+|||++.+..+    +.++|||||||++|+|++|.+||.+.........+....       ++  
T Consensus       160 ~~~-~~~~~~~~~~y~aPE~~~~~~~----~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (288)
T cd07863         160 CQM-ALTPVVVTLWYRAPEVLLQSTY----ATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD  234 (288)
T ss_pred             Ccc-cCCCccccccccCchHhhCCCC----CCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccc
Confidence            321 2233457888999999976644    445999999999999999999998776655444332210       00  


Q ss_pred             ---------C-------CCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 012887          407 ---------P-------EIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL  442 (454)
Q Consensus       407 ---------~-------~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L  442 (454)
                               +       .....++..+.+++.+||+.||.+|||+.|++.+-
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp  286 (288)
T cd07863         235 VTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHP  286 (288)
T ss_pred             ccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCC
Confidence                     0       01134678899999999999999999999998763

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.6e-39  Score=318.11  Aligned_cols=252  Identities=22%  Similarity=0.385  Sum_probs=206.3

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  263 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~  263 (454)
                      ++|++++.||+|+||.||++      +.+|+|.++.. ........+.+|+.++.+++||||+++++.+...+. +++||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~-~~lv~   78 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE-LDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGA-VYMCM   78 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecc-cCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCe-EEEEE
Confidence            46889999999999999985      57899988643 223334567889999999999999999999987776 99999


Q ss_pred             eccCCCCHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHh-cCcccCCccCCcEEEccCCcEEEEccCCccccccCCC
Q 012887          264 KLMEGGSVNDLILKS---RKLQTKEIIRIAIDVAEGIKFLND-HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE  339 (454)
Q Consensus       264 E~~~~gsL~~~l~~~---~~l~~~~~~~i~~qI~~gL~yLH~-~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~  339 (454)
                      ||+++++|..++...   ..+++..+..++.||+.||.|||+ .+++||||||+||+++.++.+||+|||++......  
T Consensus        79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--  156 (286)
T cd06622          79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS--  156 (286)
T ss_pred             eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC--
Confidence            999999999988653   379999999999999999999997 59999999999999999999999999998654322  


Q ss_pred             cccccCCCCcccccccccCCCC--CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH--HHHcCCCCCCCCCccH
Q 012887          340 ATEYETDGYRWLAPEIIAGDPE--SVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVG--IAACGLRPEIPKDCPQ  415 (454)
Q Consensus       340 ~~~~~~gt~~y~APE~l~~~~~--~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~--i~~~~~~~~~p~~~~~  415 (454)
                      ......+++.|+|||.+.+...  ...++.++|+|||||++|+|++|..||...........  ....+..+.+|..++.
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (286)
T cd06622         157 LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSD  236 (286)
T ss_pred             ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcccCH
Confidence            2333457788999999865432  12345679999999999999999999976554433222  2233455667788999


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 012887          416 ILKSLMIKCWNNSPSKRPQFSEIISLLLRT  445 (454)
Q Consensus       416 ~l~~li~~cl~~dP~~RPs~~ell~~L~~~  445 (454)
                      ++.++|.+||+.+|.+||++.+++.+-+-.
T Consensus       237 ~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~  266 (286)
T cd06622         237 DAQDFVAKCLNKIPNRRPTYAQLLEHPWLV  266 (286)
T ss_pred             HHHHHHHHHcccCcccCCCHHHHhcChhhh
Confidence            999999999999999999999999986643

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=3.3e-39  Score=317.20  Aligned_cols=244  Identities=23%  Similarity=0.301  Sum_probs=207.4

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCC-chHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  262 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV  262 (454)
                      ++|++.+.||+|+||.||++      +.+|+|.+...... ......+.+|+.++.+++||||+++++++.+.+. +++|
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~~v   79 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSN-LYLV   79 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCe-EEEE
Confidence            47899999999999999975      57999988643322 2234567889999999999999999999988776 9999


Q ss_pred             EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCccc
Q 012887          263 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE  342 (454)
Q Consensus       263 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~  342 (454)
                      |||+++++|.+++.+...+++..+..++.||+.||.|||++|++|+||+|+|||++.++.+||+|||++......   ..
T Consensus        80 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~---~~  156 (290)
T cd05580          80 MEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR---TY  156 (290)
T ss_pred             EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC---CC
Confidence            999999999999988889999999999999999999999999999999999999999999999999998765433   33


Q ss_pred             ccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHHHHHH
Q 012887          343 YETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMI  422 (454)
Q Consensus       343 ~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~li~  422 (454)
                      ...+++.|+|||.+.+...    +.++||||||+++|+|++|..||...........+.  .....+|..++..+.+++.
T Consensus       157 ~~~~~~~y~aPE~~~~~~~----~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~  230 (290)
T cd05580         157 TLCGTPEYLAPEIILSKGY----GKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKIL--EGKVRFPSFFSPDAKDLIR  230 (290)
T ss_pred             CCCCCccccChhhhcCCCC----CccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh--cCCccCCccCCHHHHHHHH
Confidence            4467889999999876543    445999999999999999999998877655554444  3345678888999999999


Q ss_pred             HhcccCCCCCC-----CHHHHHHHHH
Q 012887          423 KCWNNSPSKRP-----QFSEIISLLL  443 (454)
Q Consensus       423 ~cl~~dP~~RP-----s~~ell~~L~  443 (454)
                      +||..||.+|+     ++.|++.+-+
T Consensus       231 ~~l~~~p~~R~~~~~~~~~~l~~~~~  256 (290)
T cd05580         231 NLLQVDLTKRLGNLKNGVNDIKNHPW  256 (290)
T ss_pred             HHccCCHHHccCcccCCHHHHHcCcc
Confidence            99999999999     8888887643

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=7.8e-39  Score=306.55  Aligned_cols=241  Identities=25%  Similarity=0.506  Sum_probs=199.1

Q ss_pred             ceeeccCCceEEEe-----EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEEeccCCCC
Q 012887          196 DQIGPNSFKGVYKG-----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGS  270 (454)
Q Consensus       196 ~~LG~G~fG~Vy~g-----~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~E~~~~gs  270 (454)
                      +.||+|+||.||+|     ..+|+|.+... ........+.+|+..+..++||||+++++++...+. .++||||+++++
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~lv~e~~~~~~   78 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKED-LPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQP-IYIVMELVPGGD   78 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCc-CCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCc-cEEEEECCCCCc
Confidence            36899999999996     35888887643 233344568889999999999999999999987776 899999999999


Q ss_pred             HHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCc-ccccCCCC
Q 012887          271 VNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA-TEYETDGY  348 (454)
Q Consensus       271 L~~~l~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~-~~~~~gt~  348 (454)
                      |.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++......... .....+++
T Consensus        79 L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~  158 (250)
T cd05085          79 FLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPI  158 (250)
T ss_pred             HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCcc
Confidence            99998653 46899999999999999999999999999999999999999999999999998654322111 11223456


Q ss_pred             cccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhccc
Q 012887          349 RWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNN  427 (454)
Q Consensus       349 ~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~li~~cl~~  427 (454)
                      .|+|||++.+..    ++.++||||||+++|++++ |..||...........+ ..+.+...+..++..+.+++.+||+.
T Consensus       159 ~y~aPE~~~~~~----~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~  233 (250)
T cd05085         159 KWTAPEALNYGR----YSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQV-EKGYRMSCPQKCPDDVYKVMQRCWDY  233 (250)
T ss_pred             cccCHHHhccCC----CCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH-HcCCCCCCCCCCCHHHHHHHHHHccc
Confidence            799999997654    4456999999999999998 99999887666554444 34556667788999999999999999


Q ss_pred             CCCCCCCHHHHHHHHH
Q 012887          428 SPSKRPQFSEIISLLL  443 (454)
Q Consensus       428 dP~~RPs~~ell~~L~  443 (454)
                      +|.+||++.|+++.|.
T Consensus       234 ~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         234 KPENRPKFSELQKELA  249 (250)
T ss_pred             CcccCCCHHHHHHHhc
Confidence            9999999999998874

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=2.6e-39  Score=315.90  Aligned_cols=250  Identities=23%  Similarity=0.379  Sum_probs=200.8

Q ss_pred             CCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEEEEEEEeC-----C
Q 012887          189 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVDE-----N  256 (454)
Q Consensus       189 ~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~~~g~~~~~-----~  256 (454)
                      .+.|++.+.||.|+||.||+|      +.+|+|.+...   ......+..|+.++..+ +|+||+++++++...     +
T Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~---~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   91 (282)
T cd06636          15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT---EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHD   91 (282)
T ss_pred             hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC---hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCC
Confidence            367788999999999999986      46888887532   22335577888888887 699999999998642     3


Q ss_pred             CeEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCcccc
Q 012887          257 HGLCVVTKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC  334 (454)
Q Consensus       257 ~~l~lV~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~  334 (454)
                      ..++++|||+++|+|.+++...  ..+++..+..++.||+.||.|||+++++|+||+|+||+++.++.++|+|||++...
T Consensus        92 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~  171 (282)
T cd06636          92 DQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL  171 (282)
T ss_pred             CEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhhh
Confidence            3489999999999999998653  36889999999999999999999999999999999999999999999999997755


Q ss_pred             ccCCCcccccCCCCcccccccccCCC-CCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCc
Q 012887          335 KSVGEATEYETDGYRWLAPEIIAGDP-ESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDC  413 (454)
Q Consensus       335 ~~~~~~~~~~~gt~~y~APE~l~~~~-~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~  413 (454)
                      ...........+++.|+|||.+.... ....++.++|||||||++|+|++|..||....+......+.........+..+
T Consensus       172 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (282)
T cd06636         172 DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKSKKW  251 (282)
T ss_pred             hccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCCccccc
Confidence            43322333456788999999986321 12345567999999999999999999998776655554444333333344568


Q ss_pred             cHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012887          414 PQILKSLMIKCWNNSPSKRPQFSEIISL  441 (454)
Q Consensus       414 ~~~l~~li~~cl~~dP~~RPs~~ell~~  441 (454)
                      +.++.++|.+||..||.+||++.||+++
T Consensus       252 ~~~~~~li~~cl~~~p~~Rp~~~ell~~  279 (282)
T cd06636         252 SKKFIDFIEGCLVKNYLSRPSTEQLLKH  279 (282)
T ss_pred             CHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence            9999999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=3.7e-39  Score=312.61  Aligned_cols=234  Identities=23%  Similarity=0.400  Sum_probs=185.8

Q ss_pred             ceeeccCCceEEEeE------------------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCC
Q 012887          196 DQIGPNSFKGVYKGK------------------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH  257 (454)
Q Consensus       196 ~~LG~G~fG~Vy~g~------------------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~  257 (454)
                      +.||+|+||.||+|.                  .+++|.+...  .......+.+|+.++..++||||+++++++..+..
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~   78 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS--HRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVE   78 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh--hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence            368999999999985                  4777776532  22233456788888999999999999999987776


Q ss_pred             eEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCc-------EEEEccC
Q 012887          258 GLCVVTKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGN-------VCLGDMG  329 (454)
Q Consensus       258 ~l~lV~E~~~~gsL~~~l~~-~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~-------vKL~DFG  329 (454)
                       .++||||+++|+|..++.+ ...+++..+..++.||+.||.|||+++|+||||||+|||++.++.       +|++|||
T Consensus        79 -~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g  157 (262)
T cd05077          79 -NIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG  157 (262)
T ss_pred             -CEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence             8899999999999998865 357999999999999999999999999999999999999987764       8999999


Q ss_pred             CccccccCCCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHH-cCCCCCCCCCHHHHHHHHHHcCCCCC
Q 012887          330 IVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMV-TGEAAYAACSPVQAAVGIAACGLRPE  408 (454)
Q Consensus       330 la~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ell-tG~~Pf~~~~~~~~~~~i~~~~~~~~  408 (454)
                      ++.....    .....++..|+|||.+.+..   .++.++|||||||++|||+ .|..||......+.. .....  ...
T Consensus       158 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~---~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-~~~~~--~~~  227 (262)
T cd05077         158 IPITVLS----RQECVERIPWIAPECVEDSK---NLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-RFYEG--QCM  227 (262)
T ss_pred             CCccccC----cccccccccccChhhhcCCC---CCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-HHHhc--Ccc
Confidence            9765432    12235677899999886332   2455699999999999998 589988765543322 22222  122


Q ss_pred             CCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 012887          409 IPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL  442 (454)
Q Consensus       409 ~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L  442 (454)
                      .....+.++.+||.+||+.||.+||++.+|+..|
T Consensus       228 ~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         228 LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence            3334568899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=4.3e-39  Score=316.03  Aligned_cols=244  Identities=17%  Similarity=0.267  Sum_probs=198.7

Q ss_pred             EEEeceeeccCCceEEEe------EEEEEEEeecCCCCc-hHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEEe
Q 012887          192 LEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGN-AYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTK  264 (454)
Q Consensus       192 ~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~E  264 (454)
                      |+..+.||+|+||.||++      +.+|+|.+....... .....+.+|+.++..++|+||+.+++++.+++. +++|||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~-~~lv~e   80 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDA-LCLVLT   80 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCE-EEEEEE
Confidence            677889999999999985      579999986433222 223446789999999999999999999987775 999999


Q ss_pred             ccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCccc
Q 012887          265 LMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE  342 (454)
Q Consensus       265 ~~~~gsL~~~l~~~--~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~  342 (454)
                      |+++++|.+++...  ..+++..+..++.|++.||.|||+++|+||||||+||+++.++.+||+|||++....... ...
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~  159 (285)
T cd05632          81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE-SIR  159 (285)
T ss_pred             eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC-ccc
Confidence            99999999888543  379999999999999999999999999999999999999999999999999986543222 122


Q ss_pred             ccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH--cCCCCCCCCCccHHHHHH
Q 012887          343 YETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAA--CGLRPEIPKDCPQILKSL  420 (454)
Q Consensus       343 ~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~--~~~~~~~p~~~~~~l~~l  420 (454)
                      ...++..|+|||.+.+..+    +.++|+|||||++|+|++|..||.+.........+..  ......++..++.++.+|
T Consensus       160 ~~~g~~~~~aPE~~~~~~~----~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  235 (285)
T cd05632         160 GRVGTVGYMAPEVLNNQRY----TLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSI  235 (285)
T ss_pred             CCCCCcCccChHHhcCCCC----CcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHH
Confidence            3467899999999986654    4459999999999999999999987665433222221  122345667789999999


Q ss_pred             HHHhcccCCCCCCC-----HHHHHHH
Q 012887          421 MIKCWNNSPSKRPQ-----FSEIISL  441 (454)
Q Consensus       421 i~~cl~~dP~~RPs-----~~ell~~  441 (454)
                      +.+||+.||.+||+     +.+++.+
T Consensus       236 i~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05632         236 CKMLLTKDPKQRLGCQEEGAGEVKRH  261 (285)
T ss_pred             HHHHccCCHhHcCCCcccChHHHHcC
Confidence            99999999999999     7788876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=6.9e-39  Score=308.81  Aligned_cols=249  Identities=24%  Similarity=0.436  Sum_probs=206.4

Q ss_pred             CEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEEe
Q 012887          191 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTK  264 (454)
Q Consensus       191 ~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~E  264 (454)
                      +|.+.+.||+|+||.||+|      +.+++|.++...........+..|+.++..++|+||+++++.+.+.+. +++|+|
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~-~~lv~e   79 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREK-VYIFME   79 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCE-EEEEEe
Confidence            4788899999999999996      468999988654443456678899999999999999999999887665 999999


Q ss_pred             ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCccc--
Q 012887          265 LMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE--  342 (454)
Q Consensus       265 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~--  342 (454)
                      |+++++|.+++.+...+++..+..++.|++.||.|||++|++|+||+|+||+++.++.+||+|||++...........  
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~  159 (264)
T cd06626          80 YCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEE  159 (264)
T ss_pred             cCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccccc
Confidence            999999999998777789999999999999999999999999999999999999999999999999876644332211  


Q ss_pred             --ccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCc--cHHHH
Q 012887          343 --YETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDC--PQILK  418 (454)
Q Consensus       343 --~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~--~~~l~  418 (454)
                        ...+++.|+|||++.+.. ....+.++||||||+++|++++|..||...............+..+.+|...  +..+.
T Consensus       160 ~~~~~~~~~~~~PE~~~~~~-~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (264)
T cd06626         160 VQSLAGTPAYMAPEVITGGK-GKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGK  238 (264)
T ss_pred             ccCCcCCcCccChhhccCCC-CCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHHHH
Confidence              245678999999998654 1224567999999999999999999998654333333333335555566654  89999


Q ss_pred             HHHHHhcccCCCCCCCHHHHHHH
Q 012887          419 SLMIKCWNNSPSKRPQFSEIISL  441 (454)
Q Consensus       419 ~li~~cl~~dP~~RPs~~ell~~  441 (454)
                      +++.+||+.+|.+||++.+++.+
T Consensus       239 ~li~~~l~~~p~~R~~~~~i~~~  261 (264)
T cd06626         239 DFLDRCLESDPKKRPTASELLQH  261 (264)
T ss_pred             HHHHHHccCCcccCCCHHHHhcC
Confidence            99999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=3.9e-39  Score=314.89  Aligned_cols=246  Identities=21%  Similarity=0.379  Sum_probs=198.3

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  263 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~  263 (454)
                      ++|++++.||+|+||.||+|      +.+|+|.+... ........+.+|+.++.+++||||+++++.+...+. .++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~lv~   78 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLD-ITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENR-ISICT   78 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecC-CChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCE-EEEEE
Confidence            46788999999999999986      57899988643 233344568889999999999999999999998776 89999


Q ss_pred             eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCcccc
Q 012887          264 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY  343 (454)
Q Consensus       264 E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~  343 (454)
                      ||+++++|..+    ..+++..+..++.|++.||.|||++||+|+||||+|||++.++.++|+|||++......  ....
T Consensus        79 e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~--~~~~  152 (279)
T cd06619          79 EFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS--IAKT  152 (279)
T ss_pred             ecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc--cccC
Confidence            99999999754    35789999999999999999999999999999999999999999999999998755332  2334


Q ss_pred             cCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHH------HHHHHHHHcCCCCCCC-CCccHH
Q 012887          344 ETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPV------QAAVGIAACGLRPEIP-KDCPQI  416 (454)
Q Consensus       344 ~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~------~~~~~i~~~~~~~~~p-~~~~~~  416 (454)
                      ..++..|+|||++.+..+    +.++|+||||+++|+|++|..||......      ............+..+ ...+++
T Consensus       153 ~~~~~~y~aPE~~~~~~~----~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (279)
T cd06619         153 YVGTNAYMAPERISGEQY----GIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEK  228 (279)
T ss_pred             CCCChhhcCceeecCCCC----CCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHH
Confidence            467889999999987644    44699999999999999999999653211      1111122222233332 347889


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 012887          417 LKSLMIKCWNNSPSKRPQFSEIISLLLRTNN  447 (454)
Q Consensus       417 l~~li~~cl~~dP~~RPs~~ell~~L~~~~~  447 (454)
                      +.+++.+||+.+|.+||++.|++++.+-...
T Consensus       229 ~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~  259 (279)
T cd06619         229 FVHFITQCMRKQPKERPAPENLMDHPFIVQY  259 (279)
T ss_pred             HHHHHHHHhhCChhhCCCHHHHhcCcccccc
Confidence            9999999999999999999999998765444

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=9.2e-39  Score=310.50  Aligned_cols=245  Identities=24%  Similarity=0.357  Sum_probs=191.4

Q ss_pred             ceeeccCCceEEEeE--------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEEeccC
Q 012887          196 DQIGPNSFKGVYKGK--------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLME  267 (454)
Q Consensus       196 ~~LG~G~fG~Vy~g~--------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~E~~~  267 (454)
                      ++||+|+||.||+|+        .+++|.+... ........+.+|+..+..++||||+++++.|.+... .++||||++
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~-~~lv~e~~~   78 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKAN-ASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIP-YLLVFEYCE   78 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCC-CChHHHHHHHHHHHHHhccCCcchhheEEEecCCCc-cEEEEecCC
Confidence            369999999999974        2345554432 223345568888888999999999999999987776 899999999


Q ss_pred             CCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCC--cc
Q 012887          268 GGSVNDLILKS----RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE--AT  341 (454)
Q Consensus       268 ~gsL~~~l~~~----~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~--~~  341 (454)
                      +|+|.+++.+.    ..++...+..++.||+.||.|||+++++||||||+|||++.++.+||+|||++........  ..
T Consensus        79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~  158 (268)
T cd05086          79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE  158 (268)
T ss_pred             CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence            99999998653    2467778889999999999999999999999999999999999999999999754322111  12


Q ss_pred             cccCCCCcccccccccCCC---CCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHcC----CCCCCCCCc
Q 012887          342 EYETDGYRWLAPEIIAGDP---ESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACG----LRPEIPKDC  413 (454)
Q Consensus       342 ~~~~gt~~y~APE~l~~~~---~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~i~~~~----~~~~~p~~~  413 (454)
                      ....++..|+|||++....   .....+.++|||||||++|||++ |..||...++.+....+....    .++.++..+
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (268)
T cd05086         159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPY  238 (268)
T ss_pred             cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCC
Confidence            2335678899999985321   12234667999999999999997 678998777766555544332    234455568


Q ss_pred             cHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 012887          414 PQILKSLMIKCWNNSPSKRPQFSEIISLLL  443 (454)
Q Consensus       414 ~~~l~~li~~cl~~dP~~RPs~~ell~~L~  443 (454)
                      ++.+.+++..|| .+|++||++.++++.|.
T Consensus       239 ~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         239 SERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             cHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            899999999999 68999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=8.6e-39  Score=313.93  Aligned_cols=250  Identities=23%  Similarity=0.370  Sum_probs=203.0

Q ss_pred             CCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEEEEEEEeCC----C
Q 012887          189 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVDEN----H  257 (454)
Q Consensus       189 ~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~~~g~~~~~~----~  257 (454)
                      .++|++.+.||+|+||.||++      +.+|+|.+...   ......+.+|+.++.++ +|||++++++++...+    .
T Consensus        21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~---~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~   97 (291)
T cd06639          21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI---SDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGG   97 (291)
T ss_pred             CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccc---ccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCC
Confidence            478999999999999999985      56889988632   22345567888888888 7999999999987543    2


Q ss_pred             eEEEEEeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccc
Q 012887          258 GLCVVTKLMEGGSVNDLILK----SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTA  333 (454)
Q Consensus       258 ~l~lV~E~~~~gsL~~~l~~----~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~  333 (454)
                      ..++||||+++++|.+++..    ...+++..+..++.|++.||+|||+++++||||||+||+++.++.+||+|||++..
T Consensus        98 ~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~  177 (291)
T cd06639          98 QLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQ  177 (291)
T ss_pred             eeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccchh
Confidence            48999999999999998752    35789999999999999999999999999999999999999999999999999876


Q ss_pred             cccCCCcccccCCCCcccccccccCCC-CCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCC-CCCCCC
Q 012887          334 CKSVGEATEYETDGYRWLAPEIIAGDP-ESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGL-RPEIPK  411 (454)
Q Consensus       334 ~~~~~~~~~~~~gt~~y~APE~l~~~~-~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~-~~~~p~  411 (454)
                      ............++..|+|||.+.... ....++.++|||||||++|+|++|..||....+......+..... ....+.
T Consensus       178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  257 (291)
T cd06639         178 LTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLLHPE  257 (291)
T ss_pred             cccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCCCCccc
Confidence            544333333456788899999986542 222356779999999999999999999988776555554443211 122355


Q ss_pred             CccHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012887          412 DCPQILKSLMIKCWNNSPSKRPQFSEIISL  441 (454)
Q Consensus       412 ~~~~~l~~li~~cl~~dP~~RPs~~ell~~  441 (454)
                      ..+..+.++|.+||+.+|++||++.|++.+
T Consensus       258 ~~~~~l~~li~~~l~~~p~~Rps~~~il~~  287 (291)
T cd06639         258 KWCRSFNHFISQCLIKDFEARPSVTHLLEH  287 (291)
T ss_pred             ccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence            678899999999999999999999999976

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-41  Score=342.92  Aligned_cols=254  Identities=21%  Similarity=0.407  Sum_probs=216.7

Q ss_pred             CCCEEEeceeeccCCceEEEeEE------EEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEE
Q 012887          189 SDNLEFIDQIGPNSFKGVYKGKR------VGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  262 (454)
Q Consensus       189 ~~~~~~~~~LG~G~fG~Vy~g~~------vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV  262 (454)
                      .+.++|+..||-|+||.||++..      -|.|.+..  +......++.-||.+|..++||+||++++.|+.++. ++|+
T Consensus        31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIet--kseEELEDylVEIeILa~CdHP~ivkLl~ayy~enk-Lwil  107 (1187)
T KOG0579|consen   31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIET--KSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENK-LWIL  107 (1187)
T ss_pred             HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcc--cchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCc-eEEE
Confidence            35568899999999999999742      34455532  333445568889999999999999999999988887 9999


Q ss_pred             EeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCcc
Q 012887          263 TKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT  341 (454)
Q Consensus       263 ~E~~~~gsL~~~l~~-~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~  341 (454)
                      .|||.||-++..+.. .+.+.+.++..+++|++.||.|||+++|||||||+.|||++-+|.++|+|||++..........
T Consensus       108 iEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkR  187 (1187)
T KOG0579|consen  108 IEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKR  187 (1187)
T ss_pred             EeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHHhhh
Confidence            999999999998865 4589999999999999999999999999999999999999999999999999976555544556


Q ss_pred             cccCCCCcccccccccCCC-CCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCC-CCCCCCccHHHHH
Q 012887          342 EYETDGYRWLAPEIIAGDP-ESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR-PEIPKDCPQILKS  419 (454)
Q Consensus       342 ~~~~gt~~y~APE~l~~~~-~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~-~~~p~~~~~~l~~  419 (454)
                      ....|||-|||||+..... -..+|++++||||||++|.||..+.+|....+++..+..+.....+ +..|..++..+.+
T Consensus       188 DsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F~D  267 (1187)
T KOG0579|consen  188 DSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSFSD  267 (1187)
T ss_pred             ccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhHHHH
Confidence            6778999999999886432 2346788999999999999999999999999999999888765433 2348889999999


Q ss_pred             HHHHhcccCCCCCCCHHHHHHHHHhh
Q 012887          420 LMIKCWNNSPSKRPQFSEIISLLLRT  445 (454)
Q Consensus       420 li~~cl~~dP~~RPs~~ell~~L~~~  445 (454)
                      ++++||.+||..||++.+|++|-+--
T Consensus       268 fLk~cL~Knp~~Rp~aaqll~Hpfv~  293 (1187)
T KOG0579|consen  268 FLKRCLVKNPRNRPPAAQLLKHPFVQ  293 (1187)
T ss_pred             HHHHHHhcCCccCCCHHHHhhCcccc
Confidence            99999999999999999999987644

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=7.1e-39  Score=307.93  Aligned_cols=247  Identities=26%  Similarity=0.516  Sum_probs=203.5

Q ss_pred             cCCCEEEeceeeccCCceEEEe-----EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEE
Q 012887          188 NSDNLEFIDQIGPNSFKGVYKG-----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  262 (454)
Q Consensus       188 ~~~~~~~~~~LG~G~fG~Vy~g-----~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV  262 (454)
                      +..+|++.+.||+|+||.||++     ..+|+|.+.....   ....+.+|+..++.++|||++++++++..... .++|
T Consensus         2 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-~~~v   77 (256)
T cd05112           2 HPSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM---SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSP-ICLV   77 (256)
T ss_pred             ChhHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC---CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCc-eEEE
Confidence            4568899999999999999985     4678888763322   23457789999999999999999999887766 8999


Q ss_pred             EeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCc-
Q 012887          263 TKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA-  340 (454)
Q Consensus       263 ~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~-  340 (454)
                      |||+++++|.+++... ..+++..+..++.|++.||.|||+.+++||||||+||+++.++.+||+|||++......... 
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~  157 (256)
T cd05112          78 FEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS  157 (256)
T ss_pred             EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence            9999999999998654 47899999999999999999999999999999999999999999999999998755332111 


Q ss_pred             ccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHHH
Q 012887          341 TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKS  419 (454)
Q Consensus       341 ~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~  419 (454)
                      ......+..|+|||.+.+..    ++.++||||||+++|||++ |..||...........+. .+.++..|...+..+.+
T Consensus       158 ~~~~~~~~~~~aPe~~~~~~----~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  232 (256)
T cd05112         158 STGTKFPVKWSSPEVFSFSK----YSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETIN-AGFRLYKPRLASQSVYE  232 (256)
T ss_pred             cCCCccchhhcCHhHhccCC----cChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHh-CCCCCCCCCCCCHHHHH
Confidence            11223456899999987654    4456999999999999998 999998766655444443 34455567778999999


Q ss_pred             HHHHhcccCCCCCCCHHHHHHHHH
Q 012887          420 LMIKCWNNSPSKRPQFSEIISLLL  443 (454)
Q Consensus       420 li~~cl~~dP~~RPs~~ell~~L~  443 (454)
                      ++.+||+.+|++||++.++++.|.
T Consensus       233 l~~~~l~~~p~~Rp~~~~~l~~l~  256 (256)
T cd05112         233 LMQHCWKERPEDRPSFSLLLHQLA  256 (256)
T ss_pred             HHHHHcccChhhCCCHHHHHHhhC
Confidence            999999999999999999998873

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.4e-40  Score=309.38  Aligned_cols=253  Identities=20%  Similarity=0.257  Sum_probs=213.5

Q ss_pred             CCEEEeceeeccCCceEEE------eEEEEEEEeecCCC------CchHHHHHHHHHHHHHhC-CCCceeEEEEEEEeCC
Q 012887          190 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDK------GNAYEFELRKDLLELMTC-GHKNILQFYCVCVDEN  256 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~------g~~vavK~l~~~~~------~~~~~~~~~~Ei~~l~~l-~HpnIv~~~g~~~~~~  256 (454)
                      ..|+-.+.||.|..+.|.+      |+..|+|++.....      .........+|+.+|+++ .||||+++.+++.++.
T Consensus        17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s   96 (411)
T KOG0599|consen   17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA   96 (411)
T ss_pred             hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence            4567778899999998886      57889998854321      111334567889999986 7999999999998877


Q ss_pred             CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCcccccc
Q 012887          257 HGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS  336 (454)
Q Consensus       257 ~~l~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~  336 (454)
                      . +++|+|+|+.|.|.|++.+.-.++++....++.|+.+|++|||.++||||||||+|||++++.++||+|||++..+..
T Consensus        97 F-~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~  175 (411)
T KOG0599|consen   97 F-VFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLEP  175 (411)
T ss_pred             h-hhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccCC
Confidence            6 899999999999999998877999999999999999999999999999999999999999999999999999988754


Q ss_pred             CCCcccccCCCCcccccccccCC--CCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCC--CCC
Q 012887          337 VGEATEYETDGYRWLAPEIIAGD--PESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEI--PKD  412 (454)
Q Consensus       337 ~~~~~~~~~gt~~y~APE~l~~~--~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~--p~~  412 (454)
                      . ......+|||+|+|||.+...  ...+.|+...|.||+||+||.|+.|.+||.-....-.+.-|..+++...-  ..+
T Consensus       176 G-ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speWad  254 (411)
T KOG0599|consen  176 G-EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEWAD  254 (411)
T ss_pred             c-hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcchhh
Confidence            3 445667999999999988643  23445677899999999999999999999876666666667666655443  357


Q ss_pred             ccHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 012887          413 CPQILKSLMIKCWNNSPSKRPQFSEIISLLLR  444 (454)
Q Consensus       413 ~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~  444 (454)
                      ++..+++||.+||+.||.+|.|++|.++|-+-
T Consensus       255 is~~~KdLIsrlLqVdp~~Ritake~LaHpff  286 (411)
T KOG0599|consen  255 ISATVKDLISRLLQVDPTKRITAKEALAHPFF  286 (411)
T ss_pred             ccccHHHHHHHHHeeCchhcccHHHHhcChHH
Confidence            89999999999999999999999999988654

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=4.7e-39  Score=313.28  Aligned_cols=252  Identities=24%  Similarity=0.460  Sum_probs=205.2

Q ss_pred             CCCEEEeceeeccCCceEEEeE----------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCC-C
Q 012887          189 SDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN-H  257 (454)
Q Consensus       189 ~~~~~~~~~LG~G~fG~Vy~g~----------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~-~  257 (454)
                      .++|++.+.||+|+||.||++.          .+|+|.+...... .....+.+|+..++.+.||||+++++++...+ .
T Consensus         3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~   81 (284)
T cd05038           3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR   81 (284)
T ss_pred             hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence            4678899999999999999864          6899998754333 34567889999999999999999999987632 2


Q ss_pred             eEEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCcccccc
Q 012887          258 GLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS  336 (454)
Q Consensus       258 ~l~lV~E~~~~gsL~~~l~~~~-~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~  336 (454)
                      ..++||||+++++|.+++.+.. .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.....
T Consensus        82 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  161 (284)
T cd05038          82 SLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPE  161 (284)
T ss_pred             ceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccccccccc
Confidence            3899999999999999996654 699999999999999999999999999999999999999999999999999876653


Q ss_pred             CCCc---ccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCH--------------HHHHHH
Q 012887          337 VGEA---TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSP--------------VQAAVG  399 (454)
Q Consensus       337 ~~~~---~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~--------------~~~~~~  399 (454)
                      ....   .....++..|+|||.+.+..    ++.++||||||+++|||++|..|+.....              ......
T Consensus       162 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~----~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd05038         162 DKDYYYVKEPGESPIFWYAPECLRTSK----FSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE  237 (284)
T ss_pred             CCcceeccCCCCCcccccCcHHHccCC----CCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHH
Confidence            2211   11123445699999987664    34459999999999999999999865322              122233


Q ss_pred             HHHcCCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 012887          400 IAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRT  445 (454)
Q Consensus       400 i~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~  445 (454)
                      ......+.+.+..++.++.+++.+||..+|.+||++.|+++.|.++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         238 LLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             HHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            4444555556777899999999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=3.3e-39  Score=309.62  Aligned_cols=244  Identities=22%  Similarity=0.402  Sum_probs=203.7

Q ss_pred             CCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEE
Q 012887          189 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  262 (454)
Q Consensus       189 ~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV  262 (454)
                      .++|++.+.||+|+||.||+|      +.+++|.+....    ....+.+|+..++.++||||+++++.+.+... +|++
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~-~~l~   76 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE----DLQEIIKEISILKQCDSPYIVKYYGSYFKNTD-LWIV   76 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH----HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCc-EEEE
Confidence            478999999999999999986      468888886322    14578899999999999999999999998876 9999


Q ss_pred             EeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCcc
Q 012887          263 TKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT  341 (454)
Q Consensus       263 ~E~~~~gsL~~~l~~-~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~  341 (454)
                      +||+++++|.+++.. ...+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++..........
T Consensus        77 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~  156 (256)
T cd06612          77 MEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKR  156 (256)
T ss_pred             EecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCcccc
Confidence            999999999999965 4578999999999999999999999999999999999999999999999999987665443333


Q ss_pred             cccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcC-CCCCCCCCccHHHHHH
Q 012887          342 EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG-LRPEIPKDCPQILKSL  420 (454)
Q Consensus       342 ~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~-~~~~~p~~~~~~l~~l  420 (454)
                      ....++..|+|||++.+..    .+.++||||||+++|+|++|..||....+......+.... .....+..++.++.++
T Consensus       157 ~~~~~~~~y~~PE~~~~~~----~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (256)
T cd06612         157 NTVIGTPFWMAPEVIQEIG----YNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDF  232 (256)
T ss_pred             ccccCCccccCHHHHhcCC----CCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHH
Confidence            4455788899999987664    4456999999999999999999998766654443332211 1122345678899999


Q ss_pred             HHHhcccCCCCCCCHHHHHHH
Q 012887          421 MIKCWNNSPSKRPQFSEIISL  441 (454)
Q Consensus       421 i~~cl~~dP~~RPs~~ell~~  441 (454)
                      |.+||+.||++||++++++.+
T Consensus       233 i~~~l~~~P~~Rps~~~il~~  253 (256)
T cd06612         233 VKKCLVKDPEERPSAIQLLQH  253 (256)
T ss_pred             HHHHHhcChhhCcCHHHHhcC
Confidence            999999999999999999875

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=6.9e-39  Score=307.44  Aligned_cols=245  Identities=25%  Similarity=0.433  Sum_probs=207.3

Q ss_pred             EEEeceeeccCCceEEEe------EEEEEEEeecCCCC---chHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEE
Q 012887          192 LEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG---NAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  262 (454)
Q Consensus       192 ~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV  262 (454)
                      |+..+.||+|+||.||+|      +.+++|.+......   ......+.+|+..+..++|+||+++++++.+.+. +++|
T Consensus         2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~-~~lv   80 (258)
T cd06632           2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDN-LYIF   80 (258)
T ss_pred             ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCe-EEEE
Confidence            566788999999999985      47899988643322   2244568899999999999999999999987765 9999


Q ss_pred             EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCccc
Q 012887          263 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE  342 (454)
Q Consensus       263 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~  342 (454)
                      |||+++++|.+++.+...+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.+||+|||++....... ...
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~-~~~  159 (258)
T cd06632          81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS-FAK  159 (258)
T ss_pred             EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc-ccc
Confidence            9999999999999877789999999999999999999999999999999999999999999999999987654432 233


Q ss_pred             ccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHHHHHH
Q 012887          343 YETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMI  422 (454)
Q Consensus       343 ~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~li~  422 (454)
                      ...+++.|+|||.+....   .++.++|+||||+++|+|++|..||....+......+......+.+|..+++++.+++.
T Consensus       160 ~~~~~~~y~~pe~~~~~~---~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  236 (258)
T cd06632         160 SFKGSPYWMAPEVIAQQG---GYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFIL  236 (258)
T ss_pred             ccCCCcceeCHHHhcCCC---CCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHH
Confidence            445788899999987543   24556999999999999999999998877666655555545566678889999999999


Q ss_pred             HhcccCCCCCCCHHHHHHH
Q 012887          423 KCWNNSPSKRPQFSEIISL  441 (454)
Q Consensus       423 ~cl~~dP~~RPs~~ell~~  441 (454)
                      +||..+|++||++.+++.+
T Consensus       237 ~~l~~~p~~Rp~~~~~l~~  255 (258)
T cd06632         237 KCLQRDPSLRPTAAELLEH  255 (258)
T ss_pred             HHhhcCcccCcCHHHHhcC
Confidence            9999999999999999875

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=6.9e-39  Score=312.53  Aligned_cols=253  Identities=21%  Similarity=0.371  Sum_probs=199.4

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHH-HHhCCCCceeEEEEEEEeCCCeEEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLE-LMTCGHKNILQFYCVCVDENHGLCVV  262 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~-l~~l~HpnIv~~~g~~~~~~~~l~lV  262 (454)
                      ++|++.+.||+|+||.||++      +.||+|.++.... ...+..+..|+.. ++.++||||+++++++...+. +++|
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~-~~lv   78 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVN-SQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGD-VWIC   78 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCC-cHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCc-EEEE
Confidence            47899999999999999985      5799999874322 2233455556665 455689999999999987776 9999


Q ss_pred             EeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhc-CcccCCccCCcEEEccCCcEEEEccCCccccccC
Q 012887          263 TKLMEGGSVNDLILK----SRKLQTKEIIRIAIDVAEGIKFLNDH-GVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV  337 (454)
Q Consensus       263 ~E~~~~gsL~~~l~~----~~~l~~~~~~~i~~qI~~gL~yLH~~-~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~  337 (454)
                      |||++ |+|.+++..    ...+++..+..++.||+.||.|||++ +++||||||+|||++.++.+||+|||++......
T Consensus        79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  157 (283)
T cd06617          79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS  157 (283)
T ss_pred             hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence            99997 588888743    23789999999999999999999998 9999999999999999999999999998765332


Q ss_pred             CCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC-HHHHHHHHHHcCCCCCCC-CCccH
Q 012887          338 GEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACS-PVQAAVGIAACGLRPEIP-KDCPQ  415 (454)
Q Consensus       338 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~-~~~~~~~i~~~~~~~~~p-~~~~~  415 (454)
                      . ......++..|+|||.+.+......++.++|+|||||++|+|++|..||.... ..+...... .+..+.+| ..+|.
T Consensus       158 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  235 (283)
T cd06617         158 V-AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVV-EEPSPQLPAEKFSP  235 (283)
T ss_pred             c-ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHH-hcCCCCCCccccCH
Confidence            1 22334578889999998764433345667999999999999999999997533 233333333 33444444 35789


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 012887          416 ILKSLMIKCWNNSPSKRPQFSEIISLLLRTNN  447 (454)
Q Consensus       416 ~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~  447 (454)
                      ++.++|.+||..+|.+||++.+++++-+-...
T Consensus       236 ~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  267 (283)
T cd06617         236 EFQDFVNKCLKKNYKERPNYPELLQHPFFELH  267 (283)
T ss_pred             HHHHHHHHHccCChhhCcCHHHHhcCchhhhc
Confidence            99999999999999999999999987655444

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.4e-41  Score=338.12  Aligned_cols=248  Identities=23%  Similarity=0.322  Sum_probs=212.7

Q ss_pred             EEEeceeeccCCceEEEe------EEEEEEEeecCCCCch-HHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEEe
Q 012887          192 LEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNA-YEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTK  264 (454)
Q Consensus       192 ~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~-~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~E  264 (454)
                      |.-++.||.|+||.||-+      ..||||++....+... .-.++.+|+..|.+++|||+|.|.|+|..+.. .|+|||
T Consensus        28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~T-aWLVME  106 (948)
T KOG0577|consen   28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHT-AWLVME  106 (948)
T ss_pred             HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccch-HHHHHH
Confidence            555789999999999986      4799999976655444 44569999999999999999999999887665 899999


Q ss_pred             ccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCcccc
Q 012887          265 LMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY  343 (454)
Q Consensus       265 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~  343 (454)
                      ||-| |-.|++.- .+++.+..+..|+.+.+.||.|||+++.||||||+.|||+++.|.|||+|||.|....+    ...
T Consensus       107 YClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P----Ans  181 (948)
T KOG0577|consen  107 YCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP----ANS  181 (948)
T ss_pred             HHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCc----hhc
Confidence            9965 98888854 35899999999999999999999999999999999999999999999999999776543    456


Q ss_pred             cCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHHHHHHH
Q 012887          344 ETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIK  423 (454)
Q Consensus       344 ~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~li~~  423 (454)
                      ..|||-|||||++...... .|+-++||||||++..||.-.++|+.+.+.+..+.-|..+..+--....++..+..++..
T Consensus       182 FvGTPywMAPEVILAMDEG-qYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~Fvd~  260 (948)
T KOG0577|consen  182 FVGTPYWMAPEVILAMDEG-QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDS  260 (948)
T ss_pred             ccCCccccchhHheecccc-ccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHHHHH
Confidence            7899999999999865443 366679999999999999999999999999999888887544433345689999999999


Q ss_pred             hcccCCCCCCCHHHHHHHHHhhc
Q 012887          424 CWNNSPSKRPQFSEIISLLLRTN  446 (454)
Q Consensus       424 cl~~dP~~RPs~~ell~~L~~~~  446 (454)
                      ||++-|.+|||..+++.|---..
T Consensus       261 CLqKipqeRptse~ll~H~fv~R  283 (948)
T KOG0577|consen  261 CLQKIPQERPTSEELLKHRFVLR  283 (948)
T ss_pred             HHhhCcccCCcHHHHhhcchhcc
Confidence            99999999999999998754333

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=8.7e-39  Score=309.92  Aligned_cols=251  Identities=22%  Similarity=0.409  Sum_probs=201.6

Q ss_pred             ecCCCEEEeceeeccCCceEEEeE------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEE
Q 012887          187 LNSDNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLC  260 (454)
Q Consensus       187 ~~~~~~~~~~~LG~G~fG~Vy~g~------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~  260 (454)
                      ++.+.+.....||+|+||.||+|.      .+++|.+...  .......+.+|+.++..++|+||+++++++...+. .+
T Consensus         5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~   81 (268)
T cd06624           5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPER--DSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGF-FK   81 (268)
T ss_pred             cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCC--CHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCE-EE
Confidence            334455556689999999999974      5888887632  22334567899999999999999999999988775 99


Q ss_pred             EEEeccCCCCHHHHHHhC-CCC--CHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEcc-CCcEEEEccCCcccccc
Q 012887          261 VVTKLMEGGSVNDLILKS-RKL--QTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDR-HGNVCLGDMGIVTACKS  336 (454)
Q Consensus       261 lV~E~~~~gsL~~~l~~~-~~l--~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~-~~~vKL~DFGla~~~~~  336 (454)
                      +|+||+++++|.+++... ..+  ++..+..++.||+.||.|||++||+||||||+||+++. ++.++|+|||++.....
T Consensus        82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~  161 (268)
T cd06624          82 IFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG  161 (268)
T ss_pred             EEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheeccc
Confidence            999999999999998654 455  88899999999999999999999999999999999986 67899999999876544


Q ss_pred             CCCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHHHcCCCCCCCCCccH
Q 012887          337 VGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPV-QAAVGIAACGLRPEIPKDCPQ  415 (454)
Q Consensus       337 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~-~~~~~i~~~~~~~~~p~~~~~  415 (454)
                      .........+++.|+|||.+.+...  .++.++||||||+++|+|++|..||...... ............+.+|..+++
T Consensus       162 ~~~~~~~~~~~~~~~aPE~~~~~~~--~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (268)
T cd06624         162 INPCTETFTGTLQYMAPEVIDKGPR--GYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSA  239 (268)
T ss_pred             CCCccccCCCCccccChhhhccccc--cCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCH
Confidence            3333334467889999999865432  2445799999999999999999999764332 222223333445667888999


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHHHH
Q 012887          416 ILKSLMIKCWNNSPSKRPQFSEIISLL  442 (454)
Q Consensus       416 ~l~~li~~cl~~dP~~RPs~~ell~~L  442 (454)
                      ++.+++.+||+.+|.+||++.+++.+-
T Consensus       240 ~~~~li~~~l~~~p~~Rpt~~~ll~~~  266 (268)
T cd06624         240 EAKNFILRCFEPDPDKRASAHDLLQDP  266 (268)
T ss_pred             HHHHHHHHHcCCCchhCCCHHHHHhCC
Confidence            999999999999999999999998763

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=3.6e-39  Score=322.87  Aligned_cols=247  Identities=20%  Similarity=0.324  Sum_probs=193.2

Q ss_pred             Eeceeecc--CCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEEec
Q 012887          194 FIDQIGPN--SFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKL  265 (454)
Q Consensus       194 ~~~~LG~G--~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~E~  265 (454)
                      +++.||+|  +||+||++      +.||+|.+............+.+|+.+++.++||||+++++++..++. +++||||
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~-~~lv~e~   80 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNE-LWVVTSF   80 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCE-EEEEEec
Confidence            46789999  67899985      579999987544444455567889999999999999999999998876 9999999


Q ss_pred             cCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCC----
Q 012887          266 MEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE----  339 (454)
Q Consensus       266 ~~~gsL~~~l~~~--~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~----  339 (454)
                      +++|+|.+++...  ..+++..+..++.||+.||.|||+++|+||||||+|||++.++.++++|||.+........    
T Consensus        81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~  160 (327)
T cd08227          81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRV  160 (327)
T ss_pred             cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccccc
Confidence            9999999998643  4689999999999999999999999999999999999999999999999986443322111    


Q ss_pred             ---cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCC----------
Q 012887          340 ---ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR----------  406 (454)
Q Consensus       340 ---~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~----------  406 (454)
                         ...+..++..|+|||++.+..  ..++.++|||||||++|||++|..||.................+          
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (327)
T cd08227         161 VHDFPKYSVKVLPWLSPEVLQQNL--QGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPA  238 (327)
T ss_pred             cccccccccceecccChHHhhccc--CCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhh
Confidence               112234567799999997532  12456799999999999999999999865544333222211100          


Q ss_pred             ----------------------------------CCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 012887          407 ----------------------------------PEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLL  443 (454)
Q Consensus       407 ----------------------------------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~  443 (454)
                                                        .+....+++.+.+++.+||+.||++|||+.|++++-+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~  309 (327)
T cd08227         239 EELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSF  309 (327)
T ss_pred             hhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChh
Confidence                                              0011235678999999999999999999999998754

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=1.2e-38  Score=306.86  Aligned_cols=247  Identities=21%  Similarity=0.429  Sum_probs=208.8

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  263 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~  263 (454)
                      ++|++.+.||+|+||.||++      +.+++|.+...... .....+.+|+..+..++|+||+++++++...+. +++||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-~~lv~   78 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGE-ISIVL   78 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCe-EEEEE
Confidence            46889999999999999985      56899988754332 455678899999999999999999999988765 99999


Q ss_pred             eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-cCcccCCccCCcEEEccCCcEEEEccCCccccccCCCccc
Q 012887          264 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLND-HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE  342 (454)
Q Consensus       264 E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~-~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~  342 (454)
                      ||+++++|.+++.....+++..+..++.|++.||.|||+ .+++||||+|+||+++.++.++|+|||++...........
T Consensus        79 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~  158 (264)
T cd06623          79 EYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCN  158 (264)
T ss_pred             EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCccc
Confidence            999999999999877889999999999999999999999 9999999999999999999999999999877654443333


Q ss_pred             ccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC--HHHHHHHHHHcCCCCCCCCC-ccHHHHH
Q 012887          343 YETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACS--PVQAAVGIAACGLRPEIPKD-CPQILKS  419 (454)
Q Consensus       343 ~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~--~~~~~~~i~~~~~~~~~p~~-~~~~l~~  419 (454)
                      ...++..|+|||.+.+..    ++.++|+||||+++|+|++|..||....  ..............+..+.. ++..+.+
T Consensus       159 ~~~~~~~y~~pE~~~~~~----~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  234 (264)
T cd06623         159 TFVGTVTYMSPERIQGES----YSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRD  234 (264)
T ss_pred             ceeecccccCHhhhCCCC----CCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHH
Confidence            456788899999987664    4456999999999999999999998764  33333333334455566666 8999999


Q ss_pred             HHHHhcccCCCCCCCHHHHHHHH
Q 012887          420 LMIKCWNNSPSKRPQFSEIISLL  442 (454)
Q Consensus       420 li~~cl~~dP~~RPs~~ell~~L  442 (454)
                      ++.+||..+|++||++.+++++=
T Consensus       235 li~~~l~~~p~~R~~~~~ll~~~  257 (264)
T cd06623         235 FISACLQKDPKKRPSAAELLQHP  257 (264)
T ss_pred             HHHHHccCChhhCCCHHHHHhCH
Confidence            99999999999999999999873

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1.4e-39  Score=317.77  Aligned_cols=247  Identities=17%  Similarity=0.260  Sum_probs=194.5

Q ss_pred             CEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEEe
Q 012887          191 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTK  264 (454)
Q Consensus       191 ~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~E  264 (454)
                      +|++.+.||+|+||.||++      +.+|+|.++...........+.+|+..+..++||||+++++++.+.+. +++|+|
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~-~~lv~e   79 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKK-LTLVFE   79 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCc-eEEEEe
Confidence            4788999999999999985      578999987543333334557789999999999999999999987776 999999


Q ss_pred             ccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCcccc
Q 012887          265 LMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY  343 (454)
Q Consensus       265 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~  343 (454)
                      |+++ +|.+++.+ ...+++..+..++.||+.||.|||+++++||||||+||+++.++.+||+|||++............
T Consensus        80 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~  158 (284)
T cd07839          80 YCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSA  158 (284)
T ss_pred             cCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcCC
Confidence            9975 88887754 457999999999999999999999999999999999999999999999999998765433322333


Q ss_pred             cCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHHHcC------------------
Q 012887          344 ETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAA-CSPVQAAVGIAACG------------------  404 (454)
Q Consensus       344 ~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~-~~~~~~~~~i~~~~------------------  404 (454)
                      ..+++.|+|||.+.+..   .++.++|||||||++|+|++|..||.. .+.......+....                  
T Consensus       159 ~~~~~~y~aPE~~~~~~---~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (284)
T cd07839         159 EVVTLWYRPPDVLFGAK---LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYK  235 (284)
T ss_pred             CccccCCcChHHHhCCc---ccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccccc
Confidence            45678899999987643   245569999999999999998888643 33333222221100                  


Q ss_pred             CCC---------CCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 012887          405 LRP---------EIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL  442 (454)
Q Consensus       405 ~~~---------~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L  442 (454)
                      ..+         .....+++++.++|.+||+.||.+|||+.+++.+-
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~  282 (284)
T cd07839         236 PYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHP  282 (284)
T ss_pred             ccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCC
Confidence            000         01124678999999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.1e-39  Score=316.24  Aligned_cols=249  Identities=22%  Similarity=0.397  Sum_probs=203.9

Q ss_pred             cCCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEE
Q 012887          188 NSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCV  261 (454)
Q Consensus       188 ~~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~l  261 (454)
                      +.++|++++.||+|+||.||++      +.+|+|.+... ........+.+|+.++..++||||+++++.+...+. +++
T Consensus         3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~-~~l   80 (284)
T cd06620           3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIG-AKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENN-ICM   80 (284)
T ss_pred             cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEec-CcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCE-EEE
Confidence            4578899999999999999984      56889887643 223445678899999999999999999999998875 999


Q ss_pred             EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-cCcccCCccCCcEEEccCCcEEEEccCCccccccCCCc
Q 012887          262 VTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLND-HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA  340 (454)
Q Consensus       262 V~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~-~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~  340 (454)
                      ||||+++++|.+++.+.+.+++..+..++.+++.||.|||+ ++++||||+|+||+++.++.++|+|||++......  .
T Consensus        81 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~--~  158 (284)
T cd06620          81 CMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS--I  158 (284)
T ss_pred             EEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh--c
Confidence            99999999999999877789999999999999999999997 69999999999999999999999999997654322  1


Q ss_pred             ccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHH-----------HHHHHHHHcCCCCCC
Q 012887          341 TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPV-----------QAAVGIAACGLRPEI  409 (454)
Q Consensus       341 ~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~-----------~~~~~i~~~~~~~~~  409 (454)
                      .....++..|+|||++.+..    .+.++|+|||||++|+|++|..||......           .....+.. ..++.+
T Consensus       159 ~~~~~~~~~~~aPE~~~~~~----~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  233 (284)
T cd06620         159 ADTFVGTSTYMSPERIQGGK----YTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQ-EPPPRL  233 (284)
T ss_pred             cCccccCcccCCHHHHccCC----CCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhh-ccCCCC
Confidence            23346788999999987654    344699999999999999999999865442           11222222 223334


Q ss_pred             CCC-ccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 012887          410 PKD-CPQILKSLMIKCWNNSPSKRPQFSEIISLLLRT  445 (454)
Q Consensus       410 p~~-~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~  445 (454)
                      +.. ++.++.+++.+||..||++||++.|++++.+-.
T Consensus       234 ~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~  270 (284)
T cd06620         234 PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFI  270 (284)
T ss_pred             CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccc
Confidence            443 888999999999999999999999999875443

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=2.7e-39  Score=315.87  Aligned_cols=248  Identities=22%  Similarity=0.367  Sum_probs=200.8

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  263 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~  263 (454)
                      ++|++.+.||+|+||.||+|      +.+|+|.+............+.+|+.++..++||||+++++++.+++. .++||
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~lv~   79 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKR-LYLVF   79 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCe-EEEEE
Confidence            46899999999999999995      468999876543333344567789999999999999999999987765 99999


Q ss_pred             eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCcccc
Q 012887          264 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY  343 (454)
Q Consensus       264 E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~  343 (454)
                      ||+++++|.++......+++..+..++.||+.||.|||+.+++|+||+|+||++++++.++|+|||++............
T Consensus        80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~  159 (286)
T cd07846          80 EFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTD  159 (286)
T ss_pred             ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccccCc
Confidence            99999999888766667999999999999999999999999999999999999999999999999998765443333333


Q ss_pred             cCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcC-------------------
Q 012887          344 ETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG-------------------  404 (454)
Q Consensus       344 ~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~-------------------  404 (454)
                      ..++..|+|||++.+..   .++.++||||||+++|||++|.+||...........+....                   
T Consensus       160 ~~~~~~y~aPE~~~~~~---~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (286)
T cd07846         160 YVATRWYRAPELLVGDT---KYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAG  236 (286)
T ss_pred             ccceeeccCcHHhcccc---ccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhc
Confidence            45778899999987532   24557999999999999999999998766544333322100                   


Q ss_pred             CC-C---------CCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012887          405 LR-P---------EIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISL  441 (454)
Q Consensus       405 ~~-~---------~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  441 (454)
                      .. +         ..+..++..+.+++.+||+.+|++||++.+++.+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  283 (286)
T cd07846         237 MRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH  283 (286)
T ss_pred             cccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence            00 0         0123568889999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.1e-39  Score=309.50  Aligned_cols=250  Identities=26%  Similarity=0.425  Sum_probs=203.2

Q ss_pred             CCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEEEEEEEeCC-----
Q 012887          189 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVDEN-----  256 (454)
Q Consensus       189 ~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~~~g~~~~~~-----  256 (454)
                      .++|++.+.||+|+||.||+|      +.+++|.+....   .....+.+|+.+++++ .|+||+++++++.+..     
T Consensus         5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (275)
T cd06608           5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE---DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND   81 (275)
T ss_pred             hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence            478999999999999999986      468888876332   2345678999999998 6999999999997543     


Q ss_pred             CeEEEEEeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCcc
Q 012887          257 HGLCVVTKLMEGGSVNDLILK----SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVT  332 (454)
Q Consensus       257 ~~l~lV~E~~~~gsL~~~l~~----~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~  332 (454)
                      ..+++||||+++++|.+++..    ...+++..+..++.|++.||.|||+++++|+||+|+||+++.++.+||+|||++.
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~  161 (275)
T cd06608          82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSA  161 (275)
T ss_pred             eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccce
Confidence            238999999999999999854    3479999999999999999999999999999999999999999999999999987


Q ss_pred             ccccCCCcccccCCCCcccccccccCCCC-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCC-CCCC
Q 012887          333 ACKSVGEATEYETDGYRWLAPEIIAGDPE-SVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR-PEIP  410 (454)
Q Consensus       333 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~-~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~-~~~p  410 (454)
                      .............++..|+|||.+..... ...++.++|||||||++|+|++|..||....+......+...... ...+
T Consensus       162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  241 (275)
T cd06608         162 QLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTLKSP  241 (275)
T ss_pred             ecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCCCCch
Confidence            65443333444567888999999865422 234566799999999999999999999876665555554433221 1223


Q ss_pred             CCccHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012887          411 KDCPQILKSLMIKCWNNSPSKRPQFSEIISL  441 (454)
Q Consensus       411 ~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  441 (454)
                      ..++.++.++|.+||..||++|||+.+++++
T Consensus       242 ~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~  272 (275)
T cd06608         242 ENWSKKFNDFISECLIKNYEQRPFMEELLEH  272 (275)
T ss_pred             hhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence            4478899999999999999999999999875

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=1.1e-38  Score=311.26  Aligned_cols=250  Identities=21%  Similarity=0.400  Sum_probs=208.1

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  263 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~  263 (454)
                      ..|+.++.||.|+||.||+|      ..+|+|.+.... .......+.+|+..+..++||||+++++++.+.+. .++||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~lv~   81 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTK-LWIIM   81 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCE-EEEEE
Confidence            45678899999999999986      468999886432 23344568889999999999999999999988765 99999


Q ss_pred             eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCcccc
Q 012887          264 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY  343 (454)
Q Consensus       264 E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~  343 (454)
                      ||+++++|.+++.. .++++..+..++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||++............
T Consensus        82 e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~  160 (277)
T cd06640          82 EYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT  160 (277)
T ss_pred             ecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcccccc
Confidence            99999999999854 57899999999999999999999999999999999999999999999999998765443333334


Q ss_pred             cCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHHHHHHH
Q 012887          344 ETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIK  423 (454)
Q Consensus       344 ~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~li~~  423 (454)
                      ..++..|+|||.+.+..    .+.++|+|||||++|||++|..||....+......+ ....++.++..++..+.+++.+
T Consensus       161 ~~~~~~y~apE~~~~~~----~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~  235 (277)
T cd06640         161 FVGTPFWMAPEVIQQSA----YDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI-PKNNPPTLTGEFSKPFKEFIDA  235 (277)
T ss_pred             ccCcccccCHhHhccCC----CccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhh-hcCCCCCCchhhhHHHHHHHHH
Confidence            45778899999987654    445699999999999999999999887765544433 3344556677789999999999


Q ss_pred             hcccCCCCCCCHHHHHHHHHhhcC
Q 012887          424 CWNNSPSKRPQFSEIISLLLRTNN  447 (454)
Q Consensus       424 cl~~dP~~RPs~~ell~~L~~~~~  447 (454)
                      ||+.+|.+||++.+++.+-+-...
T Consensus       236 ~l~~~p~~Rp~~~~il~~~~~~~~  259 (277)
T cd06640         236 CLNKDPSFRPTAKELLKHKFIVKN  259 (277)
T ss_pred             HcccCcccCcCHHHHHhChHhhhc
Confidence            999999999999999988665443

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-41  Score=314.62  Aligned_cols=252  Identities=23%  Similarity=0.397  Sum_probs=211.8

Q ss_pred             ceeecCCCEEEeceeeccCCceEEE------eEEEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEEEEEEEeCC
Q 012887          184 RWLLNSDNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVDEN  256 (454)
Q Consensus       184 ~~~~~~~~~~~~~~LG~G~fG~Vy~------g~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~~~g~~~~~~  256 (454)
                      -|.++.++++-+..||.|+||+|++      |+.+|||+++.... .....++.+|....++- +.||||++||++..++
T Consensus        58 ~~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~-~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EG  136 (361)
T KOG1006|consen   58 LHTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI-EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEG  136 (361)
T ss_pred             ccccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc-hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCC
Confidence            4678888999999999999999997      89999999985433 45667788888877664 6899999999999888


Q ss_pred             CeEEEEEeccCCCCHHHHHH-----hCCCCCHHHHHHHHHHHHHHHHHHHh-cCcccCCccCCcEEEccCCcEEEEccCC
Q 012887          257 HGLCVVTKLMEGGSVNDLIL-----KSRKLQTKEIIRIAIDVAEGIKFLND-HGVAYRDLNSQRILLDRHGNVCLGDMGI  330 (454)
Q Consensus       257 ~~l~lV~E~~~~gsL~~~l~-----~~~~l~~~~~~~i~~qI~~gL~yLH~-~~iiHrDIKp~NILl~~~~~vKL~DFGl  330 (454)
                      . .||.||+|+- ||+.+.+     +...+++..+..+..-.+.||.||-+ .+|||||+||+|||++..|.|||||||+
T Consensus       137 d-cWiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGI  214 (361)
T KOG1006|consen  137 D-CWICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGI  214 (361)
T ss_pred             c-eeeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccc
Confidence            7 8899999965 8876653     34589999999999999999999964 6899999999999999999999999999


Q ss_pred             ccccccCCCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCC-
Q 012887          331 VTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEI-  409 (454)
Q Consensus       331 a~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~-  409 (454)
                      +..+.+ +...+...|...|||||.+.....  .++.+|||||||++|||+.||.+||..++........+..+.+|.+ 
T Consensus       215 cGqLv~-SiAkT~daGCrpYmAPERi~p~~~--gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~  291 (361)
T KOG1006|consen  215 CGQLVD-SIAKTVDAGCRPYMAPERIDPSDK--GYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILL  291 (361)
T ss_pred             hHhHHH-HHHhhhccCCccccChhccCCccC--CcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeec
Confidence            876543 234556678888999999986643  4778899999999999999999999998876655556666666544 


Q ss_pred             -CC---CccHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012887          410 -PK---DCPQILKSLMIKCWNNSPSKRPQFSEIISL  441 (454)
Q Consensus       410 -p~---~~~~~l~~li~~cl~~dP~~RPs~~ell~~  441 (454)
                       +.   .++..+..+|..||.+|-++||.+.+++++
T Consensus       292 ~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  292 FDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             CcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence             22   378999999999999999999999998764

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=9.8e-39  Score=351.68  Aligned_cols=251  Identities=18%  Similarity=0.262  Sum_probs=203.0

Q ss_pred             CCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCC-CeEEE
Q 012887          189 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN-HGLCV  261 (454)
Q Consensus       189 ~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~-~~l~l  261 (454)
                      .++|++++.||+|+||.||++      ..+|+|.+............+..|+.++..++|||||+++++|.+.. ..+||
T Consensus        12 l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyI   91 (1021)
T PTZ00266         12 LNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYI   91 (1021)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEE
Confidence            378999999999999999986      46889988755444445567889999999999999999999987553 45899


Q ss_pred             EEeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhc-------CcccCCccCCcEEEccC----------
Q 012887          262 VTKLMEGGSVNDLILK----SRKLQTKEIIRIAIDVAEGIKFLNDH-------GVAYRDLNSQRILLDRH----------  320 (454)
Q Consensus       262 V~E~~~~gsL~~~l~~----~~~l~~~~~~~i~~qI~~gL~yLH~~-------~iiHrDIKp~NILl~~~----------  320 (454)
                      ||||+++|+|.++|..    ...+++..++.|+.||+.||.|||+.       +||||||||+||||+..          
T Consensus        92 VMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~  171 (1021)
T PTZ00266         92 LMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQ  171 (1021)
T ss_pred             EEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccccc
Confidence            9999999999999864    24799999999999999999999984       49999999999999642          


Q ss_pred             -------CcEEEEccCCccccccCCCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCH
Q 012887          321 -------GNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSP  393 (454)
Q Consensus       321 -------~~vKL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~  393 (454)
                             +.+||+|||++....... ......+|+.|+|||++.+...  .++.++|||||||+||+|++|..||.....
T Consensus       172 ~~n~ng~~iVKLsDFGlAr~l~~~s-~~~s~vGTp~YmAPEvL~ge~~--~~s~KSDVWSLG~ILYELLTGk~PF~~~~~  248 (1021)
T PTZ00266        172 ANNLNGRPIAKIGDFGLSKNIGIES-MAHSCVGTPYYWSPELLLHETK--SYDDKSDMWALGCIIYELCSGKTPFHKANN  248 (1021)
T ss_pred             ccccCCCCceEEccCCccccccccc-cccccCCCccccCHHHHhccCC--CCCchhHHHHHHHHHHHHHHCCCCCCcCCc
Confidence                   348999999987654322 2234468999999999865432  245679999999999999999999987665


Q ss_pred             HHHHHHHHHcCCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 012887          394 VQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLL  443 (454)
Q Consensus       394 ~~~~~~i~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~  443 (454)
                      ..............+ ....+.++.+||..||..+|.+||++.+++.+-+
T Consensus       249 ~~qli~~lk~~p~lp-i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~  297 (1021)
T PTZ00266        249 FSQLISELKRGPDLP-IKGKSKELNILIKNLLNLSAKERPSALQCLGYQI  297 (1021)
T ss_pred             HHHHHHHHhcCCCCC-cCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHH
Confidence            555544444332222 2357899999999999999999999999996543

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-40  Score=317.64  Aligned_cols=251  Identities=20%  Similarity=0.324  Sum_probs=219.3

Q ss_pred             ceeecCCCEEEeceeeccCCceEEE------eEEEEEEEeecCCCCch-HHHHHHHHHHHHHhCCCCceeEEEEEEEeCC
Q 012887          184 RWLLNSDNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNA-YEFELRKDLLELMTCGHKNILQFYCVCVDEN  256 (454)
Q Consensus       184 ~~~~~~~~~~~~~~LG~G~fG~Vy~------g~~vavK~l~~~~~~~~-~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~  256 (454)
                      +-.+.-++|.+++.||+|.||.|-+      |+.+|+|.++..-.... .-.....|-++|...+||.+..+.-.|+..+
T Consensus       162 ~~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~d  241 (516)
T KOG0690|consen  162 KNKVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQD  241 (516)
T ss_pred             cceeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCc
Confidence            3445668999999999999999997      46789999876543333 3344677888999999999999988888887


Q ss_pred             CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCcccccc
Q 012887          257 HGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS  336 (454)
Q Consensus       257 ~~l~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~  336 (454)
                      + +|+||||+.||.|.-.+.+.+.+++.....+-.+|+.||.|||+++||+||||.+|+|+|.+|++||+|||+++....
T Consensus       242 r-lCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~  320 (516)
T KOG0690|consen  242 R-LCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK  320 (516)
T ss_pred             e-EEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhccc
Confidence            7 999999999999999998888999999999999999999999999999999999999999999999999999998887


Q ss_pred             CCCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHH
Q 012887          337 VGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQI  416 (454)
Q Consensus       337 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~  416 (454)
                      .+..+...+|||.|+|||++....|.    .+.|.|.+||++|||++|+.||.+......+.-|.....+  +|..++++
T Consensus       321 ~g~t~kTFCGTPEYLAPEVleDnDYg----raVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~k--FPr~ls~e  394 (516)
T KOG0690|consen  321 YGDTTKTFCGTPEYLAPEVLEDNDYG----RAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLK--FPRTLSPE  394 (516)
T ss_pred             ccceeccccCChhhcCchhhcccccc----ceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhcc--CCccCCHH
Confidence            77888888999999999999876554    4599999999999999999999988777777777766444  89999999


Q ss_pred             HHHHHHHhcccCCCCCCC-----HHHHHHH
Q 012887          417 LKSLMIKCWNNSPSKRPQ-----FSEIISL  441 (454)
Q Consensus       417 l~~li~~cl~~dP~~RPs-----~~ell~~  441 (454)
                      .+.|+..+|.+||.+|..     ++||.++
T Consensus       395 AktLLsGLL~kdP~kRLGgGpdDakEi~~h  424 (516)
T KOG0690|consen  395 AKTLLSGLLKKDPKKRLGGGPDDAKEIMRH  424 (516)
T ss_pred             HHHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence            999999999999999953     6666554

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1.7e-38  Score=304.59  Aligned_cols=244  Identities=25%  Similarity=0.384  Sum_probs=204.9

Q ss_pred             CEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEEe
Q 012887          191 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTK  264 (454)
Q Consensus       191 ~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~E  264 (454)
                      +|++.+.||+|+||.||++      +.+++|.+............+.+|+.+++.++||||+++++.+...+. .++|||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~-~~lv~e   79 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKA-LMIVME   79 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCE-EEEEEe
Confidence            4788999999999999985      568999987554444556678899999999999999999999887665 999999


Q ss_pred             ccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCC-cEEEEccCCccccccCCCcc
Q 012887          265 LMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG-NVCLGDMGIVTACKSVGEAT  341 (454)
Q Consensus       265 ~~~~gsL~~~l~~~--~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~-~vKL~DFGla~~~~~~~~~~  341 (454)
                      |+++++|.+++.+.  ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++ .+||+|||++........ .
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~-~  158 (256)
T cd08220          80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK-A  158 (256)
T ss_pred             cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc-c
Confidence            99999999999653  3689999999999999999999999999999999999998654 589999999876644322 2


Q ss_pred             cccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHHHHH
Q 012887          342 EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLM  421 (454)
Q Consensus       342 ~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~li  421 (454)
                      ....++..|+|||.+.+..    .+.++||||||+++|+|++|..||...+.......+.. ....+++..++.++.+++
T Consensus       159 ~~~~~~~~y~aPE~~~~~~----~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li  233 (256)
T cd08220         159 YTVVGTPCYISPELCEGKP----YNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMS-GTFAPISDRYSPDLRQLI  233 (256)
T ss_pred             cccccCCcccCchhccCCC----CCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHh-cCCCCCCCCcCHHHHHHH
Confidence            2345788899999997654    34569999999999999999999988776655555544 334456778899999999


Q ss_pred             HHhcccCCCCCCCHHHHHHH
Q 012887          422 IKCWNNSPSKRPQFSEIISL  441 (454)
Q Consensus       422 ~~cl~~dP~~RPs~~ell~~  441 (454)
                      .+||..+|++|||+.|++.+
T Consensus       234 ~~~l~~~p~~Rpt~~~ll~~  253 (256)
T cd08220         234 LSMLNLDPSKRPQLSQIMAQ  253 (256)
T ss_pred             HHHccCChhhCCCHHHHhhC
Confidence            99999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=5.8e-39  Score=337.30  Aligned_cols=249  Identities=15%  Similarity=0.280  Sum_probs=191.3

Q ss_pred             ecCCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhC------CCCceeEEEEEEEe
Q 012887          187 LNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTC------GHKNILQFYCVCVD  254 (454)
Q Consensus       187 ~~~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l------~HpnIv~~~g~~~~  254 (454)
                      +..++|++++.||+|+||.||++      +.||||+++....   .......|+.++..+      +|++++++++++..
T Consensus       126 ~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~---~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~  202 (467)
T PTZ00284        126 VSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK---YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN  202 (467)
T ss_pred             cCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh---hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence            34578999999999999999996      4699999864321   222334455555444      45679999999987


Q ss_pred             CCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-cCcccCCccCCcEEEccCC------------
Q 012887          255 ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLND-HGVAYRDLNSQRILLDRHG------------  321 (454)
Q Consensus       255 ~~~~l~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~-~~iiHrDIKp~NILl~~~~------------  321 (454)
                      +...+|+|||++ +++|.+++.+.+.+++..+..++.||+.||.|||+ .|||||||||+|||++.++            
T Consensus       203 ~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~  281 (467)
T PTZ00284        203 ETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALP  281 (467)
T ss_pred             CCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccC
Confidence            765599999998 66999998877889999999999999999999998 5999999999999998765            


Q ss_pred             ----cEEEEccCCccccccCCCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHH
Q 012887          322 ----NVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAA  397 (454)
Q Consensus       322 ----~vKL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~  397 (454)
                          .+||+|||++....   .......||+.|+|||++.+..+    +.++|||||||++|||++|+.||.+.+..+..
T Consensus       282 ~~~~~vkl~DfG~~~~~~---~~~~~~~gt~~Y~APE~~~~~~~----~~~~DiwSlGvil~elltG~~pf~~~~~~~~~  354 (467)
T PTZ00284        282 PDPCRVRICDLGGCCDER---HSRTAIVSTRHYRSPEVVLGLGW----MYSTDMWSMGCIIYELYTGKLLYDTHDNLEHL  354 (467)
T ss_pred             CCCceEEECCCCccccCc---cccccccCCccccCcHHhhcCCC----CcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence                49999999875322   12334578999999999987654    45699999999999999999999887665443


Q ss_pred             HHHHHcCCC-------------------------CCC-C-------------C-CccHHHHHHHHHhcccCCCCCCCHHH
Q 012887          398 VGIAACGLR-------------------------PEI-P-------------K-DCPQILKSLMIKCWNNSPSKRPQFSE  437 (454)
Q Consensus       398 ~~i~~~~~~-------------------------~~~-p-------------~-~~~~~l~~li~~cl~~dP~~RPs~~e  437 (454)
                      ..+.....+                         +.. +             . ..++.+.+||.+||..||.+|||++|
T Consensus       355 ~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e  434 (467)
T PTZ00284        355 HLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQ  434 (467)
T ss_pred             HHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHH
Confidence            322211000                         000 0             0 01356779999999999999999999


Q ss_pred             HHHHHHhhc
Q 012887          438 IISLLLRTN  446 (454)
Q Consensus       438 ll~~L~~~~  446 (454)
                      +++|-+-..
T Consensus       435 ~L~Hp~~~~  443 (467)
T PTZ00284        435 MTTHPYVLK  443 (467)
T ss_pred             HhcCccccc
Confidence            999866543

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=5.3e-39  Score=317.36  Aligned_cols=246  Identities=21%  Similarity=0.378  Sum_probs=203.7

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  263 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~  263 (454)
                      .+|.+.+.||+|+||.||++      +.+|+|.+.....  .....+.+|+.++..++||||+++++++...+. .++||
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~-~~lv~   95 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLVGDE-LWVVM   95 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc--chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCE-EEEee
Confidence            67899999999999999985      5799999864332  233457789999999999999999999987776 99999


Q ss_pred             eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCcccc
Q 012887          264 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY  343 (454)
Q Consensus       264 E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~  343 (454)
                      ||+++++|.+++.+ ..+++..+..++.|++.||.|||+.|++||||||+|||++.++.++|+|||++............
T Consensus        96 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~  174 (297)
T cd06656          96 EYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST  174 (297)
T ss_pred             cccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCccCcCc
Confidence            99999999999854 56899999999999999999999999999999999999999999999999998765443333334


Q ss_pred             cCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCC-CCCCCCCccHHHHHHHH
Q 012887          344 ETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGL-RPEIPKDCPQILKSLMI  422 (454)
Q Consensus       344 ~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~-~~~~p~~~~~~l~~li~  422 (454)
                      ..+++.|+|||.+.+...    +.++|+|||||++|+|++|..||....+......+...+. ....|..++..+.+++.
T Consensus       175 ~~~~~~y~aPE~~~~~~~----~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  250 (297)
T cd06656         175 MVGTPYWMAPEVVTRKAY----GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLN  250 (297)
T ss_pred             ccCCccccCHHHHcCCCC----CcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHHH
Confidence            467888999999986543    4569999999999999999999987665444333332222 22346678899999999


Q ss_pred             HhcccCCCCCCCHHHHHHHHH
Q 012887          423 KCWNNSPSKRPQFSEIISLLL  443 (454)
Q Consensus       423 ~cl~~dP~~RPs~~ell~~L~  443 (454)
                      +||..+|++||++.+++.+=+
T Consensus       251 ~~l~~~p~~Rps~~~il~~~~  271 (297)
T cd06656         251 RCLEMDVDRRGSAKELLQHPF  271 (297)
T ss_pred             HHccCChhhCcCHHHHhcCch
Confidence            999999999999999998654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=1.4e-38  Score=306.81  Aligned_cols=246  Identities=26%  Similarity=0.482  Sum_probs=204.2

Q ss_pred             CCEEEeceeeccCCceEEEeE------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  263 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g~------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~  263 (454)
                      ++|++.+.||.|+||.||+|.      .+++|.+....... ....+.+|+..++.++|+||+++++.+...+. .++||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-~~iv~   78 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDE-LWLVM   78 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCE-EEEEE
Confidence            478999999999999999863      68899886433222 45668899999999999999999999987776 99999


Q ss_pred             eccCCCCHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCc
Q 012887          264 KLMEGGSVNDLILKS---RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA  340 (454)
Q Consensus       264 E~~~~gsL~~~l~~~---~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~  340 (454)
                      |++++++|.+++...   ..+++..+..++.|++.||.|||++|++||||+|+||++++++.++|+|||++.........
T Consensus        79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~  158 (267)
T cd06610          79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR  158 (267)
T ss_pred             eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence            999999999999653   46899999999999999999999999999999999999999999999999998766543322


Q ss_pred             ----ccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCC-----C
Q 012887          341 ----TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIP-----K  411 (454)
Q Consensus       341 ----~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p-----~  411 (454)
                          .....++..|+|||++....   .++.++|+|||||++|+|++|..||...++........... .+.++     .
T Consensus       159 ~~~~~~~~~~~~~y~~Pe~~~~~~---~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  234 (267)
T cd06610         159 TRKVRKTFVGTPCWMAPEVMEQVH---GYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQND-PPSLETGADYK  234 (267)
T ss_pred             cccccccccCChhhcChHHHcccc---CcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCC-CCCcCCccccc
Confidence                12335788899999987651   24567999999999999999999998877766555554432 22222     2


Q ss_pred             CccHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012887          412 DCPQILKSLMIKCWNNSPSKRPQFSEIISL  441 (454)
Q Consensus       412 ~~~~~l~~li~~cl~~dP~~RPs~~ell~~  441 (454)
                      .+++.+.+++.+||..||++||++.+++.+
T Consensus       235 ~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~  264 (267)
T cd06610         235 KYSKSFRKMISLCLQKDPSKRPTAEELLKH  264 (267)
T ss_pred             cccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence            568999999999999999999999999876

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=7.6e-39  Score=314.61  Aligned_cols=248  Identities=20%  Similarity=0.299  Sum_probs=200.7

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCC-CeEEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN-HGLCVV  262 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~-~~l~lV  262 (454)
                      ++|++.+.||.|+||.||+|      +.+++|.++...........+.+|+.+++.++||||+++++++...+ ...|+|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            57899999999999999985      46899999755444434445678999999999999999999988762 349999


Q ss_pred             EeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCcc
Q 012887          263 TKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT  341 (454)
Q Consensus       263 ~E~~~~gsL~~~l~~~~-~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~  341 (454)
                      |||+++ +|.+++.... .+++..+..++.||+.||.|||+++++|+||||+|||++.++.+||+|||++..........
T Consensus        85 ~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~  163 (293)
T cd07843          85 MEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPY  163 (293)
T ss_pred             ehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCcccc
Confidence            999975 9999886544 69999999999999999999999999999999999999999999999999987665443333


Q ss_pred             cccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcC-----------------
Q 012887          342 EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG-----------------  404 (454)
Q Consensus       342 ~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~-----------------  404 (454)
                      ....+++.|+|||.+.+...   .+.++|+||||+++|+|++|..||...........+...-                 
T Consensus       164 ~~~~~~~~~~aPE~~~~~~~---~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (293)
T cd07843         164 TQLVVTLWYRAPELLLGAKE---YSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGA  240 (293)
T ss_pred             ccccccccccCchhhcCCcc---ccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchh
Confidence            33456788999999875432   3556999999999999999999998776655443322110                 


Q ss_pred             ------------CCCCCCCC-ccHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012887          405 ------------LRPEIPKD-CPQILKSLMIKCWNNSPSKRPQFSEIISL  441 (454)
Q Consensus       405 ------------~~~~~p~~-~~~~l~~li~~cl~~dP~~RPs~~ell~~  441 (454)
                                  ....++.. +++.+.++|.+||+.||++|||+.|++.+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~  290 (293)
T cd07843         241 KKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH  290 (293)
T ss_pred             cccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence                        01123333 58889999999999999999999999875

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=3.2e-39  Score=311.74  Aligned_cols=234  Identities=24%  Similarity=0.419  Sum_probs=188.0

Q ss_pred             ceeeccCCceEEEeEE-------------EEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEE
Q 012887          196 DQIGPNSFKGVYKGKR-------------VGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  262 (454)
Q Consensus       196 ~~LG~G~fG~Vy~g~~-------------vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV  262 (454)
                      +.||+|+||.||+|..             +++|.+...  .......+.+|+.++..++||||+++++++...+. .++|
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~-~~lv   77 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS--HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDE-SIMV   77 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcch--hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCC-cEEE
Confidence            3689999999999754             556665421  12233456788888999999999999999998776 8899


Q ss_pred             EeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCc--------EEEEccCCccc
Q 012887          263 TKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGN--------VCLGDMGIVTA  333 (454)
Q Consensus       263 ~E~~~~gsL~~~l~~~~-~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~--------vKL~DFGla~~  333 (454)
                      |||+++|+|.+++.+++ .+++..+..++.||+.||.|||++||+||||||+|||++.++.        ++++|||++..
T Consensus        78 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~  157 (258)
T cd05078          78 QEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT  157 (258)
T ss_pred             EecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence            99999999999996644 6899999999999999999999999999999999999987765        69999998765


Q ss_pred             cccCCCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcC-CCCCCCCCHHHHHHHHHHcCCCCCCCCC
Q 012887          334 CKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTG-EAAYAACSPVQAAVGIAACGLRPEIPKD  412 (454)
Q Consensus       334 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG-~~Pf~~~~~~~~~~~i~~~~~~~~~p~~  412 (454)
                      ...    .....+++.|+|||.+.+..   .++.++|||||||++|+|++| ..||....+..... ...  .+..+|..
T Consensus       158 ~~~----~~~~~~~~~y~aPE~~~~~~---~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~-~~~--~~~~~~~~  227 (258)
T cd05078         158 VLP----KEILLERIPWVPPECIENPQ---NLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ-FYE--DRHQLPAP  227 (258)
T ss_pred             cCC----chhccccCCccCchhccCCC---CCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH-HHH--ccccCCCC
Confidence            432    23345678899999987532   234569999999999999998 56666655443322 222  24557777


Q ss_pred             ccHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 012887          413 CPQILKSLMIKCWNNSPSKRPQFSEIISLL  442 (454)
Q Consensus       413 ~~~~l~~li~~cl~~dP~~RPs~~ell~~L  442 (454)
                      .+.++.+++.+||+.||++|||+.+|++.|
T Consensus       228 ~~~~~~~li~~~l~~~p~~Rps~~~il~~l  257 (258)
T cd05078         228 KWTELANLINQCMDYEPDFRPSFRAIIRDL  257 (258)
T ss_pred             CcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence            789999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-38  Score=309.08  Aligned_cols=250  Identities=22%  Similarity=0.403  Sum_probs=203.9

Q ss_pred             CEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCC---CCceeEEEEEEEeCCCeEEE
Q 012887          191 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCG---HKNILQFYCVCVDENHGLCV  261 (454)
Q Consensus       191 ~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~---HpnIv~~~g~~~~~~~~l~l  261 (454)
                      .|++.+.||+|+||.||+|      +.+++|.+... .......++.+|+.+++.++   |||++++++++.+.+. .++
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~-~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~-~~l   79 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLD-TPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPR-LWI   79 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCC-CCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCE-EEE
Confidence            4677889999999999986      45899988642 22333456778888888886   9999999999987765 899


Q ss_pred             EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCcc
Q 012887          262 VTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT  341 (454)
Q Consensus       262 V~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~  341 (454)
                      ||||+++++|.+++.. ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..........
T Consensus        80 v~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~  158 (277)
T cd06917          80 IMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKR  158 (277)
T ss_pred             EEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcccc
Confidence            9999999999999854 479999999999999999999999999999999999999999999999999987765544334


Q ss_pred             cccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCC-ccHHHHHH
Q 012887          342 EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKD-CPQILKSL  420 (454)
Q Consensus       342 ~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~-~~~~l~~l  420 (454)
                      ....++..|+|||.+.+..   .++.++|+|||||++|+|++|..||.+.........+.. ...+.++.. ++.++.++
T Consensus       159 ~~~~~~~~y~aPE~~~~~~---~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  234 (277)
T cd06917         159 STFVGTPYWMAPEVITEGK---YYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPK-SKPPRLEDNGYSKLLREF  234 (277)
T ss_pred             ccccCCcceeCHHHhccCC---ccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhcccc-CCCCCCCcccCCHHHHHH
Confidence            4456788899999986532   244569999999999999999999987766544332222 233444443 88999999


Q ss_pred             HHHhcccCCCCCCCHHHHHHHHHhhcC
Q 012887          421 MIKCWNNSPSKRPQFSEIISLLLRTNN  447 (454)
Q Consensus       421 i~~cl~~dP~~RPs~~ell~~L~~~~~  447 (454)
                      +.+||+.||++||++.+++.+-+-...
T Consensus       235 i~~~l~~~p~~R~~~~~il~~~~~~~~  261 (277)
T cd06917         235 VAACLDEEPKERLSAEELLKSKWIKAH  261 (277)
T ss_pred             HHHHcCCCcccCcCHHHHhhChHhhcc
Confidence            999999999999999999988766444

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=1.9e-38  Score=314.26  Aligned_cols=247  Identities=17%  Similarity=0.289  Sum_probs=200.1

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCC-chHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  262 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV  262 (454)
                      ++|++++.||+|+||.||++      +.|++|.+...... ......+.+|+.+++.++||||+++++.+.+++. +++|
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~-~~lv   79 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRH-LCMV   79 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCE-EEEE
Confidence            46899999999999999985      57999988643321 2234467789999999999999999999987765 9999


Q ss_pred             EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCC---
Q 012887          263 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE---  339 (454)
Q Consensus       263 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~---  339 (454)
                      |||+++++|.+++...+.+++..+..++.|++.||.|||+++++||||||+||+++.++.+||+|||+++.......   
T Consensus        80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~  159 (305)
T cd05609          80 MEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNL  159 (305)
T ss_pred             EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCccccc
Confidence            99999999999998778899999999999999999999999999999999999999999999999998763211000   


Q ss_pred             ------------cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCC-
Q 012887          340 ------------ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR-  406 (454)
Q Consensus       340 ------------~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~-  406 (454)
                                  ......++..|+|||.+.+..+    +.++|+|||||++|||++|..||.+.++.+....+...... 
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~----~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~  235 (305)
T cd05609         160 YEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGY----GKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEW  235 (305)
T ss_pred             cccccccchhhccccCCccCccccCchhccCCCC----CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCC
Confidence                        0112346778999999876543    45599999999999999999999987776666555543322 


Q ss_pred             CCCCCCccHHHHHHHHHhcccCCCCCCCH---HHHHHH
Q 012887          407 PEIPKDCPQILKSLMIKCWNNSPSKRPQF---SEIISL  441 (454)
Q Consensus       407 ~~~p~~~~~~l~~li~~cl~~dP~~RPs~---~ell~~  441 (454)
                      +..+..++.++.++|.+||+.||++||++   .+++++
T Consensus       236 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         236 PEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             CCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence            22233678999999999999999999985   555554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.6e-38  Score=308.56  Aligned_cols=249  Identities=20%  Similarity=0.363  Sum_probs=201.8

Q ss_pred             CEEEeceeeccCCceEEEe------EEEEEEEeecCCCC--------chHHHHHHHHHHHHHhCCCCceeEEEEEEEeCC
Q 012887          191 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG--------NAYEFELRKDLLELMTCGHKNILQFYCVCVDEN  256 (454)
Q Consensus       191 ~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~--------~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~  256 (454)
                      +|.+.+.||.|+||.||+|      +.+|+|.++.....        ......+.+|+..+..++|||++++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            3677889999999999986      46899987532111        111235678999999999999999999998776


Q ss_pred             CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCcccccc
Q 012887          257 HGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS  336 (454)
Q Consensus       257 ~~l~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~  336 (454)
                      . +++||||+++++|.+++.+...+++..+..++.||+.||.|||+++++||||+|+||+++.++.++|+|||++.....
T Consensus        82 ~-~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~  160 (272)
T cd06629          82 Y-LSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDD  160 (272)
T ss_pred             c-eEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeeccccccccc
Confidence            5 999999999999999998778899999999999999999999999999999999999999999999999999875433


Q ss_pred             CCC--cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCC---
Q 012887          337 VGE--ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPK---  411 (454)
Q Consensus       337 ~~~--~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~---  411 (454)
                      ...  ......++..|+|||.+....  ..++.++|+||||+++|++++|..||...........+......+.++.   
T Consensus       161 ~~~~~~~~~~~~~~~y~~PE~~~~~~--~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (272)
T cd06629         161 IYDNDQNMSMQGSVFWMAPEVIHSYS--QGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVS  238 (272)
T ss_pred             cccccccccccCCccccCHHHhcccc--CCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCcccc
Confidence            211  122335678899999987653  1245669999999999999999999987666555554444433444443   


Q ss_pred             -CccHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 012887          412 -DCPQILKSLMIKCWNNSPSKRPQFSEIISLL  442 (454)
Q Consensus       412 -~~~~~l~~li~~cl~~dP~~RPs~~ell~~L  442 (454)
                       .++.++.+++.+||..||++||++.+++.+-
T Consensus       239 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~  270 (272)
T cd06629         239 MNLSPVALDFLNACFTINPDNRPTARELLQHP  270 (272)
T ss_pred             ccCCHHHHHHHHHHhcCChhhCCCHHHHhhCC
Confidence             4689999999999999999999999998763

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.6e-38  Score=303.12  Aligned_cols=241  Identities=27%  Similarity=0.534  Sum_probs=199.3

Q ss_pred             ceeeccCCceEEEe-----EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEEeccCCCC
Q 012887          196 DQIGPNSFKGVYKG-----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGS  270 (454)
Q Consensus       196 ~~LG~G~fG~Vy~g-----~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~E~~~~gs  270 (454)
                      +.||.|+||.||++     +.+++|.+...... .....+.+|+.+++.++|+||+++++++.+.+. .++||||+++++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-~~~v~e~~~~~~   78 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQP-IYIVMELVPGGS   78 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCC-eEEEEEcCCCCc
Confidence            46899999999985     56899988754332 345678899999999999999999999988776 899999999999


Q ss_pred             HHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCcc--cccCCC
Q 012887          271 VNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT--EYETDG  347 (454)
Q Consensus       271 L~~~l~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~--~~~~gt  347 (454)
                      |.+++.+. ..+++..+..++.+++.||.|||+++++||||+|+|||++.++.+||+|||++..........  .....+
T Consensus        79 l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~  158 (251)
T cd05041          79 LLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIP  158 (251)
T ss_pred             HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcce
Confidence            99998653 478999999999999999999999999999999999999999999999999987554211111  111234


Q ss_pred             CcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhcc
Q 012887          348 YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWN  426 (454)
Q Consensus       348 ~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~li~~cl~  426 (454)
                      ..|+|||.+.+..+    +.++|+|||||++|+|++ |..||...........+ ....+...|..++.++.+++.+||.
T Consensus       159 ~~y~~PE~~~~~~~----~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~  233 (251)
T cd05041         159 IKWTAPEALNYGRY----TSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERI-ESGYRMPAPQLCPEEIYRLMLQCWA  233 (251)
T ss_pred             eccCChHhhccCCC----CcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHH-hcCCCCCCCccCCHHHHHHHHHHhc
Confidence            56999999876644    445999999999999999 89999887765544443 3345566778899999999999999


Q ss_pred             cCCCCCCCHHHHHHHHH
Q 012887          427 NSPSKRPQFSEIISLLL  443 (454)
Q Consensus       427 ~dP~~RPs~~ell~~L~  443 (454)
                      .+|.+||++.|+++.|.
T Consensus       234 ~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         234 YDPENRPSFSEIYNELQ  250 (251)
T ss_pred             cChhhCcCHHHHHHHhh
Confidence            99999999999999885

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.2e-39  Score=325.14  Aligned_cols=248  Identities=18%  Similarity=0.294  Sum_probs=196.9

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCC-----Ce
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN-----HG  258 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~-----~~  258 (454)
                      ++|++++.||+|+||.||++      +.||+|++............+.+|+.+++.++||||+++++++....     ..
T Consensus        15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   94 (343)
T cd07878          15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNE   94 (343)
T ss_pred             hhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCc
Confidence            78999999999999999986      47999998744333334455778999999999999999999886432     23


Q ss_pred             EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCC
Q 012887          259 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG  338 (454)
Q Consensus       259 l~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~  338 (454)
                      .|++|+++ +++|.+++ +...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... 
T Consensus        95 ~~~~~~~~-~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~-  171 (343)
T cd07878          95 VYLVTNLM-GADLNNIV-KCQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE-  171 (343)
T ss_pred             EEEEeecC-CCCHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecCCC-
Confidence            78999998 67998877 4457999999999999999999999999999999999999999999999999998765432 


Q ss_pred             CcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCC-------------
Q 012887          339 EATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGL-------------  405 (454)
Q Consensus       339 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~-------------  405 (454)
                        .....+++.|+|||++.+..   .++.++|||||||++|+|++|..||.+.........+.....             
T Consensus       172 --~~~~~~t~~y~aPE~~~~~~---~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (343)
T cd07878         172 --MTGYVATRWYRAPEIMLNWM---HYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSE  246 (343)
T ss_pred             --cCCccccccccCchHhcCCc---cCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchh
Confidence              23346788999999987632   245569999999999999999999987655443333221100             


Q ss_pred             --------CCCCC--------CCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 012887          406 --------RPEIP--------KDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRT  445 (454)
Q Consensus       406 --------~~~~p--------~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~  445 (454)
                              .+..+        ...++.+.+|+.+||..||.+|||+.|+++|-+-.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~  302 (343)
T cd07878         247 HARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFS  302 (343)
T ss_pred             hHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchh
Confidence                    00111        23567789999999999999999999999885543

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=2.5e-38  Score=303.21  Aligned_cols=243  Identities=29%  Similarity=0.546  Sum_probs=201.8

Q ss_pred             EEeceeeccCCceEEEe----------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEE
Q 012887          193 EFIDQIGPNSFKGVYKG----------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  262 (454)
Q Consensus       193 ~~~~~LG~G~fG~Vy~g----------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV  262 (454)
                      ++.+.||.|+||.||++          ..+|+|.+... ........+..|+..+..++|+||+++++++.+.+. .+++
T Consensus         2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-~~~i   79 (258)
T smart00219        2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKED-ADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEP-LMIV   79 (258)
T ss_pred             cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCC-CChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCe-eEEE
Confidence            56788999999999985          56889988643 222245678899999999999999999999988765 9999


Q ss_pred             EeccCCCCHHHHHHhCCC--CCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCc
Q 012887          263 TKLMEGGSVNDLILKSRK--LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA  340 (454)
Q Consensus       263 ~E~~~~gsL~~~l~~~~~--l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~  340 (454)
                      |||+++++|.+++.....  +++..+..++.|++.||.|||+++++|+||||+||+++.++.++|+|||++.........
T Consensus        80 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~  159 (258)
T smart00219       80 MEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY  159 (258)
T ss_pred             EeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceeccccccc
Confidence            999999999999965443  999999999999999999999999999999999999999999999999998765543221


Q ss_pred             cc-ccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHH
Q 012887          341 TE-YETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILK  418 (454)
Q Consensus       341 ~~-~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~  418 (454)
                      .. ...+++.|+|||.+.+..    ++.++||||||+++|+|++ |..||...+.......+. .......+..++.++.
T Consensus       160 ~~~~~~~~~~y~~Pe~~~~~~----~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  234 (258)
T smart00219      160 KKKGGKLPIRWMAPESLKDGK----FTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLK-KGYRLPKPENCPPEIY  234 (258)
T ss_pred             ccccCCCcccccChHHhccCC----CCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-cCCCCCCCCcCCHHHH
Confidence            11 223668899999986543    4456999999999999998 899998766655554444 3455667777999999


Q ss_pred             HHHHHhcccCCCCCCCHHHHHHHH
Q 012887          419 SLMIKCWNNSPSKRPQFSEIISLL  442 (454)
Q Consensus       419 ~li~~cl~~dP~~RPs~~ell~~L  442 (454)
                      +++.+||..||.+|||+.++++.|
T Consensus       235 ~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      235 KLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             HHHHHHCcCChhhCcCHHHHHhhC
Confidence            999999999999999999998764

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=5.1e-39  Score=313.34  Aligned_cols=246  Identities=22%  Similarity=0.417  Sum_probs=203.8

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  263 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~  263 (454)
                      +.|+..+.||+|+||.||+|      ..+|+|.+.... .......+.+|+.++..++||||+++++++...+. .++||
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~lv~   81 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTK-LWIIM   81 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc-chHHHHHHHHHHHHHHcCCCCccHhhhcccccCCc-eEEEE
Confidence            34667788999999999996      468998876332 22344568899999999999999999999987776 99999


Q ss_pred             eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCcccc
Q 012887          264 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY  343 (454)
Q Consensus       264 E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~  343 (454)
                      ||+++++|.+++. ...+++..+..++.||+.||.|||+++++|+||+|+||+++.++.++|+|||++............
T Consensus        82 e~~~~~~L~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~  160 (277)
T cd06642          82 EYLGGGSALDLLK-PGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT  160 (277)
T ss_pred             EccCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcchhhhc
Confidence            9999999999884 457899999999999999999999999999999999999999999999999998765443322333


Q ss_pred             cCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHHHHHHH
Q 012887          344 ETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIK  423 (454)
Q Consensus       344 ~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~li~~  423 (454)
                      ..++..|+|||.+.+..    ++.++|||||||++|||++|..||....+......+ .....+.++..++.++.+++.+
T Consensus       161 ~~~~~~y~aPE~~~~~~----~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~  235 (277)
T cd06642         161 FVGTPFWMAPEVIKQSA----YDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLI-PKNSPPTLEGQYSKPFKEFVEA  235 (277)
T ss_pred             ccCcccccCHHHhCcCC----CchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhh-hcCCCCCCCcccCHHHHHHHHH
Confidence            45778899999998664    445699999999999999999999876655444333 3344555667789999999999


Q ss_pred             hcccCCCCCCCHHHHHHHHH
Q 012887          424 CWNNSPSKRPQFSEIISLLL  443 (454)
Q Consensus       424 cl~~dP~~RPs~~ell~~L~  443 (454)
                      ||+.+|++||++.+++.+-+
T Consensus       236 ~l~~~p~~Rp~~~~il~~~~  255 (277)
T cd06642         236 CLNKDPRFRPTAKELLKHKF  255 (277)
T ss_pred             HccCCcccCcCHHHHHHhHH
Confidence            99999999999999999765

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-38  Score=310.44  Aligned_cols=248  Identities=19%  Similarity=0.296  Sum_probs=201.3

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  263 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~  263 (454)
                      ++|++.+.||+|+||.||+|      +.+++|.++...........+.+|+..++.++|+||+++++++.+.+. +++||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-~~iv~   79 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGR-LYLVF   79 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCE-EEEEE
Confidence            36899999999999999995      478999887544444445678899999999999999999999988765 99999


Q ss_pred             eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCC-ccc
Q 012887          264 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE-ATE  342 (454)
Q Consensus       264 E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~-~~~  342 (454)
                      ||++++.+..+..+...+++..+..++.||+.||.|||+++++|+||+|+||+++.++.+||+|||++........ ...
T Consensus        80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~  159 (288)
T cd07833          80 EYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLT  159 (288)
T ss_pred             ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcccccc
Confidence            9999877777666666799999999999999999999999999999999999999999999999999876654332 222


Q ss_pred             ccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcC------------------
Q 012887          343 YETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG------------------  404 (454)
Q Consensus       343 ~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~------------------  404 (454)
                      ...++..|+|||++.+..   .++.++||||||+++|+|++|..||.+.........+....                  
T Consensus       160 ~~~~~~~~~~PE~~~~~~---~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (288)
T cd07833         160 DYVATRWYRAPELLVGDT---NYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFA  236 (288)
T ss_pred             CcccccCCcCCchhcCCC---CcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccc
Confidence            345678899999997652   34557999999999999999999998766554333322100                  


Q ss_pred             ---CC---------CCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012887          405 ---LR---------PEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISL  441 (454)
Q Consensus       405 ---~~---------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  441 (454)
                         ..         ..++..++.++.++|++||..+|++||++++++.+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  285 (288)
T cd07833         237 GVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH  285 (288)
T ss_pred             ccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence               00         01233458899999999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=2e-38  Score=307.09  Aligned_cols=241  Identities=29%  Similarity=0.552  Sum_probs=196.1

Q ss_pred             ceeeccCCceEEEeE------------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEE
Q 012887          196 DQIGPNSFKGVYKGK------------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  263 (454)
Q Consensus       196 ~~LG~G~fG~Vy~g~------------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~  263 (454)
                      +.||+|+||.||+|+            .+++|.+... ........+.+|+..+..++||||+++++++.+.+. .++||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~~v~   78 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKG-ATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEP-QYIIM   78 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcc-cchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCC-eEEEE
Confidence            358999999999874            4677776532 222344567889999999999999999999987776 89999


Q ss_pred             eccCCCCHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCC-----cEEEEccCCc
Q 012887          264 KLMEGGSVNDLILKS-------RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG-----NVCLGDMGIV  331 (454)
Q Consensus       264 E~~~~gsL~~~l~~~-------~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~-----~vKL~DFGla  331 (454)
                      ||+++++|.+++.+.       ..+++..+..++.|++.||.|||+++++|+||||+||+++.++     .++|+|||++
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~  158 (269)
T cd05044          79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA  158 (269)
T ss_pred             eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence            999999999998532       2478899999999999999999999999999999999999887     8999999998


Q ss_pred             cccccCCC--cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHcCCCCC
Q 012887          332 TACKSVGE--ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPE  408 (454)
Q Consensus       332 ~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~  408 (454)
                      ........  .......+..|+|||.+.+...    +.++|||||||++|+|++ |..||...+.......+ ..+.+..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~----~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~-~~~~~~~  233 (269)
T cd05044         159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKF----TTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHV-TAGGRLQ  233 (269)
T ss_pred             cccccccccccCcccCCCccccCHHHHccCCc----ccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHH-hcCCccC
Confidence            65432211  1112234678999999986654    446999999999999998 99999877665544433 3344556


Q ss_pred             CCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 012887          409 IPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLL  443 (454)
Q Consensus       409 ~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~  443 (454)
                      .+..+|..+.++|.+||..+|.+||++.++++.|+
T Consensus       234 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         234 KPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             CcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            67788999999999999999999999999999886

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=7.1e-39  Score=309.17  Aligned_cols=246  Identities=21%  Similarity=0.411  Sum_probs=203.7

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  263 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~  263 (454)
                      ++|++.+.||+|+||.||++      +.+++|.+.... ......++.+|+..+++++||||+++++.+...+. .++++
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~-~~lv~   78 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEI-NEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGD-ISICM   78 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEeccc-ChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCE-EEEEE
Confidence            46788999999999999985      468999887532 23455668899999999999999999999988765 99999


Q ss_pred             eccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHh-cCcccCCccCCcEEEccCCcEEEEccCCccccccCCCcc
Q 012887          264 KLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLND-HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT  341 (454)
Q Consensus       264 E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qI~~gL~yLH~-~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~  341 (454)
                      ||+++++|.+++... ..+++..+..++.|++.||.|||+ .|++|+||||+||+++.++.++|+|||++........  
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--  156 (265)
T cd06605          79 EYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA--  156 (265)
T ss_pred             EecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh--
Confidence            999999999999765 689999999999999999999999 9999999999999999999999999999766543221  


Q ss_pred             cccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC-----HHHHHHHHHHcCCCCCCCCC-ccH
Q 012887          342 EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACS-----PVQAAVGIAACGLRPEIPKD-CPQ  415 (454)
Q Consensus       342 ~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~-----~~~~~~~i~~~~~~~~~p~~-~~~  415 (454)
                      ....++..|+|||.+.+..    ++.++||||||+++|+|++|..||....     .......+ .....+..+.. ++.
T Consensus       157 ~~~~~~~~y~~PE~~~~~~----~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  231 (265)
T cd06605         157 KTFVGTSSYMAPERIQGND----YSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYI-VNEPPPRLPSGKFSP  231 (265)
T ss_pred             hcccCChhccCHHHHcCCC----CCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHH-hcCCCCCCChhhcCH
Confidence            1256788899999997764    4456999999999999999999997642     22222222 33344555555 899


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 012887          416 ILKSLMIKCWNNSPSKRPQFSEIISLLLR  444 (454)
Q Consensus       416 ~l~~li~~cl~~dP~~RPs~~ell~~L~~  444 (454)
                      ++.++|.+||..||.+||++.+++.+-+-
T Consensus       232 ~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  260 (265)
T cd06605         232 DFQDFVNLCLIKDPRERPSYKELLEHPFI  260 (265)
T ss_pred             HHHHHHHHHcCCCchhCcCHHHHhhCchh
Confidence            99999999999999999999999987553

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=4.1e-38  Score=305.48  Aligned_cols=249  Identities=24%  Similarity=0.423  Sum_probs=201.0

Q ss_pred             EEEeceeeccCCceEEEe---------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCC-----
Q 012887          192 LEFIDQIGPNSFKGVYKG---------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH-----  257 (454)
Q Consensus       192 ~~~~~~LG~G~fG~Vy~g---------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~-----  257 (454)
                      |++.+.||+|+||.||+|         +.+|+|.+...........++.+|+..+..++||||+++++++...+.     
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            466788999999999975         468999987554444455668899999999999999999998875431     


Q ss_pred             eEEEEEeccCCCCHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCc
Q 012887          258 GLCVVTKLMEGGSVNDLILKS------RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIV  331 (454)
Q Consensus       258 ~l~lV~E~~~~gsL~~~l~~~------~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla  331 (454)
                      ..+++++|+.+|+|.+++...      ..++...+..++.||+.||+|||+++|+||||||+||+++.++.+||+|||++
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~  160 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS  160 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccccc
Confidence            147899999999999887421      25789999999999999999999999999999999999999999999999998


Q ss_pred             cccccCCC--cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHcCCCCC
Q 012887          332 TACKSVGE--ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPE  408 (454)
Q Consensus       332 ~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~  408 (454)
                      +.......  ......+++.|++||.+.+..+    +.++|||||||++|+|++ |..||.+.........+. ......
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~----~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~  235 (273)
T cd05074         161 KKIYSGDYYRQGCASKLPVKWLALESLADNVY----TTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLI-KGNRLK  235 (273)
T ss_pred             ccccCCcceecCCCccCchhhcCHhHHhcCcc----chhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHH-cCCcCC
Confidence            76543221  1112234567999999876643    445999999999999999 899998766655444333 334455


Q ss_pred             CCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 012887          409 IPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRT  445 (454)
Q Consensus       409 ~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~  445 (454)
                      .+..++..+.+++.+||+.+|++||++.+++..|..+
T Consensus       236 ~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         236 QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            6667889999999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-38  Score=314.42  Aligned_cols=248  Identities=20%  Similarity=0.288  Sum_probs=203.4

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCc-hHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGN-AYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  262 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV  262 (454)
                      ++|++.+.||+|+||.||++      +.+|+|.+....... .....+..|+..+..++||||+++++.+.+.+. .|+|
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-~~lv   79 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETY-LCLV   79 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCE-EEEE
Confidence            47899999999999999985      578999987543332 244567889999999999999999999987765 9999


Q ss_pred             EeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCc
Q 012887          263 TKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA  340 (454)
Q Consensus       263 ~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~  340 (454)
                      |||+.+++|.+++.+.  ..+++..+..++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++.........
T Consensus        80 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~  159 (316)
T cd05574          80 MDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPP  159 (316)
T ss_pred             EEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhcccccccc
Confidence            9999999999998653  47999999999999999999999999999999999999999999999999997654322110


Q ss_pred             -----------------------------ccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 012887          341 -----------------------------TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAAC  391 (454)
Q Consensus       341 -----------------------------~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~  391 (454)
                                                   .....|+..|+|||++.+..+    +.++||||||+++|+|++|..||.+.
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~----~~~~Di~slG~ll~~l~~g~~pf~~~  235 (316)
T cd05574         160 VSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH----GSAVDWWTLGILLYEMLYGTTPFKGS  235 (316)
T ss_pred             cccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCC----CchHHHHHHHHHHHHHhhCCCCCCCC
Confidence                                         112246778999999986643    45699999999999999999999887


Q ss_pred             CHHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhcccCCCCCCC----HHHHHHHH
Q 012887          392 SPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQ----FSEIISLL  442 (454)
Q Consensus       392 ~~~~~~~~i~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs----~~ell~~L  442 (454)
                      +.......+.......+.....+..+.+++.+||+.||.+||+    +.+++.+-
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~  290 (316)
T cd05574         236 NRDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHP  290 (316)
T ss_pred             chHHHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCc
Confidence            7766665555433332222336899999999999999999999    88888763

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=1.6e-38  Score=310.39  Aligned_cols=246  Identities=21%  Similarity=0.298  Sum_probs=197.8

Q ss_pred             CEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEEe
Q 012887          191 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTK  264 (454)
Q Consensus       191 ~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~E  264 (454)
                      +|++++.||.|+||.||+|      +.+|+|++............+.+|+..+.+++||||+++++++.+.+. .++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~-~~~v~e   79 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK-LYLVFE   79 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCc-EEEEee
Confidence            4788999999999999986      468999887543333344567889999999999999999999987776 999999


Q ss_pred             ccCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCccc
Q 012887          265 LMEGGSVNDLILK--SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE  342 (454)
Q Consensus       265 ~~~~gsL~~~l~~--~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~  342 (454)
                      |+. ++|.+++..  ...+++..+..++.|++.||.|||+++++||||+|+||+++.++.+||+|||++...........
T Consensus        80 ~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~  158 (284)
T cd07860          80 FLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT  158 (284)
T ss_pred             ccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccccc
Confidence            996 589988854  34789999999999999999999999999999999999999999999999999876543322233


Q ss_pred             ccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCC---------------
Q 012887          343 YETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP---------------  407 (454)
Q Consensus       343 ~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~---------------  407 (454)
                      ...+++.|+|||.+.+..   ..+.++|||||||++|+|+||..||.+.+.......+......+               
T Consensus       159 ~~~~~~~y~aPE~~~~~~---~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (284)
T cd07860         159 HEVVTLWYRAPEILLGCK---YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYK  235 (284)
T ss_pred             cccccccccCCeEEecCC---CCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHH
Confidence            334678899999887543   23556999999999999999999998776654443332211100               


Q ss_pred             ------------CCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012887          408 ------------EIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISL  441 (454)
Q Consensus       408 ------------~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  441 (454)
                                  .....++.++.++|.+||+.||.+||++.+++.+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  281 (284)
T cd07860         236 PSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH  281 (284)
T ss_pred             hhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence                        0123467889999999999999999999999876

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.8e-38  Score=306.91  Aligned_cols=246  Identities=22%  Similarity=0.400  Sum_probs=202.2

Q ss_pred             CEEEeceeeccCCceEEEe------EEEEEEEeecCCCCc----hHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEE
Q 012887          191 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGN----AYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLC  260 (454)
Q Consensus       191 ~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~----~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~  260 (454)
                      +|+..+.||+|+||.||++      +.+|+|.+.......    .....+.+|+..+..++|+||+++++++.+.++ ++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~   79 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSH-FN   79 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCe-EE
Confidence            3677889999999999985      469999886433221    134568899999999999999999999988776 89


Q ss_pred             EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCC-cEEEEccCCccccccCCC
Q 012887          261 VVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG-NVCLGDMGIVTACKSVGE  339 (454)
Q Consensus       261 lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~-~vKL~DFGla~~~~~~~~  339 (454)
                      +||||+++++|.+++.+.+++++..+..++.||+.||.|||++|++|+||+|+||+++.++ .+||+|||++........
T Consensus        80 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~  159 (268)
T cd06630          80 LFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGT  159 (268)
T ss_pred             EEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccccccc
Confidence            9999999999999998778899999999999999999999999999999999999998776 599999999876543211


Q ss_pred             ----cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHHHcCCCCCCCCC
Q 012887          340 ----ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSP---VQAAVGIAACGLRPEIPKD  412 (454)
Q Consensus       340 ----~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~---~~~~~~i~~~~~~~~~p~~  412 (454)
                          ......++..|+|||.+.+..+    +.++|+||+|+++|+|++|..||.....   ......+......+.+|..
T Consensus       160 ~~~~~~~~~~~~~~~~~PE~~~~~~~----~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (268)
T cd06630         160 GAGEFQGQLLGTIAFMAPEVLRGEQY----GRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEH  235 (268)
T ss_pred             cCCccccccccccceeCHhHhccCCC----CcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchh
Confidence                1122356788999999876543    4469999999999999999999975432   2233333334455667788


Q ss_pred             ccHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012887          413 CPQILKSLMIKCWNNSPSKRPQFSEIISL  441 (454)
Q Consensus       413 ~~~~l~~li~~cl~~dP~~RPs~~ell~~  441 (454)
                      +++++.+++.+||..+|++||++.+++.+
T Consensus       236 ~~~~~~~~i~~~l~~~p~~R~~~~~ll~~  264 (268)
T cd06630         236 LSPGLRDVTLRCLELQPEDRPPSRELLKH  264 (268)
T ss_pred             hCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence            89999999999999999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.5e-38  Score=324.17  Aligned_cols=244  Identities=22%  Similarity=0.294  Sum_probs=195.0

Q ss_pred             CCCEEEeceeeccCCceEEEe--------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEE
Q 012887          189 SDNLEFIDQIGPNSFKGVYKG--------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLC  260 (454)
Q Consensus       189 ~~~~~~~~~LG~G~fG~Vy~g--------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~  260 (454)
                      ..+|++++.||+|+||.||++        +.|++|.+...       ....+|+.+++.++||||+++++++...+. +|
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~-~~  162 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------KTPGREIDILKTISHRAIINLIHAYRWKST-VC  162 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-------ccHHHHHHHHHhcCCCCccceeeeEeeCCE-EE
Confidence            467999999999999999985        45788877532       124579999999999999999999987776 99


Q ss_pred             EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCC-
Q 012887          261 VVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE-  339 (454)
Q Consensus       261 lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~-  339 (454)
                      +|||++. ++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ 
T Consensus       163 lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~  241 (392)
T PHA03207        163 MVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDT  241 (392)
T ss_pred             EEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCccccc
Confidence            9999996 58999887677899999999999999999999999999999999999999999999999999876543222 


Q ss_pred             -cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHHH-------------
Q 012887          340 -ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSP---VQAAVGIAA-------------  402 (454)
Q Consensus       340 -~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~---~~~~~~i~~-------------  402 (454)
                       ......||+.|+|||++.+..+    +.++|||||||++|||++|..||.+...   ...+..+..             
T Consensus       242 ~~~~~~~gt~~y~aPE~~~~~~~----~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~  317 (392)
T PHA03207        242 PQCYGWSGTLETNSPELLALDPY----CAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNG  317 (392)
T ss_pred             ccccccccccCccCHhHhcCCCC----CchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCcc
Confidence             1234468999999999987654    4459999999999999999999976432   111111111             


Q ss_pred             ------------cCCCCCC--C-----CCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 012887          403 ------------CGLRPEI--P-----KDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRT  445 (454)
Q Consensus       403 ------------~~~~~~~--p-----~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~  445 (454)
                                  ...++++  |     ..++.++.++|.+||..||.+||++.|++.+-+-.
T Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~  379 (392)
T PHA03207        318 STNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFT  379 (392)
T ss_pred             chhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhh
Confidence                        0011111  1     23567889999999999999999999999986543

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=2.1e-38  Score=311.94  Aligned_cols=248  Identities=19%  Similarity=0.252  Sum_probs=200.0

Q ss_pred             CEEEeceeeccCCceEEEe------EEEEEEEeecCCCC---chHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEE
Q 012887          191 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG---NAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCV  261 (454)
Q Consensus       191 ~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~---~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~l  261 (454)
                      +|++.+.||+|+||.||+|      +.+++|.+......   ......+..|+..++.++|+||+++++++.+.+. +++
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~-~~l   79 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSN-INL   79 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCE-EEE
Confidence            4788899999999999986      47999999755433   2344557789999999999999999999988665 999


Q ss_pred             EEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCc
Q 012887          262 VTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA  340 (454)
Q Consensus       262 V~E~~~~gsL~~~l~~~~-~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~  340 (454)
                      ||||+ +++|.+++.... .+++..+..++.||++||.|||++|++|+||+|+||+++.++.++|+|||++.........
T Consensus        80 v~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~  158 (298)
T cd07841          80 VFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK  158 (298)
T ss_pred             EEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCcc
Confidence            99999 889999997665 7999999999999999999999999999999999999999999999999998766544333


Q ss_pred             ccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCC--------------
Q 012887          341 TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR--------------  406 (454)
Q Consensus       341 ~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~--------------  406 (454)
                      .....+++.|+|||.+.+..   .++.++|||||||++|+|++|.+||.+.++......+...-..              
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~---~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (298)
T cd07841         159 MTHQVVTRWYRAPELLFGAR---HYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPD  235 (298)
T ss_pred             ccccccceeeeCHHHHhCCC---CCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccc
Confidence            33345677899999885432   2455799999999999999998888876654433332211000              


Q ss_pred             -------CC-----CCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 012887          407 -------PE-----IPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLL  443 (454)
Q Consensus       407 -------~~-----~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~  443 (454)
                             +.     .....+.++.++|.+||+.||.+|||+.|++.+=+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~  284 (298)
T cd07841         236 YVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPY  284 (298)
T ss_pred             cccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCcc
Confidence                   00     11345788999999999999999999999998744

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-39  Score=340.50  Aligned_cols=258  Identities=17%  Similarity=0.281  Sum_probs=210.7

Q ss_pred             ceeecCCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCC-CCceeEEEEEEE-eC
Q 012887          184 RWLLNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCG-HKNILQFYCVCV-DE  255 (454)
Q Consensus       184 ~~~~~~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~~~g~~~-~~  255 (454)
                      .+.+..-++++.+.|.+|||+.||.+      ..+|+|++...  .......+.+|+.+|+.|. |+|||.|++... ..
T Consensus        31 ~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~  108 (738)
T KOG1989|consen   31 TFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINR  108 (738)
T ss_pred             EEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccc
Confidence            34577778999999999999999983      68999999865  3344566889999999996 999999999332 11


Q ss_pred             ---C--CeEEEEEeccCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhcC--cccCCccCCcEEEccCCcEEEE
Q 012887          256 ---N--HGLCVVTKLMEGGSVNDLILK--SRKLQTKEIIRIAIDVAEGIKFLNDHG--VAYRDLNSQRILLDRHGNVCLG  326 (454)
Q Consensus       256 ---~--~~l~lV~E~~~~gsL~~~l~~--~~~l~~~~~~~i~~qI~~gL~yLH~~~--iiHrDIKp~NILl~~~~~vKL~  326 (454)
                         +  ..++|.||||.||+|-|++.+  ..+|++.++++|+.|+|+|+.+||...  |||||||-+||||+.+|+.|||
T Consensus       109 ~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLC  188 (738)
T KOG1989|consen  109 SSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLC  188 (738)
T ss_pred             cCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeC
Confidence               1  347899999999999999964  347999999999999999999999987  9999999999999999999999


Q ss_pred             ccCCccccccCCCc---------ccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHH
Q 012887          327 DMGIVTACKSVGEA---------TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAA  397 (454)
Q Consensus       327 DFGla~~~~~~~~~---------~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~  397 (454)
                      |||-|.........         .-....|+.|.|||++.--. ...-+.|+|||||||+||-|+....||+.....   
T Consensus       189 DFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlys-g~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l---  264 (738)
T KOG1989|consen  189 DFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYS-GLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL---  264 (738)
T ss_pred             cccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhc-CCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce---
Confidence            99997644322211         11123589999999987322 123566799999999999999999999875433   


Q ss_pred             HHHHHcCCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCC
Q 012887          398 VGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNI  448 (454)
Q Consensus       398 ~~i~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~  448 (454)
                       +|+...+..+....++..+.+||+.||+.||++||++-+++..+.++.+.
T Consensus       265 -aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~  314 (738)
T KOG1989|consen  265 -AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK  314 (738)
T ss_pred             -eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence             45566666555567999999999999999999999999999999988765

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=2.8e-38  Score=303.72  Aligned_cols=233  Identities=24%  Similarity=0.419  Sum_probs=186.4

Q ss_pred             ceeeccCCceEEEeEE----------------EEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeE
Q 012887          196 DQIGPNSFKGVYKGKR----------------VGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGL  259 (454)
Q Consensus       196 ~~LG~G~fG~Vy~g~~----------------vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l  259 (454)
                      +.||+|+||.||+|..                +++|.+....   .....+.+|+.+++.++||||+++++++.. +. .
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~-~   75 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH---RDSLAFFETASLMSQLSHKHLVKLYGVCVR-DE-N   75 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch---hhHHHHHHHHHHHHcCCCcchhheeeEEec-CC-c
Confidence            4689999999998743                5566554222   114667889999999999999999999987 44 7


Q ss_pred             EEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCC-------cEEEEccCCc
Q 012887          260 CVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG-------NVCLGDMGIV  331 (454)
Q Consensus       260 ~lV~E~~~~gsL~~~l~~~~-~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~-------~vKL~DFGla  331 (454)
                      ++||||+++|+|.+++.+.. .++...+..++.||+.||.|||++||+||||||+|||++.++       .+||+|||++
T Consensus        76 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a  155 (259)
T cd05037          76 IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP  155 (259)
T ss_pred             EEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence            89999999999999997655 799999999999999999999999999999999999999888       7999999998


Q ss_pred             cccccCCCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHcCCCCCCC
Q 012887          332 TACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIP  410 (454)
Q Consensus       332 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p  410 (454)
                      .....    .....++..|+|||++.+..  ..++.++||||||+++|+|++ |..||...+......... ...  ..+
T Consensus       156 ~~~~~----~~~~~~~~~y~aPE~~~~~~--~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~-~~~--~~~  226 (259)
T cd05037         156 ITVLS----REERVERIPWIAPECIRNGQ--ASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ-DQH--RLP  226 (259)
T ss_pred             ccccc----ccccccCCCccChhhhcCCC--CCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh-cCC--CCC
Confidence            76543    22334567799999987652  234556999999999999999 688887765433322222 222  223


Q ss_pred             CCccHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 012887          411 KDCPQILKSLMIKCWNNSPSKRPQFSEIISLL  442 (454)
Q Consensus       411 ~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L  442 (454)
                      ......+.+++.+||..+|.+||++.++++.|
T Consensus       227 ~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l  258 (259)
T cd05037         227 MPDCAELANLINQCWTYDPTKRPSFRAILRDL  258 (259)
T ss_pred             CCCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence            33348899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=2.6e-38  Score=303.60  Aligned_cols=246  Identities=24%  Similarity=0.401  Sum_probs=204.7

Q ss_pred             CEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEEe
Q 012887          191 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTK  264 (454)
Q Consensus       191 ~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~E  264 (454)
                      +|++.+.||+|+||.||+|      ..+|+|.+............+.+|+.+++.++|+||+++++.+.+.+. .++|+|
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~-~~lv~e   79 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGR-LFIVME   79 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCe-EEEEEe
Confidence            4788999999999999985      468999886543333344567899999999999999999999887765 999999


Q ss_pred             ccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCc-EEEEccCCccccccCCCcc
Q 012887          265 LMEGGSVNDLILKSR--KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGN-VCLGDMGIVTACKSVGEAT  341 (454)
Q Consensus       265 ~~~~gsL~~~l~~~~--~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~-vKL~DFGla~~~~~~~~~~  341 (454)
                      |+++++|.+++.+..  .+++..+..++.|++.||.|||+.+++|+||||+||++++++. +||+|||.+..........
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~  159 (257)
T cd08225          80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELA  159 (257)
T ss_pred             cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcccc
Confidence            999999999986543  5899999999999999999999999999999999999998864 6999999987665443333


Q ss_pred             cccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHHHHH
Q 012887          342 EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLM  421 (454)
Q Consensus       342 ~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~li  421 (454)
                      ....+++.|+|||.+.+..    ++.++|+||||+++|+|++|..||...+.......+.. +...+.+..++.++.+++
T Consensus       160 ~~~~~~~~~~ape~~~~~~----~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~i  234 (257)
T cd08225         160 YTCVGTPYYLSPEICQNRP----YNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQ-GYFAPISPNFSRDLRSLI  234 (257)
T ss_pred             cccCCCccccCHHHHcCCC----CCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhc-ccCCCCCCCCCHHHHHHH
Confidence            3446788899999987654    44569999999999999999999987776665554443 334455667889999999


Q ss_pred             HHhcccCCCCCCCHHHHHHHH
Q 012887          422 IKCWNNSPSKRPQFSEIISLL  442 (454)
Q Consensus       422 ~~cl~~dP~~RPs~~ell~~L  442 (454)
                      .+||..+|++||++.+++++-
T Consensus       235 ~~~l~~~p~~Rpt~~~ll~~~  255 (257)
T cd08225         235 SQLFKVSPRDRPSITSILKRP  255 (257)
T ss_pred             HHHhccChhhCcCHHHHhhCC
Confidence            999999999999999998763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.6e-38  Score=302.91  Aligned_cols=247  Identities=21%  Similarity=0.363  Sum_probs=207.1

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCC---CchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCC-CeE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDK---GNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN-HGL  259 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~-~~l  259 (454)
                      .+|++.+.||+|+||.||+|      +.+|+|.+.....   .......+.+|+..+..++|+||+++++.+.+.. ..+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            57899999999999999986      4689998753221   2233456788999999999999999999987653 448


Q ss_pred             EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCC-
Q 012887          260 CVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG-  338 (454)
Q Consensus       260 ~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~-  338 (454)
                      ++||||+++++|.+++.+...+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++....... 
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  161 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICM  161 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccc
Confidence            8999999999999999777789999999999999999999999999999999999999999999999999987653311 


Q ss_pred             --CcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHH
Q 012887          339 --EATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQI  416 (454)
Q Consensus       339 --~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~  416 (454)
                        .......++..|+|||.+.+..    .+.++|+|||||++|+|++|..||...........+.....++.+|..+++.
T Consensus       162 ~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~  237 (264)
T cd06653         162 SGTGIKSVTGTPYWMSPEVISGEG----YGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDA  237 (264)
T ss_pred             cCccccccCCcccccCHhhhcCCC----CCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHH
Confidence              1122335788899999998654    3446999999999999999999999877777666666656667789999999


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHHH
Q 012887          417 LKSLMIKCWNNSPSKRPQFSEIISL  441 (454)
Q Consensus       417 l~~li~~cl~~dP~~RPs~~ell~~  441 (454)
                      +.+++.+||. +|..||++.+++.|
T Consensus       238 ~~~~i~~~l~-~~~~r~~~~~~~~~  261 (264)
T cd06653         238 CRDFLKQIFV-EEKRRPTAEFLLRH  261 (264)
T ss_pred             HHHHHHHHhc-CcccCccHHHHhcC
Confidence            9999999999 57999999998875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.9e-39  Score=323.96  Aligned_cols=256  Identities=21%  Similarity=0.290  Sum_probs=211.0

Q ss_pred             cceeecCCCEEEeceeeccCCceEEEe-----EEEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEEEEEEEeCC
Q 012887          183 GRWLLNSDNLEFIDQIGPNSFKGVYKG-----KRVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVDEN  256 (454)
Q Consensus       183 ~~~~~~~~~~~~~~~LG~G~fG~Vy~g-----~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~~~g~~~~~~  256 (454)
                      ....++...|+++++||+||-+.||+.     ..+|+|++............+..|+..|..| +|.+||++|++-..++
T Consensus       354 ~~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~  433 (677)
T KOG0596|consen  354 EIIKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDG  433 (677)
T ss_pred             eeEEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCc
Confidence            456688899999999999999999994     5688998877667777778899999999998 5999999999988766


Q ss_pred             CeEEEEEeccCCCCHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccc
Q 012887          257 HGLCVVTKLMEGGSVNDLILKSRK-LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK  335 (454)
Q Consensus       257 ~~l~lV~E~~~~gsL~~~l~~~~~-l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~  335 (454)
                      . +||||||=+. +|...|++... ++...+..|..||+.|+.++|++||||.||||+|+|+- .|.+||+|||+|....
T Consensus       434 ~-lYmvmE~Gd~-DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~  510 (677)
T KOG0596|consen  434 Y-LYMVMECGDI-DLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQ  510 (677)
T ss_pred             e-EEEEeecccc-cHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeechhcccC
Confidence            5 9999998644 99999976653 44458899999999999999999999999999999998 7889999999998776


Q ss_pred             cCCC--cccccCCCCcccccccccCCCCC-------CCCCchhhHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHHHcCC
Q 012887          336 SVGE--ATEYETDGYRWLAPEIIAGDPES-------VSETWMSNVYSFGMVIWEMVTGEAAYAACSP-VQAAVGIAACGL  405 (454)
Q Consensus       336 ~~~~--~~~~~~gt~~y~APE~l~~~~~~-------~~~~~ksDVwSlGviL~elltG~~Pf~~~~~-~~~~~~i~~~~~  405 (454)
                      .+..  ......||+.|||||.+.....+       .+.+.+|||||||||||+|+.|+.||..... ...+..|..-+.
T Consensus       511 ~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~  590 (677)
T KOG0596|consen  511 PDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNH  590 (677)
T ss_pred             ccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCc
Confidence            5433  35566899999999998754333       2345679999999999999999999987553 334444554444


Q ss_pred             CCCCCCCccH-HHHHHHHHhcccCCCCCCCHHHHHHH
Q 012887          406 RPEIPKDCPQ-ILKSLMIKCWNNSPSKRPQFSEIISL  441 (454)
Q Consensus       406 ~~~~p~~~~~-~l~~li~~cl~~dP~~RPs~~ell~~  441 (454)
                      ..++|..-+. ++.++|+.||+.||.+||+..|+|+|
T Consensus       591 ~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh  627 (677)
T KOG0596|consen  591 EIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH  627 (677)
T ss_pred             cccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence            4566665443 39999999999999999999999976

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=4.5e-38  Score=311.83  Aligned_cols=251  Identities=22%  Similarity=0.317  Sum_probs=203.7

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCc-hHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGN-AYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  262 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV  262 (454)
                      +.|++.+.||+|+||.||+|      +.+|+|.+....... .....+.+|+.++..++||||+++++++.+.+. .++|
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~-~~lv   93 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHT-AWLV   93 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCe-EEEE
Confidence            55888999999999999985      578999886443332 334568899999999999999999999998776 8999


Q ss_pred             EeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCcc
Q 012887          263 TKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT  341 (454)
Q Consensus       263 ~E~~~~gsL~~~l~~-~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~  341 (454)
                      |||+++ +|.+++.. ...+++..+..++.||+.||.|||+++++||||+|+||+++.++.+||+|||++......    
T Consensus        94 ~e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~----  168 (307)
T cd06607          94 MEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA----  168 (307)
T ss_pred             HHhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC----
Confidence            999975 78777643 457999999999999999999999999999999999999999999999999997654322    


Q ss_pred             cccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHHHHH
Q 012887          342 EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLM  421 (454)
Q Consensus       342 ~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~li  421 (454)
                      ....+++.|+|||.+.+... ..++.++||||||+++|||++|..||.+.........+.........+..++..+.++|
T Consensus       169 ~~~~~~~~y~aPE~~~~~~~-~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  247 (307)
T cd06607         169 NSFVGTPYWMAPEVILAMDE-GQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRNFV  247 (307)
T ss_pred             CCccCCccccCceeeeccCC-CCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHHHHH
Confidence            23456788999998853221 23556799999999999999999999887766655544433222223445789999999


Q ss_pred             HHhcccCCCCCCCHHHHHHHHHhhcC
Q 012887          422 IKCWNNSPSKRPQFSEIISLLLRTNN  447 (454)
Q Consensus       422 ~~cl~~dP~~RPs~~ell~~L~~~~~  447 (454)
                      .+||..+|++||++.+++.+.+-...
T Consensus       248 ~~~l~~~p~~Rp~~~~il~~~~~~~~  273 (307)
T cd06607         248 DSCLQKIPQDRPSSEELLKHRFVLRE  273 (307)
T ss_pred             HHHhcCChhhCcCHHHHhcChhhccc
Confidence            99999999999999999988765443

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=3.8e-38  Score=304.14  Aligned_cols=241  Identities=20%  Similarity=0.295  Sum_probs=203.6

Q ss_pred             eeccCCceEEEe------EEEEEEEeecCCCC-chHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEEeccCCCC
Q 012887          198 IGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGS  270 (454)
Q Consensus       198 LG~G~fG~Vy~g------~~vavK~l~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~E~~~~gs  270 (454)
                      ||.|+||.||++      +.+++|.+...... ......+.+|+.++..++||||+++++.+.+++. +++||||+++++
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~lv~e~~~~~~   79 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKY-IYMLMEYCLGGE   79 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCc-cEEEEecCCCCc
Confidence            699999999985      56899988644322 2345668899999999999999999999987776 999999999999


Q ss_pred             HHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCcccccCCCCcc
Q 012887          271 VNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRW  350 (454)
Q Consensus       271 L~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~gt~~y  350 (454)
                      |.+++.+...+++..+..++.||+.||.|||+++++|+||+|+||+++.++.++|+|||++....... ......+++.|
T Consensus        80 L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-~~~~~~~~~~~  158 (262)
T cd05572          80 LWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-KTWTFCGTPEY  158 (262)
T ss_pred             HHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-ccccccCCcCc
Confidence            99999877789999999999999999999999999999999999999999999999999987664432 22334678889


Q ss_pred             cccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC--HHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhcccC
Q 012887          351 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACS--PVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNS  428 (454)
Q Consensus       351 ~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~--~~~~~~~i~~~~~~~~~p~~~~~~l~~li~~cl~~d  428 (454)
                      +|||.+.+..    ++.++|+||||+++|+|++|..||....  +......+.........|...++++.++|.+||+.+
T Consensus       159 ~~PE~~~~~~----~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~  234 (262)
T cd05572         159 VAPEIILNKG----YDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRN  234 (262)
T ss_pred             cChhHhcCCC----CCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCC
Confidence            9999987654    3456999999999999999999998766  555555555445566778888999999999999999


Q ss_pred             CCCCCC-----HHHHHHHHHh
Q 012887          429 PSKRPQ-----FSEIISLLLR  444 (454)
Q Consensus       429 P~~RPs-----~~ell~~L~~  444 (454)
                      |++||+     +.|++++-+-
T Consensus       235 p~~R~~~~~~~~~~l~~~~~~  255 (262)
T cd05572         235 PEERLGNLKGGIKDIKKHKWF  255 (262)
T ss_pred             hhhCcCCcccCHHHHhcChhh
Confidence            999999     9999987653

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=5.5e-38  Score=306.29  Aligned_cols=245  Identities=23%  Similarity=0.423  Sum_probs=203.8

Q ss_pred             CEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEEe
Q 012887          191 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTK  264 (454)
Q Consensus       191 ~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~E  264 (454)
                      -|++.+.||+|+||.||+|      ..+|+|.+.... .......+.+|+..+.+++||||+++++++...+. .++|||
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~lv~e   82 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTK-LWIIME   82 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEecccc-chHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCe-EEEEEE
Confidence            4677889999999999986      468999875332 22344568889999999999999999999988776 999999


Q ss_pred             ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCccccc
Q 012887          265 LMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE  344 (454)
Q Consensus       265 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~  344 (454)
                      |+++++|.+++. ...+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.............
T Consensus        83 ~~~~~~l~~~i~-~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~  161 (277)
T cd06641          83 YLGGGSALDLLE-PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF  161 (277)
T ss_pred             eCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchhhhccc
Confidence            999999999885 3578999999999999999999999999999999999999999999999999987654332223334


Q ss_pred             CCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHHHHHHHh
Q 012887          345 TDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKC  424 (454)
Q Consensus       345 ~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~li~~c  424 (454)
                      .++..|+|||.+.+..    .+.++|+|||||++|+|++|..||....+......+ .....+.++..++.++.+++.+|
T Consensus       162 ~~~~~y~~PE~~~~~~----~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~  236 (277)
T cd06641         162 VGTPFWMAPEVIKQSA----YDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLI-PKNNPPTLEGNYSKPLKEFVEAC  236 (277)
T ss_pred             cCCccccChhhhccCC----CCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHH-hcCCCCCCCcccCHHHHHHHHHH
Confidence            5778899999987654    345699999999999999999999876665544443 33445566778899999999999


Q ss_pred             cccCCCCCCCHHHHHHHHH
Q 012887          425 WNNSPSKRPQFSEIISLLL  443 (454)
Q Consensus       425 l~~dP~~RPs~~ell~~L~  443 (454)
                      |..+|.+||++.+++.+-+
T Consensus       237 l~~~p~~Rp~~~~~l~~~~  255 (277)
T cd06641         237 LNKEPSFRPTAKELLKHKF  255 (277)
T ss_pred             ccCChhhCcCHHHHHhCHH
Confidence            9999999999999999743

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=3.3e-38  Score=346.11  Aligned_cols=252  Identities=20%  Similarity=0.306  Sum_probs=199.3

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCC-chHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  262 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV  262 (454)
                      ++|++.+.||+|+||.||+|      +.||+|++...... .....++.+|+.++..++||||+++++++.+.+. .++|
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~-lyLV   80 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDP-VYYT   80 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCE-EEEE
Confidence            57899999999999999985      57999998753322 2345568899999999999999999999988776 9999


Q ss_pred             EeccCCCCHHHHHHhC-----------CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCc
Q 012887          263 TKLMEGGSVNDLILKS-----------RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIV  331 (454)
Q Consensus       263 ~E~~~~gsL~~~l~~~-----------~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla  331 (454)
                      |||++||+|.+++...           ..++...+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus        81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLA  160 (932)
T PRK13184         81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAA  160 (932)
T ss_pred             EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcc
Confidence            9999999999998531           23456778899999999999999999999999999999999999999999998


Q ss_pred             cccccCC------------------CcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCH
Q 012887          332 TACKSVG------------------EATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSP  393 (454)
Q Consensus       332 ~~~~~~~------------------~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~  393 (454)
                      .......                  .......||+.|+|||++.+..+    +.++|||||||++|||++|..||.....
T Consensus       161 k~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~----S~kSDIWSLGVILyELLTG~~PF~~~~~  236 (932)
T PRK13184        161 IFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPA----SESTDIYALGVILYQMLTLSFPYRRKKG  236 (932)
T ss_pred             eecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCC----CcHhHHHHHHHHHHHHHHCCCCCCCcch
Confidence            7652110                  00112358999999999987654    4569999999999999999999987554


Q ss_pred             HHHHHHHHHcCCCCCC--CCCccHHHHHHHHHhcccCCCCCCC-HHHHHHHHHhhcC
Q 012887          394 VQAAVGIAACGLRPEI--PKDCPQILKSLMIKCWNNSPSKRPQ-FSEIISLLLRTNN  447 (454)
Q Consensus       394 ~~~~~~i~~~~~~~~~--p~~~~~~l~~li~~cl~~dP~~RPs-~~ell~~L~~~~~  447 (454)
                      .......... .+...  ...+|+.+.+++.+||+.||.+||+ +.++++.|.....
T Consensus       237 ~ki~~~~~i~-~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq  292 (932)
T PRK13184        237 RKISYRDVIL-SPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ  292 (932)
T ss_pred             hhhhhhhhcc-ChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            4332221111 11111  2367899999999999999999964 7777777776543

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=4e-38  Score=312.28  Aligned_cols=252  Identities=16%  Similarity=0.253  Sum_probs=202.4

Q ss_pred             CCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCC-CeEEE
Q 012887          189 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN-HGLCV  261 (454)
Q Consensus       189 ~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~-~~l~l  261 (454)
                      .++|++.+.||+|+||.||+|      +.||+|.++.............+|+.++.+++|+||+++++++.... ..+++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            478999999999999999986      46999998754433333344668999999999999999999987653 34899


Q ss_pred             EEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCc
Q 012887          262 VTKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA  340 (454)
Q Consensus       262 V~E~~~~gsL~~~l~~-~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~  340 (454)
                      ||||+.+ +|.+++.. ...+++..+..++.||+.||.|||+.|++||||||+||+++.++.+||+|||++.........
T Consensus        86 v~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~~  164 (309)
T cd07845          86 VMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKP  164 (309)
T ss_pred             EEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCccCC
Confidence            9999975 89888865 357999999999999999999999999999999999999999999999999998766543222


Q ss_pred             ccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCC--------------
Q 012887          341 TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR--------------  406 (454)
Q Consensus       341 ~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~--------------  406 (454)
                      .....++..|+|||.+.+..   .++.++|||||||++|+|++|..||.+.++......+......              
T Consensus       165 ~~~~~~~~~y~aPE~~~~~~---~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (309)
T cd07845         165 MTPKVVTLWYRAPELLLGCT---TYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPL  241 (309)
T ss_pred             CCcccccccccChhhhcCCC---CcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccc
Confidence            23334577899999987542   2455799999999999999999999988777665544431100              


Q ss_pred             ---CCCC-----------CCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 012887          407 ---PEIP-----------KDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR  444 (454)
Q Consensus       407 ---~~~p-----------~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~  444 (454)
                         ...+           ...++++.++|.+||+.||.+|||+++++.+-+-
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f  293 (309)
T cd07845         242 VGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYF  293 (309)
T ss_pred             cccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhh
Confidence               0001           1247889999999999999999999999988664

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=5.6e-38  Score=308.17  Aligned_cols=247  Identities=19%  Similarity=0.310  Sum_probs=192.2

Q ss_pred             CCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEE
Q 012887          189 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  262 (454)
Q Consensus       189 ~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV  262 (454)
                      .++|.+.+.||+|+||.||+|      +.+++|.+..... ......+.+|+..++.++|+||+++++++.+.+. .|+|
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~-~~lv   81 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE-EGVPFTAIREASLLKGLKHANIVLLHDIIHTKET-LTFV   81 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc-CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCe-EEEE
Confidence            378999999999999999985      4799999864332 2233456789999999999999999999987765 8999


Q ss_pred             EeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCcc
Q 012887          263 TKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT  341 (454)
Q Consensus       263 ~E~~~~gsL~~~l~~-~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~  341 (454)
                      |||+. ++|.+.+.. ...+++..+..++.||+.||.|||++|++|+||||+|||++.++.+||+|||+++.........
T Consensus        82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~  160 (291)
T cd07870          82 FEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTY  160 (291)
T ss_pred             Eeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCCC
Confidence            99996 577777644 3568889999999999999999999999999999999999999999999999987654333333


Q ss_pred             cccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHH-HHHHHH-cC---------------
Q 012887          342 EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQA-AVGIAA-CG---------------  404 (454)
Q Consensus       342 ~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~-~~~i~~-~~---------------  404 (454)
                      ....+++.|+|||.+.+..   .++.++|||||||++|+|++|..||.+...... ...+.. .+               
T Consensus       161 ~~~~~~~~y~aPE~~~~~~---~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (291)
T cd07870         161 SSEVVTLWYRPPDVLLGAT---DYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPN  237 (291)
T ss_pred             CCccccccccCCceeecCC---CCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhccc
Confidence            3445688899999987542   234569999999999999999999986554321 111110 00               


Q ss_pred             CCCC-----CC---------CCccHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012887          405 LRPE-----IP---------KDCPQILKSLMIKCWNNSPSKRPQFSEIISL  441 (454)
Q Consensus       405 ~~~~-----~p---------~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  441 (454)
                      ..+.     .+         ...+..+.+++.+|++.||.+|||+.|++.+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h  288 (291)
T cd07870         238 YKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH  288 (291)
T ss_pred             ccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence            0000     00         0125689999999999999999999999875

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=5.6e-38  Score=306.29  Aligned_cols=247  Identities=16%  Similarity=0.268  Sum_probs=201.1

Q ss_pred             CEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEEe
Q 012887          191 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTK  264 (454)
Q Consensus       191 ~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~E  264 (454)
                      +|++.+.||.|+||.||+|      +.+++|++............+.+|+.++.+++||||+++++++.+.+. .++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~-~~~v~e   79 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSG-FVLVME   79 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCe-eEEEec
Confidence            4789999999999999985      479999987654444455678899999999999999999999988765 999999


Q ss_pred             ccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCC-ccc
Q 012887          265 LMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE-ATE  342 (454)
Q Consensus       265 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~-~~~  342 (454)
                      |+ +++|.+++.. ...+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++........ ...
T Consensus        80 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~  158 (286)
T cd07832          80 YM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYS  158 (286)
T ss_pred             cc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCccc
Confidence            99 9999999854 45799999999999999999999999999999999999999999999999999876644321 122


Q ss_pred             ccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCC---------------
Q 012887          343 YETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP---------------  407 (454)
Q Consensus       343 ~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~---------------  407 (454)
                      ...++..|+|||.+.+..   .++.++||||+|+++|+|++|.+||.+..+......+...-..+               
T Consensus       159 ~~~~~~~y~aPE~~~~~~---~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (286)
T cd07832         159 HQVATRWYRAPELLYGAR---KYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYN  235 (286)
T ss_pred             cccCcccccCceeeeccc---cCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhh
Confidence            345788899999986542   23557999999999999999998888766655443332210000               


Q ss_pred             -------------CCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 012887          408 -------------EIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL  442 (454)
Q Consensus       408 -------------~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L  442 (454)
                                   ......+.++.+++.+||..+|.+||++++++.|-
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~  283 (286)
T cd07832         236 KITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHP  283 (286)
T ss_pred             cccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCc
Confidence                         01124578899999999999999999999999874

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=9.4e-39  Score=307.71  Aligned_cols=244  Identities=18%  Similarity=0.266  Sum_probs=203.4

Q ss_pred             CEEEeceeeccCCceEEEe------EEEEEEEeecCCCCc-hHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEE
Q 012887          191 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGN-AYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  263 (454)
Q Consensus       191 ~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~  263 (454)
                      +|++.+.||.|+||.||++      +.+|+|.+....... .....+.+|+..+.+++||||+++++.+.+.+. +++|+
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~lv~   79 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEEN-MYLVV   79 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCe-EEEEE
Confidence            4789999999999999985      578999887443222 345668899999999999999999999887665 99999


Q ss_pred             eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCcccc
Q 012887          264 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY  343 (454)
Q Consensus       264 E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~  343 (454)
                      ||+.+++|.+++.+...+++..+..++.||+.||.|||+++++|+||+|+||++++++.++|+|||++....... ....
T Consensus        80 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-~~~~  158 (258)
T cd05578          80 DLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-LTTS  158 (258)
T ss_pred             eCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc-cccc
Confidence            999999999999777789999999999999999999999999999999999999999999999999977654332 2233


Q ss_pred             cCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCH--HHHHHHHHHcCCCCCCCCCccHHHHHHH
Q 012887          344 ETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSP--VQAAVGIAACGLRPEIPKDCPQILKSLM  421 (454)
Q Consensus       344 ~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~--~~~~~~i~~~~~~~~~p~~~~~~l~~li  421 (454)
                      ..++..|+|||.+.+..    .+.++|+||||+++|+|++|..||...+.  ......... ......|..++..+.++|
T Consensus       159 ~~~~~~y~~PE~~~~~~----~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~i  233 (258)
T cd05578         159 TSGTPGYMAPEVLCRQG----YSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQE-TADVLYPATWSTEAIDAI  233 (258)
T ss_pred             cCCChhhcCHHHHcccC----CCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhc-cccccCcccCcHHHHHHH
Confidence            45778899999998664    44569999999999999999999987664  222222222 145667788999999999


Q ss_pred             HHhcccCCCCCCCH--HHHHHH
Q 012887          422 IKCWNNSPSKRPQF--SEIISL  441 (454)
Q Consensus       422 ~~cl~~dP~~RPs~--~ell~~  441 (454)
                      .+||..||.+||++  .|++++
T Consensus       234 ~~~l~~~p~~R~~~~~~~l~~~  255 (258)
T cd05578         234 NKLLERDPQKRLGDNLKDLKNH  255 (258)
T ss_pred             HHHccCChhHcCCccHHHHhcC
Confidence            99999999999999  777653

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=6.9e-38  Score=303.53  Aligned_cols=247  Identities=16%  Similarity=0.361  Sum_probs=200.7

Q ss_pred             CEEEeceeeccCCceEEEe-------EEEEEEEeecCCC--------CchHHHHHHHHHHHHHh-CCCCceeEEEEEEEe
Q 012887          191 NLEFIDQIGPNSFKGVYKG-------KRVGIEKLKGCDK--------GNAYEFELRKDLLELMT-CGHKNILQFYCVCVD  254 (454)
Q Consensus       191 ~~~~~~~LG~G~fG~Vy~g-------~~vavK~l~~~~~--------~~~~~~~~~~Ei~~l~~-l~HpnIv~~~g~~~~  254 (454)
                      +|++.+.||+|+||.||+|       +.+|+|.+.....        ......++..|+..+.. ++||||+++++++.+
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            4778899999999999985       4588888754321        12233446677777764 789999999999988


Q ss_pred             CCCeEEEEEeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHh-cCcccCCccCCcEEEccCCcEEEEccC
Q 012887          255 ENHGLCVVTKLMEGGSVNDLILK----SRKLQTKEIIRIAIDVAEGIKFLND-HGVAYRDLNSQRILLDRHGNVCLGDMG  329 (454)
Q Consensus       255 ~~~~l~lV~E~~~~gsL~~~l~~----~~~l~~~~~~~i~~qI~~gL~yLH~-~~iiHrDIKp~NILl~~~~~vKL~DFG  329 (454)
                      .+. .++||||+++++|.+++..    ...+++..++.++.|++.||.|||+ .+++|+||+|+|||++.++.+||+|||
T Consensus        81 ~~~-~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg  159 (269)
T cd08528          81 NDR-LYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFG  159 (269)
T ss_pred             CCe-EEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEeccc
Confidence            776 9999999999999998742    3478999999999999999999996 689999999999999999999999999


Q ss_pred             CccccccCCCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCC
Q 012887          330 IVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEI  409 (454)
Q Consensus       330 la~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~  409 (454)
                      ++....... ......++..|+|||.+.+..    ++.++|+||||+++|+|++|..||...........+......+..
T Consensus       160 ~~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~----~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  234 (269)
T cd08528         160 LAKQKQPES-KLTSVVGTILYSCPEIVKNEP----YGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLP  234 (269)
T ss_pred             ceeeccccc-ccccccCcccCcChhhhcCCC----CchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCC
Confidence            987654432 233456788899999998654    345699999999999999999999877666655555544444333


Q ss_pred             CCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 012887          410 PKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLL  443 (454)
Q Consensus       410 p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~  443 (454)
                      ...+++++.++|.+||+.||++||++.|+.+++.
T Consensus       235 ~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         235 EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence            3367899999999999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-37  Score=298.27  Aligned_cols=245  Identities=24%  Similarity=0.434  Sum_probs=210.0

Q ss_pred             CEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEEe
Q 012887          191 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTK  264 (454)
Q Consensus       191 ~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~E  264 (454)
                      +|++.+.||+|+||.||++      +.+++|.+............+.+|+..+.+++|||++++++++.+.+. .+++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-~~~v~e   79 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDS-LYIILE   79 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCE-EEEEEe
Confidence            4788999999999999985      479999997655443455678899999999999999999999987765 999999


Q ss_pred             ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCccccc
Q 012887          265 LMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE  344 (454)
Q Consensus       265 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~  344 (454)
                      |+++++|.+++.....+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++.............
T Consensus        80 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~  159 (254)
T cd06627          80 YAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASV  159 (254)
T ss_pred             cCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccccccc
Confidence            99999999999877889999999999999999999999999999999999999999999999999987765543333344


Q ss_pred             CCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHHHHHHHh
Q 012887          345 TDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKC  424 (454)
Q Consensus       345 ~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~li~~c  424 (454)
                      .++..|+|||.+.+..    .+.++||||||+++|+|++|..||....+......... ...+.++..++..+.+++.+|
T Consensus       160 ~~~~~y~~pe~~~~~~----~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~  234 (254)
T cd06627         160 VGTPYWMAPEVIEMSG----ASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQ-DDHPPLPEGISPELKDFLMQC  234 (254)
T ss_pred             ccchhhcCHhhhcCCC----CCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhc-cCCCCCCCCCCHHHHHHHHHH
Confidence            6788899999987654    34569999999999999999999988776555555443 445567788899999999999


Q ss_pred             cccCCCCCCCHHHHHHH
Q 012887          425 WNNSPSKRPQFSEIISL  441 (454)
Q Consensus       425 l~~dP~~RPs~~ell~~  441 (454)
                      |..+|++||++.+++.+
T Consensus       235 l~~~p~~R~~~~~~l~~  251 (254)
T cd06627         235 FQKDPNLRPTAKQLLKH  251 (254)
T ss_pred             HhCChhhCcCHHHHhcC
Confidence            99999999999999854

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.3e-39  Score=330.51  Aligned_cols=250  Identities=21%  Similarity=0.319  Sum_probs=221.7

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  263 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~  263 (454)
                      ..|.+.+.||+|.|+.|..+      ..||+|.+....-.......+.+|+.++..++|||||+++.+...... +|+||
T Consensus        56 g~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~-lylV~  134 (596)
T KOG0586|consen   56 GLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEAT-LYLVM  134 (596)
T ss_pred             cceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecce-eEEEE
Confidence            57899999999999999985      589999987655555555668999999999999999999999998877 99999


Q ss_pred             eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCcccc
Q 012887          264 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY  343 (454)
Q Consensus       264 E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~  343 (454)
                      ||+.+|.+++++.+.+++.+..+..++.|+++|++|||+++|+|||||++|||++.+.++||+|||++..+.. ......
T Consensus       135 eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~-~~~lqt  213 (596)
T KOG0586|consen  135 EYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDY-GLMLQT  213 (596)
T ss_pred             EeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeecc-cccccc
Confidence            9999999999999999999999999999999999999999999999999999999999999999999988774 344566


Q ss_pred             cCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHHHHHHH
Q 012887          344 ETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIK  423 (454)
Q Consensus       344 ~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~li~~  423 (454)
                      .+|++.|.|||.+.|..+...   .+|+||+|++||-|+.|..||++.+-...-.+.+...++  +|-.++.+..++|++
T Consensus       214 ~cgsppyAaPEl~~g~~y~gp---e~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~r--Ip~~ms~dce~lLrk  288 (596)
T KOG0586|consen  214 FCGSPPYAAPELFNGKKYDGP---EVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYR--IPFYMSCDCEDLLRK  288 (596)
T ss_pred             cCCCCCccChHhhcCcccCCc---ceehhhhhhhheeeeecccccCCcccccccchheeeeec--ccceeechhHHHHHH
Confidence            789999999999999886543   589999999999999999999987776666666665555  666778899999999


Q ss_pred             hcccCCCCCCCHHHHHHHHHhhc
Q 012887          424 CWNNSPSKRPQFSEIISLLLRTN  446 (454)
Q Consensus       424 cl~~dP~~RPs~~ell~~L~~~~  446 (454)
                      +|..+|.+|++.++++++-|.-.
T Consensus       289 ~lvl~Pskr~~~dqim~~~W~n~  311 (596)
T KOG0586|consen  289 FLVLNPSKRGPCDQIMKDRWRND  311 (596)
T ss_pred             hhccCccccCCHHHhhhhcccch
Confidence            99999999999999999877543

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=2.3e-38  Score=310.11  Aligned_cols=250  Identities=22%  Similarity=0.365  Sum_probs=196.3

Q ss_pred             CCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCC-CCceeEEEEEEEeCCCeEEE
Q 012887          189 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCG-HKNILQFYCVCVDENHGLCV  261 (454)
Q Consensus       189 ~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~~~g~~~~~~~~l~l  261 (454)
                      .++|+..+.||+|+||.||++      +.+|+|.+...... .....+.+|+..+.++. ||||+++++++..++. .++
T Consensus         3 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~-~~~   80 (288)
T cd06616           3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGD-CWI   80 (288)
T ss_pred             HHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCc-EEE
Confidence            367788899999999999984      57999988743322 44556788999999886 9999999999987766 889


Q ss_pred             EEeccCCCCHHHHHH-----hCCCCCHHHHHHHHHHHHHHHHHHHhc-CcccCCccCCcEEEccCCcEEEEccCCccccc
Q 012887          262 VTKLMEGGSVNDLIL-----KSRKLQTKEIIRIAIDVAEGIKFLNDH-GVAYRDLNSQRILLDRHGNVCLGDMGIVTACK  335 (454)
Q Consensus       262 V~E~~~~gsL~~~l~-----~~~~l~~~~~~~i~~qI~~gL~yLH~~-~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~  335 (454)
                      +|||+.. +|.++..     ....+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++....
T Consensus        81 ~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  159 (288)
T cd06616          81 CMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV  159 (288)
T ss_pred             EEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence            9999865 6665432     235799999999999999999999975 99999999999999999999999999987654


Q ss_pred             cCCCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHHHcCCCCCC----C
Q 012887          336 SVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPV-QAAVGIAACGLRPEI----P  410 (454)
Q Consensus       336 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~-~~~~~i~~~~~~~~~----p  410 (454)
                      ... ......++..|+|||.+.+.. ...++.++|||||||++|+|++|..||...... ....... .+..+.+    +
T Consensus       160 ~~~-~~~~~~~~~~y~aPE~~~~~~-~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~  236 (288)
T cd06616         160 DSI-AKTRDAGCRPYMAPERIDPSA-RDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVV-KGDPPILSNSEE  236 (288)
T ss_pred             cCC-ccccccCccCccCHHHhcccc-ccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhc-CCCCCcCCCcCC
Confidence            322 223346788899999987652 123556799999999999999999999875532 2222222 2222222    2


Q ss_pred             CCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 012887          411 KDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR  444 (454)
Q Consensus       411 ~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~  444 (454)
                      ..++.++.+||.+||+.||++||++.+++.+-+-
T Consensus       237 ~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~  270 (288)
T cd06616         237 REFSPSFVNFINLCLIKDESKRPKYKELLEHPFI  270 (288)
T ss_pred             CccCHHHHHHHHHHccCChhhCcCHHHHhcChhh
Confidence            3478999999999999999999999999987554

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=7.6e-38  Score=299.14  Aligned_cols=245  Identities=24%  Similarity=0.442  Sum_probs=209.6

Q ss_pred             CEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEEe
Q 012887          191 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTK  264 (454)
Q Consensus       191 ~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~E  264 (454)
                      +|++.+.||+|+||.||++      ..+++|.+............+.+|+..+..++|||++++++.+...+. .++|+|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~-~~lv~e   79 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGK-LCIVME   79 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCE-EEEEEE
Confidence            4788999999999999984      578999987654444556678899999999999999999999988765 999999


Q ss_pred             ccCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCc
Q 012887          265 LMEGGSVNDLILKS----RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA  340 (454)
Q Consensus       265 ~~~~gsL~~~l~~~----~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~  340 (454)
                      |+++++|.+++.+.    ..+++..+..++.+++.||.|||++|++|+||+|+||+++.++.++|+|||++.........
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~  159 (258)
T cd08215          80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDL  159 (258)
T ss_pred             ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCcce
Confidence            99999999998653    67999999999999999999999999999999999999999999999999998766554433


Q ss_pred             ccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHHHH
Q 012887          341 TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSL  420 (454)
Q Consensus       341 ~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~l  420 (454)
                      .....+++.|+|||.+.+..    ++.++|+||+|+++|+|++|..||.............. .....+|..++..+.++
T Consensus       160 ~~~~~~~~~y~~pe~~~~~~----~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  234 (258)
T cd08215         160 AKTVVGTPYYLSPELCQNKP----YNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILK-GQYPPIPSQYSSELRNL  234 (258)
T ss_pred             ecceeeeecccChhHhccCC----CCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhc-CCCCCCCCCCCHHHHHH
Confidence            34446788899999987664    34459999999999999999999988776665555543 34556777899999999


Q ss_pred             HHHhcccCCCCCCCHHHHHHH
Q 012887          421 MIKCWNNSPSKRPQFSEIISL  441 (454)
Q Consensus       421 i~~cl~~dP~~RPs~~ell~~  441 (454)
                      +.+||..+|++||++.+++.+
T Consensus       235 i~~~l~~~p~~Rp~~~~ll~~  255 (258)
T cd08215         235 VSSLLQKDPEERPSIAQILQS  255 (258)
T ss_pred             HHHHcCCChhhCcCHHHHhcC
Confidence            999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=7.8e-38  Score=306.36  Aligned_cols=248  Identities=27%  Similarity=0.481  Sum_probs=206.9

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  263 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~  263 (454)
                      +.|++...||+|+||.||+|      ..+++|.+.....   ....+.+|+..++.++|+|++++++.+...+. .++|+
T Consensus        19 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-~~lv~   94 (286)
T cd06614          19 ELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVGDE-LWVVM   94 (286)
T ss_pred             ccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCE-EEEEE
Confidence            66888999999999999985      4689999874333   44567889999999999999999999988865 99999


Q ss_pred             eccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCccc
Q 012887          264 KLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE  342 (454)
Q Consensus       264 E~~~~gsL~~~l~~~~-~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~  342 (454)
                      ||+++++|.+++.... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++...........
T Consensus        95 e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~  174 (286)
T cd06614          95 EYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRN  174 (286)
T ss_pred             eccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchhhhc
Confidence            9999999999997766 899999999999999999999999999999999999999999999999999765544332333


Q ss_pred             ccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCC-CCCCCccHHHHHHH
Q 012887          343 YETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP-EIPKDCPQILKSLM  421 (454)
Q Consensus       343 ~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~-~~p~~~~~~l~~li  421 (454)
                      ...++..|+|||.+.+..+    +.++|+|||||++|+|++|..||....+......+....... ..+..++.++.++|
T Consensus       175 ~~~~~~~y~~PE~~~~~~~----~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  250 (286)
T cd06614         175 SVVGTPYWMAPEVIKRKDY----GPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFL  250 (286)
T ss_pred             cccCCcccCCHhHhcCCCC----CCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHHH
Confidence            4457788999999876543    456999999999999999999999877766555554433322 22334889999999


Q ss_pred             HHhcccCCCCCCCHHHHHHHHHhh
Q 012887          422 IKCWNNSPSKRPQFSEIISLLLRT  445 (454)
Q Consensus       422 ~~cl~~dP~~RPs~~ell~~L~~~  445 (454)
                      .+||+.+|.+||++.+++.+.+-.
T Consensus       251 ~~~l~~~p~~Rpt~~~il~~~~~~  274 (286)
T cd06614         251 NKCLVKDPEKRPSAEELLQHPFLK  274 (286)
T ss_pred             HHHhccChhhCcCHHHHhhChHhh
Confidence            999999999999999999865543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=6.3e-38  Score=311.74  Aligned_cols=239  Identities=18%  Similarity=0.264  Sum_probs=181.0

Q ss_pred             eceeeccCCceEEEeE--------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeC-CCeEEEEEec
Q 012887          195 IDQIGPNSFKGVYKGK--------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDE-NHGLCVVTKL  265 (454)
Q Consensus       195 ~~~LG~G~fG~Vy~g~--------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~-~~~l~lV~E~  265 (454)
                      .++||+|+||.||+|+        .+|+|.+.....    ...+.+|+.++..++||||+++++++... +..+++||||
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~   81 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY   81 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEec
Confidence            4679999999999974        578998864322    23467899999999999999999998754 3458999999


Q ss_pred             cCCCCHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEE----ccCCcEEEEccCCcc
Q 012887          266 MEGGSVNDLILKS---------RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILL----DRHGNVCLGDMGIVT  332 (454)
Q Consensus       266 ~~~gsL~~~l~~~---------~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl----~~~~~vKL~DFGla~  332 (454)
                      +.+ +|.+++...         ..+++..+..++.||+.||.|||++||+||||||+|||+    +.++.+||+|||++.
T Consensus        82 ~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~  160 (317)
T cd07868          82 AEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR  160 (317)
T ss_pred             cCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence            965 888887421         258999999999999999999999999999999999999    456789999999987


Q ss_pred             ccccCCC---cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHH---------HHHHHH
Q 012887          333 ACKSVGE---ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPV---------QAAVGI  400 (454)
Q Consensus       333 ~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~---------~~~~~i  400 (454)
                      .......   ......+|+.|+|||++.+..   .++.++||||+||++|+|++|.+||......         .....+
T Consensus       161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~---~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~  237 (317)
T cd07868         161 LFNSPLKPLADLDPVVVTFWYRAPELLLGAR---HYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRI  237 (317)
T ss_pred             ccCCCCccccccCCccccccccCCHHHcCCC---CcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHH
Confidence            6543221   122346788999999997643   2455699999999999999999999643221         111111


Q ss_pred             HH-cCCCC-----------------------------------CCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012887          401 AA-CGLRP-----------------------------------EIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISL  441 (454)
Q Consensus       401 ~~-~~~~~-----------------------------------~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  441 (454)
                      .. .+.+.                                   ......+.++.++|.+||+.||.+|||++|+++|
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~h  314 (317)
T cd07868         238 FNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD  314 (317)
T ss_pred             HHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            10 00000                                   0001234678899999999999999999999976

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-39  Score=318.40  Aligned_cols=242  Identities=22%  Similarity=0.311  Sum_probs=209.6

Q ss_pred             eecCCCEEEeceeeccCCceEEEeE------EEEEEEeecCCCCchHHHH-HHHHHHHHHhC-CCCceeEEEEEEEeCCC
Q 012887          186 LLNSDNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKGNAYEFE-LRKDLLELMTC-GHKNILQFYCVCVDENH  257 (454)
Q Consensus       186 ~~~~~~~~~~~~LG~G~fG~Vy~g~------~vavK~l~~~~~~~~~~~~-~~~Ei~~l~~l-~HpnIv~~~g~~~~~~~  257 (454)
                      .+...+|.++..||+|+||.|.+++      .+|||+++..-.......+ -..|-++|... +-|.+++++..|+..+.
T Consensus       345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR  424 (683)
T KOG0696|consen  345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR  424 (683)
T ss_pred             ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence            5677899999999999999999863      5899988754322221111 23444555444 46899999999998887


Q ss_pred             eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccC
Q 012887          258 GLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV  337 (454)
Q Consensus       258 ~l~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~  337 (454)
                       +|+||||+.||+|-..+++-+++.+..+..|+.+|+.||-|||++|||+||||.+||+++.+|++||+|||+++.-.-.
T Consensus       425 -LyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~  503 (683)
T KOG0696|consen  425 -LYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFD  503 (683)
T ss_pred             -eeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccC
Confidence             9999999999999999999899999999999999999999999999999999999999999999999999998876666


Q ss_pred             CCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHH
Q 012887          338 GEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQIL  417 (454)
Q Consensus       338 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l  417 (454)
                      ...+...+|||.|+|||++..++|+..    .|.|||||+||||+.|++||++....+....|...+  -.+|..+|.+.
T Consensus       504 ~~TTkTFCGTPdYiAPEIi~YqPYgks----vDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehn--vsyPKslSkEA  577 (683)
T KOG0696|consen  504 GVTTKTFCGTPDYIAPEIIAYQPYGKS----VDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHN--VSYPKSLSKEA  577 (683)
T ss_pred             CcceeeecCCCcccccceEEecccccc----hhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcc--CcCcccccHHH
Confidence            667778899999999999998887665    899999999999999999999999999888887754  44899999999


Q ss_pred             HHHHHHhcccCCCCCCC
Q 012887          418 KSLMIKCWNNSPSKRPQ  434 (454)
Q Consensus       418 ~~li~~cl~~dP~~RPs  434 (454)
                      .++++..|.+.|.+|..
T Consensus       578 v~ickg~ltK~P~kRLG  594 (683)
T KOG0696|consen  578 VAICKGLLTKHPGKRLG  594 (683)
T ss_pred             HHHHHHHhhcCCccccC
Confidence            99999999999999964

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=1.8e-37  Score=296.13  Aligned_cols=248  Identities=26%  Similarity=0.458  Sum_probs=209.2

Q ss_pred             CEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCC-CeEEEEE
Q 012887          191 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN-HGLCVVT  263 (454)
Q Consensus       191 ~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~-~~l~lV~  263 (454)
                      +|.+.+.||+|+||.||+|      +.+++|.+............+.+|+..+.+++||||+++++.+.+.. ...++|+
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            4678899999999999996      46899988755444445667889999999999999999999998771 3489999


Q ss_pred             eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCC--cc
Q 012887          264 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE--AT  341 (454)
Q Consensus       264 E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~--~~  341 (454)
                      ||+++++|.+++.+...+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||.+........  ..
T Consensus        81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~  160 (260)
T cd06606          81 EYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGT  160 (260)
T ss_pred             EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecccccccccc
Confidence            9999999999997777999999999999999999999999999999999999999999999999999876654432  13


Q ss_pred             cccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC-HHHHHHHHHHcCCCCCCCCCccHHHHHH
Q 012887          342 EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACS-PVQAAVGIAACGLRPEIPKDCPQILKSL  420 (454)
Q Consensus       342 ~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~-~~~~~~~i~~~~~~~~~p~~~~~~l~~l  420 (454)
                      ....++..|+|||.+.+..    .+.++||||||+++|+|++|..||.... .......+......+.+|...+..+.++
T Consensus       161 ~~~~~~~~y~~pE~~~~~~----~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  236 (260)
T cd06606         161 GSVRGTPYWMAPEVIRGEE----YGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDF  236 (260)
T ss_pred             cCCCCCccccCHhhhcCCC----CCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHH
Confidence            3456788999999987764    4456999999999999999999998765 3334444443345566788889999999


Q ss_pred             HHHhcccCCCCCCCHHHHHHHH
Q 012887          421 MIKCWNNSPSKRPQFSEIISLL  442 (454)
Q Consensus       421 i~~cl~~dP~~RPs~~ell~~L  442 (454)
                      +.+||+.+|++||++.+++.+-
T Consensus       237 i~~~l~~~p~~Rp~~~~ll~~~  258 (260)
T cd06606         237 LRKCLRRDPKKRPTADELLQHP  258 (260)
T ss_pred             HHHhCcCChhhCCCHHHHhhCC
Confidence            9999999999999999998763

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=8.3e-38  Score=306.69  Aligned_cols=248  Identities=17%  Similarity=0.276  Sum_probs=192.6

Q ss_pred             CCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEE
Q 012887          189 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  262 (454)
Q Consensus       189 ~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV  262 (454)
                      .++|++.+.||+|+||.||+|      +.+|+|.+..... ......+.+|+.+++.++||||+++++++.+.+. .++|
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~-~~lv   81 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHE-EGAPFTAIREASLLKDLKHANIVTLHDIIHTKKT-LTLV   81 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccc-cCCchhHHHHHHHHhhCCCcceeeEEEEEecCCe-EEEE
Confidence            378999999999999999985      5699999874322 2222345689999999999999999999987776 9999


Q ss_pred             EeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCcc
Q 012887          263 TKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT  341 (454)
Q Consensus       263 ~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~  341 (454)
                      |||+++ +|.+++.+. ..+++..+..++.|++.||.|||+++++||||||+||+++.++.+||+|||++..........
T Consensus        82 ~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~  160 (291)
T cd07844          82 FEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTY  160 (291)
T ss_pred             EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCccc
Confidence            999985 999988654 478999999999999999999999999999999999999999999999999976543222222


Q ss_pred             cccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC-HHHHHHHHHHcCC---------------
Q 012887          342 EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACS-PVQAAVGIAACGL---------------  405 (454)
Q Consensus       342 ~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~-~~~~~~~i~~~~~---------------  405 (454)
                      ....++..|+|||.+.+..   .++.++||||||+++|+|++|..||.+.. ..+....+.....               
T Consensus       161 ~~~~~~~~~~aPE~~~~~~---~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (291)
T cd07844         161 SNEVVTLWYRPPDVLLGST---EYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPE  237 (291)
T ss_pred             cccccccccCCcHHhhcCc---ccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccc
Confidence            2234578899999987532   24456999999999999999999997655 2222211111000               


Q ss_pred             ------CC-------CCCCCcc--HHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 012887          406 ------RP-------EIPKDCP--QILKSLMIKCWNNSPSKRPQFSEIISLL  442 (454)
Q Consensus       406 ------~~-------~~p~~~~--~~l~~li~~cl~~dP~~RPs~~ell~~L  442 (454)
                            +.       ......+  .++.+++.+||+.+|.+||++.|++.+-
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~  289 (291)
T cd07844         238 FKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHP  289 (291)
T ss_pred             cccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCC
Confidence                  00       0001233  7889999999999999999999998753

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=2.1e-38  Score=312.56  Aligned_cols=247  Identities=23%  Similarity=0.416  Sum_probs=200.8

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  263 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~  263 (454)
                      +.|.....||+|+||.||++      ..+|+|.+...  .......+.+|+..++.++||||+++++.+...+. .++||
T Consensus        22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~-~~lv~   98 (292)
T cd06658          22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR--KQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDE-LWVVM   98 (292)
T ss_pred             HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc--hHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCe-EEEEE
Confidence            34455677999999999985      57899988642  22334557899999999999999999999987776 99999


Q ss_pred             eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCcccc
Q 012887          264 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY  343 (454)
Q Consensus       264 E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~  343 (454)
                      ||+++++|.+++. ...+++..+..++.||+.||.|||+++++||||||+||+++.++.++|+|||++............
T Consensus        99 e~~~~~~L~~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~  177 (292)
T cd06658          99 EFLEGGALTDIVT-HTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKS  177 (292)
T ss_pred             eCCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCce
Confidence            9999999999874 456899999999999999999999999999999999999999999999999998654433222333


Q ss_pred             cCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCC--CCCccHHHHHHH
Q 012887          344 ETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEI--PKDCPQILKSLM  421 (454)
Q Consensus       344 ~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~--p~~~~~~l~~li  421 (454)
                      ..++..|+|||.+.+..    ++.++||||||+++|||++|..||....+......+.. ......  +...+..+.+++
T Consensus       178 ~~~~~~y~aPE~~~~~~----~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li  252 (292)
T cd06658         178 LVGTPYWMAPEVISRLP----YGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRD-NLPPRVKDSHKVSSVLRGFL  252 (292)
T ss_pred             eecCccccCHHHHccCC----CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-cCCCccccccccCHHHHHHH
Confidence            46788999999987654    34569999999999999999999988776655444332 222222  335788999999


Q ss_pred             HHhcccCCCCCCCHHHHHHHHHhh
Q 012887          422 IKCWNNSPSKRPQFSEIISLLLRT  445 (454)
Q Consensus       422 ~~cl~~dP~~RPs~~ell~~L~~~  445 (454)
                      .+||..||.+|||+.+++++-+-.
T Consensus       253 ~~~l~~~P~~Rpt~~~il~~~~~~  276 (292)
T cd06658         253 DLMLVREPSQRATAQELLQHPFLK  276 (292)
T ss_pred             HHHccCChhHCcCHHHHhhChhhh
Confidence            999999999999999999885544

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1.3e-37  Score=305.40  Aligned_cols=244  Identities=25%  Similarity=0.421  Sum_probs=200.8

Q ss_pred             CEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEEe
Q 012887          191 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTK  264 (454)
Q Consensus       191 ~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~E  264 (454)
                      .|...+.||+|+||.||++      +.+++|++...  .......+.+|+.++..++||||+++++++...+. .++|+|
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~-~~~v~e   96 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR--KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDE-LWVVME   96 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc--chhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCe-EEEEEe
Confidence            3455678999999999986      45899988632  22334557889999999999999999999987776 899999


Q ss_pred             ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCccccc
Q 012887          265 LMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE  344 (454)
Q Consensus       265 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~  344 (454)
                      |+++++|.+++.. .++++..+..++.|++.||+|||++|++||||+|+||+++.++.++|+|||++.............
T Consensus        97 ~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~  175 (285)
T cd06648          97 FLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSL  175 (285)
T ss_pred             ccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCcccccc
Confidence            9999999999866 678999999999999999999999999999999999999999999999999876554332223334


Q ss_pred             CCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCC--CCCccHHHHHHHH
Q 012887          345 TDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEI--PKDCPQILKSLMI  422 (454)
Q Consensus       345 ~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~--p~~~~~~l~~li~  422 (454)
                      .+++.|+|||.+.+..+    +.++|||||||++|+|++|..||...++......+... ..+..  +..++..+.++|.
T Consensus       176 ~~~~~y~aPE~~~~~~~----~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~  250 (285)
T cd06648         176 VGTPYWMAPEVISRLPY----GTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN-LPPKLKNLHKVSPRLRSFLD  250 (285)
T ss_pred             cCCccccCHHHhcCCCC----CCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhc-CCCCCcccccCCHHHHHHHH
Confidence            67889999999876643    44699999999999999999999887766655544433 22222  3347899999999


Q ss_pred             HhcccCCCCCCCHHHHHHHHH
Q 012887          423 KCWNNSPSKRPQFSEIISLLL  443 (454)
Q Consensus       423 ~cl~~dP~~RPs~~ell~~L~  443 (454)
                      +||+.+|.+||++.+++++-+
T Consensus       251 ~~l~~~p~~Rpt~~~il~~~~  271 (285)
T cd06648         251 RMLVRDPAQRATAAELLNHPF  271 (285)
T ss_pred             HHcccChhhCcCHHHHccCcc
Confidence            999999999999999997644

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=7.4e-38  Score=305.56  Aligned_cols=245  Identities=22%  Similarity=0.289  Sum_probs=196.5

Q ss_pred             EEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEEec
Q 012887          192 LEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKL  265 (454)
Q Consensus       192 ~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~E~  265 (454)
                      |++.+.||.|++|.||+|      ..+++|++............+.+|+..+..++|||++++++++.+.+. .+++|||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~-~~iv~e~   79 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENK-LYLVFEF   79 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCe-EEEEEec
Confidence            567889999999999985      468999887543333333457789999999999999999999987765 9999999


Q ss_pred             cCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCcccc
Q 012887          266 MEGGSVNDLILKSR--KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY  343 (454)
Q Consensus       266 ~~~gsL~~~l~~~~--~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~  343 (454)
                      ++ ++|.+++....  .+++..+..++.|++.||.|||+++++||||+|+||+++.++.++|+|||++............
T Consensus        80 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~  158 (283)
T cd07835          80 LD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH  158 (283)
T ss_pred             cC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccCc
Confidence            95 59999986655  7999999999999999999999999999999999999999999999999998755433222233


Q ss_pred             cCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCC-----------------
Q 012887          344 ETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR-----------------  406 (454)
Q Consensus       344 ~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~-----------------  406 (454)
                      ..+++.|+|||++.+..   .++.++|+||||+++|+|++|..||...++......+......                 
T Consensus       159 ~~~~~~~~aPE~~~~~~---~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (283)
T cd07835         159 EVVTLWYRAPEILLGSR---QYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKP  235 (283)
T ss_pred             cccccCCCCCceeecCc---ccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhh
Confidence            35578899999886542   2345699999999999999999999877665444333221000                 


Q ss_pred             ----------CCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012887          407 ----------PEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISL  441 (454)
Q Consensus       407 ----------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  441 (454)
                                ......++..+.+++.+||+.||.+||+++|++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  280 (283)
T cd07835         236 TFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH  280 (283)
T ss_pred             hcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence                      01124567899999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=1.3e-37  Score=305.52  Aligned_cols=248  Identities=21%  Similarity=0.281  Sum_probs=195.6

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCC-CCceeEEEEEEEeCCC----e
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCG-HKNILQFYCVCVDENH----G  258 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~~~g~~~~~~~----~  258 (454)
                      ++|++.+.||+|+||.||+|      +.||+|.++...........+.+|+.++..+. ||||+++++++...+.    .
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            46899999999999999995      57999987654333333456778999999985 6999999999876543    2


Q ss_pred             EEEEEeccCCCCHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEcc-CCcEEEEccCCcc
Q 012887          259 LCVVTKLMEGGSVNDLILKS-----RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDR-HGNVCLGDMGIVT  332 (454)
Q Consensus       259 l~lV~E~~~~gsL~~~l~~~-----~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~-~~~vKL~DFGla~  332 (454)
                      .|+||||+++ +|.+++...     ..+++..+..++.||+.||.|||+++++||||+|+||+++. ++.+||+|||++.
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~  159 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR  159 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccce
Confidence            7899999986 898887532     35899999999999999999999999999999999999998 8899999999987


Q ss_pred             ccccCCCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCC-----
Q 012887          333 ACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP-----  407 (454)
Q Consensus       333 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~-----  407 (454)
                      .............+++.|+|||++.+..   .++.++||||||+++|+|++|..||.+.++......+...-..+     
T Consensus       160 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~---~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (295)
T cd07837         160 AFSIPVKSYTHEIVTLWYRAPEVLLGST---HYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW  236 (295)
T ss_pred             ecCCCccccCCcccccCCCChHHhhCCC---CCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhC
Confidence            6543322223335678899999886532   24557999999999999999999998877665544433210000     


Q ss_pred             -------------C--------CCCCccHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012887          408 -------------E--------IPKDCPQILKSLMIKCWNNSPSKRPQFSEIISL  441 (454)
Q Consensus       408 -------------~--------~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  441 (454)
                                   .        ....++.++.++|.+||..||.+||++.|++.+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~  291 (295)
T cd07837         237 PGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH  291 (295)
T ss_pred             cchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence                         0        013478889999999999999999999999876

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=1.4e-37  Score=306.41  Aligned_cols=258  Identities=20%  Similarity=0.374  Sum_probs=203.1

Q ss_pred             ceeecCCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEEEEEEEeCC
Q 012887          184 RWLLNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVDEN  256 (454)
Q Consensus       184 ~~~~~~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~~~g~~~~~~  256 (454)
                      .|.++.++|++.+.||+|+||.||+|      +.+|+|.++..... .....+.+|+..+... +||||+++++++.+..
T Consensus         9 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~   87 (296)
T cd06618           9 KYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK-EENKRILMDLDVVLKSHDCPYIVKCYGYFITDS   87 (296)
T ss_pred             eccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh-HHHHHHHHHHHHHHhccCCCchHhhheeeecCC
Confidence            45567789999999999999999984      57899998754322 2334455666656555 5999999999998877


Q ss_pred             CeEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHh-cCcccCCccCCcEEEccCCcEEEEccCCcccc
Q 012887          257 HGLCVVTKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLND-HGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC  334 (454)
Q Consensus       257 ~~l~lV~E~~~~gsL~~~l~~-~~~l~~~~~~~i~~qI~~gL~yLH~-~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~  334 (454)
                      . +|+||||+.+ +|.+++.. ...+++..+..++.||+.||.|||+ .+|+||||+|+||+++.++.+||+|||++...
T Consensus        88 ~-~~~v~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~  165 (296)
T cd06618          88 D-VFICMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRL  165 (296)
T ss_pred             e-EEEEeeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhc
Confidence            6 9999999865 88887754 4579999999999999999999997 59999999999999999999999999998765


Q ss_pred             ccCCCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHHHcCCCCCCCC--
Q 012887          335 KSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPV-QAAVGIAACGLRPEIPK--  411 (454)
Q Consensus       335 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~-~~~~~i~~~~~~~~~p~--  411 (454)
                      ..... .....+++.|+|||.+.+.......+.++||||||+++|+|++|..||...... +....+.. ...+..+.  
T Consensus       166 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~  243 (296)
T cd06618         166 VDSKA-KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQ-EEPPSLPPNE  243 (296)
T ss_pred             cCCCc-ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhc-CCCCCCCCCC
Confidence            43222 223356778999999986653444667799999999999999999999764443 23333333 22333333  


Q ss_pred             CccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 012887          412 DCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTN  446 (454)
Q Consensus       412 ~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~  446 (454)
                      .++.++.+++.+||..||.+||++.+++.+.+-..
T Consensus       244 ~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~  278 (296)
T cd06618         244 GFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRR  278 (296)
T ss_pred             CCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhc
Confidence            47899999999999999999999999999876444

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=4.6e-38  Score=310.88  Aligned_cols=247  Identities=23%  Similarity=0.368  Sum_probs=201.4

Q ss_pred             CEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEEe
Q 012887          191 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTK  264 (454)
Q Consensus       191 ~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~E  264 (454)
                      .|.....||+|+||.||++      +.+|+|.+.....  .....+.+|+..+..++||||+++++.+...+. .++|||
T Consensus        22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~-~~iv~e   98 (297)
T cd06659          22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ--QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEE-LWVLME   98 (297)
T ss_pred             hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc--chHHHHHHHHHHHHhCCCCchhhhhhheeeCCe-EEEEEe
Confidence            3445668999999999985      4699999864322  234557789999999999999999999988776 999999


Q ss_pred             ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCccccc
Q 012887          265 LMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE  344 (454)
Q Consensus       265 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~  344 (454)
                      |+++++|.+++. ...+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.............
T Consensus        99 ~~~~~~L~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~  177 (297)
T cd06659          99 FLQGGALTDIVS-QTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL  177 (297)
T ss_pred             cCCCCCHHHHHh-hcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccccccce
Confidence            999999999774 3578999999999999999999999999999999999999999999999999987554433333445


Q ss_pred             CCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCC-CCCCCCccHHHHHHHHH
Q 012887          345 TDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR-PEIPKDCPQILKSLMIK  423 (454)
Q Consensus       345 ~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~-~~~p~~~~~~l~~li~~  423 (454)
                      .++..|+|||++.+..+    +.++|||||||++|||++|..||....+......+...... ...+..++..+.++|.+
T Consensus       178 ~~~~~y~aPE~~~~~~~----~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~  253 (297)
T cd06659         178 VGTPYWMAPEVISRTPY----GTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLER  253 (297)
T ss_pred             ecCccccCHHHHccCCC----CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHH
Confidence            67889999999976643    44699999999999999999999877766655444322111 12244578899999999


Q ss_pred             hcccCCCCCCCHHHHHHHHHhh
Q 012887          424 CWNNSPSKRPQFSEIISLLLRT  445 (454)
Q Consensus       424 cl~~dP~~RPs~~ell~~L~~~  445 (454)
                      ||+.+|.+||++.+++++-+-.
T Consensus       254 ~l~~~P~~Rps~~~ll~~~~~~  275 (297)
T cd06659         254 MLTREPQERATAQELLDHPFLL  275 (297)
T ss_pred             HhcCCcccCcCHHHHhhChhhc
Confidence            9999999999999999975433

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=6.9e-38  Score=308.81  Aligned_cols=248  Identities=22%  Similarity=0.381  Sum_probs=203.2

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  263 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~  263 (454)
                      ++|++.+.||+|+||.||+|      +.+++|.+....  ......+.+|+..++.++||||+++++.+...+. .++|+
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~-~~lv~   95 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ--QPKKELIINEILVMRENKHPNIVNYLDSYLVGDE-LWVVM   95 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc--chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCc-EEEEE
Confidence            67899999999999999986      468999875322  2234557889999999999999999999988776 89999


Q ss_pred             eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCcccc
Q 012887          264 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY  343 (454)
Q Consensus       264 E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~  343 (454)
                      ||+++++|.+++.+ ..+++..+..++.|++.||.|||++|++||||+|+||+++.++.+||+|||++............
T Consensus        96 e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~~~  174 (293)
T cd06647          96 EYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST  174 (293)
T ss_pred             ecCCCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccccccc
Confidence            99999999999854 46889999999999999999999999999999999999999999999999997665444333344


Q ss_pred             cCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCC-CCCCCCCccHHHHHHHH
Q 012887          344 ETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGL-RPEIPKDCPQILKSLMI  422 (454)
Q Consensus       344 ~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~-~~~~p~~~~~~l~~li~  422 (454)
                      ..+++.|+|||.+.+..    ++.++|+||||+++|++++|..||...++......+...+. ....+..++..+.++|.
T Consensus       175 ~~~~~~y~~PE~~~~~~----~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  250 (293)
T cd06647         175 MVGTPYWMAPEVVTRKA----YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN  250 (293)
T ss_pred             ccCChhhcCchhhccCC----CCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHHH
Confidence            56788899999987654    34569999999999999999999987766544333322221 11234457889999999


Q ss_pred             HhcccCCCCCCCHHHHHHHHHhh
Q 012887          423 KCWNNSPSKRPQFSEIISLLLRT  445 (454)
Q Consensus       423 ~cl~~dP~~RPs~~ell~~L~~~  445 (454)
                      +||+.+|.+||++.+++.+-+-.
T Consensus       251 ~~l~~~p~~Rp~~~~il~h~~~~  273 (293)
T cd06647         251 RCLEMDVEKRGSAKELLQHPFLK  273 (293)
T ss_pred             HHccCChhhCcCHHHHhcCHHHh
Confidence            99999999999999999985543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-39  Score=335.38  Aligned_cols=249  Identities=27%  Similarity=0.455  Sum_probs=214.9

Q ss_pred             CCEEEeceeeccCCceEEEeE----------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeE
Q 012887          190 DNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGL  259 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g~----------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l  259 (454)
                      ...+..+.||+|+||+||+|-          +||+|++.. ....+...++..|..+|.+++|||+++++|+|....  +
T Consensus       696 telkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~-~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~--~  772 (1177)
T KOG1025|consen  696 TELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIE-FTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST--L  772 (1177)
T ss_pred             hhhhhhceeccccceeEEeeeEecCCceecceeEEEEeec-cCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch--H
Confidence            345667899999999999973          689998874 445555677899999999999999999999998765  7


Q ss_pred             EEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCC
Q 012887          260 CVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG  338 (454)
Q Consensus       260 ~lV~E~~~~gsL~~~l~~~~-~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~  338 (454)
                      .||++||++|+|.|+++.++ .+-...++.|..||++||.|||+++++||||..+|||+..-.++||.|||+++......
T Consensus       773 qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~  852 (1177)
T KOG1025|consen  773 QLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE  852 (1177)
T ss_pred             HHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence            79999999999999997655 89999999999999999999999999999999999999999999999999998876654


Q ss_pred             CcccccC--CCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHcCCCCCCCCCccH
Q 012887          339 EATEYET--DGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ  415 (454)
Q Consensus       339 ~~~~~~~--gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~  415 (454)
                      .......  -.+.|||-|.+....    ++.+||||||||++||++| |..||.+.... .+..+...+.|++.|..|+-
T Consensus       853 ~ey~~~~gK~pikwmale~i~~~~----~thqSDVWsfGVtiWElmTFGa~Py~gi~~~-eI~dlle~geRLsqPpiCti  927 (1177)
T KOG1025|consen  853 KEYSAPGGKVPIKWMALESIRIRK----YTHQSDVWSFGVTIWELMTFGAKPYDGIPAE-EIPDLLEKGERLSQPPICTI  927 (1177)
T ss_pred             ccccccccccCcHHHHHHHhhccC----CCchhhhhhhhhhHHHHHhcCCCccCCCCHH-HhhHHHhccccCCCCCCccH
Confidence            3332222  357899999988664    5556999999999999999 99999986654 45667777889999999999


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 012887          416 ILKSLMIKCWNNSPSKRPQFSEIISLLLRTN  446 (454)
Q Consensus       416 ~l~~li~~cl~~dP~~RPs~~ell~~L~~~~  446 (454)
                      +++.+|.+||..|+..||+|+++.+.+.+..
T Consensus       928 DVy~~mvkCwmid~~~rp~fkel~~~fs~~a  958 (1177)
T KOG1025|consen  928 DVYMVMVKCWMIDADSRPTFKELAEEFSRMA  958 (1177)
T ss_pred             HHHHHHHHHhccCcccCccHHHHHHHHHHHh
Confidence            9999999999999999999999999887654

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=2.3e-37  Score=304.21  Aligned_cols=249  Identities=21%  Similarity=0.277  Sum_probs=197.1

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  263 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~  263 (454)
                      ++|++.+.||+|+||.||+|      +.+++|.+............+.+|+.++++++||||+++++++.+.+. .++||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~lv~   80 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKR-LYLVF   80 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCe-EEEEE
Confidence            57899999999999999996      469999886443333344567789999999999999999999988776 99999


Q ss_pred             eccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEcc-CCcEEEEccCCccccccCCCc
Q 012887          264 KLMEGGSVNDLILKSR--KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDR-HGNVCLGDMGIVTACKSVGEA  340 (454)
Q Consensus       264 E~~~~gsL~~~l~~~~--~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~-~~~vKL~DFGla~~~~~~~~~  340 (454)
                      ||+++ +|.+++....  .+++..+..++.||+.||+|||+++++||||+|+||+++. ++.+||+|||++.........
T Consensus        81 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~  159 (294)
T PLN00009         81 EYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT  159 (294)
T ss_pred             ecccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCccc
Confidence            99965 8888875543  4688899999999999999999999999999999999985 457999999998755432222


Q ss_pred             ccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCC--------------
Q 012887          341 TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR--------------  406 (454)
Q Consensus       341 ~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~--------------  406 (454)
                      .....+++.|+|||.+.+..   .++.++|||||||++|+|++|..||...+.......+......              
T Consensus       160 ~~~~~~~~~y~~PE~~~~~~---~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (294)
T PLN00009        160 FTHEVVTLWYRAPEILLGSR---HYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPD  236 (294)
T ss_pred             cccCceeecccCHHHHhCCC---CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchh
Confidence            23335678899999986532   2455799999999999999999999887665554443221000              


Q ss_pred             -----CC--------CCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 012887          407 -----PE--------IPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLL  443 (454)
Q Consensus       407 -----~~--------~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~  443 (454)
                           +.        .....++++.+++.+||+.+|.+||++.+++.+-+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~  286 (294)
T PLN00009        237 YKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEY  286 (294)
T ss_pred             hhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCch
Confidence                 00        12346788999999999999999999999998644

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=3.6e-37  Score=307.09  Aligned_cols=254  Identities=22%  Similarity=0.330  Sum_probs=208.3

Q ss_pred             CCEEEeceeeccCCceEEEeE------EEEEEEeecCCC-CchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDK-GNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  262 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g~------~vavK~l~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV  262 (454)
                      ..|+..+.||+|+||.||+++      .+|+|.+..... .......+.+|+..++.++|||++++++++.+.+. .++|
T Consensus        25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~lv  103 (317)
T cd06635          25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHT-AWLV  103 (317)
T ss_pred             hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCe-EEEE
Confidence            347788999999999999864      689998864432 22344568889999999999999999999988776 8999


Q ss_pred             EeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCcc
Q 012887          263 TKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT  341 (454)
Q Consensus       263 ~E~~~~gsL~~~l~~-~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~  341 (454)
                      |||+++ +|.+.+.. ..++++..+..++.||+.||.|||+++++||||+|+||+++.++.+||+|||++.....    .
T Consensus       104 ~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~----~  178 (317)
T cd06635         104 MEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP----A  178 (317)
T ss_pred             EeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC----c
Confidence            999975 88777744 45799999999999999999999999999999999999999999999999999765432    2


Q ss_pred             cccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHHHHH
Q 012887          342 EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLM  421 (454)
Q Consensus       342 ~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~li  421 (454)
                      ....+++.|+|||.+..... ...+.++|||||||++|+|++|..||...........+.........+..+++.+.+++
T Consensus       179 ~~~~~~~~y~aPE~~~~~~~-~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  257 (317)
T cd06635         179 NSFVGTPYWMAPEVILAMDE-GQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFV  257 (317)
T ss_pred             ccccCCccccChhhhhcCCC-CCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHHH
Confidence            33457788999999853211 22456799999999999999999999887776666666665554445567889999999


Q ss_pred             HHhcccCCCCCCCHHHHHHHHHhhcCCCC
Q 012887          422 IKCWNNSPSKRPQFSEIISLLLRTNNISN  450 (454)
Q Consensus       422 ~~cl~~dP~~RPs~~ell~~L~~~~~~~~  450 (454)
                      .+||+.+|.+||++.+++++++......+
T Consensus       258 ~~~l~~~p~~Rpt~~~il~~~~~~~~~~~  286 (317)
T cd06635         258 DSCLQKIPQDRPTSEELLKHMFVLRERPE  286 (317)
T ss_pred             HHHccCCcccCcCHHHHHhChhhhccCcc
Confidence            99999999999999999999877665543

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.3e-39  Score=329.41  Aligned_cols=244  Identities=25%  Similarity=0.434  Sum_probs=203.4

Q ss_pred             CEEEeceeeccCCceEEEe------EEEEEEEe--ecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCC-CeEEE
Q 012887          191 NLEFIDQIGPNSFKGVYKG------KRVGIEKL--KGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN-HGLCV  261 (454)
Q Consensus       191 ~~~~~~~LG~G~fG~Vy~g------~~vavK~l--~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~-~~l~l  261 (454)
                      ..++...||+|+|.+||+|      ..||--.+  ....+......++..|+..|+.|+|||||++|.+|.+.+ ..+-+
T Consensus        41 y~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~  120 (632)
T KOG0584|consen   41 YLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINF  120 (632)
T ss_pred             eeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeee
Confidence            3466779999999999996      33442222  222233444467889999999999999999999998775 45789


Q ss_pred             EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhc--CcccCCccCCcEEEcc-CCcEEEEccCCccccccCC
Q 012887          262 VTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDH--GVAYRDLNSQRILLDR-HGNVCLGDMGIVTACKSVG  338 (454)
Q Consensus       262 V~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~--~iiHrDIKp~NILl~~-~~~vKL~DFGla~~~~~~~  338 (454)
                      |+|++..|+|..|+++.++++...+..|+.||++||.|||++  .|||||||-+||+|+. .|.|||+|+|||+......
T Consensus       121 iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~  200 (632)
T KOG0584|consen  121 ITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH  200 (632)
T ss_pred             eeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhccc
Confidence            999999999999999999999999999999999999999998  5999999999999985 5889999999998765443


Q ss_pred             CcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCC-CCCCccHHH
Q 012887          339 EATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPE-IPKDCPQIL  417 (454)
Q Consensus       339 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~-~p~~~~~~l  417 (454)
                      .  ....|||.|||||++...     |+...||||||+.|.||+|+.+||..++....+.+-+..|..|. +..--++++
T Consensus       201 a--ksvIGTPEFMAPEmYEE~-----YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPev  273 (632)
T KOG0584|consen  201 A--KSVIGTPEFMAPEMYEEN-----YNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEV  273 (632)
T ss_pred             c--ceeccCccccChHHHhhh-----cchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHH
Confidence            2  236899999999998732     55569999999999999999999999887777777777776664 334447999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHHHH
Q 012887          418 KSLMIKCWNNSPSKRPQFSEIISLL  442 (454)
Q Consensus       418 ~~li~~cl~~dP~~RPs~~ell~~L  442 (454)
                      ++||.+|+.. .++|||+.|||.+-
T Consensus       274 r~fIekCl~~-~~~R~sa~eLL~d~  297 (632)
T KOG0584|consen  274 REFIEKCLAT-KSERLSAKELLKDP  297 (632)
T ss_pred             HHHHHHHhcC-chhccCHHHHhhCh
Confidence            9999999999 99999999999753

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=3.5e-37  Score=292.99  Aligned_cols=242  Identities=26%  Similarity=0.535  Sum_probs=202.8

Q ss_pred             CEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEEe
Q 012887          191 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTK  264 (454)
Q Consensus       191 ~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~E  264 (454)
                      +|++.+.||+|+||.||++      +.+++|++.....  .....+.+|+..+..++|+|++++++.+...+. .++++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-~~l~~e   77 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDE-LWIVME   77 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCe-EEEEEe
Confidence            4788899999999999985      4688998864333  345668899999999999999999999987765 899999


Q ss_pred             ccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCcccc
Q 012887          265 LMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY  343 (454)
Q Consensus       265 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~  343 (454)
                      |+++++|.+++... ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++........ ...
T Consensus        78 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~~  156 (253)
T cd05122          78 FCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-RNT  156 (253)
T ss_pred             cCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc-ccc
Confidence            99999999998765 5899999999999999999999999999999999999999999999999999876654322 344


Q ss_pred             cCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCC--ccHHHHHHH
Q 012887          344 ETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKD--CPQILKSLM  421 (454)
Q Consensus       344 ~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~--~~~~l~~li  421 (454)
                      ..++..|+|||.+.+..    .+.++|+||||+++|+|++|..||...+.......... ...+..+..  ++..+.+++
T Consensus       157 ~~~~~~~~~PE~~~~~~----~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i  231 (253)
T cd05122         157 MVGTPYWMAPEVINGKP----YDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT-NGPPGLRNPEKWSDEFKDFL  231 (253)
T ss_pred             eecCCcccCHHHHcCCC----CCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh-cCCCCcCcccccCHHHHHHH
Confidence            56788899999998664    44569999999999999999999988766555444443 233333333  489999999


Q ss_pred             HHhcccCCCCCCCHHHHHHH
Q 012887          422 IKCWNNSPSKRPQFSEIISL  441 (454)
Q Consensus       422 ~~cl~~dP~~RPs~~ell~~  441 (454)
                      .+||..||.+|||+.+++.+
T Consensus       232 ~~~l~~~p~~R~t~~~~l~~  251 (253)
T cd05122         232 KKCLQKNPEKRPTAEQLLKH  251 (253)
T ss_pred             HHHccCChhhCCCHHHHhcC
Confidence            99999999999999999875

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=1.6e-37  Score=304.14  Aligned_cols=242  Identities=21%  Similarity=0.310  Sum_probs=189.4

Q ss_pred             eeeccCCceEEEe------EEEEEEEeecCCCCch-HHHHHHHHHH---HHHhCCCCceeEEEEEEEeCCCeEEEEEecc
Q 012887          197 QIGPNSFKGVYKG------KRVGIEKLKGCDKGNA-YEFELRKDLL---ELMTCGHKNILQFYCVCVDENHGLCVVTKLM  266 (454)
Q Consensus       197 ~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~-~~~~~~~Ei~---~l~~l~HpnIv~~~g~~~~~~~~l~lV~E~~  266 (454)
                      .||+|+||.||++      +.+|+|.+........ ......++..   .+...+||||+.+++++..++. .++||||+
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~-~~lv~e~~   79 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDK-LCFILDLM   79 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCe-EEEEEecC
Confidence            4899999999974      5789998864432222 1222233332   2333479999999999987776 89999999


Q ss_pred             CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCcccccCC
Q 012887          267 EGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETD  346 (454)
Q Consensus       267 ~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~g  346 (454)
                      ++++|.+++...+.+++..+..++.|++.||+|||+++++||||||+|||++.++.++|+|||++......  ......+
T Consensus        80 ~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~--~~~~~~~  157 (279)
T cd05633          80 NGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHASVG  157 (279)
T ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc--CccCcCC
Confidence            99999999987788999999999999999999999999999999999999999999999999998654332  1233468


Q ss_pred             CCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHHHcCCCCCCCCCccHHHHHHHHHhc
Q 012887          347 GYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQ-AAVGIAACGLRPEIPKDCPQILKSLMIKCW  425 (454)
Q Consensus       347 t~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~-~~~~i~~~~~~~~~p~~~~~~l~~li~~cl  425 (454)
                      +..|+|||.+.+..   .++.++|||||||++|+|++|..||....... ..........+..+|..++.++.++|.+||
T Consensus       158 ~~~y~aPE~~~~~~---~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  234 (279)
T cd05633         158 THGYMAPEVLQKGT---AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLL  234 (279)
T ss_pred             CcCccCHHHhcCCC---CCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHHHHHh
Confidence            89999999986421   24456999999999999999999997543211 111112223455677889999999999999


Q ss_pred             ccCCCCCC-----CHHHHHHHHHh
Q 012887          426 NNSPSKRP-----QFSEIISLLLR  444 (454)
Q Consensus       426 ~~dP~~RP-----s~~ell~~L~~  444 (454)
                      ..||.+||     ++.|+++|.+.
T Consensus       235 ~~~p~~R~~~~~~~~~~~~~h~~~  258 (279)
T cd05633         235 QRDVSKRLGCLGRGAQEVKEHVFF  258 (279)
T ss_pred             cCCHHHhcCCCCCCHHHHHhCccc
Confidence            99999999     69999987543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-39  Score=295.85  Aligned_cols=260  Identities=20%  Similarity=0.281  Sum_probs=204.2

Q ss_pred             cceeecCCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeC-
Q 012887          183 GRWLLNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDE-  255 (454)
Q Consensus       183 ~~~~~~~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~-  255 (454)
                      +...++.++|++.+.||+|+|+-||.+      +.+|+|++.-..  .......++|+...+.++||||++++++...+ 
T Consensus        14 ~tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~--~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~   91 (302)
T KOG2345|consen   14 GTVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS--QEDIEEALREIDNHRKFNSPNVLRLVDHQLREE   91 (302)
T ss_pred             CcEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc--hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhh
Confidence            345688899999999999999999986      478999987433  34556678999999999999999998765432 


Q ss_pred             ---CCeEEEEEeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhcC--cccCCccCCcEEEccCCcEEEE
Q 012887          256 ---NHGLCVVTKLMEGGSVNDLILK----SRKLQTKEIIRIAIDVAEGIKFLNDHG--VAYRDLNSQRILLDRHGNVCLG  326 (454)
Q Consensus       256 ---~~~l~lV~E~~~~gsL~~~l~~----~~~l~~~~~~~i~~qI~~gL~yLH~~~--iiHrDIKp~NILl~~~~~vKL~  326 (454)
                         .+..|+++.|...|+|.+.+..    +..+++.+++.|+.+|++||++||+..  +.||||||.|||+++.+.++|.
T Consensus        92 ~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~  171 (302)
T KOG2345|consen   92 KDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLM  171 (302)
T ss_pred             ccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEE
Confidence               3458999999999999999853    237999999999999999999999998  9999999999999999999999


Q ss_pred             ccCCccccccC----CCc-----ccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHH
Q 012887          327 DMGIVTACKSV----GEA-----TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAA  397 (454)
Q Consensus       327 DFGla~~~~~~----~~~-----~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~  397 (454)
                      |||.++...-.    .+.     .....-|..|.|||.+.-...+ .-+.++|||||||+||.|+.|..||+..-....-
T Consensus       172 D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~-ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgS  250 (302)
T KOG2345|consen  172 DLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHC-TITERTDIWSLGCTLYAMMFGESPFERIYQQGGS  250 (302)
T ss_pred             eccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCc-ccccccchhhhhHHHHHHHHcCCcchHHhhcCCe
Confidence            99987654211    000     0111346789999998766544 3567899999999999999999999742221111


Q ss_pred             HHHHHcCCCCCCCC--CccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 012887          398 VGIAACGLRPEIPK--DCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRT  445 (454)
Q Consensus       398 ~~i~~~~~~~~~p~--~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~  445 (454)
                      ..+...+....+|.  .+|..+.++|+.|++.||.+||+..+++.++..+
T Consensus       251 laLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L  300 (302)
T KOG2345|consen  251 LALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL  300 (302)
T ss_pred             EEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence            11122222223333  3899999999999999999999999999998764

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=1.7e-37  Score=302.83  Aligned_cols=240  Identities=22%  Similarity=0.339  Sum_probs=192.8

Q ss_pred             eeccCCceEEEe------EEEEEEEeecCCCC-chHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEEeccCCCC
Q 012887          198 IGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGS  270 (454)
Q Consensus       198 LG~G~fG~Vy~g------~~vavK~l~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~E~~~~gs  270 (454)
                      ||+|+||.||++      +.+|+|.+...... ......+..|+.++..++||||+++++++...+. .|+||||+++++
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-~~lv~e~~~~~~   79 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDD-LCLVMTLMNGGD   79 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCe-EEEEEecCCCCc
Confidence            699999999984      57999988643221 2233445689999999999999999999987776 999999999999


Q ss_pred             HHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCcccccCCCC
Q 012887          271 VNDLILKSR--KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY  348 (454)
Q Consensus       271 L~~~l~~~~--~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~gt~  348 (454)
                      |.+++.+..  .+++..+..++.|++.||.|||++|++||||+|+||+++.++.+||+|||++...... .......++.
T Consensus        80 L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~  158 (277)
T cd05577          80 LKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG-KKIKGRAGTP  158 (277)
T ss_pred             HHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccC-CccccccCCC
Confidence            999986655  7999999999999999999999999999999999999999999999999998765432 1222335677


Q ss_pred             cccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH--HHcCCCCCCCCCccHHHHHHHHHhcc
Q 012887          349 RWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGI--AACGLRPEIPKDCPQILKSLMIKCWN  426 (454)
Q Consensus       349 ~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i--~~~~~~~~~p~~~~~~l~~li~~cl~  426 (454)
                      .|+|||++.+..    ++.++|||||||++|+|++|..||...........+  .....+...|..+++.+.++|.+||+
T Consensus       159 ~y~~PE~~~~~~----~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  234 (277)
T cd05577         159 GYMAPEVLQGEV----YDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQ  234 (277)
T ss_pred             CcCCHHHhcCCC----CCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHcc
Confidence            899999988665    344599999999999999999999765431111111  11223445677889999999999999


Q ss_pred             cCCCCCC-----CHHHHHHHHH
Q 012887          427 NSPSKRP-----QFSEIISLLL  443 (454)
Q Consensus       427 ~dP~~RP-----s~~ell~~L~  443 (454)
                      .||.+||     ++.+++.+-+
T Consensus       235 ~~p~~R~~~~~~~~~~ll~h~~  256 (277)
T cd05577         235 KDPEKRLGCRGGSADEVREHPL  256 (277)
T ss_pred             CChhHccCCCcccHHHHHhChh
Confidence            9999999     7777877643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=2.5e-37  Score=301.64  Aligned_cols=245  Identities=19%  Similarity=0.319  Sum_probs=195.8

Q ss_pred             CEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEEe
Q 012887          191 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTK  264 (454)
Q Consensus       191 ~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~E  264 (454)
                      +|++.+.||.|+||.||+|      +.+|+|.++.... ......+.+|+.++..++||||+++++++.+.+. .++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~-~~lv~e   78 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE-EGTPSTAIREISLMKELKHENIVRLHDVIHTENK-LMLVFE   78 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc-ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCc-EEEEEe
Confidence            5789999999999999985      4689999874332 2223446689999999999999999999998876 899999


Q ss_pred             ccCCCCHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCcc
Q 012887          265 LMEGGSVNDLILKS---RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT  341 (454)
Q Consensus       265 ~~~~gsL~~~l~~~---~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~  341 (454)
                      |+++ +|.+++...   ..+++..+..++.||+.||.|||++|++||||||+||++++++.++|+|||++..........
T Consensus        79 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~  157 (284)
T cd07836          79 YMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTF  157 (284)
T ss_pred             cCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcccc
Confidence            9986 898887543   368999999999999999999999999999999999999999999999999987554332222


Q ss_pred             cccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCC----------------
Q 012887          342 EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGL----------------  405 (454)
Q Consensus       342 ~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~----------------  405 (454)
                      ....+++.|+|||.+.+..   .++.++|||||||++|+|++|..||.+.+..+....+.....                
T Consensus       158 ~~~~~~~~y~~PE~~~~~~---~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd07836         158 SNEVVTLWYRAPDVLLGSR---TYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEY  234 (284)
T ss_pred             ccccccccccChHHhcCCC---CCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchh
Confidence            3345678899999986542   245579999999999999999999987766554443322110                


Q ss_pred             CCC-----------CCCCccHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012887          406 RPE-----------IPKDCPQILKSLMIKCWNNSPSKRPQFSEIISL  441 (454)
Q Consensus       406 ~~~-----------~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  441 (454)
                      ...           +....+..+.+++.+||+.||.+||++.+++.+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~  281 (284)
T cd07836         235 KPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH  281 (284)
T ss_pred             cccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            001           112357889999999999999999999999865

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-38  Score=285.93  Aligned_cols=224  Identities=21%  Similarity=0.340  Sum_probs=187.8

Q ss_pred             eeecCCCEEEeceeeccCCceEEE------eEEEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEEEEEEEeCCC
Q 012887          185 WLLNSDNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVDENH  257 (454)
Q Consensus       185 ~~~~~~~~~~~~~LG~G~fG~Vy~------g~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~~~g~~~~~~~  257 (454)
                      +.++.+++.-+..||+|+||.|-+      |...|+|.++.. .......++.+|+.+.++. .+|++|+|||....+..
T Consensus        41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~t-vn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regd  119 (282)
T KOG0984|consen   41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRAT-VNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGD  119 (282)
T ss_pred             cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhh-cChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcccc
Confidence            668889999999999999998765      889999999843 4456677788999988775 68999999999988887


Q ss_pred             eEEEEEeccCCCCHHHHH----HhCCCCCHHHHHHHHHHHHHHHHHHHhc-CcccCCccCCcEEEccCCcEEEEccCCcc
Q 012887          258 GLCVVTKLMEGGSVNDLI----LKSRKLQTKEIIRIAIDVAEGIKFLNDH-GVAYRDLNSQRILLDRHGNVCLGDMGIVT  332 (454)
Q Consensus       258 ~l~lV~E~~~~gsL~~~l----~~~~~l~~~~~~~i~~qI~~gL~yLH~~-~iiHrDIKp~NILl~~~~~vKL~DFGla~  332 (454)
                       +++.||.|.- ||..+-    .+++.+++..+.+++..++.||.|||++ .+||||+||+||||+..|+||+||||++.
T Consensus       120 -vwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG  197 (282)
T KOG0984|consen  120 -VWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISG  197 (282)
T ss_pred             -EEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccce
Confidence             9999999966 888765    3566899999999999999999999986 89999999999999999999999999987


Q ss_pred             ccccCCCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCC
Q 012887          333 ACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKD  412 (454)
Q Consensus       333 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~  412 (454)
                      .+.+ +...+...|...|||||.+..+.....|+.+|||||||+++.||.++++||+.+.........+.....|.+|..
T Consensus       198 ~L~d-SiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep~P~Lp~~  276 (282)
T KOG0984|consen  198 YLVD-SIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEPSPQLPAD  276 (282)
T ss_pred             eehh-hhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCCCCCCccc
Confidence            7654 334555678888999999998877768899999999999999999999999987554444444444555555543

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=2.8e-37  Score=300.80  Aligned_cols=242  Identities=19%  Similarity=0.246  Sum_probs=190.4

Q ss_pred             EEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCC-CCceeEEEEEEEeC--CCeEEEE
Q 012887          192 LEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCG-HKNILQFYCVCVDE--NHGLCVV  262 (454)
Q Consensus       192 ~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~~~g~~~~~--~~~l~lV  262 (454)
                      |++.+.||+|+||.||+|      +.+|+|.++...... ......+|+..+.++. |+|++++++++.+.  +. +++|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~-~~lv   78 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSL-EQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGR-LALV   78 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCc-hhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCc-EEEE
Confidence            577899999999999996      468999887543222 2233457888888874 99999999999876  54 8999


Q ss_pred             EeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCcc
Q 012887          263 TKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT  341 (454)
Q Consensus       263 ~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~  341 (454)
                      |||+++ +|.+.+... ..+++..+..++.||+.||+|||+.|++||||+|+||+++. +.+||+|||++......... 
T Consensus        79 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~-  155 (282)
T cd07831          79 FELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPY-  155 (282)
T ss_pred             EecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCCc-
Confidence            999975 888887653 57899999999999999999999999999999999999999 99999999998765433222 


Q ss_pred             cccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcC----------------C
Q 012887          342 EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG----------------L  405 (454)
Q Consensus       342 ~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~----------------~  405 (454)
                      ....++..|+|||.+....   ..+.++|||||||++|||++|..||.+.++.+....+....                .
T Consensus       156 ~~~~~~~~y~aPE~~~~~~---~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (282)
T cd07831         156 TEYISTRWYRAPECLLTDG---YYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHM  232 (282)
T ss_pred             CCCCCCcccCChhHhhcCC---CCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccc
Confidence            2235678899999875432   24456999999999999999999998876655433322100                0


Q ss_pred             CCCC-----------CCCccHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012887          406 RPEI-----------PKDCPQILKSLMIKCWNNSPSKRPQFSEIISL  441 (454)
Q Consensus       406 ~~~~-----------p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  441 (454)
                      ...+           ...++.++.++|.+||+.+|++||++.+++.+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  279 (282)
T cd07831         233 NYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH  279 (282)
T ss_pred             cccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence            0011           12467899999999999999999999999876

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.1e-37  Score=316.45  Aligned_cols=242  Identities=20%  Similarity=0.289  Sum_probs=186.2

Q ss_pred             ecCCCEEEeceeeccCCceEEEeE------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEE
Q 012887          187 LNSDNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLC  260 (454)
Q Consensus       187 ~~~~~~~~~~~LG~G~fG~Vy~g~------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~  260 (454)
                      +...+|++++.||+|+||.||+|.      .||+|.....        ....|+.++..++||||+++++++.+.+. .+
T Consensus        63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~  133 (357)
T PHA03209         63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--------TTLIEAMLLQNVNHPSVIRMKDTLVSGAI-TC  133 (357)
T ss_pred             hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--------ccHHHHHHHHhCCCCCCcChhheEEeCCe-eE
Confidence            445679999999999999999974      5888864321        12468889999999999999999998776 89


Q ss_pred             EEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCC
Q 012887          261 VVTKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE  339 (454)
Q Consensus       261 lV~E~~~~gsL~~~l~~-~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~  339 (454)
                      +|||++. ++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .
T Consensus       134 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-~  211 (357)
T PHA03209        134 MVLPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA-P  211 (357)
T ss_pred             EEEEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccC-c
Confidence            9999996 488888854 457999999999999999999999999999999999999999999999999998653322 1


Q ss_pred             cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCC-CCCCCHH---------HHHHHHHH-cCC-CC
Q 012887          340 ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAA-YAACSPV---------QAAVGIAA-CGL-RP  407 (454)
Q Consensus       340 ~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~P-f~~~~~~---------~~~~~i~~-~~~-~~  407 (454)
                      ......||+.|+|||++.+..+    +.++|||||||++|||+++..| |......         ..+..+.. .+. +.
T Consensus       212 ~~~~~~gt~~y~aPE~~~~~~~----~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  287 (357)
T PHA03209        212 AFLGLAGTVETNAPEVLARDKY----NSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPE  287 (357)
T ss_pred             ccccccccccccCCeecCCCCC----CchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChh
Confidence            2233468899999999987654    4569999999999999985444 4331110         01111111 010 11


Q ss_pred             CCC------------------------------CCccHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 012887          408 EIP------------------------------KDCPQILKSLMIKCWNNSPSKRPQFSEIISLLL  443 (454)
Q Consensus       408 ~~p------------------------------~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~  443 (454)
                      .+|                              ..++.++.++|.+||+.||.+|||+.|++.|-+
T Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~  353 (357)
T PHA03209        288 EFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPM  353 (357)
T ss_pred             hcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCch
Confidence            111                              134667788999999999999999999998744

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=6.2e-38  Score=323.93  Aligned_cols=243  Identities=21%  Similarity=0.329  Sum_probs=198.2

Q ss_pred             CEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCC------CCceeEEEEEEEeCCCe
Q 012887          191 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCG------HKNILQFYCVCVDENHG  258 (454)
Q Consensus       191 ~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~------HpnIv~~~g~~~~~~~~  258 (454)
                      +|++++.||+|+||.|.++      +.||||.+++.   ..+..+-..|+.+|..++      .-|+|+++++|...++ 
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~---k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H-  262 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK---KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH-  262 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC---hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc-
Confidence            6899999999999999984      78999999853   334455668888888775      3589999999999998 


Q ss_pred             EEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCC--cEEEEccCCcccc
Q 012887          259 LCVVTKLMEGGSVNDLILKSR--KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG--NVCLGDMGIVTAC  334 (454)
Q Consensus       259 l~lV~E~~~~gsL~~~l~~~~--~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~--~vKL~DFGla~~~  334 (454)
                      +|||+|++.. +|+++++.++  .++...++.++.||+.||.+||+.||||+||||+||||..-+  .|||+|||.+...
T Consensus       263 lciVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~  341 (586)
T KOG0667|consen  263 LCIVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE  341 (586)
T ss_pred             eeeeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence            9999999966 9999998765  799999999999999999999999999999999999997654  6999999998765


Q ss_pred             ccCCCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHc-CCCC------
Q 012887          335 KSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAAC-GLRP------  407 (454)
Q Consensus       335 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~-~~~~------  407 (454)
                      ...-   .....+--|.|||++.|.+|+.+    .||||||||+.||++|.+.|++.+..+.+..|... |.++      
T Consensus       342 ~q~v---ytYiQSRfYRAPEVILGlpY~~~----IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~  414 (586)
T KOG0667|consen  342 SQRV---YTYIQSRFYRAPEVILGLPYDTA----IDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDT  414 (586)
T ss_pred             CCcc---eeeeeccccccchhhccCCCCCc----cceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            4322   13344556999999999976655    99999999999999999999998888766554221 1000      


Q ss_pred             -------------------------------------------CCC-C----------CccHHHHHHHHHhcccCCCCCC
Q 012887          408 -------------------------------------------EIP-K----------DCPQILKSLMIKCWNNSPSKRP  433 (454)
Q Consensus       408 -------------------------------------------~~p-~----------~~~~~l~~li~~cl~~dP~~RP  433 (454)
                                                                 ..| .          .-...+.+++++||..||.+|+
T Consensus       415 ~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~  494 (586)
T KOG0667|consen  415 AKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERI  494 (586)
T ss_pred             ccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcC
Confidence                                                       012 0          1124578999999999999999


Q ss_pred             CHHHHHHHHHhh
Q 012887          434 QFSEIISLLLRT  445 (454)
Q Consensus       434 s~~ell~~L~~~  445 (454)
                      |..+.++|-+-.
T Consensus       495 tp~qal~Hpfl~  506 (586)
T KOG0667|consen  495 TPAQALNHPFLT  506 (586)
T ss_pred             CHHHHhcCcccc
Confidence            999999986644

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-39  Score=350.16  Aligned_cols=259  Identities=20%  Similarity=0.256  Sum_probs=218.3

Q ss_pred             cceeecCCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCch-HHHHHHHHHHHHHhCCCCceeEEEEEEEeC
Q 012887          183 GRWLLNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNA-YEFELRKDLLELMTCGHKNILQFYCVCVDE  255 (454)
Q Consensus       183 ~~~~~~~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~-~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~  255 (454)
                      ....+..+||++++.||+|+||.|...      +.+|.|++........ ...-+..|-.+|.-.+.+-||.++-+|+++
T Consensus        68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~  147 (1317)
T KOG0612|consen   68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE  147 (1317)
T ss_pred             HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence            445578899999999999999999985      4567777754222211 223355666667777789999999999999


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccc
Q 012887          256 NHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK  335 (454)
Q Consensus       256 ~~~l~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~  335 (454)
                      ++ +|+|||||+||+|-.++.+-.++|+.++..|+.+|+.||.-||+.|+|||||||+|||||..||+||+|||-+-.+.
T Consensus       148 ~~-LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~  226 (1317)
T KOG0612|consen  148 RY-LYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMD  226 (1317)
T ss_pred             cc-eEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcC
Confidence            87 99999999999999999887799999999999999999999999999999999999999999999999999987776


Q ss_pred             cCC-CcccccCCCCcccccccccCCCCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCC--C
Q 012887          336 SVG-EATEYETDGYRWLAPEIIAGDPES-VSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIP--K  411 (454)
Q Consensus       336 ~~~-~~~~~~~gt~~y~APE~l~~~~~~-~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p--~  411 (454)
                      .++ ......+|||.|.+||++...... ..|+..+|.||+||++|||+.|..||...+-.+..-+|+.......+|  .
T Consensus       227 ~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~  306 (1317)
T KOG0612|consen  227 ADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDET  306 (1317)
T ss_pred             CCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCccc
Confidence            444 345666899999999999744333 556777999999999999999999999999999999999887778888  4


Q ss_pred             CccHHHHHHHHHhcccCCCCCCC---HHHHHHHHH
Q 012887          412 DCPQILKSLMIKCWNNSPSKRPQ---FSEIISLLL  443 (454)
Q Consensus       412 ~~~~~l~~li~~cl~~dP~~RPs---~~ell~~L~  443 (454)
                      .+|.++++||.+.+. +|+.|..   ++++..|..
T Consensus       307 ~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpF  340 (1317)
T KOG0612|consen  307 DVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPF  340 (1317)
T ss_pred             ccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCcc
Confidence            589999999998665 7778888   999887754

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=7.3e-37  Score=300.10  Aligned_cols=248  Identities=21%  Similarity=0.366  Sum_probs=197.9

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCC-CeEEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN-HGLCVV  262 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~-~~l~lV  262 (454)
                      ++|+..+.||.|+||.||++      +.+|+|.+..... ......+.+|+..+..++||||+++++++.+.+ ..+++|
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   79 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN-PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA   79 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc-hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEE
Confidence            46899999999999999986      4689998874322 245566889999999999999999999987654 348999


Q ss_pred             EeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCC
Q 012887          263 TKLMEGGSVNDLILK----SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG  338 (454)
Q Consensus       263 ~E~~~~gsL~~~l~~----~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~  338 (454)
                      |||+++++|.+++..    ...+++..+..++.||+.||.|||+.+++|+||+|+||+++.++.++|+|||++.......
T Consensus        80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  159 (287)
T cd06621          80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL  159 (287)
T ss_pred             EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccccccc
Confidence            999999999988642    3468999999999999999999999999999999999999999999999999976543321


Q ss_pred             CcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC-----HHHHHHHHHHcCCCCCCC---
Q 012887          339 EATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACS-----PVQAAVGIAACGLRPEIP---  410 (454)
Q Consensus       339 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~-----~~~~~~~i~~~~~~~~~p---  410 (454)
                        .....++..|+|||.+.+..+    +.++|||||||++|+|++|..||....     +.+....+. ....+.++   
T Consensus       160 --~~~~~~~~~y~~pE~~~~~~~----~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  232 (287)
T cd06621         160 --AGTFTGTSFYMAPERIQGKPY----SITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIV-NMPNPELKDEP  232 (287)
T ss_pred             --cccccCCccccCHHHhcCCCC----CchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHh-cCCchhhccCC
Confidence              123356778999999876643    456999999999999999999998652     222222222 21222222   


Q ss_pred             ---CCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 012887          411 ---KDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRT  445 (454)
Q Consensus       411 ---~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~  445 (454)
                         ..+++.+.+++.+||..+|++|||+.|++.+-+-.
T Consensus       233 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~  270 (287)
T cd06621         233 GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIK  270 (287)
T ss_pred             CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccc
Confidence               23568899999999999999999999999987653

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=2.1e-37  Score=296.77  Aligned_cols=243  Identities=25%  Similarity=0.410  Sum_probs=205.6

Q ss_pred             CEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEEe
Q 012887          191 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTK  264 (454)
Q Consensus       191 ~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~E  264 (454)
                      +|++.+.||.|+||.||++      +.+++|.+............+.+|+..++.++|+||+++++++.+... .++|||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-~~~v~e   79 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNK-LCIVME   79 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCE-EEEEeh
Confidence            4788999999999999985      478999987544444455667789999999999999999999987765 999999


Q ss_pred             ccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCc
Q 012887          265 LMEGGSVNDLILK----SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA  340 (454)
Q Consensus       265 ~~~~gsL~~~l~~----~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~  340 (454)
                      |+++++|.+++.+    ...+++..+..++.|++.||.|||++|++|+||+|.||+++.++.+||+|||++......  .
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~--~  157 (256)
T cd08530          80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN--M  157 (256)
T ss_pred             hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC--C
Confidence            9999999999855    357899999999999999999999999999999999999999999999999998766543  2


Q ss_pred             ccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHHHH
Q 012887          341 TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSL  420 (454)
Q Consensus       341 ~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~l  420 (454)
                      .....+++.|+|||.+.+..+    +.++|+||||+++|+|++|..||...+.......+. .+..+.++..++.++.++
T Consensus       158 ~~~~~~~~~~~~Pe~~~~~~~----~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l  232 (256)
T cd08530         158 AKTQIGTPHYMAPEVWKGRPY----SYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQ-RGKYPPIPPIYSQDLQNF  232 (256)
T ss_pred             cccccCCccccCHHHHCCCCC----CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh-cCCCCCCchhhCHHHHHH
Confidence            333457888999999976644    445999999999999999999998877655444443 344456677889999999


Q ss_pred             HHHhcccCCCCCCCHHHHHHH
Q 012887          421 MIKCWNNSPSKRPQFSEIISL  441 (454)
Q Consensus       421 i~~cl~~dP~~RPs~~ell~~  441 (454)
                      +.+||..+|++||++.+++.+
T Consensus       233 i~~~l~~~p~~Rp~~~~~l~~  253 (256)
T cd08530         233 IRSMLQVKPKLRPNCDKILAS  253 (256)
T ss_pred             HHHHcCCCcccCCCHHHHhcC
Confidence            999999999999999999875

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.3e-40  Score=355.50  Aligned_cols=248  Identities=24%  Similarity=0.392  Sum_probs=213.0

Q ss_pred             EEeceeeccCCceEEE------eEEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEEecc
Q 012887          193 EFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLM  266 (454)
Q Consensus       193 ~~~~~LG~G~fG~Vy~------g~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~E~~  266 (454)
                      .....||.|.||.||.      |...|+|-++..+.....-..+.+|..++..++|||+|++||+=.+.+. ++|.||||
T Consensus      1238 qrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRek-v~IFMEyC 1316 (1509)
T KOG4645|consen 1238 QRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREK-VYIFMEYC 1316 (1509)
T ss_pred             ccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHH-HHHHHHHh
Confidence            4567899999999997      5778999888766654444567899999999999999999999888876 89999999


Q ss_pred             CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCC----ccc
Q 012887          267 EGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE----ATE  342 (454)
Q Consensus       267 ~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~----~~~  342 (454)
                      ++|+|.+++...+-.++.....+..|++.|+.|||++|||||||||+|||++.+|.+|++|||.|........    ...
T Consensus      1317 ~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~ 1396 (1509)
T KOG4645|consen 1317 EGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQ 1396 (1509)
T ss_pred             ccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHHH
Confidence            9999999997777788889999999999999999999999999999999999999999999999877654421    123


Q ss_pred             ccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHHHHHH
Q 012887          343 YETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMI  422 (454)
Q Consensus       343 ~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~li~  422 (454)
                      ...||+.|||||++.+.... ....+.|||||||++.||+||+.||......-++-.-+..+..|.+|..++++-.++|.
T Consensus      1397 ~~~GT~~YMAPEvit~t~~k-G~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~g~dFle 1475 (1509)
T KOG4645|consen 1397 SMMGTPMYMAPEVITGTKGK-GHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSSEGRDFLE 1475 (1509)
T ss_pred             hhcCCchhcCchhhcccccC-CCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhHhHHHHHH
Confidence            44799999999999876532 23456899999999999999999999876665555556668888999999999999999


Q ss_pred             HhcccCCCCCCCHHHHHHHH
Q 012887          423 KCWNNSPSKRPQFSEIISLL  442 (454)
Q Consensus       423 ~cl~~dP~~RPs~~ell~~L  442 (454)
                      .||..||.+|=++.||+++-
T Consensus      1476 ~Cl~~dP~~Rw~~~qlle~~ 1495 (1509)
T KOG4645|consen 1476 HCLEQDPKMRWTASQLLEHA 1495 (1509)
T ss_pred             HHHhcCchhhhHHHHHHHhh
Confidence            99999999998888888763

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=2.2e-37  Score=305.51  Aligned_cols=251  Identities=12%  Similarity=0.160  Sum_probs=183.7

Q ss_pred             ecCCCEEEeceeeccCCceEEEeE---------EEEEEEeecCCCCchHHH---------HHHHHHHHHHhCCCCceeEE
Q 012887          187 LNSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKGCDKGNAYEF---------ELRKDLLELMTCGHKNILQF  248 (454)
Q Consensus       187 ~~~~~~~~~~~LG~G~fG~Vy~g~---------~vavK~l~~~~~~~~~~~---------~~~~Ei~~l~~l~HpnIv~~  248 (454)
                      +..++|++.+.||+|+||.||+|.         .+++|...........+.         ....++..+..+.|+|++++
T Consensus         9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~   88 (294)
T PHA02882          9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY   88 (294)
T ss_pred             cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence            445789999999999999999974         234443321111111111         11222334556789999999


Q ss_pred             EEEEEeCCC---eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEE
Q 012887          249 YCVCVDENH---GLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCL  325 (454)
Q Consensus       249 ~g~~~~~~~---~l~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL  325 (454)
                      ++.+.....   ..++++|++.. ++.+.+......++..+..++.|++.||.|||+++|+||||||+|||++.++.++|
T Consensus        89 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l  167 (294)
T PHA02882         89 YGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYI  167 (294)
T ss_pred             EEeeeEecCCceEEEEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEE
Confidence            987765542   24678888754 78777766556789999999999999999999999999999999999999999999


Q ss_pred             EccCCccccccCCC-------cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHH
Q 012887          326 GDMGIVTACKSVGE-------ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAV  398 (454)
Q Consensus       326 ~DFGla~~~~~~~~-------~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~  398 (454)
                      +|||+++.......       ......||+.|+|||++.+..+    +.++|||||||++|||++|..||..........
T Consensus       168 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~----~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~  243 (294)
T PHA02882        168 IDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACV----TRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI  243 (294)
T ss_pred             EEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCC----CcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence            99999876543211       1223468999999999987654    456999999999999999999998763322111


Q ss_pred             H-----HHHc-CCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 012887          399 G-----IAAC-GLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL  442 (454)
Q Consensus       399 ~-----i~~~-~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L  442 (454)
                      .     .... ......+..+++.+.+++..||..+|.+||++.+|.+.|
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        244 HAAKCDFIKRLHEGKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             HHhHHHHHHHhhhhhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence            1     0000 001112345789999999999999999999999999876

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=2.8e-37  Score=306.62  Aligned_cols=240  Identities=19%  Similarity=0.280  Sum_probs=180.3

Q ss_pred             eceeeccCCceEEEeE--------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeC-CCeEEEEEec
Q 012887          195 IDQIGPNSFKGVYKGK--------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDE-NHGLCVVTKL  265 (454)
Q Consensus       195 ~~~LG~G~fG~Vy~g~--------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~-~~~l~lV~E~  265 (454)
                      ..+||+|+||.||+|+        .+|+|.+.....    ...+.+|+.++..++||||+++++++... +..+++||||
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~   81 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY   81 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence            3579999999999974        588888764322    23467899999999999999999998653 3458999999


Q ss_pred             cCCCCHHHHHHh---------CCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEE----ccCCcEEEEccCCcc
Q 012887          266 MEGGSVNDLILK---------SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILL----DRHGNVCLGDMGIVT  332 (454)
Q Consensus       266 ~~~gsL~~~l~~---------~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl----~~~~~vKL~DFGla~  332 (454)
                      +.+ +|.+++..         ...+++..+..++.||+.||.|||+++|+||||||+|||+    +.++.+||+|||+++
T Consensus        82 ~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~  160 (317)
T cd07867          82 AEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR  160 (317)
T ss_pred             eCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence            975 88877642         1258899999999999999999999999999999999999    566789999999987


Q ss_pred             ccccCCC---cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHH---------HHHHHH
Q 012887          333 ACKSVGE---ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPV---------QAAVGI  400 (454)
Q Consensus       333 ~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~---------~~~~~i  400 (454)
                      .......   ......+|+.|+|||++.+..   .++.++|||||||++|||++|.+||......         .....+
T Consensus       161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~---~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~  237 (317)
T cd07867         161 LFNSPLKPLADLDPVVVTFWYRAPELLLGAR---HYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRI  237 (317)
T ss_pred             ccCCCcccccccCcceecccccCcHHhcCCC---ccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHH
Confidence            6543221   122335788999999987642   2456799999999999999999999743211         000000


Q ss_pred             HH-cCC-----------CC------------------------CCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 012887          401 AA-CGL-----------RP------------------------EIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL  442 (454)
Q Consensus       401 ~~-~~~-----------~~------------------------~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L  442 (454)
                      .. .+.           .+                        ......+..+.+|+.+||+.||.+|||+.|++++-
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp  315 (317)
T cd07867         238 FSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDP  315 (317)
T ss_pred             HHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCC
Confidence            00 000           00                        00112346688999999999999999999999763

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.5e-37  Score=312.48  Aligned_cols=248  Identities=18%  Similarity=0.250  Sum_probs=197.6

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCC----CeE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN----HGL  259 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~----~~l  259 (454)
                      ++|.+.+.||+|+||.||++      +.||+|.+............+.+|+.++..++|+||+++++++....    ..+
T Consensus         5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~   84 (337)
T cd07858           5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV   84 (337)
T ss_pred             cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence            57899999999999999985      47999998754333333455678999999999999999999887543    237


Q ss_pred             EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCC
Q 012887          260 CVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE  339 (454)
Q Consensus       260 ~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~  339 (454)
                      ++||||+. ++|.+++...+.+++..+..++.||+.||.|||+++++||||||+||+++.++.+||+|||++........
T Consensus        85 ~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~  163 (337)
T cd07858          85 YIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGD  163 (337)
T ss_pred             EEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCCcc
Confidence            99999996 59999988778899999999999999999999999999999999999999999999999999876544322


Q ss_pred             cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHc----------------
Q 012887          340 ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAAC----------------  403 (454)
Q Consensus       340 ~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~----------------  403 (454)
                      ......++..|+|||.+.+..   ..+.++|||||||++|+|++|..||.+.+.......+...                
T Consensus       164 ~~~~~~~~~~y~aPE~~~~~~---~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (337)
T cd07858         164 FMTEYVVTRWYRAPELLLNCS---EYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEK  240 (337)
T ss_pred             cccccccccCccChHHHhcCC---CCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchh
Confidence            233345678899999886532   1445699999999999999999999765433222111100                


Q ss_pred             --------C--CCC---CCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012887          404 --------G--LRP---EIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISL  441 (454)
Q Consensus       404 --------~--~~~---~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  441 (454)
                              .  .++   .....+++++.++|++||+.+|.+|||+.+++.+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h  291 (337)
T cd07858         241 ARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH  291 (337)
T ss_pred             hhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence                    0  000   1123578899999999999999999999999998

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-37  Score=297.09  Aligned_cols=239  Identities=23%  Similarity=0.316  Sum_probs=191.1

Q ss_pred             ceeeccCCceEEEe------EEEEEEEeecCCCCc-hHHHHHHHHHHH-HHhCCCCceeEEEEEEEeCCCeEEEEEeccC
Q 012887          196 DQIGPNSFKGVYKG------KRVGIEKLKGCDKGN-AYEFELRKDLLE-LMTCGHKNILQFYCVCVDENHGLCVVTKLME  267 (454)
Q Consensus       196 ~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~-~~~~~~~~Ei~~-l~~l~HpnIv~~~g~~~~~~~~l~lV~E~~~  267 (454)
                      +.||.|+||.||++      +.+|+|.+....... .....+..|... ....+|+|++++++++...+. +++||||++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~-~~lv~e~~~   80 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDY-LYLVMEYLN   80 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCe-EEEEEeccC
Confidence            56899999999985      479999886432211 122233344433 344589999999999987765 999999999


Q ss_pred             CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCcccccCCC
Q 012887          268 GGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG  347 (454)
Q Consensus       268 ~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~gt  347 (454)
                      +++|.+++.....+++..+..++.||+.||.|||+.+++|+||+|+||+++.++.+||+|||++.....    .....++
T Consensus        81 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----~~~~~~~  156 (260)
T cd05611          81 GGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----NKKFVGT  156 (260)
T ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc----cccCCCC
Confidence            999999998778899999999999999999999999999999999999999999999999999765432    2234577


Q ss_pred             CcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCC--CCCCCCCccHHHHHHHHHhc
Q 012887          348 YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGL--RPEIPKDCPQILKSLMIKCW  425 (454)
Q Consensus       348 ~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~--~~~~p~~~~~~l~~li~~cl  425 (454)
                      +.|+|||.+.+..    ++.++||||||+++|+|++|..||...+.......+.....  +...+..+++++.+++.+||
T Consensus       157 ~~y~~pe~~~~~~----~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  232 (260)
T cd05611         157 PDYLAPETILGVG----DDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLL  232 (260)
T ss_pred             cCccChhhhcCCC----CcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHc
Confidence            8899999988764    34569999999999999999999988777665555444322  23344568999999999999


Q ss_pred             ccCCCCCCCH---HHHHHHHH
Q 012887          426 NNSPSKRPQF---SEIISLLL  443 (454)
Q Consensus       426 ~~dP~~RPs~---~ell~~L~  443 (454)
                      +.+|++||++   .|++.+-+
T Consensus       233 ~~~p~~R~~~~~~~~~l~~~~  253 (260)
T cd05611         233 CMDPAKRLGANGYQEIKSHPF  253 (260)
T ss_pred             cCCHHHccCCCcHHHHHcChH
Confidence            9999999955   67666543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=3.7e-37  Score=311.69  Aligned_cols=248  Identities=19%  Similarity=0.242  Sum_probs=195.4

Q ss_pred             CCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCC-----C
Q 012887          189 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN-----H  257 (454)
Q Consensus       189 ~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~-----~  257 (454)
                      .++|++.+.||+|+||.||++      +.+|+|.+............+.+|+.++..++||||+++++++....     .
T Consensus        15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   94 (353)
T cd07850          15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ   94 (353)
T ss_pred             hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence            378999999999999999985      57999988644333334455778999999999999999999987543     2


Q ss_pred             eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccC
Q 012887          258 GLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV  337 (454)
Q Consensus       258 ~l~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~  337 (454)
                      ..|+||||+.+ +|.+.+...  +++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++......
T Consensus        95 ~~~lv~e~~~~-~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~  171 (353)
T cd07850          95 DVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS  171 (353)
T ss_pred             cEEEEEeccCC-CHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCCC
Confidence            37999999965 888887543  899999999999999999999999999999999999999999999999998765432


Q ss_pred             CCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCC------------
Q 012887          338 GEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGL------------  405 (454)
Q Consensus       338 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~------------  405 (454)
                      . ......++..|+|||.+.+..+    +.++|||||||++|+|++|..||...+.......+...-.            
T Consensus       172 ~-~~~~~~~~~~y~aPE~~~~~~~----~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (353)
T cd07850         172 F-MMTPYVVTRYYRAPEVILGMGY----KENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQP  246 (353)
T ss_pred             C-CCCCCcccccccCHHHHhCCCC----CCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhh
Confidence            2 1223356788999999987654    4459999999999999999999987654333222211000            


Q ss_pred             --------CCC--------------C-------CCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 012887          406 --------RPE--------------I-------PKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR  444 (454)
Q Consensus       406 --------~~~--------------~-------p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~  444 (454)
                              ++.              +       +...++.+.++|.+||+.||.+|||+.|++.+-+-
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~  314 (353)
T cd07850         247 TVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYI  314 (353)
T ss_pred             hhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhH
Confidence                    000              0       11346678999999999999999999999988643

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=5.8e-37  Score=302.58  Aligned_cols=249  Identities=18%  Similarity=0.285  Sum_probs=194.5

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCC------
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH------  257 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~------  257 (454)
                      ++|++.+.||+|+||.||++      +.+|+|.+..............+|+.++++++||||+++++++...+.      
T Consensus        12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   91 (310)
T cd07865          12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK   91 (310)
T ss_pred             hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence            67899999999999999985      579999887544343344456689999999999999999999876532      


Q ss_pred             -eEEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccc
Q 012887          258 -GLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK  335 (454)
Q Consensus       258 -~l~lV~E~~~~gsL~~~l~~~~-~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~  335 (454)
                       ..++||||+.+ +|.+.+.+.. .+++..+..++.||+.||.|||++|++|+||||+||+++.++.+||+|||++....
T Consensus        92 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~  170 (310)
T cd07865          92 GSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFS  170 (310)
T ss_pred             ceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCccccc
Confidence             36999999975 8888875543 78999999999999999999999999999999999999999999999999987654


Q ss_pred             cCCCc----ccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHc--CCCC--
Q 012887          336 SVGEA----TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAAC--GLRP--  407 (454)
Q Consensus       336 ~~~~~----~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~--~~~~--  407 (454)
                      .....    .....++..|+|||.+.+..   .++.++||||||+++|+|++|..||.+.++......+...  ..++  
T Consensus       171 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (310)
T cd07865         171 LSKNSKPNRYTNRVVTLWYRPPELLLGER---DYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEV  247 (310)
T ss_pred             CCcccCCCCccCcccCccccCcHHhcCCc---ccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence            32211    12234677899999887543   2345699999999999999999999876655433222111  0000  


Q ss_pred             -------------CCC-------------CCccHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 012887          408 -------------EIP-------------KDCPQILKSLMIKCWNNSPSKRPQFSEIISLL  442 (454)
Q Consensus       408 -------------~~p-------------~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L  442 (454)
                                   ..|             ...+..+.++|.+||..||.+|||+.|++++-
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~  308 (310)
T cd07865         248 WPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHD  308 (310)
T ss_pred             cccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCC
Confidence                         011             11356788999999999999999999999763

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=1.4e-37  Score=301.86  Aligned_cols=246  Identities=22%  Similarity=0.320  Sum_probs=205.1

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCC-CchHHHHHHHHHHHHHhCC-CCceeEEEEEEEeCCCeEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDK-GNAYEFELRKDLLELMTCG-HKNILQFYCVCVDENHGLCV  261 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~-~~~~~~~~~~Ei~~l~~l~-HpnIv~~~g~~~~~~~~l~l  261 (454)
                      ++|++.+.||+|+||.||++      ..+++|.+..... .......+.+|+.++..++ ||||+++++++.+.+. .++
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~-~~l   79 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEEN-LYF   79 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCce-EEE
Confidence            47899999999999999985      4689998864322 2233456788889999998 9999999999887765 999


Q ss_pred             EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCC--
Q 012887          262 VTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE--  339 (454)
Q Consensus       262 V~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~--  339 (454)
                      |||++++++|.+++.+.+.+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++........  
T Consensus        80 v~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~  159 (280)
T cd05581          80 VLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPE  159 (280)
T ss_pred             EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCccccc
Confidence            999999999999998877899999999999999999999999999999999999999999999999999876544221  


Q ss_pred             ------------------cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 012887          340 ------------------ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIA  401 (454)
Q Consensus       340 ------------------~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~  401 (454)
                                        ......++..|+|||.+.+..    .+.++|+||||+++|++++|..||...+.......+.
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~----~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~  235 (280)
T cd05581         160 SNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKP----AGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKIL  235 (280)
T ss_pred             cCCCCCccccccccccccccccccCCccccCHHHhCCCC----CChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH
Confidence                              112234678899999987654    4456999999999999999999999877655554444


Q ss_pred             HcCCCCCCCCCccHHHHHHHHHhcccCCCCCCCH----HHHHHHH
Q 012887          402 ACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQF----SEIISLL  442 (454)
Q Consensus       402 ~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~----~ell~~L  442 (454)
                      .  ....+|..+++.+.+++.+||+.+|.+||++    .+++.+-
T Consensus       236 ~--~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~  278 (280)
T cd05581         236 K--LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHP  278 (280)
T ss_pred             h--cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCC
Confidence            2  3445777889999999999999999999999    8888753

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=2.9e-37  Score=304.18  Aligned_cols=249  Identities=20%  Similarity=0.306  Sum_probs=197.3

Q ss_pred             CCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCC------
Q 012887          189 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN------  256 (454)
Q Consensus       189 ~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~------  256 (454)
                      .++|++.+.||+|+||.||+|      +.+|+|.++...........+.+|+.+++.++||||+++++++.+.+      
T Consensus         6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~   85 (302)
T cd07864           6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFK   85 (302)
T ss_pred             hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcc
Confidence            478899999999999999996      46899998754433334456778999999999999999999987654      


Q ss_pred             ---CeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCcc
Q 012887          257 ---HGLCVVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVT  332 (454)
Q Consensus       257 ---~~l~lV~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~  332 (454)
                         ..+++|+||+++ +|.+++... ..+++..+..++.||+.||.|||+.||+|+||||+||++++++.+||+|||++.
T Consensus        86 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~  164 (302)
T cd07864          86 KDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLAR  164 (302)
T ss_pred             ccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcccccc
Confidence               248999999986 777777543 479999999999999999999999999999999999999999999999999987


Q ss_pred             ccccCCC-cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCC----
Q 012887          333 ACKSVGE-ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP----  407 (454)
Q Consensus       333 ~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~----  407 (454)
                      ....... ......++..|+|||.+.+..   ..+.++|||||||++|+|++|.+||...+.......+......+    
T Consensus       165 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~---~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (302)
T cd07864         165 LYNSEESRPYTNKVITLWYRPPELLLGEE---RYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAV  241 (302)
T ss_pred             cccCCcccccccceeccCccChHHhcCCC---CCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhh
Confidence            6543322 112224567899999886432   23456999999999999999999998766655443332210000    


Q ss_pred             ------------------------CCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012887          408 ------------------------EIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISL  441 (454)
Q Consensus       408 ------------------------~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  441 (454)
                                              .....+|..+.+++.+||..||.+||++.+++.+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  299 (302)
T cd07864         242 WPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS  299 (302)
T ss_pred             cccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                                    0122468899999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=4.8e-37  Score=301.36  Aligned_cols=247  Identities=18%  Similarity=0.314  Sum_probs=198.0

Q ss_pred             CEEEeceeeccCCceEEEe---------EEEEEEEeecCCCC--chHHHHHHHHHHHHHhC-CCCceeEEEEEEEeCCCe
Q 012887          191 NLEFIDQIGPNSFKGVYKG---------KRVGIEKLKGCDKG--NAYEFELRKDLLELMTC-GHKNILQFYCVCVDENHG  258 (454)
Q Consensus       191 ~~~~~~~LG~G~fG~Vy~g---------~~vavK~l~~~~~~--~~~~~~~~~Ei~~l~~l-~HpnIv~~~g~~~~~~~~  258 (454)
                      +|++.+.||.|+||.||++         +.+|+|.++.....  ......+.+|+.++..+ +|+||+++++.+..++. 
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~-   79 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTK-   79 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCe-
Confidence            4788999999999999964         45899988743221  22345577899999998 58999999998887665 


Q ss_pred             EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCC
Q 012887          259 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG  338 (454)
Q Consensus       259 l~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~  338 (454)
                      +|+||||+++++|.+++.....+++..+..++.||+.||.|||++|++||||+|+|||++.++.+||+|||++.......
T Consensus        80 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~  159 (290)
T cd05613          80 LHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDE  159 (290)
T ss_pred             EEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceeccccc
Confidence            89999999999999999877889999999999999999999999999999999999999999999999999987654322


Q ss_pred             C-cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHHHHcCCCCCCCCCcc
Q 012887          339 E-ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPV---QAAVGIAACGLRPEIPKDCP  414 (454)
Q Consensus       339 ~-~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~---~~~~~i~~~~~~~~~p~~~~  414 (454)
                      . ......++..|+|||.+.+...  ..+.++||||||+++|+|++|..||......   ........ ...+++|..++
T Consensus       160 ~~~~~~~~~~~~y~aPE~~~~~~~--~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  236 (290)
T cd05613         160 VERAYSFCGTIEYMAPDIVRGGDG--GHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRIL-KSEPPYPQEMS  236 (290)
T ss_pred             ccccccccCCcccCChhhccCCCC--CCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhh-ccCCCCCccCC
Confidence            1 1223457888999999875421  2345699999999999999999999743221   12222221 23455677899


Q ss_pred             HHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 012887          415 QILKSLMIKCWNNSPSKRP-----QFSEIISL  441 (454)
Q Consensus       415 ~~l~~li~~cl~~dP~~RP-----s~~ell~~  441 (454)
                      +.+.+++.+||+.||.+||     +..+++.+
T Consensus       237 ~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~  268 (290)
T cd05613         237 ALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH  268 (290)
T ss_pred             HHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence            9999999999999999997     78888876

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=2.1e-37  Score=297.65  Aligned_cols=237  Identities=19%  Similarity=0.304  Sum_probs=195.3

Q ss_pred             eeccCCceEEEe------EEEEEEEeecCCCC-chHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEEeccCCCC
Q 012887          198 IGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGS  270 (454)
Q Consensus       198 LG~G~fG~Vy~g------~~vavK~l~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~E~~~~gs  270 (454)
                      ||+|+||.||++      +.+++|.+...... ......+.+|+..+.+++||||+++++.+...+. .|+||||+++++
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~-~~lv~e~~~~~~   79 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKN-LYLVMEYLPGGD   79 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcE-EEEEEecCCCCc
Confidence            689999999985      56899988643322 2344567888999999999999999998887665 999999999999


Q ss_pred             HHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCC--------ccc
Q 012887          271 VNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE--------ATE  342 (454)
Q Consensus       271 L~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~--------~~~  342 (454)
                      |.+++.+.+.+++..+..++.||+.||.|||+++++|+||+|+||+++.++.++|+|||++........        ...
T Consensus        80 L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~  159 (265)
T cd05579          80 LASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDK  159 (265)
T ss_pred             HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccccccc
Confidence            999998777899999999999999999999999999999999999999999999999999775443321        223


Q ss_pred             ccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCc--cHHHHHH
Q 012887          343 YETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDC--PQILKSL  420 (454)
Q Consensus       343 ~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~--~~~l~~l  420 (454)
                      ...++..|+|||.+.+..    .+.++||||||+++|++++|..||....+......+....  ...|..+  +..+.++
T Consensus       160 ~~~~~~~~~~Pe~~~~~~----~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~  233 (265)
T cd05579         160 RIVGTPDYIAPEVILGQG----HSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGK--IEWPEDVEVSDEAIDL  233 (265)
T ss_pred             CcccCccccCHHHhcCCC----CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC--cCCCccccCCHHHHHH
Confidence            345677899999987664    3445999999999999999999999887776665555433  3344444  8999999


Q ss_pred             HHHhcccCCCCCCCH---HHHHHH
Q 012887          421 MIKCWNNSPSKRPQF---SEIISL  441 (454)
Q Consensus       421 i~~cl~~dP~~RPs~---~ell~~  441 (454)
                      +.+||+.+|.+||++   .+++++
T Consensus       234 i~~~l~~~p~~Rpt~~~~~~~l~~  257 (265)
T cd05579         234 ISKLLVPDPEKRLGAKSIEEIKNH  257 (265)
T ss_pred             HHHHhcCCHhhcCCCccHHHHhcC
Confidence            999999999999999   555543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=4.5e-37  Score=307.79  Aligned_cols=246  Identities=22%  Similarity=0.327  Sum_probs=191.9

Q ss_pred             ceeecc--CCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEEeccC
Q 012887          196 DQIGPN--SFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLME  267 (454)
Q Consensus       196 ~~LG~G--~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~E~~~  267 (454)
                      ..||+|  +||.||++      +.||+|.+............+.+|+.++..++||||++++++|...+. +++||||+.
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~-~~~v~e~~~   82 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSW-LWVISPFMA   82 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCc-eEEEEeccc
Confidence            356666  89999985      679999987544444445678889988888999999999999998876 899999999


Q ss_pred             CCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCc-----
Q 012887          268 GGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA-----  340 (454)
Q Consensus       268 ~gsL~~~l~~~--~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~-----  340 (454)
                      +++|.+++.+.  ..+++..+..++.||+.||.|||++|++||||||+|||++.++.++++|||.+.........     
T Consensus        83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (328)
T cd08226          83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVY  162 (328)
T ss_pred             CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccc
Confidence            99999998654  36899999999999999999999999999999999999999999999999864332221111     


Q ss_pred             --ccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCC-------------
Q 012887          341 --TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGL-------------  405 (454)
Q Consensus       341 --~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~-------------  405 (454)
                        .....++..|+|||++.+...  .++.++|||||||++|+|++|..||.................             
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~~~~--~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (328)
T cd08226         163 DFPQFSTSVLPWLSPELLRQDLY--GYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEE  240 (328)
T ss_pred             cccccccCccCccChhhhcCCCC--CCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhh
Confidence              112234567999999976432  245679999999999999999999987655443332221100             


Q ss_pred             --------------------------------CCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 012887          406 --------------------------------RPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR  444 (454)
Q Consensus       406 --------------------------------~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~  444 (454)
                                                      +.+.+..++..+.+||++||..||++|||++|++++-+-
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~  311 (328)
T cd08226         241 SRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFF  311 (328)
T ss_pred             hhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHH
Confidence                                            111123467789999999999999999999999987664

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=7.4e-37  Score=299.06  Aligned_cols=242  Identities=19%  Similarity=0.279  Sum_probs=190.5

Q ss_pred             eeeccCCceEEEe------EEEEEEEeecCCCCc-hHHHHHHHH---HHHHHhCCCCceeEEEEEEEeCCCeEEEEEecc
Q 012887          197 QIGPNSFKGVYKG------KRVGIEKLKGCDKGN-AYEFELRKD---LLELMTCGHKNILQFYCVCVDENHGLCVVTKLM  266 (454)
Q Consensus       197 ~LG~G~fG~Vy~g------~~vavK~l~~~~~~~-~~~~~~~~E---i~~l~~l~HpnIv~~~g~~~~~~~~l~lV~E~~  266 (454)
                      .||+|+||.||++      +.+|+|.+....... ........|   +..+....||||+++++++.+.+. +++||||+
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~-~~~v~e~~   79 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK-LSFILDLM   79 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCE-EEEEEecC
Confidence            3899999999974      579999886432221 111122223   333445689999999999987776 99999999


Q ss_pred             CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCcccccCC
Q 012887          267 EGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETD  346 (454)
Q Consensus       267 ~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~g  346 (454)
                      +||+|.+++.+.+.+++..+..++.|++.||.|||+++++||||||+||+++.++.+||+|||++.......  .....+
T Consensus        80 ~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--~~~~~~  157 (278)
T cd05606          80 NGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--PHASVG  157 (278)
T ss_pred             CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC--CcCcCC
Confidence            999999999777789999999999999999999999999999999999999999999999999987543321  223468


Q ss_pred             CCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHHHcCCCCCCCCCccHHHHHHHHHhc
Q 012887          347 GYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQ-AAVGIAACGLRPEIPKDCPQILKSLMIKCW  425 (454)
Q Consensus       347 t~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~-~~~~i~~~~~~~~~p~~~~~~l~~li~~cl  425 (454)
                      +..|+|||.+.+..   .++.++||||+||++|+|++|..||....... ...........+.+|..++.++.+++.+||
T Consensus       158 ~~~y~aPE~~~~~~---~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l  234 (278)
T cd05606         158 THGYMAPEVLQKGV---AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLL  234 (278)
T ss_pred             CcCCcCcHHhcCCC---CCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcCCHHHHHHHHHHh
Confidence            88999999987532   24456999999999999999999998653211 111112223456677788999999999999


Q ss_pred             ccCCCCCC-----CHHHHHHHHHh
Q 012887          426 NNSPSKRP-----QFSEIISLLLR  444 (454)
Q Consensus       426 ~~dP~~RP-----s~~ell~~L~~  444 (454)
                      ..+|.+||     ++.+++++-+-
T Consensus       235 ~~~p~~R~~~~~~~~~~ll~~~~~  258 (278)
T cd05606         235 QRDVNRRLGCLGRGAQEVKEHPFF  258 (278)
T ss_pred             hcCHHhccCCCCCCHHHHHhCccc
Confidence            99999999     99999986543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5e-38  Score=310.86  Aligned_cols=246  Identities=20%  Similarity=0.306  Sum_probs=199.5

Q ss_pred             eeecCCCEEEeceeeccCCceEEEeEEEEEEEeecCCCCc-------hHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCC
Q 012887          185 WLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGN-------AYEFELRKDLLELMTCGHKNILQFYCVCVDENH  257 (454)
Q Consensus       185 ~~~~~~~~~~~~~LG~G~fG~Vy~g~~vavK~l~~~~~~~-------~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~  257 (454)
                      +.+..+.|..-+.||+|+||.||-++..|.-++..+....       .-+.-...|-.+|..++.++||.+--+|.+.+.
T Consensus       180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~  259 (591)
T KOG0986|consen  180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDA  259 (591)
T ss_pred             hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCc
Confidence            3467788999999999999999975544433333222111       122335677788889999999999888888887


Q ss_pred             eEEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccc
Q 012887          258 GLCVVTKLMEGGSVNDLILKSR--KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK  335 (454)
Q Consensus       258 ~l~lV~E~~~~gsL~~~l~~~~--~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~  335 (454)
                       +|+||..|+||+|.-+|.+.+  .+++..+..|+.+|+.||++||+.+||+|||||+|||+|+.|+++|+|+|||....
T Consensus       260 -LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~  338 (591)
T KOG0986|consen  260 -LCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIP  338 (591)
T ss_pred             -eEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecC
Confidence             999999999999999886654  89999999999999999999999999999999999999999999999999998876


Q ss_pred             cCCCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHH--HHHHHcCCCCCCCCCc
Q 012887          336 SVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAA--VGIAACGLRPEIPKDC  413 (454)
Q Consensus       336 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~--~~i~~~~~~~~~p~~~  413 (454)
                      .... .....||.+|||||++.++.|+.+    .|.|||||+||||+.|+.||.........  ...........+|+.+
T Consensus       339 ~g~~-~~~rvGT~GYMAPEvl~ne~Y~~s----~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kF  413 (591)
T KOG0986|consen  339 EGKP-IRGRVGTVGYMAPEVLQNEVYDFS----PDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKF  413 (591)
T ss_pred             CCCc-cccccCcccccCHHHHcCCcccCC----ccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhccccc
Confidence            6543 333489999999999998876655    89999999999999999999864432211  1122223456688999


Q ss_pred             cHHHHHHHHHhcccCCCCCCCHH
Q 012887          414 PQILKSLMIKCWNNSPSKRPQFS  436 (454)
Q Consensus       414 ~~~l~~li~~cl~~dP~~RPs~~  436 (454)
                      |+++++|.+..|.+||.+|....
T Consensus       414 S~eakslc~~LL~Kdp~~RLGcr  436 (591)
T KOG0986|consen  414 SEEAKSLCEGLLTKDPEKRLGCR  436 (591)
T ss_pred             CHHHHHHHHHHHccCHHHhccCC
Confidence            99999999999999999997644

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.9e-37  Score=321.17  Aligned_cols=241  Identities=20%  Similarity=0.282  Sum_probs=188.1

Q ss_pred             CCCEEEeceeeccCCceEEEeE------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEE
Q 012887          189 SDNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  262 (454)
Q Consensus       189 ~~~~~~~~~LG~G~fG~Vy~g~------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV  262 (454)
                      ...|.+.+.||+|+||.||++.      .||+|....        ....+|+.+|.+++|+|||++++++...+. .++|
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~-~~lv  238 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--------ASSVHEARLLRRLSHPAVLALLDVRVVGGL-TCLV  238 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--------cCHHHHHHHHHHCCCCCCCcEEEEEEECCE-EEEE
Confidence            4579999999999999999964      588885431        124689999999999999999999988776 8999


Q ss_pred             EeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCC--
Q 012887          263 TKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE--  339 (454)
Q Consensus       263 ~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~--  339 (454)
                      ||++. ++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......  
T Consensus       239 ~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~  317 (461)
T PHA03211        239 LPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP  317 (461)
T ss_pred             EEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccc
Confidence            99995 5898888654 4799999999999999999999999999999999999999999999999999876533221  


Q ss_pred             cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCH-------HHHHHHHHH-cCC------
Q 012887          340 ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSP-------VQAAVGIAA-CGL------  405 (454)
Q Consensus       340 ~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~-------~~~~~~i~~-~~~------  405 (454)
                      ......||+.|+|||++.+..    ++.++|||||||+||||++|..|+.....       ...+..++. ...      
T Consensus       318 ~~~~~~GT~~Y~APE~~~~~~----~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~  393 (461)
T PHA03211        318 FHYGIAGTVDTNAPEVLAGDP----YTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFP  393 (461)
T ss_pred             cccccCCCcCCcCHHHHcCCC----CCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCC
Confidence            122346899999999998765    44569999999999999998765432110       111222211 111      


Q ss_pred             -------------------CCCCC-------CCccHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 012887          406 -------------------RPEIP-------KDCPQILKSLMIKCWNNSPSKRPQFSEIISLLL  443 (454)
Q Consensus       406 -------------------~~~~p-------~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~  443 (454)
                                         ++...       ...+.++.+||.+||+.||.+|||+.|++++-+
T Consensus       394 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~  457 (461)
T PHA03211        394 QHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPL  457 (461)
T ss_pred             CCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcc
Confidence                               00000       024568999999999999999999999998854

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=3.9e-37  Score=305.44  Aligned_cols=249  Identities=19%  Similarity=0.294  Sum_probs=195.7

Q ss_pred             EEeceeeccCCceEEE----eEEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEEeccCC
Q 012887          193 EFIDQIGPNSFKGVYK----GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEG  268 (454)
Q Consensus       193 ~~~~~LG~G~fG~Vy~----g~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~E~~~~  268 (454)
                      .+.+.+|.|+++.||+    |+.+|+|++............+.+|+..+..++||||+++++++.+.+. .+++|||+++
T Consensus         5 ~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~-~~~~~e~~~~   83 (314)
T cd08216           5 LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSE-LYVVSPLMAY   83 (314)
T ss_pred             hhhHhhcCCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCe-EEEEEeccCC
Confidence            4556667777777776    4689999997654444555678999999999999999999999987776 8999999999


Q ss_pred             CCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCC-------
Q 012887          269 GSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE-------  339 (454)
Q Consensus       269 gsL~~~l~~~--~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~-------  339 (454)
                      |+|.+++.+.  ..+++..+..++.|++.||.|||+++|+||||||+||+++.++.+||+|||.+........       
T Consensus        84 ~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~  163 (314)
T cd08216          84 GSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHD  163 (314)
T ss_pred             CCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccccccccc
Confidence            9999999653  4689999999999999999999999999999999999999999999999998765533221       


Q ss_pred             cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCC-------------
Q 012887          340 ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR-------------  406 (454)
Q Consensus       340 ~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~-------------  406 (454)
                      ......++..|+|||++.+...  .++.++|+|||||++|||++|..||.................+             
T Consensus       164 ~~~~~~~~~~y~aPE~~~~~~~--~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (314)
T cd08216         164 FPKSSVKNLPWLSPEVLQQNLQ--GYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYED  241 (314)
T ss_pred             ccccccccccccCHHHhcCCCC--CCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcC
Confidence            1122345678999999875421  2455699999999999999999999876554433222211100             


Q ss_pred             -------------------CCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 012887          407 -------------------PEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR  444 (454)
Q Consensus       407 -------------------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~  444 (454)
                                         ...+..++.++.+++.+||..||++|||+++++++-+-
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~  298 (314)
T cd08216         242 SMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFF  298 (314)
T ss_pred             CcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchH
Confidence                               01112345678999999999999999999999998664

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=4.1e-37  Score=296.65  Aligned_cols=244  Identities=20%  Similarity=0.358  Sum_probs=199.1

Q ss_pred             CEEEeceeeccCCceEEEeE------EEEEEEeecCCC---CchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEE
Q 012887          191 NLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDK---GNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCV  261 (454)
Q Consensus       191 ~~~~~~~LG~G~fG~Vy~g~------~vavK~l~~~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~l  261 (454)
                      +|.+.+.||+|+||.||++.      .+++|.++....   .......+..|+.+++.++||||+++++++.+.+. .++
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~l   79 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDA-FCI   79 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCc-eEE
Confidence            47889999999999999863      244555543222   22234456778889999999999999999987776 899


Q ss_pred             EEeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccC
Q 012887          262 VTKLMEGGSVNDLILK----SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV  337 (454)
Q Consensus       262 V~E~~~~gsL~~~l~~----~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~  337 (454)
                      ||||+++++|.+++.+    ...+++..+..++.|++.||.|||++|++|+||+|+||+++. +.++|+|||++......
T Consensus        80 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~  158 (260)
T cd08222          80 ITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGS  158 (260)
T ss_pred             EEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCC
Confidence            9999999999998853    347999999999999999999999999999999999999985 66999999998766544


Q ss_pred             CCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHH
Q 012887          338 GEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQIL  417 (454)
Q Consensus       338 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l  417 (454)
                      ........+++.|+|||.+.+..+    +.++|+||||+++|+|++|..||...........+. .+..+..+..++.++
T Consensus       159 ~~~~~~~~~~~~~~~pe~~~~~~~----~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  233 (260)
T cd08222         159 CDLATTFTGTPYYMSPEALKHQGY----DSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIV-EGPTPSLPETYSRQL  233 (260)
T ss_pred             cccccCCCCCcCccCHHHHccCCC----CchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH-cCCCCCCcchhcHHH
Confidence            433444567888999999876543    445999999999999999999998766655554443 345556677889999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHHH
Q 012887          418 KSLMIKCWNNSPSKRPQFSEIISL  441 (454)
Q Consensus       418 ~~li~~cl~~dP~~RPs~~ell~~  441 (454)
                      .++|.+||..+|++||++.+++.+
T Consensus       234 ~~li~~~l~~~p~~Rp~~~~il~~  257 (260)
T cd08222         234 NSIMQSMLNKDPSLRPSAAEILRN  257 (260)
T ss_pred             HHHHHHHhcCChhhCcCHHHHhhC
Confidence            999999999999999999999876

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=5.9e-37  Score=304.29  Aligned_cols=252  Identities=23%  Similarity=0.318  Sum_probs=203.4

Q ss_pred             CCEEEeceeeccCCceEEEeE------EEEEEEeecCCC-CchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDK-GNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  262 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g~------~vavK~l~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV  262 (454)
                      +.|...+.||+|+||.||+|+      .+++|.+..... ......++.+|+.+++.++|+|++++++++...+. .++|
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~lv   93 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHT-AWLV   93 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCe-eEEE
Confidence            457778899999999999864      589998864322 22334567789999999999999999999988765 8999


Q ss_pred             EeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCcc
Q 012887          263 TKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT  341 (454)
Q Consensus       263 ~E~~~~gsL~~~l~~-~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~  341 (454)
                      |||+. |+|.+.+.. ...+++..+..++.|++.||.|||+++++||||+|+|||++.++.++|+|||++.....    .
T Consensus        94 ~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~----~  168 (308)
T cd06634          94 MEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----A  168 (308)
T ss_pred             EEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecC----c
Confidence            99997 588877743 45789999999999999999999999999999999999999999999999999765432    2


Q ss_pred             cccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHHHHH
Q 012887          342 EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLM  421 (454)
Q Consensus       342 ~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~li  421 (454)
                      ....+++.|+|||.+.+... ...+.++|||||||++|+|++|..||...........+.....+...+..++..+.++|
T Consensus       169 ~~~~~~~~y~aPE~~~~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  247 (308)
T cd06634         169 NXFVGTPYWMAPEVILAMDE-GQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFV  247 (308)
T ss_pred             ccccCCccccCHHHHhhccc-CCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHHHH
Confidence            23457788999999853211 12455699999999999999999999877665555555544333333556889999999


Q ss_pred             HHhcccCCCCCCCHHHHHHHHHhhcCC
Q 012887          422 IKCWNNSPSKRPQFSEIISLLLRTNNI  448 (454)
Q Consensus       422 ~~cl~~dP~~RPs~~ell~~L~~~~~~  448 (454)
                      .+||..+|.+||++.+++.+.+.....
T Consensus       248 ~~cl~~~P~~Rp~~~~ll~~~~~~~~~  274 (308)
T cd06634         248 DSCLQKIPQDRPTSEVLLKHRFVLRER  274 (308)
T ss_pred             HHHhhCCcccCCCHHHHhhCccccccC
Confidence            999999999999999999987765543

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=7.9e-37  Score=297.33  Aligned_cols=238  Identities=17%  Similarity=0.261  Sum_probs=186.5

Q ss_pred             CCEEEecee--eccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEE
Q 012887          190 DNLEFIDQI--GPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCV  261 (454)
Q Consensus       190 ~~~~~~~~L--G~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~l  261 (454)
                      ++|++.+.+  |+|+||.||++      +.+|+|.+.......   .  ..++..+. .+||||+++++.+...+. +++
T Consensus        14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~---~--e~~~~~~~-~~h~~iv~~~~~~~~~~~-~~i   86 (267)
T PHA03390         14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA---I--EPMVHQLM-KDNPNFIKLYYSVTTLKG-HVL   86 (267)
T ss_pred             HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch---h--hHHHHHHh-hcCCCEEEEEEEEecCCe-eEE
Confidence            455666655  99999999985      458888876432111   1  11111111 269999999999988776 999


Q ss_pred             EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCC-cEEEEccCCccccccCCCc
Q 012887          262 VTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG-NVCLGDMGIVTACKSVGEA  340 (454)
Q Consensus       262 V~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~-~vKL~DFGla~~~~~~~~~  340 (454)
                      ||||+++++|.+++.+...+++..+..++.||+.||.|||+.|++||||||+||+++.++ .++|+|||++......   
T Consensus        87 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~---  163 (267)
T PHA03390         87 IMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP---  163 (267)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC---
Confidence            999999999999998777999999999999999999999999999999999999999998 9999999998765422   


Q ss_pred             ccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH-H-HHcCCCCCCCCCccHHHH
Q 012887          341 TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVG-I-AACGLRPEIPKDCPQILK  418 (454)
Q Consensus       341 ~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~-i-~~~~~~~~~p~~~~~~l~  418 (454)
                       ....++..|+|||++.+..+    +.++||||||+++|+|++|..||........... . .........+..+++.+.
T Consensus       164 -~~~~~~~~y~aPE~~~~~~~----~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (267)
T PHA03390        164 -SCYDGTLDYFSPEKIKGHNY----DVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNAN  238 (267)
T ss_pred             -ccCCCCCcccChhhhcCCCC----CchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHHHH
Confidence             23357889999999987654    3459999999999999999999985443221111 1 111233455667899999


Q ss_pred             HHHHHhcccCCCCCCC-HHHHHHHH
Q 012887          419 SLMIKCWNNSPSKRPQ-FSEIISLL  442 (454)
Q Consensus       419 ~li~~cl~~dP~~RPs-~~ell~~L  442 (454)
                      ++|.+||+.+|.+||+ +++++++=
T Consensus       239 ~li~~~l~~~p~~R~~~~~~~l~h~  263 (267)
T PHA03390        239 DFVQSMLKYNINYRLTNYNEIIKHP  263 (267)
T ss_pred             HHHHHHhccChhhCCchHHHHhcCC
Confidence            9999999999999996 69998763

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=4e-37  Score=308.97  Aligned_cols=252  Identities=18%  Similarity=0.250  Sum_probs=200.1

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeC---CCeEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDE---NHGLC  260 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~---~~~l~  260 (454)
                      ++|++.+.||.|+||.||+|      +.+|+|++............+.+|+.++..++||||+++++++...   ...++
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY   84 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence            78999999999999999985      5799999875433333445677899999999999999999887643   23489


Q ss_pred             EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCc
Q 012887          261 VVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA  340 (454)
Q Consensus       261 lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~  340 (454)
                      +||||+. ++|.+++...+.+++..+..++.||+.||.|||+++++||||||+||+++.++.+||+|||++.........
T Consensus        85 lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~  163 (334)
T cd07855          85 VVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTE  163 (334)
T ss_pred             EEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCcC
Confidence            9999996 599999877778999999999999999999999999999999999999999999999999998765432221


Q ss_pred             ----ccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHc-------------
Q 012887          341 ----TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAAC-------------  403 (454)
Q Consensus       341 ----~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~-------------  403 (454)
                          .....++..|+|||.+.+..   .++.++|||||||++|+|++|..||.+.+.......+...             
T Consensus       164 ~~~~~~~~~~~~~y~~PE~~~~~~---~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~  240 (334)
T cd07855         164 HKYFMTEYVATRWYRAPELLLSLP---EYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIG  240 (334)
T ss_pred             CCcccccccccccccChHHhcCCc---ccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhc
Confidence                12235778899999986532   2455699999999999999999999876544332221110             


Q ss_pred             -----------CCCCCC-----CCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 012887          404 -----------GLRPEI-----PKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRT  445 (454)
Q Consensus       404 -----------~~~~~~-----p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~  445 (454)
                                 ......     ....+.++.++|.+||+.+|.+||++.+++.+.+-.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~  298 (334)
T cd07855         241 SDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLA  298 (334)
T ss_pred             hhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhh
Confidence                       111111     134688999999999999999999999999987653

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=8.4e-37  Score=306.39  Aligned_cols=247  Identities=19%  Similarity=0.275  Sum_probs=195.9

Q ss_pred             EEeceeeccCCceEEEe------EEEEEEEeecCCCCch------------HHHHHHHHHHHHHhCCCCceeEEEEEEEe
Q 012887          193 EFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNA------------YEFELRKDLLELMTCGHKNILQFYCVCVD  254 (454)
Q Consensus       193 ~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~------------~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~  254 (454)
                      .+.+.||.|+||.||++      +.+|+|+++.......            ....+.+|+.++..++||||+++++++..
T Consensus        12 ~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   91 (335)
T PTZ00024         12 QKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVE   91 (335)
T ss_pred             hhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEec
Confidence            45577999999999996      4689998864332210            12246789999999999999999999988


Q ss_pred             CCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCcccc
Q 012887          255 ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC  334 (454)
Q Consensus       255 ~~~~l~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~  334 (454)
                      .+. .++||||+. |+|.+++.....+++.....++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++...
T Consensus        92 ~~~-~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~~~~~  169 (335)
T PTZ00024         92 GDF-INLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRY  169 (335)
T ss_pred             CCc-EEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccceeec
Confidence            776 999999997 599999977778999999999999999999999999999999999999999999999999998765


Q ss_pred             ccC--------------CCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Q 012887          335 KSV--------------GEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGI  400 (454)
Q Consensus       335 ~~~--------------~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i  400 (454)
                      ...              ........++..|+|||.+.+..   ..+.++|||||||++|+|++|..||.+.++......+
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i  246 (335)
T PTZ00024        170 GYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAE---KYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRI  246 (335)
T ss_pred             ccccccccccccccccccccccccccccCCCCChhcccCC---CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            411              11112224567899999987543   2455799999999999999999999987766554433


Q ss_pred             HHcCCCC--------------------------CCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 012887          401 AACGLRP--------------------------EIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR  444 (454)
Q Consensus       401 ~~~~~~~--------------------------~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~  444 (454)
                      ......+                          ......+.++.+++.+||+.+|++||++.+++.+-+-
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~  316 (335)
T PTZ00024        247 FELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYF  316 (335)
T ss_pred             HHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCccc
Confidence            2211000                          0112457889999999999999999999999987654

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.5e-37  Score=307.33  Aligned_cols=249  Identities=18%  Similarity=0.262  Sum_probs=203.0

Q ss_pred             CEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCC----CeEE
Q 012887          191 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN----HGLC  260 (454)
Q Consensus       191 ~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~----~~l~  260 (454)
                      +|++.+.||.|+||.||++      +.+++|++............+.+|+..+..++||||+++++++.+.+    ..+|
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            4788999999999999986      47899998754433445566889999999999999999999998775    2489


Q ss_pred             EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCC-
Q 012887          261 VVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE-  339 (454)
Q Consensus       261 lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~-  339 (454)
                      +||||+++ +|.+++.+...+++..+..++.||+.||.|||++|++||||||+|||++.++.++|+|||++........ 
T Consensus        81 lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~  159 (330)
T cd07834          81 IVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDE  159 (330)
T ss_pred             EEecchhh-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeecccccc
Confidence            99999975 8999987777999999999999999999999999999999999999999999999999999887654431 


Q ss_pred             --cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCC----------
Q 012887          340 --ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP----------  407 (454)
Q Consensus       340 --~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~----------  407 (454)
                        ......++..|+|||.+.+..   ..+.++|+||||+++|+|++|..||.+.+..+....+......+          
T Consensus       160 ~~~~~~~~~~~~y~aPE~~~~~~---~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  236 (330)
T cd07834         160 KGFLTEYVVTRWYRAPELLLSSS---RYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITS  236 (330)
T ss_pred             cccccccccccCcCCceeeeccc---CCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccc
Confidence              223335678899999998762   24556999999999999999999998877655444333211100          


Q ss_pred             -------------------CCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 012887          408 -------------------EIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLL  443 (454)
Q Consensus       408 -------------------~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~  443 (454)
                                         ......+.++.++|.+||+.+|.+||++.+++.+-+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~  291 (330)
T cd07834         237 EKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPY  291 (330)
T ss_pred             cchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCcc
Confidence                               012336788999999999999999999999999743

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-36  Score=295.41  Aligned_cols=247  Identities=18%  Similarity=0.297  Sum_probs=197.4

Q ss_pred             EEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeC-CCeEEEEEe
Q 012887          192 LEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDE-NHGLCVVTK  264 (454)
Q Consensus       192 ~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~-~~~l~lV~E  264 (454)
                      |++.+.||+|+||.||+|      +.+|+|.+............+.+|+.++..++|||++++++++.+. ....++|||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            578899999999999995      5789999985442333445678899999999999999999999877 234999999


Q ss_pred             ccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCC-ccc
Q 012887          265 LMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE-ATE  342 (454)
Q Consensus       265 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~-~~~  342 (454)
                      |+++ +|.+++.+. ..+++..+..++.||+.||+|||++|++|+||+|+||++++++.+||+|||++........ ...
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~  159 (287)
T cd07840          81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYT  159 (287)
T ss_pred             cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCccccc
Confidence            9975 899888654 5899999999999999999999999999999999999999999999999999876654321 122


Q ss_pred             ccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCC---------------
Q 012887          343 YETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP---------------  407 (454)
Q Consensus       343 ~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~---------------  407 (454)
                      ...++..|+|||.+.+..   .++.++||||||+++|+|++|..||...+.......+......+               
T Consensus       160 ~~~~~~~y~~PE~~~~~~---~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (287)
T cd07840         160 NRVITLWYRPPELLLGAT---RYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFE  236 (287)
T ss_pred             ccccccccCCceeeEccc---cCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhh
Confidence            334577899999876532   24567999999999999999999998877655444332210000               


Q ss_pred             ------C--------CCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 012887          408 ------E--------IPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL  442 (454)
Q Consensus       408 ------~--------~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L  442 (454)
                            .        +...++..+.+++++||..+|.+||++.+++.+-
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~  285 (287)
T cd07840         237 NLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHE  285 (287)
T ss_pred             hccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCc
Confidence                  0        0111388899999999999999999999998763

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=6.9e-37  Score=307.43  Aligned_cols=247  Identities=21%  Similarity=0.295  Sum_probs=196.2

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEEEEEEEeCC-CeEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVDEN-HGLCV  261 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~~~g~~~~~~-~~l~l  261 (454)
                      ++|++.+.||+|+||.||+|      +.+|+|++............+.+|+..+.++ +||||+++++++...+ ..+++
T Consensus         7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~l   86 (337)
T cd07852           7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYL   86 (337)
T ss_pred             hHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEE
Confidence            67899999999999999986      5789998864333333344567899999999 9999999999987553 34899


Q ss_pred             EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCC--
Q 012887          262 VTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE--  339 (454)
Q Consensus       262 V~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~--  339 (454)
                      ||||+++ +|.+++.+. .+++.....++.||+.||.|||++||+||||||+||+++.++.+||+|||++........  
T Consensus        87 v~e~~~~-~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~~  164 (337)
T cd07852          87 VFEYMET-DLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENP  164 (337)
T ss_pred             Eeccccc-CHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccccccc
Confidence            9999975 999988654 789999999999999999999999999999999999999999999999999876543221  


Q ss_pred             ---cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCC-----------
Q 012887          340 ---ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGL-----------  405 (454)
Q Consensus       340 ---~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~-----------  405 (454)
                         ......+++.|+|||.+.+..   ..+.++||||||+++|+|++|+.||.+..+......+.....           
T Consensus       165 ~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (337)
T cd07852         165 ENPVLTDYVATRWYRAPEILLGST---RYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIK  241 (337)
T ss_pred             cCcchhcccccccccCceeeeccc---cccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHH
Confidence               122335788899999886532   244569999999999999999999987665443332211110           


Q ss_pred             ---------------C---CCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012887          406 ---------------R---PEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISL  441 (454)
Q Consensus       406 ---------------~---~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  441 (454)
                                     .   ......++.++.++|.+||+.||++|||+.+++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         242 SPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             hhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence                           0   01112368899999999999999999999999987

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=2.4e-36  Score=300.84  Aligned_cols=245  Identities=22%  Similarity=0.328  Sum_probs=199.8

Q ss_pred             EEEeceeeccCCceEEEe------EEEEEEEeecCCCCc-hHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEEe
Q 012887          192 LEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGN-AYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTK  264 (454)
Q Consensus       192 ~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~E  264 (454)
                      |...+.||+|+||.||+|      +.+++|.+....... .....+.+|+..+..++|||++++++++.+.+. .|+|||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~lv~e  101 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHT-AWLVME  101 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCE-EEEEEe
Confidence            566778999999999996      468999886443322 233467889999999999999999999988775 899999


Q ss_pred             ccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCcccc
Q 012887          265 LMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY  343 (454)
Q Consensus       265 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~  343 (454)
                      |+.+ +|.+++.. ...+++..+..++.||+.||.|||++|++|+||+|+||+++.++.+||+|||++.....    ...
T Consensus       102 ~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~----~~~  176 (313)
T cd06633         102 YCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP----ANS  176 (313)
T ss_pred             cCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCC----CCC
Confidence            9965 78777754 45799999999999999999999999999999999999999999999999999754322    233


Q ss_pred             cCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHHHHHHH
Q 012887          344 ETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIK  423 (454)
Q Consensus       344 ~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~li~~  423 (454)
                      ..++..|+|||.+..... ..++.++|||||||++|+|++|..||...........+.....+......++..+.+++.+
T Consensus       177 ~~~~~~y~aPE~~~~~~~-~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  255 (313)
T cd06633         177 FVGTPYWMAPEVILAMDE-GQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDY  255 (313)
T ss_pred             ccccccccChhhccccCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHHHH
Confidence            467888999999853211 1245679999999999999999999988777666666655444433445678899999999


Q ss_pred             hcccCCCCCCCHHHHHHHHH
Q 012887          424 CWNNSPSKRPQFSEIISLLL  443 (454)
Q Consensus       424 cl~~dP~~RPs~~ell~~L~  443 (454)
                      ||+.+|.+||++.+++.+-+
T Consensus       256 ~l~~~P~~Rp~~~~~l~~~~  275 (313)
T cd06633         256 CLQKIPQERPASAELLRHDF  275 (313)
T ss_pred             HccCChhhCcCHHHHhcCcc
Confidence            99999999999999997643

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=5.7e-38  Score=339.85  Aligned_cols=244  Identities=23%  Similarity=0.393  Sum_probs=192.7

Q ss_pred             CCEEEeceeeccCCceEEE------eEEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEe---------
Q 012887          190 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVD---------  254 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~------g~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~---------  254 (454)
                      .+|+.++.||+|+||.||+      |+.+|||++.... .......+.+|+..|.+|+|||||+||..|.+         
T Consensus       479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e  557 (1351)
T KOG1035|consen  479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE  557 (1351)
T ss_pred             hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence            6788999999999999999      5689999998654 55566779999999999999999999987763         


Q ss_pred             --------------------------------------------------------------------------------
Q 012887          255 --------------------------------------------------------------------------------  254 (454)
Q Consensus       255 --------------------------------------------------------------------------------  254 (454)
                                                                                                      
T Consensus       558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e  637 (1351)
T KOG1035|consen  558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE  637 (1351)
T ss_pred             ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence                                                                                            


Q ss_pred             ----------------------CC-------CeEEEEEeccCCCCHHHHHHhCCCC-CHHHHHHHHHHHHHHHHHHHhcC
Q 012887          255 ----------------------EN-------HGLCVVTKLMEGGSVNDLILKSRKL-QTKEIIRIAIDVAEGIKFLNDHG  304 (454)
Q Consensus       255 ----------------------~~-------~~l~lV~E~~~~gsL~~~l~~~~~l-~~~~~~~i~~qI~~gL~yLH~~~  304 (454)
                                            +.       ..+||-||||+..+|.+++.++... .....++++.+|++||.|+|++|
T Consensus       638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~g  717 (1351)
T KOG1035|consen  638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQG  717 (1351)
T ss_pred             CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCc
Confidence                                  00       2379999999997888888666544 57889999999999999999999


Q ss_pred             cccCCccCCcEEEccCCcEEEEccCCccccc----c--------------CCCcccccCCCCcccccccccCCCCCCCCC
Q 012887          305 VAYRDLNSQRILLDRHGNVCLGDMGIVTACK----S--------------VGEATEYETDGYRWLAPEIIAGDPESVSET  366 (454)
Q Consensus       305 iiHrDIKp~NILl~~~~~vKL~DFGla~~~~----~--------------~~~~~~~~~gt~~y~APE~l~~~~~~~~~~  366 (454)
                      ||||||||.||++++++.|||+|||+|+...    .              .....+...||..|+|||.+.+..- .+++
T Consensus       718 iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~-~~Yn  796 (1351)
T KOG1035|consen  718 IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSS-NKYN  796 (1351)
T ss_pred             eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccc-cccc
Confidence            9999999999999999999999999988721    0              0012334468999999999987653 4688


Q ss_pred             chhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCC------ccHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012887          367 WMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKD------CPQILKSLMIKCWNNSPSKRPQFSEIIS  440 (454)
Q Consensus       367 ~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~------~~~~l~~li~~cl~~dP~~RPs~~ell~  440 (454)
                      .|+|+|||||+++||+.   ||...-.......-..   .+.+|..      --+.-..+|+.++++||++|||+.|++.
T Consensus       797 ~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR---~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  797 SKIDMYSLGIVLFEMLY---PFGTSMERASILTNLR---KGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLN  870 (1351)
T ss_pred             chhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcc---cCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence            88999999999999986   5554222222222222   2233322      2355678999999999999999999986


Q ss_pred             H
Q 012887          441 L  441 (454)
Q Consensus       441 ~  441 (454)
                      .
T Consensus       871 s  871 (1351)
T KOG1035|consen  871 S  871 (1351)
T ss_pred             c
Confidence            3

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=9.5e-37  Score=306.46  Aligned_cols=246  Identities=19%  Similarity=0.296  Sum_probs=192.4

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCC----CeE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN----HGL  259 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~----~~l  259 (454)
                      ++|++.+.||+|+||.||+|      +.||+|.+.... .......+.+|+.++..++||||+++++++....    ..+
T Consensus         5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE-HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            68999999999999999986      579999886322 2234455778999999999999999998876543    237


Q ss_pred             EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCC
Q 012887          260 CVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE  339 (454)
Q Consensus       260 ~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~  339 (454)
                      ++|+||+.+ +|.+++ ..+.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus        84 ~lv~e~~~~-~l~~~~-~~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~  161 (336)
T cd07849          84 YIVQELMET-DLYKLI-KTQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHD  161 (336)
T ss_pred             EEEehhccc-CHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecccccc
Confidence            999999975 888877 446799999999999999999999999999999999999999999999999999876543221


Q ss_pred             c---ccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH--------------
Q 012887          340 A---TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAA--------------  402 (454)
Q Consensus       340 ~---~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~--------------  402 (454)
                      .   .....+++.|+|||.+.+..   .++.++|||||||++|+|++|+.||.+.........+..              
T Consensus       162 ~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (336)
T cd07849         162 HTGFLTEYVATRWYRAPEIMLNSK---GYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCII  238 (336)
T ss_pred             ccCCcCCcCcCCCccChHHhhCCC---CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhh
Confidence            1   12235688899999875432   245579999999999999999999976543322211110              


Q ss_pred             -c---------CCCCC-----CCCCccHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012887          403 -C---------GLRPE-----IPKDCPQILKSLMIKCWNNSPSKRPQFSEIISL  441 (454)
Q Consensus       403 -~---------~~~~~-----~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  441 (454)
                       .         .....     .....+.++.++|.+||+.||.+||++.+++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h  292 (336)
T cd07849         239 SLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH  292 (336)
T ss_pred             chhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence             0         00000     112357889999999999999999999999998

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.2e-36  Score=322.42  Aligned_cols=249  Identities=19%  Similarity=0.282  Sum_probs=184.7

Q ss_pred             CCEEEeceeeccCCceEEEeEEE-------EEEE---------------eecCCCCchHHHHHHHHHHHHHhCCCCceeE
Q 012887          190 DNLEFIDQIGPNSFKGVYKGKRV-------GIEK---------------LKGCDKGNAYEFELRKDLLELMTCGHKNILQ  247 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g~~v-------avK~---------------l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~  247 (454)
                      ++|++++.||+|+||.||++...       +.|.               .+...........+.+|+.+|..++|||||+
T Consensus       148 ~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~  227 (501)
T PHA03210        148 AHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILK  227 (501)
T ss_pred             hccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCc
Confidence            68999999999999999986421       1110               0111112223455789999999999999999


Q ss_pred             EEEEEEeCCCeEEEEEeccCCCCHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCc
Q 012887          248 FYCVCVDENHGLCVVTKLMEGGSVNDLILKS-----RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGN  322 (454)
Q Consensus       248 ~~g~~~~~~~~l~lV~E~~~~gsL~~~l~~~-----~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~  322 (454)
                      +++++.+.+. .|+|++++.+ +|.+++...     .......+..++.||+.||+|||++|||||||||+|||++.++.
T Consensus       228 l~~~~~~~~~-~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~  305 (501)
T PHA03210        228 IEEILRSEAN-TYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGK  305 (501)
T ss_pred             EeEEEEECCe-eEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC
Confidence            9999998876 8999999965 787776432     13345678889999999999999999999999999999999999


Q ss_pred             EEEEccCCccccccCCCc-ccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCC-CCCC--CHHHHHH
Q 012887          323 VCLGDMGIVTACKSVGEA-TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAA-YAAC--SPVQAAV  398 (454)
Q Consensus       323 vKL~DFGla~~~~~~~~~-~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~P-f~~~--~~~~~~~  398 (454)
                      +||+|||++......... .....|++.|+|||++.+..    ++.++|||||||++|||++|..+ |...  .+...+.
T Consensus       306 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~  381 (501)
T PHA03210        306 IVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDG----YCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL  381 (501)
T ss_pred             EEEEeCCCceecCcccccccccccCCcCCCCchhhcCCC----CCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHH
Confidence            999999998766543222 22346899999999998765    44569999999999999998754 4322  2222222


Q ss_pred             HHHHcCC--CCCC----------------------------CCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 012887          399 GIAACGL--RPEI----------------------------PKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR  444 (454)
Q Consensus       399 ~i~~~~~--~~~~----------------------------p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~  444 (454)
                      .+...-.  ...+                            ...++.++.++|.+||..||.+|||+.|++.+-+-
T Consensus       382 ~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f  457 (501)
T PHA03210        382 KIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLF  457 (501)
T ss_pred             HHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhh
Confidence            2211000  0000                            01346678889999999999999999999987654

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=1.1e-36  Score=300.38  Aligned_cols=243  Identities=24%  Similarity=0.384  Sum_probs=198.4

Q ss_pred             EEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEEecc
Q 012887          193 EFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLM  266 (454)
Q Consensus       193 ~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~E~~  266 (454)
                      .....||+|+||.||++      ..+|+|++...  .......+.+|+..++.++|+||+++++.+...+. .++||||+
T Consensus        23 ~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~lv~e~~   99 (292)
T cd06657          23 DNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR--KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDE-LWVVMEFL   99 (292)
T ss_pred             hhHHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc--chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCE-EEEEEecC
Confidence            33467999999999985      57999987532  23345568889999999999999999999988776 99999999


Q ss_pred             CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCcccccCC
Q 012887          267 EGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETD  346 (454)
Q Consensus       267 ~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~g  346 (454)
                      ++++|.+++. ...+++..+..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||++..............+
T Consensus       100 ~~~~L~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  178 (292)
T cd06657         100 EGGALTDIVT-HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVG  178 (292)
T ss_pred             CCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccccccccccccc
Confidence            9999999874 457899999999999999999999999999999999999999999999999997655433222334467


Q ss_pred             CCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCC--CCCCccHHHHHHHHHh
Q 012887          347 GYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPE--IPKDCPQILKSLMIKC  424 (454)
Q Consensus       347 t~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~--~p~~~~~~l~~li~~c  424 (454)
                      ++.|+|||.+.+..+    +.++|+||||+++|+|++|..||.+.........+.. ..+..  ....++..+.+++.+|
T Consensus       179 ~~~y~~pE~~~~~~~----~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~  253 (292)
T cd06657         179 TPYWMAPELISRLPY----GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD-NLPPKLKNLHKVSPSLKGFLDRL  253 (292)
T ss_pred             CccccCHHHhcCCCC----CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-hCCcccCCcccCCHHHHHHHHHH
Confidence            888999999876543    4469999999999999999999987666554433322 22222  2345789999999999


Q ss_pred             cccCCCCCCCHHHHHHHHHh
Q 012887          425 WNNSPSKRPQFSEIISLLLR  444 (454)
Q Consensus       425 l~~dP~~RPs~~ell~~L~~  444 (454)
                      |..+|.+||++.+++.+=+-
T Consensus       254 l~~~P~~R~~~~~ll~~~~~  273 (292)
T cd06657         254 LVRDPAQRATAAELLKHPFL  273 (292)
T ss_pred             HhCCcccCcCHHHHhcChHH
Confidence            99999999999999987443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-36  Score=301.59  Aligned_cols=247  Identities=19%  Similarity=0.250  Sum_probs=189.4

Q ss_pred             CEEEeceeeccCCceEEEeE--------EEEEEEeecCC-CCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCC-CeEE
Q 012887          191 NLEFIDQIGPNSFKGVYKGK--------RVGIEKLKGCD-KGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN-HGLC  260 (454)
Q Consensus       191 ~~~~~~~LG~G~fG~Vy~g~--------~vavK~l~~~~-~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~-~~l~  260 (454)
                      .|++.+.||+|+||.||+|.        .+|+|.+.... ........+.+|+.++..++||||+++++++.+.+ ..++
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            47889999999999999864        58999987533 11223345678999999999999999999998872 3499


Q ss_pred             EEEeccCCCCHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEcc----CCcEEEEccCCc
Q 012887          261 VVTKLMEGGSVNDLILKS-----RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDR----HGNVCLGDMGIV  331 (454)
Q Consensus       261 lV~E~~~~gsL~~~l~~~-----~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~----~~~vKL~DFGla  331 (454)
                      +||||+++ +|.+++...     ..+++..+..++.||+.||.|||+++++||||||+||+++.    ++.+||+|||++
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~  159 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA  159 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence            99999976 777776421     26899999999999999999999999999999999999999    899999999998


Q ss_pred             cccccCCC---cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHH---------HHHH
Q 012887          332 TACKSVGE---ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQ---------AAVG  399 (454)
Q Consensus       332 ~~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~---------~~~~  399 (454)
                      ........   ......+++.|+|||.+.+..   .++.++|||||||++|+|++|.+||.+.....         ....
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
T cd07842         160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGAR---HYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER  236 (316)
T ss_pred             cccCCCcccccccCCccccccccCHHHHhCCC---CCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence            76543322   122235678899999886542   24556999999999999999999997543321         0000


Q ss_pred             HHH------------------------cCCCCCCC-----------CCccHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012887          400 IAA------------------------CGLRPEIP-----------KDCPQILKSLMIKCWNNSPSKRPQFSEIISL  441 (454)
Q Consensus       400 i~~------------------------~~~~~~~p-----------~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  441 (454)
                      +..                        .......+           ...+.++.+++.+||+.||.+|||+.|++.+
T Consensus       237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~  313 (316)
T cd07842         237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH  313 (316)
T ss_pred             HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            000                        01111111           1456789999999999999999999999876

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.5e-39  Score=314.99  Aligned_cols=357  Identities=17%  Similarity=0.247  Sum_probs=247.5

Q ss_pred             EEEecchhhHHHHHHHHHHHhhhcCCCCC--CCcCCCccccccccCCCCCccCccccccccccccc--------------
Q 012887           81 LAVQAGQEKSFKSQIENALKSAIKKPKPT--SVKLPFGLCGCQEENTKGRDFGEIEEEEACDESFR--------------  144 (454)
Q Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~p~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~--------------  144 (454)
                      |+.++++.+.-|+.++++-+..+|++++.  .++.|....+-++.+.+.   .|-++....+|...              
T Consensus       335 l~KqqE~iN~qReeIerqrklLaKRKPp~~gkvqap~~~ne~kqrkskn---tNGaenifrrpeep~~ltlaEYhEqeEI  411 (775)
T KOG1151|consen  335 LIKQQERINSQREEIERQRKLLAKRKPPAMGKVQAPPATNEQKQRKSKN---TNGAENIFRRPEEPETLTLAEYHEQEEI  411 (775)
T ss_pred             HHHHHHHHHHHHHHHHHHHHHHhccCCCCCCcCCCCCCccccccccccC---CCcccccccCCCCcccccHHHHHhHHHH
Confidence            45677888888999999999988888844  457777655555543331   11111111111111              


Q ss_pred             -----ccccCCCcceecccCCCCCCccccccchhhhcCC-CccccceeecCCCEEEeceeeccCCceEEEe------EEE
Q 012887          145 -----NGVENSNLKIQLQMPLPSSSFVVSVDEWQTVQSG-GEEIGRWLLNSDNLEFIDQIGPNSFKGVYKG------KRV  212 (454)
Q Consensus       145 -----~~~~~~~~~~~~~~p~~sss~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~LG~G~fG~Vy~g------~~v  212 (454)
                           +.++.....++.+.............++..+.+. ...+.....-.++|-+++.||+|+|+.||++      +.|
T Consensus       412 fKLRlgHLkKEEaeiqaElERLErvrnlHiRELKRi~NEdnSQFkDHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYv  491 (775)
T KOG1151|consen  412 FKLRLGHLKKEEAEIQAELERLERVRNLHIRELKRIHNEDNSQFKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYV  491 (775)
T ss_pred             HHHHHhhhhhhHHHHHHHHHHHHHHHHHHHHHHHhhcccchhhhccCcchHHHHHHHHHhccccHHHHHHhcccchhhee
Confidence                 1111100001000000000000111122222111 1112222233477888999999999999985      678


Q ss_pred             EEEEeecCC-----CCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHH
Q 012887          213 GIEKLKGCD-----KGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEII  287 (454)
Q Consensus       213 avK~l~~~~-----~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~E~~~~gsL~~~l~~~~~l~~~~~~  287 (454)
                      |+|.-...+     +...+-....+|.++.+.|+||.||++|++|.-+.+.+|-|+|||+|.+|+-+|+.++.++++.+.
T Consensus       492 AvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTVLEYceGNDLDFYLKQhklmSEKEAR  571 (775)
T KOG1151|consen  492 AVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEAR  571 (775)
T ss_pred             eEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccceeeeeecCCCchhHHHHhhhhhhHHHHH
Confidence            888754322     112233446788999999999999999999987777799999999999999999999999999999


Q ss_pred             HHHHHHHHHHHHHHhc--CcccCCccCCcEEEcc---CCcEEEEccCCccccccCCCc-------ccccCCCCccccccc
Q 012887          288 RIAIDVAEGIKFLNDH--GVAYRDLNSQRILLDR---HGNVCLGDMGIVTACKSVGEA-------TEYETDGYRWLAPEI  355 (454)
Q Consensus       288 ~i~~qI~~gL~yLH~~--~iiHrDIKp~NILl~~---~~~vKL~DFGla~~~~~~~~~-------~~~~~gt~~y~APE~  355 (454)
                      .|+.||+.||.||.+.  .|||-||||.|||+-.   .|.+||.||||++.+...+..       +....||++|++||.
T Consensus       572 SIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEc  651 (775)
T KOG1151|consen  572 SIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPEC  651 (775)
T ss_pred             HHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcce
Confidence            9999999999999976  5999999999999964   367999999999988765432       344579999999999


Q ss_pred             ccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH-H-HHcCCCCCCC--CCccHHHHHHHHHhcccCCCC
Q 012887          356 IAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVG-I-AACGLRPEIP--KDCPQILKSLMIKCWNNSPSK  431 (454)
Q Consensus       356 l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~-i-~~~~~~~~~p--~~~~~~l~~li~~cl~~dP~~  431 (454)
                      +.-+...++.+.|+||||+|||+|.++.|+.||......+.+.. . +.......+|  +..+.+.+.+|++||++--++
T Consensus       652 FvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeD  731 (775)
T KOG1151|consen  652 FVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKED  731 (775)
T ss_pred             eecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhcceeccCCCCCccCHHHHHHHHHHHHhhhhh
Confidence            98777778888999999999999999999999987554443321 1 1111122233  357899999999999999999


Q ss_pred             CCCHHHHHH
Q 012887          432 RPQFSEIIS  440 (454)
Q Consensus       432 RPs~~ell~  440 (454)
                      |...-++..
T Consensus       732 R~DV~qLA~  740 (775)
T KOG1151|consen  732 RIDVQQLAC  740 (775)
T ss_pred             hhhHHHHcc
Confidence            999888764

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=1.4e-36  Score=299.96  Aligned_cols=249  Identities=20%  Similarity=0.315  Sum_probs=193.9

Q ss_pred             CCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCC-----
Q 012887          189 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH-----  257 (454)
Q Consensus       189 ~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~-----  257 (454)
                      .++|++.+.||+|+||.||+|      +.+++|.+..............+|+..++.++||||+++++++.+...     
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            378999999999999999985      468999886543333333456789999999999999999998865443     


Q ss_pred             --eEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCcccc
Q 012887          258 --GLCVVTKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC  334 (454)
Q Consensus       258 --~l~lV~E~~~~gsL~~~l~~-~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~  334 (454)
                        .+++||||+.+ +|...+.. ...+++..+..++.||++||.|||++|++|+||||+||++++++.+||+|||++...
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  165 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPY  165 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchhc
Confidence              27999999976 77777654 448999999999999999999999999999999999999999999999999998755


Q ss_pred             ccCCCcc-----------cccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHc
Q 012887          335 KSVGEAT-----------EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAAC  403 (454)
Q Consensus       335 ~~~~~~~-----------~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~  403 (454)
                      .......           ....+++.|+|||.+.+..   .++.++|||||||++|+|++|.+||.+.+.......+...
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~  242 (311)
T cd07866         166 DGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGER---RYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKL  242 (311)
T ss_pred             cCCCcccccCCcccccccccceeccCcCChHHhhCCC---ccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence            4322111           1124567799999886542   2455699999999999999999999887766544433221


Q ss_pred             CCCC---------------------CCC-------CCccHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012887          404 GLRP---------------------EIP-------KDCPQILKSLMIKCWNNSPSKRPQFSEIISL  441 (454)
Q Consensus       404 ~~~~---------------------~~p-------~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  441 (454)
                      ...+                     ..+       ...++.+.+++.+||+.||.+|||+.|++.+
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~  308 (311)
T cd07866         243 CGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH  308 (311)
T ss_pred             hCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence            1000                     001       1344678899999999999999999999875

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=1.5e-36  Score=297.51  Aligned_cols=247  Identities=19%  Similarity=0.315  Sum_probs=196.6

Q ss_pred             CEEEeceeeccCCceEEEe---------EEEEEEEeecCCCC--chHHHHHHHHHHHHHhC-CCCceeEEEEEEEeCCCe
Q 012887          191 NLEFIDQIGPNSFKGVYKG---------KRVGIEKLKGCDKG--NAYEFELRKDLLELMTC-GHKNILQFYCVCVDENHG  258 (454)
Q Consensus       191 ~~~~~~~LG~G~fG~Vy~g---------~~vavK~l~~~~~~--~~~~~~~~~Ei~~l~~l-~HpnIv~~~g~~~~~~~~  258 (454)
                      +|++.+.||+|+||.||++         +.+|+|.++.....  ......+.+|+.++.++ +||||+++++.+...+. 
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~-   79 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTK-   79 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCE-
Confidence            4788999999999999975         35889988743221  12334577899999998 59999999999887765 


Q ss_pred             EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCC
Q 012887          259 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG  338 (454)
Q Consensus       259 l~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~  338 (454)
                      +++||||+++|+|.+++.+...+++..+..++.|++.||.|||+.+++||||+|+||+++.++.++|+|||++.......
T Consensus        80 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  159 (288)
T cd05583          80 LHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEE  159 (288)
T ss_pred             EEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcccccccccc
Confidence            89999999999999999777789999999999999999999999999999999999999999999999999977654332


Q ss_pred             C-cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCH----HHHHHHHHHcCCCCCCCCCc
Q 012887          339 E-ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSP----VQAAVGIAACGLRPEIPKDC  413 (454)
Q Consensus       339 ~-~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~----~~~~~~i~~~~~~~~~p~~~  413 (454)
                      . ......++..|+|||.+.+...  ..+.++||||||+++|+|++|..||.....    ......+.  ...++.|..+
T Consensus       160 ~~~~~~~~~~~~y~aPE~~~~~~~--~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~  235 (288)
T cd05583         160 EERAYSFCGTIEYMAPEVIRGGSG--GHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRIL--KSKPPFPKTM  235 (288)
T ss_pred             ccccccccCCccccCHHHhcCCCC--CCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHH--ccCCCCCccc
Confidence            2 1223357888999999876531  134569999999999999999999964322    12222222  2344567788


Q ss_pred             cHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 012887          414 PQILKSLMIKCWNNSPSKRPQFSEIISLL  442 (454)
Q Consensus       414 ~~~l~~li~~cl~~dP~~RPs~~ell~~L  442 (454)
                      +..+.+++.+||+.||++|||+.++.+.|
T Consensus       236 ~~~l~~li~~~l~~~p~~R~t~~~~~~~l  264 (288)
T cd05583         236 SAEARDFIQKLLEKDPKKRLGANGADEIK  264 (288)
T ss_pred             CHHHHHHHHHHhcCCHhhccCcchHHHHh
Confidence            99999999999999999999976665444

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-36  Score=296.05  Aligned_cols=246  Identities=20%  Similarity=0.297  Sum_probs=198.8

Q ss_pred             EEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEEec
Q 012887          192 LEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKL  265 (454)
Q Consensus       192 ~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~E~  265 (454)
                      |++.+.||.|++|.||++      +.+++|.+............+.+|+..+++++|+||+++++++.+.+. .++||||
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~-~~~v~e~   79 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGD-LYLVFEF   79 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCC-EEEEEec
Confidence            466789999999999985      468999887554443455677889999999999999999999988776 9999999


Q ss_pred             cCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCccccc
Q 012887          266 MEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE  344 (454)
Q Consensus       266 ~~~gsL~~~l~~-~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~  344 (454)
                      +++ +|.+++.. ...+++..+..++.||+.||.|||+++++|+||||+||+++.++.++|+|||.+.............
T Consensus        80 ~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~~  158 (283)
T cd05118          80 MDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHY  158 (283)
T ss_pred             cCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccCc
Confidence            976 88888865 3589999999999999999999999999999999999999999999999999987665443222234


Q ss_pred             CCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCC------------------
Q 012887          345 TDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR------------------  406 (454)
Q Consensus       345 ~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~------------------  406 (454)
                      .++..|+|||.+.+..   ..+.++|+||||+++|+|++|..||...+.......+......                  
T Consensus       159 ~~~~~~~~PE~~~~~~---~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (283)
T cd05118         159 VVTRWYRAPELLLGDK---GYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKF  235 (283)
T ss_pred             cCcccccCcHHHhcCC---CCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhh
Confidence            5677899999987541   3556799999999999999999999877665544333221000                  


Q ss_pred             ----------CCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 012887          407 ----------PEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL  442 (454)
Q Consensus       407 ----------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L  442 (454)
                                ......++.++.++|.+||+.||.+||++.+++.+-
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~  281 (283)
T cd05118         236 SFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHP  281 (283)
T ss_pred             hhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCC
Confidence                      011234678999999999999999999999998763

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-36  Score=289.06  Aligned_cols=237  Identities=23%  Similarity=0.292  Sum_probs=199.4

Q ss_pred             eeccCCceEEEe------EEEEEEEeecCCCC-chHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEEeccCCCC
Q 012887          198 IGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGS  270 (454)
Q Consensus       198 LG~G~fG~Vy~g------~~vavK~l~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~E~~~~gs  270 (454)
                      ||.|+||.||++      +.+++|.+...... ......+..|+.++..++||||+++++.+.+.+. .++||||+++++
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~~v~e~~~~~~   79 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEK-LYLVLEYAPGGE   79 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCe-eEEEEecCCCCc
Confidence            699999999984      57899988654332 2244567889999999999999999999887766 999999999999


Q ss_pred             HHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCcccccCCCCcc
Q 012887          271 VNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRW  350 (454)
Q Consensus       271 L~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~gt~~y  350 (454)
                      |.+++.+...+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++..............++..|
T Consensus        80 L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~  159 (250)
T cd05123          80 LFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEY  159 (250)
T ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCccc
Confidence            99999877789999999999999999999999999999999999999999999999999987665443334455678889


Q ss_pred             cccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhcccCCC
Q 012887          351 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPS  430 (454)
Q Consensus       351 ~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~li~~cl~~dP~  430 (454)
                      +|||.+.+..    .+.++|+||||+++|++++|..||...........+..  ....+|...+..+.+++++||..||+
T Consensus       160 ~~Pe~~~~~~----~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~~i~~~l~~~p~  233 (250)
T cd05123         160 LAPEVLLGKG----YGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK--DPLRFPEFLSPEARDLISGLLQKDPT  233 (250)
T ss_pred             cChHHhCCCC----CCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc--CCCCCCCCCCHHHHHHHHHHhcCCHh
Confidence            9999987654    34459999999999999999999987666444444443  45667888899999999999999999


Q ss_pred             CCCCH---HHHHHH
Q 012887          431 KRPQF---SEIISL  441 (454)
Q Consensus       431 ~RPs~---~ell~~  441 (454)
                      +||++   ++++.+
T Consensus       234 ~R~~~~~~~~l~~~  247 (250)
T cd05123         234 KRLGSGGAEEIKAH  247 (250)
T ss_pred             hCCCcccHHHHHhC
Confidence            99999   666654

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.4e-36  Score=302.27  Aligned_cols=247  Identities=18%  Similarity=0.260  Sum_probs=197.7

Q ss_pred             CCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCC-----
Q 012887          189 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH-----  257 (454)
Q Consensus       189 ~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~-----  257 (454)
                      .++|++++.||+|+||.||++      +.||+|.+............+.+|+.+++.++||||+++++++.....     
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   93 (343)
T cd07880          14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFH   93 (343)
T ss_pred             ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccc
Confidence            477999999999999999985      579999986443333345567899999999999999999999876542     


Q ss_pred             eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccC
Q 012887          258 GLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV  337 (454)
Q Consensus       258 ~l~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~  337 (454)
                      .+++||||+ +++|.+++. ...+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus        94 ~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~  171 (343)
T cd07880          94 DFYLVMPFM-GTDLGKLMK-HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE  171 (343)
T ss_pred             eEEEEEecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccccccccC
Confidence            258999999 679998874 457999999999999999999999999999999999999999999999999998755332


Q ss_pred             CCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCC-----------
Q 012887          338 GEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR-----------  406 (454)
Q Consensus       338 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~-----------  406 (454)
                         .....+++.|+|||.+.+..   ..+.++|+||||+++|++++|..||.+.........+......           
T Consensus       172 ---~~~~~~~~~y~aPE~~~~~~---~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (343)
T cd07880         172 ---MTGYVVTRWYRAPEVILNWM---HYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQS  245 (343)
T ss_pred             ---ccccccCCcccCHHHHhCCC---CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcc
Confidence               22335678899999987532   2456799999999999999999999876654433332221100           


Q ss_pred             ------------------CCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 012887          407 ------------------PEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLL  443 (454)
Q Consensus       407 ------------------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~  443 (454)
                                        ..+...+++.+.++|.+|++.||.+|||+.+++.+-+
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~  300 (343)
T cd07880         246 EDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPY  300 (343)
T ss_pred             hhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCcc
Confidence                              0112356788999999999999999999999996543

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=9.6e-36  Score=298.75  Aligned_cols=248  Identities=20%  Similarity=0.254  Sum_probs=195.7

Q ss_pred             ecCCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEE
Q 012887          187 LNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLC  260 (454)
Q Consensus       187 ~~~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~  260 (454)
                      ...++|++.+.||.|+||.||++      +.+|+|++............+.+|+.++..++||||+++++++...+...+
T Consensus         7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   86 (328)
T cd07856           7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY   86 (328)
T ss_pred             ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence            34578999999999999999985      468999886433333345567789999999999999999999987554589


Q ss_pred             EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCc
Q 012887          261 VVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA  340 (454)
Q Consensus       261 lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~  340 (454)
                      +||||+ +++|.+++. ...+++..+..++.||+.||.|||+++++||||+|+||+++.++.++|+|||++.....   .
T Consensus        87 lv~e~~-~~~L~~~~~-~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~---~  161 (328)
T cd07856          87 FVTELL-GTDLHRLLT-SRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP---Q  161 (328)
T ss_pred             EEeehh-ccCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC---C
Confidence            999999 458988874 45688899999999999999999999999999999999999999999999999875432   1


Q ss_pred             ccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH------------------
Q 012887          341 TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAA------------------  402 (454)
Q Consensus       341 ~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~------------------  402 (454)
                      .....++..|+|||.+.+..   .++.++||||||+++|+|++|..||...........+..                  
T Consensus       162 ~~~~~~~~~y~aPE~~~~~~---~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (328)
T cd07856         162 MTGYVSTRYYRAPEIMLTWQ---KYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENT  238 (328)
T ss_pred             cCCCcccccccCceeeeccC---CcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhh
Confidence            22335677899999886532   245579999999999999999999987654322211110                  


Q ss_pred             ------cCCCCCC-----CCCccHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 012887          403 ------CGLRPEI-----PKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL  442 (454)
Q Consensus       403 ------~~~~~~~-----p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L  442 (454)
                            .......     ...++..+.++|++||+.+|.+||++.+++.+-
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~  289 (328)
T cd07856         239 LRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHP  289 (328)
T ss_pred             HHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCC
Confidence                  0001111     134678999999999999999999999998873

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=4e-36  Score=293.02  Aligned_cols=243  Identities=21%  Similarity=0.283  Sum_probs=192.3

Q ss_pred             EEEeceeeccCCceEEEeE------EEEEEEeecCCCCchHHHHHHHHHHHHHhCC-CCceeEEEEEEEeCCCeEEEEEe
Q 012887          192 LEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKGNAYEFELRKDLLELMTCG-HKNILQFYCVCVDENHGLCVVTK  264 (454)
Q Consensus       192 ~~~~~~LG~G~fG~Vy~g~------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~~~g~~~~~~~~l~lV~E  264 (454)
                      |++.+.||+|+||.||+|.      .+++|++...... .......+|+..+++++ ||||+++++++.+.+. .++|||
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~-~~lv~e   78 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDE-LYFVFE   78 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc-hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCc-EEEEEe
Confidence            5778899999999999874      5899988643222 23334557888899998 9999999999988766 999999


Q ss_pred             ccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCccc
Q 012887          265 LMEGGSVNDLILKSR--KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE  342 (454)
Q Consensus       265 ~~~~gsL~~~l~~~~--~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~  342 (454)
                      |+ +|+|.+++....  .+++..+..++.|++.||.|||+++++|+||+|+||+++.++.++|+|||++........ ..
T Consensus        79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~-~~  156 (283)
T cd07830          79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP-YT  156 (283)
T ss_pred             cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC-cC
Confidence            99 779999886654  789999999999999999999999999999999999999999999999999876543322 22


Q ss_pred             ccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCC----------------
Q 012887          343 YETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR----------------  406 (454)
Q Consensus       343 ~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~----------------  406 (454)
                      ...++..|+|||++.+..   ..+.++|+||||+++|+|++|..||...+.......+......                
T Consensus       157 ~~~~~~~~~aPE~~~~~~---~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (283)
T cd07830         157 DYVSTRWYRAPEILLRST---SYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKL  233 (283)
T ss_pred             CCCCcccccCceeeecCc---CcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccc
Confidence            335678899999886432   2455699999999999999999999876655443332211000                


Q ss_pred             -CC-----------CCCCccHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012887          407 -PE-----------IPKDCPQILKSLMIKCWNNSPSKRPQFSEIISL  441 (454)
Q Consensus       407 -~~-----------~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  441 (454)
                       ..           .....+.++.+++++||..||.+||+++|++.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~  280 (283)
T cd07830         234 GFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH  280 (283)
T ss_pred             cccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence             00           011236789999999999999999999999875

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=9.9e-36  Score=290.28  Aligned_cols=244  Identities=19%  Similarity=0.248  Sum_probs=191.1

Q ss_pred             EEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhC---CCCceeEEEEEEEeCCC----e
Q 012887          192 LEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTC---GHKNILQFYCVCVDENH----G  258 (454)
Q Consensus       192 ~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l---~HpnIv~~~g~~~~~~~----~  258 (454)
                      |++.+.||+|+||.||+|      +.+|+|.++...........+.+|+.++..+   +|||++++++++.+.+.    .
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            578899999999999986      4689999874433333334455676665544   69999999999987653    3


Q ss_pred             EEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCcccccc
Q 012887          259 LCVVTKLMEGGSVNDLILKSR--KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS  336 (454)
Q Consensus       259 l~lV~E~~~~gsL~~~l~~~~--~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~  336 (454)
                      ++++|||+++ +|.+++.+..  .+++..+..++.||+.||.|||+++++|+||+|+||+++.++.+||+|||++.....
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~  159 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSF  159 (287)
T ss_pred             eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccC
Confidence            8899999975 8999886543  589999999999999999999999999999999999999999999999999876543


Q ss_pred             CCCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCC----------
Q 012887          337 VGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR----------  406 (454)
Q Consensus       337 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~----------  406 (454)
                      ... .....++..|+|||.+.+...    +.++|+|||||++|+|++|.+||...+..+....+......          
T Consensus       160 ~~~-~~~~~~~~~~~~PE~~~~~~~----~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (287)
T cd07838         160 EMA-LTSVVVTLWYRAPEVLLQSSY----ATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNV  234 (287)
T ss_pred             Ccc-cccccccccccChHHhccCCC----CCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCc
Confidence            322 222346788999999987654    44599999999999999999999987766655444321100          


Q ss_pred             --------CC-------CCCCccHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012887          407 --------PE-------IPKDCPQILKSLMIKCWNNSPSKRPQFSEIISL  441 (454)
Q Consensus       407 --------~~-------~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  441 (454)
                              ..       .....+..+.+++.+||+.||.+||++.+++.+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~  284 (287)
T cd07838         235 SLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH  284 (287)
T ss_pred             ccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence                    00       011345778899999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.4e-35  Score=299.46  Aligned_cols=247  Identities=17%  Similarity=0.255  Sum_probs=195.2

Q ss_pred             CCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCC-----C
Q 012887          189 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN-----H  257 (454)
Q Consensus       189 ~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~-----~  257 (454)
                      .++|++.+.||+|+||.||+|      +.||+|++............+.+|+.++.+++||||+++++++....     .
T Consensus        16 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (345)
T cd07877          16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   95 (345)
T ss_pred             cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccc
Confidence            478999999999999999985      57999998754333333455778999999999999999999886432     2


Q ss_pred             eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccC
Q 012887          258 GLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV  337 (454)
Q Consensus       258 ~l~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~  337 (454)
                      ..+++++++ +++|.+++. ...+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++..... 
T Consensus        96 ~~~lv~~~~-~~~L~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~-  172 (345)
T cd07877          96 DVYLVTHLM-GADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-  172 (345)
T ss_pred             cEEEEehhc-ccCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccccccc-
Confidence            378888887 679988874 44699999999999999999999999999999999999999999999999999875432 


Q ss_pred             CCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCC------------
Q 012887          338 GEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGL------------  405 (454)
Q Consensus       338 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~------------  405 (454)
                        ......++..|+|||.+.+..   .++.++|||||||++|+|++|..||...........+.....            
T Consensus       173 --~~~~~~~~~~y~aPE~~~~~~---~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (345)
T cd07877         173 --EMTGYVATRWYRAPEIMLNWM---HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS  247 (345)
T ss_pred             --cccccccCCCccCHHHHhCcc---CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhccc
Confidence              223345678899999886521   245569999999999999999999987655443332221100            


Q ss_pred             ------------CCC-----CCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 012887          406 ------------RPE-----IPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLL  443 (454)
Q Consensus       406 ------------~~~-----~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~  443 (454)
                                  .+.     .....++++.++|.+||+.||.+||++.+++.+-+
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~  302 (345)
T cd07877         248 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY  302 (345)
T ss_pred             HhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChh
Confidence                        000     01235788999999999999999999999998765

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=1.9e-35  Score=296.56  Aligned_cols=249  Identities=20%  Similarity=0.251  Sum_probs=193.8

Q ss_pred             CEEEeceeeccCCceEEEeE--------EEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEEEEEEEeC---CCe
Q 012887          191 NLEFIDQIGPNSFKGVYKGK--------RVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVDE---NHG  258 (454)
Q Consensus       191 ~~~~~~~LG~G~fG~Vy~g~--------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~~~g~~~~~---~~~  258 (454)
                      +|++.+.||+|+||.||++.        .+|+|++............+.+|+.++..+ +||||+++++.+...   ...
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            47889999999999999853        689998874333333445677899999988 599999999876433   233


Q ss_pred             EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCC
Q 012887          259 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG  338 (454)
Q Consensus       259 l~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~  338 (454)
                      ++++|||+. ++|.+.+.....+++..+..++.||+.||+|||++|++||||||+||+++.++.+||+|||++.......
T Consensus        81 ~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~  159 (332)
T cd07857          81 LYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENP  159 (332)
T ss_pred             EEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceeccccc
Confidence            789999996 5999998777889999999999999999999999999999999999999999999999999987654322


Q ss_pred             C----cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHc-----------
Q 012887          339 E----ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAAC-----------  403 (454)
Q Consensus       339 ~----~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~-----------  403 (454)
                      .    ......++..|+|||.+.+..   ..+.++|+|||||++|+|++|..||...........+...           
T Consensus       160 ~~~~~~~~~~~g~~~y~aPE~~~~~~---~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (332)
T cd07857         160 GENAGFMTEYVATRWYRAPEIMLSFQ---SYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSR  236 (332)
T ss_pred             ccccccccCcccCccccCcHHHhCCC---CCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            1    122335788899999886532   2455799999999999999999999876543332221110           


Q ss_pred             ---------------CCCCC---CCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 012887          404 ---------------GLRPE---IPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLL  443 (454)
Q Consensus       404 ---------------~~~~~---~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~  443 (454)
                                     .....   .....+..+.+++.+||+.||.+||++.+++.+=+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~  294 (332)
T cd07857         237 IGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPY  294 (332)
T ss_pred             hhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChh
Confidence                           00011   11235788999999999999999999999987643

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=6.9e-36  Score=290.66  Aligned_cols=246  Identities=22%  Similarity=0.307  Sum_probs=196.8

Q ss_pred             EEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEEec
Q 012887          192 LEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKL  265 (454)
Q Consensus       192 ~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~E~  265 (454)
                      |++.+.||+|+||.||+|      +.+++|.+............+..|+..+..++|+|++++++++.+.+. .++||||
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~-~~~v~e~   79 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERK-LYLVFEY   79 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCc-eEEEecC
Confidence            467788999999999984      578999987544333344567789999999999999999999988766 9999999


Q ss_pred             cCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCccccc
Q 012887          266 MEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE  344 (454)
Q Consensus       266 ~~~gsL~~~l~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~  344 (454)
                      +++ +|.+++.+. ..+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++.............
T Consensus        80 ~~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~  158 (282)
T cd07829          80 CDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHE  158 (282)
T ss_pred             cCc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccccCcc
Confidence            985 999999765 589999999999999999999999999999999999999999999999999987654433223333


Q ss_pred             CCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcC----------------CCCC
Q 012887          345 TDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG----------------LRPE  408 (454)
Q Consensus       345 ~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~----------------~~~~  408 (454)
                      .++..|+|||.+.+..   .++.++|||||||++|||++|..||...+.......+....                ....
T Consensus       159 ~~~~~~~aPE~~~~~~---~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (282)
T cd07829         159 VVTLWYRAPEILLGSK---HYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPT  235 (282)
T ss_pred             ccCcCcCChHHhcCCc---CCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccccc
Confidence            4567799999987551   24456999999999999999999998776554443332110                0000


Q ss_pred             -----------CCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 012887          409 -----------IPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL  442 (454)
Q Consensus       409 -----------~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L  442 (454)
                                 .....+..+.+++.+||..||++||++.+++.+-
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p  280 (282)
T cd07829         236 FPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHP  280 (282)
T ss_pred             ccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCc
Confidence                       0112477899999999999999999999998763

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=8.7e-36  Score=300.49  Aligned_cols=247  Identities=16%  Similarity=0.226  Sum_probs=193.0

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCC-------
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN-------  256 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~-------  256 (454)
                      .+|++.+.||.|+||.||+|      +.||+|++.....  .....+.+|+.+++.++||||+++++++....       
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   82 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDV   82 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC--chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccc
Confidence            68999999999999999985      5799999865433  33455778999999999999999998766542       


Q ss_pred             ------CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEcc-CCcEEEEccC
Q 012887          257 ------HGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDR-HGNVCLGDMG  329 (454)
Q Consensus       257 ------~~l~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~-~~~vKL~DFG  329 (454)
                            ...++||||+++ +|.+++. ...+++..+..++.||+.||.|||++|++||||||+||+++. ++.+||+|||
T Consensus        83 ~~~~~~~~~~lv~e~~~~-~L~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~dfg  160 (342)
T cd07854          83 GSLTELNSVYIVQEYMET-DLANVLE-QGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFG  160 (342)
T ss_pred             ccccccceEEEEeecccc-cHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCcc
Confidence                  237899999974 9988874 357899999999999999999999999999999999999985 5578999999


Q ss_pred             CccccccCCCc---ccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHc---
Q 012887          330 IVTACKSVGEA---TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAAC---  403 (454)
Q Consensus       330 la~~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~---  403 (454)
                      ++.........   .....++..|+|||.+.+..   .++.++|||||||++|+|++|..||...++......+...   
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~  237 (342)
T cd07854         161 LARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPN---NYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPV  237 (342)
T ss_pred             cceecCCccccccccccccccccccCHHHHhCcc---ccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence            98765332111   12234677899999875432   2455799999999999999999999877665443332211   


Q ss_pred             --------------------CCCCC-----CCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 012887          404 --------------------GLRPE-----IPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLL  443 (454)
Q Consensus       404 --------------------~~~~~-----~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~  443 (454)
                                          .....     ....++.++.++|.+||+.||.+|||+.+++.+-+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~  302 (342)
T cd07854         238 VREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPY  302 (342)
T ss_pred             CChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCc
Confidence                                00110     12356788999999999999999999999997643

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2e-36  Score=319.21  Aligned_cols=250  Identities=26%  Similarity=0.425  Sum_probs=212.9

Q ss_pred             CCCEEEeceeeccCCceEEEeE------EEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEEEEEEEeC----CC
Q 012887          189 SDNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVDE----NH  257 (454)
Q Consensus       189 ~~~~~~~~~LG~G~fG~Vy~g~------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~~~g~~~~~----~~  257 (454)
                      .+.+++.+.||.|.+|.||+++      ..|+|++.   .....+.+++.|..+|+.+ .|||++.+||++.-.    ++
T Consensus        18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~---~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~D   94 (953)
T KOG0587|consen   18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMD---PTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGD   94 (953)
T ss_pred             CCccEEEEEEeeccceeEEEEeeeecCceeeeEeec---CCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCC
Confidence            4667999999999999999853      45666664   3333455677888888876 699999999998743    23


Q ss_pred             eEEEEEeccCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccc
Q 012887          258 GLCVVTKLMEGGSVNDLILK--SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK  335 (454)
Q Consensus       258 ~l~lV~E~~~~gsL~~~l~~--~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~  335 (454)
                      .+|||||||.+||..|+++.  ..++.|..+..|+..++.||.+||.+.++|||||-.|||++.+|.|||+|||++....
T Consensus        95 qLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQld  174 (953)
T KOG0587|consen   95 QLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD  174 (953)
T ss_pred             eEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeeee
Confidence            49999999999999999964  4589999999999999999999999999999999999999999999999999998887


Q ss_pred             cCCCcccccCCCCcccccccccCC-CCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCC--CCCC
Q 012887          336 SVGEATEYETDGYRWLAPEIIAGD-PESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPE--IPKD  412 (454)
Q Consensus       336 ~~~~~~~~~~gt~~y~APE~l~~~-~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~--~p~~  412 (454)
                      ..........|||.|||||++... .....++.++|+||||++..||-.|.+|+.+..|...++.|..+ .+|.  -|..
T Consensus       175 sT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRN-PPPkLkrp~k  253 (953)
T KOG0587|consen  175 STVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN-PPPKLKRPKK  253 (953)
T ss_pred             cccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCC-CCccccchhh
Confidence            777777788999999999999743 33445677899999999999999999999999999888877654 2222  2677


Q ss_pred             ccHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 012887          413 CPQILKSLMIKCWNNSPSKRPQFSEIISLL  442 (454)
Q Consensus       413 ~~~~l~~li~~cl~~dP~~RPs~~ell~~L  442 (454)
                      +++++.++|..||.+|..+||+..++++|-
T Consensus       254 Ws~~FndFIs~cL~Kd~e~RP~~~~ll~hp  283 (953)
T KOG0587|consen  254 WSKKFNDFISTCLVKDYEQRPSTEELLKHP  283 (953)
T ss_pred             HHHHHHHHHHHHHhhccccCcchhhhccCC
Confidence            899999999999999999999999998764

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5e-36  Score=302.39  Aligned_cols=246  Identities=20%  Similarity=0.299  Sum_probs=196.5

Q ss_pred             CCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCC-----
Q 012887          189 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH-----  257 (454)
Q Consensus       189 ~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~-----  257 (454)
                      .++|++.+.||+|+||.||+|      +.+|+|++............+.+|+.+++.++||||+++++++...+.     
T Consensus        14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   93 (343)
T cd07851          14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ   93 (343)
T ss_pred             cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence            478999999999999999986      478999886433333344557789999999999999999887765432     


Q ss_pred             eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccC
Q 012887          258 GLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV  337 (454)
Q Consensus       258 ~l~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~  337 (454)
                      .+++|+||+ +++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus        94 ~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~  171 (343)
T cd07851          94 DVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE  171 (343)
T ss_pred             cEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccccccc
Confidence            389999999 5699998854 57999999999999999999999999999999999999999999999999998765332


Q ss_pred             CCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCC----------
Q 012887          338 GEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP----------  407 (454)
Q Consensus       338 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~----------  407 (454)
                         .....++..|+|||.+.+..   ..+.++|||||||++|+|++|..||.+.........+......+          
T Consensus       172 ---~~~~~~~~~y~aPE~~~~~~---~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  245 (343)
T cd07851         172 ---MTGYVATRWYRAPEIMLNWM---HYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISS  245 (343)
T ss_pred             ---ccCCcccccccCHHHHhCCC---CCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccc
Confidence               23335678899999986532   24557999999999999999999998776655444332211000          


Q ss_pred             -------------------CCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 012887          408 -------------------EIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL  442 (454)
Q Consensus       408 -------------------~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L  442 (454)
                                         ......++++.++|.+||+.||.+|||+.+|+.+-
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~  299 (343)
T cd07851         246 ESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHP  299 (343)
T ss_pred             hhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCC
Confidence                               01123588999999999999999999999998764

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.1e-35  Score=299.72  Aligned_cols=253  Identities=17%  Similarity=0.266  Sum_probs=196.9

Q ss_pred             eeecCCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCC--
Q 012887          185 WLLNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN--  256 (454)
Q Consensus       185 ~~~~~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~--  256 (454)
                      |.+ .++|.+.+.||+|+||.||+|      +.+|+|++............+.+|+.++..++||||+++++++....  
T Consensus        11 ~~~-~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~   89 (342)
T cd07879          11 WEL-PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSG   89 (342)
T ss_pred             hcc-ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccC
Confidence            344 368999999999999999985      46999998754333334455788999999999999999999987543  


Q ss_pred             ---CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccc
Q 012887          257 ---HGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTA  333 (454)
Q Consensus       257 ---~~l~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~  333 (454)
                         ..+++||||+.. +|..++  ...+++..+..++.|++.||.|||+++++||||||+|||++.++.+||+|||++..
T Consensus        90 ~~~~~~~lv~e~~~~-~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~  166 (342)
T cd07879          90 DEFQDFYLVMPYMQT-DLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARH  166 (342)
T ss_pred             CCCceEEEEeccccc-CHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcC
Confidence               236899999965 777764  34689999999999999999999999999999999999999999999999999865


Q ss_pred             cccCCCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCC--------
Q 012887          334 CKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGL--------  405 (454)
Q Consensus       334 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~--------  405 (454)
                      ...   ......++..|+|||.+.+..   .++.++|||||||++|||++|+.||.+.+.......+.....        
T Consensus       167 ~~~---~~~~~~~~~~y~aPE~~~~~~---~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  240 (342)
T cd07879         167 ADA---EMTGYVVTRWYRAPEVILNWM---HYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQ  240 (342)
T ss_pred             CCC---CCCCceeeecccChhhhcCcc---ccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence            432   122335677899999987532   245569999999999999999999988765544433222100        


Q ss_pred             -------------CCCC--------CCCccHHHHHHHHHhcccCCCCCCCHHHHHHH--HHhhcC
Q 012887          406 -------------RPEI--------PKDCPQILKSLMIKCWNNSPSKRPQFSEIISL--LLRTNN  447 (454)
Q Consensus       406 -------------~~~~--------p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~--L~~~~~  447 (454)
                                   .+..        ....+.++.++|.+||+.||.+||++.+++.+  ++...+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~  305 (342)
T cd07879         241 KLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD  305 (342)
T ss_pred             HhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence                         0001        12357789999999999999999999999976  544433

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=5.9e-35  Score=319.08  Aligned_cols=142  Identities=21%  Similarity=0.390  Sum_probs=127.2

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCC-chHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  262 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV  262 (454)
                      ++|.+++.||+|+||.||+|      +.||+|.++..... ......+..|+.++..++||||+++++++...++ +|+|
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~-~~lV   82 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANN-VYLV   82 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCE-EEEE
Confidence            68899999999999999986      57999998754332 2234567889999999999999999999887776 9999


Q ss_pred             EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCcc
Q 012887          263 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVT  332 (454)
Q Consensus       263 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~  332 (454)
                      |||+.+++|.+++...+.+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++
T Consensus        83 mEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          83 MEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            9999999999999877789999999999999999999999999999999999999999999999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-37  Score=307.65  Aligned_cols=252  Identities=20%  Similarity=0.298  Sum_probs=221.3

Q ss_pred             cCCCEEEeceeeccCCceEEEeE----E--EEEEEeecCCC-CchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEE
Q 012887          188 NSDNLEFIDQIGPNSFKGVYKGK----R--VGIEKLKGCDK-GNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLC  260 (454)
Q Consensus       188 ~~~~~~~~~~LG~G~fG~Vy~g~----~--vavK~l~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~  260 (454)
                      ...+++.+..||-|+||.|-+.+    .  +|.|.++.... ....+..+..|-.+|+.++.|+||++|..|.+... +|
T Consensus       418 ~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~ky-vY  496 (732)
T KOG0614|consen  418 KLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKY-VY  496 (732)
T ss_pred             chhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchh-hh
Confidence            34678889999999999998743    2  56777754433 33455668889999999999999999999998876 99


Q ss_pred             EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCc
Q 012887          261 VVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA  340 (454)
Q Consensus       261 lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~  340 (454)
                      +.||-|-||.|...+++++.|++.....|+.-+++|++|||++|||+|||||+|++++.+|-+||.|||+|+...... .
T Consensus       497 mLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~-K  575 (732)
T KOG0614|consen  497 MLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR-K  575 (732)
T ss_pred             hhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccCC-c
Confidence            999999999999999999999999999999999999999999999999999999999999999999999999876543 4


Q ss_pred             ccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHHHH
Q 012887          341 TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSL  420 (454)
Q Consensus       341 ~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~l  420 (454)
                      +-..+|||.|.|||++.+.....    ++|.||||+++|||++|.+||.+.++......|...-....+|..++....+|
T Consensus       576 TwTFcGTpEYVAPEIILnKGHD~----avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~L  651 (732)
T KOG0614|consen  576 TWTFCGTPEYVAPEIILNKGHDR----AVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATDL  651 (732)
T ss_pred             eeeecCCcccccchhhhccCcch----hhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHHH
Confidence            56679999999999998765444    49999999999999999999999999998888887766778999999999999


Q ss_pred             HHHhcccCCCCCCC-----HHHHHHHHHhh
Q 012887          421 MIKCWNNSPSKRPQ-----FSEIISLLLRT  445 (454)
Q Consensus       421 i~~cl~~dP~~RPs-----~~ell~~L~~~  445 (454)
                      |+++...+|.+|..     +.+|.+|-|-.
T Consensus       652 ik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~  681 (732)
T KOG0614|consen  652 IKKLCRDNPTERLGYQKGGINDIKKHRWFE  681 (732)
T ss_pred             HHHHHhcCcHhhhccccCChHHHHhhhhhh
Confidence            99999999999976     77888887754

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=5.8e-35  Score=279.06  Aligned_cols=220  Identities=21%  Similarity=0.270  Sum_probs=176.8

Q ss_pred             cCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEEeccCCCCHHHH
Q 012887          201 NSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDL  274 (454)
Q Consensus       201 G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~E~~~~gsL~~~  274 (454)
                      |.||.||++      +.+|+|.++...       ...+|...+....||||+++++++.+.+. .++||||+++|+|.++
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~-~~lv~e~~~~~~L~~~   75 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVSEDS-VFLVLQHAEGGKLWSH   75 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheecCCe-EEEEEecCCCCCHHHH
Confidence            899999984      579999986432       12234444555679999999999987765 9999999999999999


Q ss_pred             HHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCcccccCCCCcccccc
Q 012887          275 ILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPE  354 (454)
Q Consensus       275 l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~gt~~y~APE  354 (454)
                      +.+...+++..+..++.|++.||.|||++|++||||||+||+++.++.++++|||++......   .....++..|+|||
T Consensus        76 l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~---~~~~~~~~~y~aPE  152 (237)
T cd05576          76 ISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS---CDGEAVENMYCAPE  152 (237)
T ss_pred             HHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc---cccCCcCccccCCc
Confidence            977778999999999999999999999999999999999999999999999999987654332   22234466799999


Q ss_pred             cccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhcccCCCCCCC
Q 012887          355 IIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQ  434 (454)
Q Consensus       355 ~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs  434 (454)
                      .+.+..+    +.++|+||+|+++|||++|..||......      ........+|..+++.+.++|.+||+.||++||+
T Consensus       153 ~~~~~~~----~~~~DvwslG~il~el~~g~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~  222 (237)
T cd05576         153 VGGISEE----TEACDWWSLGAILFELLTGKTLVECHPSG------INTHTTLNIPEWVSEEARSLLQQLLQFNPTERLG  222 (237)
T ss_pred             ccCCCCC----CchhhHHHHHHHHHHHHHCcchhhcCchh------cccccccCCcccCCHHHHHHHHHHccCCHHHhcC
Confidence            9876543    44599999999999999999887643211      1112234567778999999999999999999999


Q ss_pred             H-----HHHHHH
Q 012887          435 F-----SEIISL  441 (454)
Q Consensus       435 ~-----~ell~~  441 (454)
                      +     .+++.|
T Consensus       223 ~~~~~~~~~~~h  234 (237)
T cd05576         223 AGVAGVEDIKSH  234 (237)
T ss_pred             CCccchHHHHcC
Confidence            6     666543

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-36  Score=284.62  Aligned_cols=243  Identities=17%  Similarity=0.275  Sum_probs=194.1

Q ss_pred             CCEEEe-ceeeccCCceEEE------eEEEEEEEeecCCCCchHHHHHHHHHHHHHh-CCCCceeEEEEEEEeC---CCe
Q 012887          190 DNLEFI-DQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMT-CGHKNILQFYCVCVDE---NHG  258 (454)
Q Consensus       190 ~~~~~~-~~LG~G~fG~Vy~------g~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~-l~HpnIv~~~g~~~~~---~~~  258 (454)
                      ++|.+- +.||-|--|.|-.      |+++|+|.+....       ..++|+..... -.|||||.+++++...   ...
T Consensus        61 edY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~-------KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc  133 (400)
T KOG0604|consen   61 EDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSP-------KARREVELHWMASGHPHIVSIIDVYENSYQGRKC  133 (400)
T ss_pred             hhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCH-------HHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence            566654 5899999999986      5678898886422       23466665443 4799999999998643   345


Q ss_pred             EEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccC---CcEEEEccCCccc
Q 012887          259 LCVVTKLMEGGSVNDLILKSR--KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH---GNVCLGDMGIVTA  333 (454)
Q Consensus       259 l~lV~E~~~~gsL~~~l~~~~--~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~---~~vKL~DFGla~~  333 (454)
                      +.+|||+|+||.|...+..++  .+++.++..|+.||+.|+.|||+.+|.||||||+|+|...+   ..+||+|||+|+.
T Consensus       134 LLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~  213 (400)
T KOG0604|consen  134 LLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKE  213 (400)
T ss_pred             eEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccc
Confidence            889999999999999997765  59999999999999999999999999999999999999754   4699999999987


Q ss_pred             cccCCCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCH----HHHHHHHHHcCCCCCC
Q 012887          334 CKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSP----VQAAVGIAACGLRPEI  409 (454)
Q Consensus       334 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~----~~~~~~i~~~~~~~~~  409 (454)
                      ..... ......-||-|.|||++..++|..    .+|+||+||++|-|++|.+||.+...    .....+|....+..+-
T Consensus       214 t~~~~-~L~TPc~TPyYvaPevlg~eKydk----scdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~  288 (400)
T KOG0604|consen  214 TQEPG-DLMTPCFTPYYVAPEVLGPEKYDK----SCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPE  288 (400)
T ss_pred             cCCCc-cccCCcccccccCHHHhCchhcCC----CCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCC
Confidence            65432 344456688899999998876554    49999999999999999999986432    2233455555444333


Q ss_pred             C--CCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 012887          410 P--KDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR  444 (454)
Q Consensus       410 p--~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~  444 (454)
                      |  ...|++.+++|+++|..+|++|.|+.+++++-|-
T Consensus       289 pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi  325 (400)
T KOG0604|consen  289 PEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWI  325 (400)
T ss_pred             hhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchh
Confidence            3  3478999999999999999999999999998763

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-35  Score=293.14  Aligned_cols=261  Identities=23%  Similarity=0.384  Sum_probs=205.0

Q ss_pred             ecCCCEEEeceeeccCCceEEEe----EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCC---CeE
Q 012887          187 LNSDNLEFIDQIGPNSFKGVYKG----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN---HGL  259 (454)
Q Consensus       187 ~~~~~~~~~~~LG~G~fG~Vy~g----~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~---~~l  259 (454)
                      .+.+.+++++.||+|.||.||+|    +.||||++...   ....+.-+++|..+-.+.|+||++|+++-....   ..+
T Consensus       207 ~~l~pl~l~eli~~Grfg~V~KaqL~~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~ey  283 (534)
T KOG3653|consen  207 LELDPLQLLELIGRGRFGCVWKAQLDNRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEY  283 (534)
T ss_pred             ccCCchhhHHHhhcCccceeehhhccCceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccce
Confidence            44577888999999999999997    68999998632   233344556677777789999999998754332   248


Q ss_pred             EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh---------cCcccCCccCCcEEEccCCcEEEEccCC
Q 012887          260 CVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLND---------HGVAYRDLNSQRILLDRHGNVCLGDMGI  330 (454)
Q Consensus       260 ~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~---------~~iiHrDIKp~NILl~~~~~vKL~DFGl  330 (454)
                      +||+||.+.|||.++| +...+++....+++..+++||.|||+         ..|+|||||++|||+.++++..|+||||
T Consensus       284 wLVt~fh~kGsL~dyL-~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGL  362 (534)
T KOG3653|consen  284 WLVTEFHPKGSLCDYL-KANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGL  362 (534)
T ss_pred             eEEeeeccCCcHHHHH-HhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccce
Confidence            9999999999999998 45679999999999999999999996         3599999999999999999999999999


Q ss_pred             ccccccCCC--cccccCCCCcccccccccCCCCCCCC--CchhhHHHHHHHHHHHHcCCC------------CCC---C-
Q 012887          331 VTACKSVGE--ATEYETDGYRWLAPEIIAGDPESVSE--TWMSNVYSFGMVIWEMVTGEA------------AYA---A-  390 (454)
Q Consensus       331 a~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~--~~ksDVwSlGviL~elltG~~------------Pf~---~-  390 (454)
                      |..+.....  ..-...||.+|||||++.|...-...  -.+.||||+|.+||||+++..            ||+   + 
T Consensus       363 Al~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~  442 (534)
T KOG3653|consen  363 ALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGN  442 (534)
T ss_pred             eEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcC
Confidence            987764332  23336899999999999875332211  136899999999999998532            332   1 


Q ss_pred             -CCHHHHHHHHHHcCCCCCCCCCc-----cHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCCCCC
Q 012887          391 -CSPVQAAVGIAACGLRPEIPKDC-----PQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNS  451 (454)
Q Consensus       391 -~~~~~~~~~i~~~~~~~~~p~~~-----~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~~  451 (454)
                       .+-.+.....+....||.+|..+     ...+.+.+..||+.||+.|.|+.=+.++++++....+.
T Consensus       443 hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~~  509 (534)
T KOG3653|consen  443 HPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWED  509 (534)
T ss_pred             CCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCCc
Confidence             11122333456677888888753     46689999999999999999999999999888776553

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=1.1e-35  Score=282.47  Aligned_cols=249  Identities=21%  Similarity=0.305  Sum_probs=197.7

Q ss_pred             CCEEEeceeeccCCceEEEe----------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG----------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGL  259 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g----------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l  259 (454)
                      ..|+.++.||+|.||.||++          +.+|+|+++..+...-.....-+|+..++.++||||+.+..++...+..+
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v  103 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV  103 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence            57899999999999999996          25789999876554444455678999999999999999999999877679


Q ss_pred             EEEEeccCCCCHHHHHH-----hCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccC----CcEEEEccCC
Q 012887          260 CVVTKLMEGGSVNDLIL-----KSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH----GNVCLGDMGI  330 (454)
Q Consensus       260 ~lV~E~~~~gsL~~~l~-----~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~----~~vKL~DFGl  330 (454)
                      ++++||++. +|.+.|+     +.+.++...+..++.||+.|+.|||++=|+||||||+|||+..+    |.|||+|||+
T Consensus       104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGl  182 (438)
T KOG0666|consen  104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLGL  182 (438)
T ss_pred             EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecccH
Confidence            999999988 9999884     23479999999999999999999999999999999999999888    8999999999


Q ss_pred             ccccccCCCc---ccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCH-------H--HHHH
Q 012887          331 VTACKSVGEA---TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSP-------V--QAAV  398 (454)
Q Consensus       331 a~~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~-------~--~~~~  398 (454)
                      ++.+.+.-..   .....-|++|.|||.+.|...   ||.+.||||.|||+.||++-.+.|.+...       .  ..+.
T Consensus       183 aR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~h---YT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~  259 (438)
T KOG0666|consen  183 ARLFNNPLKPLASLDPVVVTIWYRAPELLLGARH---YTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD  259 (438)
T ss_pred             HHHhhccccccccCCceEEEEEecChHHhccccc---ccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence            9877654322   223346889999999998764   66789999999999999999888864221       1  1222


Q ss_pred             HHHHc-CCCC--------CCC--------------------------CCccHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 012887          399 GIAAC-GLRP--------EIP--------------------------KDCPQILKSLMIKCWNNSPSKRPQFSEIISLL  442 (454)
Q Consensus       399 ~i~~~-~~~~--------~~p--------------------------~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L  442 (454)
                      +|... +.+-        .+|                          ..-++...+|+.++|..||.+|.|+++.+++.
T Consensus       260 rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~  338 (438)
T KOG0666|consen  260 RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP  338 (438)
T ss_pred             HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc
Confidence            22111 1000        011                          11244588999999999999999999999875

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=7.5e-36  Score=299.26  Aligned_cols=242  Identities=18%  Similarity=0.266  Sum_probs=203.9

Q ss_pred             ceeeccCCceEEE------eEEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEEeccCCC
Q 012887          196 DQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGG  269 (454)
Q Consensus       196 ~~LG~G~fG~Vy~------g~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~E~~~~g  269 (454)
                      +.||+|.||+||-      |+.||||.+....-..+.+.+++.|+.+|..++||.||.+-..|...+. +++|||-+.| 
T Consensus       570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~er-vFVVMEKl~G-  647 (888)
T KOG4236|consen  570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPER-VFVVMEKLHG-  647 (888)
T ss_pred             hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCce-EEEEehhhcc-
Confidence            6899999999995      6789999998877777778899999999999999999999999988887 9999999966 


Q ss_pred             CHHHHH-H-hCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCC---cEEEEccCCccccccCCCccccc
Q 012887          270 SVNDLI-L-KSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG---NVCLGDMGIVTACKSVGEATEYE  344 (454)
Q Consensus       270 sL~~~l-~-~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~---~vKL~DFGla~~~~~~~~~~~~~  344 (454)
                      +..+.+ . +.+++++.....++.||+.||.|||-++|+|.||||+|||+.+..   ++||||||+|+.....+. ....
T Consensus       648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF-RrsV  726 (888)
T KOG4236|consen  648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF-RRSV  726 (888)
T ss_pred             hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhh-hhhh
Confidence            655555 3 346999999999999999999999999999999999999997654   699999999998766443 4556


Q ss_pred             CCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHHHHHHHh
Q 012887          345 TDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKC  424 (454)
Q Consensus       345 ~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~li~~c  424 (454)
                      .|||.|+|||++....|+..    -|+||.|||+|--++|..||....+-........-.+++.....++++..+||..+
T Consensus       727 VGTPAYLaPEVLrnkGyNrS----LDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFMyPp~PW~eis~~AidlIn~L  802 (888)
T KOG4236|consen  727 VGTPAYLAPEVLRNKGYNRS----LDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFMYPPNPWSEISPEAIDLINNL  802 (888)
T ss_pred             cCCccccCHHHHhhcccccc----ccceeeeEEEEEEecccccCCCccchhHHhhccccccCCCchhhcCHHHHHHHHHH
Confidence            89999999999998877655    79999999999999999999764432222222222344444557899999999999


Q ss_pred             cccCCCCCCCHHHHHHHHHh
Q 012887          425 WNNSPSKRPQFSEIISLLLR  444 (454)
Q Consensus       425 l~~dP~~RPs~~ell~~L~~  444 (454)
                      |+..-.+|-+.+..+.|.|-
T Consensus       803 LqVkm~kRysvdk~lsh~Wl  822 (888)
T KOG4236|consen  803 LQVKMRKRYSVDKSLSHPWL  822 (888)
T ss_pred             HHHHHHHhcchHhhccchhh
Confidence            99999999999999888763

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-35  Score=303.66  Aligned_cols=240  Identities=21%  Similarity=0.304  Sum_probs=195.1

Q ss_pred             CCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHh-CCCCceeEEEEEEEeCCCeEEE
Q 012887          189 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMT-CGHKNILQFYCVCVDENHGLCV  261 (454)
Q Consensus       189 ~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~-l~HpnIv~~~g~~~~~~~~l~l  261 (454)
                      .++|++...+|.|+|+.|..+      +..++|.+....      .+..+|+.++.. -+||||+++++++.+..+ .|+
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~------~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~-~~~  393 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA------DDNQDEIPISLLVRDHPNIVKSHDVYEDGKE-IYL  393 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheeccccc------cccccccchhhhhcCCCcceeecceecCCce-eee
Confidence            578899999999999999975      456788876442      223355544444 479999999999998877 999


Q ss_pred             EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEE-ccCCcEEEEccCCccccccCCCc
Q 012887          262 VTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILL-DRHGNVCLGDMGIVTACKSVGEA  340 (454)
Q Consensus       262 V~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl-~~~~~vKL~DFGla~~~~~~~~~  340 (454)
                      |||++.|+-|.+.+...+.+. ..+..|+.+|+.|+.|||++|+|||||||+|||+ +..++++|+|||.+......   
T Consensus       394 v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~---  469 (612)
T KOG0603|consen  394 VMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS---  469 (612)
T ss_pred             eehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh---
Confidence            999999999888876655444 7888999999999999999999999999999999 68999999999998776543   


Q ss_pred             ccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHHHH
Q 012887          341 TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSL  420 (454)
Q Consensus       341 ~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~l  420 (454)
                      ....+-|..|.|||++....    ++.++|+||||++||+|++|..||.......   .+...-..+.+...+|.++++|
T Consensus       470 ~~tp~~t~~y~APEvl~~~~----yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~---ei~~~i~~~~~s~~vS~~AKdL  542 (612)
T KOG0603|consen  470 CDTPALTLQYVAPEVLAIQE----YTEACDWWSLGVLLYEMLTGRTLFAAHPAGI---EIHTRIQMPKFSECVSDEAKDL  542 (612)
T ss_pred             hcccchhhcccChhhhccCC----CCcchhhHHHHHHHHHHHhCCCccccCCchH---HHHHhhcCCccccccCHHHHHH
Confidence            22334467799999999665    4455999999999999999999998755542   2222223455668899999999


Q ss_pred             HHHhcccCCCCCCCHHHHHHHHHhhc
Q 012887          421 MIKCWNNSPSKRPQFSEIISLLLRTN  446 (454)
Q Consensus       421 i~~cl~~dP~~RPs~~ell~~L~~~~  446 (454)
                      +++||+.||.+||++.++..+-|...
T Consensus       543 l~~LL~~dP~~Rl~~~~i~~h~w~~~  568 (612)
T KOG0603|consen  543 LQQLLQVDPALRLGADEIGAHPWFLS  568 (612)
T ss_pred             HHHhccCChhhCcChhhhccCcchhc
Confidence            99999999999999999999988733

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-34  Score=284.96  Aligned_cols=258  Identities=24%  Similarity=0.491  Sum_probs=198.7

Q ss_pred             CCEEEeceeeccCCceEEEe----EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCC---CeEEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN---HGLCVV  262 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g----~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~---~~l~lV  262 (454)
                      .++.+.+.||+|.||.|++|    ..||||.+...+...   ...+.|+..-.-++|+||+.|+++=..++   ..+|||
T Consensus       211 rqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~srdE~S---WfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLv  287 (513)
T KOG2052|consen  211 RQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSRDERS---WFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLV  287 (513)
T ss_pred             heeEEEEEecCccccceeeccccCCceEEEEecccchhh---hhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEe
Confidence            67899999999999999985    689999997543222   22334554444579999999997644333   238999


Q ss_pred             EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhc--------CcccCCccCCcEEEccCCcEEEEccCCcccc
Q 012887          263 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDH--------GVAYRDLNSQRILLDRHGNVCLGDMGIVTAC  334 (454)
Q Consensus       263 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~--------~iiHrDIKp~NILl~~~~~vKL~DFGla~~~  334 (454)
                      ++|.+.|||+|+|.+ ..++....++++..++.||.|||-.        .|.|||||+.|||+.++|...|+|+|||...
T Consensus       288 TdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h  366 (513)
T KOG2052|consen  288 TDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH  366 (513)
T ss_pred             eecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEe
Confidence            999999999999965 7899999999999999999999942        4999999999999999999999999998766


Q ss_pred             ccCCC----cccccCCCCcccccccccCCCCCCCCC--chhhHHHHHHHHHHHHcC----------CCCCCCCCH----H
Q 012887          335 KSVGE----ATEYETDGYRWLAPEIIAGDPESVSET--WMSNVYSFGMVIWEMVTG----------EAAYAACSP----V  394 (454)
Q Consensus       335 ~~~~~----~~~~~~gt~~y~APE~l~~~~~~~~~~--~ksDVwSlGviL~elltG----------~~Pf~~~~~----~  394 (454)
                      .+...    ......||-+|||||++...-...-+.  ..+||||||.++||+.-.          ..||.+..+    .
T Consensus       367 ~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~  446 (513)
T KOG2052|consen  367 DSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSF  446 (513)
T ss_pred             cccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCH
Confidence            55422    244557999999999997532211111  358999999999998763          678875332    2


Q ss_pred             HHHHH-HHHcCCCCCCCCCcc-----HHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCCCCC
Q 012887          395 QAAVG-IAACGLRPEIPKDCP-----QILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNS  451 (454)
Q Consensus       395 ~~~~~-i~~~~~~~~~p~~~~-----~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~~  451 (454)
                      +.... +-....||.+|....     ..+.++|+.||..+|.-|.|+--|.+.|.++.+..+.
T Consensus       447 eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~~ek  509 (513)
T KOG2052|consen  447 EEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNSDEK  509 (513)
T ss_pred             HHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcChhh
Confidence            23322 334567777776432     4577899999999999999999999999998875443

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-34  Score=282.55  Aligned_cols=258  Identities=21%  Similarity=0.380  Sum_probs=208.9

Q ss_pred             cceeecCCCEEEeceeeccCCceEEEeEEE-----------EEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEE
Q 012887          183 GRWLLNSDNLEFIDQIGPNSFKGVYKGKRV-----------GIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV  251 (454)
Q Consensus       183 ~~~~~~~~~~~~~~~LG~G~fG~Vy~g~~v-----------avK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~  251 (454)
                      ....+..++++....+-+|.||.||+|-+.           -+|.++.. .+...-..+..|-..+..+.|||+....++
T Consensus       277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~-AS~iQv~~~L~es~lly~~sH~nll~V~~V  355 (563)
T KOG1024|consen  277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH-ASQIQVNLLLQESMLLYGASHPNLLSVLGV  355 (563)
T ss_pred             HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc-ccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence            445567778899999999999999999543           34444322 122222335566666777899999999999


Q ss_pred             EEeCCCeEEEEEeccCCCCHHHHHHhC--------CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcE
Q 012887          252 CVDENHGLCVVTKLMEGGSVNDLILKS--------RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV  323 (454)
Q Consensus       252 ~~~~~~~l~lV~E~~~~gsL~~~l~~~--------~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~v  323 (454)
                      +.++...-++++.++.-|+|..++..+        +.+...++..++.|++.||+|||++|+||.||..+|++|++.-+|
T Consensus       356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqV  435 (563)
T KOG1024|consen  356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQV  435 (563)
T ss_pred             EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeE
Confidence            988765577889999999999999722        246778889999999999999999999999999999999999999


Q ss_pred             EEEccCCccccccCCC--cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHH
Q 012887          324 CLGDMGIVTACKSVGE--ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGI  400 (454)
Q Consensus       324 KL~DFGla~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~i  400 (454)
                      ||+|-.+++.+-+...  .......+.+||+||.+....++.    ++|||||||+||||+| |+.||...+|.+...-+
T Consensus       436 kltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yss----asDvWsfGVllWELmtlg~~PyaeIDPfEm~~yl  511 (563)
T KOG1024|consen  436 KLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSS----ASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYL  511 (563)
T ss_pred             EeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcc----hhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHH
Confidence            9999998775533211  122223567899999999876654    4999999999999999 99999998888766544


Q ss_pred             HHcCCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 012887          401 AACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTN  446 (454)
Q Consensus       401 ~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~  446 (454)
                       ..|+|...|-+||+++..+|..||+.+|++||+|.++..-|.+-+
T Consensus       512 -kdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~  556 (563)
T KOG1024|consen  512 -KDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFH  556 (563)
T ss_pred             -hccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence             568999999999999999999999999999999999998876543

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-34  Score=275.46  Aligned_cols=246  Identities=18%  Similarity=0.320  Sum_probs=204.6

Q ss_pred             cceeecCCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHH-HHHHHHHHHh-CCCCceeEEEEEEEe
Q 012887          183 GRWLLNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFE-LRKDLLELMT-CGHKNILQFYCVCVD  254 (454)
Q Consensus       183 ~~~~~~~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~-~~~Ei~~l~~-l~HpnIv~~~g~~~~  254 (454)
                      ..|.+...+|.++..||+|+|..|..+      +.+|+|+++..-.......+ ++.|-.+..+ -+||.+|-++..|+.
T Consensus       243 ~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqt  322 (593)
T KOG0695|consen  243 ISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQT  322 (593)
T ss_pred             cccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcc
Confidence            456778899999999999999999875      45788877654333222222 3445444443 479999999999888


Q ss_pred             CCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCcccc
Q 012887          255 ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC  334 (454)
Q Consensus       255 ~~~~l~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~  334 (454)
                      +.. +++|.||++||+|--.+++.+++|+..+..+..+|+.||.|||+.|||+||||.+|+|+|.+|++||.|+|+++..
T Consensus       323 esr-lffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~  401 (593)
T KOG0695|consen  323 ESR-LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG  401 (593)
T ss_pred             cce-EEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcC
Confidence            776 9999999999999988888889999999999999999999999999999999999999999999999999999988


Q ss_pred             ccCCCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCC-------CCHHHHHHHHHHcCCCC
Q 012887          335 KSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAA-------CSPVQAAVGIAACGLRP  407 (454)
Q Consensus       335 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~-------~~~~~~~~~i~~~~~~~  407 (454)
                      ..++..+...+|||.|.|||++.|..|...    .|.|+|||+++||+.|+.||..       .+...-+..++. ....
T Consensus       402 l~~gd~tstfcgtpnyiapeilrgeeygfs----vdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvil-ekqi  476 (593)
T KOG0695|consen  402 LGPGDTTSTFCGTPNYIAPEILRGEEYGFS----VDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVIL-EKQI  476 (593)
T ss_pred             CCCCcccccccCCCcccchhhhcccccCce----ehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHh-hhcc
Confidence            888888889999999999999999988766    8999999999999999999972       222223333322 2344


Q ss_pred             CCCCCccHHHHHHHHHhcccCCCCCCC
Q 012887          408 EIPKDCPQILKSLMIKCWNNSPSKRPQ  434 (454)
Q Consensus       408 ~~p~~~~~~l~~li~~cl~~dP~~RPs  434 (454)
                      .+|..+|-....+++.-|++||.+|..
T Consensus       477 riprslsvkas~vlkgflnkdp~erlg  503 (593)
T KOG0695|consen  477 RIPRSLSVKASHVLKGFLNKDPKERLG  503 (593)
T ss_pred             cccceeehhhHHHHHHhhcCCcHHhcC
Confidence            588899999999999999999999853

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=3.9e-34  Score=325.46  Aligned_cols=240  Identities=20%  Similarity=0.340  Sum_probs=183.7

Q ss_pred             EEEeceeeccCCceEEEeE------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEEec
Q 012887          192 LEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKL  265 (454)
Q Consensus       192 ~~~~~~LG~G~fG~Vy~g~------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~E~  265 (454)
                      +.....||+|+||.||+|+      .||+|++.......      ..|+..+.+++|||||+++|+|.+.+. .++||||
T Consensus       692 ~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~------~~~~~~l~~l~HpnIv~~~~~~~~~~~-~~lv~Ey  764 (968)
T PLN00113        692 LKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP------SSEIADMGKLQHPNIVKLIGLCRSEKG-AYLIHEY  764 (968)
T ss_pred             CCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcccc------HHHHHHHhhCCCCCcceEEEEEEcCCC-CEEEEeC
Confidence            4556789999999999974      68999886433221      245778889999999999999988776 8999999


Q ss_pred             cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH---hcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCccc
Q 012887          266 MEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN---DHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE  342 (454)
Q Consensus       266 ~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH---~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~  342 (454)
                      +++|+|.+++.   .+++..+..++.||+.||+|||   +.+|+||||||+||+++.++..++. ||.......    ..
T Consensus       765 ~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~----~~  836 (968)
T PLN00113        765 IEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT----DT  836 (968)
T ss_pred             CCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc----CC
Confidence            99999999985   4889999999999999999999   6699999999999999999888775 665433221    12


Q ss_pred             ccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHHH---------cCCCCCC---
Q 012887          343 YETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPV-QAAVGIAA---------CGLRPEI---  409 (454)
Q Consensus       343 ~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~-~~~~~i~~---------~~~~~~~---  409 (454)
                      ...+++.|+|||++.+..    ++.++|||||||++|||++|+.||...... ........         ....+.+   
T Consensus       837 ~~~~t~~y~aPE~~~~~~----~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  912 (968)
T PLN00113        837 KCFISSAYVAPETRETKD----ITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGD  912 (968)
T ss_pred             CccccccccCcccccCCC----CCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCC
Confidence            235788999999988665    445699999999999999999998642111 00111000         0001111   


Q ss_pred             ---CCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCCCC
Q 012887          410 ---PKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISN  450 (454)
Q Consensus       410 ---p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~  450 (454)
                         +.....++.+++.+||+.||++||++.|+++.|+++.....
T Consensus       913 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~~  956 (968)
T PLN00113        913 VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSSS  956 (968)
T ss_pred             CCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcccc
Confidence               11223467789999999999999999999999999877543

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-35  Score=279.15  Aligned_cols=243  Identities=20%  Similarity=0.345  Sum_probs=195.4

Q ss_pred             ceeeccCCceEEE------eEEEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEEEEEEEeCCCeEEEEEeccCC
Q 012887          196 DQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVDENHGLCVVTKLMEG  268 (454)
Q Consensus       196 ~~LG~G~fG~Vy~------g~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~~~g~~~~~~~~l~lV~E~~~~  268 (454)
                      +.||+|+|+.|-.      |..+|||++...  ....+.++.+|+.++.++ .|+||++++++|.++.. +|+|||-|.|
T Consensus        84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq--~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~-FYLVfEKm~G  160 (463)
T KOG0607|consen   84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ--PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTR-FYLVFEKMRG  160 (463)
T ss_pred             HHhcCccceeeeeeeeeccchhhhhhhhhcC--CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccce-EEEEEecccC
Confidence            4799999999875      578899998643  444667789999999988 59999999999998876 9999999999


Q ss_pred             CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCc---EEEEccCCccccccCCCc-----
Q 012887          269 GSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGN---VCLGDMGIVTACKSVGEA-----  340 (454)
Q Consensus       269 gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~---vKL~DFGla~~~~~~~~~-----  340 (454)
                      |+|...|.+++.+++.++.++.++|+.||.|||.+||.||||||+|||.....+   ||||||.|..........     
T Consensus       161 GplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spast  240 (463)
T KOG0607|consen  161 GPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPAST  240 (463)
T ss_pred             chHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCC
Confidence            999999999999999999999999999999999999999999999999976654   899999886543322211     


Q ss_pred             --ccccCCCCcccccccccC-CCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCH---------------HHHHHHHHH
Q 012887          341 --TEYETDGYRWLAPEIIAG-DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSP---------------VQAAVGIAA  402 (454)
Q Consensus       341 --~~~~~gt~~y~APE~l~~-~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~---------------~~~~~~i~~  402 (454)
                        .....|+-.|||||+..- -.....|+.++|.||||||||-|++|.+||.+.-.               ...+..|..
T Consensus       241 P~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQE  320 (463)
T KOG0607|consen  241 PELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQE  320 (463)
T ss_pred             ccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhc
Confidence              123356668999997641 11123477889999999999999999999974221               112333444


Q ss_pred             cCCCCCCCC----CccHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 012887          403 CGLRPEIPK----DCPQILKSLMIKCWNNSPSKRPQFSEIISLLL  443 (454)
Q Consensus       403 ~~~~~~~p~----~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~  443 (454)
                      ..+  ++|+    .+|.+.++++..++..|+.+|.++.+++.+-|
T Consensus       321 GkY--eFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw  363 (463)
T KOG0607|consen  321 GKY--EFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPW  363 (463)
T ss_pred             cCC--cCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCcc
Confidence            333  3554    47999999999999999999999999887544

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-34  Score=254.66  Aligned_cols=247  Identities=18%  Similarity=0.278  Sum_probs=201.5

Q ss_pred             CEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEEe
Q 012887          191 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTK  264 (454)
Q Consensus       191 ~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~E  264 (454)
                      +|...++||+|.||+||+|      +.||+|..+-.+..+.......+|+-+|+.++|.|||+++++...++. +-+|+|
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkk-ltlvfe   81 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKK-LTLVFE   81 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCce-eEEeHH
Confidence            4566789999999999996      579999998666555566677899999999999999999999887776 899999


Q ss_pred             ccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCcccc
Q 012887          265 LMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY  343 (454)
Q Consensus       265 ~~~~gsL~~~l~~-~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~  343 (454)
                      ||.. +|..+... ++.++......++.|+++||.|+|++++.|||+||.|+||+.+|.+|++|||+++.+.-+-.....
T Consensus        82 ~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrcysa  160 (292)
T KOG0662|consen   82 FCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSA  160 (292)
T ss_pred             HhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEeeec
Confidence            9977 89888854 568999999999999999999999999999999999999999999999999999877544333333


Q ss_pred             cCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHcCCCC---------------
Q 012887          344 ETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRP---------------  407 (454)
Q Consensus       344 ~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~---------------  407 (454)
                      ..-|..|.+|.++.|.+.   ++...|+||-||++.|+.. |++.|++..-...+.+|...--.+               
T Consensus       161 evvtlwyrppdvlfgakl---y~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk  237 (292)
T KOG0662|consen  161 EVVTLWYRPPDVLFGAKL---YSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYK  237 (292)
T ss_pred             eeeeeeccCcceeeeeeh---hccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCc
Confidence            456889999999998753   4456899999999999987 888898877766666654321110               


Q ss_pred             ---CCCC---------CccHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 012887          408 ---EIPK---------DCPQILKSLMIKCWNNSPSKRPQFSEIISLL  442 (454)
Q Consensus       408 ---~~p~---------~~~~~l~~li~~cl~~dP~~RPs~~ell~~L  442 (454)
                         .+|.         ..+..-++++++.+.-+|..|.++++.+++-
T Consensus       238 ~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhp  284 (292)
T KOG0662|consen  238 PYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHP  284 (292)
T ss_pred             ccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCc
Confidence               1111         1223457899999999999999999988763

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.3e-34  Score=293.68  Aligned_cols=242  Identities=18%  Similarity=0.295  Sum_probs=191.8

Q ss_pred             eecCCCEEEeceeeccCCceEEEeEEEE------EEEeecCCCCch-HHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCe
Q 012887          186 LLNSDNLEFIDQIGPNSFKGVYKGKRVG------IEKLKGCDKGNA-YEFELRKDLLELMTCGHKNILQFYCVCVDENHG  258 (454)
Q Consensus       186 ~~~~~~~~~~~~LG~G~fG~Vy~g~~va------vK~l~~~~~~~~-~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~  258 (454)
                      ..+..-|..++.||-|+||+|.++++|-      .|.++..+.... ....+..|-.+|..-+.+-||++|-.|.+.+. 
T Consensus       625 KMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdn-  703 (1034)
T KOG0608|consen  625 KMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDN-  703 (1034)
T ss_pred             hccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCc-
Confidence            3566678999999999999999987654      444443222211 22335677788888899999999999999887 


Q ss_pred             EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCC
Q 012887          259 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG  338 (454)
Q Consensus       259 l~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~  338 (454)
                      +|+||+|.+||++-.+|-+-+-|++..++.|+.++..|+++.|..|+|||||||+|||||.+|++||.||||++-+....
T Consensus       704 LYFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTH  783 (1034)
T KOG0608|consen  704 LYFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH  783 (1034)
T ss_pred             eEEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceecc
Confidence            99999999999999999888899999999999999999999999999999999999999999999999999986543211


Q ss_pred             Cc------------------------------------------ccccCCCCcccccccccCCCCCCCCCchhhHHHHHH
Q 012887          339 EA------------------------------------------TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGM  376 (454)
Q Consensus       339 ~~------------------------------------------~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGv  376 (454)
                      ..                                          .....||+.|+|||++....++.    .+|.||.||
T Consensus       784 dskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q----~cdwws~gv  859 (1034)
T KOG0608|consen  784 DSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQ----LCDWWSVGV  859 (1034)
T ss_pred             ccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccc----cchhhHhhH
Confidence            10                                          01125889999999998765544    499999999


Q ss_pred             HHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCC--CCCCccHHHHHHHHHhcccCCCCCC
Q 012887          377 VIWEMVTGEAAYAACSPVQAAVGIAACGLRPE--IPKDCPQILKSLMIKCWNNSPSKRP  433 (454)
Q Consensus       377 iL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~--~p~~~~~~l~~li~~cl~~dP~~RP  433 (454)
                      |||||+.|++||-..++.+...++......+.  ...+++.+..++|.+++. +++.|.
T Consensus       860 il~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~-sad~RL  917 (1034)
T KOG0608|consen  860 ILYEMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCC-SADSRL  917 (1034)
T ss_pred             HHHHHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhc-Chhhhh
Confidence            99999999999998888766555554333333  345789999999987433 455554

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-34  Score=295.29  Aligned_cols=245  Identities=19%  Similarity=0.291  Sum_probs=185.9

Q ss_pred             EEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCC-----CeEEE
Q 012887          193 EFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN-----HGLCV  261 (454)
Q Consensus       193 ~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~-----~~l~l  261 (454)
                      ...+.||+|+||.||+|      +.||||..+... .....+..-+|+.+|++++|||||+++++=.+..     ..-.+
T Consensus        16 ~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl   94 (732)
T KOG4250|consen   16 EMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL   94 (732)
T ss_pred             eehhhhcCCccceeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence            45678999999999985      589999987543 3334556789999999999999999998755433     12469


Q ss_pred             EEeccCCCCHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccC--C--cEEEEccCCcccc
Q 012887          262 VTKLMEGGSVNDLILKS---RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH--G--NVCLGDMGIVTAC  334 (454)
Q Consensus       262 V~E~~~~gsL~~~l~~~---~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~--~--~vKL~DFGla~~~  334 (454)
                      |||||.||||...+.+.   ..|++..++.+..+++.||.|||++||+||||||.||++-..  |  ..||+|||.|+..
T Consensus        95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel  174 (732)
T KOG4250|consen   95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAREL  174 (732)
T ss_pred             EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccccC
Confidence            99999999999999653   479999999999999999999999999999999999998533  3  3799999999988


Q ss_pred             ccCCCcccccCCCCcccccccccC-CCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHH----HHHHHHHHcCC----
Q 012887          335 KSVGEATEYETDGYRWLAPEIIAG-DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPV----QAAVGIAACGL----  405 (454)
Q Consensus       335 ~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~----~~~~~i~~~~~----  405 (454)
                      .++. ......||..|++||.+.. ..    ++..+|.|||||++|+++||..||......    +....+.....    
T Consensus       175 ~d~s-~~~S~vGT~~YLhPel~E~q~~----y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~  249 (732)
T KOG4250|consen  175 DDNS-LFTSLVGTEEYLHPELYERQKK----YTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVA  249 (732)
T ss_pred             CCCC-eeeeecCchhhcChHHHhhccC----cCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCcee
Confidence            7765 4556689999999999984 43    333489999999999999999999754332    23333332211    


Q ss_pred             ---------------CCCCCCCccHH----HHHHHHHhcccCCCCCC--CHHHHHHHHH
Q 012887          406 ---------------RPEIPKDCPQI----LKSLMIKCWNNSPSKRP--QFSEIISLLL  443 (454)
Q Consensus       406 ---------------~~~~p~~~~~~----l~~li~~cl~~dP~~RP--s~~ell~~L~  443 (454)
                                     ..++|...++.    +...+..+|..+|.+|-  .+.+..+.+.
T Consensus       250 i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~  308 (732)
T KOG4250|consen  250 IGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVD  308 (732)
T ss_pred             EeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHH
Confidence                           12233333333    44566677788888887  5444444433

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=1.4e-32  Score=259.11  Aligned_cols=233  Identities=26%  Similarity=0.390  Sum_probs=189.6

Q ss_pred             CCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEEeccCCCCHHHHH
Q 012887          202 SFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLI  275 (454)
Q Consensus       202 ~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~E~~~~gsL~~~l  275 (454)
                      +||.||+|      +.+++|.+........ ...+.+|+..+..++|+||+++++.+..... .++++||+++++|.+++
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~-~~l~~e~~~~~~L~~~~   78 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDEDK-LYLVMEYCDGGDLFDLL   78 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeCCE-EEEEEeCCCCCCHHHHH
Confidence            57888875      5689998864333221 5678899999999999999999999987765 89999999999999998


Q ss_pred             HhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCcccccCCCCccccccc
Q 012887          276 LKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEI  355 (454)
Q Consensus       276 ~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~gt~~y~APE~  355 (454)
                      .....++...+..++.+++.++.|||+.+++|+||+|+||+++.++.++|+|||.+....... ......+++.|+|||.
T Consensus        79 ~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~~~~~pE~  157 (244)
T smart00220       79 KKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-LLTTFVGTPEYMAPEV  157 (244)
T ss_pred             HhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc-ccccccCCcCCCCHHH
Confidence            766669999999999999999999999999999999999999999999999999987665432 2334457788999999


Q ss_pred             ccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCC--ccHHHHHHHHHhcccCCCCCC
Q 012887          356 IAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKD--CPQILKSLMIKCWNNSPSKRP  433 (454)
Q Consensus       356 l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~--~~~~l~~li~~cl~~dP~~RP  433 (454)
                      +.+..    .+.++||||||+++|++++|..||.....................+..  ++.++.+++.+||..+|++||
T Consensus       158 ~~~~~----~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp  233 (244)
T smart00220      158 LLGKG----YGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRL  233 (244)
T ss_pred             HccCC----CCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhcc
Confidence            97554    344699999999999999999999874444444444433333222222  889999999999999999999


Q ss_pred             CHHHHHHH
Q 012887          434 QFSEIISL  441 (454)
Q Consensus       434 s~~ell~~  441 (454)
                      ++.+++++
T Consensus       234 ~~~~~~~~  241 (244)
T smart00220      234 TAEEALQH  241 (244)
T ss_pred             CHHHHhhC
Confidence            99999874

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.4e-35  Score=270.38  Aligned_cols=259  Identities=18%  Similarity=0.292  Sum_probs=203.9

Q ss_pred             eeecCCCEEEeceeeccCCceEEE------eEEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCC--
Q 012887          185 WLLNSDNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN--  256 (454)
Q Consensus       185 ~~~~~~~~~~~~~LG~G~fG~Vy~------g~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~--  256 (454)
                      +....+.|+...+||+|.||.||+      |+.||+|+.--......+.....+|+.+|..++|+|++.+++.|....  
T Consensus        12 ~~~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp   91 (376)
T KOG0669|consen   12 FCDEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATP   91 (376)
T ss_pred             ceecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCC
Confidence            445557788889999999999997      467888876543333334455679999999999999999887775431  


Q ss_pred             -----CeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCC
Q 012887          257 -----HGLCVVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGI  330 (454)
Q Consensus       257 -----~~l~lV~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGl  330 (454)
                           ..+|+||.+|+. +|..++... .+++...+..++.++..||.|+|+..|+|||+||+|+||+.+|.+||+|||+
T Consensus        92 ~~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGl  170 (376)
T KOG0669|consen   92 TNRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGL  170 (376)
T ss_pred             cccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeecccc
Confidence                 238999999987 999999665 4899999999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCC----cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH--cC
Q 012887          331 VTACKSVGE----ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAA--CG  404 (454)
Q Consensus       331 a~~~~~~~~----~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~--~~  404 (454)
                      ++.+.....    ..+....|.+|.+||.+.|.+.   ++.+.|||+-||++.||.+|.+.+.+.+..+.+..|..  ..
T Consensus       171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~---yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs  247 (376)
T KOG0669|consen  171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDRE---YGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGS  247 (376)
T ss_pred             ccceecccccCCCCcccceeeeecCCHHHhhcccc---cCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhcc
Confidence            976643221    1222345889999999998754   44568999999999999999999998877766554422  11


Q ss_pred             CC------------------CCCCC-------------CccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 012887          405 LR------------------PEIPK-------------DCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNN  447 (454)
Q Consensus       405 ~~------------------~~~p~-------------~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~  447 (454)
                      ..                  +++|.             .-+++..+|+.+++..||.+|+.+++++.|.+-...
T Consensus       248 ~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kd  321 (376)
T KOG0669|consen  248 ITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKD  321 (376)
T ss_pred             CCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcC
Confidence            11                  11221             124578899999999999999999999988765543

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-33  Score=275.13  Aligned_cols=242  Identities=22%  Similarity=0.315  Sum_probs=191.3

Q ss_pred             CCCEEEeceeeccCCceEEE------eEEEEEEEeecCCCCchHHHHHHHHHHHHHhCC-C-C----ceeEEEEEEEeCC
Q 012887          189 SDNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCG-H-K----NILQFYCVCVDEN  256 (454)
Q Consensus       189 ~~~~~~~~~LG~G~fG~Vy~------g~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~-H-p----nIv~~~g~~~~~~  256 (454)
                      ..+|++.+.+|+|+||.|-.      +..||+|++++..   .+.....-|+.+|.++. + |    -+|++.++|...+
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~---kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrg  164 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD---KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRG  164 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH---HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccC
Confidence            46799999999999999997      4689999998543   34455667888888773 2 2    3677788888788


Q ss_pred             CeEEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEcc---------------
Q 012887          257 HGLCVVTKLMEGGSVNDLILKSR--KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDR---------------  319 (454)
Q Consensus       257 ~~l~lV~E~~~~gsL~~~l~~~~--~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~---------------  319 (454)
                      + .|||+|.+ |-|+.+++..+.  +++...+..++.|+++++.|||+.+++|-||||+|||+.+               
T Consensus       165 h-iCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~  242 (415)
T KOG0671|consen  165 H-ICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCF  242 (415)
T ss_pred             c-eEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccce
Confidence            7 99999999 559999997755  8999999999999999999999999999999999999842               


Q ss_pred             -----CCcEEEEccCCccccccCCCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHH
Q 012887          320 -----HGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPV  394 (454)
Q Consensus       320 -----~~~vKL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~  394 (454)
                           +..||+.|||-|+.....   .....+|--|.|||++.|..++.+    +||||+||||+|+++|...|....+.
T Consensus       243 ~r~~ks~~I~vIDFGsAtf~~e~---hs~iVsTRHYRAPEViLgLGwS~p----CDvWSiGCIL~ElytG~~LFqtHen~  315 (415)
T KOG0671|consen  243 IRPLKSTAIKVIDFGSATFDHEH---HSTIVSTRHYRAPEVILGLGWSQP----CDVWSIGCILVELYTGETLFQTHENL  315 (415)
T ss_pred             eccCCCcceEEEecCCcceeccC---cceeeeccccCCchheeccCcCCc----cCceeeeeEEEEeeccceecccCCcH
Confidence                 235899999998765432   355678889999999999887766    99999999999999999999987654


Q ss_pred             HHH---HHHHH-----------------cCCCCCCCCC-------------------------ccHHHHHHHHHhcccCC
Q 012887          395 QAA---VGIAA-----------------CGLRPEIPKD-------------------------CPQILKSLMIKCWNNSP  429 (454)
Q Consensus       395 ~~~---~~i~~-----------------~~~~~~~p~~-------------------------~~~~l~~li~~cl~~dP  429 (454)
                      +.+   ..+..                 .+ +..+|..                         -...+.+||++||..||
T Consensus       316 EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~-rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP  394 (415)
T KOG0671|consen  316 EHLAMMERILGPIPSRMIKKTRKEKYFRRG-RLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDP  394 (415)
T ss_pred             HHHHHHHHhhCCCcHHHhhhhhhHhhhhcc-cccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCc
Confidence            422   11110                 01 1111111                         11347899999999999


Q ss_pred             CCCCCHHHHHHHHH
Q 012887          430 SKRPQFSEIISLLL  443 (454)
Q Consensus       430 ~~RPs~~ell~~L~  443 (454)
                      .+|+|+.|++.|-.
T Consensus       395 ~~RiTl~EAL~HpF  408 (415)
T KOG0671|consen  395 ARRITLREALSHPF  408 (415)
T ss_pred             cccccHHHHhcCHH
Confidence            99999999998754

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=2.8e-32  Score=291.96  Aligned_cols=252  Identities=14%  Similarity=0.110  Sum_probs=166.7

Q ss_pred             eeecCCCEEEeceeeccCCceEEEe----------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEE---
Q 012887          185 WLLNSDNLEFIDQIGPNSFKGVYKG----------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV---  251 (454)
Q Consensus       185 ~~~~~~~~~~~~~LG~G~fG~Vy~g----------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~---  251 (454)
                      ..+..++|++.+.||+|+||.||+|          ..+|+|++.....   .+..+..   .+....+.++..++..   
T Consensus       127 ~~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~---~e~~~~e---~l~~~~~~~~~~~~~~~~~  200 (566)
T PLN03225        127 PSFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA---VEIWMNE---RVRRACPNSCADFVYGFLE  200 (566)
T ss_pred             CCCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch---hHHHHHH---HHHhhchhhHHHHHHhhhc
Confidence            3456789999999999999999986          4689998753221   1111111   1122222222222211   


Q ss_pred             -EE-eCCCeEEEEEeccCCCCHHHHHHhCC-C-------------------CCHHHHHHHHHHHHHHHHHHHhcCcccCC
Q 012887          252 -CV-DENHGLCVVTKLMEGGSVNDLILKSR-K-------------------LQTKEIIRIAIDVAEGIKFLNDHGVAYRD  309 (454)
Q Consensus       252 -~~-~~~~~l~lV~E~~~~gsL~~~l~~~~-~-------------------l~~~~~~~i~~qI~~gL~yLH~~~iiHrD  309 (454)
                       .. ..+..+++||||+++++|.+++.... .                   .....+..++.||+.||.|||+++|+|||
T Consensus       201 ~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRD  280 (566)
T PLN03225        201 PVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRD  280 (566)
T ss_pred             ccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCc
Confidence             11 23334899999999999999985432 1                   11334667999999999999999999999


Q ss_pred             ccCCcEEEcc-CCcEEEEccCCccccccCC-CcccccCCCCcccccccccCCCCCC------------------CCCchh
Q 012887          310 LNSQRILLDR-HGNVCLGDMGIVTACKSVG-EATEYETDGYRWLAPEIIAGDPESV------------------SETWMS  369 (454)
Q Consensus       310 IKp~NILl~~-~~~vKL~DFGla~~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~------------------~~~~ks  369 (454)
                      |||+|||++. ++.+||+|||+++...... .......+++.|+|||.+.......                  .++.++
T Consensus       281 LKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~  360 (566)
T PLN03225        281 VKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF  360 (566)
T ss_pred             CCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCc
Confidence            9999999986 5799999999987553321 1223346788999999765332221                  233457


Q ss_pred             hHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH-HcCCC---------CCC----------CCCccHHHHHHHHHhcccCC
Q 012887          370 NVYSFGMVIWEMVTGEAAYAACSPVQAAVGIA-ACGLR---------PEI----------PKDCPQILKSLMIKCWNNSP  429 (454)
Q Consensus       370 DVwSlGviL~elltG~~Pf~~~~~~~~~~~i~-~~~~~---------~~~----------p~~~~~~l~~li~~cl~~dP  429 (454)
                      |||||||+||||+++..|+..  ....+.... ..+..         ...          ....+....+||.+||++||
T Consensus       361 DVwSlGviL~el~~~~~~~~~--~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP  438 (566)
T PLN03225        361 DIYSAGLIFLQMAFPNLRSDS--NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKG  438 (566)
T ss_pred             ccHHHHHHHHHHHhCcCCCch--HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCc
Confidence            999999999999997766543  211111111 11100         000          11123345689999999999


Q ss_pred             CCCCCHHHHHHHHHh
Q 012887          430 SKRPQFSEIISLLLR  444 (454)
Q Consensus       430 ~~RPs~~ell~~L~~  444 (454)
                      .+|||+.++++|-+-
T Consensus       439 ~kR~ta~e~L~Hpff  453 (566)
T PLN03225        439 RQRISAKAALAHPYF  453 (566)
T ss_pred             ccCCCHHHHhCCcCc
Confidence            999999999998554

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=5.7e-32  Score=283.97  Aligned_cols=259  Identities=15%  Similarity=0.149  Sum_probs=182.5

Q ss_pred             ecCCCEEEeceeeccCCceEEEeE----------------------EEEEEEeecCCCCchH------------HHHHHH
Q 012887          187 LNSDNLEFIDQIGPNSFKGVYKGK----------------------RVGIEKLKGCDKGNAY------------EFELRK  232 (454)
Q Consensus       187 ~~~~~~~~~~~LG~G~fG~Vy~g~----------------------~vavK~l~~~~~~~~~------------~~~~~~  232 (454)
                      +..++|++.++||+|+||.||+|.                      .||||++.........            ......
T Consensus       142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v  221 (507)
T PLN03224        142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV  221 (507)
T ss_pred             ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence            367899999999999999999873                      5899998643221111            011234


Q ss_pred             HHHHHHhCCCCce-----eEEEEEEEeC-------CCeEEEEEeccCCCCHHHHHHhCC---------------------
Q 012887          233 DLLELMTCGHKNI-----LQFYCVCVDE-------NHGLCVVTKLMEGGSVNDLILKSR---------------------  279 (454)
Q Consensus       233 Ei~~l~~l~HpnI-----v~~~g~~~~~-------~~~l~lV~E~~~~gsL~~~l~~~~---------------------  279 (454)
                      |+..+.+++|.++     ++++++|...       ....++||||+++++|.+++....                     
T Consensus       222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~  301 (507)
T PLN03224        222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM  301 (507)
T ss_pred             HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence            5566666666544     6777777532       223899999999999999885311                     


Q ss_pred             ---CCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCC-cccccCCCCccccccc
Q 012887          280 ---KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE-ATEYETDGYRWLAPEI  355 (454)
Q Consensus       280 ---~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~-~~~~~~gt~~y~APE~  355 (454)
                         .+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+|||++........ .......++.|+|||.
T Consensus       302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~  381 (507)
T PLN03224        302 PQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEE  381 (507)
T ss_pred             ccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhh
Confidence               235667889999999999999999999999999999999999999999999865433211 1222345789999998


Q ss_pred             ccCCCCCCC------------------CCchhhHHHHHHHHHHHHcCCC-CCCCCCHHHHH-----------HHHHHcCC
Q 012887          356 IAGDPESVS------------------ETWMSNVYSFGMVIWEMVTGEA-AYAACSPVQAA-----------VGIAACGL  405 (454)
Q Consensus       356 l~~~~~~~~------------------~~~ksDVwSlGviL~elltG~~-Pf~~~~~~~~~-----------~~i~~~~~  405 (454)
                      +........                  ...+.||||+||++|+|++|.. ||.........           ........
T Consensus       382 l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~  461 (507)
T PLN03224        382 LVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKY  461 (507)
T ss_pred             hcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCC
Confidence            864322111                  1123699999999999999875 77542211110           01111122


Q ss_pred             CCCCCCCccHHHHHHHHHhcccCC---CCCCCHHHHHHHHHhh
Q 012887          406 RPEIPKDCPQILKSLMIKCWNNSP---SKRPQFSEIISLLLRT  445 (454)
Q Consensus       406 ~~~~p~~~~~~l~~li~~cl~~dP---~~RPs~~ell~~L~~~  445 (454)
                      ........++..++|+.++|..+|   .+|+|+.|+++|-+-.
T Consensus       462 ~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~  504 (507)
T PLN03224        462 DFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFL  504 (507)
T ss_pred             CcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcC
Confidence            223345578999999999999876   6899999999987643

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.97  E-value=1.2e-32  Score=283.30  Aligned_cols=249  Identities=19%  Similarity=0.388  Sum_probs=211.3

Q ss_pred             cCCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEE
Q 012887          188 NSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCV  261 (454)
Q Consensus       188 ~~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~l  261 (454)
                      +.++|+.+..+|+|+||.|||+      +..|+|.++-....  .-.-++.|+.+++.++|||||.|+|.+...+. +++
T Consensus        13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~d--d~~~iqqei~~~~dc~h~nivay~gsylr~dk-lwi   89 (829)
T KOG0576|consen   13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGD--DFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDK-LWI   89 (829)
T ss_pred             CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCc--cccccccceeeeecCCCcChHHHHhhhhhhcC-cEE
Confidence            4589999999999999999985      46788888743222  22346789999999999999999999988776 999


Q ss_pred             EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCcc
Q 012887          262 VTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT  341 (454)
Q Consensus       262 V~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~  341 (454)
                      +||||.+|+|.+.-.-.+++.+.++...+++.+.||.|||++|-+|||||-.|||+++.|.+|++|||.+......-...
T Consensus        90 cMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~Kr  169 (829)
T KOG0576|consen   90 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAKR  169 (829)
T ss_pred             EEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhhhhh
Confidence            99999999999987777899999999999999999999999999999999999999999999999999977665544455


Q ss_pred             cccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCC---CCCccHHHH
Q 012887          342 EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEI---PKDCPQILK  418 (454)
Q Consensus       342 ~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~---p~~~~~~l~  418 (454)
                      ....||+-|||||+..-+.. ..+...+|||++|++..|+---++|-....+.+...-....++.++-   +...++.+.
T Consensus       170 ksfiGtpywmapEvaaverk-ggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~fh  248 (829)
T KOG0576|consen  170 KSFIGTPYWMAPEVAAVERK-GGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFFH  248 (829)
T ss_pred             hcccCCccccchhHHHHHhc-ccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHHH
Confidence            66789999999998763322 23566799999999999999999998888888877766666666543   345789999


Q ss_pred             HHHHHhcccCCCCCCCHHHHHH
Q 012887          419 SLMIKCWNNSPSKRPQFSEIIS  440 (454)
Q Consensus       419 ~li~~cl~~dP~~RPs~~ell~  440 (454)
                      ++++.++.++|.+||+++.++.
T Consensus       249 ~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  249 NFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             HHHHHHhcCCCccCCChhhhee
Confidence            9999999999999999988764

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.97  E-value=7.3e-32  Score=283.64  Aligned_cols=235  Identities=22%  Similarity=0.342  Sum_probs=180.3

Q ss_pred             eceeeccCCce-EEE----eEEEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEEEEEEEeCCCeEEEEEeccCC
Q 012887          195 IDQIGPNSFKG-VYK----GKRVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVDENHGLCVVTKLMEG  268 (454)
Q Consensus       195 ~~~LG~G~fG~-Vy~----g~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~~~g~~~~~~~~l~lV~E~~~~  268 (454)
                      -+.+|.|+-|+ ||+    |+.||||++-.     ....-..+|+..|+.. .|||||++|+.-.+... +||+.|.|..
T Consensus       514 ~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~-----e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF-~YIalELC~~  587 (903)
T KOG1027|consen  514 KEILGYGSNGTVVFRGVYEGREVAVKRLLE-----EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQF-LYIALELCAC  587 (903)
T ss_pred             HHHcccCCCCcEEEEEeeCCceehHHHHhh-----HhHHHHHHHHHHHHhccCCCceEEEEeeccCCce-EEEEehHhhh
Confidence            45688988874 555    58999998852     2223467999999887 59999999988776666 9999999977


Q ss_pred             CCHHHHHHhC-C---CCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEcc---CC--cEEEEccCCccccccCCC
Q 012887          269 GSVNDLILKS-R---KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDR---HG--NVCLGDMGIVTACKSVGE  339 (454)
Q Consensus       269 gsL~~~l~~~-~---~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~---~~--~vKL~DFGla~~~~~~~~  339 (454)
                       +|.+++... .   .......+....|+++||.+||+.+||||||||.||||+.   ++  .++|+|||+++.......
T Consensus       588 -sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~s  666 (903)
T KOG1027|consen  588 -SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKS  666 (903)
T ss_pred             -hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcc
Confidence             999999653 1   1122456788899999999999999999999999999986   34  689999999987765432


Q ss_pred             ---cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHcCCCCCC-CCCcc
Q 012887          340 ---ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEI-PKDCP  414 (454)
Q Consensus       340 ---~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~-p~~~~  414 (454)
                         ......||.+|+|||++.......    ++||||+||++|+.++ |..||.+....+.  .|...+..... ...-.
T Consensus       667 S~~r~s~~sGt~GW~APE~L~~~~~~~----avDiFslGCvfyYvltgG~HpFGd~~~R~~--NIl~~~~~L~~L~~~~d  740 (903)
T KOG1027|consen  667 SFSRLSGGSGTSGWQAPEQLREDRKTQ----AVDIFSLGCVFYYVLTGGSHPFGDSLERQA--NILTGNYTLVHLEPLPD  740 (903)
T ss_pred             hhhcccCCCCcccccCHHHHhccccCc----ccchhhcCceEEEEecCCccCCCchHHhhh--hhhcCccceeeeccCch
Confidence               234457899999999999775443    5999999999999999 5999987544332  34443333211 11111


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 012887          415 QILKSLMIKCWNNSPSKRPQFSEIISLL  442 (454)
Q Consensus       415 ~~l~~li~~cl~~dP~~RPs~~ell~~L  442 (454)
                      .++.+||.+|+++||..||++.+++.|-
T Consensus       741 ~eA~dLI~~ml~~dP~~RPsa~~VL~HP  768 (903)
T KOG1027|consen  741 CEAKDLISRMLNPDPQLRPSATDVLNHP  768 (903)
T ss_pred             HHHHHHHHHhcCCCcccCCCHHHHhCCC
Confidence            2899999999999999999999998763

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.3e-32  Score=257.48  Aligned_cols=250  Identities=22%  Similarity=0.352  Sum_probs=200.1

Q ss_pred             CEEEeceeeccCCceEEE------eEEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCC----CeEE
Q 012887          191 NLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN----HGLC  260 (454)
Q Consensus       191 ~~~~~~~LG~G~fG~Vy~------g~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~----~~l~  260 (454)
                      +++--+.||-|+||.||.      |++||.|++.+....-.....+.+|+..|.-.+|.|++..++.....+    ..+|
T Consensus        54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY  133 (449)
T KOG0664|consen   54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY  133 (449)
T ss_pred             cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence            344556799999999995      899999999876666667778899999999999999999888776553    1278


Q ss_pred             EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCC-
Q 012887          261 VVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE-  339 (454)
Q Consensus       261 lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~-  339 (454)
                      +++|+|.. +|+..+-....++.+.+.-+..||++||.|||+.+|.||||||.|+|++++..+||||||+++.-..+.. 
T Consensus       134 V~TELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~  212 (449)
T KOG0664|consen  134 VLTELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRL  212 (449)
T ss_pred             HHHHHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhhh
Confidence            89999965 9999988888999999999999999999999999999999999999999999999999999886443222 


Q ss_pred             cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH------------------
Q 012887          340 ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIA------------------  401 (454)
Q Consensus       340 ~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~------------------  401 (454)
                      ..+...-|.-|.|||++.|.+   .|+.+.||||.|||+.|++-.+..|...++.+.+.-|.                  
T Consensus       213 hMTqEVVTQYYRAPEiLMGaR---hYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGA  289 (449)
T KOG0664|consen  213 NMTHEVVTQYYRAPELLMGAR---RYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGA  289 (449)
T ss_pred             hhHHHHHHHHhccHHHhhcch---hhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhh
Confidence            222234456699999999875   35667999999999999999999999877766543321                  


Q ss_pred             -----HcCCC-CCC--------CCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 012887          402 -----ACGLR-PEI--------PKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR  444 (454)
Q Consensus       402 -----~~~~~-~~~--------p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~  444 (454)
                           +.+.+ +.+        +..-..+...++.+++..||++|.+..+.+.++-.
T Consensus       290 k~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~  346 (449)
T KOG0664|consen  290 KNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYL  346 (449)
T ss_pred             HHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccc
Confidence                 11111 111        12334567789999999999999999998877643

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.97  E-value=9e-31  Score=239.94  Aligned_cols=244  Identities=15%  Similarity=0.234  Sum_probs=190.8

Q ss_pred             cCCCEEEeceeeccCCceEEEeE------EEEEEEeecCCCCchHHHHHHHHHHHHHhCC-CCceeEEEEEEEeCC-CeE
Q 012887          188 NSDNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKGNAYEFELRKDLLELMTCG-HKNILQFYCVCVDEN-HGL  259 (454)
Q Consensus       188 ~~~~~~~~~~LG~G~fG~Vy~g~------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~~~g~~~~~~-~~l  259 (454)
                      ..++|++.+++|+|.|+.||.|.      .+.||.++..     ....+.+|+.+|..|. ||||++++++..+.. ...
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV-----kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktp  110 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV-----KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTP  110 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH-----HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCc
Confidence            45899999999999999999984      6778888743     3456889999999986 999999999998875 336


Q ss_pred             EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCC-cEEEEccCCccccccCC
Q 012887          260 CVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG-NVCLGDMGIVTACKSVG  338 (454)
Q Consensus       260 ~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~-~vKL~DFGla~~~~~~~  338 (454)
                      .+|+||.++.+...+.   ..++..++..++.+++.||.|+|++||+|||+||.|++||... .++|+|+|+|.+.....
T Consensus       111 aLiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~  187 (338)
T KOG0668|consen  111 SLIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  187 (338)
T ss_pred             hhHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCCc
Confidence            7999999987776654   3688899999999999999999999999999999999999765 69999999998876654


Q ss_pred             CcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCC-CCCHHHHHHHHHH---------------
Q 012887          339 EATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYA-ACSPVQAAVGIAA---------------  402 (454)
Q Consensus       339 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~-~~~~~~~~~~i~~---------------  402 (454)
                      +......+. -|--||.+..-.   .++..-|+|||||++..|+..+.||. +.+....+.+|..               
T Consensus       188 eYnVRVASR-yfKGPELLVdy~---~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~  263 (338)
T KOG0668|consen  188 EYNVRVASR-YFKGPELLVDYQ---MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQ  263 (338)
T ss_pred             eeeeeeehh-hcCCchheeech---hccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHc
Confidence            433332332 367899886432   35555899999999999999998875 4444444443321               


Q ss_pred             ------------cCCCCCC----CC----CccHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 012887          403 ------------CGLRPEI----PK----DCPQILKSLMIKCWNNSPSKRPQFSEIISLLL  443 (454)
Q Consensus       403 ------------~~~~~~~----p~----~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~  443 (454)
                                  ...+..+    +.    -.++++.+++.+.|..|-.+|+|++|.++|-.
T Consensus       264 i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~Hpy  324 (338)
T KOG0668|consen  264 IDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPY  324 (338)
T ss_pred             cCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCch
Confidence                        1111111    11    14688999999999999999999999998743

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.97  E-value=5e-31  Score=264.61  Aligned_cols=243  Identities=23%  Similarity=0.307  Sum_probs=193.7

Q ss_pred             CCCEEEeceeeccCCceEEE------eEEEEEEEeecCCCCchHHHHHHHHHHHHHhCC------CCceeEEEEEEEeCC
Q 012887          189 SDNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCG------HKNILQFYCVCVDEN  256 (454)
Q Consensus       189 ~~~~~~~~~LG~G~fG~Vy~------g~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~------HpnIv~~~g~~~~~~  256 (454)
                      -+.|.+....|+|-|+.|.+      |..||||+|++.....   ..=.+|+.+|..|.      --|.++++..|...+
T Consensus       431 D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~---KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hkn  507 (752)
T KOG0670|consen  431 DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMH---KTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKN  507 (752)
T ss_pred             cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHh---hhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcc
Confidence            36799999999999999997      4689999998654332   33457888888872      468999999999888


Q ss_pred             CeEEEEEeccCCCCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCC-cEEEEccCCcc
Q 012887          257 HGLCVVTKLMEGGSVNDLILKSR---KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG-NVCLGDMGIVT  332 (454)
Q Consensus       257 ~~l~lV~E~~~~gsL~~~l~~~~---~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~-~vKL~DFGla~  332 (454)
                      + +|||+|.+.- +|.++|++-+   .|....+..|+.|+..||..|-..||+|.||||+|||+++.. .+||||||.|.
T Consensus       508 H-LClVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~  585 (752)
T KOG0670|consen  508 H-LCLVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSAS  585 (752)
T ss_pred             e-eEEEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCcccc
Confidence            8 9999999955 9999997644   688899999999999999999999999999999999999765 57999999987


Q ss_pred             ccccCCCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCC-------
Q 012887          333 ACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGL-------  405 (454)
Q Consensus       333 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~-------  405 (454)
                      ....+ +.+.|.++- .|.|||++.|.+|...    .|+||+||+||||+||+..|++.+....+.-.+...-       
T Consensus       586 ~~~en-eitPYLVSR-FYRaPEIiLG~~yd~~----iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~Kml  659 (752)
T KOG0670|consen  586 FASEN-EITPYLVSR-FYRAPEIILGLPYDYP----IDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKML  659 (752)
T ss_pred             ccccc-cccHHHHHH-hccCcceeecCcccCC----ccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHh
Confidence            66543 334444444 4999999999877655    8999999999999999999999887765432211100       


Q ss_pred             ------------------------------------CC------------CCCCC---ccHHHHHHHHHhcccCCCCCCC
Q 012887          406 ------------------------------------RP------------EIPKD---CPQILKSLMIKCWNNSPSKRPQ  434 (454)
Q Consensus       406 ------------------------------------~~------------~~p~~---~~~~l~~li~~cl~~dP~~RPs  434 (454)
                                                          .|            .+|..   .-..+.+|+.+||..||++|.|
T Consensus       660 RKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit  739 (752)
T KOG0670|consen  660 RKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRIT  739 (752)
T ss_pred             hhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCC
Confidence                                                00            01221   1245889999999999999999


Q ss_pred             HHHHHHHH
Q 012887          435 FSEIISLL  442 (454)
Q Consensus       435 ~~ell~~L  442 (454)
                      ..+.|.|-
T Consensus       740 ~nqAL~Hp  747 (752)
T KOG0670|consen  740 VNQALKHP  747 (752)
T ss_pred             HHHHhcCC
Confidence            99999874

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.97  E-value=7.3e-29  Score=227.41  Aligned_cols=207  Identities=34%  Similarity=0.564  Sum_probs=175.3

Q ss_pred             eeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEEeccCCCCH
Q 012887          198 IGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSV  271 (454)
Q Consensus       198 LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~E~~~~gsL  271 (454)
                      ||+|++|.||++      +.+++|......... ....+.+|+..+..+.|++|+++++++..... .+++||++++++|
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~-~~~~~e~~~~~~l   78 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDENH-LYLVMEYCEGGSL   78 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCe-EEEEEecCCCCcH
Confidence            689999999985      468888887443321 34568899999999999999999999987755 8999999999999


Q ss_pred             HHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEcc-CCcEEEEccCCccccccCCCcccccCCCCc
Q 012887          272 NDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDR-HGNVCLGDMGIVTACKSVGEATEYETDGYR  349 (454)
Q Consensus       272 ~~~l~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~-~~~vKL~DFGla~~~~~~~~~~~~~~gt~~  349 (454)
                      .+++... ..++...+..++.+++.+|.|||++|++|+||+|.||+++. ++.++|+|||.+..............+...
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~  158 (215)
T cd00180          79 KDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPA  158 (215)
T ss_pred             HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCCC
Confidence            9998665 47899999999999999999999999999999999999999 899999999998765443222333456778


Q ss_pred             ccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhcccCC
Q 012887          350 WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSP  429 (454)
Q Consensus       350 y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~li~~cl~~dP  429 (454)
                      |++||.+...   ...+.++|+|++|+++++|                                 ..+.+++.+|++.+|
T Consensus       159 ~~~pe~~~~~---~~~~~~~D~~~lg~~~~~l---------------------------------~~~~~~l~~~l~~~p  202 (215)
T cd00180         159 YMAPEVLLGK---GYYSEKSDIWSLGVILYEL---------------------------------PELKDLIRKMLQKDP  202 (215)
T ss_pred             ccChhHhccc---CCCCchhhhHHHHHHHHHH---------------------------------HHHHHHHHHHhhCCc
Confidence            9999998764   1244569999999999999                                 679999999999999


Q ss_pred             CCCCCHHHHHHHH
Q 012887          430 SKRPQFSEIISLL  442 (454)
Q Consensus       430 ~~RPs~~ell~~L  442 (454)
                      ++||++.++++++
T Consensus       203 ~~R~~~~~l~~~~  215 (215)
T cd00180         203 EKRPSAKEILEHL  215 (215)
T ss_pred             ccCcCHHHHhhCC
Confidence            9999999998753

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.97  E-value=3e-30  Score=246.66  Aligned_cols=245  Identities=20%  Similarity=0.255  Sum_probs=190.3

Q ss_pred             CCCEEEeceeeccCCceEE-----EeEEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCC-----Ce
Q 012887          189 SDNLEFIDQIGPNSFKGVY-----KGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN-----HG  258 (454)
Q Consensus       189 ~~~~~~~~~LG~G~fG~Vy-----~g~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~-----~~  258 (454)
                      ..+|.-++.+|.|.-..|-     .++.||+|++...........+..+|+..+..+.|+||++++.+|....     ..
T Consensus        16 ~~Ry~nL~p~~~g~~~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e   95 (369)
T KOG0665|consen   16 PKRYVNLKPIGSGAQIVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE   95 (369)
T ss_pred             eeeeeeecccCCCCceEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence            3567778889999883333     2689999998766444445566789999999999999999999998543     23


Q ss_pred             EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCC
Q 012887          259 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG  338 (454)
Q Consensus       259 l~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~  338 (454)
                      .|+|||+|.. +|...+.  -.++-..+..++.|++.|++|||+.||+||||||+||++..++.+||.|||+|+..... 
T Consensus        96 ~y~v~e~m~~-nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~-  171 (369)
T KOG0665|consen   96 VYLVMELMDA-NLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD-  171 (369)
T ss_pred             HHHHHHhhhh-HHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccCcc-
Confidence            7999999976 9998875  46788899999999999999999999999999999999999999999999998765443 


Q ss_pred             CcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHc---------------
Q 012887          339 EATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAAC---------------  403 (454)
Q Consensus       339 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~---------------  403 (454)
                      -..+....+--|.|||++.+..+..    .+||||+||++.||++|..-|.+..--....++...               
T Consensus       172 ~~mtpyVvtRyyrapevil~~~~ke----~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~  247 (369)
T KOG0665|consen  172 FMMTPYVVTRYYRAPEVILGMGYKE----NVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPT  247 (369)
T ss_pred             cccCchhheeeccCchheeccCCcc----cchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHH
Confidence            2233334566699999999887544    499999999999999999999865443322221110               


Q ss_pred             ------CCC--------CCCCC-----------CccHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012887          404 ------GLR--------PEIPK-----------DCPQILKSLMIKCWNNSPSKRPQFSEIISL  441 (454)
Q Consensus       404 ------~~~--------~~~p~-----------~~~~~l~~li~~cl~~dP~~RPs~~ell~~  441 (454)
                            +.+        ..+|+           .-...+.+++.+||..+|++|.++.+++.|
T Consensus       248 ~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H  310 (369)
T KOG0665|consen  248 VRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH  310 (369)
T ss_pred             HHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence                  000        01121           123558899999999999999999999976

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.96  E-value=4.7e-28  Score=226.61  Aligned_cols=213  Identities=23%  Similarity=0.341  Sum_probs=173.3

Q ss_pred             EEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEEec
Q 012887          192 LEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKL  265 (454)
Q Consensus       192 ~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~E~  265 (454)
                      |.+.+.||+|++|.||++      +.+++|.+...... .....+.+|+..+..++|+|++++++.+...+. .++++|+
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~-~~~v~e~   78 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDPEP-LYLVMEY   78 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecCCc-eEEEEec
Confidence            467789999999999986      56889988743322 245678889999999999999999999887665 8999999


Q ss_pred             cCCCCHHHHHHhCCC-CCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCC-Ccccc
Q 012887          266 MEGGSVNDLILKSRK-LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG-EATEY  343 (454)
Q Consensus       266 ~~~gsL~~~l~~~~~-l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~-~~~~~  343 (454)
                      +++++|.+++..... +++..+..++.+++.++.|||+++++|+||+|.||+++.++.++|+|||++....... .....
T Consensus        79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~  158 (225)
T smart00221       79 CEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKT  158 (225)
T ss_pred             cCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccccc
Confidence            999999999976665 8999999999999999999999999999999999999999999999999987665432 11233


Q ss_pred             cCCCCccccccccc-CCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHHHcCCCCCCC
Q 012887          344 ETDGYRWLAPEIIA-GDPESVSETWMSNVYSFGMVIWEMVTGEAAYAA-CSPVQAAVGIAACGLRPEIP  410 (454)
Q Consensus       344 ~~gt~~y~APE~l~-~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~-~~~~~~~~~i~~~~~~~~~p  410 (454)
                      ..++..|++||.+. ..    .++.++|+|+||+++++|++|+.||.. ..+.....+....+.++.+|
T Consensus       159 ~~~~~~~~~pe~~~~~~----~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  223 (225)
T smart00221      159 VKGTPFYLAPEVLLGGK----GYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGVPLLWE  223 (225)
T ss_pred             eeccCCcCCHhHhcCCC----CCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCCccccc
Confidence            45677899999984 32    344469999999999999999999987 56665666655555544443

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.96  E-value=1.2e-29  Score=257.45  Aligned_cols=197  Identities=21%  Similarity=0.302  Sum_probs=166.3

Q ss_pred             cCCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCch---HH---HHHHHHHHHHHhCC---CCceeEEEEEE
Q 012887          188 NSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNA---YE---FELRKDLLELMTCG---HKNILQFYCVC  252 (454)
Q Consensus       188 ~~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~---~~---~~~~~Ei~~l~~l~---HpnIv~~~g~~  252 (454)
                      ...+|..++.+|.|+||.|.++      ..|.+|.+.....-..   +.   -.+-.||.+|..++   |+||++++++|
T Consensus       559 k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF  638 (772)
T KOG1152|consen  559 KFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF  638 (772)
T ss_pred             ccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee
Confidence            3467999999999999999986      3577777754332111   00   12557899999886   99999999999


Q ss_pred             EeCCCeEEEEEeccC-CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCc
Q 012887          253 VDENHGLCVVTKLME-GGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIV  331 (454)
Q Consensus       253 ~~~~~~l~lV~E~~~-~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla  331 (454)
                      .++++ +||+||-.. |.+|.+++.....+++..+..|++||+.|+++||++||||||||-+|+.++.+|-+||+|||.+
T Consensus       639 Eddd~-yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsa  717 (772)
T KOG1152|consen  639 EDDDY-YYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSA  717 (772)
T ss_pred             ecCCe-eEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccch
Confidence            98887 999999865 5589999988889999999999999999999999999999999999999999999999999998


Q ss_pred             cccccCCCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 012887          332 TACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAA  390 (454)
Q Consensus       332 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~  390 (454)
                      ....+..  -....||..|.|||++.|.+|-.+   .-|||++|++||.++....||.+
T Consensus       718 a~~ksgp--fd~f~gtv~~aapevl~g~~y~gk---~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  718 AYTKSGP--FDVFVGTVDYAAPEVLGGEKYLGK---PQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             hhhcCCC--cceeeeeccccchhhhCCCccCCC---cchhhhhhheeeEEEeccCCCcC
Confidence            7655432  445679999999999999988655   37999999999999999999864

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=2.9e-28  Score=243.62  Aligned_cols=128  Identities=22%  Similarity=0.373  Sum_probs=108.2

Q ss_pred             ecCCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhC--------CCCceeEEEEEE
Q 012887          187 LNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTC--------GHKNILQFYCVC  252 (454)
Q Consensus       187 ~~~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l--------~HpnIv~~~g~~  252 (454)
                      +...+|.+.++||-|.|++||++      +.||+|+.+.   ...+......||.+|.++        ...+||++++.|
T Consensus        75 F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS---AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~F  151 (590)
T KOG1290|consen   75 FNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS---AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHF  151 (590)
T ss_pred             ccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh---hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccc
Confidence            66689999999999999999996      6899999884   334555677889888875        235799999999


Q ss_pred             EeCC---CeEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhc-CcccCCccCCcEEEc
Q 012887          253 VDEN---HGLCVVTKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDH-GVAYRDLNSQRILLD  318 (454)
Q Consensus       253 ~~~~---~~l~lV~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~qI~~gL~yLH~~-~iiHrDIKp~NILl~  318 (454)
                      ...+   ..+|||+|++ |.+|..+|.+.  +.++...+..|++||+.||.|||.. ||||-||||+|||+.
T Consensus       152 khsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~  222 (590)
T KOG1290|consen  152 KHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLC  222 (590)
T ss_pred             eecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence            8653   3499999999 56999998654  4799999999999999999999975 999999999999984

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.95  E-value=7.5e-28  Score=218.95  Aligned_cols=162  Identities=20%  Similarity=0.298  Sum_probs=128.8

Q ss_pred             CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCcccccCCC
Q 012887          269 GSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG  347 (454)
Q Consensus       269 gsL~~~l~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~gt  347 (454)
                      |||.+++.+. ..+++..++.++.||+.||.|||+++      ||+|||++.++.+|+  ||++.......     ..++
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~-----~~g~   67 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ-----SRVD   67 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecccc-----CCCc
Confidence            6999999764 47999999999999999999999998      999999999999999  99987654321     2578


Q ss_pred             CcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCC------CCCCccH--HHHH
Q 012887          348 YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPE------IPKDCPQ--ILKS  419 (454)
Q Consensus       348 ~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~------~p~~~~~--~l~~  419 (454)
                      +.|+|||++.+..++    .++|||||||++|||++|..||....................      .+...+.  ++.+
T Consensus        68 ~~y~aPE~~~~~~~~----~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  143 (176)
T smart00750       68 PYFMAPEVIQGQSYT----EKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFAD  143 (176)
T ss_pred             ccccChHHhcCCCCc----chhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHH
Confidence            999999999877544    469999999999999999999976544332222222222221      1223334  6999


Q ss_pred             HHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 012887          420 LMIKCWNNSPSKRPQFSEIISLLLRTNN  447 (454)
Q Consensus       420 li~~cl~~dP~~RPs~~ell~~L~~~~~  447 (454)
                      +|.+||..+|.+||++.|++++++....
T Consensus       144 ~i~~cl~~~p~~Rp~~~~ll~~~~~~~~  171 (176)
T smart00750      144 FMRVCASRLPQRREAANHYLAHCRALFA  171 (176)
T ss_pred             HHHHHHhcccccccCHHHHHHHHHHHHH
Confidence            9999999999999999999999987754

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.95  E-value=3e-28  Score=271.60  Aligned_cols=197  Identities=14%  Similarity=0.186  Sum_probs=140.4

Q ss_pred             CCC-CceeEEEEEEEe------CCCeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCcc
Q 012887          240 CGH-KNILQFYCVCVD------ENHGLCVVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLN  311 (454)
Q Consensus       240 l~H-pnIv~~~g~~~~------~~~~l~lV~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIK  311 (454)
                      +.| +||.+++++|..      .+..++.+||++ +++|.+++... ..+++..+..++.||+.||.|||++||+|||||
T Consensus        29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlK  107 (793)
T PLN00181         29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVR  107 (793)
T ss_pred             hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCC
Confidence            345 577777777621      112377889988 55999999653 469999999999999999999999999999999


Q ss_pred             CCcEEEccC-------------------CcEEEEccCCccccccCCC----------------cccccCCCCcccccccc
Q 012887          312 SQRILLDRH-------------------GNVCLGDMGIVTACKSVGE----------------ATEYETDGYRWLAPEII  356 (454)
Q Consensus       312 p~NILl~~~-------------------~~vKL~DFGla~~~~~~~~----------------~~~~~~gt~~y~APE~l  356 (454)
                      |+||||+..                   +.+|++|||+++.......                ......+|+.|||||++
T Consensus       108 P~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~  187 (793)
T PLN00181        108 PSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEED  187 (793)
T ss_pred             chhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhh
Confidence            999999654                   4556666666553211000                00112467889999999


Q ss_pred             cCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhcccCCCCCCCHH
Q 012887          357 AGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFS  436 (454)
Q Consensus       357 ~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~  436 (454)
                      .+..+    +.++|||||||+||||++|.+|+.....  ....+.....++..+ ...+....++.+||+.||.+||++.
T Consensus       188 ~~~~~----~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~~~~~~~~-~~~~~~~~~~~~~L~~~P~~Rps~~  260 (793)
T PLN00181        188 NGSSS----NCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHRVLPPQIL-LNWPKEASFCLWLLHPEPSCRPSMS  260 (793)
T ss_pred             ccCCC----CchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHhhcChhhh-hcCHHHHHHHHHhCCCChhhCcChH
Confidence            87754    4569999999999999999888764221  122222211122111 2245567899999999999999999


Q ss_pred             HHHHHHHh
Q 012887          437 EIISLLLR  444 (454)
Q Consensus       437 ell~~L~~  444 (454)
                      |++++-+-
T Consensus       261 eil~h~~~  268 (793)
T PLN00181        261 ELLQSEFI  268 (793)
T ss_pred             HHhhchhh
Confidence            99987654

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.94  E-value=1.4e-27  Score=223.85  Aligned_cols=248  Identities=16%  Similarity=0.245  Sum_probs=178.8

Q ss_pred             CCEEEeceeeccCCceEEEeE------EEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEEEEEEEeCCCeEEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVDENHGLCVV  262 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g~------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~~~g~~~~~~~~l~lV  262 (454)
                      +.|.+.+.||+|.||.+-+++      .+++|...   .......++.+|..----| .|.||+.-|++.......+.++
T Consensus        24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp---~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~  100 (378)
T KOG1345|consen   24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVP---RPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV  100 (378)
T ss_pred             hhhhHHHHhcccceeeEEeeeccCCceEEEeeccC---cchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence            778999999999999999863      56777665   3334456677887643334 5899999886644443347899


Q ss_pred             EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEcc--CCcEEEEccCCccccccCCCc
Q 012887          263 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDR--HGNVCLGDMGIVTACKSVGEA  340 (454)
Q Consensus       263 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~--~~~vKL~DFGla~~~~~~~~~  340 (454)
                      +||++.|+|..-+.. ..+.+.....++.|+++|++|||++++||||||.+||||..  ...|||||||+.+.....   
T Consensus       101 qE~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t---  176 (378)
T KOG1345|consen  101 QEFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT---  176 (378)
T ss_pred             eccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCce---
Confidence            999999999987743 46889999999999999999999999999999999999953  337999999997654322   


Q ss_pred             ccccCCCCcccccccccCCC-CCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHHHHcCCCCCCCCC---c
Q 012887          341 TEYETDGYRWLAPEIIAGDP-ESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPV---QAAVGIAACGLRPEIPKD---C  413 (454)
Q Consensus       341 ~~~~~gt~~y~APE~l~~~~-~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~---~~~~~i~~~~~~~~~p~~---~  413 (454)
                      ..+..-+..|.|||.+.... .....+..+|+|.||+++|.++||.+||......   -.....-..+..+..|..   +
T Consensus       177 V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F~~f  256 (378)
T KOG1345|consen  177 VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKFNPF  256 (378)
T ss_pred             ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhhccc
Confidence            22333456689999775321 1112334589999999999999999999842211   111111122334455654   6


Q ss_pred             cHHHHHHHHHhcccCCCCCC---CHHHHHHHHHh
Q 012887          414 PQILKSLMIKCWNNSPSKRP---QFSEIISLLLR  444 (454)
Q Consensus       414 ~~~l~~li~~cl~~dP~~RP---s~~ell~~L~~  444 (454)
                      ++.+..+.++-|..+|.+|-   +.+....-+|.
T Consensus       257 s~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~  290 (378)
T KOG1345|consen  257 SEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWK  290 (378)
T ss_pred             CHHHHHHHHHhcCCcccccchhHHHHHHHHHHHH
Confidence            88999999999999999994   44444444443

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.93  E-value=1.4e-26  Score=228.69  Aligned_cols=242  Identities=21%  Similarity=0.330  Sum_probs=185.0

Q ss_pred             CCEEEeceeeccCCceEEEe---------EEEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEEEEEEEeCCCeE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG---------KRVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVDENHGL  259 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g---------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~~~g~~~~~~~~l  259 (454)
                      ..|..+++||.|+|+.||++         +.||+|.+......    ..+..|+..|..+ .+.||+++.+++..++. .
T Consensus        36 ~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p----~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~-v  110 (418)
T KOG1167|consen   36 NAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP----SRILNELEMLYRLGGSDNIIKLNGCFRNNDQ-V  110 (418)
T ss_pred             hhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc----hHHHHHHHHHHHhccchhhhcchhhhccCCe-e
Confidence            67888999999999999974         57999999754332    3477899988887 58999999999887776 9


Q ss_pred             EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccC-CcEEEEccCCccccccCC
Q 012887          260 CVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH-GNVCLGDMGIVTACKSVG  338 (454)
Q Consensus       260 ~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~-~~vKL~DFGla~~~~~~~  338 (454)
                      ++||||++.....++..   .++...+..++..+..||.++|.+|||||||||.|+|.+.. +.-.|.|||+|.......
T Consensus       111 ~ivlp~~~H~~f~~l~~---~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~  187 (418)
T KOG1167|consen  111 AIVLPYFEHDRFRDLYR---SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQ  187 (418)
T ss_pred             EEEecccCccCHHHHHh---cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHhhh
Confidence            99999999989888874   46788999999999999999999999999999999999864 568899999987211000


Q ss_pred             --------------C----------------c--------------ccccCCCCcccccccccCCCCCCCCCchhhHHHH
Q 012887          339 --------------E----------------A--------------TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSF  374 (454)
Q Consensus       339 --------------~----------------~--------------~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSl  374 (454)
                                    .                .              .....||++|.|||++..-+   .-+.++||||.
T Consensus       188 ~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~---~QttaiDiws~  264 (418)
T KOG1167|consen  188 QTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCP---RQTTAIDIWSA  264 (418)
T ss_pred             hhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhcc---CcCCccceeec
Confidence                          0                0              00114889999999998543   34557999999


Q ss_pred             HHHHHHHHcCCCCCCCCCHH-HHHHHHH------------H-cCC-----------------------------------
Q 012887          375 GMVIWEMVTGEAAYAACSPV-QAAVGIA------------A-CGL-----------------------------------  405 (454)
Q Consensus       375 GviL~elltG~~Pf~~~~~~-~~~~~i~------------~-~~~-----------------------------------  405 (454)
                      |||+..++++.+||...... ..+..++            . .+.                                   
T Consensus       265 GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~  344 (418)
T KOG1167|consen  265 GVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNT  344 (418)
T ss_pred             cceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccce
Confidence            99999999999999632221 1111000            0 000                                   


Q ss_pred             -CCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 012887          406 -RPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL  442 (454)
Q Consensus       406 -~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L  442 (454)
                       +....+.+|..+.+++.+|++.||.+|.|+++.|.|-
T Consensus       345 ~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHp  382 (418)
T KOG1167|consen  345 EREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHP  382 (418)
T ss_pred             eeccccccccHHHHHHHHHHccCChhhcccHHHHhcCc
Confidence             0001123456899999999999999999999999763

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.93  E-value=6.8e-24  Score=205.24  Aligned_cols=248  Identities=23%  Similarity=0.383  Sum_probs=195.1

Q ss_pred             EEEeceeeccCCceEEEeEE---EEEEEeecCCCCch-HHHHHHHHHHHHHhCCCC-ceeEEEEEEEeCCCeEEEEEecc
Q 012887          192 LEFIDQIGPNSFKGVYKGKR---VGIEKLKGCDKGNA-YEFELRKDLLELMTCGHK-NILQFYCVCVDENHGLCVVTKLM  266 (454)
Q Consensus       192 ~~~~~~LG~G~fG~Vy~g~~---vavK~l~~~~~~~~-~~~~~~~Ei~~l~~l~Hp-nIv~~~g~~~~~~~~l~lV~E~~  266 (454)
                      |.+.+.||.|+||.||++..   +++|.+........ ....+.+|+..+..+.|+ +++++++.+..... .+++++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~-~~~~~~~~   80 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGS-LYLVMEYV   80 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEeccEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCE-EEEEEecC
Confidence            67889999999999999864   58888875544443 566788999999999887 79999999965554 79999999


Q ss_pred             CCCCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCC-cEEEEccCCccccccCCC---
Q 012887          267 EGGSVNDLILKSR---KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG-NVCLGDMGIVTACKSVGE---  339 (454)
Q Consensus       267 ~~gsL~~~l~~~~---~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~-~vKL~DFGla~~~~~~~~---  339 (454)
                      .++++.+++....   .++......++.|++.++.|+|+.+++|||+||+||+++..+ .++++|||++........   
T Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~  160 (384)
T COG0515          81 DGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSS  160 (384)
T ss_pred             CCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcccc
Confidence            9999998876654   799999999999999999999999999999999999999998 799999999875544332   


Q ss_pred             ---cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHHHcCCCC----CC
Q 012887          340 ---ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSP---VQAAVGIAACGLRP----EI  409 (454)
Q Consensus       340 ---~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~---~~~~~~i~~~~~~~----~~  409 (454)
                         ......++..|+|||.+.+.. .......+|+||+|++++++++|..||.....   .............+    ..
T Consensus       161 ~~~~~~~~~~t~~~~~pe~~~~~~-~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (384)
T COG0515         161 IPALPSTSVGTPGYMAPEVLLGLS-LAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPL  239 (384)
T ss_pred             ccccccccccccccCCHHHhcCCC-CCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCccccccc
Confidence               235557889999999998731 01233459999999999999999999887653   23333333222222    11


Q ss_pred             CCCc----cHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012887          410 PKDC----PQILKSLMIKCWNNSPSKRPQFSEIISL  441 (454)
Q Consensus       410 p~~~----~~~l~~li~~cl~~dP~~RPs~~ell~~  441 (454)
                      ....    ...+.+++..++..+|..|.+..+....
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         240 SPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             CccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            2222    2578999999999999999998887765

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.93  E-value=3.6e-24  Score=214.69  Aligned_cols=251  Identities=15%  Similarity=0.186  Sum_probs=189.5

Q ss_pred             CEEEeceeeccCCceEEEeE-------EEEEEEeecCCCCchHHHHHHHHHHHHHhCC----CCceeEEEEEEE-eCCCe
Q 012887          191 NLEFIDQIGPNSFKGVYKGK-------RVGIEKLKGCDKGNAYEFELRKDLLELMTCG----HKNILQFYCVCV-DENHG  258 (454)
Q Consensus       191 ~~~~~~~LG~G~fG~Vy~g~-------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~----HpnIv~~~g~~~-~~~~~  258 (454)
                      .|.+.+.||+|+||.||.+.       .+|+|...........  .+..|..++..+.    -+++..+++... .+.. 
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~--~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~-   95 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS--VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF-   95 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc--cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce-
Confidence            78999999999999999974       4667766543222211  4556666666664    268888888874 4444 


Q ss_pred             EEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccC-----CcEEEEccCCc
Q 012887          259 LCVVTKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH-----GNVCLGDMGIV  331 (454)
Q Consensus       259 l~lV~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~-----~~vKL~DFGla  331 (454)
                      -++||+.+ |.||.++....  +.++......++.|++.+|++||+.|++||||||.|+++...     ..+.|.|||++
T Consensus        96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla  174 (322)
T KOG1164|consen   96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA  174 (322)
T ss_pred             eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence            78999998 67999988443  589999999999999999999999999999999999999865     35899999999


Q ss_pred             c--ccccCC-C------c-ccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Q 012887          332 T--ACKSVG-E------A-TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIA  401 (454)
Q Consensus       332 ~--~~~~~~-~------~-~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~  401 (454)
                      +  ...... .      . .....||.+|+++....+...+..    .|+||++.++.+++.|..||.............
T Consensus       175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~----DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~  250 (322)
T KOG1164|consen  175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRR----DDLESLFYMLLELLKGSLPWEALEMTDLKSKFE  250 (322)
T ss_pred             ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCc----hhhhhHHHHHHHHhcCCCCCccccccchHHHHH
Confidence            8  321111 1      1 223458999999999988765554    899999999999999999997755432222222


Q ss_pred             HcCCCCC---CCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCCC
Q 012887          402 ACGLRPE---IPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNIS  449 (454)
Q Consensus       402 ~~~~~~~---~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~  449 (454)
                      .......   .....+.++..++..+-..+...+|.+..+...|+......
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~  301 (322)
T KOG1164|consen  251 KDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE  301 (322)
T ss_pred             HHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence            2111111   34456788889988888899999999999999988776543

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.92  E-value=8.7e-26  Score=211.73  Aligned_cols=249  Identities=23%  Similarity=0.462  Sum_probs=204.2

Q ss_pred             cCCCEEEeceeeccCCceEEEeE----EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEE
Q 012887          188 NSDNLEFIDQIGPNSFKGVYKGK----RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  263 (454)
Q Consensus       188 ~~~~~~~~~~LG~G~fG~Vy~g~----~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~  263 (454)
                      +-.++.++-+|.....|..|+|+    .+.+|.+...........++..|.-.|+-..||||+.++|+|....+ +.++.
T Consensus       188 d~~~lnl~tkl~e~hsgelwrgrwqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppn-lv~is  266 (448)
T KOG0195|consen  188 DVSSLNLITKLAESHSGELWRGRWQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPN-LVIIS  266 (448)
T ss_pred             chhhhhhhhhhccCCCcccccccccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCC-ceEee
Confidence            34556677788888889999875    46677776554444444567788888888899999999999999887 88999


Q ss_pred             eccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhcC--cccCCccCCcEEEccCCcEEEE--ccCCccccccC
Q 012887          264 KLMEGGSVNDLILKSR--KLQTKEIIRIAIDVAEGIKFLNDHG--VAYRDLNSQRILLDRHGNVCLG--DMGIVTACKSV  337 (454)
Q Consensus       264 E~~~~gsL~~~l~~~~--~l~~~~~~~i~~qI~~gL~yLH~~~--iiHrDIKp~NILl~~~~~vKL~--DFGla~~~~~~  337 (454)
                      .||+.|||+..+....  ..+..++.+++.+|++||.|||+..  |.---|.+..++||++.+.+|+  |--++.     
T Consensus       267 q~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsf-----  341 (448)
T KOG0195|consen  267 QYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSF-----  341 (448)
T ss_pred             eeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeee-----
Confidence            9999999999996544  5788899999999999999999874  3344788999999999887764  322211     


Q ss_pred             CCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHH
Q 012887          338 GEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQIL  417 (454)
Q Consensus       338 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l  417 (454)
                        +.....-.|.||+||.+...+.... -.++|+|||++++||+.|...||...++.+.--++...+.+..+|+.++..+
T Consensus       342 --qe~gr~y~pawmspealqrkped~n-~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~hm  418 (448)
T KOG0195|consen  342 --QEVGRAYSPAWMSPEALQRKPEDLN-IRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISRHM  418 (448)
T ss_pred             --eccccccCcccCCHHHHhcCchhcc-hhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccHHH
Confidence              1222234678999999987655432 2468999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 012887          418 KSLMIKCWNNSPSKRPQFSEIISLLLRT  445 (454)
Q Consensus       418 ~~li~~cl~~dP~~RPs~~ell~~L~~~  445 (454)
                      ..||.-|++.||.+||.|..|+-.|++.
T Consensus       419 ~klm~icmnedpgkrpkfdmivpilekm  446 (448)
T KOG0195|consen  419 NKLMNICMNEDPGKRPKFDMIVPILEKM  446 (448)
T ss_pred             HHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence            9999999999999999999999888765

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.91  E-value=8.6e-24  Score=213.72  Aligned_cols=159  Identities=13%  Similarity=0.108  Sum_probs=123.2

Q ss_pred             CCCEEEeceeeccCCceEEEeE-------EEEEEEeecCCC---CchHHHHHHHHHHHHHhCCCCceeE-EEEEEEeCCC
Q 012887          189 SDNLEFIDQIGPNSFKGVYKGK-------RVGIEKLKGCDK---GNAYEFELRKDLLELMTCGHKNILQ-FYCVCVDENH  257 (454)
Q Consensus       189 ~~~~~~~~~LG~G~fG~Vy~g~-------~vavK~l~~~~~---~~~~~~~~~~Ei~~l~~l~HpnIv~-~~g~~~~~~~  257 (454)
                      .++|.+.+.||+|+||.||+|.       .+|||++.....   .......+.+|+.+|..++|+|++. ++++    +.
T Consensus        17 ~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~~   92 (365)
T PRK09188         17 SARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----GK   92 (365)
T ss_pred             cCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----CC
Confidence            4789999999999999999873       468988753211   2223456889999999999999985 4432    33


Q ss_pred             eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCc-cCCcEEEccCCcEEEEccCCcccccc
Q 012887          258 GLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDL-NSQRILLDRHGNVCLGDMGIVTACKS  336 (454)
Q Consensus       258 ~l~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDI-Kp~NILl~~~~~vKL~DFGla~~~~~  336 (454)
                       .|+||||++|++|... ..   ..   ...++.|++.||.|||++||+|||| ||+|||++.++.+||+|||+++....
T Consensus        93 -~~LVmE~~~G~~L~~~-~~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~  164 (365)
T PRK09188         93 -DGLVRGWTEGVPLHLA-RP---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRR  164 (365)
T ss_pred             -cEEEEEccCCCCHHHh-Cc---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceeccc
Confidence             7899999999999732 11   11   1467889999999999999999999 99999999999999999999987654


Q ss_pred             CCCc--------ccccCCCCcccccccccCC
Q 012887          337 VGEA--------TEYETDGYRWLAPEIIAGD  359 (454)
Q Consensus       337 ~~~~--------~~~~~gt~~y~APE~l~~~  359 (454)
                      .+..        .....+++.|+|||.+...
T Consensus       165 ~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        165 RGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             CcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            3321        1233567889999998743

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.90  E-value=6.9e-23  Score=197.11  Aligned_cols=251  Identities=17%  Similarity=0.254  Sum_probs=196.1

Q ss_pred             CCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEEEEEEEeCCCeEEE
Q 012887          189 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVDENHGLCV  261 (454)
Q Consensus       189 ~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~~~g~~~~~~~~l~l  261 (454)
                      .-+|+++++||+|+||..+.|      +.||||.-......    -++..|.+..+.| ..+.|...|-+..+..+ -.|
T Consensus        27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~A----PQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~-NiL  101 (449)
T KOG1165|consen   27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEA----PQLRDEYRTYKLLGGTEGIPQVYYFGQEGKY-NIL  101 (449)
T ss_pred             cccceeccccccCcceeeecccccccCceEEEEeccccCCc----chHHHHHHHHHHHcCCCCCCceeeeccccch-hhh
Confidence            357999999999999999987      58999976543332    3455666665555 46888888855555545 569


Q ss_pred             EEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCC-----cEEEEccCCccccc
Q 012887          262 VTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG-----NVCLGDMGIVTACK  335 (454)
Q Consensus       262 V~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~-----~vKL~DFGla~~~~  335 (454)
                      |||++ |.||+|+..-+ ++|+.+.++.++.|++.-++|+|++.+|+|||||+|.||...+     .+.|.|||+|+...
T Consensus       102 VidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr  180 (449)
T KOG1165|consen  102 VIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR  180 (449)
T ss_pred             hhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence            99999 77999999644 5899999999999999999999999999999999999997655     38899999999876


Q ss_pred             cCCCc-------ccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHHHcCC
Q 012887          336 SVGEA-------TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSP---VQAAVGIAACGL  405 (454)
Q Consensus       336 ~~~~~-------~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~---~~~~~~i~~~~~  405 (454)
                      ++...       .....||-+||+-....|...+.+    -|.-|||=++.+.+-|..||.+...   .+...+|-....
T Consensus       181 Dp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRR----DDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr  256 (449)
T KOG1165|consen  181 DPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRR----DDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKR  256 (449)
T ss_pred             CccccccCccccccccccceeeeEeeccccchhhhh----hhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccc
Confidence            65432       223478999999998888766655    8999999999999999999997543   333333322211


Q ss_pred             CC---CCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCCC
Q 012887          406 RP---EIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNIS  449 (454)
Q Consensus       406 ~~---~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~  449 (454)
                      ..   .+..++|.++..-|+..-..+-.+-|.++-+...+..+....
T Consensus       257 ~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~  303 (449)
T KOG1165|consen  257 STPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRL  303 (449)
T ss_pred             cCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhc
Confidence            11   245678999999999999999999999998888877766543

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.90  E-value=4e-23  Score=191.07  Aligned_cols=251  Identities=17%  Similarity=0.229  Sum_probs=192.3

Q ss_pred             ecCCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCC-CceeEEEEEEEeCCCeE
Q 012887          187 LNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGH-KNILQFYCVCVDENHGL  259 (454)
Q Consensus       187 ~~~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~H-pnIv~~~g~~~~~~~~l  259 (454)
                      +-...|.++++||+|+||.+|.|      ..||||.-.......    ++..|..+...+++ ..|..+..+..+.++ -
T Consensus        12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hp----qL~yEskvY~iL~~g~GiP~i~~y~~e~~y-n   86 (341)
T KOG1163|consen   12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHP----QLLYESKVYRILQGGVGIPHIRHYGTEKDY-N   86 (341)
T ss_pred             eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCc----chhHHHHHHHHhccCCCCchhhhhcccccc-c
Confidence            44588999999999999999984      689999887554443    23445455555543 555556656666665 6


Q ss_pred             EEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccC---CcEEEEccCCccccc
Q 012887          260 CVVTKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH---GNVCLGDMGIVTACK  335 (454)
Q Consensus       260 ~lV~E~~~~gsL~~~l~~-~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~---~~vKL~DFGla~~~~  335 (454)
                      .+||+++ |.||+++..= .+.++.++.+-++-|++.-++|+|.+++|||||||+|.|..-+   ..+-|+|||+|+...
T Consensus        87 vlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~  165 (341)
T KOG1163|consen   87 VLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR  165 (341)
T ss_pred             eeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhc
Confidence            7999999 7799999863 4589999999999999999999999999999999999998644   358899999998876


Q ss_pred             cCCCc-------ccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHH---HHHHHHcCC
Q 012887          336 SVGEA-------TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQA---AVGIAACGL  405 (454)
Q Consensus       336 ~~~~~-------~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~---~~~i~~~~~  405 (454)
                      +....       ....+||.+|.+-....+...+.+    -|+-|+|.+|..+--|..||.+..+...   ...|.....
T Consensus       166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRR----DDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~  241 (341)
T KOG1163|consen  166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRR----DDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKM  241 (341)
T ss_pred             cccccccCccccCCccceeeeehhhhhhhhhhhhhh----hhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhc
Confidence            54322       334478999999887776654444    7999999999999999999998765432   233333222


Q ss_pred             CC---CCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 012887          406 RP---EIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNN  447 (454)
Q Consensus       406 ~~---~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~  447 (454)
                      .-   .+...+|.++.-.+..|-..--++-|.+.-|...+.-+..
T Consensus       242 s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr  286 (341)
T KOG1163|consen  242 STPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFR  286 (341)
T ss_pred             CCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHh
Confidence            21   2467889999999999999999999998877776655543

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.89  E-value=2e-24  Score=231.54  Aligned_cols=246  Identities=17%  Similarity=0.254  Sum_probs=183.3

Q ss_pred             EEeceeeccCCceEEEeEEE------EEEEee----cCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEE
Q 012887          193 EFIDQIGPNSFKGVYKGKRV------GIEKLK----GCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  262 (454)
Q Consensus       193 ~~~~~LG~G~fG~Vy~g~~v------avK~l~----~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV  262 (454)
                      .....+|.|++|.|+....+      +.|..+    ...........+..|+.+-..+.|||++..+..+.+.+. ..-+
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~-~~~~  399 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDG-ILQS  399 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhccc-chhh
Confidence            45678999999977764322      222221    111112222225556666667899999888777766654 4455


Q ss_pred             EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCC---
Q 012887          263 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE---  339 (454)
Q Consensus       263 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~---  339 (454)
                      ||||++ +|..++.+...+....+-.++.|++.|+.|||++||.|||+|++|+++..+|.+||+|||.+.......+   
T Consensus       400 mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~  478 (601)
T KOG0590|consen  400 MEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNI  478 (601)
T ss_pred             hhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchhh
Confidence            999999 9999998777899999999999999999999999999999999999999999999999999765544333   


Q ss_pred             -cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHH-HHHHHcCCC------CCCCC
Q 012887          340 -ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAA-VGIAACGLR------PEIPK  411 (454)
Q Consensus       340 -~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~-~~i~~~~~~------~~~p~  411 (454)
                       ......|+-.|+|||.+.+..|.+.   ..||||.|+++..|++|+.||......... ......+..      ..+..
T Consensus       479 ~~~~g~~gS~pY~apE~~~~~~ydpr---~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~  555 (601)
T KOG0590|consen  479 HESSGIVGSDPYLAPEVLTGKEYDPR---AVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLS  555 (601)
T ss_pred             hhhcCcccCCcCcCcccccccccCcc---hhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHH
Confidence             2334467788999999999988776   489999999999999999999753333221 111111111      11223


Q ss_pred             CccHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 012887          412 DCPQILKSLMIKCWNNSPSKRPQFSEIISLLL  443 (454)
Q Consensus       412 ~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~  443 (454)
                      .+|.+.+.+|.++|+.||.+|.|+++|++.=|
T Consensus       556 ~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W  587 (601)
T KOG0590|consen  556 LLPRETRIIIYRMLQLDPTKRITIEQILNDEW  587 (601)
T ss_pred             hchhhHHHHHHHHccCChhheecHHHHhhChH
Confidence            46788999999999999999999999997654

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.88  E-value=2.8e-22  Score=196.74  Aligned_cols=199  Identities=21%  Similarity=0.306  Sum_probs=149.0

Q ss_pred             CCCceeEEEEEEEe--------------------------CCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHH
Q 012887          241 GHKNILQFYCVCVD--------------------------ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVA  294 (454)
Q Consensus       241 ~HpnIv~~~g~~~~--------------------------~~~~l~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~  294 (454)
                      +|||||++.++|.+                          ++..+|+||.-++. +|.+++-. ...+.....-++.|++
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~-~~~s~r~~~~~laQlL  351 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWT-RHRSYRTGRVILAQLL  351 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhc-CCCchHHHHHHHHHHH
Confidence            69999999988875                          23348999999977 99999843 3456667778889999


Q ss_pred             HHHHHHHhcCcccCCccCCcEEEc--cCC--cEEEEccCCccccccCCCc------ccccCCCCcccccccccCCCCCC-
Q 012887          295 EGIKFLNDHGVAYRDLNSQRILLD--RHG--NVCLGDMGIVTACKSVGEA------TEYETDGYRWLAPEIIAGDPESV-  363 (454)
Q Consensus       295 ~gL~yLH~~~iiHrDIKp~NILl~--~~~--~vKL~DFGla~~~~~~~~~------~~~~~gt~~y~APE~l~~~~~~~-  363 (454)
                      +|..|||.+||.|||+|++|||+.  +++  .+.|+|||.+-....-+-.      .....|.-.-||||+....+-.. 
T Consensus       352 Eav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~a  431 (598)
T KOG4158|consen  352 EAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNA  431 (598)
T ss_pred             HHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCce
Confidence            999999999999999999999994  344  4789999987554432211      11223556789999886432211 


Q ss_pred             -CCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012887          364 -SETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISL  441 (454)
Q Consensus       364 -~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  441 (454)
                       -.-.|.|.|+.|.+.||++....||.+........+..+...-|.+|+.+|+.+++++...|+.||++|++..-....
T Consensus       432 vvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAANv  510 (598)
T KOG4158|consen  432 VVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANV  510 (598)
T ss_pred             eeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCccHHHhH
Confidence             111368999999999999999999987444333223333344567899999999999999999999999996654443

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.88  E-value=1.8e-23  Score=216.08  Aligned_cols=221  Identities=20%  Similarity=0.355  Sum_probs=178.5

Q ss_pred             eeccCCceEEE---------eEEEEEEEeecCCCCchHHHHHHHHHHHHHhCC-CCceeEEEEEEEeCCCeEEEEEeccC
Q 012887          198 IGPNSFKGVYK---------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCG-HKNILQFYCVCVDENHGLCVVTKLME  267 (454)
Q Consensus       198 LG~G~fG~Vy~---------g~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~~~g~~~~~~~~l~lV~E~~~  267 (454)
                      +|.|+||.|++         |..+|.|.++..............|-.++...+ ||.+|++.-.+..+.. +++++++..
T Consensus         2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~k-l~l~ld~~r   80 (612)
T KOG0603|consen    2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGK-LYLILDFLR   80 (612)
T ss_pred             CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccc-hhHhhhhcc
Confidence            79999999997         234556655433221111113334445566665 9999999988887776 999999999


Q ss_pred             CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCcccccCCC
Q 012887          268 GGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG  347 (454)
Q Consensus       268 ~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~gt  347 (454)
                      ||.|...+.+...+.+.....+...++-+++++|+.+++|||+|++||+++.+|++++.|||+++........    +||
T Consensus        81 gg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~----cgt  156 (612)
T KOG0603|consen   81 GGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA----CGT  156 (612)
T ss_pred             cchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc----ccc
Confidence            9999999877778999999999999999999999999999999999999999999999999998876543222    889


Q ss_pred             CcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhccc
Q 012887          348 YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNN  427 (454)
Q Consensus       348 ~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~li~~cl~~  427 (454)
                      +.|||||++++.  .    .++|.||||++++||++|..||..    +....|..  ..+..|...+..+.+++..++..
T Consensus       157 ~eymApEI~~gh--~----~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~--~~~~~p~~l~~~a~~~~~~l~~r  224 (612)
T KOG0603|consen  157 YEYRAPEIINGH--L----SAADWWSFGVLAFELLTGTLPFGG----DTMKRILK--AELEMPRELSAEARSLFRQLFKR  224 (612)
T ss_pred             hhhhhhHhhhcc--C----CcccchhhhhhHHHHhhCCCCCch----HHHHHHhh--hccCCchhhhHHHHHHHHHHHhh
Confidence            999999999843  2    237999999999999999999988    44444544  34568889999999999999999


Q ss_pred             CCCCCCCH
Q 012887          428 SPSKRPQF  435 (454)
Q Consensus       428 dP~~RPs~  435 (454)
                      +|.+|.-.
T Consensus       225 ~p~nrLg~  232 (612)
T KOG0603|consen  225 NPENRLGA  232 (612)
T ss_pred             CHHHHhcc
Confidence            99999765

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.86  E-value=1.7e-21  Score=201.13  Aligned_cols=211  Identities=26%  Similarity=0.431  Sum_probs=166.4

Q ss_pred             HhCCCCceeEEEEEEEeCCCeEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCc-ccCCccCCcE
Q 012887          238 MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGV-AYRDLNSQRI  315 (454)
Q Consensus       238 ~~l~HpnIv~~~g~~~~~~~~l~lV~E~~~~gsL~~~l~~-~~~l~~~~~~~i~~qI~~gL~yLH~~~i-iHrDIKp~NI  315 (454)
                      +.+.|.|+.+++|.+.+... +++|.+||..|+|.|.+.. ...+++.-...++.+|+.||.|||...| .|+.+++.|+
T Consensus         2 ~~l~h~n~~~f~g~~~~~~~-~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC   80 (484)
T KOG1023|consen    2 RQLDHDNLNKFIGASVDGPE-MIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC   80 (484)
T ss_pred             cccchhhhhhheeeEecCCc-eEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence            45789999999999999866 8999999999999999966 3478888899999999999999998866 8999999999


Q ss_pred             EEccCCcEEEEccCCccccccCCC--cccccCCCCcccccccccCCCCCCC---CCchhhHHHHHHHHHHHHcCCCCCCC
Q 012887          316 LLDRHGNVCLGDMGIVTACKSVGE--ATEYETDGYRWLAPEIIAGDPESVS---ETWMSNVYSFGMVIWEMVTGEAAYAA  390 (454)
Q Consensus       316 Ll~~~~~vKL~DFGla~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~---~~~ksDVwSlGviL~elltG~~Pf~~  390 (454)
                      +++....+||+|||+.........  ......-...|.|||.+.+......   .+.+.||||||++++|+++...||..
T Consensus        81 lvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~  160 (484)
T KOG1023|consen   81 LVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDL  160 (484)
T ss_pred             eeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccc
Confidence            999999999999999665532111  1111112356999999987543332   46679999999999999999999975


Q ss_pred             C----CHHHHHHHHHHcCC---CCCCC-C-CccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCCC
Q 012887          391 C----SPVQAAVGIAACGL---RPEIP-K-DCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNIS  449 (454)
Q Consensus       391 ~----~~~~~~~~i~~~~~---~~~~p-~-~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~  449 (454)
                      .    .+.+.+..+...+.   +|.+. . ..++++..++.+||..+|.+||+++.+-..+...+...
T Consensus       161 ~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~~  228 (484)
T KOG1023|consen  161 RNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKGG  228 (484)
T ss_pred             ccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcccc
Confidence            2    33344444444222   33332 1 35668999999999999999999999999999888754

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.85  E-value=1.7e-21  Score=180.70  Aligned_cols=137  Identities=15%  Similarity=0.093  Sum_probs=104.8

Q ss_pred             eceeeccCCceEEEe-----EEEEEEEeecCCCCchH------------------------HHHHHHHHHHHHhCCCCce
Q 012887          195 IDQIGPNSFKGVYKG-----KRVGIEKLKGCDKGNAY------------------------EFELRKDLLELMTCGHKNI  245 (454)
Q Consensus       195 ~~~LG~G~fG~Vy~g-----~~vavK~l~~~~~~~~~------------------------~~~~~~Ei~~l~~l~HpnI  245 (454)
                      ...||+|+||.||+|     +.||+|.++........                        ......|+..+..+.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            467999999999985     58999999754221111                        1123458888888876665


Q ss_pred             eEEEEEEEeCCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHH-HhcCcccCCccCCcEEEccCCcEE
Q 012887          246 LQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL-NDHGVAYRDLNSQRILLDRHGNVC  324 (454)
Q Consensus       246 v~~~g~~~~~~~~l~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yL-H~~~iiHrDIKp~NILl~~~~~vK  324 (454)
                      .....+. ..+  .+|||||++++++.....+...++...+..++.|++.+|.|| |+.||+||||||+|||++ ++.++
T Consensus        82 ~~p~~~~-~~~--~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~  157 (190)
T cd05147          82 PCPEPIL-LKS--HVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLY  157 (190)
T ss_pred             CCCcEEE-ecC--CEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEE
Confidence            3322221 122  379999999988776544556899999999999999999999 799999999999999998 58899


Q ss_pred             EEccCCccccc
Q 012887          325 LGDMGIVTACK  335 (454)
Q Consensus       325 L~DFGla~~~~  335 (454)
                      |+|||++....
T Consensus       158 LiDFG~a~~~~  168 (190)
T cd05147         158 IIDVSQSVEHD  168 (190)
T ss_pred             EEEccccccCC
Confidence            99999987543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.84  E-value=2.9e-20  Score=172.42  Aligned_cols=138  Identities=15%  Similarity=0.122  Sum_probs=106.7

Q ss_pred             eceeeccCCceEEEe-----EEEEEEEeecCCCCch------------------------HHHHHHHHHHHHHhCCCCce
Q 012887          195 IDQIGPNSFKGVYKG-----KRVGIEKLKGCDKGNA------------------------YEFELRKDLLELMTCGHKNI  245 (454)
Q Consensus       195 ~~~LG~G~fG~Vy~g-----~~vavK~l~~~~~~~~------------------------~~~~~~~Ei~~l~~l~HpnI  245 (454)
                      .+.||+|+||.||+|     +.||+|.++.......                        ......+|...+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            467999999999985     5899999875422100                        01224578888888888887


Q ss_pred             eEEEEEEEeCCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-cCcccCCccCCcEEEccCCcEE
Q 012887          246 LQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLND-HGVAYRDLNSQRILLDRHGNVC  324 (454)
Q Consensus       246 v~~~g~~~~~~~~l~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~-~~iiHrDIKp~NILl~~~~~vK  324 (454)
                      .....+....   .++||||++|+++.........++......++.|++.+|.+||+ +||+||||||+|||++ ++.++
T Consensus        82 ~~p~~~~~~~---~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~~  157 (190)
T cd05145          82 PVPEPILLKK---NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKPY  157 (190)
T ss_pred             CCceEEEecC---CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCEE
Confidence            5444333322   47999999988665443344578889999999999999999999 9999999999999999 89999


Q ss_pred             EEccCCcccccc
Q 012887          325 LGDMGIVTACKS  336 (454)
Q Consensus       325 L~DFGla~~~~~  336 (454)
                      |+|||++.....
T Consensus       158 liDFG~a~~~~~  169 (190)
T cd05145         158 IIDVSQAVELDH  169 (190)
T ss_pred             EEEcccceecCC
Confidence            999999876543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.83  E-value=1.7e-20  Score=177.66  Aligned_cols=169  Identities=11%  Similarity=0.095  Sum_probs=126.7

Q ss_pred             CCCEEEeceeeccCCceEEEe----EEEEEEEeecCCCCchHH-H------HHHHHHHHHHhCCCCceeEEEEEEEeCC-
Q 012887          189 SDNLEFIDQIGPNSFKGVYKG----KRVGIEKLKGCDKGNAYE-F------ELRKDLLELMTCGHKNILQFYCVCVDEN-  256 (454)
Q Consensus       189 ~~~~~~~~~LG~G~fG~Vy~g----~~vavK~l~~~~~~~~~~-~------~~~~Ei~~l~~l~HpnIv~~~g~~~~~~-  256 (454)
                      ..+|+.++.||.|+||.||..    ..+++|.+.......... .      .+++|+..+.++.|++|.....++.... 
T Consensus        30 ~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~  109 (232)
T PRK10359         30 SYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAER  109 (232)
T ss_pred             hCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeeccc
Confidence            478999999999999999984    469999987544333221 1      1578888999999999999988866442 


Q ss_pred             ------CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCC
Q 012887          257 ------HGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGI  330 (454)
Q Consensus       257 ------~~l~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGl  330 (454)
                            ...++||||++|.+|.++.    .+++    ....+++.+|..||+.|++|||+||+||+++.+| ++|+|||.
T Consensus       110 ~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDfg~  180 (232)
T PRK10359        110 KTLRYAHTYIMLIEYIEGVELNDMP----EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDLSG  180 (232)
T ss_pred             ccccccCCeEEEEEEECCccHHHhh----hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEECCC
Confidence                  2378999999999998873    2333    2456999999999999999999999999999988 99999998


Q ss_pred             ccccccCCCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHH
Q 012887          331 VTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMV  382 (454)
Q Consensus       331 a~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ell  382 (454)
                      ............            +.....+.    .++|+||||+++..+.
T Consensus       181 ~~~~~e~~a~d~------------~vler~y~----~~~di~~lg~~~~~~~  216 (232)
T PRK10359        181 KRCTAQRKAKDR------------IDLERHYG----IKNEIKDLGYYLLIYK  216 (232)
T ss_pred             cccccchhhHHH------------HHHHhHhc----ccccccceeEeehHHH
Confidence            655422111110            22222222    3589999999887654

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.83  E-value=4.3e-20  Score=171.83  Aligned_cols=183  Identities=11%  Similarity=0.065  Sum_probs=130.9

Q ss_pred             EeceeeccCCceEEEeE----EEEEEEeecCCCCch--HHHHHHHHHHHHHhCC-CCceeEEEEEEEeCCCeEEEEEecc
Q 012887          194 FIDQIGPNSFKGVYKGK----RVGIEKLKGCDKGNA--YEFELRKDLLELMTCG-HKNILQFYCVCVDENHGLCVVTKLM  266 (454)
Q Consensus       194 ~~~~LG~G~fG~Vy~g~----~vavK~l~~~~~~~~--~~~~~~~Ei~~l~~l~-HpnIv~~~g~~~~~~~~l~lV~E~~  266 (454)
                      +...|++|+||+||...    +++.+.+.....-..  ....+.+|+.+|.++. |+++.+++++    +. .+++|||+
T Consensus         6 ~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~-~~lvmeyI   80 (218)
T PRK12274          6 VNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DG-RHLDRSYL   80 (218)
T ss_pred             cceeecCCCcceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cC-EEEEEeee
Confidence            45679999999999854    444444442222111  1224789999999995 5889999886    22 78999999


Q ss_pred             CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCc-cCCcEEEccCCcEEEEccCCccccccCCCc-----
Q 012887          267 EGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDL-NSQRILLDRHGNVCLGDMGIVTACKSVGEA-----  340 (454)
Q Consensus       267 ~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDI-Kp~NILl~~~~~vKL~DFGla~~~~~~~~~-----  340 (454)
                      .|.+|.+.+..      . ...++.|++.+|+++|++||+|||| ||.|||++.+|.++|+|||++.........     
T Consensus        81 ~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~  153 (218)
T PRK12274         81 AGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLA  153 (218)
T ss_pred             cCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHH
Confidence            99998764321      1 1357789999999999999999999 799999999999999999999865543321     


Q ss_pred             --------ccccCCCCcccccccccCCCCCCCCCc-hhhHHHHHHHHHHHHcCCCCCCCC
Q 012887          341 --------TEYETDGYRWLAPEIIAGDPESVSETW-MSNVYSFGMVIWEMVTGEAAYAAC  391 (454)
Q Consensus       341 --------~~~~~gt~~y~APE~l~~~~~~~~~~~-ksDVwSlGviL~elltG~~Pf~~~  391 (454)
                              +.....++.|+.|+...-..   ..++ +.+.++.|+-+|.++|+..|+.+.
T Consensus       154 ~rDl~~llk~~~~y~~~~l~~~~~~~l~---~~~~~~~~w~~~g~~~~~~~~~~~~~~~~  210 (218)
T PRK12274        154 REDLRHLLKHKRMYCPAALTPVERRVLK---RTSWIRELWFATGKPVYRFVTRRVLHWED  210 (218)
T ss_pred             HHHHHHHHHHHHhcCCCCCCHHHHhhhc---cchhHHHHHHHhcchHHHHHhccCCcccc
Confidence                    11113466677777554321   1232 457778999999999999887543

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.82  E-value=8e-21  Score=205.33  Aligned_cols=244  Identities=18%  Similarity=0.214  Sum_probs=173.0

Q ss_pred             CEEEeceeeccCCceEEEeE----EEEEEEeecCCCCch-H-HHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEEe
Q 012887          191 NLEFIDQIGPNSFKGVYKGK----RVGIEKLKGCDKGNA-Y-EFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTK  264 (454)
Q Consensus       191 ~~~~~~~LG~G~fG~Vy~g~----~vavK~l~~~~~~~~-~-~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~E  264 (454)
                      ++...+.||++.|=+|.+++    .|.||+.-..+..-. . -.+..+|++ ...++|||.+.+.-+-..+.. .|||-+
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kA-AylvRq  101 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKA-AYLVRQ  101 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHH-HHHHHH
Confidence            67889999999999999864    477887765442222 1 122334444 445689999999877554443 789999


Q ss_pred             ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccc--cCCC-cc
Q 012887          265 LMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK--SVGE-AT  341 (454)
Q Consensus       265 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~--~~~~-~~  341 (454)
                      |... +|+|.+..+..+...+..-|+.|++.||.-+|..||+|+|||.+||||+.-+-+-|+||.-.++.-  .++. .-
T Consensus       102 yvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPadf  180 (1431)
T KOG1240|consen  102 YVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPADF  180 (1431)
T ss_pred             HHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCcccc
Confidence            9976 999999777778888888999999999999999999999999999999999889999998755431  1111 11


Q ss_pred             cccCC----CCcccccccccCCC-------CCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHcC-CCCC
Q 012887          342 EYETD----GYRWLAPEIIAGDP-------ESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACG-LRPE  408 (454)
Q Consensus       342 ~~~~g----t~~y~APE~l~~~~-------~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~~  408 (454)
                      .+...    ..+|.|||.+....       .....+.+-||||+||++.||++ |++||.-    ..+......+ ..++
T Consensus       181 ~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L----SQL~aYr~~~~~~~e  256 (1431)
T KOG1240|consen  181 TFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL----SQLLAYRSGNADDPE  256 (1431)
T ss_pred             eEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH----HHHHhHhccCccCHH
Confidence            12222    24799999886421       11113457899999999999998 8999851    1111111110 0000


Q ss_pred             --CCCCccHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012887          409 --IPKDCPQILKSLMIKCWNNSPSKRPQFSEIISL  441 (454)
Q Consensus       409 --~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  441 (454)
                        +-.--+..++.++..|++.||++|.++++.++.
T Consensus       257 ~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  257 QLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             HHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence              000013468999999999999999999998875

>PRK10345 hypothetical protein; Provisional

Probab=99.81  E-value=1.1e-19  Score=170.93  Aligned_cols=131  Identities=13%  Similarity=0.166  Sum_probs=101.5

Q ss_pred             eceeeccCCceEEEeEE---EEEEEeecCCCCchHHHHHHHHHHHHHhC-----CCCceeEEEEEEEeCC--CeEE-EEE
Q 012887          195 IDQIGPNSFKGVYKGKR---VGIEKLKGCDKGNAYEFELRKDLLELMTC-----GHKNILQFYCVCVDEN--HGLC-VVT  263 (454)
Q Consensus       195 ~~~LG~G~fG~Vy~g~~---vavK~l~~~~~~~~~~~~~~~Ei~~l~~l-----~HpnIv~~~g~~~~~~--~~l~-lV~  263 (454)
                      .+.||+|+||.||....   .+||++....  ......+.+|+..+..+     .||||++++|++.++.  ..++ +||
T Consensus         7 ~~~LG~G~~~~Vy~hp~~~~k~IKv~~~~~--~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~   84 (210)
T PRK10345          7 QSPLGTGRHRKCYAHPEDAQRCIKIVYHRG--DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIA   84 (210)
T ss_pred             cceecCCCceEEEECCCCcCeEEEEEeccc--cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEe
Confidence            45799999999997321   2577665422  22345689999999988     6799999999998874  2233 789


Q ss_pred             ec--cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHH-HHHHhcCcccCCccCCcEEEccC----CcEEEEccCC
Q 012887          264 KL--MEGGSVNDLILKSRKLQTKEIIRIAIDVAEGI-KFLNDHGVAYRDLNSQRILLDRH----GNVCLGDMGI  330 (454)
Q Consensus       264 E~--~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL-~yLH~~~iiHrDIKp~NILl~~~----~~vKL~DFGl  330 (454)
                      ||  +.+|+|.+++.+ ..+++.  ..++.|++.++ +|||+++|+||||||+|||++..    +.++|+||+-
T Consensus        85 e~~G~~~~tL~~~l~~-~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G  155 (210)
T PRK10345         85 DFDGKPSITLTEFAEQ-CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIG  155 (210)
T ss_pred             cCCCCcchhHHHHHHc-ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence            99  557999999965 346665  35678888888 99999999999999999999743    3799999544

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.80  E-value=1.6e-19  Score=175.97  Aligned_cols=232  Identities=16%  Similarity=0.232  Sum_probs=142.3

Q ss_pred             CEEEeceeeccCCceEEEe------EEEEEEEeecCCCCch-HHHHHHHHHHHHHhCC----------CCceeEEEEEEE
Q 012887          191 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNA-YEFELRKDLLELMTCG----------HKNILQFYCVCV  253 (454)
Q Consensus       191 ~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~-~~~~~~~Ei~~l~~l~----------HpnIv~~~g~~~  253 (454)
                      .+.....||.|+|+.||.+      +.+|+|.......... ...++.+|......+.          |-.++.-++...
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            4577889999999999984      6889998765443222 3344555543332211          111221111111


Q ss_pred             e---------C---C-C---eEEEEEeccCCCCHHHHHH---hCCC----CCHHHHHHHHHHHHHHHHHHHhcCcccCCc
Q 012887          254 D---------E---N-H---GLCVVTKLMEGGSVNDLIL---KSRK----LQTKEIIRIAIDVAEGIKFLNDHGVAYRDL  310 (454)
Q Consensus       254 ~---------~---~-~---~l~lV~E~~~~gsL~~~l~---~~~~----l~~~~~~~i~~qI~~gL~yLH~~~iiHrDI  310 (454)
                      -         .   . .   +.+++|+-+.+ +|.+++.   ....    +.......+..|+++.+++||++|++|+||
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~-dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi  171 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQG-DLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI  171 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE--SE-EHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred             EcCCCcceecCCCCccceeehhhhccchhhh-cHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence            1         0   0 0   14678888855 9988863   2221    223344556689999999999999999999


Q ss_pred             cCCcEEEccCCcEEEEccCCccccccCCCcccccCCCCcccccccccCC----CCCCCCCchhhHHHHHHHHHHHHcCCC
Q 012887          311 NSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGD----PESVSETWMSNVYSFGMVIWEMVTGEA  386 (454)
Q Consensus       311 Kp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~----~~~~~~~~ksDVwSlGviL~elltG~~  386 (454)
                      +|+|+|++.+|.+.|+||+........   ......+..|.|||.....    .....++.+.|.|+||+++|.|.+|..
T Consensus       172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~---~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l  248 (288)
T PF14531_consen  172 KPENFLLDQDGGVFLGDFSSLVRAGTR---YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL  248 (288)
T ss_dssp             SGGGEEE-TTS-EEE--GGGEEETTEE---EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred             ceeeEEEcCCCCEEEcChHHHeecCce---eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence            999999999999999999886654432   1112344668899976432    122346678999999999999999999


Q ss_pred             CCCCCCHHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhcccCCCCC
Q 012887          387 AYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKR  432 (454)
Q Consensus       387 Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~R  432 (454)
                      ||....+......      ......++|+.++.||+.+|+.+|.+|
T Consensus       249 Pf~~~~~~~~~~~------~f~~C~~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  249 PFGLSSPEADPEW------DFSRCRDMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             STCCCGGGSTSGG------GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred             CCCCCCccccccc------cchhcCCcCHHHHHHHHHHccCCcccC
Confidence            9986544321110      122333789999999999999999988

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.79  E-value=2.2e-19  Score=194.23  Aligned_cols=202  Identities=20%  Similarity=0.318  Sum_probs=145.9

Q ss_pred             CCCEEEeceeeccCCceEEEeE------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEE
Q 012887          189 SDNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  262 (454)
Q Consensus       189 ~~~~~~~~~LG~G~fG~Vy~g~------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV  262 (454)
                      .++|..++.|-.|+||.||..+      ++|. ++..             .-.+++     ||..    +.++   .+.|
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~-kiNk-------------q~lilR-----nilt----~a~n---pfvv  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAM-KINK-------------QNLILR-----NILT----FAGN---PFVV  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhh-cccc-------------cchhhh-----cccc----ccCC---ccee
Confidence            4788999999999999999863      4455 2211             011111     1211    1111   1122


Q ss_pred             EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCC---
Q 012887          263 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE---  339 (454)
Q Consensus       263 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~---  339 (454)
                            |+-..+++..+.++...        +.+++|||+.||+|||+||+|.||..-|++|+.|||+.+.......   
T Consensus       136 ------gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl  201 (1205)
T KOG0606|consen  136 ------GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNL  201 (1205)
T ss_pred             ------chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchh
Confidence                  45555555555555443        7899999999999999999999999999999999999764322110   


Q ss_pred             ------------cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcC-CC
Q 012887          340 ------------ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG-LR  406 (454)
Q Consensus       340 ------------~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~-~~  406 (454)
                                  .....+||+.|.|||++....|...    +|.|++|+|+||.+-|..||.+.++++.+-..+... ..
T Consensus       202 ~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkp----vdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~w  277 (1205)
T KOG0606|consen  202 KEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKP----VDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEW  277 (1205)
T ss_pred             hhcchHHHHHHhhhccccCCccccChhhhhhhccCCC----ccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccc
Confidence                        1223368999999999987766655    899999999999999999999999988776655431 22


Q ss_pred             CCCCCCccHHHHHHHHHhcccCCCCCCC
Q 012887          407 PEIPKDCPQILKSLMIKCWNNSPSKRPQ  434 (454)
Q Consensus       407 ~~~p~~~~~~l~~li~~cl~~dP~~RPs  434 (454)
                      ++-....++++++++.++|+.+|..|--
T Consensus       278 pE~dea~p~Ea~dli~~LL~qnp~~Rlg  305 (1205)
T KOG0606|consen  278 PEEDEALPPEAQDLIEQLLRQNPLCRLG  305 (1205)
T ss_pred             cccCcCCCHHHHHHHHHHHHhChHhhcc
Confidence            2223457899999999999999999943

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.76  E-value=4.5e-18  Score=187.01  Aligned_cols=242  Identities=16%  Similarity=0.203  Sum_probs=173.1

Q ss_pred             cceeecCCCEEEeceeeccCCceEEEe-----EEEEEEEeecCCCCchHHHHHHHHHHHHHhCC---CCceeEEEEEEEe
Q 012887          183 GRWLLNSDNLEFIDQIGPNSFKGVYKG-----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCG---HKNILQFYCVCVD  254 (454)
Q Consensus       183 ~~~~~~~~~~~~~~~LG~G~fG~Vy~g-----~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~---HpnIv~~~g~~~~  254 (454)
                      ....+..+.|.|-+.||.|+||.||+|     +.||+|.-+....   .++-+-.++  +.+|+   -+-|.++..+..-
T Consensus       691 ~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~---WEfYI~~q~--~~RLk~~~~~~~~~~~~a~~~  765 (974)
T KOG1166|consen  691 TEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNP---WEFYICLQV--MERLKPQMLPSIMHISSAHVF  765 (974)
T ss_pred             ceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCc---eeeeehHHH--HHhhchhhhcchHHHHHHHcc
Confidence            456678889999999999999999985     6899998764322   222222221  12222   2344444444443


Q ss_pred             CCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccC-------CcEEEEc
Q 012887          255 ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH-------GNVCLGD  327 (454)
Q Consensus       255 ~~~~l~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~-------~~vKL~D  327 (454)
                      .+. -++|+||.+.|+|.+++...+.+++.....++.|++.-++.||.++|||+||||+|.||...       --++|+|
T Consensus       766 ~~~-S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lID  844 (974)
T KOG1166|consen  766 QNA-SVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLID  844 (974)
T ss_pred             CCc-ceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEe
Confidence            444 56999999999999999888899999999999999999999999999999999999999532       2489999


Q ss_pred             cCCccccccCCCc--ccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCC
Q 012887          328 MGIVTACKSVGEA--TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGL  405 (454)
Q Consensus       328 FGla~~~~~~~~~--~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~  405 (454)
                      ||.+--+.-....  -....+|-.+-.+|+..|.+++.    ..|-|.|+.+++-|+.|++-=            ...+.
T Consensus       845 fG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtY----q~DyfGlAa~~h~mLFG~y~q------------~~~g~  908 (974)
T KOG1166|consen  845 FGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTY----QIDYFGLAATVHVMLFGKYME------------VKNGS  908 (974)
T ss_pred             cccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCch----hhhhHHHHHHHHHHHHHHHHH------------hcCCc
Confidence            9987654433222  22335677789999999886554    499999999999999997621            11221


Q ss_pred             C----CCCCCCccHH-HHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 012887          406 R----PEIPKDCPQI-LKSLMIKCWNNSPSKRPQFSEIISLLLRTN  446 (454)
Q Consensus       406 ~----~~~p~~~~~~-l~~li~~cl~~dP~~RPs~~ell~~L~~~~  446 (454)
                      .    ..++.....+ ..++...+|+.|-..=|...+|...++.+.
T Consensus       909 ~~~~~~~~~Ry~~~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~  954 (974)
T KOG1166|consen  909 SWMVKTNFPRYWKRDMWNKFFDLLLNPDCDTLPNLQELRTELEEVL  954 (974)
T ss_pred             ceeccccchhhhhHHHHHHHHHHHhCcCcccchhHHHHHHHHHHHH
Confidence            1    1234433333 356777788866666688888877776653

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.75  E-value=4.6e-19  Score=180.45  Aligned_cols=170  Identities=21%  Similarity=0.381  Sum_probs=129.9

Q ss_pred             EEEEEeccCCCCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccc
Q 012887          259 LCVVTKLMEGGSVNDLILKSR---KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK  335 (454)
Q Consensus       259 l~lV~E~~~~gsL~~~l~~~~---~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~  335 (454)
                      +||.|++|...+|.+++.++.   ..+...++.++.|++.|++|   ++.+|||+||.||+...+..+||+|||+.....
T Consensus       331 lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~~  407 (516)
T KOG1033|consen  331 LYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQD  407 (516)
T ss_pred             hhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheeecc
Confidence            889999999999999996443   56778899999999999999   999999999999999999999999999987665


Q ss_pred             cCC------CcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcC-CCCC
Q 012887          336 SVG------EATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG-LRPE  408 (454)
Q Consensus       336 ~~~------~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~-~~~~  408 (454)
                      ...      ...+...||..||+||.+.+..|+.    ++||||||++|+|+++   +|...............+ +++.
T Consensus       408 ~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~----kvdIyaLGlil~EL~~---~f~T~~er~~t~~d~r~g~ip~~  480 (516)
T KOG1033|consen  408 KDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSE----KVDIYALGLILAELLI---QFSTQFERIATLTDIRDGIIPPE  480 (516)
T ss_pred             cCCcccchhhhhhhcccccccCCHHHHhhhhhhh----hcchhhHHHHHHHHHH---HhccHHHHHHhhhhhhcCCCChH
Confidence            543      1244557899999999999886554    5999999999999998   122211112222223322 2223


Q ss_pred             CCCCccHHHHHHHHHhcccCCCCCCCHHHHH
Q 012887          409 IPKDCPQILKSLMIKCWNNSPSKRPQFSEII  439 (454)
Q Consensus       409 ~p~~~~~~l~~li~~cl~~dP~~RPs~~ell  439 (454)
                      +-.++ +.-+.|+.+++...|.+||++.+..
T Consensus       481 ~~~d~-p~e~~ll~~lls~~p~~RP~~~~~~  510 (516)
T KOG1033|consen  481 FLQDY-PEEYTLLQQLLSPSPEERPSAIEVA  510 (516)
T ss_pred             HhhcC-cHHHHHHHHhcCCCcccCchHHHHh
Confidence            33333 4456899999999999999655543

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.75  E-value=1.4e-17  Score=156.11  Aligned_cols=132  Identities=17%  Similarity=0.233  Sum_probs=106.9

Q ss_pred             ceeeccCCceEEEe----EEEEEEEeecCCCCch------HHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEEec
Q 012887          196 DQIGPNSFKGVYKG----KRVGIEKLKGCDKGNA------YEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKL  265 (454)
Q Consensus       196 ~~LG~G~fG~Vy~g----~~vavK~l~~~~~~~~------~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~E~  265 (454)
                      +.||+|++|.||+|    ..+++|+.........      ....+.+|+..+..+.|+++.....++.+.+. .++||||
T Consensus         2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~-~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPEN-FIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCC-CEEEEEE
Confidence            57899999999997    5788887653322111      12346788889999989988776666665555 7899999


Q ss_pred             cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccc
Q 012887          266 MEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTA  333 (454)
Q Consensus       266 ~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~  333 (454)
                      ++|++|.+++.....    ....++.+++.+|.+||+.+++|+|++|.|||++ ++.++|+|||++..
T Consensus        81 ~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            999999999854322    7889999999999999999999999999999999 88899999998654

>smart00090 RIO RIO-like kinase

Probab=99.74  E-value=8.1e-18  Score=161.46  Aligned_cols=140  Identities=15%  Similarity=0.129  Sum_probs=108.2

Q ss_pred             CCEEEeceeeccCCceEEEeE-------EEEEEEeecCCCCc-------------------h---HHHHHHHHHHHHHhC
Q 012887          190 DNLEFIDQIGPNSFKGVYKGK-------RVGIEKLKGCDKGN-------------------A---YEFELRKDLLELMTC  240 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g~-------~vavK~l~~~~~~~-------------------~---~~~~~~~Ei~~l~~l  240 (454)
                      ..|++.+.||+|+||.||+|.       .||+|.++......                   .   ....+.+|+..+.++
T Consensus        28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L  107 (237)
T smart00090       28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL  107 (237)
T ss_pred             chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence            357888999999999999974       79999987532110                   0   112356888888888


Q ss_pred             CC--CceeEEEEEEEeCCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC-cccCCccCCcEEE
Q 012887          241 GH--KNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHG-VAYRDLNSQRILL  317 (454)
Q Consensus       241 ~H--pnIv~~~g~~~~~~~~l~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~-iiHrDIKp~NILl  317 (454)
                      .+  ..+.+.++.   . . .++||||++|++|.........+.......++.||+.+|.|||++| ++||||||+||++
T Consensus       108 ~~~~i~~p~~~~~---~-~-~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli  182 (237)
T smart00090      108 YEAGVPVPKPIAW---R-R-NVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILV  182 (237)
T ss_pred             HhcCCCCCeeeEe---c-C-ceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEE
Confidence            65  334444442   2 2 4799999999888776544456677778899999999999999999 9999999999999


Q ss_pred             ccCCcEEEEccCCccccc
Q 012887          318 DRHGNVCLGDMGIVTACK  335 (454)
Q Consensus       318 ~~~~~vKL~DFGla~~~~  335 (454)
                      + ++.++|+|||.+....
T Consensus       183 ~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      183 H-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             E-CCCEEEEEChhhhccC
Confidence            9 8899999999976543

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.73  E-value=3.1e-17  Score=152.43  Aligned_cols=128  Identities=16%  Similarity=0.205  Sum_probs=100.3

Q ss_pred             eeeccCCceEEEeE----EEEEEEeecCCC-Cch-----HHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEEecc
Q 012887          197 QIGPNSFKGVYKGK----RVGIEKLKGCDK-GNA-----YEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLM  266 (454)
Q Consensus       197 ~LG~G~fG~Vy~g~----~vavK~l~~~~~-~~~-----~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~E~~  266 (454)
                      .||+|+||.||+|.    .+++|....... ...     ....+.+|+..+..+.|+++.....++...+. .++||||+
T Consensus         1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~-~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDN-KTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCC-CEEEEEEE
Confidence            38999999999976    888888653221 111     12446789999988888765544444444444 68999999


Q ss_pred             CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccc
Q 012887          267 EGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTA  333 (454)
Q Consensus       267 ~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~  333 (454)
                      +|++|.+++.....       .++.+++.+|.+||+.|++|+|++|.||+++ ++.+++.|||++..
T Consensus        80 ~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        80 EGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             CCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            99999998754321       7899999999999999999999999999999 89999999999754

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.71  E-value=7.2e-17  Score=172.66  Aligned_cols=131  Identities=17%  Similarity=0.163  Sum_probs=105.0

Q ss_pred             EEeceeeccCCceEEEe----EEEEEEEeecCC-CCc-----hHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEE
Q 012887          193 EFIDQIGPNSFKGVYKG----KRVGIEKLKGCD-KGN-----AYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  262 (454)
Q Consensus       193 ~~~~~LG~G~fG~Vy~g----~~vavK~l~~~~-~~~-----~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV  262 (454)
                      ...+.||+|+||.||+|    ..+++|+..... ...     .....+.+|+..+..++|++++..+.++.+.+. .++|
T Consensus       336 ~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~-~~lv  414 (535)
T PRK09605        336 IPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE-KTIV  414 (535)
T ss_pred             CccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC-CEEE
Confidence            45789999999999995    344555432111 111     123457889999999999999888777776555 7899


Q ss_pred             EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccc
Q 012887          263 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTA  333 (454)
Q Consensus       263 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~  333 (454)
                      |||+++++|.+++.        ....++.+++.+|.|||+.|++||||||+|||+ .++.++|+|||+++.
T Consensus       415 ~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~  476 (535)
T PRK09605        415 MEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY  476 (535)
T ss_pred             EEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence            99999999999874        356789999999999999999999999999999 578899999999765

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.70  E-value=6.1e-17  Score=150.88  Aligned_cols=133  Identities=17%  Similarity=0.165  Sum_probs=101.9

Q ss_pred             EEEeceeeccCCceEEEe-----EEEEEEEeecCCCCc--------------------hHHHHHHHHHHHHHhCCCC--c
Q 012887          192 LEFIDQIGPNSFKGVYKG-----KRVGIEKLKGCDKGN--------------------AYEFELRKDLLELMTCGHK--N  244 (454)
Q Consensus       192 ~~~~~~LG~G~fG~Vy~g-----~~vavK~l~~~~~~~--------------------~~~~~~~~Ei~~l~~l~Hp--n  244 (454)
                      |.+.+.||+|+||.||++     +.+|||.+.......                    ........|+..+..+.|+  .
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~   96 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP   96 (198)
T ss_pred             hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence            677889999999999985     579999876422110                    0112356778888887776  4


Q ss_pred             eeEEEEEEEeCCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEE
Q 012887          245 ILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVC  324 (454)
Q Consensus       245 Iv~~~g~~~~~~~~l~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vK  324 (454)
                      +...++.    .. .++||||++|++|.++...      .....++.+++.++.++|+.|++||||||+||+++.++.++
T Consensus        97 v~~~~~~----~~-~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~  165 (198)
T cd05144          97 VPKPIDW----NR-HAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIY  165 (198)
T ss_pred             CCceeec----CC-ceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEE
Confidence            4454432    22 6899999999999775421      34567889999999999999999999999999999999999


Q ss_pred             EEccCCccccc
Q 012887          325 LGDMGIVTACK  335 (454)
Q Consensus       325 L~DFGla~~~~  335 (454)
                      |+|||++....
T Consensus       166 liDfg~~~~~~  176 (198)
T cd05144         166 IIDWPQMVSTD  176 (198)
T ss_pred             EEECCccccCC
Confidence            99999986544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.67  E-value=3.3e-18  Score=183.72  Aligned_cols=253  Identities=18%  Similarity=0.216  Sum_probs=194.1

Q ss_pred             CCEEEeceeeccCCceEEEe-------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCC-CCceeEEEEEEEeCCCeEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG-------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCG-HKNILQFYCVCVDENHGLCV  261 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g-------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~~~g~~~~~~~~l~l  261 (454)
                      ..|.+.+.||+|+|+.|-..       ..+|+|.+............+..|..+-..+. |+|++.+++...+.+. .++
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~-~~~   98 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRS-YLL   98 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcc-ccc
Confidence            55677888999999999863       34666666544434444555666776666665 9999999999887776 889


Q ss_pred             EEeccCCCCHHHHH-HhCC-CCCHHHHHHHHHHHHHHHHHHH-hcCcccCCccCCcEEEccCC-cEEEEccCCcccccc-
Q 012887          262 VTKLMEGGSVNDLI-LKSR-KLQTKEIIRIAIDVAEGIKFLN-DHGVAYRDLNSQRILLDRHG-NVCLGDMGIVTACKS-  336 (454)
Q Consensus       262 V~E~~~~gsL~~~l-~~~~-~l~~~~~~~i~~qI~~gL~yLH-~~~iiHrDIKp~NILl~~~~-~vKL~DFGla~~~~~-  336 (454)
                      +++|..|+++.+.+ .... ..+......++.|+..++.|+| ..++.||||||+|.+++..+ ..+++|||+|..... 
T Consensus        99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~  178 (601)
T KOG0590|consen   99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNK  178 (601)
T ss_pred             ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhcccccc
Confidence            99999999999988 4444 6788889999999999999999 99999999999999999999 999999999887665 


Q ss_pred             CCC--cccccCC-CCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHH-HHHHHcCC--CCCCC
Q 012887          337 VGE--ATEYETD-GYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAA-VGIAACGL--RPEIP  410 (454)
Q Consensus       337 ~~~--~~~~~~g-t~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~-~~i~~~~~--~~~~p  410 (454)
                      .+.  ......| ++.|+|||...+..+..   ...|+||.|+++.-+++|..||......... ........  .....
T Consensus       179 ~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~---~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (601)
T KOG0590|consen  179 NGAERSLKDRCGSSPPYGAPEHLSGKAYRG---PSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPW  255 (601)
T ss_pred             CCcceeeecccCCCCCCCCcccccchhhcC---CCcccccccccccccccCCCCccccccccccceeecccccccccCcc
Confidence            222  2333456 89999999998743322   2479999999999999999999754333211 11111111  23344


Q ss_pred             CCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 012887          411 KDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTN  446 (454)
Q Consensus       411 ~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~  446 (454)
                      ..++....+++.+++..+|+.|.+.+++...-+-..
T Consensus       256 ~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  256 NSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS  291 (601)
T ss_pred             ccCChhhhhcccccccCCchhccccccccccccccc
Confidence            567888999999999999999999999877655544

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.62  E-value=1.6e-15  Score=139.33  Aligned_cols=133  Identities=17%  Similarity=0.185  Sum_probs=92.7

Q ss_pred             eceeeccCCceEEEe-----EEEEEEEeecCCCCchHHHH----------------------HHHHHHHHHhCCCC--ce
Q 012887          195 IDQIGPNSFKGVYKG-----KRVGIEKLKGCDKGNAYEFE----------------------LRKDLLELMTCGHK--NI  245 (454)
Q Consensus       195 ~~~LG~G~fG~Vy~g-----~~vavK~l~~~~~~~~~~~~----------------------~~~Ei~~l~~l~Hp--nI  245 (454)
                      .+.||+|+||.||++     +.||||.++...........                      ...|...+..+.+.  .+
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            467999999999984     67999988753222111111                      13455555555332  34


Q ss_pred             eEEEEEEEeCCCeEEEEEeccCCCCHHHH-HHhCCCCCHHHHHHHHHHHHHHHHHHHh-cCcccCCccCCcEEEccCCcE
Q 012887          246 LQFYCVCVDENHGLCVVTKLMEGGSVNDL-ILKSRKLQTKEIIRIAIDVAEGIKFLND-HGVAYRDLNSQRILLDRHGNV  323 (454)
Q Consensus       246 v~~~g~~~~~~~~l~lV~E~~~~gsL~~~-l~~~~~l~~~~~~~i~~qI~~gL~yLH~-~~iiHrDIKp~NILl~~~~~v  323 (454)
                      .+.++.    .. .++||||++++++... +... ... ..+..++.+++.++.++|. ++|+||||||+||+++ ++.+
T Consensus        82 ~~~~~~----~~-~~lv~e~~~g~~~~~~~l~~~-~~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~  153 (187)
T cd05119          82 PKPIDL----NR-HVLVMEFIGGDGIPAPRLKDV-RLL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKV  153 (187)
T ss_pred             CceEec----CC-CEEEEEEeCCCCccChhhhhh-hhc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcE
Confidence            555543    12 6899999999543221 1111 111 6678899999999999999 9999999999999999 8999


Q ss_pred             EEEccCCccccc
Q 012887          324 CLGDMGIVTACK  335 (454)
Q Consensus       324 KL~DFGla~~~~  335 (454)
                      +|+|||.+....
T Consensus       154 ~liDfg~a~~~~  165 (187)
T cd05119         154 YIIDVPQAVEID  165 (187)
T ss_pred             EEEECccccccc
Confidence            999999986543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.62  E-value=7.2e-15  Score=141.24  Aligned_cols=132  Identities=17%  Similarity=0.134  Sum_probs=96.9

Q ss_pred             eee-ccCCceEEE----eEEEEEEEeecCCC-----------CchHHHHHHHHHHHHHhCCCCce--eEEEEEEEeCCCe
Q 012887          197 QIG-PNSFKGVYK----GKRVGIEKLKGCDK-----------GNAYEFELRKDLLELMTCGHKNI--LQFYCVCVDENHG  258 (454)
Q Consensus       197 ~LG-~G~fG~Vy~----g~~vavK~l~~~~~-----------~~~~~~~~~~Ei~~l~~l~HpnI--v~~~g~~~~~~~~  258 (454)
                      .|| .|+.|+||.    +..+++|.......           .........+|+..+..+.|++|  ++.+++.......
T Consensus        38 ~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~~  117 (239)
T PRK01723         38 VVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHGL  117 (239)
T ss_pred             eeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecCc
Confidence            355 555555555    56788887743211           01223457789999999988774  6777765443322


Q ss_pred             ---EEEEEeccCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccc
Q 012887          259 ---LCVVTKLMEG-GSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTA  333 (454)
Q Consensus       259 ---l~lV~E~~~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~  333 (454)
                         .++|||+++| .+|.+++.+ ..+++..    +.+|+.+|.+||++||+||||||.|||++.++.++|+|||.+..
T Consensus       118 ~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~~~  191 (239)
T PRK01723        118 FYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRGEL  191 (239)
T ss_pred             ceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCccc
Confidence               3599999997 699988754 4555543    56899999999999999999999999999999999999998654

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.57  E-value=1.7e-14  Score=125.88  Aligned_cols=128  Identities=15%  Similarity=0.114  Sum_probs=104.1

Q ss_pred             EeceeeccCCceEEEeE----EEEEEEeecCCCCchHHHHHHHHHHHHHhCCC--CceeEEEEEEEeCCCeEEEEEeccC
Q 012887          194 FIDQIGPNSFKGVYKGK----RVGIEKLKGCDKGNAYEFELRKDLLELMTCGH--KNILQFYCVCVDENHGLCVVTKLME  267 (454)
Q Consensus       194 ~~~~LG~G~fG~Vy~g~----~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~H--pnIv~~~g~~~~~~~~l~lV~E~~~  267 (454)
                      +.+.||+|.++.||++.    .+++|.......    ...+.+|+..+..+.|  .++.+++++....+. .+++|||++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~-~~~v~e~~~   76 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKDEDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGESDGW-SYLLMEWIE   76 (155)
T ss_pred             cceecccccccceEEEEecCCeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCc-cEEEEEecC
Confidence            35679999999999864    678887753322    4567788888888865  588898888776554 899999999


Q ss_pred             CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhc---CcccCCccCCcEEEccCCcEEEEccCCccc
Q 012887          268 GGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDH---GVAYRDLNSQRILLDRHGNVCLGDMGIVTA  333 (454)
Q Consensus       268 ~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~---~iiHrDIKp~NILl~~~~~vKL~DFGla~~  333 (454)
                      ++.+..+       +......++.+++.+|.+||..   +++|+|++|+||+++..+.+++.|||.+..
T Consensus        77 g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          77 GETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             CeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            8777643       5566778899999999999985   699999999999999989999999998754

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.51  E-value=1e-14  Score=151.27  Aligned_cols=242  Identities=17%  Similarity=0.186  Sum_probs=182.3

Q ss_pred             CCEEEeceeec--cCCceEEEe--------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCC-CCceeEEEEEEEeCCCe
Q 012887          190 DNLEFIDQIGP--NSFKGVYKG--------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCG-HKNILQFYCVCVDENHG  258 (454)
Q Consensus       190 ~~~~~~~~LG~--G~fG~Vy~g--------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~~~g~~~~~~~~  258 (454)
                      ..+.+.+.+|+  |.+|.||.+        ..+|+|+-+...........-.+|+...+.++ |+|.++.+..+...+. 
T Consensus       114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~-  192 (524)
T KOG0601|consen  114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGI-  192 (524)
T ss_pred             hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCc-
Confidence            34566788999  999999984        46888886555444443344445666555554 9999999988887776 


Q ss_pred             EEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHH----HHHHHHhcCcccCCccCCcEEEccC-CcEEEEccCCcc
Q 012887          259 LCVVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAE----GIKFLNDHGVAYRDLNSQRILLDRH-GNVCLGDMGIVT  332 (454)
Q Consensus       259 l~lV~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qI~~----gL~yLH~~~iiHrDIKp~NILl~~~-~~vKL~DFGla~  332 (454)
                      +++-+|+|. .+|..+.... ..++...++....+...    ||.++|+.+++|-|+||+||+...+ ...+++|||+..
T Consensus       193 lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~  271 (524)
T KOG0601|consen  193 LFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVS  271 (524)
T ss_pred             ceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcceeE
Confidence            999999996 5888776543 35899999999999999    9999999999999999999999999 789999999988


Q ss_pred             ccccCCCccccc-----CCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC--CHHHHHHHHHHcCC
Q 012887          333 ACKSVGEATEYE-----TDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAAC--SPVQAAVGIAACGL  405 (454)
Q Consensus       333 ~~~~~~~~~~~~-----~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~--~~~~~~~~i~~~~~  405 (454)
                      ...+........     .+...|++||...+.     ++.++|+||+|.+..+..++..+....  .....+   ...-.
T Consensus       272 ~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l-----~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~---r~~~i  343 (524)
T KOG0601|consen  272 KISDGNFSSVFKVSKRPEGDCIYAAKELLNGL-----ATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQL---RQGYI  343 (524)
T ss_pred             EccCCccccceeeeecCCCCceEeChhhhccc-----cchHhhhcchhhhhHhhHhhcccccCCCCCCcccc---ccccC
Confidence            776654333322     567789999999865     344589999999999998876554432  111111   11113


Q ss_pred             CCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012887          406 RPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISL  441 (454)
Q Consensus       406 ~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  441 (454)
                      +.++.+..+.++...+..+++.+|..|+++..+.++
T Consensus       344 p~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l  379 (524)
T KOG0601|consen  344 PLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL  379 (524)
T ss_pred             chhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence            344555667778889999999999999999887754

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.40  E-value=1.3e-13  Score=150.01  Aligned_cols=247  Identities=17%  Similarity=0.220  Sum_probs=179.3

Q ss_pred             eeecCCCEEEeceeeccCCceEEEeE------EEEEEEeecCCCCch-HHHHHHHHHHHHHhCCCCceeEEEEEEEeCCC
Q 012887          185 WLLNSDNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKGNA-YEFELRKDLLELMTCGHKNILQFYCVCVDENH  257 (454)
Q Consensus       185 ~~~~~~~~~~~~~LG~G~fG~Vy~g~------~vavK~l~~~~~~~~-~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~  257 (454)
                      +-...+.+.+++-+-+|+|+.++..+      ..+++.......... ....+..+-.++...++|.++...-.+.... 
T Consensus       799 yrsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rs-  877 (1205)
T KOG0606|consen  799 YRSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRS-  877 (1205)
T ss_pred             ccCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCC-
Confidence            33455788888999999999999642      333443332221111 0111122222222234577776554433333 


Q ss_pred             eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccc--
Q 012887          258 GLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK--  335 (454)
Q Consensus       258 ~l~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~--  335 (454)
                      +++++++|+.+++|...+...+..+..-...++..++.+++|||+..++|||++|.|+|+..+|+.+++|||......  
T Consensus       878 P~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~  957 (1205)
T KOG0606|consen  878 PLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLI  957 (1205)
T ss_pred             CcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccc
Confidence            489999999999999999877778888888889999999999999999999999999999999999999998422110  


Q ss_pred             ----cCC-------------------------CcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCC
Q 012887          336 ----SVG-------------------------EATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEA  386 (454)
Q Consensus       336 ----~~~-------------------------~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~  386 (454)
                          ...                         .......+|+.|.+||...+......    +|.|++|++++|.++|.+
T Consensus       958 ~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~----ad~~~~g~~l~e~l~g~p 1033 (1205)
T KOG0606|consen  958 PPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSA----ADWWSSGVCLFEVLTGIP 1033 (1205)
T ss_pred             cCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCc----chhhhhhhhhhhhhcCCC
Confidence                000                         00122257889999999998765544    899999999999999999


Q ss_pred             CCCCCCHHHHHHHHHHcCCC-CCCCCCccHHHHHHHHHhcccCCCCCCCHH
Q 012887          387 AYAACSPVQAAVGIAACGLR-PEIPKDCPQILKSLMIKCWNNSPSKRPQFS  436 (454)
Q Consensus       387 Pf~~~~~~~~~~~i~~~~~~-~~~p~~~~~~l~~li~~cl~~dP~~RPs~~  436 (454)
                      ||...++.+.+..+...... +.-|...+.++.+++...+..+|.+|-.+.
T Consensus      1034 p~na~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1034 PFNAETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             CCCCcchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence            99999998888776654333 233556789999999999999999998765

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.35  E-value=7.9e-13  Score=128.03  Aligned_cols=202  Identities=20%  Similarity=0.290  Sum_probs=139.9

Q ss_pred             HHHHHhCCCCceeEEEEEEEeCC----CeEEEEEeccCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhc--
Q 012887          234 LLELMTCGHKNILQFYCVCVDEN----HGLCVVTKLMEGGSVNDLILKS----RKLQTKEIIRIAIDVAEGIKFLNDH--  303 (454)
Q Consensus       234 i~~l~~l~HpnIv~~~g~~~~~~----~~l~lV~E~~~~gsL~~~l~~~----~~l~~~~~~~i~~qI~~gL~yLH~~--  303 (454)
                      ...|..+-|.|||+++.+|.+..    ....+++|||..|+|..+|++.    ..+......+|+-||..||.|||+.  
T Consensus       118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~P  197 (458)
T KOG1266|consen  118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDP  197 (458)
T ss_pred             HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCC
Confidence            44566678999999999987653    2377899999999999999642    3688999999999999999999987  


Q ss_pred             CcccCCccCCcEEEccCCcEEEEccCCcccccc----CCCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHH
Q 012887          304 GVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS----VGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIW  379 (454)
Q Consensus       304 ~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~----~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~  379 (454)
                      -|+|+++..+-|++..+|-+|++----...-..    ....+....+-+.|.|||.=.-..    .+-++|||+||+...
T Consensus       198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn----~~~a~dIy~fgmcAl  273 (458)
T KOG1266|consen  198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTN----TTGASDIYKFGMCAL  273 (458)
T ss_pred             ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccc----cccchhhhhhhHHHH
Confidence            599999999999999999998853211100000    001122334567789999654322    334599999999999


Q ss_pred             HHHcCCCCCC-CCCHHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 012887          380 EMVTGEAAYA-ACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR  444 (454)
Q Consensus       380 elltG~~Pf~-~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~  444 (454)
                      ||..+..--. +.+....-..+...  ..-+.   .+.-+.++++|++-+|..||++.+++-|...
T Consensus       274 emailEiq~tnseS~~~~ee~ia~~--i~~le---n~lqr~~i~kcl~~eP~~rp~ar~llfHpll  334 (458)
T KOG1266|consen  274 EMAILEIQSTNSESKVEVEENIANV--IIGLE---NGLQRGSITKCLEGEPNGRPDARLLLFHPLL  334 (458)
T ss_pred             HHHHheeccCCCcceeehhhhhhhh--eeecc---CccccCcCcccccCCCCCCcchhhhhcCcee
Confidence            9988765422 22211111111110  00010   1224578999999999999999999877543

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.34  E-value=4.1e-12  Score=132.44  Aligned_cols=138  Identities=17%  Similarity=0.203  Sum_probs=91.3

Q ss_pred             ceeeccCCceEEEe-----EEEEEEEeecCCCCch--------------------------------------HHHHHHH
Q 012887          196 DQIGPNSFKGVYKG-----KRVGIEKLKGCDKGNA--------------------------------------YEFELRK  232 (454)
Q Consensus       196 ~~LG~G~fG~Vy~g-----~~vavK~l~~~~~~~~--------------------------------------~~~~~~~  232 (454)
                      +.||+|++|.||+|     +.||||+.+......-                                      .+.++.+
T Consensus       123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~  202 (437)
T TIGR01982       123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR  202 (437)
T ss_pred             cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence            46999999999985     5799999864211000                                      0112333


Q ss_pred             HHHHHHhC----CCCceeEEEEEEEeCCCeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHH-HHHHHHhcCcc
Q 012887          233 DLLELMTC----GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAE-GIKFLNDHGVA  306 (454)
Q Consensus       233 Ei~~l~~l----~HpnIv~~~g~~~~~~~~l~lV~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qI~~-gL~yLH~~~ii  306 (454)
                      |...+.++    .|.+-+.+-.++.+-....++||||++|++|.++.... ...+   ...++.+++. .+..+|..|++
T Consensus       203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g~~  279 (437)
T TIGR01982       203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDGFF  279 (437)
T ss_pred             HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCCce
Confidence            44443333    33333333333322222367999999999999876422 1222   2345555555 46888999999


Q ss_pred             cCCccCCcEEEccCCcEEEEccCCcccccc
Q 012887          307 YRDLNSQRILLDRHGNVCLGDMGIVTACKS  336 (454)
Q Consensus       307 HrDIKp~NILl~~~~~vKL~DFGla~~~~~  336 (454)
                      |+|++|.||+++.++.++++|||++.....
T Consensus       280 H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       280 HADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             eCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence            999999999999999999999999876643

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.34  E-value=2.6e-11  Score=127.46  Aligned_cols=220  Identities=16%  Similarity=0.240  Sum_probs=145.2

Q ss_pred             eEEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHH
Q 012887          209 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIR  288 (454)
Q Consensus       209 g~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~E~~~~gsL~~~l~~~~~l~~~~~~~  288 (454)
                      |..|.|...+....  .......+-+..|+.++||||++|++.+..++. +|||+|-+.  .|..++.+.+   ......
T Consensus        37 ~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~-~ylvTErV~--Pl~~~lk~l~---~~~v~~  108 (690)
T KOG1243|consen   37 GGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGT-LYLVTERVR--PLETVLKELG---KEEVCL  108 (690)
T ss_pred             CCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhhcccCc-eEEEeeccc--cHHHHHHHhH---HHHHHH
Confidence            45777887775433  333446677888999999999999999988876 999999985  7777775433   555666


Q ss_pred             HHHHHHHHHHHHH-hcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCcccccCCCCcccccccccCCCCCCCCCc
Q 012887          289 IAIDVAEGIKFLN-DHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETW  367 (454)
Q Consensus       289 i~~qI~~gL~yLH-~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~  367 (454)
                      -+.||+.||.||| ..+++|++|.-+.|+++..|..||++|-++......+........-..|..|+.+....      +
T Consensus       109 Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~------~  182 (690)
T KOG1243|consen  109 GLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE------W  182 (690)
T ss_pred             HHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccc------c
Confidence            7889999999997 67899999999999999999999999988755443332112222223467777665332      4


Q ss_pred             hhhHHHHHHHHHHHHcCCCCCCCCCHH-------HHHHHHHHcCCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012887          368 MSNVYSFGMVIWEMVTGEAAYAACSPV-------QAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIIS  440 (454)
Q Consensus       368 ksDVwSlGviL~elltG~~Pf~~~~~~-------~~~~~i~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~  440 (454)
                      ..|.|.||+++||++.|.  +......       ......... .-...+..-+. ...++..|...-.--|-.+-+++.
T Consensus       183 s~D~~~Lg~li~el~ng~--~~~~~~~~~~~~ipk~~~~~~~k-~~~~~~~~r~n-~~~~~~~~~~~~gff~n~fvd~~~  258 (690)
T KOG1243|consen  183 SIDSWGLGCLIEELFNGS--LLTKTDLSNTGKIPKALIELYCK-KLGATELKRPN-KLRFILECRLLGGFFRNDFVDTLL  258 (690)
T ss_pred             chhhhhHHHHHHHHhCcc--cCcchhhhccCccchhHHHHHHH-Hhccccccccc-hhhHHHHHHhccccccchHHHHHH
Confidence            479999999999999982  2211110       011110000 00000011111 456666666666666666666666


Q ss_pred             HHHhhc
Q 012887          441 LLLRTN  446 (454)
Q Consensus       441 ~L~~~~  446 (454)
                      .|.++.
T Consensus       259 fLeel~  264 (690)
T KOG1243|consen  259 FLEELR  264 (690)
T ss_pred             HHHhcc
Confidence            666554

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.33  E-value=4.5e-13  Score=139.07  Aligned_cols=245  Identities=16%  Similarity=0.151  Sum_probs=174.4

Q ss_pred             cCCCEEEeceeeccCCceEEE-------eEEEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEEEEEEEeCCCeE
Q 012887          188 NSDNLEFIDQIGPNSFKGVYK-------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVDENHGL  259 (454)
Q Consensus       188 ~~~~~~~~~~LG~G~fG~Vy~-------g~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~~~g~~~~~~~~l  259 (454)
                      ...++..+..||.|.|+.|+.       +..+++|.+.........+..-..|+.....+ .|.|++.++..|...++ .
T Consensus       263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~-~  341 (524)
T KOG0601|consen  263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ-G  341 (524)
T ss_pred             ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc-c
Confidence            345788999999999999997       34677777664433333333334555555555 59999999888877766 7


Q ss_pred             EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccC-CcEEEEccCCccccccCC
Q 012887          260 CVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH-GNVCLGDMGIVTACKSVG  338 (454)
Q Consensus       260 ~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~-~~vKL~DFGla~~~~~~~  338 (454)
                      |+-.|||.++++...+.-...+.+...+++..|++.++.++|++.++|+|+||+||++..+ +.-+++|||..+.+..  
T Consensus       342 ~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~--  419 (524)
T KOG0601|consen  342 YIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAF--  419 (524)
T ss_pred             cCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccce--
Confidence            7999999999988776444478889999999999999999999999999999999999986 6788999999764221  


Q ss_pred             CcccccCCCCcccc-cccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHH
Q 012887          339 EATEYETDGYRWLA-PEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQIL  417 (454)
Q Consensus       339 ~~~~~~~gt~~y~A-PE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l  417 (454)
                       ........-+++| .|++.....   +..+.|++|||..+.+.+++.+--.....    ...+..+.-+..|.. ...+
T Consensus       420 -~~~~~~~~~r~~p~~~~~~e~~~---~~~~~~~~sl~~~~~e~~~~~~ls~~~~~----~~~i~~~~~p~~~~~-~~~~  490 (524)
T KOG0601|consen  420 -SSGVFHHIDRLYPIAEILLEDYP---HLSKADIFSLGLSVDEAITGSPLSESGVQ----SLTIRSGDTPNLPGL-KLQL  490 (524)
T ss_pred             -ecccccccccccccchhhccccc---cccccccccccccccccccCcccCccccc----ceeeecccccCCCch-HHhh
Confidence             1122223334452 555543321   23358999999999999997653222111    111222333333433 3888


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHHHHHh
Q 012887          418 KSLMIKCWNNSPSKRPQFSEIISLLLR  444 (454)
Q Consensus       418 ~~li~~cl~~dP~~RPs~~ell~~L~~  444 (454)
                      ..+.+.+...++..||.+.++..+...
T Consensus       491 q~~~kv~~~~~~~~~~l~~~l~~~~~~  517 (524)
T KOG0601|consen  491 QVLLKVMINPDRKRRPSAVELSLHSEF  517 (524)
T ss_pred             hhhhhhhcCCccccchhhhhhcccchh
Confidence            899999999999999999998766544

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.25  E-value=2.2e-11  Score=109.66  Aligned_cols=124  Identities=15%  Similarity=0.142  Sum_probs=88.4

Q ss_pred             eceeeccCCceEEE----eEEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCcee-EEEEEEEeCCCeEEEEEeccCCC
Q 012887          195 IDQIGPNSFKGVYK----GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNIL-QFYCVCVDENHGLCVVTKLMEGG  269 (454)
Q Consensus       195 ~~~LG~G~fG~Vy~----g~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv-~~~g~~~~~~~~l~lV~E~~~~g  269 (454)
                      ++.|+.|.++.||+    |..+++|.......   ....+.+|...+..+.+.+++ +++...  ... -++|||+++|.
T Consensus         3 ~~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~-~~lv~e~i~G~   76 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVANKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFD--PET-GVLITEFIEGS   76 (170)
T ss_pred             eeecCCcccCceEEEEECCeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEe--CCC-CeEEEEecCCC
Confidence            45689999999997    46788887653221   122356777777776544443 455443  222 46999999998


Q ss_pred             CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCc-----ccCCccCCcEEEccCCcEEEEccCCccc
Q 012887          270 SVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGV-----AYRDLNSQRILLDRHGNVCLGDMGIVTA  333 (454)
Q Consensus       270 sL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~i-----iHrDIKp~NILl~~~~~vKL~DFGla~~  333 (454)
                      ++.+.    . .   ....++.+++.+|..||+.++     +|+|++|.||+++ ++.++++|||.+..
T Consensus        77 ~l~~~----~-~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          77 ELLTE----D-F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             ccccc----c-c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            87643    0 1   113456789999999999985     9999999999999 67899999998653

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.23  E-value=1.4e-11  Score=130.47  Aligned_cols=139  Identities=18%  Similarity=0.195  Sum_probs=89.7

Q ss_pred             CCEEEeceeeccCCceEEE------eEEEEEEEeecCCCC--------------------------------chHH----
Q 012887          190 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKG--------------------------------NAYE----  227 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~------g~~vavK~l~~~~~~--------------------------------~~~~----  227 (454)
                      .+|+. +.||+|++|.||+      |+.||||+++.....                                ....    
T Consensus       120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~  198 (537)
T PRK04750        120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH  198 (537)
T ss_pred             HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence            34555 7899999999997      468999998743100                                0111    


Q ss_pred             --HHHHHHHHHHHhC----CCCceeEEEEEEEeCCCeEEEEEeccCCCCHHHHH--HhCC----CCCHHHHHHHHHHHHH
Q 012887          228 --FELRKDLLELMTC----GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLI--LKSR----KLQTKEIIRIAIDVAE  295 (454)
Q Consensus       228 --~~~~~Ei~~l~~l----~HpnIv~~~g~~~~~~~~l~lV~E~~~~gsL~~~l--~~~~----~l~~~~~~~i~~qI~~  295 (454)
                        .++.+|...+.++    .+.+.+.+-.++.+-....+|||||++|+.+.++-  ...+    .+.+..+..++.|+  
T Consensus       199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi--  276 (537)
T PRK04750        199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV--  276 (537)
T ss_pred             HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH--
Confidence              1233444433333    24444444344433222367999999999998753  2222    23333444444444  


Q ss_pred             HHHHHHhcCcccCCccCCcEEEccCC----cEEEEccCCcccccc
Q 012887          296 GIKFLNDHGVAYRDLNSQRILLDRHG----NVCLGDMGIVTACKS  336 (454)
Q Consensus       296 gL~yLH~~~iiHrDIKp~NILl~~~~----~vKL~DFGla~~~~~  336 (454)
                           ...|++|+|+||.||+++.+|    .+++.|||++.....
T Consensus       277 -----f~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        277 -----FRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             -----HhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence                 469999999999999999988    999999999876643

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.19  E-value=2.2e-10  Score=106.37  Aligned_cols=99  Identities=18%  Similarity=0.199  Sum_probs=74.0

Q ss_pred             HHHHHHHHhCC--CCceeEEEEEEEeCCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHH-HhcCccc
Q 012887          231 RKDLLELMTCG--HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL-NDHGVAY  307 (454)
Q Consensus       231 ~~Ei~~l~~l~--HpnIv~~~g~~~~~~~~l~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yL-H~~~iiH  307 (454)
                      ++|...|.++.  .-++.+.+++   .+  -++||||+.++.+..-..+...++......+..+++.+|..| |+.|+||
T Consensus        74 ~kE~r~L~rl~~~Gv~vP~pi~~---~~--~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVH  148 (197)
T cd05146          74 EKEMHNLKRMQKAGIPCPEVVVL---KK--HVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVH  148 (197)
T ss_pred             HHHHHHHHHHHHcCCCCCeEEEe---cC--CEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeec
Confidence            38888888873  3456666654   22  469999997754432222233456667778889999999999 8999999


Q ss_pred             CCccCCcEEEccCCcEEEEccCCccccc
Q 012887          308 RDLNSQRILLDRHGNVCLGDMGIVTACK  335 (454)
Q Consensus       308 rDIKp~NILl~~~~~vKL~DFGla~~~~  335 (454)
                      +||++.|||++ ++.+.|+|||.+....
T Consensus       149 GDLs~~NIL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         149 ADLSEYNMLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             CCCCHHHEEEE-CCcEEEEECCCceeCC
Confidence            99999999997 5789999999876543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=98.96  E-value=7.4e-09  Score=94.00  Aligned_cols=126  Identities=17%  Similarity=0.170  Sum_probs=86.6

Q ss_pred             eeeccCCceEEEeEE---EEEEEeecCC--CCch-----HHHHHHHHHHHHHhCCC--CceeEEEEEEEeCCCeEEEEEe
Q 012887          197 QIGPNSFKGVYKGKR---VGIEKLKGCD--KGNA-----YEFELRKDLLELMTCGH--KNILQFYCVCVDENHGLCVVTK  264 (454)
Q Consensus       197 ~LG~G~fG~Vy~g~~---vavK~l~~~~--~~~~-----~~~~~~~Ei~~l~~l~H--pnIv~~~g~~~~~~~~l~lV~E  264 (454)
                      .+++|+=+.+|.+..   -||.|.+..+  ..+.     ......+|..++..+.-  -++..+++  .+.+. ..|+||
T Consensus         3 ~i~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~d--vD~~~-~~I~me   79 (204)
T COG3642           3 LIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYD--VDPDN-GLIVME   79 (204)
T ss_pred             hhhCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEE--EcCCC-CEEEEE
Confidence            467888888887622   1444443322  1122     22345677777776543  23333333  34444 569999


Q ss_pred             ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccc
Q 012887          265 LMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTA  333 (454)
Q Consensus       265 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~  333 (454)
                      |.+|..|.+.+...       ...++..+-.-+.-||..||+|+||.++||+++.++ +.++||||+..
T Consensus        80 ~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          80 YIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             EeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            99999999898654       255667777778889999999999999999999655 99999999753

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=98.90  E-value=5.9e-09  Score=97.68  Aligned_cols=136  Identities=15%  Similarity=0.183  Sum_probs=97.1

Q ss_pred             ceeeccCCceEEEe-----EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCC--CceeEEEEEEEeCC--CeEEEEEecc
Q 012887          196 DQIGPNSFKGVYKG-----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGH--KNILQFYCVCVDEN--HGLCVVTKLM  266 (454)
Q Consensus       196 ~~LG~G~fG~Vy~g-----~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~H--pnIv~~~g~~~~~~--~~l~lV~E~~  266 (454)
                      +.||.|.++.||+.     +.+++|........ .....+..|...+..+.+  .++.+++.+.....  ...++||||+
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i   82 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV   82 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence            56899999999983     56777776533221 123456788888887754  44566776655432  1368999999


Q ss_pred             CCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------------
Q 012887          267 EGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLND--------------------------------------------  302 (454)
Q Consensus       267 ~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~--------------------------------------------  302 (454)
                      +|.++.+.+.. ..+++.....++.+++.+|.+||+                                            
T Consensus        83 ~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (223)
T cd05154          83 DGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLL  161 (223)
T ss_pred             CCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHH
Confidence            99888765422 356777777777788888777773                                            


Q ss_pred             ------------cCcccCCccCCcEEEcc--CCcEEEEccCCccc
Q 012887          303 ------------HGVAYRDLNSQRILLDR--HGNVCLGDMGIVTA  333 (454)
Q Consensus       303 ------------~~iiHrDIKp~NILl~~--~~~vKL~DFGla~~  333 (454)
                                  ..++|+|+.|.||+++.  ++.+.|.||+.+..
T Consensus       162 ~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         162 RWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                        23689999999999998  56789999998653

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=98.84  E-value=2.1e-08  Score=90.82  Aligned_cols=139  Identities=20%  Similarity=0.274  Sum_probs=91.1

Q ss_pred             EeceeeccCCceEEEe----EEEEEE-----EeecCCCCch-HHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEE
Q 012887          194 FIDQIGPNSFKGVYKG----KRVGIE-----KLKGCDKGNA-YEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  263 (454)
Q Consensus       194 ~~~~LG~G~fG~Vy~g----~~vavK-----~l~~~~~~~~-~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~  263 (454)
                      .+..|-+|+=+.|+++    +..-||     ..+....... ...+..+|.+.|.++.--.|.--.=++.+... -.|+|
T Consensus        11 ~l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~-~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYG-GQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCC-CeEEE
Confidence            3456778888888875    333333     2222111111 23456778888877642222221113334433 56999


Q ss_pred             eccCC-CCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCc---EEEEccCCccc
Q 012887          264 KLMEG-GSVNDLILKSR--KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGN---VCLGDMGIVTA  333 (454)
Q Consensus       264 E~~~~-gsL~~~l~~~~--~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~---vKL~DFGla~~  333 (454)
                      ||.+| .++.+++....  .........++..|-+.+.-||..+|||+||..+||++..++.   +-+.|||++..
T Consensus        90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence            99977 47888886532  3333444788999999999999999999999999999977663   57999999643

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.80  E-value=9.1e-08  Score=93.44  Aligned_cols=103  Identities=11%  Similarity=0.059  Sum_probs=75.4

Q ss_pred             HHHHHHHHHhCC--CCceeEEEEEEEeC----CCeEEEEEeccCCC-CHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHH
Q 012887          230 LRKDLLELMTCG--HKNILQFYCVCVDE----NHGLCVVTKLMEGG-SVNDLILK--SRKLQTKEIIRIAIDVAEGIKFL  300 (454)
Q Consensus       230 ~~~Ei~~l~~l~--HpnIv~~~g~~~~~----~~~l~lV~E~~~~g-sL~~~l~~--~~~l~~~~~~~i~~qI~~gL~yL  300 (454)
                      ..+|...+..+.  .-.+.+.+++....    ...-++|||++++. +|.+++..  ....+......++.+++..+.-|
T Consensus        75 a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~L  154 (268)
T PRK15123         75 ADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDM  154 (268)
T ss_pred             HHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHH
Confidence            557776666552  22222333333221    12367999999886 89999853  33566777889999999999999


Q ss_pred             HhcCcccCCccCCcEEEcc-------CCcEEEEccCCcc
Q 012887          301 NDHGVAYRDLNSQRILLDR-------HGNVCLGDMGIVT  332 (454)
Q Consensus       301 H~~~iiHrDIKp~NILl~~-------~~~vKL~DFGla~  332 (454)
                      |..||+|+|+++.|||++.       ++.+.|+||+.+.
T Consensus       155 H~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~  193 (268)
T PRK15123        155 HAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ  193 (268)
T ss_pred             HHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence            9999999999999999985       4578999999864

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.74  E-value=4e-09  Score=111.55  Aligned_cols=144  Identities=22%  Similarity=0.375  Sum_probs=101.9

Q ss_pred             HHHHHHHHHHhc-CcccCCccCCcEEEccCCcEEEEccCCccccccCCCc--cccc-------CCCCcccccccccCCCC
Q 012887          292 DVAEGIKFLNDH-GVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA--TEYE-------TDGYRWLAPEIIAGDPE  361 (454)
Q Consensus       292 qI~~gL~yLH~~-~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~--~~~~-------~gt~~y~APE~l~~~~~  361 (454)
                      +++.||.|+|.. ++||+.|.|++|.++.+|..||+-|+++.......+.  ..+.       .....|.|||++.+...
T Consensus       107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~~  186 (700)
T KOG2137|consen  107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTTN  186 (700)
T ss_pred             cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccccc
Confidence            344899999975 8999999999999999999999999986544432221  1111       12346999999987533


Q ss_pred             CCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHH--HHHHHHHHcCCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHH
Q 012887          362 SVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPV--QAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEI  438 (454)
Q Consensus       362 ~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~--~~~~~i~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~el  438 (454)
                          +.++|+||+||++|-++. |..-+......  ........+-.....+.++|.++++=+.+++..++.-||++.++
T Consensus       187 ----~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l  262 (700)
T KOG2137|consen  187 ----TPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLL  262 (700)
T ss_pred             ----cccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhh
Confidence                345999999999999995 55555433211  11111111112233457789999999999999999999977766


Q ss_pred             H
Q 012887          439 I  439 (454)
Q Consensus       439 l  439 (454)
                      .
T Consensus       263 ~  263 (700)
T KOG2137|consen  263 L  263 (700)
T ss_pred             h
Confidence            4

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.72  E-value=2e-07  Score=93.89  Aligned_cols=247  Identities=15%  Similarity=0.198  Sum_probs=155.5

Q ss_pred             EEeceeeccCCceEEEe-E--EEEEEEeecCCCCchHHHHHHHHHHHHHh-CCCCceeE--------EEEEEEeCCCeEE
Q 012887          193 EFIDQIGPNSFKGVYKG-K--RVGIEKLKGCDKGNAYEFELRKDLLELMT-CGHKNILQ--------FYCVCVDENHGLC  260 (454)
Q Consensus       193 ~~~~~LG~G~fG~Vy~g-~--~vavK~l~~~~~~~~~~~~~~~Ei~~l~~-l~HpnIv~--------~~g~~~~~~~~l~  260 (454)
                      .....||+|+-+.+|.- .  .-..|+....  ......+...|   |.. -.||-+-.        ++|-  +....+.
T Consensus        14 ~~gr~LgqGgea~ly~l~e~~d~VAKIYh~P--ppa~~aqk~a~---la~~p~~p~~~~rvaWPqa~L~G~--~~~~~iG   86 (637)
T COG4248          14 PPGRPLGQGGEADLYTLGEVRDQVAKIYHAP--PPAAQAQKVAE---LAATPDAPLLNYRVAWPQATLHGG--RRGKVIG   86 (637)
T ss_pred             CCCccccCCccceeeecchhhchhheeecCC--CchHHHHHHHH---hccCCCCcchhhhhcccHHHhhCC--CccceeE
Confidence            34567999999999972 2  1223433322  22222222222   222 24554332        1111  1111256


Q ss_pred             EEEeccCCCC-HHHHHH---h---CCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccc
Q 012887          261 VVTKLMEGGS-VNDLIL---K---SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTA  333 (454)
Q Consensus       261 lV~E~~~~gs-L~~~l~---~---~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~  333 (454)
                      +.|..+++.. +.++++   +   ....++.-+++.+..++.+..-||++|.+-+|+.++|+|+++++.|.|.|-.....
T Consensus        87 flmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi  166 (637)
T COG4248          87 FLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQI  166 (637)
T ss_pred             EecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccceee
Confidence            7777776542 333332   1   12477899999999999999999999999999999999999999999988543222


Q ss_pred             cccCCCcccccCCCCccccccccc-CCCCCCCCCchhhHHHHHHHHHHHHcC-CCCCCCCC-------HHHHH--HH---
Q 012887          334 CKSVGEATEYETDGYRWLAPEIIA-GDPESVSETWMSNVYSFGMVIWEMVTG-EAAYAACS-------PVQAA--VG---  399 (454)
Q Consensus       334 ~~~~~~~~~~~~gt~~y~APE~l~-~~~~~~~~~~ksDVwSlGviL~elltG-~~Pf~~~~-------~~~~~--~~---  399 (454)
                       ..++.......|...|++||.-. +.......+...|.|.|||++++++.| +.||.+..       +.+..  ..   
T Consensus       167 -~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~  245 (637)
T COG4248         167 -NANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFA  245 (637)
T ss_pred             -ccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceee
Confidence             23333445567888999999765 222222233458999999999999885 99997521       22211  00   


Q ss_pred             ---HHHcCCCC---CCCC-CccHHHHHHHHHhcccC--CCCCCCHHHHHHHHHhhcC
Q 012887          400 ---IAACGLRP---EIPK-DCPQILKSLMIKCWNNS--PSKRPQFSEIISLLLRTNN  447 (454)
Q Consensus       400 ---i~~~~~~~---~~p~-~~~~~l~~li~~cl~~d--P~~RPs~~ell~~L~~~~~  447 (454)
                         ....+.++   .+|- -+++++..+..+|+..-  +.-|||++..+..|..+..
T Consensus       246 ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~  302 (637)
T COG4248         246 YASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQ  302 (637)
T ss_pred             echhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHH
Confidence               01112221   1222 35789999999999864  5689999999988877654

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.62  E-value=1.6e-06  Score=89.51  Aligned_cols=202  Identities=13%  Similarity=0.207  Sum_probs=138.0

Q ss_pred             eEEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeC---CCeEEEEEeccCC-CCHHHHHH--------
Q 012887          209 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDE---NHGLCVVTKLMEG-GSVNDLIL--------  276 (454)
Q Consensus       209 g~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~---~~~l~lV~E~~~~-gsL~~~l~--------  276 (454)
                      |..+..|++.........  ....-+..++++.|+|||++.+++...   +..+++|++|.++ ++|.++--        
T Consensus       301 G~~YvLkRlhg~r~~~~n--k~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~  378 (655)
T KOG3741|consen  301 GNAYVLKRLHGDRDQSTN--KDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLYFANPPFTKR  378 (655)
T ss_pred             CceeeeeeeccccccCcc--cchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHHccCCccccc
Confidence            667888888322111111  112345667888999999999998733   3458999999885 46776641        


Q ss_pred             -------hCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCcccccCCCCc
Q 012887          277 -------KSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR  349 (454)
Q Consensus       277 -------~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~gt~~  349 (454)
                             .+...++..+|.|+.|+..||.++|+.|+.-+-|.|.+||++.+.+++|+--|+......+.       +   
T Consensus       379 ~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~-------~---  448 (655)
T KOG3741|consen  379 TNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDP-------T---  448 (655)
T ss_pred             cccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecCCC-------C---
Confidence                   12357889999999999999999999999999999999999988888887666533222111       0   


Q ss_pred             ccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCC-CCCCHHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhcccC
Q 012887          350 WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAY-AACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNS  428 (454)
Q Consensus       350 y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf-~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~li~~cl~~d  428 (454)
                          |-+.+.       .+-|.=.||.++..|.+|..-- ......+....        .+-..++.++++++.......
T Consensus       449 ----~~le~~-------Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~--------~I~~~yS~D~rn~v~yl~s~~  509 (655)
T KOG3741|consen  449 ----EPLESQ-------QQNDLRDLGLLLLALATGTENSNRTDSTQSSHLT--------RITTTYSTDLRNVVEYLESLN  509 (655)
T ss_pred             ----cchhHH-------hhhhHHHHHHHHHHHhhcccccccccchHHHHHH--------HhhhhhhHHHHHHHHHHHhcC
Confidence                112111       1358899999999999985431 11222221111        123456788889998888888


Q ss_pred             CCCCCCHHHHHHHH
Q 012887          429 PSKRPQFSEIISLL  442 (454)
Q Consensus       429 P~~RPs~~ell~~L  442 (454)
                      +++ -+..+++.++
T Consensus       510 ~~~-ksI~~llp~~  522 (655)
T KOG3741|consen  510 FRE-KSIQDLLPMI  522 (655)
T ss_pred             ccc-ccHHHHHHHH
Confidence            876 6778877665

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.62  E-value=5.4e-07  Score=84.62  Aligned_cols=105  Identities=18%  Similarity=0.197  Sum_probs=79.9

Q ss_pred             HHHHHHHHHHhCC--CCceeEEEEEEEeCC---CeEEEEEeccCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh
Q 012887          229 ELRKDLLELMTCG--HKNILQFYCVCVDEN---HGLCVVTKLMEGG-SVNDLILKSRKLQTKEIIRIAIDVAEGIKFLND  302 (454)
Q Consensus       229 ~~~~Ei~~l~~l~--HpnIv~~~g~~~~~~---~~l~lV~E~~~~g-sL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~  302 (454)
                      ...+|...+..+.  .-.+.+.+++.....   ...++|||++++. +|.+++......+......++.+++..+.-||+
T Consensus        57 ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH~  136 (206)
T PF06293_consen   57 RAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLHD  136 (206)
T ss_pred             HHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHHH
Confidence            3556666655542  223344444444322   2357999999874 799998765557788889999999999999999


Q ss_pred             cCcccCCccCCcEEEccCC---cEEEEccCCccc
Q 012887          303 HGVAYRDLNSQRILLDRHG---NVCLGDMGIVTA  333 (454)
Q Consensus       303 ~~iiHrDIKp~NILl~~~~---~vKL~DFGla~~  333 (454)
                      +||+|+|+++.|||++.++   .+.++||+.+..
T Consensus       137 ~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  137 AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             CcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            9999999999999999887   799999997654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PRK09902 hypothetical protein; Provisional

Probab=98.54  E-value=2.1e-06  Score=80.36  Aligned_cols=134  Identities=13%  Similarity=0.027  Sum_probs=94.7

Q ss_pred             eccCCceEEE----eEEEEEEEeecCCCC----chHHHHHHHHHHHHHhCC--CCceeEEE--EEEEeC-CCeEEEEEec
Q 012887          199 GPNSFKGVYK----GKRVGIEKLKGCDKG----NAYEFELRKDLLELMTCG--HKNILQFY--CVCVDE-NHGLCVVTKL  265 (454)
Q Consensus       199 G~G~fG~Vy~----g~~vavK~l~~~~~~----~~~~~~~~~Ei~~l~~l~--HpnIv~~~--g~~~~~-~~~l~lV~E~  265 (454)
                      |+|+.+.|++    |+.+-+|.-.+.-..    ..-+..+.+|+..|..+.  .-.+.+..  +.-... ....+||+|-
T Consensus        27 ~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVTe~  106 (216)
T PRK09902         27 RRNGMSGVQCVERNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVTED  106 (216)
T ss_pred             CCCCcceEEEEEeCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEEEe
Confidence            6788888987    556777765421111    223456788888887763  22244444  211111 1236799996


Q ss_pred             cC-CCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCc--EEEEccCCcc
Q 012887          266 ME-GGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGN--VCLGDMGIVT  332 (454)
Q Consensus       266 ~~-~gsL~~~l~~~--~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~--vKL~DFGla~  332 (454)
                      ++ .-+|.+++.+.  .+.+......++.+|+..+.-||+.|+.|+|+.+.|||++.+|.  ++++||--++
T Consensus       107 L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r  178 (216)
T PRK09902        107 MAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR  178 (216)
T ss_pred             CCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence            65 35899887543  25677888899999999999999999999999999999987777  9999997644

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.46  E-value=1.3e-08  Score=106.68  Aligned_cols=187  Identities=15%  Similarity=0.080  Sum_probs=138.7

Q ss_pred             CEEEeceeeccCCceEEEeEEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCc-eeEEEEEEEeCCCeEEEEEeccCCC
Q 012887          191 NLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKN-ILQFYCVCVDENHGLCVVTKLMEGG  269 (454)
Q Consensus       191 ~~~~~~~LG~G~fG~Vy~g~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~Hpn-Iv~~~g~~~~~~~~l~lV~E~~~~g  269 (454)
                      .+...+..++|+++.++|.+..|-|.+........  ..+.-++..|.+++||| .+.+++-+..++. .+++|+++.++
T Consensus       243 ws~~fh~fvK~altknpKkRptaeklL~h~fvs~~--l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~-~~i~~~i~s~~  319 (829)
T KOG0576|consen  243 WSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT--LSRRLAIELLDKVNNPNPVVRYLEDYDGEDY-LWIPMRICSTG  319 (829)
T ss_pred             chHHHHHHHHHHhcCCCccCCChhhheeceeeccc--hhhHHHHHHHHHccCCCCcccccccCCcccc-cchhhhhhcCC
Confidence            35667889999999999999988888874333332  34556777889999999 7777777766665 88999999887


Q ss_pred             -CHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCcccccCCC
Q 012887          270 -SVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG  347 (454)
Q Consensus       270 -sL~~~l~~-~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~gt  347 (454)
                       +....... .-.+...+...+...-.++|+|||+..=+|||    ||+.++ +..|.+||+....+.... ......++
T Consensus       320 rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~-~~~t~~~~  393 (829)
T KOG0576|consen  320 RSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM-KPRTAIGT  393 (829)
T ss_pred             ccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCccc-ccccCCCC
Confidence             32222111 11355556666777788899999998889999    888774 679999999876655433 34455788


Q ss_pred             CcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 012887          348 YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAA  390 (454)
Q Consensus       348 ~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~  390 (454)
                      +.|+|||+...+.+..    +.|+|++|+--.+|.-|-+|-..
T Consensus       394 ~~~~~pev~~~~~~~~----~p~~~~~~~~~~~~ap~~pPr~~  432 (829)
T KOG0576|consen  394 PEPLAPEVIQENTIDG----CPDSGSLAVSAIQMAPGLPPRSS  432 (829)
T ss_pred             CCCCCchhhccccccc----CCCccCCCcchhhcCCCCCCCCC
Confidence            9999999988776544    48999999988888888777543

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.44  E-value=4.1e-07  Score=84.16  Aligned_cols=100  Identities=20%  Similarity=0.210  Sum_probs=66.0

Q ss_pred             HHHHHHHHHHHhCCCC--ceeEEEEEEEeCCCeEEEEEeccC--CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHH-HHh
Q 012887          228 FELRKDLLELMTCGHK--NILQFYCVCVDENHGLCVVTKLME--GGSVNDLILKSRKLQTKEIIRIAIDVAEGIKF-LND  302 (454)
Q Consensus       228 ~~~~~Ei~~l~~l~Hp--nIv~~~g~~~~~~~~l~lV~E~~~--~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~y-LH~  302 (454)
                      ....+|...|..+..-  ++.+.+++  . +  -.|||||++  |..+..+...  .++......++.+++..+.. +|+
T Consensus        53 ~~~~~E~~~L~~l~~~Gv~vP~p~~~--~-~--~~ivME~I~~~G~~~~~l~~~--~~~~~~~~~~~~~il~~~~~~~~~  125 (188)
T PF01163_consen   53 EWAKKEFRNLKRLYEAGVPVPKPYDY--N-R--NVIVMEYIGEDGVPLPRLKDV--DLSPEEPKELLEEILEEIIKMLHK  125 (188)
T ss_dssp             HHHHHHHHHHHHCCCTT-SS--EEEE--E-T--TEEEEE--EETTEEGGCHHHC--GGGGSTHHHHHHHHHHHHHHHHHC
T ss_pred             HHHHHHHHHHHHHHHCCccCCcEEEE--e-C--CEEEEEecCCCccchhhHHhc--cccchhHHHHHHHHHHHHHHHHHh
Confidence            3467899999998654  45666644  2 2  359999998  6555544321  12244556677788886665 579


Q ss_pred             cCcccCCccCCcEEEccCCcEEEEccCCccccc
Q 012887          303 HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK  335 (454)
Q Consensus       303 ~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~  335 (454)
                      .||+|+||.+.|||++.+ .+.|+|||.+....
T Consensus       126 ~givHGDLs~~NIlv~~~-~~~iIDf~qav~~~  157 (188)
T PF01163_consen  126 AGIVHGDLSEYNILVDDG-KVYIIDFGQAVDSS  157 (188)
T ss_dssp             TTEEESS-STTSEEEETT-CEEE--GTTEEETT
T ss_pred             cCceecCCChhhEEeecc-eEEEEecCcceecC
Confidence            999999999999999977 89999999876543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.25  E-value=5e-06  Score=80.00  Aligned_cols=130  Identities=17%  Similarity=0.210  Sum_probs=89.4

Q ss_pred             EEeceeeccCCceEEEe-----EEEEEEEeecC------------------CCC--chHHHHHHHHHHHHHhCCCC--ce
Q 012887          193 EFIDQIGPNSFKGVYKG-----KRVGIEKLKGC------------------DKG--NAYEFELRKDLLELMTCGHK--NI  245 (454)
Q Consensus       193 ~~~~~LG~G~fG~Vy~g-----~~vavK~l~~~------------------~~~--~~~~~~~~~Ei~~l~~l~Hp--nI  245 (454)
                      .++..||-|.=+.||.|     .++++|.=+..                  ..+  .......++|...|..|...  .|
T Consensus        94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V  173 (304)
T COG0478          94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV  173 (304)
T ss_pred             hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence            46788999999999984     67888843211                  011  11234467888888887533  56


Q ss_pred             eEEEEEEEeCCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEE
Q 012887          246 LQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCL  325 (454)
Q Consensus       246 v~~~g~~~~~~~~l~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL  325 (454)
                      .+-+++    +. ..+||||.+|--|...     +++....-.++..|+.-+.-+-..|+||+|+.+-||+++++|.+.+
T Consensus       174 P~P~~~----nR-HaVvMe~ieG~eL~~~-----r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~v  243 (304)
T COG0478         174 PKPIAW----NR-HAVVMEYIEGVELYRL-----RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIVV  243 (304)
T ss_pred             CCcccc----cc-ceeeeehcccceeecc-----cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEEE
Confidence            665543    22 5799999999666543     2234444445555555555555899999999999999999999999


Q ss_pred             EccCCcc
Q 012887          326 GDMGIVT  332 (454)
Q Consensus       326 ~DFGla~  332 (454)
                      +||--+.
T Consensus       244 IDwPQ~v  250 (304)
T COG0478         244 IDWPQAV  250 (304)
T ss_pred             EeCcccc
Confidence            9996543

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.18  E-value=2.6e-05  Score=73.46  Aligned_cols=134  Identities=17%  Similarity=0.239  Sum_probs=81.3

Q ss_pred             CCEEEeceeeccCCceEEE----eEEEEEEEeecCCCCchHHHH-------HHHHHHH---HHhCCCCceeEEEEEEEeC
Q 012887          190 DNLEFIDQIGPNSFKGVYK----GKRVGIEKLKGCDKGNAYEFE-------LRKDLLE---LMTCGHKNILQFYCVCVDE  255 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~----g~~vavK~l~~~~~~~~~~~~-------~~~Ei~~---l~~l~HpnIv~~~g~~~~~  255 (454)
                      .+|++++.+-......|.+    |+..-+|.-+.........+.       ..+.+..   +....-.....++.+..-.
T Consensus        31 ~~~~~~kv~k~~~r~~ValIei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk  110 (229)
T PF06176_consen   31 NNYKIIKVFKNTKRNYVALIEIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKK  110 (229)
T ss_pred             CCceEEEeecCCCccEEEEEEECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeee
Confidence            5667777666666666665    556666665543322211111       1122222   2222223333333222211


Q ss_pred             C----CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCc
Q 012887          256 N----HGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIV  331 (454)
Q Consensus       256 ~----~~l~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla  331 (454)
                      .    ...+++|||++|..|.+..    .+++    .+...|..++.-||+.|+.|+|..|.|++++.++ +++.||+..
T Consensus       111 ~~~~~~~~~ll~EYIeG~~l~d~~----~i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~-i~iID~~~k  181 (229)
T PF06176_consen  111 IFRYTSSYVLLMEYIEGVELNDIE----DIDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG-IRIIDTQGK  181 (229)
T ss_pred             eccceeEEEEEEEEecCeecccch----hcCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc-EEEEECccc
Confidence            1    2256899999998887653    2333    2445677889999999999999999999999555 999999875


Q ss_pred             c
Q 012887          332 T  332 (454)
Q Consensus       332 ~  332 (454)
                      +
T Consensus       182 ~  182 (229)
T PF06176_consen  182 R  182 (229)
T ss_pred             c
Confidence            4

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.11  E-value=8.6e-05  Score=69.12  Aligned_cols=136  Identities=17%  Similarity=0.247  Sum_probs=94.2

Q ss_pred             CCccccceeecCCCEEEeceeeccCC-ceEEE----eEEEEEEEeecCC---C------Cc----------hHHHHHHHH
Q 012887          178 GGEEIGRWLLNSDNLEFIDQIGPNSF-KGVYK----GKRVGIEKLKGCD---K------GN----------AYEFELRKD  233 (454)
Q Consensus       178 ~~~~~~~~~~~~~~~~~~~~LG~G~f-G~Vy~----g~~vavK~l~~~~---~------~~----------~~~~~~~~E  233 (454)
                      .++.++++.....++++++.||.|.- |.||+    |+.+|+|..+.-.   .      ..          .....+..|
T Consensus        25 ~gPKL~~F~~h~~~I~flefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~E  104 (207)
T PF13095_consen   25 PGPKLEPFTHHGDDIEFLEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCE  104 (207)
T ss_pred             CCCCcCCcCCCCCcEeeeeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHH
Confidence            45666777776689999999999999 99998    6789999932210   0      00          112235566


Q ss_pred             HHHHHhC---CCCce--eEEEEEEEeCC-----------------CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHH
Q 012887          234 LLELMTC---GHKNI--LQFYCVCVDEN-----------------HGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAI  291 (454)
Q Consensus       234 i~~l~~l---~HpnI--v~~~g~~~~~~-----------------~~l~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~  291 (454)
                      .+...+|   ++.++  |+++||..-..                 ....||.||.+...         .+...    =+.
T Consensus       105 CRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~~----~~~  171 (207)
T PF13095_consen  105 CRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQIR----DIP  171 (207)
T ss_pred             HHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccchh----HHH
Confidence            6655544   56667  99999985331                 11457888776533         22222    245


Q ss_pred             HHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCc
Q 012887          292 DVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIV  331 (454)
Q Consensus       292 qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla  331 (454)
                      +|.+-|..+|..||+-+|+++.|..   +|  ||+|||.+
T Consensus       172 ~~~~dl~~~~k~gI~~~Dv~~~ny~---~G--~lvDfs~~  206 (207)
T PF13095_consen  172 QMLRDLKILHKLGIVPRDVKPRNYR---GG--KLVDFSSS  206 (207)
T ss_pred             HHHHHHHHHHHCCeeeccCcccccc---CC--EEEecccC
Confidence            7778889999999999999999987   33  89999864

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.09  E-value=2e-05  Score=88.27  Aligned_cols=204  Identities=13%  Similarity=0.191  Sum_probs=144.9

Q ss_pred             HHHHHHHHHHHhCCCCceeEEEEEEEeCCC-e--EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 012887          228 FELRKDLLELMTCGHKNILQFYCVCVDENH-G--LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHG  304 (454)
Q Consensus       228 ~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~-~--l~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~  304 (454)
                      ...+.|+..+....|+|++.++++-..... +  +.+..|++...++...+..-..++....+.+..++.+||.|+|+..
T Consensus       227 ~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~  306 (1351)
T KOG1035|consen  227 QTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLS  306 (1351)
T ss_pred             HHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhc
Confidence            335566777788899999999988765532 1  2345588999999999887789999999999999999999999997


Q ss_pred             cccCCccCC---cEEEccCCcEEEE--ccCCccccccCCCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHH
Q 012887          305 VAYRDLNSQ---RILLDRHGNVCLG--DMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIW  379 (454)
Q Consensus       305 iiHrDIKp~---NILl~~~~~vKL~--DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~  379 (454)
                      ..|.-+...   +--.+..+.+.++  ||+.......... ......+..|.|||........  .....|+|.+|....
T Consensus       307 l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~-~~~~~~~~~~~~~e~~~~~~~~--~~r~~dL~~lgll~~  383 (1351)
T KOG1035|consen  307 LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK-SFSDLLAEIRNADEDLKENTAK--KSRLTDLWCLGLLLL  383 (1351)
T ss_pred             cceeEEecccccccccCccceeecchhhhcccccCCCccc-chhhcCccccccccccccccch--hhhhhHHHHHHHHHh
Confidence            777666555   4445566667776  8888776554332 2222334457788887765443  334579999999999


Q ss_pred             HHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 012887          380 EMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRT  445 (454)
Q Consensus       380 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~  445 (454)
                      .+..|..+-.-....           ..-++..+..+..+...+|+..++++|++..+++.+...-
T Consensus       384 ~~~~~~~i~~~~~~~-----------~~~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~  438 (1351)
T KOG1035|consen  384 QLSQGEDISEKSAVP-----------VSLLDVLSTSELLDALPKCLDEDSEERLSALELLTHPFLR  438 (1351)
T ss_pred             hhhhcCcccccccch-----------hhhhccccchhhhhhhhhhcchhhhhccchhhhhhchhcc
Confidence            998876542211000           1112333333788999999999999999999999876543

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.08  E-value=3.8e-05  Score=73.22  Aligned_cols=131  Identities=11%  Similarity=0.085  Sum_probs=76.2

Q ss_pred             ceeeccCCceEEE--eEEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCC--ceeEEEEEEEeCCCeEEEEEeccCCCC-
Q 012887          196 DQIGPNSFKGVYK--GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHK--NILQFYCVCVDENHGLCVVTKLMEGGS-  270 (454)
Q Consensus       196 ~~LG~G~fG~Vy~--g~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~Hp--nIv~~~g~~~~~~~~l~lV~E~~~~gs-  270 (454)
                      ..||+|..+.||+  |....+|....    ......+.+|.+.+..+..-  .+.+.+++..+.+. ..+|||+++|.+ 
T Consensus         7 ~~i~~G~t~~~y~~~~~~~VlR~~~~----~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~-~glv~e~i~G~~~   81 (226)
T TIGR02172         7 TQTGEGGNGESYTHKTGKWMLKLYNP----GFDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGR-LGLIYELIVGKRS   81 (226)
T ss_pred             eeecCCCCcceeEecCCCEEEEeCCC----CCCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCe-eeeeeeecCCccc
Confidence            4689999999998  44555555432    11234467888888776432  24556666655554 788999999863 


Q ss_pred             HHHH--------------HH-------hC--CCCCHHH-HHHHHHH----------HHHH-HHHHH----hcCcccCCcc
Q 012887          271 VNDL--------------IL-------KS--RKLQTKE-IIRIAID----------VAEG-IKFLN----DHGVAYRDLN  311 (454)
Q Consensus       271 L~~~--------------l~-------~~--~~l~~~~-~~~i~~q----------I~~g-L~yLH----~~~iiHrDIK  311 (454)
                      +...              +.       ..  ...+... ...+..+          +... ..+|.    ...++|+|+.
T Consensus        82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~  161 (226)
T TIGR02172        82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ  161 (226)
T ss_pred             hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence            2111              10       00  0111110 1111111          1111 22222    1247899999


Q ss_pred             CCcEEEccCCcEEEEccCCcc
Q 012887          312 SQRILLDRHGNVCLGDMGIVT  332 (454)
Q Consensus       312 p~NILl~~~~~vKL~DFGla~  332 (454)
                      |.||+++.++ +.+.||+.+.
T Consensus       162 ~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       162 IGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             CCcEEEcCCC-cEEEechhcC
Confidence            9999999888 9999999864

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.06  E-value=1.9e-05  Score=83.75  Aligned_cols=76  Identities=24%  Similarity=0.368  Sum_probs=57.6

Q ss_pred             EEEEEeccCCCCHHHHH-HhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCcccccc
Q 012887          259 LCVVTKLMEGGSVNDLI-LKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS  336 (454)
Q Consensus       259 l~lV~E~~~~gsL~~~l-~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~  336 (454)
                      -.|+|||++|..+.+.. .+...++.+.+.....++  -+.-+-..|+.|.|..|.||+++.+|.+.+.|||+.....+
T Consensus       241 ~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~--f~~q~~~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         241 RVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRA--FLRQLLRDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             cEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHH--HHHHHHhcCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            56999999999998885 233556655554444333  23444458999999999999999999999999999776654

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.03  E-value=4.5e-05  Score=72.77  Aligned_cols=136  Identities=18%  Similarity=0.178  Sum_probs=89.7

Q ss_pred             EeceeeccCCceEEE-----eEEEEEEEeecCCCCchH-----------------H-----HHHHHHHHHHHhCC--CCc
Q 012887          194 FIDQIGPNSFKGVYK-----GKRVGIEKLKGCDKGNAY-----------------E-----FELRKDLLELMTCG--HKN  244 (454)
Q Consensus       194 ~~~~LG~G~fG~Vy~-----g~~vavK~l~~~~~~~~~-----------------~-----~~~~~Ei~~l~~l~--Hpn  244 (454)
                      +...|.+|.-..||+     +..+|+|+.+.....-..                 .     .=.++|+..|.++.  +-.
T Consensus        52 ~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr  131 (268)
T COG1718          52 LVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR  131 (268)
T ss_pred             eEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence            345788888899999     468999987643211100                 0     01346777777752  344


Q ss_pred             eeEEEEEEEeCCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-cCcccCCccCCcEEEccCCcE
Q 012887          245 ILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLND-HGVAYRDLNSQRILLDRHGNV  323 (454)
Q Consensus       245 Iv~~~g~~~~~~~~l~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~-~~iiHrDIKp~NILl~~~~~v  323 (454)
                      +.+-+++..     -.|||||+....+--=..+.-.+.......+..+++.++.-|-. .++||+||+.-|||+. ++.+
T Consensus       132 vP~Pi~~~~-----nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p  205 (268)
T COG1718         132 VPEPIAFRN-----NVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEP  205 (268)
T ss_pred             CCCceeecC-----CeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeE
Confidence            445554432     35999999653110000011123334678888899999988866 8999999999999999 8889


Q ss_pred             EEEccCCccccc
Q 012887          324 CLGDMGIVTACK  335 (454)
Q Consensus       324 KL~DFGla~~~~  335 (454)
                      .|+|||-|....
T Consensus       206 ~iID~~QaV~~~  217 (268)
T COG1718         206 YIIDVSQAVTID  217 (268)
T ss_pred             EEEECccccccC
Confidence            999999876544

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.95  E-value=0.00016  Score=67.43  Aligned_cols=129  Identities=22%  Similarity=0.323  Sum_probs=85.6

Q ss_pred             ceeeccCCceEEEe---EEEEEEEeecCC--------------CCchHHHHHHHHHHHHHhC------CCCceeEEEEEE
Q 012887          196 DQIGPNSFKGVYKG---KRVGIEKLKGCD--------------KGNAYEFELRKDLLELMTC------GHKNILQFYCVC  252 (454)
Q Consensus       196 ~~LG~G~fG~Vy~g---~~vavK~l~~~~--------------~~~~~~~~~~~Ei~~l~~l------~HpnIv~~~g~~  252 (454)
                      ..||+|+.-.||.-   ....||+.+...              .......+..+|+.....+      .+.+|.+++|+.
T Consensus         7 ~~i~~G~~R~cy~HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~v   86 (199)
T PF10707_consen    7 DLIAQGGERDCYQHPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYGFV   86 (199)
T ss_pred             cccccCCCceEEECCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeEEE
Confidence            45899999999972   344566665433              0011223445555544333      489999999999


Q ss_pred             EeCCCeEEEEEeccCC------CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCC----c
Q 012887          253 VDENHGLCVVTKLMEG------GSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG----N  322 (454)
Q Consensus       253 ~~~~~~l~lV~E~~~~------gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~----~  322 (454)
                      .++-. +.+|+|...+      .+|.+++. .+.+++ .+...   +-+=.+||-+++|+.+|++|.||++....    .
T Consensus        87 eT~~G-~Glv~e~I~d~dG~~s~TL~~~l~-~~~~~~-~~~~~---L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~~~  160 (199)
T PF10707_consen   87 ETNLG-LGLVVELIRDADGNISPTLEDYLK-EGGLTE-ELRQA---LDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGEFR  160 (199)
T ss_pred             ecCCc-eEEEEEEEECCCCCcCccHHHHHH-cCCccH-HHHHH---HHHHHHHHHHcCCeecCCCcccEEEEecCCCceE
Confidence            87765 8889988642      36888884 344655 33333   33345688899999999999999996543    4


Q ss_pred             EEEEc-cCC
Q 012887          323 VCLGD-MGI  330 (454)
Q Consensus       323 vKL~D-FGl  330 (454)
                      +.|.| ||-
T Consensus       161 lvlIDG~G~  169 (199)
T PF10707_consen  161 LVLIDGLGE  169 (199)
T ss_pred             EEEEeCCCC
Confidence            77888 443

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.78  E-value=6.7e-05  Score=69.46  Aligned_cols=97  Identities=15%  Similarity=0.150  Sum_probs=77.5

Q ss_pred             HHHHHHHhCCC-CceeEEEEEEEeCCCeEEEEEeccCCCCHHHH---HHhCCCCCHHHHHHHHHHHHHHHHHHHh---cC
Q 012887          232 KDLLELMTCGH-KNILQFYCVCVDENHGLCVVTKLMEGGSVNDL---ILKSRKLQTKEIIRIAIDVAEGIKFLND---HG  304 (454)
Q Consensus       232 ~Ei~~l~~l~H-pnIv~~~g~~~~~~~~l~lV~E~~~~gsL~~~---l~~~~~l~~~~~~~i~~qI~~gL~yLH~---~~  304 (454)
                      .|..++..+.+ +++.+++|+|.     -.+|+||...+++.+.   +.+-...++....+++.++++.+++|+.   ..
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~CG-----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSCG-----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeECC-----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            46667777765 69999999994     3579999987766432   1122356899999999999999999987   35


Q ss_pred             cccCCccCCcEEEccCCcEEEEccCCccc
Q 012887          305 VAYRDLNSQRILLDRHGNVCLGDMGIVTA  333 (454)
Q Consensus       305 iiHrDIKp~NILl~~~~~vKL~DFGla~~  333 (454)
                      +.-.|++|+|+-++++|++|+.|...+..
T Consensus        83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~  111 (188)
T PF12260_consen   83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFV  111 (188)
T ss_pred             EEEeecchHHeEEeCCCcEEEEechhcch
Confidence            77789999999999999999999987544

Proteins in this uncharacterised family are described as transmembrane proteins.

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=97.77  E-value=0.00043  Score=64.83  Aligned_cols=134  Identities=13%  Similarity=0.131  Sum_probs=75.4

Q ss_pred             eceeeccCCceEEEeE----EEEEEEeecCCCCchHHHHHHHHHHHHHhCCC--CceeEEEEEEEeCC--CeEEEEEecc
Q 012887          195 IDQIGPNSFKGVYKGK----RVGIEKLKGCDKGNAYEFELRKDLLELMTCGH--KNILQFYCVCVDEN--HGLCVVTKLM  266 (454)
Q Consensus       195 ~~~LG~G~fG~Vy~g~----~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~H--pnIv~~~g~~~~~~--~~l~lV~E~~  266 (454)
                      ++.|+.|..+.||+..    .+.+|.....    .....+.+|...+..+..  ..+.+++.......  ...+++|+++
T Consensus         2 i~~l~~G~~n~~~~v~~~~~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i   77 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDDGRYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYI   77 (239)
T ss_dssp             EEEEEESSSSEEEEEEETTSEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEE
T ss_pred             CccCCCCCeeeEEEEEECCcEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEe
Confidence            4678999999999843    5777775421    344566777777666532  23556666443332  2368999999


Q ss_pred             CCCCHHH----------------HHH---hC--C--CCCHHH---------HHHH------------HHHHHH-HHHHHH
Q 012887          267 EGGSVND----------------LIL---KS--R--KLQTKE---------IIRI------------AIDVAE-GIKFLN  301 (454)
Q Consensus       267 ~~gsL~~----------------~l~---~~--~--~l~~~~---------~~~i------------~~qI~~-gL~yLH  301 (454)
                      +|..+..                .+.   +.  .  .+....         ....            ...+.. .++.++
T Consensus        78 ~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (239)
T PF01636_consen   78 PGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELE  157 (239)
T ss_dssp             SSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHH
Confidence            9988877                111   11  1  111000         0000            111222 233333


Q ss_pred             -------hcCcccCCccCCcEEEc-cCCcEEEEccCCcc
Q 012887          302 -------DHGVAYRDLNSQRILLD-RHGNVCLGDMGIVT  332 (454)
Q Consensus       302 -------~~~iiHrDIKp~NILl~-~~~~vKL~DFGla~  332 (454)
                             ...++|+|+.|.|||++ .++.+-|.||+.+.
T Consensus       158 ~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  158 ALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             hhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence                   24599999999999999 66767899998754

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=97.63  E-value=0.00055  Score=65.57  Aligned_cols=29  Identities=21%  Similarity=0.127  Sum_probs=25.7

Q ss_pred             CcccCCccCCcEEEccCCcEEEEccCCcc
Q 012887          304 GVAYRDLNSQRILLDRHGNVCLGDMGIVT  332 (454)
Q Consensus       304 ~iiHrDIKp~NILl~~~~~vKL~DFGla~  332 (454)
                      .++|+|+.|.|||++.++.+.|.||+.+.
T Consensus       164 ~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         164 VVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             EEECCCCCCccEEEeCCcEEEEEEccccc
Confidence            48999999999999988778899998754

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.50  E-value=0.00046  Score=62.73  Aligned_cols=128  Identities=17%  Similarity=0.224  Sum_probs=85.0

Q ss_pred             CCEEEeceeeccCCceEEEe----EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeE-EEEEEEeCCCeEEEEEe
Q 012887          190 DNLEFIDQIGPNSFKGVYKG----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQ-FYCVCVDENHGLCVVTK  264 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g----~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~-~~g~~~~~~~~l~lV~E  264 (454)
                      -..+..+.||+|.+|.||+|    ..+|+|+-+.    +.....++.|..+|..+.-.++.. +|.+-  .+   .+.||
T Consensus        22 ~~~~v~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~----ds~r~~l~kEakiLeil~g~~~~p~vy~yg--~~---~i~me   92 (201)
T COG2112          22 YELRVEKELAKGTTSVVYLGEWRGGEVALKVRRR----DSPRRNLEKEAKILEILAGEGVTPEVYFYG--ED---FIRME   92 (201)
T ss_pred             hhhhhhhhhhcccccEEEEeeccCceEEEEEecC----CcchhhHHHHHHHHHHhhhcCCCceEEEec--hh---hhhhh
Confidence            34466789999999999996    4677777653    233455778888777776656554 44332  22   35699


Q ss_pred             ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCcc-CCcEEEccCCcEEEEccCCccc
Q 012887          265 LMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLN-SQRILLDRHGNVCLGDMGIVTA  333 (454)
Q Consensus       265 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIK-p~NILl~~~~~vKL~DFGla~~  333 (454)
                      |..|-.|.+.....   +...    ...+++.-.-|-..||-|..|. |...+|..++.+-|+||.-|+.
T Consensus        93 ~i~G~~L~~~~~~~---~rk~----l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112          93 YIDGRPLGKLEIGG---DRKH----LLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             hhcCcchhhhhhcc---cHHH----HHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            99998888765321   2233    3345555555677899999886 4444444455899999998764

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=97.50  E-value=0.00029  Score=74.77  Aligned_cols=76  Identities=17%  Similarity=0.285  Sum_probs=54.8

Q ss_pred             EEEEEeccCCCCHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEcc----CCcEEEEccCCccc
Q 012887          259 LCVVTKLMEGGSVNDLIL-KSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDR----HGNVCLGDMGIVTA  333 (454)
Q Consensus       259 l~lV~E~~~~gsL~~~l~-~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~----~~~vKL~DFGla~~  333 (454)
                      -.|+||||+|..+.|+-. +...++...+...+.++.  ++-|-..|++|.|=.|.||++..    ++.+.+.|||+...
T Consensus       277 RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~--~~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~  354 (538)
T KOG1235|consen  277 RVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAY--LEQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAV  354 (538)
T ss_pred             eEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHH--HHHHHhcCCccCCCCCCcEEEecCCCCCccEEEEccccccc
Confidence            679999999998877641 334566665554444432  23344578999999999999994    56799999999766


Q ss_pred             ccc
Q 012887          334 CKS  336 (454)
Q Consensus       334 ~~~  336 (454)
                      ...
T Consensus       355 is~  357 (538)
T KOG1235|consen  355 ISH  357 (538)
T ss_pred             ccH
Confidence            543

>PLN02876 acyl-CoA dehydrogenase

Probab=97.39  E-value=0.0016  Score=73.64  Aligned_cols=75  Identities=19%  Similarity=0.322  Sum_probs=49.0

Q ss_pred             eceeeccCCceEEEe--------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCC-CCce--eEEEEEEEeCC--CeEEE
Q 012887          195 IDQIGPNSFKGVYKG--------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCG-HKNI--LQFYCVCVDEN--HGLCV  261 (454)
Q Consensus       195 ~~~LG~G~fG~Vy~g--------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~-HpnI--v~~~g~~~~~~--~~l~l  261 (454)
                      +..++.|.++.+|+-        ..+.+|+..... .......+.+|..++..+. |+++  .+.+.+|.+..  ...|+
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~-~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~fl  121 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGK-LLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFY  121 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCc-cCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceE
Confidence            567899999998862        244455443211 1122345778999988885 6654  77888876642  23679


Q ss_pred             EEeccCCCC
Q 012887          262 VTKLMEGGS  270 (454)
Q Consensus       262 V~E~~~~gs  270 (454)
                      ||||++|..
T Consensus       122 VME~v~G~~  130 (822)
T PLN02876        122 IMEYLEGRI  130 (822)
T ss_pred             EEEecCCcc
Confidence            999999864

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=97.34  E-value=0.00085  Score=69.97  Aligned_cols=158  Identities=22%  Similarity=0.259  Sum_probs=98.4

Q ss_pred             HHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcc
Q 012887          227 EFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVA  306 (454)
Q Consensus       227 ~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~ii  306 (454)
                      ..++.-....++.+.|+|...++.+.........+|||++. .||++.+..+. +-.....              .+++.
T Consensus        26 s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~~-~Sled~~~~~~-l~~~s~~--------------~~~~~   89 (725)
T KOG1093|consen   26 SIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHYT-MSLEDILKTGN-LKDESLL--------------AHGVL   89 (725)
T ss_pred             HHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhhc-cchHHHHHhcc-cchhhhc--------------ccccc
Confidence            35566677788889999999999887766555889999994 59999985543 2211111              23333


Q ss_pred             cCCccCCcEEEccCCcEEEEccCCccccccCCCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCC
Q 012887          307 YRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEA  386 (454)
Q Consensus       307 HrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~  386 (454)
                      |     .|+       ++.+| -+    .     +.+         |-.+.         .|+||||+|.++.++.-|..
T Consensus        90 ~-----~~~-------~~~td-~~----~-----t~~---------~~~~~---------pKsdVwsl~~i~~el~L~~~  129 (725)
T KOG1093|consen   90 H-----LNI-------IYITD-HF----L-----TKY---------PSPIG---------PKSDVWSLGFIILELYLGIS  129 (725)
T ss_pred             e-----ehh-------hhccc-cc----c-----ccC---------CCCCC---------cchhhhhHHHHHHHHHHhhH
Confidence            2     222       23333 00    0     000         10010         15999999999999999987


Q ss_pred             CCCCCCHHHHHHHHHHcCCCC----------CCCCCccHHHHHHHHHhcccCCCCCCCHHHHHH
Q 012887          387 AYAACSPVQAAVGIAACGLRP----------EIPKDCPQILKSLMIKCWNNSPSKRPQFSEIIS  440 (454)
Q Consensus       387 Pf~~~~~~~~~~~i~~~~~~~----------~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~  440 (454)
                      -+......+....+..-....          .+-..++..+.++..+|+-..|..||.+.++.+
T Consensus       130 l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k  193 (725)
T KOG1093|consen  130 LEAELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSK  193 (725)
T ss_pred             HHHHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhc
Confidence            776555544443333211111          111245677889999999999999998777654

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.24  E-value=0.0016  Score=62.21  Aligned_cols=31  Identities=16%  Similarity=0.097  Sum_probs=25.6

Q ss_pred             cCcccCCccCCcEEEccCCcEEEEccCCccc
Q 012887          303 HGVAYRDLNSQRILLDRHGNVCLGDMGIVTA  333 (454)
Q Consensus       303 ~~iiHrDIKp~NILl~~~~~vKL~DFGla~~  333 (454)
                      .+++|+|+.|.||+++.++..-|.||+.+..
T Consensus       164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~  194 (235)
T cd05155         164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV  194 (235)
T ss_pred             ceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence            3589999999999998766567999998643

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.09  E-value=8.9e-05  Score=85.02  Aligned_cols=150  Identities=14%  Similarity=0.005  Sum_probs=108.0

Q ss_pred             HHHhCCCCceeEEEEEEEeC-CCeEEEEEeccCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhc-----Cc
Q 012887          236 ELMTCGHKNILQFYCVCVDE-NHGLCVVTKLMEGGSVNDLILKS----RKLQTKEIIRIAIDVAEGIKFLNDH-----GV  305 (454)
Q Consensus       236 ~l~~l~HpnIv~~~g~~~~~-~~~l~lV~E~~~~gsL~~~l~~~----~~l~~~~~~~i~~qI~~gL~yLH~~-----~i  305 (454)
                      .++...|+++...+.-.... +...+.+++|+.+|.+.+.+.++    ..++..-......+.+.+..-+|+.     -.
T Consensus      1282 e~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~ 1361 (2724)
T KOG1826|consen 1282 ELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTN 1361 (2724)
T ss_pred             hhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccc
Confidence            34456799888766443322 23467999999999999998543    2344444444444447777777754     26


Q ss_pred             ccCCccCCcEEEccCCcEEEEccCCccccccCCCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCC
Q 012887          306 AYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGE  385 (454)
Q Consensus       306 iHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~  385 (454)
                      +|+++|+.|.+|..+.++|++++|+.+.............+++-|++|+..+...    ++.++|+|..|+.+|+.-.|.
T Consensus      1362 v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik----~t~rsdilr~s~~ly~rs~~n 1437 (2724)
T KOG1826|consen 1362 VSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIK----FTKRSDILRRSLSLYLRSDGN 1437 (2724)
T ss_pred             hhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHh----hhhHHHHHHHHHHHHHHhccc
Confidence            8999999999999999999999999884444333344445667788999887654    444599999999999998888


Q ss_pred             CCCC
Q 012887          386 AAYA  389 (454)
Q Consensus       386 ~Pf~  389 (454)
                      .+|-
T Consensus      1438 ~~fi 1441 (2724)
T KOG1826|consen 1438 AYFI 1441 (2724)
T ss_pred             HHHH
Confidence            7764

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=96.16  E-value=0.019  Score=58.06  Aligned_cols=138  Identities=17%  Similarity=0.144  Sum_probs=89.4

Q ss_pred             EEeceeeccCCceEEE-----eEEEEEEEeecCC---------------------CCch-H--HHHHHHHHHHHHhCCCC
Q 012887          193 EFIDQIGPNSFKGVYK-----GKRVGIEKLKGCD---------------------KGNA-Y--EFELRKDLLELMTCGHK  243 (454)
Q Consensus       193 ~~~~~LG~G~fG~Vy~-----g~~vavK~l~~~~---------------------~~~~-~--~~~~~~Ei~~l~~l~Hp  243 (454)
                      ++-.+|..|.=.-||.     |..+|||+.+...                     ..+. .  ..=.++|++.|.+++..
T Consensus       147 ~inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a  226 (520)
T KOG2270|consen  147 EINGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA  226 (520)
T ss_pred             ecccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence            4556788899999997     5678999764321                     0110 0  01134677777776433


Q ss_pred             ceeEEEEEEEeCCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHH-HhcCcccCCccCCcEEEccCCc
Q 012887          244 NILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL-NDHGVAYRDLNSQRILLDRHGN  322 (454)
Q Consensus       244 nIv~~~g~~~~~~~~l~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yL-H~~~iiHrDIKp~NILl~~~~~  322 (454)
                      .|.- =.-..-.+  ..|||+|+.......-..+...++...+..+-.+++.-|.-| |..++||.||.--|+|+. +|.
T Consensus       227 GIP~-PePIlLk~--hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyh-dG~  302 (520)
T KOG2270|consen  227 GIPC-PEPILLKN--HVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYH-DGK  302 (520)
T ss_pred             CCCC-CCceeeec--ceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEE-CCE
Confidence            3211 00011112  358999996433222222344677888889999999999888 667999999999999998 788


Q ss_pred             EEEEccCCcccc
Q 012887          323 VCLGDMGIVTAC  334 (454)
Q Consensus       323 vKL~DFGla~~~  334 (454)
                      +.|+|-+-+...
T Consensus       303 lyiIDVSQSVE~  314 (520)
T KOG2270|consen  303 LYIIDVSQSVEH  314 (520)
T ss_pred             EEEEEccccccC
Confidence            999998765443

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=95.97  E-value=0.096  Score=51.46  Aligned_cols=30  Identities=23%  Similarity=0.226  Sum_probs=26.4

Q ss_pred             cCcccCCccCCcEEEccCCcEEEEccCCcc
Q 012887          303 HGVAYRDLNSQRILLDRHGNVCLGDMGIVT  332 (454)
Q Consensus       303 ~~iiHrDIKp~NILl~~~~~vKL~DFGla~  332 (454)
                      .+++|+|+.|.|||++.++.+.|.||+.+.
T Consensus       175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence            479999999999999987777899998754

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=95.92  E-value=0.052  Score=51.38  Aligned_cols=30  Identities=20%  Similarity=0.133  Sum_probs=26.1

Q ss_pred             cCcccCCccCCcEEEcc-CCcEEEEccCCcc
Q 012887          303 HGVAYRDLNSQRILLDR-HGNVCLGDMGIVT  332 (454)
Q Consensus       303 ~~iiHrDIKp~NILl~~-~~~vKL~DFGla~  332 (454)
                      .+++|+|+.+.|||++. ++.+.|.||..+.
T Consensus       170 ~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~  200 (235)
T cd05157         170 IVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG  200 (235)
T ss_pred             EEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence            35899999999999998 5789999998764

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=95.71  E-value=0.0092  Score=59.34  Aligned_cols=129  Identities=16%  Similarity=0.133  Sum_probs=81.0

Q ss_pred             EEEeceeeccCCceEEEe-----EEEEEEE-------------ee----cC---CCCchHHHHHHHHHHHHHhCC-C-Cc
Q 012887          192 LEFIDQIGPNSFKGVYKG-----KRVGIEK-------------LK----GC---DKGNAYEFELRKDLLELMTCG-H-KN  244 (454)
Q Consensus       192 ~~~~~~LG~G~fG~Vy~g-----~~vavK~-------------l~----~~---~~~~~~~~~~~~Ei~~l~~l~-H-pn  244 (454)
                      +.++.+||-|.=+.||.+     +..++|.             -+    ..   ......+....+|..-|..+. | --
T Consensus        94 ~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gfp  173 (465)
T KOG2268|consen   94 ESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGFP  173 (465)
T ss_pred             hhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCCC
Confidence            456788999999999973     3343331             11    00   011112334567777777663 3 23


Q ss_pred             eeEEEEEEEeCCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEE
Q 012887          245 ILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVC  324 (454)
Q Consensus       245 Iv~~~g~~~~~~~~l~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vK  324 (454)
                      |.+.+++    +. .++|||++.|-.|...-   ...+...+   ...+..-+--|..+|+||+|..-=||++.+++.++
T Consensus       174 VPkpiD~----~R-H~Vvmelv~g~Pl~~v~---~v~d~~~l---y~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~  242 (465)
T KOG2268|consen  174 VPKPIDH----NR-HCVVMELVDGYPLRQVR---HVEDPPTL---YDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIV  242 (465)
T ss_pred             CCCcccc----cc-eeeHHHhhcccceeeee---ecCChHHH---HHHHHHHHHHHHHcCceecccchheeEEecCCCEE
Confidence            3344432    22 68999999987776542   12233332   33333445567889999999999999999999999


Q ss_pred             EEccCCc
Q 012887          325 LGDMGIV  331 (454)
Q Consensus       325 L~DFGla  331 (454)
                      ++||--.
T Consensus       243 vIDFPQm  249 (465)
T KOG2268|consen  243 VIDFPQM  249 (465)
T ss_pred             EeechHh
Confidence            9999653

>TIGR02721 ycfN_thiK thiamine kinase

Probab=95.69  E-value=0.046  Score=52.71  Aligned_cols=29  Identities=14%  Similarity=0.189  Sum_probs=25.4

Q ss_pred             CcccCCccCCcEEEccCCcEEEEccCCccc
Q 012887          304 GVAYRDLNSQRILLDRHGNVCLGDMGIVTA  333 (454)
Q Consensus       304 ~iiHrDIKp~NILl~~~~~vKL~DFGla~~  333 (454)
                      .++|+|+.|.||+++.++ +.|.||..+..
T Consensus       147 ~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       147 APLHMDVHAYNLVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             eeecCCCCcCcEEEeCCC-CEEEeccccCc
Confidence            589999999999999877 78999988654

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=95.47  E-value=0.35  Score=50.10  Aligned_cols=73  Identities=15%  Similarity=0.079  Sum_probs=43.9

Q ss_pred             eceeeccCCceEEEe------EEEEEEEeecCC----CC-chHHHHHHHHHHHHHhC---CCCceeEEEEEEEeCCCeEE
Q 012887          195 IDQIGPNSFKGVYKG------KRVGIEKLKGCD----KG-NAYEFELRKDLLELMTC---GHKNILQFYCVCVDENHGLC  260 (454)
Q Consensus       195 ~~~LG~G~fG~Vy~g------~~vavK~l~~~~----~~-~~~~~~~~~Ei~~l~~l---~HpnIv~~~g~~~~~~~~l~  260 (454)
                      .+.||.|.+..||+.      +.+.||.-....    .. .....+...|...|..+   ...++.+++.+  +++. .+
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~-~~  107 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEEL-AV  107 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCC-CE
Confidence            467999999999983      367777643111    11 11223344555555553   23467777766  3343 57


Q ss_pred             EEEeccCCCC
Q 012887          261 VVTKLMEGGS  270 (454)
Q Consensus       261 lV~E~~~~gs  270 (454)
                      +|||++++..
T Consensus       108 lVME~L~~~~  117 (401)
T PRK09550        108 TVMEDLSDHK  117 (401)
T ss_pred             EEEecCCCcc
Confidence            9999998643

>PRK05231 homoserine kinase; Provisional

Probab=95.42  E-value=0.35  Score=48.08  Aligned_cols=31  Identities=19%  Similarity=0.194  Sum_probs=26.0

Q ss_pred             cCcccCCccCCcEEEccCCcEEEEccCCccc
Q 012887          303 HGVAYRDLNSQRILLDRHGNVCLGDMGIVTA  333 (454)
Q Consensus       303 ~~iiHrDIKp~NILl~~~~~vKL~DFGla~~  333 (454)
                      .++||+|+.|.|||++.+...-|.||+.+..
T Consensus       187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        187 RGVIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             cccCCCCCCCCcEEEECCceEEEEecccccC
Confidence            4799999999999999665567999998643

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=95.30  E-value=0.068  Score=54.11  Aligned_cols=86  Identities=21%  Similarity=0.219  Sum_probs=60.4

Q ss_pred             CCceeEEEEEEEeCCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhc-CcccCCccCCcEEEccC
Q 012887          242 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDH-GVAYRDLNSQRILLDRH  320 (454)
Q Consensus       242 HpnIv~~~g~~~~~~~~l~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~-~iiHrDIKp~NILl~~~  320 (454)
                      -++..+.+-+-.++....|++|++- |++|.-    ...-...+...++.+.+.-+.-+..+ .+=|||+.-.||||+ +
T Consensus       284 ~~~~e~~~vv~~de~~y~yl~~kdh-gt~is~----ik~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~  357 (488)
T COG5072         284 SVFLETLKVVSLDETLYLYLHFKDH-GTPISI----IKADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-E  357 (488)
T ss_pred             chhhhcceEEecCCceEEEEEEecC-Cceeee----eecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-c
Confidence            3444444433334444577888876 445542    23446778888888877766666544 578999999999999 9


Q ss_pred             CcEEEEccCCccc
Q 012887          321 GNVCLGDMGIVTA  333 (454)
Q Consensus       321 ~~vKL~DFGla~~  333 (454)
                      |+|.|+||-+++.
T Consensus       358 GnvtLIDfklsRl  370 (488)
T COG5072         358 GNVTLIDFKLSRL  370 (488)
T ss_pred             CceEEEEeeeeec
Confidence            9999999999874

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=94.13  E-value=0.5  Score=47.37  Aligned_cols=32  Identities=13%  Similarity=0.106  Sum_probs=28.3

Q ss_pred             CcccCCccCCcEEEccCCcEEEEccCCccccc
Q 012887          304 GVAYRDLNSQRILLDRHGNVCLGDMGIVTACK  335 (454)
Q Consensus       304 ~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~  335 (454)
                      .++|+|+.+.||+++.++-+=+.||+++....
T Consensus       199 ~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD  230 (321)
T COG3173         199 VLVHGDYRPGNLIIDPGRPTGVLDWELATLGD  230 (321)
T ss_pred             eeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence            48999999999999999889999999976544

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=93.73  E-value=0.95  Score=46.19  Aligned_cols=30  Identities=20%  Similarity=0.160  Sum_probs=24.8

Q ss_pred             cCcccCCccCCcEEEccCCcEEEEccCCccc
Q 012887          303 HGVAYRDLNSQRILLDRHGNVCLGDMGIVTA  333 (454)
Q Consensus       303 ~~iiHrDIKp~NILl~~~~~vKL~DFGla~~  333 (454)
                      ..++|+|+.+.||+++.++ +++.|+.++..
T Consensus       192 ~~llHGDl~~gNi~~~~~~-~~~iD~e~~~~  221 (370)
T TIGR01767       192 ETLLHGDLHSGSIFVSEHE-TKVIDPEFAFY  221 (370)
T ss_pred             ceeeeccCCcccEEEcCCC-CEEEcCccccc
Confidence            4689999999999998655 77999976543

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=93.71  E-value=0.37  Score=47.34  Aligned_cols=31  Identities=23%  Similarity=0.197  Sum_probs=25.5

Q ss_pred             CcccCCccCCcEEEccCCc-EEEEccCCcccc
Q 012887          304 GVAYRDLNSQRILLDRHGN-VCLGDMGIVTAC  334 (454)
Q Consensus       304 ~iiHrDIKp~NILl~~~~~-vKL~DFGla~~~  334 (454)
                      .++|+|+.|.|||++.++. .-|.||+.+...
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG  217 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVG  217 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence            4899999999999997565 459999987543

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PLN02756 S-methyl-5-thioribose kinase

Probab=93.53  E-value=1.1  Score=46.54  Aligned_cols=78  Identities=12%  Similarity=0.055  Sum_probs=44.1

Q ss_pred             eceeeccCCceEEEe----EEEEEEEeecCCC--Cc---hHHHHHHHHHHHHHhC---CCCceeEEEEEEEeCCCeEEEE
Q 012887          195 IDQIGPNSFKGVYKG----KRVGIEKLKGCDK--GN---AYEFELRKDLLELMTC---GHKNILQFYCVCVDENHGLCVV  262 (454)
Q Consensus       195 ~~~LG~G~fG~Vy~g----~~vavK~l~~~~~--~~---~~~~~~~~Ei~~l~~l---~HpnIv~~~g~~~~~~~~l~lV  262 (454)
                      .+.||-|.-..||+-    ..+.||.-.....  +.   ....+...|...|..+   ...++.+++.++.+.   -+++
T Consensus        37 ~~eiggGn~N~VyrV~~~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded~---~vlv  113 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSSSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRTM---ALIG  113 (418)
T ss_pred             EEEcCCCceeeEEEEEcCCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCCC---CEEE
Confidence            567899999999973    3566665431111  00   0112223334445443   235778888877633   4589


Q ss_pred             EeccCC--CCHHHHH
Q 012887          263 TKLMEG--GSVNDLI  275 (454)
Q Consensus       263 ~E~~~~--gsL~~~l  275 (454)
                      ||++++  ..+.+-+
T Consensus       114 ME~L~~~~~ilr~~L  128 (418)
T PLN02756        114 MRYLEPPHIILRKGL  128 (418)
T ss_pred             EeecCCcceehhhhh
Confidence            999977  3454443

>PRK10593 hypothetical protein; Provisional

Probab=92.71  E-value=0.83  Score=45.32  Aligned_cols=103  Identities=11%  Similarity=0.058  Sum_probs=66.0

Q ss_pred             EEEeceeeccCCceEEEe----EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCC---CceeEEEEEEEeC--CCeEEEE
Q 012887          192 LEFIDQIGPNSFKGVYKG----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGH---KNILQFYCVCVDE--NHGLCVV  262 (454)
Q Consensus       192 ~~~~~~LG~G~fG~Vy~g----~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~H---pnIv~~~g~~~~~--~~~l~lV  262 (454)
                      ..-.+.||.|..+.||.-    ..+.+|..+ ....   ...+..|...|..+..   -.+.+.++++.+.  ...-++|
T Consensus        16 ~~~~~~i~~G~~~~vy~~~~~~~~~~~k~~~-~~~~---~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LV   91 (297)
T PRK10593         16 LSRVECISEQPYAALWALYDSQGNPMPLMAR-SFST---PGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLL   91 (297)
T ss_pred             hheeeecCCccceeEEEEEcCCCCEEEEEec-cccc---chHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEE
Confidence            345678999999999982    234445433 2111   1346677777776632   4677888877643  2337899


Q ss_pred             EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhc
Q 012887          263 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDH  303 (454)
Q Consensus       263 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~  303 (454)
                      ||+++|+++.+.     .........+..+++.+|.-||+.
T Consensus        92 mE~i~G~~~~~~-----~~~~~~~~~l~~~l~~~La~LH~~  127 (297)
T PRK10593         92 LERLRGVSVEAP-----ARTPERWEQLKDQIVEGLLAWHRI  127 (297)
T ss_pred             EeccCCEecCCC-----CCCHHHHHHHHHHHHHHHHHHhCC
Confidence            999999887651     123344556667777888888864

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=92.70  E-value=0.18  Score=49.98  Aligned_cols=30  Identities=23%  Similarity=0.247  Sum_probs=26.9

Q ss_pred             cCcccCCccCCcEEEccCCcEEEEccCCcc
Q 012887          303 HGVAYRDLNSQRILLDRHGNVCLGDMGIVT  332 (454)
Q Consensus       303 ~~iiHrDIKp~NILl~~~~~vKL~DFGla~  332 (454)
                      .+++|+|+.+.||+++.++.+.|.||+.+.
T Consensus       187 ~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       187 RGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             CccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            589999999999999988877899999864

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=92.38  E-value=0.45  Score=49.05  Aligned_cols=60  Identities=15%  Similarity=0.110  Sum_probs=44.2

Q ss_pred             EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHH-HhcCcccCCccCCcEEEcc
Q 012887          259 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL-NDHGVAYRDLNSQRILLDR  319 (454)
Q Consensus       259 l~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yL-H~~~iiHrDIKp~NILl~~  319 (454)
                      ..++-+|+.|-++..++. ....++.....++.-.+.||--+ --.+++|.|+.|.||++--
T Consensus       320 ~vl~E~~~~Gl~v~~~v~-~~~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf  380 (565)
T KOG1236|consen  320 LVLVETYERGLSVLRFVK-WKSQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRF  380 (565)
T ss_pred             ceeeeeccccccHHhhhh-cccChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEe
Confidence            567888999999998884 34456666666666666665444 3468999999999999953

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=92.27  E-value=0.74  Score=46.39  Aligned_cols=29  Identities=24%  Similarity=0.316  Sum_probs=25.1

Q ss_pred             cccCCccCCcEEEcc-CCcEEEEccCCccc
Q 012887          305 VAYRDLNSQRILLDR-HGNVCLGDMGIVTA  333 (454)
Q Consensus       305 iiHrDIKp~NILl~~-~~~vKL~DFGla~~  333 (454)
                      ++|.|+.+.|||+++ ++.++++||..|..
T Consensus       184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             EEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            689999999999975 47899999988654

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=91.80  E-value=0.31  Score=48.12  Aligned_cols=29  Identities=28%  Similarity=0.381  Sum_probs=25.2

Q ss_pred             cCcccCCccCCcEEEccCCcEEEEccCCcc
Q 012887          303 HGVAYRDLNSQRILLDRHGNVCLGDMGIVT  332 (454)
Q Consensus       303 ~~iiHrDIKp~NILl~~~~~vKL~DFGla~  332 (454)
                      .+++|+|+.+.||+++. +.+.|.||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            57899999999999997 678999998643

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=90.91  E-value=0.91  Score=43.21  Aligned_cols=100  Identities=13%  Similarity=0.033  Sum_probs=63.7

Q ss_pred             EEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHH
Q 012887          212 VGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAI  291 (454)
Q Consensus       212 vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~  291 (454)
                      .-+|++......-. ..-+..+.+++.+++  .|+++.   .++++.+.++.|.|-....         .+    ..++.
T Consensus        88 L~lKKi~slp~~~~-~~~y~nky~v~Armh--GilrL~---NDn~~~yGvIlE~Cy~~~i---------~~----~N~i~  148 (308)
T PF07387_consen   88 LFLKKIRSLPCCIN-DALYFNKYRVFARMH--GILRLK---NDNNYKYGVILERCYKIKI---------NF----SNFIT  148 (308)
T ss_pred             hhhhhccCCCcccc-hhhhhhhhhHHHHhh--heeEee---cCCCceeEEEEeeccCccc---------ch----hHHHH
Confidence            34677765443311 122356677777753  466666   3455668899999843111         11    11111


Q ss_pred             HHHHHHHHHHh--cCcccCCccCCcEEEccCCcEEEEccCC
Q 012887          292 DVAEGIKFLND--HGVAYRDLNSQRILLDRHGNVCLGDMGI  330 (454)
Q Consensus       292 qI~~gL~yLH~--~~iiHrDIKp~NILl~~~~~vKL~DFGl  330 (454)
                      -=+.+|.-.|+  .+.+|+|-.|+||+-|..|.+||.|-+.
T Consensus       149 agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~  189 (308)
T PF07387_consen  149 AGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVC  189 (308)
T ss_pred             HhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhh
Confidence            12456777784  4799999999999999999999999764

The function of this family is unknown.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=90.64  E-value=0.38  Score=47.48  Aligned_cols=29  Identities=24%  Similarity=0.219  Sum_probs=25.8

Q ss_pred             CcccCCccCCcEEEccC----CcEEEEccCCcc
Q 012887          304 GVAYRDLNSQRILLDRH----GNVCLGDMGIVT  332 (454)
Q Consensus       304 ~iiHrDIKp~NILl~~~----~~vKL~DFGla~  332 (454)
                      .++|+|+.|.|||++.+    +.+.++||..+.
T Consensus       180 ~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~  212 (302)
T cd05156         180 VFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS  212 (302)
T ss_pred             eEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence            58999999999999975    889999998864

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PRK10271 thiK thiamine kinase; Provisional

Probab=89.41  E-value=0.3  Score=45.12  Aligned_cols=30  Identities=13%  Similarity=0.099  Sum_probs=25.7

Q ss_pred             CcccCCccCCcEEEccCCcEEEEccCCcccc
Q 012887          304 GVAYRDLNSQRILLDRHGNVCLGDMGIVTAC  334 (454)
Q Consensus       304 ~iiHrDIKp~NILl~~~~~vKL~DFGla~~~  334 (454)
                      -.+|+|+.|.|++++++| ++|+||+.+...
T Consensus        78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~g  107 (188)
T PRK10271         78 APLHMDVHAGNLVHSASG-LRLIDWEYAGDG  107 (188)
T ss_pred             eeecCCCCCccEEEECCC-EEEEeCCcccCC
Confidence            368999999999998777 899999987543

>PRK12396 5-methylribose kinase; Reviewed

Probab=89.23  E-value=3.6  Score=42.59  Aligned_cols=29  Identities=10%  Similarity=0.153  Sum_probs=23.9

Q ss_pred             cCcccCCccCCcEEEccCCcEEEEccCCcc
Q 012887          303 HGVAYRDLNSQRILLDRHGNVCLGDMGIVT  332 (454)
Q Consensus       303 ~~iiHrDIKp~NILl~~~~~vKL~DFGla~  332 (454)
                      .-++|+||.|.||++++++ +|+.|.-++.
T Consensus       227 ~aLlHGDlHtGSI~v~~~~-~kvIDpEFAf  255 (409)
T PRK12396        227 QALIHGDLHTGSVFVKNDS-TKVIDPEFAF  255 (409)
T ss_pred             hhhccCcCCCCCEEecCCc-eEEEcccccc
Confidence            3589999999999999764 8999976654

>PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly

Probab=88.56  E-value=0.38  Score=48.41  Aligned_cols=48  Identities=19%  Similarity=0.326  Sum_probs=32.2

Q ss_pred             HHHHHHHHHHHHHHHHHH------hcCcccCCccCCcEEEccCC------------------cEEEEccCCccc
Q 012887          284 KEIIRIAIDVAEGIKFLN------DHGVAYRDLNSQRILLDRHG------------------NVCLGDMGIVTA  333 (454)
Q Consensus       284 ~~~~~i~~qI~~gL~yLH------~~~iiHrDIKp~NILl~~~~------------------~vKL~DFGla~~  333 (454)
                      .-+..++.||+  |-|+-      ..+++|-||||+|||+.+..                  ..+|.||.++..
T Consensus       275 ~YvkfifLQia--LLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv  346 (434)
T PF05445_consen  275 EYVKFIFLQIA--LLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGNRNYVFKEPIRCCLNDFDFSQV  346 (434)
T ss_pred             HHHHHHHHHHH--HHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECCeEEEecccceeeecccCHHHh
Confidence            34555667774  44532      35799999999999995432                  256778877654

; GO: 0004672 protein kinase activity, 0005524 ATP binding

>PHA03111 Ser/Thr kinase; Provisional

Probab=88.49  E-value=0.5  Score=47.41  Aligned_cols=37  Identities=19%  Similarity=0.051  Sum_probs=25.3

Q ss_pred             HHHHHHHHHHHHHHHHHH----hcCcccCCccCCcEEEccC
Q 012887          284 KEIIRIAIDVAEGIKFLN----DHGVAYRDLNSQRILLDRH  320 (454)
Q Consensus       284 ~~~~~i~~qI~~gL~yLH----~~~iiHrDIKp~NILl~~~  320 (454)
                      .-+..++.||+.-.-.+-    ..+++|-||||+|||+.+.
T Consensus       279 ~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds  319 (444)
T PHA03111        279 EYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDS  319 (444)
T ss_pred             HHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecC
Confidence            345667778754332232    3469999999999999644

>smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain

Probab=86.70  E-value=1.2  Score=41.16  Aligned_cols=31  Identities=19%  Similarity=0.234  Sum_probs=25.5

Q ss_pred             cCcccCCccCCcEEEccCC-----cEEEEccCCccc
Q 012887          303 HGVAYRDLNSQRILLDRHG-----NVCLGDMGIVTA  333 (454)
Q Consensus       303 ~~iiHrDIKp~NILl~~~~-----~vKL~DFGla~~  333 (454)
                      ..++|+|+.+.||++..++     .+.+.||..+..
T Consensus       120 ~vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~~  155 (196)
T smart00587      120 NVLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSHY  155 (196)
T ss_pred             eEEeeCCCCccceeeccCCCCCccceEEEecccCCc
Confidence            4689999999999998554     588999988643

subfamily of choline kinases

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=86.66  E-value=1  Score=41.91  Aligned_cols=30  Identities=30%  Similarity=0.367  Sum_probs=21.1

Q ss_pred             CcccCCccCCcEEE-ccCCcEEEEccCCccc
Q 012887          304 GVAYRDLNSQRILL-DRHGNVCLGDMGIVTA  333 (454)
Q Consensus       304 ~iiHrDIKp~NILl-~~~~~vKL~DFGla~~  333 (454)
                      .++|.|+.|.|||+ +.++.++|+||..+..
T Consensus       144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred             eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence            57899999999999 8889999999988653

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PTZ00384 choline kinase; Provisional

Probab=86.58  E-value=6.9  Score=40.34  Aligned_cols=29  Identities=17%  Similarity=0.015  Sum_probs=23.7

Q ss_pred             cCcccCCccCCcEEEccCCcEEEEccCCcc
Q 012887          303 HGVAYRDLNSQRILLDRHGNVCLGDMGIVT  332 (454)
Q Consensus       303 ~~iiHrDIKp~NILl~~~~~vKL~DFGla~  332 (454)
                      ..++|.|+-+.|||.++ +.+.++||-.|.
T Consensus       227 ~VfCHNDL~~gNIL~~~-~~l~lID~EYA~  255 (383)
T PTZ00384        227 VLFCHNDLFFTNILDFN-QGIYFIDFDFAG  255 (383)
T ss_pred             eeeeeccCCcccEEecC-CCEEEEEecccc
Confidence            45789999999999764 459999997754

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=86.43  E-value=0.97  Score=44.89  Aligned_cols=30  Identities=10%  Similarity=0.031  Sum_probs=27.0

Q ss_pred             CcccCCccCCcEEEccCCcEEEEccCCccc
Q 012887          304 GVAYRDLNSQRILLDRHGNVCLGDMGIVTA  333 (454)
Q Consensus       304 ~iiHrDIKp~NILl~~~~~vKL~DFGla~~  333 (454)
                      +++|+|+.+.|+|++.++.+-+.||..+..
T Consensus       197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            799999999999999999999999987643

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PLN02236 choline kinase

Probab=85.77  E-value=0.95  Score=45.88  Aligned_cols=30  Identities=20%  Similarity=0.318  Sum_probs=25.8

Q ss_pred             CcccCCccCCcEEEcc-CCcEEEEccCCccc
Q 012887          304 GVAYRDLNSQRILLDR-HGNVCLGDMGIVTA  333 (454)
Q Consensus       304 ~iiHrDIKp~NILl~~-~~~vKL~DFGla~~  333 (454)
                      .++|+|+++.|||+++ ++.+.+.||..+..
T Consensus       201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        201 GFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             eEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            5899999999999986 46799999988653

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=85.64  E-value=12  Score=37.12  Aligned_cols=72  Identities=8%  Similarity=0.116  Sum_probs=40.2

Q ss_pred             EEEeceeeccCCceEEE----eEEEEEEEeecCCCCchHHHHHHHHHHHHHhC---CCCceeEEEEEEEeCCCeEEEEEe
Q 012887          192 LEFIDQIGPNSFKGVYK----GKRVGIEKLKGCDKGNAYEFELRKDLLELMTC---GHKNILQFYCVCVDENHGLCVVTK  264 (454)
Q Consensus       192 ~~~~~~LG~G~fG~Vy~----g~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l---~HpnIv~~~g~~~~~~~~l~lV~E  264 (454)
                      ++-.+.++-|....+|+    ++.+-||.-.....     ..+..|..-|..|   .--.+.+.+++....+. -++|||
T Consensus        19 i~~~~~v~GG~i~~a~~~~~~~~~~FvK~~~~~~~-----~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~-~fLlle   92 (288)
T PF03881_consen   19 ITSIEPVSGGDINEAYRLDTDGGSYFVKVNSESGR-----DMFEGEAEGLKALAEANPIRVPKVIAWGEYDDD-AFLLLE   92 (288)
T ss_dssp             --EEEEE--SSSSEEEEEETTS-EEEEEEEEGGGC-----CHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSC-CEEEEE
T ss_pred             eeeeEecCCCChhheEEEECCCccEEEEecChhhH-----HHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCC-ceEEEE
Confidence            45567889899999997    56788887762211     2345666666655   34557788888776665 589999


Q ss_pred             ccCCC
Q 012887          265 LMEGG  269 (454)
Q Consensus       265 ~~~~g  269 (454)
                      |++.+
T Consensus        93 ~l~~~   97 (288)
T PF03881_consen   93 FLEMG   97 (288)
T ss_dssp             -----
T ss_pred             eecCC
Confidence            99876

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	454
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		6e-25
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		2e-24
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		3e-24
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		3e-24
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		9e-24
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		1e-23
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		2e-23
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		4e-23
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		4e-23
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		6e-23
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		3e-22
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-22
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-22
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-22
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-22
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		4e-22
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		4e-22
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		4e-22
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		5e-22
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		5e-22
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		5e-22
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		6e-22
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		6e-22
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		6e-22
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		7e-22
4h58_A	275	Braf In Complex With Compound 3 Length = 275		7e-22
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		7e-22
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		8e-22
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		8e-22
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		8e-22
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		8e-22
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		8e-22
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		9e-22
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		9e-22
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		1e-21
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		1e-21
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		1e-21
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		2e-21
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		4e-21
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		4e-21
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		5e-21
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		6e-21
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		6e-21
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		2e-20
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-20
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-20
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		3e-20
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		3e-20
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		3e-20
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		4e-20
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		4e-20
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		4e-20
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		4e-20
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		5e-20
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		5e-20
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		5e-20
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		5e-20
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		7e-20
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		1e-19
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		1e-19
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		1e-19
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		1e-19
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		1e-19
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		2e-19
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		3e-19
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		4e-19
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-19
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		4e-19
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		4e-19
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		5e-19
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		6e-19
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		6e-19
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		6e-19
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		7e-19
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		7e-19
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		7e-19
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		7e-19
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		7e-19
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		8e-19
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		8e-19
2pl0_A	289	Lck Bound To Imatinib Length = 289		8e-19
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		9e-19
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		1e-18
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		1e-18
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		2e-18
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		2e-18
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		2e-18
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		2e-18
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		2e-18
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		2e-18
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		3e-18
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		3e-18
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		3e-18
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		3e-18
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		3e-18
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		3e-18
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		3e-18
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		4e-18
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		4e-18
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		4e-18
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		4e-18
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		5e-18
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		5e-18
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		5e-18
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		5e-18
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		6e-18
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		7e-18
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		8e-18
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		8e-18
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		8e-18
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		8e-18
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		9e-18
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		9e-18
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		1e-17
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-17
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		1e-17
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		1e-17
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-17
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		2e-17
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		2e-17
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		2e-17
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		2e-17
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		2e-17
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		2e-17
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-17
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-17
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		2e-17
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		2e-17
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-17
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		2e-17
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		2e-17
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		3e-17
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		3e-17
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		3e-17
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		3e-17
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		3e-17
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		3e-17
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		3e-17
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		3e-17
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		3e-17
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		3e-17
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		3e-17
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		3e-17
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		3e-17
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		3e-17
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		3e-17
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		3e-17
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		3e-17
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		3e-17
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		3e-17
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		3e-17
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		3e-17
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		3e-17
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		3e-17
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		4e-17
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		4e-17
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		4e-17
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		4e-17
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		4e-17
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-17
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		6e-17
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-17
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		6e-17
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-17
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		9e-17
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-17
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		9e-17
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-17
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-17
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		1e-16
3b2t_A	311	Structure Of Phosphotransferase Length = 311		1e-16
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-16
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		1e-16
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		2e-16
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-16
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		2e-16
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-16
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		2e-16
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-16
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		2e-16
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		2e-16
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-16
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-16
1oec_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		2e-16
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		2e-16
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		2e-16
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-16
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-16
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		3e-16
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		3e-16
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		3e-16
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		3e-16
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-16
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		4e-16
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-16
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		4e-16
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		4e-16
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		4e-16
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		6e-16
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		6e-16
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		6e-16
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		7e-16
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		8e-16
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-15
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		1e-15
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		1e-15
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		1e-15
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		1e-15
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		1e-15
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-15
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		1e-15
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		1e-15
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-15
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		1e-15
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		1e-15
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		1e-15
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		1e-15
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		2e-15
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		2e-15
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		2e-15
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		2e-15
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		2e-15
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-15
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-15
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-15
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-15
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		2e-15
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		2e-15
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		2e-15
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		2e-15
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		3e-15
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		3e-15
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		3e-15
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-15
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-15
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		3e-15
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-15
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		4e-15
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		4e-15
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		4e-15
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		4e-15
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		4e-15
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		4e-15
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		4e-15
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		5e-15
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		5e-15
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		5e-15
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		5e-15
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		5e-15
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		6e-15
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		6e-15
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		6e-15
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		6e-15
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		7e-15
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		7e-15
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		7e-15
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		8e-15
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		9e-15
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		9e-15
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		9e-15
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		1e-14
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		1e-14
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		1e-14
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		1e-14
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-14
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		1e-14
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		1e-14
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		1e-14
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		1e-14
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		1e-14
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		1e-14
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		1e-14
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		2e-14
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		2e-14
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		2e-14
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		2e-14
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		2e-14
1fvr_A	327	Tie2 Kinase Domain Length = 327		2e-14
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		2e-14
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-14
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		2e-14
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		2e-14
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		3e-14
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		3e-14
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		3e-14
4fl3_A	635	Structural And Biophysical Characterization Of The		3e-14
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		3e-14
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		3e-14
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		3e-14
4fl2_A	636	Structural And Biophysical Characterization Of The		3e-14
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		3e-14
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		3e-14
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		3e-14
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		4e-14
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		4e-14
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		4e-14
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		5e-14
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		5e-14
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		5e-14
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		6e-14
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		6e-14
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		6e-14
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		6e-14
3a4o_X	286	Lyn Kinase Domain Length = 286		6e-14
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		6e-14
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		6e-14
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		7e-14
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		7e-14
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		7e-14
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		1e-13
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		1e-13
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		1e-13
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		1e-13
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		1e-13
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		1e-13
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		1e-13
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		1e-13
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		1e-13
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		1e-13
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-13
4fie_A	423	Full-Length Human Pak4 Length = 423		2e-13
3a7f_A	303	Human Mst3 Kinase Length = 303		2e-13
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-13
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-13
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		3e-13
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-13
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		3e-13
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-13
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		3e-13
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		3e-13
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		3e-13
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		3e-13
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		3e-13
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		3e-13
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-13
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		3e-13
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		3e-13
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		3e-13
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		3e-13
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		3e-13
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		3e-13
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		4e-13
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		6e-13
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		6e-13
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		6e-13
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		6e-13
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		6e-13
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		7e-13
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		7e-13
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		7e-13
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		9e-13
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		1e-12
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		1e-12
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		1e-12
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		1e-12
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-12
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-12
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		2e-12
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-12
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-12
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		2e-12
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		2e-12
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		2e-12
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		2e-12
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		2e-12
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		2e-12
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		3e-12
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		3e-12
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		4e-12
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		5e-12
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		7e-12
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		8e-12
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		9e-12
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		1e-11
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		1e-11
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		1e-11
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		1e-11
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		1e-11
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		1e-11
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		1e-11
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		2e-11
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		2e-11
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		2e-11
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		2e-11
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		2e-11
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		2e-11
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		3e-11
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		3e-11
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		5e-11
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		5e-11
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		5e-11
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		6e-11
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		6e-11
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		6e-11
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		7e-11
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		7e-11
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		7e-11
3g51_A	325	Structural Diversity Of The Active Conformation Of		1e-10
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		1e-10
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		1e-10
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		1e-10
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		2e-10
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-10
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		2e-10
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		2e-10
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		2e-10
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		2e-10
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		3e-10
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		3e-10
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		3e-10
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		3e-10
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		3e-10
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		3e-10
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		4e-10
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		5e-10
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		5e-10
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		5e-10
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		5e-10
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		5e-10
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		5e-10
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		5e-10
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		6e-10
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		6e-10
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		6e-10
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		7e-10
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		7e-10
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		7e-10
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		1e-09
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		2e-09
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		2e-09
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-09
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-09
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		3e-09
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		3e-09
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		3e-09
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		3e-09
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		5e-09
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		5e-09
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		6e-09
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		6e-09
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		7e-09
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		7e-09
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-09
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-09
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		8e-09
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		9e-09
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		9e-09
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		9e-09
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		1e-08
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		1e-08
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		1e-08
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		1e-08
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		1e-08
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		1e-08
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		1e-08
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		1e-08
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		1e-08
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		2e-08
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		2e-08
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		2e-08
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-08
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		2e-08
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-08
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		2e-08
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-08
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		2e-08
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		2e-08
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		2e-08
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-08
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		2e-08
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		2e-08
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		2e-08
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		2e-08
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-08
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		3e-08
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		3e-08
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		3e-08
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		3e-08
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-08
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-08
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-08
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-08
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		3e-08
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		3e-08
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		3e-08
4ae6_A	343	Structure And Function Of The Human Sperm-specific		3e-08
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		3e-08
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		3e-08
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		3e-08
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		3e-08
4ae9_A	343	Structure And Function Of The Human Sperm-specific		4e-08
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		4e-08
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		4e-08
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-08
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		4e-08
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		4e-08
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		4e-08
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		4e-08
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		4e-08
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		4e-08
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		4e-08
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		4e-08
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		4e-08
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		4e-08
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		4e-08
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		4e-08
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		4e-08
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		4e-08
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		4e-08
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		4e-08
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		4e-08
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		4e-08
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		4e-08
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		4e-08
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		4e-08
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		4e-08
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		4e-08
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		4e-08
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		4e-08
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		4e-08
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		4e-08
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		4e-08
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		5e-08
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		5e-08
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		5e-08
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-08
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		5e-08
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		5e-08
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		5e-08
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		5e-08
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		5e-08
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		6e-08
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		6e-08
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		6e-08
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		6e-08
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		6e-08
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		6e-08
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		6e-08
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		6e-08
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		7e-08
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		7e-08
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		7e-08
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		7e-08
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		7e-08
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		8e-08
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		8e-08
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		8e-08
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		8e-08
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		8e-08
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		8e-08
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		8e-08
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		9e-08
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		9e-08
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		9e-08
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		9e-08
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		9e-08
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		9e-08
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		9e-08
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		9e-08
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		9e-08
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		9e-08
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		9e-08
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		1e-07
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		1e-07
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		1e-07
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-07
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		1e-07
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		1e-07
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-07
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		1e-07
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		1e-07
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-07
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		1e-07
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-07
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		2e-07
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		2e-07
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-07
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-07
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		2e-07
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		2e-07
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		2e-07
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-07
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-07
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		2e-07
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-07
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		2e-07
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		2e-07
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		2e-07
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-07
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		2e-07
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-07
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		2e-07
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-07
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		2e-07
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		2e-07
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		2e-07
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		3e-07
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		3e-07
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		3e-07
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		4e-07
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		4e-07
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		4e-07
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		4e-07
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		5e-07
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		5e-07
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		5e-07
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		5e-07
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		6e-07
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		6e-07
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		6e-07
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		6e-07
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		6e-07
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		7e-07
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		7e-07
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		7e-07
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		8e-07
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		1e-06
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		1e-06
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-06
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		1e-06
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		1e-06
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		1e-06
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		1e-06
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		1e-06
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		1e-06
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		1e-06
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		1e-06
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		1e-06
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		1e-06
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		2e-06
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		2e-06
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-06
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		2e-06
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		2e-06
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		2e-06
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		2e-06
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		2e-06
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-06
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		2e-06
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		2e-06
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		3e-06
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		3e-06
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		3e-06
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-06
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		4e-06
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		4e-06
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		4e-06
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		4e-06
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		4e-06
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		5e-06
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		5e-06
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		6e-06
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		6e-06
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		6e-06
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		6e-06
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		6e-06
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		6e-06
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		6e-06
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		6e-06
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		7e-06
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		7e-06
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		7e-06
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		7e-06
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		7e-06
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		7e-06
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		7e-06
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		8e-06
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		8e-06
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		8e-06
2oza_B	366	Structure Of P38alpha Complex Length = 366		8e-06
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		8e-06
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		9e-06
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		1e-05
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		1e-05
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		1e-05
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		1e-05
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		1e-05
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		1e-05
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		1e-05
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		1e-05
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		1e-05
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		1e-05
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		1e-05
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		1e-05
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		1e-05
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		1e-05
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		1e-05
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		1e-05
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		1e-05
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		1e-05
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		1e-05
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		1e-05
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		1e-05
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		1e-05
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		1e-05
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-05
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		1e-05
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		1e-05
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		1e-05
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-05
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		1e-05
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		1e-05
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		1e-05
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		1e-05
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		1e-05
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		1e-05
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		1e-05
3hec_A	348	P38 In Complex With Imatinib Length = 348		1e-05
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		1e-05
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		1e-05
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		2e-05
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		2e-05
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		2e-05
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-05
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-05
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		2e-05
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		2e-05
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-05
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		2e-05
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-05
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		2e-05
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		2e-05
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		2e-05
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		2e-05
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		2e-05
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		3e-05
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		3e-05
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		3e-05
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		3e-05
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		3e-05
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		3e-05
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		3e-05
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-05
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		4e-05
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		4e-05
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-05
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		4e-05
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		4e-05
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		4e-05
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		4e-05
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		4e-05
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		4e-05
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		4e-05
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		4e-05
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		4e-05
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		4e-05
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		4e-05
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		5e-05
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		5e-05
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		5e-05
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		5e-05
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		5e-05
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		5e-05
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		5e-05
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		5e-05
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		5e-05
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		5e-05
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		5e-05
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		5e-05
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		5e-05
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		6e-05
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		6e-05
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		6e-05
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		6e-05
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		7e-05
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		7e-05
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		7e-05
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		8e-05
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		8e-05
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		8e-05
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		8e-05
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		8e-05
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		8e-05
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		8e-05
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		9e-05
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		9e-05
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		1e-04
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		1e-04
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		1e-04
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		1e-04
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		1e-04
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		1e-04
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		1e-04
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		1e-04
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		1e-04
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		1e-04
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		1e-04
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-04
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-04
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		1e-04
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		1e-04
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		1e-04
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		1e-04
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		2e-04
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		2e-04
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		2e-04
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		2e-04
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-04
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		2e-04
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		2e-04
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		2e-04
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		2e-04
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		2e-04
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		2e-04
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-04
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-04
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-04
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		2e-04
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		2e-04
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		2e-04
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		2e-04
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		2e-04
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		2e-04
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		2e-04
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		2e-04
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		2e-04
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		2e-04
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		2e-04
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		2e-04
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		2e-04
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		2e-04
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		2e-04
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		2e-04
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		2e-04
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		3e-04
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		3e-04
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		3e-04
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		3e-04
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		3e-04
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		4e-04
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		4e-04
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		5e-04
4exu_A	371	Mapk13, Inactive Form Length = 371		5e-04
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		5e-04
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		5e-04
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		5e-04
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		5e-04
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		5e-04
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		6e-04
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		6e-04
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		6e-04
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		6e-04
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		6e-04
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		6e-04
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		6e-04
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		6e-04
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		6e-04
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		7e-04
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		7e-04

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score =  112 bits (279), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 79/266 (29%), Positives = 131/266 (49%), Gaps = 13/266 (4%)
Query: 185 WLLNSDNLEFIDQIGPNSFKGVYKGK---RVGIEKLKGCDKGNAYEFELRKDLLELMTCG 241
           W + +  +    +IG  SF  VYKGK    V ++ LK  D         R ++  L    
Sbjct: 31  WEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTR 90
Query: 242 HKNILQFYCVCVDENHGLCVVTKLMEGGSV-NDLILKSRKLQTKEIIRIAIDVAEGIKFL 300
           H NIL F      +N  L +VT+  EG S+   L ++  K Q  ++I IA   A+G+ +L
Sbjct: 91  HVNILLFMGYMTKDN--LAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYL 148
Query: 301 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK--SVGEATEYETDGYRWLAPEIIAG 358
           +   + +RD+ S  I L     V +GD G+ T     S  +  E  T    W+APE+I  
Sbjct: 149 HAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRM 208
Query: 359 DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGL-RPEIP---KDCP 414
             ++   ++ S+VYS+G+V++E++TGE  Y+  +     + +   G   P++    K+CP
Sbjct: 209 Q-DNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCP 267
Query: 415 QILKSLMIKCWNNSPSKRPQFSEIIS 440
           + +K L+  C      +RP F +I+S
Sbjct: 268 KAMKRLVADCVKKVKEERPLFPQILS 293

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  110 bits (275), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 72/261 (27%), Positives = 130/261 (49%), Gaps = 14/261 (5%)
Query: 191 NLEFIDQIGPNSFKGVYK----GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNIL 246
           +L   ++IG  SF  V++    G  V ++ L   D       E  +++  +    H NI+
Sbjct: 38  DLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIV 97
Query: 247 QFYCVCVDENHGLCVVTKLMEGGSVNDLILKS---RKLQTKEIIRIAIDVAEGIKFLNDH 303
            F    V +   L +VT+ +  GS+  L+ KS    +L  +  + +A DVA+G+ +L++ 
Sbjct: 98  LFMG-AVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR 156
Query: 304 G--VAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPE 361
              + +RDL S  +L+D+   V + D G+     S    ++       W+APE++  +P 
Sbjct: 157 NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKXAAGTPEWMAPEVLRDEPS 216
Query: 362 SVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLM 421
           +      S+VYSFG+++WE+ T +  +   +P Q    +     R EIP++    + +++
Sbjct: 217 NEK----SDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAII 272
Query: 422 IKCWNNSPSKRPQFSEIISLL 442
             CW N P KRP F+ I+ LL
Sbjct: 273 EGCWTNEPWKRPSFATIMDLL 293

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  109 bits (272), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 71/261 (27%), Positives = 131/261 (50%), Gaps = 14/261 (5%)
Query: 191 NLEFIDQIGPNSFKGVYK----GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNIL 246
           +L   ++IG  SF  V++    G  V ++ L   D       E  +++  +    H NI+
Sbjct: 38  DLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIV 97
Query: 247 QFYCVCVDENHGLCVVTKLMEGGSVNDLILKS---RKLQTKEIIRIAIDVAEGIKFLNDH 303
            F    V +   L +VT+ +  GS+  L+ KS    +L  +  + +A DVA+G+ +L++ 
Sbjct: 98  LFMG-AVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR 156
Query: 304 G--VAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPE 361
              + +R+L S  +L+D+   V + D G+     S   +++       W+APE++  +P 
Sbjct: 157 NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPS 216
Query: 362 SVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLM 421
           +      S+VYSFG+++WE+ T +  +   +P Q    +     R EIP++    + +++
Sbjct: 217 NEK----SDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAII 272
Query: 422 IKCWNNSPSKRPQFSEIISLL 442
             CW N P KRP F+ I+ LL
Sbjct: 273 EGCWTNEPWKRPSFATIMDLL 293

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score =  109 bits (272), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 78/274 (28%), Positives = 135/274 (49%), Gaps = 23/274 (8%)
Query: 187 LNSDNLEFIDQIGPNSFKGVYKGKRV------GIEKLKGCDKGNAYEF-----ELRKDLL 235
           L  + +E+  QIG   F  V+KG+ V       I+ L   D     E      E ++++ 
Sbjct: 16  LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVF 75
Query: 236 ELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAE 295
            +    H NI++ Y +    N    V+  +  G   + L+ K+  ++    +R+ +D+A 
Sbjct: 76  IMSNLNHPNIVKLYGLM--HNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIAL 133
Query: 296 GIKFLNDHG--VAYRDLNSQRILL---DRHGNVCLGDMGIVTACKSVGEATEYETDGYRW 350
           GI+++ +    + +RDL S  I L   D +  VC       T+ +SV   +      ++W
Sbjct: 134 GIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQSVHSVSGL-LGNFQW 192
Query: 351 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACS--PVQAAVGIAACGLRPE 408
           +APE I  + ES +E   ++ YSF M+++ ++TGE  +   S   ++    I   GLRP 
Sbjct: 193 MAPETIGAEEESYTEK--ADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPT 250
Query: 409 IPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
           IP+DCP  L++++  CW+  P KRP FS I+  L
Sbjct: 251 IPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score =  107 bits (268), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 79/276 (28%), Positives = 138/276 (50%), Gaps = 27/276 (9%)
Query: 187 LNSDNLEFIDQIGPNSFKGVYKGKRV------GIEKLKGCDKGNAYEF-----ELRKDLL 235
           L  + +E+  QIG   F  V+KG+ V       I+ L   D     E      E ++++ 
Sbjct: 16  LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVF 75
Query: 236 ELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAE 295
            +    H NI++ Y +    N    V+  +  G   + L+ K+  ++    +R+ +D+A 
Sbjct: 76  IMSNLNHPNIVKLYGLM--HNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIAL 133
Query: 296 GIKFLNDHG--VAYRDLNSQRILL---DRHGNVC--LGDMGIVTACKSVGEATEYETDGY 348
           GI+++ +    + +RDL S  I L   D +  VC  + D G+  + +SV   +      +
Sbjct: 134 GIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGL--SQQSVHSVSGL-LGNF 190
Query: 349 RWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACS--PVQAAVGIAACGLR 406
           +W+APE I  + ES +E   ++ YSF M+++ ++TGE  +   S   ++    I   GLR
Sbjct: 191 QWMAPETIGAEEESYTEK--ADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLR 248
Query: 407 PEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
           P IP+DCP  L++++  CW+  P KRP FS I+  L
Sbjct: 249 PTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score =  107 bits (268), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 77/274 (28%), Positives = 134/274 (48%), Gaps = 23/274 (8%)
Query: 187 LNSDNLEFIDQIGPNSFKGVYKGKRV------GIEKLKGCDKGNAYEF-----ELRKDLL 235
           L  + +E+  QIG   F  V+KG+ V       I+ L   D     E      E ++++ 
Sbjct: 16  LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVF 75
Query: 236 ELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAE 295
            +    H NI++ Y +    N    V+  +  G   + L+ K+  ++    +R+ +D+A 
Sbjct: 76  IMSNLNHPNIVKLYGLM--HNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIAL 133
Query: 296 GIKFLNDHG--VAYRDLNSQRILL---DRHGNVCLGDMGIVTACKSVGEATEYETDGYRW 350
           GI+++ +    + +RDL S  I L   D +  VC        + +SV   +      ++W
Sbjct: 134 GIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQSVHSVSGL-LGNFQW 192
Query: 351 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACS--PVQAAVGIAACGLRPE 408
           +APE I  + ES +E   ++ YSF M+++ ++TGE  +   S   ++    I   GLRP 
Sbjct: 193 MAPETIGAEEESYTEK--ADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPT 250
Query: 409 IPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
           IP+DCP  L++++  CW+  P KRP FS I+  L
Sbjct: 251 IPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 74/262 (28%), Positives = 121/262 (46%), Gaps = 25/262 (9%)
Query: 198 IGPNSFKGVYKGKRVGIEKLKGCDKGNAYEF------ELRKDLLELMTCGHKNILQFYCV 251
           IG   F  VY+   +G E      + +  E        +R++        H NI+    V
Sbjct: 15  IGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGV 74
Query: 252 CVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVA---YR 308
           C+ E + LC+V +   GG +N  +L  +++    ++  A+ +A G+ +L+D  +    +R
Sbjct: 75  CLKEPN-LCLVMEFARGGPLNR-VLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHR 132
Query: 309 DLNSQRILLDRHGNVCLGDMG-IVTACKSVGEATEYE-------TDGYRWLAPEIIAGDP 360
           DL S  IL+ +   V  GD+   +      G A E+           Y W+APE+I    
Sbjct: 133 DLKSSNILILQ--KVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYAWMAPEVIRASM 190
Query: 361 ESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSL 420
            S      S+V+S+G+++WE++TGE  +     +  A G+A   L   IP  CP+    L
Sbjct: 191 FSKG----SDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCPEPFAKL 246
Query: 421 MIKCWNNSPSKRPQFSEIISLL 442
           M  CWN  P  RP F+ I+  L
Sbjct: 247 MEDCWNPDPHSRPSFTNILDQL 268

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score =  105 bits (263), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 76/266 (28%), Positives = 129/266 (48%), Gaps = 13/266 (4%)
Query: 185 WLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL---RKDLLELMTCG 241
           W +    +    +IG  SF  VYKGK  G   +K  +       +L   + ++  L    
Sbjct: 7   WEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR 66
Query: 242 HKNILQFYCVCVDENHGLCVVTKLMEGGSV-NDLILKSRKLQTKEIIRIAIDVAEGIKFL 300
           H NIL F          L +VT+  EG S+ + L     K + K++I IA   A G+ +L
Sbjct: 67  HVNILLFMGYSTKPQ--LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYL 124
Query: 301 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE--TDGYRWLAPEIIAG 358
           +   + +RDL S  I L     V +GD G+ T       + ++E  +    W+APE+I  
Sbjct: 125 HAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 184
Query: 359 DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG-LRPEIPK---DCP 414
             +S   ++ S+VY+FG+V++E++TG+  Y+  +     + +   G L P++ K   +CP
Sbjct: 185 Q-DSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCP 243
Query: 415 QILKSLMIKCWNNSPSKRPQFSEIIS 440
           + +K LM +C      +RP F  I++
Sbjct: 244 KRMKRLMAECLKKKRDERPSFPRILA 269

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score =  105 bits (263), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 76/266 (28%), Positives = 129/266 (48%), Gaps = 13/266 (4%)
Query: 185 WLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL---RKDLLELMTCG 241
           W +    +    +IG  SF  VYKGK  G   +K  +       +L   + ++  L    
Sbjct: 19  WEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR 78
Query: 242 HKNILQFYCVCVDENHGLCVVTKLMEGGSV-NDLILKSRKLQTKEIIRIAIDVAEGIKFL 300
           H NIL F          L +VT+  EG S+ + L     K + K++I IA   A G+ +L
Sbjct: 79  HVNILLFMGYSTKPQ--LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYL 136
Query: 301 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE--TDGYRWLAPEIIAG 358
           +   + +RDL S  I L     V +GD G+ T       + ++E  +    W+APE+I  
Sbjct: 137 HAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRM 196
Query: 359 DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG-LRPEIPK---DCP 414
             +S   ++ S+VY+FG+V++E++TG+  Y+  +     + +   G L P++ K   +CP
Sbjct: 197 Q-DSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCP 255
Query: 415 QILKSLMIKCWNNSPSKRPQFSEIIS 440
           + +K LM +C      +RP F  I++
Sbjct: 256 KRMKRLMAECLKKKRDERPSFPRILA 281

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score =  105 bits (261), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 76/266 (28%), Positives = 129/266 (48%), Gaps = 13/266 (4%)
Query: 185 WLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL---RKDLLELMTCG 241
           W +    +    +IG  SF  VYKGK  G   +K  +       +L   + ++  L    
Sbjct: 19  WEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR 78
Query: 242 HKNILQFYCVCVDENHGLCVVTKLMEGGSV-NDLILKSRKLQTKEIIRIAIDVAEGIKFL 300
           H NIL F          L +VT+  EG S+ + L     K + K++I IA   A G+ +L
Sbjct: 79  HVNILLFMGYSTAPQ--LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYL 136
Query: 301 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE--TDGYRWLAPEIIAG 358
           +   + +RDL S  I L     V +GD G+ T       + ++E  +    W+APE+I  
Sbjct: 137 HAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRM 196
Query: 359 DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG-LRPEIPK---DCP 414
             +S   ++ S+VY+FG+V++E++TG+  Y+  +     + +   G L P++ K   +CP
Sbjct: 197 Q-DSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCP 255
Query: 415 QILKSLMIKCWNNSPSKRPQFSEIIS 440
           + +K LM +C      +RP F  I++
Sbjct: 256 KRMKRLMAECLKKKRDERPSFPRILA 281

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 79/290 (27%), Positives = 135/290 (46%), Gaps = 41/290 (14%)
Query: 192 LEFIDQIGPNSFKGVYKG-----------KRVGIEKLKGCDKGNAYEFELRKDLLELMTC 240
           + F++++G + F  VYKG           + V I+ LK   +G   E E R + +     
Sbjct: 28  VRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLRE-EFRHEAMLRARL 86
Query: 241 GHKNILQF---------------YCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKE 285
            H N++                 YC   D +  L + +   + GS +D       L+  +
Sbjct: 87  QHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPD 146
Query: 286 IIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYET 345
            + +   +A G+++L+ H V ++DL ++ +L+    NV + D+G+    + V  A  Y+ 
Sbjct: 147 FVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLF---REVYAADYYKL 203
Query: 346 DG-----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVG 399
            G      RW+APE I     S+     S+++S+G+V+WE+ + G   Y   S       
Sbjct: 204 LGNSLLPIRWMAPEAIMYGKFSID----SDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEM 259
Query: 400 IAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNIS 449
           I    + P  P DCP  + +LMI+CWN  PS+RP+F +I S L    N+S
Sbjct: 260 IRNRQVLP-CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWGNLS 308

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 87/292 (29%), Positives = 140/292 (47%), Gaps = 36/292 (12%)
Query: 170 DEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKGC 220
           D  QTV    +E     L++ N+     +G   F  V  G+          V I+ LK  
Sbjct: 30  DPTQTVHEFAKE-----LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK-- 82
Query: 221 DKGNAYEFELRKDLL-ELMTCG---HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL 276
                Y  + R+D L E    G   H NI++   V V ++  + +VT+ ME GS++  + 
Sbjct: 83  ---VGYTEKQRRDFLGEASIMGQFDHPNIIRLEGV-VTKSKPVMIVTEYMENGSLDSFLR 138
Query: 277 K-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK 335
           K   +    +++ +   +A G+K+L+D G  +RDL ++ IL++ +    + D G+    +
Sbjct: 139 KHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLARVLE 198
Query: 336 SVGEATEYETDG----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAA 390
              EA  Y T G     RW +PE IA        T  S+V+S+G+V+WE+++ GE  Y  
Sbjct: 199 DDPEAA-YTTRGGKIPIRWTSPEAIA----YRKFTSASDVWSYGIVLWEVMSYGERPYWE 253
Query: 391 CSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
            S  Q  +     G R   P DCP  L  LM+ CW    + RP+F +I+S+L
Sbjct: 254 MSN-QDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score =  102 bits (255), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 87/292 (29%), Positives = 140/292 (47%), Gaps = 36/292 (12%)
Query: 170 DEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKGC 220
           D  QTV    +E     L++ N+     +G   F  V  G+          V I+ LK  
Sbjct: 30  DPTQTVHEFAKE-----LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK-- 82
Query: 221 DKGNAYEFELRKDLL-ELMTCG---HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL 276
                Y  + R+D L E    G   H NI++   V V ++  + +VT+ ME GS++  + 
Sbjct: 83  ---VGYTEKQRRDFLGEASIMGQFDHPNIIRLEGV-VTKSKPVMIVTEYMENGSLDSFLR 138
Query: 277 K-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK 335
           K   +    +++ +   +A G+K+L+D G  +RDL ++ IL++ +    + D G+    +
Sbjct: 139 KHDAQFTVIQLVGMLRGIASGMKYLSDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLE 198
Query: 336 SVGEATEYETDG----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAA 390
              EA  Y T G     RW +PE IA        T  S+V+S+G+V+WE+++ GE  Y  
Sbjct: 199 DDPEAA-YTTRGGKIPIRWTSPEAIA----YRKFTSASDVWSYGIVLWEVMSYGERPYWE 253
Query: 391 CSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
            S  Q  +     G R   P DCP  L  LM+ CW    + RP+F +I+S+L
Sbjct: 254 MSN-QDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 87/292 (29%), Positives = 140/292 (47%), Gaps = 36/292 (12%)
Query: 170 DEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKGC 220
           D  QTV    +E     L++ N+     +G   F  V  G+          V I+ LK  
Sbjct: 30  DPTQTVHEFAKE-----LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK-- 82
Query: 221 DKGNAYEFELRKDLL-ELMTCG---HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL 276
                Y  + R+D L E    G   H NI++   V V ++  + +VT+ ME GS++  + 
Sbjct: 83  ---VGYTEKQRRDFLGEASIMGQFDHPNIIRLEGV-VTKSKPVMIVTEXMENGSLDSFLR 138
Query: 277 K-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK 335
           K   +    +++ +   +A G+K+L+D G  +RDL ++ IL++ +    + D G+    +
Sbjct: 139 KHDAQFTVIQLVGMLRGIASGMKYLSDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLE 198
Query: 336 SVGEATEYETDG----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAA 390
              EA  Y T G     RW +PE IA        T  S+V+S+G+V+WE+++ GE  Y  
Sbjct: 199 DDPEAA-YTTRGGKIPIRWTSPEAIA----YRKFTSASDVWSYGIVLWEVMSYGERPYWE 253
Query: 391 CSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
            S  Q  +     G R   P DCP  L  LM+ CW    + RP+F +I+S+L
Sbjct: 254 MSN-QDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 87/292 (29%), Positives = 140/292 (47%), Gaps = 36/292 (12%)
Query: 170 DEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKGC 220
           D  QTV    +E     L++ N+     +G   F  V  G+          V I+ LK  
Sbjct: 30  DPTQTVHEFAKE-----LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK-- 82
Query: 221 DKGNAYEFELRKDLL-ELMTCG---HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL 276
                Y  + R+D L E    G   H NI++   V V ++  + +VT+ ME GS++  + 
Sbjct: 83  ---VGYTEKQRRDFLGEASIMGQFDHPNIIRLEGV-VTKSKPVMIVTEYMENGSLDSFLR 138
Query: 277 K-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK 335
           K   +    +++ +   +A G+K+L+D G  +RDL ++ IL++ +    + D G+    +
Sbjct: 139 KHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLE 198
Query: 336 SVGEATEYETDG----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAA 390
              EA  Y T G     RW +PE IA        T  S+V+S+G+V+WE+++ GE  Y  
Sbjct: 199 DDPEAA-YTTRGGKIPIRWTSPEAIA----YRKFTSASDVWSYGIVLWEVMSYGERPYWE 253
Query: 391 CSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
            S  Q  +     G R   P DCP  L  LM+ CW    + RP+F +I+S+L
Sbjct: 254 MSN-QDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 79/281 (28%), Positives = 136/281 (48%), Gaps = 16/281 (5%)
Query: 178 GGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL---RKDL 234
           G +    W +    +    +IG  SF  VYKGK  G   +K  +       +L   + ++
Sbjct: 1   GSDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEV 60
Query: 235 LELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSV-NDLILKSRKLQTKEIIRIAIDV 293
             L    H NIL F          L +VT+  EG S+ + L +   K +  ++I IA   
Sbjct: 61  GVLRKTRHVNILLFMGYSTKPQ--LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQT 118
Query: 294 AEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE--TDGYRWL 351
           A+G+ +L+   + +RDL S  I L     V +GD G+ T       + ++E  +    W+
Sbjct: 119 AQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM 178
Query: 352 APEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG-LRPEIP 410
           APE+I    ++   ++ S+VY+FG+V++E++TG+  Y+  +     + +   G L P++ 
Sbjct: 179 APEVIRMQDKN-PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLS 237
Query: 411 K---DCPQILKSLMIKCWNNSPSKRPQFSEI---ISLLLRT 445
           K   +CP+ +K LM +C      +RP F +I   I LL R+
Sbjct: 238 KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 278

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 87/292 (29%), Positives = 140/292 (47%), Gaps = 36/292 (12%)
Query: 170 DEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKGC 220
           D  QTV    +E     L++ N+     +G   F  V  G+          V I+ LK  
Sbjct: 30  DPTQTVHEFAKE-----LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK-- 82
Query: 221 DKGNAYEFELRKDLL-ELMTCG---HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL 276
                Y  + R+D L E    G   H NI++   V V ++  + +VT+ ME GS++  + 
Sbjct: 83  ---VGYTEKQRRDFLGEASIMGQFDHPNIIRLEGV-VTKSKPVMIVTEYMENGSLDSFLR 138
Query: 277 K-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK 335
           K   +    +++ +   +A G+K+L+D G  +RDL ++ IL++ +    + D G+    +
Sbjct: 139 KHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLE 198
Query: 336 SVGEATEYETDG----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAA 390
              EA  Y T G     RW +PE IA        T  S+V+S+G+V+WE+++ GE  Y  
Sbjct: 199 DDPEAA-YTTRGGKIPIRWTSPEAIA----YRKFTSASDVWSYGIVLWEVMSYGERPYWE 253
Query: 391 CSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
            S  Q  +     G R   P DCP  L  LM+ CW    + RP+F +I+S+L
Sbjct: 254 MSN-QDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 87/292 (29%), Positives = 140/292 (47%), Gaps = 36/292 (12%)
Query: 170 DEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKGC 220
           D  QTV    +E     L++ N+     +G   F  V  G+          V I+ LK  
Sbjct: 30  DPTQTVHEFAKE-----LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK-- 82
Query: 221 DKGNAYEFELRKDLL-ELMTCG---HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL 276
                Y  + R+D L E    G   H NI++   V V ++  + +VT+ ME GS++  + 
Sbjct: 83  ---VGYTEKQRRDFLGEASIMGQFDHPNIIRLEGV-VTKSKPVMIVTEYMENGSLDSFLR 138
Query: 277 K-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK 335
           K   +    +++ +   +A G+K+L+D G  +RDL ++ IL++ +    + D G+    +
Sbjct: 139 KHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLE 198
Query: 336 SVGEATEYETDG----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAA 390
              EA  Y T G     RW +PE IA        T  S+V+S+G+V+WE+++ GE  Y  
Sbjct: 199 DDPEAA-YTTRGGKIPIRWTSPEAIA----YRKFTSASDVWSYGIVLWEVMSYGERPYWE 253
Query: 391 CSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
            S  Q  +     G R   P DCP  L  LM+ CW    + RP+F +I+S+L
Sbjct: 254 MSN-QDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 79/281 (28%), Positives = 136/281 (48%), Gaps = 16/281 (5%)
Query: 178 GGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL---RKDL 234
           G +    W +    +    +IG  SF  VYKGK  G   +K  +       +L   + ++
Sbjct: 1   GSDSSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEV 60
Query: 235 LELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSV-NDLILKSRKLQTKEIIRIAIDV 293
             L    H NIL F          L +VT+  EG S+ + L +   K +  ++I IA   
Sbjct: 61  GVLRKTRHVNILLFMGYSTKPQ--LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQT 118
Query: 294 AEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE--TDGYRWL 351
           A+G+ +L+   + +RDL S  I L     V +GD G+ T       + ++E  +    W+
Sbjct: 119 AQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM 178
Query: 352 APEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG-LRPEIP 410
           APE+I    ++   ++ S+VY+FG+V++E++TG+  Y+  +     + +   G L P++ 
Sbjct: 179 APEVIRMQDKN-PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLS 237
Query: 411 K---DCPQILKSLMIKCWNNSPSKRPQFSEI---ISLLLRT 445
           K   +CP+ +K LM +C      +RP F +I   I LL R+
Sbjct: 238 KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 278

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 87/292 (29%), Positives = 140/292 (47%), Gaps = 36/292 (12%)
Query: 170 DEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKGC 220
           D  QTV    +E     L++ N+     +G   F  V  G+          V I+ LK  
Sbjct: 30  DPTQTVHEFAKE-----LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK-- 82
Query: 221 DKGNAYEFELRKDLL-ELMTCG---HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL 276
                Y  + R+D L E    G   H NI++   V V ++  + +VT+ ME GS++  + 
Sbjct: 83  ---VGYTEKQRRDFLGEASIMGQFDHPNIIRLEGV-VTKSKPVMIVTEYMENGSLDSFLR 138
Query: 277 K-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK 335
           K   +    +++ +   +A G+K+L+D G  +RDL ++ IL++ +    + D G+    +
Sbjct: 139 KHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLE 198
Query: 336 SVGEATEYETDG----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAA 390
              EA  Y T G     RW +PE IA        T  S+V+S+G+V+WE+++ GE  Y  
Sbjct: 199 DDPEAA-YTTRGGKIPIRWTSPEAIA----YRKFTSASDVWSYGIVLWEVMSYGERPYWE 253
Query: 391 CSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
            S  Q  +     G R   P DCP  L  LM+ CW    + RP+F +I+S+L
Sbjct: 254 MSN-QDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 81/278 (29%), Positives = 137/278 (49%), Gaps = 23/278 (8%)
Query: 188 NSDNLEFID-------QIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL---RKDLLEL 237
           +SD+ E  D       +IG  SF  VYKGK  G   +K  +       +L   + ++  L
Sbjct: 1   SSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVL 60
Query: 238 MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSV-NDLILKSRKLQTKEIIRIAIDVAEG 296
               H NIL F          L +VT+  EG S+ + L +   K +  ++I IA   A+G
Sbjct: 61  RKTRHVNILLFMGYSTKPQ--LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQG 118
Query: 297 IKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE--TDGYRWLAPE 354
           + +L+   + +RDL S  I L     V +GD G+ T       + ++E  +    W+APE
Sbjct: 119 MDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE 178
Query: 355 IIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG-LRPEIPK-- 411
           +I    ++   ++ S+VY+FG+V++E++TG+  Y+  +     + +   G L P++ K  
Sbjct: 179 VIRMQDKN-PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVR 237
Query: 412 -DCPQILKSLMIKCWNNSPSKRPQFSEI---ISLLLRT 445
            +CP+ +K LM +C      +RP F +I   I LL R+
Sbjct: 238 SNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 275

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score =  102 bits (253), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 87/292 (29%), Positives = 140/292 (47%), Gaps = 36/292 (12%)
Query: 170 DEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKGC 220
           D  QTV    +E     L++ N+     +G   F  V  G+          V I+ LK  
Sbjct: 28  DPTQTVHEFAKE-----LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK-- 80
Query: 221 DKGNAYEFELRKDLL-ELMTCG---HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL 276
                Y  + R+D L E    G   H NI++   V V ++  + +VT+ ME GS++  + 
Sbjct: 81  ---VGYTEKQRRDFLGEASIMGQFDHPNIIRLEGV-VTKSKPVMIVTEYMENGSLDSFLR 136
Query: 277 K-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK 335
           K   +    +++ +   +A G+K+L+D G  +RDL ++ IL++ +    + D G+    +
Sbjct: 137 KHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLE 196
Query: 336 SVGEATEYETDG----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAA 390
              EA  Y T G     RW +PE IA        T  S+V+S+G+V+WE+++ GE  Y  
Sbjct: 197 DDPEAA-YTTRGGKIPIRWTSPEAIA----YRKFTSASDVWSYGIVLWEVMSYGERPYWE 251
Query: 391 CSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
            S  Q  +     G R   P DCP  L  LM+ CW    + RP+F +I+S+L
Sbjct: 252 MSN-QDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 302

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score =  102 bits (253), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 78/274 (28%), Positives = 134/274 (48%), Gaps = 16/274 (5%)
Query: 185 WLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL---RKDLLELMTCG 241
           W +    +    +IG  SF  VYKGK  G   +K  +       +L   + ++  L    
Sbjct: 31  WEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR 90
Query: 242 HKNILQFYCVCVDENHGLCVVTKLMEGGSV-NDLILKSRKLQTKEIIRIAIDVAEGIKFL 300
           H NIL F          L +VT+  EG S+ + L +   K +  ++I IA   A+G+ +L
Sbjct: 91  HVNILLFMGYSTKPQ--LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYL 148
Query: 301 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE--TDGYRWLAPEIIAG 358
           +   + +RDL S  I L     V +GD G+ T       + ++E  +    W+APE+I  
Sbjct: 149 HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 208
Query: 359 DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG-LRPEIPK---DCP 414
             ++   ++ S+VY+FG+V++E++TG+  Y+  +     + +   G L P++ K   +CP
Sbjct: 209 QDKN-PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCP 267
Query: 415 QILKSLMIKCWNNSPSKRPQFSEI---ISLLLRT 445
           + +K LM +C      +RP F +I   I LL R+
Sbjct: 268 KAMKRLMAECLKKKRDERPLFPQILASIELLARS 301

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score =  102 bits (253), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 87/292 (29%), Positives = 140/292 (47%), Gaps = 36/292 (12%)
Query: 170 DEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKGC 220
           D  QTV    +E     L++ N+     +G   F  V  G+          V I+ LK  
Sbjct: 30  DPTQTVHEFAKE-----LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK-- 82
Query: 221 DKGNAYEFELRKDLL-ELMTCG---HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL 276
                Y  + R+D L E    G   H NI++   V V ++  + +VT+ ME GS++  + 
Sbjct: 83  ---VGYTEKQRRDFLGEASIMGQFDHPNIIRLEGV-VTKSKPVMIVTEXMENGSLDSFLR 138
Query: 277 K-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK 335
           K   +    +++ +   +A G+K+L+D G  +RDL ++ IL++ +    + D G+    +
Sbjct: 139 KHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLE 198
Query: 336 SVGEATEYETDG----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAA 390
              EA  Y T G     RW +PE IA        T  S+V+S+G+V+WE+++ GE  Y  
Sbjct: 199 DDPEAA-YTTRGGKIPIRWTSPEAIA----YRKFTSASDVWSYGIVLWEVMSYGERPYWE 253
Query: 391 CSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
            S  Q  +     G R   P DCP  L  LM+ CW    + RP+F +I+S+L
Sbjct: 254 MSN-QDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score =  101 bits (252), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 81/278 (29%), Positives = 137/278 (49%), Gaps = 23/278 (8%)
Query: 188 NSDNLEFID-------QIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL---RKDLLEL 237
           +SD+ E  D       +IG  SF  VYKGK  G   +K  +       +L   + ++  L
Sbjct: 26  SSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVL 85
Query: 238 MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSV-NDLILKSRKLQTKEIIRIAIDVAEG 296
               H NIL F          L +VT+  EG S+ + L +   K +  ++I IA   A+G
Sbjct: 86  RKTRHVNILLFMGYSTKPQ--LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQG 143
Query: 297 IKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE--TDGYRWLAPE 354
           + +L+   + +RDL S  I L     V +GD G+ T       + ++E  +    W+APE
Sbjct: 144 MDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE 203
Query: 355 IIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG-LRPEIPK-- 411
           +I    ++   ++ S+VY+FG+V++E++TG+  Y+  +     + +   G L P++ K  
Sbjct: 204 VIRMQDKN-PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVR 262
Query: 412 -DCPQILKSLMIKCWNNSPSKRPQFSEI---ISLLLRT 445
            +CP+ +K LM +C      +RP F +I   I LL R+
Sbjct: 263 SNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 300

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score =  101 bits (252), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 78/274 (28%), Positives = 134/274 (48%), Gaps = 16/274 (5%)
Query: 185 WLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL---RKDLLELMTCG 241
           W +    +    +IG  SF  VYKGK  G   +K  +       +L   + ++  L    
Sbjct: 3   WEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR 62
Query: 242 HKNILQFYCVCVDENHGLCVVTKLMEGGSV-NDLILKSRKLQTKEIIRIAIDVAEGIKFL 300
           H NIL F          L +VT+  EG S+ + L +   K +  ++I IA   A+G+ +L
Sbjct: 63  HVNILLFMGYSTKPQ--LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYL 120
Query: 301 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE--TDGYRWLAPEIIAG 358
           +   + +RDL S  I L     V +GD G+ T       + ++E  +    W+APE+I  
Sbjct: 121 HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 180
Query: 359 DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG-LRPEIPK---DCP 414
             ++   ++ S+VY+FG+V++E++TG+  Y+  +     + +   G L P++ K   +CP
Sbjct: 181 QDKN-PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCP 239
Query: 415 QILKSLMIKCWNNSPSKRPQFSEI---ISLLLRT 445
           + +K LM +C      +RP F +I   I LL R+
Sbjct: 240 KAMKRLMAECLKKKRDERPLFPQILASIELLARS 273

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score =  101 bits (252), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 70/268 (26%), Positives = 131/268 (48%), Gaps = 17/268 (6%)
Query: 183 GRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEK--LKGCDKGNAYEFELRKDLLELMTC 240
           G+W+++   L F+ +IG   F  V+ G  +  +K  +K   +G   E +  ++   +M  
Sbjct: 1   GKWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKL 60
Query: 241 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKE-IIRIAIDVAEGIKF 299
            H  ++Q Y VC+ E   +C+VT+ ME G ++D +   R L   E ++ + +DV EG+ +
Sbjct: 61  SHPKLVQLYGVCL-EQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAY 119
Query: 300 LNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC----KSVGEATEYETDGYRWLAPEI 355
           L +  V +RDL ++  L+  +  + + D G+         +    T++     +W +PE+
Sbjct: 120 LEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV---KWASPEV 176
Query: 356 IAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCP 414
            +    S      S+V+SFG+++WE+ + G+  Y   S  +    I+  G R   P+   
Sbjct: 177 FSFSRYSSK----SDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST-GFRLYKPRLAS 231
Query: 415 QILKSLMIKCWNNSPSKRPQFSEIISLL 442
             +  +M  CW   P  RP FS ++  L
Sbjct: 232 THVYQIMNHCWRERPEDRPAFSRLLRQL 259

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score =  101 bits (252), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 87/292 (29%), Positives = 140/292 (47%), Gaps = 36/292 (12%)
Query: 170 DEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKGC 220
           D  QTV    +E     L++ N+     +G   F  V  G+          V I+ LK  
Sbjct: 30  DPTQTVHEFAKE-----LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK-- 82
Query: 221 DKGNAYEFELRKDLL-ELMTCG---HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL 276
                Y  + R+D L E    G   H NI++   V V ++  + +VT+ ME GS++  + 
Sbjct: 83  ---VGYTEKQRRDFLGEASIMGQFDHPNIIRLEGV-VTKSKPVMIVTEYMENGSLDSFLR 138
Query: 277 K-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK 335
           K   +    +++ +   +A G+K+L+D G  +RDL ++ IL++ +    + D G+    +
Sbjct: 139 KHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLE 198
Query: 336 SVGEATEYETDG----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAA 390
              EA  Y T G     RW +PE IA        T  S+V+S+G+V+WE+++ GE  Y  
Sbjct: 199 DDPEAA-YTTRGGKIPIRWTSPEAIA----YRKFTSASDVWSYGIVLWEVMSYGERPYWE 253
Query: 391 CSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
            S  Q  +     G R   P DCP  L  LM+ CW    + RP+F +I+S+L
Sbjct: 254 MSN-QDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score =  101 bits (252), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 81/278 (29%), Positives = 137/278 (49%), Gaps = 23/278 (8%)
Query: 188 NSDNLEFID-------QIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL---RKDLLEL 237
           +SD+ E  D       +IG  SF  VYKGK  G   +K  +       +L   + ++  L
Sbjct: 19  SSDDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVL 78
Query: 238 MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSV-NDLILKSRKLQTKEIIRIAIDVAEG 296
               H NIL F          L +VT+  EG S+ + L +   K +  ++I IA   A+G
Sbjct: 79  RKTRHVNILLFMGYSTKPQ--LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQG 136
Query: 297 IKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE--TDGYRWLAPE 354
           + +L+   + +RDL S  I L     V +GD G+ T       + ++E  +    W+APE
Sbjct: 137 MDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE 196
Query: 355 IIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG-LRPEIPK-- 411
           +I    ++   ++ S+VY+FG+V++E++TG+  Y+  +     + +   G L P++ K  
Sbjct: 197 VIRMQDKN-PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVR 255
Query: 412 -DCPQILKSLMIKCWNNSPSKRPQFSEI---ISLLLRT 445
            +CP+ +K LM +C      +RP F +I   I LL R+
Sbjct: 256 SNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 293

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score =  101 bits (252), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 86/289 (29%), Positives = 139/289 (48%), Gaps = 36/289 (12%)
Query: 173 QTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKGCDKG 223
           QTV    +E     L++ N+     +G   F  V  G+          V I+ LK     
Sbjct: 4   QTVHEFAKE-----LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK----- 53
Query: 224 NAYEFELRKDLL-ELMTCG---HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILK-S 278
             Y  + R+D L E    G   H NI++   V V ++  + +VT+ ME GS++  + K  
Sbjct: 54  VGYTEKQRRDFLGEASIMGQFDHPNIIRLEGV-VTKSKPVMIVTEYMENGSLDSFLRKHD 112
Query: 279 RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG 338
            +    +++ +   +A G+K+L+D G  +RDL ++ IL++ +    + D G+    +   
Sbjct: 113 AQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDP 172
Query: 339 EATEYETDG----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSP 393
           EA  Y T G     RW +PE IA        T  S+V+S+G+V+WE+++ GE  Y   S 
Sbjct: 173 EAA-YTTRGGKIPIRWTSPEAIA----YRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN 227
Query: 394 VQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
            Q  +     G R   P DCP  L  LM+ CW    + RP+F +I+S+L
Sbjct: 228 -QDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 275

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score =  101 bits (252), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 78/274 (28%), Positives = 134/274 (48%), Gaps = 16/274 (5%)
Query: 185 WLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL---RKDLLELMTCG 241
           W +    +    +IG  SF  VYKGK  G   +K  +       +L   + ++  L    
Sbjct: 31  WEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR 90
Query: 242 HKNILQFYCVCVDENHGLCVVTKLMEGGSV-NDLILKSRKLQTKEIIRIAIDVAEGIKFL 300
           H NIL F          L +VT+  EG S+ + L +   K +  ++I IA   A+G+ +L
Sbjct: 91  HVNILLFMGYSTKPQ--LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYL 148
Query: 301 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE--TDGYRWLAPEIIAG 358
           +   + +RDL S  I L     V +GD G+ T       + ++E  +    W+APE+I  
Sbjct: 149 HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRM 208
Query: 359 DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG-LRPEIPK---DCP 414
             ++   ++ S+VY+FG+V++E++TG+  Y+  +     + +   G L P++ K   +CP
Sbjct: 209 QDKN-PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCP 267
Query: 415 QILKSLMIKCWNNSPSKRPQFSEI---ISLLLRT 445
           + +K LM +C      +RP F +I   I LL R+
Sbjct: 268 KAMKRLMAECLKKKRDERPLFPQILASIELLARS 301

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score =  101 bits (252), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 86/289 (29%), Positives = 139/289 (48%), Gaps = 36/289 (12%)
Query: 173 QTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKGCDKG 223
           QTV    +E     L++ N+     +G   F  V  G+          V I+ LK     
Sbjct: 21  QTVHEFAKE-----LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK----- 70
Query: 224 NAYEFELRKDLL-ELMTCG---HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILK-S 278
             Y  + R+D L E    G   H NI++   V V ++  + +VT+ ME GS++  + K  
Sbjct: 71  VGYTEKQRRDFLGEASIMGQFDHPNIIRLEGV-VTKSKPVMIVTEYMENGSLDSFLRKHD 129
Query: 279 RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG 338
            +    +++ +   +A G+K+L+D G  +RDL ++ IL++ +    + D G+    +   
Sbjct: 130 AQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDP 189
Query: 339 EATEYETDG----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSP 393
           EA  Y T G     RW +PE IA        T  S+V+S+G+V+WE+++ GE  Y   S 
Sbjct: 190 EAA-YTTRGGKIPIRWTSPEAIA----YRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN 244
Query: 394 VQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
            Q  +     G R   P DCP  L  LM+ CW    + RP+F +I+S+L
Sbjct: 245 -QDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 292

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score =  101 bits (251), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 86/289 (29%), Positives = 139/289 (48%), Gaps = 36/289 (12%)
Query: 173 QTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKGCDKG 223
           QTV    +E     L++ N+     +G   F  V  G+          V I+ LK     
Sbjct: 4   QTVHEFAKE-----LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLK----- 53
Query: 224 NAYEFELRKDLL-ELMTCG---HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILK-S 278
             Y  + R+D L E    G   H NI++   V V ++  + +VT+ ME GS++  + K  
Sbjct: 54  VGYTEKQRRDFLGEASIMGQFDHPNIIRLEGV-VTKSKPVMIVTEXMENGSLDSFLRKHD 112
Query: 279 RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG 338
            +    +++ +   +A G+K+L+D G  +RDL ++ IL++ +    + D G+    +   
Sbjct: 113 AQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDP 172
Query: 339 EATEYETDG----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSP 393
           EA  Y T G     RW +PE IA        T  S+V+S+G+V+WE+++ GE  Y   S 
Sbjct: 173 EAA-YTTRGGKIPIRWTSPEAIA----YRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN 227
Query: 394 VQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
            Q  +     G R   P DCP  L  LM+ CW    + RP+F +I+S+L
Sbjct: 228 -QDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 275

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score =  101 bits (251), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 78/274 (28%), Positives = 134/274 (48%), Gaps = 16/274 (5%)
Query: 185 WLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL---RKDLLELMTCG 241
           W +    +    +IG  SF  VYKGK  G   +K  +       +L   + ++  L    
Sbjct: 3   WEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR 62
Query: 242 HKNILQFYCVCVDENHGLCVVTKLMEGGSV-NDLILKSRKLQTKEIIRIAIDVAEGIKFL 300
           H NIL F          L +VT+  EG S+ + L +   K +  ++I IA   A+G+ +L
Sbjct: 63  HVNILLFMGYSTAPQ--LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYL 120
Query: 301 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE--TDGYRWLAPEIIAG 358
           +   + +RDL S  I L     V +GD G+ T       + ++E  +    W+APE+I  
Sbjct: 121 HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 180
Query: 359 DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG-LRPEIPK---DCP 414
             ++   ++ S+VY+FG+V++E++TG+  Y+  +     + +   G L P++ K   +CP
Sbjct: 181 QDKN-PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCP 239
Query: 415 QILKSLMIKCWNNSPSKRPQFSEI---ISLLLRT 445
           + +K LM +C      +RP F +I   I LL R+
Sbjct: 240 KAMKRLMAECLKKKRDERPLFPQILASIELLARS 273

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 78/274 (28%), Positives = 134/274 (48%), Gaps = 16/274 (5%)
Query: 185 WLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL---RKDLLELMTCG 241
           W +    +    +IG  SF  VYKGK  G   +K  +       +L   + ++  L    
Sbjct: 3   WEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR 62
Query: 242 HKNILQFYCVCVDENHGLCVVTKLMEGGSV-NDLILKSRKLQTKEIIRIAIDVAEGIKFL 300
           H NIL F          L +VT+  EG S+ + L +   K +  ++I IA   A+G+ +L
Sbjct: 63  HVNILLFMGYSTKPQ--LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYL 120
Query: 301 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE--TDGYRWLAPEIIAG 358
           +   + +RDL S  I L     V +GD G+ T       + ++E  +    W+APE+I  
Sbjct: 121 HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRM 180
Query: 359 DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG-LRPEIPK---DCP 414
             ++   ++ S+VY+FG+V++E++TG+  Y+  +     + +   G L P++ K   +CP
Sbjct: 181 QDKN-PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCP 239
Query: 415 QILKSLMIKCWNNSPSKRPQFSEI---ISLLLRT 445
           + +K LM +C      +RP F +I   I LL R+
Sbjct: 240 KAMKRLMAECLKKKRDERPLFPQILASIELLARS 273

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 78/265 (29%), Positives = 129/265 (48%), Gaps = 32/265 (12%)
Query: 198 IGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLLE----LMTCGHK 243
           IG   F  VYKG            V I+ LK       Y  + R D L     +    H 
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKA-----GYTEKQRVDFLGEAGIMGQFSHH 106
Query: 244 NILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL-KSRKLQTKEIIRIAIDVAEGIKFLND 302
           NI++   V + +   + ++T+ ME G+++  +  K  +    +++ +   +A G+K+L +
Sbjct: 107 NIIRLEGV-ISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN 165
Query: 303 HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRWLAPEIIAG 358
               +RDL ++ IL++ +    + D G+    +   EAT Y T G     RW APE I+ 
Sbjct: 166 MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAT-YTTSGGKIPIRWTAPEAIS- 223
Query: 359 DPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQIL 417
                  T  S+V+SFG+V+WE++T GE  Y   S  +    I   G R   P DCP  +
Sbjct: 224 ---YRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIND-GFRLPTPMDCPSAI 279
Query: 418 KSLMIKCWNNSPSKRPQFSEIISLL 442
             LM++CW    ++RP+F++I+S+L
Sbjct: 280 YQLMMQCWQQERARRPKFADIVSIL 304

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 78/288 (27%), Positives = 133/288 (46%), Gaps = 41/288 (14%)
Query: 192 LEFIDQIGPNSFKGVYKG-----------KRVGIEKLKGCDKGNAYEFELRKDLLELMTC 240
           + F++++G + F  VYKG           + V I+ LK   +G   E E R + +     
Sbjct: 11  VRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLRE-EFRHEAMLRARL 69
Query: 241 GHKNILQF---------------YCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKE 285
            H N++                 YC   D +  L + +   + GS +D       L+  +
Sbjct: 70  QHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPD 129
Query: 286 IIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYET 345
            + +   +A G+++L+ H V ++DL ++ +L+    NV + D+G+    + V  A  Y+ 
Sbjct: 130 FVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLF---REVYAADYYKL 186
Query: 346 DG-----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVG 399
            G      RW+APE I     S+     S+++S+G+V+WE+ + G   Y   S       
Sbjct: 187 LGNSLLPIRWMAPEAIMYGKFSID----SDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEM 242
Query: 400 IAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNN 447
           I    + P  P DCP  + +LMI+CWN  PS+RP+F +I S L    N
Sbjct: 243 IRNRQVLP-CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWGN 289

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 79/247 (31%), Positives = 126/247 (51%), Gaps = 25/247 (10%)
Query: 209 GKR---VGIEKLKGCDKGNAYEFELRKDLL-ELMTCG---HKNILQFYCVCVDENHGLCV 261
           GKR   V I+ LK       Y  + R+D L E    G   H NI+    V V ++  + +
Sbjct: 47  GKRELPVAIKTLK-----VGYTEKQRRDFLGEASIMGQFDHPNIIHLEGV-VTKSKPVMI 100
Query: 262 VTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH 320
           VT+ ME GS++  + K+  +    +++ +   ++ G+K+L+D G  +RDL ++ IL++ +
Sbjct: 101 VTEYMENGSLDTFLKKNDGQFTVIQLVGMLRGISAGMKYLSDMGYVHRDLAARNILINSN 160
Query: 321 GNVCLGDMGIVTACKSVGEATEYETDG----YRWLAPEIIAGDPESVSETWMSNVYSFGM 376
               + D G+    +   EA  Y T G     RW APE IA        T  S+V+S+G+
Sbjct: 161 LVCKVSDFGLSRVLEDDPEAA-YTTRGGKIPIRWTAPEAIAFR----KFTSASDVWSYGI 215
Query: 377 VIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQF 435
           V+WE+V+ GE  Y   +  Q  +     G R   P DCP  L  LM+ CW    + RP+F
Sbjct: 216 VMWEVVSYGERPYWEMTN-QDVIKAVEEGYRLPSPMDCPAALYQLMLDCWQKERNSRPKF 274
Query: 436 SEIISLL 442
            EI+++L
Sbjct: 275 DEIVNML 281

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 69/268 (25%), Positives = 130/268 (48%), Gaps = 17/268 (6%)
Query: 183 GRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEK--LKGCDKGNAYEFELRKDLLELMTC 240
           G+W+++   L F+ +IG   F  V+ G  +  +K  +K   +G   E +  ++   +M  
Sbjct: 3   GKWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKL 62
Query: 241 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKE-IIRIAIDVAEGIKF 299
            H  ++Q Y VC+ E   +C+V + ME G ++D +   R L   E ++ + +DV EG+ +
Sbjct: 63  SHPKLVQLYGVCL-EQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAY 121
Query: 300 LNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC----KSVGEATEYETDGYRWLAPEI 355
           L +  V +RDL ++  L+  +  + + D G+         +    T++     +W +PE+
Sbjct: 122 LEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV---KWASPEV 178
Query: 356 IAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCP 414
            +    S      S+V+SFG+++WE+ + G+  Y   S  +    I+  G R   P+   
Sbjct: 179 FSFSRYSSK----SDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST-GFRLYKPRLAS 233
Query: 415 QILKSLMIKCWNNSPSKRPQFSEIISLL 442
             +  +M  CW   P  RP FS ++  L
Sbjct: 234 THVYQIMNHCWRERPEDRPAFSRLLRQL 261

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 72/274 (26%), Positives = 128/274 (46%), Gaps = 23/274 (8%)
Query: 185 WLLNSDNLEFIDQIGPNSFKGV----YKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTC 240
           W LN   L+ +  IG   F  V    Y+G +V ++    C K +A       +   +   
Sbjct: 188 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVK----CIKNDATAQAFLAEASVMTQL 243
Query: 241 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK---LQTKEIIRIAIDVAEGI 297
            H N++Q   V V+E  GL +VT+ M  GS+ D  L+SR    L    +++ ++DV E +
Sbjct: 244 RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDY-LRSRGRSVLGGDCLLKFSLDVCEAM 302
Query: 298 KFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIA 357
           ++L  +   +RDL ++ +L+       + D G+     S  +  +      +W APE + 
Sbjct: 303 EYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV---KWTAPEALR 359
Query: 358 GDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQI 416
               S      S+V+SFG+++WE+ + G   Y    P++  V     G + + P  CP  
Sbjct: 360 EKKFSTK----SDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPRVEKGYKMDAPDGCPPA 414
Query: 417 LKSLMIKCWNNSPSKRPQFSEIISLL--LRTNNI 448
           +  +M  CW+   + RP F ++   L  +RT+ +
Sbjct: 415 VYDVMKNCWHLDAATRPTFLQLREQLEHIRTHEL 448

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 99.0 bits (245), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 69/262 (26%), Positives = 122/262 (46%), Gaps = 21/262 (8%)
Query: 185 WLLNSDNLEFIDQIGPNSFKGV----YKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTC 240
           W LN   L+ +  IG   F  V    Y+G +V ++    C K +A       +   +   
Sbjct: 16  WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVK----CIKNDATAQAFLAEASVMTQL 71
Query: 241 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK---LQTKEIIRIAIDVAEGI 297
            H N++Q   V V+E  GL +VT+ M  GS+ D  L+SR    L    +++ ++DV E +
Sbjct: 72  RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVD-YLRSRGRSVLGGDCLLKFSLDVCEAM 130
Query: 298 KFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIA 357
           ++L  +   +RDL ++ +L+       + D G+     S  +  +      +W APE + 
Sbjct: 131 EYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV---KWTAPEALR 187
Query: 358 GDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQI 416
               S      S+V+SFG+++WE+ + G   Y    P++  V     G + + P  CP  
Sbjct: 188 EKKFSTK----SDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPRVEKGYKMDAPDGCPPA 242
Query: 417 LKSLMIKCWNNSPSKRPQFSEI 438
           +  +M  CW+   + RP F ++
Sbjct: 243 VYEVMKNCWHLDAAMRPSFLQL 264

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 98.6 bits (244), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 70/262 (26%), Positives = 124/262 (47%), Gaps = 21/262 (8%)
Query: 185 WLLNSDNLEFIDQIGPNSFKGV----YKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTC 240
           W LN   L+ +  IG   F  V    Y+G +V ++    C K +A       +   +   
Sbjct: 7   WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVK----CIKNDATAQAFLAEASVMTQL 62
Query: 241 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK---LQTKEIIRIAIDVAEGI 297
            H N++Q   V V+E  GL +VT+ M  GS+ D  L+SR    L    +++ ++DV E +
Sbjct: 63  RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVD-YLRSRGRSVLGGDCLLKFSLDVCEAM 121
Query: 298 KFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIA 357
           ++L  +   +RDL ++ +L+       + D G+     S  +  +      +W APE + 
Sbjct: 122 EYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV---KWTAPEALR 178
Query: 358 GDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQI 416
              E+   T  S+V+SFG+++WE+ + G   Y    P++  V     G + + P  CP  
Sbjct: 179 ---EAAFST-KSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPRVEKGYKMDAPDGCPPA 233
Query: 417 LKSLMIKCWNNSPSKRPQFSEI 438
           +  +M  CW+   + RP F ++
Sbjct: 234 VYEVMKNCWHLDAAMRPSFLQL 255

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 98.6 bits (244), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 69/262 (26%), Positives = 122/262 (46%), Gaps = 21/262 (8%)
Query: 185 WLLNSDNLEFIDQIGPNSFKGV----YKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTC 240
           W LN   L+ +  IG   F  V    Y+G +V ++    C K +A       +   +   
Sbjct: 1   WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVK----CIKNDATAQAFLAEASVMTQL 56
Query: 241 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK---LQTKEIIRIAIDVAEGI 297
            H N++Q   V V+E  GL +VT+ M  GS+ D  L+SR    L    +++ ++DV E +
Sbjct: 57  RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVD-YLRSRGRSVLGGDCLLKFSLDVCEAM 115
Query: 298 KFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIA 357
           ++L  +   +RDL ++ +L+       + D G+     S  +  +      +W APE + 
Sbjct: 116 EYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV---KWTAPEALR 172
Query: 358 GDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQI 416
               S      S+V+SFG+++WE+ + G   Y    P++  V     G + + P  CP  
Sbjct: 173 EKKFSTK----SDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPRVEKGYKMDAPDGCPPA 227
Query: 417 LKSLMIKCWNNSPSKRPQFSEI 438
           +  +M  CW+   + RP F ++
Sbjct: 228 VYEVMKNCWHLDAAMRPSFLQL 249

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 78/259 (30%), Positives = 126/259 (48%), Gaps = 25/259 (9%)
Query: 209 GKR---VGIEKLKGCDKGNAYEFELRKDLLE----LMTCGHKNILQFYCVCVDENHGLCV 261
           GKR   V I+ LK       Y  + R+D L     +    H NI+    V V +   + +
Sbjct: 54  GKREICVAIKTLKA-----GYTDKQRRDFLSEASIMGQFDHPNIIHLEGV-VTKCKPVMI 107
Query: 262 VTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH 320
           +T+ ME GS++  + K+  +    +++ +   +  G+K+L+D    +RDL ++ IL++ +
Sbjct: 108 ITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDMSAVHRDLAARNILVNSN 167
Query: 321 GNVCLGDMGIVTACKSVGEATEYETDG----YRWLAPEIIAGDPESVSETWMSNVYSFGM 376
               + D G+    +   EA  Y T G     RW APE IA        T  S+V+S+G+
Sbjct: 168 LVCKVSDFGMSRVLEDDPEAA-YTTRGGKIPIRWTAPEAIA----YRKFTSASDVWSYGI 222
Query: 377 VIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQF 435
           V+WE+++ GE  Y   S  Q  +     G R   P DCP  L  LM+ CW    S RP+F
Sbjct: 223 VMWEVMSYGERPYWDMSN-QDVIKAIEEGYRLPPPMDCPIALHQLMLDCWQKERSDRPKF 281
Query: 436 SEIISLLLRTNNISNSSNR 454
            +I+++L +     NS  R
Sbjct: 282 GQIVNMLDKLIRNPNSLKR 300

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 72/241 (29%), Positives = 119/241 (49%), Gaps = 22/241 (9%)
Query: 212 VGIEKLKGCDKGNAYEFELRKDLLE----LMTCGHKNILQFYCVCVDENHGLCVVTKLME 267
           V I+ LK       Y    R+D L     +    H NI++   V V       +VT+ ME
Sbjct: 80  VAIKALKA-----GYTERQRRDFLSEASIMGQFDHPNIIRLEGV-VTRGRLAMIVTEYME 133
Query: 268 GGSVNDLILKSR--KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCL 325
            GS+ D  L++   +    +++ +   V  G+++L+D G  +RDL ++ +L+D +    +
Sbjct: 134 NGSL-DTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKV 192
Query: 326 GDMGIVTACKSVGEATEYETDG---YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMV 382
            D G+    +   +A    T G    RW APE IA    S +    S+V+SFG+V+WE++
Sbjct: 193 SDFGLSRVLEDDPDAAXTTTGGKIPIRWTAPEAIAFRTFSSA----SDVWSFGVVMWEVL 248
Query: 383 T-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISL 441
             GE  Y   +  +  +     G R   P  CP  L  LM+ CW+   ++RP+FS+I+S+
Sbjct: 249 AYGERPYWNMTN-RDVISSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSV 307
Query: 442 L 442
           L
Sbjct: 308 L 308

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 72/241 (29%), Positives = 119/241 (49%), Gaps = 22/241 (9%)
Query: 212 VGIEKLKGCDKGNAYEFELRKDLLE----LMTCGHKNILQFYCVCVDENHGLCVVTKLME 267
           V I+ LK       Y    R+D L     +    H NI++   V V       +VT+ ME
Sbjct: 80  VAIKALKA-----GYTERQRRDFLSEASIMGQFDHPNIIRLEGV-VTRGRLAMIVTEYME 133
Query: 268 GGSVNDLILKSR--KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCL 325
            GS+ D  L++   +    +++ +   V  G+++L+D G  +RDL ++ +L+D +    +
Sbjct: 134 NGSL-DTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKV 192
Query: 326 GDMGIVTACKSVGEATEYETDG---YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMV 382
            D G+    +   +A    T G    RW APE IA    S +    S+V+SFG+V+WE++
Sbjct: 193 SDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSA----SDVWSFGVVMWEVL 248
Query: 383 T-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISL 441
             GE  Y   +  +  +     G R   P  CP  L  LM+ CW+   ++RP+FS+I+S+
Sbjct: 249 AYGERPYWNMTN-RDVISSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSV 307
Query: 442 L 442
           L
Sbjct: 308 L 308

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 78/259 (30%), Positives = 126/259 (48%), Gaps = 25/259 (9%)
Query: 209 GKR---VGIEKLKGCDKGNAYEFELRKDLLE----LMTCGHKNILQFYCVCVDENHGLCV 261
           GKR   V I+ LK       Y  + R+D L     +    H NI+    V V +   + +
Sbjct: 39  GKREICVAIKTLKA-----GYTDKQRRDFLSEASIMGQFDHPNIIHLEGV-VTKCKPVMI 92
Query: 262 VTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH 320
           +T+ ME GS++  + K+  +    +++ +   +  G+K+L+D    +RDL ++ IL++ +
Sbjct: 93  ITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDMSYVHRDLAARNILVNSN 152
Query: 321 GNVCLGDMGIVTACKSVGEATEYETDG----YRWLAPEIIAGDPESVSETWMSNVYSFGM 376
               + D G+    +   EA  Y T G     RW APE IA        T  S+V+S+G+
Sbjct: 153 LVCKVSDFGMSRVLEDDPEAA-YTTRGGKIPIRWTAPEAIA----YRKFTSASDVWSYGI 207
Query: 377 VIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQF 435
           V+WE+++ GE  Y   S  Q  +     G R   P DCP  L  LM+ CW    S RP+F
Sbjct: 208 VMWEVMSYGERPYWDMSN-QDVIKAIEEGYRLPPPMDCPIALHQLMLDCWQKERSDRPKF 266
Query: 436 SEIISLLLRTNNISNSSNR 454
            +I+++L +     NS  R
Sbjct: 267 GQIVNMLDKLIRNPNSLKR 285

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 78/259 (30%), Positives = 126/259 (48%), Gaps = 25/259 (9%)
Query: 209 GKR---VGIEKLKGCDKGNAYEFELRKDLLE----LMTCGHKNILQFYCVCVDENHGLCV 261
           GKR   V I+ LK       Y  + R+D L     +    H NI+    V V +   + +
Sbjct: 33  GKREICVAIKTLKA-----GYTDKQRRDFLSEASIMGQFDHPNIIHLEGV-VTKCKPVMI 86
Query: 262 VTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH 320
           +T+ ME GS++  + K+  +    +++ +   +  G+K+L+D    +RDL ++ IL++ +
Sbjct: 87  ITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDMSYVHRDLAARNILVNSN 146
Query: 321 GNVCLGDMGIVTACKSVGEATEYETDG----YRWLAPEIIAGDPESVSETWMSNVYSFGM 376
               + D G+    +   EA  Y T G     RW APE IA        T  S+V+S+G+
Sbjct: 147 LVCKVSDFGMSRVLEDDPEAA-YTTRGGKIPIRWTAPEAIA----YRKFTSASDVWSYGI 201
Query: 377 VIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQF 435
           V+WE+++ GE  Y   S  Q  +     G R   P DCP  L  LM+ CW    S RP+F
Sbjct: 202 VMWEVMSYGERPYWDMSN-QDVIKAIEEGYRLPPPMDCPIALHQLMLDCWQKERSDRPKF 260
Query: 436 SEIISLLLRTNNISNSSNR 454
            +I+++L +     NS  R
Sbjct: 261 GQIVNMLDKLIRNPNSLKR 279

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 69/275 (25%), Positives = 136/275 (49%), Gaps = 17/275 (6%)
Query: 177 SGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEK--LKGCDKGNAYEFELRKDL 234
           + G   G W ++  +L F+ ++G   F  V  GK  G     +K   +G+  E E  ++ 
Sbjct: 11  TAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEA 70
Query: 235 LELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDV 293
             +M   H+ ++Q Y VC  +   + ++T+ M  G + + + + R + QT++++ +  DV
Sbjct: 71  KVMMNLSHEKLVQLYGVCTKQR-PIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDV 129
Query: 294 AEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YR 349
            E +++L      +RDL ++  L++  G V + D G+    + V +  E  + G     R
Sbjct: 130 CEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGL---SRYVLDDEETSSVGSKFPVR 186
Query: 350 WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPE 408
           W  PE++     S      S++++FG+++WE+ + G+  Y   +  + A  IA  GLR  
Sbjct: 187 WSPPEVLMYSKFSSK----SDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ-GLRLY 241
Query: 409 IPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLL 443
            P    + + ++M  CW+    +RP F  ++S +L
Sbjct: 242 RPHLASEKVYTIMYSCWHEKADERPTFKILLSNIL 276

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 74/275 (26%), Positives = 132/275 (48%), Gaps = 25/275 (9%)
Query: 186 LLNSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKG--CDKGNAYEFELRKDL 234
           L+   +L  ++++G  SF  V +G+          V ++ LK     +  A + +  +++
Sbjct: 14  LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMD-DFIREV 72
Query: 235 LELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDV 293
             + +  H+N+++ Y V +     + +VT+L   GS+ D + K +       + R A+ V
Sbjct: 73  NAMHSLDHRNLIRLYGVVLTPP--MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQV 130
Query: 294 AEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT---EYETDGYRW 350
           AEG+ +L      +RDL ++ +LL     V +GD G++ A     +     E+    + W
Sbjct: 131 AEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAW 190
Query: 351 LAPEIIAGDPES-VSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPE 408
            APE +     S  S+TWM     FG+ +WEM T G+  +   +  Q    I   G R  
Sbjct: 191 CAPESLKTRTFSHASDTWM-----FGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP 245
Query: 409 IPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLL 443
            P+DCPQ + ++M++CW + P  RP F  +   LL
Sbjct: 246 RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 280

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 74/275 (26%), Positives = 132/275 (48%), Gaps = 25/275 (9%)
Query: 186 LLNSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKG--CDKGNAYEFELRKDL 234
           L+   +L  ++++G  SF  V +G+          V ++ LK     +  A + +  +++
Sbjct: 8   LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMD-DFIREV 66
Query: 235 LELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDV 293
             + +  H+N+++ Y V +     + +VT+L   GS+ D + K +       + R A+ V
Sbjct: 67  NAMHSLDHRNLIRLYGVVLTPP--MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQV 124
Query: 294 AEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE---ATEYETDGYRW 350
           AEG+ +L      +RDL ++ +LL     V +GD G++ A     +     E+    + W
Sbjct: 125 AEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 184
Query: 351 LAPEIIAGDPES-VSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPE 408
            APE +     S  S+TWM     FG+ +WEM T G+  +   +  Q    I   G R  
Sbjct: 185 CAPESLKTRTFSHASDTWM-----FGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP 239
Query: 409 IPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLL 443
            P+DCPQ + ++M++CW + P  RP F  +   LL
Sbjct: 240 RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 274

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 74/275 (26%), Positives = 132/275 (48%), Gaps = 25/275 (9%)
Query: 186 LLNSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKG--CDKGNAYEFELRKDL 234
           L+   +L  ++++G  SF  V +G+          V ++ LK     +  A + +  +++
Sbjct: 8   LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMD-DFIREV 66
Query: 235 LELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDV 293
             + +  H+N+++ Y V +     + +VT+L   GS+ D + K +       + R A+ V
Sbjct: 67  NAMHSLDHRNLIRLYGVVLTPP--MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQV 124
Query: 294 AEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE---ATEYETDGYRW 350
           AEG+ +L      +RDL ++ +LL     V +GD G++ A     +     E+    + W
Sbjct: 125 AEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 184
Query: 351 LAPEIIAGDPES-VSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPE 408
            APE +     S  S+TWM     FG+ +WEM T G+  +   +  Q    I   G R  
Sbjct: 185 CAPESLKTRTFSHASDTWM-----FGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP 239
Query: 409 IPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLL 443
            P+DCPQ + ++M++CW + P  RP F  +   LL
Sbjct: 240 RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 274

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 74/275 (26%), Positives = 132/275 (48%), Gaps = 25/275 (9%)
Query: 186 LLNSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKG--CDKGNAYEFELRKDL 234
           L+   +L  ++++G  SF  V +G+          V ++ LK     +  A + +  +++
Sbjct: 14  LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMD-DFIREV 72
Query: 235 LELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDV 293
             + +  H+N+++ Y V +     + +VT+L   GS+ D + K +       + R A+ V
Sbjct: 73  NAMHSLDHRNLIRLYGVVLTPP--MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQV 130
Query: 294 AEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE---ATEYETDGYRW 350
           AEG+ +L      +RDL ++ +LL     V +GD G++ A     +     E+    + W
Sbjct: 131 AEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 190
Query: 351 LAPEIIAGDPES-VSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPE 408
            APE +     S  S+TWM     FG+ +WEM T G+  +   +  Q    I   G R  
Sbjct: 191 CAPESLKTRTFSHASDTWM-----FGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP 245
Query: 409 IPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLL 443
            P+DCPQ + ++M++CW + P  RP F  +   LL
Sbjct: 246 RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 280

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 74/275 (26%), Positives = 132/275 (48%), Gaps = 25/275 (9%)
Query: 186 LLNSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKG--CDKGNAYEFELRKDL 234
           L+   +L  ++++G  SF  V +G+          V ++ LK     +  A + +  +++
Sbjct: 4   LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMD-DFIREV 62
Query: 235 LELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDV 293
             + +  H+N+++ Y V +     + +VT+L   GS+ D + K +       + R A+ V
Sbjct: 63  NAMHSLDHRNLIRLYGVVLTPP--MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQV 120
Query: 294 AEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE---ATEYETDGYRW 350
           AEG+ +L      +RDL ++ +LL     V +GD G++ A     +     E+    + W
Sbjct: 121 AEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 180
Query: 351 LAPEIIAGDPES-VSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPE 408
            APE +     S  S+TWM     FG+ +WEM T G+  +   +  Q    I   G R  
Sbjct: 181 CAPESLKTRTFSHASDTWM-----FGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP 235
Query: 409 IPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLL 443
            P+DCPQ + ++M++CW + P  RP F  +   LL
Sbjct: 236 RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 74/275 (26%), Positives = 132/275 (48%), Gaps = 25/275 (9%)
Query: 186 LLNSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKG--CDKGNAYEFELRKDL 234
           L+   +L  ++++G  SF  V +G+          V ++ LK     +  A + +  +++
Sbjct: 4   LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMD-DFIREV 62
Query: 235 LELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDV 293
             + +  H+N+++ Y V +     + +VT+L   GS+ D + K +       + R A+ V
Sbjct: 63  NAMHSLDHRNLIRLYGVVLTPP--MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQV 120
Query: 294 AEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE---ATEYETDGYRW 350
           AEG+ +L      +RDL ++ +LL     V +GD G++ A     +     E+    + W
Sbjct: 121 AEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 180
Query: 351 LAPEIIAGDPES-VSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPE 408
            APE +     S  S+TWM     FG+ +WEM T G+  +   +  Q    I   G R  
Sbjct: 181 CAPESLKTRTFSHASDTWM-----FGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP 235
Query: 409 IPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLL 443
            P+DCPQ + ++M++CW + P  RP F  +   LL
Sbjct: 236 RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 74/275 (26%), Positives = 132/275 (48%), Gaps = 25/275 (9%)
Query: 186 LLNSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKG--CDKGNAYEFELRKDL 234
           L+   +L  ++++G  SF  V +G+          V ++ LK     +  A + +  +++
Sbjct: 4   LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMD-DFIREV 62
Query: 235 LELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDV 293
             + +  H+N+++ Y V +     + +VT+L   GS+ D + K +       + R A+ V
Sbjct: 63  NAMHSLDHRNLIRLYGVVLTPP--MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQV 120
Query: 294 AEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT---EYETDGYRW 350
           AEG+ +L      +RDL ++ +LL     V +GD G++ A     +     E+    + W
Sbjct: 121 AEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAW 180
Query: 351 LAPEIIAGDPES-VSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPE 408
            APE +     S  S+TWM     FG+ +WEM T G+  +   +  Q    I   G R  
Sbjct: 181 CAPESLKTRTFSHASDTWM-----FGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP 235
Query: 409 IPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLL 443
            P+DCPQ + ++M++CW + P  RP F  +   LL
Sbjct: 236 RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 69/269 (25%), Positives = 133/269 (49%), Gaps = 26/269 (9%)
Query: 186 LLNSDNLEFIDQIGPNSF----KGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCG 241
           +++   +E  + +G  +F    K  ++ K V I++++   +  A+  ELR    +L    
Sbjct: 5   MIDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESESERKAFIVELR----QLSRVN 60
Query: 242 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKL---QTKEIIRIAIDVAEGIK 298
           H NI++ Y  C++    +C+V +  EGGS+ +++  +  L        +   +  ++G+ 
Sbjct: 61  HPNIVKLYGACLNP---VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVA 117
Query: 299 FLND---HGVAYRDLNSQRILLDRHGNVC-LGDMGIVTACKSVGEATEYETDGYRWLAPE 354
           +L+      + +RDL    +LL   G V  + D G  TAC      T  +     W+APE
Sbjct: 118 YLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFG--TACDIQTHMTNNKGSA-AWMAPE 174
Query: 355 IIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACS-PVQAAVGIAACGLRPEIPKDC 413
           +  G   + SE    +V+S+G+++WE++T    +     P    +     G RP + K+ 
Sbjct: 175 VFEGS--NYSEK--CDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNL 230
Query: 414 PQILKSLMIKCWNNSPSKRPQFSEIISLL 442
           P+ ++SLM +CW+  PS+RP   EI+ ++
Sbjct: 231 PKPIESLMTRCWSKDPSQRPSMEEIVKIM 259

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 69/269 (25%), Positives = 133/269 (49%), Gaps = 26/269 (9%)
Query: 186 LLNSDNLEFIDQIGPNSF----KGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCG 241
           +++   +E  + +G  +F    K  ++ K V I++++   +  A+  ELR    +L    
Sbjct: 4   MIDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESESERKAFIVELR----QLSRVN 59
Query: 242 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKL---QTKEIIRIAIDVAEGIK 298
           H NI++ Y  C++    +C+V +  EGGS+ +++  +  L        +   +  ++G+ 
Sbjct: 60  HPNIVKLYGACLNP---VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVA 116
Query: 299 FLND---HGVAYRDLNSQRILLDRHGNVC-LGDMGIVTACKSVGEATEYETDGYRWLAPE 354
           +L+      + +RDL    +LL   G V  + D G  TAC      T  +     W+APE
Sbjct: 117 YLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFG--TACDIQTHMTNNKGSA-AWMAPE 173
Query: 355 IIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACS-PVQAAVGIAACGLRPEIPKDC 413
           +  G   + SE    +V+S+G+++WE++T    +     P    +     G RP + K+ 
Sbjct: 174 VFEGS--NYSEK--CDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNL 229
Query: 414 PQILKSLMIKCWNNSPSKRPQFSEIISLL 442
           P+ ++SLM +CW+  PS+RP   EI+ ++
Sbjct: 230 PKPIESLMTRCWSKDPSQRPSMEEIVKIM 258

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 67/267 (25%), Positives = 131/267 (49%), Gaps = 13/267 (4%)
Query: 183 GRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEK--LKGCDKGNAYEFELRKDLLELMTC 240
           G W ++  +L F+ ++G   F  V  GK  G     +K   +G+  E E  ++   +M  
Sbjct: 2   GSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNL 61
Query: 241 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKF 299
            H+ ++Q Y VC  +   + ++T+ M  G + + + + R + QT++++ +  DV E +++
Sbjct: 62  SHEKLVQLYGVCTKQR-PIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEY 120
Query: 300 LNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY--RWLAPEIIA 357
           L      +RDL ++  L++  G V + D G+        E T      +  RW  PE++ 
Sbjct: 121 LESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD-DEYTSSRGSKFPVRWSPPEVLM 179
Query: 358 GDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQI 416
               S      S++++FG+++WE+ + G+  Y   +  + A  IA  GLR   P    + 
Sbjct: 180 YSKFSSK----SDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ-GLRLYRPHLASEK 234
Query: 417 LKSLMIKCWNNSPSKRPQFSEIISLLL 443
           + ++M  CW+    +RP F  ++S +L
Sbjct: 235 VYTIMYSCWHEKADERPTFKILLSNIL 261

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 69/277 (24%), Positives = 133/277 (48%), Gaps = 21/277 (7%)
Query: 177 SGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEK--LKGCDKGNAYEFELRKDL 234
           + G   G W ++  +L F+ ++G   F  V  GK  G     +K   +G+  E E  ++ 
Sbjct: 11  TAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEA 70
Query: 235 LELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDV 293
             +M   H+ ++Q Y VC  +   + ++T+ M  G + + + + R + QT++++ +  DV
Sbjct: 71  KVMMNLSHEKLVQLYGVCTKQR-PIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDV 129
Query: 294 AEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC------KSVGEATEYETDG 347
            E +++L      +RDL ++  L++  G V + D G+           SVG         
Sbjct: 130 CEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFP----- 184
Query: 348 YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLR 406
            RW  PE++     S      S++++FG+++WE+ + G+  Y   +  + A  IA  GLR
Sbjct: 185 VRWSPPEVLMYSKFSSK----SDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ-GLR 239
Query: 407 PEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLL 443
              P    + + ++M  CW+    +RP F  ++S +L
Sbjct: 240 LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNIL 276

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 69/277 (24%), Positives = 133/277 (48%), Gaps = 21/277 (7%)
Query: 177 SGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEK--LKGCDKGNAYEFELRKDL 234
           + G   G W ++  +L F+ ++G   F  V  GK  G     +K   +G+  E E  ++ 
Sbjct: 2   TAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEA 61
Query: 235 LELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDV 293
             +M   H+ ++Q Y VC  +   + ++T+ M  G + + + + R + QT++++ +  DV
Sbjct: 62  KVMMNLSHEKLVQLYGVCTKQR-PIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDV 120
Query: 294 AEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC------KSVGEATEYETDG 347
            E +++L      +RDL ++  L++  G V + D G+           SVG         
Sbjct: 121 CEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFP----- 175
Query: 348 YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLR 406
            RW  PE++     S      S++++FG+++WE+ + G+  Y   +  + A  IA  GLR
Sbjct: 176 VRWSPPEVLMYSKFSSK----SDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ-GLR 230
Query: 407 PEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLL 443
              P    + + ++M  CW+    +RP F  ++S +L
Sbjct: 231 LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNIL 267

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 68/272 (25%), Positives = 132/272 (48%), Gaps = 21/272 (7%)
Query: 182 IGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEK--LKGCDKGNAYEFELRKDLLELMT 239
           +G W ++  +L F+ ++G   F  V  GK  G     +K   +G+  E E  ++   +M 
Sbjct: 1   MGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMN 60
Query: 240 CGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIK 298
             H+ ++Q Y VC  +   + ++T+ M  G + + + + R + QT++++ +  DV E ++
Sbjct: 61  LSHEKLVQLYGVCTKQR-PIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAME 119
Query: 299 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC------KSVGEATEYETDGYRWLA 352
           +L      +RDL ++  L++  G V + D G+           SVG          RW  
Sbjct: 120 YLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFP-----VRWSP 174
Query: 353 PEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPK 411
           PE++     S      S++++FG+++WE+ + G+  Y   +  + A  IA  GLR   P 
Sbjct: 175 PEVLMYSKFSSK----SDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ-GLRLYRPH 229
Query: 412 DCPQILKSLMIKCWNNSPSKRPQFSEIISLLL 443
              + + ++M  CW+    +RP F  ++S +L
Sbjct: 230 LASEKVYTIMYSCWHEKADERPTFKILLSNIL 261

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 68/271 (25%), Positives = 131/271 (48%), Gaps = 21/271 (7%)
Query: 183 GRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEK--LKGCDKGNAYEFELRKDLLELMTC 240
           G W ++  +L F+ ++G   F  V  GK  G     +K   +G+  E E  ++   +M  
Sbjct: 1   GSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNL 60
Query: 241 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKF 299
            H+ ++Q Y VC  +   + ++T+ M  G + + + + R + QT++++ +  DV E +++
Sbjct: 61  SHEKLVQLYGVCTKQR-PIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEY 119
Query: 300 LNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC------KSVGEATEYETDGYRWLAP 353
           L      +RDL ++  L++  G V + D G+           SVG          RW  P
Sbjct: 120 LESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFP-----VRWSPP 174
Query: 354 EIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKD 412
           E++     S      S++++FG+++WE+ + G+  Y   +  + A  IA  GLR   P  
Sbjct: 175 EVLMYSKFSSK----SDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ-GLRLYRPHL 229
Query: 413 CPQILKSLMIKCWNNSPSKRPQFSEIISLLL 443
             + + ++M  CW+    +RP F  ++S +L
Sbjct: 230 ASEKVYTIMYSCWHEKADERPTFKILLSNIL 260

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 75/256 (29%), Positives = 124/256 (48%), Gaps = 23/256 (8%)
Query: 209 GKR---VGIEKLKGCDKGNAYEFELRKDLL-ELMTCG---HKNILQFYCVCVDENHGLCV 261
           GKR   V I+ LK       Y  + R+D L E    G   H N++    V V     + +
Sbjct: 68  GKRDVAVAIKTLK-----VGYTEKQRRDFLCEASIMGQFDHPNVVHLEGV-VTRGKPVMI 121
Query: 262 VTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH 320
           V + ME G+++  + K   +    +++ +   +A G+++L D G  +RDL ++ IL++ +
Sbjct: 122 VIEFMENGALDAFLRKHDGQFTVIQLVGMLRGIAAGMRYLADMGYVHRDLAARNILVNSN 181
Query: 321 GNVCLGDMGIVTACKSVGEATEYETDG---YRWLAPEIIAGDPESVSETWMSNVYSFGMV 377
               + D G+    +   EA    T G    RW APE I    +    T  S+V+S+G+V
Sbjct: 182 LVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAPEAI----QYRKFTSASDVWSYGIV 237
Query: 378 IWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFS 436
           +WE+++ GE  Y   S  Q  +     G R   P DCP  L  LM+ CW    ++RP+F 
Sbjct: 238 MWEVMSYGERPYWDMSN-QDVIKAIEEGYRLPAPMDCPAGLHQLMLDCWQKERAERPKFE 296
Query: 437 EIISLLLRTNNISNSS 452
           +I+ +L +     NS+
Sbjct: 297 QIVGILDKMIRNPNSA 312

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 67/265 (25%), Positives = 127/265 (47%), Gaps = 17/265 (6%)
Query: 186 LLNSDNLEFIDQIGPNSFKGVYKGKRVGIEK--LKGCDKGNAYEFELRKDLLELMTCGHK 243
           +++   L F+ +IG   F  V+ G  +  +K  +K   +G   E +  ++   +M   H 
Sbjct: 3   VIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHP 62
Query: 244 NILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKE-IIRIAIDVAEGIKFLND 302
            ++Q Y VC+ E   +C+V + ME G ++D +   R L   E ++ + +DV EG+ +L +
Sbjct: 63  KLVQLYGVCL-EQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE 121
Query: 303 HGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC----KSVGEATEYETDGYRWLAPEIIAG 358
             V +RDL ++  L+  +  + + D G+         +    T++     +W +PE+ + 
Sbjct: 122 ASVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV---KWASPEVFSF 178
Query: 359 DPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQIL 417
              S      S+V+SFG+++WE+ + G+  Y   S  +    I+  G R   P+     +
Sbjct: 179 SRYSSK----SDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST-GFRLYKPRLASTHV 233
Query: 418 KSLMIKCWNNSPSKRPQFSEIISLL 442
             +M  CW   P  RP FS ++  L
Sbjct: 234 YQIMNHCWKERPEDRPAFSRLLRQL 258

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 67/265 (25%), Positives = 128/265 (48%), Gaps = 17/265 (6%)
Query: 186 LLNSDNLEFIDQIGPNSFKGVYKGKRVGIEK--LKGCDKGNAYEFELRKDLLELMTCGHK 243
           +++   L F+ +IG   F  V+ G  +  +K  +K   +G+  E +  ++   +M   H 
Sbjct: 23  VIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIKEGSMSEDDFIEEAEVMMKLSHP 82
Query: 244 NILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKE-IIRIAIDVAEGIKFLND 302
            ++Q Y VC+ E   +C+V + ME G ++D +   R L   E ++ + +DV EG+ +L +
Sbjct: 83  KLVQLYGVCL-EQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE 141
Query: 303 HGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC----KSVGEATEYETDGYRWLAPEIIAG 358
             V +RDL ++  L+  +  + + D G+         +    T++     +W +PE+ + 
Sbjct: 142 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV---KWASPEVFSF 198
Query: 359 DPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQIL 417
              S      S+V+SFG+++WE+ + G+  Y   S  +    I+  G R   P+     +
Sbjct: 199 SRYSSK----SDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST-GFRLYKPRLASTHV 253
Query: 418 KSLMIKCWNNSPSKRPQFSEIISLL 442
             +M  CW   P  RP FS ++  L
Sbjct: 254 YQIMNHCWKERPEDRPAFSRLLRQL 278

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 81/316 (25%), Positives = 138/316 (43%), Gaps = 64/316 (20%)
Query: 160 LPSSSFVVSVDEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGK--------- 210
            PSS FV   DEW+             ++ + +  + ++G  SF  VY+G          
Sbjct: 2   FPSSVFVP--DEWE-------------VSREKITLLRELGQGSFGMVYEGNARDIIKGEA 46
Query: 211 --RVGIEKL-KGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLME 267
             RV ++ + +        EF     +++  TC H  +++   V V +     VV +LM 
Sbjct: 47  ETRVAVKTVNESASLRERIEFLNEASVMKGFTCHH--VVRLLGV-VSKGQPTLVVMELMA 103
Query: 268 GGSVNDLILKSRK----------LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILL 317
            G +   +   R              +E+I++A ++A+G+ +LN     +RDL ++  ++
Sbjct: 104 HGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMV 163
Query: 318 DRHGNVCLGDMGIVTACKSVGEATEYETDGYR----------WLAPEIIAGDPESVSETW 367
                V +GD G+            YETD YR          W+APE +     + S   
Sbjct: 164 AHDFTVKIGDFGMTRDI--------YETDYYRKGGKGLLPVRWMAPESLKDGVFTTS--- 212
Query: 368 MSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWN 426
            S+++SFG+V+WE+ +  E  Y   S  Q    +   G   + P +CP+ +  LM  CW 
Sbjct: 213 -SDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQ-PDNCPERVTDLMRMCWQ 270
Query: 427 NSPSKRPQFSEIISLL 442
            +P  RP F EI++LL
Sbjct: 271 FNPKMRPTFLEIVNLL 286

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 79/311 (25%), Positives = 138/311 (44%), Gaps = 54/311 (17%)
Query: 160 LPSSSFVVSVDEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGK--------- 210
            PSS FV   DEW+             ++ + +  + ++G  SF  VY+G          
Sbjct: 2   FPSSVFVP--DEWE-------------VSREKITLLRELGQGSFGMVYEGNARDIIKGEA 46
Query: 211 --RVGIEKL-KGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLME 267
             RV ++ + +        EF     +++  TC H  +++   V V +     VV +LM 
Sbjct: 47  ETRVAVKTVNESASLRERIEFLNEASVMKGFTCHH--VVRLLGV-VSKGQPTLVVMELMA 103
Query: 268 GGSVNDLILKSRK----------LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILL 317
            G +   +   R              +E+I++A ++A+G+ +LN     +RDL ++  ++
Sbjct: 104 HGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMV 163
Query: 318 DRHGNVCLGDMGIVTACKSVGEATEYETDG-----YRWLAPEIIAGDPESVSETWMSNVY 372
                V +GD G+    + + E   Y   G      RW+APE +     + S    S+++
Sbjct: 164 AHDFTVKIGDFGM---TRDIYETAYYRKGGKGLLPVRWMAPESLKDGVFTTS----SDMW 216
Query: 373 SFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSK 431
           SFG+V+WE+ +  E  Y   S  Q    +   G   + P +CP+ +  LM  CW  +P  
Sbjct: 217 SFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQ-PDNCPERVTDLMRMCWQFNPKM 275
Query: 432 RPQFSEIISLL 442
           RP F EI++LL
Sbjct: 276 RPTFLEIVNLL 286

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 63/260 (24%), Positives = 121/260 (46%), Gaps = 15/260 (5%)
Query: 192 LEFIDQIGPNS----FKGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQ 247
           L F+ ++  N     +KG ++G  + ++ LK  D       +  ++   L    H N+L 
Sbjct: 12  LNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLP 71
Query: 248 FYCVCVDEN-HGLCVVTKLMEGGSVNDLILKSRKL--QTKEIIRIAIDVAEGIKFLN--D 302
               C         ++T  M  GS+ +++ +         + ++ A+D+A G+ FL+  +
Sbjct: 72  VLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLE 131
Query: 303 HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPES 362
             +    LNS+ +++D      +    +  + +S G           W+APE +   PE 
Sbjct: 132 PLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRMY-----APAWVAPEALQKKPED 186
Query: 363 VSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMI 422
            +    ++++SF +++WE+VT E  +A  S ++  + +A  GLRP IP      +  LM 
Sbjct: 187 TNRR-SADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHVSKLMK 245
Query: 423 KCWNNSPSKRPQFSEIISLL 442
            C N  P+KRP+F  I+ +L
Sbjct: 246 ICMNEDPAKRPKFDMIVPIL 265

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 70/268 (26%), Positives = 127/268 (47%), Gaps = 21/268 (7%)
Query: 183 GRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKL--KGCDKGNAYEFELRKDLLELMTC 240
           G   L  + +  + ++G   F  V  GK  G   +  K   +G+  E E  ++   +M  
Sbjct: 1   GHMELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKL 60
Query: 241 GHKNILQFYCVCVDENHGLCVVTKLMEGGS-VNDLILKSRKLQTKEIIRIAIDVAEGIKF 299
            H  +++FY VC  E + + +VT+ +  G  +N L    + L+  +++ +  DV EG+ F
Sbjct: 61  SHPKLVKFYGVCSKE-YPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAF 119
Query: 300 LNDHGVAYRDLNSQRILLDRHGNVCLGDMGIV------TACKSVGEATEYETDGYRWLAP 353
           L  H   +RDL ++  L+DR   V + D G+           SVG  T++     +W AP
Sbjct: 120 LESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVG--TKFPV---KWSAP 174
Query: 354 EIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKD 412
           E+      S      S+V++FG+++WE+ + G+  Y   +  +  + ++  G R   P  
Sbjct: 175 EVFHYFKYSSK----SDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQ-GHRLYRPHL 229
Query: 413 CPQILKSLMIKCWNNSPSKRPQFSEIIS 440
               +  +M  CW+  P KRP F +++S
Sbjct: 230 ASDTIYQIMYSCWHELPEKRPTFQQLLS 257

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 67/265 (25%), Positives = 127/265 (47%), Gaps = 17/265 (6%)
Query: 186 LLNSDNLEFIDQIGPNSFKGVYKGKRVGIEK--LKGCDKGNAYEFELRKDLLELMTCGHK 243
           +++   L F+ +IG   F  V+ G  +  +K  +K   +G   E +  ++   +M   H 
Sbjct: 3   VIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHP 62
Query: 244 NILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKE-IIRIAIDVAEGIKFLND 302
            ++Q Y VC+ E   +C+V + ME G ++D +   R L   E ++ + +DV EG+ +L +
Sbjct: 63  KLVQLYGVCL-EQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE 121
Query: 303 HGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC----KSVGEATEYETDGYRWLAPEIIAG 358
             V +RDL ++  L+  +  + + D G+         +    T++     +W +PE+ + 
Sbjct: 122 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV---KWASPEVFSF 178
Query: 359 DPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQIL 417
              S      S+V+SFG+++WE+ + G+  Y   S  +    I+  G R   P+     +
Sbjct: 179 SRYSSK----SDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST-GFRLYKPRLASTHV 233
Query: 418 KSLMIKCWNNSPSKRPQFSEIISLL 442
             +M  CW   P  RP FS ++  L
Sbjct: 234 YQIMNHCWKERPEDRPAFSRLLRQL 258

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 128/271 (47%), Gaps = 27/271 (9%)
Query: 185 WLLNSDNLEFIDQIGPNSFKGVYKG-----KRVGIEKLK-GCDKGNAY--EFELRKDLLE 236
           W +  + L+ ++++G   F  V+ G      +V ++ LK G    +A+  E  L K L  
Sbjct: 14  WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQL-- 71
Query: 237 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR--KLQTKEIIRIAIDVA 294
                H+ +++ Y V   E   + ++T+ ME GS+ D +      KL   +++ +A  +A
Sbjct: 72  ----QHQRLVRLYAVVTQE--PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 125
Query: 295 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY--RWLA 352
           EG+ F+ +    +RDL +  IL+    +  + D G+    +   E T  E   +  +W A
Sbjct: 126 EGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIED-NEXTAREGAKFPIKWTA 184
Query: 353 PEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPK 411
           PE I     ++     S+V+SFG+++ E+VT G   Y   +  +    +   G R   P 
Sbjct: 185 PEAINYGTFTIK----SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER-GYRMVRPD 239
Query: 412 DCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
           +CP+ L  LM  CW   P  RP F  + S+L
Sbjct: 240 NCPEELYQLMRLCWKERPEDRPTFDYLRSVL 270

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 67/265 (25%), Positives = 127/265 (47%), Gaps = 17/265 (6%)
Query: 186 LLNSDNLEFIDQIGPNSFKGVYKGKRVGIEK--LKGCDKGNAYEFELRKDLLELMTCGHK 243
           +++   L F+ +IG   F  V+ G  +  +K  +K   +G   E +  ++   +M   H 
Sbjct: 1   VIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHP 60
Query: 244 NILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKE-IIRIAIDVAEGIKFLND 302
            ++Q Y VC+ E   +C+V + ME G ++D +   R L   E ++ + +DV EG+ +L +
Sbjct: 61  KLVQLYGVCL-EQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE 119
Query: 303 HGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC----KSVGEATEYETDGYRWLAPEIIAG 358
             V +RDL ++  L+  +  + + D G+         +    T++     +W +PE+ + 
Sbjct: 120 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV---KWASPEVFSF 176
Query: 359 DPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQIL 417
              S      S+V+SFG+++WE+ + G+  Y   S  +    I+  G R   P+     +
Sbjct: 177 SRYSSK----SDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST-GFRLYKPRLASTHV 231
Query: 418 KSLMIKCWNNSPSKRPQFSEIISLL 442
             +M  CW   P  RP FS ++  L
Sbjct: 232 YQIMNHCWKERPEDRPAFSRLLRQL 256

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 92.0 bits (227), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 128/271 (47%), Gaps = 27/271 (9%)
Query: 185 WLLNSDNLEFIDQIGPNSFKGVYKG-----KRVGIEKLK-GCDKGNAY--EFELRKDLLE 236
           W +  + L+ ++++G   F  V+ G      +V ++ LK G    +A+  E  L K L  
Sbjct: 16  WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQL-- 73
Query: 237 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR--KLQTKEIIRIAIDVA 294
                H+ +++ Y V   E   + ++T+ ME GS+ D +      KL   +++ +A  +A
Sbjct: 74  ----QHQRLVRLYAVVTQE--PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 127
Query: 295 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY--RWLA 352
           EG+ F+ +    +RDL +  IL+    +  + D G+    +   E T  E   +  +W A
Sbjct: 128 EGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIED-NEXTAREGAKFPIKWTA 186
Query: 353 PEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPK 411
           PE I     ++     S+V+SFG+++ E+VT G   Y   +  +    +   G R   P 
Sbjct: 187 PEAINYGTFTIK----SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER-GYRMVRPD 241
Query: 412 DCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
           +CP+ L  LM  CW   P  RP F  + S+L
Sbjct: 242 NCPEELYQLMRLCWKERPEDRPTFDYLRSVL 272

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 92.0 bits (227), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 128/271 (47%), Gaps = 27/271 (9%)
Query: 185 WLLNSDNLEFIDQIGPNSFKGVYKG-----KRVGIEKLK-GCDKGNAY--EFELRKDLLE 236
           W +  + L+ ++++G   F  V+ G      +V ++ LK G    +A+  E  L K L  
Sbjct: 17  WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQL-- 74
Query: 237 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR--KLQTKEIIRIAIDVA 294
                H+ +++ Y V   E   + ++T+ ME GS+ D +      KL   +++ +A  +A
Sbjct: 75  ----QHQRLVRLYAVVTQE--PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 128
Query: 295 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY--RWLA 352
           EG+ F+ +    +RDL +  IL+    +  + D G+    +   E T  E   +  +W A
Sbjct: 129 EGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIED-NEXTAREGAKFPIKWTA 187
Query: 353 PEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPK 411
           PE I     ++     S+V+SFG+++ E+VT G   Y   +  +    +   G R   P 
Sbjct: 188 PEAINYGTFTIK----SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER-GYRMVRPD 242
Query: 412 DCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
           +CP+ L  LM  CW   P  RP F  + S+L
Sbjct: 243 NCPEELYQLMRLCWKERPEDRPTFDYLRSVL 273

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 128/271 (47%), Gaps = 27/271 (9%)
Query: 185 WLLNSDNLEFIDQIGPNSFKGVYKG-----KRVGIEKLK-GCDKGNAY--EFELRKDLLE 236
           W +  + L+ ++++G   F  V+ G      +V ++ LK G    +A+  E  L K L  
Sbjct: 8   WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQL-- 65
Query: 237 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR--KLQTKEIIRIAIDVA 294
                H+ +++ Y V   E   + ++T+ ME GS+ D +      KL   +++ +A  +A
Sbjct: 66  ----QHQRLVRLYAVVTQE--PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 119
Query: 295 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY--RWLA 352
           EG+ F+ +    +RDL +  IL+    +  + D G+    +   E T  E   +  +W A
Sbjct: 120 EGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIED-NEXTAREGAKFPIKWTA 178
Query: 353 PEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPK 411
           PE I     ++     S+V+SFG+++ E+VT G   Y   +  +    +   G R   P 
Sbjct: 179 PEAINYGTFTIK----SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER-GYRMVRPD 233
Query: 412 DCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
           +CP+ L  LM  CW   P  RP F  + S+L
Sbjct: 234 NCPEELYQLMRLCWKERPEDRPTFDYLRSVL 264

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 128/271 (47%), Gaps = 27/271 (9%)
Query: 185 WLLNSDNLEFIDQIGPNSFKGVYKG-----KRVGIEKLK-GCDKGNAY--EFELRKDLLE 236
           W +  + L+ ++++G   F  V+ G      +V ++ LK G    +A+  E  L K L  
Sbjct: 14  WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQL-- 71
Query: 237 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR--KLQTKEIIRIAIDVA 294
                H+ +++ Y V   E   + ++T+ ME GS+ D +      KL   +++ +A  +A
Sbjct: 72  ----QHQRLVRLYAVVTQE--PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 125
Query: 295 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY--RWLA 352
           EG+ F+ +    +RDL +  IL+    +  + D G+    +   E T  E   +  +W A
Sbjct: 126 EGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIED-NEYTAREGAKFPIKWTA 184
Query: 353 PEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPK 411
           PE I     ++     S+V+SFG+++ E+VT G   Y   +  +    +   G R   P 
Sbjct: 185 PEAINYGTFTIK----SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER-GYRMVRPD 239
Query: 412 DCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
           +CP+ L  LM  CW   P  RP F  + S+L
Sbjct: 240 NCPEELYQLMRLCWKERPEDRPTFDYLRSVL 270

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 128/271 (47%), Gaps = 27/271 (9%)
Query: 185 WLLNSDNLEFIDQIGPNSFKGVYKG-----KRVGIEKLK-GCDKGNAY--EFELRKDLLE 236
           W +  + L+ ++++G   F  V+ G      +V ++ LK G    +A+  E  L K L  
Sbjct: 9   WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQL-- 66
Query: 237 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR--KLQTKEIIRIAIDVA 294
                H+ +++ Y V   E   + ++T+ ME GS+ D +      KL   +++ +A  +A
Sbjct: 67  ----QHQRLVRLYAVVTQE--PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 120
Query: 295 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY--RWLA 352
           EG+ F+ +    +RDL +  IL+    +  + D G+    +   E T  E   +  +W A
Sbjct: 121 EGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIED-NEXTAREGAKFPIKWTA 179
Query: 353 PEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPK 411
           PE I     ++     S+V+SFG+++ E+VT G   Y   +  +    +   G R   P 
Sbjct: 180 PEAINYGTFTIK----SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER-GYRMVRPD 234
Query: 412 DCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
           +CP+ L  LM  CW   P  RP F  + S+L
Sbjct: 235 NCPEELYQLMRLCWKERPEDRPTFDYLRSVL 265

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 128/271 (47%), Gaps = 27/271 (9%)
Query: 185 WLLNSDNLEFIDQIGPNSFKGVYKG-----KRVGIEKLK-GCDKGNAY--EFELRKDLLE 236
           W +  + L+ ++++G   F  V+ G      +V ++ LK G    +A+  E  L K L  
Sbjct: 13  WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQL-- 70
Query: 237 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR--KLQTKEIIRIAIDVA 294
                H+ +++ Y V   E   + ++T+ ME GS+ D +      KL   +++ +A  +A
Sbjct: 71  ----QHQRLVRLYAVVTQE--PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 124
Query: 295 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY--RWLA 352
           EG+ F+ +    +RDL +  IL+    +  + D G+    +   E T  E   +  +W A
Sbjct: 125 EGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIED-NEYTAREGAKFPIKWTA 183
Query: 353 PEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPK 411
           PE I     ++     S+V+SFG+++ E+VT G   Y   +  +    +   G R   P 
Sbjct: 184 PEAINYGTFTIK----SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER-GYRMVRPD 238
Query: 412 DCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
           +CP+ L  LM  CW   P  RP F  + S+L
Sbjct: 239 NCPEELYQLMRLCWKERPEDRPTFDYLRSVL 269

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 128/271 (47%), Gaps = 27/271 (9%)
Query: 185 WLLNSDNLEFIDQIGPNSFKGVYKG-----KRVGIEKLK-GCDKGNAY--EFELRKDLLE 236
           W +  + L+ ++++G   F  V+ G      +V ++ LK G    +A+  E  L K L  
Sbjct: 10  WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQL-- 67
Query: 237 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR--KLQTKEIIRIAIDVA 294
                H+ +++ Y V   E   + ++T+ ME GS+ D +      KL   +++ +A  +A
Sbjct: 68  ----QHQRLVRLYAVVTQE--PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 121
Query: 295 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY--RWLA 352
           EG+ F+ +    +RDL +  IL+    +  + D G+    +   E T  E   +  +W A
Sbjct: 122 EGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIED-NEXTAREGAKFPIKWTA 180
Query: 353 PEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPK 411
           PE I     ++     S+V+SFG+++ E+VT G   Y   +  +    +   G R   P 
Sbjct: 181 PEAINYGTFTIK----SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER-GYRMVRPD 235
Query: 412 DCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
           +CP+ L  LM  CW   P  RP F  + S+L
Sbjct: 236 NCPEELYQLMRLCWKERPEDRPTFDYLRSVL 266

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 128/271 (47%), Gaps = 27/271 (9%)
Query: 185 WLLNSDNLEFIDQIGPNSFKGVYKG-----KRVGIEKLK-GCDKGNAY--EFELRKDLLE 236
           W +  + L+ ++++G   F  V+ G      +V ++ LK G    +A+  E  L K L  
Sbjct: 18  WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQL-- 75
Query: 237 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR--KLQTKEIIRIAIDVA 294
                H+ +++ Y V   E   + ++T+ ME GS+ D +      KL   +++ +A  +A
Sbjct: 76  ----QHQRLVRLYAVVTQE--PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 129
Query: 295 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY--RWLA 352
           EG+ F+ +    +RDL +  IL+    +  + D G+    +   E T  E   +  +W A
Sbjct: 130 EGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIED-NEYTAREGAKFPIKWTA 188
Query: 353 PEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPK 411
           PE I     ++     S+V+SFG+++ E+VT G   Y   +  +    +   G R   P 
Sbjct: 189 PEAINYGTFTIK----SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER-GYRMVRPD 243
Query: 412 DCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
           +CP+ L  LM  CW   P  RP F  + S+L
Sbjct: 244 NCPEELYQLMRLCWKERPEDRPTFDYLRSVL 274

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 128/271 (47%), Gaps = 27/271 (9%)
Query: 185 WLLNSDNLEFIDQIGPNSFKGVYKG-----KRVGIEKLK-GCDKGNAY--EFELRKDLLE 236
           W +  + L+ ++++G   F  V+ G      +V ++ LK G    +A+  E  L K L  
Sbjct: 8   WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQL-- 65
Query: 237 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR--KLQTKEIIRIAIDVA 294
                H+ +++ Y V   E   + ++T+ ME GS+ D +      KL   +++ +A  +A
Sbjct: 66  ----QHQRLVRLYAVVTQE--PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 119
Query: 295 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY--RWLA 352
           EG+ F+ +    +RDL +  IL+    +  + D G+    +   E T  E   +  +W A
Sbjct: 120 EGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIED-NEXTAREGAKFPIKWTA 178
Query: 353 PEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPK 411
           PE I     ++     S+V+SFG+++ E+VT G   Y   +  +    +   G R   P 
Sbjct: 179 PEAINYGTFTIK----SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER-GYRMVRPD 233
Query: 412 DCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
           +CP+ L  LM  CW   P  RP F  + S+L
Sbjct: 234 NCPEELYQLMRLCWKERPEDRPTFDYLRSVL 264

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 128/271 (47%), Gaps = 27/271 (9%)
Query: 185 WLLNSDNLEFIDQIGPNSFKGVYKG-----KRVGIEKLK-GCDKGNAY--EFELRKDLLE 236
           W +  + L+ ++++G   F  V+ G      +V ++ LK G    +A+  E  L K L  
Sbjct: 3   WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQL-- 60
Query: 237 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR--KLQTKEIIRIAIDVA 294
                H+ +++ Y V   E   + ++T+ ME GS+ D +      KL   +++ +A  +A
Sbjct: 61  ----QHQRLVRLYAVVTQE--PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 114
Query: 295 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY--RWLA 352
           EG+ F+ +    +RDL +  IL+    +  + D G+    +   E T  E   +  +W A
Sbjct: 115 EGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIED-NEYTAREGAKFPIKWTA 173
Query: 353 PEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPK 411
           PE I     ++     S+V+SFG+++ E+VT G   Y   +  +    +   G R   P 
Sbjct: 174 PEAINYGTFTIK----SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER-GYRMVRPD 228
Query: 412 DCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
           +CP+ L  LM  CW   P  RP F  + S+L
Sbjct: 229 NCPEELYQLMRLCWKERPEDRPTFDYLRSVL 259

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 128/271 (47%), Gaps = 27/271 (9%)
Query: 185 WLLNSDNLEFIDQIGPNSFKGVYKG-----KRVGIEKLK-GCDKGNAY--EFELRKDLLE 236
           W +  + L+ ++++G   F  V+ G      +V ++ LK G    +A+  E  L K L  
Sbjct: 8   WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQL-- 65
Query: 237 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR--KLQTKEIIRIAIDVA 294
                H+ +++ Y V   E   + ++T+ ME GS+ D +      KL   +++ +A  +A
Sbjct: 66  ----QHQRLVRLYAVVTQE--PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 119
Query: 295 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY--RWLA 352
           EG+ F+ +    +RDL +  IL+    +  + D G+    +   E T  E   +  +W A
Sbjct: 120 EGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIED-NEYTAREGAKFPIKWTA 178
Query: 353 PEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPK 411
           PE I     ++     S+V+SFG+++ E+VT G   Y   +  +    +   G R   P 
Sbjct: 179 PEAINYGTFTIK----SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER-GYRMVRPD 233
Query: 412 DCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
           +CP+ L  LM  CW   P  RP F  + S+L
Sbjct: 234 NCPEELYQLMRLCWKERPEDRPTFDYLRSVL 264

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 76/289 (26%), Positives = 130/289 (44%), Gaps = 49/289 (16%)
Query: 185 WLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEK--------LKGCDKGNAY----EFELRK 232
           W +  + +    ++G  SF  VY+G   G+ K        +K  ++  +     EF    
Sbjct: 20  WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEA 79
Query: 233 DLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTK-------- 284
            +++   C H  +++   V V +     V+ +LM  G +   +   R             
Sbjct: 80  SVMKEFNCHH--VVRLLGV-VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPS 136
Query: 285 --EIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE 342
             ++I++A ++A+G+ +LN +   +RDL ++  ++     V +GD G+            
Sbjct: 137 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI-------- 188
Query: 343 YETDGYR----------WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAAC 391
           YETD YR          W++PE +    + V  T+ S+V+SFG+V+WE+ T  E  Y   
Sbjct: 189 YETDYYRKGGKGLLPVRWMSPESLK---DGVFTTY-SDVWSFGVVLWEIATLAEQPYQGL 244
Query: 392 SPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIIS 440
           S  Q    +   GL  + P +CP +L  LM  CW  +P  RP F EIIS
Sbjct: 245 SNEQVLRFVMEGGLL-DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 292

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 76/289 (26%), Positives = 130/289 (44%), Gaps = 49/289 (16%)
Query: 185 WLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEK--------LKGCDKGNAY----EFELRK 232
           W +  + +    ++G  SF  VY+G   G+ K        +K  ++  +     EF    
Sbjct: 10  WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEA 69
Query: 233 DLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTK-------- 284
            +++   C H  +++   V V +     V+ +LM  G +   +   R             
Sbjct: 70  SVMKEFNCHH--VVRLLGV-VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPS 126
Query: 285 --EIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE 342
             ++I++A ++A+G+ +LN +   +RDL ++  ++     V +GD G+            
Sbjct: 127 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI-------- 178
Query: 343 YETDGYR----------WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAAC 391
           YETD YR          W++PE +    + V  T+ S+V+SFG+V+WE+ T  E  Y   
Sbjct: 179 YETDYYRKGGKGLLPVRWMSPESLK---DGVFTTY-SDVWSFGVVLWEIATLAEQPYQGL 234
Query: 392 SPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIIS 440
           S  Q    +   GL  + P +CP +L  LM  CW  +P  RP F EIIS
Sbjct: 235 SNEQVLRFVMEGGLL-DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 282

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 72/266 (27%), Positives = 123/266 (46%), Gaps = 17/266 (6%)
Query: 185 WLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEK--LKGCDKGNAYEFELRKDLLELMTCGH 242
           W +  ++L+ I ++G   F  V+ G   G  K  +K    G        ++   +    H
Sbjct: 4   WEIPRESLQLIKRLGNGQFGEVWMGTWNGNTKVAIKTLKPGTMSPESFLEEAQIMKKLKH 63
Query: 243 KNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL--KSRKLQTKEIIRIAIDVAEGIKFL 300
             ++Q Y V  +E   + +VT+ M  GS+ D +   + R L+   ++ +A  VA G+ ++
Sbjct: 64  DKLVQLYAVVSEEP--IYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYI 121
Query: 301 NDHGVAYRDLNSQRILLDRHGNVC-LGDMGIVTACKSVGEATEYETDGY--RWLAPEIIA 357
                 +RDL S  IL+  +G +C + D G+    +   E T  +   +  +W APE   
Sbjct: 122 ERMNYIHRDLRSANILVG-NGLICKIADFGLARLIED-NEXTARQGAKFPIKWTAPEAAL 179
Query: 358 GDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQI 416
               ++     S+V+SFG+++ E+VT G   Y   +  +    +   G R   P+DCP  
Sbjct: 180 YGRFTIK----SDVWSFGILLTELVTKGRVPYPGMNNREVLEQVER-GYRMPCPQDCPIS 234
Query: 417 LKSLMIKCWNNSPSKRPQFSEIISLL 442
           L  LMI CW   P +RP F  + S L
Sbjct: 235 LHELMIHCWKKDPEERPTFEYLQSFL 260

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 73/291 (25%), Positives = 131/291 (45%), Gaps = 49/291 (16%)
Query: 185 WLLNSDNLEFIDQIGPNSFKGVYKGK-----------RVGIEKL-KGCDKGNAYEFELRK 232
           W ++ + +  + ++G  SF  VY+G            RV ++ + +        EF    
Sbjct: 12  WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEA 71
Query: 233 DLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK----------LQ 282
            +++  TC H  +++   V V +     VV +LM  G +   +   R             
Sbjct: 72  SVMKGFTCHH--VVRLLGV-VSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPT 128
Query: 283 TKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE 342
            +E+I++A ++A+G+ +LN     +R+L ++  ++     V +GD G+            
Sbjct: 129 LQEMIQMAAEIADGMAYLNAKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDI-------- 180
Query: 343 YETDGYR----------WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAAC 391
           YETD YR          W+APE +     + S    S+++SFG+V+WE+ +  E  Y   
Sbjct: 181 YETDYYRKGGKGLLPVRWMAPESLKDGVFTTS----SDMWSFGVVLWEITSLAEQPYQGL 236
Query: 392 SPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
           S  Q    +   G   + P +CP+ +  LM  CW  +P+ RP F EI++LL
Sbjct: 237 SNEQVLKFVMDGGYLDQ-PDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLL 286

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 78/291 (26%), Positives = 133/291 (45%), Gaps = 53/291 (18%)
Query: 185 WLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEK--------LKGCDKGNAY----EFELRK 232
           W +  + +    ++G  SF  VY+G   G+ K        +K  ++  +     EF    
Sbjct: 13  WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEA 72
Query: 233 DLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSV------------NDLILKSRK 280
            +++   C H  +++   V V +     V+ +LM  G +            N+ +L    
Sbjct: 73  SVMKEFNCHH--VVRLLGV-VSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 129
Query: 281 LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA 340
           L   ++I++A ++A+G+ +LN +   +RDL ++  ++     V +GD G+          
Sbjct: 130 LS--KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI------ 181
Query: 341 TEYETDGYR----------WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYA 389
             YETD YR          W++PE +    + V  T+ S+V+SFG+V+WE+ T  E  Y 
Sbjct: 182 --YETDYYRKGGKGLLPVRWMSPESLK---DGVFTTY-SDVWSFGVVLWEIATLAEQPYQ 235
Query: 390 ACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIIS 440
             S  Q    +   GL  + P +CP +L  LM  CW  +P  RP F EIIS
Sbjct: 236 GLSNEQVLRFVMEGGLL-DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 285

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 73/291 (25%), Positives = 131/291 (45%), Gaps = 49/291 (16%)
Query: 185 WLLNSDNLEFIDQIGPNSFKGVYKGK-----------RVGIEKL-KGCDKGNAYEFELRK 232
           W ++ + +  + ++G  SF  VY+G            RV ++ + +        EF    
Sbjct: 13  WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEA 72
Query: 233 DLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK----------LQ 282
            +++  TC H  +++   V V +     VV +LM  G +   +   R             
Sbjct: 73  SVMKGFTCHH--VVRLLGV-VSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPT 129
Query: 283 TKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE 342
            +E+I++A ++A+G+ +LN     +R+L ++  ++     V +GD G+            
Sbjct: 130 LQEMIQMAAEIADGMAYLNAKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDI-------- 181
Query: 343 YETDGYR----------WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAAC 391
           YETD YR          W+APE +     + S    S+++SFG+V+WE+ +  E  Y   
Sbjct: 182 YETDYYRKGGKGLLPVRWMAPESLKDGVFTTS----SDMWSFGVVLWEITSLAEQPYQGL 237
Query: 392 SPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
           S  Q    +   G   + P +CP+ +  LM  CW  +P+ RP F EI++LL
Sbjct: 238 SNEQVLKFVMDGGYLDQ-PDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLL 287

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 78/291 (26%), Positives = 133/291 (45%), Gaps = 53/291 (18%)
Query: 185 WLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEK--------LKGCDKGNAY----EFELRK 232
           W +  + +    ++G  SF  VY+G   G+ K        +K  ++  +     EF    
Sbjct: 7   WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEA 66
Query: 233 DLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSV------------NDLILKSRK 280
            +++   C H  +++   V V +     V+ +LM  G +            N+ +L    
Sbjct: 67  SVMKEFNCHH--VVRLLGV-VSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 123
Query: 281 LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA 340
           L   ++I++A ++A+G+ +LN +   +RDL ++  ++     V +GD G+          
Sbjct: 124 LS--KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI------ 175
Query: 341 TEYETDGYR----------WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYA 389
             YETD YR          W++PE +    + V  T+ S+V+SFG+V+WE+ T  E  Y 
Sbjct: 176 --YETDYYRKGGKGLLPVRWMSPESLK---DGVFTTY-SDVWSFGVVLWEIATLAEQPYQ 229
Query: 390 ACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIIS 440
             S  Q    +   GL  + P +CP +L  LM  CW  +P  RP F EIIS
Sbjct: 230 GLSNEQVLRFVMEGGLL-DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 279

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 78/291 (26%), Positives = 133/291 (45%), Gaps = 53/291 (18%)
Query: 185 WLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEK--------LKGCDKGNAY----EFELRK 232
           W +  + +    ++G  SF  VY+G   G+ K        +K  ++  +     EF    
Sbjct: 20  WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEA 79
Query: 233 DLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSV------------NDLILKSRK 280
            +++   C H  +++   V V +     V+ +LM  G +            N+ +L    
Sbjct: 80  SVMKEFNCHH--VVRLLGV-VSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 136
Query: 281 LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA 340
           L   ++I++A ++A+G+ +LN +   +RDL ++  ++     V +GD G+          
Sbjct: 137 LS--KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI------ 188
Query: 341 TEYETDGYR----------WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYA 389
             YETD YR          W++PE +    + V  T+ S+V+SFG+V+WE+ T  E  Y 
Sbjct: 189 --YETDYYRKGGKGLLPVRWMSPESLK---DGVFTTY-SDVWSFGVVLWEIATLAEQPYQ 242
Query: 390 ACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIIS 440
             S  Q    +   GL  + P +CP +L  LM  CW  +P  RP F EIIS
Sbjct: 243 GLSNEQVLRFVMEGGLL-DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 292

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 78/291 (26%), Positives = 133/291 (45%), Gaps = 53/291 (18%)
Query: 185 WLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEK--------LKGCDKGNAY----EFELRK 232
           W +  + +    ++G  SF  VY+G   G+ K        +K  ++  +     EF    
Sbjct: 11  WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEA 70
Query: 233 DLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSV------------NDLILKSRK 280
            +++   C H  +++   V V +     V+ +LM  G +            N+ +L    
Sbjct: 71  SVMKEFNCHH--VVRLLGV-VSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 127
Query: 281 LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA 340
           L   ++I++A ++A+G+ +LN +   +RDL ++  ++     V +GD G+          
Sbjct: 128 LS--KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI------ 179
Query: 341 TEYETDGYR----------WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYA 389
             YETD YR          W++PE +    + V  T+ S+V+SFG+V+WE+ T  E  Y 
Sbjct: 180 --YETDYYRKGGKGLLPVRWMSPESLK---DGVFTTY-SDVWSFGVVLWEIATLAEQPYQ 233
Query: 390 ACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIIS 440
             S  Q    +   GL  + P +CP +L  LM  CW  +P  RP F EIIS
Sbjct: 234 GLSNEQVLRFVMEGGLL-DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 283

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 78/291 (26%), Positives = 133/291 (45%), Gaps = 53/291 (18%)
Query: 185 WLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEK--------LKGCDKGNAY----EFELRK 232
           W +  + +    ++G  SF  VY+G   G+ K        +K  ++  +     EF    
Sbjct: 13  WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEA 72
Query: 233 DLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSV------------NDLILKSRK 280
            +++   C H  +++   V V +     V+ +LM  G +            N+ +L    
Sbjct: 73  SVMKEFNCHH--VVRLLGV-VSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 129
Query: 281 LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA 340
           L   ++I++A ++A+G+ +LN +   +RDL ++  ++     V +GD G+          
Sbjct: 130 LS--KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI------ 181
Query: 341 TEYETDGYR----------WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYA 389
             YETD YR          W++PE +    + V  T+ S+V+SFG+V+WE+ T  E  Y 
Sbjct: 182 --YETDYYRKGGKGLLPVRWMSPESLK---DGVFTTY-SDVWSFGVVLWEIATLAEQPYQ 235
Query: 390 ACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIIS 440
             S  Q    +   GL  + P +CP +L  LM  CW  +P  RP F EIIS
Sbjct: 236 GLSNEQVLRFVMEGGLL-DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 285

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 78/291 (26%), Positives = 133/291 (45%), Gaps = 53/291 (18%)
Query: 185 WLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEK--------LKGCDKGNAY----EFELRK 232
           W +  + +    ++G  SF  VY+G   G+ K        +K  ++  +     EF    
Sbjct: 14  WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEA 73
Query: 233 DLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSV------------NDLILKSRK 280
            +++   C H  +++   V V +     V+ +LM  G +            N+ +L    
Sbjct: 74  SVMKEFNCHH--VVRLLGV-VSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 130
Query: 281 LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA 340
           L   ++I++A ++A+G+ +LN +   +RDL ++  ++     V +GD G+          
Sbjct: 131 LS--KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI------ 182
Query: 341 TEYETDGYR----------WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYA 389
             YETD YR          W++PE +    + V  T+ S+V+SFG+V+WE+ T  E  Y 
Sbjct: 183 --YETDYYRKGGKGLLPVRWMSPESLK---DGVFTTY-SDVWSFGVVLWEIATLAEQPYQ 236
Query: 390 ACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIIS 440
             S  Q    +   GL  + P +CP +L  LM  CW  +P  RP F EIIS
Sbjct: 237 GLSNEQVLRFVMEGGLL-DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 286

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 128/271 (47%), Gaps = 27/271 (9%)
Query: 185 WLLNSDNLEFIDQIGPNS----FKGVYKGK-RVGIEKLK-GCDKGNAY--EFELRKDLLE 236
           W +  + L+ ++++G       + G Y G  +V ++ LK G    +A+  E  L K L  
Sbjct: 8   WEVPRETLKLVERLGAGQAGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQL-- 65
Query: 237 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR--KLQTKEIIRIAIDVA 294
                H+ +++ Y V   E   + ++T+ ME GS+ D +      KL   +++ +A  +A
Sbjct: 66  ----QHQRLVRLYAVVTQE--PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 119
Query: 295 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY--RWLA 352
           EG+ F+ +    +RDL +  IL+    +  + D G+    +   E T  E   +  +W A
Sbjct: 120 EGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIED-AEXTAREGAKFPIKWTA 178
Query: 353 PEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPK 411
           PE I     ++     S+V+SFG+++ E+VT G   Y   +  +    +   G R   P 
Sbjct: 179 PEAINYGTFTIK----SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER-GYRMVRPD 233
Query: 412 DCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
           +CP+ L  LM  CW   P  RP F  + S+L
Sbjct: 234 NCPEELYQLMRLCWKERPEDRPTFDYLRSVL 264

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 78/311 (25%), Positives = 137/311 (44%), Gaps = 54/311 (17%)
Query: 160 LPSSSFVVSVDEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGK--------- 210
            PSS FV   DEW+             ++ + +  + ++G  SF  VY+G          
Sbjct: 2   FPSSVFVP--DEWE-------------VSREKITLLRELGQGSFGMVYEGNARDIIKGEA 46
Query: 211 --RVGIEKL-KGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLME 267
             RV ++ + +        EF     +++  TC H  +++   V V +     VV +LM 
Sbjct: 47  ETRVAVKTVNESASLRERIEFLNEASVMKGFTCHH--VVRLLGV-VSKGQPTLVVMELMA 103
Query: 268 GGSVNDLILKSRK----------LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILL 317
            G +   +   R              +E+I++A ++A+G+ +LN     +RDL ++  ++
Sbjct: 104 HGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMV 163
Query: 318 DRHGNVCLGDMGIVTACKSVGEATEYETDG-----YRWLAPEIIAGDPESVSETWMSNVY 372
                V +GD G+    + + E       G      RW+APE +     + S    S+++
Sbjct: 164 AHDFTVKIGDFGM---TRDIXETDXXRKGGKGLLPVRWMAPESLKDGVFTTS----SDMW 216
Query: 373 SFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSK 431
           SFG+V+WE+ +  E  Y   S  Q    +   G   + P +CP+ +  LM  CW  +P  
Sbjct: 217 SFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQ-PDNCPERVTDLMRMCWQFNPKM 275
Query: 432 RPQFSEIISLL 442
           RP F EI++LL
Sbjct: 276 RPTFLEIVNLL 286

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 72/271 (26%), Positives = 128/271 (47%), Gaps = 27/271 (9%)
Query: 185 WLLNSDNLEFIDQIGPNSFKGVYKG-----KRVGIEKLK-GCDKGNAY--EFELRKDLLE 236
           W +  + L+ ++++G   F  V+ G      +V ++ LK G    +A+  E  L K L  
Sbjct: 4   WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQL-- 61
Query: 237 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR--KLQTKEIIRIAIDVA 294
                H+ +++ Y V   E   + ++T+ ME GS+ D +      KL   +++ +A  +A
Sbjct: 62  ----QHQRLVRLYAVVTQE--PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 115
Query: 295 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY--RWLA 352
           EG+ F+ +    +R+L +  IL+    +  + D G+    +   E T  E   +  +W A
Sbjct: 116 EGMAFIEERNYIHRNLRAANILVSDTLSCKIADFGLARLIED-NEYTAREGAKFPIKWTA 174
Query: 353 PEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPK 411
           PE I     ++     S+V+SFG+++ E+VT G   Y   +  +    +   G R   P 
Sbjct: 175 PEAINYGTFTIK----SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER-GYRMVRPD 229
Query: 412 DCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
           +CP+ L  LM  CW   P  RP F  + S+L
Sbjct: 230 NCPEELYQLMRLCWKERPEDRPTFDYLRSVL 260

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 78/291 (26%), Positives = 133/291 (45%), Gaps = 53/291 (18%)
Query: 185 WLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEK--------LKGCDKGNAY----EFELRK 232
           W +  + +    ++G  SF  VY+G   G+ K        +K  ++  +     EF    
Sbjct: 42  WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEA 101
Query: 233 DLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSV------------NDLILKSRK 280
            +++   C H  +++   V V +     V+ +LM  G +            N+ +L    
Sbjct: 102 SVMKEFNCHH--VVRLLGV-VSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 158
Query: 281 LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA 340
           L   ++I++A ++A+G+ +LN +   +RDL ++  ++     V +GD G+          
Sbjct: 159 LS--KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI------ 210
Query: 341 TEYETDGYR----------WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYA 389
             YETD YR          W++PE +    + V  T+ S+V+SFG+V+WE+ T  E  Y 
Sbjct: 211 --YETDYYRKGGKGLLPVRWMSPESLK---DGVFTTY-SDVWSFGVVLWEIATLAEQPYQ 264
Query: 390 ACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIIS 440
             S  Q    +   GL  + P +CP +L  LM  CW  +P  RP F EIIS
Sbjct: 265 GLSNEQVLRFVMEGGLLDK-PDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 314

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 66/267 (24%), Positives = 129/267 (48%), Gaps = 21/267 (7%)
Query: 187 LNSDNLEFIDQIGPNSFKGVYKGKRVGIEK--LKGCDKGNAYEFELRKDLLELMTCGHKN 244
           ++  +L F+ ++G   F  V  GK  G     +K   +G+  E E  ++   +M   H+ 
Sbjct: 1   IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEK 60
Query: 245 ILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDH 303
           ++Q Y VC  +   + ++T+ M  G + + + + R + QT++++ +  DV E +++L   
Sbjct: 61  LVQLYGVCTKQR-PIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK 119
Query: 304 GVAYRDLNSQRILLDRHGNVCLGDMGIVTAC------KSVGEATEYETDGYRWLAPEIIA 357
              +RDL ++  L++  G V + D G+           SVG          RW  PE++ 
Sbjct: 120 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFP-----VRWSPPEVLM 174
Query: 358 GDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQI 416
               S      S++++FG+++WE+ + G+  Y   +  + A  IA  GLR   P    + 
Sbjct: 175 YSKFSSK----SDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ-GLRLYRPHLASEK 229
Query: 417 LKSLMIKCWNNSPSKRPQFSEIISLLL 443
           + ++M  CW+    +RP F  ++S +L
Sbjct: 230 VYTIMYSCWHEKADERPTFKILLSNIL 256

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 62/250 (24%), Positives = 123/250 (49%), Gaps = 24/250 (9%)
Query: 209 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCV-DENHGLCVVTKLME 267
           G++V ++ LK    GN    +L+K++  L    H+NI+++  +C  D  +G+ ++ + + 
Sbjct: 50  GEQVAVKSLKPESGGNHIA-DLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLP 108
Query: 268 GGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLG 326
            GS+ + + K++ K+  K+ ++ A+ + +G+ +L      +RDL ++ +L++    V +G
Sbjct: 109 SGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIG 168
Query: 327 DMGIVTACKSVGEATEYETD---GYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT 383
           D G+  A ++  E    + D      W APE +      ++    S+V+SFG+ + E++T
Sbjct: 169 DFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSKFYIA----SDVWSFGVTLHELLT 224
Query: 384 ---GEAAYAAC-----SPVQAAVGIAAC------GLRPEIPKDCPQILKSLMIKCWNNSP 429
               +++  A       P    + +         G R   P +CP  +  LM KCW   P
Sbjct: 225 YCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQP 284
Query: 430 SKRPQFSEII 439
           S R  F  +I
Sbjct: 285 SNRTSFQNLI 294

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 62/250 (24%), Positives = 123/250 (49%), Gaps = 24/250 (9%)
Query: 209 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCV-DENHGLCVVTKLME 267
           G++V ++ LK    GN    +L+K++  L    H+NI+++  +C  D  +G+ ++ + + 
Sbjct: 38  GEQVAVKSLKPESGGNHIA-DLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLP 96
Query: 268 GGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLG 326
            GS+ + + K++ K+  K+ ++ A+ + +G+ +L      +RDL ++ +L++    V +G
Sbjct: 97  SGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIG 156
Query: 327 DMGIVTACKSVGEATEYETD---GYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT 383
           D G+  A ++  E    + D      W APE +      ++    S+V+SFG+ + E++T
Sbjct: 157 DFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSKFYIA----SDVWSFGVTLHELLT 212
Query: 384 ---GEAAYAAC-----SPVQAAVGIAAC------GLRPEIPKDCPQILKSLMIKCWNNSP 429
               +++  A       P    + +         G R   P +CP  +  LM KCW   P
Sbjct: 213 YCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQP 272
Query: 430 SKRPQFSEII 439
           S R  F  +I
Sbjct: 273 SNRTSFQNLI 282

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 76/297 (25%), Positives = 135/297 (45%), Gaps = 36/297 (12%)
Query: 185 WLLNSDNLEFIDQIGPNS---FKGVY---KGKRVGIEKLKGCDKGNAYEFELRKDLLELM 238
           W +N D+ E  + IG  +    +  Y   K ++V I+++   +K      EL K++  + 
Sbjct: 10  WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRI-NLEKCQTSMDELLKEIQAMS 68
Query: 239 TCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLI--------LKSRKLQTKEIIRIA 290
            C H NI+ +Y   V ++  L +V KL+ GGSV D+I         KS  L    I  I 
Sbjct: 69  QCHHPNIVSYYTSFVVKDE-LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATIL 127
Query: 291 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR- 349
            +V EG+++L+ +G  +RD+ +  ILL   G+V + D G+     + G+ T  +      
Sbjct: 128 REVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV 187
Query: 350 ----WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAV------- 398
               W+APE++    +     + ++++SFG+   E+ TG A Y    P++  +       
Sbjct: 188 GTPCWMAPEVME---QVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDP 244
Query: 399 -GIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNSSNR 454
             +       E+ K   +  + ++  C    P KRP  +E    LLR      + N+
Sbjct: 245 PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAE----LLRHKFFQKAKNK 297

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 74/297 (24%), Positives = 133/297 (44%), Gaps = 40/297 (13%)
Query: 181 EIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD---------KGNAYEFELR 231
           E  RW L  D L     +G  +F  V   + +G++K K            K +A E +L 
Sbjct: 19  EDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLS 78
Query: 232 KDLLEL----MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-------- 279
             + E+    M   HKNI+     C  ++  L V+ +    G++ + +   R        
Sbjct: 79  DLISEMEMMKMIGKHKNIINLLGACT-QDGPLYVIVEYASKGNLREYLQARRPPGLEFSF 137
Query: 280 --------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIV 331
                   +L +K+++  A  VA G+++L      +RDL ++ +L+     + + D G+ 
Sbjct: 138 NPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA 197
Query: 332 TACKSVGEATEYETDG---YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAA 387
                + +  +  T+G    +W+APE +         T  S+V+SFG+++WE+ T G + 
Sbjct: 198 RDIHHI-DXXKKTTNGRLPVKWMAPEALF----DRIYTHQSDVWSFGVLLWEIFTLGGSP 252
Query: 388 YAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR 444
           Y    PV+    +   G R + P +C   L  +M  CW+  PS+RP F +++  L R
Sbjct: 253 YPGV-PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 308

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 71/286 (24%), Positives = 130/286 (45%), Gaps = 39/286 (13%)
Query: 185 WLLNSDNLEFIDQIGPNSFKGVYKGK-----------RVGIEKL-KGCDKGNAYEFELRK 232
           W ++ + +  + ++G  SF  VY+G            RV ++ + +        EF    
Sbjct: 12  WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEA 71
Query: 233 DLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK----------LQ 282
            +++  TC H  +++   V V +     VV +LM  G +   +   R             
Sbjct: 72  SVMKGFTCHH--VVRLLGV-VSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPT 128
Query: 283 TKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE 342
            +E+I++A ++A+G+ +LN     +RDL ++  ++     V +GD G+    + + E   
Sbjct: 129 LQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGM---TRDIXETDX 185
Query: 343 YETDG-----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQA 396
               G      RW+APE +     + S    S+++SFG+V+WE+ +  E  Y   S  Q 
Sbjct: 186 XRKGGKGLLPVRWMAPESLKDGVFTTS----SDMWSFGVVLWEITSLAEQPYQGLSNEQV 241
Query: 397 AVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
              +   G   + P +CP+ +  LM  CW  +P+ RP F EI++LL
Sbjct: 242 LKFVMDGGYLDQ-PDNCPERVTDLMRMCWQFNPNMRPTFLEIVNLL 286

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 71/286 (24%), Positives = 129/286 (45%), Gaps = 39/286 (13%)
Query: 185 WLLNSDNLEFIDQIGPNSFKGVYKGK-----------RVGIEKL-KGCDKGNAYEFELRK 232
           W ++ + +  + ++G  SF  VY+G            RV ++ + +        EF    
Sbjct: 9   WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEA 68
Query: 233 DLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK----------LQ 282
            +++  TC H  +++   V V +     VV +LM  G +   +   R             
Sbjct: 69  SVMKGFTCHH--VVRLLGV-VSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPT 125
Query: 283 TKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE 342
            +E+I++A ++A+G+ +LN     +RDL ++  ++     V +GD G+    + + E   
Sbjct: 126 LQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGM---TRDIXETDX 182
Query: 343 YETDG-----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQA 396
               G      RW+APE +     + S    S+++SFG+V+WE+ +  E  Y   S  Q 
Sbjct: 183 XRKGGKGLLPVRWMAPESLKDGVFTTS----SDMWSFGVVLWEITSLAEQPYQGLSNEQV 238
Query: 397 AVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
              +   G   + P +CP+ +  LM  CW  +P  RP F EI++LL
Sbjct: 239 LKFVMDGGYLDQ-PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLL 283

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 73/289 (25%), Positives = 129/289 (44%), Gaps = 49/289 (16%)
Query: 187 LNSDNLEFIDQIGPNSFKGVYKGK-----------RVGIEKL-KGCDKGNAYEFELRKDL 234
           ++ + +  + ++G  SF  VY+G            RV ++ + +        EF     +
Sbjct: 13  VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASV 72
Query: 235 LELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK----------LQTK 284
           ++  TC H  +++   V V +     VV +LM  G +   +   R              +
Sbjct: 73  MKGFTCHH--VVRLLGV-VSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQ 129
Query: 285 EIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE 344
           E+I++A ++A+G+ +LN     +RDL ++  ++     V +GD G+            YE
Sbjct: 130 EMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDI--------YE 181
Query: 345 TDGYR----------WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSP 393
           TD YR          W+APE +     + S    S+++SFG+V+WE+ +  E  Y   S 
Sbjct: 182 TDYYRKGGKGLLPVRWMAPESLKDGVFTTS----SDMWSFGVVLWEITSLAEQPYQGLSN 237
Query: 394 VQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
            Q    +   G   + P +CP+ +  LM  CW  +P  RP F EI++LL
Sbjct: 238 EQVLKFVMDGGYLDQ-PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLL 285

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 74/297 (24%), Positives = 133/297 (44%), Gaps = 40/297 (13%)
Query: 181 EIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD---------KGNAYEFELR 231
           E  RW L  D L     +G  +F  V   + +G++K K            K +A E +L 
Sbjct: 11  EDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLS 70
Query: 232 KDLLEL----MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-------- 279
             + E+    M   HKNI+     C  ++  L V+ +    G++ + +   R        
Sbjct: 71  DLISEMEMMKMIGKHKNIINLLGACT-QDGPLYVIVEYASKGNLREYLQARRPPGLEYSY 129
Query: 280 --------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIV 331
                   +L +K+++  A  VA G+++L      +RDL ++ +L+     + + D G+ 
Sbjct: 130 NPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA 189
Query: 332 TACKSVGEATEYETDG---YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAA 387
                + +  +  T+G    +W+APE +         T  S+V+SFG+++WE+ T G + 
Sbjct: 190 RDIHHI-DYYKKTTNGRLPVKWMAPEALF----DRIYTHQSDVWSFGVLLWEIFTLGGSP 244
Query: 388 YAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR 444
           Y    PV+    +   G R + P +C   L  +M  CW+  PS+RP F +++  L R
Sbjct: 245 YPGV-PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 300

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 78/291 (26%), Positives = 132/291 (45%), Gaps = 53/291 (18%)
Query: 185 WLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEK--------LKGCDKGNAY----EFELRK 232
           W +  + +    ++G  SF  VY+G   G+ K        +K  ++  +     EF    
Sbjct: 7   WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEA 66
Query: 233 DLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSV------------NDLILKSRK 280
            +++   C H  +++   V V +     V+ +LM  G +            N+ +L    
Sbjct: 67  SVMKEFNCHH--VVRLLGV-VSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 123
Query: 281 LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA 340
           L   ++I++A ++A+G+ +LN +   +RDL ++   +     V +GD G+          
Sbjct: 124 LS--KMIQMAGEIADGMAYLNANKFVHRDLAARNCXVAEDFTVKIGDFGMTRDI------ 175
Query: 341 TEYETDGYR----------WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYA 389
             YETD YR          W++PE +    + V  T+ S+V+SFG+V+WE+ T  E  Y 
Sbjct: 176 --YETDYYRKGGKGLLPVRWMSPESLK---DGVFTTY-SDVWSFGVVLWEIATLAEQPYQ 229
Query: 390 ACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIIS 440
             S  Q    +   GL  + P +CP +L  LM  CW  +P  RP F EIIS
Sbjct: 230 GLSNEQVLRFVMEGGLL-DKPDNCPDMLLELMRMCWQYNPKMRPSFLEIIS 279

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 74/297 (24%), Positives = 133/297 (44%), Gaps = 40/297 (13%)
Query: 181 EIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD---------KGNAYEFELR 231
           E  RW L  D L     +G  +F  V   + +G++K K            K +A E +L 
Sbjct: 8   EDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLS 67
Query: 232 KDLLEL----MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-------- 279
             + E+    M   HKNI+     C  ++  L V+ +    G++ + +   R        
Sbjct: 68  DLISEMEMMKMIGKHKNIINLLGACT-QDGPLYVIVEYASKGNLREYLQARRPPGLEYSY 126
Query: 280 --------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIV 331
                   +L +K+++  A  VA G+++L      +RDL ++ +L+     + + D G+ 
Sbjct: 127 NPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA 186
Query: 332 TACKSVGEATEYETDG---YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAA 387
                + +  +  T+G    +W+APE +         T  S+V+SFG+++WE+ T G + 
Sbjct: 187 RDIHHI-DYYKKTTNGRLPVKWMAPEALF----DRIYTHQSDVWSFGVLLWEIFTLGGSP 241
Query: 388 YAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR 444
           Y    PV+    +   G R + P +C   L  +M  CW+  PS+RP F +++  L R
Sbjct: 242 YPGV-PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 297

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 74/297 (24%), Positives = 133/297 (44%), Gaps = 40/297 (13%)
Query: 181 EIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD---------KGNAYEFELR 231
           E  RW L  D L     +G  +F  V   + +G++K K            K +A E +L 
Sbjct: 19  EDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLS 78
Query: 232 KDLLEL----MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-------- 279
             + E+    M   HKNI+     C  ++  L V+ +    G++ + +   R        
Sbjct: 79  DLISEMEMMKMIGKHKNIINLLGACT-QDGPLYVIVEYASKGNLREYLQARRPPGLEYSY 137
Query: 280 --------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIV 331
                   +L +K+++  A  VA G+++L      +RDL ++ +L+     + + D G+ 
Sbjct: 138 NPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA 197
Query: 332 TACKSVGEATEYETDG---YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAA 387
                + +  +  T+G    +W+APE +         T  S+V+SFG+++WE+ T G + 
Sbjct: 198 RDIHHI-DYYKKTTNGRLPVKWMAPEALF----DRIYTHQSDVWSFGVLLWEIFTLGGSP 252
Query: 388 YAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR 444
           Y    PV+    +   G R + P +C   L  +M  CW+  PS+RP F +++  L R
Sbjct: 253 YPGV-PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 308

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 74/297 (24%), Positives = 133/297 (44%), Gaps = 40/297 (13%)
Query: 181 EIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD---------KGNAYEFELR 231
           E  RW L  D L     +G  +F  V   + +G++K K            K +A E +L 
Sbjct: 12  EDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLS 71
Query: 232 KDLLEL----MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-------- 279
             + E+    M   HKNI+     C  ++  L V+ +    G++ + +   R        
Sbjct: 72  DLISEMEMMKMIGKHKNIINLLGACT-QDGPLYVIVEYASKGNLREYLQARRPPGLEYSY 130
Query: 280 --------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIV 331
                   +L +K+++  A  VA G+++L      +RDL ++ +L+     + + D G+ 
Sbjct: 131 NPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA 190
Query: 332 TACKSVGEATEYETDG---YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAA 387
                + +  +  T+G    +W+APE +         T  S+V+SFG+++WE+ T G + 
Sbjct: 191 RDIHHI-DYYKKTTNGRLPVKWMAPEALF----DRIYTHQSDVWSFGVLLWEIFTLGGSP 245
Query: 388 YAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR 444
           Y    PV+    +   G R + P +C   L  +M  CW+  PS+RP F +++  L R
Sbjct: 246 YPGV-PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 301

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 74/297 (24%), Positives = 133/297 (44%), Gaps = 40/297 (13%)
Query: 181 EIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD---------KGNAYEFELR 231
           E  RW L  D L     +G  +F  V   + +G++K K            K +A E +L 
Sbjct: 4   EDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLS 63
Query: 232 KDLLEL----MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-------- 279
             + E+    M   HKNI+     C  ++  L V+ +    G++ + +   R        
Sbjct: 64  DLISEMEMMKMIGKHKNIINLLGACT-QDGPLYVIVEYASKGNLREYLQARRPPGLEYCY 122
Query: 280 --------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIV 331
                   +L +K+++  A  VA G+++L      +RDL ++ +L+     + + D G+ 
Sbjct: 123 NPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA 182
Query: 332 TACKSVGEATEYETDG---YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAA 387
                + +  +  T+G    +W+APE +         T  S+V+SFG+++WE+ T G + 
Sbjct: 183 RDIHHI-DYYKKTTNGRLPVKWMAPEALF----DRIYTHQSDVWSFGVLLWEIFTLGGSP 237
Query: 388 YAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR 444
           Y    PV+    +   G R + P +C   L  +M  CW+  PS+RP F +++  L R
Sbjct: 238 YPGV-PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 293

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 73/294 (24%), Positives = 132/294 (44%), Gaps = 40/294 (13%)
Query: 184 RWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD---------KGNAYEFELRKDL 234
           RW L  D L     +G  +F  V   + +G++K K            K +A E +L   +
Sbjct: 63  RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLI 122
Query: 235 LEL----MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR----------- 279
            E+    M   HKNI+     C  ++  L V+ +    G++ + +   R           
Sbjct: 123 SEMEMMKMIGKHKNIINLLGACT-QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPS 181
Query: 280 -----KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC 334
                +L +K+++  A  VA G+++L      +RDL ++ +L+     + + D G+    
Sbjct: 182 HNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI 241
Query: 335 KSVGEATEYETDG---YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAA 390
             + +  +  T+G    +W+APE +         T  S+V+SFG+++WE+ T G + Y  
Sbjct: 242 HHI-DYYKKTTNGRLPVKWMAPEALF----DRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 296
Query: 391 CSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR 444
             PV+    +   G R + P +C   L  +M  CW+  PS+RP F +++  L R
Sbjct: 297 V-PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 349

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 74/297 (24%), Positives = 133/297 (44%), Gaps = 40/297 (13%)
Query: 181 EIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD---------KGNAYEFELR 231
           E  RW L  D L     +G  +F  V   + +G++K K            K +A E +L 
Sbjct: 19  EDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLS 78
Query: 232 KDLLEL----MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-------- 279
             + E+    M   HKNI+     C  ++  L V+ +    G++ + +   R        
Sbjct: 79  DLISEMEMMKMIGKHKNIINLLGACT-QDGPLYVIVEYASKGNLREYLQARRPPGLEYCY 137
Query: 280 --------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIV 331
                   +L +K+++  A  VA G+++L      +RDL ++ +L+     + + D G+ 
Sbjct: 138 NPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA 197
Query: 332 TACKSVGEATEYETDG---YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAA 387
                + +  +  T+G    +W+APE +         T  S+V+SFG+++WE+ T G + 
Sbjct: 198 RDIHHI-DYYKKTTNGRLPVKWMAPEALF----DRIYTHQSDVWSFGVLLWEIFTLGGSP 252
Query: 388 YAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR 444
           Y    PV+    +   G R + P +C   L  +M  CW+  PS+RP F +++  L R
Sbjct: 253 YPGV-PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 308

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 74/270 (27%), Positives = 127/270 (47%), Gaps = 25/270 (9%)
Query: 185 WLLNSDNLEFIDQIGPNSFKGVY-----KGKRVGIEKLK-GCDKGNAYEFELRKDLLELM 238
           W +  ++L+   ++G   F  V+     K  +V ++ +K G     A+  E       + 
Sbjct: 10  WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANV----MK 65
Query: 239 TCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKS---RKLQTKEIIRIAIDVAE 295
           T  H  +++ + V   E   + ++T+ M  GS+ D  LKS    K    ++I  +  +AE
Sbjct: 66  TLQHDKLVKLHAVVTKE--PIYIITEFMAKGSLLDF-LKSDEGSKQPLPKLIDFSAQIAE 122
Query: 296 GIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY--RWLAP 353
           G+ F+      +RDL +  IL+       + D G+    +   E T  E   +  +W AP
Sbjct: 123 GMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIED-NEYTAREGAKFPIKWTAP 181
Query: 354 EIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKD 412
           E I       S T  S+V+SFG+++ E+VT G   Y   S  +    +   G R   P++
Sbjct: 182 EAINFG----SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER-GYRMPRPEN 236
Query: 413 CPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
           CP+ L ++M++CW N P +RP F  I S+L
Sbjct: 237 CPEELYNIMMRCWKNRPEERPTFEYIQSVL 266

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 72/282 (25%), Positives = 131/282 (46%), Gaps = 32/282 (11%)
Query: 185 WLLNSDNLEFIDQIGPNS---FKGVY---KGKRVGIEKLKGCDKGNAYEFELRKDLLELM 238
           W +N D+ E  + IG  +    +  Y   K ++V I+++   +K      EL K++  + 
Sbjct: 5   WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRI-NLEKCQTSMDELLKEIQAMS 63
Query: 239 TCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLI--------LKSRKLQTKEIIRIA 290
            C H NI+ +Y   V ++  L +V KL+ GGSV D+I         KS  L    I  I 
Sbjct: 64  QCHHPNIVSYYTSFVVKDE-LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATIL 122
Query: 291 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR- 349
            +V EG+++L+ +G  +RD+ +  ILL   G+V + D G+     + G+ T  +      
Sbjct: 123 REVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV 182
Query: 350 ----WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAV------- 398
               W+APE++    +     + ++++SFG+   E+ TG A Y    P++  +       
Sbjct: 183 GTPCWMAPEVME---QVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDP 239
Query: 399 -GIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEII 439
             +       E+ K   +  + ++  C    P KRP  +E++
Sbjct: 240 PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELL 281

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 64/265 (24%), Positives = 125/265 (47%), Gaps = 15/265 (5%)
Query: 182 IGRWLLNSDNLEFIDQIGPNSFKGVYKG--KRVGIEKLKGCDKGNAYEFE-LRKDLLELM 238
           + +W +   ++    ++G   F  VY+G  K+  +       K +  E E   K+   + 
Sbjct: 3   LDKWEMERTDITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMK 62
Query: 239 TCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEII--RIAIDVAEG 296
              H N++Q   VC  E     ++T+ M  G++ D + +  + +   ++   +A  ++  
Sbjct: 63  EIKHPNLVQLLGVCTREP-PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA 121
Query: 297 IKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY--RWLAPE 354
           +++L      +RDL ++  L+  +  V + D G+ +   +    T +    +  +W APE
Sbjct: 122 MEYLEKKNFIHRDLAARNCLVGENHLVKVADFGL-SRLMTGDTXTAHAGAKFPIKWTAPE 180
Query: 355 IIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDC 413
            +A +  S+     S+V++FG+++WE+ T G + Y    P Q    +     R E P+ C
Sbjct: 181 SLAYNKFSIK----SDVWAFGVLLWEIATYGMSPYPGIDPSQV-YELLEKDYRMERPEGC 235
Query: 414 PQILKSLMIKCWNNSPSKRPQFSEI 438
           P+ +  LM  CW  +PS RP F+EI
Sbjct: 236 PEKVYELMRACWQWNPSDRPSFAEI 260

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 74/270 (27%), Positives = 127/270 (47%), Gaps = 25/270 (9%)
Query: 185 WLLNSDNLEFIDQIGPNSFKGVY-----KGKRVGIEKLK-GCDKGNAYEFELRKDLLELM 238
           W +  ++L+   ++G   F  V+     K  +V ++ +K G     A+  E       + 
Sbjct: 183 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANV----MK 238
Query: 239 TCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKS---RKLQTKEIIRIAIDVAE 295
           T  H  +++ + V   E   + ++T+ M  GS+ D  LKS    K    ++I  +  +AE
Sbjct: 239 TLQHDKLVKLHAVVTKEP--IYIITEFMAKGSLLDF-LKSDEGSKQPLPKLIDFSAQIAE 295
Query: 296 GIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY--RWLAP 353
           G+ F+      +RDL +  IL+       + D G+    +   E T  E   +  +W AP
Sbjct: 296 GMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIED-NEYTAREGAKFPIKWTAP 354
Query: 354 EIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKD 412
           E I       S T  S+V+SFG+++ E+VT G   Y   S  +    +   G R   P++
Sbjct: 355 EAINFG----SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER-GYRMPRPEN 409
Query: 413 CPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
           CP+ L ++M++CW N P +RP F  I S+L
Sbjct: 410 CPEELYNIMMRCWKNRPEERPTFEYIQSVL 439

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 98/205 (47%), Gaps = 11/205 (5%)
Query: 242 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL-KSRKLQTKEIIRIAIDVAEGIKFL 300
           H N+L    +C+       VV   M+ G + + I  ++     K++I   + VA+G+K+L
Sbjct: 89  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL 148
Query: 301 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRWLAPEII 356
                 +RDL ++  +LD    V + D G+          + +   G     +W+A E +
Sbjct: 149 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESL 208
Query: 357 AGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ 415
               ++   T  S+V+SFG+++WE++T G   Y   +     V +   G R   P+ CP 
Sbjct: 209 ----QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ-GRRLLQPEYCPD 263
Query: 416 ILKSLMIKCWNNSPSKRPQFSEIIS 440
            L  +M+KCW+     RP FSE++S
Sbjct: 264 PLYEVMLKCWHPKAEMRPSFSELVS 288

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/260 (27%), Positives = 124/260 (47%), Gaps = 21/260 (8%)
Query: 198 IGPNSFKGVYKGKRVGIEKLKGCD-----KGNAYEFELRKDLLELMTCG---HKNILQFY 249
           IG   F  V +G+     K + C      KG   E + R+ L E    G   H NI++  
Sbjct: 24  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLE 83
Query: 250 CVCVDENHGLCVVTKLMEGGSVNDLI-LKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYR 308
            V V  +  + ++T+ ME G+++  + L   +    +++ +   +A G+++L +    +R
Sbjct: 84  GV-VTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLAEMSYVHR 142
Query: 309 DLNSQRILLDRHGNVCLGDMGIVTACK-SVGEATEYETDG----YRWLAPEIIAGDPESV 363
           DL ++ IL++ +    + D G+    + +  + TE  + G     RW APE IA      
Sbjct: 143 DLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAIAFR---- 198
Query: 364 SETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMI 422
             T  S+ +S+G+V+WE+++ GE  Y   S  Q  +       R   P DCP  L  LM+
Sbjct: 199 KFTSASDAWSYGIVMWEVMSFGERPYWDMSN-QDVINAIEQDYRLPPPPDCPTSLHQLML 257
Query: 423 KCWNNSPSKRPQFSEIISLL 442
            CW    + RP+F +++S L
Sbjct: 258 DCWQKDRNARPRFPQVVSAL 277

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 125/270 (46%), Gaps = 27/270 (10%)
Query: 184 RWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKL---KGCDKGNAYEFELRKDLLE---- 236
           +W+LN ++L   +QIG  +F  V+ G+      L   K C +      +L+   L+    
Sbjct: 108 KWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRE--TLPPDLKAKFLQEARI 165
Query: 237 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGS-VNDLILKSRKLQTKEIIRIAIDVAE 295
           L    H NI++   VC  +   + +V +L++GG  +  L  +  +L+ K ++++  D A 
Sbjct: 166 LKQYSHPNIVRLIGVCT-QKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAA 224
Query: 296 GIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR-----W 350
           G+++L      +RDL ++  L+     + + D G+    +   +     + G R     W
Sbjct: 225 GMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGM---SREEADGVXAASGGLRQVPVKW 281
Query: 351 LAPEII-AGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPE 408
            APE +  G   S S+ W     SFG+++WE  + G + Y   S  Q    +   G  P 
Sbjct: 282 TAPEALNYGRYSSESDVW-----SFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLP- 335
Query: 409 IPKDCPQILKSLMIKCWNNSPSKRPQFSEI 438
            P+ CP  +  LM +CW   P +RP FS I
Sbjct: 336 CPELCPDAVFRLMEQCWAYEPGQRPSFSTI 365

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 98/205 (47%), Gaps = 11/205 (5%)
Query: 242 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL-KSRKLQTKEIIRIAIDVAEGIKFL 300
           H N+L    +C+       VV   M+ G + + I  ++     K++I   + VA+G+KFL
Sbjct: 90  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL 149
Query: 301 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRWLAPEII 356
                 +RDL ++  +LD    V + D G+          + +   G     +W+A E +
Sbjct: 150 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 209
Query: 357 AGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ 415
               ++   T  S+V+SFG+++WE++T G   Y   +     V +   G R   P+ CP 
Sbjct: 210 ----QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ-GRRLLQPEYCPD 264
Query: 416 ILKSLMIKCWNNSPSKRPQFSEIIS 440
            L  +M+KCW+     RP FSE++S
Sbjct: 265 PLYEVMLKCWHPKAEMRPSFSELVS 289

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 75/286 (26%), Positives = 132/286 (46%), Gaps = 43/286 (15%)
Query: 185 WLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEK--------LKGCDKGNAY----EFELRK 232
           W +  + +    ++G  SF  VY+G   G+ K        +K  ++  +     EF    
Sbjct: 5   WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEA 64
Query: 233 DLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSV------------NDLILKSRK 280
            +++   C H  +++   V V +     V+ +LM  G +            N+ +L    
Sbjct: 65  SVMKEFNCHH--VVRLLGV-VSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 121
Query: 281 LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA 340
           L   ++I++A ++A+G+ +LN +   +RDL ++  ++     V +GD G+    + + E 
Sbjct: 122 LS--KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGM---TRDIXET 176
Query: 341 TEYETDG-----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPV 394
                 G      RW++PE +    + V  T+ S+V+SFG+V+WE+ T  E  Y   S  
Sbjct: 177 DXXRKGGKGLLPVRWMSPESLK---DGVFTTY-SDVWSFGVVLWEIATLAEQPYQGLSNE 232
Query: 395 QAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIIS 440
           Q    +   GL  + P +CP +L  LM  CW  +P  RP F EIIS
Sbjct: 233 QVLRFVMEGGLL-DKPDNCPDMLLELMRMCWQYNPKMRPSFLEIIS 277

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 98/205 (47%), Gaps = 11/205 (5%)
Query: 242 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL-KSRKLQTKEIIRIAIDVAEGIKFL 300
           H N+L    +C+       VV   M+ G + + I  ++     K++I   + VA+G+KFL
Sbjct: 88  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL 147
Query: 301 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRWLAPEII 356
                 +RDL ++  +LD    V + D G+          + +   G     +W+A E +
Sbjct: 148 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 207
Query: 357 AGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ 415
               ++   T  S+V+SFG+++WE++T G   Y   +     V +   G R   P+ CP 
Sbjct: 208 ----QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ-GRRLLQPEYCPD 262
Query: 416 ILKSLMIKCWNNSPSKRPQFSEIIS 440
            L  +M+KCW+     RP FSE++S
Sbjct: 263 PLYEVMLKCWHPKAEMRPSFSELVS 287

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 98/205 (47%), Gaps = 11/205 (5%)
Query: 242 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL-KSRKLQTKEIIRIAIDVAEGIKFL 300
           H N+L    +C+       VV   M+ G + + I  ++     K++I   + VA+G+KFL
Sbjct: 149 HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL 208
Query: 301 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRWLAPEII 356
                 +RDL ++  +LD    V + D G+          + +   G     +W+A E +
Sbjct: 209 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 268
Query: 357 AGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ 415
               ++   T  S+V+SFG+++WE++T G   Y   +     V +   G R   P+ CP 
Sbjct: 269 ----QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ-GRRLLQPEYCPD 323
Query: 416 ILKSLMIKCWNNSPSKRPQFSEIIS 440
            L  +M+KCW+     RP FSE++S
Sbjct: 324 PLYEVMLKCWHPKAEMRPSFSELVS 348

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 125/270 (46%), Gaps = 27/270 (10%)
Query: 184 RWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKL---KGCDKGNAYEFELRKDLLE---- 236
           +W+LN ++L   +QIG  +F  V+ G+      L   K C +      +L+   L+    
Sbjct: 108 KWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRE--TLPPDLKAKFLQEARI 165
Query: 237 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGS-VNDLILKSRKLQTKEIIRIAIDVAE 295
           L    H NI++   VC  +   + +V +L++GG  +  L  +  +L+ K ++++  D A 
Sbjct: 166 LKQYSHPNIVRLIGVCT-QKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAA 224
Query: 296 GIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR-----W 350
           G+++L      +RDL ++  L+     + + D G+    +   +     + G R     W
Sbjct: 225 GMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGM---SREEADGVYAASGGLRQVPVKW 281
Query: 351 LAPEII-AGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPE 408
            APE +  G   S S+ W     SFG+++WE  + G + Y   S  Q    +   G  P 
Sbjct: 282 TAPEALNYGRYSSESDVW-----SFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLP- 335
Query: 409 IPKDCPQILKSLMIKCWNNSPSKRPQFSEI 438
            P+ CP  +  LM +CW   P +RP FS I
Sbjct: 336 CPELCPDAVFRLMEQCWAYEPGQRPSFSTI 365

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 98/205 (47%), Gaps = 11/205 (5%)
Query: 242 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL-KSRKLQTKEIIRIAIDVAEGIKFL 300
           H N+L    +C+       VV   M+ G + + I  ++     K++I   + VA+G+KFL
Sbjct: 91  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL 150
Query: 301 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRWLAPEII 356
                 +RDL ++  +LD    V + D G+          + +   G     +W+A E +
Sbjct: 151 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 210
Query: 357 AGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ 415
               ++   T  S+V+SFG+++WE++T G   Y   +     V +   G R   P+ CP 
Sbjct: 211 ----QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ-GRRLLQPEYCPD 265
Query: 416 ILKSLMIKCWNNSPSKRPQFSEIIS 440
            L  +M+KCW+     RP FSE++S
Sbjct: 266 PLYEVMLKCWHPKAEMRPSFSELVS 290

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 98/205 (47%), Gaps = 11/205 (5%)
Query: 242 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL-KSRKLQTKEIIRIAIDVAEGIKFL 300
           H N+L    +C+       VV   M+ G + + I  ++     K++I   + VA+G+KFL
Sbjct: 90  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL 149
Query: 301 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRWLAPEII 356
                 +RDL ++  +LD    V + D G+          + +   G     +W+A E +
Sbjct: 150 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 209
Query: 357 AGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ 415
               ++   T  S+V+SFG+++WE++T G   Y   +     V +   G R   P+ CP 
Sbjct: 210 ----QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ-GRRLLQPEYCPD 264
Query: 416 ILKSLMIKCWNNSPSKRPQFSEIIS 440
            L  +M+KCW+     RP FSE++S
Sbjct: 265 PLYEVMLKCWHPKAEMRPSFSELVS 289

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 98/205 (47%), Gaps = 11/205 (5%)
Query: 242 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL-KSRKLQTKEIIRIAIDVAEGIKFL 300
           H N+L    +C+       VV   M+ G + + I  ++     K++I   + VA+G+KFL
Sbjct: 95  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL 154
Query: 301 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRWLAPEII 356
                 +RDL ++  +LD    V + D G+          + +   G     +W+A E +
Sbjct: 155 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 214
Query: 357 AGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ 415
               ++   T  S+V+SFG+++WE++T G   Y   +     V +   G R   P+ CP 
Sbjct: 215 ----QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ-GRRLLQPEYCPD 269
Query: 416 ILKSLMIKCWNNSPSKRPQFSEIIS 440
            L  +M+KCW+     RP FSE++S
Sbjct: 270 PLYEVMLKCWHPKAEMRPSFSELVS 294

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 75/298 (25%), Positives = 135/298 (45%), Gaps = 42/298 (14%)
Query: 181 EIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD---------KGNAYEFELR 231
           E  RW L  D L     +G  +F  V   + +G++K K            K +A E +L 
Sbjct: 19  EDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLS 78
Query: 232 KDLLEL----MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-------- 279
             + E+    M   HKNI+     C  ++  L V+ +    G++ +  L++R        
Sbjct: 79  DLISEMEMMKMIGKHKNIINLLGACT-QDGPLYVIVEYASKGNLRE-YLQAREPPGLEYS 136
Query: 280 ---------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGI 330
                    +L +K+++  A  VA G+++L      +RDL ++ +L+     + + D G+
Sbjct: 137 YNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGL 196
Query: 331 VTACKSVGEATEYETDG---YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEA 386
                 + +  +  T+G    +W+APE +         T  S+V+SFG+++WE+ T G +
Sbjct: 197 ARDIHHI-DYYKKTTNGRLPVKWMAPEALF----DRIYTHQSDVWSFGVLLWEIFTLGGS 251
Query: 387 AYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR 444
            Y    PV+    +   G R + P +C   L  +M  CW+  PS+RP F +++  L R
Sbjct: 252 PYPGV-PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 308

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 98/205 (47%), Gaps = 11/205 (5%)
Query: 242 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL-KSRKLQTKEIIRIAIDVAEGIKFL 300
           H N+L    +C+       VV   M+ G + + I  ++     K++I   + VA+G+K+L
Sbjct: 88  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL 147
Query: 301 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRWLAPEII 356
                 +RDL ++  +LD    V + D G+          + +   G     +W+A E +
Sbjct: 148 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 207
Query: 357 AGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ 415
               ++   T  S+V+SFG+++WE++T G   Y   +     V +   G R   P+ CP 
Sbjct: 208 ----QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ-GRRLLQPEYCPD 262
Query: 416 ILKSLMIKCWNNSPSKRPQFSEIIS 440
            L  +M+KCW+     RP FSE++S
Sbjct: 263 PLYEVMLKCWHPKAEMRPSFSELVS 287

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 98/205 (47%), Gaps = 11/205 (5%)
Query: 242 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL-KSRKLQTKEIIRIAIDVAEGIKFL 300
           H N+L    +C+       VV   M+ G + + I  ++     K++I   + VA+G+K+L
Sbjct: 108 HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL 167
Query: 301 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRWLAPEII 356
                 +RDL ++  +LD    V + D G+          + +   G     +W+A E +
Sbjct: 168 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 227
Query: 357 AGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ 415
               ++   T  S+V+SFG+++WE++T G   Y   +     V +   G R   P+ CP 
Sbjct: 228 ----QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ-GRRLLQPEYCPD 282
Query: 416 ILKSLMIKCWNNSPSKRPQFSEIIS 440
            L  +M+KCW+     RP FSE++S
Sbjct: 283 PLYEVMLKCWHPKAEMRPSFSELVS 307

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 98/205 (47%), Gaps = 11/205 (5%)
Query: 242 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL-KSRKLQTKEIIRIAIDVAEGIKFL 300
           H N+L    +C+       VV   M+ G + + I  ++     K++I   + VA+G+K+L
Sbjct: 109 HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL 168
Query: 301 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRWLAPEII 356
                 +RDL ++  +LD    V + D G+          + +   G     +W+A E +
Sbjct: 169 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 228
Query: 357 AGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ 415
               ++   T  S+V+SFG+++WE++T G   Y   +     V +   G R   P+ CP 
Sbjct: 229 ----QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ-GRRLLQPEYCPD 283
Query: 416 ILKSLMIKCWNNSPSKRPQFSEIIS 440
            L  +M+KCW+     RP FSE++S
Sbjct: 284 PLYEVMLKCWHPKAEMRPSFSELVS 308

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 75/286 (26%), Positives = 132/286 (46%), Gaps = 43/286 (15%)
Query: 185 WLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEK--------LKGCDKGNAY----EFELRK 232
           W +  + +    ++G  SF  VY+G   G+ K        +K  ++  +     EF    
Sbjct: 14  WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEA 73
Query: 233 DLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSV------------NDLILKSRK 280
            +++   C H  +++   V V +     V+ +LM  G +            N+ +L    
Sbjct: 74  SVMKEFNCHH--VVRLLGV-VSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPS 130
Query: 281 LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA 340
           L   ++I++A ++A+G+ +LN +   +RDL ++  ++     V +GD G+    + + E 
Sbjct: 131 LS--KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGM---TRDIXET 185
Query: 341 TEYETDG-----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPV 394
                 G      RW++PE +    + V  T+ S+V+SFG+V+WE+ T  E  Y   S  
Sbjct: 186 DXXRKGGKGLLPVRWMSPESLK---DGVFTTY-SDVWSFGVVLWEIATLAEQPYQGLSNE 241
Query: 395 QAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIIS 440
           Q    +   GL  + P +CP +L  LM  CW  +P  RP F EIIS
Sbjct: 242 QVLRFVMEGGLL-DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 286

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 98/205 (47%), Gaps = 11/205 (5%)
Query: 242 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL-KSRKLQTKEIIRIAIDVAEGIKFL 300
           H N+L    +C+       VV   M+ G + + I  ++     K++I   + VA+G+K+L
Sbjct: 90  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL 149
Query: 301 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRWLAPEII 356
                 +RDL ++  +LD    V + D G+          + +   G     +W+A E +
Sbjct: 150 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 209
Query: 357 AGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ 415
               ++   T  S+V+SFG+++WE++T G   Y   +     V +   G R   P+ CP 
Sbjct: 210 ----QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ-GRRLLQPEYCPD 264
Query: 416 ILKSLMIKCWNNSPSKRPQFSEIIS 440
            L  +M+KCW+     RP FSE++S
Sbjct: 265 PLYEVMLKCWHPKAEMRPSFSELVS 289

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 98/205 (47%), Gaps = 11/205 (5%)
Query: 242 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL-KSRKLQTKEIIRIAIDVAEGIKFL 300
           H N+L    +C+       VV   M+ G + + I  ++     K++I   + VA+G+K+L
Sbjct: 82  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL 141
Query: 301 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRWLAPEII 356
                 +RDL ++  +LD    V + D G+          + +   G     +W+A E +
Sbjct: 142 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 201
Query: 357 AGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ 415
               ++   T  S+V+SFG+++WE++T G   Y   +     V +   G R   P+ CP 
Sbjct: 202 ----QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ-GRRLLQPEYCPD 256
Query: 416 ILKSLMIKCWNNSPSKRPQFSEIIS 440
            L  +M+KCW+     RP FSE++S
Sbjct: 257 PLYEVMLKCWHPKAEMRPSFSELVS 281

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 98/205 (47%), Gaps = 11/205 (5%)
Query: 242 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL-KSRKLQTKEIIRIAIDVAEGIKFL 300
           H N+L    +C+       VV   M+ G + + I  ++     K++I   + VA+G+K+L
Sbjct: 85  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL 144
Query: 301 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRWLAPEII 356
                 +RDL ++  +LD    V + D G+          + +   G     +W+A E +
Sbjct: 145 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 204
Query: 357 AGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ 415
               ++   T  S+V+SFG+++WE++T G   Y   +     V +   G R   P+ CP 
Sbjct: 205 ----QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ-GRRLLQPEYCPD 259
Query: 416 ILKSLMIKCWNNSPSKRPQFSEIIS 440
            L  +M+KCW+     RP FSE++S
Sbjct: 260 PLYEVMLKCWHPKAEMRPSFSELVS 284

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 69/291 (23%), Positives = 137/291 (47%), Gaps = 39/291 (13%)
Query: 191 NLEFIDQIGPNSFKGV----------YKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTC 240
           +L+F+ Q+G  +F  V            G+ V ++KL+   + +  +FE   ++L+  + 
Sbjct: 16  HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK--SL 73
Query: 241 GHKNILQFYCVCVDE-NHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIK 298
            H NI+++  VC       L ++ + +  GS+ D + K + ++   ++++    + +G++
Sbjct: 74  QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGME 133
Query: 299 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR---WLAPEI 355
           +L      +RDL ++ IL++    V +GD G+        E  + +  G     W APE 
Sbjct: 134 YLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 193
Query: 356 IAGDPESVSETWMSNVYSFGMVIWEMVTG-EAAYAACSPVQAAVGIAACGL--------- 405
           +     SV+    S+V+SFG+V++E+ T  E + +  +     +G    G          
Sbjct: 194 LTESKFSVA----SDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 249
Query: 406 -----RPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNS 451
                R   P  CP  +  +M +CWNN+ ++RP F +   L LR + I ++
Sbjct: 250 LKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRD---LALRVDQIRDN 297

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 98/205 (47%), Gaps = 11/205 (5%)
Query: 242 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL-KSRKLQTKEIIRIAIDVAEGIKFL 300
           H N+L    +C+       VV   M+ G + + I  ++     K++I   + VA+G+K+L
Sbjct: 89  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL 148
Query: 301 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRWLAPEII 356
                 +RDL ++  +LD    V + D G+          + +   G     +W+A E +
Sbjct: 149 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 208
Query: 357 AGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ 415
               ++   T  S+V+SFG+++WE++T G   Y   +     V +   G R   P+ CP 
Sbjct: 209 ----QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ-GRRLLQPEYCPD 263
Query: 416 ILKSLMIKCWNNSPSKRPQFSEIIS 440
            L  +M+KCW+     RP FSE++S
Sbjct: 264 PLYEVMLKCWHPKAEMRPSFSELVS 288

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 69/291 (23%), Positives = 137/291 (47%), Gaps = 39/291 (13%)
Query: 191 NLEFIDQIGPNSFKGV----------YKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTC 240
           +L+F+ Q+G  +F  V            G+ V ++KL+   + +  +FE   ++L+  + 
Sbjct: 14  HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK--SL 71
Query: 241 GHKNILQFYCVCVDE-NHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIK 298
            H NI+++  VC       L ++ + +  GS+ D + K + ++   ++++    + +G++
Sbjct: 72  QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGME 131
Query: 299 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR---WLAPEI 355
           +L      +RDL ++ IL++    V +GD G+        E  + +  G     W APE 
Sbjct: 132 YLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 191
Query: 356 IAGDPESVSETWMSNVYSFGMVIWEMVTG-EAAYAACSPVQAAVGIAACGL--------- 405
           +     SV+    S+V+SFG+V++E+ T  E + +  +     +G    G          
Sbjct: 192 LTESKFSVA----SDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 247
Query: 406 -----RPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNS 451
                R   P  CP  +  +M +CWNN+ ++RP F +   L LR + I ++
Sbjct: 248 LKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRD---LALRVDQIRDN 295

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 98/205 (47%), Gaps = 11/205 (5%)
Query: 242 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL-KSRKLQTKEIIRIAIDVAEGIKFL 300
           H N+L    +C+       VV   M+ G + + I  ++     K++I   + VA+G+KFL
Sbjct: 91  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL 150
Query: 301 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRWLAPEII 356
                 +RDL ++  +LD    V + D G+          + +   G     +W+A E +
Sbjct: 151 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALESL 210
Query: 357 AGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ 415
               ++   T  S+V+SFG+++WE++T G   Y   +     V +   G R   P+ CP 
Sbjct: 211 ----QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ-GRRLLQPEYCPD 265
Query: 416 ILKSLMIKCWNNSPSKRPQFSEIIS 440
            L  +M+KCW+     RP FSE++S
Sbjct: 266 PLYEVMLKCWHPKAEMRPSFSELVS 290

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 98/205 (47%), Gaps = 11/205 (5%)
Query: 242 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL-KSRKLQTKEIIRIAIDVAEGIKFL 300
           H N+L    +C+       VV   M+ G + + I  ++     K++I   + VA+G+K+L
Sbjct: 87  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL 146
Query: 301 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRWLAPEII 356
                 +RDL ++  +LD    V + D G+          + +   G     +W+A E +
Sbjct: 147 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 206
Query: 357 AGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ 415
               ++   T  S+V+SFG+++WE++T G   Y   +     V +   G R   P+ CP 
Sbjct: 207 ----QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ-GRRLLQPEYCPD 261
Query: 416 ILKSLMIKCWNNSPSKRPQFSEIIS 440
            L  +M+KCW+     RP FSE++S
Sbjct: 262 PLYEVMLKCWHPKAEMRPSFSELVS 286

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 69/291 (23%), Positives = 137/291 (47%), Gaps = 39/291 (13%)
Query: 191 NLEFIDQIGPNSFKGV----------YKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTC 240
           +L+F+ Q+G  +F  V            G+ V ++KL+   + +  +FE   ++L+  + 
Sbjct: 18  HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK--SL 75
Query: 241 GHKNILQFYCVCVDE-NHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIK 298
            H NI+++  VC       L ++ + +  GS+ D + K + ++   ++++    + +G++
Sbjct: 76  QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGME 135
Query: 299 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR---WLAPEI 355
           +L      +RDL ++ IL++    V +GD G+        E  + +  G     W APE 
Sbjct: 136 YLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 195
Query: 356 IAGDPESVSETWMSNVYSFGMVIWEMVTG-EAAYAACSPVQAAVGIAACGL--------- 405
           +     SV+    S+V+SFG+V++E+ T  E + +  +     +G    G          
Sbjct: 196 LTESKFSVA----SDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 251
Query: 406 -----RPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNS 451
                R   P  CP  +  +M +CWNN+ ++RP F +   L LR + I ++
Sbjct: 252 LKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRD---LALRVDQIRDN 299

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 69/291 (23%), Positives = 137/291 (47%), Gaps = 39/291 (13%)
Query: 191 NLEFIDQIGPNSFKGV----------YKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTC 240
           +L+F+ Q+G  +F  V            G+ V ++KL+   + +  +FE   ++L+  + 
Sbjct: 11  HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK--SL 68
Query: 241 GHKNILQFYCVCVDE-NHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIK 298
            H NI+++  VC       L ++ + +  GS+ D + K + ++   ++++    + +G++
Sbjct: 69  QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGME 128
Query: 299 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR---WLAPEI 355
           +L      +RDL ++ IL++    V +GD G+        E  + +  G     W APE 
Sbjct: 129 YLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 188
Query: 356 IAGDPESVSETWMSNVYSFGMVIWEMVTG-EAAYAACSPVQAAVGIAACGL--------- 405
           +     SV+    S+V+SFG+V++E+ T  E + +  +     +G    G          
Sbjct: 189 LTESKFSVA----SDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 244
Query: 406 -----RPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNS 451
                R   P  CP  +  +M +CWNN+ ++RP F +   L LR + I ++
Sbjct: 245 LKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRD---LALRVDQIRDN 292

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 69/291 (23%), Positives = 137/291 (47%), Gaps = 39/291 (13%)
Query: 191 NLEFIDQIGPNSFKGV----------YKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTC 240
           +L+F+ Q+G  +F  V            G+ V ++KL+   + +  +FE   ++L+  + 
Sbjct: 17  HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK--SL 74
Query: 241 GHKNILQFYCVCVDE-NHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIK 298
            H NI+++  VC       L ++ + +  GS+ D + K + ++   ++++    + +G++
Sbjct: 75  QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGME 134
Query: 299 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR---WLAPEI 355
           +L      +RDL ++ IL++    V +GD G+        E  + +  G     W APE 
Sbjct: 135 YLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 194
Query: 356 IAGDPESVSETWMSNVYSFGMVIWEMVTG-EAAYAACSPVQAAVGIAACGL--------- 405
           +     SV+    S+V+SFG+V++E+ T  E + +  +     +G    G          
Sbjct: 195 LTESKFSVA----SDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 250
Query: 406 -----RPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNS 451
                R   P  CP  +  +M +CWNN+ ++RP F +   L LR + I ++
Sbjct: 251 LKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRD---LALRVDQIRDN 298

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 69/291 (23%), Positives = 137/291 (47%), Gaps = 39/291 (13%)
Query: 191 NLEFIDQIGPNSFKGV----------YKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTC 240
           +L+F+ Q+G  +F  V            G+ V ++KL+   + +  +FE   ++L+  + 
Sbjct: 10  HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK--SL 67
Query: 241 GHKNILQFYCVCVDE-NHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIK 298
            H NI+++  VC       L ++ + +  GS+ D + K + ++   ++++    + +G++
Sbjct: 68  QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGME 127
Query: 299 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR---WLAPEI 355
           +L      +RDL ++ IL++    V +GD G+        E  + +  G     W APE 
Sbjct: 128 YLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 187
Query: 356 IAGDPESVSETWMSNVYSFGMVIWEMVTG-EAAYAACSPVQAAVGIAACGL--------- 405
           +     SV+    S+V+SFG+V++E+ T  E + +  +     +G    G          
Sbjct: 188 LTESKFSVA----SDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 243
Query: 406 -----RPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNS 451
                R   P  CP  +  +M +CWNN+ ++RP F +   L LR + I ++
Sbjct: 244 LKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRD---LALRVDQIRDN 291

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 66/248 (26%), Positives = 119/248 (47%), Gaps = 25/248 (10%)
Query: 209 GKR---VGIEKLKGCDKGNAYEFELRKDLLE----LMTCGHKNILQFYCVCVDENHGLCV 261
           GKR   V I+ LK     + Y  + R+D L     +    H N++    V V ++  + +
Sbjct: 58  GKREIFVAIKTLK-----SGYTEKQRRDFLSEASIMGQFDHPNVIHLEGV-VTKSTPVMI 111
Query: 262 VTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH 320
           +T+ ME GS++  + ++  +    +++ +   +A G+K+L D    +RDL ++ IL++ +
Sbjct: 112 ITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSN 171
Query: 321 GNVCLGDMGIVTACKSVGEATEYETD-----GYRWLAPEIIAGDPESVSETWMSNVYSFG 375
               + D G+    +       Y +        RW APE I    +    T  S+V+S+G
Sbjct: 172 LVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAI----QYRKFTSASDVWSYG 227
Query: 376 MVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQ 434
           +V+WE+++ GE  Y   +  Q  +       R   P DCP  L  LM+ CW    + RP+
Sbjct: 228 IVMWEVMSYGERPYWDMTN-QDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPK 286
Query: 435 FSEIISLL 442
           F +I++ L
Sbjct: 287 FGQIVNTL 294

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 69/291 (23%), Positives = 137/291 (47%), Gaps = 39/291 (13%)
Query: 191 NLEFIDQIGPNSFKGV----------YKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTC 240
           +L+F+ Q+G  +F  V            G+ V ++KL+   + +  +FE   ++L+  + 
Sbjct: 15  HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK--SL 72
Query: 241 GHKNILQFYCVCVDE-NHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIK 298
            H NI+++  VC       L ++ + +  GS+ D + K + ++   ++++    + +G++
Sbjct: 73  QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGME 132
Query: 299 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR---WLAPEI 355
           +L      +RDL ++ IL++    V +GD G+        E  + +  G     W APE 
Sbjct: 133 YLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 192
Query: 356 IAGDPESVSETWMSNVYSFGMVIWEMVTG-EAAYAACSPVQAAVGIAACGL--------- 405
           +     SV+    S+V+SFG+V++E+ T  E + +  +     +G    G          
Sbjct: 193 LTESKFSVA----SDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 248
Query: 406 -----RPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNS 451
                R   P  CP  +  +M +CWNN+ ++RP F +   L LR + I ++
Sbjct: 249 LKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRD---LALRVDQIRDN 296

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 69/291 (23%), Positives = 137/291 (47%), Gaps = 39/291 (13%)
Query: 191 NLEFIDQIGPNSFKGV----------YKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTC 240
           +L+F+ Q+G  +F  V            G+ V ++KL+   + +  +FE   ++L+  + 
Sbjct: 11  HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK--SL 68
Query: 241 GHKNILQFYCVCVDE-NHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIK 298
            H NI+++  VC       L ++ + +  GS+ D + K + ++   ++++    + +G++
Sbjct: 69  QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGME 128
Query: 299 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR---WLAPEI 355
           +L      +RDL ++ IL++    V +GD G+        E  + +  G     W APE 
Sbjct: 129 YLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 188
Query: 356 IAGDPESVSETWMSNVYSFGMVIWEMVTG-EAAYAACSPVQAAVGIAACGL--------- 405
           +     SV+    S+V+SFG+V++E+ T  E + +  +     +G    G          
Sbjct: 189 LTESKFSVA----SDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 244
Query: 406 -----RPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNS 451
                R   P  CP  +  +M +CWNN+ ++RP F +   L LR + I ++
Sbjct: 245 LKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRD---LALRVDQIRDN 292

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 98/205 (47%), Gaps = 11/205 (5%)
Query: 242 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL-KSRKLQTKEIIRIAIDVAEGIKFL 300
           H N+L    +C+       VV   M+ G + + I  ++     K++I   + VA+G+K+L
Sbjct: 90  HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL 149
Query: 301 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRWLAPEII 356
                 +RDL ++  +LD    V + D G+          + +   G     +W+A E +
Sbjct: 150 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 209
Query: 357 AGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ 415
               ++   T  S+V+SFG+++WE++T G   Y   +     V +   G R   P+ CP 
Sbjct: 210 ----QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ-GRRLLQPEYCPD 264
Query: 416 ILKSLMIKCWNNSPSKRPQFSEIIS 440
            L  +M+KCW+     RP FSE++S
Sbjct: 265 PLYEVMLKCWHPKAEMRPSFSELVS 289

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 69/290 (23%), Positives = 136/290 (46%), Gaps = 39/290 (13%)
Query: 191 NLEFIDQIGPNSFKGV----------YKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTC 240
           +L+F+ Q+G  +F  V            G+ V ++KL+   + +  +FE   ++L+  + 
Sbjct: 42  HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK--SL 99
Query: 241 GHKNILQFYCVCVDE-NHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIK 298
            H NI+++  VC       L ++ + +  GS+ D + K + ++   ++++    + +G++
Sbjct: 100 QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGME 159
Query: 299 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR---WLAPEI 355
           +L      +RDL ++ IL++    V +GD G+        E  + +  G     W APE 
Sbjct: 160 YLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 219
Query: 356 IAGDPESVSETWMSNVYSFGMVIWEMVTG-EAAYAACSPVQAAVGIAACGL--------- 405
           +     SV+    S+V+SFG+V++E+ T  E + +  +     +G    G          
Sbjct: 220 LTESKFSVA----SDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 275
Query: 406 -----RPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISN 450
                R   P  CP  +  +M +CWNN+ ++RP F +   L LR + I +
Sbjct: 276 LKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRD---LALRVDQIRD 322

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 69/291 (23%), Positives = 137/291 (47%), Gaps = 39/291 (13%)
Query: 191 NLEFIDQIGPNSFKGV----------YKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTC 240
           +L+F+ Q+G  +F  V            G+ V ++KL+   + +  +FE   ++L+  + 
Sbjct: 29  HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK--SL 86
Query: 241 GHKNILQFYCVCVDE-NHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIK 298
            H NI+++  VC       L ++ + +  GS+ D + K + ++   ++++    + +G++
Sbjct: 87  QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGME 146
Query: 299 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR---WLAPEI 355
           +L      +RDL ++ IL++    V +GD G+        E  + +  G     W APE 
Sbjct: 147 YLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 206
Query: 356 IAGDPESVSETWMSNVYSFGMVIWEMVTG-EAAYAACSPVQAAVGIAACGL--------- 405
           +     SV+    S+V+SFG+V++E+ T  E + +  +     +G    G          
Sbjct: 207 LTESKFSVA----SDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 262
Query: 406 -----RPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNS 451
                R   P  CP  +  +M +CWNN+ ++RP F +   L LR + I ++
Sbjct: 263 LKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRD---LALRVDQIRDN 310

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 69/291 (23%), Positives = 136/291 (46%), Gaps = 39/291 (13%)
Query: 191 NLEFIDQIGPNSFKGV----------YKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTC 240
           +L+F+ Q+G  +F  V            G+ V ++KL+   + +  +FE   ++L+  + 
Sbjct: 9   HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK--SL 66
Query: 241 GHKNILQFYCVCVDE-NHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIK 298
            H NI+++  VC       L ++ + +  GS+ D + K + ++   ++++    + +G++
Sbjct: 67  QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGME 126
Query: 299 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR---WLAPEI 355
           +L      +RDL ++ IL++    V +GD G+        E  + +  G     W APE 
Sbjct: 127 YLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 186
Query: 356 IAGDPESVSETWMSNVYSFGMVIWEMVTG-EAAYAACSPVQAAVGIAACGL--------- 405
           +     SV+    S+V+SFG+V++E+ T  E + +  +     +G    G          
Sbjct: 187 LTESKFSVA----SDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 242
Query: 406 -----RPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNS 451
                R   P  CP  +  +M +CWNN+ ++RP F +   L LR + I + 
Sbjct: 243 LKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRD---LALRVDQIRDQ 290

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 69/291 (23%), Positives = 137/291 (47%), Gaps = 39/291 (13%)
Query: 191 NLEFIDQIGPNSFKGV----------YKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTC 240
           +L+F+ Q+G  +F  V            G+ V ++KL+   + +  +FE   ++L+  + 
Sbjct: 29  HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK--SL 86
Query: 241 GHKNILQFYCVCVDE-NHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIK 298
            H NI+++  VC       L ++ + +  GS+ D + K + ++   ++++    + +G++
Sbjct: 87  QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGME 146
Query: 299 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR---WLAPEI 355
           +L      +RDL ++ IL++    V +GD G+        E  + +  G     W APE 
Sbjct: 147 YLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 206
Query: 356 IAGDPESVSETWMSNVYSFGMVIWEMVTG-EAAYAACSPVQAAVGIAACGL--------- 405
           +     SV+    S+V+SFG+V++E+ T  E + +  +     +G    G          
Sbjct: 207 LTESKFSVA----SDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 262
Query: 406 -----RPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNS 451
                R   P  CP  +  +M +CWNN+ ++RP F +   L LR + I ++
Sbjct: 263 LKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRD---LALRVDQIRDN 310

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 69/260 (26%), Positives = 120/260 (46%), Gaps = 21/260 (8%)
Query: 198 IGPNSFKGVYKGKRVGIEKLKGCD-----KGNAYEFELRKDLLELMTCG---HKNILQFY 249
           IG   F  V +G+     K + C      KG   E + R+ L E    G   H NI++  
Sbjct: 22  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLE 81
Query: 250 CVCVDENHGLCVVTKLMEGGSVNDLI-LKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYR 308
            V V  +  + ++T+ ME G+++  + L   +    +++ +   +A G+++L +    +R
Sbjct: 82  GV-VTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLAEMSYVHR 140
Query: 309 DLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETD-----GYRWLAPEIIAGDPESV 363
           DL ++ IL++ +    + D G+    +       Y +        RW APE IA      
Sbjct: 141 DLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEAIAFR---- 196
Query: 364 SETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMI 422
             T  S+ +S+G+V+WE+++ GE  Y   S  Q  +       R   P DCP  L  LM+
Sbjct: 197 KFTSASDAWSYGIVMWEVMSFGERPYWDMSN-QDVINAIEQDYRLPPPPDCPTSLHQLML 255
Query: 423 KCWNNSPSKRPQFSEIISLL 442
            CW    + RP+F +++S L
Sbjct: 256 DCWQKDRNARPRFPQVVSAL 275

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 71/304 (23%), Positives = 136/304 (44%), Gaps = 40/304 (13%)
Query: 181 EIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD---------KGNAYEFELR 231
           E  +W    D L     +G  +F  V   + VGI+K K  +         K +A E +L 
Sbjct: 26  EDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS 85
Query: 232 KDLLEL----MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-------- 279
             + E+    M   HKNI+     C  ++  L V+ +    G++ + +   R        
Sbjct: 86  DLVSEMEMMKMIGKHKNIINLLGACT-QDGPLYVIVEYASKGNLREYLRARRPPGMEXSY 144
Query: 280 --------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIV 331
                   ++  K+++     +A G+++L      +RDL ++ +L+  +  + + D G+ 
Sbjct: 145 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA 204
Query: 332 TACKSVGEATEYETDG---YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAA 387
               ++ +  +  T+G    +W+APE +         T  S+V+SFG+++WE+ T G + 
Sbjct: 205 RDINNI-DXXKKTTNGRLPVKWMAPEALF----DRVYTHQSDVWSFGVLMWEIFTLGGSP 259
Query: 388 YAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNN 447
           Y    PV+    +   G R + P +C   L  +M  CW+  PS+RP F +++  L R   
Sbjct: 260 YPGI-PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318
Query: 448 ISNS 451
           ++ +
Sbjct: 319 LTTN 322

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 71/304 (23%), Positives = 136/304 (44%), Gaps = 40/304 (13%)
Query: 181 EIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD---------KGNAYEFELR 231
           E  +W    D L     +G  +F  V   + VGI+K K  +         K +A E +L 
Sbjct: 26  EDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS 85
Query: 232 KDLLEL----MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-------- 279
             + E+    M   HKNI+     C  ++  L V+ +    G++ + +   R        
Sbjct: 86  DLVSEMEMMKMIGKHKNIINLLGACT-QDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 144
Query: 280 --------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIV 331
                   ++  K+++     +A G+++L      +RDL ++ +L+  +  + + D G+ 
Sbjct: 145 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA 204
Query: 332 TACKSVGEATEYETDG---YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAA 387
               ++ +  +  T+G    +W+APE +         T  S+V+SFG+++WE+ T G + 
Sbjct: 205 RDINNI-DXXKKTTNGRLPVKWMAPEALF----DRVYTHQSDVWSFGVLMWEIFTLGGSP 259
Query: 388 YAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNN 447
           Y    PV+    +   G R + P +C   L  +M  CW+  PS+RP F +++  L R   
Sbjct: 260 YPGI-PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318
Query: 448 ISNS 451
           ++ +
Sbjct: 319 LTTN 322

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 64/247 (25%), Positives = 120/247 (48%), Gaps = 18/247 (7%)
Query: 198 IGPNSFKGVYKGK------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV 251
           +G  ++  VY G+      R+ I+++   ++ + Y   L +++       HKNI+Q Y  
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIP--ERDSRYSQPLHEEIALHKHLKHKNIVQ-YLG 86
Query: 252 CVDENHGLCVVTKLMEGGSVNDLILKSR----KLQTKEIIRIAIDVAEGIKFLNDHGVAY 307
              EN  + +  + + GGS++ L L+S+    K   + I      + EG+K+L+D+ + +
Sbjct: 87  SFSENGFIKIFMEQVPGGSLSAL-LRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVH 145
Query: 308 RDLNSQRILLDRHGNVC-LGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSET 366
           RD+    +L++ +  V  + D G       +   TE  T   +++APEII   P    + 
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKA 205
Query: 367 WMSNVYSFGMVIWEMVTGEAAYAACSPVQAAV-GIAACGLRPEIPKDCPQILKSLMIKCW 425
             ++++S G  I EM TG+  +      QAA+  +    + PEIP+      K+ ++KC+
Sbjct: 206 --ADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCF 263
Query: 426 NNSPSKR 432
              P KR
Sbjct: 264 EPDPDKR 270

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 63/265 (23%), Positives = 125/265 (47%), Gaps = 15/265 (5%)
Query: 182 IGRWLLNSDNLEFIDQIGPNSFKGVYKG--KRVGIEKLKGCDKGNAYEFE-LRKDLLELM 238
           + +W +   ++    ++G   +  VY+G  K+  +       K +  E E   K+   + 
Sbjct: 3   LDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMK 62
Query: 239 TCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEII--RIAIDVAEG 296
              H N++Q   VC  E     ++T+ M  G++ D + +  + +   ++   +A  ++  
Sbjct: 63  EIKHPNLVQLLGVCTREP-PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA 121
Query: 297 IKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY--RWLAPE 354
           +++L      +RDL ++  L+  +  V + D G+ +   +    T +    +  +W APE
Sbjct: 122 MEYLEKKNFIHRDLAARNCLVGENHLVKVADFGL-SRLMTGDTFTAHAGAKFPIKWTAPE 180
Query: 355 IIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDC 413
            +A +  S+     S+V++FG+++WE+ T G + Y    P Q    +     R E P+ C
Sbjct: 181 SLAYNKFSIK----SDVWAFGVLLWEIATYGMSPYPGIDPSQV-YELLEKDYRMERPEGC 235
Query: 414 PQILKSLMIKCWNNSPSKRPQFSEI 438
           P+ +  LM  CW  +PS RP F+EI
Sbjct: 236 PEKVYELMRACWQWNPSDRPSFAEI 260

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 64/247 (25%), Positives = 120/247 (48%), Gaps = 18/247 (7%)
Query: 198 IGPNSFKGVYKGK------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV 251
           +G  ++  VY G+      R+ I+++   ++ + Y   L +++       HKNI+Q Y  
Sbjct: 16  LGKGTYGIVYAGRDLSNQVRIAIKEIP--ERDSRYSQPLHEEIALHKHLKHKNIVQ-YLG 72
Query: 252 CVDENHGLCVVTKLMEGGSVNDLILKSR----KLQTKEIIRIAIDVAEGIKFLNDHGVAY 307
              EN  + +  + + GGS++ L L+S+    K   + I      + EG+K+L+D+ + +
Sbjct: 73  SFSENGFIKIFMEQVPGGSLSAL-LRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVH 131
Query: 308 RDLNSQRILLDRHGNVC-LGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSET 366
           RD+    +L++ +  V  + D G       +   TE  T   +++APEII   P    + 
Sbjct: 132 RDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKA 191
Query: 367 WMSNVYSFGMVIWEMVTGEAAYAACSPVQAAV-GIAACGLRPEIPKDCPQILKSLMIKCW 425
             ++++S G  I EM TG+  +      QAA+  +    + PEIP+      K+ ++KC+
Sbjct: 192 --ADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCF 249
Query: 426 NNSPSKR 432
              P KR
Sbjct: 250 EPDPDKR 256

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 71/304 (23%), Positives = 136/304 (44%), Gaps = 40/304 (13%)
Query: 181 EIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD---------KGNAYEFELR 231
           E  +W    D L     +G  +F  V   + VGI+K K  +         K +A E +L 
Sbjct: 26  EDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS 85
Query: 232 KDLLEL----MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-------- 279
             + E+    M   HKNI+     C  ++  L V+ +    G++ + +   R        
Sbjct: 86  DLVSEMEMMKMIGKHKNIIHLLGACT-QDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 144
Query: 280 --------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIV 331
                   ++  K+++     +A G+++L      +RDL ++ +L+  +  + + D G+ 
Sbjct: 145 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA 204
Query: 332 TACKSVGEATEYETDG---YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAA 387
               ++ +  +  T+G    +W+APE +         T  S+V+SFG+++WE+ T G + 
Sbjct: 205 RDINNI-DYYKKTTNGRLPVKWMAPEALF----DRVYTHQSDVWSFGVLMWEIFTLGGSP 259
Query: 388 YAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNN 447
           Y    PV+    +   G R + P +C   L  +M  CW+  PS+RP F +++  L R   
Sbjct: 260 YPGI-PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318
Query: 448 ISNS 451
           ++ +
Sbjct: 319 LTTN 322

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 69/291 (23%), Positives = 137/291 (47%), Gaps = 39/291 (13%)
Query: 191 NLEFIDQIGPNSFKGV----------YKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTC 240
           +L+F+ Q+G  +F  V            G+ V ++KL+   + +  +FE   ++L+  + 
Sbjct: 11  HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK--SL 68
Query: 241 GHKNILQFYCVCVDE-NHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIK 298
            H NI+++  VC       L ++ + +  GS+ D + K + ++   ++++    + +G++
Sbjct: 69  QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGME 128
Query: 299 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR---WLAPEI 355
           +L      +RDL ++ IL++    V +GD G+        E  + +  G     W APE 
Sbjct: 129 YLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPES 188
Query: 356 IAGDPESVSETWMSNVYSFGMVIWEMVTG-EAAYAACSPVQAAVGIAACGL--------- 405
           +     SV+    S+V+SFG+V++E+ T  E + +  +     +G    G          
Sbjct: 189 LTESKFSVA----SDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 244
Query: 406 -----RPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNS 451
                R   P  CP  +  +M +CWNN+ ++RP F +   L LR + I ++
Sbjct: 245 LKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRD---LALRVDQIRDN 292

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 71/304 (23%), Positives = 136/304 (44%), Gaps = 40/304 (13%)
Query: 181 EIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD---------KGNAYEFELR 231
           E  +W    D L     +G  +F  V   + VGI+K K  +         K +A E +L 
Sbjct: 26  EDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLS 85
Query: 232 KDLLEL----MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-------- 279
             + E+    M   HKNI+     C  ++  L V+ +    G++ + +   R        
Sbjct: 86  DLVSEMEMMKMIGKHKNIINLLGACT-QDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 144
Query: 280 --------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIV 331
                   ++  K+++     +A G+++L      +RDL ++ +L+  +  + + D G+ 
Sbjct: 145 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA 204
Query: 332 TACKSVGEATEYETDG---YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAA 387
               ++ +  +  T+G    +W+APE +         T  S+V+SFG+++WE+ T G + 
Sbjct: 205 RDINNI-DYYKKTTNGRLPVKWMAPEALF----DRVYTHQSDVWSFGVLMWEIFTLGGSP 259
Query: 388 YAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNN 447
           Y    PV+    +   G R + P +C   L  +M  CW+  PS+RP F +++  L R   
Sbjct: 260 YPGI-PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318
Query: 448 ISNS 451
           ++ +
Sbjct: 319 LTTN 322

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 77/317 (24%), Positives = 135/317 (42%), Gaps = 64/317 (20%)
Query: 167 VSVDEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD----- 221
           +SVD ++ +     E  +W     NL     +G   F  V K     ++   G       
Sbjct: 5   LSVDAFKIL-----EDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVK 59
Query: 222 --KGNAYEFELRKDLLE---LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL 276
             K NA   ELR  L E   L    H ++++ Y  C  ++  L ++ +  + GS+   + 
Sbjct: 60  MLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGAC-SQDGPLLLIVEYAKYGSLRGFLR 118
Query: 277 KSRK------------------------LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNS 312
           +SRK                        L   ++I  A  +++G+++L +  + +RDL +
Sbjct: 119 ESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAA 178
Query: 313 QRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY----------RWLAPEIIAGDPES 362
           + IL+     + + D G+            YE D Y          +W+A E +    + 
Sbjct: 179 RNILVAEGRKMKISDFGLSRDV--------YEEDSYVKRSQGRIPVKWMAIESLF---DH 227
Query: 363 VSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLM 421
           +  T  S+V+SFG+++WE+VT G   Y    P +    +   G R E P +C + +  LM
Sbjct: 228 IYTT-QSDVWSFGVLLWEIVTLGGNPYPGIPP-ERLFNLLKTGHRMERPDNCSEEMYRLM 285
Query: 422 IKCWNNSPSKRPQFSEI 438
           ++CW   P KRP F++I
Sbjct: 286 LQCWKQEPDKRPVFADI 302

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 71/304 (23%), Positives = 136/304 (44%), Gaps = 40/304 (13%)
Query: 181 EIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD---------KGNAYEFELR 231
           E  +W    D L     +G  +F  V   + VGI+K K  +         K +A E +L 
Sbjct: 26  EDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS 85
Query: 232 KDLLEL----MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-------- 279
             + E+    M   HKNI+     C  ++  L V+ +    G++ + +   R        
Sbjct: 86  DLVSEMEMMKMIGKHKNIINLLGACT-QDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 144
Query: 280 --------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIV 331
                   ++  K+++     +A G+++L      +RDL ++ +L+  +  + + D G+ 
Sbjct: 145 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMRIADFGLA 204
Query: 332 TACKSVGEATEYETDG---YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAA 387
               ++ +  +  T+G    +W+APE +         T  S+V+SFG+++WE+ T G + 
Sbjct: 205 RDINNI-DYYKKTTNGRLPVKWMAPEALF----DRVYTHQSDVWSFGVLMWEIFTLGGSP 259
Query: 388 YAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNN 447
           Y    PV+    +   G R + P +C   L  +M  CW+  PS+RP F +++  L R   
Sbjct: 260 YPGI-PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318
Query: 448 ISNS 451
           ++ +
Sbjct: 319 LTTN 322

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 68/291 (23%), Positives = 137/291 (47%), Gaps = 39/291 (13%)
Query: 191 NLEFIDQIGPNSFKGV----------YKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTC 240
           +L+F+ Q+G  +F  V            G+ V ++KL+   + +  +FE   ++L+  + 
Sbjct: 14  HLKFLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK--SL 71
Query: 241 GHKNILQFYCVCVDE-NHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIK 298
            H NI+++  VC       L ++ + +  GS+ + + K + ++   ++++    + +G++
Sbjct: 72  QHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQICKGME 131
Query: 299 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR---WLAPEI 355
           +L      +RDL ++ IL++    V +GD G+        E  + +  G     W APE 
Sbjct: 132 YLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 191
Query: 356 IAGDPESVSETWMSNVYSFGMVIWEMVTG-EAAYAACSPVQAAVGIAACGL--------- 405
           +     SV+    S+V+SFG+V++E+ T  E + +  +     +G    G          
Sbjct: 192 LTESKFSVA----SDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 247
Query: 406 -----RPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNS 451
                R   P  CP  +  +M +CWNN+ ++RP F +   L LR + I ++
Sbjct: 248 LKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRD---LALRVDQIRDN 295

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 71/304 (23%), Positives = 136/304 (44%), Gaps = 40/304 (13%)
Query: 181 EIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD---------KGNAYEFELR 231
           E  +W    D L     +G  +F  V   + VGI+K K  +         K +A E +L 
Sbjct: 26  EDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS 85
Query: 232 KDLLEL----MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-------- 279
             + E+    M   HKNI+     C  ++  L V+ +    G++ + +   R        
Sbjct: 86  DLVSEMEMMKMIGKHKNIITLLGACT-QDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 144
Query: 280 --------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIV 331
                   ++  K+++     +A G+++L      +RDL ++ +L+  +  + + D G+ 
Sbjct: 145 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA 204
Query: 332 TACKSVGEATEYETDG---YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAA 387
               ++ +  +  T+G    +W+APE +         T  S+V+SFG+++WE+ T G + 
Sbjct: 205 RDINNI-DYYKKTTNGRLPVKWMAPEALF----DRVYTHQSDVWSFGVLMWEIFTLGGSP 259
Query: 388 YAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNN 447
           Y    PV+    +   G R + P +C   L  +M  CW+  PS+RP F +++  L R   
Sbjct: 260 YPGI-PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318
Query: 448 ISNS 451
           ++ +
Sbjct: 319 LTTN 322

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 71/304 (23%), Positives = 136/304 (44%), Gaps = 40/304 (13%)
Query: 181 EIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD---------KGNAYEFELR 231
           E  +W    D L     +G  +F  V   + VGI+K K  +         K +A E +L 
Sbjct: 26  EDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS 85
Query: 232 KDLLEL----MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-------- 279
             + E+    M   HKNI+     C  ++  L V+ +    G++ + +   R        
Sbjct: 86  DLVSEMEMMKMIGKHKNIINLLGACT-QDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 144
Query: 280 --------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIV 331
                   ++  K+++     +A G+++L      +RDL ++ +L+  +  + + D G+ 
Sbjct: 145 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA 204
Query: 332 TACKSVGEATEYETDG---YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAA 387
               ++ +  +  T+G    +W+APE +         T  S+V+SFG+++WE+ T G + 
Sbjct: 205 RDINNI-DYYKNTTNGRLPVKWMAPEALF----DRVYTHQSDVWSFGVLMWEIFTLGGSP 259
Query: 388 YAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNN 447
           Y    PV+    +   G R + P +C   L  +M  CW+  PS+RP F +++  L R   
Sbjct: 260 YPGI-PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318
Query: 448 ISNS 451
           ++ +
Sbjct: 319 LTTN 322

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/260 (23%), Positives = 113/260 (43%), Gaps = 15/260 (5%)
Query: 192 LEFIDQIGPNS----FKGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQ 247
           L F+ ++  N     +KG ++G  + ++ LK  D       +  ++   L    H N+L 
Sbjct: 12  LNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLP 71
Query: 248 FYCVCVDEN-HGLCVVTKLMEGGSVNDLILKSRKL--QTKEIIRIAIDVAEGIKFLN--D 302
               C         ++T     GS+ +++ +         + ++ A+D A G  FL+  +
Sbjct: 72  VLGACQSPPAPHPTLITHWXPYGSLYNVLHEGTNFVVDQSQAVKFALDXARGXAFLHTLE 131
Query: 303 HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPES 362
             +    LNS+ + +D      +    +  + +S G           W+APE +   PE 
Sbjct: 132 PLIPRHALNSRSVXIDEDXTARISXADVKFSFQSPGRXY-----APAWVAPEALQKKPED 186
Query: 363 VSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMI 422
            +    ++ +SF +++WE+VT E  +A  S  +    +A  GLRP IP      +  L  
Sbjct: 187 TNRR-SADXWSFAVLLWELVTREVPFADLSNXEIGXKVALEGLRPTIPPGISPHVSKLXK 245
Query: 423 KCWNNSPSKRPQFSEIISLL 442
            C N  P+KRP+F  I+ +L
Sbjct: 246 ICXNEDPAKRPKFDXIVPIL 265

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 71/304 (23%), Positives = 135/304 (44%), Gaps = 40/304 (13%)
Query: 181 EIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD---------KGNAYEFELR 231
           E  +W    D L     +G   F  V   + VGI+K K  +         K +A E +L 
Sbjct: 13  EDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS 72
Query: 232 KDLLEL----MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-------- 279
             + E+    M   HKNI+     C  ++  L V+ +    G++ + +   R        
Sbjct: 73  DLVSEMEMMKMIGKHKNIINLLGACT-QDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 131
Query: 280 --------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIV 331
                   ++  K+++     +A G+++L      +RDL ++ +L+  +  + + D G+ 
Sbjct: 132 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLTARNVLVTENNVMKIADFGLA 191
Query: 332 TACKSVGEATEYETDG---YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAA 387
               ++ +  +  T+G    +W+APE +         T  S+V+SFG+++WE+ T G + 
Sbjct: 192 RDINNI-DYYKKTTNGRLPVKWMAPEALF----DRVYTHQSDVWSFGVLMWEIFTLGGSP 246
Query: 388 YAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNN 447
           Y    PV+    +   G R + P +C   L  +M  CW+  PS+RP F +++  L R   
Sbjct: 247 YPGI-PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 305
Query: 448 ISNS 451
           ++ +
Sbjct: 306 LTTN 309

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 71/304 (23%), Positives = 135/304 (44%), Gaps = 40/304 (13%)
Query: 181 EIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD---------KGNAYEFELR 231
           E  +W    D L     +G  +F  V   + VGI+K K  +         K +A E +L 
Sbjct: 26  EDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS 85
Query: 232 KDLLEL----MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-------- 279
             + E+    M   HKNI+     C  ++  L V+      G++ + +   R        
Sbjct: 86  DLVSEMEMMKMIGKHKNIINLLGACT-QDGPLYVIVAYASKGNLREYLRARRPPGMEYSY 144
Query: 280 --------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIV 331
                   ++  K+++     +A G+++L      +RDL ++ +L+  +  + + D G+ 
Sbjct: 145 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA 204
Query: 332 TACKSVGEATEYETDG---YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAA 387
               ++ +  +  T+G    +W+APE +         T  S+V+SFG+++WE+ T G + 
Sbjct: 205 RDINNI-DYYKKTTNGRLPVKWMAPEALF----DRVYTHQSDVWSFGVLMWEIFTLGGSP 259
Query: 388 YAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNN 447
           Y    PV+    +   G R + P +C   L  +M  CW+  PS+RP F +++  L R   
Sbjct: 260 YPGI-PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318
Query: 448 ISNS 451
           ++ +
Sbjct: 319 LTTN 322

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 68/291 (23%), Positives = 136/291 (46%), Gaps = 39/291 (13%)
Query: 191 NLEFIDQIGPNSFKGV----------YKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTC 240
           +L+F+ Q+G  +F  V            G+ V ++KL+   + +  +FE   ++L+  + 
Sbjct: 14  HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK--SL 71
Query: 241 GHKNILQFYCVCVDE-NHGLCVVTKLMEGGSVNDLI-LKSRKLQTKEIIRIAIDVAEGIK 298
            H NI+++  VC       L ++ + +  GS+ D +   + ++   ++++    + +G++
Sbjct: 72  QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQICKGME 131
Query: 299 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR---WLAPEI 355
           +L      +RDL ++ IL++    V +GD G+        E  + +  G     W APE 
Sbjct: 132 YLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 191
Query: 356 IAGDPESVSETWMSNVYSFGMVIWEMVTG-EAAYAACSPVQAAVGIAACGL--------- 405
           +     SV+    S+V+SFG+V++E+ T  E + +  +     +G    G          
Sbjct: 192 LTESKFSVA----SDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 247
Query: 406 -----RPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNS 451
                R   P  CP  +  +M +CWNN+ ++RP F +   L LR + I ++
Sbjct: 248 LKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRD---LALRVDQIRDN 295

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/291 (23%), Positives = 137/291 (47%), Gaps = 39/291 (13%)
Query: 191 NLEFIDQIGPNSFKGV----------YKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTC 240
           +L+F+ Q+G  +F  V            G+ V ++KL+   + +  +FE   ++L+  + 
Sbjct: 12  HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK--SL 69
Query: 241 GHKNILQFYCVCVDE-NHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIK 298
            H NI+++  VC       L ++ + +  GS+ D + K + ++   ++++    + +G++
Sbjct: 70  QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGME 129
Query: 299 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR---WLAPEI 355
           +L      +R+L ++ IL++    V +GD G+        E  + +  G     W APE 
Sbjct: 130 YLGTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPES 189
Query: 356 IAGDPESVSETWMSNVYSFGMVIWEMVTG-EAAYAACSPVQAAVGIAACGL--------- 405
           +     SV+    S+V+SFG+V++E+ T  E + +  +     +G    G          
Sbjct: 190 LTESKFSVA----SDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 245
Query: 406 -----RPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNS 451
                R   P  CP  +  +M +CWNN+ ++RP F +   L LR + I ++
Sbjct: 246 LKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRD---LALRVDQIRDN 293

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/304 (23%), Positives = 135/304 (44%), Gaps = 40/304 (13%)
Query: 181 EIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD---------KGNAYEFELR 231
           E  +W    D L     +G  +F  V   + VGI+K K  +         K +A E +L 
Sbjct: 26  EDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS 85
Query: 232 KDLLEL----MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-------- 279
             + E+    M   HKNI+     C  ++  L V+      G++ + +   R        
Sbjct: 86  DLVSEMEMMKMIGKHKNIINLLGACT-QDGPLYVIVGYASKGNLREYLRARRPPGMEYSY 144
Query: 280 --------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIV 331
                   ++  K+++     +A G+++L      +RDL ++ +L+  +  + + D G+ 
Sbjct: 145 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA 204
Query: 332 TACKSVGEATEYETDG---YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAA 387
               ++ +  +  T+G    +W+APE +         T  S+V+SFG+++WE+ T G + 
Sbjct: 205 RDINNI-DYYKKTTNGRLPVKWMAPEALF----DRVYTHQSDVWSFGVLMWEIFTLGGSP 259
Query: 388 YAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNN 447
           Y    PV+    +   G R + P +C   L  +M  CW+  PS+RP F +++  L R   
Sbjct: 260 YPGI-PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318
Query: 448 ISNS 451
           ++ +
Sbjct: 319 LTTN 322

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/268 (26%), Positives = 122/268 (45%), Gaps = 31/268 (11%)
Query: 185 WLLNSDNLEFIDQIGPNSFKGVY-----KGKRVGIEKLK-GCDKGNAYEFELRKDLLELM 238
           W +  ++L+   ++G   F  V+     K  +V ++ +K G     A+  E       + 
Sbjct: 177 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANV----MK 232
Query: 239 TCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKS---RKLQTKEIIRIAIDVAE 295
           T  H  +++ + V   E   + ++T+ M  GS+ D  LKS    K    ++I  +  +AE
Sbjct: 233 TLQHDKLVKLHAVVTKEP--IYIITEFMAKGSLLDF-LKSDEGSKQPLPKLIDFSAQIAE 289
Query: 296 GIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEI 355
           G+ F+      +RDL +  IL+       + D G+                  +W APE 
Sbjct: 290 GMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVGAKFP---------IKWTAPEA 340
Query: 356 IAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCP 414
           I       S T  S+V+SFG+++ E+VT G   Y   S  +    +   G R   P++CP
Sbjct: 341 INFG----SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER-GYRMPRPENCP 395
Query: 415 QILKSLMIKCWNNSPSKRPQFSEIISLL 442
           + L ++M++CW N P +RP F  I S+L
Sbjct: 396 EELYNIMMRCWKNRPEERPTFEYIQSVL 423

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/276 (24%), Positives = 133/276 (48%), Gaps = 37/276 (13%)
Query: 191 NLEFIDQIGPNSFKGVYKGK-----------RVGIEKL-KGCDKGNAYEFELRKDLLELM 238
           N+  I  +G  +F  VY+G+           +V ++ L + C + +  +F +  + L + 
Sbjct: 58  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM--EALIIS 115
Query: 239 TCGHKNILQFYCVCVD-ENHGLCVVTKLMEGGSVNDLILKSRK-------LQTKEIIRIA 290
              H+NI++  C+ V  ++    ++ +LM GG +   + ++R        L   +++ +A
Sbjct: 116 KFNHQNIVR--CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 173
Query: 291 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG--- 347
            D+A G ++L ++   +RD+ ++  LL   G   +  +G     + +  A+ Y   G   
Sbjct: 174 RDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 233
Query: 348 --YRWLAPE-IIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAAC 403
              +W+ PE  + G   S ++TW     SFG+++WE+ + G   Y + S  Q  +     
Sbjct: 234 LPVKWMPPEAFMEGIFTSKTDTW-----SFGVLLWEIFSLGYMPYPSKS-NQEVLEFVTS 287
Query: 404 GLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEII 439
           G R + PK+CP  +  +M +CW + P  RP F+ I+
Sbjct: 288 GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIIL 323

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/276 (24%), Positives = 133/276 (48%), Gaps = 37/276 (13%)
Query: 191 NLEFIDQIGPNSFKGVYKGK-----------RVGIEKL-KGCDKGNAYEFELRKDLLELM 238
           N+  I  +G  +F  VY+G+           +V ++ L + C + +  +F +  + L + 
Sbjct: 32  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM--EALIIS 89
Query: 239 TCGHKNILQFYCVCVD-ENHGLCVVTKLMEGGSVNDLILKSRK-------LQTKEIIRIA 290
              H+NI++  C+ V  ++    ++ +LM GG +   + ++R        L   +++ +A
Sbjct: 90  KLNHQNIVR--CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 147
Query: 291 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG--- 347
            D+A G ++L ++   +RD+ ++  LL   G   +  +G     + +  A+ Y   G   
Sbjct: 148 RDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 207
Query: 348 --YRWLAPE-IIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAAC 403
              +W+ PE  + G   S ++TW     SFG+++WE+ + G   Y + S  Q  +     
Sbjct: 208 LPVKWMPPEAFMEGIFTSKTDTW-----SFGVLLWEIFSLGYMPYPSKS-NQEVLEFVTS 261
Query: 404 GLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEII 439
           G R + PK+CP  +  +M +CW + P  RP F+ I+
Sbjct: 262 GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIIL 297

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/265 (23%), Positives = 124/265 (46%), Gaps = 15/265 (5%)
Query: 182 IGRWLLNSDNLEFIDQIGPNSFKGVYKG--KRVGIEKLKGCDKGNAYEFE-LRKDLLELM 238
           + +W +   ++    ++G   +  VY+G  K+  +       K +  E E   K+   + 
Sbjct: 3   LDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMK 62
Query: 239 TCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEII--RIAIDVAEG 296
              H N++Q   VC  E     ++ + M  G++ D + +  + +   ++   +A  ++  
Sbjct: 63  EIKHPNLVQLLGVCTREP-PFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA 121
Query: 297 IKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY--RWLAPE 354
           +++L      +RDL ++  L+  +  V + D G+ +   +    T +    +  +W APE
Sbjct: 122 MEYLEKKNFIHRDLAARNCLVGENHLVKVADFGL-SRLMTGDTXTAHAGAKFPIKWTAPE 180
Query: 355 IIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDC 413
            +A +  S+     S+V++FG+++WE+ T G + Y    P Q    +     R E P+ C
Sbjct: 181 SLAYNKFSIK----SDVWAFGVLLWEIATYGMSPYPGIDPSQV-YELLEKDYRMERPEGC 235
Query: 414 PQILKSLMIKCWNNSPSKRPQFSEI 438
           P+ +  LM  CW  +PS RP F+EI
Sbjct: 236 PEKVYELMRACWQWNPSDRPSFAEI 260

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/304 (23%), Positives = 135/304 (44%), Gaps = 40/304 (13%)
Query: 181 EIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD---------KGNAYEFELR 231
           E  +W    D L     +G   F  V   + VGI+K K  +         K +A E +L 
Sbjct: 15  EDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS 74
Query: 232 KDLLEL----MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-------- 279
             + E+    M   HKNI+     C  ++  L V+ +    G++ + +   R        
Sbjct: 75  DLVSEMEMMKMIGKHKNIINLLGACT-QDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 133
Query: 280 --------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIV 331
                   ++  K+++     +A G+++L      +RDL ++ +L+  +  + + D G+ 
Sbjct: 134 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA 193
Query: 332 TACKSVGEATEYETDG---YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAA 387
               ++ +  +  T+G    +W+APE +         T  S+V+SFG+++WE+ T G + 
Sbjct: 194 RDINNI-DYYKKTTNGRLPVKWMAPEALF----DRVYTHQSDVWSFGVLMWEIFTLGGSP 248
Query: 388 YAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNN 447
           Y    PV+    +   G R + P +C   L  +M  CW+  PS+RP F +++  L R   
Sbjct: 249 YPGI-PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 307
Query: 448 ISNS 451
           ++ +
Sbjct: 308 LTTN 311

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/276 (24%), Positives = 133/276 (48%), Gaps = 37/276 (13%)
Query: 191 NLEFIDQIGPNSFKGVYKGK-----------RVGIEKL-KGCDKGNAYEFELRKDLLELM 238
           N+  I  +G  +F  VY+G+           +V ++ L + C + +  +F +  + L + 
Sbjct: 48  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM--EALIIS 105
Query: 239 TCGHKNILQFYCVCVD-ENHGLCVVTKLMEGGSVNDLILKSRK-------LQTKEIIRIA 290
              H+NI++  C+ V  ++    ++ +LM GG +   + ++R        L   +++ +A
Sbjct: 106 KFNHQNIVR--CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 163
Query: 291 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG--- 347
            D+A G ++L ++   +RD+ ++  LL   G   +  +G     + +  A+ Y   G   
Sbjct: 164 RDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 223
Query: 348 --YRWLAPE-IIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAAC 403
              +W+ PE  + G   S ++TW     SFG+++WE+ + G   Y + S  Q  +     
Sbjct: 224 LPVKWMPPEAFMEGIFTSKTDTW-----SFGVLLWEIFSLGYMPYPSKS-NQEVLEFVTS 277
Query: 404 GLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEII 439
           G R + PK+CP  +  +M +CW + P  RP F+ I+
Sbjct: 278 GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIIL 313

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/276 (24%), Positives = 133/276 (48%), Gaps = 37/276 (13%)
Query: 191 NLEFIDQIGPNSFKGVYKGK-----------RVGIEKL-KGCDKGNAYEFELRKDLLELM 238
           N+  I  +G  +F  VY+G+           +V ++ L + C + +  +F +  + L + 
Sbjct: 38  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM--EALIIS 95
Query: 239 TCGHKNILQFYCVCVD-ENHGLCVVTKLMEGGSVNDLILKSRK-------LQTKEIIRIA 290
              H+NI++  C+ V  ++    ++ +LM GG +   + ++R        L   +++ +A
Sbjct: 96  KFNHQNIVR--CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 153
Query: 291 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG--- 347
            D+A G ++L ++   +RD+ ++  LL   G   +  +G     + +  A+ Y   G   
Sbjct: 154 RDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 213
Query: 348 --YRWLAPE-IIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAAC 403
              +W+ PE  + G   S ++TW     SFG+++WE+ + G   Y + S  Q  +     
Sbjct: 214 LPVKWMPPEAFMEGIFTSKTDTW-----SFGVLLWEIFSLGYMPYPSKS-NQEVLEFVTS 267
Query: 404 GLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEII 439
           G R + PK+CP  +  +M +CW + P  RP F+ I+
Sbjct: 268 GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIIL 303

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/276 (24%), Positives = 133/276 (48%), Gaps = 37/276 (13%)
Query: 191 NLEFIDQIGPNSFKGVYKGK-----------RVGIEKL-KGCDKGNAYEFELRKDLLELM 238
           N+  I  +G  +F  VY+G+           +V ++ L + C + +  +F +  + L + 
Sbjct: 32  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM--EALIIS 89
Query: 239 TCGHKNILQFYCVCVD-ENHGLCVVTKLMEGGSVNDLILKSRK-------LQTKEIIRIA 290
              H+NI++  C+ V  ++    ++ +LM GG +   + ++R        L   +++ +A
Sbjct: 90  KFNHQNIVR--CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 147
Query: 291 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG--- 347
            D+A G ++L ++   +RD+ ++  LL   G   +  +G     + +  A+ Y   G   
Sbjct: 148 RDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 207
Query: 348 --YRWLAPE-IIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAAC 403
              +W+ PE  + G   S ++TW     SFG+++WE+ + G   Y + S  Q  +     
Sbjct: 208 LPVKWMPPEAFMEGIFTSKTDTW-----SFGVLLWEIFSLGYMPYPSKS-NQEVLEFVTS 261
Query: 404 GLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEII 439
           G R + PK+CP  +  +M +CW + P  RP F+ I+
Sbjct: 262 GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIIL 297

>pdb|1OEC|A Chain A, Fgfr2 Kinase Domain Length = 316

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/304 (23%), Positives = 135/304 (44%), Gaps = 40/304 (13%)
Query: 181 EIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD---------KGNAYEFELR 231
           E  +W    D L     +G   F  V   + VGI+K K  +         K +A E +L 
Sbjct: 18  EDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS 77
Query: 232 KDLLEL----MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-------- 279
             + E+    M   HKNI+     C  ++  L V+ +    G++ + +   R        
Sbjct: 78  DLVSEMEMMKMIGKHKNIINLLGACT-QDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 136
Query: 280 --------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIV 331
                   ++  K+++     +A G+++L      +RDL ++ +L+  +  + + D G+ 
Sbjct: 137 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA 196
Query: 332 TACKSVGEATEYETDG---YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAA 387
               ++ +  +  T+G    +W+APE +         T  S+V+SFG+++WE+ T G + 
Sbjct: 197 RDINNI-DYYKKTTNGRLPVKWMAPEALF----DRVYTHQSDVWSFGVLMWEIFTLGGSP 251
Query: 388 YAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNN 447
           Y    PV+    +   G R + P +C   L  +M  CW+  PS+RP F +++  L R   
Sbjct: 252 YPGI-PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 310
Query: 448 ISNS 451
           ++ +
Sbjct: 311 LTTN 314

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/304 (23%), Positives = 135/304 (44%), Gaps = 40/304 (13%)
Query: 181 EIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD---------KGNAYEFELR 231
           E  +W    D L     +G   F  V   + VGI+K K  +         K +A E +L 
Sbjct: 72  EDPKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLS 131
Query: 232 KDLLEL----MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-------- 279
             + E+    M   HKNI+     C  ++  L V+ +    G++ + +   R        
Sbjct: 132 DLVSEMEMMKMIGKHKNIINLLGACT-QDGPLYVIVEYASKGNLREYLRARRPPGMEYSY 190
Query: 280 --------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIV 331
                   ++  K+++     +A G+++L      +RDL ++ +L+  +  + + D G+ 
Sbjct: 191 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA 250
Query: 332 TACKSVGEATEYETDG---YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAA 387
               ++ +  +  T+G    +W+APE +         T  S+V+SFG+++WE+ T G + 
Sbjct: 251 RDINNI-DYYKKTTNGRLPVKWMAPEALF----DRVYTHQSDVWSFGVLMWEIFTLGGSP 305
Query: 388 YAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNN 447
           Y    PV+    +   G R + P +C   L  +M  CW+  PS+RP F +++  L R   
Sbjct: 306 YPGI-PVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 364
Query: 448 ISNS 451
           ++ +
Sbjct: 365 LTTN 368

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/276 (24%), Positives = 133/276 (48%), Gaps = 37/276 (13%)
Query: 191 NLEFIDQIGPNSFKGVYKGK-----------RVGIEKL-KGCDKGNAYEFELRKDLLELM 238
           N+  I  +G  +F  VY+G+           +V ++ L + C + +  +F +  + L + 
Sbjct: 46  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM--EALIIS 103
Query: 239 TCGHKNILQFYCVCVD-ENHGLCVVTKLMEGGSVNDLILKSRK-------LQTKEIIRIA 290
              H+NI++  C+ V  ++    ++ +LM GG +   + ++R        L   +++ +A
Sbjct: 104 KLNHQNIVR--CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 161
Query: 291 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG--- 347
            D+A G ++L ++   +RD+ ++  LL   G   +  +G     + +  A+ Y   G   
Sbjct: 162 RDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 221
Query: 348 --YRWLAPE-IIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAAC 403
              +W+ PE  + G   S ++TW     SFG+++WE+ + G   Y + S  Q  +     
Sbjct: 222 LPVKWMPPEAFMEGIFTSKTDTW-----SFGVLLWEIFSLGYMPYPSKS-NQEVLEFVTS 275
Query: 404 GLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEII 439
           G R + PK+CP  +  +M +CW + P  RP F+ I+
Sbjct: 276 GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIIL 311

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/276 (24%), Positives = 133/276 (48%), Gaps = 37/276 (13%)
Query: 191 NLEFIDQIGPNSFKGVYKGK-----------RVGIEKL-KGCDKGNAYEFELRKDLLELM 238
           N+  I  +G  +F  VY+G+           +V ++ L + C + +  +F +  + L + 
Sbjct: 31  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM--EALIIS 88
Query: 239 TCGHKNILQFYCVCVD-ENHGLCVVTKLMEGGSVNDLILKSRK-------LQTKEIIRIA 290
              H+NI++  C+ V  ++    ++ +LM GG +   + ++R        L   +++ +A
Sbjct: 89  KFNHQNIVR--CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 146
Query: 291 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG--- 347
            D+A G ++L ++   +RD+ ++  LL   G   +  +G     + +  A+ Y   G   
Sbjct: 147 RDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 206
Query: 348 --YRWLAPE-IIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAAC 403
              +W+ PE  + G   S ++TW     SFG+++WE+ + G   Y + S  Q  +     
Sbjct: 207 LPVKWMPPEAFMEGIFTSKTDTW-----SFGVLLWEIFSLGYMPYPSKS-NQEVLEFVTS 260
Query: 404 GLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEII 439
           G R + PK+CP  +  +M +CW + P  RP F+ I+
Sbjct: 261 GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIIL 296

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/276 (24%), Positives = 133/276 (48%), Gaps = 37/276 (13%)
Query: 191 NLEFIDQIGPNSFKGVYKGK-----------RVGIEKL-KGCDKGNAYEFELRKDLLELM 238
           N+  I  +G  +F  VY+G+           +V ++ L + C + +  +F +  + L + 
Sbjct: 46  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM--EALIIS 103
Query: 239 TCGHKNILQFYCVCVD-ENHGLCVVTKLMEGGSVNDLILKSRK-------LQTKEIIRIA 290
              H+NI++  C+ V  ++    ++ +LM GG +   + ++R        L   +++ +A
Sbjct: 104 KFNHQNIVR--CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 161
Query: 291 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG--- 347
            D+A G ++L ++   +RD+ ++  LL   G   +  +G     + +  A+ Y   G   
Sbjct: 162 RDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 221
Query: 348 --YRWLAPE-IIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAAC 403
              +W+ PE  + G   S ++TW     SFG+++WE+ + G   Y + S  Q  +     
Sbjct: 222 LPVKWMPPEAFMEGIFTSKTDTW-----SFGVLLWEIFSLGYMPYPSKS-NQEVLEFVTS 275
Query: 404 GLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEII 439
           G R + PK+CP  +  +M +CW + P  RP F+ I+
Sbjct: 276 GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIIL 311

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/276 (24%), Positives = 133/276 (48%), Gaps = 37/276 (13%)
Query: 191 NLEFIDQIGPNSFKGVYKGK-----------RVGIEKL-KGCDKGNAYEFELRKDLLELM 238
           N+  I  +G  +F  VY+G+           +V ++ L + C + +  +F +  + L + 
Sbjct: 31  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM--EALIIS 88
Query: 239 TCGHKNILQFYCVCVD-ENHGLCVVTKLMEGGSVNDLILKSRK-------LQTKEIIRIA 290
              H+NI++  C+ V  ++    ++ +LM GG +   + ++R        L   +++ +A
Sbjct: 89  KFNHQNIVR--CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 146
Query: 291 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG--- 347
            D+A G ++L ++   +RD+ ++  LL   G   +  +G     + +  A+ Y   G   
Sbjct: 147 RDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 206
Query: 348 --YRWLAPE-IIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAAC 403
              +W+ PE  + G   S ++TW     SFG+++WE+ + G   Y + S  Q  +     
Sbjct: 207 LPVKWMPPEAFMEGIFTSKTDTW-----SFGVLLWEIFSLGYMPYPSKS-NQEVLEFVTS 260
Query: 404 GLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEII 439
           G R + PK+CP  +  +M +CW + P  RP F+ I+
Sbjct: 261 GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIIL 296

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/276 (24%), Positives = 133/276 (48%), Gaps = 37/276 (13%)
Query: 191 NLEFIDQIGPNSFKGVYKGK-----------RVGIEKL-KGCDKGNAYEFELRKDLLELM 238
           N+  I  +G  +F  VY+G+           +V ++ L + C + +  +F +  + L + 
Sbjct: 32  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM--EALIIS 89
Query: 239 TCGHKNILQFYCVCVD-ENHGLCVVTKLMEGGSVNDLILKSRK-------LQTKEIIRIA 290
              H+NI++  C+ V  ++    ++ +LM GG +   + ++R        L   +++ +A
Sbjct: 90  KFNHQNIVR--CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 147
Query: 291 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG--- 347
            D+A G ++L ++   +RD+ ++  LL   G   +  +G     + +  A+ Y   G   
Sbjct: 148 RDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAM 207
Query: 348 --YRWLAPE-IIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAAC 403
              +W+ PE  + G   S ++TW     SFG+++WE+ + G   Y + S  Q  +     
Sbjct: 208 LPVKWMPPEAFMEGIFTSKTDTW-----SFGVLLWEIFSLGYMPYPSKS-NQEVLEFVTS 261
Query: 404 GLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEII 439
           G R + PK+CP  +  +M +CW + P  RP F+ I+
Sbjct: 262 GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIIL 297

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/276 (24%), Positives = 133/276 (48%), Gaps = 37/276 (13%)
Query: 191 NLEFIDQIGPNSFKGVYKGK-----------RVGIEKL-KGCDKGNAYEFELRKDLLELM 238
           N+  I  +G  +F  VY+G+           +V ++ L + C + +  +F +  + L + 
Sbjct: 23  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM--EALIIS 80
Query: 239 TCGHKNILQFYCVCVD-ENHGLCVVTKLMEGGSVNDLILKSRK-------LQTKEIIRIA 290
              H+NI++  C+ V  ++    ++ +LM GG +   + ++R        L   +++ +A
Sbjct: 81  KFNHQNIVR--CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 138
Query: 291 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG--- 347
            D+A G ++L ++   +RD+ ++  LL   G   +  +G     + +  A+ Y   G   
Sbjct: 139 RDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 198
Query: 348 --YRWLAPE-IIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAAC 403
              +W+ PE  + G   S ++TW     SFG+++WE+ + G   Y + S  Q  +     
Sbjct: 199 LPVKWMPPEAFMEGIFTSKTDTW-----SFGVLLWEIFSLGYMPYPSKS-NQEVLEFVTS 252
Query: 404 GLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEII 439
           G R + PK+CP  +  +M +CW + P  RP F+ I+
Sbjct: 253 GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIIL 288

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/248 (26%), Positives = 118/248 (47%), Gaps = 25/248 (10%)
Query: 209 GKR---VGIEKLKGCDKGNAYEFELRKDLLE----LMTCGHKNILQFYCVCVDENHGLCV 261
           GKR   V I+ LK     + Y  + R+D L     +    H N++    V V ++  + +
Sbjct: 32  GKREIFVAIKTLK-----SGYTEKQRRDFLSEASIMGQFDHPNVIHLEGV-VTKSTPVMI 85
Query: 262 VTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH 320
           +T+ ME GS++  + ++  +    +++ +   +A G+K+L D    +R L ++ IL++ +
Sbjct: 86  ITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRALAARNILVNSN 145
Query: 321 GNVCLGDMGIVTACKSVGEATEYETD-----GYRWLAPEIIAGDPESVSETWMSNVYSFG 375
               + D G+    +       Y +        RW APE I    +    T  S+V+S+G
Sbjct: 146 LVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAI----QYRKFTSASDVWSYG 201
Query: 376 MVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQ 434
           +V+WE+++ GE  Y   +  Q  +       R   P DCP  L  LM+ CW    + RP+
Sbjct: 202 IVMWEVMSYGERPYWDMTN-QDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPK 260
Query: 435 FSEIISLL 442
           F +I++ L
Sbjct: 261 FGQIVNTL 268

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 71/295 (24%), Positives = 123/295 (41%), Gaps = 40/295 (13%)
Query: 181 EIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD-------KGNAYEFELRKD 233
           +  +W    D L+    +G  +F  V +    GI+K   C        K  A   E R  
Sbjct: 9   DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRAL 68
Query: 234 LLEL---MTCGHK-NILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK--------- 280
           + EL   +  GH  N++     C      L V+T+  + G+++  +   R          
Sbjct: 69  MSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAP 128
Query: 281 -------LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTA 333
                  L  + +I  +  VA+G++FL      +RDL ++ ILL     V + D G+   
Sbjct: 129 EDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA-- 186
Query: 334 CKSVGEATEYETDG-----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAA 387
            + + +  +Y   G      +W+APE I     ++     S+V+SFG+++WE+ + G + 
Sbjct: 187 -RDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQ----SDVWSFGVLLWEIFSLGASP 241
Query: 388 YAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
           Y      +        G R   P      +   M+ CW+  PS+RP FSE++  L
Sbjct: 242 YPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 296

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 65/252 (25%), Positives = 115/252 (45%), Gaps = 24/252 (9%)
Query: 209 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHG-LCVVTKLME 267
           G+ V ++ LK  D G  +    ++++  L T  H++I+++   C D     L +V + + 
Sbjct: 60  GEMVAVKALKA-DAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVP 118
Query: 268 GGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGD 327
            GS+ D  L    +   +++  A  + EG+ +L+     +RDL ++ +LLD    V +GD
Sbjct: 119 LGSLRD-YLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGD 177
Query: 328 MGIVTACKSVGEATEYETDG---YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTG 384
            G+  A     E      DG     W APE +    +     + S+V+SFG+ ++E++T 
Sbjct: 178 FGLAKAVPEGHEXYRVREDGDSPVFWYAPECL----KEYKFYYASDVWSFGVTLYELLTH 233
Query: 385 -EAAYAACSPVQAAVGIAAC-------------GLRPEIPKDCPQILKSLMIKCWNNSPS 430
            +++ +  +     +GIA               G R   P  CP  +  LM  CW    S
Sbjct: 234 CDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEAS 293
Query: 431 KRPQFSEIISLL 442
            RP F  +I +L
Sbjct: 294 FRPTFENLIPIL 305

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 71/295 (24%), Positives = 123/295 (41%), Gaps = 40/295 (13%)
Query: 181 EIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD-------KGNAYEFELRKD 233
           +  +W    D L+    +G  +F  V +    GI+K   C        K  A   E R  
Sbjct: 9   DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRAL 68
Query: 234 LLEL---MTCGHK-NILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK--------- 280
           + EL   +  GH  N++     C      L V+T+  + G+++  +   R          
Sbjct: 69  MSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAP 128
Query: 281 -------LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTA 333
                  L  + +I  +  VA+G++FL      +RDL ++ ILL     V + D G+   
Sbjct: 129 EDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA-- 186
Query: 334 CKSVGEATEYETDG-----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAA 387
            + + +  +Y   G      +W+APE I     ++     S+V+SFG+++WE+ + G + 
Sbjct: 187 -RDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQ----SDVWSFGVLLWEIFSLGASP 241
Query: 388 YAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
           Y      +        G R   P      +   M+ CW+  PS+RP FSE++  L
Sbjct: 242 YPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 296

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 67/276 (24%), Positives = 132/276 (47%), Gaps = 37/276 (13%)
Query: 191 NLEFIDQIGPNSFKGVYKGK-----------RVGIEKL-KGCDKGNAYEFELRKDLLELM 238
           N+  I  +G  +F  VY+G+           +V ++ L + C + +  +F +  + L + 
Sbjct: 72  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM--EALIIS 129
Query: 239 TCGHKNILQFYCVCVD-ENHGLCVVTKLMEGGSVNDLILKSRK-------LQTKEIIRIA 290
              H+NI++  C+ V  ++    ++ +LM GG +   + ++R        L   +++ +A
Sbjct: 130 KFNHQNIVR--CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 187
Query: 291 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG--- 347
            D+A G ++L ++   +RD+ ++  LL   G   +  +G     + +  A  Y   G   
Sbjct: 188 RDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAM 247
Query: 348 --YRWLAPE-IIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAAC 403
              +W+ PE  + G   S ++TW     SFG+++WE+ + G   Y + S  Q  +     
Sbjct: 248 LPVKWMPPEAFMEGIFTSKTDTW-----SFGVLLWEIFSLGYMPYPSKS-NQEVLEFVTS 301
Query: 404 GLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEII 439
           G R + PK+CP  +  +M +CW + P  RP F+ I+
Sbjct: 302 GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIIL 337

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 68/274 (24%), Positives = 129/274 (47%), Gaps = 33/274 (12%)
Query: 191 NLEFIDQIGPNSFKGVYKGKRVGI----EKLKGCDKGNAYEFELRKDLLELMTC------ 240
           N+  I  +G  +F  VY+G+  G+      L+   K     +  + +L  LM        
Sbjct: 46  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKF 105
Query: 241 GHKNILQFYCVCVD-ENHGLCVVTKLMEGGSVNDLILKSRK-------LQTKEIIRIAID 292
            H+NI++  C+ V  ++    ++ +LM GG +   + ++R        L   +++ +A D
Sbjct: 106 NHQNIVR--CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARD 163
Query: 293 VAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----- 347
           +A G ++L ++   +RD+ ++  LL   G   +  +G     + +  A+ Y   G     
Sbjct: 164 IACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLP 223
Query: 348 YRWLAPE-IIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGL 405
            +W+ PE  + G   S ++TW     SFG+++WE+ + G   Y + S  Q  +     G 
Sbjct: 224 VKWMPPEAFMEGIFTSKTDTW-----SFGVLLWEIFSLGYMPYPSKS-NQEVLEFVTSGG 277
Query: 406 RPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEII 439
           R + PK+CP  +  +M +CW + P  RP F+ I+
Sbjct: 278 RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIIL 311

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 67/276 (24%), Positives = 132/276 (47%), Gaps = 37/276 (13%)
Query: 191 NLEFIDQIGPNSFKGVYKGK-----------RVGIEKL-KGCDKGNAYEFELRKDLLELM 238
           N+  I  +G  +F  VY+G+           +V ++ L + C + +  +F +  + L + 
Sbjct: 49  NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLM--EALIIS 106
Query: 239 TCGHKNILQFYCVCVD-ENHGLCVVTKLMEGGSVNDLILKSRK-------LQTKEIIRIA 290
              H+NI++  C+ V  ++    ++ +LM GG +   + ++R        L   +++ +A
Sbjct: 107 KFNHQNIVR--CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 164
Query: 291 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG--- 347
            D+A G ++L ++   +RD+ ++  LL   G   +  +G     + +  A  Y   G   
Sbjct: 165 RDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAM 224
Query: 348 --YRWLAPE-IIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAAC 403
              +W+ PE  + G   S ++TW     SFG+++WE+ + G   Y + S  Q  +     
Sbjct: 225 LPVKWMPPEAFMEGIFTSKTDTW-----SFGVLLWEIFSLGYMPYPSKS-NQEVLEFVTS 278
Query: 404 GLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEII 439
           G R + PK+CP  +  +M +CW + P  RP F+ I+
Sbjct: 279 GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIIL 314

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 63/269 (23%), Positives = 124/269 (46%), Gaps = 15/269 (5%)
Query: 178 GGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKG--KRVGIEKLKGCDKGNAYEFE-LRKDL 234
           G     +W +   ++    ++G   +  VY+G  K+  +       K +  E E   K+ 
Sbjct: 1   GSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEA 60
Query: 235 LELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEII--RIAID 292
             +    H N++Q   VC  E     ++T+ M  G++ D + +  + +   ++   +A  
Sbjct: 61  AVMKEIKHPNLVQLLGVCTREP-PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ 119
Query: 293 VAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY--RW 350
           ++  +++L      +RDL ++  L+  +  V + D G+ +   +    T +    +  +W
Sbjct: 120 ISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGL-SRLMTGDTYTAHAGAKFPIKW 178
Query: 351 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEI 409
            APE +A +  S+     S+V++FG+++WE+ T G + Y      Q    +     R E 
Sbjct: 179 TAPESLAYNKFSIK----SDVWAFGVLLWEIATYGMSPYPGIDLSQV-YELLEKDYRMER 233
Query: 410 PKDCPQILKSLMIKCWNNSPSKRPQFSEI 438
           P+ CP+ +  LM  CW  +PS RP F+EI
Sbjct: 234 PEGCPEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 63/269 (23%), Positives = 124/269 (46%), Gaps = 15/269 (5%)
Query: 178 GGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKG--KRVGIEKLKGCDKGNAYEFE-LRKDL 234
           G     +W +   ++    ++G   +  VY+G  K+  +       K +  E E   K+ 
Sbjct: 14  GSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEA 73
Query: 235 LELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEII--RIAID 292
             +    H N++Q   VC  E     ++T+ M  G++ D + +  + +   ++   +A  
Sbjct: 74  AVMKEIKHPNLVQLLGVCTREP-PFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQ 132
Query: 293 VAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY--RW 350
           ++  +++L      +RDL ++  L+  +  V + D G+ +   +    T +    +  +W
Sbjct: 133 ISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGL-SRLMTGDTYTAHAGAKFPIKW 191
Query: 351 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEI 409
            APE +A +  S+     S+V++FG+++WE+ T G + Y      Q    +     R E 
Sbjct: 192 TAPESLAYNKFSIK----SDVWAFGVLLWEIATYGMSPYPGIDLSQV-YELLEKDYRMER 246
Query: 410 PKDCPQILKSLMIKCWNNSPSKRPQFSEI 438
           P+ CP+ +  LM  CW  +PS RP F+EI
Sbjct: 247 PEGCPEKVYELMRACWQWNPSDRPSFAEI 275

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 63/269 (23%), Positives = 124/269 (46%), Gaps = 15/269 (5%)
Query: 178 GGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKG--KRVGIEKLKGCDKGNAYEFE-LRKDL 234
           G     +W +   ++    ++G   +  VY+G  K+  +       K +  E E   K+ 
Sbjct: 1   GSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEA 60
Query: 235 LELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEII--RIAID 292
             +    H N++Q   VC  E     ++T+ M  G++ D + +  + +   ++   +A  
Sbjct: 61  AVMKEIKHPNLVQLLGVCTREP-PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ 119
Query: 293 VAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY--RW 350
           ++  +++L      +RDL ++  L+  +  V + D G+ +   +    T +    +  +W
Sbjct: 120 ISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGL-SRLMTGDTYTAHAGAKFPIKW 178
Query: 351 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEI 409
            APE +A +  S+     S+V++FG+++WE+ T G + Y      Q    +     R E 
Sbjct: 179 TAPESLAYNKFSIK----SDVWAFGVLLWEIATYGMSPYPGIDLSQV-YELLEKDYRMER 233
Query: 410 PKDCPQILKSLMIKCWNNSPSKRPQFSEI 438
           P+ CP+ +  LM  CW  +PS RP F+EI
Sbjct: 234 PEGCPEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 76/317 (23%), Positives = 134/317 (42%), Gaps = 64/317 (20%)
Query: 167 VSVDEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD----- 221
           +SVD ++ +     E  +W     NL     +G   F  V K     ++   G       
Sbjct: 5   LSVDAFKIL-----EDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVK 59
Query: 222 --KGNAYEFELRKDLLE---LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL 276
             K NA   ELR  L E   L    H ++++ Y  C  ++  L ++ +  + GS+   + 
Sbjct: 60  MLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGAC-SQDGPLLLIVEYAKYGSLRGFLR 118
Query: 277 KSRK------------------------LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNS 312
           +SRK                        L   ++I  A  +++G+++L +  + +RDL +
Sbjct: 119 ESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMSLVHRDLAA 178
Query: 313 QRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY----------RWLAPEIIAGDPES 362
           + IL+     + + D G+            YE D            +W+A E +    + 
Sbjct: 179 RNILVAEGRKMKISDFGLSRDV--------YEEDSXVKRSQGRIPVKWMAIESLF---DH 227
Query: 363 VSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLM 421
           +  T  S+V+SFG+++WE+VT G   Y    P +    +   G R E P +C + +  LM
Sbjct: 228 IYTT-QSDVWSFGVLLWEIVTLGGNPYPGIPP-ERLFNLLKTGHRMERPDNCSEEMYRLM 285
Query: 422 IKCWNNSPSKRPQFSEI 438
           ++CW   P KRP F++I
Sbjct: 286 LQCWKQEPDKRPVFADI 302

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 68/288 (23%), Positives = 121/288 (42%), Gaps = 36/288 (12%)
Query: 184 RWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEK--------LKGCDKGNAY--EFELRKD 233
           +W    D L     +G  +F  V +    GI+K        +K   +G  +     L  +
Sbjct: 21  KWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSE 80
Query: 234 LLELMTCGHK-NILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK------------ 280
           L  L+  GH  N++     C      L V+ +  + G+++  +   R             
Sbjct: 81  LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDF 140
Query: 281 LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA 340
           L  + +I  +  VA+G++FL      +RDL ++ ILL     V + D G+    + + + 
Sbjct: 141 LTLEHLIXYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKIXDFGL---ARDIYKD 197
Query: 341 TEYETDG-----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPV 394
            +Y   G      +W+APE I     ++     S+V+SFG+++WE+ + G + Y      
Sbjct: 198 PDYVRKGDARLPLKWMAPETIFDRVYTIQ----SDVWSFGVLLWEIFSLGASPYPGVKID 253
Query: 395 QAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
           +        G R   P      +   M+ CW+  PS+RP FSE++  L
Sbjct: 254 EEFXRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 301

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 76/317 (23%), Positives = 134/317 (42%), Gaps = 64/317 (20%)
Query: 167 VSVDEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD----- 221
           +SVD ++ +     E  +W     NL     +G   F  V K     ++   G       
Sbjct: 5   LSVDAFKIL-----EDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVK 59
Query: 222 --KGNAYEFELRKDLLE---LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL 276
             K NA   ELR  L E   L    H ++++ Y  C  ++  L ++ +  + GS+   + 
Sbjct: 60  MLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGAC-SQDGPLLLIVEYAKYGSLRGFLR 118
Query: 277 KSRK------------------------LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNS 312
           +SRK                        L   ++I  A  +++G+++L +  + +RDL +
Sbjct: 119 ESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAA 178
Query: 313 QRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY----------RWLAPEIIAGDPES 362
           + IL+     + + D G+            YE D            +W+A E +    + 
Sbjct: 179 RNILVAEGRKMKISDFGLSRDV--------YEEDSXVKRSQGRIPVKWMAIESLF---DH 227
Query: 363 VSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLM 421
           +  T  S+V+SFG+++WE+VT G   Y    P +    +   G R E P +C + +  LM
Sbjct: 228 IYTT-QSDVWSFGVLLWEIVTLGGNPYPGIPP-ERLFNLLKTGHRMERPDNCSEEMYRLM 285
Query: 422 IKCWNNSPSKRPQFSEI 438
           ++CW   P KRP F++I
Sbjct: 286 LQCWKQEPDKRPVFADI 302

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/263 (23%), Positives = 123/263 (46%), Gaps = 15/263 (5%)
Query: 184 RWLLNSDNLEFIDQIGPNSFKGVYKG--KRVGIEKLKGCDKGNAYEFE-LRKDLLELMTC 240
           +W +   ++    ++G   +  VY+G  K+  +       K +  E E   K+   +   
Sbjct: 12  KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI 71
Query: 241 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEII--RIAIDVAEGIK 298
            H N++Q   VC  E     ++T+ M  G++ D + +  + +   ++   +A  ++  ++
Sbjct: 72  KHPNLVQLLGVCTREP-PFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAME 130
Query: 299 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY--RWLAPEII 356
           +L      +RDL ++  L+  +  V + D G+ +   +    T +    +  +W APE +
Sbjct: 131 YLEKKNFIHRDLAARNCLVGENHLVKVADFGL-SRLMTGDTYTAHAGAKFPIKWTAPESL 189
Query: 357 AGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ 415
           A +  S+     S+V++FG+++WE+ T G + Y      Q    +     R E P+ CP+
Sbjct: 190 AYNKFSIK----SDVWAFGVLLWEIATYGMSPYPGIDLSQV-YELLEKDYRMERPEGCPE 244
Query: 416 ILKSLMIKCWNNSPSKRPQFSEI 438
            +  LM  CW  +PS RP F+EI
Sbjct: 245 KVYELMRACWQWNPSDRPSFAEI 267

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 70/260 (26%), Positives = 118/260 (45%), Gaps = 33/260 (12%)
Query: 212 VGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSV 271
           V ++ LK        +F    +LL      H++I++FY VCV E   L +V + M+ G +
Sbjct: 46  VAVKTLKDASDNARKDFHREAELLT--NLQHEHIVKFYGVCV-EGDPLIMVFEYMKHGDL 102
Query: 272 N--------DLILKSR-----KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLD 318
           N        D +L +      +L   +++ IA  +A G+ +L      +RDL ++  L+ 
Sbjct: 103 NKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVG 162
Query: 319 RHGNVCLGDMGIVTACKSVGEATEYETDGY-----RWLAPEIIAGDPESVSETWMSNVYS 373
            +  V +GD G+    + V     Y   G+     RW+ PE I     +      S+V+S
Sbjct: 163 ENLLVKIGDFGM---SRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTE----SDVWS 215
Query: 374 FGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKR 432
            G+V+WE+ T G+  +   S  +    I   G   + P+ CPQ +  LM+ CW   P  R
Sbjct: 216 LGVVLWEIFTYGKQPWYQLSNNEVIECITQ-GRVLQRPRTCPQEVYELMLGCWQREPHMR 274
Query: 433 PQFSEIISLLLRTNNISNSS 452
                I +LL    N++ +S
Sbjct: 275 KNIKGIHTLL---QNLAKAS 291

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/263 (23%), Positives = 123/263 (46%), Gaps = 15/263 (5%)
Query: 184 RWLLNSDNLEFIDQIGPNSFKGVYKG--KRVGIEKLKGCDKGNAYEFE-LRKDLLELMTC 240
           +W +   ++    ++G   +  VY+G  K+  +       K +  E E   K+   +   
Sbjct: 12  KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI 71
Query: 241 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEII--RIAIDVAEGIK 298
            H N++Q   VC  E     ++T+ M  G++ D + +  + +   ++   +A  ++  ++
Sbjct: 72  KHPNLVQLLGVCTREP-PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAME 130
Query: 299 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY--RWLAPEII 356
           +L      +RDL ++  L+  +  V + D G+ +   +    T +    +  +W APE +
Sbjct: 131 YLEKKNFIHRDLAARNCLVGENHLVKVADFGL-SRLMTGDTYTAHAGAKFPIKWTAPESL 189
Query: 357 AGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ 415
           A +  S+     S+V++FG+++WE+ T G + Y      Q    +     R E P+ CP+
Sbjct: 190 AYNKFSIK----SDVWAFGVLLWEIATYGMSPYPGIDLSQV-YELLEKDYRMERPEGCPE 244
Query: 416 ILKSLMIKCWNNSPSKRPQFSEI 438
            +  LM  CW  +PS RP F+EI
Sbjct: 245 KVYELMRACWQWNPSDRPSFAEI 267

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/263 (23%), Positives = 123/263 (46%), Gaps = 15/263 (5%)
Query: 184 RWLLNSDNLEFIDQIGPNSFKGVYKG--KRVGIEKLKGCDKGNAYEFE-LRKDLLELMTC 240
           +W +   ++    ++G   +  VY+G  K+  +       K +  E E   K+   +   
Sbjct: 12  KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI 71
Query: 241 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEII--RIAIDVAEGIK 298
            H N++Q   VC  E     ++T+ M  G++ D + +  + +   ++   +A  ++  ++
Sbjct: 72  KHPNLVQLLGVCTREP-PFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAME 130
Query: 299 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY--RWLAPEII 356
           +L      +RDL ++  L+  +  V + D G+ +   +    T +    +  +W APE +
Sbjct: 131 YLEKKNFIHRDLAARNCLVGENHLVKVADFGL-SRLMTGDTXTAHAGAKFPIKWTAPESL 189
Query: 357 AGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ 415
           A +  S+     S+V++FG+++WE+ T G + Y      Q    +     R E P+ CP+
Sbjct: 190 AYNKFSIK----SDVWAFGVLLWEIATYGMSPYPGIDLSQV-YELLEKDYRMERPEGCPE 244
Query: 416 ILKSLMIKCWNNSPSKRPQFSEI 438
            +  LM  CW  +PS RP F+EI
Sbjct: 245 KVYELMRACWQWNPSDRPSFAEI 267

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/262 (26%), Positives = 121/262 (46%), Gaps = 16/262 (6%)
Query: 192 LEFIDQIGPNSFKGVYKGKRVGIEKL---KGCDKGNAYEFELRKDLLELMT-CGHKNILQ 247
            E ++ +G  ++  VYKG+ V   +L   K  D     E E+++++  L     H+NI  
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 85
Query: 248 FYCVCVDEN-----HGLCVVTKLMEGGSVNDLI--LKSRKLQTKEIIRIAIDVAEGIKFL 300
           +Y   + +N       L +V +    GSV DLI   K   L+ + I  I  ++  G+  L
Sbjct: 86  YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHL 145
Query: 301 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC-KSVGEATEYETDGYRWLAPEIIAGD 359
           + H V +RD+  Q +LL  +  V L D G+     ++VG    +    Y W+APE+IA D
Sbjct: 146 HQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPY-WMAPEVIACD 204
Query: 360 --PESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQIL 417
             P++  + + S+++S G+   EM  G        P++A   I          K   +  
Sbjct: 205 ENPDATYD-FKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWSKKF 263
Query: 418 KSLMIKCWNNSPSKRPQFSEII 439
           +S +  C   + S+RP   +++
Sbjct: 264 QSFIESCLVKNHSQRPATEQLM 285

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/263 (23%), Positives = 123/263 (46%), Gaps = 15/263 (5%)
Query: 184 RWLLNSDNLEFIDQIGPNSFKGVYKG--KRVGIEKLKGCDKGNAYEFE-LRKDLLELMTC 240
           +W +   ++    ++G   +  VY+G  K+  +       K +  E E   K+   +   
Sbjct: 9   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI 68
Query: 241 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEII--RIAIDVAEGIK 298
            H N++Q   VC  E     ++T+ M  G++ D + +  + +   ++   +A  ++  ++
Sbjct: 69  KHPNLVQLLGVCTREP-PFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAME 127
Query: 299 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY--RWLAPEII 356
           +L      +RDL ++  L+  +  V + D G+ +   +    T +    +  +W APE +
Sbjct: 128 YLEKKNFIHRDLAARNCLVGENHLVKVADFGL-SRLMTGDTYTAHAGAKFPIKWTAPESL 186
Query: 357 AGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ 415
           A +  S+     S+V++FG+++WE+ T G + Y      Q    +     R E P+ CP+
Sbjct: 187 AYNKFSIK----SDVWAFGVLLWEIATYGMSPYPGIDLSQV-YELLEKDYRMERPEGCPE 241
Query: 416 ILKSLMIKCWNNSPSKRPQFSEI 438
            +  LM  CW  +PS RP F+EI
Sbjct: 242 KVYELMRACWQWNPSDRPSFAEI 264

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/263 (23%), Positives = 123/263 (46%), Gaps = 15/263 (5%)
Query: 184 RWLLNSDNLEFIDQIGPNSFKGVYKG--KRVGIEKLKGCDKGNAYEFE-LRKDLLELMTC 240
           +W +   ++    ++G   +  VY+G  K+  +       K +  E E   K+   +   
Sbjct: 12  KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI 71
Query: 241 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEII--RIAIDVAEGIK 298
            H N++Q   VC  E     ++T+ M  G++ D + +  + +   ++   +A  ++  ++
Sbjct: 72  KHPNLVQLLGVCTREP-PFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAME 130
Query: 299 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY--RWLAPEII 356
           +L      +RDL ++  L+  +  V + D G+ +   +    T +    +  +W APE +
Sbjct: 131 YLEKKNFIHRDLAARNCLVGENHLVKVADFGL-SRLMTGDTYTAHAGAKFPIKWTAPESL 189
Query: 357 AGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ 415
           A +  S+     S+V++FG+++WE+ T G + Y      Q    +     R E P+ CP+
Sbjct: 190 AYNKFSIK----SDVWAFGVLLWEIATYGMSPYPGIDLSQV-YELLEKDYRMERPEGCPE 244
Query: 416 ILKSLMIKCWNNSPSKRPQFSEI 438
            +  LM  CW  +PS RP F+EI
Sbjct: 245 KVYELMRACWQWNPSDRPSFAEI 267

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/263 (23%), Positives = 123/263 (46%), Gaps = 15/263 (5%)
Query: 184 RWLLNSDNLEFIDQIGPNSFKGVYKG--KRVGIEKLKGCDKGNAYEFE-LRKDLLELMTC 240
           +W +   ++    ++G   +  VY+G  K+  +       K +  E E   K+   +   
Sbjct: 9   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI 68
Query: 241 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEII--RIAIDVAEGIK 298
            H N++Q   VC  E     ++T+ M  G++ D + +  + +   ++   +A  ++  ++
Sbjct: 69  KHPNLVQLLGVCTREP-PFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAME 127
Query: 299 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY--RWLAPEII 356
           +L      +RDL ++  L+  +  V + D G+ +   +    T +    +  +W APE +
Sbjct: 128 YLEKKNFIHRDLAARNCLVGENHLVKVADFGL-SRLMTGDTYTAHAGAKFPIKWTAPESL 186
Query: 357 AGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ 415
           A +  S+     S+V++FG+++WE+ T G + Y      Q    +     R E P+ CP+
Sbjct: 187 AYNKFSIK----SDVWAFGVLLWEIATYGMSPYPGIDLSQV-YELLEKDYRMERPEGCPE 241
Query: 416 ILKSLMIKCWNNSPSKRPQFSEI 438
            +  LM  CW  +PS RP F+EI
Sbjct: 242 KVYELMRACWQWNPSDRPSFAEI 264

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 67/272 (24%), Positives = 122/272 (44%), Gaps = 36/272 (13%)
Query: 187 LNSDNLEFIDQIGPNSFKGVYKG---------KRVGIEKLKGCDKGNAYEFELRKDLLEL 237
           +  + +E    IG   F  V++G           V I+  K C   +  E +  ++ L +
Sbjct: 7   IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVRE-KFLQEALTM 65
Query: 238 MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLI-LKSRKLQTKEIIRIAIDVAEG 296
               H +I++   V + EN  + ++ +L   G +   + ++   L    +I  A  ++  
Sbjct: 66  RQFDHPHIVKLIGV-ITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA 123
Query: 297 IKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRWLA 352
           + +L      +RD+ ++ +L+  +  V LGD G+    + + ++T Y+        +W+A
Sbjct: 124 LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGL---SRYMEDSTYYKASKGKLPIKWMA 180
Query: 353 PEIIAGDP-ESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAA-----VGIAACGLR 406
           PE I      S S+ WM     FG+ +WE++          P Q       +G    G R
Sbjct: 181 PESINFRRFTSASDVWM-----FGVCMWEILM-----HGVKPFQGVKNNDVIGRIENGER 230
Query: 407 PEIPKDCPQILKSLMIKCWNNSPSKRPQFSEI 438
             +P +CP  L SLM KCW   PS+RP+F+E+
Sbjct: 231 LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTEL 262

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/263 (23%), Positives = 123/263 (46%), Gaps = 15/263 (5%)
Query: 184 RWLLNSDNLEFIDQIGPNSFKGVYKG--KRVGIEKLKGCDKGNAYEFE-LRKDLLELMTC 240
           +W +   ++    ++G   +  VY+G  K+  +       K +  E E   K+   +   
Sbjct: 11  KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI 70
Query: 241 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEII--RIAIDVAEGIK 298
            H N++Q   VC  E     ++T+ M  G++ D + +  + +   ++   +A  ++  ++
Sbjct: 71  KHPNLVQLLGVCTREP-PFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAME 129
Query: 299 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY--RWLAPEII 356
           +L      +RDL ++  L+  +  V + D G+ +   +    T +    +  +W APE +
Sbjct: 130 YLEKKNFIHRDLAARNCLVGENHLVKVADFGL-SRLMTGDTYTAHAGAKFPIKWTAPESL 188
Query: 357 AGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ 415
           A +  S+     S+V++FG+++WE+ T G + Y      Q    +     R E P+ CP+
Sbjct: 189 AYNKFSIK----SDVWAFGVLLWEIATYGMSPYPGIDLSQV-YELLEKDYRMERPEGCPE 243
Query: 416 ILKSLMIKCWNNSPSKRPQFSEI 438
            +  LM  CW  +PS RP F+EI
Sbjct: 244 KVYELMRACWQWNPSDRPSFAEI 266

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/263 (23%), Positives = 123/263 (46%), Gaps = 15/263 (5%)
Query: 184 RWLLNSDNLEFIDQIGPNSFKGVYKG--KRVGIEKLKGCDKGNAYEFE-LRKDLLELMTC 240
           +W +   ++    ++G   +  VY+G  K+  +       K +  E E   K+   +   
Sbjct: 7   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI 66
Query: 241 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEII--RIAIDVAEGIK 298
            H N++Q   VC  E     ++T+ M  G++ D + +  + +   ++   +A  ++  ++
Sbjct: 67  KHPNLVQLLGVCTREP-PFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAME 125
Query: 299 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY--RWLAPEII 356
           +L      +RDL ++  L+  +  V + D G+ +   +    T +    +  +W APE +
Sbjct: 126 YLEKKNFIHRDLAARNCLVGENHLVKVADFGL-SRLMTGDTYTAHAGAKFPIKWTAPESL 184
Query: 357 AGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ 415
           A +  S+     S+V++FG+++WE+ T G + Y      Q    +     R E P+ CP+
Sbjct: 185 AYNKFSIK----SDVWAFGVLLWEIATYGMSPYPGIDLSQV-YELLEKDYRMERPEGCPE 239
Query: 416 ILKSLMIKCWNNSPSKRPQFSEI 438
            +  LM  CW  +PS RP F+EI
Sbjct: 240 KVYELMRACWQWNPSDRPSFAEI 262

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 67/272 (24%), Positives = 122/272 (44%), Gaps = 36/272 (13%)
Query: 187 LNSDNLEFIDQIGPNSFKGVYKG---------KRVGIEKLKGCDKGNAYEFELRKDLLEL 237
           +  + +E    IG   F  V++G           V I+  K C   +  E +  ++ L +
Sbjct: 35  IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVRE-KFLQEALTM 93
Query: 238 MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLI-LKSRKLQTKEIIRIAIDVAEG 296
               H +I++   V + EN  + ++ +L   G +   + ++   L    +I  A  ++  
Sbjct: 94  RQFDHPHIVKLIGV-ITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA 151
Query: 297 IKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRWLA 352
           + +L      +RD+ ++ +L+  +  V LGD G+    + + ++T Y+        +W+A
Sbjct: 152 LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGL---SRYMEDSTYYKASKGKLPIKWMA 208
Query: 353 PEIIAGDP-ESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAA-----VGIAACGLR 406
           PE I      S S+ WM     FG+ +WE++          P Q       +G    G R
Sbjct: 209 PESINFRRFTSASDVWM-----FGVCMWEILM-----HGVKPFQGVKNNDVIGRIENGER 258
Query: 407 PEIPKDCPQILKSLMIKCWNNSPSKRPQFSEI 438
             +P +CP  L SLM KCW   PS+RP+F+E+
Sbjct: 259 LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTEL 290

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/263 (23%), Positives = 123/263 (46%), Gaps = 15/263 (5%)
Query: 184 RWLLNSDNLEFIDQIGPNSFKGVYKG--KRVGIEKLKGCDKGNAYEFE-LRKDLLELMTC 240
           +W +   ++    ++G   +  VY+G  K+  +       K +  E E   K+   +   
Sbjct: 7   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI 66
Query: 241 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEII--RIAIDVAEGIK 298
            H N++Q   VC  E     ++T+ M  G++ D + +  + +   ++   +A  ++  ++
Sbjct: 67  KHPNLVQLLGVCTREP-PFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAME 125
Query: 299 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY--RWLAPEII 356
           +L      +RDL ++  L+  +  V + D G+ +   +    T +    +  +W APE +
Sbjct: 126 YLEKKNFIHRDLAARNCLVGENHLVKVADFGL-SRLMTGDTYTAHAGAKFPIKWTAPESL 184
Query: 357 AGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ 415
           A +  S+     S+V++FG+++WE+ T G + Y      Q    +     R E P+ CP+
Sbjct: 185 AYNKFSIK----SDVWAFGVLLWEIATYGMSPYPGIDLSQV-YELLEKDYRMERPEGCPE 239
Query: 416 ILKSLMIKCWNNSPSKRPQFSEI 438
            +  LM  CW  +PS RP F+EI
Sbjct: 240 KVYELMRACWQWNPSDRPSFAEI 262

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/295 (23%), Positives = 122/295 (41%), Gaps = 40/295 (13%)
Query: 181 EIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD-------KGNAYEFELRKD 233
           +  +W    D L+    +G  +F  V +    GI+K   C        K  A   E R  
Sbjct: 20  DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRAL 79
Query: 234 LLEL---MTCGHK-NILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK--------- 280
           + EL   +  GH  N++     C      L V+ +  + G+++  +   R          
Sbjct: 80  MSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAP 139
Query: 281 -------LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTA 333
                  L  + +I  +  VA+G++FL      +RDL ++ ILL     V + D G+   
Sbjct: 140 EDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA-- 197
Query: 334 CKSVGEATEYETDG-----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAA 387
            + + +  +Y   G      +W+APE I     ++     S+V+SFG+++WE+ + G + 
Sbjct: 198 -RDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQ----SDVWSFGVLLWEIFSLGASP 252
Query: 388 YAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
           Y      +        G R   P      +   M+ CW+  PS+RP FSE++  L
Sbjct: 253 YPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 307

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/276 (24%), Positives = 124/276 (44%), Gaps = 36/276 (13%)
Query: 187 LNSDNLEFIDQIGPNSFKGVYKG---------KRVGIEKLKGCDKGNAYEFELRKDLLEL 237
           +  + +E    IG   F  V++G           V I+  K C   +  E +  ++ L +
Sbjct: 9   IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVRE-KFLQEALTM 67
Query: 238 MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLI-LKSRKLQTKEIIRIAIDVAEG 296
               H +I++   V + EN  + ++ +L   G +   + ++   L    +I  A  ++  
Sbjct: 68  RQFDHPHIVKLIGV-ITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA 125
Query: 297 IKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRWLA 352
           + +L      +RD+ ++ +L+  +  V LGD G+    + + ++T Y+        +W+A
Sbjct: 126 LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGL---SRYMEDSTYYKASKGKLPIKWMA 182
Query: 353 PEIIAGDP-ESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAA-----VGIAACGLR 406
           PE I      S S+ WM     FG+ +WE++          P Q       +G    G R
Sbjct: 183 PESINFRRFTSASDVWM-----FGVCMWEILM-----HGVKPFQGVKNNDVIGRIENGER 232
Query: 407 PEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
             +P +CP  L SLM KCW   PS+RP+F+E+ + L
Sbjct: 233 LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQL 268

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/292 (23%), Positives = 121/292 (41%), Gaps = 40/292 (13%)
Query: 184 RWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD-------KGNAYEFELRKDLLE 236
           +W    D L+    +G  +F  V +    GI+K   C        K  A   E R  + E
Sbjct: 58  KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSE 117
Query: 237 L---MTCGHK-NILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK------------ 280
           L   +  GH  N++     C      L V+ +  + G+++  +   R             
Sbjct: 118 LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 177
Query: 281 ----LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS 336
               L  + +I  +  VA+G++FL      +RDL ++ ILL     V + D G+    + 
Sbjct: 178 YKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA---RD 234
Query: 337 VGEATEYETDG-----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAA 390
           + +  +Y   G      +W+APE I     ++     S+V+SFG+++WE+ + G + Y  
Sbjct: 235 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQ----SDVWSFGVLLWEIFSLGASPYPG 290
Query: 391 CSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
               +        G R   P      +   M+ CW+  PS+RP FSE++  L
Sbjct: 291 VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 342

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/262 (23%), Positives = 119/262 (45%), Gaps = 13/262 (4%)
Query: 184 RWLLNSDNLEFIDQIGPNSFKGVYKG--KRVGIEKLKGCDKGNAYEFE-LRKDLLELMTC 240
           +W +   ++    ++G   +  VY+G  K+  +       K +  E E   K+   +   
Sbjct: 8   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI 67
Query: 241 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEII--RIAIDVAEGIK 298
            H N++Q   VC  E     ++T+ M  G++ D + +  + +   ++   +A  ++  ++
Sbjct: 68  KHPNLVQLLGVCTREP-PFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAME 126
Query: 299 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK-SVGEATEYETDGYRWLAPEIIA 357
           +L      +RDL ++  L+  +  V + D G+          A        +W APE +A
Sbjct: 127 YLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLA 186
Query: 358 GDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQI 416
            +  S+     S+V++FG+++WE+ T G + Y      Q    +     R E P+ CP+ 
Sbjct: 187 YNKFSIK----SDVWAFGVLLWEIATYGMSPYPGIDLSQV-YELLEKDYRMERPEGCPEK 241
Query: 417 LKSLMIKCWNNSPSKRPQFSEI 438
           +  LM  CW  +PS RP F+EI
Sbjct: 242 VYELMRACWQWNPSDRPSFAEI 263

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/272 (24%), Positives = 122/272 (44%), Gaps = 36/272 (13%)
Query: 187 LNSDNLEFIDQIGPNSFKGVYKG---------KRVGIEKLKGCDKGNAYEFELRKDLLEL 237
           +  + +E    IG   F  V++G           V I+  K C   +  E +  ++ L +
Sbjct: 12  IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVRE-KFLQEALTM 70
Query: 238 MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLI-LKSRKLQTKEIIRIAIDVAEG 296
               H +I++   V + EN  + ++ +L   G +   + ++   L    +I  A  ++  
Sbjct: 71  RQFDHPHIVKLIGV-ITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA 128
Query: 297 IKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRWLA 352
           + +L      +RD+ ++ +L+  +  V LGD G+    + + ++T Y+        +W+A
Sbjct: 129 LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGL---SRYMEDSTYYKASKGKLPIKWMA 185
Query: 353 PEIIAGDP-ESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAA-----VGIAACGLR 406
           PE I      S S+ WM     FG+ +WE++          P Q       +G    G R
Sbjct: 186 PESINFRRFTSASDVWM-----FGVCMWEILM-----HGVKPFQGVKNNDVIGRIENGER 235
Query: 407 PEIPKDCPQILKSLMIKCWNNSPSKRPQFSEI 438
             +P +CP  L SLM KCW   PS+RP+F+E+
Sbjct: 236 LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTEL 267

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/295 (23%), Positives = 122/295 (41%), Gaps = 40/295 (13%)
Query: 181 EIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD-------KGNAYEFELRKD 233
           +  +W    D L+    +G  +F  V +    GI+K   C        K  A   E R  
Sbjct: 18  DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRAL 77
Query: 234 LLEL---MTCGHK-NILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK--------- 280
           + EL   +  GH  N++     C      L V+ +  + G+++  +   R          
Sbjct: 78  MSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAP 137
Query: 281 -------LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTA 333
                  L  + +I  +  VA+G++FL      +RDL ++ ILL     V + D G+   
Sbjct: 138 EDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA-- 195
Query: 334 CKSVGEATEYETDG-----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAA 387
            + + +  +Y   G      +W+APE I     ++     S+V+SFG+++WE+ + G + 
Sbjct: 196 -RDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQ----SDVWSFGVLLWEIFSLGASP 250
Query: 388 YAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
           Y      +        G R   P      +   M+ CW+  PS+RP FSE++  L
Sbjct: 251 YPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/265 (25%), Positives = 120/265 (45%), Gaps = 36/265 (13%)
Query: 198 IGPNSFKGVYKG---------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQF 248
           IG   F  V++G           V I+  K C   +  E +  ++ L +    H +I++ 
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVRE-KFLQEALTMRQFDHPHIVKL 456
Query: 249 YCVCVDENHGLCVVTKLMEGGSVNDLI-LKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAY 307
             V + EN  + ++ +L   G +   + ++   L    +I  A  ++  + +L      +
Sbjct: 457 IGV-ITEN-PVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVH 514
Query: 308 RDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRWLAPEIIAGDP-ES 362
           RD+ ++ +L+  +  V LGD G+    + + ++T Y+        +W+APE I      S
Sbjct: 515 RDIAARNVLVSSNDCVKLGDFGL---SRYMEDSTYYKASKGKLPIKWMAPESINFRRFTS 571
Query: 363 VSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAA-----VGIAACGLRPEIPKDCPQIL 417
            S+ WM     FG+ +WE++          P Q       +G    G R  +P +CP  L
Sbjct: 572 ASDVWM-----FGVCMWEILMH-----GVKPFQGVKNNDVIGRIENGERLPMPPNCPPTL 621
Query: 418 KSLMIKCWNNSPSKRPQFSEIISLL 442
            SLM KCW   PS+RP+F+E+ + L
Sbjct: 622 YSLMTKCWAYDPSRRPRFTELKAQL 646

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/276 (24%), Positives = 124/276 (44%), Gaps = 36/276 (13%)
Query: 187 LNSDNLEFIDQIGPNSFKGVYKG---------KRVGIEKLKGCDKGNAYEFELRKDLLEL 237
           +  + +E    IG   F  V++G           V I+  K C   +  E +  ++ L +
Sbjct: 10  IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVRE-KFLQEALTM 68
Query: 238 MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLI-LKSRKLQTKEIIRIAIDVAEG 296
               H +I++   V + EN  + ++ +L   G +   + ++   L    +I  A  ++  
Sbjct: 69  RQFDHPHIVKLIGV-ITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA 126
Query: 297 IKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRWLA 352
           + +L      +RD+ ++ +L+  +  V LGD G+    + + ++T Y+        +W+A
Sbjct: 127 LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGL---SRYMEDSTYYKASKGKLPIKWMA 183
Query: 353 PEIIAGDP-ESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAA-----VGIAACGLR 406
           PE I      S S+ WM     FG+ +WE++          P Q       +G    G R
Sbjct: 184 PESINFRRFTSASDVWM-----FGVCMWEILM-----HGVKPFQGVKNNDVIGRIENGER 233
Query: 407 PEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
             +P +CP  L SLM KCW   PS+RP+F+E+ + L
Sbjct: 234 LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQL 269

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/262 (23%), Positives = 119/262 (45%), Gaps = 13/262 (4%)
Query: 184 RWLLNSDNLEFIDQIGPNSFKGVYKG--KRVGIEKLKGCDKGNAYEFE-LRKDLLELMTC 240
           +W +   ++    ++G   +  VY+G  K+  +       K +  E E   K+   +   
Sbjct: 9   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI 68
Query: 241 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEII--RIAIDVAEGIK 298
            H N++Q   VC  E     ++T+ M  G++ D + +  + +   ++   +A  ++  ++
Sbjct: 69  KHPNLVQLLGVCTREP-PFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAME 127
Query: 299 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK-SVGEATEYETDGYRWLAPEIIA 357
           +L      +RDL ++  L+  +  V + D G+          A        +W APE +A
Sbjct: 128 YLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLA 187
Query: 358 GDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQI 416
            +  S+     S+V++FG+++WE+ T G + Y      Q    +     R E P+ CP+ 
Sbjct: 188 YNKFSIK----SDVWAFGVLLWEIATYGMSPYPGIDLSQV-YELLEKDYRMERPEGCPEK 242
Query: 417 LKSLMIKCWNNSPSKRPQFSEI 438
           +  LM  CW  +PS RP F+EI
Sbjct: 243 VYELMRACWQWNPSDRPSFAEI 264

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/272 (24%), Positives = 122/272 (44%), Gaps = 36/272 (13%)
Query: 187 LNSDNLEFIDQIGPNSFKGVYKG---------KRVGIEKLKGCDKGNAYEFELRKDLLEL 237
           +  + +E    IG   F  V++G           V I+  K C   +  E +  ++ L +
Sbjct: 4   IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVRE-KFLQEALTM 62
Query: 238 MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLI-LKSRKLQTKEIIRIAIDVAEG 296
               H +I++   V + EN  + ++ +L   G +   + ++   L    +I  A  ++  
Sbjct: 63  RQFDHPHIVKLIGV-ITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA 120
Query: 297 IKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRWLA 352
           + +L      +RD+ ++ +L+  +  V LGD G+    + + ++T Y+        +W+A
Sbjct: 121 LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGL---SRYMEDSTYYKASKGKLPIKWMA 177
Query: 353 PEIIAGDP-ESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAA-----VGIAACGLR 406
           PE I      S S+ WM     FG+ +WE++          P Q       +G    G R
Sbjct: 178 PESINFRRFTSASDVWM-----FGVCMWEILMH-----GVKPFQGVKNNDVIGRIENGER 227
Query: 407 PEIPKDCPQILKSLMIKCWNNSPSKRPQFSEI 438
             +P +CP  L SLM KCW   PS+RP+F+E+
Sbjct: 228 LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTEL 259

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/272 (24%), Positives = 122/272 (44%), Gaps = 36/272 (13%)
Query: 187 LNSDNLEFIDQIGPNSFKGVYKG---------KRVGIEKLKGCDKGNAYEFELRKDLLEL 237
           +  + +E    IG   F  V++G           V I+  K C   +  E +  ++ L +
Sbjct: 7   IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVRE-KFLQEALTM 65
Query: 238 MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLI-LKSRKLQTKEIIRIAIDVAEG 296
               H +I++   V + EN  + ++ +L   G +   + ++   L    +I  A  ++  
Sbjct: 66  RQFDHPHIVKLIGV-ITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA 123
Query: 297 IKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRWLA 352
           + +L      +RD+ ++ +L+  +  V LGD G+    + + ++T Y+        +W+A
Sbjct: 124 LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGL---SRYMEDSTYYKASKGKLPIKWMA 180
Query: 353 PEIIAGDP-ESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAA-----VGIAACGLR 406
           PE I      S S+ WM     FG+ +WE++          P Q       +G    G R
Sbjct: 181 PESINFRRFTSASDVWM-----FGVCMWEILMH-----GVKPFQGVKNNDVIGRIENGER 230
Query: 407 PEIPKDCPQILKSLMIKCWNNSPSKRPQFSEI 438
             +P +CP  L SLM KCW   PS+RP+F+E+
Sbjct: 231 LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTEL 262

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/260 (25%), Positives = 113/260 (43%), Gaps = 27/260 (10%)
Query: 198 IGPNSFKGVYKGKRV---------GIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQF 248
           IG   F  VY G+ +          I+ L    +    E  LR+ LL +    H N+L  
Sbjct: 29  IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLL-MRGLNHPNVLAL 87
Query: 249 YCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQT-KEIIRIAIDVAEGIKFLNDHGVAY 307
             + +       V+   M  G +   I   ++  T K++I   + VA G+++L +    +
Sbjct: 88  IGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVH 147
Query: 308 RDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR-------WLAPEIIAGDP 360
           RDL ++  +LD    V + D G+    + + +   Y    +R       W A E +    
Sbjct: 148 RDLAARNCMLDESFTVKVADFGL---ARDILDREYYSVQQHRHARLPVKWTALESL---- 200
Query: 361 ESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKS 419
           ++   T  S+V+SFG+++WE++T G   Y    P      +A  G R   P+ CP  L  
Sbjct: 201 QTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQ-GRRLPQPEYCPDSLYQ 259
Query: 420 LMIKCWNNSPSKRPQFSEII 439
           +M +CW   P+ RP F  ++
Sbjct: 260 VMQQCWEADPAVRPTFRVLV 279

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 52/193 (26%), Positives = 93/193 (48%), Gaps = 30/193 (15%)
Query: 261 VVTKLMEGGSVNDLILKSR------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQR 314
           V+   M+ G ++  +L SR       L  + ++R  +D+A G+++L+     +RDL ++ 
Sbjct: 108 VILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARN 167
Query: 315 ILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR----------WLAPEIIAGDPESVS 364
            +L     VC+ D G+            Y  D YR          WLA E +A +  +V 
Sbjct: 168 CMLAEDMTVCVADFGLSRKI--------YSGDYYRQGCASKLPVKWLALESLADNLYTVH 219
Query: 365 ETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIK 423
               S+V++FG+ +WE++T G+  YA     +    +   G R + P +C + +  LM +
Sbjct: 220 ----SDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIG-GNRLKQPPECMEEVYDLMYQ 274
Query: 424 CWNNSPSKRPQFS 436
           CW+  P +RP F+
Sbjct: 275 CWSADPKQRPSFT 287

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/252 (25%), Positives = 116/252 (46%), Gaps = 24/252 (9%)
Query: 209 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH-GLCVVTKLME 267
           G+ V ++ LK  D G  +    ++++  L T  H++I+++   C D+    L +V + + 
Sbjct: 43  GEMVAVKALKA-DCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVP 101
Query: 268 GGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGD 327
            GS+ D  L    +   +++  A  + EG+ +L+     +R+L ++ +LLD    V +GD
Sbjct: 102 LGSLRD-YLPRHSIGLAQLLLFAQQICEGMAYLHSQHYIHRNLAARNVLLDNDRLVKIGD 160
Query: 328 MGIVTACKSVGEATEYETDG---YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTG 384
            G+  A     E      DG     W APE +    +     + S+V+SFG+ ++E++T 
Sbjct: 161 FGLAKAVPEGHEYYRVREDGDSPVFWYAPECL----KEYKFYYASDVWSFGVTLYELLTH 216
Query: 385 -EAAYAACSPVQAAVGIAAC-------------GLRPEIPKDCPQILKSLMIKCWNNSPS 430
            +++ +  +     +GIA               G R   P  CP  +  LM  CW    S
Sbjct: 217 CDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPCEVYHLMKNCWETEAS 276
Query: 431 KRPQFSEIISLL 442
            RP F  +I +L
Sbjct: 277 FRPTFENLIPIL 288

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/269 (23%), Positives = 123/269 (45%), Gaps = 15/269 (5%)
Query: 178 GGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKG--KRVGIEKLKGCDKGNAYEFE-LRKDL 234
           G     +W +   ++    ++G   +  VY+G  K+  +       K +  E E   K+ 
Sbjct: 1   GSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEA 60
Query: 235 LELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEII--RIAID 292
             +    H N++Q   VC  E     ++ + M  G++ D + +  + +   ++   +A  
Sbjct: 61  AVMKEIKHPNLVQLLGVCTREP-PFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ 119
Query: 293 VAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY--RW 350
           ++  +++L      +RDL ++  L+  +  V + D G+ +   +    T +    +  +W
Sbjct: 120 ISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGL-SRLMTGDTYTAHAGAKFPIKW 178
Query: 351 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEI 409
            APE +A +  S+     S+V++FG+++WE+ T G + Y      Q    +     R E 
Sbjct: 179 TAPESLAYNKFSIK----SDVWAFGVLLWEIATYGMSPYPGIDLSQV-YELLEKDYRMER 233
Query: 410 PKDCPQILKSLMIKCWNNSPSKRPQFSEI 438
           P+ CP+ +  LM  CW  +PS RP F+EI
Sbjct: 234 PEGCPEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 70/269 (26%), Positives = 120/269 (44%), Gaps = 22/269 (8%)
Query: 187 LNSDNLEF--------IDQIGPNSF------KGVYKGKRVGIEKLKGCDKGNAYEFELRK 232
           L ++NL F        + +IG  SF      K    G++  I+++      +    E R+
Sbjct: 13  LGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRR 72
Query: 233 DLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLI--LKSRKLQTKEIIRIA 290
           ++  L    H NI+Q Y    +EN  L +V    EGG +   I   K    Q  +I+   
Sbjct: 73  EVAVLANMKHPNIVQ-YRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWF 131
Query: 291 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRW 350
           + +   +K ++D  + +RD+ SQ I L + G V LGD GI     S  E          +
Sbjct: 132 VQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYY 191
Query: 351 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIP 410
           L+PEI    P +      S++++ G V++E+ T + A+ A S     + I + G  P + 
Sbjct: 192 LSPEICENKPYNNK----SDIWALGCVLYELCTLKHAFEAGSMKNLVLKIIS-GSFPPVS 246
Query: 411 KDCPQILKSLMIKCWNNSPSKRPQFSEII 439
                 L+SL+ + +  +P  RP  + I+
Sbjct: 247 LHYSYDLRSLVSQLFKRNPRDRPSVNSIL 275

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 70/295 (23%), Positives = 122/295 (41%), Gaps = 40/295 (13%)
Query: 181 EIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD-------KGNAYEFELRKD 233
           +  +W    D L+    +G  +F  V +    GI+K   C        K  A   E R  
Sbjct: 9   DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRAL 68
Query: 234 LLEL---MTCGHK-NILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK--------- 280
           + EL   +  GH  N++     C      L V+T+  + G+++  +   R          
Sbjct: 69  MSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAP 128
Query: 281 -------LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTA 333
                  L  + +I  +  VA+G++FL      +RDL ++ ILL     V + D G+   
Sbjct: 129 EDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA-- 186
Query: 334 CKSVGEATEYETDG-----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAA 387
            + + +  +    G      +W+APE I     ++     S+V+SFG+++WE+ + G + 
Sbjct: 187 -RDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQ----SDVWSFGVLLWEIFSLGASP 241
Query: 388 YAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
           Y      +        G R   P      +   M+ CW+  PS+RP FSE++  L
Sbjct: 242 YPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 296

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/265 (25%), Positives = 119/265 (44%), Gaps = 36/265 (13%)
Query: 198 IGPNSFKGVYKG---------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQF 248
           IG   F  V++G           V I+  K C   +  E +  ++ L +    H +I++ 
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVRE-KFLQEALTMRQFDHPHIVKL 456
Query: 249 YCVCVDENHGLCVVTKLMEGGSVNDLI-LKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAY 307
             V + EN  + ++ +L   G +   + ++   L    +I  A  ++  + +L      +
Sbjct: 457 IGV-ITEN-PVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVH 514
Query: 308 RDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRWLAPEIIAGDP-ES 362
           RD+ ++ +L+     V LGD G+    + + ++T Y+        +W+APE I      S
Sbjct: 515 RDIAARNVLVSATDCVKLGDFGL---SRYMEDSTYYKASKGKLPIKWMAPESINFRRFTS 571
Query: 363 VSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAA-----VGIAACGLRPEIPKDCPQIL 417
            S+ WM     FG+ +WE++          P Q       +G    G R  +P +CP  L
Sbjct: 572 ASDVWM-----FGVCMWEILMH-----GVKPFQGVKNNDVIGRIENGERLPMPPNCPPTL 621
Query: 418 KSLMIKCWNNSPSKRPQFSEIISLL 442
            SLM KCW   PS+RP+F+E+ + L
Sbjct: 622 YSLMTKCWAYDPSRRPRFTELKAQL 646

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/269 (23%), Positives = 123/269 (45%), Gaps = 15/269 (5%)
Query: 178 GGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKG--KRVGIEKLKGCDKGNAYEFE-LRKDL 234
           G     +W +   ++    ++G   +  VY+G  K+  +       K +  E E   K+ 
Sbjct: 1   GSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEA 60
Query: 235 LELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEII--RIAID 292
             +    H N++Q   VC  E     ++ + M  G++ D + +  + +   ++   +A  
Sbjct: 61  AVMKEIKHPNLVQLLGVCTREP-PFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ 119
Query: 293 VAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY--RW 350
           ++  +++L      +RDL ++  L+  +  V + D G+ +   +    T +    +  +W
Sbjct: 120 ISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGL-SRLMTGDTYTAHAGAKFPIKW 178
Query: 351 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEI 409
            APE +A +  S+     S+V++FG+++WE+ T G + Y      Q    +     R E 
Sbjct: 179 TAPESLAYNKFSIK----SDVWAFGVLLWEIATYGMSPYPGIDLSQV-YELLEKDYRMER 233
Query: 410 PKDCPQILKSLMIKCWNNSPSKRPQFSEI 438
           P+ CP+ +  LM  CW  +PS RP F+EI
Sbjct: 234 PEGCPEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/272 (24%), Positives = 121/272 (44%), Gaps = 36/272 (13%)
Query: 187 LNSDNLEFIDQIGPNSFKGVYKG---------KRVGIEKLKGCDKGNAYEFELRKDLLEL 237
           +  + +E    IG   F  V++G           V I+  K C   +  E +  ++ L +
Sbjct: 7   IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVRE-KFLQEALTM 65
Query: 238 MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLI-LKSRKLQTKEIIRIAIDVAEG 296
               H +I++   V + EN  + ++ +L   G +   + ++   L    +I  A  ++  
Sbjct: 66  RQFDHPHIVKLIGV-ITEN-PVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTA 123
Query: 297 IKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRWLA 352
           + +L      +RD+ ++ +L+     V LGD G+    + + ++T Y+        +W+A
Sbjct: 124 LAYLESKRFVHRDIAARNVLVSATDCVKLGDFGL---SRYMEDSTYYKASKGKLPIKWMA 180
Query: 353 PEIIAGDP-ESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAA-----VGIAACGLR 406
           PE I      S S+ WM     FG+ +WE++          P Q       +G    G R
Sbjct: 181 PESINFRRFTSASDVWM-----FGVCMWEILMH-----GVKPFQGVKNNDVIGRIENGER 230
Query: 407 PEIPKDCPQILKSLMIKCWNNSPSKRPQFSEI 438
             +P +CP  L SLM KCW   PS+RP+F+E+
Sbjct: 231 LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTEL 262

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 63/266 (23%), Positives = 123/266 (46%), Gaps = 15/266 (5%)
Query: 180 EEIGRWLLNSDNLEFIDQIGPNSFKGVYKG--KRVGIEKLKGCDKGNAYEFE-LRKDLLE 236
           + + +W +   ++    ++G   +  VY G  K+  +       K +  E E   K+   
Sbjct: 22  QSMDKWEMERTDITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAV 81
Query: 237 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEII--RIAIDVA 294
           +    H N++Q   VC  E     +VT+ M  G++ D + +  + +   ++   +A  ++
Sbjct: 82  MKEIKHPNLVQLLGVCTLEP-PFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQIS 140
Query: 295 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY--RWLA 352
             +++L      +RDL ++  L+  +  V + D G+ +   +    T +    +  +W A
Sbjct: 141 SAMEYLEKKNFIHRDLAARNCLVGENHVVKVADFGL-SRLMTGDTYTAHAGAKFPIKWTA 199
Query: 353 PEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPK 411
           PE +A +  S+     S+V++FG+++WE+ T G + Y      Q    +   G R E P+
Sbjct: 200 PESLAYNTFSIK----SDVWAFGVLLWEIATYGMSPYPGIDLSQV-YDLLEKGYRMEQPE 254
Query: 412 DCPQILKSLMIKCWNNSPSKRPQFSE 437
            CP  +  LM  CW  SP+ RP F+E
Sbjct: 255 GCPPKVYELMRACWKWSPADRPSFAE 280

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 63/267 (23%), Positives = 123/267 (46%), Gaps = 22/267 (8%)
Query: 186 LLNSDNLEFIDQIGPNSFKGVYKG------KRVGIE---KLKGCDKGNAYEFELRKDLLE 236
           +L    L+ +  +G  +F  VYKG      + V I    K+     G     E   + L 
Sbjct: 11  ILKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALI 70
Query: 237 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAE 295
           + +  H ++++   VC+     + +VT+LM  G + + + + +  + ++ ++   + +A+
Sbjct: 71  MASMDHPHLVRLLGVCLSPT--IQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAK 128
Query: 296 GIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRWL 351
           G+ +L +  + +RDL ++ +L+    +V + D G+    +  G+  EY  DG     +W+
Sbjct: 129 GMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLE--GDEKEYNADGGKMPIKWM 186
Query: 352 APEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPK 411
           A E I         T  S+V+S+G+ IWE++T         P +    +   G R   P 
Sbjct: 187 ALECI----HYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPP 242
Query: 412 DCPQILKSLMIKCWNNSPSKRPQFSEI 438
            C   +  +M+KCW      RP+F E+
Sbjct: 243 ICTIDVYMVMVKCWMIDADSRPKFKEL 269

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 64/252 (25%), Positives = 116/252 (46%), Gaps = 24/252 (9%)
Query: 209 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH-GLCVVTKLME 267
           G+ V ++ LK  D G  +    ++++  L T  H++I+++   C D+    L +V + + 
Sbjct: 43  GEMVAVKALKA-DCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVP 101
Query: 268 GGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGD 327
            GS+ D  L    +   +++  A  + EG+ +L+     +R+L ++ +LLD    V +GD
Sbjct: 102 LGSLRD-YLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRNLAARNVLLDNDRLVKIGD 160
Query: 328 MGIVTACKSVGEATEYETDG---YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTG 384
            G+  A     E      DG     W APE +    +     + S+V+SFG+ ++E++T 
Sbjct: 161 FGLAKAVPEGHEYYRVREDGDSPVFWYAPECL----KEYKFYYASDVWSFGVTLYELLTH 216
Query: 385 -EAAYAACSPVQAAVGIAAC-------------GLRPEIPKDCPQILKSLMIKCWNNSPS 430
            +++ +  +     +GIA               G R   P  CP  +  LM  CW    S
Sbjct: 217 CDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPCEVYHLMKNCWETEAS 276
Query: 431 KRPQFSEIISLL 442
            RP F  +I +L
Sbjct: 277 FRPTFENLIPIL 288

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 61/263 (23%), Positives = 122/263 (46%), Gaps = 15/263 (5%)
Query: 184 RWLLNSDNLEFIDQIGPNSFKGVYKG--KRVGIEKLKGCDKGNAYEFE-LRKDLLELMTC 240
           +W +   ++    ++G   +  VY+G  K+  +       K +  E E   K+   +   
Sbjct: 8   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI 67
Query: 241 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEII--RIAIDVAEGIK 298
            H N++Q   VC  E     ++ + M  G++ D + +  + +   ++   +A  ++  ++
Sbjct: 68  KHPNLVQLLGVCTREP-PFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAME 126
Query: 299 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY--RWLAPEII 356
           +L      +RDL ++  L+  +  V + D G+ +   +    T +    +  +W APE +
Sbjct: 127 YLEKKNFIHRDLAARNCLVGENHLVKVADFGL-SRLMTGDTXTAHAGAKFPIKWTAPESL 185
Query: 357 AGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ 415
           A +  S+     S+V++FG+++WE+ T G + Y      Q    +     R E P+ CP+
Sbjct: 186 AYNKFSIK----SDVWAFGVLLWEIATYGMSPYPGIDLSQV-YELLEKDYRMERPEGCPE 240
Query: 416 ILKSLMIKCWNNSPSKRPQFSEI 438
            +  LM  CW  +PS RP F+EI
Sbjct: 241 KVYELMRACWQWNPSDRPSFAEI 263

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 68/288 (23%), Positives = 121/288 (42%), Gaps = 36/288 (12%)
Query: 184 RWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEK--------LKGCDKGNAY--EFELRKD 233
           +W    D L     +G  +F  V +    GI+K        +K   +G  +     L  +
Sbjct: 21  KWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSE 80
Query: 234 LLELMTCGHK-NILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK------------ 280
           L  L+  GH  N++     C      L V+ +  + G+++  +   R             
Sbjct: 81  LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDF 140
Query: 281 LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA 340
           L  + +I  +  VA+G++FL      +RDL ++ ILL     V + D G+    + + + 
Sbjct: 141 LTLEHLICYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGL---ARDIYKD 197
Query: 341 TEYETDG-----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPV 394
            +Y   G      +W+APE I     ++     S+V+SFG+++WE+ + G + Y      
Sbjct: 198 PDYVRKGDARLPLKWMAPETIFDRVYTIQ----SDVWSFGVLLWEIFSLGASPYPGVKID 253
Query: 395 QAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
           +        G R   P      +   M+ CW+  PS+RP FSE++  L
Sbjct: 254 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 301

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 63/267 (23%), Positives = 123/267 (46%), Gaps = 22/267 (8%)
Query: 186 LLNSDNLEFIDQIGPNSFKGVYKG------KRVGIE---KLKGCDKGNAYEFELRKDLLE 236
           +L    L+ +  +G  +F  VYKG      + V I    K+     G     E   + L 
Sbjct: 34  ILKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALI 93
Query: 237 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAE 295
           + +  H ++++   VC+     + +VT+LM  G + + + + +  + ++ ++   + +A+
Sbjct: 94  MASMDHPHLVRLLGVCLSPT--IQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAK 151
Query: 296 GIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRWL 351
           G+ +L +  + +RDL ++ +L+    +V + D G+    +  G+  EY  DG     +W+
Sbjct: 152 GMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLE--GDEKEYNADGGKMPIKWM 209
Query: 352 APEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPK 411
           A E I         T  S+V+S+G+ IWE++T         P +    +   G R   P 
Sbjct: 210 ALECI----HYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPP 265
Query: 412 DCPQILKSLMIKCWNNSPSKRPQFSEI 438
            C   +  +M+KCW      RP+F E+
Sbjct: 266 ICTIDVYMVMVKCWMIDADSRPKFKEL 292

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 70/289 (24%), Positives = 121/289 (41%), Gaps = 37/289 (12%)
Query: 184 RWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDK---------GNAYEFELRKDL 234
           +W    +NL+F   +G  +F  V +    G+ K     K          +A E E     
Sbjct: 40  KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSE 99
Query: 235 LELMTC--GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQT--------- 283
           L++M+    H+NI+     C      L +      G  +N L  KSR L+T         
Sbjct: 100 LKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANS 159
Query: 284 ----KEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE 339
               ++++  +  VA+G+ FL      +RD+ ++ +LL       +GD G+    + +  
Sbjct: 160 TASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGL---ARDIMN 216
Query: 340 ATEYETDG-----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSP 393
            + Y   G      +W+APE I     +V     S+V+S+G+++WE+ + G   Y     
Sbjct: 217 DSNYIVKGNARLPVKWMAPESIFDCVYTVQ----SDVWSYGILLWEIFSLGLNPYPGILV 272
Query: 394 VQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
                 +   G +   P   P+ + S+M  CW   P+ RP F +I S L
Sbjct: 273 NSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFL 321

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 70/289 (24%), Positives = 121/289 (41%), Gaps = 37/289 (12%)
Query: 184 RWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDK---------GNAYEFELRKDL 234
           +W    +NL+F   +G  +F  V +    G+ K     K          +A E E     
Sbjct: 40  KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSE 99
Query: 235 LELMTC--GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQT--------- 283
           L++M+    H+NI+     C      L +      G  +N L  KSR L+T         
Sbjct: 100 LKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANS 159
Query: 284 ----KEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE 339
               ++++  +  VA+G+ FL      +RD+ ++ +LL       +GD G+    + +  
Sbjct: 160 TLSTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGL---ARDIMN 216
Query: 340 ATEYETDG-----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSP 393
            + Y   G      +W+APE I     +V     S+V+S+G+++WE+ + G   Y     
Sbjct: 217 DSNYIVKGNARLPVKWMAPESIFDCVYTVQ----SDVWSYGILLWEIFSLGLNPYPGILV 272
Query: 394 VQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
                 +   G +   P   P+ + S+M  CW   P+ RP F +I S L
Sbjct: 273 NSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFL 321

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 68/271 (25%), Positives = 123/271 (45%), Gaps = 27/271 (9%)
Query: 185 WLLNSDNLEFIDQIGPNSFKGVYKGK-----RVGIEKLK-GCDKGNAY--EFELRKDLLE 236
           W +  ++L    ++G   F  V+ G      RV I+ LK G     A+  E ++ K L  
Sbjct: 3   WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKL-- 60
Query: 237 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL--KSRKLQTKEIIRIAIDVA 294
                H+ ++Q Y V  +E   + +VT+ M  GS+ D +     + L+  +++ +A  +A
Sbjct: 61  ----RHEKLVQLYAVVSEEP--IXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIA 114
Query: 295 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY--RWLA 352
            G+ ++      +RDL +  IL+  +    + D G+    +   E T  +   +  +W A
Sbjct: 115 SGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEXTARQGAKFPIKWTA 173
Query: 353 PEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPK 411
           PE       ++     S+V+SFG+++ E+ T G   Y      +    +   G R   P 
Sbjct: 174 PEAALYGRFTIK----SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER-GYRMPCPP 228
Query: 412 DCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
           +CP+ L  LM +CW   P +RP F  + + L
Sbjct: 229 ECPESLHDLMCQCWRKEPEERPTFEYLQAFL 259

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 63/273 (23%), Positives = 125/273 (45%), Gaps = 15/273 (5%)
Query: 174 TVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKG--KRVGIEKLKGCDKGNAYEFE-L 230
           TV        +W +   ++    ++G   +  VY+G  K+  +       K +  E E  
Sbjct: 243 TVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEF 302
Query: 231 RKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEII--R 288
            K+   +    H N++Q   VC  E     ++T+ M  G++ D + +  + +   ++   
Sbjct: 303 LKEAAVMKEIKHPNLVQLLGVCTREP-PFYIITEFMTYGNLLDYLRECNRQEVNAVVLLY 361
Query: 289 IAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY 348
           +A  ++  +++L      +R+L ++  L+  +  V + D G+ +   +    T +    +
Sbjct: 362 MATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGL-SRLMTGDTYTAHAGAKF 420
Query: 349 --RWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGL 405
             +W APE +A +  S+     S+V++FG+++WE+ T G + Y      Q    +     
Sbjct: 421 PIKWTAPESLAYNKFSIK----SDVWAFGVLLWEIATYGMSPYPGIDLSQV-YELLEKDY 475
Query: 406 RPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEI 438
           R E P+ CP+ +  LM  CW  +PS RP F+EI
Sbjct: 476 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 508

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 61/263 (23%), Positives = 122/263 (46%), Gaps = 15/263 (5%)
Query: 184 RWLLNSDNLEFIDQIGPNSFKGVYKG--KRVGIEKLKGCDKGNAYEFE-LRKDLLELMTC 240
           +W +   ++    ++G   +  VY+G  K+  +       K +  E E   K+   +   
Sbjct: 12  KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI 71
Query: 241 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEII--RIAIDVAEGIK 298
            H N++Q   VC  E     ++ + M  G++ D + +  + +   ++   +A  ++  ++
Sbjct: 72  KHPNLVQLLGVCTREP-PFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAME 130
Query: 299 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY--RWLAPEII 356
           +L      +RDL ++  L+  +  V + D G+ +   +    T +    +  +W APE +
Sbjct: 131 YLEKKNFIHRDLAARNCLVGENHLVKVADFGL-SRLMTGDTYTAHAGAKFPIKWTAPESL 189
Query: 357 AGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ 415
           A +  S+     S+V++FG+++WE+ T G + Y      Q    +     R E P+ CP+
Sbjct: 190 AYNKFSIK----SDVWAFGVLLWEIATYGMSPYPGIDLSQV-YELLEKDYRMERPEGCPE 244
Query: 416 ILKSLMIKCWNNSPSKRPQFSEI 438
            +  LM  CW  +PS RP F+EI
Sbjct: 245 KVYELMRACWQWNPSDRPSFAEI 267

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 67/270 (24%), Positives = 124/270 (45%), Gaps = 24/270 (8%)
Query: 186 LLNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLL 235
           +L    L  +  +G  +F  VYKG            V I+ L+      A + E+  +  
Sbjct: 13  ILKETELRKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANK-EILDEAY 71
Query: 236 ELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVA 294
            +   G   + +   +C+     L  VT+LM  G + D + ++R +L +++++   + +A
Sbjct: 72  VMAGVGSPYVSRLLGICLTSTVQL--VTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQIA 129
Query: 295 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRW 350
           +G+ +L D  + +RDL ++ +L+    +V + D G+        + TEY  DG     +W
Sbjct: 130 KGMSYLEDVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI--DETEYHADGGKVPIKW 187
Query: 351 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIP 410
           +A E I         T  S+V+S+G+ +WE++T  A      P +    +   G R   P
Sbjct: 188 MALESIL----RRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQP 243
Query: 411 KDCPQILKSLMIKCWNNSPSKRPQFSEIIS 440
             C   +  +M+KCW      RP+F E++S
Sbjct: 244 PICTIDVYMIMVKCWMIDSECRPRFRELVS 273

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 61/263 (23%), Positives = 123/263 (46%), Gaps = 15/263 (5%)
Query: 184 RWLLNSDNLEFIDQIGPNSFKGVYKG--KRVGIEKLKGCDKGNAYEFE-LRKDLLELMTC 240
           +W +   ++    ++G   +  VY+G  K+  +       K +  E E   K+   +   
Sbjct: 214 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI 273
Query: 241 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEII--RIAIDVAEGIK 298
            H N++Q   VC  E     ++T+ M  G++ D + +  + +   ++   +A  ++  ++
Sbjct: 274 KHPNLVQLLGVCTREP-PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAME 332
Query: 299 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY--RWLAPEII 356
           +L      +R+L ++  L+  +  V + D G+ +   +    T +    +  +W APE +
Sbjct: 333 YLEKKNFIHRNLAARNCLVGENHLVKVADFGL-SRLMTGDTYTAHAGAKFPIKWTAPESL 391
Query: 357 AGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ 415
           A +  S+     S+V++FG+++WE+ T G + Y      Q    +     R E P+ CP+
Sbjct: 392 AYNKFSIK----SDVWAFGVLLWEIATYGMSPYPGIDLSQV-YELLEKDYRMERPEGCPE 446
Query: 416 ILKSLMIKCWNNSPSKRPQFSEI 438
            +  LM  CW  +PS RP F+EI
Sbjct: 447 KVYELMRACWQWNPSDRPSFAEI 469

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 70/281 (24%), Positives = 127/281 (45%), Gaps = 27/281 (9%)
Query: 175 VQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGK-----RVGIEKLK-GCDKGNAY-- 226
           +Q+ G     W +  ++L    ++G   F  V+ G      RV I+ LK G     A+  
Sbjct: 3   MQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ 62
Query: 227 EFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL--KSRKLQTK 284
           E ++ K L       H+ ++Q Y V  +E   + +VT+ M  GS+ D +     + L+  
Sbjct: 63  EAQVMKKL------RHEKLVQLYAVVSEEP--IYIVTEYMSKGSLLDFLKGEMGKYLRLP 114
Query: 285 EIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE 344
           +++ +A  +A G+ ++      +RDL +  IL+  +    + D G+    +   E T  +
Sbjct: 115 QLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQ 173
Query: 345 TDGY--RWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIA 401
              +  +W APE       ++     S+V+SFG+++ E+ T G   Y      +    + 
Sbjct: 174 GAKFPIKWTAPEAALYGRFTIK----SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 229
Query: 402 ACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
             G R   P +CP+ L  LM +CW   P +RP F  + + L
Sbjct: 230 R-GYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFL 269

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 70/280 (25%), Positives = 126/280 (45%), Gaps = 27/280 (9%)
Query: 176 QSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGK-----RVGIEKLK-GCDKGNAY--E 227
           Q+ G     W +  ++L    ++G   F  V+ G      RV I+ LK G     A+  E
Sbjct: 170 QTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQE 229
Query: 228 FELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL--KSRKLQTKE 285
            ++ K L       H+ ++Q Y V  +E   + +VT+ M  GS+ D +     + L+  +
Sbjct: 230 AQVMKKL------RHEKLVQLYAVVSEEP--IYIVTEYMSKGSLLDFLKGETGKYLRLPQ 281
Query: 286 IIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYET 345
           ++ +A  +A G+ ++      +RDL +  IL+  +    + D G+    +   E T  + 
Sbjct: 282 LVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQG 340
Query: 346 DGY--RWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAA 402
             +  +W APE       ++     S+V+SFG+++ E+ T G   Y      +    +  
Sbjct: 341 AKFPIKWTAPEAALYGRFTIK----SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 396
Query: 403 CGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
            G R   P +CP+ L  LM +CW   P +RP F  + + L
Sbjct: 397 -GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 435

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 70/280 (25%), Positives = 126/280 (45%), Gaps = 27/280 (9%)
Query: 176 QSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGK-----RVGIEKLK-GCDKGNAY--E 227
           Q+ G     W +  ++L    ++G   F  V+ G      RV I+ LK G     A+  E
Sbjct: 170 QTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQE 229
Query: 228 FELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL--KSRKLQTKE 285
            ++ K L       H+ ++Q Y V  +E   + +VT+ M  GS+ D +     + L+  +
Sbjct: 230 AQVMKKL------RHEKLVQLYAVVSEEP--IYIVTEYMSKGSLLDFLKGETGKYLRLPQ 281
Query: 286 IIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYET 345
           ++ +A  +A G+ ++      +RDL +  IL+  +    + D G+    +   E T  + 
Sbjct: 282 LVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQG 340
Query: 346 DGY--RWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAA 402
             +  +W APE       ++     S+V+SFG+++ E+ T G   Y      +    +  
Sbjct: 341 AKFPIKWTAPEAALYGRFTIK----SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 396
Query: 403 CGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
            G R   P +CP+ L  LM +CW   P +RP F  + + L
Sbjct: 397 -GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 435

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 67/277 (24%), Positives = 123/277 (44%), Gaps = 21/277 (7%)
Query: 176 QSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGK-----RVGIEKLKGCDKGNAYEFEL 230
           Q+ G     W +  ++L    ++G   F  V+ G      RV I+ LK    GN      
Sbjct: 171 QTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK---PGNMSPEAF 227
Query: 231 RKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL--KSRKLQTKEIIR 288
            ++   +    H+ ++Q Y V  +E   + +VT+ M  GS+ D +     + L+  +++ 
Sbjct: 228 LQEAQVMKKLRHEKLVQLYAVVSEEP--IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVD 285
Query: 289 IAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY 348
           +A  +A G+ ++      +RDL +  IL+  +    + D G+    +   E T  +   +
Sbjct: 286 MAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLGRLIED-NEYTARQGAKF 344
Query: 349 --RWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGL 405
             +W APE       ++     S+V+SFG+++ E+ T G   Y      +    +   G 
Sbjct: 345 PIKWTAPEAALYGRFTIK----SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER-GY 399
Query: 406 RPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
           R   P +CP+ L  LM +CW   P +RP F  + + L
Sbjct: 400 RMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFL 436

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 64/239 (26%), Positives = 115/239 (48%), Gaps = 19/239 (7%)
Query: 207 YKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCV--DENHGLCVVTK 264
           + GK+V ++K+    K    E  L  +++ +    H N++  Y   +  DE   L VV +
Sbjct: 68  HTGKQVAVKKMD-LRKQQRREL-LFNEVVIMRDYHHDNVVDMYSSYLVGDE---LWVVME 122
Query: 265 LMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVC 324
            +EGG++ D++  +R +  ++I  + + V   + +L++ GV +RD+ S  ILL   G + 
Sbjct: 123 FLEGGALTDIVTHTR-MNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIK 181
Query: 325 LGDMGI-VTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT 383
           L D G      K V +        Y W+APE+I+  P         +++S G+++ EM+ 
Sbjct: 182 LSDFGFCAQVSKEVPKRKXLVGTPY-WMAPEVISRLPYGTE----VDIWSLGIMVIEMID 236
Query: 384 GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ---ILKSLMIKCWNNSPSKRPQFSEII 439
           GE  Y    P+QA   I    L P + KD  +   +L+  +       PS+R    E++
Sbjct: 237 GEPPYFNEPPLQAMRRIRDS-LPPRV-KDLHKVSSVLRGFLDLMLVREPSQRATAQELL 293

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 68/271 (25%), Positives = 123/271 (45%), Gaps = 27/271 (9%)
Query: 185 WLLNSDNLEFIDQIGPNSFKGVYKGK-----RVGIEKLK-GCDKGNAY--EFELRKDLLE 236
           W +  ++L    ++G   F  V+ G      RV I+ LK G     A+  E ++ K L  
Sbjct: 6   WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKL-- 63
Query: 237 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL--KSRKLQTKEIIRIAIDVA 294
                H+ ++Q Y V  +E   + +VT+ M  GS+ D +     + L+  +++ +A  +A
Sbjct: 64  ----RHEKLVQLYAVVSEEP--IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIA 117
Query: 295 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY--RWLA 352
            G+ ++      +RDL +  IL+  +    + D G+    +   E T  +   +  +W A
Sbjct: 118 SGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKWTA 176
Query: 353 PEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPK 411
           PE       ++     S+V+SFG+++ E+ T G   Y      +    +   G R   P 
Sbjct: 177 PEAALYGRFTIK----SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER-GYRMPCPP 231
Query: 412 DCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
           +CP+ L  LM +CW   P +RP F  + + L
Sbjct: 232 ECPESLHDLMCQCWRKEPEERPTFEYLQAFL 262

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 70/281 (24%), Positives = 127/281 (45%), Gaps = 27/281 (9%)
Query: 175 VQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGK-----RVGIEKLK-GCDKGNAY-- 226
           +Q+ G     W +  ++L    ++G   F  V+ G      RV I+ LK G     A+  
Sbjct: 3   MQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ 62
Query: 227 EFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL--KSRKLQTK 284
           E ++ K L       H+ ++Q Y V  +E   + +VT+ M  GS+ D +     + L+  
Sbjct: 63  EAQVMKKL------RHEKLVQLYAVVSEEP--IYIVTEYMSKGSLLDFLKGEMGKYLRLP 114
Query: 285 EIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE 344
           +++ +A  +A G+ ++      +RDL +  IL+  +    + D G+    +   E T  +
Sbjct: 115 QLVDMAAQIASGMAYVERMNYVHRDLAAANILVGENLVCKVADFGLARLIED-NEYTARQ 173
Query: 345 TDGY--RWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIA 401
              +  +W APE       ++     S+V+SFG+++ E+ T G   Y      +    + 
Sbjct: 174 GAKFPIKWTAPEAALYGRFTIK----SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 229
Query: 402 ACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
             G R   P +CP+ L  LM +CW   P +RP F  + + L
Sbjct: 230 R-GYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFL 269

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 68/271 (25%), Positives = 123/271 (45%), Gaps = 27/271 (9%)
Query: 185 WLLNSDNLEFIDQIGPNSFKGVYKGK-----RVGIEKLK-GCDKGNAY--EFELRKDLLE 236
           W +  ++L    ++G   F  V+ G      RV I+ LK G     A+  E ++ K L  
Sbjct: 4   WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKL-- 61
Query: 237 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL--KSRKLQTKEIIRIAIDVA 294
                H+ ++Q Y V  +E   + +VT+ M  GS+ D +     + L+  +++ +A  +A
Sbjct: 62  ----RHEKLVQLYAVVSEEP--IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIA 115
Query: 295 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY--RWLA 352
            G+ ++      +RDL +  IL+  +    + D G+    +   E T  +   +  +W A
Sbjct: 116 SGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKWTA 174
Query: 353 PEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPK 411
           PE       ++     S+V+SFG+++ E+ T G   Y      +    +   G R   P 
Sbjct: 175 PEAALYGRFTIK----SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER-GYRMPCPP 229
Query: 412 DCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
           +CP+ L  LM +CW   P +RP F  + + L
Sbjct: 230 ECPESLHDLMCQCWRKDPEERPTFEYLQAFL 260

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 66/278 (23%), Positives = 123/278 (44%), Gaps = 21/278 (7%)
Query: 175 VQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGK-----RVGIEKLKGCDKGNAYEFE 229
           +Q+ G     W +  ++L    ++G   F  V+ G      RV I+ LK    G      
Sbjct: 3   MQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK---PGTMSPEA 59
Query: 230 LRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL--KSRKLQTKEII 287
             ++   +    H+ ++Q Y V  +E   + +VT+ M  GS+ D +     + L+  +++
Sbjct: 60  FLQEAQVMKKIRHEKLVQLYAVVSEEP--IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLV 117
Query: 288 RIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG 347
            +A  +A G+ ++      +RDL +  IL+  +    + D G+    +   E T  +   
Sbjct: 118 DMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGAK 176
Query: 348 Y--RWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACG 404
           +  +W APE       ++     S+V+SFG+++ E+ T G   Y      +    +   G
Sbjct: 177 FPIKWTAPEAALYGRFTIK----SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER-G 231
Query: 405 LRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
            R   P +CP+ L  LM +CW   P +RP F  + + L
Sbjct: 232 YRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFL 269

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 68/271 (25%), Positives = 123/271 (45%), Gaps = 27/271 (9%)
Query: 185 WLLNSDNLEFIDQIGPNSFKGVYKGK-----RVGIEKLK-GCDKGNAY--EFELRKDLLE 236
           W +  ++L    ++G   F  V+ G      RV I+ LK G     A+  E ++ K L  
Sbjct: 2   WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKL-- 59
Query: 237 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL--KSRKLQTKEIIRIAIDVA 294
                H+ ++Q Y V  +E   + +VT+ M  GS+ D +     + L+  +++ +A  +A
Sbjct: 60  ----RHEKLVQLYAVVSEEP--IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIA 113
Query: 295 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY--RWLA 352
            G+ ++      +RDL +  IL+  +    + D G+    +   E T  +   +  +W A
Sbjct: 114 SGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKWTA 172
Query: 353 PEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPK 411
           PE       ++     S+V+SFG+++ E+ T G   Y      +    +   G R   P 
Sbjct: 173 PEAALYGRFTIK----SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER-GYRMPCPP 227
Query: 412 DCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
           +CP+ L  LM +CW   P +RP F  + + L
Sbjct: 228 ECPESLHDLMCQCWRKDPEERPTFEYLQAFL 258

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/253 (25%), Positives = 116/253 (45%), Gaps = 33/253 (13%)
Query: 212 VGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSV 271
           V ++ LK        +F+   +LL      H++I++FY VC D +  L +V + M+ G +
Sbjct: 48  VAVKALKDPTLAARKDFQREAELLT--NLQHEHIVKFYGVCGDGD-PLIMVFEYMKHGDL 104
Query: 272 ND----------LILKSRKLQTK------EIIRIAIDVAEGIKFLNDHGVAYRDLNSQRI 315
           N           +++  +  Q K      +++ IA  +A G+ +L      +RDL ++  
Sbjct: 105 NKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNC 164
Query: 316 LLDRHGNVCLGDMGIVTACKSVGEATEYETDGY-----RWLAPEIIAGDPESVSETWMSN 370
           L+  +  V +GD G+    + V     Y   G+     RW+ PE I     +      S+
Sbjct: 165 LVGANLLVKIGDFGM---SRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTE----SD 217
Query: 371 VYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSP 429
           V+SFG+++WE+ T G+  +   S  +    I   G   E P+ CP+ +  +M+ CW   P
Sbjct: 218 VWSFGVILWEIFTYGKQPWFQLSNTEVIECITQ-GRVLERPRVCPKEVYDVMLGCWQREP 276
Query: 430 SKRPQFSEIISLL 442
            +R    EI  +L
Sbjct: 277 QQRLNIKEIYKIL 289

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 70/280 (25%), Positives = 126/280 (45%), Gaps = 27/280 (9%)
Query: 176 QSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGK-----RVGIEKLK-GCDKGNAY--E 227
           Q+ G     W +  ++L    ++G   F  V+ G      RV I+ LK G     A+  E
Sbjct: 253 QTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQE 312
Query: 228 FELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL--KSRKLQTKE 285
            ++ K L       H+ ++Q Y V  +E   + +VT+ M  GS+ D +     + L+  +
Sbjct: 313 AQVMKKLR------HEKLVQLYAVVSEEP--IYIVTEYMSKGSLLDFLKGETGKYLRLPQ 364
Query: 286 IIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYET 345
           ++ +A  +A G+ ++      +RDL +  IL+  +    + D G+    +   E T  + 
Sbjct: 365 LVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQG 423
Query: 346 DGY--RWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAA 402
             +  +W APE       ++     S+V+SFG+++ E+ T G   Y      +  +    
Sbjct: 424 AKFPIKWTAPEAALYGRFTIK----SDVWSFGILLTELTTKGRVPYPGMV-NREVLDQVE 478
Query: 403 CGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
            G R   P +CP+ L  LM +CW   P +RP F  + + L
Sbjct: 479 RGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 518

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/290 (23%), Positives = 121/290 (41%), Gaps = 38/290 (13%)
Query: 184 RWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEK--------LKGCDKGNAY--EFELRKD 233
           +W    D L+    +G  +F  V +    GI+K        +K   +G  +     L  +
Sbjct: 23  KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSE 82
Query: 234 LLELMTCGHK-NILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK------------ 280
           L  L+  GH  N++     C      L V+ +  + G+++  +   R             
Sbjct: 83  LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYK 142
Query: 281 --LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG 338
             L  + +I  +  VA+G++FL      +RDL ++ ILL     V + D G+    + + 
Sbjct: 143 DFLTLEHLIXYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGL---ARDIX 199
Query: 339 EATEYETDG-----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACS 392
           +  +    G      +W+APE I     ++     S+V+SFG+++WE+ + G + Y    
Sbjct: 200 KDPDXVRKGDARLPLKWMAPETIFDRVYTIQ----SDVWSFGVLLWEIFSLGASPYPGVK 255
Query: 393 PVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
             +        G R   P      +   M+ CW+  PS+RP FSE++  L
Sbjct: 256 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/292 (23%), Positives = 120/292 (41%), Gaps = 40/292 (13%)
Query: 184 RWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD-------KGNAYEFELRKDLLE 236
           +W    D L+    +G  +F  V +    GI+K   C        K  A   E R  + E
Sbjct: 12  KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSE 71
Query: 237 L---MTCGHK-NILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK------------ 280
           L   +  GH  N++     C      L V+ +  + G+++  +   R             
Sbjct: 72  LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 131
Query: 281 ----LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS 336
               L  + +I  +  VA+G++FL      +RDL ++ ILL     V + D G+    + 
Sbjct: 132 YKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA---RD 188
Query: 337 VGEATEYETDG-----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAA 390
           + +  +    G      +W+APE I     ++     S+V+SFG+++WE+ + G + Y  
Sbjct: 189 IXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQ----SDVWSFGVLLWEIFSLGASPYPG 244
Query: 391 CSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
               +        G R   P      +   M+ CW+  PS+RP FSE++  L
Sbjct: 245 VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 296

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 68/285 (23%), Positives = 120/285 (42%), Gaps = 33/285 (11%)
Query: 184 RWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDK---------GNAYEFELRKDL 234
           +W    +NL+F   +G  +F  V +    G+ K     K          +A E E     
Sbjct: 32  KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSE 91
Query: 235 LELMTC--GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKS---------RKLQT 283
           L++M+    H+NI+     C      L +      G  +N L  K+         R L+ 
Sbjct: 92  LKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLEL 151
Query: 284 KEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY 343
           ++++  +  VA+G+ FL      +RD+ ++ +LL       +GD G+    + +   + Y
Sbjct: 152 RDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGL---ARDIMNDSNY 208
Query: 344 ETDG-----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAA 397
              G      +W+APE I     +V     S+V+S+G+++WE+ + G   Y         
Sbjct: 209 IVKGNARLPVKWMAPESIFDCVYTVQ----SDVWSYGILLWEIFSLGLNPYPGILVNSKF 264
Query: 398 VGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
             +   G +   P   P+ + S+M  CW   P+ RP F +I S L
Sbjct: 265 YKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFL 309

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/295 (23%), Positives = 121/295 (41%), Gaps = 40/295 (13%)
Query: 181 EIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD-------KGNAYEFELRKD 233
           +  +W    D L+    +G  +F  V +    GI+K   C        K  A   E R  
Sbjct: 18  DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRAL 77
Query: 234 LLEL---MTCGHK-NILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK--------- 280
           + EL   +  GH  N++     C      L V+ +  + G+++  +   R          
Sbjct: 78  MSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAP 137
Query: 281 -------LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTA 333
                  L  + +I  +  VA+G++FL      +RDL ++ ILL     V + D G+   
Sbjct: 138 EDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA-- 195
Query: 334 CKSVGEATEYETDG-----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAA 387
            + + +  +    G      +W+APE I     ++     S+V+SFG+++WE+ + G + 
Sbjct: 196 -RDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQ----SDVWSFGVLLWEIFSLGASP 250
Query: 388 YAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
           Y      +        G R   P      +   M+ CW+  PS+RP FSE++  L
Sbjct: 251 YPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/275 (23%), Positives = 132/275 (48%), Gaps = 22/275 (8%)
Query: 185 WLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFELR---KDLLELMTCG 241
           W +  + LE  + IG   F  VY G+  G   ++  D     E +L+   ++++      
Sbjct: 28  WDIPFEQLEIGELIGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTR 87
Query: 242 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFL 300
           H+N++ F   C+   H L ++T L +G ++  ++  ++  L   +  +IA ++ +G+ +L
Sbjct: 88  HENVVLFMGACMSPPH-LAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYL 146
Query: 301 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR----WL---AP 353
           +  G+ ++DL S+ +  D +G V + D G+ +    V +A   E D  R    WL   AP
Sbjct: 147 HAKGILHKDLKSKNVFYD-NGKVVITDFGLFS-ISGVLQAGRRE-DKLRIQNGWLCHLAP 203
Query: 354 EIIAGDPESVSETWM-----SNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPE 408
           EII        E  +     S+V++ G + +E+   E  +    P +A +     G++P 
Sbjct: 204 EIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFK-TQPAEAIIWQMGTGMKPN 262
Query: 409 IPK-DCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
           + +    + +  +++ CW     +RP F++++ +L
Sbjct: 263 LSQIGMGKEISDILLFCWAFEQEERPTFTKLMDML 297

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/294 (23%), Positives = 120/294 (40%), Gaps = 39/294 (13%)
Query: 181 EIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD-------KGNAYEFELRKD 233
           +  +W    D L     +G  +F  V +    GI+K   C        K  A   E R  
Sbjct: 19  DASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRAL 78
Query: 234 LLEL---MTCGHK-NILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK--------- 280
           + EL   +  GH  N++     C      L V+ +  + G+++  +   R          
Sbjct: 79  MSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPE 138
Query: 281 ------LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC 334
                 L  + +I  +  VA+G++FL      +RDL ++ ILL     V + D G+    
Sbjct: 139 DLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA--- 195
Query: 335 KSVGEATEYETDG-----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAY 388
           + + +  +    G      +W+APE I     ++     S+V+SFG+++WE+ + G + Y
Sbjct: 196 RDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQ----SDVWSFGVLLWEIFSLGASPY 251
Query: 389 AACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
                 +        G R   P      +   M+ CW+  PS+RP FSE++  L
Sbjct: 252 PGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/280 (24%), Positives = 126/280 (45%), Gaps = 27/280 (9%)
Query: 176 QSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGK-----RVGIEKLK-GCDKGNAY--E 227
           Q+ G     W +  ++L    ++G   F  V+ G      RV I+ LK G     A+  E
Sbjct: 1   QTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQE 60
Query: 228 FELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL--KSRKLQTKE 285
            ++ K L       H+ ++Q Y V  +E   + +VT+ M  GS+ D +     + L+  +
Sbjct: 61  AQVMKKL------RHEKLVQLYAVVSEEP--IYIVTEYMNKGSLLDFLKGETGKYLRLPQ 112
Query: 286 IIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYET 345
           ++ ++  +A G+ ++      +RDL +  IL+  +    + D G+    +   E T  + 
Sbjct: 113 LVDMSAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQG 171
Query: 346 DGY--RWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAA 402
             +  +W APE       ++     S+V+SFG+++ E+ T G   Y      +    +  
Sbjct: 172 AKFPIKWTAPEAALYGRFTIK----SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 227
Query: 403 CGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
            G R   P +CP+ L  LM +CW   P +RP F  + + L
Sbjct: 228 -GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 266

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 68/285 (23%), Positives = 119/285 (41%), Gaps = 33/285 (11%)
Query: 184 RWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDK---------GNAYEFELRKDL 234
           +W    +NL+F   +G  +F  V +    G+ K     K          +A E E     
Sbjct: 40  KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSE 99
Query: 235 LELMTC--GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKS---------RKLQT 283
           L++M+    H+NI+     C      L +      G  +N L  K+         R L+ 
Sbjct: 100 LKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLEL 159
Query: 284 KEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY 343
           ++++  +  VA+G+ FL      +RD+ ++ +LL       +GD G+    + +   + Y
Sbjct: 160 RDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGL---ARDIMNDSNY 216
Query: 344 ETDG-----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAA 397
              G      +W+APE I         T  S+V+S+G+++WE+ + G   Y         
Sbjct: 217 IVKGNARLPVKWMAPESIF----DCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF 272
Query: 398 VGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
             +   G +   P   P+ + S+M  CW   P+ RP F +I S L
Sbjct: 273 YKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFL 317

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/287 (22%), Positives = 130/287 (45%), Gaps = 49/287 (17%)
Query: 189 SDNLEFIDQIGPNSF----KGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKN 244
           +  ++ + QIG   +     G ++G++V ++     ++ + +      ++ + +   H+N
Sbjct: 36  AKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTEEASWFR---ETEIYQTVLMRHEN 92
Query: 245 ILQFYCVCVDENHG---LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 301
           IL F    +        L ++T   E GS+ D  LKS  L  K ++++A     G+  L+
Sbjct: 93  ILGFIAADIKGTGSWTQLYLITDYHENGSLYDY-LKSTTLDAKSMLKLAYSSVSGLCHLH 151
Query: 302 DH--------GVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE------TDG 347
                      +A+RDL S+ IL+ ++G  C+ D+G+  A K + +  E +         
Sbjct: 152 TEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL--AVKFISDTNEVDIPPNTRVGT 209
Query: 348 YRWLAPEII--AGDPESVSETWMSNVYSFGMVIWEM----VTG------EAAYAACSPVQ 395
            R++ PE++  + +        M+++YSFG+++WE+    V+G      +  Y    P  
Sbjct: 210 KRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSD 269
Query: 396 AAVG-----IAACGLRPEIPK-----DCPQILKSLMIKCWNNSPSKR 432
            +       +    LRP  P      +C + +  LM +CW ++P+ R
Sbjct: 270 PSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASR 316

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/267 (23%), Positives = 119/267 (44%), Gaps = 26/267 (9%)
Query: 187 LNSDNLEFIDQIGPNSFKGVYKG---------KRVGIEKLKGCDKGNAYEFELRKDLLEL 237
           +  + +E    IG   F  V++G           V I+  K C   +  E +  ++ L +
Sbjct: 7   IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVRE-KFLQEALTM 65
Query: 238 MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLI-LKSRKLQTKEIIRIAIDVAEG 296
               H +I++   V + EN  + ++ +L   G +   + ++   L    +I  A  ++  
Sbjct: 66  RQFDHPHIVKLIGV-ITEN-PVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTA 123
Query: 297 IKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRWLA 352
           + +L      +RD+ ++ +L+  +  V LGD G+    + + ++T  +        +W+A
Sbjct: 124 LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGL---SRYMEDSTXXKASKGKLPIKWMA 180
Query: 353 PEIIAGDP-ESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPK 411
           PE I      S S+ WM     FG+ +WE++               +G    G R  +P 
Sbjct: 181 PESINFRRFTSASDVWM-----FGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPP 235
Query: 412 DCPQILKSLMIKCWNNSPSKRPQFSEI 438
           +CP  L SLM KCW   PS+RP+F+E+
Sbjct: 236 NCPPTLYSLMTKCWAYDPSRRPRFTEL 262

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 69/295 (23%), Positives = 121/295 (41%), Gaps = 40/295 (13%)
Query: 181 EIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD-------KGNAYEFELRKD 233
           +  +W    D L+    +G  +F  V +    GI+K   C        K  A   E R  
Sbjct: 18  DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRAL 77
Query: 234 LLEL---MTCGHK-NILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK--------- 280
           + EL   +  GH  N++     C      L V+ +  + G+++  +   R          
Sbjct: 78  MSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAP 137
Query: 281 -------LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTA 333
                  L  + +I  +  VA+G++FL      +RDL ++ ILL     V + D G+   
Sbjct: 138 EDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA-- 195
Query: 334 CKSVGEATEYETDG-----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAA 387
            + + +  +    G      +W+APE I     ++     S+V+SFG+++WE+ + G + 
Sbjct: 196 -RDIYKDPDXVRKGDARLPLKWMAPETIFDRVYTIQ----SDVWSFGVLLWEIFSLGASP 250
Query: 388 YAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
           Y      +        G R   P      +   M+ CW+  PS+RP FSE++  L
Sbjct: 251 YPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 69/280 (24%), Positives = 126/280 (45%), Gaps = 27/280 (9%)
Query: 176 QSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGK-----RVGIEKLK-GCDKGNAY--E 227
           Q+ G     W +  ++L    ++G   F  V+ G      RV I+ LK G     A+  E
Sbjct: 1   QTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQE 60
Query: 228 FELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL--KSRKLQTKE 285
            ++ K L       H+ ++Q Y V  +E   + +VT+ M  GS+ D +     + L+  +
Sbjct: 61  AQVMKKL------RHEKLVQLYAVVSEEP--IYIVTEYMNKGSLLDFLKGETGKYLRLPQ 112
Query: 286 IIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYET 345
           ++ ++  +A G+ ++      +RDL +  IL+  +    + D G+    +   E T  + 
Sbjct: 113 LVDMSAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEWTARQG 171
Query: 346 DGY--RWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAA 402
             +  +W APE       ++     S+V+SFG+++ E+ T G   Y      +    +  
Sbjct: 172 AKFPIKWTAPEAALYGRFTIK----SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 227
Query: 403 CGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
            G R   P +CP+ L  LM +CW   P +RP F  + + L
Sbjct: 228 -GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 266

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 69/272 (25%), Positives = 125/272 (45%), Gaps = 28/272 (10%)
Query: 185 WLLNSDNLEFIDQIGPNSFKGVYKG-----KRVGIEKLK-GCDKGNAY--EFELRKDLLE 236
           W +  ++++ + ++G   F  V+ G      +V ++ LK G     A+  E  L K    
Sbjct: 7   WEIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMK---- 62
Query: 237 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR---KLQTKEIIRIAIDV 293
             T  H  +++ Y V   E   + ++T+ M  GS+ D  LKS    K+   ++I  +  +
Sbjct: 63  --TLQHDKLVRLYAVVTKE-EPIYIITEFMAKGSLLDF-LKSDEGGKVLLPKLIDFSAQI 118
Query: 294 AEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY--RWL 351
           AEG+ ++      +RDL +  +L+       + D G+    +   E T  E   +  +W 
Sbjct: 119 AEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIED-NEYTAREGAKFPIKWT 177
Query: 352 APEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIP 410
           APE I     ++     SNV+SFG++++E+VT G+  Y   +       ++  G R    
Sbjct: 178 APEAINFGCFTIK----SNVWSFGILLYEIVTYGKIPYPGRTNADVMSALSQ-GYRMPRM 232
Query: 411 KDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
           ++CP  L  +M  CW     +RP F  + S+L
Sbjct: 233 ENCPDELYDIMKMCWKEKAEERPTFDYLQSVL 264

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/271 (24%), Positives = 126/271 (46%), Gaps = 28/271 (10%)
Query: 186 LLNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLL 235
           +L     + I  +G  +F  VYKG            V I++L+      A + E+  +  
Sbjct: 8   ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EILDEAY 66
Query: 236 ELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVA 294
            + +  + ++ +   +C+     + ++T+LM  G + D + + +  + ++ ++   + +A
Sbjct: 67  VMASVDNPHVCRLLGICLTST--VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 124
Query: 295 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG-EATEYETDG----YR 349
           EG+ +L D  + +RDL ++ +L+    +V + D G+    K +G E  EY  +G     +
Sbjct: 125 EGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGL---AKLLGAEEKEYHAEGGKVPIK 181
Query: 350 WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPE 408
           W+A E I         T  S+V+S+G+ +WE++T G   Y    P      I   G R  
Sbjct: 182 WMALESILHR----IYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLP 236
Query: 409 IPKDCPQILKSLMIKCWNNSPSKRPQFSEII 439
            P  C   +  +M+KCW      RP+F E+I
Sbjct: 237 QPPICTIDVYMIMVKCWMIDADSRPKFRELI 267

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 76/290 (26%), Positives = 132/290 (45%), Gaps = 44/290 (15%)
Query: 186 LLNSDNLEFIDQIGPNSFKGVYKG--KRVGIEKLKGCDKGNAY-----EFELRKDLLELM 238
           +L+ ++++F D IG  +F  V K   K+ G+       +   Y       +   +L  L 
Sbjct: 21  VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLC 80
Query: 239 TCGHK-NILQFYCVCVDENHG-LCVVTKLMEGGSVNDLILKSRKLQT------------- 283
             GH  NI+     C  E+ G L +  +    G++ D + KSR L+T             
Sbjct: 81  KLGHHPNIINLLGAC--EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 138
Query: 284 ---KEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGI-----VTACK 335
              ++++  A DVA G+ +L+     +RDL ++ IL+  +    + D G+     V   K
Sbjct: 139 LSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK 198
Query: 336 SVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPV 394
           ++G          RW+A E +     SV  T  S+V+S+G+++WE+V+ G   Y   +  
Sbjct: 199 TMGRLP------VRWMAIESLN---YSVYTT-NSDVWSYGVLLWEIVSLGGTPYCGMTCA 248
Query: 395 QAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR 444
           +    +   G R E P +C   +  LM +CW   P +RP F++I+  L R
Sbjct: 249 ELYEKLPQ-GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 297

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 96/216 (44%), Gaps = 34/216 (15%)
Query: 242 HKNILQFYCVCVD-ENHGL---CVVTKLMEGGSVNDLILKSR------KLQTKEIIRIAI 291
           H N+++   VC++  + G+    V+   M+ G ++  +L SR       +  + +++  +
Sbjct: 95  HPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMV 154
Query: 292 DVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR-- 349
           D+A G+++L++    +RDL ++  +L     VC+ D G+            Y  D YR  
Sbjct: 155 DIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKI--------YSGDYYRQG 206
Query: 350 --------WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGI 400
                   W+A E +A        T  S+V++FG+ +WE+ T G   Y            
Sbjct: 207 RIAKMPVKWIAIESLA----DRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN-HEMYDY 261
Query: 401 AACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFS 436
              G R + P+DC   L  +M  CW   P  RP FS
Sbjct: 262 LLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFS 297

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 12/205 (5%)
Query: 245 ILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHG 304
           I++   +C  E     +V ++ E G +N  + ++R ++ K II +   V+ G+K+L +  
Sbjct: 74  IVRMIGIC--EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN 131
Query: 305 VAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG---YRWLAPEIIAGDPE 361
             +RDL ++ +LL       + D G+  A ++     + +T G    +W APE I     
Sbjct: 132 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAPECINYYKF 191
Query: 362 SVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSL 420
           S      S+V+SFG+++WE  + G+  Y      +    +   G R   P  CP+ +  L
Sbjct: 192 SSK----SDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK-GERMGCPAGCPREMYDL 246
Query: 421 MIKCWNNSPSKRPQFSEIISLLLRT 445
           M  CW      RP F+  + L LR 
Sbjct: 247 MNLCWTYDVENRPGFA-AVELRLRN 270

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 12/205 (5%)
Query: 245 ILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHG 304
           I++   +C  E     +V ++ E G +N  + ++R ++ K II +   V+ G+K+L +  
Sbjct: 68  IVRMIGIC--EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN 125
Query: 305 VAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG---YRWLAPEIIAGDPE 361
             +RDL ++ +LL       + D G+  A ++     + +T G    +W APE I     
Sbjct: 126 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF 185
Query: 362 SVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSL 420
           S      S+V+SFG+++WE  + G+  Y      +    +   G R   P  CP+ +  L
Sbjct: 186 SSK----SDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK-GERMGCPAGCPREMYDL 240
Query: 421 MIKCWNNSPSKRPQFSEIISLLLRT 445
           M  CW      RP F+  + L LR 
Sbjct: 241 MNLCWTYDVENRPGFA-AVELRLRN 264

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 75/291 (25%), Positives = 134/291 (46%), Gaps = 46/291 (15%)
Query: 186 LLNSDNLEFIDQIGPNSFKGVYKGK--------RVGIEKLKGCDKGNAYEFELRKDLLEL 237
           +L+ ++++F D IG  +F  V K +           I+++K     + +  +   +L  L
Sbjct: 11  VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHR-DFAGELEVL 69
Query: 238 MTCGHK-NILQFYCVCVDENHG-LCVVTKLMEGGSVNDLILKSRKLQT------------ 283
              GH  NI+     C  E+ G L +  +    G++ D + KSR L+T            
Sbjct: 70  CKLGHHPNIINLLGAC--EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAS 127
Query: 284 ----KEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGI-----VTAC 334
               ++++  A DVA G+ +L+     +RDL ++ IL+  +    + D G+     V   
Sbjct: 128 TLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK 187
Query: 335 KSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSP 393
           K++G          RW+A E +     SV  T  S+V+S+G+++WE+V+ G   Y   + 
Sbjct: 188 KTMGRLP------VRWMAIESLN---YSVYTT-NSDVWSYGVLLWEIVSLGGTPYCGMTC 237
Query: 394 VQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR 444
            +    +   G R E P +C   +  LM +CW   P +RP F++I+  L R
Sbjct: 238 AELYEKLPQ-GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 287

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 69/281 (24%), Positives = 126/281 (44%), Gaps = 27/281 (9%)
Query: 175 VQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGK-----RVGIEKLK-GCDKGNAY-- 226
           +Q+ G     W +  ++L    ++G   F  V+ G      RV I+ LK G     A+  
Sbjct: 3   MQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ 62
Query: 227 EFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL--KSRKLQTK 284
           E ++ K L       H+ ++Q Y V  +E   + +VT+ M  G + D +     + L+  
Sbjct: 63  EAQVMKKL------RHEKLVQLYAVVSEEP--IYIVTEYMSKGCLLDFLKGEMGKYLRLP 114
Query: 285 EIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE 344
           +++ +A  +A G+ ++      +RDL +  IL+  +    + D G+    +   E T  +
Sbjct: 115 QLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQ 173
Query: 345 TDGY--RWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIA 401
              +  +W APE       ++     S+V+SFG+++ E+ T G   Y      +    + 
Sbjct: 174 GAKFPIKWTAPEAALYGRFTIK----SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 229
Query: 402 ACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
             G R   P +CP+ L  LM +CW   P +RP F  + + L
Sbjct: 230 R-GYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFL 269

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 69/281 (24%), Positives = 126/281 (44%), Gaps = 27/281 (9%)
Query: 175 VQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGK-----RVGIEKLK-GCDKGNAY-- 226
           +Q+ G     W +  ++L    ++G   F  V+ G      RV I+ LK G     A+  
Sbjct: 3   MQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ 62
Query: 227 EFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL--KSRKLQTK 284
           E ++ K L       H+ ++Q Y V  +E   + +V + M  GS+ D +     + L+  
Sbjct: 63  EAQVMKKL------RHEKLVQLYAVVSEEP--IYIVIEYMSKGSLLDFLKGEMGKYLRLP 114
Query: 285 EIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE 344
           +++ +A  +A G+ ++      +RDL +  IL+  +    + D G+    +   E T  +
Sbjct: 115 QLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEXTARQ 173
Query: 345 TDGY--RWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIA 401
              +  +W APE       ++     S+V+SFG+++ E+ T G   Y      +    + 
Sbjct: 174 GAKFPIKWTAPEAALYGRFTIK----SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 229
Query: 402 ACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
             G R   P +CP+ L  LM +CW   P +RP F  + + L
Sbjct: 230 R-GYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFL 269

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 12/205 (5%)
Query: 245 ILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHG 304
           I++   +C  E     +V ++ E G +N  + ++R ++ K II +   V+ G+K+L +  
Sbjct: 80  IVRMIGIC--EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN 137
Query: 305 VAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG---YRWLAPEIIAGDPE 361
             +RDL ++ +LL       + D G+  A ++     + +T G    +W APE I     
Sbjct: 138 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF 197
Query: 362 SVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSL 420
           S      S+V+SFG+++WE  + G+  Y      +    +   G R   P  CP+ +  L
Sbjct: 198 SSK----SDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK-GERMGCPAGCPREMYDL 252
Query: 421 MIKCWNNSPSKRPQFSEIISLLLRT 445
           M  CW      RP F+  + L LR 
Sbjct: 253 MNLCWTYDVENRPGFA-AVELRLRN 276

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 96/205 (46%), Gaps = 12/205 (5%)
Query: 245 ILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHG 304
           I++   +C  E     +V ++ E G +N  + ++R ++ K II +   V+ G+K+L +  
Sbjct: 432 IVRMIGIC--EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN 489
Query: 305 VAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG---YRWLAPEIIAGDPE 361
             +RDL ++ +LL       + D G+  A ++     + +T G    +W APE I     
Sbjct: 490 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI----N 545
Query: 362 SVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSL 420
               +  S+V+SFG+++WE  + G+  Y      +    +   G R   P  CP+ +  L
Sbjct: 546 YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK-GERMGCPAGCPREMYDL 604
Query: 421 MIKCWNNSPSKRPQFSEIISLLLRT 445
           M  CW      RP F+  + L LR 
Sbjct: 605 MNLCWTYDVENRPGFA-AVELRLRN 628

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 12/205 (5%)
Query: 245 ILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHG 304
           I++   +C  E     +V ++ E G +N  + ++R ++ K II +   V+ G+K+L +  
Sbjct: 70  IVRMIGIC--EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN 127
Query: 305 VAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG---YRWLAPEIIAGDPE 361
             +RDL ++ +LL       + D G+  A ++     + +T G    +W APE I     
Sbjct: 128 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF 187
Query: 362 SVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSL 420
           S      S+V+SFG+++WE  + G+  Y      +    +   G R   P  CP+ +  L
Sbjct: 188 SSK----SDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK-GERMGCPAGCPREMYDL 242
Query: 421 MIKCWNNSPSKRPQFSEIISLLLRT 445
           M  CW      RP F+  + L LR 
Sbjct: 243 MNLCWTYDVENRPGFA-AVELRLRN 266

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 12/205 (5%)
Query: 245 ILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHG 304
           I++   +C  E     +V ++ E G +N  + ++R ++ K II +   V+ G+K+L +  
Sbjct: 74  IVRMIGIC--EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN 131
Query: 305 VAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG---YRWLAPEIIAGDPE 361
             +RDL ++ +LL       + D G+  A ++     + +T G    +W APE I     
Sbjct: 132 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF 191
Query: 362 SVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSL 420
           S      S+V+SFG+++WE  + G+  Y      +    +   G R   P  CP+ +  L
Sbjct: 192 SSK----SDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK-GERMGCPAGCPREMYDL 246
Query: 421 MIKCWNNSPSKRPQFSEIISLLLRT 445
           M  CW      RP F+  + L LR 
Sbjct: 247 MNLCWTYDVENRPGFA-AVELRLRN 270

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 12/205 (5%)
Query: 245 ILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHG 304
           I++   +C  E     +V ++ E G +N  + ++R ++ K II +   V+ G+K+L +  
Sbjct: 88  IVRMIGIC--EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN 145
Query: 305 VAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG---YRWLAPEIIAGDPE 361
             +RDL ++ +LL       + D G+  A ++     + +T G    +W APE I     
Sbjct: 146 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF 205
Query: 362 SVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSL 420
           S      S+V+SFG+++WE  + G+  Y      +    +   G R   P  CP+ +  L
Sbjct: 206 SSK----SDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK-GERMGCPAGCPREMYDL 260
Query: 421 MIKCWNNSPSKRPQFSEIISLLLRT 445
           M  CW      RP F+  + L LR 
Sbjct: 261 MNLCWTYDVENRPGFA-AVELRLRN 284

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 96/205 (46%), Gaps = 12/205 (5%)
Query: 245 ILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHG 304
           I++   +C  E     +V ++ E G +N  + ++R ++ K II +   V+ G+K+L +  
Sbjct: 433 IVRMIGIC--EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN 490
Query: 305 VAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG---YRWLAPEIIAGDPE 361
             +RDL ++ +LL       + D G+  A ++     + +T G    +W APE I     
Sbjct: 491 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI----N 546
Query: 362 SVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSL 420
               +  S+V+SFG+++WE  + G+  Y      +    +   G R   P  CP+ +  L
Sbjct: 547 YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK-GERMGCPAGCPREMYDL 605
Query: 421 MIKCWNNSPSKRPQFSEIISLLLRT 445
           M  CW      RP F+  + L LR 
Sbjct: 606 MNLCWTYDVENRPGFA-AVELRLRN 629

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 12/205 (5%)
Query: 245 ILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHG 304
           I++   +C  E     +V ++ E G +N  + ++R ++ K II +   V+ G+K+L +  
Sbjct: 90  IVRMIGIC--EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN 147
Query: 305 VAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG---YRWLAPEIIAGDPE 361
             +RDL ++ +LL       + D G+  A ++     + +T G    +W APE I     
Sbjct: 148 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF 207
Query: 362 SVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSL 420
           S      S+V+SFG+++WE  + G+  Y      +    +   G R   P  CP+ +  L
Sbjct: 208 SSK----SDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK-GERMGCPAGCPREMYDL 262
Query: 421 MIKCWNNSPSKRPQFSEIISLLLRT 445
           M  CW      RP F+  + L LR 
Sbjct: 263 MNLCWTYDVENRPGFA-AVELRLRN 286

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 12/205 (5%)
Query: 245 ILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHG 304
           I++   +C  E     +V ++ E G +N  + ++R ++ K II +   V+ G+K+L +  
Sbjct: 90  IVRMIGIC--EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN 147
Query: 305 VAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG---YRWLAPEIIAGDPE 361
             +RDL ++ +LL       + D G+  A ++     + +T G    +W APE I     
Sbjct: 148 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF 207
Query: 362 SVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSL 420
           S      S+V+SFG+++WE  + G+  Y      +    +   G R   P  CP+ +  L
Sbjct: 208 SSK----SDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK-GERMGCPAGCPREMYDL 262
Query: 421 MIKCWNNSPSKRPQFSEIISLLLRT 445
           M  CW      RP F+  + L LR 
Sbjct: 263 MNLCWTYDVENRPGFA-AVELRLRN 286

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 69/281 (24%), Positives = 126/281 (44%), Gaps = 27/281 (9%)
Query: 175 VQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGK-----RVGIEKLK-GCDKGNAY-- 226
           +Q+ G     W +  ++L    ++G   F  V+ G      RV I+ LK G     A+  
Sbjct: 3   MQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ 62
Query: 227 EFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL--KSRKLQTK 284
           E ++ K L       H+ ++Q Y V  +E   + +V + M  GS+ D +     + L+  
Sbjct: 63  EAQVMKKL------RHEKLVQLYAVVSEEP--IYIVIEYMSKGSLLDFLKGEMGKYLRLP 114
Query: 285 EIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE 344
           +++ +A  +A G+ ++      +RDL +  IL+  +    + D G+    +   E T  +
Sbjct: 115 QLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQ 173
Query: 345 TDGY--RWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIA 401
              +  +W APE       ++     S+V+SFG+++ E+ T G   Y      +    + 
Sbjct: 174 GAKFPIKWTAPEAALYGRFTIK----SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 229
Query: 402 ACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
             G R   P +CP+ L  LM +CW   P +RP F  + + L
Sbjct: 230 R-GYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFL 269

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 65/271 (23%), Positives = 126/271 (46%), Gaps = 28/271 (10%)
Query: 186 LLNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLL 235
           +L     + I  +G  +F  VYKG            V I++L+      A + E+  +  
Sbjct: 11  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EILDEAY 69
Query: 236 ELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVA 294
            + +  + ++ +   +C+     + ++T+LM  G + D + + +  + ++ ++   + +A
Sbjct: 70  VMASVDNPHVCRLLGICLTST--VQLITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIA 127
Query: 295 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG-EATEYETDG----YR 349
           +G+ +L D  + +RDL ++ +L+    +V + D G+    K +G E  EY  +G     +
Sbjct: 128 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGL---AKLLGAEEKEYHAEGGKVPIK 184
Query: 350 WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPE 408
           W+A E I         T  S+V+S+G+ +WE++T G   Y    P      I   G R  
Sbjct: 185 WMALESILHR----IYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLP 239
Query: 409 IPKDCPQILKSLMIKCWNNSPSKRPQFSEII 439
            P  C   +  +M+KCW      RP+F E+I
Sbjct: 240 QPPICTIDVYMIMVKCWMIDADSRPKFRELI 270

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 69/281 (24%), Positives = 126/281 (44%), Gaps = 27/281 (9%)
Query: 175 VQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGK-----RVGIEKLK-GCDKGNAY-- 226
           +Q+ G     W +  ++L    ++G   F  V+ G      RV I+ LK G     A+  
Sbjct: 3   MQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ 62
Query: 227 EFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL--KSRKLQTK 284
           E ++ K L       H+ ++Q Y V  +E   + +V + M  GS+ D +     + L+  
Sbjct: 63  EAQVMKKL------RHEKLVQLYAVVSEEP--IYIVCEYMSKGSLLDFLKGEMGKYLRLP 114
Query: 285 EIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE 344
           +++ +A  +A G+ ++      +RDL +  IL+  +    + D G+    +   E T  +
Sbjct: 115 QLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQ 173
Query: 345 TDGY--RWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIA 401
              +  +W APE       ++     S+V+SFG+++ E+ T G   Y      +    + 
Sbjct: 174 GAKFPIKWTAPEAALYGRFTIK----SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 229
Query: 402 ACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
             G R   P +CP+ L  LM +CW   P +RP F  + + L
Sbjct: 230 R-GYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFL 269

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 69/280 (24%), Positives = 125/280 (44%), Gaps = 27/280 (9%)
Query: 176 QSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGK-----RVGIEKLK-GCDKGNAY--E 227
           Q+ G     W +  ++L    ++G   F  V+ G      RV I+ LK G     A+  E
Sbjct: 170 QTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQE 229
Query: 228 FELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL--KSRKLQTKE 285
            ++ K L       H+ ++Q Y V  +E   + +V + M  GS+ D +     + L+  +
Sbjct: 230 AQVMKKLR------HEKLVQLYAVVSEEP--IYIVGEYMSKGSLLDFLKGETGKYLRLPQ 281
Query: 286 IIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYET 345
           ++ +A  +A G+ ++      +RDL +  IL+  +    + D G+    +   E T  + 
Sbjct: 282 LVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQG 340
Query: 346 DGY--RWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAA 402
             +  +W APE       ++     S+V+SFG+++ E+ T G   Y      +    +  
Sbjct: 341 AKFPIKWTAPEAALYGRFTIK----SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 396
Query: 403 CGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
            G R   P +CP+ L  LM +CW   P +RP F  + + L
Sbjct: 397 -GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 435

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 65/250 (26%), Positives = 116/250 (46%), Gaps = 28/250 (11%)
Query: 212 VGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSV 271
           V ++ LK   +    +F+   +LL ++   H++I++F+ VC  E   L +V + M  G +
Sbjct: 74  VAVKALKEASESARQDFQREAELLTMLQ--HQHIVRFFGVCT-EGRPLLMVFEYMRHGDL 130
Query: 272 NDLI---------------LKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRIL 316
           N  +               +    L   +++ +A  VA G+ +L      +RDL ++  L
Sbjct: 131 NRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCL 190
Query: 317 LDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESV---SETWMSNVYS 373
           + +   V +GD G+     S    T+Y   G R + P I    PES+     T  S+V+S
Sbjct: 191 VGQGLVVKIGDFGMSRDIYS----TDYYRVGGRTMLP-IRWMPPESILYRKFTTESDVWS 245
Query: 374 FGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKR 432
           FG+V+WE+ T G+  +   S  +A +     G   E P+ CP  + ++M  CW   P +R
Sbjct: 246 FGVVLWEIFTYGKQPWYQLSNTEA-IDCITQGRELERPRACPPEVYAIMRGCWQREPQQR 304
Query: 433 PQFSEIISLL 442
               ++ + L
Sbjct: 305 HSIKDVHARL 314

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 63/270 (23%), Positives = 124/270 (45%), Gaps = 26/270 (9%)
Query: 186 LLNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLL 235
           +L     + I  +G  +F  VYKG            V I++L+      A + E+  +  
Sbjct: 17  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EILDEAY 75
Query: 236 ELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVA 294
            + +  + ++ +   +C+     + ++T+LM  G + D + + +  + ++ ++   + +A
Sbjct: 76  VMASVDNPHVCRLLGICLTST--VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 133
Query: 295 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRW 350
           +G+ +L D  + +RDL ++ +L+    +V + D G+     +  E  EY  +G     +W
Sbjct: 134 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA--EEKEYHAEGGKVPIKW 191
Query: 351 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEI 409
           +A E I         T  S+V+S+G+ +WE++T G   Y    P      I   G R   
Sbjct: 192 MALESILHR----IYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQ 246
Query: 410 PKDCPQILKSLMIKCWNNSPSKRPQFSEII 439
           P  C   +  +M+KCW      RP+F E+I
Sbjct: 247 PPICTIDVYMIMVKCWMIDADSRPKFRELI 276

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 104/222 (46%), Gaps = 24/222 (10%)
Query: 235 LELMTC-GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQT--KEIIRIAI 291
           +++M C  H N+L+F  V   +   L  +T+ ++GG++  +I KS   Q    + +  A 
Sbjct: 58  VKVMRCLEHPNVLKFIGVLYKDKR-LNFITEYIKGGTLRGII-KSMDSQYPWSQRVSFAK 115
Query: 292 DVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGI-------------VTACKSVG 338
           D+A G+ +L+   + +RDLNS   L+  + NV + D G+             + + K   
Sbjct: 116 DIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPD 175
Query: 339 EATEYETDGY-RWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAA 397
               Y   G   W+APE+I G   S  E    +V+SFG+V+ E++    A     P    
Sbjct: 176 RKKRYTVVGNPYWMAPEMING--RSYDEK--VDVFSFGIVLCEIIGRVNADPDYLPRTMD 231
Query: 398 VGIAACG-LRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEI 438
            G+   G L    P +CP     + ++C +  P KRP F ++
Sbjct: 232 FGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKL 273

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 63/270 (23%), Positives = 124/270 (45%), Gaps = 26/270 (9%)
Query: 186 LLNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLL 235
           +L     + I  +G  +F  VYKG            V I++L+      A + E+  +  
Sbjct: 18  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EILDEAY 76
Query: 236 ELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVA 294
            + +  + ++ +   +C+     + ++T+LM  G + D + + +  + ++ ++   + +A
Sbjct: 77  VMASVDNPHVCRLLGICLTST--VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 134
Query: 295 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRW 350
           +G+ +L D  + +RDL ++ +L+    +V + D G+     +  E  EY  +G     +W
Sbjct: 135 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA--EEKEYHAEGGKVPIKW 192
Query: 351 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEI 409
           +A E I         T  S+V+S+G+ +WE++T G   Y    P      I   G R   
Sbjct: 193 MALESILHR----IYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQ 247
Query: 410 PKDCPQILKSLMIKCWNNSPSKRPQFSEII 439
           P  C   +  +M+KCW      RP+F E+I
Sbjct: 248 PPICTIDVYMIMVKCWMIDADSRPKFRELI 277

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 63/270 (23%), Positives = 124/270 (45%), Gaps = 26/270 (9%)
Query: 186 LLNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLL 235
           +L     + I  +G  +F  VYKG            V I++L+      A + E+  +  
Sbjct: 14  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EILDEAY 72
Query: 236 ELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVA 294
            + +  + ++ +   +C+     + ++T+LM  G + D + + +  + ++ ++   + +A
Sbjct: 73  VMASVDNPHVCRLLGICLTST--VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 130
Query: 295 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRW 350
           +G+ +L D  + +RDL ++ +L+    +V + D G+     +  E  EY  +G     +W
Sbjct: 131 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA--EEKEYHAEGGKVPIKW 188
Query: 351 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEI 409
           +A E I         T  S+V+S+G+ +WE++T G   Y    P      I   G R   
Sbjct: 189 MALESILHR----IYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQ 243
Query: 410 PKDCPQILKSLMIKCWNNSPSKRPQFSEII 439
           P  C   +  +M+KCW      RP+F E+I
Sbjct: 244 PPICTIDVYMIMVKCWMIDADSRPKFRELI 273

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 65/250 (26%), Positives = 116/250 (46%), Gaps = 28/250 (11%)
Query: 212 VGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSV 271
           V ++ LK   +    +F+   +LL ++   H++I++F+ VC  E   L +V + M  G +
Sbjct: 45  VAVKALKEASESARQDFQREAELLTMLQ--HQHIVRFFGVCT-EGRPLLMVFEYMRHGDL 101
Query: 272 NDLI---------------LKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRIL 316
           N  +               +    L   +++ +A  VA G+ +L      +RDL ++  L
Sbjct: 102 NRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCL 161
Query: 317 LDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESV---SETWMSNVYS 373
           + +   V +GD G+     S    T+Y   G R + P I    PES+     T  S+V+S
Sbjct: 162 VGQGLVVKIGDFGMSRDIYS----TDYYRVGGRTMLP-IRWMPPESILYRKFTTESDVWS 216
Query: 374 FGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKR 432
           FG+V+WE+ T G+  +   S  +A +     G   E P+ CP  + ++M  CW   P +R
Sbjct: 217 FGVVLWEIFTYGKQPWYQLSNTEA-IDCITQGRELERPRACPPEVYAIMRGCWQREPQQR 275
Query: 433 PQFSEIISLL 442
               ++ + L
Sbjct: 276 HSIKDVHARL 285

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 63/270 (23%), Positives = 124/270 (45%), Gaps = 26/270 (9%)
Query: 186 LLNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLL 235
           +L     + I  +G  +F  VYKG            V I++L+      A + E+  +  
Sbjct: 11  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EILDEAY 69
Query: 236 ELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVA 294
            + +  + ++ +   +C+     + ++T+LM  G + D + + +  + ++ ++   + +A
Sbjct: 70  VMASVDNPHVCRLLGICLTST--VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 127
Query: 295 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRW 350
           +G+ +L D  + +RDL ++ +L+    +V + D G+     +  E  EY  +G     +W
Sbjct: 128 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA--EEKEYHAEGGKVPIKW 185
Query: 351 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEI 409
           +A E I         T  S+V+S+G+ +WE++T G   Y    P      I   G R   
Sbjct: 186 MALESILHR----IYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQ 240
Query: 410 PKDCPQILKSLMIKCWNNSPSKRPQFSEII 439
           P  C   +  +M+KCW      RP+F E+I
Sbjct: 241 PPICTIDVYMIMVKCWMIDADSRPKFRELI 270

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 66/270 (24%), Positives = 127/270 (47%), Gaps = 24/270 (8%)
Query: 185 WLLNSDNLEFIDQIGPNSFKGVYKG-----KRVGIEKLK-GCDKGNAYEFELRKDLLELM 238
           W +  ++++ + ++G   F  V+ G      +V ++ LK G     A+  E   +L++  
Sbjct: 8   WEIPRESIKLVKRLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEE--ANLMK-- 63
Query: 239 TCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR---KLQTKEIIRIAIDVAE 295
           T  H  +++ Y V   E   + ++T+ M  GS+ D  LKS    K+   ++I  +  +AE
Sbjct: 64  TLQHDKLVRLYAVVTRE-EPIYIITEYMAKGSLLDF-LKSDEGGKVLLPKLIDFSAQIAE 121
Query: 296 GIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY--RWLAP 353
           G+ ++      +RDL +  +L+       + D G+    +   E T  E   +  +W AP
Sbjct: 122 GMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIED-NEYTAREGAKFPIKWTAP 180
Query: 354 EIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKD 412
           E I     ++     S+V+SFG++++E+VT G+  Y   +       ++     P + ++
Sbjct: 181 EAINFGCFTIK----SDVWSFGILLYEIVTYGKIPYPGRTNADVMTALSQGYRMPRV-EN 235
Query: 413 CPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
           CP  L  +M  CW     +RP F  + S+L
Sbjct: 236 CPDELYDIMKMCWKEKAEERPTFDYLQSVL 265

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 63/270 (23%), Positives = 124/270 (45%), Gaps = 26/270 (9%)
Query: 186 LLNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLL 235
           +L     + I  +G  +F  VYKG            V I++L+      A + E+  +  
Sbjct: 14  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EILDEAY 72
Query: 236 ELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVA 294
            + +  + ++ +   +C+     + ++T+LM  G + D + + +  + ++ ++   + +A
Sbjct: 73  VMASVDNPHVCRLLGICLTST--VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 130
Query: 295 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRW 350
           +G+ +L D  + +RDL ++ +L+    +V + D G+     +  E  EY  +G     +W
Sbjct: 131 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA--EEKEYHAEGGKVPIKW 188
Query: 351 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEI 409
           +A E I         T  S+V+S+G+ +WE++T G   Y    P      I   G R   
Sbjct: 189 MALESILHR----IYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQ 243
Query: 410 PKDCPQILKSLMIKCWNNSPSKRPQFSEII 439
           P  C   +  +M+KCW      RP+F E+I
Sbjct: 244 PPICTIDVYMIMVKCWMIDADSRPKFRELI 273

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 63/270 (23%), Positives = 124/270 (45%), Gaps = 26/270 (9%)
Query: 186 LLNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLL 235
           +L     + I  +G  +F  VYKG            V I++L+      A + E+  +  
Sbjct: 13  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EILDEAY 71
Query: 236 ELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVA 294
            + +  + ++ +   +C+     + ++T+LM  G + D + + +  + ++ ++   + +A
Sbjct: 72  VMASVDNPHVCRLLGICLTST--VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 129
Query: 295 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRW 350
           +G+ +L D  + +RDL ++ +L+    +V + D G+     +  E  EY  +G     +W
Sbjct: 130 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA--EEKEYHAEGGKVPIKW 187
Query: 351 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEI 409
           +A E I         T  S+V+S+G+ +WE++T G   Y    P      I   G R   
Sbjct: 188 MALESILHR----IYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQ 242
Query: 410 PKDCPQILKSLMIKCWNNSPSKRPQFSEII 439
           P  C   +  +M+KCW      RP+F E+I
Sbjct: 243 PPICTIDVYMIMVKCWMIDADSRPKFRELI 272

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 63/270 (23%), Positives = 124/270 (45%), Gaps = 26/270 (9%)
Query: 186 LLNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLL 235
           +L     + I  +G  +F  VYKG            V I++L+      A + E+  +  
Sbjct: 36  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EILDEAY 94
Query: 236 ELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVA 294
            + +  + ++ +   +C+     + ++T+LM  G + D + + +  + ++ ++   + +A
Sbjct: 95  VMASVDNPHVCRLLGICLTST--VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 152
Query: 295 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRW 350
           +G+ +L D  + +RDL ++ +L+    +V + D G+     +  E  EY  +G     +W
Sbjct: 153 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA--EEKEYHAEGGKVPIKW 210
Query: 351 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEI 409
           +A E I         T  S+V+S+G+ +WE++T G   Y    P      I   G R   
Sbjct: 211 MALESILHR----IYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQ 265
Query: 410 PKDCPQILKSLMIKCWNNSPSKRPQFSEII 439
           P  C   +  +M+KCW      RP+F E+I
Sbjct: 266 PPICTIDVYMIMVKCWMIDADSRPKFRELI 295

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 66/271 (24%), Positives = 125/271 (46%), Gaps = 28/271 (10%)
Query: 186 LLNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLL 235
           +L     + I  +G  +F  VYKG            V I++L+      A + E+  +  
Sbjct: 5   ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EILDEAY 63
Query: 236 ELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVA 294
            + +  + ++ +   +C+     L  +T+LM  G + D + + +  + ++ ++   + +A
Sbjct: 64  VMASVDNPHVCRLLGICLTSTVQL--ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 121
Query: 295 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG-EATEYETDG----YR 349
           +G+ +L D  + +RDL ++ +L+    +V + D G+    K +G E  EY  +G     +
Sbjct: 122 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGL---AKLLGAEEKEYHAEGGKVPIK 178
Query: 350 WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPE 408
           W+A E I         T  S+V+S+G+ +WE++T G   Y    P      I   G R  
Sbjct: 179 WMALESILHR----IYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLP 233
Query: 409 IPKDCPQILKSLMIKCWNNSPSKRPQFSEII 439
            P  C   +  +M+KCW      RP+F E+I
Sbjct: 234 QPPICTIDVYMIMVKCWMIDADSRPKFRELI 264

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 65/250 (26%), Positives = 116/250 (46%), Gaps = 28/250 (11%)
Query: 212 VGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSV 271
           V ++ LK   +    +F+   +LL ++   H++I++F+ VC  E   L +V + M  G +
Sbjct: 51  VAVKALKEASESARQDFQREAELLTMLQ--HQHIVRFFGVCT-EGRPLLMVFEYMRHGDL 107
Query: 272 NDLI---------------LKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRIL 316
           N  +               +    L   +++ +A  VA G+ +L      +RDL ++  L
Sbjct: 108 NRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCL 167
Query: 317 LDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESV---SETWMSNVYS 373
           + +   V +GD G+     S    T+Y   G R + P I    PES+     T  S+V+S
Sbjct: 168 VGQGLVVKIGDFGMSRDIYS----TDYYRVGGRTMLP-IRWMPPESILYRKFTTESDVWS 222
Query: 374 FGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKR 432
           FG+V+WE+ T G+  +   S  +A +     G   E P+ CP  + ++M  CW   P +R
Sbjct: 223 FGVVLWEIFTYGKQPWYQLSNTEA-IDCITQGRELERPRACPPEVYAIMRGCWQREPQQR 281
Query: 433 PQFSEIISLL 442
               ++ + L
Sbjct: 282 HSIKDVHARL 291

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 75/290 (25%), Positives = 132/290 (45%), Gaps = 44/290 (15%)
Query: 186 LLNSDNLEFIDQIGPNSFKGVYKG--KRVGIEKLKGCDKGNAY-----EFELRKDLLELM 238
           +L+ ++++F D IG  +F  V K   K+ G+       +   Y       +   +L  L 
Sbjct: 18  VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLC 77
Query: 239 TCGHK-NILQFYCVCVDENHG-LCVVTKLMEGGSVNDLILKSRKLQT------------- 283
             GH  NI+     C  E+ G L +  +    G++ D + KSR L+T             
Sbjct: 78  KLGHHPNIINLLGAC--EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 135
Query: 284 ---KEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGI-----VTACK 335
              ++++  A DVA G+ +L+     +R+L ++ IL+  +    + D G+     V   K
Sbjct: 136 LSSQQLLHFAADVARGMDYLSQKQFIHRNLAARNILVGENYVAKIADFGLSRGQEVYVKK 195
Query: 336 SVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPV 394
           ++G          RW+A E +     SV  T  S+V+S+G+++WE+V+ G   Y   +  
Sbjct: 196 TMGRLP------VRWMAIESLN---YSVYTT-NSDVWSYGVLLWEIVSLGGTPYCGMTCA 245
Query: 395 QAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR 444
           +    +   G R E P +C   +  LM +CW   P +RP F++I+  L R
Sbjct: 246 ELYEKLPQ-GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 294

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 68/281 (24%), Positives = 125/281 (44%), Gaps = 27/281 (9%)
Query: 175 VQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGK-----RVGIEKLK-GCDKGNAY-- 226
           +Q+ G     W +  ++L    ++G   F  V+ G      RV I+ LK G     A+  
Sbjct: 3   MQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ 62
Query: 227 EFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL--KSRKLQTK 284
           E ++ K L       H+ ++Q Y V  +E   + +V + M  G + D +     + L+  
Sbjct: 63  EAQVMKKL------RHEKLVQLYAVVSEEP--IYIVMEYMSKGCLLDFLKGEMGKYLRLP 114
Query: 285 EIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE 344
           +++ +A  +A G+ ++      +RDL +  IL+  +    + D G+    +   E T  +
Sbjct: 115 QLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQ 173
Query: 345 TDGY--RWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIA 401
              +  +W APE       ++     S+V+SFG+++ E+ T G   Y      +    + 
Sbjct: 174 GAKFPIKWTAPEAALYGRFTIK----SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 229
Query: 402 ACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
             G R   P +CP+ L  LM +CW   P +RP F  + + L
Sbjct: 230 R-GYRMPCPPECPESLHDLMCQCWRKDPEERPTFEYLQAFL 269

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 68/294 (23%), Positives = 124/294 (42%), Gaps = 45/294 (15%)
Query: 184 RWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDK---------GNAYEFELRKDL 234
           +W    +NL+F   +G  +F  V +    G+ K     K          +A E E     
Sbjct: 40  KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSE 99
Query: 235 LELMTC--GHKNILQFYCVCVDENHG--LCVVTKLMEGGSVNDLILKSR----------- 279
           L++M+    H+NI+     C    HG  + V+T+    G + + + + R           
Sbjct: 100 LKIMSHLGQHENIVNLLGACT---HGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPS 156
Query: 280 -----KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC 334
                +L +++++  +  VA+G+ FL      +RD+ ++ +LL       +GD G+    
Sbjct: 157 HNPEEQLSSRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGL---A 213
Query: 335 KSVGEATEYETDG-----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAY 388
           + +   + Y   G      +W+APE I         T  S+V+S+G+++WE+ + G   Y
Sbjct: 214 RDIMNDSNYIVKGNARLPVKWMAPESIF----DCVYTVQSDVWSYGILLWEIFSLGLNPY 269
Query: 389 AACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
                      +   G +   P   P+ + S+M  CW   P+ RP F +I S L
Sbjct: 270 PGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFL 323

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 52/194 (26%), Positives = 89/194 (45%), Gaps = 13/194 (6%)
Query: 242 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 301
           H  +   +C        L  V + + GG +   I    K         A ++  G++FL+
Sbjct: 78  HPFLTHMFCT-FQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH 136
Query: 302 DHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS--VGEATEYETDGY-RWLAPEIIAG 358
             G+ YRDL    ILLD+ G++ + D G+   CK   +G+A   E  G   ++APEI+ G
Sbjct: 137 SKGIVYRDLKLDNILLDKDGHIKIADFGM---CKENMLGDAKTNEFCGTPDYIAPEILLG 193
Query: 359 DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILK 418
              + S  W    +SFG++++EM+ G++ +      +    I      P  P+   +  K
Sbjct: 194 QKYNHSVDW----WSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN--PFYPRWLEKEAK 247
Query: 419 SLMIKCWNNSPSKR 432
            L++K +   P KR
Sbjct: 248 DLLVKLFVREPEKR 261

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/271 (24%), Positives = 124/271 (45%), Gaps = 28/271 (10%)
Query: 186 LLNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLL 235
           +L     + I  +G  +F  VYKG            V I +L+      A + E+  +  
Sbjct: 45  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANK-EILDEAY 103
Query: 236 ELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVA 294
            + +  + ++ +   +C+     L  +T+LM  G + D + + +  + ++ ++   + +A
Sbjct: 104 VMASVDNPHVCRLLGICLTSTVQL--ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 161
Query: 295 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG-EATEYETDG----YR 349
           +G+ +L D  + +RDL ++ +L+    +V + D G+    K +G E  EY  +G     +
Sbjct: 162 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGL---AKLLGAEEKEYHAEGGKVPIK 218
Query: 350 WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPE 408
           W+A E I         T  S+V+S+G+ +WE++T G   Y    P      I   G R  
Sbjct: 219 WMALESILHR----IYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLP 273
Query: 409 IPKDCPQILKSLMIKCWNNSPSKRPQFSEII 439
            P  C   +  +M+KCW      RP+F E+I
Sbjct: 274 QPPICTIDVYMIMVKCWMIDADSRPKFRELI 304

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/271 (23%), Positives = 125/271 (46%), Gaps = 28/271 (10%)
Query: 186 LLNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLL 235
           +L     + I  +G  +F  VYKG            V I++L+      A + E+  +  
Sbjct: 18  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EILDEAY 76
Query: 236 ELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVA 294
            + +  + ++ +   +C+     + ++T+LM  G + D + + +  + ++ ++   + +A
Sbjct: 77  VMASVDNPHVCRLLGICLTST--VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 134
Query: 295 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG-EATEYETDG----YR 349
           +G+ +L D  + +RDL ++ +L+    +V + D G     K +G E  EY  +G     +
Sbjct: 135 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFG---RAKLLGAEEKEYHAEGGKVPIK 191
Query: 350 WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPE 408
           W+A E I         T  S+V+S+G+ +WE++T G   Y    P      I   G R  
Sbjct: 192 WMALESILHR----IYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLP 246
Query: 409 IPKDCPQILKSLMIKCWNNSPSKRPQFSEII 439
            P  C   +  +M+KCW      RP+F E+I
Sbjct: 247 QPPICTIDVYMIMVKCWMIDADSRPKFRELI 277

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 107/229 (46%), Gaps = 12/229 (5%)
Query: 221 DKGNAYEFELRKD-LLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR 279
           DK     F+   D +L + +  H +I++   +C      L +VT+ +  GS+ D + + R
Sbjct: 70  DKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLC--PGSSLQLVTQYLPLGSLLDHVRQHR 127
Query: 280 -KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG 338
             L  + ++   + +A+G+ +L +HG+ +R+L ++ +LL     V + D G+        
Sbjct: 128 GALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDD 187
Query: 339 EATEYE--TDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQ 395
           +   Y       +W+A E I         T  S+V+S+G+ +WE++T G   YA     +
Sbjct: 188 KQLLYSEAKTPIKWMALESI----HFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE 243
Query: 396 AAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR 444
               +   G R   P+ C   +  +M+KCW    + RP F E+ +   R
Sbjct: 244 VP-DLLEKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTR 291

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 70/300 (23%), Positives = 131/300 (43%), Gaps = 59/300 (19%)
Query: 190 DNLEFIDQIGPNSFKGVYKGKRVGI----------EKLKGCDKGNAYEFELRKDLLELMT 239
           +N+E++  IG  +F  V++ +  G+           K+   +     + + +++   +  
Sbjct: 47  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 106
Query: 240 CGHKNILQFYCVCVDENHGLCVVTKLMEGGSVN-----------------DLILKSR--- 279
             + NI++   VC      +C++ + M  G +N                 DL  ++R   
Sbjct: 107 FDNPNIVKLLGVCA-VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSS 165
Query: 280 ----KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK 335
                L   E + IA  VA G+ +L++    +RDL ++  L+  +  V + D G+    +
Sbjct: 166 PGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGL---SR 222
Query: 336 SVGEATEYETDG-----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYA 389
           ++  A  Y+ DG      RW+ PE I  +      T  S+V+++G+V+WE+ + G   Y 
Sbjct: 223 NIYSADYYKADGNDAIPIRWMPPESIFYN----RYTTESDVWAYGVVLWEIFSYGLQPYY 278
Query: 390 ACSPVQAAV-----GIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR 444
             +  +         I AC      P++CP  L +LM  CW+  P+ RP F  I  +L R
Sbjct: 279 GMAHEEVIYYVRDGNILAC------PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQR 332

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/271 (23%), Positives = 125/271 (46%), Gaps = 28/271 (10%)
Query: 186 LLNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLL 235
           +L     + I  +G  +F  VYKG            V I++L+      A + E+  +  
Sbjct: 11  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EILDEAY 69
Query: 236 ELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVA 294
            + +  + ++ +   +C+     + ++T+LM  G + D + + +  + ++ ++   + +A
Sbjct: 70  VMASVDNPHVCRLLGICLTST--VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 127
Query: 295 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG-EATEYETDG----YR 349
           +G+ +L D  + +RDL ++ +L+    +V + D G     K +G E  EY  +G     +
Sbjct: 128 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFG---RAKLLGAEEKEYHAEGGKVPIK 184
Query: 350 WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPE 408
           W+A E I         T  S+V+S+G+ +WE++T G   Y    P      I   G R  
Sbjct: 185 WMALESILHR----IYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLP 239
Query: 409 IPKDCPQILKSLMIKCWNNSPSKRPQFSEII 439
            P  C   +  +M+KCW      RP+F E+I
Sbjct: 240 QPPICTIDVYMIMVKCWMIDADSRPKFRELI 270

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 108/229 (47%), Gaps = 12/229 (5%)
Query: 221 DKGNAYEFELRKD-LLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR 279
           DK     F+   D +L + +  H +I++   +C   +  L +VT+ +  GS+ D + + R
Sbjct: 52  DKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSS--LQLVTQYLPLGSLLDHVRQHR 109
Query: 280 -KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG 338
             L  + ++   + +A+G+ +L +HG+ +R+L ++ +LL     V + D G+        
Sbjct: 110 GALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDD 169
Query: 339 EATEYE--TDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQ 395
           +   Y       +W+A E I         T  S+V+S+G+ +WE++T G   YA     +
Sbjct: 170 KQLLYSEAKTPIKWMALESI----HFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE 225
Query: 396 AAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR 444
               +   G R   P+ C   +  +M+KCW    + RP F E+ +   R
Sbjct: 226 VP-DLLEKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTR 273

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/270 (22%), Positives = 123/270 (45%), Gaps = 26/270 (9%)
Query: 186 LLNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLL 235
           +L     + I  +G  +F  VYKG            V I++L+      A + E+  +  
Sbjct: 12  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EILDEAY 70
Query: 236 ELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVA 294
            + +  + ++ +   +C+     + ++ +LM  G + D + + +  + ++ ++   + +A
Sbjct: 71  VMASVDNPHVCRLLGICLTST--VQLIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIA 128
Query: 295 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRW 350
           +G+ +L D  + +RDL ++ +L+    +V + D G+     +  E  EY  +G     +W
Sbjct: 129 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA--EEKEYHAEGGKVPIKW 186
Query: 351 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEI 409
           +A E I         T  S+V+S+G+ +WE++T G   Y    P      I   G R   
Sbjct: 187 MALESILHR----IYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQ 241
Query: 410 PKDCPQILKSLMIKCWNNSPSKRPQFSEII 439
           P  C   +  +M+KCW      RP+F E+I
Sbjct: 242 PPICTIDVYMIMVKCWMIDADSRPKFRELI 271

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 81/158 (51%), Gaps = 12/158 (7%)
Query: 242 HKNILQFY--CVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKF 299
           H+N+++ Y   +  DE   L VV + +EGG++ D++  +R +  ++I  + + V + +  
Sbjct: 207 HENVVEMYNSYLVGDE---LWVVMEFLEGGALTDIVTHTR-MNEEQIAAVCLAVLQALSV 262
Query: 300 LNDHGVAYRDLNSQRILLDRHGNVCLGDMGI-VTACKSVGEATEYETDGYRWLAPEIIAG 358
           L+  GV +RD+ S  ILL   G V L D G      K V          Y W+APE+I+ 
Sbjct: 263 LHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPY-WMAPELISR 321
Query: 359 DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQA 396
            P         +++S G+++ EMV GE  Y    P++A
Sbjct: 322 LPYGPE----VDIWSLGIMVIEMVDGEPPYFNEPPLKA 355

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/263 (22%), Positives = 118/263 (44%), Gaps = 12/263 (4%)
Query: 195 IDQIGPNSFKGVYKG-----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFY 249
           +++IG  SF  V+KG     ++V   K+   ++      ++++++  L  C    + ++Y
Sbjct: 27  LEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 86
Query: 250 CVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRD 309
              + +   L ++ + + GGS  DL L+   L   +I  I  ++ +G+ +L+     +RD
Sbjct: 87  GSYLKDTK-LWIIMEYLGGGSALDL-LEPGPLDETQIATILREILKGLDYLHSEKKIHRD 144
Query: 310 LNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMS 369
           + +  +LL  HG V L D G+                   W+APE+I    +S  ++  +
Sbjct: 145 IKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIK---QSAYDS-KA 200
Query: 370 NVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSP 429
           +++S G+   E+  GE  ++   P++    I      P +  +  + LK  +  C N  P
Sbjct: 201 DIWSLGITAIELARGEPPHSELHPMKVLFLIPKNN-PPTLEGNYSKPLKEFVEACLNKEP 259
Query: 430 SKRPQFSEIISLLLRTNNISNSS 452
           S RP   E++       N   +S
Sbjct: 260 SFRPTAKELLKHKFILRNAKKTS 282

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/263 (22%), Positives = 118/263 (44%), Gaps = 12/263 (4%)
Query: 195 IDQIGPNSFKGVYKG-----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFY 249
           +++IG  SF  V+KG     ++V   K+   ++      ++++++  L  C    + ++Y
Sbjct: 12  LEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 71
Query: 250 CVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRD 309
              + +   L ++ + + GGS  DL L+   L   +I  I  ++ +G+ +L+     +RD
Sbjct: 72  GSYLKDTK-LWIIMEYLGGGSALDL-LEPGPLDETQIATILREILKGLDYLHSEKKIHRD 129
Query: 310 LNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMS 369
           + +  +LL  HG V L D G+                   W+APE+I    +S  ++  +
Sbjct: 130 IKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIK---QSAYDS-KA 185
Query: 370 NVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSP 429
           +++S G+   E+  GE  ++   P++    I      P +  +  + LK  +  C N  P
Sbjct: 186 DIWSLGITAIELARGEPPHSELHPMKVLFLIPKNN-PPTLEGNYSKPLKEFVEACLNKEP 244
Query: 430 SKRPQFSEIISLLLRTNNISNSS 452
           S RP   E++       N   +S
Sbjct: 245 SFRPTAKELLKHKFILRNAKKTS 267

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 102/204 (50%), Gaps = 17/204 (8%)
Query: 242 HKNILQFY--CVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKF 299
           H+N+++ Y   +  DE   L VV + +EGG++ D++  +R +  ++I  + + V + +  
Sbjct: 130 HENVVEMYNSYLVGDE---LWVVMEFLEGGALTDIVTHTR-MNEEQIAAVCLAVLQALSV 185
Query: 300 LNDHGVAYRDLNSQRILLDRHGNVCLGDMGI-VTACKSVGEATEYETDGYRWLAPEIIAG 358
           L+  GV +RD+ S  ILL   G V L D G      K V          Y W+APE+I+ 
Sbjct: 186 LHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPY-WMAPELISR 244
Query: 359 DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQI-- 416
            P         +++S G+++ EMV GE  Y    P++ A+ +    L P + K+  ++  
Sbjct: 245 LPYGPE----VDIWSLGIMVIEMVDGEPPYFNEPPLK-AMKMIRDNLPPRL-KNLHKVSP 298
Query: 417 -LKSLMIKCWNNSPSKRPQFSEII 439
            LK  + +     P++R   +E++
Sbjct: 299 SLKGFLDRLLVRDPAQRATAAELL 322

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 70/268 (26%), Positives = 121/268 (45%), Gaps = 30/268 (11%)
Query: 186 LLNSDNLEFID-QIGPNSF----KGVYKGKR----VGIEKLK-GCDKGNAYEFELRKDLL 235
            L  DNL   D ++G  +F    +GVY+ ++    V I+ LK G +K +  E      ++
Sbjct: 5   FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIM 64
Query: 236 ELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK-LQTKEIIRIAIDVA 294
             +   +  I++   VC  E   L +V ++  GG ++  ++  R+ +    +  +   V+
Sbjct: 65  HQLDNPY--IVRLIGVCQAE--ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVS 120
Query: 295 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETD------GY 348
            G+K+L +    +RDL ++ +LL       + D G+    K++G    Y T         
Sbjct: 121 MGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGL---SKALGADDSYYTARSAGKWPL 177
Query: 349 RWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRP 407
           +W APE I     S      S+V+S+G+ +WE ++ G+  Y      +    I   G R 
Sbjct: 178 KWYAPECINFRKFSSR----SDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ-GKRM 232
Query: 408 EIPKDCPQILKSLMIKCWNNSPSKRPQF 435
           E P +CP  L +LM  CW      RP F
Sbjct: 233 ECPPECPPELYALMSDCWIYKWEDRPDF 260

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/270 (22%), Positives = 123/270 (45%), Gaps = 26/270 (9%)
Query: 186 LLNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLL 235
           +L     + I  +G  +F  VYKG            V I++L+      A + E+  +  
Sbjct: 12  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EILDEAY 70
Query: 236 ELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVA 294
            + +  + ++ +   +C+     + ++ +LM  G + D + + +  + ++ ++   + +A
Sbjct: 71  VMASVDNPHVCRLLGICLTST--VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 128
Query: 295 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRW 350
           +G+ +L D  + +RDL ++ +L+    +V + D G+     +  E  EY  +G     +W
Sbjct: 129 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA--EEKEYHAEGGKVPIKW 186
Query: 351 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEI 409
           +A E I         T  S+V+S+G+ +WE++T G   Y    P      I   G R   
Sbjct: 187 MALESILHR----IYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQ 241
Query: 410 PKDCPQILKSLMIKCWNNSPSKRPQFSEII 439
           P  C   +  +M+KCW      RP+F E+I
Sbjct: 242 PPICTIDVYMIMVKCWMIDADSRPKFRELI 271

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/270 (22%), Positives = 123/270 (45%), Gaps = 26/270 (9%)
Query: 186 LLNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLL 235
           +L     + I  +G  +F  VYKG            V I++L+      A + E+  +  
Sbjct: 14  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EILDEAY 72
Query: 236 ELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVA 294
            + +  + ++ +   +C+     + ++ +LM  G + D + + +  + ++ ++   + +A
Sbjct: 73  VMASVDNPHVCRLLGICLTST--VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 130
Query: 295 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRW 350
           +G+ +L D  + +RDL ++ +L+    +V + D G+     +  E  EY  +G     +W
Sbjct: 131 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA--EEKEYHAEGGKVPIKW 188
Query: 351 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEI 409
           +A E I         T  S+V+S+G+ +WE++T G   Y    P      I   G R   
Sbjct: 189 MALESILHR----IYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQ 243
Query: 410 PKDCPQILKSLMIKCWNNSPSKRPQFSEII 439
           P  C   +  +M+KCW      RP+F E+I
Sbjct: 244 PPICTIDVYMIMVKCWMIDADSRPKFRELI 273

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/263 (22%), Positives = 118/263 (44%), Gaps = 12/263 (4%)
Query: 195 IDQIGPNSFKGVYKG-----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFY 249
           +++IG  SF  V+KG     ++V   K+   ++      ++++++  L  C    + ++Y
Sbjct: 12  LEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 71
Query: 250 CVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRD 309
              + +   L ++ + + GGS  DL L+   L   +I  I  ++ +G+ +L+     +RD
Sbjct: 72  GSYLKDTK-LWIIMEYLGGGSALDL-LEPGPLDETQIATILREILKGLDYLHSEKKIHRD 129
Query: 310 LNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMS 369
           + +  +LL  HG V L D G+                   W+APE+I    +S  ++  +
Sbjct: 130 IKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIK---QSAYDS-KA 185
Query: 370 NVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSP 429
           +++S G+   E+  GE  ++   P++    I      P +  +  + LK  +  C N  P
Sbjct: 186 DIWSLGITAIELARGEPPHSELHPMKVLFLIPKNN-PPTLEGNYSKPLKEFVEACLNKEP 244
Query: 430 SKRPQFSEIISLLLRTNNISNSS 452
           S RP   E++       N   +S
Sbjct: 245 SFRPTAKELLKHKFILRNAKKTS 267

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/270 (22%), Positives = 123/270 (45%), Gaps = 26/270 (9%)
Query: 186 LLNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLL 235
           +L     + I  +G  +F  VYKG            V I++L+      A + E+  +  
Sbjct: 13  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EILDEAY 71
Query: 236 ELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVA 294
            + +  + ++ +   +C+     + ++ +LM  G + D + + +  + ++ ++   + +A
Sbjct: 72  VMASVDNPHVCRLLGICLTST--VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 129
Query: 295 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRW 350
           +G+ +L D  + +RDL ++ +L+    +V + D G+     +  E  EY  +G     +W
Sbjct: 130 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA--EEKEYHAEGGKVPIKW 187
Query: 351 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEI 409
           +A E I         T  S+V+S+G+ +WE++T G   Y    P      I   G R   
Sbjct: 188 MALESILHR----IYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQ 242
Query: 410 PKDCPQILKSLMIKCWNNSPSKRPQFSEII 439
           P  C   +  +M+KCW      RP+F E+I
Sbjct: 243 PPICTIDVYMIMVKCWMIDADSRPKFRELI 272

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/270 (22%), Positives = 123/270 (45%), Gaps = 26/270 (9%)
Query: 186 LLNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLL 235
           +L     + I  +G  +F  VYKG            V I++L+      A + E+  +  
Sbjct: 15  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EILDEAY 73
Query: 236 ELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVA 294
            + +  + ++ +   +C+     + ++ +LM  G + D + + +  + ++ ++   + +A
Sbjct: 74  VMASVDNPHVCRLLGICLTST--VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 131
Query: 295 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRW 350
           +G+ +L D  + +RDL ++ +L+    +V + D G+     +  E  EY  +G     +W
Sbjct: 132 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA--EEKEYHAEGGKVPIKW 189
Query: 351 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEI 409
           +A E I         T  S+V+S+G+ +WE++T G   Y    P      I   G R   
Sbjct: 190 MALESILHR----IYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQ 244
Query: 410 PKDCPQILKSLMIKCWNNSPSKRPQFSEII 439
           P  C   +  +M+KCW      RP+F E+I
Sbjct: 245 PPICTIDVYMIMVKCWMIDADSRPKFRELI 274

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/270 (22%), Positives = 123/270 (45%), Gaps = 26/270 (9%)
Query: 186 LLNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLL 235
           +L     + I  +   +F  VYKG            V I++L+      A + E+  +  
Sbjct: 18  ILKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EILDEAY 76
Query: 236 ELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVA 294
            + +  + ++ +   +C+     + ++T+LM  G + D + + +  + ++ ++   + +A
Sbjct: 77  VMASVDNPHVCRLLGICLTST--VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 134
Query: 295 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRW 350
           +G+ +L D  + +RDL ++ +L+    +V + D G+     +  E  EY  +G     +W
Sbjct: 135 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA--EEKEYHAEGGKVPIKW 192
Query: 351 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEI 409
           +A E I         T  S+V+S+G+ +WE++T G   Y    P      I   G R   
Sbjct: 193 MALESILHR----IYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQ 247
Query: 410 PKDCPQILKSLMIKCWNNSPSKRPQFSEII 439
           P  C   +  +M+KCW      RP+F E+I
Sbjct: 248 PPICTIDVYMIMVKCWMIDADSRPKFRELI 277

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 116/237 (48%), Gaps = 19/237 (8%)
Query: 209 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFY--CVCVDENHGLCVVTKLM 266
           GK V ++K+    K    E  L  +++ +    H+N+++ Y   +  DE   L VV + +
Sbjct: 56  GKLVAVKKMD-LRKQQRREL-LFNEVVIMRDYQHENVVEMYNSYLVGDE---LWVVMEFL 110
Query: 267 EGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLG 326
           EGG++ D++  +R +  ++I  + + V + +  L+  GV +RD+ S  ILL   G V L 
Sbjct: 111 EGGALTDIVTHTR-MNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLS 169
Query: 327 DMGI-VTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGE 385
           D G      K V          Y W+APE+I+  P         +++S G+++ EMV GE
Sbjct: 170 DFGFCAQVSKEVPRRKXLVGTPY-WMAPELISRLPYGPE----VDIWSLGIMVIEMVDGE 224
Query: 386 AAYAACSPVQAAVGIAACGLRPEIPKDCPQI---LKSLMIKCWNNSPSKRPQFSEII 439
             Y    P++ A+ +    L P + K+  ++   LK  + +     P++R   +E++
Sbjct: 225 PPYFNEPPLK-AMKMIRDNLPPRL-KNLHKVSPSLKGFLDRLLVRDPAQRATAAELL 279

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 116/237 (48%), Gaps = 19/237 (8%)
Query: 209 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFY--CVCVDENHGLCVVTKLM 266
           GK V ++K+    K    E  L  +++ +    H+N+++ Y   +  DE   L VV + +
Sbjct: 54  GKLVAVKKMD-LRKQQRREL-LFNEVVIMRDYQHENVVEMYNSYLVGDE---LWVVMEFL 108
Query: 267 EGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLG 326
           EGG++ D++  +R +  ++I  + + V + +  L+  GV +RD+ S  ILL   G V L 
Sbjct: 109 EGGALTDIVTHTR-MNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLS 167
Query: 327 DMGI-VTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGE 385
           D G      K V          Y W+APE+I+  P         +++S G+++ EMV GE
Sbjct: 168 DFGFCAQVSKEVPRRKXLVGTPY-WMAPELISRLPYGPE----VDIWSLGIMVIEMVDGE 222
Query: 386 AAYAACSPVQAAVGIAACGLRPEIPKDCPQI---LKSLMIKCWNNSPSKRPQFSEII 439
             Y    P++ A+ +    L P + K+  ++   LK  + +     P++R   +E++
Sbjct: 223 PPYFNEPPLK-AMKMIRDNLPPRL-KNLHKVSPSLKGFLDRLLVRDPAQRATAAELL 277

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/271 (23%), Positives = 125/271 (46%), Gaps = 28/271 (10%)
Query: 186 LLNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLL 235
           +L     + I  +   +F  VYKG            V I++L+      A + E+  +  
Sbjct: 11  ILKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EILDEAY 69
Query: 236 ELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVA 294
            + +  + ++ +   +C+     + ++T+LM  G + D + + +  + ++ ++   + +A
Sbjct: 70  VMASVDNPHVCRLLGICLTST--VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 127
Query: 295 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG-EATEYETDG----YR 349
           +G+ +L D  + +RDL ++ +L+    +V + D G+    K +G E  EY  +G     +
Sbjct: 128 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGL---AKLLGAEEKEYHAEGGKVPIK 184
Query: 350 WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPE 408
           W+A E I         T  S+V+S+G+ +WE++T G   Y    P      I   G R  
Sbjct: 185 WMALESILHR----IYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLP 239
Query: 409 IPKDCPQILKSLMIKCWNNSPSKRPQFSEII 439
            P  C   +  +M+KCW      RP+F E+I
Sbjct: 240 QPPICTIDVYMIMVKCWMIDADSRPKFRELI 270

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/270 (22%), Positives = 123/270 (45%), Gaps = 26/270 (9%)
Query: 186 LLNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLL 235
           +L     + I  +G  +F  VYKG            V I++L+      A + E+  +  
Sbjct: 11  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EILDEAY 69
Query: 236 ELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVA 294
            + +  + ++ +   +C+     + ++ +LM  G + D + + +  + ++ ++   + +A
Sbjct: 70  VMASVDNPHVCRLLGICLTST--VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 127
Query: 295 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRW 350
           +G+ +L D  + +RDL ++ +L+    +V + D G+     +  E  EY  +G     +W
Sbjct: 128 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA--EEKEYHAEGGKVPIKW 185
Query: 351 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEI 409
           +A E I         T  S+V+S+G+ +WE++T G   Y    P      I   G R   
Sbjct: 186 MALESILHR----IYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQ 240
Query: 410 PKDCPQILKSLMIKCWNNSPSKRPQFSEII 439
           P  C   +  +M+KCW      RP+F E+I
Sbjct: 241 PPICTIDVYMIMVKCWMIDADSRPKFRELI 270

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/271 (23%), Positives = 125/271 (46%), Gaps = 28/271 (10%)
Query: 186 LLNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLL 235
           +L     + I  +G  +F  VYKG            V I++L+      A + E+  +  
Sbjct: 21  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EILDEAY 79
Query: 236 ELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVA 294
            + +  + ++ +   +C+     + ++T+LM  G + D + + +  + ++ ++   + +A
Sbjct: 80  VMASVDNPHVCRLLGICLTST--VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 137
Query: 295 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG-EATEYETDG----YR 349
           +G+ +L D  + +RDL ++ +L+    +V + D G+    K +G E  EY  +G     +
Sbjct: 138 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGL---AKLLGAEEKEYHAEGGKVPIK 194
Query: 350 WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPE 408
           W+A E I         T  S+V+S+G+ +WE++T G   Y    P      I   G R  
Sbjct: 195 WMALESILHR----IYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLP 249
Query: 409 IPKDCPQILKSLMIKCWNNSPSKRPQFSEII 439
            P  C   +  +M KCW      RP+F E+I
Sbjct: 250 QPPICTIDVYMIMRKCWMIDADSRPKFRELI 280

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/263 (22%), Positives = 118/263 (44%), Gaps = 12/263 (4%)
Query: 195 IDQIGPNSFKGVYKG-----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFY 249
           +++IG  SF  V+KG     ++V   K+   ++      ++++++  L  C    + ++Y
Sbjct: 32  LEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 91
Query: 250 CVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRD 309
              + +   L ++ + + GGS  DL L+   L   +I  I  ++ +G+ +L+     +RD
Sbjct: 92  GSYLKDTK-LWIIMEYLGGGSALDL-LEPGPLDETQIATILREILKGLDYLHSEKKIHRD 149
Query: 310 LNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMS 369
           + +  +LL  HG V L D G+                   W+APE+I    +S  ++  +
Sbjct: 150 IKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIK---QSAYDS-KA 205
Query: 370 NVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSP 429
           +++S G+   E+  GE  ++   P++    I      P +  +  + LK  +  C N  P
Sbjct: 206 DIWSLGITAIELARGEPPHSELHPMKVLFLIPKNN-PPTLEGNYSKPLKEFVEACLNKEP 264
Query: 430 SKRPQFSEIISLLLRTNNISNSS 452
           S RP   E++       N   +S
Sbjct: 265 SFRPTAKELLKHKFILRNAKKTS 287

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 102/204 (50%), Gaps = 17/204 (8%)
Query: 242 HKNILQFY--CVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKF 299
           H+N+++ Y   +  DE   L VV + +EGG++ D++  +R +  ++I  + + V + +  
Sbjct: 80  HENVVEMYNSYLVGDE---LWVVMEFLEGGALTDIVTHTR-MNEEQIAAVCLAVLQALSV 135
Query: 300 LNDHGVAYRDLNSQRILLDRHGNVCLGDMGI-VTACKSVGEATEYETDGYRWLAPEIIAG 358
           L+  GV +RD+ S  ILL   G V L D G      K V          Y W+APE+I+ 
Sbjct: 136 LHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPY-WMAPELISR 194
Query: 359 DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQI-- 416
            P         +++S G+++ EMV GE  Y    P++ A+ +    L P + K+  ++  
Sbjct: 195 LPYGPE----VDIWSLGIMVIEMVDGEPPYFNEPPLK-AMKMIRDNLPPRL-KNLHKVSP 248
Query: 417 -LKSLMIKCWNNSPSKRPQFSEII 439
            LK  + +     P++R   +E++
Sbjct: 249 SLKGFLDRLLVRDPAQRATAAELL 272

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 102/204 (50%), Gaps = 17/204 (8%)
Query: 242 HKNILQFY--CVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKF 299
           H+N+++ Y   +  DE   L VV + +EGG++ D++  +R +  ++I  + + V + +  
Sbjct: 76  HENVVEMYNSYLVGDE---LWVVMEFLEGGALTDIVTHTR-MNEEQIAAVCLAVLQALSV 131
Query: 300 LNDHGVAYRDLNSQRILLDRHGNVCLGDMGI-VTACKSVGEATEYETDGYRWLAPEIIAG 358
           L+  GV +RD+ S  ILL   G V L D G      K V          Y W+APE+I+ 
Sbjct: 132 LHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPY-WMAPELISR 190
Query: 359 DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQI-- 416
            P         +++S G+++ EMV GE  Y    P++ A+ +    L P + K+  ++  
Sbjct: 191 LPYGPE----VDIWSLGIMVIEMVDGEPPYFNEPPLK-AMKMIRDNLPPRL-KNLHKVSP 244
Query: 417 -LKSLMIKCWNNSPSKRPQFSEII 439
            LK  + +     P++R   +E++
Sbjct: 245 SLKGFLDRLLVRDPAQRATAAELL 268

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/270 (23%), Positives = 123/270 (45%), Gaps = 26/270 (9%)
Query: 186 LLNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLL 235
           +L     + I  +G  +F  VYKG            V I++L+      A + E+  +  
Sbjct: 14  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EILDEAY 72
Query: 236 ELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVA 294
            + +  + ++ +   +C+     + ++T+LM  G + D + + +  + ++ ++   + +A
Sbjct: 73  VMASVDNPHVCRLLGICLTST--VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 130
Query: 295 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRW 350
           +G+ +L D  + +RDL ++ +L+    +V + D G+     +  E  EY  +G     +W
Sbjct: 131 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA--EEKEYHAEGGKVPIKW 188
Query: 351 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEI 409
           +A E I         T  S+V+S+G+ +WE++T G   Y    P      I   G R   
Sbjct: 189 MALESILHR----IYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQ 243
Query: 410 PKDCPQILKSLMIKCWNNSPSKRPQFSEII 439
           P  C   +  +M KCW      RP+F E+I
Sbjct: 244 PPICTIDVYMIMRKCWMIDADSRPKFRELI 273

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/270 (23%), Positives = 122/270 (45%), Gaps = 26/270 (9%)
Query: 186 LLNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLL 235
           +L     + I  +G  +F  VYKG            V I++L+      A + E+  +  
Sbjct: 11  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EILDEAY 69
Query: 236 ELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVA 294
            + +  + ++ +   +C+     L  +T+LM  G + D + + +  + ++ ++   + +A
Sbjct: 70  VMASVDNPHVCRLLGICLTSTVQL--ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 127
Query: 295 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRW 350
           +G+ +L D  + +RDL ++ +L+    +V + D G+     +  E  EY  +G     +W
Sbjct: 128 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA--EEKEYHAEGGKVPIKW 185
Query: 351 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEI 409
           +A E I         T  S+V+S+G+ +WE++T G   Y    P      I   G R   
Sbjct: 186 MALESILHR----IYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQ 240
Query: 410 PKDCPQILKSLMIKCWNNSPSKRPQFSEII 439
           P  C   +  +M KCW      RP+F E+I
Sbjct: 241 PPICTIDVYMIMRKCWMIDADSRPKFRELI 270

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 68/298 (22%), Positives = 119/298 (39%), Gaps = 46/298 (15%)
Query: 184 RWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDK---------GNAYEFELRKDL 234
           +W    +NL+F   +G  +F  V +    G+ K     K          +A E E     
Sbjct: 25  KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSE 84
Query: 235 LELMTC--GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKS-------------- 278
           L++M+    H+NI+     C      L +      G  +N L  K+              
Sbjct: 85  LKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDP 144
Query: 279 --------RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGI 330
                   R L+ ++++  +  VA+G+ FL      +RD+ ++ +LL       +GD G+
Sbjct: 145 EGLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGL 204
Query: 331 VTACKSVGEATEYETDG-----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-G 384
               + +   + Y   G      +W+APE I         T  S+V+S+G+++WE+ + G
Sbjct: 205 ---ARDIMNDSNYIVKGNARLPVKWMAPESIF----DCVYTVQSDVWSYGILLWEIFSLG 257
Query: 385 EAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
              Y           +   G +   P   P+ + S+M  CW   P+ RP F +I S L
Sbjct: 258 LNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFL 315

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 51/194 (26%), Positives = 88/194 (45%), Gaps = 13/194 (6%)
Query: 242 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 301
           H  +   +C        L  V + + GG +   I    K         A ++  G++FL+
Sbjct: 77  HPFLTHMFCT-FQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH 135
Query: 302 DHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS--VGEATEYETDGY-RWLAPEIIAG 358
             G+ YRDL    ILLD+ G++ + D G+   CK   +G+A      G   ++APEI+ G
Sbjct: 136 SKGIVYRDLKLDNILLDKDGHIKIADFGM---CKENMLGDAKTNXFCGTPDYIAPEILLG 192
Query: 359 DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILK 418
              + S  W    +SFG++++EM+ G++ +      +    I      P  P+   +  K
Sbjct: 193 QKYNHSVDW----WSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN--PFYPRWLEKEAK 246
Query: 419 SLMIKCWNNSPSKR 432
            L++K +   P KR
Sbjct: 247 DLLVKLFVREPEKR 260

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 48/191 (25%), Positives = 91/191 (47%), Gaps = 10/191 (5%)
Query: 235 LELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVA 294
           L L    H  I++ +    D    + ++   +EGG +  L+ KS++         A +V 
Sbjct: 58  LMLSIVTHPFIIRMWGTFQDAQQ-IFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVC 116
Query: 295 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPE 354
             +++L+   + YRDL  + ILLD++G++ + D G     K V + T        ++APE
Sbjct: 117 LALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGF---AKYVPDVTYXLCGTPDYIAPE 173
Query: 355 IIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR--PEIPKD 412
           +++  P + S  W    +SFG++I+EM+ G   +   + ++    I    LR  P   +D
Sbjct: 174 VVSTKPYNKSIDW----WSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNED 229
Query: 413 CPQILKSLMIK 423
              +L  L+ +
Sbjct: 230 VKDLLSRLITR 240

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 65/271 (23%), Positives = 124/271 (45%), Gaps = 28/271 (10%)
Query: 186 LLNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLL 235
           +L     + I  +G  +F  VYKG            V I++L+      A + E+  +  
Sbjct: 13  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EILDEAY 71
Query: 236 ELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVA 294
            + +  + ++ +   +C+     + ++T+LM  G + D + + +  + ++ ++   + +A
Sbjct: 72  VMASVDNPHVCRLLGICLTST--VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 129
Query: 295 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG-EATEYETDG----YR 349
           +G+ +L D  + +RDL ++ +L+    +V + D G     K +G E  EY  +G     +
Sbjct: 130 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFG---RAKLLGAEEKEYHAEGGKVPIK 186
Query: 350 WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPE 408
           W+A E I         T  S+V+S+G+ +WE++T G   Y    P      I   G R  
Sbjct: 187 WMALESILHR----IYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLP 241
Query: 409 IPKDCPQILKSLMIKCWNNSPSKRPQFSEII 439
            P  C   +  +M KCW      RP+F E+I
Sbjct: 242 QPPICTIDVYMIMRKCWMIDADSRPKFRELI 272

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 64/271 (23%), Positives = 124/271 (45%), Gaps = 28/271 (10%)
Query: 186 LLNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLL 235
           +L     + I  +G  +F  VYKG            V I++L+      A + E+  +  
Sbjct: 13  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EILDEAY 71
Query: 236 ELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVA 294
            + +  + ++ +   +C+     + ++ +LM  G + D + + +  + ++ ++   + +A
Sbjct: 72  VMASVDNPHVCRLLGICLTST--VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 129
Query: 295 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG-EATEYETDG----YR 349
           +G+ +L D  + +RDL ++ +L+    +V + D G     K +G E  EY  +G     +
Sbjct: 130 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFG---RAKLLGAEEKEYHAEGGKVPIK 186
Query: 350 WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPE 408
           W+A E I         T  S+V+S+G+ +WE++T G   Y    P      I   G R  
Sbjct: 187 WMALESILHR----IYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLP 241
Query: 409 IPKDCPQILKSLMIKCWNNSPSKRPQFSEII 439
            P  C   +  +M+KCW      RP+F E+I
Sbjct: 242 QPPICTIDVYMIMVKCWMIDADSRPKFRELI 272

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 64/271 (23%), Positives = 124/271 (45%), Gaps = 28/271 (10%)
Query: 186 LLNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLL 235
           +L     + I  +G  +F  VYKG            V I++L+      A + E+  +  
Sbjct: 15  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EILDEAY 73
Query: 236 ELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVA 294
            + +  + ++ +   +C+     + ++ +LM  G + D + + +  + ++ ++   + +A
Sbjct: 74  VMASVDNPHVCRLLGICLTST--VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 131
Query: 295 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG-EATEYETDG----YR 349
           +G+ +L D  + +RDL ++ +L+    +V + D G     K +G E  EY  +G     +
Sbjct: 132 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFG---RAKLLGAEEKEYHAEGGKVPIK 188
Query: 350 WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPE 408
           W+A E I         T  S+V+S+G+ +WE++T G   Y    P      I   G R  
Sbjct: 189 WMALESILHR----IYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLP 243
Query: 409 IPKDCPQILKSLMIKCWNNSPSKRPQFSEII 439
            P  C   +  +M+KCW      RP+F E+I
Sbjct: 244 QPPICTIDVYMIMVKCWMIDADSRPKFRELI 274

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 57/192 (29%), Positives = 100/192 (52%), Gaps = 12/192 (6%)
Query: 207 YKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFY-CVCVDENHGLCVVTKL 265
           + G++V + K+    K    E  L  +++ +    H N+++ Y    V E   L V+ + 
Sbjct: 68  HSGRQVAV-KMMDLRKQQRREL-LFNEVVIMRDYQHFNVVEMYKSYLVGEE--LWVLMEF 123
Query: 266 MEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCL 325
           ++GG++ D++ + R L  ++I  +   V + + +L+  GV +RD+ S  ILL   G V L
Sbjct: 124 LQGGALTDIVSQVR-LNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKL 182
Query: 326 GDMGI-VTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTG 384
            D G      K V +        Y W+APE+I+    S+  T + +++S G+++ EMV G
Sbjct: 183 SDFGFCAQISKDVPKRKXLVGTPY-WMAPEVIS---RSLYATEV-DIWSLGIMVIEMVDG 237
Query: 385 EAAYAACSPVQA 396
           E  Y + SPVQA
Sbjct: 238 EPPYFSDSPVQA 249

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 64/285 (22%), Positives = 120/285 (42%), Gaps = 41/285 (14%)
Query: 186 LLNSDNLEFIDQIGPNSFKGVY----------KGKRVGIEKLKGCDKGNAYEFELRKDLL 235
           +    +L++I Q+G  +F  V            G  V +++L+        +F+    +L
Sbjct: 7   IFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQIL 66
Query: 236 ELMTCGHKN-ILQFYCVCVDE-NHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAID 292
           + +   H + I+++  V        L +V + +  G + D + + R +L    ++  +  
Sbjct: 67  KAL---HSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQ 123
Query: 293 VAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC---KSVGEATEYETDGYR 349
           + +G+++L      +RDL ++ IL++   +V + D G+       K      E       
Sbjct: 124 ICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIF 183
Query: 350 WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAAC------ 403
           W APE ++ +  S      S+V+SFG+V++E+ T      +CSP    + +  C      
Sbjct: 184 WYAPESLSDNIFSRQ----SDVWSFGVVLYELFT--YCDKSCSPSAEFLRMMGCERDVPA 237
Query: 404 ----------GLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEI 438
                     G R   P  CP  +  LM  CW  SP  RP FS +
Sbjct: 238 LCRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSAL 282

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 64/285 (22%), Positives = 120/285 (42%), Gaps = 41/285 (14%)
Query: 186 LLNSDNLEFIDQIGPNSFKGVY----------KGKRVGIEKLKGCDKGNAYEFELRKDLL 235
           +    +L++I Q+G  +F  V            G  V +++L+        +F+    +L
Sbjct: 19  IFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQIL 78
Query: 236 ELMTCGHKN-ILQFYCVCVDE-NHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAID 292
           + +   H + I+++  V        L +V + +  G + D + + R +L    ++  +  
Sbjct: 79  KAL---HSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQ 135
Query: 293 VAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC---KSVGEATEYETDGYR 349
           + +G+++L      +RDL ++ IL++   +V + D G+       K      E       
Sbjct: 136 ICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIF 195
Query: 350 WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAAC------ 403
           W APE ++ +  S      S+V+SFG+V++E+ T      +CSP    + +  C      
Sbjct: 196 WYAPESLSDNIFSRQ----SDVWSFGVVLYELFT--YCDKSCSPSAEFLRMMGCERDVPA 249
Query: 404 ----------GLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEI 438
                     G R   P  CP  +  LM  CW  SP  RP FS +
Sbjct: 250 LSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSAL 294

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 76/298 (25%), Positives = 134/298 (44%), Gaps = 39/298 (13%)
Query: 158 MPLPSSSFVVSVDEWQTVQSGGEEIG--RWLLNSDNLEFID-QIGPNSF----KGVYKGK 210
           MP+ +S F       ++  S  EE+   +  L  DNL   D ++G  +F    +GVY+ +
Sbjct: 308 MPMDTSVF-------ESPFSDPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMR 360
Query: 211 R----VGIEKLK-GCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKL 265
           +    V I+ LK G +K +  E      ++  +   +  I++   VC  E   L +V ++
Sbjct: 361 KKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD--NPYIVRLIGVCQAE--ALMLVMEM 416
Query: 266 MEGGSVNDLILKSRK-LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVC 324
             GG ++  ++  R+ +    +  +   V+ G+K+L +    +R+L ++ +LL       
Sbjct: 417 AGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAK 476
Query: 325 LGDMGIVTACKSVGEATEYETD------GYRWLAPEIIAGDPESVSETWMSNVYSFGMVI 378
           + D G+    K++G    Y T         +W APE I     S      S+V+S+G+ +
Sbjct: 477 ISDFGL---SKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSR----SDVWSYGVTM 529
Query: 379 WEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQF 435
           WE ++ G+  Y      +    I   G R E P +CP  L +LM  CW      RP F
Sbjct: 530 WEALSYGQKPYKKMKGPEVMAFIEQ-GKRMECPPECPPELYALMSDCWIYKWEDRPDF 586

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 43/168 (25%), Positives = 84/168 (50%), Gaps = 13/168 (7%)
Query: 281 LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA 340
           +  +++I  +  VA G++FL+     +RDL ++ ILL  +  V + D G+    + + + 
Sbjct: 196 ITMEDLISYSFQVARGMEFLSSRKCIHRDLAARNILLSENNVVKICDFGL---ARDIYKN 252
Query: 341 TEYETDG-----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPV 394
            +Y   G      +W+APE I     S      S+V+S+G+++WE+ + G + Y      
Sbjct: 253 PDYVRKGDTRLPLKWMAPESIFDKIYSTK----SDVWSYGVLLWEIFSLGGSPYPGVQMD 308
Query: 395 QAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
           +        G+R   P+     +  +M+ CW+  P +RP+F+E++  L
Sbjct: 309 EDFCSRLREGMRMRAPEYSTPEIYQIMLDCWHRDPKERPRFAELVEKL 356

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 100/222 (45%), Gaps = 33/222 (14%)
Query: 187 LNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFE-LRKDLL---ELMTC-- 240
           L  DN EFI  +G  SF       +V + ++K  + G+ Y  + L+KD++   + + C  
Sbjct: 20  LGIDNFEFIRVLGKGSFG------KVMLARVK--ETGDLYAVKVLKKDVILQDDDVECTM 71
Query: 241 ----------GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIA 290
                      H  + Q +C C      L  V + + GG +   I KSR+         A
Sbjct: 72  TEKRILSLARNHPFLTQLFC-CFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYA 130
Query: 291 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTA--CKSVGEATEYETDGY 348
            ++   + FL+D G+ YRDL    +LLD  G+  L D G+     C  V  AT   T  Y
Sbjct: 131 AEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDY 190
Query: 349 RWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAA 390
             +APEI+       +  W    ++ G++++EM+ G A + A
Sbjct: 191 --IAPEILQEMLYGPAVDW----WAMGVLLYEMLCGHAPFEA 226

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/285 (22%), Positives = 120/285 (42%), Gaps = 41/285 (14%)
Query: 186 LLNSDNLEFIDQIGPNSFKGVY----------KGKRVGIEKLKGCDKGNAYEFELRKDLL 235
           +    +L++I Q+G  +F  V            G  V +++L+        +F+    +L
Sbjct: 3   IFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQIL 62
Query: 236 ELMTCGHKN-ILQFYCVCVDENHG-LCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAID 292
           + +   H + I+++  V        L +V + +  G + D + + R +L    ++  +  
Sbjct: 63  KAL---HSDFIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQ 119
Query: 293 VAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC---KSVGEATEYETDGYR 349
           + +G+++L      +RDL ++ IL++   +V + D G+       K      E       
Sbjct: 120 ICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIF 179
Query: 350 WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAAC------ 403
           W APE ++ +  S      S+V+SFG+V++E+ T      +CSP    + +  C      
Sbjct: 180 WYAPESLSDNIFSRQ----SDVWSFGVVLYELFT--YCDKSCSPSAEFLRMMGCERDVPA 233
Query: 404 ----------GLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEI 438
                     G R   P  CP  +  LM  CW  SP  RP FS +
Sbjct: 234 LCRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSAL 278

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/270 (22%), Positives = 122/270 (45%), Gaps = 26/270 (9%)
Query: 186 LLNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLL 235
           +L     + I  +   +F  VYKG            V I++L+      A + E+  +  
Sbjct: 18  ILKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EILDEAY 76
Query: 236 ELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVA 294
            + +  + ++ +   +C+     + ++ +LM  G + D + + +  + ++ ++   + +A
Sbjct: 77  VMASVDNPHVCRLLGICLTST--VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 134
Query: 295 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRW 350
           +G+ +L D  + +RDL ++ +L+    +V + D G+     +  E  EY  +G     +W
Sbjct: 135 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA--EEKEYHAEGGKVPIKW 192
Query: 351 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEI 409
           +A E I         T  S+V+S+G+ +WE++T G   Y    P      I   G R   
Sbjct: 193 MALESILHR----IYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLPQ 247
Query: 410 PKDCPQILKSLMIKCWNNSPSKRPQFSEII 439
           P  C   +  +M+KCW      RP+F E+I
Sbjct: 248 PPICTIDVYMIMVKCWMIDADSRPKFRELI 277

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 80/168 (47%), Gaps = 13/168 (7%)
Query: 281 LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA 340
           L  + +I  +  VA+G++FL      +RDL ++ ILL     V + D G+    + + + 
Sbjct: 188 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA---RDIYKD 244
Query: 341 TEYETDG-----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPV 394
            +Y   G      +W+APE I     ++     S+V+SFG+++WE+ + G + Y      
Sbjct: 245 PDYVRKGDARLPLKWMAPETIFDRVYTIQ----SDVWSFGVLLWEIFSLGASPYPGVKID 300
Query: 395 QAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
           +        G R   P      +   M+ CW+  PS+RP FSE++  L
Sbjct: 301 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 348

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 80/168 (47%), Gaps = 13/168 (7%)
Query: 281 LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA 340
           L  + +I  +  VA+G++FL      +RDL ++ ILL     V + D G+    + + + 
Sbjct: 190 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA---RDIYKD 246
Query: 341 TEYETDG-----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPV 394
            +Y   G      +W+APE I     ++     S+V+SFG+++WE+ + G + Y      
Sbjct: 247 PDYVRKGDARLPLKWMAPETIFDRVYTIQ----SDVWSFGVLLWEIFSLGASPYPGVKID 302
Query: 395 QAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
           +        G R   P      +   M+ CW+  PS+RP FSE++  L
Sbjct: 303 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 350

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 80/168 (47%), Gaps = 13/168 (7%)
Query: 281 LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA 340
           L  + +I  +  VA+G++FL      +RDL ++ ILL     V + D G+    + + + 
Sbjct: 195 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA---RDIYKD 251
Query: 341 TEYETDG-----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPV 394
            +Y   G      +W+APE I     ++     S+V+SFG+++WE+ + G + Y      
Sbjct: 252 PDYVRKGDARLPLKWMAPETIFDRVYTIQ----SDVWSFGVLLWEIFSLGASPYPGVKID 307
Query: 395 QAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
           +        G R   P      +   M+ CW+  PS+RP FSE++  L
Sbjct: 308 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 355

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 80/168 (47%), Gaps = 13/168 (7%)
Query: 281 LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA 340
           L  + +I  +  VA+G++FL      +RDL ++ ILL     V + D G+    + + + 
Sbjct: 197 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA---RDIYKD 253
Query: 341 TEYETDG-----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPV 394
            +Y   G      +W+APE I     ++     S+V+SFG+++WE+ + G + Y      
Sbjct: 254 PDYVRKGDARLPLKWMAPETIFDRVYTIQ----SDVWSFGVLLWEIFSLGASPYPGVKID 309
Query: 395 QAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
           +        G R   P      +   M+ CW+  PS+RP FSE++  L
Sbjct: 310 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 357

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/229 (24%), Positives = 108/229 (47%), Gaps = 9/229 (3%)
Query: 180 EEIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDK-GNAYEFELRKDLLE-- 236
           E + R L   D  E I ++G  +F  VYK +      L          E EL   ++E  
Sbjct: 27  EHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEID 86
Query: 237 -LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVA 294
            L +C H NI++       EN+ L ++ +   GG+V+ ++L+  R L   +I  +     
Sbjct: 87  ILASCDHPNIVKLLDAFYYENN-LWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTL 145
Query: 295 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGI-VTACKSVGEATEYETDGYRWLAP 353
           + + +L+D+ + +RDL +  IL    G++ L D G+     +++     +    Y W+AP
Sbjct: 146 DALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPY-WMAP 204
Query: 354 EIIAGDP-ESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIA 401
           E++  +  +     + ++V+S G+ + EM   E  +   +P++  + IA
Sbjct: 205 EVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIA 253

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 83/173 (47%), Gaps = 17/173 (9%)
Query: 289 IAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVC-LGDMGIVTACKSVGEATEYETDG 347
            +  VA+G+ FL      +RDL ++ ILL  HG +  + D G+    + +   + Y   G
Sbjct: 166 FSYQVAKGMAFLASKNCIHRDLAARNILLT-HGRITKICDFGL---ARDIKNDSNYVVKG 221
Query: 348 -----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIA 401
                 +W+APE I     +   T+ S+V+S+G+ +WE+ + G + Y           + 
Sbjct: 222 NARLPVKWMAPESIF----NCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMI 277
Query: 402 ACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNSSNR 454
             G R   P+  P  +  +M  CW+  P KRP F +I+ L+ +   IS S+N 
Sbjct: 278 KEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK--QISESTNH 328

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 83/173 (47%), Gaps = 17/173 (9%)
Query: 289 IAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVC-LGDMGIVTACKSVGEATEYETDG 347
            +  VA+G+ FL      +RDL ++ ILL  HG +  + D G+    + +   + Y   G
Sbjct: 173 FSYQVAKGMAFLASKNCIHRDLAARNILLT-HGRITKICDFGL---ARHIKNDSNYVVKG 228
Query: 348 -----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIA 401
                 +W+APE I     +   T+ S+V+S+G+ +WE+ + G + Y           + 
Sbjct: 229 NARLPVKWMAPESIF----NCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMI 284
Query: 402 ACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNSSNR 454
             G R   P+  P  +  +M  CW+  P KRP F +I+ L+ +   IS S+N 
Sbjct: 285 KEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK--QISESTNH 335

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 83/173 (47%), Gaps = 17/173 (9%)
Query: 289 IAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVC-LGDMGIVTACKSVGEATEYETDG 347
            +  VA+G+ FL      +RDL ++ ILL  HG +  + D G+    + +   + Y   G
Sbjct: 168 FSYQVAKGMAFLASKNCIHRDLAARNILLT-HGRITKICDFGL---ARDIKNDSNYVVKG 223
Query: 348 -----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIA 401
                 +W+APE I     +   T+ S+V+S+G+ +WE+ + G + Y           + 
Sbjct: 224 NARLPVKWMAPESIF----NCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMI 279
Query: 402 ACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNSSNR 454
             G R   P+  P  +  +M  CW+  P KRP F +I+ L+ +   IS S+N 
Sbjct: 280 KEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK--QISESTNH 330

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 83/173 (47%), Gaps = 17/173 (9%)
Query: 289 IAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVC-LGDMGIVTACKSVGEATEYETDG 347
            +  VA+G+ FL      +RDL ++ ILL  HG +  + D G+    + +   + Y   G
Sbjct: 173 FSYQVAKGMAFLASKNCIHRDLAARNILLT-HGRITKICDFGL---ARDIKNDSNYVVKG 228
Query: 348 -----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIA 401
                 +W+APE I     +   T+ S+V+S+G+ +WE+ + G + Y           + 
Sbjct: 229 NARLPVKWMAPESIF----NCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMI 284
Query: 402 ACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNSSNR 454
             G R   P+  P  +  +M  CW+  P KRP F +I+ L+ +   IS S+N 
Sbjct: 285 KEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK--QISESTNH 335

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 49/173 (28%), Positives = 83/173 (47%), Gaps = 17/173 (9%)
Query: 289 IAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVC-LGDMGIVTACKSVGEATEYETDG 347
            +  VA+G+ FL      +RDL ++ ILL  HG +  + D G+    + +   + Y   G
Sbjct: 150 FSYQVAKGMAFLASKNCIHRDLAARNILLT-HGRITKICDFGLA---RDIKNDSNYVVKG 205
Query: 348 -----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIA 401
                 +W+APE I     +   T+ S+V+S+G+ +WE+ + G + Y           + 
Sbjct: 206 NARLPVKWMAPESIF----NCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMI 261
Query: 402 ACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNSSNR 454
             G R   P+  P  +  +M  CW+  P KRP F +I+ L+ +   IS S+N 
Sbjct: 262 KEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK--QISESTNH 312

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/228 (24%), Positives = 105/228 (46%), Gaps = 7/228 (3%)
Query: 180 EEIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDK-GNAYEFELRKDLLE-- 236
           E + R L   D  E I ++G  +F  VYK +      L          E EL   ++E  
Sbjct: 27  EHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEID 86
Query: 237 -LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVA 294
            L +C H NI++       EN+ L ++ +   GG+V+ ++L+  R L   +I  +     
Sbjct: 87  ILASCDHPNIVKLLDAFYYENN-LWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTL 145
Query: 295 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPE 354
           + + +L+D+ + +RDL +  IL    G++ L D G+        +  +       W+APE
Sbjct: 146 DALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDXFIGTPYWMAPE 205
Query: 355 IIAGDP-ESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIA 401
           ++  +  +     + ++V+S G+ + EM   E  +   +P++  + IA
Sbjct: 206 VVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIA 253

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/271 (23%), Positives = 123/271 (45%), Gaps = 28/271 (10%)
Query: 186 LLNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLL 235
           +L     + I  +G  +F  VYKG            V I++L+      A + E+  +  
Sbjct: 13  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EILDEAY 71
Query: 236 ELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVA 294
            + +  + ++ +   +C+     + ++ +LM  G + D + + +  + ++ ++   + +A
Sbjct: 72  VMASVDNPHVCRLLGICLTST--VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 129
Query: 295 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG-EATEYETDG----YR 349
           +G+ +L D  + +RDL ++ +L+    +V + D G     K +G E  EY  +G     +
Sbjct: 130 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFG---RAKLLGAEEKEYHAEGGKVPIK 186
Query: 350 WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPE 408
           W+A E I         T  S+V+S+G+ +WE++T G   Y    P      I   G R  
Sbjct: 187 WMALESILHR----IYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEKGERLP 241
Query: 409 IPKDCPQILKSLMIKCWNNSPSKRPQFSEII 439
            P  C   +  +M KCW      RP+F E+I
Sbjct: 242 QPPICTIDVYMIMRKCWMIDADSRPKFRELI 272

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 55/228 (24%), Positives = 105/228 (46%), Gaps = 7/228 (3%)
Query: 180 EEIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDK-GNAYEFELRKDLLE-- 236
           E + R L   D  E I ++G  +F  VYK +      L          E EL   ++E  
Sbjct: 27  EHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEID 86
Query: 237 -LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVA 294
            L +C H NI++       EN+ L ++ +   GG+V+ ++L+  R L   +I  +     
Sbjct: 87  ILASCDHPNIVKLLDAFYYENN-LWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTL 145
Query: 295 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPE 354
           + + +L+D+ + +RDL +  IL    G++ L D G+        +  +       W+APE
Sbjct: 146 DALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSFIGTPYWMAPE 205
Query: 355 IIAGDP-ESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIA 401
           ++  +  +     + ++V+S G+ + EM   E  +   +P++  + IA
Sbjct: 206 VVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIA 253

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/271 (22%), Positives = 115/271 (42%), Gaps = 28/271 (10%)
Query: 195 IDQIGPNSFKGVYKG-----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFY 249
           +D+IG  SF  VYKG     K V   K+   ++      ++++++  L  C    I +++
Sbjct: 24  LDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYF 83
Query: 250 CVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRD 309
              + ++  L ++ + + GGS  DL LK   L+   I  I  ++ +G+ +L+     +RD
Sbjct: 84  GSYL-KSTKLWIIMEYLGGGSALDL-LKPGPLEETYIATILREILKGLDYLHSERKIHRD 141
Query: 310 LNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMS 369
           + +  +LL   G+V L D G+                   W+APE+I    +  +  + +
Sbjct: 142 IKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVI----KQSAYDFKA 197
Query: 370 NVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQIL--------KSLM 421
           +++S G+   E+  GE   +   P++             IPK+ P  L        K  +
Sbjct: 198 DIWSLGITAIELAKGEPPNSDLHPMRVLF---------LIPKNSPPTLEGQHSKPFKEFV 248
Query: 422 IKCWNNSPSKRPQFSEIISLLLRTNNISNSS 452
             C N  P  RP   E++     T     +S
Sbjct: 249 EACLNKDPRFRPTAKELLKHKFITRYTKKTS 279

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/256 (23%), Positives = 118/256 (46%), Gaps = 17/256 (6%)
Query: 192 LEFIDQIGPNSFKGVYKG--KRVG-IEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQF 248
            + ++++G  S+  VYK   K  G I  +K     +  + E+ K++  +  C   +++++
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQ-EIIKEISIMQQCDSPHVVKY 89
Query: 249 YCVCVDENHGLCVVTKLMEGGSVNDLI-LKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAY 307
           Y     +N  L +V +    GSV+D+I L+++ L   EI  I     +G+++L+     +
Sbjct: 90  YGSYF-KNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIH 148
Query: 308 RDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETW 367
           RD+ +  ILL+  G+  L D G+                   W+APE+I    + +    
Sbjct: 149 RDIKAGNILLNTEGHAKLADFGVAGQLTDXMAKRNXVIGTPFWMAPEVI----QEIGYNC 204
Query: 368 MSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAA----CGLRPEIPKDCPQILKSLMIK 423
           +++++S G+   EM  G+  YA   P++A   I         +PE+  D        + +
Sbjct: 205 VADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDN---FTDFVKQ 261
Query: 424 CWNNSPSKRPQFSEII 439
           C   SP +R   ++++
Sbjct: 262 CLVKSPEQRATATQLL 277

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 61/253 (24%), Positives = 113/253 (44%), Gaps = 26/253 (10%)
Query: 209 GKRVGIEKLK-GCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH-GLCVVTKLM 266
           G+ V ++ LK GC  G       ++++  L T  H++I+++   C D+    + +V + +
Sbjct: 37  GEMVAVKALKEGC--GPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYV 94
Query: 267 EGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLG 326
             GS+ D  L    +   +++  A  + EG+ +L+     +R L ++ +LLD    V +G
Sbjct: 95  PLGSLRD-YLPRHCVGLAQLLLFAQQICEGMAYLHAQHYIHRALAARNVLLDNDRLVKIG 153
Query: 327 DMGIVTACKSVGEATEYETDG---YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT 383
           D G+  A     E      DG     W APE +    +     + S+V+SFG+ ++E++T
Sbjct: 154 DFGLAKAVPEGHEYYRVREDGDSPVFWYAPECL----KECKFYYASDVWSFGVTLYELLT 209
Query: 384 G-EAAYAACSPVQAAVG-------------IAACGLRPEIPKDCPQILKSLMIKCWNNSP 429
             ++  +  +     +G             +   G R   P  CP  +  LM  CW    
Sbjct: 210 YCDSNQSPHTKFTELIGHTQGQMTVLRLTELLERGERLPRPDRCPCEIYHLMKNCWETEA 269
Query: 430 SKRPQFSEIISLL 442
           S RP F  ++ +L
Sbjct: 270 SFRPTFQNLVPIL 282

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 61/253 (24%), Positives = 113/253 (44%), Gaps = 26/253 (10%)
Query: 209 GKRVGIEKLK-GCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH-GLCVVTKLM 266
           G+ V ++ LK GC  G       ++++  L T  H++I+++   C D+    + +V + +
Sbjct: 38  GEMVAVKALKEGC--GPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYV 95
Query: 267 EGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLG 326
             GS+ D  L    +   +++  A  + EG+ +L+     +R L ++ +LLD    V +G
Sbjct: 96  PLGSLRD-YLPRHCVGLAQLLLFAQQICEGMAYLHAQHYIHRALAARNVLLDNDRLVKIG 154
Query: 327 DMGIVTACKSVGEATEYETDG---YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT 383
           D G+  A     E      DG     W APE +    +     + S+V+SFG+ ++E++T
Sbjct: 155 DFGLAKAVPEGHEYYRVREDGDSPVFWYAPECL----KECKFYYASDVWSFGVTLYELLT 210
Query: 384 G-EAAYAACSPVQAAVG-------------IAACGLRPEIPKDCPQILKSLMIKCWNNSP 429
             ++  +  +     +G             +   G R   P  CP  +  LM  CW    
Sbjct: 211 YCDSNQSPHTKFTELIGHTQGQMTVLRLTELLERGERLPRPDRCPCEIYHLMKNCWETEA 270
Query: 430 SKRPQFSEIISLL 442
           S RP F  ++ +L
Sbjct: 271 SFRPTFQNLVPIL 283

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 63/285 (22%), Positives = 119/285 (41%), Gaps = 41/285 (14%)
Query: 186 LLNSDNLEFIDQIGPNSFKGV----------YKGKRVGIEKLKGCDKGNAYEFELRKDLL 235
           +    +L++I Q+G  +F  V            G  V +++L+        +F+    +L
Sbjct: 6   IFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQIL 65
Query: 236 ELMTCGHKN-ILQFYCVCVDE-NHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAID 292
           + +   H + I+++  V        L +V + +  G + D + + R +L    ++  +  
Sbjct: 66  KAL---HSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQ 122
Query: 293 VAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC---KSVGEATEYETDGYR 349
           + +G+++L      +RDL ++ IL++   +V + D G+       K      E       
Sbjct: 123 ICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIF 182
Query: 350 WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAAC------ 403
           W APE ++ +  S      S+V+SFG+V++E+ T      +CSP    + +         
Sbjct: 183 WYAPESLSDNIFSRQ----SDVWSFGVVLYELFT--YCDKSCSPSAEFLRMMGSERDVPA 236
Query: 404 ----------GLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEI 438
                     G R   P  CP  +  LM  CW  SP  RP FS +
Sbjct: 237 LSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSAL 281

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/247 (21%), Positives = 117/247 (47%), Gaps = 20/247 (8%)
Query: 203 FKGVY---KGKRVGIEKLKGCDKGNAYEFE--LRKDLLELMTCGHKNILQFYCVCVDENH 257
           ++GVY   KG+++ +  +K C K    + +     + + +    H +I++   + + E  
Sbjct: 25  YEGVYTNHKGEKINV-AVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL--IGIIEEE 81
Query: 258 GLCVVTKLMEGGSVNDLILKSRK-LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRIL 316
              ++ +L   G +   + +++  L+   ++  ++ + + + +L      +RD+  + IL
Sbjct: 82  PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNIL 141
Query: 317 LDRHGNVCLGDMGIVTACKSVGEATEYETDGYR----WLAPEIIAGDPESVSETWMSNVY 372
           +     V LGD G+    + + +   Y+    R    W++PE I     + +    S+V+
Sbjct: 142 VASPECVKLGDFGL---SRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTA----SDVW 194
Query: 373 SFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKR 432
            F + +WE+++           +  +G+   G R   P  CP +L +LM +CW+  PS R
Sbjct: 195 MFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDR 254
Query: 433 PQFSEII 439
           P+F+E++
Sbjct: 255 PRFTELV 261

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/247 (21%), Positives = 117/247 (47%), Gaps = 20/247 (8%)
Query: 203 FKGVY---KGKRVGIEKLKGCDKGNAYEFE--LRKDLLELMTCGHKNILQFYCVCVDENH 257
           ++GVY   KG+++ +  +K C K    + +     + + +    H +I++   + + E  
Sbjct: 41  YEGVYTNHKGEKINV-AVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL--IGIIEEE 97
Query: 258 GLCVVTKLMEGGSVNDLILKSRK-LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRIL 316
              ++ +L   G +   + +++  L+   ++  ++ + + + +L      +RD+  + IL
Sbjct: 98  PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNIL 157
Query: 317 LDRHGNVCLGDMGIVTACKSVGEATEYETDGYR----WLAPEIIAGDPESVSETWMSNVY 372
           +     V LGD G+    + + +   Y+    R    W++PE I     + +    S+V+
Sbjct: 158 VASPECVKLGDFGL---SRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTA----SDVW 210
Query: 373 SFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKR 432
            F + +WE+++           +  +G+   G R   P  CP +L +LM +CW+  PS R
Sbjct: 211 MFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDR 270
Query: 433 PQFSEII 439
           P+F+E++
Sbjct: 271 PRFTELV 277

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/269 (24%), Positives = 114/269 (42%), Gaps = 45/269 (16%)
Query: 203 FKGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHG---L 259
           ++G ++G+ V ++     D+ + +      +L   +   H+NIL F    +   H    L
Sbjct: 25  WRGSWQGENVAVKIFSSRDEKSWFR---ETELYNTVMLRHENILGFIASDMTSRHSSTQL 81
Query: 260 CVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN--------DHGVAYRDLN 311
            ++T   E GS+ D  L+   L T   +RI + +A G+  L+           +A+RDL 
Sbjct: 82  WLITHYHEMGSLYDY-LQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLK 140
Query: 312 SQRILLDRHGNVCLGDMGIV------TACKSVGEATEYETDGYRWLAPEII--AGDPESV 363
           S+ IL+ ++G  C+ D+G+       T    VG      T   R++APE++      +  
Sbjct: 141 SKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTK--RYMAPEVLDETIQVDCF 198
Query: 364 SETWMSNVYSFGMVIWE----MVTGEAAYAACSPVQAAVG-----------IAACGLRPE 408
                 ++++FG+V+WE    MV+         P    V            +     RP 
Sbjct: 199 DSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPN 258
Query: 409 IPKDC---PQI--LKSLMIKCWNNSPSKR 432
           IP      P +  L  LM +CW  +PS R
Sbjct: 259 IPNRWFSDPTLTSLAKLMKECWYQNPSAR 287

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/269 (24%), Positives = 114/269 (42%), Gaps = 45/269 (16%)
Query: 203 FKGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHG---L 259
           ++G ++G+ V ++     D+ + +      +L   +   H+NIL F    +   H    L
Sbjct: 25  WRGSWQGENVAVKIFSSRDEKSWFR---ETELYNTVMLRHENILGFIASDMTSRHSSTQL 81
Query: 260 CVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN--------DHGVAYRDLN 311
            ++T   E GS+ D  L+   L T   +RI + +A G+  L+           +A+RDL 
Sbjct: 82  WLITHYHEMGSLYDY-LQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLK 140
Query: 312 SQRILLDRHGNVCLGDMGIV------TACKSVGEATEYETDGYRWLAPEII--AGDPESV 363
           S+ IL+ ++G  C+ D+G+       T    VG      T   R++APE++      +  
Sbjct: 141 SKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTK--RYMAPEVLDETIQVDCF 198
Query: 364 SETWMSNVYSFGMVIWE----MVTGEAAYAACSPVQAAVG-----------IAACGLRPE 408
                 ++++FG+V+WE    MV+         P    V            +     RP 
Sbjct: 199 DSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPN 258
Query: 409 IPKDC---PQI--LKSLMIKCWNNSPSKR 432
           IP      P +  L  LM +CW  +PS R
Sbjct: 259 IPNRWFSDPTLTSLAKLMKECWYQNPSAR 287

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 94/201 (46%), Gaps = 17/201 (8%)
Query: 240 CGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKF 299
             H+NI+    V  +E+    +V + +EG ++++ I     L     I     + +GIK 
Sbjct: 68  LSHQNIVSMIDVD-EEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKH 126
Query: 300 LNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG-EATEYETDGYRWLAPEIIAG 358
            +D  + +RD+  Q IL+D +  + + D GI  A        T +     ++ +PE   G
Sbjct: 127 AHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKG 186
Query: 359 DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIP-------K 411
             E+  E   +++YS G+V++EM+ GE  +      + AV IA   ++  +P       K
Sbjct: 187 --EATDEC--TDIYSIGIVLYEMLVGEPPFNG----ETAVSIAIKHIQDSVPNVTTDVRK 238
Query: 412 DCPQILKSLMIKCWNNSPSKR 432
           D PQ L +++++      + R
Sbjct: 239 DIPQSLSNVILRATEKDKANR 259

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/247 (21%), Positives = 117/247 (47%), Gaps = 20/247 (8%)
Query: 203 FKGVY---KGKRVGIEKLKGCDKGNAYEFE--LRKDLLELMTCGHKNILQFYCVCVDENH 257
           ++GVY   KG+++ +  +K C K    + +     + + +    H +I++   + + E  
Sbjct: 29  YEGVYTNHKGEKINV-AVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL--IGIIEEE 85
Query: 258 GLCVVTKLMEGGSVNDLILKSRK-LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRIL 316
              ++ +L   G +   + +++  L+   ++  ++ + + + +L      +RD+  + IL
Sbjct: 86  PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNIL 145
Query: 317 LDRHGNVCLGDMGIVTACKSVGEATEYETDGYR----WLAPEIIAGDPESVSETWMSNVY 372
           +     V LGD G+    + + +   Y+    R    W++PE I     + +    S+V+
Sbjct: 146 VASPECVKLGDFGL---SRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTA----SDVW 198
Query: 373 SFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKR 432
            F + +WE+++           +  +G+   G R   P  CP +L +LM +CW+  PS R
Sbjct: 199 MFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDR 258
Query: 433 PQFSEII 439
           P+F+E++
Sbjct: 259 PRFTELV 265

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/269 (24%), Positives = 114/269 (42%), Gaps = 45/269 (16%)
Query: 203 FKGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHG---L 259
           ++G ++G+ V ++     D+ + +      +L   +   H+NIL F    +   H    L
Sbjct: 54  WRGSWQGENVAVKIFSSRDEKSWFR---ETELYNTVMLRHENILGFIASDMTSRHSSTQL 110
Query: 260 CVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN--------DHGVAYRDLN 311
            ++T   E GS+ D  L+   L T   +RI + +A G+  L+           +A+RDL 
Sbjct: 111 WLITHYHEMGSLYDY-LQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLK 169
Query: 312 SQRILLDRHGNVCLGDMGIV------TACKSVGEATEYETDGYRWLAPEII--AGDPESV 363
           S+ IL+ ++G  C+ D+G+       T    VG      T   R++APE++      +  
Sbjct: 170 SKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTK--RYMAPEVLDETIQVDCF 227
Query: 364 SETWMSNVYSFGMVIWE----MVTGEAAYAACSPVQAAVG-----------IAACGLRPE 408
                 ++++FG+V+WE    MV+         P    V            +     RP 
Sbjct: 228 DSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPN 287
Query: 409 IPKDC---PQI--LKSLMIKCWNNSPSKR 432
           IP      P +  L  LM +CW  +PS R
Sbjct: 288 IPNRWFSDPTLTSLAKLMKECWYQNPSAR 316

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 68/302 (22%), Positives = 124/302 (41%), Gaps = 42/302 (13%)
Query: 177 SGGEEIGR---WLLNSDNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYE 227
           S G ++G    +  + +  E +  +G  S+  V K      G+ V I+K    D     +
Sbjct: 9   SSGVDLGTENLYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVK 68
Query: 228 FELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEII 287
               +++  L    H+N++    VC  +     +V + ++   ++DL L    L  + + 
Sbjct: 69  KIAMREIKLLKQLRHENLVNLLEVCKKKKRWY-LVFEFVDHTILDDLELFPNGLDYQVVQ 127
Query: 288 RIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG 347
           +    +  GI F + H + +RD+  + IL+ + G V L D G      + GE  + E   
Sbjct: 128 KYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVAT 187
Query: 348 YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAAC---- 403
             + APE++ GD   V      +V++ G ++ EM  GE  +   S +     I  C    
Sbjct: 188 RWYRAPELLVGD---VKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNL 244
Query: 404 ---------------GLR-PEIPKDCP---------QILKSLMIKCWNNSPSKRPQFSEI 438
                          G+R PEI +  P         +++  L  KC +  P KRP  +E+
Sbjct: 245 IPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAEL 304
Query: 439 IS 440
           + 
Sbjct: 305 LH 306

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 38/137 (27%), Positives = 67/137 (48%), Gaps = 4/137 (2%)
Query: 252 CVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLN 311
           C      L  V + + GG +   I +  + +    +  A ++A G+ FL   G+ YRDL 
Sbjct: 410 CFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLK 469
Query: 312 SQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNV 371
              ++LD  G++ + D G+       G  T+       ++APEIIA  P   S  W    
Sbjct: 470 LDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQPYGKSVDW---- 525
Query: 372 YSFGMVIWEMVTGEAAY 388
           ++FG++++EM+ G+A +
Sbjct: 526 WAFGVLLYEMLAGQAPF 542

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 38/137 (27%), Positives = 67/137 (48%), Gaps = 4/137 (2%)
Query: 252 CVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLN 311
           C      L  V + + GG +   I +  + +    +  A ++A G+ FL   G+ YRDL 
Sbjct: 89  CFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLK 148
Query: 312 SQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNV 371
              ++LD  G++ + D G+       G  T+       ++APEIIA  P   S  W    
Sbjct: 149 LDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQPYGKSVDW---- 204
Query: 372 YSFGMVIWEMVTGEAAY 388
           ++FG++++EM+ G+A +
Sbjct: 205 WAFGVLLYEMLAGQAPF 221

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/293 (21%), Positives = 131/293 (44%), Gaps = 30/293 (10%)
Query: 180 EEIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDK-GNAYEFELRKDLLE-- 236
           E + R L  ++  E + ++G  +F  VYK K      L          E EL   ++E  
Sbjct: 9   EHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIE 68
Query: 237 -LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVA 294
            L TC H  I++       +   L ++ +   GG+V+ ++L+  R L   +I  +   + 
Sbjct: 69  ILATCDHPYIVKLLGAYYHDG-KLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQML 127
Query: 295 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGI-VTACKSVGEATEYETDGYRWLAP 353
           E + FL+   + +RDL +  +L+   G++ L D G+     K++ +   +    Y W+AP
Sbjct: 128 EALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPY-WMAP 186
Query: 354 EIIAGDPESVSET---WMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIP 410
           E++    E++ +T   + ++++S G+ + EM   E  +   +P++  + IA         
Sbjct: 187 EVVMC--ETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS------- 237
Query: 411 KDCPQIL---------KSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNSSNR 454
            D P +L         +  +    + +P  RP  ++++     ++  SN + R
Sbjct: 238 -DPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSNKALR 289

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/293 (21%), Positives = 131/293 (44%), Gaps = 30/293 (10%)
Query: 180 EEIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDK-GNAYEFELRKDLLE-- 236
           E + R L  ++  E + ++G  +F  VYK K      L          E EL   ++E  
Sbjct: 1   EHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIE 60
Query: 237 -LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVA 294
            L TC H  I++       +   L ++ +   GG+V+ ++L+  R L   +I  +   + 
Sbjct: 61  ILATCDHPYIVKLLGAYYHDG-KLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQML 119
Query: 295 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGI-VTACKSVGEATEYETDGYRWLAP 353
           E + FL+   + +RDL +  +L+   G++ L D G+     K++ +   +    Y W+AP
Sbjct: 120 EALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPY-WMAP 178
Query: 354 EIIAGDPESVSET---WMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIP 410
           E++    E++ +T   + ++++S G+ + EM   E  +   +P++  + IA         
Sbjct: 179 EVVMC--ETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS------- 229
Query: 411 KDCPQIL---------KSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNSSNR 454
            D P +L         +  +    + +P  RP  ++++     ++  SN + R
Sbjct: 230 -DPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSNKALR 281

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/284 (22%), Positives = 118/284 (41%), Gaps = 51/284 (17%)
Query: 173 QTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFE-LR 231
             V++G E+      +  + E +  +G  SF     GK   + K+   D G+ Y  + L+
Sbjct: 16  HHVKAGSEKA-----DPSHFELLKVLGQGSF-----GKVFLVRKVTRPDSGHLYAMKVLK 65
Query: 232 KDLLE-------------LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKS 278
           K  L+             L    H  +++ +     E   L ++   + GG +   + K 
Sbjct: 66  KATLKVRDRVRTKMERDILADVNHPFVVKLHYAFQTEG-KLYLILDFLRGGDLFTRLSKE 124
Query: 279 RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG 338
                +++     ++A G+  L+  G+ YRDL  + ILLD  G++ L D G+        
Sbjct: 125 VMFTEEDVKFYLAELALGLDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK------ 178
Query: 339 EATEYETDGY------RWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACS 392
           EA ++E   Y       ++APE++     S S  W    +S+G++++EM+TG   +    
Sbjct: 179 EAIDHEKKAYSFCGTVEYMAPEVVNRQGHSHSADW----WSYGVLMFEMLTGSLPFQGKD 234
Query: 393 PVQAAVGIAACGLRPEIPKDCPQIL----KSLMIKCWNNSPSKR 432
             +    I    L        PQ L    +SL+   +  +P+ R
Sbjct: 235 RKETMTLILKAKL------GMPQFLSTEAQSLLRALFKRNPANR 272

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 105/224 (46%), Gaps = 27/224 (12%)
Query: 176 QSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGK------RVGI-----EKLKGCDKGN 224
             G  +IG ++L        D +G  +F  V  GK      +V +     +K++  D   
Sbjct: 9   HDGRVKIGHYILG-------DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVG 61
Query: 225 AYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTK 284
               ++R+++  L    H +I++ Y V +     + +V + + GG + D I K+ +L  K
Sbjct: 62  ----KIRREIQNLKLFRHPHIIKLYQV-ISTPSDIFMVMEYVSGGELFDYICKNGRLDEK 116
Query: 285 EIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE 344
           E  R+   +  G+ + + H V +RDL  + +LLD H N  + D G+ +   S GE     
Sbjct: 117 ESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGL-SNMMSDGEFLRXS 175
Query: 345 TDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAY 388
                + APE+I+G   +  E    +++S G++++ ++ G   +
Sbjct: 176 CGSPNYAAPEVISGRLYAGPEV---DIWSSGVILYALLCGTLPF 216

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/263 (21%), Positives = 116/263 (44%), Gaps = 12/263 (4%)
Query: 195 IDQIGPNSFKGVYKG-----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFY 249
           +++IG  SF  V+KG     ++V   K+   ++      ++++++  L  C    + ++Y
Sbjct: 28  LERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVTKYY 87
Query: 250 CVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRD 309
              + +   L ++ + + GGS  DL L++      +I  +  ++ +G+ +L+     +RD
Sbjct: 88  GSYL-KGSKLWIIMEYLGGGSALDL-LRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRD 145
Query: 310 LNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMS 369
           + +  +LL   G+V L D G+                   W+APE+I    +S  ++  +
Sbjct: 146 IKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQ---QSAYDS-KA 201
Query: 370 NVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSP 429
           +++S G+   E+  GE   +   P++    I      P +  D  +  K  +  C N  P
Sbjct: 202 DIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNN-PPTLVGDFTKSFKEFIDACLNKDP 260
Query: 430 SKRPQFSEIISLLLRTNNISNSS 452
           S RP   E++       N   +S
Sbjct: 261 SFRPTAKELLKHKFIVKNSKKTS 283

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 66/288 (22%), Positives = 127/288 (44%), Gaps = 44/288 (15%)
Query: 189 SDNLEFIDQIGPNSFKGVYKGKR-----VGIEKLKGCDKGNAYEFELRKDLLELMTCGHK 243
           SDN    + +G   F  VYKG+      V +++LK  ++    E + + ++  +    H+
Sbjct: 29  SDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKE-ERTQGGELQFQTEVEMISMAVHR 87
Query: 244 NILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK-----LQTKEIIRIAIDVAEGIK 298
           N+L+    C+     L +V   M  GSV    L+ R      L   +  RIA+  A G+ 
Sbjct: 88  NLLRLRGFCMTPTERL-LVYPYMANGSVAS-CLRERPESQPPLDWPKRQRIALGSARGLA 145
Query: 299 FLNDH---GVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY-RWLAPE 354
           +L+DH    + +RD+ +  ILLD      +GD G+                G    +APE
Sbjct: 146 YLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGXIGHIAPE 205
Query: 355 IIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAAC--------------------SPV 394
            ++    S      ++V+ +G+++ E++TG+ A+                         +
Sbjct: 206 YLSTGKSSEK----TDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL 261
Query: 395 QAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
           +A V +   G   +  ++  Q+++  ++ C  +SP +RP+ SE++ +L
Sbjct: 262 EALVDVDLQGNYKD--EEVEQLIQVALL-CTQSSPMERPKMSEVVRML 306

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/287 (22%), Positives = 127/287 (44%), Gaps = 42/287 (14%)
Query: 189 SDNLEFIDQIGPNSFKGVYKGKR-----VGIEKLKGCDKGNAYEFELRKDLLELMTCGHK 243
           SDN    + +G   F  VYKG+      V +++LK  ++    E + + ++  +    H+
Sbjct: 37  SDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKE-ERXQGGELQFQTEVEMISMAVHR 95
Query: 244 NILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTK----EIIRIAIDVAEGIKF 299
           N+L+    C+     L +V   M  GSV   + +  + Q      +  RIA+  A G+ +
Sbjct: 96  NLLRLRGFCMTPTERL-LVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAY 154
Query: 300 LNDH---GVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG-YRWLAPEI 355
           L+DH    + +RD+ +  ILLD      +GD G+                G    +APE 
Sbjct: 155 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGTIGHIAPEY 214
Query: 356 IAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAAC--------------------SPVQ 395
           ++    S      ++V+ +G+++ E++TG+ A+                         ++
Sbjct: 215 LSTGKSSEK----TDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLE 270
Query: 396 AAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
           A V +   G   +  ++  Q+++  ++ C  +SP +RP+ SE++ +L
Sbjct: 271 ALVDVDLQGNYKD--EEVEQLIQVALL-CTQSSPMERPKMSEVVRML 314

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/275 (22%), Positives = 120/275 (43%), Gaps = 39/275 (14%)
Query: 196 DQIGPNSFKGVYKGKRVGIE-KLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVD 254
           + IG   F  V++GK  G E  +K         +    ++ + +   H+NIL F      
Sbjct: 48  ESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNK 107
Query: 255 EN---HGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN--------DH 303
           +N     L +V+   E GS+ D  L    +  + +I++A+  A G+  L+          
Sbjct: 108 DNGTWTQLWLVSDYHEHGSLFDY-LNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP 166
Query: 304 GVAYRDLNSQRILLDRHGNVCLGDMGIV----TACKSVGEATEYETDGYRWLAPEII--A 357
            +A+RDL S+ IL+ ++G  C+ D+G+     +A  ++  A  +     R++APE++  +
Sbjct: 167 AIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDS 226
Query: 358 GDPESVSETWMSNVYSFGMVIWEMVTG----------EAAYAACSPVQAAVG-----IAA 402
            + +       +++Y+ G+V WE+             +  Y    P   +V      +  
Sbjct: 227 INMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCE 286
Query: 403 CGLRPEIPK-----DCPQILKSLMIKCWNNSPSKR 432
             LRP IP      +  +++  +M +CW  + + R
Sbjct: 287 QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAAR 321

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 61/275 (22%), Positives = 120/275 (43%), Gaps = 39/275 (14%)
Query: 196 DQIGPNSFKGVYKGKRVGIE-KLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVD 254
           + IG   F  V++GK  G E  +K         +    ++ + +   H+NIL F      
Sbjct: 10  ESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNK 69
Query: 255 EN---HGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN--------DH 303
           +N     L +V+   E GS+ D  L    +  + +I++A+  A G+  L+          
Sbjct: 70  DNGTWTQLWLVSDYHEHGSLFDY-LNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP 128
Query: 304 GVAYRDLNSQRILLDRHGNVCLGDMGIV----TACKSVGEATEYETDGYRWLAPEII--A 357
            +A+RDL S+ IL+ ++G  C+ D+G+     +A  ++  A  +     R++APE++  +
Sbjct: 129 AIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDS 188
Query: 358 GDPESVSETWMSNVYSFGMVIWEMVTG----------EAAYAACSPVQAAVG-----IAA 402
            + +       +++Y+ G+V WE+             +  Y    P   +V      +  
Sbjct: 189 INMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCE 248
Query: 403 CGLRPEIPK-----DCPQILKSLMIKCWNNSPSKR 432
             LRP IP      +  +++  +M +CW  + + R
Sbjct: 249 QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAAR 283

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 61/275 (22%), Positives = 120/275 (43%), Gaps = 39/275 (14%)
Query: 196 DQIGPNSFKGVYKGKRVGIE-KLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVD 254
           + IG   F  V++GK  G E  +K         +    ++ + +   H+NIL F      
Sbjct: 12  ESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNK 71
Query: 255 EN---HGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN--------DH 303
           +N     L +V+   E GS+ D  L    +  + +I++A+  A G+  L+          
Sbjct: 72  DNGTWTQLWLVSDYHEHGSLFDY-LNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP 130
Query: 304 GVAYRDLNSQRILLDRHGNVCLGDMGIV----TACKSVGEATEYETDGYRWLAPEII--A 357
            +A+RDL S+ IL+ ++G  C+ D+G+     +A  ++  A  +     R++APE++  +
Sbjct: 131 AIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDS 190
Query: 358 GDPESVSETWMSNVYSFGMVIWEMVTG----------EAAYAACSPVQAAVG-----IAA 402
            + +       +++Y+ G+V WE+             +  Y    P   +V      +  
Sbjct: 191 INMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCE 250
Query: 403 CGLRPEIPK-----DCPQILKSLMIKCWNNSPSKR 432
             LRP IP      +  +++  +M +CW  + + R
Sbjct: 251 QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAAR 285

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 61/275 (22%), Positives = 120/275 (43%), Gaps = 39/275 (14%)
Query: 196 DQIGPNSFKGVYKGKRVGIE-KLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVD 254
           + IG   F  V++GK  G E  +K         +    ++ + +   H+NIL F      
Sbjct: 9   ESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNK 68
Query: 255 EN---HGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN--------DH 303
           +N     L +V+   E GS+ D  L    +  + +I++A+  A G+  L+          
Sbjct: 69  DNGTWTQLWLVSDYHEHGSLFDY-LNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP 127
Query: 304 GVAYRDLNSQRILLDRHGNVCLGDMGIV----TACKSVGEATEYETDGYRWLAPEII--A 357
            +A+RDL S+ IL+ ++G  C+ D+G+     +A  ++  A  +     R++APE++  +
Sbjct: 128 AIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDS 187
Query: 358 GDPESVSETWMSNVYSFGMVIWEMVTG----------EAAYAACSPVQAAVG-----IAA 402
            + +       +++Y+ G+V WE+             +  Y    P   +V      +  
Sbjct: 188 INMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCE 247
Query: 403 CGLRPEIPK-----DCPQILKSLMIKCWNNSPSKR 432
             LRP IP      +  +++  +M +CW  + + R
Sbjct: 248 QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAAR 282

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 36/137 (26%), Positives = 67/137 (48%), Gaps = 4/137 (2%)
Query: 252 CVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLN 311
           C      L  V + + GG +   I +  K +  + +  A +++ G+ FL+  G+ YRDL 
Sbjct: 88  CFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISIGLFFLHKRGIIYRDLK 147
Query: 312 SQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNV 371
              ++LD  G++ + D G+       G  T        ++APEIIA  P   S  W    
Sbjct: 148 LDNVMLDSEGHIKIADFGMCKEHMMDGVTTREFCGTPDYIAPEIIAYQPYGKSVDW---- 203
Query: 372 YSFGMVIWEMVTGEAAY 388
           +++G++++EM+ G+  +
Sbjct: 204 WAYGVLLYEMLAGQPPF 220

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 61/275 (22%), Positives = 120/275 (43%), Gaps = 39/275 (14%)
Query: 196 DQIGPNSFKGVYKGKRVGIE-KLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVD 254
           + IG   F  V++GK  G E  +K         +    ++ + +   H+NIL F      
Sbjct: 35  ESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNK 94
Query: 255 EN---HGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN--------DH 303
           +N     L +V+   E GS+ D  L    +  + +I++A+  A G+  L+          
Sbjct: 95  DNGTWTQLWLVSDYHEHGSLFDY-LNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP 153
Query: 304 GVAYRDLNSQRILLDRHGNVCLGDMGIV----TACKSVGEATEYETDGYRWLAPEII--A 357
            +A+RDL S+ IL+ ++G  C+ D+G+     +A  ++  A  +     R++APE++  +
Sbjct: 154 AIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDS 213
Query: 358 GDPESVSETWMSNVYSFGMVIWEMVTG----------EAAYAACSPVQAAVG-----IAA 402
            + +       +++Y+ G+V WE+             +  Y    P   +V      +  
Sbjct: 214 INMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCE 273
Query: 403 CGLRPEIPK-----DCPQILKSLMIKCWNNSPSKR 432
             LRP IP      +  +++  +M +CW  + + R
Sbjct: 274 QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAAR 308

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 61/275 (22%), Positives = 120/275 (43%), Gaps = 39/275 (14%)
Query: 196 DQIGPNSFKGVYKGKRVGIE-KLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVD 254
           + IG   F  V++GK  G E  +K         +    ++ + +   H+NIL F      
Sbjct: 15  ESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNK 74
Query: 255 EN---HGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN--------DH 303
           +N     L +V+   E GS+ D  L    +  + +I++A+  A G+  L+          
Sbjct: 75  DNGTWTQLWLVSDYHEHGSLFDY-LNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP 133
Query: 304 GVAYRDLNSQRILLDRHGNVCLGDMGIV----TACKSVGEATEYETDGYRWLAPEII--A 357
            +A+RDL S+ IL+ ++G  C+ D+G+     +A  ++  A  +     R++APE++  +
Sbjct: 134 AIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDS 193
Query: 358 GDPESVSETWMSNVYSFGMVIWEMVTG----------EAAYAACSPVQAAVG-----IAA 402
            + +       +++Y+ G+V WE+             +  Y    P   +V      +  
Sbjct: 194 INMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCE 253
Query: 403 CGLRPEIPK-----DCPQILKSLMIKCWNNSPSKR 432
             LRP IP      +  +++  +M +CW  + + R
Sbjct: 254 QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAAR 288

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/269 (22%), Positives = 111/269 (41%), Gaps = 46/269 (17%)
Query: 188 NSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFE-LRKDLLE---------- 236
           +    E +  +G  SF     GK   ++K+ G D    Y  + L+K  L+          
Sbjct: 22  DPSQFELLKVLGQGSF-----GKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKME 76
Query: 237 ---LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDV 293
              L+   H  I++ +     E   L ++   + GG +   + K      +++     ++
Sbjct: 77  RDILVEVNHPFIVKLHYAFQTEG-KLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAEL 135
Query: 294 AEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY----- 348
           A  +  L+  G+ YRDL  + ILLD  G++ L D G+        E+ ++E   Y     
Sbjct: 136 ALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK------ESIDHEKKAYSFCGT 189
Query: 349 -RWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP 407
             ++APE++     + S  W    +SFG++++EM+TG   +      +    I    L  
Sbjct: 190 VEYMAPEVVNRRGHTQSADW----WSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKL-- 243
Query: 408 EIPKDCPQIL----KSLMIKCWNNSPSKR 432
                 PQ L    +SL+   +  +P+ R
Sbjct: 244 ----GMPQFLSPEAQSLLRMLFKRNPANR 268

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/269 (22%), Positives = 111/269 (41%), Gaps = 46/269 (17%)
Query: 188 NSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFE-LRKDLLE---------- 236
           +    E +  +G  SF     GK   ++K+ G D    Y  + L+K  L+          
Sbjct: 22  DPSQFELLKVLGQGSF-----GKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKME 76
Query: 237 ---LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDV 293
              L+   H  I++ +     E   L ++   + GG +   + K      +++     ++
Sbjct: 77  RDILVEVNHPFIVKLHYAFQTEG-KLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAEL 135
Query: 294 AEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY----- 348
           A  +  L+  G+ YRDL  + ILLD  G++ L D G+        E+ ++E   Y     
Sbjct: 136 ALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK------ESIDHEKKAYSFCGT 189
Query: 349 -RWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP 407
             ++APE++     + S  W    +SFG++++EM+TG   +      +    I    L  
Sbjct: 190 VEYMAPEVVNRRGHTQSADW----WSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKL-- 243
Query: 408 EIPKDCPQIL----KSLMIKCWNNSPSKR 432
                 PQ L    +SL+   +  +P+ R
Sbjct: 244 ----GMPQFLSPEAQSLLRMLFKRNPANR 268

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/269 (22%), Positives = 111/269 (41%), Gaps = 46/269 (17%)
Query: 188 NSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFE-LRKDLLE---------- 236
           +    E +  +G  SF     GK   ++K+ G D    Y  + L+K  L+          
Sbjct: 23  DPSQFELLKVLGQGSF-----GKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKME 77
Query: 237 ---LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDV 293
              L+   H  I++ +     E   L ++   + GG +   + K      +++     ++
Sbjct: 78  RDILVEVNHPFIVKLHYAFQTEG-KLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAEL 136
Query: 294 AEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY----- 348
           A  +  L+  G+ YRDL  + ILLD  G++ L D G+        E+ ++E   Y     
Sbjct: 137 ALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK------ESIDHEKKAYSFCGT 190
Query: 349 -RWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP 407
             ++APE++     + S  W    +SFG++++EM+TG   +      +    I    L  
Sbjct: 191 VEYMAPEVVNRRGHTQSADW----WSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKL-- 244
Query: 408 EIPKDCPQIL----KSLMIKCWNNSPSKR 432
                 PQ L    +SL+   +  +P+ R
Sbjct: 245 ----GMPQFLSPEAQSLLRMLFKRNPANR 269

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 93/201 (46%), Gaps = 18/201 (8%)
Query: 244 NILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDH 303
           N L  Y V  DE   L VV + + GGS+ D++ ++  +   +I  +  +  + ++FL+ +
Sbjct: 82  NYLDSYLVG-DE---LWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSN 136
Query: 304 GVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEII---AGDP 360
            V +RD+ S  ILL   G+V L D G                    W+APE++   A  P
Sbjct: 137 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKAYGP 196
Query: 361 ESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEI--PKDCPQILK 418
           +        +++S G++  EM+ GE  Y   +P++A   IA  G  PE+  P+    I +
Sbjct: 197 K-------VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG-TPELQNPEKLSAIFR 248
Query: 419 SLMIKCWNNSPSKRPQFSEII 439
             + +C      KR    E+I
Sbjct: 249 DFLNRCLEMDVEKRGSAKELI 269

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 94/201 (46%), Gaps = 18/201 (8%)
Query: 244 NILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDH 303
           N L  Y V  DE   L VV + + GGS+ D++ ++  +   +I  +  +  + ++FL+ +
Sbjct: 81  NYLDSYLVG-DE---LWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSN 135
Query: 304 GVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEII---AGDP 360
            V +RD+ S  ILL   G+V L D G                    W+APE++   A  P
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 195
Query: 361 ESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEI--PKDCPQILK 418
           +        +++S G++  EM+ GE  Y   +P++A   IA  G  PE+  P+    I +
Sbjct: 196 K-------VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG-TPELQNPEKLSAIFR 247
Query: 419 SLMIKCWNNSPSKRPQFSEII 439
             + +C +    KR    E++
Sbjct: 248 DFLNRCLDMDVEKRGSAKELL 268

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 94/201 (46%), Gaps = 18/201 (8%)
Query: 244 NILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDH 303
           N L  Y V  DE   L VV + + GGS+ D++ ++  +   +I  +  +  + ++FL+ +
Sbjct: 81  NYLDSYLVG-DE---LWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSN 135
Query: 304 GVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEII---AGDP 360
            V +RD+ S  ILL   G+V L D G                    W+APE++   A  P
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMVGTPYWMAPEVVTRKAYGP 195
Query: 361 ESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEI--PKDCPQILK 418
           +        +++S G++  EM+ GE  Y   +P++A   IA  G  PE+  P+    I +
Sbjct: 196 K-------VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG-TPELQNPEKLSAIFR 247
Query: 419 SLMIKCWNNSPSKRPQFSEII 439
             + +C +    KR    E++
Sbjct: 248 DFLNRCLDMDVEKRGSAKELL 268

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 84/163 (51%), Gaps = 27/163 (16%)
Query: 242 HKNILQFY-------CVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVA 294
           H+NILQF         V VD    L ++T   E GS++D  LK+  +   E+  IA  +A
Sbjct: 77  HENILQFIGAEKRGTSVDVD----LWLITAFHEKGSLSDF-LKANVVSWNELCHIAETMA 131
Query: 295 EGIKFLNDH----------GVAYRDLNSQRILLDRHGNVCLGDMGIVT---ACKSVGEAT 341
            G+ +L++            +++RD+ S+ +LL  +   C+ D G+     A KS G+ T
Sbjct: 132 RGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGD-T 190
Query: 342 EYETDGYRWLAPEIIAGDPESVSETWMS-NVYSFGMVIWEMVT 383
             +    R++APE++ G      + ++  ++Y+ G+V+WE+ +
Sbjct: 191 HGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELAS 233

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/236 (23%), Positives = 103/236 (43%), Gaps = 21/236 (8%)
Query: 225 AYEFELRKDLLELMTCGHKNILQFYCVCVDENHG---LCVVTKLMEGGSVNDLILKSRKL 281
           ++    R++        H  I+  Y     E        +V + ++G ++ D++     +
Sbjct: 54  SFYLRFRREAQNAAALNHPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPM 113
Query: 282 QTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA- 340
             K  I +  D  + + F + +G+ +RD+    I++     V + D GI  A    G + 
Sbjct: 114 TPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSV 173
Query: 341 --TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAV 398
             T       ++L+PE   GD    S    S+VYS G V++E++TGE  +   SPV    
Sbjct: 174 TQTAAVIGTAQYLSPEQARGD----SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS--- 226
Query: 399 GIAACGLRPE-IPKDCPQ-----ILKSLMIKCWNNSPSKRPQF-SEIISLLLRTNN 447
            +A   +R + IP           L ++++K    +P  R Q  +E+ + L+R +N
Sbjct: 227 -VAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 281

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 93/201 (46%), Gaps = 18/201 (8%)
Query: 244 NILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDH 303
           N L  Y V  DE   L VV + + GGS+ D++ ++  +   +I  +  +  + ++FL+ +
Sbjct: 81  NYLDSYLVG-DE---LWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSN 135
Query: 304 GVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEII---AGDP 360
            V +RD+ S  ILL   G+V L D G                    W+APE++   A  P
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKAYGP 195
Query: 361 ESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEI--PKDCPQILK 418
           +        +++S G++  EM+ GE  Y   +P++A   IA  G  PE+  P+    I +
Sbjct: 196 K-------VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG-TPELQNPEKLSAIFR 247
Query: 419 SLMIKCWNNSPSKRPQFSEII 439
             + +C      KR    E++
Sbjct: 248 DFLNRCLEMDVEKRGSAKELL 268

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/236 (23%), Positives = 103/236 (43%), Gaps = 21/236 (8%)
Query: 225 AYEFELRKDLLELMTCGHKNILQFYCVCVDENHG---LCVVTKLMEGGSVNDLILKSRKL 281
           ++    R++        H  I+  Y     E        +V + ++G ++ D++     +
Sbjct: 54  SFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPM 113
Query: 282 QTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA- 340
             K  I +  D  + + F + +G+ +RD+    IL+     V + D GI  A    G + 
Sbjct: 114 TPKRAIEVIADACQALNFSHQNGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSV 173
Query: 341 --TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAV 398
             T       ++L+PE   GD    S    S+VYS G V++E++TGE  +   SPV    
Sbjct: 174 XQTAAVIGTAQYLSPEQARGD----SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS--- 226
Query: 399 GIAACGLRPE-IPKDCPQ-----ILKSLMIKCWNNSPSKRPQF-SEIISLLLRTNN 447
            +A   +R + IP           L ++++K    +P  R Q  +E+ + L+R +N
Sbjct: 227 -VAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 281

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 34/137 (24%), Positives = 67/137 (48%), Gaps = 4/137 (2%)
Query: 252 CVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLN 311
           C      L  V + + GG +   + + RKL  +     + +++  + +L++ G+ YRDL 
Sbjct: 78  CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLK 137
Query: 312 SQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNV 371
              +LLD  G++ L D G+       G+ T        ++APEI+ G+    S  W    
Sbjct: 138 LDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGEDYGFSVDW---- 193
Query: 372 YSFGMVIWEMVTGEAAY 388
           ++ G++++EM+ G + +
Sbjct: 194 WALGVLMFEMMAGRSPF 210

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 34/137 (24%), Positives = 67/137 (48%), Gaps = 4/137 (2%)
Query: 252 CVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLN 311
           C      L  V + + GG +   + + RKL  +     + +++  + +L++ G+ YRDL 
Sbjct: 89  CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLK 148
Query: 312 SQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNV 371
              +LLD  G++ L D G+       G+ T        ++APEI+ G+    S  W    
Sbjct: 149 LDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGEDYGFSVDW---- 204
Query: 372 YSFGMVIWEMVTGEAAY 388
           ++ G++++EM+ G + +
Sbjct: 205 WALGVLMFEMMAGRSPF 221

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/285 (21%), Positives = 124/285 (43%), Gaps = 38/285 (13%)
Query: 191 NLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLE----LMTC 240
           N     +IG   F  VY+      G  V ++K++  D  +A   + R D ++    L   
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDA---KARADCIKEIDLLKQL 89
Query: 241 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK----LQTKEIIRIAIDVAEG 296
            H N++++Y   +++N  L +V +L + G ++ +I   +K    +  + + +  + +   
Sbjct: 90  NHPNVIKYYASFIEDNE-LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSA 148
Query: 297 IKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEII 356
           ++ ++   V +RD+    + +   G V LGD+G+     S   A         +++PE I
Sbjct: 149 LEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERI 208
Query: 357 AGDPESVSETWMSNVYSFGMVIWEMVTGEAA--------YAACSPVQAAVGIAACGLRPE 408
             +       + S+++S G +++EM   ++         Y+ C        I  C   P 
Sbjct: 209 HEN----GYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK------KIEQCDY-PP 257
Query: 409 IPKD-CPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNSS 452
           +P D   + L+ L+  C N  P KRP  + +  +  R +  + SS
Sbjct: 258 LPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASS 302

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 34/137 (24%), Positives = 67/137 (48%), Gaps = 4/137 (2%)
Query: 252 CVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLN 311
           C      L  V + + GG +   + + RKL  +     + +++  + +L++ G+ YRDL 
Sbjct: 74  CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLK 133
Query: 312 SQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNV 371
              +LLD  G++ L D G+       G+ T        ++APEI+ G+    S  W    
Sbjct: 134 LDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGEDYGFSVDW---- 189
Query: 372 YSFGMVIWEMVTGEAAY 388
           ++ G++++EM+ G + +
Sbjct: 190 WALGVLMFEMMAGRSPF 206

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 34/137 (24%), Positives = 67/137 (48%), Gaps = 4/137 (2%)
Query: 252 CVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLN 311
           C      L  V + + GG +   + + RKL  +     + +++  + +L++ G+ YRDL 
Sbjct: 121 CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLK 180
Query: 312 SQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNV 371
              +LLD  G++ L D G+       G+ T        ++APEI+ G+    S  W    
Sbjct: 181 LDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDW---- 236
Query: 372 YSFGMVIWEMVTGEAAY 388
           ++ G++++EM+ G + +
Sbjct: 237 WALGVLMFEMMAGRSPF 253

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 93/203 (45%), Gaps = 17/203 (8%)
Query: 196 DQIGPNSFKGVYKG----KRVGIEKLKGCDKGNAYEF--ELRKDLLELMTCGHKNILQFY 249
           +++G   F  VYKG      V ++KL         E   +  +++  +  C H+N+++  
Sbjct: 37  NKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELL 96
Query: 250 CVCVDENHGLCVVTKLMEGGSVNDLIL---KSRKLQTKEIIRIAIDVAEGIKFLNDHGVA 306
               D +  LC+V   M  GS+ D +     +  L      +IA   A GI FL+++   
Sbjct: 97  GFSSDGD-DLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHI 155
Query: 307 YRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE--TDGYRWLAPEIIAGDPESVS 364
           +RD+ S  ILLD      + D G+  A +   +            ++APE + G+     
Sbjct: 156 HRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXSRIVGTTAYMAPEALRGEI---- 211
Query: 365 ETWMSNVYSFGMVIWEMVTGEAA 387
            T  S++YSFG+V+ E++TG  A
Sbjct: 212 -TPKSDIYSFGVVLLEIITGLPA 233

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 55/236 (23%), Positives = 103/236 (43%), Gaps = 21/236 (8%)
Query: 225 AYEFELRKDLLELMTCGHKNILQFYCVCVDENHG---LCVVTKLMEGGSVNDLILKSRKL 281
           ++    R++        H  I+  Y     E        +V + ++G ++ D++     +
Sbjct: 54  SFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPM 113
Query: 282 QTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA- 340
             K  I +  D  + + F + +G+ +RD+    I++     V + D GI  A    G + 
Sbjct: 114 TPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSV 173
Query: 341 --TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAV 398
             T       ++L+PE   GD    S    S+VYS G V++E++TGE  +   SPV    
Sbjct: 174 TQTAAVIGTAQYLSPEQARGD----SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS--- 226
Query: 399 GIAACGLRPE-IPKDCPQ-----ILKSLMIKCWNNSPSKRPQF-SEIISLLLRTNN 447
            +A   +R + IP           L ++++K    +P  R Q  +E+ + L+R +N
Sbjct: 227 -VAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 281

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 55/236 (23%), Positives = 103/236 (43%), Gaps = 21/236 (8%)
Query: 225 AYEFELRKDLLELMTCGHKNILQFYCVCVDENHG---LCVVTKLMEGGSVNDLILKSRKL 281
           ++    R++        H  I+  Y     E        +V + ++G ++ D++     +
Sbjct: 54  SFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPM 113
Query: 282 QTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA- 340
             K  I +  D  + + F + +G+ +RD+    I++     V + D GI  A    G + 
Sbjct: 114 TPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSV 173
Query: 341 --TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAV 398
             T       ++L+PE   GD    S    S+VYS G V++E++TGE  +   SPV    
Sbjct: 174 TQTAAVIGTAQYLSPEQARGD----SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS--- 226
Query: 399 GIAACGLRPE-IPKDCPQ-----ILKSLMIKCWNNSPSKRPQF-SEIISLLLRTNN 447
            +A   +R + IP           L ++++K    +P  R Q  +E+ + L+R +N
Sbjct: 227 -VAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 281

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 93/203 (45%), Gaps = 17/203 (8%)
Query: 196 DQIGPNSFKGVYKG----KRVGIEKLKGCDKGNAYEF--ELRKDLLELMTCGHKNILQFY 249
           +++G   F  VYKG      V ++KL         E   +  +++  +  C H+N+++  
Sbjct: 37  NKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELL 96
Query: 250 CVCVDENHGLCVVTKLMEGGSVNDLIL---KSRKLQTKEIIRIAIDVAEGIKFLNDHGVA 306
               D +  LC+V   M  GS+ D +     +  L      +IA   A GI FL+++   
Sbjct: 97  GFSSDGD-DLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHI 155
Query: 307 YRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE--TDGYRWLAPEIIAGDPESVS 364
           +RD+ S  ILLD      + D G+  A +   +            ++APE + G+     
Sbjct: 156 HRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXXRIVGTTAYMAPEALRGEI---- 211
Query: 365 ETWMSNVYSFGMVIWEMVTGEAA 387
            T  S++YSFG+V+ E++TG  A
Sbjct: 212 -TPKSDIYSFGVVLLEIITGLPA 233

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 38/157 (24%), Positives = 69/157 (43%), Gaps = 16/157 (10%)
Query: 242 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK----LQTKEIIRIAIDVAEGI 297
           H   +       +    LC+V  +M GG +   I    +     Q    I     +  G+
Sbjct: 243 HSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGL 302
Query: 298 KFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR----WLAP 353
           + L+   + YRDL  + +LLD  GNV + D+G+    K    A + +T GY     ++AP
Sbjct: 303 EHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK----AGQTKTKGYAGTPGFMAP 358
Query: 354 EIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAA 390
           E++ G+    S     + ++ G+ ++EM+     + A
Sbjct: 359 ELLLGEEYDFS----VDYFALGVTLYEMIAARGPFRA 391

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 38/157 (24%), Positives = 69/157 (43%), Gaps = 16/157 (10%)
Query: 242 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK----LQTKEIIRIAIDVAEGI 297
           H   +       +    LC+V  +M GG +   I    +     Q    I     +  G+
Sbjct: 243 HSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGL 302
Query: 298 KFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR----WLAP 353
           + L+   + YRDL  + +LLD  GNV + D+G+    K    A + +T GY     ++AP
Sbjct: 303 EHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK----AGQTKTKGYAGTPGFMAP 358
Query: 354 EIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAA 390
           E++ G+    S     + ++ G+ ++EM+     + A
Sbjct: 359 ELLLGEEYDFS----VDYFALGVTLYEMIAARGPFRA 391

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 71/301 (23%), Positives = 118/301 (39%), Gaps = 52/301 (17%)
Query: 184 RWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEK-----------LKGCDKGNAYEFELRK 232
           +W    +NLEF   +G  +F  V      GI K           LK  +K ++ E E   
Sbjct: 39  KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLK--EKADSSEREALM 96
Query: 233 DLLELMT--CGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEI---- 286
             L++MT    H+NI+     C        +      G  +N L  K  K    EI    
Sbjct: 97  SELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYEN 156
Query: 287 ------------------IRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDM 328
                             +  A  VA+G++FL      +RDL ++ +L+     V + D 
Sbjct: 157 QKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDF 216
Query: 329 GIVTACKSVGEATEYETDG-----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT 383
           G+    + +   + Y   G      +W+APE +     ++     S+V+S+G+++WE+ +
Sbjct: 217 GL---ARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIK----SDVWSYGILLWEIFS 269
Query: 384 -GEAAYAACSPVQAAV-GIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISL 441
            G   Y    PV A    +   G + + P    + +  +M  CW     KRP F  + S 
Sbjct: 270 LGVNPYPGI-PVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 328
Query: 442 L 442
           L
Sbjct: 329 L 329

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 93/201 (46%), Gaps = 18/201 (8%)
Query: 244 NILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDH 303
           N L  Y V  DE   L VV + + GGS+ D++ ++  +   +I  +  +  + ++FL+ +
Sbjct: 82  NYLDSYLVG-DE---LWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSN 136
Query: 304 GVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEII---AGDP 360
            V +R++ S  ILL   G+V L D G                    W+APE++   A  P
Sbjct: 137 QVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 196
Query: 361 ESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEI--PKDCPQILK 418
           +        +++S G++  EM+ GE  Y   +P++A   IA  G  PE+  P+    I +
Sbjct: 197 K-------VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG-TPELQNPEKLSAIFR 248
Query: 419 SLMIKCWNNSPSKRPQFSEII 439
             + +C      KR    E+I
Sbjct: 249 DFLNRCLEMDVEKRGSAKELI 269

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 38/157 (24%), Positives = 69/157 (43%), Gaps = 16/157 (10%)
Query: 242 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK----LQTKEIIRIAIDVAEGI 297
           H   +       +    LC+V  +M GG +   I    +     Q    I     +  G+
Sbjct: 243 HSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGL 302
Query: 298 KFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR----WLAP 353
           + L+   + YRDL  + +LLD  GNV + D+G+    K    A + +T GY     ++AP
Sbjct: 303 EHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK----AGQTKTKGYAGTPGFMAP 358
Query: 354 EIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAA 390
           E++ G+    S     + ++ G+ ++EM+     + A
Sbjct: 359 ELLLGEEYDFS----VDYFALGVTLYEMIAARGPFRA 391

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 93/203 (45%), Gaps = 17/203 (8%)
Query: 196 DQIGPNSFKGVYKG----KRVGIEKLKGCDKGNAYEF--ELRKDLLELMTCGHKNILQFY 249
           +++G   F  VYKG      V ++KL         E   +  +++  +  C H+N+++  
Sbjct: 31  NKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELL 90
Query: 250 CVCVDENHGLCVVTKLMEGGSVNDLIL---KSRKLQTKEIIRIAIDVAEGIKFLNDHGVA 306
               D +  LC+V   M  GS+ D +     +  L      +IA   A GI FL+++   
Sbjct: 91  GFSSDGD-DLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHI 149
Query: 307 YRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE--TDGYRWLAPEIIAGDPESVS 364
           +RD+ S  ILLD      + D G+  A +   +            ++APE + G+     
Sbjct: 150 HRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMAPEALRGEI---- 205
Query: 365 ETWMSNVYSFGMVIWEMVTGEAA 387
            T  S++YSFG+V+ E++TG  A
Sbjct: 206 -TPKSDIYSFGVVLLEIITGLPA 227

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 38/157 (24%), Positives = 69/157 (43%), Gaps = 16/157 (10%)
Query: 242 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK----LQTKEIIRIAIDVAEGI 297
           H   +       +    LC+V  +M GG +   I    +     Q    I     +  G+
Sbjct: 243 HSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGL 302
Query: 298 KFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR----WLAP 353
           + L+   + YRDL  + +LLD  GNV + D+G+    K    A + +T GY     ++AP
Sbjct: 303 EHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK----AGQTKTKGYAGTPGFMAP 358
Query: 354 EIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAA 390
           E++ G+    S     + ++ G+ ++EM+     + A
Sbjct: 359 ELLLGEEYDFS----VDYFALGVTLYEMIAARGPFRA 391

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 34/133 (25%), Positives = 67/133 (50%), Gaps = 7/133 (5%)
Query: 258 GLCVVTKLMEGGSVNDLILKSRKLQTKEI--IRIAIDVAEGIKFLNDHGVAYRDLNSQRI 315
            LC+V  LM GG +   I    +    E   +  A ++  G++ L+   + YRDL  + I
Sbjct: 258 ALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENI 317
Query: 316 LLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFG 375
           LLD HG++ + D+G+       G+  +       ++APE++  +  + S  W    ++ G
Sbjct: 318 LLDDHGHIRISDLGLAVHVPE-GQTIKGRVGTVGYMAPEVVKNERYTFSPDW----WALG 372
Query: 376 MVIWEMVTGEAAY 388
            +++EM+ G++ +
Sbjct: 373 CLLYEMIAGQSPF 385

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 55/236 (23%), Positives = 103/236 (43%), Gaps = 21/236 (8%)
Query: 225 AYEFELRKDLLELMTCGHKNILQFYCVCVDENHG---LCVVTKLMEGGSVNDLILKSRKL 281
           ++    R++        H  I+  Y     E        +V + ++G ++ D++     +
Sbjct: 71  SFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPM 130
Query: 282 QTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA- 340
             K  I +  D  + + F + +G+ +RD+    I++     V + D GI  A    G + 
Sbjct: 131 TPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSV 190
Query: 341 --TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAV 398
             T       ++L+PE   GD    S    S+VYS G V++E++TGE  +   SPV    
Sbjct: 191 TQTAAVIGTAQYLSPEQARGD----SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS--- 243
Query: 399 GIAACGLRPE-IPKDCPQ-----ILKSLMIKCWNNSPSKRPQF-SEIISLLLRTNN 447
            +A   +R + IP           L ++++K    +P  R Q  +E+ + L+R +N
Sbjct: 244 -VAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 298

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 34/133 (25%), Positives = 67/133 (50%), Gaps = 7/133 (5%)
Query: 258 GLCVVTKLMEGGSVNDLILKSRKLQTKEI--IRIAIDVAEGIKFLNDHGVAYRDLNSQRI 315
            LC+V  LM GG +   I    +    E   +  A ++  G++ L+   + YRDL  + I
Sbjct: 258 ALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENI 317
Query: 316 LLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFG 375
           LLD HG++ + D+G+       G+  +       ++APE++  +  + S  W    ++ G
Sbjct: 318 LLDDHGHIRISDLGLAVHVPE-GQTIKGRVGTVGYMAPEVVKNERYTFSPDW----WALG 372
Query: 376 MVIWEMVTGEAAY 388
            +++EM+ G++ +
Sbjct: 373 CLLYEMIAGQSPF 385

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 71/303 (23%), Positives = 123/303 (40%), Gaps = 66/303 (21%)
Query: 187 LNSDNLEFIDQIGPNSFKGVYKG----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGH 242
           L+ DNL+ ++ IG   +  VYKG    + V ++     ++ N   F   K++  +    H
Sbjct: 10  LDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANRQN---FINEKNIYRVPLMEH 66
Query: 243 KNILQFYC----VCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEII---RIAIDVAE 295
            NI +F      V  D      +V +    GS    + K   L T + +   R+A  V  
Sbjct: 67  DNIARFIVGDERVTADGRMEYLLVMEYYPNGS----LXKYLSLHTSDWVSSCRLAHSVTR 122
Query: 296 GIKFLN------DH---GVAYRDLNSQRILLDRHGNVCLGDMGI---VTACKSVGEATE- 342
           G+ +L+      DH    +++RDLNS+ +L+   G   + D G+   +T  + V    E 
Sbjct: 123 GLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEED 182
Query: 343 ----YETDGYRWLAPEIIAG-----DPESVSETWMSNVYSFGMVIWE-------MVTGEA 386
                E    R++APE++ G     D ES  +    ++Y+ G++ WE       +  GE+
Sbjct: 183 NAAISEVGTIRYMAPEVLEGAVNLRDXESALKQ--VDMYALGLIYWEIFMRCTDLFPGES 240
Query: 387 AYAACSPVQAAVG-----------IAACGLRPEIPKD------CPQILKSLMIKCWNNSP 429
                   Q  VG           ++    RP+ P+         + LK  +  CW+   
Sbjct: 241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDA 300
Query: 430 SKR 432
             R
Sbjct: 301 EAR 303

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/264 (22%), Positives = 111/264 (42%), Gaps = 17/264 (6%)
Query: 198 IGPNSFKGVYKGKRV--GIE-KLKGCDKGNAYEF----ELRKDLLELMTCGHKNILQFYC 250
           +G  SF GVY+ + +  G+E  +K  DK   Y+      ++ ++       H +IL+ Y 
Sbjct: 19  LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 251 VCVDENHGLCVVTKLMEGGSVNDLILKSR--KLQTKEIIRIAIDVAEGIKFLNDHGVAYR 308
              D N+ + +V ++   G +N   LK+R       E       +  G+ +L+ HG+ +R
Sbjct: 79  YFEDSNY-VYLVLEMCHNGEMNR-YLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHR 136
Query: 309 DLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWM 368
           DL    +LL R+ N+ + D G+ T  K   E          +++PEI       +     
Sbjct: 137 DLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLE---- 192
Query: 369 SNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNS 428
           S+V+S G + + ++ G   +   +       +       E+P       K L+ +    +
Sbjct: 193 SDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADY--EMPSFLSIEAKDLIHQLLRRN 250
Query: 429 PSKRPQFSEIISLLLRTNNISNSS 452
           P+ R   S ++     + N S  S
Sbjct: 251 PADRLSLSSVLDHPFMSRNSSTKS 274

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 37/155 (23%), Positives = 75/155 (48%), Gaps = 10/155 (6%)
Query: 237 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEG 296
           L    H NI++ + +  D +    +V +L  GG + D I+K ++    +  RI   V  G
Sbjct: 75  LKKLDHPNIMKLFEILEDSS-SFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSG 133
Query: 297 IKFLNDHGVAYRDLNSQRILLDRHGNVC---LGDMGIVTACKSVGEATEYETDGYRWLAP 353
           I +++ H + +RDL  + ILL+     C   + D G+ T  +   +  +     Y ++AP
Sbjct: 134 ITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAY-YIAP 192
Query: 354 EIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAY 388
           E++ G  +   + W     S G++++ +++G   +
Sbjct: 193 EVLRGTYDEKCDVW-----SAGVILYILLSGTPPF 222

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/248 (24%), Positives = 107/248 (43%), Gaps = 31/248 (12%)
Query: 190 DNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL--RKDLLELMTCGH----K 243
           D  E I  IG  SF       RV +  +K  + GN Y  ++  ++ +++L    H    K
Sbjct: 41  DQFERIKTIGTGSFG------RVML--VKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 244 NILQF----YCVCVD----ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAE 295
            ILQ     + V ++    +N  L +V + M GG +   + +  +         A  +  
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 296 GIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEI 355
             ++L+   + YRDL  + +L+D+ G + + D G     K V   T        +LAPEI
Sbjct: 153 TFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGF---AKRVKGRTWXLCGTPEYLAPEI 209
Query: 356 IAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR--PEIPKDC 413
           I     + +  W    ++ G++I+EM  G   + A  P+Q    I +  +R       D 
Sbjct: 210 ILSKGYNKAVDW----WALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 265
Query: 414 PQILKSLM 421
             +L++L+
Sbjct: 266 KDLLRNLL 273

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/248 (24%), Positives = 107/248 (43%), Gaps = 31/248 (12%)
Query: 190 DNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL--RKDLLELMTCGH----K 243
           D  E I  IG  SF       RV +  +K  + GN Y  ++  ++ +++L    H    K
Sbjct: 41  DQFERIKTIGTGSFG------RVML--VKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 244 NILQF----YCVCVD----ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAE 295
            ILQ     + V ++    +N  L +V + M GG +   + +  +         A  +  
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 296 GIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEI 355
             ++L+   + YRDL  + +L+D+ G + + D G     K V   T        +LAPEI
Sbjct: 153 TFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGF---AKRVKGRTWXLCGTPEYLAPEI 209
Query: 356 IAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR--PEIPKDC 413
           I     + +  W    ++ G++I+EM  G   + A  P+Q    I +  +R       D 
Sbjct: 210 ILSKGYNKAVDW----WALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 265
Query: 414 PQILKSLM 421
             +L++L+
Sbjct: 266 KDLLRNLL 273

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 36/155 (23%), Positives = 77/155 (49%), Gaps = 10/155 (6%)
Query: 237 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEG 296
           L    H NI++ + + ++++    +V +L  GG + D I+K ++    +  RI   V  G
Sbjct: 75  LKKLDHPNIMKLFEI-LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSG 133
Query: 297 IKFLNDHGVAYRDLNSQRILLDRHGNVC---LGDMGIVTACKSVGEATEYETDGYRWLAP 353
           I +++ H + +RDL  + ILL+     C   + D G+ T  +   +  +     Y ++AP
Sbjct: 134 ITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAY-YIAP 192
Query: 354 EIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAY 388
           E++ G  +   + W     S G++++ +++G   +
Sbjct: 193 EVLRGTYDEKCDVW-----SAGVILYILLSGTPPF 222

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 36/155 (23%), Positives = 77/155 (49%), Gaps = 10/155 (6%)
Query: 237 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEG 296
           L    H NI++ + + ++++    +V +L  GG + D I+K ++    +  RI   V  G
Sbjct: 75  LKKLDHPNIMKLFEI-LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSG 133
Query: 297 IKFLNDHGVAYRDLNSQRILLDRHGNVC---LGDMGIVTACKSVGEATEYETDGYRWLAP 353
           I +++ H + +RDL  + ILL+     C   + D G+ T  +   +  +     Y ++AP
Sbjct: 134 ITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAY-YIAP 192
Query: 354 EIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAY 388
           E++ G  +   + W     S G++++ +++G   +
Sbjct: 193 EVLRGTYDEKCDVW-----SAGVILYILLSGTPPF 222

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/225 (22%), Positives = 101/225 (44%), Gaps = 34/225 (15%)
Query: 188 NSDNLEFIDQIGPNSFKGVYKG-----------KRVGIEKLKGCDKGNAYEFELRKDLLE 236
           +S   + ++++G  ++  VYKG           K V ++  +G       E  L K+L  
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKEL-- 60
Query: 237 LMTCGHKNILQFYCVCVDENHGLCV-------VTKLMEGGSVNDLILKSRKLQTKEIIRI 289
                H+NI++ Y V   EN    V       + K M+  +V +     R L+   +   
Sbjct: 61  ----KHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGN---TPRGLELNLVKYF 113
Query: 290 AIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR 349
              + +G+ F +++ + +RDL  Q +L+++ G + LGD G+  A          E     
Sbjct: 114 QWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLW 173
Query: 350 WLAPEIIAGDPESVSETWMS--NVYSFGMVIWEMVTGEAAYAACS 392
           + AP+++ G     S T+ +  +++S G ++ EM+TG+  +   +
Sbjct: 174 YRAPDVLMG-----SRTYSTSIDIWSCGCILAEMITGKPLFPGTN 213

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/236 (22%), Positives = 102/236 (43%), Gaps = 21/236 (8%)
Query: 225 AYEFELRKDLLELMTCGHKNILQFYCVCVDENHG---LCVVTKLMEGGSVNDLILKSRKL 281
           ++    R++        H  I+  Y     E        +V + ++G ++ D++     +
Sbjct: 54  SFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPM 113
Query: 282 QTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA- 340
             K  I +  D  + + F + +G+ +RD+    I++     V + D GI  A    G + 
Sbjct: 114 TPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSV 173
Query: 341 --TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAV 398
             T       ++L+PE   GD    S    S+VYS G V++E++TGE  +   SP     
Sbjct: 174 TQTAAVIGTAQYLSPEQARGD----SVDARSDVYSLGCVLYEVLTGEPPFTGDSPDS--- 226
Query: 399 GIAACGLRPE-IPKDCPQ-----ILKSLMIKCWNNSPSKRPQF-SEIISLLLRTNN 447
            +A   +R + IP           L ++++K    +P  R Q  +E+ + L+R +N
Sbjct: 227 -VAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 281

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 66/286 (23%), Positives = 123/286 (43%), Gaps = 38/286 (13%)
Query: 186 LLNSDNLEFIDQIGPNSF------KGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMT 239
           ++++ +  FI ++G   F      +G++ G    ++++   ++ +  E +   D+  L  
Sbjct: 25  IIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFN 84
Query: 240 CGHKNILQFYCVCVDEN---HGLCVVTKLMEGGS----VNDLILKSRKLQTKEIIRIAID 292
             H NIL+    C+ E    H   ++    + G+    +  L  K   L   +I+ + + 
Sbjct: 85  --HPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLG 142
Query: 293 VAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVT-ACKSV----------GEAT 341
           +  G++ ++  G A+RDL    ILL   G   L D+G +  AC  V            A 
Sbjct: 143 ICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAA 202
Query: 342 EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIA 401
           +  T  YR  APE+ +     V +   ++V+S G V++ M+ GE  Y        +V +A
Sbjct: 203 QRCTISYR--APELFSVQSHCVIDE-RTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALA 259
Query: 402 ACGLR--PEIPKDCP---QILKSLMIKCWNNSPSKRPQFSEIISLL 442
                  P+ P+      Q+L S+M       P +RP    ++S L
Sbjct: 260 VQNQLSIPQSPRHSSALWQLLNSMM----TVDPHQRPHIPLLLSQL 301

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 67/268 (25%), Positives = 115/268 (42%), Gaps = 23/268 (8%)
Query: 189 SDNLEFIDQIGPNSFKGVYKGKRVGIEKL---KGCDKGNAYEFE---LRKDLLELMTCGH 242
           +++ E +  IG  S+    K +R    K+   K  D G+  E E   L  ++  L    H
Sbjct: 5   AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKH 64
Query: 243 KNILQFYCVCVDE-NHGLCVVTKLMEGGSVNDLILKSRK----LQTKEIIRIAIDVAEGI 297
            NI+++Y   +D  N  L +V +  EGG +  +I K  K    L  + ++R+   +   +
Sbjct: 65  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 298 KFLND-----HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE-ATEYETDGYRWL 351
           K  +      H V +RDL    + LD   NV LGD G+        + A E+    Y ++
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAKEFVGTPY-YM 183
Query: 352 APEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPK 411
           +PE +      +S    S+++S G +++E+      + A S  + A  I     R  IP 
Sbjct: 184 SPEQM----NRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR-RIPY 238
Query: 412 DCPQILKSLMIKCWNNSPSKRPQFSEII 439
                L  ++ +  N     RP   EI+
Sbjct: 239 RYSDELNEIITRMLNLKDYHRPSVEEIL 266

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 57/264 (21%), Positives = 116/264 (43%), Gaps = 30/264 (11%)
Query: 190 DNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFELRKD---LLELMTCGH---- 242
           +N E +  +G  ++     GK   + K+ G D G  Y  ++ K    + +  T  H    
Sbjct: 54  ENFELLKVLGTGAY-----GKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTE 108
Query: 243 KNILQFY---CVCVDENHGLCVVTKL------MEGGSVNDLILKSRKLQTKEIIRIAIDV 293
           + +L+        V  ++     TKL      + GG +   + +  +    E+     ++
Sbjct: 109 RQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEI 168
Query: 294 AEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETD---GYRW 350
              ++ L+  G+ YRD+  + ILLD +G+V L D G+  + + V + TE   D      +
Sbjct: 169 VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGL--SKEFVADETERAYDFCGTIEY 226
Query: 351 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR--PE 408
           +AP+I+ G      +    + +S G++++E++TG + +       +   I+   L+  P 
Sbjct: 227 MAPDIVRGGDSGHDKA--VDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP 284
Query: 409 IPKDCPQILKSLMIKCWNNSPSKR 432
            P++   + K L+ +     P KR
Sbjct: 285 YPQEMSALAKDLIQRLLMKDPKKR 308

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 60/252 (23%), Positives = 108/252 (42%), Gaps = 14/252 (5%)
Query: 195 IDQIGPNSFKGVYKGKRV------GIEKLKGCDKGNAYEFE-LRKDLLELMTCGHKNILQ 247
           + +IG  SF  VY  + V       I+K+    K +  +++ + K++  L    H N +Q
Sbjct: 20  LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ 79
Query: 248 FYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAY 307
            Y  C    H   +V +   G + + L +  + LQ  EI  +     +G+ +L+ H + +
Sbjct: 80  -YRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIH 138
Query: 308 RDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETW 367
           RD+ +  ILL   G V LGD G   +   +  A  +    Y W+APE+I    E   +  
Sbjct: 139 RDVKAGNILLSEPGLVKLGDFG---SASIMAPANXFVGTPY-WMAPEVILAMDEGQYDGK 194
Query: 368 MSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNN 427
           + +V+S G+   E+   +      + + A   IA             +  ++ +  C   
Sbjct: 195 V-DVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQK 253
Query: 428 SPSKRPQFSEII 439
            P  RP  SE++
Sbjct: 254 IPQDRPT-SEVL 264

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 57/264 (21%), Positives = 117/264 (44%), Gaps = 23/264 (8%)
Query: 187 LNSDNLEFIDQIGPNSFKGVYKGKR-----VGIEKLKGCDKGNAYEFELRKDLLELMTCG 241
           L  D+ E I ++G  +   V+K        V   KL   +   A   ++ ++L  L  C 
Sbjct: 6   LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECN 65
Query: 242 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 301
              I+ FY     +   + +  + M+GGS++ ++ K+ ++  + + +++I V +G+ +L 
Sbjct: 66  SPYIVGFYGAFYSDGE-ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 124
Query: 302 D-HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDP 360
           + H + +RD+    IL++  G + L D G+  + + + E          +++PE + G  
Sbjct: 125 EKHKIMHRDVKPSNILVNSRGEIKLCDFGV--SGQLIDEMANEFVGTRSYMSPERLQGTH 182
Query: 361 ESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSL 420
            SV     S+++S G+ + EM  G       +  +    I       E P   P  + SL
Sbjct: 183 YSVQ----SDIWSMGLSLVEMAVGRYPRPPMAIFELLDYIVN-----EPPPKLPSAVFSL 233
Query: 421 MI-----KCWNNSPSKRPQFSEII 439
                  KC   +P++R    +++
Sbjct: 234 EFQDFVNKCLIKNPAERADLKQLM 257

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 60/252 (23%), Positives = 108/252 (42%), Gaps = 14/252 (5%)
Query: 195 IDQIGPNSFKGVYKGKRV------GIEKLKGCDKGNAYEFE-LRKDLLELMTCGHKNILQ 247
           + +IG  SF  VY  + V       I+K+    K +  +++ + K++  L    H N +Q
Sbjct: 59  LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ 118
Query: 248 FYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAY 307
            Y  C    H   +V +   G + + L +  + LQ  EI  +     +G+ +L+ H + +
Sbjct: 119 -YRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIH 177
Query: 308 RDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETW 367
           RD+ +  ILL   G V LGD G   +   +  A  +    Y W+APE+I    E   +  
Sbjct: 178 RDVKAGNILLSEPGLVKLGDFG---SASIMAPANXFVGTPY-WMAPEVILAMDEGQYDGK 233
Query: 368 MSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNN 427
           + +V+S G+   E+   +      + + A   IA             +  ++ +  C   
Sbjct: 234 V-DVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQK 292
Query: 428 SPSKRPQFSEII 439
            P  RP  SE++
Sbjct: 293 IPQDRPT-SEVL 303

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 53/259 (20%), Positives = 112/259 (43%), Gaps = 21/259 (8%)
Query: 191 NLEFIDQIGPNSF------KGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKN 244
           N   +  IG  +F      + +  GK V ++ +      ++   +L +++  +    H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 245 ILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHG 304
           I++ + V ++    L +V +   GG V D ++   +++ KE       +   +++ +   
Sbjct: 75  IVKLFEV-IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF 133
Query: 305 VAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVS 364
           + +RDL ++ +LLD   N+ + D G      + G   +       + APE+  G      
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFSNEF-TFGNKLDTFCGSPPYAAPELFQGKKYDGP 192
Query: 365 ETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIP----KDCPQILKSL 420
           E    +V+S G++++ +V+G   +   +  +    +     R  IP     DC  +LK  
Sbjct: 193 EV---DVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYR--IPFYMSTDCENLLKKF 247
Query: 421 MIKCWNNSPSKRPQFSEII 439
           +I     +PSKR    +I+
Sbjct: 248 LIL----NPSKRGTLEQIM 262

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 53/259 (20%), Positives = 112/259 (43%), Gaps = 21/259 (8%)
Query: 191 NLEFIDQIGPNSF------KGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKN 244
           N   +  IG  +F      + +  GK V ++ +      ++   +L +++  +    H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 245 ILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHG 304
           I++ + V ++    L +V +   GG V D ++   +++ KE       +   +++ +   
Sbjct: 75  IVKLFEV-IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF 133
Query: 305 VAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVS 364
           + +RDL ++ +LLD   N+ + D G      + G   +       + APE+  G      
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFSNEF-TFGNKLDAFCGAPPYAAPELFQGKKYDGP 192
Query: 365 ETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIP----KDCPQILKSL 420
           E    +V+S G++++ +V+G   +   +  +    +     R  IP     DC  +LK  
Sbjct: 193 EV---DVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYR--IPFYMSTDCENLLKKF 247
Query: 421 MIKCWNNSPSKRPQFSEII 439
           +I     +PSKR    +I+
Sbjct: 248 LIL----NPSKRGTLEQIM 262

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 53/259 (20%), Positives = 112/259 (43%), Gaps = 21/259 (8%)
Query: 191 NLEFIDQIGPNSF------KGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKN 244
           N   +  IG  +F      + +  GK V ++ +      ++   +L +++  +    H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 245 ILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHG 304
           I++ + V ++    L +V +   GG V D ++   +++ KE       +   +++ +   
Sbjct: 75  IVKLFEV-IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF 133
Query: 305 VAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVS 364
           + +RDL ++ +LLD   N+ + D G      + G   +       + APE+  G      
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFSNEF-TFGNKLDTFCGSPPYAAPELFQGKKYDGP 192
Query: 365 ETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIP----KDCPQILKSL 420
           E    +V+S G++++ +V+G   +   +  +    +     R  IP     DC  +LK  
Sbjct: 193 EV---DVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYR--IPFYMSTDCENLLKKF 247
Query: 421 MIKCWNNSPSKRPQFSEII 439
           +I     +PSKR    +I+
Sbjct: 248 LIL----NPSKRGTLEQIM 262

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 59/248 (23%), Positives = 107/248 (43%), Gaps = 31/248 (12%)
Query: 190 DNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL--RKDLLELMTCGH----K 243
           D  E I  IG  SF       RV +  +K  + GN Y  ++  ++ +++L    H    K
Sbjct: 41  DQFERIKTIGTGSFG------RVML--VKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 244 NILQF----YCVCVD----ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAE 295
            ILQ     + V ++    +N  L +V + + GG +   + +  +         A  +  
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 296 GIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEI 355
             ++L+   + YRDL  + +L+D+ G + + D G     K V   T        +LAPEI
Sbjct: 153 TFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGF---AKRVKGRTWXLCGTPEYLAPEI 209
Query: 356 IAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR--PEIPKDC 413
           I     + +  W    ++ G++I+EM  G   + A  P+Q    I +  +R       D 
Sbjct: 210 ILSKGYNKAVDW----WALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 265
Query: 414 PQILKSLM 421
             +L++L+
Sbjct: 266 KDLLRNLL 273

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 53/259 (20%), Positives = 111/259 (42%), Gaps = 21/259 (8%)
Query: 191 NLEFIDQIGPNSF------KGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKN 244
           N   +  IG  +F      + +  GK V +  +      ++   +L +++  +    H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 245 ILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHG 304
           I++ + V ++    L +V +   GG V D ++   +++ KE       +   +++ +   
Sbjct: 75  IVKLFEV-IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF 133
Query: 305 VAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVS 364
           + +RDL ++ +LLD   N+ + D G      + G   +       + APE+  G      
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFSNEF-TFGNKLDTFCGSPPYAAPELFQGKKYDGP 192
Query: 365 ETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIP----KDCPQILKSL 420
           E    +V+S G++++ +V+G   +   +  +    +     R  IP     DC  +LK  
Sbjct: 193 EV---DVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYR--IPFYMSTDCENLLKKF 247
Query: 421 MIKCWNNSPSKRPQFSEII 439
           +I     +PSKR    +I+
Sbjct: 248 LIL----NPSKRGTLEQIM 262

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 70/305 (22%), Positives = 122/305 (40%), Gaps = 23/305 (7%)
Query: 159 PLPSSSFVVSVDEWQTVQSGGEEIGR-WLLNSDNLEFIDQIGPNSFKGVYKGKRVG---I 214
           PLPS+      +E  + Q   E   R W L  ++ E    +G   F  VY  +      I
Sbjct: 4   PLPSAPENNPEEELASKQKNEESKKRQWAL--EDFEIGRPLGKGKFGNVYLAREKQSKFI 61
Query: 215 EKLKGCDKGN----AYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGS 270
             LK   K        E +LR+++       H NIL+ Y    D    + ++ +    G+
Sbjct: 62  LALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATR-VYLILEYAPLGT 120
Query: 271 VNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGI 330
           V   + K  K   +       ++A  + + +   V +RD+  + +LL   G + + D G 
Sbjct: 121 VYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW 180
Query: 331 VTACKSVGEATEYETDGYRWLAPEIIAG--DPESVSETWMSNVYSFGMVIWEMVTGEAAY 388
                S    T   T  Y  L PE+I G    E V      +++S G++ +E + G+  +
Sbjct: 181 SVHAPSSRRTTLCGTLDY--LPPEMIEGRMHDEKV------DLWSLGVLCYEFLVGKPPF 232
Query: 389 AACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNI 448
            A +  +    I+        P    +  + L+ +   ++PS+RP   E++     T N 
Sbjct: 233 EANTYQETYKRISRVEF--TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANS 290
Query: 449 SNSSN 453
           S  SN
Sbjct: 291 SKPSN 295

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 64/267 (23%), Positives = 111/267 (41%), Gaps = 21/267 (7%)
Query: 189 SDNLEFIDQIGPNSFKGVYKGKRVGIEKL---KGCDKGNAYEFE---LRKDLLELMTCGH 242
           +++ E +  IG  S+    K +R    K+   K  D G+  E E   L  ++  L    H
Sbjct: 5   AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKH 64
Query: 243 KNILQFYCVCVDE-NHGLCVVTKLMEGGSVNDLILKSRK----LQTKEIIRIAIDVAEGI 297
            NI+++Y   +D  N  L +V +  EGG +  +I K  K    L  + ++R+   +   +
Sbjct: 65  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 298 KFLND-----HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLA 352
           K  +      H V +RDL    + LD   NV LGD G+           +       +++
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMS 184
Query: 353 PEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKD 412
           PE +      +S    S+++S G +++E+      + A S  + A  I     R  IP  
Sbjct: 185 PEQM----NRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR-RIPYR 239
Query: 413 CPQILKSLMIKCWNNSPSKRPQFSEII 439
               L  ++ +  N     RP   EI+
Sbjct: 240 YSDELNEIITRMLNLKDYHRPSVEEIL 266

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/259 (20%), Positives = 111/259 (42%), Gaps = 21/259 (8%)
Query: 191 NLEFIDQIGPNSF------KGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKN 244
           N   +  IG  +F      + +  GK V +  +      ++   +L +++  +    H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPN 74
Query: 245 ILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHG 304
           I++ + V ++    L +V +   GG V D ++   +++ KE       +   +++ +   
Sbjct: 75  IVKLFEV-IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF 133
Query: 305 VAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVS 364
           + +RDL ++ +LLD   N+ + D G      + G   +       + APE+  G      
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFSNEF-TFGNKLDEFCGSPPYAAPELFQGKKYDGP 192
Query: 365 ETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIP----KDCPQILKSL 420
           E    +V+S G++++ +V+G   +   +  +    +     R  IP     DC  +LK  
Sbjct: 193 EV---DVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYR--IPFYMSTDCENLLKKF 247
Query: 421 MIKCWNNSPSKRPQFSEII 439
           +I     +PSKR    +I+
Sbjct: 248 LIL----NPSKRGTLEQIM 262

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 37/160 (23%), Positives = 79/160 (49%), Gaps = 5/160 (3%)
Query: 229 ELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIR 288
           ++++++  L    H +I++ Y V +       +V + + GG + D I K  +++  E  R
Sbjct: 57  KIKREIQNLKLFRHPHIIKLYQV-ISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARR 115
Query: 289 IAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY 348
           +   +   + + + H V +RDL  + +LLD H N  + D G+ +   S GE         
Sbjct: 116 LFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGL-SNMMSDGEFLRTSCGSP 174
Query: 349 RWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAY 388
            + APE+I+G   +  E    +++S G++++ ++ G   +
Sbjct: 175 NYAAPEVISGRLYAGPEV---DIWSCGVILYALLCGTLPF 211

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/263 (20%), Positives = 119/263 (45%), Gaps = 17/263 (6%)
Query: 187 LNSDNLEFIDQIGPNSFKGVYKGKR-----VGIEKLKGCDKGNAYEFELRKDLLELMTCG 241
           L  D+ E I ++G  +   V+K        V   KL   +   A   ++ ++L  L  C 
Sbjct: 22  LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECN 81
Query: 242 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 301
              I+ FY     +   + +  + M+GGS++ ++ K+ ++  + + +++I V +G+ +L 
Sbjct: 82  SPYIVGFYGAFYSDGE-ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 140
Query: 302 D-HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDP 360
           + H + +RD+    IL++  G + L D G+  + + +            +++PE + G  
Sbjct: 141 EKHKIMHRDVKPSNILVNSRGEIKLCDFGV--SGQLIDSMANSFVGTRSYMSPERLQGTH 198
Query: 361 ESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR---PEIPKDCPQI- 416
            SV     S+++S G+ + EM  G     + S   A   +    +    P++P     + 
Sbjct: 199 YSVQ----SDIWSMGLSLVEMAVGRYPIGSGSGSMAIFELLDYIVNEPPPKLPSGVFSLE 254
Query: 417 LKSLMIKCWNNSPSKRPQFSEII 439
            +  + KC   +P++R    +++
Sbjct: 255 FQDFVNKCLIKNPAERADLKQLM 277

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/256 (23%), Positives = 110/256 (42%), Gaps = 25/256 (9%)
Query: 182 IGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL--RKDLLELMT 239
           + +W   S N   +DQ       G     RV + K K  + GN Y  ++  ++ +++L  
Sbjct: 48  LKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHK--ESGNHYAMKILDKQKVVKLKQ 105
Query: 240 CGH----KNILQF----YCVCVD----ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEII 287
             H    K ILQ     + V ++    +N  L +V + + GG +   + +  +       
Sbjct: 106 IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHAR 165
Query: 288 RIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG 347
             A  +    ++L+   + YRDL  + +L+D+ G + + D G     K V  AT      
Sbjct: 166 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF---AKRVKGATWTLCGT 222
Query: 348 YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR- 406
             +LAPEII     + +  W    ++ G++I+EM  G   + A  P+Q    I +  +R 
Sbjct: 223 PEYLAPEIILSKGYNKAVDW----WALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF 278
Query: 407 -PEIPKDCPQILKSLM 421
                 D   +L++L+
Sbjct: 279 PSHFSSDLKDLLRNLL 294

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/184 (23%), Positives = 74/184 (40%), Gaps = 6/184 (3%)
Query: 259 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLD 318
           L  V   + GG +   + + R          A ++A  + +L+   + YRDL  + ILLD
Sbjct: 114 LYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLD 173
Query: 319 RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVI 378
             G++ L D G+          T        +LAPE++   P   +  W    +  G V+
Sbjct: 174 SQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDW----WCLGAVL 229
Query: 379 WEMVTGEAAYAACSPVQAAVGI--AACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFS 436
           +EM+ G   + + +  +    I      L+P I      +L+ L+ K        +  F 
Sbjct: 230 YEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFM 289
Query: 437 EIIS 440
           EI S
Sbjct: 290 EIKS 293

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 64/267 (23%), Positives = 111/267 (41%), Gaps = 21/267 (7%)
Query: 189 SDNLEFIDQIGPNSFKGVYKGKRVGIEKL---KGCDKGNAYEFE---LRKDLLELMTCGH 242
           +++ E +  IG  S+    K +R    K+   K  D G+  E E   L  ++  L    H
Sbjct: 5   AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKH 64
Query: 243 KNILQFYCVCVDE-NHGLCVVTKLMEGGSVNDLILKSRK----LQTKEIIRIAIDVAEGI 297
            NI+++Y   +D  N  L +V +  EGG +  +I K  K    L  + ++R+   +   +
Sbjct: 65  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 298 KFLND-----HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLA 352
           K  +      H V +RDL    + LD   NV LGD G+           +       +++
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMS 184
Query: 353 PEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKD 412
           PE +      +S    S+++S G +++E+      + A S  + A  I     R  IP  
Sbjct: 185 PEQM----NRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR-RIPYR 239
Query: 413 CPQILKSLMIKCWNNSPSKRPQFSEII 439
               L  ++ +  N     RP   EI+
Sbjct: 240 YSDELNEIITRMLNLKDYHRPSVEEIL 266

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/226 (23%), Positives = 97/226 (42%), Gaps = 35/226 (15%)
Query: 186 LLNSDNLEFIDQIGPNSFKGVYK------GKRVGIEKLK------GCDKGNAYEFELRKD 233
           L++ +N + +++IG  ++  VYK      G+ V ++K++      G       E  L K+
Sbjct: 3   LVDMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKE 62
Query: 234 LLELMTCGHKNILQFYCVCVDENHGLCV-------VTKLMEGGSVNDLILKSRKLQTKEI 286
           L       H NI++   V   EN    V       + K M+  ++  + L   K    ++
Sbjct: 63  L------NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQL 116
Query: 287 IRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETD 346
           +       +G+ F + H V +RDL  Q +L++  G + L D G+  A         +E  
Sbjct: 117 L-------QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV 169
Query: 347 GYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACS 392
              + APEI+ G       +   +++S G +  EMVT  A +   S
Sbjct: 170 TLWYRAPEILLG---CKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 212

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/208 (21%), Positives = 95/208 (45%), Gaps = 12/208 (5%)
Query: 230 LRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRI 289
           L +++  L    H NI++ Y    D+ +   +V ++  GG + D I+  ++    +  RI
Sbjct: 79  LLREVQLLKQLDHPNIMKLYEFFEDKGY-FYLVGEVYTGGELFDEIISRKRFSEVDAARI 137
Query: 290 AIDVAEGIKFLNDHGVAYRDLNSQRILLD---RHGNVCLGDMGIVTACKSVGEATEYETD 346
              V  GI +++ + + +RDL  + +LL+   +  N+ + D G+ T  ++  +  +    
Sbjct: 138 IRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGT 197
Query: 347 GYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR 406
            Y ++APE++ G  +   + W     S G++++ +++G   +   +       +      
Sbjct: 198 AY-YIAPEVLHGTYDEKCDVW-----STGVILYILLSGCPPFNGANEYDILKKVEKGKYT 251
Query: 407 PEIP--KDCPQILKSLMIKCWNNSPSKR 432
            E+P  K   +  K L+ K     PS R
Sbjct: 252 FELPQWKKVSESAKDLIRKMLTYVPSMR 279

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 89/203 (43%), Gaps = 17/203 (8%)
Query: 196 DQIGPNSFKGVYKG----KRVGIEKLKGCDKGNAYEF--ELRKDLLELMTCGHKNILQFY 249
           ++ G   F  VYKG      V ++KL         E   +  +++     C H+N+++  
Sbjct: 28  NKXGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVXAKCQHENLVELL 87
Query: 250 CVCVDENHGLCVVTKLMEGGSVNDLIL---KSRKLQTKEIIRIAIDVAEGIKFLNDHGVA 306
               D +  LC+V      GS+ D +     +  L      +IA   A GI FL+++   
Sbjct: 88  GFSSDGD-DLCLVYVYXPNGSLLDRLSCLDGTPPLSWHXRCKIAQGAANGINFLHENHHI 146
Query: 307 YRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE--TDGYRWLAPEIIAGDPESVS 364
           +RD+ S  ILLD      + D G+  A +   +            + APE + G+     
Sbjct: 147 HRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXAPEALRGEI---- 202
Query: 365 ETWMSNVYSFGMVIWEMVTGEAA 387
            T  S++YSFG+V+ E++TG  A
Sbjct: 203 -TPKSDIYSFGVVLLEIITGLPA 224

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 94/222 (42%), Gaps = 35/222 (15%)
Query: 190 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLK------GCDKGNAYEFELRKDLLEL 237
           +N + +++IG  ++  VYK      G+ V ++K++      G       E  L K+L   
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL--- 59
Query: 238 MTCGHKNILQFYCVCVDENHGLCV-------VTKLMEGGSVNDLILKSRKLQTKEIIRIA 290
               H NI++   V   EN    V       + K M+  ++  + L   K    +++   
Sbjct: 60  ---NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL--- 113
Query: 291 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRW 350
               +G+ F + H V +RDL  Q +L++  G + L D G+  A         +E     +
Sbjct: 114 ----QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWY 169
Query: 351 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACS 392
            APEI+ G     +     +++S G +  EMVT  A +   S
Sbjct: 170 RAPEILLGXKYYSTAV---DIWSLGCIFAEMVTRRALFPGDS 208

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 94/222 (42%), Gaps = 35/222 (15%)
Query: 190 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLK------GCDKGNAYEFELRKDLLEL 237
           +N + +++IG  ++  VYK      G+ V ++K++      G       E  L K+L   
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL--- 66
Query: 238 MTCGHKNILQFYCVCVDENHGLCV-------VTKLMEGGSVNDLILKSRKLQTKEIIRIA 290
               H NI++   V   EN    V       + K M+  ++  + L   K    +++   
Sbjct: 67  ---NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL--- 120
Query: 291 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRW 350
               +G+ F + H V +RDL  Q +L++  G + L D G+  A         +E     +
Sbjct: 121 ----QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWY 176
Query: 351 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACS 392
            APEI+ G     +     +++S G +  EMVT  A +   S
Sbjct: 177 RAPEILLGXKYYSTAV---DIWSLGCIFAEMVTRRALFPGDS 215

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/202 (20%), Positives = 93/202 (46%), Gaps = 7/202 (3%)
Query: 239 TCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIK 298
           +  H++++ F+    ++N  + VV +L    S+ +L  + + L   E       +  G +
Sbjct: 73  SLAHQHVVGFHGF-FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ 131
Query: 299 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAG 358
           +L+ + V +RDL    + L+    V +GD G+ T  +  GE  +       ++APE+++ 
Sbjct: 132 YLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSK 191
Query: 359 DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILK 418
                  ++  +V+S G +++ ++ G+  +      +  + I        IPK    +  
Sbjct: 192 K----GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY--SIPKHINPVAA 245
Query: 419 SLMIKCWNNSPSKRPQFSEIIS 440
           SL+ K     P+ RP  +E+++
Sbjct: 246 SLIQKMLQTDPTARPTINELLN 267

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/202 (20%), Positives = 93/202 (46%), Gaps = 7/202 (3%)
Query: 239 TCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIK 298
           +  H++++ F+    ++N  + VV +L    S+ +L  + + L   E       +  G +
Sbjct: 95  SLAHQHVVGFHGF-FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ 153
Query: 299 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAG 358
           +L+ + V +RDL    + L+    V +GD G+ T  +  GE  +       ++APE+++ 
Sbjct: 154 YLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSK 213
Query: 359 DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILK 418
                  ++  +V+S G +++ ++ G+  +      +  + I        IPK    +  
Sbjct: 214 K----GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY--SIPKHINPVAA 267
Query: 419 SLMIKCWNNSPSKRPQFSEIIS 440
           SL+ K     P+ RP  +E+++
Sbjct: 268 SLIQKMLQTDPTARPTINELLN 289

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/202 (20%), Positives = 93/202 (46%), Gaps = 7/202 (3%)
Query: 239 TCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIK 298
           +  H++++ F+    ++N  + VV +L    S+ +L  + + L   E       +  G +
Sbjct: 73  SLAHQHVVGFHGF-FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ 131
Query: 299 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAG 358
           +L+ + V +RDL    + L+    V +GD G+ T  +  GE  +       ++APE+++ 
Sbjct: 132 YLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSK 191
Query: 359 DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILK 418
                  ++  +V+S G +++ ++ G+  +      +  + I        IPK    +  
Sbjct: 192 K----GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY--SIPKHINPVAA 245
Query: 419 SLMIKCWNNSPSKRPQFSEIIS 440
           SL+ K     P+ RP  +E+++
Sbjct: 246 SLIQKMLQTDPTARPTINELLN 267

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/202 (20%), Positives = 93/202 (46%), Gaps = 7/202 (3%)
Query: 239 TCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIK 298
           +  H++++ F+    ++N  + VV +L    S+ +L  + + L   E       +  G +
Sbjct: 97  SLAHQHVVGFHGF-FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ 155
Query: 299 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAG 358
           +L+ + V +RDL    + L+    V +GD G+ T  +  GE  +       ++APE+++ 
Sbjct: 156 YLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSK 215
Query: 359 DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILK 418
                  ++  +V+S G +++ ++ G+  +      +  + I        IPK    +  
Sbjct: 216 K----GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY--SIPKHINPVAA 269
Query: 419 SLMIKCWNNSPSKRPQFSEIIS 440
           SL+ K     P+ RP  +E+++
Sbjct: 270 SLIQKMLQTDPTARPTINELLN 291

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 37/160 (23%), Positives = 79/160 (49%), Gaps = 5/160 (3%)
Query: 229 ELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIR 288
           ++++++  L    H +I++ Y V +       +V + + GG + D I K  +++  E  R
Sbjct: 57  KIKREIQNLKLFRHPHIIKLYQV-ISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARR 115
Query: 289 IAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY 348
           +   +   + + + H V +RDL  + +LLD H N  + D G+ +   S GE         
Sbjct: 116 LFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGL-SNMMSDGEFLRDSCGSP 174
Query: 349 RWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAY 388
            + APE+I+G   +  E    +++S G++++ ++ G   +
Sbjct: 175 NYAAPEVISGRLYAGPEV---DIWSCGVILYALLCGTLPF 211

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/202 (20%), Positives = 93/202 (46%), Gaps = 7/202 (3%)
Query: 239 TCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIK 298
           +  H++++ F+    ++N  + VV +L    S+ +L  + + L   E       +  G +
Sbjct: 71  SLAHQHVVGFHGF-FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ 129
Query: 299 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAG 358
           +L+ + V +RDL    + L+    V +GD G+ T  +  GE  +       ++APE+++ 
Sbjct: 130 YLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSK 189
Query: 359 DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILK 418
                  ++  +V+S G +++ ++ G+  +      +  + I        IPK    +  
Sbjct: 190 K----GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY--SIPKHINPVAA 243
Query: 419 SLMIKCWNNSPSKRPQFSEIIS 440
           SL+ K     P+ RP  +E+++
Sbjct: 244 SLIQKMLQTDPTARPTINELLN 265

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/202 (20%), Positives = 93/202 (46%), Gaps = 7/202 (3%)
Query: 239 TCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIK 298
           +  H++++ F+    ++N  + VV +L    S+ +L  + + L   E       +  G +
Sbjct: 77  SLAHQHVVGFHGF-FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ 135
Query: 299 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAG 358
           +L+ + V +RDL    + L+    V +GD G+ T  +  GE  +       ++APE+++ 
Sbjct: 136 YLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSK 195
Query: 359 DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILK 418
                  ++  +V+S G +++ ++ G+  +      +  + I        IPK    +  
Sbjct: 196 K----GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEY--SIPKHINPVAA 249
Query: 419 SLMIKCWNNSPSKRPQFSEIIS 440
           SL+ K     P+ RP  +E+++
Sbjct: 250 SLIQKMLQTDPTARPTINELLN 271

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/204 (22%), Positives = 97/204 (47%), Gaps = 13/204 (6%)
Query: 187 LNSDNLEFIDQIGPNSFKGVYKGKR-----VGIEKLKGCDKGNAYEFELRKDLLELMTCG 241
           L  D+ E I ++G  +   V+K        V   KL   +   A   ++ ++L  L  C 
Sbjct: 65  LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECN 124
Query: 242 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 301
              I+ FY     +   + +  + M+GGS++ ++ K+ ++  + + +++I V +G+ +L 
Sbjct: 125 SPYIVGFYGAFYSDGE-ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 183
Query: 302 D-HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDP 360
           + H + +RD+    IL++  G + L D G+  + + +            +++PE + G  
Sbjct: 184 EKHKIMHRDVKPSNILVNSRGEIKLCDFGV--SGQLIDSMANSFVGTRSYMSPERLQGTH 241
Query: 361 ESVSETWMSNVYSFGMVIWEMVTG 384
            SV     S+++S G+ + EM  G
Sbjct: 242 YSVQ----SDIWSMGLSLVEMAVG 261

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 43/201 (21%), Positives = 91/201 (45%), Gaps = 12/201 (5%)
Query: 237 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEG 296
           L    H NI++ Y    D+ +   +V ++  GG + D I+  ++    +  RI   V  G
Sbjct: 80  LKQLDHPNIMKLYEFFEDKGY-FYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSG 138
Query: 297 IKFLNDHGVAYRDLNSQRILLD---RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAP 353
           I +++ + + +RDL  + +LL+   +  N+ + D G+ T  ++  +  +     Y ++AP
Sbjct: 139 ITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAY-YIAP 197
Query: 354 EIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIP--K 411
           E++ G  +   + W     S G++++ +++G   +   +       +       E+P  K
Sbjct: 198 EVLHGTYDEKCDVW-----STGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWK 252
Query: 412 DCPQILKSLMIKCWNNSPSKR 432
              +  K L+ K     PS R
Sbjct: 253 KVSESAKDLIRKMLTYVPSMR 273

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/256 (23%), Positives = 109/256 (42%), Gaps = 25/256 (9%)
Query: 182 IGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL--RKDLLELMT 239
           + +W   S N   +DQ       G     RV + K K  + GN Y  ++  ++ +++L  
Sbjct: 27  LKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHK--ESGNHYAMKILDKQKVVKLKQ 84
Query: 240 CGH----KNILQF----YCVCVD----ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEII 287
             H    K ILQ     + V ++    +N  L +V + + GG +   + +  +       
Sbjct: 85  IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHAR 144
Query: 288 RIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG 347
             A  +    ++L+   + YRDL  + +L+D+ G + + D G     K V   T      
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF---AKRVKGRTWXLAGT 201
Query: 348 YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR- 406
             +LAPEII     + +  W    ++ G++I+EM  G   + A  P+Q    I +  +R 
Sbjct: 202 PEYLAPEIILSKGYNKAVDW----WALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF 257
Query: 407 -PEIPKDCPQILKSLM 421
                 D   +L++L+
Sbjct: 258 PSHFSSDLKDLLRNLL 273

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/208 (21%), Positives = 95/208 (45%), Gaps = 12/208 (5%)
Query: 230 LRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRI 289
           L +++  L    H NI++ Y    D+ +   +V ++  GG + D I+  ++    +  RI
Sbjct: 97  LLREVQLLKQLDHPNIMKLYEFFEDKGY-FYLVGEVYTGGELFDEIISRKRFSEVDAARI 155
Query: 290 AIDVAEGIKFLNDHGVAYRDLNSQRILLD---RHGNVCLGDMGIVTACKSVGEATEYETD 346
              V  GI +++ + + +RDL  + +LL+   +  N+ + D G+ T  ++  +  +    
Sbjct: 156 IRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGT 215
Query: 347 GYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR 406
            Y ++APE++ G  +   + W     S G++++ +++G   +   +       +      
Sbjct: 216 AY-YIAPEVLHGTYDEKCDVW-----STGVILYILLSGCPPFNGANEYDILKKVEKGKYT 269
Query: 407 PEIP--KDCPQILKSLMIKCWNNSPSKR 432
            E+P  K   +  K L+ K     PS R
Sbjct: 270 FELPQWKKVSESAKDLIRKMLTYVPSMR 297

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/208 (21%), Positives = 95/208 (45%), Gaps = 12/208 (5%)
Query: 230 LRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRI 289
           L +++  L    H NI++ Y    D+ +   +V ++  GG + D I+  ++    +  RI
Sbjct: 96  LLREVQLLKQLDHPNIMKLYEFFEDKGY-FYLVGEVYTGGELFDEIISRKRFSEVDAARI 154
Query: 290 AIDVAEGIKFLNDHGVAYRDLNSQRILLD---RHGNVCLGDMGIVTACKSVGEATEYETD 346
              V  GI +++ + + +RDL  + +LL+   +  N+ + D G+ T  ++  +  +    
Sbjct: 155 IRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGT 214
Query: 347 GYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR 406
            Y ++APE++ G  +   + W     S G++++ +++G   +   +       +      
Sbjct: 215 AY-YIAPEVLHGTYDEKCDVW-----STGVILYILLSGCPPFNGANEYDILKKVEKGKYT 268
Query: 407 PEIP--KDCPQILKSLMIKCWNNSPSKR 432
            E+P  K   +  K L+ K     PS R
Sbjct: 269 FELPQWKKVSESAKDLIRKMLTYVPSMR 296

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/256 (23%), Positives = 109/256 (42%), Gaps = 25/256 (9%)
Query: 182 IGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL--RKDLLELMT 239
           + +W   S N   +DQ       G     RV + K K  + GN Y  ++  ++ +++L  
Sbjct: 27  LKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHK--ESGNHYAMKILDKQKVVKLKQ 84
Query: 240 CGH----KNILQF----YCVCVD----ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEII 287
             H    K ILQ     + V ++    +N  L +V + + GG +   + +  +       
Sbjct: 85  IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHAR 144
Query: 288 RIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG 347
             A  +    ++L+   + YRDL  + +L+D+ G + + D G     K V   T      
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF---AKRVKGRTWXLXGT 201
Query: 348 YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR- 406
             +LAPEII     + +  W    ++ G++I+EM  G   + A  P+Q    I +  +R 
Sbjct: 202 PEYLAPEIILSKGYNKAVDW----WALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF 257
Query: 407 -PEIPKDCPQILKSLM 421
                 D   +L++L+
Sbjct: 258 PSHFSSDLKDLLRNLL 273

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/248 (23%), Positives = 107/248 (43%), Gaps = 31/248 (12%)
Query: 190 DNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL--RKDLLELMTCGH----K 243
           D  E I  +G  SF       RV +  +K  + GN Y  ++  ++ +++L    H    K
Sbjct: 42  DQFERIKTLGTGSFG------RVML--VKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 244 NILQF----YCVCVD----ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAE 295
            ILQ     + V ++    +N  L +V + + GG +   + +  +         A  +  
Sbjct: 94  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL 153
Query: 296 GIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEI 355
             ++L+   + YRDL  + +L+D+ G + + D G     K V   T        +LAPEI
Sbjct: 154 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF---AKRVKGRTWXLCGTPEYLAPEI 210
Query: 356 IAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR--PEIPKDC 413
           I     + +  W    ++ G++I+EM  G   + A  P+Q    I +  +R       D 
Sbjct: 211 ILSKGYNKAVDW----WALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 266
Query: 414 PQILKSLM 421
             +L++L+
Sbjct: 267 KDLLRNLL 274

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/248 (23%), Positives = 107/248 (43%), Gaps = 31/248 (12%)
Query: 190 DNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL--RKDLLELMTCGH----K 243
           D  E I  +G  SF       RV +  +K  + GN Y  ++  ++ +++L    H    K
Sbjct: 41  DQFERIKTLGTGSFG------RVML--VKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 244 NILQF----YCVCVD----ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAE 295
            ILQ     + V ++    +N  L +V + + GG +   + +  +         A  +  
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 296 GIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEI 355
             ++L+   + YRDL  + +L+D+ G + + D G     K V   T        +LAPEI
Sbjct: 153 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF---AKRVKGRTWXLCGTPEYLAPEI 209
Query: 356 IAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR--PEIPKDC 413
           I     + +  W    ++ G++I+EM  G   + A  P+Q    I +  +R       D 
Sbjct: 210 ILSKGYNKAVDW----WALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 265
Query: 414 PQILKSLM 421
             +L++L+
Sbjct: 266 KDLLRNLL 273

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/263 (20%), Positives = 113/263 (42%), Gaps = 21/263 (7%)
Query: 187 LNSDNLEFIDQIGPNSF------KGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTC 240
           L+  N   +  IG  +F      + +  GK V ++ +      ++   +L +++  +   
Sbjct: 4   LHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVL 63
Query: 241 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL 300
            H NI++ + V ++    L +V +   GG V D ++    ++ KE       +   +++ 
Sbjct: 64  NHPNIVKLFEV-IETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVSAVQYC 122
Query: 301 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDP 360
           +   + +RDL ++ +LLD   N+ + D G      + G   +       + APE+  G  
Sbjct: 123 HQKFIVHRDLKAENLLLDADMNIKIADFGFSNEF-TFGNKLDTFCGSPPYAAPELFQGKK 181
Query: 361 ESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIP----KDCPQI 416
               E    +V+S G++++ +V+G   +   +  +    +     R  IP     DC  +
Sbjct: 182 YDGPEV---DVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYR--IPFYMSTDCENL 236
Query: 417 LKSLMIKCWNNSPSKRPQFSEII 439
           LK  +I     +PSKR    +I+
Sbjct: 237 LKKFLIL----NPSKRGTLEQIM 255

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/248 (23%), Positives = 107/248 (43%), Gaps = 31/248 (12%)
Query: 190 DNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL--RKDLLELMTCGH----K 243
           D  E I  +G  SF       RV +  +K  + GN Y  ++  ++ +++L    H    K
Sbjct: 42  DQFERIKTLGTGSFG------RVML--VKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 244 NILQF----YCVCVD----ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAE 295
            ILQ     + V ++    +N  L +V + + GG +   + +  +         A  +  
Sbjct: 94  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL 153
Query: 296 GIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEI 355
             ++L+   + YRDL  + +L+D+ G + + D G     K V   T        +LAPEI
Sbjct: 154 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF---AKRVKGRTWTLCGTPEYLAPEI 210
Query: 356 IAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR--PEIPKDC 413
           I     + +  W    ++ G++I+EM  G   + A  P+Q    I +  +R       D 
Sbjct: 211 ILSKGYNKAVDW----WALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 266
Query: 414 PQILKSLM 421
             +L++L+
Sbjct: 267 KDLLRNLL 274

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/248 (23%), Positives = 107/248 (43%), Gaps = 31/248 (12%)
Query: 190 DNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL--RKDLLELMTCGH----K 243
           D  E I  +G  SF       RV +  +K  + GN Y  ++  ++ +++L    H    K
Sbjct: 41  DQFERIKTLGTGSFG------RVML--VKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 244 NILQF----YCVCVD----ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAE 295
            ILQ     + V ++    +N  L +V + + GG +   + +  +         A  +  
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 296 GIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEI 355
             ++L+   + YRDL  + +L+D+ G + + D G     K V   T        +LAPEI
Sbjct: 153 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF---AKRVKGRTWXLCGTPEYLAPEI 209
Query: 356 IAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR--PEIPKDC 413
           I     + +  W    ++ G++I+EM  G   + A  P+Q    I +  +R       D 
Sbjct: 210 ILSKGYNKAVDW----WALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 265
Query: 414 PQILKSLM 421
             +L++L+
Sbjct: 266 KDLLRNLL 273

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/248 (23%), Positives = 107/248 (43%), Gaps = 31/248 (12%)
Query: 190 DNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL--RKDLLELMTCGH----K 243
           D  E I  +G  SF       RV +  +K  + GN Y  ++  ++ +++L    H    K
Sbjct: 41  DQFERIKTLGTGSFG------RVML--VKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 244 NILQF----YCVCVD----ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAE 295
            ILQ     + V ++    +N  L +V + + GG +   + +  +         A  +  
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVL 152
Query: 296 GIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEI 355
             ++L+   + YRDL  + +L+D+ G + + D G     K V   T        +LAPEI
Sbjct: 153 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF---AKRVKGRTWXLCGTPEYLAPEI 209
Query: 356 IAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR--PEIPKDC 413
           I     + +  W    ++ G++I+EM  G   + A  P+Q    I +  +R       D 
Sbjct: 210 ILSKGYNKAVDW----WALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 265
Query: 414 PQILKSLM 421
             +L++L+
Sbjct: 266 KDLLRNLL 273

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 46/204 (22%), Positives = 97/204 (47%), Gaps = 13/204 (6%)
Query: 187 LNSDNLEFIDQIGPNSFKGVYKGKR-----VGIEKLKGCDKGNAYEFELRKDLLELMTCG 241
           L  D+ E I ++G  +   V+K        V   KL   +   A   ++ ++L  L  C 
Sbjct: 30  LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECN 89
Query: 242 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 301
              I+ FY     +   + +  + M+GGS++ ++ K+ ++  + + +++I V +G+ +L 
Sbjct: 90  SPYIVGFYGAFYSDGE-ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 148
Query: 302 D-HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDP 360
           + H + +RD+    IL++  G + L D G+  + + +            +++PE + G  
Sbjct: 149 EKHKIMHRDVKPSNILVNSRGEIKLCDFGV--SGQLIDSMANSFVGTRSYMSPERLQGTH 206
Query: 361 ESVSETWMSNVYSFGMVIWEMVTG 384
            SV     S+++S G+ + EM  G
Sbjct: 207 YSVQ----SDIWSMGLSLVEMAVG 226

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/248 (23%), Positives = 107/248 (43%), Gaps = 31/248 (12%)
Query: 190 DNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL--RKDLLELMTCGH----K 243
           D  E I  +G  SF       RV +  +K  + GN Y  ++  ++ +++L    H    K
Sbjct: 42  DQFERIKTLGTGSFG------RVML--VKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 244 NILQF----YCVCVD----ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAE 295
            ILQ     + V ++    +N  L +V + + GG +   + +  +         A  +  
Sbjct: 94  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVL 153
Query: 296 GIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEI 355
             ++L+   + YRDL  + +L+D+ G + + D G     K V   T        +LAPEI
Sbjct: 154 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF---AKRVKGRTWXLCGTPEYLAPEI 210
Query: 356 IAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR--PEIPKDC 413
           I     + +  W    ++ G++I+EM  G   + A  P+Q    I +  +R       D 
Sbjct: 211 ILSKGYNKAVDW----WALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 266
Query: 414 PQILKSLM 421
             +L++L+
Sbjct: 267 KDLLRNLL 274

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 46/204 (22%), Positives = 97/204 (47%), Gaps = 13/204 (6%)
Query: 187 LNSDNLEFIDQIGPNSFKGVYKGKR-----VGIEKLKGCDKGNAYEFELRKDLLELMTCG 241
           L  D+ E I ++G  +   V+K        V   KL   +   A   ++ ++L  L  C 
Sbjct: 3   LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECN 62
Query: 242 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 301
              I+ FY     +   + +  + M+GGS++ ++ K+ ++  + + +++I V +G+ +L 
Sbjct: 63  SPYIVGFYGAFYSDGE-ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 121
Query: 302 D-HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDP 360
           + H + +RD+    IL++  G + L D G+  + + +            +++PE + G  
Sbjct: 122 EKHKIMHRDVKPSNILVNSRGEIKLCDFGV--SGQLIDSMANSFVGTRSYMSPERLQGTH 179
Query: 361 ESVSETWMSNVYSFGMVIWEMVTG 384
            SV     S+++S G+ + EM  G
Sbjct: 180 YSVQ----SDIWSMGLSLVEMAVG 199

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/248 (23%), Positives = 107/248 (43%), Gaps = 31/248 (12%)
Query: 190 DNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL--RKDLLELMTCGH----K 243
           D  E I  +G  SF       RV +  +K  + GN Y  ++  ++ +++L    H    K
Sbjct: 41  DQFERIKTLGTGSFG------RVML--VKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 244 NILQF----YCVCVD----ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAE 295
            ILQ     + V ++    +N  L +V + + GG +   + +  +         A  +  
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVL 152
Query: 296 GIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEI 355
             ++L+   + YRDL  + +L+D+ G + + D G     K V   T        +LAPEI
Sbjct: 153 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF---AKRVKGRTWXLCGTPEYLAPEI 209
Query: 356 IAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR--PEIPKDC 413
           I     + +  W    ++ G++I+EM  G   + A  P+Q    I +  +R       D 
Sbjct: 210 ILSKGYNKAVDW----WALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 265
Query: 414 PQILKSLM 421
             +L++L+
Sbjct: 266 KDLLRNLL 273

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 46/204 (22%), Positives = 97/204 (47%), Gaps = 13/204 (6%)
Query: 187 LNSDNLEFIDQIGPNSFKGVYKGKR-----VGIEKLKGCDKGNAYEFELRKDLLELMTCG 241
           L  D+ E I ++G  +   V+K        V   KL   +   A   ++ ++L  L  C 
Sbjct: 3   LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECN 62
Query: 242 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 301
              I+ FY     +   + +  + M+GGS++ ++ K+ ++  + + +++I V +G+ +L 
Sbjct: 63  SPYIVGFYGAFYSDGE-ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 121
Query: 302 D-HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDP 360
           + H + +RD+    IL++  G + L D G+  + + +            +++PE + G  
Sbjct: 122 EKHKIMHRDVKPSNILVNSRGEIKLCDFGV--SGQLIDSMANSFVGTRSYMSPERLQGTH 179
Query: 361 ESVSETWMSNVYSFGMVIWEMVTG 384
            SV     S+++S G+ + EM  G
Sbjct: 180 YSVQ----SDIWSMGLSLVEMAVG 199

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/248 (23%), Positives = 107/248 (43%), Gaps = 31/248 (12%)
Query: 190 DNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL--RKDLLELMTCGH----K 243
           D  E I  +G  SF       RV +  +K  + GN Y  ++  ++ +++L    H    K
Sbjct: 41  DQFERIKTLGTGSFG------RVML--VKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 244 NILQF----YCVCVD----ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAE 295
            ILQ     + V ++    +N  L +V + + GG +   + +  +         A  +  
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 296 GIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEI 355
             ++L+   + YRDL  + +L+D+ G + + D G     K V   T        +LAPEI
Sbjct: 153 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF---AKRVKGRTWXLCGTPEYLAPEI 209
Query: 356 IAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR--PEIPKDC 413
           I     + +  W    ++ G++I+EM  G   + A  P+Q    I +  +R       D 
Sbjct: 210 ILSKGYNKAVDW----WALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 265
Query: 414 PQILKSLM 421
             +L++L+
Sbjct: 266 KDLLRNLL 273

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/248 (23%), Positives = 107/248 (43%), Gaps = 31/248 (12%)
Query: 190 DNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL--RKDLLELMTCGH----K 243
           D  E I  +G  SF       RV + K K  + GN Y  ++  ++ +++L    H    K
Sbjct: 34  DQFERIKTLGTGSFG------RVMLVKHK--ETGNHYAMKILDKQKVVKLKQIEHTLNEK 85
Query: 244 NILQF----YCVCVD----ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAE 295
            ILQ     + V ++    +N  L +V + + GG +   + +  +         A  +  
Sbjct: 86  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL 145
Query: 296 GIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEI 355
             ++L+   + YRDL  + +L+D+ G + + D G     K V   T        +LAPEI
Sbjct: 146 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF---AKRVKGRTWXLCGTPEYLAPEI 202
Query: 356 IAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR--PEIPKDC 413
           I     + +  W    ++ G++I+EM  G   + A  P+Q    I +  +R       D 
Sbjct: 203 ILSKGYNKAVDW----WALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 258
Query: 414 PQILKSLM 421
             +L++L+
Sbjct: 259 KDLLRNLL 266

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/248 (23%), Positives = 107/248 (43%), Gaps = 31/248 (12%)
Query: 190 DNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL--RKDLLELMTCGH----K 243
           D  E I  +G  SF       RV +  +K  + GN Y  ++  ++ +++L    H    K
Sbjct: 41  DQFERIKTLGTGSFG------RVML--VKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 244 NILQF----YCVCVD----ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAE 295
            ILQ     + V ++    +N  L +V + + GG +   + +  +         A  +  
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 296 GIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEI 355
             ++L+   + YRDL  + +L+D+ G + + D G     K V   T        +LAPEI
Sbjct: 153 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF---AKRVKGRTWXLCGTPEYLAPEI 209
Query: 356 IAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR--PEIPKDC 413
           I     + +  W    ++ G++I+EM  G   + A  P+Q    I +  +R       D 
Sbjct: 210 ILSKGYNKAVDW----WALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 265
Query: 414 PQILKSLM 421
             +L++L+
Sbjct: 266 KDLLRNLL 273

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/248 (23%), Positives = 107/248 (43%), Gaps = 31/248 (12%)
Query: 190 DNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL--RKDLLELMTCGH----K 243
           D  E I  +G  SF       RV + K K  + GN Y  ++  ++ +++L    H    K
Sbjct: 42  DQFERIKTLGTGSFG------RVMLVKHK--ETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 244 NILQF----YCVCVD----ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAE 295
            ILQ     + V ++    +N  L +V + + GG +   + +  +         A  +  
Sbjct: 94  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL 153
Query: 296 GIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEI 355
             ++L+   + YRDL  + +L+D+ G + + D G     K V   T        +LAPEI
Sbjct: 154 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF---AKRVKGRTWXLCGTPEYLAPEI 210
Query: 356 IAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR--PEIPKDC 413
           I     + +  W    ++ G++I+EM  G   + A  P+Q    I +  +R       D 
Sbjct: 211 ILSKGYNKAVDW----WALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 266
Query: 414 PQILKSLM 421
             +L++L+
Sbjct: 267 KDLLRNLL 274

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/248 (23%), Positives = 107/248 (43%), Gaps = 31/248 (12%)
Query: 190 DNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL--RKDLLELMTCGH----K 243
           D  E I  +G  SF       RV + K K  + GN Y  ++  ++ +++L    H    K
Sbjct: 62  DQFERIKTLGTGSFG------RVMLVKHK--ETGNHYAMKILDKQKVVKLKQIEHTLNEK 113
Query: 244 NILQF----YCVCVD----ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAE 295
            ILQ     + V ++    +N  L +V + + GG +   + +  +         A  +  
Sbjct: 114 RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL 173
Query: 296 GIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEI 355
             ++L+   + YRDL  + +L+D+ G + + D G     K V   T        +LAPEI
Sbjct: 174 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF---AKRVKGRTWXLCGTPEYLAPEI 230
Query: 356 IAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR--PEIPKDC 413
           I     + +  W    ++ G++I+EM  G   + A  P+Q    I +  +R       D 
Sbjct: 231 ILSKGYNKAVDW----WALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 286
Query: 414 PQILKSLM 421
             +L++L+
Sbjct: 287 KDLLRNLL 294

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/248 (23%), Positives = 107/248 (43%), Gaps = 31/248 (12%)
Query: 190 DNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL--RKDLLELMTCGH----K 243
           D  E I  +G  SF       RV + K K  + GN Y  ++  ++ +++L    H    K
Sbjct: 42  DQFERIKTLGTGSFG------RVMLVKHK--ETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 244 NILQF----YCVCVD----ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAE 295
            ILQ     + V ++    +N  L +V + + GG +   + +  +         A  +  
Sbjct: 94  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL 153
Query: 296 GIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEI 355
             ++L+   + YRDL  + +L+D+ G + + D G     K V   T        +LAPEI
Sbjct: 154 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF---AKRVKGRTWXLCGTPEYLAPEI 210
Query: 356 IAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR--PEIPKDC 413
           I     + +  W    ++ G++I+EM  G   + A  P+Q    I +  +R       D 
Sbjct: 211 ILSKGYNKAVDW----WALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 266
Query: 414 PQILKSLM 421
             +L++L+
Sbjct: 267 KDLLRNLL 274

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/248 (23%), Positives = 107/248 (43%), Gaps = 31/248 (12%)
Query: 190 DNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL--RKDLLELMTCGH----K 243
           D  E I  +G  SF       RV + K K  + GN Y  ++  ++ +++L    H    K
Sbjct: 34  DQFERIKTLGTGSFG------RVMLVKHK--ETGNHYAMKILDKQKVVKLKQIEHTLNEK 85
Query: 244 NILQF----YCVCVD----ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAE 295
            ILQ     + V ++    +N  L +V + + GG +   + +  +         A  +  
Sbjct: 86  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVL 145
Query: 296 GIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEI 355
             ++L+   + YRDL  + +L+D+ G + + D G     K V   T        +LAPEI
Sbjct: 146 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF---AKRVKGRTWXLCGTPEYLAPEI 202
Query: 356 IAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR--PEIPKDC 413
           I     + +  W    ++ G++I+EM  G   + A  P+Q    I +  +R       D 
Sbjct: 203 ILSKGYNKAVDW----WALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 258
Query: 414 PQILKSLM 421
             +L++L+
Sbjct: 259 KDLLRNLL 266

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/248 (23%), Positives = 107/248 (43%), Gaps = 31/248 (12%)
Query: 190 DNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL--RKDLLELMTCGH----K 243
           D  E I  +G  SF       RV + K K  + GN Y  ++  ++ +++L    H    K
Sbjct: 42  DQFERIKTLGTGSFG------RVMLVKHK--ETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 244 NILQF----YCVCVD----ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAE 295
            ILQ     + V ++    +N  L +V + + GG +   + +  +         A  +  
Sbjct: 94  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL 153
Query: 296 GIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEI 355
             ++L+   + YRDL  + +L+D+ G + + D G     K V   T        +LAPEI
Sbjct: 154 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF---AKRVKGRTWXLCGTPEYLAPEI 210
Query: 356 IAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR--PEIPKDC 413
           I     + +  W    ++ G++I+EM  G   + A  P+Q    I +  +R       D 
Sbjct: 211 ILSKGYNKAVDW----WALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 266
Query: 414 PQILKSLM 421
             +L++L+
Sbjct: 267 KDLLRNLL 274

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 94/222 (42%), Gaps = 35/222 (15%)
Query: 190 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLK------GCDKGNAYEFELRKDLLEL 237
           +N + +++IG  ++  VYK      G+ V ++K++      G       E  L K+L   
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL--- 59
Query: 238 MTCGHKNILQFYCVCVDENHGLCV-------VTKLMEGGSVNDLILKSRKLQTKEIIRIA 290
               H NI++   V   EN    V       + K M+  ++  + L   K    +++   
Sbjct: 60  ---NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL--- 113
Query: 291 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRW 350
               +G+ F + H V +RDL  Q +L++  G + L D G+  A         +E     +
Sbjct: 114 ----QGLSFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWY 169
Query: 351 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACS 392
            APEI+ G     +     +++S G +  EMVT  A +   S
Sbjct: 170 RAPEILLGCKYYSTAV---DIWSLGCIFAEMVTRRALFPGDS 208

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 46/204 (22%), Positives = 97/204 (47%), Gaps = 13/204 (6%)
Query: 187 LNSDNLEFIDQIGPNSFKGVYKGKR-----VGIEKLKGCDKGNAYEFELRKDLLELMTCG 241
           L  D+ E I ++G  +   V+K        V   KL   +   A   ++ ++L  L  C 
Sbjct: 3   LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECN 62
Query: 242 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 301
              I+ FY     +   + +  + M+GGS++ ++ K+ ++  + + +++I V +G+ +L 
Sbjct: 63  SPYIVGFYGAFYSDGE-ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 121
Query: 302 D-HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDP 360
           + H + +RD+    IL++  G + L D G+  + + +            +++PE + G  
Sbjct: 122 EKHKIMHRDVKPSNILVNSRGEIKLCDFGV--SGQLIDSMANSFVGTRSYMSPERLQGTH 179
Query: 361 ESVSETWMSNVYSFGMVIWEMVTG 384
            SV     S+++S G+ + EM  G
Sbjct: 180 YSVQ----SDIWSMGLSLVEMAVG 199

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/248 (23%), Positives = 107/248 (43%), Gaps = 31/248 (12%)
Query: 190 DNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL--RKDLLELMTCGH----K 243
           D  E I  +G  SF       RV +  +K  + GN Y  ++  ++ +++L    H    K
Sbjct: 27  DQFERIKTLGTGSFG------RVML--VKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 78
Query: 244 NILQF----YCVCVD----ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAE 295
            ILQ     + V ++    +N  L +V + + GG +   + +  +         A  +  
Sbjct: 79  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL 138
Query: 296 GIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEI 355
             ++L+   + YRDL  + +L+D+ G + + D G     K V   T        +LAPEI
Sbjct: 139 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF---AKRVKGRTWTLCGTPEYLAPEI 195
Query: 356 IAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR--PEIPKDC 413
           I     + +  W    ++ G++I+EM  G   + A  P+Q    I +  +R       D 
Sbjct: 196 ILSKGYNKAVDW----WALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 251
Query: 414 PQILKSLM 421
             +L++L+
Sbjct: 252 KDLLRNLL 259

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/256 (23%), Positives = 109/256 (42%), Gaps = 25/256 (9%)
Query: 182 IGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL--RKDLLELMT 239
           + +W   S N   +DQ       G     RV + K K  + GN Y  ++  ++ +++L  
Sbjct: 27  LKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHK--ESGNHYAMKILDKQKVVKLKQ 84
Query: 240 CGH----KNILQF----YCVCVD----ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEII 287
             H    K ILQ     + V ++    +N  L +V + + GG +   + +  +       
Sbjct: 85  IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHAR 144
Query: 288 RIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG 347
             A  +    ++L+   + YRDL  + +L+D+ G + + D G     K V   T      
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF---AKRVKGRTWXLCGT 201
Query: 348 YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR- 406
             +LAPEII     + +  W    ++ G++I+EM  G   + A  P+Q    I +  +R 
Sbjct: 202 PEYLAPEIILSKGYNKAVDW----WALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF 257
Query: 407 -PEIPKDCPQILKSLM 421
                 D   +L++L+
Sbjct: 258 PSHFSSDLKDLLRNLL 273

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 94/222 (42%), Gaps = 35/222 (15%)
Query: 190 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLK------GCDKGNAYEFELRKDLLEL 237
           +N + +++IG  ++  VYK      G+ V ++K++      G       E  L K+L   
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL--- 59
Query: 238 MTCGHKNILQFYCVCVDENHGLCV-------VTKLMEGGSVNDLILKSRKLQTKEIIRIA 290
               H NI++   V   EN    V       + K M+  ++  + L   K    +++   
Sbjct: 60  ---NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL--- 113
Query: 291 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRW 350
               +G+ F + H V +RDL  Q +L++  G + L D G+  A         +E     +
Sbjct: 114 ----QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWY 169
Query: 351 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACS 392
            APEI+ G     +     +++S G +  EMVT  A +   S
Sbjct: 170 RAPEILLGCKYYSTAV---DIWSLGCIFAEMVTRRALFPGDS 208

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/224 (23%), Positives = 95/224 (42%), Gaps = 35/224 (15%)
Query: 188 NSDNLEFIDQIGPNSFKGVYK------GKRVGIEKLK------GCDKGNAYEFELRKDLL 235
           + +N + +++IG  ++  VYK      G+ V ++K++      G       E  L K+L 
Sbjct: 2   HMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL- 60
Query: 236 ELMTCGHKNILQFYCVCVDENHGLCV-------VTKLMEGGSVNDLILKSRKLQTKEIIR 288
                 H NI++   V   EN    V       + K M+  ++  + L   K    +++ 
Sbjct: 61  -----NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL- 114
Query: 289 IAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY 348
                 +G+ F + H V +RDL  Q +L++  G + L D G+  A         +E    
Sbjct: 115 ------QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTL 168
Query: 349 RWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACS 392
            + APEI+ G     +     +++S G +  EMVT  A +   S
Sbjct: 169 WYRAPEILLGCKYYSTAV---DIWSLGCIFAEMVTRRALFPGDS 209

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 94/222 (42%), Gaps = 35/222 (15%)
Query: 190 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLK------GCDKGNAYEFELRKDLLEL 237
           +N + +++IG  ++  VYK      G+ V ++K++      G       E  L K+L   
Sbjct: 7   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL--- 63
Query: 238 MTCGHKNILQFYCVCVDENHGLCV-------VTKLMEGGSVNDLILKSRKLQTKEIIRIA 290
               H NI++   V   EN    V       + K M+  ++  + L   K    +++   
Sbjct: 64  ---NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL--- 117
Query: 291 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRW 350
               +G+ F + H V +RDL  Q +L++  G + L D G+  A         +E     +
Sbjct: 118 ----QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWY 173
Query: 351 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACS 392
            APEI+ G     +     +++S G +  EMVT  A +   S
Sbjct: 174 RAPEILLGCKYYSTAV---DIWSLGCIFAEMVTRRALFPGDS 212

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 94/222 (42%), Gaps = 35/222 (15%)
Query: 190 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLK------GCDKGNAYEFELRKDLLEL 237
           +N + +++IG  ++  VYK      G+ V ++K++      G       E  L K+L   
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL--- 59
Query: 238 MTCGHKNILQFYCVCVDENHGLCV-------VTKLMEGGSVNDLILKSRKLQTKEIIRIA 290
               H NI++   V   EN    V       + K M+  ++  + L   K    +++   
Sbjct: 60  ---NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL--- 113
Query: 291 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRW 350
               +G+ F + H V +RDL  Q +L++  G + L D G+  A         +E     +
Sbjct: 114 ----QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWY 169
Query: 351 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACS 392
            APEI+ G     +     +++S G +  EMVT  A +   S
Sbjct: 170 RAPEILLGCKYYSTAV---DIWSLGCIFAEMVTRRALFPGDS 208

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 94/222 (42%), Gaps = 35/222 (15%)
Query: 190 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLK------GCDKGNAYEFELRKDLLEL 237
           +N + +++IG  ++  VYK      G+ V ++K++      G       E  L K+L   
Sbjct: 5   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL--- 61
Query: 238 MTCGHKNILQFYCVCVDENHGLCV-------VTKLMEGGSVNDLILKSRKLQTKEIIRIA 290
               H NI++   V   EN    V       + K M+  ++  + L   K    +++   
Sbjct: 62  ---NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL--- 115
Query: 291 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRW 350
               +G+ F + H V +RDL  Q +L++  G + L D G+  A         +E     +
Sbjct: 116 ----QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWY 171
Query: 351 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACS 392
            APEI+ G     +     +++S G +  EMVT  A +   S
Sbjct: 172 RAPEILLGCKYYSTAV---DIWSLGCIFAEMVTRRALFPGDS 210

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 94/222 (42%), Gaps = 35/222 (15%)
Query: 190 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLK------GCDKGNAYEFELRKDLLEL 237
           +N + +++IG  ++  VYK      G+ V ++K++      G       E  L K+L   
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL--- 62
Query: 238 MTCGHKNILQFYCVCVDENHGLCV-------VTKLMEGGSVNDLILKSRKLQTKEIIRIA 290
               H NI++   V   EN    V       + K M+  ++  + L   K    +++   
Sbjct: 63  ---NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL--- 116
Query: 291 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRW 350
               +G+ F + H V +RDL  Q +L++  G + L D G+  A         +E     +
Sbjct: 117 ----QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWY 172
Query: 351 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACS 392
            APEI+ G     +     +++S G +  EMVT  A +   S
Sbjct: 173 RAPEILLGCKYYSTAV---DIWSLGCIFAEMVTRRALFPGDS 211

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 94/222 (42%), Gaps = 35/222 (15%)
Query: 190 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLK------GCDKGNAYEFELRKDLLEL 237
           +N + +++IG  ++  VYK      G+ V ++K++      G       E  L K+L   
Sbjct: 5   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL--- 61
Query: 238 MTCGHKNILQFYCVCVDENHGLCV-------VTKLMEGGSVNDLILKSRKLQTKEIIRIA 290
               H NI++   V   EN    V       + K M+  ++  + L   K    +++   
Sbjct: 62  ---NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL--- 115
Query: 291 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRW 350
               +G+ F + H V +RDL  Q +L++  G + L D G+  A         +E     +
Sbjct: 116 ----QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWY 171
Query: 351 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACS 392
            APEI+ G     +     +++S G +  EMVT  A +   S
Sbjct: 172 RAPEILLGCKYYSTAV---DIWSLGCIFAEMVTRRALFPGDS 210

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/256 (23%), Positives = 109/256 (42%), Gaps = 25/256 (9%)
Query: 182 IGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL--RKDLLELMT 239
           + +W   S N   +DQ       G     RV + K K  + GN Y  ++  ++ +++L  
Sbjct: 27  LKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHK--ESGNHYAMKILDKQKVVKLKQ 84
Query: 240 CGH----KNILQF----YCVCVD----ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEII 287
             H    K ILQ     + V ++    +N  L +V + + GG +   + +  +       
Sbjct: 85  IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHAR 144
Query: 288 RIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG 347
             A  +    ++L+   + YRDL  + +L+D+ G + + D G     K V   T      
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF---AKRVKGRTWXLCGT 201
Query: 348 YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR- 406
             +LAPEII     + +  W    ++ G++I+EM  G   + A  P+Q    I +  +R 
Sbjct: 202 PEYLAPEIILSKGYNKAVDW----WALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF 257
Query: 407 -PEIPKDCPQILKSLM 421
                 D   +L++L+
Sbjct: 258 PSHFSSDLKDLLRNLL 273

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 94/222 (42%), Gaps = 35/222 (15%)
Query: 190 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLK------GCDKGNAYEFELRKDLLEL 237
           +N + +++IG  ++  VYK      G+ V ++K++      G       E  L K+L   
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL--- 66
Query: 238 MTCGHKNILQFYCVCVDENHGLCV-------VTKLMEGGSVNDLILKSRKLQTKEIIRIA 290
               H NI++   V   EN    V       + K M+  ++  + L   K    +++   
Sbjct: 67  ---NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL--- 120
Query: 291 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRW 350
               +G+ F + H V +RDL  Q +L++  G + L D G+  A         +E     +
Sbjct: 121 ----QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWY 176
Query: 351 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACS 392
            APEI+ G     +     +++S G +  EMVT  A +   S
Sbjct: 177 RAPEILLGCKYYSTAV---DIWSLGCIFAEMVTRRALFPGDS 215

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 46/204 (22%), Positives = 97/204 (47%), Gaps = 13/204 (6%)
Query: 187 LNSDNLEFIDQIGPNSFKGVYKGKR-----VGIEKLKGCDKGNAYEFELRKDLLELMTCG 241
           L  D+ E I ++G  +   V+K        V   KL   +   A   ++ ++L  L  C 
Sbjct: 3   LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECN 62
Query: 242 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 301
              I+ FY     +   + +  + M+GGS++ ++ K+ ++  + + +++I V +G+ +L 
Sbjct: 63  SPYIVGFYGAFYSDGE-ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 121
Query: 302 D-HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDP 360
           + H + +RD+    IL++  G + L D G+  + + +            +++PE + G  
Sbjct: 122 EKHKIMHRDVKPSNILVNSRGEIKLCDFGV--SGQLIDSMANSFVGTRSYMSPERLQGTH 179
Query: 361 ESVSETWMSNVYSFGMVIWEMVTG 384
            SV     S+++S G+ + EM  G
Sbjct: 180 YSVQ----SDIWSMGLSLVEMAVG 199

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 46/204 (22%), Positives = 97/204 (47%), Gaps = 13/204 (6%)
Query: 187 LNSDNLEFIDQIGPNSFKGVYKGKR-----VGIEKLKGCDKGNAYEFELRKDLLELMTCG 241
           L  D+ E I ++G  +   V+K        V   KL   +   A   ++ ++L  L  C 
Sbjct: 3   LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECN 62
Query: 242 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 301
              I+ FY     +   + +  + M+GGS++ ++ K+ ++  + + +++I V +G+ +L 
Sbjct: 63  SPYIVGFYGAFYSDGE-ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 121
Query: 302 D-HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDP 360
           + H + +RD+    IL++  G + L D G+  + + +            +++PE + G  
Sbjct: 122 EKHKIMHRDVKPSNILVNSRGEIKLCDFGV--SGQLIDSMANSFVGTRSYMSPERLQGTH 179
Query: 361 ESVSETWMSNVYSFGMVIWEMVTG 384
            SV     S+++S G+ + EM  G
Sbjct: 180 YSVQ----SDIWSMGLSLVEMAVG 199

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/256 (23%), Positives = 109/256 (42%), Gaps = 25/256 (9%)
Query: 182 IGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL--RKDLLELMT 239
           + +W   S N   +DQ       G     RV + K K  + GN Y  ++  ++ +++L  
Sbjct: 27  LKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHK--ESGNHYAMKILDKQKVVKLKQ 84
Query: 240 CGH----KNILQF----YCVCVD----ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEII 287
             H    K ILQ     + V ++    +N  L +V + + GG +   + +  +       
Sbjct: 85  IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHAR 144
Query: 288 RIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG 347
             A  +    ++L+   + YRDL  + +L+D+ G + + D G     K V   T      
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF---AKRVKGRTWXLCGT 201
Query: 348 YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR- 406
             +LAPEII     + +  W    ++ G++I+EM  G   + A  P+Q    I +  +R 
Sbjct: 202 PEYLAPEIILSKGYNKAVDW----WALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF 257
Query: 407 -PEIPKDCPQILKSLM 421
                 D   +L++L+
Sbjct: 258 PSHFSSDLKDLLRNLL 273

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 94/222 (42%), Gaps = 35/222 (15%)
Query: 190 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLK------GCDKGNAYEFELRKDLLEL 237
           +N + +++IG  ++  VYK      G+ V ++K++      G       E  L K+L   
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL--- 59
Query: 238 MTCGHKNILQFYCVCVDENHGLCV-------VTKLMEGGSVNDLILKSRKLQTKEIIRIA 290
               H NI++   V   EN    V       + K M+  ++  + L   K    +++   
Sbjct: 60  ---NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL--- 113
Query: 291 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRW 350
               +G+ F + H V +RDL  Q +L++  G + L D G+  A         +E     +
Sbjct: 114 ----QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWY 169
Query: 351 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACS 392
            APEI+ G     +     +++S G +  EMVT  A +   S
Sbjct: 170 RAPEILLGCKYYSTAV---DIWSLGCIFAEMVTRRALFPGDS 208

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 94/222 (42%), Gaps = 35/222 (15%)
Query: 190 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLK------GCDKGNAYEFELRKDLLEL 237
           +N + +++IG  ++  VYK      G+ V ++K++      G       E  L K+L   
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL--- 58
Query: 238 MTCGHKNILQFYCVCVDENHGLCV-------VTKLMEGGSVNDLILKSRKLQTKEIIRIA 290
               H NI++   V   EN    V       + K M+  ++  + L   K    +++   
Sbjct: 59  ---NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL--- 112
Query: 291 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRW 350
               +G+ F + H V +RDL  Q +L++  G + L D G+  A         +E     +
Sbjct: 113 ----QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWY 168
Query: 351 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACS 392
            APEI+ G     +     +++S G +  EMVT  A +   S
Sbjct: 169 RAPEILLGCKYYSTAV---DIWSLGCIFAEMVTRRALFPGDS 207

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 94/222 (42%), Gaps = 35/222 (15%)
Query: 190 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLK------GCDKGNAYEFELRKDLLEL 237
           +N + +++IG  ++  VYK      G+ V ++K++      G       E  L K+L   
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL--- 59
Query: 238 MTCGHKNILQFYCVCVDENHGLCV-------VTKLMEGGSVNDLILKSRKLQTKEIIRIA 290
               H NI++   V   EN    V       + K M+  ++  + L   K    +++   
Sbjct: 60  ---NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL--- 113
Query: 291 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRW 350
               +G+ F + H V +RDL  Q +L++  G + L D G+  A         +E     +
Sbjct: 114 ----QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWY 169
Query: 351 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACS 392
            APEI+ G     +     +++S G +  EMVT  A +   S
Sbjct: 170 RAPEILLGCKYYSTAV---DIWSLGCIFAEMVTRRALFPGDS 208

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 94/222 (42%), Gaps = 35/222 (15%)
Query: 190 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLK------GCDKGNAYEFELRKDLLEL 237
           +N + +++IG  ++  VYK      G+ V ++K++      G       E  L K+L   
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL--- 58
Query: 238 MTCGHKNILQFYCVCVDENHGLCV-------VTKLMEGGSVNDLILKSRKLQTKEIIRIA 290
               H NI++   V   EN    V       + K M+  ++  + L   K    +++   
Sbjct: 59  ---NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL--- 112
Query: 291 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRW 350
               +G+ F + H V +RDL  Q +L++  G + L D G+  A         +E     +
Sbjct: 113 ----QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWY 168
Query: 351 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACS 392
            APEI+ G     +     +++S G +  EMVT  A +   S
Sbjct: 169 RAPEILLGCKYYSTAV---DIWSLGCIFAEMVTRRALFPGDS 207

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 94/222 (42%), Gaps = 35/222 (15%)
Query: 190 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLK------GCDKGNAYEFELRKDLLEL 237
           +N + +++IG  ++  VYK      G+ V ++K++      G       E  L K+L   
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL--- 59
Query: 238 MTCGHKNILQFYCVCVDENHGLCV-------VTKLMEGGSVNDLILKSRKLQTKEIIRIA 290
               H NI++   V   EN    V       + K M+  ++  + L   K    +++   
Sbjct: 60  ---NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL--- 113
Query: 291 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRW 350
               +G+ F + H V +RDL  Q +L++  G + L D G+  A         +E     +
Sbjct: 114 ----QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWY 169
Query: 351 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACS 392
            APEI+ G     +     +++S G +  EMVT  A +   S
Sbjct: 170 RAPEILLGCKYYSTAV---DIWSLGCIFAEMVTRRALFPGDS 208

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/256 (23%), Positives = 109/256 (42%), Gaps = 25/256 (9%)
Query: 182 IGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL--RKDLLELMT 239
           + +W   S N   +DQ       G     RV + K K  + GN Y  ++  ++ +++L  
Sbjct: 27  LKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHK--ESGNHYAMKILDKQKVVKLKQ 84
Query: 240 CGH----KNILQF----YCVCVD----ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEII 287
             H    K ILQ     + V ++    +N  L +V + + GG +   + +  +       
Sbjct: 85  IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHAR 144
Query: 288 RIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG 347
             A  +    ++L+   + YRDL  + +L+D+ G + + D G     K V   T      
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF---AKRVKGRTWXLCGT 201
Query: 348 YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR- 406
             +LAPEII     + +  W    ++ G++I+EM  G   + A  P+Q    I +  +R 
Sbjct: 202 PEYLAPEIILSKGYNKAVDW----WALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF 257
Query: 407 -PEIPKDCPQILKSLM 421
                 D   +L++L+
Sbjct: 258 PSHFSSDLKDLLRNLL 273

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 94/222 (42%), Gaps = 35/222 (15%)
Query: 190 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLK------GCDKGNAYEFELRKDLLEL 237
           +N + +++IG  ++  VYK      G+ V ++K++      G       E  L K+L   
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL--- 60
Query: 238 MTCGHKNILQFYCVCVDENHGLCV-------VTKLMEGGSVNDLILKSRKLQTKEIIRIA 290
               H NI++   V   EN    V       + K M+  ++  + L   K    +++   
Sbjct: 61  ---NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL--- 114
Query: 291 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRW 350
               +G+ F + H V +RDL  Q +L++  G + L D G+  A         +E     +
Sbjct: 115 ----QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWY 170
Query: 351 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACS 392
            APEI+ G     +     +++S G +  EMVT  A +   S
Sbjct: 171 RAPEILLGCKYYSTAV---DIWSLGCIFAEMVTRRALFPGDS 209

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 94/222 (42%), Gaps = 35/222 (15%)
Query: 190 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLK------GCDKGNAYEFELRKDLLEL 237
           +N + +++IG  ++  VYK      G+ V ++K++      G       E  L K+L   
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL--- 60
Query: 238 MTCGHKNILQFYCVCVDENHGLCV-------VTKLMEGGSVNDLILKSRKLQTKEIIRIA 290
               H NI++   V   EN    V       + K M+  ++  + L   K    +++   
Sbjct: 61  ---NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL--- 114
Query: 291 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRW 350
               +G+ F + H V +RDL  Q +L++  G + L D G+  A         +E     +
Sbjct: 115 ----QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWY 170
Query: 351 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACS 392
            APEI+ G     +     +++S G +  EMVT  A +   S
Sbjct: 171 RAPEILLGCKYYSTAV---DIWSLGCIFAEMVTRRALFPGDS 209

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/256 (23%), Positives = 109/256 (42%), Gaps = 25/256 (9%)
Query: 182 IGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL--RKDLLELMT 239
           + +W   S N   +DQ       G     RV + K K  + GN Y  ++  ++ +++L  
Sbjct: 27  LKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHK--ESGNHYAMKILDKQKVVKLKQ 84
Query: 240 CGH----KNILQF----YCVCVD----ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEII 287
             H    K ILQ     + V ++    +N  L +V + + GG +   + +  +       
Sbjct: 85  IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHAR 144
Query: 288 RIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG 347
             A  +    ++L+   + YRDL  + +L+D+ G + + D G     K V   T      
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF---AKRVKGRTWXLCGT 201
Query: 348 YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR- 406
             +LAPEII     + +  W    ++ G++I+EM  G   + A  P+Q    I +  +R 
Sbjct: 202 PEYLAPEIILSKGYNKAVDW----WALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF 257
Query: 407 -PEIPKDCPQILKSLM 421
                 D   +L++L+
Sbjct: 258 PSHFSSDLKDLLRNLL 273

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/256 (23%), Positives = 109/256 (42%), Gaps = 25/256 (9%)
Query: 182 IGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL--RKDLLELMT 239
           + +W   S N   +DQ       G     RV + K K  + GN Y  ++  ++ +++L  
Sbjct: 28  LKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHK--ESGNHYAMKILDKQKVVKLKQ 85
Query: 240 CGH----KNILQF----YCVCVD----ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEII 287
             H    K ILQ     + V ++    +N  L +V + + GG +   + +  +       
Sbjct: 86  IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHAR 145
Query: 288 RIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG 347
             A  +    ++L+   + YRDL  + +L+D+ G + + D G     K V   T      
Sbjct: 146 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF---AKRVKGRTWXLCGT 202
Query: 348 YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR- 406
             +LAPEII     + +  W    ++ G++I+EM  G   + A  P+Q    I +  +R 
Sbjct: 203 PEYLAPEIILSKGYNKAVDW----WALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF 258
Query: 407 -PEIPKDCPQILKSLM 421
                 D   +L++L+
Sbjct: 259 PSHFSSDLKDLLRNLL 274

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/224 (23%), Positives = 95/224 (42%), Gaps = 35/224 (15%)
Query: 190 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLK------GCDKGNAYEFELRKDLLEL 237
           +N + +++IG  ++  VYK      G+ V ++K++      G       E  L K+L   
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL--- 59
Query: 238 MTCGHKNILQFYCVCVDENHGLCV-------VTKLMEGGSVNDLILKSRKLQTKEIIRIA 290
               H NI++   V   EN    V       + K M+  ++  + L   K    +++   
Sbjct: 60  ---NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL--- 113
Query: 291 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRW 350
               +G+ F + H V +RDL  Q +L++  G + L D G+  A         +E     +
Sbjct: 114 ----QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWY 169
Query: 351 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPV 394
            APEI+ G     +     +++S G +  EMVT  A +   S +
Sbjct: 170 RAPEILLGCKYYSTAV---DIWSLGCIFAEMVTRRALFPGDSEI 210

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 94/222 (42%), Gaps = 35/222 (15%)
Query: 190 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLK------GCDKGNAYEFELRKDLLEL 237
           +N + +++IG  ++  VYK      G+ V ++K++      G       E  L K+L   
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL--- 62
Query: 238 MTCGHKNILQFYCVCVDENHGLCV-------VTKLMEGGSVNDLILKSRKLQTKEIIRIA 290
               H NI++   V   EN    V       + K M+  ++  + L   K    +++   
Sbjct: 63  ---NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL--- 116
Query: 291 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRW 350
               +G+ F + H V +RDL  Q +L++  G + L D G+  A         +E     +
Sbjct: 117 ----QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWY 172
Query: 351 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACS 392
            APEI+ G     +     +++S G +  EMVT  A +   S
Sbjct: 173 RAPEILLGCKYYSTAV---DIWSLGCIFAEMVTRRALFPGDS 211

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/256 (23%), Positives = 109/256 (42%), Gaps = 25/256 (9%)
Query: 182 IGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL--RKDLLELMT 239
           + +W   S N   +DQ       G     RV + K K  + GN Y  ++  ++ +++L  
Sbjct: 27  LKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHK--ESGNHYAMKILDKQKVVKLKQ 84
Query: 240 CGH----KNILQF----YCVCVD----ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEII 287
             H    K ILQ     + V ++    +N  L +V + + GG +   + +  +       
Sbjct: 85  IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHAR 144
Query: 288 RIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG 347
             A  +    ++L+   + YRDL  + +L+D+ G + + D G     K V   T      
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF---AKRVKGRTWXLCGT 201
Query: 348 YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR- 406
             +LAPEII     + +  W    ++ G++I+EM  G   + A  P+Q    I +  +R 
Sbjct: 202 PEYLAPEIILSKGYNKAVDW----WALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF 257
Query: 407 -PEIPKDCPQILKSLM 421
                 D   +L++L+
Sbjct: 258 PSHFSSDLKDLLRNLL 273

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 94/222 (42%), Gaps = 35/222 (15%)
Query: 190 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLK------GCDKGNAYEFELRKDLLEL 237
           +N + +++IG  ++  VYK      G+ V ++K++      G       E  L K+L   
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL--- 58
Query: 238 MTCGHKNILQFYCVCVDENHGLCV-------VTKLMEGGSVNDLILKSRKLQTKEIIRIA 290
               H NI++   V   EN    V       + K M+  ++  + L   K    +++   
Sbjct: 59  ---NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL--- 112
Query: 291 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRW 350
               +G+ F + H V +RDL  Q +L++  G + L D G+  A         +E     +
Sbjct: 113 ----QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWY 168
Query: 351 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACS 392
            APEI+ G     +     +++S G +  EMVT  A +   S
Sbjct: 169 RAPEILLGCKYYSTAV---DIWSLGCIFAEMVTRRALFPGDS 207

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 94/222 (42%), Gaps = 35/222 (15%)
Query: 190 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLK------GCDKGNAYEFELRKDLLEL 237
           +N + +++IG  ++  VYK      G+ V ++K++      G       E  L K+L   
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL--- 58
Query: 238 MTCGHKNILQFYCVCVDENHGLCV-------VTKLMEGGSVNDLILKSRKLQTKEIIRIA 290
               H NI++   V   EN    V       + K M+  ++  + L   K    +++   
Sbjct: 59  ---NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL--- 112
Query: 291 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRW 350
               +G+ F + H V +RDL  Q +L++  G + L D G+  A         +E     +
Sbjct: 113 ----QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWY 168
Query: 351 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACS 392
            APEI+ G     +     +++S G +  EMVT  A +   S
Sbjct: 169 RAPEILLGCKYYSTAV---DIWSLGCIFAEMVTRRALFPGDS 207

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 94/222 (42%), Gaps = 35/222 (15%)
Query: 190 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLK------GCDKGNAYEFELRKDLLEL 237
           +N + +++IG  ++  VYK      G+ V ++K++      G       E  L K+L   
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL--- 62
Query: 238 MTCGHKNILQFYCVCVDENHGLCV-------VTKLMEGGSVNDLILKSRKLQTKEIIRIA 290
               H NI++   V   EN    V       + K M+  ++  + L   K    +++   
Sbjct: 63  ---NHPNIVKLLDVIHTENKLYLVFEHVDQDLKKFMDASALTGIPLPLIKSYLFQLL--- 116
Query: 291 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRW 350
               +G+ F + H V +RDL  Q +L++  G + L D G+  A         +E     +
Sbjct: 117 ----QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWY 172
Query: 351 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACS 392
            APEI+ G     +     +++S G +  EMVT  A +   S
Sbjct: 173 RAPEILLGCKYYSTAV---DIWSLGCIFAEMVTRRALFPGDS 211

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 59/256 (23%), Positives = 109/256 (42%), Gaps = 25/256 (9%)
Query: 182 IGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL--RKDLLELMT 239
           + +W   S N   +DQ       G     RV + K K  + GN Y  ++  ++ +++L  
Sbjct: 22  LKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHK--ESGNHYAMKILDKQKVVKLKQ 79
Query: 240 CGH----KNILQF----YCVCVD----ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEII 287
             H    K ILQ     + V ++    +N  L +V + + GG +   + +  +       
Sbjct: 80  IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHAR 139
Query: 288 RIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG 347
             A  +    ++L+   + YRDL  + +L+D+ G + + D G     K V   T      
Sbjct: 140 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF---AKRVKGRTWXLCGT 196
Query: 348 YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR- 406
             +LAPEII     + +  W    ++ G++I+EM  G   + A  P+Q    I +  +R 
Sbjct: 197 PEYLAPEIILSKGYNKAVDW----WALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF 252
Query: 407 -PEIPKDCPQILKSLM 421
                 D   +L++L+
Sbjct: 253 PSHFSSDLKDLLRNLL 268

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/258 (20%), Positives = 109/258 (42%), Gaps = 21/258 (8%)
Query: 191 NLEFIDQIGPNSF------KGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKN 244
           N   +  IG  +F      + +  GK V ++ +      ++   +L +++       H N
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPN 74
Query: 245 ILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHG 304
           I++ + V ++    L +V +   GG V D ++   + + KE       +   +++ +   
Sbjct: 75  IVKLFEV-IETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSAVQYCHQKF 133
Query: 305 VAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVS 364
           + +RDL ++ +LLD   N+ + D G      + G   +       + APE+  G      
Sbjct: 134 IVHRDLKAENLLLDADXNIKIADFGFSNEF-TFGNKLDAFCGAPPYAAPELFQGKKYDGP 192
Query: 365 ETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIP----KDCPQILKSL 420
           E    +V+S G++++ +V+G   +   +  +    +     R  IP     DC  +LK  
Sbjct: 193 EV---DVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYR--IPFYXSTDCENLLKKF 247
Query: 421 MIKCWNNSPSKRPQFSEI 438
           +I     +PSKR    +I
Sbjct: 248 LIL----NPSKRGTLEQI 261

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 59/256 (23%), Positives = 109/256 (42%), Gaps = 25/256 (9%)
Query: 182 IGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL--RKDLLELMT 239
           + +W   S N   +DQ       G     RV + K K  + GN Y  ++  ++ +++L  
Sbjct: 48  LKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHK--ESGNHYAMKILDKQKVVKLKQ 105
Query: 240 CGH----KNILQF----YCVCVD----ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEII 287
             H    K ILQ     + V ++    +N  L +V + + GG +   + +  +       
Sbjct: 106 IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHAR 165
Query: 288 RIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG 347
             A  +    ++L+   + YRDL  + +L+D+ G + + D G     K V   T      
Sbjct: 166 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF---AKRVKGRTWXLCGT 222
Query: 348 YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR- 406
             +LAPEII     + +  W    ++ G++I+EM  G   + A  P+Q    I +  +R 
Sbjct: 223 PEYLAPEIILSKGYNKAVDW----WALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF 278
Query: 407 -PEIPKDCPQILKSLM 421
                 D   +L++L+
Sbjct: 279 PSHFSSDLKDLLRNLL 294

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 59/256 (23%), Positives = 109/256 (42%), Gaps = 25/256 (9%)
Query: 182 IGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL--RKDLLELMT 239
           + +W   S N   +DQ       G     RV + K K  + GN Y  ++  ++ +++L  
Sbjct: 27  LKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHK--ESGNHYAMKILDKQKVVKLKQ 84
Query: 240 CGH----KNILQF----YCVCVD----ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEII 287
             H    K ILQ     + V ++    +N  L +V + + GG +   + +  +       
Sbjct: 85  IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHAR 144
Query: 288 RIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG 347
             A  +    ++L+   + YRDL  + +L+D+ G + + D G     K V   T      
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF---AKRVKGRTWXLCGT 201
Query: 348 YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR- 406
             +LAPEII     + +  W    ++ G++I+EM  G   + A  P+Q    I +  +R 
Sbjct: 202 PEYLAPEIILSKGYNKAVDW----WALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF 257
Query: 407 -PEIPKDCPQILKSLM 421
                 D   +L++L+
Sbjct: 258 PSHFSSDLKDLLRNLL 273

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 59/256 (23%), Positives = 109/256 (42%), Gaps = 25/256 (9%)
Query: 182 IGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL--RKDLLELMT 239
           + +W   S N   +DQ       G     RV + K K  + GN Y  ++  ++ +++L  
Sbjct: 27  LKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHK--ESGNHYAMKILDKQKVVKLKQ 84
Query: 240 CGH----KNILQF----YCVCVD----ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEII 287
             H    K ILQ     + V ++    +N  L +V + + GG +   + +  +       
Sbjct: 85  IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHAR 144
Query: 288 RIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG 347
             A  +    ++L+   + YRDL  + +L+D+ G + + D G     K V   T      
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF---AKRVKGRTWXLCGT 201
Query: 348 YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR- 406
             +LAPEII     + +  W    ++ G++I+EM  G   + A  P+Q    I +  +R 
Sbjct: 202 PEYLAPEIILSKGYNKAVDW----WALGVLIYEMAAGYPPFFADEPIQIYEKIVSGKVRF 257
Query: 407 -PEIPKDCPQILKSLM 421
                 D   +L++L+
Sbjct: 258 PSHFSSDLKDLLRNLL 273

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 59/256 (23%), Positives = 109/256 (42%), Gaps = 25/256 (9%)
Query: 182 IGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL--RKDLLELMT 239
           + +W   S N   +DQ       G     RV + K K  + GN Y  ++  ++ +++L  
Sbjct: 27  LKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHK--ESGNHYAMKILDKQKVVKLKQ 84
Query: 240 CGH----KNILQF----YCVCVD----ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEII 287
             H    K ILQ     + V ++    +N  L +V + + GG +   + +  +       
Sbjct: 85  IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHAR 144
Query: 288 RIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG 347
             A  +    ++L+   + YRDL  + +L+D+ G + + D G     K V   T      
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF---AKRVKGRTWXLCGT 201
Query: 348 YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR- 406
             +LAPEII     + +  W    ++ G++I+EM  G   + A  P+Q    I +  +R 
Sbjct: 202 PEYLAPEIILSKGYNKAVDW----WALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF 257
Query: 407 -PEIPKDCPQILKSLM 421
                 D   +L++L+
Sbjct: 258 PSHFSSDLKDLLRNLL 273

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 51/229 (22%), Positives = 95/229 (41%), Gaps = 13/229 (5%)
Query: 227 EFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEI 286
           E +LR+++       H NIL+ Y    D    + ++ +    G V   + K  K   +  
Sbjct: 57  EHQLRREVEIQSHLRHPNILRLYGYFHDATR-VYLILEYAPRGEVYKELQKLSKFDEQRT 115
Query: 287 IRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETD 346
                ++A  + + +   V +RD+  + +LL   G + + D G      S    T   T 
Sbjct: 116 ATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTL 175
Query: 347 GYRWLAPEIIAG--DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG 404
            Y  L PE+I G    E V      +++S G++ +E + G+  + A +  +    I+   
Sbjct: 176 DY--LPPEMIEGRMHDEKV------DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE 227
Query: 405 LRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNSSN 453
                P    +  + L+ +   ++PS+RP   E++     T N S  SN
Sbjct: 228 F--TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSN 274

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 51/229 (22%), Positives = 96/229 (41%), Gaps = 13/229 (5%)
Query: 227 EFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEI 286
           E +LR+++       H NIL+ Y    D    + ++ +    G+V   + K  K   +  
Sbjct: 69  EHQLRREVEIQSHLRHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRT 127
Query: 287 IRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETD 346
                ++A  + + +   V +RD+  + +LL   G + + D G      S    T   T 
Sbjct: 128 ATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTL 187
Query: 347 GYRWLAPEIIAG--DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG 404
            Y  L PE+I G    E V      +++S G++ +E + G+  + A +  +    I+   
Sbjct: 188 DY--LPPEMIEGRMHDEKV------DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE 239
Query: 405 LRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNSSN 453
                P    +  + L+ +   ++PS+RP   E++     T N S  SN
Sbjct: 240 F--TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSN 286

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 69/305 (22%), Positives = 121/305 (39%), Gaps = 23/305 (7%)
Query: 159 PLPSSSFVVSVDEWQTVQSGGEEIGR-WLLNSDNLEFIDQIGPNSFKGVYKGKRVG---I 214
           PLPS+      +E  + Q   E   R W L  ++ E    +G   F  VY  +      I
Sbjct: 4   PLPSAPENNPEEELASKQKNEESKKRQWAL--EDFEIGRPLGKGKFGNVYLAREKQSKFI 61
Query: 215 EKLKGCDKGN----AYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGS 270
             LK   K        E +LR+++       H NIL+ Y    D    + ++ +    G+
Sbjct: 62  LALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATR-VYLILEYAPLGT 120
Query: 271 VNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGI 330
           V   + K  K   +       ++A  + + +   V +RD+  + +LL   G + + D G 
Sbjct: 121 VYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW 180
Query: 331 VTACKSVGEATEYETDGYRWLAPEIIAG--DPESVSETWMSNVYSFGMVIWEMVTGEAAY 388
                S        T  Y  L PE+I G    E V      +++S G++ +E + G+  +
Sbjct: 181 SVHAPSSRRDDLCGTLDY--LPPEMIEGRMHDEKV------DLWSLGVLCYEFLVGKPPF 232
Query: 389 AACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNI 448
            A +  +    I+        P    +  + L+ +   ++PS+RP   E++     T N 
Sbjct: 233 EANTYQETYKRISRVEF--TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANS 290
Query: 449 SNSSN 453
           S  SN
Sbjct: 291 SKPSN 295

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 51/229 (22%), Positives = 96/229 (41%), Gaps = 13/229 (5%)
Query: 227 EFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEI 286
           E +LR+++       H NIL+ Y    D    + ++ +    G+V   + K  K   +  
Sbjct: 53  EHQLRREVEIQSHLRHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRT 111
Query: 287 IRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETD 346
                ++A  + + +   V +RD+  + +LL   G + + D G      S    T   T 
Sbjct: 112 ATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSCHAPSSRRTTLSGTL 171
Query: 347 GYRWLAPEIIAG--DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG 404
            Y  L PE+I G    E V      +++S G++ +E + G+  + A +  +    I+   
Sbjct: 172 DY--LPPEMIEGRMHDEKV------DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE 223
Query: 405 LRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNSSN 453
                P    +  + L+ +   ++PS+RP   E++     T N S  SN
Sbjct: 224 F--TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSN 270

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 39/152 (25%), Positives = 74/152 (48%), Gaps = 9/152 (5%)
Query: 242 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 301
           H NI+    V  D+   + VVT+LM+GG + D IL+ +    +E   +   + + +++L+
Sbjct: 75  HPNIITLKDV-YDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLH 133
Query: 302 DHGVAYRDLNSQRIL-LDRHGN---VCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIA 357
             GV +RDL    IL +D  GN   + + D G     ++             ++APE++ 
Sbjct: 134 AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVL- 192
Query: 358 GDPESVSETWMSNVYSFGMVIWEMVTGEAAYA 389
              E        +++S G++++ M+TG   +A
Sbjct: 193 ---ERQGYDAACDIWSLGVLLYTMLTGYTPFA 221

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 93/222 (41%), Gaps = 35/222 (15%)
Query: 190 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLK------GCDKGNAYEFELRKDLLEL 237
           +N + +++IG  ++  VYK      G+ V + K++      G       E  L K+L   
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKEL--- 59
Query: 238 MTCGHKNILQFYCVCVDENHGLCV-------VTKLMEGGSVNDLILKSRKLQTKEIIRIA 290
               H NI++   V   EN    V       + K M+  ++  + L   K    +++   
Sbjct: 60  ---NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL--- 113
Query: 291 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRW 350
               +G+ F + H V +RDL  Q +L++  G + L D G+  A         +E     +
Sbjct: 114 ----QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWY 169
Query: 351 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACS 392
            APEI+ G     +     +++S G +  EMVT  A +   S
Sbjct: 170 RAPEILLGCKYYSTAV---DIWSLGCIFAEMVTRRALFPGDS 208

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 57/248 (22%), Positives = 107/248 (43%), Gaps = 31/248 (12%)
Query: 190 DNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL--RKDLLELMTCGH----K 243
           D  E I  +G  SF       RV +  +K  + GN Y  ++  ++ +++L    H    K
Sbjct: 41  DQFERIKTLGTGSFG------RVML--VKHMETGNHYAMKILDKQKVVKLKEIEHTLNEK 92
Query: 244 NILQF----YCVCVD----ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAE 295
            ILQ     + V ++    +N  L +V +   GG +   + +  +         A  +  
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 296 GIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEI 355
             ++L+   + YRDL  + +++D+ G + + D G+    K V   T        +LAPEI
Sbjct: 153 TFEYLHSLDLIYRDLKPENLMIDQQGYIQVTDFGL---AKRVKGRTWXLCGTPEYLAPEI 209
Query: 356 IAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR--PEIPKDC 413
           I     + +  W    ++ G++I+EM  G   + A  P+Q    I +  +R       D 
Sbjct: 210 ILSKGYNKAVDW----WALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 265
Query: 414 PQILKSLM 421
             +L++L+
Sbjct: 266 KDLLRNLL 273

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 93/222 (41%), Gaps = 35/222 (15%)
Query: 190 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLK------GCDKGNAYEFELRKDLLEL 237
           +N + +++IG  ++  VYK      G+ V + K++      G       E  L K+L   
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKEL--- 58
Query: 238 MTCGHKNILQFYCVCVDENHGLCV-------VTKLMEGGSVNDLILKSRKLQTKEIIRIA 290
               H NI++   V   EN    V       + K M+  ++  + L   K    +++   
Sbjct: 59  ---NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL--- 112
Query: 291 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRW 350
               +G+ F + H V +RDL  Q +L++  G + L D G+  A         +E     +
Sbjct: 113 ----QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWY 168
Query: 351 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACS 392
            APEI+ G     +     +++S G +  EMVT  A +   S
Sbjct: 169 RAPEILLGCKYYSTAV---DIWSLGCIFAEMVTRRALFPGDS 207

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 57/248 (22%), Positives = 107/248 (43%), Gaps = 31/248 (12%)
Query: 190 DNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL--RKDLLELMTCGH----K 243
           D  E I  +G  SF       RV +  +K  + GN Y  ++  ++ +++L    H    K
Sbjct: 41  DQFERIKTLGTGSFG------RVML--VKHMETGNHYAMKILDKQKVVKLKEIEHTLNEK 92
Query: 244 NILQF----YCVCVD----ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAE 295
            ILQ     + V ++    +N  L +V +   GG +   + +  +         A  +  
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 296 GIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEI 355
             ++L+   + YRDL  + +++D+ G + + D G+    K V   T        +LAPEI
Sbjct: 153 TFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGL---AKRVKGRTWXLCGTPEYLAPEI 209
Query: 356 IAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR--PEIPKDC 413
           I     + +  W    ++ G++I+EM  G   + A  P+Q    I +  +R       D 
Sbjct: 210 ILSKGYNKAVDW----WALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 265
Query: 414 PQILKSLM 421
             +L++L+
Sbjct: 266 KDLLRNLL 273

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 43/200 (21%), Positives = 94/200 (47%), Gaps = 29/200 (14%)
Query: 203 FKGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYC---VCVDENHGL 259
           ++G++ G+ V ++     D+ + +      ++   +   H NIL F        + +  L
Sbjct: 25  WRGLWHGESVAVKIFSSRDEQSWFR---ETEIYNTVLLRHDNILGFIASDMTSRNSSTQL 81
Query: 260 CVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN--------DHGVAYRDLN 311
            ++T   E GS+ D  L+ + L+    +R+A+  A G+  L+           +A+RD  
Sbjct: 82  WLITHYHEHGSLYDF-LQRQTLEPHLALRLAVSAACGLAHLHVEIFGTQGKPAIAHRDFK 140
Query: 312 SQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG-------YRWLAPEIIAGDPES-- 362
           S+ +L+  +   C+ D+G+        + ++Y   G        R++APE++     +  
Sbjct: 141 SRNVLVKSNLQCCIADLGLAVMH---SQGSDYLDIGNNPRVGTKRYMAPEVLDEQIRTDC 197
Query: 363 -VSETWMSNVYSFGMVIWEM 381
             S  W +++++FG+V+WE+
Sbjct: 198 FESYKW-TDIWAFGLVLWEI 216

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 51/229 (22%), Positives = 96/229 (41%), Gaps = 13/229 (5%)
Query: 227 EFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEI 286
           E +LR+++       H NIL+ Y    D    + ++ +    G+V   + K  K   +  
Sbjct: 57  EHQLRREVEIQSHLRHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRT 115
Query: 287 IRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETD 346
                ++A  + + +   V +RD+  + +LL   G + + D G      S    T   T 
Sbjct: 116 ATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTL 175
Query: 347 GYRWLAPEIIAG--DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG 404
            Y  L PE+I G    E V      +++S G++ +E + G+  + A +  +    I+   
Sbjct: 176 DY--LPPEMIEGRMHDEKV------DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE 227
Query: 405 LRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNSSN 453
                P    +  + L+ +   ++PS+RP   E++     T N S  SN
Sbjct: 228 F--TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSN 274

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 59/256 (23%), Positives = 108/256 (42%), Gaps = 25/256 (9%)
Query: 182 IGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL--RKDLLELMT 239
           + +W   S N   +DQ       G     RV + K K  + GN Y  ++  ++ +++L  
Sbjct: 14  LKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHK--ESGNHYAMKILDKQKVVKLKQ 71
Query: 240 CGH----KNILQF----YCVCVD----ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEII 287
             H    K ILQ     + V ++    +N  L +V + + GG +   + +  +       
Sbjct: 72  IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHAR 131
Query: 288 RIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG 347
             A  +    ++L+   + YRDL  + +L+D  G + + D G     K V   T      
Sbjct: 132 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDEQGYIQVTDFGF---AKRVKGRTWXLCGT 188
Query: 348 YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR- 406
             +LAPEII     + +  W    ++ G++I+EM  G   + A  P+Q    I +  +R 
Sbjct: 189 PEYLAPEIILSKGYNKAVDW----WALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF 244
Query: 407 -PEIPKDCPQILKSLM 421
                 D   +L++L+
Sbjct: 245 PSHFSSDLKDLLRNLL 260

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 51/229 (22%), Positives = 96/229 (41%), Gaps = 13/229 (5%)
Query: 227 EFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEI 286
           E +LR+++       H NIL+ Y    D    + ++ +    G+V   + K  K   +  
Sbjct: 52  EHQLRREVEIQSHLRHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRT 110
Query: 287 IRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETD 346
                ++A  + + +   V +RD+  + +LL   G + + D G      S    T   T 
Sbjct: 111 ATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTL 170
Query: 347 GYRWLAPEIIAG--DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG 404
            Y  L PE+I G    E V      +++S G++ +E + G+  + A +  +    I+   
Sbjct: 171 DY--LPPEMIEGRMHDEKV------DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE 222
Query: 405 LRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNSSN 453
                P    +  + L+ +   ++PS+RP   E++     T N S  SN
Sbjct: 223 F--TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSN 269

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 51/229 (22%), Positives = 96/229 (41%), Gaps = 13/229 (5%)
Query: 227 EFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEI 286
           E +LR+++       H NIL+ Y    D    + ++ +    G+V   + K  K   +  
Sbjct: 55  EHQLRREVEIQSHLRHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRT 113
Query: 287 IRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETD 346
                ++A  + + +   V +RD+  + +LL   G + + D G      S    T   T 
Sbjct: 114 ATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTL 173
Query: 347 GYRWLAPEIIAG--DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG 404
            Y  L PE+I G    E V      +++S G++ +E + G+  + A +  +    I+   
Sbjct: 174 DY--LPPEMIEGRMHDEKV------DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE 225
Query: 405 LRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNSSN 453
                P    +  + L+ +   ++PS+RP   E++     T N S  SN
Sbjct: 226 F--TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSN 272

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 60/271 (22%), Positives = 123/271 (45%), Gaps = 26/271 (9%)
Query: 187 LNSDNLEFIDQIGPNSFKGVYKGKRVGIEK----------LKGCDKGNAYEFELRKDLLE 236
           + +++L F + +G  +F  ++KG R  +            LK  DK +    E   +   
Sbjct: 5   IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAAS 64
Query: 237 LMT-CGHKNILQFY--CVCVDENHGLCVVTKLMEGGSVNDLILKSRK-LQTKEIIRIAID 292
           +M+   HK+++  Y  CVC DEN    +V + ++ GS++  + K++  +     + +A  
Sbjct: 65  MMSKLSHKHLVLNYGVCVCGDEN---ILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQ 121
Query: 293 VAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR--- 349
           +A  + FL ++ + + ++ ++ ILL R  +   G+   +         T    D  +   
Sbjct: 122 LAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERI 181
Query: 350 -WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPE 408
            W+ PE I  +P++++    ++ +SFG  +WE+ +G       S + +   +     R +
Sbjct: 182 PWVPPECIE-NPKNLN--LATDKWSFGTTLWEICSG--GDKPLSALDSQRKLQFYEDRHQ 236
Query: 409 IPKDCPQILKSLMIKCWNNSPSKRPQFSEII 439
           +P      L +L+  C +  P  RP F  II
Sbjct: 237 LPAPKAAELANLINNCMDYEPDHRPSFRAII 267

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 57/248 (22%), Positives = 106/248 (42%), Gaps = 31/248 (12%)
Query: 190 DNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL--RKDLLELMTCGH----K 243
           D  E I  +G  SF       RV +  +K  + GN Y  ++  ++ +++L    H    K
Sbjct: 41  DQFERIKTLGTGSFG------RVML--VKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 244 NILQF----YCVCVD----ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAE 295
            ILQ     + V ++    +N  L +V +   GG +   + +  +         A  +  
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 296 GIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEI 355
             ++L+   + YRDL  + +++D+ G + + D G     K V   T        +LAPEI
Sbjct: 153 TFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGF---AKRVKGRTWXLCGTPEYLAPEI 209
Query: 356 IAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR--PEIPKDC 413
           I     + +  W    ++ G++I+EM  G   + A  P+Q    I +  +R       D 
Sbjct: 210 ILSKGYNKAVDW----WALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 265
Query: 414 PQILKSLM 421
             +L++L+
Sbjct: 266 KDLLRNLL 273

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 43/201 (21%), Positives = 89/201 (44%), Gaps = 12/201 (5%)
Query: 237 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEG 296
           L    H NI + Y    D+ +   +V ++  GG + D I+  ++    +  RI   V  G
Sbjct: 80  LKQLDHPNIXKLYEFFEDKGY-FYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSG 138
Query: 297 IKFLNDHGVAYRDLNSQRILLD---RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAP 353
           I + + + + +RDL  + +LL+   +  N+ + D G+ T  ++  +  +     Y ++AP
Sbjct: 139 ITYXHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDKIGTAY-YIAP 197
Query: 354 EIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIP--K 411
           E++ G  +   + W     S G++++ +++G   +   +       +       E+P  K
Sbjct: 198 EVLHGTYDEKCDVW-----STGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWK 252
Query: 412 DCPQILKSLMIKCWNNSPSKR 432
              +  K L+ K     PS R
Sbjct: 253 KVSESAKDLIRKXLTYVPSXR 273

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 57/248 (22%), Positives = 106/248 (42%), Gaps = 31/248 (12%)
Query: 190 DNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL--RKDLLELMTCGH----K 243
           D  E I  +G  SF       RV +  +K  + GN Y  ++  ++ +++L    H    K
Sbjct: 41  DQFERIKTLGTGSFG------RVML--VKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 244 NILQF----YCVCVD----ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAE 295
            ILQ     + V ++    +N  L +V +   GG +   + +  +         A  +  
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 296 GIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEI 355
             ++L+   + YRDL  + +++D+ G + + D G     K V   T        +LAPEI
Sbjct: 153 TFEYLHSLDLIYRDLKPENLMIDQQGYIQVTDFGF---AKRVKGRTWXLCGTPEYLAPEI 209
Query: 356 IAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR--PEIPKDC 413
           I     + +  W    ++ G++I+EM  G   + A  P+Q    I +  +R       D 
Sbjct: 210 ILSKGYNKAVDW----WALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 265
Query: 414 PQILKSLM 421
             +L++L+
Sbjct: 266 KDLLRNLL 273

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 58/256 (22%), Positives = 109/256 (42%), Gaps = 25/256 (9%)
Query: 182 IGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL--RKDLLELMT 239
           + +W   S N   +DQ       G     RV + K K  + GN Y  ++  ++ +++L  
Sbjct: 27  LKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHK--ESGNHYAMKILDKQKVVKLKQ 84
Query: 240 CGH----KNILQF----YCVCVD----ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEII 287
             H    K ILQ     + V ++    +N  L +V + + GG +   + +  +       
Sbjct: 85  IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHAR 144
Query: 288 RIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG 347
             A  +    ++L+   + YRDL  + +L+D+ G + + D G     K V   T      
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF---AKRVKGRTWXLCGT 201
Query: 348 YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR- 406
             +LAPEII     + +  W    ++ G++I++M  G   + A  P+Q    I +  +R 
Sbjct: 202 PEYLAPEIILSKGYNKAVDW----WALGVLIYQMAAGYPPFFADQPIQIYEKIVSGKVRF 257
Query: 407 -PEIPKDCPQILKSLM 421
                 D   +L++L+
Sbjct: 258 PSHFSSDLKDLLRNLL 273

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 58/256 (22%), Positives = 109/256 (42%), Gaps = 25/256 (9%)
Query: 182 IGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL--RKDLLELMT 239
           + +W   S N   +DQ       G     RV + K K  + GN Y  ++  ++ +++L  
Sbjct: 27  LKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHK--ESGNHYAMKILDKQKVVKLKQ 84
Query: 240 CGH----KNILQF----YCVCVD----ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEII 287
             H    K ILQ     + V ++    +N  L +V + + GG +   + +  +       
Sbjct: 85  IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHAR 144
Query: 288 RIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG 347
             A  +    ++L+   + YRDL  + +++D+ G + + D G     K V   T      
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLIIDQQGYIQVTDFGF---AKRVKGRTWXLCGT 201
Query: 348 YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR- 406
             +LAPEII     + +  W    ++ G++I+EM  G   + A  P+Q    I +  +R 
Sbjct: 202 PEYLAPEIIISKGYNKAVDW----WALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF 257
Query: 407 -PEIPKDCPQILKSLM 421
                 D   +L++L+
Sbjct: 258 PSHFSSDLKDLLRNLL 273

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 57/248 (22%), Positives = 103/248 (41%), Gaps = 31/248 (12%)
Query: 190 DNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL--RKDLLELMTCGH----K 243
           D  E I  +G  SF       RV +  +K  + GN Y  ++  ++ +++L    H    K
Sbjct: 42  DQFERIKTLGTGSFG------RVML--VKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 244 NILQ-----FYC---VCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAE 295
            ILQ     F         +N  L +V +   GG +   + +  +         A  +  
Sbjct: 94  RILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVL 153
Query: 296 GIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEI 355
             ++L+   + YRDL  + +++D+ G + + D G     K V   T        +LAPEI
Sbjct: 154 TFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGF---AKRVKGRTWXLCGTPEYLAPEI 210
Query: 356 IAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR--PEIPKDC 413
           I     + +  W    ++ G++I+EM  G   + A  P+Q    I +  +R       D 
Sbjct: 211 ILSKGYNKAVDW----WALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 266
Query: 414 PQILKSLM 421
             +L++L+
Sbjct: 267 KDLLRNLL 274

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 32/131 (24%), Positives = 65/131 (49%), Gaps = 7/131 (5%)
Query: 259 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLD 318
           L  +  LM GG ++  + +       ++   A ++  G++ +++  V YRDL    ILLD
Sbjct: 267 LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLD 326
Query: 319 RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEII-AGDPESVSETWMSNVYSFGMV 377
            HG+V + D+G+  AC    +        + ++APE++  G     S  W    +S G +
Sbjct: 327 EHGHVRISDLGL--ACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADW----FSLGCM 380
Query: 378 IWEMVTGEAAY 388
           +++++ G + +
Sbjct: 381 LFKLLRGHSPF 391

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 32/131 (24%), Positives = 65/131 (49%), Gaps = 7/131 (5%)
Query: 259 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLD 318
           L  +  LM GG ++  + +       ++   A ++  G++ +++  V YRDL    ILLD
Sbjct: 267 LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLD 326
Query: 319 RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEII-AGDPESVSETWMSNVYSFGMV 377
            HG+V + D+G+  AC    +        + ++APE++  G     S  W    +S G +
Sbjct: 327 EHGHVRISDLGL--ACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADW----FSLGCM 380
Query: 378 IWEMVTGEAAY 388
           +++++ G + +
Sbjct: 381 LFKLLRGHSPF 391

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 58/248 (23%), Positives = 107/248 (43%), Gaps = 31/248 (12%)
Query: 190 DNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL--RKDLLELMTCGH----K 243
           D  E I  +G  SF       RV + K K  + GN +  ++  ++ +++L    H    K
Sbjct: 41  DQFERIKTLGTGSFG------RVMLVKHK--ETGNHFAMKILDKQKVVKLKQIEHTLNEK 92
Query: 244 NILQF----YCVCVD----ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAE 295
            ILQ     + V ++    +N  L +V + + GG +   + +  +         A  +  
Sbjct: 93  RILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 296 GIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEI 355
             ++L+   + YRDL  + +L+D+ G + + D G     K V   T        +LAPEI
Sbjct: 153 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF---AKRVKGRTWXLCGTPEYLAPEI 209
Query: 356 IAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR--PEIPKDC 413
           I     + +  W    ++ G++I+EM  G   + A  P+Q    I +  +R       D 
Sbjct: 210 ILSKGYNKAVDW----WALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 265
Query: 414 PQILKSLM 421
             +L++L+
Sbjct: 266 KDLLRNLL 273

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 57/248 (22%), Positives = 103/248 (41%), Gaps = 31/248 (12%)
Query: 190 DNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL--RKDLLELMTCGH----K 243
           D  E I  +G  SF       RV +  +K  + GN Y  ++  ++ +++L    H    K
Sbjct: 42  DQFERIKTLGTGSFG------RVML--VKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 244 NILQ-----FYC---VCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAE 295
            ILQ     F         +N  L +V +   GG +   + +  +         A  +  
Sbjct: 94  RILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVL 153
Query: 296 GIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEI 355
             ++L+   + YRDL  + +++D+ G + + D G     K V   T        +LAPEI
Sbjct: 154 TFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGF---AKRVKGRTWXLCGTPEYLAPEI 210
Query: 356 IAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR--PEIPKDC 413
           I     + +  W    ++ G++I+EM  G   + A  P+Q    I +  +R       D 
Sbjct: 211 ILSKGYNKAVDW----WALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 266
Query: 414 PQILKSLM 421
             +L++L+
Sbjct: 267 KDLLRNLL 274

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 58/248 (23%), Positives = 107/248 (43%), Gaps = 31/248 (12%)
Query: 190 DNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL--RKDLLELMTCGH----K 243
           D  E I  +G  SF       RV + K K  + GN +  ++  ++ +++L    H    K
Sbjct: 41  DQFERIKTLGTGSFG------RVMLVKHK--ETGNHFAMKILDKQKVVKLKQIEHTLNEK 92
Query: 244 NILQF----YCVCVD----ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAE 295
            ILQ     + V ++    +N  L +V + + GG +   + +  +         A  +  
Sbjct: 93  RILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 296 GIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEI 355
             ++L+   + YRDL  + +L+D+ G + + D G     K V   T        +LAPEI
Sbjct: 153 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF---AKRVKGRTWXLCGTPEYLAPEI 209
Query: 356 IAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR--PEIPKDC 413
           I     + +  W    ++ G++I+EM  G   + A  P+Q    I +  +R       D 
Sbjct: 210 ILSKGYNKAVDW----WALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 265
Query: 414 PQILKSLM 421
             +L++L+
Sbjct: 266 KDLLRNLL 273

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 32/131 (24%), Positives = 65/131 (49%), Gaps = 7/131 (5%)
Query: 259 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLD 318
           L  +  LM GG ++  + +       ++   A ++  G++ +++  V YRDL    ILLD
Sbjct: 267 LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLD 326
Query: 319 RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEII-AGDPESVSETWMSNVYSFGMV 377
            HG+V + D+G+  AC    +        + ++APE++  G     S  W    +S G +
Sbjct: 327 EHGHVRISDLGL--ACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADW----FSLGCM 380
Query: 378 IWEMVTGEAAY 388
           +++++ G + +
Sbjct: 381 LFKLLRGHSPF 391

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 51/229 (22%), Positives = 96/229 (41%), Gaps = 13/229 (5%)
Query: 227 EFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEI 286
           E +LR+++       H NIL+ Y    D    + ++ +    G+V   + K  K   +  
Sbjct: 55  EHQLRREVEIQSHLRHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRT 113
Query: 287 IRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETD 346
                ++A  + + +   V +RD+  + +LL   G + + D G      S   A    T 
Sbjct: 114 ATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALCGTL 173
Query: 347 GYRWLAPEIIAG--DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG 404
            Y  L PE+I G    E V      +++S G++ +E + G+  + A +  +    I+   
Sbjct: 174 DY--LPPEMIEGRMHDEKV------DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE 225
Query: 405 LRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNSSN 453
                P    +  + L+ +   ++PS+RP   E++     T N S  SN
Sbjct: 226 F--TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSN 272

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 30/130 (23%), Positives = 67/130 (51%), Gaps = 5/130 (3%)
Query: 259 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLD 318
           L  +  LM GG ++  + +       ++   A ++  G++ +++  V YRDL    ILLD
Sbjct: 266 LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLD 325
Query: 319 RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVI 378
            HG+V + D+G+  AC    +        + ++APE++    + V+    ++ +S G ++
Sbjct: 326 EHGHVRISDLGL--ACDFSKKKPHASVGTHGYMAPEVLQ---KGVAYDSSADWFSLGCML 380
Query: 379 WEMVTGEAAY 388
           ++++ G + +
Sbjct: 381 FKLLRGHSPF 390

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 57/248 (22%), Positives = 106/248 (42%), Gaps = 31/248 (12%)
Query: 190 DNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL--RKDLLELMTCGH----K 243
           D  E I  +G  SF       RV +  +K  + GN Y  ++  ++ +++L    H    K
Sbjct: 41  DQFERIKTLGTGSFG------RVML--VKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 244 NILQF----YCVCVD----ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAE 295
            ILQ     + V ++    +N  L +V +   GG +   + +  +         A  +  
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVL 152
Query: 296 GIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEI 355
             ++L+   + YRDL  + +++D+ G + + D G     K V   T        +LAPEI
Sbjct: 153 TFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGF---AKRVKGRTWXLCGTPEYLAPEI 209
Query: 356 IAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR--PEIPKDC 413
           I     + +  W    ++ G++I+EM  G   + A  P+Q    I +  +R       D 
Sbjct: 210 ILSKGYNKAVDW----WALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 265
Query: 414 PQILKSLM 421
             +L++L+
Sbjct: 266 KDLLRNLL 273

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 58/248 (23%), Positives = 106/248 (42%), Gaps = 31/248 (12%)
Query: 190 DNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL--RKDLLELMTCGH----K 243
           D  E I  +G  SF       RV + K K  + GN Y  ++  ++ +++L    H    K
Sbjct: 42  DQFERIKTLGTGSFG------RVMLVKHK--ETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 244 NILQF----YCVCVD----ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAE 295
            ILQ     + V ++    +N  L +V +   GG +   + +  +         A  +  
Sbjct: 94  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVL 153
Query: 296 GIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEI 355
             ++L+   + YRDL  + +++D+ G + + D G     K V   T        +LAPEI
Sbjct: 154 TFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGF---AKRVKGRTWXLCGTPEYLAPEI 210
Query: 356 IAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR--PEIPKDC 413
           I     + +  W    ++ G++I+EM  G   + A  P+Q    I +  +R       D 
Sbjct: 211 ILSKGYNKAVDW----WALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 266
Query: 414 PQILKSLM 421
             +L++L+
Sbjct: 267 KDLLRNLL 274

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 57/248 (22%), Positives = 103/248 (41%), Gaps = 31/248 (12%)
Query: 190 DNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL--RKDLLELMTCGH----K 243
           D  E I  +G  SF       RV +  +K  + GN Y  ++  ++ +++L    H    K
Sbjct: 42  DQFERIKTLGTGSFG------RVML--VKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 244 NILQ-----FYC---VCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAE 295
            ILQ     F         +N  L +V +   GG +   + +  +         A  +  
Sbjct: 94  RILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVL 153
Query: 296 GIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEI 355
             ++L+   + YRDL  + +++D+ G + + D G     K V   T        +LAPEI
Sbjct: 154 TFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGF---AKRVKGRTWXLCGTPEYLAPEI 210
Query: 356 IAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR--PEIPKDC 413
           I     + +  W    ++ G++I+EM  G   + A  P+Q    I +  +R       D 
Sbjct: 211 ILSKGYNKAVDW----WALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 266
Query: 414 PQILKSLM 421
             +L++L+
Sbjct: 267 KDLLRNLL 274

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/227 (21%), Positives = 93/227 (40%), Gaps = 9/227 (3%)
Query: 227 EFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEI 286
           E +LR+++       H NIL+ Y    D    + ++ +    G+V   + K  K   +  
Sbjct: 57  EHQLRREVEIQSHLRHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRT 115
Query: 287 IRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETD 346
                ++A  + + +   V +RD+  + +LL   G + + D G      S    T   T 
Sbjct: 116 ATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTL 175
Query: 347 GYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR 406
            Y  L PE I G           +++S G++ +E + G+  + A +  +    I+     
Sbjct: 176 DY--LPPEXIEGRXHDEK----VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF- 228
Query: 407 PEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNSSN 453
              P    +  + L+ +   ++PS+RP   E++     T N S  SN
Sbjct: 229 -TFPDFVTEGARDLISRLLKHNPSQRPXLREVLEHPWITANSSKPSN 274

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/253 (24%), Positives = 106/253 (41%), Gaps = 29/253 (11%)
Query: 169 VDEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKG--KRVGIE----KLKGCDK 222
           ++E +T   G    GR+L      +F  +IG  SFK VYKG      +E    +L+    
Sbjct: 11  IEELETKAVGXSNDGRFL------KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL 64
Query: 223 GNAYEFELRKDLLELMTCGHKNILQFYCV---CVDENHGLCVVTKLMEGGSVNDLILKSR 279
             +     +++   L    H NI++FY      V     + +VT+L   G++   + + +
Sbjct: 65  TKSERQRFKEEAEXLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFK 124
Query: 280 KLQTKEIIRIAIDVAEGIKFLNDHG--VAYRDLNSQRILLD-RHGNVCLGDMGIVTACKS 336
             + K +      + +G++FL+     + +RDL    I +    G+V +GD+G+ T  ++
Sbjct: 125 VXKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184
Query: 337 VGEATEYETDGYRWLAPEIIAGDPESVSETWMS--NVYSFGMVIWEMVTGEAAYAACSPV 394
                   T       PE  A  PE   E +    +VY+FG    E  T E  Y+ C   
Sbjct: 185 SFAKAVIGT-------PEFXA--PEXYEEKYDESVDVYAFGXCXLEXATSEYPYSECQNA 235
Query: 395 QAAVGIAACGLRP 407
                    G++P
Sbjct: 236 AQIYRRVTSGVKP 248

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/262 (21%), Positives = 110/262 (41%), Gaps = 27/262 (10%)
Query: 191 NLEFIDQIGPNSF------KGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLE---LMTCG 241
           N   +  IG  +F      + +  G+ V I   K  DK       L+K   E   +    
Sbjct: 16  NYRLLKTIGKGNFAKVKLARHILTGREVAI---KIIDKTQLNPTSLQKLFREVRIMKILN 72
Query: 242 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 301
           H NI++ + V ++    L ++ +   GG V D ++   +++ KE       +   +++ +
Sbjct: 73  HPNIVKLFEV-IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCH 131
Query: 302 DHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPE 361
              + +RDL ++ +LLD   N+ + D G      +VG   +       + APE+  G   
Sbjct: 132 QKRIVHRDLKAENLLLDADMNIKIADFGFSNEF-TVGGKLDAFCGAPPYAAPELFQGKKY 190
Query: 362 SVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIP----KDCPQIL 417
              E    +V+S G++++ +V+G   +   +  +    +     R  IP     DC  +L
Sbjct: 191 DGPEV---DVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYR--IPFYMSTDCENLL 245
Query: 418 KSLMIKCWNNSPSKRPQFSEII 439
           K  ++     +P KR    +I+
Sbjct: 246 KRFLVL----NPIKRGTLEQIM 263

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/222 (23%), Positives = 94/222 (42%), Gaps = 35/222 (15%)
Query: 190 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLK------GCDKGNAYEFELRKDLLEL 237
           +N + +++IG  ++  VYK      G+ V ++K++      G       E  L K+L   
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL--- 62
Query: 238 MTCGHKNILQFYCVCVDENHGLCV-------VTKLMEGGSVNDLILKSRKLQTKEIIRIA 290
               H NI++   V   EN    V       + K M+  ++  + L   K    +++   
Sbjct: 63  ---NHPNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQLL--- 116
Query: 291 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRW 350
               +G+ F + H V +RDL  + +L++  G + L D G+  A         +E     +
Sbjct: 117 ----QGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWY 172
Query: 351 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACS 392
            APEI+ G     +     +++S G +  EMVT  A +   S
Sbjct: 173 RAPEILLGCKYYSTAV---DIWSLGCIFAEMVTRRALFPGDS 211

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/262 (21%), Positives = 110/262 (41%), Gaps = 27/262 (10%)
Query: 191 NLEFIDQIGPNSF------KGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLE---LMTCG 241
           N   +  IG  +F      + +  G+ V I   K  DK       L+K   E   +    
Sbjct: 13  NYRLLKTIGKGNFAKVKLARHILTGREVAI---KIIDKTQLNPTSLQKLFREVRIMKILN 69
Query: 242 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 301
           H NI++ + V ++    L ++ +   GG V D ++   +++ KE       +   +++ +
Sbjct: 70  HPNIVKLFEV-IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCH 128
Query: 302 DHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPE 361
              + +RDL ++ +LLD   N+ + D G      +VG   +       + APE+  G   
Sbjct: 129 QKRIVHRDLKAENLLLDADMNIKIADFGFSNEF-TVGGKLDTFCGSPPYAAPELFQGKKY 187
Query: 362 SVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIP----KDCPQIL 417
              E    +V+S G++++ +V+G   +   +  +    +     R  IP     DC  +L
Sbjct: 188 DGPEV---DVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYR--IPFYMSTDCENLL 242
Query: 418 KSLMIKCWNNSPSKRPQFSEII 439
           K  ++     +P KR    +I+
Sbjct: 243 KRFLVL----NPIKRGTLEQIM 260

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/264 (22%), Positives = 108/264 (40%), Gaps = 41/264 (15%)
Query: 182 IGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL--RKDLLELMT 239
           + +W   S N   +DQ       G     RV + K K  + GN Y  ++  ++ +++L  
Sbjct: 27  LKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHK--ESGNHYAMKILDKQKVVKLKQ 84
Query: 240 CGH----KNILQF----YCVCVD----ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEII 287
             H    K ILQ     + V ++    +N  L +V + + GG +   + +  +       
Sbjct: 85  IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHAR 144
Query: 288 RIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG 347
             A  +    ++L+   + YRDL  + +L+D+ G + + D G     K           G
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----------G 193
Query: 348 YRW--------LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVG 399
             W        LAPEII     + +  W    ++ G++I+EM  G   + A  P+Q    
Sbjct: 194 RTWXLCGTPEALAPEIILSKGYNKAVDW----WALGVLIYEMAAGYPPFFADQPIQIYEK 249
Query: 400 IAACGLR--PEIPKDCPQILKSLM 421
           I +  +R       D   +L++L+
Sbjct: 250 IVSGKVRFPSHFSSDLKDLLRNLL 273

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/222 (23%), Positives = 94/222 (42%), Gaps = 35/222 (15%)
Query: 190 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLK------GCDKGNAYEFELRKDLLEL 237
           +N + +++IG  ++  VYK      G+ V ++K++      G       E  L K+L   
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL--- 60
Query: 238 MTCGHKNILQFYCVCVDENHGLCV-------VTKLMEGGSVNDLILKSRKLQTKEIIRIA 290
               H NI++   V   EN    V       + K M+  ++  + L   K    +++   
Sbjct: 61  ---NHPNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQLL--- 114
Query: 291 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRW 350
               +G+ F + H V +RDL  + +L++  G + L D G+  A         +E     +
Sbjct: 115 ----QGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWY 170
Query: 351 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACS 392
            APEI+ G     +     +++S G +  EMVT  A +   S
Sbjct: 171 RAPEILLGCKYYSTAV---DIWSLGCIFAEMVTRRALFPGDS 209

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/248 (23%), Positives = 107/248 (43%), Gaps = 31/248 (12%)
Query: 190 DNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL--RKDLLELMTCGH----K 243
           D  E I  +G  SF       RV + K K  + GN +  ++  ++ +++L    H    K
Sbjct: 41  DQFERIKTLGTGSFG------RVMLVKHK--ETGNHFAMKILDKQKVVKLKQIEHTLNEK 92
Query: 244 NILQF----YCVCVD----ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAE 295
            ILQ     + V ++    +N  L +V + + GG +   + +  +         A  +  
Sbjct: 93  RILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVL 152
Query: 296 GIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEI 355
             ++L+   + YRDL  + +L+D+ G + + D G     K V   T        +LAPEI
Sbjct: 153 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF---AKRVKGRTWXLCGTPEYLAPEI 209
Query: 356 IAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR--PEIPKDC 413
           I     + +  W    ++ G++I+EM  G   + A  P+Q    I +  +R       D 
Sbjct: 210 ILSKGYNKAVDW----WALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 265
Query: 414 PQILKSLM 421
             +L++L+
Sbjct: 266 KDLLRNLL 273

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/229 (21%), Positives = 94/229 (41%), Gaps = 13/229 (5%)
Query: 227 EFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEI 286
           E +LR+++       H NIL+ Y    D    + ++ +    G V   + K  K   +  
Sbjct: 57  EHQLRREVEIQSHLRHPNILRLYGYFHDATR-VYLILEYAPRGEVYKELQKLSKFDEQRT 115
Query: 287 IRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETD 346
                ++A  + + +   V +RD+  + +LL   G + + D G      S        T 
Sbjct: 116 ATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLXGTL 175
Query: 347 GYRWLAPEIIAG--DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG 404
            Y  L PE+I G    E V      +++S G++ +E + G+  + A +  +    I+   
Sbjct: 176 DY--LPPEMIEGRMHDEKV------DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE 227
Query: 405 LRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNSSN 453
                P    +  + L+ +   ++PS+RP   E++     T N S  SN
Sbjct: 228 F--TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSN 274

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/222 (23%), Positives = 94/222 (42%), Gaps = 35/222 (15%)
Query: 190 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLK------GCDKGNAYEFELRKDLLEL 237
           +N + +++IG  ++  VYK      G+ V ++K++      G       E  L K+L   
Sbjct: 5   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL--- 61
Query: 238 MTCGHKNILQFYCVCVDENHGLCV-------VTKLMEGGSVNDLILKSRKLQTKEIIRIA 290
               H NI++   V   EN    V       + K M+  ++  + L   K    +++   
Sbjct: 62  ---NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL--- 115
Query: 291 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRW 350
               +G+ F + H V +RDL  + +L++  G + L D G+  A         +E     +
Sbjct: 116 ----QGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWY 171
Query: 351 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACS 392
            APEI+ G     +     +++S G +  EMVT  A +   S
Sbjct: 172 RAPEILLGCKYYSTAV---DIWSLGCIFAEMVTRRALFPGDS 210

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/229 (22%), Positives = 96/229 (41%), Gaps = 13/229 (5%)
Query: 227 EFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEI 286
           E +LR+++       H NIL+ Y    D    + ++ +    G+V   + K  K   +  
Sbjct: 53  EHQLRREVEIQSHLRHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRT 111
Query: 287 IRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETD 346
                ++A  + + +   V +RD+  + +LL   G + + D G      S    T   T 
Sbjct: 112 ATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDTLCGTL 171
Query: 347 GYRWLAPEIIAG--DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG 404
            Y  L PE+I G    E V      +++S G++ +E + G+  + A +  +    I+   
Sbjct: 172 DY--LPPEMIEGRMHDEKV------DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE 223
Query: 405 LRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNSSN 453
                P    +  + L+ +   ++PS+RP   E++     T N S  SN
Sbjct: 224 F--TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSN 270

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/222 (23%), Positives = 94/222 (42%), Gaps = 35/222 (15%)
Query: 190 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLK------GCDKGNAYEFELRKDLLEL 237
           +N + +++IG  ++  VYK      G+ V ++K++      G       E  L K+L   
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL--- 60
Query: 238 MTCGHKNILQFYCVCVDENHGLCV-------VTKLMEGGSVNDLILKSRKLQTKEIIRIA 290
               H NI++   V   EN    V       + K M+  ++  + L   K    +++   
Sbjct: 61  ---NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL--- 114
Query: 291 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRW 350
               +G+ F + H V +RDL  + +L++  G + L D G+  A         +E     +
Sbjct: 115 ----QGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWY 170
Query: 351 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACS 392
            APEI+ G     +     +++S G +  EMVT  A +   S
Sbjct: 171 RAPEILLGCKYYSTAV---DIWSLGCIFAEMVTRRALFPGDS 209

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/132 (24%), Positives = 62/132 (46%), Gaps = 6/132 (4%)
Query: 292 DVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWL 351
           +++  +  L+  G+ YRDL  + I+L+  G+V L D G+       G  T        ++
Sbjct: 129 EISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHXFCGTIEYM 188
Query: 352 APEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR--PEI 409
           APEI+     + +  W    +S G ++++M+TG   +   +  +    I  C L   P +
Sbjct: 189 APEILMRSGHNRAVDW----WSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYL 244
Query: 410 PKDCPQILKSLM 421
            ++   +LK L+
Sbjct: 245 TQEARDLLKKLL 256

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/253 (24%), Positives = 106/253 (41%), Gaps = 44/253 (17%)
Query: 162 SSSFVVSVDEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKG----------KR 211
           SSS++V  + ++      EE       ++N +    IG   F  VYKG          KR
Sbjct: 17  SSSYLVPFESYRVPLVDLEEA------TNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKR 70
Query: 212 VGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSV 271
              E  +G ++       L         C H +++     C DE + + ++ K ME G++
Sbjct: 71  RTPESSQGIEEFETEIETLS-------FCRHPHLVSLIGFC-DERNEMILIYKYMENGNL 122
Query: 272 NDLI----LKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGD 327
              +    L +  +  ++ + I I  A G+ +L+   + +RD+ S  ILLD +    + D
Sbjct: 123 KRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITD 182
Query: 328 MGIVTACKSVGEATEYE----TDGYRWLAPEIIAGDPESVSE---TWMSNVYSFGMVIWE 380
            GI      +G+         T GY          DPE   +   T  S+VYSFG+V++E
Sbjct: 183 FGISKKGTELGQTHLXXVVKGTLGYI---------DPEYFIKGRLTEKSDVYSFGVVLFE 233
Query: 381 MVTGEAAYAACSP 393
           ++   +A     P
Sbjct: 234 VLCARSAIVQSLP 246

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/169 (23%), Positives = 73/169 (43%), Gaps = 9/169 (5%)
Query: 255 ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQR 314
           +N  L +V +   GG +   + +  +         A  +    ++L+   + YRDL  + 
Sbjct: 113 DNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPEN 172
Query: 315 ILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSF 374
           +L+D+ G + + D G     K V   T        +LAPEII     + +  W    ++ 
Sbjct: 173 LLIDQQGYIKVADFGF---AKRVKGRTWXLCGTPEYLAPEIILSKGYNKAVDW----WAL 225
Query: 375 GMVIWEMVTGEAAYAACSPVQAAVGIAACGLR--PEIPKDCPQILKSLM 421
           G++I+EM  G   + A  P+Q    I +  +R       D   +L++L+
Sbjct: 226 GVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLL 274

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/222 (23%), Positives = 93/222 (41%), Gaps = 35/222 (15%)
Query: 190 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLK------GCDKGNAYEFELRKDLLEL 237
           +N + +++IG  ++  VYK      G+ V ++K++      G       E  L K+L   
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL--- 62
Query: 238 MTCGHKNILQFYCVCVDENHGLCV-------VTKLMEGGSVNDLILKSRKLQTKEIIRIA 290
               H NI++   V   EN    V       +   M+  ++  + L   K    +++   
Sbjct: 63  ---NHPNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLL--- 116
Query: 291 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRW 350
               +G+ F + H V +RDL  Q +L++  G + L D G+  A         +E     +
Sbjct: 117 ----QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWY 172
Query: 351 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACS 392
            APEI+ G     +     +++S G +  EMVT  A +   S
Sbjct: 173 RAPEILLGCKYYSTAV---DIWSLGCIFAEMVTRRALFPGDS 211

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/132 (24%), Positives = 62/132 (46%), Gaps = 6/132 (4%)
Query: 292 DVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWL 351
           +++  +  L+  G+ YRDL  + I+L+  G+V L D G+       G  T        ++
Sbjct: 129 EISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYM 188
Query: 352 APEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR--PEI 409
           APEI+     + +  W    +S G ++++M+TG   +   +  +    I  C L   P +
Sbjct: 189 APEILMRSGHNRAVDW----WSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYL 244
Query: 410 PKDCPQILKSLM 421
            ++   +LK L+
Sbjct: 245 TQEARDLLKKLL 256

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/154 (22%), Positives = 76/154 (49%), Gaps = 6/154 (3%)
Query: 229 ELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIR 288
            + +++  L    H +I++ Y V   ++  + V+     G  + D I++  K+  +E  R
Sbjct: 50  RIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIE--YAGNELFDYIVQRDKMSEQEARR 107
Query: 289 IAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY 348
               +   +++ + H + +RDL  + +LLD H NV + D G+ +   + G   +      
Sbjct: 108 FFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGL-SNIMTDGNFLKTSCGSP 166
Query: 349 RWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMV 382
            + APE+I+G   +  E    +V+S G++++ M+
Sbjct: 167 NYAAPEVISGKLYAGPEV---DVWSCGVILYVML 197

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/154 (22%), Positives = 76/154 (49%), Gaps = 6/154 (3%)
Query: 229 ELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIR 288
            + +++  L    H +I++ Y V   ++  + V+     G  + D I++  K+  +E  R
Sbjct: 59  RIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIE--YAGNELFDYIVQRDKMSEQEARR 116
Query: 289 IAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY 348
               +   +++ + H + +RDL  + +LLD H NV + D G+ +   + G   +      
Sbjct: 117 FFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGL-SNIMTDGNFLKTSCGSP 175
Query: 349 RWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMV 382
            + APE+I+G   +  E    +V+S G++++ M+
Sbjct: 176 NYAAPEVISGKLYAGPEV---DVWSCGVILYVML 206

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/233 (21%), Positives = 98/233 (42%), Gaps = 22/233 (9%)
Query: 195 IDQIGPNSFKGVYK-----GKRVGIEKLK------GCDKGNAYEFELRKDLLELMTCGHK 243
           ++++G  ++  VYK     G+ V +++++      G       E  L K+L       H 
Sbjct: 26  LEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKEL------HHP 79
Query: 244 NILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDH 303
           NI+    V   E   L +V + ME      L      LQ  +I      +  G+   + H
Sbjct: 80  NIVSLIDVIHSER-CLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQH 138
Query: 304 GVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESV 363
            + +RDL  Q +L++  G + L D G+  A      +  +E     + AP+++ G  +  
Sbjct: 139 RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYS 198
Query: 364 SETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQI 416
           +     +++S G +  EM+TG+  +   +       I +    P  P++ PQ+
Sbjct: 199 TSV---DIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPN-PREWPQV 247

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/232 (21%), Positives = 98/232 (42%), Gaps = 19/232 (8%)
Query: 227 EFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEI 286
           E +LR+++       H NIL+ Y    D    + ++ +    G+V   + K  K   +  
Sbjct: 57  EHQLRREVEIQSHLRHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRT 115
Query: 287 IRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETD 346
                ++A  + + +   V +RD+  + +LL   G + + D G      SV   +   TD
Sbjct: 116 ATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW-----SVHAPSSRRTD 170
Query: 347 ---GYRWLAPEIIAG--DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIA 401
                 +L PE+I G    E V      +++S G++ +E + G+  + A +  +    I+
Sbjct: 171 LCGTLDYLPPEMIEGRMHDEKV------DLWSLGVLCYEFLVGKPPFEANTYQETYKRIS 224
Query: 402 ACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNSSN 453
                   P    +  + L+ +   ++PS+RP   E++     T N S  SN
Sbjct: 225 RVEF--TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSN 274

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/222 (23%), Positives = 93/222 (41%), Gaps = 35/222 (15%)
Query: 190 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLK------GCDKGNAYEFELRKDLLEL 237
           +N + +++IG  ++  VYK      G+ V ++K++      G       E  L K+L   
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL--- 62
Query: 238 MTCGHKNILQFYCVCVDENHGLCV-------VTKLMEGGSVNDLILKSRKLQTKEIIRIA 290
               H NI++   V   EN    V       +   M+  ++  + L   K    +++   
Sbjct: 63  ---NHPNIVKLLDVIHTENKLYLVFEFLHQDLKTFMDASALTGIPLPLIKSYLFQLL--- 116
Query: 291 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRW 350
               +G+ F + H V +RDL  Q +L++  G + L D G+  A         +E     +
Sbjct: 117 ----QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWY 172
Query: 351 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACS 392
            APEI+ G     +     +++S G +  EMVT  A +   S
Sbjct: 173 RAPEILLGCKYYSTAV---DIWSLGCIFAEMVTRRALFPGDS 211

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/204 (21%), Positives = 97/204 (47%), Gaps = 13/204 (6%)
Query: 187 LNSDNLEFIDQIGPNSFKGVYKGKR-----VGIEKLKGCDKGNAYEFELRKDLLELMTCG 241
           L  D+ E I ++G  +   V K +      +   KL   +   A   ++ ++L  L  C 
Sbjct: 13  LKDDDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECN 72
Query: 242 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 301
              I+ FY     +   + +  + M+GGS++ ++ +++++  + + +++I V  G+ +L 
Sbjct: 73  SPYIVGFYGAFYSDGE-ISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLR 131
Query: 302 D-HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDP 360
           + H + +RD+    IL++  G + L D G+  + + +            ++APE + G  
Sbjct: 132 EKHQIMHRDVKPSNILVNSRGEIKLCDFGV--SGQLIDSMANSFVGTRSYMAPERLQGTH 189
Query: 361 ESVSETWMSNVYSFGMVIWEMVTG 384
            SV     S+++S G+ + E+  G
Sbjct: 190 YSVQ----SDIWSMGLSLVELAVG 209

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/163 (25%), Positives = 77/163 (47%), Gaps = 26/163 (15%)
Query: 242 HKNILQFYCVCVDENHG------LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAE 295
           H+N+LQF      E  G      L ++T   + GS+ D  LK   +   E+  +A  ++ 
Sbjct: 68  HENLLQFIAA---EKRGSNLEVELWLITAFHDKGSLTDY-LKGNIITWNELCHVAETMSR 123
Query: 296 GIKFLNDH-----------GVAYRDLNSQRILLDRHGNVCLGDMGIVTAC---KSVGEAT 341
           G+ +L++             +A+RD  S+ +LL       L D G+       K  G+ T
Sbjct: 124 GLSYLHEDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGD-T 182
Query: 342 EYETDGYRWLAPEIIAGDPESVSETWMS-NVYSFGMVIWEMVT 383
             +    R++APE++ G      + ++  ++Y+ G+V+WE+V+
Sbjct: 183 HGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELVS 225

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/154 (22%), Positives = 76/154 (49%), Gaps = 6/154 (3%)
Query: 229 ELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIR 288
            + +++  L    H +I++ Y V   ++  + V+     G  + D I++  K+  +E  R
Sbjct: 54  RIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIE--YAGNELFDYIVQRDKMSEQEARR 111
Query: 289 IAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY 348
               +   +++ + H + +RDL  + +LLD H NV + D G+ +   + G   +      
Sbjct: 112 FFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGL-SNIMTDGNFLKTSCGSP 170
Query: 349 RWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMV 382
            + APE+I+G   +  E    +V+S G++++ M+
Sbjct: 171 NYAAPEVISGKLYAGPEV---DVWSCGVILYVML 201

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/222 (23%), Positives = 93/222 (41%), Gaps = 35/222 (15%)
Query: 190 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLK------GCDKGNAYEFELRKDLLEL 237
           +N + +++IG  ++  VYK      G+ V ++K++      G       E  L K+L   
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL--- 58
Query: 238 MTCGHKNILQFYCVCVDENHGLCV-------VTKLMEGGSVNDLILKSRKLQTKEIIRIA 290
               H NI++   V   EN    V       +   M+  ++  + L   K    +++   
Sbjct: 59  ---NHPNIVKLLDVIHTENKLYLVFEHVHQDLKTFMDASALTGIPLPLIKSYLFQLL--- 112
Query: 291 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRW 350
               +G+ F + H V +RDL  Q +L++  G + L D G+  A         +E     +
Sbjct: 113 ----QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWY 168
Query: 351 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACS 392
            APEI+ G     +     +++S G +  EMVT  A +   S
Sbjct: 169 RAPEILLGCKYYSTAV---DIWSLGCIFAEMVTRRALFPGDS 207

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/233 (21%), Positives = 98/233 (42%), Gaps = 22/233 (9%)
Query: 195 IDQIGPNSFKGVYK-----GKRVGIEKLK------GCDKGNAYEFELRKDLLELMTCGHK 243
           ++++G  ++  VYK     G+ V +++++      G       E  L K+L       H 
Sbjct: 26  LEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKEL------HHP 79
Query: 244 NILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDH 303
           NI+    V   E   L +V + ME      L      LQ  +I      +  G+   + H
Sbjct: 80  NIVSLIDVIHSER-CLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQH 138
Query: 304 GVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESV 363
            + +RDL  Q +L++  G + L D G+  A      +  +E     + AP+++ G  +  
Sbjct: 139 RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYS 198
Query: 364 SETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQI 416
           +     +++S G +  EM+TG+  +   +       I +    P  P++ PQ+
Sbjct: 199 TSV---DIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPN-PREWPQV 247

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/154 (22%), Positives = 76/154 (49%), Gaps = 6/154 (3%)
Query: 229 ELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIR 288
            + +++  L    H +I++ Y V   ++  + V+     G  + D I++  K+  +E  R
Sbjct: 60  RIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIE--YAGNELFDYIVQRDKMSEQEARR 117
Query: 289 IAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY 348
               +   +++ + H + +RDL  + +LLD H NV + D G+ +   + G   +      
Sbjct: 118 FFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGL-SNIMTDGNFLKTSCGSP 176
Query: 349 RWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMV 382
            + APE+I+G   +  E    +V+S G++++ M+
Sbjct: 177 NYAAPEVISGKLYAGPEV---DVWSCGVILYVML 207

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/222 (23%), Positives = 93/222 (41%), Gaps = 35/222 (15%)
Query: 190 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLK------GCDKGNAYEFELRKDLLEL 237
           +N + +++IG  ++  VYK      G+ V ++K++      G       E  L K+L   
Sbjct: 5   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL--- 61
Query: 238 MTCGHKNILQFYCVCVDENHGLCV-------VTKLMEGGSVNDLILKSRKLQTKEIIRIA 290
               H NI++   V   EN    V       +   M+  ++  + L   K    +++   
Sbjct: 62  ---NHPNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLL--- 115
Query: 291 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRW 350
               +G+ F + H V +RDL  Q +L++  G + L D G+  A         +E     +
Sbjct: 116 ----QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWY 171
Query: 351 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACS 392
            APEI+ G     +     +++S G +  EMVT  A +   S
Sbjct: 172 RAPEILLGCKYYSTAV---DIWSLGCIFAEMVTRRALFPGDS 210

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/232 (21%), Positives = 98/232 (42%), Gaps = 19/232 (8%)
Query: 227 EFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEI 286
           E +LR+++       H NIL+ Y    D    + ++ +    G+V   + K  K   +  
Sbjct: 53  EHQLRREVEIQSHLRHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRT 111
Query: 287 IRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETD 346
                ++A  + + +   V +RD+  + +LL   G + + D G      SV   +   TD
Sbjct: 112 ATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW-----SVHAPSSRRTD 166
Query: 347 ---GYRWLAPEIIAG--DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIA 401
                 +L PE+I G    E V      +++S G++ +E + G+  + A +  +    I+
Sbjct: 167 LCGTLDYLPPEMIEGRMHDEKV------DLWSLGVLCYEFLVGKPPFEANTYQETYKRIS 220
Query: 402 ACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNSSN 453
                   P    +  + L+ +   ++PS+RP   E++     T N S  SN
Sbjct: 221 RVEF--TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSN 270

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/232 (21%), Positives = 98/232 (42%), Gaps = 19/232 (8%)
Query: 227 EFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEI 286
           E +LR+++       H NIL+ Y    D    + ++ +    G+V   + K  K   +  
Sbjct: 52  EHQLRREVEIQSHLRHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRT 110
Query: 287 IRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETD 346
                ++A  + + +   V +RD+  + +LL   G + + D G      SV   +   TD
Sbjct: 111 ATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW-----SVHAPSSRRTD 165
Query: 347 ---GYRWLAPEIIAG--DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIA 401
                 +L PE+I G    E V      +++S G++ +E + G+  + A +  +    I+
Sbjct: 166 LCGTLDYLPPEMIEGRMHDEKV------DLWSLGVLCYEFLVGKPPFEANTYQETYKRIS 219
Query: 402 ACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNSSN 453
                   P    +  + L+ +   ++PS+RP   E++     T N S  SN
Sbjct: 220 RVEF--TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSN 269

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/256 (22%), Positives = 108/256 (42%), Gaps = 25/256 (9%)
Query: 182 IGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFEL--RKDLLELMT 239
           + +W   S N   +DQ       G     RV + K K  + GN Y  ++  ++ +++L  
Sbjct: 27  LKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHK--ESGNHYAMKILDKQKVVKLKQ 84
Query: 240 CGH----KNILQF----YCVCVD----ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEII 287
             H    K ILQ     + V ++    +N  L +V + + GG +   + +  +       
Sbjct: 85  IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHAR 144
Query: 288 RIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG 347
             A  +    ++L+   + YRDL  + +L+D+ G + + D G     K V   T      
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF---AKRVKGRTWXLCGT 201
Query: 348 YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR- 406
             +LAP II     + +  W    ++ G++I+EM  G   + A  P+Q    I +  +R 
Sbjct: 202 PEYLAPAIILSKGYNKAVDW----WALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF 257
Query: 407 -PEIPKDCPQILKSLM 421
                 D   +L++L+
Sbjct: 258 PSHFSSDLKDLLRNLL 273

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/188 (26%), Positives = 87/188 (46%), Gaps = 20/188 (10%)
Query: 214 IEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVDENHGLCVVTKLMEGGSVN 272
           IEK  G  +   +     +++  L  C G+KNIL+      D+     V  KL +GGS+ 
Sbjct: 46  IEKQAGHSRSRVF-----REVETLYQCQGNKNILELIEFFEDDTRFYLVFEKL-QGGSIL 99
Query: 273 DLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV-----CLGD 327
             I K +    +E  R+  DVA  + FL+  G+A+RDL  + IL +    V     C  D
Sbjct: 100 AHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCESPEKVSPVKICDFD 159
Query: 328 MG----IVTACKSVGEATEYETD--GYRWLAPEII-AGDPESVSETWMSNVYSFGMVIWE 380
           +G    +  +C  +    E  T      ++APE++     ++       +++S G+V++ 
Sbjct: 160 LGSGMKLNNSCTPI-TTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYI 218
Query: 381 MVTGEAAY 388
           M++G   +
Sbjct: 219 MLSGYPPF 226

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/232 (21%), Positives = 98/232 (42%), Gaps = 19/232 (8%)
Query: 227 EFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEI 286
           E +LR+++       H NIL+ Y    D    + ++ +    G+V   + K  K   +  
Sbjct: 52  EHQLRREVEIQSHLRHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRT 110
Query: 287 IRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETD 346
                ++A  + + +   V +RD+  + +LL   G + + D G      SV   +   TD
Sbjct: 111 ATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW-----SVHAPSSRRTD 165
Query: 347 ---GYRWLAPEIIAG--DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIA 401
                 +L PE+I G    E V      +++S G++ +E + G+  + A +  +    I+
Sbjct: 166 LCGTLDYLPPEMIEGRMHDEKV------DLWSLGVLCYEFLVGKPPFEANTYQETYKRIS 219
Query: 402 ACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNSSN 453
                   P    +  + L+ +   ++PS+RP   E++     T N S  SN
Sbjct: 220 RVEF--TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSN 269

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/229 (21%), Positives = 96/229 (41%), Gaps = 13/229 (5%)
Query: 227 EFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEI 286
           E +LR+++       H NIL+ Y    D    + ++ +    G+V   + K  K   +  
Sbjct: 54  EHQLRREVEIQSHLRHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRT 112
Query: 287 IRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETD 346
                ++A  + + +   V +RD+  + +LL   G + + + G      S    T   T 
Sbjct: 113 ATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRTTLCGTL 172
Query: 347 GYRWLAPEIIAG--DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG 404
            Y  L PE+I G    E V      +++S G++ +E + G+  + A +  +    I+   
Sbjct: 173 DY--LPPEMIEGRMHDEKV------DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE 224
Query: 405 LRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNSSN 453
                P    +  + L+ +   ++PS+RP   E++     T N S  SN
Sbjct: 225 F--TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSN 271

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/229 (21%), Positives = 96/229 (41%), Gaps = 13/229 (5%)
Query: 227 EFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEI 286
           E +LR+++       H NIL+ Y    D    + ++ +    G+V   + K  K   +  
Sbjct: 55  EHQLRREVEIQSHLRHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRT 113
Query: 287 IRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETD 346
                ++A  + + +   V +RD+  + +LL   G + + + G      S    T   T 
Sbjct: 114 ATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRTTLCGTL 173
Query: 347 GYRWLAPEIIAG--DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG 404
            Y  L PE+I G    E V      +++S G++ +E + G+  + A +  +    I+   
Sbjct: 174 DY--LPPEMIEGRMHDEKV------DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE 225
Query: 405 LRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNSSN 453
                P    +  + L+ +   ++PS+RP   E++     T N S  SN
Sbjct: 226 F--TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSN 272

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/229 (21%), Positives = 95/229 (41%), Gaps = 13/229 (5%)
Query: 227 EFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEI 286
           E +LR+++       H NIL+ Y    D    + ++ +    G+V   + K  K   +  
Sbjct: 52  EHQLRREVEIQSHLRHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRT 110
Query: 287 IRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETD 346
                ++A  + + +   V +RD+  + +LL   G + + D G      S        T 
Sbjct: 111 ATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTELCGTL 170
Query: 347 GYRWLAPEIIAG--DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG 404
            Y  L PE+I G    E V      +++S G++ +E + G+  + A +  +    I+   
Sbjct: 171 DY--LPPEMIEGRMHDEKV------DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE 222
Query: 405 LRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNSSN 453
                P    +  + L+ +   ++PS+RP   E++     T N S  SN
Sbjct: 223 F--TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSN 269

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/229 (21%), Positives = 95/229 (41%), Gaps = 13/229 (5%)
Query: 227 EFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEI 286
           E +LR+++       H NIL+ Y    D    + ++ +    G+V   + K  K   +  
Sbjct: 54  EHQLRREVEIQSHLRHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRT 112
Query: 287 IRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETD 346
                ++A  + + +   V +RD+  + +LL   G + + D G      S        T 
Sbjct: 113 ATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLCGTL 172
Query: 347 GYRWLAPEIIAG--DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG 404
            Y  L PE+I G    E V      +++S G++ +E + G+  + A +  +    I+   
Sbjct: 173 DY--LPPEMIEGRMHDEKV------DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE 224
Query: 405 LRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNSSN 453
                P    +  + L+ +   ++PS+RP   E++     T N S  SN
Sbjct: 225 F--TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSN 271

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 59/271 (21%), Positives = 122/271 (45%), Gaps = 26/271 (9%)
Query: 187 LNSDNLEFIDQIGPNSFKGVYKGKRVGIEK----------LKGCDKGNAYEFELRKDLLE 236
           + +++L F + +G  +F  ++KG R  +            LK  DK +    E   +   
Sbjct: 5   IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAAS 64
Query: 237 LMT-CGHKNILQFY--CVCVDENHGLCVVTKLMEGGSVNDLILKSRK-LQTKEIIRIAID 292
           +M+   HK+++  Y  C C DEN    +V + ++ GS++  + K++  +     + +A  
Sbjct: 65  MMSKLSHKHLVLNYGVCFCGDEN---ILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQ 121
Query: 293 VAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR--- 349
           +A  + FL ++ + + ++ ++ ILL R  +   G+   +         T    D  +   
Sbjct: 122 LAWAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERI 181
Query: 350 -WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPE 408
            W+ PE I  +P++++    ++ +SFG  +WE+ +G       S + +   +     R +
Sbjct: 182 PWVPPECIE-NPKNLN--LATDKWSFGTTLWEICSG--GDKPLSALDSQRKLQFYEDRHQ 236
Query: 409 IPKDCPQILKSLMIKCWNNSPSKRPQFSEII 439
           +P      L +L+  C +  P  RP F  II
Sbjct: 237 LPAPKAAELANLINNCMDYEPDHRPSFRAII 267

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 77/161 (47%), Gaps = 14/161 (8%)
Query: 288 RIAIDVAEGIKFLNDH-GVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETD 346
           +I +   + +  L ++  + +RD+    ILLDR GN+ L D GI  + + V    +    
Sbjct: 129 KITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGI--SGQLVDSIAKTRDA 186
Query: 347 GYR-WLAPEIIAGDPESVSETW--MSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAAC 403
           G R ++APE I  DP +  + +   S+V+S G+ ++E+ TG   Y   + V   +     
Sbjct: 187 GCRPYMAPERI--DPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVK 244
Query: 404 GLRPEIPKD-----CPQILKSLMIKCWNNSPSKRPQFSEII 439
           G  P++         P  +  + + C     SKRP++ E++
Sbjct: 245 GDPPQLSNSEEREFSPSFINFVNL-CLTKDESKRPKYKELL 284

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 41/159 (25%), Positives = 75/159 (47%), Gaps = 12/159 (7%)
Query: 241 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL 300
           GH+N+L+      +E+    V  K M GGS+   I K R     E   +  DVA  + FL
Sbjct: 69  GHRNVLELIEFFEEEDRFYLVFEK-MRGGSILSHIHKRRHFNELEASVVVQDVASALDFL 127
Query: 301 NDHGVAYRDLNSQRILLDRHGNVC---LGDMGIVTACKSVGEATEYETD-------GYRW 350
           ++ G+A+RDL  + IL +    V    + D G+ +  K  G+ +   T           +
Sbjct: 128 HNKGIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEY 187
Query: 351 LAPEIIAGDPESVS-ETWMSNVYSFGMVIWEMVTGEAAY 388
           +APE++    E  S      +++S G++++ +++G   +
Sbjct: 188 MAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPF 226

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 50/228 (21%), Positives = 95/228 (41%), Gaps = 13/228 (5%)
Query: 227 EFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEI 286
           E +LR+++       H NIL+ Y    D    + ++ +    G+V   + K  K   +  
Sbjct: 56  EHQLRREVEIQSHLRHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRT 114
Query: 287 IRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETD 346
                ++A  + + +   V +RD+  + +LL   G + + D G      S    T   T 
Sbjct: 115 ATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTL 174
Query: 347 GYRWLAPEIIAG--DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG 404
            Y  L PE+I G    E V      +++S G++ +E + G+  + A +  +    I+   
Sbjct: 175 DY--LPPEMIEGRMHDEKV------DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE 226
Query: 405 LRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNSS 452
                P    +  + L+ +   ++PS+RP   E++     T N S  S
Sbjct: 227 F--TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPS 272

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 50/228 (21%), Positives = 95/228 (41%), Gaps = 13/228 (5%)
Query: 227 EFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEI 286
           E +LR+++       H NIL+ Y    D    + ++ +    G+V   + K  K   +  
Sbjct: 51  EHQLRREVEIQSHLRHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRT 109
Query: 287 IRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETD 346
                ++A  + + +   V +RD+  + +LL   G + + D G      S    T   T 
Sbjct: 110 ATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTL 169
Query: 347 GYRWLAPEIIAG--DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG 404
            Y  L PE+I G    E V      +++S G++ +E + G+  + A +  +    I+   
Sbjct: 170 DY--LPPEMIEGRMHDEKV------DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE 221
Query: 405 LRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNSS 452
                P    +  + L+ +   ++PS+RP   E++     T N S  S
Sbjct: 222 F--TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPS 267

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 60/250 (24%), Positives = 106/250 (42%), Gaps = 38/250 (15%)
Query: 162 SSSFVVSVDEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKG----------KR 211
           SSS++V  + ++      EE       ++N +    IG   F  VYKG          KR
Sbjct: 17  SSSYLVPFESYRVPLVDLEEA------TNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKR 70
Query: 212 VGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSV 271
              E  +G ++       L         C H +++     C DE + + ++ K ME G++
Sbjct: 71  RTPESSQGIEEFETEIETLS-------FCRHPHLVSLIGFC-DERNEMILIYKYMENGNL 122
Query: 272 NDLI----LKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGD 327
              +    L +  +  ++ + I I  A G+ +L+   + +RD+ S  ILLD +    + D
Sbjct: 123 KRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITD 182
Query: 328 MGIVTACKSVGEATEYETDGYRWLAPEIIAG-DPESVSE---TWMSNVYSFGMVIWEMVT 383
            GI        + TE +      +    +   DPE   +   T  S+VYSFG+V++E++ 
Sbjct: 183 FGISK------KGTELDQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLC 236
Query: 384 GEAAYAACSP 393
             +A     P
Sbjct: 237 ARSAIVQSLP 246

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 97/209 (46%), Gaps = 18/209 (8%)
Query: 190 DNLEFIDQIGPNSFKGVYKGKRVGIEKLKG--CDKGNAYEFE---LRKDLLELMTCGHKN 244
           D  +F D +G  +F  V   +    +KL    C    A E +   +  ++  L    H N
Sbjct: 18  DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPN 77
Query: 245 ILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHG 304
           I+    +     H L ++ +L+ GG + D I++      ++  R+   V + +K+L+D G
Sbjct: 78  IVALDDIYESGGH-LYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG 136
Query: 305 VAYRDLNSQRIL---LDRHGNVCLGDMGIVTACKSVGE--ATEYETDGYRWLAPEIIAGD 359
           + +RDL  + +L   LD    + + D G+ +  +  G   +T   T GY  +APE++A  
Sbjct: 137 IVHRDLKPENLLYYSLDEDSKIMISDFGL-SKMEDPGSVLSTACGTPGY--VAPEVLAQK 193
Query: 360 PESVSETWMSNVYSFGMVIWEMVTGEAAY 388
           P S +     + +S G++ + ++ G   +
Sbjct: 194 PYSKA----VDCWSIGVIAYILLCGYPPF 218

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 52/217 (23%), Positives = 91/217 (41%), Gaps = 25/217 (11%)
Query: 190 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLK------GCDKGNAYEFELRKDLLEL 237
           +N + +++IG  ++  VYK      G+ V ++K++      G       E  L K+L   
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL--- 59
Query: 238 MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAE 295
               H NI++   V   EN    V   L +   + D +  S    +    I      + +
Sbjct: 60  ---NHPNIVKLLDVIHTENKLYLVFEFLHQ--DLKDFMDASALTGIPLPLIKSYLFQLLQ 114
Query: 296 GIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEI 355
           G+ F + H V +RDL  + +L++  G + L D G+  A         +E     + APEI
Sbjct: 115 GLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEI 174
Query: 356 IAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACS 392
           + G     +     +++S G +  EMVT  A +   S
Sbjct: 175 LLGCKYYSTAV---DIWSLGCIFAEMVTRRALFPGDS 208

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 50/228 (21%), Positives = 95/228 (41%), Gaps = 13/228 (5%)
Query: 227 EFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEI 286
           E +LR+++       H NIL+ Y    D    + ++ +    G+V   + K  K   +  
Sbjct: 52  EHQLRREVEIQSHLRHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRT 110
Query: 287 IRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETD 346
                ++A  + + +   V +RD+  + +LL   G + + D G      S   A    T 
Sbjct: 111 ATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALCGTL 170
Query: 347 GYRWLAPEIIAG--DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG 404
            Y  L PE+I G    E V      +++S G++ +E + G+  + A +  +    I+   
Sbjct: 171 DY--LPPEMIEGRMHDEKV------DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE 222
Query: 405 LRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNSS 452
                P    +  + L+ +   ++PS+RP   E++     T N S  S
Sbjct: 223 F--TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPS 268

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 50/205 (24%), Positives = 96/205 (46%), Gaps = 18/205 (8%)
Query: 190 DNLEFIDQIGPNSFKGVYKGKRVGIEKLKG--CDKGNAYEFE---LRKDLLELMTCGHKN 244
           D  +F D +G  +F  V   +    +KL    C    A E +   +  ++  L    H N
Sbjct: 18  DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPN 77
Query: 245 ILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHG 304
           I+    +     H L ++ +L+ GG + D I++      ++  R+   V + +K+L+D G
Sbjct: 78  IVALDDIYESGGH-LYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG 136
Query: 305 VAYRDLNSQRIL---LDRHGNVCLGDMGIVTACKSVGE--ATEYETDGYRWLAPEIIAGD 359
           + +RDL  + +L   LD    + + D G+ +  +  G   +T   T GY  +APE++A  
Sbjct: 137 IVHRDLKPENLLYYSLDEDSKIMISDFGL-SKMEDPGSVLSTACGTPGY--VAPEVLAQK 193
Query: 360 PESVSETWMSNVYSFGMVIWEMVTG 384
           P S +     + +S G++ + ++ G
Sbjct: 194 PYSKA----VDCWSIGVIAYILLCG 214

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 92/200 (46%), Gaps = 31/200 (15%)
Query: 209 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 263
           G RV ++KL    +   +     ++L  L    H+N++    V      ++E + + +VT
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 106
Query: 264 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 323
            LM G  +N+ I+KS+KL    +  +   +  G+K+++   + +RDL    + ++    +
Sbjct: 107 HLM-GADLNN-IVKSQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDSEL 164
Query: 324 CLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIAGDPESVSETWMS-----NVYSF 374
            + D G+   C+     T+ E  GY   RW  APEI+          WM      +++S 
Sbjct: 165 KILDFGL---CRH----TDDEMTGYVATRWYRAPEIMLN--------WMHYNQTVDIWSV 209
Query: 375 GMVIWEMVTGEAAYAACSPV 394
           G ++ E++TG   +     +
Sbjct: 210 GCIMAELLTGRTLFPGTDHI 229

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 50/205 (24%), Positives = 96/205 (46%), Gaps = 18/205 (8%)
Query: 190 DNLEFIDQIGPNSFKGVYKGKRVGIEKLKG--CDKGNAYEFE---LRKDLLELMTCGHKN 244
           D  +F D +G  +F  V   +    +KL    C    A E +   +  ++  L    H N
Sbjct: 18  DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPN 77
Query: 245 ILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHG 304
           I+    +     H L ++ +L+ GG + D I++      ++  R+   V + +K+L+D G
Sbjct: 78  IVALDDIYESGGH-LYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG 136
Query: 305 VAYRDLNSQRIL---LDRHGNVCLGDMGIVTACKSVGE--ATEYETDGYRWLAPEIIAGD 359
           + +RDL  + +L   LD    + + D G+ +  +  G   +T   T GY  +APE++A  
Sbjct: 137 IVHRDLKPENLLYYSLDEDSKIMISDFGL-SKMEDPGSVLSTACGTPGY--VAPEVLAQK 193
Query: 360 PESVSETWMSNVYSFGMVIWEMVTG 384
           P S +     + +S G++ + ++ G
Sbjct: 194 PYSKA----VDCWSIGVIAYILLCG 214

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 58/265 (21%), Positives = 108/265 (40%), Gaps = 22/265 (8%)
Query: 184 RWLLNSDNLEFIDQIGPNSFKGVYKGK---RVGIEKLKGCDKGN----AYEFELRKDLLE 236
           +W L  ++ E    +G   F  VY  +   R  I  LK   K        E +LR+++  
Sbjct: 1   QWAL--EDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEI 58
Query: 237 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEG 296
                H NIL+ Y    D    + ++ +    G+V   + K  K   +       ++A  
Sbjct: 59  QSHLRHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 117
Query: 297 IKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEII 356
           + + +   V +RD+  + +LL   G + + D G      S    T   T  Y  L PE+I
Sbjct: 118 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDY--LPPEMI 175
Query: 357 AG--DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCP 414
            G    E V      +++S G++ +E + G+  + A +  +    I+        P    
Sbjct: 176 EGRMHDEKV------DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF--TFPDFVT 227
Query: 415 QILKSLMIKCWNNSPSKRPQFSEII 439
           +  + L+ +   ++PS+RP   E++
Sbjct: 228 EGARDLISRLLKHNPSQRPMLREVL 252

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 38/167 (22%), Positives = 78/167 (46%), Gaps = 6/167 (3%)
Query: 222 KGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKL 281
           K +     + +++  L    H +I++ Y V       + V+     GG + D I++ +++
Sbjct: 48  KKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIE--YAGGELFDYIVEKKRM 105
Query: 282 QTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT 341
              E  R    +   I++ + H + +RDL  + +LLD + NV + D G+ +   + G   
Sbjct: 106 TEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGL-SNIMTDGNFL 164
Query: 342 EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAY 388
           +       + APE+I G   +  E    +V+S G+V++ M+ G   +
Sbjct: 165 KTSCGSPNYAAPEVINGKLYAGPEV---DVWSCGIVLYVMLVGRLPF 208

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 49/213 (23%), Positives = 94/213 (44%), Gaps = 34/213 (15%)
Query: 190 DNLEFIDQIGPNSFKGVYKGKRVGIEKLKG--CDKGNAYEFE---LRKDLLELMTCGHKN 244
           D  +F D +G  +F  V   +    +KL    C    A E +   +  ++  L    H N
Sbjct: 18  DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPN 77
Query: 245 ILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHG 304
           I+    +     H L ++ +L+ GG + D I++      ++  R+   V + +K+L+D G
Sbjct: 78  IVALDDIYESGGH-LYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG 136
Query: 305 VAYRDLNSQRIL---LDRHGNVCLGDMG----------IVTACKSVGEATEYETDGYRWL 351
           + +RDL  + +L   LD    + + D G          + TAC + G           ++
Sbjct: 137 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPG-----------YV 185
Query: 352 APEIIAGDPESVSETWMSNVYSFGMVIWEMVTG 384
           APE++A  P S +     + +S G++ + ++ G
Sbjct: 186 APEVLAQKPYSKA----VDCWSIGVIAYILLCG 214

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 50/228 (21%), Positives = 94/228 (41%), Gaps = 13/228 (5%)
Query: 227 EFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEI 286
           E +LR+++       H NIL+ Y    D    + ++ +    G+V   + K  K   +  
Sbjct: 52  EHQLRREVEIQSHLRHPNILRLYGYFHDSTR-VYLILEYAPLGTVYRELQKLSKFDEQRT 110
Query: 287 IRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETD 346
                ++A  + + +   V +RD+  + +LL   G + + D G      S   A    T 
Sbjct: 111 ATYITELANALSYCHSKKVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALCGTL 170
Query: 347 GYRWLAPEIIAG--DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG 404
            Y  L PE+I G    E V      +++S G++ +E + G+  + A +       I+   
Sbjct: 171 DY--LPPEMIEGRMHDEKV------DLWSLGVLCYEFLVGKPPFEANTYQDTYKRISRVE 222
Query: 405 LRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNSS 452
                P    +  + L+ +   ++PS+RP   E++     T N S  S
Sbjct: 223 F--TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPS 268

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 38/157 (24%), Positives = 73/157 (46%), Gaps = 7/157 (4%)
Query: 288 RIAIDVAEGIKFLND-HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETD 346
           ++ + + + + +L + HGV +RD+    ILLD  G + L D GI  + + V +  +  + 
Sbjct: 128 KMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGI--SGRLVDDKAKDRSA 185
Query: 347 G-YRWLAPEII-AGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG 404
           G   ++APE I   DP        ++V+S G+ + E+ TG+  Y  C      +      
Sbjct: 186 GCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQE 245
Query: 405 LRPEIPKDC--PQILKSLMIKCWNNSPSKRPQFSEII 439
             P +P         +S +  C      KRP++++++
Sbjct: 246 EPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLL 282

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 36/174 (20%), Positives = 73/174 (41%), Gaps = 6/174 (3%)
Query: 259 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLD 318
           LC V +   GG +   + + R    +       ++   +++L+   V YRD+  + ++LD
Sbjct: 80  LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLD 139
Query: 319 RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVI 378
           + G++ + D G+     S G   +       +LAPE++  +    +  W    +  G+V+
Sbjct: 140 KDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYGRAVDW----WGLGVVM 195
Query: 379 WEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKR 432
           +EM+ G   +      +    I    +R   P+      KSL+       P +R
Sbjct: 196 YEMMCGRLPFYNQDHERLFELILMEEIR--FPRTLSPEAKSLLAGLLKKDPKQR 247

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/202 (23%), Positives = 97/202 (48%), Gaps = 14/202 (6%)
Query: 194 FIDQIGPNSFKGVY--KGKRVG-IEKLKGCDKGNAY-EFELRKDLLELMTCGHKNILQFY 249
           F++ +G  +F  V+  K +  G +  LK   K  A+ +  L  ++  L    H+NI+   
Sbjct: 13  FMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLE 72
Query: 250 CVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRD 309
            +     H   +V +L+ GG + D IL+      K+   +   V   +K+L+++G+ +RD
Sbjct: 73  DIYESTTH-YYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRD 131
Query: 310 LNSQRILL---DRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSET 366
           L  + +L    + +  + + D G+    ++   +T   T GY  +APE++A  P S +  
Sbjct: 132 LKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGTPGY--VAPEVLAQKPYSKA-- 187
Query: 367 WMSNVYSFGMVIWEMVTGEAAY 388
              + +S G++ + ++ G   +
Sbjct: 188 --VDCWSIGVITYILLCGYPPF 207

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 36/174 (20%), Positives = 73/174 (41%), Gaps = 6/174 (3%)
Query: 259 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLD 318
           LC V +   GG +   + + R    +       ++   +++L+   V YRD+  + ++LD
Sbjct: 80  LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLD 139
Query: 319 RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVI 378
           + G++ + D G+     S G   +       +LAPE++  +    +  W    +  G+V+
Sbjct: 140 KDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYGRAVDW----WGLGVVM 195
Query: 379 WEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKR 432
           +EM+ G   +      +    I    +R   P+      KSL+       P +R
Sbjct: 196 YEMMCGRLPFYNQDHERLFELILMEEIR--FPRTLSPEAKSLLAGLLKKDPKQR 247

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 36/174 (20%), Positives = 73/174 (41%), Gaps = 6/174 (3%)
Query: 259 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLD 318
           LC V +   GG +   + + R    +       ++   +++L+   V YRD+  + ++LD
Sbjct: 80  LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLD 139
Query: 319 RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVI 378
           + G++ + D G+     S G   +       +LAPE++  +    +  W    +  G+V+
Sbjct: 140 KDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYGRAVDW----WGLGVVM 195
Query: 379 WEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKR 432
           +EM+ G   +      +    I    +R   P+      KSL+       P +R
Sbjct: 196 YEMMCGRLPFYNQDHERLFELILMEEIR--FPRTLSPEAKSLLAGLLKKDPKQR 247

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 36/174 (20%), Positives = 73/174 (41%), Gaps = 6/174 (3%)
Query: 259 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLD 318
           LC V +   GG +   + + R    +       ++   +++L+   V YRD+  + ++LD
Sbjct: 85  LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLD 144
Query: 319 RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVI 378
           + G++ + D G+     S G   +       +LAPE++  +    +  W    +  G+V+
Sbjct: 145 KDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYGRAVDW----WGLGVVM 200
Query: 379 WEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKR 432
           +EM+ G   +      +    I    +R   P+      KSL+       P +R
Sbjct: 201 YEMMCGRLPFYNQDHERLFELILMEEIR--FPRTLSPEAKSLLAGLLKKDPKQR 252

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 46/215 (21%), Positives = 91/215 (42%), Gaps = 13/215 (6%)
Query: 227 EFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEI 286
           E +LR+++       H NIL+ Y    D    + ++ +    G+V   + K  K   +  
Sbjct: 55  EHQLRREVEIQSHLRHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRT 113
Query: 287 IRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETD 346
                ++A  + + +   V +RD+  + +LL   G + + D G      S    T   T 
Sbjct: 114 ATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTL 173
Query: 347 GYRWLAPEIIAG--DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG 404
            Y  L PE+I G    E V      +++S G++ +E + G+  + A +  +    I+   
Sbjct: 174 DY--LPPEMIEGRMHDEKV------DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE 225
Query: 405 LRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEII 439
                P    +  + L+ +   ++PS+RP   E++
Sbjct: 226 F--TFPDFVTEGARDLISRLLKHNPSQRPMLREVL 258

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 34/160 (21%), Positives = 76/160 (47%), Gaps = 5/160 (3%)
Query: 229 ELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIR 288
           +L +++  +    H NI++ + V ++    L +V +   GG V D ++   +++ KE   
Sbjct: 60  KLFREVRIMKILNHPNIVKLFEV-IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARA 118
Query: 289 IAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY 348
               +   +++ +   + +RDL ++ +LLD   N+ + D G      +VG   +      
Sbjct: 119 KFRQIVSAVQYCHQKYIVHRDLKAENLLLDGDMNIKIADFGFSNEF-TVGNKLDTFCGSP 177
Query: 349 RWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAY 388
            + APE+  G      E    +V+S G++++ +V+G   +
Sbjct: 178 PYAAPELFQGKKYDGPEV---DVWSLGVILYTLVSGSLPF 214

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/233 (19%), Positives = 107/233 (45%), Gaps = 15/233 (6%)
Query: 207 YKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLM 266
           Y  K +   +L    +G + E E+ +++  L    H NI+  + +  ++   + ++ +L+
Sbjct: 40  YAAKFIKKRRLSSSRRGVSRE-EIEREVNILREIRHPNIITLHDIFENKT-DVVLILELV 97
Query: 267 EGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRI-LLDR---HGN 322
            GG + D + +   L   E  +    + +G+ +L+   +A+ DL  + I LLD+   +  
Sbjct: 98  SGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPR 157
Query: 323 VCLGDMGIVTACKSVGEATE-YETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEM 381
           + L D GI    ++  E    + T    ++APEI+  +P  +     ++++S G++ + +
Sbjct: 158 IKLIDFGIAHKIEAGNEFKNIFGTP--EFVAPEIVNYEPLGLE----ADMWSIGVITYIL 211
Query: 382 VTGEAAYAACSPVQAAVGIAACG--LRPEIPKDCPQILKSLMIKCWNNSPSKR 432
           ++G + +   +  +    I+A       E   +  ++ K  + +     P +R
Sbjct: 212 LSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRR 264

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 84/198 (42%), Gaps = 24/198 (12%)
Query: 193 EFIDQIGPNSFKGVYKGKR------VGIEKLKGCDKGNAYEFELRKDLLE---LMTCGHK 243
           E +D +G   F  VYK +       V I+K+K   +  A +   R  L E   L    H 
Sbjct: 13  EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 72
Query: 244 NILQFYCVCVDENHGLCVVTKLMEGGSVNDLILK--SRKLQTKEIIRIAIDVAEGIKFLN 301
           NI+            + +V   ME     ++I+K  S  L    I    +   +G+++L+
Sbjct: 73  NIIGL-LDAFGHKSNISLVFDFMETDL--EVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH 129
Query: 302 DHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPE 361
            H + +RDL    +LLD +G + L D G+  +  S   A  ++     + APE++ G   
Sbjct: 130 QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVVTRWYRAPELLFG--- 186
Query: 362 SVSETWMSNVYSFGMVIW 379
                  + +Y  G+ +W
Sbjct: 187 -------ARMYGVGVDMW 197

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 37/152 (24%), Positives = 72/152 (47%), Gaps = 9/152 (5%)
Query: 242 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 301
           H NI+    V  D+   + VVT+L +GG + D IL+ +    +E   +   + + +++L+
Sbjct: 75  HPNIITLKDV-YDDGKYVYVVTELXKGGELLDKILRQKFFSEREASAVLFTITKTVEYLH 133
Query: 302 DHGVAYRDLNSQRIL-LDRHGN---VCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIA 357
             GV +RDL    IL +D  GN   + + D G     ++             ++APE++ 
Sbjct: 134 AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTPCYTANFVAPEVL- 192
Query: 358 GDPESVSETWMSNVYSFGMVIWEMVTGEAAYA 389
              E        +++S G++++  +TG   +A
Sbjct: 193 ---ERQGYDAACDIWSLGVLLYTXLTGYTPFA 221

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 36/174 (20%), Positives = 73/174 (41%), Gaps = 6/174 (3%)
Query: 259 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLD 318
           LC V +   GG +   + + R    +       ++   +++L+   V YRD+  + ++LD
Sbjct: 80  LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLD 139
Query: 319 RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVI 378
           + G++ + D G+     S G   +       +LAPE++  +    +  W    +  G+V+
Sbjct: 140 KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDW----WGLGVVM 195
Query: 379 WEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKR 432
           +EM+ G   +      +    I    +R   P+      KSL+       P +R
Sbjct: 196 YEMMCGRLPFYNQDHERLFELILMEEIR--FPRTLSPEAKSLLAGLLKKDPKQR 247

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 36/174 (20%), Positives = 73/174 (41%), Gaps = 6/174 (3%)
Query: 259 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLD 318
           LC V +   GG +   + + R    +       ++   +++L+   V YRD+  + ++LD
Sbjct: 80  LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLD 139
Query: 319 RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVI 378
           + G++ + D G+     S G   +       +LAPE++  +    +  W    +  G+V+
Sbjct: 140 KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDW----WGLGVVM 195
Query: 379 WEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKR 432
           +EM+ G   +      +    I    +R   P+      KSL+       P +R
Sbjct: 196 YEMMCGRLPFYNQDHERLFELILMEEIR--FPRTLSPEAKSLLAGLLKKDPKQR 247

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/261 (19%), Positives = 117/261 (44%), Gaps = 26/261 (9%)
Query: 190 DNLEFIDQIGPNSF--------KGV---YKGKRVGIEKLKGCDKGNAYEFELRKDLLELM 238
           D+ E  +++G   F        KG    Y  K +   +L    +G + E E+ +++  L 
Sbjct: 5   DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSRE-EIEREVNILR 63
Query: 239 TCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIK 298
              H NI+  + +  ++   + ++ +L+ GG + D + +   L   E  +    + +G+ 
Sbjct: 64  EIRHPNIITLHDIFENKT-DVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVH 122
Query: 299 FLNDHGVAYRDLNSQRI-LLDR---HGNVCLGDMGIVTACKSVGEATE-YETDGYRWLAP 353
           +L+   +A+ DL  + I LLD+   +  + L D GI    ++  E    + T    ++AP
Sbjct: 123 YLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTP--EFVAP 180
Query: 354 EIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG--LRPEIPK 411
           EI+  +P  +     ++++S G++ + +++G + +   +  +    I+A       E   
Sbjct: 181 EIVNYEPLGLE----ADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFS 236
Query: 412 DCPQILKSLMIKCWNNSPSKR 432
           +  ++ K  + +     P +R
Sbjct: 237 NTSELAKDFIRRLLVKDPKRR 257

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/279 (18%), Positives = 111/279 (39%), Gaps = 35/279 (12%)
Query: 186 LLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELM---TCGH 242
           L  + + E I  +G  +F  V K +     +     K    E +L   L E+M   +  H
Sbjct: 2   LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNH 61
Query: 243 KNILQFYC------------VCVDENHGLCVVTKLMEGGSVNDLILKSRKL--QTKEIIR 288
           + ++++Y               V +   L +  +  E G++ DLI  S  L  Q  E  R
Sbjct: 62  QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI-HSENLNQQRDEYWR 120
Query: 289 IAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY 348
           +   + E + +++  G+ +RDL    I +D   NV +GD G+        +  + ++   
Sbjct: 121 LFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180
Query: 349 --------------RWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPV 394
                          ++A E++ G      +    ++YS G++ +EM+   +       +
Sbjct: 181 PGSSDNLTSAIGTAMYVATEVLDGTGHYNEKI---DMYSLGIIFFEMIYPFSTGMERVNI 237
Query: 395 QAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRP 433
              +   +    P+   +  ++ K ++    ++ P+KRP
Sbjct: 238 LKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRP 276

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 36/174 (20%), Positives = 73/174 (41%), Gaps = 6/174 (3%)
Query: 259 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLD 318
           LC V +   GG +   + + R    +       ++   +++L+   V YRD+  + ++LD
Sbjct: 83  LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLD 142
Query: 319 RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVI 378
           + G++ + D G+     S G   +       +LAPE++  +    +  W    +  G+V+
Sbjct: 143 KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDW----WGLGVVM 198
Query: 379 WEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKR 432
           +EM+ G   +      +    I    +R   P+      KSL+       P +R
Sbjct: 199 YEMMCGRLPFYNQDHERLFELILMEEIR--FPRTLSPEAKSLLAGLLKKDPKQR 250

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/165 (19%), Positives = 79/165 (47%), Gaps = 7/165 (4%)
Query: 277 KSRKLQTKEIIRIAI-DVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK 335
           K RK  T+   R  +    +G+++L+++ V +RDL    + L+   +V +GD G+ T  +
Sbjct: 134 KRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIE 193
Query: 336 SVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQ 395
             GE  +       ++APE++         ++  +++S G +++ ++ G+  +      +
Sbjct: 194 FDGERKKXLCGTPNYIAPEVLCKK----GHSFEVDIWSLGCILYTLLVGKPPFETSCLKE 249
Query: 396 AAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIIS 440
             + I        +P+    +  +L+ +  +  P+ RP  +E+++
Sbjct: 250 TYIRIKKNEY--SVPRHINPVASALIRRMLHADPTLRPSVAELLT 292

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 54/276 (19%), Positives = 122/276 (44%), Gaps = 26/276 (9%)
Query: 175 VQSGGEEIGRWLLNSDNLEFIDQIGPNSF--------KGV---YKGKRVGIEKLKGCDKG 223
           V  G E +    +  D+ E  +++G   F        KG    Y  K +   +L    +G
Sbjct: 11  VDLGTENLYFQSMVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRG 70
Query: 224 NAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQT 283
            + E E+ +++  L    H NI+  + +  ++   + ++ +L+ GG + D + +   L  
Sbjct: 71  VSRE-EIEREVNILREIRHPNIITLHDIFENKT-DVVLILELVSGGELFDFLAEKESLTE 128
Query: 284 KEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRI-LLDR---HGNVCLGDMGIVTACKSVGE 339
            E  +    + +G+ +L+   +A+ DL  + I LLD+   +  + L D GI    ++  E
Sbjct: 129 DEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE 188
Query: 340 ATE-YETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAV 398
               + T    ++APEI+  +P  +     ++++S G++ + +++G + +   +  +   
Sbjct: 189 FKNIFGTP--EFVAPEIVNYEPLGLE----ADMWSIGVITYILLSGASPFLGETKQETLT 242
Query: 399 GIAACG--LRPEIPKDCPQILKSLMIKCWNNSPSKR 432
            I+A       E   +  ++ K  + +     P +R
Sbjct: 243 NISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRR 278

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 49/228 (21%), Positives = 94/228 (41%), Gaps = 13/228 (5%)
Query: 227 EFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEI 286
           E +LR+++       H NIL+ Y    D    + ++ +    G+V   + K  K   +  
Sbjct: 52  EHQLRREVEIQSHLRHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRT 110
Query: 287 IRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETD 346
                ++A  + + +   V +RD+  + +LL   G + + D G      S        T 
Sbjct: 111 ATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTXLCGTL 170
Query: 347 GYRWLAPEIIAG--DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG 404
            Y  L PE+I G    E V      +++S G++ +E + G+  + A +  +    I+   
Sbjct: 171 DY--LPPEMIEGRMHDEKV------DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE 222
Query: 405 LRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNSS 452
                P    +  + L+ +   ++PS+RP   E++     T N S  S
Sbjct: 223 F--TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPS 268

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/165 (19%), Positives = 79/165 (47%), Gaps = 7/165 (4%)
Query: 277 KSRKLQTKEIIRIAI-DVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK 335
           K RK  T+   R  +    +G+++L+++ V +RDL    + L+   +V +GD G+ T  +
Sbjct: 134 KRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIE 193
Query: 336 SVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQ 395
             GE  +       ++APE++         ++  +++S G +++ ++ G+  +      +
Sbjct: 194 FDGERKKTLCGTPNYIAPEVLCKK----GHSFEVDIWSLGCILYTLLVGKPPFETSCLKE 249
Query: 396 AAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIIS 440
             + I        +P+    +  +L+ +  +  P+ RP  +E+++
Sbjct: 250 TYIRIKKNEY--SVPRHINPVASALIRRMLHADPTLRPSVAELLT 292

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/165 (19%), Positives = 79/165 (47%), Gaps = 7/165 (4%)
Query: 277 KSRKLQTKEIIRIAI-DVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK 335
           K RK  T+   R  +    +G+++L+++ V +RDL    + L+   +V +GD G+ T  +
Sbjct: 118 KRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIE 177
Query: 336 SVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQ 395
             GE  +       ++APE++         ++  +++S G +++ ++ G+  +      +
Sbjct: 178 FDGERKKDLCGTPNYIAPEVLCKK----GHSFEVDIWSLGCILYTLLVGKPPFETSCLKE 233
Query: 396 AAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIIS 440
             + I        +P+    +  +L+ +  +  P+ RP  +E+++
Sbjct: 234 TYIRIKKNEY--SVPRHINPVASALIRRMLHADPTLRPSVAELLT 276

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 44/163 (26%), Positives = 77/163 (47%), Gaps = 27/163 (16%)
Query: 245 ILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL------KSRKLQTKEIIRIAIDVAEGIK 298
           ++Q +C   D+ + L +V + M GG + +L+       K  K  T E++ +A+D    + 
Sbjct: 137 VVQLFCAFQDDKY-LYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVV-LALDAIHSM- 193
Query: 299 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA---TEYETDGYRWLAPEI 355
                G+ +RD+    +LLD+HG++ L D G        G     T   T  Y  ++PE+
Sbjct: 194 -----GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAVGTPDY--ISPEV 246
Query: 356 I---AGDPESVSE-TWMSNVYSFGMVIWEMVTGEAAYAACSPV 394
           +    GD     E  W    +S G+ ++EM+ G+  + A S V
Sbjct: 247 LKSQGGDGYYGRECDW----WSVGVFLFEMLVGDTPFYADSLV 285

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/245 (23%), Positives = 103/245 (42%), Gaps = 24/245 (9%)
Query: 204 KGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTC---GHKNILQFYCVCVDENHGLC 260
           K + K   V I    GC  G  Y+ E   D LE         KN  +    C      L 
Sbjct: 57  KALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKC------LF 110
Query: 261 VVTKLMEGGSVNDLILKSRKLQTKEIIRIAI--DVAEGIKFLNDHGVAYRDLNSQRILLD 318
           +  +  + G++   I K R  +  +++ + +   + +G+ +++   + +RDL    I L 
Sbjct: 111 IQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLV 170
Query: 319 RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVI 378
               V +GD G+VT+ K+ G+ T  +    R+++PE I+    S       ++Y+ G+++
Sbjct: 171 DTKQVKIGDFGLVTSLKNDGKRTRSKG-TLRYMSPEQIS----SQDYGKEVDLYALGLIL 225
Query: 379 WEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDC-PQILKSLMIKCWNNSPSKRPQFSE 437
            E++        C             LR  I  D   +  K+L+ K  +  P  RP  SE
Sbjct: 226 AELL------HVCDTAFETSKFFT-DLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSE 278
Query: 438 IISLL 442
           I+  L
Sbjct: 279 ILRTL 283

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/228 (21%), Positives = 94/228 (41%), Gaps = 13/228 (5%)
Query: 227 EFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEI 286
           E +LR+++       H NIL+ Y    D    + ++ +    G+V   + K  K   +  
Sbjct: 52  EHQLRREVEIQSHLRHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRT 110
Query: 287 IRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETD 346
                ++A  + + +   V +RD+  + +LL   G + + D G      S        T 
Sbjct: 111 ATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLCGTL 170
Query: 347 GYRWLAPEIIAG--DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG 404
            Y  L PE+I G    E V      +++S G++ +E + G+  + A +  +    I+   
Sbjct: 171 DY--LPPEMIEGRMHDEKV------DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE 222
Query: 405 LRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNSS 452
                P    +  + L+ +   ++PS+RP   E++     T N S  S
Sbjct: 223 F--TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPS 268

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 77/162 (47%), Gaps = 18/162 (11%)
Query: 241 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL 300
           GH+N+L+      +E+    V  K M GGS+   I K R     E   +  DVA  + FL
Sbjct: 69  GHRNVLELIEFFEEEDRFYLVFEK-MRGGSILSHIHKRRHFNELEASVVVQDVASALDFL 127
Query: 301 NDHGVAYRDLNSQRILLDRHGN------VCLGDMGIVTACKSVGEATEYETD-------G 347
           ++ G+A+RDL  + IL + H N      +C  D+G  +  K  G+ +   T         
Sbjct: 128 HNKGIAHRDLKPENILCE-HPNQVSPVKICDFDLG--SGIKLNGDCSPISTPELLTPCGS 184
Query: 348 YRWLAPEIIAGDPESVS-ETWMSNVYSFGMVIWEMVTGEAAY 388
             ++APE++    E  S      +++S G++++ +++G   +
Sbjct: 185 AEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPF 226

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/184 (22%), Positives = 82/184 (44%), Gaps = 19/184 (10%)
Query: 204 KGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT 263
           KG Y      IEK         +  E+  ++  L +  H NI++ + V  D+ +   +VT
Sbjct: 76  KGRYSDDNKNIEK---------FHEEIYNEISLLKSLDHPNIIKLFDVFEDKKY-FYLVT 125
Query: 264 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG-- 321
           +  EGG + + I+   K    +   I   +  GI +L+ H + +RD+  + ILL+     
Sbjct: 126 EFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSL 185
Query: 322 -NVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWE 380
            N+ + D G+ +      +  +     Y ++APE++        + W     S G++++ 
Sbjct: 186 LNIKIVDFGLSSFFSKDYKLRDRLGTAY-YIAPEVLKKKYNEKCDVW-----SCGVIMYI 239
Query: 381 MVTG 384
           ++ G
Sbjct: 240 LLCG 243

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 32/165 (19%), Positives = 79/165 (47%), Gaps = 7/165 (4%)
Query: 277 KSRKLQTKEIIRIAI-DVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK 335
           K RK  T+   R  +    +G+++L+++ V +RDL    + L+   +V +GD G+ T  +
Sbjct: 134 KRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIE 193
Query: 336 SVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQ 395
             GE  +       ++APE++         ++  +++S G +++ ++ G+  +      +
Sbjct: 194 FDGERKKDLCGTPNYIAPEVLCKK----GHSFEVDIWSLGCILYTLLVGKPPFETSCLKE 249
Query: 396 AAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIIS 440
             + I        +P+    +  +L+ +  +  P+ RP  +E+++
Sbjct: 250 TYIRIKKNEY--SVPRHINPVASALIRRMLHADPTLRPSVAELLT 292

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 45/200 (22%), Positives = 89/200 (44%), Gaps = 31/200 (15%)
Query: 209 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 263
           G RV ++KL    +   +     ++L  L    H+N++    V      ++E + + +VT
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 106
Query: 264 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 323
            LM G  +N+ I+K +KL    +  +   +  G+K+++   + +RDL    + ++    +
Sbjct: 107 HLM-GADLNN-IVKXQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDXEL 164
Query: 324 CLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIAGDPESVSETWMS-----NVYSF 374
            + D G+          T+ E  GY   RW  APEI+          WM      +++S 
Sbjct: 165 KILDFGL-------ARHTDDEMTGYVATRWYRAPEIMLN--------WMHYNQTVDIWSV 209
Query: 375 GMVIWEMVTGEAAYAACSPV 394
           G ++ E++TG   +     +
Sbjct: 210 GCIMAELLTGRTLFPGTDHI 229

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 49/228 (21%), Positives = 94/228 (41%), Gaps = 13/228 (5%)
Query: 227 EFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEI 286
           E +LR+++       H NIL+ Y    D    + ++ +    G+V   + K  K   +  
Sbjct: 55  EHQLRREVEIQSHLRHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRT 113
Query: 287 IRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETD 346
                ++A  + + +   V +RD+  + +LL   G + + D G      S        T 
Sbjct: 114 ATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDLCGTL 173
Query: 347 GYRWLAPEIIAG--DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG 404
            Y  L PE+I G    E V      +++S G++ +E + G+  + A +  +    I+   
Sbjct: 174 DY--LPPEMIEGRMHDEKV------DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE 225
Query: 405 LRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNSS 452
                P    +  + L+ +   ++PS+RP   E++     T N S  S
Sbjct: 226 F--TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPS 271

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 42/187 (22%), Positives = 89/187 (47%), Gaps = 22/187 (11%)
Query: 259 LCVVTKLMEGGSVNDLILK--SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRIL 316
           + ++ +   GG +  L L   +  +   ++IR+   + EG+ +L+ + + + DL  Q IL
Sbjct: 104 IILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNIL 163
Query: 317 LDRHGNVCLGDMGIVT--ACKSVGEATEY-ETDGY-RWLAPEIIAGDPESVSETWMSNVY 372
           L       LGD+ IV     + +G A E  E  G   +LAPEI+  DP + +    ++++
Sbjct: 164 LS--SIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTA----TDMW 217
Query: 373 SFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR------PEIPKDCPQILKSLMIKCWN 426
           + G++ + ++T  + +      +  + I+   +         + +     ++SL++K   
Sbjct: 218 NIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVK--- 274
Query: 427 NSPSKRP 433
            +P KRP
Sbjct: 275 -NPEKRP 280

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 45/200 (22%), Positives = 89/200 (44%), Gaps = 31/200 (15%)
Query: 209 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 263
           G RV ++KL    +   +     ++L  L    H+N++    V      ++E + + +VT
Sbjct: 53  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 112
Query: 264 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 323
            LM G  +N+ I+K +KL    +  +   +  G+K+++   + +RDL    + ++    +
Sbjct: 113 HLM-GADLNN-IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDSEL 170
Query: 324 CLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIAGDPESVSETWMS-----NVYSF 374
            + D G+          T+ E  GY   RW  APEI+          WM      +++S 
Sbjct: 171 KILDFGL-------ARHTDDEMTGYVATRWYRAPEIMLN--------WMHYNQTVDIWSV 215
Query: 375 GMVIWEMVTGEAAYAACSPV 394
           G ++ E++TG   +     +
Sbjct: 216 GCIMAELLTGRTLFPGTDHI 235

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 45/200 (22%), Positives = 89/200 (44%), Gaps = 31/200 (15%)
Query: 209 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 263
           G RV ++KL    +   +     ++L  L    H+N++    V      ++E + + +VT
Sbjct: 49  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 108
Query: 264 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 323
            LM G  +N+ I+K +KL    +  +   +  G+K+++   + +RDL    + ++    +
Sbjct: 109 HLM-GADLNN-IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDSEL 166
Query: 324 CLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIAGDPESVSETWMS-----NVYSF 374
            + D G+          T+ E  GY   RW  APEI+          WM      +++S 
Sbjct: 167 KILDFGL-------ARHTDDEMTGYVATRWYRAPEIMLN--------WMHYNQTVDIWSV 211
Query: 375 GMVIWEMVTGEAAYAACSPV 394
           G ++ E++TG   +     +
Sbjct: 212 GCIMAELLTGRTLFPGTDHI 231

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 59/264 (22%), Positives = 109/264 (41%), Gaps = 21/264 (7%)
Query: 187 LNSDNLEFIDQIGPNSFKGV---YKGKRVGIEKLKGCDKGNAYEF-ELR---KDLLELMT 239
           +N D+ E +  IG  SF  V    K     +  +K  +K    E  E+R   K+L  +  
Sbjct: 12  VNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQG 71
Query: 240 CGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKF 299
             H  ++  +    DE   + +V  L+ GG +   + ++   + + +     ++   + +
Sbjct: 72  LEHPFLVNLWYSFQDEE-DMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDY 130
Query: 300 LNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE-TDGYRWLAPEIIA- 357
           L +  + +RD+    ILLD HG+V + D  I        + T    T  Y  +APE+ + 
Sbjct: 131 LQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPY--MAPEMFSS 188
Query: 358 --GDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR-PEIPKDCP 414
             G   S +  W    +S G+  +E++ G   Y   S   +   +          P    
Sbjct: 189 RKGAGYSFAVDW----WSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWS 244
Query: 415 QILKSLMIKCWNNSPSKRPQFSEI 438
           Q + SL+ K    +P +R  FS++
Sbjct: 245 QEMVSLLKKLLEPNPDQR--FSQL 266

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 42/203 (20%), Positives = 89/203 (43%), Gaps = 9/203 (4%)
Query: 195 IDQIGPNSFKGVYK-----GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFY 249
           +++IG  ++  VYK     G+   ++K++   +         +++  L    H NI++ Y
Sbjct: 7   LEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLY 66
Query: 250 CVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRD 309
            V +     L +V + ++      L +    L++       + +  GI + +D  V +RD
Sbjct: 67  DV-IHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRD 125
Query: 310 LNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMS 369
           L  Q +L++R G + + D G+  A         +E     + AP+++ G  +  +     
Sbjct: 126 LKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKKYSTTI--- 182
Query: 370 NVYSFGMVIWEMVTGEAAYAACS 392
           +++S G +  EMV G   +   S
Sbjct: 183 DIWSVGCIFAEMVNGTPLFPGVS 205

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 42/203 (20%), Positives = 89/203 (43%), Gaps = 9/203 (4%)
Query: 195 IDQIGPNSFKGVYK-----GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFY 249
           +++IG  ++  VYK     G+   ++K++   +         +++  L    H NI++ Y
Sbjct: 7   LEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLY 66
Query: 250 CVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRD 309
            V +     L +V + ++      L +    L++       + +  GI + +D  V +RD
Sbjct: 67  DV-IHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRD 125
Query: 310 LNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMS 369
           L  Q +L++R G + + D G+  A         +E     + AP+++ G  +  +     
Sbjct: 126 LKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKKYSTTI--- 182
Query: 370 NVYSFGMVIWEMVTGEAAYAACS 392
           +++S G +  EMV G   +   S
Sbjct: 183 DIWSVGCIFAEMVNGAPLFPGVS 205

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 45/200 (22%), Positives = 89/200 (44%), Gaps = 31/200 (15%)
Query: 209 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 263
           G RV ++KL    +   +     ++L  L    H+N++    V      ++E + + +VT
Sbjct: 52  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 111
Query: 264 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 323
            LM G  +N+ I+K +KL    +  +   +  G+K+++   + +RDL    + ++    +
Sbjct: 112 HLM-GADLNN-IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDXEL 169
Query: 324 CLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIAGDPESVSETWMS-----NVYSF 374
            + D G+          T+ E  GY   RW  APEI+          WM      +++S 
Sbjct: 170 KILDFGL-------ARHTDDEMTGYVATRWYRAPEIMLN--------WMHYNQTVDIWSV 214
Query: 375 GMVIWEMVTGEAAYAACSPV 394
           G ++ E++TG   +     +
Sbjct: 215 GCIMAELLTGRTLFPGTDHI 234

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 45/200 (22%), Positives = 89/200 (44%), Gaps = 31/200 (15%)
Query: 209 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 263
           G RV ++KL    +   +     ++L  L    H+N++    V      ++E + + +VT
Sbjct: 47  GHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 106
Query: 264 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 323
            LM G  +N+ I+K +KL    +  +   +  G+K+++   + +RDL    + ++    +
Sbjct: 107 HLM-GADLNN-IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL 164
Query: 324 CLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIAGDPESVSETWMS-----NVYSF 374
            + D G+          T+ E  GY   RW  APEI+          WM      +++S 
Sbjct: 165 KILDFGL-------ARHTDDEMTGYVATRWYRAPEIMLN--------WMHYNQTVDIWSV 209
Query: 375 GMVIWEMVTGEAAYAACSPV 394
           G ++ E++TG   +     +
Sbjct: 210 GCIMAELLTGRTLFPGTDHI 229

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 45/200 (22%), Positives = 89/200 (44%), Gaps = 31/200 (15%)
Query: 209 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 263
           G RV ++KL    +   +     ++L  L    H+N++    V      ++E + + +VT
Sbjct: 52  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 111
Query: 264 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 323
            LM G  +N+ I+K +KL    +  +   +  G+K+++   + +RDL    + ++    +
Sbjct: 112 HLM-GADLNN-IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDXEL 169
Query: 324 CLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIAGDPESVSETWMS-----NVYSF 374
            + D G+          T+ E  GY   RW  APEI+          WM      +++S 
Sbjct: 170 KILDFGL-------ARHTDDEMTGYVATRWYRAPEIMLN--------WMHYNQTVDIWSV 214
Query: 375 GMVIWEMVTGEAAYAACSPV 394
           G ++ E++TG   +     +
Sbjct: 215 GCIMAELLTGRTLFPGTDHI 234

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 45/200 (22%), Positives = 89/200 (44%), Gaps = 31/200 (15%)
Query: 209 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 263
           G RV ++KL    +   +     ++L  L    H+N++    V      ++E + + +VT
Sbjct: 57  GHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 116
Query: 264 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 323
            LM G  +N+ I+K +KL    +  +   +  G+K+++   + +RDL    + ++    +
Sbjct: 117 HLM-GADLNN-IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL 174
Query: 324 CLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIAGDPESVSETWMS-----NVYSF 374
            + D G+          T+ E  GY   RW  APEI+          WM      +++S 
Sbjct: 175 KILDFGL-------ARHTDDEMTGYVATRWYRAPEIMLN--------WMHYNQTVDIWSV 219
Query: 375 GMVIWEMVTGEAAYAACSPV 394
           G ++ E++TG   +     +
Sbjct: 220 GCIMAELLTGRTLFPGTDHI 239

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 42/203 (20%), Positives = 89/203 (43%), Gaps = 9/203 (4%)
Query: 195 IDQIGPNSFKGVYK-----GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFY 249
           +++IG  ++  VYK     G+   ++K++   +         +++  L    H NI++ Y
Sbjct: 7   LEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLY 66
Query: 250 CVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRD 309
            V +     L +V + ++      L +    L++       + +  GI + +D  V +RD
Sbjct: 67  DV-IHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRD 125
Query: 310 LNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMS 369
           L  Q +L++R G + + D G+  A         +E     + AP+++ G  +  +     
Sbjct: 126 LKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTI--- 182
Query: 370 NVYSFGMVIWEMVTGEAAYAACS 392
           +++S G +  EMV G   +   S
Sbjct: 183 DIWSVGCIFAEMVNGTPLFPGVS 205

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 45/200 (22%), Positives = 89/200 (44%), Gaps = 31/200 (15%)
Query: 209 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 263
           G RV ++KL    +   +     ++L  L    H+N++    V      ++E + + +VT
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 106
Query: 264 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 323
            LM G  +N+ I+K +KL    +  +   +  G+K+++   + +RDL    + ++    +
Sbjct: 107 HLM-GADLNN-IVKXQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL 164
Query: 324 CLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIAGDPESVSETWMS-----NVYSF 374
            + D G+          T+ E  GY   RW  APEI+          WM      +++S 
Sbjct: 165 KILDFGL-------ARHTDDEMTGYVATRWYRAPEIMLN--------WMHYNQTVDIWSV 209
Query: 375 GMVIWEMVTGEAAYAACSPV 394
           G ++ E++TG   +     +
Sbjct: 210 GCIMAELLTGRTLFPGTDHI 229

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 70/154 (45%), Gaps = 12/154 (7%)
Query: 241 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL 300
           GH NI+Q      + N    +V  LM+ G + D + +   L  KE  +I   + E I  L
Sbjct: 69  GHPNIIQLKDT-YETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICAL 127
Query: 301 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK-SVGEATEYETDGYRWLAPEIIA-- 357
           +   + +RDL  + ILLD   N+ L D G   +C+   GE          +LAPEII   
Sbjct: 128 HKLNIVHRDLKPENILLDDDMNIKLTDFGF--SCQLDPGEKLREVCGTPSYLAPEIIECS 185
Query: 358 ---GDPESVSETWMSNVYSFGMVIWEMVTGEAAY 388
                P    E    +++S G++++ ++ G   +
Sbjct: 186 MNDNHPGYGKEV---DMWSTGVIMYTLLAGSPPF 216

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 45/215 (20%), Positives = 90/215 (41%), Gaps = 13/215 (6%)
Query: 227 EFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEI 286
           E +LR+++       H NIL+ Y    D    + ++ +    G+V   + K  K   +  
Sbjct: 55  EHQLRREVEIQSHLRHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRT 113
Query: 287 IRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETD 346
                ++A  + + +   V +RD+  + +LL   G + + D G      S        T 
Sbjct: 114 ATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLCGTL 173
Query: 347 GYRWLAPEIIAG--DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG 404
            Y  L PE+I G    E V      +++S G++ +E + G+  + A +  +    I+   
Sbjct: 174 DY--LPPEMIEGRMHDEKV------DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE 225
Query: 405 LRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEII 439
                P    +  + L+ +   ++PS+RP   E++
Sbjct: 226 F--TFPDFVTEGARDLISRLLKHNPSQRPMLREVL 258

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 46/202 (22%), Positives = 86/202 (42%), Gaps = 14/202 (6%)
Query: 237 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEG 296
           L    H NI++ Y    D+ +   +V ++  GG + D I+  +K    +   I   V  G
Sbjct: 58  LKQLDHPNIMKLYEFFEDKRN-YYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSG 116
Query: 297 IKFLNDHGVAYRDLNSQRILLD---RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAP 353
             +L+ H + +RDL  + +LL+   R   + + D G+    +  G+  E     Y ++AP
Sbjct: 117 TTYLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAY-YIAP 175
Query: 354 EIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDC 413
           E++    +   + W     S G++++ ++ G   +   +  Q  +     G     P D 
Sbjct: 176 EVLRKKYDEKCDVW-----SCGVILYILLCGYPPFGGQTD-QEILKRVEKGKFSFDPPDW 229
Query: 414 PQI---LKSLMIKCWNNSPSKR 432
            Q+    K L+       PSKR
Sbjct: 230 TQVSDEAKQLVKLMLTYEPSKR 251

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 46/202 (22%), Positives = 86/202 (42%), Gaps = 14/202 (6%)
Query: 237 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEG 296
           L    H NI++ Y    D+ +   +V ++  GG + D I+  +K    +   I   V  G
Sbjct: 75  LKQLDHPNIMKLYEFFEDKRN-YYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSG 133
Query: 297 IKFLNDHGVAYRDLNSQRILLD---RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAP 353
             +L+ H + +RDL  + +LL+   R   + + D G+    +  G+  E     Y ++AP
Sbjct: 134 TTYLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAY-YIAP 192
Query: 354 EIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDC 413
           E++    +   + W     S G++++ ++ G   +   +  Q  +     G     P D 
Sbjct: 193 EVLRKKYDEKCDVW-----SCGVILYILLCGYPPFGGQTD-QEILKRVEKGKFSFDPPDW 246
Query: 414 PQI---LKSLMIKCWNNSPSKR 432
            Q+    K L+       PSKR
Sbjct: 247 TQVSDEAKQLVKLMLTYEPSKR 268

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 45/200 (22%), Positives = 89/200 (44%), Gaps = 31/200 (15%)
Query: 209 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 263
           G RV ++KL    +   +     ++L  L    H+N++    V      ++E + + +VT
Sbjct: 66  GHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 125
Query: 264 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 323
            LM G  +N+ I+K +KL    +  +   +  G+K+++   + +RDL    + ++    +
Sbjct: 126 HLM-GADLNN-IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL 183
Query: 324 CLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIAGDPESVSETWMS-----NVYSF 374
            + D G+          T+ E  GY   RW  APEI+          WM      +++S 
Sbjct: 184 KILDFGL-------ARHTDDEMTGYVATRWYRAPEIMLN--------WMHYNQTVDIWSV 228
Query: 375 GMVIWEMVTGEAAYAACSPV 394
           G ++ E++TG   +     +
Sbjct: 229 GCIMAELLTGRTLFPGTDHI 248

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 45/200 (22%), Positives = 89/200 (44%), Gaps = 31/200 (15%)
Query: 209 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 263
           G RV ++KL    +   +     ++L  L    H+N++    V      ++E + + +VT
Sbjct: 58  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 117
Query: 264 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 323
            LM G  +N+ I+K +KL    +  +   +  G+K+++   + +RDL    + ++    +
Sbjct: 118 HLM-GADLNN-IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDXEL 175
Query: 324 CLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIAGDPESVSETWMS-----NVYSF 374
            + D G+          T+ E  GY   RW  APEI+          WM      +++S 
Sbjct: 176 KILDFGL-------ARHTDDEMTGYVATRWYRAPEIMLN--------WMHYNQTVDIWSV 220
Query: 375 GMVIWEMVTGEAAYAACSPV 394
           G ++ E++TG   +     +
Sbjct: 221 GCIMAELLTGRTLFPGTDHI 240

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 44/208 (21%), Positives = 95/208 (45%), Gaps = 10/208 (4%)
Query: 186 LLNSDNLEFIDQIGPNSFKGVYKGKRVGIEK----LKGCDKGNAYEFELRKDLLELMTCG 241
           + +SD  +F+  IG  +F GV +  R  + K    +K  ++G A +  ++++++   +  
Sbjct: 16  MHDSDRYDFVKDIGSGNF-GVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLR 74
Query: 242 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 301
           H NI++F  V +   H L ++ +   GG + + I  + +    E       +  G+ + +
Sbjct: 75  HPNIVRFKEVILTPTH-LAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCH 133
Query: 302 DHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY-RWLAPEIIAGDP 360
              + +RDL  +  LLD      L       +  SV  +    T G   ++APE++    
Sbjct: 134 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL--- 190
Query: 361 ESVSETWMSNVYSFGMVIWEMVTGEAAY 388
               +  +++V+S G+ ++ M+ G   +
Sbjct: 191 RQEYDGKIADVWSCGVTLYVMLVGAYPF 218

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 45/200 (22%), Positives = 89/200 (44%), Gaps = 31/200 (15%)
Query: 209 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 263
           G RV ++KL    +   +     ++L  L    H+N++    V      ++E + + +VT
Sbjct: 67  GHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 126
Query: 264 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 323
            LM G  +N+ I+K +KL    +  +   +  G+K+++   + +RDL    + ++    +
Sbjct: 127 HLM-GADLNN-IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL 184
Query: 324 CLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIAGDPESVSETWMS-----NVYSF 374
            + D G+          T+ E  GY   RW  APEI+          WM      +++S 
Sbjct: 185 KILDFGL-------ARHTDDEMTGYVATRWYRAPEIMLN--------WMHYNQTVDIWSV 229
Query: 375 GMVIWEMVTGEAAYAACSPV 394
           G ++ E++TG   +     +
Sbjct: 230 GCIMAELLTGRTLFPGTDHI 249

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 45/200 (22%), Positives = 89/200 (44%), Gaps = 31/200 (15%)
Query: 209 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 263
           G RV ++KL    +   +     ++L  L    H+N++    V      ++E + + +VT
Sbjct: 43  GHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 102
Query: 264 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 323
            LM G  +N+ I+K +KL    +  +   +  G+K+++   + +RDL    + ++    +
Sbjct: 103 HLM-GADLNN-IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL 160
Query: 324 CLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIAGDPESVSETWMS-----NVYSF 374
            + D G+          T+ E  GY   RW  APEI+          WM      +++S 
Sbjct: 161 KILDFGL-------ARHTDDEMTGYVATRWYRAPEIMLN--------WMHYNQTVDIWSV 205
Query: 375 GMVIWEMVTGEAAYAACSPV 394
           G ++ E++TG   +     +
Sbjct: 206 GCIMAELLTGRTLFPGTDHI 225

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 53/220 (24%), Positives = 92/220 (41%), Gaps = 17/220 (7%)
Query: 187 LNSDNLEFIDQIGPNSFK--GVYKGKRVG-------IEKLKGCDKGNAYEFELRKDLLEL 237
           L  D+ E +  IG  +F    V K K+ G       + K     +G    F   +D+L  
Sbjct: 58  LQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVL-- 115
Query: 238 MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAI-DVAEG 296
           +    + I Q +    DEN+ L +V +   GG +  L+ K  +    E+ R  + ++   
Sbjct: 116 VNGDRRWITQLHFAFQDENY-LYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMA 174
Query: 297 IKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY-RWLAPEI 355
           I  ++  G  +RD+    ILLDR G++ L D G     ++ G        G   +L+PEI
Sbjct: 175 IDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEI 234
Query: 356 IAGDPESVSETWMS---NVYSFGMVIWEMVTGEAAYAACS 392
           +                + ++ G+  +EM  G+  + A S
Sbjct: 235 LQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADS 274

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 70/154 (45%), Gaps = 12/154 (7%)
Query: 241 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL 300
           GH NI+Q      + N    +V  LM+ G + D + +   L  KE  +I   + E I  L
Sbjct: 82  GHPNIIQLKDT-YETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICAL 140
Query: 301 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK-SVGEATEYETDGYRWLAPEIIA-- 357
           +   + +RDL  + ILLD   N+ L D G   +C+   GE          +LAPEII   
Sbjct: 141 HKLNIVHRDLKPENILLDDDMNIKLTDFGF--SCQLDPGEKLRSVCGTPSYLAPEIIECS 198
Query: 358 ---GDPESVSETWMSNVYSFGMVIWEMVTGEAAY 388
                P    E    +++S G++++ ++ G   +
Sbjct: 199 MNDNHPGYGKEV---DMWSTGVIMYTLLAGSPPF 229

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 45/200 (22%), Positives = 89/200 (44%), Gaps = 31/200 (15%)
Query: 209 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 263
           G RV ++KL    +   +     ++L  L    H+N++    V      ++E + + +VT
Sbjct: 53  GHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 112
Query: 264 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 323
            LM G  +N+ I+K +KL    +  +   +  G+K+++   + +RDL    + ++    +
Sbjct: 113 HLM-GADLNN-IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL 170
Query: 324 CLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIAGDPESVSETWMS-----NVYSF 374
            + D G+          T+ E  GY   RW  APEI+          WM      +++S 
Sbjct: 171 KILDFGL-------ARHTDDEMTGYVATRWYRAPEIMLN--------WMHYNQTVDIWSV 215
Query: 375 GMVIWEMVTGEAAYAACSPV 394
           G ++ E++TG   +     +
Sbjct: 216 GCIMAELLTGRTLFPGTDHI 235

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 70/154 (45%), Gaps = 12/154 (7%)
Query: 241 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL 300
           GH NI+Q      + N    +V  LM+ G + D + +   L  KE  +I   + E I  L
Sbjct: 82  GHPNIIQLKDT-YETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICAL 140
Query: 301 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK-SVGEATEYETDGYRWLAPEIIA-- 357
           +   + +RDL  + ILLD   N+ L D G   +C+   GE          +LAPEII   
Sbjct: 141 HKLNIVHRDLKPENILLDDDMNIKLTDFGF--SCQLDPGEKLREVCGTPSYLAPEIIECS 198
Query: 358 ---GDPESVSETWMSNVYSFGMVIWEMVTGEAAY 388
                P    E    +++S G++++ ++ G   +
Sbjct: 199 MNDNHPGYGKEV---DMWSTGVIMYTLLAGSPPF 229

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 97/216 (44%), Gaps = 33/216 (15%)
Query: 190 DNLEFIDQIGPNSFKGVYKGKR------VGIEKLKGCDKGNAYEF--ELRKDLLELMTCG 241
           D  E I+ IG  ++  V   +R      V I+K+      NA++     ++ L EL    
Sbjct: 55  DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIP-----NAFDVVTNAKRTLRELKILK 109
Query: 242 H---------KNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAID 292
           H         K+IL+   V   E   + VV  LME   ++ +I  S+ L  + +      
Sbjct: 110 HFKHDNIIAIKDILR-PTVPYGEFKSVYVVLDLMES-DLHQIIHSSQPLTLEHVRYFLYQ 167
Query: 293 VAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTA-CKSVGEATEYETD--GYR 349
           +  G+K+++   V +RDL    +L++ +  + +GD G+    C S  E   + T+    R
Sbjct: 168 LLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATR 227
Query: 350 WL-APEIIAGDPESVSE-TWMSNVYSFGMVIWEMVT 383
           W  APE++     S+ E T   +++S G +  EM+ 
Sbjct: 228 WYRAPELML----SLHEYTQAIDLWSVGCIFGEMLA 259

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/200 (22%), Positives = 89/200 (44%), Gaps = 31/200 (15%)
Query: 209 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 263
           G RV ++KL    +   +     ++L  L    H+N++    V      ++E + + +VT
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 106
Query: 264 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 323
            LM G  +N+ I+K +KL    +  +   +  G+K+++   + +RDL    + ++    +
Sbjct: 107 HLM-GADLNN-IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL 164
Query: 324 CLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIAGDPESVSETWMS-----NVYSF 374
            + D G+          T+ E  GY   RW  APEI+          WM      +++S 
Sbjct: 165 KILDFGL-------ARHTDDEMTGYVATRWYRAPEIMLN--------WMHYNQTVDIWSV 209
Query: 375 GMVIWEMVTGEAAYAACSPV 394
           G ++ E++TG   +     +
Sbjct: 210 GCIMAELLTGRTLFPGTDHI 229

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/197 (23%), Positives = 90/197 (45%), Gaps = 25/197 (12%)
Query: 209 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 263
           G RV ++KL    +   +     ++L  L    H+N++    V      ++E + + +VT
Sbjct: 54  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 113
Query: 264 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 323
            LM G  +N+ I+K +KL    +  +   +  G+K+++   + +RDL    + ++    +
Sbjct: 114 HLM-GADLNN-IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL 171
Query: 324 CLGDMGIVTACKSVGEATEY-ETDGYRWLAPEIIAGDPESVSETWMS-----NVYSFGMV 377
            + D G+  A  +  E T Y  T  YR  APEI+          WM      +++S G +
Sbjct: 172 KILDFGL--ARHTADEMTGYVATRWYR--APEIMLN--------WMHYNQTVDIWSVGCI 219
Query: 378 IWEMVTGEAAYAACSPV 394
           + E++TG   +     +
Sbjct: 220 MAELLTGRTLFPGTDHI 236

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/200 (22%), Positives = 89/200 (44%), Gaps = 31/200 (15%)
Query: 209 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 263
           G RV ++KL    +   +     ++L  L    H+N++    V      ++E + + +VT
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 106
Query: 264 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 323
            LM G  +N+ I+K +KL    +  +   +  G+K+++   + +RDL    + ++    +
Sbjct: 107 HLM-GADLNN-IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL 164
Query: 324 CLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIAGDPESVSETWMS-----NVYSF 374
            + D G+          T+ E  GY   RW  APEI+          WM      +++S 
Sbjct: 165 KILDFGL-------ARHTDDEMTGYVATRWYRAPEIMLN--------WMHYNQTVDIWSV 209
Query: 375 GMVIWEMVTGEAAYAACSPV 394
           G ++ E++TG   +     +
Sbjct: 210 GCIMAELLTGRTLFPGTDHI 229

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/200 (22%), Positives = 89/200 (44%), Gaps = 31/200 (15%)
Query: 209 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 263
           G RV ++KL    +   +     ++L  L    H+N++    V      ++E + + +VT
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 106
Query: 264 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 323
            LM G  +N+ I+K +KL    +  +   +  G+K+++   + +RDL    + ++    +
Sbjct: 107 HLM-GADLNN-IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL 164
Query: 324 CLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIAGDPESVSETWMS-----NVYSF 374
            + D G+          T+ E  GY   RW  APEI+          WM      +++S 
Sbjct: 165 KILDFGL-------ARHTDDEMTGYVATRWYRAPEIMLN--------WMHYNQTVDIWSV 209
Query: 375 GMVIWEMVTGEAAYAACSPV 394
           G ++ E++TG   +     +
Sbjct: 210 GCIMAELLTGRTLFPGTDHI 229

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/153 (24%), Positives = 69/153 (45%), Gaps = 6/153 (3%)
Query: 239 TCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIK 298
             GH +I+       + +  + +V  LM  G + D + +   L  KE   I   + E + 
Sbjct: 156 VAGHPHIITL-IDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVS 214
Query: 299 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY-ETDGYRWLAPEIIA 357
           FL+ + + +RDL  + ILLD +  + L D G     +   +  E   T GY  LAPEI+ 
Sbjct: 215 FLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGY--LAPEILK 272
Query: 358 GDPESVSETWMSNV--YSFGMVIWEMVTGEAAY 388
              +     +   V  ++ G++++ ++ G   +
Sbjct: 273 CSMDETHPGYGKEVDLWACGVILFTLLAGSPPF 305

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/200 (22%), Positives = 89/200 (44%), Gaps = 31/200 (15%)
Query: 209 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 263
           G RV ++KL    +   +     ++L  L    H+N++    V      ++E + + +VT
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 106
Query: 264 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 323
            LM G  +N+ I+K +KL    +  +   +  G+K+++   + +RDL    + ++    +
Sbjct: 107 HLM-GADLNN-IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL 164
Query: 324 CLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIAGDPESVSETWMS-----NVYSF 374
            + D G+          T+ E  GY   RW  APEI+          WM      +++S 
Sbjct: 165 KILDFGL-------ARHTDDEMTGYVATRWYRAPEIMLN--------WMHYNQTVDIWSV 209
Query: 375 GMVIWEMVTGEAAYAACSPV 394
           G ++ E++TG   +     +
Sbjct: 210 GCIMAELLTGRTLFPGTDHI 229

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/200 (22%), Positives = 89/200 (44%), Gaps = 31/200 (15%)
Query: 209 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 263
           G RV ++KL    +   +     ++L  L    H+N++    V      ++E + + +VT
Sbjct: 59  GLRVAVKKLSKPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 118
Query: 264 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 323
            LM G  +N+ I+K +KL    +  +   +  G+K+++   + +RDL    + ++    +
Sbjct: 119 HLM-GADLNN-IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL 176
Query: 324 CLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIAGDPESVSETWMS-----NVYSF 374
            + D G+          T+ E  GY   RW  APEI+          WM      +++S 
Sbjct: 177 KILDFGL-------ARHTDDEMTGYVATRWYRAPEIMLN--------WMHYNQTVDIWSV 221
Query: 375 GMVIWEMVTGEAAYAACSPV 394
           G ++ E++TG   +     +
Sbjct: 222 GCIMAELLTGRTLFPGTDHI 241

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/200 (22%), Positives = 89/200 (44%), Gaps = 31/200 (15%)
Query: 209 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 263
           G RV ++KL    +   +     ++L  L    H+N++    V      ++E + + +VT
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 106
Query: 264 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 323
            LM G  +N+ I+K +KL    +  +   +  G+K+++   + +RDL    + ++    +
Sbjct: 107 HLM-GADLNN-IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL 164
Query: 324 CLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIAGDPESVSETWMS-----NVYSF 374
            + D G+          T+ E  GY   RW  APEI+          WM      +++S 
Sbjct: 165 KILDFGL-------ARHTDDEMTGYVATRWYRAPEIMLN--------WMHYNQTVDIWSV 209
Query: 375 GMVIWEMVTGEAAYAACSPV 394
           G ++ E++TG   +     +
Sbjct: 210 GCIMAELLTGRTLFPGTDHI 229

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/200 (22%), Positives = 89/200 (44%), Gaps = 31/200 (15%)
Query: 209 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 263
           G RV ++KL    +   +     ++L  L    H+N++    V      ++E + + +VT
Sbjct: 52  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 111
Query: 264 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 323
            LM G  +N+ I+K +KL    +  +   +  G+K+++   + +RDL    + ++    +
Sbjct: 112 HLM-GADLNN-IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL 169
Query: 324 CLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIAGDPESVSETWMS-----NVYSF 374
            + D G+          T+ E  GY   RW  APEI+          WM      +++S 
Sbjct: 170 KILDFGL-------ARHTDDEMTGYVATRWYRAPEIMLN--------WMHYNQTVDIWSV 214
Query: 375 GMVIWEMVTGEAAYAACSPV 394
           G ++ E++TG   +     +
Sbjct: 215 GCIMAELLTGRTLFPGTDHI 234

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/200 (22%), Positives = 89/200 (44%), Gaps = 31/200 (15%)
Query: 209 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 263
           G RV ++KL    +   +     ++L  L    H+N++    V      ++E + + +VT
Sbjct: 46  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 105
Query: 264 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 323
            LM G  +N+ I+K +KL    +  +   +  G+K+++   + +RDL    + ++    +
Sbjct: 106 HLM-GADLNN-IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL 163
Query: 324 CLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIAGDPESVSETWMS-----NVYSF 374
            + D G+          T+ E  GY   RW  APEI+          WM      +++S 
Sbjct: 164 KILDFGL-------ARHTDDEMTGYVATRWYRAPEIMLN--------WMHYNQTVDIWSV 208
Query: 375 GMVIWEMVTGEAAYAACSPV 394
           G ++ E++TG   +     +
Sbjct: 209 GCIMAELLTGRTLFPGTDHI 228

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/200 (22%), Positives = 89/200 (44%), Gaps = 31/200 (15%)
Query: 209 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 263
           G RV ++KL    +   +     ++L  L    H+N++    V      ++E + + +VT
Sbjct: 54  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 113
Query: 264 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 323
            LM G  +N+ I+K +KL    +  +   +  G+K+++   + +RDL    + ++    +
Sbjct: 114 HLM-GADLNN-IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL 171
Query: 324 CLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIAGDPESVSETWMS-----NVYSF 374
            + D G+          T+ E  GY   RW  APEI+          WM      +++S 
Sbjct: 172 KILDFGL-------ARHTDDEMTGYVATRWYRAPEIMLN--------WMHYNQTVDIWSV 216
Query: 375 GMVIWEMVTGEAAYAACSPV 394
           G ++ E++TG   +     +
Sbjct: 217 GCIMAELLTGRTLFPGTDHI 236

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/197 (23%), Positives = 90/197 (45%), Gaps = 25/197 (12%)
Query: 209 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 263
           G RV ++KL    +   +     ++L  L    H+N++    V      ++E + + +VT
Sbjct: 54  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 113
Query: 264 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 323
            LM G  +N+ I+K +KL    +  +   +  G+K+++   + +RDL    + ++    +
Sbjct: 114 HLM-GADLNN-IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL 171
Query: 324 CLGDMGIVTACKSVGEATEY-ETDGYRWLAPEIIAGDPESVSETWMS-----NVYSFGMV 377
            + D G+  A  +  E T Y  T  YR  APEI+          WM      +++S G +
Sbjct: 172 KILDFGL--ARHTADEMTGYVATRWYR--APEIMLN--------WMHYNQTVDIWSVGCI 219
Query: 378 IWEMVTGEAAYAACSPV 394
           + E++TG   +     +
Sbjct: 220 MAELLTGRTLFPGTDHI 236

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/200 (22%), Positives = 89/200 (44%), Gaps = 31/200 (15%)
Query: 209 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 263
           G RV ++KL    +   +     ++L  L    H+N++    V      ++E + + +VT
Sbjct: 49  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 108
Query: 264 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 323
            LM G  +N+ I+K +KL    +  +   +  G+K+++   + +RDL    + ++    +
Sbjct: 109 HLM-GADLNN-IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL 166
Query: 324 CLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIAGDPESVSETWMS-----NVYSF 374
            + D G+          T+ E  GY   RW  APEI+          WM      +++S 
Sbjct: 167 KILDFGL-------ARHTDDEMTGYVATRWYRAPEIMLN--------WMHYNQTVDIWSV 211
Query: 375 GMVIWEMVTGEAAYAACSPV 394
           G ++ E++TG   +     +
Sbjct: 212 GCIMAELLTGRTLFPGTDHI 231

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/200 (22%), Positives = 89/200 (44%), Gaps = 31/200 (15%)
Query: 209 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 263
           G RV ++KL    +   +     ++L  L    H+N++    V      ++E + + +VT
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 106
Query: 264 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 323
            LM G  +N+ I+K +KL    +  +   +  G+K+++   + +RDL    + ++    +
Sbjct: 107 HLM-GADLNN-IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL 164
Query: 324 CLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIAGDPESVSETWMS-----NVYSF 374
            + D G+          T+ E  GY   RW  APEI+          WM      +++S 
Sbjct: 165 KILDFGL-------ARHTDDEMTGYVATRWYRAPEIMLN--------WMHYNQTVDIWSV 209
Query: 375 GMVIWEMVTGEAAYAACSPV 394
           G ++ E++TG   +     +
Sbjct: 210 GCIMAELLTGRTLFPGTDHI 229

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/200 (22%), Positives = 89/200 (44%), Gaps = 31/200 (15%)
Query: 209 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 263
           G RV ++KL    +   +     ++L  L    H+N++    V      ++E + + +VT
Sbjct: 49  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 108
Query: 264 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 323
            LM G  +N+ I+K +KL    +  +   +  G+K+++   + +RDL    + ++    +
Sbjct: 109 HLM-GADLNN-IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL 166
Query: 324 CLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIAGDPESVSETWMS-----NVYSF 374
            + D G+          T+ E  GY   RW  APEI+          WM      +++S 
Sbjct: 167 KILDFGL-------ARHTDDEMTGYVATRWYRAPEIMLN--------WMHYNQTVDIWSV 211
Query: 375 GMVIWEMVTGEAAYAACSPV 394
           G ++ E++TG   +     +
Sbjct: 212 GCIMAELLTGRTLFPGTDHI 231

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/200 (22%), Positives = 89/200 (44%), Gaps = 31/200 (15%)
Query: 209 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 263
           G RV ++KL    +   +     ++L  L    H+N++    V      ++E + + +VT
Sbjct: 53  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 112
Query: 264 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 323
            LM G  +N+ I+K +KL    +  +   +  G+K+++   + +RDL    + ++    +
Sbjct: 113 HLM-GADLNN-IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL 170
Query: 324 CLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIAGDPESVSETWMS-----NVYSF 374
            + D G+          T+ E  GY   RW  APEI+          WM      +++S 
Sbjct: 171 KILDFGL-------ARHTDDEMTGYVATRWYRAPEIMLN--------WMHYNQTVDIWSV 215
Query: 375 GMVIWEMVTGEAAYAACSPV 394
           G ++ E++TG   +     +
Sbjct: 216 GCIMAELLTGRTLFPGTDHI 235

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/197 (23%), Positives = 90/197 (45%), Gaps = 25/197 (12%)
Query: 209 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 263
           G RV ++KL    +   +     ++L  L    H+N++    V      ++E + + +VT
Sbjct: 54  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 113
Query: 264 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 323
            LM G  +N+ I+K +KL    +  +   +  G+K+++   + +RDL    + ++    +
Sbjct: 114 HLM-GADLNN-IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL 171
Query: 324 CLGDMGIVTACKSVGEATEY-ETDGYRWLAPEIIAGDPESVSETWMS-----NVYSFGMV 377
            + D G+  A  +  E T Y  T  YR  APEI+          WM      +++S G +
Sbjct: 172 KILDFGL--ARHTADEMTGYVATRWYR--APEIMLN--------WMHYNQTVDIWSVGCI 219
Query: 378 IWEMVTGEAAYAACSPV 394
           + E++TG   +     +
Sbjct: 220 MAELLTGRTLFPGTDHI 236

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/182 (23%), Positives = 85/182 (46%), Gaps = 17/182 (9%)
Query: 210 KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVTK 264
           + V I+KL    +   +     ++L+ +    HKNI+    V      ++E   + +V +
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVME 109
Query: 265 LMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVC 324
           LM+  +++ +I    +L  + +  +   +  GIK L+  G+ +RDL    I++     + 
Sbjct: 110 LMDA-NLSQVI--QMELDHERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLK 166
Query: 325 LGDMGIVTACKSVGEATEYETDGYRWLAPEII--AGDPESVSETWMSNVYSFGMVIWEMV 382
           + D G+     +    T Y    Y + APE+I   G  E+V      +++S G+++ EM+
Sbjct: 167 ILDFGLARTAGTSFMMTPYVVTRY-YRAPEVILGMGYKENV------DIWSVGVIMGEMI 219
Query: 383 TG 384
            G
Sbjct: 220 KG 221

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/200 (22%), Positives = 89/200 (44%), Gaps = 31/200 (15%)
Query: 209 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 263
           G RV ++KL    +   +     ++L  L    H+N++    V      ++E + + +VT
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 106
Query: 264 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 323
            LM G  +N+ I+K +KL    +  +   +  G+K+++   + +RDL    + ++    +
Sbjct: 107 HLM-GADLNN-IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL 164
Query: 324 CLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIAGDPESVSETWMS-----NVYSF 374
            + D G+          T+ E  GY   RW  APEI+          WM      +++S 
Sbjct: 165 KILDFGL-------ARHTDDEMTGYVATRWYRAPEIMLN--------WMHYNQTVDIWSV 209
Query: 375 GMVIWEMVTGEAAYAACSPV 394
           G ++ E++TG   +     +
Sbjct: 210 GCIMAELLTGRTLFPGTDHI 229

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/200 (22%), Positives = 89/200 (44%), Gaps = 31/200 (15%)
Query: 209 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 263
           G RV ++KL    +   +     ++L  L    H+N++    V      ++E + + +VT
Sbjct: 58  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 117
Query: 264 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 323
            LM G  +N+ I+K +KL    +  +   +  G+K+++   + +RDL    + ++    +
Sbjct: 118 HLM-GADLNN-IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL 175
Query: 324 CLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIAGDPESVSETWMS-----NVYSF 374
            + D G+          T+ E  GY   RW  APEI+          WM      +++S 
Sbjct: 176 KILDFGL-------ARHTDDEMTGYVATRWYRAPEIMLN--------WMHYNQTVDIWSV 220
Query: 375 GMVIWEMVTGEAAYAACSPV 394
           G ++ E++TG   +     +
Sbjct: 221 GCIMAELLTGRTLFPGTDHI 240

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/200 (22%), Positives = 89/200 (44%), Gaps = 31/200 (15%)
Query: 209 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 263
           G RV ++KL    +   +     ++L  L    H+N++    V      ++E + + +VT
Sbjct: 59  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 118
Query: 264 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 323
            LM G  +N+ I+K +KL    +  +   +  G+K+++   + +RDL    + ++    +
Sbjct: 119 HLM-GADLNN-IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL 176
Query: 324 CLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIAGDPESVSETWMS-----NVYSF 374
            + D G+          T+ E  GY   RW  APEI+          WM      +++S 
Sbjct: 177 KILDFGL-------ARHTDDEMTGYVATRWYRAPEIMLN--------WMHYNQTVDIWSV 221
Query: 375 GMVIWEMVTGEAAYAACSPV 394
           G ++ E++TG   +     +
Sbjct: 222 GCIMAELLTGRTLFPGTDHI 241

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/200 (22%), Positives = 89/200 (44%), Gaps = 31/200 (15%)
Query: 209 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 263
           G RV ++KL    +   +     ++L  L    H+N++    V      ++E + + +VT
Sbjct: 49  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 108
Query: 264 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 323
            LM G  +N+ I+K +KL    +  +   +  G+K+++   + +RDL    + ++    +
Sbjct: 109 HLM-GADLNN-IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL 166
Query: 324 CLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIAGDPESVSETWMS-----NVYSF 374
            + D G+          T+ E  GY   RW  APEI+          WM      +++S 
Sbjct: 167 KILDFGL-------ARHTDDEMTGYVATRWYRAPEIMLN--------WMHYNQTVDIWSV 211
Query: 375 GMVIWEMVTGEAAYAACSPV 394
           G ++ E++TG   +     +
Sbjct: 212 GCIMAELLTGRTLFPGTDHI 231

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/200 (22%), Positives = 89/200 (44%), Gaps = 31/200 (15%)
Query: 209 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 263
           G RV ++KL    +   +     ++L  L    H+N++    V      ++E + + +VT
Sbjct: 59  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 118
Query: 264 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 323
            LM G  +N+ I+K +KL    +  +   +  G+K+++   + +RDL    + ++    +
Sbjct: 119 HLM-GADLNN-IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL 176
Query: 324 CLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIAGDPESVSETWMS-----NVYSF 374
            + D G+          T+ E  GY   RW  APEI+          WM      +++S 
Sbjct: 177 KILDFGL-------ARHTDDEMTGYVATRWYRAPEIMLN--------WMHYNQTVDIWSV 221
Query: 375 GMVIWEMVTGEAAYAACSPV 394
           G ++ E++TG   +     +
Sbjct: 222 GCIMAELLTGRTLFPGTDHI 241

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/182 (23%), Positives = 85/182 (46%), Gaps = 17/182 (9%)
Query: 210 KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVTK 264
           + V I+KL    +   +     ++L+ +    HKNI+    V      ++E   + +V +
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVME 109
Query: 265 LMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVC 324
           LM+  +++ +I    +L  + +  +   +  GIK L+  G+ +RDL    I++     + 
Sbjct: 110 LMDA-NLSQVI--QMELDHERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLK 166
Query: 325 LGDMGIVTACKSVGEATEYETDGYRWLAPEII--AGDPESVSETWMSNVYSFGMVIWEMV 382
           + D G+     +    T Y    Y + APE+I   G  E+V      +++S G+++ EM+
Sbjct: 167 ILDFGLARTAGTSFMMTPYVVTRY-YRAPEVILGMGYKENV------DIWSVGVIMGEMI 219
Query: 383 TG 384
            G
Sbjct: 220 KG 221

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/200 (22%), Positives = 89/200 (44%), Gaps = 31/200 (15%)
Query: 209 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 263
           G RV ++KL    +   +     ++L  L    H+N++    V      ++E + + +VT
Sbjct: 66  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 125
Query: 264 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 323
            LM G  +N+ I+K +KL    +  +   +  G+K+++   + +RDL    + ++    +
Sbjct: 126 HLM-GADLNN-IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL 183
Query: 324 CLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIAGDPESVSETWMS-----NVYSF 374
            + D G+          T+ E  GY   RW  APEI+          WM      +++S 
Sbjct: 184 KILDFGL-------ARHTDDEMTGYVATRWYRAPEIMLN--------WMHYNQTVDIWSV 228
Query: 375 GMVIWEMVTGEAAYAACSPV 394
           G ++ E++TG   +     +
Sbjct: 229 GCIMAELLTGRTLFPGTDHI 248

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 43/195 (22%), Positives = 89/195 (45%), Gaps = 21/195 (10%)
Query: 209 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 263
           G RV ++KL    +   +     ++L  L    H+N++    V      ++E + + +VT
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 106
Query: 264 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 323
            LM G  +N+ I+K +KL    +  +   +  G+K+++   + +RDL    + ++    +
Sbjct: 107 HLM-GADLNN-IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL 164
Query: 324 CLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIAGDPESVSETWMSNVYSFGMVIW 379
            + D G+          T+ E  GY   RW  APEI+     ++      +++S G ++ 
Sbjct: 165 KILDFGL-------ARHTDDEMTGYVATRWYRAPEIMLN---AMHYNQTVDIWSVGCIMA 214
Query: 380 EMVTGEAAYAACSPV 394
           E++TG   +     +
Sbjct: 215 ELLTGRTLFPGTDHI 229

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/200 (22%), Positives = 89/200 (44%), Gaps = 31/200 (15%)
Query: 209 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 263
           G RV ++KL    +   +     ++L  L    H+N++    V      ++E + + +VT
Sbjct: 67  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 126
Query: 264 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 323
            LM G  +N+ I+K +KL    +  +   +  G+K+++   + +RDL    + ++    +
Sbjct: 127 HLM-GADLNN-IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL 184
Query: 324 CLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIAGDPESVSETWMS-----NVYSF 374
            + D G+          T+ E  GY   RW  APEI+          WM      +++S 
Sbjct: 185 KILDFGL-------ARHTDDEMTGYVATRWYRAPEIMLN--------WMHYNQTVDIWSV 229
Query: 375 GMVIWEMVTGEAAYAACSPV 394
           G ++ E++TG   +     +
Sbjct: 230 GCIMAELLTGRTLFPGTDHI 249

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/279 (18%), Positives = 110/279 (39%), Gaps = 35/279 (12%)
Query: 186 LLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELM---TCGH 242
           L  + + E I  +G  +F  V K +     +     K    E +L   L E+M   +  H
Sbjct: 2   LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNH 61
Query: 243 KNILQFYC------------VCVDENHGLCVVTKLMEGGSVNDLILKSRKL--QTKEIIR 288
           + ++++Y               V +   L +  +  E  ++ DLI  S  L  Q  E  R
Sbjct: 62  QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLI-HSENLNQQRDEYWR 120
Query: 289 IAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY 348
           +   + E + +++  G+ +RDL    I +D   NV +GD G+        +  + ++   
Sbjct: 121 LFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180
Query: 349 --------------RWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPV 394
                          ++A E++ G      +    ++YS G++ +EM+   +       +
Sbjct: 181 PGSSDNLTSAIGTAMYVATEVLDGTGHYNEKI---DMYSLGIIFFEMIYPFSTGMERVNI 237
Query: 395 QAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRP 433
              +   +    P+   +  ++ K ++    ++ P+KRP
Sbjct: 238 LKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRP 276

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/200 (22%), Positives = 89/200 (44%), Gaps = 31/200 (15%)
Query: 209 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 263
           G RV ++KL    +   +     ++L  L    H+N++    V      ++E + + +VT
Sbjct: 44  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 103
Query: 264 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 323
            LM G  +N+ I+K +KL    +  +   +  G+K+++   + +RDL    + ++    +
Sbjct: 104 HLM-GADLNN-IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL 161
Query: 324 CLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIAGDPESVSETWMS-----NVYSF 374
            + D G+          T+ E  GY   RW  APEI+          WM      +++S 
Sbjct: 162 KILDFGL-------ARHTDDEMTGYVATRWYRAPEIMLN--------WMHYNQTVDIWSV 206
Query: 375 GMVIWEMVTGEAAYAACSPV 394
           G ++ E++TG   +     +
Sbjct: 207 GCIMAELLTGRTLFPGTDHI 226

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/200 (22%), Positives = 89/200 (44%), Gaps = 31/200 (15%)
Query: 209 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 263
           G RV ++KL    +   +     ++L  L    H+N++    V      ++E + + +VT
Sbjct: 52  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 111
Query: 264 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 323
            LM G  +N+ I+K +KL    +  +   +  G+K+++   + +RDL    + ++    +
Sbjct: 112 HLM-GADLNN-IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL 169
Query: 324 CLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIAGDPESVSETWMS-----NVYSF 374
            + D G+          T+ E  GY   RW  APEI+          WM      +++S 
Sbjct: 170 KILDFGL-------ARHTDDEMTGYVATRWYRAPEIMLN--------WMHYNQTVDIWSV 214
Query: 375 GMVIWEMVTGEAAYAACSPV 394
           G ++ E++TG   +     +
Sbjct: 215 GCIMAELLTGRTLFPGTDHI 234

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/200 (22%), Positives = 89/200 (44%), Gaps = 31/200 (15%)
Query: 209 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 263
           G RV ++KL    +   +     ++L  L    H+N++    V      ++E + + +VT
Sbjct: 70  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 129
Query: 264 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 323
            LM G  +N+ I+K +KL    +  +   +  G+K+++   + +RDL    + ++    +
Sbjct: 130 HLM-GADLNN-IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL 187
Query: 324 CLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIAGDPESVSETWMS-----NVYSF 374
            + D G+          T+ E  GY   RW  APEI+          WM      +++S 
Sbjct: 188 KILDFGL-------ARHTDDEMXGYVATRWYRAPEIMLN--------WMHYNQTVDIWSV 232
Query: 375 GMVIWEMVTGEAAYAACSPV 394
           G ++ E++TG   +     +
Sbjct: 233 GCIMAELLTGRTLFPGTDHI 252

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/200 (22%), Positives = 89/200 (44%), Gaps = 31/200 (15%)
Query: 209 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 263
           G RV ++KL    +   +     ++L  L    H+N++    V      ++E + + +VT
Sbjct: 45  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 104
Query: 264 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 323
            LM G  +N+ I+K +KL    +  +   +  G+K+++   + +RDL    + ++    +
Sbjct: 105 HLM-GADLNN-IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL 162
Query: 324 CLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIAGDPESVSETWMS-----NVYSF 374
            + D G+          T+ E  GY   RW  APEI+          WM      +++S 
Sbjct: 163 KILDFGL-------ARHTDDEMTGYVATRWYRAPEIMLN--------WMHYNQTVDIWSV 207
Query: 375 GMVIWEMVTGEAAYAACSPV 394
           G ++ E++TG   +     +
Sbjct: 208 GCIMAELLTGRTLFPGTDHI 227

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/200 (22%), Positives = 89/200 (44%), Gaps = 31/200 (15%)
Query: 209 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 263
           G RV ++KL    +   +     ++L  L    H+N++    V      ++E + + +VT
Sbjct: 44  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 103
Query: 264 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 323
            LM G  +N+ I+K +KL    +  +   +  G+K+++   + +RDL    + ++    +
Sbjct: 104 HLM-GADLNN-IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL 161
Query: 324 CLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIAGDPESVSETWMS-----NVYSF 374
            + D G+          T+ E  GY   RW  APEI+          WM      +++S 
Sbjct: 162 KILDFGL-------ARHTDDEMTGYVATRWYRAPEIMLN--------WMHYNQTVDIWSV 206
Query: 375 GMVIWEMVTGEAAYAACSPV 394
           G ++ E++TG   +     +
Sbjct: 207 GCIMAELLTGRTLFPGTDHI 226

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/200 (22%), Positives = 89/200 (44%), Gaps = 31/200 (15%)
Query: 209 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 263
           G RV ++KL    +   +     ++L  L    H+N++    V      ++E + + +VT
Sbjct: 70  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 129
Query: 264 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 323
            LM G  +N+ I+K +KL    +  +   +  G+K+++   + +RDL    + ++    +
Sbjct: 130 HLM-GADLNN-IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL 187
Query: 324 CLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIAGDPESVSETWMS-----NVYSF 374
            + D G+          T+ E  GY   RW  APEI+          WM      +++S 
Sbjct: 188 KILDFGL-------ARHTDDEMTGYVATRWYRAPEIMLN--------WMHYNQTVDIWSV 232
Query: 375 GMVIWEMVTGEAAYAACSPV 394
           G ++ E++TG   +     +
Sbjct: 233 GCIMAELLTGRTLFPGTDHI 252

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/200 (22%), Positives = 89/200 (44%), Gaps = 31/200 (15%)
Query: 209 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 263
           G RV ++KL    +   +     ++L  L    H+N++    V      ++E + + +VT
Sbjct: 53  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 112
Query: 264 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 323
            LM G  +N+ I+K +KL    +  +   +  G+K+++   + +RDL    + ++    +
Sbjct: 113 HLM-GADLNN-IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL 170
Query: 324 CLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIAGDPESVSETWMS-----NVYSF 374
            + D G+          T+ E  GY   RW  APEI+          WM      +++S 
Sbjct: 171 KILDFGL-------ARHTDDEMTGYVATRWYRAPEIMLN--------WMHYNQTVDIWSV 215
Query: 375 GMVIWEMVTGEAAYAACSPV 394
           G ++ E++TG   +     +
Sbjct: 216 GCIMAELLTGRTLFPGTDHI 235

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/200 (22%), Positives = 89/200 (44%), Gaps = 31/200 (15%)
Query: 209 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 263
           G RV ++KL    +   +     ++L  L    H+N++    V      ++E + + +VT
Sbjct: 43  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 102
Query: 264 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 323
            LM G  +N+ I+K +KL    +  +   +  G+K+++   + +RDL    + ++    +
Sbjct: 103 HLM-GADLNN-IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL 160
Query: 324 CLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIAGDPESVSETWMS-----NVYSF 374
            + D G+          T+ E  GY   RW  APEI+          WM      +++S 
Sbjct: 161 KILDFGL-------ARHTDDEMTGYVATRWYRAPEIMLN--------WMHYNQTVDIWSV 205
Query: 375 GMVIWEMVTGEAAYAACSPV 394
           G ++ E++TG   +     +
Sbjct: 206 GCIMAELLTGRTLFPGTDHI 225

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/246 (22%), Positives = 100/246 (40%), Gaps = 28/246 (11%)
Query: 195 IDQIGPNSFKGVYKGK-----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHK 243
           +D++G  ++  VYKGK            + +E  +G       E  L KDL       H 
Sbjct: 7   LDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDL------KHA 60
Query: 244 NILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDH 303
           NI+  + +   E   L +V + ++      L      +    +      +  G+ + +  
Sbjct: 61  NIVTLHDIIHTEK-SLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQ 119
Query: 304 GVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT---EYETDGYRWLAPEIIAGDP 360
            V +RDL  Q +L++  G + L D G+  A KS+   T   E  T  YR   P+I+ G  
Sbjct: 120 KVLHRDLKPQNLLINERGELKLADFGLARA-KSIPTKTYDNEVVTLWYR--PPDILLGST 176
Query: 361 ESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSL 420
           +  ++    +++  G + +EM TG   +   S V+  +      L     +  P IL + 
Sbjct: 177 DYSTQI---DMWGVGCIFYEMATGRPLFPG-STVEEQLHFIFRILGTPTEETWPGILSNE 232
Query: 421 MIKCWN 426
             K +N
Sbjct: 233 EFKTYN 238

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/194 (23%), Positives = 87/194 (44%), Gaps = 31/194 (15%)
Query: 209 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 263
           G RV ++KL    +   +     ++L  L    H+N++    V      ++E + + +VT
Sbjct: 43  GHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 102
Query: 264 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 323
            LM G  +N+ I+K  KL    +  +   +  G+K+++   + +RDL    + ++    +
Sbjct: 103 HLM-GADLNN-IVKCAKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL 160
Query: 324 CLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIAGDPESVSETWMS-----NVYSF 374
            + D G+          T+ E  GY   RW  APEI+          WM      +++S 
Sbjct: 161 KILDFGL-------ARHTDDEMTGYVATRWYRAPEIMLN--------WMHYNQTVDIWSV 205
Query: 375 GMVIWEMVTGEAAY 388
           G ++ E++TG   +
Sbjct: 206 GCIMAELLTGRTLF 219

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 95/215 (44%), Gaps = 31/215 (14%)
Query: 190 DNLEFIDQIGPNSFKGVYKGKR------VGIEKLKGCDKGNAYEF--ELRKDLLELMTCG 241
           D  E I+ IG  ++  V   +R      V I+K+      NA++     ++ L EL    
Sbjct: 54  DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIP-----NAFDVVTNAKRTLRELKILK 108
Query: 242 H---------KNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAID 292
           H         K+IL+   V   E   + VV  LME   ++ +I  S+ L  + +      
Sbjct: 109 HFKHDNIIAIKDILR-PTVPYGEFKSVYVVLDLMES-DLHQIIHSSQPLTLEHVRYFLYQ 166
Query: 293 VAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTA-CKSVGEATEYETD--GYR 349
           +  G+K+++   V +RDL    +L++ +  + +GD G+    C S  E   + T+    R
Sbjct: 167 LLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATR 226
Query: 350 WL-APEIIAGDPESVSETWMSNVYSFGMVIWEMVT 383
           W  APE++    E    T   +++S G +  EM+ 
Sbjct: 227 WYRAPELMLSLHEY---TQAIDLWSVGCIFGEMLA 258

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/185 (22%), Positives = 84/185 (45%), Gaps = 13/185 (7%)
Query: 211 RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV----CVDENHGLCVVTKLM 266
           RV I+K+   +     +  LR ++  L+   H+NI+    +     +++   + +V  LM
Sbjct: 54  RVAIKKISPFEHQTYXQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 112
Query: 267 EGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLG 326
           E       +LK++ L    I      +  G+K+++   V +RDL    +LL+   ++ + 
Sbjct: 113 ETDLYK--LLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKIC 170
Query: 327 DMGIVTACKSVGEATEYETD--GYRWL-APEIIAGDPESVSETWMSNVYSFGMVIWEMVT 383
           D G+        + T + T+    RW  APEI+     S   T   +++S G ++ EM++
Sbjct: 171 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN---SKGYTKSIDIWSVGCILAEMLS 227
Query: 384 GEAAY 388
               +
Sbjct: 228 NRPIF 232

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/166 (24%), Positives = 77/166 (46%), Gaps = 21/166 (12%)
Query: 287 IRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE------- 339
           + I I +AE ++FL+  G+ +RDL    I       V +GD G+VTA     E       
Sbjct: 167 LHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 226
Query: 340 ----ATEYETDGYR-WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPV 394
               AT     G + +++PE I G+  S       +++S G++++E++   +       V
Sbjct: 227 MPAYATHXGQVGTKLYMSPEQIHGNNYSHK----VDIFSLGLILFELLYSFS--TQMERV 280
Query: 395 QAAVGIAACGLRPEIPKDCPQILKSLMIK-CWNNSPSKRPQFSEII 439
           +    +          +  PQ  + +M++   + SP++RP+ ++II
Sbjct: 281 RIITDVRNLKFPLLFTQKYPQ--EHMMVQDMLSPSPTERPEATDII 324

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/200 (22%), Positives = 89/200 (44%), Gaps = 31/200 (15%)
Query: 209 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 263
           G RV ++KL    +   +     ++L  L    H+N++    V      ++E + + +VT
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 106
Query: 264 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 323
            LM G  +N+ I+K +KL    +  +   +  G+K+++   + +RDL    + ++    +
Sbjct: 107 HLM-GADLNN-IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL 164
Query: 324 CLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIAGDPESVSETWMS-----NVYSF 374
            + D G+          T+ E  GY   RW  APEI+          WM      +++S 
Sbjct: 165 KILDYGL-------ARHTDDEMTGYVATRWYRAPEIMLN--------WMHYNQTVDIWSV 209
Query: 375 GMVIWEMVTGEAAYAACSPV 394
           G ++ E++TG   +     +
Sbjct: 210 GCIMAELLTGRTLFPGTDHI 229

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/185 (22%), Positives = 84/185 (45%), Gaps = 13/185 (7%)
Query: 211 RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV----CVDENHGLCVVTKLM 266
           RV I+K+   +     +  LR ++  L+   H+NI+    +     +++   + +V  LM
Sbjct: 52  RVAIKKISPFEHQTYCQRTLR-EIKILLAFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 110
Query: 267 EGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLG 326
           E       +LK++ L    I      +  G+K+++   V +RDL    +LL+   ++ + 
Sbjct: 111 ETDLYK--LLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTSDLKIC 168
Query: 327 DMGIVTACKSVGEATEYETD--GYRWL-APEIIAGDPESVSETWMSNVYSFGMVIWEMVT 383
           D G+        + T + T+    RW  APEI+     S   T   +++S G ++ EM++
Sbjct: 169 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN---SKGYTKSIDIWSVGCILAEMLS 225
Query: 384 GEAAY 388
               +
Sbjct: 226 NRPIF 230

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/185 (22%), Positives = 84/185 (45%), Gaps = 13/185 (7%)
Query: 211 RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV----CVDENHGLCVVTKLM 266
           RV I+K+   +     +  LR ++  L+   H+NI+    +     +++   + +V  LM
Sbjct: 50  RVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 108
Query: 267 EGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLG 326
           E       +LK++ L    I      +  G+K+++   V +RDL    +LL+   ++ + 
Sbjct: 109 ETDLYK--LLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKIX 166
Query: 327 DMGIVTACKSVGEATEYETD--GYRWL-APEIIAGDPESVSETWMSNVYSFGMVIWEMVT 383
           D G+        + T + T+    RW  APEI+     S   T   +++S G ++ EM++
Sbjct: 167 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN---SKGYTKSIDIWSVGCILAEMLS 223
Query: 384 GEAAY 388
               +
Sbjct: 224 NRPIF 228

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/200 (22%), Positives = 89/200 (44%), Gaps = 31/200 (15%)
Query: 209 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 263
           G RV ++KL    +   +     ++L  L    H+N++    V      ++E + + +VT
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 106
Query: 264 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 323
            LM G  +N+ I+K +KL    +  +   +  G+K+++   + +RDL    + ++    +
Sbjct: 107 HLM-GADLNN-IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL 164
Query: 324 CLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIAGDPESVSETWMS-----NVYSF 374
            + D G+          T+ E  GY   RW  APEI+          WM      +++S 
Sbjct: 165 KILDAGL-------ARHTDDEMTGYVATRWYRAPEIMLN--------WMHYNQTVDIWSV 209
Query: 375 GMVIWEMVTGEAAYAACSPV 394
           G ++ E++TG   +     +
Sbjct: 210 GCIMAELLTGRTLFPGTDHI 229

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 38/204 (18%), Positives = 96/204 (47%), Gaps = 15/204 (7%)
Query: 207 YKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLM 266
           Y  K +   + +   +G + E E+ +++  L    H N++  + V  +    + ++ +L+
Sbjct: 40  YAAKFIKKRQSRASRRGVSRE-EIEREVSILRQVLHHNVITLHDVY-ENRTDVVLILELV 97
Query: 267 EGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRI-LLDRH---GN 322
            GG + D + +   L  +E       + +G+ +L+   +A+ DL  + I LLD++    +
Sbjct: 98  SGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPH 157
Query: 323 VCLGDMGIVTACKSVGEATEYET--DGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWE 380
           + L D G+      + +  E++       ++APEI+  +P  +     ++++S G++ + 
Sbjct: 158 IKLIDFGL---AHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLE----ADMWSIGVITYI 210
Query: 381 MVTGEAAYAACSPVQAAVGIAACG 404
           +++G + +   +  +    I A  
Sbjct: 211 LLSGASPFLGDTKQETLANITAVS 234

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/190 (23%), Positives = 92/190 (48%), Gaps = 25/190 (13%)
Query: 210 KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVTK 264
           ++V ++KL    +   +     ++L  L    H+N++    V      +++   + +VT 
Sbjct: 54  QKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTT 113
Query: 265 LMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVC 324
           LM G  +N+ I+KS+ L  + +  +   +  G+K+++  G+ +RDL    + ++    + 
Sbjct: 114 LM-GADLNN-IVKSQALSDEHVQFLVYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDSELR 171
Query: 325 LGDMGIVTACKSVGEATEY-ETDGYRWLAPEIIAGDPESVSETWMS-----NVYSFGMVI 378
           + D G+  A ++  E T Y  T  YR  APEI+          WM      +++S G ++
Sbjct: 172 ILDFGL--ARQADEEMTGYVATRWYR--APEIML--------NWMHYNQTVDIWSVGCIM 219
Query: 379 WEMVTGEAAY 388
            E++ G+A +
Sbjct: 220 AELLQGKALF 229

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/200 (22%), Positives = 89/200 (44%), Gaps = 31/200 (15%)
Query: 209 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 263
           G RV ++KL    +   +     ++L  L    H+N++    V      ++E + + +VT
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 106
Query: 264 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 323
            LM G  +N+ I+K +KL    +  +   +  G+K+++   + +RDL    + ++    +
Sbjct: 107 HLM-GADLNN-IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL 164
Query: 324 CLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIAGDPESVSETWMS-----NVYSF 374
            + D G+          T+ E  GY   RW  APEI+          WM      +++S 
Sbjct: 165 KILDRGL-------ARHTDDEMTGYVATRWYRAPEIMLN--------WMHYNQTVDIWSV 209
Query: 375 GMVIWEMVTGEAAYAACSPV 394
           G ++ E++TG   +     +
Sbjct: 210 GCIMAELLTGRTLFPGTDHI 229

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 38/204 (18%), Positives = 96/204 (47%), Gaps = 15/204 (7%)
Query: 207 YKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLM 266
           Y  K +   + +   +G + E E+ +++  L    H N++  + V  +    + ++ +L+
Sbjct: 40  YAAKFIKKRQSRASRRGVSRE-EIEREVSILRQVLHHNVITLHDVY-ENRTDVVLILELV 97
Query: 267 EGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRI-LLDRH---GN 322
            GG + D + +   L  +E       + +G+ +L+   +A+ DL  + I LLD++    +
Sbjct: 98  SGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPH 157
Query: 323 VCLGDMGIVTACKSVGEATEYET--DGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWE 380
           + L D G+      + +  E++       ++APEI+  +P  +     ++++S G++ + 
Sbjct: 158 IKLIDFGL---AHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLE----ADMWSIGVITYI 210
Query: 381 MVTGEAAYAACSPVQAAVGIAACG 404
           +++G + +   +  +    I A  
Sbjct: 211 LLSGASPFLGDTKQETLANITAVS 234

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/151 (21%), Positives = 70/151 (46%), Gaps = 10/151 (6%)
Query: 237 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEG 296
           L    H NI++ Y    D+ +   +V +  +GG + D I+   K    +   I   V  G
Sbjct: 90  LKLLDHPNIMKLYDFFEDKRN-YYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSG 148
Query: 297 IKFLNDHGVAYRDLNSQRILL---DRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAP 353
           + +L+ H + +RDL  + +LL   ++   + + D G+    ++  +  E     Y ++AP
Sbjct: 149 VTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAY-YIAP 207
Query: 354 EIIAGDPESVSETWMSNVYSFGMVIWEMVTG 384
           E++    +   + W     S G++++ ++ G
Sbjct: 208 EVLRKKYDEKCDVW-----SIGVILFILLAG 233

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/200 (22%), Positives = 89/200 (44%), Gaps = 31/200 (15%)
Query: 209 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 263
           G RV ++KL    +   +     ++L  L    H+N++    V      ++E + + +VT
Sbjct: 47  GHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 106
Query: 264 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 323
            LM G  +N+ I+K +KL    +  +   +  G+K+++   + +RDL    + ++    +
Sbjct: 107 HLM-GADLNN-IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL 164
Query: 324 CLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIAGDPESVSETWMS-----NVYSF 374
            + D G+          T+ E  G+   RW  APEI+          WM      +++S 
Sbjct: 165 KILDFGL-------ARHTDDEMAGFVATRWYRAPEIMLN--------WMHYNQTVDIWSV 209
Query: 375 GMVIWEMVTGEAAYAACSPV 394
           G ++ E++TG   +     +
Sbjct: 210 GCIMAELLTGRTLFPGTDHI 229

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/242 (22%), Positives = 99/242 (40%), Gaps = 15/242 (6%)
Query: 187 LNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYE---------FELRKDLLEL 237
           L+ ++ E I  IG  +F  V   K    E++      N +E         F   +D+L  
Sbjct: 87  LHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVN 146
Query: 238 MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAI-DVAEG 296
             C  + I   +    DENH L +V     GG +  L+ K      +++ R  I ++   
Sbjct: 147 GDC--QWITALHYAFQDENH-LYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLA 203
Query: 297 IKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY-RWLAPEI 355
           I  ++     +RD+    +LLD +G++ L D G        G        G   +++PEI
Sbjct: 204 IDSIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEI 263
Query: 356 IAGDPESVSETWMS-NVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCP 414
           +    + + +     + +S G+ ++EM+ GE  + A S V+    I     R + P    
Sbjct: 264 LQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHVT 323
Query: 415 QI 416
            +
Sbjct: 324 DV 325

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/200 (22%), Positives = 89/200 (44%), Gaps = 31/200 (15%)
Query: 209 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 263
           G RV ++KL    +   +     ++L  L    H+N++    V      ++E + + +VT
Sbjct: 47  GHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 106
Query: 264 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 323
            LM G  +N+ I+K +KL    +  +   +  G+K+++   + +RDL    + ++    +
Sbjct: 107 HLM-GADLNN-IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL 164
Query: 324 CLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIAGDPESVSETWMS-----NVYSF 374
            + D G+          T+ E  G+   RW  APEI+          WM      +++S 
Sbjct: 165 KILDFGL-------ARHTDDEMAGFVATRWYRAPEIMLN--------WMHYNQTVDIWSV 209
Query: 375 GMVIWEMVTGEAAYAACSPV 394
           G ++ E++TG   +     +
Sbjct: 210 GCIMAELLTGRTLFPGTDHI 229

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/185 (23%), Positives = 86/185 (46%), Gaps = 13/185 (7%)
Query: 211 RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV----CVDENHGLCVVTKLM 266
           RV I+K+   +     +  LR ++  L+   H+NI+    +     +++   + +VT LM
Sbjct: 70  RVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLM 128
Query: 267 EGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLG 326
            G  +  L LK++ L    I      +  G+K+++   V +RDL    +LL+   ++ + 
Sbjct: 129 -GADLYKL-LKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKIC 186
Query: 327 DMGIVTACKSVGEATEYETD--GYRWL-APEIIAGDPESVSETWMSNVYSFGMVIWEMVT 383
           D G+        + T + T+    RW  APEI+     S   T   +++S G ++ EM++
Sbjct: 187 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN---SKGYTKSIDIWSVGCILAEMLS 243
Query: 384 GEAAY 388
               +
Sbjct: 244 NRPIF 248

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/200 (22%), Positives = 89/200 (44%), Gaps = 31/200 (15%)
Query: 209 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 263
           G RV ++KL    +   +     ++L  L    H+N++    V      ++E + + +VT
Sbjct: 43  GHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 102
Query: 264 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 323
            LM G  +N+ I+K +KL    +  +   +  G+K+++   + +RDL    + ++    +
Sbjct: 103 HLM-GADLNN-IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL 160
Query: 324 CLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIAGDPESVSETWMS-----NVYSF 374
            + D G+          T+ E  G+   RW  APEI+          WM      +++S 
Sbjct: 161 KILDFGL-------ARHTDDEMAGFVATRWYRAPEIMLN--------WMHYNQTVDIWSV 205
Query: 375 GMVIWEMVTGEAAYAACSPV 394
           G ++ E++TG   +     +
Sbjct: 206 GCIMAELLTGRTLFPGTDHI 225

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 55/242 (22%), Positives = 99/242 (40%), Gaps = 15/242 (6%)
Query: 187 LNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYE---------FELRKDLLEL 237
           L+ ++ E I  IG  +F  V   K    E++      N +E         F   +D+L  
Sbjct: 71  LHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVLVN 130
Query: 238 MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAI-DVAEG 296
             C  + I   +    DENH L +V     GG +  L+ K      +++ R  I ++   
Sbjct: 131 GDC--QWITALHYAFQDENH-LYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLA 187
Query: 297 IKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY-RWLAPEI 355
           I  ++     +RD+    +LLD +G++ L D G        G        G   +++PEI
Sbjct: 188 IDSIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEI 247
Query: 356 IAGDPESVSETWMS-NVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCP 414
           +    + + +     + +S G+ ++EM+ GE  + A S V+    I     R + P    
Sbjct: 248 LQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHVT 307
Query: 415 QI 416
            +
Sbjct: 308 DV 309

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 42/185 (22%), Positives = 84/185 (45%), Gaps = 13/185 (7%)
Query: 211 RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV----CVDENHGLCVVTKLM 266
           RV I+K+   +     +  LR ++  L+   H+NI+    +     +++   + +V  LM
Sbjct: 54  RVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 112
Query: 267 EGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLG 326
           E       +LK++ L    I      +  G+K+++   V +RDL    +LL+   ++ + 
Sbjct: 113 ETDLYK--LLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKIC 170
Query: 327 DMGIVTACKSVGEATEYETD--GYRWL-APEIIAGDPESVSETWMSNVYSFGMVIWEMVT 383
           D G+        + T + T+    RW  APEI+     S   T   +++S G ++ EM++
Sbjct: 171 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN---SKGYTKSIDIWSVGCILAEMLS 227
Query: 384 GEAAY 388
               +
Sbjct: 228 NRPIF 232

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 42/185 (22%), Positives = 84/185 (45%), Gaps = 13/185 (7%)
Query: 211 RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV----CVDENHGLCVVTKLM 266
           RV I+K+   +     +  LR ++  L+   H+NI+    +     +++   + +V  LM
Sbjct: 50  RVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 108
Query: 267 EGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLG 326
           E       +LK++ L    I      +  G+K+++   V +RDL    +LL+   ++ + 
Sbjct: 109 ETDLYK--LLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKIC 166
Query: 327 DMGIVTACKSVGEATEYETD--GYRWL-APEIIAGDPESVSETWMSNVYSFGMVIWEMVT 383
           D G+        + T + T+    RW  APEI+     S   T   +++S G ++ EM++
Sbjct: 167 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN---SKGYTKSIDIWSVGCILAEMLS 223
Query: 384 GEAAY 388
               +
Sbjct: 224 NRPIF 228

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 42/185 (22%), Positives = 84/185 (45%), Gaps = 13/185 (7%)
Query: 211 RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV----CVDENHGLCVVTKLM 266
           RV I+K+   +     +  LR ++  L+   H+NI+    +     +++   + +V  LM
Sbjct: 50  RVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 108
Query: 267 EGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLG 326
           E       +LK++ L    I      +  G+K+++   V +RDL    +LL+   ++ + 
Sbjct: 109 ETDLYK--LLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKIC 166
Query: 327 DMGIVTACKSVGEATEYETD--GYRWL-APEIIAGDPESVSETWMSNVYSFGMVIWEMVT 383
           D G+        + T + T+    RW  APEI+     S   T   +++S G ++ EM++
Sbjct: 167 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN---SKGYTKSIDIWSVGCILAEMLS 223
Query: 384 GEAAY 388
               +
Sbjct: 224 NRPIF 228

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/197 (22%), Positives = 89/197 (45%), Gaps = 31/197 (15%)
Query: 206 VYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLC 260
           V  G ++ ++KL    +   +     ++L  L    H+N++    V      ++E + + 
Sbjct: 73  VKSGLKIAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPATSLEEFNDVY 132
Query: 261 VVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH 320
           +VT LM G  +N+ I+K +KL    +  +   +  G+K+++   + +RDL    + ++  
Sbjct: 133 LVTHLM-GADLNN-IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 190
Query: 321 GNVCLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIAGDPESVSETWMS-----NV 371
             + + D G+          T+ E  GY   RW  APEI+          WM      ++
Sbjct: 191 CELKILDFGL-------ARHTDDEMTGYVATRWYRAPEIMLN--------WMHYNMTVDI 235
Query: 372 YSFGMVIWEMVTGEAAY 388
           +S G ++ E++TG   +
Sbjct: 236 WSVGCIMAELLTGRTLF 252

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 45/200 (22%), Positives = 89/200 (44%), Gaps = 31/200 (15%)
Query: 209 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 263
           G RV ++KL    +   +     ++L  L    H+N++    V      ++E + + +VT
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 106
Query: 264 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 323
            LM G  +N+ I+K +KL    +  +   +  G+K+++   + +RDL    + ++    +
Sbjct: 107 HLM-GADLNN-IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL 164
Query: 324 CLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIAGDPESVSETWMS-----NVYSF 374
            + D G+          T+ E  GY   RW  APEI+          WM      +++S 
Sbjct: 165 KILDGGL-------ARHTDDEMTGYVATRWYRAPEIMLN--------WMHYNQTVDIWSV 209
Query: 375 GMVIWEMVTGEAAYAACSPV 394
           G ++ E++TG   +     +
Sbjct: 210 GCIMAELLTGRTLFPGTDHI 229

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 39/204 (19%), Positives = 95/204 (46%), Gaps = 15/204 (7%)
Query: 207 YKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLM 266
           Y  K +   + +   +G   E E+ +++  L    H NI+  + V  +    + ++ +L+
Sbjct: 40  YAAKFIKKRQSRASRRGVCRE-EIEREVSILRQVLHPNIITLHDVY-ENRTDVVLILELV 97
Query: 267 EGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRI-LLDRH---GN 322
            GG + D + +   L  +E       + +G+ +L+   +A+ DL  + I LLD++    +
Sbjct: 98  SGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPH 157
Query: 323 VCLGDMGIVTACKSVGEATEYET--DGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWE 380
           + L D G+      + +  E++       ++APEI+  +P  +     ++++S G++ + 
Sbjct: 158 IKLIDFGL---AHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLE----ADMWSIGVITYI 210
Query: 381 MVTGEAAYAACSPVQAAVGIAACG 404
           +++G + +   +  +    I A  
Sbjct: 211 LLSGASPFLGDTKQETLANITAVS 234

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 42/182 (23%), Positives = 84/182 (46%), Gaps = 17/182 (9%)
Query: 210 KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVTK 264
           + V I+KL    +   +     ++L+ +    HKNI+    V      ++E   + +V +
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVME 109
Query: 265 LMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVC 324
           LM+  +++ +I    +L  + +  +   +  GIK L+  G+ +RDL    I++     + 
Sbjct: 110 LMDA-NLSQVI--QMELDHERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLK 166
Query: 325 LGDMGIVTACKSVGEATEYETDGYRWLAPEII--AGDPESVSETWMSNVYSFGMVIWEMV 382
           + D G+     +    T Y    Y + APE+I   G  E+V      +++S G ++ EM+
Sbjct: 167 ILDFGLARTAGTSFMMTPYVVTRY-YRAPEVILGMGYKENV------DIWSVGCIMGEMI 219
Query: 383 TG 384
            G
Sbjct: 220 KG 221

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 42/185 (22%), Positives = 84/185 (45%), Gaps = 13/185 (7%)
Query: 211 RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV----CVDENHGLCVVTKLM 266
           RV I+K+   +     +  LR ++  L+   H+NI+    +     +++   + +V  LM
Sbjct: 52  RVAIKKISPFEHQTYCQRTLR-EIKILLAFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 110
Query: 267 EGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLG 326
           E       +LK++ L    I      +  G+K+++   V +RDL    +LL+   ++ + 
Sbjct: 111 ETDLYK--LLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKIC 168
Query: 327 DMGIVTACKSVGEATEYETD--GYRWL-APEIIAGDPESVSETWMSNVYSFGMVIWEMVT 383
           D G+        + T + T+    RW  APEI+     S   T   +++S G ++ EM++
Sbjct: 169 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN---SKGYTKSIDIWSVGCILAEMLS 225
Query: 384 GEAAY 388
               +
Sbjct: 226 NRPIF 230

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 37/203 (18%), Positives = 96/203 (47%), Gaps = 15/203 (7%)
Query: 207 YKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLM 266
           Y  K +   + +   +G + E E+ +++  L    H N++  + V  +    + ++ +L+
Sbjct: 40  YAAKFIKKRQSRASRRGVSRE-EIEREVSILRQVLHHNVITLHDVYENRT-DVVLILELV 97
Query: 267 EGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRI-LLDRH---GN 322
            GG + D + +   L  +E       + +G+ +L+   +A+ DL  + I LLD++    +
Sbjct: 98  SGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPH 157
Query: 323 VCLGDMGIVTACKSVGEATEYET--DGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWE 380
           + L D G+      + +  E++       ++APEI+  +P  +     ++++S G++ + 
Sbjct: 158 IKLIDFGL---AHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLE----ADMWSIGVITYI 210
Query: 381 MVTGEAAYAACSPVQAAVGIAAC 403
           +++G + +   +  +    I + 
Sbjct: 211 LLSGASPFLGDTKQETLANITSV 233

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 37/204 (18%), Positives = 96/204 (47%), Gaps = 15/204 (7%)
Query: 207 YKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLM 266
           Y  K +   + +   +G + E E+ +++  L    H N++  + V  +    + ++ +L+
Sbjct: 40  YAAKFIKKRQSRASRRGVSRE-EIEREVSILRQVLHHNVITLHDVYENRT-DVVLILELV 97
Query: 267 EGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRI-LLDRH---GN 322
            GG + D + +   L  +E       + +G+ +L+   +A+ DL  + I LLD++    +
Sbjct: 98  SGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPH 157
Query: 323 VCLGDMGIVTACKSVGEATEYET--DGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWE 380
           + L D G+      + +  E++       ++APEI+  +P  +     ++++S G++ + 
Sbjct: 158 IKLIDFGL---AHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLE----ADMWSIGVITYI 210
Query: 381 MVTGEAAYAACSPVQAAVGIAACG 404
           +++G + +   +  +    I +  
Sbjct: 211 LLSGASPFLGDTKQETLANITSVS 234

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 51/235 (21%), Positives = 98/235 (41%), Gaps = 25/235 (10%)
Query: 210 KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVTK 264
           + V I+KL    +   +     ++L+ +    HKNI+    V      ++E   + +V +
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVME 109
Query: 265 LMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVC 324
           LM+      + ++   L  + +  +   +  GIK L+  G+ +RDL    I++     + 
Sbjct: 110 LMDANLXQVIQME---LDHERMSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKSDXTLK 166
Query: 325 LGDMGIVTACKSVGEATEYETDGYRWLAPEII--AGDPESVSETWMSNVYSFGMVIWEMV 382
           + D G+     +    T Y    Y + APE+I   G  E+V      +++S G ++ EMV
Sbjct: 167 ILDFGLARTAGTSFMMTPYVVTRY-YRAPEVILGMGYKENV------DIWSVGCIMGEMV 219
Query: 383 TGEAAYAACSPV-QAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFS 436
             +  +     + Q    I   G        CP+ +K L      N    RP+++
Sbjct: 220 RHKILFPGRDYIDQWNKVIEQLG------TPCPEFMKKLQPTV-RNYVENRPKYA 267

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 57/263 (21%), Positives = 104/263 (39%), Gaps = 38/263 (14%)
Query: 197 QIGP----NSFKGVYKGKRVG---------IEKLKGCDKG---NAYEFELRKDLLELMTC 240
           Q+GP      F  VY G RV          +EK +  D G   N     +   LL+ ++ 
Sbjct: 11  QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 70
Query: 241 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL 300
           G   +++        +  + ++ ++     + D I +   LQ +        V E ++  
Sbjct: 71  GFSGVIRLLDWFERPDSFVLILERMEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC 130
Query: 301 NDHGVAYRDLNSQRILLD-RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGD 359
           ++ GV +RD+  + IL+D   G + L D G     K   +    + DG R  +P      
Sbjct: 131 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSP------ 181
Query: 360 PESVSETWM----SNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ 415
           PE +         + V+S G+++++MV G+  +         +       R  +  +C  
Sbjct: 182 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH----DEEIIRGQVFFRQRVSSECQH 237
Query: 416 ILKSLMIKCWNNSPSKRPQFSEI 438
           +++     C    PS RP F EI
Sbjct: 238 LIRW----CLALRPSDRPTFEEI 256

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 42/185 (22%), Positives = 84/185 (45%), Gaps = 13/185 (7%)
Query: 211 RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV----CVDENHGLCVVTKLM 266
           RV I+K+   +     +  LR ++  L+   H+NI+    +     +++   + +V  LM
Sbjct: 58  RVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 116
Query: 267 EGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLG 326
           E       +LK++ L    I      +  G+K+++   V +RDL    +LL+   ++ + 
Sbjct: 117 ETDLYK--LLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKIC 174
Query: 327 DMGIVTACKSVGEATEYETD--GYRWL-APEIIAGDPESVSETWMSNVYSFGMVIWEMVT 383
           D G+        + T + T+    RW  APEI+     S   T   +++S G ++ EM++
Sbjct: 175 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN---SKGYTKSIDIWSVGCILAEMLS 231
Query: 384 GEAAY 388
               +
Sbjct: 232 NRPIF 236

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 42/185 (22%), Positives = 84/185 (45%), Gaps = 13/185 (7%)
Query: 211 RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV----CVDENHGLCVVTKLM 266
           RV I+K+   +     +  LR ++  L+   H+NI+    +     +++   + +V  LM
Sbjct: 50  RVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 108
Query: 267 EGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLG 326
           E       +LK++ L    I      +  G+K+++   V +RDL    +LL+   ++ + 
Sbjct: 109 ETDLYK--LLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKIC 166
Query: 327 DMGIVTACKSVGEATEYETD--GYRWL-APEIIAGDPESVSETWMSNVYSFGMVIWEMVT 383
           D G+        + T + T+    RW  APEI+     S   T   +++S G ++ EM++
Sbjct: 167 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN---SKGYTKSIDIWSVGCILAEMLS 223
Query: 384 GEAAY 388
               +
Sbjct: 224 NRPIF 228

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 37/204 (18%), Positives = 96/204 (47%), Gaps = 15/204 (7%)
Query: 207 YKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLM 266
           Y  K +   + +   +G + E E+ +++  L    H N++  + V  +    + ++ +L+
Sbjct: 40  YAAKFIKKRQSRASRRGVSRE-EIEREVSILRQVLHHNVITLHDVYENRT-DVVLILELV 97
Query: 267 EGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRI-LLDRH---GN 322
            GG + D + +   L  +E       + +G+ +L+   +A+ DL  + I LLD++    +
Sbjct: 98  SGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPH 157
Query: 323 VCLGDMGIVTACKSVGEATEYET--DGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWE 380
           + L D G+      + +  E++       ++APEI+  +P  +     ++++S G++ + 
Sbjct: 158 IKLIDFGL---AHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLE----ADMWSIGVITYI 210
Query: 381 MVTGEAAYAACSPVQAAVGIAACG 404
           +++G + +   +  +    I +  
Sbjct: 211 LLSGASPFLGDTKQETLANITSVS 234

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 42/185 (22%), Positives = 84/185 (45%), Gaps = 13/185 (7%)
Query: 211 RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV----CVDENHGLCVVTKLM 266
           RV I+K+   +     +  LR ++  L+   H+NI+    +     +++   + +V  LM
Sbjct: 55  RVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 113
Query: 267 EGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLG 326
           E       +LK++ L    I      +  G+K+++   V +RDL    +LL+   ++ + 
Sbjct: 114 ETDLYK--LLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKIC 171
Query: 327 DMGIVTACKSVGEATEYETD--GYRWL-APEIIAGDPESVSETWMSNVYSFGMVIWEMVT 383
           D G+        + T + T+    RW  APEI+     S   T   +++S G ++ EM++
Sbjct: 172 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN---SKGYTKSIDIWSVGCILAEMLS 228
Query: 384 GEAAY 388
               +
Sbjct: 229 NRPIF 233

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 42/185 (22%), Positives = 84/185 (45%), Gaps = 13/185 (7%)
Query: 211 RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV----CVDENHGLCVVTKLM 266
           RV I+K+   +     +  LR ++  L+   H+NI+    +     +++   + +V  LM
Sbjct: 56  RVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 114
Query: 267 EGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLG 326
           E       +LK++ L    I      +  G+K+++   V +RDL    +LL+   ++ + 
Sbjct: 115 ETDLYK--LLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKIC 172
Query: 327 DMGIVTACKSVGEATEYETD--GYRWL-APEIIAGDPESVSETWMSNVYSFGMVIWEMVT 383
           D G+        + T + T+    RW  APEI+     S   T   +++S G ++ EM++
Sbjct: 173 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN---SKGYTKSIDIWSVGCILAEMLS 229
Query: 384 GEAAY 388
               +
Sbjct: 230 NRPIF 234

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 42/185 (22%), Positives = 84/185 (45%), Gaps = 13/185 (7%)
Query: 211 RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV----CVDENHGLCVVTKLM 266
           RV I+K+   +     +  LR ++  L+   H+NI+    +     +++   + +V  LM
Sbjct: 47  RVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 105
Query: 267 EGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLG 326
           E       +LK++ L    I      +  G+K+++   V +RDL    +LL+   ++ + 
Sbjct: 106 ETDLYK--LLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKIC 163
Query: 327 DMGIVTACKSVGEATEYETD--GYRWL-APEIIAGDPESVSETWMSNVYSFGMVIWEMVT 383
           D G+        + T + T+    RW  APEI+     S   T   +++S G ++ EM++
Sbjct: 164 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN---SKGYTKSIDIWSVGCILAEMLS 220
Query: 384 GEAAY 388
               +
Sbjct: 221 NRPIF 225

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 42/185 (22%), Positives = 84/185 (45%), Gaps = 13/185 (7%)
Query: 211 RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV----CVDENHGLCVVTKLM 266
           RV I+K+   +     +  LR ++  L+   H+NI+    +     +++   + +V  LM
Sbjct: 54  RVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 112
Query: 267 EGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLG 326
           E       +LK++ L    I      +  G+K+++   V +RDL    +LL+   ++ + 
Sbjct: 113 ETDLYK--LLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKIC 170
Query: 327 DMGIVTACKSVGEATEYETD--GYRWL-APEIIAGDPESVSETWMSNVYSFGMVIWEMVT 383
           D G+        + T + T+    RW  APEI+     S   T   +++S G ++ EM++
Sbjct: 171 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN---SKGYTKSIDIWSVGCILAEMLS 227
Query: 384 GEAAY 388
               +
Sbjct: 228 NRPIF 232

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 42/185 (22%), Positives = 84/185 (45%), Gaps = 13/185 (7%)
Query: 211 RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV----CVDENHGLCVVTKLM 266
           RV I+K+   +     +  LR ++  L+   H+NI+    +     +++   + +V  LM
Sbjct: 50  RVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 108
Query: 267 EGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLG 326
           E       +LK++ L    I      +  G+K+++   V +RDL    +LL+   ++ + 
Sbjct: 109 ETDLYK--LLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKIC 166
Query: 327 DMGIVTACKSVGEATEYETD--GYRWL-APEIIAGDPESVSETWMSNVYSFGMVIWEMVT 383
           D G+        + T + T+    RW  APEI+     S   T   +++S G ++ EM++
Sbjct: 167 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN---SKGYTKSIDIWSVGCILAEMLS 223
Query: 384 GEAAY 388
               +
Sbjct: 224 NRPIF 228

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 42/185 (22%), Positives = 84/185 (45%), Gaps = 13/185 (7%)
Query: 211 RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV----CVDENHGLCVVTKLM 266
           RV I+K+   +     +  LR ++  L+   H+NI+    +     +++   + +V  LM
Sbjct: 48  RVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 106
Query: 267 EGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLG 326
           E       +LK++ L    I      +  G+K+++   V +RDL    +LL+   ++ + 
Sbjct: 107 ETDLYK--LLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKIC 164
Query: 327 DMGIVTACKSVGEATEYETD--GYRWL-APEIIAGDPESVSETWMSNVYSFGMVIWEMVT 383
           D G+        + T + T+    RW  APEI+     S   T   +++S G ++ EM++
Sbjct: 165 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN---SKGYTKSIDIWSVGCILAEMLS 221
Query: 384 GEAAY 388
               +
Sbjct: 222 NRPIF 226

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 42/185 (22%), Positives = 84/185 (45%), Gaps = 13/185 (7%)
Query: 211 RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV----CVDENHGLCVVTKLM 266
           RV I+K+   +     +  LR ++  L+   H+NI+    +     +++   + +V  LM
Sbjct: 48  RVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 106
Query: 267 EGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLG 326
           E       +LK++ L    I      +  G+K+++   V +RDL    +LL+   ++ + 
Sbjct: 107 ETDLYK--LLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKIC 164
Query: 327 DMGIVTACKSVGEATEYETD--GYRWL-APEIIAGDPESVSETWMSNVYSFGMVIWEMVT 383
           D G+        + T + T+    RW  APEI+     S   T   +++S G ++ EM++
Sbjct: 165 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN---SKGYTKSIDIWSVGCILAEMLS 221
Query: 384 GEAAY 388
               +
Sbjct: 222 NRPIF 226

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 44/200 (22%), Positives = 88/200 (44%), Gaps = 31/200 (15%)
Query: 209 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 263
           G RV ++KL    +   +     ++L  L    H+N++    V      ++E + + +VT
Sbjct: 47  GHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 106
Query: 264 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 323
            LM G  +N+ I+K +KL    +  +   +  G+K+++   + +RDL    + ++    +
Sbjct: 107 HLM-GADLNN-IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL 164
Query: 324 CLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIAGDPESVSETWMS-----NVYSF 374
            + D  +          T+ E  GY   RW  APEI+          WM      +++S 
Sbjct: 165 KILDFYL-------ARHTDDEMTGYVATRWYRAPEIMLN--------WMHYNQTVDIWSV 209
Query: 375 GMVIWEMVTGEAAYAACSPV 394
           G ++ E++TG   +     +
Sbjct: 210 GCIMAELLTGRTLFPGTDHI 229

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 56/269 (20%), Positives = 110/269 (40%), Gaps = 16/269 (5%)
Query: 177 SGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGKR------VGIEKL-KGCDKGNAYEFE 229
           SG  +I       D+ E    +G   F  VY  +       V ++ L K   +    E +
Sbjct: 10  SGTPDILTRHFTIDDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQ 69
Query: 230 LRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRI 289
           LR+++       H NIL+ Y    D    + ++ +    G +   + KS     +    I
Sbjct: 70  LRREIEIQAHLHHPNILRLYNYFYDRRR-IYLILEYAPRGELYKELQKSCTFDEQRTATI 128
Query: 290 AIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR 349
             ++A+ + + +   V +RD+  + +LL   G + + D G      S+   T   T  Y 
Sbjct: 129 MEELADALMYCHGKKVIHRDIKPENLLLGLKGELKIADFGWSVHAPSLRRKTMCGTLDY- 187
Query: 350 WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEI 409
            L PE+I G   +       +++  G++ +E++ G   + + S  +    I    L+   
Sbjct: 188 -LPPEMIEGRMHNEK----VDLWCIGVLCYELLVGNPPFESASHNETYRRIVKVDLK--F 240
Query: 410 PKDCPQILKSLMIKCWNNSPSKRPQFSEI 438
           P   P   + L+ K   ++PS+R   +++
Sbjct: 241 PASVPTGAQDLISKLLRHNPSERLPLAQV 269

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 42/185 (22%), Positives = 84/185 (45%), Gaps = 13/185 (7%)
Query: 211 RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV----CVDENHGLCVVTKLM 266
           RV I+K+   +     +  LR ++  L+   H+NI+    +     +++   + +V  LM
Sbjct: 52  RVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 110
Query: 267 EGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLG 326
           E       +LK++ L    I      +  G+K+++   V +RDL    +LL+   ++ + 
Sbjct: 111 ETDLYK--LLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKIC 168
Query: 327 DMGIVTACKSVGEATEYETD--GYRWL-APEIIAGDPESVSETWMSNVYSFGMVIWEMVT 383
           D G+        + T + T+    RW  APEI+     S   T   +++S G ++ EM++
Sbjct: 169 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN---SKGYTKSIDIWSVGCILAEMLS 225
Query: 384 GEAAY 388
               +
Sbjct: 226 NRPIF 230

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 54/230 (23%), Positives = 92/230 (40%), Gaps = 37/230 (16%)
Query: 234 LLELMTCGHKNILQFYCVCV----DENHGLCVVTKLMEGGSVNDL-ILKSRKLQTKEIIR 288
           L  L T  H N+++ + VC     D    L +V + ++      L  +    + T+ I  
Sbjct: 65  LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKD 124
Query: 289 IAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK-SVGEATEYETDG 347
           +   +  G+ FL+ H V +RDL  Q IL+   G + L D G+       +   +   T  
Sbjct: 125 MMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLW 184
Query: 348 YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPV-QAAVGIAACGLR 406
           YR  APE++       S     +++S G +  EM   +  +   S V Q    +   GL 
Sbjct: 185 YR--APEVLL----QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLP 238
Query: 407 PE--------IPK----------------DCPQILKSLMIKCWNNSPSKR 432
            E        +P+                D  ++ K L++KC   +P+KR
Sbjct: 239 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKR 288

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 54/230 (23%), Positives = 92/230 (40%), Gaps = 37/230 (16%)
Query: 234 LLELMTCGHKNILQFYCVCV----DENHGLCVVTKLMEGGSVNDL-ILKSRKLQTKEIIR 288
           L  L T  H N+++ + VC     D    L +V + ++      L  +    + T+ I  
Sbjct: 65  LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKD 124
Query: 289 IAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK-SVGEATEYETDG 347
           +   +  G+ FL+ H V +RDL  Q IL+   G + L D G+       +   +   T  
Sbjct: 125 MMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLW 184
Query: 348 YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPV-QAAVGIAACGLR 406
           YR  APE++       S     +++S G +  EM   +  +   S V Q    +   GL 
Sbjct: 185 YR--APEVLL----QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLP 238
Query: 407 PE--------IPK----------------DCPQILKSLMIKCWNNSPSKR 432
            E        +P+                D  ++ K L++KC   +P+KR
Sbjct: 239 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKR 288

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 54/230 (23%), Positives = 92/230 (40%), Gaps = 37/230 (16%)
Query: 234 LLELMTCGHKNILQFYCVCV----DENHGLCVVTKLMEGGSVNDL-ILKSRKLQTKEIIR 288
           L  L T  H N+++ + VC     D    L +V + ++      L  +    + T+ I  
Sbjct: 65  LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKD 124
Query: 289 IAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK-SVGEATEYETDG 347
           +   +  G+ FL+ H V +RDL  Q IL+   G + L D G+       +   +   T  
Sbjct: 125 MMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLW 184
Query: 348 YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPV-QAAVGIAACGLR 406
           YR  APE++       S     +++S G +  EM   +  +   S V Q    +   GL 
Sbjct: 185 YR--APEVLLQS----SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLP 238
Query: 407 PE--------IPK----------------DCPQILKSLMIKCWNNSPSKR 432
            E        +P+                D  ++ K L++KC   +P+KR
Sbjct: 239 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKR 288

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 28/131 (21%), Positives = 58/131 (44%), Gaps = 5/131 (3%)
Query: 259 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN-DHGVAYRDLNSQRILL 317
           LC V +   GG +   + + R            ++   + +L+ +  V YRDL  + ++L
Sbjct: 83  LCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLML 142
Query: 318 DRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMV 377
           D+ G++ + D G+       G   +       +LAPE++  +    +  W    +  G+V
Sbjct: 143 DKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDNDYGRAVDW----WGLGVV 198
Query: 378 IWEMVTGEAAY 388
           ++EM+ G   +
Sbjct: 199 MYEMMCGRLPF 209

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 28/131 (21%), Positives = 58/131 (44%), Gaps = 5/131 (3%)
Query: 259 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN-DHGVAYRDLNSQRILL 317
           LC V +   GG +   + + R            ++   + +L+ +  V YRDL  + ++L
Sbjct: 85  LCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLML 144
Query: 318 DRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMV 377
           D+ G++ + D G+       G   +       +LAPE++  +    +  W    +  G+V
Sbjct: 145 DKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDNDYGRAVDW----WGLGVV 200
Query: 378 IWEMVTGEAAY 388
           ++EM+ G   +
Sbjct: 201 MYEMMCGRLPF 211

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 42/185 (22%), Positives = 84/185 (45%), Gaps = 13/185 (7%)
Query: 211 RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV----CVDENHGLCVVTKLM 266
           RV I+K+   +     +  LR ++  L+   H+NI+    +     +++   + +V  LM
Sbjct: 70  RVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 128
Query: 267 EGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLG 326
           E       +LK++ L    I      +  G+K+++   V +RDL    +LL+   ++ + 
Sbjct: 129 ETDLYK--LLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKIC 186
Query: 327 DMGIVTACKSVGEATEYETD--GYRWL-APEIIAGDPESVSETWMSNVYSFGMVIWEMVT 383
           D G+        + T + T+    RW  APEI+     S   T   +++S G ++ EM++
Sbjct: 187 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN---SKGYTKSIDIWSVGCILAEMLS 243
Query: 384 GEAAY 388
               +
Sbjct: 244 NRPIF 248

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 42/185 (22%), Positives = 83/185 (44%), Gaps = 13/185 (7%)
Query: 211 RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV----CVDENHGLCVVTKLM 266
           RV I K+   +     +  LR ++  L+   H+NI+    +     +++   + +V  LM
Sbjct: 54  RVAIRKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 112
Query: 267 EGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLG 326
           E       +LK++ L    I      +  G+K+++   V +RDL    +LL+   ++ + 
Sbjct: 113 ETDLYK--LLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKIC 170
Query: 327 DMGIVTACKSVGEATEYETD--GYRWL-APEIIAGDPESVSETWMSNVYSFGMVIWEMVT 383
           D G+        + T + T+    RW  APEI+     S   T   +++S G ++ EM++
Sbjct: 171 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN---SKGYTKSIDIWSVGCILAEMLS 227
Query: 384 GEAAY 388
               +
Sbjct: 228 NRPIF 232

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 28/131 (21%), Positives = 58/131 (44%), Gaps = 5/131 (3%)
Query: 259 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN-DHGVAYRDLNSQRILL 317
           LC V +   GG +   + + R            ++   + +L+ +  V YRDL  + ++L
Sbjct: 84  LCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLML 143
Query: 318 DRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMV 377
           D+ G++ + D G+       G   +       +LAPE++  +    +  W    +  G+V
Sbjct: 144 DKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDNDYGRAVDW----WGLGVV 199
Query: 378 IWEMVTGEAAY 388
           ++EM+ G   +
Sbjct: 200 MYEMMCGRLPF 210

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 47/210 (22%), Positives = 94/210 (44%), Gaps = 19/210 (9%)
Query: 232 KDLLELM-TCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIA 290
           K  +E+M +  H NI++ Y    ++N  + +V +L  GG + + ++  R  +  +  RI 
Sbjct: 71  KQEIEIMKSLDHPNIIRLY-ETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIM 129
Query: 291 IDVAEGIKFLNDHGVAYRDLNSQRILL---DRHGNVCLGDMGIVTACKSVGEATEYETDG 347
            DV   + + +   VA+RDL  +  L         + L D G+    K  G+    +   
Sbjct: 130 KDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP-GKMMRTKVGT 188
Query: 348 YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR- 406
             +++P+++ G      + W     S G++++ ++ G   ++A +  +  + I       
Sbjct: 189 PYYVSPQVLEGLYGPECDEW-----SAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTF 243
Query: 407 PEIPKD----CPQILKSLMIKCWNNSPSKR 432
           PE  KD     PQ  +SL+ +    SP +R
Sbjct: 244 PE--KDWLNVSPQA-ESLIRRLLTKSPKQR 270

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 49/215 (22%), Positives = 98/215 (45%), Gaps = 16/215 (7%)
Query: 186 LLNSDNLEFIDQIGPNSFKGVYKGKRVG----IEKLKGCDKGNAYEFELRKDLLELMTCG 241
           + +SD  E +  IG  +F GV +  R      +  +K  ++G   +  ++++++   +  
Sbjct: 15  MHDSDRYELVKDIGAGNF-GVARLMRDKQANELVAVKYIERGEKIDENVKREIINHRSLR 73
Query: 242 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 301
           H NI++F  V +   H L +V +   GG + + I  + +    E       +  G+ + +
Sbjct: 74  HPNIVRFKEVILTPTH-LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYAH 132
Query: 302 DHGVAYRDLNSQRILLD--RHGNVCLGDMGIVTACKSVGEATEYETDGY-RWLAPEIIAG 358
              VA+RDL  +  LLD      + + D G   A  SV  +      G   ++APE++  
Sbjct: 133 AMQVAHRDLKLENTLLDGSPAPRLKIADFGYSKA--SVLHSQPKSAVGTPAYIAPEVLL- 189
Query: 359 DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSP 393
             +   +  +++V+S G+ ++ M+ G  AY    P
Sbjct: 190 --KKEYDGKVADVWSCGVTLYVMLVG--AYPFEDP 220

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 53/237 (22%), Positives = 103/237 (43%), Gaps = 20/237 (8%)
Query: 205 GVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELM-TCGHKNILQFYCVCVDENHGLCVVT 263
            V KG R+     K   K    + +  K  +E+M +  H NI++ Y    ++N  + +V 
Sbjct: 28  AVQKGTRIR-RAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLY-ETFEDNTDIYLVM 85
Query: 264 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILL---DRH 320
           +L  GG + + ++  R  +  +  RI  DV   + + +   VA+RDL  +  L       
Sbjct: 86  ELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPD 145
Query: 321 GNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWE 380
             + L D G+    K  G+    +     +++P+++ G      + W     S G++++ 
Sbjct: 146 SPLKLIDFGLAARFKP-GKMMRTKVGTPYYVSPQVLEGLYGPECDEW-----SAGVMMYV 199
Query: 381 MVTGEAAYAACSPVQAAVGIAACGLR-PEIPKD----CPQILKSLMIKCWNNSPSKR 432
           ++ G   ++A +  +  + I       PE  KD     PQ  +SL+ +    SP +R
Sbjct: 200 LLCGYPPFSAPTDXEVMLKIREGTFTFPE--KDWLNVSPQA-ESLIRRLLTKSPKQR 253

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 48/234 (20%), Positives = 98/234 (41%), Gaps = 23/234 (9%)
Query: 210 KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVTK 264
           + V I+KL    +   +     ++L+ +    HKNI+    V      ++E   + +V +
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVME 109
Query: 265 LMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVC 324
           LM+      + ++   L  + +  +   +  GIK L+  G+ +RDL    I++     + 
Sbjct: 110 LMDANLXQVIQME---LDHERMSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKSDXTLK 166
Query: 325 LGDMGIVTACKSVGEATEYETDGYRWLAPEII--AGDPESVSETWMSNVYSFGMVIWEMV 382
           + D G+     +    T Y    Y + APE+I   G  E+V      +++S G ++ EMV
Sbjct: 167 ILDFGLARTAGTSFMMTPYVVTRY-YRAPEVILGMGYKENV------DIWSVGCIMGEMV 219
Query: 383 TGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFS 436
             +  +     +     +       ++   CP+ +K L      N    RP+++
Sbjct: 220 RHKILFPGRDYIDQWNKVIE-----QLGTPCPEFMKKLQPTV-RNYVENRPKYA 267

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 28/131 (21%), Positives = 58/131 (44%), Gaps = 5/131 (3%)
Query: 259 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN-DHGVAYRDLNSQRILL 317
           LC V +   GG +   + + R            ++   + +L+ +  V YRDL  + ++L
Sbjct: 226 LCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLML 285
Query: 318 DRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMV 377
           D+ G++ + D G+       G   +       +LAPE++  +    +  W    +  G+V
Sbjct: 286 DKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDW----WGLGVV 341
Query: 378 IWEMVTGEAAY 388
           ++EM+ G   +
Sbjct: 342 MYEMMCGRLPF 352

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 28/131 (21%), Positives = 58/131 (44%), Gaps = 5/131 (3%)
Query: 259 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN-DHGVAYRDLNSQRILL 317
           LC V +   GG +   + + R            ++   + +L+ +  V YRDL  + ++L
Sbjct: 223 LCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLML 282
Query: 318 DRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMV 377
           D+ G++ + D G+       G   +       +LAPE++  +    +  W    +  G+V
Sbjct: 283 DKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDW----WGLGVV 338
Query: 378 IWEMVTGEAAY 388
           ++EM+ G   +
Sbjct: 339 MYEMMCGRLPF 349

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 51/235 (21%), Positives = 98/235 (41%), Gaps = 25/235 (10%)
Query: 210 KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVTK 264
           + V I+KL    +   +     ++L+ +    HKNI+    V      ++E   + +V +
Sbjct: 43  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVME 102
Query: 265 LMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVC 324
           LM+      + ++   L  + +  +   +  GIK L+  G+ +RDL    I++     + 
Sbjct: 103 LMDANLXQVIQME---LDHERMSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKSDXTLK 159
Query: 325 LGDMGIVTACKSVGEATEYETDGYRWLAPEII--AGDPESVSETWMSNVYSFGMVIWEMV 382
           + D G+     +    T Y    Y + APE+I   G  E+V      +++S G ++ EMV
Sbjct: 160 ILDFGLARTAGTSFMMTPYVVTRY-YRAPEVILGMGYKENV------DIWSVGCIMGEMV 212
Query: 383 TGEAAYAACSPV-QAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFS 436
             +  +     + Q    I   G        CP+ +K L      N    RP+++
Sbjct: 213 RHKILFPGRDYIDQWNKVIEQLG------TPCPEFMKKLQPTV-RNYVENRPKYA 260

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 42/185 (22%), Positives = 83/185 (44%), Gaps = 13/185 (7%)
Query: 211 RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV----CVDENHGLCVVTKLM 266
           RV I+K+   +     +  LR ++  L+   H+NI+    +     +++   + +V  LM
Sbjct: 54  RVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 112
Query: 267 EGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLG 326
           E       +LK++ L    I      +  G+K+++   V +RDL    +LL+   ++ + 
Sbjct: 113 ETDLYK--LLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKIC 170
Query: 327 DMGIVTACKSVGEATEY--ETDGYRWL-APEIIAGDPESVSETWMSNVYSFGMVIWEMVT 383
           D G+        + T +  E    RW  APEI+     S   T   +++S G ++ EM++
Sbjct: 171 DFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLN---SKGYTKSIDIWSVGCILAEMLS 227
Query: 384 GEAAY 388
               +
Sbjct: 228 NRPIF 232

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 42/185 (22%), Positives = 83/185 (44%), Gaps = 13/185 (7%)
Query: 211 RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV----CVDENHGLCVVTKLM 266
           RV I+K+   +     +  LR ++  L+   H+NI+    +     +++   + +V  LM
Sbjct: 55  RVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 113
Query: 267 EGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLG 326
           E       +LK++ L    I      +  G+K+++   V +RDL    +LL+   ++ + 
Sbjct: 114 ETDLYK--LLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKIC 171
Query: 327 DMGIVTACKSVGEATEY--ETDGYRWL-APEIIAGDPESVSETWMSNVYSFGMVIWEMVT 383
           D G+        + T +  E    RW  APEI+     S   T   +++S G ++ EM++
Sbjct: 172 DFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLN---SKGYTKSIDIWSVGCILAEMLS 228
Query: 384 GEAAY 388
               +
Sbjct: 229 NRPIF 233

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 44/200 (22%), Positives = 88/200 (44%), Gaps = 31/200 (15%)
Query: 209 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 263
           G RV ++KL    +   +     ++L  L    H+N++    V      ++E + + +VT
Sbjct: 67  GHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 126
Query: 264 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 323
            LM G  +N+ I+K +KL    +  +   +  G+K+++   + +RDL    + ++    +
Sbjct: 127 HLM-GADLNN-IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL 184
Query: 324 CLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIAGDPESVSETWMS-----NVYSF 374
            + D G+          T+ E  G    RW  APEI+          WM      +++S 
Sbjct: 185 KILDFGL-------ARHTDDEMXGXVATRWYRAPEIMLN--------WMHYNQTVDIWSV 229
Query: 375 GMVIWEMVTGEAAYAACSPV 394
           G ++ E++TG   +     +
Sbjct: 230 GCIMAELLTGRTLFPGTDHI 249

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 49/223 (21%), Positives = 103/223 (46%), Gaps = 20/223 (8%)
Query: 229 ELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL-KSRKLQTKEII 287
           E++ ++  +    H N++Q Y     +N  + +V + ++GG + D I+ +S  L   + I
Sbjct: 132 EVKNEISVMNQLDHANLIQLYDAFESKN-DIVLVMEYVDGGELFDRIIDESYNLTELDTI 190
Query: 288 RIAIDVAEGIKFLNDHGVAYRDLNSQRIL-LDRHG-NVCLGDMGIVTACKSVGEATEYET 345
                + EGI+ ++   + + DL  + IL ++R    + + D G+    K   E  +   
Sbjct: 191 LFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP-REKLKVNF 249
Query: 346 DGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGL 405
               +LAPE++  D  S    + ++++S G++ + +++G + +   +  +    I AC  
Sbjct: 250 GTPEFLAPEVVNYDFVS----FPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRW 305
Query: 406 RPE------IPKDCPQILKSLMI--KCWNNSPS---KRPQFSE 437
             E      I ++  + +  L+I  K W  S S   K P  S+
Sbjct: 306 DLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSD 348

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 42/182 (23%), Positives = 84/182 (46%), Gaps = 17/182 (9%)
Query: 210 KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVTK 264
           + V I+KL    +   +     ++L+ +    HKNI+    V      ++E   + +V +
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVME 109
Query: 265 LMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVC 324
           LM+  +++ +I    +L  + +  +   +  GIK L+  G+ +RDL    I++     + 
Sbjct: 110 LMDA-NLSQVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDATLK 166
Query: 325 LGDMGIVTACKSVGEATEYETDGYRWLAPEII--AGDPESVSETWMSNVYSFGMVIWEMV 382
           + D G+     +    T Y    Y + APE+I   G  E+V      +++S G ++ EM+
Sbjct: 167 ILDFGLARTAGTSFMMTPYVVTRY-YRAPEVILGMGYKENV------DIWSVGCIMGEMI 219
Query: 383 TG 384
            G
Sbjct: 220 KG 221

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 57/263 (21%), Positives = 103/263 (39%), Gaps = 38/263 (14%)
Query: 197 QIGP----NSFKGVYKGKRVG---------IEKLKGCDKG---NAYEFELRKDLLELMTC 240
           Q+GP      F  VY G RV          +EK +  D G   N     +   LL+ ++ 
Sbjct: 7   QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 66
Query: 241 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL 300
           G   +++        +  + ++ +      + D I +   LQ +        V E ++  
Sbjct: 67  GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC 126
Query: 301 NDHGVAYRDLNSQRILLD-RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGD 359
           ++ GV +RD+  + IL+D   G + L D G     K   +    + DG R  +P      
Sbjct: 127 HNXGVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSP------ 177
Query: 360 PESVSETWM----SNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ 415
           PE +         + V+S G+++++MV G+  +         +       R  +  +C  
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH----DEEIIRGQVFFRQRVSXECQH 233
Query: 416 ILKSLMIKCWNNSPSKRPQFSEI 438
           +++     C    PS RP F EI
Sbjct: 234 LIRW----CLALRPSDRPTFEEI 252

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 43/190 (22%), Positives = 87/190 (45%), Gaps = 17/190 (8%)
Query: 208 KGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV----CVDENHGLCVVT 263
           +  RV I+K+   +     +  LR ++  L+   H+N++    +     ++    + +V 
Sbjct: 67  RKTRVAIKKISPFEHQTYCQRTLR-EIQILLRFRHENVIGIRDILRASTLEAMRDVYIVQ 125
Query: 264 KLMEGGSVNDL--ILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG 321
            LME     DL  +LKS++L    I      +  G+K+++   V +RDL    +L++   
Sbjct: 126 DLME----TDLYKLLKSQQLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLINTTC 181
Query: 322 NVCLGDMGIVTACKSVGEATEYETD--GYRWL-APEIIAGDPESVSETWMSNVYSFGMVI 378
           ++ + D G+        + T + T+    RW  APEI+     S   T   +++S G ++
Sbjct: 182 DLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEIMLN---SKGYTKSIDIWSVGCIL 238
Query: 379 WEMVTGEAAY 388
            EM++    +
Sbjct: 239 AEMLSNRPIF 248

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 41/187 (21%), Positives = 82/187 (43%), Gaps = 15/187 (8%)
Query: 259 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAI--DVAEGIKFLNDHGVAYRDLNSQRIL 316
           L +  +  + G++   I K R  +  +++ + +   + +G+ +++   +  RDL    I 
Sbjct: 95  LFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIF 154
Query: 317 LDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGM 376
           L     V +GD G+VT+ K+ G+    +    R+++PE I+            ++Y+ G+
Sbjct: 155 LVDTKQVKIGDFGLVTSLKNDGKRXRSKG-TLRYMSPEQISSQDYGKE----VDLYALGL 209
Query: 377 VIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDC-PQILKSLMIKCWNNSPSKRPQF 435
           ++ E++        C             LR  I  D   +  K+L+ K  +  P  RP  
Sbjct: 210 ILAELL------HVCDTAFETSKFFT-DLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNT 262
Query: 436 SEIISLL 442
           SEI+  L
Sbjct: 263 SEILRTL 269

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/108 (25%), Positives = 52/108 (48%), Gaps = 16/108 (14%)
Query: 287 IRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYET- 345
           + I + +AE ++FL+  G+ +RDL    I       V +GD G+VTA     E     T 
Sbjct: 121 LHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 180
Query: 346 -DGYR----------WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMV 382
              Y           +++PE I G+    S +   +++S G++++E++
Sbjct: 181 MPAYARHTGQVGTKLYMSPEQIHGN----SYSHKVDIFSLGLILFELL 224

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/190 (22%), Positives = 91/190 (47%), Gaps = 25/190 (13%)
Query: 210 KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVTK 264
           ++V ++KL    +   +     ++L  L    H+N++    V      +++   + +VT 
Sbjct: 54  QKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTT 113
Query: 265 LMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVC 324
           LM G  +N+ I+K + L  + +  +   +  G+K+++  G+ +RDL    + ++    + 
Sbjct: 114 LM-GADLNN-IVKCQALSDEHVQFLVYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDSELR 171
Query: 325 LGDMGIVTACKSVGEATEY-ETDGYRWLAPEIIAGDPESVSETWMS-----NVYSFGMVI 378
           + D G+  A ++  E T Y  T  YR  APEI+          WM      +++S G ++
Sbjct: 172 ILDFGL--ARQADEEMTGYVATRWYR--APEIML--------NWMHYNQTVDIWSVGCIM 219
Query: 379 WEMVTGEAAY 388
            E++ G+A +
Sbjct: 220 AELLQGKALF 229

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/185 (22%), Positives = 83/185 (44%), Gaps = 13/185 (7%)
Query: 211 RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV----CVDENHGLCVVTKLM 266
           RV I+K+   +     +  LR ++  L+   H+NI+    +     +++   + +V  LM
Sbjct: 54  RVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 112
Query: 267 EGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLG 326
           E       +LK + L    I      +  G+K+++   V +RDL    +LL+   ++ + 
Sbjct: 113 ETDLYK--LLKCQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKIC 170
Query: 327 DMGIVTACKSVGEATEYETD--GYRWL-APEIIAGDPESVSETWMSNVYSFGMVIWEMVT 383
           D G+        + T + T+    RW  APEI+     S   T   +++S G ++ EM++
Sbjct: 171 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN---SKGYTKSIDIWSVGCILAEMLS 227
Query: 384 GEAAY 388
               +
Sbjct: 228 NRPIF 232

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/200 (22%), Positives = 88/200 (44%), Gaps = 31/200 (15%)
Query: 209 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 263
           G RV ++KL    +   +     ++L  L    H+N++    V      ++E + + +VT
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 106
Query: 264 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 323
            LM G  +N+ I+K +KL    +  +   +  G+K+++   + +RDL    + ++    +
Sbjct: 107 HLM-GADLNN-IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL 164
Query: 324 CLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIAGDPESVSETWMS-----NVYSF 374
            +   G+          T+ E  GY   RW  APEI+          WM      +++S 
Sbjct: 165 KILGFGL-------ARHTDDEMTGYVATRWYRAPEIMLN--------WMHYNQTVDIWSV 209
Query: 375 GMVIWEMVTGEAAYAACSPV 394
           G ++ E++TG   +     +
Sbjct: 210 GCIMAELLTGRTLFPGTDHI 229

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/182 (23%), Positives = 82/182 (45%), Gaps = 15/182 (8%)
Query: 209 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 263
           G  V ++KL    +   +     ++L+ L    HKNI+    V      ++E   + +V 
Sbjct: 49  GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVM 108
Query: 264 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 323
           +LM+      + ++   L  + +  +   +  GIK L+  G+ +RDL    I++     +
Sbjct: 109 ELMDANLCQVIHME---LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL 165
Query: 324 CLGDMGIV-TACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMV 382
            + D G+  TAC +        T  YR  APE+I G   + +     +++S G ++ E+V
Sbjct: 166 KILDFGLARTACTNFMMTPYVVTRYYR--APEVILGMGYAAN----VDIWSVGCIMGELV 219
Query: 383 TG 384
            G
Sbjct: 220 KG 221

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/203 (21%), Positives = 93/203 (45%), Gaps = 28/203 (13%)
Query: 256 NHG---LCVVTKLMEGGSVNDLILK--SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDL 310
           +HG   L ++ + MEGG +   I +   +    +E   I  D+   I+FL+ H +A+RD+
Sbjct: 76  HHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDV 135
Query: 311 NSQRILL---DRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETW 367
             + +L    ++   + L D G           T   T  Y  +APE++   PE   ++ 
Sbjct: 136 KPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYY--VAPEVLG--PEKYDKS- 190
Query: 368 MSNVYSFGMVIWEMVTGEAAY-----AACSP-VQAAVGIAACGLR----PEIPKDCPQIL 417
             +++S G++++ ++ G   +      A SP ++  + +   G       E+ +D  Q++
Sbjct: 191 -CDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLI 249
Query: 418 KSLMIKCWNNSPSKRPQFSEIIS 440
           + L+       P++R   ++ ++
Sbjct: 250 RLLL----KTDPTERLTITQFMN 268

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 58/263 (22%), Positives = 105/263 (39%), Gaps = 38/263 (14%)
Query: 197 QIGP----NSFKGVYKGKRVG---------IEKLKGCDKG---NAYEFELRKDLLELMTC 240
           Q+GP      F  VY G RV          +EK +  D G   N     +   LL+ ++ 
Sbjct: 7   QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 66
Query: 241 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL 300
           G   +++        +  + ++ +      + D I +   LQ +        V E ++  
Sbjct: 67  GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC 126
Query: 301 NDHGVAYRDLNSQRILLD-RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGD 359
           ++ GV +RD+  + IL+D   G + L D G     K   +    + DG R  +P      
Sbjct: 127 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSP------ 177
Query: 360 PESVSETWM----SNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ 415
           PE +         + V+S G+++++MV G+  +     +   +G      R  +  +C  
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI---IG-GQVFFRQRVSSECQH 233
Query: 416 ILKSLMIKCWNNSPSKRPQFSEI 438
           +++     C    PS RP F EI
Sbjct: 234 LIRW----CLALRPSDRPTFEEI 252

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/203 (21%), Positives = 93/203 (45%), Gaps = 28/203 (13%)
Query: 256 NHG---LCVVTKLMEGGSVNDLILK--SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDL 310
           +HG   L ++ + MEGG +   I +   +    +E   I  D+   I+FL+ H +A+RD+
Sbjct: 95  HHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDV 154
Query: 311 NSQRILL---DRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETW 367
             + +L    ++   + L D G           T   T  Y  +APE++   PE   ++ 
Sbjct: 155 KPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYY--VAPEVLG--PEKYDKS- 209
Query: 368 MSNVYSFGMVIWEMVTGEAAY-----AACSP-VQAAVGIAACGLR----PEIPKDCPQIL 417
             +++S G++++ ++ G   +      A SP ++  + +   G       E+ +D  Q++
Sbjct: 210 -CDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLI 268
Query: 418 KSLMIKCWNNSPSKRPQFSEIIS 440
           + L+       P++R   ++ ++
Sbjct: 269 RLLL----KTDPTERLTITQFMN 287

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/200 (22%), Positives = 88/200 (44%), Gaps = 31/200 (15%)
Query: 209 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 263
           G RV ++KL    +   +     ++L  L    H+N++    V      ++E + + +VT
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 106
Query: 264 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 323
            LM G  +N+ I+K +KL    +  +   +  G+K+++   + +RDL    + ++    +
Sbjct: 107 HLM-GADLNN-IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCEL 164
Query: 324 CLGDMGIVTACKSVGEATEYETDGY---RWL-APEIIAGDPESVSETWMS-----NVYSF 374
            + D G+          T+ E  G    RW  APEI+          WM      +++S 
Sbjct: 165 KILDFGL-------ARHTDDEMTGXVATRWYRAPEIMLN--------WMHYNQTVDIWSV 209
Query: 375 GMVIWEMVTGEAAYAACSPV 394
           G ++ E++TG   +     +
Sbjct: 210 GCIMAELLTGRTLFPGTDHI 229

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/175 (18%), Positives = 82/175 (46%), Gaps = 8/175 (4%)
Query: 232 KDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL-KSRKLQTKEIIRIA 290
           K+ + +M   H   L       ++ + + ++ + + GG + D I  +  K+   E+I   
Sbjct: 96  KNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYM 155
Query: 291 IDVAEGIKFLNDHGVAYRDLNSQRILLD--RHGNVCLGDMGIVTACKSVGEATEYETDGY 348
               EG+K +++H + + D+  + I+ +  +  +V + D G+ T      E  +  T   
Sbjct: 156 RQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP-DEIVKVTTATA 214
Query: 349 RWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAAC 403
            + APEI+  +P      + +++++ G++ + +++G + +A    ++    +  C
Sbjct: 215 EFAAPEIVDREPVG----FYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRC 265

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 57/263 (21%), Positives = 103/263 (39%), Gaps = 38/263 (14%)
Query: 197 QIGP----NSFKGVYKGKRVG---------IEKLKGCDKG---NAYEFELRKDLLELMTC 240
           Q+GP      F  VY G RV          +EK +  D G   N     +   LL+ ++ 
Sbjct: 12  QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 71
Query: 241 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL 300
           G   +++        +  + ++ +      + D I +   LQ +        V E ++  
Sbjct: 72  GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC 131
Query: 301 NDHGVAYRDLNSQRILLD-RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGD 359
           ++ GV +RD+  + IL+D   G + L D G     K   +    + DG R  +P      
Sbjct: 132 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSP------ 182
Query: 360 PESVSETWM----SNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ 415
           PE +         + V+S G+++++MV G+  +         +       R  +  +C  
Sbjct: 183 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH----DEEIIRGQVFFRQRVSSECQH 238
Query: 416 ILKSLMIKCWNNSPSKRPQFSEI 438
           +++     C    PS RP F EI
Sbjct: 239 LIRW----CLALRPSDRPTFEEI 257

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 60/268 (22%), Positives = 107/268 (39%), Gaps = 38/268 (14%)
Query: 192 LEFIDQIGP----NSFKGVYKGKRVG---------IEKLKGCDKG---NAYEFELRKDLL 235
           LE   Q+GP      F  VY G RV          +EK +  D G   N     +   LL
Sbjct: 35  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 94
Query: 236 ELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAE 295
           + ++ G   +++        +  + ++ +      + D I +   LQ +        V E
Sbjct: 95  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 154
Query: 296 GIKFLNDHGVAYRDLNSQRILLD-RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPE 354
            ++  ++ GV +RD+  + IL+D   G + L D G     K   +    + DG R  +P 
Sbjct: 155 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSP- 210
Query: 355 IIAGDPESVSETWM----SNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIP 410
                PE +         + V+S G+++++MV G+  +     +   +G      R  + 
Sbjct: 211 -----PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI---IG-GQVFFRQRVS 261
Query: 411 KDCPQILKSLMIKCWNNSPSKRPQFSEI 438
            +C  +++     C    PS RP F EI
Sbjct: 262 SECQHLIRW----CLALRPSDRPTFEEI 285

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 60/268 (22%), Positives = 107/268 (39%), Gaps = 38/268 (14%)
Query: 192 LEFIDQIGP----NSFKGVYKGKRVG---------IEKLKGCDKG---NAYEFELRKDLL 235
           LE   Q+GP      F  VY G RV          +EK +  D G   N     +   LL
Sbjct: 35  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 94
Query: 236 ELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAE 295
           + ++ G   +++        +  + ++ +      + D I +   LQ +        V E
Sbjct: 95  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 154
Query: 296 GIKFLNDHGVAYRDLNSQRILLD-RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPE 354
            ++  ++ GV +RD+  + IL+D   G + L D G     K   +    + DG R  +P 
Sbjct: 155 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSP- 210
Query: 355 IIAGDPESVSETWM----SNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIP 410
                PE +         + V+S G+++++MV G+  +     +   +G      R  + 
Sbjct: 211 -----PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI---IG-GQVFFRQRVS 261
Query: 411 KDCPQILKSLMIKCWNNSPSKRPQFSEI 438
            +C  +++     C    PS RP F EI
Sbjct: 262 SECQHLIRW----CLALRPSDRPTFEEI 285

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/182 (23%), Positives = 84/182 (46%), Gaps = 17/182 (9%)
Query: 210 KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVTK 264
           + V I+KL    +   +     ++L+ +    HKNI+    V      ++E   + +V +
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME 109
Query: 265 LMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVC 324
           LM+  +++ +I    +L  + +  +   +  GIK L+  G+ +RDL    I++     + 
Sbjct: 110 LMDA-NLSQVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDATLK 166
Query: 325 LGDMGIVTACKSVGEATEYETDGYRWLAPEII--AGDPESVSETWMSNVYSFGMVIWEMV 382
           + D G+     +    T Y    Y + APE+I   G  E+V      +++S G ++ EM+
Sbjct: 167 ILDFGLARTAGTSFMMTPYVVTRY-YRAPEVILGMGYKENV------DIWSVGCIMGEMI 219
Query: 383 TG 384
            G
Sbjct: 220 KG 221

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 60/268 (22%), Positives = 107/268 (39%), Gaps = 38/268 (14%)
Query: 192 LEFIDQIGP----NSFKGVYKGKRVG---------IEKLKGCDKG---NAYEFELRKDLL 235
           LE   Q+GP      F  VY G RV          +EK +  D G   N     +   LL
Sbjct: 34  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 93
Query: 236 ELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAE 295
           + ++ G   +++        +  + ++ +      + D I +   LQ +        V E
Sbjct: 94  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 153
Query: 296 GIKFLNDHGVAYRDLNSQRILLD-RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPE 354
            ++  ++ GV +RD+  + IL+D   G + L D G     K   +    + DG R  +P 
Sbjct: 154 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSP- 209
Query: 355 IIAGDPESVSETWM----SNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIP 410
                PE +         + V+S G+++++MV G+  +     +   +G      R  + 
Sbjct: 210 -----PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI---IG-GQVFFRQRVS 260
Query: 411 KDCPQILKSLMIKCWNNSPSKRPQFSEI 438
            +C  +++     C    PS RP F EI
Sbjct: 261 SECQHLIRW----CLALRPSDRPTFEEI 284

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 57/263 (21%), Positives = 103/263 (39%), Gaps = 38/263 (14%)
Query: 197 QIGP----NSFKGVYKGKRVG---------IEKLKGCDKG---NAYEFELRKDLLELMTC 240
           Q+GP      F  VY G RV          +EK +  D G   N     +   LL+ ++ 
Sbjct: 11  QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 70
Query: 241 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL 300
           G   +++        +  + ++ +      + D I +   LQ +        V E ++  
Sbjct: 71  GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC 130
Query: 301 NDHGVAYRDLNSQRILLD-RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGD 359
           ++ GV +RD+  + IL+D   G + L D G     K   +    + DG R  +P      
Sbjct: 131 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSP------ 181
Query: 360 PESVSETWM----SNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ 415
           PE +         + V+S G+++++MV G+  +         +       R  +  +C  
Sbjct: 182 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH----DEEIIRGQVFFRQRVSSECQH 237
Query: 416 ILKSLMIKCWNNSPSKRPQFSEI 438
           +++     C    PS RP F EI
Sbjct: 238 LIRW----CLALRPSDRPTFEEI 256

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 57/263 (21%), Positives = 103/263 (39%), Gaps = 38/263 (14%)
Query: 197 QIGP----NSFKGVYKGKRVG---------IEKLKGCDKG---NAYEFELRKDLLELMTC 240
           Q+GP      F  VY G RV          +EK +  D G   N     +   LL+ ++ 
Sbjct: 12  QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 71
Query: 241 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL 300
           G   +++        +  + ++ +      + D I +   LQ +        V E ++  
Sbjct: 72  GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC 131
Query: 301 NDHGVAYRDLNSQRILLD-RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGD 359
           ++ GV +RD+  + IL+D   G + L D G     K   +    + DG R  +P      
Sbjct: 132 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSP------ 182
Query: 360 PESVSETWM----SNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ 415
           PE +         + V+S G+++++MV G+  +         +       R  +  +C  
Sbjct: 183 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH----DEEIIRGQVFFRQRVSSECQH 238
Query: 416 ILKSLMIKCWNNSPSKRPQFSEI 438
           +++     C    PS RP F EI
Sbjct: 239 LIRW----CLALRPSDRPTFEEI 257

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 60/268 (22%), Positives = 107/268 (39%), Gaps = 38/268 (14%)
Query: 192 LEFIDQIGP----NSFKGVYKGKRVG---------IEKLKGCDKG---NAYEFELRKDLL 235
           LE   Q+GP      F  VY G RV          +EK +  D G   N     +   LL
Sbjct: 34  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 93
Query: 236 ELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAE 295
           + ++ G   +++        +  + ++ +      + D I +   LQ +        V E
Sbjct: 94  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 153
Query: 296 GIKFLNDHGVAYRDLNSQRILLD-RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPE 354
            ++  ++ GV +RD+  + IL+D   G + L D G     K   +    + DG R  +P 
Sbjct: 154 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSP- 209
Query: 355 IIAGDPESVSETWM----SNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIP 410
                PE +         + V+S G+++++MV G+  +     +   +G      R  + 
Sbjct: 210 -----PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI---IG-GQVFFRQRVS 260
Query: 411 KDCPQILKSLMIKCWNNSPSKRPQFSEI 438
            +C  +++     C    PS RP F EI
Sbjct: 261 SECQHLIRW----CLALRPSDRPTFEEI 284

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/229 (23%), Positives = 104/229 (45%), Gaps = 19/229 (8%)
Query: 219 GCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHG-LCVVTKLMEGGSVNDLILK 277
           GC +      ++ +++  L    H N+++   V  D N   L +V +L+  G V ++   
Sbjct: 72  GCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEV--P 129
Query: 278 SRKLQTKEIIRIAI-DVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS 336
           + K  +++  R    D+ +GI++L+   + +RD+    +L+   G++ + D G+    K 
Sbjct: 130 TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKG 189
Query: 337 VGEATEYETDGYRWLAPEIIAGDPESVSETW------MSNVYSFGMVIWEMVTGEAAYAA 390
             +A    T G     P  +A  PES+SET         +V++ G+ ++  V G+  +  
Sbjct: 190 -SDALLSNTVG----TPAFMA--PESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242
Query: 391 CSPVQAAVGIAACGLR-PEIPKDCPQILKSLMIKCWNNSPSKRPQFSEI 438
              +     I +  L  P+ P D  + LK L+ +  + +P  R    EI
Sbjct: 243 ERIMCLHSKIKSQALEFPDQP-DIAEDLKDLITRMLDKNPESRIVVPEI 290

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/234 (20%), Positives = 98/234 (41%), Gaps = 23/234 (9%)
Query: 210 KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVTK 264
           + V I+KL    +   +     ++L+ +    HKNI+    V      ++E   + +V +
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVME 109
Query: 265 LMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVC 324
           LM+      + ++   L  + +  +   +  GIK L+  G+ +RDL    I++     + 
Sbjct: 110 LMDANLXQVIQME---LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDXTLK 166
Query: 325 LGDMGIVTACKSVGEATEYETDGYRWLAPEII--AGDPESVSETWMSNVYSFGMVIWEMV 382
           + D G+     +    T Y    Y + APE+I   G  E+V      +++S G ++ EMV
Sbjct: 167 ILDFGLARTAGTSFMMTPYVVTRY-YRAPEVILGMGYKENV------DIWSVGCIMGEMV 219
Query: 383 TGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFS 436
             +  +     +     +       ++   CP+ +K L      N    RP+++
Sbjct: 220 RHKILFPGRDYIDQWNKVIE-----QLGTPCPEFMKKLQPTV-RNYVENRPKYA 267

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 31/136 (22%), Positives = 68/136 (50%), Gaps = 13/136 (9%)
Query: 261 VVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH 320
           +V +LMEGG + D ++ +++L+          +   +++L+++G+ +RDL  + +LL   
Sbjct: 97  IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQ 156
Query: 321 GNVCLGDMGIVTACKSVGEATEYET--DGYRWLAPEII-----AGDPESVSETWMSNVYS 373
              CL  +      K +GE +   T      +LAPE++     AG   +V      + +S
Sbjct: 157 EEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAV------DCWS 210
Query: 374 FGMVIWEMVTGEAAYA 389
            G++++  ++G   ++
Sbjct: 211 LGVILFICLSGYPPFS 226

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 31/136 (22%), Positives = 68/136 (50%), Gaps = 13/136 (9%)
Query: 261 VVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH 320
           +V +LMEGG + D ++ +++L+          +   +++L+++G+ +RDL  + +LL   
Sbjct: 91  IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQ 150
Query: 321 GNVCLGDMGIVTACKSVGEATEYET--DGYRWLAPEII-----AGDPESVSETWMSNVYS 373
              CL  +      K +GE +   T      +LAPE++     AG   +V      + +S
Sbjct: 151 EEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAV------DCWS 204
Query: 374 FGMVIWEMVTGEAAYA 389
            G++++  ++G   ++
Sbjct: 205 LGVILFICLSGYPPFS 220

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 57/263 (21%), Positives = 103/263 (39%), Gaps = 38/263 (14%)
Query: 197 QIGP----NSFKGVYKGKRVG---------IEKLKGCDKG---NAYEFELRKDLLELMTC 240
           Q+GP      F  VY G RV          +EK +  D G   N     +   LL+ ++ 
Sbjct: 12  QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 71
Query: 241 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL 300
           G   +++        +  + ++ +      + D I +   LQ +        V E ++  
Sbjct: 72  GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC 131
Query: 301 NDHGVAYRDLNSQRILLD-RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGD 359
           ++ GV +RD+  + IL+D   G + L D G     K   +    + DG R  +P      
Sbjct: 132 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSP------ 182
Query: 360 PESVSETWM----SNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ 415
           PE +         + V+S G+++++MV G+  +         +       R  +  +C  
Sbjct: 183 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH----DEEIIRGQVFFRQRVSSECQH 238
Query: 416 ILKSLMIKCWNNSPSKRPQFSEI 438
           +++     C    PS RP F EI
Sbjct: 239 LIRW----CLALRPSDRPTFEEI 257

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 31/136 (22%), Positives = 68/136 (50%), Gaps = 13/136 (9%)
Query: 261 VVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH 320
           +V +LMEGG + D ++ +++L+          +   +++L+++G+ +RDL  + +LL   
Sbjct: 91  IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQ 150
Query: 321 GNVCLGDMGIVTACKSVGEATEYET--DGYRWLAPEII-----AGDPESVSETWMSNVYS 373
              CL  +      K +GE +   T      +LAPE++     AG   +V      + +S
Sbjct: 151 EEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAV------DCWS 204
Query: 374 FGMVIWEMVTGEAAYA 389
            G++++  ++G   ++
Sbjct: 205 LGVILFICLSGYPPFS 220

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 57/263 (21%), Positives = 103/263 (39%), Gaps = 38/263 (14%)
Query: 197 QIGP----NSFKGVYKGKRVG---------IEKLKGCDKG---NAYEFELRKDLLELMTC 240
           Q+GP      F  VY G RV          +EK +  D G   N     +   LL+ ++ 
Sbjct: 10  QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 69
Query: 241 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL 300
           G   +++        +  + ++ +      + D I +   LQ +        V E ++  
Sbjct: 70  GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC 129
Query: 301 NDHGVAYRDLNSQRILLD-RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGD 359
           ++ GV +RD+  + IL+D   G + L D G     K   +    + DG R  +P      
Sbjct: 130 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSP------ 180
Query: 360 PESVSETWM----SNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ 415
           PE +         + V+S G+++++MV G+  +         +       R  +  +C  
Sbjct: 181 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH----DEEIIRGQVFFRQRVSSECQH 236
Query: 416 ILKSLMIKCWNNSPSKRPQFSEI 438
           +++     C    PS RP F EI
Sbjct: 237 LIRW----CLALRPSDRPTFEEI 255

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 60/268 (22%), Positives = 107/268 (39%), Gaps = 38/268 (14%)
Query: 192 LEFIDQIGP----NSFKGVYKGKRVG---------IEKLKGCDKG---NAYEFELRKDLL 235
           LE   Q+GP      F  VY G RV          +EK +  D G   N     +   LL
Sbjct: 34  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 93
Query: 236 ELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAE 295
           + ++ G   +++        +  + ++ +      + D I +   LQ +        V E
Sbjct: 94  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 153
Query: 296 GIKFLNDHGVAYRDLNSQRILLD-RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPE 354
            ++  ++ GV +RD+  + IL+D   G + L D G     K   +    + DG R  +P 
Sbjct: 154 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSP- 209
Query: 355 IIAGDPESVSETWM----SNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIP 410
                PE +         + V+S G+++++MV G+  +     +   +G      R  + 
Sbjct: 210 -----PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI---IG-GQVFFRQRVS 260
Query: 411 KDCPQILKSLMIKCWNNSPSKRPQFSEI 438
            +C  +++     C    PS RP F EI
Sbjct: 261 XECQHLIRW----CLALRPSDRPTFEEI 284

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/213 (22%), Positives = 96/213 (45%), Gaps = 12/213 (5%)
Query: 186 LLNSDNLEFIDQIGPNSFKGVYKGKRVG----IEKLKGCDKGNAYEFELRKDLLELMTCG 241
           + +SD  E +  IG  +F GV +  R      +  +K  ++G   +  ++++++   +  
Sbjct: 15  MHDSDRYELVKDIGSGNF-GVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLR 73
Query: 242 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 301
           H NI++F  V +   H L +V +   GG + + I  + +    E       +  G+ + +
Sbjct: 74  HPNIVRFKEVILTPTH-LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 132
Query: 302 DHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY-RWLAPEIIAGDP 360
              V +RDL  +  LLD      L       +  SV  +   +T G   ++APE++    
Sbjct: 133 AMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDTVGTPAYIAPEVLL--- 189
Query: 361 ESVSETWMSNVYSFGMVIWEMVTGEAAYAACSP 393
           +   +  +++V+S G+ ++ M+ G  AY    P
Sbjct: 190 KKEYDGKVADVWSCGVTLYVMLVG--AYPFEDP 220

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 31/136 (22%), Positives = 68/136 (50%), Gaps = 13/136 (9%)
Query: 261 VVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH 320
           +V +LMEGG + D ++ +++L+          +   +++L+++G+ +RDL  + +LL   
Sbjct: 216 IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQ 275
Query: 321 GNVCLGDMGIVTACKSVGEATEYET--DGYRWLAPEII-----AGDPESVSETWMSNVYS 373
              CL  +      K +GE +   T      +LAPE++     AG   +V      + +S
Sbjct: 276 EEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAV------DCWS 329
Query: 374 FGMVIWEMVTGEAAYA 389
            G++++  ++G   ++
Sbjct: 330 LGVILFICLSGYPPFS 345

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 31/136 (22%), Positives = 68/136 (50%), Gaps = 13/136 (9%)
Query: 261 VVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH 320
           +V +LMEGG + D ++ +++L+          +   +++L+++G+ +RDL  + +LL   
Sbjct: 91  IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQ 150
Query: 321 GNVCLGDMGIVTACKSVGEATEYET--DGYRWLAPEII-----AGDPESVSETWMSNVYS 373
              CL  +      K +GE +   T      +LAPE++     AG   +V      + +S
Sbjct: 151 EEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAV------DCWS 204
Query: 374 FGMVIWEMVTGEAAYA 389
            G++++  ++G   ++
Sbjct: 205 LGVILFICLSGYPPFS 220

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 60/268 (22%), Positives = 107/268 (39%), Gaps = 38/268 (14%)
Query: 192 LEFIDQIGP----NSFKGVYKGKRVG---------IEKLKGCDKG---NAYEFELRKDLL 235
           LE   Q+GP      F  VY G RV          +EK +  D G   N     +   LL
Sbjct: 35  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 94
Query: 236 ELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAE 295
           + ++ G   +++        +  + ++ +      + D I +   LQ +        V E
Sbjct: 95  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 154
Query: 296 GIKFLNDHGVAYRDLNSQRILLD-RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPE 354
            ++  ++ GV +RD+  + IL+D   G + L D G     K   +    + DG R  +P 
Sbjct: 155 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSP- 210
Query: 355 IIAGDPESVSETWM----SNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIP 410
                PE +         + V+S G+++++MV G+  +     +   +G      R  + 
Sbjct: 211 -----PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI---IG-GQVFFRQRVS 261
Query: 411 KDCPQILKSLMIKCWNNSPSKRPQFSEI 438
            +C  +++     C    PS RP F EI
Sbjct: 262 XECQHLIRW----CLALRPSDRPTFEEI 285

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 60/268 (22%), Positives = 107/268 (39%), Gaps = 38/268 (14%)
Query: 192 LEFIDQIGP----NSFKGVYKGKRVG---------IEKLKGCDKG---NAYEFELRKDLL 235
           LE   Q+GP      F  VY G RV          +EK +  D G   N     +   LL
Sbjct: 35  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 94
Query: 236 ELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAE 295
           + ++ G   +++        +  + ++ +      + D I +   LQ +        V E
Sbjct: 95  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 154
Query: 296 GIKFLNDHGVAYRDLNSQRILLD-RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPE 354
            ++  ++ GV +RD+  + IL+D   G + L D G     K   +    + DG R  +P 
Sbjct: 155 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSP- 210
Query: 355 IIAGDPESVSETWM----SNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIP 410
                PE +         + V+S G+++++MV G+  +     +   +G      R  + 
Sbjct: 211 -----PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI---IG-GQVFFRQRVS 261
Query: 411 KDCPQILKSLMIKCWNNSPSKRPQFSEI 438
            +C  +++     C    PS RP F EI
Sbjct: 262 XECQHLIRW----CLALRPSDRPTFEEI 285

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 31/136 (22%), Positives = 68/136 (50%), Gaps = 13/136 (9%)
Query: 261 VVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH 320
           +V +LMEGG + D ++ +++L+          +   +++L+++G+ +RDL  + +LL   
Sbjct: 90  IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQ 149
Query: 321 GNVCLGDMGIVTACKSVGEATEYET--DGYRWLAPEII-----AGDPESVSETWMSNVYS 373
              CL  +      K +GE +   T      +LAPE++     AG   +V      + +S
Sbjct: 150 EEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAV------DCWS 203
Query: 374 FGMVIWEMVTGEAAYA 389
            G++++  ++G   ++
Sbjct: 204 LGVILFICLSGYPPFS 219

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 57/263 (21%), Positives = 103/263 (39%), Gaps = 38/263 (14%)
Query: 197 QIGP----NSFKGVYKGKRVG---------IEKLKGCDKG---NAYEFELRKDLLELMTC 240
           Q+GP      F  VY G RV          +EK +  D G   N     +   LL+ ++ 
Sbjct: 7   QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 66
Query: 241 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL 300
           G   +++        +  + ++ +      + D I +   LQ +        V E ++  
Sbjct: 67  GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC 126
Query: 301 NDHGVAYRDLNSQRILLD-RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGD 359
           ++ GV +RD+  + IL+D   G + L D G     K   +    + DG R  +P      
Sbjct: 127 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSP------ 177
Query: 360 PESVSETWM----SNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ 415
           PE +         + V+S G+++++MV G+  +         +       R  +  +C  
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH----DEEIIRGQVFFRQRVSSECQH 233
Query: 416 ILKSLMIKCWNNSPSKRPQFSEI 438
           +++     C    PS RP F EI
Sbjct: 234 LIRW----CLALRPSDRPTFEEI 252

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 59/268 (22%), Positives = 105/268 (39%), Gaps = 38/268 (14%)
Query: 192 LEFIDQIGP----NSFKGVYKGKRVG---------IEKLKGCDKG---NAYEFELRKDLL 235
           LE   Q+GP      F  VY G RV          +EK +  D G   N     +   LL
Sbjct: 49  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 108
Query: 236 ELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAE 295
           + ++ G   +++        +  + ++ +      + D I +   LQ +        V E
Sbjct: 109 KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 168
Query: 296 GIKFLNDHGVAYRDLNSQRILLD-RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPE 354
            ++  ++ GV +RD+  + IL+D   G + L D G     K   +    + DG R  +P 
Sbjct: 169 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSP- 224
Query: 355 IIAGDPESVSETWM----SNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIP 410
                PE +         + V+S G+++++MV G+  +         +       R  + 
Sbjct: 225 -----PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH----DEEIIRGQVFFRQRVS 275
Query: 411 KDCPQILKSLMIKCWNNSPSKRPQFSEI 438
            +C  +++     C    PS RP F EI
Sbjct: 276 SECQHLIRW----CLALRPSDRPTFEEI 299

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 59/268 (22%), Positives = 105/268 (39%), Gaps = 38/268 (14%)
Query: 192 LEFIDQIGP----NSFKGVYKGKRVG---------IEKLKGCDKG---NAYEFELRKDLL 235
           LE   Q+GP      F  VY G RV          +EK +  D G   N     +   LL
Sbjct: 22  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 81
Query: 236 ELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAE 295
           + ++ G   +++        +  + ++ +      + D I +   LQ +        V E
Sbjct: 82  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 141
Query: 296 GIKFLNDHGVAYRDLNSQRILLD-RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPE 354
            ++  ++ GV +RD+  + IL+D   G + L D G     K   +    + DG R  +P 
Sbjct: 142 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSP- 197
Query: 355 IIAGDPESVS----ETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIP 410
                PE +         + V+S G+++++MV G+  +         +       R  + 
Sbjct: 198 -----PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH----DEEIIRGQVFFRQRVS 248
Query: 411 KDCPQILKSLMIKCWNNSPSKRPQFSEI 438
            +C  +++     C    PS RP F EI
Sbjct: 249 SECQHLIRW----CLALRPSDRPTFEEI 272

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 59/268 (22%), Positives = 105/268 (39%), Gaps = 38/268 (14%)
Query: 192 LEFIDQIGP----NSFKGVYKGKRVG---------IEKLKGCDKG---NAYEFELRKDLL 235
           LE   Q+GP      F  VY G RV          +EK +  D G   N     +   LL
Sbjct: 41  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 100
Query: 236 ELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAE 295
           + ++ G   +++        +  + ++ +      + D I +   LQ +        V E
Sbjct: 101 KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 160
Query: 296 GIKFLNDHGVAYRDLNSQRILLD-RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPE 354
            ++  ++ GV +RD+  + IL+D   G + L D G     K   +    + DG R  +P 
Sbjct: 161 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSP- 216
Query: 355 IIAGDPESVS----ETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIP 410
                PE +         + V+S G+++++MV G+  +         +       R  + 
Sbjct: 217 -----PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH----DEEIIRGQVFFRQRVS 267
Query: 411 KDCPQILKSLMIKCWNNSPSKRPQFSEI 438
            +C  +++     C    PS RP F EI
Sbjct: 268 SECQHLIRW----CLALRPSDRPTFEEI 291

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 59/268 (22%), Positives = 105/268 (39%), Gaps = 38/268 (14%)
Query: 192 LEFIDQIGP----NSFKGVYKGKRVG---------IEKLKGCDKG---NAYEFELRKDLL 235
           LE   Q+GP      F  VY G RV          +EK +  D G   N     +   LL
Sbjct: 34  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 93
Query: 236 ELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAE 295
           + ++ G   +++        +  + ++ +      + D I +   LQ +        V E
Sbjct: 94  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 153
Query: 296 GIKFLNDHGVAYRDLNSQRILLD-RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPE 354
            ++  ++ GV +RD+  + IL+D   G + L D G     K   +    + DG R  +P 
Sbjct: 154 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSP- 209
Query: 355 IIAGDPESVSETWM----SNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIP 410
                PE +         + V+S G+++++MV G+  +         +       R  + 
Sbjct: 210 -----PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH----DEEIIRGQVFFRQRVS 260
Query: 411 KDCPQILKSLMIKCWNNSPSKRPQFSEI 438
            +C  +++     C    PS RP F EI
Sbjct: 261 SECQHLIRW----CLALRPSDRPTFEEI 284

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 59/268 (22%), Positives = 105/268 (39%), Gaps = 38/268 (14%)
Query: 192 LEFIDQIGP----NSFKGVYKGKRVG---------IEKLKGCDKG---NAYEFELRKDLL 235
           LE   Q+GP      F  VY G RV          +EK +  D G   N     +   LL
Sbjct: 21  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 80
Query: 236 ELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAE 295
           + ++ G   +++        +  + ++ +      + D I +   LQ +        V E
Sbjct: 81  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 140
Query: 296 GIKFLNDHGVAYRDLNSQRILLD-RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPE 354
            ++  ++ GV +RD+  + IL+D   G + L D G     K   +    + DG R  +P 
Sbjct: 141 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSP- 196
Query: 355 IIAGDPESVSETWM----SNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIP 410
                PE +         + V+S G+++++MV G+  +         +       R  + 
Sbjct: 197 -----PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH----DEEIIRGQVFFRQRVS 247
Query: 411 KDCPQILKSLMIKCWNNSPSKRPQFSEI 438
            +C  +++     C    PS RP F EI
Sbjct: 248 SECQHLIRW----CLALRPSDRPTFEEI 271

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 57/263 (21%), Positives = 103/263 (39%), Gaps = 38/263 (14%)
Query: 197 QIGP----NSFKGVYKGKRVG---------IEKLKGCDKG---NAYEFELRKDLLELMTC 240
           Q+GP      F  VY G RV          +EK +  D G   N     +   LL+ ++ 
Sbjct: 34  QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 93
Query: 241 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL 300
           G   +++        +  + ++ +      + D I +   LQ +        V E ++  
Sbjct: 94  GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC 153
Query: 301 NDHGVAYRDLNSQRILLD-RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGD 359
           ++ GV +RD+  + IL+D   G + L D G     K   +    + DG R  +P      
Sbjct: 154 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSP------ 204
Query: 360 PESVSETWM----SNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ 415
           PE +         + V+S G+++++MV G+  +         +       R  +  +C  
Sbjct: 205 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH----DEEIIRGQVFFRQRVSXECQH 260
Query: 416 ILKSLMIKCWNNSPSKRPQFSEI 438
           +++     C    PS RP F EI
Sbjct: 261 LIRW----CLALRPSDRPTFEEI 279

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 31/136 (22%), Positives = 68/136 (50%), Gaps = 13/136 (9%)
Query: 261 VVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH 320
           +V +LMEGG + D ++ +++L+          +   +++L+++G+ +RDL  + +LL   
Sbjct: 230 IVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQ 289
Query: 321 GNVCLGDMGIVTACKSVGEATEYET--DGYRWLAPEII-----AGDPESVSETWMSNVYS 373
              CL  +      K +GE +   T      +LAPE++     AG   +V      + +S
Sbjct: 290 EEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAV------DCWS 343
Query: 374 FGMVIWEMVTGEAAYA 389
            G++++  ++G   ++
Sbjct: 344 LGVILFICLSGYPPFS 359

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/191 (22%), Positives = 85/191 (44%), Gaps = 26/191 (13%)
Query: 209 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN-----HGLCVVT 263
           G++V I+KL    +   +     ++LL L    H+N++    V    +     +   +V 
Sbjct: 49  GEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVM 108
Query: 264 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 323
             M+      + LK      ++I  +   + +G+K+++  GV +RDL    + ++    +
Sbjct: 109 PFMQTDLQKIMGLK---FSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCEL 165
Query: 324 CLGDMGIVTACKSVGEATEYETDGYRWL-APEIIAGDPESVSETWMS-----NVYSFGMV 377
            + D G+  A  +  E T Y     RW  APE+I         +WM      +++S G +
Sbjct: 166 KILDFGL--ARHADAEMTGYVVT--RWYRAPEVIL--------SWMHYNQTVDIWSVGCI 213
Query: 378 IWEMVTGEAAY 388
           + EM+TG+  +
Sbjct: 214 MAEMLTGKTLF 224

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/217 (21%), Positives = 92/217 (42%), Gaps = 20/217 (9%)
Query: 210 KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVTK 264
           + V I+KL    +   +     ++L+ +    HKNI+    V      ++E   + +V +
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME 109
Query: 265 LMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVC 324
           LM+      + ++   L  + +  +   +  GIK L+  G+ +RDL    I++     + 
Sbjct: 110 LMDANLCQVIQME---LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLK 166
Query: 325 LGDMGIV-TACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT 383
           + D G+  TA  S     E  T  YR  APE+I G    +      +++S G ++ EM+ 
Sbjct: 167 ILDFGLARTAGTSFMMTPEVVTRYYR--APEVILG----MGYKENVDIWSVGCIMGEMIK 220
Query: 384 GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSL 420
           G   +     +     +       ++   CP+ +K L
Sbjct: 221 GGVLFPGTDHIDQWNKVIE-----QLGTPCPEFMKKL 252

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 57/263 (21%), Positives = 103/263 (39%), Gaps = 38/263 (14%)
Query: 197 QIGP----NSFKGVYKGKRVG---------IEKLKGCDKG---NAYEFELRKDLLELMTC 240
           Q+GP      F  VY G RV          +EK +  D G   N     +   LL+ ++ 
Sbjct: 54  QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 113
Query: 241 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL 300
           G   +++        +  + ++ +      + D I +   LQ +        V E ++  
Sbjct: 114 GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC 173
Query: 301 NDHGVAYRDLNSQRILLD-RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGD 359
           ++ GV +RD+  + IL+D   G + L D G     K   +    + DG R  +P      
Sbjct: 174 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSP------ 224
Query: 360 PESVSETWM----SNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ 415
           PE +         + V+S G+++++MV G+  +         +       R  +  +C  
Sbjct: 225 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH----DEEIIRGQVFFRQRVSXECQH 280
Query: 416 ILKSLMIKCWNNSPSKRPQFSEI 438
           +++     C    PS RP F EI
Sbjct: 281 LIRW----CLALRPSDRPTFEEI 299

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 57/263 (21%), Positives = 103/263 (39%), Gaps = 38/263 (14%)
Query: 197 QIGP----NSFKGVYKGKRVG---------IEKLKGCDKG---NAYEFELRKDLLELMTC 240
           Q+GP      F  VY G RV          +EK +  D G   N     +   LL+ ++ 
Sbjct: 26  QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 85
Query: 241 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL 300
           G   +++        +  + ++ +      + D I +   LQ +        V E ++  
Sbjct: 86  GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC 145
Query: 301 NDHGVAYRDLNSQRILLD-RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGD 359
           ++ GV +RD+  + IL+D   G + L D G     K   +    + DG R  +P      
Sbjct: 146 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSP------ 196
Query: 360 PESVSETWM----SNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ 415
           PE +         + V+S G+++++MV G+  +         +       R  +  +C  
Sbjct: 197 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH----DEEIIRGQVFFRQRVSXECQH 252
Query: 416 ILKSLMIKCWNNSPSKRPQFSEI 438
           +++     C    PS RP F EI
Sbjct: 253 LIRW----CLALRPSDRPTFEEI 271

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 59/268 (22%), Positives = 105/268 (39%), Gaps = 38/268 (14%)
Query: 192 LEFIDQIGP----NSFKGVYKGKRVG---------IEKLKGCDKG---NAYEFELRKDLL 235
           LE   Q+GP      F  VY G RV          +EK +  D G   N     +   LL
Sbjct: 22  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 81
Query: 236 ELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAE 295
           + ++ G   +++        +  + ++ +      + D I +   LQ +        V E
Sbjct: 82  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 141
Query: 296 GIKFLNDHGVAYRDLNSQRILLD-RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPE 354
            ++  ++ GV +RD+  + IL+D   G + L D G     K   +    + DG R  +P 
Sbjct: 142 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSP- 197
Query: 355 IIAGDPESVS----ETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIP 410
                PE +         + V+S G+++++MV G+  +         +       R  + 
Sbjct: 198 -----PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH----DEEIIRGQVFFRQRVS 248
Query: 411 KDCPQILKSLMIKCWNNSPSKRPQFSEI 438
            +C  +++     C    PS RP F EI
Sbjct: 249 XECQHLIRW----CLALRPSDRPTFEEI 272

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/234 (20%), Positives = 98/234 (41%), Gaps = 23/234 (9%)
Query: 210 KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVTK 264
           + V I+KL    +   +     ++L+ +    HKNI+    V      ++E   + +V +
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVME 109
Query: 265 LMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVC 324
           LM+      + ++   L  + +  +   +  GIK L+  G+ +RDL    I++     + 
Sbjct: 110 LMDANLCQVIQME---LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDXTLK 166
Query: 325 LGDMGIVTACKSVGEATEYETDGYRWLAPEII--AGDPESVSETWMSNVYSFGMVIWEMV 382
           + D G+     +    T Y    Y + APE+I   G  E+V      +++S G ++ EMV
Sbjct: 167 ILDFGLARTAGTSFMMTPYVVTRY-YRAPEVILGMGYKENV------DIWSVGCIMGEMV 219
Query: 383 TGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFS 436
             +  +     +     +       ++   CP+ +K L      N    RP+++
Sbjct: 220 RHKILFPGRDYIDQWNKVIE-----QLGTPCPEFMKKLQPTV-RNYVENRPKYA 267

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 59/268 (22%), Positives = 105/268 (39%), Gaps = 38/268 (14%)
Query: 192 LEFIDQIGP----NSFKGVYKGKRVG---------IEKLKGCDKG---NAYEFELRKDLL 235
           LE   Q+GP      F  VY G RV          +EK +  D G   N     +   LL
Sbjct: 54  LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 113
Query: 236 ELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAE 295
           + ++ G   +++        +  + ++ +      + D I +   LQ +        V E
Sbjct: 114 KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 173
Query: 296 GIKFLNDHGVAYRDLNSQRILLD-RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPE 354
            ++  ++ GV +RD+  + IL+D   G + L D G     K   +    + DG R  +P 
Sbjct: 174 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSP- 229
Query: 355 IIAGDPESVSETWM----SNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIP 410
                PE +         + V+S G+++++MV G+  +         +       R  + 
Sbjct: 230 -----PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH----DEEIIRGQVFFRQRVS 280
Query: 411 KDCPQILKSLMIKCWNNSPSKRPQFSEI 438
            +C  +++     C    PS RP F EI
Sbjct: 281 XECQHLIRW----CLALRPSDRPTFEEI 304

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/190 (22%), Positives = 91/190 (47%), Gaps = 25/190 (13%)
Query: 210 KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVTK 264
           ++V ++KL    +   +     ++L  L    H+N++    V      +++   + +VT 
Sbjct: 46  QKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTT 105
Query: 265 LMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVC 324
           LM G  +N+ I+K + L  + +  +   +  G+K+++  G+ +RDL    + ++    + 
Sbjct: 106 LM-GADLNN-IVKCQALSDEHVQFLVYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELR 163
Query: 325 LGDMGIVTACKSVGEATEY-ETDGYRWLAPEIIAGDPESVSETWMS-----NVYSFGMVI 378
           + D G+  A ++  E T Y  T  YR  APEI+          WM      +++S G ++
Sbjct: 164 ILDFGL--ARQADEEMTGYVATRWYR--APEIMLN--------WMHYNQTVDIWSVGCIM 211
Query: 379 WEMVTGEAAY 388
            E++ G+A +
Sbjct: 212 AELLQGKALF 221

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 44/208 (21%), Positives = 93/208 (44%), Gaps = 10/208 (4%)
Query: 186 LLNSDNLEFIDQIGPNSFKGVYKGKRVG----IEKLKGCDKGNAYEFELRKDLLELMTCG 241
           + +SD  E +  IG  +F GV +  R      +  +K  ++G   +  ++++++   +  
Sbjct: 15  MHDSDRYELVKDIGSGNF-GVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLR 73
Query: 242 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 301
           H NI++F  V +   H L +V +   GG + + I  + +    E       +  G+ + +
Sbjct: 74  HPNIVRFKEVILTPTH-LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 132
Query: 302 DHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY-RWLAPEIIAGDP 360
              V +RDL  +  LLD      L       +  SV  +    T G   ++APE++    
Sbjct: 133 AMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKSTVGTPAYIAPEVLL--- 189
Query: 361 ESVSETWMSNVYSFGMVIWEMVTGEAAY 388
           +   +  +++V+S G+ ++ M+ G   +
Sbjct: 190 KKEYDGKVADVWSCGVTLYVMLVGAYPF 217

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 45/218 (20%), Positives = 92/218 (42%), Gaps = 22/218 (10%)
Query: 210 KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVTK 264
           + V I+KL    +   +     ++L+ +    HKNI+    V      ++E   + +V +
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME 109
Query: 265 LMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVC 324
           LM+      + ++   L  + +  +   +  GIK L+  G+ +RDL    I++     + 
Sbjct: 110 LMDANLCQVIQME---LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLK 166
Query: 325 LGDMGIVTACKSVGEATEYETDGYRWLAPEII--AGDPESVSETWMSNVYSFGMVIWEMV 382
           + D G+     +    T Y    Y + APE+I   G  E+V      +++S G ++ EM+
Sbjct: 167 ILDFGLARTAGTSFMMTPYVVTRY-YRAPEVILGMGYKENV------DIWSVGCIMGEMI 219
Query: 383 TGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSL 420
            G   +     +     +       ++   CP+ +K L
Sbjct: 220 KGGVLFPGTDHIDQWNKVIE-----QLGTPCPEFMKKL 252

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 43/216 (19%), Positives = 90/216 (41%), Gaps = 18/216 (8%)
Query: 210 KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVTK 264
           + V I+KL    +   +     ++L+ +    HKNI+    V      ++E   + +V +
Sbjct: 51  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME 110
Query: 265 LMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVC 324
           LM+      + ++   L  + +  +   +  GIK L+  G+ +RDL    I++     + 
Sbjct: 111 LMDANLCQVIQME---LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLK 167
Query: 325 LGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTG 384
           + D G+     +    T Y    Y + APE+I G    +      +++S G ++ EM+ G
Sbjct: 168 ILDFGLARTAGTSFMMTPYVVTRY-YRAPEVILG----MGYKENVDIWSVGCIMGEMIKG 222
Query: 385 EAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSL 420
              +     +     +       ++   CP+ +K L
Sbjct: 223 GVLFPGTDHIDQWNKVIE-----QLGTPCPEFMKKL 253

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 42/187 (22%), Positives = 82/187 (43%), Gaps = 17/187 (9%)
Query: 209 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVT 263
           G  V ++KL    +   +     ++L+ L    HKNI+    V      ++E   + +V 
Sbjct: 47  GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVM 106
Query: 264 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 323
           +LM+      + ++   L  + +  +   +  GIK L+  G+ +RDL    I++     +
Sbjct: 107 ELMDANLCQVIHME---LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL 163
Query: 324 CLGDMGIVTACKSVGEATEYETDGYRWLAPEII--AGDPESVSETWMSNVYSFGMVIWEM 381
            + D G+     +    T Y    Y + APE+I   G  E+V      +++S G ++ E+
Sbjct: 164 KILDFGLARTASTNFMMTPYVVTRY-YRAPEVILGMGYKENV------DIWSVGCIMGEL 216
Query: 382 VTGEAAY 388
           V G   +
Sbjct: 217 VKGSVIF 223

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 43/215 (20%), Positives = 90/215 (41%), Gaps = 13/215 (6%)
Query: 227 EFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEI 286
           E +LR+++       H NIL+ Y    D    + ++ +    G+V   + K  +   +  
Sbjct: 56  EHQLRREVEIQSHLRHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSRFDEQRT 114
Query: 287 IRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETD 346
                ++A  + + +   V +RD+  + +LL  +G + + D G      S    T   T 
Sbjct: 115 ATYITELANALSYCHSKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRTTLCGTL 174
Query: 347 GYRWLAPEIIAG--DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG 404
            Y  L PE+I G    E V      +++S G++ +E + G   + A +  +    I+   
Sbjct: 175 DY--LPPEMIEGRMHDEKV------DLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVE 226
Query: 405 LRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEII 439
                P    +  + L+ +   ++ S+R   +E++
Sbjct: 227 F--TFPDFVTEGARDLISRLLKHNASQRLTLAEVL 259

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 42/182 (23%), Positives = 84/182 (46%), Gaps = 17/182 (9%)
Query: 210 KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVTK 264
           + V I+KL    +   +     ++L+ +    HKNI+    V      ++E   + +V +
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME 109
Query: 265 LMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVC 324
           LM+  +++ +I    +L  + +  +   +  GIK L+  G+ +RDL    I++     + 
Sbjct: 110 LMDA-NLSQVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLK 166
Query: 325 LGDMGIVTACKSVGEATEYETDGYRWLAPEII--AGDPESVSETWMSNVYSFGMVIWEMV 382
           + D G+     +    T Y    Y + APE+I   G  E+V      +++S G ++ EM+
Sbjct: 167 ILDFGLARTAGTSFMMTPYVVTRY-YRAPEVILGMGYKENV------DIWSVGCIMGEMI 219
Query: 383 TG 384
            G
Sbjct: 220 KG 221

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 42/211 (19%), Positives = 86/211 (40%), Gaps = 10/211 (4%)
Query: 190 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHK 243
           +  E I +IG  S+  V+K      G+ V I+K    +     +    +++  L    H 
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62
Query: 244 NILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDH 303
           N++    V       L +V +  +   +++L    R +    +  I     + + F + H
Sbjct: 63  NLVNLLEV-FRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKH 121
Query: 304 GVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESV 363
              +RD+  + IL+ +H  + L D G         +  + E     + +PE++ GD +  
Sbjct: 122 NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYG 181
Query: 364 SETWMSNVYSFGMVIWEMVTGEAAYAACSPV 394
                 +V++ G V  E+++G   +   S V
Sbjct: 182 PPV---DVWAIGCVFAELLSGVPLWPGKSDV 209

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 44/208 (21%), Positives = 93/208 (44%), Gaps = 10/208 (4%)
Query: 186 LLNSDNLEFIDQIGPNSFKGVYKGKRVG----IEKLKGCDKGNAYEFELRKDLLELMTCG 241
           + +SD  E +  IG  +F GV +  R      +  +K  ++G   +  ++++++   +  
Sbjct: 14  MHDSDRYELVKDIGSGNF-GVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLR 72
Query: 242 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 301
           H NI++F  V +   H L +V +   GG + + I  + +    E       +  G+ + +
Sbjct: 73  HPNIVRFKEVILTPTH-LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 131
Query: 302 DHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY-RWLAPEIIAGDP 360
              V +RDL  +  LLD      L       +  SV  +    T G   ++APE++    
Sbjct: 132 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL--- 188
Query: 361 ESVSETWMSNVYSFGMVIWEMVTGEAAY 388
           +   +  +++V+S G+ ++ M+ G   +
Sbjct: 189 KKEYDGKVADVWSCGVTLYVMLVGAYPF 216

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 43/192 (22%), Positives = 86/192 (44%), Gaps = 28/192 (14%)
Query: 209 GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN-----HGLCVVT 263
           G++V I+KL    +   +     ++LL L    H+N++    V    +     +   +V 
Sbjct: 67  GEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVM 126
Query: 264 KLMEGGSVNDL-ILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGN 322
             M+     DL  +   +   ++I  +   + +G+K+++  GV +RDL    + ++    
Sbjct: 127 PFMQ----TDLQKIMGMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCE 182
Query: 323 VCLGDMGIVTACKSVGEATEYETDGYRWL-APEIIAGDPESVSETWMS-----NVYSFGM 376
           + + D G+  A  +  E T Y     RW  APE+I         +WM      +++S G 
Sbjct: 183 LKILDFGL--ARHADAEMTGYVVT--RWYRAPEVIL--------SWMHYNQTVDIWSVGC 230
Query: 377 VIWEMVTGEAAY 388
           ++ EM+TG+  +
Sbjct: 231 IMAEMLTGKTLF 242

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 48/234 (20%), Positives = 98/234 (41%), Gaps = 23/234 (9%)
Query: 210 KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVTK 264
           + V I+KL    +   +     ++L+ +    HKNI+    V      ++E   + +V +
Sbjct: 49  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVME 108
Query: 265 LMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVC 324
           LM+      + ++   L  + +  +   +  GIK L+  G+ +RDL    I++     + 
Sbjct: 109 LMDANLCQVIQME---LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLK 165
Query: 325 LGDMGIVTACKSVGEATEYETDGYRWLAPEII--AGDPESVSETWMSNVYSFGMVIWEMV 382
           + D G+     +    T Y    Y + APE+I   G  E+V      +++S G ++ EMV
Sbjct: 166 ILDFGLARTAGTSFMMTPYVVTRY-YRAPEVILGMGYKENV------DIWSVGCIMGEMV 218
Query: 383 TGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFS 436
             +  +     +     +       ++   CP+ +K L      N    RP+++
Sbjct: 219 RHKILFPGRDYIDQWNKVIE-----QLGTPCPEFMKKLQPTV-RNYVENRPKYA 266

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 48/234 (20%), Positives = 98/234 (41%), Gaps = 23/234 (9%)
Query: 210 KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVTK 264
           + V I+KL    +   +     ++L+ +    HKNI+    V      ++E   + +V +
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVME 109
Query: 265 LMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVC 324
           LM+      + ++   L  + +  +   +  GIK L+  G+ +RDL    I++     + 
Sbjct: 110 LMDANLCQVIQME---LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLK 166
Query: 325 LGDMGIVTACKSVGEATEYETDGYRWLAPEII--AGDPESVSETWMSNVYSFGMVIWEMV 382
           + D G+     +    T Y    Y + APE+I   G  E+V      +++S G ++ EMV
Sbjct: 167 ILDFGLARTAGTSFMMTPYVVTRY-YRAPEVILGMGYKENV------DIWSVGCIMGEMV 219
Query: 383 TGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFS 436
             +  +     +     +       ++   CP+ +K L      N    RP+++
Sbjct: 220 RHKILFPGRDYIDQWNKVIE-----QLGTPCPEFMKKLQPTV-RNYVENRPKYA 267

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 44/208 (21%), Positives = 92/208 (44%), Gaps = 10/208 (4%)
Query: 186 LLNSDNLEFIDQIGPNSFKGVYKGKRVG----IEKLKGCDKGNAYEFELRKDLLELMTCG 241
           + +SD  E +  IG  +F GV +  R      +  +K  ++G      ++++++   +  
Sbjct: 15  MHDSDRYELVKDIGSGNF-GVARLMRDKQSNELVAVKYIERGEKIAANVKREIINHRSLR 73
Query: 242 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 301
           H NI++F  V +   H L +V +   GG + + I  + +    E       +  G+ + +
Sbjct: 74  HPNIVRFKEVILTPTH-LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 132
Query: 302 DHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY-RWLAPEIIAGDP 360
              V +RDL  +  LLD      L       +  SV  +    T G   ++APE++    
Sbjct: 133 AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL--- 189
Query: 361 ESVSETWMSNVYSFGMVIWEMVTGEAAY 388
           +   +  +++V+S G+ ++ M+ G   +
Sbjct: 190 KKEYDGKVADVWSCGVTLYVMLVGAYPF 217

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 46/232 (19%), Positives = 96/232 (41%), Gaps = 19/232 (8%)
Query: 210 KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVTK 264
           + V I+KL    +   +     ++L+ +    HKNI+    V      ++E   + +V +
Sbjct: 88  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVME 147
Query: 265 LMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVC 324
           LM+      + ++   L  + +  +   +  GIK L+  G+ +RDL    I++     + 
Sbjct: 148 LMDANLCQVIQME---LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLK 204
Query: 325 LGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTG 384
           + D G+     +    T Y    Y + APE+I G    +      +++S G ++ EMV  
Sbjct: 205 ILDFGLARTAGTSFMMTPYVVTRY-YRAPEVILG----MGYKENVDIWSVGCIMGEMVRH 259
Query: 385 EAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFS 436
           +  +     +     +       ++   CP+ +K L      N    RP+++
Sbjct: 260 KILFPGRDYIDQWNKVIE-----QLGTPCPEFMKKLQPTV-RNYVENRPKYA 305

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 48/234 (20%), Positives = 98/234 (41%), Gaps = 23/234 (9%)
Query: 210 KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVTK 264
           + V I+KL    +   +     ++L+ +    HKNI+    V      ++E   + +V +
Sbjct: 51  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVME 110
Query: 265 LMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVC 324
           LM+      + ++   L  + +  +   +  GIK L+  G+ +RDL    I++     + 
Sbjct: 111 LMDANLCQVIQME---LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLK 167
Query: 325 LGDMGIVTACKSVGEATEYETDGYRWLAPEII--AGDPESVSETWMSNVYSFGMVIWEMV 382
           + D G+     +    T Y    Y + APE+I   G  E+V      +++S G ++ EMV
Sbjct: 168 ILDFGLARTAGTSFMMTPYVVTRY-YRAPEVILGMGYKENV------DIWSVGCIMGEMV 220
Query: 383 TGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFS 436
             +  +     +     +       ++   CP+ +K L      N    RP+++
Sbjct: 221 RHKILFPGRDYIDQWNKVIE-----QLGTPCPEFMKKLQPTV-RNYVENRPKYA 268

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 41/182 (22%), Positives = 81/182 (44%), Gaps = 17/182 (9%)
Query: 210 KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVTK 264
           + V I+KL    +   +     ++L+ +    HKNI+    V      ++E   + +V +
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME 109
Query: 265 LMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVC 324
           LM+      + ++   L  + +  +   +  GIK L+  G+ +RDL    I++     + 
Sbjct: 110 LMDANLCQVIQME---LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLK 166
Query: 325 LGDMGIVTACKSVGEATEYETDGYRWLAPEII--AGDPESVSETWMSNVYSFGMVIWEMV 382
           + D G+     +    T Y    Y + APE+I   G  E+V      +++S G ++ EM+
Sbjct: 167 ILDFGLARTAGTSFMMTPYVVTRY-YRAPEVILGMGYKENV------DIWSVGCIMGEMI 219
Query: 383 TG 384
            G
Sbjct: 220 KG 221

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 43/215 (20%), Positives = 90/215 (41%), Gaps = 13/215 (6%)
Query: 227 EFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEI 286
           E +LR+++       H NIL+ Y    D    + ++ +    G+V   + K  +   +  
Sbjct: 56  EHQLRREVEIQSHLRHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSRFDEQRT 114
Query: 287 IRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETD 346
                ++A  + + +   V +RD+  + +LL  +G + + D G      S    T   T 
Sbjct: 115 ATYITELANALSYCHSKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRDTLCGTL 174
Query: 347 GYRWLAPEIIAG--DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG 404
            Y  L PE+I G    E V      +++S G++ +E + G   + A +  +    I+   
Sbjct: 175 DY--LPPEMIEGRMHDEKV------DLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVE 226
Query: 405 LRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEII 439
                P    +  + L+ +   ++ S+R   +E++
Sbjct: 227 F--TFPDFVTEGARDLISRLLKHNASQRLTLAEVL 259

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 48/234 (20%), Positives = 98/234 (41%), Gaps = 23/234 (9%)
Query: 210 KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVTK 264
           + V I+KL    +   +     ++L+ +    HKNI+    V      ++E   + +V +
Sbjct: 51  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVME 110
Query: 265 LMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVC 324
           LM+      + ++   L  + +  +   +  GIK L+  G+ +RDL    I++     + 
Sbjct: 111 LMDANLCQVIQME---LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLK 167
Query: 325 LGDMGIVTACKSVGEATEYETDGYRWLAPEII--AGDPESVSETWMSNVYSFGMVIWEMV 382
           + D G+     +    T Y    Y + APE+I   G  E+V      +++S G ++ EMV
Sbjct: 168 ILDFGLARTAGTSFMMTPYVVTRY-YRAPEVILGMGYKENV------DIWSVGCIMGEMV 220
Query: 383 TGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFS 436
             +  +     +     +       ++   CP+ +K L      N    RP+++
Sbjct: 221 RHKILFPGRDYIDQWNKVIE-----QLGTPCPEFMKKLQPTV-RNYVENRPKYA 268

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 48/234 (20%), Positives = 98/234 (41%), Gaps = 23/234 (9%)
Query: 210 KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVTK 264
           + V I+KL    +   +     ++L+ +    HKNI+    V      ++E   + +V +
Sbjct: 50  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVME 109
Query: 265 LMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVC 324
           LM+      + ++   L  + +  +   +  GIK L+  G+ +RDL    I++     + 
Sbjct: 110 LMDANLCQVIQME---LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLK 166
Query: 325 LGDMGIVTACKSVGEATEYETDGYRWLAPEII--AGDPESVSETWMSNVYSFGMVIWEMV 382
           + D G+     +    T Y    Y + APE+I   G  E+V      +++S G ++ EMV
Sbjct: 167 ILDFGLARTAGTSFMMTPYVVTRY-YRAPEVILGMGYKENV------DIWSVGCIMGEMV 219
Query: 383 TGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFS 436
             +  +     +     +       ++   CP+ +K L      N    RP+++
Sbjct: 220 RHKILFPGRDYIDQWNKVIE-----QLGTPCPEFMKKLQPTV-RNYVENRPKYA 267

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 56/263 (21%), Positives = 102/263 (38%), Gaps = 38/263 (14%)
Query: 197 QIGP----NSFKGVYKGKRVG---------IEKLKGCDKG---NAYEFELRKDLLELMTC 240
           Q+GP      F  VY G RV          +EK +  D G   N     +   LL+ ++ 
Sbjct: 27  QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 86
Query: 241 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL 300
           G   +++        +  + ++ +      + D I +   LQ +        V E ++  
Sbjct: 87  GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC 146
Query: 301 NDHGVAYRDLNSQRILLD-RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGD 359
           ++ GV +RD+  + IL+D   G + L D G     K   +    + DG R  +P      
Sbjct: 147 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSP------ 197
Query: 360 PESVSETWM----SNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ 415
           PE +         + V+S G+++++MV G+  +         +       R  +  +C  
Sbjct: 198 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH----DEEIIRGQVFFRQRVSXECQH 253
Query: 416 ILKSLMIKCWNNSPSKRPQFSEI 438
           +++     C    P  RP F EI
Sbjct: 254 LIRW----CLALRPXDRPTFEEI 272

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 46/232 (19%), Positives = 96/232 (41%), Gaps = 19/232 (8%)
Query: 210 KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVTK 264
           + V I+KL    +   +     ++L+ +    HKNI+    V      ++E   + +V +
Sbjct: 88  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVME 147
Query: 265 LMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVC 324
           LM+      + ++   L  + +  +   +  GIK L+  G+ +RDL    I++     + 
Sbjct: 148 LMDANLCQVIQME---LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLK 204
Query: 325 LGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTG 384
           + D G+     +    T Y    Y + APE+I G    +      +++S G ++ EMV  
Sbjct: 205 ILDFGLARTAGTSFMMTPYVVTRY-YRAPEVILG----MGYKENVDIWSVGCIMGEMVRH 259
Query: 385 EAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFS 436
           +  +     +     +       ++   CP+ +K L      N    RP+++
Sbjct: 260 KILFPGRDYIDQWNKVIE-----QLGTPCPEFMKKLQ-PTVRNYVENRPKYA 305

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 38/152 (25%), Positives = 68/152 (44%), Gaps = 10/152 (6%)
Query: 242 HKNILQFYCVCVD----ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGI 297
           H NIL    + V       H L +VT+LM       +  +   +  + I      +  G+
Sbjct: 88  HPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGL 147
Query: 298 KFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWL-APEII 356
             L++ GV +RDL+   ILL  + ++ + D  +     +    T Y T  +RW  APE++
Sbjct: 148 HVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVT--HRWYRAPELV 205
Query: 357 AGDPESVSETWMSNVYSFGMVIWEMVTGEAAY 388
               +    T + +++S G V+ EM   +A +
Sbjct: 206 M---QFKGFTKLVDMWSAGCVMAEMFNRKALF 234

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 38/152 (25%), Positives = 68/152 (44%), Gaps = 10/152 (6%)
Query: 242 HKNILQFYCVCVD----ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGI 297
           H NIL    + V       H L +VT+LM       +  +   +  + I      +  G+
Sbjct: 88  HPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGL 147
Query: 298 KFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWL-APEII 356
             L++ GV +RDL+   ILL  + ++ + D  +     +    T Y T  +RW  APE++
Sbjct: 148 HVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVT--HRWYRAPELV 205
Query: 357 AGDPESVSETWMSNVYSFGMVIWEMVTGEAAY 388
               +    T + +++S G V+ EM   +A +
Sbjct: 206 M---QFKGFTKLVDMWSAGCVMAEMFNRKALF 234

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 48/234 (20%), Positives = 98/234 (41%), Gaps = 23/234 (9%)
Query: 210 KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVTK 264
           + V I+KL    +   +     ++L+ +    HKNI+    V      ++E   + +V +
Sbjct: 43  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVME 102
Query: 265 LMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVC 324
           LM+      + ++   L  + +  +   +  GIK L+  G+ +RDL    I++     + 
Sbjct: 103 LMDANLCQVIQME---LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLK 159
Query: 325 LGDMGIVTACKSVGEATEYETDGYRWLAPEII--AGDPESVSETWMSNVYSFGMVIWEMV 382
           + D G+     +    T Y    Y + APE+I   G  E+V      +++S G ++ EMV
Sbjct: 160 ILDFGLARTAGTSFMMTPYVVTRY-YRAPEVILGMGYKENV------DIWSVGCIMGEMV 212
Query: 383 TGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFS 436
             +  +     +     +       ++   CP+ +K L      N    RP+++
Sbjct: 213 RHKILFPGRDYIDQWNKVIE-----QLGTPCPEFMKKLQPTV-RNYVENRPKYA 260

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 48/234 (20%), Positives = 98/234 (41%), Gaps = 23/234 (9%)
Query: 210 KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVTK 264
           + V I+KL    +   +     ++L+ +    HKNI+    V      ++E   + +V +
Sbjct: 44  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVME 103
Query: 265 LMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVC 324
           LM+      + ++   L  + +  +   +  GIK L+  G+ +RDL    I++     + 
Sbjct: 104 LMDANLCQVIQME---LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLK 160
Query: 325 LGDMGIVTACKSVGEATEYETDGYRWLAPEII--AGDPESVSETWMSNVYSFGMVIWEMV 382
           + D G+     +    T Y    Y + APE+I   G  E+V      +++S G ++ EMV
Sbjct: 161 ILDFGLARTAGTSFMMTPYVVTRY-YRAPEVILGMGYKENV------DIWSVGCIMGEMV 213
Query: 383 TGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFS 436
             +  +     +     +       ++   CP+ +K L      N    RP+++
Sbjct: 214 RHKILFPGRDYIDQWNKVIE-----QLGTPCPEFMKKLQPTV-RNYVENRPKYA 261

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 46/232 (19%), Positives = 96/232 (41%), Gaps = 19/232 (8%)
Query: 210 KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVTK 264
           + V I+KL    +   +     ++L+ +    HKNI+    V      ++E   + +V +
Sbjct: 44  RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVME 103
Query: 265 LMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVC 324
           LM+      + ++   L  + +  +   +  GIK L+  G+ +RDL    I++     + 
Sbjct: 104 LMDANLCQVIQME---LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLK 160
Query: 325 LGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTG 384
           + D G+     +    T Y    Y + APE+I G    +      +++S G ++ EMV  
Sbjct: 161 ILDFGLARTAGTSFMMTPYVVTRY-YRAPEVILG----MGYKENVDIWSVGCIMGEMVRH 215
Query: 385 EAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFS 436
           +  +     +     +       ++   CP+ +K L      N    RP+++
Sbjct: 216 KILFPGRDYIDQWNKVIE-----QLGTPCPEFMKKLQPTV-RNYVENRPKYA 261

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	454
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	3e-66
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	4e-66
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	4e-64
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	5e-62
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	3e-61
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	2e-59
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	8e-59
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	4e-58
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	1e-57
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	6e-56
3q4u_A	301	Activin receptor type-1; structural genomics conso	4e-54
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	6e-51
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	2e-50
3soc_A	322	Activin receptor type-2A; structural genomics cons	2e-49
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	7e-46
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	9e-41
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	9e-40
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	1e-39
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	6e-39
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	6e-39
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	8e-39
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	1e-38
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	4e-38
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	6e-38
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	9e-38
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	1e-37
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	2e-37
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	2e-37
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	3e-37
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	4e-37
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	5e-37
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	5e-37
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	6e-37
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	6e-37
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	9e-37
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	1e-36
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	2e-36
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	2e-36
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	2e-36
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	3e-36
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	3e-36
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	3e-36
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	4e-36
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	8e-36
4aoj_A	329	High affinity nerve growth factor receptor; transf	8e-36
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	8e-36
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	9e-36
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	1e-35
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	1e-35
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	2e-35
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	2e-35
3pls_A	298	Macrophage-stimulating protein receptor; protein k	2e-35
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	3e-35
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	4e-35
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	5e-35
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	5e-35
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	1e-34
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	1e-34
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	1e-34
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	1e-34
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	2e-34
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	3e-34
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	3e-34
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	4e-33
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	8e-33
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	1e-32
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	8e-32
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-31
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	2e-31
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	7e-31
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	4e-28
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	9e-28
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	3e-26
2a19_B	284	Interferon-induced, double-stranded RNA-activated	1e-25
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-25
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	3e-25
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	5e-25
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	2e-24
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	1e-23
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-23
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-23
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-07
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	2e-23
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	5e-23
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	2e-22
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	2e-22
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	2e-22
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	9e-22
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	1e-21
2dyl_A	318	Dual specificity mitogen-activated protein kinase	2e-21
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	4e-21
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	4e-21
3aln_A	327	Dual specificity mitogen-activated protein kinase;	1e-20
3ork_A	311	Serine/threonine protein kinase; structural genomi	5e-20
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	7e-20
3an0_A	340	Dual specificity mitogen-activated protein kinase;	8e-20
3fme_A	290	Dual specificity mitogen-activated protein kinase;	8e-19
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	1e-18
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	1e-18
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	1e-18
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	6e-18
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	1e-17
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	1e-17
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-16
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	3e-16
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	3e-16
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	6e-16
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	1e-15
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	1e-15
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	2e-15
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	2e-15
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	9e-15
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	9e-15
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	1e-14
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	3e-14
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	3e-14
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	4e-14
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	5e-14
3uqc_A	286	Probable conserved transmembrane protein; structur	7e-14
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	4e-13
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	5e-13
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	7e-13
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	7e-13
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	7e-13
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	8e-13
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	8e-13
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	1e-12
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	2e-12
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	2e-12
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	2e-12
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	2e-12
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	2e-12
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	4e-12
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	6e-12
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	6e-12
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	6e-12
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	1e-11
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	1e-11
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	2e-11
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	2e-11
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	5e-11
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	6e-11
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	6e-11
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	3e-10
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	4e-10
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	4e-10
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	6e-10
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	2e-09
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	5e-09
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	1e-08
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	2e-08
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	3e-08
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	3e-08
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	3e-08
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	5e-08
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	6e-08
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	7e-08
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	1e-07
3bhy_A	283	Death-associated protein kinase 3; death associate	1e-07
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	1e-07
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	1e-07
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	1e-07
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	1e-07
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	2e-07
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	2e-07
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	2e-07
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	3e-07
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	3e-07
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	3e-07
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	3e-07
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	3e-07
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	3e-07
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	4e-07
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	4e-07
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	4e-07
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	5e-07
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	5e-07
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	5e-07
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	6e-07
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	6e-07
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	7e-07
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	8e-07
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	9e-07
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	9e-07
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	1e-06
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-06
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	1e-06
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-06
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	1e-06
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	1e-06
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-06
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	2e-06
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	2e-06
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	2e-06
3niz_A	311	Rhodanese family protein; structural genomics, str	2e-06
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	2e-06
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	3e-06
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	3e-06
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	3e-06
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	3e-06
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	3e-06
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	4e-06
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	7e-06
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	1e-05
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	1e-05
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	2e-05
3o0g_A	292	Cell division protein kinase 5; kinase activator c	2e-05
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	3e-05
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	3e-05
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	3e-05
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	4e-05
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	5e-05
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	5e-05
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	5e-05
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	6e-05
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	6e-05
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	6e-05
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	7e-05
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	1e-04
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	1e-04
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	2e-04
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-04
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	3e-04
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	3e-04
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	4e-04
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	8e-04
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	8e-04

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  213 bits (545), Expect = 3e-66
 Identities = 70/271 (25%), Positives = 131/271 (48%), Gaps = 14/271 (5%)

Query: 181 EIGRWLLNSDNLEFIDQIGPNSF----KGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLE 236
           +     +   +L   ++IG  SF    +  + G  V ++ L   D       E  +++  
Sbjct: 28  DGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAI 87

Query: 237 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKS---RKLQTKEIIRIAIDV 293
           +    H NI+ F        + L +VT+ +  GS+  L+ KS    +L  +  + +A DV
Sbjct: 88  MKRLRHPNIVLFMGAVTQPPN-LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDV 146

Query: 294 AEGIKFL--NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWL 351
           A+G+ +L   +  + +R+L S  +L+D+   V + D G+     S   +++       W+
Sbjct: 147 AKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWM 206

Query: 352 APEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPK 411
           APE++  +P   +E   S+VYSFG+++WE+ T +  +   +P Q    +     R EIP+
Sbjct: 207 APEVLRDEP--SNE--KSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPR 262

Query: 412 DCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
           +    + +++  CW N P KRP F+ I+ LL
Sbjct: 263 NLNPQVAAIIEGCWTNEPWKRPSFATIMDLL 293

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  212 bits (542), Expect = 4e-66
 Identities = 62/271 (22%), Positives = 123/271 (45%), Gaps = 23/271 (8%)

Query: 185 WLLNSDNLEFIDQIGPNSF----KGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTC 240
             ++   L F+ ++  N      KG ++G  + ++ LK  D       +  ++   L   
Sbjct: 5   SGIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIF 64

Query: 241 GHKNILQFYCVCVDENHG-LCVVTKLMEGGSVNDLILK--SRKLQTKEIIRIAIDVAEGI 297
            H N+L     C         ++T  M  GS+ +++ +  +  +   + ++ A+D+A G+
Sbjct: 65  SHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGM 124

Query: 298 KFL--NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRWL 351
            FL   +  +    LNS+ +++D      +    +            +++ G      W+
Sbjct: 125 AFLHTLEPLIPRHALNSRSVMIDEDMTARISMADV---------KFSFQSPGRMYAPAWV 175

Query: 352 APEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPK 411
           APE +   PE  +    ++++SF +++WE+VT E  +A  S ++  + +A  GLRP IP 
Sbjct: 176 APEALQKKPED-TNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPP 234

Query: 412 DCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
                +  LM  C N  P+KRP+F  I+ +L
Sbjct: 235 GISPHVSKLMKICMNEDPAKRPKFDMIVPIL 265

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  207 bits (528), Expect = 4e-64
 Identities = 68/275 (24%), Positives = 120/275 (43%), Gaps = 25/275 (9%)

Query: 185 WLLNSDNLEFIDQIGPNSF----KGVYKGKRVGIEKLKGCDKGNAYEF--ELRKDLLELM 238
             ++   L   + IG   F    +  + G  V ++  +     +  +    +R++     
Sbjct: 2   LEIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFA 61

Query: 239 TCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIK 298
              H NI+    VC+ E + LC+V +   GG +N + L  +++    ++  A+ +A G+ 
Sbjct: 62  MLKHPNIIALRGVCLKEPN-LCLVMEFARGGPLNRV-LSGKRIPPDILVNWAVQIARGMN 119

Query: 299 FL---NDHGVAYRDLNSQRILLDRHGNVCLGDMGIV------TACKSVGEATEYETDG-- 347
           +L       + +RDL S  IL+ +          I+       A       T   +    
Sbjct: 120 YLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR--EWHRTTKMSAAGA 177

Query: 348 YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP 407
           Y W+APE+I       S+   S+V+S+G+++WE++TGE  +     +  A G+A   L  
Sbjct: 178 YAWMAPEVIRASM--FSKG--SDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLAL 233

Query: 408 EIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
            IP  CP+    LM  CWN  P  RP F+ I+  L
Sbjct: 234 PIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQL 268

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  202 bits (517), Expect = 5e-62
 Identities = 68/270 (25%), Positives = 130/270 (48%), Gaps = 26/270 (9%)

Query: 185 WLLNSDNLEFIDQIGPNSF----KGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTC 240
            +++   +E  + +G  +F    K  ++ K V I++++   +  A+  ELR+    L   
Sbjct: 3   HMIDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESESERKAFIVELRQ----LSRV 58

Query: 241 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR---KLQTKEIIRIAIDVAEGI 297
            H NI++ Y  C++    +C+V +  EGGS+ +++  +           +   +  ++G+
Sbjct: 59  NHPNIVKLYGACLNP---VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGV 115

Query: 298 KFL---NDHGVAYRDLNSQRILLDRHGNVC-LGDMGIVTACKSVGEATEYETDGYRWLAP 353
            +L       + +RDL    +LL   G V  + D G  TAC      T        W+AP
Sbjct: 116 AYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFG--TACDIQTHMTN-NKGSAAWMAP 172

Query: 354 EIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACS-PVQAAVGIAACGLRPEIPKD 412
           E+  G   + SE    +V+S+G+++WE++T    +     P    +     G RP + K+
Sbjct: 173 EVFEG--SNYSEK--CDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKN 228

Query: 413 CPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
            P+ ++SLM +CW+  PS+RP   EI+ ++
Sbjct: 229 LPKPIESLMTRCWSKDPSQRPSMEEIVKIM 258

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  200 bits (510), Expect = 3e-61
 Identities = 76/279 (27%), Positives = 131/279 (46%), Gaps = 29/279 (10%)

Query: 185 WLLNSDNLEFIDQIGPNSFKGVYKGK------RVGIEKLK-GCDKGNAYEFELRKDLLE- 236
             L  + +E+  QIG   F  V+KG+       V I+ L  G  +G     E  ++    
Sbjct: 14  PTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQRE 73

Query: 237 ---LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL-KSRKLQTKEIIRIAID 292
              +    H NI++ Y +  +      +V + +  G +   +L K+  ++    +R+ +D
Sbjct: 74  VFIMSNLNHPNIVKLYGLMHN---PPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLD 130

Query: 293 VAEGIKFLNDHGVAY--RDLNSQRILLD---RHGNVCL--GDMGIVTACKSVGEATEYET 345
           +A GI+++ +       RDL S  I L     +  VC    D G   + +SV   +    
Sbjct: 131 IALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFG--LSQQSVHSVSG-LL 187

Query: 346 DGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAAC-- 403
             ++W+APE I  + ES +E   ++ YSF M+++ ++TGE  +   S  +          
Sbjct: 188 GNFQWMAPETIGAEEESYTE--KADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREE 245

Query: 404 GLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
           GLRP IP+DCP  L++++  CW+  P KRP FS I+  L
Sbjct: 246 GLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKEL 284

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  195 bits (498), Expect = 2e-59
 Identities = 72/278 (25%), Positives = 123/278 (44%), Gaps = 15/278 (5%)

Query: 176 QSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGK---RVGIEKLKGCDKGNAYEFELRK 232
               +    W +    +    +IG  SF  VYKGK    V ++ L             + 
Sbjct: 10  HGSRDAADDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKN 69

Query: 233 DLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAI 291
           ++  L    H NIL F          L +VT+  EG S+   +  S  K + K++I IA 
Sbjct: 70  EVGVLRKTRHVNILLFMGYSTAPQ--LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIAR 127

Query: 292 DVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG--YR 349
             A G+ +L+   + +RDL S  I L     V +GD G+ T       + ++E       
Sbjct: 128 QTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSIL 187

Query: 350 WLAPEIIAGDPES-VSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR-- 406
           W+APE+I     +  S    S+VY+FG+V++E++TG+  Y+  +     + +   G    
Sbjct: 188 WMAPEVIRMQDSNPYSF--QSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSP 245

Query: 407 --PEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
              ++  +CP+ +K LM +C      +RP F  I++ +
Sbjct: 246 DLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEI 283

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  194 bits (495), Expect = 8e-59
 Identities = 63/284 (22%), Positives = 120/284 (42%), Gaps = 37/284 (13%)

Query: 185 WLLNSDNLEFIDQIGPNSF----KGVYK--GKRVGIEKLKGCDKGNAYEFELRKDLL--- 235
            +    +L   + +G   F    K  ++  G+ + +++L   D+      E ++  L   
Sbjct: 5   RIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDE------ETQRTFLKEV 58

Query: 236 ELMTC-GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILK-SRKLQTKEIIRIAIDV 293
           ++M C  H N+L+F  V   +   L  +T+ ++GG++  +I     +    + +  A D+
Sbjct: 59  KVMRCLEHPNVLKFIGVLYKDKR-LNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDI 117

Query: 294 AEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGI--------------VTACKSVGE 339
           A G+ +L+   + +RDLNS   L+  + NV + D G+               +  K   +
Sbjct: 118 ASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRK 177

Query: 340 ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVG 399
                     W+APE+I G           +V+SFG+V+ E++    A     P     G
Sbjct: 178 KRYTVVGNPYWMAPEMINGRSYDEK----VDVFSFGIVLCEIIGRVNADPDYLPRTMDFG 233

Query: 400 IAAC-GLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
           +     L    P +CP     + ++C +  P KRP F ++   L
Sbjct: 234 LNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWL 277

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  191 bits (488), Expect = 1e-57
 Identities = 62/309 (20%), Positives = 132/309 (42%), Gaps = 31/309 (10%)

Query: 149 NSNLKIQLQMPLPSSSFVVSVDEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYK 208
           N +L      P  +S   + + EW        +I       + LE  + IG   F  VY 
Sbjct: 5   NLSLLSARSFPRKASQTSIFLQEW--------DI-----PFEQLEIGELIGKGRFGQVYH 51

Query: 209 GK---RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKL 265
           G+    V I  +             +++++      H+N++ F   C+   H L ++T L
Sbjct: 52  GRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPH-LAIITSL 110

Query: 266 MEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVC 324
            +G ++  ++  ++  L   +  +IA ++ +G+ +L+  G+ ++DL S+ +  D +G V 
Sbjct: 111 CKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVV 169

Query: 325 LGDMGI-----VTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWM-----SNVYSF 374
           + D G+     V       +    +      LAPEII        E  +     S+V++ 
Sbjct: 170 ITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFAL 229

Query: 375 GMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPK-DCPQILKSLMIKCWNNSPSKRP 433
           G + +E+   E  +      +A +     G++P + +    + +  +++ CW     +RP
Sbjct: 230 GTIWYELHAREWPFKTQPA-EAIIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERP 288

Query: 434 QFSEIISLL 442
            F++++ +L
Sbjct: 289 TFTKLMDML 297

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  188 bits (478), Expect = 6e-56
 Identities = 69/335 (20%), Positives = 137/335 (40%), Gaps = 49/335 (14%)

Query: 161 PSSSFVVSVDEWQTVQSG-GEEIGRWLLNSDNLEFIDQIGPNSF----KGVYKGKRVGIE 215
           P  S    +++ Q+  SG G  +      +  ++ + QIG   +     G ++G++V ++
Sbjct: 7   PGESLRDLIEQSQSSGSGSGLPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVK 66

Query: 216 KLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHG---LCVVTKLMEGGSVN 272
                ++     +    ++ + +   H+NIL F    +        L ++T   E GS+ 
Sbjct: 67  VFFTTEEA---SWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLY 123

Query: 273 DLILKSRKLQTKEIIRIAIDVAEGIKFL--------NDHGVAYRDLNSQRILLDRHGNVC 324
           D  LKS  L  K ++++A     G+  L            +A+RDL S+ IL+ ++G  C
Sbjct: 124 DY-LKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCC 182

Query: 325 LGDMGIVTACKSVGEATEYETDG----YRWLAPEIIAGDPESVSE--TWMSNVYSFGMVI 378
           + D+G+     S     +   +      R++ PE++             M+++YSFG+++
Sbjct: 183 IADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLIL 242

Query: 379 WEMVTGEAA----------YAACSPVQAAVG-----IAACGLRPEIPK-----DCPQILK 418
           WE+     +          Y    P   +       +    LRP  P      +C + + 
Sbjct: 243 WEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMG 302

Query: 419 SLMIKCWNNSPSKRPQFSEIISLLLRTNNISNSSN 453
            LM +CW ++P+ R     +   L     +S S +
Sbjct: 303 KLMTECWAHNPASRLTALRVKKTL---AKMSESQD 334

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  181 bits (462), Expect = 4e-54
 Identities = 64/296 (21%), Positives = 121/296 (40%), Gaps = 45/296 (15%)

Query: 188 NSDNLEFIDQIGPNSF----KGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHK 243
            + ++  ++ +G   +    +G ++G+ V ++     D+  ++  E   +L   +   H+
Sbjct: 6   VARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDE-KSWFRE--TELYNTVMLRHE 62

Query: 244 NILQFYCVCVDENHG---LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL 300
           NIL F    +   H    L ++T   E GS+ D  L+   L T   +RI + +A G+  L
Sbjct: 63  NILGFIASDMTSRHSSTQLWLITHYHEMGSLYDY-LQLTTLDTVSCLRIVLSIASGLAHL 121

Query: 301 --------NDHGVAYRDLNSQRILLDRHGNVCLGDMG---IVTACKSVGEATEYETDG-Y 348
                       +A+RDL S+ IL+ ++G  C+ D+G   + +   +  +       G  
Sbjct: 122 HIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTK 181

Query: 349 RWLAPEIIAGDPESVSETW--MSNVYSFGMVIWEMVTG----------EAAYAACSPVQA 396
           R++APE++    +          ++++FG+V+WE+             +  +    P   
Sbjct: 182 RYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDP 241

Query: 397 AVGI---AAC--GLRPEIPKD-----CPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
           +        C    RP IP           L  LM +CW  +PS R     I   L
Sbjct: 242 SFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTL 297

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  174 bits (444), Expect = 6e-51
 Identities = 59/301 (19%), Positives = 121/301 (40%), Gaps = 49/301 (16%)

Query: 185 WLLNSDNLEFIDQIGPNSF----KGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTC 240
               +  +   + IG   F    +G ++G+ V ++     ++  ++  E   ++ + +  
Sbjct: 37  QRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREE-RSWFRE--AEIYQTVML 93

Query: 241 GHKNILQFYCVCVDENHG---LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGI 297
            H+NIL F      +N     L +V+   E GS+ D  L    +  + +I++A+  A G+
Sbjct: 94  RHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDY-LNRYTVTVEGMIKLALSTASGL 152

Query: 298 KFLNDH--------GVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG-- 347
             L+           +A+RDL S+ IL+ ++G  C+ D+G+     S  +  +   +   
Sbjct: 153 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV 212

Query: 348 --YRWLAPEIIAGDPESVSETWMSN----VYSFGMVIWEMVTGEAAYAACSPVQAA---- 397
              R++APE++        + + S     +Y+ G+V WE+    +        Q      
Sbjct: 213 GTKRYMAPEVLDD--SINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL 270

Query: 398 -----------VGIAACGLRPEIPK-----DCPQILKSLMIKCWNNSPSKRPQFSEIISL 441
                        +    LRP IP      +  +++  +M +CW  + + R     I   
Sbjct: 271 VPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330

Query: 442 L 442
           L
Sbjct: 331 L 331

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  169 bits (431), Expect = 2e-49
 Identities = 63/312 (20%), Positives = 122/312 (39%), Gaps = 51/312 (16%)

Query: 176 QSGGEEIG--RWLLNSDNLEFIDQIGPNSF----KGVYKGKRVGIEKLKGCDKGNAYEFE 229
            S G ++G       S  L+ ++      F    K     + V ++     DK  +++ E
Sbjct: 8   HSSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDK-QSWQNE 66

Query: 230 LRKDLLELMTCGHKNILQFYCVCVDENHG---LCVVTKLMEGGSVNDLILKSRKLQTKEI 286
              ++  L    H+NILQF             L ++T   E GS++D  LK+  +   E+
Sbjct: 67  --YEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDF-LKANVVSWNEL 123

Query: 287 IRIAIDVAEGIKFLNDH----------GVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS 336
             IA  +A G+ +L++            +++RD+ S+ +LL  +   C+ D G+  A K 
Sbjct: 124 CHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGL--ALKF 181

Query: 337 VGEATEYETDG----YRWLAPEIIAGDPESVSE-TWMSNVYSFGMVIWEMVTGEAAYAAC 391
               +  +T G     R++APE++ G      +     ++Y+ G+V+WE+ +   A    
Sbjct: 182 EAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGP 241

Query: 392 S-----PVQAAVGIAAC-----------GLRPEIPKDCP-----QILKSLMIKCWNNSPS 430
                 P +  +G                 RP +           +L   + +CW++   
Sbjct: 242 VDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAE 301

Query: 431 KRPQFSEIISLL 442
            R     +   +
Sbjct: 302 ARLSAGCVGERI 313

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  161 bits (409), Expect = 7e-46
 Identities = 57/312 (18%), Positives = 105/312 (33%), Gaps = 60/312 (19%)

Query: 185 WLLNSDNLEFIDQIGPNSF----KGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTC 240
             L+ DNL+ ++ IG   +    KG    + V ++     ++     F   K++  +   
Sbjct: 8   PSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANRQ---NFINEKNIYRVPLM 64

Query: 241 GHKNILQFYCVC----VDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEG 296
            H NI +F         D      +V +    GS+    L           R+A  V  G
Sbjct: 65  EHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKY-LSLHTSDWVSSCRLAHSVTRG 123

Query: 297 IKFL---------NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG 347
           + +L             +++RDLNS+ +L+   G   + D G+             E D 
Sbjct: 124 LAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDN 183

Query: 348 --------YRWLAPEIIAGD---PESVSETWMSNVYSFGMVIWEMVTG------------ 384
                    R++APE++ G     +  S     ++Y+ G++ WE+               
Sbjct: 184 AAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPE 243

Query: 385 -EAAYAACSP-------VQAAVGIAACGLRPEIPKDC------PQILKSLMIKCWNNSPS 430
            + A+            +Q  V       RP+ P+         + LK  +  CW+    
Sbjct: 244 YQMAFQTEVGNHPTFEDMQVLVSRE--KQRPKFPEAWKENSLAVRSLKETIEDCWDQDAE 301

Query: 431 KRPQFSEIISLL 442
            R         +
Sbjct: 302 ARLTAQXAEERM 313

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  148 bits (376), Expect = 9e-41
 Identities = 69/276 (25%), Positives = 123/276 (44%), Gaps = 33/276 (11%)

Query: 185 WLLNSDNLEFIDQIGPNSFKGVYKGK------RVGIEKLK-GCDKGNAYEFELRKDLLE- 236
           W+LN ++L   +QIG  +F  V+ G+       V ++  +         +F     L E 
Sbjct: 109 WVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKF-----LQEA 163

Query: 237 --LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK--LQTKEIIRIAID 292
             L    H NI++   VC  +   + +V +L++GG      L++    L+ K ++++  D
Sbjct: 164 RILKQYSHPNIVRLIGVCTQKQP-IYIVMELVQGGDFLTF-LRTEGARLRVKTLLQMVGD 221

Query: 293 VAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----- 347
            A G+++L      +RDL ++  L+     + + D G+    +   +     + G     
Sbjct: 222 AAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGM---SREEADGVYAASGGLRQVP 278

Query: 348 YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLR 406
            +W APE +         +  S+V+SFG+++WE  + G + Y   S  Q    +   G R
Sbjct: 279 VKWTAPEALN---YGRY-SSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEK-GGR 333

Query: 407 PEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
              P+ CP  +  LM +CW   P +RP FS I   L
Sbjct: 334 LPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQEL 369

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  144 bits (365), Expect = 9e-40
 Identities = 81/322 (25%), Positives = 132/322 (40%), Gaps = 74/322 (22%)

Query: 162 SSSFVVSVDEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD 221
           S++ V   DEW        E+ R     + +    ++G  SF  VY+G   G+ K +   
Sbjct: 10  SAADVYVPDEW--------EVAR-----EKITMSRELGQGSFGMVYEGVAKGVVKDEPET 56

Query: 222 -------KGNAYEFELRKDLL---ELMT-CGHKNILQFYCVCVDENHGLCVVTKLMEGGS 270
                     A   E R + L    +M      ++++   V         V+ +LM  G 
Sbjct: 57  RVAIKTVNEAASMRE-RIEFLNEASVMKEFNCHHVVRLLGVVSQGQP-TLVIMELMTRGD 114

Query: 271 VNDLILKSR----------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH 320
           +   +   R               ++I++A ++A+G+ +LN +   +RDL ++  ++   
Sbjct: 115 LKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED 174

Query: 321 GNVCLGDMG----IVTACKSVGEATEYETDGY----------RWLAPEIIAGDPESVSE- 365
             V +GD G    I            YETD Y          RW++PE       S+ + 
Sbjct: 175 FTVKIGDFGMTRDI------------YETDYYRKGGKGLLPVRWMSPE-------SLKDG 215

Query: 366 --TWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMI 422
             T  S+V+SFG+V+WE+ T  E  Y   S  Q    +   G   + P +CP +L  LM 
Sbjct: 216 VFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME-GGLLDKPDNCPDMLFELMR 274

Query: 423 KCWNNSPSKRPQFSEIISLLLR 444
            CW  +P  RP F EIIS +  
Sbjct: 275 MCWQYNPKMRPSFLEIISSIKE 296

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  147 bits (372), Expect = 1e-39
 Identities = 67/276 (24%), Positives = 118/276 (42%), Gaps = 39/276 (14%)

Query: 184 RWLLNSDNLEFIDQIGPNSF----KGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLE--- 236
            W LN   L+ +  IG   F     G Y+G +V ++ +K             +  L    
Sbjct: 187 GWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK--------NDATAQAFLAEAS 238

Query: 237 -LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK---LQTKEIIRIAID 292
            +    H N++Q   V V+E  GL +VT+ M  GS+ D  L+SR    L    +++ ++D
Sbjct: 239 VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDY-LRSRGRSVLGGDCLLKFSLD 297

Query: 293 VAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY---- 348
           V E +++L  +   +RDL ++ +L+       + D G+    +         T       
Sbjct: 298 VCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGL--TKE------ASSTQDTGKLP 349

Query: 349 -RWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLR 406
            +W APE +     S      S+V+SFG+++WE+ + G   Y           +   G +
Sbjct: 350 VKWTAPEALREKKFST----KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK-GYK 404

Query: 407 PEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
            + P  CP  +  +M  CW+   + RP F ++   L
Sbjct: 405 MDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQL 440

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  142 bits (359), Expect = 6e-39
 Identities = 69/323 (21%), Positives = 126/323 (39%), Gaps = 72/323 (22%)

Query: 158 MPLPSSSFVVSVDEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKL 217
           +P  S      +++          I R     + L     +G   F  V +G     +  
Sbjct: 15  VPRGSEELQNKLEDV--------VIDR-----NLLILGKILGEGEFGSVMEGNLKQEDGT 61

Query: 218 ------KGCDKGNAYEFELRKDLL---ELM-TCGHKNILQFYCVCVDEN----HGLCVVT 263
                 K     N+ + E  ++ L     M    H N+++   VC++ +        V+ 
Sbjct: 62  SLKVAVKTMKLDNSSQRE-IEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVIL 120

Query: 264 KLMEGGSVNDLILKSR------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILL 317
             M+ G ++  +L SR       +  + +++  +D+A G+++L++    +RDL ++  +L
Sbjct: 121 PFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCML 180

Query: 318 DRHGNVCLGDMG----IVTACKSVGEATEYETDGY----------RWLAPEIIAGDPESV 363
                VC+ D G    I            Y  D Y          +W+A E       S+
Sbjct: 181 RDDMTVCVADFGLSKKI------------YSGDYYRQGRIAKMPVKWIAIE-------SL 221

Query: 364 SE---TWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKS 419
           ++   T  S+V++FG+ +WE+ T G   Y      +    +   G R + P+DC   L  
Sbjct: 222 ADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLH-GHRLKQPEDCLDELYE 280

Query: 420 LMIKCWNNSPSKRPQFSEIISLL 442
           +M  CW   P  RP FS +   L
Sbjct: 281 IMYSCWRTDPLDRPTFSVLRLQL 303

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  141 bits (357), Expect = 6e-39
 Identities = 71/279 (25%), Positives = 125/279 (44%), Gaps = 31/279 (11%)

Query: 184 RWLLNSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKGCDKGNAYEFELRKDL 234
             L+   +L  ++++G  SF  V +G+          V ++ LK        + E   D 
Sbjct: 12  TCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLK---PDVLSQPEAMDDF 68

Query: 235 LE----LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRI 289
           +     + +  H+N+++ Y V +     + +VT+L   GS+ D + K +       + R 
Sbjct: 69  IREVNAMHSLDHRNLIRLYGVVLTPP--MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRY 126

Query: 290 AIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG-- 347
           A+ VAEG+ +L      +RDL ++ +LL     V +GD G++ A         Y      
Sbjct: 127 AVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ--NDDHYVMQEHR 184

Query: 348 ---YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAAC 403
              + W APE +     S +    S+ + FG+ +WEM T G+  +   +  Q    I   
Sbjct: 185 KVPFAWCAPESLKTRTFSHA----SDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE 240

Query: 404 GLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
           G R   P+DCPQ + ++M++CW + P  RP F  +   L
Sbjct: 241 GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFL 279

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  140 bits (356), Expect = 8e-39
 Identities = 67/277 (24%), Positives = 118/277 (42%), Gaps = 41/277 (14%)

Query: 184 RWLLNSDNLEFIDQIGPNSF----KGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLE--- 236
            W LN   L+ +  IG   F     G Y+G +V ++ +K             +  L    
Sbjct: 15  GWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK--------NDATAQAFLAEAS 66

Query: 237 -LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK---LQTKEIIRIAID 292
            +    H N++Q   V V+E  GL +VT+ M  GS+ D  L+SR    L    +++ ++D
Sbjct: 67  VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDY-LRSRGRSVLGGDCLLKFSLD 125

Query: 293 VAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA-TEYETDG---- 347
           V E +++L  +   +RDL ++ +L+       + D G+               T      
Sbjct: 126 VCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGL---------TKEASSTQDTGKL 176

Query: 348 -YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGL 405
             +W APE +    E    +  S+V+SFG+++WE+ + G   Y           +   G 
Sbjct: 177 PVKWTAPEALR---EKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK-GY 231

Query: 406 RPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
           + + P  CP  +  +M  CW+   + RP F ++   L
Sbjct: 232 KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQL 268

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  141 bits (358), Expect = 1e-38
 Identities = 64/302 (21%), Positives = 121/302 (40%), Gaps = 60/302 (19%)

Query: 180 EEIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEK------LKGCDKGNAYEFELRKD 233
           E++   L+          +G   F  V + +    +       +K   K +       ++
Sbjct: 13  EKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKML-KADIIASSDIEE 71

Query: 234 LL---ELMT-CGHKNILQFYCVCVDE-----NHGLCVVTKLMEGGSVNDLILKSR----- 279
            L     M    H ++ +   V +            V+   M+ G ++  +L SR     
Sbjct: 72  FLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENP 131

Query: 280 -KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMG----IVTAC 334
             L  + ++R  +D+A G+++L+     +RDL ++  +L     VC+ D G    I    
Sbjct: 132 FNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKI---- 187

Query: 335 KSVGEATEYETDGY----------RWLAPEIIAGDPESVSE---TWMSNVYSFGMVIWEM 381
                   Y  D Y          +WLA E       S+++   T  S+V++FG+ +WE+
Sbjct: 188 --------YSGDYYRQGCASKLPVKWLALE-------SLADNLYTVHSDVWAFGVTMWEI 232

Query: 382 VT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIIS 440
           +T G+  YA     +    +   G R + P +C + +  LM +CW+  P +RP F+ +  
Sbjct: 233 MTRGQTPYAGIENAEIYNYLIG-GNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRM 291

Query: 441 LL 442
            L
Sbjct: 292 EL 293

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  144 bits (364), Expect = 4e-38
 Identities = 63/294 (21%), Positives = 124/294 (42%), Gaps = 47/294 (15%)

Query: 173 QTVQSGGEEIGRWLLNSDNLEFIDQIGPNSF----KGVYKGK--RVGIEKLKGCDKGNAY 226
            T+        +W +   ++    ++G   +    +GV+K     V ++ LK        
Sbjct: 203 PTIYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----- 257

Query: 227 EFELRKDLLE----LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR--- 279
                ++ L+    +    H N++Q   VC  E     ++T+ M  G++ D  L+     
Sbjct: 258 --MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP-FYIITEFMTYGNLLDY-LRECNRQ 313

Query: 280 KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE 339
           ++    ++ +A  ++  +++L      +R+L ++  L+  +  V + D G+         
Sbjct: 314 EVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGL--------- 364

Query: 340 ATEYETDGY----------RWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAY 388
           +     D Y          +W APE +A +  S+     S+V++FG+++WE+ T G + Y
Sbjct: 365 SRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK----SDVWAFGVLLWEIATYGMSPY 420

Query: 389 AACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
                 Q    +     R E P+ CP+ +  LM  CW  +PS RP F+EI    
Sbjct: 421 PGIDLSQVYELLEK-DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 473

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  139 bits (353), Expect = 6e-38
 Identities = 70/325 (21%), Positives = 127/325 (39%), Gaps = 61/325 (18%)

Query: 155 QLQMPLPSSSFVVSVDEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGI 214
           +L +            +W        E  R     D L+    +G  +F  V +    GI
Sbjct: 5   ELPLDEHCERLPYDASKW--------EFPR-----DRLKLGKPLGRGAFGQVIEADAFGI 51

Query: 215 EKLKGCD-------KGNAYEFELRKDLL---ELMT--CGHKNILQFYCVCVDENHGLCVV 262
           +K   C        K  A   E  + L+   +++     H N++     C      L V+
Sbjct: 52  DKTATCRTVAVKMLKEGATHSE-HRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVI 110

Query: 263 TKLMEGGSVNDLILKSR----------------KLQTKEIIRIAIDVAEGIKFLNDHGVA 306
            +  + G+++  +   R                 L  + +I  +  VA+G++FL      
Sbjct: 111 VEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCI 170

Query: 307 YRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG-----YRWLAPEIIAGDPE 361
           +RDL ++ ILL     V + D G+    + + +  +Y   G      +W+APE       
Sbjct: 171 HRDLAARNILLSEKNVVKICDFGL---ARDIYKDPDYVRKGDARLPLKWMAPE------- 220

Query: 362 SVSE---TWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQIL 417
           ++ +   T  S+V+SFG+++WE+ + G + Y      +        G R   P      +
Sbjct: 221 TIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEM 280

Query: 418 KSLMIKCWNNSPSKRPQFSEIISLL 442
              M+ CW+  PS+RP FSE++  L
Sbjct: 281 YQTMLDCWHGEPSQRPTFSELVEHL 305

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  140 bits (354), Expect = 9e-38
 Identities = 64/288 (22%), Positives = 127/288 (44%), Gaps = 43/288 (14%)

Query: 185 WLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD-------KGNAYEFELRKDLL-- 235
             +   N+  I  +G  +F  VY+G+  G+                   E +   D L  
Sbjct: 66  KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD-ELDFLME 124

Query: 236 -ELMT-CGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-------KLQTKEI 286
             +++   H+NI++   V +       ++ +LM GG +   + ++R        L   ++
Sbjct: 125 ALIISKFNHQNIVRCIGVSLQSLP-RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL 183

Query: 287 IRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGN---VCLGDMGIVTACKSVGEATEY 343
           + +A D+A G ++L ++   +RD+ ++  LL   G      +GD G+    + +  A  Y
Sbjct: 184 LHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA---RDIYRAGYY 240

Query: 344 ETDGY-----RWLAPEIIAGDPESVSE---TWMSNVYSFGMVIWEMVT-GEAAYAACSPV 394
              G      +W+ PE       +  E   T  ++ +SFG+++WE+ + G   Y + S  
Sbjct: 241 RKGGCAMLPVKWMPPE-------AFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ 293

Query: 395 QAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
           +    + + G R + PK+CP  +  +M +CW + P  RP F+ I+  +
Sbjct: 294 EVLEFVTS-GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 340

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  138 bits (351), Expect = 1e-37
 Identities = 64/288 (22%), Positives = 128/288 (44%), Gaps = 43/288 (14%)

Query: 185 WLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD-------KGNAYEFELRKDLL-- 235
             +   N+  I  +G  +F  VY+G+  G+                   E +   D L  
Sbjct: 25  KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD-ELDFLME 83

Query: 236 -ELMT-CGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-------KLQTKEI 286
             +++   H+NI++   V +       ++ +LM GG +   + ++R        L   ++
Sbjct: 84  ALIISKFNHQNIVRCIGVSLQSLP-RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDL 142

Query: 287 IRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGN---VCLGDMGIVTACKSVGEATEY 343
           + +A D+A G ++L ++   +RD+ ++  LL   G      +GD G+    + +  A+ Y
Sbjct: 143 LHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA---RDIYRASYY 199

Query: 344 ETDGY-----RWLAPEIIAGDPESVSE---TWMSNVYSFGMVIWEMVT-GEAAYAACSPV 394
              G      +W+ PE       +  E   T  ++ +SFG+++WE+ + G   Y + S  
Sbjct: 200 RKGGCAMLPVKWMPPE-------AFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ 252

Query: 395 QAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
           +    + + G R + PK+CP  +  +M +CW + P  RP F+ I+  +
Sbjct: 253 EVLEFVTS-GGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 299

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  138 bits (351), Expect = 2e-37
 Identities = 69/312 (22%), Positives = 129/312 (41%), Gaps = 65/312 (20%)

Query: 170 DEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD-------- 221
            +W        E  R     D L     +G  +F  V   + VGI+K K  +        
Sbjct: 28  PKW--------EFPR-----DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKM 74

Query: 222 -KGNAYEFELRKDLL---ELMT--CGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLI 275
            K +A E +   DL+   E+M     HKNI+     C  +   L V+ +    G++ + +
Sbjct: 75  LKDDATEKD-LSDLVSEMEMMKMIGKHKNIINLLGACTQDGP-LYVIVEYASKGNLREYL 132

Query: 276 LKSRK----------------LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDR 319
              R                 +  K+++     +A G+++L      +RDL ++ +L+  
Sbjct: 133 RARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTE 192

Query: 320 HGNVCLGDMGIVTACKSVGEATEYETDG-----YRWLAPEIIAGDPESVSE---TWMSNV 371
           +  + + D G+    + +     Y+         +W+APE       ++ +   T  S+V
Sbjct: 193 NNVMKIADFGL---ARDINNIDYYKKTTNGRLPVKWMAPE-------ALFDRVYTHQSDV 242

Query: 372 YSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPS 430
           +SFG+++WE+ T G + Y      +    +   G R + P +C   L  +M  CW+  PS
Sbjct: 243 WSFGVLMWEIFTLGGSPYPGIPVEELFKLLKE-GHRMDKPANCTNELYMMMRDCWHAVPS 301

Query: 431 KRPQFSEIISLL 442
           +RP F +++  L
Sbjct: 302 QRPTFKQLVEDL 313

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  136 bits (345), Expect = 2e-37
 Identities = 68/275 (24%), Positives = 131/275 (47%), Gaps = 31/275 (11%)

Query: 183 GRWLLNSDNLEFIDQIGPNSFKGVYKGK-----RVGIEKLKGCDKGNAYEFELRKDLLE- 236
           G+W+++   L F+ +IG   F  V+ G      +V I+ ++             +D +E 
Sbjct: 1   GKWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-------EEDFIEE 53

Query: 237 ---LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAID 292
              +M   H  ++Q Y VC+++   +C+VT+ ME G ++D +   R     + ++ + +D
Sbjct: 54  AEVMMKLSHPKLVQLYGVCLEQAP-ICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLD 112

Query: 293 VAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----Y 348
           V EG+ +L +  V +RDL ++  L+  +  + + D G+    + V +     + G     
Sbjct: 113 VCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGM---TRFVLDDQYTSSTGTKFPV 169

Query: 349 RWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRP 407
           +W +PE+ +    S      S+V+SFG+++WE+ + G+  Y   S  +    I+  G R 
Sbjct: 170 KWASPEVFSFSRYSS----KSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST-GFRL 224

Query: 408 EIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
             P+     +  +M  CW   P  RP FS ++  L
Sbjct: 225 YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQL 259

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  137 bits (348), Expect = 3e-37
 Identities = 61/277 (22%), Positives = 126/277 (45%), Gaps = 34/277 (12%)

Query: 186 LLNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLL 235
           +L     + I  +G  +F  VYKG            V I++L+      A   +  K++L
Sbjct: 11  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-----EATSPKANKEIL 65

Query: 236 E----LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIA 290
           +    + +  + ++ +   +C+     + ++T+LM  G + D + + +  + ++ ++   
Sbjct: 66  DEAYVMASVDNPHVCRLLGICLTST--VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC 123

Query: 291 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG--- 347
           + +A+G+ +L D  + +RDL ++ +L+    +V + D G+     +  E  EY  +G   
Sbjct: 124 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA--EEKEYHAEGGKV 181

Query: 348 -YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGL 405
             +W+A E I     +      S+V+S+G+ +WE++T G   Y      + +  +   G 
Sbjct: 182 PIKWMALESILHRIYTHQ----SDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK-GE 236

Query: 406 RPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
           R   P  C   +  +M KCW      RP+F E+I   
Sbjct: 237 RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEF 273

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  137 bits (346), Expect = 4e-37
 Identities = 67/280 (23%), Positives = 117/280 (41%), Gaps = 41/280 (14%)

Query: 188 NSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKGCDKGNAYEFELRKDLL--- 235
           +S  + F + IG   F  VY G             ++ L         +       L   
Sbjct: 23  SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-----TDIGEVSQFLTEG 77

Query: 236 ELMT-CGHKNILQFYCVCVDENHGLCVVTKLMEGGSVND-LILKSRKLQTKEIIRIAIDV 293
            +M    H N+L    +C+       VV   M+ G + + +  ++     K++I   + V
Sbjct: 78  IIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV 137

Query: 294 AEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY----- 348
           A+G+K+L      +RDL ++  +LD    V + D G+    + + +   Y          
Sbjct: 138 AKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLA---RDMYDKEYYSVHNKTGAKL 194

Query: 349 --RWLAPEIIAGDPESVSE---TWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAA 402
             +W+A E       S+     T  S+V+SFG+++WE++T G   Y   +     V +  
Sbjct: 195 PVKWMALE-------SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 247

Query: 403 CGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
            G R   P+ CP  L  +M+KCW+     RP FSE++S +
Sbjct: 248 -GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRI 286

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  135 bits (343), Expect = 5e-37
 Identities = 63/275 (22%), Positives = 123/275 (44%), Gaps = 31/275 (11%)

Query: 183 GRWLLNSDNLEFIDQIGPNSFKGVYKGK-----RVGIEKLKGCDKGNAYEFELRKDLLE- 236
           G   L  + +  + ++G   F  V  GK      V ++ +K              +  + 
Sbjct: 1   GHMELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS-------EDEFFQE 53

Query: 237 ---LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVND-LILKSRKLQTKEIIRIAID 292
              +M   H  +++FY VC  E   + +VT+ +  G + + L    + L+  +++ +  D
Sbjct: 54  AQTMMKLSHPKLVKFYGVCSKEYP-IYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYD 112

Query: 293 VAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----Y 348
           V EG+ FL  H   +RDL ++  L+DR   V + D G+    + V +     + G     
Sbjct: 113 VCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGM---TRYVLDDQYVSSVGTKFPV 169

Query: 349 RWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRP 407
           +W APE+          +  S+V++FG+++WE+ + G+  Y   +  +  + ++  G R 
Sbjct: 170 KWSAPEVFH---YFKY-SSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQ-GHRL 224

Query: 408 EIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
             P      +  +M  CW+  P KRP F +++S +
Sbjct: 225 YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSI 259

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  135 bits (343), Expect = 5e-37
 Identities = 64/277 (23%), Positives = 120/277 (43%), Gaps = 34/277 (12%)

Query: 185 WLLNSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLK-GCDKGNAYEFELRKDL 234
           + +  + +E    IG   F  V++G           V I+  K         +F     L
Sbjct: 10  YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKF-----L 64

Query: 235 LE---LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVND-LILKSRKLQTKEIIRIA 290
            E   +    H +I++   V  +    + ++ +L   G +   L ++   L    +I  A
Sbjct: 65  QEALTMRQFDHPHIVKLIGVITENP--VWIIMELCTLGELRSFLQVRKYSLDLASLILYA 122

Query: 291 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG--- 347
             ++  + +L      +RD+ ++ +L+  +  V LGD G+    + + ++T Y+      
Sbjct: 123 YQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLS---RYMEDSTYYKASKGKL 179

Query: 348 -YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGL 405
             +W+APE I     + +    S+V+ FG+ +WE++  G   +           I   G 
Sbjct: 180 PIKWMAPESINFRRFTSA----SDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN-GE 234

Query: 406 RPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
           R  +P +CP  L SLM KCW   PS+RP+F+E+ + L
Sbjct: 235 RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQL 271

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  135 bits (343), Expect = 6e-37
 Identities = 57/279 (20%), Positives = 118/279 (42%), Gaps = 34/279 (12%)

Query: 183 GRWLLNSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLK-GCDKGNAYEFELRK 232
            ++ +  +++     +G   F  VY+G           V ++  K  C   N  +F    
Sbjct: 5   PQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKF---- 60

Query: 233 DLLE---LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVND-LILKSRKLQTKEIIR 288
            + E   +    H +I++   +  +E     ++ +L   G +   L      L+   ++ 
Sbjct: 61  -MSEAVIMKNLDHPHIVKLIGIIEEEP--TWIIMELYPYGELGHYLERNKNSLKVLTLVL 117

Query: 289 IAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG- 347
            ++ + + + +L      +RD+  + IL+     V LGD G+    + + +   Y+    
Sbjct: 118 YSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLS---RYIEDEDYYKASVT 174

Query: 348 ---YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAAC 403
               +W++PE I         T  S+V+ F + +WE+++ G+  +           +   
Sbjct: 175 RLPIKWMSPESIN----FRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEK- 229

Query: 404 GLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
           G R   P  CP +L +LM +CW+  PS RP+F+E++  L
Sbjct: 230 GDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSL 268

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  138 bits (349), Expect = 6e-37
 Identities = 76/340 (22%), Positives = 137/340 (40%), Gaps = 69/340 (20%)

Query: 146 GVENSNLKIQLQMPLPSSSFVVSVDEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKG 205
                NL  Q  +   S   +     W        E+ R     D L     +G  +F  
Sbjct: 38  IPTTENLYFQGMLAGVSEYELPEDPRW--------ELPR-----DRLVLGKPLGEGAFGQ 84

Query: 206 VYKGKRVGIEKLKGCD---------KGNAYEFELRKDLL---ELMT--CGHKNILQFYCV 251
           V   + +G++K K            K +A E +   DL+   E+M     HKNI+     
Sbjct: 85  VVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD-LSDLISEMEMMKMIGKHKNIINLLGA 143

Query: 252 CVDENHGLCVVTKLMEGGSVNDLILKSRK----------------LQTKEIIRIAIDVAE 295
           C  +   L V+ +    G++ + +   R                 L +K+++  A  VA 
Sbjct: 144 CTQDGP-LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVAR 202

Query: 296 GIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY------- 348
           G+++L      +RDL ++ +L+     + + D G+    + +     +  D Y       
Sbjct: 203 GMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGL---ARDI-----HHIDYYKKTTNGR 254

Query: 349 ---RWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACG 404
              +W+APE +    + +  T  S+V+SFG+++WE+ T G + Y      +    +   G
Sbjct: 255 LPVKWMAPEALF---DRIY-THQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKE-G 309

Query: 405 LRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR 444
            R + P +C   L  +M  CW+  PS+RP F +++  L R
Sbjct: 310 HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 349

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  135 bits (342), Expect = 9e-37
 Identities = 67/287 (23%), Positives = 123/287 (42%), Gaps = 43/287 (14%)

Query: 178 GGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKGNAYEFELR 231
           G     +W +   ++    ++G   +  VY+G        V ++ LK  D     EF   
Sbjct: 1   GSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEF--- 56

Query: 232 KDLLE---LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK--LQTKEI 286
             L E   +    H N++Q   VC  E     ++T+ M  G++ D + +  +  +    +
Sbjct: 57  --LKEAAVMKEIKHPNLVQLLGVCTREPP-FYIITEFMTYGNLLDYLRECNRQEVSAVVL 113

Query: 287 IRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETD 346
           + +A  ++  +++L      +RDL ++  L+  +  V + D G+         +     D
Sbjct: 114 LYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGL---------SRLMTGD 164

Query: 347 GY----------RWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQ 395
            Y          +W APE +A +  S+     S+V++FG+++WE+ T G + Y      Q
Sbjct: 165 TYTAHAGAKFPIKWTAPESLAYNKFSI----KSDVWAFGVLLWEIATYGMSPYPGIDLSQ 220

Query: 396 AAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
               +     R E P+ CP+ +  LM  CW  +PS RP F+EI    
Sbjct: 221 VYELLEK-DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 266

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  135 bits (341), Expect = 1e-36
 Identities = 67/275 (24%), Positives = 121/275 (44%), Gaps = 26/275 (9%)

Query: 184 RWLLNSDNLEFIDQ-IGPNSF----KGVYKGKRVGIE-KLKGCDKGNAYEFELRKDLLE- 236
              L+   L   D+ +G  +F    KG Y+ K+V     +K   K  A +  L+ +LL  
Sbjct: 10  EVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNEANDPALKDELLAE 68

Query: 237 ---LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDV 293
              +    +  I++   +C  E     +V ++ E G +N  + ++R ++ K II +   V
Sbjct: 69  ANVMQQLDNPYIVRMIGICEAE--SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQV 126

Query: 294 AEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG-----Y 348
           + G+K+L +    +RDL ++ +LL       + D G+  A ++  +   Y+         
Sbjct: 127 SMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA--DENYYKAQTHGKWPV 184

Query: 349 RWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRP 407
           +W APE I         +  S+V+SFG+++WE  + G+  Y      +    +   G R 
Sbjct: 185 KWYAPECIN----YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK-GERM 239

Query: 408 EIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
             P  CP+ +  LM  CW      RP F+ +   L
Sbjct: 240 GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRL 274

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  138 bits (350), Expect = 2e-36
 Identities = 68/293 (23%), Positives = 123/293 (41%), Gaps = 35/293 (11%)

Query: 167 VSVDEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSF----KGVYKGK-RVGIEKLKGCD 221
            +V      Q+ G     W +  ++L    ++G   F     G + G  RV I+ LK   
Sbjct: 161 TTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT 220

Query: 222 KGNAYEFELRKDLLE----LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILK 277
                     +  L+    +    H+ ++Q Y V  +E   + +VT+ M  GS+ D  LK
Sbjct: 221 -------MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEE--PIYIVTEYMSKGSLLDF-LK 270

Query: 278 SRK---LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC 334
                 L+  +++ +A  +A G+ ++      +RDL +  IL+  +    + D G+    
Sbjct: 271 GETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLA--- 327

Query: 335 KSVGEATEYETDG----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYA 389
           + + +       G     +W APE       ++     S+V+SFG+++ E+ T G   Y 
Sbjct: 328 RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK----SDVWSFGILLTELTTKGRVPYP 383

Query: 390 ACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
                +    +   G R   P +CP+ L  LM +CW   P +RP F  + + L
Sbjct: 384 GMVNREVLDQVER-GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 435

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  136 bits (345), Expect = 2e-36
 Identities = 67/298 (22%), Positives = 126/298 (42%), Gaps = 52/298 (17%)

Query: 184 RWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD---------KGNAYEFELRKDL 234
           +W    D L     +G   F  V   + VGI+K K  +         K +A E +   DL
Sbjct: 75  KWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD-LSDL 133

Query: 235 L---ELMT--CGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK--------- 280
           +   E+M     HKNI+     C  +   L V+ +    G++ + +   R          
Sbjct: 134 VSEMEMMKMIGKHKNIINLLGACTQDGP-LYVIVEYASKGNLREYLRARRPPGMEYSYDI 192

Query: 281 -------LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTA 333
                  +  K+++     +A G+++L      +RDL ++ +L+  +  + + D G+   
Sbjct: 193 NRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGL--- 249

Query: 334 CKSVGEATEYETDG-----YRWLAPEIIAGDPESVSE---TWMSNVYSFGMVIWEMVT-G 384
            + +     Y+         +W+APE       ++ +   T  S+V+SFG+++WE+ T G
Sbjct: 250 ARDINNIDYYKKTTNGRLPVKWMAPE-------ALFDRVYTHQSDVWSFGVLMWEIFTLG 302

Query: 385 EAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
            + Y      +    +   G R + P +C   L  +M  CW+  PS+RP F +++  L
Sbjct: 303 GSPYPGIPVEELFKLLKE-GHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 359

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  136 bits (345), Expect = 2e-36
 Identities = 74/316 (23%), Positives = 123/316 (38%), Gaps = 40/316 (12%)

Query: 149 NSNLKIQLQMPLPSSSFVVSVDEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYK 208
           + NL  Q    +      ++ +  Q VQ               + F + IG   F  VY 
Sbjct: 53  SENLYFQGANTVHIDLSALNPELVQAVQHVVIGPSS-----LIVHFNEVIGRGHFGCVYH 107

Query: 209 GK---------RVGIEKLKGCDKGNAYEFELRKDLL---ELMT-CGHKNILQFYCVCVDE 255
           G             ++ L         +       L    +M    H N+L    +C+  
Sbjct: 108 GTLLDNDGKKIHCAVKSLNRI-----TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 162

Query: 256 NHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQR 314
                VV   M+ G + + I         K++I   + VA+G+KFL      +RDL ++ 
Sbjct: 163 EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARN 222

Query: 315 ILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRWLAPEIIAGDPESVSE---TW 367
            +LD    V + D G+          + +   G     +W+A E       S+     T 
Sbjct: 223 CMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE-------SLQTQKFTT 275

Query: 368 MSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWN 426
            S+V+SFG+++WE++T G   Y   +     V +   G R   P+ CP  L  +M+KCW+
Sbjct: 276 KSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ-GRRLLQPEYCPDPLYEVMLKCWH 334

Query: 427 NSPSKRPQFSEIISLL 442
                RP FSE++S +
Sbjct: 335 PKAEMRPSFSELVSRI 350

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  134 bits (339), Expect = 3e-36
 Identities = 55/282 (19%), Positives = 111/282 (39%), Gaps = 38/282 (13%)

Query: 185 WLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEK----------LKGCDKGNAYEFELRKDL 234
             + +++L F + +G  +F  ++KG R  +            LK  DK +       +  
Sbjct: 3   HKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHR---NYSESF 59

Query: 235 LE----LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVND-LILKSRKLQTKEIIRI 289
            E    +    HK+++  Y VCV  +    +V + ++ GS++  L      +     + +
Sbjct: 60  FEAASMMSKLSHKHLVLNYGVCVCGDE-NILVQEFVKFGSLDTYLKKNKNCINILWKLEV 118

Query: 290 AIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG--------EAT 341
           A  +A  + FL ++ + + ++ ++ ILL R  +   G+       K +            
Sbjct: 119 AKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPF---IK-LSDPGISITVLPK 174

Query: 342 EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGI 400
           +   +   W+ PE I       +    ++ +SFG  +WE+ + G+   +A    +     
Sbjct: 175 DILQERIPWVPPECIE---NPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY 231

Query: 401 AACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
                +   PK     L +L+  C +  P  RP F  II  L
Sbjct: 232 ED-RHQLPAPKAAE--LANLINNCMDYEPDHRPSFRAIIRDL 270

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  135 bits (341), Expect = 3e-36
 Identities = 80/318 (25%), Positives = 135/318 (42%), Gaps = 34/318 (10%)

Query: 144 RNGVENSNLKIQLQMPLPSSSFVVSVDEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSF 203
            +     NL  Q ++P P   +       +  ++G        + +  +     IG    
Sbjct: 6   HHSSGRENLYFQGKLPEPQF-YAEPHTYEEPGRAGRSF--TREIEASRIHIEKIIGSGDS 62

Query: 204 KGVYKGK---------RVGIEKLK-GCDKGNAYEFELRKDLLE---LMTCGHKNILQFYC 250
             V  G+          V I+ LK G  +    +F     L E   +    H NI++   
Sbjct: 63  GEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDF-----LSEASIMGQFDHPNIIRLEG 117

Query: 251 VCVDENHGLCVVTKLMEGGSVND-LILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRD 309
           V         +VT+ ME GS++  L     +    +++ +   V  G+++L+D G  +RD
Sbjct: 118 VVTRGRL-AMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRD 176

Query: 310 LNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRWLAPEIIAGDPESVSE 365
           L ++ +L+D +    + D G+    +       Y T G     RW APE IA    S   
Sbjct: 177 LAARNVLVDSNLVCKVSDFGLSRVLED-DPDAAYTTTGGKIPIRWTAPEAIAFRTFSS-- 233

Query: 366 TWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKC 424
              S+V+SFG+V+WE++  GE  Y   +       +   G R   P  CP  L  LM+ C
Sbjct: 234 --ASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEE-GYRLPAPMGCPHALHQLMLDC 290

Query: 425 WNNSPSKRPQFSEIISLL 442
           W+   ++RP+FS+I+S+L
Sbjct: 291 WHKDRAQRPRFSQIVSVL 308

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  139 bits (351), Expect = 3e-36
 Identities = 65/275 (23%), Positives = 118/275 (42%), Gaps = 35/275 (12%)

Query: 185 WLLNSDNLEFIDQIGPNSFKGVYKGK-----RVGIEKLKGCDKGNAYEFELRKDLLE--- 236
           W +  ++L    ++G   F  V+ G      RV I+ LK             +  L+   
Sbjct: 262 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-------MSPEAFLQEAQ 314

Query: 237 -LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK---LQTKEIIRIAID 292
            +    H+ ++Q Y V  +E   + +VT+ M  GS+ D  LK      L+  +++ +A  
Sbjct: 315 VMKKLRHEKLVQLYAVVSEE--PIYIVTEYMSKGSLLDF-LKGETGKYLRLPQLVDMAAQ 371

Query: 293 VAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----Y 348
           +A G+ ++      +RDL +  IL+  +    + D G+    + + +       G     
Sbjct: 372 IASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLA---RLIEDNEYTARQGAKFPI 428

Query: 349 RWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRP 407
           +W APE       ++     S+V+SFG+++ E+ T G   Y      +    +   G R 
Sbjct: 429 KWTAPEAALYGRFTIK----SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER-GYRM 483

Query: 408 EIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
             P +CP+ L  LM +CW   P +RP F  + + L
Sbjct: 484 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 518

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  133 bits (337), Expect = 4e-36
 Identities = 69/277 (24%), Positives = 122/277 (44%), Gaps = 37/277 (13%)

Query: 184 RWLLNSDNLEFIDQIGPNSFKGVYKGK-----RVGIEKLKGCDKGNAYEFELRKDLLE-- 236
            W +  + L+ ++++G   F  V+ G      +V ++ LK                L   
Sbjct: 7   EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-------MSPDAFLAEA 59

Query: 237 --LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK---LQTKEIIRIAI 291
             +    H+ +++ Y V   E   + ++T+ ME GS+ D  LK+     L   +++ +A 
Sbjct: 60  NLMKQLQHQRLVRLYAVVTQE--PIYIITEYMENGSLVDF-LKTPSGIKLTINKLLDMAA 116

Query: 292 DVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG---- 347
            +AEG+ F+ +    +RDL +  IL+    +  + D G+      + E  EY        
Sbjct: 117 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGL----ARLIEDNEYTAREGAKF 172

Query: 348 -YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGL 405
             +W APE I     ++     S+V+SFG+++ E+VT G   Y   +  +    +   G 
Sbjct: 173 PIKWTAPEAINYGTFTI----KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER-GY 227

Query: 406 RPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
           R   P +CP+ L  LM  CW   P  RP F  + S+L
Sbjct: 228 RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVL 264

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  136 bits (345), Expect = 8e-36
 Identities = 69/276 (25%), Positives = 123/276 (44%), Gaps = 37/276 (13%)

Query: 185 WLLNSDNLEFIDQIGPNSFKGVYKGK-----RVGIEKLKGCDKGNAYEFELRKDLLE--- 236
           W +  ++L+   ++G   F  V+        +V ++ +K             +  L    
Sbjct: 183 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-------VEAFLAEAN 235

Query: 237 -LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK---LQTKEIIRIAID 292
            + T  H  +++ + V   E   + ++T+ M  GS+ D  LKS +       ++I  +  
Sbjct: 236 VMKTLQHDKLVKLHAVVTKE--PIYIITEFMAKGSLLDF-LKSDEGSKQPLPKLIDFSAQ 292

Query: 293 VAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----- 347
           +AEG+ F+      +RDL +  IL+       + D G+      V E  EY         
Sbjct: 293 IAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGL----ARVIEDNEYTAREGAKFP 348

Query: 348 YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLR 406
            +W APE I     ++     S+V+SFG+++ E+VT G   Y   S  +    +   G R
Sbjct: 349 IKWTAPEAINFGSFTI----KSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER-GYR 403

Query: 407 PEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
              P++CP+ L ++M++CW N P +RP F  I S+L
Sbjct: 404 MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVL 439

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  133 bits (338), Expect = 8e-36
 Identities = 67/297 (22%), Positives = 123/297 (41%), Gaps = 57/297 (19%)

Query: 185 WLLNSDNLEFIDQIGPNSFKGVYKGK-----------RVGIEKLKGCDKGNAYEFELRKD 233
             +   ++    ++G  +F  V+  +            V ++ LK   +        R+D
Sbjct: 36  HHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASE------SARQD 89

Query: 234 LL---ELMT-CGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR---------- 279
                EL+T   H++I++F+ VC +    L +V + M  G +N  +              
Sbjct: 90  FQREAELLTMLQHQHIVRFFGVCTEGRP-LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGE 148

Query: 280 -----KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC 334
                 L   +++ +A  VA G+ +L      +RDL ++  L+ +   V +GD G+    
Sbjct: 149 DVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMS--- 205

Query: 335 KSVGEATEYETDGY-----RWLAPEIIAGDPESVSE---TWMSNVYSFGMVIWEMVT-GE 385
           + +     Y   G      RW+ PE       S+     T  S+V+SFG+V+WE+ T G+
Sbjct: 206 RDIYSTDYYRVGGRTMLPIRWMPPE-------SILYRKFTTESDVWSFGVVLWEIFTYGK 258

Query: 386 AAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
             +   S  +A   I   G   E P+ CP  + ++M  CW   P +R    ++ + L
Sbjct: 259 QPWYQLSNTEAIDCITQ-GRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARL 314

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  133 bits (338), Expect = 8e-36
 Identities = 76/278 (27%), Positives = 130/278 (46%), Gaps = 32/278 (11%)

Query: 185 WLLNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLK-GCDKGNAYEFELRKD 233
             ++   +     IG   F  VYKG            V I+ LK G  +    +F     
Sbjct: 39  TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDF----- 93

Query: 234 LLE---LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVND-LILKSRKLQTKEIIRI 289
           L E   +    H NI++   V       + ++T+ ME G+++  L  K  +    +++ +
Sbjct: 94  LGEAGIMGQFSHHNIIRLEGVISKYKP-MMIITEYMENGALDKFLREKDGEFSVLQLVGM 152

Query: 290 AIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG-- 347
              +A G+K+L +    +RDL ++ IL++ +    + D G+    +   E   Y T G  
Sbjct: 153 LRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE-ATYTTSGGK 211

Query: 348 --YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACG 404
              RW APE I+    + +    S+V+SFG+V+WE++T GE  Y   S  +    I   G
Sbjct: 212 IPIRWTAPEAISYRKFTSA----SDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIND-G 266

Query: 405 LRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
            R   P DCP  +  LM++CW    ++RP+F++I+S+L
Sbjct: 267 FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSIL 304

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  132 bits (335), Expect = 9e-36
 Identities = 66/283 (23%), Positives = 132/283 (46%), Gaps = 33/283 (11%)

Query: 176 QSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGK-----RVGIEKLKGCDKGNAYEFEL 230
            + G   G W ++  +L F+ ++G   F  V  GK      V I+ +K            
Sbjct: 10  STAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-------MS 62

Query: 231 RKDLLE----LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR--KLQTK 284
             + +E    +M   H+ ++Q Y VC  +   + ++T+ M  G + +  L+    + QT+
Sbjct: 63  EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRP-IFIITEYMANGCLLNY-LREMRHRFQTQ 120

Query: 285 EIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE 344
           +++ +  DV E +++L      +RDL ++  L++  G V + D G+    + V +     
Sbjct: 121 QLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGL---SRYVLDDEYTS 177

Query: 345 TDG----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVG 399
           + G     RW  PE++     S   +  S++++FG+++WE+ + G+  Y   +  + A  
Sbjct: 178 SVGSKFPVRWSPPEVLM---YSKF-SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH 233

Query: 400 IAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
           IA  GLR   P    + + ++M  CW+    +RP F  ++S +
Sbjct: 234 IAQ-GLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNI 275

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  133 bits (336), Expect = 1e-35
 Identities = 73/314 (23%), Positives = 130/314 (41%), Gaps = 64/314 (20%)

Query: 170 DEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD-------K 222
            +W        E  R      NL     +G   F  V K     ++   G         K
Sbjct: 16  PKW--------EFPR-----KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLK 62

Query: 223 GNAYEFELRKDLL---ELM-TCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKS 278
            NA   E  +DLL    ++    H ++++ Y  C  +   L ++ +  + GS+   + +S
Sbjct: 63  ENASPSE-LRDLLSEFNVLKQVNHPHVIKLYGACSQDGP-LLLIVEYAKYGSLRGFLRES 120

Query: 279 RK------------------------LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQR 314
           RK                        L   ++I  A  +++G+++L +  + +RDL ++ 
Sbjct: 121 RKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARN 180

Query: 315 ILLDRHGNVCLGDMGIVTACKSVGEATEYETDG-----YRWLAPEIIAGDPESVSETWMS 369
           IL+     + + D G+    + V E   Y          +W+A E +    + +  T  S
Sbjct: 181 ILVAEGRKMKISDFGL---SRDVYEEDSYVKRSQGRIPVKWMAIESLF---DHIY-TTQS 233

Query: 370 NVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNS 428
           +V+SFG+++WE+VT G   Y    P +    +   G R E P +C + +  LM++CW   
Sbjct: 234 DVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKT-GHRMERPDNCSEEMYRLMLQCWKQE 292

Query: 429 PSKRPQFSEIISLL 442
           P KRP F++I   L
Sbjct: 293 PDKRPVFADISKDL 306

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  133 bits (336), Expect = 1e-35
 Identities = 67/312 (21%), Positives = 123/312 (39%), Gaps = 64/312 (20%)

Query: 170 DEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD-------K 222
            +W        E  R     + L F   +G  +F  V +    G+ K            K
Sbjct: 16  HKW--------EFPR-----NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLK 62

Query: 223 GNAYEFELRKDLL---ELMT--CGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILK 277
            +A+  E R+ L+   ++++    H NI+     C        V+T+    G + + + +
Sbjct: 63  PSAHLTE-REALMSELKVLSYLGNHMNIVNLLGACTIGGP-TLVITEYCCYGDLLNFLRR 120

Query: 278 SRK------------------LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDR 319
            R                   L  ++++  +  VA+G+ FL      +RDL ++ ILL  
Sbjct: 121 KRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTH 180

Query: 320 HGNVCLGDMGIVTACKSVGEATEYETDG-----YRWLAPEIIAGDPESVSE---TWMSNV 371
                + D G+    + +   + Y   G      +W+APE       S+     T+ S+V
Sbjct: 181 GRITKICDFGL---ARDIKNDSNYVVKGNARLPVKWMAPE-------SIFNCVYTFESDV 230

Query: 372 YSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPS 430
           +S+G+ +WE+ + G + Y           +   G R   P+  P  +  +M  CW+  P 
Sbjct: 231 WSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPL 290

Query: 431 KRPQFSEIISLL 442
           KRP F +I+ L+
Sbjct: 291 KRPTFKQIVQLI 302

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  133 bits (337), Expect = 2e-35
 Identities = 73/365 (20%), Positives = 131/365 (35%), Gaps = 88/365 (24%)

Query: 131 GEIEEEEACDESFRNGVENSNLKIQLQMPLPSSSFVVSVDEWQTVQSGGEEIGRWLLNSD 190
           G +E       +  + +    L                +           E  R     +
Sbjct: 1   GAMESAAVTLTTLPSELLLDRLHPNPMYQRMPLLLNPKLLSL--------EYPR-----N 47

Query: 191 NLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD-------KGNAYEFELRKDLL---ELMT- 239
           N+E++  IG  +F  V++ +  G+   +          K  A   +++ D      LM  
Sbjct: 48  NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA-DMQADFQREAALMAE 106

Query: 240 CGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-------------------- 279
             + NI++   VC      +C++ + M  G +N+ +                        
Sbjct: 107 FDNPNIVKLLGVCAVGKP-MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSS 165

Query: 280 ----KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMG----IV 331
                L   E + IA  VA G+ +L++    +RDL ++  L+  +  V + D G    I 
Sbjct: 166 PGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNI- 224

Query: 332 TACKSVGEATEYETDGY----------RWLAPEIIAGDPESVSE---TWMSNVYSFGMVI 378
                      Y  D Y          RW+ PE       S+     T  S+V+++G+V+
Sbjct: 225 -----------YSADYYKADGNDAIPIRWMPPE-------SIFYNRYTTESDVWAYGVVL 266

Query: 379 WEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSE 437
           WE+ + G   Y   +  +    +   G     P++CP  L +LM  CW+  P+ RP F  
Sbjct: 267 WEIFSYGLQPYYGMAHEEVIYYVRD-GNILACPENCPLELYNLMRLCWSKLPADRPSFCS 325

Query: 438 IISLL 442
           I  +L
Sbjct: 326 IHRIL 330

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  138 bits (348), Expect = 2e-35
 Identities = 65/277 (23%), Positives = 121/277 (43%), Gaps = 34/277 (12%)

Query: 185 WLLNSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKGCDKGNAYEFELRKDLL 235
           + +  + +E    IG   F  V++G           V I+  K     N     +R+  L
Sbjct: 385 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCK-----NCTSDSVREKFL 439

Query: 236 E----LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVND-LILKSRKLQTKEIIRIA 290
           +    +    H +I++   V  +    + ++ +L   G +   L ++   L    +I  A
Sbjct: 440 QEALTMRQFDHPHIVKLIGVITENP--VWIIMELCTLGELRSFLQVRKFSLDLASLILYA 497

Query: 291 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG--- 347
             ++  + +L      +RD+ ++ +L+  +  V LGD G+    + + ++T Y+      
Sbjct: 498 YQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGL---SRYMEDSTYYKASKGKL 554

Query: 348 -YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGL 405
             +W+APE I         T  S+V+ FG+ +WE++  G   +           I   G 
Sbjct: 555 PIKWMAPESINFR----RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN-GE 609

Query: 406 RPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
           R  +P +CP  L SLM KCW   PS+RP+F+E+ + L
Sbjct: 610 RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQL 646

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  132 bits (333), Expect = 2e-35
 Identities = 68/316 (21%), Positives = 114/316 (36%), Gaps = 70/316 (22%)

Query: 161 PSSSFVVSVDEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGK---------R 211
             S+ +  V +          I               IG   F  VY G+         +
Sbjct: 3   LDSALLAEVKDV--------LIPH---ERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQ 51

Query: 212 VGIEKLKGCDKGNAYEFELRKDLL---ELM-TCGHKNILQFYCVCVDENHGLCVVTKLME 267
             I+ L         E +  +  L    LM    H N+L    + +       V+   M 
Sbjct: 52  CAIKSLS-----RITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMC 106

Query: 268 GGSVNDLILKSRK-LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLG 326
            G +   I   ++    K++I   + VA G+++L +    +RDL ++  +LD    V + 
Sbjct: 107 HGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVA 166

Query: 327 DMG----IVTACKSVGEATEYETDGY------------RWLAPEIIAGDPESVSE---TW 367
           D G    I             + + Y            +W A E       S+     T 
Sbjct: 167 DFGLARDI------------LDREYYSVQQHRHARLPVKWTALE-------SLQTYRFTT 207

Query: 368 MSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWN 426
            S+V+SFG+++WE++T G   Y    P      +A  G R   P+ CP  L  +M +CW 
Sbjct: 208 KSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQ-GRRLPQPEYCPDSLYQVMQQCWE 266

Query: 427 NSPSKRPQFSEIISLL 442
             P+ RP F  ++  +
Sbjct: 267 ADPAVRPTFRVLVGEV 282

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  131 bits (331), Expect = 3e-35
 Identities = 67/279 (24%), Positives = 119/279 (42%), Gaps = 34/279 (12%)

Query: 184 RWLLNSDNLEFID-QIGPNSFKGVYKGK--------RVGIEKLK-GCDKGNAYEFELRKD 233
           +  L  DNL   D ++G  +F  V +G          V I+ LK G +K +  E      
Sbjct: 3   KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEM----- 57

Query: 234 LLE---LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRI 289
           + E   +    +  I++   VC  E   L +V ++  GG ++  ++  R ++    +  +
Sbjct: 58  MREAQIMHQLDNPYIVRLIGVCQAEA--LMLVMEMAGGGPLHKFLVGKREEIPVSNVAEL 115

Query: 290 AIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG-- 347
              V+ G+K+L +    +RDL ++ +LL       + D G+  A  +  + + Y      
Sbjct: 116 LHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA--DDSYYTARSAG 173

Query: 348 ---YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAAC 403
               +W APE I         +  S+V+S+G+ +WE ++ G+  Y      +    I   
Sbjct: 174 KWPLKWYAPECIN----FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ- 228

Query: 404 GLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
           G R E P +CP  L +LM  CW      RP F  +   +
Sbjct: 229 GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM 267

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  132 bits (333), Expect = 4e-35
 Identities = 57/279 (20%), Positives = 119/279 (42%), Gaps = 36/279 (12%)

Query: 185 WLLNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDL 234
            +     L  +  +G   F  V+KG            V I+ ++     +    +  + +
Sbjct: 8   RIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIE-----DKSGRQSFQAV 62

Query: 235 LE----LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRI 289
            +    + +  H +I++   +C      L +VT+ +  GS+ D + + R  L  + ++  
Sbjct: 63  TDHMLAIGSLDHAHIVRLLGLCPGS--SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNW 120

Query: 290 AIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG-- 347
            + +A+G+ +L +HG+ +R+L ++ +LL     V + D G+      +    +       
Sbjct: 121 GVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVA---DLLPPDDKQLLYSEA 177

Query: 348 ---YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAAC 403
               +W+A E I     +      S+V+S+G+ +WE++T G   YA     +    +   
Sbjct: 178 KTPIKWMALESIHFGKYTHQ----SDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEK- 232

Query: 404 GLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
           G R   P+ C   +  +M+KCW    + RP F E+ +  
Sbjct: 233 GERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEF 271

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  130 bits (330), Expect = 5e-35
 Identities = 62/270 (22%), Positives = 112/270 (41%), Gaps = 30/270 (11%)

Query: 183 GRWLLNSDNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLE 236
           GR+L      +F  +IG  SFK VYK         V   +L+      +     +++   
Sbjct: 25  GRFL------KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEM 78

Query: 237 LMTCGHKNILQFY---CVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDV 293
           L    H NI++FY      V     + +VT+LM  G++   + + + ++ K +      +
Sbjct: 79  LKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQI 138

Query: 294 AEGIKFLNDHG--VAYRDLNSQRILLDRH-GNVCLGDMGIVTACKSVGEATEYETDG--Y 348
            +G++FL+     + +RDL    I +    G+V +GD+G+         +      G   
Sbjct: 139 LKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGL---ATLKRASFAKAVIGTPE 195

Query: 349 RWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPE 408
            ++APE+     E   E    +VY+FGM + EM T E  Y+ C            G++P 
Sbjct: 196 -FMAPEMYE---EKYDE--SVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPA 249

Query: 409 -IPKDCPQILKSLMIKCWNNSPSKRPQFSE 437
              K     +K ++  C   +  +R    +
Sbjct: 250 SFDKVAIPEVKEIIEGCIRQNKDERYSIKD 279

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  132 bits (335), Expect = 5e-35
 Identities = 75/276 (27%), Positives = 126/276 (45%), Gaps = 29/276 (10%)

Query: 185 WLLNSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLK-GCDKGNAYEFELRKDL 234
             L++ N+     +G   F  V  G+          V I+ LK G  +    +F     L
Sbjct: 40  KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF-----L 94

Query: 235 LE---LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVND-LILKSRKLQTKEIIRIA 290
            E   +    H NI++   V       + +VT+ ME GS++  L     +    +++ + 
Sbjct: 95  GEASIMGQFDHPNIIRLEGVVTKSKP-VMIVTEYMENGSLDSFLRKHDAQFTVIQLVGML 153

Query: 291 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG--- 347
             +A G+K+L+D G  +RDL ++ IL++ +    + D G+    +   EA      G   
Sbjct: 154 RGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIP 213

Query: 348 YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLR 406
            RW +PE IA    +      S+V+S+G+V+WE+++ GE  Y   S       +   G R
Sbjct: 214 IRWTSPEAIAYRKFTS----ASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDE-GYR 268

Query: 407 PEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
              P DCP  L  LM+ CW    + RP+F +I+S+L
Sbjct: 269 LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  130 bits (330), Expect = 1e-34
 Identities = 69/296 (23%), Positives = 119/296 (40%), Gaps = 54/296 (18%)

Query: 185 WLLNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDL 234
            + +   L+ I  +G   F  V               V ++ LK            R   
Sbjct: 26  TVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQH-----RSGW 80

Query: 235 LE----LMTCGHKNILQFYCVCVDEN-HGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRI 289
            +    L T  H++I+++   C D     L +V + +  GS+ D  L    +   +++  
Sbjct: 81  KQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDY-LPRHSIGLAQLLLF 139

Query: 290 AIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY---ETD 346
           A  + EG+ +L+     +RDL ++ +LLD    V +GD G+    K+V E  EY     D
Sbjct: 140 AQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLA---KAVPEGHEYYRVRED 196

Query: 347 G---YRWLAPEIIAGDPESVSE---TWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAV- 398
           G     W APE        + E    + S+V+SFG+ ++E++T  +++ +  +     + 
Sbjct: 197 GDSPVFWYAPE-------CLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIG 249

Query: 399 ----GIAAC--------GLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
                +           G R   P  CP  +  LM  CW    S RP F  +I +L
Sbjct: 250 IAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPIL 305

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  130 bits (330), Expect = 1e-34
 Identities = 69/293 (23%), Positives = 127/293 (43%), Gaps = 52/293 (17%)

Query: 185 WLLNSDNLEFIDQIGPNSFKGVYKGK--------RVGIEKLKGCDKGNAYEFELRKDLL- 235
            +L+ ++++F D IG  +F  V K +           I+++K      A + +  +D   
Sbjct: 20  PVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE----YASKDD-HRDFAG 74

Query: 236 --ELMT--CGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR------------ 279
             E++     H NI+     C    + L +  +    G++ D + KSR            
Sbjct: 75  ELEVLCKLGHHPNIINLLGACEHRGY-LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIAN 133

Query: 280 ----KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK 335
                L +++++  A DVA G+ +L+     +RDL ++ IL+  +    + D G+     
Sbjct: 134 STASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR--- 190

Query: 336 SVGEATEYETDG-----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYA 389
                  Y          RW+A E +     SV  T  S+V+S+G+++WE+V+ G   Y 
Sbjct: 191 ---GQEVYVKKTMGRLPVRWMAIESLN---YSVY-TTNSDVWSYGVLLWEIVSLGGTPYC 243

Query: 390 ACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
             +  +    +   G R E P +C   +  LM +CW   P +RP F++I+  L
Sbjct: 244 GMTCAELYEKLPQ-GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL 295

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  130 bits (330), Expect = 1e-34
 Identities = 70/341 (20%), Positives = 130/341 (38%), Gaps = 55/341 (16%)

Query: 143 FRNGVENSNLKIQLQMPLPSSSFVVSVDEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNS 202
           ++      +    +Q+   S +    VD  +      E   +W    +NLEF   +G  +
Sbjct: 3   YKKQFRYESQLQMVQVTGSSDNEYFYVDFREY-----EYDLKWEFPRENLEFGKVLGSGA 57

Query: 203 FKGVYKGKRVGIEKLKGCD-------KGNAYEFELRKDLL---ELMT--CGHKNILQFYC 250
           F  V      GI K            K  A   E R+ L+   ++MT    H+NI+    
Sbjct: 58  FGKVMNATAYGISKTGVSIQVAVKMLKEKADSSE-REALMSELKMMTQLGSHENIVNLLG 116

Query: 251 VCVDENHGLCVVTKLMEGGSVNDLILKSR-----------------------KLQTKEII 287
            C      + ++ +    G + + +   R                        L  ++++
Sbjct: 117 ACTLSGP-IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLL 175

Query: 288 RIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG 347
             A  VA+G++FL      +RDL ++ +L+     V + D G+    + +   + Y   G
Sbjct: 176 CFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGL---ARDIMSDSNYVVRG 232

Query: 348 -----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIA 401
                 +W+APE +    E +  T  S+V+S+G+++WE+ + G   Y           + 
Sbjct: 233 NARLPVKWMAPESLF---EGIY-TIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLI 288

Query: 402 ACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
             G + + P    + +  +M  CW     KRP F  + S L
Sbjct: 289 QNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 329

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  130 bits (330), Expect = 1e-34
 Identities = 69/306 (22%), Positives = 131/306 (42%), Gaps = 56/306 (18%)

Query: 170 DEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD-------K 222
           ++W        E  R     +NL+F   +G  +F  V +    G+ K            K
Sbjct: 39  EKW--------EFPR-----NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLK 85

Query: 223 GNAYEFELRKDLL---ELMT--CGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILK 277
             A+  E ++ L+   ++M+    H+NI+     C      + V+T+    G + + + +
Sbjct: 86  STAHADE-KEALMSELKIMSHLGQHENIVNLLGACTHGGP-VLVITEYCCYGDLLNFLRR 143

Query: 278 SRK--------------LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNV 323
             +                T++++  +  VA+G+ FL      +RD+ ++ +LL  +G+V
Sbjct: 144 KSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT-NGHV 202

Query: 324 C-LGDMGIVTACKSVGEATEYETDG-----YRWLAPEIIAGDPESVSETWMSNVYSFGMV 377
             +GD G+    + +   + Y   G      +W+APE I    + V  T  S+V+S+G++
Sbjct: 203 AKIGDFGL---ARDIMNDSNYIVKGNARLPVKWMAPESIF---DCVY-TVQSDVWSYGIL 255

Query: 378 IWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFS 436
           +WE+ + G   Y           +   G +   P   P+ + S+M  CW   P+ RP F 
Sbjct: 256 LWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQ 315

Query: 437 EIISLL 442
           +I S L
Sbjct: 316 QICSFL 321

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  130 bits (329), Expect = 2e-34
 Identities = 61/277 (22%), Positives = 127/277 (45%), Gaps = 34/277 (12%)

Query: 186 LLNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLL 235
           +L     + I  +G  +F  VYKG            V I++L+      A   +  K++L
Sbjct: 11  ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-----EATSPKANKEIL 65

Query: 236 E----LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIA 290
           +    + +  + ++ +   +C+     + ++T+LM  G + D + + +  + ++ ++   
Sbjct: 66  DEAYVMASVDNPHVCRLLGICLTST--VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC 123

Query: 291 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG--- 347
           + +A+G+ +L D  + +RDL ++ +L+    +V + D G+     +  E  EY  +G   
Sbjct: 124 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA--EEKEYHAEGGKV 181

Query: 348 -YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGL 405
             +W+A E I     +      S+V+S+G+ +WE++T G   Y      + +  +   G 
Sbjct: 182 PIKWMALESILHRIYTHQ----SDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK-GE 236

Query: 406 RPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
           R   P  C   +  +M+KCW      RP+F E+I   
Sbjct: 237 RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEF 273

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  128 bits (325), Expect = 3e-34
 Identities = 67/294 (22%), Positives = 126/294 (42%), Gaps = 49/294 (16%)

Query: 185 WLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD-------KGNAYEFELRKDLL-- 235
             ++   + F++++G + F  VYKG   G    +          K  A     R++    
Sbjct: 4   KEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPL-REEFRHE 62

Query: 236 -ELMTCG-HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-------------- 279
             L     H N++    V   +   L ++      G +++ ++                 
Sbjct: 63  AMLRARLQHPNVVCLLGVVTKDQP-LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTV 121

Query: 280 --KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV 337
              L+  + + +   +A G+++L+ H V ++DL ++ +L+    NV + D+G+    + V
Sbjct: 122 KSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLF---REV 178

Query: 338 GEATEYETDGY-----RWLAPEIIAGDPESVSE---TWMSNVYSFGMVIWEMVT-GEAAY 388
             A  Y+  G      RW+APE       ++     +  S+++S+G+V+WE+ + G   Y
Sbjct: 179 YAADYYKLLGNSLLPIRWMAPE-------AIMYGKFSIDSDIWSYGVVLWEVFSYGLQPY 231

Query: 389 AACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
              S       I         P DCP  + +LMI+CWN  PS+RP+F +I S L
Sbjct: 232 CGYSNQDVVEMIRN-RQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRL 284

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  128 bits (325), Expect = 3e-34
 Identities = 73/315 (23%), Positives = 128/315 (40%), Gaps = 71/315 (22%)

Query: 168 SVDEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGK-----------RVGIEK 216
            +            I R      ++    ++G  +F  V+  +            V ++ 
Sbjct: 6   GIHVQ--------HIKR-----RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKA 52

Query: 217 LKGCDKGNAYEFELRKDLL---ELMT-CGHKNILQFYCVCVDENHGLCVVTKLMEGGSVN 272
           LK            RKD     EL+T   H++I++FY VC D +  L +V + M+ G +N
Sbjct: 53  LKDPTL------AARKDFQREAELLTNLQHEHIVKFYGVCGDGDP-LIMVFEYMKHGDLN 105

Query: 273 DLILKSR----------------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRIL 316
             +                    +L   +++ IA  +A G+ +L      +RDL ++  L
Sbjct: 106 KFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCL 165

Query: 317 LDRHGNVCLGDMGIVTACKSVGEATEYETDGY-----RWLAPEIIAGDPESVSE---TWM 368
           +  +  V +GD G+    + V     Y   G+     RW+ PE       S+     T  
Sbjct: 166 VGANLLVKIGDFGMS---RDVYSTDYYRVGGHTMLPIRWMPPE-------SIMYRKFTTE 215

Query: 369 SNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNN 427
           S+V+SFG+++WE+ T G+  +   S  +    I   G   E P+ CP+ +  +M+ CW  
Sbjct: 216 SDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQ-GRVLERPRVCPKEVYDVMLGCWQR 274

Query: 428 SPSKRPQFSEIISLL 442
            P +R    EI  +L
Sbjct: 275 EPQQRLNIKEIYKIL 289

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  130 bits (329), Expect = 4e-33
 Identities = 68/310 (21%), Positives = 127/310 (40%), Gaps = 36/310 (11%)

Query: 155 QLQMPLPSSSFVVSVDEWQTVQSGGEEIGR--WLLNSDNLEFID-QIGPNSFKGVYKGK- 210
           ++  P       +    +++  S  EE+      L  DNL   D ++G  +F  V +G  
Sbjct: 298 RITSPDKPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVY 357

Query: 211 -------RVGIEKLKGCDKGNAYEFELRKDLLE----LMTCGHKNILQFYCVCVDENHGL 259
                   V I+ LK        E    ++++     +    +  I++   VC  E   L
Sbjct: 358 RMRKKQIDVAIKVLK-----QGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEA--L 410

Query: 260 CVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLD 318
            +V ++  GG ++  ++  R ++    +  +   V+ G+K+L +    +R+L ++ +LL 
Sbjct: 411 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLV 470

Query: 319 RHGNVCLGDMGIVTACKSVGEATEYETDG-----YRWLAPEIIAGDPESVSETWMSNVYS 373
                 + D G+  A  +  + + Y          +W APE I     S      S+V+S
Sbjct: 471 NRHYAKISDFGLSKALGA--DDSYYTARSAGKWPLKWYAPECINFRKFSS----RSDVWS 524

Query: 374 FGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKR 432
           +G+ +WE ++ G+  Y      +    I   G R E P +CP  L +LM  CW      R
Sbjct: 525 YGVTMWEALSYGQKPYKKMKGPEVMAFIEQ-GKRMECPPECPPELYALMSDCWIYKWEDR 583

Query: 433 PQFSEIISLL 442
           P F  +   +
Sbjct: 584 PDFLTVEQRM 593

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  125 bits (317), Expect = 8e-33
 Identities = 60/294 (20%), Positives = 118/294 (40%), Gaps = 49/294 (16%)

Query: 185 WLLNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDL 234
            +    +L++I Q+G  +F  V   +           V +++L+          + ++D 
Sbjct: 18  TIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGP------DQQRDF 71

Query: 235 LE----LMTCGHKNILQFYCVCVD-ENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIR 288
                 L       I+++  V        L +V + +  G + D + + R +L    ++ 
Sbjct: 72  QREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLL 131

Query: 289 IAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY---ET 345
            +  + +G+++L      +RDL ++ IL++   +V + D G+    K +    +Y     
Sbjct: 132 YSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLA---KLLPLDKDYYVVRE 188

Query: 346 DG---YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIA 401
            G     W APE ++ +  S      S+V+SFG+V++E+ T  + + +  +     +G  
Sbjct: 189 PGQSPIFWYAPESLSDNIFSRQ----SDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCE 244

Query: 402 ACGL-------------RPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
                            R   P  CP  +  LM  CW  SP  RP FS +   L
Sbjct: 245 RDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQL 298

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  124 bits (314), Expect = 1e-32
 Identities = 62/297 (20%), Positives = 121/297 (40%), Gaps = 54/297 (18%)

Query: 185 WLLNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDL 234
                  L+ I  +G   F  V   +          +V ++ LK              DL
Sbjct: 16  THFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLK-----PESGGNHIADL 70

Query: 235 LE----LMTCGHKNILQFYCVCVDE-NHGLCVVTKLMEGGSVND-LILKSRKLQTKEIIR 288
            +    L    H+NI+++  +C ++  +G+ ++ + +  GS+ + L     K+  K+ ++
Sbjct: 71  KKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLK 130

Query: 289 IAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY---ET 345
            A+ + +G+ +L      +RDL ++ +L++    V +GD G+    K++    EY   + 
Sbjct: 131 YAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLT---KAIETDKEYYTVKD 187

Query: 346 DG---YRWLAPEIIAGDPESVSE---TWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAV 398
           D      W APE        + +      S+V+SFG+ + E++T  ++  +  +     +
Sbjct: 188 DRDSPVFWYAPE-------CLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMI 240

Query: 399 -----GIAAC--------GLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
                 +           G R   P +CP  +  LM KCW   PS R  F  +I   
Sbjct: 241 GPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGF 297

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  123 bits (310), Expect = 8e-32
 Identities = 67/311 (21%), Positives = 129/311 (41%), Gaps = 60/311 (19%)

Query: 174 TVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLK-GCDK 222
            + S  E+         +L+F+ Q+G  +F  V   +           V ++KL+   ++
Sbjct: 25  AMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE 84

Query: 223 GNAYEFELRKDLLE----LMTCGHKNILQFYCVCV-DENHGLCVVTKLMEGGSVND-LIL 276
                    +D       L +  H NI+++  VC       L ++ + +  GS+ D L  
Sbjct: 85  H-------LRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQK 137

Query: 277 KSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS 336
              ++   ++++    + +G+++L      +RDL ++ IL++    V +GD G+    K 
Sbjct: 138 HKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT---KV 194

Query: 337 VGEATEY---ETDG---YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAA 390
           + +  EY   +  G     W APE +     SV+    S+V+SFG+V++E+ T    Y  
Sbjct: 195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVA----SDVWSFGVVLYELFT----YIE 246

Query: 391 CSPVQAAVGIAACGLRP-------------------EIPKDCPQILKSLMIKCWNNSPSK 431
            S    A  +   G                        P  CP  +  +M +CWNN+ ++
Sbjct: 247 KSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQ 306

Query: 432 RPQFSEIISLL 442
           RP F ++   +
Sbjct: 307 RPSFRDLALRV 317

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  121 bits (305), Expect = 2e-31
 Identities = 64/300 (21%), Positives = 125/300 (41%), Gaps = 60/300 (20%)

Query: 185 WLLNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLK-GCDKGNAYEFELRKD 233
                 +L+F+ Q+G  +F  V   +           V ++KL+   ++         +D
Sbjct: 5   TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH-------LRD 57

Query: 234 LLE----LMTCGHKNILQFYCVCV-DENHGLCVVTKLMEGGSVND-LILKSRKLQTKEII 287
                  L +  H NI+++  VC       L ++ + +  GS+ D L     ++   +++
Sbjct: 58  FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLL 117

Query: 288 RIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY---E 344
           +    + +G+++L      +RDL ++ IL++    V +GD G+    K + +  E+   +
Sbjct: 118 QYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT---KVLPQDKEFFKVK 174

Query: 345 TDG---YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIA 401
             G     W APE +     SV+    S+V+SFG+V++E+ T    Y   S    A  + 
Sbjct: 175 EPGESPIFWYAPESLTESKFSVA----SDVWSFGVVLYELFT----YIEKSKSPPAEFMR 226

Query: 402 ACGLRP-------------------EIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
             G                        P  CP  +  +M +CWNN+ ++RP F ++   +
Sbjct: 227 MIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRV 286

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  122 bits (307), Expect = 2e-31
 Identities = 63/267 (23%), Positives = 110/267 (41%), Gaps = 30/267 (11%)

Query: 190 DNLEFIDQIGPNSFKGVYKGKRVGIEK---LKGCDKGNAYEFELRKDLLE---LMTCGHK 243
           +    + +IG  SF      K     +   +K  +       E  +   E   L    H 
Sbjct: 24  EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83

Query: 244 NILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK--LQTKEIIRIAIDVAEGIKFLN 301
           NI+Q+     +    L +V    EGG +   I   +    Q  +I+   + +   +K ++
Sbjct: 84  NIVQYRESFEENGS-LYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH 142

Query: 302 DHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS--------VGEATEYETDGYRWLAP 353
           D  + +RD+ SQ I L + G V LGD GI     S        +G  T Y      +L+P
Sbjct: 143 DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIG--TPY------YLSP 194

Query: 354 EIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDC 413
           EI    P +      S++++ G V++E+ T + A+ A S     + I + G  P +    
Sbjct: 195 EICENKPYN----NKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIIS-GSFPPVSLHY 249

Query: 414 PQILKSLMIKCWNNSPSKRPQFSEIIS 440
              L+SL+ + +  +P  RP  + I+ 
Sbjct: 250 SYDLRSLVSQLFKRNPRDRPSVNSILE 276

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  120 bits (302), Expect = 7e-31
 Identities = 44/262 (16%), Positives = 86/262 (32%), Gaps = 31/262 (11%)

Query: 193 EFIDQIGPNSFKGVYKGKRVGIEKLKGC-------DKGNAYEFELRKDLLE----LMTCG 241
           + + ++G  S+  V+K +     K  G                +  + L E         
Sbjct: 60  QRLSRLGHGSYGEVFKVRS----KEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQ 115

Query: 242 HKNILQFYCVCVDENHGLCVVTKLME--GGSVNDLILKSRK-LQTKEIIRIAIDVAEGIK 298
           H   ++      +    L +     E  G S+          L   ++     D    + 
Sbjct: 116 HPCCVRLEQAWEEGGI-LYLQ---TELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALA 171

Query: 299 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAG 358
            L+  G+ + D+    I L   G   LGD G++    + G     E D   ++APE++ G
Sbjct: 172 HLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPR-YMAPELLQG 230

Query: 359 DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILK 418
              + ++ +     S G+ I E+             Q    +    L PE        L+
Sbjct: 231 SYGTAADVF-----SLGLTILEVACNMELPHGGEGWQQ---LRQGYLPPEFTAGLSSELR 282

Query: 419 SLMIKCWNNSPSKRPQFSEIIS 440
           S+++      P  R     +++
Sbjct: 283 SVLVMMLEPDPKLRATAEALLA 304

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  112 bits (282), Expect = 4e-28
 Identities = 57/284 (20%), Positives = 121/284 (42%), Gaps = 34/284 (11%)

Query: 190 DNLEFIDQIGPNSFKGVYKGKRVGIEK---LKGCDKGNAYEFELRKDLLE----LMTCGH 242
            N     +IG   F  VY+   +       LK     +  + + R D ++    L    H
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91

Query: 243 KNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQT----KEIIRIAIDVAEGIK 298
            N++++Y   +++N  L +V +L + G ++ +I   +K +     + + +  + +   ++
Sbjct: 92  PNVIKYYASFIEDNE-LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALE 150

Query: 299 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS--------VGEATEYETDGYRW 350
            ++   V +RD+    + +   G V LGD+G+     S        VG  T Y      +
Sbjct: 151 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVG--TPY------Y 202

Query: 351 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAA-CSPVQAAVGIAACGLRPEI 409
           ++PE I  +  +    + S+++S G +++EM   ++ +      + +          P +
Sbjct: 203 MSPERIHENGYN----FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPL 258

Query: 410 PKDC-PQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNSS 452
           P D   + L+ L+  C N  P KRP  + +  +  R +  + SS
Sbjct: 259 PSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASS 302

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  110 bits (278), Expect = 9e-28
 Identities = 46/280 (16%), Positives = 105/280 (37%), Gaps = 50/280 (17%)

Query: 193 EFIDQIGPNSFKGVYKGKRVGIEKLKGC-------DKGNAYEFELRKDLLE----LMTCG 241
             +++IG   F  V+K  +    +L GC        K  A   + +  L E     +   
Sbjct: 14  HELEKIGSGEFGSVFKCVK----RLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69

Query: 242 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQT----KEIIRIAIDVAEGI 297
           H ++++++    +++H + +  +   GGS+ D I ++ ++ +     E+  + + V  G+
Sbjct: 70  HSHVVRYFSAWAEDDH-MLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 128

Query: 298 KFLNDHGVAYRDLNSQRILLDRHGNVC-------------------LGDMGIVTACKSVG 338
           ++++   + + D+    I + R                        +GD+G VT    + 
Sbjct: 129 RYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT---RIS 185

Query: 339 EATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAV 398
                E D   +LA E++  +    +    +++++  + +      E             
Sbjct: 186 SPQVEEGDSR-FLANEVLQENY---THLPKADIFALALTVVCAAGAEPLPRNGDQWHE-- 239

Query: 399 GIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEI 438
            I   G  P IP+   Q    L+    +  P +RP    +
Sbjct: 240 -IRQ-GRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMAL 277

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  107 bits (269), Expect = 3e-26
 Identities = 58/283 (20%), Positives = 106/283 (37%), Gaps = 38/283 (13%)

Query: 187 LNSDNLEFIDQIGPNSFKGVYKGKRVG---------IEKLKGCDKGNAY-EFELRKDLLE 236
           +++ +  FI ++G   F  V   + +          I   +  D+  A  E ++ +    
Sbjct: 26  IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLF-- 83

Query: 237 LMTCGHKNILQFYCVCVDENHG---LCVVTKLMEGGSVNDLI----LKSRKLQTKEIIRI 289
                H NIL+    C+ E        ++    + G++ + I     K   L   +I+ +
Sbjct: 84  ----NHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWL 139

Query: 290 AIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV-----------G 338
            + +  G++ ++  G A+RDL    ILL   G   L D+G +                  
Sbjct: 140 LLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQD 199

Query: 339 EATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAV 398
            A +  T  YR  APE+ +     V     ++V+S G V++ M+ GE  Y        +V
Sbjct: 200 WAAQRCTISYR--APELFSVQSHCVI-DERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSV 256

Query: 399 GIAACG-LRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIIS 440
            +A    L           L  L+       P +RP    ++S
Sbjct: 257 ALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLS 299

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  104 bits (262), Expect = 1e-25
 Identities = 56/283 (19%), Positives = 106/283 (37%), Gaps = 36/283 (12%)

Query: 193 EFIDQIGPNSFKGVYKGKRVGIEK---LKGCDKGNAYEFELRKDLLELMTCGHKNILQFY 249
           + I+ IG   F  V+K K     K   +K     N    +  +++  L    H NI+ + 
Sbjct: 14  KEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE---KAEREVKALAKLDHVNIVHYN 70

Query: 250 CVCVDENHG---------------LCVVTKLMEGGSVNDLILKSRK--LQTKEIIRIAID 292
                 ++                L +  +  + G++   I K R   L     + +   
Sbjct: 71  GCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQ 130

Query: 293 VAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG-YRWL 351
           + +G+ +++   +  RDL    I L     V +GD G+VT+ K+ G+ T   + G  R++
Sbjct: 131 ITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRT--RSKGTLRYM 188

Query: 352 APEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPK 411
           +PE I+            ++Y+ G+++ E++        C                 I  
Sbjct: 189 SPEQISSQDYG----KEVDLYALGLILAELLHV------CDTAFETSKFFTDLRDGIISD 238

Query: 412 DCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNSSNR 454
              +  K+L+ K  +  P  RP  SEI+  L         + R
Sbjct: 239 IFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNER 281

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  103 bits (260), Expect = 2e-25
 Identities = 64/273 (23%), Positives = 111/273 (40%), Gaps = 31/273 (11%)

Query: 190 DNLEFIDQIGPNSFKGVYKGKRVGIEK---LKGCDKGNAYEFELRKDLLE---LMTCGHK 243
           ++ E +  IG  S+    K +R    K    K  D G+  E E +  + E   L    H 
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65

Query: 244 NILQFYCVCVDENHG-LCVVTKLMEGGSVNDLILKSRKLQT----KEIIRIAIDVAEGIK 298
           NI+++Y   +D  +  L +V +  EGG +  +I K  K +     + ++R+   +   +K
Sbjct: 66  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125

Query: 299 FL-----NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY-----ETDGY 348
                    H V +RDL    + LD   NV LGD G+    + +   T +      T  Y
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL---ARILNHDTSFAKTFVGTPYY 182

Query: 349 RWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPE 408
             ++PE +     +      S+++S G +++E+      + A S  + A  I   G    
Sbjct: 183 --MSPEQMNRMSYN----EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE-GKFRR 235

Query: 409 IPKDCPQILKSLMIKCWNNSPSKRPQFSEIISL 441
           IP      L  ++ +  N     RP   EI+  
Sbjct: 236 IPYRYSDELNEIITRMLNLKDYHRPSVEEILEN 268

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  103 bits (260), Expect = 3e-25
 Identities = 57/289 (19%), Positives = 111/289 (38%), Gaps = 43/289 (14%)

Query: 183 GRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEK---LKGCDKGNAYEFELRKDLLE--- 236
           GR+L    + E I  +G   F  V++ K    +    +K     N  E    K + E   
Sbjct: 1   GRYL---TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNR-ELAREKVMREVKA 56

Query: 237 LMTCGHKNILQFYCVCVDENHG-----------LCVVTKLMEGGSVNDLILKSRKLQTKE 285
           L    H  I++++   +++N             L +  +L    ++ D +     ++ +E
Sbjct: 57  LAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERE 116

Query: 286 ---IIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE 342
               + I + +AE ++FL+  G+ +RDL    I       V +GD G+VTA     E   
Sbjct: 117 RSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQT 176

Query: 343 YETDGYR------------WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAA 390
             T                +++PE I G+  S       +++S G++++E++        
Sbjct: 177 VLTPMPAYARHTGQVGTKLYMSPEQIHGNSYS----HKVDIFSLGLILFELLY--PFSTQ 230

Query: 391 CSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEII 439
              V+    +      P +          ++    + SP +RP+   II
Sbjct: 231 MERVRTLTDVRNLKF-PPLFTQKYPCEYVMVQDMLSPSPMERPEAINII 278

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  104 bits (261), Expect = 5e-25
 Identities = 52/314 (16%), Positives = 102/314 (32%), Gaps = 48/314 (15%)

Query: 142 SFRNGVENSNLKIQLQMPLPSSSFVVSVDEWQTVQSG-GEEIGRWLLNSDNLEFIDQIGP 200
           S      + + K+Q   P    +  V + E          E   W+          ++G 
Sbjct: 15  SLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWM------THQPRVGR 68

Query: 201 NSFKGVYKG-----------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFY 249
            SF  V++            K+V +E  +        E                 I+  Y
Sbjct: 69  GSFGEVHRMKDKQTGFQCAVKKVRLEVFR------VEELVA------CAGLSSPRIVPLY 116

Query: 250 CVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRD 309
               +    + +  +L+EGGS+  LI +   L     +       EG+++L+   + + D
Sbjct: 117 GAVREGPW-VNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGD 175

Query: 310 LNSQRILLDRHGNVC-LGDMGIVTACKSVGEATEYETDGYR--------WLAPEIIAGDP 360
           + +  +LL   G+   L D G       +      ++             +APE++ G P
Sbjct: 176 VKADNVLLSSDGSRAALCDFGH---ALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP 232

Query: 361 ESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG-LRPEIPKDCPQILKS 419
                    +++S   ++  M+ G   +         + IA+      EIP  C  +   
Sbjct: 233 CDAK----VDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQ 288

Query: 420 LMIKCWNNSPSKRP 433
            + +     P  R 
Sbjct: 289 AIQEGLRKEPVHRA 302

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  102 bits (255), Expect = 2e-24
 Identities = 47/276 (17%), Positives = 96/276 (34%), Gaps = 42/276 (15%)

Query: 193 EFIDQIGPNSFKGVYKG----------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGH 242
             + QIG      V++           K V +E+       ++Y  E+    L  +    
Sbjct: 31  SILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTL-DSYRNEI--AYLNKLQQHS 87

Query: 243 KNILQFYCVCVDENHGLCVVTKLME--GGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL 300
             I++ Y   + + + + +V   ME     +N  + K + +   E      ++ E +  +
Sbjct: 88  DKIIRLYDYEITDQY-IYMV---MECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTI 143

Query: 301 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR--------WLA 352
           + HG+ + DL     L+   G + L D GI      +   T   T   +        ++ 
Sbjct: 144 HQHGIVHSDLKPANFLIVD-GMLKLIDFGI---ANQMQPDT---TSVVKDSQVGTVNYMP 196

Query: 353 PEIIAGDPESVSETWMSNVY-------SFGMVIWEMVTGEAAYAAC-SPVQAAVGIAACG 404
           PE I     S       +         S G +++ M  G+  +    + +     I    
Sbjct: 197 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN 256

Query: 405 LRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIIS 440
              E P    + L+ ++  C    P +R    E+++
Sbjct: 257 HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 292

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  101 bits (253), Expect = 1e-23
 Identities = 50/313 (15%), Positives = 106/313 (33%), Gaps = 28/313 (8%)

Query: 145 NGVENSNLKIQLQMPLPSSSFVVSVDEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFK 204
           +G++ +      +  + S       D+  +  S  E I    +       + QIG     
Sbjct: 15  SGMKETAAAKFERQHMDSPDLGTDDDDKAS-SSANECIS---VKGRIYSILKQIGSGGSS 70

Query: 205 GVYKGKRVGIEK--LKGCDKGNAYEFELRK-----DLLELMTCGHKNILQFYCVCVDENH 257
            V++      +   +K  +   A    L         L  +      I++ Y   + + +
Sbjct: 71  KVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 130

Query: 258 GLCVVTKLME--GGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRI 315
            + +V   ME     +N  + K + +   E      ++ E +  ++ HG+ + DL     
Sbjct: 131 -IYMV---MECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANF 186

Query: 316 LLDRHGNVCLGDMGIVTACKSVGEATEYETD-G-YRWLAPEIIAGDPESVSETWMSNVY- 372
           L+   G + L D GI    +    +   ++  G   ++ PE I     S       +   
Sbjct: 187 LIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKIS 245

Query: 373 ------SFGMVIWEMVTGEAAYAAC-SPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCW 425
                 S G +++ M  G+  +    + +     I       E P    + L+ ++  C 
Sbjct: 246 PKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCL 305

Query: 426 NNSPSKRPQFSEI 438
              P +R    E+
Sbjct: 306 KRDPKQRISIPEL 318

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score = 99.8 bits (249), Expect = 2e-23
 Identities = 44/265 (16%), Positives = 91/265 (34%), Gaps = 24/265 (9%)

Query: 193 EFIDQIGPNSFKGVYKGKRVGIEK--LKGCDKGNAYEFELRK-----DLLELMTCGHKNI 245
             + QIG      V++      +   +K  +   A    L         L  +      I
Sbjct: 12  SILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKI 71

Query: 246 LQFYCVCVDENHGLCVVTKLME--GGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDH 303
           ++ Y   + + + + +V   ME     +N  + K + +   E      ++ E +  ++ H
Sbjct: 72  IRLYDYEITDQY-IYMV---MECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 127

Query: 304 GVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETD-G-YRWLAPEIIAGDPE 361
           G+ + DL     L+   G + L D GI    +    +   ++  G   ++ PE I     
Sbjct: 128 GIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 186

Query: 362 SVSETWMSNVY-------SFGMVIWEMVTGEAAYAAC-SPVQAAVGIAACGLRPEIPKDC 413
           S       +         S G +++ M  G+  +    + +     I       E P   
Sbjct: 187 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIP 246

Query: 414 PQILKSLMIKCWNNSPSKRPQFSEI 438
            + L+ ++  C    P +R    E+
Sbjct: 247 EKDLQDVLKCCLKRDPKQRISIPEL 271

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score =  100 bits (249), Expect = 2e-23
 Identities = 49/177 (27%), Positives = 82/177 (46%), Gaps = 13/177 (7%)

Query: 272 NDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIV 331
               L    L  + +I  +  VA+G++FL      +RDL ++ ILL     V + D G+ 
Sbjct: 181 APEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGL- 239

Query: 332 TACKSVGEATEYETDG-----YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GE 385
              + + +  +Y   G      +W+APE I    + V  T  S+V+SFG+++WE+ + G 
Sbjct: 240 --ARDIYKDPDYVRKGDARLPLKWMAPETIF---DRVY-TIQSDVWSFGVLLWEIFSLGA 293

Query: 386 AAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
           + Y      +        G R   P      +   M+ CW+  PS+RP FSE++  L
Sbjct: 294 SPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 350

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 52.2 bits (125), Expect = 1e-07
 Identities = 27/151 (17%), Positives = 51/151 (33%), Gaps = 27/151 (17%)

Query: 170 DEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD-------K 222
            +W        E  R     D L+    +G  +F  V +    GI+K   C        K
Sbjct: 15  SKW--------EFPR-----DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK 61

Query: 223 GNAYEFELRKDL---LELMT--CGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILK 277
             A   E  + L   L+++     H N++     C      L V+ +  + G+++  +  
Sbjct: 62  EGATHSE-HRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRS 120

Query: 278 SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYR 308
            R        + A    +G  ++    V  +
Sbjct: 121 KRNEFVPYKTKGA-RFRQGKDYVGAIPVDLK 150

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  100 bits (250), Expect = 2e-23
 Identities = 47/242 (19%), Positives = 82/242 (33%), Gaps = 36/242 (14%)

Query: 180 EEIGRWLLNSDNLEFIDQIG--PNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELR 231
           + +  +L      E +  IG        V        G+ V + ++      N     L+
Sbjct: 15  QGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQ 74

Query: 232 KDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLI--LKSRKLQTKEIIRI 289
            +L       H NI+ +    + +N  L VVT  M  GS  DLI       +    I  I
Sbjct: 75  GELHVSKLFNHPNIVPYRATFIADNE-LWVVTSFMAYGSAKDLICTHFMDGMNELAIAYI 133

Query: 290 AIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGI---------------VTAC 334
              V + + +++  G  +R + +  IL+   G V L  +                     
Sbjct: 134 LQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPK 193

Query: 335 KSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPV 394
            SV            WL+PE++  + +       S++YS G+   E+  G   +      
Sbjct: 194 YSVK--VLP------WLSPEVLQQNLQGYDAK--SDIYSVGITACELANGHVPFKDMPAT 243

Query: 395 QA 396
           Q 
Sbjct: 244 QM 245

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 97.8 bits (244), Expect = 5e-23
 Identities = 70/280 (25%), Positives = 121/280 (43%), Gaps = 38/280 (13%)

Query: 184 RWLLNSDNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLEL 237
            W +N D+ E  + IG  +   V         ++V I K    +K      EL K++  +
Sbjct: 9   PWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAI-KRINLEKCQTSMDELLKEIQAM 67

Query: 238 MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLI--------LKSRKLQTKEIIRI 289
             C H NI+ +Y   V ++  L +V KL+ GGSV D+I         KS  L    I  I
Sbjct: 68  SQCHHPNIVSYYTSFVVKDE-LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATI 126

Query: 290 AIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR 349
             +V EG+++L+ +G  +RD+ +  ILL   G+V + D G+      +    +   +  R
Sbjct: 127 LREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGV---SAFLATGGDITRNKVR 183

Query: 350 --------WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIA 401
                   W+APE++    +     + ++++SFG+   E+ TG A Y    P++  +   
Sbjct: 184 KTFVGTPCWMAPEVME---QVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTL 240

Query: 402 --------ACGLRPEIPKDCPQILKSLMIKCWNNSPSKRP 433
                         E+ K   +  + ++  C    P KRP
Sbjct: 241 QNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRP 280

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 96.2 bits (240), Expect = 2e-22
 Identities = 62/257 (24%), Positives = 113/257 (43%), Gaps = 34/257 (13%)

Query: 193 EFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNIL 246
             +++IG  SF  V+K       K V I K+   ++      ++++++  L  C    + 
Sbjct: 25  TKLEKIGKGSFGEVFKGIDNRTQKVVAI-KIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83

Query: 247 QFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVA 306
           ++Y     ++  L ++ + + GGS  DL L+   L   +I  I  ++ +G+ +L+     
Sbjct: 84  KYYG-SYLKDTKLWIIMEYLGGGSALDL-LEPGPLDETQIATILREILKGLDYLHSEKKI 141

Query: 307 YRDLNSQRILLDRHGNVCLGDMGIVTACKS---------VGEATEYETDGYRWLAPEIIA 357
           +RD+ +  +LL  HG V L D G V    +         VG  T +      W+APE+I 
Sbjct: 142 HRDIKAANVLLSEHGEVKLADFG-VAGQLTDTQIKRNTFVG--TPF------WMAPEVIK 192

Query: 358 GDP-ESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQI 416
               +S ++ W     S G+   E+  GE  ++   P++    I      P +  +  + 
Sbjct: 193 QSAYDSKADIW-----SLGITAIELARGEPPHSELHPMKVLFLIPKNN-PPTLEGNYSKP 246

Query: 417 LKSLMIKCWNNSPSKRP 433
           LK  +  C N  PS RP
Sbjct: 247 LKEFVEACLNKEPSFRP 263

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 96.2 bits (240), Expect = 2e-22
 Identities = 62/260 (23%), Positives = 111/260 (42%), Gaps = 31/260 (11%)

Query: 189 SDNLEFIDQIGPNSFKGVYKGKRVGIEKL---KGCDKGNAYEFEL-RKDLLELMTCGHKN 244
                  ++IG  +   VY    V   +    +  +     + EL   ++L +    + N
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78

Query: 245 ILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHG 304
           I+ +    +  +  L VV + + GGS+ D++     +   +I  +  +  + ++FL+ + 
Sbjct: 79  IVNYLDSYLVGDE-LWVVMEYLAGGSLTDVV-TETCMDEGQIAAVCRECLQALEFLHSNQ 136

Query: 305 VAYRDLNSQRILLDRHGNVCLGDMGI---VTACKS-----VGEATEYETDGYRWLAPEII 356
           V +RD+ S  ILL   G+V L D G    +T  +S     VG  T Y      W+APE++
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVG--TPY------WMAPEVV 188

Query: 357 AGDP-ESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEI--PKDC 413
                    + W     S G++  EM+ GE  Y   +P++A   IA  G  PE+  P+  
Sbjct: 189 TRKAYGPKVDIW-----SLGIMAIEMIEGEPPYLNENPLRALYLIATNG-TPELQNPEKL 242

Query: 414 PQILKSLMIKCWNNSPSKRP 433
             I +  + +C      KR 
Sbjct: 243 SAIFRDFLNRCLEMDVEKRG 262

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 96.3 bits (240), Expect = 2e-22
 Identities = 62/260 (23%), Positives = 110/260 (42%), Gaps = 31/260 (11%)

Query: 189 SDNLEFIDQIGPNSFKGVYKGKRVGIEKL---KGCDKGNAYEFEL-RKDLLELMTCGHKN 244
              L+   +IG  S   V   +     +    K  D       EL   +++ +    H N
Sbjct: 44  RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103

Query: 245 ILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHG 304
           +++ Y   +     L V+ + ++GG++ D I+   +L  ++I  +   V + + +L+  G
Sbjct: 104 VVEMYKSYLVGEE-LWVLMEFLQGGALTD-IVSQVRLNEEQIATVCEAVLQALAYLHAQG 161

Query: 305 VAYRDLNSQRILLDRHGNVCLGDMGI---VTACKS-----VGEATEYETDGYRWLAPEII 356
           V +RD+ S  ILL   G V L D G    ++         VG  T Y      W+APE+I
Sbjct: 162 VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVG--TPY------WMAPEVI 213

Query: 357 AGDP-ESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEI--PKDC 413
           +     +  + W     S G+++ EMV GE  Y + SPVQA   +      P++      
Sbjct: 214 SRSLYATEVDIW-----SLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSP-PPKLKNSHKV 267

Query: 414 PQILKSLMIKCWNNSPSKRP 433
             +L+  + +     P +R 
Sbjct: 268 SPVLRDFLERMLVRDPQERA 287

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score = 94.3 bits (235), Expect = 9e-22
 Identities = 61/256 (23%), Positives = 112/256 (43%), Gaps = 34/256 (13%)

Query: 198 IGPNSFKGVYKG-----------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNIL 246
           +G  ++  VY G           K +     +          E+   L +     HKNI+
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEI---PERDSRYSQPLHEEI--ALHK--HLKHKNIV 82

Query: 247 QFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR--KLQTKE--IIRIAIDVAEGIKFLND 302
           Q+     +    + +  + + GGS++ L L+S+   L+  E  I      + EG+K+L+D
Sbjct: 83  QYLGSFSENGF-IKIFMEQVPGGSLSAL-LRSKWGPLKDNEQTIGFYTKQILEGLKYLHD 140

Query: 303 HGVAYRDLNSQRILLDRH-GNVCLGDMGIVTACKSVGEATEYET-DG--YRWLAPEIIAG 358
           + + +RD+    +L++ + G + + D G   + +  G     ET  G    ++APEII  
Sbjct: 141 NQIVHRDIKGDNVLINTYSGVLKISDFGT--SKRLAGINPCTETFTGTLQ-YMAPEIIDK 197

Query: 359 DPESVSETWMSNVYSFGMVIWEMVTGEAAYAAC-SPVQAAVGIAACGLRPEIPKDCPQIL 417
            P    +   ++++S G  I EM TG+  +     P  A   +    + PEIP+      
Sbjct: 198 GPRGYGK--AADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEA 255

Query: 418 KSLMIKCWNNSPSKRP 433
           K+ ++KC+   P KR 
Sbjct: 256 KAFILKCFEPDPDKRA 271

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 93.8 bits (234), Expect = 1e-21
 Identities = 47/202 (23%), Positives = 96/202 (47%), Gaps = 19/202 (9%)

Query: 242 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 301
           H+NI+    V  +++    +V + +EG ++++ I     L     I     + +GIK  +
Sbjct: 70  HQNIVSMIDVDEEDDCYY-LVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAH 128

Query: 302 DHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG------YRWLAPEI 355
           D  + +RD+  Q IL+D +  + + D GI  A   + E +  +T+       Y   +PE 
Sbjct: 129 DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKA---LSETSLTQTNHVLGTVQY--FSPEQ 183

Query: 356 IAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAA---VGIAACGLRPEIPKD 412
             G+     E   +++YS G+V++EM+ GE  +   + V  A   +  +   +  ++ KD
Sbjct: 184 AKGEA--TDEC--TDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKD 239

Query: 413 CPQILKSLMIKCWNNSPSKRPQ 434
            PQ L +++++      + R +
Sbjct: 240 IPQSLSNVILRATEKDKANRYK 261

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 93.6 bits (233), Expect = 2e-21
 Identities = 54/277 (19%), Positives = 103/277 (37%), Gaps = 28/277 (10%)

Query: 176 QSGGEEIG--RWLLNSDNLEFIDQIGPNSFKGVYKG-----KRVGIEKLKGCDKGNAYEF 228
           Q+G   IG  R+    ++LE + ++G  +   V+K        V   K            
Sbjct: 9   QTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENK 68

Query: 229 ELRKDLLELM-TCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEII 287
            +  DL  ++ +     I+Q +   +     + +  +LM   +          +  + + 
Sbjct: 69  RILMDLDVVLKSHDCPYIVQCFGTFITNTD-VFIAMELMGTCAEKLKKRMQGPIPERILG 127

Query: 288 RIAIDVAEGIKFL-NDHGVAYRDLNSQRILLDRHGNVCLGDMGI-------VTACKSVGE 339
           ++ + + + + +L   HGV +RD+    ILLD  G + L D GI           +S G 
Sbjct: 128 KMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAG- 186

Query: 340 ATEYETDGYRWLAPEIIAGDPESVSE-TWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAV 398
                     ++APE I     +  +    ++V+S G+ + E+ TG+  Y  C      +
Sbjct: 187 -CAA------YMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVL 239

Query: 399 GIAACGLRPEIPKDC--PQILKSLMIKCWNNSPSKRP 433
                   P +P         +S +  C      KRP
Sbjct: 240 TKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRP 276

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score = 92.4 bits (230), Expect = 4e-21
 Identities = 45/282 (15%), Positives = 111/282 (39%), Gaps = 33/282 (11%)

Query: 189 SDNLEFIDQIGPNSFKGVYKGKRVGIEKL---KGCDKGNAYEFELRKDLLELMTCGHKNI 245
           + + E I  +G  +F  V K +     +    K           +  +++ L +  H+ +
Sbjct: 5   ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYV 64

Query: 246 LQFYCVCVDENHG------------LCVVTKLMEGGSVNDLILK-SRKLQTKEIIRIAID 292
           +++Y   ++  +             L +  +  E G++ DLI   +   Q  E  R+   
Sbjct: 65  VRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQ 124

Query: 293 VAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR--- 349
           + E + +++  G+ +RDL    I +D   NV +GD G+        +  + ++       
Sbjct: 125 ILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSS 184

Query: 350 -----------WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAV 398
                      ++A E++ G      +    ++YS G++ +EM+   +       +   +
Sbjct: 185 DNLTSAIGTAMYVATEVLDGTGHYNEK---IDMYSLGIIFFEMIYPFSTGMERVNILKKL 241

Query: 399 GIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIIS 440
              +    P+   +  ++ K ++    ++ P+KRP    +++
Sbjct: 242 RSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 93.4 bits (232), Expect = 4e-21
 Identities = 52/267 (19%), Positives = 107/267 (40%), Gaps = 25/267 (9%)

Query: 187 LNSDNLEFIDQIGPNSFKGVYKG--KRVGIE---KLKGCDKGNAYEFELRKDLLELMTCG 241
           L  D+ E I ++G  +   V+K   K  G+    KL   +   A   ++ ++L  L  C 
Sbjct: 30  LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECN 89

Query: 242 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL- 300
              I+ FY     +   + +  + M+GGS++ ++ K+ ++  + + +++I V +G+ +L 
Sbjct: 90  SPYIVGFYGAFYSDGE-ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 148

Query: 301 NDHGVAYRDLNSQRILLDRHGNVCLGDMGI-----VTACKS-VGEATEYETDGYRWLAPE 354
             H + +RD+    IL++  G + L D G+      +   S VG  T        +++PE
Sbjct: 149 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVG--TRS------YMSPE 200

Query: 355 IIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCP 414
            + G   SV     S+++S G+ + EM  G          +  +                
Sbjct: 201 RLQGTHYSVQ----SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPR 256

Query: 415 QILKSLMIKCWNNSPSKRPQFSEIISL 441
                  +  +           E++  
Sbjct: 257 PRTPGRPLNKFGMDSRPPMAIFELLDY 283

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 91.6 bits (228), Expect = 1e-20
 Identities = 62/295 (21%), Positives = 111/295 (37%), Gaps = 37/295 (12%)

Query: 167 VSVDEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKG--KRVGIE---KLKGCD 221
           +S++    ++   E+   W   +++L+ + +IG  ++  V K   K  G     K     
Sbjct: 1   MSIESSGKLKISPEQH--WDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRST 58

Query: 222 KGNAYEFELRKDLLELM-TCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK 280
                + +L  DL  +M +     I+QFY     E     +  +LM      D   K   
Sbjct: 59  VDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGD-CWICMELMSTSF--DKFYKYVY 115

Query: 281 LQTKEII------RIAIDVAEGIKFL-NDHGVAYRDLNSQRILLDRHGNVCLGDMGI--- 330
               ++I      +I +   + +  L  +  + +RD+    ILLDR GN+ L D GI   
Sbjct: 116 SVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQ 175

Query: 331 ----VTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEA 386
               +   +  G           ++APE I            S+V+S G+ ++E+ TG  
Sbjct: 176 LVDSIAKTRDAG--CRP------YMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRF 227

Query: 387 AYAACSPV----QAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSE 437
            Y   + V       V      L     ++      + +  C     SKRP++ E
Sbjct: 228 PYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKE 282

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 89.2 bits (222), Expect = 5e-20
 Identities = 49/208 (23%), Positives = 89/208 (42%), Gaps = 26/208 (12%)

Query: 242 HKNILQFYCVCVDENHGLCV---VTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIK 298
           H  I+  Y     E     +   V + ++G ++ D++     +  K  I +  D  + + 
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALN 130

Query: 299 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG------YRWLA 352
           F + +G+ +RD+    I++     V + D GI  A    G  +  +T        Y  L+
Sbjct: 131 FSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG-NSVTQTAAVIGTAQY--LS 187

Query: 353 PEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIP-- 410
           PE   G  +SV     S+VYS G V++E++TGE  +   SPV     +A   +R +    
Sbjct: 188 PEQARG--DSVDAR--SDVYSLGCVLYEVLTGEPPFTGDSPVS----VAYQHVREDPIPP 239

Query: 411 ----KDCPQILKSLMIKCWNNSPSKRPQ 434
               +     L ++++K    +P  R Q
Sbjct: 240 SARHEGLSADLDAVVLKALAKNPENRYQ 267

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 88.9 bits (221), Expect = 7e-20
 Identities = 56/257 (21%), Positives = 112/257 (43%), Gaps = 26/257 (10%)

Query: 193 EFIDQIGPNSFKGVYKGKRVGIEKL---KGCDKGNAYEFE-LRKDLLELMTCGHKNILQF 248
           E + ++G  +F  VYK K      L   K  +  +  E E    ++  L TC H  I++ 
Sbjct: 22  EIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKL 81

Query: 249 YCVCVDENHGLCVVTKLMEGGSVNDLILKSRK-LQTKEIIRIAIDVAEGIKFLNDHGVAY 307
                 +   L ++ +   GG+V+ ++L+  + L   +I  +   + E + FL+   + +
Sbjct: 82  LGAYYHDGK-LWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIH 140

Query: 308 RDLNSQRILLDRHGNVCLGDMGI-----VTACK---SVGEATEYETDGYRWLAPEIIAGD 359
           RDL +  +L+   G++ L D G+      T  K    +G  T Y      W+APE++  +
Sbjct: 141 RDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIG--TPY------WMAPEVVMCE 192

Query: 360 PESVSE-TWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEI--PKDCPQI 416
               +   + ++++S G+ + EM   E  +   +P++  + IA     P +  P      
Sbjct: 193 TMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSD-PPTLLTPSKWSVE 251

Query: 417 LKSLMIKCWNNSPSKRP 433
            +  +    + +P  RP
Sbjct: 252 FRDFLKIALDKNPETRP 268

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 85.4 bits (212), Expect = 8e-19
 Identities = 52/269 (19%), Positives = 99/269 (36%), Gaps = 27/269 (10%)

Query: 187 LNSDNLEFIDQIGPNSFKGVYKG--KRVGIE---KLKGCDKGNAYEFELRKDLLELM-TC 240
           + +D+LE I ++G  ++  V K      G     K       +  +  L  DL   M T 
Sbjct: 4   VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTV 63

Query: 241 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQT---KEIIRIAIDVAEGI 297
                + FY     E   + +  +LM+            K QT     + +IA+ + + +
Sbjct: 64  DCPFTVTFYGALFREGD-VWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKAL 122

Query: 298 KFL-NDHGVAYRDLNSQRILLDRHGNVCLGDMGI-------VTACKSVGEATEYETDGYR 349
           + L +   V +RD+    +L++  G V + D GI       V      G   +       
Sbjct: 123 EHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAG--CKP------ 174

Query: 350 WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEI 409
           ++APE I  +      +  S+++S G+ + E+      Y +       +        P++
Sbjct: 175 YMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQL 234

Query: 410 PKD-CPQILKSLMIKCWNNSPSKRPQFSE 437
           P D           +C   +  +RP + E
Sbjct: 235 PADKFSAEFVDFTSQCLKKNSKERPTYPE 263

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 85.9 bits (213), Expect = 1e-18
 Identities = 69/262 (26%), Positives = 115/262 (43%), Gaps = 30/262 (11%)

Query: 193 EFIDQIGPNSFKGVYKGKRVGIEKL---KGCDKGNAYEFELRKDLLELMT-CGHKNILQF 248
           E ++ +G  ++  VYKG+ V   +L   K  D     E E+++++  L     H+NI  +
Sbjct: 27  ELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATY 86

Query: 249 Y-----CVCVDENHGLCVVTKLMEGGSVNDLI--LKSRKLQTKEIIRIAIDVAEGIKFLN 301
           Y           +  L +V +    GSV DLI   K   L+ + I  I  ++  G+  L+
Sbjct: 87  YGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLH 146

Query: 302 DHGVAYRDLNSQRILLDRHGNVCLGDMGI-----VTACK---SVGEATEYETDGYRWLAP 353
            H V +RD+  Q +LL  +  V L D G+      T  +    +G  T Y      W+AP
Sbjct: 147 QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIG--TPY------WMAP 198

Query: 354 EIIAGDPESVSE-TWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEI-PK 411
           E+IA D    +   + S+++S G+   EM  G        P++A   I      P +  K
Sbjct: 199 EVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP-APRLKSK 257

Query: 412 DCPQILKSLMIKCWNNSPSKRP 433
              +  +S +  C   + S+RP
Sbjct: 258 KWSKKFQSFIESCLVKNHSQRP 279

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 86.6 bits (214), Expect = 1e-18
 Identities = 28/214 (13%), Positives = 64/214 (29%), Gaps = 26/214 (12%)

Query: 242 HKNILQFYCVCVDENHG----LCVVTKLMEG------GSVNDLILKSRKLQTKEIIRIAI 291
                +   V +DE          +   M+         +       + L     +++ +
Sbjct: 159 DPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTL 218

Query: 292 DVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWL 351
            V   +  L+ +G+ +  L    I+LD+ G V L            G +      G  + 
Sbjct: 219 QVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEH---LVRDGASAVSPI-GRGFA 274

Query: 352 APEIIAG------DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGL 405
            PE  A              T+  + ++ G+ I+ +   +      + +  +  I     
Sbjct: 275 PPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIFR--S 332

Query: 406 RPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEII 439
              IP+    +L+  +          R    + +
Sbjct: 333 CKNIPQPVRALLEGFLRY----PKEDRLLPLQAM 362

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 85.8 bits (212), Expect = 1e-18
 Identities = 46/260 (17%), Positives = 95/260 (36%), Gaps = 39/260 (15%)

Query: 155 QLQMPLPSSSFVVSVDEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGI 214
            L  P+ S     +  EWQ      +    + L S  +     +G  +F  VY+  +  +
Sbjct: 33  GLSKPVSSYP---NTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDL 89

Query: 215 EK--------LKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVDENHGLCVVTKL 265
                     LK     N +EF +   L+E +        ++FY   + +N    +V +L
Sbjct: 90  NDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNG-SVLVGEL 148

Query: 266 MEGGSVNDLILKSRKLQTK-----EIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILL--- 317
              G++ + I   +    K      +I  A+ +   I+ ++D  + + D+     +L   
Sbjct: 149 YSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNG 208

Query: 318 --------DRHGNVCLGDMGIVTACKSVGEATEY----ETDGYRWLAPEIIAGDPESVSE 365
                   D    + L D+G     K   + T +    ET G++    E+++  P     
Sbjct: 209 FLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQ--CVEMLSNKP----W 262

Query: 366 TWMSNVYSFGMVIWEMVTGE 385
            +  + +     ++ M+ G 
Sbjct: 263 NYQIDYFGVAATVYCMLFGT 282

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 83.2 bits (206), Expect = 6e-18
 Identities = 62/263 (23%), Positives = 114/263 (43%), Gaps = 37/263 (14%)

Query: 189 SDNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGH 242
            +  + ++++G  S+  VYK      G+ V I+++           E+ K++  +  C  
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD----LQEIIKEISIMQQCDS 83

Query: 243 KNILQFYCVCVDENHGLCVVTKLMEGGSVNDLI-LKSRKLQTKEIIRIAIDVAEGIKFLN 301
            +++++Y         L +V +    GSV+D+I L+++ L   EI  I     +G+++L+
Sbjct: 84  PHVVKYYGSYFKNTD-LWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLH 142

Query: 302 DHGVAYRDLNSQRILLDRHGNVCLGDMGI-----VTACKS---VGEATEYETDGYRWLAP 353
                +RD+ +  ILL+  G+  L D G+      T  K    +G  T +      W+AP
Sbjct: 143 FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIG--TPF------WMAP 194

Query: 354 EIIAGDP-ESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEI--P 410
           E+I       V++ W     S G+   EM  G+  YA   P++A   I      P    P
Sbjct: 195 EVIQEIGYNCVADIW-----SLGITAIEMAEGKPPYADIHPMRAIFMIPTNP-PPTFRKP 248

Query: 411 KDCPQILKSLMIKCWNNSPSKRP 433
           +         + +C   SP +R 
Sbjct: 249 ELWSDNFTDFVKQCLVKSPEQRA 271

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score = 82.5 bits (204), Expect = 1e-17
 Identities = 56/299 (18%), Positives = 98/299 (32%), Gaps = 47/299 (15%)

Query: 187 LNSDNLEFIDQIGPNSFKGVYKGKRVGIEK---LKGCDKGNAYEFELRKDLLELMT--CG 241
           L    L     +    F  VY+ + VG  +   LK        +       +  M    G
Sbjct: 25  LGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSG 84

Query: 242 HKNILQFYCVCVDENHGLCVVTK----LME--GGSVNDLILKSR---KLQTKEIIRIAID 292
           H NI+QF                    L E   G + + + K      L    +++I   
Sbjct: 85  HPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQ 144

Query: 293 VAEGIKFLNDHG--VAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG------------ 338
               ++ ++     + +RDL  + +LL   G + L D G  T                  
Sbjct: 145 TCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALV 204

Query: 339 --EATEYETDGYRWLAPEIIAGDPES---VSETWMSNVYSFGMVIWEMVTGEAAYAACSP 393
             E T   T  YR   PEII  D  S   + E    ++++ G +++ +   +       P
Sbjct: 205 EEEITRNTTPMYR--TPEII--DLYSNFPIGEK--QDIWALGCILYLLCFRQ------HP 252

Query: 394 VQAAVGIAACGLRPEIPKDCPQ--ILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISN 450
            +    +     +  IP    Q  +  SL+      +P +R   +E++  L       N
Sbjct: 253 FEDGAKLRIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARN 311

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score = 83.3 bits (206), Expect = 1e-17
 Identities = 57/281 (20%), Positives = 111/281 (39%), Gaps = 39/281 (13%)

Query: 177 SGGEEIGRWLLNSDNLEFIDQIGPNSF-----KGVYKG-----KRVGIEKLKGCDKGNAY 226
            G EE    ++   +    D +G  +      +G++       KR+  E     D+    
Sbjct: 11  DGDEETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADR---- 66

Query: 227 EFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQT-KE 285
           E +L ++  E     H N+++++C   D      +  +L    ++ + + +        E
Sbjct: 67  EVQLLRESDE-----HPNVIRYFCTEKDRQF-QYIAIELC-AATLQEYVEQKDFAHLGLE 119

Query: 286 IIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGN-----VCLGDMGIVTACK--SVG 338
            I +      G+  L+   + +RDL    IL+            + D G+   CK  +VG
Sbjct: 120 PITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGL---CKKLAVG 176

Query: 339 EATEYETDGYR----WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSP 393
             +     G      W+APE+++ D +  + T+  +++S G V + +++ G   +     
Sbjct: 177 RHSFSRRSGVPGTEGWIAPEMLSEDCKE-NPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ 235

Query: 394 VQAAVGIAACGL-RPEIPKDCPQILKSLMIKCWNNSPSKRP 433
            QA + + AC L      K    I + L+ K     P KRP
Sbjct: 236 RQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRP 276

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 79.2 bits (195), Expect = 2e-16
 Identities = 40/213 (18%), Positives = 79/213 (37%), Gaps = 34/213 (15%)

Query: 248 FYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKE---IIRIAIDVAEGIKFLNDHG 304
                      L +  +L    ++ D + +   L+ +E    + I I +AE ++FL+  G
Sbjct: 125 GQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG 184

Query: 305 VAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR------------WLA 352
           + +RDL    I       V +GD G+VTA     E     T                +++
Sbjct: 185 LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244

Query: 353 PEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAA------VGIAACGLR 406
           PE I G+  S       +++S G++++E+                      +        
Sbjct: 245 PEQIHGNNYSHK----VDIFSLGLILFEL---------LYSFSTQMERVRIITDVRNLKF 291

Query: 407 PEIPKDCPQILKSLMIKCWNNSPSKRPQFSEII 439
           P +          ++    + SP++RP+ ++II
Sbjct: 292 PLLFTQKYPQEHMMVQDMLSPSPTERPEATDII 324

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 78.0 bits (193), Expect = 3e-16
 Identities = 42/200 (21%), Positives = 83/200 (41%), Gaps = 13/200 (6%)

Query: 242 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 301
           H NIL+ Y    D    + ++ +    G+V   + K  K   +       ++A  + + +
Sbjct: 68  HPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 126

Query: 302 DHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDP- 360
              V +RD+  + +LL   G + + D G      S        T  Y  L PE+I G   
Sbjct: 127 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDY--LPPEMIEGRMH 184

Query: 361 -ESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKS 419
            E V      +++S G++ +E + G+  + A +  +    I+        P    +  + 
Sbjct: 185 DEKV------DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT--FPDFVTEGARD 236

Query: 420 LMIKCWNNSPSKRPQFSEII 439
           L+ +   ++PS+RP   E++
Sbjct: 237 LISRLLKHNPSQRPMLREVL 256

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 78.9 bits (194), Expect = 3e-16
 Identities = 31/227 (13%), Positives = 72/227 (31%), Gaps = 26/227 (11%)

Query: 228 FELRKDLLELMTCGHKNILQFYCVCVDENH-GLCVVTKLME------GGSVNDLILKSRK 280
           F    DL++      K +++      D        +   M+      G  +       + 
Sbjct: 145 FIFPFDLVKDP--QKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKS 202

Query: 281 LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA 340
           L     +++ + V   +  L+ +G+ +  L    I+LD+ G V L         +     
Sbjct: 203 LVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEH--LVRDGARV 260

Query: 341 TEYETDGYRWLAPEIIA-------GDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSP 393
               + G+    PE+ A               T+  + ++ G+VI+ +   +      + 
Sbjct: 261 VSSVSRGF--EPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAA 318

Query: 394 VQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIIS 440
           +  +  I        IP+    +L+  +          R    + + 
Sbjct: 319 LGGSEWIFRS--CKNIPQPVRALLEGFLRY----PKEDRLLPLQAME 359

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 77.8 bits (192), Expect = 6e-16
 Identities = 59/258 (22%), Positives = 105/258 (40%), Gaps = 33/258 (12%)

Query: 193 EFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFE-LRKDLLELMTCGHKNI 245
             + +IG  SF  VY        + V I+K+    K +  +++ + K++  L    H N 
Sbjct: 57  SDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNT 116

Query: 246 LQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGV 305
           +Q+    + E+    +V +   G + + L +  + LQ  EI  +     +G+ +L+ H +
Sbjct: 117 IQYRGCYLREHT-AWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNM 175

Query: 306 AYRDLNSQRILLDRHGNVCLGDMGIVTACKS-----VGEATEYETDGYRWLAPEIIAGDP 360
            +RD+ +  ILL   G V LGD G   +  +     VG  T Y      W+APE+I    
Sbjct: 176 IHRDVKAGNILLSEPGLVKLGDFG-SASIMAPANSFVG--TPY------WMAPEVILAMD 226

Query: 361 ES----VSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEI-PKDCPQ 415
           E       + W     S G+   E+   +      + + A   IA     P +      +
Sbjct: 227 EGQYDGKVDVW-----SLGITCIELAERKPPLFNMNAMSALYHIAQNE-SPALQSGHWSE 280

Query: 416 ILKSLMIKCWNNSPSKRP 433
             ++ +  C    P  RP
Sbjct: 281 YFRNFVDSCLQKIPQDRP 298

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 76.5 bits (189), Expect = 1e-15
 Identities = 34/205 (16%), Positives = 71/205 (34%), Gaps = 27/205 (13%)

Query: 242 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 301
             +++  +     +   L V  +L+ G  +  ++ +   L     + I   +   +   +
Sbjct: 93  EPHVVPIHDFGEIDGQ-LYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAH 151

Query: 302 DHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG------YRWLAPEI 355
             G  +RD+  + IL+       L D GI +A     +    +         Y  +APE 
Sbjct: 152 AAGATHRDVKPENILVSADDFAYLVDFGIASA---TTDEKLTQLGNTVGTLYY--MAPER 206

Query: 356 IAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVG------IAACGLRPEI 409
            +      +    +++Y+   V++E +TG   Y     +                +RP I
Sbjct: 207 FSESH--ATYR--ADIYALTCVLYECLTGSPPYQG-DQLSVMGAHINQAIPRPSTVRPGI 261

Query: 410 PKDCPQILKSLMIKCWNNSPSKRPQ 434
           P     ++   M K    +P  R  
Sbjct: 262 PVAFDAVIARGMAK----NPEDRYV 282

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 76.6 bits (189), Expect = 1e-15
 Identities = 46/211 (21%), Positives = 92/211 (43%), Gaps = 31/211 (14%)

Query: 242 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 301
           H++++ F+    D +  + VV +L    S+ +L  + + L   E       +  G ++L+
Sbjct: 100 HQHVVGFHGFFEDNDF-VFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLH 158

Query: 302 DHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR---------WLA 352
            + V +RDL    + L+    V +GD G+         AT+ E DG R         ++A
Sbjct: 159 RNRVIHRDLKLGNLFLNEDLEVKIGDFGL---------ATKVEYDGERKKVLCGTPNYIA 209

Query: 353 PEIIAG---DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEI 409
           PE+++      E        +V+S G +++ ++ G+  +      +  + I        I
Sbjct: 210 PEVLSKKGHSFE-------VDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYS--I 260

Query: 410 PKDCPQILKSLMIKCWNNSPSKRPQFSEIIS 440
           PK    +  SL+ K     P+ RP  +E+++
Sbjct: 261 PKHINPVAASLIQKMLQTDPTARPTINELLN 291

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 75.7 bits (187), Expect = 2e-15
 Identities = 46/211 (21%), Positives = 91/211 (43%), Gaps = 31/211 (14%)

Query: 242 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 301
           H++++ F+    D +  + VV +L    S+ +L  + + L   E       +  G ++L+
Sbjct: 74  HQHVVGFHGFFEDNDF-VFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLH 132

Query: 302 DHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR---------WLA 352
            + V +RDL    + L+    V +GD G+         AT+ E DG R         ++A
Sbjct: 133 RNRVIHRDLKLGNLFLNEDLEVKIGDFGL---------ATKVEYDGERKKVLCGTPNYIA 183

Query: 353 PEIIAG---DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEI 409
           PE+++      E   + W     S G +++ ++ G+  +      +  + I        I
Sbjct: 184 PEVLSKKGHSFE--VDVW-----SIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYS--I 234

Query: 410 PKDCPQILKSLMIKCWNNSPSKRPQFSEIIS 440
           PK    +  SL+ K     P+ RP  +E+++
Sbjct: 235 PKHINPVAASLIQKMLQTDPTARPTINELLN 265

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 77.6 bits (191), Expect = 2e-15
 Identities = 39/173 (22%), Positives = 66/173 (38%), Gaps = 25/173 (14%)

Query: 266 ME---GGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGN 322
           ME   G S+       +KL   E I   +++   + +L+  G+ Y DL  + I+L     
Sbjct: 163 MEYVGGQSLKRSK--GQKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEEQ- 219

Query: 323 VCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMV 382
           + L D+G V+   S G    Y T G+   APEI+   P     T  +++Y+ G  +  + 
Sbjct: 220 LKLIDLGAVSRINSFGYL--YGTPGF--QAPEIVRTGP-----TVATDIYTVGRTLAALT 270

Query: 383 TGEAAYAACSPVQAAVGIAACGLRPEIPK-DCPQILKSLMIKCWNNSPSKRPQ 434
                           G    GL  + P          L+ +  +  P +R  
Sbjct: 271 LDLPTRN---------GRYVDGLPEDDPVLKTYDSYGRLLRRAIDPDPRQRFT 314

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 74.7 bits (183), Expect = 9e-15
 Identities = 24/228 (10%), Positives = 60/228 (26%), Gaps = 19/228 (8%)

Query: 227 EFELRKDLLELMTCGHKNILQFYCVCVDENHG-LCVVTKLMEG------GSVNDLILKSR 279
              L      +         Q      D       ++             +++ + +   
Sbjct: 130 RRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRG 189

Query: 280 KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE 339
                 +  +   +      L   G+ +       + +   G + LGD+  +    + G 
Sbjct: 190 DEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGP 249

Query: 340 ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVG 399
           A+      Y     E +     + +     N +  G+ I+ +      +   +P      
Sbjct: 250 ASS-VPVTY--APREFLNASTATFTHA--LNAWQLGLSIYRVWCLFLPFGLVTPGIKGSW 304

Query: 400 IAACGLRPEIP----KDCPQI---LKSLMIKCWNNSPSKRPQFSEIIS 440
                  P         C  +   +K+L+ +  N    +R    E + 
Sbjct: 305 KRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 74.2 bits (183), Expect = 9e-15
 Identities = 43/205 (20%), Positives = 82/205 (40%), Gaps = 28/205 (13%)

Query: 237 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEG 296
           L       +++      D ++ L +V + + GG +   + +  +         A  +   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSN-LYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT 153

Query: 297 IKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT-------EYETDGYR 349
            ++L+   + YRDL  + +L+D+ G + + D G     K V   T       E       
Sbjct: 154 FEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF---AKRVKGRTWTLCGTPEA------ 204

Query: 350 WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR--P 407
            LAPEII     + +  W    ++ G++I+EM  G   + A  P+Q    I +  +R   
Sbjct: 205 -LAPEIILSKGYNKAVDW----WALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS 259

Query: 408 EIPKDCPQILKSLMIKCWNNSPSKR 432
               D   +L++L+        +KR
Sbjct: 260 HFSSDLKDLLRNLLQV----DLTKR 280

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 74.8 bits (184), Expect = 1e-14
 Identities = 65/299 (21%), Positives = 112/299 (37%), Gaps = 51/299 (17%)

Query: 161 PSSSFVVSVDEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGC 220
           P + ++ S+   + +Q    E     +  +       +G   F  V   +     K+  C
Sbjct: 157 PFADYLDSIYFNRFLQWKWLERQP--VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYAC 214

Query: 221 DKGNAYEFELRKDLL-----ELMTCGHKNILQ----------FYCVCVDENHGLCVVTKL 265
            K       L K  +     E M    K IL+           Y     +   LC+V  L
Sbjct: 215 KK-------LEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDA--LCLVLTL 265

Query: 266 MEGGSVNDL---ILKSRKLQTKEIIRIAIDVAE---GIKFLNDHGVAYRDLNSQRILLDR 319
           M GG   DL   I    +    E  R     AE   G++ L+   + YRDL  + ILLD 
Sbjct: 266 MNGG---DLKFHIYHMGQAGFPEA-RAVFYAAEICCGLEDLHRERIVYRDLKPENILLDD 321

Query: 320 HGNVCLGDMGIVTACKSVGEATEYE----TDGYRWLAPEIIAGDPESVSETWMSNVYSFG 375
           HG++ + D+G+      V E    +    T GY  +APE++  +  + S  W    ++ G
Sbjct: 322 HGHIRISDLGL---AVHVPEGQTIKGRVGTVGY--MAPEVVKNERYTFSPDW----WALG 372

Query: 376 MVIWEMVTGEAAYAACSPVQAAVGIAACGLR--PEIPKDCPQILKSLMIKCWNNSPSKR 432
            +++EM+ G++ +           +         E  +      +SL  +     P++R
Sbjct: 373 CLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQLLCKDPAER 431

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 71.9 bits (177), Expect = 3e-14
 Identities = 39/199 (19%), Positives = 78/199 (39%), Gaps = 13/199 (6%)

Query: 242 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 301
           H NIL+ Y    D    + ++ +    G +   + K  +   +       ++A+ + + +
Sbjct: 73  HPNILRMYNYFHDRKR-IYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCH 131

Query: 302 DHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDP- 360
           +  V +RD+  + +L+   G + + D G      S+   T   T  Y  L PE+I G   
Sbjct: 132 ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMCGTLDY--LPPEMIEGKTH 189

Query: 361 -ESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKS 419
            E V      +++  G++ +E + G   + + S  +    I    L+   P       K 
Sbjct: 190 DEKV------DLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLK--FPPFLSDGSKD 241

Query: 420 LMIKCWNNSPSKRPQFSEI 438
           L+ K     P +R     +
Sbjct: 242 LISKLLRYHPPQRLPLKGV 260

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 74.2 bits (182), Expect = 3e-14
 Identities = 53/278 (19%), Positives = 105/278 (37%), Gaps = 48/278 (17%)

Query: 131 GEIEEEEACDESFRNGVE--NSNLKIQLQMPLPSSSFVVSVDEWQTVQSGGEEIGRWLLN 188
           G + +++   + F+  +E    NL+  +      S       +W+ V+          L 
Sbjct: 134 GHLVKKQVPPDLFQPYIEEICQNLRGDVFQKFIESDKFTRFCQWKNVELNIH------LT 187

Query: 189 SDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCDKGNAYEFELRKDLL-----ELMTCGHK 243
            ++      IG   F  VY  ++    K+            L K  +     E +    +
Sbjct: 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKC-------LDKKRIKMKQGETLALNER 240

Query: 244 NILQ-------------FYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIA 290
            +L               Y     +   L  +  LM GG ++  + +       ++   A
Sbjct: 241 IMLSLVSTGDCPFIVCMSYAFHTPDK--LSFILDLMNGGDLHYHLSQHGVFSEADMRFYA 298

Query: 291 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE---TDG 347
            ++  G++ +++  V YRDL    ILLD HG+V + D+G+        +   +    T G
Sbjct: 299 AEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGL---ACDFSKKKPHASVGTHG 355

Query: 348 YRWLAPEIIA-GDPESVSETWMSNVYSFGMVIWEMVTG 384
           Y  +APE++  G     S  W    +S G ++++++ G
Sbjct: 356 Y--MAPEVLQKGVAYDSSADW----FSLGCMLFKLLRG 387

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 71.8 bits (177), Expect = 4e-14
 Identities = 62/268 (23%), Positives = 101/268 (37%), Gaps = 42/268 (15%)

Query: 203 FKGVYKGKRVGIEKLKGCDKGNAY----EFELRKDLLELMTCG---HKNILQFYCVCVDE 255
           +KG      V ++KL             +F       E+       H+N+++      D 
Sbjct: 48  YKGYVNNTTVAVKKLAAMVDITTEELKQQF-----DQEIKVMAKCQHENLVELLGFSSDG 102

Query: 256 NHGLCVVTKLMEGGSVNDLILKSRKLQT---KEIIRIAIDVAEGIKFLNDHGVAYRDLNS 312
           +  LC+V   M  GS+ D +               +IA   A GI FL+++   +RD+ S
Sbjct: 103 DD-LCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKS 161

Query: 313 QRILLDRHGNVCLGDMGIVTACKSVGEATEYE-----TDGYRWLAPEIIAGDPESVSETW 367
             ILLD      + D G+  A       T        T  Y  +APE + G+      T 
Sbjct: 162 ANILLDEAFTAKISDFGLARA-SEKFAQTVMTSRIVGTTAY--MAPEALRGEI-----TP 213

Query: 368 MSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR-----PEI--PK----DCPQI 416
            S++YSFG+V+ E++TG  A       Q  + I            +    K    D   +
Sbjct: 214 KSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSV 273

Query: 417 LKSLMI--KCWNNSPSKRPQFSEIISLL 442
                +  +C +   +KRP   ++  LL
Sbjct: 274 EAMYSVASQCLHEKKNKRPDIKKVQQLL 301

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 71.4 bits (176), Expect = 5e-14
 Identities = 39/149 (26%), Positives = 71/149 (47%), Gaps = 27/149 (18%)

Query: 293 VAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT-------EYET 345
           V   +++L+   + YRDL  + ILLD++G++ + D G     K V + T       +Y  
Sbjct: 115 VCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGF---AKYVPDVTYTLCGTPDY-- 169

Query: 346 DGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGL 405
                +APE+++  P + S  W    +SFG++I+EM+ G   +   + ++    I    L
Sbjct: 170 -----IAPEVVSTKPYNKSIDW----WSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL 220

Query: 406 R--PEIPKDCPQILKSLMIKCWNNSPSKR 432
           R  P   +D   +L  L+ +      S+R
Sbjct: 221 RFPPFFNEDVKDLLSRLITR----DLSQR 245

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 70.9 bits (174), Expect = 7e-14
 Identities = 26/209 (12%), Positives = 62/209 (29%), Gaps = 42/209 (20%)

Query: 242 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 301
              + +   V V    G  VV + + GGS+ ++            IR    +A      +
Sbjct: 90  KPGVARVLDV-VHTRAGGLVVAEWIRGGSLQEVA--DTSPSPVGAIRAMQSLAAAADAAH 146

Query: 302 DHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPE 361
             GVA    +  R+ +   G+V L                         +       +P+
Sbjct: 147 RAGVALSIDHPSRVRVSIDGDVVLAYPAT--------------------MPDA----NPQ 182

Query: 362 SVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIP------KDCPQ 415
                   ++   G  ++ ++            ++ +  A      +        +D P 
Sbjct: 183 -------DDIRGIGASLYALLVNRWPLPEAGV-RSGLAPAERDTAGQPIEPADIDRDIPF 234

Query: 416 ILKSLMIKCWNNSPSKRPQFSEIISLLLR 444
            + ++  +        R   S +++L+ +
Sbjct: 235 QISAVAARSVQGDGGIRSA-STLLNLMQQ 262

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 69.2 bits (170), Expect = 4e-13
 Identities = 52/189 (27%), Positives = 80/189 (42%), Gaps = 36/189 (19%)

Query: 259 LCVVTKLMEGGSVNDL---ILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRI 315
           L  V + + GG   DL   I KSR+         A ++   + FL+D G+ YRDL    +
Sbjct: 99  LFFVMEFVNGG---DLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNV 155

Query: 316 LLDRHGNVCLGDMGIVTACK---SVGEAT-------EYETDGYRWLAPEIIAGDPESVSE 365
           LLD  G+  L D G+   CK     G  T       +Y       +APEI+       + 
Sbjct: 156 LLDHEGHCKLADFGM---CKEGICNGVTTATFCGTPDY-------IAPEILQEMLYGPAV 205

Query: 366 TWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR--PEIPKDCPQILKSLMIK 423
            W    ++ G++++EM+ G A + A +       I    +     + +D   ILKS M K
Sbjct: 206 DW----WAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATGILKSFMTK 261

Query: 424 CWNNSPSKR 432
                P+ R
Sbjct: 262 N----PTMR 266

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 70.2 bits (172), Expect = 5e-13
 Identities = 61/308 (19%), Positives = 103/308 (33%), Gaps = 66/308 (21%)

Query: 161 PSSSFVVSVDEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGC 220
           P   F+ S+   + +Q    E     +  D       +G   F  V+  +     KL  C
Sbjct: 158 PFQEFLDSLYFLRFLQWKWLEAQP--MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYAC 215

Query: 221 DKGNAYEFELRKDLL-----ELMTCGHKNILQ----------FYCVCVDENHGLCVVTKL 265
            K       L K  L            K IL            Y      +  LC+V  +
Sbjct: 216 KK-------LNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTD--LCLVMTI 266

Query: 266 MEGGSVNDLILKSRKLQTKEII----RIAIDVAE---GIKFLNDHGVAYRDLNSQRILLD 318
           M GG   D+      +          R     A+   G++ L+   + YRDL  + +LLD
Sbjct: 267 MNGG---DIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLD 323

Query: 319 RHGNVCLGDMGIVTACKSVGEATEYE--------TDGYRWLAPEIIAGDPESVSETWMSN 370
             GNV + D+G+        E    +        T G+  +APE++ G+    S  +   
Sbjct: 324 DDGNVRISDLGL---AV---ELKAGQTKTKGYAGTPGF--MAPELLLGEEYDFSVDY--- 372

Query: 371 VYSFGMVIWEMVTG------EAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKC 424
            ++ G+ ++EM+                 ++  V   A     +         ++L+ K 
Sbjct: 373 -FALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDFCEALLQK- 430

Query: 425 WNNSPSKR 432
               P KR
Sbjct: 431 ---DPEKR 435

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 68.8 bits (169), Expect = 7e-13
 Identities = 39/152 (25%), Positives = 64/152 (42%), Gaps = 30/152 (19%)

Query: 293 VAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK---SVGEAT-------E 342
           +A  + +L+   + YRDL  + ILLD  G++ L D G+   CK        T       E
Sbjct: 148 IASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGL---CKENIEHNSTTSTFCGTPE 204

Query: 343 YETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAA 402
           Y       LAPE++   P   +  W    +  G V++EM+ G   + + +  +    I  
Sbjct: 205 Y-------LAPEVLHKQPYDRTVDW----WCLGAVLYEMLYGLPPFYSRNTAEMYDNILN 253

Query: 403 CGLR--PEIPKDCPQILKSLMIKCWNNSPSKR 432
             L+  P I      +L+ L+ K      +KR
Sbjct: 254 KPLQLKPNITNSARHLLEGLLQKD----RTKR 281

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 69.0 bits (169), Expect = 7e-13
 Identities = 46/274 (16%), Positives = 104/274 (37%), Gaps = 51/274 (18%)

Query: 203 FKGVYKGKRVGIEK--LKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLC 260
           F+G ++G+ V + K  L         E +L  +  +     H N++++YC    +   L 
Sbjct: 33  FQGSFQGRPVAV-KRMLIDFCDIALMEIKLLTESDD-----HPNVIRYYCSETTDRF-LY 85

Query: 261 VVTKLMEGGSVNDLILK-------SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQ 313
           +  +L    ++ DL+          +  +    I +   +A G+  L+   + +RDL  Q
Sbjct: 86  IALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQ 144

Query: 314 RILLD-------------RHGNVCLGDMGIVTACKSVGEATEYE---------TDGYRWL 351
            IL+               +  + + D G+   CK +                T G+R  
Sbjct: 145 NILVSTSSRFTADQQTGAENLRILISDFGL---CKKLDSGQSSFRTNLNNPSGTSGWR-- 199

Query: 352 APEIIAGDPESVSETWMSN---VYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRP 407
           APE++       ++  ++    ++S G V + +++ G+  +      ++ +      L  
Sbjct: 200 APELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIFSLDE 259

Query: 408 EIPKDCPQIL---KSLMIKCWNNSPSKRPQFSEI 438
                   ++     L+ +  ++ P KRP   ++
Sbjct: 260 MKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKV 293

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 68.4 bits (168), Expect = 7e-13
 Identities = 67/300 (22%), Positives = 122/300 (40%), Gaps = 71/300 (23%)

Query: 188 NSDNLEFIDQIGPNSFKGVYKG-----KRVGIEKLK-GCDKGNAYEFELRKDLLELMTCG 241
           ++ N+     +G   F  VYKG       V +++LK    +G   +F       E+    
Sbjct: 33  SNKNI-----LGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQF-----QTEVEMIS 82

Query: 242 ---HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTK---EI-IRIAIDVA 294
              H+N+L+    C+       +V   M  GSV   + +  + Q         RIA+  A
Sbjct: 83  MAVHRNLLRLRGFCMTPTE-RLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSA 141

Query: 295 EGIKFLNDHG---VAYRDLNSQRILLDRHGNVCLGDMG-----------IVTACKSVGEA 340
            G+ +L+DH    + +RD+ +  ILLD      +GD G           + TA +     
Sbjct: 142 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRG---- 197

Query: 341 TEYETDGYRWLAPE-IIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVG 399
               T G+  +APE +  G     SE   ++V+ +G+++ E++TG+ A+           
Sbjct: 198 ----TIGH--IAPEYLSTG---KSSE--KTDVFGYGVMLLELITGQRAFDLARLANDDDV 246

Query: 400 IA---ACGLR----------PEIPKDCPQILKSLMIK----CWNNSPSKRPQFSEIISLL 442
           +      GL            ++  +        +I+    C  +SP +RP+ SE++ +L
Sbjct: 247 MLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 68.4 bits (168), Expect = 8e-13
 Identities = 48/189 (25%), Positives = 80/189 (42%), Gaps = 36/189 (19%)

Query: 259 LCVVTKLMEGGSVNDL---ILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRI 315
           L  V + + GG   DL   I    K         A ++  G++FL+  G+ YRDL    I
Sbjct: 93  LFFVMEYLNGG---DLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNI 149

Query: 316 LLDRHGNVCLGDMGIVTACK---SVGEAT-------EYETDGYRWLAPEIIAGDPESVSE 365
           LLD+ G++ + D G+   CK        T       +Y       +APEI+ G   + S 
Sbjct: 150 LLDKDGHIKIADFGM---CKENMLGDAKTNTFCGTPDY-------IAPEILLGQKYNHSV 199

Query: 366 TWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR--PEIPKDCPQILKSLMIK 423
            W    +SFG++++EM+ G++ +      +    I          + K+   +L  L ++
Sbjct: 200 DW----WSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVR 255

Query: 424 CWNNSPSKR 432
                P KR
Sbjct: 256 E----PEKR 260

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 69.3 bits (169), Expect = 8e-13
 Identities = 52/189 (27%), Positives = 83/189 (43%), Gaps = 36/189 (19%)

Query: 259 LCVVTKLMEGGSVNDL---ILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRI 315
           L  V + + GG   DL   I +  + +    +  A ++A G+ FL   G+ YRDL    +
Sbjct: 417 LYFVMEYVNGG---DLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNV 473

Query: 316 LLDRHGNVCLGDMGIVTACK---SVGEAT-------EYETDGYRWLAPEIIAGDPESVSE 365
           +LD  G++ + D G+   CK     G  T       +Y       +APEIIA  P   S 
Sbjct: 474 MLDSEGHIKIADFGM---CKENIWDGVTTKTFCGTPDY-------IAPEIIAYQPYGKSV 523

Query: 366 TWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR--PEIPKDCPQILKSLMIK 423
            W    ++FG++++EM+ G+A +      +    I    +     + K+   I K LM K
Sbjct: 524 DW----WAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTK 579

Query: 424 CWNNSPSKR 432
                P KR
Sbjct: 580 H----PGKR 584

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 68.0 bits (167), Expect = 1e-12
 Identities = 52/189 (27%), Positives = 83/189 (43%), Gaps = 36/189 (19%)

Query: 259 LCVVTKLMEGGSVNDL---ILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRI 315
           L  V + + GG   DL   I +  + +    +  A ++A G+ FL   G+ YRDL    +
Sbjct: 96  LYFVMEYVNGG---DLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNV 152

Query: 316 LLDRHGNVCLGDMGIVTACK---SVGEAT-------EYETDGYRWLAPEIIAGDPESVSE 365
           +LD  G++ + D G+   CK     G  T       +Y       +APEIIA  P   S 
Sbjct: 153 MLDSEGHIKIADFGM---CKENIWDGVTTKTFCGTPDY-------IAPEIIAYQPYGKSV 202

Query: 366 TWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR--PEIPKDCPQILKSLMIK 423
            W    ++FG++++EM+ G+A +      +    I    +     + K+   I K LM K
Sbjct: 203 DW----WAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTK 258

Query: 424 CWNNSPSKR 432
                P KR
Sbjct: 259 H----PGKR 263

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 67.2 bits (165), Expect = 2e-12
 Identities = 33/152 (21%), Positives = 64/152 (42%), Gaps = 30/152 (19%)

Query: 293 VAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK---SVGEAT-------E 342
           +   +++L+   V YRD+  + ++LD+ G++ + D G+   CK   S G          E
Sbjct: 114 IVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGL---CKEGISDGATMKTFCGTPE 170

Query: 343 YETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAA 402
           Y       LAPE++  +    +  W    +  G+V++EM+ G   +      +    I  
Sbjct: 171 Y-------LAPEVLEDNDYGRAVDW----WGLGVVMYEMMCGRLPFYNQDHERLFELILM 219

Query: 403 CGLR--PEIPKDCPQILKSLMIKCWNNSPSKR 432
             +R    +  +   +L  L+ K     P +R
Sbjct: 220 EEIRFPRTLSPEAKSLLAGLLKKD----PKQR 247

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 67.3 bits (165), Expect = 2e-12
 Identities = 37/161 (22%), Positives = 66/161 (40%), Gaps = 39/161 (24%)

Query: 293 VAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK---SVGEAT-------E 342
           ++  + +L++ G+ YRDL    +LLD  G++ L D G+   CK     G+ T        
Sbjct: 119 ISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGM---CKEGLRPGDTTSTFCGTPN 175

Query: 343 YETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVG--- 399
           Y       +APEI+ G+    S  W    ++ G++++EM+ G + +              
Sbjct: 176 Y-------IAPEILRGEDYGFSVDW----WALGVLMFEMMAGRSPFDIVGSSDNPDQNTE 224

Query: 400 ------IAACGLR--PEIPKDCPQILKSLMIKCWNNSPSKR 432
                 I    +R    +      +LKS + K     P +R
Sbjct: 225 DYLFQVILEKQIRIPRSLSVKAASVLKSFLNKD----PKER 261

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 67.2 bits (165), Expect = 2e-12
 Identities = 39/154 (25%), Positives = 68/154 (44%), Gaps = 33/154 (21%)

Query: 294 AE---GIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK---SVGEAT------ 341
           AE    +  L+  G+ YRDL  + I+L+  G+V L D G+   CK     G  T      
Sbjct: 128 AEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGL---CKESIHDGTVTHTFCGT 184

Query: 342 -EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGI 400
            EY       +APEI+     + +  W    +S G ++++M+TG   +   +  +    I
Sbjct: 185 IEY-------MAPEILMRSGHNRAVDW----WSLGALMYDMLTGAPPFTGENRKKTIDKI 233

Query: 401 AACGLR--PEIPKDCPQILKSLMIKCWNNSPSKR 432
             C L   P + ++   +LK L+ +    + + R
Sbjct: 234 LKCKLNLPPYLTQEARDLLKKLLKR----NAASR 263

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 67.8 bits (166), Expect = 2e-12
 Identities = 37/161 (22%), Positives = 66/161 (40%), Gaps = 39/161 (24%)

Query: 293 VAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK---SVGEAT-------E 342
           ++  + +L++ G+ YRDL    +LLD  G++ L D G+   CK     G+ T        
Sbjct: 162 ISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGM---CKEGLRPGDTTSTFCGTPN 218

Query: 343 YETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVG--- 399
           Y       +APEI+ G+    S  W    ++ G++++EM+ G + +              
Sbjct: 219 Y-------IAPEILRGEDYGFSVDW----WALGVLMFEMMAGRSPFDIVGSSDNPDQNTE 267

Query: 400 ------IAACGLR--PEIPKDCPQILKSLMIKCWNNSPSKR 432
                 I    +R    +      +LKS + K     P +R
Sbjct: 268 DYLFQVILEKQIRIPRSLSVKAASVLKSFLNKD----PKER 304

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 66.9 bits (164), Expect = 2e-12
 Identities = 43/270 (15%), Positives = 98/270 (36%), Gaps = 52/270 (19%)

Query: 190 DNLEFIDQIGPNSFKGVYKGKRVGIEK---LKGCDKGNAYEFELRKDLLE--------LM 238
           ++ +F   +G  SF  V   + +   +   +K  +K       ++++ +         + 
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEK----RHIIKENKVPYVTRERDVMS 85

Query: 239 TCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKL---QTK----EIIRIAI 291
              H   ++ Y    D+   L       + G +   I K        T+    EI+  A+
Sbjct: 86  RLDHPFFVKLYFTFQDDEK-LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIV-SAL 143

Query: 292 DVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE------- 344
           +      +L+  G+ +RDL  + ILL+   ++ + D G     K +   ++         
Sbjct: 144 E------YLHGKGIIHRDLKPENILLNEDMHIQITDFGT---AKVLSPESKQARANSFVG 194

Query: 345 TDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG 404
           T  Y  ++PE++       S       ++ G +I+++V G   + A +       I    
Sbjct: 195 TAQY--VSPELLTEKSACKSSDL----WALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE 248

Query: 405 LR--PEIPKDCPQILKSLMIKCWNNSPSKR 432
                +       +++ L++       +KR
Sbjct: 249 YDFPEKFFPKARDLVEKLLVL----DATKR 274

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 66.0 bits (162), Expect = 4e-12
 Identities = 37/154 (24%), Positives = 64/154 (41%), Gaps = 33/154 (21%)

Query: 294 AE---GIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK---SVGEAT------ 341
           AE    +  L+  G+ YRDL  + ILLD  G++ L D G+    K      +        
Sbjct: 133 AELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGL---SKESIDHEKKAYSFCGT 189

Query: 342 -EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGI 400
            EY       +APE++     + S  W    +SFG++++EM+TG   +      +    I
Sbjct: 190 VEY-------MAPEVVNRRGHTQSADW----WSFGVLMFEMLTGTLPFQGKDRKETMTMI 238

Query: 401 AACGLR--PEIPKDCPQILKSLMIKCWNNSPSKR 432
               L     +  +   +L+ L  +    +P+ R
Sbjct: 239 LKAKLGMPQFLSPEAQSLLRMLFKR----NPANR 268

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score = 66.6 bits (162), Expect = 6e-12
 Identities = 52/306 (16%), Positives = 104/306 (33%), Gaps = 62/306 (20%)

Query: 176 QSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFE 229
               +  G W       E  +++G   F  V +      G++V I   K C +      E
Sbjct: 7   SLPTQTCGPW-------EMKERLGTGGFGYVLRWIHQDTGEQVAI---KQCRQ------E 50

Query: 230 LRKDLLE--------LMTCGHKNILQFYCV-----CVDENHGLCVVTKLMEGGSVNDLIL 276
           L     E        +    H N++    V      +  N    +  +  EGG +   + 
Sbjct: 51  LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLN 110

Query: 277 KSRK---LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVC---LGDMGI 330
           +      L+   I  +  D++  +++L+++ + +RDL  + I+L          + D+G 
Sbjct: 111 QFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLG- 169

Query: 331 VTACKSVGE----ATEYETDGYRWLAPEIIAGDP--ESVSETWMSNVYSFGMVIWEMVTG 384
               K + +         T  Y  LAPE++       +V      + +SFG + +E +TG
Sbjct: 170 --YAKELDQGELCTEFVGTLQY--LAPELLEQKKYTVTV------DYWSFGTLAFECITG 219

Query: 385 EAAYAACSPVQAAVGIAACGLRPEIP---KDCPQILKSLMIKCWNN-SPSKRPQFSEIIS 440
              +          G         I         +  S ++   N+ S     +    + 
Sbjct: 220 FRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQ 279

Query: 441 LLLRTN 446
            +L  +
Sbjct: 280 CMLMWH 285

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 65.5 bits (160), Expect = 6e-12
 Identities = 37/262 (14%), Positives = 83/262 (31%), Gaps = 51/262 (19%)

Query: 159 PLPSSSFVVSVDEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVG----- 213
           PL S   ++S        +   +     +N  +   I  +    F  +   ++       
Sbjct: 2   PLGSMKDILSNYSNLIYLNKYVKEKDKYIN--DYRIIRTLNQGKFNKIILCEKDNKFYAL 59

Query: 214 -------IEKLKGCDKGNAYEFELRKDLLE-------LMTCGHKNILQFYCVCVDENHGL 259
                  +EK +   K N  +  ++    +       +    ++  L    +  + +  +
Sbjct: 60  KKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDE-V 118

Query: 260 CVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVA--------EGIKFLNDH-GVAYRDL 310
            ++ + ME  S+         L       I I V             ++++   + +RD+
Sbjct: 119 YIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDV 178

Query: 311 NSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRW--------LAPEIIAGDPES 362
               IL+D++G V L D G      S      Y  D            + PE  + +   
Sbjct: 179 KPSNILMDKNGRVKLSDFGE-----SE-----YMVDKKIKGSRGTYEFMPPEFFSNESSY 228

Query: 363 VSETWMSNVYSFGMVIWEMVTG 384
                  +++S G+ ++ M   
Sbjct: 229 NGAK--VDIWSLGICLYVMFYN 248

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score = 66.0 bits (161), Expect = 6e-12
 Identities = 36/216 (16%), Positives = 78/216 (36%), Gaps = 32/216 (14%)

Query: 193 EFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFE--LRKDLLELMTCGHKN 244
              D +G  +   V++      G    I   K  +  +         ++   L    HKN
Sbjct: 12  LLSDILGQGATANVFRGRHKKTGDLFAI---KVFNNISFLRPVDVQMREFEVLKKLNHKN 68

Query: 245 ILQFYCVCVDENHG-LCVVTKLMEGGSVNDLILK---SRKLQTKEIIRIAIDVAEGIKFL 300
           I++ + +  +       ++ +    GS+  ++ +   +  L   E + +  DV  G+  L
Sbjct: 69  IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128

Query: 301 NDHGVAYRDLNSQRILL----DRHGNVCLGDMGIVTACKSVGE----ATEYETDGYRWLA 352
            ++G+ +R++    I+     D      L D G   A + + +     + Y T+ Y  L 
Sbjct: 129 RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFG---AARELEDDEQFVSLYGTEEY--LH 183

Query: 353 PEIIAGDPESVSETWMSN----VYSFGMVIWEMVTG 384
           P++                   ++S G+  +   TG
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATG 219

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score = 64.8 bits (158), Expect = 1e-11
 Identities = 36/216 (16%), Positives = 78/216 (36%), Gaps = 32/216 (14%)

Query: 193 EFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFE--LRKDLLELMTCGHKN 244
              D +G  +   V++      G    I   K  +  +         ++   L    HKN
Sbjct: 12  LLSDILGQGATANVFRGRHKKTGDLFAI---KVFNNISFLRPVDVQMREFEVLKKLNHKN 68

Query: 245 ILQFYCVCVDEN-HGLCVVTKLMEGGSVNDLILK---SRKLQTKEIIRIAIDVAEGIKFL 300
           I++ + +  +       ++ +    GS+  ++ +   +  L   E + +  DV  G+  L
Sbjct: 69  IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128

Query: 301 NDHGVAYRDLNSQRILL----DRHGNVCLGDMGIVTACKSVGE----ATEYETDGYRWLA 352
            ++G+ +R++    I+     D      L D G   A + + +     + Y T+ Y  L 
Sbjct: 129 RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFG---AARELEDDEQFVSLYGTEEY--LH 183

Query: 353 PEIIAGDPESVSETWMSN----VYSFGMVIWEMVTG 384
           P++                   ++S G+  +   TG
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATG 219

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 64.7 bits (158), Expect = 1e-11
 Identities = 38/190 (20%), Positives = 79/190 (41%), Gaps = 33/190 (17%)

Query: 259 LCVVTKLMEGGSVNDL---ILKSRKLQTKEIIRI-AIDVAEGIKFLNDHGVAYRDLNSQR 314
           + +V  L+ GG   DL   + ++     +E +++   ++   + +L +  + +RD+    
Sbjct: 90  MFMVVDLLLGG---DLRYHLQQNVHF-KEETVKLFICELVMALDYLQNQRIIHRDMKPDN 145

Query: 315 ILLDRHGNVCLGDMGIVTACKSVGEATEYE----TDGYRWLAPEIIAGDPE---SVSETW 367
           ILLD HG+V + D  I      +   T+      T  Y  +APE+ +       S +  W
Sbjct: 146 ILLDEHGHVHITDFNI---AAMLPRETQITTMAGTKPY--MAPEMFSSRKGAGYSFAVDW 200

Query: 368 MSNVYSFGMVIWEMVTGEAAY---AACSPVQAAVGIAACGLR--PEIPKDCPQILKSLMI 422
               +S G+  +E++ G   Y   ++ S  +         +       ++   +LK L+ 
Sbjct: 201 ----WSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMVSLLKKLLE 256

Query: 423 KCWNNSPSKR 432
                +P +R
Sbjct: 257 P----NPDQR 262

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 64.8 bits (158), Expect = 2e-11
 Identities = 67/360 (18%), Positives = 123/360 (34%), Gaps = 63/360 (17%)

Query: 103 IKKPKPTSVKLPFGLCGCQEENTKGRDFG-EIEEEEACDESFRNGVEN--SNLKIQLQMP 159
            ++P+P      F +   Q      R F  E  EE    E +   ++     LK Q    
Sbjct: 65  TERPRPN----TFIIRCLQWTTVIERTFHVETPEE---REEWTTAIQTVADGLKKQAAAE 117

Query: 160 LPSSSFVVSVDEWQTVQSGGEEIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKL-- 217
           +   S   S +             +  +  +  E++  +G  +F  V   K     +   
Sbjct: 118 MDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYA 177

Query: 218 -KGCDKGNAYEFELRKDLLE--------LMTCGHKNILQFYCVCVDENHGLCVVTKLMEG 268
            K   K    E  + KD +         L    H  +          +  LC V +   G
Sbjct: 178 MKILKK----EVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDR-LCFVMEYANG 232

Query: 269 GSVNDL---ILKSRKLQTKEIIRIAIDVAEGIKFL-NDHGVAYRDLNSQRILLDRHGNVC 324
           G   +L   + + R            ++   + +L ++  V YRDL  + ++LD+ G++ 
Sbjct: 233 G---ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIK 289

Query: 325 LGDMGIVTACK---SVGEAT-------EYETDGYRWLAPEIIAGDPESVSETWMSNVYSF 374
           + D G+   CK     G          EY       LAPE++  +    +  W    +  
Sbjct: 290 ITDFGL---CKEGIKDGATMKTFCGTPEY-------LAPEVLEDNDYGRAVDW----WGL 335

Query: 375 GMVIWEMVTGEAAYAACSPVQAAVGIAACGLR--PEIPKDCPQILKSLMIKCWNNSPSKR 432
           G+V++EM+ G   +      +    I    +R    +  +   +L  L+ K     P +R
Sbjct: 336 GVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKD----PKQR 391

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 63.8 bits (156), Expect = 2e-11
 Identities = 37/161 (22%), Positives = 65/161 (40%), Gaps = 40/161 (24%)

Query: 294 AE---GIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK----SVGEAT----- 341
            E    ++ L+  G+ YRD+  + ILLD +G+V L D G+    K       E       
Sbjct: 166 GEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGL---SKEFVADETERAYDFCG 222

Query: 342 --EYETDGYRWLAPEIIAGDPESVSET--WMSNVYSFGMVIWEMVTG----EAAYAACSP 393
             EY       +AP+I+ G      +   W    +S G++++E++TG           S 
Sbjct: 223 TIEY-------MAPDIVRGGDSGHDKAVDW----WSLGVLMYELLTGASPFTVDGEKNSQ 271

Query: 394 VQAAVGIAACGLR--PEIPKDCPQILKSLMIKCWNNSPSKR 432
            + +  I         E+      +++ L++K     P KR
Sbjct: 272 AEISRRILKSEPPYPQEMSALAKDLIQRLLMK----DPKKR 308

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 63.2 bits (154), Expect = 5e-11
 Identities = 39/210 (18%), Positives = 81/210 (38%), Gaps = 28/210 (13%)

Query: 237 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDL--ILKSRKLQTKEIIRIAIDVA 294
           +       ++Q +    D+ + L +V + M GG   DL  ++ +  +  K       +V 
Sbjct: 123 MAFANSPWVVQLFYAFQDDRY-LYMVMEYMPGG---DLVNLMSNYDVPEKWARFYTAEVV 178

Query: 295 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETD---G---Y 348
             +  ++  G  +RD+    +LLD+ G++ L D G    C  + +      D   G   Y
Sbjct: 179 LALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGT---CMKMNKEGMVRCDTAVGTPDY 235

Query: 349 RWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR-- 406
             ++PE++             + +S G+ ++EM+ G+  + A S V     I        
Sbjct: 236 --ISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLT 293

Query: 407 ----PEIPKDCPQILKSLMIKCWNNSPSKR 432
                +I K+   ++ + +          R
Sbjct: 294 FPDDNDISKEAKNLICAFL-----TDREVR 318

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 62.2 bits (152), Expect = 6e-11
 Identities = 40/212 (18%), Positives = 84/212 (39%), Gaps = 32/212 (15%)

Query: 242 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLI-LKSRKLQTKEIIRIAIDVAEGIKFL 300
           H +IL+ Y    D N+ + +V ++   G +N  +  + +     E       +  G+ +L
Sbjct: 70  HPSILELYNYFEDSNY-VYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYL 128

Query: 301 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR---------WL 351
           + HG+ +RDL    +LL R+ N+ + D G+         AT+ +    +         ++
Sbjct: 129 HSHGILHRDLTLSNLLLTRNMNIKIADFGL---------ATQLKMPHEKHYTLCGTPNYI 179

Query: 352 APEIIAG---DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPE 408
           +PEI        E       S+V+S G + + ++ G   +   +       +        
Sbjct: 180 SPEIATRSAHGLE-------SDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYE-- 230

Query: 409 IPKDCPQILKSLMIKCWNNSPSKRPQFSEIIS 440
           +P       K L+ +    +P+ R   S ++ 
Sbjct: 231 MPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 62.2 bits (152), Expect = 6e-11
 Identities = 67/277 (24%), Positives = 110/277 (39%), Gaps = 45/277 (16%)

Query: 198 IGPNSFKGVYKG-----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVC 252
           IG   F  VYKG      +V +++          EFE   + L    C H +++     C
Sbjct: 47  IGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETL--SFCRHPHLVSLIGFC 104

Query: 253 VDENHGLCVVTKLMEGGSVNDLILKSRKLQT----KEIIRIAIDVAEGIKFLNDHGVAYR 308
            + N  + ++ K ME G++   +  S         ++ + I I  A G+ +L+   + +R
Sbjct: 105 DERNE-MILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHR 163

Query: 309 DLNSQRILLDRHGNVCLGDMGIVTACKS--VGEATEYETD-----GYRWLAPE-IIAGDP 360
           D+ S  ILLD +    + D GI    K     + T   T      GY  + PE  I G  
Sbjct: 164 DVKSINILLDENFVPKITDFGI---SKKGTELDQTHLSTVVKGTLGY--IDPEYFIKGRL 218

Query: 361 ESVSETWMSNVYSFGMVIWEMVTGEAAYAACSP------VQAAVGIAACG---------L 405
                T  S+VYSFG+V++E++   +A     P       + AV     G         L
Sbjct: 219 -----TEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNL 273

Query: 406 RPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
             +I  +  +      +KC   S   RP   +++  L
Sbjct: 274 ADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 60.4 bits (147), Expect = 3e-10
 Identities = 32/153 (20%), Positives = 67/153 (43%), Gaps = 25/153 (16%)

Query: 242 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 301
           H NI++ + V   E   L ++ +   GG V D ++   +++ KE       +   +++ +
Sbjct: 73  HPNIVKLFEVIETEKT-LYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCH 131

Query: 302 DHGVAYRDLNSQRILLDRHGNVCLGDMG----------IVTACKSVGEATEYETDGYRWL 351
              + +RDL ++ +LLD   N+ + D G          +   C +             + 
Sbjct: 132 QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGA-----------PPYA 180

Query: 352 APEIIAGDPESVSETWMSNVYSFGMVIWEMVTG 384
           APE+  G      E    +V+S G++++ +V+G
Sbjct: 181 APELFQGKKYDGPE---VDVWSLGVILYTLVSG 210

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 60.5 bits (147), Expect = 4e-10
 Identities = 43/189 (22%), Positives = 74/189 (39%), Gaps = 25/189 (13%)

Query: 259 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRI-AIDVAEGIKFLNDHGVAYRDLNSQRILL 317
           L +V     GG +  L+ K      +E+ R    ++   I  ++     +RD+    IL+
Sbjct: 149 LYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM 208

Query: 318 DRHGNVCLGDMGIVTACKSVGEATEYETD---G---YRWLAPEIIAGDPESVSE-----T 366
           D +G++ L D G    C  + E    ++    G   Y  ++PEI+               
Sbjct: 209 DMNGHIRLADFGS---CLKLMEDGTVQSSVAVGTPDY--ISPEILQAMEGGKGRYGPECD 263

Query: 367 WMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQI---LKSLMIK 423
           W    +S G+ ++EM+ GE  + A S V+    I     R + P     +    K L I+
Sbjct: 264 W----WSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENAKDL-IR 318

Query: 424 CWNNSPSKR 432
               S   R
Sbjct: 319 RLICSREHR 327

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 60.5 bits (147), Expect = 4e-10
 Identities = 43/200 (21%), Positives = 80/200 (40%), Gaps = 36/200 (18%)

Query: 254 DENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRI-AIDVAEGIKFLNDHGVAYRDLNS 312
           DEN+ L +V +   GG +  L+ K  +    E+ R    ++   I  ++  G  +RD+  
Sbjct: 132 DENY-LYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKP 190

Query: 313 QRILLDRHGNVCLGDMGIVTACKSVGEATEYETD---G---YRWLAPEIIAGDPESVSET 366
             ILLDR G++ L D G    C  +       +    G   Y  L+PEI+    ++V   
Sbjct: 191 DNILLDRCGHIRLADFGS---CLKLRADGTVRSLVAVGTPDY--LSPEIL----QAVGGG 241

Query: 367 WMSNVY-------SFGMVIWEMVTGEAAYAACSPVQ-------AAVGIAACGLRPEIPKD 412
             +  Y       + G+  +EM  G+  + A S  +           ++   +   +P++
Sbjct: 242 PGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEE 301

Query: 413 CPQILKSLMIKCWNNSPSKR 432
               ++ L+       P  R
Sbjct: 302 ARDFIQRLL-----CPPETR 316

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 59.2 bits (144), Expect = 6e-10
 Identities = 43/164 (26%), Positives = 61/164 (37%), Gaps = 21/164 (12%)

Query: 214 IEKLKGCDKGNAYEFELRKDLL---ELMT--CGHKNILQFYCVCVDENHGLCVVTKLMEG 268
           I+   G         ELR+  L   +++    GH NI+Q             +V  LM+ 
Sbjct: 50  IDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTF-FFLVFDLMKK 108

Query: 269 GSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDM 328
           G + D + +   L  KE  +I   + E I  L+   + +RDL  + ILLD   N+ L D 
Sbjct: 109 GELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDF 168

Query: 329 GIVTACK-------SVGEATEYETDGYRWLAPEIIAGDPESVSE 365
           G               G      T  Y  LAPEII         
Sbjct: 169 GFSCQLDPGEKLREVCG------TPSY--LAPEIIECSMNDNHP 204

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 57.8 bits (140), Expect = 2e-09
 Identities = 34/133 (25%), Positives = 54/133 (40%), Gaps = 16/133 (12%)

Query: 240 CGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKF 299
            GH +I+         +  + +V  LM  G + D + +   L  KE   I   + E + F
Sbjct: 157 AGHPHIITLIDSYESSSF-MFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSF 215

Query: 300 LNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK-------SVGEATEYETDGYRWLA 352
           L+ + + +RDL  + ILLD +  + L D G     +         G      T GY  LA
Sbjct: 216 LHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCG------TPGY--LA 267

Query: 353 PEIIAGDPESVSE 365
           PEI+    +    
Sbjct: 268 PEILKCSMDETHP 280

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 56.4 bits (137), Expect = 5e-09
 Identities = 46/228 (20%), Positives = 80/228 (35%), Gaps = 46/228 (20%)

Query: 188 NSDNLEFIDQIGPNSFKGVYK------GKRVGIEKLK-GCDKGNAYEF---ELR--KDLL 235
            +   E + +IG  ++  VYK      G  V ++ ++     G         +R    L 
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66

Query: 236 ELMTCGHKNILQFYCVCVDENHG----LCVVTKLMEGGSVNDL--ILKSRK---LQTKEI 286
            L    H N+++   VC          + +V + ++     DL   L       L  + I
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD----QDLRTYLDKAPPPGLPAETI 122

Query: 287 IRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT-EYET 345
             +      G+ FL+ + + +RDL  + IL+   G V L D G+          T    T
Sbjct: 123 KDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVT 182

Query: 346 DGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIW-------EMVTGEA 386
             YR  APE++               Y+  + +W       EM   + 
Sbjct: 183 LWYR--APEVLLQST-----------YATPVDMWSVGCIFAEMFRRKP 217

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 55.1 bits (133), Expect = 1e-08
 Identities = 44/272 (16%), Positives = 93/272 (34%), Gaps = 48/272 (17%)

Query: 193 EFIDQIGPNSFKGVYKGKRVG---------IEKLKGCDKGNAYEFELRKDLLE---LMTC 240
             +  +G  +F  V+               I+K K  +     + +L K  LE   L   
Sbjct: 27  STMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRV 86

Query: 241 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL 300
            H NI++   +  ++     V+ K   G  +   I +  +L       I   +   + +L
Sbjct: 87  EHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYL 146

Query: 301 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIV----------TACKSVGEATEYETDGYRW 350
               + +RD+  + I++     + L D G            T C ++             
Sbjct: 147 RLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYC---------- 196

Query: 351 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR--PE 408
            APE++ G+P    E     ++S G+ ++ +V  E       P           +     
Sbjct: 197 -APEVLMGNPYRGPEL---EMWSLGVTLYTLVFEEN------PFCELEETVEAAIHPPYL 246

Query: 409 IPKDCPQILKSLMIKCWNNSPSKRPQFSEIIS 440
           + K+   ++  L+       P +R    ++++
Sbjct: 247 VSKELMSLVSGLLQP----VPERRTTLEKLVT 274

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 55.0 bits (133), Expect = 2e-08
 Identities = 32/130 (24%), Positives = 58/130 (44%), Gaps = 9/130 (6%)

Query: 237 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEG 296
           L    H NI+    V  D  + + VVT+LM+GG + D IL+ +    +E   +   + + 
Sbjct: 70  LRYGQHPNIITLKDVYDDGKY-VYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKT 128

Query: 297 IKFLNDHGVAYRDLNSQRILL----DRHGNVCLGDMGIVTACKSVGEA--TEYETDGYRW 350
           +++L+  GV +RDL    IL         ++ + D G     ++      T   T  +  
Sbjct: 129 VEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANF-- 186

Query: 351 LAPEIIAGDP 360
           +APE++    
Sbjct: 187 VAPEVLERQG 196

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 55.2 bits (132), Expect = 3e-08
 Identities = 63/436 (14%), Positives = 123/436 (28%), Gaps = 148/436 (33%)

Query: 121 QEENTKGRDFGEIEEEEACDESFRNGVENSNLKIQLQMPLPSSSFVVSVDEWQTVQSGGE 180
           ++      D  ++++        ++ +    +   +      S  +       T+ S  E
Sbjct: 26  EDAFVDNFDCKDVQDMP------KSILSKEEIDHIIMSKDAVSGTLRLFW---TLLSKQE 76

Query: 181 EIGRWLLNS---DNLEFI------DQIGPNSFKGVYKGKRVGIEKLKG----CDKGNAYE 227
           E+ +  +      N +F+      +Q  P+    +Y  +R   ++L        K N   
Sbjct: 77  EMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQR---DRLYNDNQVFAKYNVSR 133

Query: 228 FE----LRKDLLEL----------MT-CGHKNILQFYCVCVDENHGLCVVTKLMEGG--- 269
            +    LR+ LLEL          +   G K  +    VC+        V   M+     
Sbjct: 134 LQPYLKLRQALLELRPAKNVLIDGVLGSG-KTWVALD-VCLSYK-----VQCKMDFKIFW 186

Query: 270 -------SVNDLILKSRKL--QTKEIIRIAIDVAEGIKF-LNDHGVAYRDLNSQR----- 314
                  S   ++   +KL  Q         D +  IK  ++      R L   +     
Sbjct: 187 LNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENC 246

Query: 315 -ILLDRHGNVCLGDMGIVTA----CK--------SVGEA------------------TEY 343
            ++L    NV   +     A    CK         V +                   T  
Sbjct: 247 LLVLL---NVQ--NAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPD 301

Query: 344 ETDGY--RW-------LAPEIIAGDP-------ESVSE---TW----MSNVYSFGMVIWE 380
           E      ++       L  E++  +P       ES+ +   TW      N      +I  
Sbjct: 302 EVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTII-- 359

Query: 381 MVTGEAAYAACSPVQAAVGIAACGLRPE---IPKDCPQILKSLMIKCWNNSPSKRPQFSE 437
               E++     P +         + P    IP     +L  +    W +          
Sbjct: 360 ----ESSLNVLEPAEYRKMFDRLSVFPPSAHIP---TILLSLI----WFDVIKSDVM--V 406

Query: 438 II------SLLLRTNN 447
           ++      SL+ +   
Sbjct: 407 VVNKLHKYSLVEKQPK 422

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 54.7 bits (132), Expect = 3e-08
 Identities = 30/129 (23%), Positives = 61/129 (47%), Gaps = 14/129 (10%)

Query: 237 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEG 296
           L    H  I++       E++ +  V +LMEGG + D ++ +++L+          +   
Sbjct: 194 LKKLNHPCIIKIKNFFDAEDYYI--VLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLA 251

Query: 297 IKFLNDHGVAYRDLNSQRILL---DRHGNVCLGDMGIVTACKSVGEATEYETD----GYR 349
           +++L+++G+ +RDL  + +LL   +    + + D G     K +GE +   T      Y 
Sbjct: 252 VQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGH---SKILGETSLMRTLCGTPTY- 307

Query: 350 WLAPEIIAG 358
            LAPE++  
Sbjct: 308 -LAPEVLVS 315

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 54.8 bits (132), Expect = 3e-08
 Identities = 22/123 (17%), Positives = 49/123 (39%), Gaps = 7/123 (5%)

Query: 242 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQT-KEIIRIAIDVAEGIKFL 300
           H  ++  +    D+N  + ++ + M GG + + +       +  E +     V +G+  +
Sbjct: 213 HPTLVNLHDAFEDDNE-MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHM 271

Query: 301 NDHGVAYRDLNSQRILL-DRHGN-VCLGDMGIVTACKSVGEATE-YETDGYRWLAPEIIA 357
           +++   + DL  + I+   +  N + L D G+               T  +   APE+  
Sbjct: 272 HENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEF--AAPEVAE 329

Query: 358 GDP 360
           G P
Sbjct: 330 GKP 332

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 53.4 bits (129), Expect = 5e-08
 Identities = 36/134 (26%), Positives = 61/134 (45%), Gaps = 15/134 (11%)

Query: 241 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL 300
           GH+N+L+      +E+    +V + M GGS+   I K R     E   +  DVA  + FL
Sbjct: 69  GHRNVLELIEFFEEEDR-FYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFL 127

Query: 301 NDHGVAYRDLNSQRILL---DRHGNVCLGDMGIVTACKSVGEATEYETD---------GY 348
           ++ G+A+RDL  + IL    ++   V + D  + +  K  G+ +   T           Y
Sbjct: 128 HNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEY 187

Query: 349 RWLAPEIIAGDPES 362
             +APE++    E 
Sbjct: 188 --MAPEVVEAFSEE 199

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 53.1 bits (128), Expect = 6e-08
 Identities = 30/125 (24%), Positives = 55/125 (44%), Gaps = 8/125 (6%)

Query: 241 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL 300
           GH NI++ + V  D+ H   +V +L+ GG + + I K +     E   I   +   +  +
Sbjct: 64  GHPNIVKLHEVFHDQLH-TFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHM 122

Query: 301 NDHGVAYRDLNSQRILL---DRHGNVCLGDMGIVTACKSVGEA--TEYETDGYRWLAPEI 355
           +D GV +RDL  + +L    + +  + + D G         +   T   T  Y   APE+
Sbjct: 123 HDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHY--AAPEL 180

Query: 356 IAGDP 360
           +  + 
Sbjct: 181 LNQNG 185

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 52.6 bits (127), Expect = 7e-08
 Identities = 37/153 (24%), Positives = 70/153 (45%), Gaps = 25/153 (16%)

Query: 242 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 301
           H +I++ Y V         +V + + GG + D I K  +++  E  R+   +   + + +
Sbjct: 70  HPHIIKLYQVISTPTD-FFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCH 128

Query: 302 DHGVAYRDLNSQRILLDRHGNVCLGDMGIV----------TACKSVGEATEYETDGYRWL 351
            H V +RDL  + +LLD H N  + D G+           T+C S   A           
Sbjct: 129 RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYA----------- 177

Query: 352 APEIIAGDPESVSETWMSNVYSFGMVIWEMVTG 384
           APE+I+G   +  E    +++S G++++ ++ G
Sbjct: 178 APEVISGRLYAGPE---VDIWSCGVILYALLCG 207

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 53.2 bits (128), Expect = 1e-07
 Identities = 38/198 (19%), Positives = 79/198 (39%), Gaps = 36/198 (18%)

Query: 189 SDNLEFIDQIGPNSFKGVYKGKRVG---------IEKLKGCDKGNAYEFELRKDLLE--- 236
            ++   + ++G  ++  V   K            I+K +      + + +  +   E   
Sbjct: 35  GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94

Query: 237 -----LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAI 291
                L +  H NI++ + V  D+ +   +VT+  EGG + + I+   K    +   I  
Sbjct: 95  NEISLLKSLDHPNIIKLFDVFEDKKY-FYLVTEFYEGGELFEQIINRHKFDECDAANIMK 153

Query: 292 DVAEGIKFLNDHGVAYRDLNSQRILL---DRHGNVCLGDMGIVTACKS-------VGEAT 341
            +  GI +L+ H + +RD+  + ILL   +   N+ + D G+ +           +G   
Sbjct: 154 QILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLG--- 210

Query: 342 EYETDGYRWLAPEIIAGD 359
              T  Y  +APE++   
Sbjct: 211 ---TAYY--IAPEVLKKK 223

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 52.2 bits (126), Expect = 1e-07
 Identities = 33/156 (21%), Positives = 73/156 (46%), Gaps = 9/156 (5%)

Query: 210 KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGG 269
           K +   +L    +G + E E+ +++  L    H NI+  + +  ++   + ++ +L+ GG
Sbjct: 36  KFIKKRRLSSSRRGVSRE-EIEREVNILREIRHPNIITLHDIFENKTD-VVLILELVSGG 93

Query: 270 SVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILL----DRHGNVCL 325
            + D + +   L   E  +    + +G+ +L+   +A+ DL  + I+L      +  + L
Sbjct: 94  ELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKL 153

Query: 326 GDMGIVTACKSVGEATE-YETDGYRWLAPEIIAGDP 360
            D GI    ++  E    + T  +  +APEI+  +P
Sbjct: 154 IDFGIAHKIEAGNEFKNIFGTPEF--VAPEIVNYEP 187

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 52.4 bits (126), Expect = 1e-07
 Identities = 25/123 (20%), Positives = 53/123 (43%), Gaps = 7/123 (5%)

Query: 242 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL-KSRKLQTKEIIRIAIDVAEGIKFL 300
           H  ++  +    D+   + ++ + + GG + D I  +  K+   E+I       EG+K +
Sbjct: 107 HPKLINLHDAFEDKYE-MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHM 165

Query: 301 NDHGVAYRDLNSQRILLDRHGN--VCLGDMGIVTACKSVGEATE-YETDGYRWLAPEIIA 357
           ++H + + D+  + I+ +      V + D G+ T             T  +   APEI+ 
Sbjct: 166 HEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEF--AAPEIVD 223

Query: 358 GDP 360
            +P
Sbjct: 224 REP 226

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 52.2 bits (126), Expect = 1e-07
 Identities = 24/124 (19%), Positives = 50/124 (40%), Gaps = 7/124 (5%)

Query: 241 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL-KSRKLQTKEIIRIAIDVAEGIKF 299
            H+NIL  +         L ++ + + G  + + I   + +L  +EI+     V E ++F
Sbjct: 59  RHRNILHLHESFESMEE-LVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQF 117

Query: 300 LNDHGVAYRDLNSQRILLDRHGN--VCLGDMGIVTACKSVGEATE-YETDGYRWLAPEII 356
           L+ H + + D+  + I+     +  + + + G     K        +    Y   APE+ 
Sbjct: 118 LHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEY--YAPEVH 175

Query: 357 AGDP 360
             D 
Sbjct: 176 QHDV 179

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 52.4 bits (126), Expect = 1e-07
 Identities = 32/156 (20%), Positives = 70/156 (44%), Gaps = 9/156 (5%)

Query: 210 KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGG 269
           K +   + +   +G   E E+ +++  L    H NI+  + V  +    + ++ +L+ GG
Sbjct: 43  KFIKKRQSRASRRGVCRE-EIEREVSILRQVLHPNIITLHDVYENRTD-VVLILELVSGG 100

Query: 270 SVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILL----DRHGNVCL 325
            + D + +   L  +E       + +G+ +L+   +A+ DL  + I+L        ++ L
Sbjct: 101 ELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKL 160

Query: 326 GDMGIVTACKSVGEATE-YETDGYRWLAPEIIAGDP 360
            D G+    +   E    + T  +  +APEI+  +P
Sbjct: 161 IDFGLAHEIEDGVEFKNIFGTPEF--VAPEIVNYEP 194

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 51.9 bits (125), Expect = 1e-07
 Identities = 26/124 (20%), Positives = 57/124 (45%), Gaps = 8/124 (6%)

Query: 242 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 301
           H N++  + V  +    + ++ +L+ GG + D + +   L  +E       + +G+ +L+
Sbjct: 74  HHNVITLHDVYENRTD-VVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH 132

Query: 302 DHGVAYRDLNSQRILLDRH----GNVCLGDMGIVTACKSVGEATE-YETDGYRWLAPEII 356
              +A+ DL  + I+L        ++ L D G+    +   E    + T  +  +APEI+
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEF--VAPEIV 190

Query: 357 AGDP 360
             +P
Sbjct: 191 NYEP 194

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 52.0 bits (125), Expect = 2e-07
 Identities = 30/125 (24%), Positives = 57/125 (45%), Gaps = 7/125 (5%)

Query: 242 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL-KSRKLQTKEIIRIAIDVAEGIKFL 300
           H N++Q Y     +N  + +V + ++GG + D I+ +S  L   + I     + EGI+ +
Sbjct: 145 HANLIQLYDAFESKND-IVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHM 203

Query: 301 NDHGVAYRDLNSQRILLDRHGN--VCLGDMGIVTACKSVGEATE-YETDGYRWLAPEIIA 357
           +   + + DL  + IL        + + D G+    K   +    + T  +  LAPE++ 
Sbjct: 204 HQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEF--LAPEVVN 261

Query: 358 GDPES 362
            D  S
Sbjct: 262 YDFVS 266

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 52.4 bits (126), Expect = 2e-07
 Identities = 39/213 (18%), Positives = 90/213 (42%), Gaps = 30/213 (14%)

Query: 189 SDNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGH 242
           S+  + + ++G  ++  V             I+ ++      +   +L +++  L    H
Sbjct: 36  SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95

Query: 243 KNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLND 302
            NI++ Y    D+ +   +V +  +GG + D I+   K    +   I   V  G+ +L+ 
Sbjct: 96  PNIMKLYDFFEDKRN-YYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHK 154

Query: 303 HGVAYRDLNSQRILL---DRHGNVCLGDMGIVTACKS-------VGEATEYETDGYRWLA 352
           H + +RDL  + +LL   ++   + + D G+    ++       +G      T  Y  +A
Sbjct: 155 HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLG------TAYY--IA 206

Query: 353 PEIIAGDPESVSETWMSNVYSFGMVIWEMVTGE 385
           PE++    +   + W     S G++++ ++ G 
Sbjct: 207 PEVLRKKYDEKCDVW-----SIGVILFILLAGY 234

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 51.5 bits (124), Expect = 2e-07
 Identities = 30/129 (23%), Positives = 60/129 (46%), Gaps = 14/129 (10%)

Query: 237 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEG 296
           L    H  I++       E++ +  V +LMEGG + D ++ +++L+          +   
Sbjct: 69  LKKLNHPCIIKIKNFFDAEDYYI--VLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLA 126

Query: 297 IKFLNDHGVAYRDLNSQRILLDRHG---NVCLGDMGIVTACKSVGEATEYETD----GYR 349
           +++L+++G+ +RDL  + +LL        + + D G     K +GE +   T      Y 
Sbjct: 127 VQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGH---SKILGETSLMRTLCGTPTY- 182

Query: 350 WLAPEIIAG 358
            LAPE++  
Sbjct: 183 -LAPEVLVS 190

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 51.6 bits (124), Expect = 3e-07
 Identities = 48/208 (23%), Positives = 94/208 (45%), Gaps = 19/208 (9%)

Query: 189 SDNLEFIDQIGPNSFKGVYKG--KRVGIEK-LKGCDKGNAYEFELRKDLLE----LMTCG 241
           SD  +    +G  SF  V     K  G E  +K   K    +   ++ LL     L    
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84

Query: 242 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 301
           H NI++ Y    D+ +   +V ++  GG + D I+  ++    +  RI   V  GI +++
Sbjct: 85  HPNIMKLYEFFEDKGY-FYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMH 143

Query: 302 DHGVAYRDLNSQRILL---DRHGNVCLGDMGIVTACKSVGEATEY-ETDGYRWLAPEIIA 357
            + + +RDL  + +LL    +  N+ + D G+ T  ++  +  +   T  Y  +APE++ 
Sbjct: 144 KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYY--IAPEVLH 201

Query: 358 GDPESVSETWMSNVYSFGMVIWEMVTGE 385
           G  +   + W     S G++++ +++G 
Sbjct: 202 GTYDEKCDVW-----STGVILYILLSGC 224

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 51.6 bits (124), Expect = 3e-07
 Identities = 33/159 (20%), Positives = 75/159 (47%), Gaps = 24/159 (15%)

Query: 241 GHKNILQ----FYCVCVDENHGLCVVTKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVA 294
           G  +IL+    F     +  H + +V +++ G ++  LI K   R +    + +I+  + 
Sbjct: 84  GANHILKLLDHFNHKGPNGVH-VVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLL 141

Query: 295 EGIKFLNDH-GVAYRDLNSQRILLDR------HGNVCLGDMGIVTACKSVGEATEY-ETD 346
            G+ +++   G+ + D+  + +L++          + + D+G   AC      T   +T 
Sbjct: 142 LGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLG--NACWYDEHYTNSIQTR 199

Query: 347 GYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGE 385
            YR  +PE++ G P        ++++S   +I+E++TG+
Sbjct: 200 EYR--SPEVLLGAPWGCG----ADIWSTACLIFELITGD 232

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 51.0 bits (123), Expect = 3e-07
 Identities = 43/224 (19%), Positives = 84/224 (37%), Gaps = 52/224 (23%)

Query: 190 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFE------LR--KDLL 235
           +  E I +IG  S+  V+K      G+ V I+K        + +        LR  + L 
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFL-----ESEDDPVIKKIALREIRMLK 57

Query: 236 ELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDL--ILKSRK--LQTKEIIRIAI 291
           +L    H N++    V   +   L +V +  +    + +   L   +  +    +  I  
Sbjct: 58  QL---KHPNLVNLLEVFRRKRR-LHLVFEYCD----HTVLHELDRYQRGVPEHLVKSITW 109

Query: 292 DVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA-TEY-ETDGYR 349
              + + F + H   +RD+  + IL+ +H  + L D G         +   +   T  YR
Sbjct: 110 QTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYR 169

Query: 350 WLAPEIIAGDPESVSETWMSNVYSFGMVIW-------EMVTGEA 386
             +PE++ GD +          Y   + +W       E+++G  
Sbjct: 170 --SPELLVGDTQ----------YGPPVDVWAIGCVFAELLSGVP 201

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 51.5 bits (124), Expect = 3e-07
 Identities = 29/129 (22%), Positives = 54/129 (41%), Gaps = 8/129 (6%)

Query: 237 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEG 296
                H NI++ +    +E H   ++  L+ GG + + I+        +       + E 
Sbjct: 64  CRLLKHPNIVRLHDSISEEGH-HYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEA 122

Query: 297 IKFLNDHGVAYRDLNSQRILL---DRHGNVCLGDMGIVTACKSVGEA--TEYETDGYRWL 351
           +   +  GV +R+L  + +LL    +   V L D G+    +   +A      T GY  L
Sbjct: 123 VLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGY--L 180

Query: 352 APEIIAGDP 360
           +PE++  DP
Sbjct: 181 SPEVLRKDP 189

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 51.1 bits (123), Expect = 3e-07
 Identities = 47/234 (20%), Positives = 86/234 (36%), Gaps = 64/234 (27%)

Query: 190 DNLEFIDQIGPNSFKGVYK-------GKRVGIEKLKGCDKGNAYEFE--------LR--K 232
              E + +IG  ++  V+K       G+ V +++++        +          +R   
Sbjct: 11  QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR-------VQTGEEGMPLSTIREVA 63

Query: 233 DLLELMTCGHKNILQFYCVCV----DENHGLCVVTKLMEGGSVNDL-----ILKSRKLQT 283
            L  L T  H N+++ + VC     D    L +V + ++     DL      +    + T
Sbjct: 64  VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD----QDLTTYLDKVPEPGVPT 119

Query: 284 KEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY 343
           + I  +   +  G+ FL+ H V +RDL  Q IL+   G + L D G+    +        
Sbjct: 120 ETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA---RIYSFQMAL 176

Query: 344 ----ETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIW-------EMVTGEA 386
                T  YR  APE++               Y+  + +W       EM   + 
Sbjct: 177 TSVVVTLWYR--APEVLLQSS-----------YATPVDLWSVGCIFAEMFRRKP 217

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 51.3 bits (123), Expect = 3e-07
 Identities = 40/153 (26%), Positives = 74/153 (48%), Gaps = 25/153 (16%)

Query: 242 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 301
           H +I++ Y V    +  + +V + + GG + D I K+ +L  KE  R+   +  G+ + +
Sbjct: 75  HPHIIKLYQVISTPSD-IFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCH 133

Query: 302 DHGVAYRDLNSQRILLDRHGNVCLGDMGIV----------TACKSVGEATEYETDGYRWL 351
            H V +RDL  + +LLD H N  + D G+           T+C S   A           
Sbjct: 134 RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYA----------- 182

Query: 352 APEIIAGDPESVSETWMSNVYSFGMVIWEMVTG 384
           APE+I+G   +  E    +++S G++++ ++ G
Sbjct: 183 APEVISGRLYAGPE---VDIWSSGVILYALLCG 212

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 51.2 bits (123), Expect = 4e-07
 Identities = 46/173 (26%), Positives = 78/173 (45%), Gaps = 37/173 (21%)

Query: 229 ELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVTKLMEGGSVNDL--ILKSRKL 281
           ELR  LL+ M   H+N++    V      ++E + + +VT LM      DL  I+K +KL
Sbjct: 78  ELR--LLKHMK--HENVIGLLDVFTPARSLEEFNDVYLVTHLMG----ADLNNIVKCQKL 129

Query: 282 QTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT 341
               +  +   +  G+K+++   + +RDL    + ++    + + D G+  A  +  E T
Sbjct: 130 TDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGL--ARHTADEMT 187

Query: 342 EY-ETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIW-------EMVTGEA 386
            Y  T  YR  APEI+          WM   Y+  + IW       E++TG  
Sbjct: 188 GYVATRWYR--APEIMLN--------WMH--YNQTVDIWSVGCIMAELLTGRT 228

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 50.7 bits (122), Expect = 4e-07
 Identities = 25/124 (20%), Positives = 55/124 (44%), Gaps = 8/124 (6%)

Query: 242 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 301
           H N++  + V  ++   + ++ +L+ GG + D + +   L  +E       +  G+ +L+
Sbjct: 73  HPNVITLHEVYENKTD-VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131

Query: 302 DHGVAYRDLNSQRILL----DRHGNVCLGDMGIVTACKSVGEATE-YETDGYRWLAPEII 356
              +A+ DL  + I+L         + + D G+        E    + T  +  +APEI+
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF--VAPEIV 189

Query: 357 AGDP 360
             +P
Sbjct: 190 NYEP 193

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 51.1 bits (123), Expect = 4e-07
 Identities = 47/236 (19%), Positives = 87/236 (36%), Gaps = 64/236 (27%)

Query: 190 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKD------LLE- 236
              E + +IG  +F  V+K      G++V ++K+           E  K+      L E 
Sbjct: 17  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL---------MENEKEGFPITALREI 67

Query: 237 --LMTCGHKNILQFYCVCVDENHGLCV-------VTKLMEGGSVNDL--ILKSR--KLQT 283
             L    H+N++    +C  +             V    E    +DL  +L +   K   
Sbjct: 68  KILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCE----HDLAGLLSNVLVKFTL 123

Query: 284 KEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY 343
            EI R+   +  G+ +++ + + +RD+ +  +L+ R G + L D G+  A      +   
Sbjct: 124 SEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPN 183

Query: 344 E------TDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIW-------EMVTGEA 386
                  T  YR   PE++ G+ +          Y   + +W       EM T   
Sbjct: 184 RYTNRVVTLWYR--PPELLLGERD----------YGPPIDLWGAGCIMAEMWTRSP 227

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 49.9 bits (120), Expect = 5e-07
 Identities = 26/121 (21%), Positives = 52/121 (42%), Gaps = 7/121 (5%)

Query: 242 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 301
           H+N+++FY    + N    +  +   GG + D I     +   +  R    +  G+ +L+
Sbjct: 64  HENVVKFYGHRREGNI-QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 122

Query: 302 DHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETD----GYRWLAPEIIA 357
             G+ +RD+  + +LLD   N+ + D G+ T  +                Y  +APE++ 
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY--VAPELLK 180

Query: 358 G 358
            
Sbjct: 181 R 181

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 50.4 bits (121), Expect = 5e-07
 Identities = 40/155 (25%), Positives = 72/155 (46%), Gaps = 30/155 (19%)

Query: 242 HKNILQFYCVCVDENHGLCVVTKLME--GGSVNDLILKSRKLQTKEIIRIAIDVAEGIKF 299
           H +I++ Y V       + +V   +E  GG + D I++ +++   E  R    +   I++
Sbjct: 68  HPHIIKLYDVITTPTD-IVMV---IEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEY 123

Query: 300 LNDHGVAYRDLNSQRILLDRHGNVCLGDMGIV----------TACKSVGEATEYETDGYR 349
            + H + +RDL  + +LLD + NV + D G+           T+C S   A         
Sbjct: 124 CHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYA--------- 174

Query: 350 WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTG 384
             APE+I G   +  E    +V+S G+V++ M+ G
Sbjct: 175 --APEVINGKLYAGPE---VDVWSCGIVLYVMLVG 204

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 49.9 bits (120), Expect = 5e-07
 Identities = 34/132 (25%), Positives = 63/132 (47%), Gaps = 19/132 (14%)

Query: 237 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEG 296
           L    H NI++ + +  D +    +V +L  GG + D I+K ++    +  RI   V  G
Sbjct: 75  LKKLDHPNIMKLFEILEDSSS-FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSG 133

Query: 297 IKFLNDHGVAYRDLNSQRILL---DRHGNVCLGDMGIVTACKS-------VGEATEYETD 346
           I +++ H + +RDL  + ILL   ++  ++ + D G+ T  +        +G      T 
Sbjct: 134 ITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIG------TA 187

Query: 347 GYRWLAPEIIAG 358
            Y  +APE++ G
Sbjct: 188 YY--IAPEVLRG 197

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 49.9 bits (120), Expect = 6e-07
 Identities = 29/134 (21%), Positives = 54/134 (40%), Gaps = 19/134 (14%)

Query: 237 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEG 296
                H NI++ +    +E+    +V  L+ GG + + I+        +       + E 
Sbjct: 59  CRKLQHPNIVRLHDSIQEESF-HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILES 117

Query: 297 IKFLNDHGVAYRDLNSQRILL---DRHGNVCLGDMGIVTACKS-------VGEATEYETD 346
           I + + +G+ +R+L  + +LL    +   V L D G+              G      T 
Sbjct: 118 IAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAG------TP 171

Query: 347 GYRWLAPEIIAGDP 360
           GY  L+PE++  DP
Sbjct: 172 GY--LSPEVLKKDP 183

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 50.0 bits (120), Expect = 6e-07
 Identities = 33/147 (22%), Positives = 68/147 (46%), Gaps = 9/147 (6%)

Query: 242 HKNILQFYCVCVDEN-HGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL 300
           H N+++   V  D N   L +V +L+  G V ++      L   +      D+ +GI++L
Sbjct: 95  HPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKP-LSEDQARFYFQDLIKGIEYL 153

Query: 301 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG---YRWLAPEIIA 357
           +   + +RD+    +L+   G++ + D G V+      +A    T G   +  +APE ++
Sbjct: 154 HYQKIIHRDIKPSNLLVGEDGHIKIADFG-VSNEFKGSDALLSNTVGTPAF--MAPESLS 210

Query: 358 GDPESVSETWMSNVYSFGMVIWEMVTG 384
              +  S     +V++ G+ ++  V G
Sbjct: 211 ETRKIFSGK-ALDVWAMGVTLYCFVFG 236

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 50.0 bits (120), Expect = 7e-07
 Identities = 40/182 (21%), Positives = 78/182 (42%), Gaps = 17/182 (9%)

Query: 189 SDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGC---DKGNAYEFELRKDLLELMTCGHKNI 245
           SD  E   ++G  +   VY+ K+ G +K        K    +  +R ++  L+   H NI
Sbjct: 52  SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKK-IVRTEIGVLLRLSHPNI 110

Query: 246 LQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGV 305
           ++   +       + +V +L+ GG + D I++      ++       + E + +L+++G+
Sbjct: 111 IKLKEIFETPTE-ISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGI 169

Query: 306 AYRDLNSQRILL---DRHGNVCLGDMGIVTACKSVGEATEYE----TDGYRWLAPEIIAG 358
            +RDL  + +L         + + D G+    K V      +    T GY   APEI+ G
Sbjct: 170 VHRDLKPENLLYATPAPDAPLKIADFGL---SKIVEHQVLMKTVCGTPGY--CAPEILRG 224

Query: 359 DP 360
             
Sbjct: 225 CA 226

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 50.0 bits (120), Expect = 8e-07
 Identities = 44/237 (18%), Positives = 74/237 (31%), Gaps = 72/237 (30%)

Query: 193 EFIDQIGPNSFKGVY---------KGKRVGIEKLKGCDKGNAYE--FELRKD-------- 233
                I      G Y         +G  V I+++                          
Sbjct: 25  TVQRFIS----SGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80

Query: 234 -LLELMTCGHKNILQ----FYCVCVDENHGLCVVTKLMEGGSVNDL--ILKSRKLQTKE- 285
            LL      H NIL     F        H L +VT+LM      DL  ++  +++     
Sbjct: 81  RLLNHFH--HPNILGLRDIFVHFEEPAMHKLYLVTELMR----TDLAQVIHDQRIVISPQ 134

Query: 286 --------IIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV 337
                   I+        G+  L++ GV +RDL+   ILL  + ++ + D  +     + 
Sbjct: 135 HIQYFMYHILL-------GLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTAD 187

Query: 338 GEATEY-ETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIW-------EMVTGEA 386
              T Y     YR  APE++               ++  + +W       EM   +A
Sbjct: 188 ANKTHYVTHRWYR--APELVMQ----------FKGFTKLVDMWSAGCVMAEMFNRKA 232

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 49.5 bits (119), Expect = 9e-07
 Identities = 57/227 (25%), Positives = 93/227 (40%), Gaps = 51/227 (22%)

Query: 188 NSDNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFE-------LR--K 232
            +   E +D +G   F  VYK       + V I+K+K    G+  E +       LR  K
Sbjct: 8   RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIK---LGHRSEAKDGINRTALREIK 64

Query: 233 DLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDL--ILKSRK--LQTKEIIR 288
            L EL    H NI+        ++  + +V   ME     DL  I+K     L    I  
Sbjct: 65  LLQEL---SHPNIIGLLDAFGHKS-NISLVFDFME----TDLEVIIKDNSLVLTPSHIKA 116

Query: 289 IAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA--TEYETD 346
             +   +G+++L+ H + +RDL    +LLD +G + L D G+  +  S   A   +  T 
Sbjct: 117 YMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTR 176

Query: 347 GYRWLAPEIIAGDPESVSETWMSNVYSFGMVIW-------EMVTGEA 386
            YR  APE++ G          + +Y  G+ +W       E++    
Sbjct: 177 WYR--APELLFG----------ARMYGVGVDMWAVGCILAELLLRVP 211

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 49.6 bits (119), Expect = 1e-06
 Identities = 29/129 (22%), Positives = 54/129 (41%), Gaps = 19/129 (14%)

Query: 242 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 301
           H NI++ +    +E+    +V  L+ GG + + I+        +       + E I + +
Sbjct: 87  HPNIVRLHDSIQEESF-HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCH 145

Query: 302 DHGVAYRDLNSQRILL---DRHGNVCLGDMGIVTACKS-------VGEATEYETDGYRWL 351
            +G+ +R+L  + +LL    +   V L D G+              G      T GY  L
Sbjct: 146 SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAG------TPGY--L 197

Query: 352 APEIIAGDP 360
           +PE++  DP
Sbjct: 198 SPEVLKKDP 206

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 49.2 bits (118), Expect = 1e-06
 Identities = 31/129 (24%), Positives = 59/129 (45%), Gaps = 15/129 (11%)

Query: 241 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK--LQTKEIIRIAIDVAEGIK 298
               ++  + V  + +  + ++ +   GG +  L L      +   ++IR+   + EG+ 
Sbjct: 87  SCPRVINLHEVYENTSE-IILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVY 145

Query: 299 FLNDHGVAYRDLNSQRILL---DRHGNVCLGDMGIVTACKSVGEATEYE----TDGYRWL 351
           +L+ + + + DL  Q ILL      G++ + D G+    + +G A E      T  Y  L
Sbjct: 146 YLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGM---SRKIGHACELREIMGTPEY--L 200

Query: 352 APEIIAGDP 360
           APEI+  DP
Sbjct: 201 APEILNYDP 209

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 49.3 bits (118), Expect = 1e-06
 Identities = 57/266 (21%), Positives = 100/266 (37%), Gaps = 36/266 (13%)

Query: 193 EFIDQIGPNSFKGVYKGKRVG---------IEKLKGCDKGNAYEFELRK---DLLELMTC 240
           +    +G   F  VY G RV          +EK +  D G             LL+ ++ 
Sbjct: 46  QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 105

Query: 241 GHKNILQFYCVCVDENHGLCVVTKLMEG-GSVNDLILKSRKLQTKEIIRIAIDVAEGIKF 299
           G   +++        +    ++ +  E    + D I +   LQ +        V E ++ 
Sbjct: 106 GFSGVIRLLDWFERPDS-FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 164

Query: 300 LNDHGVAYRDLNSQRILLD-RHGNVCLGDMGIVTACKSVGEATEYET-DG---YRWLAPE 354
            ++ GV +RD+  + IL+D   G + L D G      ++ + T Y   DG   Y    PE
Sbjct: 165 CHNCGVLHRDIKDENILIDLNRGELKLIDFG----SGALLKDTVYTDFDGTRVY--SPPE 218

Query: 355 IIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCP 414
            I            + V+S G+++++MV G+       P +    I    +     +   
Sbjct: 219 WIRYHRYHGRS---AAVWSLGILLYDMVCGDI------PFEHDEEIIRGQVF--FRQRVS 267

Query: 415 QILKSLMIKCWNNSPSKRPQFSEIIS 440
              + L+  C    PS RP F EI +
Sbjct: 268 SECQHLIRWCLALRPSDRPTFEEIQN 293

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 49.1 bits (118), Expect = 1e-06
 Identities = 50/226 (22%), Positives = 87/226 (38%), Gaps = 57/226 (25%)

Query: 190 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFE-------LR--KDL 234
           +    +D++G  ++  VYK         V +++++        E E       +R    L
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIR-------LEHEEGAPCTAIREVSLL 54

Query: 235 LELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDL--ILKSRK--LQTKEIIRIA 290
            +L    H NI+  + +   E   L +V + ++     DL   L      +    +    
Sbjct: 55  KDL---KHANIVTLHDIIHTEKS-LTLVFEYLD----KDLKQYLDDCGNIINMHNVKLFL 106

Query: 291 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT---EYETDG 347
             +  G+ + +   V +RDL  Q +L++  G + L D G+  A KS+   T   E  T  
Sbjct: 107 FQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARA-KSIPTKTYDNEVVTLW 165

Query: 348 YRWLAPEIIAGDPESVSETWMSNVYSFGMVIW-------EMVTGEA 386
           YR   P+I+ G          S  YS  + +W       EM TG  
Sbjct: 166 YR--PPDILLG----------STDYSTQIDMWGVGCIFYEMATGRP 199

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 49.2 bits (118), Expect = 1e-06
 Identities = 26/121 (21%), Positives = 52/121 (42%), Gaps = 7/121 (5%)

Query: 242 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 301
           H+N+++FY    + N    +  +   GG + D I     +   +  R    +  G+ +L+
Sbjct: 64  HENVVKFYGHRREGNI-QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLH 122

Query: 302 DHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETD----GYRWLAPEIIA 357
             G+ +RD+  + +LLD   N+ + D G+ T  +                Y  +APE++ 
Sbjct: 123 GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY--VAPELLK 180

Query: 358 G 358
            
Sbjct: 181 R 181

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 48.7 bits (117), Expect = 1e-06
 Identities = 41/185 (22%), Positives = 78/185 (42%), Gaps = 30/185 (16%)

Query: 193 EFIDQIGPNSFKGVYK------GKRVG---IEKLKGCDKGNAYEFELRKDLLELMTCGHK 243
            F++ +G  +F  V+       GK      I+K       +     L  ++  L    H+
Sbjct: 12  IFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSS-----LENEIAVLKKIKHE 66

Query: 244 NILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDH 303
           NI+    +     H   +V +L+ GG + D IL+      K+   +   V   +K+L+++
Sbjct: 67  NIVTLEDIYESTTH-YYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHEN 125

Query: 304 GVAYRDLNSQRILL---DRHGNVCLGDMGIVTACKSVGEATEYETD-----GYRWLAPEI 355
           G+ +RDL  + +L    + +  + + D G+     S  E     +      GY  +APE+
Sbjct: 126 GIVHRDLKPENLLYLTPEENSKIMITDFGL-----SKMEQNGIMSTACGTPGY--VAPEV 178

Query: 356 IAGDP 360
           +A  P
Sbjct: 179 LAQKP 183

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 48.7 bits (117), Expect = 1e-06
 Identities = 30/132 (22%), Positives = 55/132 (41%), Gaps = 19/132 (14%)

Query: 237 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEG 296
           + +  H NI++ Y    D    + +V +L  GG + + ++  R  +  +  RI  DV   
Sbjct: 60  MKSLDHPNIIRLYETFEDNTD-IYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSA 118

Query: 297 IKFLNDHGVAYRDLNSQRILL---DRHGNVCLGDMGIVTACKS-------VGEATEYETD 346
           + + +   VA+RDL  +  L         + L D G+    K        VG      T 
Sbjct: 119 VAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVG------TP 172

Query: 347 GYRWLAPEIIAG 358
            Y  ++P+++ G
Sbjct: 173 YY--VSPQVLEG 182

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 48.9 bits (117), Expect = 2e-06
 Identities = 52/224 (23%), Positives = 92/224 (41%), Gaps = 57/224 (25%)

Query: 193 EFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEF---------ELRKDLLEL 237
             +  +G  ++  V        G +V I+KL        ++          ELR  LL+ 
Sbjct: 28  RDLQPVGSGAYGAVCSAVDGRTGAKVAIKKL-----YRPFQSELFAKRAYRELR--LLKH 80

Query: 238 MTCGHKNILQFYCV-----CVDENHGLCVVTKLMEGGSVNDL--ILKSRKLQTKEIIRIA 290
           M   H+N++    V      +D+     +V   M      DL  ++K  KL    I  + 
Sbjct: 81  MR--HENVIGLLDVFTPDETLDDFTDFYLVMPFMG----TDLGKLMKHEKLGEDRIQFLV 134

Query: 291 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY-ETDGYR 349
             + +G+++++  G+ +RDL    + ++    + + D G+  A ++  E T Y  T  YR
Sbjct: 135 YQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGL--ARQADSEMTGYVVTRWYR 192

Query: 350 WLAPEIIAGDPESVSETWMSNVYSFGMVIW-------EMVTGEA 386
             APE+I          WM   Y+  + IW       EM+TG+ 
Sbjct: 193 --APEVILN--------WMR--YTQTVDIWSVGCIMAEMITGKT 224

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 48.8 bits (117), Expect = 2e-06
 Identities = 49/224 (21%), Positives = 89/224 (39%), Gaps = 52/224 (23%)

Query: 190 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFE------LR--KDLL 235
           +  E +  +G  S+  V K      G+ V I+K        + + +      +R  K L 
Sbjct: 25  EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFL-----ESDDDKMVKKIAMREIKLLK 79

Query: 236 ELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDL--ILKSRK--LQTKEIIRIAI 291
           +L    H+N++    VC  +     +V + ++    + +   L+     L  + + +   
Sbjct: 80  QL---RHENLVNLLEVCKKKKR-WYLVFEFVD----HTILDDLELFPNGLDYQVVQKYLF 131

Query: 292 DVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA-TEY-ETDGYR 349
            +  GI F + H + +RD+  + IL+ + G V L D G      + GE   +   T  YR
Sbjct: 132 QIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYR 191

Query: 350 WLAPEIIAGDPESVSETWMSNVYSFGMVIW-------EMVTGEA 386
             APE++ GD +          Y   + +W       EM  GE 
Sbjct: 192 --APELLVGDVK----------YGKAVDVWAIGCLVTEMFMGEP 223

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 48.5 bits (116), Expect = 2e-06
 Identities = 45/209 (21%), Positives = 77/209 (36%), Gaps = 30/209 (14%)

Query: 241 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL 300
           GH  +++       +   + V+ + +    + D I +   L           V   I+  
Sbjct: 96  GHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHC 155

Query: 301 NDHGVAYRDLNSQRILLD-RHGNVCLGDMGIVTACKSVGEATEYET-DG---YRWLAPEI 355
           +  GV +RD+  + IL+D R G   L D G      ++     Y   DG   Y    PE 
Sbjct: 156 HSRGVVHRDIKDENILIDLRRGCAKLIDFG----SGALLHDEPYTDFDGTRVY--SPPEW 209

Query: 356 IAGD----PESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPK 411
           I+               + V+S G+++++MV G+       P +    I    L    P 
Sbjct: 210 ISRHQYHALP-------ATVWSLGILLYDMVCGDI------PFERDQEILEAELH--FPA 254

Query: 412 DCPQILKSLMIKCWNNSPSKRPQFSEIIS 440
                  +L+ +C    PS RP   EI+ 
Sbjct: 255 HVSPDCCALIRRCLAPKPSSRPSLEEILL 283

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 48.3 bits (116), Expect = 2e-06
 Identities = 54/224 (24%), Positives = 92/224 (41%), Gaps = 53/224 (23%)

Query: 190 DNLEFIDQIGPNSFKGVYK-----GKRVGIEKLKGCDKGNAYEFELRKD------LLE-- 236
           +  + ++++G  ++  VYK     G+ V +++++          +   +      + E  
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIR---------LDAEDEGIPSTAIREIS 71

Query: 237 -LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDL--ILKSRK--LQTKEIIRIAI 291
            L    H NI+    V   E   L +V + ME     DL  +L   K  LQ  +I     
Sbjct: 72  LLKELHHPNIVSLIDVIHSERC-LTLVFEFME----KDLKKVLDENKTGLQDSQIKIYLY 126

Query: 292 DVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS-VGEAT-EYETDGYR 349
            +  G+   + H + +RDL  Q +L++  G + L D G+  A    V   T E  T  YR
Sbjct: 127 QLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYR 186

Query: 350 WLAPEIIAGDPESVSETWMSNVYSFGMVIW-------EMVTGEA 386
             AP+++ G          S  YS  + IW       EM+TG+ 
Sbjct: 187 --APDVLMG----------SKKYSTSVDIWSIGCIFAEMITGKP 218

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 48.3 bits (116), Expect = 2e-06
 Identities = 53/224 (23%), Positives = 93/224 (41%), Gaps = 53/224 (23%)

Query: 190 DNLEFIDQIGPNSFKGVYK-----GKRVGIEKLKGCDKGNAYEFELRKD------LLE-- 236
           +    +++IG  ++  VYK     G+   ++K++          E   +      + E  
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIR---------LEKEDEGIPSTTIREIS 52

Query: 237 -LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDL--ILKSRK--LQTKEIIRIAI 291
            L    H NI++ Y V   +   L +V + ++     DL  +L   +  L++       +
Sbjct: 53  ILKELKHSNIVKLYDVIHTKKR-LVLVFEHLD----QDLKKLLDVCEGGLESVTAKSFLL 107

Query: 292 DVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS-VGEAT-EYETDGYR 349
            +  GI + +D  V +RDL  Q +L++R G + + D G+  A    V + T E  T  YR
Sbjct: 108 QLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYR 167

Query: 350 WLAPEIIAGDPESVSETWMSNVYSFGMVIW-------EMVTGEA 386
             AP+++ G          S  YS  + IW       EMV G  
Sbjct: 168 --APDVLMG----------SKKYSTTIDIWSVGCIFAEMVNGTP 199

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 48.1 bits (115), Expect = 3e-06
 Identities = 40/187 (21%), Positives = 81/187 (43%), Gaps = 25/187 (13%)

Query: 189 SDNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGH 242
           ++    +  +G  SF  V K       +   ++ +      N     + +++  L    H
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80

Query: 243 KNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLND 302
            NI++ + +  D +    +V +L  GG + D I+K ++    +  RI   V  GI +++ 
Sbjct: 81  PNIMKLFEILEDSSS-FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHK 139

Query: 303 HGVAYRDLNSQRILL---DRHGNVCLGDMGIVTACKS-------VGEATEYETDGYRWLA 352
           H + +RDL  + ILL   ++  ++ + D G+ T  +        +G      T  Y  +A
Sbjct: 140 HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIG------TAYY--IA 191

Query: 353 PEIIAGD 359
           PE++ G 
Sbjct: 192 PEVLRGT 198

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 47.7 bits (114), Expect = 3e-06
 Identities = 33/135 (24%), Positives = 58/135 (42%), Gaps = 12/135 (8%)

Query: 235 LELMTCGHKNILQFYCVCVDENHG---LCVVTKLMEGGSVNDLILKSRKLQT---KEIIR 288
                 G  +I+    V  + +HG   L ++ + MEGG +   I + R  Q    +E   
Sbjct: 74  HHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQE-RGDQAFTEREAAE 132

Query: 289 IAIDVAEGIKFLNDHGVAYRDLNSQRILL---DRHGNVCLGDMGIVTACKSVGEATEYET 345
           I  D+   I+FL+ H +A+RD+  + +L    ++   + L D G           T   T
Sbjct: 133 IMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYT 192

Query: 346 DGYRWLAPEIIAGDP 360
             Y  +APE++  + 
Sbjct: 193 PYY--VAPEVLGPEK 205

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 48.1 bits (115), Expect = 3e-06
 Identities = 26/156 (16%), Positives = 58/156 (37%), Gaps = 12/156 (7%)

Query: 214 IEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVND 273
           ++  K          +L+++        H +I++       +   L +V + M+G  +  
Sbjct: 57  VDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGM-LYMVFEFMDGADLCF 115

Query: 274 LILKSRKLQT----KEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILL---DRHGNVCLG 326
            I+K                   + E +++ +D+ + +RD+    +LL   +    V LG
Sbjct: 116 EIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLG 175

Query: 327 DMGIVTACKSVGEA--TEYETDGYRWLAPEIIAGDP 360
             G+       G        T  +  +APE++  +P
Sbjct: 176 GFGVAIQLGESGLVAGGRVGTPHF--MAPEVVKREP 209

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 48.2 bits (115), Expect = 3e-06
 Identities = 43/210 (20%), Positives = 89/210 (42%), Gaps = 28/210 (13%)

Query: 193 EFIDQIGPNSFKGVYK------GKRVGIEKLKGCDK-GNAYEFELRKDLLELM----TCG 241
           E +  IG  SF  V K       + V ++ ++   +       E+R  +LE +       
Sbjct: 100 EVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIR--ILEHLRKQDKDN 157

Query: 242 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKF 299
             N++         NH +C+  +L+   ++ +LI K+  +      + + A  + + +  
Sbjct: 158 TMNVIHMLENFTFRNH-ICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDA 215

Query: 300 LNDHGVAYRDLNSQRILL--DRHGNVCLGDMGIVTACKSVGEATEY-ETDGYRWLAPEII 356
           L+ + + + DL  + ILL       + + D G  ++C        Y ++  YR  APE+I
Sbjct: 216 LHKNRIIHCDLKPENILLKQQGRSGIKVIDFG--SSCYEHQRVYTYIQSRFYR--APEVI 271

Query: 357 AGDPESVSETWMSNVYSFGMVIWEMVTGEA 386
            G    +      +++S G ++ E++TG  
Sbjct: 272 LGARYGMP----IDMWSLGCILAELLTGYP 297

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 47.7 bits (114), Expect = 4e-06
 Identities = 50/227 (22%), Positives = 86/227 (37%), Gaps = 59/227 (25%)

Query: 193 EFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEF---------ELRKDLLEL 237
             +  IG  ++  V          RV I+K+      + +E          E++  +L  
Sbjct: 30  TNLSYIGEGAYGMVCSAYDNLNKVRVAIKKI------SPFEHQTYCQRTLREIK--ILLR 81

Query: 238 MTCGHKNILQ----FYCVCVDENHGLCVVTKLMEGGSVNDL--ILKSRKLQTKEIIRIAI 291
               H+NI+          +++   + +V  LME     DL  +LK++ L    I     
Sbjct: 82  FR--HENIIGINDIIRAPTIEQMKDVYIVQDLME----TDLYKLLKTQHLSNDHICYFLY 135

Query: 292 DVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMG----IVTACKSVGEATEY-ETD 346
            +  G+K+++   V +RDL    +LL+   ++ + D G            G  TEY  T 
Sbjct: 136 QILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 195

Query: 347 GYRWLAPEIIAGDPESVSETWMSNVYSFGMVIW-------EMVTGEA 386
            YR  APEI+            S  Y+  + IW       EM++   
Sbjct: 196 WYR--APEIMLN----------SKGYTKSIDIWSVGCILAEMLSNRP 230

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 46.9 bits (112), Expect = 7e-06
 Identities = 34/221 (15%), Positives = 78/221 (35%), Gaps = 51/221 (23%)

Query: 188 NSDNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCG 241
           N D+ + + ++G   +  V++       ++V ++ LK   K      E++  +LE +  G
Sbjct: 34  NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKR-EIK--ILENL-RG 89

Query: 242 HKNILQFYCVCVDENHGLC--VVTKLMEGGSVNDL-----ILKSRKLQ--TKEIIRIAID 292
             NI+    +  D        V   +       D       L    ++    EI++    
Sbjct: 90  GPNIITLADIVKDPVSRTPALVFEHVNN----TDFKQLYQTLTDYDIRFYMYEILK---- 141

Query: 293 VAEGIKFLNDHGVAYRDLNSQRILLDR-HGNVCLGDMGIVTACKSVGEATEY-ETDGYRW 350
               + + +  G+ +RD+    +++D  H  + L D G+        E      +  ++ 
Sbjct: 142 ---ALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFK- 197

Query: 351 LAPEIIAGDPESVSETWMSNVYSFGMVIW-------EMVTG 384
             PE++              +Y + + +W        M+  
Sbjct: 198 -GPELLVD----------YQMYDYSLDMWSLGCMLASMIFR 227

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 46.1 bits (110), Expect = 1e-05
 Identities = 51/224 (22%), Positives = 90/224 (40%), Gaps = 58/224 (25%)

Query: 193 EFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEF---------ELRKDLLEL 237
                +G  ++  V        G++V I+KL        ++          EL   LL+ 
Sbjct: 27  VSPTHVGSGAYGSVCSAIDKRSGEKVAIKKL-----SRPFQSEIFAKRAYRELL--LLKH 79

Query: 238 MTCGHKNILQFYCV-----CVDENHGLCVVTKLMEGGSVNDL--ILKSRKLQTKEIIRIA 290
           M   H+N++    V      +   +   +V   M+     DL  I+   K   ++I  + 
Sbjct: 80  MQ--HENVIGLLDVFTPASSLRNFYDFYLVMPFMQ----TDLQKIMGL-KFSEEKIQYLV 132

Query: 291 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY-ETDGYR 349
             + +G+K+++  GV +RDL    + ++    + + D G+  A  +  E T Y  T  YR
Sbjct: 133 YQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGL--ARHADAEMTGYVVTRWYR 190

Query: 350 WLAPEIIAGDPESVSETWMSNVYSFGMVIW-------EMVTGEA 386
             APE+I          WM   Y+  + IW       EM+TG+ 
Sbjct: 191 --APEVILS--------WMH--YNQTVDIWSVGCIMAEMLTGKT 222

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 45.8 bits (109), Expect = 1e-05
 Identities = 47/224 (20%), Positives = 86/224 (38%), Gaps = 57/224 (25%)

Query: 193 EFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEF---------ELRKDLLEL 237
           + +  IG  +   V         + V I+KL        ++          EL   L++ 
Sbjct: 28  QNLKPIGSGAQGIVCAAYDAILERNVAIKKL-----SRPFQNQTHAKRAYRELV--LMKC 80

Query: 238 MTCGHKNILQFYCV-----CVDENHGLCVVTKLMEGGSVNDL--ILKSRKLQTKEIIRIA 290
           +   HKNI+    V      ++E   + +V +LM+     +L  +++  +L  + +  + 
Sbjct: 81  V--NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD----ANLCQVIQM-ELDHERMSYLL 133

Query: 291 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY-ETDGYR 349
             +  GIK L+  G+ +RDL    I++     + + D G+     +    T Y  T  YR
Sbjct: 134 YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYR 193

Query: 350 WLAPEIIAGDPESVSETWMSNVYSFGMVIW-------EMVTGEA 386
             APE+I           +   Y   + IW       EM+ G  
Sbjct: 194 --APEVI-----------LGMGYKENVDIWSVGCIMGEMIKGGV 224

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 45.3 bits (108), Expect = 2e-05
 Identities = 27/155 (17%), Positives = 62/155 (40%), Gaps = 22/155 (14%)

Query: 242 HKNILQFYCVCVDENHG-LCVVTKLMEGGSVN--DLILKSRKLQTKEIIRIAIDVAEGIK 298
           HKN++Q   V  +E    + +V +    G     D + + ++    +       + +G++
Sbjct: 65  HKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPE-KRFPVCQAHGYFCQLIDGLE 123

Query: 299 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETD----GYRWLAPE 354
           +L+  G+ ++D+    +LL   G + +  +G+  A           T      +    PE
Sbjct: 124 YLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAF--QPPE 181

Query: 355 IIAGD-----PESVSETWMSNVYSFGMVIWEMVTG 384
           I  G       +        +++S G+ ++ + TG
Sbjct: 182 IANGLDTFSGFK-------VDIWSAGVTLYNITTG 209

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 44.8 bits (107), Expect = 2e-05
 Identities = 44/222 (19%), Positives = 88/222 (39%), Gaps = 54/222 (24%)

Query: 190 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKD------LLE- 236
              E +++IG  ++  V+K       + V +++++          +   +      L E 
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR---------LDDDDEGVPSSALREI 52

Query: 237 --LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDL--ILKSRK--LQTKEIIRIA 290
             L    HKNI++ + V   +   L +V +  +     DL     S    L  + +    
Sbjct: 53  CLLKELKHKNIVRLHDVLHSDKK-LTLVFEFCD----QDLKKYFDSCNGDLDPEIVKSFL 107

Query: 291 IDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS-VGEAT-EYETDGY 348
             + +G+ F +   V +RDL  Q +L++R+G + L + G+  A    V   + E  T  Y
Sbjct: 108 FQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWY 167

Query: 349 RWLAPEIIAGDPESVSETWMSNVYSFGMVIW-------EMVT 383
           R   P+++ G          + +YS  + +W       E+  
Sbjct: 168 R--PPDVLFG----------AKLYSTSIDMWSAGCIFAELAN 197

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 44.9 bits (107), Expect = 3e-05
 Identities = 28/137 (20%), Positives = 56/137 (40%), Gaps = 23/137 (16%)

Query: 237 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQT----KEIIRIAID 292
           L +  H NI++ + V  D ++ + +V +  EGG + + I+ ++          +  +   
Sbjct: 74  LKSLDHPNIIKIFEVFEDYHN-MYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQ 132

Query: 293 VAEGIKFLNDHGVAYRDLNSQRILL---DRHGNVCLGDMGIVTACKS-------VGEATE 342
           +   + + +   V ++DL  + IL      H  + + D G+    KS        G    
Sbjct: 133 MMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAG---- 188

Query: 343 YETDGYRWLAPEIIAGD 359
             T  Y  +APE+   D
Sbjct: 189 --TALY--MAPEVFKRD 201

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 44.9 bits (107), Expect = 3e-05
 Identities = 55/230 (23%), Positives = 99/230 (43%), Gaps = 58/230 (25%)

Query: 189 SDNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFE-------LR--KD 233
           S   + ++++G  ++  VYK      G  V ++++K        + E       +R    
Sbjct: 4   SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVK-------LDSEEGTPSTAIREISL 56

Query: 234 LLELMTCGHKNILQFYCVCVDENHGLCVV--------TKLMEGGSVNDLILKSRKLQTKE 285
           + EL    H+NI++ Y V   EN  L +V         K M+  +V +     R L+   
Sbjct: 57  MKEL---KHENIVRLYDVIHTENK-LTLVFEFMDNDLKKYMDSRTVGN---TPRGLELNL 109

Query: 286 IIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS-VGEAT-EY 343
           +      + +G+ F +++ + +RDL  Q +L+++ G + LGD G+  A    V   + E 
Sbjct: 110 VKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEV 169

Query: 344 ETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIW-------EMVTGEA 386
            T  YR  AP+++ G             YS  + IW       EM+TG+ 
Sbjct: 170 VTLWYR--APDVLMGSRT----------YSTSIDIWSCGCILAEMITGKP 207

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 45.2 bits (107), Expect = 3e-05
 Identities = 40/172 (23%), Positives = 68/172 (39%), Gaps = 35/172 (20%)

Query: 229 ELRKDLLELMTCGHKNILQFYCV-----CVDENHGLCVVTKLMEGGSVNDLILKSRKLQT 283
           EL   L++ +   HKNI+    V      ++E   + +V +LM+     +L    +    
Sbjct: 111 ELV--LMKCV--NHKNIISLLNVFTPQKTLEEFQDVYLVMELMD----ANLCQVIQMELD 162

Query: 284 KEIIR-IAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE 342
            E +  +   +  GIK L+  G+ +RDL    I++     + + D G+     +    T 
Sbjct: 163 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP 222

Query: 343 Y-ETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIW-------EMVTGEA 386
           Y  T  YR  APE+I           +   Y   + IW       EMV  + 
Sbjct: 223 YVVTRYYR--APEVI-----------LGMGYKENVDIWSVGCIMGEMVRHKI 261

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 44.5 bits (106), Expect = 4e-05
 Identities = 50/229 (21%), Positives = 86/229 (37%), Gaps = 58/229 (25%)

Query: 190 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKD------LLE- 236
           D    I ++G  ++  VYK       + V I++++          E  ++      + E 
Sbjct: 34  DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIR---------LEHEEEGVPGTAIREV 84

Query: 237 --LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDL---ILKSRKLQTKEIIRIAI 291
             L    H+NI++   V    +  L ++ +  E    NDL   + K+  +  + I     
Sbjct: 85  SLLKELQHRNIIELKSVIHHNHR-LHLIFEYAE----NDLKKYMDKNPDVSMRVIKSFLY 139

Query: 292 DVAEGIKFLNDHGVAYRDLNSQRILLD-----RHGNVCLGDMGIVTACKS-VGEAT-EYE 344
            +  G+ F +     +RDL  Q +LL          + +GD G+  A    + + T E  
Sbjct: 140 QLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII 199

Query: 345 TDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIW-------EMVTGEA 386
           T  YR   PEI+ G          S  YS  + IW       EM+    
Sbjct: 200 TLWYR--PPEILLG----------SRHYSTSVDIWSIACIWAEMLMKTP 236

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 44.4 bits (105), Expect = 5e-05
 Identities = 41/249 (16%), Positives = 80/249 (32%), Gaps = 62/249 (24%)

Query: 193 EFIDQIGPNSFKGVYKGKRVG---------IEKLKGCDKGNAYEFELRKDLLELMTCGHK 243
                IG  S+  V                + K K           ++ ++  +    H 
Sbjct: 29  HLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHP 88

Query: 244 NILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQT-------------------- 283
           NI + Y V  DE + +C+V +L  GG + D +       T                    
Sbjct: 89  NIARLYEVYEDEQY-ICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNE 147

Query: 284 --------------------KEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILL--DRHG 321
                               K I  I   +   + +L++ G+ +RD+  +  L   ++  
Sbjct: 148 EAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSF 207

Query: 322 NVCLGDMGIVTACKSVGEATEYE------TDGYRWLAPEIIAGDPESVSETWMSNVYSFG 375
            + L D G+      +     Y       T  +  +APE++    ES       + +S G
Sbjct: 208 EIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYF--VAPEVLNTTNESYGP--KCDAWSAG 263

Query: 376 MVIWEMVTG 384
           +++  ++ G
Sbjct: 264 VLLHLLLMG 272

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 44.2 bits (105), Expect = 5e-05
 Identities = 44/220 (20%), Positives = 83/220 (37%), Gaps = 52/220 (23%)

Query: 195 IDQIGPNSFKGVYKGK-----RVGIEKLKGCDKGNAYEFELRK-DLLELMTCGHKNILQF 248
              IG  SF  V++ K      V I+K+   DK     F+ R+  ++ ++   H N++  
Sbjct: 45  CKVIGNGSFGVVFQAKLVESDEVAIKKVLQ-DK----RFKNRELQIMRIVK--HPNVVDL 97

Query: 249 YCV------CVDENHGLCVVTKLMEGGSVNDL--ILKSRKLQTKEIIRIAIDV-----AE 295
                      DE   L +V + +       +    +      + +  + I +       
Sbjct: 98  KAFFYSNGDKKDEVF-LNLVLEYVP----ETVYRASRHYAKLKQTMPMLLIKLYMYQLLR 152

Query: 296 GIKFLNDHGVAYRDLNSQRILLDRH-GNVCLGDMGIVTACKSVGEATEY-ETDGYRWLAP 353
            + +++  G+ +RD+  Q +LLD   G + L D G      +      Y  +  YR  AP
Sbjct: 153 SLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYR--AP 210

Query: 354 EIIAGDPESVSETWMSNVYSFGMVIW-------EMVTGEA 386
           E+I G          +  Y+  + IW       E++ G+ 
Sbjct: 211 ELIFG----------ATNYTTNIDIWSTGCVMAELMQGQP 240

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 44.3 bits (105), Expect = 5e-05
 Identities = 33/150 (22%), Positives = 58/150 (38%), Gaps = 21/150 (14%)

Query: 195 IDQIGPNSFKGVYKGKRVG--------IEKLKGCDKGNAYEFELRKDLLELMTCGHKNIL 246
             +IG  +F  +  GK +         +E +K        E+   K L          I 
Sbjct: 14  GKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQL-----GSGDGIP 68

Query: 247 QFYCVCVDENHGLCVVTKLMEGGSVNDLI-LKSRKLQTKEIIRIAIDVAEGIKFLNDHGV 305
           Q Y       +   V+  L  G S+ DL  L  R    K ++ IAI +   +++++   +
Sbjct: 69  QVYYFGPCGKYNAMVLELL--GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNL 126

Query: 306 AYRDLNSQRILLDRHGN-----VCLGDMGI 330
            YRD+  +  L+ R GN     + + D  +
Sbjct: 127 IYRDVKPENFLIGRPGNKTQQVIHIIDFAL 156

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 44.0 bits (104), Expect = 6e-05
 Identities = 46/233 (19%), Positives = 88/233 (37%), Gaps = 54/233 (23%)

Query: 190 DNLEFID-QIGPNSFKGVYK--------GKRVGIEKLK--GCDKGNAYEFELRKDLLELM 238
           D  E+   ++G  ++  VYK         K   +++++  G       E  L   L EL 
Sbjct: 20  DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIAL---LRELK 76

Query: 239 TCGHKNILQFYCVCVD-ENHGLCVV--------TKLMEGGSVNDLILKSRKLQTKEIIRI 289
              H N++    V +   +  + ++          +++    +    K  +L    +  +
Sbjct: 77  ---HPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSL 133

Query: 290 AIDVAEGIKFLNDHGVAYRDLNSQRILL----DRHGNVCLGDMGIVTACKS-VGEATEYE 344
              + +GI +L+ + V +RDL    IL+       G V + DMG      S +    + +
Sbjct: 134 LYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLD 193

Query: 345 ----TDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIW-------EMVTGEA 386
               T  YR  APE++ G          +  Y+  + IW       E++T E 
Sbjct: 194 PVVVTFWYR--APELLLG----------ARHYTKAIDIWAIGCIFAELLTSEP 234

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 44.0 bits (104), Expect = 6e-05
 Identities = 28/136 (20%), Positives = 53/136 (38%), Gaps = 25/136 (18%)

Query: 241 GHKNILQFYCVCVDENHG---LCVVTKLMEGGSVNDLILKSRKLQT---KEIIRIAIDVA 294
              +I++   V  +   G   L +V + ++GG +   I   R  Q    +E   I   + 
Sbjct: 113 QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQD-RGDQAFTEREASEIMKSIG 171

Query: 295 EGIKFLNDHGVAYRDLNSQRILL---DRHGNVCLGDMGIVTACKS-------VGEATEYE 344
           E I++L+   +A+RD+  + +L      +  + L D G      S               
Sbjct: 172 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY------ 225

Query: 345 TDGYRWLAPEIIAGDP 360
           T  Y  +APE++  + 
Sbjct: 226 TPYY--VAPEVLGPEK 239

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 44.2 bits (104), Expect = 6e-05
 Identities = 33/148 (22%), Positives = 60/148 (40%), Gaps = 19/148 (12%)

Query: 195 IDQIGPNSFKGVYKGKRVG--------IEKLKGCDKGNAYEFELRKDLLELMTCGHKNIL 246
             +IG  SF  +Y G  +         +E +K       YE ++ + L      G   I 
Sbjct: 12  GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQ-----GGTGIP 66

Query: 247 QFYCVCVDENHGLCVVTKLMEGGSVNDLI-LKSRKLQTKEIIRIAIDVAEGIKFLNDHGV 305
                 V+ ++ + V+  L  G S+ DL    SRKL  K ++ +A  +   ++F++    
Sbjct: 67  NVRWFGVEGDYNVLVMDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSF 124

Query: 306 AYRDLNSQRILLDRHGN---VCLGDMGI 330
            +RD+     L+        V + D G+
Sbjct: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGL 152

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 43.9 bits (104), Expect = 7e-05
 Identities = 44/222 (19%), Positives = 83/222 (37%), Gaps = 53/222 (23%)

Query: 193 EFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRK-DLLELMTCGHKNI 245
                IG  SF  VY+      G+ V I+K+   DK     F+ R+  ++  +   H NI
Sbjct: 57  TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-DK----RFKNRELQIMRKLD--HCNI 109

Query: 246 LQFYCV------CVDENHGLCVVTKLMEGGSVNDL--ILKSRKLQTKEIIRIAID----- 292
           ++            DE + L +V   +       +  + +      + +  I +      
Sbjct: 110 VRLRYFFYSSGEKKDEVY-LNLVLDYVP----ETVYRVARHYSRAKQTLPVIYVKLYMYQ 164

Query: 293 VAEGIKFLNDHGVAYRDLNSQRILLDRH-GNVCLGDMGIVTACKSVGEATEY-ETDGYRW 350
           +   + +++  G+ +RD+  Q +LLD     + L D G             Y  +  YR 
Sbjct: 165 LFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYR- 223

Query: 351 LAPEIIAGDPESVSETWMSNVYSFGMVIW-------EMVTGE 385
            APE+I G          +  Y+  + +W       E++ G+
Sbjct: 224 -APELIFG----------ATDYTSSIDVWSAGCVLAELLLGQ 254

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 43.1 bits (102), Expect = 1e-04
 Identities = 25/121 (20%), Positives = 50/121 (41%), Gaps = 8/121 (6%)

Query: 242 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 301
           H NI++F  V +   H L ++ +   GG + + I  + +    E       +  G+ + +
Sbjct: 75  HPNIVRFKEVILTPTH-LAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCH 133

Query: 302 DHGVAYRDLNSQRILLDRH--GNVCLGDMGIVTACKSVGEA--TEYETDGYRWLAPEIIA 357
              + +RDL  +  LLD      + + D G  +    +     +   T  Y  +APE++ 
Sbjct: 134 SMQICHRDLKLENTLLDGSPAPRLKICDFGY-SKSSVLHSQPKSTVGTPAY--IAPEVLL 190

Query: 358 G 358
            
Sbjct: 191 R 191

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 43.1 bits (102), Expect = 1e-04
 Identities = 30/148 (20%), Positives = 57/148 (38%), Gaps = 19/148 (12%)

Query: 195 IDQIGPNSFKGVYKGKRVG--------IEKLKGCDKGNAYEFELRKDLLELMTCGHKNIL 246
             +IG  SF  +Y G  +         +E +K        E ++ K +      G   I 
Sbjct: 14  GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQ-----GGVGIP 68

Query: 247 QFYCVCVDENHGLCVVTKLMEGGSVNDLI-LKSRKLQTKEIIRIAIDVAEGIKFLNDHGV 305
                  + ++ + V+  L  G S+ DL    SRK   K ++ +A  +   I++++    
Sbjct: 69  TIRWCGAEGDYNVMVMELL--GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNF 126

Query: 306 AYRDLNSQRILLDRHGN---VCLGDMGI 330
            +RD+     L+        V + D G+
Sbjct: 127 IHRDVKPDNFLMGLGKKGNLVYIIDFGL 154

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 42.8 bits (101), Expect = 2e-04
 Identities = 47/210 (22%), Positives = 92/210 (43%), Gaps = 26/210 (12%)

Query: 193 EFIDQIGPNSFKGVYK------GKRVGIEKLKGCDK-GNAYEFELR--KDLLELMTCGHK 243
           E    IG  SF  V K       + V I+ +K      N  + E+R  + + +  T    
Sbjct: 57  EIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKY 116

Query: 244 NILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK--LQTKEIIRIAIDVAEGIKFL- 300
            I+      +  NH LC+V +++   ++ DL+  +    +      + A  +   + FL 
Sbjct: 117 YIVHLKRHFMFRNH-LCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLA 174

Query: 301 -NDHGVAYRDLNSQRILL--DRHGNVCLGDMGIVTACKSVGEATEY-ETDGYRWLAPEII 356
             +  + + DL  + ILL   +   + + D G  ++C+      +Y ++  YR  +PE++
Sbjct: 175 TPELSIIHCDLKPENILLCNPKRSAIKIVDFG--SSCQLGQRIYQYIQSRFYR--SPEVL 230

Query: 357 AGDPESVSETWMSNVYSFGMVIWEMVTGEA 386
            G P  ++     +++S G ++ EM TGE 
Sbjct: 231 LGMPYDLA----IDMWSLGCILVEMHTGEP 256

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 42.9 bits (101), Expect = 2e-04
 Identities = 49/313 (15%), Positives = 101/313 (32%), Gaps = 92/313 (29%)

Query: 189 SDNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKD----LLELM 238
            D  E    IG  S+  V +       + V I+K+          FE   D    L E+ 
Sbjct: 52  PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILR-------VFEDLIDCKRILREIA 104

Query: 239 ---TCGHKNILQFYCVCV----DENHGLCVVTKLMEGGSVNDL--ILKSRKLQTKEIIR- 288
                 H ++++   + +    ++   L VV ++ +    +D   + ++    T+  I+ 
Sbjct: 105 ILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIAD----SDFKKLFRTPVYLTELHIKT 160

Query: 289 IAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMG------------------- 329
           +  ++  G+K+++  G+ +RDL     L+++  +V + D G                   
Sbjct: 161 LLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISP 220

Query: 330 ---------IVTACKSVGEATEY-ETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIW 379
                             + T +  T  YR  APE+I               Y+  + +W
Sbjct: 221 REDDMNLVTFPHTKNLKRQLTGHVVTRWYR--APELILL----------QENYTEAIDVW 268

Query: 380 -------EMVTGEAAYAACSPVQAAVGIAACGLRPEIP-KDCPQILKSLMIKCWNNSPSK 431
                  E++       A    +           P  P   C  +             ++
Sbjct: 269 SIGCIFAELLNMIKENVAYHADR----------GPLFPGSSCFPLSPDQKAGNDFKFHTR 318

Query: 432 RP--QFSEIISLL 442
               Q + I ++L
Sbjct: 319 GNRDQLNVIFNIL 331

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 41.6 bits (98), Expect = 3e-04
 Identities = 31/151 (20%), Positives = 57/151 (37%), Gaps = 21/151 (13%)

Query: 194 FIDQIGPNSFKGVYKGKRVG--------IEKLKGCDKGNAYEFELRKDLLELMTCGHKNI 245
              +IG  SF  +++G  +          E  +        E+   K L      G   I
Sbjct: 14  VGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLL-----AGCTGI 68

Query: 246 LQFYCVCVDENHGLCVVTKLMEGGSVNDLI-LKSRKLQTKEIIRIAIDVAEGIKFLNDHG 304
              Y    +  H + V+  L  G S+ DL+ L  RK   K +   A  +   ++ +++  
Sbjct: 69  PNVYYFGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS 126

Query: 305 VAYRDLNSQRILLDRHGN-----VCLGDMGI 330
           + YRD+     L+ R  +     + + D G+
Sbjct: 127 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGM 157

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 41.5 bits (98), Expect = 3e-04
 Identities = 34/184 (18%), Positives = 70/184 (38%), Gaps = 48/184 (26%)

Query: 229 ELRKDLLELMTCGHKNILQFY-------------CVCVDENHGLCVVTKLMEGGSVNDL- 274
           E++  ++  +   H NI++ +                + E + + +V + ME     DL 
Sbjct: 58  EIK--IIRRL--DHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME----TDLA 109

Query: 275 -ILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG-NVCLGDMG--- 329
            +L+   L  +        +  G+K+++   V +RDL    + ++     + +GD G   
Sbjct: 110 NVLEQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLAR 169

Query: 330 -IVTACKSVGEATEY-ETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIW-------E 380
            +       G  +E   T  YR  +P ++             N Y+  + +W       E
Sbjct: 170 IMDPHYSHKGHLSEGLVTKWYR--SPRLLLS----------PNNYTKAIDMWAAGCIFAE 217

Query: 381 MVTG 384
           M+TG
Sbjct: 218 MLTG 221

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 41.1 bits (97), Expect = 4e-04
 Identities = 16/78 (20%), Positives = 35/78 (44%), Gaps = 11/78 (14%)

Query: 241 GHKNILQFYCVCVDENHG---LCVVTKLMEGGSVNDLILKSRKL-----QTKEIIRIAID 292
              +I++   V  +   G   L +V + ++GG +   I           +  EI++    
Sbjct: 69  QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMK---S 125

Query: 293 VAEGIKFLNDHGVAYRDL 310
           + E I++L+   +A+RD+
Sbjct: 126 IGEAIQYLHSINIAHRDV 143

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 40.3 bits (95), Expect = 8e-04
 Identities = 33/183 (18%), Positives = 65/183 (35%), Gaps = 45/183 (24%)

Query: 229 ELRKDLLELMTCGHKNILQ----FYCVCVDENHGLCVVTKLMEGGSVNDL--ILKSRKLQ 282
           E++  +L+     H+NI+           +  + + ++ +LM+     DL  ++ ++ L 
Sbjct: 59  EIK--ILKHFK--HENIITIFNIQRPDSFENFNEVYIIQELMQ----TDLHRVISTQMLS 110

Query: 283 TKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMG-----------IV 331
              I          +K L+   V +RDL    +L++ + ++ + D G             
Sbjct: 111 DDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNS 170

Query: 332 TACKSVGEATEY-ETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIW-------EMVT 383
                     E+  T  YR  APE++            S  YS  M +W       E+  
Sbjct: 171 EPTGQQSGMVEFVATRWYR--APEVMLT----------SAKYSRAMDVWSCGCILAELFL 218

Query: 384 GEA 386
              
Sbjct: 219 RRP 221

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 40.4 bits (95), Expect = 8e-04
 Identities = 28/167 (16%), Positives = 60/167 (35%), Gaps = 30/167 (17%)

Query: 241 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK--LQTKEIIRIAIDVAEGIK 298
                +          H +C+  +L+ G +  + + ++         +  +A  +   ++
Sbjct: 80  NKFLCVLMSDWFNFHGH-MCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALR 137

Query: 299 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV----------GEATEYETDG- 347
           FL+++ + + DL  + IL        L +       KSV          G AT ++ +  
Sbjct: 138 FLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSAT-FDHEHH 196

Query: 348 --------YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEA 386
                   YR   PE+I     +       +V+S G +++E   G  
Sbjct: 197 TTIVATRHYR--PPEVILELGWAQP----CDVWSIGCILFEYYRGFT 237

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	454
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.97
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.93
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.88
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.79
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.62
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.18
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.01
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.93
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.79
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.54
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.28
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	97.91
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	97.9
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.73
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.65
3ats_A	357	Putative uncharacterized protein; hypothetical pro	97.5
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.4
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.26
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.11
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	96.67
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	96.65
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	95.46
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	95.26
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	94.38
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	94.19
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	90.16
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	88.34
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	84.42
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	84.32

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=4.2e-59  Score=462.14  Aligned_cols=269  Identities=29%  Similarity=0.481  Sum_probs=224.7

Q ss_pred             cceeecCCCEEEeceeeccCCceEEEeE---EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeE
Q 012887          183 GRWLLNSDNLEFIDQIGPNSFKGVYKGK---RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGL  259 (454)
Q Consensus       183 ~~~~~~~~~~~~~~~LG~G~fG~Vy~g~---~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l  259 (454)
                      ..|.++.+++++.++||+|+||.||+|+   .||||+++...........+.+|+.++++++|||||+++|++.+ +. +
T Consensus        29 ~~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~-~  106 (307)
T 3omv_A           29 YYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DN-L  106 (307)
T ss_dssp             CCCBCCTTSCCEEEECCCCSSSEEEEEESSSEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SS-C
T ss_pred             cCcEEcHHHeEEeeEEeeCCCcEEEEEEECCcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-Ce-E
Confidence            5688999999999999999999999985   69999998666555566779999999999999999999998854 44 8


Q ss_pred             EEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCC
Q 012887          260 CVVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG  338 (454)
Q Consensus       260 ~lV~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~  338 (454)
                      |||||||++|+|.+++... .++++..+..|+.||+.||.|||+++||||||||+|||+++++++||+|||+|+......
T Consensus       107 ~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~  186 (307)
T 3omv_A          107 AIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWS  186 (307)
T ss_dssp             EEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC-----
T ss_pred             EEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCC
Confidence            9999999999999999654 589999999999999999999999999999999999999999999999999998654322


Q ss_pred             --CcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCC----CCCCC
Q 012887          339 --EATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP----EIPKD  412 (454)
Q Consensus       339 --~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~----~~p~~  412 (454)
                        .......||+.|||||++.+.... .++.++|||||||+||||+||+.||.+.++......+...+...    ..+.+
T Consensus       187 ~~~~~~~~~GT~~ymAPE~l~~~~~~-~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~  265 (307)
T 3omv_A          187 GSQQVEQPTGSVLWMAPEVIRMQDNN-PFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKN  265 (307)
T ss_dssp             -------CCCCTTSCCHHHHHCCSSC-CCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTT
T ss_pred             cceeecccccCCCccCHHHhhccCCC-CCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCccccccc
Confidence              233455799999999999765322 47788999999999999999999999877776666666555432    34678


Q ss_pred             ccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCCCCCCCC
Q 012887          413 CPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNSSNR  454 (454)
Q Consensus       413 ~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~~~~~  454 (454)
                      +|+++.+||.+||+.||++|||+.||+++|+.+....-..+|
T Consensus       266 ~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lpk~~R  307 (307)
T 3omv_A          266 CPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINR  307 (307)
T ss_dssp             SCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCCC---
T ss_pred             chHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCCCCCC
Confidence            999999999999999999999999999999887654433333

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=3.9e-58  Score=455.97  Aligned_cols=256  Identities=26%  Similarity=0.491  Sum_probs=220.7

Q ss_pred             eecCCCEEEeceeeccCCceEEEeE-----------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEe
Q 012887          186 LLNSDNLEFIDQIGPNSFKGVYKGK-----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVD  254 (454)
Q Consensus       186 ~~~~~~~~~~~~LG~G~fG~Vy~g~-----------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~  254 (454)
                      .++.++++++++||+|+||.||+|+           .||||+++... ......++.+|+.++.+++|||||+++|+|.+
T Consensus        22 ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~  100 (308)
T 4gt4_A           22 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQHPNVVCLLGVVTK  100 (308)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C-CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc-ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEE
Confidence            3556788999999999999999975           59999997432 33345678999999999999999999999988


Q ss_pred             CCCeEEEEEeccCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEc
Q 012887          255 ENHGLCVVTKLMEGGSVNDLILKS----------------RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLD  318 (454)
Q Consensus       255 ~~~~l~lV~E~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~  318 (454)
                      ++. ++||||||++|+|.++|...                ..+++..+..++.||+.||+|||+++||||||||+|||++
T Consensus       101 ~~~-~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~  179 (308)
T 4gt4_A          101 DQP-LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVY  179 (308)
T ss_dssp             SSS-CEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred             CCE-EEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEEC
Confidence            776 99999999999999999542                2589999999999999999999999999999999999999


Q ss_pred             cCCcEEEEccCCccccccCCC--cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHH
Q 012887          319 RHGNVCLGDMGIVTACKSVGE--ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQ  395 (454)
Q Consensus       319 ~~~~vKL~DFGla~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~  395 (454)
                      +++++||+|||+++.......  ......||+.|||||++.+..    ++.++|||||||+||||+| |..||.+.+..+
T Consensus       180 ~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~----~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~  255 (308)
T 4gt4_A          180 DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGK----FSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD  255 (308)
T ss_dssp             GGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCC----CCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH
T ss_pred             CCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCC----CCccchhhhHHHHHHHHHhCCCCCCCCCCHHH
Confidence            999999999999986644322  233457899999999998764    5567999999999999999 899999988876


Q ss_pred             HHHHHHHcCCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCC
Q 012887          396 AAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNI  448 (454)
Q Consensus       396 ~~~~i~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~  448 (454)
                      ....+ ..+.+++.|..+|+++.+||.+||+.||.+||||.||+++|+.+.+.
T Consensus       256 ~~~~i-~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~nl  307 (308)
T 4gt4_A          256 VVEMI-RNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWGNL  307 (308)
T ss_dssp             HHHHH-HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCC-
T ss_pred             HHHHH-HcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhccCC
Confidence            66554 45677788999999999999999999999999999999999987654

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=5.3e-58  Score=453.16  Aligned_cols=253  Identities=26%  Similarity=0.473  Sum_probs=219.3

Q ss_pred             ecCCCEEEeceeeccCCceEEEeE-----------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeC
Q 012887          187 LNSDNLEFIDQIGPNSFKGVYKGK-----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDE  255 (454)
Q Consensus       187 ~~~~~~~~~~~LG~G~fG~Vy~g~-----------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~  255 (454)
                      |..++|.+.+.||+|+||.||+|+           .||||+++..  ......++.+|+.+|.+++|||||+++|+|.++
T Consensus        10 I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~   87 (299)
T 4asz_A           10 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEG   87 (299)
T ss_dssp             CCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred             cCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC--ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC
Confidence            566899999999999999999974           5999999743  344556789999999999999999999999987


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhC-------------CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCc
Q 012887          256 NHGLCVVTKLMEGGSVNDLILKS-------------RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGN  322 (454)
Q Consensus       256 ~~~l~lV~E~~~~gsL~~~l~~~-------------~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~  322 (454)
                      +. +|||||||++|+|.++|.+.             ..+++..+..++.||+.||.|||+++||||||||+|||++.+++
T Consensus        88 ~~-~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~  166 (299)
T 4asz_A           88 DP-LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL  166 (299)
T ss_dssp             SS-EEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC
T ss_pred             CE-EEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCc
Confidence            76 99999999999999999653             36999999999999999999999999999999999999999999


Q ss_pred             EEEEccCCccccccCCCc--ccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHH
Q 012887          323 VCLGDMGIVTACKSVGEA--TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVG  399 (454)
Q Consensus       323 vKL~DFGla~~~~~~~~~--~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~  399 (454)
                      +||+|||+|+........  .....||+.|||||++.+..    ++.++|||||||+||||+| |+.||.+.++.+....
T Consensus       167 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~----~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~  242 (299)
T 4asz_A          167 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK----FTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIEC  242 (299)
T ss_dssp             EEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCC----CCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH
T ss_pred             EEECCcccceecCCCCceeecCceecChhhcCHHHHcCCC----CCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            999999999865443222  22335899999999998765    5567999999999999999 9999999888777666


Q ss_pred             HHHcCCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 012887          400 IAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNN  447 (454)
Q Consensus       400 i~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~  447 (454)
                      +.. +.+++.|..+|+++.+||.+||+.||++|||+.+|.+.|+++.+
T Consensus       243 i~~-~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~  289 (299)
T 4asz_A          243 ITQ-GRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK  289 (299)
T ss_dssp             HHH-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHc-CCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence            654 56778899999999999999999999999999999999987654

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=3.9e-58  Score=464.00  Aligned_cols=261  Identities=25%  Similarity=0.432  Sum_probs=228.0

Q ss_pred             cceeecCCCEEEeceeeccCCceEEEe-----------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCC-CceeEEEE
Q 012887          183 GRWLLNSDNLEFIDQIGPNSFKGVYKG-----------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGH-KNILQFYC  250 (454)
Q Consensus       183 ~~~~~~~~~~~~~~~LG~G~fG~Vy~g-----------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~H-pnIv~~~g  250 (454)
                      .+|+|+.++|++++.||+|+||.||+|           +.||||.++.. ........+.+|+.+|.++.| ||||+++|
T Consensus        57 ~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~-~~~~~~~~~~~E~~il~~l~hhpnIV~l~g  135 (353)
T 4ase_A           57 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVNLLG  135 (353)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             cccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccc-cChHHHHHHHHHHHHHHHcCCCCcEEEEEE
Confidence            579999999999999999999999997           46999999743 333445668899999999965 99999999


Q ss_pred             EEEeCCCeEEEEEeccCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCc
Q 012887          251 VCVDENHGLCVVTKLMEGGSVNDLILKS----------------RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQR  314 (454)
Q Consensus       251 ~~~~~~~~l~lV~E~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~N  314 (454)
                      +|.+++..++||||||++|+|.++|++.                ..+++..+..++.||+.||+|||+++||||||||+|
T Consensus       136 ~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~N  215 (353)
T 4ase_A          136 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN  215 (353)
T ss_dssp             EECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             EEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccc
Confidence            9987665599999999999999999642                248999999999999999999999999999999999


Q ss_pred             EEEccCCcEEEEccCCccccccCCCc--ccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 012887          315 ILLDRHGNVCLGDMGIVTACKSVGEA--TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAAC  391 (454)
Q Consensus       315 ILl~~~~~vKL~DFGla~~~~~~~~~--~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~  391 (454)
                      ||++.++++||+|||+|+........  .....||+.|||||++.+..    ++.++|||||||+||||+| |..||.+.
T Consensus       216 ILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~----y~~ksDVwS~Gv~l~El~t~G~~Pf~~~  291 (353)
T 4ase_A          216 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV----YTIQSDVWSFGVLLWEIFSLGASPYPGV  291 (353)
T ss_dssp             EEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCC----CCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred             eeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCC----CCCcccEeehHHHHHHHHhCCCCCCCCC
Confidence            99999999999999999876543322  23346789999999998764    5567999999999999998 99999987


Q ss_pred             CHHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCC
Q 012887          392 SPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNI  448 (454)
Q Consensus       392 ~~~~~~~~i~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~  448 (454)
                      +..+.+...+..+.+++.|..+|+++.++|.+||+.||++|||+.||+++|.++.+.
T Consensus       292 ~~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~  348 (353)
T 4ase_A          292 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  348 (353)
T ss_dssp             CCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence            766677777777889999999999999999999999999999999999999988654

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=5e-57  Score=451.98  Aligned_cols=256  Identities=24%  Similarity=0.424  Sum_probs=216.2

Q ss_pred             eeecCCCEEEeceeeccCCceEEEeE-----------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEE
Q 012887          185 WLLNSDNLEFIDQIGPNSFKGVYKGK-----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCV  253 (454)
Q Consensus       185 ~~~~~~~~~~~~~LG~G~fG~Vy~g~-----------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~  253 (454)
                      +.+..++|.+.++||+|+||.||+|+           .||||+++.  .......++.+|+.+|.+++|||||+++|+|.
T Consensus        36 ~~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~--~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~  113 (329)
T 4aoj_A           36 HHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE--ASESARQDFQREAELLTMLQHQHIVRFFGVCT  113 (329)
T ss_dssp             CBCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESC--CSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred             cccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECc--CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence            34566889999999999999999974           599999974  33445567899999999999999999999999


Q ss_pred             eCCCeEEEEEeccCCCCHHHHHHhC---------------CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEc
Q 012887          254 DENHGLCVVTKLMEGGSVNDLILKS---------------RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLD  318 (454)
Q Consensus       254 ~~~~~l~lV~E~~~~gsL~~~l~~~---------------~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~  318 (454)
                      +.+. +|||||||++|+|.+++.+.               .++++..+..|+.||+.||.|||+++||||||||+|||++
T Consensus       114 ~~~~-~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~  192 (329)
T 4aoj_A          114 EGRP-LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVG  192 (329)
T ss_dssp             SSSS-EEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE
T ss_pred             ECCE-EEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEEC
Confidence            8776 99999999999999998643               3589999999999999999999999999999999999999


Q ss_pred             cCCcEEEEccCCccccccCCC--cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHH
Q 012887          319 RHGNVCLGDMGIVTACKSVGE--ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQ  395 (454)
Q Consensus       319 ~~~~vKL~DFGla~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~  395 (454)
                      .++++||+|||+++.......  ......||+.|||||++.+..    ++.++|||||||+||||+| |+.||.+.+..+
T Consensus       193 ~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~----~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~  268 (329)
T 4aoj_A          193 QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRK----FTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE  268 (329)
T ss_dssp             TTTEEEECCCC----------------CCCCGGGCCHHHHTTCC----CCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH
T ss_pred             CCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCC----CCccccccchHHHHHHHHcCCCCCCCCCCHHH
Confidence            999999999999986544322  233456899999999998765    5567999999999999999 999999988877


Q ss_pred             HHHHHHHcCCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCC
Q 012887          396 AAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNI  448 (454)
Q Consensus       396 ~~~~i~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~  448 (454)
                      ....+. .+.+++.|..+|+++.+||.+||+.||++|||+.||+++|+.+.+.
T Consensus       269 ~~~~i~-~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~  320 (329)
T 4aoj_A          269 AIDCIT-QGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA  320 (329)
T ss_dssp             HHHHHH-HTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             HHHHHH-cCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence            666555 4667889999999999999999999999999999999999987654

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.3e-57  Score=458.31  Aligned_cols=249  Identities=24%  Similarity=0.347  Sum_probs=214.8

Q ss_pred             CCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEE
Q 012887          189 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  262 (454)
Q Consensus       189 ~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV  262 (454)
                      -++|++++.||+|+||.||++      +.||||++............+.+|+.+|++++|||||++++++.+++. +|||
T Consensus        23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~-~yiV  101 (350)
T 4b9d_A           23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGS-LYIV  101 (350)
T ss_dssp             CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE-EEEE
T ss_pred             ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCE-EEEE
Confidence            478999999999999999995      579999998665555566778999999999999999999999998876 9999


Q ss_pred             EeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCc
Q 012887          263 TKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA  340 (454)
Q Consensus       263 ~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~  340 (454)
                      ||||+||+|.+++...  ..+++..++.|+.||+.||+|||++|||||||||+|||++.+|++||+|||+|+........
T Consensus       102 mEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~  181 (350)
T 4b9d_A          102 MDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVEL  181 (350)
T ss_dssp             EECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHHH
T ss_pred             EeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCccc
Confidence            9999999999999644  36799999999999999999999999999999999999999999999999999876543333


Q ss_pred             ccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHHHH
Q 012887          341 TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSL  420 (454)
Q Consensus       341 ~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~l  420 (454)
                      .....||+.|||||++.+..    ++.++|||||||+||||++|+.||.+.+..+....+.... .++.+..+|+++.+|
T Consensus       182 ~~~~~GT~~YmAPE~l~~~~----y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~-~~~~~~~~s~~~~~l  256 (350)
T 4b9d_A          182 ARACIGTPYYLSPEICENKP----YNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGS-FPPVSLHYSYDLRSL  256 (350)
T ss_dssp             HHHHHSCCTTCCHHHHTTCC----CCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC-CCCCCTTSCHHHHHH
T ss_pred             ccccCCCccccCHHHHCCCC----CCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCC-CCCCCccCCHHHHHH
Confidence            44557999999999998765    4557999999999999999999999998888887777654 446778899999999


Q ss_pred             HHHhcccCCCCCCCHHHHHHHHH
Q 012887          421 MIKCWNNSPSKRPQFSEIISLLL  443 (454)
Q Consensus       421 i~~cl~~dP~~RPs~~ell~~L~  443 (454)
                      |.+||+.||.+|||+.|+++|-|
T Consensus       257 i~~~L~~dP~~R~s~~e~l~hp~  279 (350)
T 4b9d_A          257 VSQLFKRNPRDRPSVNSILEKGF  279 (350)
T ss_dssp             HHHHTCSSGGGSCCHHHHHTSHH
T ss_pred             HHHHccCChhHCcCHHHHhcCHH
Confidence            99999999999999999998754

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=2.3e-57  Score=448.97  Aligned_cols=250  Identities=20%  Similarity=0.323  Sum_probs=212.0

Q ss_pred             ecCCCEEEeceeeccCCceEEEeE---------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCC
Q 012887          187 LNSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH  257 (454)
Q Consensus       187 ~~~~~~~~~~~LG~G~fG~Vy~g~---------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~  257 (454)
                      ++.++|++++.||+|+||.||+++         .||+|.++...........+.+|+.+|.+++|||||++++++.+++.
T Consensus        21 ~~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~  100 (304)
T 3ubd_A           21 ADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGK  100 (304)
T ss_dssp             CCGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTE
T ss_pred             CCccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCE
Confidence            345789999999999999999864         59999987543322233457789999999999999999999998876


Q ss_pred             eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccC
Q 012887          258 GLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV  337 (454)
Q Consensus       258 ~l~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~  337 (454)
                       +|+|||||+||+|.+++.+.+.+++..+..++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.....
T Consensus       101 -~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~  179 (304)
T 3ubd_A          101 -LYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH  179 (304)
T ss_dssp             -EEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC----
T ss_pred             -EEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCC
Confidence             9999999999999999988889999999999999999999999999999999999999999999999999999876555


Q ss_pred             CCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHH
Q 012887          338 GEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQIL  417 (454)
Q Consensus       338 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l  417 (454)
                      ........||+.|||||++.+..+    +.++|||||||++|||++|..||.+.+..+....+...  .+.+|..+|+++
T Consensus       180 ~~~~~~~~GT~~YmAPE~~~~~~y----~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~--~~~~p~~~s~~~  253 (304)
T 3ubd_A          180 EKKAYSFCGTVEYMAPEVVNRRGH----TQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKA--KLGMPQFLSPEA  253 (304)
T ss_dssp             -CCCCSCCCCGGGCCHHHHHTSCC----CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTTSCHHH
T ss_pred             CccccccccCcccCCHHHhccCCC----CCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcC--CCCCCCcCCHHH
Confidence            445556689999999999987754    45699999999999999999999999888888777765  455788999999


Q ss_pred             HHHHHHhcccCCCCCCC-----HHHHHHHHH
Q 012887          418 KSLMIKCWNNSPSKRPQ-----FSEIISLLL  443 (454)
Q Consensus       418 ~~li~~cl~~dP~~RPs-----~~ell~~L~  443 (454)
                      .+||.+||++||++|||     ++|+++|-|
T Consensus       254 ~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~  284 (304)
T 3ubd_A          254 QSLLRMLFKRNPANRLGAGPDGVEEIKRHSF  284 (304)
T ss_dssp             HHHHHHHTCSSGGGSTTCSTTTHHHHHTSGG
T ss_pred             HHHHHHHcccCHHHCCCCCcCCHHHHHcCcc
Confidence            99999999999999998     578887654

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=9.5e-56  Score=434.89  Aligned_cols=245  Identities=23%  Similarity=0.402  Sum_probs=210.2

Q ss_pred             EEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeC---CCeEEEE
Q 012887          192 LEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDE---NHGLCVV  262 (454)
Q Consensus       192 ~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~---~~~l~lV  262 (454)
                      |++.++||+|+||.||+|      +.||+|++............+.+|+.+|++++|||||+++++|.+.   +..+|||
T Consensus        28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv  107 (290)
T 3fpq_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV  107 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence            578889999999999996      4799999986555555666789999999999999999999998753   2348999


Q ss_pred             EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC--cccCCccCCcEEEcc-CCcEEEEccCCccccccCCC
Q 012887          263 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHG--VAYRDLNSQRILLDR-HGNVCLGDMGIVTACKSVGE  339 (454)
Q Consensus       263 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~--iiHrDIKp~NILl~~-~~~vKL~DFGla~~~~~~~~  339 (454)
                      ||||+||+|.+++.+.+.+++..+..|+.||+.||+|||+++  ||||||||+|||++. +|++||+|||+|+....  .
T Consensus       108 mEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~--~  185 (290)
T 3fpq_A          108 TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA--S  185 (290)
T ss_dssp             EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT--T
T ss_pred             EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC--C
Confidence            999999999999988889999999999999999999999998  999999999999984 79999999999975433  2


Q ss_pred             cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCC-CCCCCCccHHHH
Q 012887          340 ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR-PEIPKDCPQILK  418 (454)
Q Consensus       340 ~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~-~~~p~~~~~~l~  418 (454)
                      ......||+.|||||++.+     .++.++|||||||+||||+||..||.+......+......+.+ +.++..+++++.
T Consensus       186 ~~~~~~GTp~YmAPE~~~~-----~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  260 (290)
T 3fpq_A          186 FAKAVIGTPEFMAPEMYEE-----KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVK  260 (290)
T ss_dssp             SBEESCSSCCCCCGGGGGT-----CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHH
T ss_pred             ccCCcccCccccCHHHcCC-----CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHHHH
Confidence            3445689999999999864     2566799999999999999999999876666555555554443 345677899999


Q ss_pred             HHHHHhcccCCCCCCCHHHHHHHHH
Q 012887          419 SLMIKCWNNSPSKRPQFSEIISLLL  443 (454)
Q Consensus       419 ~li~~cl~~dP~~RPs~~ell~~L~  443 (454)
                      +||.+||+.||++|||+.|+++|-|
T Consensus       261 ~li~~~L~~dP~~R~s~~e~l~Hp~  285 (290)
T 3fpq_A          261 EIIEGCIRQNKDERYSIKDLLNHAF  285 (290)
T ss_dssp             HHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred             HHHHHHccCChhHCcCHHHHhcCcc
Confidence            9999999999999999999998754

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1.3e-55  Score=430.59  Aligned_cols=248  Identities=19%  Similarity=0.285  Sum_probs=203.5

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCC-chHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  262 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV  262 (454)
                      ++|++++.||+|+||.||++      +.||+|.+...... ......+.+|+.+|+.++|||||++++++.+++. +|+|
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~-~~iv   91 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDE-IIMV   91 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE-EEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCE-EEEE
Confidence            67999999999999999995      58999999754322 2234568899999999999999999999998776 9999


Q ss_pred             EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCccc
Q 012887          263 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE  342 (454)
Q Consensus       263 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~  342 (454)
                      |||| +|+|.+++.+.+++++..+..++.||+.||+|||++||+||||||+|||++.++++||+|||+|+...... ...
T Consensus        92 mEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~-~~~  169 (275)
T 3hyh_A           92 IEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN-FLK  169 (275)
T ss_dssp             EECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC-----------
T ss_pred             EeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCC-ccC
Confidence            9999 67999999888899999999999999999999999999999999999999999999999999998665432 234


Q ss_pred             ccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHHHHHH
Q 012887          343 YETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMI  422 (454)
Q Consensus       343 ~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~li~  422 (454)
                      ...||+.|||||++.+..+.   +.++||||+||++|+|++|..||.+.+.......+...  ...+|..+|+++.+||.
T Consensus       170 ~~~GT~~Y~APE~~~~~~y~---~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~  244 (275)
T 3hyh_A          170 TSCGSPNYAAPEVISGKLYA---GPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNG--VYTLPKFLSPGAAGLIK  244 (275)
T ss_dssp             -----CTTSCHHHHSSSSCC---CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT--CCCCCTTSCHHHHHHHH
T ss_pred             CeeECcccCChhhhcCCCCC---CChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHHHHHHHH
Confidence            46799999999999887542   34699999999999999999999998887777666654  44578899999999999


Q ss_pred             HhcccCCCCCCCHHHHHHHHHhh
Q 012887          423 KCWNNSPSKRPQFSEIISLLLRT  445 (454)
Q Consensus       423 ~cl~~dP~~RPs~~ell~~L~~~  445 (454)
                      +||+.||++|||+.|+++|-|--
T Consensus       245 ~~L~~dP~~R~s~~eil~hpw~k  267 (275)
T 3hyh_A          245 RMLIVNPLNRISIHEIMQDDWFK  267 (275)
T ss_dssp             HHSCSSGGGSCCHHHHHHCHHHH
T ss_pred             HHccCChhHCcCHHHHHcCcccc
Confidence            99999999999999999987653

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=5.7e-56  Score=445.78  Aligned_cols=248  Identities=23%  Similarity=0.365  Sum_probs=216.2

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  263 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~  263 (454)
                      +.|+++++||+|+||.||+|      +.||||++.......  ...+.+|+.+|+.++|||||+++++|.+++. +||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~--~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~-~~ivm  150 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR--RELLFNEVVIMRDYQHENVVEMYNSYLVGDE-LWVVM  150 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS--GGGGHHHHHHHHHCCCTTBCCEEEEEEETTE-EEEEE
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH--HHHHHHHHHHHHhCCCCCCCcEEEEEEECCE-EEEEE
Confidence            57999999999999999995      579999997543322  3447799999999999999999999998886 99999


Q ss_pred             eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCcccc
Q 012887          264 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY  343 (454)
Q Consensus       264 E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~  343 (454)
                      |||+||+|.+++.+ +++++..+..|+.||+.||+|||++|||||||||+|||++.+|++||+|||+|+...........
T Consensus       151 Ey~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~  229 (346)
T 4fih_A          151 EFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS  229 (346)
T ss_dssp             CCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCC
T ss_pred             eCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCcccc
Confidence            99999999999865 57999999999999999999999999999999999999999999999999999887665555666


Q ss_pred             cCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCC-CCCCCCCccHHHHHHHH
Q 012887          344 ETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGL-RPEIPKDCPQILKSLMI  422 (454)
Q Consensus       344 ~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~-~~~~p~~~~~~l~~li~  422 (454)
                      ..||+.|||||++.+..|    +.++|||||||++|||++|.+||.+.++.+....+..... ....+..+|+++.+||.
T Consensus       230 ~~GTp~YmAPEvl~~~~y----~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~  305 (346)
T 4fih_A          230 LVGTPYWMAPELISRLPY----GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLD  305 (346)
T ss_dssp             CCSCGGGCCHHHHTTCCB----CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHH
T ss_pred             cccCcCcCCHHHHCCCCC----CcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHHH
Confidence            789999999999987754    4569999999999999999999999888877766665322 22334578999999999


Q ss_pred             HhcccCCCCCCCHHHHHHHHHhh
Q 012887          423 KCWNNSPSKRPQFSEIISLLLRT  445 (454)
Q Consensus       423 ~cl~~dP~~RPs~~ell~~L~~~  445 (454)
                      +||+.||.+|||+.|+++|-|-.
T Consensus       306 ~~L~~dP~~R~ta~e~l~Hp~~~  328 (346)
T 4fih_A          306 RLLVRDPAQRATAAELLKHPFLA  328 (346)
T ss_dssp             HHSCSSTTTSCCHHHHTTCGGGG
T ss_pred             HHcCCChhHCcCHHHHhcCHhhc
Confidence            99999999999999999986543

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=9.5e-57  Score=445.20  Aligned_cols=246  Identities=16%  Similarity=0.249  Sum_probs=216.2

Q ss_pred             CCCEEEeceeeccCCceEEEe------EEEEEEEeecCCC-CchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEE
Q 012887          189 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDK-GNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCV  261 (454)
Q Consensus       189 ~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~l  261 (454)
                      .++|++++.||+|+||.||++      +.||+|.+..... .......+.+|+.+|+.++|||||++++++.+++. +||
T Consensus        31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~-~yi  109 (311)
T 4aw0_A           31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEK-LYF  109 (311)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE-EEE
T ss_pred             ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCE-EEE
Confidence            478999999999999999996      5799999964321 12234568899999999999999999999998876 999


Q ss_pred             EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCC--
Q 012887          262 VTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE--  339 (454)
Q Consensus       262 V~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~--  339 (454)
                      |||||+||+|.+++.+.+.+++..+..|+.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.......  
T Consensus       110 vmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~  189 (311)
T 4aw0_A          110 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA  189 (311)
T ss_dssp             EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCC
T ss_pred             EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcc
Confidence            999999999999998888999999999999999999999999999999999999999999999999999987654322  


Q ss_pred             cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHHH
Q 012887          340 ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKS  419 (454)
Q Consensus       340 ~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~  419 (454)
                      ......||+.|||||++.+..+    +.++|||||||++|||++|..||.+.+..+....+....  ..+|..+|+++++
T Consensus       190 ~~~~~~GTp~YmAPEvl~~~~y----~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~--~~~p~~~s~~~~d  263 (311)
T 4aw0_A          190 RANSFVGTAQYVSPELLTEKSA----CKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLE--YDFPEKFFPKARD  263 (311)
T ss_dssp             CBCCCCSCGGGCCHHHHHHSCB----CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC--CCCCTTCCHHHHH
T ss_pred             cccCcccCcccCCHHHHcCCCC----CcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC--CCCCcccCHHHHH
Confidence            3445689999999999987754    456999999999999999999999988888888887754  4578899999999


Q ss_pred             HHHHhcccCCCCCCCHHHHHHH
Q 012887          420 LMIKCWNNSPSKRPQFSEIISL  441 (454)
Q Consensus       420 li~~cl~~dP~~RPs~~ell~~  441 (454)
                      ||.+||++||.+|||+.|++.+
T Consensus       264 li~~lL~~dp~~R~t~~e~~~~  285 (311)
T 4aw0_A          264 LVEKLLVLDATKRLGCEEMEGY  285 (311)
T ss_dssp             HHHHHSCSSGGGSTTSGGGTCH
T ss_pred             HHHHHccCCHhHCcChHHHcCC
Confidence            9999999999999999986543

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=4e-56  Score=445.50  Aligned_cols=248  Identities=18%  Similarity=0.276  Sum_probs=213.1

Q ss_pred             cCCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEE
Q 012887          188 NSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCV  261 (454)
Q Consensus       188 ~~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~l  261 (454)
                      ..++|++.++||+|+||.||+|      +.||||+++....       ..+|+.++..++|||||++++++.+++. +||
T Consensus        56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-------~~~E~~il~~l~HpnIV~l~~~~~~~~~-~~i  127 (336)
T 4g3f_A           56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-------RVEELVACAGLSSPRIVPLYGAVREGPW-VNI  127 (336)
T ss_dssp             TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-------CTHHHHTTTTCCCTTBCCEEEEEEETTE-EEE
T ss_pred             chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-------HHHHHHHHHhCCCCCCCcEEEEEEECCE-EEE
Confidence            4467899999999999999996      5799999974322       2368999999999999999999998876 999


Q ss_pred             EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCC-cEEEEccCCccccccCCCc
Q 012887          262 VTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG-NVCLGDMGIVTACKSVGEA  340 (454)
Q Consensus       262 V~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~-~vKL~DFGla~~~~~~~~~  340 (454)
                      |||||+||+|.+++.+.+.+++..+..|+.||+.||+|||++|||||||||+|||++.+| ++||+|||+|+........
T Consensus       128 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~  207 (336)
T 4g3f_A          128 FMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG  207 (336)
T ss_dssp             EECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------
T ss_pred             EEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcc
Confidence            999999999999998888999999999999999999999999999999999999999988 6999999999876543221


Q ss_pred             -----ccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCC-CCCCCCcc
Q 012887          341 -----TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR-PEIPKDCP  414 (454)
Q Consensus       341 -----~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~-~~~p~~~~  414 (454)
                           .....||+.|||||++.+..+    +.++|||||||++|||++|..||.+.+.......+.....+ ..+|..+|
T Consensus       208 ~~~~~~~~~~GT~~YmAPE~~~~~~y----~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s  283 (336)
T 4g3f_A          208 KSLLTGDYIPGTETHMAPEVVMGKPC----DAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCA  283 (336)
T ss_dssp             ------CCCCCCGGGCCHHHHTTCCC----CTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSC
T ss_pred             cceecCCccccCccccCHHHHCCCCC----CcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCC
Confidence                 223469999999999988754    45699999999999999999999987776666667665433 24688899


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 012887          415 QILKSLMIKCWNNSPSKRPQFSEIISLLLRTNN  447 (454)
Q Consensus       415 ~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~  447 (454)
                      +++.++|.+||++||.+|||+.||+++|.....
T Consensus       284 ~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~  316 (336)
T 4g3f_A          284 PLTAQAIQEGLRKEPVHRASAMELRRKVGKALQ  316 (336)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence            999999999999999999999999999887643

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.1e-54  Score=447.02  Aligned_cols=247  Identities=23%  Similarity=0.365  Sum_probs=216.6

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  263 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~  263 (454)
                      +.|+++++||+|+||.||+|      +.||||++.......  ...+.+|+.+|+.++|||||+++++|.+++. +||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~--~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~-~~iVm  227 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR--RELLFNEVVIMRDYQHENVVEMYNSYLVGDE-LWVVM  227 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS--GGGHHHHHHHHHHCCCTTBCCEEEEEEETTE-EEEEE
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH--HHHHHHHHHHHHhCCCCCCCceEEEEEECCE-EEEEE
Confidence            57999999999999999995      579999997543332  3457899999999999999999999998876 99999


Q ss_pred             eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCcccc
Q 012887          264 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY  343 (454)
Q Consensus       264 E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~  343 (454)
                      |||+||+|.+++.. +.+++..+..|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+...........
T Consensus       228 Ey~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~  306 (423)
T 4fie_A          228 EFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS  306 (423)
T ss_dssp             ECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCBCC
T ss_pred             eCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCccccc
Confidence            99999999999854 56999999999999999999999999999999999999999999999999999887665555566


Q ss_pred             cCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCC-CCCCCCCccHHHHHHHH
Q 012887          344 ETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGL-RPEIPKDCPQILKSLMI  422 (454)
Q Consensus       344 ~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~-~~~~p~~~~~~l~~li~  422 (454)
                      ..||+.|||||++.+..|    +.++|||||||++|||++|..||.+.++.+.+..+..... ....+..+|+++.+||.
T Consensus       307 ~~GTp~YmAPEvl~~~~y----~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~  382 (423)
T 4fie_A          307 LVGTPYWMAPELISRLPY----GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLD  382 (423)
T ss_dssp             CEECTTTCCHHHHTTCCB----CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHH
T ss_pred             cccCcCcCCHHHHCCCCC----CcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHHH
Confidence            789999999999987754    4569999999999999999999999888887776665422 23345678999999999


Q ss_pred             HhcccCCCCCCCHHHHHHHHHh
Q 012887          423 KCWNNSPSKRPQFSEIISLLLR  444 (454)
Q Consensus       423 ~cl~~dP~~RPs~~ell~~L~~  444 (454)
                      +||+.||.+|||+.|+++|-|-
T Consensus       383 ~~L~~dP~~R~ta~ell~Hp~~  404 (423)
T 4fie_A          383 RLLVRDPAQRATAAELLKHPFL  404 (423)
T ss_dssp             HHSCSSTTTSCCHHHHTTCGGG
T ss_pred             HHcCCChhHCcCHHHHhcCHHh
Confidence            9999999999999999998554

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1.8e-53  Score=421.78  Aligned_cols=255  Identities=22%  Similarity=0.426  Sum_probs=204.3

Q ss_pred             CCEEEeceeeccCCceEEEe----EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCC---eEEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH---GLCVV  262 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g----~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~---~l~lV  262 (454)
                      ++|.+.+.||+|+||.||+|    +.||||++..   ........+.|+..+..++|||||+++|+|.+++.   .+|||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~---~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV   79 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV   79 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTEEEEEEEECG---GGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECc---cchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence            56899999999999999996    6899999863   22333445667777778999999999999987652   48999


Q ss_pred             EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhc--------CcccCCccCCcEEEccCCcEEEEccCCcccc
Q 012887          263 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDH--------GVAYRDLNSQRILLDRHGNVCLGDMGIVTAC  334 (454)
Q Consensus       263 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~--------~iiHrDIKp~NILl~~~~~vKL~DFGla~~~  334 (454)
                      ||||++|+|.+++.+ ..+++..+..++.|++.||.|||++        +||||||||+|||++.++++||+|||+++..
T Consensus        80 ~Ey~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~  158 (303)
T 3hmm_A           80 SDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH  158 (303)
T ss_dssp             EECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred             ecCCCCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccc
Confidence            999999999999964 5699999999999999999999987        9999999999999999999999999999876


Q ss_pred             ccCCCc----ccccCCCCcccccccccCCCCC--CCCCchhhHHHHHHHHHHHHcCCCCCCC----------C-----CH
Q 012887          335 KSVGEA----TEYETDGYRWLAPEIIAGDPES--VSETWMSNVYSFGMVIWEMVTGEAAYAA----------C-----SP  393 (454)
Q Consensus       335 ~~~~~~----~~~~~gt~~y~APE~l~~~~~~--~~~~~ksDVwSlGviL~elltG~~Pf~~----------~-----~~  393 (454)
                      ......    .....||+.|||||++.+....  ..++.++|||||||+||||+||..||..          .     ..
T Consensus       159 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~  238 (303)
T 3hmm_A          159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV  238 (303)
T ss_dssp             ETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred             cCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchH
Confidence            543322    2234699999999999865321  1345689999999999999999776532          1     11


Q ss_pred             HHHHHHHHHcCCCCCCCCC-----ccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCC
Q 012887          394 VQAAVGIAACGLRPEIPKD-----CPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNI  448 (454)
Q Consensus       394 ~~~~~~i~~~~~~~~~p~~-----~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~  448 (454)
                      ......+...+.++.+|..     ++..+.+||.+||+.||++|||+.||++.|+++.+.
T Consensus       239 ~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~  298 (303)
T 3hmm_A          239 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             HHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence            2333334455677777754     346789999999999999999999999999988764

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=7.4e-53  Score=416.50  Aligned_cols=246  Identities=18%  Similarity=0.305  Sum_probs=189.5

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCC------
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH------  257 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~------  257 (454)
                      ++|++++.||+|+||.||+|      +.||||+++... .......+.+|+.+|++++|||||+++++|.+.+.      
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~   83 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP   83 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence            46999999999999999986      579999997433 33445678899999999999999999999976542      


Q ss_pred             -----eEEEEEeccCCCCHHHHHHhCCC---CCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccC
Q 012887          258 -----GLCVVTKLMEGGSVNDLILKSRK---LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMG  329 (454)
Q Consensus       258 -----~l~lV~E~~~~gsL~~~l~~~~~---l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFG  329 (454)
                           .+|+|||||++|+|.+++.+...   .++..++.++.||+.||+|||++|||||||||+|||++.+|++||+|||
T Consensus        84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFG  163 (299)
T 4g31_A           84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFG  163 (299)
T ss_dssp             ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCC
T ss_pred             cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCc
Confidence                 27999999999999999976553   4567789999999999999999999999999999999999999999999


Q ss_pred             CccccccCCCc------------ccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHH
Q 012887          330 IVTACKSVGEA------------TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAA  397 (454)
Q Consensus       330 la~~~~~~~~~------------~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~  397 (454)
                      +|+........            .....||+.|||||++.+..    ++.++|||||||++|||++   ||.+.......
T Consensus       164 la~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~----y~~~~DiwSlGvilyell~---Pf~~~~~~~~~  236 (299)
T 4g31_A          164 LVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNS----YSHKVDIFSLGLILFELLY---PFSTQMERVRT  236 (299)
T ss_dssp             CC--------------------------CCCTTSCHHHHTTCC----CCTHHHHHHHHHHHHHHHS---CCSSHHHHHHH
T ss_pred             cceecCCCccccccccccccccccCCcccCccccCHHHHcCCC----CCCHHHHHHHHHHHHHHcc---CCCCccHHHHH
Confidence            99876543221            12346999999999998775    4556999999999999996   78653332222


Q ss_pred             HHHHHcCCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 012887          398 VGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLL  443 (454)
Q Consensus       398 ~~i~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~  443 (454)
                      .........++.+...++.+.+||.+||+.||.+|||+.|+++|-+
T Consensus       237 ~~~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~  282 (299)
T 4g31_A          237 LTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAV  282 (299)
T ss_dssp             HHHHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred             HHHHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHh
Confidence            2222222223333445677889999999999999999999998644

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.3e-51  Score=422.91  Aligned_cols=251  Identities=20%  Similarity=0.230  Sum_probs=211.2

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeC-----CCe
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDE-----NHG  258 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~-----~~~  258 (454)
                      ++|++++.||+|+||.||+|      +.||||+++...........+.+|+.+|+.++|||||++++++...     ...
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            68999999999999999995      5799999976555555566788999999999999999999998643     234


Q ss_pred             EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCC
Q 012887          259 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG  338 (454)
Q Consensus       259 l~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~  338 (454)
                      +|||||||+ |+|.+++.+.+.+++..+..|+.||+.||.|||++|||||||||+|||++.+|.+||+|||+|+......
T Consensus       134 ~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~  212 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSP  212 (398)
T ss_dssp             EEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC----
T ss_pred             EEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccCc
Confidence            999999996 5899999888899999999999999999999999999999999999999999999999999998654321


Q ss_pred             ----CcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCC------
Q 012887          339 ----EATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPE------  408 (454)
Q Consensus       339 ----~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~------  408 (454)
                          .......||+.|||||++.+..+   ++.++||||+||++|||++|.+||.+.+....+..+......+.      
T Consensus       213 ~~~~~~~~~~~GT~~Y~APEv~~~~~~---~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~  289 (398)
T 4b99_A          213 AEHQYFMTEYVATRWYRAPELMLSLHE---YTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQA  289 (398)
T ss_dssp             ---CCCCCSSCCCCTTCCHHHHTTCSC---CCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-
T ss_pred             cccccccccceeChHhcCHHHhcCCCC---CCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhh
Confidence                22344579999999999887543   45679999999999999999999999888877766654321111      


Q ss_pred             ----------------C-------CCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 012887          409 ----------------I-------PKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR  444 (454)
Q Consensus       409 ----------------~-------p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~  444 (454)
                                      .       ...+++++.+||.+||..||.+|||+.|+++|-|-
T Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f  348 (398)
T 4b99_A          290 VGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFL  348 (398)
T ss_dssp             ----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGG
T ss_pred             hhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhh
Confidence                            1       12468899999999999999999999999998654

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=4.3e-49  Score=399.44  Aligned_cols=243  Identities=19%  Similarity=0.327  Sum_probs=195.9

Q ss_pred             CCEEEeceeeccCCceEEEe---------EEEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEEEEEEEeCCCeE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG---------KRVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVDENHGL  259 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g---------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~~~g~~~~~~~~l  259 (454)
                      +.|++++.||+|+||.||+|         +.||+|++....    ...++.+|+.+|..+ +|||||++++++.+.++ +
T Consensus        21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~-~   95 (361)
T 4f9c_A           21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS----HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDH-V   95 (361)
T ss_dssp             GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTE-E
T ss_pred             CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc----CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCE-E
Confidence            67999999999999999986         469999986422    234577899999988 69999999999998876 9


Q ss_pred             EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccC-CcEEEEccCCccccccCC
Q 012887          260 CVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH-GNVCLGDMGIVTACKSVG  338 (454)
Q Consensus       260 ~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~-~~vKL~DFGla~~~~~~~  338 (454)
                      |+|||||++|+|.+++.   .+++..+..++.||+.||+|||++||+||||||+|||++.+ +++||+|||+|+......
T Consensus        96 ~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~  172 (361)
T 4f9c_A           96 VIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTK  172 (361)
T ss_dssp             EEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCS
T ss_pred             EEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcc
Confidence            99999999999999983   59999999999999999999999999999999999999877 799999999997554321


Q ss_pred             C----------------------------cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 012887          339 E----------------------------ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAA  390 (454)
Q Consensus       339 ~----------------------------~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~  390 (454)
                      .                            ......||+.|+|||++.+..   .++.++||||+||++|||++|+.||..
T Consensus       173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~---~y~~~~DiWSlG~il~ell~G~~Pf~~  249 (361)
T 4f9c_A          173 IELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCP---NQTTAIDMWSAGVIFLSLLSGRYPFYK  249 (361)
T ss_dssp             CGGGGGC--------------------------CCCCGGGCCHHHHTTCS---CCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred             ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCC---CCCCccchhhhHHHHHHHHHCCCCCCC
Confidence            1                            112346999999999998753   255679999999999999999999965


Q ss_pred             CC-HHHHHHHHHHc------------------------------------CC----------------CCCCCCCccHHH
Q 012887          391 CS-PVQAAVGIAAC------------------------------------GL----------------RPEIPKDCPQIL  417 (454)
Q Consensus       391 ~~-~~~~~~~i~~~------------------------------------~~----------------~~~~p~~~~~~l  417 (454)
                      .+ ....+..+...                                    ..                .......+|+++
T Consensus       250 ~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a  329 (361)
T 4f9c_A          250 ASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEA  329 (361)
T ss_dssp             CSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHH
T ss_pred             CCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHH
Confidence            44 33332222110                                    00                001123578999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHHHHH
Q 012887          418 KSLMIKCWNNSPSKRPQFSEIISLLL  443 (454)
Q Consensus       418 ~~li~~cl~~dP~~RPs~~ell~~L~  443 (454)
                      .+||.+||+.||.+|||+.|+++|-|
T Consensus       330 ~DLl~~lL~~dP~~R~ta~eaL~Hp~  355 (361)
T 4f9c_A          330 YDLLDKLLDLNPASRITAEEALLHPF  355 (361)
T ss_dssp             HHHHHHHTCSCTTTSCCHHHHHTSGG
T ss_pred             HHHHHHHCcCChhHCcCHHHHhcCcc
Confidence            99999999999999999999998755

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=2.8e-49  Score=425.03  Aligned_cols=249  Identities=19%  Similarity=0.305  Sum_probs=205.9

Q ss_pred             ecCCCEEEeceeeccCCceEEEe------EEEEEEEeecCC----CCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCC
Q 012887          187 LNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCD----KGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN  256 (454)
Q Consensus       187 ~~~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~----~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~  256 (454)
                      +..++|++++.||+|+||.||++      +.||+|++....    .........+.++.++..++|||||+++++|.+.+
T Consensus       186 ~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~  265 (689)
T 3v5w_A          186 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD  265 (689)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS
T ss_pred             CchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECC
Confidence            44589999999999999999985      579999996421    11111122233455666789999999999999887


Q ss_pred             CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCcccccc
Q 012887          257 HGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS  336 (454)
Q Consensus       257 ~~l~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~  336 (454)
                      + +|+|||||+||+|.++|.+.+.+++..+..|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+....
T Consensus       266 ~-lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~  344 (689)
T 3v5w_A          266 K-LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK  344 (689)
T ss_dssp             E-EEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             E-EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCC
Confidence            6 999999999999999998888999999999999999999999999999999999999999999999999999987654


Q ss_pred             CCCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC---HHHHHHHHHHcCCCCCCCCCc
Q 012887          337 VGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACS---PVQAAVGIAACGLRPEIPKDC  413 (454)
Q Consensus       337 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~---~~~~~~~i~~~~~~~~~p~~~  413 (454)
                      .  .....+||+.|||||++.++.   .++.++|+|||||+||||++|.+||.+.+   .......+..  ....+|..+
T Consensus       345 ~--~~~t~~GTp~YmAPEvl~~~~---~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~--~~~~~p~~~  417 (689)
T 3v5w_A          345 K--KPHASVGTHGYMAPEVLQKGV---AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT--MAVELPDSF  417 (689)
T ss_dssp             C--CCCSCCSCGGGCCHHHHSTTC---CCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHH--CCCCCCTTS
T ss_pred             C--CCCCccCCcCccCHHHHhCCC---CCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcC--CCCCCCccC
Confidence            3  234568999999999996432   25557999999999999999999997532   2233333433  355688999


Q ss_pred             cHHHHHHHHHhcccCCCCCCC-----HHHHHHHHH
Q 012887          414 PQILKSLMIKCWNNSPSKRPQ-----FSEIISLLL  443 (454)
Q Consensus       414 ~~~l~~li~~cl~~dP~~RPs-----~~ell~~L~  443 (454)
                      |+++.+||.+||+.||.+|++     +.||++|-+
T Consensus       418 S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~Hpf  452 (689)
T 3v5w_A          418 SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPF  452 (689)
T ss_dssp             CHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGG
T ss_pred             CHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCcc
Confidence            999999999999999999998     789988755

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=4.7e-49  Score=421.83  Aligned_cols=246  Identities=15%  Similarity=0.295  Sum_probs=214.8

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  263 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~  263 (454)
                      ++|++++.||+|+||.||++      +.||+|.+...  .......+.+|+.+|..++|||||+++++|.+.+. +||||
T Consensus       157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~--~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~-~~iv~  233 (573)
T 3uto_A          157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP--HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNE-MVMIY  233 (573)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSE-EEEEE
T ss_pred             cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEecc--chhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE-EEEEE
Confidence            68999999999999999985      58999999743  23345568899999999999999999999998776 99999


Q ss_pred             eccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccC--CcEEEEccCCccccccCCCc
Q 012887          264 KLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH--GNVCLGDMGIVTACKSVGEA  340 (454)
Q Consensus       264 E~~~~gsL~~~l~~-~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~--~~vKL~DFGla~~~~~~~~~  340 (454)
                      |||+||+|.+++.+ .+.+++..+..|+.||+.||+|||++||+||||||+|||++.+  +++||+|||+++...... .
T Consensus       234 E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~-~  312 (573)
T 3uto_A          234 EFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ-S  312 (573)
T ss_dssp             ECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS-E
T ss_pred             eecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCC-c
Confidence            99999999999854 4589999999999999999999999999999999999999854  899999999998765432 3


Q ss_pred             ccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCC--CCCCccHHHH
Q 012887          341 TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPE--IPKDCPQILK  418 (454)
Q Consensus       341 ~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~--~p~~~~~~l~  418 (454)
                      .....||+.|||||++.+..+    +.++|||||||++|||++|..||.+.+..+.+..+.......+  .+..+|+++.
T Consensus       313 ~~~~~GT~~y~APEv~~~~~y----~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  388 (573)
T 3uto_A          313 VKVTTGTAEFAAPEVAEGKPV----GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGK  388 (573)
T ss_dssp             EEEECSSGGGCCHHHHTTCCB----CHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHH
T ss_pred             eeeeEECccccCHHHhCCCCC----CcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHH
Confidence            345579999999999988754    4569999999999999999999999998888888776654432  3457899999


Q ss_pred             HHHHHhcccCCCCCCCHHHHHHHHH
Q 012887          419 SLMIKCWNNSPSKRPQFSEIISLLL  443 (454)
Q Consensus       419 ~li~~cl~~dP~~RPs~~ell~~L~  443 (454)
                      +||.+||+.||.+|||+.|+++|-|
T Consensus       389 dli~~~L~~dp~~R~t~~e~l~Hpw  413 (573)
T 3uto_A          389 DFIRKLLLADPNTRMTIHQALEHPW  413 (573)
T ss_dssp             HHHHTTSCSSGGGSCCHHHHHHSTT
T ss_pred             HHHHHHccCChhHCcCHHHHhcCcC
Confidence            9999999999999999999999855

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=6.4e-48  Score=381.96  Aligned_cols=261  Identities=26%  Similarity=0.458  Sum_probs=219.9

Q ss_pred             cceeecCCCEEEeceeeccCCceEEEe----EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCe
Q 012887          183 GRWLLNSDNLEFIDQIGPNSFKGVYKG----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHG  258 (454)
Q Consensus       183 ~~~~~~~~~~~~~~~LG~G~fG~Vy~g----~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~  258 (454)
                      ..+.+..++|++.+.||+|+||.||+|    +.||+|.+............+.+|+.++.+++||||+++++++.+.+. 
T Consensus        30 ~~~~i~~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~-  108 (309)
T 3p86_A           30 DDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPN-  108 (309)
T ss_dssp             --CBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTC-
T ss_pred             ccccCChhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCc-
Confidence            456677789999999999999999996    589999998665555556678899999999999999999999987776 


Q ss_pred             EEEEEeccCCCCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhcC--cccCCccCCcEEEccCCcEEEEccCCccc
Q 012887          259 LCVVTKLMEGGSVNDLILKSR---KLQTKEIIRIAIDVAEGIKFLNDHG--VAYRDLNSQRILLDRHGNVCLGDMGIVTA  333 (454)
Q Consensus       259 l~lV~E~~~~gsL~~~l~~~~---~l~~~~~~~i~~qI~~gL~yLH~~~--iiHrDIKp~NILl~~~~~vKL~DFGla~~  333 (454)
                      +++||||+++|+|.+++.+..   .+++..++.++.||+.||.|||++|  |+||||||+|||++.++.+||+|||++..
T Consensus       109 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~  188 (309)
T 3p86_A          109 LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL  188 (309)
T ss_dssp             CEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC----
T ss_pred             eEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCcc
Confidence            899999999999999997654   3999999999999999999999999  99999999999999999999999999876


Q ss_pred             cccCCCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCc
Q 012887          334 CKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDC  413 (454)
Q Consensus       334 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~  413 (454)
                      ............||+.|+|||.+.+..+    +.++|||||||++|+|++|..||.+.+.......+.....+..+|..+
T Consensus       189 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~----~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~  264 (309)
T 3p86_A          189 KASTFLSSKSAAGTPEWMAPEVLRDEPS----NEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNL  264 (309)
T ss_dssp             -------------CCTTSCHHHHTTCCC----CTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTTS
T ss_pred             ccccccccccCCCCccccChhhhcCCCC----CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCccC
Confidence            5544333445678999999999987654    445999999999999999999999988888877777777788899999


Q ss_pred             cHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCC
Q 012887          414 PQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNI  448 (454)
Q Consensus       414 ~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~  448 (454)
                      ++++.++|.+||+.||.+|||+.++++.|+.+.+.
T Consensus       265 ~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~  299 (309)
T 3p86_A          265 NPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS  299 (309)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            99999999999999999999999999999988764

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=3e-47  Score=380.79  Aligned_cols=248  Identities=19%  Similarity=0.302  Sum_probs=218.9

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  263 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~  263 (454)
                      ++|++++.||+|+||.||+|      +.||+|++............+.+|+.+++.++||||+++++++.+.+. +|+||
T Consensus        15 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~-~~lv~   93 (328)
T 3fe3_A           15 GNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKT-LYLIM   93 (328)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE-EEEEE
T ss_pred             CCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCE-EEEEE
Confidence            78999999999999999986      479999998655555556678899999999999999999999987776 99999


Q ss_pred             eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCcccc
Q 012887          264 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY  343 (454)
Q Consensus       264 E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~  343 (454)
                      ||+++|+|.+++.+.+.+++..+..++.||+.||.|||++||+||||||+|||++.++++||+|||++....... ....
T Consensus        94 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-~~~~  172 (328)
T 3fe3_A           94 EYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG-KLDA  172 (328)
T ss_dssp             CCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC-GGGT
T ss_pred             ECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC-cccc
Confidence            999999999999888899999999999999999999999999999999999999999999999999987654432 3445


Q ss_pred             cCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHHHHHHH
Q 012887          344 ETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIK  423 (454)
Q Consensus       344 ~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~li~~  423 (454)
                      ..||+.|+|||++.+..+.   +.++|||||||++|+|++|..||.+.+.......+.....  .+|..+++++.++|.+
T Consensus       173 ~~gt~~y~aPE~~~~~~~~---~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~--~~p~~~s~~~~~li~~  247 (328)
T 3fe3_A          173 FCGAPPYAAPELFQGKKYD---GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY--RIPFYMSTDCENLLKR  247 (328)
T ss_dssp             TSSSGGGCCHHHHHTCCCC---SHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC--CCCTTSCHHHHHHHHH
T ss_pred             ccCCcceeCcccccCCCcC---CchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC--CCCCCCCHHHHHHHHH
Confidence            5789999999999876542   3579999999999999999999999888877777776543  4677899999999999


Q ss_pred             hcccCCCCCCCHHHHHHHHHh
Q 012887          424 CWNNSPSKRPQFSEIISLLLR  444 (454)
Q Consensus       424 cl~~dP~~RPs~~ell~~L~~  444 (454)
                      ||..||.+|||+.|+++|-|-
T Consensus       248 ~L~~dP~~R~t~~eil~h~~~  268 (328)
T 3fe3_A          248 FLVLNPIKRGTLEQIMKDRWI  268 (328)
T ss_dssp             HCCSSTTTSCCHHHHTTCTTT
T ss_pred             HCCCChhHCcCHHHHhcCHhh
Confidence            999999999999999998654

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=4.8e-47  Score=385.22  Aligned_cols=260  Identities=23%  Similarity=0.469  Sum_probs=221.6

Q ss_pred             cceeecCCCEEEeceeeccCCceEEEeE-------------EEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEE
Q 012887          183 GRWLLNSDNLEFIDQIGPNSFKGVYKGK-------------RVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQF  248 (454)
Q Consensus       183 ~~~~~~~~~~~~~~~LG~G~fG~Vy~g~-------------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~~  248 (454)
                      ..|.+..++|++++.||+|+||.||+|+             .||+|.++.. ........+.+|+.++..+ +||||+++
T Consensus        74 ~~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~  152 (370)
T 2psq_A           74 PKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINL  152 (370)
T ss_dssp             TTTBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT-CBHHHHHHHHHHHHHHHHSCCCTTBCCE
T ss_pred             ccccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC-cCHHHHHHHHHHHHHHHHhcCCCCEeeE
Confidence            3466777899999999999999999875             4999999743 3334456688999999999 89999999


Q ss_pred             EEEEEeCCCeEEEEEeccCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhcCcccCCccC
Q 012887          249 YCVCVDENHGLCVVTKLMEGGSVNDLILKSR----------------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNS  312 (454)
Q Consensus       249 ~g~~~~~~~~l~lV~E~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp  312 (454)
                      ++++.+.+. +|+||||+++|+|.+++...+                .+++..+..++.||+.||+|||++||+||||||
T Consensus       153 ~~~~~~~~~-~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp  231 (370)
T 2psq_A          153 LGACTQDGP-LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAA  231 (370)
T ss_dssp             EEEECSSSS-CEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCG
T ss_pred             EEEEccCCC-EEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccch
Confidence            999987776 999999999999999996543                478999999999999999999999999999999


Q ss_pred             CcEEEccCCcEEEEccCCccccccCCC--cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCC
Q 012887          313 QRILLDRHGNVCLGDMGIVTACKSVGE--ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYA  389 (454)
Q Consensus       313 ~NILl~~~~~vKL~DFGla~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~  389 (454)
                      +|||++.++.+||+|||+++.......  ......+|+.|+|||++.+..    ++.++|||||||++|||++ |..||.
T Consensus       232 ~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~----~~~~~DvwslG~il~ellt~g~~p~~  307 (370)
T 2psq_A          232 RNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRV----YTHQSDVWSFGVLMWEIFTLGGSPYP  307 (370)
T ss_dssp             GGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCC----CCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             hhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCC----CCcHHHHHHHHHHHHHHHcCCCCCCC
Confidence            999999999999999999886544322  223345678899999998764    5567999999999999999 999999


Q ss_pred             CCCHHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCCC
Q 012887          390 ACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNIS  449 (454)
Q Consensus       390 ~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~  449 (454)
                      +....+... ....+.++..|..++.++.++|.+||+.||.+||++.|+++.|+++....
T Consensus       308 ~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~  366 (370)
T 2psq_A          308 GIPVEELFK-LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT  366 (370)
T ss_dssp             TCCGGGHHH-HHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             CCCHHHHHH-HHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence            876655443 44556677888999999999999999999999999999999999987543

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=2.2e-47  Score=383.56  Aligned_cols=260  Identities=25%  Similarity=0.438  Sum_probs=224.0

Q ss_pred             cceeecCCCEEEeceeeccCCceEEEe-----------EEEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEEEE
Q 012887          183 GRWLLNSDNLEFIDQIGPNSFKGVYKG-----------KRVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYC  250 (454)
Q Consensus       183 ~~~~~~~~~~~~~~~LG~G~fG~Vy~g-----------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~~~g  250 (454)
                      ..|.+..++|++.+.||+|+||.||+|           +.||+|.++.. ........+.+|+.++.++ +||||+++++
T Consensus        15 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpniv~~~~   93 (359)
T 3vhe_A           15 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVNLLG   93 (359)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             ccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCc-CCHHHHHHHHHHHHHHHhhcCCcceeeeee
Confidence            567788899999999999999999997           47999999743 3333456688999999999 7899999999


Q ss_pred             EEEeCCCeEEEEEeccCCCCHHHHHHhCCC--------------------------------------------------
Q 012887          251 VCVDENHGLCVVTKLMEGGSVNDLILKSRK--------------------------------------------------  280 (454)
Q Consensus       251 ~~~~~~~~l~lV~E~~~~gsL~~~l~~~~~--------------------------------------------------  280 (454)
                      ++.+.+..+++||||+++|+|.+++.....                                                  
T Consensus        94 ~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  173 (359)
T 3vhe_A           94 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSL  173 (359)
T ss_dssp             EECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC--------------------------------------------
T ss_pred             eeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccccc
Confidence            998876668999999999999999965432                                                  


Q ss_pred             ----------------CCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCC--ccc
Q 012887          281 ----------------LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE--ATE  342 (454)
Q Consensus       281 ----------------l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~--~~~  342 (454)
                                      +++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........  ...
T Consensus       174 ~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~  253 (359)
T 3vhe_A          174 SDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG  253 (359)
T ss_dssp             ----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC-
T ss_pred             chhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhcc
Confidence                            89999999999999999999999999999999999999999999999999876543322  223


Q ss_pred             ccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHHHHH
Q 012887          343 YETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLM  421 (454)
Q Consensus       343 ~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~li  421 (454)
                      ...+|+.|+|||++.+..    ++.++|||||||++|||++ |..||.+.............+.....|..+++++.++|
T Consensus       254 ~~~~t~~y~aPE~~~~~~----~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  329 (359)
T 3vhe_A          254 DARLPLKWMAPETIFDRV----YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTM  329 (359)
T ss_dssp             -CEECGGGCCHHHHHHCC----CCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHH
T ss_pred             ccCCCceeEChhhhcCCC----CCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence            345678899999998654    4567999999999999998 99999987766666666777778888999999999999


Q ss_pred             HHhcccCCCCCCCHHHHHHHHHhhcC
Q 012887          422 IKCWNNSPSKRPQFSEIISLLLRTNN  447 (454)
Q Consensus       422 ~~cl~~dP~~RPs~~ell~~L~~~~~  447 (454)
                      .+||+.||.+|||+.|++++|+.+.+
T Consensus       330 ~~~l~~dP~~Rps~~ell~~L~~~~~  355 (359)
T 3vhe_A          330 LDCWHGEPSQRPTFSELVEHLGNLLQ  355 (359)
T ss_dssp             HHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHccCChhhCCCHHHHHHHHHHHHH
Confidence            99999999999999999999998764

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=9.4e-47  Score=378.77  Aligned_cols=249  Identities=16%  Similarity=0.290  Sum_probs=216.0

Q ss_pred             cCCCEEEeceeeccCCceEEEe------EEEEEEEeecCCC-CchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEE
Q 012887          188 NSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDK-GNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLC  260 (454)
Q Consensus       188 ~~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~  260 (454)
                      ..++|++++.||+|+||.||++      +.+|+|.++.... .......+.+|+.++..++||||+++++++.+.+. +|
T Consensus         3 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~-~~   81 (337)
T 1o6l_A            3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDR-LC   81 (337)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSE-EE
T ss_pred             ChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCE-EE
Confidence            3478999999999999999985      5799999974311 11233457789999999999999999999998776 99


Q ss_pred             EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCc
Q 012887          261 VVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA  340 (454)
Q Consensus       261 lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~  340 (454)
                      +||||+++|+|.+++.+.+.+++..+..++.||+.||+|||++||+||||||+|||++.+|++||+|||+++........
T Consensus        82 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~  161 (337)
T 1o6l_A           82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT  161 (337)
T ss_dssp             EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCC
T ss_pred             EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCCc
Confidence            99999999999999988889999999999999999999999999999999999999999999999999998865444444


Q ss_pred             ccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHHHH
Q 012887          341 TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSL  420 (454)
Q Consensus       341 ~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~l  420 (454)
                      .....||+.|+|||++.+..++    .++|||||||++|||++|..||.+.+.......+...  ...+|..+++++.++
T Consensus       162 ~~~~~gt~~y~aPE~~~~~~~~----~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~l  235 (337)
T 1o6l_A          162 MKTFCGTPEYLAPEVLEDNDYG----RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME--EIRFPRTLSPEAKSL  235 (337)
T ss_dssp             BCCCEECGGGCCGGGGSSSCBC----TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTTSCHHHHHH
T ss_pred             ccccccChhhCChhhhcCCCCC----chhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHHHHHH
Confidence            5556789999999999876544    4599999999999999999999988887777666664  345788899999999


Q ss_pred             HHHhcccCCCCCC-----CHHHHHHHHH
Q 012887          421 MIKCWNNSPSKRP-----QFSEIISLLL  443 (454)
Q Consensus       421 i~~cl~~dP~~RP-----s~~ell~~L~  443 (454)
                      |.+||+.||.+||     ++.|+++|-+
T Consensus       236 i~~lL~~dP~~R~g~~~~~~~ei~~h~~  263 (337)
T 1o6l_A          236 LAGLLKKDPKQRLGGGPSDAKEVMEHRF  263 (337)
T ss_dssp             HHHHTCSSTTTSTTCSTTTHHHHHTSGG
T ss_pred             HHHHhhcCHHHhcCCCCCCHHHHHcCCC
Confidence            9999999999999     8999998754

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=9.5e-47  Score=375.94  Aligned_cols=260  Identities=26%  Similarity=0.440  Sum_probs=219.4

Q ss_pred             eecCCCEEEeceeeccCCceEEEeEE---------EEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCC
Q 012887          186 LLNSDNLEFIDQIGPNSFKGVYKGKR---------VGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN  256 (454)
Q Consensus       186 ~~~~~~~~~~~~LG~G~fG~Vy~g~~---------vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~  256 (454)
                      .+..++|++.+.||+|+||.||+|+.         ||+|.++.. ........+.+|+.++..++||||+++++++.+.+
T Consensus        45 ~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  123 (325)
T 3kul_A           45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAG-YTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGR  123 (325)
T ss_dssp             BCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTT-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGG
T ss_pred             ccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCC-CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence            45668999999999999999999753         999999743 23445567889999999999999999999998776


Q ss_pred             CeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccc
Q 012887          257 HGLCVVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK  335 (454)
Q Consensus       257 ~~l~lV~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~  335 (454)
                      . +++||||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus       124 ~-~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  202 (325)
T 3kul_A          124 L-AMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE  202 (325)
T ss_dssp             C-CEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred             c-cEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence            6 89999999999999999654 589999999999999999999999999999999999999999999999999988765


Q ss_pred             cCCCc---ccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHcCCCCCCCC
Q 012887          336 SVGEA---TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPK  411 (454)
Q Consensus       336 ~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~  411 (454)
                      .....   .....+|+.|+|||++.+..    ++.++|||||||++|+|++ |..||.+.........+. .+.+.+.|.
T Consensus       203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~----~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~  277 (325)
T 3kul_A          203 DDPDAAYTTTGGKIPIRWTAPEAIAFRT----FSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVE-EGYRLPAPM  277 (325)
T ss_dssp             ----CCEECC---CCGGGSCHHHHHHCE----ECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHH-TTCCCCCCT
T ss_pred             cCccceeeccCCCCcccccCHhHhcCCC----CCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH-cCCCCCCCC
Confidence            43222   22224567899999998664    4456999999999999999 999999887776655544 456777888


Q ss_pred             CccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCCCCCC
Q 012887          412 DCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNSS  452 (454)
Q Consensus       412 ~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~~~  452 (454)
                      .+++.+.++|.+||..||.+|||+.++++.|+.+....++.
T Consensus       278 ~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~~  318 (325)
T 3kul_A          278 GCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPESL  318 (325)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC--
T ss_pred             CcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcccc
Confidence            99999999999999999999999999999999988766543

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=1.1e-46  Score=362.42  Aligned_cols=257  Identities=23%  Similarity=0.441  Sum_probs=225.5

Q ss_pred             eeecCCCEEEeceeeccCCceEEEe----EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCC-CeE
Q 012887          185 WLLNSDNLEFIDQIGPNSFKGVYKG----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN-HGL  259 (454)
Q Consensus       185 ~~~~~~~~~~~~~LG~G~fG~Vy~g----~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~-~~l  259 (454)
                      +.+..++|++.+.||+|+||.||+|    +.+|+|.++...........+.+|+.++..++||||+++++++.+.+ ...
T Consensus         5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   84 (271)
T 3kmu_A            5 SGIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHP   84 (271)
T ss_dssp             CCCCGGGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSC
T ss_pred             CCCCHHHhHHHHHhcCCCcceEEEEEECCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCe
Confidence            3456688999999999999999996    57999999866555556677899999999999999999999998762 348


Q ss_pred             EEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhcC--cccCCccCCcEEEccCCcEEEEccCCccccc
Q 012887          260 CVVTKLMEGGSVNDLILKSR--KLQTKEIIRIAIDVAEGIKFLNDHG--VAYRDLNSQRILLDRHGNVCLGDMGIVTACK  335 (454)
Q Consensus       260 ~lV~E~~~~gsL~~~l~~~~--~l~~~~~~~i~~qI~~gL~yLH~~~--iiHrDIKp~NILl~~~~~vKL~DFGla~~~~  335 (454)
                      ++||||+++|+|.+++.+..  .+++..+..++.||+.||.|||+++  ++||||||+|||++.++.++|+|||++....
T Consensus        85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~  164 (271)
T 3kmu_A           85 TLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ  164 (271)
T ss_dssp             EEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred             EeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeec
Confidence            99999999999999997654  5899999999999999999999999  9999999999999999999999998865432


Q ss_pred             cCCCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccH
Q 012887          336 SVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ  415 (454)
Q Consensus       336 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~  415 (454)
                           .....+|+.|+|||.+.+..+.. ++.++||||||+++|+|++|..||.+.+.......+...+.++..|..+++
T Consensus       165 -----~~~~~~t~~y~aPE~~~~~~~~~-~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (271)
T 3kmu_A          165 -----SPGRMYAPAWVAPEALQKKPEDT-NRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISP  238 (271)
T ss_dssp             -----CTTCBSCGGGSCHHHHHSCGGGS-CHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCTTCCH
T ss_pred             -----ccCccCCccccChhhhccCCCCC-CCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCCCCCH
Confidence                 23346789999999998765432 344799999999999999999999999888888888888888899999999


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 012887          416 ILKSLMIKCWNNSPSKRPQFSEIISLLLRTNN  447 (454)
Q Consensus       416 ~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~  447 (454)
                      ++.+++.+||+.||.+|||+.++++.|.++.+
T Consensus       239 ~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~  270 (271)
T 3kmu_A          239 HVSKLMKICMNEDPAKRPKFDMIVPILEKMQD  270 (271)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence            99999999999999999999999999998764

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.4e-46  Score=361.46  Aligned_cols=256  Identities=24%  Similarity=0.523  Sum_probs=219.0

Q ss_pred             cceeecCCCEEEeceeeccCCceEEEe-----EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCC
Q 012887          183 GRWLLNSDNLEFIDQIGPNSFKGVYKG-----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH  257 (454)
Q Consensus       183 ~~~~~~~~~~~~~~~LG~G~fG~Vy~g-----~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~  257 (454)
                      +.|.+..++|++.+.||+|+||.||+|     +.||+|++.....   ....+.+|+.++.+++||||+++++++.+.+.
T Consensus         3 ~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   79 (269)
T 4hcu_A            3 GKWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM---SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAP   79 (269)
T ss_dssp             --CBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB---CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             ccEEeChhhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc---CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCc
Confidence            568899999999999999999999996     4699999974332   23568899999999999999999999987776


Q ss_pred             eEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCcccccc
Q 012887          258 GLCVVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS  336 (454)
Q Consensus       258 ~l~lV~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~  336 (454)
                       .++||||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus        80 -~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  158 (269)
T 4hcu_A           80 -ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD  158 (269)
T ss_dssp             -EEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred             -eEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccc
Confidence             99999999999999999654 4799999999999999999999999999999999999999999999999999876543


Q ss_pred             CCC-cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHcCCCCCCCCCcc
Q 012887          337 VGE-ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCP  414 (454)
Q Consensus       337 ~~~-~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~  414 (454)
                      ... ......+++.|+|||.+.+..    ++.++||||||+++|+|++ |..||...........+. .+.++..|..++
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~  233 (269)
T 4hcu_A          159 DQYTSSTGTKFPVKWASPEVFSFSR----YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS-TGFRLYKPRLAS  233 (269)
T ss_dssp             HHHHSTTSTTCCGGGCCHHHHHHCC----CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-TTCCCCCCTTSC
T ss_pred             cccccccCcccccccCCHHHhcCCC----CCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh-cCccCCCCCcCC
Confidence            211 122334577899999997664    4557999999999999999 999999887776655554 456667788899


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 012887          415 QILKSLMIKCWNNSPSKRPQFSEIISLLLRTNN  447 (454)
Q Consensus       415 ~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~  447 (454)
                      +.+.+++.+||+.||.+||++.+++++|+++.+
T Consensus       234 ~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~  266 (269)
T 4hcu_A          234 THVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  266 (269)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence            999999999999999999999999999998764

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=2e-46  Score=368.79  Aligned_cols=247  Identities=21%  Similarity=0.380  Sum_probs=214.3

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  263 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~  263 (454)
                      ++|++++.||+|+||.||++      +.||+|.+.......  ...+.+|+.++..++||||+++++++.+.+. +++||
T Consensus        20 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~-~~lv~   96 (297)
T 3fxz_A           20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLVGDE-LWVVM   96 (297)
T ss_dssp             GTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHHCCCTTBCCEEEEEEETTE-EEEEE
T ss_pred             hceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH--HHHHHHHHHHHhcCCCCCCCeEeEEEEECCE-EEEEE
Confidence            67899999999999999996      479999987543332  3457899999999999999999999998876 99999


Q ss_pred             eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCcccc
Q 012887          264 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY  343 (454)
Q Consensus       264 E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~  343 (454)
                      ||+++|+|.+++.+. .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++............
T Consensus        97 e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  175 (297)
T 3fxz_A           97 EYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST  175 (297)
T ss_dssp             ECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCC
T ss_pred             ECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccccCC
Confidence            999999999998654 6999999999999999999999999999999999999999999999999998876655545556


Q ss_pred             cCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCC-CCCCCCCccHHHHHHHH
Q 012887          344 ETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGL-RPEIPKDCPQILKSLMI  422 (454)
Q Consensus       344 ~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~-~~~~p~~~~~~l~~li~  422 (454)
                      ..||+.|+|||.+.+..+    +.++|||||||++|+|++|..||.+..+......+..... ....|..+++.+.++|.
T Consensus       176 ~~gt~~y~aPE~~~~~~~----~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  251 (297)
T 3fxz_A          176 MVGTPYWMAPEVVTRKAY----GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN  251 (297)
T ss_dssp             CCSCGGGCCHHHHHCSCB----CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHHHH
T ss_pred             ccCCcCccChhhhcCCCC----CcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHHHH
Confidence            678999999999987654    4569999999999999999999998888776666554433 34457789999999999


Q ss_pred             HhcccCCCCCCCHHHHHHHHHh
Q 012887          423 KCWNNSPSKRPQFSEIISLLLR  444 (454)
Q Consensus       423 ~cl~~dP~~RPs~~ell~~L~~  444 (454)
                      +||+.||.+|||+.|++++-+-
T Consensus       252 ~~l~~dp~~Rps~~ell~h~~~  273 (297)
T 3fxz_A          252 RCLEMDVEKRGSAKELLQHQFL  273 (297)
T ss_dssp             HHSCSSTTTSCCHHHHTTCGGG
T ss_pred             HHccCChhHCcCHHHHhhChhh
Confidence            9999999999999999987554

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=6.8e-46  Score=377.82  Aligned_cols=261  Identities=25%  Similarity=0.485  Sum_probs=223.7

Q ss_pred             cceeecCCCEEEeceeeccCCceEEEeE-------------EEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEE
Q 012887          183 GRWLLNSDNLEFIDQIGPNSFKGVYKGK-------------RVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQF  248 (454)
Q Consensus       183 ~~~~~~~~~~~~~~~LG~G~fG~Vy~g~-------------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~~  248 (454)
                      ..|.+..++|++.+.||+|+||.||+++             .||+|+++.. ........+.+|+.++..+ +||||+++
T Consensus        62 ~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hpnIv~~  140 (382)
T 3tt0_A           62 PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-ATEKDLSDLISEMEMMKMIGKHKNIINL  140 (382)
T ss_dssp             TTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             cccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc-cCHHHHHHHHHHHHHHHHhcCCchhhhh
Confidence            5677888999999999999999999985             5999999743 3334456788999999999 89999999


Q ss_pred             EEEEEeCCCeEEEEEeccCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhcCcccCCccC
Q 012887          249 YCVCVDENHGLCVVTKLMEGGSVNDLILKSR----------------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNS  312 (454)
Q Consensus       249 ~g~~~~~~~~l~lV~E~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp  312 (454)
                      ++++.+.+. +++||||+++|+|.+++....                .+++..++.++.||+.||.|||++||+||||||
T Consensus       141 ~~~~~~~~~-~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp  219 (382)
T 3tt0_A          141 LGACTQDGP-LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAA  219 (382)
T ss_dssp             EEEECSSSS-CEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred             eeeeccCCc-eEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCc
Confidence            999988776 899999999999999996543                499999999999999999999999999999999


Q ss_pred             CcEEEccCCcEEEEccCCccccccCCC--cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCC
Q 012887          313 QRILLDRHGNVCLGDMGIVTACKSVGE--ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYA  389 (454)
Q Consensus       313 ~NILl~~~~~vKL~DFGla~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~  389 (454)
                      +|||++.++.+||+|||++........  ......+|+.|+|||++.+..    ++.++|||||||++|+|++ |..||.
T Consensus       220 ~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~----~~~~~DiwslG~il~ellt~g~~p~~  295 (382)
T 3tt0_A          220 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI----YTHQSDVWSFGVLLWEIFTLGGSPYP  295 (382)
T ss_dssp             GGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCC----CCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             ceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCC----CCchhHHHHHHHHHHHHHhCCCCCCC
Confidence            999999999999999999876544322  233345678899999998764    4567999999999999999 999999


Q ss_pred             CCCHHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCCCC
Q 012887          390 ACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISN  450 (454)
Q Consensus       390 ~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~  450 (454)
                      +....... .....+.++..|..+++++.++|.+||+.||.+|||+.|++++|+++.....
T Consensus       296 ~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~  355 (382)
T 3tt0_A          296 GVPVEELF-KLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTS  355 (382)
T ss_dssp             TCCHHHHH-HHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSC
T ss_pred             CCCHHHHH-HHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence            87766544 4445566777888999999999999999999999999999999999876543

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=3.5e-46  Score=372.20  Aligned_cols=262  Identities=24%  Similarity=0.450  Sum_probs=220.0

Q ss_pred             cceeecCCCEEEeceeeccCCceEEEe-----------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEE
Q 012887          183 GRWLLNSDNLEFIDQIGPNSFKGVYKG-----------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV  251 (454)
Q Consensus       183 ~~~~~~~~~~~~~~~LG~G~fG~Vy~g-----------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~  251 (454)
                      ..+.+..++|++++.||+|+||.||+|           +.||+|.++.. ........+.+|+.++..++||||++++++
T Consensus        40 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~  118 (343)
T 1luf_A           40 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE-ASADMQADFQREAALMAEFDNPNIVKLLGV  118 (343)
T ss_dssp             HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             ceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence            345567789999999999999999996           46899998743 233445678899999999999999999999


Q ss_pred             EEeCCCeEEEEEeccCCCCHHHHHHhC------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCccc
Q 012887          252 CVDENHGLCVVTKLMEGGSVNDLILKS------------------------RKLQTKEIIRIAIDVAEGIKFLNDHGVAY  307 (454)
Q Consensus       252 ~~~~~~~l~lV~E~~~~gsL~~~l~~~------------------------~~l~~~~~~~i~~qI~~gL~yLH~~~iiH  307 (454)
                      +.+.+. +++||||+++|+|.+++.+.                        ..+++..++.++.||+.||.|||++||+|
T Consensus       119 ~~~~~~-~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH  197 (343)
T 1luf_A          119 CAVGKP-MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVH  197 (343)
T ss_dssp             ECSSSS-CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             EccCCc-eEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence            987776 89999999999999999653                        56899999999999999999999999999


Q ss_pred             CCccCCcEEEccCCcEEEEccCCccccccCC--CcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-C
Q 012887          308 RDLNSQRILLDRHGNVCLGDMGIVTACKSVG--EATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-G  384 (454)
Q Consensus       308 rDIKp~NILl~~~~~vKL~DFGla~~~~~~~--~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G  384 (454)
                      |||||+|||++.++.+||+|||++.......  .......+++.|+|||.+.+..    ++.++||||||+++|+|++ |
T Consensus       198 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~----~~~~~Di~slG~il~el~t~g  273 (343)
T 1luf_A          198 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNR----YTTESDVWAYGVVLWEIFSYG  273 (343)
T ss_dssp             SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCC----CCHHHHHHHHHHHHHHHHTTT
T ss_pred             CCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCC----cCcccccHHHHHHHHHHHhcC
Confidence            9999999999999999999999987654322  1223345788999999998664    4567999999999999999 9


Q ss_pred             CCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCCCCC
Q 012887          385 EAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNS  451 (454)
Q Consensus       385 ~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~~  451 (454)
                      ..||.+.........+. .+..+..|..+++.+.++|.+||+.||.+||++.+++++|+++....+.
T Consensus       274 ~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~~  339 (343)
T 1luf_A          274 LQPYYGMAHEEVIYYVR-DGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAEG  339 (343)
T ss_dssp             CCTTTTSCHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC----
T ss_pred             CCcCCCCChHHHHHHHh-CCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhhh
Confidence            99999887766655544 4555677889999999999999999999999999999999999877654

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=8.2e-46  Score=385.38  Aligned_cols=249  Identities=17%  Similarity=0.237  Sum_probs=216.6

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  263 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~  263 (454)
                      ++|++++.||+|+||.||++      +.+|+|.+............+.+|+.++..++||||+++++++.+.+. .|+||
T Consensus        11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~-~~lv~   89 (444)
T 3soa_A           11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGH-HYLIF   89 (444)
T ss_dssp             HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSE-EEEEE
T ss_pred             CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCE-EEEEE
Confidence            67999999999999999985      679999998655444455678899999999999999999999988776 99999


Q ss_pred             eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEc---cCCcEEEEccCCccccccCCCc
Q 012887          264 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLD---RHGNVCLGDMGIVTACKSVGEA  340 (454)
Q Consensus       264 E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~---~~~~vKL~DFGla~~~~~~~~~  340 (454)
                      ||+++|+|.+.+...+.+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||++.........
T Consensus        90 E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~~  169 (444)
T 3soa_A           90 DLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQA  169 (444)
T ss_dssp             CCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCCB
T ss_pred             EeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCce
Confidence            9999999999998888999999999999999999999999999999999999998   4578999999999876655444


Q ss_pred             ccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCC--CCccHHHH
Q 012887          341 TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIP--KDCPQILK  418 (454)
Q Consensus       341 ~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p--~~~~~~l~  418 (454)
                      .....||+.|+|||++.+..+    +.++|||||||++|+|++|..||.+.+.......+.......+.+  ..+++++.
T Consensus       170 ~~~~~gt~~Y~APE~l~~~~~----~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  245 (444)
T 3soa_A          170 WFGFAGTPGYLSPEVLRKDPY----GKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAK  245 (444)
T ss_dssp             CCCSCSCGGGCCHHHHTTCCB----CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHH
T ss_pred             eecccCCcccCCHHHhcCCCC----CCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHHH
Confidence            455679999999999987654    456999999999999999999999988888877777765554433  46899999


Q ss_pred             HHHHHhcccCCCCCCCHHHHHHHHH
Q 012887          419 SLMIKCWNNSPSKRPQFSEIISLLL  443 (454)
Q Consensus       419 ~li~~cl~~dP~~RPs~~ell~~L~  443 (454)
                      +||.+||+.||.+|||+.|+++|-|
T Consensus       246 ~li~~~L~~dP~~Rpta~e~L~hp~  270 (444)
T 3soa_A          246 DLINKMLTINPSKRITAAEALKHPW  270 (444)
T ss_dssp             HHHHHHSCSSTTTSCCHHHHHHSCT
T ss_pred             HHHHHHcCCChhHCCCHHHHhcCcc
Confidence            9999999999999999999998755

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=6.2e-46  Score=358.05  Aligned_cols=257  Identities=24%  Similarity=0.461  Sum_probs=218.1

Q ss_pred             ceeecCCCEEEeceeeccCCceEEEeE-----EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCe
Q 012887          184 RWLLNSDNLEFIDQIGPNSFKGVYKGK-----RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHG  258 (454)
Q Consensus       184 ~~~~~~~~~~~~~~LG~G~fG~Vy~g~-----~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~  258 (454)
                      .+.+..++|++++.||+|+||.||+++     .||+|.++....   ....+.+|+.++..++||||+++++++.+.+. 
T Consensus         2 ~~~l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~-   77 (268)
T 3sxs_A            2 HMELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM---SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYP-   77 (268)
T ss_dssp             TTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB---CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS-
T ss_pred             ceEechhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC---cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCc-
Confidence            355677899999999999999999964     799999974332   23567899999999999999999999987766 


Q ss_pred             EEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccC
Q 012887          259 LCVVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV  337 (454)
Q Consensus       259 l~lV~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~  337 (454)
                      .++||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus        78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~  157 (268)
T 3sxs_A           78 IYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD  157 (268)
T ss_dssp             EEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTT
T ss_pred             eEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchh
Confidence            99999999999999999654 46999999999999999999999999999999999999999999999999998765443


Q ss_pred             CCc-ccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHcCCCCCCCCCccH
Q 012887          338 GEA-TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ  415 (454)
Q Consensus       338 ~~~-~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~  415 (454)
                      ... .....+++.|+|||.+.+..++    .++||||||+++|+|++ |..||...........+. .+.+...|..+++
T Consensus       158 ~~~~~~~~~~~~~y~aPE~~~~~~~~----~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~  232 (268)
T 3sxs_A          158 QYVSSVGTKFPVKWSAPEVFHYFKYS----SKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVS-QGHRLYRPHLASD  232 (268)
T ss_dssp             CEEECCSCCCCGGGCCHHHHHHSEEE----TTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH-TTCCCCCCTTSCH
T ss_pred             hhhcccCCCcCcccCCHHHHhccCCc----hhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHH-cCCCCCCCCcChH
Confidence            221 2233456789999999876544    45999999999999999 999999887776665554 3456667788899


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCCC
Q 012887          416 ILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNIS  449 (454)
Q Consensus       416 ~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~  449 (454)
                      .+.+++.+||+.||.+|||+.+++++|+.+.+..
T Consensus       233 ~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~  266 (268)
T 3sxs_A          233 TIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKD  266 (268)
T ss_dssp             HHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC--
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhcc
Confidence            9999999999999999999999999999987653

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=4.2e-46  Score=387.88  Aligned_cols=253  Identities=24%  Similarity=0.488  Sum_probs=218.4

Q ss_pred             cceeecCCCEEEeceeeccCCceEEEe----EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCe
Q 012887          183 GRWLLNSDNLEFIDQIGPNSFKGVYKG----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHG  258 (454)
Q Consensus       183 ~~~~~~~~~~~~~~~LG~G~fG~Vy~g----~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~  258 (454)
                      ..|.++.++|++.+.||+|+||.||+|    +.||||.++...    ....+.+|+.++.+++||||+++++++.+.+..
T Consensus       186 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  261 (450)
T 1k9a_A          186 SGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG  261 (450)
T ss_dssp             TTCBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSC
T ss_pred             cccccChHHeEEEeeecCcCCeeEEEEEecCCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCc
Confidence            468889999999999999999999995    679999997532    234678999999999999999999999887655


Q ss_pred             EEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCcccccc
Q 012887          259 LCVVTKLMEGGSVNDLILKSR--KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS  336 (454)
Q Consensus       259 l~lV~E~~~~gsL~~~l~~~~--~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~  336 (454)
                      +++||||+++|+|.+++.+.+  .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       262 ~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  341 (450)
T 1k9a_A          262 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  341 (450)
T ss_dssp             EEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC-
T ss_pred             eEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccc
Confidence            999999999999999997544  479999999999999999999999999999999999999999999999999875432


Q ss_pred             CCCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHcCCCCCCCCCccH
Q 012887          337 VGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ  415 (454)
Q Consensus       337 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~  415 (454)
                      .   .....+++.|+|||.+.+..    ++.++|||||||++|||++ |..||...+..+....+ ..+.+++.|..+|+
T Consensus       342 ~---~~~~~~~~~y~aPE~~~~~~----~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i-~~~~~~~~p~~~~~  413 (450)
T 1k9a_A          342 T---QDTGKLPVKWTAPEALREKK----FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV-EKGYKMDAPDGCPP  413 (450)
T ss_dssp             --------CCCTTTSCHHHHHSSC----CCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHH-HTTCCCCCCTTCCH
T ss_pred             c---ccCCCCCcceeCHHHhcCCC----CCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-HcCCCCCCCCcCCH
Confidence            2   22335678899999998664    5567999999999999998 99999987666555444 45678888999999


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 012887          416 ILKSLMIKCWNNSPSKRPQFSEIISLLLRTNN  447 (454)
Q Consensus       416 ~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~  447 (454)
                      .+.++|.+||+.||.+|||+.++++.|+.+..
T Consensus       414 ~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~  445 (450)
T 1k9a_A          414 AVYDVMKNCWHLDAATRPTFLQLREQLEHIRT  445 (450)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence            99999999999999999999999999988764

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=8.2e-47  Score=384.14  Aligned_cols=259  Identities=25%  Similarity=0.477  Sum_probs=219.3

Q ss_pred             cceeecCCCEEEeceeeccCCceEEEeE------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCC
Q 012887          183 GRWLLNSDNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN  256 (454)
Q Consensus       183 ~~~~~~~~~~~~~~~LG~G~fG~Vy~g~------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~  256 (454)
                      ..|.++.++|++.+.||+|+||.||+|+      .||+|.++.. ........+.+|+.++..++||||+++++++.+.+
T Consensus       107 ~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  185 (377)
T 3cbl_A          107 DKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQ  185 (377)
T ss_dssp             CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT-SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             cccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc-CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCC
Confidence            4678888999999999999999999964      6999998743 23334456789999999999999999999998776


Q ss_pred             CeEEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccc
Q 012887          257 HGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK  335 (454)
Q Consensus       257 ~~l~lV~E~~~~gsL~~~l~~~~-~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~  335 (454)
                      . +++||||+++|+|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus       186 ~-~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~  264 (377)
T 3cbl_A          186 P-IYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEA  264 (377)
T ss_dssp             S-CEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECT
T ss_pred             C-cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecC
Confidence            6 899999999999999996543 79999999999999999999999999999999999999999999999999987543


Q ss_pred             cCCCcc--cccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHcCCCCCCCCC
Q 012887          336 SVGEAT--EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKD  412 (454)
Q Consensus       336 ~~~~~~--~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~  412 (454)
                      ......  ....+++.|+|||.+.+..    ++.++|||||||++|||++ |..||.+.+...... ....+.+++.|..
T Consensus       265 ~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~  339 (377)
T 3cbl_A          265 DGVYAASGGLRQVPVKWTAPEALNYGR----YSSESDVWSFGILLWETFSLGASPYPNLSNQQTRE-FVEKGGRLPCPEL  339 (377)
T ss_dssp             TSEEECCSSCCEEEGGGSCHHHHHHCE----EEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHH-HHHTTCCCCCCTT
T ss_pred             CCceeecCCCCCCCcCcCCHhHhccCC----CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-HHHcCCCCCCCCC
Confidence            321111  1112456799999998664    4556999999999999998 999999877765544 4455677788999


Q ss_pred             ccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCC
Q 012887          413 CPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNI  448 (454)
Q Consensus       413 ~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~  448 (454)
                      +|+++.++|.+||+.||.+|||+.++++.|+++.+.
T Consensus       340 ~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~  375 (377)
T 3cbl_A          340 CPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR  375 (377)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence            999999999999999999999999999999987653

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=4.6e-46  Score=366.26  Aligned_cols=262  Identities=24%  Similarity=0.435  Sum_probs=224.7

Q ss_pred             cceeecCCCEEEeceeeccCCceEEEeE-----------EEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEEEE
Q 012887          183 GRWLLNSDNLEFIDQIGPNSFKGVYKGK-----------RVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYC  250 (454)
Q Consensus       183 ~~~~~~~~~~~~~~~LG~G~fG~Vy~g~-----------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~~~g  250 (454)
                      ..|.+..++|++.+.||+|+||.||+|+           .||+|.++.. ........+.+|+.++.++ +||||+++++
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~   94 (313)
T 1t46_A           16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS-AHLTEREALMSELKVLSYLGNHMNIVNLLG   94 (313)
T ss_dssp             GGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             cccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcc-hhHHHHHHHHHHHHHHhhcccCCCeeeEEE
Confidence            5677888999999999999999999874           7999999743 2333456788999999999 8999999999


Q ss_pred             EEEeCCCeEEEEEeccCCCCHHHHHHhCC------------------CCCHHHHHHHHHHHHHHHHHHHhcCcccCCccC
Q 012887          251 VCVDENHGLCVVTKLMEGGSVNDLILKSR------------------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNS  312 (454)
Q Consensus       251 ~~~~~~~~l~lV~E~~~~gsL~~~l~~~~------------------~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp  312 (454)
                      ++.+.+. .++||||+++|+|.+++....                  .+++..+..++.||+.||.|||++||+||||||
T Consensus        95 ~~~~~~~-~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp  173 (313)
T 1t46_A           95 ACTIGGP-TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAA  173 (313)
T ss_dssp             EECSSSS-CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred             EEecCCC-cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCcc
Confidence            9988776 899999999999999996543                  489999999999999999999999999999999


Q ss_pred             CcEEEccCCcEEEEccCCccccccCCCc--ccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCC
Q 012887          313 QRILLDRHGNVCLGDMGIVTACKSVGEA--TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYA  389 (454)
Q Consensus       313 ~NILl~~~~~vKL~DFGla~~~~~~~~~--~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~  389 (454)
                      +|||++.++.+||+|||++.........  .....+++.|+|||.+.+..    ++.++||||||+++|+|++ |..||.
T Consensus       174 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~Di~slG~il~ellt~g~~p~~  249 (313)
T 1t46_A          174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCV----YTFESDVWSYGIFLWELFSLGSSPYP  249 (313)
T ss_dssp             GGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCC----CCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred             ceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCC----CChHHHHHHHHHHHHHHHhCCCCCCC
Confidence            9999999999999999998766543321  22234577899999987654    5567999999999999999 999999


Q ss_pred             CCCHHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCCCC
Q 012887          390 ACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISN  450 (454)
Q Consensus       390 ~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~  450 (454)
                      +.............+.+...+..+++.+.++|.+||+.||.+|||+.|++++|++......
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~  310 (313)
T 1t46_A          250 GMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISEST  310 (313)
T ss_dssp             TCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred             cccchhHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHhh
Confidence            8776666666666677777788899999999999999999999999999999998876544

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.7e-46  Score=373.80  Aligned_cols=261  Identities=22%  Similarity=0.382  Sum_probs=220.9

Q ss_pred             cceeecCCCEEEeceeeccCCceEEEeE-----------EEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEEEE
Q 012887          183 GRWLLNSDNLEFIDQIGPNSFKGVYKGK-----------RVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYC  250 (454)
Q Consensus       183 ~~~~~~~~~~~~~~~LG~G~fG~Vy~g~-----------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~~~g  250 (454)
                      ..|.+..++|++.+.||+|+||.||+|.           .||+|.+.... .......+.+|+.++.++ +||||+++++
T Consensus        38 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~  116 (344)
T 1rjb_A           38 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLG  116 (344)
T ss_dssp             GGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             cCcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence            4577888999999999999999999976           49999997432 223345688999999999 8999999999


Q ss_pred             EEEeCCCeEEEEEeccCCCCHHHHHHhCC-----------------------CCCHHHHHHHHHHHHHHHHHHHhcCccc
Q 012887          251 VCVDENHGLCVVTKLMEGGSVNDLILKSR-----------------------KLQTKEIIRIAIDVAEGIKFLNDHGVAY  307 (454)
Q Consensus       251 ~~~~~~~~l~lV~E~~~~gsL~~~l~~~~-----------------------~l~~~~~~~i~~qI~~gL~yLH~~~iiH  307 (454)
                      ++.+.+. +++||||+++|+|.+++....                       .+++..+..++.||+.||.|||++||+|
T Consensus       117 ~~~~~~~-~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH  195 (344)
T 1rjb_A          117 ACTLSGP-IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVH  195 (344)
T ss_dssp             EECSSSS-CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEE
T ss_pred             EEeeCCc-cEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence            9988776 899999999999999996543                       3789999999999999999999999999


Q ss_pred             CCccCCcEEEccCCcEEEEccCCccccccCCCc--ccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-C
Q 012887          308 RDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA--TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-G  384 (454)
Q Consensus       308 rDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~--~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G  384 (454)
                      |||||+|||++.++.+||+|||++.........  .....+|+.|+|||.+.+..    ++.++|||||||++|+|++ |
T Consensus       196 ~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~----~~~~~Di~slG~il~el~t~g  271 (344)
T 1rjb_A          196 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGI----YTIKSDVWSYGILLWEIFSLG  271 (344)
T ss_dssp             TTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCC----CCHHHHHHHHHHHHHHHTTTS
T ss_pred             CCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCC----CChhHhHHHHHHHHHHHHcCC
Confidence            999999999999999999999998766443321  22334677899999997654    4567999999999999998 9


Q ss_pred             CCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCCC
Q 012887          385 EAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNIS  449 (454)
Q Consensus       385 ~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~  449 (454)
                      ..||.+.............+.++..|..+++++.++|.+||+.||.+|||+.+++++|+.+....
T Consensus       272 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~  336 (344)
T 1rjb_A          272 VNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADA  336 (344)
T ss_dssp             CCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred             CCCcccCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHH
Confidence            99999877666677777777888888999999999999999999999999999999999887653

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.3e-46  Score=380.10  Aligned_cols=250  Identities=23%  Similarity=0.305  Sum_probs=209.7

Q ss_pred             ecCCCEEEeceeeccCCceEEEe------EEEEEEEeecCCC-CchHHHHHHHHHHHHHhC-CCCceeEEEEEEEeCCCe
Q 012887          187 LNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDK-GNAYEFELRKDLLELMTC-GHKNILQFYCVCVDENHG  258 (454)
Q Consensus       187 ~~~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~-~~~~~~~~~~Ei~~l~~l-~HpnIv~~~g~~~~~~~~  258 (454)
                      +..++|++++.||+|+||.||++      +.+|+|.++.... .......+.+|..++..+ +||||+++++++.+.+. 
T Consensus        20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~-   98 (353)
T 3txo_A           20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDR-   98 (353)
T ss_dssp             ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE-
T ss_pred             CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCE-
Confidence            45589999999999999999986      4799999974311 112234567888888887 79999999999988776 


Q ss_pred             EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCC
Q 012887          259 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG  338 (454)
Q Consensus       259 l~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~  338 (454)
                      +|+||||+++|+|.+++.+.+.+++..+..++.||+.||+|||++||+||||||+|||++.+|++||+|||+++......
T Consensus        99 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~  178 (353)
T 3txo_A           99 LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG  178 (353)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccCC
Confidence            99999999999999999888899999999999999999999999999999999999999999999999999988655444


Q ss_pred             CcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHH
Q 012887          339 EATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILK  418 (454)
Q Consensus       339 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~  418 (454)
                      .......||+.|+|||++.+..+    +.++|||||||++|||++|..||.+.+.......+...  ...+|..+++++.
T Consensus       179 ~~~~~~~gt~~y~aPE~~~~~~~----~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~~~~~~  252 (353)
T 3txo_A          179 VTTATFCGTPDYIAPEILQEMLY----GPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND--EVVYPTWLHEDAT  252 (353)
T ss_dssp             -------CCGGGCCHHHHHHHHC----TTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTTSCHHHH
T ss_pred             ccccccCCCcCeEChhhcCCCCc----CCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHHHH
Confidence            44556679999999999987654    45699999999999999999999998888887777765  4457888999999


Q ss_pred             HHHHHhcccCCCCCCCH------HHHHHHHH
Q 012887          419 SLMIKCWNNSPSKRPQF------SEIISLLL  443 (454)
Q Consensus       419 ~li~~cl~~dP~~RPs~------~ell~~L~  443 (454)
                      ++|.+||+.||.+||++      .|+++|-+
T Consensus       253 ~li~~lL~~dP~~R~~~~~~~~~~~il~hp~  283 (353)
T 3txo_A          253 GILKSFMTKNPTMRLGSLTQGGEHAILRHPF  283 (353)
T ss_dssp             HHHHHHTCSSGGGSTTSGGGTCTHHHHTSGG
T ss_pred             HHHHHHhhhCHHHccCCcccCCHHHHhhCCc
Confidence            99999999999999998      88887654

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=7e-46  Score=363.77  Aligned_cols=254  Identities=18%  Similarity=0.241  Sum_probs=209.8

Q ss_pred             cCCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCc------------------------hHHHHHHHHHHHH
Q 012887          188 NSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGN------------------------AYEFELRKDLLEL  237 (454)
Q Consensus       188 ~~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~------------------------~~~~~~~~Ei~~l  237 (454)
                      ..++|++.+.||+|+||.||++      +.||+|.+.......                        .....+.+|+.++
T Consensus        11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l   90 (298)
T 2zv2_A           11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL   90 (298)
T ss_dssp             EETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred             eecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence            3478999999999999999996      579999987543211                        1124578999999


Q ss_pred             HhCCCCceeEEEEEEEeC-CCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEE
Q 012887          238 MTCGHKNILQFYCVCVDE-NHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRIL  316 (454)
Q Consensus       238 ~~l~HpnIv~~~g~~~~~-~~~l~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NIL  316 (454)
                      ..++||||+++++++.+. +..+++||||+++++|.+++ ....+++..+..++.||+.||.|||++||+||||||+|||
T Consensus        91 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil  169 (298)
T 2zv2_A           91 KKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLL  169 (298)
T ss_dssp             HTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS-CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred             HhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEE
Confidence            999999999999999874 34589999999999998865 4468999999999999999999999999999999999999


Q ss_pred             EccCCcEEEEccCCccccccCCCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHH
Q 012887          317 LDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQA  396 (454)
Q Consensus       317 l~~~~~vKL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~  396 (454)
                      ++.++.+||+|||++..............+|+.|+|||.+.+.... ..+.++|||||||++|+|++|..||........
T Consensus       170 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~  248 (298)
T 2zv2_A          170 VGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKI-FSGKALDVWAMGVTLYCFVFGQCPFMDERIMCL  248 (298)
T ss_dssp             ECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCC-EESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             ECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCC-CCCchhhhHhHHHHHHHHHHCCCCCCCccHHHH
Confidence            9999999999999988765544444456789999999999765421 124579999999999999999999998877766


Q ss_pred             HHHHHHcCCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 012887          397 AVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLL  443 (454)
Q Consensus       397 ~~~i~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~  443 (454)
                      ...+.......+.+..+++++.++|.+||+.||.+||++.|+++|-+
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~  295 (298)
T 2zv2_A          249 HSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPW  295 (298)
T ss_dssp             HHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHH
T ss_pred             HHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcc
Confidence            66666655554555678999999999999999999999999998755

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=6.9e-46  Score=365.20  Aligned_cols=258  Identities=25%  Similarity=0.476  Sum_probs=220.0

Q ss_pred             cceeecCCCEEEeceeeccCCceEEEe-----------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEE
Q 012887          183 GRWLLNSDNLEFIDQIGPNSFKGVYKG-----------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV  251 (454)
Q Consensus       183 ~~~~~~~~~~~~~~~LG~G~fG~Vy~g-----------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~  251 (454)
                      ..|.+..++|++.+.||+|+||.||++           +.||+|.+... ........+.+|+.++..++||||++++++
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~   94 (314)
T 2ivs_A           16 PKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN-ASPSELRDLLSEFNVLKQVNHPHVIKLYGA   94 (314)
T ss_dssp             TTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTT-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             cccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCC-CCHHHHHHHHHHHHHHhhCCCCceeeEEEE
Confidence            456677899999999999999999997           56999998743 333445668899999999999999999999


Q ss_pred             EEeCCCeEEEEEeccCCCCHHHHHHhCC------------------------CCCHHHHHHHHHHHHHHHHHHHhcCccc
Q 012887          252 CVDENHGLCVVTKLMEGGSVNDLILKSR------------------------KLQTKEIIRIAIDVAEGIKFLNDHGVAY  307 (454)
Q Consensus       252 ~~~~~~~l~lV~E~~~~gsL~~~l~~~~------------------------~l~~~~~~~i~~qI~~gL~yLH~~~iiH  307 (454)
                      +.+.+. .++||||+++++|.+++....                        .+++..+..++.||+.||.|||++||+|
T Consensus        95 ~~~~~~-~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH  173 (314)
T 2ivs_A           95 CSQDGP-LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVH  173 (314)
T ss_dssp             ECSSSS-CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             EecCCc-eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcc
Confidence            987776 899999999999999997543                        3899999999999999999999999999


Q ss_pred             CCccCCcEEEccCCcEEEEccCCccccccCCC--cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-C
Q 012887          308 RDLNSQRILLDRHGNVCLGDMGIVTACKSVGE--ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-G  384 (454)
Q Consensus       308 rDIKp~NILl~~~~~vKL~DFGla~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G  384 (454)
                      |||||+|||++.++.+||+|||++........  ......+++.|+|||.+.+..    ++.++|||||||++|+|++ |
T Consensus       174 ~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~Di~slG~il~el~t~g  249 (314)
T 2ivs_A          174 RDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHI----YTTQSDVWSFGVLLWEIVTLG  249 (314)
T ss_dssp             CCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCE----ECHHHHHHHHHHHHHHHHTTS
T ss_pred             cccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCC----cCchhhHHHHHHHHHHHHhCC
Confidence            99999999999999999999999876544322  123335678899999998654    4556999999999999999 9


Q ss_pred             CCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 012887          385 EAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNN  447 (454)
Q Consensus       385 ~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~  447 (454)
                      ..||.+........ ....+..+..|..+++++.+++.+||+.||.+||++.+++++|+++..
T Consensus       250 ~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~  311 (314)
T 2ivs_A          250 GNPYPGIPPERLFN-LLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV  311 (314)
T ss_dssp             CCSSTTCCGGGHHH-HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCCCCCHHHHHH-HhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            99999877655443 444556677888999999999999999999999999999999998754

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=8.4e-46  Score=360.21  Aligned_cols=257  Identities=24%  Similarity=0.456  Sum_probs=206.9

Q ss_pred             cceeecCCCEEEeceeeccCCceEEEeE---------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEE
Q 012887          183 GRWLLNSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCV  253 (454)
Q Consensus       183 ~~~~~~~~~~~~~~~LG~G~fG~Vy~g~---------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~  253 (454)
                      ..|.+..++|++.+.||+|+||.||+|.         .||+|.+... ........+.+|+..+..++||||+++++++.
T Consensus         8 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~   86 (281)
T 1mp8_A            8 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT   86 (281)
T ss_dssp             -CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             cceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCccceEEEEEc
Confidence            4566777899999999999999999874         4888888643 23344566889999999999999999999984


Q ss_pred             eCCCeEEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCcc
Q 012887          254 DENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVT  332 (454)
Q Consensus       254 ~~~~~l~lV~E~~~~gsL~~~l~~~~-~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~  332 (454)
                      + +. .++||||+++++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus        87 ~-~~-~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  164 (281)
T 1mp8_A           87 E-NP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR  164 (281)
T ss_dssp             S-SS-CEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred             c-Cc-cEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECcccccc
Confidence            3 33 889999999999999997554 79999999999999999999999999999999999999999999999999987


Q ss_pred             ccccCCC-cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHcCCCCCCC
Q 012887          333 ACKSVGE-ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIP  410 (454)
Q Consensus       333 ~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p  410 (454)
                      ....... ......+++.|+|||.+.+..    ++.++||||||+++|||++ |..||.+.........+. .+.+.+.+
T Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~-~~~~~~~~  239 (281)
T 1mp8_A          165 YMEDSTYYKASKGKLPIKWMAPESINFRR----FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-NGERLPMP  239 (281)
T ss_dssp             --------------CCGGGCCHHHHHHCC----CSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-TTCCCCCC
T ss_pred             ccCcccccccccCCCcccccChhhcccCC----CCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHH-cCCCCCCC
Confidence            6644322 122335677899999997654    4557999999999999997 999999877766555444 34566788


Q ss_pred             CCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 012887          411 KDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNN  447 (454)
Q Consensus       411 ~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~  447 (454)
                      ..+|+.+.++|.+||+.||.+|||+.+++++|+++.+
T Consensus       240 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  276 (281)
T 1mp8_A          240 PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE  276 (281)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            8999999999999999999999999999999998754

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=2.3e-45  Score=360.40  Aligned_cols=255  Identities=20%  Similarity=0.349  Sum_probs=213.4

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCc-hHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGN-AYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  262 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV  262 (454)
                      ++|++++.||+|+||.||++      +.||+|.+....... .....+.+|+..+..++||||+++++++.+.+. +++|
T Consensus        11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~-~~lv   89 (294)
T 4eqm_A           11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDC-YYLV   89 (294)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSE-EEEE
T ss_pred             ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCe-EEEE
Confidence            78999999999999999986      479999987544333 344568899999999999999999999987765 9999


Q ss_pred             EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCC-cc
Q 012887          263 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE-AT  341 (454)
Q Consensus       263 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~-~~  341 (454)
                      |||+++++|.+++.+.+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ ..
T Consensus        90 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  169 (294)
T 4eqm_A           90 MEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQT  169 (294)
T ss_dssp             EECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC--------
T ss_pred             EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCcccccccccccc
Confidence            99999999999998878999999999999999999999999999999999999999999999999999876544322 23


Q ss_pred             cccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCC---CCCCCccHHHH
Q 012887          342 EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP---EIPKDCPQILK  418 (454)
Q Consensus       342 ~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~---~~p~~~~~~l~  418 (454)
                      ....||+.|+|||.+.+..+    +.++||||||+++|+|++|..||.+.+.............+.   ..+..+|+.+.
T Consensus       170 ~~~~gt~~y~aPE~~~~~~~----~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  245 (294)
T 4eqm_A          170 NHVLGTVQYFSPEQAKGEAT----DECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLS  245 (294)
T ss_dssp             -----CCSSCCHHHHHTCCC----CTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHHH
T ss_pred             CccccCccccCHhHhcCCCC----CchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHHH
Confidence            33468999999999987654    445999999999999999999999988877666655543332   24567899999


Q ss_pred             HHHHHhcccCCCCCC-CHHHHHHHHHhhcCCC
Q 012887          419 SLMIKCWNNSPSKRP-QFSEIISLLLRTNNIS  449 (454)
Q Consensus       419 ~li~~cl~~dP~~RP-s~~ell~~L~~~~~~~  449 (454)
                      ++|.+||+.||.+|| ++.++.+.|..+....
T Consensus       246 ~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~  277 (294)
T 4eqm_A          246 NVILRATEKDKANRYKTIQEMKDDLSSVLHEN  277 (294)
T ss_dssp             HHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSS
T ss_pred             HHHHHHhcCCHhHccccHHHHHHHHHHHHhhc
Confidence            999999999999998 8999999998876643

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=8.2e-46  Score=360.01  Aligned_cols=256  Identities=24%  Similarity=0.495  Sum_probs=217.5

Q ss_pred             cceeecCCCEEEeceeeccCCceEEEe-----EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCC
Q 012887          183 GRWLLNSDNLEFIDQIGPNSFKGVYKG-----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH  257 (454)
Q Consensus       183 ~~~~~~~~~~~~~~~LG~G~fG~Vy~g-----~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~  257 (454)
                      +.|.+..++|++++.||+|+||.||++     ..||+|.++....   ....+.+|+.++..++||||+++++++.+.+.
T Consensus        17 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   93 (283)
T 3gen_A           17 GSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM---SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRP   93 (283)
T ss_dssp             CTTBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB---CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             CCccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC---CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCC
Confidence            677888899999999999999999996     4799999974332   23567899999999999999999999987776


Q ss_pred             eEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCcccccc
Q 012887          258 GLCVVTKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS  336 (454)
Q Consensus       258 ~l~lV~E~~~~gsL~~~l~~-~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~  336 (454)
                       +++||||+++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus        94 -~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  172 (283)
T 3gen_A           94 -IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD  172 (283)
T ss_dssp             -EEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCC
T ss_pred             -eEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccccc
Confidence             9999999999999999965 45899999999999999999999999999999999999999999999999999876543


Q ss_pred             CCC-cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHcCCCCCCCCCcc
Q 012887          337 VGE-ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCP  414 (454)
Q Consensus       337 ~~~-~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~  414 (454)
                      ... ......+|+.|+|||.+.+..    ++.++||||||+++|+|++ |..||...........+. .+.+...|..++
T Consensus       173 ~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~  247 (283)
T 3gen_A          173 DEYTSSVGSKFPVRWSPPEVLMYSK----FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-QGLRLYRPHLAS  247 (283)
T ss_dssp             HHHHSTTSTTSCGGGCCHHHHHHCC----CSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH-TTCCCCCCTTCC
T ss_pred             cccccccCCccCcccCCHHHhccCC----CCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHh-cccCCCCCCcCC
Confidence            211 122334577899999998664    4557999999999999998 999999888776655554 456666788899


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 012887          415 QILKSLMIKCWNNSPSKRPQFSEIISLLLRTNN  447 (454)
Q Consensus       415 ~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~  447 (454)
                      +.+.+++.+||+.||.+|||+.+++++|+.+.+
T Consensus       248 ~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~  280 (283)
T 3gen_A          248 EKVYTIMYSCWHEKADERPTFKILLSNILDVMD  280 (283)
T ss_dssp             HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence            999999999999999999999999999998765

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=5.7e-46  Score=376.77  Aligned_cols=256  Identities=23%  Similarity=0.474  Sum_probs=216.9

Q ss_pred             eecCCCEEEeceeeccCCceEEEeE-----------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEe
Q 012887          186 LLNSDNLEFIDQIGPNSFKGVYKGK-----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVD  254 (454)
Q Consensus       186 ~~~~~~~~~~~~LG~G~fG~Vy~g~-----------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~  254 (454)
                      .+..++|++++.||+|+||.||+|+           .||+|+++.. ........+.+|+.++..++||||+++++++.+
T Consensus        67 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~  145 (367)
T 3l9p_A           67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ  145 (367)
T ss_dssp             BCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             hcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc-cChhhHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence            4556889999999999999999976           6999998632 334455668899999999999999999999987


Q ss_pred             CCCeEEEEEeccCCCCHHHHHHhC-------CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCC---cEE
Q 012887          255 ENHGLCVVTKLMEGGSVNDLILKS-------RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG---NVC  324 (454)
Q Consensus       255 ~~~~l~lV~E~~~~gsL~~~l~~~-------~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~---~vK  324 (454)
                      .+. .++||||+++|+|.+++...       ..+++..++.++.||+.||.|||++||+||||||+|||++.++   .+|
T Consensus       146 ~~~-~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~k  224 (367)
T 3l9p_A          146 SLP-RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK  224 (367)
T ss_dssp             SSS-CEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred             CCC-CEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEE
Confidence            776 89999999999999999643       2589999999999999999999999999999999999999655   499


Q ss_pred             EEccCCccccccCC--CcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHH
Q 012887          325 LGDMGIVTACKSVG--EATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIA  401 (454)
Q Consensus       325 L~DFGla~~~~~~~--~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~i~  401 (454)
                      |+|||+++......  .......+|+.|+|||++.+..    ++.++|||||||++|||++ |..||...........+.
T Consensus       225 L~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~----~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~  300 (367)
T 3l9p_A          225 IGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGI----FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT  300 (367)
T ss_dssp             ECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCC----CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH
T ss_pred             ECCCccccccccccccccCCCcCCcccEECHHHhcCCC----CCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            99999987553322  2233445788999999997664    4557999999999999998 999999877766554444


Q ss_pred             HcCCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCC
Q 012887          402 ACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNI  448 (454)
Q Consensus       402 ~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~  448 (454)
                       .+.++..+..+++.+.+||.+||+.||.+||++.+++++|+.+.+.
T Consensus       301 -~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~  346 (367)
T 3l9p_A          301 -SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD  346 (367)
T ss_dssp             -TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             -cCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence             4556677888999999999999999999999999999999987654

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1.7e-45  Score=372.91  Aligned_cols=249  Identities=17%  Similarity=0.244  Sum_probs=215.4

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  263 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~  263 (454)
                      ++|++.+.||+|+||.||++      +.+|+|.+............+.+|+.++..++||||+++++++.+.+. .|+||
T Consensus        29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~-~~lv~  107 (362)
T 2bdw_A           29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESF-HYLVF  107 (362)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE-EEEEE
T ss_pred             cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCE-EEEEE
Confidence            57999999999999999985      579999998655555555678899999999999999999999988776 99999


Q ss_pred             eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCC---cEEEEccCCccccccCCCc
Q 012887          264 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG---NVCLGDMGIVTACKSVGEA  340 (454)
Q Consensus       264 E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~---~vKL~DFGla~~~~~~~~~  340 (454)
                      ||+++|+|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++   .+||+|||++....... .
T Consensus       108 e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~-~  186 (362)
T 2bdw_A          108 DLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE-A  186 (362)
T ss_dssp             CCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCC-S
T ss_pred             ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCc-c
Confidence            9999999999998778899999999999999999999999999999999999998654   59999999987665432 2


Q ss_pred             ccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCC--CCccHHHH
Q 012887          341 TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIP--KDCPQILK  418 (454)
Q Consensus       341 ~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p--~~~~~~l~  418 (454)
                      .....||+.|+|||++.+..    ++.++|||||||++|+|++|..||.+.+.......+.......+.+  ..+++++.
T Consensus       187 ~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  262 (362)
T 2bdw_A          187 WHGFAGTPGYLSPEVLKKDP----YSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAK  262 (362)
T ss_dssp             CCCSCSCTTTCCHHHHTTCC----CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHH
T ss_pred             cccCCCCccccCHHHHccCC----CCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHH
Confidence            33457899999999998764    4556999999999999999999999988877777777665543333  35799999


Q ss_pred             HHHHHhcccCCCCCCCHHHHHHHHHh
Q 012887          419 SLMIKCWNNSPSKRPQFSEIISLLLR  444 (454)
Q Consensus       419 ~li~~cl~~dP~~RPs~~ell~~L~~  444 (454)
                      +||.+||+.||.+||++.+++++-|-
T Consensus       263 ~li~~~L~~dP~~R~t~~e~l~hp~~  288 (362)
T 2bdw_A          263 SLIDSMLTVNPKKRITADQALKVPWI  288 (362)
T ss_dssp             HHHHHHSCSSGGGSCCHHHHTTSHHH
T ss_pred             HHHHHHcCCChhhCcCHHHHhcCccc
Confidence            99999999999999999999988654

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=6.3e-46  Score=369.13  Aligned_cols=262  Identities=20%  Similarity=0.342  Sum_probs=212.1

Q ss_pred             cceeecCCCEEEeceeeccCCceEEEe----EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCC-
Q 012887          183 GRWLLNSDNLEFIDQIGPNSFKGVYKG----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH-  257 (454)
Q Consensus       183 ~~~~~~~~~~~~~~~LG~G~fG~Vy~g----~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~-  257 (454)
                      ..+.+..++|++.+.||+|+||.||+|    +.||+|++..   .........+|+.++.+++||||+++++++.+... 
T Consensus        17 ~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~---~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   93 (322)
T 3soc_A           17 ENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPI---QDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSV   93 (322)
T ss_dssp             CCEEETTEEEEEEEEEECSTTCEEEEEEETTEEEEEEEECG---GGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSS
T ss_pred             cccccchhhchhhheecccCceEEEEEEECCCEEEEEEeec---CchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCC
Confidence            567788999999999999999999996    5799999863   23344556778888999999999999999987542 


Q ss_pred             --eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhc----------CcccCCccCCcEEEccCCcEEE
Q 012887          258 --GLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDH----------GVAYRDLNSQRILLDRHGNVCL  325 (454)
Q Consensus       258 --~l~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~----------~iiHrDIKp~NILl~~~~~vKL  325 (454)
                        .+++||||+++|+|.+++.+ ..+++..+..++.||+.||.|||++          ||+||||||+|||++.++.+||
T Consensus        94 ~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL  172 (322)
T 3soc_A           94 DVDLWLITAFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACI  172 (322)
T ss_dssp             SEEEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEE
T ss_pred             CceEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEE
Confidence              37999999999999999965 4599999999999999999999999          9999999999999999999999


Q ss_pred             EccCCccccccCCCc--ccccCCCCcccccccccCCCCC-CCCCchhhHHHHHHHHHHHHcCCCCCCCCC----------
Q 012887          326 GDMGIVTACKSVGEA--TEYETDGYRWLAPEIIAGDPES-VSETWMSNVYSFGMVIWEMVTGEAAYAACS----------  392 (454)
Q Consensus       326 ~DFGla~~~~~~~~~--~~~~~gt~~y~APE~l~~~~~~-~~~~~ksDVwSlGviL~elltG~~Pf~~~~----------  392 (454)
                      +|||++.........  .....+|+.|+|||++.+.... ..++.++|||||||++|||++|..||.+..          
T Consensus       173 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~  252 (322)
T 3soc_A          173 ADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEE  252 (322)
T ss_dssp             CCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHH
T ss_pred             ccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhh
Confidence            999999766543322  2334689999999999864321 234457899999999999999999997532          


Q ss_pred             ------HHHHHHHHHHcCCCCCCCCC-----ccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCC
Q 012887          393 ------PVQAAVGIAACGLRPEIPKD-----CPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNI  448 (454)
Q Consensus       393 ------~~~~~~~i~~~~~~~~~p~~-----~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~  448 (454)
                            .......+.....++.++..     .++++.+||.+||+.||.+|||+.|+++.|+++...
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~  319 (322)
T 3soc_A          253 IGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL  319 (322)
T ss_dssp             HCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             hccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence                  12222223333344444332     356699999999999999999999999999988654

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1.2e-45  Score=372.95  Aligned_cols=250  Identities=20%  Similarity=0.276  Sum_probs=213.8

Q ss_pred             ecCCCEEEeceeeccCCceEEEe------EEEEEEEeecCCC-CchHHHHHHHHHHHHHhC-CCCceeEEEEEEEeCCCe
Q 012887          187 LNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDK-GNAYEFELRKDLLELMTC-GHKNILQFYCVCVDENHG  258 (454)
Q Consensus       187 ~~~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~-~~~~~~~~~~Ei~~l~~l-~HpnIv~~~g~~~~~~~~  258 (454)
                      +..++|++++.||+|+||.||++      +.+|+|.++.... .......+..|..++..+ +||||+++++++.+.+. 
T Consensus        17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~-   95 (353)
T 2i0e_A           17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR-   95 (353)
T ss_dssp             --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSE-
T ss_pred             CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCE-
Confidence            45689999999999999999984      5799999874321 112234567888888877 79999999999988776 


Q ss_pred             EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCC
Q 012887          259 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG  338 (454)
Q Consensus       259 l~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~  338 (454)
                      +|+||||++||+|.+++.+.+.+++..+..++.||+.||+|||++||+||||||+|||++.+|++||+|||+++......
T Consensus        96 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~  175 (353)
T 2i0e_A           96 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG  175 (353)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred             EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccCC
Confidence            99999999999999999877889999999999999999999999999999999999999999999999999988654444


Q ss_pred             CcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHH
Q 012887          339 EATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILK  418 (454)
Q Consensus       339 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~  418 (454)
                      .......||+.|+|||++.+..+    +.++|||||||++|||++|..||.+.+.......+...  ...+|..+++++.
T Consensus       176 ~~~~~~~gt~~y~aPE~~~~~~~----~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~  249 (353)
T 2i0e_A          176 VTTKTFCGTPDYIAPEIIAYQPY----GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH--NVAYPKSMSKEAV  249 (353)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCCB----STHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTTSCHHHH
T ss_pred             cccccccCCccccChhhhcCCCc----CCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhC--CCCCCCCCCHHHH
Confidence            44556679999999999987654    45699999999999999999999998888777777765  4457889999999


Q ss_pred             HHHHHhcccCCCCCCC-----HHHHHHHHH
Q 012887          419 SLMIKCWNNSPSKRPQ-----FSEIISLLL  443 (454)
Q Consensus       419 ~li~~cl~~dP~~RPs-----~~ell~~L~  443 (454)
                      +||.+||..||.+||+     +.++++|-+
T Consensus       250 ~li~~lL~~dP~~R~~~~~~~~~~i~~h~~  279 (353)
T 2i0e_A          250 AICKGLMTKHPGKRLGCGPEGERDIKEHAF  279 (353)
T ss_dssp             HHHHHHTCSCTTSCTTCSTTHHHHHHTSGG
T ss_pred             HHHHHHhhcCHHHcCCCCCCCHHHHhcCcc
Confidence            9999999999999995     688887754

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=4.3e-46  Score=375.19  Aligned_cols=250  Identities=22%  Similarity=0.346  Sum_probs=212.8

Q ss_pred             ecCCCEEEeceeeccCCceEEEe------EEEEEEEeecCCC-CchHHHHHHHHHHHHHhC-CCCceeEEEEEEEeCCCe
Q 012887          187 LNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDK-GNAYEFELRKDLLELMTC-GHKNILQFYCVCVDENHG  258 (454)
Q Consensus       187 ~~~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~-~~~~~~~~~~Ei~~l~~l-~HpnIv~~~g~~~~~~~~  258 (454)
                      +..++|++.+.||+|+||.||++      +.||+|.++.... .......+..|..++..+ +||||+++++++.+.+. 
T Consensus        14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~-   92 (345)
T 1xjd_A           14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN-   92 (345)
T ss_dssp             --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE-
T ss_pred             CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE-
Confidence            45689999999999999999985      5799999974311 111234466777888765 89999999999998776 


Q ss_pred             EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCC
Q 012887          259 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG  338 (454)
Q Consensus       259 l~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~  338 (454)
                      +|+||||+++|+|.+++.+.+.+++..+..++.||+.||+|||++||+||||||+|||++.+|++||+|||+++......
T Consensus        93 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~  172 (345)
T 1xjd_A           93 LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD  172 (345)
T ss_dssp             EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccCC
Confidence            99999999999999999887889999999999999999999999999999999999999999999999999987654444


Q ss_pred             CcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHH
Q 012887          339 EATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILK  418 (454)
Q Consensus       339 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~  418 (454)
                      .......||+.|+|||++.+..    ++.++|||||||++|||++|..||.+.+.......+...  .+.+|..+++++.
T Consensus       173 ~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~  246 (345)
T 1xjd_A          173 AKTNTFCGTPDYIAPEILLGQK----YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD--NPFYPRWLEKEAK  246 (345)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCC----BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTTSCHHHH
T ss_pred             CcccCCCCCcccCChhhhcCCC----CCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhC--CCCCCcccCHHHH
Confidence            4455667999999999998765    445699999999999999999999998887777777664  4557888999999


Q ss_pred             HHHHHhcccCCCCCCCHH-HHHHHHH
Q 012887          419 SLMIKCWNNSPSKRPQFS-EIISLLL  443 (454)
Q Consensus       419 ~li~~cl~~dP~~RPs~~-ell~~L~  443 (454)
                      ++|.+||..||.+||++. ++++|-+
T Consensus       247 ~li~~lL~~dp~~R~~~~~~i~~hp~  272 (345)
T 1xjd_A          247 DLLVKLFVREPEKRLGVRGDIRQHPL  272 (345)
T ss_dssp             HHHHHHSCSSGGGSBTTBSCGGGSGG
T ss_pred             HHHHHHhcCCHhHcCCChHHHHcCcc
Confidence            999999999999999997 7776543

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=9.7e-46  Score=385.47  Aligned_cols=259  Identities=25%  Similarity=0.456  Sum_probs=221.7

Q ss_pred             cceeecCCCEEEeceeeccCCceEEEe-----EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCC
Q 012887          183 GRWLLNSDNLEFIDQIGPNSFKGVYKG-----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH  257 (454)
Q Consensus       183 ~~~~~~~~~~~~~~~LG~G~fG~Vy~g-----~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~  257 (454)
                      ..|.+..++|++.+.||+|+||.||+|     ..||||.++...   .....+.+|+.++..++||||+++++++. .+.
T Consensus       181 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~  256 (454)
T 1qcf_A          181 DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS---MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEP  256 (454)
T ss_dssp             TCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS---BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSS
T ss_pred             cceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC---ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCc
Confidence            568889999999999999999999997     469999997533   23456889999999999999999999986 333


Q ss_pred             eEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccc
Q 012887          258 GLCVVTKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK  335 (454)
Q Consensus       258 ~l~lV~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~  335 (454)
                       +++||||+++|+|.+++.+.  ..+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++...
T Consensus       257 -~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~  335 (454)
T 1qcf_A          257 -IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIE  335 (454)
T ss_dssp             -CEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBC
T ss_pred             -cEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcC
Confidence             89999999999999999643  378999999999999999999999999999999999999999999999999987654


Q ss_pred             cCCC-cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHcCCCCCCCCCc
Q 012887          336 SVGE-ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDC  413 (454)
Q Consensus       336 ~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~  413 (454)
                      .... ......+++.|+|||++.+..    ++.++|||||||++|||++ |..||.+.+..+....+. .+.+++.|..+
T Consensus       336 ~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~-~~~~~~~~~~~  410 (454)
T 1qcf_A          336 DNEYTAREGAKFPIKWTAPEAINFGS----FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE-RGYRMPRPENC  410 (454)
T ss_dssp             CHHHHTTCSSSSCGGGSCHHHHHHCC----CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH-HTCCCCCCTTS
T ss_pred             CCceeccCCCcccccccCHHHhccCC----CCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCC
Confidence            3211 122334577899999998654    5567999999999999999 999999888777665554 46777788999


Q ss_pred             cHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCCCCC
Q 012887          414 PQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNS  451 (454)
Q Consensus       414 ~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~~  451 (454)
                      |+++.+||.+||+.||.+|||+.+|++.|+.+....++
T Consensus       411 ~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~~~  448 (454)
T 1qcf_A          411 PEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATES  448 (454)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSSCC
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcccc
Confidence            99999999999999999999999999999998765443

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=2.2e-45  Score=366.44  Aligned_cols=250  Identities=17%  Similarity=0.306  Sum_probs=206.0

Q ss_pred             ecCCCEEEeceeeccCCceEEEeE---------EEEEEEeecCCCC--chHHHHHHHHHHHHHhCCCCceeEEEEEEEeC
Q 012887          187 LNSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKGCDKG--NAYEFELRKDLLELMTCGHKNILQFYCVCVDE  255 (454)
Q Consensus       187 ~~~~~~~~~~~LG~G~fG~Vy~g~---------~vavK~l~~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~  255 (454)
                      +..++|++++.||+|+||.||+++         .+|+|.++.....  ......+.+|+.++..++||||+++++++.+.
T Consensus        14 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   93 (327)
T 3a62_A           14 IRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTG   93 (327)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECS
T ss_pred             CCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcC
Confidence            456889999999999999999754         5999998754321  22334577899999999999999999999987


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccc
Q 012887          256 NHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK  335 (454)
Q Consensus       256 ~~~l~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~  335 (454)
                      +. +|+||||+++++|.+++.+.+.+++..+..++.||+.||.|||++||+||||||+|||++.++++||+|||+++...
T Consensus        94 ~~-~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~  172 (327)
T 3a62_A           94 GK-LYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESI  172 (327)
T ss_dssp             SC-EEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC----
T ss_pred             CE-EEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccccc
Confidence            76 99999999999999999877889999999999999999999999999999999999999999999999999987654


Q ss_pred             cCCCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccH
Q 012887          336 SVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ  415 (454)
Q Consensus       336 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~  415 (454)
                      ..........||+.|+|||++.+..    ++.++|||||||++|+|++|..||.+.+.......+...  ...+|..+++
T Consensus       173 ~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~--~~~~p~~~~~  246 (327)
T 3a62_A          173 HDGTVTHTFCGTIEYMAPEILMRSG----HNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKC--KLNLPPYLTQ  246 (327)
T ss_dssp             ------CTTSSCCTTSCHHHHTTSC----CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT--CCCCCTTSCH
T ss_pred             cCCccccccCCCcCccCHhhCcCCC----CCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC--CCCCCCCCCH
Confidence            4444445567899999999998764    455799999999999999999999998887777777664  4457788999


Q ss_pred             HHHHHHHHhcccCCCCCC-----CHHHHHHHHH
Q 012887          416 ILKSLMIKCWNNSPSKRP-----QFSEIISLLL  443 (454)
Q Consensus       416 ~l~~li~~cl~~dP~~RP-----s~~ell~~L~  443 (454)
                      ++.++|.+||..||.+||     ++.|+++|-+
T Consensus       247 ~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~  279 (327)
T 3a62_A          247 EARDLLKKLLKRNAASRLGAGPGDAGEVQAHPF  279 (327)
T ss_dssp             HHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGG
T ss_pred             HHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCc
Confidence            999999999999999999     8889988765

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1.6e-45  Score=373.33  Aligned_cols=248  Identities=18%  Similarity=0.284  Sum_probs=213.3

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCc----hHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGN----AYEFELRKDLLELMTCGHKNILQFYCVCVDENHGL  259 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~----~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l  259 (454)
                      ++|++++.||+|+||.||++      +.+|+|.++......    .....+.+|+.++..++||||+++++++.+.+. +
T Consensus        12 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~-~   90 (361)
T 2yab_A           12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD-V   90 (361)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE-E
T ss_pred             hceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE-E
Confidence            67999999999999999985      579999997543321    134568899999999999999999999988775 9


Q ss_pred             EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCC----cEEEEccCCccccc
Q 012887          260 CVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG----NVCLGDMGIVTACK  335 (454)
Q Consensus       260 ~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~----~vKL~DFGla~~~~  335 (454)
                      ++||||+++|+|.+++.+.+.+++..+..++.||+.||.|||++||+||||||+|||++.++    .+||+|||++....
T Consensus        91 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~  170 (361)
T 2yab_A           91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE  170 (361)
T ss_dssp             EEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECC
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcC
Confidence            99999999999999998778999999999999999999999999999999999999998877    79999999988765


Q ss_pred             cCCCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCC--CCCCCc
Q 012887          336 SVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP--EIPKDC  413 (454)
Q Consensus       336 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~--~~p~~~  413 (454)
                      ... ......||+.|+|||++.+..    ++.++|||||||++|+|++|..||.+.+.......+.......  ..+..+
T Consensus       171 ~~~-~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  245 (361)
T 2yab_A          171 DGV-EFKNIFGTPEFVAPEIVNYEP----LGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQT  245 (361)
T ss_dssp             TTC-CCCCCCSCGGGCCHHHHTTCC----CCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTS
T ss_pred             CCC-ccccCCCCccEECchHHcCCC----CCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccCC
Confidence            432 234457899999999998764    4556999999999999999999999988887777776544332  223578


Q ss_pred             cHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 012887          414 PQILKSLMIKCWNNSPSKRPQFSEIISLLL  443 (454)
Q Consensus       414 ~~~l~~li~~cl~~dP~~RPs~~ell~~L~  443 (454)
                      ++++.+||.+||..||.+|||+.|+++|-|
T Consensus       246 s~~~~~li~~~L~~dP~~R~t~~e~l~hp~  275 (361)
T 2yab_A          246 SELAKDFIRKLLVKETRKRLTIQEALRHPW  275 (361)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHHTSTT
T ss_pred             CHHHHHHHHHHCCCChhHCcCHHHHhcCcC
Confidence            999999999999999999999999998755

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=2.9e-45  Score=368.90  Aligned_cols=249  Identities=18%  Similarity=0.310  Sum_probs=210.1

Q ss_pred             cCCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCc-hHHHHHHHHHHHHHhC-CCCceeEEEEEEEeCCCeE
Q 012887          188 NSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGN-AYEFELRKDLLELMTC-GHKNILQFYCVCVDENHGL  259 (454)
Q Consensus       188 ~~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~-~~~~~~~~Ei~~l~~l-~HpnIv~~~g~~~~~~~~l  259 (454)
                      ..++|++++.||+|+||.||++      +.+|+|.++...... .....+.+|..++..+ +||||+++++++.+.+. +
T Consensus         7 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~-~   85 (345)
T 3a8x_A            7 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR-L   85 (345)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE-E
T ss_pred             chhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCE-E
Confidence            3478999999999999999985      579999998544333 3345578899999887 89999999999988776 9


Q ss_pred             EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCC
Q 012887          260 CVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE  339 (454)
Q Consensus       260 ~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~  339 (454)
                      |+||||+++|+|.+++.+.+.+++..+..++.||+.||+|||++||+||||||+|||++.+|++||+|||+++.......
T Consensus        86 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~  165 (345)
T 3a8x_A           86 FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD  165 (345)
T ss_dssp             EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTTC
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCCCC
Confidence            99999999999999998778899999999999999999999999999999999999999999999999999886544444


Q ss_pred             cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC---------CHHHHHHHHHHcCCCCCCC
Q 012887          340 ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAAC---------SPVQAAVGIAACGLRPEIP  410 (454)
Q Consensus       340 ~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~---------~~~~~~~~i~~~~~~~~~p  410 (454)
                      ......||+.|+|||++.+..+    +.++|||||||++|||++|..||...         ........+..  ....+|
T Consensus       166 ~~~~~~gt~~y~aPE~~~~~~~----~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~--~~~~~p  239 (345)
T 3a8x_A          166 TTSTFCGTPNYIAPEILRGEDY----GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE--KQIRIP  239 (345)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCB----CTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHH--CCCCCC
T ss_pred             cccccCCCccccCccccCCCCC----ChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHc--CCCCCC
Confidence            4556689999999999987644    45699999999999999999999752         12222333333  345678


Q ss_pred             CCccHHHHHHHHHhcccCCCCCCCH------HHHHHHHH
Q 012887          411 KDCPQILKSLMIKCWNNSPSKRPQF------SEIISLLL  443 (454)
Q Consensus       411 ~~~~~~l~~li~~cl~~dP~~RPs~------~ell~~L~  443 (454)
                      ..++.++.++|.+||+.||.+||++      .|+++|-+
T Consensus       240 ~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~  278 (345)
T 3a8x_A          240 RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPF  278 (345)
T ss_dssp             TTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGG
T ss_pred             CCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCc
Confidence            8999999999999999999999995      78887654

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-45  Score=366.70  Aligned_cols=245  Identities=20%  Similarity=0.311  Sum_probs=213.2

Q ss_pred             CCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCC-chHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEE
Q 012887          189 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCV  261 (454)
Q Consensus       189 ~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~l  261 (454)
                      .++|++++.||+|+||.||++      +.+|+|.++..... ......+.+|..++..++||||+++++++.+.+. +|+
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~-~~l   83 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQ-IFM   83 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSE-EEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCE-EEE
Confidence            478999999999999999984      57999998743211 1123456789999999999999999999988776 999


Q ss_pred             EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCcc
Q 012887          262 VTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT  341 (454)
Q Consensus       262 V~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~  341 (454)
                      ||||+++|+|.+++.+.+.+++..+..++.||+.||+|||++||+||||||+|||++.+|++||+|||+++....   ..
T Consensus        84 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~---~~  160 (318)
T 1fot_A           84 IMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD---VT  160 (318)
T ss_dssp             EECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS---CB
T ss_pred             EEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCC---cc
Confidence            999999999999998888999999999999999999999999999999999999999999999999999876543   23


Q ss_pred             cccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHHHHH
Q 012887          342 EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLM  421 (454)
Q Consensus       342 ~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~li  421 (454)
                      ....||+.|+|||++.+..++    .++|||||||++|||++|..||.+.+.......+....  ..+|..+++++.++|
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~----~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~--~~~p~~~~~~~~~li  234 (318)
T 1fot_A          161 YTLCGTPDYIAPEVVSTKPYN----KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE--LRFPPFFNEDVKDLL  234 (318)
T ss_dssp             CCCCSCTTTCCHHHHTTCCBC----TTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCC--CCCCTTSCHHHHHHH
T ss_pred             ccccCCccccCHhHhcCCCCC----cccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--CCCCCCCCHHHHHHH
Confidence            445789999999999876544    45999999999999999999999988887777777653  457888999999999


Q ss_pred             HHhcccCCCCCC-----CHHHHHHHHH
Q 012887          422 IKCWNNSPSKRP-----QFSEIISLLL  443 (454)
Q Consensus       422 ~~cl~~dP~~RP-----s~~ell~~L~  443 (454)
                      .+||..||.+||     ++.++++|-+
T Consensus       235 ~~lL~~dp~~R~~~~~~~~~~i~~hp~  261 (318)
T 1fot_A          235 SRLITRDLSQRLGNLQNGTEDVKNHPW  261 (318)
T ss_dssp             HHHTCSCTTTCTTSSTTTTHHHHTSGG
T ss_pred             HHHhccCHHHcCCCcCCCHHHHhcCcc
Confidence            999999999999     8999998754

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=9.2e-46  Score=364.62  Aligned_cols=261  Identities=25%  Similarity=0.433  Sum_probs=222.4

Q ss_pred             cceeecCCCEEEeceeeccCCceEEEe-----------EEEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEEEE
Q 012887          183 GRWLLNSDNLEFIDQIGPNSFKGVYKG-----------KRVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYC  250 (454)
Q Consensus       183 ~~~~~~~~~~~~~~~LG~G~fG~Vy~g-----------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~~~g  250 (454)
                      ..|.+..++|++.+.||+|+||.||++           +.||+|.++.. ........+.+|+.++..+ +||||+++++
T Consensus        20 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~   98 (316)
T 2xir_A           20 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVNLLG   98 (316)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             cceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccC-CCcHHHHHHHHHHHHHHhcccCCCeeeEEE
Confidence            456777899999999999999999997           57999999743 3333445688999999998 6999999999


Q ss_pred             EEEeCCCeEEEEEeccCCCCHHHHHHhCCC----------------CCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCc
Q 012887          251 VCVDENHGLCVVTKLMEGGSVNDLILKSRK----------------LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQR  314 (454)
Q Consensus       251 ~~~~~~~~l~lV~E~~~~gsL~~~l~~~~~----------------l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~N  314 (454)
                      ++...+..+++||||+++|+|.+++.....                +++..+..++.||+.||.|||++||+||||||+|
T Consensus        99 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~N  178 (316)
T 2xir_A           99 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN  178 (316)
T ss_dssp             EECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             EEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccce
Confidence            998776558999999999999999976543                8999999999999999999999999999999999


Q ss_pred             EEEccCCcEEEEccCCccccccCCCc--ccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCC
Q 012887          315 ILLDRHGNVCLGDMGIVTACKSVGEA--TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAAC  391 (454)
Q Consensus       315 ILl~~~~~vKL~DFGla~~~~~~~~~--~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~  391 (454)
                      ||++.++.+||+|||++.........  .....+|+.|+|||.+.+..    ++.++||||||+++|+|++ |..||.+.
T Consensus       179 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~----~~~~~Di~slG~il~~l~t~g~~p~~~~  254 (316)
T 2xir_A          179 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV----YTIQSDVWSFGVLLWEIFSLGASPYPGV  254 (316)
T ss_dssp             EEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCC----CCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             EEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhcccc----ccchhHHHHHHHHHHHHHhCCCCCCccc
Confidence            99999999999999998765433221  22335678899999997654    4567999999999999998 99999887


Q ss_pred             CHHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCC
Q 012887          392 SPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNI  448 (454)
Q Consensus       392 ~~~~~~~~i~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~  448 (454)
                      ............+.+...|..+++.+.++|.+||+.||.+|||+.+++++|+.+.+.
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  311 (316)
T 2xir_A          255 KIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  311 (316)
T ss_dssp             CCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             chhHHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence            665555566666677778888999999999999999999999999999999987653

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=2.5e-45  Score=354.02  Aligned_cols=251  Identities=27%  Similarity=0.557  Sum_probs=207.9

Q ss_pred             ecCCCEEEeceeeccCCceEEEe----EEEEEEEeecCCCCc--hHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEE
Q 012887          187 LNSDNLEFIDQIGPNSFKGVYKG----KRVGIEKLKGCDKGN--AYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLC  260 (454)
Q Consensus       187 ~~~~~~~~~~~LG~G~fG~Vy~g----~~vavK~l~~~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~  260 (454)
                      ++.++|++.+.||+|+||.||+|    +.+|+|.++......  .....+.+|+.++..++||||+++++++.+.+. .+
T Consensus         4 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~   82 (271)
T 3dtc_A            4 IDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPN-LC   82 (271)
T ss_dssp             CCTTSEEEEEEEEEETTEEEEEEEETTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC---CE
T ss_pred             cchhheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCc-eE
Confidence            45689999999999999999996    689999987543222  223567899999999999999999999987776 89


Q ss_pred             EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC---cccCCccCCcEEEcc--------CCcEEEEccC
Q 012887          261 VVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHG---VAYRDLNSQRILLDR--------HGNVCLGDMG  329 (454)
Q Consensus       261 lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~---iiHrDIKp~NILl~~--------~~~vKL~DFG  329 (454)
                      +||||+++++|.+++. .+.+++..+..++.||+.||.|||++|   |+||||||+|||++.        ++.+||+|||
T Consensus        83 lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg  161 (271)
T 3dtc_A           83 LVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG  161 (271)
T ss_dssp             EEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred             EEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence            9999999999999984 568999999999999999999999999   899999999999986        7789999999


Q ss_pred             CccccccCCCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCC
Q 012887          330 IVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEI  409 (454)
Q Consensus       330 la~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~  409 (454)
                      ++.......  .....+++.|+|||.+.+..    ++.++||||||+++|+|++|..||.+.........+.......+.
T Consensus       162 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~----~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  235 (271)
T 3dtc_A          162 LAREWHRTT--KMSAAGAYAWMAPEVIRASM----FSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPI  235 (271)
T ss_dssp             C---------------CCGGGSCHHHHHHCC----CSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCC
T ss_pred             ccccccccc--ccCCCCccceeCHHHhccCC----CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCC
Confidence            987654332  22446889999999998664    455799999999999999999999998888888888888888888


Q ss_pred             CCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 012887          410 PKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRT  445 (454)
Q Consensus       410 p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~  445 (454)
                      |..+++.+.++|.+||+.||.+|||+.|++++|+++
T Consensus       236 ~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          236 PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             CcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence            999999999999999999999999999999999763

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=4.5e-45  Score=356.81  Aligned_cols=258  Identities=25%  Similarity=0.411  Sum_probs=216.2

Q ss_pred             cceeecCCCEEEec-eeeccCCceEEEe--------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEE
Q 012887          183 GRWLLNSDNLEFID-QIGPNSFKGVYKG--------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCV  253 (454)
Q Consensus       183 ~~~~~~~~~~~~~~-~LG~G~fG~Vy~g--------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~  253 (454)
                      ..+.++.++|++.+ .||+|+||.||+|        +.||+|.++...........+.+|+.++..++||||+++++++.
T Consensus         9 ~~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   88 (291)
T 1xbb_A            9 KEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE   88 (291)
T ss_dssp             --CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             ceeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEC
Confidence            34556778899998 9999999999986        57999999865555555677899999999999999999999994


Q ss_pred             eCCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccc
Q 012887          254 DENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTA  333 (454)
Q Consensus       254 ~~~~~l~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~  333 (454)
                       .+. .++||||+++++|.+++.+.+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus        89 -~~~-~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~  166 (291)
T 1xbb_A           89 -AES-WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKA  166 (291)
T ss_dssp             -SSS-EEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             -CCC-cEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCccee
Confidence             444 899999999999999998888899999999999999999999999999999999999999999999999999876


Q ss_pred             cccCCCc---ccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHcCCCCCC
Q 012887          334 CKSVGEA---TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEI  409 (454)
Q Consensus       334 ~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~  409 (454)
                      .......   .....+++.|+|||.+.+..    ++.++||||||+++|+|++ |..||.+.+....... ...+.++..
T Consensus       167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~-~~~~~~~~~  241 (291)
T 1xbb_A          167 LRADENYYKAQTHGKWPVKWYAPECINYYK----FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM-LEKGERMGC  241 (291)
T ss_dssp             CCTTCSEEEC----CCCGGGCCHHHHHHCE----EEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH-HHTTCCCCC
T ss_pred             eccCCCcccccccCCCCceeeChHHhccCC----CChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH-HHcCCCCCC
Confidence            6443221   12234568899999997654    3456999999999999999 9999998777655444 444566778


Q ss_pred             CCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 012887          410 PKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNN  447 (454)
Q Consensus       410 p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~  447 (454)
                      |..+++.+.++|.+||+.||.+||++.++++.|+++..
T Consensus       242 ~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~  279 (291)
T 1xbb_A          242 PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY  279 (291)
T ss_dssp             CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            88999999999999999999999999999999988754

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=3e-45  Score=375.71  Aligned_cols=250  Identities=19%  Similarity=0.311  Sum_probs=208.7

Q ss_pred             ecCCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCch-HHHHHHHHHHHHHhC-CCCceeEEEEEEEeCCCe
Q 012887          187 LNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNA-YEFELRKDLLELMTC-GHKNILQFYCVCVDENHG  258 (454)
Q Consensus       187 ~~~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~-~~~~~~~Ei~~l~~l-~HpnIv~~~g~~~~~~~~  258 (454)
                      +..++|++++.||+|+||.||++      +.+|+|+++....... ....+.+|..++.++ +||||+++++++.+.+. 
T Consensus        49 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~-  127 (396)
T 4dc2_A           49 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR-  127 (396)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSE-
T ss_pred             CChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCE-
Confidence            44578999999999999999985      5799999975432222 223467888888776 89999999999998776 


Q ss_pred             EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCC
Q 012887          259 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG  338 (454)
Q Consensus       259 l~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~  338 (454)
                      +|+||||+++|+|.+++.+.+.+++..+..++.||+.||+|||++||+||||||+|||++.+|++||+|||+++......
T Consensus       128 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~  207 (396)
T 4dc2_A          128 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG  207 (396)
T ss_dssp             EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred             EEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccCC
Confidence            99999999999999999888899999999999999999999999999999999999999999999999999998654444


Q ss_pred             CcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC---------HHHHHHHHHHcCCCCCC
Q 012887          339 EATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACS---------PVQAAVGIAACGLRPEI  409 (454)
Q Consensus       339 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~---------~~~~~~~i~~~~~~~~~  409 (454)
                      .......||+.|+|||++.+..+    +.++|||||||++|||++|..||....         .......+..  ....+
T Consensus       208 ~~~~~~~gt~~Y~aPE~l~~~~~----~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~--~~~~~  281 (396)
T 4dc2_A          208 DTTSTFCGTPNYIAPEILRGEDY----GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE--KQIRI  281 (396)
T ss_dssp             CCBCCCCBCGGGCCHHHHTTCCB----CTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHH--CCCCC
T ss_pred             CccccccCCcccCCchhhcCCCC----ChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhc--cccCC
Confidence            55566689999999999987654    456999999999999999999996421         1122233333  35568


Q ss_pred             CCCccHHHHHHHHHhcccCCCCCCCH------HHHHHHHH
Q 012887          410 PKDCPQILKSLMIKCWNNSPSKRPQF------SEIISLLL  443 (454)
Q Consensus       410 p~~~~~~l~~li~~cl~~dP~~RPs~------~ell~~L~  443 (454)
                      |..+++++.+||++||+.||.+||++      .|+++|-+
T Consensus       282 p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpf  321 (396)
T 4dc2_A          282 PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPF  321 (396)
T ss_dssp             CTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTT
T ss_pred             CCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCcc
Confidence            88999999999999999999999984      78877654

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=1.4e-45  Score=365.39  Aligned_cols=262  Identities=23%  Similarity=0.408  Sum_probs=207.1

Q ss_pred             ccceeecCCCEEEeceeeccCCceEEEeE---------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEE
Q 012887          182 IGRWLLNSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVC  252 (454)
Q Consensus       182 ~~~~~~~~~~~~~~~~LG~G~fG~Vy~g~---------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~  252 (454)
                      +..+.+..++|++.+.||+|+||.||+|+         .||+|.++...........+.+|+.++..++||||+++++++
T Consensus        15 ~~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   94 (323)
T 3qup_A           15 LEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVS   94 (323)
T ss_dssp             -CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEE
T ss_pred             hhhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhcee
Confidence            35566788999999999999999999973         689999976544555667789999999999999999999999


Q ss_pred             EeCCCe-----EEEEEeccCCCCHHHHHHhCC------CCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCC
Q 012887          253 VDENHG-----LCVVTKLMEGGSVNDLILKSR------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG  321 (454)
Q Consensus       253 ~~~~~~-----l~lV~E~~~~gsL~~~l~~~~------~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~  321 (454)
                      .+.+..     .++||||+++|+|.+++....      .+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus        95 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~  174 (323)
T 3qup_A           95 LRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDM  174 (323)
T ss_dssp             ECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS
T ss_pred             eccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCC
Confidence            876541     389999999999999985322      699999999999999999999999999999999999999999


Q ss_pred             cEEEEccCCccccccCCC--cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHH
Q 012887          322 NVCLGDMGIVTACKSVGE--ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAV  398 (454)
Q Consensus       322 ~vKL~DFGla~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~  398 (454)
                      .+||+|||++........  ......+++.|+|||.+.+..    ++.++|||||||++|+|++ |..||.+........
T Consensus       175 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~  250 (323)
T 3qup_A          175 TVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNL----YTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYN  250 (323)
T ss_dssp             CEEECCCCC-----------------CCGGGCCHHHHHHCC----CCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH
T ss_pred             CEEEeeccccccccccccccccccccCcccccCchhhcCCC----CCCccchhhHHHHHHHHHhCCCCCccccChHHHHH
Confidence            999999999876544322  122334577899999998764    4557999999999999999 999999877766555


Q ss_pred             HHHHcCCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCC
Q 012887          399 GIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNI  448 (454)
Q Consensus       399 ~i~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~  448 (454)
                      .+. .+.....+..+++++.+++.+||+.||.+|||+.++++.|+++...
T Consensus       251 ~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~  299 (323)
T 3qup_A          251 YLI-GGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGH  299 (323)
T ss_dssp             HHH-TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HHh-cCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence            444 4456677888999999999999999999999999999999887654

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=4.9e-45  Score=356.49  Aligned_cols=262  Identities=28%  Similarity=0.504  Sum_probs=207.7

Q ss_pred             cceeecCCCEEEeceeeccCCceEEEeE---EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeE
Q 012887          183 GRWLLNSDNLEFIDQIGPNSFKGVYKGK---RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGL  259 (454)
Q Consensus       183 ~~~~~~~~~~~~~~~LG~G~fG~Vy~g~---~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l  259 (454)
                      ..+.+..++|++.+.||+|+||.||+|+   .+|+|.++...........+.+|+.++..++||||+++++++. .+. +
T Consensus        17 ~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~-~   94 (289)
T 3og7_A           17 DDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQ-L   94 (289)
T ss_dssp             -CCBCCTTSCEEEEEEEECSSEEEEEEESSSEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSS-C
T ss_pred             CCCccCccceeeeeEecCCCCeEEEEEEEcCceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc-CCc-c
Confidence            4566788999999999999999999974   6999999866555556677899999999999999999999654 334 8


Q ss_pred             EEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCC
Q 012887          260 CVVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG  338 (454)
Q Consensus       260 ~lV~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~  338 (454)
                      ++||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus        95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  174 (289)
T 3og7_A           95 AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS  174 (289)
T ss_dssp             EEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC---------
T ss_pred             EEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceecccccccc
Confidence            8999999999999999543 479999999999999999999999999999999999999999999999999987554321


Q ss_pred             --CcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCC-CCC---CCCC
Q 012887          339 --EATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGL-RPE---IPKD  412 (454)
Q Consensus       339 --~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~-~~~---~p~~  412 (454)
                        .......+|+.|+|||.+.... ...++.++||||||+++|+|++|..||...............+. .+.   .+..
T Consensus       175 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (289)
T 3og7_A          175 GSHQFEQLSGSILWMAPEVIRMQD-SNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSN  253 (289)
T ss_dssp             ---------CCCTTCCHHHHC-----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTT
T ss_pred             ccccccccCCCccccCchhhcccC-CCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhcccc
Confidence              1223346899999999987332 12356679999999999999999999998766655555444332 222   3457


Q ss_pred             ccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 012887          413 CPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNN  447 (454)
Q Consensus       413 ~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~  447 (454)
                      +|+.+.++|.+||+.||.+|||+.++++.|+++..
T Consensus       254 ~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~  288 (289)
T 3og7_A          254 CPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR  288 (289)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             CCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence            89999999999999999999999999999998754

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=5.1e-45  Score=356.59  Aligned_cols=249  Identities=16%  Similarity=0.231  Sum_probs=206.2

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  263 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~  263 (454)
                      ++|++++.||+|+||.||++      +.||+|.+............+.+|+.++.+++||||+++++++.+.+. +++||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~lv~   80 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKK-LTLVF   80 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTE-EEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCE-EEEEE
Confidence            67999999999999999996      469999998666555566778899999999999999999999998776 99999


Q ss_pred             eccCCCCHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCccc
Q 012887          264 KLMEGGSVNDLIL-KSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE  342 (454)
Q Consensus       264 E~~~~gsL~~~l~-~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~  342 (454)
                      ||+++ +|.+.+. ..+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...........
T Consensus        81 e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  159 (292)
T 3o0g_A           81 EFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYS  159 (292)
T ss_dssp             ECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCCC
T ss_pred             ecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcccccc
Confidence            99987 6665554 456899999999999999999999999999999999999999999999999999987655444455


Q ss_pred             ccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCC-CCCCHHHHHHHHHHcCCC---------------
Q 012887          343 YETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAY-AACSPVQAAVGIAACGLR---------------  406 (454)
Q Consensus       343 ~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf-~~~~~~~~~~~i~~~~~~---------------  406 (454)
                      ...+|+.|+|||++.+..   .++.++|||||||++|+|++|..|| .+.+.......+......               
T Consensus       160 ~~~~t~~y~aPE~~~~~~---~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  236 (292)
T 3o0g_A          160 AEVVTLWYRPPDVLFGAK---LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY  236 (292)
T ss_dssp             SCCSCGGGCCHHHHTTCS---CCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred             CCccccCCcChHHHcCCC---CcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccc
Confidence            567899999999997653   2456799999999999999987774 555555444444321100               


Q ss_pred             ------------CCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 012887          407 ------------PEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLL  443 (454)
Q Consensus       407 ------------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~  443 (454)
                                  ......+++++.+||.+||+.||.+|||+.|+++|-+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~  285 (292)
T 3o0g_A          237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPY  285 (292)
T ss_dssp             CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred             cccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcc
Confidence                        0122357899999999999999999999999998755

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=1.4e-45  Score=366.87  Aligned_cols=259  Identities=23%  Similarity=0.435  Sum_probs=222.0

Q ss_pred             cceeecCCCEEEeceeeccCCceEEEeE-----------EEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEEEE
Q 012887          183 GRWLLNSDNLEFIDQIGPNSFKGVYKGK-----------RVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYC  250 (454)
Q Consensus       183 ~~~~~~~~~~~~~~~LG~G~fG~Vy~g~-----------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~~~g  250 (454)
                      ..|.+..++|++.+.||+|+||.||+|.           .||+|.+.... .......+.+|+.++..+ +||||+++++
T Consensus        39 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~  117 (333)
T 2i1m_A           39 EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-HADEKEALMSELKIMSHLGQHENIVNLLG  117 (333)
T ss_dssp             GGGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             ccccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc-ChHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence            3577888999999999999999999975           59999997432 334456688999999999 8999999999


Q ss_pred             EEEeCCCeEEEEEeccCCCCHHHHHHh--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEE
Q 012887          251 VCVDENHGLCVVTKLMEGGSVNDLILK--------------SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRIL  316 (454)
Q Consensus       251 ~~~~~~~~l~lV~E~~~~gsL~~~l~~--------------~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NIL  316 (454)
                      ++.+.+. +++||||+++|+|.+++.+              ...+++..+..++.||+.||.|||++||+||||||+|||
T Consensus       118 ~~~~~~~-~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl  196 (333)
T 2i1m_A          118 ACTHGGP-VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVL  196 (333)
T ss_dssp             EECSSSS-CEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCE
T ss_pred             EEecCCc-eEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEE
Confidence            9987776 8999999999999999854              236899999999999999999999999999999999999


Q ss_pred             EccCCcEEEEccCCccccccCCCc--ccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCH
Q 012887          317 LDRHGNVCLGDMGIVTACKSVGEA--TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSP  393 (454)
Q Consensus       317 l~~~~~vKL~DFGla~~~~~~~~~--~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~  393 (454)
                      ++.++.+||+|||++.........  .....+++.|+|||.+.+..    ++.++|||||||++|+|++ |..||.+...
T Consensus       197 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~Di~slG~il~el~t~g~~p~~~~~~  272 (333)
T 2i1m_A          197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCV----YTVQSDVWSYGILLWEIFSLGLNPYPGILV  272 (333)
T ss_dssp             EEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCC----CCHHHHHHHHHHHHHHHTTTSCCSSTTCCS
T ss_pred             ECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCC----CChHHHHHHHHHHHHHHHcCCCCCCcccch
Confidence            999999999999998765443221  22234577899999998654    4567999999999999999 9999998776


Q ss_pred             HHHHHHHHHcCCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 012887          394 VQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNN  447 (454)
Q Consensus       394 ~~~~~~i~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~  447 (454)
                      ......+...+.++..|..+++.+.++|.+||+.||.+|||+.+++++|++...
T Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~  326 (333)
T 2i1m_A          273 NSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ  326 (333)
T ss_dssp             SHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHH
Confidence            666667777777778888899999999999999999999999999999988653

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=3.3e-45  Score=352.11  Aligned_cols=256  Identities=25%  Similarity=0.532  Sum_probs=218.3

Q ss_pred             cceeecCCCEEEeceeeccCCceEEEe-----EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCC
Q 012887          183 GRWLLNSDNLEFIDQIGPNSFKGVYKG-----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH  257 (454)
Q Consensus       183 ~~~~~~~~~~~~~~~LG~G~fG~Vy~g-----~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~  257 (454)
                      ++|.++.++|++.+.||+|+||.||++     +.+|+|.+......   ...+.+|+.++..++||||+++++++.+.+.
T Consensus         1 ~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   77 (267)
T 3t9t_A            1 GKWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAP   77 (267)
T ss_dssp             --CBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBC---HHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             CceEEchhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence            367888899999999999999999996     47999999754322   3568899999999999999999999987776


Q ss_pred             eEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCcccccc
Q 012887          258 GLCVVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS  336 (454)
Q Consensus       258 ~l~lV~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~  336 (454)
                       .++||||+++++|.+++... ..+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++.....
T Consensus        78 -~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~  156 (267)
T 3t9t_A           78 -ICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD  156 (267)
T ss_dssp             -CEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred             -eEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccc
Confidence             89999999999999999765 4799999999999999999999999999999999999999999999999999876533


Q ss_pred             CCC-cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHcCCCCCCCCCcc
Q 012887          337 VGE-ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCP  414 (454)
Q Consensus       337 ~~~-~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~  414 (454)
                      ... ......+++.|+|||.+.+..    ++.++||||||+++|+|++ |..||...........+. .+.+...|..++
T Consensus       157 ~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~-~~~~~~~~~~~~  231 (267)
T 3t9t_A          157 DQYTSSTGTKFPVKWASPEVFSFSR----YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS-TGFRLYKPRLAS  231 (267)
T ss_dssp             HHHHSTTSTTCCGGGCCHHHHHHCC----CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-TTCCCCCCTTSC
T ss_pred             ccccccccccccccccChhhhcCCC----ccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHh-cCCcCCCCccCc
Confidence            211 122335677899999997654    4557999999999999999 999999877766655544 455666788899


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 012887          415 QILKSLMIKCWNNSPSKRPQFSEIISLLLRTNN  447 (454)
Q Consensus       415 ~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~  447 (454)
                      ..+.+++.+||+.||.+||++.+++++|.++.+
T Consensus       232 ~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (267)
T 3t9t_A          232 THVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  264 (267)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            999999999999999999999999999998754

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=6.7e-46  Score=365.93  Aligned_cols=253  Identities=22%  Similarity=0.383  Sum_probs=210.3

Q ss_pred             ceeecCCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCC
Q 012887          184 RWLLNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH  257 (454)
Q Consensus       184 ~~~~~~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~  257 (454)
                      .+.+..++|++.+.||+|+||.||++      +.+|+|++..  ........+.+|+.++..++||||+++++++.+.+.
T Consensus         4 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   81 (310)
T 3s95_A            4 HRIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR--FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKR   81 (310)
T ss_dssp             CEEECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESC--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTE
T ss_pred             ceeeChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEecc--CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCe
Confidence            45677899999999999999999996      4699998853  334455678899999999999999999999998776


Q ss_pred             eEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCcccccc
Q 012887          258 GLCVVTKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS  336 (454)
Q Consensus       258 ~l~lV~E~~~~gsL~~~l~~-~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~  336 (454)
                       .++||||+++|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus        82 -~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  160 (310)
T 3s95_A           82 -LNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVD  160 (310)
T ss_dssp             -EEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC-
T ss_pred             -eEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceeccc
Confidence             9999999999999999976 45899999999999999999999999999999999999999999999999999876543


Q ss_pred             CCCcc--------------cccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHH-----H
Q 012887          337 VGEAT--------------EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQA-----A  397 (454)
Q Consensus       337 ~~~~~--------------~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~-----~  397 (454)
                      .....              ....||+.|+|||.+.+..    ++.++||||||+++|+|++|..||....+...     .
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~  236 (310)
T 3s95_A          161 EKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRS----YDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNV  236 (310)
T ss_dssp             -------------------CCCCSCGGGCCHHHHTTCC----CCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCH
T ss_pred             ccccccccccccccccccccccCCCcceeCHHHhcCCC----CCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhh
Confidence            32211              1446899999999998764    45569999999999999999999875432110     1


Q ss_pred             HHHHHcCCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 012887          398 VGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNN  447 (454)
Q Consensus       398 ~~i~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~  447 (454)
                      ....    ....|..+|+.+.++|.+||+.||.+|||+.++++.|+.+..
T Consensus       237 ~~~~----~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~  282 (310)
T 3s95_A          237 RGFL----DRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRM  282 (310)
T ss_dssp             HHHH----HHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hccc----cccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            1111    123467788899999999999999999999999999988754

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=1.6e-45  Score=360.48  Aligned_cols=257  Identities=22%  Similarity=0.430  Sum_probs=209.9

Q ss_pred             eecCCCEEEeceeeccCCceEEEeE----------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeC
Q 012887          186 LLNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDE  255 (454)
Q Consensus       186 ~~~~~~~~~~~~LG~G~fG~Vy~g~----------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~  255 (454)
                      .+..++|++++.||+|+||.||+++          .||+|++...  .......+.+|+.++..++||||+++++++...
T Consensus         6 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   83 (295)
T 3ugc_A            6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA   83 (295)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHH
T ss_pred             cCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence            3556899999999999999999864          7999998742  333445688999999999999999999998654


Q ss_pred             C-CeEEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccc
Q 012887          256 N-HGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTA  333 (454)
Q Consensus       256 ~-~~l~lV~E~~~~gsL~~~l~~~~-~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~  333 (454)
                      + ..+++||||+++|+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus        84 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~  163 (295)
T 3ugc_A           84 GRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKV  163 (295)
T ss_dssp             HHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred             CCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCccccc
Confidence            2 33899999999999999997654 699999999999999999999999999999999999999999999999999876


Q ss_pred             cccCCC---cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHH---------------H
Q 012887          334 CKSVGE---ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPV---------------Q  395 (454)
Q Consensus       334 ~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~---------------~  395 (454)
                      ......   ......++..|+|||.+.+..    ++.++||||||+++|+|++|..||......               .
T Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (295)
T 3ugc_A          164 LPQDKEFFKVKEPGESPIFWYAPESLTESK----FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF  239 (295)
T ss_dssp             ------------CTTCGGGGCCHHHHHHCC----CCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHH
T ss_pred             ccCCcceeeeccCCCCccceeCcHHhcCCC----CChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHH
Confidence            644322   122334567799999998664    456799999999999999999998643211               1


Q ss_pred             HHHHHHHcCCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCC
Q 012887          396 AAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNI  448 (454)
Q Consensus       396 ~~~~i~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~  448 (454)
                      ........+.+.+.|..+|+++.++|.+||+.||.+|||+.|+++.|+++.+.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~  292 (295)
T 3ugc_A          240 HLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN  292 (295)
T ss_dssp             HHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence            22334455667778889999999999999999999999999999999988654

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=2.2e-45  Score=358.74  Aligned_cols=249  Identities=19%  Similarity=0.300  Sum_probs=204.0

Q ss_pred             CCEEEeceeeccCCceEEEe-----EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEEe
Q 012887          190 DNLEFIDQIGPNSFKGVYKG-----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTK  264 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g-----~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~E  264 (454)
                      ++|++++.||+|+||.||++     +.+|+|++............+.+|+.++..++||||+++++++.+.+. +++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~lv~e   80 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKR-LVLVFE   80 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSC-EEEEEE
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCe-EEEEEE
Confidence            67999999999999999996     479999997544333334567899999999999999999999998776 999999


Q ss_pred             ccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCcccc
Q 012887          265 LMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY  343 (454)
Q Consensus       265 ~~~~gsL~~~l~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~  343 (454)
                      |+++ +|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++............
T Consensus        81 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  159 (288)
T 1ob3_A           81 HLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH  159 (288)
T ss_dssp             CCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-------
T ss_pred             ecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcccccccc
Confidence            9986 999998654 58999999999999999999999999999999999999999999999999998766543333444


Q ss_pred             cCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCC----------------C
Q 012887          344 ETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR----------------P  407 (454)
Q Consensus       344 ~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~----------------~  407 (454)
                      ..+|+.|+|||++.+..   .++.++|||||||++|+|++|..||.+.+.......+......                +
T Consensus       160 ~~~t~~y~aPE~~~~~~---~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (288)
T 1ob3_A          160 EIVTLWYRAPDVLMGSK---KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP  236 (288)
T ss_dssp             --CCCTTCCHHHHTTCC---SCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred             ccccccccCchheeCCC---CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccccc
Confidence            56899999999997542   3556799999999999999999999988777665554431000                0


Q ss_pred             -----------CCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 012887          408 -----------EIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLL  443 (454)
Q Consensus       408 -----------~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~  443 (454)
                                 ..+..+++++.++|.+||+.||.+|||+.|+++|-+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~  283 (288)
T 1ob3_A          237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAY  283 (288)
T ss_dssp             TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGG
T ss_pred             ccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcc
Confidence                       112457899999999999999999999999998765

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=5.7e-45  Score=363.57  Aligned_cols=259  Identities=23%  Similarity=0.466  Sum_probs=220.3

Q ss_pred             cceeecCCCEEEeceeeccCCceEEEeE-------------EEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEE
Q 012887          183 GRWLLNSDNLEFIDQIGPNSFKGVYKGK-------------RVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQF  248 (454)
Q Consensus       183 ~~~~~~~~~~~~~~~LG~G~fG~Vy~g~-------------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~~  248 (454)
                      ..|.+..++|++.+.||+|+||.||+|+             .||+|.++.. ........+.+|+.++..+ +||||+++
T Consensus        28 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~  106 (334)
T 2pvf_A           28 PKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-ATEKDLSDLVSEMEMMKMIGKHKNIINL  106 (334)
T ss_dssp             TTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             ccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccC-CcHHHHHHHHHHHHHHHHhhcCCCEeeE
Confidence            4577788999999999999999999975             4999998743 2334456688999999999 89999999


Q ss_pred             EEEEEeCCCeEEEEEeccCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhcCcccCCccC
Q 012887          249 YCVCVDENHGLCVVTKLMEGGSVNDLILKSR----------------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNS  312 (454)
Q Consensus       249 ~g~~~~~~~~l~lV~E~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp  312 (454)
                      ++++.+.+. +++||||+++|+|.+++....                .+++..++.++.||+.||.|||++||+||||||
T Consensus       107 ~~~~~~~~~-~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp  185 (334)
T 2pvf_A          107 LGACTQDGP-LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAA  185 (334)
T ss_dssp             EEEECSSSC-CEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred             EEEEccCCc-eEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCcc
Confidence            999987776 899999999999999996543                389999999999999999999999999999999


Q ss_pred             CcEEEccCCcEEEEccCCccccccCCC--cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCC
Q 012887          313 QRILLDRHGNVCLGDMGIVTACKSVGE--ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYA  389 (454)
Q Consensus       313 ~NILl~~~~~vKL~DFGla~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~  389 (454)
                      +|||++.++.+||+|||++........  ......+++.|+|||++.+..    ++.++||||||+++|+|++ |..||.
T Consensus       186 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~Di~slG~il~ellt~g~~p~~  261 (334)
T 2pvf_A          186 RNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRV----YTHQSDVWSFGVLMWEIFTLGGSPYP  261 (334)
T ss_dssp             GGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCE----ECHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             ceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCC----cChHHHHHHHHHHHHHHHhCCCCCcC
Confidence            999999999999999999876554322  123335678899999997654    4557999999999999999 999999


Q ss_pred             CCCHHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCC
Q 012887          390 ACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNI  448 (454)
Q Consensus       390 ~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~  448 (454)
                      +.........+. .+.+...+..++..+.++|.+||+.||.+||++.+++++|+++...
T Consensus       262 ~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~  319 (334)
T 2pvf_A          262 GIPVEELFKLLK-EGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL  319 (334)
T ss_dssp             TCCHHHHHHHHH-HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             cCCHHHHHHHHh-cCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            877665554444 4556677888999999999999999999999999999999988654

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=3.6e-45  Score=364.45  Aligned_cols=253  Identities=23%  Similarity=0.457  Sum_probs=210.6

Q ss_pred             ecCCCEEEeceeeccCCceEEEeE----------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCC
Q 012887          187 LNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN  256 (454)
Q Consensus       187 ~~~~~~~~~~~LG~G~fG~Vy~g~----------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~  256 (454)
                      +..++|++++.||+|+||.||+|+          .||+|.+.... .......+.+|+.++..++||||++++++|.+.+
T Consensus        12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   90 (327)
T 3poz_A           12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTST   90 (327)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS
T ss_pred             cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC
Confidence            556889999999999999999974          36888876332 2334466889999999999999999999998654


Q ss_pred             CeEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccc
Q 012887          257 HGLCVVTKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK  335 (454)
Q Consensus       257 ~~l~lV~E~~~~gsL~~~l~~-~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~  335 (454)
                        .++|+||+.+|+|.+++.+ ...+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||+++...
T Consensus        91 --~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~  168 (327)
T 3poz_A           91 --VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  168 (327)
T ss_dssp             --EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred             --eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence              7899999999999999976 4589999999999999999999999999999999999999999999999999988664


Q ss_pred             cCCCc--ccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHcCCCCCCCCC
Q 012887          336 SVGEA--TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKD  412 (454)
Q Consensus       336 ~~~~~--~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~  412 (454)
                      .....  .....+|+.|+|||.+.+..    ++.++|||||||++|||++ |..||.+....... .....+.+.+.|..
T Consensus       169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~----~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~  243 (327)
T 3poz_A          169 AEEKEYHAEGGKVPIKWMALESILHRI----YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SILEKGERLPQPPI  243 (327)
T ss_dssp             TTCC-------CCCGGGSCHHHHHHCC----CCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH-HHHHTTCCCCCCTT
T ss_pred             CCcccccccCCCccccccChHHhccCC----CCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHH-HHHHcCCCCCCCcc
Confidence            43222  22334577899999998764    4567999999999999999 99999887665543 44455667778888


Q ss_pred             ccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 012887          413 CPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNN  447 (454)
Q Consensus       413 ~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~  447 (454)
                      ++.++.+++.+||+.||.+||++.+++++|+++..
T Consensus       244 ~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~  278 (327)
T 3poz_A          244 CTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             BCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred             CCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            99999999999999999999999999999988754

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=5.1e-45  Score=361.03  Aligned_cols=250  Identities=20%  Similarity=0.277  Sum_probs=203.3

Q ss_pred             CCCEEEeceeeccCCceEEEeE-----EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEE
Q 012887          189 SDNLEFIDQIGPNSFKGVYKGK-----RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  263 (454)
Q Consensus       189 ~~~~~~~~~LG~G~fG~Vy~g~-----~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~  263 (454)
                      .++|++++.||+|+||.||+++     .||+|++............+.+|+.++..++||||+++++++.+.+. +++||
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~-~~lv~   98 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERC-LTLVF   98 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSC-EEEEE
T ss_pred             HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCE-EEEEE
Confidence            3789999999999999999964     69999997554444455678899999999999999999999987776 99999


Q ss_pred             eccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCccc
Q 012887          264 KLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE  342 (454)
Q Consensus       264 E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~  342 (454)
                      ||+++ +|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...........
T Consensus        99 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~  177 (311)
T 3niz_A           99 EFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYT  177 (311)
T ss_dssp             ECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC---
T ss_pred             cCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCccccc
Confidence            99986 888888654 4699999999999999999999999999999999999999999999999999987654444445


Q ss_pred             ccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHc---CCCCC-----------
Q 012887          343 YETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAAC---GLRPE-----------  408 (454)
Q Consensus       343 ~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~---~~~~~-----------  408 (454)
                      ...+|+.|+|||++.+..   .++.++|||||||++|+|++|..||.+.+.......+...   ..+..           
T Consensus       178 ~~~~t~~y~aPE~~~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  254 (311)
T 3niz_A          178 HEVVTLWYRAPDVLMGSK---KYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWK  254 (311)
T ss_dssp             CCCCCCTTCCHHHHTTCC---SCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHH
T ss_pred             CCcccCCcCCHHHhcCCC---CCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhh
Confidence            557899999999987642   2456799999999999999999999876665544443321   11100           


Q ss_pred             --------------CCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 012887          409 --------------IPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLL  443 (454)
Q Consensus       409 --------------~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~  443 (454)
                                    ....+++++.+||.+||+.||.+|||+.|+++|-+
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~  303 (311)
T 3niz_A          255 QRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPY  303 (311)
T ss_dssp             SCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGG
T ss_pred             hcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcc
Confidence                          12346789999999999999999999999998754

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.5e-45  Score=362.93  Aligned_cols=249  Identities=16%  Similarity=0.220  Sum_probs=214.3

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  263 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~  263 (454)
                      ++|++.+.||+|+||.||++      +.+|+|.+..   .......+.+|+.++..++||||+++++++.+.+. +++||
T Consensus         5 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~-~~lv~   80 (321)
T 1tki_A            5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV---KGTDQVLVKKEISILNIARHRNILHLHESFESMEE-LVMIF   80 (321)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---CTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTE-EEEEE
T ss_pred             hceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEec---CcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCE-EEEEE
Confidence            78999999999999999985      6799998863   23345568899999999999999999999988776 99999


Q ss_pred             eccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEcc--CCcEEEEccCCccccccCCCc
Q 012887          264 KLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDR--HGNVCLGDMGIVTACKSVGEA  340 (454)
Q Consensus       264 E~~~~gsL~~~l~~~~-~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~--~~~vKL~DFGla~~~~~~~~~  340 (454)
                      ||+++|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.  ++.+||+|||++....... .
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~-~  159 (321)
T 1tki_A           81 EFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD-N  159 (321)
T ss_dssp             CCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC-E
T ss_pred             EeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC-c
Confidence            9999999999996554 7999999999999999999999999999999999999997  7899999999987764432 2


Q ss_pred             ccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCC--CCCccHHHH
Q 012887          341 TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEI--PKDCPQILK  418 (454)
Q Consensus       341 ~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~--p~~~~~~l~  418 (454)
                      .....+|+.|+|||++.+..    ++.++|||||||++|+|++|..||.+.+.......+.........  ...+|.++.
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  235 (321)
T 1tki_A          160 FRLLFTAPEYYAPEVHQHDV----VSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAM  235 (321)
T ss_dssp             EEEEESCGGGSCHHHHTTCE----ECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHH
T ss_pred             cccccCChhhcCcHHhcCCC----CCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHH
Confidence            34456899999999998764    345799999999999999999999998888777777765444321  246899999


Q ss_pred             HHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 012887          419 SLMIKCWNNSPSKRPQFSEIISLLLRTNN  447 (454)
Q Consensus       419 ~li~~cl~~dP~~RPs~~ell~~L~~~~~  447 (454)
                      ++|.+||..||.+|||+.|+++|-+-...
T Consensus       236 ~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  264 (321)
T 1tki_A          236 DFVDRLLVKERKSRMTASEALQHPWLKQK  264 (321)
T ss_dssp             HHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred             HHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence            99999999999999999999998875543

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1.7e-44  Score=351.45  Aligned_cols=251  Identities=28%  Similarity=0.523  Sum_probs=211.5

Q ss_pred             ecCCCEEEeceeeccCCceEEEeE------EEEEEEeecCCCCchHH-----HHHHHHHHHHHhCCCCceeEEEEEEEeC
Q 012887          187 LNSDNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKGNAYE-----FELRKDLLELMTCGHKNILQFYCVCVDE  255 (454)
Q Consensus       187 ~~~~~~~~~~~LG~G~fG~Vy~g~------~vavK~l~~~~~~~~~~-----~~~~~Ei~~l~~l~HpnIv~~~g~~~~~  255 (454)
                      +..++|++.+.||+|+||.||+|+      .||+|.+..........     ..+.+|+.++..++||||+++++++.+.
T Consensus        16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   95 (287)
T 4f0f_A           16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP   95 (287)
T ss_dssp             CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT
T ss_pred             hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC
Confidence            456899999999999999999964      69999987544333222     5688999999999999999999998654


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcC--cccCCccCCcEEEccCCc-----EEEEc
Q 012887          256 NHGLCVVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHG--VAYRDLNSQRILLDRHGN-----VCLGD  327 (454)
Q Consensus       256 ~~~l~lV~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~--iiHrDIKp~NILl~~~~~-----vKL~D  327 (454)
                      .   ++||||+++|+|.+++.+. ..+++..+..++.||+.||.|||++|  |+||||||+|||++.++.     +||+|
T Consensus        96 ~---~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D  172 (287)
T 4f0f_A           96 P---RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD  172 (287)
T ss_dssp             T---EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred             C---eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence            3   5999999999999888654 48999999999999999999999999  999999999999988876     99999


Q ss_pred             cCCccccccCCCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHH--HHHHHHHHcCC
Q 012887          328 MGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPV--QAAVGIAACGL  405 (454)
Q Consensus       328 FGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~--~~~~~i~~~~~  405 (454)
                      ||++.....   ......+|+.|+|||.+.+..  ..++.++|||||||++|+|++|..||......  .....+...+.
T Consensus       173 fg~~~~~~~---~~~~~~g~~~y~aPE~~~~~~--~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  247 (287)
T 4f0f_A          173 FGLSQQSVH---SVSGLLGNFQWMAPETIGAEE--ESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGL  247 (287)
T ss_dssp             CTTCBCCSS---CEECCCCCCTTSCGGGSSCSS--CEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCC
T ss_pred             CCccccccc---cccccCCCccccCchhhccCC--CCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCC
Confidence            999875432   234457899999999985432  23556799999999999999999999865443  33455666777


Q ss_pred             CCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 012887          406 RPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRT  445 (454)
Q Consensus       406 ~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~  445 (454)
                      ++.++..+|+++.++|.+||+.||.+|||+.++++.|+++
T Consensus       248 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          248 RPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             CCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence            8888999999999999999999999999999999999763

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=6.7e-45  Score=362.71  Aligned_cols=248  Identities=16%  Similarity=0.276  Sum_probs=212.3

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCc----hHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGN----AYEFELRKDLLELMTCGHKNILQFYCVCVDENHGL  259 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~----~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l  259 (454)
                      ++|++.+.||+|+||.||++      +.+|+|.+.......    .....+.+|+.++..++||||+++++++.+.+. +
T Consensus        11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~-~   89 (326)
T 2y0a_A           11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD-V   89 (326)
T ss_dssp             HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE-E
T ss_pred             cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE-E
Confidence            56899999999999999995      579999987543321    134668899999999999999999999988776 9


Q ss_pred             EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCC----cEEEEccCCccccc
Q 012887          260 CVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG----NVCLGDMGIVTACK  335 (454)
Q Consensus       260 ~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~----~vKL~DFGla~~~~  335 (454)
                      ++||||+++++|.+++.+...+++..+..++.||+.||.|||++||+||||||+|||++.++    .+||+|||++....
T Consensus        90 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~  169 (326)
T 2y0a_A           90 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID  169 (326)
T ss_dssp             EEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred             EEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECC
Confidence            99999999999999998778899999999999999999999999999999999999999888    79999999988764


Q ss_pred             cCCCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCC--CCCCc
Q 012887          336 SVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPE--IPKDC  413 (454)
Q Consensus       336 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~--~p~~~  413 (454)
                      ... ......||+.|+|||++.+..    ++.++|||||||++|+|++|..||.+.+.......+........  .+..+
T Consensus       170 ~~~-~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (326)
T 2y0a_A          170 FGN-EFKNIFGTPEFVAPEIVNYEP----LGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNT  244 (326)
T ss_dssp             TTS-CCCCCCSCTTTCCHHHHTTCC----CCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTS
T ss_pred             CCC-ccccccCCcCcCCceeecCCC----CCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccC
Confidence            332 233457899999999998664    45569999999999999999999998888777766665443322  23568


Q ss_pred             cHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 012887          414 PQILKSLMIKCWNNSPSKRPQFSEIISLLL  443 (454)
Q Consensus       414 ~~~l~~li~~cl~~dP~~RPs~~ell~~L~  443 (454)
                      +..+.++|.+||+.||.+|||+.|+++|-+
T Consensus       245 ~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~  274 (326)
T 2y0a_A          245 SALAKDFIRRLLVKDPKKRMTIQDSLQHPW  274 (326)
T ss_dssp             CHHHHHHHHHHSCSSGGGSCCHHHHHHSTT
T ss_pred             CHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence            999999999999999999999999998754

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=4.6e-45  Score=380.25  Aligned_cols=258  Identities=24%  Similarity=0.441  Sum_probs=216.5

Q ss_pred             cceeecCCCEEEeceeeccCCceEEEe-----EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCC
Q 012887          183 GRWLLNSDNLEFIDQIGPNSFKGVYKG-----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH  257 (454)
Q Consensus       183 ~~~~~~~~~~~~~~~LG~G~fG~Vy~g-----~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~  257 (454)
                      ..|.+..++|++.+.||+|+||.||+|     ..||||.++....   ....+.+|+.++..++||||+++++++.+ +.
T Consensus       177 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~  252 (452)
T 1fmk_A          177 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EP  252 (452)
T ss_dssp             TCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred             cccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC---CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-Cc
Confidence            568888999999999999999999997     4699999975332   23568899999999999999999999865 43


Q ss_pred             eEEEEEeccCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccc
Q 012887          258 GLCVVTKLMEGGSVNDLILK--SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK  335 (454)
Q Consensus       258 ~l~lV~E~~~~gsL~~~l~~--~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~  335 (454)
                       +++||||+++|+|.+++..  ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus       253 -~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~  331 (452)
T 1fmk_A          253 -IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE  331 (452)
T ss_dssp             -CEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred             -eEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecC
Confidence             8999999999999999954  3469999999999999999999999999999999999999999999999999987654


Q ss_pred             cCCC-cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHcCCCCCCCCCc
Q 012887          336 SVGE-ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDC  413 (454)
Q Consensus       336 ~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~  413 (454)
                      .... ......+++.|+|||.+.+..    ++.++|||||||++|||++ |..||.+....+....+ ..+.+++.|..+
T Consensus       332 ~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i-~~~~~~~~~~~~  406 (452)
T 1fmk_A          332 DNEYTARQGAKFPIKWTAPEAALYGR----FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV-ERGYRMPCPPEC  406 (452)
T ss_dssp             -----------CCGGGSCHHHHHHCC----CCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH-HTTCCCCCCTTS
T ss_pred             CCceecccCCcccccccCHhHHhcCC----CCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH-HcCCCCCCCCCC
Confidence            3221 122334578899999998664    5567999999999999999 99999988877665544 456777888999


Q ss_pred             cHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCCCC
Q 012887          414 PQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISN  450 (454)
Q Consensus       414 ~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~  450 (454)
                      |+.+.++|.+||+.||.+|||+.+|++.|..+....+
T Consensus       407 ~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~  443 (452)
T 1fmk_A          407 PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE  443 (452)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCC
Confidence            9999999999999999999999999999998876543

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.3e-44  Score=359.76  Aligned_cols=257  Identities=27%  Similarity=0.472  Sum_probs=213.0

Q ss_pred             eecCCCEEEeceeeccCCceEEEeE----------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeC
Q 012887          186 LLNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDE  255 (454)
Q Consensus       186 ~~~~~~~~~~~~LG~G~fG~Vy~g~----------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~  255 (454)
                      .+..++|++.+.||+|+||.||+|.          .||+|.++.. ........+.+|+.++..++||||+++++++.+.
T Consensus        40 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  118 (333)
T 1mqb_A           40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG-YTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY  118 (333)
T ss_dssp             BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             cCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecC
Confidence            4667899999999999999999974          3899998743 2334455688999999999999999999999877


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCcccc
Q 012887          256 NHGLCVVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC  334 (454)
Q Consensus       256 ~~~l~lV~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~  334 (454)
                      +. .++||||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus       119 ~~-~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~  197 (333)
T 1mqb_A          119 KP-MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL  197 (333)
T ss_dssp             SS-EEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             CC-cEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhh
Confidence            66 99999999999999999654 58999999999999999999999999999999999999999999999999998766


Q ss_pred             ccCCCc---ccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHcCCCCCCC
Q 012887          335 KSVGEA---TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIP  410 (454)
Q Consensus       335 ~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p  410 (454)
                      ......   .....+++.|+|||.+.+..    ++.++|||||||++|||++ |..||...........+ ..+.+++.+
T Consensus       198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~-~~~~~~~~~  272 (333)
T 1mqb_A          198 EDDPEATYTTSGGKIPIRWTAPEAISYRK----FTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI-NDGFRLPTP  272 (333)
T ss_dssp             -------------CCCGGGSCHHHHHSCC----CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH-HTTCCCCCC
T ss_pred             ccccccccccCCCCccccccCchhcccCC----CCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHH-HCCCcCCCc
Confidence            543221   12234577899999998664    4557999999999999999 99999987776655444 445666778


Q ss_pred             CCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCCC
Q 012887          411 KDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNIS  449 (454)
Q Consensus       411 ~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~  449 (454)
                      ..++..+.++|.+||+.||.+||++.+++++|+++....
T Consensus       273 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~  311 (333)
T 1mqb_A          273 MDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP  311 (333)
T ss_dssp             TTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred             ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence            889999999999999999999999999999999876543

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=9.1e-45  Score=367.25  Aligned_cols=253  Identities=17%  Similarity=0.264  Sum_probs=201.2

Q ss_pred             ecCCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEE
Q 012887          187 LNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLC  260 (454)
Q Consensus       187 ~~~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~  260 (454)
                      ...++|++++.||+|+||.||++      +.||+|++......   ...+.+|+..++.++||||+++++++.+.+. ++
T Consensus        17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~-~~   92 (361)
T 3uc3_A           17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI---DENVQREIINHRSLRHPNIVRFKEVILTPTH-LA   92 (361)
T ss_dssp             CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS---CHHHHHHHHHHHHCCCTTBCCEEEEEECSSE-EE
T ss_pred             CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc---cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCE-EE
Confidence            44588999999999999999985      46999999754332   2457799999999999999999999998776 99


Q ss_pred             EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCc--EEEEccCCccccccCC
Q 012887          261 VVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGN--VCLGDMGIVTACKSVG  338 (454)
Q Consensus       261 lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~--vKL~DFGla~~~~~~~  338 (454)
                      +||||+++|+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++......
T Consensus        93 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~  172 (361)
T 3uc3_A           93 IIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS  172 (361)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred             EEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccC
Confidence            99999999999999987788999999999999999999999999999999999999987775  9999999987533222


Q ss_pred             CcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCH----HHHHHHHHHcCCCCCCCCCcc
Q 012887          339 EATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSP----VQAAVGIAACGLRPEIPKDCP  414 (454)
Q Consensus       339 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~----~~~~~~i~~~~~~~~~p~~~~  414 (454)
                       ......||+.|+|||++.+..+.   +.++|||||||++|+|++|..||.+...    ......+.......+.+..++
T Consensus       173 -~~~~~~gt~~y~aPE~~~~~~~~---~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  248 (361)
T 3uc3_A          173 -QPKSTVGTPAYIAPEVLLRQEYD---GKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRIS  248 (361)
T ss_dssp             ---------CTTSCHHHHHCSSCC---HHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCC
T ss_pred             -CCCCCcCCCCcCChhhhcCCCCC---CCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCC
Confidence             23345689999999999876432   2348999999999999999999986443    333344444444444444689


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 012887          415 QILKSLMIKCWNNSPSKRPQFSEIISLLLRTNN  447 (454)
Q Consensus       415 ~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~  447 (454)
                      +++.+||.+||+.||.+|||+.|+++|-+-...
T Consensus       249 ~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~  281 (361)
T 3uc3_A          249 PECCHLISRIFVADPATRISIPEIKTHSWFLKN  281 (361)
T ss_dssp             HHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence            999999999999999999999999999776443

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=2.1e-44  Score=349.89  Aligned_cols=253  Identities=18%  Similarity=0.250  Sum_probs=217.9

Q ss_pred             CCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEE
Q 012887          189 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  262 (454)
Q Consensus       189 ~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV  262 (454)
                      .++|++.+.||+|+||.||++      +.||+|.+............+.+|+.++..++||||+++++++.+.+. .++|
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~~v   83 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESF-HYLV   83 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE-EEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCE-EEEE
Confidence            378999999999999999985      579999998655555555678899999999999999999999987765 8999


Q ss_pred             EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCc---EEEEccCCccccccCCC
Q 012887          263 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGN---VCLGDMGIVTACKSVGE  339 (454)
Q Consensus       263 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~---vKL~DFGla~~~~~~~~  339 (454)
                      |||+++++|.+.+.....+++..+..++.||+.||.|||++||+||||||+|||++.++.   +||+|||++....... 
T Consensus        84 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~-  162 (284)
T 3kk8_A           84 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE-  162 (284)
T ss_dssp             ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSC-
T ss_pred             EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCc-
Confidence            999999999999987788999999999999999999999999999999999999987665   9999999987655432 


Q ss_pred             cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCC--CCccHHH
Q 012887          340 ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIP--KDCPQIL  417 (454)
Q Consensus       340 ~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p--~~~~~~l  417 (454)
                      ......+++.|+|||.+.+..+    +.++||||||+++|+|++|..||.+.........+.......+.+  ..+++++
T Consensus       163 ~~~~~~~~~~y~aPE~~~~~~~----~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T 3kk8_A          163 AWHGFAGTPGYLSPEVLKKDPY----SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEA  238 (284)
T ss_dssp             BCCCSCSCGGGCCHHHHTTCCB----CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHH
T ss_pred             cccCCCCCcCCcCchhhcCCCC----CcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHH
Confidence            2334578999999999987653    456999999999999999999999988887777776665544333  4689999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 012887          418 KSLMIKCWNNSPSKRPQFSEIISLLLRTNN  447 (454)
Q Consensus       418 ~~li~~cl~~dP~~RPs~~ell~~L~~~~~  447 (454)
                      .++|.+||+.||.+|||+.|++++-+-...
T Consensus       239 ~~li~~~l~~dp~~Rps~~~~l~h~~~~~~  268 (284)
T 3kk8_A          239 KSLIDSMLTVNPKKRITADQALKVPWICNR  268 (284)
T ss_dssp             HHHHHHHSCSSTTTSCCHHHHTTSHHHHSC
T ss_pred             HHHHHHHcccChhhCCCHHHHhcCccccCC
Confidence            999999999999999999999998765443

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=3.5e-45  Score=369.06  Aligned_cols=245  Identities=20%  Similarity=0.254  Sum_probs=213.6

Q ss_pred             CCCEEEeceeeccCCceEEEe------EEEEEEEeecCCC-CchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEE
Q 012887          189 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDK-GNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCV  261 (454)
Q Consensus       189 ~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~l  261 (454)
                      .++|++++.||+|+||.||++      +.||+|.+..... .......+.+|+.++..++||||+++++++.+.+. +|+
T Consensus        40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~-~~l  118 (350)
T 1rdq_E           40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSN-LYM  118 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE-EEE
T ss_pred             HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE-EEE
Confidence            478999999999999999985      5799999864321 11223457789999999999999999999998776 999


Q ss_pred             EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCcc
Q 012887          262 VTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT  341 (454)
Q Consensus       262 V~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~  341 (454)
                      ||||+++|+|.+++.+.+.+++..+..++.||+.||+|||++||+||||||+|||++.+|++||+|||+++.....   .
T Consensus       119 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~---~  195 (350)
T 1rdq_E          119 VMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR---T  195 (350)
T ss_dssp             EEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC---B
T ss_pred             EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC---c
Confidence            9999999999999988788999999999999999999999999999999999999999999999999998765432   3


Q ss_pred             cccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHHHHH
Q 012887          342 EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLM  421 (454)
Q Consensus       342 ~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~li  421 (454)
                      ....||+.|+|||++.+..    ++.++|||||||++|||++|..||.+.+.......+...  ...+|..+++++.++|
T Consensus       196 ~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~--~~~~p~~~~~~~~~li  269 (350)
T 1rdq_E          196 WTLCGTPEALAPEIILSKG----YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG--KVRFPSHFSSDLKDLL  269 (350)
T ss_dssp             CCCEECGGGCCHHHHTTCC----BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTTCCHHHHHHH
T ss_pred             ccccCCccccCHHHhcCCC----CCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcC--CCCCCCCCCHHHHHHH
Confidence            3456899999999998764    445699999999999999999999998888777777765  4457888999999999


Q ss_pred             HHhcccCCCCCCC-----HHHHHHHHH
Q 012887          422 IKCWNNSPSKRPQ-----FSEIISLLL  443 (454)
Q Consensus       422 ~~cl~~dP~~RPs-----~~ell~~L~  443 (454)
                      .+||+.||.+||+     +.+|++|-+
T Consensus       270 ~~lL~~dp~~R~~~~~~~~~ei~~h~~  296 (350)
T 1rdq_E          270 RNLLQVDLTKRFGNLKNGVNDIKNHKW  296 (350)
T ss_dssp             HHHSCSCTTTCTTSSTTTTHHHHTSGG
T ss_pred             HHHhhcCHHhccCCccCCHHHHHhCcC
Confidence            9999999999998     999988765

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=3.9e-45  Score=385.17  Aligned_cols=258  Identities=23%  Similarity=0.439  Sum_probs=221.6

Q ss_pred             ccceeecCCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeC
Q 012887          182 IGRWLLNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDE  255 (454)
Q Consensus       182 ~~~~~~~~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~  255 (454)
                      ...|.+..++|++.+.||+|+||.||+|      ..||||.++....   ....+.+|+.++..++||||++++++|.+.
T Consensus       212 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~  288 (495)
T 1opk_A          212 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTRE  288 (495)
T ss_dssp             SSCCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             ccccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc---chHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            4678889999999999999999999996      5799999974322   345688999999999999999999999877


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccc
Q 012887          256 NHGLCVVTKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTA  333 (454)
Q Consensus       256 ~~~l~lV~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~  333 (454)
                      +. +++||||+++|+|.+++.+.  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus       289 ~~-~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~  367 (495)
T 1opk_A          289 PP-FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRL  367 (495)
T ss_dssp             SS-CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEEC
T ss_pred             Cc-EEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeeccccee
Confidence            76 89999999999999999753  3699999999999999999999999999999999999999999999999999886


Q ss_pred             cccCCC-cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHcCCCCCCCC
Q 012887          334 CKSVGE-ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPK  411 (454)
Q Consensus       334 ~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~  411 (454)
                      ...... ......+++.|+|||++.+..    ++.++|||||||++|||++ |..||.+.+..... .....+.++..|.
T Consensus       368 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~-~~~~~~~~~~~~~  442 (495)
T 1opk_A          368 MTGDTYTAHAGAKFPIKWTAPESLAYNK----FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY-ELLEKDYRMERPE  442 (495)
T ss_dssp             CTTCCEECCTTCCCCGGGCCHHHHHHCE----ECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH-HHHHTTCCCCCCT
T ss_pred             ccCCceeecCCCcCCcceeCHhHHhcCC----CCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHH-HHHHcCCCCCCCC
Confidence            543221 122234567899999998664    4557999999999999999 99999987765544 4455677888899


Q ss_pred             CccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCC
Q 012887          412 DCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNI  448 (454)
Q Consensus       412 ~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~  448 (454)
                      .+|+.+.+||.+||+.||.+|||+.+|++.|+.+...
T Consensus       443 ~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~  479 (495)
T 1opk_A          443 GCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE  479 (495)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred             CCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence            9999999999999999999999999999999987654

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=6.6e-45  Score=354.16  Aligned_cols=259  Identities=24%  Similarity=0.449  Sum_probs=221.0

Q ss_pred             ccccceeecCCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEE
Q 012887          180 EEIGRWLLNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCV  253 (454)
Q Consensus       180 ~~~~~~~~~~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~  253 (454)
                      +....|.+..++|++.+.||+|+||.||+|      ..+|+|.+..   .......+.+|+.++..++||||+++++++.
T Consensus         3 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   79 (288)
T 3kfa_A            3 PNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT   79 (288)
T ss_dssp             TTCCTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECS---CSTHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             CchhcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCc---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEc
Confidence            344678888899999999999999999995      5799999873   2334566889999999999999999999998


Q ss_pred             eCCCeEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCc
Q 012887          254 DENHGLCVVTKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIV  331 (454)
Q Consensus       254 ~~~~~l~lV~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla  331 (454)
                      +.+. +++||||+++++|.+++...  ..+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++
T Consensus        80 ~~~~-~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~  158 (288)
T 3kfa_A           80 REPP-FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLS  158 (288)
T ss_dssp             SSSS-EEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGG
T ss_pred             cCCC-EEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccc
Confidence            7776 99999999999999999763  36999999999999999999999999999999999999999999999999998


Q ss_pred             cccccCCC-cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHcCCCCCC
Q 012887          332 TACKSVGE-ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEI  409 (454)
Q Consensus       332 ~~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~  409 (454)
                      ........ ......+++.|+|||.+.+..    ++.++||||||+++|+|++ |..||.......... ......+...
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~-~~~~~~~~~~  233 (288)
T 3kfa_A          159 RLMTGDTYTAHAGAKFPIKWTAPESLAYNK----FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE-LLEKDYRMER  233 (288)
T ss_dssp             GTSCSSSSEEETTEEECGGGCCHHHHHHCC----CCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH-HHHTTCCCCC
T ss_pred             eeccCCccccccCCccccCcCChhhhccCC----CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-HHhccCCCCC
Confidence            76554322 122334577899999998664    4557999999999999999 999998876655443 4445667778


Q ss_pred             CCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 012887          410 PKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNN  447 (454)
Q Consensus       410 p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~  447 (454)
                      |..+|+.+.+++.+||+.||.+|||+.++++.|+.+..
T Consensus       234 ~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~  271 (288)
T 3kfa_A          234 PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  271 (288)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHH
Confidence            88999999999999999999999999999999988754

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=7.5e-45  Score=358.63  Aligned_cols=264  Identities=22%  Similarity=0.420  Sum_probs=212.5

Q ss_pred             cccceeecCCCEEEeceeeccCCceEEEeE---------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEE
Q 012887          181 EIGRWLLNSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV  251 (454)
Q Consensus       181 ~~~~~~~~~~~~~~~~~LG~G~fG~Vy~g~---------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~  251 (454)
                      .+..+.+..++|.+.+.||+|+||.||+|.         .||+|.+............+.+|+..+..++||||++++++
T Consensus        25 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~  104 (313)
T 3brb_A           25 KLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGV  104 (313)
T ss_dssp             CTTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEE
T ss_pred             hHHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEE
Confidence            345667788999999999999999999863         69999987655555555678899999999999999999999


Q ss_pred             EEeCCC----eEEEEEeccCCCCHHHHHH------hCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCC
Q 012887          252 CVDENH----GLCVVTKLMEGGSVNDLIL------KSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG  321 (454)
Q Consensus       252 ~~~~~~----~l~lV~E~~~~gsL~~~l~------~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~  321 (454)
                      +.+.+.    ..++||||+++|+|.+++.      ....+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus       105 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~  184 (313)
T 3brb_A          105 CIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDM  184 (313)
T ss_dssp             EEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTS
T ss_pred             EeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCC
Confidence            987652    2589999999999999984      234799999999999999999999999999999999999999999


Q ss_pred             cEEEEccCCccccccCCC--cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHH
Q 012887          322 NVCLGDMGIVTACKSVGE--ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAV  398 (454)
Q Consensus       322 ~vKL~DFGla~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~  398 (454)
                      .+||+|||++........  ......+++.|+|||.+.+..    ++.++||||||+++|+|++ |..||.+........
T Consensus       185 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~  260 (313)
T 3brb_A          185 TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRV----YTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYD  260 (313)
T ss_dssp             CEEECSCSCC----------------CCGGGSCHHHHHSSC----CCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH
T ss_pred             cEEEeecCcceecccccccCcccccCCCccccCchhhcCCC----ccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHH
Confidence            999999999876543321  223335678899999998664    4557999999999999999 999998877665554


Q ss_pred             HHHHcCCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCCC
Q 012887          399 GIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNIS  449 (454)
Q Consensus       399 ~i~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~  449 (454)
                      .+. .+.++..|..+++.+.++|.+||+.||.+||++.+++++|.++.+..
T Consensus       261 ~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l  310 (313)
T 3brb_A          261 YLL-HGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL  310 (313)
T ss_dssp             HHH-TTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             HHH-cCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence            443 45567788899999999999999999999999999999999886543

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=2.3e-45  Score=373.30  Aligned_cols=256  Identities=28%  Similarity=0.476  Sum_probs=206.7

Q ss_pred             eecCCCEEEeceeeccCCceEEEeE---------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCC
Q 012887          186 LLNSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN  256 (454)
Q Consensus       186 ~~~~~~~~~~~~LG~G~fG~Vy~g~---------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~  256 (454)
                      .+..++|++.+.||+|+||.||+|+         .||+|.++.. ........+.+|+.++.+++||||+++++++.+.+
T Consensus        41 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  119 (373)
T 2qol_A           41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG-YTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSK  119 (373)
T ss_dssp             BCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTT-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred             hcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCc-cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCC
Confidence            3556789999999999999999863         4999998743 23345567889999999999999999999998776


Q ss_pred             CeEEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccc
Q 012887          257 HGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK  335 (454)
Q Consensus       257 ~~l~lV~E~~~~gsL~~~l~~~~-~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~  335 (454)
                      . +++||||+++|+|.+++.+.. .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus       120 ~-~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  198 (373)
T 2qol_A          120 P-VMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLE  198 (373)
T ss_dssp             S-CEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             c-eEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence            6 899999999999999997654 79999999999999999999999999999999999999999999999999987665


Q ss_pred             cCCCc---ccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHcCCCCCCCC
Q 012887          336 SVGEA---TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPK  411 (454)
Q Consensus       336 ~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~  411 (454)
                      .....   .....+++.|+|||.+.+..    ++.++|||||||++|||++ |..||...+.......+ ..+.+.+.+.
T Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i-~~~~~~~~~~  273 (373)
T 2qol_A          199 DDPEAAYTTRGGKIPIRWTSPEAIAYRK----FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV-DEGYRLPPPM  273 (373)
T ss_dssp             ---------------CTTSCHHHHHHCC----CCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHH-HTTEECCCCT
T ss_pred             cCCccceeccCCCcCCCccChhhhccCC----cCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-HcCCCCCCCc
Confidence            43221   11223467899999998664    4557999999999999998 99999987776655444 4456667788


Q ss_pred             CccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCC
Q 012887          412 DCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNI  448 (454)
Q Consensus       412 ~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~  448 (454)
                      .++..+.++|.+||+.||.+||++.++++.|.++...
T Consensus       274 ~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~  310 (373)
T 2qol_A          274 DCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN  310 (373)
T ss_dssp             TCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             cccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence            8999999999999999999999999999999988654

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.4e-44  Score=362.54  Aligned_cols=257  Identities=16%  Similarity=0.249  Sum_probs=212.2

Q ss_pred             eecCCCEEEeceeeccCCceEEEe-----EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCC--CceeEEEEEEEeCCCe
Q 012887          186 LLNSDNLEFIDQIGPNSFKGVYKG-----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGH--KNILQFYCVCVDENHG  258 (454)
Q Consensus       186 ~~~~~~~~~~~~LG~G~fG~Vy~g-----~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~H--pnIv~~~g~~~~~~~~  258 (454)
                      .+..+.|++++.||+|+||.||++     +.||+|++............+.+|+.++..++|  |||+++++++.+.+. 
T Consensus         5 ~~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~-   83 (343)
T 3dbq_A            5 SVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY-   83 (343)
T ss_dssp             ESSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE-
T ss_pred             eeecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCE-
Confidence            355688999999999999999986     579999998655555556778899999999976  999999999998776 


Q ss_pred             EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCC
Q 012887          259 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG  338 (454)
Q Consensus       259 l~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~  338 (454)
                      +++|||+ .+++|.+++.+.+.+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.......
T Consensus        84 ~~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~  161 (343)
T 3dbq_A           84 IYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT  161 (343)
T ss_dssp             EEEEECC-CSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC----
T ss_pred             EEEEEeC-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCccc
Confidence            9999995 5779999998888999999999999999999999999999999999999997 6889999999987664432


Q ss_pred             C--cccccCCCCcccccccccCCCC-------CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHHHcCCCCC
Q 012887          339 E--ATEYETDGYRWLAPEIIAGDPE-------SVSETWMSNVYSFGMVIWEMVTGEAAYAACSP-VQAAVGIAACGLRPE  408 (454)
Q Consensus       339 ~--~~~~~~gt~~y~APE~l~~~~~-------~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~-~~~~~~i~~~~~~~~  408 (454)
                      .  ......||+.|+|||++.+...       ...++.++|||||||++|+|++|..||..... ......+........
T Consensus       162 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  241 (343)
T 3dbq_A          162 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE  241 (343)
T ss_dssp             --------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCC
T ss_pred             ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcccC
Confidence            2  2234568999999999865211       13466789999999999999999999987543 344555555566677


Q ss_pred             CCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 012887          409 IPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRT  445 (454)
Q Consensus       409 ~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~  445 (454)
                      +|...+.++.++|.+||+.||.+|||+.|++++.+-.
T Consensus       242 ~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~  278 (343)
T 3dbq_A          242 FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ  278 (343)
T ss_dssp             CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred             CcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccc
Confidence            8888999999999999999999999999999987754

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=2.1e-45  Score=381.89  Aligned_cols=251  Identities=18%  Similarity=0.275  Sum_probs=207.6

Q ss_pred             ecCCCEEEeceeeccCCceEEEe------EEEEEEEeecCCC-CchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeE
Q 012887          187 LNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDK-GNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGL  259 (454)
Q Consensus       187 ~~~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l  259 (454)
                      +..++|++++.||+|+||.||++      +.||+|.++.... .......+.+|+.++..++||||+++++++.+.+. +
T Consensus       145 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~-~  223 (446)
T 4ejn_A          145 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDR-L  223 (446)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTE-E
T ss_pred             CChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCE-E
Confidence            44578999999999999999985      4899999974321 12223456788888889999999999999998876 9


Q ss_pred             EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-cCcccCCccCCcEEEccCCcEEEEccCCccccccCC
Q 012887          260 CVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLND-HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG  338 (454)
Q Consensus       260 ~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~-~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~  338 (454)
                      ++||||+++|+|.+++.+.+.+++..+..++.||+.||+|||+ +||+||||||+|||++.++++||+|||+++......
T Consensus       224 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  303 (446)
T 4ejn_A          224 CFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG  303 (446)
T ss_dssp             EEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC--
T ss_pred             EEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCCC
Confidence            9999999999999999888899999999999999999999998 999999999999999999999999999988655444


Q ss_pred             CcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHH
Q 012887          339 EATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILK  418 (454)
Q Consensus       339 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~  418 (454)
                      .......||+.|+|||++.+..    ++.++|||||||++|||++|..||.+.+.......+....  ..+|..+++++.
T Consensus       304 ~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~--~~~p~~~~~~~~  377 (446)
T 4ejn_A          304 ATMKTFCGTPEYLAPEVLEDND----YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE--IRFPRTLGPEAK  377 (446)
T ss_dssp             ---CCSSSCGGGCCHHHHHTSC----CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--CCCCTTSCHHHH
T ss_pred             cccccccCCccccCHhhcCCCC----CCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCC--CCCCccCCHHHH
Confidence            4455668999999999998765    4556999999999999999999999988877777776653  447888999999


Q ss_pred             HHHHHhcccCCCCCC-----CHHHHHHHHHh
Q 012887          419 SLMIKCWNNSPSKRP-----QFSEIISLLLR  444 (454)
Q Consensus       419 ~li~~cl~~dP~~RP-----s~~ell~~L~~  444 (454)
                      +||.+||+.||.+||     ++.|+++|-+-
T Consensus       378 ~li~~~L~~dP~~R~~~~~~t~~ell~hp~f  408 (446)
T 4ejn_A          378 SLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF  408 (446)
T ss_dssp             HHHHHHTCSSTTTSTTCSTTTHHHHHTSGGG
T ss_pred             HHHHHHcccCHHHhCCCCCCCHHHHHhCccc
Confidence            999999999999999     99999987553

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=3.7e-45  Score=372.16  Aligned_cols=247  Identities=19%  Similarity=0.275  Sum_probs=204.9

Q ss_pred             cCCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCc-hHHHHHHHHHHH-HHhCCCCceeEEEEEEEeCCCeE
Q 012887          188 NSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGN-AYEFELRKDLLE-LMTCGHKNILQFYCVCVDENHGL  259 (454)
Q Consensus       188 ~~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~-~~~~~~~~Ei~~-l~~l~HpnIv~~~g~~~~~~~~l  259 (454)
                      ..++|++++.||+|+||.||++      +.+|+|.++...... .....+.+|..+ +..++||||+++++++.+.+. +
T Consensus        36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~-~  114 (373)
T 2r5t_A           36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADK-L  114 (373)
T ss_dssp             CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSE-E
T ss_pred             ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCE-E
Confidence            4478999999999999999996      469999997543322 233445566665 356799999999999998776 9


Q ss_pred             EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCC
Q 012887          260 CVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE  339 (454)
Q Consensus       260 ~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~  339 (454)
                      |+||||++||+|.+++.+.+.+++..+..++.||+.||+|||++||+||||||+|||++.+|++||+|||+++.......
T Consensus       115 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~~  194 (373)
T 2r5t_A          115 YFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS  194 (373)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCCC
T ss_pred             EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccCCC
Confidence            99999999999999998878899999999999999999999999999999999999999999999999999886554444


Q ss_pred             cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHHH
Q 012887          340 ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKS  419 (454)
Q Consensus       340 ~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~  419 (454)
                      ......||+.|+|||++.+..    ++.++|+|||||++|||++|..||.+.+..+....+...  ...+|..++.++.+
T Consensus       195 ~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~  268 (373)
T 2r5t_A          195 TTSTFCGTPEYLAPEVLHKQP----YDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK--PLQLKPNITNSARH  268 (373)
T ss_dssp             CCCSBSCCCCCCCHHHHTTCC----CCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHS--CCCCCSSSCHHHHH
T ss_pred             ccccccCCccccCHHHhCCCC----CCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc--ccCCCCCCCHHHHH
Confidence            455668999999999998764    455699999999999999999999998888777777764  44577889999999


Q ss_pred             HHHHhcccCCCCCCCHH----HHHHH
Q 012887          420 LMIKCWNNSPSKRPQFS----EIISL  441 (454)
Q Consensus       420 li~~cl~~dP~~RPs~~----ell~~  441 (454)
                      ||.+||+.||.+||++.    ++++|
T Consensus       269 li~~lL~~dp~~R~~~~~~~~~i~~h  294 (373)
T 2r5t_A          269 LLEGLLQKDRTKRLGAKDDFMEIKSH  294 (373)
T ss_dssp             HHHHHTCSSGGGSTTTTTTHHHHHTS
T ss_pred             HHHHHcccCHHhCCCCCCCHHHHhCC
Confidence            99999999999999974    55544

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=3.6e-45  Score=363.85  Aligned_cols=254  Identities=23%  Similarity=0.425  Sum_probs=210.7

Q ss_pred             eecCCCEEEeceeeccCCceEEEeE----------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeC
Q 012887          186 LLNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDE  255 (454)
Q Consensus       186 ~~~~~~~~~~~~LG~G~fG~Vy~g~----------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~  255 (454)
                      .+..++|++++.||+|+||.||+|.          .||+|.+..... ......+.+|+.++..++||||+++++++.+ 
T Consensus         9 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-   86 (325)
T 3kex_A            9 IFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG-RQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG-   86 (325)
T ss_dssp             BCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTS-CSCBCSCCHHHHHHHTCCCTTBCCEEEEECB-
T ss_pred             hcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEecccccc-HHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-
Confidence            3567899999999999999999975          388888754321 2222345688899999999999999998863 


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCcccc
Q 012887          256 NHGLCVVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC  334 (454)
Q Consensus       256 ~~~l~lV~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~  334 (454)
                      +. .++||||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++++||+|||+++..
T Consensus        87 ~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~  165 (325)
T 3kex_A           87 SS-LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLL  165 (325)
T ss_dssp             SS-EEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred             Cc-cEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCccccc
Confidence            33 89999999999999999764 48999999999999999999999999999999999999999999999999999876


Q ss_pred             ccCCC--cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHcCCCCCCCC
Q 012887          335 KSVGE--ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPK  411 (454)
Q Consensus       335 ~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~  411 (454)
                      .....  ......+++.|+|||.+.+..    ++.++|||||||++|+|++ |..||.+........ ....+.+...|.
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~  240 (325)
T 3kex_A          166 PPDDKQLLYSEAKTPIKWMALESIHFGK----YTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPD-LLEKGERLAQPQ  240 (325)
T ss_dssp             CCCTTCCC-----CCTTTSCHHHHHHCC----CCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHH-HHHTTCBCCCCT
T ss_pred             CcccccccccCCCCcccccChHHhccCC----CChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHH-HHHcCCCCCCCC
Confidence            54332  223345677899999998664    4557999999999999999 999999876655443 344556677788


Q ss_pred             CccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 012887          412 DCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNN  447 (454)
Q Consensus       412 ~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~  447 (454)
                      .++.++.++|.+||+.||.+||++.+++++|.++..
T Consensus       241 ~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~  276 (325)
T 3kex_A          241 ICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR  276 (325)
T ss_dssp             TBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred             cCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            899999999999999999999999999999998764

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=1.1e-44  Score=370.11  Aligned_cols=252  Identities=19%  Similarity=0.311  Sum_probs=209.9

Q ss_pred             ecCCCEEEeceeeccCCceEEEe------EEEEEEEeecCCC-CchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeE
Q 012887          187 LNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDK-GNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGL  259 (454)
Q Consensus       187 ~~~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l  259 (454)
                      +..++|++++.||+|+||.||++      +.+|+|.+..... .......+.+|+.++..++|||||++++++.+.+. +
T Consensus        12 v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~-~   90 (384)
T 4fr4_A           12 VNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEED-M   90 (384)
T ss_dssp             CCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE-E
T ss_pred             CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE-E
Confidence            45588999999999999999986      4699999864221 11223567899999999999999999999998876 9


Q ss_pred             EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCC
Q 012887          260 CVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE  339 (454)
Q Consensus       260 ~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~  339 (454)
                      |+||||+.+|+|.+++.+...+++..+..++.||+.||.|||++||+||||||+|||++.+|++||+|||++...... .
T Consensus        91 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~-~  169 (384)
T 4fr4_A           91 FMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE-T  169 (384)
T ss_dssp             EEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT-C
T ss_pred             EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCC-C
Confidence            999999999999999988889999999999999999999999999999999999999999999999999999865433 2


Q ss_pred             cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC---HHHHHHHHHHcCCCCCCCCCccHH
Q 012887          340 ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACS---PVQAAVGIAACGLRPEIPKDCPQI  416 (454)
Q Consensus       340 ~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~---~~~~~~~i~~~~~~~~~p~~~~~~  416 (454)
                      ......||+.|+|||++.+... ..++.++|||||||++|||++|..||....   .......+..  ....+|..++++
T Consensus       170 ~~~~~~gt~~Y~aPE~~~~~~~-~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~--~~~~~p~~~s~~  246 (384)
T 4fr4_A          170 QITTMAGTKPYMAPEMFSSRKG-AGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFET--TVVTYPSAWSQE  246 (384)
T ss_dssp             CBCCCCSCGGGCCGGGTCCCSS-CCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHH--CCCCCCTTSCHH
T ss_pred             ceeccCCCccccCCeeeccCCC-CCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhh--cccCCCCcCCHH
Confidence            3445679999999999975321 235567999999999999999999997432   2333333333  345678889999


Q ss_pred             HHHHHHHhcccCCCCCCC-HHHHHHHHH
Q 012887          417 LKSLMIKCWNNSPSKRPQ-FSEIISLLL  443 (454)
Q Consensus       417 l~~li~~cl~~dP~~RPs-~~ell~~L~  443 (454)
                      +.+||.+||+.||.+||+ +.++++|-+
T Consensus       247 ~~~li~~lL~~dP~~R~s~~~~l~~hp~  274 (384)
T 4fr4_A          247 MVSLLKKLLEPNPDQRFSQLSDVQNFPY  274 (384)
T ss_dssp             HHHHHHHHSCSSGGGSCCSHHHHHTSGG
T ss_pred             HHHHHHHHhcCCHhHhcccHHHHHcChh
Confidence            999999999999999998 888876543

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=7.1e-45  Score=370.57  Aligned_cols=258  Identities=20%  Similarity=0.328  Sum_probs=208.3

Q ss_pred             cceeecCCCEEEeceeecc--CCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEe
Q 012887          183 GRWLLNSDNLEFIDQIGPN--SFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVD  254 (454)
Q Consensus       183 ~~~~~~~~~~~~~~~LG~G--~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~  254 (454)
                      ..+....++|++++.||+|  +||.||++      +.||+|.+............+.+|+.+++.++|||||++++++.+
T Consensus        18 s~~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~   97 (389)
T 3gni_B           18 SSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIA   97 (389)
T ss_dssp             CCCCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred             hcccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEE
Confidence            3455566889999999999  99999985      579999998655555556678899999999999999999999998


Q ss_pred             CCCeEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCcc
Q 012887          255 ENHGLCVVTKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVT  332 (454)
Q Consensus       255 ~~~~l~lV~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~  332 (454)
                      .+. +++||||+++|+|.+++...  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus        98 ~~~-~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~  176 (389)
T 3gni_B           98 DNE-LWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNL  176 (389)
T ss_dssp             TTE-EEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCE
T ss_pred             CCE-EEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccce
Confidence            876 99999999999999999765  579999999999999999999999999999999999999999999999999876


Q ss_pred             ccccCC-------CcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCC
Q 012887          333 ACKSVG-------EATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGL  405 (454)
Q Consensus       333 ~~~~~~-------~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~  405 (454)
                      ......       .......+|+.|+|||++.+..  ..++.++|||||||++|+|++|..||.+.+.......+.....
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  254 (389)
T 3gni_B          177 SMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNL--QGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTV  254 (389)
T ss_dssp             ECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTS--SCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-----
T ss_pred             eeccccccccccccccccccccccccCHHHHhccC--CCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCC
Confidence            543221       1123346788999999998631  1355679999999999999999999987555443332221110


Q ss_pred             --------------------------------------------CCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012887          406 --------------------------------------------RPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISL  441 (454)
Q Consensus       406 --------------------------------------------~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  441 (454)
                                                                  ..+.+..+++++.+||.+||+.||.+|||+.|+++|
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h  334 (389)
T 3gni_B          255 PCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  334 (389)
T ss_dssp             ---------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             CccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence                                                        112445678999999999999999999999999987


Q ss_pred             HH
Q 012887          442 LL  443 (454)
Q Consensus       442 L~  443 (454)
                      -+
T Consensus       335 p~  336 (389)
T 3gni_B          335 SF  336 (389)
T ss_dssp             GG
T ss_pred             HH
Confidence            43

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=7.3e-46  Score=381.97  Aligned_cols=261  Identities=18%  Similarity=0.252  Sum_probs=216.6

Q ss_pred             cceeecCCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCC-chHHHHHHHHHHHHHhCCCCceeEEEEEEEeC
Q 012887          183 GRWLLNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLELMTCGHKNILQFYCVCVDE  255 (454)
Q Consensus       183 ~~~~~~~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~  255 (454)
                      ..+.+..++|++++.||+|+||.||++      +.+|+|.++..... ......+.+|+.++..++|||||++++++.+.
T Consensus        62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~  141 (410)
T 3v8s_A           62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD  141 (410)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence            345566789999999999999999986      46999998642110 01112366888999999999999999999987


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccc
Q 012887          256 NHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK  335 (454)
Q Consensus       256 ~~~l~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~  335 (454)
                      +. +|+||||++||+|.+++.+ ..+++..+..++.||+.||+|||++||+||||||+|||++.+|++||+|||+++...
T Consensus       142 ~~-~~lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~  219 (410)
T 3v8s_A          142 RY-LYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN  219 (410)
T ss_dssp             SE-EEEEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             CE-EEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeec
Confidence            76 9999999999999999864 579999999999999999999999999999999999999999999999999997665


Q ss_pred             cCCC-cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCC--CC
Q 012887          336 SVGE-ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIP--KD  412 (454)
Q Consensus       336 ~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p--~~  412 (454)
                      .... ......||+.|+|||++.+......++.++|||||||++|||++|..||.+.+.......+........+|  ..
T Consensus       220 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~  299 (410)
T 3v8s_A          220 KEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDND  299 (410)
T ss_dssp             TTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCC
T ss_pred             cCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCccc
Confidence            4332 23355799999999999876433335567999999999999999999999988888777776543233344  46


Q ss_pred             ccHHHHHHHHHhcccCCCC--CCCHHHHHHHHHhh
Q 012887          413 CPQILKSLMIKCWNNSPSK--RPQFSEIISLLLRT  445 (454)
Q Consensus       413 ~~~~l~~li~~cl~~dP~~--RPs~~ell~~L~~~  445 (454)
                      +++++.+||.+||..+|.+  ||++.||++|-+--
T Consensus       300 ~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~  334 (410)
T 3v8s_A          300 ISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFK  334 (410)
T ss_dssp             CCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGC
T ss_pred             ccHHHHHHHHHHccChhhhCCCCCHHHHhcCcccc
Confidence            8999999999999999988  99999999987653

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.6e-44  Score=350.77  Aligned_cols=257  Identities=24%  Similarity=0.418  Sum_probs=217.1

Q ss_pred             ceeecCCCEEEec-eeeccCCceEEEeE--------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEe
Q 012887          184 RWLLNSDNLEFID-QIGPNSFKGVYKGK--------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVD  254 (454)
Q Consensus       184 ~~~~~~~~~~~~~-~LG~G~fG~Vy~g~--------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~  254 (454)
                      .+.+..++|.+.+ .||+|+||.||+|.        .||+|.++.. ........+.+|+.++..++||||+++++++. 
T Consensus         3 ~~~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-   80 (287)
T 1u59_A            3 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-   80 (287)
T ss_dssp             CCBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-
T ss_pred             cccccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCc-cchhHHHHHHHHHHHHHhCCCCCEeEEEEEec-
Confidence            4556778888887 99999999999863        5999999753 23345566889999999999999999999994 


Q ss_pred             CCCeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccc
Q 012887          255 ENHGLCVVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTA  333 (454)
Q Consensus       255 ~~~~l~lV~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~  333 (454)
                      .+. .++||||+++++|.+++.+. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus        81 ~~~-~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~  159 (287)
T 1u59_A           81 AEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKA  159 (287)
T ss_dssp             SSS-EEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             CCC-cEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceee
Confidence            444 89999999999999998644 4799999999999999999999999999999999999999999999999999876


Q ss_pred             cccCCCc---ccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHcCCCCCC
Q 012887          334 CKSVGEA---TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEI  409 (454)
Q Consensus       334 ~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~  409 (454)
                      .......   .....+|+.|+|||.+.+..    ++.++||||||+++|+|++ |..||...........+ ..+.++..
T Consensus       160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i-~~~~~~~~  234 (287)
T 1u59_A          160 LGADDSYYTARSAGKWPLKWYAPECINFRK----FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI-EQGKRMEC  234 (287)
T ss_dssp             CTTCSCEECCCCSSCCCGGGCCHHHHHHCE----ECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHH-HTTCCCCC
T ss_pred             eccCcceeeccccccccccccCHHHhccCC----CCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHH-hcCCcCCC
Confidence            6433221   22334578899999997654    4557999999999999998 99999987776655444 44566778


Q ss_pred             CCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCC
Q 012887          410 PKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNI  448 (454)
Q Consensus       410 p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~  448 (454)
                      |..+|+++.++|.+||+.||.+||++.+++++|+.+...
T Consensus       235 ~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  273 (287)
T 1u59_A          235 PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS  273 (287)
T ss_dssp             CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence            889999999999999999999999999999999987543

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=2.1e-44  Score=352.97  Aligned_cols=255  Identities=25%  Similarity=0.451  Sum_probs=210.7

Q ss_pred             ecCCCEEEeceeeccCCceEEEe----------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCC
Q 012887          187 LNSDNLEFIDQIGPNSFKGVYKG----------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN  256 (454)
Q Consensus       187 ~~~~~~~~~~~LG~G~fG~Vy~g----------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~  256 (454)
                      +..+.|++++.||+|+||.||++          +.||+|.+.... .......+.+|+.++..++||||+++++++.+.+
T Consensus        18 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   96 (302)
T 4e5w_A           18 FEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDG   96 (302)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC--
T ss_pred             hhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCC
Confidence            45577999999999999999975          479999997443 2233456889999999999999999999998763


Q ss_pred             -CeEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCcccc
Q 012887          257 -HGLCVVTKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC  334 (454)
Q Consensus       257 -~~l~lV~E~~~~gsL~~~l~~-~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~  334 (454)
                       ..+++||||+++|+|.+++.+ ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus        97 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  176 (302)
T 4e5w_A           97 GNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI  176 (302)
T ss_dssp             -CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             CceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccccc
Confidence             348999999999999999954 457999999999999999999999999999999999999999999999999998776


Q ss_pred             ccCCC---cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCC--------------CCHHHHH
Q 012887          335 KSVGE---ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAA--------------CSPVQAA  397 (454)
Q Consensus       335 ~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~--------------~~~~~~~  397 (454)
                      .....   ......+|..|+|||.+.+..+    +.++||||||+++|+|++|..|+..              .......
T Consensus       177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~----~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  252 (302)
T 4e5w_A          177 ETDKEYYTVKDDRDSPVFWYAPECLMQSKF----YIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRL  252 (302)
T ss_dssp             CTTCCEEECCCCTTCCGGGCCHHHHHHCEE----EHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHH
T ss_pred             cCCCcceeccCCCCCCccccCCeeecCCCC----CcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHH
Confidence            54432   2233457788999999987644    4569999999999999999987642              2223334


Q ss_pred             HHHHHcCCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 012887          398 VGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTN  446 (454)
Q Consensus       398 ~~i~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~  446 (454)
                      ......+.+.+.|..+|+.+.++|.+||+.||.+|||+.++++.|+++.
T Consensus       253 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          253 VNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence            4455566777788999999999999999999999999999999998864

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=3.6e-45  Score=364.37  Aligned_cols=252  Identities=17%  Similarity=0.244  Sum_probs=207.2

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  263 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~  263 (454)
                      ++|++++.||+|+||.||++      +.||+|.+..... ......+.+|+.++..++||||+++++++.+.+. .++||
T Consensus         7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~-~~lv~   84 (323)
T 3tki_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNI-QYLFL   84 (323)
T ss_dssp             TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEECSSE-EEEEE
T ss_pred             hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc-cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCe-EEEEE
Confidence            78999999999999999986      5799999864322 2233557899999999999999999999988776 89999


Q ss_pred             eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCC--Ccc
Q 012887          264 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG--EAT  341 (454)
Q Consensus       264 E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~--~~~  341 (454)
                      ||+++|+|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......  ...
T Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  164 (323)
T 3tki_A           85 EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL  164 (323)
T ss_dssp             ECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred             EcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCccccc
Confidence            999999999999777789999999999999999999999999999999999999999999999999987654322  223


Q ss_pred             cccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHH-HHHHHHcCCCCCCCCCccHHHHHH
Q 012887          342 EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQA-AVGIAACGLRPEIPKDCPQILKSL  420 (454)
Q Consensus       342 ~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~-~~~i~~~~~~~~~p~~~~~~l~~l  420 (454)
                      ....||+.|+|||++.+..+   .+.++|||||||++|+|++|..||........ ................+++.+.+|
T Consensus       165 ~~~~gt~~y~aPE~~~~~~~---~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  241 (323)
T 3tki_A          165 NKMCGTLPYVAPELLKRREF---HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL  241 (323)
T ss_dssp             CSCCSCGGGSCHHHHHCSSB---CHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHH
T ss_pred             CCCccCcCccCcHHhccCCC---CCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHHHH
Confidence            34578999999999986643   24569999999999999999999987655422 223333333333345689999999


Q ss_pred             HHHhcccCCCCCCCHHHHHHHHHhhc
Q 012887          421 MIKCWNNSPSKRPQFSEIISLLLRTN  446 (454)
Q Consensus       421 i~~cl~~dP~~RPs~~ell~~L~~~~  446 (454)
                      |.+||+.||.+|||+.|++++-|-..
T Consensus       242 i~~~L~~dP~~R~t~~eil~h~~~~~  267 (323)
T 3tki_A          242 LHKILVENPSARITIPDIKKDRWYNK  267 (323)
T ss_dssp             HHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred             HHHHccCChhhCcCHHHHhhChhhcc
Confidence            99999999999999999999876543

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=2e-44  Score=350.17  Aligned_cols=257  Identities=20%  Similarity=0.391  Sum_probs=213.1

Q ss_pred             ceeecCCCEEEeceeeccCCceEEEeE---------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEe
Q 012887          184 RWLLNSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVD  254 (454)
Q Consensus       184 ~~~~~~~~~~~~~~LG~G~fG~Vy~g~---------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~  254 (454)
                      .+.+..++|++.+.||+|+||.||+|.         .||+|.+... ........+.+|+.++..++||||+++++++.+
T Consensus         6 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   84 (281)
T 3cc6_A            6 QYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKD-CTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE   84 (281)
T ss_dssp             CCSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTT-SCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS
T ss_pred             cceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccc-cCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC
Confidence            355667899999999999999999974         4899998743 233455678899999999999999999999864


Q ss_pred             CCCeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccc
Q 012887          255 ENHGLCVVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTA  333 (454)
Q Consensus       255 ~~~~l~lV~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~  333 (454)
                      . . .++||||+++++|.+++.+. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus        85 ~-~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  162 (281)
T 3cc6_A           85 E-P-TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRY  162 (281)
T ss_dssp             S-S-CEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred             C-C-CEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCcc
Confidence            4 3 68999999999999999654 4699999999999999999999999999999999999999999999999999876


Q ss_pred             cccCCC-cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHcCCCCCCCC
Q 012887          334 CKSVGE-ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPK  411 (454)
Q Consensus       334 ~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~  411 (454)
                      ...... ......+++.|+|||.+.+..    ++.++||||||+++|+|++ |..||...........+. .+.+.+.|.
T Consensus       163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~-~~~~~~~~~  237 (281)
T 3cc6_A          163 IEDEDYYKASVTRLPIKWMSPESINFRR----FTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE-KGDRLPKPD  237 (281)
T ss_dssp             C---------CCCCCGGGCCHHHHHHCC----CCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHH-HTCCCCCCT
T ss_pred             cccccccccccCCCCcceeCchhhccCC----CCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHh-cCCCCCCCC
Confidence            544322 223345678899999997654    4557999999999999998 999998766655444443 345666788


Q ss_pred             CccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCC
Q 012887          412 DCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNI  448 (454)
Q Consensus       412 ~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~  448 (454)
                      .+++.+.++|.+||+.||.+||++.|++++|+++.+.
T Consensus       238 ~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~  274 (281)
T 3cc6_A          238 LCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM  274 (281)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence            8999999999999999999999999999999987653

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1.5e-44  Score=351.75  Aligned_cols=258  Identities=17%  Similarity=0.282  Sum_probs=197.9

Q ss_pred             eecCCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeE
Q 012887          186 LLNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGL  259 (454)
Q Consensus       186 ~~~~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l  259 (454)
                      .+..++|++++.||+|+||.||++      +.||+|.++...........+.++...+..++||||+++++++.+.+. .
T Consensus         3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~-~   81 (290)
T 3fme_A            3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGD-V   81 (290)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSS-E
T ss_pred             cccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCC-E
Confidence            355689999999999999999996      569999997543333233334444445667899999999999998776 9


Q ss_pred             EEEEeccCCCCHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhc-CcccCCccCCcEEEccCCcEEEEccCCcccc
Q 012887          260 CVVTKLMEGGSVNDLIL----KSRKLQTKEIIRIAIDVAEGIKFLNDH-GVAYRDLNSQRILLDRHGNVCLGDMGIVTAC  334 (454)
Q Consensus       260 ~lV~E~~~~gsL~~~l~----~~~~l~~~~~~~i~~qI~~gL~yLH~~-~iiHrDIKp~NILl~~~~~vKL~DFGla~~~  334 (454)
                      ++||||+++ +|.+++.    ....+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++...
T Consensus        82 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  160 (290)
T 3fme_A           82 WICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL  160 (290)
T ss_dssp             EEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred             EEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence            999999975 8887764    346899999999999999999999998 9999999999999999999999999998765


Q ss_pred             ccCCCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC-CHHHHHHHHHHcCCCCCCCCCc
Q 012887          335 KSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAAC-SPVQAAVGIAACGLRPEIPKDC  413 (454)
Q Consensus       335 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~-~~~~~~~~i~~~~~~~~~p~~~  413 (454)
                      .... ......+|+.|+|||.+........++.++||||||+++|+|++|..||... .+................+..+
T Consensus       161 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (290)
T 3fme_A          161 VDDV-AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKF  239 (290)
T ss_dssp             ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTTTS
T ss_pred             cccc-cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcccccC
Confidence            4432 2334468999999999854433445677899999999999999999999874 4444555555544444445678


Q ss_pred             cHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 012887          414 PQILKSLMIKCWNNSPSKRPQFSEIISLLLRTN  446 (454)
Q Consensus       414 ~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~  446 (454)
                      ++++.++|.+||+.||.+|||+.|+++|-+-..
T Consensus       240 ~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~  272 (290)
T 3fme_A          240 SAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL  272 (290)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred             CHHHHHHHHHHhhcChhhCcCHHHHHhCccccc
Confidence            999999999999999999999999999766443

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=7.5e-45  Score=366.19  Aligned_cols=249  Identities=16%  Similarity=0.247  Sum_probs=206.3

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCC---CCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCD---KGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLC  260 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~---~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~  260 (454)
                      ++|++.+.||+|+||.||++      +.||+|.+....   ........+.+|+.++..++||||+++++++.+.+. +|
T Consensus        24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~-~~  102 (351)
T 3c0i_A           24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGM-LY  102 (351)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE-EE
T ss_pred             cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE-EE
Confidence            67999999999999999995      579999986321   111234568899999999999999999999998776 99


Q ss_pred             EEEeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCc---EEEEccCCccc
Q 012887          261 VVTKLMEGGSVNDLILK----SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGN---VCLGDMGIVTA  333 (454)
Q Consensus       261 lV~E~~~~gsL~~~l~~----~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~---vKL~DFGla~~  333 (454)
                      +||||+++++|.+.+.+    ...+++..+..++.||+.||.|||++||+||||||+|||++.++.   +||+|||++..
T Consensus       103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~  182 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ  182 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEE
T ss_pred             EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeE
Confidence            99999999999988743    236899999999999999999999999999999999999987665   99999999987


Q ss_pred             cccCCCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCC--CCC
Q 012887          334 CKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPE--IPK  411 (454)
Q Consensus       334 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~--~p~  411 (454)
                      ............||+.|+|||++.+..+    +.++|||||||++|+|++|..||.+. .......+........  ...
T Consensus       183 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~----~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~i~~~~~~~~~~~~~  257 (351)
T 3c0i_A          183 LGESGLVAGGRVGTPHFMAPEVVKREPY----GKPVDVWGCGVILFILLSGCLPFYGT-KERLFEGIIKGKYKMNPRQWS  257 (351)
T ss_dssp             CCTTSCBCCCCCSCGGGCCHHHHTTCCB----CTHHHHHHHHHHHHHHHHSSCSSCSS-HHHHHHHHHHTCCCCCHHHHT
T ss_pred             ecCCCeeecCCcCCcCccCHHHHcCCCC----CchHhhHHHHHHHHHHHHCCCCCCCc-HHHHHHHHHcCCCCCCccccc
Confidence            6654444455678999999999987654    45699999999999999999999874 3344444554433322  124


Q ss_pred             CccHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 012887          412 DCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR  444 (454)
Q Consensus       412 ~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~  444 (454)
                      .+++++.+||.+||+.||.+|||+.|+++|-+-
T Consensus       258 ~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~  290 (351)
T 3c0i_A          258 HISESAKDLVRRMLMLDPAERITVYEALNHPWL  290 (351)
T ss_dssp             TSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred             cCCHHHHHHHHHHCCCChhHCcCHHHHhcChhh
Confidence            689999999999999999999999999987654

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=3.1e-44  Score=367.10  Aligned_cols=257  Identities=16%  Similarity=0.250  Sum_probs=212.5

Q ss_pred             eecCCCEEEeceeeccCCceEEEe-----EEEEEEEeecCCCCchHHHHHHHHHHHHHhCC--CCceeEEEEEEEeCCCe
Q 012887          186 LLNSDNLEFIDQIGPNSFKGVYKG-----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCG--HKNILQFYCVCVDENHG  258 (454)
Q Consensus       186 ~~~~~~~~~~~~LG~G~fG~Vy~g-----~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~--HpnIv~~~g~~~~~~~~  258 (454)
                      .+..++|++++.||+|+||.||++     +.||||.+............+.+|+.++..+.  ||||+++++++...+. 
T Consensus        52 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~-  130 (390)
T 2zmd_A           52 SVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY-  130 (390)
T ss_dssp             EETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE-
T ss_pred             cccCCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCE-
Confidence            355567999999999999999985     57999999865555555677899999999986  5999999999998776 


Q ss_pred             EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCC
Q 012887          259 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG  338 (454)
Q Consensus       259 l~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~  338 (454)
                      +|+||| +.+++|.+++.+...+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++......
T Consensus       131 ~~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~  208 (390)
T 2zmd_A          131 IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT  208 (390)
T ss_dssp             EEEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred             EEEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence            999999 56779999998888999999999999999999999999999999999999996 6899999999988664332


Q ss_pred             C--cccccCCCCcccccccccCCCC-------CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHHHcCCCCC
Q 012887          339 E--ATEYETDGYRWLAPEIIAGDPE-------SVSETWMSNVYSFGMVIWEMVTGEAAYAACSP-VQAAVGIAACGLRPE  408 (454)
Q Consensus       339 ~--~~~~~~gt~~y~APE~l~~~~~-------~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~-~~~~~~i~~~~~~~~  408 (454)
                      .  ......||+.|+|||++.+...       ...++.++|||||||++|||++|..||..... ......+........
T Consensus       209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~  288 (390)
T 2zmd_A          209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE  288 (390)
T ss_dssp             -----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCC
T ss_pred             ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCC
Confidence            2  2234568999999999875321       12467789999999999999999999987543 345555665566667


Q ss_pred             CCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 012887          409 IPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRT  445 (454)
Q Consensus       409 ~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~  445 (454)
                      +|...+.++.+||.+||+.||.+||++.|++++.+-.
T Consensus       289 ~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~  325 (390)
T 2zmd_A          289 FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ  325 (390)
T ss_dssp             CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred             CCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCcc
Confidence            7888899999999999999999999999999887653

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=9.4e-45  Score=353.27  Aligned_cols=249  Identities=22%  Similarity=0.399  Sum_probs=206.0

Q ss_pred             ecCCCEEEeceeeccCCceEEEe-------------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEE
Q 012887          187 LNSDNLEFIDQIGPNSFKGVYKG-------------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCV  253 (454)
Q Consensus       187 ~~~~~~~~~~~LG~G~fG~Vy~g-------------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~  253 (454)
                      +..++|++.+.||+|+||.||+|             ..||+|.+...  .......+.+|+.++..++||||+++++++.
T Consensus         5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   82 (289)
T 4fvq_A            5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA--HRNYSESFFEAASMMSKLSHKHLVLNYGVCV   82 (289)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGG--GGGGHHHHHHHHHHHHTSCCTTBCCEEEEEC
T ss_pred             echhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccc--cHHHHHHHHHHHHHHHhCCCCCEeEEEEEEE
Confidence            45588999999999999999996             35889988642  2334466889999999999999999999998


Q ss_pred             eCCCeEEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCc--------EE
Q 012887          254 DENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGN--------VC  324 (454)
Q Consensus       254 ~~~~~l~lV~E~~~~gsL~~~l~~~~-~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~--------vK  324 (454)
                      +.+. .++||||+++|+|.+++.+.+ .+++..+..++.||+.||.|||++||+||||||+|||++.++.        +|
T Consensus        83 ~~~~-~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~k  161 (289)
T 4fvq_A           83 CGDE-NILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIK  161 (289)
T ss_dssp             CTTC-CEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred             eCCC-CEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceee
Confidence            8776 889999999999999997655 4999999999999999999999999999999999999999887        99


Q ss_pred             EEccCCccccccCCCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcC-CCCCCCCCHHHHHHHHHHc
Q 012887          325 LGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTG-EAAYAACSPVQAAVGIAAC  403 (454)
Q Consensus       325 L~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG-~~Pf~~~~~~~~~~~i~~~  403 (454)
                      |+|||++.....    .....+++.|+|||.+.+..   .++.++|||||||++|+|++| .+||......... .... 
T Consensus       162 l~Dfg~~~~~~~----~~~~~~~~~y~aPE~~~~~~---~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~-~~~~-  232 (289)
T 4fvq_A          162 LSDPGISITVLP----KDILQERIPWVPPECIENPK---NLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKL-QFYE-  232 (289)
T ss_dssp             ECCCCSCTTTSC----HHHHHHTTTTSCHHHHHCGG---GCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH-HHHH-
T ss_pred             eccCcccccccC----ccccCCcCcccCHHHhCCCC---CCCchhHHHHHHHHHHHHHcCCCCCccccchHHHH-HHhh-
Confidence            999999765432    22345688899999998622   256679999999999999995 5555554444333 3333 


Q ss_pred             CCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCC
Q 012887          404 GLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNI  448 (454)
Q Consensus       404 ~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~  448 (454)
                       ....+|...++++.++|.+||+.||.+|||+.+++++|+++...
T Consensus       233 -~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p  276 (289)
T 4fvq_A          233 -DRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP  276 (289)
T ss_dssp             -TTCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--
T ss_pred             -ccCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence             24556777788999999999999999999999999999988764

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=3.3e-44  Score=355.05  Aligned_cols=258  Identities=25%  Similarity=0.445  Sum_probs=217.4

Q ss_pred             cceeecCCCEEEeceeeccCCceEEEe-----------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEE
Q 012887          183 GRWLLNSDNLEFIDQIGPNSFKGVYKG-----------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV  251 (454)
Q Consensus       183 ~~~~~~~~~~~~~~~LG~G~fG~Vy~g-----------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~  251 (454)
                      ..|.+..++|++.+.||+|+||.||+|           +.||+|.+... ........+.+|+.++..++||||++++++
T Consensus        18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~   96 (322)
T 1p4o_A           18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRLLGV   96 (322)
T ss_dssp             CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT-SCHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred             hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccc-cCHHHHHHHHHHHHHHHhcCCCCEeeeEEE
Confidence            456777889999999999999999985           46889988733 333445568899999999999999999999


Q ss_pred             EEeCCCeEEEEEeccCCCCHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCC
Q 012887          252 CVDENHGLCVVTKLMEGGSVNDLILKS----------RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG  321 (454)
Q Consensus       252 ~~~~~~~l~lV~E~~~~gsL~~~l~~~----------~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~  321 (454)
                      +.+.+. .++||||+++|+|.+++...          ..+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus        97 ~~~~~~-~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~  175 (322)
T 1p4o_A           97 VSQGQP-TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF  175 (322)
T ss_dssp             ECSSSS-CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTC
T ss_pred             EccCCc-cEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCC
Confidence            987766 89999999999999998542          3579999999999999999999999999999999999999999


Q ss_pred             cEEEEccCCccccccCCCc--ccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHH
Q 012887          322 NVCLGDMGIVTACKSVGEA--TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAV  398 (454)
Q Consensus       322 ~vKL~DFGla~~~~~~~~~--~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~  398 (454)
                      .+||+|||++.........  .....+++.|+|||.+.+..    ++.++||||||+++|+|++ |..||.+.+......
T Consensus       176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~  251 (322)
T 1p4o_A          176 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV----FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR  251 (322)
T ss_dssp             CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCC----CCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHH
T ss_pred             eEEECcCccccccccccccccccCCCCCCCccChhhhccCC----CCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHH
Confidence            9999999998765443221  22334578899999998654    4557999999999999999 899999877766555


Q ss_pred             HHHHcCCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 012887          399 GIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNN  447 (454)
Q Consensus       399 ~i~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~  447 (454)
                      .+.. +..+..+..++..+.++|.+||+.||.+|||+.|++++|++...
T Consensus       252 ~~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~  299 (322)
T 1p4o_A          252 FVME-GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  299 (322)
T ss_dssp             HHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             HHHc-CCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence            5444 44556778899999999999999999999999999999988754

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=1.5e-44  Score=350.44  Aligned_cols=256  Identities=26%  Similarity=0.485  Sum_probs=217.4

Q ss_pred             cceeecCCCEEEeceeeccCCceEEEe-----EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCC
Q 012887          183 GRWLLNSDNLEFIDQIGPNSFKGVYKG-----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH  257 (454)
Q Consensus       183 ~~~~~~~~~~~~~~~LG~G~fG~Vy~g-----~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~  257 (454)
                      ..|.+..++|++++.||+|+||.||+|     ..||+|.+.....   ....+.+|+.++..++||||+++++++.++ .
T Consensus         6 ~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~   81 (279)
T 1qpc_A            6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM---SPDAFLAEANLMKQLQHQRLVRLYAVVTQE-P   81 (279)
T ss_dssp             CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECSS-S
T ss_pred             hhcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc---cHHHHHHHHHHHHhCCCcCcceEEEEEcCC-C
Confidence            467788899999999999999999996     5799999874332   245678999999999999999999998643 3


Q ss_pred             eEEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccc
Q 012887          258 GLCVVTKLMEGGSVNDLILKSR--KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK  335 (454)
Q Consensus       258 ~l~lV~E~~~~gsL~~~l~~~~--~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~  335 (454)
                       .++||||+++++|.+++....  .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus        82 -~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~  160 (279)
T 1qpc_A           82 -IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE  160 (279)
T ss_dssp             -CEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             -cEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCccccccc
Confidence             789999999999999986433  79999999999999999999999999999999999999999999999999987664


Q ss_pred             cCCC-cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHcCCCCCCCCCc
Q 012887          336 SVGE-ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDC  413 (454)
Q Consensus       336 ~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~  413 (454)
                      .... ......+++.|+|||.+.+..    ++.++||||||+++|+|++ |..||.+.+.......+ ..+.+...+..+
T Consensus       161 ~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~  235 (279)
T 1qpc_A          161 DNEYTAREGAKFPIKWTAPEAINYGT----FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL-ERGYRMVRPDNC  235 (279)
T ss_dssp             SSCEECCTTCCCCTTTSCHHHHHHCE----ECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH-HTTCCCCCCTTC
T ss_pred             CcccccccCCCCccCccChhhhccCC----CCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHH-hcccCCCCcccc
Confidence            4321 122334577899999997654    4456999999999999999 99999987776655444 445667778889


Q ss_pred             cHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCC
Q 012887          414 PQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNI  448 (454)
Q Consensus       414 ~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~  448 (454)
                      ++.+.+++.+||+.||.+|||+.++++.|..+...
T Consensus       236 ~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  270 (279)
T 1qpc_A          236 PEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (279)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             cHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHh
Confidence            99999999999999999999999999999887654

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=3.7e-44  Score=353.02  Aligned_cols=250  Identities=19%  Similarity=0.291  Sum_probs=204.3

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  263 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~  263 (454)
                      ++|++++.||+|+||.||++      +.||+|++............+.+|+.++..++||||+++++++.+.+. .++||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~-~~lv~   81 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRR-LHLVF   81 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE-EEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCe-EEEEE
Confidence            67999999999999999985      569999987655555556678899999999999999999999998776 99999


Q ss_pred             eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCcccc
Q 012887          264 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY  343 (454)
Q Consensus       264 E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~  343 (454)
                      ||+++++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++............
T Consensus        82 e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  161 (311)
T 4agu_A           82 EYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDD  161 (311)
T ss_dssp             ECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC--------
T ss_pred             EeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccccCC
Confidence            99999999999877788999999999999999999999999999999999999999999999999998876554444455


Q ss_pred             cCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHc-------------------C
Q 012887          344 ETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAAC-------------------G  404 (454)
Q Consensus       344 ~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~-------------------~  404 (454)
                      ..+|+.|+|||.+.+..   .++.++||||||+++|+|++|..||.+.........+...                   +
T Consensus       162 ~~~~~~y~aPE~~~~~~---~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (311)
T 4agu_A          162 EVATRWYRSPELLVGDT---QYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSG  238 (311)
T ss_dssp             ----GGGCCHHHHHTCS---CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTT
T ss_pred             CcCCccccChHHHhcCC---CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccccc
Confidence            57889999999997632   3556799999999999999999999988776655443221                   0


Q ss_pred             CCCCCC----------CCccHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 012887          405 LRPEIP----------KDCPQILKSLMIKCWNNSPSKRPQFSEIISLLL  443 (454)
Q Consensus       405 ~~~~~p----------~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~  443 (454)
                      ...+.+          ..++.++.++|.+||+.||.+|||+.|+++|-+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~  287 (311)
T 4agu_A          239 VKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPY  287 (311)
T ss_dssp             CCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGG
T ss_pred             CcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChH
Confidence            111111          357889999999999999999999999998754

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3e-44  Score=350.87  Aligned_cols=254  Identities=23%  Similarity=0.370  Sum_probs=210.5

Q ss_pred             CEEEeceeeccCCceEEEeE---------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEE
Q 012887          191 NLEFIDQIGPNSFKGVYKGK---------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCV  261 (454)
Q Consensus       191 ~~~~~~~LG~G~fG~Vy~g~---------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~l  261 (454)
                      .|++.+.||+|+||.||+|.         .+|+|.+... ........+.+|+.++..++||||+++++++.+.+...++
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  100 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI-TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHV  100 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc-ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEE
Confidence            35567999999999999975         6899998642 3333456688999999999999999999999877764589


Q ss_pred             EEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCC--
Q 012887          262 VTKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG--  338 (454)
Q Consensus       262 V~E~~~~gsL~~~l~~-~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~--  338 (454)
                      ||||+.+|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......  
T Consensus       101 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~  180 (298)
T 3pls_A          101 LLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYY  180 (298)
T ss_dssp             EECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGG
T ss_pred             EEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCccc
Confidence            9999999999999976 4578999999999999999999999999999999999999999999999999987554321  


Q ss_pred             --CcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcC-CCCCCCCCHHHHHHHHHHcCCCCCCCCCccH
Q 012887          339 --EATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTG-EAAYAACSPVQAAVGIAACGLRPEIPKDCPQ  415 (454)
Q Consensus       339 --~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG-~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~  415 (454)
                        .......+++.|+|||.+.+..    ++.++||||||+++|+|++| .+||....... .......+.....+..+++
T Consensus       181 ~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  255 (298)
T 3pls_A          181 SVQQHRHARLPVKWTALESLQTYR----FTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD-LTHFLAQGRRLPQPEYCPD  255 (298)
T ss_dssp             CSCCSSCTTCGGGGSCHHHHTTCC----CCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG-HHHHHHTTCCCCCCTTCCH
T ss_pred             ccccCcCCCCCccccChhhhccCC----CChhhchhhHHHHHHHHhhCCCCCCccCCHHH-HHHHhhcCCCCCCCccchH
Confidence              1223345678899999998664    45579999999999999995 55555555444 3444445566777888999


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCCCC
Q 012887          416 ILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISN  450 (454)
Q Consensus       416 ~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~  450 (454)
                      .+.+++.+||+.||.+|||+.++++.|+++.....
T Consensus       256 ~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~  290 (298)
T 3pls_A          256 SLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALL  290 (298)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHh
Confidence            99999999999999999999999999999876543

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=4e-44  Score=356.36  Aligned_cols=247  Identities=22%  Similarity=0.349  Sum_probs=210.1

Q ss_pred             CEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEEe
Q 012887          191 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTK  264 (454)
Q Consensus       191 ~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~E  264 (454)
                      .|+..+.||+|+||.||+|      +.||||.+.....  .....+.+|+.++..++||||+++++++...+. .++|||
T Consensus        46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~lv~e  122 (321)
T 2c30_A           46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ--QRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEE-LWVLME  122 (321)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--CSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTE-EEEEEC
T ss_pred             hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccch--hHHHHHHHHHHHHHhCCCCCcceEEEEEEECCE-EEEEEe
Confidence            4778889999999999985      5799999975433  234557799999999999999999999998776 999999


Q ss_pred             ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCccccc
Q 012887          265 LMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE  344 (454)
Q Consensus       265 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~  344 (454)
                      |+++++|.+++. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.............
T Consensus       123 ~~~~~~L~~~l~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~  201 (321)
T 2c30_A          123 FLQGGALTDIVS-QVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL  201 (321)
T ss_dssp             CCCSCBHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCC
T ss_pred             cCCCCCHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccccccc
Confidence            999999999885 4579999999999999999999999999999999999999999999999999988765544444556


Q ss_pred             CCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCC-CCCCCCccHHHHHHHHH
Q 012887          345 TDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR-PEIPKDCPQILKSLMIK  423 (454)
Q Consensus       345 ~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~-~~~p~~~~~~l~~li~~  423 (454)
                      .||+.|+|||++.+..    ++.++|||||||++|+|++|..||...........+.....+ ...+..+++.+.++|.+
T Consensus       202 ~gt~~y~aPE~~~~~~----~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  277 (321)
T 2c30_A          202 VGTPYWMAPEVISRSL----YATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLER  277 (321)
T ss_dssp             CSCGGGCCHHHHTTCC----BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHH
T ss_pred             cCCccccCHhhhcCCC----CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHHH
Confidence            7899999999998764    445699999999999999999999988877766665543222 12234678999999999


Q ss_pred             hcccCCCCCCCHHHHHHHHHhh
Q 012887          424 CWNNSPSKRPQFSEIISLLLRT  445 (454)
Q Consensus       424 cl~~dP~~RPs~~ell~~L~~~  445 (454)
                      ||+.||.+|||+.|++++.+-.
T Consensus       278 ~l~~dp~~Rps~~ell~hp~~~  299 (321)
T 2c30_A          278 MLVRDPQERATAQELLDHPFLL  299 (321)
T ss_dssp             HSCSSTTTSCCHHHHHTSGGGG
T ss_pred             HccCChhhCcCHHHHhcChhhc
Confidence            9999999999999999986644

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=7.2e-44  Score=359.04  Aligned_cols=252  Identities=22%  Similarity=0.311  Sum_probs=214.7

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCch-HHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNA-YEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  262 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~-~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV  262 (454)
                      +.|++++.||+|+||.||+|      +.||+|++........ ....+.+|+.++..++||||+++++++.+.+. .++|
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~-~~lv  132 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHT-AWLV  132 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE-EEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCe-EEEE
Confidence            45899999999999999985      5799999975433332 34568899999999999999999999998775 9999


Q ss_pred             EeccCCCCHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCcc
Q 012887          263 TKLMEGGSVNDLIL-KSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT  341 (454)
Q Consensus       263 ~E~~~~gsL~~~l~-~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~  341 (454)
                      |||+. |+|.+++. ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....    .
T Consensus       133 ~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~----~  207 (348)
T 1u5q_A          133 MEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----A  207 (348)
T ss_dssp             EECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS----B
T ss_pred             EecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC----C
Confidence            99997 58888874 456899999999999999999999999999999999999999999999999999876543    2


Q ss_pred             cccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHHHHH
Q 012887          342 EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLM  421 (454)
Q Consensus       342 ~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~li  421 (454)
                      ....||+.|+|||++.+... ..++.++|||||||++|||++|..||.+.+.......+.....+...+..+++.+.++|
T Consensus       208 ~~~~gt~~y~aPE~~~~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  286 (348)
T 1u5q_A          208 NSFVGTPYWMAPEVILAMDE-GQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFV  286 (348)
T ss_dssp             CCCCSCGGGCCHHHHHTTSS-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHH
T ss_pred             CcccCCcceeCHhhhccccC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHH
Confidence            34578999999999864211 23566799999999999999999999998888777777776655556678899999999


Q ss_pred             HHhcccCCCCCCCHHHHHHHHHhhcCC
Q 012887          422 IKCWNNSPSKRPQFSEIISLLLRTNNI  448 (454)
Q Consensus       422 ~~cl~~dP~~RPs~~ell~~L~~~~~~  448 (454)
                      .+||+.||.+|||+.+++++.+-....
T Consensus       287 ~~~l~~dP~~Rps~~~ll~h~~~~~~~  313 (348)
T 1u5q_A          287 DSCLQKIPQDRPTSEVLLKHRFVLRER  313 (348)
T ss_dssp             HHHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred             HHHcccChhhCcCHHHHhhChhhhccC
Confidence            999999999999999999988765543

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=1.8e-44  Score=352.91  Aligned_cols=252  Identities=23%  Similarity=0.459  Sum_probs=198.9

Q ss_pred             CCCEEEeceeeccCCceEEEe----EEEEEEEeecCCCCchHHHHHHHHHHHHHh--CCCCceeEEEEEEEeC---CCeE
Q 012887          189 SDNLEFIDQIGPNSFKGVYKG----KRVGIEKLKGCDKGNAYEFELRKDLLELMT--CGHKNILQFYCVCVDE---NHGL  259 (454)
Q Consensus       189 ~~~~~~~~~LG~G~fG~Vy~g----~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~--l~HpnIv~~~g~~~~~---~~~l  259 (454)
                      .++|++++.||+|+||.||+|    +.||+|.+...   .  .....+|..++..  ++||||+++++++.+.   ...+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~---~--~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~   81 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSR---D--EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL   81 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGG---G--HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEECCEEEEEEEeccc---c--chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence            378999999999999999996    57999998632   2  2333444444444  7999999999997653   2348


Q ss_pred             EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH--------hcCcccCCccCCcEEEccCCcEEEEccCCc
Q 012887          260 CVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN--------DHGVAYRDLNSQRILLDRHGNVCLGDMGIV  331 (454)
Q Consensus       260 ~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH--------~~~iiHrDIKp~NILl~~~~~vKL~DFGla  331 (454)
                      ++||||+++|+|.+++ +...+++..+..++.||+.||.|||        +++|+||||||+|||++.++.+||+|||++
T Consensus        82 ~lv~e~~~~g~L~~~l-~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a  160 (301)
T 3q4u_A           82 WLITHYHEMGSLYDYL-QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA  160 (301)
T ss_dssp             EEEECCCTTCBHHHHH-TTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EEehhhccCCCHHHHH-hhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCe
Confidence            9999999999999998 4457999999999999999999999        999999999999999999999999999998


Q ss_pred             cccccCCCc----ccccCCCCcccccccccCCCCCC--CCCchhhHHHHHHHHHHHHcC----------CCCCCCCCH--
Q 012887          332 TACKSVGEA----TEYETDGYRWLAPEIIAGDPESV--SETWMSNVYSFGMVIWEMVTG----------EAAYAACSP--  393 (454)
Q Consensus       332 ~~~~~~~~~----~~~~~gt~~y~APE~l~~~~~~~--~~~~ksDVwSlGviL~elltG----------~~Pf~~~~~--  393 (454)
                      .........    .....||+.|+|||++.+.....  .++.++|||||||++|||++|          ..||....+  
T Consensus       161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~  240 (301)
T 3q4u_A          161 VMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPND  240 (301)
T ss_dssp             EEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             eecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCC
Confidence            765443322    22336899999999998763321  233579999999999999999          888865322  


Q ss_pred             --HHHHHH-HHHcCCCCCCCC-----CccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 012887          394 --VQAAVG-IAACGLRPEIPK-----DCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTN  446 (454)
Q Consensus       394 --~~~~~~-i~~~~~~~~~p~-----~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~  446 (454)
                        ...... ......++.+|.     .+++++.++|.+||+.||.+|||+.++++.|++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~  301 (301)
T 3q4u_A          241 PSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKID  301 (301)
T ss_dssp             CCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHC
T ss_pred             cchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhccC
Confidence              222222 233344444443     35688999999999999999999999999998864

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.2e-44  Score=357.96  Aligned_cols=255  Identities=23%  Similarity=0.443  Sum_probs=210.1

Q ss_pred             eecCCCEEEeceeeccCCceEEEeE----------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeC
Q 012887          186 LLNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDE  255 (454)
Q Consensus       186 ~~~~~~~~~~~~LG~G~fG~Vy~g~----------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~  255 (454)
                      .+..++|++++.||+|+||.||+|.          .+++|.+.... .......+.+|+.++..++||||+++++++.+.
T Consensus        11 ~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~   89 (327)
T 3lzb_A           11 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS   89 (327)
T ss_dssp             ECCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS-SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS
T ss_pred             ccCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC
Confidence            3567899999999999999999975          36888876432 333456688999999999999999999999865


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCcccc
Q 012887          256 NHGLCVVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC  334 (454)
Q Consensus       256 ~~~l~lV~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~  334 (454)
                      +  .++|+||+.+|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus        90 ~--~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~  167 (327)
T 3lzb_A           90 T--VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL  167 (327)
T ss_dssp             S--EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred             C--ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence            4  78999999999999999664 57999999999999999999999999999999999999999999999999998765


Q ss_pred             ccCCC--cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHcCCCCCCCC
Q 012887          335 KSVGE--ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPK  411 (454)
Q Consensus       335 ~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~  411 (454)
                      .....  ......+|+.|+|||.+.+..    ++.++|||||||++|+|++ |..||.+....... .....+.+.+.|.
T Consensus       168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~----~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~  242 (327)
T 3lzb_A          168 GAEEKEYHAEGGKVPIKWMALESILHRI----YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SILEKGERLPQPP  242 (327)
T ss_dssp             ------------CCCGGGSCHHHHHHCC----CCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH-HHHHTTCCCCCCT
T ss_pred             cCccccccccCCCccccccCHHHHcCCC----CChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH-HHHHcCCCCCCCc
Confidence            43322  222334577899999998764    4557999999999999999 99999987665544 4444566777888


Q ss_pred             CccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCC
Q 012887          412 DCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNI  448 (454)
Q Consensus       412 ~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~  448 (454)
                      .++.++.++|.+||+.||.+||++.|+++.|.++...
T Consensus       243 ~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  279 (327)
T 3lzb_A          243 ICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             TBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred             cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence            8999999999999999999999999999999988653

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=2e-44  Score=349.82  Aligned_cols=252  Identities=19%  Similarity=0.318  Sum_probs=212.5

Q ss_pred             cCCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCC-chHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEE
Q 012887          188 NSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLC  260 (454)
Q Consensus       188 ~~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~  260 (454)
                      ..++|++.+.||+|+||.||++      ..+|+|.+...... ......+.+|+.++..++||||+++++++.+.+. .+
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~   85 (279)
T 3fdn_A            7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATR-VY   85 (279)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE-EE
T ss_pred             ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCE-EE
Confidence            4478999999999999999996      36999998642211 1124557889999999999999999999987765 99


Q ss_pred             EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCc
Q 012887          261 VVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA  340 (454)
Q Consensus       261 lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~  340 (454)
                      +||||+++++|.+++.+...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......  .
T Consensus        86 lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~--~  163 (279)
T 3fdn_A           86 LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--R  163 (279)
T ss_dssp             EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC------
T ss_pred             EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCcc--c
Confidence            99999999999999987788999999999999999999999999999999999999999999999999997554332  2


Q ss_pred             ccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHHHH
Q 012887          341 TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSL  420 (454)
Q Consensus       341 ~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~l  420 (454)
                      .....+++.|+|||.+.+..+    +.++||||||+++|+|++|..||...........+...  ...+|..+++.+.++
T Consensus       164 ~~~~~~~~~y~aPE~~~~~~~----~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l  237 (279)
T 3fdn_A          164 RTDLCGTLDYLPPEMIEGRMH----DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--EFTFPDFVTEGARDL  237 (279)
T ss_dssp             ----CCCCTTCCHHHHTTCCC----CTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT--CCCCCTTSCHHHHHH
T ss_pred             ccccCCCCCccCHhHhccCCC----CccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhC--CCCCCCcCCHHHHHH
Confidence            334568899999999987654    44599999999999999999999988877766666553  445778899999999


Q ss_pred             HHHhcccCCCCCCCHHHHHHHHHhhcCC
Q 012887          421 MIKCWNNSPSKRPQFSEIISLLLRTNNI  448 (454)
Q Consensus       421 i~~cl~~dP~~RPs~~ell~~L~~~~~~  448 (454)
                      |.+||+.||.+||++.|+++|-+-....
T Consensus       238 i~~~l~~~p~~Rps~~e~l~h~~~~~~~  265 (279)
T 3fdn_A          238 ISRLLKHNPSQRPMLREVLEHPWITANS  265 (279)
T ss_dssp             HHHHCCSSGGGSCCHHHHHHCHHHHHHC
T ss_pred             HHHHhccChhhCCCHHHHhhCccccCCc
Confidence            9999999999999999999998865544

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-44  Score=368.26  Aligned_cols=254  Identities=25%  Similarity=0.440  Sum_probs=204.2

Q ss_pred             CEEEeceeeccCCceEEEeE---------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEE
Q 012887          191 NLEFIDQIGPNSFKGVYKGK---------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCV  261 (454)
Q Consensus       191 ~~~~~~~LG~G~fG~Vy~g~---------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~l  261 (454)
                      .|++.+.||+|+||.||+|.         .+|+|.++.. ........+.+|+.++..++||||+++++++...+...++
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l  168 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  168 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC-SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence            47888999999999999874         4788988642 3334556788999999999999999999998766545899


Q ss_pred             EEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCC-
Q 012887          262 VTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE-  339 (454)
Q Consensus       262 V~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~-  339 (454)
                      ||||+++|+|.+++.+. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... 
T Consensus       169 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~  248 (373)
T 3c1x_A          169 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD  248 (373)
T ss_dssp             EEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------------
T ss_pred             EEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccccccc
Confidence            99999999999999754 4689999999999999999999999999999999999999999999999999876543221 


Q ss_pred             ---cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHcCCCCCCCCCccH
Q 012887          340 ---ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ  415 (454)
Q Consensus       340 ---~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~  415 (454)
                         ......+++.|+|||.+.+..    ++.++|||||||++|||++ |.+||...+.......+ ..+.++..|..+|.
T Consensus       249 ~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~-~~~~~~~~p~~~~~  323 (373)
T 3c1x_A          249 SVHNKTGAKLPVKWMALESLQTQK----FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL-LQGRRLLQPEYCPD  323 (373)
T ss_dssp             ---------CCGGGSCHHHHHHCC----CCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHH-HTTCCCCCCTTCCH
T ss_pred             cccccCCCCCcccccChHHhcCCC----CCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHH-HcCCCCCCCCCCCH
Confidence               122334677899999998664    4567999999999999999 78888876655444443 34556677888999


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCCCC
Q 012887          416 ILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISN  450 (454)
Q Consensus       416 ~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~  450 (454)
                      .+.++|.+||+.||.+||++.|++++|+++.....
T Consensus       324 ~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~  358 (373)
T 3c1x_A          324 PLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI  358 (373)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCC
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcc
Confidence            99999999999999999999999999999876543

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=2.2e-44  Score=350.70  Aligned_cols=258  Identities=27%  Similarity=0.489  Sum_probs=212.0

Q ss_pred             eeecCCCEEEeceeeccCCceEEEeE---------EEEEEEeecCCC-CchHHHHHHHHHHHHHhCCCCceeEEEEEEEe
Q 012887          185 WLLNSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKGCDK-GNAYEFELRKDLLELMTCGHKNILQFYCVCVD  254 (454)
Q Consensus       185 ~~~~~~~~~~~~~LG~G~fG~Vy~g~---------~vavK~l~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~  254 (454)
                      ..+..++|++++.||+|+||.||+|+         .||+|.++.... .......+.+|+.++..++||||+++++++.+
T Consensus        13 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   92 (291)
T 1u46_A           13 CLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT   92 (291)
T ss_dssp             EECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcc
Confidence            44667899999999999999999975         489998875432 23345678899999999999999999999976


Q ss_pred             CCCeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccc
Q 012887          255 ENHGLCVVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTA  333 (454)
Q Consensus       255 ~~~~l~lV~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~  333 (454)
                      .+  .++||||+++++|.+++.+. ..+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++..
T Consensus        93 ~~--~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~  170 (291)
T 1u46_A           93 PP--MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRA  170 (291)
T ss_dssp             SS--CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             CC--ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEcccccccc
Confidence            54  78999999999999999654 5799999999999999999999999999999999999999999999999999876


Q ss_pred             cccCCCc---ccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHcCCCCCC
Q 012887          334 CKSVGEA---TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEI  409 (454)
Q Consensus       334 ~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~  409 (454)
                      .......   .....+++.|+|||.+.+..    ++.++||||||+++|+|++ |..||.+.+.......+.....+.+.
T Consensus       171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~  246 (291)
T 1u46_A          171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRT----FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR  246 (291)
T ss_dssp             CCC-CCEEEC-----CCGGGCCHHHHHHCE----EEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCC
T ss_pred             ccccccchhhhccCCCCceeeCchhhcCCC----CCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCC
Confidence            6443321   22335677899999997654    3456999999999999999 99999998888888778777777778


Q ss_pred             CCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCC
Q 012887          410 PKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNI  448 (454)
Q Consensus       410 p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~  448 (454)
                      +..+|.++.++|.+||+.||.+||++.+++++|.+..+.
T Consensus       247 ~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  285 (291)
T 1u46_A          247 PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT  285 (291)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred             CcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence            889999999999999999999999999999999988764

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=9.1e-45  Score=351.58  Aligned_cols=252  Identities=23%  Similarity=0.306  Sum_probs=212.7

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeC-CCeEEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDE-NHGLCVV  262 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~-~~~l~lV  262 (454)
                      ++|++++.||+|+||.||++      +.+|+|.+............+.+|+..+..++||||+++++++.+. +..+++|
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   85 (279)
T 2w5a_A            6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   85 (279)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEE
T ss_pred             hheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEE
Confidence            68999999999999999995      5699999986555555666789999999999999999999998753 3458999


Q ss_pred             EeccCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhcC-----cccCCccCCcEEEccCCcEEEEccCCccc
Q 012887          263 TKLMEGGSVNDLILKS----RKLQTKEIIRIAIDVAEGIKFLNDHG-----VAYRDLNSQRILLDRHGNVCLGDMGIVTA  333 (454)
Q Consensus       263 ~E~~~~gsL~~~l~~~----~~l~~~~~~~i~~qI~~gL~yLH~~~-----iiHrDIKp~NILl~~~~~vKL~DFGla~~  333 (454)
                      |||+++++|.+++...    ..+++..++.++.||+.||.|||+++     |+||||||+|||++.++.+||+|||++..
T Consensus        86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~  165 (279)
T 2w5a_A           86 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI  165 (279)
T ss_dssp             EECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHHH
T ss_pred             EeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhee
Confidence            9999999999998542    35999999999999999999999999     99999999999999999999999999876


Q ss_pred             cccCCCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCc
Q 012887          334 CKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDC  413 (454)
Q Consensus       334 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~  413 (454)
                      ............+++.|+|||.+.+..    ++.++||||||+++|+|++|..||...+.......+.. +..+.+|..+
T Consensus       166 ~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~-~~~~~~~~~~  240 (279)
T 2w5a_A          166 LNHDTSFAKTFVGTPYYMSPEQMNRMS----YNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE-GKFRRIPYRY  240 (279)
T ss_dssp             C---CHHHHHHHSCCTTCCHHHHHCC-----CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-TCCCCCCTTS
T ss_pred             eccccccccccCCCccccChHHhccCC----CCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhh-cccccCCccc
Confidence            554332233446889999999998764    45679999999999999999999998877665555544 4455678889


Q ss_pred             cHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 012887          414 PQILKSLMIKCWNNSPSKRPQFSEIISLLLRTN  446 (454)
Q Consensus       414 ~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~  446 (454)
                      +.++.++|.+||+.||.+||++.|++++++...
T Consensus       241 ~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~  273 (279)
T 2w5a_A          241 SDELNEIITRMLNLKDYHRPSVEEILENPLILE  273 (279)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCG
T ss_pred             CHHHHHHHHHHcCCCcccCCCHHHHHhChhhhh
Confidence            999999999999999999999999999876543

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=3.2e-44  Score=351.31  Aligned_cols=255  Identities=25%  Similarity=0.432  Sum_probs=211.5

Q ss_pred             CCEEEeceeeccCCceEEEeE---------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLC  260 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g~---------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~  260 (454)
                      ..|++.+.||+|+||.||+|.         .+|+|.+... ........+.+|+.++.+++||||+++++++.+.+...+
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  103 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL  103 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC-CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred             eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC-CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence            468899999999999999875         4788888642 333445668899999999999999999999876665589


Q ss_pred             EEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCC
Q 012887          261 VVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE  339 (454)
Q Consensus       261 lV~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~  339 (454)
                      +||||+++|+|.+++.+. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus       104 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  183 (298)
T 3f66_A          104 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEY  183 (298)
T ss_dssp             EEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGG
T ss_pred             EEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccccch
Confidence            999999999999999653 4789999999999999999999999999999999999999999999999999876543221


Q ss_pred             ----cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHcCCCCCCCCCcc
Q 012887          340 ----ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCP  414 (454)
Q Consensus       340 ----~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~  414 (454)
                          ......+|+.|+|||.+.+..    ++.++||||||+++|+|++ |.+||...........+. .+.+...|..+|
T Consensus       184 ~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  258 (298)
T 3f66_A          184 YSVHNKTGAKLPVKWMALESLQTQK----FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-QGRRLLQPEYCP  258 (298)
T ss_dssp             CBC-----CCBCGGGSCHHHHHHCC----CCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHH-TTCCCCCCTTCC
T ss_pred             hccccccCCCCCccccChHHhcCCC----CChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHh-cCCCCCCCccCC
Confidence                122335677899999997664    4557999999999999999 677777666555444443 455666788899


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCCCC
Q 012887          415 QILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISN  450 (454)
Q Consensus       415 ~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~  450 (454)
                      +.+.+++.+||+.||.+|||+.|+++.|.++.....
T Consensus       259 ~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~  294 (298)
T 3f66_A          259 DPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI  294 (298)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSC
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence            999999999999999999999999999999876543

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=1.7e-44  Score=359.78  Aligned_cols=251  Identities=18%  Similarity=0.231  Sum_probs=199.7

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  263 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~  263 (454)
                      ++|++++.||+|+||.||++      +.||+|.++...........+.+|+.++..++||||+++++++.+.+. +++||
T Consensus        34 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~lv~  112 (329)
T 3gbz_A           34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHR-LHLIF  112 (329)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTE-EEEEE
T ss_pred             hhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCE-EEEEE
Confidence            68999999999999999996      589999997554444445567799999999999999999999998876 99999


Q ss_pred             eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEc-----cCCcEEEEccCCccccccCC
Q 012887          264 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLD-----RHGNVCLGDMGIVTACKSVG  338 (454)
Q Consensus       264 E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~-----~~~~vKL~DFGla~~~~~~~  338 (454)
                      ||+++ +|.+++.+...+++..+..++.||+.||.|||++||+||||||+|||++     .++.+||+|||++.......
T Consensus       113 e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~  191 (329)
T 3gbz_A          113 EYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPI  191 (329)
T ss_dssp             ECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC---
T ss_pred             ecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCcc
Confidence            99985 9999998888999999999999999999999999999999999999994     45569999999988765444


Q ss_pred             CcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCC----------
Q 012887          339 EATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPE----------  408 (454)
Q Consensus       339 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~----------  408 (454)
                      .......+|+.|+|||++.+..   .++.++|||||||++|+|++|..||.+.+.......+......+.          
T Consensus       192 ~~~~~~~~t~~y~aPE~~~~~~---~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (329)
T 3gbz_A          192 RQFTHEIITLWYRPPEILLGSR---HYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTAL  268 (329)
T ss_dssp             --------CCTTCCHHHHTTCC---CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred             cccCCCcCCccccCHHHhcCCC---CCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhh
Confidence            4445556799999999997643   255679999999999999999999999888776665543211110          


Q ss_pred             ------C------------CCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 012887          409 ------I------------PKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRT  445 (454)
Q Consensus       409 ------~------------p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~  445 (454)
                            +            +..+++++.+||.+||+.||.+|||+.|+++|-+--
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~  323 (329)
T 3gbz_A          269 PDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFS  323 (329)
T ss_dssp             TTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGS
T ss_pred             hhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccC
Confidence                  0            112678999999999999999999999999876643

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=3.6e-44  Score=388.58  Aligned_cols=257  Identities=26%  Similarity=0.423  Sum_probs=215.5

Q ss_pred             ceeecCCCEEEec-eeeccCCceEEEe--------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEe
Q 012887          184 RWLLNSDNLEFID-QIGPNSFKGVYKG--------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVD  254 (454)
Q Consensus       184 ~~~~~~~~~~~~~-~LG~G~fG~Vy~g--------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~  254 (454)
                      .+.++...+.+.. .||+|+||.||+|        +.||||.++..........++.+|+.++..++|||||++++++.+
T Consensus       362 ~~~~~~~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~  441 (635)
T 4fl3_A          362 EVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA  441 (635)
T ss_dssp             SSBCCGGGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred             cccccchhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            3445555666644 8999999999986        579999998654445556778999999999999999999999964


Q ss_pred             CCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCcccc
Q 012887          255 ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC  334 (454)
Q Consensus       255 ~~~~l~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~  334 (454)
                      + . +++||||+++|+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus       442 ~-~-~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~  519 (635)
T 4fl3_A          442 E-S-WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKAL  519 (635)
T ss_dssp             S-S-EEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHT
T ss_pred             C-C-EEEEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCcccc
Confidence            3 3 8899999999999999988889999999999999999999999999999999999999999999999999998866


Q ss_pred             ccCCC---cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHcCCCCCCC
Q 012887          335 KSVGE---ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIP  410 (454)
Q Consensus       335 ~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p  410 (454)
                      .....   ......+|+.|+|||++.+..    ++.++|||||||++|||++ |..||.+.+..+.... ...+.++..|
T Consensus       520 ~~~~~~~~~~~~~~~t~~y~APE~~~~~~----~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~-i~~~~~~~~p  594 (635)
T 4fl3_A          520 RADENYYKAQTHGKWPVKWYAPECINYYK----FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM-LEKGERMGCP  594 (635)
T ss_dssp             TC-------------CGGGSCHHHHHHCC----CCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH-HHTTCCCCCC
T ss_pred             ccCccccccccCCCCceeeeChhhhcCCC----CCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-HHcCCCCCCC
Confidence            44322   122234578899999997654    4567999999999999998 9999998877665544 4456677889


Q ss_pred             CCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 012887          411 KDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNN  447 (454)
Q Consensus       411 ~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~  447 (454)
                      ..+|+++.+||.+||+.||.+||++.+|++.|+....
T Consensus       595 ~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~  631 (635)
T 4fl3_A          595 AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY  631 (635)
T ss_dssp             TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             CCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            9999999999999999999999999999999987653

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=2.1e-44  Score=357.35  Aligned_cols=250  Identities=19%  Similarity=0.310  Sum_probs=193.1

Q ss_pred             CCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEE
Q 012887          189 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  262 (454)
Q Consensus       189 ~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV  262 (454)
                      .++|++++.||+|+||.||+|      +.||+|.++.... ......+.+|+.++..++||||+++++++.+++. +++|
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~-~~lv   81 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE-EGTPSTAIREISLMKELKHENIVRLYDVIHTENK-LTLV   81 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCST-TCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTE-EEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccc-cccHHHHHHHHHHHHhcCCCCcceEEEEEEECCe-EEEE
Confidence            368899999999999999985      5799999975432 2233457789999999999999999999987765 9999


Q ss_pred             EeccCCCCHHHHHHhC------CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCcccccc
Q 012887          263 TKLMEGGSVNDLILKS------RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS  336 (454)
Q Consensus       263 ~E~~~~gsL~~~l~~~------~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~  336 (454)
                      |||+++ +|.+++...      ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus        82 ~e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  160 (317)
T 2pmi_A           82 FEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGI  160 (317)
T ss_dssp             EECCCC-BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTS
T ss_pred             EEecCC-CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCC
Confidence            999985 999998542      3589999999999999999999999999999999999999999999999999887654


Q ss_pred             CCCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCC----------
Q 012887          337 VGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR----------  406 (454)
Q Consensus       337 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~----------  406 (454)
                      .........+|+.|+|||++.+..   .++.++|||||||++|+|++|..||.+.+.......+......          
T Consensus       161 ~~~~~~~~~~t~~y~aPE~~~~~~---~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  237 (317)
T 2pmi_A          161 PVNTFSSEVVTLWYRAPDVLMGSR---TYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT  237 (317)
T ss_dssp             CCCCCCCCCSCCTTCCHHHHTTCC---CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGG
T ss_pred             CcccCCCCcccccccCchHhhCCC---CCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhh
Confidence            433444557899999999997542   2556799999999999999999999988877666554331000          


Q ss_pred             ----------------------CCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 012887          407 ----------------------PEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR  444 (454)
Q Consensus       407 ----------------------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~  444 (454)
                                            +..+..++.++.+||.+||+.||.+|||+.|++++-+-
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f  297 (317)
T 2pmi_A          238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWF  297 (317)
T ss_dssp             GCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGG
T ss_pred             hhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhh
Confidence                                  01123578899999999999999999999999987554

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=3.8e-45  Score=379.51  Aligned_cols=260  Identities=20%  Similarity=0.242  Sum_probs=214.0

Q ss_pred             ceeecCCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCc-hHHHHHHHHHHHHHhCCCCceeEEEEEEEeCC
Q 012887          184 RWLLNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGN-AYEFELRKDLLELMTCGHKNILQFYCVCVDEN  256 (454)
Q Consensus       184 ~~~~~~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~  256 (454)
                      ...+..++|++++.||+|+||.||++      +.+|+|++....... .....+.+|..++..++||||++++++|.+.+
T Consensus        68 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~  147 (437)
T 4aw2_A           68 QMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDN  147 (437)
T ss_dssp             HHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSS
T ss_pred             cccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCC
Confidence            34466689999999999999999996      579999986421111 11123678889999999999999999999877


Q ss_pred             CeEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccc
Q 012887          257 HGLCVVTKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK  335 (454)
Q Consensus       257 ~~l~lV~E~~~~gsL~~~l~~-~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~  335 (454)
                      . +|+||||+++|+|.+++.+ .+.+++..+..++.||+.||.|||++||+||||||+|||++.+|++||+|||+++...
T Consensus       148 ~-~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~  226 (437)
T 4aw2_A          148 N-LYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLM  226 (437)
T ss_dssp             E-EEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             E-EEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcc
Confidence            6 9999999999999999976 4689999999999999999999999999999999999999999999999999987665


Q ss_pred             cCCCc-ccccCCCCcccccccccCCC-CCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCC---
Q 012887          336 SVGEA-TEYETDGYRWLAPEIIAGDP-ESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIP---  410 (454)
Q Consensus       336 ~~~~~-~~~~~gt~~y~APE~l~~~~-~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p---  410 (454)
                      ..... .....||+.|+|||++.+.. ....++.++|||||||++|||++|..||.+.+..+....+.....+..+|   
T Consensus       227 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~  306 (437)
T 4aw2_A          227 EDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQV  306 (437)
T ss_dssp             TTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSC
T ss_pred             cCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCccc
Confidence            43332 33357999999999987210 01135567999999999999999999999988888777776543333344   


Q ss_pred             CCccHHHHHHHHHhcccCCCC--CCCHHHHHHHHHh
Q 012887          411 KDCPQILKSLMIKCWNNSPSK--RPQFSEIISLLLR  444 (454)
Q Consensus       411 ~~~~~~l~~li~~cl~~dP~~--RPs~~ell~~L~~  444 (454)
                      ..+++++.+||++||..+|.+  ||++.|+++|-+-
T Consensus       307 ~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff  342 (437)
T 4aw2_A          307 TDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFF  342 (437)
T ss_dssp             CCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGG
T ss_pred             ccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCcc
Confidence            458999999999999988888  9999999988664

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.3e-44  Score=351.03  Aligned_cols=253  Identities=24%  Similarity=0.482  Sum_probs=208.5

Q ss_pred             cceeecCCCEEEeceeeccCCceEEEe----EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCe
Q 012887          183 GRWLLNSDNLEFIDQIGPNSFKGVYKG----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHG  258 (454)
Q Consensus       183 ~~~~~~~~~~~~~~~LG~G~fG~Vy~g----~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~  258 (454)
                      ..|.+..++|++.+.||+|+||.||++    +.||+|.++...    ....+.+|+.++..++||||+++++++.+.+..
T Consensus        14 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   89 (278)
T 1byg_A           14 SGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG   89 (278)
T ss_dssp             -CCBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--C
T ss_pred             ccccCChhhceEEeEEecCCCceEEEEEEcCCEEEEEEecchh----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCc
Confidence            456778899999999999999999995    679999986432    345678999999999999999999998766545


Q ss_pred             EEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCcccccc
Q 012887          259 LCVVTKLMEGGSVNDLILKSR--KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS  336 (454)
Q Consensus       259 l~lV~E~~~~gsL~~~l~~~~--~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~  336 (454)
                      +++||||+++++|.+++.+..  .+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++.....
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~  169 (278)
T 1byg_A           90 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  169 (278)
T ss_dssp             CEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred             eEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence            899999999999999996544  489999999999999999999999999999999999999999999999999875443


Q ss_pred             CCCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHcCCCCCCCCCccH
Q 012887          337 VGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ  415 (454)
Q Consensus       337 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~  415 (454)
                      .   .....+++.|+|||.+.+..    ++.++||||||+++|+|++ |..||........... ...+.++..+..+++
T Consensus       170 ~---~~~~~~~~~y~aPE~~~~~~----~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~  241 (278)
T 1byg_A          170 T---QDTGKLPVKWTAPEALREKK----FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR-VEKGYKMDAPDGCPP  241 (278)
T ss_dssp             ---------CCTTTSCHHHHHHCC----CCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHH-HTTTCCCCCCTTCCH
T ss_pred             c---ccCCCccccccCHHHhCCCC----CCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-HhcCCCCCCcccCCH
Confidence            2   22335678899999997654    4557999999999999998 9999988766554433 344566778889999


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 012887          416 ILKSLMIKCWNNSPSKRPQFSEIISLLLRTNN  447 (454)
Q Consensus       416 ~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~  447 (454)
                      .+.++|.+||+.||.+||++.++++.|+++..
T Consensus       242 ~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~  273 (278)
T 1byg_A          242 AVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT  273 (278)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHhcCChhhCCCHHHHHHHHHHHHh
Confidence            99999999999999999999999999998754

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=3.2e-45  Score=370.07  Aligned_cols=256  Identities=11%  Similarity=0.179  Sum_probs=199.7

Q ss_pred             cCCCEEEeceeeccCCceEEEe-----------EEEEEEEeecCCCCchHHHH---------HHHHHHHHHhCCCCceeE
Q 012887          188 NSDNLEFIDQIGPNSFKGVYKG-----------KRVGIEKLKGCDKGNAYEFE---------LRKDLLELMTCGHKNILQ  247 (454)
Q Consensus       188 ~~~~~~~~~~LG~G~fG~Vy~g-----------~~vavK~l~~~~~~~~~~~~---------~~~Ei~~l~~l~HpnIv~  247 (454)
                      ..++|++.+.||+|+||.||+|           +.||+|.+.........+..         ...|+..+..++||||++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            4578999999999999999997           45899998754321111111         223445566778999999


Q ss_pred             EEEEEEeCC---CeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEc--cCC
Q 012887          248 FYCVCVDEN---HGLCVVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLD--RHG  321 (454)
Q Consensus       248 ~~g~~~~~~---~~l~lV~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~--~~~  321 (454)
                      +++++.+..   ...++||||+ +++|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++  .++
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~  191 (364)
T 3op5_A          113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPD  191 (364)
T ss_dssp             EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTT
T ss_pred             EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCC
Confidence            999987652   3389999999 89999999765 5899999999999999999999999999999999999999  889


Q ss_pred             cEEEEccCCccccccCCCc-------ccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHH
Q 012887          322 NVCLGDMGIVTACKSVGEA-------TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPV  394 (454)
Q Consensus       322 ~vKL~DFGla~~~~~~~~~-------~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~  394 (454)
                      .+||+|||+++........       .....||+.|+|||++.+..    ++.++|||||||++|||++|..||.+....
T Consensus       192 ~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Di~slG~~l~el~~g~~Pf~~~~~~  267 (364)
T 3op5_A          192 QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVA----PSRRGDLEILGYCMIQWLTGHLPWEDNLKD  267 (364)
T ss_dssp             CEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCC----CCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred             eEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCC----CCchhhHHHHHHHHHHHHhCCCCccccccC
Confidence            9999999999765443221       12334899999999998764    456799999999999999999999853322


Q ss_pred             HHHHHHHHcCCCCC---------CCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCC
Q 012887          395 QAAVGIAACGLRPE---------IPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNI  448 (454)
Q Consensus       395 ~~~~~i~~~~~~~~---------~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~  448 (454)
                      ...........+..         .+..+|+++.++|..||+.||.+||++.+|++.|.++...
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~  330 (364)
T 3op5_A          268 PKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKA  330 (364)
T ss_dssp             HHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Confidence            22211111111111         1256799999999999999999999999999999887654

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=5.7e-44  Score=385.69  Aligned_cols=257  Identities=24%  Similarity=0.415  Sum_probs=214.2

Q ss_pred             ceeecCCCEEEec-eeeccCCceEEEeE--------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEe
Q 012887          184 RWLLNSDNLEFID-QIGPNSFKGVYKGK--------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVD  254 (454)
Q Consensus       184 ~~~~~~~~~~~~~-~LG~G~fG~Vy~g~--------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~  254 (454)
                      .+.+..+++.+.+ .||+|+||.||+|.        .||||.++... .......+.+|+.++..++|||||++++++.+
T Consensus       329 ~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~  407 (613)
T 2ozo_A          329 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA  407 (613)
T ss_dssp             CSBCCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC-SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES
T ss_pred             ceeccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc
Confidence            4567778888887 89999999999863        48999997542 33345678899999999999999999999976


Q ss_pred             CCCeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccc
Q 012887          255 ENHGLCVVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTA  333 (454)
Q Consensus       255 ~~~~l~lV~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~  333 (454)
                       +. +++||||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus       408 -~~-~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~  485 (613)
T 2ozo_A          408 -EA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKA  485 (613)
T ss_dssp             -SS-EEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTT
T ss_pred             -CC-eEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCccc
Confidence             33 89999999999999999654 4799999999999999999999999999999999999999999999999999886


Q ss_pred             cccCCCc---ccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHcCCCCCC
Q 012887          334 CKSVGEA---TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEI  409 (454)
Q Consensus       334 ~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~  409 (454)
                      .......   .....+++.|+|||++.+..    ++.++|||||||++|||++ |..||.+.+..+....+ ..+.++..
T Consensus       486 ~~~~~~~~~~~~~~~~~~~y~APE~~~~~~----~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i-~~~~~~~~  560 (613)
T 2ozo_A          486 LGADDSYYTARSAGKWPLKWYAPECINFRK----FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI-EQGKRMEC  560 (613)
T ss_dssp             CC--------------CCTTSCHHHHHHCC----CCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHH-HTTCCCCC
T ss_pred             ccCCCceeeeccCCCCccceeCHhhhcCCC----CCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHH-HcCCCCCC
Confidence            5432211   12223567899999997654    5567999999999999998 99999988776655444 45677888


Q ss_pred             CCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCC
Q 012887          410 PKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNI  448 (454)
Q Consensus       410 p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~  448 (454)
                      |..+|+++.+||.+||+.||.+||++.+|++.|..+...
T Consensus       561 p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~  599 (613)
T 2ozo_A          561 PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS  599 (613)
T ss_dssp             CTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence            999999999999999999999999999999999886543

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=3.3e-44  Score=356.74  Aligned_cols=255  Identities=26%  Similarity=0.467  Sum_probs=211.2

Q ss_pred             ecCCCEEEeceeeccCCceEEEeE--------EEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEEEEEEEeCCC
Q 012887          187 LNSDNLEFIDQIGPNSFKGVYKGK--------RVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVDENH  257 (454)
Q Consensus       187 ~~~~~~~~~~~LG~G~fG~Vy~g~--------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~~~g~~~~~~~  257 (454)
                      +..++|++.+.||+|+||.||+++        .+|+|.++... .......+.+|+.++.++ +||||+++++++.+.+.
T Consensus        22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~  100 (327)
T 1fvr_A           22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY  100 (327)
T ss_dssp             CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTE
T ss_pred             ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc-chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCc
Confidence            344789999999999999999963        35888887432 223345578999999999 89999999999988876


Q ss_pred             eEEEEEeccCCCCHHHHHHhCC----------------CCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCC
Q 012887          258 GLCVVTKLMEGGSVNDLILKSR----------------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG  321 (454)
Q Consensus       258 ~l~lV~E~~~~gsL~~~l~~~~----------------~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~  321 (454)
                       +++||||+++|+|.+++.+.+                .+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus       101 -~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~  179 (327)
T 1fvr_A          101 -LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY  179 (327)
T ss_dssp             -EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred             -eEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCC
Confidence             999999999999999996543                799999999999999999999999999999999999999999


Q ss_pred             cEEEEccCCccccccCCCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHH
Q 012887          322 NVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGI  400 (454)
Q Consensus       322 ~vKL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~i  400 (454)
                      .+||+|||++...... .......+++.|+|||.+.+..    ++.++||||||+++|+|++ |..||.+.+.......+
T Consensus       180 ~~kL~Dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~----~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~  254 (327)
T 1fvr_A          180 VAKIADFGLSRGQEVY-VKKTMGRLPVRWMAIESLNYSV----YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL  254 (327)
T ss_dssp             CEEECCTTCEESSCEE-CCC----CCTTTCCHHHHHHCE----ECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHG
T ss_pred             eEEEcccCcCcccccc-ccccCCCCCccccChhhhcccc----CCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHh
Confidence            9999999998643321 1223345678899999997654    4456999999999999998 99999988776655444


Q ss_pred             HHcCCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCCC
Q 012887          401 AACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNIS  449 (454)
Q Consensus       401 ~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~  449 (454)
                       ..+.+...|..+++.+.++|.+||+.||.+||++.+++++|.++....
T Consensus       255 -~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  302 (327)
T 1fvr_A          255 -PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER  302 (327)
T ss_dssp             -GGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred             -hcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhh
Confidence             345666778889999999999999999999999999999999887654

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=4e-44  Score=376.17  Aligned_cols=250  Identities=19%  Similarity=0.346  Sum_probs=214.4

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  263 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~  263 (454)
                      ++|++++.||+|+||.||++      +.||+|.+............+.+|+.++..++||||+++++++.+.+. +++||
T Consensus        22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~-~~lv~  100 (486)
T 3mwu_A           22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSS-FYIVG  100 (486)
T ss_dssp             HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE-EEEEE
T ss_pred             cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCE-EEEEE
Confidence            67899999999999999986      479999986433333345668899999999999999999999988776 99999


Q ss_pred             eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEc---cCCcEEEEccCCccccccCCCc
Q 012887          264 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLD---RHGNVCLGDMGIVTACKSVGEA  340 (454)
Q Consensus       264 E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~---~~~~vKL~DFGla~~~~~~~~~  340 (454)
                      ||+.+|+|.+.+.+.+.+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||++....... .
T Consensus       101 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~-~  179 (486)
T 3mwu_A          101 ELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT-K  179 (486)
T ss_dssp             CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC---
T ss_pred             EcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCC-c
Confidence            9999999999998778999999999999999999999999999999999999995   45679999999987654432 2


Q ss_pred             ccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCC--CCccHHHH
Q 012887          341 TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIP--KDCPQILK  418 (454)
Q Consensus       341 ~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p--~~~~~~l~  418 (454)
                      .....||+.|+|||++.+.     ++.++|||||||++|+|++|..||.+.+.......+.........|  ..+|+++.
T Consensus       180 ~~~~~gt~~y~aPE~~~~~-----~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  254 (486)
T 3mwu_A          180 MKDRIGTAYYIAPEVLRGT-----YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAK  254 (486)
T ss_dssp             --CCTTGGGGCCGGGGGSC-----CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHH
T ss_pred             cCCCcCCCCCCCHHHhCCC-----CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHH
Confidence            3345689999999999753     5667999999999999999999999988888888877766555444  46899999


Q ss_pred             HHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 012887          419 SLMIKCWNNSPSKRPQFSEIISLLLRTN  446 (454)
Q Consensus       419 ~li~~cl~~dP~~RPs~~ell~~L~~~~  446 (454)
                      ++|.+||+.||.+|||+.++++|-|-..
T Consensus       255 ~li~~~L~~dp~~R~t~~~~l~hp~~~~  282 (486)
T 3mwu_A          255 DLIRKMLTFHPSLRITATQCLEHPWIQK  282 (486)
T ss_dssp             HHHHHHTCSSTTTSCCHHHHHHCHHHHH
T ss_pred             HHHHHHcCCChhhCcCHHHHhcCHhhcc
Confidence            9999999999999999999999876543

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=6.6e-44  Score=348.77  Aligned_cols=250  Identities=18%  Similarity=0.277  Sum_probs=216.5

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCC-chHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  262 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV  262 (454)
                      ++|++.+.||+|+||.||++      +.+|+|.+...... ......+.+|+.++..++||||+++++++.+.+. .++|
T Consensus        15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~~lv   93 (294)
T 2rku_A           15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDF-VFVV   93 (294)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE-EEEE
T ss_pred             cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCE-EEEE
Confidence            67899999999999999995      46899998754322 3345668899999999999999999999988775 9999


Q ss_pred             EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCccc
Q 012887          263 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE  342 (454)
Q Consensus       263 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~  342 (454)
                      |||+++++|.+++...+.+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++...........
T Consensus        94 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~  173 (294)
T 2rku_A           94 LELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKK  173 (294)
T ss_dssp             EECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTCCBC
T ss_pred             EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCccccc
Confidence            99999999999998778899999999999999999999999999999999999999999999999999887654444455


Q ss_pred             ccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHHHHHH
Q 012887          343 YETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMI  422 (454)
Q Consensus       343 ~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~li~  422 (454)
                      ...+++.|+|||.+.+..    ++.++||||||+++|+|++|..||...........+...  ...+|..+++.+.++|.
T Consensus       174 ~~~~~~~y~aPE~~~~~~----~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~  247 (294)
T 2rku_A          174 VLCGTPNYIAPEVLSKKG----HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN--EYSIPKHINPVAASLIQ  247 (294)
T ss_dssp             CCCSCCSSCCHHHHTTSC----BCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT--CCCCCTTSCHHHHHHHH
T ss_pred             cccCCCCcCCcchhccCC----CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhc--cCCCccccCHHHHHHHH
Confidence            567899999999998664    345699999999999999999999988777666555543  44577889999999999


Q ss_pred             HhcccCCCCCCCHHHHHHHHHhhc
Q 012887          423 KCWNNSPSKRPQFSEIISLLLRTN  446 (454)
Q Consensus       423 ~cl~~dP~~RPs~~ell~~L~~~~  446 (454)
                      +||+.||.+|||+.+++++-+-..
T Consensus       248 ~~l~~~p~~Rps~~~ll~~~~~~~  271 (294)
T 2rku_A          248 KMLQTDPTARPTINELLNDEFFTS  271 (294)
T ss_dssp             HHTCSSGGGSCCGGGGGGSHHHHT
T ss_pred             HHcccChhhCcCHHHHhhChheec
Confidence            999999999999999999876543

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=2.3e-44  Score=382.81  Aligned_cols=258  Identities=24%  Similarity=0.441  Sum_probs=220.5

Q ss_pred             cceeecCCCEEEeceeeccCCceEEEe-----EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCC
Q 012887          183 GRWLLNSDNLEFIDQIGPNSFKGVYKG-----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH  257 (454)
Q Consensus       183 ~~~~~~~~~~~~~~~LG~G~fG~Vy~g-----~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~  257 (454)
                      ..|.+..++|++.+.||+|+||.||+|     ..||||+++....   ....+.+|+.+|..++||||+++++++.+ +.
T Consensus       260 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~  335 (535)
T 2h8h_A          260 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EP  335 (535)
T ss_dssp             TCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred             cceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC---CHHHHHHHHHHHHhCCCCCEeeEEEEEee-cc
Confidence            568889999999999999999999997     4699999975332   23568899999999999999999999865 33


Q ss_pred             eEEEEEeccCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccc
Q 012887          258 GLCVVTKLMEGGSVNDLILK--SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK  335 (454)
Q Consensus       258 ~l~lV~E~~~~gsL~~~l~~--~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~  335 (454)
                       +++||||+++|+|.+++..  ...+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++...
T Consensus       336 -~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  414 (535)
T 2h8h_A          336 -IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE  414 (535)
T ss_dssp             -CEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCC
T ss_pred             -ceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecC
Confidence             8999999999999999954  3469999999999999999999999999999999999999999999999999987654


Q ss_pred             cCCC-cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHcCCCCCCCCCc
Q 012887          336 SVGE-ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDC  413 (454)
Q Consensus       336 ~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~  413 (454)
                      .... ......+++.|+|||.+.+..    ++.++|||||||+||||++ |..||.+....+....+ ..+.+++.|..+
T Consensus       415 ~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i-~~~~~~~~~~~~  489 (535)
T 2h8h_A          415 DNEYTARQGAKFPIKWTAPEAALYGR----FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV-ERGYRMPCPPEC  489 (535)
T ss_dssp             CHHHHTTCSTTSCGGGSCHHHHHHCC----CCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHH-HTTCCCCCCTTC
T ss_pred             CCceecccCCcCcccccCHHHhccCC----CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-HcCCCCCCCCCC
Confidence            3211 122234577899999998654    5567999999999999999 99999988777665544 456777888999


Q ss_pred             cHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCCCC
Q 012887          414 PQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISN  450 (454)
Q Consensus       414 ~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~  450 (454)
                      +..+.+||.+||+.||++|||+.+|++.|+.+....+
T Consensus       490 ~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~  526 (535)
T 2h8h_A          490 PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE  526 (535)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCS
T ss_pred             CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccC
Confidence            9999999999999999999999999999998876443

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=1.1e-43  Score=346.64  Aligned_cols=250  Identities=23%  Similarity=0.383  Sum_probs=210.9

Q ss_pred             ecCCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeC---CC
Q 012887          187 LNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDE---NH  257 (454)
Q Consensus       187 ~~~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~---~~  257 (454)
                      ...+.|++.+.||+|+||.||+|      ..||+|.+............+.+|+.++..++||||+++++++...   +.
T Consensus        23 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~  102 (290)
T 1t4h_A           23 NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKK  102 (290)
T ss_dssp             TTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCE
T ss_pred             cCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCc
Confidence            34466899999999999999997      4699999986555555667788999999999999999999998753   34


Q ss_pred             eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC--cccCCccCCcEEEc-cCCcEEEEccCCcccc
Q 012887          258 GLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHG--VAYRDLNSQRILLD-RHGNVCLGDMGIVTAC  334 (454)
Q Consensus       258 ~l~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~--iiHrDIKp~NILl~-~~~~vKL~DFGla~~~  334 (454)
                      .+++||||+++++|.+++.+.+.+++..+..++.||+.||.|||+++  |+||||||+|||++ .++.+||+|||++...
T Consensus       103 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~  182 (290)
T 1t4h_A          103 CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK  182 (290)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred             eEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccc
Confidence            48999999999999999987788999999999999999999999999  99999999999998 7899999999998654


Q ss_pred             ccCCCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCC-CCCCCCCc
Q 012887          335 KSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGL-RPEIPKDC  413 (454)
Q Consensus       335 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~-~~~~p~~~  413 (454)
                      ...  ......+++.|+|||.+.+.     ++.++||||||+++|+|++|..||...............+. ...++...
T Consensus       183 ~~~--~~~~~~~t~~y~aPE~~~~~-----~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (290)
T 1t4h_A          183 RAS--FAKAVIGTPEFMAPEMYEEK-----YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVA  255 (290)
T ss_dssp             CTT--SBEESCSSCCCCCGGGGGTC-----CCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCC
T ss_pred             ccc--ccccccCCcCcCCHHHHhcc-----CCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCC
Confidence            332  23345689999999988643     55679999999999999999999998666555554444443 33456677


Q ss_pred             cHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 012887          414 PQILKSLMIKCWNNSPSKRPQFSEIISLLL  443 (454)
Q Consensus       414 ~~~l~~li~~cl~~dP~~RPs~~ell~~L~  443 (454)
                      ++++.++|.+||+.||.+|||+.+++++-+
T Consensus       256 ~~~l~~li~~~l~~dp~~Rps~~ell~h~~  285 (290)
T 1t4h_A          256 IPEVKEIIEGCIRQNKDERYSIKDLLNHAF  285 (290)
T ss_dssp             CHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred             CHHHHHHHHHHccCChhhCCCHHHHhhCcc
Confidence            899999999999999999999999998754

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1.8e-44  Score=356.35  Aligned_cols=254  Identities=22%  Similarity=0.358  Sum_probs=204.7

Q ss_pred             CCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCc-hHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCC---e
Q 012887          189 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGN-AYEFELRKDLLELMTCGHKNILQFYCVCVDENH---G  258 (454)
Q Consensus       189 ~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~---~  258 (454)
                      .++|++.+.||+|+||.||++      +.||+|.+....... .....+.+|+.++..++||||+++++++.....   .
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            378999999999999999986      579999997543333 344568899999999999999999999876643   2


Q ss_pred             EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCC
Q 012887          259 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG  338 (454)
Q Consensus       259 l~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~  338 (454)
                      .|+||||+++++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus        91 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  170 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG  170 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC-------
T ss_pred             cEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcccccccc
Confidence            48999999999999999877889999999999999999999999999999999999999999999999999987654432


Q ss_pred             C---cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCC--CCCCc
Q 012887          339 E---ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPE--IPKDC  413 (454)
Q Consensus       339 ~---~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~--~p~~~  413 (454)
                      .   ......||+.|+|||.+.+..    ++.++|||||||++|+|++|..||.+..+.............+.  .+..+
T Consensus       171 ~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (311)
T 3ork_A          171 NSVTQTAAVIGTAQYLSPEQARGDS----VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGL  246 (311)
T ss_dssp             -----------CCTTCCHHHHHTCC----CCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTTC
T ss_pred             cccccccccCcCcccCCHHHhcCCC----CCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCCC
Confidence            2   122345899999999998764    45579999999999999999999999888877766666544332  24568


Q ss_pred             cHHHHHHHHHhcccCCCCCCCHHHHH-HHHHhhc
Q 012887          414 PQILKSLMIKCWNNSPSKRPQFSEII-SLLLRTN  446 (454)
Q Consensus       414 ~~~l~~li~~cl~~dP~~RPs~~ell-~~L~~~~  446 (454)
                      ++++.++|.+||+.||.+||+..+++ +.+.+..
T Consensus       247 ~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~  280 (311)
T 3ork_A          247 SADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  280 (311)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence            99999999999999999999765555 4454443

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=1.8e-43  Score=348.18  Aligned_cols=254  Identities=20%  Similarity=0.384  Sum_probs=200.0

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCC-chHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  262 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV  262 (454)
                      ++|++.+.||+|+||.||+|      +.||+|+++..... ......+.+|+.++..++||||+++++++.+.+. .++|
T Consensus        32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~-~~lv  110 (310)
T 2wqm_A           32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNE-LNIV  110 (310)
T ss_dssp             GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE-EEEE
T ss_pred             cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCc-EEEE
Confidence            67899999999999999985      57999999754333 3345668899999999999999999999998776 9999


Q ss_pred             EeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCC
Q 012887          263 TKLMEGGSVNDLILK----SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG  338 (454)
Q Consensus       263 ~E~~~~gsL~~~l~~----~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~  338 (454)
                      |||+++++|.+++..    ...+++..++.++.||+.||.|||++|++||||||+|||++.++.+||+|||++.......
T Consensus       111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~  190 (310)
T 2wqm_A          111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT  190 (310)
T ss_dssp             EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC----------
T ss_pred             EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCCC
Confidence            999999999999853    4579999999999999999999999999999999999999999999999999987665444


Q ss_pred             CcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC--HHHHHHHHHHcCCCCCCCCCccHH
Q 012887          339 EATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACS--PVQAAVGIAACGLRPEIPKDCPQI  416 (454)
Q Consensus       339 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~--~~~~~~~i~~~~~~~~~p~~~~~~  416 (454)
                      .......+++.|+|||.+.+..    ++.++||||||+++|+|++|..||.+..  .......+.....++..+..++++
T Consensus       191 ~~~~~~~~~~~y~aPE~~~~~~----~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (310)
T 2wqm_A          191 TAAHSLVGTPYYMSPERIHENG----YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEE  266 (310)
T ss_dssp             --------CCSSCCHHHHTTCC----CCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCHH
T ss_pred             ccccccCCCeeEeChHHhCCCC----CCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCHH
Confidence            3344456889999999998654    4567999999999999999999997542  233334444444444344678999


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHHHHHhhcCC
Q 012887          417 LKSLMIKCWNNSPSKRPQFSEIISLLLRTNNI  448 (454)
Q Consensus       417 l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~  448 (454)
                      +.++|.+||+.||.+||++.++++.|+++...
T Consensus       267 l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~  298 (310)
T 2wqm_A          267 LRQLVNMCINPDPEKRPDVTYVYDVAKRMHAC  298 (310)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence            99999999999999999999999999988654

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.7e-45  Score=375.51  Aligned_cols=259  Identities=20%  Similarity=0.267  Sum_probs=211.1

Q ss_pred             ceeecCCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCc-hHHHHHHHHHHHHHhCCCCceeEEEEEEEeCC
Q 012887          184 RWLLNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGN-AYEFELRKDLLELMTCGHKNILQFYCVCVDEN  256 (454)
Q Consensus       184 ~~~~~~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~  256 (454)
                      +..+..++|++++.||+|+||.||++      +.||+|++....... .....+.+|..++..++||||+++++++.+.+
T Consensus        55 ~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~  134 (412)
T 2vd5_A           55 EVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDEN  134 (412)
T ss_dssp             HHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSS
T ss_pred             hccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCC
Confidence            44566789999999999999999985      579999996421111 11223678889999999999999999999877


Q ss_pred             CeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccc
Q 012887          257 HGLCVVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK  335 (454)
Q Consensus       257 ~~l~lV~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~  335 (454)
                      . +|+||||+++|+|.+++.+. ..+++..+..++.||+.||+|||++||+||||||+|||++.+|++||+|||+++...
T Consensus       135 ~-~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~  213 (412)
T 2vd5_A          135 Y-LYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLR  213 (412)
T ss_dssp             E-EEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             E-EEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheecc
Confidence            6 99999999999999999764 489999999999999999999999999999999999999999999999999988765


Q ss_pred             cCCCc-ccccCCCCcccccccccCC---CCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCC---CC
Q 012887          336 SVGEA-TEYETDGYRWLAPEIIAGD---PESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR---PE  408 (454)
Q Consensus       336 ~~~~~-~~~~~gt~~y~APE~l~~~---~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~---~~  408 (454)
                      ..... .....||+.|+|||++.+.   .....++.++|||||||++|||++|..||.+.+..+....+......   +.
T Consensus       214 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~  293 (412)
T 2vd5_A          214 ADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPL  293 (412)
T ss_dssp             TTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC-
T ss_pred             CCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCc
Confidence            43332 2345799999999998731   11123566799999999999999999999998888777666543222   22


Q ss_pred             CCCCccHHHHHHHHHhcccCCCCC---CCHHHHHHHHHh
Q 012887          409 IPKDCPQILKSLMIKCWNNSPSKR---PQFSEIISLLLR  444 (454)
Q Consensus       409 ~p~~~~~~l~~li~~cl~~dP~~R---Ps~~ell~~L~~  444 (454)
                      .+..+|+++.+||++||. +|.+|   |++.|+++|-+-
T Consensus       294 ~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff  331 (412)
T 2vd5_A          294 VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFF  331 (412)
T ss_dssp             ---CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGG
T ss_pred             cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCc
Confidence            346799999999999999 99998   699999987653

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=6.5e-44  Score=375.44  Aligned_cols=247  Identities=16%  Similarity=0.292  Sum_probs=208.2

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  263 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~  263 (454)
                      ++|++++.||+|+||.||++      ..+|+|.+............+.+|+.++..++||||+++++++.+.+. +|+||
T Consensus        37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~-~~lv~  115 (494)
T 3lij_A           37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRN-YYLVM  115 (494)
T ss_dssp             HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSE-EEEEE
T ss_pred             cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCE-EEEEE
Confidence            56899999999999999986      479999998654444445668899999999999999999999988776 99999


Q ss_pred             eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccC---CcEEEEccCCccccccCCCc
Q 012887          264 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH---GNVCLGDMGIVTACKSVGEA  340 (454)
Q Consensus       264 E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~---~~vKL~DFGla~~~~~~~~~  340 (454)
                      ||+++|+|.+.+.....+++..+..++.||+.||.|||++||+||||||+|||++..   +.+||+|||++....... .
T Consensus       116 e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~-~  194 (494)
T 3lij_A          116 ECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK-K  194 (494)
T ss_dssp             ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTB-C
T ss_pred             ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCc-c
Confidence            999999999999877889999999999999999999999999999999999999764   459999999987765432 2


Q ss_pred             ccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCC--CCccHHHH
Q 012887          341 TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIP--KDCPQILK  418 (454)
Q Consensus       341 ~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p--~~~~~~l~  418 (454)
                      .....||+.|+|||++.+.     ++.++|||||||++|+|++|..||.+.+..+....+.........+  ..+|+.+.
T Consensus       195 ~~~~~gt~~y~aPE~l~~~-----~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  269 (494)
T 3lij_A          195 MKERLGTAYYIAPEVLRKK-----YDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAK  269 (494)
T ss_dssp             BCCCCSCTTTCCHHHHTTC-----BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHH
T ss_pred             ccccCCCcCeeCHHHHccc-----CCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHH
Confidence            3445789999999998642     5567999999999999999999999988888887777765554433  46899999


Q ss_pred             HHHHHhcccCCCCCCCHHHHHHHHH
Q 012887          419 SLMIKCWNNSPSKRPQFSEIISLLL  443 (454)
Q Consensus       419 ~li~~cl~~dP~~RPs~~ell~~L~  443 (454)
                      +||.+||+.||.+|||+.++++|-|
T Consensus       270 ~li~~~L~~dp~~R~s~~e~l~hp~  294 (494)
T 3lij_A          270 DLIKQMLQFDSQRRISAQQALEHPW  294 (494)
T ss_dssp             HHHHHHTCSSTTTSCCHHHHHTCHH
T ss_pred             HHHHHHCCCChhhCccHHHHhcCcc
Confidence            9999999999999999999998754

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=4.2e-44  Score=375.49  Aligned_cols=250  Identities=21%  Similarity=0.300  Sum_probs=214.9

Q ss_pred             CCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCC-chHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEE
Q 012887          189 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCV  261 (454)
Q Consensus       189 ~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~l  261 (454)
                      .++|.+++.||+|+||.||+|      +.||+|.+...... ......+.+|+.++..++||||+++++++.+.+. +++
T Consensus        15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~-~~l   93 (476)
T 2y94_A           15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSD-IFM   93 (476)
T ss_dssp             ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE-EEE
T ss_pred             ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE-EEE
Confidence            378999999999999999985      57999998643211 1223568899999999999999999999988776 999


Q ss_pred             EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCcc
Q 012887          262 VTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT  341 (454)
Q Consensus       262 V~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~  341 (454)
                      ||||+++|+|.+++.+.+.+++..+..++.||+.||+|||++||+||||||+|||++.++++||+|||++...... ...
T Consensus        94 v~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~-~~~  172 (476)
T 2y94_A           94 VMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-EFL  172 (476)
T ss_dssp             EEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTT-CCB
T ss_pred             EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcccc-ccc
Confidence            9999999999999988789999999999999999999999999999999999999999999999999998875443 233


Q ss_pred             cccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHHHHH
Q 012887          342 EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLM  421 (454)
Q Consensus       342 ~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~li  421 (454)
                      ....||+.|+|||++.+..+   .+.++|||||||++|+|++|..||.+.+.......+...  ....|..+++++.+||
T Consensus       173 ~~~~gt~~y~aPE~~~~~~~---~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~Li  247 (476)
T 2y94_A          173 RTSCGSPNYAAPEVISGRLY---AGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDG--IFYTPQYLNPSVISLL  247 (476)
T ss_dssp             CCCCSCSTTCCHHHHTTCCB---CSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTT--CCCCCTTCCHHHHHHH
T ss_pred             cccCCCcCeEChhhccCCCC---CCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcC--CcCCCccCCHHHHHHH
Confidence            44578999999999987643   245799999999999999999999988777666666543  3456778999999999


Q ss_pred             HHhcccCCCCCCCHHHHHHHHHhh
Q 012887          422 IKCWNNSPSKRPQFSEIISLLLRT  445 (454)
Q Consensus       422 ~~cl~~dP~~RPs~~ell~~L~~~  445 (454)
                      .+||+.||.+|||+.|+++|-+-.
T Consensus       248 ~~~L~~dP~~Rpt~~eil~hp~~~  271 (476)
T 2y94_A          248 KHMLQVDPMKRATIKDIREHEWFK  271 (476)
T ss_dssp             HHHTCSSTTTSCCHHHHHTCHHHH
T ss_pred             HHHcCCCchhCcCHHHHHhCHHhh
Confidence            999999999999999999986643

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=3.2e-45  Score=367.55  Aligned_cols=249  Identities=19%  Similarity=0.254  Sum_probs=207.5

Q ss_pred             CCEEEeceeeccCCceEEEeE------EEEEEEeecCCCC-chHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKG-NAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  262 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g~------~vavK~l~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV  262 (454)
                      ++|++.+.||+|+||.||+|.      .||+|.+...... ......+.+|+.++..++||||+++++++.+.+. +++|
T Consensus         9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~-~~lv   87 (336)
T 3h4j_B            9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTD-IVMV   87 (336)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSE-EEEE
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCE-EEEE
Confidence            679999999999999999964      7999998632111 1122457899999999999999999999998776 9999


Q ss_pred             EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCccc
Q 012887          263 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE  342 (454)
Q Consensus       263 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~  342 (454)
                      |||+ +|+|.+++.+.+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ...
T Consensus        88 ~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~-~~~  165 (336)
T 3h4j_B           88 IEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN-FLK  165 (336)
T ss_dssp             ECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB-TTC
T ss_pred             EECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCc-ccc
Confidence            9999 67999999887899999999999999999999999999999999999999999999999999987654432 234


Q ss_pred             ccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHHHHHH
Q 012887          343 YETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMI  422 (454)
Q Consensus       343 ~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~li~  422 (454)
                      ...||+.|+|||++.+..+   .+.++|||||||++|+|++|..||.+.........+  ......+|..+|+++.++|.
T Consensus       166 ~~~gt~~y~aPE~~~~~~~---~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i--~~~~~~~p~~~s~~~~~li~  240 (336)
T 3h4j_B          166 TSCGSPNYAAPEVINGKLY---AGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV--NSCVYVMPDFLSPGAQSLIR  240 (336)
T ss_dssp             CCTTSTTTSCGGGSCCSGG---GCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCC--CSSCCCCCTTSCHHHHHHHH
T ss_pred             cccCCcCcCCHHHHcCCCC---CCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHH--HcCCCCCcccCCHHHHHHHH
Confidence            4578999999999987653   245799999999999999999999875433221111  11234567889999999999


Q ss_pred             HhcccCCCCCCCHHHHHHHHHhhc
Q 012887          423 KCWNNSPSKRPQFSEIISLLLRTN  446 (454)
Q Consensus       423 ~cl~~dP~~RPs~~ell~~L~~~~  446 (454)
                      +||+.||.+|||+.|++++-|-..
T Consensus       241 ~~L~~dP~~Rpt~~eil~hp~~~~  264 (336)
T 3h4j_B          241 RMIVADPMQRITIQEIRRDPWFNV  264 (336)
T ss_dssp             TTSCSSGGGSCCHHHHTTCHHHHT
T ss_pred             HHcCCChhHCcCHHHHHhChhhcc
Confidence            999999999999999999887543

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=5.6e-44  Score=355.08  Aligned_cols=259  Identities=22%  Similarity=0.405  Sum_probs=215.3

Q ss_pred             eeecCCCEEEeceeeccCCceEEEeE----------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEe
Q 012887          185 WLLNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVD  254 (454)
Q Consensus       185 ~~~~~~~~~~~~~LG~G~fG~Vy~g~----------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~  254 (454)
                      ..++.++|++++.||+|+||.||+++          .||+|.+...  .......+.+|+.++..++||||+++++++..
T Consensus        18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   95 (327)
T 3lxl_A           18 TIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQILKALHSDFIVKYRGVSYG   95 (327)
T ss_dssp             CBCCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred             hhhchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC--CHHHHHHHHHHHHHHHhcCCCceeEEEEEEec
Confidence            34777899999999999999999864          6999998743  33445568899999999999999999999875


Q ss_pred             C-CCeEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCcc
Q 012887          255 E-NHGLCVVTKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVT  332 (454)
Q Consensus       255 ~-~~~l~lV~E~~~~gsL~~~l~~-~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~  332 (454)
                      . +..+++||||+++++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus        96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~  175 (327)
T 3lxl_A           96 PGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAK  175 (327)
T ss_dssp             SSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred             CCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccce
Confidence            4 3458999999999999999965 4479999999999999999999999999999999999999999999999999988


Q ss_pred             ccccCCC---cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHH--------------H
Q 012887          333 ACKSVGE---ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPV--------------Q  395 (454)
Q Consensus       333 ~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~--------------~  395 (454)
                      .......   ......+++.|+|||.+.+..+    +.++||||||+++|+|++|..||......              .
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~----~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~  251 (327)
T 3lxl_A          176 LLPLDKDYYVVREPGQSPIFWYAPESLSDNIF----SRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALS  251 (327)
T ss_dssp             ECCTTCSEEECSSCCCSCGGGSCHHHHHHCEE----EHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHH
T ss_pred             ecccCCccceeeccCCccccccCHHHhccCCC----ChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHH
Confidence            6644332   1223357788999999987643    45699999999999999999998653321              2


Q ss_pred             HHHHHHHcCCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCCC
Q 012887          396 AAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNIS  449 (454)
Q Consensus       396 ~~~~i~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~  449 (454)
                      ........+.+.+.+..+++.+.++|.+||+.||.+|||+.+++++|+.+....
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~  305 (327)
T 3lxl_A          252 RLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS  305 (327)
T ss_dssp             HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred             HHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence            334455566777888899999999999999999999999999999999876543

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=6.4e-44  Score=354.65  Aligned_cols=255  Identities=23%  Similarity=0.464  Sum_probs=212.1

Q ss_pred             ecCCCEEEeceeeccCCceEEEeE-----------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeC
Q 012887          187 LNSDNLEFIDQIGPNSFKGVYKGK-----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDE  255 (454)
Q Consensus       187 ~~~~~~~~~~~LG~G~fG~Vy~g~-----------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~  255 (454)
                      +..++|++++.||+|+||.||+|+           .||+|.+... ........+.+|+.++..++||||+++++++.+.
T Consensus        27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  105 (327)
T 2yfx_A           27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS  105 (327)
T ss_dssp             CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc-cchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCC
Confidence            455889999999999999999986           6999998633 3344556788999999999999999999999887


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhCC-------CCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccC---CcEEE
Q 012887          256 NHGLCVVTKLMEGGSVNDLILKSR-------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH---GNVCL  325 (454)
Q Consensus       256 ~~~l~lV~E~~~~gsL~~~l~~~~-------~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~---~~vKL  325 (454)
                      +. .++||||+++++|.+++....       .+++..++.++.||+.||.|||++||+||||||+|||++.+   ..+||
T Consensus       106 ~~-~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl  184 (327)
T 2yfx_A          106 LP-RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKI  184 (327)
T ss_dssp             SS-CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             CC-cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEE
Confidence            76 899999999999999997542       48999999999999999999999999999999999999944   46999


Q ss_pred             EccCCccccccCCC--cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHH
Q 012887          326 GDMGIVTACKSVGE--ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAA  402 (454)
Q Consensus       326 ~DFGla~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~i~~  402 (454)
                      +|||++........  ......+++.|+|||.+.+..    ++.++||||||+++|+|++ |..||...........+ .
T Consensus       185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~-~  259 (327)
T 2yfx_A          185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGI----FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV-T  259 (327)
T ss_dssp             CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCC----CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH-H
T ss_pred             CccccccccccccccccCCCcCCCcceeCHhHhcCCC----CCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHH-h
Confidence            99999875543221  223345788999999997654    4557999999999999998 99999987766555444 4


Q ss_pred             cCCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCC
Q 012887          403 CGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNI  448 (454)
Q Consensus       403 ~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~  448 (454)
                      .+.++..+..++..+.++|.+||+.||.+||++.+++++|+.+.+.
T Consensus       260 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~  305 (327)
T 2yfx_A          260 SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD  305 (327)
T ss_dssp             TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             cCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence            4556677888999999999999999999999999999999987653

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=4.9e-44  Score=359.54  Aligned_cols=245  Identities=20%  Similarity=0.321  Sum_probs=205.6

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEEEEEEEeCCCeEEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVDENHGLCVV  262 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~~~g~~~~~~~~l~lV  262 (454)
                      ++|++.+.||+|+||.||++      +.+|+|.+......      ..+|+.++.++ +||||+++++++.+.+. +|+|
T Consensus        22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~-~~lv   94 (342)
T 2qr7_A           22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD------PTEEIEILLRYGQHPNIITLKDVYDDGKY-VYVV   94 (342)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC------CHHHHHHHHHHTTSTTBCCEEEEEECSSE-EEEE
T ss_pred             ccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC------hHHHHHHHHHhcCCCCcCeEEEEEEcCCE-EEEE
Confidence            67999999999999999985      57999999754332      23566777776 79999999999987776 9999


Q ss_pred             EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccC----CcEEEEccCCccccccCC
Q 012887          263 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH----GNVCLGDMGIVTACKSVG  338 (454)
Q Consensus       263 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~----~~vKL~DFGla~~~~~~~  338 (454)
                      |||+++|+|.+++.+.+.+++..+..++.||+.||.|||++||+||||||+|||+..+    +.+||+|||++.......
T Consensus        95 ~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~  174 (342)
T 2qr7_A           95 TELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN  174 (342)
T ss_dssp             ECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTT
T ss_pred             EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCC
Confidence            9999999999999888899999999999999999999999999999999999998543    359999999998765544


Q ss_pred             CcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCC---CCHHHHHHHHHHcCCCCC--CCCCc
Q 012887          339 EATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAA---CSPVQAAVGIAACGLRPE--IPKDC  413 (454)
Q Consensus       339 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~---~~~~~~~~~i~~~~~~~~--~p~~~  413 (454)
                      .......+|+.|+|||++.+..    ++.++|||||||++|+|++|..||.+   .+..+....+........  .+..+
T Consensus       175 ~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~  250 (342)
T 2qr7_A          175 GLLMTPCYTANFVAPEVLERQG----YDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSV  250 (342)
T ss_dssp             CCBCCSSCCSSCCCHHHHHHHH----HHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTS
T ss_pred             CceeccCCCccccCHHHhcCCC----CCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccC
Confidence            4455567899999999998654    34569999999999999999999985   344555555655444332  34578


Q ss_pred             cHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 012887          414 PQILKSLMIKCWNNSPSKRPQFSEIISLLLRT  445 (454)
Q Consensus       414 ~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~  445 (454)
                      ++++.+||.+||..||.+||++.++++|-|-.
T Consensus       251 s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~  282 (342)
T 2qr7_A          251 SDTAKDLVSKMLHVDPHQRLTAALVLRHPWIV  282 (342)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHH
T ss_pred             CHHHHHHHHHHCCCChhHCcCHHHHhcCCeec
Confidence            99999999999999999999999999987753

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=1.1e-43  Score=346.82  Aligned_cols=254  Identities=17%  Similarity=0.253  Sum_probs=208.5

Q ss_pred             ecCCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEEEEEEEeCCCeE
Q 012887          187 LNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVDENHGL  259 (454)
Q Consensus       187 ~~~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~~~g~~~~~~~~l  259 (454)
                      +..++|++.+.||+|+||.||+|      +.||+|.+......    ..+.+|+..+..+ +|+|++++++++.+... .
T Consensus         7 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~-~   81 (298)
T 1csn_A            7 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLH-N   81 (298)
T ss_dssp             EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTE-E
T ss_pred             ccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc----HHHHHHHHHHHHHhcCCCCCeEEeecCCCce-e
Confidence            34588999999999999999996      58999998743322    2367888888888 79999999999987776 8


Q ss_pred             EEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCc-----EEEEccCCccc
Q 012887          260 CVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGN-----VCLGDMGIVTA  333 (454)
Q Consensus       260 ~lV~E~~~~gsL~~~l~~~~-~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~-----vKL~DFGla~~  333 (454)
                      ++||||+ +++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++.     +||+|||++..
T Consensus        82 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~  160 (298)
T 1csn_A           82 VLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  160 (298)
T ss_dssp             EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             EEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence            9999999 889999997654 6999999999999999999999999999999999999987776     99999999886


Q ss_pred             cccCCC-------cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC---HHHHHHHHHHc
Q 012887          334 CKSVGE-------ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACS---PVQAAVGIAAC  403 (454)
Q Consensus       334 ~~~~~~-------~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~---~~~~~~~i~~~  403 (454)
                      ......       ......||+.|+|||.+.+..    ++.++|||||||++|+|++|..||.+..   .......+...
T Consensus       161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  236 (298)
T 1csn_A          161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGRE----QSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEK  236 (298)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC----CCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHH
T ss_pred             cccccccccccccCccCCCCCcccCCchhhcCCC----CChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhh
Confidence            654322       123446899999999998764    4567999999999999999999998743   33333333222


Q ss_pred             CCC---CCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCCCC
Q 012887          404 GLR---PEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISN  450 (454)
Q Consensus       404 ~~~---~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~  450 (454)
                      ...   +..+..+|+++.+++.+||+.||.+||++.+|++.|.++.+..+
T Consensus       237 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~  286 (298)
T 1csn_A          237 KQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN  286 (298)
T ss_dssp             HHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             ccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcC
Confidence            112   22345789999999999999999999999999999998876543

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=1.7e-43  Score=347.35  Aligned_cols=251  Identities=23%  Similarity=0.418  Sum_probs=216.3

Q ss_pred             CCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEE
Q 012887          189 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  262 (454)
Q Consensus       189 ~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV  262 (454)
                      .+.|++++.||+|+||.||+|      +.||+|.+..... ......+.+|+.++..++||||+++++++.+.+. +++|
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~lv   98 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTK-LWII   98 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC-STTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE-EEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCe-EEEE
Confidence            367999999999999999996      4799999975433 2345668899999999999999999999998776 9999


Q ss_pred             EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCccc
Q 012887          263 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE  342 (454)
Q Consensus       263 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~  342 (454)
                      |||+++++|.+++. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...........
T Consensus        99 ~e~~~~~~L~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  177 (303)
T 3a7i_A           99 MEYLGGGSALDLLE-PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN  177 (303)
T ss_dssp             EECCTTEEHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCBC
T ss_pred             EEeCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccccccC
Confidence            99999999999985 46799999999999999999999999999999999999999999999999999877655444445


Q ss_pred             ccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHHHHHH
Q 012887          343 YETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMI  422 (454)
Q Consensus       343 ~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~li~  422 (454)
                      ...+++.|+|||.+.+..    ++.++||||||+++|+|++|..||...........+.. +.++.++..++..+.++|.
T Consensus       178 ~~~~~~~y~aPE~~~~~~----~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~  252 (303)
T 3a7i_A          178 TFVGTPFWMAPEVIKQSA----YDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPK-NNPPTLEGNYSKPLKEFVE  252 (303)
T ss_dssp             CCCSCGGGCCHHHHTTCC----BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH-SCCCCCCSSCCHHHHHHHH
T ss_pred             ccCCCcCccCHHHHhcCC----CCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhc-CCCCCCccccCHHHHHHHH
Confidence            557899999999998764    34569999999999999999999998877766555443 4556678889999999999


Q ss_pred             HhcccCCCCCCCHHHHHHHHHhhcC
Q 012887          423 KCWNNSPSKRPQFSEIISLLLRTNN  447 (454)
Q Consensus       423 ~cl~~dP~~RPs~~ell~~L~~~~~  447 (454)
                      +||+.||.+|||+.+++++.+-..+
T Consensus       253 ~~l~~dp~~Rps~~~ll~~~~~~~~  277 (303)
T 3a7i_A          253 ACLNKEPSFRPTAKELLKHKFILRN  277 (303)
T ss_dssp             HHCCSSGGGSCCHHHHTTCHHHHHH
T ss_pred             HHcCCChhhCcCHHHHhhChhhhcC
Confidence            9999999999999999998765443

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=7.2e-45  Score=359.06  Aligned_cols=266  Identities=19%  Similarity=0.397  Sum_probs=215.0

Q ss_pred             ccceeecCCCEEEeceeeccCCceEEEeE---EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCe
Q 012887          182 IGRWLLNSDNLEFIDQIGPNSFKGVYKGK---RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHG  258 (454)
Q Consensus       182 ~~~~~~~~~~~~~~~~LG~G~fG~Vy~g~---~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~  258 (454)
                      ...|.+..++|++.+.||+|+||.||+|+   .+|+|.++...........+.+|+.++..++||||+++++++.+.+. 
T Consensus        25 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-  103 (319)
T 2y4i_B           25 LQEWDIPFEQLEIGELIGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPH-  103 (319)
T ss_dssp             GGGSSSCCSCEECCCBCCCSSSSEEEEEEESSSEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSC-
T ss_pred             cccccCCHHHeEEeeEeccCCceEEEEEEEcCeEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCc-
Confidence            35677888999999999999999999975   58999987543333333446788899999999999999999998876 


Q ss_pred             EEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccC
Q 012887          259 LCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV  337 (454)
Q Consensus       259 l~lV~E~~~~gsL~~~l~~~~-~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~  337 (454)
                      +++||||+++++|.+++.+.+ .+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++......
T Consensus       104 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~  182 (319)
T 2y4i_B          104 LAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVL  182 (319)
T ss_dssp             EEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC-----
T ss_pred             eEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCccccccc
Confidence            999999999999999997654 799999999999999999999999999999999999998 789999999997654321


Q ss_pred             -----CCcccccCCCCcccccccccCCCC-----CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCC
Q 012887          338 -----GEATEYETDGYRWLAPEIIAGDPE-----SVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP  407 (454)
Q Consensus       338 -----~~~~~~~~gt~~y~APE~l~~~~~-----~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~  407 (454)
                           ........+++.|+|||.+.+...     ...++.++||||||+++|+|++|..||...........+.....+.
T Consensus       183 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~  262 (319)
T 2y4i_B          183 QAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPN  262 (319)
T ss_dssp             -----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCC
T ss_pred             cccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCC
Confidence                 112333457889999999975321     2235678999999999999999999999888777666655543333


Q ss_pred             CCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCCC
Q 012887          408 EIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNIS  449 (454)
Q Consensus       408 ~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~  449 (454)
                      ..+..++.++.++|.+||+.||.+|||+.++++.|+++....
T Consensus       263 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~  304 (319)
T 2y4i_B          263 LSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN  304 (319)
T ss_dssp             CCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred             CCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence            334568999999999999999999999999999999887653

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=5.5e-44  Score=354.28  Aligned_cols=259  Identities=25%  Similarity=0.420  Sum_probs=215.0

Q ss_pred             eecCCCEEEeceeeccCCceEEE----------eEEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeC
Q 012887          186 LLNSDNLEFIDQIGPNSFKGVYK----------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDE  255 (454)
Q Consensus       186 ~~~~~~~~~~~~LG~G~fG~Vy~----------g~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~  255 (454)
                      .+..+.|++++.||+|+||.||+          |+.||+|.++.. ........+.+|+.++..++||||+++++++.+.
T Consensus        27 ~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  105 (318)
T 3lxp_A           27 VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD-AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDA  105 (318)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred             eecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc-cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecC
Confidence            35556679999999999999975          357999999743 3334556788999999999999999999999876


Q ss_pred             C-CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCcccc
Q 012887          256 N-HGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC  334 (454)
Q Consensus       256 ~-~~l~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~  334 (454)
                      + ..+++||||+++|+|.+++.+ ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus       106 ~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~  184 (318)
T 3lxp_A          106 GAASLQLVMEYVPLGSLRDYLPR-HSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV  184 (318)
T ss_dssp             TTTEEEEEECCCTTCBHHHHGGG-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred             CCceEEEEEecccCCcHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccccc
Confidence            3 458999999999999999855 45999999999999999999999999999999999999999999999999998876


Q ss_pred             ccCCC---cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHH--------------HHH
Q 012887          335 KSVGE---ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPV--------------QAA  397 (454)
Q Consensus       335 ~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~--------------~~~  397 (454)
                      .....   ......+++.|+|||.+.+..+    +.++||||||+++|+|++|..||......              ...
T Consensus       185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~----~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  260 (318)
T 3lxp_A          185 PEGHEYYRVREDGDSPVFWYAPECLKEYKF----YYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRL  260 (318)
T ss_dssp             CTTCSEEEC---CCCCGGGCCHHHHHHCEE----EHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHH
T ss_pred             cccccccccccCCCCCceeeChHHhcCCCC----CcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHH
Confidence            54332   1233456788999999986643    45699999999999999999999753221              122


Q ss_pred             HHHHHcCCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCCCC
Q 012887          398 VGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISN  450 (454)
Q Consensus       398 ~~i~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~  450 (454)
                      ......+.+.+.+..+++++.++|.+||+.||.+|||+.|+++.|+.+.+...
T Consensus       261 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~  313 (318)
T 3lxp_A          261 TELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQ  313 (318)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhc
Confidence            34455566777888999999999999999999999999999999998876543

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=7.5e-44  Score=356.06  Aligned_cols=251  Identities=18%  Similarity=0.280  Sum_probs=217.4

Q ss_pred             CCCEEEeceeeccCCceEEEe------EEEEEEEeecCCC-CchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEE
Q 012887          189 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDK-GNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCV  261 (454)
Q Consensus       189 ~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~l  261 (454)
                      .++|.+.+.||+|+||.||++      +.+|+|.+..... .......+.+|+.++..++||||+++++++.+.+. +++
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~l  118 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDF-VFV  118 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE-EEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCe-EEE
Confidence            367999999999999999996      4789999875432 23345668899999999999999999999998775 999


Q ss_pred             EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCcc
Q 012887          262 VTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT  341 (454)
Q Consensus       262 V~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~  341 (454)
                      ||||+++++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..........
T Consensus       119 v~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~  198 (335)
T 2owb_A          119 VLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK  198 (335)
T ss_dssp             EECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTCCB
T ss_pred             EEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCcccc
Confidence            99999999999999877889999999999999999999999999999999999999999999999999988765444445


Q ss_pred             cccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHHHHH
Q 012887          342 EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLM  421 (454)
Q Consensus       342 ~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~li  421 (454)
                      ....+++.|+|||.+.+..+    +.++||||||+++|+|++|..||...........+...  ...+|..+++.+.++|
T Consensus       199 ~~~~gt~~y~aPE~~~~~~~----~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li  272 (335)
T 2owb_A          199 KVLCGTPNYIAPEVLSKKGH----SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN--EYSIPKHINPVAASLI  272 (335)
T ss_dssp             CCCCSCCSSCCHHHHHTSCB----CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT--CCCCCTTSCHHHHHHH
T ss_pred             cccCCCccccCHHHhccCCC----CchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcC--CCCCCccCCHHHHHHH
Confidence            55678999999999987643    45699999999999999999999988777666666554  3456788999999999


Q ss_pred             HHhcccCCCCCCCHHHHHHHHHhhc
Q 012887          422 IKCWNNSPSKRPQFSEIISLLLRTN  446 (454)
Q Consensus       422 ~~cl~~dP~~RPs~~ell~~L~~~~  446 (454)
                      .+||+.||.+||++.|++++-+-..
T Consensus       273 ~~~l~~dp~~Rps~~ell~~~~~~~  297 (335)
T 2owb_A          273 QKMLQTDPTARPTINELLNDEFFTS  297 (335)
T ss_dssp             HHHTCSSGGGSCCGGGGGGSHHHHT
T ss_pred             HHHccCChhHCcCHHHHhcCccccC
Confidence            9999999999999999998766443

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.3e-43  Score=350.18  Aligned_cols=249  Identities=23%  Similarity=0.513  Sum_probs=204.1

Q ss_pred             ecCCCEEEeceeeccCCceEEEe----EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEE
Q 012887          187 LNSDNLEFIDQIGPNSFKGVYKG----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  262 (454)
Q Consensus       187 ~~~~~~~~~~~LG~G~fG~Vy~g----~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV  262 (454)
                      ++.++|++.+.||+|+||.||++    +.||+|.+..    ......+.+|+..+.+++||||+++++++.+  . .++|
T Consensus         5 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~----~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~-~~lv   77 (307)
T 2eva_A            5 IDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIES----ESERKAFIVELRQLSRVNHPNIVKLYGACLN--P-VCLV   77 (307)
T ss_dssp             CCGGGEEEEEEEECCSSSEEEEEEETTEEEEEEECSS----TTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT--T-TEEE
T ss_pred             CCHhHeeeeeEeecCCCceEEEEEECCeeEEEEEecC----hhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--C-cEEE
Confidence            45678999999999999999996    5799999863    2344568899999999999999999998763  3 7899


Q ss_pred             EeccCCCCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHh---cCcccCCccCCcEEEccCCc-EEEEccCCccccc
Q 012887          263 TKLMEGGSVNDLILKSR---KLQTKEIIRIAIDVAEGIKFLND---HGVAYRDLNSQRILLDRHGN-VCLGDMGIVTACK  335 (454)
Q Consensus       263 ~E~~~~gsL~~~l~~~~---~l~~~~~~~i~~qI~~gL~yLH~---~~iiHrDIKp~NILl~~~~~-vKL~DFGla~~~~  335 (454)
                      |||+++|+|.+++....   .++...+..++.||+.||.|||+   +||+||||||+|||++.++. +||+|||++....
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~  157 (307)
T 2eva_A           78 MEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ  157 (307)
T ss_dssp             EECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-----
T ss_pred             EEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccc
Confidence            99999999999997654   47899999999999999999999   89999999999999998886 7999999987543


Q ss_pred             cCCCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHHHcCCCCCCCCCcc
Q 012887          336 SVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSP-VQAAVGIAACGLRPEIPKDCP  414 (454)
Q Consensus       336 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~-~~~~~~i~~~~~~~~~p~~~~  414 (454)
                      ..   .....||+.|+|||.+.+..    ++.++||||||+++|+|++|..||..... ..........+.++..+..+|
T Consensus       158 ~~---~~~~~gt~~y~aPE~~~~~~----~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (307)
T 2eva_A          158 TH---MTNNKGSAAWMAPEVFEGSN----YSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLP  230 (307)
T ss_dssp             ----------CCTTSSCHHHHTCCC----CCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTCC
T ss_pred             cc---cccCCCCCceEChhhhCCCC----CCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCcccccC
Confidence            32   23346899999999998764    45579999999999999999999986432 222333344566777888899


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCCC
Q 012887          415 QILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNIS  449 (454)
Q Consensus       415 ~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~  449 (454)
                      +.+.++|.+||+.||.+|||+.+++++|..+....
T Consensus       231 ~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  265 (307)
T 2eva_A          231 KPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF  265 (307)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGC
T ss_pred             HHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhc
Confidence            99999999999999999999999999999887654

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=1e-43  Score=352.59  Aligned_cols=248  Identities=17%  Similarity=0.280  Sum_probs=211.5

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCc----hHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGN----AYEFELRKDLLELMTCGHKNILQFYCVCVDENHGL  259 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~----~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l  259 (454)
                      ++|++.+.||+|+||.||++      +.+|+|.+.......    .....+.+|+.++..++||||+++++++.+.+. +
T Consensus        12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~   90 (321)
T 2a2a_A           12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD-V   90 (321)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE-E
T ss_pred             ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE-E
Confidence            67899999999999999995      479999997543322    135668899999999999999999999987765 9


Q ss_pred             EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCC----cEEEEccCCccccc
Q 012887          260 CVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG----NVCLGDMGIVTACK  335 (454)
Q Consensus       260 ~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~----~vKL~DFGla~~~~  335 (454)
                      ++||||+++++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++    .+||+|||++....
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~  170 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE  170 (321)
T ss_dssp             EEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECC
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceecC
Confidence            99999999999999998878899999999999999999999999999999999999999888    79999999987665


Q ss_pred             cCCCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCC--CCCCCc
Q 012887          336 SVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP--EIPKDC  413 (454)
Q Consensus       336 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~--~~p~~~  413 (454)
                      ... ......+|+.|+|||.+.+..    ++.++||||||+++|+|++|..||.+.+.......+.......  ..+..+
T Consensus       171 ~~~-~~~~~~gt~~y~aPE~~~~~~----~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  245 (321)
T 2a2a_A          171 DGV-EFKNIFGTPEFVAPEIVNYEP----LGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHT  245 (321)
T ss_dssp             TTC-CCCCCCSCGGGCCHHHHTTCC----CCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTC
T ss_pred             ccc-cccccCCCCCccCcccccCCC----CCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhccc
Confidence            432 233456899999999998764    4556999999999999999999999888777666665433221  123568


Q ss_pred             cHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 012887          414 PQILKSLMIKCWNNSPSKRPQFSEIISLLL  443 (454)
Q Consensus       414 ~~~l~~li~~cl~~dP~~RPs~~ell~~L~  443 (454)
                      ++.+.++|.+||+.||.+|||+.|++++-+
T Consensus       246 ~~~~~~li~~~l~~dp~~Rps~~e~l~hp~  275 (321)
T 2a2a_A          246 SELAKDFIRKLLVKETRKRLTIQEALRHPW  275 (321)
T ss_dssp             CHHHHHHHHTTSCSSTTTSCCHHHHHHSTT
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHhcCcc
Confidence            899999999999999999999999998754

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=6.2e-44  Score=363.70  Aligned_cols=249  Identities=20%  Similarity=0.303  Sum_probs=197.2

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCC-CCceeEEEEEEEeCC-CeEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCG-HKNILQFYCVCVDEN-HGLCV  261 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~~~g~~~~~~-~~l~l  261 (454)
                      ++|++++.||+|+||.||+|      +.||+|++............+.+|+.++..+. ||||+++++++...+ ..+|+
T Consensus         9 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l   88 (388)
T 3oz6_A            9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYL   88 (388)
T ss_dssp             TTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEE
T ss_pred             CceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEE
Confidence            68999999999999999986      57999999755455556667889999999997 999999999998654 34899


Q ss_pred             EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCC---
Q 012887          262 VTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG---  338 (454)
Q Consensus       262 V~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~---  338 (454)
                      ||||+++ +|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......   
T Consensus        89 v~e~~~~-~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~  166 (388)
T 3oz6_A           89 VFDYMET-DLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVT  166 (388)
T ss_dssp             EEECCSE-EHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCCC
T ss_pred             EecccCc-CHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccccccccc
Confidence            9999974 99999865 579999999999999999999999999999999999999999999999999987653211   


Q ss_pred             ------------------CcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Q 012887          339 ------------------EATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGI  400 (454)
Q Consensus       339 ------------------~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i  400 (454)
                                        .......||+.|+|||++.+..   .++.++|||||||++|||++|.+||.+.+.......+
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i  243 (388)
T 3oz6_A          167 NNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGST---KYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERI  243 (388)
T ss_dssp             CCGGGCCC---------------CCCGGGGCCHHHHTTCC---CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred             ccccccccccccccccccccccCCcccCCcCCHHHhcCCC---CCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence                              1122346889999999997632   3566799999999999999999999998877666555


Q ss_pred             HHcCCCC---------------------------------------------CCCCCccHHHHHHHHHhcccCCCCCCCH
Q 012887          401 AACGLRP---------------------------------------------EIPKDCPQILKSLMIKCWNNSPSKRPQF  435 (454)
Q Consensus       401 ~~~~~~~---------------------------------------------~~p~~~~~~l~~li~~cl~~dP~~RPs~  435 (454)
                      ......+                                             ..+..+++++.+||.+||+.||.+|||+
T Consensus       244 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~  323 (388)
T 3oz6_A          244 IGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISA  323 (388)
T ss_dssp             HHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred             HHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCH
Confidence            4211111                                             0122678999999999999999999999


Q ss_pred             HHHHHHHH
Q 012887          436 SEIISLLL  443 (454)
Q Consensus       436 ~ell~~L~  443 (454)
                      .|+++|-+
T Consensus       324 ~e~l~Hp~  331 (388)
T 3oz6_A          324 NDALKHPF  331 (388)
T ss_dssp             HHHTTSTT
T ss_pred             HHHhCCHH
Confidence            99999854

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=9e-44  Score=363.67  Aligned_cols=247  Identities=15%  Similarity=0.313  Sum_probs=211.3

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  263 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~  263 (454)
                      ++|++++.||+|+||.||+|      +.+|+|.+....  ......+.+|+.++..++||||+++++++.+.+. +++||
T Consensus        51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~-~~lv~  127 (387)
T 1kob_A           51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYE-MVLIL  127 (387)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSE-EEEEE
T ss_pred             cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc--hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCE-EEEEE
Confidence            67999999999999999996      468999987432  2344568899999999999999999999987765 99999


Q ss_pred             eccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEcc--CCcEEEEccCCccccccCCCc
Q 012887          264 KLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDR--HGNVCLGDMGIVTACKSVGEA  340 (454)
Q Consensus       264 E~~~~gsL~~~l~~~~-~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~--~~~vKL~DFGla~~~~~~~~~  340 (454)
                      ||+++|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.  .+.+||+|||++....... .
T Consensus       128 E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~-~  206 (387)
T 1kob_A          128 EFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE-I  206 (387)
T ss_dssp             ECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS-C
T ss_pred             EcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCc-c
Confidence            9999999999986544 7999999999999999999999999999999999999974  4679999999988765432 2


Q ss_pred             ccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCC--CCCCCccHHHH
Q 012887          341 TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP--EIPKDCPQILK  418 (454)
Q Consensus       341 ~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~--~~p~~~~~~l~  418 (454)
                      .....+|+.|+|||++.+..    ++.++|||||||++|+|++|..||.+.+.......+.......  ..+..+++++.
T Consensus       207 ~~~~~gt~~y~aPE~~~~~~----~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  282 (387)
T 1kob_A          207 VKVTTATAEFAAPEIVDREP----VGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAK  282 (387)
T ss_dssp             EEEECSSGGGCCHHHHTTCC----BCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHH
T ss_pred             eeeeccCCCccCchhccCCC----CCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHH
Confidence            34457899999999998764    4556999999999999999999999988877777776654432  33457899999


Q ss_pred             HHHHHhcccCCCCCCCHHHHHHHHHh
Q 012887          419 SLMIKCWNNSPSKRPQFSEIISLLLR  444 (454)
Q Consensus       419 ~li~~cl~~dP~~RPs~~ell~~L~~  444 (454)
                      ++|.+||+.||.+|||+.|++++-+-
T Consensus       283 ~li~~~L~~dP~~Rpt~~ell~hp~~  308 (387)
T 1kob_A          283 DFIKNLLQKEPRKRLTVHDALEHPWL  308 (387)
T ss_dssp             HHHHTTSCSSGGGSCCHHHHHTSTTT
T ss_pred             HHHHHHcCCChhHCcCHHHHhhCccc
Confidence            99999999999999999999998654

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1.7e-43  Score=345.21  Aligned_cols=246  Identities=17%  Similarity=0.291  Sum_probs=202.0

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  263 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~  263 (454)
                      ++|.+.+.||+|+||.||++      ..+|+|++..... ......+.+|+.++..++||||+++++++.+.+. +++||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~-~~lv~   99 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS-QVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHN-MYIVM   99 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC-CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE-EEEEE
T ss_pred             hheeecceeccCCCeEEEEEEEccCCceEEEEEeecccc-chhHHHHHHHHHHHHhCCCchHHhHHHheecCCe-EEEEE
Confidence            67899999999999999985      4799999875432 2334568899999999999999999999987765 99999


Q ss_pred             eccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEE---ccCCcEEEEccCCcccccc
Q 012887          264 KLMEGGSVNDLILK----SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILL---DRHGNVCLGDMGIVTACKS  336 (454)
Q Consensus       264 E~~~~gsL~~~l~~----~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl---~~~~~vKL~DFGla~~~~~  336 (454)
                      ||+++|+|.+++..    ...+++..+..++.||+.||+|||++||+||||||+|||+   +.++.+||+|||++.....
T Consensus       100 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~  179 (285)
T 3is5_A          100 ETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS  179 (285)
T ss_dssp             CCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC---
T ss_pred             EeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCC
Confidence            99999999998843    3689999999999999999999999999999999999999   4567899999999876544


Q ss_pred             CCCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCC-CCCccH
Q 012887          337 VGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEI-PKDCPQ  415 (454)
Q Consensus       337 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~-p~~~~~  415 (454)
                      .. ......+++.|+|||.+.+.     ++.++||||||+++|+|++|..||.+................... ...+++
T Consensus       180 ~~-~~~~~~~t~~y~aPE~~~~~-----~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (285)
T 3is5_A          180 DE-HSTNAAGTALYMAPEVFKRD-----VTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTP  253 (285)
T ss_dssp             --------CTTGGGCCHHHHTTC-----CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCCCH
T ss_pred             cc-cCcCcccccCcCChHHhccC-----CCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCcCCH
Confidence            32 23445689999999998642     556799999999999999999999988877766655554333222 234789


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 012887          416 ILKSLMIKCWNNSPSKRPQFSEIISLLL  443 (454)
Q Consensus       416 ~l~~li~~cl~~dP~~RPs~~ell~~L~  443 (454)
                      ++.++|.+||+.||.+|||+.|++++-+
T Consensus       254 ~~~~li~~~L~~dP~~Rps~~e~l~hp~  281 (285)
T 3is5_A          254 QAVDLLKQMLTKDPERRPSAAQVLHHEW  281 (285)
T ss_dssp             HHHHHHHHHTCSCTTTSCCHHHHHTSGG
T ss_pred             HHHHHHHHHccCChhhCcCHHHHhcCHH
Confidence            9999999999999999999999997643

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=9e-44  Score=346.09  Aligned_cols=250  Identities=17%  Similarity=0.306  Sum_probs=213.6

Q ss_pred             ecCCCEEEeceeeccCCceEEEe------EEEEEEEeecCCC-CchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeE
Q 012887          187 LNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDK-GNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGL  259 (454)
Q Consensus       187 ~~~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l  259 (454)
                      +..++|++.+.||+|+||.||++      +.+|+|.+..... .......+.+|+.++..++||||+++++++.+.+. .
T Consensus        11 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~   89 (284)
T 2vgo_A           11 FTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKR-I   89 (284)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE-E
T ss_pred             hhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCE-E
Confidence            44578999999999999999996      4699999864211 11123567899999999999999999999987765 9


Q ss_pred             EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCC
Q 012887          260 CVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE  339 (454)
Q Consensus       260 ~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~  339 (454)
                      ++||||+++++|.+++.+.+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......  
T Consensus        90 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~--  167 (284)
T 2vgo_A           90 YLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL--  167 (284)
T ss_dssp             EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS--
T ss_pred             EEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCccc--
Confidence            999999999999999987788999999999999999999999999999999999999999999999999998655432  


Q ss_pred             cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHHH
Q 012887          340 ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKS  419 (454)
Q Consensus       340 ~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~  419 (454)
                      ......+++.|+|||.+.+..+    +.++||||||+++|+|++|..||...........+..  ....+|..++.++.+
T Consensus       168 ~~~~~~~~~~y~aPE~~~~~~~----~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~  241 (284)
T 2vgo_A          168 RRRTMCGTLDYLPPEMIEGKTH----DEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVN--VDLKFPPFLSDGSKD  241 (284)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCB----CTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT--TCCCCCTTSCHHHHH
T ss_pred             ccccccCCCCcCCHHHhccCCC----CcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhc--cccCCCCcCCHHHHH
Confidence            2334568899999999987654    4459999999999999999999998777666555554  345577889999999


Q ss_pred             HHHHhcccCCCCCCCHHHHHHHHHhh
Q 012887          420 LMIKCWNNSPSKRPQFSEIISLLLRT  445 (454)
Q Consensus       420 li~~cl~~dP~~RPs~~ell~~L~~~  445 (454)
                      +|.+||+.||.+||++.+++++-+-.
T Consensus       242 li~~~l~~~p~~Rps~~~ll~h~~~~  267 (284)
T 2vgo_A          242 LISKLLRYHPPQRLPLKGVMEHPWVK  267 (284)
T ss_dssp             HHHHHSCSSGGGSCCHHHHHTCHHHH
T ss_pred             HHHHHhhcCHhhCCCHHHHhhCHHHH
Confidence            99999999999999999999876644

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.8e-43  Score=349.07  Aligned_cols=256  Identities=23%  Similarity=0.389  Sum_probs=206.6

Q ss_pred             ecCCCEEEeceeeccCCceEEEeE------EEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEEEEEEEeC----
Q 012887          187 LNSDNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVDE----  255 (454)
Q Consensus       187 ~~~~~~~~~~~LG~G~fG~Vy~g~------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~~~g~~~~~----  255 (454)
                      ...++|++++.||+|+||.||+|+      .||+|.+.....   ....+.+|+..+..+ +||||+++++++...    
T Consensus        21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~   97 (326)
T 2x7f_A           21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD---EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG   97 (326)
T ss_dssp             CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS---TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--C
T ss_pred             CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc---cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcc
Confidence            446889999999999999999964      699999874332   235677899999988 799999999999874    


Q ss_pred             -CCeEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCcc
Q 012887          256 -NHGLCVVTKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVT  332 (454)
Q Consensus       256 -~~~l~lV~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~  332 (454)
                       +..+++||||+++++|.+++...  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus        98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~  177 (326)
T 2x7f_A           98 MDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA  177 (326)
T ss_dssp             CCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC
T ss_pred             ccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCce
Confidence             23489999999999999999654  479999999999999999999999999999999999999999999999999987


Q ss_pred             ccccCCCcccccCCCCcccccccccCCCC-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCC
Q 012887          333 ACKSVGEATEYETDGYRWLAPEIIAGDPE-SVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPK  411 (454)
Q Consensus       333 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~-~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~  411 (454)
                      .............+++.|+|||++.+... ...++.++|||||||++|+|++|..||...........+.....+...+.
T Consensus       178 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  257 (326)
T 2x7f_A          178 QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSK  257 (326)
T ss_dssp             -------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCS
T ss_pred             ecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccccCCcc
Confidence            66543333444568999999999873211 22355679999999999999999999998888777666666555555567


Q ss_pred             CccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 012887          412 DCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRT  445 (454)
Q Consensus       412 ~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~  445 (454)
                      .++..+.++|.+||..||.+||++.+++++-+-.
T Consensus       258 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~  291 (326)
T 2x7f_A          258 KWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIR  291 (326)
T ss_dssp             CSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHH
T ss_pred             ccCHHHHHHHHHHhccChhhCCCHHHHhhChHHh
Confidence            7899999999999999999999999999976543

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=5.4e-44  Score=374.64  Aligned_cols=249  Identities=19%  Similarity=0.320  Sum_probs=216.8

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCC-chHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  262 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV  262 (454)
                      ++|++.+.||+|+||.||++      +.||+|.+...... ......+.+|+.++..++||||+++++++.+.+. +++|
T Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~-~~lv  104 (484)
T 3nyv_A           26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGY-FYLV  104 (484)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE-EEEE
T ss_pred             CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE-EEEE
Confidence            67999999999999999985      57999999754332 3345668899999999999999999999988776 9999


Q ss_pred             EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEE---ccCCcEEEEccCCccccccCCC
Q 012887          263 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILL---DRHGNVCLGDMGIVTACKSVGE  339 (454)
Q Consensus       263 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl---~~~~~vKL~DFGla~~~~~~~~  339 (454)
                      |||+.+|+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++....... 
T Consensus       105 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~-  183 (484)
T 3nyv_A          105 GEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK-  183 (484)
T ss_dssp             ECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCC-
T ss_pred             EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccccc-
Confidence            9999999999999888899999999999999999999999999999999999999   567899999999987665432 


Q ss_pred             cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCC--CCccHHH
Q 012887          340 ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIP--KDCPQIL  417 (454)
Q Consensus       340 ~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p--~~~~~~l  417 (454)
                      ......||+.|+|||++.+.     ++.++|||||||++|+|++|..||.+.+.......+.........|  ..+|+++
T Consensus       184 ~~~~~~gt~~y~aPE~~~~~-----~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  258 (484)
T 3nyv_A          184 KMKDKIGTAYYIAPEVLHGT-----YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESA  258 (484)
T ss_dssp             SHHHHTTGGGTCCHHHHHTC-----CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHH
T ss_pred             ccccCCCCccccCceeecCC-----CCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHH
Confidence            23345789999999999763     5567999999999999999999999998888888888776655544  4689999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 012887          418 KSLMIKCWNNSPSKRPQFSEIISLLLRT  445 (454)
Q Consensus       418 ~~li~~cl~~dP~~RPs~~ell~~L~~~  445 (454)
                      .+||.+||+.||.+|||+.|+++|-|-.
T Consensus       259 ~~li~~~L~~dp~~R~s~~e~l~h~~~~  286 (484)
T 3nyv_A          259 KDLIRKMLTYVPSMRISARDALDHEWIQ  286 (484)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHTSHHHH
T ss_pred             HHHHHHHCCCChhHCcCHHHHhhChhhc
Confidence            9999999999999999999999987754

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.1e-43  Score=357.68  Aligned_cols=247  Identities=19%  Similarity=0.250  Sum_probs=194.0

Q ss_pred             CCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEE
Q 012887          189 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  262 (454)
Q Consensus       189 ~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV  262 (454)
                      .++|++.+.||+|+||.||+|      +.||+|.++...    ....+.+|+.++..++||||+++++++.+.+. +++|
T Consensus        52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~lv  126 (349)
T 2w4o_A           52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTE-ISLV  126 (349)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEECSSE-EEEE
T ss_pred             cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCe-EEEE
Confidence            367999999999999999996      469999997432    23457789999999999999999999987765 9999


Q ss_pred             EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEcc---CCcEEEEccCCccccccCCC
Q 012887          263 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDR---HGNVCLGDMGIVTACKSVGE  339 (454)
Q Consensus       263 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~---~~~vKL~DFGla~~~~~~~~  339 (454)
                      |||+++|+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.   ++.+||+|||++....... 
T Consensus       127 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~-  205 (349)
T 2w4o_A          127 LELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV-  205 (349)
T ss_dssp             ECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC----------
T ss_pred             EEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCccc-
Confidence            999999999999987788999999999999999999999999999999999999976   8899999999987654322 


Q ss_pred             cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHHHcCCCC--CCCCCccHH
Q 012887          340 ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQ-AAVGIAACGLRP--EIPKDCPQI  416 (454)
Q Consensus       340 ~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~-~~~~i~~~~~~~--~~p~~~~~~  416 (454)
                      ......||+.|+|||++.+..    ++.++|||||||++|||++|..||....... ....+.......  +....++.+
T Consensus       206 ~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  281 (349)
T 2w4o_A          206 LMKTVCGTPGYCAPEILRGCA----YGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLN  281 (349)
T ss_dssp             -------CGGGSCHHHHTTCC----CCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHH
T ss_pred             ccccccCCCCccCHHHhcCCC----CCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHH
Confidence            233456899999999998764    4557999999999999999999998766555 333444433322  233578999


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 012887          417 LKSLMIKCWNNSPSKRPQFSEIISLLLRT  445 (454)
Q Consensus       417 l~~li~~cl~~dP~~RPs~~ell~~L~~~  445 (454)
                      +.+||.+||+.||.+|||+.|++++-+-.
T Consensus       282 ~~~li~~~L~~dP~~Rpt~~e~l~hp~~~  310 (349)
T 2w4o_A          282 AKDLVRKLIVLDPKKRLTTFQALQHPWVT  310 (349)
T ss_dssp             HHHHHHTTSCSSGGGSCCHHHHHHSTTTT
T ss_pred             HHHHHHHHccCChhhCcCHHHHhcCcccC
Confidence            99999999999999999999999976543

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=1.8e-43  Score=342.39  Aligned_cols=248  Identities=17%  Similarity=0.248  Sum_probs=211.6

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  263 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~  263 (454)
                      ++|++.+.||+|+||.||+|      ..+|+|++.......  ...+.+|+.++..++||||+++++++.+.+. .++||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~-~~lv~   85 (277)
T 3f3z_A            9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED--VDRFKQEIEIMKSLDHPNIIRLYETFEDNTD-IYLVM   85 (277)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHTCCCTTBCCEEEEEECSSE-EEEEE
T ss_pred             hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch--HHHHHHHHHHHHhCCCCCEeeEEEEEecCCe-EEEEE
Confidence            57899999999999999996      378999987543332  4567899999999999999999999987765 99999


Q ss_pred             eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEE---ccCCcEEEEccCCccccccCCCc
Q 012887          264 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILL---DRHGNVCLGDMGIVTACKSVGEA  340 (454)
Q Consensus       264 E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl---~~~~~vKL~DFGla~~~~~~~~~  340 (454)
                      ||+++++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++....... .
T Consensus        86 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~-~  164 (277)
T 3f3z_A           86 ELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK-M  164 (277)
T ss_dssp             ECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS-C
T ss_pred             eccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc-c
Confidence            999999999999887889999999999999999999999999999999999999   788999999999987654432 3


Q ss_pred             ccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCC--CCCccHHHH
Q 012887          341 TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEI--PKDCPQILK  418 (454)
Q Consensus       341 ~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~--p~~~~~~l~  418 (454)
                      .....+|+.|+|||.+.+.     ++.++||||||+++|+|++|..||...........+.......+.  ...+++.+.
T Consensus       165 ~~~~~~t~~y~aPE~~~~~-----~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (277)
T 3f3z_A          165 MRTKVGTPYYVSPQVLEGL-----YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAE  239 (277)
T ss_dssp             BCCCCSCTTTCCHHHHTTC-----BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHH
T ss_pred             hhccCCCCCccChHHhccc-----CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHHH
Confidence            3445689999999998754     445699999999999999999999998887777777665443221  126899999


Q ss_pred             HHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 012887          419 SLMIKCWNNSPSKRPQFSEIISLLLRTN  446 (454)
Q Consensus       419 ~li~~cl~~dP~~RPs~~ell~~L~~~~  446 (454)
                      ++|.+||+.||.+||++.+++++-+-..
T Consensus       240 ~li~~~l~~dp~~R~s~~~~l~h~~~~~  267 (277)
T 3f3z_A          240 SLIRRLLTKSPKQRITSLQALEHEWFEK  267 (277)
T ss_dssp             HHHHHHTCSSTTTSCCHHHHTTSHHHHH
T ss_pred             HHHHHHccCChhhCcCHHHHhcCHHHhc
Confidence            9999999999999999999998766433

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=7.2e-44  Score=352.57  Aligned_cols=243  Identities=18%  Similarity=0.271  Sum_probs=197.6

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEEEEEEEeCCCeEEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVDENHGLCVV  262 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~~~g~~~~~~~~l~lV  262 (454)
                      ++|++++.||+|+||.||+|      +.||||++...............|+..+..+ +||||++++++|.+.+. +++|
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~-~~lv  135 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGI-LYLQ  135 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE-EEEE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCE-EEEE
Confidence            67999999999999999995      5799999876555555555566666666554 89999999999988776 9999


Q ss_pred             EeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCcc
Q 012887          263 TKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT  341 (454)
Q Consensus       263 ~E~~~~gsL~~~l~~-~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~  341 (454)
                      |||+ +++|.+++.. ...+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||++....... ..
T Consensus       136 ~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~-~~  213 (311)
T 3p1a_A          136 TELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG-AG  213 (311)
T ss_dssp             EECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC------
T ss_pred             Eecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCC-CC
Confidence            9999 5699998855 4479999999999999999999999999999999999999999999999999987654432 23


Q ss_pred             cccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHHHHH
Q 012887          342 EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLM  421 (454)
Q Consensus       342 ~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~li  421 (454)
                      ....||+.|+|||++.+.     ++.++|||||||++|||++|..|+.+...   ...+.....++.++..+++++.++|
T Consensus       214 ~~~~gt~~y~aPE~~~~~-----~~~~~DiwslG~il~el~~g~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~l~~li  285 (311)
T 3p1a_A          214 EVQEGDPRYMAPELLQGS-----YGTAADVFSLGLTILEVACNMELPHGGEG---WQQLRQGYLPPEFTAGLSSELRSVL  285 (311)
T ss_dssp             -CCCCCGGGCCGGGGGTC-----CSTHHHHHHHHHHHHHHHHTCCCCSSHHH---HHHHTTTCCCHHHHTTSCHHHHHHH
T ss_pred             cccCCCccccCHhHhcCC-----CCchhhHHHHHHHHHHHHhCCCCCCCccH---HHHHhccCCCcccccCCCHHHHHHH
Confidence            445689999999998752     55679999999999999999776654322   2223333333445677899999999


Q ss_pred             HHhcccCCCCCCCHHHHHHHHH
Q 012887          422 IKCWNNSPSKRPQFSEIISLLL  443 (454)
Q Consensus       422 ~~cl~~dP~~RPs~~ell~~L~  443 (454)
                      .+||+.||.+|||+.|++++-+
T Consensus       286 ~~~L~~dP~~Rpt~~ell~hp~  307 (311)
T 3p1a_A          286 VMMLEPDPKLRATAEALLALPV  307 (311)
T ss_dssp             HHHSCSSTTTSCCHHHHHTSGG
T ss_pred             HHHcCCChhhCcCHHHHHhCcc
Confidence            9999999999999999998754

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=6.6e-44  Score=356.27  Aligned_cols=254  Identities=17%  Similarity=0.243  Sum_probs=208.1

Q ss_pred             CCCEEEeceeeccCCceEEEeE------EEEEEEeecCC---CCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeE
Q 012887          189 SDNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCD---KGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGL  259 (454)
Q Consensus       189 ~~~~~~~~~LG~G~fG~Vy~g~------~vavK~l~~~~---~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l  259 (454)
                      .++|++.+.||+|+||.||++.      .+|+|.+....   ........+.+|+.++..++||||+++++++.+.+. .
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~-~  103 (345)
T 3hko_A           25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQY-I  103 (345)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE-E
T ss_pred             hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCe-E
Confidence            3679999999999999999964      68999986431   123345678899999999999999999999988775 9


Q ss_pred             EEEEeccCCCCHHHHHHh----------------------------------------CCCCCHHHHHHHHHHHHHHHHH
Q 012887          260 CVVTKLMEGGSVNDLILK----------------------------------------SRKLQTKEIIRIAIDVAEGIKF  299 (454)
Q Consensus       260 ~lV~E~~~~gsL~~~l~~----------------------------------------~~~l~~~~~~~i~~qI~~gL~y  299 (454)
                      ++||||+++|+|.+++..                                        ...+++..+..++.||+.||.|
T Consensus       104 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~  183 (345)
T 3hko_A          104 CLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHY  183 (345)
T ss_dssp             EEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHH
Confidence            999999999999999841                                        1124677889999999999999


Q ss_pred             HHhcCcccCCccCCcEEEccCC--cEEEEccCCccccccCCC----cccccCCCCcccccccccCCCCCCCCCchhhHHH
Q 012887          300 LNDHGVAYRDLNSQRILLDRHG--NVCLGDMGIVTACKSVGE----ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYS  373 (454)
Q Consensus       300 LH~~~iiHrDIKp~NILl~~~~--~vKL~DFGla~~~~~~~~----~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwS  373 (454)
                      ||++||+||||||+|||++.++  .+||+|||++........    ......+|+.|+|||.+.+..  ..++.++||||
T Consensus       184 LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~~Diws  261 (345)
T 3hko_A          184 LHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTN--ESYGPKCDAWS  261 (345)
T ss_dssp             HHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSS--SCCCTHHHHHH
T ss_pred             HHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCC--CCCCcHHHHHH
Confidence            9999999999999999998776  899999999876543222    123446899999999997532  23566799999


Q ss_pred             HHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCC--CccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 012887          374 FGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPK--DCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRT  445 (454)
Q Consensus       374 lGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~--~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~  445 (454)
                      |||++|+|++|..||.+.+.......+.........+.  .+++++.++|.+||+.||.+||++.+++++-+--
T Consensus       262 lG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~  335 (345)
T 3hko_A          262 AGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWIS  335 (345)
T ss_dssp             HHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHH
T ss_pred             HHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhc
Confidence            99999999999999999888888877777655544433  4799999999999999999999999999986543

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1.9e-43  Score=372.76  Aligned_cols=250  Identities=18%  Similarity=0.288  Sum_probs=211.8

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCc-----------hHHHHHHHHHHHHHhCCCCceeEEEEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGN-----------AYEFELRKDLLELMTCGHKNILQFYCVC  252 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~-----------~~~~~~~~Ei~~l~~l~HpnIv~~~g~~  252 (454)
                      ++|++++.||+|+||.||++      +.+|+|.+.......           .....+.+|+.++..++||||+++++++
T Consensus        36 ~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~  115 (504)
T 3q5i_A           36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVF  115 (504)
T ss_dssp             GTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             cceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence            67999999999999999986      479999987543221           2345688999999999999999999999


Q ss_pred             EeCCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCC---cEEEEccC
Q 012887          253 VDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG---NVCLGDMG  329 (454)
Q Consensus       253 ~~~~~~l~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~---~vKL~DFG  329 (454)
                      .+.+. +++|||||++|+|.+++.+.+.+++..+..++.||+.||.|||++||+||||||+|||++.++   .+||+|||
T Consensus       116 ~~~~~-~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg  194 (504)
T 3q5i_A          116 EDKKY-FYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFG  194 (504)
T ss_dssp             ECSSE-EEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCCT
T ss_pred             EcCCE-EEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEECC
Confidence            88776 999999999999999998878899999999999999999999999999999999999999876   69999999


Q ss_pred             CccccccCCCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCC
Q 012887          330 IVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEI  409 (454)
Q Consensus       330 la~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~  409 (454)
                      ++....... ......||+.|+|||++.+.     ++.++|||||||++|+|++|..||.+.+.......+.........
T Consensus       195 ~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~-----~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~  268 (504)
T 3q5i_A          195 LSSFFSKDY-KLRDRLGTAYYIAPEVLKKK-----YNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDF  268 (504)
T ss_dssp             TCEECCTTS-CBCCCCSCTTTCCHHHHTTC-----BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCH
T ss_pred             CCEEcCCCC-ccccccCCcCCCCHHHhccC-----CCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc
Confidence            988665432 23445789999999998742     456799999999999999999999998888888777776554332


Q ss_pred             C--CCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 012887          410 P--KDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTN  446 (454)
Q Consensus       410 p--~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~  446 (454)
                      +  ..+|+++.+||.+||+.||.+|||+.|+++|-|-..
T Consensus       269 ~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~  307 (504)
T 3q5i_A          269 NDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKK  307 (504)
T ss_dssp             HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred             cccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhh
Confidence            2  568999999999999999999999999999877543

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=1.2e-43  Score=353.47  Aligned_cols=249  Identities=16%  Similarity=0.226  Sum_probs=204.1

Q ss_pred             CCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEEEEEEEeCCCeEEE
Q 012887          189 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVDENHGLCV  261 (454)
Q Consensus       189 ~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~~~g~~~~~~~~l~l  261 (454)
                      .++|++.+.||+|+||.||+|      +.||+|.+......    ..+.+|+.++..+ +||||+++++++.+.+. .++
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~-~~l   82 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA----PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKY-NAM   82 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS----CCHHHHHHHHHHHCSCTTSCCEEEEEEETTE-EEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch----HHHHHHHHHHHHhhCCCCCCEEEEEEecCCc-cEE
Confidence            488999999999999999986      57999998754322    2467899999999 89999999999988775 899


Q ss_pred             EEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCc-----EEEEccCCccccc
Q 012887          262 VTKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGN-----VCLGDMGIVTACK  335 (454)
Q Consensus       262 V~E~~~~gsL~~~l~~-~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~-----vKL~DFGla~~~~  335 (454)
                      ||||+ +++|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++.++.     +||+|||++....
T Consensus        83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~  161 (330)
T 2izr_A           83 VLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI  161 (330)
T ss_dssp             EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESB
T ss_pred             EEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeee
Confidence            99999 8899999976 468999999999999999999999999999999999999999887     9999999998654


Q ss_pred             cCCCc-------ccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHHHcCC
Q 012887          336 SVGEA-------TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSP---VQAAVGIAACGL  405 (454)
Q Consensus       336 ~~~~~-------~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~---~~~~~~i~~~~~  405 (454)
                      .....       .....||+.|+|||++.+..    ++.++|||||||++|||++|..||.+.+.   .+....+.....
T Consensus       162 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~  237 (330)
T 2izr_A          162 DPETKKHIPYREHKSLTGTARYMSINTHLGKE----QSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKR  237 (330)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC----CCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHH
T ss_pred             cCCCCccccccccCCcCCCccccChHHHcCCC----CCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhc
Confidence            43221       23457899999999998764    45579999999999999999999987433   233333322111


Q ss_pred             CC---CCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCC
Q 012887          406 RP---EIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNI  448 (454)
Q Consensus       406 ~~---~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~  448 (454)
                      ..   .....+| ++.+++..||+.||.+||++.+|.+.|..+.+.
T Consensus       238 ~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~  282 (330)
T 2izr_A          238 ATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDR  282 (330)
T ss_dssp             HSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             cCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHH
Confidence            11   1223456 999999999999999999999999999877654

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=4.8e-44  Score=356.44  Aligned_cols=253  Identities=23%  Similarity=0.371  Sum_probs=207.3

Q ss_pred             cCCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEE
Q 012887          188 NSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCV  261 (454)
Q Consensus       188 ~~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~l  261 (454)
                      ..++|++++.||+|+||.||++      +.||+|++............+.+|+.++..++||||+++++++.+.+. .++
T Consensus        23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~l  101 (331)
T 4aaa_A           23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKR-WYL  101 (331)
T ss_dssp             CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE-EEE
T ss_pred             hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCE-EEE
Confidence            4478999999999999999985      479999997665555556668899999999999999999999998776 999


Q ss_pred             EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCcc
Q 012887          262 VTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT  341 (454)
Q Consensus       262 V~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~  341 (454)
                      ||||+++++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..........
T Consensus       102 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  181 (331)
T 4aaa_A          102 VFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY  181 (331)
T ss_dssp             EEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC----------
T ss_pred             EEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCcccc
Confidence            99999999999988777789999999999999999999999999999999999999999999999999987765544444


Q ss_pred             cccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcC-----------------
Q 012887          342 EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG-----------------  404 (454)
Q Consensus       342 ~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~-----------------  404 (454)
                      ....+++.|+|||.+.+..   .++.++|||||||++|+|++|..||.+.........+....                 
T Consensus       182 ~~~~~t~~y~aPE~~~~~~---~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (331)
T 4aaa_A          182 DDEVATRWYRAPELLVGDV---KYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVF  258 (331)
T ss_dssp             --CCCCCTTCCHHHHTTCT---TCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGG
T ss_pred             CCCcCCccccCcccccCCC---CcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccc
Confidence            5567899999999997642   34567999999999999999999999888766555443210                 


Q ss_pred             --CCC-C---------CCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 012887          405 --LRP-E---------IPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR  444 (454)
Q Consensus       405 --~~~-~---------~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~  444 (454)
                        ... .         ....+++.+.+||.+||+.||.+|||+.|++++-+-
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f  310 (331)
T 4aaa_A          259 AGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFF  310 (331)
T ss_dssp             TTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHH
T ss_pred             ccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchh
Confidence              010 0         113578999999999999999999999999987654

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.8e-43  Score=342.34  Aligned_cols=243  Identities=18%  Similarity=0.325  Sum_probs=205.8

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEEEEEEEeCCCeEEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVDENHGLCVV  262 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~~~g~~~~~~~~l~lV  262 (454)
                      ++|++++.||+|+||.||++      +.||+|.+............+.+|+..+..+ +||||+++++++.+.+. +++|
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~-~~lv   89 (289)
T 1x8b_A           11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDH-MLIQ   89 (289)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTE-EEEE
T ss_pred             chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCe-EEEE
Confidence            67899999999999999995      5799999987656666677788999999998 89999999999988776 9999


Q ss_pred             EeccCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccC------------------
Q 012887          263 TKLMEGGSVNDLILKS----RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH------------------  320 (454)
Q Consensus       263 ~E~~~~gsL~~~l~~~----~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~------------------  320 (454)
                      |||+++++|.+++.+.    ..+++..+..++.||+.||.|||++||+||||||+|||++.+                  
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~  169 (289)
T 1x8b_A           90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASN  169 (289)
T ss_dssp             EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------
T ss_pred             EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCC
Confidence            9999999999999653    679999999999999999999999999999999999999844                  


Q ss_pred             -CcEEEEccCCccccccCCCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH
Q 012887          321 -GNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVG  399 (454)
Q Consensus       321 -~~vKL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~  399 (454)
                       ..+||+|||++......    ....+|+.|+|||.+.+..   .++.++|||||||++|+|++|.+|+......    .
T Consensus       170 ~~~~kl~Dfg~~~~~~~~----~~~~gt~~y~aPE~~~~~~---~~~~~~Di~slG~il~~l~~~~~~~~~~~~~----~  238 (289)
T 1x8b_A          170 KVMFKIGDLGHVTRISSP----QVEEGDSRFLANEVLQENY---THLPKADIFALALTVVCAAGAEPLPRNGDQW----H  238 (289)
T ss_dssp             CCCEEECCCTTCEETTCS----CCCCCCGGGCCHHHHTTCC---TTHHHHHHHHHHHHHHHHTTCCCCCSSSHHH----H
T ss_pred             ceEEEEcccccccccCCc----cccCCCccccChhHhcCCC---CCCchhhHHHHHHHHHHHhcCCCCCcchhHH----H
Confidence             47999999998765432    2345899999999997642   2445799999999999999998877554322    2


Q ss_pred             HHHcCCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 012887          400 IAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR  444 (454)
Q Consensus       400 i~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~  444 (454)
                      ....+..+.+|..+++++.++|.+||+.||.+|||+.+++++-+-
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~  283 (289)
T 1x8b_A          239 EIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVL  283 (289)
T ss_dssp             HHHTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC
T ss_pred             HHHcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHh
Confidence            233455667888999999999999999999999999999987553

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.5e-43  Score=350.84  Aligned_cols=259  Identities=14%  Similarity=0.200  Sum_probs=205.7

Q ss_pred             cCCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCC-CeEE
Q 012887          188 NSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN-HGLC  260 (454)
Q Consensus       188 ~~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~-~~l~  260 (454)
                      ..++|++.+.||+|+||.||+|      +.||+|.+...... .....+.+|+.++..++||||+++++++...+ ..++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   85 (319)
T 4euu_A            7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL-RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV   85 (319)
T ss_dssp             SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG-SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred             CCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEecccccc-chHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEE
Confidence            3478999999999999999985      57999998743322 22455679999999999999999999998765 2489


Q ss_pred             EEEeccCCCCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEE----ccCCcEEEEccCCccc
Q 012887          261 VVTKLMEGGSVNDLILKSR---KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILL----DRHGNVCLGDMGIVTA  333 (454)
Q Consensus       261 lV~E~~~~gsL~~~l~~~~---~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl----~~~~~vKL~DFGla~~  333 (454)
                      +||||+++++|.+++....   .+++..+..++.||+.||.|||++||+||||||+|||+    +.++.+||+|||++..
T Consensus        86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~  165 (319)
T 4euu_A           86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE  165 (319)
T ss_dssp             EEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred             EEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence            9999999999999996543   39999999999999999999999999999999999999    7788899999999987


Q ss_pred             cccCCCcccccCCCCcccccccccCC----CCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCH----HHHHHHHHHcCC
Q 012887          334 CKSVGEATEYETDGYRWLAPEIIAGD----PESVSETWMSNVYSFGMVIWEMVTGEAAYAACSP----VQAAVGIAACGL  405 (454)
Q Consensus       334 ~~~~~~~~~~~~gt~~y~APE~l~~~----~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~----~~~~~~i~~~~~  405 (454)
                      ...... .....+|+.|+|||++...    .....++.++|||||||++|||++|..||.....    ......+.....
T Consensus       166 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p  244 (319)
T 4euu_A          166 LEDDEQ-FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP  244 (319)
T ss_dssp             CCTTCC-BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCC
T ss_pred             cCCCCc-eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCC
Confidence            654332 3345689999999988621    1122355679999999999999999999974322    334444443221


Q ss_pred             CC-----------------------CCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCC
Q 012887          406 RP-----------------------EIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNI  448 (454)
Q Consensus       406 ~~-----------------------~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~  448 (454)
                      ..                       .++..++..+.++|.+||+.||.+|||+.|++++.......
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~~  310 (319)
T 4euu_A          245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR  310 (319)
T ss_dssp             TTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC-
T ss_pred             cccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhhc
Confidence            10                       12234567899999999999999999999999999876543

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=2.9e-43  Score=346.80  Aligned_cols=250  Identities=18%  Similarity=0.273  Sum_probs=200.6

Q ss_pred             CCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCC---chHHHHHHHHHHHHHhC---CCCceeEEEEEEEeCC
Q 012887          189 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG---NAYEFELRKDLLELMTC---GHKNILQFYCVCVDEN  256 (454)
Q Consensus       189 ~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~---~~~~~~~~~Ei~~l~~l---~HpnIv~~~g~~~~~~  256 (454)
                      .++|++++.||+|+||.||++      +.||+|.+......   ......+.+|+.++..+   +||||+++++++....
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~   87 (308)
T 3g33_A            8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR   87 (308)
T ss_dssp             --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence            478999999999999999996      47999998743211   11223455666665554   5999999999998765


Q ss_pred             C----eEEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCC
Q 012887          257 H----GLCVVTKLMEGGSVNDLILKSR--KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGI  330 (454)
Q Consensus       257 ~----~l~lV~E~~~~gsL~~~l~~~~--~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGl  330 (454)
                      .    .+++||||+.+ +|.+++....  .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus        88 ~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~  166 (308)
T 3g33_A           88 TDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGL  166 (308)
T ss_dssp             SSSEEEEEEEEECCCC-BHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCSC
T ss_pred             CCCceeEEEEehhhhc-CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCcc
Confidence            2    37999999975 9999997654  499999999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcC-CCC--
Q 012887          331 VTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG-LRP--  407 (454)
Q Consensus       331 a~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~-~~~--  407 (454)
                      +....... ......+|+.|+|||++.+..+    +.++|||||||++|+|++|..||.+.+.......+.... ..+  
T Consensus       167 a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~----~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  241 (308)
T 3g33_A          167 ARIYSYQM-ALTPVVVTLWYRAPEVLLQSTY----ATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPED  241 (308)
T ss_dssp             TTTSTTCC-CSGGGGCCCSSCCHHHHHTSCC----CSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred             ccccCCCc-ccCCccccccccCchHHcCCCC----CchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence            87654332 2344578999999999987654    445999999999999999999999988877666554321 110  


Q ss_pred             C----------------------CCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 012887          408 E----------------------IPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR  444 (454)
Q Consensus       408 ~----------------------~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~  444 (454)
                      .                      ....+++++.+||.+||+.||.+|||+.|+++|-+-
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~  300 (308)
T 3g33_A          242 DWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYL  300 (308)
T ss_dssp             TSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC
T ss_pred             hccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccc
Confidence            0                      123578999999999999999999999999987653

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=5.5e-44  Score=389.66  Aligned_cols=252  Identities=20%  Similarity=0.268  Sum_probs=214.1

Q ss_pred             eeecCCCEEEeceeeccCCceEEEeE------EEEEEEeecCCC-CchHHHHHHHHHHHHHhC-CCCceeEEEEEEEeCC
Q 012887          185 WLLNSDNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDK-GNAYEFELRKDLLELMTC-GHKNILQFYCVCVDEN  256 (454)
Q Consensus       185 ~~~~~~~~~~~~~LG~G~fG~Vy~g~------~vavK~l~~~~~-~~~~~~~~~~Ei~~l~~l-~HpnIv~~~g~~~~~~  256 (454)
                      ..+..++|++++.||+|+||.||+++      .||+|+++.... .......+..|..++..+ +||||+++++++.+.+
T Consensus       336 ~~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~  415 (674)
T 3pfq_A          336 DRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD  415 (674)
T ss_dssp             ----CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSS
T ss_pred             ccccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCC
Confidence            34566899999999999999999864      699999974211 111234466788888876 7999999999998777


Q ss_pred             CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCcccccc
Q 012887          257 HGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS  336 (454)
Q Consensus       257 ~~l~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~  336 (454)
                      . +|+||||+++|+|.+++.+.+.+++..+..|+.||+.||+|||++||+||||||+|||++.+|++||+|||+++....
T Consensus       416 ~-~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~  494 (674)
T 3pfq_A          416 R-LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW  494 (674)
T ss_dssp             E-EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCC
T ss_pred             E-EEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeecccc
Confidence            6 999999999999999998878999999999999999999999999999999999999999999999999999986554


Q ss_pred             CCCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHH
Q 012887          337 VGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQI  416 (454)
Q Consensus       337 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~  416 (454)
                      .........||+.|+|||++.+..+    +.++|||||||+||||++|..||.+.+..+....+...  ...+|..++++
T Consensus       495 ~~~~~~~~~GT~~Y~APE~l~~~~~----~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~  568 (674)
T 3pfq_A          495 DGVTTKTFCGTPDYIAPEIIAYQPY----GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH--NVAYPKSMSKE  568 (674)
T ss_dssp             TTCCBCCCCSCSSSCCHHHHTCCCB----STHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSS--CCCCCTTSCHH
T ss_pred             CCcccccccCCCcccCHhhhcCCCC----CccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhC--CCCCCccCCHH
Confidence            4445566689999999999987654    45699999999999999999999998888877777754  45678899999


Q ss_pred             HHHHHHHhcccCCCCCCCH-----HHHHHHHH
Q 012887          417 LKSLMIKCWNNSPSKRPQF-----SEIISLLL  443 (454)
Q Consensus       417 l~~li~~cl~~dP~~RPs~-----~ell~~L~  443 (454)
                      +.+||++||+.||.+||++     .||++|-+
T Consensus       569 ~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~f  600 (674)
T 3pfq_A          569 AVAICKGLMTKHPGKRLGCGPEGERDIKEHAF  600 (674)
T ss_dssp             HHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGG
T ss_pred             HHHHHHHHccCCHHHCCCCCCCcHHHHhcCcc
Confidence            9999999999999999997     88877643

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1.5e-44  Score=358.22  Aligned_cols=258  Identities=23%  Similarity=0.375  Sum_probs=208.4

Q ss_pred             cCCCEEEeceeeccCCceEEEe-----EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEE
Q 012887          188 NSDNLEFIDQIGPNSFKGVYKG-----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  262 (454)
Q Consensus       188 ~~~~~~~~~~LG~G~fG~Vy~g-----~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV  262 (454)
                      ..++|++.+.||+|+||.||+|     +.||+|++....  ......+.+|+.++..++||||+++++++.+.+. +++|
T Consensus        37 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~lv  113 (321)
T 2qkw_B           37 ATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPES--SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNE-MILI  113 (321)
T ss_dssp             CCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCC--SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTC-CEEE
T ss_pred             HHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCe-EEEE
Confidence            4478999999999999999995     589999886532  2344568899999999999999999999987776 8999


Q ss_pred             EeccCCCCHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCC
Q 012887          263 TKLMEGGSVNDLILKSR----KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG  338 (454)
Q Consensus       263 ~E~~~~gsL~~~l~~~~----~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~  338 (454)
                      |||+++|+|.+++....    .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus       114 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  193 (321)
T 2qkw_B          114 YKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELD  193 (321)
T ss_dssp             EECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSS
T ss_pred             EEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccccccccccc
Confidence            99999999999985432    58999999999999999999999999999999999999999999999999987644322


Q ss_pred             C--cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHH------HHHHHHc-------
Q 012887          339 E--ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQA------AVGIAAC-------  403 (454)
Q Consensus       339 ~--~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~------~~~i~~~-------  403 (454)
                      .  ......||+.|+|||++.+..    ++.++|||||||++|||++|..||....+...      .......       
T Consensus       194 ~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (321)
T 2qkw_B          194 QTHLSTVVKGTLGYIDPEYFIKGR----LTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIV  269 (321)
T ss_dssp             CCCCBCCCEEETTTCCHHHHHHCB----CCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSS
T ss_pred             ccccccccCCCccccCHHHhcCCC----CCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhc
Confidence            1  123335788999999997664    45569999999999999999999976443211      1111111       


Q ss_pred             --CCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCCCCCC
Q 012887          404 --GLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNSS  452 (454)
Q Consensus       404 --~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~~~  452 (454)
                        .....++..++..+.+++.+||+.||.+|||+.|++++|+.+....++.
T Consensus       270 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~~~~  320 (321)
T 2qkw_B          270 DPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQESV  320 (321)
T ss_dssp             SSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSCCC
T ss_pred             ChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhcccCc
Confidence              1111233446788999999999999999999999999999988766553

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=1.1e-43  Score=343.14  Aligned_cols=256  Identities=17%  Similarity=0.244  Sum_probs=209.7

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  263 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~  263 (454)
                      ++|++++.||+|+||.||++      +.||+|.+..... ......+.+|+.++..++||||+++++++.+.+. .++||
T Consensus         7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~lv~   84 (276)
T 2yex_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNI-QYLFL   84 (276)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC-TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE-EEEEE
T ss_pred             cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc-hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCE-EEEEE
Confidence            57899999999999999986      5799999874332 3345668899999999999999999999988775 89999


Q ss_pred             eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCC--Ccc
Q 012887          264 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG--EAT  341 (454)
Q Consensus       264 E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~--~~~  341 (454)
                      ||+++++|.+++.....+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++.......  ...
T Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  164 (276)
T 2yex_A           85 EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL  164 (276)
T ss_dssp             ECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred             EecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhcc
Confidence            999999999998777789999999999999999999999999999999999999999999999999987654322  123


Q ss_pred             cccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHHHcCCCCCCCCCccHHHHHH
Q 012887          342 EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQ-AAVGIAACGLRPEIPKDCPQILKSL  420 (454)
Q Consensus       342 ~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~-~~~~i~~~~~~~~~p~~~~~~l~~l  420 (454)
                      ....+++.|+|||.+.+..+   .+.++||||||+++|+|++|..||....... ....+.........+..+++.+.++
T Consensus       165 ~~~~~~~~y~aPE~~~~~~~---~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  241 (276)
T 2yex_A          165 NKMCGTLPYVAPELLKRREF---HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL  241 (276)
T ss_dssp             CCCCSCGGGCCGGGGTCSSB---CHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHH
T ss_pred             cCCccccCccChHHHhcCCC---CCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHH
Confidence            34568899999999986543   2457999999999999999999998755432 2223333222223345689999999


Q ss_pred             HHHhcccCCCCCCCHHHHHHHHHhhcCCCC
Q 012887          421 MIKCWNNSPSKRPQFSEIISLLLRTNNISN  450 (454)
Q Consensus       421 i~~cl~~dP~~RPs~~ell~~L~~~~~~~~  450 (454)
                      |.+||+.||.+|||+.|++++-+-......
T Consensus       242 i~~~l~~~p~~Rps~~~il~~~~~~~~~~~  271 (276)
T 2yex_A          242 LHKILVENPSARITIPDIKKDRWYNKPLKK  271 (276)
T ss_dssp             HHHHSCSSTTTSCCHHHHTTCTTTTCCCC-
T ss_pred             HHHHCCCCchhCCCHHHHhcCccccChhhc
Confidence            999999999999999999988665444333

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.3e-44  Score=348.93  Aligned_cols=249  Identities=20%  Similarity=0.338  Sum_probs=187.2

Q ss_pred             CCEEEeceeeccCCceEEEeE------EEEEEEeecCCCC-chHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKG-NAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  262 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g~------~vavK~l~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV  262 (454)
                      ++|++.+.||+|+||.||+|+      .||+|.+...... ......+.+|+.++..++||||+++++++.+.+. .++|
T Consensus        11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~lv   89 (278)
T 3cok_A           11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNY-VYLV   89 (278)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSE-EEEE
T ss_pred             ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCe-EEEE
Confidence            678999999999999999964      6999998632111 1123567899999999999999999999988765 9999


Q ss_pred             EeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCcc
Q 012887          263 TKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT  341 (454)
Q Consensus       263 ~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~  341 (454)
                      |||+++++|.+++... ..+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++..........
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~  169 (278)
T 3cok_A           90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKH  169 (278)
T ss_dssp             EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC------
T ss_pred             EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCcc
Confidence            9999999999999765 579999999999999999999999999999999999999999999999999987765443334


Q ss_pred             cccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHHHHH
Q 012887          342 EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLM  421 (454)
Q Consensus       342 ~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~li  421 (454)
                      ....+++.|+|||.+.+..+    +.++||||||+++|+|++|..||...........+..  .....|..++.++.++|
T Consensus       170 ~~~~~~~~y~aPE~~~~~~~----~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li  243 (278)
T 3cok_A          170 YTLCGTPNYISPEIATRSAH----GLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVL--ADYEMPSFLSIEAKDLI  243 (278)
T ss_dssp             --------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCS--SCCCCCTTSCHHHHHHH
T ss_pred             eeccCCCCcCCcchhcCCCC----CchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhh--cccCCccccCHHHHHHH
Confidence            44568899999999987654    3459999999999999999999987654443332222  23346778899999999


Q ss_pred             HHhcccCCCCCCCHHHHHHHHHhh
Q 012887          422 IKCWNNSPSKRPQFSEIISLLLRT  445 (454)
Q Consensus       422 ~~cl~~dP~~RPs~~ell~~L~~~  445 (454)
                      .+||+.||.+|||+.+++++-+-.
T Consensus       244 ~~~l~~dp~~Rps~~~~l~h~~~~  267 (278)
T 3cok_A          244 HQLLRRNPADRLSLSSVLDHPFMS  267 (278)
T ss_dssp             HHHSCSSGGGSCCHHHHTTSTTTC
T ss_pred             HHHcccCHhhCCCHHHHhcCcccc
Confidence            999999999999999999876543

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.5e-43  Score=351.87  Aligned_cols=256  Identities=23%  Similarity=0.486  Sum_probs=199.6

Q ss_pred             CCEEEeceeeccCCceEEEe----EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCC---CeEEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN---HGLCVV  262 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g----~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~---~~l~lV  262 (454)
                      ++|++.+.||+|+||.||+|    +.||+|.+...   .......+.|+.....++||||+++++++.+..   ..+++|
T Consensus        37 ~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv  113 (337)
T 3mdy_A           37 KQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLI  113 (337)
T ss_dssp             HHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEE
T ss_pred             cceEEEeEeecCCCeEEEEEEECCceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEE
Confidence            67899999999999999996    68999998632   222222333343334458999999999998773   348999


Q ss_pred             EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhc--------CcccCCccCCcEEEccCCcEEEEccCCcccc
Q 012887          263 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDH--------GVAYRDLNSQRILLDRHGNVCLGDMGIVTAC  334 (454)
Q Consensus       263 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~--------~iiHrDIKp~NILl~~~~~vKL~DFGla~~~  334 (454)
                      |||+++|+|.+++.+ ..+++..+..++.|++.||.|||++        ||+||||||+|||++.++.+||+|||++...
T Consensus       114 ~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~  192 (337)
T 3mdy_A          114 TDYHENGSLYDYLKS-TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKF  192 (337)
T ss_dssp             ECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EeccCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCceee
Confidence            999999999999954 4799999999999999999999999        9999999999999999999999999998765


Q ss_pred             ccCCCc----ccccCCCCcccccccccCCCCCCCCC--chhhHHHHHHHHHHHHcC----------CCCCCCCCH----H
Q 012887          335 KSVGEA----TEYETDGYRWLAPEIIAGDPESVSET--WMSNVYSFGMVIWEMVTG----------EAAYAACSP----V  394 (454)
Q Consensus       335 ~~~~~~----~~~~~gt~~y~APE~l~~~~~~~~~~--~ksDVwSlGviL~elltG----------~~Pf~~~~~----~  394 (454)
                      ......    .....||+.|+|||++.+......+.  .++|||||||++|||++|          ..||....+    .
T Consensus       193 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~  272 (337)
T 3mdy_A          193 ISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSY  272 (337)
T ss_dssp             C---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred             ccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCch
Confidence            443222    12346899999999998765433211  248999999999999999          777764321    2


Q ss_pred             HHH-HHHHHcCCCCCCCC-----CccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCCC
Q 012887          395 QAA-VGIAACGLRPEIPK-----DCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNIS  449 (454)
Q Consensus       395 ~~~-~~i~~~~~~~~~p~-----~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~  449 (454)
                      ... ........++.+|.     .+++++.++|.+||+.||.+|||+.+++++|+++.+..
T Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~  333 (337)
T 3mdy_A          273 EDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ  333 (337)
T ss_dssp             HHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred             hhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence            222 22333444555554     56788999999999999999999999999999987643

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=9.6e-44  Score=351.86  Aligned_cols=245  Identities=18%  Similarity=0.299  Sum_probs=195.0

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCC------
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH------  257 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~------  257 (454)
                      ++|++++.||+|+||.||++      +.||+|+++... .......+.+|+.++..++||||++++++|.+.+.      
T Consensus         6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred             hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence            57899999999999999986      469999997543 33455678999999999999999999999876532      


Q ss_pred             --------------------------------------------------eEEEEEeccCCCCHHHHHHhCC---CCCHH
Q 012887          258 --------------------------------------------------GLCVVTKLMEGGSVNDLILKSR---KLQTK  284 (454)
Q Consensus       258 --------------------------------------------------~l~lV~E~~~~gsL~~~l~~~~---~l~~~  284 (454)
                                                                        .+++||||+++++|.+++.+..   ..++.
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~  164 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG  164 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence                                                              2799999999999999997654   35667


Q ss_pred             HHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCC------------cccccCCCCcccc
Q 012887          285 EIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE------------ATEYETDGYRWLA  352 (454)
Q Consensus       285 ~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~------------~~~~~~gt~~y~A  352 (454)
                      .++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........            ......||+.|+|
T Consensus       165 ~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a  244 (332)
T 3qd2_B          165 VCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS  244 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSC
T ss_pred             HHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccC
Confidence            7899999999999999999999999999999999999999999999887654321            1233468999999


Q ss_pred             cccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhcccCCCCC
Q 012887          353 PEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKR  432 (454)
Q Consensus       353 PE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~R  432 (454)
                      ||++.+..    ++.++|||||||++|+|++|..|+..   .............+..+...++++.++|.+||+.||.+|
T Consensus       245 PE~~~~~~----~~~~~Di~slG~il~el~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R  317 (332)
T 3qd2_B          245 PEQIHGNN----YSHKVDIFSLGLILFELLYSFSTQME---RVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTER  317 (332)
T ss_dssp             HHHHHCCC----CCTHHHHHHHHHHHHHHHSCCCCHHH---HHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGGGS
T ss_pred             hHHhcCCC----CcchhhHHHHHHHHHHHHHcCCChhH---HHHHHHHhhccCCCcccccCChhHHHHHHHHccCCCCcC
Confidence            99998764    45579999999999999998665421   112222222222222334567889999999999999999


Q ss_pred             CCHHHHHHHH
Q 012887          433 PQFSEIISLL  442 (454)
Q Consensus       433 Ps~~ell~~L  442 (454)
                      ||+.|++++-
T Consensus       318 ps~~~~l~~~  327 (332)
T 3qd2_B          318 PEATDIIENA  327 (332)
T ss_dssp             CCHHHHHHST
T ss_pred             CCHHHHhhch
Confidence            9999999864

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=4e-43  Score=346.71  Aligned_cols=254  Identities=13%  Similarity=0.228  Sum_probs=204.0

Q ss_pred             CCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCc-hHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEE
Q 012887          189 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGN-AYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCV  261 (454)
Q Consensus       189 ~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~l  261 (454)
                      .++|++.+.||+|+||.||++      +.||+|.+....... .....+.+|+..+..++||||+++++++.+.+. +++
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~-~~l  111 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQ-LYV  111 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTE-EEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCe-EEE
Confidence            378999999999999999986      579999987543322 234668899999999999999999999988776 999


Q ss_pred             EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCC-c
Q 012887          262 VTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE-A  340 (454)
Q Consensus       262 V~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~-~  340 (454)
                      ||||+++++|.+++.+...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ .
T Consensus       112 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~  191 (309)
T 2h34_A          112 DMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQ  191 (309)
T ss_dssp             EEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC-----------
T ss_pred             EEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccccccccc
Confidence            999999999999998778899999999999999999999999999999999999999999999999999876543221 2


Q ss_pred             ccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCC--CCCCCCccHHHH
Q 012887          341 TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR--PEIPKDCPQILK  418 (454)
Q Consensus       341 ~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~--~~~p~~~~~~l~  418 (454)
                      .....+++.|+|||.+.+..++    .++||||||+++|+|++|..||.+...... .........  ...+..+|+++.
T Consensus       192 ~~~~~~~~~y~aPE~~~~~~~~----~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~  266 (309)
T 2h34_A          192 LGNTVGTLYYMAPERFSESHAT----YRADIYALTCVLYECLTGSPPYQGDQLSVM-GAHINQAIPRPSTVRPGIPVAFD  266 (309)
T ss_dssp             -----CCGGGCCGGGTCC--------CCCHHHHHHHHHHHHHHSSCSSCSCHHHHH-HHHHHSCCCCGGGTSTTCCTHHH
T ss_pred             ccccCCCcCccCHHHHcCCCCC----chHhHHHHHHHHHHHHHCCCCCCCchHHHH-HHHhccCCCCccccCCCCCHHHH
Confidence            2344688999999999876544    459999999999999999999988665433 333333222  234667899999


Q ss_pred             HHHHHhcccCCCCCC-CHHHHHHHHHhhcCC
Q 012887          419 SLMIKCWNNSPSKRP-QFSEIISLLLRTNNI  448 (454)
Q Consensus       419 ~li~~cl~~dP~~RP-s~~ell~~L~~~~~~  448 (454)
                      ++|.+||+.||.+|| ++.++++.|++....
T Consensus       267 ~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~  297 (309)
T 2h34_A          267 AVIARGMAKNPEDRYVTCGDLSAAAHAALAT  297 (309)
T ss_dssp             HHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-
T ss_pred             HHHHHhccCCHHHHHHhHHHHHHHHHHHHHh
Confidence            999999999999999 999999999987654

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=3.3e-43  Score=345.69  Aligned_cols=247  Identities=18%  Similarity=0.306  Sum_probs=209.6

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  263 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~  263 (454)
                      ++|++.+.||+|+||.||++      +.||+|.++....  .....+.+|+.++..++||||+++++++.+.+. .++||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~lv~   85 (304)
T 2jam_A            9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA--FRDSSLENEIAVLKKIKHENIVTLEDIYESTTH-YYLVM   85 (304)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEECSSE-EEEEE
T ss_pred             ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc--cchHHHHHHHHHHHhCCCCCeeehhhhcccCCE-EEEEE
Confidence            57899999999999999985      5799999985332  233457899999999999999999999987776 99999


Q ss_pred             eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEE---ccCCcEEEEccCCccccccCCCc
Q 012887          264 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILL---DRHGNVCLGDMGIVTACKSVGEA  340 (454)
Q Consensus       264 E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl---~~~~~vKL~DFGla~~~~~~~~~  340 (454)
                      ||+++++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++......  .
T Consensus        86 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~--~  163 (304)
T 2jam_A           86 QLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG--I  163 (304)
T ss_dssp             CCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB--T
T ss_pred             EcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC--c
Confidence            999999999999877889999999999999999999999999999999999999   77889999999998654322  2


Q ss_pred             ccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCC--CCCCCccHHHH
Q 012887          341 TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP--EIPKDCPQILK  418 (454)
Q Consensus       341 ~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~--~~p~~~~~~l~  418 (454)
                      .....+++.|+|||.+.+..    ++.++||||||+++|+|++|..||...+.......+.......  +.+..+++++.
T Consensus       164 ~~~~~~~~~y~aPE~~~~~~----~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  239 (304)
T 2jam_A          164 MSTACGTPGYVAPEVLAQKP----YSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAK  239 (304)
T ss_dssp             THHHHSCCCBCCTTTBSSCS----CCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHH
T ss_pred             cccccCCCCccChHHhccCC----CCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHH
Confidence            23345889999999998664    4567999999999999999999999888877766666654332  34567899999


Q ss_pred             HHHHHhcccCCCCCCCHHHHHHHHHhh
Q 012887          419 SLMIKCWNNSPSKRPQFSEIISLLLRT  445 (454)
Q Consensus       419 ~li~~cl~~dP~~RPs~~ell~~L~~~  445 (454)
                      ++|.+||..||.+||++.+++++-+-.
T Consensus       240 ~li~~~l~~dp~~Rps~~~~l~h~~~~  266 (304)
T 2jam_A          240 DFICHLLEKDPNERYTCEKALSHPWID  266 (304)
T ss_dssp             HHHHHHHCSSTTTSCCHHHHHTSHHHH
T ss_pred             HHHHHHcCCChhHCcCHHHHhcCcccc
Confidence            999999999999999999999987643

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=3.3e-43  Score=366.19  Aligned_cols=251  Identities=18%  Similarity=0.221  Sum_probs=190.1

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCC----CeE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN----HGL  259 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~----~~l  259 (454)
                      ++|++++.||+|+||.||++      +.||+|++............+.+|+.+|..++|||||++++++...+    ..+
T Consensus        53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  132 (458)
T 3rp9_A           53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL  132 (458)
T ss_dssp             TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred             CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence            78999999999999999986      57999999765555556677899999999999999999999996442    348


Q ss_pred             EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCC
Q 012887          260 CVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE  339 (454)
Q Consensus       260 ~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~  339 (454)
                      |+||||+. ++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus       133 ~lv~e~~~-~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~  211 (458)
T 3rp9_A          133 YVVLEIAD-SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPEN  211 (458)
T ss_dssp             EEEECCCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCTT
T ss_pred             EEEEeccc-cchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccCccc
Confidence            99999985 59999998888899999999999999999999999999999999999999999999999999986543211


Q ss_pred             ---------------------------cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc---------
Q 012887          340 ---------------------------ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT---------  383 (454)
Q Consensus       340 ---------------------------~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt---------  383 (454)
                                                 ......||+.|+|||++....   .++.++|||||||++|||++         
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~---~~~~~~DiwSlG~il~elltg~~~~~~~~  288 (458)
T 3rp9_A          212 GNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQE---NYTEAIDVWSIGCIFAELLNMIKENVAYH  288 (458)
T ss_dssp             CCCCCC---------------------------CCCTTCCHHHHTTCC---CCCTHHHHHHHHHHHHHHHTTSTTTCSSG
T ss_pred             cccccccCccccccccccccccccccccccCCcccccccChHHhhCCC---CCCcHhHHHHHHHHHHHHHHhcccccccc
Confidence                                       122336799999999875332   35667999999999999998         


Q ss_pred             --CCCCCCCCCH--------------------HHHHHHHHH-cCC---------------------CC-------CCCCC
Q 012887          384 --GEAAYAACSP--------------------VQAAVGIAA-CGL---------------------RP-------EIPKD  412 (454)
Q Consensus       384 --G~~Pf~~~~~--------------------~~~~~~i~~-~~~---------------------~~-------~~p~~  412 (454)
                        |.++|.+.+.                    ...+..+.. .+.                     +.       .....
T Consensus       289 ~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  368 (458)
T 3rp9_A          289 ADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPA  368 (458)
T ss_dssp             GGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTT
T ss_pred             ccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCC
Confidence              7777766432                    111111110 000                     00       01234


Q ss_pred             ccHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 012887          413 CPQILKSLMIKCWNNSPSKRPQFSEIISLLLR  444 (454)
Q Consensus       413 ~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~  444 (454)
                      .++++.+||.+||..||.+|||+.|+++|-+-
T Consensus       369 ~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f  400 (458)
T 3rp9_A          369 SSADAIHLLKRMLVFNPNKRITINECLAHPFF  400 (458)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGG
T ss_pred             CCHHHHHHHHHHhccCccccCCHHHHhcCHhh
Confidence            58999999999999999999999999998653

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=2.4e-43  Score=358.59  Aligned_cols=243  Identities=19%  Similarity=0.283  Sum_probs=202.2

Q ss_pred             EEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEEecc
Q 012887          193 EFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLM  266 (454)
Q Consensus       193 ~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~E~~  266 (454)
                      ...+.||+|+||.||+|      +.||+|.++...  ......+.+|+.++..++||||+++++++.+.+. +++||||+
T Consensus        92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~-~~lv~E~~  168 (373)
T 2x4f_A           92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG--MKDKEEVKNEISVMNQLDHANLIQLYDAFESKND-IVLVMEYV  168 (373)
T ss_dssp             EEEEECC-----CEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE-EEEEEECC
T ss_pred             ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc--cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE-EEEEEeCC
Confidence            34678999999999985      479999997532  2345568899999999999999999999988776 99999999


Q ss_pred             CCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEE--ccCCcEEEEccCCccccccCCCcccc
Q 012887          267 EGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILL--DRHGNVCLGDMGIVTACKSVGEATEY  343 (454)
Q Consensus       267 ~~gsL~~~l~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl--~~~~~vKL~DFGla~~~~~~~~~~~~  343 (454)
                      ++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||+  +.++.+||+|||++....... ....
T Consensus       169 ~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~-~~~~  247 (373)
T 2x4f_A          169 DGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE-KLKV  247 (373)
T ss_dssp             TTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC-BCCC
T ss_pred             CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc-cccc
Confidence            999999988654 479999999999999999999999999999999999999  566789999999988765432 2334


Q ss_pred             cCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCC--CCCccHHHHHHH
Q 012887          344 ETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEI--PKDCPQILKSLM  421 (454)
Q Consensus       344 ~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~--p~~~~~~l~~li  421 (454)
                      ..||+.|+|||++.+..    ++.++|||||||++|||++|..||.+.+.......+.........  ...+++++.+||
T Consensus       248 ~~gt~~y~aPE~~~~~~----~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li  323 (373)
T 2x4f_A          248 NFGTPEFLAPEVVNYDF----VSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFI  323 (373)
T ss_dssp             CCSSCTTCCHHHHTTCB----CCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHH
T ss_pred             ccCCCcEeChhhccCCC----CCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHH
Confidence            46899999999997654    455799999999999999999999998888877777776544322  356899999999


Q ss_pred             HHhcccCCCCCCCHHHHHHHHH
Q 012887          422 IKCWNNSPSKRPQFSEIISLLL  443 (454)
Q Consensus       422 ~~cl~~dP~~RPs~~ell~~L~  443 (454)
                      .+||+.||.+||++.|++++-+
T Consensus       324 ~~~L~~dp~~Rps~~e~l~hp~  345 (373)
T 2x4f_A          324 SKLLIKEKSWRISASEALKHPW  345 (373)
T ss_dssp             HTTSCSSGGGSCCHHHHHHSHH
T ss_pred             HHHcCCChhhCCCHHHHhcCcC
Confidence            9999999999999999999765

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=2.7e-43  Score=354.79  Aligned_cols=250  Identities=18%  Similarity=0.350  Sum_probs=207.7

Q ss_pred             ecCCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEE
Q 012887          187 LNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLC  260 (454)
Q Consensus       187 ~~~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~  260 (454)
                      +..++|++++.||+|+||.||++      +.+|+|.+... ........+.+|+.++..++||||+++++++.+.+. ++
T Consensus        30 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~  107 (360)
T 3eqc_A           30 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE-IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE-IS  107 (360)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECC-CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTE-EE
T ss_pred             cccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccc-cCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCE-EE
Confidence            44578999999999999999995      57999998753 334455678899999999999999999999998776 99


Q ss_pred             EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhc-CcccCCccCCcEEEccCCcEEEEccCCccccccCCC
Q 012887          261 VVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDH-GVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE  339 (454)
Q Consensus       261 lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~-~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~  339 (454)
                      +||||+++++|.+++.+.+.+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++......  
T Consensus       108 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--  185 (360)
T 3eqc_A          108 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  185 (360)
T ss_dssp             EEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH--
T ss_pred             EEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc--
Confidence            9999999999999998878899999999999999999999996 9999999999999999999999999998755332  


Q ss_pred             cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHH---------------------
Q 012887          340 ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAV---------------------  398 (454)
Q Consensus       340 ~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~---------------------  398 (454)
                      ......+|+.|+|||++.+..    ++.++|||||||++|+|++|..||..........                     
T Consensus       186 ~~~~~~gt~~y~aPE~~~~~~----~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (360)
T 3eqc_A          186 MANSFVGTRSYMSPERLQGTH----YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG  261 (360)
T ss_dssp             C----CCCCTTCCHHHHTTCC----CSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------
T ss_pred             cccCCCCCCCeECHHHHcCCC----CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCC
Confidence            233447899999999998764    4567999999999999999999998765543211                     


Q ss_pred             ---------------------HHHHcCCCCCC-CCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 012887          399 ---------------------GIAACGLRPEI-PKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRT  445 (454)
Q Consensus       399 ---------------------~i~~~~~~~~~-p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~  445 (454)
                                           .+.. ...+.. +..++.++.+||.+||+.||.+|||+.|+++|-+-.
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~  329 (360)
T 3eqc_A          262 RPLNKFGMDSRPPMAIFELLDYIVN-EPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIK  329 (360)
T ss_dssp             ------------CCCHHHHHHHHHH-SCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHH
T ss_pred             CcccccccCCCCcccchhhhhHHhc-cCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhh
Confidence                                 1122 222233 335799999999999999999999999999987643

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=4.8e-44  Score=358.88  Aligned_cols=255  Identities=14%  Similarity=0.187  Sum_probs=195.9

Q ss_pred             cCCCEEEeceeeccCCceEEEeE---------EEEEEEeecCCCCchHH---------HHHHHHHHHHHhCCCCceeEEE
Q 012887          188 NSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKGCDKGNAYE---------FELRKDLLELMTCGHKNILQFY  249 (454)
Q Consensus       188 ~~~~~~~~~~LG~G~fG~Vy~g~---------~vavK~l~~~~~~~~~~---------~~~~~Ei~~l~~l~HpnIv~~~  249 (454)
                      ..++|++.+.||+|+||.||+|.         .+|+|.+.........+         ..+.+|+..+..++||||++++
T Consensus        35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~  114 (345)
T 2v62_A           35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFY  114 (345)
T ss_dssp             TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEE
T ss_pred             cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceee
Confidence            34789999999999999999975         48899887543221111         1245677788889999999999


Q ss_pred             EEEEeC---CCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCC--cEE
Q 012887          250 CVCVDE---NHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG--NVC  324 (454)
Q Consensus       250 g~~~~~---~~~l~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~--~vK  324 (454)
                      +++.+.   +..+++||||+ +++|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++  .+|
T Consensus       115 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~k  193 (345)
T 2v62_A          115 GSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVY  193 (345)
T ss_dssp             EEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEE
T ss_pred             cccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEE
Confidence            999873   33499999999 899999997777899999999999999999999999999999999999999887  999


Q ss_pred             EEccCCccccccCCCc-------ccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHH
Q 012887          325 LGDMGIVTACKSVGEA-------TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAA  397 (454)
Q Consensus       325 L~DFGla~~~~~~~~~-------~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~  397 (454)
                      |+|||+++........       .....+|+.|+|||++.+..    ++.++|||||||++|||++|..||.+.......
T Consensus       194 L~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~  269 (345)
T 2v62_A          194 LADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVA----LSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVA  269 (345)
T ss_dssp             ECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCC----CCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHH
T ss_pred             EEeCCCceecccccccccchhccccccCCCccccCHHHhcCCC----CCchhhHHHHHHHHHHHHhCCCCccccccccHH
Confidence            9999998765432211       13446899999999998764    456799999999999999999999652221111


Q ss_pred             HHHHHcCCCCCCC---------CCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 012887          398 VGIAACGLRPEIP---------KDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNN  447 (454)
Q Consensus       398 ~~i~~~~~~~~~p---------~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~  447 (454)
                      ...........+|         ..+|+++.++|.+||+.||.+||++.+|++.|++..-
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~  328 (345)
T 2v62_A          270 VQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI  328 (345)
T ss_dssp             HHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred             HHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence            1111111111122         2788999999999999999999999999999988654

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=8.4e-43  Score=361.08  Aligned_cols=258  Identities=19%  Similarity=0.216  Sum_probs=201.4

Q ss_pred             ccceeecCCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeC
Q 012887          182 IGRWLLNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDE  255 (454)
Q Consensus       182 ~~~~~~~~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~  255 (454)
                      +..+.+ .++|++++.||+|+||.||++      +.||+|++............+.+|+.+|..++||||+++++++...
T Consensus        19 ~~~~~i-~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~   97 (432)
T 3n9x_A           19 IKNVHV-PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPD   97 (432)
T ss_dssp             GGGCCC-CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCS
T ss_pred             CCccee-cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecC
Confidence            344444 388999999999999999996      6799999986555555667789999999999999999999999876


Q ss_pred             C----CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCc
Q 012887          256 N----HGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIV  331 (454)
Q Consensus       256 ~----~~l~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla  331 (454)
                      +    ..+|+||||+++ +|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus        98 ~~~~~~~~~lv~e~~~~-~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla  176 (432)
T 3n9x_A           98 DLLKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLA  176 (432)
T ss_dssp             CTTTCCCEEEEEECCSE-EHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             CCCcCCeEEEEEecCCc-CHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCc
Confidence            3    349999999975 99999988788999999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCC----------------------cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcC-----
Q 012887          332 TACKSVGE----------------------ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTG-----  384 (454)
Q Consensus       332 ~~~~~~~~----------------------~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG-----  384 (454)
                      +.......                      ......+|+.|+|||++....   .++.++|||||||++|||++|     
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~---~~~~~~DiwSlG~il~ell~g~~p~~  253 (432)
T 3n9x_A          177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQE---NYTKSIDIWSTGCIFAELLNMLQSHI  253 (432)
T ss_dssp             EEC-------------------------------CCCCCTTCCHHHHTTCS---CCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred             ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCC---CCCcccccchHHHHHHHHHhcccccc
Confidence            87644321                      124457899999999875432   356679999999999999984     


Q ss_pred             ------CCCCCCCCH-----------------HHHHHHH------------------------HHcCCCCCC-----CCC
Q 012887          385 ------EAAYAACSP-----------------VQAAVGI------------------------AACGLRPEI-----PKD  412 (454)
Q Consensus       385 ------~~Pf~~~~~-----------------~~~~~~i------------------------~~~~~~~~~-----p~~  412 (454)
                            .++|.+.+.                 ...+..+                        .........     ...
T Consensus       254 ~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  333 (432)
T 3n9x_A          254 NDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPS  333 (432)
T ss_dssp             SSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTT
T ss_pred             cccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCC
Confidence                  444444321                 1111111                        110111111     135


Q ss_pred             ccHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 012887          413 CPQILKSLMIKCWNNSPSKRPQFSEIISLLLR  444 (454)
Q Consensus       413 ~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~  444 (454)
                      +++++.+||.+||+.||.+|||+.|+++|-+-
T Consensus       334 ~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f  365 (432)
T 3n9x_A          334 ISDDGINLLESMLKFNPNKRITIDQALDHPYL  365 (432)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGG
T ss_pred             CCHHHHHHHHHHhcCCcccCCCHHHHhcChhh
Confidence            78999999999999999999999999998653

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=3.5e-43  Score=339.87  Aligned_cols=251  Identities=19%  Similarity=0.294  Sum_probs=205.5

Q ss_pred             CCCEEEeceeeccCCceEEEe------EEEEEEEeecCCC-CchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEE
Q 012887          189 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDK-GNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCV  261 (454)
Q Consensus       189 ~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~l  261 (454)
                      .++|++.+.||+|+||.||+|      +.||+|.+..... .......+.+|+..+..++||||+++++++.+.+. .++
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~l   88 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTD-FFM   88 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE-EEE
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCe-EEE
Confidence            478999999999999999985      4799999864321 11223467899999999999999999999988775 999


Q ss_pred             EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCcc
Q 012887          262 VTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT  341 (454)
Q Consensus       262 V~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~  341 (454)
                      ||||+++++|.+++.+.+.+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++....... ..
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~-~~  167 (276)
T 2h6d_A           89 VMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE-FL  167 (276)
T ss_dssp             EEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-----
T ss_pred             EEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCCc-ce
Confidence            99999999999999877889999999999999999999999999999999999999999999999999987654322 23


Q ss_pred             cccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHHHHH
Q 012887          342 EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLM  421 (454)
Q Consensus       342 ~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~li  421 (454)
                      ....+++.|+|||.+.+..+   .+.++||||||+++|+|++|..||...........+...  ...+|..++..+.++|
T Consensus       168 ~~~~~~~~y~aPE~~~~~~~---~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li  242 (276)
T 2h6d_A          168 RTSCGSPNYAAPEVISGRLY---AGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGG--VFYIPEYLNRSVATLL  242 (276)
T ss_dssp             ---------CCTGGGTTSCC---CHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTTSCHHHHHHH
T ss_pred             ecccCCccccCHHHHcCCCC---CCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcC--cccCchhcCHHHHHHH
Confidence            34467889999999986542   245799999999999999999999987776666555543  3446788899999999


Q ss_pred             HHhcccCCCCCCCHHHHHHHHHhhc
Q 012887          422 IKCWNNSPSKRPQFSEIISLLLRTN  446 (454)
Q Consensus       422 ~~cl~~dP~~RPs~~ell~~L~~~~  446 (454)
                      .+||+.||.+|||+.+++++-+-..
T Consensus       243 ~~~l~~~p~~Rps~~~~l~h~~~~~  267 (276)
T 2h6d_A          243 MHMLQVDPLKRATIKDIREHEWFKQ  267 (276)
T ss_dssp             HHHTCSSGGGSCCHHHHHHSHHHHT
T ss_pred             HHHccCChhhCCCHHHHHhChhhcc
Confidence            9999999999999999999866443

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=3.7e-43  Score=340.94  Aligned_cols=248  Identities=18%  Similarity=0.317  Sum_probs=207.2

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCc----hHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGN----AYEFELRKDLLELMTCGHKNILQFYCVCVDENHGL  259 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~----~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l  259 (454)
                      ++|++++.||+|+||.||++      +.+|+|.++......    .....+.+|+.++..++||||+++++++.+.+. .
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~-~   83 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTD-V   83 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE-E
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCe-E
Confidence            57899999999999999985      579999987543221    135668899999999999999999999988765 9


Q ss_pred             EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCC----cEEEEccCCccccc
Q 012887          260 CVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG----NVCLGDMGIVTACK  335 (454)
Q Consensus       260 ~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~----~vKL~DFGla~~~~  335 (454)
                      ++||||+++++|.+++.+...+++..+..++.||+.||.|||++|++||||||+||+++.++    .+||+|||++....
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~  163 (283)
T 3bhy_A           84 VLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE  163 (283)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC
T ss_pred             EEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceecc
Confidence            99999999999999998778899999999999999999999999999999999999999877    79999999987654


Q ss_pred             cCCCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCC--CCCCCc
Q 012887          336 SVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP--EIPKDC  413 (454)
Q Consensus       336 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~--~~p~~~  413 (454)
                      .... .....+++.|+|||.+.+..    ++.++||||||+++|+|++|..||.+.........+.......  ..+..+
T Consensus       164 ~~~~-~~~~~~~~~y~aPE~~~~~~----~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (283)
T 3bhy_A          164 AGNE-FKNIFGTPEFVAPEIVNYEP----LGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNT  238 (283)
T ss_dssp             ---------CCCGGGCCHHHHTTCC----CCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTC
T ss_pred             CCCc-ccccCCCcCccCcceecCCC----CCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccC
Confidence            4322 23446889999999998664    4556999999999999999999999888776666555433322  123567


Q ss_pred             cHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 012887          414 PQILKSLMIKCWNNSPSKRPQFSEIISLLL  443 (454)
Q Consensus       414 ~~~l~~li~~cl~~dP~~RPs~~ell~~L~  443 (454)
                      ++.+.+++.+||..||.+||++.+++++-+
T Consensus       239 ~~~~~~li~~~l~~dp~~Rps~~~~l~h~~  268 (283)
T 3bhy_A          239 SELAKDFIRRLLVKDPKRRMTIAQSLEHSW  268 (283)
T ss_dssp             CHHHHHHHHTTSCSSGGGSCCHHHHHHCHH
T ss_pred             CHHHHHHHHHHccCCHhHCcCHHHHHhCHH
Confidence            899999999999999999999999998644

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=8.3e-44  Score=354.86  Aligned_cols=245  Identities=20%  Similarity=0.305  Sum_probs=182.8

Q ss_pred             CEEEe---ceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCC-CCceeEEEEEEEeCCCeEE
Q 012887          191 NLEFI---DQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCG-HKNILQFYCVCVDENHGLC  260 (454)
Q Consensus       191 ~~~~~---~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~~~g~~~~~~~~l~  260 (454)
                      +|++.   +.||+|+||.||++      +.||+|.+..     .......+|+.++..+. ||||+++++++.+.+. .|
T Consensus         9 ~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-----~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~-~~   82 (325)
T 3kn6_A            9 HYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISK-----RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLH-TF   82 (325)
T ss_dssp             HEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEG-----GGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE-EE
T ss_pred             ccccccCCCccccCCCeEEEEEEECCCCCEEEEEEECh-----hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCE-EE
Confidence            44554   68999999999995      5799999863     23456778999999986 9999999999988776 99


Q ss_pred             EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCC---cEEEEccCCccccccC
Q 012887          261 VVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG---NVCLGDMGIVTACKSV  337 (454)
Q Consensus       261 lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~---~vKL~DFGla~~~~~~  337 (454)
                      +||||+++|+|.+++.+.+.+++..+..++.||+.||.|||++||+||||||+|||++.++   .+||+|||++......
T Consensus        83 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~  162 (325)
T 3kn6_A           83 LVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD  162 (325)
T ss_dssp             EEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-
T ss_pred             EEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCC
Confidence            9999999999999998888999999999999999999999999999999999999998766   7999999999866554


Q ss_pred             CCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCH-------HHHHHHHHHcCCCCCC-
Q 012887          338 GEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSP-------VQAAVGIAACGLRPEI-  409 (454)
Q Consensus       338 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~-------~~~~~~i~~~~~~~~~-  409 (454)
                      ........+|+.|+|||.+.+..    ++.++|||||||++|+|++|..||.+...       .+....+......... 
T Consensus       163 ~~~~~~~~~t~~y~aPE~~~~~~----~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~  238 (325)
T 3kn6_A          163 NQPLKTPCFTLHYAAPELLNQNG----YDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGE  238 (325)
T ss_dssp             ---------------------CC----CCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSH
T ss_pred             CCcccccCCCcCccCHHHhcCCC----CCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcc
Confidence            44445567899999999997664    45579999999999999999999986433       2333333332222111 


Q ss_pred             -CCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 012887          410 -PKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRT  445 (454)
Q Consensus       410 -p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~  445 (454)
                       ...+++++.+||.+||+.||.+|||+.|++++-|-.
T Consensus       239 ~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~  275 (325)
T 3kn6_A          239 AWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQ  275 (325)
T ss_dssp             HHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGC
T ss_pred             cccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhc
Confidence             135799999999999999999999999999886643

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=1.3e-43  Score=350.03  Aligned_cols=265  Identities=19%  Similarity=0.267  Sum_probs=210.1

Q ss_pred             cceeecCCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeC-
Q 012887          183 GRWLLNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDE-  255 (454)
Q Consensus       183 ~~~~~~~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~-  255 (454)
                      .-+.+..++|++++.||+|+||.||++      +.||+|.+...  .......+.+|+.++..++||||+++++++... 
T Consensus        22 ~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   99 (317)
T 2buj_A           22 HMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH--EQQDREEAQREADMHRLFNHPNILRLVAYCLRER   99 (317)
T ss_dssp             EEEEETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEE
T ss_pred             cEEEECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC--CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEecc
Confidence            445678889999999999999999986      47999998642  334456688999999999999999999998742 


Q ss_pred             --CCeEEEEEeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccC
Q 012887          256 --NHGLCVVTKLMEGGSVNDLILK----SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMG  329 (454)
Q Consensus       256 --~~~l~lV~E~~~~gsL~~~l~~----~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFG  329 (454)
                        ....++||||+++|+|.+++..    ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus       100 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg  179 (317)
T 2buj_A          100 GAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLG  179 (317)
T ss_dssp             TTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCS
T ss_pred             CCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecC
Confidence              2358999999999999999864    4579999999999999999999999999999999999999999999999999


Q ss_pred             CccccccCCCc---------ccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHH-HHHHH
Q 012887          330 IVTACKSVGEA---------TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPV-QAAVG  399 (454)
Q Consensus       330 la~~~~~~~~~---------~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~-~~~~~  399 (454)
                      ++.........         .....+++.|+|||.+.+.... .++.++||||||+++|+|++|..||...... .....
T Consensus       180 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~  258 (317)
T 2buj_A          180 SMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHC-VIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVAL  258 (317)
T ss_dssp             SCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEE-EECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHH
T ss_pred             cchhcccccccccccccccccccccCCcccCCHhHhccCCCc-CCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhH
Confidence            97654321110         1123468899999998765321 2456799999999999999999999631110 01122


Q ss_pred             HHHcCCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCCCC
Q 012887          400 IAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISN  450 (454)
Q Consensus       400 i~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~  450 (454)
                      ........+.+..++.++.++|.+||+.||.+||++.+++++|+.+.....
T Consensus       259 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~  309 (317)
T 2buj_A          259 AVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAP  309 (317)
T ss_dssp             HHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCC
T ss_pred             HhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCC
Confidence            233344455566789999999999999999999999999999999876543

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=1.1e-42  Score=349.99  Aligned_cols=245  Identities=18%  Similarity=0.282  Sum_probs=200.8

Q ss_pred             ecCCCEEEeceeeccCCceEEEeE------EEEEEEeecCCCCchHHHHHHHHHHHHHhCC-----CCceeEEEEEEEeC
Q 012887          187 LNSDNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKGNAYEFELRKDLLELMTCG-----HKNILQFYCVCVDE  255 (454)
Q Consensus       187 ~~~~~~~~~~~LG~G~fG~Vy~g~------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~-----HpnIv~~~g~~~~~  255 (454)
                      +-.++|++++.||+|+||.||+++      .||+|.++.   ..........|+.++..+.     ||||+++++++...
T Consensus        32 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~  108 (360)
T 3llt_A           32 LLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN---IKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYY  108 (360)
T ss_dssp             EETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEET
T ss_pred             EecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc---chhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeEC
Confidence            345899999999999999999964      699999863   2334455677888888875     99999999999988


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEcc--------------
Q 012887          256 NHGLCVVTKLMEGGSVNDLILKSR--KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDR--------------  319 (454)
Q Consensus       256 ~~~l~lV~E~~~~gsL~~~l~~~~--~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~--------------  319 (454)
                      +. +++||||+ +++|.+++....  .+++..+..++.||+.||.|||++||+||||||+|||++.              
T Consensus       109 ~~-~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~  186 (360)
T 3llt_A          109 DH-MCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVT  186 (360)
T ss_dssp             TE-EEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTT
T ss_pred             Ce-eEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhccc
Confidence            76 99999999 889999997654  6999999999999999999999999999999999999975              


Q ss_pred             -----------CCcEEEEccCCccccccCCCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCC
Q 012887          320 -----------HGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAY  388 (454)
Q Consensus       320 -----------~~~vKL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf  388 (454)
                                 ++.+||+|||++.....   ......+|+.|+|||++.+..+    +.++|||||||++|+|++|..||
T Consensus       187 ~~~~~~~~~~~~~~~kl~DFG~a~~~~~---~~~~~~gt~~y~aPE~~~~~~~----~~~~DiwslG~il~ell~g~~pf  259 (360)
T 3llt_A          187 DGKKIQIYRTKSTGIKLIDFGCATFKSD---YHGSIINTRQYRAPEVILNLGW----DVSSDMWSFGCVLAELYTGSLLF  259 (360)
T ss_dssp             TCCEEEEEEESCCCEEECCCTTCEETTS---CCCSCCSCGGGCCHHHHTTCCC----CTTHHHHHHHHHHHHHHHSSCSC
T ss_pred             ccccccccccCCCCEEEEeccCceecCC---CCcCccCcccccCcHHHcCCCC----CCccchHHHHHHHHHHHHCCCCC
Confidence                       78999999999876433   2334578999999999987654    44599999999999999999999


Q ss_pred             CCCCHHHHHHHHHHcCCCC------------------------CCCC--------------------CccHHHHHHHHHh
Q 012887          389 AACSPVQAAVGIAACGLRP------------------------EIPK--------------------DCPQILKSLMIKC  424 (454)
Q Consensus       389 ~~~~~~~~~~~i~~~~~~~------------------------~~p~--------------------~~~~~l~~li~~c  424 (454)
                      ...+.......+.....+.                        .+|.                    ..++.+.+||.+|
T Consensus       260 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  339 (360)
T 3llt_A          260 RTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSI  339 (360)
T ss_dssp             CCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHH
T ss_pred             CCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHH
Confidence            9877766554443321111                        0111                    1236788999999


Q ss_pred             cccCCCCCCCHHHHHHHHH
Q 012887          425 WNNSPSKRPQFSEIISLLL  443 (454)
Q Consensus       425 l~~dP~~RPs~~ell~~L~  443 (454)
                      |+.||.+|||+.|+++|-+
T Consensus       340 L~~dP~~Rpta~elL~hp~  358 (360)
T 3llt_A          340 LQIDPTLRPSPAELLKHKF  358 (360)
T ss_dssp             CCSSGGGSCCHHHHTTSGG
T ss_pred             hcCChhhCCCHHHHhcCcc
Confidence            9999999999999987643

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=4e-43  Score=346.41  Aligned_cols=250  Identities=20%  Similarity=0.325  Sum_probs=198.0

Q ss_pred             CCEEEe-ceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEEEEEEEeCCCeEEE
Q 012887          190 DNLEFI-DQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVDENHGLCV  261 (454)
Q Consensus       190 ~~~~~~-~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~~~g~~~~~~~~l~l  261 (454)
                      +.|++. +.||+|+||.||++      +.||+|.+....  ......+.+|+.++.++ +||||+++++++.+.+. +++
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~-~~l   88 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP--GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDR-FYL   88 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS--SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE-EEE
T ss_pred             eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc--chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCE-EEE
Confidence            678885 78999999999995      489999997543  22345678999999884 79999999999998776 999


Q ss_pred             EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCc---EEEEccCCccccccCC
Q 012887          262 VTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGN---VCLGDMGIVTACKSVG  338 (454)
Q Consensus       262 V~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~---vKL~DFGla~~~~~~~  338 (454)
                      ||||+++|+|.+++.+.+.+++..+..++.||+.||.|||++||+||||||+|||++.++.   +||+|||++.......
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~  168 (316)
T 2ac3_A           89 VFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNG  168 (316)
T ss_dssp             EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC------
T ss_pred             EEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCC
Confidence            9999999999999988788999999999999999999999999999999999999998776   9999999987553221


Q ss_pred             C-------cccccCCCCcccccccccCCCC-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCH---------------HH
Q 012887          339 E-------ATEYETDGYRWLAPEIIAGDPE-SVSETWMSNVYSFGMVIWEMVTGEAAYAACSP---------------VQ  395 (454)
Q Consensus       339 ~-------~~~~~~gt~~y~APE~l~~~~~-~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~---------------~~  395 (454)
                      .       ......||+.|+|||++.+... ...++.++|||||||++|+|++|..||.+...               ..
T Consensus       169 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  248 (316)
T 2ac3_A          169 DCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNM  248 (316)
T ss_dssp             -------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHH
T ss_pred             ccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHH
Confidence            1       1223358999999999874210 01234569999999999999999999986532               22


Q ss_pred             HHHHHHHcCCCCCCC----CCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 012887          396 AAVGIAACGLRPEIP----KDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR  444 (454)
Q Consensus       396 ~~~~i~~~~~~~~~p----~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~  444 (454)
                      ....+.....  .+|    ..+++++.+||.+||+.||.+|||+.|+++|-+-
T Consensus       249 ~~~~i~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~  299 (316)
T 2ac3_A          249 LFESIQEGKY--EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWV  299 (316)
T ss_dssp             HHHHHHHCCC--CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTC
T ss_pred             HHHHHhccCc--ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhh
Confidence            2333443322  233    4588999999999999999999999999997653

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.7e-42  Score=341.62  Aligned_cols=249  Identities=21%  Similarity=0.393  Sum_probs=206.2

Q ss_pred             cCCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEE
Q 012887          188 NSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCV  261 (454)
Q Consensus       188 ~~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~l  261 (454)
                      ..++|++++.||+|+||.||+|      +.||+|.+.....    ...+.+|+.++..++||||+++++++.+.+. +++
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~l  101 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD----LQEIIKEISIMQQCDSPHVVKYYGSYFKNTD-LWI  101 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC----CHHHHHHHHHHHTCCCTTBCCEEEEEEETTE-EEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH----HHHHHHHHHHHHhCCCCCCccEEEEEEeCCE-EEE
Confidence            3578999999999999999985      5799999975322    2457789999999999999999999988776 999


Q ss_pred             EEeccCCCCHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCc
Q 012887          262 VTKLMEGGSVNDLIL-KSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA  340 (454)
Q Consensus       262 V~E~~~~gsL~~~l~-~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~  340 (454)
                      ||||+++++|.+++. ....+++..+..++.||+.||.|||++|++|+||||+||+++.++.+||+|||++.........
T Consensus       102 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~  181 (314)
T 3com_A          102 VMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAK  181 (314)
T ss_dssp             EEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBSC
T ss_pred             EeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhccc
Confidence            999999999999986 4568999999999999999999999999999999999999999999999999998776554444


Q ss_pred             ccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCC-CCCCCCCccHHHHH
Q 012887          341 TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGL-RPEIPKDCPQILKS  419 (454)
Q Consensus       341 ~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~-~~~~p~~~~~~l~~  419 (454)
                      .....+++.|+|||.+.+..+    +.++||||||+++|+|++|..||...........+..... ....+..++..+.+
T Consensus       182 ~~~~~~~~~y~aPE~~~~~~~----~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  257 (314)
T 3com_A          182 RNTVIGTPFWMAPEVIQEIGY----NCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTD  257 (314)
T ss_dssp             BCCCCSCGGGCCHHHHSSSCB----CTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHH
T ss_pred             cCccCCCCCccChhhcCCCCC----CccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHHH
Confidence            455578999999999987654    4459999999999999999999998877666555444322 22335668999999


Q ss_pred             HHHHhcccCCCCCCCHHHHHHHHHhh
Q 012887          420 LMIKCWNNSPSKRPQFSEIISLLLRT  445 (454)
Q Consensus       420 li~~cl~~dP~~RPs~~ell~~L~~~  445 (454)
                      +|.+||+.||.+|||+.+++++-+-.
T Consensus       258 li~~~l~~dp~~Rpt~~~ll~~~~~~  283 (314)
T 3com_A          258 FVKQCLVKSPEQRATATQLLQHPFVR  283 (314)
T ss_dssp             HHHHHTCSCTTTSCCHHHHTTSHHHH
T ss_pred             HHHHHccCChhhCcCHHHHHhCHHHh
Confidence            99999999999999999999876543

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=6.9e-43  Score=340.71  Aligned_cols=256  Identities=23%  Similarity=0.406  Sum_probs=208.0

Q ss_pred             ceeecCCCEEEeceeeccCCceEEEeE------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCC
Q 012887          184 RWLLNSDNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH  257 (454)
Q Consensus       184 ~~~~~~~~~~~~~~LG~G~fG~Vy~g~------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~  257 (454)
                      .+.+..++|.....||+|+||.||+|.      .||+|.+....  ......+.+|+.++..++||||+++++++.+.+.
T Consensus        16 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   93 (295)
T 2clq_A           16 EYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD--SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGF   93 (295)
T ss_dssp             CEEECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC--C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred             cccccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc--hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCc
Confidence            344445566666789999999999974      79999997543  2344568899999999999999999999988776


Q ss_pred             eEEEEEeccCCCCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEcc-CCcEEEEccCCccc
Q 012887          258 GLCVVTKLMEGGSVNDLILKSR---KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDR-HGNVCLGDMGIVTA  333 (454)
Q Consensus       258 ~l~lV~E~~~~gsL~~~l~~~~---~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~-~~~vKL~DFGla~~  333 (454)
                       +++||||+++++|.+++....   .+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||++..
T Consensus        94 -~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~  172 (295)
T 2clq_A           94 -IKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKR  172 (295)
T ss_dssp             -EEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEE
T ss_pred             -EEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccc
Confidence             999999999999999996542   5678999999999999999999999999999999999998 89999999999877


Q ss_pred             cccCCCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHHHcCCCCCCCCC
Q 012887          334 CKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSP-VQAAVGIAACGLRPEIPKD  412 (454)
Q Consensus       334 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~-~~~~~~i~~~~~~~~~p~~  412 (454)
                      ............+++.|+|||.+.+...  .++.++||||||+++|+|++|..||..... .............+.+|..
T Consensus       173 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  250 (295)
T 2clq_A          173 LAGINPCTETFTGTLQYMAPEIIDKGPR--GYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPES  250 (295)
T ss_dssp             SCC-----CCCCCCGGGCCHHHHHHGGG--GCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTT
T ss_pred             cCCCCCcccccCCCccccChhhhcCCCC--CCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcccccccccccc
Confidence            6544333445578999999999975431  245679999999999999999999976433 3333333444566778889


Q ss_pred             ccHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 012887          413 CPQILKSLMIKCWNNSPSKRPQFSEIISLLLR  444 (454)
Q Consensus       413 ~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~  444 (454)
                      +++++.++|.+||+.||.+||++.+++++-+-
T Consensus       251 ~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~  282 (295)
T 2clq_A          251 MSAEAKAFILKCFEPDPDKRACANDLLVDEFL  282 (295)
T ss_dssp             SCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGG
T ss_pred             CCHHHHHHHHHHccCChhhCCCHHHHhcChhh
Confidence            99999999999999999999999999987554

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.8e-43  Score=355.41  Aligned_cols=247  Identities=18%  Similarity=0.274  Sum_probs=200.8

Q ss_pred             CCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCC-----C
Q 012887          189 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN-----H  257 (454)
Q Consensus       189 ~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~-----~  257 (454)
                      .++|++++.||+|+||.||+|      +.||+|++............+.+|+.++..++||||+++++++...+     .
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            378999999999999999986      57999999765555555667889999999999999999999998653     2


Q ss_pred             eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccC
Q 012887          258 GLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV  337 (454)
Q Consensus       258 ~l~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~  337 (454)
                      .+|+||||+ +++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  181 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE  181 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSS
T ss_pred             eEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecccccccc
Confidence            369999999 7799999865 67999999999999999999999999999999999999999999999999998765432


Q ss_pred             CCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCC----------
Q 012887          338 GEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP----------  407 (454)
Q Consensus       338 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~----------  407 (454)
                         .....+|+.|+|||++.+..   .++.++|||||||++|||++|..||.+.+.......+......+          
T Consensus       182 ---~~~~~~t~~y~aPE~~~~~~---~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~  255 (367)
T 1cm8_A          182 ---MTGYVVTRWYRAPEVILNWM---RYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS  255 (367)
T ss_dssp             ---CCSSCSCGGGCCTHHHHTTT---CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred             ---cCcCcCCCCcCCHHHHhCCC---CCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhh
Confidence               33456799999999987632   24556999999999999999999999887766555443211110          


Q ss_pred             -------------------CCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 012887          408 -------------------EIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLL  443 (454)
Q Consensus       408 -------------------~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~  443 (454)
                                         .+....++.+.+||.+||..||.+|||+.|+++|-+
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~  310 (367)
T 1cm8_A          256 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPY  310 (367)
T ss_dssp             HHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred             HHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChH
Confidence                               123467899999999999999999999999999754

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.7e-43  Score=353.54  Aligned_cols=252  Identities=20%  Similarity=0.267  Sum_probs=203.4

Q ss_pred             CCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCch---HHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeE
Q 012887          189 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNA---YEFELRKDLLELMTCGHKNILQFYCVCVDENHGL  259 (454)
Q Consensus       189 ~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~---~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l  259 (454)
                      .++|++++.||+|+||.||+|      +.||+|.+........   ....+.+|+.++..++||||+++++++.+.+. +
T Consensus         9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~   87 (346)
T 1ua2_A            9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN-I   87 (346)
T ss_dssp             ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC-C
T ss_pred             hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc-e
Confidence            378999999999999999986      4799999874322211   12357789999999999999999999987776 8


Q ss_pred             EEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCC
Q 012887          260 CVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG  338 (454)
Q Consensus       260 ~lV~E~~~~gsL~~~l~~~~-~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~  338 (454)
                      ++||||+++ +|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus        88 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  166 (346)
T 1ua2_A           88 SLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN  166 (346)
T ss_dssp             EEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred             EEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCCc
Confidence            999999986 8998886543 79999999999999999999999999999999999999999999999999998765544


Q ss_pred             CcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCC---CC------
Q 012887          339 EATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP---EI------  409 (454)
Q Consensus       339 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~---~~------  409 (454)
                      .......+|+.|+|||.+.+..   .++.++|||||||++|+|++|.+||.+.+.......+......+   .+      
T Consensus       167 ~~~~~~~~t~~y~aPE~~~~~~---~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  243 (346)
T 1ua2_A          167 RAYTHQVVTRWYRAPELLFGAR---MYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSL  243 (346)
T ss_dssp             CCCCCSCCCCTTCCHHHHTTCS---CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSS
T ss_pred             ccCCcccccccccCchHhhCCC---CCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccC
Confidence            4455567899999999997542   25567999999999999999999999988877766654421111   00      


Q ss_pred             -----------------CCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 012887          410 -----------------PKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRT  445 (454)
Q Consensus       410 -----------------p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~  445 (454)
                                       ...+++++.+||.+||+.||.+|||+.|++++-+-.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~  296 (346)
T 1ua2_A          244 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFS  296 (346)
T ss_dssp             TTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGT
T ss_pred             cccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhh
Confidence                             145678999999999999999999999999987653

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=8.4e-44  Score=354.10  Aligned_cols=250  Identities=16%  Similarity=0.248  Sum_probs=197.6

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  263 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~  263 (454)
                      ++|++++.||+|+||.||+|      +.||+|.+...... .....+.+|+.++..++||||+++++++.+.+. +++||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~-~~lv~   79 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKS-LTLVF   79 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSC-EEEEE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc-ccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCE-EEEEe
Confidence            67999999999999999996      46999998643211 111234578899999999999999999988776 99999


Q ss_pred             eccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCccc
Q 012887          264 KLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE  342 (454)
Q Consensus       264 E~~~~gsL~~~l~~~~-~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~  342 (454)
                      ||+++ +|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...........
T Consensus        80 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~  158 (324)
T 3mtl_A           80 EYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYD  158 (324)
T ss_dssp             ECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC--------
T ss_pred             ccccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCccccc
Confidence            99975 9999886644 699999999999999999999999999999999999999999999999999876554444444


Q ss_pred             ccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCC---CC----------
Q 012887          343 YETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP---EI----------  409 (454)
Q Consensus       343 ~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~---~~----------  409 (454)
                      ...+|+.|+|||++.+..   .++.++|||||||++|+|++|..||.+.+.......+......+   .+          
T Consensus       159 ~~~~t~~y~aPE~~~~~~---~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  235 (324)
T 3mtl_A          159 NEVVTLWYRPPDILLGST---DYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK  235 (324)
T ss_dssp             ----CGGGCCHHHHTTCC---CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHH
T ss_pred             cccCcccccChhhhcCCC---CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhc
Confidence            557799999999987642   35567999999999999999999999988776665544321111   11          


Q ss_pred             ---------------CCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 012887          410 ---------------PKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRT  445 (454)
Q Consensus       410 ---------------p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~  445 (454)
                                     +..+++++.+||.+||+.||.+|||+.|+++|-+-.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~  286 (324)
T 3mtl_A          236 TYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFL  286 (324)
T ss_dssp             HTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGG
T ss_pred             ccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhh
Confidence                           124688999999999999999999999999976643

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=1.1e-42  Score=352.38  Aligned_cols=252  Identities=18%  Similarity=0.245  Sum_probs=211.8

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCc------hHHHHHHHHHHHHHhC-CCCceeEEEEEEEeCC
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGN------AYEFELRKDLLELMTC-GHKNILQFYCVCVDEN  256 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~------~~~~~~~~Ei~~l~~l-~HpnIv~~~g~~~~~~  256 (454)
                      ++|++.+.||+|+||.||++      +.||||.+.......      .....+.+|+.++..+ +||||+++++++...+
T Consensus        94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  173 (365)
T 2y7j_A           94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS  173 (365)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred             hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence            56999999999999999985      579999987543211      1234577899999998 7999999999998776


Q ss_pred             CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCcccccc
Q 012887          257 HGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS  336 (454)
Q Consensus       257 ~~l~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~  336 (454)
                      . .++||||+++++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus       174 ~-~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~  252 (365)
T 2y7j_A          174 F-MFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP  252 (365)
T ss_dssp             E-EEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred             E-EEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccCC
Confidence            5 999999999999999998777899999999999999999999999999999999999999999999999999876654


Q ss_pred             CCCcccccCCCCcccccccccCCCC--CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCC--CC
Q 012887          337 VGEATEYETDGYRWLAPEIIAGDPE--SVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIP--KD  412 (454)
Q Consensus       337 ~~~~~~~~~gt~~y~APE~l~~~~~--~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p--~~  412 (454)
                      .. ......||+.|+|||++.+...  ...++.++|||||||++|+|++|..||...........+.........|  ..
T Consensus       253 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  331 (365)
T 2y7j_A          253 GE-KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDD  331 (365)
T ss_dssp             TC-CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHHSS
T ss_pred             Cc-ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCccccc
Confidence            32 2344578999999999874321  2235667999999999999999999999887777666666654443332  46


Q ss_pred             ccHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 012887          413 CPQILKSLMIKCWNNSPSKRPQFSEIISLLL  443 (454)
Q Consensus       413 ~~~~l~~li~~cl~~dP~~RPs~~ell~~L~  443 (454)
                      ++..+.++|.+||+.||.+||++.+++++-+
T Consensus       332 ~~~~~~~li~~~L~~dP~~Rps~~ell~hp~  362 (365)
T 2y7j_A          332 RSSTVKDLISRLLQVDPEARLTAEQALQHPF  362 (365)
T ss_dssp             SCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred             CCHHHHHHHHHHcCCChhHCcCHHHHhcCcc
Confidence            7899999999999999999999999998754

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-43  Score=356.86  Aligned_cols=252  Identities=19%  Similarity=0.336  Sum_probs=205.5

Q ss_pred             cCCCEEEeceeeccCCceEEEeE---------EEEEEEeecCCC--CchHHHHHHHHHHHHHhC-CCCceeEEEEEEEeC
Q 012887          188 NSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKGCDK--GNAYEFELRKDLLELMTC-GHKNILQFYCVCVDE  255 (454)
Q Consensus       188 ~~~~~~~~~~LG~G~fG~Vy~g~---------~vavK~l~~~~~--~~~~~~~~~~Ei~~l~~l-~HpnIv~~~g~~~~~  255 (454)
                      ..++|++++.||+|+||.||+++         .||+|.++....  .......+.+|+.++..+ +||||+++++++.+.
T Consensus        52 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~  131 (355)
T 1vzo_A           52 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE  131 (355)
T ss_dssp             CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred             cccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeC
Confidence            34789999999999999999764         599999864221  111223356788888888 699999999999887


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccc
Q 012887          256 NHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK  335 (454)
Q Consensus       256 ~~~l~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~  335 (454)
                      +. +++||||+++|+|.+++.+...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus       132 ~~-~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~  210 (355)
T 1vzo_A          132 TK-LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV  210 (355)
T ss_dssp             TE-EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred             ce-EEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeecc
Confidence            76 99999999999999999877889999999999999999999999999999999999999999999999999987653


Q ss_pred             cCC-CcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC----HHHHHHHHHHcCCCCCCC
Q 012887          336 SVG-EATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACS----PVQAAVGIAACGLRPEIP  410 (454)
Q Consensus       336 ~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~----~~~~~~~i~~~~~~~~~p  410 (454)
                      ... .......||+.|+|||++.+...  .++.++|||||||++|||++|..||....    .......+..  ..+.+|
T Consensus       211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~  286 (355)
T 1vzo_A          211 ADETERAYDFCGTIEYMAPDIVRGGDS--GHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK--SEPPYP  286 (355)
T ss_dssp             GGGGGGGCGGGSCCTTCCHHHHTTCC-----CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHH--CCCCCC
T ss_pred             cCCCCcccCcccCcCccChhhhcCCCC--CCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhc--cCCCCC
Confidence            322 12333468999999999986422  34567999999999999999999997432    2233333333  355678


Q ss_pred             CCccHHHHHHHHHhcccCCCCCC-----CHHHHHHHHHh
Q 012887          411 KDCPQILKSLMIKCWNNSPSKRP-----QFSEIISLLLR  444 (454)
Q Consensus       411 ~~~~~~l~~li~~cl~~dP~~RP-----s~~ell~~L~~  444 (454)
                      ..++..+.+||.+||..||.+||     ++.|++++.+-
T Consensus       287 ~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f  325 (355)
T 1vzo_A          287 QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF  325 (355)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGG
T ss_pred             cccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcch
Confidence            88999999999999999999999     99999998764

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=1.5e-42  Score=342.46  Aligned_cols=261  Identities=16%  Similarity=0.237  Sum_probs=212.4

Q ss_pred             cceeecCCCEEEeceeeccCCceEEEe-----EEEEEEEeecCCCCchHHHHHHHHHHHHHhCC--CCceeEEEEEEEeC
Q 012887          183 GRWLLNSDNLEFIDQIGPNSFKGVYKG-----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCG--HKNILQFYCVCVDE  255 (454)
Q Consensus       183 ~~~~~~~~~~~~~~~LG~G~fG~Vy~g-----~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~--HpnIv~~~g~~~~~  255 (454)
                      ....+..++|++++.||+|+||.||++     +.+|+|.+............+.+|+.++..++  ||||+++++++.+.
T Consensus        21 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~  100 (313)
T 3cek_A           21 QSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD  100 (313)
T ss_dssp             CEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECS
T ss_pred             eeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecC
Confidence            345566788999999999999999985     57999999865555556677889999999986  59999999999887


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccc
Q 012887          256 NHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK  335 (454)
Q Consensus       256 ~~~l~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~  335 (454)
                      +. +++||| +.+++|.+++.+.+.+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++....
T Consensus       101 ~~-~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~  177 (313)
T 3cek_A          101 QY-IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ  177 (313)
T ss_dssp             SE-EEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC--
T ss_pred             CE-EEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeecccccccc
Confidence            76 999999 55779999998888999999999999999999999999999999999999997 5899999999987654


Q ss_pred             cCCC--cccccCCCCcccccccccCCCC-------CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHHHcCC
Q 012887          336 SVGE--ATEYETDGYRWLAPEIIAGDPE-------SVSETWMSNVYSFGMVIWEMVTGEAAYAACSP-VQAAVGIAACGL  405 (454)
Q Consensus       336 ~~~~--~~~~~~gt~~y~APE~l~~~~~-------~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~-~~~~~~i~~~~~  405 (454)
                      ....  ......+++.|+|||.+.+...       ...++.++||||||+++|+|++|..||..... ......+.....
T Consensus       178 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  257 (313)
T 3cek_A          178 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH  257 (313)
T ss_dssp             ------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTS
T ss_pred             CccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhccc
Confidence            3322  1233468999999999876321       12466789999999999999999999987543 344445555556


Q ss_pred             CCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 012887          406 RPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTN  446 (454)
Q Consensus       406 ~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~  446 (454)
                      ...+|...+.++.++|.+||+.||.+||++.|++++.+-..
T Consensus       258 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~  298 (313)
T 3cek_A          258 EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQI  298 (313)
T ss_dssp             CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHC
T ss_pred             ccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccC
Confidence            66778888999999999999999999999999999876543

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=3.4e-43  Score=373.64  Aligned_cols=250  Identities=20%  Similarity=0.312  Sum_probs=209.0

Q ss_pred             ecCCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCC-chHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeE
Q 012887          187 LNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGL  259 (454)
Q Consensus       187 ~~~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l  259 (454)
                      +..++|++++.||+|+||.||++      +.+|+|++...... ......+.+|+.++..++||||+++++++.+.+. +
T Consensus       182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~-l  260 (543)
T 3c4z_A          182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTD-L  260 (543)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE-E
T ss_pred             CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCE-E
Confidence            44588999999999999999985      57999999643211 1123457789999999999999999999988776 9


Q ss_pred             EEEEeccCCCCHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccc
Q 012887          260 CVVTKLMEGGSVNDLILKS----RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK  335 (454)
Q Consensus       260 ~lV~E~~~~gsL~~~l~~~----~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~  335 (454)
                      |+||||++||+|.+++.+.    ..+++..+..++.||+.||+|||++||+||||||+|||++.+|++||+|||++....
T Consensus       261 ~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~  340 (543)
T 3c4z_A          261 CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK  340 (543)
T ss_dssp             EEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence            9999999999999998653    369999999999999999999999999999999999999999999999999998765


Q ss_pred             cCCCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC----HHHHHHHHHHcCCCCCCCC
Q 012887          336 SVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACS----PVQAAVGIAACGLRPEIPK  411 (454)
Q Consensus       336 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~----~~~~~~~i~~~~~~~~~p~  411 (454)
                      ..........||+.|+|||++.+..    ++.++|||||||++|||++|..||.+..    .......+...  ...+|.
T Consensus       341 ~~~~~~~~~~GT~~Y~APE~l~~~~----~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~--~~~~p~  414 (543)
T 3c4z_A          341 AGQTKTKGYAGTPGFMAPELLLGEE----YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQ--AVTYPD  414 (543)
T ss_dssp             TTCCCBCCCCSCTTTSCHHHHTTCC----BCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHC--CCCCCT
T ss_pred             CCCcccccccCCccccChhhhcCCC----CChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhc--ccCCCc
Confidence            5444444458999999999998764    4456999999999999999999998653    33444444443  455788


Q ss_pred             CccHHHHHHHHHhcccCCCCCCCH-----HHHHHHHH
Q 012887          412 DCPQILKSLMIKCWNNSPSKRPQF-----SEIISLLL  443 (454)
Q Consensus       412 ~~~~~l~~li~~cl~~dP~~RPs~-----~ell~~L~  443 (454)
                      .+|+++.+||.+||+.||.+||++     .+|++|-+
T Consensus       415 ~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpf  451 (543)
T 3c4z_A          415 KFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPL  451 (543)
T ss_dssp             TSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGG
T ss_pred             ccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCcc
Confidence            899999999999999999999965     77776543

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=1.1e-42  Score=378.19  Aligned_cols=257  Identities=24%  Similarity=0.458  Sum_probs=215.4

Q ss_pred             cceeecCCCEEEeceeeccCCceEEEeE---------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEE
Q 012887          183 GRWLLNSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCV  253 (454)
Q Consensus       183 ~~~~~~~~~~~~~~~LG~G~fG~Vy~g~---------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~  253 (454)
                      ..+.+..++|++.+.||+|+||.||+|.         .||+|.++.. ........+.+|+.++..++||||+++++++.
T Consensus       383 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~  461 (656)
T 2j0j_A          383 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT  461 (656)
T ss_dssp             GGTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST-TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence            3456677899999999999999999974         4889988643 33344567889999999999999999999985


Q ss_pred             eCCCeEEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCcc
Q 012887          254 DENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVT  332 (454)
Q Consensus       254 ~~~~~l~lV~E~~~~gsL~~~l~~~~-~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~  332 (454)
                      + +. +++||||+++|+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus       462 ~-~~-~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~  539 (656)
T 2j0j_A          462 E-NP-VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR  539 (656)
T ss_dssp             S-SS-CEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCC
T ss_pred             c-Cc-eEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCe
Confidence            3 44 889999999999999997554 79999999999999999999999999999999999999999999999999987


Q ss_pred             ccccCCC-cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHcCCCCCCC
Q 012887          333 ACKSVGE-ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIP  410 (454)
Q Consensus       333 ~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p  410 (454)
                      ....... ......+++.|+|||.+.+..    ++.++|||||||++|||++ |..||.+.........+.. +.+++.|
T Consensus       540 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~----~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~-~~~~~~~  614 (656)
T 2j0j_A          540 YMEDSTYYKASKGKLPIKWMAPESINFRR----FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN-GERLPMP  614 (656)
T ss_dssp             SCCC----------CCGGGCCHHHHHHCC----CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHH-TCCCCCC
T ss_pred             ecCCCcceeccCCCCCcceeCHHHhcCCC----CCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc-CCCCCCC
Confidence            6544322 122335678899999997654    4557999999999999997 9999998887776655554 5566788


Q ss_pred             CCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 012887          411 KDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNN  447 (454)
Q Consensus       411 ~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~  447 (454)
                      ..+|+.+.++|.+||+.||.+||++.++++.|.++.+
T Consensus       615 ~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~  651 (656)
T 2j0j_A          615 PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE  651 (656)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence            8999999999999999999999999999999998754

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=6.2e-43  Score=365.61  Aligned_cols=248  Identities=19%  Similarity=0.245  Sum_probs=198.8

Q ss_pred             CCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCC-----C
Q 012887          189 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN-----H  257 (454)
Q Consensus       189 ~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~-----~  257 (454)
                      .++|++++.||+|+||.||++      +.||+|++............+.+|+.++..++||||+++++++...+     .
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            378999999999999999985      68999999865444555667889999999999999999999997553     3


Q ss_pred             eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccC
Q 012887          258 GLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV  337 (454)
Q Consensus       258 ~l~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~  337 (454)
                      .+|+||||+++ +|.+.+..  .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus       141 ~~~lv~E~~~~-~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  217 (464)
T 3ttj_A          141 DVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS  217 (464)
T ss_dssp             EEEEEEECCSE-EHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-----C
T ss_pred             eEEEEEeCCCC-CHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCCC
Confidence            47999999976 67776643  5999999999999999999999999999999999999999999999999999865443


Q ss_pred             CCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCC-----------
Q 012887          338 GEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR-----------  406 (454)
Q Consensus       338 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~-----------  406 (454)
                       .......+|+.|+|||++.+..+    +.++|||||||++|||++|+.||.+.+.......+......           
T Consensus       218 -~~~~~~~gt~~y~aPE~~~~~~~----~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~  292 (464)
T 3ttj_A          218 -FMMTPYVVTRYYRAPEVILGMGY----KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP  292 (464)
T ss_dssp             -CCC----CCCTTCCHHHHTTCCC----CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCH
T ss_pred             -cccCCCcccccccCHHHHcCCCC----CHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcch
Confidence             22344578999999999987654    44699999999999999999999998877665554431110           


Q ss_pred             ---------CC---------CCCC-----------ccHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 012887          407 ---------PE---------IPKD-----------CPQILKSLMIKCWNNSPSKRPQFSEIISLLLR  444 (454)
Q Consensus       407 ---------~~---------~p~~-----------~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~  444 (454)
                               +.         +|..           .++++.+||.+||..||.+|||+.|+++|-+-
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~  359 (464)
T 3ttj_A          293 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI  359 (464)
T ss_dssp             HHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTT
T ss_pred             hhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhh
Confidence                     00         0110           15679999999999999999999999998653

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=5.7e-43  Score=359.04  Aligned_cols=245  Identities=16%  Similarity=0.256  Sum_probs=193.1

Q ss_pred             CCEEEe-ceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHh-CCCCceeEEEEEEEe---CCCe
Q 012887          190 DNLEFI-DQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMT-CGHKNILQFYCVCVD---ENHG  258 (454)
Q Consensus       190 ~~~~~~-~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~-l~HpnIv~~~g~~~~---~~~~  258 (454)
                      ++|.+. +.||+|+||.||++      +.||+|.+...       ..+.+|+.++.+ .+||||+++++++..   .+..
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~  133 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC  133 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcE
Confidence            567776 68999999999986      46999999632       235677777644 589999999999875   2334


Q ss_pred             EEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEcc---CCcEEEEccCCccc
Q 012887          259 LCVVTKLMEGGSVNDLILKSR--KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDR---HGNVCLGDMGIVTA  333 (454)
Q Consensus       259 l~lV~E~~~~gsL~~~l~~~~--~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~---~~~vKL~DFGla~~  333 (454)
                      +|+||||+++|+|.+++.+..  .+++..+..++.||+.||.|||++||+||||||+|||++.   ++.+||+|||+++.
T Consensus       134 ~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~  213 (400)
T 1nxk_A          134 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE  213 (400)
T ss_dssp             EEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred             EEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccc
Confidence            899999999999999997643  6999999999999999999999999999999999999998   78899999999876


Q ss_pred             cccCCCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHH----HHHHHHHcCCCCCC
Q 012887          334 CKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQ----AAVGIAACGLRPEI  409 (454)
Q Consensus       334 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~----~~~~i~~~~~~~~~  409 (454)
                      ..... ......+|+.|+|||++.+..    ++.++|||||||++|+|++|..||.+.....    ....+.......+.
T Consensus       214 ~~~~~-~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~  288 (400)
T 1nxk_A          214 TTSHN-SLTTPCYTPYYVAPEVLGPEK----YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN  288 (400)
T ss_dssp             CC------------CTTCCGGGSCCCC----SSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCT
T ss_pred             cCCCC-ccccCCCCCCccCHhhcCCCC----CCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCC
Confidence            54322 234456899999999997664    4456999999999999999999998654321    23334444333332


Q ss_pred             --CCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 012887          410 --PKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTN  446 (454)
Q Consensus       410 --p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~  446 (454)
                        ...++.++.+||.+||+.||.+|||+.|+++|-|-..
T Consensus       289 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~  327 (400)
T 1nxk_A          289 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ  327 (400)
T ss_dssp             TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHT
T ss_pred             cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccC
Confidence              2568999999999999999999999999999977653

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=8.8e-45  Score=360.16  Aligned_cols=256  Identities=23%  Similarity=0.398  Sum_probs=202.6

Q ss_pred             eeecCCCEEEeceeeccCCceEEEe-----EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeE
Q 012887          185 WLLNSDNLEFIDQIGPNSFKGVYKG-----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGL  259 (454)
Q Consensus       185 ~~~~~~~~~~~~~LG~G~fG~Vy~g-----~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l  259 (454)
                      ..+..++|++.+.||+|+||.||+|     +.||+|.+...... .....+.+|+.++..++||||+++++++.+.+. .
T Consensus        25 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~-~  102 (326)
T 3uim_A           25 LQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE-R  102 (326)
T ss_dssp             HHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSC-C
T ss_pred             HHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCc-hHHHHHHHHHHHHHhccCCCccceEEEEecCCc-e
Confidence            4456688999999999999999995     56999998753322 122357899999999999999999999988776 8


Q ss_pred             EEEEeccCCCCHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhc---CcccCCccCCcEEEccCCcEEEEccCCcc
Q 012887          260 CVVTKLMEGGSVNDLILKSR----KLQTKEIIRIAIDVAEGIKFLNDH---GVAYRDLNSQRILLDRHGNVCLGDMGIVT  332 (454)
Q Consensus       260 ~lV~E~~~~gsL~~~l~~~~----~l~~~~~~~i~~qI~~gL~yLH~~---~iiHrDIKp~NILl~~~~~vKL~DFGla~  332 (454)
                      ++||||+++|+|.+++....    .+++..+..++.||+.||.|||++   ||+||||||+|||++.++.+||+|||++.
T Consensus       103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~  182 (326)
T 3uim_A          103 LLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK  182 (326)
T ss_dssp             EEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCE
T ss_pred             EEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCcccc
Confidence            89999999999999996543    499999999999999999999999   99999999999999999999999999988


Q ss_pred             ccccCCC-cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC----HHHHHHHHHHc----
Q 012887          333 ACKSVGE-ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACS----PVQAAVGIAAC----  403 (454)
Q Consensus       333 ~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~----~~~~~~~i~~~----  403 (454)
                      ....... ......||+.|+|||.+.+..    ++.++|||||||++|+|++|..||....    ...........    
T Consensus       183 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  258 (326)
T 3uim_A          183 LMDYKDTHVTTAVRGTIGHIAPEYLSTGK----SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE  258 (326)
T ss_dssp             ECCSSSSCEECCCCSCGGGCCHHHHHHSE----ECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSS
T ss_pred             ccCcccccccccccCCcCccCHHHhccCC----CCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhc
Confidence            6643322 233345899999999997664    4557999999999999999999996210    00001111111    


Q ss_pred             ---------CCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 012887          404 ---------GLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTN  446 (454)
Q Consensus       404 ---------~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~  446 (454)
                               ......+...+..+.+++.+||+.||.+|||+.|++++|+...
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~  310 (326)
T 3uim_A          259 KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG  310 (326)
T ss_dssp             CCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred             hhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence                     1111223344578999999999999999999999999998643

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1.6e-43  Score=354.49  Aligned_cols=242  Identities=15%  Similarity=0.203  Sum_probs=204.8

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCch------HHHHHHHHHHHHHhCCCCceeEEEEEEEeCCC
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNA------YEFELRKDLLELMTCGHKNILQFYCVCVDENH  257 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~------~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~  257 (454)
                      ++|++++.||+|+||.||++      +.||+|.+........      ....+.+|+.++..++||||+++++++.+.+.
T Consensus        24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~  103 (335)
T 3dls_A           24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF  103 (335)
T ss_dssp             HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCE
Confidence            67899999999999999996      5799999986432211      22346679999999999999999999987776


Q ss_pred             eEEEEEeccCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCcccccc
Q 012887          258 GLCVVTKLMEGG-SVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS  336 (454)
Q Consensus       258 ~l~lV~E~~~~g-sL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~  336 (454)
                       +++||||+.+| +|.+++.+.+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus       104 -~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~  182 (335)
T 3dls_A          104 -FQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLER  182 (335)
T ss_dssp             -EEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             -EEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECCC
Confidence             99999999777 9999998888999999999999999999999999999999999999999999999999999876654


Q ss_pred             CCCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHH
Q 012887          337 VGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQI  416 (454)
Q Consensus       337 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~  416 (454)
                      .. ......||+.|+|||++.+..+   .+.++|||||||++|+|++|..||.....        ........|..++++
T Consensus       183 ~~-~~~~~~gt~~y~aPE~~~~~~~---~~~~~DiwslG~il~el~~g~~pf~~~~~--------~~~~~~~~~~~~~~~  250 (335)
T 3dls_A          183 GK-LFYTFCGTIEYCAPEVLMGNPY---RGPELEMWSLGVTLYTLVFEENPFCELEE--------TVEAAIHPPYLVSKE  250 (335)
T ss_dssp             TC-CBCEECSCGGGCCHHHHTTCCB---CSHHHHHHHHHHHHHHHHHSSCSCSSGGG--------GTTTCCCCSSCCCHH
T ss_pred             CC-ceeccCCCccccChhhhcCCCC---CCCcccchhHHHHHHHHHhCCCchhhHHH--------HHhhccCCCcccCHH
Confidence            32 2334568999999999987643   24569999999999999999999976322        112234456678999


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 012887          417 LKSLMIKCWNNSPSKRPQFSEIISLLLR  444 (454)
Q Consensus       417 l~~li~~cl~~dP~~RPs~~ell~~L~~  444 (454)
                      +.+||.+||+.||.+|||+.+++++-+-
T Consensus       251 l~~li~~~L~~dP~~Rps~~ell~hp~~  278 (335)
T 3dls_A          251 LMSLVSGLLQPVPERRTTLEKLVTDPWV  278 (335)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHCTTT
T ss_pred             HHHHHHHHccCChhhCcCHHHHhcCccc
Confidence            9999999999999999999999998653

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=8.9e-43  Score=340.10  Aligned_cols=252  Identities=18%  Similarity=0.210  Sum_probs=204.4

Q ss_pred             CCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEE
Q 012887          189 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  262 (454)
Q Consensus       189 ~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV  262 (454)
                      .++|++.+.||+|+||.||+|      +.||+|.+......    ..+.+|+.++..++|++++..++.+...+...++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   83 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV   83 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC----CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch----hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEE
Confidence            378999999999999999996      57999998754332    24678999999999988777777776666568999


Q ss_pred             EeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEE---ccCCcEEEEccCCccccccCC
Q 012887          263 TKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILL---DRHGNVCLGDMGIVTACKSVG  338 (454)
Q Consensus       263 ~E~~~~gsL~~~l~~-~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl---~~~~~vKL~DFGla~~~~~~~  338 (454)
                      |||+ +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++.......
T Consensus        84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~  162 (296)
T 3uzp_A           84 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR  162 (296)
T ss_dssp             EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred             EEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccc
Confidence            9999 8899999964 4589999999999999999999999999999999999999   488999999999988765433


Q ss_pred             C-------cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHHHcC---C
Q 012887          339 E-------ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSP---VQAAVGIAACG---L  405 (454)
Q Consensus       339 ~-------~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~---~~~~~~i~~~~---~  405 (454)
                      .       ......+|+.|+|||.+.+..    ++.++|||||||++|+|++|..||.+...   ......+....   .
T Consensus       163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  238 (296)
T 3uzp_A          163 THQHIPYRENKNLTGTARYASINTHLGIE----QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP  238 (296)
T ss_dssp             TCCBCCCCCSCCCCSCTTTCCHHHHTTCC----CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred             cccccccccccccccccccCChhhhcCCC----CCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc
Confidence            2       123456899999999998764    45579999999999999999999986432   11222222111   1


Q ss_pred             CCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCCC
Q 012887          406 RPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNIS  449 (454)
Q Consensus       406 ~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~  449 (454)
                      ....+..+|+++.+++.+||+.||.+||++.++++.|+++....
T Consensus       239 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~  282 (296)
T 3uzp_A          239 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ  282 (296)
T ss_dssp             HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhc
Confidence            11234678999999999999999999999999999999876543

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=4.5e-43  Score=343.49  Aligned_cols=252  Identities=18%  Similarity=0.372  Sum_probs=204.8

Q ss_pred             CCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEE
Q 012887          189 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  262 (454)
Q Consensus       189 ~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV  262 (454)
                      .+.|++++.||+|+||.||+|      +.+|+|.+.....  .....+.+|+.++..++||||+++++++.+.+. +++|
T Consensus        18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~lv   94 (302)
T 2j7t_A           18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSE--EELEDYIVEIEILATCDHPYIVKLLGAYYHDGK-LWIM   94 (302)
T ss_dssp             GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-C-EEEE
T ss_pred             ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCH--HHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCe-EEEE
Confidence            478999999999999999996      4689998864322  234567789999999999999999999998776 9999


Q ss_pred             EeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCcc
Q 012887          263 TKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT  341 (454)
Q Consensus       263 ~E~~~~gsL~~~l~~-~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~  341 (454)
                      |||+++++|.+++.+ ...+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++..........
T Consensus        95 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  174 (302)
T 2j7t_A           95 IEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKR  174 (302)
T ss_dssp             EECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC-
T ss_pred             EEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCcccccccccc
Confidence            999999999999865 5679999999999999999999999999999999999999999999999999875433222223


Q ss_pred             cccCCCCcccccccccCCC-CCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCC-CCCCCccHHHHH
Q 012887          342 EYETDGYRWLAPEIIAGDP-ESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP-EIPKDCPQILKS  419 (454)
Q Consensus       342 ~~~~gt~~y~APE~l~~~~-~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~-~~p~~~~~~l~~  419 (454)
                      ....+++.|+|||.+.... ....++.++||||||+++|+|++|..||...+.......+.....+. ..+..++..+.+
T Consensus       175 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  254 (302)
T 2j7t_A          175 DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFRD  254 (302)
T ss_dssp             ----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHH
T ss_pred             ccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccccCHHHHH
Confidence            3446889999999984210 11235567999999999999999999999888877766666544332 345678999999


Q ss_pred             HHHHhcccCCCCCCCHHHHHHHHH
Q 012887          420 LMIKCWNNSPSKRPQFSEIISLLL  443 (454)
Q Consensus       420 li~~cl~~dP~~RPs~~ell~~L~  443 (454)
                      +|.+||+.||.+|||+.+++++-+
T Consensus       255 li~~~l~~dp~~Rps~~~ll~h~~  278 (302)
T 2j7t_A          255 FLKIALDKNPETRPSAAQLLEHPF  278 (302)
T ss_dssp             HHHHHSCSCTTTSCCHHHHTTSTT
T ss_pred             HHHHHcccChhhCCCHHHHhcChH
Confidence            999999999999999999998654

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=9.5e-43  Score=339.66  Aligned_cols=248  Identities=19%  Similarity=0.348  Sum_probs=211.4

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  263 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~  263 (454)
                      ++|++++.||+|+||.||++      +.||+|.+............+.+|+.++.+++||||+++++++.+.+. +++||
T Consensus        22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~-~~lv~  100 (287)
T 2wei_A           22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSS-FYIVG  100 (287)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE-EEEEE
T ss_pred             hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCe-EEEEE
Confidence            67899999999999999996      479999997654444455678899999999999999999999987765 99999


Q ss_pred             eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCC---cEEEEccCCccccccCCCc
Q 012887          264 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG---NVCLGDMGIVTACKSVGEA  340 (454)
Q Consensus       264 E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~---~vKL~DFGla~~~~~~~~~  340 (454)
                      ||+++++|.+++.+...+++..+..++.||+.||.|||++|++||||||+|||++.++   .+||+|||++........ 
T Consensus       101 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~-  179 (287)
T 2wei_A          101 ELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK-  179 (287)
T ss_dssp             CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSS-
T ss_pred             EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCCc-
Confidence            9999999999997777899999999999999999999999999999999999997644   699999999876543322 


Q ss_pred             ccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCC--CCccHHHH
Q 012887          341 TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIP--KDCPQILK  418 (454)
Q Consensus       341 ~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p--~~~~~~l~  418 (454)
                      .....+++.|+|||.+.+.     ++.++||||||+++|+|++|..||.+.+.......+.........+  ..+++++.
T Consensus       180 ~~~~~~~~~y~aPE~~~~~-----~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (287)
T 2wei_A          180 MKDRIGTAYYIAPEVLRGT-----YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAK  254 (287)
T ss_dssp             CSCHHHHHTTCCHHHHTTC-----CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHH
T ss_pred             cccccCcccccChHHhcCC-----CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHH
Confidence            2233467889999998753     4567999999999999999999999988877776666655544443  56899999


Q ss_pred             HHHHHhcccCCCCCCCHHHHHHHHHh
Q 012887          419 SLMIKCWNNSPSKRPQFSEIISLLLR  444 (454)
Q Consensus       419 ~li~~cl~~dP~~RPs~~ell~~L~~  444 (454)
                      ++|.+||+.||.+|||+.|++++-+-
T Consensus       255 ~li~~~l~~dp~~Rps~~ell~hp~~  280 (287)
T 2wei_A          255 DLIRKMLTFHPSLRITATQCLEHPWI  280 (287)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHSHHH
T ss_pred             HHHHHHcccChhhCcCHHHHhcCHHH
Confidence            99999999999999999999997543

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=1.4e-42  Score=348.44  Aligned_cols=253  Identities=17%  Similarity=0.277  Sum_probs=205.7

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCC-------
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN-------  256 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~-------  256 (454)
                      ++|++++.||+|+||.||++      +.||+|++............+.+|+.++..++||||+++++++.+..       
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   96 (351)
T 3mi9_A           17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   96 (351)
T ss_dssp             GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred             cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence            68899999999999999996      47999998755544444556779999999999999999999998742       


Q ss_pred             CeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccc
Q 012887          257 HGLCVVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK  335 (454)
Q Consensus       257 ~~l~lV~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~  335 (454)
                      ..+++||||+++ +|.+.+... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus        97 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~  175 (351)
T 3mi9_A           97 GSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFS  175 (351)
T ss_dssp             CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             ceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhccccc
Confidence            248999999986 887777544 589999999999999999999999999999999999999999999999999987654


Q ss_pred             cCC----CcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHc--CCCCCC
Q 012887          336 SVG----EATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAAC--GLRPEI  409 (454)
Q Consensus       336 ~~~----~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~--~~~~~~  409 (454)
                      ...    .......+|+.|+|||++.+..   .++.++|||||||++|+|++|..||.+.+.......+...  ...+..
T Consensus       176 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  252 (351)
T 3mi9_A          176 LAKNSQPNRYTNRVVTLWYRPPELLLGER---DYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV  252 (351)
T ss_dssp             CCSSSSCCCCCSSCSCGGGCCHHHHTTCC---SCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred             ccccccccccCCcccccCccCchhhcCCC---CCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhh
Confidence            321    1223446789999999987642   2456799999999999999999999998877665554432  122211


Q ss_pred             CCC----------------------------ccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 012887          410 PKD----------------------------CPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTN  446 (454)
Q Consensus       410 p~~----------------------------~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~  446 (454)
                      ...                            .++.+.+||.+||+.||.+|||+.|+++|-+-..
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  317 (351)
T 3mi9_A          253 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS  317 (351)
T ss_dssp             STTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGS
T ss_pred             ccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCC
Confidence            111                            2678999999999999999999999999877543

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=8e-43  Score=346.85  Aligned_cols=255  Identities=22%  Similarity=0.433  Sum_probs=210.8

Q ss_pred             ecCCCEEEeceeeccCCceEEEeE----------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCC
Q 012887          187 LNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN  256 (454)
Q Consensus       187 ~~~~~~~~~~~LG~G~fG~Vy~g~----------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~  256 (454)
                      +..++|++++.||+|+||.||+++          .||+|++...  .......+.+|+.++..++||||+++++++...+
T Consensus        38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  115 (326)
T 2w1i_A           38 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG  115 (326)
T ss_dssp             CCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC--CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC--
T ss_pred             cCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecC
Confidence            455789999999999999999864          7999998742  3344566889999999999999999999987654


Q ss_pred             -CeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCcccc
Q 012887          257 -HGLCVVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC  334 (454)
Q Consensus       257 -~~l~lV~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~  334 (454)
                       ..+++||||+++++|.+++.+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus       116 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~  195 (326)
T 2w1i_A          116 RRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVL  195 (326)
T ss_dssp             --CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             CCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhhc
Confidence             2489999999999999999765 46999999999999999999999999999999999999999999999999998876


Q ss_pred             ccCCCc---ccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHH---------------HH
Q 012887          335 KSVGEA---TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPV---------------QA  396 (454)
Q Consensus       335 ~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~---------------~~  396 (454)
                      ......   .....++..|+|||.+.+..    ++.++||||||+++|+|++|..||......               ..
T Consensus       196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (326)
T 2w1i_A          196 PQDKEYYKVKEPGESPIFWYAPESLTESK----FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH  271 (326)
T ss_dssp             CSSCSEEECSSCCSCCGGGCCHHHHHHCE----EEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHH
T ss_pred             cccccccccccCCCCceeEECchhhcCCC----CCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHH
Confidence            543321   22334667899999998664    345699999999999999999988642110               11


Q ss_pred             HHHHHHcCCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 012887          397 AVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNN  447 (454)
Q Consensus       397 ~~~i~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~  447 (454)
                      .......+.+++.|..+|+++.++|.+||+.||.+|||+.++++.|+++..
T Consensus       272 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~  322 (326)
T 2w1i_A          272 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD  322 (326)
T ss_dssp             HHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            223444556677788999999999999999999999999999999998754

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=2.7e-43  Score=350.60  Aligned_cols=262  Identities=22%  Similarity=0.356  Sum_probs=200.2

Q ss_pred             eeecCCCEEEeceeeccCCceEEEe----EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeC----C
Q 012887          185 WLLNSDNLEFIDQIGPNSFKGVYKG----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDE----N  256 (454)
Q Consensus       185 ~~~~~~~~~~~~~LG~G~fG~Vy~g----~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~----~  256 (454)
                      ..+..++|++++.||+|+||.||+|    +.||+|.+...   .......+.++..+..++||||+++++.+...    .
T Consensus         8 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~   84 (336)
T 3g2f_A            8 PSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGR   84 (336)
T ss_dssp             -CCCTTSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSC
T ss_pred             CCcChHHhheeeecccCCCeEEEEEEECCeEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheecccccccCCC
Confidence            3456789999999999999999996    67999998732   22233334555555568999999999866432    2


Q ss_pred             CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhc---------CcccCCccCCcEEEccCCcEEEEc
Q 012887          257 HGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDH---------GVAYRDLNSQRILLDRHGNVCLGD  327 (454)
Q Consensus       257 ~~l~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~---------~iiHrDIKp~NILl~~~~~vKL~D  327 (454)
                      ..+++||||+++|+|.+++... ..++..+..++.||+.||.|||++         ||+||||||+|||++.++.+||+|
T Consensus        85 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~D  163 (336)
T 3g2f_A           85 MEYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISD  163 (336)
T ss_dssp             EEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECC
T ss_pred             ceEEEEEecCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEee
Confidence            3478999999999999999554 458999999999999999999999         999999999999999999999999


Q ss_pred             cCCccccccCC--------CcccccCCCCcccccccccCCCCC---CCCCchhhHHHHHHHHHHHHcCCCCCCCCCH---
Q 012887          328 MGIVTACKSVG--------EATEYETDGYRWLAPEIIAGDPES---VSETWMSNVYSFGMVIWEMVTGEAAYAACSP---  393 (454)
Q Consensus       328 FGla~~~~~~~--------~~~~~~~gt~~y~APE~l~~~~~~---~~~~~ksDVwSlGviL~elltG~~Pf~~~~~---  393 (454)
                      ||++.......        .......||+.|+|||++.+....   ..++.++|||||||++|||++|..||.....   
T Consensus       164 FG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~  243 (336)
T 3g2f_A          164 FGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPE  243 (336)
T ss_dssp             CTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCC
T ss_pred             ccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhH
Confidence            99987654321        112234689999999999864221   1234579999999999999999776642211   


Q ss_pred             ---------------HHHHHHHHHcCCCCCCCCC------ccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCCCC
Q 012887          394 ---------------VQAAVGIAACGLRPEIPKD------CPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISN  450 (454)
Q Consensus       394 ---------------~~~~~~i~~~~~~~~~p~~------~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~  450 (454)
                                     ............++.+|..      +++++.+||.+||+.||.+|||+.|+++.|+++....+
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~  321 (336)
T 3g2f_A          244 YQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWE  321 (336)
T ss_dssp             CCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCC
T ss_pred             HHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHH
Confidence                           1111222333445555554      45689999999999999999999999999999876544

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=1.2e-42  Score=338.93  Aligned_cols=250  Identities=18%  Similarity=0.224  Sum_probs=200.4

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  263 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~  263 (454)
                      ++|++.+.||+|+||.||+|      +.||+|.+......    ..+.+|+.++..+.|++++..++.+...+...++||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 4hgt_A            9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             --CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C----CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             CceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc----hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence            78999999999999999996      47999987643322    236788889999998888877777766655589999


Q ss_pred             eccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEE---ccCCcEEEEccCCccccccCCC
Q 012887          264 KLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILL---DRHGNVCLGDMGIVTACKSVGE  339 (454)
Q Consensus       264 E~~~~gsL~~~l~~-~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl---~~~~~vKL~DFGla~~~~~~~~  339 (454)
                      ||+ +++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++........
T Consensus        85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~  163 (296)
T 4hgt_A           85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART  163 (296)
T ss_dssp             ECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred             Ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCccc
Confidence            999 8899999964 4589999999999999999999999999999999999999   7899999999999887654322


Q ss_pred             -------cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHHHHcCCC---
Q 012887          340 -------ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPV---QAAVGIAACGLR---  406 (454)
Q Consensus       340 -------~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~---~~~~~i~~~~~~---  406 (454)
                             ......+|+.|+|||.+.+..    ++.++|||||||++|+|++|..||.+....   .....+......   
T Consensus       164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  239 (296)
T 4hgt_A          164 HQHIPYRENKNLTGTARYASINTHLGIE----QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI  239 (296)
T ss_dssp             CCBCCCCCSCCCCSCGGGCCHHHHTTCC----CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred             CccCCCCcccccCCCccccchHHhcCCC----CCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchh
Confidence                   123456899999999998764    455799999999999999999999864332   122222221111   


Q ss_pred             CCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCC
Q 012887          407 PEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNI  448 (454)
Q Consensus       407 ~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~  448 (454)
                      ...+..+|+++.++|.+||+.||.+|||+.++++.|.++...
T Consensus       240 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~  281 (296)
T 4hgt_A          240 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR  281 (296)
T ss_dssp             HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHH
T ss_pred             hhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHH
Confidence            123367899999999999999999999999999999987664

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.8e-43  Score=377.29  Aligned_cols=249  Identities=18%  Similarity=0.309  Sum_probs=209.2

Q ss_pred             ecCCCEEEeceeeccCCceEEEe------EEEEEEEeecCCC-CchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeE
Q 012887          187 LNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDK-GNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGL  259 (454)
Q Consensus       187 ~~~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l  259 (454)
                      +..++|++++.||+|+||.||++      +.||+|++..... .......+.+|+.+|..++|||||++++++.+.+. +
T Consensus       181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~-l  259 (576)
T 2acx_A          181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDA-L  259 (576)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE-E
T ss_pred             ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCE-E
Confidence            56688999999999999999985      5799999864321 11223457789999999999999999999988776 9


Q ss_pred             EEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccC
Q 012887          260 CVVTKLMEGGSVNDLILKSR--KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV  337 (454)
Q Consensus       260 ~lV~E~~~~gsL~~~l~~~~--~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~  337 (454)
                      |+||||++||+|.+++...+  .+++..+..++.||+.||+|||++||+||||||+|||++.+|++||+|||++......
T Consensus       260 ~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~  339 (576)
T 2acx_A          260 CLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG  339 (576)
T ss_dssp             EEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccC
Confidence            99999999999999996644  4999999999999999999999999999999999999999999999999999776443


Q ss_pred             CCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC----HHHHHHHHHHcCCCCCCCCCc
Q 012887          338 GEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACS----PVQAAVGIAACGLRPEIPKDC  413 (454)
Q Consensus       338 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~----~~~~~~~i~~~~~~~~~p~~~  413 (454)
                      . ......||+.|+|||++.+..+    +.++|||||||++|||++|..||.+..    .......+..  .+..+|..+
T Consensus       340 ~-~~~~~~GT~~Y~APEvl~~~~~----~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~--~~~~~p~~~  412 (576)
T 2acx_A          340 Q-TIKGRVGTVGYMAPEVVKNERY----TFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE--VPEEYSERF  412 (576)
T ss_dssp             C-CEECCCSCGGGCCHHHHTTCEE----SSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHH--CCCCCCTTS
T ss_pred             c-cccccCCCccccCHHHHcCCCC----CccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhc--ccccCCccC
Confidence            2 2334579999999999987654    456999999999999999999998753    2333333332  355678889


Q ss_pred             cHHHHHHHHHhcccCCCCCC-----CHHHHHHHHH
Q 012887          414 PQILKSLMIKCWNNSPSKRP-----QFSEIISLLL  443 (454)
Q Consensus       414 ~~~l~~li~~cl~~dP~~RP-----s~~ell~~L~  443 (454)
                      ++++.+||.+||+.||.+||     ++.|+++|-+
T Consensus       413 s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~Hpf  447 (576)
T 2acx_A          413 SPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPL  447 (576)
T ss_dssp             CHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGG
T ss_pred             CHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChh
Confidence            99999999999999999999     7899998754

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.4e-42  Score=353.25  Aligned_cols=246  Identities=17%  Similarity=0.247  Sum_probs=199.9

Q ss_pred             ecCCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCC----
Q 012887          187 LNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN----  256 (454)
Q Consensus       187 ~~~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~----  256 (454)
                      ...++|++++.||+|+||.||++      +.||+|++......      ..+|+.+++.++||||+++++++....    
T Consensus         4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~------~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~   77 (383)
T 3eb0_A            4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY------KNRELDIMKVLDHVNIIKLVDYFYTTGDEEP   77 (383)
T ss_dssp             --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS------CCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred             cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch------HHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence            45688999999999999999996      57999998744322      236889999999999999999985432    


Q ss_pred             ---------------------------------CeEEEEEeccCCCCHHHHHH----hCCCCCHHHHHHHHHHHHHHHHH
Q 012887          257 ---------------------------------HGLCVVTKLMEGGSVNDLIL----KSRKLQTKEIIRIAIDVAEGIKF  299 (454)
Q Consensus       257 ---------------------------------~~l~lV~E~~~~gsL~~~l~----~~~~l~~~~~~~i~~qI~~gL~y  299 (454)
                                                       ..+++||||+++ +|.+.+.    ....+++..+..++.||+.||.|
T Consensus        78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~  156 (383)
T 3eb0_A           78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF  156 (383)
T ss_dssp             --------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence                                             238899999985 8777764    35689999999999999999999


Q ss_pred             HHhcCcccCCccCCcEEEc-cCCcEEEEccCCccccccCCCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHH
Q 012887          300 LNDHGVAYRDLNSQRILLD-RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVI  378 (454)
Q Consensus       300 LH~~~iiHrDIKp~NILl~-~~~~vKL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL  378 (454)
                      ||++||+||||||+|||++ .++.+||+|||+++...... ......+|+.|+|||.+.+..   .++.++|||||||++
T Consensus       157 LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~---~~~~~~DiwslG~il  232 (383)
T 3eb0_A          157 IHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE-PSVAYICSRFYRAPELMLGAT---EYTPSIDLWSIGCVF  232 (383)
T ss_dssp             HHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS-CCCCCCCCSSCCCHHHHTTCS---SCCTHHHHHHHHHHH
T ss_pred             HHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC-CCcCcccCCCccCHHHhcCCC---CCCcchhhhhHHHHH
Confidence            9999999999999999998 68899999999998664433 233456788999999987643   255679999999999


Q ss_pred             HHHHcCCCCCCCCCHHHHHHHHHHcCCC---------------------------CCCCCCccHHHHHHHHHhcccCCCC
Q 012887          379 WEMVTGEAAYAACSPVQAAVGIAACGLR---------------------------PEIPKDCPQILKSLMIKCWNNSPSK  431 (454)
Q Consensus       379 ~elltG~~Pf~~~~~~~~~~~i~~~~~~---------------------------~~~p~~~~~~l~~li~~cl~~dP~~  431 (454)
                      |||++|..||.+.+.......+......                           ..+|..+|+++.+||.+||+.||.+
T Consensus       233 ~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~  312 (383)
T 3eb0_A          233 GELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDL  312 (383)
T ss_dssp             HHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGG
T ss_pred             HHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhh
Confidence            9999999999998887766665431111                           1145668999999999999999999


Q ss_pred             CCCHHHHHHHHH
Q 012887          432 RPQFSEIISLLL  443 (454)
Q Consensus       432 RPs~~ell~~L~  443 (454)
                      |||+.|+++|-+
T Consensus       313 R~t~~e~l~hp~  324 (383)
T 3eb0_A          313 RINPYEAMAHPF  324 (383)
T ss_dssp             SCCHHHHHTSGG
T ss_pred             CCCHHHHhcCHH
Confidence            999999997644

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=4.3e-43  Score=361.98  Aligned_cols=252  Identities=16%  Similarity=0.225  Sum_probs=196.3

Q ss_pred             CCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCC------chHHHHHHHHHHHHHhCCCCceeEEEEEEEeCC
Q 012887          189 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG------NAYEFELRKDLLELMTCGHKNILQFYCVCVDEN  256 (454)
Q Consensus       189 ~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~------~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~  256 (454)
                      .++|.+.+.||+|+||.||+|      +.||+|.+......      ......+.+|+.+|.+++||||+++++++..+ 
T Consensus       134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-  212 (419)
T 3i6u_A          134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE-  212 (419)
T ss_dssp             HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEESS-
T ss_pred             hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEecC-
Confidence            378999999999999999996      58999998753211      11122478999999999999999999998543 


Q ss_pred             CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCC---cEEEEccCCccc
Q 012887          257 HGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG---NVCLGDMGIVTA  333 (454)
Q Consensus       257 ~~l~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~---~vKL~DFGla~~  333 (454)
                      . +++||||+++|+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++   .+||+|||+++.
T Consensus       213 ~-~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~  291 (419)
T 3i6u_A          213 D-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI  291 (419)
T ss_dssp             E-EEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTS
T ss_pred             c-eEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeeccccee
Confidence            3 889999999999999988778999999999999999999999999999999999999997654   599999999987


Q ss_pred             cccCCCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCC---CC
Q 012887          334 CKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPE---IP  410 (454)
Q Consensus       334 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~---~p  410 (454)
                      ..... ......||+.|+|||++.+... ..++.++|||||||++|+|++|..||...............+....   .+
T Consensus       292 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~-~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~  369 (419)
T 3i6u_A          292 LGETS-LMRTLCGTPTYLAPEVLVSVGT-AGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVW  369 (419)
T ss_dssp             CC------------CTTCCTTTTC-----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHH
T ss_pred             cCCCc-cccccCCCCCccCceeeecCCC-CCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhh
Confidence            64432 2334578999999999864321 2356689999999999999999999987544333333333332222   22


Q ss_pred             CCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 012887          411 KDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR  444 (454)
Q Consensus       411 ~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~  444 (454)
                      ..+++.+.++|.+||+.||.+||++.|+++|-|-
T Consensus       370 ~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~  403 (419)
T 3i6u_A          370 AEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL  403 (419)
T ss_dssp             TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGG
T ss_pred             cccCHHHHHHHHHHccCChhHCcCHHHHhCCccc
Confidence            4689999999999999999999999999998653

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=4e-42  Score=336.14  Aligned_cols=254  Identities=21%  Similarity=0.234  Sum_probs=212.8

Q ss_pred             CCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCC-------chHHHHHHHHHHHHHhCC-CCceeEEEEEEEe
Q 012887          189 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG-------NAYEFELRKDLLELMTCG-HKNILQFYCVCVD  254 (454)
Q Consensus       189 ~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~-------~~~~~~~~~Ei~~l~~l~-HpnIv~~~g~~~~  254 (454)
                      .++|++.+.||+|+||.||++      +.||+|.+......       ......+.+|+.++.++. ||||+++++++.+
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   95 (298)
T 1phk_A           16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   95 (298)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence            378999999999999999985      57999999754321       122345778999999985 9999999999987


Q ss_pred             CCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCcccc
Q 012887          255 ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC  334 (454)
Q Consensus       255 ~~~~l~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~  334 (454)
                      .+. .++||||+++++|.+++.+...+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++...
T Consensus        96 ~~~-~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~  174 (298)
T 1phk_A           96 NTF-FFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL  174 (298)
T ss_dssp             SSE-EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             CCe-EEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhhc
Confidence            765 9999999999999999987788999999999999999999999999999999999999999999999999998765


Q ss_pred             ccCCCcccccCCCCcccccccccCCC--CCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCC--
Q 012887          335 KSVGEATEYETDGYRWLAPEIIAGDP--ESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIP--  410 (454)
Q Consensus       335 ~~~~~~~~~~~gt~~y~APE~l~~~~--~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p--  410 (454)
                      .... ......+++.|+|||.+.+..  ....++.++||||||+++|+|++|..||...+.......+.........+  
T Consensus       175 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  253 (298)
T 1phk_A          175 DPGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEW  253 (298)
T ss_dssp             CTTC-CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTG
T ss_pred             CCCc-ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCcccc
Confidence            4432 234456889999999985321  11235667999999999999999999999888777766666655544333  


Q ss_pred             CCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 012887          411 KDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR  444 (454)
Q Consensus       411 ~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~  444 (454)
                      ..++..+.++|.+||+.||.+|||+.|++++-+-
T Consensus       254 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~  287 (298)
T 1phk_A          254 DDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFF  287 (298)
T ss_dssp             GGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGG
T ss_pred             cccCHHHHHHHHHHccCCcccCCCHHHHHhChHh
Confidence            4689999999999999999999999999987654

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=2.6e-43  Score=344.73  Aligned_cols=256  Identities=27%  Similarity=0.462  Sum_probs=191.8

Q ss_pred             cceeecCCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCC
Q 012887          183 GRWLLNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN  256 (454)
Q Consensus       183 ~~~~~~~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~  256 (454)
                      -.|.+..++|++.+.||+|+||.||++      +.||+|.+..... ......+.+|+..+..++||||+++++++...+
T Consensus         8 ~p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   86 (303)
T 2vwi_A            8 LPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC-QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKD   86 (303)
T ss_dssp             -----CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESSS
T ss_pred             cccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc-chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecC
Confidence            346678899999999999999999986      4799998864322 223455778999999999999999999999887


Q ss_pred             CeEEEEEeccCCCCHHHHHHh--------CCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEcc
Q 012887          257 HGLCVVTKLMEGGSVNDLILK--------SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDM  328 (454)
Q Consensus       257 ~~l~lV~E~~~~gsL~~~l~~--------~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DF  328 (454)
                      . .++||||+++++|.+++..        ...+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+||
T Consensus        87 ~-~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~df  165 (303)
T 2vwi_A           87 E-LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADF  165 (303)
T ss_dssp             C-EEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCC
T ss_pred             C-cEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEec
Confidence            6 9999999999999999863        346999999999999999999999999999999999999999999999999


Q ss_pred             CCccccccCCC-----cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHc
Q 012887          329 GIVTACKSVGE-----ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAAC  403 (454)
Q Consensus       329 Gla~~~~~~~~-----~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~  403 (454)
                      |++........     ......+++.|+|||.+.+..   .++.++||||||+++|+|++|..||...............
T Consensus       166 g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~  242 (303)
T 2vwi_A          166 GVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVR---GYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQN  242 (303)
T ss_dssp             HHHHHCC---------------CCCTTCCHHHHHHHH---CCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTS
T ss_pred             cchheeccCCCccchhhhcccCCCccccCHHHhcccc---CCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhcc
Confidence            99876543221     123346889999999986521   2456799999999999999999999987766555444332


Q ss_pred             CCC--------CCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 012887          404 GLR--------PEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLL  443 (454)
Q Consensus       404 ~~~--------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~  443 (454)
                      ...        ...+..++.++.++|.+||+.||.+||++.+++++-+
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~  290 (303)
T 2vwi_A          243 DPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKF  290 (303)
T ss_dssp             SCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTT
T ss_pred             CCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChh
Confidence            211        1233567899999999999999999999999998654

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=7.6e-43  Score=343.01  Aligned_cols=249  Identities=25%  Similarity=0.391  Sum_probs=201.3

Q ss_pred             EEeceeeccCCceEEEe----EEEEEEEeecCCC--CchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEEecc
Q 012887          193 EFIDQIGPNSFKGVYKG----KRVGIEKLKGCDK--GNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLM  266 (454)
Q Consensus       193 ~~~~~LG~G~fG~Vy~g----~~vavK~l~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~E~~  266 (454)
                      ...+.||+|+||.||+|    +.+|+|++.....  .......+.+|+.++..++||||+++++++.+.+. .++||||+
T Consensus        34 ~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~-~~lv~e~~  112 (307)
T 2nru_A           34 VGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDD-LCLVYVYM  112 (307)
T ss_dssp             TTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS-CEEEEECC
T ss_pred             ccCCccccCCCeEEEEEEECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCc-eEEEEEec
Confidence            34578999999999996    5899999875432  23345678899999999999999999999987776 89999999


Q ss_pred             CCCCHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCc--c
Q 012887          267 EGGSVNDLILK---SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA--T  341 (454)
Q Consensus       267 ~~gsL~~~l~~---~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~--~  341 (454)
                      ++++|.+++..   ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.........  .
T Consensus       113 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~  192 (307)
T 2nru_A          113 PNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMT  192 (307)
T ss_dssp             TTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEEC
T ss_pred             CCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccccccccc
Confidence            99999999853   346999999999999999999999999999999999999999999999999998765443221  2


Q ss_pred             cccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHH----HHHHHc---------CCCCC
Q 012887          342 EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAA----VGIAAC---------GLRPE  408 (454)
Q Consensus       342 ~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~----~~i~~~---------~~~~~  408 (454)
                      ....+++.|+|||.+.+.     ++.++||||||+++|+|++|..||.........    ..+...         .....
T Consensus       193 ~~~~g~~~y~aPE~~~~~-----~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (307)
T 2nru_A          193 SRIVGTTAYMAPEALRGE-----ITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMND  267 (307)
T ss_dssp             SSCCSCGGGCCHHHHTTE-----ECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSC
T ss_pred             cccCCCcCcCChHHhcCC-----CCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccccc
Confidence            334689999999998753     455799999999999999999999865432211    111110         11122


Q ss_pred             CCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 012887          409 IPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNN  447 (454)
Q Consensus       409 ~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~  447 (454)
                      .+..++..+.+++.+||+.||.+|||+.+++++|+++..
T Consensus       268 ~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~  306 (307)
T 2nru_A          268 ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA  306 (307)
T ss_dssp             CCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred             cchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence            344567889999999999999999999999999998753

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=1.6e-42  Score=335.94  Aligned_cols=245  Identities=21%  Similarity=0.319  Sum_probs=202.1

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeC--------
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDE--------  255 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~--------  255 (454)
                      ++|++++.||+|+||.||++      +.||+|.+....      ..+.+|+.++..++||||+++++++...        
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   84 (284)
T 2a19_B           11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS   84 (284)
T ss_dssp             HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred             cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence            57899999999999999986      579999997432      2356899999999999999999988641        


Q ss_pred             -------CCeEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEE
Q 012887          256 -------NHGLCVVTKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLG  326 (454)
Q Consensus       256 -------~~~l~lV~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~  326 (454)
                             ...+++||||+++++|.+++.+.  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+
T Consensus        85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~  164 (284)
T 2a19_B           85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIG  164 (284)
T ss_dssp             ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEEC
T ss_pred             ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEEC
Confidence                   23389999999999999999643  579999999999999999999999999999999999999999999999


Q ss_pred             ccCCccccccCCCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCC
Q 012887          327 DMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR  406 (454)
Q Consensus       327 DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~  406 (454)
                      |||++....... ......+++.|+|||.+.+..    ++.++||||||+++|+|++|..||...  ......+.    .
T Consensus       165 Dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~----~~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~~~----~  233 (284)
T 2a19_B          165 DFGLVTSLKNDG-KRTRSKGTLRYMSPEQISSQD----YGKEVDLYALGLILAELLHVCDTAFET--SKFFTDLR----D  233 (284)
T ss_dssp             CCTTCEESSCCS-CCCCCCSCCTTSCHHHHHCSC----CCTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHHHHH----T
T ss_pred             cchhheeccccc-cccccCCcccccChhhhccCC----CcchhhhHHHHHHHHHHHhcCCcchhH--HHHHHHhh----c
Confidence            999987765433 233446889999999998764    455799999999999999999887532  11122222    2


Q ss_pred             CCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCCCCC
Q 012887          407 PEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNS  451 (454)
Q Consensus       407 ~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~~  451 (454)
                      ..++..++..+.++|.+||+.||.+||++.|++++|+.+.+..+.
T Consensus       234 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~  278 (284)
T 2a19_B          234 GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEK  278 (284)
T ss_dssp             TCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC----
T ss_pred             ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCc
Confidence            335677899999999999999999999999999999998876543

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=7.6e-43  Score=346.62  Aligned_cols=259  Identities=21%  Similarity=0.363  Sum_probs=185.2

Q ss_pred             cceeecCCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHH-HHHhCCCCceeEEEEEEEeC
Q 012887          183 GRWLLNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLL-ELMTCGHKNILQFYCVCVDE  255 (454)
Q Consensus       183 ~~~~~~~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~-~l~~l~HpnIv~~~g~~~~~  255 (454)
                      ..|.+..++|++++.||+|+||.||++      +.||+|.+.... .......+.+|+. .+..++||||+++++++.+.
T Consensus        15 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~   93 (327)
T 3aln_A           15 QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV-DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFRE   93 (327)
T ss_dssp             EEECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC-CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECS
T ss_pred             HhcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc-CchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeC
Confidence            467788899999999999999999985      579999997543 2333445556665 55567999999999999987


Q ss_pred             CCeEEEEEeccCCCCHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHhc-CcccCCccCCcEEEccCCcEEEEccC
Q 012887          256 NHGLCVVTKLMEGGSVNDLILK-----SRKLQTKEIIRIAIDVAEGIKFLNDH-GVAYRDLNSQRILLDRHGNVCLGDMG  329 (454)
Q Consensus       256 ~~~l~lV~E~~~~gsL~~~l~~-----~~~l~~~~~~~i~~qI~~gL~yLH~~-~iiHrDIKp~NILl~~~~~vKL~DFG  329 (454)
                      +. .++||||+++ +|.+++..     ...+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||+|||
T Consensus        94 ~~-~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg  171 (327)
T 3aln_A           94 GD-CWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFG  171 (327)
T ss_dssp             SE-EEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCS
T ss_pred             Cc-eEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCC
Confidence            75 9999999986 88888753     56899999999999999999999999 99999999999999999999999999


Q ss_pred             CccccccCCCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCC
Q 012887          330 IVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEI  409 (454)
Q Consensus       330 la~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~  409 (454)
                      ++....... ......+++.|+|||.+.+......++.++|||||||++|+|++|..||...............+.++.+
T Consensus       172 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  250 (327)
T 3aln_A          172 ISGQLVDSI-AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQL  250 (327)
T ss_dssp             SSCC-------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCC
T ss_pred             Cceeccccc-ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCC
Confidence            987654332 2233468899999999954333334667899999999999999999999875433221111112222223


Q ss_pred             C----CCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 012887          410 P----KDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRT  445 (454)
Q Consensus       410 p----~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~  445 (454)
                      +    ..+++.+.++|.+||+.||.+||++.+++++-+-.
T Consensus       251 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~  290 (327)
T 3aln_A          251 SNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFIL  290 (327)
T ss_dssp             CCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHH
T ss_pred             CCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHH
Confidence            2    45899999999999999999999999999876543

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=2.1e-42  Score=339.30  Aligned_cols=252  Identities=18%  Similarity=0.289  Sum_probs=208.7

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCC--CchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCC-CeEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDK--GNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN-HGLC  260 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~--~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~-~~l~  260 (454)
                      ++|++++.||+|+||.||++      +.+|+|.+.....  .......+.+|+.++..++||||+++++++...+ ..++
T Consensus         5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (305)
T 2wtk_C            5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMY   84 (305)
T ss_dssp             CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEE
T ss_pred             cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEE
Confidence            67899999999999999985      5799999864321  1234566889999999999999999999986443 3489


Q ss_pred             EEEeccCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCC
Q 012887          261 VVTKLMEGGSVNDLILK--SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG  338 (454)
Q Consensus       261 lV~E~~~~gsL~~~l~~--~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~  338 (454)
                      +||||++++ |.+++..  ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus        85 lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~  163 (305)
T 2wtk_C           85 MVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFA  163 (305)
T ss_dssp             EEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTC
T ss_pred             EEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCccc
Confidence            999999885 7777754  3579999999999999999999999999999999999999999999999999987654322


Q ss_pred             --CcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHH
Q 012887          339 --EATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQI  416 (454)
Q Consensus       339 --~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~  416 (454)
                        .......+++.|+|||.+.+...  ..+.++||||||+++|+|++|..||.+.+.......+...  ...+|..+++.
T Consensus       164 ~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~--~~~~~~~~~~~  239 (305)
T 2wtk_C          164 ADDTCRTSQGSPAFQPPEIANGLDT--FSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKG--SYAIPGDCGPP  239 (305)
T ss_dssp             SSCEECCCCSCGGGCCHHHHTCCSC--EESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHC--CCCCCSSSCHH
T ss_pred             cccccccCCCCCCCcChhhccCccc--CCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcC--CCCCCCccCHH
Confidence              22334468999999999976432  2355799999999999999999999988777766666554  34577889999


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 012887          417 LKSLMIKCWNNSPSKRPQFSEIISLLLRTN  446 (454)
Q Consensus       417 l~~li~~cl~~dP~~RPs~~ell~~L~~~~  446 (454)
                      +.++|.+||+.||.+|||+.|++++-+-..
T Consensus       240 l~~li~~~l~~dp~~Rps~~~ll~~~~~~~  269 (305)
T 2wtk_C          240 LSDLLKGMLEYEPAKRFSIRQIRQHSWFRK  269 (305)
T ss_dssp             HHHHHHHHTCSSTTTSCCHHHHHHSHHHHS
T ss_pred             HHHHHHHHccCChhhCCCHHHHhcCccccc
Confidence            999999999999999999999999876543

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=1.2e-42  Score=346.10  Aligned_cols=249  Identities=18%  Similarity=0.315  Sum_probs=208.1

Q ss_pred             CCEEEe-ceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEEEEEEEeCCCeEEE
Q 012887          190 DNLEFI-DQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVDENHGLCV  261 (454)
Q Consensus       190 ~~~~~~-~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~~~g~~~~~~~~l~l  261 (454)
                      +.|.+. +.||+|+||.||++      +.||+|.+............+.+|+.++..+ +||||+++++++.+.+. +++
T Consensus        28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~-~~l  106 (327)
T 3lm5_A           28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSE-IIL  106 (327)
T ss_dssp             HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE-EEE
T ss_pred             hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCe-EEE
Confidence            456666 89999999999985      5899999986555555567788999999988 46999999999987776 999


Q ss_pred             EEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEcc---CCcEEEEccCCcccccc
Q 012887          262 VTKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDR---HGNVCLGDMGIVTACKS  336 (454)
Q Consensus       262 V~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~---~~~vKL~DFGla~~~~~  336 (454)
                      ||||+++|+|.+++...  ..+++..+..++.||+.||+|||++||+||||||+|||++.   ++.+||+|||++.....
T Consensus       107 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~  186 (327)
T 3lm5_A          107 ILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH  186 (327)
T ss_dssp             EEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC--
T ss_pred             EEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCC
Confidence            99999999999998543  57999999999999999999999999999999999999998   78999999999886644


Q ss_pred             CCCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCC--CCCCCCcc
Q 012887          337 VGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR--PEIPKDCP  414 (454)
Q Consensus       337 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~--~~~p~~~~  414 (454)
                      ... .....+|+.|+|||++.+..    ++.++||||||+++|+|++|..||.+.........+......  ...+..++
T Consensus       187 ~~~-~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  261 (327)
T 3lm5_A          187 ACE-LREIMGTPEYLAPEILNYDP----ITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVS  261 (327)
T ss_dssp             --------CCCGGGCCHHHHTTCC----CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSC
T ss_pred             ccc-cccccCCcCccCCeeecCCC----CCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcccC
Confidence            322 33456899999999998664    445699999999999999999999998887777666654433  33446789


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 012887          415 QILKSLMIKCWNNSPSKRPQFSEIISLLLR  444 (454)
Q Consensus       415 ~~l~~li~~cl~~dP~~RPs~~ell~~L~~  444 (454)
                      +.+.++|.+||+.||.+|||+.+++++-+-
T Consensus       262 ~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~  291 (327)
T 3lm5_A          262 QLATDFIQSLLVKNPEKRPTAEICLSHSWL  291 (327)
T ss_dssp             HHHHHHHHHHSCSSGGGSCCHHHHTTCGGG
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHhCCHhh
Confidence            999999999999999999999999988653

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=7.1e-43  Score=351.09  Aligned_cols=250  Identities=10%  Similarity=0.139  Sum_probs=203.4

Q ss_pred             CCCEEEeceeeccCCceEEEe--------------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeE-------
Q 012887          189 SDNLEFIDQIGPNSFKGVYKG--------------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQ-------  247 (454)
Q Consensus       189 ~~~~~~~~~LG~G~fG~Vy~g--------------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~-------  247 (454)
                      .++|++.+.||+|+||.||+|              +.||+|.+...       ..+.+|+.++..++||||++       
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~  113 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKLYS  113 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHHTT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhhcc
Confidence            478999999999999999986              35899998743       24678899999999999887       


Q ss_pred             --------EEEEEEeCCCeEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEE
Q 012887          248 --------FYCVCVDENHGLCVVTKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILL  317 (454)
Q Consensus       248 --------~~g~~~~~~~~l~lV~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl  317 (454)
                              +++++...+...++||||+ +++|.+++...  ..+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus       114 ~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~  192 (352)
T 2jii_A          114 TPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFV  192 (352)
T ss_dssp             CTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEE
T ss_pred             CCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEE
Confidence                    6788877555699999999 89999999765  689999999999999999999999999999999999999


Q ss_pred             ccCC--cEEEEccCCccccccCCC-------cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCC
Q 012887          318 DRHG--NVCLGDMGIVTACKSVGE-------ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAY  388 (454)
Q Consensus       318 ~~~~--~vKL~DFGla~~~~~~~~-------~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf  388 (454)
                      +.++  .+||+|||++........       ......+|+.|+|||.+.+..    ++.++|||||||++|+|++|..||
T Consensus       193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Di~slG~il~el~~g~~pf  268 (352)
T 2jii_A          193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCG----PSRRSDLQSLGYCMLKWLYGFLPW  268 (352)
T ss_dssp             ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCC----CCHHHHHHHHHHHHHHHHHSCCTT
T ss_pred             cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCC----CCchhhHHHHHHHHHHHHhCCCCc
Confidence            9998  899999999876544322       112336889999999998764    456799999999999999999999


Q ss_pred             CCCC-HHHHHHHHHH--cCCCCCCC------CCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCCCC
Q 012887          389 AACS-PVQAAVGIAA--CGLRPEIP------KDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISN  450 (454)
Q Consensus       389 ~~~~-~~~~~~~i~~--~~~~~~~p------~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~  450 (454)
                      .... ..........  ......++      ..+++++.++|.+||+.||.+||++.++++.|+++.+..+
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~  339 (352)
T 2jii_A          269 TNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLR  339 (352)
T ss_dssp             GGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             ccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcC
Confidence            8754 2222222111  11122222      2468999999999999999999999999999998876543

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=2.6e-42  Score=344.04  Aligned_cols=255  Identities=23%  Similarity=0.434  Sum_probs=206.4

Q ss_pred             CCEEEeceeeccCCceEEEe----EEEEEEEeecCCCCchHHHHHHHHHHHHHh--CCCCceeEEEEEEEeCC---CeEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG----KRVGIEKLKGCDKGNAYEFELRKDLLELMT--CGHKNILQFYCVCVDEN---HGLC  260 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g----~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~--l~HpnIv~~~g~~~~~~---~~l~  260 (454)
                      ++|++.+.||+|+||.||+|    +.||+|.+...     ....+.+|..++..  ++||||+++++++...+   ..++
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~  116 (342)
T 1b6c_B           42 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW  116 (342)
T ss_dssp             HHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGG-----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEE
T ss_pred             ccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCch-----hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeE
Confidence            67899999999999999995    68999998632     23445677777766  78999999999998776   1489


Q ss_pred             EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH--------hcCcccCCccCCcEEEccCCcEEEEccCCcc
Q 012887          261 VVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN--------DHGVAYRDLNSQRILLDRHGNVCLGDMGIVT  332 (454)
Q Consensus       261 lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH--------~~~iiHrDIKp~NILl~~~~~vKL~DFGla~  332 (454)
                      +||||+++|+|.+++.+ ..+++..++.++.||+.||.|||        +++|+||||||+|||++.++.+||+|||++.
T Consensus       117 lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~  195 (342)
T 1b6c_B          117 LVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  195 (342)
T ss_dssp             EEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             EEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCCce
Confidence            99999999999999965 47999999999999999999999        8999999999999999999999999999987


Q ss_pred             ccccCCC----cccccCCCCcccccccccCCCCCC--CCCchhhHHHHHHHHHHHHcC----------CCCCCCCC----
Q 012887          333 ACKSVGE----ATEYETDGYRWLAPEIIAGDPESV--SETWMSNVYSFGMVIWEMVTG----------EAAYAACS----  392 (454)
Q Consensus       333 ~~~~~~~----~~~~~~gt~~y~APE~l~~~~~~~--~~~~ksDVwSlGviL~elltG----------~~Pf~~~~----  392 (454)
                      .......    ......+|+.|+|||.+.+.....  .++.++|||||||++|||++|          ..||....    
T Consensus       196 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~  275 (342)
T 1b6c_B          196 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP  275 (342)
T ss_dssp             EEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred             eccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcc
Confidence            6654332    123446899999999998653221  122579999999999999999          78887542    


Q ss_pred             -HHHHHHHHHHcCCCCCCCC-----CccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCCCC
Q 012887          393 -PVQAAVGIAACGLRPEIPK-----DCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISN  450 (454)
Q Consensus       393 -~~~~~~~i~~~~~~~~~p~-----~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~  450 (454)
                       .......+.....++.+|.     .+++.+.+||.+||+.||++|||+.+++++|+++.+..+
T Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~~  339 (342)
T 1b6c_B          276 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG  339 (342)
T ss_dssp             CHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTTC
T ss_pred             cHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHhc
Confidence             2223333334455565554     345789999999999999999999999999999877543

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=7e-42  Score=346.85  Aligned_cols=248  Identities=19%  Similarity=0.241  Sum_probs=196.5

Q ss_pred             CCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCC-----C
Q 012887          189 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN-----H  257 (454)
Q Consensus       189 ~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~-----~  257 (454)
                      .++|++++.||+|+||.||++      +.||+|++............+.+|+.++..++||||+++++++...+     .
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            378999999999999999986      57999999865555555667889999999999999999999998664     2


Q ss_pred             eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccC
Q 012887          258 GLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV  337 (454)
Q Consensus       258 ~l~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~  337 (454)
                      .+|+||||+++ +|.+++.  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus       104 ~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~  180 (371)
T 2xrw_A          104 DVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS  180 (371)
T ss_dssp             EEEEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC-------
T ss_pred             ceEEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccccccc
Confidence            48999999975 8888875  36899999999999999999999999999999999999999999999999998765432


Q ss_pred             CCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCC-----------
Q 012887          338 GEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR-----------  406 (454)
Q Consensus       338 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~-----------  406 (454)
                      . ......+|+.|+|||++.+..+    +.++|||||||++|+|++|..||.+.+.......+......           
T Consensus       181 ~-~~~~~~gt~~y~aPE~~~~~~~----~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  255 (371)
T 2xrw_A          181 F-MMTPYVVTRYYRAPEVILGMGY----KENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP  255 (371)
T ss_dssp             ----------CTTCCHHHHTTCCC----CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCH
T ss_pred             c-ccCCceecCCccCHHHhcCCCC----CchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhh
Confidence            2 2334568899999999987654    44699999999999999999999988776665554432111           


Q ss_pred             ---------CCC--------------CC------CccHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 012887          407 ---------PEI--------------PK------DCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR  444 (454)
Q Consensus       407 ---------~~~--------------p~------~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~  444 (454)
                               +.+              |.      ..+.++.+||.+||+.||.+|||+.|+++|-+-
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~  322 (371)
T 2xrw_A          256 TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI  322 (371)
T ss_dssp             HHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHH
T ss_pred             HHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcch
Confidence                     000              11      125789999999999999999999999998764

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=3.5e-42  Score=341.30  Aligned_cols=258  Identities=15%  Similarity=0.241  Sum_probs=191.6

Q ss_pred             cceeecCCCEEEeceeeccCCceEEEeE------EEEEEEeecCCCCchHHHHHHHHHHHHHhCC-CCceeEEEEEEEe-
Q 012887          183 GRWLLNSDNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKGNAYEFELRKDLLELMTCG-HKNILQFYCVCVD-  254 (454)
Q Consensus       183 ~~~~~~~~~~~~~~~LG~G~fG~Vy~g~------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~~~g~~~~-  254 (454)
                      ..+.+...+|++.+.||+|+||.||+++      .||+|.+...  .......+.+|+..+.++. ||||+++++++.. 
T Consensus        21 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~   98 (337)
T 3ll6_A           21 QTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN--EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIG   98 (337)
T ss_dssp             CEEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEEC
T ss_pred             ceeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC--chHHHHHHHHHHHHHHHhccCCChhhcccccccc
Confidence            3456777899999999999999999964      6999998643  3334556789999999985 9999999999952 


Q ss_pred             ------CCCeEEEEEeccCCCCHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhcC--cccCCccCCcEEEccCCcE
Q 012887          255 ------ENHGLCVVTKLMEGGSVNDLILK---SRKLQTKEIIRIAIDVAEGIKFLNDHG--VAYRDLNSQRILLDRHGNV  323 (454)
Q Consensus       255 ------~~~~l~lV~E~~~~gsL~~~l~~---~~~l~~~~~~~i~~qI~~gL~yLH~~~--iiHrDIKp~NILl~~~~~v  323 (454)
                            ....+++||||+. |+|.+++..   .+.+++..++.++.||+.||.|||++|  |+||||||+|||++.++.+
T Consensus        99 ~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~  177 (337)
T 3ll6_A           99 KEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTI  177 (337)
T ss_dssp             TTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCE
T ss_pred             ccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCE
Confidence                  3334899999996 599998854   457999999999999999999999999  9999999999999999999


Q ss_pred             EEEccCCccccccCCCc------------ccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC
Q 012887          324 CLGDMGIVTACKSVGEA------------TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAAC  391 (454)
Q Consensus       324 KL~DFGla~~~~~~~~~------------~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~  391 (454)
                      ||+|||++.........            .....+|+.|+|||++.... ...++.++|||||||++|+|++|..||...
T Consensus       178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~~~~Dv~slG~il~el~~g~~p~~~~  256 (337)
T 3ll6_A          178 KLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYS-NFPIGEKQDIWALGCILYLLCFRQHPFEDG  256 (337)
T ss_dssp             EBCCCTTCBCCSSCC-------------------------------CCT-TSCSSHHHHHHHHHHHHHHHHHSSCCC---
T ss_pred             EEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccc-cCCCChHHhHHHHHHHHHHHHhCCCCCcch
Confidence            99999998765443221            11335788999999984321 223566899999999999999999999865


Q ss_pred             CHHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCC
Q 012887          392 SPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNI  448 (454)
Q Consensus       392 ~~~~~~~~i~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~  448 (454)
                      ....    +.......+.+...+..+.+||.+||+.||.+||++.|++++|+.+...
T Consensus       257 ~~~~----~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~  309 (337)
T 3ll6_A          257 AKLR----IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAA  309 (337)
T ss_dssp             -------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             hHHH----hhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            4432    2333344445666788899999999999999999999999999988654

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=9.2e-43  Score=345.57  Aligned_cols=249  Identities=16%  Similarity=0.253  Sum_probs=197.7

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCC------chHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCC
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG------NAYEFELRKDLLELMTCGHKNILQFYCVCVDENH  257 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~------~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~  257 (454)
                      ++|++.+.||+|+||.||++      +.||+|.+......      ......+.+|+.++..++||||+++++++...+ 
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   88 (322)
T 2ycf_A           10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-   88 (322)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred             hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence            57899999999999999996      57999998643211      112234789999999999999999999987543 


Q ss_pred             eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCc---EEEEccCCcccc
Q 012887          258 GLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGN---VCLGDMGIVTAC  334 (454)
Q Consensus       258 ~l~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~---vKL~DFGla~~~  334 (454)
                       .++||||+++++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.   +||+|||++...
T Consensus        89 -~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~  167 (322)
T 2ycf_A           89 -YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL  167 (322)
T ss_dssp             -EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEEC
T ss_pred             -eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceec
Confidence             8999999999999999987789999999999999999999999999999999999999987665   999999998765


Q ss_pred             ccCCCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCC---CCCC
Q 012887          335 KSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP---EIPK  411 (454)
Q Consensus       335 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~---~~p~  411 (454)
                      .... ......+++.|+|||++.+.. ...++.++|||||||++|+|++|..||...............+...   ..+.
T Consensus       168 ~~~~-~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (322)
T 2ycf_A          168 GETS-LMRTLCGTPTYLAPEVLVSVG-TAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWA  245 (322)
T ss_dssp             CCCH-HHHHHHSCCTTCCHHHHHHTT-TTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHHT
T ss_pred             cccc-ccccccCCcCccCchhhccCC-CCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchhhh
Confidence            4321 122346889999999975321 1235667999999999999999999998654432222222222222   2235


Q ss_pred             CccHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 012887          412 DCPQILKSLMIKCWNNSPSKRPQFSEIISLL  442 (454)
Q Consensus       412 ~~~~~l~~li~~cl~~dP~~RPs~~ell~~L  442 (454)
                      .+++.+.++|.+||+.||.+||++.+++++-
T Consensus       246 ~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~  276 (322)
T 2ycf_A          246 EVSEKALDLVKKLLVVDPKARFTTEEALRHP  276 (322)
T ss_dssp             TSCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred             hcCHHHHHHHHHHcccCHhhCCCHHHHhhCc
Confidence            6899999999999999999999999999753

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=3.7e-42  Score=347.65  Aligned_cols=250  Identities=18%  Similarity=0.254  Sum_probs=204.6

Q ss_pred             CCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCC----Ce
Q 012887          189 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN----HG  258 (454)
Q Consensus       189 ~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~----~~  258 (454)
                      .++|++++.||+|+||.||++      +.||+|++... ........+.+|+.++..++||||+++++++....    ..
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  104 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF-EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD  104 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCT-TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccc-cCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence            368999999999999999996      57999999742 33344566889999999999999999999997653    34


Q ss_pred             EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCC
Q 012887          259 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG  338 (454)
Q Consensus       259 l~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~  338 (454)
                      +++||||+.+ +|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus       105 ~~iv~e~~~~-~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~  182 (364)
T 3qyz_A          105 VYIVQDLMET-DLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH  182 (364)
T ss_dssp             EEEEEECCSE-EHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred             EEEEEcccCc-CHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCC
Confidence            8999999975 99999854 579999999999999999999999999999999999999999999999999987665432


Q ss_pred             Cc---ccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCC---------
Q 012887          339 EA---TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR---------  406 (454)
Q Consensus       339 ~~---~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~---------  406 (454)
                      ..   .....||+.|+|||++.+..   .++.++|||||||++|+|++|..||.+.+.......+......         
T Consensus       183 ~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  259 (364)
T 3qyz_A          183 DHTGFLTEYVATRWYRAPEIMLNSK---GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI  259 (364)
T ss_dssp             CBCCTTCCCCSCGGGCCHHHHHTBC---SCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTC
T ss_pred             CccccccccccccCCCCCHHhcCCC---CCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence            21   23347899999999876543   2456799999999999999999999987765554443321000         


Q ss_pred             ---------------CC-----CCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 012887          407 ---------------PE-----IPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR  444 (454)
Q Consensus       407 ---------------~~-----~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~  444 (454)
                                     ..     .+..+++++.+||.+||+.||.+|||+.|+++|-+-
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~  317 (364)
T 3qyz_A          260 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL  317 (364)
T ss_dssp             CCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGG
T ss_pred             hhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcch
Confidence                           00     124578999999999999999999999999998664

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=8.6e-42  Score=336.50  Aligned_cols=257  Identities=19%  Similarity=0.358  Sum_probs=189.3

Q ss_pred             cceeecCCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCC
Q 012887          183 GRWLLNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN  256 (454)
Q Consensus       183 ~~~~~~~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~  256 (454)
                      .++.+..++|++++.||+|+||.||++      +.||+|.+............+.++...+..++||||+++++++.+.+
T Consensus        18 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~   97 (318)
T 2dyl_A           18 QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNT   97 (318)
T ss_dssp             SEEECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred             hhhhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCC
Confidence            456677789999999999999999995      57999999854333223333344445577789999999999999877


Q ss_pred             CeEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhc-CcccCCccCCcEEEccCCcEEEEccCCcccc
Q 012887          257 HGLCVVTKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDH-GVAYRDLNSQRILLDRHGNVCLGDMGIVTAC  334 (454)
Q Consensus       257 ~~l~lV~E~~~~gsL~~~l~~-~~~l~~~~~~~i~~qI~~gL~yLH~~-~iiHrDIKp~NILl~~~~~vKL~DFGla~~~  334 (454)
                      . +++||||+ ++.+..+... ...+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++...
T Consensus        98 ~-~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  175 (318)
T 2dyl_A           98 D-VFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRL  175 (318)
T ss_dssp             E-EEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred             c-EEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhc
Confidence            5 99999999 5566666543 56899999999999999999999995 9999999999999999999999999998765


Q ss_pred             ccCCCcccccCCCCcccccccccCCC-CCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHHHcCCCCCCC--
Q 012887          335 KSVGEATEYETDGYRWLAPEIIAGDP-ESVSETWMSNVYSFGMVIWEMVTGEAAYAACSP-VQAAVGIAACGLRPEIP--  410 (454)
Q Consensus       335 ~~~~~~~~~~~gt~~y~APE~l~~~~-~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~-~~~~~~i~~~~~~~~~p--  410 (454)
                      .... ......+++.|+|||.+.+.. ....++.++||||||+++|+|++|..||..... ......+.. ..++.+|  
T Consensus       176 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~  253 (318)
T 2dyl_A          176 VDDK-AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQ-EEPPLLPGH  253 (318)
T ss_dssp             ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHH-SCCCCCCSS
T ss_pred             cCCc-cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhc-cCCCCCCcc
Confidence            4332 233446889999999996422 122356689999999999999999999987544 344444443 3444444  


Q ss_pred             CCccHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 012887          411 KDCPQILKSLMIKCWNNSPSKRPQFSEIISLLL  443 (454)
Q Consensus       411 ~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~  443 (454)
                      ..+++++.++|.+||+.||.+||++.+++++-+
T Consensus       254 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~  286 (318)
T 2dyl_A          254 MGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSF  286 (318)
T ss_dssp             SCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHH
T ss_pred             CCCCHHHHHHHHHHccCChhHCcCHHHHhhCHH
Confidence            358999999999999999999999999998754

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=9.7e-42  Score=352.97  Aligned_cols=245  Identities=17%  Similarity=0.257  Sum_probs=200.8

Q ss_pred             CCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhC------CCCceeEEEEEEEeCC
Q 012887          189 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTC------GHKNILQFYCVCVDEN  256 (454)
Q Consensus       189 ~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l------~HpnIv~~~g~~~~~~  256 (454)
                      ..+|++++.||+|+||.||+|      +.||+|.++.   .......+.+|+.++..+      +|+||+++++++...+
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~---~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~  172 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRN---EKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRN  172 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECS---CHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETT
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECC---ccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCC
Confidence            367999999999999999996      6899999973   233345566777777665      6789999999999887


Q ss_pred             CeEEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCc--EEEEccCCcc
Q 012887          257 HGLCVVTKLMEGGSVNDLILKSR--KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGN--VCLGDMGIVT  332 (454)
Q Consensus       257 ~~l~lV~E~~~~gsL~~~l~~~~--~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~--vKL~DFGla~  332 (454)
                      . +++||||+. ++|.+++....  .+++..+..++.||+.||.|||++||+||||||+|||++.++.  +||+|||++.
T Consensus       173 ~-~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~  250 (429)
T 3kvw_A          173 H-ICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSC  250 (429)
T ss_dssp             E-EEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred             e-EEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccce
Confidence            6 999999996 59999986654  5999999999999999999999999999999999999999987  9999999986


Q ss_pred             ccccCCCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHc-CCCC----
Q 012887          333 ACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAAC-GLRP----  407 (454)
Q Consensus       333 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~-~~~~----  407 (454)
                      ....   ......+|+.|+|||++.+..    ++.++|||||||++|||++|..||.+.+....+..+... +.++    
T Consensus       251 ~~~~---~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~  323 (429)
T 3kvw_A          251 YEHQ---RVYTYIQSRFYRAPEVILGAR----YGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLL  323 (429)
T ss_dssp             ETTC---CCCSSCSCGGGCCHHHHHTBC----CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             ecCC---cccccCCCCCccChHHHhCCC----CCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHH
Confidence            5432   233457899999999998765    455699999999999999999999988877655544321 0000    


Q ss_pred             ----------------------------------------------------CCCCCccHHHHHHHHHhcccCCCCCCCH
Q 012887          408 ----------------------------------------------------EIPKDCPQILKSLMIKCWNNSPSKRPQF  435 (454)
Q Consensus       408 ----------------------------------------------------~~p~~~~~~l~~li~~cl~~dP~~RPs~  435 (454)
                                                                          .++...++.+.+||.+||+.||.+|||+
T Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta  403 (429)
T 3kvw_A          324 DASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTP  403 (429)
T ss_dssp             HTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCH
T ss_pred             HhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCH
Confidence                                                                0112347889999999999999999999


Q ss_pred             HHHHHHHHhh
Q 012887          436 SEIISLLLRT  445 (454)
Q Consensus       436 ~ell~~L~~~  445 (454)
                      .|+++|-|-.
T Consensus       404 ~e~L~Hpw~~  413 (429)
T 3kvw_A          404 GQALRHPWLR  413 (429)
T ss_dssp             HHHHTSTTTC
T ss_pred             HHHhCChhhc
Confidence            9999986643

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=1.7e-42  Score=351.58  Aligned_cols=246  Identities=17%  Similarity=0.250  Sum_probs=187.8

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCC-----Ce
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN-----HG  258 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~-----~~  258 (454)
                      ++|++++.||+|+||.||+|      +.||+|++............+.+|+.++..++||||+++++++....     ..
T Consensus        29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  108 (367)
T 2fst_X           29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND  108 (367)
T ss_dssp             TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred             CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence            78999999999999999986      58999999755444455667889999999999999999999997541     33


Q ss_pred             EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCC
Q 012887          259 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG  338 (454)
Q Consensus       259 l~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~  338 (454)
                      +|+|||++ +++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... 
T Consensus       109 ~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~-  185 (367)
T 2fst_X          109 VYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE-  185 (367)
T ss_dssp             CEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC-----------
T ss_pred             EEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecccccccccc-
Confidence            79999999 6799998854 67999999999999999999999999999999999999999999999999998765432 


Q ss_pred             CcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCC------------
Q 012887          339 EATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR------------  406 (454)
Q Consensus       339 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~------------  406 (454)
                        .....+|+.|+|||++.+..   .++.++|||||||++|||++|..||.+.+.......+......            
T Consensus       186 --~~~~~~t~~y~aPE~~~~~~---~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~  260 (367)
T 2fst_X          186 --MTGYVATRWYRAPEIMLNWM---HYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE  260 (367)
T ss_dssp             -------CCCTTCCHHHHTTCC---SCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCH
T ss_pred             --CCCcCcCcCccChHHHcCCc---CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhH
Confidence              33457899999999987632   2455699999999999999999999988776655544321000            


Q ss_pred             ------------CC-----CCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 012887          407 ------------PE-----IPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLL  443 (454)
Q Consensus       407 ------------~~-----~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~  443 (454)
                                  +.     .....++.+.+||.+||..||.+|||+.|+++|-+
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~  314 (367)
T 2fst_X          261 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY  314 (367)
T ss_dssp             HHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred             HHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChh
Confidence                        00     11346889999999999999999999999998855

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=1.3e-41  Score=347.96  Aligned_cols=243  Identities=20%  Similarity=0.226  Sum_probs=197.3

Q ss_pred             CCEEEeceeeccCCceEEEeE-----EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCC-----eE
Q 012887          190 DNLEFIDQIGPNSFKGVYKGK-----RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH-----GL  259 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g~-----~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~-----~l  259 (454)
                      .+|++.+.||+|+||.||+++     .+|+|++.......      .+|+.++..++||||+++++++...+.     .+
T Consensus        40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~~------~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~  113 (394)
T 4e7w_A           40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFK------NRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL  113 (394)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTSC------CHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEE
T ss_pred             ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcchH------HHHHHHHHhCCCCCcceEEEEEEecCCCCCceEE
Confidence            579999999999999999863     59999987433222      368899999999999999999975432     27


Q ss_pred             EEEEeccCCCCHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEc-cCCcEEEEccCCcccc
Q 012887          260 CVVTKLMEGGSVNDLIL----KSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLD-RHGNVCLGDMGIVTAC  334 (454)
Q Consensus       260 ~lV~E~~~~gsL~~~l~----~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~-~~~~vKL~DFGla~~~  334 (454)
                      ++||||+++ ++.+.+.    ....+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++..
T Consensus       114 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~  192 (394)
T 4e7w_A          114 NLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL  192 (394)
T ss_dssp             EEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             EEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence            899999987 4444332    256899999999999999999999999999999999999999 7999999999999866


Q ss_pred             ccCCCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCC-------
Q 012887          335 KSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP-------  407 (454)
Q Consensus       335 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~-------  407 (454)
                      ..... .....+|+.|+|||++.+..   .++.++|||||||++|||++|..||.+.+.......+......+       
T Consensus       193 ~~~~~-~~~~~~t~~y~aPE~~~~~~---~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~  268 (394)
T 4e7w_A          193 IAGEP-NVSYICSRYYRAPELIFGAT---NYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKT  268 (394)
T ss_dssp             CTTCC-CCSSCSCGGGCCHHHHTTCS---SCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred             cCCCC-CcccccCcCccCHHHHcCCC---CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            44322 33456789999999997643   25567999999999999999999999988777666554321000       


Q ss_pred             --------------------CCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 012887          408 --------------------EIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLL  443 (454)
Q Consensus       408 --------------------~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~  443 (454)
                                          .++..+++++.+||.+||+.||.+|||+.|+++|-+
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~  324 (394)
T 4e7w_A          269 MNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPF  324 (394)
T ss_dssp             HCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGG
T ss_pred             hChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChh
Confidence                                133457899999999999999999999999998854

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=6.5e-44  Score=362.40  Aligned_cols=246  Identities=11%  Similarity=0.084  Sum_probs=190.6

Q ss_pred             ecCCCEEEeceeeccCCceEEEe------EEEEEEEeecCCC-CchHHHHHHHHH---HHHHhCCCCceeEEE-------
Q 012887          187 LNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDK-GNAYEFELRKDL---LELMTCGHKNILQFY-------  249 (454)
Q Consensus       187 ~~~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~-~~~~~~~~~~Ei---~~l~~l~HpnIv~~~-------  249 (454)
                      ...++|++.+.||+|+||.||+|      +.||||.+..... .......+.+|+   ..+..++|||||+++       
T Consensus        70 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~  149 (377)
T 3byv_A           70 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF  149 (377)
T ss_dssp             CCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCS
T ss_pred             CCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhh
Confidence            34578999999999999999985      4799999975432 233456688998   455566899999988       


Q ss_pred             EEEEeCCC----------------eEEEEEeccCCCCHHHHHHhCCCCCH-------HHHHHHHHHHHHHHHHHHhcCcc
Q 012887          250 CVCVDENH----------------GLCVVTKLMEGGSVNDLILKSRKLQT-------KEIIRIAIDVAEGIKFLNDHGVA  306 (454)
Q Consensus       250 g~~~~~~~----------------~l~lV~E~~~~gsL~~~l~~~~~l~~-------~~~~~i~~qI~~gL~yLH~~~ii  306 (454)
                      +++.+.+.                ..|+||||+ +|+|.+++.+.+.+++       ..+..++.||+.||.|||++||+
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iv  228 (377)
T 3byv_A          150 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLV  228 (377)
T ss_dssp             EEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred             hhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCee
Confidence            77665532                278999999 5799999976544444       78888999999999999999999


Q ss_pred             cCCccCCcEEEccCCcEEEEccCCccccccCCCcccccCCCCcccccccccCC-------CCCCCCCchhhHHHHHHHHH
Q 012887          307 YRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGD-------PESVSETWMSNVYSFGMVIW  379 (454)
Q Consensus       307 HrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~-------~~~~~~~~ksDVwSlGviL~  379 (454)
                      ||||||+|||++.++.+||+|||+++....   ......| +.|+|||++.+.       .....++.++|||||||++|
T Consensus       229 HrDikp~NIll~~~~~~kL~DFG~a~~~~~---~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~  304 (377)
T 3byv_A          229 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGA---RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIY  304 (377)
T ss_dssp             CSCCCGGGEEECTTCCEEECCGGGCEETTC---EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHH
T ss_pred             cCCCCHHHEEEcCCCCEEEEechhheecCC---cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHH
Confidence            999999999999999999999999875332   2334456 899999999865       00012556799999999999


Q ss_pred             HHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 012887          380 EMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLL  443 (454)
Q Consensus       380 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~  443 (454)
                      ||++|..||.+.........+      ...+..+|+++.+||.+||+.||.+||++.+++++-+
T Consensus       305 elltg~~Pf~~~~~~~~~~~~------~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~  362 (377)
T 3byv_A          305 WIWCADLPITKDAALGGSEWI------FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPE  362 (377)
T ss_dssp             HHHHSSCCC------CCSGGG------GSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHH
T ss_pred             HHHHCCCCCcccccccchhhh------hhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChH
Confidence            999999999765433221111      1234578999999999999999999999999997543

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=6.2e-42  Score=339.04  Aligned_cols=249  Identities=20%  Similarity=0.320  Sum_probs=199.5

Q ss_pred             CCCEEEeceeeccCCceEEEe-------EEEEEEEeecCCCCchHHHHHHHHHHHHHh---CCCCceeEEEEEEEe----
Q 012887          189 SDNLEFIDQIGPNSFKGVYKG-------KRVGIEKLKGCDKGNAYEFELRKDLLELMT---CGHKNILQFYCVCVD----  254 (454)
Q Consensus       189 ~~~~~~~~~LG~G~fG~Vy~g-------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~---l~HpnIv~~~g~~~~----  254 (454)
                      .++|++++.||+|+||.||++       +.||+|.+............+.+|+.++..   ++||||+++++++..    
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~   89 (326)
T 1blx_A           10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   89 (326)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccC
Confidence            478999999999999999986       468999986433222222234456655554   489999999999872    


Q ss_pred             CCCeEEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCcc
Q 012887          255 ENHGLCVVTKLMEGGSVNDLILKSR--KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVT  332 (454)
Q Consensus       255 ~~~~l~lV~E~~~~gsL~~~l~~~~--~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~  332 (454)
                      ....+++||||++ |+|.+++....  .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus        90 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~  168 (326)
T 1blx_A           90 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR  168 (326)
T ss_dssp             SEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred             CCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCcccc
Confidence            2334899999998 59999997643  59999999999999999999999999999999999999999999999999987


Q ss_pred             ccccCCCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCC-C-----
Q 012887          333 ACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGL-R-----  406 (454)
Q Consensus       333 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~-~-----  406 (454)
                      ...... ......+++.|+|||.+.+..    ++.++|||||||++|+|++|..||.+.........+..... +     
T Consensus       169 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~----~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  243 (326)
T 1blx_A          169 IYSFQM-ALTSVVVTLWYRAPEVLLQSS----YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW  243 (326)
T ss_dssp             CCCGGG-GGCCCCCCCTTCCHHHHTTCC----CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred             cccCCC-CccccccccceeCHHHHhcCC----CCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccC
Confidence            654322 233456789999999998764    45569999999999999999999998887766655543110 0     


Q ss_pred             -------------------CCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 012887          407 -------------------PEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLL  443 (454)
Q Consensus       407 -------------------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~  443 (454)
                                         ..++..++..+.+||.+||+.||.+||++.|++++-+
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~  299 (326)
T 1blx_A          244 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY  299 (326)
T ss_dssp             CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred             ccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCcc
Confidence                               0133568899999999999999999999999997644

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1.2e-41  Score=340.94  Aligned_cols=250  Identities=15%  Similarity=0.227  Sum_probs=201.6

Q ss_pred             CCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCC----Ce
Q 012887          189 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN----HG  258 (454)
Q Consensus       189 ~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~----~~  258 (454)
                      .++|++.+.||+|+||.||+|      +.||+|.+... ........+.+|+.++..++||||+++++++....    ..
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   88 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF-DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE   88 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc-ccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence            378999999999999999985      57999999632 33344556789999999999999999999987641    34


Q ss_pred             EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCC
Q 012887          259 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG  338 (454)
Q Consensus       259 l~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~  338 (454)
                      .++||||+. ++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus        89 ~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  166 (353)
T 2b9h_A           89 VYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESA  166 (353)
T ss_dssp             EEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred             EEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEeccccccccccc
Confidence            899999997 499999865 579999999999999999999999999999999999999999999999999987654322


Q ss_pred             Cc----------ccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCC-
Q 012887          339 EA----------TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP-  407 (454)
Q Consensus       339 ~~----------~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~-  407 (454)
                      ..          .....||+.|+|||++.+..   .++.++|||||||++|+|++|..||.+.+.......+......+ 
T Consensus       167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  243 (353)
T 2b9h_A          167 ADNSEPTGQQSGMVEFVATRWYRAPEVMLTSA---KYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPH  243 (353)
T ss_dssp             -------------CCCCCCGGGCCHHHHHSCC---CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             ccccCccccccchhhccccccccCCeeeccCC---CccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCc
Confidence            11          12236789999999876432   35667999999999999999999999877665444332210000 


Q ss_pred             -----------------------------CCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 012887          408 -----------------------------EIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR  444 (454)
Q Consensus       408 -----------------------------~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~  444 (454)
                                                   ..+..+++++.++|.+||+.||.+|||+.|++++-+-
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~  309 (353)
T 2b9h_A          244 SDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYL  309 (353)
T ss_dssp             STTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred             hhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccc
Confidence                                         0124678999999999999999999999999987654

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=7.9e-42  Score=346.49  Aligned_cols=251  Identities=17%  Similarity=0.255  Sum_probs=204.4

Q ss_pred             ceeecCCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCC
Q 012887          184 RWLLNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH  257 (454)
Q Consensus       184 ~~~~~~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~  257 (454)
                      .|.+. ++|.+.+.||+|+||.||+|      +.||+|++............+.+|+.++..++||||+++++++...+.
T Consensus        37 ~~~l~-~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  115 (371)
T 4exu_A           37 AWELP-KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASS  115 (371)
T ss_dssp             EEEEE-TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred             eeccc-ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCC
Confidence            45554 78999999999999999985      689999998655555566778899999999999999999999987654


Q ss_pred             e-----EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCcc
Q 012887          258 G-----LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVT  332 (454)
Q Consensus       258 ~-----l~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~  332 (454)
                      .     +++||||+. ++|.+++.  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus       116 ~~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~  192 (371)
T 4exu_A          116 LRNFYDFYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLAR  192 (371)
T ss_dssp             STTCCCCEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC-
T ss_pred             cccceeEEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCccc
Confidence            1     399999997 58988863  359999999999999999999999999999999999999999999999999987


Q ss_pred             ccccCCCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCC-----
Q 012887          333 ACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP-----  407 (454)
Q Consensus       333 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~-----  407 (454)
                      .....   .....+|+.|+|||.+.+..   .++.++|||||||++|+|++|..||.+.+..+....+......+     
T Consensus       193 ~~~~~---~~~~~~t~~y~aPE~~~~~~---~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  266 (371)
T 4exu_A          193 HADAE---MTGYVVTRWYRAPEVILSWM---HYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFV  266 (371)
T ss_dssp             ----------CTTCCCTTSCHHHHSCCS---CCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             ccccC---cCCcccCccccCHHHhcCCC---CCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHH
Confidence            65432   33456799999999997632   24556999999999999999999999887766655543311110     


Q ss_pred             ------------------------CCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 012887          408 ------------------------EIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR  444 (454)
Q Consensus       408 ------------------------~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~  444 (454)
                                              ..+..+++.+.+||.+||+.||.+|||+.|++++-+-
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f  327 (371)
T 4exu_A          267 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFF  327 (371)
T ss_dssp             TTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGG
T ss_pred             HHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCccc
Confidence                                    0124578999999999999999999999999998663

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=1.5e-42  Score=346.93  Aligned_cols=247  Identities=15%  Similarity=0.224  Sum_probs=205.9

Q ss_pred             CCCEEEeceeeccCCceEEEe----EEEEEEEeecCCCCch---------------HHHHHHHHHHHHHhCCCCceeEEE
Q 012887          189 SDNLEFIDQIGPNSFKGVYKG----KRVGIEKLKGCDKGNA---------------YEFELRKDLLELMTCGHKNILQFY  249 (454)
Q Consensus       189 ~~~~~~~~~LG~G~fG~Vy~g----~~vavK~l~~~~~~~~---------------~~~~~~~Ei~~l~~l~HpnIv~~~  249 (454)
                      .++|++++.||+|+||.||++    +.||+|.+........               ....+.+|+.++..++||||++++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~  109 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCE  109 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCS
T ss_pred             cCceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEE
Confidence            478999999999999999996    6899999864322111               116688999999999999999999


Q ss_pred             EEEEeCCCeEEEEEeccCCCCHHHH------HHh--CCCCCHHHHHHHHHHHHHHHHHHHh-cCcccCCccCCcEEEccC
Q 012887          250 CVCVDENHGLCVVTKLMEGGSVNDL------ILK--SRKLQTKEIIRIAIDVAEGIKFLND-HGVAYRDLNSQRILLDRH  320 (454)
Q Consensus       250 g~~~~~~~~l~lV~E~~~~gsL~~~------l~~--~~~l~~~~~~~i~~qI~~gL~yLH~-~~iiHrDIKp~NILl~~~  320 (454)
                      +++.+.+. +++||||+++|+|.++      +.+  ...+++..+..++.||+.||.|||+ +||+||||||+|||++.+
T Consensus       110 ~~~~~~~~-~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~~  188 (348)
T 2pml_X          110 GIITNYDE-VYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKN  188 (348)
T ss_dssp             EEEESSSE-EEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEECTT
T ss_pred             EEEeeCCe-EEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEcCC
Confidence            99998775 9999999999999998      655  5689999999999999999999999 999999999999999999


Q ss_pred             CcEEEEccCCccccccCCCcccccCCCCcccccccccCCCCCCCCCc-hhhHHHHHHHHHHHHcCCCCCCCCCH-HHHHH
Q 012887          321 GNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETW-MSNVYSFGMVIWEMVTGEAAYAACSP-VQAAV  398 (454)
Q Consensus       321 ~~vKL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~-ksDVwSlGviL~elltG~~Pf~~~~~-~~~~~  398 (454)
                      +.+||+|||++......  ......+++.|+|||.+.+..   .++. ++||||||+++|+|++|..||..... .....
T Consensus       189 ~~~kl~dfg~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~---~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~  263 (348)
T 2pml_X          189 GRVKLSDFGESEYMVDK--KIKGSRGTYEFMPPEFFSNES---SYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFN  263 (348)
T ss_dssp             SCEEECCCTTCEECBTT--EECSSCSCGGGCCGGGGSSCC---CEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHH
T ss_pred             CcEEEeccccccccccc--cccCCCCCcCccCchhhcCCC---CCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHH
Confidence            99999999998765432  334457889999999998652   1233 69999999999999999999998766 44444


Q ss_pred             HHHHcCCCCCCC-------------------CCccHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 012887          399 GIAACGLRPEIP-------------------KDCPQILKSLMIKCWNNSPSKRPQFSEIISLLL  443 (454)
Q Consensus       399 ~i~~~~~~~~~p-------------------~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~  443 (454)
                      .+...  ...+|                   ..+++++.++|.+||+.||.+||++.|++++-+
T Consensus       264 ~i~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~  325 (348)
T 2pml_X          264 NIRTK--NIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEW  325 (348)
T ss_dssp             HHTSC--CCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGG
T ss_pred             HHhcc--CcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCcc
Confidence            44333  22333                   568999999999999999999999999998754

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1.4e-41  Score=343.37  Aligned_cols=249  Identities=13%  Similarity=0.176  Sum_probs=201.7

Q ss_pred             cceeecCCCEEEeceeeccCCceEEEe-----------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCC---CCceeEE
Q 012887          183 GRWLLNSDNLEFIDQIGPNSFKGVYKG-----------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCG---HKNILQF  248 (454)
Q Consensus       183 ~~~~~~~~~~~~~~~LG~G~fG~Vy~g-----------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~---HpnIv~~  248 (454)
                      ..+.+..++|++.+.||+|+||.||+|           +.||+|.+...     ...++.+|+.++..++   |+||+++
T Consensus        58 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~~~~l~~~~~~~iv~~  132 (365)
T 3e7e_A           58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA-----NPWEFYIGTQLMERLKPSMQHMFMKF  132 (365)
T ss_dssp             CEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC-----CHHHHHHHHHHHHHSCGGGGGGBCCE
T ss_pred             eeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC-----ChhHHHHHHHHHHHhhhhhhhhhhhh
Confidence            566788899999999999999999998           26899998632     1234567777777775   9999999


Q ss_pred             EEEEEeCCCeEEEEEeccCCCCHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEcc----
Q 012887          249 YCVCVDENHGLCVVTKLMEGGSVNDLILK-----SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDR----  319 (454)
Q Consensus       249 ~g~~~~~~~~l~lV~E~~~~gsL~~~l~~-----~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~----  319 (454)
                      ++++...+. .++||||+++|+|.+++..     ...+++..+..++.||+.||+|||++||+||||||+|||++.    
T Consensus       133 ~~~~~~~~~-~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~  211 (365)
T 3e7e_A          133 YSAHLFQNG-SVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLE  211 (365)
T ss_dssp             EEEEECSSC-EEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTC
T ss_pred             heeeecCCC-cEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccC
Confidence            999998877 8999999999999999963     457999999999999999999999999999999999999998    


Q ss_pred             -------CCcEEEEccCCccccccC--CCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCC
Q 012887          320 -------HGNVCLGDMGIVTACKSV--GEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAA  390 (454)
Q Consensus       320 -------~~~vKL~DFGla~~~~~~--~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~  390 (454)
                             ++.+||+|||+++.....  ........||+.|+|||++.+..    ++.++|||||||++|||++|..||..
T Consensus       212 ~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~il~elltg~~pf~~  287 (365)
T 3e7e_A          212 QDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKP----WNYQIDYFGVAATVYCMLFGTYMKVK  287 (365)
T ss_dssp             C------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCC----BSTHHHHHHHHHHHHHHHHSSCCCEE
T ss_pred             ccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCC----CCccccHHHHHHHHHHHHhCCCcccc
Confidence                   899999999999754322  22334456899999999998765    44569999999999999999999965


Q ss_pred             CCHHHHHHHHHHcCCCCCCC-CCccHHHHHHHHHhcccCCCCC-CCHHHHHHHHHhhcCC
Q 012887          391 CSPVQAAVGIAACGLRPEIP-KDCPQILKSLMIKCWNNSPSKR-PQFSEIISLLLRTNNI  448 (454)
Q Consensus       391 ~~~~~~~~~i~~~~~~~~~p-~~~~~~l~~li~~cl~~dP~~R-Ps~~ell~~L~~~~~~  448 (454)
                      ......       .....++ ...++.+.+++..|++.+|.+| |++.++.+.|..+...
T Consensus       288 ~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~  340 (365)
T 3e7e_A          288 NEGGEC-------KPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ  340 (365)
T ss_dssp             EETTEE-------EECSCCTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             CCCCce-------eechhccccCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence            322100       0011111 1247789999999999999999 6788888888776553

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.6e-42  Score=353.18  Aligned_cols=259  Identities=14%  Similarity=0.192  Sum_probs=206.1

Q ss_pred             cCCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCC-CeEE
Q 012887          188 NSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN-HGLC  260 (454)
Q Consensus       188 ~~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~-~~l~  260 (454)
                      ..++|++.+.||+|+||.||+|      +.||+|.+...... .....+.+|+.++..++||||+++++++.+.+ ...+
T Consensus         7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~   85 (396)
T 4eut_A            7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL-RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKV   85 (396)
T ss_dssp             SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG-SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEE
T ss_pred             CCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEecccccc-chHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeE
Confidence            3478999999999999999995      57999999743222 22355678999999999999999999998765 2489


Q ss_pred             EEEeccCCCCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEE----ccCCcEEEEccCCccc
Q 012887          261 VVTKLMEGGSVNDLILKSR---KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILL----DRHGNVCLGDMGIVTA  333 (454)
Q Consensus       261 lV~E~~~~gsL~~~l~~~~---~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl----~~~~~vKL~DFGla~~  333 (454)
                      +||||+++|+|.+++.+..   .+++..++.++.||+.||.|||++||+||||||+|||+    +.++.+||+|||++..
T Consensus        86 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~  165 (396)
T 4eut_A           86 LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE  165 (396)
T ss_dssp             EEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred             EEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence            9999999999999996533   39999999999999999999999999999999999999    7778899999999876


Q ss_pred             cccCCCcccccCCCCcccccccccCCCCC----CCCCchhhHHHHHHHHHHHHcCCCCCCCC----CHHHHHHHHHHcCC
Q 012887          334 CKSVGEATEYETDGYRWLAPEIIAGDPES----VSETWMSNVYSFGMVIWEMVTGEAAYAAC----SPVQAAVGIAACGL  405 (454)
Q Consensus       334 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~----~~~~~ksDVwSlGviL~elltG~~Pf~~~----~~~~~~~~i~~~~~  405 (454)
                      ..... ......||+.|+|||++.+....    ..++.++|||||||++|||++|..||...    ...+....+.....
T Consensus       166 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p  244 (396)
T 4eut_A          166 LEDDE-QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP  244 (396)
T ss_dssp             CCCGG-GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCC
T ss_pred             ccCCC-ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCC
Confidence            54432 23345689999999998642111    12455799999999999999999999742    23344444544321


Q ss_pred             CC-----------------------CCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCC
Q 012887          406 RP-----------------------EIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNI  448 (454)
Q Consensus       406 ~~-----------------------~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~  448 (454)
                      ..                       .++..++..+.++|.+||+.||.+||++.++++.+..+.+.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~  310 (396)
T 4eut_A          245 SGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR  310 (396)
T ss_dssp             TTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred             cccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence            11                       11234567899999999999999999999999999887653

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.4e-41  Score=350.72  Aligned_cols=244  Identities=20%  Similarity=0.197  Sum_probs=196.9

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCC-----Ce
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN-----HG  258 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~-----~~  258 (454)
                      .+|++++.||+|+||.||+|      +.||||++......      ..+|+.++..++|||||++++++....     ..
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~------~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~  127 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY  127 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTS------CCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchh------HHHHHHHHHHcCCCCccceeeEEeccCCCCccee
Confidence            46899999999999999996      46999998743222      236889999999999999999986431     23


Q ss_pred             EEEEEeccCCCCHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccC-CcEEEEccCCccc
Q 012887          259 LCVVTKLMEGGSVNDLIL----KSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH-GNVCLGDMGIVTA  333 (454)
Q Consensus       259 l~lV~E~~~~gsL~~~l~----~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~-~~vKL~DFGla~~  333 (454)
                      +++||||+++ +|.+.+.    ....+++..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++.
T Consensus       128 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~  206 (420)
T 1j1b_A          128 LNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ  206 (420)
T ss_dssp             EEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhh
Confidence            6799999986 7776653    34589999999999999999999999999999999999999965 5789999999986


Q ss_pred             cccCCCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCC--------
Q 012887          334 CKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGL--------  405 (454)
Q Consensus       334 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~--------  405 (454)
                      ...... .....+|+.|+|||++.+..   .++.++|||||||++|||++|+.||.+.+....+..+.....        
T Consensus       207 ~~~~~~-~~~~~~t~~y~aPE~~~~~~---~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~  282 (420)
T 1j1b_A          207 LVRGEP-NVSYICSRYYRAPELIFGAT---DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR  282 (420)
T ss_dssp             CCTTCC-CCSCCSCTTSCCHHHHTTCS---SCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred             cccCCC-ceeeeeCCCcCCHHHHcCCC---CCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            544322 33456799999999997542   355679999999999999999999999887766655443100        


Q ss_pred             -------CCC------------CCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 012887          406 -------RPE------------IPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR  444 (454)
Q Consensus       406 -------~~~------------~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~  444 (454)
                             ...            ++..+++++.+||.+||+.||.+||++.|+++|-+-
T Consensus       283 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f  340 (420)
T 1j1b_A          283 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF  340 (420)
T ss_dssp             HHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred             hhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhh
Confidence                   001            234578999999999999999999999999987654

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=1.4e-41  Score=336.97  Aligned_cols=243  Identities=19%  Similarity=0.263  Sum_probs=197.9

Q ss_pred             CCCEEEeceeeccCCceEEEe-------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCC------ceeEEEEEEEeC
Q 012887          189 SDNLEFIDQIGPNSFKGVYKG-------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHK------NILQFYCVCVDE  255 (454)
Q Consensus       189 ~~~~~~~~~LG~G~fG~Vy~g-------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~Hp------nIv~~~g~~~~~  255 (454)
                      .++|++++.||+|+||.||++       +.||+|.++.   .......+.+|+.++..++|+      +++++++++.+.
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~   89 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKN---VDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHH   89 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS---SHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEET
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEec---CCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccC
Confidence            478999999999999999985       5799999863   233445677888888877554      599999999888


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEcc--------------
Q 012887          256 NHGLCVVTKLMEGGSVNDLILKSR--KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDR--------------  319 (454)
Q Consensus       256 ~~~l~lV~E~~~~gsL~~~l~~~~--~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~--------------  319 (454)
                      +. +++||||+ +++|.+++...+  .+++..+..++.||+.||.|||++||+||||||+|||++.              
T Consensus        90 ~~-~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~  167 (339)
T 1z57_A           90 GH-ICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRD  167 (339)
T ss_dssp             TE-EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred             Cc-EEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccccc
Confidence            76 99999999 789999997654  7899999999999999999999999999999999999987              


Q ss_pred             -----CCcEEEEccCCccccccCCCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHH
Q 012887          320 -----HGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPV  394 (454)
Q Consensus       320 -----~~~vKL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~  394 (454)
                           ++.+||+|||++.....   ......+|+.|+|||++.+..    ++.++|||||||++|||++|..||...+..
T Consensus       168 ~~~~~~~~~kl~Dfg~~~~~~~---~~~~~~gt~~y~aPE~~~~~~----~~~~~Di~slG~il~el~~g~~pf~~~~~~  240 (339)
T 1z57_A          168 ERTLINPDIKVVDFGSATYDDE---HHSTLVSTRHYRAPEVILALG----WSQPCDVWSIGCILIEYYLGFTVFPTHDSK  240 (339)
T ss_dssp             EEEESCCCEEECCCSSCEETTS---CCCSSCSCGGGCCHHHHTTSC----CCTHHHHHHHHHHHHHHHHSSCSCCCSCHH
T ss_pred             cccccCCCceEeeCcccccCcc---ccccccCCccccChHHhhCCC----CCcchhhHHHHHHHHHHHhCCCCCCCCChH
Confidence                 66899999999876433   233457899999999998764    455799999999999999999999987766


Q ss_pred             HHHHHHHHcCCC------------------------------------------CCCCCCccHHHHHHHHHhcccCCCCC
Q 012887          395 QAAVGIAACGLR------------------------------------------PEIPKDCPQILKSLMIKCWNNSPSKR  432 (454)
Q Consensus       395 ~~~~~i~~~~~~------------------------------------------~~~p~~~~~~l~~li~~cl~~dP~~R  432 (454)
                      .....+......                                          ...+...++++.+||.+||+.||.+|
T Consensus       241 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R  320 (339)
T 1z57_A          241 EHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKR  320 (339)
T ss_dssp             HHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred             HHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccc
Confidence            544332211000                                          01122346789999999999999999


Q ss_pred             CCHHHHHHHHH
Q 012887          433 PQFSEIISLLL  443 (454)
Q Consensus       433 Ps~~ell~~L~  443 (454)
                      ||+.|++++-+
T Consensus       321 pt~~ell~hp~  331 (339)
T 1z57_A          321 ITLREALKHPF  331 (339)
T ss_dssp             CCHHHHTTSGG
T ss_pred             cCHHHHhcCHH
Confidence            99999998743

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=1.6e-41  Score=331.34  Aligned_cols=246  Identities=19%  Similarity=0.357  Sum_probs=194.0

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeC--------
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDE--------  255 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~--------  255 (454)
                      ++|++++.||+|+||.||+|      +.||+|.+..   .......+.+|+.++..++||||+++++++.+.        
T Consensus         6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   82 (303)
T 1zy4_A            6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH---TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT   82 (303)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE---EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred             ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec---cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence            57899999999999999996      4799999863   233446688999999999999999999998753        


Q ss_pred             ----CCeEEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCC
Q 012887          256 ----NHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGI  330 (454)
Q Consensus       256 ----~~~l~lV~E~~~~gsL~~~l~~~~-~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGl  330 (454)
                          ...+++||||+++|+|.+++.+.. .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus        83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~  162 (303)
T 1zy4_A           83 AVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGL  162 (303)
T ss_dssp             ---CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred             ccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCcc
Confidence                234899999999999999997544 788999999999999999999999999999999999999999999999999


Q ss_pred             ccccccCC--------------CcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHH-
Q 012887          331 VTACKSVG--------------EATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQ-  395 (454)
Q Consensus       331 a~~~~~~~--------------~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~-  395 (454)
                      +.......              .......+++.|+|||.+.+..   .++.++|||||||++|+|++   ||....... 
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~~Di~slG~il~~l~~---p~~~~~~~~~  236 (303)
T 1zy4_A          163 AKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTG---HYNEKIDMYSLGIIFFEMIY---PFSTGMERVN  236 (303)
T ss_dssp             CSCTTC-------------------------CTTSCHHHHTSCS---CCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH
T ss_pred             hhhcccccchhccccccccccccccccCCCcccccCcccccCCC---CCcchhhHHHHHHHHHHHHh---ccCCchhHHH
Confidence            87654221              1123345788999999997542   35567999999999999998   565432222 


Q ss_pred             HHHHHHHc--CCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 012887          396 AAVGIAAC--GLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR  444 (454)
Q Consensus       396 ~~~~i~~~--~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~  444 (454)
                      ....+...  ..++.++...+..+.++|.+||+.||.+|||+.+++++-+-
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~  287 (303)
T 1zy4_A          237 ILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWL  287 (303)
T ss_dssp             HHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCS
T ss_pred             HHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCc
Confidence            22222221  23344566778899999999999999999999999987553

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=2.4e-41  Score=335.74  Aligned_cols=245  Identities=14%  Similarity=0.226  Sum_probs=197.3

Q ss_pred             cCCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCC-CCceeEEEEEEEeC-CCeE
Q 012887          188 NSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCG-HKNILQFYCVCVDE-NHGL  259 (454)
Q Consensus       188 ~~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~~~g~~~~~-~~~l  259 (454)
                      ..++|++++.||+|+||.||+|      +.||+|.+...     ....+.+|+.++..+. ||||+++++++.+. ....
T Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~  108 (330)
T 3nsz_A           34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTP  108 (330)
T ss_dssp             EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCE
T ss_pred             CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc-----chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCce
Confidence            3578999999999999999996      57999998632     2355789999999996 99999999999874 2348


Q ss_pred             EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCC-cEEEEccCCccccccCC
Q 012887          260 CVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG-NVCLGDMGIVTACKSVG  338 (454)
Q Consensus       260 ~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~-~vKL~DFGla~~~~~~~  338 (454)
                      ++||||+++++|.+++.   .+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.......
T Consensus       109 ~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~  185 (330)
T 3nsz_A          109 ALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ  185 (330)
T ss_dssp             EEEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred             EEEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC
Confidence            99999999999999874   489999999999999999999999999999999999999777 89999999987654432


Q ss_pred             CcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC-HHHHHHHHHH-------------cC
Q 012887          339 EATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACS-PVQAAVGIAA-------------CG  404 (454)
Q Consensus       339 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~-~~~~~~~i~~-------------~~  404 (454)
                       ......++..|+|||.+.+..   .++.++|||||||++|+|++|..||.... .......+..             ..
T Consensus       186 -~~~~~~~~~~y~aPE~~~~~~---~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  261 (330)
T 3nsz_A          186 -EYNVRVASRYFKGPELLVDYQ---MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN  261 (330)
T ss_dssp             -CCCSCCSCGGGCCHHHHTTCC---CCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred             -ccccccccccccChhhhcCCC---cCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhc
Confidence             234457888999999987632   35567999999999999999999996433 3222221111             00


Q ss_pred             C----------------------CCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 012887          405 L----------------------RPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR  444 (454)
Q Consensus       405 ~----------------------~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~  444 (454)
                      .                      ....+..+++++.+||.+||+.||.+|||+.|+++|-+-
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f  323 (330)
T 3nsz_A          262 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF  323 (330)
T ss_dssp             CCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGG
T ss_pred             cccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccH
Confidence            0                      011122378999999999999999999999999987553

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=2.2e-41  Score=340.14  Aligned_cols=246  Identities=17%  Similarity=0.251  Sum_probs=200.9

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCC-----e
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH-----G  258 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~-----~  258 (454)
                      ++|.+.+.||+|+||.||+|      +.||+|.+............+.+|+.++..++||||+++++++...+.     .
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  103 (353)
T 3coi_A           24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD  103 (353)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred             ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence            78999999999999999985      589999997655455556678899999999999999999999987653     2


Q ss_pred             EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCC
Q 012887          259 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG  338 (454)
Q Consensus       259 l~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~  338 (454)
                      +++||||+. ++|.+++.  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... 
T Consensus       104 ~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~-  179 (353)
T 3coi_A          104 FYLVMPFMQ-TDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE-  179 (353)
T ss_dssp             CEEEEECCS-EEGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC-----
T ss_pred             EEEEecccc-CCHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCCC-
Confidence            599999997 48888763  35999999999999999999999999999999999999999999999999998764432 


Q ss_pred             CcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcC--------------
Q 012887          339 EATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG--------------  404 (454)
Q Consensus       339 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~--------------  404 (454)
                        .....+|+.|+|||.+.+..   .++.++|||||||++|+|++|..||.+.+.......+....              
T Consensus       180 --~~~~~~t~~y~aPE~~~~~~---~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  254 (353)
T 3coi_A          180 --MTGYVVTRWYRAPEVILSWM---HYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDK  254 (353)
T ss_dssp             ------CCSBCCSCHHHHSCCS---CCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCH
T ss_pred             --ccccccCcCcCCHHHHhCcC---CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhH
Confidence              33446789999999987632   24556999999999999999999999877765554433210              


Q ss_pred             ------------CC---CCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 012887          405 ------------LR---PEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR  444 (454)
Q Consensus       405 ------------~~---~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~  444 (454)
                                  .+   ...+..+++++.+||.+||+.||.+|||+.++++|-+-
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f  309 (353)
T 3coi_A          255 AAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFF  309 (353)
T ss_dssp             HHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGG
T ss_pred             HHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcch
Confidence                        01   12334678999999999999999999999999987653

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=3.2e-41  Score=332.03  Aligned_cols=250  Identities=15%  Similarity=0.201  Sum_probs=196.5

Q ss_pred             CCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeC-------
Q 012887          189 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDE-------  255 (454)
Q Consensus       189 ~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~-------  255 (454)
                      .++|++++.||+|+||.||+|      +.||+|++...  .......+.+|+.++..++||||+++++++...       
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   87 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT--DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDD   87 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC-
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC--ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccc
Confidence            378999999999999999985      68999998743  234456688999999999999999999987432       


Q ss_pred             ------CCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEc-cCCcEEEEcc
Q 012887          256 ------NHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLD-RHGNVCLGDM  328 (454)
Q Consensus       256 ------~~~l~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~-~~~~vKL~DF  328 (454)
                            ...+++||||++ |+|.+++. .+.+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+||
T Consensus        88 ~~~~~~~~~~~lv~e~~~-~~L~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Df  165 (320)
T 2i6l_A           88 VGSLTELNSVYIVQEYME-TDLANVLE-QGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDF  165 (320)
T ss_dssp             ---CCSCSEEEEEEECCS-EEHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCC
T ss_pred             cccccccCceeEEeeccC-CCHHHHhh-cCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccC
Confidence                  245899999998 59999984 46799999999999999999999999999999999999997 5679999999


Q ss_pred             CCccccccCC---CcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCC
Q 012887          329 GIVTACKSVG---EATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGL  405 (454)
Q Consensus       329 Gla~~~~~~~---~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~  405 (454)
                      |++.......   .......++..|+|||.+.+..   .++.++|||||||++|+|++|..||.+.........+.....
T Consensus       166 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  242 (320)
T 2i6l_A          166 GLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPN---NYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIP  242 (320)
T ss_dssp             TTCBCC--------CCCGGGSCCTTCCHHHHHCTT---CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSC
T ss_pred             ccccccCCCcccccccccccccccccCcHHhcCcc---cCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence            9987654321   1223345688899999886532   356679999999999999999999998877665554433211


Q ss_pred             C-----------------------C-----CCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 012887          406 R-----------------------P-----EIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRT  445 (454)
Q Consensus       406 ~-----------------------~-----~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~  445 (454)
                      .                       +     ..+..++.++.++|.+||+.||.+|||+.|++++-+-.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~  310 (320)
T 2i6l_A          243 VVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMS  310 (320)
T ss_dssp             CCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHH
T ss_pred             CCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccc
Confidence            0                       0     12346899999999999999999999999999986643

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=1.2e-41  Score=341.81  Aligned_cols=248  Identities=18%  Similarity=0.164  Sum_probs=188.7

Q ss_pred             CCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCC-----
Q 012887          189 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH-----  257 (454)
Q Consensus       189 ~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~-----  257 (454)
                      .++|++.+.||+|+||.||+|      +.||+|++.......   ....+++..+..++||||+++++++...+.     
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~   98 (360)
T 3e3p_A           22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR---NRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRD   98 (360)
T ss_dssp             HTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCC---CHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcccc---HHHHHHHHHHHhcCCCCcccHHHhhhccccccccc
Confidence            478999999999999999986      479999987543332   234566777788899999999999976432     


Q ss_pred             -eEEEEEeccCCCCHHHHH----HhCCCCCHHHHHHHHHHHHHHHHHHH--hcCcccCCccCCcEEEcc-CCcEEEEccC
Q 012887          258 -GLCVVTKLMEGGSVNDLI----LKSRKLQTKEIIRIAIDVAEGIKFLN--DHGVAYRDLNSQRILLDR-HGNVCLGDMG  329 (454)
Q Consensus       258 -~l~lV~E~~~~gsL~~~l----~~~~~l~~~~~~~i~~qI~~gL~yLH--~~~iiHrDIKp~NILl~~-~~~vKL~DFG  329 (454)
                       .+++||||+++ +|.+.+    .....+++..+..++.||+.||.|||  ++||+||||||+|||++. ++.+||+|||
T Consensus        99 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg  177 (360)
T 3e3p_A           99 IYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFG  177 (360)
T ss_dssp             EEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCT
T ss_pred             eeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCC
Confidence             27899999987 555444    24568999999999999999999999  999999999999999997 8999999999


Q ss_pred             CccccccCCCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCC---
Q 012887          330 IVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR---  406 (454)
Q Consensus       330 la~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~---  406 (454)
                      ++....... ......+|+.|+|||++.+..   .++.++|||||||++|+|++|..||.+.+.......+......   
T Consensus       178 ~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~---~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  253 (360)
T 3e3p_A          178 SAKKLSPSE-PNVAYICSRYYRAPELIFGNQ---HYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSR  253 (360)
T ss_dssp             TCBCCCTTS-CCCSTTSCGGGCCHHHHTTCS---SCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred             CceecCCCC-CcccccCCcceeCHHHHcCCC---CCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCH
Confidence            988665433 233456799999999986543   2556799999999999999999999998877666555431111   


Q ss_pred             ---------------------------CCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 012887          407 ---------------------------PEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR  444 (454)
Q Consensus       407 ---------------------------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~  444 (454)
                                                 ...+...++++.+||.+||+.||.+|||+.|+++|-+-
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f  318 (360)
T 3e3p_A          254 EVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYF  318 (360)
T ss_dssp             HHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGG
T ss_pred             HHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccc
Confidence                                       11223367899999999999999999999999998654

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=2.2e-42  Score=350.12  Aligned_cols=247  Identities=10%  Similarity=0.063  Sum_probs=180.9

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCc-hHHHHHHHHH---HHHHhCCCCceeEEE-------EEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGN-AYEFELRKDL---LELMTCGHKNILQFY-------CVC  252 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~-~~~~~~~~Ei---~~l~~l~HpnIv~~~-------g~~  252 (454)
                      .+|++.+.||+|+||.||+|      +.||+|++....... .....+.+|+   ..|.. +||||++++       +++
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEE
T ss_pred             eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehhe
Confidence            45899999999999999996      579999998654433 2344566774   44555 799988865       455


Q ss_pred             EeCC----------------CeEEEEEeccCCCCHHHHHHhC-CCCCHHHH------HHHHHHHHHHHHHHHhcCcccCC
Q 012887          253 VDEN----------------HGLCVVTKLMEGGSVNDLILKS-RKLQTKEI------IRIAIDVAEGIKFLNDHGVAYRD  309 (454)
Q Consensus       253 ~~~~----------------~~l~lV~E~~~~gsL~~~l~~~-~~l~~~~~------~~i~~qI~~gL~yLH~~~iiHrD  309 (454)
                      ...+                ..+|+||||++ |+|.+++... ..+++...      ..++.||+.||.|||++||+|||
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrD  219 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGH  219 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCc
Confidence            4332                23899999998 7999999653 34555555      67779999999999999999999


Q ss_pred             ccCCcEEEccCCcEEEEccCCccccccCCCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCC
Q 012887          310 LNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYA  389 (454)
Q Consensus       310 IKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~  389 (454)
                      |||+|||++.++.+||+|||+++....   ......+|+.|+|||++.+..  ..++.++|||||||++|||++|..||.
T Consensus       220 ikp~NIll~~~~~~kL~DFG~a~~~~~---~~~~~~~t~~y~aPE~~~~~~--~~~~~~~DiwSlG~il~elltg~~Pf~  294 (371)
T 3q60_A          220 FTPDNLFIMPDGRLMLGDVSALWKVGT---RGPASSVPVTYAPREFLNAST--ATFTHALNAWQLGLSIYRVWCLFLPFG  294 (371)
T ss_dssp             CSGGGEEECTTSCEEECCGGGEEETTC---EEEGGGSCGGGCCHHHHTCSE--EECCHHHHHHHHHHHHHHHHHSSCSTT
T ss_pred             CCHHHEEECCCCCEEEEecceeeecCC---CccCccCCcCCcChhhccCCC--CCcCccccHHHHHHHHHHHHhCCCCCC
Confidence            999999999999999999999876542   222445679999999997621  135667999999999999999999998


Q ss_pred             CCCHHHHH--HH---HHH--cCCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 012887          390 ACSPVQAA--VG---IAA--CGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLL  443 (454)
Q Consensus       390 ~~~~~~~~--~~---i~~--~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~  443 (454)
                      +..+....  ..   ...  .....+.+..+|+.+.+||.+||+.||.+|||+.++++|-+
T Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~  355 (371)
T 3q60_A          295 LVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPE  355 (371)
T ss_dssp             BCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHH
T ss_pred             CcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHH
Confidence            76432110  00   000  11122233578999999999999999999999999987654

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=1.6e-41  Score=341.70  Aligned_cols=251  Identities=19%  Similarity=0.238  Sum_probs=196.8

Q ss_pred             cCCCEEEeceeeccCCceEEEe-----EEEEEEEeecCCCC---------chHHHHHHHHHHHHHhCCCCceeEEEEEEE
Q 012887          188 NSDNLEFIDQIGPNSFKGVYKG-----KRVGIEKLKGCDKG---------NAYEFELRKDLLELMTCGHKNILQFYCVCV  253 (454)
Q Consensus       188 ~~~~~~~~~~LG~G~fG~Vy~g-----~~vavK~l~~~~~~---------~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~  253 (454)
                      ..++|++.+.||+|+||.||+|     +.||+|++......         ......+.+|+.++..++||||+++++++.
T Consensus        20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   99 (362)
T 3pg1_A           20 MQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFV   99 (362)
T ss_dssp             TTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEE
T ss_pred             hccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEE
Confidence            3478999999999999999996     57999998643221         112366889999999999999999999986


Q ss_pred             eCC----CeEEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEcc
Q 012887          254 DEN----HGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDM  328 (454)
Q Consensus       254 ~~~----~~l~lV~E~~~~gsL~~~l~~~~-~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DF  328 (454)
                      ..+    ..+++||||++ |+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus       100 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Df  178 (362)
T 3pg1_A          100 HFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDF  178 (362)
T ss_dssp             ECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCT
T ss_pred             eccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEec
Confidence            532    24899999998 58888886543 7999999999999999999999999999999999999999999999999


Q ss_pred             CCccccccCCCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCC-
Q 012887          329 GIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP-  407 (454)
Q Consensus       329 Gla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~-  407 (454)
                      |++....... ......+|+.|+|||.+.+..   .++.++|||||||++|+|++|..||.+.+.......+......+ 
T Consensus       179 g~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~---~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~  254 (362)
T 3pg1_A          179 NLAREDTADA-NKTHYVTHRWYRAPELVMQFK---GFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPK  254 (362)
T ss_dssp             TC----------------CGGGCCHHHHTTCT---TCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             Cccccccccc-ccceecccceecCcHHhcCCC---CCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence            9987543322 233456788999999987632   25567999999999999999999999887766555443211111 


Q ss_pred             -----------------------------CCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 012887          408 -----------------------------EIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLL  443 (454)
Q Consensus       408 -----------------------------~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~  443 (454)
                                                   ..+..+++.+.+||.+||+.||.+|||+.|+++|-+
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~  319 (362)
T 3pg1_A          255 IEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPY  319 (362)
T ss_dssp             HHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred             hHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCch
Confidence                                         112356889999999999999999999999998755

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=1.7e-41  Score=344.30  Aligned_cols=244  Identities=17%  Similarity=0.255  Sum_probs=193.0

Q ss_pred             CCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCC--------CCceeEEEEEEEe
Q 012887          189 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCG--------HKNILQFYCVCVD  254 (454)
Q Consensus       189 ~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~--------HpnIv~~~g~~~~  254 (454)
                      .++|++++.||+|+||.||++      +.||+|.+..   .......+.+|+.++..+.        |+||+++++++..
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~  112 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKS---AEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKI  112 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS---CHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEec---CCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceee
Confidence            478999999999999999996      5799999863   2344556788998888874        8889999999873


Q ss_pred             ---CCCeEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhc-CcccCCccCCcEEEccCC-------
Q 012887          255 ---ENHGLCVVTKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDH-GVAYRDLNSQRILLDRHG-------  321 (454)
Q Consensus       255 ---~~~~l~lV~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~qI~~gL~yLH~~-~iiHrDIKp~NILl~~~~-------  321 (454)
                         .+..+++||||+ +++|.+.+.+.  ..+++..+..++.||+.||.|||++ ||+||||||+|||++.++       
T Consensus       113 ~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~  191 (397)
T 1wak_A          113 SGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLA  191 (397)
T ss_dssp             EETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHH
T ss_pred             cCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhh
Confidence               223489999999 55776666443  4799999999999999999999999 999999999999999775       


Q ss_pred             ------------------------------------------cEEEEccCCccccccCCCcccccCCCCcccccccccCC
Q 012887          322 ------------------------------------------NVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGD  359 (454)
Q Consensus       322 ------------------------------------------~vKL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~  359 (454)
                                                                .+||+|||++......   .....+|+.|+|||++.+.
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~---~~~~~gt~~y~aPE~~~~~  268 (397)
T 1wak_A          192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH---FTEDIQTRQYRSLEVLIGS  268 (397)
T ss_dssp             HHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC---SCSCCSCGGGCCHHHHHTS
T ss_pred             hhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc---CccCCCCCcccCChhhcCC
Confidence                                                      7999999998765432   3344689999999999876


Q ss_pred             CCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCH------HHHHHHHHH-cCCC--------------------------
Q 012887          360 PESVSETWMSNVYSFGMVIWEMVTGEAAYAACSP------VQAAVGIAA-CGLR--------------------------  406 (454)
Q Consensus       360 ~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~------~~~~~~i~~-~~~~--------------------------  406 (454)
                      .    ++.++|||||||++|||++|..||.+.+.      ......+.. .+..                          
T Consensus       269 ~----~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~  344 (397)
T 1wak_A          269 G----YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK  344 (397)
T ss_dssp             C----CCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCC
T ss_pred             C----CCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccc
Confidence            5    44569999999999999999999986442      222211111 0000                          


Q ss_pred             -------------CCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 012887          407 -------------PEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLL  443 (454)
Q Consensus       407 -------------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~  443 (454)
                                   ...+...++.+.+||.+||+.||.+|||+.|+++|-+
T Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~  394 (397)
T 1wak_A          345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPW  394 (397)
T ss_dssp             CCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGG
T ss_pred             cCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcc
Confidence                         0123345678899999999999999999999998754

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.2e-41  Score=335.60  Aligned_cols=242  Identities=19%  Similarity=0.260  Sum_probs=195.5

Q ss_pred             CCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCch----HHHHHHHHHHHHHhC----CCCceeEEEEEEEe
Q 012887          189 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNA----YEFELRKDLLELMTC----GHKNILQFYCVCVD  254 (454)
Q Consensus       189 ~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~----~~~~~~~Ei~~l~~l----~HpnIv~~~g~~~~  254 (454)
                      .++|++.+.||+|+||.||+|      +.||+|.+........    ....+.+|+..+..+    +||||+++++++.+
T Consensus        30 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~  109 (312)
T 2iwi_A           30 EAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFET  109 (312)
T ss_dssp             ---CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC--
T ss_pred             hhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEec
Confidence            478999999999999999996      4799999875432221    222355788888887    89999999999987


Q ss_pred             CCCeEEEEEec-cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEc-cCCcEEEEccCCcc
Q 012887          255 ENHGLCVVTKL-MEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLD-RHGNVCLGDMGIVT  332 (454)
Q Consensus       255 ~~~~l~lV~E~-~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~-~~~~vKL~DFGla~  332 (454)
                      .+. .++|||+ +.+++|.+++.+.+.+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++.
T Consensus       110 ~~~-~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~~  188 (312)
T 2iwi_A          110 QEG-FMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGA  188 (312)
T ss_dssp             ----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSSCE
T ss_pred             CCe-EEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcchhh
Confidence            776 8899999 78999999998878899999999999999999999999999999999999999 88999999999987


Q ss_pred             ccccCCCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCC
Q 012887          333 ACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKD  412 (454)
Q Consensus       333 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~  412 (454)
                      .....  ......+++.|+|||++.+..+   .+.++||||||+++|+|++|..||....      .+..  ....++..
T Consensus       189 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~---~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~--~~~~~~~~  255 (312)
T 2iwi_A          189 LLHDE--PYTDFDGTRVYSPPEWISRHQY---HALPATVWSLGILLYDMVCGDIPFERDQ------EILE--AELHFPAH  255 (312)
T ss_dssp             ECCSS--CBCCCCSCTTTSCHHHHHHSCB---CHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHH--TCCCCCTT
T ss_pred             hcccC--cccccCCcccccCceeeecCCC---CCccchHHHHHHHHHHHHHCCCCCCChH------HHhh--hccCCccc
Confidence            66543  2334568899999999876543   2346999999999999999999997532      1222  24457788


Q ss_pred             ccHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 012887          413 CPQILKSLMIKCWNNSPSKRPQFSEIISLLLR  444 (454)
Q Consensus       413 ~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~  444 (454)
                      ++..+.++|.+||+.||.+||++.|++++-+-
T Consensus       256 ~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~  287 (312)
T 2iwi_A          256 VSPDCCALIRRCLAPKPSSRPSLEEILLDPWM  287 (312)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTT
T ss_pred             CCHHHHHHHHHHccCChhhCcCHHHHhcChhh
Confidence            99999999999999999999999999987653

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=9.7e-41  Score=350.57  Aligned_cols=249  Identities=19%  Similarity=0.248  Sum_probs=200.1

Q ss_pred             CCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCC-CceeEEEEEEEeCCCeEEE
Q 012887          189 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGH-KNILQFYCVCVDENHGLCV  261 (454)
Q Consensus       189 ~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~H-pnIv~~~g~~~~~~~~l~l  261 (454)
                      .++|++++.||+|+||.||+|      +.||||.+.......    .+.+|+.++..+.| +++..+..++.+.+ ..++
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~----~~~~E~~il~~L~~~~~i~~i~~~~~~~~-~~~l   80 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP----QLLYESKIYRILQGGTGIPNVRWFGVEGD-YNVL   80 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSC----CHHHHHHHHHHTTTSTTCCCEEEEEEETT-EEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccH----HHHHHHHHHHHhcCCCCCCeEEEEEeeCC-EEEE
Confidence            378999999999999999996      479999887543332    36688888999877 55555555555544 4899


Q ss_pred             EEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEE---ccCCcEEEEccCCccccccC
Q 012887          262 VTKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILL---DRHGNVCLGDMGIVTACKSV  337 (454)
Q Consensus       262 V~E~~~~gsL~~~l~~-~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl---~~~~~vKL~DFGla~~~~~~  337 (454)
                      ||||+ +++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+||||   +.++.+||+|||+++.....
T Consensus        81 vme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~  159 (483)
T 3sv0_A           81 VMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT  159 (483)
T ss_dssp             EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             EEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCC
Confidence            99999 8899999965 4589999999999999999999999999999999999999   68899999999999876543


Q ss_pred             CCc-------ccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHHHc---C
Q 012887          338 GEA-------TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSP---VQAAVGIAAC---G  404 (454)
Q Consensus       338 ~~~-------~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~---~~~~~~i~~~---~  404 (454)
                      ...       .....||+.|+|||.+.+..    ++.++|||||||+||||++|..||.+...   ......+...   .
T Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~----~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~  235 (483)
T 3sv0_A          160 STHQHIPYRENKNLTGTARYASVNTHLGIE----QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVAT  235 (483)
T ss_dssp             TTCCBCCCCCCCCCCSCTTTCCHHHHTTCC----CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHS
T ss_pred             ccccccccccccccCCCccccCHHHhcCCC----CChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccc
Confidence            321       22456899999999998765    45679999999999999999999987443   2222222221   1


Q ss_pred             CCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 012887          405 LRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNN  447 (454)
Q Consensus       405 ~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~  447 (454)
                      ....++..++.++.+||.+||+.||.+||++.+|++.|..+..
T Consensus       236 ~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~  278 (483)
T 3sv0_A          236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFI  278 (483)
T ss_dssp             CHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred             cHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence            1122346789999999999999999999999999999988754

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=1.2e-40  Score=332.66  Aligned_cols=243  Identities=16%  Similarity=0.230  Sum_probs=195.9

Q ss_pred             CCCEEEeceeeccCCceEEEe-------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCc------eeEEEEEEEeC
Q 012887          189 SDNLEFIDQIGPNSFKGVYKG-------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKN------ILQFYCVCVDE  255 (454)
Q Consensus       189 ~~~~~~~~~LG~G~fG~Vy~g-------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~Hpn------Iv~~~g~~~~~  255 (454)
                      .++|++++.||+|+||.||++       +.||+|.++.   .......+.+|+.++..+.|++      ++.+++++...
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~---~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~   94 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRN---VGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFH   94 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS---CHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEET
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcc---cccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeC
Confidence            479999999999999999985       5799999863   2344556778888888876555      99999999887


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEE----------------
Q 012887          256 NHGLCVVTKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILL----------------  317 (454)
Q Consensus       256 ~~~l~lV~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl----------------  317 (454)
                      +. +++||||+ +++|.+++...  ..+++..+..++.||+.||.|||++||+||||||+|||+                
T Consensus        95 ~~-~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~  172 (355)
T 2eu9_A           95 GH-MCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCE  172 (355)
T ss_dssp             TE-EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred             Ce-EEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccccccc
Confidence            76 99999999 55777777554  379999999999999999999999999999999999999                


Q ss_pred             ---ccCCcEEEEccCCccccccCCCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHH
Q 012887          318 ---DRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPV  394 (454)
Q Consensus       318 ---~~~~~vKL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~  394 (454)
                         +.++.+||+|||++.....   ......+|+.|+|||++.+..    ++.++|||||||++|||++|..||......
T Consensus       173 ~~~~~~~~~kl~Dfg~~~~~~~---~~~~~~gt~~y~aPE~~~~~~----~~~~~Di~slG~il~el~~g~~pf~~~~~~  245 (355)
T 2eu9_A          173 EKSVKNTSIRVADFGSATFDHE---HHTTIVATRHYRPPEVILELG----WAQPCDVWSIGCILFEYYRGFTLFQTHENR  245 (355)
T ss_dssp             EEEESCCCEEECCCTTCEETTS---CCCSSCSCGGGCCHHHHTTCC----CCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             ccccCCCcEEEeecCccccccc---cccCCcCCCcccCCeeeecCC----CCCccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence               6678999999999876433   234457899999999998764    455699999999999999999999987766


Q ss_pred             HHHHHHHHcCCCC------------------------------------------CCCCCccHHHHHHHHHhcccCCCCC
Q 012887          395 QAAVGIAACGLRP------------------------------------------EIPKDCPQILKSLMIKCWNNSPSKR  432 (454)
Q Consensus       395 ~~~~~i~~~~~~~------------------------------------------~~p~~~~~~l~~li~~cl~~dP~~R  432 (454)
                      .....+.......                                          ......+.++.+||.+||+.||.+|
T Consensus       246 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R  325 (355)
T 2eu9_A          246 EHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQR  325 (355)
T ss_dssp             HHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred             HHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhC
Confidence            5443332211000                                          0011235689999999999999999


Q ss_pred             CCHHHHHHHHH
Q 012887          433 PQFSEIISLLL  443 (454)
Q Consensus       433 Ps~~ell~~L~  443 (454)
                      ||+.|+++|-+
T Consensus       326 pt~~e~l~hp~  336 (355)
T 2eu9_A          326 ITLAEALLHPF  336 (355)
T ss_dssp             CCHHHHTTSGG
T ss_pred             cCHHHHhcChh
Confidence            99999998754

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=2.4e-41  Score=335.75  Aligned_cols=242  Identities=19%  Similarity=0.262  Sum_probs=201.2

Q ss_pred             cCCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCc----hHHHHHHHHHHHHHhCC--CCceeEEEEEEEeC
Q 012887          188 NSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGN----AYEFELRKDLLELMTCG--HKNILQFYCVCVDE  255 (454)
Q Consensus       188 ~~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~----~~~~~~~~Ei~~l~~l~--HpnIv~~~g~~~~~  255 (454)
                      -.++|++.+.||+|+||.||+|      +.||+|.+.......    .....+.+|+.++..+.  ||||+++++++.+.
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~  120 (320)
T 3a99_A           41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP  120 (320)
T ss_dssp             CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred             ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC
Confidence            3578999999999999999996      579999997543221    11233567888888885  69999999999887


Q ss_pred             CCeEEEEEeccCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEc-cCCcEEEEccCCccc
Q 012887          256 NHGLCVVTKLMEG-GSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLD-RHGNVCLGDMGIVTA  333 (454)
Q Consensus       256 ~~~l~lV~E~~~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~-~~~~vKL~DFGla~~  333 (454)
                      +. .++|||++.+ ++|.+++.+.+.+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++..
T Consensus       121 ~~-~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~  199 (320)
T 3a99_A          121 DS-FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL  199 (320)
T ss_dssp             SE-EEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             Cc-EEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCccccc
Confidence            76 9999999976 89999998878999999999999999999999999999999999999999 789999999999876


Q ss_pred             cccCCCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCc
Q 012887          334 CKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDC  413 (454)
Q Consensus       334 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~  413 (454)
                      ....  ......+|+.|+|||++.+..+   .+.++||||||+++|||++|..||....      .+..  ....++..+
T Consensus       200 ~~~~--~~~~~~gt~~y~aPE~~~~~~~---~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~--~~~~~~~~~  266 (320)
T 3a99_A          200 LKDT--VYTDFDGTRVYSPPEWIRYHRY---HGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIR--GQVFFRQRV  266 (320)
T ss_dssp             CCSS--CBCCCCSCGGGSCHHHHHHSCB---CHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHH--CCCCCSSCC
T ss_pred             cccc--cccCCCCCccCCChHHhccCCC---CCccchHHhHHHHHHHHHHCCCCCCChh------hhhc--ccccccccC
Confidence            6432  2334568999999999876543   2456899999999999999999997632      1222  234467789


Q ss_pred             cHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 012887          414 PQILKSLMIKCWNNSPSKRPQFSEIISLLL  443 (454)
Q Consensus       414 ~~~l~~li~~cl~~dP~~RPs~~ell~~L~  443 (454)
                      ++++.++|.+||+.||.+||++.+++++-+
T Consensus       267 ~~~~~~li~~~l~~dp~~Rps~~~ll~hp~  296 (320)
T 3a99_A          267 SSECQHLIRWCLALRPSDRPTFEEIQNHPW  296 (320)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHhcCHh
Confidence            999999999999999999999999998754

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=6e-41  Score=347.55  Aligned_cols=252  Identities=17%  Similarity=0.290  Sum_probs=191.2

Q ss_pred             cceeecCCCEEEeceeeccCCceEEE-----eEEEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEEEEEEEeCC
Q 012887          183 GRWLLNSDNLEFIDQIGPNSFKGVYK-----GKRVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVDEN  256 (454)
Q Consensus       183 ~~~~~~~~~~~~~~~LG~G~fG~Vy~-----g~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~~~g~~~~~~  256 (454)
                      ..+.+...+|.+.+.||+|+||.|+.     |+.||||++......     ...+|+.+|..+ +|||||++++++.+.+
T Consensus        17 ~~~~i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~-----~~~~E~~~l~~l~~HpnIv~l~~~~~~~~   91 (432)
T 3p23_A           17 SVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS-----FADREVQLLRESDEHPNVIRYFCTEKDRQ   91 (432)
T ss_dssp             -CEEETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE-----ECHHHHHHHHHSCCCTTBCCEEEEEEETT
T ss_pred             CcEEEccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH-----HHHHHHHHHHhccCCCCcCeEEEEEecCC
Confidence            45667778899999999999999654     468999999643222     245788899988 7999999999998877


Q ss_pred             CeEEEEEeccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEcc---C--CcEEEEccCC
Q 012887          257 HGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDR---H--GNVCLGDMGI  330 (454)
Q Consensus       257 ~~l~lV~E~~~~gsL~~~l~~~~-~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~---~--~~vKL~DFGl  330 (454)
                      . +|+|||||.+ +|.+++.... .+.+..+..++.||+.||.|||++||+||||||+|||++.   +  ..+||+|||+
T Consensus        92 ~-~~lv~E~~~g-~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~  169 (432)
T 3p23_A           92 F-QYIAIELCAA-TLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGL  169 (432)
T ss_dssp             E-EEEEEECCSE-EHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTE
T ss_pred             E-EEEEEECCCC-CHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccc
Confidence            6 8999999975 9999996554 5666677899999999999999999999999999999953   2  3588999999


Q ss_pred             ccccccCC---CcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHcCCC
Q 012887          331 VTACKSVG---EATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLR  406 (454)
Q Consensus       331 a~~~~~~~---~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~  406 (454)
                      ++......   .......||+.|+|||++.+... ..++.++|||||||++|||++ |..||..................
T Consensus       170 a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~-~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~  248 (432)
T 3p23_A          170 CKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCK-ENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLD  248 (432)
T ss_dssp             EECC------------CCSCTTSCCGGGTSCC----CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCT
T ss_pred             eeeccCCCcceeeccccCCCcCccChhhhhcccc-cCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCcc
Confidence            87664332   12334568999999999975322 235667999999999999999 99999765544332222111111


Q ss_pred             CCC-CCCccHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 012887          407 PEI-PKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL  442 (454)
Q Consensus       407 ~~~-p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L  442 (454)
                      ... +...+..+.+||.+||+.||.+|||+.++++|-
T Consensus       249 ~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp  285 (432)
T 3p23_A          249 CLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHP  285 (432)
T ss_dssp             TSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTST
T ss_pred             ccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCc
Confidence            111 223467789999999999999999999999764

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=1e-40  Score=333.90  Aligned_cols=250  Identities=16%  Similarity=0.279  Sum_probs=173.6

Q ss_pred             cceeecCCCEEEec-eeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHH-HHHHhCCCCceeEEEEEEEe
Q 012887          183 GRWLLNSDNLEFID-QIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDL-LELMTCGHKNILQFYCVCVD  254 (454)
Q Consensus       183 ~~~~~~~~~~~~~~-~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei-~~l~~l~HpnIv~~~g~~~~  254 (454)
                      .++.+. ++|.+.+ .||+|+||.||++      +.||+|.+...   ..    ..+|+ ..+..++||||+++++++..
T Consensus        22 ~~~~~~-~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~----~~~e~~~~~~~~~h~~i~~~~~~~~~   93 (336)
T 3fhr_A           22 KKYAVT-DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS---PK----ARQEVDHHWQASGGPHIVCILDVYEN   93 (336)
T ss_dssp             BCSCGG-GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS---HH----HHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred             CCcccc-ceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc---HH----HHHHHHHHHHhcCCCChHHHHHHHhh
Confidence            344343 6788865 6999999999985      58999998632   11    12233 33456789999999999876


Q ss_pred             C---CCeEEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccC---CcEEEE
Q 012887          255 E---NHGLCVVTKLMEGGSVNDLILKSR--KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH---GNVCLG  326 (454)
Q Consensus       255 ~---~~~l~lV~E~~~~gsL~~~l~~~~--~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~---~~vKL~  326 (454)
                      .   +..+++||||+++|+|.+++.+..  .+++..++.++.||+.||.|||++||+||||||+|||++.+   +.+||+
T Consensus        94 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~  173 (336)
T 3fhr_A           94 MHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLT  173 (336)
T ss_dssp             EETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEEC
T ss_pred             ccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEe
Confidence            2   234899999999999999997653  79999999999999999999999999999999999999864   459999


Q ss_pred             ccCCccccccCCCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHH----HHHH
Q 012887          327 DMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAV----GIAA  402 (454)
Q Consensus       327 DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~----~i~~  402 (454)
                      |||++......  ......+|+.|+|||++.+..    ++.++|||||||++|+|++|..||..........    .+..
T Consensus       174 Dfg~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~----~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  247 (336)
T 3fhr_A          174 DFGFAKETTQN--ALQTPCYTPYYVAPEVLGPEK----YDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRL  247 (336)
T ss_dssp             CCTTCEEC------------------------CH----HHHHHHHHHHHHHHHHHHHSSCCC------------------
T ss_pred             ccccceecccc--ccccCCCCcCccChhhhCCCC----CCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhc
Confidence            99998765432  233456789999999997654    3456999999999999999999998655433211    1111


Q ss_pred             c--CCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 012887          403 C--GLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTN  446 (454)
Q Consensus       403 ~--~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~  446 (454)
                      .  ..+.+....+++++.+||.+||+.||.+|||+.|++++-+-..
T Consensus       248 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  293 (336)
T 3fhr_A          248 GQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQ  293 (336)
T ss_dssp             ---CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred             cccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccc
Confidence            1  1222233578999999999999999999999999999877543

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=6.2e-41  Score=337.95  Aligned_cols=251  Identities=15%  Similarity=0.269  Sum_probs=196.6

Q ss_pred             eeecCCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCC-----------CCceeE
Q 012887          185 WLLNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCG-----------HKNILQ  247 (454)
Q Consensus       185 ~~~~~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~-----------HpnIv~  247 (454)
                      ..+..++|++++.||+|+||.||++      +.||+|.+..   .......+.+|+.++..+.           ||||++
T Consensus        14 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~   90 (373)
T 1q8y_A           14 EPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG---DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILK   90 (373)
T ss_dssp             CEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS---CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCC
T ss_pred             CcccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC---CccchhhhhHHHHHHHHhhcccccchhccccchHHH
Confidence            3456689999999999999999996      5799999863   3334456778888887765           899999


Q ss_pred             EEEEEEeCC---CeEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhc-CcccCCccCCcEEEcc--
Q 012887          248 FYCVCVDEN---HGLCVVTKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDH-GVAYRDLNSQRILLDR--  319 (454)
Q Consensus       248 ~~g~~~~~~---~~l~lV~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~qI~~gL~yLH~~-~iiHrDIKp~NILl~~--  319 (454)
                      +++++...+   ..+++||||+ +++|.+++.+.  ..+++..+..++.||+.||.|||++ ||+||||||+|||++.  
T Consensus        91 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~  169 (373)
T 1q8y_A           91 LLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVD  169 (373)
T ss_dssp             CCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEE
T ss_pred             HHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccC
Confidence            999988653   2489999999 88999999653  4699999999999999999999998 9999999999999953  


Q ss_pred             ----CCcEEEEccCCccccccCCCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCH--
Q 012887          320 ----HGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSP--  393 (454)
Q Consensus       320 ----~~~vKL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~--  393 (454)
                          .+.+||+|||++......   .....+|+.|+|||++.+..    ++.++|||||||++|||++|..||.+...  
T Consensus       170 ~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~t~~y~aPE~~~~~~----~~~~~Di~slG~il~el~~g~~pf~~~~~~~  242 (373)
T 1q8y_A          170 SPENLIQIKIADLGNACWYDEH---YTNSIQTREYRSPEVLLGAP----WGCGADIWSTACLIFELITGDFLFEPDEGHS  242 (373)
T ss_dssp             TTTTEEEEEECCCTTCEETTBC---CCSCCSCGGGCCHHHHHTCC----CCTHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred             CCcCcceEEEcccccccccCCC---CCCCCCCccccCcHHHhCCC----CCchHhHHHHHHHHHHHHhCCCCCCCCcccc
Confidence                347999999998765432   33447899999999998765    45569999999999999999999986442  


Q ss_pred             ----HHHHHHHHH-cC---------------------------------------CCCCCCCCccHHHHHHHHHhcccCC
Q 012887          394 ----VQAAVGIAA-CG---------------------------------------LRPEIPKDCPQILKSLMIKCWNNSP  429 (454)
Q Consensus       394 ----~~~~~~i~~-~~---------------------------------------~~~~~p~~~~~~l~~li~~cl~~dP  429 (454)
                          ......+.. .+                                       ....++..++.++.+||.+||+.||
T Consensus       243 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP  322 (373)
T 1q8y_A          243 YTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDP  322 (373)
T ss_dssp             --CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSST
T ss_pred             cCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCc
Confidence                112211111 00                                       0112445567889999999999999


Q ss_pred             CCCCCHHHHHHHHHhhc
Q 012887          430 SKRPQFSEIISLLLRTN  446 (454)
Q Consensus       430 ~~RPs~~ell~~L~~~~  446 (454)
                      .+|||+.|+++|-+-..
T Consensus       323 ~~Rpt~~ell~hp~f~~  339 (373)
T 1q8y_A          323 RKRADAGGLVNHPWLKD  339 (373)
T ss_dssp             TTCBCHHHHHTCGGGTT
T ss_pred             cccCCHHHHhhChhhhc
Confidence            99999999999866443

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.1e-40  Score=341.73  Aligned_cols=249  Identities=18%  Similarity=0.262  Sum_probs=182.2

Q ss_pred             CCEEE-eceeeccCCceEEEeE--------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeC-CCeE
Q 012887          190 DNLEF-IDQIGPNSFKGVYKGK--------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDE-NHGL  259 (454)
Q Consensus       190 ~~~~~-~~~LG~G~fG~Vy~g~--------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~-~~~l  259 (454)
                      +.|++ .++||+|+||.||+|+        .||+|++......    ..+.+|+.+|..++||||+++++++.+. +..+
T Consensus        20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   95 (405)
T 3rgf_A           20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSHADRKV   95 (405)
T ss_dssp             HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC----HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEE
T ss_pred             hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC----HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeE
Confidence            34666 4579999999999975        5899998643222    3567899999999999999999999753 3459


Q ss_pred             EEEEeccCCCCHHHHHHhC---------CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEE----ccCCcEEEE
Q 012887          260 CVVTKLMEGGSVNDLILKS---------RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILL----DRHGNVCLG  326 (454)
Q Consensus       260 ~lV~E~~~~gsL~~~l~~~---------~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl----~~~~~vKL~  326 (454)
                      ++||||+.+ +|.+++...         ..+++..+..++.||+.||.|||++||+||||||+|||+    +.++.+||+
T Consensus        96 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~  174 (405)
T 3rgf_A           96 WLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIA  174 (405)
T ss_dssp             EEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred             EEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEE
Confidence            999999975 888887421         249999999999999999999999999999999999999    677899999


Q ss_pred             ccCCccccccCC---CcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHH---------
Q 012887          327 DMGIVTACKSVG---EATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPV---------  394 (454)
Q Consensus       327 DFGla~~~~~~~---~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~---------  394 (454)
                      |||++.......   .......||+.|+|||++.+..   .++.++|||||||++|+|++|..||.+....         
T Consensus       175 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~  251 (405)
T 3rgf_A          175 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGAR---HYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHH  251 (405)
T ss_dssp             CTTCCC----------------CCCTTCCHHHHTTCC---SCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCH
T ss_pred             ECCCceecCCCCcccccCCCceecCcccCchhhcCCC---cccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchH
Confidence            999987664322   1223446899999999998643   2566799999999999999999999765432         


Q ss_pred             HHHHHHHH-cCCCCC-----------------------------------CCCCccHHHHHHHHHhcccCCCCCCCHHHH
Q 012887          395 QAAVGIAA-CGLRPE-----------------------------------IPKDCPQILKSLMIKCWNNSPSKRPQFSEI  438 (454)
Q Consensus       395 ~~~~~i~~-~~~~~~-----------------------------------~p~~~~~~l~~li~~cl~~dP~~RPs~~el  438 (454)
                      ..+..+.. .+.+..                                   .....++.+.+||.+||+.||.+|||+.|+
T Consensus       252 ~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~  331 (405)
T 3rgf_A          252 DQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQA  331 (405)
T ss_dssp             HHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred             HHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHH
Confidence            22222221 111110                                   001126788999999999999999999999


Q ss_pred             HHHHHhhc
Q 012887          439 ISLLLRTN  446 (454)
Q Consensus       439 l~~L~~~~  446 (454)
                      ++|-|-..
T Consensus       332 L~hp~f~~  339 (405)
T 3rgf_A          332 MQDPYFLE  339 (405)
T ss_dssp             HTSGGGTS
T ss_pred             hcChhhcc
Confidence            99987644

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=5e-40  Score=334.34  Aligned_cols=243  Identities=22%  Similarity=0.301  Sum_probs=195.6

Q ss_pred             CCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCC-CC-----ceeEEEEEEEeCC
Q 012887          189 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCG-HK-----NILQFYCVCVDEN  256 (454)
Q Consensus       189 ~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~-Hp-----nIv~~~g~~~~~~  256 (454)
                      .++|++.+.||+|+||.||+|      +.||+|.++.   .......+..|+.++..+. |+     +|+++++++...+
T Consensus        53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~  129 (382)
T 2vx3_A           53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKN---KKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN  129 (382)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECS---SHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred             eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEec---cHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence            478999999999999999996      5799999973   2333455667777777663 44     5999999999887


Q ss_pred             CeEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHH--hcCcccCCccCCcEEEc--cCCcEEEEccCC
Q 012887          257 HGLCVVTKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLN--DHGVAYRDLNSQRILLD--RHGNVCLGDMGI  330 (454)
Q Consensus       257 ~~l~lV~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~qI~~gL~yLH--~~~iiHrDIKp~NILl~--~~~~vKL~DFGl  330 (454)
                      . +|+||||+++ +|.+++...  +.+++..+..++.||+.||.|||  +.||+||||||+|||++  .++.+||+|||+
T Consensus       130 ~-~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~  207 (382)
T 2vx3_A          130 H-LCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGS  207 (382)
T ss_dssp             E-EEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTT
T ss_pred             c-eEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccC
Confidence            6 9999999965 999999654  46999999999999999999999  57999999999999995  477899999999


Q ss_pred             ccccccCCCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCC--
Q 012887          331 VTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPE--  408 (454)
Q Consensus       331 a~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~--  408 (454)
                      +.....   ......+|+.|+|||++.+..    ++.++|||||||++|||++|..||.+.+.......+......++  
T Consensus       208 a~~~~~---~~~~~~~t~~y~aPE~~~~~~----~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~  280 (382)
T 2vx3_A          208 SCQLGQ---RIYQYIQSRFYRSPEVLLGMP----YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAH  280 (382)
T ss_dssp             CEETTC---CCCSSCSCGGGCCHHHHTTCC----CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHH
T ss_pred             ceeccc---ccccccCCccccChHHHcCCC----CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence            876543   233457899999999998765    45579999999999999999999998887776655543211000  


Q ss_pred             --------------CCC----------------------------------------------CccHHHHHHHHHhcccC
Q 012887          409 --------------IPK----------------------------------------------DCPQILKSLMIKCWNNS  428 (454)
Q Consensus       409 --------------~p~----------------------------------------------~~~~~l~~li~~cl~~d  428 (454)
                                    +|.                                              ..++++.+||.+||+.|
T Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~d  360 (382)
T 2vx3_A          281 ILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYD  360 (382)
T ss_dssp             HHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSC
T ss_pred             HHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCC
Confidence                          000                                              00147899999999999


Q ss_pred             CCCCCCHHHHHHHHH
Q 012887          429 PSKRPQFSEIISLLL  443 (454)
Q Consensus       429 P~~RPs~~ell~~L~  443 (454)
                      |.+|||+.|+++|-+
T Consensus       361 P~~Rpta~e~L~hp~  375 (382)
T 2vx3_A          361 PKTRIQPYYALQHSF  375 (382)
T ss_dssp             TTTSCCHHHHTTSGG
T ss_pred             hhhCCCHHHHhcCcc
Confidence            999999999998755

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=8.9e-40  Score=338.68  Aligned_cols=245  Identities=18%  Similarity=0.269  Sum_probs=185.1

Q ss_pred             CCEEEeceeeccCCceEEE-----eEEEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEEEEEEEeCCCeEEEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYK-----GKRVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVDENHGLCVVT  263 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~-----g~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~~~g~~~~~~~~l~lV~  263 (454)
                      +.|.+.+.||+|+||+||.     |+.||||++...     ....+.+|+.++..+ +|||||++++++.+.+. +++||
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~-----~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~-~~lv~   88 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID-----FCDIALMEIKLLTESDDHPNVIRYYCSETTDRF-LYIAL   88 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG-----GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSE-EEEEE
T ss_pred             heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH-----HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCe-EEEEE
Confidence            4566678999999999975     468999998642     233467899988875 89999999999987765 99999


Q ss_pred             eccCCCCHHHHHHhCCCC-------CHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccC-------------CcE
Q 012887          264 KLMEGGSVNDLILKSRKL-------QTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH-------------GNV  323 (454)
Q Consensus       264 E~~~~gsL~~~l~~~~~l-------~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~-------------~~v  323 (454)
                      ||++ |+|.+++......       ++..+..++.||+.||.|||++||+||||||+|||++.+             +.+
T Consensus        89 E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~  167 (434)
T 2rio_A           89 ELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRI  167 (434)
T ss_dssp             CCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred             ecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEE
Confidence            9996 5999999655432       233457899999999999999999999999999999754             489


Q ss_pred             EEEccCCccccccCCCc----ccccCCCCcccccccccCCC---CCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHH
Q 012887          324 CLGDMGIVTACKSVGEA----TEYETDGYRWLAPEIIAGDP---ESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQ  395 (454)
Q Consensus       324 KL~DFGla~~~~~~~~~----~~~~~gt~~y~APE~l~~~~---~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~  395 (454)
                      ||+|||++.........    .....||+.|+|||++.+..   ....++.++|||||||++|||++ |..||.......
T Consensus       168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~  247 (434)
T 2rio_A          168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE  247 (434)
T ss_dssp             EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred             EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence            99999998876543221    22346899999999997632   12346778999999999999999 999998755443


Q ss_pred             HHHHHHHcCCCCCC-----CCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 012887          396 AAVGIAACGLRPEI-----PKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLL  443 (454)
Q Consensus       396 ~~~~i~~~~~~~~~-----p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~  443 (454)
                        ..+.........     +..+++++.++|.+||+.||.+|||+.++++|-+
T Consensus       248 --~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~  298 (434)
T 2rio_A          248 --SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPL  298 (434)
T ss_dssp             --HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred             --HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCc
Confidence              223333222211     1235688999999999999999999999998644

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1.5e-39  Score=318.56  Aligned_cols=226  Identities=13%  Similarity=0.139  Sum_probs=184.0

Q ss_pred             CCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCC-chHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEE
Q 012887          189 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCV  261 (454)
Q Consensus       189 ~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~l  261 (454)
                      .++|++.+.||+|+||.||+|      +.||+|.+...... ......+.+|+..+..++||||+++++++.+.+. .|+
T Consensus        30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~-~~l  108 (286)
T 3uqc_A           30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAG-GLV  108 (286)
T ss_dssp             TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE-EEE
T ss_pred             cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCc-EEE
Confidence            478999999999999999985      68999999755443 2344668899999999999999999999998876 999


Q ss_pred             EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCcc
Q 012887          262 VTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT  341 (454)
Q Consensus       262 V~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~  341 (454)
                      ||||++|++|.+++.+ + .....+..++.||+.||.|||++||+||||||+|||++.+|.+||+++|.           
T Consensus       109 v~e~~~g~~L~~~l~~-~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~~-----------  175 (286)
T 3uqc_A          109 VAEWIRGGSLQEVADT-S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPAT-----------  175 (286)
T ss_dssp             EEECCCEEEHHHHHTT-C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCCC-----------
T ss_pred             EEEecCCCCHHHHHhc-C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEeccc-----------
Confidence            9999999999999854 3 46667899999999999999999999999999999999999999985542           


Q ss_pred             cccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHH---HHHHcCCCC--CCCCCccHH
Q 012887          342 EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAV---GIAACGLRP--EIPKDCPQI  416 (454)
Q Consensus       342 ~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~---~i~~~~~~~--~~p~~~~~~  416 (454)
                               ++|           ++.++|||||||++|||++|..||.+.+......   .........  ..+..+|++
T Consensus       176 ---------~~~-----------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (286)
T 3uqc_A          176 ---------MPD-----------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQ  235 (286)
T ss_dssp             ---------CTT-----------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHH
T ss_pred             ---------cCC-----------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHH
Confidence                     332           4557999999999999999999998755432110   001111110  123578999


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHHHHHhhcCCC
Q 012887          417 LKSLMIKCWNNSPSKRPQFSEIISLLLRTNNIS  449 (454)
Q Consensus       417 l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~  449 (454)
                      +.++|.+||+.||.+| |+.|+++.|.++....
T Consensus       236 l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~  267 (286)
T 3uqc_A          236 ISAVAARSVQGDGGIR-SASTLLNLMQQATAVA  267 (286)
T ss_dssp             HHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC--
T ss_pred             HHHHHHHHcccCCccC-CHHHHHHHHHHHhccC
Confidence            9999999999999999 9999999999987653

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=7.5e-39  Score=314.36  Aligned_cols=223  Identities=16%  Similarity=0.289  Sum_probs=175.9

Q ss_pred             CCEEEe-ceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHH-HhCCCCceeEEEEEEEe---CCCe
Q 012887          190 DNLEFI-DQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLEL-MTCGHKNILQFYCVCVD---ENHG  258 (454)
Q Consensus       190 ~~~~~~-~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l-~~l~HpnIv~~~g~~~~---~~~~  258 (454)
                      ++|.++ +.||+|+||.||++      +.||+|.++..       ....+|+..+ ...+||||+++++++.+   .+..
T Consensus        17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~   89 (299)
T 3m2w_A           17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC   89 (299)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred             cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCce
Confidence            567777 78999999999986      47999999631       2356777776 45689999999999876   2334


Q ss_pred             EEEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEcc---CCcEEEEccCCccc
Q 012887          259 LCVVTKLMEGGSVNDLILKSR--KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDR---HGNVCLGDMGIVTA  333 (454)
Q Consensus       259 l~lV~E~~~~gsL~~~l~~~~--~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~---~~~vKL~DFGla~~  333 (454)
                      +++||||+++|+|.+++....  .+++..+..++.||+.||.|||++||+||||||+|||++.   ++.+||+|||++..
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~  169 (299)
T 3m2w_A           90 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE  169 (299)
T ss_dssp             EEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred             EEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccccc
Confidence            899999999999999997654  7999999999999999999999999999999999999998   78899999999754


Q ss_pred             cccCCCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHc--CCCCCCC-
Q 012887          334 CKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAAC--GLRPEIP-  410 (454)
Q Consensus       334 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~--~~~~~~p-  410 (454)
                      ...                          ..++.++|||||||++|+|++|..||.+.............  .....+| 
T Consensus       170 ~~~--------------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  223 (299)
T 3m2w_A          170 TTG--------------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN  223 (299)
T ss_dssp             CTT--------------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCH
T ss_pred             ccc--------------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCc
Confidence            321                          12345699999999999999999999875543321111110  0111222 


Q ss_pred             ---CCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 012887          411 ---KDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRT  445 (454)
Q Consensus       411 ---~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~  445 (454)
                         ..+++++.++|.+||+.||.+|||+.|+++|.+-.
T Consensus       224 ~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~  261 (299)
T 3m2w_A          224 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM  261 (299)
T ss_dssp             HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred             hhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhc
Confidence               56899999999999999999999999999987644

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=6.9e-39  Score=346.07  Aligned_cols=244  Identities=16%  Similarity=0.178  Sum_probs=190.1

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEe-----CCCe
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVD-----ENHG  258 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~-----~~~~  258 (454)
                      ++|++.+.||+|+||.||+|      +.||+|.+... ........+.+|+.++..++||||+++++++..     .+..
T Consensus        14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~-~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~   92 (676)
T 3qa8_A           14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL   92 (676)
T ss_dssp             ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC-CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred             CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence            67899999999999999984      67999998743 334455678899999999999999999998765     1333


Q ss_pred             EEEEEeccCCCCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCc---EEEEccCCcc
Q 012887          259 LCVVTKLMEGGSVNDLILKSR---KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGN---VCLGDMGIVT  332 (454)
Q Consensus       259 l~lV~E~~~~gsL~~~l~~~~---~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~---vKL~DFGla~  332 (454)
                      .++||||+++|+|.+++....   .+++..+..++.||+.||.|||++||+||||||+|||++.++.   +||+|||++.
T Consensus        93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~  172 (676)
T 3qa8_A           93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK  172 (676)
T ss_dssp             CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCC
T ss_pred             EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccccccc
Confidence            789999999999999997543   6999999999999999999999999999999999999997765   9999999988


Q ss_pred             ccccCCCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH---------HHH-
Q 012887          333 ACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVG---------IAA-  402 (454)
Q Consensus       333 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~---------i~~-  402 (454)
                      ...... ......+++.|+|||.+.+..+    +.++|||||||++|+|++|..||.+.........         +.. 
T Consensus       173 ~~~~~~-~~~~~~gt~~Y~APE~l~~~~~----s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~  247 (676)
T 3qa8_A          173 ELDQGE-LCTEFVGTLQYLAPELLEQKKY----TVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVY  247 (676)
T ss_dssp             BTTSCC-CCCCCCSCCTTCSSCSSCCSCC----STTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSC
T ss_pred             cccccc-ccccccCCcccCChHHhccCCC----CchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhh
Confidence            765432 2344578999999999987654    4459999999999999999999976433221100         000 


Q ss_pred             ----c----CC----CCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHH
Q 012887          403 ----C----GL----RPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEII  439 (454)
Q Consensus       403 ----~----~~----~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell  439 (454)
                          .    ..    +..++..+++.+.++|.+||+.||.+|||+.+++
T Consensus       248 ~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL  296 (676)
T 3qa8_A          248 DDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNP  296 (676)
T ss_dssp             CCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCC
T ss_pred             hhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHh
Confidence                0    00    0112334678999999999999999999998743

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=8.8e-38  Score=341.22  Aligned_cols=234  Identities=18%  Similarity=0.234  Sum_probs=187.4

Q ss_pred             CCCEEEeceeeccCCceEEEe-------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCe---
Q 012887          189 SDNLEFIDQIGPNSFKGVYKG-------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHG---  258 (454)
Q Consensus       189 ~~~~~~~~~LG~G~fG~Vy~g-------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~---  258 (454)
                      .++|++.+.||+|+||.||++       +.||+|.+... ........+.+|+.++..++||||+++++++.+.+..   
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~  157 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS-GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP  157 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS-CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc-CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence            478999999999999999985       57999988642 2334455678999999999999999999999876532   


Q ss_pred             -EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccC
Q 012887          259 -LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV  337 (454)
Q Consensus       259 -l~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~  337 (454)
                       .|+||||++|++|.+++..  .+++..+..++.||+.||.|||++||+||||||+|||++.+ .+||+|||+++.....
T Consensus       158 ~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~  234 (681)
T 2pzi_A          158 VGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF  234 (681)
T ss_dssp             EEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEETTCC
T ss_pred             eeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhcccC
Confidence             6999999999999988744  79999999999999999999999999999999999999975 8999999998765432


Q ss_pred             CCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCC-CCCccHH
Q 012887          338 GEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEI-PKDCPQI  416 (454)
Q Consensus       338 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~-p~~~~~~  416 (454)
                          ....||+.|+|||++.+.     ++.++|||||||++|+|++|..||.+....         ...... ....++.
T Consensus       235 ----~~~~gt~~y~aPE~~~~~-----~~~~sDi~slG~~l~~l~~g~~~~~~~~~~---------~~~~~~~~~~~~~~  296 (681)
T 2pzi_A          235 ----GYLYGTPGFQAPEIVRTG-----PTVATDIYTVGRTLAALTLDLPTRNGRYVD---------GLPEDDPVLKTYDS  296 (681)
T ss_dssp             ----SCCCCCTTTSCTTHHHHC-----SCHHHHHHHHHHHHHHHHSCCCEETTEECS---------SCCTTCHHHHHCHH
T ss_pred             ----CccCCCccccCHHHHcCC-----CCCceehhhhHHHHHHHHhCCCCCcccccc---------cccccccccccCHH
Confidence                445689999999998764     256799999999999999999988752110         011111 1124578


Q ss_pred             HHHHHHHhcccCCCCCCC-HHHHHHHHHh
Q 012887          417 LKSLMIKCWNNSPSKRPQ-FSEIISLLLR  444 (454)
Q Consensus       417 l~~li~~cl~~dP~~RPs-~~ell~~L~~  444 (454)
                      +.++|.+||+.||.+||+ +.++.+.|..
T Consensus       297 l~~li~~~l~~dP~~R~~~~~~l~~~l~~  325 (681)
T 2pzi_A          297 YGRLLRRAIDPDPRQRFTTAEEMSAQLTG  325 (681)
T ss_dssp             HHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             HHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence            999999999999999996 5555555544

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1e-38  Score=328.60  Aligned_cols=242  Identities=14%  Similarity=0.123  Sum_probs=177.9

Q ss_pred             CCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCC-chHHHHHHHHHHHHHhCCC-Cce---------------
Q 012887          189 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG-NAYEFELRKDLLELMTCGH-KNI---------------  245 (454)
Q Consensus       189 ~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~-~~~~~~~~~Ei~~l~~l~H-pnI---------------  245 (454)
                      ...|.+.+.||+|+||.||+|      +.||||++...... ......+.+|+.++..+.| +|.               
T Consensus        77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~  156 (413)
T 3dzo_A           77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  156 (413)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred             ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence            356889999999999999996      47999998743322 2234557889888888876 211               


Q ss_pred             ------eEEEEEEEeC----CCeEEEEEeccCCCCHHHHHHh-------CCCCCHHHHHHHHHHHHHHHHHHHhcCcccC
Q 012887          246 ------LQFYCVCVDE----NHGLCVVTKLMEGGSVNDLILK-------SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYR  308 (454)
Q Consensus       246 ------v~~~g~~~~~----~~~l~lV~E~~~~gsL~~~l~~-------~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHr  308 (454)
                            ..+..++...    ...++++|+++ +++|.+++..       ...+++..+..++.||+.||.|||++||+||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHr  235 (413)
T 3dzo_A          157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT  235 (413)
T ss_dssp             EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence                  1111111111    12367888877 5699999841       2357888999999999999999999999999


Q ss_pred             CccCCcEEEccCCcEEEEccCCccccccCCCcccccCCCCcccccccccCCC------CCCCCCchhhHHHHHHHHHHHH
Q 012887          309 DLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDP------ESVSETWMSNVYSFGMVIWEMV  382 (454)
Q Consensus       309 DIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~------~~~~~~~ksDVwSlGviL~ell  382 (454)
                      ||||+|||++.++.+||+|||+++.....   .....| +.|+|||++.+..      ....++.++|||||||++|||+
T Consensus       236 DiKp~NILl~~~~~~kL~DFG~a~~~~~~---~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ell  311 (413)
T 3dzo_A          236 YLRPVDIVLDQRGGVFLTGFEHLVRDGAS---AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIW  311 (413)
T ss_dssp             CCCGGGEEECTTCCEEECCGGGCEETTEE---ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHH
T ss_pred             CcccceEEEecCCeEEEEeccceeecCCc---cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHH
Confidence            99999999999999999999998765432   334456 8999999994221      2234566899999999999999


Q ss_pred             cCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012887          383 TGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISL  441 (454)
Q Consensus       383 tG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  441 (454)
                      +|+.||...+.......+      ......+|+++.+||.+||+.||.+||++.+++++
T Consensus       312 tg~~Pf~~~~~~~~~~~~------~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~  364 (413)
T 3dzo_A          312 CADLPNTDDAALGGSEWI------FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMET  364 (413)
T ss_dssp             HSSCCCCTTGGGSCSGGG------GSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             HCCCCCCCcchhhhHHHH------HhhcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            999999876543321111      11224678999999999999999999997776554

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=7.6e-38  Score=312.21  Aligned_cols=239  Identities=12%  Similarity=0.112  Sum_probs=183.8

Q ss_pred             cCCCEEEeceeeccCCceEEEe----EEEEEEEeecCCC------CchHHHHHHHHHHHHHhCC---------CCceeEE
Q 012887          188 NSDNLEFIDQIGPNSFKGVYKG----KRVGIEKLKGCDK------GNAYEFELRKDLLELMTCG---------HKNILQF  248 (454)
Q Consensus       188 ~~~~~~~~~~LG~G~fG~Vy~g----~~vavK~l~~~~~------~~~~~~~~~~Ei~~l~~l~---------HpnIv~~  248 (454)
                      ..++|++++.||+|+||.||+|    +.||+|.+.....      .......+.+|+.+++.++         |||||++
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           18 PTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             CHHHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             ccccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            3467889999999999999996    6899999975432      1222355778888777764         8899888


Q ss_pred             EEEEEe-----------------------------CCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHH
Q 012887          249 YCVCVD-----------------------------ENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKF  299 (454)
Q Consensus       249 ~g~~~~-----------------------------~~~~l~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~y  299 (454)
                      .+++..                             .+..+|+||||+++|++.+.+.+ +.+++..+..++.||+.||.|
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~~  176 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLAV  176 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHHH
Confidence            887642                             13349999999999977666633 678999999999999999999


Q ss_pred             HH-hcCcccCCccCCcEEEccCC--------------------cEEEEccCCccccccCCCcccccCCCCcccccccccC
Q 012887          300 LN-DHGVAYRDLNSQRILLDRHG--------------------NVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAG  358 (454)
Q Consensus       300 LH-~~~iiHrDIKp~NILl~~~~--------------------~vKL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~  358 (454)
                      || ++||+||||||+|||++.++                    .+||+|||+++....     ....||+.|+|||++.+
T Consensus       177 lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-----~~~~gt~~y~aPE~~~g  251 (336)
T 2vuw_A          177 AEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-----GIVVFCDVSMDEDLFTG  251 (336)
T ss_dssp             HHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-----TEEECCCCTTCSGGGCC
T ss_pred             HHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-----CcEEEeecccChhhhcC
Confidence            99 99999999999999999987                    899999999987653     23478999999999986


Q ss_pred             CCCCCCCCchhhHHHHHHH-HHHHHcCCCCCCCCCHHH-HHHHHHHc-CCCCC----CCCCccHHHHHHHHHhcccCCCC
Q 012887          359 DPESVSETWMSNVYSFGMV-IWEMVTGEAAYAACSPVQ-AAVGIAAC-GLRPE----IPKDCPQILKSLMIKCWNNSPSK  431 (454)
Q Consensus       359 ~~~~~~~~~ksDVwSlGvi-L~elltG~~Pf~~~~~~~-~~~~i~~~-~~~~~----~p~~~~~~l~~li~~cl~~dP~~  431 (454)
                      ..     +.++||||||++ .+++++|..||.+..... ....+... .....    .+..+|+++.+||++||+.|   
T Consensus       252 ~~-----~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d---  323 (336)
T 2vuw_A          252 DG-----DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS---  323 (336)
T ss_dssp             CS-----SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS---
T ss_pred             CC-----ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC---
Confidence            63     457999998777 777888999985422211 12222211 11111    12357899999999999977   


Q ss_pred             CCCHHHHH-HHH
Q 012887          432 RPQFSEII-SLL  442 (454)
Q Consensus       432 RPs~~ell-~~L  442 (454)
                        |+.|++ +|-
T Consensus       324 --sa~e~l~~Hp  333 (336)
T 2vuw_A          324 --SATDLLCQHS  333 (336)
T ss_dssp             --SHHHHHHHCG
T ss_pred             --CHHHHHhcCC
Confidence              999998 664

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.97  E-value=4.6e-32  Score=290.02  Aligned_cols=181  Identities=11%  Similarity=0.082  Sum_probs=128.5

Q ss_pred             ceeeccCCceEE------EeEEEEEEEeecCCCC--------chHHHHHHHHHHHHHhC-CCCceeEEEEEEEeCCCeEE
Q 012887          196 DQIGPNSFKGVY------KGKRVGIEKLKGCDKG--------NAYEFELRKDLLELMTC-GHKNILQFYCVCVDENHGLC  260 (454)
Q Consensus       196 ~~LG~G~fG~Vy------~g~~vavK~l~~~~~~--------~~~~~~~~~Ei~~l~~l-~HpnIv~~~g~~~~~~~~l~  260 (454)
                      ...+.|++|.+.      .|+.+++|.+......        .....++.+|+.+|.++ .|+||+++++++.+++. +|
T Consensus       240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~-~y  318 (569)
T 4azs_A          240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQS-GW  318 (569)
T ss_dssp             CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSE-EE
T ss_pred             hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCE-EE
Confidence            345555555443      3678899998743211        11234588999999999 69999999999988776 99


Q ss_pred             EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCc
Q 012887          261 VVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA  340 (454)
Q Consensus       261 lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~  340 (454)
                      |||||++|++|.++|.+.+++++.   .|+.||+.||+|||++|||||||||+|||++.+|++||+|||+|+........
T Consensus       319 LVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~  395 (569)
T 4azs_A          319 LVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSW  395 (569)
T ss_dssp             EEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---CC
T ss_pred             EEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCcc
Confidence            999999999999999888888875   47899999999999999999999999999999999999999999877655555


Q ss_pred             ccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCC
Q 012887          341 TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGE  385 (454)
Q Consensus       341 ~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~  385 (454)
                      .....||+.|||||++.+.     ...++|+||+|++++++.++.
T Consensus       396 ~~t~vGTp~YmAPE~l~g~-----~~~~~d~~s~g~~~~~l~~~~  435 (569)
T 4azs_A          396 PTNLVQSFFVFVNELFAEN-----KSWNGFWRSAPVHPFNLPQPW  435 (569)
T ss_dssp             SHHHHHHHHHHHHHHC----------------------CCCCTTH
T ss_pred             ccCceechhhccHHHhCCC-----CCCcccccccccchhhhcccc
Confidence            5556799999999999865     233589999999988776553

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.93  E-value=1.3e-27  Score=254.10  Aligned_cols=182  Identities=15%  Similarity=0.119  Sum_probs=138.0

Q ss_pred             eceeeccCCceEEE----eEEEEEEEeecCCCCch------HHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEEe
Q 012887          195 IDQIGPNSFKGVYK----GKRVGIEKLKGCDKGNA------YEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTK  264 (454)
Q Consensus       195 ~~~LG~G~fG~Vy~----g~~vavK~l~~~~~~~~------~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~E  264 (454)
                      .+.||+|+||.||+    ++.+++|+.........      ....+.+|+.++.+++||||+++..++...+. .|+|||
T Consensus       341 ~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~-~~lVmE  419 (540)
T 3en9_A          341 EHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDN-KRIMMS  419 (540)
T ss_dssp             -------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTT-TEEEEE
T ss_pred             CCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCc-cEEEEE
Confidence            56899999999996    46789998764332211      12347899999999999999955555555555 789999


Q ss_pred             ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCc----
Q 012887          265 LMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA----  340 (454)
Q Consensus       265 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~----  340 (454)
                      |+++++|.+++.+        +..++.||+.||+|||++||+||||||+|||++.  ++||+|||+++........    
T Consensus       420 ~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~~  489 (540)
T 3en9_A          420 YINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVDL  489 (540)
T ss_dssp             CCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHHH
T ss_pred             CCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccccccch
Confidence            9999999999865        5689999999999999999999999999999998  9999999999876543221    


Q ss_pred             ---ccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCC
Q 012887          341 ---TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYA  389 (454)
Q Consensus       341 ---~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~  389 (454)
                         .....||+.|||||++.+...  .|+..+|+||..+-..+.+.++.+|.
T Consensus       490 ~~~~~~~~GT~~y~APEv~~~~~~--~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          490 IVFKKAVLSTHHEKFDEIWERFLE--GYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             HHHHHHHHHHCGGGHHHHHHHHHH--HHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             hhhhhhhcCCCCcCCHHHHHHHHH--HHHHHHhHHHHHHHHHHHHHhccccC
Confidence               124468999999999986211  23445899999998888888777663

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.88  E-value=3.3e-23  Score=202.39  Aligned_cols=143  Identities=12%  Similarity=0.037  Sum_probs=111.0

Q ss_pred             CCCEEEeceeeccCCceEEEe-----EEEEEEEeecCCCCc----------------hHHHHHHHHHHHHHhCCCCceeE
Q 012887          189 SDNLEFIDQIGPNSFKGVYKG-----KRVGIEKLKGCDKGN----------------AYEFELRKDLLELMTCGHKNILQ  247 (454)
Q Consensus       189 ~~~~~~~~~LG~G~fG~Vy~g-----~~vavK~l~~~~~~~----------------~~~~~~~~Ei~~l~~l~HpnIv~  247 (454)
                      ...|.+++.||+|+||.||+|     +.||+|.++......                .....+.+|+.++..++|   ++
T Consensus        89 ~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~---~~  165 (282)
T 1zar_A           89 GKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG---LA  165 (282)
T ss_dssp             TSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT---SS
T ss_pred             CeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC---CC
Confidence            345667799999999999985     589999986432111                134568899999999984   55


Q ss_pred             EEEEEEeCCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEc
Q 012887          248 FYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGD  327 (454)
Q Consensus       248 ~~g~~~~~~~~l~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~D  327 (454)
                      +++++.. +. .|+||||++|++|.+ +..      .....++.||+.||.|||++||+||||||+|||++ ++.+||+|
T Consensus       166 v~~~~~~-~~-~~lvmE~~~g~~L~~-l~~------~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~D  235 (282)
T 1zar_A          166 VPKVYAW-EG-NAVLMELIDAKELYR-VRV------ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIID  235 (282)
T ss_dssp             SCCEEEE-ET-TEEEEECCCCEEGGG-CCC------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECC
T ss_pred             cCeEEec-cc-eEEEEEecCCCcHHH-cch------hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEE
Confidence            5554433 33 689999999999988 421      23457999999999999999999999999999999 99999999


Q ss_pred             cCCccccccCCCcccccCCCCccccccccc
Q 012887          328 MGIVTACKSVGEATEYETDGYRWLAPEIIA  357 (454)
Q Consensus       328 FGla~~~~~~~~~~~~~~gt~~y~APE~l~  357 (454)
                      ||++...             ..|+|||.+.
T Consensus       236 FG~a~~~-------------~~~~a~e~l~  252 (282)
T 1zar_A          236 FPQSVEV-------------GEEGWREILE  252 (282)
T ss_dssp             CTTCEET-------------TSTTHHHHHH
T ss_pred             CCCCeEC-------------CCCCHHHHHH
Confidence            9997642             2368899875

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.79  E-value=1.8e-19  Score=173.48  Aligned_cols=134  Identities=16%  Similarity=0.129  Sum_probs=101.2

Q ss_pred             CEEEeceeeccCCceEEEeE------E--EEEEEeecCCCCc----------------------hHHHHHHHHHHHHHhC
Q 012887          191 NLEFIDQIGPNSFKGVYKGK------R--VGIEKLKGCDKGN----------------------AYEFELRKDLLELMTC  240 (454)
Q Consensus       191 ~~~~~~~LG~G~fG~Vy~g~------~--vavK~l~~~~~~~----------------------~~~~~~~~Ei~~l~~l  240 (454)
                      -|++.+.||+|+||.||+|.      .  ||||.++......                      .....+.+|+..|..+
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  127 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA  127 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence            36889999999999999864      5  9999875431110                      1123578899999888


Q ss_pred             CCCce--eEEEEEEEeCCCeEEEEEeccCC-C----CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH-hcCcccCCccC
Q 012887          241 GHKNI--LQFYCVCVDENHGLCVVTKLMEG-G----SVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN-DHGVAYRDLNS  312 (454)
Q Consensus       241 ~HpnI--v~~~g~~~~~~~~l~lV~E~~~~-g----sL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH-~~~iiHrDIKp  312 (454)
                      .|+++  ...++.    +. .++||||+.+ |    +|.++...   .++..+..++.||+.||.||| ++||+||||||
T Consensus       128 ~~~~i~~p~~~~~----~~-~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp  199 (258)
T 1zth_A          128 KEAGVSVPQPYTY----MK-NVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSE  199 (258)
T ss_dssp             HHTTCCCCCEEEE----ET-TEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCST
T ss_pred             HhCCCCCCeEEEc----CC-CEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCH
Confidence            77653  344432    12 6799999942 3    77776532   235567889999999999999 99999999999


Q ss_pred             CcEEEccCCcEEEEccCCcccc
Q 012887          313 QRILLDRHGNVCLGDMGIVTAC  334 (454)
Q Consensus       313 ~NILl~~~~~vKL~DFGla~~~  334 (454)
                      +|||++.  .++|+|||++...
T Consensus       200 ~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          200 YNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             TSEEESS--SEEECCCTTCEET
T ss_pred             HHEEEcC--cEEEEECcccccC
Confidence            9999998  9999999998653

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.62  E-value=3.8e-16  Score=158.32  Aligned_cols=133  Identities=11%  Similarity=0.075  Sum_probs=94.8

Q ss_pred             EEEeceeeccCCceEEEe-----EEEEEEEeecCCCC--------------ch------HHHHHHHHHHHHHhCCCCce-
Q 012887          192 LEFIDQIGPNSFKGVYKG-----KRVGIEKLKGCDKG--------------NA------YEFELRKDLLELMTCGHKNI-  245 (454)
Q Consensus       192 ~~~~~~LG~G~fG~Vy~g-----~~vavK~l~~~~~~--------------~~------~~~~~~~Ei~~l~~l~HpnI-  245 (454)
                      |++++.||+|+||.||+|     +.||||.++.....              ..      ......+|...|.++.+.++ 
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~  176 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP  176 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred             EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence            799999999999999985     68999987532100              00      00112456666666644433 


Q ss_pred             -eEEEEEEEeCCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCC---
Q 012887          246 -LQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG---  321 (454)
Q Consensus       246 -v~~~g~~~~~~~~l~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~---  321 (454)
                       ...++.   ..  .+|||||++|++|.++..    .  .....++.||+.+|.|||++|||||||||.|||++++|   
T Consensus       177 vp~p~~~---~~--~~LVME~i~G~~L~~l~~----~--~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~  245 (397)
T 4gyi_A          177 VPEPIAQ---SR--HTIVMSLVDALPMRQVSS----V--PDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAE  245 (397)
T ss_dssp             CCCEEEE---ET--TEEEEECCSCEEGGGCCC----C--SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSS
T ss_pred             CCeeeec---cC--ceEEEEecCCccHhhhcc----c--HHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcc
Confidence             222322   22  369999999988865431    1  23457889999999999999999999999999999887   


Q ss_pred             -------cEEEEccCCccccc
Q 012887          322 -------NVCLGDMGIVTACK  335 (454)
Q Consensus       322 -------~vKL~DFGla~~~~  335 (454)
                             .+.|+||+-+....
T Consensus       246 d~~~~~~~~~iID~~Q~V~~~  266 (397)
T 4gyi_A          246 DPSSITLTPIIIXFPQMVSMD  266 (397)
T ss_dssp             CTTSEEEEEEECCCTTCEETT
T ss_pred             cccccccceEEEEeCCcccCC
Confidence                   38899999765443

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.18  E-value=7.5e-11  Score=112.44  Aligned_cols=135  Identities=12%  Similarity=0.097  Sum_probs=103.4

Q ss_pred             CCEEEeceeeccCCceEEEe----EEEEEEEeecCCCCchHHHHHHHHHHHHHhCC-CCceeEEEEEEEeCCCeEEEEEe
Q 012887          190 DNLEFIDQIGPNSFKGVYKG----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCG-HKNILQFYCVCVDENHGLCVVTK  264 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g----~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~~~g~~~~~~~~l~lV~E  264 (454)
                      +.|++...+|.|+++.||+.    ..+++|.........  ...+.+|...+..+. +.++.++++++.+.+. .|+|||
T Consensus        14 ~~~~~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~-~~lv~e   90 (263)
T 3tm0_A           14 EKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGT--TYDVEREKDMMLWLEGKLPVPKVLHFERHDGW-SNLLMS   90 (263)
T ss_dssp             TTSEEEECCSCCSSSEEEEEECSSCEEEEEEECGGGTTS--TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTE-EEEEEE
T ss_pred             ccceeEeeccCCCCCeEEEEECCCCcEEEEeCCcccCCC--HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCc-eEEEEE
Confidence            45788888999999999984    588899886421111  124678888888774 6778889988877655 899999


Q ss_pred             ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh------------------------------------------
Q 012887          265 LMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLND------------------------------------------  302 (454)
Q Consensus       265 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~------------------------------------------  302 (454)
                      +++|.+|.+.+.     +......++.+++.+|..||+                                          
T Consensus        91 ~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (263)
T 3tm0_A           91 EADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFK  165 (263)
T ss_dssp             CCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSS
T ss_pred             ecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCC
Confidence            999999987631     122234778899999999998                                          


Q ss_pred             -----------------cCcccCCccCCcEEEccCCcEEEEccCCcc
Q 012887          303 -----------------HGVAYRDLNSQRILLDRHGNVCLGDMGIVT  332 (454)
Q Consensus       303 -----------------~~iiHrDIKp~NILl~~~~~vKL~DFGla~  332 (454)
                                       ..++|+|++|.|||++.++.+.|.||+.+.
T Consensus       166 ~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          166 DPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             SHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             CHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                             458999999999999876556799998754

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.01  E-value=1.8e-09  Score=101.87  Aligned_cols=128  Identities=13%  Similarity=0.033  Sum_probs=88.8

Q ss_pred             CEEEeceeeccCCceEEEe-----EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCc--eeEEEEEEEeCCCeEEEEE
Q 012887          191 NLEFIDQIGPNSFKGVYKG-----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKN--ILQFYCVCVDENHGLCVVT  263 (454)
Q Consensus       191 ~~~~~~~LG~G~fG~Vy~g-----~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~Hpn--Iv~~~g~~~~~~~~l~lV~  263 (454)
                      ++.+....+.|..+.||+.     ..+++|......     ...+.+|+..+..+.+.+  +.+++++..+.+. .++||
T Consensus        21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~-----~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~-~~~v~   94 (264)
T 1nd4_A           21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA-----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGR-DWLLL   94 (264)
T ss_dssp             TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCT-----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSC-EEEEE
T ss_pred             CCceEecccCCCCceEEEEecCCCCeEEEEeCCccc-----chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCC-CEEEE
Confidence            3444443356667999985     358888865431     123567777777764334  5568887776655 88999


Q ss_pred             eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC---------------------------------------
Q 012887          264 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHG---------------------------------------  304 (454)
Q Consensus       264 E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~---------------------------------------  304 (454)
                      ||++|.+|.  ..   ...   ...++.+++..|..||+..                                       
T Consensus        95 e~i~G~~l~--~~---~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (264)
T 1nd4_A           95 GEVPGQDLL--SS---HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLA  166 (264)
T ss_dssp             ECCSSEETT--TS---CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCC
T ss_pred             EecCCcccC--cC---cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCcc
Confidence            999998884  21   112   2256677777788887643                                       


Q ss_pred             -------------------cccCCccCCcEEEccCCcEEEEccCCcc
Q 012887          305 -------------------VAYRDLNSQRILLDRHGNVCLGDMGIVT  332 (454)
Q Consensus       305 -------------------iiHrDIKp~NILl~~~~~vKL~DFGla~  332 (454)
                                         ++|+|++|.|||++.++.+.|.|||.+.
T Consensus       167 ~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          167 PAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             HHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                               9999999999999877667799999864

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.93  E-value=2.7e-09  Score=106.65  Aligned_cols=138  Identities=10%  Similarity=0.122  Sum_probs=100.0

Q ss_pred             EeceeeccCCceEEEe----EEEEEEEee--cCCCCchHHHHHHHHHHHHHhCC--CCceeEEEEEEEeCC--CeEEEEE
Q 012887          194 FIDQIGPNSFKGVYKG----KRVGIEKLK--GCDKGNAYEFELRKDLLELMTCG--HKNILQFYCVCVDEN--HGLCVVT  263 (454)
Q Consensus       194 ~~~~LG~G~fG~Vy~g----~~vavK~l~--~~~~~~~~~~~~~~Ei~~l~~l~--HpnIv~~~g~~~~~~--~~l~lV~  263 (454)
                      -++.|+.|.++.||+.    ..+.+|+..  ... .......+.+|..++..+.  +..+.+++.++.+.+  ...++||
T Consensus        42 ~~~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~-~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm  120 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSK-LLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM  120 (359)
T ss_dssp             EEEECCC-CCSCEEEEECSSCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred             eEEEcCCcccceEEEEEECCceEEEEeCCCCCCC-CCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence            3577899999999984    456666654  211 1112345778888888875  456788888887652  2368999


Q ss_pred             eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-----------------------------------------
Q 012887          264 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLND-----------------------------------------  302 (454)
Q Consensus       264 E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~-----------------------------------------  302 (454)
                      ||++|.++.+..  ...++......++.+++..|..||+                                         
T Consensus       121 e~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  198 (359)
T 3dxp_A          121 EFVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMD  198 (359)
T ss_dssp             ECCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHH
T ss_pred             EecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHH
Confidence            999998875421  2357788888999999999999997                                         


Q ss_pred             -----------------cCcccCCccCCcEEEccCCc--EEEEccCCcccc
Q 012887          303 -----------------HGVAYRDLNSQRILLDRHGN--VCLGDMGIVTAC  334 (454)
Q Consensus       303 -----------------~~iiHrDIKp~NILl~~~~~--vKL~DFGla~~~  334 (454)
                                       ..++|+|++|.|||++.++.  +.|.||+.+...
T Consensus       199 ~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g  249 (359)
T 3dxp_A          199 SLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG  249 (359)
T ss_dssp             HHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred             HHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence                             35899999999999997753  689999987653

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.79  E-value=3e-09  Score=103.92  Aligned_cols=188  Identities=15%  Similarity=0.097  Sum_probs=117.3

Q ss_pred             eceeeccCCceEEEe-EEEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCc--eeEEEEEEEeCCC--eEEEEEeccCC
Q 012887          195 IDQIGPNSFKGVYKG-KRVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKN--ILQFYCVCVDENH--GLCVVTKLMEG  268 (454)
Q Consensus       195 ~~~LG~G~fG~Vy~g-~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l-~Hpn--Iv~~~g~~~~~~~--~l~lV~E~~~~  268 (454)
                      ++.++.|....||+. ..+.+|....    ......+.+|...|..+ .+..  +.+.+......+.  .-|+||++++|
T Consensus        25 i~~~~~G~~n~v~~v~~~~vlR~~~~----~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G  100 (304)
T 3sg8_A           25 IEISGEGNDCIAYEINRDFIFKFPKH----SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKG  100 (304)
T ss_dssp             CCEEEECSSEEEEESTTSEEEEEESS----HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCC
T ss_pred             eEecCCCCcceEEEECCEEEEEecCC----cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCC
Confidence            345899999999984 4566666432    23445678898888776 3322  3445544333321  13789999999


Q ss_pred             CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------------------
Q 012887          269 GSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLND----------------------------------------------  302 (454)
Q Consensus       269 gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~----------------------------------------------  302 (454)
                      .+|.+...  ..++......++.+++..|..||+                                              
T Consensus       101 ~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  178 (304)
T 3sg8_A          101 VPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYR  178 (304)
T ss_dssp             EECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHH
T ss_pred             eECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHH
Confidence            88875432  246777778888888888888885                                              


Q ss_pred             ------------cCcccCCccCCcEEEcc--CCcEEEEccCCccccccCCCcccccCCCCcccccccccC--CCCCC---
Q 012887          303 ------------HGVAYRDLNSQRILLDR--HGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAG--DPESV---  363 (454)
Q Consensus       303 ------------~~iiHrDIKp~NILl~~--~~~vKL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~--~~~~~---  363 (454)
                                  ..++|+|++|.||+++.  .+.+.|.||+.+.......+........ .-..|+....  ..|..   
T Consensus       179 ~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~-~~~~~~~~~~~l~~Y~~~~~  257 (304)
T 3sg8_A          179 DILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDD-EEYGMEFVSKILNHYKHKDI  257 (304)
T ss_dssp             HHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTT-TSCCHHHHHHHHHHHTCSCH
T ss_pred             HHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhc-cccCHHHHHHHHHHcCCCCc
Confidence                        13699999999999998  4567899999876543211110000000 0012221110  00000   


Q ss_pred             -----CCCchhhHHHHHHHHHHHHcCCCCCC
Q 012887          364 -----SETWMSNVYSFGMVIWEMVTGEAAYA  389 (454)
Q Consensus       364 -----~~~~ksDVwSlGviL~elltG~~Pf~  389 (454)
                           ......+.|++|.++|.+.+|..+|.
T Consensus       258 ~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~  288 (304)
T 3sg8_A          258 PTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY  288 (304)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence                 01123689999999999999988763

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.28  E-value=7.4e-06  Score=80.00  Aligned_cols=134  Identities=16%  Similarity=0.098  Sum_probs=88.8

Q ss_pred             eceeeccCCceEEE-eEEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCC---ceeEEEEEEEeCCCeEEEEEeccCCCC
Q 012887          195 IDQIGPNSFKGVYK-GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHK---NILQFYCVCVDENHGLCVVTKLMEGGS  270 (454)
Q Consensus       195 ~~~LG~G~fG~Vy~-g~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~Hp---nIv~~~g~~~~~~~~l~lV~E~~~~gs  270 (454)
                      ++.++.|....||+ |..+.+|.-.    .......+.+|...|..+.+.   .+.+.+.+....+...++|||+++|.+
T Consensus        24 v~~l~~G~~n~v~~vg~~~VlR~~~----~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~   99 (306)
T 3tdw_A           24 VESLGEGFRNYAILVNGDWVFRFPK----SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQI   99 (306)
T ss_dssp             EEEEEECSSEEEEEETTTEEEEEES----SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEE
T ss_pred             eeecCCCcceeEEEECCEEEEEecC----CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeE
Confidence            34578888889987 4566676632    223445688999998887542   355666666533434779999999988


Q ss_pred             HHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhc-----------------------------------------------
Q 012887          271 VNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDH-----------------------------------------------  303 (454)
Q Consensus       271 L~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~-----------------------------------------------  303 (454)
                      |.+...  ..++......++.++...|..||+.                                               
T Consensus       100 l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~  177 (306)
T 3tdw_A          100 LGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQ  177 (306)
T ss_dssp             CHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHHH
T ss_pred             Cchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHHH
Confidence            876321  1234444444555555555544432                                               


Q ss_pred             -------------CcccCCccCCcEEEcc---CCc-EEEEccCCcccc
Q 012887          304 -------------GVAYRDLNSQRILLDR---HGN-VCLGDMGIVTAC  334 (454)
Q Consensus       304 -------------~iiHrDIKp~NILl~~---~~~-vKL~DFGla~~~  334 (454)
                                   .++|+|++|.|||++.   ++. +.|.||+.+...
T Consensus       178 ~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g  225 (306)
T 3tdw_A          178 SYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS  225 (306)
T ss_dssp             HHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred             HHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence                         3589999999999997   455 479999987654

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=97.90  E-value=0.00012  Score=69.40  Aligned_cols=126  Identities=12%  Similarity=0.105  Sum_probs=82.1

Q ss_pred             eeccCCc-eEEE------eEEEEEEEeecCCCCchHHHHHHHHHHHHHhCC-CCceeEEEEEEEeCCCeEEEEEeccCCC
Q 012887          198 IGPNSFK-GVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCG-HKNILQFYCVCVDENHGLCVVTKLMEGG  269 (454)
Q Consensus       198 LG~G~fG-~Vy~------g~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~~~g~~~~~~~~l~lV~E~~~~g  269 (454)
                      +..|.-| .||+      +..+.+|.-..     .....+.+|...|..+. +--+.+.++++.+.+. -++|||+++|.
T Consensus        32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~-----~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~-~~lvme~l~G~  105 (272)
T 4gkh_A           32 DNVGQSGATIYRLYGKPNAPELFLKHGKG-----SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDD-AWLLTTAIPGK  105 (272)
T ss_dssp             EECSSSSCEEEEEECCTTCCCEEEEEEET-----HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTE-EEEEEECCCSE
T ss_pred             ccCCCcCCeEEEEEecCCCeEEEEEECCC-----CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCe-EEEEEEeeCCc
Confidence            4445554 5886      23566776542     13345778888887663 3336677888887765 88999999998


Q ss_pred             CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-----------------------------------------------
Q 012887          270 SVNDLILKSRKLQTKEIIRIAIDVAEGIKFLND-----------------------------------------------  302 (454)
Q Consensus       270 sL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~-----------------------------------------------  302 (454)
                      ++.+.....    ......+..++...|.-||+                                               
T Consensus       106 ~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  181 (272)
T 4gkh_A          106 TAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK  181 (272)
T ss_dssp             EHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred             cccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence            887664321    11122334444444444442                                               


Q ss_pred             -----------cCcccCCccCCcEEEccCCcEEEEccCCccc
Q 012887          303 -----------HGVAYRDLNSQRILLDRHGNVCLGDMGIVTA  333 (454)
Q Consensus       303 -----------~~iiHrDIKp~NILl~~~~~vKL~DFGla~~  333 (454)
                                 ..++|+|+.+.|||++.++.+-|.||+.+..
T Consensus       182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                       1278999999999999777677999998653

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.73  E-value=0.00045  Score=63.85  Aligned_cols=142  Identities=12%  Similarity=0.114  Sum_probs=96.0

Q ss_pred             CCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHh-cCcccCCccCCcEEEccCCcEEEEccCCccccccCCCcccccCC
Q 012887          269 GSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLND-HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETD  346 (454)
Q Consensus       269 gsL~~~l~~-~~~l~~~~~~~i~~qI~~gL~yLH~-~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~~g  346 (454)
                      .||.+.|.. ..++++.+++.++.|.+.+|.-+-. ..-..+=+-|..|++..+|.|.+.+ +.+.            ..
T Consensus        33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------~~   99 (229)
T 2yle_A           33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD------------AG   99 (229)
T ss_dssp             EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C-----------------
T ss_pred             ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc------------cc
Confidence            389999964 5699999999999999999877621 1112344457999999999998874 2110            11


Q ss_pred             CCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhcc
Q 012887          347 GYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWN  426 (454)
Q Consensus       347 t~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~li~~cl~  426 (454)
                      ...+.|||...     ...+.+.-|||||++||..+--.                   .+...+..+|+.+.+||..|..
T Consensus       100 ~~~~~~pe~~~-----~~~te~~~IysLG~tLY~ALDyg-------------------L~e~eE~eLS~~LE~LL~~Mt~  155 (229)
T 2yle_A          100 EPPPVAGKLGY-----SQCMETEVIESLGIIIYKALDYG-------------------LKENEERELSPPLEQLIDHMAN  155 (229)
T ss_dssp             -------CCSS-----SSSCHHHHHHHHHHHHHHHHTTT-------------------CCTTEEECCCHHHHHHHHHHTT
T ss_pred             ccCCCChhhcc-----ccchHHHHHHHHHHHHHHHhhcC-------------------CCcccchhhCHHHHHHHHHHHh
Confidence            22356888763     12345689999999999988722                   2344556678889999988875


Q ss_pred             c-------------------------CCCCCCCHHHHHHHHHhhcC
Q 012887          427 N-------------------------SPSKRPQFSEIISLLLRTNN  447 (454)
Q Consensus       427 ~-------------------------dP~~RPs~~ell~~L~~~~~  447 (454)
                      -                         .+..|+++.+|++.-.....
T Consensus       156 ~~~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~~C~~hl~  201 (229)
T 2yle_A          156 TVEADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMKLCAAHLP  201 (229)
T ss_dssp             CCC--------------------CCSCCCCCCSHHHHHHHHHTTSS
T ss_pred             cccccccccccccccccccccccccccccCcCCHHHHHHHHHhhcc
Confidence            5                         34688999999887765544

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=97.50  E-value=9.7e-05  Score=73.10  Aligned_cols=31  Identities=16%  Similarity=0.168  Sum_probs=25.8

Q ss_pred             cCcccCCccCCcEEEccCCcEEEEccCCccc
Q 012887          303 HGVAYRDLNSQRILLDRHGNVCLGDMGIVTA  333 (454)
Q Consensus       303 ~~iiHrDIKp~NILl~~~~~vKL~DFGla~~  333 (454)
                      ..++|+|+.|.|||++++..+.|.||+.+..
T Consensus       222 ~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~~  252 (357)
T 3ats_A          222 PVLLWGDARVGNVLYRDFQPVAVLDWEMVAL  252 (357)
T ss_dssp             CEEECSSCSGGGEEEETTEEEEECCGGGCEE
T ss_pred             ceEEeCCCCCCeEEEeCCcEEEEEccccccc
Confidence            4689999999999999644578999998654

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.40  E-value=0.00094  Score=64.99  Aligned_cols=30  Identities=17%  Similarity=0.303  Sum_probs=27.0

Q ss_pred             cCcccCCccCCcEEEccCCcEEEEccCCcc
Q 012887          303 HGVAYRDLNSQRILLDRHGNVCLGDMGIVT  332 (454)
Q Consensus       303 ~~iiHrDIKp~NILl~~~~~vKL~DFGla~  332 (454)
                      ..++|+|+++.|||++.++.+.|.||+.+.
T Consensus       222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            579999999999999888889999999764

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.26  E-value=0.0016  Score=65.29  Aligned_cols=31  Identities=16%  Similarity=0.098  Sum_probs=25.9

Q ss_pred             cCcccCCccCCcEEEccCCcEEEEccCCcccc
Q 012887          303 HGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC  334 (454)
Q Consensus       303 ~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~  334 (454)
                      ..++|+|+.|.||+++.++ +++.||..+...
T Consensus       227 ~~L~HGDl~~~Nil~~~~~-~~lID~e~a~~G  257 (397)
T 2olc_A          227 ETLIHGDLHTGSIFASEHE-TKVIDPEFAFYG  257 (397)
T ss_dssp             CEEECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred             CceeeCCCCcCcEEEeCCC-eEEEeCcccccC
Confidence            5689999999999998654 899999876543

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.11  E-value=0.0027  Score=64.44  Aligned_cols=82  Identities=9%  Similarity=0.041  Sum_probs=48.7

Q ss_pred             HhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCccccc-CCCCcccccccccCCCCCCCCCchhhHHHHHHHHH
Q 012887          301 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE-TDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIW  379 (454)
Q Consensus       301 H~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~-~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~  379 (454)
                      +...++|+|++|.|||++.++ +++.||+.+......-+..... .-...|.+|+....... .......++.+....+|
T Consensus       230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  307 (420)
T 2pyw_A          230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQEN-DRKEYKQWILRTIEQTW  307 (420)
T ss_dssp             BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSC-CSHHHHHHHHHHHHHHH
T ss_pred             CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhccccccccc-chHHHHHHHHHHHHHHH
Confidence            356799999999999999777 9999999876543211111000 00134666665532111 01112345557788888


Q ss_pred             HHHcC
Q 012887          380 EMVTG  384 (454)
Q Consensus       380 elltG  384 (454)
                      +.+++
T Consensus       308 ~~y~~  312 (420)
T 2pyw_A          308 NLFNK  312 (420)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            87765

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=96.67  E-value=0.0084  Score=57.66  Aligned_cols=29  Identities=14%  Similarity=0.063  Sum_probs=24.7

Q ss_pred             CcccCCccCCcEEEccCCcEEEEccCCccc
Q 012887          304 GVAYRDLNSQRILLDRHGNVCLGDMGIVTA  333 (454)
Q Consensus       304 ~iiHrDIKp~NILl~~~~~vKL~DFGla~~  333 (454)
                      .++|+|+.+.||+ ..++.+.|.||..+..
T Consensus       174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          174 AACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             eeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence            4899999999999 5677789999988654

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=96.65  E-value=0.012  Score=57.32  Aligned_cols=73  Identities=10%  Similarity=0.132  Sum_probs=52.0

Q ss_pred             EEeceeeccCCceEEEe----EEEEEEEeecCCCCchHHHHHHHHHHHHHhCC---CCceeEEEEEEEeCCCeEEEEEec
Q 012887          193 EFIDQIGPNSFKGVYKG----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCG---HKNILQFYCVCVDENHGLCVVTKL  265 (454)
Q Consensus       193 ~~~~~LG~G~fG~Vy~g----~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~---HpnIv~~~g~~~~~~~~l~lV~E~  265 (454)
                      .-.+.|+.|....+|+.    ..+.+|.....     ....+..|...|..+.   ...+.+.++++...+. .++|||+
T Consensus        39 ~~~~~l~gG~~n~~y~v~~~~~~~vlK~~~~~-----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~-~~lvme~  112 (312)
T 3jr1_A           39 KHKEKLYSGEMNEIWLINDEVQTVFVKINERS-----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGH-SFLLLEA  112 (312)
T ss_dssp             CEEEEECCSSSSEEEEEESSSCEEEEEEEEGG-----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSE-EEEEEEC
T ss_pred             eeeEEeCCccceeeeEEEECCCeEEEEeCCcc-----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCc-eEEEEEe
Confidence            34567899999999984    46777766531     2345677777776652   3667788888776654 8899999


Q ss_pred             cCCCCH
Q 012887          266 MEGGSV  271 (454)
Q Consensus       266 ~~~gsL  271 (454)
                      +++..+
T Consensus       113 l~G~~~  118 (312)
T 3jr1_A          113 LNKSKN  118 (312)
T ss_dssp             CCCCCC
T ss_pred             ccCCCC
Confidence            998764

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=95.46  E-value=0.093  Score=49.84  Aligned_cols=75  Identities=13%  Similarity=0.128  Sum_probs=48.4

Q ss_pred             CCEEEeceeeccCCceEEE-----eEEEEEEEeecCCCCchHHHHHHHHHHHHHhCCC---CceeEEEEEEEeCCCeEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYK-----GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGH---KNILQFYCVCVDENHGLCV  261 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~-----g~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~H---pnIv~~~g~~~~~~~~l~l  261 (454)
                      ..+.-++.+|.|..+.||+     |+.+.+|.-.......  ...+..|...|..+.-   -.+.+.+++  +.   -++
T Consensus        15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~--~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~---~~l   87 (288)
T 3f7w_A           15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPAL--DGLFRAEALGLDWLGRSFGSPVPQVAGW--DD---RTL   87 (288)
T ss_dssp             CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCC--TTHHHHHHHHHHHHTCSTTCCSCCEEEE--ET---TEE
T ss_pred             CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcch--hhHHHHHHHHHHHHHhhCCCCcceEEec--cC---ceE
Confidence            4556678899999999998     5678888765332221  2235678777776631   234455543  22   358


Q ss_pred             EEeccCCCCH
Q 012887          262 VTKLMEGGSV  271 (454)
Q Consensus       262 V~E~~~~gsL  271 (454)
                      |||+++++..
T Consensus        88 v~e~l~~~~~   97 (288)
T 3f7w_A           88 AMEWVDERPP   97 (288)
T ss_dssp             EEECCCCCCC
T ss_pred             EEEeecccCC
Confidence            9999987653

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=95.26  E-value=0.1  Score=50.55  Aligned_cols=32  Identities=19%  Similarity=0.103  Sum_probs=27.4

Q ss_pred             cCcccCCccCCcEEEccC----CcEEEEccCCcccc
Q 012887          303 HGVAYRDLNSQRILLDRH----GNVCLGDMGIVTAC  334 (454)
Q Consensus       303 ~~iiHrDIKp~NILl~~~----~~vKL~DFGla~~~  334 (454)
                      ..++|+|+.+.||+++.+    +.+.|.||+.+...
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            469999999999999874    67899999987654

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=94.38  E-value=0.1  Score=53.07  Aligned_cols=68  Identities=9%  Similarity=0.055  Sum_probs=39.0

Q ss_pred             eceeeccCCceEEEeE-------------EEEEEEeecCCCCchHHHHHHHHHHHHHhCC-CCceeEEEEEEEeCCCeEE
Q 012887          195 IDQIGPNSFKGVYKGK-------------RVGIEKLKGCDKGNAYEFELRKDLLELMTCG-HKNILQFYCVCVDENHGLC  260 (454)
Q Consensus       195 ~~~LG~G~fG~Vy~g~-------------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~~~g~~~~~~~~l~  260 (454)
                      ++.|+.|....||+..             .+.+|.....  ..  ...+..|..++..+. +.-..++++.+  .+   .
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~--~~~li~E~~~l~~L~~~g~~P~l~~~~--~~---g  148 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ET--ESHLVAESVIFTLLSERHLGPKLYGIF--SG---G  148 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CC--HHHHHHHHHHHHHHHHTTSSSCEEEEE--TT---E
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--Cc--HHHHHHHHHHHHHHHhCCCCCcEEEEe--CC---C
Confidence            4568888888999854             4555554221  11  123446777766653 22234566654  22   2


Q ss_pred             EEEeccCCCCH
Q 012887          261 VVTKLMEGGSV  271 (454)
Q Consensus       261 lV~E~~~~gsL  271 (454)
                      +|+||++|.+|
T Consensus       149 ~v~e~l~G~~l  159 (429)
T 1nw1_A          149 RLEEYIPSRPL  159 (429)
T ss_dssp             EEECCCCEEEC
T ss_pred             EEEEEeCCccc
Confidence            89999986443

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=94.19  E-value=0.056  Score=54.18  Aligned_cols=30  Identities=20%  Similarity=0.191  Sum_probs=26.4

Q ss_pred             CcccCCccCCcEEEccC----CcEEEEccCCccc
Q 012887          304 GVAYRDLNSQRILLDRH----GNVCLGDMGIVTA  333 (454)
Q Consensus       304 ~iiHrDIKp~NILl~~~----~~vKL~DFGla~~  333 (454)
                      .++|+|+.+.||+++.+    +.+.+.||..+..
T Consensus       221 ~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          221 VFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             EEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             EEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            58999999999999876    7899999998654

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=90.16  E-value=0.13  Score=49.46  Aligned_cols=41  Identities=20%  Similarity=0.202  Sum_probs=30.8

Q ss_pred             HHHHHHHHHh-------cCcccCCccCCcEEEccCCcEEEEccCCccc
Q 012887          293 VAEGIKFLND-------HGVAYRDLNSQRILLDRHGNVCLGDMGIVTA  333 (454)
Q Consensus       293 I~~gL~yLH~-------~~iiHrDIKp~NILl~~~~~vKL~DFGla~~  333 (454)
                      +...++++.+       .+++|+|+.+.|||++.++.+.|.||+.+..
T Consensus       170 l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          170 IRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             HHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence            3444555542       4689999999999999776568999987643

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=88.34  E-value=0.38  Score=46.20  Aligned_cols=30  Identities=13%  Similarity=-0.028  Sum_probs=25.3

Q ss_pred             cCcccCCccCCcEEEccCCcEEEEccCCcccc
Q 012887          303 HGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC  334 (454)
Q Consensus       303 ~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~  334 (454)
                      ..++|+|+++.|||++ + .+.|.||+.+...
T Consensus       195 ~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g  224 (328)
T 1zyl_A          195 VLRLHGDCHAGNILWR-D-GPMFVDLDDARNG  224 (328)
T ss_dssp             CEECCSSCSGGGEEES-S-SEEECCCTTCCEE
T ss_pred             eeeeeCCCCcccEeEc-C-CCEEEECCCCCcC
Confidence            4589999999999999 4 8999999876543

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=84.42  E-value=0.7  Score=45.03  Aligned_cols=32  Identities=9%  Similarity=0.129  Sum_probs=27.7

Q ss_pred             cCcccCCccCCcEEEccCCcEEEEccCCcccc
Q 012887          303 HGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC  334 (454)
Q Consensus       303 ~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~  334 (454)
                      ..++|+|+.+.||+++.++.+.|.||+.+...
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~  237 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA  237 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence            46899999999999998888999999876543

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=84.32  E-value=0.85  Score=44.72  Aligned_cols=29  Identities=17%  Similarity=0.096  Sum_probs=24.2

Q ss_pred             CcccCCccCCcEEEccCCcEEEEccCCccc
Q 012887          304 GVAYRDLNSQRILLDRHGNVCLGDMGIVTA  333 (454)
Q Consensus       304 ~iiHrDIKp~NILl~~~~~vKL~DFGla~~  333 (454)
                      .++|+|+.+.|||++.++ +.|.||..+..
T Consensus       213 ~l~HgDl~~~Nil~~~~~-~~lID~e~a~~  241 (369)
T 3c5i_A          213 VFCHNDLQENNIINTNKC-LRLIDFEYSGF  241 (369)
T ss_dssp             EEECSCCCGGGEEECC-C-EEECCCTTCEE
T ss_pred             EEEeCCCCcccEEecCCc-EEEEEecCCCC
Confidence            589999999999998655 89999987654

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	454
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	9e-53
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	3e-49
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	5e-48
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	6e-47
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	3e-46
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	5e-46
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	1e-45
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	2e-45
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	4e-45
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	1e-44
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	8e-44
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	9e-44
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	1e-43
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	2e-43
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	5e-43
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	2e-42
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	3e-41
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	5e-41
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	8e-41
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	1e-40
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	2e-40
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	2e-40
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	3e-40
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	5e-40
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	9e-40
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	1e-39
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	2e-39
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-39
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	3e-39
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	5e-39
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	7e-39
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	1e-38
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	4e-38
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	5e-38
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	5e-37
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	6e-37
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	1e-35
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	2e-35
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	2e-35
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-35
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	3e-34
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	6e-34
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	8e-34
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	3e-32
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	1e-31
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	1e-31
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	1e-31
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	1e-30
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	5e-30
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	1e-29
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	9e-29
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	2e-27
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	4e-25
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	4e-25
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	6e-25
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	4e-24
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	3e-23
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	5e-22
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	1e-20
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	1e-19
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	1e-16
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	3e-12
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	5e-06

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (448), Expect = 9e-53
 Identities = 69/268 (25%), Positives = 124/268 (46%), Gaps = 13/268 (4%)

Query: 185 WLLNSDNLEFIDQIGPNSFKGVYKGKR---VGIEKLKGCDKGNAYEFELRKDLLELMTCG 241
           W +    +    +IG  SF  VYKGK    V ++ L             + ++  L    
Sbjct: 3   WEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR 62

Query: 242 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFL 300
           H NIL F          L +VT+  EG S+   +     K +  ++I IA   A+G+ +L
Sbjct: 63  HVNILLFMGYS--TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYL 120

Query: 301 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG--YRWLAPEIIAG 358
           +   + +RDL S  I L     V +GD G+ T       + ++E       W+APE+I  
Sbjct: 121 HAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 180

Query: 359 DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR----PEIPKDCP 414
             ++   ++ S+VY+FG+V++E++TG+  Y+  +     + +   G       ++  +CP
Sbjct: 181 QDKNPY-SFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCP 239

Query: 415 QILKSLMIKCWNNSPSKRPQFSEIISLL 442
           + +K LM +C      +RP F +I++ +
Sbjct: 240 KAMKRLMAECLKKKRDERPLFPQILASI 267

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (423), Expect = 3e-49
 Identities = 66/272 (24%), Positives = 123/272 (45%), Gaps = 19/272 (6%)

Query: 185 WLLNSDNLEFIDQIGPNSF----KGVYKGKRVGIEKLKGCDKGNAYEFELRKDLLELMTC 240
           W LN   L+ +  IG   F     G Y+G +V ++ +K      A+  E       +   
Sbjct: 2   WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASV----MTQL 57

Query: 241 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK--LQTKEIIRIAIDVAEGIK 298
            H N++Q   V V+E  GL +VT+ M  GS+ D +    +  L    +++ ++DV E ++
Sbjct: 58  RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 117

Query: 299 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAG 358
           +L  +   +RDL ++ +L+       + D G+    K      +      +W APE +  
Sbjct: 118 YLEGNNFVHRDLAARNVLVSEDNVAKVSDFGL---TKEASSTQDTGKLPVKWTAPEALRE 174

Query: 359 DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILK 418
              S      S+V+SFG+++WE+ +         P++  V     G + + P  CP  + 
Sbjct: 175 KKFSTK----SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVY 230

Query: 419 SLMIKCWNNSPSKRPQFSEIISLL--LRTNNI 448
            +M  CW+   + RP F ++   L  ++T+ +
Sbjct: 231 EVMKNCWHLDAAMRPSFLQLREQLEHIKTHEL 262

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (415), Expect = 5e-48
 Identities = 63/264 (23%), Positives = 115/264 (43%), Gaps = 11/264 (4%)

Query: 184 RWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEK--LKGCDKGNAYEFELRKDLLELMTCG 241
            W +  + L+ ++++G   F  V+ G   G  K  +K   +G+        +   +    
Sbjct: 7   EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQ 66

Query: 242 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR--KLQTKEIIRIAIDVAEGIKF 299
           H+ +++ Y V   E   + ++T+ ME GS+ D +      KL   +++ +A  +AEG+ F
Sbjct: 67  HQRLVRLYAVVTQEP--IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 124

Query: 300 LNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG-YRWLAPEIIAG 358
           + +    +RDL +  IL+    +  + D G+    +              +W APE I  
Sbjct: 125 IEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY 184

Query: 359 DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILK 418
              ++     S+V+SFG+++ E+VT              +     G R   P +CP+ L 
Sbjct: 185 GTFTIK----SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELY 240

Query: 419 SLMIKCWNNSPSKRPQFSEIISLL 442
            LM  CW   P  RP F  + S+L
Sbjct: 241 QLMRLCWKERPEDRPTFDYLRSVL 264

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (406), Expect = 6e-47
 Identities = 62/261 (23%), Positives = 121/261 (46%), Gaps = 9/261 (3%)

Query: 186 LLNSDNLEFIDQIGPNSFKGVYKGKRVGIEK--LKGCDKGNAYEFELRKDLLELMTCGHK 243
           +++   L F+ +IG   F  V+ G  +  +K  +K   +G   E +  ++   +M   H 
Sbjct: 1   VIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHP 60

Query: 244 NILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQT-KEIIRIAIDVAEGIKFLND 302
            ++Q Y VC+++   +C+V + ME G ++D +   R L   + ++ + +DV EG+ +L +
Sbjct: 61  KLVQLYGVCLEQAP-ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE 119

Query: 303 HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG-YRWLAPEIIAGDPE 361
             V +RDL ++  L+  +  + + D G+          +   T    +W +PE+ +    
Sbjct: 120 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRY 179

Query: 362 SVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLM 421
           S      S+V+SFG+++WE+ +              V   + G R   P+     +  +M
Sbjct: 180 SSK----SDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIM 235

Query: 422 IKCWNNSPSKRPQFSEIISLL 442
             CW   P  RP FS ++  L
Sbjct: 236 NHCWKERPEDRPAFSRLLRQL 256

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (401), Expect = 3e-46
 Identities = 62/262 (23%), Positives = 126/262 (48%), Gaps = 11/262 (4%)

Query: 187 LNSDNLEFIDQIGPNSFKGVYKGKRVGIEK--LKGCDKGNAYEFELRKDLLELMTCGHKN 244
           ++  +L F+ ++G   F  V  GK  G     +K   +G+  E E  ++   +M   H+ 
Sbjct: 1   IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEK 60

Query: 245 ILQFYCVCVDENHGLCVVTKLMEGGSVNDLI-LKSRKLQTKEIIRIAIDVAEGIKFLNDH 303
           ++Q Y VC  +   + ++T+ M  G + + +     + QT++++ +  DV E +++L   
Sbjct: 61  LVQLYGVCTKQRP-IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK 119

Query: 304 GVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG-YRWLAPEIIAGDPES 362
              +RDL ++  L++  G V + D G+          +   +    RW  PE++     S
Sbjct: 120 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFS 179

Query: 363 VSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLM 421
                 S++++FG+++WE+ + G+  Y   +  + A  IA  GLR   P    + + ++M
Sbjct: 180 SK----SDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ-GLRLYRPHLASEKVYTIM 234

Query: 422 IKCWNNSPSKRPQFSEIISLLL 443
             CW+    +RP F  ++S +L
Sbjct: 235 YSCWHEKADERPTFKILLSNIL 256

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (405), Expect = 5e-46
 Identities = 56/297 (18%), Positives = 108/297 (36%), Gaps = 44/297 (14%)

Query: 184 RWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKL------------KGCDKGNAYEFELR 231
           +W    +NLEF   +G  +F  V      GI K             +  D          
Sbjct: 31  KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSE 90

Query: 232 KDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK----------- 280
             ++  +   H+NI+     C      + ++ +    G + + +   R+           
Sbjct: 91  LKMMTQLG-SHENIVNLLGACTLSGP-IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYEN 148

Query: 281 ------------LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDM 328
                       L  ++++  A  VA+G++FL      +RDL ++ +L+     V + D 
Sbjct: 149 QKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDF 208

Query: 329 GIVTACKSVGEATEYETDG--YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GE 385
           G+     S              +W+APE +     ++     S+V+S+G+++WE+ + G 
Sbjct: 209 GLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIK----SDVWSYGILLWEIFSLGV 264

Query: 386 AAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
             Y           +   G + + P    + +  +M  CW     KRP F  + S L
Sbjct: 265 NPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 321

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (400), Expect = 1e-45
 Identities = 60/268 (22%), Positives = 115/268 (42%), Gaps = 8/268 (2%)

Query: 180 EEIGRWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEK---LKGCDKGNAYEFE-LRKDLL 235
           E + R L   D  E I ++G  +F  VYK +          K  D  +  E E    ++ 
Sbjct: 2   EHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEID 61

Query: 236 ELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVA 294
            L +C H NI++       EN+ L ++ +   GG+V+ ++L+  R L   +I  +     
Sbjct: 62  ILASCDHPNIVKLLDAFYYENN-LWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTL 120

Query: 295 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPE 354
           + + +L+D+ + +RDL +  IL    G++ L D G+        +  +       W+APE
Sbjct: 121 DALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPE 180

Query: 355 IIAGDPESVSE-TWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG-LRPEIPKD 412
           ++  +        + ++V+S G+ + EM   E  +   +P++  + IA         P  
Sbjct: 181 VVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSR 240

Query: 413 CPQILKSLMIKCWNNSPSKRPQFSEIIS 440
                K  + KC   +   R   S+++ 
Sbjct: 241 WSSNFKDFLKKCLEKNVDARWTTSQLLQ 268

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (397), Expect = 2e-45
 Identities = 52/264 (19%), Positives = 101/264 (38%), Gaps = 18/264 (6%)

Query: 184 RWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEK---LKGCDKGNAYEFELRKDLLE---- 236
           +W L  ++ E    +G   F  VY  +    +    LK   K    +  +   L      
Sbjct: 2   QWAL--EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEI 59

Query: 237 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEG 296
                H NIL+ Y    D    + ++ +    G+V   + K  K   +       ++A  
Sbjct: 60  QSHLRHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 118

Query: 297 IKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEII 356
           + + +   V +RD+  + +LL   G + + D G      S    T   T  Y  L PE+I
Sbjct: 119 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDY--LPPEMI 176

Query: 357 AGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQI 416
            G           +++S G++ +E + G+  + A +  +    I+        P    + 
Sbjct: 177 EGRMHDEK----VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--EFTFPDFVTEG 230

Query: 417 LKSLMIKCWNNSPSKRPQFSEIIS 440
            + L+ +   ++PS+RP   E++ 
Sbjct: 231 ARDLISRLLKHNPSQRPMLREVLE 254

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (395), Expect = 4e-45
 Identities = 66/274 (24%), Positives = 117/274 (42%), Gaps = 24/274 (8%)

Query: 184 RWLLNSDNLEFID-QIGPNSFKGVYKGK--------RVGIEKLK-GCDKGNAYEFELRKD 233
           +  L  DNL   D ++G  +F  V +G          V I+ LK G +K +  E      
Sbjct: 2   KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 61

Query: 234 LLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK-LQTKEIIRIAID 292
           ++      +  I++   VC  +   L +V ++  GG ++  ++  R+ +    +  +   
Sbjct: 62  IM--HQLDNPYIVRLIGVC--QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQ 117

Query: 293 VAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG---YR 349
           V+ G+K+L +    +RDL ++ +LL       + D G+  A  +        + G    +
Sbjct: 118 VSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK 177

Query: 350 WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPE 408
           W APE I     S      S+V+S+G+ +WE ++ G+  Y      +    I   G R E
Sbjct: 178 WYAPECINFRKFSSR----SDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ-GKRME 232

Query: 409 IPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
            P +CP  L +LM  CW      RP F  +   +
Sbjct: 233 CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM 266

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (391), Expect = 1e-44
 Identities = 62/266 (23%), Positives = 108/266 (40%), Gaps = 21/266 (7%)

Query: 190 DNLEFIDQIGPNSFKGVYKGKRVGIEK---LKGCDKGNAYEFELRKDLLE---LMTCGHK 243
           ++ E +  IG  S+    K +R    K    K  D G+  E E +  + E   L    H 
Sbjct: 4   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63

Query: 244 NILQFYCVCVDENHG-LCVVTKLMEGGSVNDLILKSRK----LQTKEIIRIAIDVAEGIK 298
           NI+++Y   +D  +  L +V +  EGG +  +I K  K    L  + ++R+   +   +K
Sbjct: 64  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123

Query: 299 FLND-----HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAP 353
             +      H V +RDL    + LD   NV LGD G+           +       +++P
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSP 183

Query: 354 EIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDC 413
           E +     +      S+++S G +++E+      + A S  + A  I   G    IP   
Sbjct: 184 EQMNRMSYNEK----SDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE-GKFRRIPYRY 238

Query: 414 PQILKSLMIKCWNNSPSKRPQFSEII 439
              L  ++ +  N     RP   EI+
Sbjct: 239 SDELNEIITRMLNLKDYHRPSVEEIL 264

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  154 bits (389), Expect = 8e-44
 Identities = 54/255 (21%), Positives = 99/255 (38%), Gaps = 13/255 (5%)

Query: 193 EFIDQIGPNSFKGVYKGKRVGIEK---LKGCDKGNAYEFELRKDLLE----LMTCGHKNI 245
             + +IG  SF  VY  + V   +   +K          E  +D+++    L    H N 
Sbjct: 18  SDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNT 77

Query: 246 LQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGV 305
           +Q+    + E+    +V +   G + + L +  + LQ  EI  +     +G+ +L+ H +
Sbjct: 78  IQYRGCYLREHT-AWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNM 136

Query: 306 AYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSE 365
            +RD+ +  ILL   G V LGD G       +  A  +      W+APE+I    E    
Sbjct: 137 IHRDVKAGNILLSEPGLVKLGDFGS---ASIMAPANSFVGT-PYWMAPEVILAMDEGQY- 191

Query: 366 TWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCW 425
               +V+S G+   E+   +      + + A   IA             +  ++ +  C 
Sbjct: 192 DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCL 251

Query: 426 NNSPSKRPQFSEIIS 440
              P  RP    ++ 
Sbjct: 252 QKIPQDRPTSEVLLK 266

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (386), Expect = 9e-44
 Identities = 65/258 (25%), Positives = 116/258 (44%), Gaps = 19/258 (7%)

Query: 197 QIGPNSFKGVYKG--------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQF 248
           ++G  +F  V KG        K V ++ LK      A + EL  +   +    +  I++ 
Sbjct: 14  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73

Query: 249 YCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYR 308
             +C  E+    +V ++ E G +N  + ++R ++ K II +   V+ G+K+L +    +R
Sbjct: 74  IGICEAES--WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 131

Query: 309 DLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG---YRWLAPEIIAGDPESVSE 365
           DL ++ +LL       + D G+  A ++     + +T G    +W APE I     S   
Sbjct: 132 DLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSK- 190

Query: 366 TWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKC 424
              S+V+SFG+++WE  + G+  Y      +    +   G R   P  CP+ +  LM  C
Sbjct: 191 ---SDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK-GERMGCPAGCPREMYDLMNLC 246

Query: 425 WNNSPSKRPQFSEIISLL 442
           W      RP F+ +   L
Sbjct: 247 WTYDVENRPGFAAVELRL 264

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (386), Expect = 1e-43
 Identities = 55/263 (20%), Positives = 106/263 (40%), Gaps = 11/263 (4%)

Query: 185 WLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEK--LKGCDKGNAYEFELRKDLLELMTCGH 242
           W +  ++L    ++G   F  V+ G   G  +  +K    G        ++   +    H
Sbjct: 12  WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRH 71

Query: 243 KNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQT--KEIIRIAIDVAEGIKFL 300
           + ++Q Y V       + +VT+ M  GS+ D +           +++ +A  +A G+ ++
Sbjct: 72  EKLVQLYAVV--SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV 129

Query: 301 NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG-YRWLAPEIIAGD 359
                 +RDL +  IL+  +    + D G+    +              +W APE     
Sbjct: 130 ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 189

Query: 360 PESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKS 419
             ++     S+V+SFG+++ E+ T           +  +     G R   P +CP+ L  
Sbjct: 190 RFTIK----SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD 245

Query: 420 LMIKCWNNSPSKRPQFSEIISLL 442
           LM +CW   P +RP F  + + L
Sbjct: 246 LMCQCWRKEPEERPTFEYLQAFL 268

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (386), Expect = 2e-43
 Identities = 67/302 (22%), Positives = 115/302 (38%), Gaps = 39/302 (12%)

Query: 184 RWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGC----------DKGNAYEFELRKD 233
           +W    + L F   +G  +F  V +    G+ K                       L  +
Sbjct: 17  KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSE 76

Query: 234 LLELMTCG-HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR------------- 279
           L  L   G H NI+     C        V+T+    G + + + + R             
Sbjct: 77  LKVLSYLGNHMNIVNLLGACTIGGP-TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIM 135

Query: 280 -----KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC 334
                 L  ++++  +  VA+G+ FL      +RDL ++ ILL       + D G+    
Sbjct: 136 EDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDI 195

Query: 335 KSVGEATEYETDGY--RWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAAC 391
           K+              +W+APE I         T+ S+V+S+G+ +WE+ + G + Y   
Sbjct: 196 KNDSNYVVKGNARLPVKWMAPESIFNCVY----TFESDVWSYGIFLWELFSLGSSPYPGM 251

Query: 392 SPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNS 451
                   +   G R   P+  P  +  +M  CW+  P KRP F +I+ L+ +   IS S
Sbjct: 252 PVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK--QISES 309

Query: 452 SN 453
           +N
Sbjct: 310 TN 311

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (380), Expect = 5e-43
 Identities = 69/274 (25%), Positives = 125/274 (45%), Gaps = 21/274 (7%)

Query: 186 LLNSDNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKGNAYEFELRKDLLE--- 236
           L+   +L  ++++G  SF  V +G+      +     +K        + E   D +    
Sbjct: 4   LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVN 63

Query: 237 -LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVA 294
            + +  H+N+++ Y V +     + +VT+L   GS+ D + K +       + R A+ VA
Sbjct: 64  AMHSLDHRNLIRLYGVVLTPP--MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVA 121

Query: 295 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG---YRWL 351
           EG+ +L      +RDL ++ +LL     V +GD G++ A     +    +      + W 
Sbjct: 122 EGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181

Query: 352 APEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIP 410
           APE +     S +    S+ + FG+ +WEM T G+  +   +  Q    I   G R   P
Sbjct: 182 APESLKTRTFSHA----SDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRP 237

Query: 411 KDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR 444
           +DCPQ + ++M++CW + P  RP F  +   LL 
Sbjct: 238 EDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  149 bits (378), Expect = 2e-42
 Identities = 58/276 (21%), Positives = 119/276 (43%), Gaps = 14/276 (5%)

Query: 184 RWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEK---LKGCDKGNAYEFELRKDLLELMTC 240
           +W +   ++    ++G   +  VY+G          +K   +      E  K+   +   
Sbjct: 11  KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI 70

Query: 241 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK--LQTKEIIRIAIDVAEGIK 298
            H N++Q   VC  E     ++T+ M  G++ D + +  +  +    ++ +A  ++  ++
Sbjct: 71  KHPNLVQLLGVCTREPP-FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAME 129

Query: 299 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG-YRWLAPEIIA 357
           +L      +RDL ++  L+  +  V + D G+                   +W APE +A
Sbjct: 130 YLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLA 189

Query: 358 GDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQIL 417
            +  S+     S+V++FG+++WE+ T   +      +     +     R E P+ CP+ +
Sbjct: 190 YNKFSIK----SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKV 245

Query: 418 KSLMIKCWNNSPSKRPQFSEIISLL---LRTNNISN 450
             LM  CW  +PS RP F+EI        + ++IS+
Sbjct: 246 YELMRACWQWNPSDRPSFAEIHQAFETMFQESSISD 281

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (371), Expect = 3e-41
 Identities = 61/274 (22%), Positives = 122/274 (44%), Gaps = 24/274 (8%)

Query: 186 LLNSDNLEFIDQIGPNSFKGVYKGKR----------VGIEKLKGCDKGNAYEFELRKDLL 235
           +L     + I  +G  +F  VYKG            V I++L+      A + E+  +  
Sbjct: 5   ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EILDEAY 63

Query: 236 ELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQT-KEIIRIAIDVA 294
            + +  + ++ +   +C+     + ++T+LM  G + D + + +     + ++   + +A
Sbjct: 64  VMASVDNPHVCRLLGICLTST--VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 121

Query: 295 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG----YRW 350
           +G+ +L D  + +RDL ++ +L+    +V + D G+  A     E  EY  +G     +W
Sbjct: 122 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGL--AKLLGAEEKEYHAEGGKVPIKW 179

Query: 351 LAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIP 410
           +A E I     +      S+V+S+G+ +WE++T  +      P      I   G R   P
Sbjct: 180 MALESILHRIYTHQ----SDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQP 235

Query: 411 KDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR 444
             C   +  +M+KCW      RP+F E+I    +
Sbjct: 236 PICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 269

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (368), Expect = 5e-41
 Identities = 54/257 (21%), Positives = 108/257 (42%), Gaps = 11/257 (4%)

Query: 189 SDNLEFIDQIGPNSFKGVYKGKRVGIEK---LKGCDKGNAYEFELRKDLLELM-TCGHKN 244
                  ++IG  +   VY    V   +   ++  +     + EL  + + +M    + N
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78

Query: 245 ILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHG 304
           I+ +    +  +  L VV + + GGS+ D++ ++      +I  +  +  + ++FL+ + 
Sbjct: 79  IVNYLDSYLVGDE-LWVVMEYLAGGSLTDVVTETCM-DEGQIAAVCRECLQALEFLHSNQ 136

Query: 305 VAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVS 364
           V +RD+ S  ILL   G+V L D G                    W+APE++        
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK 196

Query: 365 ETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG-LRPEIPKDCPQILKSLMIK 423
                +++S G++  EM+ GE  Y   +P++A   IA  G    + P+    I +  + +
Sbjct: 197 ----VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR 252

Query: 424 CWNNSPSKRPQFSEIIS 440
           C +    KR    E++ 
Sbjct: 253 CLDMDVEKRGSAKELLQ 269

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (365), Expect = 8e-41
 Identities = 48/259 (18%), Positives = 99/259 (38%), Gaps = 12/259 (4%)

Query: 190 DNLEFIDQIGPNSFKGVYKGKRVGIEK---LKGCDKGNAYEF--ELRKDLLELMTCGHKN 244
           ++ + +  +G  ++  V        E+   +K  D   A +    ++K++       H+N
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64

Query: 245 ILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHG 304
           +++FY    + N    +  +   GG + D I     +   +  R    +  G+ +L+  G
Sbjct: 65  VVKFYGHRREGNI-QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 123

Query: 305 VAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG--YRWLAPEIIAGDPES 362
           + +RD+  + +LLD   N+ + D G+ T  +                ++APE++      
Sbjct: 124 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 183

Query: 363 VSETWMSNVYSFGMVIWEMVTGEAAYAACSP-VQAAVGIAACGLRPEIPKDCPQILKSLM 421
                  +V+S G+V+  M+ GE  +   S   Q               K       +L+
Sbjct: 184 ---AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL 240

Query: 422 IKCWNNSPSKRPQFSEIIS 440
            K    +PS R    +I  
Sbjct: 241 HKILVENPSARITIPDIKK 259

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (366), Expect = 1e-40
 Identities = 60/289 (20%), Positives = 114/289 (39%), Gaps = 34/289 (11%)

Query: 184 RWLLNSDNLEFIDQIGPNSFKGVYK-----------GKRVGIEKLKGCDKGNAYEFELRK 232
           +W    D L+    +G  +F  V +            + V ++ LK     + +   + +
Sbjct: 7   KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSE 66

Query: 233 DLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK------------ 280
             + +    H N++     C      L V+ +  + G+++  +   R             
Sbjct: 67  LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDL 126

Query: 281 ----LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS 336
               L  + +I  +  VA+G++FL      +RDL ++ ILL     V + D G+      
Sbjct: 127 YKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK 186

Query: 337 VGEATEYETDG--YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAA-YAACSP 393
             +           +W+APE I     ++     S+V+SFG+++WE+ +  A+ Y     
Sbjct: 187 DPDYVRKGDARLPLKWMAPETIFDRVYTIQ----SDVWSFGVLLWEIFSLGASPYPGVKI 242

Query: 394 VQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
            +        G R   P      +   M+ CW+  PS+RP FSE++  L
Sbjct: 243 DEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 291

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (366), Expect = 2e-40
 Identities = 63/279 (22%), Positives = 114/279 (40%), Gaps = 21/279 (7%)

Query: 180 EEIGRWLLNSDNLE--FIDQIGPNSFKGVYKGK---------RVGIEKLKGCDKGNAYEF 228
           + +   ++   +L   F + IG   F  VY G             ++ L           
Sbjct: 15  QAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS- 73

Query: 229 ELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLIL-KSRKLQTKEII 287
           +   + + +    H N+L    +C+       VV   M+ G + + I  ++     K++I
Sbjct: 74  QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI 133

Query: 288 RIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG 347
              + VA+G+KFL      +RDL ++  +LD    V + D G+          + +   G
Sbjct: 134 GFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTG 193

Query: 348 YR----WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAAC 403
            +    W+A E +     +      S+V+SFG+++WE++T  A                 
Sbjct: 194 AKLPVKWMALESLQTQKFTTK----SDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 249

Query: 404 GLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
           G R   P+ CP  L  +M+KCW+     RP FSE++S +
Sbjct: 250 GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRI 288

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (364), Expect = 2e-40
 Identities = 40/260 (15%), Positives = 95/260 (36%), Gaps = 16/260 (6%)

Query: 190 DNLEFIDQIGPNSFKGVYKGKRVGIEK---LKGCDKGNAYEFELRKDLLE----LMTCGH 242
           ++ +F   +G  SF  V   + +   +   +K  +K +  +      +      +    H
Sbjct: 8   EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67

Query: 243 KNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLND 302
              ++ Y    D+   L       + G +   I K              ++   +++L+ 
Sbjct: 68  PFFVKLYFTFQDDEK-LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 126

Query: 303 HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYET--DGYRWLAPEIIAGDP 360
            G+ +RDL  + ILL+   ++ + D G         +     +     ++++PE++    
Sbjct: 127 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKS 186

Query: 361 ESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSL 420
              S    S++++ G +I+++V G   + A +       I       + P+      + L
Sbjct: 187 ACKS----SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL--EYDFPEKFFPKARDL 240

Query: 421 MIKCWNNSPSKRPQFSEIIS 440
           + K      +KR    E+  
Sbjct: 241 VEKLLVLDATKRLGCEEMEG 260

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  145 bits (367), Expect = 3e-40
 Identities = 40/262 (15%), Positives = 106/262 (40%), Gaps = 19/262 (7%)

Query: 190 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHK 243
           D  + ++++G  +F  V++      G+    + +      + Y  +    ++      H 
Sbjct: 29  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMN--QLHHP 86

Query: 244 NILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLND 302
            ++  +    D+   + ++ + + GG + D I     K+   E+I       EG+K +++
Sbjct: 87  KLINLHDAFEDKYE-MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE 145

Query: 303 HGVAYRDLNSQRILLD--RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDP 360
           H + + D+  + I+ +  +  +V + D G+ T      E  +  T    + APEI+  +P
Sbjct: 146 HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP-DEIVKVTTATAEFAAPEIVDREP 204

Query: 361 ESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP--EIPKDCPQILK 418
                 + +++++ G++ + +++G + +A    ++    +  C      +         K
Sbjct: 205 ----VGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAK 260

Query: 419 SLMIKCWNNSPSKRPQFSEIIS 440
             +       P KR    + + 
Sbjct: 261 DFIKNLLQKEPRKRLTVHDALE 282

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (361), Expect = 5e-40
 Identities = 60/292 (20%), Positives = 115/292 (39%), Gaps = 39/292 (13%)

Query: 189 SDNLEFIDQIGPNSFKGVYKGKRVGIE-KLKGCDKGNAYEFELRKDLLELMTCGHKNILQ 247
           +  +   + IG   F  V++GK  G E  +K         +    ++ + +   H+NIL 
Sbjct: 2   ARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILG 61

Query: 248 FYCVCVDENHG---LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL---- 300
           F      +N     L +V+   E GS+ D  L    +  + +I++A+  A G+  L    
Sbjct: 62  FIAADNKDNGTWTQLWLVSDYHEHGSLFDY-LNRYTVTVEGMIKLALSTASGLAHLHMEI 120

Query: 301 ----NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY----RWLA 352
                   +A+RDL S+ IL+ ++G  C+ D+G+     S  +  +   +      R++A
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 180

Query: 353 PEIIAGDPESVSE--TWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAV------------ 398
           PE++              +++Y+ G+V WE+    +        Q               
Sbjct: 181 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 240

Query: 399 ---GIAACGLRPEIPK-----DCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
               +    LRP IP      +  +++  +M +CW  + + R     I   L
Sbjct: 241 MRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 292

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (360), Expect = 9e-40
 Identities = 64/283 (22%), Positives = 122/283 (43%), Gaps = 32/283 (11%)

Query: 187 LNSDNLEFIDQIGPNSFKGVYKGKR--------VGIEKLK-GCDKGNAYEFELRKDLLEL 237
           L+ ++++F D IG  +F  V K +           I+++K    K +  +F    ++L  
Sbjct: 7   LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCK 66

Query: 238 MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKS----------------RKL 281
           +   H NI+     C    + L +  +    G++ D + KS                  L
Sbjct: 67  L-GHHPNIINLLGACEHRGY-LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 124

Query: 282 QTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT 341
            +++++  A DVA G+ +L+     +RDL ++ IL+  +    + D G+    +   + T
Sbjct: 125 SSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKT 184

Query: 342 EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIA 401
                  RW+A E +     + +    S+V+S+G+++WE+V+                  
Sbjct: 185 MGRL-PVRWMAIESLNYSVYTTN----SDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 239

Query: 402 ACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR 444
             G R E P +C   +  LM +CW   P +RP F++I+  L R
Sbjct: 240 PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 282

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (360), Expect = 1e-39
 Identities = 55/258 (21%), Positives = 104/258 (40%), Gaps = 15/258 (5%)

Query: 190 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLK--GCDKGNAYEFELRKDLLELMTCG 241
           ++      +G  SF  V+        +   I+ LK       +  E  + +  +  +   
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 242 HKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 301
           H  +   +C    + + L  V + + GG +   I    K         A ++  G++FL+
Sbjct: 62  HPFLTHMFCTFQTKEN-LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH 120

Query: 302 DHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPE 361
             G+ YRDL    ILLD+ G++ + D G+          T        ++APEI+ G   
Sbjct: 121 SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKY 180

Query: 362 SVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLM 421
           + S     + +SFG++++EM+ G++ +      +    I      P  P+   +  K L+
Sbjct: 181 NHS----VDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD--NPFYPRWLEKEAKDLL 234

Query: 422 IKCWNNSPSKRPQFSEII 439
           +K +   P KR      I
Sbjct: 235 VKLFVREPEKRLGVRGDI 252

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (356), Expect = 2e-39
 Identities = 66/270 (24%), Positives = 120/270 (44%), Gaps = 20/270 (7%)

Query: 187 LNSDNLEFIDQIGPNSFKGVYKGKR----------VGIEKLKGCDKGNAYEFELRKDLLE 236
           ++   +     IG   F  VYKG            V I+ LK          +   +   
Sbjct: 4   IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKA-GYTEKQRVDFLGEAGI 62

Query: 237 LMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK-LQTKEIIRIAIDVAE 295
           +    H NI++   V       + ++T+ ME G+++  + +        +++ +   +A 
Sbjct: 63  MGQFSHHNIIRLEGVISKYKP-MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAA 121

Query: 296 GIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG---YRWLA 352
           G+K+L +    +RDL ++ IL++ +    + D G+    +   EAT   + G    RW A
Sbjct: 122 GMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 181

Query: 353 PEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKD 412
           PE I+        T  S+V+SFG+V+WE++T              +     G R   P D
Sbjct: 182 PEAISYRKF----TSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMD 237

Query: 413 CPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
           CP  +  LM++CW    ++RP+F++I+S+L
Sbjct: 238 CPSAIYQLMMQCWQQERARRPKFADIVSIL 267

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  143 bits (361), Expect = 2e-39
 Identities = 37/264 (14%), Positives = 101/264 (38%), Gaps = 23/264 (8%)

Query: 190 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHK 243
           D+ +  +++G  +F  V++      G     + +    + +      RK++  +    H 
Sbjct: 26  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETV--RKEIQTMSVLRHP 83

Query: 244 NILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLND 302
            ++  +    D+N  + ++ + M GG + + +     K+   E +     V +G+  +++
Sbjct: 84  TLVNLHDAFEDDNE-MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE 142

Query: 303 HGVAYRDLNSQRILL--DRHGNVCLGDMGIVTACKSVGEATEYETDGY--RWLAPEIIAG 358
           +   + DL  + I+    R   + L D G+      +      +       + APE+  G
Sbjct: 143 NNYVHLDLKPENIMFTTKRSNELKLIDFGL---TAHLDPKQSVKVTTGTAEFAAPEVAEG 199

Query: 359 DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP--EIPKDCPQI 416
            P        ++++S G++ + +++G + +   +  +    + +C             + 
Sbjct: 200 KPVGYY----TDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISED 255

Query: 417 LKSLMIKCWNNSPSKRPQFSEIIS 440
            K  + K     P+ R    + + 
Sbjct: 256 GKDFIRKLLLADPNTRMTIHQALE 279

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  141 bits (355), Expect = 3e-39
 Identities = 57/275 (20%), Positives = 108/275 (39%), Gaps = 20/275 (7%)

Query: 189 SDNLEFIDQIGPNSFKGVYKGKRVGIEK---LKGCDKGNAYEFELRKDLLE----LMTCG 241
           SD  E  + +G      V+  + + + +   +K      A +                  
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65

Query: 242 HKNILQFYCVCVDENHG---LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIK 298
           H  I+  Y     E        +V + ++G ++ D++     +  K  I +  D  + + 
Sbjct: 66  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALN 125

Query: 299 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG---YRWLAPEI 355
           F + +G+ +RD+    I++     V + D GI  A    G +           ++L+PE 
Sbjct: 126 FSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 185

Query: 356 IAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP--EIPKDC 413
             GD         S+VYS G V++E++TGE  +   SPV  A         P     +  
Sbjct: 186 ARGDSV----DARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGL 241

Query: 414 PQILKSLMIKCWNNSPSKRPQ-FSEIISLLLRTNN 447
              L ++++K    +P  R Q  +E+ + L+R +N
Sbjct: 242 SADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  140 bits (353), Expect = 5e-39
 Identities = 54/269 (20%), Positives = 99/269 (36%), Gaps = 20/269 (7%)

Query: 190 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMT---- 239
           +N E  + +G      V +       K   ++ +     G+    E+++     +     
Sbjct: 3   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62

Query: 240 ----CGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAE 295
                GH NI+Q             +V  LM+ G + D + +   L  KE  +I   + E
Sbjct: 63  LRKVSGHPNIIQLKDTYETNTF-FFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLE 121

Query: 296 GIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEI 355
            I  L+   + +RDL  + ILLD   N+ L D G         +  E       +LAPEI
Sbjct: 122 VICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREV-CGTPSYLAPEI 180

Query: 356 IAGDPESVSE--TWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIP--K 411
           I               +++S G++++ ++ G   +     +     I +   +   P   
Sbjct: 181 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWD 240

Query: 412 DCPQILKSLMIKCWNNSPSKRPQFSEIIS 440
           D    +K L+ +     P KR    E ++
Sbjct: 241 DYSDTVKDLVSRFLVVQPQKRYTAEEALA 269

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (352), Expect = 7e-39
 Identities = 61/269 (22%), Positives = 115/269 (42%), Gaps = 18/269 (6%)

Query: 185 WLLNSDNLEFIDQIGPNSFKGVYKGKR---------VGIEKLKGCDKGNAYEFELRKDLL 235
           + +  + +E    IG   F  V++G           V I+  K C   +  E +  ++ L
Sbjct: 2   YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVRE-KFLQEAL 60

Query: 236 ELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVA 294
            +    H +I++   V  +  + + ++ +L   G +   +      L    +I  A  ++
Sbjct: 61  TMRQFDHPHIVKLIGVITE--NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLS 118

Query: 295 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG-YRWLAP 353
             + +L      +RD+ ++ +L+  +  V LGD G+    +        +     +W+AP
Sbjct: 119 TALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 178

Query: 354 EIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDC 413
           E I         T  S+V+ FG+ +WE++               +G    G R  +P +C
Sbjct: 179 ESINFRRF----TSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNC 234

Query: 414 PQILKSLMIKCWNNSPSKRPQFSEIISLL 442
           P  L SLM KCW   PS+RP+F+E+ + L
Sbjct: 235 PPTLYSLMTKCWAYDPSRRPRFTELKAQL 263

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  139 bits (351), Expect = 1e-38
 Identities = 58/268 (21%), Positives = 112/268 (41%), Gaps = 15/268 (5%)

Query: 187 LNSDNLEFIDQIGPNSFKGVYKGKR---------VGIEKLKGCDKGNAYEFELRKDLLEL 237
           ++   ++    IG   F  V  G           V I+ LK          +   +   +
Sbjct: 23  IDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRR-DFLSEASIM 81

Query: 238 MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQT-KEIIRIAIDVAEG 296
               H N++    V       + ++T+ ME GS++  + ++    T  +++ +   +A G
Sbjct: 82  GQFDHPNVIHLEGVVTKSTP-VMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAG 140

Query: 297 IKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEII 356
           +K+L D    +RDL ++ IL++ +    + D G+    +       Y +     +     
Sbjct: 141 MKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWT 200

Query: 357 AGDPESVSETW-MSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCP 414
           A +     +    S+V+S+G+V+WE+++ GE  Y   +       I     R   P DCP
Sbjct: 201 APEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQ-DYRLPPPMDCP 259

Query: 415 QILKSLMIKCWNNSPSKRPQFSEIISLL 442
             L  LM+ CW    + RP+F +I++ L
Sbjct: 260 SALHQLMLDCWQKDRNHRPKFGQIVNTL 287

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (348), Expect = 4e-38
 Identities = 61/281 (21%), Positives = 112/281 (39%), Gaps = 29/281 (10%)

Query: 185 WLLNSDNLEFIDQIGPNSFKGVYKG-----------KRVGIEKLKGCDKGNAYEFELRKD 233
           W +  + +    ++G  SF  VY+G            RV I+ +           E   +
Sbjct: 15  WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNE-AASMRERIEFLNE 73

Query: 234 LLELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK----------LQT 283
              +      ++++   V         V+ +LM  G +   +   R              
Sbjct: 74  ASVMKEFNCHHVVRLLGVVSQGQP-TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL 132

Query: 284 KEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY 343
            ++I++A ++A+G+ +LN +   +RDL ++  ++     V +GD G+           + 
Sbjct: 133 SKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKG 192

Query: 344 ETD--GYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIA 401
                  RW++PE +         T  S+V+SFG+V+WE+ T           +  +   
Sbjct: 193 GKGLLPVRWMSPESLKDGVF----TTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 248

Query: 402 ACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
             G   + P +CP +L  LM  CW  +P  RP F EIIS +
Sbjct: 249 MEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 289

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  138 bits (347), Expect = 5e-38
 Identities = 58/294 (19%), Positives = 116/294 (39%), Gaps = 41/294 (13%)

Query: 185 WLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGC----------DKGNAYEFELRKDL 234
                +N+E++  IG  +F  V++ +  G+   +            +     + + +++ 
Sbjct: 8   LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREA 67

Query: 235 LELMTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK-------------- 280
             +    + NI++   VC      +C++ + M  G +N+ +                   
Sbjct: 68  ALMAEFDNPNIVKLLGVCAVGKP-MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTR 126

Query: 281 ----------LQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGI 330
                     L   E + IA  VA G+ +L++    +RDL ++  L+  +  V + D G+
Sbjct: 127 ARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGL 186

Query: 331 VTACKSVGEATEYETDG--YRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAY 388
                S         D    RW+ PE I  +  +      S+V+++G+V+WE+ +     
Sbjct: 187 SRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTE----SDVWAYGVVLWEIFSYGLQP 242

Query: 389 AACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
                 +  +     G     P++CP  L +LM  CW+  P+ RP F  I  +L
Sbjct: 243 YYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRIL 296

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (340), Expect = 5e-37
 Identities = 68/290 (23%), Positives = 124/290 (42%), Gaps = 36/290 (12%)

Query: 184 RWLLNSDNLEFIDQIGPNSFKGVYKGKRVGIEKLKGCD---------KGNAYEFELRKDL 234
           RW L  D L     +G  +F  V   + +G++K K            K +A E +L   +
Sbjct: 7   RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLI 66

Query: 235 LEL----MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR----------- 279
            E+    M   HKNI+     C  +   L V+ +    G++ + +   R           
Sbjct: 67  SEMEMMKMIGKHKNIINLLGACTQDGP-LYVIVEYASKGNLREYLQARRPPGLEYSYNPS 125

Query: 280 -----KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC 334
                +L +K+++  A  VA G+++L      +RDL ++ +L+     + + D G+    
Sbjct: 126 HNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI 185

Query: 335 KSVGE--ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACS 392
             +     T       +W+APE +     +      S+V+SFG+++WE+ T   +     
Sbjct: 186 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQ----SDVWSFGVLLWEIFTLGGSPYPGV 241

Query: 393 PVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
           PV+    +   G R + P +C   L  +M  CW+  PS+RP F +++  L
Sbjct: 242 PVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 291

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (338), Expect = 6e-37
 Identities = 60/262 (22%), Positives = 113/262 (43%), Gaps = 20/262 (7%)

Query: 192 LEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNI 245
           L+F  +IG  SFK VYKG        V   +L+      +     +++   L    H NI
Sbjct: 11  LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70

Query: 246 LQFYCVCVDENHG---LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLND 302
           ++FY        G   + +VT+LM  G++   + + + ++ K +      + +G++FL+ 
Sbjct: 71  VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHT 130

Query: 303 HG--VAYRDLNSQRILL-DRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGD 359
               + +RDL    I +    G+V +GD+G+ T  ++        T    ++APE+    
Sbjct: 131 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGT--PEFMAPEMYEEK 188

Query: 360 PESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP-EIPKDCPQILK 418
                     +VY+FGM + EM T E  Y+ C            G++P    K     +K
Sbjct: 189 Y-----DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVK 243

Query: 419 SLMIKCWNNSPSKRPQFSEIIS 440
            ++  C   +  +R    ++++
Sbjct: 244 EIIEGCIRQNKDERYSIKDLLN 265

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (332), Expect = 1e-35
 Identities = 54/304 (17%), Positives = 117/304 (38%), Gaps = 59/304 (19%)

Query: 187 LNSDNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTC 240
           L  D+ E I ++G  +   V+K      G  +  + +   +   A   ++ ++L  L  C
Sbjct: 3   LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIH-LEIKPAIRNQIIRELQVLHEC 61

Query: 241 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL 300
               I+ FY     +   + +  + M+GGS++ ++ K+ ++  + + +++I V +G+ +L
Sbjct: 62  NSPYIVGFYGAFYSDGE-ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYL 120

Query: 301 -NDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYR-WLAPEIIAG 358
              H + +RD+    IL++  G + L D G+      + ++      G R +++PE + G
Sbjct: 121 REKHKIMHRDVKPSNILVNSRGEIKLCDFGV---SGQLIDSMANSFVGTRSYMSPERLQG 177

Query: 359 DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSP--VQAAVGIAACGLRPEIPKDC--- 413
              SV     S+++S G+ + EM  G           ++   G    G   E P      
Sbjct: 178 THYSVQ----SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 233

Query: 414 -------------------------------------PQILKSLMIKCWNNSPSKRPQFS 436
                                                    +  + KC   +P++R    
Sbjct: 234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLK 293

Query: 437 EIIS 440
           +++ 
Sbjct: 294 QLMV 297

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  131 bits (331), Expect = 2e-35
 Identities = 51/263 (19%), Positives = 101/263 (38%), Gaps = 18/263 (6%)

Query: 189 SDNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGH 242
            D  +F D +G  +F  V         K V I+ +         E  +  ++  L    H
Sbjct: 8   RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAK-KALEGKEGSMENEIAVLHKIKH 66

Query: 243 KNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLND 302
            NI+    +     H L ++ +L+ GG + D I++      ++  R+   V + +K+L+D
Sbjct: 67  PNIVALDDIYESGGH-LYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHD 125

Query: 303 HGVAYRDLNSQRILL---DRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGD 359
            G+ +RDL  + +L    D    + + D G+       G           ++APE++A  
Sbjct: 126 LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP-GSVLSTACGTPGYVAPEVLAQK 184

Query: 360 PESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIP--KDCPQIL 417
           P S +     + +S G++ + ++ G   +   +  +    I       + P   D     
Sbjct: 185 PYSKA----VDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSA 240

Query: 418 KSLMIKCWNNSPSKRPQFSEIIS 440
           K  +       P KR    + + 
Sbjct: 241 KDFIRHLMEKDPEKRFTCEQALQ 263

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (331), Expect = 2e-35
 Identities = 45/257 (17%), Positives = 96/257 (37%), Gaps = 14/257 (5%)

Query: 190 DNLEFIDQIGPNSFKGVYKGKRVGIEK---LKGCDKGNAYEFELRKDLLELMTCGHKNIL 246
           +     + +G   F  V++      +K    K        +  ++K++  L    H+NIL
Sbjct: 5   EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNIL 64

Query: 247 QFYCVCVDENHGLCVVTKLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGV 305
             +         L ++ + + G  + + I  S  +L  +EI+     V E ++FL+ H +
Sbjct: 65  HLHESFESMEE-LVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNI 123

Query: 306 AYRDLNSQRILLD--RHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESV 363
            + D+  + I+    R   + + + G     K         T    + APE+   D  S 
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFT-APEYYAPEVHQHDVVST 182

Query: 364 SETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP--EIPKDCPQILKSLM 421
           +    ++++S G +++ +++G   + A +  Q    I         E  K+        +
Sbjct: 183 A----TDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFV 238

Query: 422 IKCWNNSPSKRPQFSEI 438
            +        R   SE 
Sbjct: 239 DRLLVKERKSRMTASEA 255

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (329), Expect = 2e-35
 Identities = 43/268 (16%), Positives = 107/268 (39%), Gaps = 22/268 (8%)

Query: 189 SDNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLE----LM 238
            D  +  +++G   F  V K      G +   + +K     ++     R+D+      L 
Sbjct: 9   DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 68

Query: 239 TCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIK 298
              H N++  + V  ++   + ++ +L+ GG + D + +   L  +E       +  G+ 
Sbjct: 69  EIQHPNVITLHEVYENKTD-VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVY 127

Query: 299 FLNDHGVAYRDLNSQRILLDRHG----NVCLGDMGIVTACKSVGEATEYETDGYRWLAPE 354
           +L+   +A+ DL  + I+L         + + D G+       G   +       ++APE
Sbjct: 128 YLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF-GNEFKNIFGTPEFVAPE 186

Query: 355 IIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG--LRPEIPKD 412
           I+  +P  +     ++++S G++ + +++G + +   +  +    ++A       E   +
Sbjct: 187 IVNYEPLGL----EADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN 242

Query: 413 CPQILKSLMIKCWNNSPSKRPQFSEIIS 440
              + K  + +     P KR    + + 
Sbjct: 243 TSALAKDFIRRLLVKDPKKRMTIQDSLQ 270

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (319), Expect = 3e-34
 Identities = 48/261 (18%), Positives = 94/261 (36%), Gaps = 26/261 (9%)

Query: 193 EFIDQIGPNSFKGVYK------GKRVGIEKLK------GCDKGNAYEFELRKDLLELMTC 240
           +    +G   F  VY          V I+ ++        +  N     +   LL+ ++ 
Sbjct: 7   QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 66

Query: 241 GHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFL 300
           G   +++        +  + ++ +      + D I +   LQ +        V E ++  
Sbjct: 67  GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC 126

Query: 301 NDHGVAYRDLNSQRILLDRH-GNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGD 359
           ++ GV +RD+  + IL+D + G + L D G     K         T  Y    PE I   
Sbjct: 127 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVY--SPPEWIRYH 184

Query: 360 PESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKS 419
                    + V+S G+++++MV G+  +     +           +    +      + 
Sbjct: 185 R---YHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRG--------QVFFRQRVSSECQH 233

Query: 420 LMIKCWNNSPSKRPQFSEIIS 440
           L+  C    PS RP F EI +
Sbjct: 234 LIRWCLALRPSDRPTFEEIQN 254

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  128 bits (323), Expect = 6e-34
 Identities = 46/255 (18%), Positives = 101/255 (39%), Gaps = 17/255 (6%)

Query: 190 DNLEFIDQIGPNSFKGVYKGKRVG---------IEKLKGCDKGNAYEFELRKDLLELM-T 239
           ++      IG   F  VY  ++           ++K +   K         + +L L+ T
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 240 CGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKF 299
                I+         +  L  +  LM GG ++  + +       ++   A ++  G++ 
Sbjct: 64  GDCPFIVCMSYAFHTPDK-LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEH 122

Query: 300 LNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGD 359
           +++  V YRDL    ILLD HG+V + D+G+  AC    +        + ++APE++   
Sbjct: 123 MHNRFVVYRDLKPANILLDEHGHVRISDLGL--ACDFSKKKPHASVGTHGYMAPEVLQKG 180

Query: 360 PESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPV-QAAVGIAACGLRPEIPKDCPQILK 418
                    ++ +S G ++++++ G + +       +  +      +  E+P      L+
Sbjct: 181 VAY---DSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELR 237

Query: 419 SLMIKCWNNSPSKRP 433
           SL+        ++R 
Sbjct: 238 SLLEGLLQRDVNRRL 252

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  127 bits (319), Expect = 8e-34
 Identities = 51/252 (20%), Positives = 107/252 (42%), Gaps = 17/252 (6%)

Query: 190 DNLEFIDQIGPNSFKGVYKGKRVGIEK---LKGCDKGNAYEFELRKDLLE----LMTCGH 242
            + + +  +G  SF  V+  +     +   +K   K      +  +   +    L    H
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63

Query: 243 KNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLND 302
             I++ +    D    + ++   +EGG +  L+ KS++         A +V   +++L+ 
Sbjct: 64  PFIIRMWGTFQDAQQ-IFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS 122

Query: 303 HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPES 362
             + YRDL  + ILLD++G++ + D G     K V + T        ++APE+++  P +
Sbjct: 123 KDIIYRDLKPENILLDKNGHIKITDFGF---AKYVPDVTYTLCGTPDYIAPEVVSTKPYN 179

Query: 363 VSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMI 422
            S     + +SFG++I+EM+ G   +   + ++    I         P    + +K L+ 
Sbjct: 180 KS----IDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA--ELRFPPFFNEDVKDLLS 233

Query: 423 KCWNNSPSKRPQ 434
           +      S+R  
Sbjct: 234 RLITRDLSQRLG 245

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  122 bits (307), Expect = 3e-32
 Identities = 36/272 (13%), Positives = 80/272 (29%), Gaps = 24/272 (8%)

Query: 190 DNLEFIDQIGPNSFKGVYKGKRVGIEK---LKGCDKGNAYEFELRKDLLELMTCGHKNIL 246
           +      +IG  SF  +Y G  +   +   +K       +  +L  +            +
Sbjct: 7   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP-QLHIESKIYKMMQGGVGI 65

Query: 247 QFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVA 306
                C  E     +V +L+     +     SRK   K ++ +A  +   I++++     
Sbjct: 66  PTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFI 125

Query: 307 YRDLNSQRIL---LDRHGNVCLGDMGIVTACKSVGEATEYETDG-------YRWLAPEII 356
           +RD+     L     +   V + D G+    +                    R+ +    
Sbjct: 126 HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTH 185

Query: 357 AGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR------PEIP 410
            G  +    +   ++ S G V+     G   +                 +        + 
Sbjct: 186 LGIEQ----SRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLC 241

Query: 411 KDCPQILKSLMIKCWNNSPSKRPQFSEIISLL 442
           K  P    + +  C +     +P +S +  L 
Sbjct: 242 KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLF 273

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (305), Expect = 1e-31
 Identities = 42/251 (16%), Positives = 91/251 (36%), Gaps = 14/251 (5%)

Query: 190 DNLEFIDQIGPNSFKGVYKGKRVGIEK---LKGCDKGNAYEFELRKDLLE----LMTCGH 242
           ++ +++  +G  +F  V   +     +   +K   K      +     +     L    H
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 243 KNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLND 302
             +          +  LC V +   GG +   + + R    +       ++   +++L+ 
Sbjct: 65  PFLTALKYAFQTHDR-LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 123

Query: 303 HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPES 362
             V YRD+  + ++LD+ G++ + D G+     S G   +       +LAPE++  +   
Sbjct: 124 RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYG 183

Query: 363 VSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMI 422
            +  W       G+V++EM+ G   +      +    I         P+      KSL+ 
Sbjct: 184 RAVDWW----GLGVVMYEMMCGRLPFYNQDHERLFELILME--EIRFPRTLSPEAKSLLA 237

Query: 423 KCWNNSPSKRP 433
                 P +R 
Sbjct: 238 GLLKKDPKQRL 248

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  120 bits (302), Expect = 1e-31
 Identities = 40/283 (14%), Positives = 86/283 (30%), Gaps = 29/283 (10%)

Query: 193 EFIDQIGPNSFKGVYKGKRVGIEK---LKGCDKGNAYEFELRKDLLELMTCGHKNILQFY 249
           +   +IG  SF  +++G  +   +   +K   + +    +LR +            +   
Sbjct: 8   KVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAP-QLRDEYRTYKLLAGCTGIPNV 66

Query: 250 CVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRD 309
                E     +V  L+     + L L  RK   K +   A  +   ++ +++  + YRD
Sbjct: 67  YYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRD 126

Query: 310 LNSQRILLDR-----HGNVCLGDMGIVTACKSVGEATEYETDGY-------RWLAPEIIA 357
           +     L+ R        + + D G+V   +                    R+++     
Sbjct: 127 IKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHL 186

Query: 358 GDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR------PEIPK 411
           G  +S       ++ + G V    + G   +               G +       E+  
Sbjct: 187 GREQSRR----DDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCA 242

Query: 412 DCPQILKSLMIKCWNNSPSKRPQFSEIISLL---LRTNNISNS 451
             P+     M    N +    P +  +  L    L   N +  
Sbjct: 243 GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTED 285

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (304), Expect = 1e-31
 Identities = 42/271 (15%), Positives = 103/271 (38%), Gaps = 30/271 (11%)

Query: 190 DNLEFIDQ-IGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGH 242
           D+ +   Q +G      V +       ++  ++ L+ C K    E EL     +      
Sbjct: 11  DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR-EVELHWRASQ-----C 64

Query: 243 KNILQFYCVCVD---ENHGLCVVTKLMEGGSVNDLILK--SRKLQTKEIIRIAIDVAEGI 297
            +I++   V  +       L +V + ++GG +   I     +    +E   I   + E I
Sbjct: 65  PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAI 124

Query: 298 KFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY--RWLAPEI 355
           ++L+   +A+RD+  + +L        +  +      K         T  Y   ++APE+
Sbjct: 125 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEV 184

Query: 356 IAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEI------ 409
           +  +    S     +++S G++++ ++ G   + +   +  + G+       +       
Sbjct: 185 LGPEKYDKS----CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPE 240

Query: 410 PKDCPQILKSLMIKCWNNSPSKRPQFSEIIS 440
             +  + +K L+       P++R   +E ++
Sbjct: 241 WSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (296), Expect = 1e-30
 Identities = 54/285 (18%), Positives = 108/285 (37%), Gaps = 38/285 (13%)

Query: 190 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHK 243
           +N + +++IG  ++  VYK      G+ V ++K++   +         +++  L    H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61

Query: 244 NILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRK-LQTKEIIRIAIDVAEGIKFLND 302
           NI++   V   EN  L +V + +       +   +   +    I      + +G+ F + 
Sbjct: 62  NIVKLLDVIHTENK-LYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120

Query: 303 HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPES 362
           H V +RDL  Q +L++  G + L D G+  A         +E     + APEI+ G    
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY- 179

Query: 363 VSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP--------------- 407
              +   +++S G +  EMVT  A +   S +     I      P               
Sbjct: 180 --YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237

Query: 408 ------------EIPKDCPQILKSLMIKCWNNSPSKRPQFSEIIS 440
                       ++     +  +SL+ +  +  P+KR      ++
Sbjct: 238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (292), Expect = 5e-30
 Identities = 46/259 (17%), Positives = 106/259 (40%), Gaps = 18/259 (6%)

Query: 190 DNLEFIDQIGPNSFKGVYKGKRVG------------IEKLKGCDKGNAYEFELRKDLLEL 237
           +N E +  +G  ++  V+  +++             ++K     K    E    +  +  
Sbjct: 24  ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83

Query: 238 MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGI 297
                  ++  +     E   L ++   + GG +   + +  +    E+     ++   +
Sbjct: 84  HIRQSPFLVTLHYAFQTETK-LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLAL 142

Query: 298 KFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDG-YRWLAPEII 356
           + L+  G+ YRD+  + ILLD +G+V L D G+     +      Y+  G   ++AP+I+
Sbjct: 143 EHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIV 202

Query: 357 AGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR--PEIPKDCP 414
            G      +    + +S G++++E++TG + +       +   I+   L+  P  P++  
Sbjct: 203 RGGDSGHDKA--VDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMS 260

Query: 415 QILKSLMIKCWNNSPSKRP 433
            + K L+ +     P KR 
Sbjct: 261 ALAKDLIQRLLMKDPKKRL 279

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (288), Expect = 1e-29
 Identities = 54/282 (19%), Positives = 101/282 (35%), Gaps = 39/282 (13%)

Query: 193 EFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLE---LMTCGHK 243
           E +D +G   F  VYK       + V I+K+K   +  A +   R  L E   L    H 
Sbjct: 1   EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60

Query: 244 NILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDH 303
           NI+        +++ + +V   ME      +   S  L    I    +   +G+++L+ H
Sbjct: 61  NIIGLLDAFGHKSN-ISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH 119

Query: 304 GVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESV 363
            + +RDL    +LLD +G + L D G+  +  S   A  ++     + APE++ G     
Sbjct: 120 WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARM-- 177

Query: 364 SETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP---------------- 407
                 ++++ G ++ E++         S +     I      P                
Sbjct: 178 -YGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT 236

Query: 408 ----------EIPKDCPQILKSLMIKCWNNSPSKRPQFSEII 439
                      I       L  L+   +  +P  R   ++ +
Sbjct: 237 FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQAL 278

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  112 bits (280), Expect = 9e-29
 Identities = 49/283 (17%), Positives = 104/283 (36%), Gaps = 36/283 (12%)

Query: 190 DNLEFIDQIGPNSFKGVYK-----GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKN 244
           +    +++IG  ++  VYK     G+   ++K++   +         +++  L    H N
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61

Query: 245 ILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHG 304
           I++ Y V   +   L +V + ++      L +    L++       + +  GI + +D  
Sbjct: 62  IVKLYDVIHTKKR-LVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120

Query: 305 VAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVS 364
           V +RDL  Q +L++R G + + D G+  A         +E     + AP+++ G  +   
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKK--- 177

Query: 365 ETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP----------------- 407
            +   +++S G +  EMV G   +   S     + I      P                 
Sbjct: 178 YSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237

Query: 408 ----------EIPKDCPQILKSLMIKCWNNSPSKRPQFSEIIS 440
                        K   +    L+ K     P++R    + + 
Sbjct: 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  109 bits (274), Expect = 2e-27
 Identities = 50/252 (19%), Positives = 93/252 (36%), Gaps = 17/252 (6%)

Query: 190 DNLEFIDQIGPNSFKGVYKGKRVGIEK---LKGCDKGNAYEFELRKDLLE----LMTCGH 242
           D  + I  +G  SF  V   K         +K  DK    + +  +  L     L     
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100

Query: 243 KNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLND 302
             +++      D ++ L +V + + GG +   + +  +         A  +    ++L+ 
Sbjct: 101 PFLVKLEFSFKDNSN-LYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159

Query: 303 HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPES 362
             + YRDL  + +L+D+ G + + D G     K               LAPEII     +
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTP---EALAPEIILSKGYN 216

Query: 363 VSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMI 422
            +     + ++ G++I+EM  G   + A  P+Q    I +   +   P      LK L+ 
Sbjct: 217 KA----VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG--KVRFPSHFSSDLKDLLR 270

Query: 423 KCWNNSPSKRPQ 434
                  +KR  
Sbjct: 271 NLLQVDLTKRFG 282

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  103 bits (257), Expect = 4e-25
 Identities = 44/288 (15%), Positives = 97/288 (33%), Gaps = 44/288 (15%)

Query: 193 EFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNIL 246
             +  IG  ++  V          RV I+K+   +     +    +++  L+   H+NI+
Sbjct: 11  TNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQ-RTLREIKILLRFRHENII 69

Query: 247 QFYCVCVDENHGLCVVTKLMEG--GSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHG 304
               +             L+    G+    +LK++ L    I      +  G+K+++   
Sbjct: 70  GINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 129

Query: 305 VAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETD---GYRWLAPEIIAGDPE 361
           V +RDL    +LL+   ++ + D G+        + T + T+      + APEI+     
Sbjct: 130 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 189

Query: 362 SVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP-------------- 407
                   +++S G ++ EM++    +     +     I      P              
Sbjct: 190 YTKSI---DIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKAR 246

Query: 408 ---------------EIPKDCPQILKSLMIKCWNNSPSKRPQFSEIIS 440
                           +  +       L+ K    +P KR +  + ++
Sbjct: 247 NYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  103 bits (256), Expect = 4e-25
 Identities = 44/299 (14%), Positives = 102/299 (34%), Gaps = 52/299 (17%)

Query: 190 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHK 243
              E + +IG  +F  V+K      G++V ++K+   ++   +     +++  L    H+
Sbjct: 10  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69

Query: 244 NILQFYCVCVDENHG-------LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEG 296
           N++    +C  +          + +V    E      L     K    EI R+   +  G
Sbjct: 70  NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNG 129

Query: 297 IKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGY----RWLA 352
           + +++ + + +RD+ +  +L+ R G + L D G+  A      +             +  
Sbjct: 130 LYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRP 189

Query: 353 PEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKD 412
           PE++ G+ +        +++  G ++ EM T        +       I+        P+ 
Sbjct: 190 PELLLGERDY---GPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT-PEV 245

Query: 413 CPQI-------------------------------LKSLMIKCWNNSPSKRPQFSEIIS 440
            P +                                  L+ K     P++R    + ++
Sbjct: 246 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  102 bits (254), Expect = 6e-25
 Identities = 56/291 (19%), Positives = 106/291 (36%), Gaps = 45/291 (15%)

Query: 190 DNLEFIDQIGPNSFKGVYK-------GKRVGIEKLKGCDKGNAYEFELRKD---LLELMT 239
              E + +IG  ++  V+K       G+ V +++++             ++   L  L T
Sbjct: 7   QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 66

Query: 240 CGHKNILQFYCVCV----DENHGLCVVTKLMEGGSVNDL-ILKSRKLQTKEIIRIAIDVA 294
             H N+++ + VC     D    L +V + ++      L  +    + T+ I  +   + 
Sbjct: 67  FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 126

Query: 295 EGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPE 354
            G+ FL+ H V +RDL  Q IL+   G + L D G+          T        + APE
Sbjct: 127 RGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVT-LWYRAPE 185

Query: 355 IIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP------- 407
           ++     +       +++S G +  EM   +  +   S V     I      P       
Sbjct: 186 VLLQSSYATP----VDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR 241

Query: 408 ------------------EIPKDCPQILKSLMIKCWNNSPSKRPQFSEIIS 440
                             +   D  ++ K L++KC   +P+KR      +S
Sbjct: 242 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  100 bits (250), Expect = 4e-24
 Identities = 44/291 (15%), Positives = 97/291 (33%), Gaps = 48/291 (16%)

Query: 190 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHK 243
                +  +G  ++  V        G +V I+KL    +   +     ++L  L    H+
Sbjct: 18  AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77

Query: 244 NILQFYCVCVDENHG-----LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIK 298
           N++    V   +          +V   M  G+    ++K  KL    I  +   + +G++
Sbjct: 78  NVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGLR 135

Query: 299 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAG 358
           +++  G+ +RDL    + ++    + + D G+    +              + APE+I  
Sbjct: 136 YIHAAGIIHRDLKPGNLAVNEDCELKILDFGL---ARQADSEMTGYVVTRWYRAPEVILN 192

Query: 359 DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP----------- 407
                  T   +++S G ++ EM+TG+  +     +     I      P           
Sbjct: 193 WMRY---TQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSD 249

Query: 408 ------------------EIPKDCPQILKSLMIKCWNNSPSKRPQFSEIIS 440
                              I  +   +  +L+ K       +R    E ++
Sbjct: 250 EAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 97.3 bits (241), Expect = 3e-23
 Identities = 40/285 (14%), Positives = 94/285 (32%), Gaps = 38/285 (13%)

Query: 190 DNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHK 243
              E +++IG  ++  V+K       + V +++++  D          +++  L    HK
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61

Query: 244 NILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDH 303
           NI++ + V   +     +V +  +          +  L  + +      + +G+ F +  
Sbjct: 62  NIVRLHDVLHSDKKL-TLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR 120

Query: 304 GVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESV 363
            V +RDL  Q +L++R+G + L + G+  A          E     +  P+++ G     
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLY- 179

Query: 364 SETWMSNVYSFGMVIWEMVTGEAA-YAACSPVQAAVGIAACGLRP--------------- 407
             +   +++S G +  E+       +           I      P               
Sbjct: 180 --STSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237

Query: 408 ------------EIPKDCPQILKSLMIKCWNNSPSKRPQFSEIIS 440
                        +        + L+      +P +R    E + 
Sbjct: 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 94.9 bits (235), Expect = 5e-22
 Identities = 54/290 (18%), Positives = 91/290 (31%), Gaps = 52/290 (17%)

Query: 193 EFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNIL 246
                IG  SF  VY+      G+ V I+K+    +    E ++      +    H NI+
Sbjct: 23  TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQI------MRKLDHCNIV 76

Query: 247 QFYCVCVDENHG-----LCVVTKLMEGGSVNDLILKSRK---LQTKEIIRIAIDVAEGIK 298
           +                L +V   +           SR    L    +      +   + 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136

Query: 299 FLNDHGVAYRDLNSQRILLDRHGNVC-LGDMGIVTACKSVGEATEYETDGYRWLAPEIIA 357
           +++  G+ +RD+  Q +LLD    V  L D G        GE          + APE+I 
Sbjct: 137 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR-GEPNVSYICSRYYRAPELIF 195

Query: 358 GDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP---------- 407
           G  +    T   +V+S G V+ E++ G+  +   S V   V I      P          
Sbjct: 196 GATDY---TSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP 252

Query: 408 -----------------EIPKDCPQILKSLMIKCWNNSPSKRPQFSEIIS 440
                                  P    +L  +    +P+ R    E  +
Sbjct: 253 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score = 90.3 bits (223), Expect = 1e-20
 Identities = 33/252 (13%), Positives = 88/252 (34%), Gaps = 13/252 (5%)

Query: 188 NSDNLEFIDQIGPNSFKGVYKGKRVGIEK---LKGCDKGNAYEFELRKDLLELMTCGHKN 244
           N D+ + + ++G   +  V++   +   +   +K        + +    +LE +     N
Sbjct: 33  NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRG-GPN 91

Query: 245 ILQFYCVCVDENHG-LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDH 303
           I+    +  D       +V + +       L    + L   +I     ++ + + + +  
Sbjct: 92  IITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSM 148

Query: 304 GVAYRDLNSQRILLDR-HGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPES 362
           G+ +RD+    +++D  H  + L D G+       G+          +  PE++      
Sbjct: 149 GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP-GQEYNVRVASRYFKGPELLVDYQMY 207

Query: 363 VSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMI 422
               +  +++S G ++  M+  +  +         +   A  L  E   D        + 
Sbjct: 208 ---DYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 264

Query: 423 KCWNNSPSKRPQ 434
             +N+   +  +
Sbjct: 265 PRFNDILGRHSR 276

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 87.3 bits (215), Expect = 1e-19
 Identities = 39/291 (13%), Positives = 96/291 (32%), Gaps = 46/291 (15%)

Query: 189 SDNLEFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGH 242
            +  + +  +G  ++  V        G RV ++KL    +   +     ++L  L    H
Sbjct: 17  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76

Query: 243 KNILQFYCVCVDENH----GLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIK 298
           +N++    V              +   + G  +N+++ K +KL    +  +   +  G+K
Sbjct: 77  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-KCQKLTDDHVQFLIYQILRGLK 135

Query: 299 FLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAG 358
           +++   + +RDL    + ++    + + D G+    +   +          + APEI+  
Sbjct: 136 YIHSADIIHRDLKPSNLAVNEDCELKILDFGL---ARHTDDEMTGYVATRWYRAPEIMLN 192

Query: 359 DPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP----------- 407
                      +++S G ++ E++TG   +     +     I      P           
Sbjct: 193 WMHY---NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 249

Query: 408 ------------------EIPKDCPQILKSLMIKCWNNSPSKRPQFSEIIS 440
                              +      +   L+ K       KR   ++ ++
Sbjct: 250 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 79.2 bits (194), Expect = 1e-16
 Identities = 44/258 (17%), Positives = 94/258 (36%), Gaps = 20/258 (7%)

Query: 193 EFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNIL 246
           + +  IG  +   V         + V I+KL    +   +     ++L+ +    HKNI+
Sbjct: 20  QNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII 79

Query: 247 QFYCVCVDENHG-----LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLN 301
               V   +        + +V +LM+      +     +L  + +  +   +  GIK L+
Sbjct: 80  SLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLH 136

Query: 302 DHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPE 361
             G+ +RDL    I++     + + D G+     +    T Y      + APE+I G   
Sbjct: 137 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY-VVTRYYRAPEVILGMGY 195

Query: 362 SVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLM 421
                   +++S G ++ EMV  +  +     +     +      P  P+   ++  ++ 
Sbjct: 196 ----KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP-CPEFMKKLQPTVR 250

Query: 422 IKCWNNSPSKRPQFSEII 439
               N        F ++ 
Sbjct: 251 NYVENRPKYAGLTFPKLF 268

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 65.4 bits (158), Expect = 3e-12
 Identities = 42/268 (15%), Positives = 94/268 (35%), Gaps = 35/268 (13%)

Query: 193 EFIDQIGPNSFKGVYK------GKRVGIEKLKGCDKGNAYEFELRKDLLE---------L 237
             + ++G   F  V+          V ++ ++G DK      E    LL+          
Sbjct: 16  ILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTKE 74

Query: 238 MTCGHKNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQT----KEIIRIAIDV 293
            + G  +IL+       +      V  + E    N L L  +          + +I+  +
Sbjct: 75  DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQL 134

Query: 294 AEGIKFLN-DHGVAYRDLNSQRILLDRHGNVC-LGDMGIVTACKSVGEATEYETDG--YR 349
             G+ +++   G+ + D+  + +L++   +   L  + I     +      Y        
Sbjct: 135 LLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTRE 194

Query: 350 WLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEI 409
           + +PE++ G P        ++++S   +I+E++TG+         +   G +       I
Sbjct: 195 YRSPEVLLGAPWGCG----ADIWSTACLIFELITGD------FLFEPDEGHSYTKDDDHI 244

Query: 410 PKDCPQILKSLMIKCWNNSPSKRPQFSE 437
            +   ++L  L      N    R  F+ 
Sbjct: 245 AQII-ELLGELPSYLLRNGKYTRTFFNS 271

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 44.8 bits (105), Expect = 5e-06
 Identities = 23/198 (11%), Positives = 58/198 (29%), Gaps = 32/198 (16%)

Query: 196 DQIGPNSFKGVYK-----GKRVGIEKLK--------GCDKGNAYEFELRKDLLELMTCGH 242
             +G      V+           ++  K          +K +  +       +       
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 243 KNILQFYCVCVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLND 302
           + + +   + V + +       LME     +      +++ +    +   + E +     
Sbjct: 66  RALQKLQGLAVPKVYAWEGNAVLMELIDAKE----LYRVRVENPDEVLDMILEEVAKFYH 121

Query: 303 HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPES 362
            G+ + DL+   +L+   G + + D            + E   +G      EI+  D  +
Sbjct: 122 RGIVHGDLSQYNVLVSEEG-IWIIDFPQ---------SVEVGEEG----WREILERDVRN 167

Query: 363 VSETWMSNVYSFGMVIWE 380
           +   + S  Y     I  
Sbjct: 168 IIT-YFSRTYRTEKDINS 184

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	454
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.88
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	97.86
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	96.99
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	96.62
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	93.06
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	90.98
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	85.27

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-57  Score=439.83  Aligned_cols=261  Identities=26%  Similarity=0.470  Sum_probs=220.8

Q ss_pred             ceeecCCCEEEeceeeccCCceEEEeE---EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEE
Q 012887          184 RWLLNSDNLEFIDQIGPNSFKGVYKGK---RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLC  260 (454)
Q Consensus       184 ~~~~~~~~~~~~~~LG~G~fG~Vy~g~---~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~  260 (454)
                      +|+++.++|++++.||+|+||.||+|+   .||||+++...........+.+|+.++.+++|||||+++|++.+ +. ++
T Consensus         2 dwei~~~~~~~~~~lG~G~fg~Vy~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~-~~   79 (276)
T d1uwha_           2 DWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQ-LA   79 (276)
T ss_dssp             CCBCCTTCCCCCSEEEECSSCEEEEEESSSEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SS-CE
T ss_pred             CcccccccEEEEEEEeeCCCcEEEEEEECCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cE-EE
Confidence            588999999999999999999999985   69999997665555566778999999999999999999998754 33 89


Q ss_pred             EEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCC
Q 012887          261 VVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE  339 (454)
Q Consensus       261 lV~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~  339 (454)
                      +|||||++|+|.+++... ..+++..+..++.||+.||+|||+++||||||||+|||++.++++||+|||+|+.......
T Consensus        80 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~  159 (276)
T d1uwha_          80 IVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG  159 (276)
T ss_dssp             EEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC------
T ss_pred             EEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCC
Confidence            999999999999999654 4799999999999999999999999999999999999999999999999999876644222


Q ss_pred             --cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCC----CCCCCc
Q 012887          340 --ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP----EIPKDC  413 (454)
Q Consensus       340 --~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~----~~p~~~  413 (454)
                        ......||+.|||||++.+.... .++.++|||||||+||||+||+.||.+.++..........+...    ..+..+
T Consensus       160 ~~~~~~~~gt~~y~APE~l~~~~~~-~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~  238 (276)
T d1uwha_         160 SHQFEQLSGSILWMAPEVIRMQDKN-PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNC  238 (276)
T ss_dssp             ------CCCCGGGCCHHHHTTCSSC-CCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTC
T ss_pred             cccccccccCcccCCHHHHhcccCC-CCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccc
Confidence              23345789999999999765332 46778999999999999999999999887776665555544433    356789


Q ss_pred             cHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 012887          414 PQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNN  447 (454)
Q Consensus       414 ~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~  447 (454)
                      |+++.+||.+||+.||++|||+.||+++|+.+.+
T Consensus       239 ~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~  272 (276)
T d1uwha_         239 PKAMKRLMAECLKKKRDERPLFPQILASIELLAR  272 (276)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            9999999999999999999999999999988754

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=6.5e-56  Score=433.59  Aligned_cols=260  Identities=22%  Similarity=0.408  Sum_probs=224.6

Q ss_pred             ccceeecCCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeC
Q 012887          182 IGRWLLNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDE  255 (454)
Q Consensus       182 ~~~~~~~~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~  255 (454)
                      ..+|+++.++|++.+.||+|+||.||+|      +.||||+++....   ...++.+|+.+|.+++|||||+++|+|.++
T Consensus         9 ~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~---~~~~~~~E~~il~~l~HpnIv~~~~~~~~~   85 (287)
T d1opja_           9 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTRE   85 (287)
T ss_dssp             CCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS---CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             CcccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc---hHHHHHHHHHHHHhCCCCCEecCCccEeeC
Confidence            3678899999999999999999999996      4799999874322   345688999999999999999999999887


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccc
Q 012887          256 NHGLCVVTKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTA  333 (454)
Q Consensus       256 ~~~l~lV~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~  333 (454)
                      +. +++|||||++|+|.+++.+.  ..+++..+..++.||+.||+|||++||+||||||+|||++.++++||+|||+++.
T Consensus        86 ~~-~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~  164 (287)
T d1opja_          86 PP-FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL  164 (287)
T ss_dssp             SS-CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTT
T ss_pred             Ce-eEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceee
Confidence            76 89999999999999999654  4789999999999999999999999999999999999999999999999999987


Q ss_pred             cccCCCc-ccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCC
Q 012887          334 CKSVGEA-TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKD  412 (454)
Q Consensus       334 ~~~~~~~-~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~  412 (454)
                      ....... .....+++.|+|||++.+..    ++.++|||||||++|||++|..||...............+.+++.|..
T Consensus       165 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~----~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~  240 (287)
T d1opja_         165 MTGDTYTAHAGAKFPIKWTAPESLAYNK----FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEG  240 (287)
T ss_dssp             CCSSSSEEETTEEECGGGCCHHHHHHCC----CSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTT
T ss_pred             cCCCCceeeccccccccccChHHHcCCC----CCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCcc
Confidence            6543332 22335788999999998765    455799999999999999976666555555556667777888999999


Q ss_pred             ccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCCC
Q 012887          413 CPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNIS  449 (454)
Q Consensus       413 ~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~  449 (454)
                      +|+++.+||.+||+.||.+|||+.|+++.|+.+.+.+
T Consensus       241 ~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~~  277 (287)
T d1opja_         241 CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES  277 (287)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSSS
T ss_pred             chHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhC
Confidence            9999999999999999999999999999998876643

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-55  Score=422.86  Aligned_cols=252  Identities=23%  Similarity=0.493  Sum_probs=207.9

Q ss_pred             ecCCCEEEeceeeccCCceEEEe-----EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEE
Q 012887          187 LNSDNLEFIDQIGPNSFKGVYKG-----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCV  261 (454)
Q Consensus       187 ~~~~~~~~~~~LG~G~fG~Vy~g-----~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~l  261 (454)
                      ++.++|++++.||+|+||.||+|     +.||||+++...   ....++.+|+.++.+++|||||+++|+|.+++. +++
T Consensus         2 idp~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~-~~l   77 (263)
T d1sm2a_           2 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA---MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAP-ICL   77 (263)
T ss_dssp             BCCSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS-CEE
T ss_pred             CChHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc---CcHHHHHHHHHHHHhcCCCCcccccceeccCCc-eEE
Confidence            56789999999999999999996     469999987432   234568899999999999999999999988776 899


Q ss_pred             EEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCc
Q 012887          262 VTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA  340 (454)
Q Consensus       262 V~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~  340 (454)
                      ||||+++|+|.+++... ..+++..+..++.||+.||.|||+++|+||||||+|||++.++++||+|||+++........
T Consensus        78 v~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~  157 (263)
T d1sm2a_          78 VFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT  157 (263)
T ss_dssp             EEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC-----------
T ss_pred             EEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCce
Confidence            99999999999998654 47899999999999999999999999999999999999999999999999999876543322


Q ss_pred             -ccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHH
Q 012887          341 -TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILK  418 (454)
Q Consensus       341 -~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~  418 (454)
                       .....||+.|+|||++.+..    ++.++|||||||++|||+| |.+||...+..+.... ...+.++..|..+|+++.
T Consensus       158 ~~~~~~gt~~y~aPE~l~~~~----~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~-i~~~~~~~~p~~~~~~l~  232 (263)
T d1sm2a_         158 SSTGTKFPVKWASPEVFSFSR----YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVED-ISTGFRLYKPRLASTHVY  232 (263)
T ss_dssp             -------CTTSCCHHHHTTCC----CCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHH-HHHTCCCCCCTTSCHHHH
T ss_pred             eecceecCcccCChHHhcCCC----CCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHH-HHhcCCCCCccccCHHHH
Confidence             23346889999999998764    5567999999999999999 5666666666555544 445678888999999999


Q ss_pred             HHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 012887          419 SLMIKCWNNSPSKRPQFSEIISLLLRTNN  447 (454)
Q Consensus       419 ~li~~cl~~dP~~RPs~~ell~~L~~~~~  447 (454)
                      +||.+||+.||++|||++||+++|+++.+
T Consensus       233 ~li~~cl~~~p~~Rps~~~il~~L~~i~e  261 (263)
T d1sm2a_         233 QIMNHCWKERPEDRPAFSRLLRQLAEIAE  261 (263)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence            99999999999999999999999998753

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-55  Score=438.95  Aligned_cols=255  Identities=23%  Similarity=0.402  Sum_probs=221.1

Q ss_pred             cceeecCCCEEEeceeeccCCceEEEeE-----------EEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEEEE
Q 012887          183 GRWLLNSDNLEFIDQIGPNSFKGVYKGK-----------RVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYC  250 (454)
Q Consensus       183 ~~~~~~~~~~~~~~~LG~G~fG~Vy~g~-----------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~~~g  250 (454)
                      .+|.++.++|++++.||+|+||.||+|+           .||+|.+.... .......+.+|+.+++++ +|||||++++
T Consensus        30 ~kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~l~~  108 (325)
T d1rjba_          30 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLG  108 (325)
T ss_dssp             GGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             ccccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc-CHHHHHHHHHHHHHHHHhcCCCcEeEEEE
Confidence            4688999999999999999999999975           48999886432 233345678999999988 8999999999


Q ss_pred             EEEeCCCeEEEEEeccCCCCHHHHHHhCC-----------------------CCCHHHHHHHHHHHHHHHHHHHhcCccc
Q 012887          251 VCVDENHGLCVVTKLMEGGSVNDLILKSR-----------------------KLQTKEIIRIAIDVAEGIKFLNDHGVAY  307 (454)
Q Consensus       251 ~~~~~~~~l~lV~E~~~~gsL~~~l~~~~-----------------------~l~~~~~~~i~~qI~~gL~yLH~~~iiH  307 (454)
                      +|.+.+. +++|||||++|+|.+++.+.+                       .+++..++.++.||+.||.|||+++|||
T Consensus       109 ~~~~~~~-~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiH  187 (325)
T d1rjba_         109 ACTLSGP-IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVH  187 (325)
T ss_dssp             EECSSSS-CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEE
T ss_pred             EEeeCCe-EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeee
Confidence            9998877 999999999999999996532                       4889999999999999999999999999


Q ss_pred             CCccCCcEEEccCCcEEEEccCCccccccCCCcc--cccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-C
Q 012887          308 RDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT--EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-G  384 (454)
Q Consensus       308 rDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~--~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G  384 (454)
                      |||||+|||++.++++||+|||+|+.........  ....+|+.|||||++.+..    ++.++|||||||++|||+| |
T Consensus       188 RDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~----~~~~~DiwS~Gvil~emlt~g  263 (325)
T d1rjba_         188 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGI----YTIKSDVWSYGILLWEIFSLG  263 (325)
T ss_dssp             TTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCC----CCHHHHHHHHHHHHHHHTTTS
T ss_pred             ccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCC----CCcceeccchhHHHHHHHhCC
Confidence            9999999999999999999999998765543322  2345789999999998765    4567999999999999998 8


Q ss_pred             CCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 012887          385 EAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLL  443 (454)
Q Consensus       385 ~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~  443 (454)
                      ..||.+.+....+..+...+.+++.|..+|+++.+||.+||+.||++|||++||+++|.
T Consensus       264 ~~Pf~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         264 VNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             CCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCCCCCCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            99999887777788888888999999999999999999999999999999999999985

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.4e-55  Score=430.97  Aligned_cols=258  Identities=25%  Similarity=0.436  Sum_probs=212.3

Q ss_pred             ecCCCEEEeceeeccCCceEEEeE---------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCC
Q 012887          187 LNSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH  257 (454)
Q Consensus       187 ~~~~~~~~~~~LG~G~fG~Vy~g~---------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~  257 (454)
                      +..++|++.+.||+|+||.||+|.         .||||.+... ........+.+|+.+|++++|||||+++|+|.+++.
T Consensus        23 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~  101 (299)
T d1jpaa_          23 IDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTP  101 (299)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             hChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCE
Confidence            556789999999999999999975         3788887632 233445668999999999999999999999987776


Q ss_pred             eEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCcccccc
Q 012887          258 GLCVVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS  336 (454)
Q Consensus       258 ~l~lV~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~  336 (454)
                       +++|||||++|+|.+++... +.+++..+..++.||+.||.|||+++|+||||||+|||++.++++||+|||+++....
T Consensus       102 -~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~  180 (299)
T d1jpaa_         102 -VMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED  180 (299)
T ss_dssp             -CEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             -EEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccC
Confidence             99999999999999988664 4799999999999999999999999999999999999999999999999999987654


Q ss_pred             CCCcc-----cccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHcCCCCCCC
Q 012887          337 VGEAT-----EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIP  410 (454)
Q Consensus       337 ~~~~~-----~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p  410 (454)
                      .....     ....+|+.|||||.+.+..    ++.++|||||||++|||+| |..||.+.+..+....+ ..+.+++.|
T Consensus       181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~----~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i-~~~~~~~~~  255 (299)
T d1jpaa_         181 DTSDPTYTSALGGKIPIRWTAPEAIQYRK----FTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAI-EQDYRLPPP  255 (299)
T ss_dssp             ---------------CGGGSCHHHHHSCC----CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH-HTTCCCCCC
T ss_pred             CCCcceeeecccccCCccccCHHHHhcCC----CCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHH-HcCCCCCCC
Confidence            32221     1234688999999998764    4556999999999999998 89999998877665554 456778889


Q ss_pred             CCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCCCCC
Q 012887          411 KDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISNS  451 (454)
Q Consensus       411 ~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~~  451 (454)
                      ..+|+++.+||.+||+.||++|||+.||++.|+++.+..++
T Consensus       256 ~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~p~s  296 (299)
T d1jpaa_         256 MDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNPNS  296 (299)
T ss_dssp             TTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGG
T ss_pred             ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcChhh
Confidence            99999999999999999999999999999999998766554

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-55  Score=424.82  Aligned_cols=247  Identities=19%  Similarity=0.327  Sum_probs=216.4

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCC-CchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDK-GNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  262 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV  262 (454)
                      ++|++++.||+|+||.||++      +.||+|.+..... .......+.+|+.+++.++|||||++++++.+++. +|+|
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~-~~iv   84 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATR-VYLI   84 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE-EEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCE-EEEE
Confidence            68999999999999999996      5799999864221 12234567899999999999999999999998876 9999


Q ss_pred             EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCccc
Q 012887          263 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE  342 (454)
Q Consensus       263 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~  342 (454)
                      ||||++|+|.+++.+.+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++......  ...
T Consensus        85 mEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~--~~~  162 (263)
T d2j4za1          85 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--RRT  162 (263)
T ss_dssp             EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC--CCE
T ss_pred             EeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCC--ccc
Confidence            999999999999988889999999999999999999999999999999999999999999999999998765433  234


Q ss_pred             ccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHHHHHH
Q 012887          343 YETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMI  422 (454)
Q Consensus       343 ~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~li~  422 (454)
                      ...||+.|+|||++.+..++    .++|||||||++|||++|+.||.+.+..+....+...  .+.+|..+|+++.+||.
T Consensus       163 ~~~Gt~~Y~APE~~~~~~~~----~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~  236 (263)
T d2j4za1         163 TLCGTLDYLPPEMIEGRMHD----EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV--EFTFPDFVTEGARDLIS  236 (263)
T ss_dssp             ETTEEGGGCCHHHHTTCCCC----TTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT--CCCCCTTSCHHHHHHHH
T ss_pred             ccCCCCcccCHHHHcCCCCC----chhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcC--CCCCCccCCHHHHHHHH
Confidence            45789999999999987544    4599999999999999999999998887777666553  45678899999999999


Q ss_pred             HhcccCCCCCCCHHHHHHHHHhh
Q 012887          423 KCWNNSPSKRPQFSEIISLLLRT  445 (454)
Q Consensus       423 ~cl~~dP~~RPs~~ell~~L~~~  445 (454)
                      +||+.||.+|||+.|+++|-|-.
T Consensus       237 ~~L~~dp~~R~t~~eil~hp~~~  259 (263)
T d2j4za1         237 RLLKHNPSQRPMLREVLEHPWIT  259 (263)
T ss_dssp             HHTCSSGGGSCCHHHHHTCHHHH
T ss_pred             HHccCCHhHCcCHHHHHcCcCcC
Confidence            99999999999999999976643

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-55  Score=424.77  Aligned_cols=249  Identities=22%  Similarity=0.297  Sum_probs=204.8

Q ss_pred             CCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeC-CCeEEE
Q 012887          189 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDE-NHGLCV  261 (454)
Q Consensus       189 ~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~-~~~l~l  261 (454)
                      .++|++++.||+|+||.||+|      +.||+|.+............+.+|+.++++++|||||++++++.+. +..+|+
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i   82 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   82 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred             chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence            378999999999999999996      4799999986655555566788999999999999999999999764 344899


Q ss_pred             EEeccCCCCHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhcC-----cccCCccCCcEEEccCCcEEEEccCCcc
Q 012887          262 VTKLMEGGSVNDLILK----SRKLQTKEIIRIAIDVAEGIKFLNDHG-----VAYRDLNSQRILLDRHGNVCLGDMGIVT  332 (454)
Q Consensus       262 V~E~~~~gsL~~~l~~----~~~l~~~~~~~i~~qI~~gL~yLH~~~-----iiHrDIKp~NILl~~~~~vKL~DFGla~  332 (454)
                      |||||++|+|.+++.+    ...+++..++.++.||+.||.|||+++     |+||||||+|||++.++.+||+|||+++
T Consensus        83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~  162 (269)
T d2java1          83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  162 (269)
T ss_dssp             EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred             EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence            9999999999999853    458999999999999999999999976     9999999999999999999999999998


Q ss_pred             ccccCCCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCC
Q 012887          333 ACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKD  412 (454)
Q Consensus       333 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~  412 (454)
                      .............||+.|+|||++.+..    ++.++|||||||++|||++|..||.+.+..+....+... ..+.+|..
T Consensus       163 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~----~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~-~~~~~~~~  237 (269)
T d2java1         163 ILNHDTSFAKAFVGTPYYMSPEQMNRMS----YNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREG-KFRRIPYR  237 (269)
T ss_dssp             HC-----------CCCSCCCHHHHTTCC----CCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT-CCCCCCTT
T ss_pred             ecccCCCccccCCCCcccCCHHHHcCCC----CChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcC-CCCCCCcc
Confidence            8765544455568899999999998764    456799999999999999999999998887776666554 44567889


Q ss_pred             ccHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 012887          413 CPQILKSLMIKCWNNSPSKRPQFSEIISLL  442 (454)
Q Consensus       413 ~~~~l~~li~~cl~~dP~~RPs~~ell~~L  442 (454)
                      +|+++.+||.+||+.||.+|||+.|+++|-
T Consensus       238 ~s~~l~~li~~~L~~dp~~Rps~~ell~hp  267 (269)
T d2java1         238 YSDELNEIITRMLNLKDYHRPSVEEILENP  267 (269)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred             cCHHHHHHHHHHcCCChhHCcCHHHHHhCC
Confidence            999999999999999999999999998763

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-54  Score=422.72  Aligned_cols=255  Identities=25%  Similarity=0.436  Sum_probs=218.3

Q ss_pred             ceeecCCCEEEec-eeeccCCceEEEeE--------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEe
Q 012887          184 RWLLNSDNLEFID-QIGPNSFKGVYKGK--------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVD  254 (454)
Q Consensus       184 ~~~~~~~~~~~~~-~LG~G~fG~Vy~g~--------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~  254 (454)
                      ++.+..++|.+.+ +||+|+||.||+|.        .||||.++.. ........+.+|+.+|.+++|||||+++|++.+
T Consensus         2 ~l~l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~   80 (285)
T d1u59a_           2 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA   80 (285)
T ss_dssp             CCBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred             ceeecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChh-cCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc
Confidence            4567778899998 49999999999973        5999999743 333445678999999999999999999999875


Q ss_pred             CCCeEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccc
Q 012887          255 ENHGLCVVTKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTA  333 (454)
Q Consensus       255 ~~~~l~lV~E~~~~gsL~~~l~~-~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~  333 (454)
                      + . +|+|||||++|+|.+++.. ...+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++.
T Consensus        81 ~-~-~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~  158 (285)
T d1u59a_          81 E-A-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKA  158 (285)
T ss_dssp             S-S-EEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             C-e-EEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhc
Confidence            4 3 8999999999999999854 45899999999999999999999999999999999999999999999999999987


Q ss_pred             cccCCC---cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHcCCCCCC
Q 012887          334 CKSVGE---ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEI  409 (454)
Q Consensus       334 ~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~  409 (454)
                      ......   ......+|+.|+|||++.+..    ++.++|||||||++|||+| |..||.+.+..+... .+..+.+++.
T Consensus       159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~-~i~~~~~~~~  233 (285)
T d1u59a_         159 LGADDSYYTARSAGKWPLKWYAPECINFRK----FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMA-FIEQGKRMEC  233 (285)
T ss_dssp             CTTCSCEECCCCSSCCCGGGCCHHHHHHCE----ECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHH-HHHTTCCCCC
T ss_pred             ccccccccccccccccCccccChHHHhCCC----CCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHH-HHHcCCCCCC
Confidence            654332   223345789999999998664    4557999999999999998 999999887765544 4456778889


Q ss_pred             CCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 012887          410 PKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTN  446 (454)
Q Consensus       410 p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~  446 (454)
                      |..+|+++.+||.+||+.||++|||+.+|.+.|+...
T Consensus       234 p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~  270 (285)
T d1u59a_         234 PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY  270 (285)
T ss_dssp             CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence            9999999999999999999999999999999887654

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-54  Score=425.28  Aligned_cols=246  Identities=22%  Similarity=0.380  Sum_probs=216.3

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  263 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~  263 (454)
                      ++|++++.||+|+||.||+|      +.||+|++......  ....+.+|+.+++.++|||||++++++.+.+. +|+||
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~-~~ivm   96 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDE-LWVVM   96 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE-EEEEE
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh--HHHHHHHHHHHHHhCCCCCEeeEeEEEEECCE-EEEEE
Confidence            57999999999999999995      58999998754332  23568899999999999999999999998886 99999


Q ss_pred             eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCcccc
Q 012887          264 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY  343 (454)
Q Consensus       264 E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~  343 (454)
                      |||+||+|.+++.+ +.+++..+..++.||+.||+|||++||+||||||+|||++.+|++||+|||+++...........
T Consensus        97 Ey~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~  175 (293)
T d1yhwa1          97 EYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST  175 (293)
T ss_dssp             ECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCC
T ss_pred             EecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeeccccccccc
Confidence            99999999998754 57999999999999999999999999999999999999999999999999999887665555666


Q ss_pred             cCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCC-CCCCCCCccHHHHHHHH
Q 012887          344 ETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGL-RPEIPKDCPQILKSLMI  422 (454)
Q Consensus       344 ~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~-~~~~p~~~~~~l~~li~  422 (454)
                      ..||+.|+|||++.+..+    +.++|||||||++|+|++|..||.+.+.......+...+. ....|..+|+++.+||.
T Consensus       176 ~~gt~~Y~aPE~~~~~~~----~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  251 (293)
T d1yhwa1         176 MVGTPYWMAPEVVTRKAY----GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN  251 (293)
T ss_dssp             CCSCGGGCCHHHHSSSCB----CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHH
T ss_pred             cccCCCccChhhhcCCCC----CchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHH
Confidence            689999999999987754    4569999999999999999999999888777766665443 34567789999999999


Q ss_pred             HhcccCCCCCCCHHHHHHHHH
Q 012887          423 KCWNNSPSKRPQFSEIISLLL  443 (454)
Q Consensus       423 ~cl~~dP~~RPs~~ell~~L~  443 (454)
                      +||+.||.+|||+.|+++|-+
T Consensus       252 ~~L~~dP~~R~s~~eil~Hp~  272 (293)
T d1yhwa1         252 RCLDMDVEKRGSAKELLQHQF  272 (293)
T ss_dssp             HHTCSSTTTSCCHHHHTTCGG
T ss_pred             HHccCChhHCcCHHHHhcCHh
Confidence            999999999999999998754

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-55  Score=423.33  Aligned_cols=255  Identities=25%  Similarity=0.469  Sum_probs=216.2

Q ss_pred             cceeecCCCEEEeceeeccCCceEEEe-----EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCC
Q 012887          183 GRWLLNSDNLEFIDQIGPNSFKGVYKG-----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH  257 (454)
Q Consensus       183 ~~~~~~~~~~~~~~~LG~G~fG~Vy~g-----~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~  257 (454)
                      ..|.++.++|++++.||+|+||.||+|     +.||||+++...   .....+.+|+.++.+++|||||+++|++.+ +.
T Consensus         6 ~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~   81 (272)
T d1qpca_           6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS---MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EP   81 (272)
T ss_dssp             CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred             CCeecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc---CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CC
Confidence            578899999999999999999999996     579999997432   233568899999999999999999998754 33


Q ss_pred             eEEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccc
Q 012887          258 GLCVVTKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK  335 (454)
Q Consensus       258 ~l~lV~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~  335 (454)
                       +++||||+++|+|.+++...  .++++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+|+...
T Consensus        82 -~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~  160 (272)
T d1qpca_          82 -IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE  160 (272)
T ss_dssp             -CEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             -eEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEcc
Confidence             78999999999999987432  369999999999999999999999999999999999999999999999999998765


Q ss_pred             cCCC-cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcC-CCCCCCCCHHHHHHHHHHcCCCCCCCCCc
Q 012887          336 SVGE-ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTG-EAAYAACSPVQAAVGIAACGLRPEIPKDC  413 (454)
Q Consensus       336 ~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG-~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~  413 (454)
                      .... ......+|+.|+|||++.+..    ++.++|||||||++|||+|| .+||...+..+. ......+.++..|..+
T Consensus       161 ~~~~~~~~~~~gt~~y~APE~~~~~~----~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~-~~~i~~~~~~~~p~~~  235 (272)
T d1qpca_         161 DNEYTAREGAKFPIKWTAPEAINYGT----FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV-IQNLERGYRMVRPDNC  235 (272)
T ss_dssp             SSCEECCTTCCCCTTTSCHHHHHHCE----ECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH-HHHHHTTCCCCCCTTC
T ss_pred             CCccccccccCCcccccChHHHhCCC----CCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHH-HHHHHhcCCCCCcccC
Confidence            4322 233456889999999998664    45579999999999999995 555555555444 4445567888889999


Q ss_pred             cHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 012887          414 PQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNN  447 (454)
Q Consensus       414 ~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~  447 (454)
                      |+++.+||.+||+.||++|||+.||++.|+....
T Consensus       236 ~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft  269 (272)
T d1qpca_         236 PEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT  269 (272)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence            9999999999999999999999999999887643

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-55  Score=427.17  Aligned_cols=252  Identities=21%  Similarity=0.371  Sum_probs=216.5

Q ss_pred             CCCEEEeceeeccCCceEEEeE------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEE
Q 012887          189 SDNLEFIDQIGPNSFKGVYKGK------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  262 (454)
Q Consensus       189 ~~~~~~~~~LG~G~fG~Vy~g~------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV  262 (454)
                      .+.|++++.||+|+||.||+|+      .||+|++....  ......+.+|+.+|++++|||||++++++.+++. +++|
T Consensus        11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~-~~lv   87 (288)
T d2jfla1          11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYYENN-LWIL   87 (288)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS--SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTE-EEEE
T ss_pred             ccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCe-EEEE
Confidence            3679999999999999999964      79999997532  2333457899999999999999999999998876 9999


Q ss_pred             EeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCcc
Q 012887          263 TKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT  341 (454)
Q Consensus       263 ~E~~~~gsL~~~l~~-~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~  341 (454)
                      ||||++|+|.+++.+ .+.+++..+..++.||+.||.|||++||+||||||+|||++.++++||+|||+|+.........
T Consensus        88 mEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~  167 (288)
T d2jfla1          88 IEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR  167 (288)
T ss_dssp             EECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHH
T ss_pred             EecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCcccc
Confidence            999999999999754 4579999999999999999999999999999999999999999999999999987655433334


Q ss_pred             cccCCCCcccccccccCCCC-CCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCC-CCCCCCccHHHHH
Q 012887          342 EYETDGYRWLAPEIIAGDPE-SVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR-PEIPKDCPQILKS  419 (454)
Q Consensus       342 ~~~~gt~~y~APE~l~~~~~-~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~-~~~p~~~~~~l~~  419 (454)
                      ....||+.|+|||++.+... ...++.++|||||||++|||++|..||.+.++.+....+.....+ ...|..+|+++.+
T Consensus       168 ~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~  247 (288)
T d2jfla1         168 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKD  247 (288)
T ss_dssp             TCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHHHH
T ss_pred             cccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHHHHH
Confidence            45679999999999865432 334677899999999999999999999998888887777765432 3456789999999


Q ss_pred             HHHHhcccCCCCCCCHHHHHHHHH
Q 012887          420 LMIKCWNNSPSKRPQFSEIISLLL  443 (454)
Q Consensus       420 li~~cl~~dP~~RPs~~ell~~L~  443 (454)
                      ||.+||+.||.+|||+.|+++|-+
T Consensus       248 li~~~L~~dp~~R~t~~ell~hp~  271 (288)
T d2jfla1         248 FLKKCLEKNVDARWTTSQLLQHPF  271 (288)
T ss_dssp             HHHHHSCSSTTTSCCHHHHTTSGG
T ss_pred             HHHHHccCChhHCcCHHHHhcCcc
Confidence            999999999999999999998754

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-55  Score=423.91  Aligned_cols=250  Identities=18%  Similarity=0.247  Sum_probs=208.5

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  263 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~  263 (454)
                      ++|++++.||+|+||.||+|      +.||+|.+..... ......+.+|+.+|++++|||||++++++.+++. +|+||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~-~~ivm   82 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNI-QYLFL   82 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEETTE-EEEEE
T ss_pred             cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCce-eEEEE
Confidence            68999999999999999985      5799999974332 2233458899999999999999999999998876 99999


Q ss_pred             eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCC--cc
Q 012887          264 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE--AT  341 (454)
Q Consensus       264 E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~--~~  341 (454)
                      |||++|+|.+++.+.+.+++..+..++.||+.||+|||++||+||||||+|||++.++++||+|||+|+.......  ..
T Consensus        83 Ey~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~  162 (271)
T d1nvra_          83 EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL  162 (271)
T ss_dssp             ECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred             eccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCccccc
Confidence            9999999999998778999999999999999999999999999999999999999999999999999987654322  23


Q ss_pred             cccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH-HHHcCCCCCCCCCccHHHHHH
Q 012887          342 EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVG-IAACGLRPEIPKDCPQILKSL  420 (454)
Q Consensus       342 ~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~-i~~~~~~~~~p~~~~~~l~~l  420 (454)
                      ....||+.|||||++.+..+   ++.++|||||||++|||++|+.||...+....... ..........+..+|+++.+|
T Consensus       163 ~~~~GT~~Y~APE~~~~~~~---~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  239 (271)
T d1nvra_         163 NKMCGTLPYVAPELLKRREF---HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL  239 (271)
T ss_dssp             CCCCSCGGGSCTHHHHCSSB---CHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHH
T ss_pred             cceeeCcCccCHhHhcCCCC---CCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHH
Confidence            44579999999999987654   24569999999999999999999987655433333 333333333345689999999


Q ss_pred             HHHhcccCCCCCCCHHHHHHHHHh
Q 012887          421 MIKCWNNSPSKRPQFSEIISLLLR  444 (454)
Q Consensus       421 i~~cl~~dP~~RPs~~ell~~L~~  444 (454)
                      |.+||+.||.+|||+.|+++|-|-
T Consensus       240 i~~~L~~dP~~R~t~~eil~hpwf  263 (271)
T d1nvra_         240 LHKILVENPSARITIPDIKKDRWY  263 (271)
T ss_dssp             HHHHSCSSTTTSCCHHHHTTCTTT
T ss_pred             HHHHcCCChhHCcCHHHHhcCHhh
Confidence            999999999999999999987654

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-54  Score=418.86  Aligned_cols=248  Identities=25%  Similarity=0.432  Sum_probs=209.6

Q ss_pred             CEEEe-ceeeccCCceEEEe--------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEE
Q 012887          191 NLEFI-DQIGPNSFKGVYKG--------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCV  261 (454)
Q Consensus       191 ~~~~~-~~LG~G~fG~Vy~g--------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~l  261 (454)
                      .+.+- ++||+|+||.||+|        +.||||+++...........+.+|+.+|++++|||||+++|+|.++ . .++
T Consensus         7 ~~~le~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~-~~l   84 (277)
T d1xbba_           7 LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-S-WML   84 (277)
T ss_dssp             GEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-S-EEE
T ss_pred             hCeecCCCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-C-EEE
Confidence            33443 47999999999996        4699999976555555567799999999999999999999998643 3 789


Q ss_pred             EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCc-
Q 012887          262 VTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA-  340 (454)
Q Consensus       262 V~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~-  340 (454)
                      |||||++|+|.+++.+...+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++........ 
T Consensus        85 vmE~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~  164 (277)
T d1xbba_          85 VMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY  164 (277)
T ss_dssp             EEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred             EEEcCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence            9999999999999988889999999999999999999999999999999999999999999999999999866543221 


Q ss_pred             --ccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHH
Q 012887          341 --TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQIL  417 (454)
Q Consensus       341 --~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l  417 (454)
                        .....||+.|+|||.+.+..    ++.++|||||||++|||++ |..||.+.+..+... .+..+.+++.|..+|+++
T Consensus       165 ~~~~~~~gt~~y~APE~l~~~~----~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~-~i~~~~~~~~p~~~~~~~  239 (277)
T d1xbba_         165 KAQTHGKWPVKWYAPECINYYK----FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTA-MLEKGERMGCPAGCPREM  239 (277)
T ss_dssp             EC----CCCGGGCCHHHHHHCE----EEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH-HHHTTCCCCCCTTCCHHH
T ss_pred             ccccccCCCceecCchhhcCCC----CCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHH-HHHcCCCCCCCcccCHHH
Confidence              22346889999999998765    4456999999999999998 999999887765544 445577888999999999


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 012887          418 KSLMIKCWNNSPSKRPQFSEIISLLLRT  445 (454)
Q Consensus       418 ~~li~~cl~~dP~~RPs~~ell~~L~~~  445 (454)
                      .+||.+||+.||++|||+.+|.+.|+..
T Consensus       240 ~~li~~cl~~dp~~RPs~~~i~~~L~~~  267 (277)
T d1xbba_         240 YDLMNLCWTYDVENRPGFAAVELRLRNY  267 (277)
T ss_dssp             HHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             HHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence            9999999999999999999999888764

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.3e-54  Score=424.93  Aligned_cols=248  Identities=22%  Similarity=0.310  Sum_probs=217.5

Q ss_pred             CEEEeceeeccCCceEEEe------EEEEEEEeecCCCCch-HHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEE
Q 012887          191 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNA-YEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  263 (454)
Q Consensus       191 ~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~-~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~  263 (454)
                      .|+.++.||+|+||.||+|      +.||||++........ ....+.+|+.+|++++|||||++++++.+++. +|+||
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~-~~iv~   94 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHT-AWLVM   94 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTE-EEEEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCE-EEEEE
Confidence            4899999999999999996      5799999975443333 34568899999999999999999999998876 99999


Q ss_pred             eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCcccc
Q 012887          264 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY  343 (454)
Q Consensus       264 E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~  343 (454)
                      |||.+|+|..++...+++++..+..++.||+.||.|||++||+||||||+|||++.++++||+|||++.....    ...
T Consensus        95 E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~----~~~  170 (309)
T d1u5ra_          95 EYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----ANS  170 (309)
T ss_dssp             ECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS----BCC
T ss_pred             EecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC----CCc
Confidence            9999999988777778999999999999999999999999999999999999999999999999999876543    334


Q ss_pred             cCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHHHHHHH
Q 012887          344 ETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIK  423 (454)
Q Consensus       344 ~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~li~~  423 (454)
                      ..||+.|||||++.+.... .++.++|||||||++|||++|..||.+.+..+....+.....+...+..+|+++.+||.+
T Consensus       171 ~~GT~~Y~APE~~~~~~~~-~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~  249 (309)
T d1u5ra_         171 FVGTPYWMAPEVILAMDEG-QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDS  249 (309)
T ss_dssp             CCSCGGGCCHHHHTTTTSC-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHHHHH
T ss_pred             cccCccccCHHHHhccCCC-CcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHH
Confidence            5799999999999764322 366789999999999999999999999888888888887766666677899999999999


Q ss_pred             hcccCCCCCCCHHHHHHHHHh
Q 012887          424 CWNNSPSKRPQFSEIISLLLR  444 (454)
Q Consensus       424 cl~~dP~~RPs~~ell~~L~~  444 (454)
                      ||+.||.+|||+.|+++|-+-
T Consensus       250 ~L~~dP~~Rpt~~ell~Hp~~  270 (309)
T d1u5ra_         250 CLQKIPQDRPTSEVLLKHRFV  270 (309)
T ss_dssp             HTCSSGGGSCCHHHHTTCHHH
T ss_pred             HCcCChhHCcCHHHHHhCHHh
Confidence            999999999999999986443

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7e-54  Score=418.11  Aligned_cols=259  Identities=25%  Similarity=0.424  Sum_probs=213.0

Q ss_pred             eecCCCEEEeceeeccCCceEEEeE----------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeC
Q 012887          186 LLNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDE  255 (454)
Q Consensus       186 ~~~~~~~~~~~~LG~G~fG~Vy~g~----------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~  255 (454)
                      ++..+.|++.+.||+|+||.||+|.          .||||++... .......++.+|+.++..++|||||+++|++.+.
T Consensus         3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~   81 (283)
T d1mqba_           3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG-YTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY   81 (283)
T ss_dssp             BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcc-cChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC
Confidence            3567889999999999999999974          5899998643 3344456688999999999999999999999887


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCcccc
Q 012887          256 NHGLCVVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC  334 (454)
Q Consensus       256 ~~~l~lV~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~  334 (454)
                      +. +++||||+.+|++.+++... ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++..
T Consensus        82 ~~-~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~  160 (283)
T d1mqba_          82 KP-MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL  160 (283)
T ss_dssp             SS-EEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             Cc-eEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcc
Confidence            76 99999999999999988654 58999999999999999999999999999999999999999999999999999876


Q ss_pred             ccCCCc---ccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCC
Q 012887          335 KSVGEA---TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPK  411 (454)
Q Consensus       335 ~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~  411 (454)
                      ......   .....||+.|+|||++.+..    ++.++|||||||++|||++|..||............+..+.+++.|.
T Consensus       161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~----~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~  236 (283)
T d1mqba_         161 EDDPEATYTTSGGKIPIRWTAPEAISYRK----FTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPM  236 (283)
T ss_dssp             -------------CCCGGGSCHHHHHSCC----CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCT
T ss_pred             cCCCccceEeccCCCCccccCHHHHccCC----CCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCch
Confidence            543222   22335788999999998764    45679999999999999996555544444444555666788889999


Q ss_pred             CccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCCCC
Q 012887          412 DCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISN  450 (454)
Q Consensus       412 ~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~  450 (454)
                      .+|.++.+||.+||+.||++|||+.||++.|+++.+..+
T Consensus       237 ~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p~  275 (283)
T d1mqba_         237 DCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD  275 (283)
T ss_dssp             TCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred             hhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhCcc
Confidence            999999999999999999999999999999988765443

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8e-54  Score=412.49  Aligned_cols=248  Identities=25%  Similarity=0.490  Sum_probs=216.9

Q ss_pred             cCCCEEEeceeeccCCceEEEeE-----EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEE
Q 012887          188 NSDNLEFIDQIGPNSFKGVYKGK-----RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  262 (454)
Q Consensus       188 ~~~~~~~~~~LG~G~fG~Vy~g~-----~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV  262 (454)
                      +.++|++++.||+|+||.||+|+     .||||+++....   .+.++.+|+.++.+++|||||+++|+|.+++. +++|
T Consensus         2 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~---~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~-~~iv   77 (258)
T d1k2pa_           2 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM---SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRP-IFII   77 (258)
T ss_dssp             CCCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS---CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSS-EEEE
T ss_pred             ChHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC---CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCc-eEEE
Confidence            56899999999999999999974     799999985332   34568899999999999999999999987776 9999


Q ss_pred             EeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCc-
Q 012887          263 TKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA-  340 (454)
Q Consensus       263 ~E~~~~gsL~~~l~~-~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~-  340 (454)
                      |||+++|+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++........ 
T Consensus        78 ~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~  157 (258)
T d1k2pa_          78 TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS  157 (258)
T ss_dssp             EECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCC
T ss_pred             EEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCcee
Confidence            999999999999754 458999999999999999999999999999999999999999999999999999765543322 


Q ss_pred             ccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHHH
Q 012887          341 TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKS  419 (454)
Q Consensus       341 ~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~  419 (454)
                      .....+|+.|+|||.+.+..    ++.++|||||||++|||+| |+.||.+.+..+....+ ..+.++..|..+++++.+
T Consensus       158 ~~~~~~t~~y~aPE~~~~~~----~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i-~~~~~~~~p~~~~~~l~~  232 (258)
T d1k2pa_         158 SVGSKFPVRWSPPEVLMYSK----FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI-AQGLRLYRPHLASEKVYT  232 (258)
T ss_dssp             CCCSCCCGGGCCHHHHHHCC----CCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHH-HTTCCCCCCTTCCHHHHH
T ss_pred             ecccCCCCCcCCcHHhcCCC----CCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHH-HhCCCCCCcccccHHHHH
Confidence            22346788999999998765    4567999999999999998 89999998877766555 457788899999999999


Q ss_pred             HHHHhcccCCCCCCCHHHHHHHHHh
Q 012887          420 LMIKCWNNSPSKRPQFSEIISLLLR  444 (454)
Q Consensus       420 li~~cl~~dP~~RPs~~ell~~L~~  444 (454)
                      ||.+||+.||++|||+.+|+++|..
T Consensus       233 li~~cl~~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         233 IMYSCWHEKADERPTFKILLSNILD  257 (258)
T ss_dssp             HHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred             HHHHHccCCHhHCcCHHHHHHHhhC
Confidence            9999999999999999999999864

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-54  Score=423.48  Aligned_cols=261  Identities=24%  Similarity=0.410  Sum_probs=216.2

Q ss_pred             ccceeecCCCEEEeceeeccCCceEEEe-----------EEEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEEE
Q 012887          182 IGRWLLNSDNLEFIDQIGPNSFKGVYKG-----------KRVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFY  249 (454)
Q Consensus       182 ~~~~~~~~~~~~~~~~LG~G~fG~Vy~g-----------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~~~  249 (454)
                      ..+|.++.++|++++.||+|+||.||+|           +.||||+++.. ........+.+|...+.++ +|+|||.++
T Consensus         5 ~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-~~~~~~~~~~~e~~~l~~~~~h~~iv~~~   83 (299)
T d1ywna1           5 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-ATHSEHRALMSELKILIHIGHHLNVVNLL   83 (299)
T ss_dssp             HHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-----CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccc-cCcHHHHHHHHHHHHHHhhcCCCeEEEee
Confidence            4678899999999999999999999996           46999998743 2333445567777777776 689999999


Q ss_pred             EEEEeCCCeEEEEEeccCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCC
Q 012887          250 CVCVDENHGLCVVTKLMEGGSVNDLILKS----------------RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQ  313 (454)
Q Consensus       250 g~~~~~~~~l~lV~E~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~  313 (454)
                      +++.+++..+++|||||++|+|.+++...                ..+++..+..++.||+.||.|||+++||||||||+
T Consensus        84 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~  163 (299)
T d1ywna1          84 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR  163 (299)
T ss_dssp             EEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred             eeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCcc
Confidence            99987776699999999999999999542                24889999999999999999999999999999999


Q ss_pred             cEEEccCCcEEEEccCCccccccCCC--cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcC-CCCCCC
Q 012887          314 RILLDRHGNVCLGDMGIVTACKSVGE--ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTG-EAAYAA  390 (454)
Q Consensus       314 NILl~~~~~vKL~DFGla~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG-~~Pf~~  390 (454)
                      |||++.++++||+|||+|+.......  ......||+.|+|||++.+..    ++.++|||||||++|||++| .+||.+
T Consensus       164 NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~----~~~~sDiwS~Gvil~ellt~~~~p~~~  239 (299)
T d1ywna1         164 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV----YTIQSDVWSFGVLLWEIFSLGASPYPG  239 (299)
T ss_dssp             GEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCC----CCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             ceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCC----CCcccceeehHHHHHHHHhCCCCCCCC
Confidence            99999999999999999986654333  233456899999999998764    45679999999999999996 678988


Q ss_pred             CCHHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 012887          391 CSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNN  447 (454)
Q Consensus       391 ~~~~~~~~~i~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~  447 (454)
                      .............+.++..|..+|+++.++|.+||+.||++|||+.|++++|+++.+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq  296 (299)
T d1ywna1         240 VKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  296 (299)
T ss_dssp             CCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence            776667777777788899999999999999999999999999999999999998765

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-53  Score=413.49  Aligned_cols=246  Identities=23%  Similarity=0.392  Sum_probs=209.3

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeC---CCeEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDE---NHGLC  260 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~---~~~l~  260 (454)
                      +.|++.++||+|+||.||+|      +.||+|++............+.+|+.+|++++|||||++++++.+.   +..+|
T Consensus         9 ry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~   88 (270)
T d1t4ha_           9 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV   88 (270)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred             CEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEE
Confidence            34578889999999999996      4799999986555555566789999999999999999999998753   34489


Q ss_pred             EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC--cccCCccCCcEEEc-cCCcEEEEccCCccccccC
Q 012887          261 VVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHG--VAYRDLNSQRILLD-RHGNVCLGDMGIVTACKSV  337 (454)
Q Consensus       261 lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~--iiHrDIKp~NILl~-~~~~vKL~DFGla~~~~~~  337 (454)
                      +||||+++|+|.+++.+...+++..+..++.||+.||+|||+++  |+||||||+|||++ .++.+||+|||+++.....
T Consensus        89 ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~  168 (270)
T d1t4ha_          89 LVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS  168 (270)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred             EEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC
Confidence            99999999999999988889999999999999999999999998  99999999999996 4789999999999754332


Q ss_pred             CCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCC-CCCCCCccHH
Q 012887          338 GEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR-PEIPKDCPQI  416 (454)
Q Consensus       338 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~-~~~p~~~~~~  416 (454)
                        ......||+.|||||++.+.     ++.++|||||||++|||++|+.||.+.............+.+ +.++..++++
T Consensus       169 --~~~~~~GT~~Y~aPE~~~~~-----~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~  241 (270)
T d1t4ha_         169 --FAKAVIGTPEFMAPEMYEEK-----YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPE  241 (270)
T ss_dssp             --SBEESCSSCCCCCGGGGGTC-----CCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHH
T ss_pred             --ccCCcccCccccCHHHhCCC-----CCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHH
Confidence              23455799999999998652     566799999999999999999999877666555555544443 3456778999


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHHHH
Q 012887          417 LKSLMIKCWNNSPSKRPQFSEIISLL  442 (454)
Q Consensus       417 l~~li~~cl~~dP~~RPs~~ell~~L  442 (454)
                      +.+||.+||+.||++|||+.|+++|-
T Consensus       242 ~~~li~~~l~~dp~~R~s~~ell~Hp  267 (270)
T d1t4ha_         242 VKEIIEGCIRQNKDERYSIKDLLNHA  267 (270)
T ss_dssp             HHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred             HHHHHHHHccCCHhHCcCHHHHhCCc
Confidence            99999999999999999999999864

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-53  Score=413.93  Aligned_cols=256  Identities=24%  Similarity=0.453  Sum_probs=209.8

Q ss_pred             ceeecCCCEEEeceeeccCCceEEEeE---------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEe
Q 012887          184 RWLLNSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVD  254 (454)
Q Consensus       184 ~~~~~~~~~~~~~~LG~G~fG~Vy~g~---------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~  254 (454)
                      .|+|+.++|++++.||+|+||.||+|.         .||||.++.. ........+.+|+.++++++|||||+++|++.+
T Consensus         1 ~~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~   79 (273)
T d1mp8a_           1 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-TSDSVREKFLQEALTMRQFDHPHIVKLIGVITE   79 (273)
T ss_dssp             CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             CCCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc-cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            377888999999999999999999974         4788887633 333445668899999999999999999999854


Q ss_pred             CCCeEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccc
Q 012887          255 ENHGLCVVTKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTA  333 (454)
Q Consensus       255 ~~~~l~lV~E~~~~gsL~~~l~~-~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~  333 (454)
                       +. +++||||+++|+|.+++.. ...+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++.
T Consensus        80 -~~-~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~  157 (273)
T d1mp8a_          80 -NP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY  157 (273)
T ss_dssp             -SS-CEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC------
T ss_pred             -Ce-EEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhhee
Confidence             44 8999999999999998755 45899999999999999999999999999999999999999999999999999987


Q ss_pred             cccCCC-cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHcCCCCCCCC
Q 012887          334 CKSVGE-ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPK  411 (454)
Q Consensus       334 ~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~  411 (454)
                      ...... ......+|+.|+|||.+.+..    ++.++|||||||++|||++ |.+||.+.+..+....+. .+.++++|.
T Consensus       158 ~~~~~~~~~~~~~gt~~y~apE~l~~~~----~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~-~~~~~~~~~  232 (273)
T d1mp8a_         158 MEDSTYYKASKGKLPIKWMAPESINFRR----FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE-NGERLPMPP  232 (273)
T ss_dssp             -------------CCGGGCCHHHHHHCC----CSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-TTCCCCCCT
T ss_pred             ccCCcceeccceecCcccchhhHhccCC----CCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHH-cCCCCCCCC
Confidence            654322 233456789999999998765    4456999999999999998 899999888776665554 567778899


Q ss_pred             CccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 012887          412 DCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNN  447 (454)
Q Consensus       412 ~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~  447 (454)
                      .+|+++.+||.+||+.||.+|||+.||+++|+++.+
T Consensus       233 ~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~  268 (273)
T d1mp8a_         233 NCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE  268 (273)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            999999999999999999999999999999988754

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-54  Score=421.31  Aligned_cols=247  Identities=16%  Similarity=0.244  Sum_probs=212.1

Q ss_pred             CCCEEEeceeeccCCceEEEe------EEEEEEEeecCCC-CchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEE
Q 012887          189 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDK-GNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCV  261 (454)
Q Consensus       189 ~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~l  261 (454)
                      .++|++++.||+|+||.||+|      +.||||.+..... .......+.+|+.++.+++|||||++++++.+++. +|+
T Consensus         7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~-~~i   85 (288)
T d1uu3a_           7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEK-LYF   85 (288)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSE-EEE
T ss_pred             CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCE-EEE
Confidence            478999999999999999986      4799999864221 12233568899999999999999999999998776 999


Q ss_pred             EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCC--
Q 012887          262 VTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE--  339 (454)
Q Consensus       262 V~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~--  339 (454)
                      |||||+||+|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++++|.+||+|||+|+.......  
T Consensus        86 vmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~  165 (288)
T d1uu3a_          86 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA  165 (288)
T ss_dssp             EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred             EEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCccc
Confidence            999999999999998888999999999999999999999999999999999999999999999999999987654322  


Q ss_pred             cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHHH
Q 012887          340 ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKS  419 (454)
Q Consensus       340 ~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~  419 (454)
                      ......||+.|+|||++.+..    ++.++|||||||++|||++|..||.+.+.......+...  ...+|..+++++.+
T Consensus       166 ~~~~~~GT~~Y~APE~~~~~~----~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~  239 (288)
T d1uu3a_         166 RANSFVGTAQYVSPELLTEKS----ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL--EYDFPEKFFPKARD  239 (288)
T ss_dssp             ----CCCCGGGCCHHHHHTCC----CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTT--CCCCCTTCCHHHHH
T ss_pred             ccccccCCccccCceeeccCC----CCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcC--CCCCCccCCHHHHH
Confidence            233457999999999998765    455799999999999999999999998888777777654  45678899999999


Q ss_pred             HHHHhcccCCCCCCCHHHHHHHH
Q 012887          420 LMIKCWNNSPSKRPQFSEIISLL  442 (454)
Q Consensus       420 li~~cl~~dP~~RPs~~ell~~L  442 (454)
                      ||.+||+.||.+|||++|++.+.
T Consensus       240 li~~~L~~dP~~R~t~~e~~~~~  262 (288)
T d1uu3a_         240 LVEKLLVLDATKRLGCEEMEGYG  262 (288)
T ss_dssp             HHHTTSCSSGGGSTTSGGGTCHH
T ss_pred             HHHHHccCCHhHCcCHHHHcCCH
Confidence            99999999999999999976553

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-53  Score=422.04  Aligned_cols=249  Identities=19%  Similarity=0.366  Sum_probs=207.2

Q ss_pred             ecCCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEE
Q 012887          187 LNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLC  260 (454)
Q Consensus       187 ~~~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~  260 (454)
                      +..++|++++.||+|+||.||+|      +.||+|+++.. ........+.+|+.+|+.++|||||+++++|.++++ +|
T Consensus         3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~-~~   80 (322)
T d1s9ja_           3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE-IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE-IS   80 (322)
T ss_dssp             CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECC-CCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSE-EE
T ss_pred             CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChh-hCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE-EE
Confidence            45689999999999999999995      68999999753 333445678899999999999999999999998876 99


Q ss_pred             EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-cCcccCCccCCcEEEccCCcEEEEccCCccccccCCC
Q 012887          261 VVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLND-HGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE  339 (454)
Q Consensus       261 lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~-~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~  339 (454)
                      +|||||+||+|.+++.+.+.+++..+..++.||+.||.|||+ +||+||||||+|||++.+|++||+|||+|+...+.. 
T Consensus        81 iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~-  159 (322)
T d1s9ja_          81 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-  159 (322)
T ss_dssp             EEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT-
T ss_pred             EEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCCc-
Confidence            999999999999999888899999999999999999999997 599999999999999999999999999998764422 


Q ss_pred             cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHH----------------------
Q 012887          340 ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAA----------------------  397 (454)
Q Consensus       340 ~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~----------------------  397 (454)
                       .....||+.|+|||++.+..++    .++||||+||++|||++|+.||.+.+.....                      
T Consensus       160 -~~~~~GT~~Y~APEvl~~~~y~----~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (322)
T d1s9ja_         160 -ANSFVGTRSYMSPERLQGTHYS----VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG  234 (322)
T ss_dssp             -C---CCSSCCCCHHHHHCSCCC----TTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------------
T ss_pred             -cccccCCccccCchHHcCCCCC----cHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccc
Confidence             3345799999999999987654    4599999999999999999999765432210                      


Q ss_pred             -------------------HHHHHcCCCCCCCC-CccHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 012887          398 -------------------VGIAACGLRPEIPK-DCPQILKSLMIKCWNNSPSKRPQFSEIISLLL  443 (454)
Q Consensus       398 -------------------~~i~~~~~~~~~p~-~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~  443 (454)
                                         ........++..|. .+|.++.+||.+||..||.+|||+.|+++|-+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf  300 (322)
T d1s9ja_         235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAF  300 (322)
T ss_dssp             -----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred             ccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHh
Confidence                               01111122233333 36899999999999999999999999999743

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.2e-53  Score=418.30  Aligned_cols=247  Identities=19%  Similarity=0.309  Sum_probs=199.4

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  263 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~  263 (454)
                      +.|++++.||+|+||.||++      +.||+|.+...... .....+.+|+.+|..++|||||++++++.+++. +|+||
T Consensus         9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~-~~lvm   86 (307)
T d1a06a_           9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE-GKEGSMENEIAVLHKIKHPNIVALDDIYESGGH-LYLIM   86 (307)
T ss_dssp             GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEECSSE-EEEEE
T ss_pred             cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh-hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE-EEEEE
Confidence            66999999999999999995      57999999743322 234567899999999999999999999998776 99999


Q ss_pred             eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEc---cCCcEEEEccCCccccccCCCc
Q 012887          264 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLD---RHGNVCLGDMGIVTACKSVGEA  340 (454)
Q Consensus       264 E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~---~~~~vKL~DFGla~~~~~~~~~  340 (454)
                      |||+||+|.+++.+.+.+++..+..++.||+.||+|||++||+||||||+|||+.   .++.+||+|||+++...... .
T Consensus        87 E~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~-~  165 (307)
T d1a06a_          87 QLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS-V  165 (307)
T ss_dssp             CCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC------------
T ss_pred             eccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCC-e
Confidence            9999999999998888999999999999999999999999999999999999995   47899999999998654432 2


Q ss_pred             ccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCC--CCCCccHHHH
Q 012887          341 TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPE--IPKDCPQILK  418 (454)
Q Consensus       341 ~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~--~p~~~~~~l~  418 (454)
                      .....||+.|||||++.+..    ++.++|||||||++|||++|..||.+.+.......+.......+  .+..+|+++.
T Consensus       166 ~~~~~GT~~y~APE~~~~~~----~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  241 (307)
T d1a06a_         166 LSTACGTPGYVAPEVLAQKP----YSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAK  241 (307)
T ss_dssp             -------CTTSCHHHHTTCC----CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHH
T ss_pred             eeeeeeCccccCcHHHcCCC----CCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHH
Confidence            34457999999999998765    45579999999999999999999999888887777776655443  3467899999


Q ss_pred             HHHHHhcccCCCCCCCHHHHHHHHH
Q 012887          419 SLMIKCWNNSPSKRPQFSEIISLLL  443 (454)
Q Consensus       419 ~li~~cl~~dP~~RPs~~ell~~L~  443 (454)
                      +||.+||++||++|||+.|+++|-+
T Consensus       242 ~li~~~L~~dP~~R~s~~eil~hp~  266 (307)
T d1a06a_         242 DFIRHLMEKDPEKRFTCEQALQHPW  266 (307)
T ss_dssp             HHHHHHSCSSGGGSCCHHHHHHSTT
T ss_pred             HHHHHHccCCHhHCcCHHHHhcCHh
Confidence            9999999999999999999999744

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-53  Score=421.95  Aligned_cols=249  Identities=16%  Similarity=0.287  Sum_probs=219.2

Q ss_pred             cCCCEEEeceeeccCCceEEEe------EEEEEEEeecCCC-CchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEE
Q 012887          188 NSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDK-GNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLC  260 (454)
Q Consensus       188 ~~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~  260 (454)
                      +-++|++++.||+|+||.||++      +.||+|+++.... .......+.+|+.+|+.++|||||++++++.+.+. +|
T Consensus         3 ~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~-~~   81 (337)
T d1o6la_           3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDR-LC   81 (337)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSE-EE
T ss_pred             chHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccc-cc
Confidence            3478999999999999999985      5899999974321 12234567899999999999999999999998876 99


Q ss_pred             EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCc
Q 012887          261 VVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA  340 (454)
Q Consensus       261 lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~  340 (454)
                      +|||||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+........
T Consensus        82 iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~~  161 (337)
T d1o6la_          82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT  161 (337)
T ss_dssp             EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCC
T ss_pred             cceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCCcc
Confidence            99999999999999988889999999999999999999999999999999999999999999999999999876655555


Q ss_pred             ccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHHHH
Q 012887          341 TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSL  420 (454)
Q Consensus       341 ~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~l  420 (454)
                      .....||+.|+|||++.+..++    .++|||||||++|||++|.+||.+.+..+....+...  .+.+|..+|+++.+|
T Consensus       162 ~~~~~GT~~Y~aPE~~~~~~y~----~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~dl  235 (337)
T d1o6la_         162 MKTFCGTPEYLAPEVLEDNDYG----RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME--EIRFPRTLSPEAKSL  235 (337)
T ss_dssp             BCCCEECGGGCCGGGGSSSCBC----TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTTSCHHHHHH
T ss_pred             cccceeCHHHhhhhhccCCCCC----hhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcC--CCCCCccCCHHHHHH
Confidence            5667899999999999987654    4599999999999999999999998888777777664  456889999999999


Q ss_pred             HHHhcccCCCCCCC-----HHHHHHHHH
Q 012887          421 MIKCWNNSPSKRPQ-----FSEIISLLL  443 (454)
Q Consensus       421 i~~cl~~dP~~RPs-----~~ell~~L~  443 (454)
                      |.+||++||.+||+     +.|+++|-+
T Consensus       236 i~~~L~~dP~~R~~~~~~~~~eil~Hp~  263 (337)
T d1o6la_         236 LAGLLKKDPKQRLGGGPSDAKEVMEHRF  263 (337)
T ss_dssp             HHHHTCSSTTTSTTCSTTTHHHHHTSGG
T ss_pred             HHhhccCCchhhcccccccHHHHHcCcc
Confidence            99999999999995     899988743

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-53  Score=411.50  Aligned_cols=254  Identities=27%  Similarity=0.499  Sum_probs=212.2

Q ss_pred             eecCCCEEEeceeeccCCceEEEeE---------EEEEEEeecCCC-CchHHHHHHHHHHHHHhCCCCceeEEEEEEEeC
Q 012887          186 LLNSDNLEFIDQIGPNSFKGVYKGK---------RVGIEKLKGCDK-GNAYEFELRKDLLELMTCGHKNILQFYCVCVDE  255 (454)
Q Consensus       186 ~~~~~~~~~~~~LG~G~fG~Vy~g~---------~vavK~l~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~  255 (454)
                      .++.++|++++.||+|+||.||+|+         .||||+++.... .......+.+|+.+|.+++|||||+++|+|.++
T Consensus         4 ~i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~   83 (273)
T d1u46a_           4 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP   83 (273)
T ss_dssp             ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             EEchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec
Confidence            3567889999999999999999974         589999875433 333456789999999999999999999999654


Q ss_pred             CCeEEEEEeccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCcccc
Q 012887          256 NHGLCVVTKLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC  334 (454)
Q Consensus       256 ~~~l~lV~E~~~~gsL~~~l~~-~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~  334 (454)
                       . +++||||+++|+|.+++.. .+.+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++..
T Consensus        84 -~-~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~  161 (273)
T d1u46a_          84 -P-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL  161 (273)
T ss_dssp             -S-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             -c-hheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhc
Confidence             3 7899999999999998754 457999999999999999999999999999999999999999999999999999876


Q ss_pred             ccCCCc---ccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHcCCCCCCC
Q 012887          335 KSVGEA---TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIP  410 (454)
Q Consensus       335 ~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p  410 (454)
                      ......   .....+++.|+|||.+.+..+    +.++|||||||++|||+| |..||.+.+..+....+...+.+++.|
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~----~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~  237 (273)
T d1u46a_         162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTF----SHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRP  237 (273)
T ss_dssp             CC-CCEEEC-----CCGGGCCHHHHHHCEE----EHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCC
T ss_pred             ccCCCcceecCccccCcccCCHHHHhCCCC----CcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCc
Confidence            544332   223356789999999987654    456999999999999998 899999999999888888888899999


Q ss_pred             CCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 012887          411 KDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRT  445 (454)
Q Consensus       411 ~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~  445 (454)
                      ..+|+++.+||.+||+.||++|||+.||.+.|.+.
T Consensus       238 ~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         238 EDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            99999999999999999999999999999999864

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.7e-53  Score=410.61  Aligned_cols=259  Identities=23%  Similarity=0.408  Sum_probs=212.5

Q ss_pred             cceeecCCCEEEeceeeccCCceEEEe-----EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCC
Q 012887          183 GRWLLNSDNLEFIDQIGPNSFKGVYKG-----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH  257 (454)
Q Consensus       183 ~~~~~~~~~~~~~~~LG~G~fG~Vy~g-----~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~  257 (454)
                      +.|.|+.++|++.+.||+|+||.||+|     +.||||+++....   ....+.+|+.++++++|||||+++|+|.+ +.
T Consensus        10 ~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~---~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~   85 (285)
T d1fmka3          10 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EP   85 (285)
T ss_dssp             TCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred             cceEcCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccC---CHHHHHHHHHHHHhcccCCEeEEEEEEec-CC
Confidence            678888999999999999999999997     4799999974332   23568899999999999999999999854 33


Q ss_pred             eEEEEEeccCCCCHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccc
Q 012887          258 GLCVVTKLMEGGSVNDLILK--SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK  335 (454)
Q Consensus       258 ~l~lV~E~~~~gsL~~~l~~--~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~  335 (454)
                       +++||||+++|+|..++..  .+.+++..++.++.||+.||.|||++||+||||||+||||+.++++||+|||+++...
T Consensus        86 -~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~  164 (285)
T d1fmka3          86 -IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE  164 (285)
T ss_dssp             -CEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred             -eEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhcc
Confidence             7899999999999998843  3579999999999999999999999999999999999999999999999999997654


Q ss_pred             cCCC-cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCcc
Q 012887          336 SVGE-ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCP  414 (454)
Q Consensus       336 ~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~  414 (454)
                      .... ......+|+.|+|||++.+..    ++.++|||||||++|||++|..||............+..+.+++.|..+|
T Consensus       165 ~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~  240 (285)
T d1fmka3         165 DNEYTARQGAKFPIKWTAPEAALYGR----FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECP  240 (285)
T ss_dssp             -----------CCGGGSCHHHHHHCC----CCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSC
T ss_pred             CCCceeeccccccccccChHHHhCCC----CCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccC
Confidence            3322 233456889999999998765    44569999999999999996555544444444445555677888899999


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCCCC
Q 012887          415 QILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNISN  450 (454)
Q Consensus       415 ~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~  450 (454)
                      +++.++|.+||+.||++||++++|++.|+.......
T Consensus       241 ~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~  276 (285)
T d1fmka3         241 ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE  276 (285)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred             HHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCC
Confidence            999999999999999999999999999988765443

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=9.9e-53  Score=413.37  Aligned_cols=257  Identities=25%  Similarity=0.453  Sum_probs=219.5

Q ss_pred             cceeecCCCEEEeceeeccCCceEEEeE-----------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEE
Q 012887          183 GRWLLNSDNLEFIDQIGPNSFKGVYKGK-----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV  251 (454)
Q Consensus       183 ~~~~~~~~~~~~~~~LG~G~fG~Vy~g~-----------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~  251 (454)
                      ..|+++.++|++++.||+|+||.||+|+           .||||+++. ........++.+|+.+|++++||||++++++
T Consensus         6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~-~~~~~~~~~~~~E~~il~~l~h~niv~~~~~   84 (301)
T d1lufa_           6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKE-EASADMQADFQREAALMAEFDNPNIVKLLGV   84 (301)
T ss_dssp             HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCT-TCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             hhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEECh-hcChHHHHHHHHHHHHHHhcCCCCcccceee
Confidence            3466778899999999999999999984           689999873 3334455678999999999999999999999


Q ss_pred             EEeCCCeEEEEEeccCCCCHHHHHHhCC------------------------CCCHHHHHHHHHHHHHHHHHHHhcCccc
Q 012887          252 CVDENHGLCVVTKLMEGGSVNDLILKSR------------------------KLQTKEIIRIAIDVAEGIKFLNDHGVAY  307 (454)
Q Consensus       252 ~~~~~~~l~lV~E~~~~gsL~~~l~~~~------------------------~l~~~~~~~i~~qI~~gL~yLH~~~iiH  307 (454)
                      |.+.+. +++||||+++|+|.+++....                        .+++..+..++.||+.||+|||+++|||
T Consensus        85 ~~~~~~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivH  163 (301)
T d1lufa_          85 CAVGKP-MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVH  163 (301)
T ss_dssp             ECSSSS-CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             eccCCc-eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEe
Confidence            988776 999999999999999985422                        3889999999999999999999999999


Q ss_pred             CCccCCcEEEccCCcEEEEccCCccccccCCC--cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCC
Q 012887          308 RDLNSQRILLDRHGNVCLGDMGIVTACKSVGE--ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGE  385 (454)
Q Consensus       308 rDIKp~NILl~~~~~vKL~DFGla~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~  385 (454)
                      |||||+|||++.++++||+|||+++...+...  ......+++.|+|||.+.+..    ++.++|||||||++|||++|.
T Consensus       164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~t~ksDVwS~Gvvl~ell~~~  239 (301)
T d1lufa_         164 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNR----YTTESDVWAYGVVLWEIFSYG  239 (301)
T ss_dssp             SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCC----CCHHHHHHHHHHHHHHHHTTT
T ss_pred             eEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCC----CChhhhhccchhhHHHHHccC
Confidence            99999999999999999999999876544332  223446788999999998765    456799999999999999985


Q ss_pred             -CCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 012887          386 -AAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTN  446 (454)
Q Consensus       386 -~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~  446 (454)
                       +||.+.+..+....+ ..+.+++.|..+|+++.+||.+||+.||++|||+.||++.|+++.
T Consensus       240 ~~p~~~~~~~e~~~~v-~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         240 LQPYYGMAHEEVIYYV-RDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             CCTTTTSCHHHHHHHH-HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             CCCCCCCCHHHHHHHH-HcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence             678887777666554 456678889999999999999999999999999999999999875

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-52  Score=413.18  Aligned_cols=252  Identities=23%  Similarity=0.455  Sum_probs=212.8

Q ss_pred             ecCCCEEEeceeeccCCceEEEeE----------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCC
Q 012887          187 LNSDNLEFIDQIGPNSFKGVYKGK----------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN  256 (454)
Q Consensus       187 ~~~~~~~~~~~LG~G~fG~Vy~g~----------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~  256 (454)
                      +..++|++++.||+|+||.||+|.          .||+|+++... .......+.+|+.++.+++|||||+++|+|.+++
T Consensus         6 ~k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~   84 (317)
T d1xkka_           6 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTST   84 (317)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred             CCHHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence            456789999999999999999974          48999887432 2334567889999999999999999999998653


Q ss_pred             CeEEEEEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccc
Q 012887          257 HGLCVVTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK  335 (454)
Q Consensus       257 ~~l~lV~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~  335 (454)
                        .+++|||+.+|+|.+++... ..+++..+..++.||+.||.|||+++||||||||+|||++.++++||+|||+++...
T Consensus        85 --~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~  162 (317)
T d1xkka_          85 --VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  162 (317)
T ss_dssp             --EEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred             --eeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceecc
Confidence              77899999999999988654 589999999999999999999999999999999999999999999999999998765


Q ss_pred             cCCCc--ccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHcCCCCCCCCC
Q 012887          336 SVGEA--TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKD  412 (454)
Q Consensus       336 ~~~~~--~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~  412 (454)
                      .....  .....||+.|+|||++.+..    ++.++|||||||++|||+| |.+||.+.+..+. ......+.+++.|..
T Consensus       163 ~~~~~~~~~~~~gt~~y~APE~l~~~~----~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~-~~~i~~~~~~~~p~~  237 (317)
T d1xkka_         163 AEEKEYHAEGGKVPIKWMALESILHRI----YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-SSILEKGERLPQPPI  237 (317)
T ss_dssp             TTCC--------CCTTTSCHHHHHHCC----CCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGH-HHHHHHTCCCCCCTT
T ss_pred             cccccccccccccCccccChHHHhcCC----CChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHH-HHHHHcCCCCCCCcc
Confidence            43322  23345789999999998764    4567999999999999999 8999988766554 445556788889999


Q ss_pred             ccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 012887          413 CPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTN  446 (454)
Q Consensus       413 ~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~  446 (454)
                      +|+++.+||.+||+.||.+|||+.||+++|.++.
T Consensus       238 ~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~  271 (317)
T d1xkka_         238 CTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA  271 (317)
T ss_dssp             BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHH
Confidence            9999999999999999999999999999988764

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-52  Score=407.59  Aligned_cols=248  Identities=16%  Similarity=0.275  Sum_probs=214.5

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCC----chHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKG----NAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGL  259 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~----~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l  259 (454)
                      ++|++++.||+|+||.||+|      +.||||.+......    ......+.+|+.+|++++|||||++++++.+.+. +
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~-~   88 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD-V   88 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE-E
T ss_pred             cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE-E
Confidence            67999999999999999995      57999998644322    2235678899999999999999999999998876 9


Q ss_pred             EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCC----cEEEEccCCccccc
Q 012887          260 CVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG----NVCLGDMGIVTACK  335 (454)
Q Consensus       260 ~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~----~vKL~DFGla~~~~  335 (454)
                      |+|||||++|+|.+++.+.+.+++..+..++.||+.||+|||+++|+||||||+|||++.++    ++||+|||++....
T Consensus        89 ~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~  168 (293)
T d1jksa_          89 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID  168 (293)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECT
T ss_pred             EEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcC
Confidence            99999999999999998888999999999999999999999999999999999999998877    49999999988765


Q ss_pred             cCCCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCC--CCCCc
Q 012887          336 SVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPE--IPKDC  413 (454)
Q Consensus       336 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~--~p~~~  413 (454)
                      ... ......+|+.|+|||++.+..+    +.++|||||||++|||++|..||.+.+..+....+.......+  .+..+
T Consensus       169 ~~~-~~~~~~~t~~y~APE~~~~~~~----~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  243 (293)
T d1jksa_         169 FGN-EFKNIFGTPEFVAPEIVNYEPL----GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNT  243 (293)
T ss_dssp             TSC-BCSCCCCCGGGCCHHHHTTCCB----CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTS
T ss_pred             CCc-cccccCCCCcccCHHHHcCCCC----CCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCC
Confidence            433 2344578999999999987654    4569999999999999999999999888888777766544432  34678


Q ss_pred             cHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 012887          414 PQILKSLMIKCWNNSPSKRPQFSEIISLLL  443 (454)
Q Consensus       414 ~~~l~~li~~cl~~dP~~RPs~~ell~~L~  443 (454)
                      |+++.+||++||+.||++|||+.|+++|-+
T Consensus       244 s~~~~~li~~~L~~dP~~R~s~~eil~hp~  273 (293)
T d1jksa_         244 SALAKDFIRRLLVKDPKKRMTIQDSLQHPW  273 (293)
T ss_dssp             CHHHHHHHHTTSCSSGGGSCCHHHHHHSTT
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence            999999999999999999999999998643

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-52  Score=405.57  Aligned_cols=251  Identities=25%  Similarity=0.489  Sum_probs=211.3

Q ss_pred             ceeecCCCEEEeceeeccCCceEEEe----EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeE
Q 012887          184 RWLLNSDNLEFIDQIGPNSFKGVYKG----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGL  259 (454)
Q Consensus       184 ~~~~~~~~~~~~~~LG~G~fG~Vy~g----~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l  259 (454)
                      +|.++.++|++++.||+|+||.||+|    +.||||+++..    .....+.+|+.++++++|||||+++|+|.+++..+
T Consensus         1 ~w~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~   76 (262)
T d1byga_           1 GWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL   76 (262)
T ss_dssp             CCBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCC----C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CC
T ss_pred             CCccCHHHeEEeEEEecCCCeEEEEEEECCeEEEEEEECcH----HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcE
Confidence            48899999999999999999999985    68999999642    22356789999999999999999999997665458


Q ss_pred             EEEEeccCCCCHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccC
Q 012887          260 CVVTKLMEGGSVNDLILKSR--KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV  337 (454)
Q Consensus       260 ~lV~E~~~~gsL~~~l~~~~--~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~  337 (454)
                      ++||||+++|+|.+++.+..  .+++..++.++.||+.||.|||+++|+||||||+|||++.++++||+|||+++.....
T Consensus        77 ~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~  156 (262)
T d1byga_          77 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  156 (262)
T ss_dssp             EEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred             EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCC
Confidence            99999999999999996533  6999999999999999999999999999999999999999999999999998765432


Q ss_pred             CCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHH
Q 012887          338 GEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYAACSPVQAAVGIAACGLRPEIPKDCPQI  416 (454)
Q Consensus       338 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~  416 (454)
                         .....+++.|+|||++.+..    ++.++|||||||++|||+| |++||...+..+.... +..+.++++|..++++
T Consensus       157 ---~~~~~~~~~y~aPE~l~~~~----~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~-i~~~~~~~~~~~~~~~  228 (262)
T d1byga_         157 ---QDTGKLPVKWTAPEALREKK----FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR-VEKGYKMDAPDGCPPA  228 (262)
T ss_dssp             --------CCTTTSCHHHHHHCC----CCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHH-HTTTCCCCCCTTCCHH
T ss_pred             ---CccccccccCCChHHHhCCC----CChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHH-HHcCCCCCCCccCCHH
Confidence               33446788999999998764    4567999999999999998 7888888766655544 4557888999999999


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 012887          417 LKSLMIKCWNNSPSKRPQFSEIISLLLRTN  446 (454)
Q Consensus       417 l~~li~~cl~~dP~~RPs~~ell~~L~~~~  446 (454)
                      +.+||.+||+.||.+|||+.+++++|+++.
T Consensus       229 ~~~li~~cl~~dP~~Rps~~~l~~~L~~i~  258 (262)
T d1byga_         229 VYEVMKNCWHLDAAMRPSFLQLREQLEHIK  258 (262)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence            999999999999999999999999998864

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-52  Score=406.92  Aligned_cols=258  Identities=25%  Similarity=0.484  Sum_probs=217.9

Q ss_pred             ccceeecCCCEEEeceeeccCCceEEEeE-------------EEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeE
Q 012887          182 IGRWLLNSDNLEFIDQIGPNSFKGVYKGK-------------RVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQ  247 (454)
Q Consensus       182 ~~~~~~~~~~~~~~~~LG~G~fG~Vy~g~-------------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~  247 (454)
                      ..+|.|+.++|++++.||+|+||.||+|+             .||||+++. +.......++.+|...+.++ +|||||+
T Consensus         5 ~~~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~-~~~~~~~~~~~~e~~~l~~~~~HpnIv~   83 (299)
T d1fgka_           5 DPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKS-DATEKDLSDLISEMEMMKMIGKHKNIIN   83 (299)
T ss_dssp             CTTTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCT-TCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             CCcCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECc-ccChHHHHHHHHHHHHHHHhcCCCeEEe
Confidence            35799999999999999999999999974             589999874 33334456678888888887 7999999


Q ss_pred             EEEEEEeCCCeEEEEEeccCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCcc
Q 012887          248 FYCVCVDENHGLCVVTKLMEGGSVNDLILKS----------------RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLN  311 (454)
Q Consensus       248 ~~g~~~~~~~~l~lV~E~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIK  311 (454)
                      ++++|.+++. +++|||||++|+|.+++...                ..+++..++.++.||+.||+|||+++|||||||
T Consensus        84 ~~~~~~~~~~-~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiK  162 (299)
T d1fgka_          84 LLGACTQDGP-LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLA  162 (299)
T ss_dssp             EEEEECSSSS-CEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred             cccccccCCe-EEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeec
Confidence            9999998776 99999999999999999643                258999999999999999999999999999999


Q ss_pred             CCcEEEccCCcEEEEccCCccccccCCC--cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCC
Q 012887          312 SQRILLDRHGNVCLGDMGIVTACKSVGE--ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAY  388 (454)
Q Consensus       312 p~NILl~~~~~vKL~DFGla~~~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf  388 (454)
                      |+|||++.++.+||+|||+++.......  ......+++.|+|||.+.+..    ++.++|||||||++|||++ |.+||
T Consensus       163 p~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~----y~~k~DiwS~Gvvl~ell~~g~~p~  238 (299)
T d1fgka_         163 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI----YTHQSDVWSFGVLLWEIFTLGGSPY  238 (299)
T ss_dssp             GGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCC----CCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred             ccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCC----CCchhhhHHhHHHHHHhccCCCCCC
Confidence            9999999999999999999887655332  233446788999999998764    5567999999999999998 79999


Q ss_pred             CCCCHHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhc
Q 012887          389 AACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTN  446 (454)
Q Consensus       389 ~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~  446 (454)
                      .+.+..... .....+.+++.|..+|+++.+||.+||+.||++|||+.||++.|+++.
T Consensus       239 ~~~~~~~~~-~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~  295 (299)
T d1fgka_         239 PGVPVEELF-KLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV  295 (299)
T ss_dssp             TTCCHHHHH-HHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCHHHHH-HHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence            887776544 555568888999999999999999999999999999999999998874

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-52  Score=410.82  Aligned_cols=259  Identities=24%  Similarity=0.440  Sum_probs=225.5

Q ss_pred             cceeecCCCEEEeceeeccCCceEEEeE-----------EEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEEEE
Q 012887          183 GRWLLNSDNLEFIDQIGPNSFKGVYKGK-----------RVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYC  250 (454)
Q Consensus       183 ~~~~~~~~~~~~~~~LG~G~fG~Vy~g~-----------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~~~g  250 (454)
                      ..|.++.++|++++.||+|+||.||+|+           .||||+++.. ........+.+|+.+++.+ +|||||+++|
T Consensus        16 ~~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~-~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g   94 (311)
T d1t46a_          16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS-AHLTEREALMSELKVLSYLGNHMNIVNLLG   94 (311)
T ss_dssp             GGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             ccccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcc-cCHHHHHHHHHHHHHHHhccCCCCEEEEEE
Confidence            3688889999999999999999999974           6999999743 3334555688999999998 6999999999


Q ss_pred             EEEeCCCeEEEEEeccCCCCHHHHHHhCC------------------CCCHHHHHHHHHHHHHHHHHHHhcCcccCCccC
Q 012887          251 VCVDENHGLCVVTKLMEGGSVNDLILKSR------------------KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNS  312 (454)
Q Consensus       251 ~~~~~~~~l~lV~E~~~~gsL~~~l~~~~------------------~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp  312 (454)
                      +|.+.+. +++|||||++|+|.+++.+..                  .+++..+..++.||+.||+|||++++|||||||
T Consensus        95 ~~~~~~~-~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp  173 (311)
T d1t46a_          95 ACTIGGP-TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAA  173 (311)
T ss_dssp             EECSSSS-CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred             EEeeCCE-EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccc
Confidence            9988776 899999999999999986432                  589999999999999999999999999999999


Q ss_pred             CcEEEccCCcEEEEccCCccccccCCCc--ccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHc-CCCCCC
Q 012887          313 QRILLDRHGNVCLGDMGIVTACKSVGEA--TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVT-GEAAYA  389 (454)
Q Consensus       313 ~NILl~~~~~vKL~DFGla~~~~~~~~~--~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~ellt-G~~Pf~  389 (454)
                      +|||++.++.+||+|||+++........  .....+|+.|+|||.+.+..    ++.++|||||||++|||+| |.+||.
T Consensus       174 ~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DIwS~G~~l~ellt~g~p~~~  249 (311)
T d1t46a_         174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCV----YTFESDVWSYGIFLWELFSLGSSPYP  249 (311)
T ss_dssp             GGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCC----CCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred             ccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCC----CCCcccccchHHHHHHHHhCCCCCCC
Confidence            9999999999999999999876543332  23346789999999998654    5567999999999999999 777787


Q ss_pred             CCCHHHHHHHHHHcCCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 012887          390 ACSPVQAAVGIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNN  447 (454)
Q Consensus       390 ~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~  447 (454)
                      ..+....+..+...+.++..|..+|+++.+||.+||+.||.+|||+.+|++.|++...
T Consensus       250 ~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~  307 (311)
T d1t46a_         250 GMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS  307 (311)
T ss_dssp             TCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCHHHHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhc
Confidence            7777777778888889999999999999999999999999999999999999987644

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=9.8e-52  Score=401.88  Aligned_cols=251  Identities=21%  Similarity=0.221  Sum_probs=217.1

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCch-------HHHHHHHHHHHHHhCC-CCceeEEEEEEEeC
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNA-------YEFELRKDLLELMTCG-HKNILQFYCVCVDE  255 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~-------~~~~~~~Ei~~l~~l~-HpnIv~~~g~~~~~  255 (454)
                      ++|++++.||+|+||+||++      +.+|||++........       ....+.+|+.++++++ |||||++++++.++
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            78999999999999999995      6899999976543221       2235788999999997 99999999999987


Q ss_pred             CCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccc
Q 012887          256 NHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACK  335 (454)
Q Consensus       256 ~~~l~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~  335 (454)
                      ++ +|+|||||++|+|.+++..++.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus        83 ~~-~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~  161 (277)
T d1phka_          83 TF-FFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD  161 (277)
T ss_dssp             SE-EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             cc-eEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEcc
Confidence            76 99999999999999999888899999999999999999999999999999999999999999999999999998765


Q ss_pred             cCCCcccccCCCCcccccccccCCC--CCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCC--CC
Q 012887          336 SVGEATEYETDGYRWLAPEIIAGDP--ESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEI--PK  411 (454)
Q Consensus       336 ~~~~~~~~~~gt~~y~APE~l~~~~--~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~--p~  411 (454)
                      ... ......||+.|+|||++.+..  ....++.++||||+||++|||++|+.||.+.++......+.........  +.
T Consensus       162 ~~~-~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  240 (277)
T d1phka_         162 PGE-KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWD  240 (277)
T ss_dssp             TTC-CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGG
T ss_pred             CCC-ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCcccc
Confidence            533 334457899999999997532  2334677899999999999999999999998888877777776554433  34


Q ss_pred             CccHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 012887          412 DCPQILKSLMIKCWNNSPSKRPQFSEIISLL  442 (454)
Q Consensus       412 ~~~~~l~~li~~cl~~dP~~RPs~~ell~~L  442 (454)
                      ++|+++.+||.+||+.||.+|||+.|+++|-
T Consensus       241 ~~s~~~~~li~~~L~~~p~~R~s~~eil~h~  271 (277)
T d1phka_         241 DYSDTVKDLVSRFLVVQPQKRYTAEEALAHP  271 (277)
T ss_dssp             GSCHHHHHHHHHHCCSSGGGSCCHHHHTTSG
T ss_pred             cCCHHHHHHHHHHccCChhHCcCHHHHHcCH
Confidence            7899999999999999999999999998873

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=6.5e-52  Score=416.06  Aligned_cols=246  Identities=15%  Similarity=0.294  Sum_probs=213.3

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  263 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~  263 (454)
                      ++|++++.||+|+||.||+|      +.||||++...  .......+.+|+.+|.+++|||||++++++.+++. +|+||
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~--~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~-~~ivm  102 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP--HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNE-MVMIY  102 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCC--SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTE-EEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEccc--chhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE-EEEEE
Confidence            58999999999999999985      68999999643  23345568899999999999999999999998876 99999


Q ss_pred             eccCCCCHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEcc--CCcEEEEccCCccccccCCCc
Q 012887          264 KLMEGGSVNDLILK-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDR--HGNVCLGDMGIVTACKSVGEA  340 (454)
Q Consensus       264 E~~~~gsL~~~l~~-~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~--~~~vKL~DFGla~~~~~~~~~  340 (454)
                      |||+||+|.+++.+ .+.+++..+..++.||+.||.|||++|||||||||+|||++.  ++.+||+|||+++...... .
T Consensus       103 E~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~-~  181 (350)
T d1koaa2         103 EFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ-S  181 (350)
T ss_dssp             CCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS-C
T ss_pred             EcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheeccccc-c
Confidence            99999999999854 458999999999999999999999999999999999999964  5789999999998765433 3


Q ss_pred             ccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCC--CCCCccHHHH
Q 012887          341 TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPE--IPKDCPQILK  418 (454)
Q Consensus       341 ~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~--~p~~~~~~l~  418 (454)
                      .....||+.|||||++.+..+    +.++|||||||++|+|++|..||.+.+..+....+.......+  .+..+|+++.
T Consensus       182 ~~~~~gT~~Y~aPEv~~~~~~----~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  257 (350)
T d1koaa2         182 VKVTTGTAEFAAPEVAEGKPV----GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGK  257 (350)
T ss_dssp             EEEECSCTTTCCHHHHHTCCB----CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHH
T ss_pred             cceecCcccccCHHHHcCCCC----ChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHH
Confidence            445678999999999987654    4569999999999999999999999888888888877655433  2356899999


Q ss_pred             HHHHHhcccCCCCCCCHHHHHHHHH
Q 012887          419 SLMIKCWNNSPSKRPQFSEIISLLL  443 (454)
Q Consensus       419 ~li~~cl~~dP~~RPs~~ell~~L~  443 (454)
                      +||.+||+.||++|||+.|+++|-+
T Consensus       258 ~li~~~L~~dP~~R~t~~eil~hp~  282 (350)
T d1koaa2         258 DFIRKLLLADPNTRMTIHQALEHPW  282 (350)
T ss_dssp             HHHHHHCCSSGGGSCCHHHHHHSTT
T ss_pred             HHHHHHccCChhHCcCHHHHhcCcc
Confidence            9999999999999999999999743

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=8.8e-52  Score=415.40  Aligned_cols=246  Identities=15%  Similarity=0.326  Sum_probs=214.1

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  263 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~  263 (454)
                      ++|++++.||+|+||.||+|      +.||+|.+...  .......+.+|+.+|++++|||||++++++.+++. +|+||
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~--~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~-~~ivm  105 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP--YPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYE-MVLIL  105 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSE-EEEEE
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCc--chhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE-EEEEE
Confidence            67999999999999999995      57999998743  22344568899999999999999999999998776 99999


Q ss_pred             eccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEc--cCCcEEEEccCCccccccCCCc
Q 012887          264 KLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLD--RHGNVCLGDMGIVTACKSVGEA  340 (454)
Q Consensus       264 E~~~~gsL~~~l~~~~-~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~--~~~~vKL~DFGla~~~~~~~~~  340 (454)
                      |||+||+|.+++.+.+ ++++..++.++.||+.||.|||++||+||||||+|||++  .++.+||+|||+|+..... ..
T Consensus       106 E~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~-~~  184 (352)
T d1koba_         106 EFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD-EI  184 (352)
T ss_dssp             ECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT-SC
T ss_pred             EcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCC-Cc
Confidence            9999999999876544 799999999999999999999999999999999999998  5789999999999876543 23


Q ss_pred             ccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCC--CCCCCccHHHH
Q 012887          341 TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP--EIPKDCPQILK  418 (454)
Q Consensus       341 ~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~--~~p~~~~~~l~  418 (454)
                      .....+|+.|+|||++.+..+    +.++|||||||++|+|++|..||.+.+.......+.......  ..+..+|+++.
T Consensus       185 ~~~~~gt~~y~aPE~~~~~~~----~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  260 (352)
T d1koba_         185 VKVTTATAEFAAPEIVDREPV----GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAK  260 (352)
T ss_dssp             EEEECSSGGGCCHHHHTTCCB----CHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHH
T ss_pred             eeeccCcccccCHHHHcCCCC----CCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHH
Confidence            445578999999999987754    556999999999999999999999998888888877765543  34567899999


Q ss_pred             HHHHHhcccCCCCCCCHHHHHHHHH
Q 012887          419 SLMIKCWNNSPSKRPQFSEIISLLL  443 (454)
Q Consensus       419 ~li~~cl~~dP~~RPs~~ell~~L~  443 (454)
                      +||.+||+.||.+|||+.|+++|-|
T Consensus       261 ~li~~~L~~dp~~R~s~~eil~Hp~  285 (352)
T d1koba_         261 DFIKNLLQKEPRKRLTVHDALEHPW  285 (352)
T ss_dssp             HHHHTTSCSSGGGSCCHHHHHTSTT
T ss_pred             HHHHHHccCChhHCcCHHHHhcCHh
Confidence            9999999999999999999998743

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=8.9e-52  Score=409.55  Aligned_cols=243  Identities=21%  Similarity=0.325  Sum_probs=214.3

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCC-CchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDK-GNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  262 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV  262 (454)
                      ++|++++.||+|+||.||++      +.||+|+++.... .......+.+|+.++..++|||||++++++.+++. +|+|
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~-~~iv   82 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQ-IFMI   82 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSE-EEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCe-eeeE
Confidence            68999999999999999985      5799999864221 11234567899999999999999999999998776 9999


Q ss_pred             EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCccc
Q 012887          263 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE  342 (454)
Q Consensus       263 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~  342 (454)
                      ||||+||+|..++.....+++..+..++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.....   ..
T Consensus        83 mE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~---~~  159 (316)
T d1fota_          83 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV---TY  159 (316)
T ss_dssp             ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC---BC
T ss_pred             eeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc---cc
Confidence            999999999999988889999999999999999999999999999999999999999999999999999876532   34


Q ss_pred             ccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHHHHHH
Q 012887          343 YETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMI  422 (454)
Q Consensus       343 ~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~li~  422 (454)
                      ...||+.|||||++.+..++    .++|||||||++|||++|+.||.+.+..+....+....  ..+|..+|+++.+++.
T Consensus       160 ~~~Gt~~Y~APE~l~~~~y~----~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~~~li~  233 (316)
T d1fota_         160 TLCGTPDYIAPEVVSTKPYN----KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE--LRFPPFFNEDVKDLLS  233 (316)
T ss_dssp             CCCSCTTTCCHHHHTTCCBC----TTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCC--CCCCTTSCHHHHHHHH
T ss_pred             cccCcccccCHHHHcCCCCC----chhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCC--CCCCCCCCHHHHHHHH
Confidence            56799999999999887654    45999999999999999999999998888887777653  4578889999999999


Q ss_pred             HhcccCCCCCC-----CHHHHHHHH
Q 012887          423 KCWNNSPSKRP-----QFSEIISLL  442 (454)
Q Consensus       423 ~cl~~dP~~RP-----s~~ell~~L  442 (454)
                      +||+.||.+|+     |++++++|-
T Consensus       234 ~~L~~dp~~R~~~~r~t~~~il~Hp  258 (316)
T d1fota_         234 RLITRDLSQRLGNLQNGTEDVKNHP  258 (316)
T ss_dssp             HHTCSCTTTCTTSSTTTTHHHHTSG
T ss_pred             HHhhhCHHhccccchhhHHHHHcCc
Confidence            99999999996     899999874

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9e-52  Score=410.19  Aligned_cols=245  Identities=22%  Similarity=0.347  Sum_probs=212.3

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCC-CchHHHHHHHHHHHHH-hCCCCceeEEEEEEEeCCCeEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDK-GNAYEFELRKDLLELM-TCGHKNILQFYCVCVDENHGLCV  261 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~-~~~~~~~~~~Ei~~l~-~l~HpnIv~~~g~~~~~~~~l~l  261 (454)
                      ++|++++.||+|+||+||+|      +.||||+++.... .......+..|..++. .++|||||++++++.+.+. +|+
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~-~yi   80 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN-LFF   80 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE-EEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCc-eeE
Confidence            68999999999999999995      6799999964211 1112233455666555 6899999999999998876 999


Q ss_pred             EEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCcc
Q 012887          262 VTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT  341 (454)
Q Consensus       262 V~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~  341 (454)
                      |||||++|+|.+++.....+++..+..++.||+.||+|||++||+||||||+|||++.++++||+|||+++.........
T Consensus        81 vmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~~~  160 (320)
T d1xjda_          81 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT  160 (320)
T ss_dssp             EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCB
T ss_pred             EEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccccccc
Confidence            99999999999999888899999999999999999999999999999999999999999999999999998766655556


Q ss_pred             cccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHHHHH
Q 012887          342 EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLM  421 (454)
Q Consensus       342 ~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~li  421 (454)
                      ....||+.|+|||++.+..+    +.++|||||||++|||++|+.||.+.++.+....+...  .+.+|..+|+++.+||
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~----~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~--~~~~p~~~s~~~~dli  234 (320)
T d1xjda_         161 NTFCGTPDYIAPEILLGQKY----NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD--NPFYPRWLEKEAKDLL  234 (320)
T ss_dssp             CCCCSCGGGCCHHHHTTCCB----CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTTSCHHHHHHH
T ss_pred             cccCCCCCcCCHHHHcCCCC----CchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CCCCCccCCHHHHHHH
Confidence            66789999999999987754    45699999999999999999999998888877777654  4568889999999999


Q ss_pred             HHhcccCCCCCCCHH-HHHHH
Q 012887          422 IKCWNNSPSKRPQFS-EIISL  441 (454)
Q Consensus       422 ~~cl~~dP~~RPs~~-ell~~  441 (454)
                      .+||+.||.+||++. ++++|
T Consensus       235 ~~~L~~dP~~R~s~~~~l~~h  255 (320)
T d1xjda_         235 VKLFVREPEKRLGVRGDIRQH  255 (320)
T ss_dssp             HHHSCSSGGGSBTTBSCGGGS
T ss_pred             HHhcccCCCCCcCHHHHHHhC
Confidence            999999999999995 77654

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-51  Score=407.47  Aligned_cols=254  Identities=25%  Similarity=0.441  Sum_probs=212.7

Q ss_pred             ecCCCEEEeceeeccCCceEEEeE--------EEEEEEeecCCCCchHHHHHHHHHHHHHhC-CCCceeEEEEEEEeCCC
Q 012887          187 LNSDNLEFIDQIGPNSFKGVYKGK--------RVGIEKLKGCDKGNAYEFELRKDLLELMTC-GHKNILQFYCVCVDENH  257 (454)
Q Consensus       187 ~~~~~~~~~~~LG~G~fG~Vy~g~--------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~~~g~~~~~~~  257 (454)
                      ++.++|++.+.||+|+||.||+|.        .||||+++.... ......+.+|+.+|.++ +|||||+++|+|.+++.
T Consensus         7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~   85 (309)
T d1fvra_           7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS-KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY   85 (309)
T ss_dssp             CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTE
T ss_pred             cCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccC-hHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCe
Confidence            456899999999999999999974        478888864322 22345688999999998 79999999999998876


Q ss_pred             eEEEEEeccCCCCHHHHHHhC----------------CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCC
Q 012887          258 GLCVVTKLMEGGSVNDLILKS----------------RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG  321 (454)
Q Consensus       258 ~l~lV~E~~~~gsL~~~l~~~----------------~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~  321 (454)
                       +++||||+++|+|.+++.+.                ..+++..+..++.||+.||.|||+++|+||||||+|||++.++
T Consensus        86 -~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~  164 (309)
T d1fvra_          86 -LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY  164 (309)
T ss_dssp             -EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred             -eEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCC
Confidence             99999999999999998643                4799999999999999999999999999999999999999999


Q ss_pred             cEEEEccCCccccccCCCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcC-CCCCCCCCHHHHHHHH
Q 012887          322 NVCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTG-EAAYAACSPVQAAVGI  400 (454)
Q Consensus       322 ~vKL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG-~~Pf~~~~~~~~~~~i  400 (454)
                      .+||+|||+++...... ......+|+.|+|||.+.+..    ++.++|||||||++|||++| .+||.+.+..+.... 
T Consensus       165 ~~kl~DfG~a~~~~~~~-~~~~~~gt~~y~aPE~l~~~~----~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~-  238 (309)
T d1fvra_         165 VAKIADFGLSRGQEVYV-KKTMGRLPVRWMAIESLNYSV----YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK-  238 (309)
T ss_dssp             CEEECCTTCEESSCEEC-CC----CCTTTCCHHHHHHCE----ECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH-
T ss_pred             ceEEccccccccccccc-cccceecCCcccchHHhccCC----CCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHH-
Confidence            99999999987654332 233446889999999998765    45569999999999999996 467877776665544 


Q ss_pred             HHcCCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCC
Q 012887          401 AACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNI  448 (454)
Q Consensus       401 ~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~  448 (454)
                      +..+.+++.|..+|+++.+||.+||+.||++|||++||+++|+++.+.
T Consensus       239 i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~  286 (309)
T d1fvra_         239 LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE  286 (309)
T ss_dssp             GGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             HHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence            445778889999999999999999999999999999999999887654

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=4.1e-51  Score=396.87  Aligned_cols=254  Identities=22%  Similarity=0.361  Sum_probs=213.4

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCc-hHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCC---eE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGN-AYEFELRKDLLELMTCGHKNILQFYCVCVDENH---GL  259 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~---~l  259 (454)
                      ++|++.+.||+|+||.||+|      +.||+|.++...... .....+.+|+.+++.++|||||++++++.+.+.   .+
T Consensus         7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~   86 (277)
T d1o6ya_           7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP   86 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence            77999999999999999995      689999997554433 345568999999999999999999999987542   37


Q ss_pred             EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCC
Q 012887          260 CVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE  339 (454)
Q Consensus       260 ~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~  339 (454)
                      |+||||++|++|.+++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++........
T Consensus        87 ~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~  166 (277)
T d1o6ya_          87 YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGN  166 (277)
T ss_dssp             EEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC----
T ss_pred             EEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhccccc
Confidence            89999999999999998888999999999999999999999999999999999999999999999999999765433221


Q ss_pred             ---cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCC--CCCCcc
Q 012887          340 ---ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPE--IPKDCP  414 (454)
Q Consensus       340 ---~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~--~p~~~~  414 (454)
                         ......||+.|+|||++.+..    ++.++|||||||++|||+||..||.+.++.+....+......++  .+..+|
T Consensus       167 ~~~~~~~~~Gt~~Y~aPE~~~~~~----~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s  242 (277)
T d1o6ya_         167 SVTQTAAVIGTAQYLSPEQARGDS----VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLS  242 (277)
T ss_dssp             ------------TTCCHHHHTTCC----CCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCC
T ss_pred             cccccccccCcccccCHHHHcCCC----CCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCC
Confidence               233446899999999998764    45569999999999999999999999998888877777655442  356789


Q ss_pred             HHHHHHHHHhcccCCCCCC-CHHHHHHHHHhhcC
Q 012887          415 QILKSLMIKCWNNSPSKRP-QFSEIISLLLRTNN  447 (454)
Q Consensus       415 ~~l~~li~~cl~~dP~~RP-s~~ell~~L~~~~~  447 (454)
                      +++.++|.+||+.||.+|| |++++++.|.++.+
T Consensus       243 ~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~n  276 (277)
T d1o6ya_         243 ADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN  276 (277)
T ss_dssp             HHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHC
T ss_pred             HHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHhC
Confidence            9999999999999999999 89999999998764

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-51  Score=402.81  Aligned_cols=254  Identities=24%  Similarity=0.388  Sum_probs=211.7

Q ss_pred             EEeceeeccCCceEEEeE---------EEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEE
Q 012887          193 EFIDQIGPNSFKGVYKGK---------RVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  263 (454)
Q Consensus       193 ~~~~~LG~G~fG~Vy~g~---------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~  263 (454)
                      .+.+.||+|+||+||+|.         .||||+++. ........++.+|+.+|.+++|||||+++|++.+.+..+++||
T Consensus        30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~-~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~  108 (311)
T d1r0pa_          30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR-ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL  108 (311)
T ss_dssp             EEEEEEEEETTEEEEEEEECC----CEEEEEEEECC-CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEE
T ss_pred             ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECc-ccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEE
Confidence            346789999999999975         489999864 2344455679999999999999999999999987765699999


Q ss_pred             eccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCc--
Q 012887          264 KLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEA--  340 (454)
Q Consensus       264 E~~~~gsL~~~l~~~~-~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~--  340 (454)
                      |||++|+|.+++.... .+++..++.++.|++.||.|||+.+|+||||||+|||+++++.+||+|||+++........  
T Consensus       109 E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~  188 (311)
T d1r0pa_         109 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV  188 (311)
T ss_dssp             ECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred             EEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccccc
Confidence            9999999999986544 7889999999999999999999999999999999999999999999999998866543221  


Q ss_pred             --ccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHH
Q 012887          341 --TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILK  418 (454)
Q Consensus       341 --~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~  418 (454)
                        .....||+.|+|||.+.+..    ++.++||||||+++|||++|..||...............+.++..|..+++++.
T Consensus       189 ~~~~~~~gt~~y~aPE~~~~~~----~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l~  264 (311)
T d1r0pa_         189 HNKTGAKLPVKWMALESLQTQK----FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLY  264 (311)
T ss_dssp             TCTTCSSCCGGGSCHHHHHHCC----CCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCCHHHH
T ss_pred             eecccccccccccChHHHhcCC----CCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcHHHH
Confidence              22346789999999998664    566799999999999999977777665444444445556778889999999999


Q ss_pred             HHHHHhcccCCCCCCCHHHHHHHHHhhcCCCCC
Q 012887          419 SLMIKCWNNSPSKRPQFSEIISLLLRTNNISNS  451 (454)
Q Consensus       419 ~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~~  451 (454)
                      +||.+||+.||++||++.||+++|+++.+.+..
T Consensus       265 ~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~  297 (311)
T d1r0pa_         265 EVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG  297 (311)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred             HHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhh
Confidence            999999999999999999999999998776443

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4e-51  Score=410.35  Aligned_cols=244  Identities=20%  Similarity=0.258  Sum_probs=213.7

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCC-CchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDK-GNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVV  262 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~-~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV  262 (454)
                      ++|++++.||+|+||.||++      +.||+|.+..... .......+.+|+.+|+.++|||||++++++.+.+. +++|
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~-~~~v  119 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSN-LYMV  119 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE-EEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccc-cccc
Confidence            68999999999999999995      5799999863221 11223457899999999999999999999998876 9999


Q ss_pred             EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCccc
Q 012887          263 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATE  342 (454)
Q Consensus       263 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~  342 (454)
                      |||+.+|+|.+++.+.+.+++..+..++.||+.||.|||++|||||||||+|||++.+|++||+|||+|+.....   ..
T Consensus       120 ~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~---~~  196 (350)
T d1rdqe_         120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR---TW  196 (350)
T ss_dssp             EECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC---BC
T ss_pred             cccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc---cc
Confidence            999999999999988889999999999999999999999999999999999999999999999999999876532   34


Q ss_pred             ccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccHHHHHHHH
Q 012887          343 YETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQILKSLMI  422 (454)
Q Consensus       343 ~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~l~~li~  422 (454)
                      ...||+.|||||++.+..+    +.++|||||||++|||++|..||.+.+.......+...  .+..|..+|+++.++|+
T Consensus       197 ~~~Gt~~Y~APE~~~~~~~----~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~  270 (350)
T d1rdqe_         197 TLCGTPEALAPEIILSKGY----NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG--KVRFPSHFSSDLKDLLR  270 (350)
T ss_dssp             CCEECGGGCCHHHHTTCCB----CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CCCCCTTCCHHHHHHHH
T ss_pred             cccCccccCCHHHHcCCCC----CccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcC--CCCCCccCCHHHHHHHH
Confidence            4578999999999987754    45699999999999999999999998888877777765  34567889999999999


Q ss_pred             HhcccCCCCCC-----CHHHHHHHHH
Q 012887          423 KCWNNSPSKRP-----QFSEIISLLL  443 (454)
Q Consensus       423 ~cl~~dP~~RP-----s~~ell~~L~  443 (454)
                      +||+.||.+|+     |+.++++|-+
T Consensus       271 ~~L~~dP~kR~~~~r~t~~ell~Hp~  296 (350)
T d1rdqe_         271 NLLQVDLTKRFGNLKNGVNDIKNHKW  296 (350)
T ss_dssp             HHSCSCTTTCTTSSTTTTHHHHTSGG
T ss_pred             HHhhhCHHhccccccccHHHHHcCcc
Confidence            99999999994     8999998644

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=8.6e-51  Score=409.98  Aligned_cols=250  Identities=18%  Similarity=0.293  Sum_probs=205.1

Q ss_pred             cCCCEEEeceeeccCCceEEEe------EEEEEEEeecCCC----CchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCC
Q 012887          188 NSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDK----GNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH  257 (454)
Q Consensus       188 ~~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~----~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~  257 (454)
                      .-++|++++.||+|+||.||+|      +.||+|.+.....    ..........++.++..++|||||++++++.+++.
T Consensus         2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~   81 (364)
T d1omwa3           2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK   81 (364)
T ss_dssp             CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred             CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCE
Confidence            3478999999999999999985      5799999863211    11111122344566677789999999999998876


Q ss_pred             eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccC
Q 012887          258 GLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSV  337 (454)
Q Consensus       258 ~l~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~  337 (454)
                       +|+|||||+||+|.+++.+...+++..+..++.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+.....
T Consensus        82 -~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~  160 (364)
T d1omwa3          82 -LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK  160 (364)
T ss_dssp             -EEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSS
T ss_pred             -EEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCC
Confidence             9999999999999999988889999999999999999999999999999999999999999999999999999866543


Q ss_pred             CCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHH-HHHHcCCCCCCCCCccHH
Q 012887          338 GEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAV-GIAACGLRPEIPKDCPQI  416 (454)
Q Consensus       338 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~-~i~~~~~~~~~p~~~~~~  416 (454)
                        ......||+.|+|||++.++.   .++.++|||||||++|||++|..||.+.+...... .......+..+|..+|++
T Consensus       161 --~~~~~~GT~~y~APE~~~~~~---~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  235 (364)
T d1omwa3         161 --KPHASVGTHGYMAPEVLQKGV---AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPE  235 (364)
T ss_dssp             --CCCSCCSCGGGCCHHHHSTTC---CCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHH
T ss_pred             --cccccccccccchhHHhhcCC---CCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHH
Confidence              244557999999999997542   35567999999999999999999998754432221 122234456678899999


Q ss_pred             HHHHHHHhcccCCCCCCC-----HHHHHHHHH
Q 012887          417 LKSLMIKCWNNSPSKRPQ-----FSEIISLLL  443 (454)
Q Consensus       417 l~~li~~cl~~dP~~RPs-----~~ell~~L~  443 (454)
                      +.+||.+||+.||.+|||     ++|+++|-+
T Consensus       236 ~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~  267 (364)
T d1omwa3         236 LRSLLEGLLQRDVNRRLGCLGRGAQEVKESPF  267 (364)
T ss_dssp             HHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGG
T ss_pred             HHHHHHHHcccCHHHhCCCcccCHHHHHcCcc
Confidence            999999999999999999     799988744

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-50  Score=399.90  Aligned_cols=258  Identities=25%  Similarity=0.435  Sum_probs=221.1

Q ss_pred             cceeecCCCEEEeceeeccCCceEEEe-----------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEE
Q 012887          183 GRWLLNSDNLEFIDQIGPNSFKGVYKG-----------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCV  251 (454)
Q Consensus       183 ~~~~~~~~~~~~~~~LG~G~fG~Vy~g-----------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~  251 (454)
                      ++|.|+.++|++++.||+|+||.||+|           +.||||+++.. ........+.+|+.++++++|||||+++|+
T Consensus        13 ~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~-~~~~~~~~~~~E~~il~~l~h~nIv~~~~~   91 (308)
T d1p4oa_          13 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-ASMRERIEFLNEASVMKEFNCHHVVRLLGV   91 (308)
T ss_dssp             CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT-SCHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred             cceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcc-cChHHHHHHHHHHHHHHHcCCCCEeeeeeE
Confidence            568899999999999999999999986           36899998743 333445568899999999999999999999


Q ss_pred             EEeCCCeEEEEEeccCCCCHHHHHHhC----------CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCC
Q 012887          252 CVDENHGLCVVTKLMEGGSVNDLILKS----------RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG  321 (454)
Q Consensus       252 ~~~~~~~l~lV~E~~~~gsL~~~l~~~----------~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~  321 (454)
                      |..++. .++||||+++|+|.+++...          ..+++..+..++.||+.||.|||+++|+||||||+|||++.++
T Consensus        92 ~~~~~~-~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~  170 (308)
T d1p4oa_          92 VSQGQP-TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF  170 (308)
T ss_dssp             ECSSSS-CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTC
T ss_pred             EecCCc-eeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCc
Confidence            987776 89999999999999998431          2478899999999999999999999999999999999999999


Q ss_pred             cEEEEccCCccccccCCCc--ccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcC-CCCCCCCCHHHHHH
Q 012887          322 NVCLGDMGIVTACKSVGEA--TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTG-EAAYAACSPVQAAV  398 (454)
Q Consensus       322 ~vKL~DFGla~~~~~~~~~--~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG-~~Pf~~~~~~~~~~  398 (454)
                      ++||+|||+++........  .....+|+.|+|||.+.+..    ++.++|||||||++|||+|| ..||.+.+..+...
T Consensus       171 ~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~----~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~  246 (308)
T d1p4oa_         171 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV----FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR  246 (308)
T ss_dssp             CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCC----CCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHH
T ss_pred             eEEEeecccceeccCCcceeeccceecccccCCHHHHccCC----CCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            9999999999866543332  23335789999999998765    44569999999999999997 58888877777665


Q ss_pred             HHHHcCCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 012887          399 GIAACGLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNN  447 (454)
Q Consensus       399 ~i~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~  447 (454)
                      .+. .+.+++.|..+|+.+.++|.+||+.||++|||+.+|+++|++..+
T Consensus       247 ~i~-~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~  294 (308)
T d1p4oa_         247 FVM-EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  294 (308)
T ss_dssp             HHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             HHH-hCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            544 566788899999999999999999999999999999999987644

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-50  Score=401.69  Aligned_cols=246  Identities=17%  Similarity=0.226  Sum_probs=212.5

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  263 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~  263 (454)
                      ++|++++.||+|+||.||+|      +.||+|.++..   ......+.+|+.+|..++|||||++++++.++++ +|+||
T Consensus         5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~---~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~-~~lvm   80 (321)
T d1tkia_           5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESFESMEE-LVMIF   80 (321)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTE-EEEEE
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCC---cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE-EEEEE
Confidence            78999999999999999995      57999999742   3344567899999999999999999999998876 99999


Q ss_pred             eccCCCCHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccC--CcEEEEccCCccccccCCCc
Q 012887          264 KLMEGGSVNDLILKSR-KLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRH--GNVCLGDMGIVTACKSVGEA  340 (454)
Q Consensus       264 E~~~~gsL~~~l~~~~-~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~--~~vKL~DFGla~~~~~~~~~  340 (454)
                      |||+||+|.+++.+.+ .+++..+..++.||+.||+|||++||+||||||+|||++.+  +.+||+|||++...... ..
T Consensus        81 E~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~-~~  159 (321)
T d1tkia_          81 EFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-DN  159 (321)
T ss_dssp             CCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT-CE
T ss_pred             ecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccC-Cc
Confidence            9999999999997655 79999999999999999999999999999999999999854  47999999998765433 23


Q ss_pred             ccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCC--CCCCccHHHH
Q 012887          341 TEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPE--IPKDCPQILK  418 (454)
Q Consensus       341 ~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~--~p~~~~~~l~  418 (454)
                      .....+|+.|+|||.+.+..+    +.++|||||||++|+|++|..||.+.+.......+.......+  .+..+|+++.
T Consensus       160 ~~~~~~t~~y~ape~~~~~~~----~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  235 (321)
T d1tkia_         160 FRLLFTAPEYYAPEVHQHDVV----STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAM  235 (321)
T ss_dssp             EEEEESCGGGSCHHHHTTCEE----CHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHH
T ss_pred             ccccccccccccchhccCCCC----CchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHH
Confidence            444568899999999987654    4569999999999999999999999998888888877654432  2246899999


Q ss_pred             HHHHHhcccCCCCCCCHHHHHHHHHh
Q 012887          419 SLMIKCWNNSPSKRPQFSEIISLLLR  444 (454)
Q Consensus       419 ~li~~cl~~dP~~RPs~~ell~~L~~  444 (454)
                      +||.+||+.||.+|||+.|+++|-|-
T Consensus       236 ~li~~~L~~dp~~R~s~~eil~hp~~  261 (321)
T d1tkia_         236 DFVDRLLVKERKSRMTASEALQHPWL  261 (321)
T ss_dssp             HHHHTTSCSSGGGSCCHHHHHHSHHH
T ss_pred             HHHHHHccCChhHCcCHHHHhcCHhh
Confidence            99999999999999999999997543

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-50  Score=397.16  Aligned_cols=246  Identities=20%  Similarity=0.248  Sum_probs=202.8

Q ss_pred             EeceeeccCCceEEEe------EEEEEEEeecCCCCch---HHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEEe
Q 012887          194 FIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNA---YEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTK  264 (454)
Q Consensus       194 ~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~---~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~E  264 (454)
                      .++.||+|+||+||+|      +.||||+++.......   ....+.+|+.+|..++|||||++++++.++++ +|+|||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~-~~ivmE   80 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN-ISLVFD   80 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC-CEEEEE
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCc-eeehhh
Confidence            4688999999999985      5799999864432222   22457899999999999999999999998887 999999


Q ss_pred             ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCccccc
Q 012887          265 LMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE  344 (454)
Q Consensus       265 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~  344 (454)
                      |+.++++..+......+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++............
T Consensus        81 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~~  160 (299)
T d1ua2a_          81 FMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQ  160 (299)
T ss_dssp             CCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCS
T ss_pred             hhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCcccccce
Confidence            99998877776666789999999999999999999999999999999999999999999999999998776655555556


Q ss_pred             CCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCC-----------------
Q 012887          345 TDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP-----------------  407 (454)
Q Consensus       345 ~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~-----------------  407 (454)
                      .+|+.|+|||++.+..   .++.++|||||||++|||++|.+||.+.+..+.+..+...-..+                 
T Consensus       161 ~gt~~y~aPE~~~~~~---~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~  237 (299)
T d1ua2a_         161 VVTRWYRAPELLFGAR---MYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF  237 (299)
T ss_dssp             CCCCTTCCHHHHTTCS---CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCC
T ss_pred             ecChhhccHHHHccCC---CCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhh
Confidence            7899999999987543   35667999999999999999999999988887766654321000                 


Q ss_pred             ----C-----CCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 012887          408 ----E-----IPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLL  443 (454)
Q Consensus       408 ----~-----~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~  443 (454)
                          .     .....++++.+||.+||+.||++|||++|+++|-+
T Consensus       238 ~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~  282 (299)
T d1ua2a_         238 KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKY  282 (299)
T ss_dssp             CCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGG
T ss_pred             ccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHh
Confidence                0     01246789999999999999999999999998744

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-50  Score=394.19  Aligned_cols=247  Identities=21%  Similarity=0.298  Sum_probs=204.8

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  263 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~  263 (454)
                      ++|++++.||+|+||.||+|      +.||+|+++...........+.+|+.+|++++|||||++++++.+.++ +|+||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~-~~iv~   80 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK-LYLVF   80 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTE-EEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccc-eeEEE
Confidence            78999999999999999996      579999997543333344678899999999999999999999998876 99999


Q ss_pred             eccCCCCHHHHHH-h-CCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCcc
Q 012887          264 KLMEGGSVNDLIL-K-SRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEAT  341 (454)
Q Consensus       264 E~~~~gsL~~~l~-~-~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~  341 (454)
                      ||+.+ ++.+++. . ...+++..+..++.||+.||+|||++|||||||||+|||++.++++||+|||+++.........
T Consensus        81 e~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~~  159 (298)
T d1gz8a_          81 EFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY  159 (298)
T ss_dssp             ECCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBCT
T ss_pred             eecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCcccc
Confidence            99976 5554543 3 4579999999999999999999999999999999999999999999999999998876665666


Q ss_pred             cccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCC---------------
Q 012887          342 EYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR---------------  406 (454)
Q Consensus       342 ~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~---------------  406 (454)
                      ....||+.|+|||.+....+   .+.++|||||||++|+|++|+.||.+.+.......+......               
T Consensus       160 ~~~~gt~~y~apE~~~~~~~---~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  236 (298)
T d1gz8a_         160 THEVVTLWYRAPEILLGCKY---YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY  236 (298)
T ss_dssp             TCCBCCCTTCCHHHHTTCSS---CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred             eeecccceeeehhhhccccC---CCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccc
Confidence            66789999999999876543   456799999999999999999999988877766554331111               


Q ss_pred             -CCC-----------CCCccHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 012887          407 -PEI-----------PKDCPQILKSLMIKCWNNSPSKRPQFSEIISL  441 (454)
Q Consensus       407 -~~~-----------p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~  441 (454)
                       ..+           ...+++++.+||.+||..||.+|||+.|+++|
T Consensus       237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H  283 (298)
T d1gz8a_         237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH  283 (298)
T ss_dssp             CTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence             011           12467899999999999999999999999998

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=5.5e-50  Score=390.34  Aligned_cols=249  Identities=19%  Similarity=0.273  Sum_probs=206.7

Q ss_pred             CCEEEeceeeccCCceEEEe-----EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEEe
Q 012887          190 DNLEFIDQIGPNSFKGVYKG-----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVTK  264 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g-----~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~E  264 (454)
                      ++|++++.||+|+||+||+|     +.||||+++...........+.+|+.+|++++|||||++++++.+++. .+++||
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~-~~i~~e   80 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKR-LVLVFE   80 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSC-EEEEEE
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCc-eeEEEE
Confidence            68999999999999999996     469999997654444445678899999999999999999999998887 999999


Q ss_pred             ccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCccccc
Q 012887          265 LMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEYE  344 (454)
Q Consensus       265 ~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~~  344 (454)
                      ++.++.+..+....+.+++..+..++.||+.||+|||++|||||||||+|||++.++.+||+|||++.............
T Consensus        81 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~  160 (286)
T d1ob3a_          81 HLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHE  160 (286)
T ss_dssp             CCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--------
T ss_pred             eehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCcccccee
Confidence            99887777776667799999999999999999999999999999999999999999999999999998776655555566


Q ss_pred             CCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCC------------------
Q 012887          345 TDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR------------------  406 (454)
Q Consensus       345 ~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~------------------  406 (454)
                      .+++.|+|||.+.+..   .++.++|||||||++|||++|+.||.+.+..+....+......                  
T Consensus       161 ~~~~~y~~pE~~~~~~---~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  237 (286)
T d1ob3a_         161 IVTLWYRAPDVLMGSK---KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN  237 (286)
T ss_dssp             -CCCTTCCHHHHTTCC---SCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred             cccchhhhHHHHhCCC---CCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccc
Confidence            7889999999997653   2456799999999999999999999988877666554321100                  


Q ss_pred             ---------CCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 012887          407 ---------PEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL  442 (454)
Q Consensus       407 ---------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L  442 (454)
                               ...+..+++++.+||++||+.||++|||++|+++|-
T Consensus       238 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp  282 (286)
T d1ob3a_         238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHA  282 (286)
T ss_dssp             CCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSG
T ss_pred             cccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCc
Confidence                     012346789999999999999999999999999763

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-49  Score=386.50  Aligned_cols=250  Identities=20%  Similarity=0.305  Sum_probs=200.5

Q ss_pred             CCCEEEeceeeccCCceEEEe-------EEEEEEEeecCCCCchHHHHHHHHHHHHHh---CCCCceeEEEEEEEeC---
Q 012887          189 SDNLEFIDQIGPNSFKGVYKG-------KRVGIEKLKGCDKGNAYEFELRKDLLELMT---CGHKNILQFYCVCVDE---  255 (454)
Q Consensus       189 ~~~~~~~~~LG~G~fG~Vy~g-------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~---l~HpnIv~~~g~~~~~---  255 (454)
                      .++|++++.||+|+||.||+|       +.||||+++...........+.+|+.+++.   .+||||++++++|...   
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            378999999999999999996       468999986543322222234466665554   5899999999998642   


Q ss_pred             -CCeEEEEEeccCCCCHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccc
Q 012887          256 -NHGLCVVTKLMEGGSVNDLIL-KSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTA  333 (454)
Q Consensus       256 -~~~l~lV~E~~~~gsL~~~l~-~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~  333 (454)
                       +..++++|||++++++..... ....+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+++.
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~  165 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI  165 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCC
T ss_pred             cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhh
Confidence             234899999999877765543 345799999999999999999999999999999999999999999999999999876


Q ss_pred             cccCCCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCC-------
Q 012887          334 CKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR-------  406 (454)
Q Consensus       334 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~-------  406 (454)
                      .... .......||+.|+|||++.+..    ++.++||||+||++|||++|.+||.+.++......+......       
T Consensus       166 ~~~~-~~~~~~~gT~~Y~APE~~~~~~----y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  240 (305)
T d1blxa_         166 YSFQ-MALTSVVVTLWYRAPEVLLQSS----YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP  240 (305)
T ss_dssp             CCGG-GGGCCCCCCCTTCCHHHHTTCC----CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSC
T ss_pred             hccc-ccCCCcccChhhcCcchhcCCC----CChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhccc
Confidence            5433 2345567899999999998765    455799999999999999999999998887766655431000       


Q ss_pred             ------------------CCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 012887          407 ------------------PEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLL  443 (454)
Q Consensus       407 ------------------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~  443 (454)
                                        ..++..+++++.+||.+||+.||.+|||+.|+++|-+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpf  295 (305)
T d1blxa_         241 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY  295 (305)
T ss_dssp             TTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred             ccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChh
Confidence                              1134567899999999999999999999999998743

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-49  Score=393.52  Aligned_cols=243  Identities=16%  Similarity=0.288  Sum_probs=195.9

Q ss_pred             CCEEEec-eeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHh-CCCCceeEEEEEEEeC---CCe
Q 012887          190 DNLEFID-QIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMT-CGHKNILQFYCVCVDE---NHG  258 (454)
Q Consensus       190 ~~~~~~~-~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~-l~HpnIv~~~g~~~~~---~~~  258 (454)
                      ++|++++ .||+|+||.||+|      +.||||+++..       ..+.+|+.++.+ .+|||||+++++|.+.   +..
T Consensus        11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~   83 (335)
T d2ozaa1          11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC   83 (335)
T ss_dssp             GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred             cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCE
Confidence            6789876 5999999999996      57999998632       346688888665 5899999999998752   344


Q ss_pred             EEEEEeccCCCCHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEcc---CCcEEEEccCCccc
Q 012887          259 LCVVTKLMEGGSVNDLILKS--RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDR---HGNVCLGDMGIVTA  333 (454)
Q Consensus       259 l~lV~E~~~~gsL~~~l~~~--~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~---~~~vKL~DFGla~~  333 (454)
                      +|+|||||+||+|.+++.+.  ..+++..+..++.||+.||+|||++||+||||||+|||++.   .+.+||+|||+++.
T Consensus        84 ~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~  163 (335)
T d2ozaa1          84 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE  163 (335)
T ss_dssp             EEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred             EEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeee
Confidence            89999999999999999764  37999999999999999999999999999999999999985   45799999999987


Q ss_pred             cccCCCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcC--CCCCCCC
Q 012887          334 CKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG--LRPEIPK  411 (454)
Q Consensus       334 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~--~~~~~p~  411 (454)
                      ..... ......||+.|+|||++.+..+    +.++|||||||++|+|++|..||.+.+.......+...-  ....+|.
T Consensus       164 ~~~~~-~~~~~~gt~~y~aPE~~~~~~y----~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~  238 (335)
T d2ozaa1         164 TTSHN-SLTTPCYTPYYVAPEVLGPEKY----DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN  238 (335)
T ss_dssp             CCCCC-CCCCCSCCCSSCCCCCCCGGGG----SHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCT
T ss_pred             ccCCC-ccccccCCcccCCcHHHcCCCC----CHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCC
Confidence            65433 3455679999999999987654    456999999999999999999998765544333332211  1122332


Q ss_pred             ----CccHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 012887          412 ----DCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR  444 (454)
Q Consensus       412 ----~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~  444 (454)
                          .+|+++.+||.+||+.||++|||+.|+++|-|-
T Consensus       239 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~  275 (335)
T d2ozaa1         239 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI  275 (335)
T ss_dssp             THHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHH
T ss_pred             cccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHh
Confidence                478999999999999999999999999998543

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-49  Score=386.43  Aligned_cols=240  Identities=19%  Similarity=0.262  Sum_probs=200.3

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCch----HHHHHHHHHHHHHhCC--CCceeEEEEEEEeCCC
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNA----YEFELRKDLLELMTCG--HKNILQFYCVCVDENH  257 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~----~~~~~~~Ei~~l~~l~--HpnIv~~~g~~~~~~~  257 (454)
                      ++|++.+.||+|+||.||+|      +.||||++........    ...++.+|+.+|+.++  |||||++++++.+.+.
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~   83 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS   83 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence            67999999999999999985      5799999874322211    1123568888988875  8999999999998876


Q ss_pred             eEEEEEeccCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEcc-CCcEEEEccCCccccc
Q 012887          258 GLCVVTKLMEG-GSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDR-HGNVCLGDMGIVTACK  335 (454)
Q Consensus       258 ~l~lV~E~~~~-gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~-~~~vKL~DFGla~~~~  335 (454)
                       +++||||+.+ +++.+++.+...+++..+..++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++...
T Consensus        84 -~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~  162 (273)
T d1xwsa_          84 -FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK  162 (273)
T ss_dssp             -EEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             -EEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceecc
Confidence             9999999975 688888888889999999999999999999999999999999999999985 4799999999987654


Q ss_pred             cCCCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCCCCCCCccH
Q 012887          336 SVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRPEIPKDCPQ  415 (454)
Q Consensus       336 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~  415 (454)
                      ..  ......||+.|+|||++.+..+   ++.++|||||||++|||++|+.||.+.+      .+...  ...++..+|+
T Consensus       163 ~~--~~~~~~GT~~y~aPE~~~~~~~---~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~--~~~~~~~~s~  229 (273)
T d1xwsa_         163 DT--VYTDFDGTRVYSPPEWIRYHRY---HGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRG--QVFFRQRVSS  229 (273)
T ss_dssp             SS--CBCCCCSCGGGSCHHHHHHSCB---CHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHC--CCCCSSCCCH
T ss_pred             cc--cccccccCCCcCCHHHHcCCCC---CCcccccccceeeehhHhhCCCCCCCch------HHhhc--ccCCCCCCCH
Confidence            32  2344578999999999986643   3456899999999999999999998632      23332  3457788999


Q ss_pred             HHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 012887          416 ILKSLMIKCWNNSPSKRPQFSEIISLLL  443 (454)
Q Consensus       416 ~l~~li~~cl~~dP~~RPs~~ell~~L~  443 (454)
                      ++.+||.+||+.||.+|||+.|+++|-+
T Consensus       230 ~~~~li~~~L~~dp~~R~s~~eil~hp~  257 (273)
T d1xwsa_         230 ECQHLIRWCLALRPSDRPTFEEIQNHPW  257 (273)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred             HHHHHHHHHccCCHhHCcCHHHHhcCHh
Confidence            9999999999999999999999998744

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-48  Score=384.50  Aligned_cols=254  Identities=22%  Similarity=0.425  Sum_probs=203.3

Q ss_pred             CCEEEeceeeccCCceEEEe----EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCC---eEEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG----KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH---GLCVV  262 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g----~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~---~l~lV  262 (454)
                      ++|.+.+.||+|+||.||+|    +.||||++...   .......+.|+..+..++|||||+++|++.+++.   .+|+|
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv   79 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV   79 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEETTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECcc---chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence            57889999999999999996    58999998632   2333444566777777899999999999987652   48999


Q ss_pred             EeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh--------cCcccCCccCCcEEEccCCcEEEEccCCcccc
Q 012887          263 TKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLND--------HGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC  334 (454)
Q Consensus       263 ~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~--------~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~  334 (454)
                      ||||++|+|.+++++ ..+++.....++.|++.||.|||+        +||+||||||+|||++.++++||+|||+++..
T Consensus        80 ~Ey~~~g~L~~~l~~-~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~  158 (303)
T d1vjya_          80 SDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH  158 (303)
T ss_dssp             EECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEE
T ss_pred             EecccCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccc
Confidence            999999999999965 468999999999999999999996        59999999999999999999999999998876


Q ss_pred             ccCCCc----ccccCCCCcccccccccCCCCCC--CCCchhhHHHHHHHHHHHHcCCCCCCCC---------------CH
Q 012887          335 KSVGEA----TEYETDGYRWLAPEIIAGDPESV--SETWMSNVYSFGMVIWEMVTGEAAYAAC---------------SP  393 (454)
Q Consensus       335 ~~~~~~----~~~~~gt~~y~APE~l~~~~~~~--~~~~ksDVwSlGviL~elltG~~Pf~~~---------------~~  393 (454)
                      ......    .....||+.|+|||++.+.....  .++.++|||||||+||||+||..||...               ..
T Consensus       159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~  238 (303)
T d1vjya_         159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV  238 (303)
T ss_dssp             ETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred             cCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchH
Confidence            554322    23456899999999988653221  2456799999999999999998877421               22


Q ss_pred             HHHHHHHHHcCCCCCCCCC-----ccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcC
Q 012887          394 VQAAVGIAACGLRPEIPKD-----CPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNN  447 (454)
Q Consensus       394 ~~~~~~i~~~~~~~~~p~~-----~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~  447 (454)
                      ..........+.++.+|..     .+..+.+||.+||+.||.+|||+.||+++|.++..
T Consensus       239 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~  297 (303)
T d1vjya_         239 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ  297 (303)
T ss_dssp             HHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence            2233334445566666554     33569999999999999999999999999998875

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-47  Score=370.96  Aligned_cols=250  Identities=16%  Similarity=0.209  Sum_probs=211.1

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  263 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~  263 (454)
                      ++|++++.||+|+||+||+|      +.||||+++...........+.+|+.+|+.++||||+++++++.+.+. .++||
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~-~~iv~   80 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKK-LTLVF   80 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE-EEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccc-eeEEe
Confidence            68999999999999999996      469999998666555667788999999999999999999999998876 89999


Q ss_pred             eccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCCcccc
Q 012887          264 KLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGEATEY  343 (454)
Q Consensus       264 E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~~~~~  343 (454)
                      |++.+++|..++...+.+++..+..++.|++.||+|||++||+||||||+|||++.++++||+|||.+............
T Consensus        81 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~~~  160 (292)
T d1unla_          81 EFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA  160 (292)
T ss_dssp             ECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCCCS
T ss_pred             eeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCcccee
Confidence            99999999998888889999999999999999999999999999999999999999999999999999887665555556


Q ss_pred             cCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCC-CHHHHHHHHHHcCC-----------------
Q 012887          344 ETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAAC-SPVQAAVGIAACGL-----------------  405 (454)
Q Consensus       344 ~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~-~~~~~~~~i~~~~~-----------------  405 (454)
                      ..+++.|+|||.+.+..+   ++.++|||||||++|||++|..||... +..+....+.....                 
T Consensus       161 ~~~~~~~~~pe~~~~~~~---~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (292)
T d1unla_         161 EVVTLWYRPPDVLFGAKL---YSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK  237 (292)
T ss_dssp             CCSCGGGCCHHHHTTCSC---CCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred             eccccchhhhhHhccCCC---CCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccccc
Confidence            667888999999876542   456799999999999999999986544 44443333322100                 


Q ss_pred             ----------CCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 012887          406 ----------RPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLL  443 (454)
Q Consensus       406 ----------~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~  443 (454)
                                ....+..+++.+.+||.+||+.||.+|||++|+++|-|
T Consensus       238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~  285 (292)
T d1unla_         238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPY  285 (292)
T ss_dssp             CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGG
T ss_pred             ccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChh
Confidence                      11133457889999999999999999999999998743

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-47  Score=380.92  Aligned_cols=249  Identities=18%  Similarity=0.289  Sum_probs=201.0

Q ss_pred             eeecCCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCC-
Q 012887          185 WLLNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENH-  257 (454)
Q Consensus       185 ~~~~~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~-  257 (454)
                      |.+ .++|++++.||+|+||.||+|      +.||||+++...........+.+|+.+|..++|||||+++++|...+. 
T Consensus        14 ~~~-~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~   92 (346)
T d1cm8a_          14 WEV-RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETL   92 (346)
T ss_dssp             ECC-BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSST
T ss_pred             eec-CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccc
Confidence            445 478999999999999999995      579999998655555556678899999999999999999999986542 


Q ss_pred             ----eEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccc
Q 012887          258 ----GLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTA  333 (454)
Q Consensus       258 ----~l~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~  333 (454)
                          .+|+||||+ +++|..++ +..++++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus        93 ~~~~~~~lv~e~~-~~~l~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~  170 (346)
T d1cm8a_          93 DDFTDFYLVMPFM-GTDLGKLM-KHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ  170 (346)
T ss_dssp             TTCCCCEEEEECC-SEEHHHHH-HHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             cccceEEEEEecc-cccHHHHH-HhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceec
Confidence                379999999 55788776 456799999999999999999999999999999999999999999999999999876


Q ss_pred             cccCCCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCC-------
Q 012887          334 CKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR-------  406 (454)
Q Consensus       334 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~-------  406 (454)
                      ...   ......+|+.|+|||.+.+..+   ++.++||||+||++|+|++|.+||.+.+.......+......       
T Consensus       171 ~~~---~~~~~~~t~~y~aPE~~~~~~~---~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  244 (346)
T d1cm8a_         171 ADS---EMTGYVVTRWYRAPEVILNWMR---YTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ  244 (346)
T ss_dssp             CCS---SCCSSCSCGGGCCTHHHHTTTC---CCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred             cCC---ccccccccccccCHHHHcCCCC---CCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHh
Confidence            543   2445678999999999876532   455699999999999999999999987766554433221110       


Q ss_pred             ----------------------CCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 012887          407 ----------------------PEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL  442 (454)
Q Consensus       407 ----------------------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L  442 (454)
                                            ......+++++.+||.+||..||.+|||+.|+++|-
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp  302 (346)
T d1cm8a_         245 RLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHP  302 (346)
T ss_dssp             TCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred             hhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcCh
Confidence                                  012346789999999999999999999999999983

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.8e-48  Score=381.35  Aligned_cols=252  Identities=19%  Similarity=0.341  Sum_probs=207.0

Q ss_pred             CCCEEEeceeeccCCceEEEe---------EEEEEEEeecCCC--CchHHHHHHHHHHHHHhCCC-CceeEEEEEEEeCC
Q 012887          189 SDNLEFIDQIGPNSFKGVYKG---------KRVGIEKLKGCDK--GNAYEFELRKDLLELMTCGH-KNILQFYCVCVDEN  256 (454)
Q Consensus       189 ~~~~~~~~~LG~G~fG~Vy~g---------~~vavK~l~~~~~--~~~~~~~~~~Ei~~l~~l~H-pnIv~~~g~~~~~~  256 (454)
                      -++|++++.||+|+||+||++         +.||+|.++....  .......+.+|+.++.+++| |||+++++++.+.+
T Consensus        23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~  102 (322)
T d1vzoa_          23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  102 (322)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence            378999999999999999996         4699998853221  11223456789999999966 89999999999887


Q ss_pred             CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCcccccc
Q 012887          257 HGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS  336 (454)
Q Consensus       257 ~~l~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~  336 (454)
                      . +++||||+.+|+|.+++...+.+++..+..++.||+.||+|||+++|+||||||+|||++.+|.+||+|||+++....
T Consensus       103 ~-~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~  181 (322)
T d1vzoa_         103 K-LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA  181 (322)
T ss_dssp             E-EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCG
T ss_pred             c-eeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhcc
Confidence            6 999999999999999998888899999999999999999999999999999999999999999999999999876543


Q ss_pred             CC-CcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH--cCCCCCCCCCc
Q 012887          337 VG-EATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAA--CGLRPEIPKDC  413 (454)
Q Consensus       337 ~~-~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~--~~~~~~~p~~~  413 (454)
                      .. .......+++.|+|||.+.+...  .++.++|||||||+||+|++|..||.+.+.......+..  ....+++|..+
T Consensus       182 ~~~~~~~~~~g~~~~~~pe~~~~~~~--~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~  259 (322)
T d1vzoa_         182 DETERAYDFCGTIEYMAPDIVRGGDS--GHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEM  259 (322)
T ss_dssp             GGGGGGCGGGSCCTTCCHHHHTTCC-----CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTS
T ss_pred             cccccccccccccccchhHHhhcCCc--CCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcccC
Confidence            22 23444578999999999986543  255679999999999999999999976544332222221  13356678899


Q ss_pred             cHHHHHHHHHhcccCCCCCC-----CHHHHHHHHH
Q 012887          414 PQILKSLMIKCWNNSPSKRP-----QFSEIISLLL  443 (454)
Q Consensus       414 ~~~l~~li~~cl~~dP~~RP-----s~~ell~~L~  443 (454)
                      |+++.+||.+||++||.+||     +++|+++|-+
T Consensus       260 s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpf  294 (322)
T d1vzoa_         260 SALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF  294 (322)
T ss_dssp             CHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGG
T ss_pred             CHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHh
Confidence            99999999999999999999     4899988643

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-46  Score=370.99  Aligned_cols=252  Identities=17%  Similarity=0.250  Sum_probs=199.8

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCC-------
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN-------  256 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~-------  256 (454)
                      ++|++++.||+|+||+||+|      +.||||++............+.+|+.+|..++||||+++++++....       
T Consensus        10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~   89 (318)
T d3blha1          10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   89 (318)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred             CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence            67899999999999999996      47999998755444445566789999999999999999999986532       


Q ss_pred             CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCcccccc
Q 012887          257 HGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKS  336 (454)
Q Consensus       257 ~~l~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~  336 (454)
                      ..+|+||||+.++.+.........+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus        90 ~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~  169 (318)
T d3blha1          90 GSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSL  169 (318)
T ss_dssp             -CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCC
T ss_pred             ceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeeccc
Confidence            23899999998876665555566899999999999999999999999999999999999999999999999999876543


Q ss_pred             CCC----cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcC--CCCCCC
Q 012887          337 VGE----ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG--LRPEIP  410 (454)
Q Consensus       337 ~~~----~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~--~~~~~p  410 (454)
                      ...    ......||+.|+|||.+.+..   .++.++|||||||++|||++|+.||.+.++......+....  ..+...
T Consensus       170 ~~~~~~~~~~~~~gT~~Y~aPE~~~~~~---~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  246 (318)
T d3blha1         170 AKNSQPNRYTNRVVTLWYRPPELLLGER---DYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW  246 (318)
T ss_dssp             -----CCCCCSCCSCGGGCCHHHHTTCS---SCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred             ccccccccccceecCHHHhhHHHHcCCC---CCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhc
Confidence            221    222346899999999987653   35667999999999999999999999887766555443311  111100


Q ss_pred             C----------------------------CccHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 012887          411 K----------------------------DCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR  444 (454)
Q Consensus       411 ~----------------------------~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~  444 (454)
                      .                            ..++++.+||.+||+.||++|||++|+++|-+-
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff  308 (318)
T d3blha1         247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF  308 (318)
T ss_dssp             TTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGG
T ss_pred             cccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhh
Confidence            0                            125678899999999999999999999998663

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.8e-46  Score=366.25  Aligned_cols=247  Identities=17%  Similarity=0.202  Sum_probs=192.7

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCCCeEEEEE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDENHGLCVVT  263 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~~~l~lV~  263 (454)
                      ++|++++.||+|+||.||+|      +.||||.+......    .++..|+.++..++|+|++..++.+...+...++||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivm   82 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   82 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEE
Confidence            57999999999999999996      58999988754322    236788999999987776666555555554589999


Q ss_pred             eccCCCCHHHHHH-hCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEcc---CCcEEEEccCCccccccCCC
Q 012887          264 KLMEGGSVNDLIL-KSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDR---HGNVCLGDMGIVTACKSVGE  339 (454)
Q Consensus       264 E~~~~gsL~~~l~-~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~---~~~vKL~DFGla~~~~~~~~  339 (454)
                      ||+. ++|.+.+. ..+.+++..+..++.|++.||+|||++||+||||||+|||++.   +..+||+|||+|+.......
T Consensus        83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~  161 (299)
T d1ckia_          83 ELLG-PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART  161 (299)
T ss_dssp             ECCC-CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTT
T ss_pred             EEcC-CchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecccccc
Confidence            9995 47776664 4558999999999999999999999999999999999999864   45799999999987654322


Q ss_pred             -------cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH---HH---cCCC
Q 012887          340 -------ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGI---AA---CGLR  406 (454)
Q Consensus       340 -------~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i---~~---~~~~  406 (454)
                             ......||+.|+|||.+.+..    ++.++|||||||++|||++|..||...........+   ..   ....
T Consensus       162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~  237 (299)
T d1ckia_         162 HQHIPYRENKNLTGTARYASINTHLGIE----QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI  237 (299)
T ss_dssp             CCBCCCCBCCSCCCCSSSCCHHHHTTBC----CCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCH
T ss_pred             ccceeccccCCcCCCccccCHHHHhCCC----CCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCCh
Confidence                   123446899999999998765    455699999999999999999999876554332221   11   1112


Q ss_pred             CCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhh
Q 012887          407 PEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRT  445 (454)
Q Consensus       407 ~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~  445 (454)
                      +..+.++|+++.++|.+||+.||++||++.+|.+.|+..
T Consensus       238 ~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~  276 (299)
T d1ckia_         238 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL  276 (299)
T ss_dssp             HHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred             hHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence            234567899999999999999999999999888777665

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-46  Score=373.92  Aligned_cols=247  Identities=17%  Similarity=0.260  Sum_probs=196.0

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCC----CeE
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN----HGL  259 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~----~~l  259 (454)
                      ++|++++.||+|+||+||+|      +.||||++.... .......+.+|+.+|..++||||+++++++....    ..+
T Consensus         8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc-ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            56999999999999999996      479999997432 3444567889999999999999999999997653    224


Q ss_pred             EEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCCC
Q 012887          260 CVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVGE  339 (454)
Q Consensus       260 ~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~~  339 (454)
                      |++ +++.+|+|.+++.. +.+++..+..++.||+.||+|||++|||||||||+|||++.++.+||+|||++........
T Consensus        87 ~l~-~~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~  164 (345)
T d1pmea_          87 YLV-THLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD  164 (345)
T ss_dssp             EEE-EECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGC
T ss_pred             EEE-EeecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCc
Confidence            555 55668899999854 4799999999999999999999999999999999999999999999999999876544322


Q ss_pred             ---cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcC------------
Q 012887          340 ---ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG------------  404 (454)
Q Consensus       340 ---~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~------------  404 (454)
                         ......||+.|+|||.+....   .++.++||||+||++|+|++|..||.+.+............            
T Consensus       165 ~~~~~~~~~gt~~y~aPE~l~~~~---~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (345)
T d1pmea_         165 HTGFLTEYVATRWYRAPEIMLNSK---GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII  241 (345)
T ss_dssp             BCCTTCCCCSCGGGCCGGGTTTBC---SCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCC
T ss_pred             cceeeccccccceechHHHhhcCC---CCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhh
Confidence               234456899999999986543   24567999999999999999999998877654443322110            


Q ss_pred             ----------CC--C-----CCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 012887          405 ----------LR--P-----EIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL  442 (454)
Q Consensus       405 ----------~~--~-----~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L  442 (454)
                                ..  .     .....+++++.+|+.+||+.||.+|||+.|+++|-
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hp  296 (345)
T d1pmea_         242 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHP  296 (345)
T ss_dssp             CHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred             hhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCH
Confidence                      00  0     01235678999999999999999999999999873

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-46  Score=373.46  Aligned_cols=242  Identities=19%  Similarity=0.185  Sum_probs=195.2

Q ss_pred             CEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeC-----CCeE
Q 012887          191 NLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDE-----NHGL  259 (454)
Q Consensus       191 ~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~-----~~~l  259 (454)
                      +|+.++.||+|+||+||+|      +.||||++......      ..+|+.+|++++|||||+++++|...     ...+
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~   94 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL   94 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH------HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence            6899999999999999985      57999999754322      23789999999999999999998653     2237


Q ss_pred             EEEEeccCCCCHHHHH---HhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCC-cEEEEccCCccccc
Q 012887          260 CVVTKLMEGGSVNDLI---LKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG-NVCLGDMGIVTACK  335 (454)
Q Consensus       260 ~lV~E~~~~gsL~~~l---~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~-~vKL~DFGla~~~~  335 (454)
                      |+|||||+++.+..+.   .....+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||++....
T Consensus        95 ~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~  174 (350)
T d1q5ka_          95 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV  174 (350)
T ss_dssp             EEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECC
T ss_pred             EEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhcc
Confidence            8999999875433332   2455899999999999999999999999999999999999999775 89999999988765


Q ss_pred             cCCCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcC-----------
Q 012887          336 SVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACG-----------  404 (454)
Q Consensus       336 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~-----------  404 (454)
                      ... ......|++.|+|||.+.+..   .++.++||||+||++|||++|..||...+.......+....           
T Consensus       175 ~~~-~~~~~~gt~~y~aPE~~~~~~---~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~  250 (350)
T d1q5ka_         175 RGE-PNVSYICSRYYRAPELIFGAT---DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM  250 (350)
T ss_dssp             TTS-CCCSCCSCTTSCCHHHHTTCS---SCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred             CCc-ccccccccccccChHHhhccc---CCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhh
Confidence            433 234457889999999987543   35667999999999999999999999887766655543210           


Q ss_pred             ----CCC------------CCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 012887          405 ----LRP------------EIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLL  442 (454)
Q Consensus       405 ----~~~------------~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L  442 (454)
                          ...            .....+++++.+||.+||..||.+|||+.|+++|-
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp  304 (350)
T d1q5ka_         251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHS  304 (350)
T ss_dssp             CC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred             ccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCH
Confidence                000            11235789999999999999999999999999873

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.9e-46  Score=370.76  Aligned_cols=251  Identities=15%  Similarity=0.241  Sum_probs=202.2

Q ss_pred             eeecCCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeCC--
Q 012887          185 WLLNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDEN--  256 (454)
Q Consensus       185 ~~~~~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~~--  256 (454)
                      |.+ .++|++++.||+|+||+||+|      +.||||++............+.+|+.+|.+++|||||++++++....  
T Consensus        14 ~~~-~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~   92 (348)
T d2gfsa1          14 WEV-PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSL   92 (348)
T ss_dssp             EEE-ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSST
T ss_pred             ccC-CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeecccc
Confidence            555 378999999999999999995      68999999865555556667889999999999999999999986432  


Q ss_pred             --CeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCcccc
Q 012887          257 --HGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTAC  334 (454)
Q Consensus       257 --~~l~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~  334 (454)
                        ...+++|+|+.+|+|.+++. .+++++..+..++.||+.||+|||++||+||||||+|||++.+|.+|++|||++...
T Consensus        93 ~~~~~~~i~~~~~gg~L~~~~~-~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~  171 (348)
T d2gfsa1          93 EEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT  171 (348)
T ss_dssp             TTCCCCEEEEECCSEEHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CC
T ss_pred             ccCceEEEEEeecCCchhhhcc-cccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhccc
Confidence              12456677778999999984 457999999999999999999999999999999999999999999999999998654


Q ss_pred             ccCCCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCCC-------
Q 012887          335 KSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLRP-------  407 (454)
Q Consensus       335 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~~-------  407 (454)
                      ..   ......|++.|+|||.+.+..+   .+.++|||||||++|+|++|.+||.+.+.......+......+       
T Consensus       172 ~~---~~~~~~g~~~y~apE~~~~~~~---~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~  245 (348)
T d2gfsa1         172 DD---EMTGYVATRWYRAPEIMLNWMH---YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK  245 (348)
T ss_dssp             TG---GGSSSCHHHHTSCHHHHTTCSC---CCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred             Cc---ccccccccccccCchhhcCCcc---CCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhh
Confidence            33   2344567889999998876532   3456999999999999999999999887766555443321111       


Q ss_pred             --------------CC--------CCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 012887          408 --------------EI--------PKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLL  443 (454)
Q Consensus       408 --------------~~--------p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~  443 (454)
                                    ..        ...+++++.+||.+||..||.+|||+.|+++|-+
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~  303 (348)
T d2gfsa1         246 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY  303 (348)
T ss_dssp             CCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred             ccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHh
Confidence                          01        1357899999999999999999999999999744

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=3.6e-45  Score=362.94  Aligned_cols=243  Identities=14%  Similarity=0.225  Sum_probs=195.5

Q ss_pred             CCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCC-CCceeEEEEEEEeCC-CeEE
Q 012887          189 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCG-HKNILQFYCVCVDEN-HGLC  260 (454)
Q Consensus       189 ~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~~~g~~~~~~-~~l~  260 (454)
                      .++|++++.||+|+||+||+|      +.||+|+++...     ...+.+|+.+|..+. ||||+++++++.... ..++
T Consensus        34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~  108 (328)
T d3bqca1          34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA  108 (328)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEE
T ss_pred             CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH-----HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCcee
Confidence            368999999999999999995      679999986322     345789999999985 999999999998553 3499


Q ss_pred             EEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCC-cEEEEccCCccccccCCC
Q 012887          261 VVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHG-NVCLGDMGIVTACKSVGE  339 (454)
Q Consensus       261 lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~-~vKL~DFGla~~~~~~~~  339 (454)
                      +|||||++++|.++.   +.+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++....... 
T Consensus       109 ~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~-  184 (328)
T d3bqca1         109 LVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ-  184 (328)
T ss_dssp             EEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC-
T ss_pred             EEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCCC-
Confidence            999999999987653   4799999999999999999999999999999999999998765 59999999988765433 


Q ss_pred             cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHHH-------------cCC
Q 012887          340 ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQ-AAVGIAA-------------CGL  405 (454)
Q Consensus       340 ~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~-~~~~i~~-------------~~~  405 (454)
                      ......+|+.|+|||.+.+..   .++.++||||+||++|||++|..||....... ....+..             ...
T Consensus       185 ~~~~~~~t~~y~aPE~~~~~~---~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~  261 (328)
T d3bqca1         185 EYNVRVASRYFKGPELLVDYQ---MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI  261 (328)
T ss_dssp             CCCSCCSCGGGCCHHHHTTCC---CCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred             cccccccCccccCcccccCCC---CCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccc
Confidence            244457889999999987653   24567999999999999999999997654332 1111110             000


Q ss_pred             ----------------------CCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHH
Q 012887          406 ----------------------RPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLL  443 (454)
Q Consensus       406 ----------------------~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~  443 (454)
                                            .......+++++.+||++||..||.+|||++|+++|-+
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~  321 (328)
T d3bqca1         262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY  321 (328)
T ss_dssp             CCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred             ccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence                                  00112346889999999999999999999999998654

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=6e-45  Score=356.35  Aligned_cols=250  Identities=17%  Similarity=0.249  Sum_probs=201.5

Q ss_pred             CCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCC-CceeEEEEEEEeCCCeEEE
Q 012887          189 SDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGH-KNILQFYCVCVDENHGLCV  261 (454)
Q Consensus       189 ~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~H-pnIv~~~g~~~~~~~~l~l  261 (454)
                      .++|++++.||+|+||.||+|      +.||||.+......    ..+.+|+..+..+.| +|++.+++++.+... .++
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~-~~~   78 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLH-NVL   78 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTE-EEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc----HHHHHHHHHHHHhcCCCCCCEEEEEeecCCc-cEE
Confidence            368999999999999999996      57999988643322    235678888888865 899999999887776 899


Q ss_pred             EEeccCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEcc-----CCcEEEEccCCccccc
Q 012887          262 VTKLMEGGSVNDLILKS-RKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDR-----HGNVCLGDMGIVTACK  335 (454)
Q Consensus       262 V~E~~~~gsL~~~l~~~-~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~-----~~~vKL~DFGla~~~~  335 (454)
                      ||||+ +++|.+++... ..++...+..++.|++.||+|||++||+||||||+|||++.     ++.+||+|||+|+...
T Consensus        79 vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~  157 (293)
T d1csna_          79 VIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR  157 (293)
T ss_dssp             EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred             EEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence            99999 67999998654 47999999999999999999999999999999999999974     5789999999998764


Q ss_pred             cCCC-------cccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHHHc--
Q 012887          336 SVGE-------ATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSP---VQAAVGIAAC--  403 (454)
Q Consensus       336 ~~~~-------~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~---~~~~~~i~~~--  403 (454)
                      ....       ......||+.|||||++.+..    ++.++|||||||++|||++|..||.+...   ......+...  
T Consensus       158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~----~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~  233 (293)
T d1csna_         158 DPVTKQHIPYREKKNLSGTARYMSINTHLGRE----QSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ  233 (293)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC----CCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH
T ss_pred             cCccccceeecccCceEEchhhcCHHHhcCCC----CChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccC
Confidence            4221       123346899999999998764    45579999999999999999999975432   2222222221  


Q ss_pred             -CCCCCCCCCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHhhcCC
Q 012887          404 -GLRPEIPKDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLRTNNI  448 (454)
Q Consensus       404 -~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~  448 (454)
                       .....++..+|+++.+++..||..+|++||++..+.+.|.++.+.
T Consensus       234 ~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~  279 (293)
T d1csna_         234 STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER  279 (293)
T ss_dssp             HSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             CCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHH
Confidence             112234567899999999999999999999999999888876543

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-45  Score=366.04  Aligned_cols=247  Identities=19%  Similarity=0.241  Sum_probs=191.1

Q ss_pred             CCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhCCCCceeEEEEEEEeC-----CCe
Q 012887          190 DNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTCGHKNILQFYCVCVDE-----NHG  258 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~g~~~~~-----~~~  258 (454)
                      ++|++++.||+|+||+||+|      +.||||++............+.+|+.+|.+++|||||+++++|...     ...
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            67999999999999999995      6899999986555555556788999999999999999999999754     234


Q ss_pred             EEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCccccccCC
Q 012887          259 LCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIVTACKSVG  338 (454)
Q Consensus       259 l~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla~~~~~~~  338 (454)
                      +|+|||||.++ +.+.+  ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+|++|||+++......
T Consensus        97 ~~iv~Ey~~~~-l~~~~--~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~~  173 (355)
T d2b1pa1          97 VYLVMELMDAN-LCQVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF  173 (355)
T ss_dssp             EEEEEECCSEE-HHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC--------
T ss_pred             eEEEEeccchH-HHHhh--hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhcccccc
Confidence            89999999774 44444  3478999999999999999999999999999999999999999999999999977654432


Q ss_pred             CcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcCCC------------
Q 012887          339 EATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQAAVGIAACGLR------------  406 (454)
Q Consensus       339 ~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~~~~~i~~~~~~------------  406 (454)
                       ......+|+.|+|||++.+..+    +.++||||+||++|+|++|++||.+.+.......+......            
T Consensus       174 -~~~~~~~t~~y~aPE~l~~~~~----~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  248 (355)
T d2b1pa1         174 -MMTPYVVTRYYRAPEVILGMGY----KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT  248 (355)
T ss_dssp             --------CCTTCCHHHHTTCCC----CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHH
T ss_pred             -ccccccccccccChhhhcCCCC----CCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhh
Confidence             3445578899999999987654    44599999999999999999999987766554433211000            


Q ss_pred             --------CC--------------CC------CCccHHHHHHHHHhcccCCCCCCCHHHHHHHHHh
Q 012887          407 --------PE--------------IP------KDCPQILKSLMIKCWNNSPSKRPQFSEIISLLLR  444 (454)
Q Consensus       407 --------~~--------------~p------~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~  444 (454)
                              +.              .+      ...++++.+||++||..||++|||++|+++|-|-
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~  314 (355)
T d2b1pa1         249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI  314 (355)
T ss_dssp             HHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTT
T ss_pred             HHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCccc
Confidence                    00              00      1236778999999999999999999999988543

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=7.5e-39  Score=320.57  Aligned_cols=247  Identities=16%  Similarity=0.279  Sum_probs=183.0

Q ss_pred             ecCCCEEEeceeeccCCceEEEe------EEEEEEEeecCCCCchHHHHHHHHHHHHHhC-----------CCCceeEEE
Q 012887          187 LNSDNLEFIDQIGPNSFKGVYKG------KRVGIEKLKGCDKGNAYEFELRKDLLELMTC-----------GHKNILQFY  249 (454)
Q Consensus       187 ~~~~~~~~~~~LG~G~fG~Vy~g------~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l-----------~HpnIv~~~  249 (454)
                      +...+|++++.||+|+||.||+|      +.||||+++.   .........+|+.++..+           .|+||++++
T Consensus        10 ~~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~---~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~   86 (362)
T d1q8ya_          10 YKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG---DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL   86 (362)
T ss_dssp             ETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS---CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCC
T ss_pred             ccCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEec---cccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEE
Confidence            33456999999999999999986      6799999973   223344567787777665           368899999


Q ss_pred             EEEEeCC-CeEEEEEeccCCCCHHHH-H--HhCCCCCHHHHHHHHHHHHHHHHHHHh-cCcccCCccCCcEEEccCCc--
Q 012887          250 CVCVDEN-HGLCVVTKLMEGGSVNDL-I--LKSRKLQTKEIIRIAIDVAEGIKFLND-HGVAYRDLNSQRILLDRHGN--  322 (454)
Q Consensus       250 g~~~~~~-~~l~lV~E~~~~gsL~~~-l--~~~~~l~~~~~~~i~~qI~~gL~yLH~-~~iiHrDIKp~NILl~~~~~--  322 (454)
                      +++...+ ...+++|+++..+..... .  .....+++..+..++.||+.||+|||+ +||+||||||+|||++.++.  
T Consensus        87 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~  166 (362)
T d1q8ya_          87 DHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPE  166 (362)
T ss_dssp             EEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTT
T ss_pred             EEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccc
Confidence            9886543 346677777665543332 2  234589999999999999999999998 89999999999999987664  


Q ss_pred             ----EEEEccCCccccccCCCcccccCCCCcccccccccCCCCCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCHHH---
Q 012887          323 ----VCLGDMGIVTACKSVGEATEYETDGYRWLAPEIIAGDPESVSETWMSNVYSFGMVIWEMVTGEAAYAACSPVQ---  395 (454)
Q Consensus       323 ----vKL~DFGla~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~ksDVwSlGviL~elltG~~Pf~~~~~~~---  395 (454)
                          +|++|||.+.....   ......+|+.|+|||++.+..    ++.++||||+||++++|++|+.||.......   
T Consensus       167 ~~~~~kl~dfg~s~~~~~---~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~  239 (362)
T d1q8ya_         167 NLIQIKIADLGNACWYDE---HYTNSIQTREYRSPEVLLGAP----WGCGADIWSTACLIFELITGDFLFEPDEGHSYTK  239 (362)
T ss_dssp             TEEEEEECCCTTCEETTB---CCCSCCSCGGGCCHHHHHTCC----CCTHHHHHHHHHHHHHHHHSSCCC---------C
T ss_pred             ccceeeEeeccccccccc---ccccccccccccChhhccccC----CCccccccchHHHHHHHHHCCCCCCCCccccccc
Confidence                99999999875543   234557899999999998765    4456999999999999999999997533211   


Q ss_pred             ---HHHHHH-HcC---------------------------------------CCCCCCCCccHHHHHHHHHhcccCCCCC
Q 012887          396 ---AAVGIA-ACG---------------------------------------LRPEIPKDCPQILKSLMIKCWNNSPSKR  432 (454)
Q Consensus       396 ---~~~~i~-~~~---------------------------------------~~~~~p~~~~~~l~~li~~cl~~dP~~R  432 (454)
                         ...... ..+                                       .....+...++++.+||.+||..||.+|
T Consensus       240 ~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R  319 (362)
T d1q8ya_         240 DDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKR  319 (362)
T ss_dssp             HHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTC
T ss_pred             hhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHC
Confidence               111000 000                                       0111223456889999999999999999


Q ss_pred             CCHHHHHHHHH
Q 012887          433 PQFSEIISLLL  443 (454)
Q Consensus       433 Ps~~ell~~L~  443 (454)
                      ||++|+++|-+
T Consensus       320 pta~e~L~Hp~  330 (362)
T d1q8ya_         320 ADAGGLVNHPW  330 (362)
T ss_dssp             BCHHHHHTCGG
T ss_pred             cCHHHHhcCcc
Confidence            99999998844

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.88  E-value=7.9e-24  Score=192.51  Aligned_cols=130  Identities=12%  Similarity=0.119  Sum_probs=100.9

Q ss_pred             EEeceeeccCCceEEEe-----EEEEEEEeecCCCC----------------chHHHHHHHHHHHHHhCCCCceeEEEEE
Q 012887          193 EFIDQIGPNSFKGVYKG-----KRVGIEKLKGCDKG----------------NAYEFELRKDLLELMTCGHKNILQFYCV  251 (454)
Q Consensus       193 ~~~~~LG~G~fG~Vy~g-----~~vavK~l~~~~~~----------------~~~~~~~~~Ei~~l~~l~HpnIv~~~g~  251 (454)
                      .+.+.||+|+||.||+|     +.||||.++.....                ........+|...+.++.|++++..+++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence            57899999999999995     68999987532110                0112234567888889999999998865


Q ss_pred             EEeCCCeEEEEEeccCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcCcccCCccCCcEEEccCCcEEEEccCCc
Q 012887          252 CVDENHGLCVVTKLMEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLNDHGVAYRDLNSQRILLDRHGNVCLGDMGIV  331 (454)
Q Consensus       252 ~~~~~~~l~lV~E~~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~~~iiHrDIKp~NILl~~~~~vKL~DFGla  331 (454)
                      .   .  .+++|||++++.+.+       ++......++.|++.||.|||++||+||||||+|||+++++ ++|+|||+|
T Consensus        83 ~---~--~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~-~~liDFG~a  149 (191)
T d1zara2          83 E---G--NAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQS  149 (191)
T ss_dssp             E---T--TEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTE-EEECCCTTC
T ss_pred             c---C--CEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCCC-EEEEECCCc
Confidence            3   2  369999998865432       44555678999999999999999999999999999999654 899999998


Q ss_pred             cccc
Q 012887          332 TACK  335 (454)
Q Consensus       332 ~~~~  335 (454)
                      ....
T Consensus       150 ~~~~  153 (191)
T d1zara2         150 VEVG  153 (191)
T ss_dssp             EETT
T ss_pred             ccCC
Confidence            7654

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=97.86  E-value=3.2e-05  Score=70.66  Aligned_cols=134  Identities=12%  Similarity=0.095  Sum_probs=79.6

Q ss_pred             CEEEeceeeccCCceEEE----eEEEEEEEeecCCCCchHHHHHHHHHHHHHhCC-CCceeEEEEEEEeCCCeEEEEEec
Q 012887          191 NLEFIDQIGPNSFKGVYK----GKRVGIEKLKGCDKGNAYEFELRKDLLELMTCG-HKNILQFYCVCVDENHGLCVVTKL  265 (454)
Q Consensus       191 ~~~~~~~LG~G~fG~Vy~----g~~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~~~g~~~~~~~~l~lV~E~  265 (454)
                      .|++.+..+-|+-+.||+    +..+.+|.........  ...+.+|...+..+. +--+.+++.+..+++. .++||++
T Consensus        15 ~~~~~~~~~G~s~~~v~rv~~~~~~~vlk~~~~~~~~~--~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~-~~lv~~~   91 (263)
T d1j7la_          15 KYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGT--TYDVEREKDMMLWLEGKLPVPKVLHFERHDGW-SNLLMSE   91 (263)
T ss_dssp             TSEEEECSCCCSSSEEEEEECSSCEEEEEEECGGGTTS--TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTE-EEEEEEC
T ss_pred             ceEEEEcCCCCCCCcEEEEEeCCCeEEEEEcCCCcccc--hhhHHHHHHHHHHHhccCCCCcEEEEEecCCc-eEEEEEe
Confidence            445556555555578887    3456677765432222  123556766665542 3335566766666655 7899999


Q ss_pred             cCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-------------------------------------------
Q 012887          266 MEGGSVNDLILKSRKLQTKEIIRIAIDVAEGIKFLND-------------------------------------------  302 (454)
Q Consensus       266 ~~~gsL~~~l~~~~~l~~~~~~~i~~qI~~gL~yLH~-------------------------------------------  302 (454)
                      ++|.++.+.....  ..   ...++.++...|..||+                                           
T Consensus        92 l~G~~~~~~~~~~--~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (263)
T d1j7la_          92 ADGVLCSEEYEDE--QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKD  166 (263)
T ss_dssp             CSSEEHHHHTTTC--SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSS
T ss_pred             ccccccccccccc--cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchH
Confidence            9998876543111  01   11122222233333331                                           


Q ss_pred             ----------------cCcccCCccCCcEEEccCCcEEEEccCCcc
Q 012887          303 ----------------HGVAYRDLNSQRILLDRHGNVCLGDMGIVT  332 (454)
Q Consensus       303 ----------------~~iiHrDIKp~NILl~~~~~vKL~DFGla~  332 (454)
                                      ..++|+|+.|.|||+++++.+-|.||+.+.
T Consensus       167 ~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         167 PRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             HHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                            127899999999999976666799998764

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=96.99  E-value=0.0021  Score=57.71  Aligned_cols=28  Identities=18%  Similarity=0.119  Sum_probs=24.5

Q ss_pred             cccCCccCCcEEEccCCcEEEEccCCcc
Q 012887          305 VAYRDLNSQRILLDRHGNVCLGDMGIVT  332 (454)
Q Consensus       305 iiHrDIKp~NILl~~~~~vKL~DFGla~  332 (454)
                      ++|+|+.|.|||++.+..+-|.||+.+.
T Consensus       177 liHgD~~~~Nvl~~~~~~~~iID~~~~~  204 (255)
T d1nd4a_         177 VTHGDACLPNIMVENGRFSGFIDCGRLG  204 (255)
T ss_dssp             EECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             EEeCCCCCcceEEeCCceEEEEEchhcc
Confidence            7999999999999977667799998754

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=96.62  E-value=0.0053  Score=59.38  Aligned_cols=30  Identities=17%  Similarity=0.097  Sum_probs=25.5

Q ss_pred             CcccCCccCCcEEEccCCcEEEEccCCcccc
Q 012887          304 GVAYRDLNSQRILLDRHGNVCLGDMGIVTAC  334 (454)
Q Consensus       304 ~iiHrDIKp~NILl~~~~~vKL~DFGla~~~  334 (454)
                      .++|+|+.|.|||++.++ ++|.||..+...
T Consensus       224 ~LiHGDl~~gNIlv~~~~-~~vID~E~a~~G  253 (392)
T d2pula1         224 TLIHGDLHTGSIFASEHE-TKVIDPEFAFYG  253 (392)
T ss_dssp             EEECSCCCGGGEEECSSC-EEECCCTTCEEE
T ss_pred             ceeccCCcCCceeEcCCc-eEEechhhcccC
Confidence            589999999999999665 899999886543

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=93.06  E-value=0.11  Score=49.61  Aligned_cols=72  Identities=8%  Similarity=0.081  Sum_probs=41.4

Q ss_pred             CCEEEeceeeccCCceEEEeE-------------EEEEEEeecCCCCchHHHHHHHHHHHHHhCC-CCceeEEEEEEEeC
Q 012887          190 DNLEFIDQIGPNSFKGVYKGK-------------RVGIEKLKGCDKGNAYEFELRKDLLELMTCG-HKNILQFYCVCVDE  255 (454)
Q Consensus       190 ~~~~~~~~LG~G~fG~Vy~g~-------------~vavK~l~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~~~g~~~~~  255 (454)
                      +++++ +.|+-|---.+|+..             .+-+ ++... ...  .....+|..++..+. +.-..++++++.  
T Consensus        43 ~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vll-Ri~g~-~~~--~idr~~E~~i~~~ls~~gl~Pkll~~~~--  115 (395)
T d1nw1a_          43 EHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLL-RVYFN-PET--ESHLVAESVIFTLLSERHLGPKLYGIFS--  115 (395)
T ss_dssp             GGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEE-EEECS-CCC--HHHHHHHHHHHHHHHHTTSSSCEEEEET--
T ss_pred             cceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEE-EecCC-cch--hhHHHHHHHHHHHHHhCCCCCeEEEEcC--
Confidence            45554 567778888888743             2333 33322 222  234567777777653 333346776653  


Q ss_pred             CCeEEEEEeccCCCCH
Q 012887          256 NHGLCVVTKLMEGGSV  271 (454)
Q Consensus       256 ~~~l~lV~E~~~~gsL  271 (454)
                      +   .+||||++|.+|
T Consensus       116 ~---g~I~efi~g~~l  128 (395)
T d1nw1a_         116 G---GRLEEYIPSRPL  128 (395)
T ss_dssp             T---EEEECCCCEEEC
T ss_pred             C---ceEEEEeccccC
Confidence            3   378999987544

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=90.98  E-value=0.031  Score=51.59  Aligned_cols=30  Identities=20%  Similarity=0.121  Sum_probs=26.5

Q ss_pred             cCcccCCccCCcEEEccCCcEEEEccCCcc
Q 012887          303 HGVAYRDLNSQRILLDRHGNVCLGDMGIVT  332 (454)
Q Consensus       303 ~~iiHrDIKp~NILl~~~~~vKL~DFGla~  332 (454)
                      .|+||+|+.+.||+++.+...-|.||+.+.
T Consensus       183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cccccCCcchhhhhcccccceeEecccccc
Confidence            579999999999999988777899999864

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=85.27  E-value=0.44  Score=43.81  Aligned_cols=29  Identities=17%  Similarity=0.056  Sum_probs=23.3

Q ss_pred             cCcccCCccCCcEEEccCCcEEEEccCCccc
Q 012887          303 HGVAYRDLNSQRILLDRHGNVCLGDMGIVTA  333 (454)
Q Consensus       303 ~~iiHrDIKp~NILl~~~~~vKL~DFGla~~  333 (454)
                      .++||+|+.+.|||++. + ..+.||+-+..
T Consensus       192 ~~liHgDlh~~NvL~~~-~-~~~IDFdd~~~  220 (325)
T d1zyla1         192 VLRLHGDCHAGNILWRD-G-PMFVDLDDARN  220 (325)
T ss_dssp             CEECCSSCSGGGEEESS-S-EEECCCTTCCE
T ss_pred             ceeecCCCCcccEEEeC-C-ceEEechhccc
Confidence            36899999999999974 4 45899998654